PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Palty, R; Isacoff, EY				Palty, Raz; Isacoff, Ehud Y.			Cooperative Binding of Stromal Interaction Molecule 1 (STIM1) to the N and C Termini of Calcium Release-activated Calcium Modulator 1 (Orai1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium channel; calcium release-activated calcium channel protein 1 (ORAI1); gating; ion channel; stromal interaction molecule 1 (STIM1)	CRAC CHANNEL ACTIVATION; OPERATED CA2+ ENTRY; PLASMA-MEMBRANE; DOMAIN; PROTEIN; SENSOR; OLIGOMERIZATION; CONFORMATION; DEPLETION; COUPLES	Calcium flux through store-operated calcium entry is a central regulator of intracellular calcium signaling. The two key components of the store-operated calcium release-activated calcium channel are the Ca2+-sensing protein stromal interaction molecule 1 (STIM1) and the channel pore-forming protein Orai1. During store-operated calcium entry activation, calcium depletion from the endoplasmic reticulum triggers a series of conformational changes in STIM1 that unmask a minimal Orai1-activating domain (CRAC activation region (CAD)). To gate Orai1 channels, the exposed STIM1-activating domain binds to two sites in Orai1, one in the N terminus and one in the C terminus. Whether the two sites operate as distinct binding domains or cooperate in CAD binding is unknown. In this study, we show that the N and C-terminal domains of Orai1 synergistically contribute to the interaction with STIM1 and couple STIM1 binding with channel gating and modulation of ion selectivity.	[Palty, Raz; Isacoff, Ehud Y.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Isacoff, Ehud Y.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Isacoff, Ehud Y.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Isacoff, EY (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	ehud@berkeley.edu	Palty, Raz/HCH-3978-2022; isacoff, ehud/AAP-1459-2020	Isacoff, Ehud Y./0000-0003-4775-9359	American Heart Association Postdoctoral Fellowship [13POST14000008]; National Institutes of Health [R01 NS35549]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035549] Funding Source: NIH RePORTER	American Heart Association Postdoctoral Fellowship(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by American Heart Association Postdoctoral Fellowship 13POST14000008 (to R.P.) and National Institutes of Health Grant R01 NS35549 (to E.Y.I.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Covington ED, 2010, MOL BIOL CELL, V21, P1897, DOI 10.1091/mbc.E10-02-0145; Derler I, 2013, J BIOL CHEM, V288, P29025, DOI 10.1074/jbc.M113.501510; Gudlur A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6164; Hoover PJ, 2011, P NATL ACAD SCI USA, V108, P13299, DOI 10.1073/pnas.1101664108; Li ZZ, 2011, CELL RES, V21, P305, DOI 10.1038/cr.2010.131; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lioudyno MI, 2008, P NATL ACAD SCI USA, V105, P2011, DOI 10.1073/pnas.0706122105; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; McNally BA, 2013, J PHYSIOL-LONDON, V591, P2833, DOI 10.1113/jphysiol.2012.250456; McNally BA, 2012, NATURE, V482, P241, DOI 10.1038/nature10752; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Muik M, 2011, EMBO J, V30, P1678, DOI 10.1038/emboj.2011.79; Mullins FM, 2009, P NATL ACAD SCI USA, V106, P15495, DOI 10.1073/pnas.0906781106; Navarro-Borelly L, 2008, J PHYSIOL-LONDON, V586, P5383, DOI 10.1113/jphysiol.2008.162503; Palty R, 2015, CELL RES, V25, P963, DOI 10.1038/cr.2015.80; Palty R, 2012, CELL, V149, P425, DOI 10.1016/j.cell.2012.01.055; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Sharma S, 2013, NATURE, V499, P238, DOI 10.1038/nature12229; Soboleski MR, 2005, FASEB J, V19, P440, DOI 10.1096/fj.04-3180fje; Srikanth S, 2010, NAT CELL BIOL, V12, P436, DOI 10.1038/ncb2045; Stathopulos PB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3963; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Xu PY, 2006, BIOCHEM BIOPH RES CO, V350, P969, DOI 10.1016/j.bbrc.2006.09.134; Yu F, 2013, J CELL SCI, V126, P2401, DOI 10.1242/jcs.117200; Yu F, 2011, J BIOL CHEM, V286, P8375, DOI 10.1074/jbc.M110.188789; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zheng HY, 2013, J BIOL CHEM, V288, P11263, DOI 10.1074/jbc.M113.450254; Zhou YB, 2013, NAT STRUCT MOL BIOL, V20, P973, DOI 10.1038/nsmb.2625; Zhou YB, 2010, NAT STRUCT MOL BIOL, V17, P112, DOI 10.1038/nsmb.1724	31	33	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					334	341		10.1074/jbc.M115.685289	http://dx.doi.org/10.1074/jbc.M115.685289			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26546674	hybrid, Green Published			2022-12-26	WOS:000367589500026
J	Lin, CL; Fesi, BD; Marquis, M; Bosak, NP; Theodorides, ML; Avigdor, M; McDaniel, AH; Duke, FF; Lysenko, A; Khoshnevisan, A; Gantick, BR; Arayata, CJ; Nelson, TM; Bachmanov, AA; Reed, DR				Lin, Cailu; Fesi, Brad D.; Marquis, Michael; Bosak, Natalia P.; Theodorides, Maria L.; Avigdor, Mauricio; McDaniel, Amanda H.; Duke, Fujiko F.; Lysenko, Anna; Khoshnevisan, Amin; Gantick, Brian R.; Arayata, Charles J.; Nelson, Theodore M.; Bachmanov, Alexander A.; Reed, Danielle R.			Body Composition QTLs Identified in Intercross Populations Are Reproducible in Consomic Mouse Strains	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; GENOME-WIDE SET; GENETIC ARCHITECTURE; POSITIONAL CLONING; CANDIDATE GENES; COMPLEX TRAITS; OBESITY QTLS; C57BL/6J; MICE; ADIPOSITY	Genetic variation contributes to individual differences in obesity, but defining the exact relationships between naturally occurring genotypes and their effects on fatness remains elusive. As a step toward positional cloning of previously identified body composition quantitative trait loci (QTLs) from F-2 crosses of mice from the C57BL/6ByJ and 129P3/J inbred strains, we sought to recapture them on a homogenous genetic background of consomic (chromosome substitution) strains. Male and female mice from reciprocal consomic strains originating from the C57BL/6ByJ and 129P3/J strains were bred and measured for body weight, length, and adiposity. Chromosomes 2, 7, and 9 were selected for substitution because previous F2 intercross studies revealed body composition QTLs on these chromosomes. We considered a QTL confirmed if one or both sexes of one or both reciprocal consomic strains differed significantly from the host strain in the expected direction after correction for multiple testing. Using these criteria, we confirmed two of two QTLs for body weight (Bwq5-6), three of three QTLs for body length (Bdln3-5), and three of three QTLs for adiposity (Adip20, Adip26 and Adip27). Overall, this study shows that despite the biological complexity of body size and composition, most QTLs for these traits are preserved when transferred to consomic strains; in addition, studying reciprocal consomic strains of both sexes is useful in assessing the robustness of a particular QTL.	[Lin, Cailu; Fesi, Brad D.; Marquis, Michael; Bosak, Natalia P.; Theodorides, Maria L.; Avigdor, Mauricio; McDaniel, Amanda H.; Duke, Fujiko F.; Lysenko, Anna; Khoshnevisan, Amin; Gantick, Brian R.; Arayata, Charles J.; Nelson, Theodore M.; Bachmanov, Alexander A.; Reed, Danielle R.] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA	Monell Chemical Senses Center	Reed, DR (corresponding author), Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA.	reed@monell.org	Bachmanov, Alexander A./AAH-8857-2020; Lin, Cailu/E-5316-2011	Bachmanov, Alexander A./0000-0002-2861-3322; Lin, Cailu/0000-0001-8909-7758	National Institutes of Health [DK094759, DK058797, AA011028, DC000882]; Monell Institutional Funds; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094759, R01DK058797] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000882] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Monell Institutional Funds; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Funding: These studies were funded by the National Institutes of Health, DK094759, DK058797, AA011028, DC000882 and Monell Institutional Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Bachmanov AA, 2001, PHYSIOL BEHAV, V72, P603, DOI 10.1016/S0031-9384(01)00412-7; Bachmanov AA, 2001, CHEM SENSES, V26, P925, DOI 10.1093/chemse/26.7.925; Bogue MA, 2004, GENETICA, V122, P71, DOI 10.1007/s10709-004-1438-4; Brockmann GA, 2000, GENOME RES, V10, P1941, DOI 10.1101/gr.GR1499R; Buchner DA, 2008, PHYSIOL GENOMICS, V35, P116, DOI 10.1152/physiolgenomics.00033.2008; Casellas J, 2009, MAMM GENOME, V20, P269, DOI 10.1007/s00335-009-9182-9; Cheverud JM, 2001, MAMM GENOME, V12, P3, DOI 10.1007/s003350010218; Collins FS, 2014, NATURE, V505, P612, DOI 10.1038/505612a; Crabbe JC, 1999, SCIENCE, V284, P1670, DOI 10.1126/science.284.5420.1670; Davis RC, 2005, GENOMICS, V86, P259, DOI 10.1016/j.ygeno.2005.05.010; Davis RC, 2007, GENOMICS, V90, P306, DOI 10.1016/j.ygeno.2007.05.009; Eppig JT, 2005, NUCLEIC ACIDS RES, V33, pD471, DOI 10.1093/nar/gki113; Farber CR, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2146-7-102; Fawcett GL, 2008, OBESITY, V16, P1861, DOI 10.1038/oby.2008.300; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; GODFREY P, 1993, NAT GENET, V4, P227, DOI 10.1038/ng0793-227; Gregorova S, 2008, GENOME RES, V18, P509, DOI 10.1101/gr.7160508; Gularte-Merida R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-014-1191-8; Ishikawa A, 2007, MAMM GENOME, V18, P229, DOI 10.1007/s00335-007-9009-5; Ishimori N, 2006, J BONE MINER RES, V21, P105, DOI 10.1359/JBMR.050902; Ishimori N, 2004, J LIPID RES, V45, P1624, DOI 10.1194/jlr.M400098-JLR200; Jerez-Timaure NC, 2005, PHYSIOL GENOMICS, V21, P411, DOI 10.1152/physiolgenomics.00256.2004; Lin CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068776; Markel P, 1997, NAT GENET, V17, P280, DOI 10.1038/ng1197-280; McDaniel AH, 2006, MAMM GENOME, V17, P1078, DOI 10.1007/s00335-006-0055-1; Mollah MBR, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-84; Nadeau JH, 2000, NAT GENET, V24, P221, DOI 10.1038/73427; Reed DR, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-4; Reed DR, 2008, OBESITY, V16, P483, DOI 10.1038/oby.2007.26; Reed DR, 2007, PHYSIOL BEHAV, V91, P593, DOI 10.1016/j.physbeh.2007.03.026; Reed DR, 2006, MAMM GENOME, V17, P1065, DOI 10.1007/s00335-006-0054-2; Reed DR, 2011, PHYSIOL BEHAV, V103, P523, DOI 10.1016/j.physbeh.2011.04.006; Reed DR, 2003, MAMM GENOME, V14, P302, DOI 10.1007/s00335-002-2170-y; Shao HF, 2010, MAMM GENOME, V21, P276, DOI 10.1007/s00335-010-9267-5; Shao HF, 2008, P NATL ACAD SCI USA, V105, P19910, DOI 10.1073/pnas.0810388105; Silver Lee M., 1995; Singer JB, 2004, SCIENCE, V304, P445, DOI 10.1126/science.1093139; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; SNELL GD, 1948, J GENET, V49, P87, DOI 10.1007/BF02986826; Su Z, 2008, INT J OBESITY, V32, P1180, DOI 10.1038/ijo.2008.56; Su ZG, 2009, J LIPID RES, V50, P116, DOI 10.1194/jlr.M800411-JLR200; Takada T, 2008, GENOME RES, V18, P500, DOI 10.1101/gr.7175308; Taylor BA, 1999, MAMM GENOME, V10, P963, DOI 10.1007/s003359901141; Taylor BA, 1997, GENOMICS, V43, P249, DOI 10.1006/geno.1997.4835; Ussar S, 2015, CELL METAB, V22, P516, DOI 10.1016/j.cmet.2015.07.007; Wakeland E, 1997, IMMUNOL TODAY, V18, P472, DOI 10.1016/S0167-5699(97)01126-2; White JK, 2013, CELL, V154, P452, DOI 10.1016/j.cell.2013.06.022; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	49	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2015	10	11							e0141494	10.1371/journal.pone.0141494	http://dx.doi.org/10.1371/journal.pone.0141494			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7AC	26551037	Green Published, gold, Green Submitted			2022-12-26	WOS:000364422800005
J	Benavente, JN; Seeb, LW; Seeb, JE; Arismendi, I; Hernandez, CE; Gajardo, G; Galleguillos, R; Cadiz, MI; Musleh, SS; Gomez-Uchida, D				Benavente, Javiera N.; Seeb, Lisa W.; Seeb, James E.; Arismendi, Ivan; Hernandez, Cristian E.; Gajardo, Gonzalo; Galleguillos, Ricardo; Cadiz, Maria I.; Musleh, Selim S.; Gomez-Uchida, Daniel			Temporal Genetic Variance and Propagule-Driven Genetic Structure Characterize Naturalized Rainbow Trout (Oncorhynchus mykiss) from a Patagonian Lake Impacted by Trout Farming	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; SOUTHERN CHILE; LINKAGE DISEQUILIBRIUM; INVASIVE SALMONIDS; SOCKEYE-SALMON; NATIVE FISHES; DIVERSITY; PATTERNS; STABILITY; EVOLUTION	Knowledge about the genetic underpinnings of invasions-a theme addressed by invasion genetics as a discipline-is still scarce amid well documented ecological impacts of non-native species on ecosystems of Patagonia in South America. One of the most invasive species in Patagonia's freshwater systems and elsewhere is rainbow trout (Oncorhynchus mykiss). This species was introduced to Chile during the early twentieth century for stocking and promoting recreational fishing; during the late twentieth century was reintroduced for farming purposes and is now naturalized. We used population-and individual-based inference from single nucleotide polymorphisms (SNPs) to illuminate three objectives related to the establishment and naturalization of Rainbow Trout in Lake Llanquihue. This lake has been intensively used for trout farming during the last three decades. Our results emanate from samples collected from five inlet streams over two seasons, winter and spring. First, we found that significant intra- population (temporal) genetic variance was greater than inter-population (spatial) genetic variance, downplaying the importance of spatial divergence during the process of naturalization. Allele frequency differences between cohorts, consistent with variation in fish length between spring and winter collections, might explain temporal genetic differences. Second, individual-based Bayesian clustering suggested that genetic structure within Lake Llanquihue was largely driven by putative farm propagules found at one single stream during spring, but not in winter. This suggests that farm brood-stock might migrate upstream to breed during spring at that particular stream. It is unclear whether interbreeding has occurred between "pure" naturalized and farm trout in this and other streams. Third, estimates of the annual number of breeders (N-b) were below 73 in half of the collections, suggestive of genetically small and recently founded populations that might experience substantial genetic drift. Our results reinforce the notion that naturalized trout originated recently from a small yet genetically diverse source and that farm propagules might have played a significant role in the invasion of Rainbow Trout within a single lake with intensive trout farming. Our results also argue for proficient mitigation measures that include management of escapes and strategies to minimize unintentional releases from farm facilities.	[Benavente, Javiera N.; Hernandez, Cristian E.; Cadiz, Maria I.; Musleh, Selim S.; Gomez-Uchida, Daniel] Univ Concepcion, Dept Zool, Concepcion, Chile; [Seeb, Lisa W.; Seeb, James E.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Arismendi, Ivan] Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA; [Gajardo, Gonzalo] Univ Los Lagos, Lab Genet Acuicultura & Biodiversidad, Osorno, Chile; [Galleguillos, Ricardo; Musleh, Selim S.] Univ Concepcion, Dept Oceanog, Concepcion, Chile; [Cadiz, Maria I.; Gomez-Uchida, Daniel] Univ Concepcion, Interdisciplinary Ctr Aquaculture Res INCAR, Concepcion, Chile	Universidad de Concepcion; University of Washington; University of Washington Seattle; Oregon State University; Universidad de Los Lagos; Universidad de Concepcion; Universidad de Concepcion	Gomez-Uchida, D (corresponding author), Univ Concepcion, Dept Zool, Casilla 160-C, Concepcion, Chile.	dgomezu@udec.cl	G., Gonzalo Gajardo/H-6104-2019; Hernández, Cristián E./GLS-1111-2022; Arismendi, Ivan/B-3144-2010; Gajardo, Gonzalo/AAN-3507-2020; Seeb, Lisa W/GSN-3076-2022; Gomez-Uchida, Daniel/AAB-7043-2019; Hernández, Cristián E./AAS-1286-2020	Hernández, Cristián E./0000-0002-9811-2881; Arismendi, Ivan/0000-0002-8774-9350; Gajardo, Gonzalo/0000-0001-8634-141X; Gomez-Uchida, Daniel/0000-0002-5150-2030; Hernández, Cristián E./0000-0002-9811-2881; Benavente, Javiera/0000-0001-7045-1171	Fondo de Desarrollo Cientifico y Tecnologico, FONDECYT [1130807]; Fondo de Desarrollo de Areas Prioritarias, FONDAP [15110027]; Direccion de Investigacion Universidad de Concepcion, DIUC [212.113.082-1.0]	Fondo de Desarrollo Cientifico y Tecnologico, FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Fondo de Desarrollo de Areas Prioritarias, FONDAP(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP); Direccion de Investigacion Universidad de Concepcion, DIUC	This work was supported by the Fondo de Desarrollo Cientifico y Tecnologico, FONDECYT 1130807, Fondo de Desarrollo de Areas Prioritarias, FONDAP 15110027, and Direccion de Investigacion Universidad de Concepcion, DIUC 212.113.082-1.0.	Allendorf FW, 2003, CONSERV BIOL, V17, P24, DOI 10.1046/j.1523-1739.2003.02365.x; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 2015, BBC NEWS; Arismendi I, 2014, REV FISH BIOL FISHER, V24, P919, DOI 10.1007/s11160-014-9351-0; Arismendi I, 2011, ANN LIMNOL-INT J LIM, V47, P133, DOI 10.1051/limn/2011012; Arismendi I, 2009, FRESHWATER BIOL, V54, P1135, DOI 10.1111/j.1365-2427.2008.02157.x; Barrett SCH, 2015, MOL ECOL, V24, P1927, DOI 10.1111/mec.13014; Basulto S., 2003, LARGO VIAJE SALMONES; Becker LA, 2007, CONSERV BIOL, V21, P1347, DOI 10.1111/j.1523-1739.2007.00761.x; Berthelot C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4657; Blankenship SM, 2009, T AM FISH SOC, V138, P1052, DOI 10.1577/T08-165.1; Buschmann AH, 2009, OCEAN COAST MANAGE, V52, P243, DOI 10.1016/j.ocecoaman.2009.03.002; Campos H, 1988, ARCH HYDROBIOL S, V81, P37; Consuegra S, 2011, EVOL APPL, V4, P660, DOI 10.1111/j.1752-4571.2011.00189.x; Correa C, 2012, ECOL APPL, V22, P828, DOI 10.1890/11-1174.1; De Leaniz CG, 2010, SYST BIODIVERS, V8, P447, DOI 10.1080/14772000.2010.537706; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Falush D, 2003, GENETICS, V164, P1567; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Frankham R, 2010, BIOL CONSERV, V143, P1919, DOI 10.1016/j.biocon.2010.05.011; Fraser EJ, 2013, BIOL CONSERV, V167, P35, DOI 10.1016/j.biocon.2013.07.011; Garcia Alvarado M., 2008, BASES TECNICAS PARAE; Garcia-Berthou E, 2007, J FISH BIOL, V71, P33, DOI 10.1111/j.1095-8649.2007.01668.x; Glover KA, 2010, AQUACULT ENV INTERAC, V1, P1, DOI 10.3354/aei00002; Gomez-Uchida D, 2012, CAN J FISH AQUAT SCI, V69, P916, DOI 10.1139/F2012-029; Gomez-Uchida D, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-48; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Habit E, 2012, DIVERS DISTRIB, V18, P1153, DOI 10.1111/j.1472-4642.2012.00906.x; Habit E, 2010, GLOBAL ECOL BIOGEOGR, V19, P697, DOI 10.1111/j.1466-8238.2010.00541.x; Hanfling B, 2007, J FISH BIOL, V71, P115, DOI 10.1111/j.1095-8649.2007.01685.x; Hansen MM, 2002, MOL ECOL, V11, P2523, DOI 10.1046/j.1365-294X.2002.01634.x; Heath DD, 2002, MOL ECOL, V11, P197, DOI 10.1046/j.1365-294X.2002.01434.x; Helyar SJ, 2011, MOL ECOL RESOUR, V11, P123, DOI 10.1111/j.1755-0998.2010.02943.x; Hendry AP, 2000, SCIENCE, V290, P516, DOI 10.1126/science.290.5491.516; Hendry AP, 2003, EVOLUTION ILLUMINATED: SALMON AND THEIR RELATIVES, P52; Herborg LM, 2007, MOL ECOL, V16, P231, DOI 10.1111/j.1365-294X.2006.03133.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jones MH, 2015, T AM FISH SOC, V144, P977, DOI 10.1080/00028487.2015.1057346; Keller SR, 2010, J EVOLUTION BIOL, V23, P1720, DOI 10.1111/j.1420-9101.2010.02037.x; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; LEBERG PL, 1992, EVOLUTION, V46, P477, DOI 10.1111/j.1558-5646.1992.tb02053.x; Leon-Munoz J, 2007, SALMON FARMING LAKES; Limborg MT, 2012, ECOL EVOL, V2, P1, DOI 10.1002/ece3.59; Lowe S., 2000, ENCY BIOL INVASIONS; Luikart G, 1998, CONSERV BIOL, V12, P228, DOI 10.1046/j.1523-1739.1998.96388.x; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Marchetti MP, 2004, FRESHWATER BIOL, V49, P646, DOI 10.1111/j.1365-2427.2004.01202.x; McGlauflin MT, 2010, T AM FISH SOC, V139, P676, DOI 10.1577/T09-103.1; Monzon-Arguello C, 2014, IMMUNOGENETICS, V66, P393, DOI 10.1007/s00251-014-0771-8; Monzon-Arguello C, 2014, EVOL APPL, V7, P921, DOI 10.1111/eva.12188; Monzon-Arguello C, 2013, ECOL EVOL, V3, P3359, DOI 10.1002/ece3.701; Ostberg CO, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-570; Ozerov MY, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-88; Palstra FP, 2012, ECOL EVOL, V2, P2357, DOI 10.1002/ece3.329; Palstra FP, 2010, CAN J FISH AQUAT SCI, V67, P225, DOI 10.1139/F09-176; Pascual MA, 2007, AQUAT ECOSYST HEALTH, V10, P212, DOI 10.1080/14634980701351361; Pascual MA, 2009, FRONT ECOL ENVIRON, V7, P533, DOI 10.1890/070127; Perez C, 2014, SKRETTING PARTICIPA; Praebel K, 2013, ECOL EVOL, V3, P1400, DOI 10.1002/ece3.552; Pritchard JK, 2000, GENETICS, V155, P945; Pysek P, 2010, ANNU REV ENV RESOUR, V35, P25, DOI 10.1146/annurev-environ-033009-095548; Quinn T. P, 2018, BEHAV ECOLOGY PACIFI; Rossi CMR, 2012, GENETICA, V140, P439, DOI 10.1007/s10709-012-9692-3; Rollins LA, 2013, ECOL EVOL, V3, P4501, DOI 10.1002/ece3.824; Roman J, 2007, TRENDS ECOL EVOL, V22, P454, DOI 10.1016/j.tree.2007.07.002; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Ryman N, 2006, MOL ECOL NOTES, V6, P285, DOI 10.1111/j.1471-8286.2005.01146.x; Schroder V, 2011, BIOL INVASIONS, V13, P203, DOI 10.1007/s10530-010-9802-z; Seeb JE, 2009, SNP GENOTYPING 5 NUC; Seeb LW, 2000, T AM FISH SOC, V129, P1223, DOI 10.1577/1548-8659(2000)129&lt;1223:GDOSSO&gt;2.0.CO;2; Sepulveda M, 2013, AQUACULT ENV INTERAC, V4, P273, DOI 10.3354/aei00089; Simberloff D, 2009, ANNU REV ECOL EVOL S, V40, P81, DOI 10.1146/annurev.ecolsys.110308.120304; Smith MJ, 2011, MOL ECOL RESOUR, V11, P268, DOI 10.1111/j.1755-0998.2010.02965.x; Soto D, 2006, REV CHIL HIST NAT, V79, P97; Soto D, 2001, ECOL APPL, V11, P1750, DOI 10.2307/3061093; Thorstad EB., 2008, NINA SPECIAL REP, V36; Vargas PV, 2010, REV BIOL MAR OCEANOG, V45, P285; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Waples RS, 2007, GENETICS, V175, P219, DOI 10.1534/genetics.106.065300; Waples RS, 2011, GENETICS, V189, P633, DOI 10.1534/genetics.111.132233; Waples RS, 2010, EVOL APPL, V3, P244, DOI 10.1111/j.1752-4571.2009.00104.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Whitlock MC, 1999, HEREDITY, V82, P117, DOI 10.1038/sj.hdy.6884960	86	3	4	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142040	10.1371/journal.pone.0142040	http://dx.doi.org/10.1371/journal.pone.0142040			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544983	Green Submitted, gold, Green Published			2022-12-26	WOS:000364398700074
J	Martinez-Garcia, C; Izquierdo-Lahuerta, A; Vivas, Y; Velasco, I; Yeo, TK; Chen, S; Medina-Gomez, G				Martinez-Garcia, Cristina; Izquierdo-Lahuerta, Adriana; Vivas, Yurena; Velasco, Ismael; Yeo, Tet-Kin; Chen, Sheldon; Medina-Gomez, Gema			Renal Lipotoxicity-Associated Inflammation and Insulin Resistance Affects Actin Cytoskeleton Organization in Podocytes	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; TGF-BETA; FILAMENT ORGANIZATION; FOOT PROCESSES; ER-STRESS; CELLS; PROTEIN; INJURY; SENSITIVITY; INHIBITION	In the last few decades a change in lifestyle has led to an alarming increase in the prevalence of obesity and obesity-associated complications. Obese patients are at increased risk of developing hypertension, heart disease, insulin resistance (IR), dyslipidemia, type 2 diabetes and renal disease. The excess calories are stored as triglycerides in adipose tissue, but also may accumulate ectopically in other organs, including the kidney, which contributes to the damage through a toxic process named lipotoxicity. Recently, the evidence suggests that renal lipid accumulation leads to glomerular damage and, more specifically, produces dysfunction in podocytes, key cells that compose and maintain the glomerular filtration barrier. Our aim was to analyze the early mechanisms underlying the development of renal disease associated with the process of lipotoxicity in podocytes. Our results show that treatment of podocytes with palmitic acid produced intracellular accumulation of lipid droplets and abnormal glucose and lipid metabolism. This was accompanied by the development of inflammation, oxidative stress and endoplasmic reticulum stress and insulin resistance. We found specific rearrangements of the actin cytoskeleton and slit diaphragm proteins (Nephrin, P-Cadherin, Vimentin) associated with this insulin resistance in palmitic-treated podocytes. We conclude that lipotoxicity accelerates glomerular disease through lipid accumulation and inflammation. Moreover, saturated fatty acids specifically promote insulin resistance by disturbing the cytoarchitecture of podocytes. These data suggest that renal lipid metabolism and cytoskeleton rearrangements may serve as a target for specific therapies aimed at slowing the progression of podocyte failure during metabolic syndrome.	[Martinez-Garcia, Cristina; Izquierdo-Lahuerta, Adriana; Vivas, Yurena; Velasco, Ismael; Medina-Gomez, Gema] Univ Rey Juan Carlos, Dept Ciencias Basicas Salud, Area Bioquim & Genet Mol, Madrid, Spain; [Yeo, Tet-Kin; Chen, Sheldon] Northwestern Univ, Div Nephrol Hypertens, Chicago, IL 60611 USA	Universidad Rey Juan Carlos; Northwestern University	Medina-Gomez, G (corresponding author), Univ Rey Juan Carlos, Dept Ciencias Basicas Salud, Area Bioquim & Genet Mol, Avda Atenas S-N, Madrid, Spain.	gema.medina@urjc.es	Medina-Gomez, Gema/CAI-1063-2022; Medina-Gomez, Gema/F-5667-2016; Medina-Gomez, Gema/CAF-4668-2022	Medina-Gomez, Gema/0000-0001-8169-681X; Medina-Gomez, Gema/0000-0001-8169-681X; Medina-Gomez, Gema/0000-0001-8169-681X; Vivas-Garcia, Yurena/0000-0002-0230-4521; Chen, Sheldon/0000-0002-5427-4969	Programa de Ramon y Cajal, Ministerio de Ciencia e Innovacion [RYC-2008-02068]; Ministerio de economia y competitividad [BFU2012- 33594, BFU2013-47384-R]; Comunidad de Madrid [S2010/BMD-2423]; Ayudas a la Movilidad, Universidad Rey Juan Carlos	Programa de Ramon y Cajal, Ministerio de Ciencia e Innovacion; Ministerio de economia y competitividad(Spanish Government); Comunidad de Madrid(Comunidad de Madrid); Ayudas a la Movilidad, Universidad Rey Juan Carlos	This work was supported by RYC-2008-02068, Programa de Ramon y Cajal, Ministerio de Ciencia e Innovacion, http://www.idi.mineco.gob.es/portal/site/MICINN/, GMG; BFU2012- 33594, Ministerio de economia y competitividad, http://www.mineco.gob.es/portal/site/mineco/idi, GMG; BFU2013-47384-R, Ministerio de economia y competitividad, http://www.mineco.gob.es/portal/site/mineco/idi, GMG; S2010/BMD-2423, Comunidad de Madrid, http://www.madrid.org/cs/Satellite? pagename=ComunidadMadrid/Home, GMG; Ayudas a la Movilidad 2012, Universidad Rey Juan Carlos, http://www.urjc.es, CMG.	Ariyama H, 2010, J BIOL CHEM, V285, P22027, DOI 10.1074/jbc.M110.126870; Bijian K, 2005, AM J PHYSL RENAL PHY; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braissant O, 1998, ENDOCRINOLOGY, V139, P2748, DOI 10.1210/en.139.6.2748; Brown EJ, 2010, NAT GENET, V42, P72, DOI 10.1038/ng.505; Carobbio S, 2011, CURR OPIN CLIN NUTR, V14, P520, DOI 10.1097/MCO.0b013e32834ad966; Chavez-Tapia NC, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-20; Chuang PY, 2009, NEPHRON PHYSIOL, V111, P9, DOI 10.1159/000191075; Coward RJM, 2005, J AM SOC NEPHROL, V16, P629, DOI 10.1681/ASN.2004030172; Coward RJM, 2005, DIABETES; Crean JKG, 2002, J BIOL CHEM, V277, P44187, DOI 10.1074/jbc.M203715200; Fornoni A, 2014, FRONTIERS ENDOCRINOL, DOI [10.3339/fendo.2014.00127, DOI 10.3339/FENDO.2014.00127]; Fornoni A, 2014, NAT REV NEPHROL, V10, P379, DOI 10.1038/nrneph.2014.87; Frieden C, 1986, ACTIN POLYM, P15974; Gao D, 2010, J BIOL CHEM, V285, P29965, DOI 10.1074/jbc.M110.128694; Gao ZG, 2004, MOL ENDOCRINOL, V18, P2024, DOI 10.1210/me.2003-0383; Gonzalez-rodriguez A, 2013, NIH PUBLIC ACCESS, V11, P284, DOI [10.1111/j.1474-9726.2011.00786.x.ESSENTIAL, DOI 10.1111/J.1474-9726.2011.00786.X.ESSENTIAL]; Ha TS, 2015, DIABETES-METAB RES, V31, P50, DOI 10.1002/dmrr.2562; Haffner SM, 2006, AM J MED, V119, p3S, DOI 10.1016/j.amjmed.2006.01.008; Hagen RM, 2010, FEBS LETT, V584, P2689, DOI 10.1016/j.febslet.2010.04.004; Hale LJ, 2013, AM J PHYSIOL-RENAL, V305, pF182, DOI 10.1152/ajprenal.00548.2012; Hivert MF, 2008, J CLIN ENDOCR METAB, V93, P3165, DOI 10.1210/jc.2008-0425; Ichimura K, 2003, J HISTOCHEM CYTOCHEM, V51, P1589, DOI 10.1177/002215540305101203; Ichimura K, 2007, CELL TISSUE RES, V329, P541, DOI 10.1007/s00441-007-0440-4; Ijaz A, 2009, KIDNEY INT, V75, P381, DOI 10.1038/ki.2008.559; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; Jimenez-Altayo F, 2006, J PHARMACOL EXP THER, V316, P42, DOI 10.1124/jpet.105.088435; Joles JA, 2000, J AM SOC NEPHROL, V11, P669, DOI 10.1681/ASN.V114669; Kamata H, 2005, ARCH BIOCHEM BIOPHYS, V434, P16, DOI 10.1016/j.abb.2004.07.036; KEANE WF, 1994, KIDNEY INT, V46, P910, DOI 10.1038/ki.1994.349; Kume S, 2007, J AM SOC NEPHROL, V18, P2715, DOI 10.1681/ASN.2007010089; Kwoh C, 2006, ANNU REV PATHOL-MECH, V1, P349, DOI 10.1146/annurev.pathol.1.110304.100119; Lavin PJ, 2008, CURR OPIN NEPHROL HY, V17, P386, DOI 10.1097/MNH.0b013e32830464f4; Lee EY, 2009, AM J PHYSIOL-RENAL, V297, pF85, DOI 10.1152/ajprenal.90642.2008; Lee HS, 1999, AM J PHYSIOL-RENAL, V277, pF369, DOI 10.1152/ajprenal.1999.277.3.F369; Lennon R, 2009, NEPHROL DIAL TRANSPL; Li XJ, 2014, INT J MOL SCI, V15, P6657, DOI 10.3390/ijms15046657; Macconi D, 2006, AM J PATHOL, V168, P1073, DOI 10.2353/ajpath.2006.050701; MACHUCA E, 2009, HUM MOL GENET, V18, P185; Madhusudhan T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7496; Martinez-Garcia C, 2012, DIS MODELS MECH; Moorhead JF, 2015, LANCET ELSEVIER, V320, P1309, DOI DOI 10.1016/S0140-6736(82)91513-6; Morino K, 2014, MUSCLE SPECIFIC IRS, V57, DOI [10.2337/db06-0454.K.M, DOI 10.2337/DB06-0454.K.M]; Muller-Krebs S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080340; Mundel P, 2002, J AM SOC NEPHROL, V13, P3005, DOI 10.1097/01.ASN.0000039661.06947.FD; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Nam BY, 2012, APOPTOSIS, V17, P1, DOI 10.1007/s10495-011-0661-6; Nemeth ZH, 2004, J CELL PHYSIOL, V200, P71, DOI 10.1002/jcp.10477; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Rotter V, 2003, J BIOL CHEM, V278, P45777, DOI 10.1074/jbc.M301977200; Ruan XZ, 2004, BIOCHEM SOC T, V32, P88, DOI 10.1042/BST0320088; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Schmitz-Peiffer C, 1999, J BIOL CHEM, V274, P24202, DOI 10.1074/jbc.274.34.24202; Senn JJ, 2006, J BIOL CHEM, V281, P26865, DOI 10.1074/jbc.M513304200; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; THOMAS ME, 1993, KIDNEY INT, V44, P1124, DOI 10.1038/ki.1993.358; Thomas ME, 2002, AM J PHYSIOL-RENAL, V283, pF640, DOI 10.1152/ajprenal.00001.2002; THOMAS ME, 1995, AM J PHYSIOL-RENAL, V268, pF1177, DOI 10.1152/ajprenal.1995.268.6.F1177; Thorn K, 2010, J CELL BIOCHEM, V111, P497, DOI 10.1002/jcb.22734; Valverde Angela M., 2011, Archives of Physiology and Biochemistry, V117, P105, DOI 10.3109/13813455.2011.557386; Vivas Y, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-86; Welsh GI, 2012, NAT REV NEPHROL, V8, P14, DOI 10.1038/nrneph.2011.151; Welsh GI, 2010, CELL METAB, V12, P329, DOI 10.1016/j.cmet.2010.08.015; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Xaus J, 2001, BLOOD, V98, P2124, DOI 10.1182/blood.V98.7.2124; Ziyadeh FN, 2004, J AM SOC NEPHROL, V15, pS55, DOI 10.1097/01.ASN.0000093460.24823.5B	67	55	56	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142291	10.1371/journal.pone.0142291	http://dx.doi.org/10.1371/journal.pone.0142291			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545114	gold, Green Published, Green Submitted			2022-12-26	WOS:000364398700107
J	Prill, K; Reid, PW; Wohlgemuth, SL; Pilgrim, DB				Prill, Kendal; Reid, Pamela Windsor; Wohlgemuth, Serene L.; Pilgrim, David B.			Still Heart Encodes a Structural HMT, SMYD1b, with Chaperone-Like Function during Fast Muscle Sarcomere Assembly	PLOS ONE			English	Article							MYOFIBRIL ORGANIZATION; SKELETAL-MUSCLES; ZEBRAFISH; UNC-45; HSP90A; METHYLTRANSFERASE; MUTATIONS; INTERACTS; COMPONENT; PROTEINS	The vertebrate sarcomere is a complex and highly organized contractile structure whose assembly and function requires the coordination of hundreds of proteins. Proteins require proper folding and inco rporation into the sarcomere by assembly factors, and they must also be maintained and replaced due to the constant physical stress of muscle contraction. Zebrafish mutants affecting muscle assembly and maintenance have proven to be an ideal tool for identification and analysis of factors necessary for these processes. The still heart mutant was identified due to motility defects and a nonfunctional heart. The cognate gene for the mutant was shown to be smyd1b and the still heart mutation results in an early nonsense codon. SMYD1 mutants show a lack of heart looping and chamber definition due to a lack of expression of heart morphogenesis factors gata4, gata5 and hand2. On a cellular level, fast muscle fibers in homozygous mutants do not form mature sarcomeres due to the lack of fast muscle myosin incorporation by SMYD1b when sarcomeres are first being assembled (19hpf), supporting SMYD1b as an assembly protein during sarcomere formation.	[Prill, Kendal; Reid, Pamela Windsor; Wohlgemuth, Serene L.; Pilgrim, David B.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Alberta	Pilgrim, DB (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	dpilgrim@ualberta.ca		Wohlgemuth, Serene/0000-0001-7287-0935	Canadian Institutes of health Research [126606]; Natural Sciences and Engineering Research Council [105466]	Canadian Institutes of health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Canadian Institutes of health Research, www.cihr.ca, #126606; and the Natural Sciences and Engineering Research Council, www.nserc-crsng.gc.ca, #105466. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao WY, 2000, J CELL BIOL, V148, P375, DOI 10.1083/jcb.148.2.375; Bernick EP, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-70; Bonnemann CG, 2004, CURR OPIN NEUROL, V17, P529; Brown MA, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-26; Bryson-Richardson R, 2005, DEV DYNAM, V233, P1018, DOI 10.1002/dvdy.20380; Clark KA, 2002, ANNU REV CELL DEV BI, V18, P637, DOI 10.1146/annurev.cellbio.18.012502.105840; Codina M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008416; Donlin LT, 2012, GENE DEV, V26, P114, DOI 10.1101/gad.177758.111; Du SJ, 2008, P NATL ACAD SCI USA, V105, P554, DOI 10.1073/pnas.0707330105; Etard C, 2008, J CELL BIOL, V180, P1163, DOI 10.1083/jcb.200709128; Etard C, 2007, DEV BIOL, V308, P133, DOI 10.1016/j.ydbio.2007.05.014; Ferrante MI, 2011, J CELL SCI, V124, P565, DOI 10.1242/jcs.071274; Frumkin A, 2014, FRONT MOL BIOSCI, V1; Geach TJ, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-75; Gongal PA, 2008, HUM MOL GENET, V17, P525, DOI 10.1093/hmg/ddm328; Gottlieb PD, 2002, NAT GENET, V31, P25, DOI 10.1038/ng866; Granato M, 1996, DEVELOPMENT, V123, P399; Hawkins TA, 2008, DEVELOPMENT, V135, P1147, DOI 10.1242/dev.018150; Johnson SL, 1999, METHOD CELL BIOL, V60, P357; Just S, 2011, J CELL SCI, V124, P3127, DOI 10.1242/jcs.084772; Li H, 2011, ZOOKEYS, P1, DOI 10.3897/zookeys.96.1495; Li HQ, 2013, MOL BIOL CELL, V24, P3511, DOI 10.1091/mbc.E13-06-0352; Maves L, 2007, DEVELOPMENT, V134, P3371, DOI 10.1242/dev.003905; Melkani GC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022579; Melkani GC, 2010, BIOCHEM BIOPH RES CO, V396, P317, DOI 10.1016/j.bbrc.2010.04.090; Myhre J, 2014, DEV BIOL; Myhre JL, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/712315; Phan D, 2005, DEVELOPMENT, V132, P2669, DOI 10.1242/dev.01849; POSTLETHWAIT JH, 1994, SCIENCE, V264, P699, DOI 10.1126/science.8171321; Price MG, 2002, J CELL SCI, V115, P4013, DOI 10.1242/jcs.00108; Rottbauer W, 2006, CIRC RES, V99, P323, DOI 10.1161/01.RES.0000234807.16034.fe; Sato Y, 2010, J BIOL CHEM, V285, P7111, DOI 10.1074/jbc.M109.052977; Sparrow JC, 2009, NAT REV MOL CELL BIO, V10, P293, DOI 10.1038/nrm2634; Stainier DYR, 1996, DEVELOPMENT, V123, P285; STREISINGER G, 1981, NATURE, V291, P293, DOI 10.1038/291293a0; Tan XG, 2006, P NATL ACAD SCI USA, V103, P2713, DOI 10.1073/pnas.0509503103; Westerfield M., 2000, THE ZEBRAFISH BOOK A; Wohlgemuth SL, 2007, DEV BIOL, V303, P483, DOI 10.1016/j.ydbio.2006.11.027; Yu Q, 2003, CURR BIOL, V13, pR525, DOI 10.1016/S0960-9822(03)00447-0	39	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142528	10.1371/journal.pone.0142528	http://dx.doi.org/10.1371/journal.pone.0142528			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544721	Green Published, Green Submitted, gold			2022-12-26	WOS:000364398700152
J	Albert, MJ; Haridas, S; Ebenezer, M; Raghupathy, R; Khan, I				Albert, M. John; Haridas, Shilpa; Ebenezer, Mathew; Raghupathy, Raj; Khan, Islam			Immunization with a Double-Mutant (R192G/L211A) of the Heat-Labile Enterotoxin of Escherichia coli Offers Partial Protection against Campylobacter jejuni in an Adult Mouse Intestinal Colonization Model	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; IMMUNOGENICITY; ADJUVANT; ANTIBODIES; IMMUNITY; SAFETY; IDENTIFICATION; INFECTION; RESPONSES; VACCINE	We have previously shown that antibodies to cholera toxin (CT) reacted with the major outer membrane proteins (MOMPs) from Campylobacter jejuni strains on Western blot. Further, oral immunization with CT significantly protected against challenge with C. jejuni in an adult mouse colonization model of infection. CT and the heat-labile enterotoxin (LT) of enterotoxigenic Escherichia coli are structurally and functionally related. LT and its mutants including the double-mutant LT (R192G/L211A) (dmLT), are powerful mucosal adjuvants. Unlike LT which is reactogenic, dmLT has been shown to be safe for human use. In the current study, we determined whether rabbit anti-dmLT antibodies reacted with MOMPs from C. jejuni strains and whether immunization with dmLT would afford protection against C. jejuni. On Western blot, the MOMPs from C. jejuni 48 (Penner serotype O:19), C. jejuni 75 (O: 3) and C. jejuni 111 (O: 1,44) were probed with rabbit antibodies to dmLT or LT-E112K (a non-toxic LT mutant), which showed a lack of reaction. Adult BALB/c mice were orally immunized with dmLT and orally challenged with C. jejuni 48 or 111. Protection from colonization with the challenge bacteria was studied by enumerating Campylobacter colonies in feces daily for 9 days. Vaccination produced robust serum and stool antibody responses to dmLT and no antibody responses to C. jejuni MOMP. Vaccinated mice showed reduced colonization and excretion of both challenge strains compared to control mice. However, the differences were not statistically significant. The protective efficacy of the dmLT vaccine varied from 9.1% to 54.5%. The lack of cross-reaction between the MOMP and dmLT suggests that protection is not mediated by cross-reacting antibodies, but may be due to activation of innate immunity. As dmLT is safe for humans, it could be incorporated into a C. jejuni vaccine to enhance its efficacy.	[Albert, M. John; Haridas, Shilpa; Ebenezer, Mathew; Raghupathy, Raj] Kuwait Univ, Dept Microbiol, Fac Med, Jabriya, Kuwait; [Khan, Islam] Kuwait Univ, Dept Biochem, Fac Med, Jabriya, Kuwait	Kuwait University; Kuwait University	Albert, MJ (corresponding author), Kuwait Univ, Dept Microbiol, Fac Med, Jabriya, Kuwait.	john@hsc.edu.kw			Kuwait University [MI03/13]	Kuwait University	This work was supported by Kuwait University grant no. MI03/13.	Albert MJ, 2008, CLIN VACCINE IMMUNOL, V15, P859, DOI 10.1128/CVI.00471-07; Albert MJ, 2007, INFECT IMMUN, V75, P3070, DOI 10.1128/IAI.00139-07; Albert MJ, 2013, MBIO, V4, DOI 10.1128/mBio.00246-13; Albert MJ, 2009, MICROB DRUG RESIST, V15, P115, DOI 10.1089/mdr.2009.0892; ALBERT MJ, 2014, AUSTIN CLIN IMMUNOL, V1, P1013; BAQAR S, 1995, VACCINE, V13, P22, DOI 10.1016/0264-410X(95)80006-Y; Baqar S, 1996, INFECT IMMUN, V64, P4933, DOI 10.1128/IAI.64.12.4933-4939.1996; BAQAR S, 1993, ANTIMICROB AGENTS CH, V37, P2688, DOI 10.1128/AAC.37.12.2688; Baqar S, 2008, INFECT IMMUN, V76, P3170, DOI 10.1128/IAI.00076-08; BLACK RE, 1992, CAMPLYLOBACTER JEJUNI, P207; BLASER MJ, 1987, JAMA-J AM MED ASSOC, V257, P43, DOI 10.1001/jama.257.1.43; BLASER MJ, 1984, INFECT IMMUN, V43, P986, DOI 10.1128/IAI.43.3.986-993.1984; Blaser MJ, 1997, J INFECT DIS, V176, pS103, DOI 10.1086/513780; BLASER MJ, 1983, INFECT IMMUN, V42, P276, DOI 10.1128/IAI.42.1.276-284.1983; Brereton CF, 2011, J IMMUNOL, V186, P5896, DOI 10.4049/jimmunol.1003789; Buzby JC, 1997, J INFECT DIS, V176, pS192, DOI 10.1086/513785; Edwards LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015398; El-Kamary SS, 2013, CLIN VACCINE IMMUNOL, V20, P1764, DOI 10.1128/CVI.00464-13; Freytag LC, 2005, VACCINE, V23, P1804, DOI 10.1016/j.vaccine.2004.11.010; Friedman C.R., 2000, CAMPYLOBACTER, P121; Holmner A, 2011, J MOL BIOL, V406, P387, DOI 10.1016/j.jmb.2010.11.060; HONDA T, 1981, INFECT IMMUN, V34, P333, DOI 10.1128/IAI.34.2.333-336.1981; Huang SX, 2007, FEMS MICROBIOL LETT, V272, P137, DOI 10.1111/j.1574-6968.2007.00752.x; Islam A, 2010, CLIN VACCINE IMMUNOL, V17, P1666, DOI 10.1128/CVI.00255-10; Jertborn M, 2001, INFECT IMMUN, V69, P4125, DOI 10.1128/IAI.69.6.4125-4128.2001; Katz JM, 1997, J INFECT DIS, V175, P352, DOI 10.1093/infdis/175.2.352; Kotloff KL, 2001, INFECT IMMUN, V69, P3581, DOI 10.1128/IAI.69.6.3581-3590.2001; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leach S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051718; Lu YJ, 2010, CLIN VACCINE IMMUNOL, V17, P1005, DOI 10.1128/CVI.00036-10; Newell DG, 2010, INT J FOOD MICROBIOL, V139, pS3, DOI 10.1016/j.ijfoodmicro.2010.01.021; Norton EB, 2011, CLIN VACCINE IMMUNOL, V18, P546, DOI 10.1128/CVI.00538-10; Oberhelman RA, 2000, CAMPYLOBACTER, V2nd, P139, DOI 10.1016/s0360-3016(00)00774-4; Ottsjo LS, 2013, INFECT IMMUN, V81, P1532, DOI 10.1128/IAI.01407-12; PANIGRAHI P, 1992, INFECT IMMUN, V60, P4938, DOI 10.1128/IAI.60.11.4938-4944.1992; Patton WA, 2000, HANDB EXP PHARM, V145, P133; RUIZPALACIOS GM, 1990, J PEDIATR-US, V116, P707, DOI 10.1016/S0022-3476(05)82652-6; Schroder W, 1997, FEMS MICROBIOL LETT, V150, P141, DOI 10.1016/S0378-1097(97)00111-0; Scott DA, 1997, J INFECT DIS, V176, pS183, DOI 10.1086/513791; TAYLOR DN, 1992, CAMPLYLOBACTER JEJUNI, P20; TAYLOR DN, 1993, J INFECT DIS, V168, P754, DOI 10.1093/infdis/168.3.754; Tribble DR, 2008, CAMPYLOBACTER, 3RD EDITION, P429; Verweij WR, 1998, VACCINE, V16, P2069, DOI 10.1016/S0264-410X(98)00076-0; World Health Organization, 2006, WHOIVB061; Zhang QJ, 2000, INFECT IMMUN, V68, P5679, DOI 10.1128/IAI.68.10.5679-5689.2000	45	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142090	10.1371/journal.pone.0142090	http://dx.doi.org/10.1371/journal.pone.0142090			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540197	Green Published, Green Submitted, gold			2022-12-26	WOS:000364303800054
J	Li, M; Arner, A				Li, Mei; Arner, Anders			Immobilization of Dystrophin and Laminin alpha 2-Chain Deficient Zebrafish Larvae In Vivo Prevents the Development of Muscular Dystrophy	PLOS ONE			English	Article							CONTRACTION-INDUCED INJURY; SKELETAL-MUSCLE; MDX MOUSE; MICE; PROTEIN; EMBRYO; MODEL	Muscular dystrophies are often caused by genetic alterations in the dystrophin-dystroglycan complex or its extracellular ligands. These structures are associated with the cell membrane and provide mechanical links between the cytoskeleton and the matrix. Mechanical stress is considered a pathological mechanism and muscle immobilization has been shown to be beneficial in some mouse models of muscular dystrophy. The zebrafish enables novel and less complex models to examine the effects of extended immobilization or muscle relaxation in vivo in different dystrophy models. We have examined effects of immobilization in larvae from two zebrafish strains with muscular dystrophy, the Sapje dystrophin-deficient and the Candyfloss laminin alpha 2-chain-deficient strains. Larvae (4 days post fertilization, dpf) of both mutants have significantly lower active force in vitro, alterations in the muscle structure with gaps between muscle fibers and altered birefringence patterns compared to their normal siblings. Complete immobilization (18 hrs to 4 dpf) was achieved using a small molecular inhibitor of actin-myosin interaction (BTS, 50 mu M). This treatment resulted in a significantly weaker active contraction at 4 dpf in both mutated larvae and normal siblings, most likely reflecting a general effect of immobilization on myofibrillogenesis. The immobilization also significantly reduced the structural damage in the mutated strains, showing that muscle activity is an important pathological mechanism. Following one-day washout of BTS, muscle tension partly recovered in the Candyfloss siblings and caused structural damage in these mutants, indicating activity-induced muscle recovery and damage, respectively.	[Li, Mei; Arner, Anders] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden	Karolinska Institutet	Arner, A (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden.	anders.arner@ki.se			Swedish Research Council [2013-3003]; Karolinska Institutet; French Muscular Dystrophy Association (AFM)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet); French Muscular Dystrophy Association (AFM)(Association Francaise contre les Myopathies)	This work was supported by the Swedish Research Council (www.vr.se) for AA, 2013-3003; the Karolinska Institutet (www.ki.se) for AA; and The French Muscular Dystrophy Association (AFM, http://www.afm-telethon.com/) for AA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassett D, 2004, CLIN EXP PHARMACOL P, V31, P537, DOI 10.1111/j.1440-1681.2004.04030.x; Bassett DI, 2003, DEVELOPMENT, V130, P5851, DOI 10.1242/dev.00799; Berger J, 2012, BIOCHEM BIOPH RES CO, V423, P785, DOI 10.1016/j.bbrc.2012.06.040; Bhatnagar S, 2010, J MOL MED, V88, P155, DOI 10.1007/s00109-009-0550-4; Brooks SV, 1998, J MUSCLE RES CELL M, V19, P179, DOI 10.1023/A:1005364713451; CAMPBELL KP, 1995, CELL, V80, P675, DOI 10.1016/0092-8674(95)90344-5; Cheung A, 2002, NAT CELL BIOL, V4, P83, DOI 10.1038/ncb734; Dou Y, 2008, J GEN PHYSIOL, V131, P445, DOI 10.1085/jgp.200809982; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; Gawlik KI, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-9; Hall TE, 2007, P NATL ACAD SCI USA, V104, P7092, DOI 10.1073/pnas.0700942104; Han R, 2009, P NATL ACAD SCI USA, V106, P12573, DOI 10.1073/pnas.0906545106; Head SI, 2004, EXP PHYSIOL, V89, P531, DOI 10.1113/expphysiol.2004.027383; HELBLINGLECLERC A, 1995, NAT GENET, V11, P216, DOI 10.1038/ng1095-216; Hourde C, 2013, AM J PATHOL, V182, P1509, DOI 10.1016/j.ajpath.2013.01.020; Kim HR, 2009, DEV DYNAM, V238, P56, DOI 10.1002/dvdy.21812; Li M, 2014, FASEB J, V28, P1593, DOI 10.1096/fj.13-240044; Li M, 2013, J GEN PHYSIOL, V141, P335, DOI 10.1085/jgp.201210915; Lim JH, 2004, MUSCLE NERVE, V30, P456, DOI 10.1002/mus.20139; MATSUMURA K, 1992, NATURE, V360, P588, DOI 10.1038/360588a0; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; Mokhtarian A, 1999, J APPL PHYSIOL, V86, P924, DOI 10.1152/jappl.1999.86.3.924; Petrof BJ, 1993, P NATL ACAD SCI USA, V90, P3710; Ramachandran I, 2003, CELL MOTIL CYTOSKEL, V55, P61, DOI 10.1002/cm.10113; Selsby JT, 2013, J APPL PHYSIOL, V115, P660, DOI 10.1152/japplphysiol.00252.2013; Straub V, 1997, J CELL BIOL, V139, P375, DOI 10.1083/jcb.139.2.375; Sztal TE, 2012, HUM MOL GENET, V21, P4718, DOI 10.1093/hmg/dds312; TANABE Y, 1986, ACTA NEUROPATHOL, V69, P91, DOI 10.1007/BF00687043; Vachon PH, 1997, J CLIN INVEST, V100, P1870, DOI 10.1172/JCI119716; Waugh TA, 2014, HUM MOL GENET, V23, P4651, DOI 10.1093/hmg/ddu185	30	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0139483	10.1371/journal.pone.0139483	http://dx.doi.org/10.1371/journal.pone.0139483			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536238	gold, Green Published, Green Submitted			2022-12-26	WOS:000364298400008
J	Mamidi, AS; Arora, P; Surolia, A				Mamidi, Ashalatha Sreshty; Arora, Prerna; Surolia, Avadhesha			Multivariate PLS Modeling of Apicomplexan FabD-Ligand Interaction Space for Mapping Target-Specific Chemical Space and Pharmacophore Fingerprints	PLOS ONE			English	Article							CARRIER PROTEIN TRANSACYLASE; FATTY-ACID SYNTHASE; ACP DOCKING SITE; MALONYL-COA; TOXOPLASMA-GONDII; PLASMODIUM-FALCIPARUM; MOLECULAR-DYNAMICS; DRUG DISCOVERY; FORCE-FIELD; DESIGN	Biomolecular recognition underlying drug-target interactions is determined by both binding affinity and specificity. Whilst, quantification of binding efficacy is possible, determining specificity remains a challenge, as it requires affinity data for multiple targets with the same ligand dataset. Thus, understanding the interaction space by mapping the target space to model its complementary chemical space through computational techniques are desirable. In this study, active site architecture of FabD drug target in two apicomplexan parasites viz. Plasmodium falciparum (PfFabD) and Toxoplasma gondii (TgFabD) is explored, followed by consensus docking calculations and identification of fifteen best hit compounds, most of which are found to be derivatives of natural products. Subsequently, machine learning techniques were applied on molecular descriptors of six FabD homologs and sixty ligands to induce distinct multivariate partial-least square models. The biological space of FabD mapped by the various chemical entities explain their interaction space in general. It also highlights the selective variations in FabD of apicomplexan parasites with that of the host. Furthermore, chemometric models revealed the principal chemical scaffolds in PfFabD and TgFabD as pyrrolidines and imidazoles, respectively, which render target specificity and improve binding affinity in combination with other functional descriptors conducive for the design and optimization of the leads.	[Mamidi, Ashalatha Sreshty; Arora, Prerna; Surolia, Avadhesha] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Surolia, A (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	surolia@mbu.iisc.ernet.in			Department of Biotechnology (DBT), Government of India; University Grants Commission (UGC), India; Council of Scientific and Industrial Research (CSIR), India; UGC, India; Indian Council of Medical Research (ICMR); University Grants Commission (UGC), India [63/84/2001-BMS, F.4-2/2006(BSR)/13-545/2011(BSR)]	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); University Grants Commission (UGC), India(University Grants Commission, India); Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); UGC, India(University Grants Commission, India); Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); University Grants Commission (UGC), India(University Grants Commission, India)	The authors thank Department of Biotechnology (DBT), Government of India to AS and University Grants Commission (UGC), India for the financial support to carry out this work. AS thanks Council of Scientific and Industrial Research (CSIR), India for Bhatnagar Fellowship, and ASM thanks UGC, India for Dr. D. S. Kothari Fellowship.; Authors thank Indian Council of Medical Research (ICMR) and University Grants Commission (UGC), India 63/84/2001-BMS and F.4-2/2006(BSR)/13-545/2011(BSR) for financial support to AS and ASM, respectively. AS thanks Council of Scientific and Industrial Research (CSIR), India for Bhatnagar Fellowship and ASM thanks UGC, India for Dr. D. S. Kothari Fellowship.	Baell JB, 2013, J CHEM INF MODEL, V53, P39, DOI 10.1021/ci300461a; BARONI M, 1993, QUANT STRUCT-ACT REL, V12, P9, DOI 10.1002/qsar.19930120103; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Blake James F, 2005, Med Chem, V1, P649, DOI 10.2174/157340605774598081; Bolon DN, 2005, P NATL ACAD SCI USA, V102, P12724, DOI 10.1073/pnas.0506124102; Brenk R, 2008, CHEMMEDCHEM, V3, P435, DOI 10.1002/cmdc.200700139; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Eriksson L, 1997, SETAC SP P, P381; Eriksson L, 1999, MULTI MEGAVARIATE DA; Eriksson L, 2006, MOL DIVERS, V10, P169, DOI 10.1007/s11030-006-9024-6; Eriksson L, 2008, J CHEMOMETR, V22, P594, DOI 10.1002/cem.1187; Ermondi G, 2006, BIOCHEM PHARMACOL, V72, P1633, DOI 10.1016/j.bcp.2006.05.022; Goodman CD, 2007, CURR DRUG TARGETS, V8, P15, DOI 10.2174/138945007779315579; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Havranek JJ, 2003, NAT STRUCT BIOL, V10, P45, DOI 10.1038/nsb877; He CY, 2001, EMBO J, V20, P330, DOI 10.1093/emboj/20.3.330; Jakalian A, 2000, J COMPUT CHEM, V21, P132, DOI 10.1002/(SICI)1096-987X(20000130)21:2<132::AID-JCC5>3.0.CO;2-P; Junaid M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014353; Keatinge-Clay AT, 2003, STRUCTURE, V11, P147, DOI 10.1016/S0969-2126(03)00004-2; Kremer L, 2001, J BIOL CHEM, V276, P27967, DOI 10.1074/jbc.M103687200; Kufareva I, 2011, STRUCTURE, V19, P1108, DOI 10.1016/j.str.2011.05.012; Lagorce D, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-396; Lapins M, 2009, J CHEM INF MODEL, V49, P1202, DOI 10.1021/ci800453k; Lapins M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-181; Lapinsh M, 2005, BIOINFORMATICS, V21, P4289, DOI 10.1093/bioinformatics/bti703; Lapinsh M, 2002, MOL PHARMACOL, V61, P1465, DOI 10.1124/mol.61.6.1465; Liu WZ, 2006, FEBS LETT, V580, P697, DOI 10.1016/j.febslet.2005.12.085; Lundstedt T, 1998, CHEMOMETR INTELL LAB, V42, P3, DOI 10.1016/S0169-7439(98)00065-3; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maier T, 2006, SCIENCE, V311, P1258, DOI 10.1126/science.1123248; McFadden GI, 1996, NATURE, V381, P482, DOI 10.1038/381482a0; McLeod R, 2001, INT J PARASITOL, V31, P109, DOI 10.1016/S0020-7519(01)00111-4; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Muench SP, 2007, ACTA CRYSTALLOGR D, V63, P328, DOI 10.1107/S0907444906053625; Oefner C, 2006, ACTA CRYSTALLOGR D, V62, P613, DOI 10.1107/S0907444906009474; Oprea TL, 2002, MOLECULES, V7, P51, DOI 10.3390/70100051; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sandberg M, 1998, J MED CHEM, V41, P2481, DOI 10.1021/jm9700575; Sato T, 2010, J CHEM INF MODEL, V50, P170, DOI 10.1021/ci900382e; Seeber F, 2010, INT REV CEL MOL BIO, V281, P161, DOI 10.1016/S1937-6448(10)81005-6; SERRE L, 1995, J BIOL CHEM, V270, P12961, DOI 10.1074/jbc.270.22.12961; Sinha I, 2004, J ANTIMICROB CHEMOTH, V53, P1072, DOI 10.1093/jac/dkh241; Sreshty MAL, 2012, MOL INFORM, V31, P281, DOI 10.1002/minf.201100051; Surolia N, 2001, NAT MED, V7, P167, DOI 10.1038/84612; van Westen GJP, 2011, MEDCHEMCOMM, V2, P16, DOI 10.1039/c0md00165a; Vaughan AM, 2009, CELL MICROBIOL, V11, P506, DOI 10.1111/j.1462-5822.2008.01270.x; Waller RF, 1998, P NATL ACAD SCI USA, V95, P12352, DOI 10.1073/pnas.95.21.12352; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Wang RX, 2002, J COMPUT AID MOL DES, V16, P11, DOI 10.1023/A:1016357811882; Wold S., 1995, QSAR CHEMOMETRIC MET, V2, P195; Yan ZQ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00309; Zhang YM, 2001, J BIOL CHEM, V276, P8231, DOI 10.1074/jbc.M008042200; Zoete V, 2011, J COMPUT CHEM, V32, P2359, DOI 10.1002/jcc.21816	57	2	2	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141674	10.1371/journal.pone.0141674	http://dx.doi.org/10.1371/journal.pone.0141674			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26535573	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000364298400076
J	Schossleitner, K; Habertheuer, A; Finsterwalder, R; Friedl, HP; Rauscher, S; Groger, M; Kocher, A; Wagner, C; Wagner, SN; Fischer, G; Schultz, MJ; Wiedemann, D; Petzelbauer, P				Schossleitner, Klaudia; Habertheuer, Andreas; Finsterwalder, Richard; Friedl, Heinz P.; Rauscher, Sabine; Groeger, Marion; Kocher, Alfred; Wagner, Christine; Wagner, Stephan N.; Fischer, Gottfried; Schultz, Marcus J.; Wiedemann, Dominik; Petzelbauer, Peter			A Peptide to Reduce Pulmonary Edema in a Rat Model of Lung Transplantation	PLOS ONE			English	Article							ENDOTHELIAL BARRIER FUNCTION; ISCHEMIA-REPERFUSION INJURY; PRIMARY GRAFT DYSFUNCTION; OXIDIZED PHOSPHOLIPIDS; INTERNATIONAL SOCIETY; IMPROVES SURVIVAL; PERMEABILITY; ACTIVATION; JUNCTIONS; REGISTRY	Background Despite significant advances in organ preservation, surgical techniques and perioperative care, primary graft dysfunction is a serious medical problem in transplantation medicine in general and a specific problem in patients undergoing lung transplantation. As a result, patients develop lung edema, causing reduced tissue oxygenation capacity, reduced lung compliance and increased requirements for mechanical ventilatory support. Yet, there is no effective strategy available to protect the grafted organ from stress reactions induced by ischemia/reperfusion and by the surgical procedure itself. Methods We assessed the effect of a cingulin-derived peptide, XIB13 or a random peptide in an established rat model of allogeneic lung transplantation. Donor lungs and recipients received therapeutic peptide at the time of transplantation and outcome was analyzed 100min and 28 days post grafting. Results XIB13 improved blood oxygenation and reduced vascular leak 100min post grafting. Even after 28 days, lung edema was significantly reduced by XIB13 and lungs had reduced fibrotic or necrotic zones. Moreover, the induction of an allogeneic T cell response was delayed indicating a reduced antigen exchange between the donor and the host. Conclusions In summary, we provide a new tool to strengthen endothelial barrier function thereby improving outcomes in lung transplantation.	[Schossleitner, Klaudia; Finsterwalder, Richard; Friedl, Heinz P.; Petzelbauer, Peter] Med Univ Vienna, Dept Dermatol, Skin & Endothelium Res Div SERD, Vienna, Austria; [Habertheuer, Andreas; Kocher, Alfred; Wiedemann, Dominik] Med Univ Vienna, Dept Cardiac Surg, Vienna, Austria; [Rauscher, Sabine; Groeger, Marion] Med Univ Vienna, Core Facil Imaging, Vienna, Austria; [Wagner, Christine; Wagner, Stephan N.] Med Univ Vienna, Dept Dermatol, Div Immunol Allergy & Infect Dis, Vienna, Austria; [Fischer, Gottfried] Med Univ Vienna, Dept Blood Grp Serol & Transfus Med, Vienna, Austria; [Schultz, Marcus J.] Univ Amsterdam, Acad Med Ctr, Dept Intens Care, NL-1105 AZ Amsterdam, Netherlands; [Schultz, Marcus J.] Univ Amsterdam, Acad Med Ctr, Lab Expt Intens Care & Anesthesiol LEICA, NL-1105 AZ Amsterdam, Netherlands	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Petzelbauer, P (corresponding author), Med Univ Vienna, Dept Dermatol, Skin & Endothelium Res Div SERD, Vienna, Austria.	Peter.Petzelbauer@meduniwien.ac.at	Schossleitner, Klaudia/AFQ-7865-2022; Wiedemann, Dominik/AAH-2649-2020; Schultz, Marcus/AAB-6379-2021; petzelbauer, peter/GLU-3941-2022	Wiedemann, Dominik/0000-0002-2055-8293; Schultz, Marcus/0000-0003-3969-7792; Wagner, Stephan/0000-0003-4941-7029; Schossleitner, Klaudia/0000-0003-1202-5961; Petzelbauer, Peter/0000-0001-7080-5259; Habertheuer, Andreas/0000-0001-7310-8838	Vienna Science and Technology Fund (WWTF) [LS11-8, LS11-045]; Burgermeisterfond [14088]; Hochschuljubilaumsstiftung [H-289325/2013]; Austrian Science Fund [F5408-B21]	Vienna Science and Technology Fund (WWTF); Burgermeisterfond; Hochschuljubilaumsstiftung; Austrian Science Fund(Austrian Science Fund (FWF))	This work was funded by the Vienna Science and Technology Fund (WWTF, www.wwtf.at) LS11-8 to PP and in part by projects WWTF LS11-045 to SNW, Burgermeisterfond (www.wien.gv.at/gesundheit/einrichtungen/med-wiss-fonds) 14088 and Hochschuljubilaumsstiftung (www.wien.gv.at/amtshelfer/kultur/archiv/forschung/hochschuljubilaeumsstiftung.html) H-289325/2013 to DW and the Austrian Science Fund (www.fwf.ac.at) F5408-B21 to PP.	Aigner C, 2007, EUR J CARDIO-THORAC, V31, P468, DOI 10.1016/j.ejcts.2006.11.049; Aijaz S, 2005, DEV CELL, V8, P777, DOI 10.1016/j.devcel.2005.03.003; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Birukov KG, 2009, MICROVASC RES, V77, P46, DOI 10.1016/j.mvr.2008.09.006; Birukova AA, 2006, AM J PHYSIOL-LUNG C, V290, pL540, DOI 10.1152/ajplung.00259.2005; Birukova AA, 2014, MOL BIOL CELL, V25, P2006, DOI 10.1091/mbc.E13-12-0743; Birukova AA, 2012, J CELL PHYSIOL, V227, P1883, DOI 10.1002/jcp.22916; Chen WG, 2014, AM J RESP CELL MOL, V50, P328, DOI 10.1165/rcmb.2013-0058OC; Christie JD, 2012, J HEART LUNG TRANSPL, V31, P1073, DOI 10.1016/j.healun.2012.08.004; Christie JD, 2005, AM J RESP CRIT CARE, V171, P1312, DOI 10.1164/rccm.200409-1243OC; D'Atri F, 2001, FEBS LETT, V507, P21, DOI 10.1016/S0014-5793(01)02936-2; Darwish I, 2013, VIRULENCE, V4, P572, DOI 10.4161/viru.25740; Gawlak G, 2014, FASEB J, V28, P3249, DOI 10.1096/fj.13-245142; Goertz O, 2014, MICROVASC RES, V93, P98, DOI 10.1016/j.mvr.2014.04.003; Groger M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005391; Habertheuer A, 2013, J SURG RES, V185, P419, DOI 10.1016/j.jss.2013.05.006; Jaksch P, 2013, TRANSPL INT, V26, P34, DOI 10.1111/j.1432-2277.2012.01570.x; Jing HR, 2014, J SURG RES, V187, P252, DOI 10.1016/j.jss.2013.10.009; Kage H, 2014, AM J PHYSIOL-LUNG C, V307, pL524, DOI 10.1152/ajplung.00077.2014; Meng F, 2014, AM J PHYSL LUNG CELL, V2014; Neto ASF R.R., 2014, F1000PRIME REP; Okazaki M, 2007, AM J TRANSPLANT, V7, P751, DOI 10.1111/j.1600-6143.2006.01710.x; Prakash A, 2012, ANESTHESIOLOGY, V117, P822, DOI 10.1097/ALN.0b013e31826a4ae3; Stehlik J, 2011, J HEART LUNG TRANSPL, V30, P1078, DOI 10.1016/j.healun.2011.08.003; Su G, 2007, AM J RESP CELL MOL, V36, P377, DOI 10.1165/rcmb.2006-0238OC; Sugimoto R, 2012, AM J TRANSPLANT, V12, P2938, DOI 10.1111/j.1600-6143.2012.04169.x; Suzuki Y, 2013, SEMIN RESP CRIT CARE, V34, P305, DOI 10.1055/s-0033-1348474; Terry SJ, 2011, NAT CELL BIOL, V13, P159, DOI 10.1038/ncb2156; Tian ZG, 2013, ANN THORAC SURG, V95, P1028, DOI 10.1016/j.athoracsur.2012.11.023; Yamane M, 2005, AM J TRANSPLANT, V5, P2160, DOI 10.1111/j.1600-6143.2005.01017.x	30	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142115	10.1371/journal.pone.0142115	http://dx.doi.org/10.1371/journal.pone.0142115			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536466	gold, Green Published, Green Submitted			2022-12-26	WOS:000364298400136
J	Anderegg, MCJ; de Groof, EJ; Gisbertz, SS; Bennink, RJ; Lagarde, SM; Klinkenbijl, JHG; Dijkgraaf, MGW; Bergman, JJGHM; Hulshof, MCCM; van Laarhoven, HWM; Henegouwen, MIV				Anderegg, Maarten C. J.; de Groof, Elisabeth J.; Gisbertz, Suzanne S.; Bennink, Roel J.; Lagarde, Sjoerd M.; Klinkenbijl, Jean H. G.; Dijkgraaf, Marcel G. W.; Bergman, Jacques J. G. H. M.; Hulshof, Maarten C. C. M.; van Laarhoven, Hanneke W. M.; Henegouwen, Mark I. van Berge			F-18-FDG PET-CT after Neoadjuvant Chemoradiotherapy in Esophageal Cancer Patients to Optimize Surgical Decision Making	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; COMPUTED-TOMOGRAPHY; THORACIC ESOPHAGUS; CARCINOMA; IMPACT; INTERVAL; UTILITY; RECOMMENDATIONS; CHEMOTHERAPY; METASTASES	Background Prognosis of esophageal cancer patients can be significantly improved by neoadjuvant chemoradiotherapy (nCRT). Given the aggressive nature of esophageal tumors, it is conceivable that in a significant portion of patients treated with nCRT, dissemination already becomes manifest during the period of nCRT. The aim of this retrospective study was to determine the value and diagnostic accuracy of PET-CT after neoadjuvant chemoradiotherapy to identify patients with metastases preoperatively in order to prevent non-curative surgery. Methods From January 2011 until February 2013 esophageal cancer patients deemed eligible for a curative approach with nCRT and surgical resection underwent a PET-CT after completion of nCRT. If abnormalities on PET-CT were suspected metastases, histological proof was acquired. A clinical decision model was designed to assess the cost-effectiveness of this diagnostic strategy. Results 156 patients underwent a PET-CT after nCRT. In 31 patients (19.9%) PET-CT showed abnormalities suspicious for dissemination, resulting in 17 cases of proven metastases (10.9%). Of the patients without proven metastases 133 patients were operated. In 6 of these 133 cases distant metastases were detected intraoperatively, corresponding to 4.5% false-negative results. The standard introduction of a post-neoadjuvant therapy PET-CT led to a reduction of overall health care costs per patient compared to a scenario without restaging with PET-CT ($34,088 vs. $36,490). Conclusion In 10.9% of esophageal cancer patients distant metastases were detected by standard PET-CT after neoadjuvant chemoradiotherapy. To avoid non-curative resections we advocate post-neoadjuvant therapy PET-CT as a cost-effective step in the standard work-up of candidates for surgery.	[Anderegg, Maarten C. J.; de Groof, Elisabeth J.; Gisbertz, Suzanne S.; Lagarde, Sjoerd M.; Klinkenbijl, Jean H. G.; Henegouwen, Mark I. van Berge] Univ Amsterdam, Acad Med Ctr, Dept Surg, NL-1105 AZ Amsterdam, Netherlands; [Bennink, Roel J.] Univ Amsterdam, Acad Med Ctr, Nucl Med, NL-1105 AZ Amsterdam, Netherlands; [Dijkgraaf, Marcel G. W.] Univ Amsterdam, Acad Med Ctr, Clin Res Unit, NL-1105 AZ Amsterdam, Netherlands; [Bergman, Jacques J. G. H. M.] Univ Amsterdam, Acad Med Ctr, Gastroenterl & Hepatol, NL-1105 AZ Amsterdam, Netherlands; [Hulshof, Maarten C. C. M.] Univ Amsterdam, Acad Med Ctr, Radiat Oncol, NL-1105 AZ Amsterdam, Netherlands; [van Laarhoven, Hanneke W. M.] Univ Amsterdam, Acad Med Ctr, Med Oncol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Henegouwen, MIV (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Surg, NL-1105 AZ Amsterdam, Netherlands.	m.c.anderegg@amc.nl; m.i.vanbergehenegouwen@amc.uva.nl	De Groof, Joline/AAK-7613-2020; van Laarhoven, Hanneke/AAW-3464-2021; Gisbertz, Suzanne/AAG-5370-2020; Bergman, Jacques/AAS-2500-2021	Gisbertz, Suzanne/0000-0001-9655-7601; Bergman, Jacques/0000-0001-7548-6955; Hulshof, Maarten CCM/0000-0001-5240-3467	Koningin Wilhelmina Fonds (KWF, Dutch Cancer Society) Fellowship [UVA 2013-5853]	Koningin Wilhelmina Fonds (KWF, Dutch Cancer Society) Fellowship	This work was supported by Koningin Wilhelmina Fonds (KWF, Dutch Cancer Society) Fellowship, UVA 2013-5853 to SL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber TW, 2012, J NUCL MED, V53, P864, DOI 10.2967/jnumed.111.101568; Biere SSAY, 2012, LANCET, V379, P1887, DOI 10.1016/S0140-6736(12)60516-9; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Blencowe NS, 2013, BRIT J CANCER, V109, P1445, DOI 10.1038/bjc.2013.478; Blom RLGM, 2011, EJSO-EUR J SURG ONC, V37, P774, DOI 10.1016/j.ejso.2011.06.002; Bruzzi JF, 2007, CANCER, V109, P125, DOI 10.1002/cncr.22397; Cerfolio RJ, 2005, J THORAC CARDIOV SUR, V129, P1232, DOI 10.1016/j.jtcvs.2004.12.042; Chowdhury FU, 2008, CLIN RADIOL, V63, P1297, DOI 10.1016/j.crad.2008.05.010; Flamen P, 2002, ANN ONCOL, V13, P361, DOI 10.1093/annonc/mdf081; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kim JY, 2012, ANN THORAC SURG, V93, P207, DOI 10.1016/j.athoracsur.2011.05.021; Kordes S, 2014, INT J RADIAT ONCOL, V90, P190, DOI 10.1016/j.ijrobp.2014.05.022; Lagarde SM, 2008, ANN SURG, V247, P71, DOI 10.1097/SLA.0b013e31815b695e; LIEBERMAN MD, 1995, J THORAC CARDIOV SUR, V109, P130, DOI 10.1016/S0022-5223(95)70428-0; Maas KW, 2012, REV ESP ENFERM DIG, V104, P197, DOI 10.4321/s1130-01082012000400005; Malik V, 2012, CLIN NUCL MED, V37, P1152, DOI 10.1097/RLU.0b013e31827083ba; Metser U, 2014, ANN NUCL MED, V28, P295, DOI 10.1007/s12149-014-0812-2; Meyers BF, 2007, J THORAC CARDIOV SUR, V133, P738, DOI 10.1016/j.jtcvs.2006.09.079; Monjazeb AM, 2010, J CLIN ONCOL, V28, P4714, DOI 10.1200/JCO.2010.30.7702; Rice TW, 2010, ANN SURG ONCOL, V17, P1721, DOI 10.1245/s10434-010-1024-1; Ruol A, 2010, ANN SURG, V252, P788, DOI 10.1097/SLA.0b013e3181fc7f86; Salahudeen HM, 2008, CLIN RADIOL, V63, P765, DOI 10.1016/j.crad.2008.02.002; Thurau K, 2011, WORLD J SURG, V35, P608, DOI 10.1007/s00268-010-0946-x; van Hagen P, 2012, NEW ENGL J MED, V366, P2074, DOI 10.1056/NEJMoa1112088; van Vliet EPM, 2008, BRIT J CANCER, V98, P547, DOI 10.1038/sj.bjc.6604200; van Westreenen HL, 2007, BRIT J SURG, V94, P1515, DOI 10.1002/bjs.5708; van Westreenen HL, 2004, J CLIN ONCOL, V22, P3805, DOI 10.1200/JCO.2004.01.083; Weber WA, 2001, J CLIN ONCOL, V19, P3058, DOI 10.1200/JCO.2001.19.12.3058; Wong R, 2012, CLIN ONCOL-UK, V24, P86, DOI 10.1016/j.clon.2011.09.006; Yanagawa M, 2012, J NUCL MED, V53, P872, DOI 10.2967/jnumed.111.098699	30	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0133690	10.1371/journal.pone.0133690	http://dx.doi.org/10.1371/journal.pone.0133690			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529313	Green Published, gold, Green Submitted			2022-12-26	WOS:000364032600001
J	Chowdhary, K; Kaushik, N				Chowdhary, Kanika; Kaushik, Nutan			Fungal Endophyte Diversity and Bioactivity in the Indian Medicinal Plant Ocimum sanctum Linn	PLOS ONE			English	Article							ALTERNARIA-ALTERNATA; ANTIFUNGAL ACTIVITY; NATURAL-PRODUCTS; ANALYSIS REVEALS; IN-VITRO; 6-PENTYL-2H-PYRAN-2-ONE; METABOLITES; PHYLOGENIES; HOST	Endophytic mycopopulation isolated from India's Queen of herbs Tulsi (Ocimum sanctum) were explored and investigated for their diversity and antiphytopathogenic activity against widespread plant pathogens Botrytis cinerea, Sclerotinia sclerotiorum, Rhizoctonia solani and Fusarium oxysporum. 90 fungal isolates, representing 17 genera were recovered from 313 disease-free and surface sterilised plant segments (leaf and stem tissues) from three different geographic locations (Delhi, Hyderabad and Mukteshwar) during distinct sampling times in consequent years 2010 and 2011 in India. Fungal endophytes were subjected to molecular identification based on rDNA ITS sequence analysis. Plant pathogens such as F. verticillioides, B. maydis, C. coarctatum, R. bataticola, Hypoxylon sp., Diaporthe phaseolorum, Alternaria tenuissima and A. alternata have occurred as endophyte only during second sampling (second sampling in 2011) in the present study. Bi-plot generated by principal component analysis suggested tissue specificity of certain fungal endophytes. Dendrogram revealed species abundance as a function of mean temperature of the location at the time of sampling. Shannon diversity in the first collection is highest in Hyderabad leaf tissues (H' = 1.907) whereas in second collection it was highest from leaf tissues of Delhi (H' = 1.846). Mukteshwar (altitude: 7500 feet) reported least isolation rate in second collection. Nearly 23% of the total fungal isolates were considered as potent biocontrol agent. Hexane extract of M. phaseolina recovered from Hyderabad in first collection demonstrated highest activity against S. sclerotiorum with IC50 value of 0.38 mg/ml. Additionally, its components 2H-pyran-2-one, 5,6-dihydro-6-pentyl and palmitic acid, methyl ester as reported by GC-MS Chromatogram upon evaluation for their antiphytopathogenic activity exhibited IC50 value of 1.002 and 0.662 against respectively S. sclerotiorum indicating their significant role in antiphytopathogenic activity of hexane extract. The production of 2H-pyran-2-one, 5,6-dihydro-6-pentyl from M. phaseolina, an endophytic fungus is being reported for the first time.	[Chowdhary, Kanika] TERI Univ, New Delhi, India; [Kaushik, Nutan] Energy & Resources Inst TERI, India Habitat Ctr, New Delhi, India	TERI University; TERI University	Kaushik, N (corresponding author), Energy & Resources Inst TERI, India Habitat Ctr, Lodhi Rd, New Delhi, India.	kaushikn@teri.res.in	Kaushik, Nutan/H-7271-2012	Chowdhary, Kanika/0000-0002-2142-8757; Kaushik, Nutan/0000-0002-3870-8093	Council of Scientific and Industrial Research, New Delhi [09/550 (0037)2009-EMR-1]	Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	The study was funded by the host institution, Council of Scientific and Industrial Research, New Delhi in the form of JRF and SRF (09/550 (0037)2009-EMR-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubacker Maghdu Nainamohamed, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, pS661; Ahluwalia V, 2014, NAT PROD RE IN PRESS; Aly AH, 2011, APPL MICROBIOL BIOT, V90, P1829, DOI 10.1007/s00253-011-3270-y; Arnold AE, 2000, ECOL LETT, V3, P267, DOI 10.1046/j.1461-0248.2000.00159.x; Bashyal B, 1999, MYCOTAXON, V72, P33; BERTONI MD, 1988, NOVA HEDWIGIA, V46, P491; Bezerra JDP, 2015, BRAZ J MICROBIOL, V46, P49, DOI 10.1590/S1517-838246120130657; Brown Kenneth B., 1998, Fungal Diversity, V1, P27; CARROLL G, 1988, ECOLOGY, V69, P2, DOI 10.2307/1943154; CARROLL GC, 1978, CAN J BOT, V56, P3034, DOI 10.1139/b78-367; Chowdhary K, 2012, PHYTOCHEM REV, V11, P467, DOI 10.1007/s11101-012-9264-2; Cosoveanu A., 2012, Journal of Horticulture, Forestry and Biotechnology, V16, P87; Daoubi M, 2009, TETRAHEDRON, V65, P4834, DOI 10.1016/j.tet.2009.04.051; Debdulal Banerjee, 2011, Research Journal of Microbiology, V6, P54, DOI 10.3923/jm.2011.54.62; Diaz Arias MM, 2011, DIS NOTES, V95, P1316; Dreyfuss M M, 1994, Biotechnology, V26, P49; Eaton CJ, 2011, PLANT SCI, V180, P190, DOI 10.1016/j.plantsci.2010.10.002; Edison S, 2002, ACTA HORTIC, P231, DOI 10.17660/ActaHortic.2002.583.26; Ekta Singh, 2012, Journal of Natural Product and Plant Resources, V2, P39; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Garcia E, 2013, FUNGAL DIVERS, V60, P71, DOI 10.1007/s13225-012-0219-0; Gat T, 2012, PLANT DIS, V96, P1513, DOI 10.1094/PDIS-12-11-1041-RE; Gazis R, 2011, MOL ECOL, V20, P3001, DOI 10.1111/j.1365-294X.2011.05110.x; Gibbs RD., 1974, CHEMOTAXONOMY FLOWER, V1; Gibbs RD, 1974, CHEMOTAXONOMY FLOWER, VIII; Gond SK, 2012, MYCOSCIENCE, V53, P113, DOI 10.1007/s10267-011-0146-z; Gunatilaka AAL, 2006, J NAT PROD, V69, P509, DOI 10.1021/np058128n; Gupta SK, 2002, J EXP BIOL, V40, P765; Hawksworth DL, 2004, STUD MYCOL, P9; Hawksworth DL, 2001, MYCOL RES, V105, P1422, DOI 10.1017/S0953756201004725; Hoffman Michele, 2008, Journal of the Arizona-Nevada Academy of Science, V40, P91, DOI 10.2181/1533-6085(2008)40[91:MARADF]2.0.CO;2; Huang WY, 2008, FUNGAL DIVERS, V33, P61; Hyde KD, 2008, FUNGAL DIVERS, V33, P163; Isaac S, 1992, FUNGAL PLANT INTERAC; Jayasinghe CK, 1998, MYCOPATHOLOGIA, V143, P93, DOI 10.1023/A:1006958623733; Kaur R., 2007, Asian Journal of Plant Sciences, V6, P446; Khanna N, 2003, J ETHNOPHARMACOL, V88, P293, DOI 10.1016/S0378-8741(03)00215-0; Kumar S, 2011, WORLD J MICROB BIOT, V27, P571, DOI 10.1007/s11274-010-0492-6; Kumar Susheel, 2008, V3, P365, DOI 10.1007/978-1-4020-8571-0_17; Kumar S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0052416, 10.1371/journal.pone.0056202]; Kusari P, 2013, FUNGAL DIVERS, V60, P137, DOI 10.1007/s13225-012-0216-3; Liu D, 2013, HELV CHIM ACTA, V96, P437, DOI 10.1002/hlca.201200195; Liu SY, 2008, MYCOPATHOLOGIA, V166, P93, DOI 10.1007/s11046-008-9124-1; MAHESHWARI R, 2012, BULL ENVIRON PHARMAC, V1, P67; Min Chang-lil, 2014, Zhongguo Zhong Yao Za Zhi, V39, P4288; Musetti R, 2007, MICRON, V38, P643, DOI 10.1016/j.micron.2006.09.001; Nuryanti WH, 2015, INT J PHARMACOGN PHY, V7, P132; Parker SR, 1997, J AGR FOOD CHEM, V45, P2774, DOI 10.1021/jf960681a; Pena PA, 2013, CROP PROT, V54, P92, DOI 10.1016/j.cropro.2013.04.014; Petrini O, 1991, MICROBIAL ECOLOGY LE, P179, DOI DOI 10.1007/978-1-4612-3168-4_9; Photita W, 2004, FUNGAL DIVERS, V16, P131; Pretsch A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097929; Ramgopal D, 2013, PLANT GENET RESOUR-C, V11, P212, DOI 10.1017/S1479262112000470; Reina M, 1997, PHYTOCHEMISTRY, V46, P845, DOI 10.1016/S0031-9422(97)00354-3; Rivera-Orduna FN, 2011, FUNGAL DIVERS, V47, P65, DOI 10.1007/s13225-010-0045-1; Rubio MB, 2009, FUNGAL GENET BIOL, V46, P17, DOI 10.1016/j.fgb.2008.10.008; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Savithramma N., 2011, Middle East Journal of Scientific Research, V8, P579; Schoch CL, 2009, SYST BIOL, V58, P224, DOI 10.1093/sysbio/syp020; SCHULZ B, 1993, MYCOL RES, V97, P1447, DOI 10.1016/S0953-7562(09)80215-3; Schulz B, 1999, MYCOL RES, V103, P1275, DOI 10.1017/S0953756299008540; Sethi S., 2013, Indian Journal of Natural Products and Resources, V4, P392; Shah CS, 1995, TXB PHARMACOGNOSY, P155; Shweta S, 2013, PHYTOMEDICINE, V20, P913, DOI 10.1016/j.phymed.2013.04.004; Strobel G, 2004, J NAT PROD, V67, P257, DOI 10.1021/np030397v; Strobel G, 2003, MICROBIOL MOL BIOL R, V67, P491, DOI 10.1128/MMBR.67.4.491-502.2003; Strobel GA, 2003, MICROBES INFECT, V5, P535, DOI 10.1016/S1286-4579(03)00073-X; Strobel G, 2006, CURR OPIN MICROBIOL, V9, P240, DOI 10.1016/j.mib.2006.04.001; Suganthi RU, 2013, INDIAN J ANIM SCI, V83, P888; Suryanarayanan TS, 2000, MYCOL RES, V104, P1465, DOI 10.1017/S0953756200002859; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tan RX, 2001, NAT PROD REP, V18, P448, DOI 10.1039/b100918o; Tao G, 2008, FUNGAL DIVERS, V33, P101; Trejo-Estrada SR, 1998, WORLD J MICROB BIOT, V14, P865, DOI 10.1023/A:1008877224089; Tripathi AK, 2009, VEGETOS, V22, P1; U'Ren JM, 2012, AM J BOT, V99, P898, DOI 10.3732/ajb.1100459; Valente AMMP, 2013, AN ACAD BRAS CIENC, V85, P487, DOI 10.1590/S0001-37652013005000024; Vico I, 2014, PLANT DIS, V98, P1430, DOI 10.1094/PDIS-02-14-0179-PDN; Vuorela P, 2004, CURR MED CHEM, V11, P1375, DOI 10.2174/0929867043365116; Walters D, 2004, MYCOPATHOLOGIA, V157, P87, DOI 10.1023/B:MYCO.0000012222.68156.2c; Wang Y, 2014, FITOTERAPIA, V99, P153, DOI 10.1016/j.fitote.2014.09.015; Whittaker R.H., 1977, Evolutionary Biol, V10, P1; Xiong ZQ, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-71; Yadav MS, 2011, PLANT DIS RES, V26, P202; Zhang HW, 2006, NAT PROD REP, V23, P753, DOI 10.1039/b609472b	86	56	68	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141444	10.1371/journal.pone.0141444	http://dx.doi.org/10.1371/journal.pone.0141444			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529087	Green Submitted, gold, Green Published			2022-12-26	WOS:000364032600029
J	Liu, CD; Zhang, YL; Wang, LC; Zhang, XH; Chen, QY; Wu, BL				Liu, Chundong; Zhang, Yanli; Wang, Lichao; Zhang, Xinhua; Chen, Qiuyue; Wu, Buling			A Strontium-Modified Titanium Surface Produced by a New Method and Its Biocompatibility In Vitro	PLOS ONE			English	Article							DENTAL IMPLANTS; POSTMENOPAUSAL OSTEOPOROSIS; HYDROXYAPATITE COATINGS; OSTEOBLAST RESPONSE; ZOLEDRONIC ACID; GENE-EXPRESSION; CANCELLOUS BONE; RANELATE; OSSEOINTEGRATION; RABBIT	Objective To present a new and effective method of producing titanium surfaces modified with strontium and to investigate the surface characteristics and in vitro biocompatibility of titanium (Ti) surfaces modified with strontium (Sr) for bone implant applications. Materials and Methods Sr-modified Ti surfaces were produced by sequential treatments with NaOH, strontium acetate, heat and water. The surface characteristics and the concentration of the Sr ions released from the samples were examined. Cell adhesion, morphology and growth were investigated using osteoblasts isolated from the calvaria of neonatal Sprague-Dawley rats. Expression of osteogenesis-related genes and proteins was examined to assess the effect of the Sr-modified Ti surfaces on osteoblasts. Results The modified titanium surface had a mesh structure with significantly greater porosity, and approximately 5.37 +/- 0.35 at.% of Sr was incorporated into the surface. The hydrophilicity was enhanced by the incorporation of Sr ions and water treatment. The average amounts of Sr released from the Sr-modified plates subjected to water treatment were slight higher than the plates without water treatment. Sr promoted cellular adhesion, spreading and growth compared with untreated Ti surfaces. The Sr-modified Ti plates also promoted expression of osteogenesis-related genes, and expression of OPN and COL-I by osteoblasts. Ti plates heat treated at 700 degrees C showed increased bioactivity in comparison with those treated at 600 degrees C. Water treatment upregulated the expression of osteogenesis-related genes. Conclusions These results show that Sr-modification of Ti surfaces may improve bioactivity in vitro. Water treatment has enhanced the response of osteoblasts. The Sr-modified Ti heat-treated at 700 degrees C exhibited better bioactivity compared with that heated at 600 degrees C.	[Liu, Chundong; Zhang, Yanli; Wang, Lichao; Chen, Qiuyue; Wu, Buling] Southern Med Univ, Dept Stomatol, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China; [Liu, Chundong; Zhang, Yanli; Wang, Lichao; Chen, Qiuyue; Wu, Buling] Southern Med Univ, Coll Stomatol, Guangzhou, Guangdong, Peoples R China; [Zhang, Xinhua] Guangzhou Med Univ, Affiliated Hosp 2, Dept Stomatol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Guangzhou Medical University	Wu, BL (corresponding author), Southern Med Univ, Dept Stomatol, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China.	bulingwu@smu.edu.cn	Liu, Chun Dong/P-6322-2015	Liu, Chun Dong/0000-0003-2166-2487				Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2; Barbara A, 2004, METABOLISM, V53, P532, DOI 10.1016/j.metabol.2003.10.022; Bonnelye E, 2008, BONE, V42, P129, DOI 10.1016/j.bone.2007.08.043; Braux J, 2011, ACTA BIOMATER, V7, P2593, DOI 10.1016/j.actbio.2011.02.013; Capuccini C, 2008, ACTA BIOMATER, V4, P1885, DOI 10.1016/j.actbio.2008.05.005; Cardemil C, 2013, BIOMATERIALS, V34, P1546, DOI 10.1016/j.biomaterials.2012.11.003; Carvalho Carine M, 2010, Indian J Dent Res, V21, P349, DOI 10.4103/0970-9290.70798; Chen B, 2013, OSTEOPOROSIS INT, V24, P2115, DOI 10.1007/s00198-013-2288-7; Chung CJ, 2011, ACTA BIOMATER, V7, P4081, DOI 10.1016/j.actbio.2011.07.004; Dao T T, 1993, Int J Oral Maxillofac Implants, V8, P137; Deeks ED, 2010, DRUGS, V70, P733, DOI 10.2165/10481900-000000000-00000; Fahlgren A, 2013, BONE, V52, P718, DOI 10.1016/j.bone.2012.05.005; Fukuda A, 2011, ACTA BIOMATER, V7, P1379, DOI 10.1016/j.actbio.2010.09.026; Gaetti-Jardim EC, 2011, J CRANIOFAC SURG, V22, P1111, DOI 10.1097/SCS.0b013e3182108ec9; Gao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068086; Gentleman E, 2010, BIOMATERIALS, V31, P3949, DOI 10.1016/j.biomaterials.2010.01.121; Giro G, 2011, CLIN ORAL IMPLAN RES, V22, P259, DOI 10.1111/j.1600-0501.2010.01989.x; Hamouda IM, 2012, INT J ORAL MAX IMPL, V27, P776; Hurtel-Lemaire AS, 2009, J BIOL CHEM, V284, P575, DOI 10.1074/jbc.M801668200; Kawanabe K, 2009, J BIOMED MATER RES B, V90B, P476, DOI 10.1002/jbm.b.31309; Kizuki T, 2010, ACTA BIOMATER, V6, P2836, DOI 10.1016/j.actbio.2010.01.007; Lavenus S, 2011, ACTA BIOMATER, V7, P1525, DOI 10.1016/j.actbio.2010.12.033; Li YF, 2012, CLIN ORAL IMPLAN RES, V23, P1038, DOI 10.1111/j.1600-0501.2011.02252.x; Li YF, 2010, J ORTHOP RES, V28, P578, DOI 10.1002/jor.21050; Maimoun L, 2010, BONE, V46, P1436, DOI 10.1016/j.bone.2010.01.379; Marie PJ, 2011, OSTEOPOROSIS INT, V22, P1659, DOI 10.1007/s00198-010-1369-0; Marie PJ, 2006, CURR OPIN RHEUMATOL, V18, pS11, DOI 10.1097/01.bor.0000229522.89546.7b; Mellado-Valero A, 2010, MED ORAL PATOL ORAL, V15, pE52, DOI 10.4317/medoral.15.e52; Mori H, 1997, J ORAL MAXIL SURG, V55, P351, DOI 10.1016/S0278-2391(97)90124-5; Navarro M, 2008, J R SOC INTERFACE, V5, P1137, DOI 10.1098/rsif.2008.0151; Ni GX, 2007, J BIOMED MATER RES A, V83A, P570, DOI 10.1002/jbm.a.31294; Ni GX, 2011, J MATER SCI-MATER M, V22, P961, DOI 10.1007/s10856-011-4264-0; Orriss IR, 2012, METHODS MOL BIOL, V816, P31, DOI 10.1007/978-1-61779-415-5_3; Oshida Y, 2010, INT J MOL SCI, V11, P1580, DOI 10.3390/ijms11041580; Ozeki K, 2014, BIO-MED MATER ENG, V24, P1447, DOI 10.3233/BME-130949; Panzavolta S, 2008, J BIOMED MATER RES A, V84A, P965, DOI 10.1002/jbm.a.31412; Park JW, 2013, J BIOMED MATER RES A, V101, P298, DOI 10.1002/jbm.a.34433; Park JW, 2010, ACTA BIOMATER, V6, P2843, DOI 10.1016/j.actbio.2010.01.017; Park JW, 2010, CLIN ORAL IMPLAN RES, V21, P398, DOI 10.1111/j.1600-0501.2009.01863.x; Qiu K, 2006, BIOMATERIALS, V27, P1277, DOI 10.1016/j.biomaterials.2005.08.006; Rachner TD, 2011, LANCET, V377, P1276, DOI 10.1016/S0140-6736(10)62349-5; Reginster JY, 2012, OSTEOPOROSIS INT, V23, P1115, DOI 10.1007/s00198-011-1847-z; Roux C, 2008, ANN RHEUM DIS, V67, P1736, DOI 10.1136/ard.2008.094516; Seeman E, 2006, J BONE MINER RES, V21, P1113, DOI 10.1359/JBMR.060404; Sila-Asna Monnipha, 2007, Kobe J Med Sci, V53, P25; Stein GS, 2004, ONCOGENE, V23, P4315, DOI 10.1038/sj.onc.1207676; Tsolaki IN, 2009, J PROSTHODONT, V18, P309, DOI 10.1111/j.1532-849X.2008.00433.x; Tsukimura N, 2011, ACTA BIOMATER, V7, P4267, DOI 10.1016/j.actbio.2011.08.016; Xin YC, 2009, ACS NANO, V3, P3228, DOI 10.1021/nn9007675; Xue WC, 2006, J BIOMED MATER RES A, V79A, P804, DOI 10.1002/jbm.a.30815; Yamaguchi S, 2013, BIOACTIVE TI METAL C; Yamaguchi S, 2010, J MATER SCI-MATER M, V21, P439, DOI 10.1007/s10856-009-3904-0; Zhang WB, 2011, ACTA BIOMATER, V7, P800, DOI 10.1016/j.actbio.2010.08.031; Zhao LZ, 2013, BIOMATERIALS, V34, P19, DOI 10.1016/j.biomaterials.2012.09.041	54	12	14	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0140669	10.1371/journal.pone.0140669	http://dx.doi.org/10.1371/journal.pone.0140669			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529234	Green Published, Green Submitted, gold			2022-12-26	WOS:000364032600010
J	Wang, M; Altinoglu, S; Takeda, YS; Xu, QB				Wang, Ming; Altinoglu, Sarah; Takeda, Yuji S.; Xu, Qiaobing			Integrating Protein Engineering and Bioorthogonal Click Conjugation for Extracellular Vesicle Modulation and Intracellular Delivery	PLOS ONE			English	Article							NEWLY SYNTHESIZED PROTEINS; CANCER-THERAPY; MAMMALIAN-CELLS; IN-VIVO; EXOSOMES; CHEMISTRY; MOUSE; NANOPARTICLES; SIRNA	Exosomes are small, cell-secreted vesicles that transfer proteins and genetic information between cells. This intercellular transmission regulates many physiological and pathological processes. Therefore, exosomes have emerged as novel biomarkers for disease diagnosis and as nanocarriers for drug delivery. Here, we report an easy-to-adapt and highly versatile methodology to modulate exosome composition and conjugate exosomes for intracellular delivery. Our strategy combines the metabolic labeling of newly synthesized proteins or glycan/glycoproteins of exosome-secreting cells with active azides and bioorthogonal click conjugation to modify and functionalize the exosomes. The azide-integrated can be conjugated to a variety of small molecules and proteins and can efficiently deliver conjugates into cells. The metabolic engineering of exosomes diversifies the chemistry of exosomes and expands the functions that can be introduced into exosomes, providing novel, powerful tools to study the roles of exosomes in biology and expand the biomedical potential of exosomes.	[Wang, Ming; Altinoglu, Sarah; Takeda, Yuji S.; Xu, Qiaobing] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA	Tufts University	Xu, QB (corresponding author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.	Qiaobing.xu@tufts.edu	; Wang, Ming/G-8269-2012	Takeda, Yuji/0000-0002-0065-2063; Wang, Ming/0000-0002-2783-9426	NSF CAREER Award [DMR1452122]	NSF CAREER Award(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by the NSF CAREER Award (Grant No. DMR1452122). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Beatty KE, 2006, ANGEW CHEM INT EDIT, V45, P7364, DOI 10.1002/anie.200602114; Dieterich DC, 2006, P NATL ACAD SCI USA, V103, P9482, DOI 10.1073/pnas.0601637103; EL Andaloussi S, 2013, NAT REV DRUG DISCOV, V12, P348, DOI 10.1038/nrd3978; El-Andaloussi S, 2012, NAT PROTOC, V7, P2112, DOI 10.1038/nprot.2012.131; Escrevente C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078631; Hangauer MJ, 2008, ANGEW CHEM INT EDIT, V47, P2394, DOI 10.1002/anie.200704847; Im H, 2014, NAT BIOTECHNOL, V32, P490, DOI 10.1038/nbt.2886; Jewett JC, 2010, J AM CHEM SOC, V132, P3688, DOI 10.1021/ja100014q; Johnson JA, 2010, CURR OPIN CHEM BIOL, V14, P774, DOI 10.1016/j.cbpa.2010.09.013; Lai CP, 2014, ACS NANO, V8, P483, DOI 10.1021/nn404945r; Marcus ME, 2013, PHARMACEUTICALS-BASE, V6, P659, DOI 10.3390/ph6050659; Saxon E, 2000, SCIENCE, V287, P2007, DOI 10.1126/science.287.5460.2007; Sletten EM, 2011, ACCOUNTS CHEM RES, V44, P666, DOI 10.1021/ar200148z; Sletten EM, 2009, ANGEW CHEM INT EDIT, V48, P6974, DOI 10.1002/anie.200900942; Smyth T, 2014, BIOCONJUGATE CHEM, V25, P1777, DOI 10.1021/bc500291r; Suetsugu A, 2013, ADV DRUG DELIVER REV, V65, P383, DOI 10.1016/j.addr.2012.08.007; Sun DM, 2013, ADV DRUG DELIVER REV, V65, P342, DOI 10.1016/j.addr.2012.07.002; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Vader P, 2014, TRENDS MOL MED, V20, P385, DOI 10.1016/j.molmed.2014.03.002; Wang M, 2014, ANGEW CHEM INT EDIT, V53, P13444, DOI 10.1002/anie.201407234; Wang M, 2014, ANGEW CHEM INT EDIT, V53, P2893, DOI 10.1002/anie.201311245; Yeo RWY, 2013, ADV DRUG DELIVER REV, V65, P336, DOI 10.1016/j.addr.2012.07.001; Yoshioka Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4591	24	77	77	5	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141860	10.1371/journal.pone.0141860	http://dx.doi.org/10.1371/journal.pone.0141860			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529317	Green Published, gold, Green Submitted			2022-12-26	WOS:000364032600071
J	Kanu, N; Zhang, T; Burrell, RA; Chakraborty, A; Cronshaw, J; DaCosta, C; Gronroos, E; Pemberton, HN; Anderton, E; Gonzalez, L; Sabbioneda, S; Ulrich, HD; Swanton, C; Behrens, A				Kanu, N.; Zhang, T.; Burrell, R. A.; Chakraborty, A.; Cronshaw, J.; DaCosta, C.; Gronroos, E.; Pemberton, H. N.; Anderton, E.; Gonzalez, L.; Sabbioneda, S.; Ulrich, H. D.; Swanton, C.; Behrens, A.			RAD18, WRNIP1 and ATMIN promote ATM signalling in response to replication stress	ONCOGENE			English	Article							DOUBLE-STRAND BREAKS; CELL NUCLEAR ANTIGEN; DNA-DAMAGE; MONOUBIQUITINATED PCNA; ANAPHASE BRIDGES; MAMMALIAN-CELLS; FOCUS FORMATION; ACTIVATION; FORKS; CHECKPOINT	The DNA replication machinery invariably encounters obstacles that slow replication fork progression, and threaten to prevent complete replication and faithful segregation of sister chromatids. The resulting replication stress activates ATR, the major kinase involved in resolving impaired DNA replication. In addition, replication stress also activates the related kinase ATM, which is required to prevent mitotic segregation errors. However, the molecular mechanism of ATM activation by replication stress is not defined. Here, we show that monoubiquitinated Proliferating Cell Nuclear Antigen (PCNA), a marker of stalled replication forks, interacts with the ATM cofactor ATMIN via WRN-interacting protein 1 (WRNIP1). ATMIN, WRNIP1 and RAD18, the E3 ligase responsible for PCNA monoubiquitination, are specifically required for ATM signalling and 53BP1 focus formation induced by replication stress, not ionising radiation. Thus, WRNIP1 connects PCNA monoubiquitination with ATMIN/ATM to activate ATM signalling in response to replication stress and contribute to the maintenance of genomic stability.	[Kanu, N.; Zhang, T.; Chakraborty, A.; Cronshaw, J.; DaCosta, C.; Behrens, A.] Francis Crick Inst, Mammalian Genet Lab, 44 Lincolns Inn Fields, London WC2A 3LY, England; [Burrell, R. A.; Gronroos, E.; Swanton, C.] Francis Crick Inst, Translat Canc Therapeut Lab, London, England; [Pemberton, H. N.; Anderton, E.] Francis Crick Inst, Mol Oncol Lab, London, England; [Gonzalez, L.; Ulrich, H. D.] Francis Crick Inst, DNA Damage Tolerance Lab, London, England; [Sabbioneda, S.] CNR, Ist Genet Mol, Pavia, Italy; [Swanton, C.] UCL Canc Inst, London, England; [Behrens, A.] Kings Coll London, Sch Med, Guys Campus, London, England; [Kanu, N.] UCL Canc Inst, Translat Canc Therapeut Lab, 72 Huntley St, London WC1E 6BT, England; [Zhang, T.] Inst Med Biol, 8 A Biomed Grove,06-06 Immunos, Singapore 138648, Singapore; [Gonzalez, L.; Ulrich, H. D.] Inst Mol Biol, Ackermannweg 4, D-55122 Mainz, Germany; [Chakraborty, A.] AstraZeneca, Li Ka Shing Ctr, Robinson Way, Cambridge CB2 0RE, England	Francis Crick Institute; Francis Crick Institute; Francis Crick Institute; Francis Crick Institute; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); University of London; University College London; University of London; King's College London; University of London; University College London; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); Institute of Molecular Biology (IMB); AstraZeneca; CRUK Cambridge Institute	Behrens, A (corresponding author), Francis Crick Inst, Mammalian Genet Lab, 44 Lincolns Inn Fields, London WC2A 3LY, England.	axel.behrens@crick.ac.uk	Sabbioneda, Simone/N-7017-2015	Sabbioneda, Simone/0000-0001-8551-5465; Gronroos, Eva/0000-0001-8303-5409; Swanton, Charles/0000-0002-4299-3018; Behrens, Axel/0000-0002-1557-1143; Da Costa, Clive/0000-0002-0435-6747; Ulrich, Helle D./0000-0003-0431-2223	Francis Crick Institute; Breast Cancer Research Foundation; A*STAR NSS-PhD scholarship (Singapore); ERC [281661 ATMINDDR]; Cancer Research UK [15679] Funding Source: researchfish; The Francis Crick Institute [10039, 10040] Funding Source: researchfish	Francis Crick Institute; Breast Cancer Research Foundation; A*STAR NSS-PhD scholarship (Singapore)(Agency for Science Technology & Research (A*STAR)); ERC(European Research Council (ERC)European Commission); Cancer Research UK(Cancer Research UK); The Francis Crick Institute	Support was given from Mass Spectrometry, Bioinformatics and Biostatistics and the Equipment Park in the Cancer Research UK London Research Institute (now part of the Francis Crick Institute). We are grateful to JL Parker in the Ulrich laboratory for preparing ubiquitinated PCNA. R Bish, I Dikic, M Myers, E Soutoglou and A Lehmann kindly provided experimental materials. NK is funded by the Breast Cancer Research Foundation. TZ was financially supported by an A*STAR NSS-PhD scholarship (Singapore). This work was supported by an ERC grant (281661 ATMINDDR) to AB.	Ammazzalorso F, 2010, EMBO J, V29, P3156, DOI 10.1038/emboj.2010.205; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Baumann C, 2007, CELL, V128, P101, DOI 10.1016/j.cell.2006.11.041; Bish RA, 2008, J PROTEOME RES, V7, P3481, DOI 10.1021/pr800217q; Bish RA, 2007, J BIOL CHEM, V282, P23184, DOI 10.1074/jbc.M701042200; Blackford AN, 2012, HUM MOL GENET, V21, P2005, DOI 10.1093/hmg/dds013; Burrell RA, 2013, NATURE, V494, P492, DOI 10.1038/nature11935; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Chan KL, 2011, SEMIN CELL DEV BIOL, V22, P906, DOI 10.1016/j.semcdb.2011.07.001; Chan KL, 2009, NAT CELL BIOL, V11, P753, DOI 10.1038/ncb1882; Chan KL, 2007, EMBO J, V26, P3397, DOI 10.1038/sj.emboj.7601777; Crosetto N, 2008, J BIOL CHEM, V283, P35173, DOI 10.1074/jbc.M803219200; Davalos AR, 2004, CELL CYCLE, V3, P1579, DOI 10.4161/cc.3.12.1286; Derheimer FA, 2010, FEBS LETT, V584, P3675, DOI 10.1016/j.febslet.2010.05.031; Difilippantonio S, 2005, NAT CELL BIOL, V7, P675, DOI 10.1038/ncb1270; Fugger K, 2015, CELL REP; Gamper AM, 2012, J BIOL CHEM, V287, P12445, DOI 10.1074/jbc.M112.352310; GLOVER TW, 1984, HUM GENET, V67, P136, DOI 10.1007/BF00272988; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Harrigan JA, 2011, J CELL BIOL, V193, P97, DOI 10.1083/jcb.201011083; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kanu N, 2008, CELL CYCLE, V7, P3483, DOI 10.4161/cc.7.22.7044; Kanu N, 2007, EMBO J, V26, P2933, DOI 10.1038/sj.emboj.7601733; Kawabe Y, 2001, J BIOL CHEM, V276, P20364, DOI 10.1074/jbc.C100035200; Lee JH, 2007, ONCOGENE, V26, P7741, DOI 10.1038/sj.onc.1210872; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Lilley CE, 2010, EMBO J, V29, P943, DOI 10.1038/emboj.2009.400; Loizou JI, 2011, CANCER CELL, V19, P587, DOI 10.1016/j.ccr.2011.03.022; Lukas C, 2011, NAT CELL BIOL, V13, P243, DOI 10.1038/ncb2201; McNees CJ, 2005, EMBO J, V24, P2447, DOI 10.1038/sj.emboj.7600704; Niimi A, 2008, P NATL ACAD SCI USA, V105, P16125, DOI 10.1073/pnas.0802727105; Olcina MM, 2013, MOL CELL, V52, P758, DOI 10.1016/j.molcel.2013.10.019; Parker Joanne L, 2012, Methods Mol Biol, V920, P569, DOI 10.1007/978-1-61779-998-3_37; Payne BTI, 2006, NUCLEIC ACIDS RES, V34, P5194, DOI 10.1093/nar/gkl682; Saugar I, 2012, NUCLEIC ACIDS RES, V40, P245, DOI 10.1093/nar/gkr738; Schmidt L, 2014, DNA REPAIR, V24, P122, DOI 10.1016/j.dnarep.2014.09.001; Sirbu BM, 2011, GENE DEV, V25, P1320, DOI 10.1101/gad.2053211; Soutoglou E, 2007, NAT CELL BIOL, V9, P675, DOI 10.1038/ncb1591; Trenz K, 2006, EMBO J, V25, P1764, DOI 10.1038/sj.emboj.7601045; Ulrich HD, 2009, DNA REPAIR, V8, P461, DOI 10.1016/j.dnarep.2009.01.006; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Ying SM, 2013, NAT CELL BIOL, V15, P1001, DOI 10.1038/ncb2773; Yoshimura A, 2009, GENES GENET SYST, V84, P171, DOI 10.1266/ggs.84.171; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897; Zhang ZT, 2012, CELL CYCLE, V11, P2128, DOI 10.4161/cc.20595	48	24	24	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 28	2016	35	30					4009	4019		10.1038/onc.2015.427	http://dx.doi.org/10.1038/onc.2015.427			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DS8DJ	26549024	Green Accepted, Green Submitted			2022-12-26	WOS:000381013100012
J	Prajapati, RK; Sengupta, S; Rudra, P; Mukhopadhyay, J				Prajapati, Ranjit Kumar; Sengupta, Shreya; Rudra, Paulami; Mukhopadhyay, Jayanta			Bacillus subtilis delta Factor Functions as a Transcriptional Regulator by Facilitating the Open Complex Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL DOMAIN; RNA-POLYMERASE; ESCHERICHIA-COLI; MYCOBACTERIUM-TUBERCULOSIS; STREPTOCOCCUS-MUTANS; PROMOTER SELECTIVITY; SUBUNIT; DNA; PROTEIN; ELONGATION	Most bacterial RNA polymerases (RNAP) contain five conserved subunits, viz. 2 alpha , beta, beta ', and omega. However, in many Grampositive bacteria, especially in fermicutes, RNAP is associated with an additional factor, called delta. For over three decades since its identification, it had been thought that delta functioned as a subunit of RNAP to enhance the level of transcripts by recycling RNAP. In support of the previous observations, we also find that delta is involved in recycling of RNAP by releasing the RNA from the ternary complex. We further show that delta binds to RNA and is able to recycle RNAP when the length of the nascent RNA reaches a critical length. However, in this work we decipher a new function of delta. Performing biochemical and mutational analysis, we show that Bacillus subtilis delta binds to DNA immediately upstream of the promoter element at A-rich sequences on the abrB and rrnB1 promoters and facilitates open complex formation. As a result, delta facilitates RNAP to initiate transcription in the second scale, compared with minute scale in the absence of delta. Using transcription assay, we show that delta-mediated recycling of RNAP cannot be the sole reason for the enhancement of transcript yield. Our observation that delta does not bind to RNAP holo enzyme but is required to bind to DNA upstream of the -35 promoter element for transcription activation suggests that delta functions as a transcriptional regulator.	[Prajapati, Ranjit Kumar; Sengupta, Shreya; Rudra, Paulami; Mukhopadhyay, Jayanta] Bose Inst, Dept Chem, Kolkata 700009, India	Department of Science & Technology (India); Bose Institute	Mukhopadhyay, J (corresponding author), Bose Inst, Dept Chem, Kolkata 700009, India.	jayanta@jcbose.ac.in	Rudra, Paulami/ABD-2534-2022	Prajapati, Ranjit/0000-0002-9294-3537	Department of Biotechnology, Ministry of Science and Technology, India [BT/PR5345/MED/29/648/2012, BT/PR5270/BRB/10/1066/2012]; CSIR India	Department of Biotechnology, Ministry of Science and Technology, India; CSIR India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by Research Grants BT/PR5345/MED/29/648/2012 and BT/PR5270/BRB/10/1066/2012 from the Department of Biotechnology, Ministry of Science and Technology, India. The authors declare that they have no conflicts of interest with the contents of this article.r Recipient of fellowships from CSIR India.	Aravind L, 2012, CELL CYCLE, V11, P119, DOI 10.4161/cc.11.1.18475; ARNDT KM, 1990, J MOL BIOL, V213, P79, DOI 10.1016/S0022-2836(05)80123-8; Banerjee R, 2015, J BACTERIOL, V197, P646, DOI 10.1128/JB.02445-14; CHOY HE, 1995, EMBO J, V14, P4523, DOI 10.1002/j.1460-2075.1995.tb00131.x; DAUBENDIEK SL, 1995, J AM CHEM SOC, V117, P7818, DOI 10.1021/ja00134a032; Davydova EK, 2003, P NATL ACAD SCI USA, V100, P9250, DOI 10.1073/pnas.1133325100; de Saro FJL, 1999, J BIOL CHEM, V274, P15953, DOI 10.1074/jbc.274.22.15953; Demo G, 2014, J STRUCT BIOL, V187, P174, DOI 10.1016/j.jsb.2014.06.001; DESARO FJL, 1995, J MOL BIOL, V252, P189, DOI 10.1006/jmbi.1995.0487; DICKEL CD, 1980, BIOCHEM BIOPH RES CO, V95, P1789, DOI 10.1016/S0006-291X(80)80106-9; DOBINSON KF, 1987, BIOCHEMISTRY-US, V26, P8206, DOI 10.1021/bi00399a028; Gao HC, 2004, CURR MICROBIOL, V48, P401, DOI 10.1007/s00284-003-4229-8; HELMANN JD, 1995, NUCLEIC ACIDS RES, V23, P2351, DOI 10.1093/nar/23.13.2351; HYDE EI, 1986, J BIOL CHEM, V261, P6565; JUANG YL, 1994, J MOL BIOL, V239, P1, DOI 10.1006/jmbi.1994.1346; Kim YG, 2008, BIOCONJUGATE CHEM, V19, P786, DOI 10.1021/bc7002499; Kolb KE, 2014, J BIOL CHEM, V289, P1151, DOI 10.1074/jbc.M113.521393; Komissarova N, 1998, P NATL ACAD SCI USA, V95, P14699, DOI 10.1073/pnas.95.25.14699; Motackova V, 2010, PROTEINS, V78, P1807, DOI 10.1002/prot.22708; Mukhopadhyay J, 2003, METHOD ENZYMOL, V371, P144; Murakami KS, 2003, CURR OPIN STRUC BIOL, V13, P31, DOI 10.1016/S0959-440X(02)00005-2; Nudler E, 1998, SCIENCE, V281, P424, DOI 10.1126/science.281.5375.424; PERO J, 1975, P NATL ACAD SCI USA, V72, P1589, DOI 10.1073/pnas.72.4.1589; Quinones M, 2006, J BIOL CHEM, V281, P39407, DOI 10.1074/jbc.M609694200; Rabatinova A, 2013, J BACTERIOL, V195, P2603, DOI 10.1128/JB.00188-13; Rudra P, 2015, NUCLEIC ACIDS RES, V43, P5855, DOI 10.1093/nar/gkv516; Sambrook J., 2001, MOL CLONING LAB MANU; STEWART GC, 1983, NUCLEIC ACIDS RES, V11, P6289, DOI 10.1093/nar/11.18.6289; STRAUCH MA, 1989, MOL MICROBIOL, V3, P1203, DOI 10.1111/j.1365-2958.1989.tb00270.x; TJIAN R, 1977, EUR J BIOCHEM, V74, P149, DOI 10.1111/j.1432-1033.1977.tb11376.x; Varughese KI, 1998, MOL CELL, V2, P485, DOI 10.1016/S1097-2765(00)80148-3; Weiss A, 2014, INFECT IMMUN, V82, P1424, DOI 10.1128/IAI.01508-14; WILLIAMSON VM, 1979, MOL GEN GENET, V174, P47, DOI 10.1007/BF00433304; Xue XL, 2012, MICROBIOL-SGM, V158, P191, DOI 10.1099/mic.0.047936-0; Xue XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020075; Xue XL, 2010, J BACTERIOL, V192, P5081, DOI 10.1128/JB.00653-10; Yang X, 2008, PROTEIN EXPRES PURIF, V59, P86, DOI 10.1016/j.pep.2008.01.006	37	11	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1064	1075		10.1074/jbc.M115.686170	http://dx.doi.org/10.1074/jbc.M115.686170			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26546673	Green Published, hybrid			2022-12-26	WOS:000368068300004
J	Shah, S; Mostafa, MM; McWhae, A; Traves, SL; Newton, R				Shah, Suharsh; Mostafa, Mahmoud M.; McWhae, Andrew; Traves, Suzanne L.; Newton, Robert			Negative Feed-forward Control of Tumor Necrosis Factor (TNF) by Tristetraprolin (ZFP36) Is Limited by the Mitogen-activated Protein Kinase Phosphatase, Dual-specificity Phosphatase 1 (DUSP1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						dual-specificity phosphoprotein phosphatase; glucocorticoid; inflammation; mitogen-activated protein kinase (MAPK); tumor necrosis factor (TNF); anti-inflammatory; DUSP1; feed-forward control	ALPHA-MESSENGER-RNA; AU-RICH ELEMENTS; INNATE IMMUNE-RESPONSES; EPITHELIAL-CELLS; MAST-CELLS; P38 MAPK; GLUCOCORTICOID-RECEPTOR; CYTOKINE SECRETION; SIGNALING PATHWAYS; BINDING-PROTEIN	Background: ZFP36 negatively regulates AU-rich element-containing mRNAs. Results: DUSP1 silencing increases ZFP36 expression and enhances negative feed-forward control of TNF. Conclusion: MAPK inhibition initially attenuates TNF mRNA, but reduced feed-forward control subsequently produces an increase. Significance: Understanding such networks is essential to develop novel anti-inflammatory therapies or understand TNF repression by glucocorticoids, which may not require DUSP1 or ZFP36 expression. TNF is central to inflammation and may play a role in the pathogenesis of asthma. The 3-untranslated region of the TNF transcript contains AU-rich elements (AREs) that are targeted by the RNA-binding protein, tristetraprolin (also known as zinc finger protein 36 (ZFP36)), which is itself up-regulated by inflammatory stimuli, to promote mRNA degradation. Using primary human bronchial epithelial and pulmonary epithelial A549 cells, we confirm that interleukin-1 (IL1B) induces expression of dual-specificity phosphatase 1 (DUSP1), ZFP36, and TNF. Whereas IL1B-induced DUSP1 is involved in feedback control of MAPK pathways, ZFP36 exerts negative (incoherent) feed-forward control of TNF mRNA and protein expression. DUSP1 silencing increased IL1B-induced ZFP36 expression at 2 h and profoundly repressed TNF mRNA at 6 h. This was partly due to increased TNF mRNA degradation, an effect that was reduced by ZFP36 silencing. This confirms a regulatory network, whereby DUSP1-dependent negative feedback control reduces feed-forward control by ZFP36. Conversely, whereas DUSP1 overexpression and inhibition of MAPKs prevented IL1B-induced expression of ZFP36, this was associated with increased TNF mRNA expression at 6 h, an effect that was predominantly due to elevated transcription. This points to MAPK-dependent feed-forward control of TNF involving ZFP36-dependent and -independent mechanisms. In terms of repression by dexamethasone, neither silencing of DUSP1, silencing of ZFP36, nor silencing of both together prevented the repression of IL1B-induced TNF expression, thereby demonstrating the need for further repressive mechanisms by anti-inflammatory glucocorticoids. In summary, these data illustrate why understanding the competing effects of feedback and feed-forward control is relevant to the development of novel anti-inflammatory therapies.	[Shah, Suharsh; Mostafa, Mahmoud M.; McWhae, Andrew; Traves, Suzanne L.; Newton, Robert] Univ Calgary, Snyder Inst Chron Dis, Airways Inflammat Res Grp, Calgary, AB T2N 4N1, Canada	University of Calgary	Newton, R (corresponding author), Univ Calgary, Dept Cell Biol & Anat, Calgary, AB T2N 4N1, Canada.	rnewton@ucalgary.ca	Newton, Robert/C-6814-2012	Newton, Robert/0000-0002-4919-8498; Mostafa, Mahmoud/0000-0001-6377-911X	Canadian Institutes of Health Research [MOP68828, 125918]; Lung Association of Alberta; North West Territories Studentship; University of Calgary Studentship; Canadian Fund for Innovation; Alberta Science and Research Authority; AstraZeneca; GlaxoSmithKline; Alberta Innovates [201500268] Funding Source: researchfish	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Lung Association of Alberta; North West Territories Studentship; University of Calgary Studentship; Canadian Fund for Innovation; Alberta Science and Research Authority; AstraZeneca(AstraZeneca); GlaxoSmithKline(GlaxoSmithKline); Alberta Innovates	This research was supported by Canadian Institutes of Health Research Grants MOP68828 and 125918 (to R. N.) and by Lung Association of Alberta and the North West Territories and University of Calgary Studentships (to S. S.). Real-time PCR was performed by virtue of an equipment and infrastructure grant from the Canadian Fund for Innovation and the Alberta Science and Research Authority. Work in the laboratory of R. N. was also supported by grants from AstraZeneca and GlaxoSmithKline. The authors declare that they have no conflicts of interest with the contents of this article.	Abraham SM, 2006, BIOCHEM SOC T, V34, P1018, DOI 10.1042/BST0341018; Abraham SM, 2006, J EXP MED, V203, P1883, DOI 10.1084/jem.20060336; Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Aslam N, 2011, J BIOL CHEM, V286, P3767, DOI 10.1074/jbc.M110.168757; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Baumgartner RA, 1996, J IMMUNOL, V157, P4087; BISSONNETTE EY, 1995, CLIN EXP IMMUNOL, V102, P78; Brook M, 2006, MOL CELL BIOL, V26, P2408, DOI 10.1128/MCB.26.6.2408-2418.2006; Brook M, 2000, FEBS LETT, V483, P57, DOI 10.1016/S0014-5793(00)02084-6; Carballo E, 1997, J CLIN INVEST, V100, P986, DOI 10.1172/JCI119649; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Chi HB, 2006, P NATL ACAD SCI USA, V103, P2274, DOI 10.1073/pnas.0510965103; Chivers JE, 2006, MOL PHARMACOL, V70, P2084, DOI 10.1124/mol.106.025841; Clark AR, 2008, J BIOL CHEM, V283, P25765, DOI 10.1074/jbc.R700053200; Clark AR, 2007, MOL CELL ENDOCRINOL, V275, P79, DOI 10.1016/j.mce.2007.04.013; Clark AR, 2012, PHARMACOL THERAPEUT, V134, P54, DOI 10.1016/j.pharmthera.2011.12.004; Clark AR, 2009, ARTHRITIS RHEUM-US, V60, P3513, DOI 10.1002/art.24919; Crawford EK, 1997, J BIOL CHEM, V272, P21120, DOI 10.1074/jbc.272.34.21120; Darnell JE, 2013, RNA, V19, P443, DOI 10.1261/rna.038596.113; Dean JLE, 2004, CELL SIGNAL, V16, P1113, DOI 10.1016/j.cellsig.2004.04.006; Dean JLE, 2003, J BIOL CHEM, V278, P39470, DOI 10.1074/jbc.M306345200; Dean JLE, 2001, MOL CELL BIOL, V21, P721, DOI 10.1128/MCB.21.3.721-730.2001; Dean JLE, 1999, J BIOL CHEM, V274, P264, DOI 10.1074/jbc.274.1.264; Deleault KM, 2008, MOL IMMUNOL, V45, P13, DOI 10.1016/j.molimm.2007.05.017; Falvo JV, 2010, CURR DIR AUTOIMMUN, V11, P27, DOI 10.1159/000289196; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; Holden NS, 2007, BRIT J PHARMACOL, V152, P891, DOI 10.1038/sj.bjp.0707457; Horiuchi T, 2010, RHEUMATOLOGY, V49, P1215, DOI 10.1093/rheumatology/keq031; Hudy MH, 2010, EUR RESPIR J, V35, P1256, DOI 10.1183/09031936.00128809; Huotari N, 2012, APMIS, V120, P988, DOI 10.1111/j.1600-0463.2012.02927.x; Ishmael FT, 2008, J IMMUNOL, V180, P8342, DOI 10.4049/jimmunol.180.12.8342; Jalonen U, 2005, BIOCHEM PHARMACOL, V69, P733, DOI 10.1016/j.bcp.2004.11.027; Kassel O, 2001, EMBO J, V20, P7108, DOI 10.1093/emboj/20.24.7108; Khair OA, 1996, EUR RESPIR J, V9, P1913, DOI 10.1183/09031936.96.09091913; King EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053936; King EM, 2009, J BIOL CHEM, V284, P26803, DOI 10.1074/jbc.M109.028381; King EM, 2009, J PHARMACOL EXP THER, V330, P575, DOI 10.1124/jpet.109.151423; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lippert U, 2000, EXP DERMATOL, V9, P118, DOI 10.1034/j.1600-0625.2000.009002118.x; Mahtani KR, 2001, MOL CELL BIOL, V21, P6461, DOI 10.1128/MCB.21.9.6461-6469.2001; MALTER JS, 1989, SCIENCE, V246, P664, DOI 10.1126/science.2814487; Manetsch M, 2012, CELL SIGNAL, V24, P907, DOI 10.1016/j.cellsig.2011.12.013; MCGEEHAN GM, 1994, NATURE, V370, P558, DOI 10.1038/370558a0; Newton R, 2000, THORAX, V55, P603, DOI 10.1136/thorax.55.7.603; Newton R, 1998, J BIOL CHEM, V273, P32312, DOI 10.1074/jbc.273.48.32312; Newton R, 2007, MOL PHARMACOL, V72, P799, DOI 10.1124/mol.107.038794; Newton R, 2014, EUR J PHARMACOL, V724, P231, DOI 10.1016/j.ejphar.2013.05.035; Newton R, 2010, BIOCHEM J, V427, P113, DOI 10.1042/BJ20091038; Prabhala P, 2015, AM J PHYSIOL-LUNG C, V308, pL973, DOI 10.1152/ajplung.00219.2014; Qiu LQ, 2015, J LEUKOCYTE BIOL, V97, P723, DOI 10.1189/jlb.3A0214-106R; Ronkina N, 2010, BIOCHEM PHARMACOL, V80, P1915, DOI 10.1016/j.bcp.2010.06.021; Sandler H, 2008, BIOCHEM SOC T, V36, P491, DOI 10.1042/BST0360491; Shah S, 2014, J BIOL CHEM, V289, P13667, DOI 10.1074/jbc.M113.540799; Shi JX, 2014, INT IMMUNOPHARMACOL, V22, P480, DOI 10.1016/j.intimp.2014.07.031; Smallie T, 2015, J IMMUNOL, V195, P277, DOI 10.4049/jimmunol.1402830; Smoak K, 2006, MOL CELL BIOL, V26, P9126, DOI 10.1128/MCB.00679-06; Solomon KA, 1997, J IMMUNOL, V159, P4524; Swantek JL, 1997, MOL CELL BIOL, V17, P6274, DOI 10.1128/MCB.17.11.6274; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Tudor C, 2009, FEBS LETT, V583, P1933, DOI 10.1016/j.febslet.2009.04.039; WILLIAMS CMM, 1995, IMMUNOLOGY, V86, P244; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; Winzen R, 2007, MOL CELL BIOL, V27, P8388, DOI 10.1128/MCB.01493-07; Zhao Y, 2004, INFLAMM RES, V53, P664, DOI 10.1007/s00011-004-1309-6	66	19	20	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					110	125		10.1074/jbc.M115.697599	http://dx.doi.org/10.1074/jbc.M115.697599			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26546680	Green Published, hybrid			2022-12-26	WOS:000367589500009
J	Huang, J; Han, SS; Qin, DD; Wu, LH; Song, Y; Yu, F; Wang, SX; Liu, G; Zhao, MH				Huang, Jing; Han, Sha-sha; Qin, Dan-dan; Wu, Li-hua; Song, Yan; Yu, Feng; Wang, Su-xia; Liu, Gang; Zhao, Ming-hui			Renal Interstitial Arteriosclerotic Lesions in Lupus Nephritis Patients: A Cohort Study from China	PLOS ONE			English	Article							VASCULAR-LESIONS; AMERICAN-COLLEGE; IMMUNE-COMPLEXES; DISEASE-ACTIVITY; ERYTHEMATOSUS; ATHEROSCLEROSIS; MORTALITY; GLOMERULONEPHRITIS; CYCLOPHOSPHAMIDE; CLASSIFICATION	Objective The aim of this study was to evaluate renal arteriosclerotic lesions in patients with lupus nephritis and investigate their associations with clinical and pathological characteristics, especially cardio-vascular features. Design A retrospective cohort study. Participants Seventy-nine patients with renal biopsy-proven lupus nephritis, diagnosed between January 2000 and June 2008 from Peking University First Hospital. Results In clinico-pathological data, patients with arteriosclerosis had higher ratio of hypertension and more severe renal injury indices compared with patients with no renal vascular lesions. More importantly, patients with renal arteriosclerosis had worse cardiac structure and function under transthoracic echocardiographic examination. Patients with renal arteriosclerosis tend to have higher ratios of combined endpoints compared with those of no renal vascular lesions, although the difference didn't reach statistical meanings (P = 0.104). Conclusion Renal arteriosclerotic lesion was common and associated with vascular immune complex deposits in lupus nephritis. It might have a certain degree of association with poor outcomes and cardiovascular events, which needs further explorations.	[Huang, Jing; Han, Sha-sha; Yu, Feng; Wang, Su-xia; Liu, Gang; Zhao, Ming-hui] Peking Univ, Hosp 1, Dept Med, Div Renal, Beijing 100034, Peoples R China; [Huang, Jing; Han, Sha-sha; Yu, Feng; Wang, Su-xia; Liu, Gang; Zhao, Ming-hui] Peking Univ, Inst Nephrol, Beijing 100034, Peoples R China; [Huang, Jing; Han, Sha-sha; Yu, Feng; Wang, Su-xia; Liu, Gang; Zhao, Ming-hui] Minist Hlth China, Key Lab Renal Dis, Beijing 100034, Peoples R China; [Huang, Jing; Han, Sha-sha; Yu, Feng; Wang, Su-xia; Liu, Gang; Zhao, Ming-hui] Minist Educ China, Key Lab CKD Prevent & Treatment, Beijing 100034, Peoples R China; [Qin, Dan-dan] Harbin Med Univ, Affiliated Hosp 2, Dept Nephrol, Harbin 150000, Heilongjiang, Peoples R China; [Wu, Li-hua] Ningxia Med Univ, Gen Hosp, Dept Nephrol, Yinchuan 750004, Ningxia, Peoples R China; [Song, Yan] Chinese Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Nephrol, Beijing 100048, Peoples R China; [Zhao, Ming-hui] Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China	Peking University; Peking University; Ministry of Education, China; Harbin Medical University; Ningxia Medical University; Chinese People's Liberation Army General Hospital	Song, Y (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Nephrol, 51 Fucheng Rd, Beijing 100048, Peoples R China.	songyan0209@163.com; yufengevert1@sina.com			Chinese 973 project [2012CB517702]; National Natural Science Foundation of China [81321064, 81470932]	Chinese 973 project(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by (1) a grant of Chinese 973 project (No. 2012CB517702), Ming-hui Zhao designed and directed the study; (2) National Natural Science Foundation of China to Innovation Research Group (No. 81321064), http://www.nsfc.gov.cn/, Ming-hui Zhao designed and directed the study; (3) National Natural Science Foundation of China (No. 81470932), http://www.nsfc.gov.cn/, Feng Yu recruited patients, collected samples and clinical data of patients, designed and directed the study.	Andreoli L, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0343-1; APPEL GB, 1994, J AM SOC NEPHROL, V4, P1499; Asanuma Y, 2003, NEW ENGL J MED, V349, P2407, DOI 10.1056/NEJMoa035611; AUSTIN HA, 1994, KIDNEY INT, V45, P544, DOI 10.1038/ki.1994.70; AUSTIN HA, 1984, KIDNEY INT, V25, P689, DOI 10.1038/ki.1984.75; BANFI G, 1991, AM J KIDNEY DIS, V18, P240, DOI 10.1016/S0272-6386(12)80885-7; Berden JHM, 1997, KIDNEY INT, V52, P538, DOI 10.1038/ki.1997.365; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Cervera R, 2006, AUTOIMMUN REV, V5, P180, DOI 10.1016/j.autrev.2005.06.004; Cervera R, 2003, MEDICINE, V82, P299, DOI 10.1097/01.md.0000091181.93122.55; Cervera R, 2006, AUTOIMMUN REV, V5, P549, DOI 10.1016/j.autrev.2006.02.015; Chan TM, 2005, LUPUS, V14, P265, DOI 10.1191/0961203305lu2081oa; Cheitlin MD, 2003, CIRCULATION, V108, P1146, DOI 10.1161/01.CIR.0000073597.57414.A9; Contreras G, 2004, NEW ENGL J MED, V350, P971, DOI 10.1056/NEJMoa031855; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; de Leeuw K, 2009, ATHEROSCLEROSIS, V206, P546, DOI 10.1016/j.atherosclerosis.2009.03.018; Descombes E, 1997, MEDICINE, V76, P355, DOI 10.1097/00005792-199709000-00003; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Griffin B, 2013, LUPUS, V22, P1267, DOI 10.1177/0961203313505927; GRISHMAN E, 1988, MODERN PATHOL, V1, P235; Grootscholten C, 2006, KIDNEY INT, V70, P732, DOI 10.1038/sj.ki.5001630; Hallan SI, 2012, JAMA-J AM MED ASSOC, V308, P2349, DOI 10.1001/jama.2012.16817; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Inoue T, 2012, THER APHER DIAL, V16, P134, DOI 10.1111/j.1744-9987.2011.01048.x; JONSSON H, 1989, MEDICINE, V68, P141, DOI 10.1097/00005792-198905000-00002; LEONG KH, 1994, J RHEUMATOL, V21, P1264; Lewis MJ, 2012, ARTHRITIS RHEUM-US, V64, P2707, DOI 10.1002/art.34451; LIANG MH, 1989, ARTHRITIS RHEUM, V32, P1107, DOI 10.1002/anr.1780320909; Mak A, 2007, LUPUS, V16, P28, DOI 10.1177/0961203306074469; Mattos P, 2011, CLIN RHEUMATOL, V30, P165, DOI 10.1007/s10067-010-1662-5; McMahon M, 2007, CURR OPIN IMMUNOL, V19, P633, DOI 10.1016/j.coi.2007.11.001; Mustafa A, 2000, CIRCULATION, V102, P2576; Narshi CB, 2011, LUPUS, V20, P5, DOI 10.1177/0961203310382429; ROSNER S, 1982, ARTHRITIS RHEUM, V25, P612, DOI 10.1002/art.1780250602; Sun WP, 2013, LAB INVEST, V93, P626, DOI 10.1038/labinvest.2013.61; Thacker SG, 2012, ARTHRITIS RHEUM-US, V64, P2975, DOI 10.1002/art.34504; UROWITZ MB, 1976, AM J MED, V60, P221, DOI 10.1016/0002-9343(76)90431-9; Wang HY, 2008, LUPUS, V17, P638, DOI 10.1177/0961203308089408; Wang J, 2007, LUPUS, V16, P707, DOI 10.1177/0961203307081340; Weening JJ, 2004, KIDNEY INT, V65, P521, DOI 10.1111/j.1523-1755.2004.00443.x; Wu LH, 2013, KIDNEY INT, V83, P715, DOI 10.1038/ki.2012.409; Zhang JJ, 2008, NEPHROLOGY, V13, P712, DOI 10.1111/j.1440-1797.2008.00983.x	42	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141547	10.1371/journal.pone.0141547	http://dx.doi.org/10.1371/journal.pone.0141547			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544865	gold, Green Published, Green Submitted			2022-12-26	WOS:000364398700033
J	Prieto, C; Destouni, G				Prieto, Carmen; Destouni, Georgia			Climate-Driven Phenological Change: Developing Robust Spatiotemporal Modeling and Projection Capability	PLoS One			English	Article							BUTTERFLIES; TEMPERATURE; INSOLATION	Our possibility to appropriately detect, interpret and respond to climate-driven phenological changes depends on our ability to model and predict the changes. This ability may be hampered by non-linearity in climate-phenological relations, and by spatiotemporal variability and scale mismatches of climate and phenological data. A modeling methodology capable of handling such complexities can be a powerful tool for phenological change projection. Here we develop such a methodology using citizen scientists' observations of first flight dates for orange tip butterflies (Anthocharis cardamines) in three areas extending along a steep climate gradient. The developed methodology links point data of first flight observations to calculated cumulative degree-days until first flight based on gridded temperature data. Using this methodology we identify and quantify a first flight model that is consistent across different regions, data support scales and assumptions of subgrid variability and observation bias. Model application to observed warming over the past 60 years demonstrates the model usefulness for assessment of climate-driven first flight change. The cross-regional consistency of the model implies predictive capability for future changes, and calls for further application and testing of analogous modeling approaches to other species, phenological variables and parts of the world.	[Prieto, Carmen; Destouni, Georgia] Stockholm Univ, Bolin Ctr Climate Res, Dept Phys Geog, S-10691 Stockholm, Sweden	Stockholm University	Prieto, C (corresponding author), Stockholm Univ, Bolin Ctr Climate Res, Dept Phys Geog, S-10691 Stockholm, Sweden.	carmen.prieto@natgeo.su.se	Destouni, Georgia/AAS-5375-2020; Destouni, Georgia/M-9662-2016	Destouni, Georgia/0000-0001-9408-4425; Destouni, Georgia/0000-0001-9408-4425	strategic program Ekoklim at Stockholm University	strategic program Ekoklim at Stockholm University	The authors acknowledge financial funding for this research from the strategic program Ekoklim at Stockholm University (http://www.zoologi.su.se/ekoklim/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CIBSE, 2006, DEGREE DAYS THEORY A; Forister ML, 2003, GLOBAL CHANGE BIOL, V9, P1130, DOI 10.1046/j.1365-2486.2003.00643.x; Gienapp P, 2005, GLOBAL CHANGE BIOL, V11, P600, DOI 10.1111/j.1365-2486.2005.00925.x; Haylock MR, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD010201; Hodgson JA, 2011, GLOBAL CHANGE BIOL, V17, P1289, DOI 10.1111/j.1365-2486.2010.02308.x; Karlsson B, 2014, INT J BIOMETEOROL, V58, P691, DOI 10.1007/s00484-013-0649-8; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Posledovich D, 2014, BIOL J LINN SOC, V113, P981, DOI 10.1111/bij.12371; Roy DB, 2000, GLOB CHANGE BIOL, V6, P407, DOI 10.1046/j.1365-2486.2000.00322.x; Stefanescu C, 2003, GLOBAL CHANGE BIOL, V9, P1494, DOI 10.1046/j.1365-2486.2003.00682.x; [Swedish Environmental Protection Agency Swedish Species Information Centre], 2012, ARTP; Vercauteren N, 2014, J APPL METEOROL CLIM, V53, P323, DOI 10.1175/JAMC-D-13-0217.1; Vercauteren N, 2013, J APPL METEOROL CLIM, V52, P1208, DOI 10.1175/JAMC-D-12-0115.1; Westwood AR, 2010, ENVIRON ENTOMOL, V39, P1122, DOI 10.1603/EN09143	14	2	2	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141207	10.1371/journal.pone.0141207	http://dx.doi.org/10.1371/journal.pone.0141207			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545112	Green Published, gold, Green Submitted			2022-12-26	WOS:000364398700019
J	Qin, L; Zhang, LF; Zhang, YQ; Shi, XC; Zhang, Y; Liu, XQ				Qin, Ling; Zhang, Lifan; Zhang, Yueqiu; Shi, Xiaochun; Zhang, Yao; Liu, Xiaoqing			Diagnostic Value of T-Cell Interferon-gamma Release Assays on Cerebrospinal Fluid for Tuberculous Meningitis	PLOS ONE			English	Article							RAPID DIAGNOSIS; SKIN-TEST; INFECTION; ENUMERATION; DISEASE	Diagnosis of tuberculous meningitis (TBM) remains a challenge. This study aimed to evaluate the performance of T-SPOT. TB test on cerebrospinal fluid mononuclear cells (CSFMCs) for suspected TBM patients. 43 consecutive patients with suspected TBM were enrolled in the study from June 2011 to September 2014. T-SPOT. TB was performed on both CSFMCs and peripheral blood mononuclear cells (PBMCs). The final diagnosis of TBM was independent of the T-SPOT. TB result. The diagnostic sensitivity, specificity, predictive value, and likelihood ratio of T-SPOT. TB on CSFMCs and PBMCs were analyzed. Of the 43 patients, 12 (27.9%) were finally diagnosed with TBM, 28 (65.1%) with non-TBM, and 3 (7.0%) with indeterminate diagnoses. Of 40 cases with definite diagnoses, the sensitivity and specificity were 92.0% and 96.0% for T-SPOT. TB on CSFMCs, and 83.0% and 82.0% for T-SPOT. TB on PBMCs, respectively. The positive predictive value (PPV) and negative predictive value (NPV) of T-SPOT. TB on CSFMCs were 85.0% and 96.0%, respectively. The PPV and NPV were 67.0% and 92.0% for T-SPOT. TB on PBMCs. The difference of T-SPOT. TB between CSFMCs and PBMCs was not significant so far as sensitivity, specificity, PPV, and NPV were concerned (P>0.05 for each). However, T-SPOT. TB on CSFMC and CSFMC: PBMC in TBM cases seemed higher than that in non-TBM cases. Our study further showed that T-SPOT. TB on CSFMCs might be a rapid and accurate diagnostic test for TBM. CSFMC: PBMC T-SPOT. TB ratio might be useful for the early diagnosis of TBM.	[Qin, Ling; Zhang, Lifan; Zhang, Yueqiu; Shi, Xiaochun; Liu, Xiaoqing] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Infect Dis, Beijing 100730, Peoples R China; [Qin, Ling; Zhang, Lifan; Zhang, Yueqiu; Shi, Xiaochun; Liu, Xiaoqing] Peking Union Med Coll, Beijing 100730, Peoples R China; [Zhang, Lifan; Zhang, Yao; Liu, Xiaoqing] Peking Union Med Coll, Clin Epidemiol Unit, Int Clin Epidemiol Network, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Liu, XQ (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Infect Dis, Beijing 100730, Peoples R China.	liuxqpumch@126.com			National Major Science and Technology Research Projects for the Control and Prevention of Major Infectious Diseases of China [2014ZX10003003]; Health Research & Special Projects [201402001]	National Major Science and Technology Research Projects for the Control and Prevention of Major Infectious Diseases of China; Health Research & Special Projects	This study was supported by grants from the National Major Science and Technology Research Projects for the Control and Prevention of Major Infectious Diseases of China (2014ZX10003003; http://www.nmp.gov.cn/zxjs/crb/201012/t20101208_2127.htm), and the Health Research & Special Projects (201402001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu GN, 2008, NEUROSCI LETT, V436, P48, DOI 10.1016/j.neulet.2008.02.060; Bidstrup C, 2002, SCAND J INFECT DIS, V34, P811, DOI 10.1080/0036554021000026938; Ewer K, 2003, LANCET, V361, P1168, DOI 10.1016/S0140-6736(03)12950-9; Karam F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001441; Lalvani A, 2001, LANCET, V357, P2017, DOI 10.1016/S0140-6736(00)05115-1; Lee YM, 2013, INFECTION, V41, P1089, DOI 10.1007/s15010-013-0478-z; Pai M, 2003, LANCET INFECT DIS, V3, P633, DOI 10.1016/S1473-3099(03)00772-2; Park KH, 2012, EUR RESPIR J, V39, P768, DOI 10.1183/09031936.00098111; Patel VB, 2010, AM J RESP CRIT CARE, V182, P569, DOI 10.1164/rccm.200912-1931OC; Philip N, 2015, MALAYS J PATHOL, V37, P1; Rock RB, 2008, CLIN MICROBIOL REV, V21, P243, DOI 10.1128/CMR.00042-07; Takahashi Teruyuki, 2012, Tuberc Res Treat, V2012, P831292, DOI 10.1155/2012/831292; Thomas MM, 2008, INT J TUBERC LUNG D, V12, P651; Wilkinson KA, 2005, CLIN INFECT DIS, V40, P184, DOI 10.1086/426139; Zhang LF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0099946, 10.1371/journal.pone.0084950]	15	9	12	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141814	10.1371/journal.pone.0141814	http://dx.doi.org/10.1371/journal.pone.0141814			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545256	gold, Green Published, Green Submitted			2022-12-26	WOS:000364398700052
J	Zhao, W; Zhang, WZ; Yang, ZY; Liu, AQ; Zhang, LX; Yang, FK; Wang, RJ; Ling, H				Zhao, Wei; Zhang, Weizhe; Yang, Ziyin; Liu, Aiqin; Zhang, Longxian; Yang, Fengkun; Wang, Rongjun; Ling, Hong			Genotyping of Enterocytozoon bieneusi in Farmed Blue Foxes (Alopex lagopus) and Raccoon Dogs (Nyctereutes procyonoides) in China	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; GIARDIA-DUODENALIS; GENETIC DIVERSITY; NORTHEAST CHINA; MICROSPORIDIOSIS; PREVALENCE; CRYPTOSPORIDIUM; INFECTION; SPECIFICITY; CATTLE	Enterocytozoon bieneusi is the most common species of microsporidia found both in humans and animals. Farmed animals, particularly closely associated to humans, may play an important role of zoonotic reservoir in transmitting this disease to humans. The fur industry is a major economic component in some parts of China. To understand the prevalence, genotype variety and zoonotic risk of E. bieneusi in farmed foxes and raccoon dogs, two species of fur animals, fecal specimens of 110 blue foxes and 49 raccoon dogs from Heilongjiang and Jilin provinces in China were examined by internal transcribed spacer (ITS)-based PCR. E. bieneusi was detected in 16.4% (18/110) blue foxes and 4.1%(2/49) raccoon dogs. Altogether, four genotypes of E. bieneusi were identified, including two known genotypes D (n = 13) and EbpC (n = 5), and two novel genotypes named as CHN-F1 (n = 1) in a fox and CHN-R1 (n = 1) in a raccoon dog. Phylogenetic analysis revealed that all the four genotypes were the members of zoonotic group 1. Genotypes D and EbpC were found in humans previously. The findings of zoonotic genotypes of E. bieneusi in the foxes and raccoon dogs suggest these animals infected with E. bieneusi may pose a threat to human health.	[Zhao, Wei; Zhang, Weizhe; Yang, Ziyin; Liu, Aiqin; Yang, Fengkun; Ling, Hong] Harbin Med Univ China, Dept Parasitol, Harbin 150081, Heilongjiang, Peoples R China; [Zhao, Wei; Zhang, Weizhe; Yang, Ziyin; Liu, Aiqin; Yang, Fengkun; Ling, Hong] Harbin Med Univ, Heilongjiang Prov Key Lab Infect & Immun, Harbin 150081, Heilongjiang, Peoples R China; [Zhao, Wei; Zhang, Weizhe; Yang, Ziyin; Liu, Aiqin; Yang, Fengkun; Ling, Hong] Heilongjiang Key Lab Pathogen Biol, Harbin 150081, Heilongjiang, Peoples R China; [Zhang, Longxian; Wang, Rongjun] Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou 450002, Henan, Peoples R China	Harbin Medical University; Harbin Medical University; Henan Agricultural University	Liu, AQ (corresponding author), Harbin Med Univ China, Dept Parasitol, Harbin 150081, Heilongjiang, Peoples R China.	liuaiqin1128@126.com; Lingh@ems.hrbmu.edu.cn	Zhang, Longxian/R-7799-2019; Zhang, Longxian/I-9223-2019; Zhang, Longxian/HGE-1918-2022	Zhang, Longxian/0000-0002-5706-131X; ling, hong/0000-0002-1886-1242	State Key Program of the National Natural Science Foundation of China [31330079]; Heilongjiang Province Education Bureau [12531266]	State Key Program of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Heilongjiang Province Education Bureau	The study was supported partially by the State Key Program of the National Natural Science Foundation of China (grant 31330079) (Longxian Zhang) and the Heilongjiang Province Education Bureau of No. 12531266 (Aiqin Liu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben Ayed L, 2012, J WATER HEALTH, V10, P431, DOI 10.2166/wh.2012.204; Buckholt MA, 2002, APPL ENVIRON MICROB, V68, P2595, DOI 10.1128/AEM.68.5.2595-2599.2002; Cheng HWA, 2011, PARASITOL RES, V109, P595, DOI 10.1007/s00436-011-2291-x; Decraene V, 2012, EPIDEMIOL INFECT, V140, P519, DOI 10.1017/S095026881100077X; Didier ES, 2006, CURR OPIN INFECT DIS, V19, P485, DOI 10.1097/01.qco.0000244055.46382.23; Didier ES, 2011, CURR OPIN INFECT DIS, V24, P490, DOI 10.1097/QCO.0b013e32834aa152; Didier ES, 2005, ACTA TROP, V94, P61, DOI 10.1016/j.actatropica.2005.01.010; Fayer R, 2014, MICROSPORIDIA: PATHOGENS OF OPPORTUNITY, 1ST EDITION, P135; Guo YQ, 2014, APPL ENVIRON MICROB, V80, P218, DOI 10.1128/AEM.02997-13; Henriques-Gil N, 2010, APPL ENVIRON MICROB, V76, P3333, DOI 10.1128/AEM.03026-09; Hu Y, 2014, ENVIRON SCI TECHNOL, V48, P14219, DOI 10.1021/es504464t; Jiang YX, 2015, APPL ENVIRON MICROB, V81, P3326, DOI 10.1128/AEM.00328-15; Karim MR, 2014, PARASITOL RES, V113, P3041, DOI 10.1007/s00436-014-3967-9; Karim MR, 2014, APPL ENVIRON MICROB, V80, P1893, DOI 10.1128/AEM.03845-13; Keeling P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000489; Li N, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001809; Li W, 2015, VET PARASITOL, V208, P125, DOI 10.1016/j.vetpar.2015.01.014; Li W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108279; Galvan-Diaz AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092289; Matos Olga, 2012, J Parasitol Res, V2012, P981424, DOI 10.1155/2012/981424; Mori H, 2013, VET PARASITOL, V197, P696, DOI 10.1016/j.vetpar.2013.07.025; Santin M, 2011, RES VET SCI, V90, P363, DOI 10.1016/j.rvsc.2010.07.014; Santin M, 2009, J EUKARYOT MICROBIOL, V56, P34, DOI 10.1111/j.1550-7408.2008.00380.x; Sulaiman IM, 2003, APPL ENVIRON MICROB, V69, P4495, DOI 10.1128/AEM.69.8.4495-4501.2003; Widmer G, 2010, INFECT GENET EVOL, V10, P122, DOI 10.1016/j.meegid.2009.11.009; Yang JP, 2014, J CLIN MICROBIOL, V52, P4363, DOI 10.1128/JCM.02295-14; Ye JB, 2012, EMERG INFECT DIS, V18, P1640, DOI 10.3201/eid1810.120653; Zhao W, 2015, J EUKARYOT MICROBIOL, V62, P553, DOI 10.1111/jeu.12210; Zhao W, 2015, INFECT GENET EVOL, V32, P265, DOI 10.1016/j.meegid.2015.03.026; Zhao W, 2014, PARASITOL RES, V113, P4243, DOI 10.1007/s00436-014-4100-9; Zhao W, 2014, APPL ENVIRON MICROB, V80, P3699, DOI 10.1128/AEM.00807-14	31	29	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142611	10.1371/journal.pone.0142611	http://dx.doi.org/10.1371/journal.pone.0142611			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544711	Green Published, gold			2022-12-26	WOS:000364398700160
J	Mastalerz, L; Celinska-Lowenhoff, M; Krawiec, P; Batko, B; Tlustochowicz, W; Undas, A				Mastalerz, Lucyna; Celinska-Loewenhoff, Magdalena; Krawiec, Piotr; Batko, Bogdan; Tlustochowicz, Witold; Undas, Anetta			Unfavorably Altered Fibrin Clot Properties in Patients with Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome): Association with Thrombin Generation and Eosinophilia	PLOS ONE			English	Article							HYPEREOSINOPHILIC SYNDROME; MICROSCOPIC POLYANGIITIS; WEGENERS-GRANULOMATOSIS; POLYARTERITIS-NODOSA; CATIONIC PROTEIN; DISEASE; VASCULITIS; ARCHITECTURE; STRUCTURE/FUNCTION; HYPOFIBRINOLYSIS	Objectives Given reports on the increased prevalence of thromboembolic incidents in patients with eosinophilic granulomatosis with polyangiitis (EGPA; Churg-Strauss syndrome), we investigated whether fibrin clot properties are unfavorably altered in EGPA. Methods Ex vivo plasma fibrin clot characteristics, including clot permeability, turbidimetry and efficiency of fibrinolysis using two assays, were investigated in 34 consecutive patients with remission in EGPA according to the Birmingham Vasculitis Activity Score version 3 (23 female, 11 male), aged 48 (range, 21-80) years. The control group comprised 34 age-and sex-matched volunteers. Results Compared with controls, patients with EGPA were characterized by denser fiber clots (estimated pore size, Ks, 7.30 +/- 0.93 vs 10.14 +/- 1.07 10(-9) cm(2)), faster fibrin polymerization (lag phase in a turbidimetric curve, 41.8 +/- 3.6 vs 47.4 +/- 2.9 s), thicker fibrin fibers (maximum absorbance,Delta Abs, 0.87 +/- 0.09 vs 0.72 +/- 0.07), higher maximum levels of D-dimer released from clots (DDmax 4.10 +/- 0.46 vs 3.54 +/- 0.35 mg/L), and prolonged clot lysis time (t(50%); 9.50 +/- 1.45 vs 7.56 +/- 0.87 min); all p<0.0001. Scanning electron microscopy images confirmed denser plasma fibrin networks composed of thinner fibers formed in EGPA. Antineutrophil cytoplasmic antibody status and C-reactive protein did not affect clot variables. Multivariate analysis adjusted for fibrinogen showed that Ks was predicted by eosinophil count, peak thrombin generation, factor VIII, and soluble CD40 ligand, whereas eosinophil count, peak thrombin generation and antiplasmin predicted t(50%). Conclusion This study is the first to show that EGPA is associated with prothrombotic plasma fibrin clot phenotype, which may contribute to thromboembolic manifestations reported in this disease.	[Mastalerz, Lucyna; Celinska-Loewenhoff, Magdalena] Jagiellonian Univ, Coll Med, Dept Med 2, Krakow, Poland; [Krawiec, Piotr; Batko, Bogdan] Dietl Hosp, Dept Rheumatol, Krakow, Poland; [Tlustochowicz, Witold] Cent Clin Hosp, Mil Inst, Dept Internal Dis & Rheumatol, Dept Natl Def,Hlth Serv, Warsaw, Poland; [Undas, Anetta] Jagiellonian Univ, Coll Med, Inst Cardiol, Krakow, Poland	Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University	Undas, A (corresponding author), Jagiellonian Univ, Coll Med, Inst Cardiol, Krakow, Poland.	mmundas@cyf-kr.edu.pl	Batko, Bogdan/D-5548-2019; Krawiec, Piotr/A-7578-2015; Mastalerz, Lucyna/U-5974-2018	Batko, Bogdan/0000-0003-3999-8093; Mastalerz, Lucyna/0000-0002-8994-0036	Jagiellonian University Medical College [K/ZDS/002936]	Jagiellonian University Medical College	The study was funded by Jagiellonian University Medical College (grant K/ZDS/002936 to AU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Dieri R, 2012, BLOOD REV, V26, P197, DOI 10.1016/j.blre.2012.06.001; Allenbach Y, 2009, ANN RHEUM DIS, V68, P564, DOI 10.1136/ard.2008.099051; Ames PRJ, 2010, CLIN APPL THROMB-HEM, V16, P628, DOI 10.1177/1076029609348647; Bochner BS, 2010, J ALLERGY CLIN IMMUN, V126, P16, DOI 10.1016/j.jaci.2010.02.026; Celinska-Lowenhoff M, 2014, THROMB HAEMOSTASIS, V112, P287, DOI 10.1160/TH13-11-0980; Collet JP, 2006, ARTERIOSCL THROM VAS, V26, P2567, DOI 10.1161/01.ATV.0000241589.52950.4c; Collet JP, 1999, THROMB HAEMOSTASIS, V82, P1482; Comarmond C, 2013, ARTHRITIS RHEUM-US, V65, P270, DOI 10.1002/art.37721; Cugno M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111862; Dejaco C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121737; FATAH K, 1992, THROMB HAEMOSTASIS, V68, P130; Flossmann O, 2007, ANN RHEUM DIS, V66, P283, DOI 10.1136/ard.2005.051078; FREDENS K, 1991, ALLERGY, V46, P27, DOI 10.1111/j.1398-9995.1991.tb00538.x; FRIES JF, 1990, ARTHRITIS RHEUM, V33, P1135; Garcia G, 2005, ALLERGY, V60, P409, DOI 10.1111/j.1398-9995.2004.00691.x; Grayson PC, 2015, RHEUMATOLOGY, V54, P1351, DOI 10.1093/rheumatology/keu427; Keceoglu S, 2014, CLIN APPL THROMB-HEM, V20, P285, DOI 10.1177/1076029613483208; Khoury P, 2014, NAT REV RHEUMATOL, V10, P474, DOI 10.1038/nrrheum.2014.98; Kojima K, 1995, INTERNAL MED, V34, P1194, DOI 10.2169/internalmedicine.34.1194; Kurdee Z, 2014, POL ARCH MED WEWN, V124, P617, DOI 10.20452/pamw.2501; Kwasny-Krochin B, 2010, THROMB RES, V126, pE11, DOI 10.1016/j.thromres.2010.04.007; Mahr A, 2004, ARTHRIT RHEUM-ARTHR, V51, P92, DOI 10.1002/art.20077; Maino A, 2012, CURR VASC PHARMACOL, V10, P670, DOI 10.2174/157016112801784594; Miedinger D, 2011, CURR MED RES OPIN, V27, P2301, DOI 10.1185/03007995.2011.630722; Mills JD, 2002, CIRCULATION, V106, P1938, DOI 10.1161/01.CIR.0000033221.73082.06; Pagnoux C, 2007, CURR OPIN RHEUMATOL, V19, P25, DOI 10.1097/BOR.0b013e3280119854; Sovershaev MA, 2008, J THROMB HAEMOST, V6, P1742, DOI 10.1111/j.1538-7836.2008.03105.x; Undas A, 2008, ATHEROSCLEROSIS, V196, P551, DOI 10.1016/j.atherosclerosis.2007.05.028; Undas A, 2014, THROMB HAEMOSTASIS, V112, P32, DOI 10.1160/TH14-01-0032; Undas A, 2011, ARTERIOSCL THROM VAS, V31, pE88, DOI 10.1161/ATVBAHA.111.230631; Undas A, 2010, ARTERIOSCL THROM VAS, V30, P276, DOI 10.1161/ATVBAHA.109.194936; Undas A, 2009, BLOOD, V114, P4272, DOI 10.1182/blood-2009-05-222380; Undas A, 2009, STROKE, V40, P1499, DOI 10.1161/STROKEAHA.108.532812; Vaglio A, 2013, ALLERGY, V68, P261, DOI 10.1111/all.12088; Wolberg AS, 2007, BLOOD REV, V21, P131, DOI 10.1016/j.blre.2006.11.001; Xu X, 2000, CLIN EXP ALLERGY, V30, P794; Zolcinski M, 2010, J HEART VALVE DIS, V19, P596	37	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142167	10.1371/journal.pone.0142167	http://dx.doi.org/10.1371/journal.pone.0142167			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540111	gold, Green Published, Green Submitted			2022-12-26	WOS:000364303800062
J	Villalpando, DM; Navarro, R; del Campo, L; Largo, C; Munoz, D; Tabernero, M; Baeza, R; Otero, C; Garcia, HS; Ferrer, M				Villalpando, Diva M.; Navarro, Rocio; del Campo, Lara; Largo, Carlota; Munoz, David; Tabernero, Maria; Baeza, Ramiro; Otero, Cristina; Garcia, Hugo S.; Ferrer, Mercedes			Effect of Dietary Docosahexaenoic Acid Supplementation on the Participation of Vasodilator Factors in Aorta from Orchidectomized Rats	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; ACETYLCHOLINE-INDUCED RELAXATION; ENDOTHELIUM-DEPENDENT VASORELAXATION; NITRIC-OXIDE RELEASE; POTASSIUM CHANNELS; MESENTERIC-ARTERY; FISH-OIL; HYPERCHOLESTEROLEMIC RATS; SUPEROXIDE-DISMUTASE; CORONARY-ARTERIES	Benefits of n-3 polyunsaturated fatty acids (PUFAs) against cardiovascular diseases have been reported. Vascular tone regulation is largely mediated by endothelial factors whose release is modulated by sex hormones. Since the incidence of cardiovascular pathologies has been correlated with decreased levels of sex hormones, the aim of this study was to analyze whether a diet supplemented with the specific PUFA docosahexaenoic acid (DHA) could prevent vascular changes induced by an impaired gonadal function. For this purpose, control and orchidectomized rats were fed with a standard diet supplemented with 5% (w/w) sunflower oil or with 3% (w/w) sunflower oil plus 2% (w/w) DHA. The lipid profile, the blood pressure, the production of prostanoids and nitric oxide (NO), and the redox status of biological samples from control and orchidectomized rats, fed control or DHA-supplemented diet, were analyzed. The vasodilator response and the contribution of NO, prostanoids and hyperpolarizing mechanisms were also studied. The results showed that orchidectomy negatively affected the lipid profile, increased the production of prostanoids and reactive oxygen species (ROS), and decreased NO production and the antioxidant capacity, as well as the participation of hyperpolarizing mechanisms in the vasodilator responses. The DHA-supplemented diet of the orchidectomized rats decreased the release of prostanoids and ROS, while increasing NO production and the antioxidant capacity, and it also improved the lipid profile. Additionally, it restored the participation of hyperpolarizing mechanisms by activating potassium. Since the modifications induced by the DHA-supplemented diet were observed in the orchidectomized, but not in the healthy group, DHA seems to exert cardio-protective effects in physiopathological situations in which vascular dysfunction exists.	[Villalpando, Diva M.; Navarro, Rocio; del Campo, Lara; Ferrer, Mercedes] Univ Autonoma Madrid, Fac Med, Dept Fisiol, Madrid, Spain; [Villalpando, Diva M.; Navarro, Rocio; del Campo, Lara; Ferrer, Mercedes] Hosp Univ La Paz IdiPAZ, Inst Invest, Area Cardiovasc, Madrid, Spain; [Largo, Carlota; Tabernero, Maria] Hosp Univ La Paz IdiPAZ, Inst Invest, Cirugia Expt, Madrid, Spain; [Munoz, David] Univ Autonoma Madrid, Fac Med, Gabinete Vet, Madrid, Spain; [Baeza, Ramiro; Otero, Cristina] CSIC, Inst Catalisis & Petr Quim, Madrid, Spain; [Garcia, Hugo S.] Inst Tecnol Veracruz, Veracruz, Veracruz, Mexico	Autonomous University of Madrid; Hospital Universitario La Paz; Hospital Universitario La Paz; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Catalisis y Petroleoquimica (ICP)	Ferrer, M (corresponding author), Univ Autonoma Madrid, Fac Med, Dept Fisiol, Madrid, Spain.	mercedes.ferrer@uam.es	del Campo, Lara/A-8317-2015; Navarro, Rocío/N-5505-2016; Ferrer, Mercedes/E-3556-2018; Parra, Mercedes Ferrer/AAE-1746-2020; Villalpando, Diva/AAG-6337-2020; del Campo Milán, Lara/ABD-4219-2021	del Campo, Lara/0000-0002-0394-116X; Navarro, Rocío/0000-0002-0083-7711; Parra, Mercedes Ferrer/0000-0002-4670-7146; del Campo Milán, Lara/0000-0002-0394-116X; Largo, Carlota/0000-0003-3306-7925	Fondo de Investigaciones Sanitarias [PI1100406]; Comunidad de Madrid [S2013/ABI-2783]; Fondo Europeo de Desarrollo Regional; Centro de Estudios America Latina (Grupo Santander-UAM)	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Comunidad de Madrid(Comunidad de Madrid); Fondo Europeo de Desarrollo Regional(European Commission); Centro de Estudios America Latina (Grupo Santander-UAM)	This study was supported by grants to MF from the Fondo de Investigaciones Sanitarias (PI1100406), Comunidad de Madrid (S2013/ABI-2783, "INSPIRA1-CM"), Fondo Europeo de Desarrollo Regional, and Centro de Estudios America Latina (Grupo Santander-UAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeywardena MY, 2001, CARDIOVASC RES, V52, P361, DOI 10.1016/S0008-6363(01)00406-0; Bian K, 2014, NITRIC OXIDE-BIOL CH, V43, P3, DOI 10.1016/j.niox.2014.08.006; Blanco-Rivero J, 2006, J VASC RES, V43, P101, DOI 10.1159/000089791; Blanco-Rivero J, 2007, J ENDOCRINOL, V192, P189, DOI 10.1677/joe.1.07079; Blanco-Rivero J, 2006, J ENDOCRINOL, V190, P771, DOI 10.1677/joe.1.06887; BOLOTINA VM, 1994, NATURE, V368, P850, DOI 10.1038/368850a0; Cao Jian, 2010, Chinese Medical Sciences Journal, V25, P44; Casos K, 2010, FREE RADICAL RES, V44, P821, DOI 10.3109/10715762.2010.485992; Chen JN, 2012, ATHEROSCLEROSIS, V221, P397, DOI 10.1016/j.atherosclerosis.2012.01.005; Chen LY, 2000, J CARDIOVASC PHARM, V35, P502, DOI 10.1097/00005344-200003000-00022; Cohen AT, 2015, THROMB RES, V135, P217, DOI 10.1016/j.thromres.2014.11.036; Das UN, 2004, EUR J CLIN NUTR, V58, P195, DOI 10.1038/sj.ejcn.1601766; del Campo L, 2008, J ENDOCRINOL, V197, P371, DOI 10.1677/JOE-07-0647; del Campo M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102523; Edwards G, 2010, PFLUG ARCH EUR J PHY, V459, P863, DOI 10.1007/s00424-010-0817-1; Engler M B, 2000, Biol Res Nurs, V2, P85, DOI 10.1177/109980040000200202; Engler MM, 2003, EXP BIOL MED, V228, P299, DOI 10.1177/153537020322800309; Enns JE, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-70; Farre LA, 2006, REV ESP CARDIOL S6, p31D; Feletou M, 2006, ARTERIOSCL THROM VAS, V26, P1215, DOI 10.1161/01.ATV.0000217611.81085.c5; Feletou M, 2009, CLIN SCI, V117, P139, DOI 10.1042/CS20090096; Feletou M, 2009, BRIT J PHARMACOL, V156, P545, DOI 10.1111/j.1476-5381.2009.00052.x; Ferrer M, 1999, CLIN SCI, V97, P625, DOI 10.1042/CS19990102; Freese R, 1997, AM J CLIN NUTR, V66, P591, DOI 10.1093/ajcn/66.3.591; Goirand F, 2005, CLIN EXP PHARMACOL P, V32, P184, DOI 10.1111/j.1440-1681.2005.04169.x; Guder G, 2010, HEART, V96, P504, DOI 10.1136/hrt.2009.181065; Gutterman DD, 2005, ARTERIOSCL THROM VAS, V25, P671, DOI 10.1161/01.ATV.0000158497.09626.3b; Guzik B, 2013, INT J CARDIOL, V168, P2389, DOI 10.1016/j.ijcard.2013.01.278; Hashimoto M, 1999, J NUTR, V129, P70, DOI 10.1093/jn/129.1.70; Hirafuji M, 2003, J PHARMACOL SCI, V92, P308; Ishikado A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069415; Kalyanaraman B, 2012, FREE RADICAL BIO MED, V52, P1, DOI 10.1016/j.freeradbiomed.2011.09.030; Kelley DS, 1999, LIPIDS, V34, P317, DOI 10.1007/s11745-999-0369-5; Khan SA, 1996, J PHARMACOL EXP THER, V267, P1327; Lagarde M, 2013, PROSTAG LEUKOTR ESS, V88, P49, DOI 10.1016/j.plefa.2012.04.001; Lee TC, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-196; Lucas A, 2008, METABOLISM, V57, P233, DOI 10.1016/j.metabol.2007.09.006; Martin MD, 2005, NITRIC OXIDE-BIOL CH, V12, P163, DOI 10.1016/j.niox.2005.02.003; Martorell A, 2008, CARDIOVASC RES, V77, P590, DOI 10.1093/cvr/cvm059; Martorell A, 2009, CARDIOVASC RES, V84, P300, DOI 10.1093/cvr/cvp214; Matesanz N, 2010, INVEST OPHTH VIS SCI, V51, P6815, DOI 10.1167/iovs.10-5339; McDonald DM, 2013, DIABETES CARE, V36, P998, DOI 10.2337/dc12-0304; NIELSEN KC, 1971, BRAIN RES, V27, P33, DOI 10.1016/0006-8993(71)90370-2; Omura M, 2001, FEBS LETT, V487, P361, DOI 10.1016/S0014-5793(00)02351-6; Papapostolou L, 2004, ANAL BIOCHEM, V332, P290, DOI 10.1016/j.ab.2004.06.022; Richard D, 2009, BIOCHEM BIOPH RES CO, V389, P516, DOI 10.1016/j.bbrc.2009.09.013; Rousseau-Ralliard D, 2009, PROSTAG LEUKOTR ESS, V80, P269, DOI 10.1016/j.plefa.2009.03.003; Ruan DN, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-143; Sagredo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073474; Sato K, 2014, PHARMACOLOGY, V93, P229, DOI 10.1159/000360543; Sellers MM, 2008, AM J PHYSIOL-HEART C, V294, pH1978, DOI 10.1152/ajpheart.01318.2007; Seyrek M, 2007, J PHARMACOL SCI, V103, P309, DOI 10.1254/jphs.FP0060883; Smith MR, 2004, UROLOGY, V63, P742, DOI 10.1016/j.urology.2003.10.063; Tabernero M, 2014, FOOD FUNCT, V5, P1556, DOI 10.1039/c3fo60677e; Tabernero M, 2013, J FUNCT FOODS, V5, P755, DOI 10.1016/j.jff.2013.01.021; Tagawa T, 2002, HYPERTENS RES, V25, P823; Tep-areenan P, 2002, BRIT J PHARMACOL, V135, P735, DOI 10.1038/sj.bjp.0704522; Trebble TM, 2003, AM J CLIN NUTR, V78, P376, DOI 10.1093/ajcn/78.3.376; Vanhoutte PM, 2003, CIRC J, V67, P572; Varagic J, 2014, INTEGR BLOOD PRESS C, V7, P61, DOI 10.2147/IBPC.S50954; Vogt A, 2015, APPL CLIN GENET, V8, P27, DOI 10.2147/TACG.S44315; Wang RX, 2011, CARDIOVASC RES, V90, P344, DOI 10.1093/cvr/cvq411; Wei EP, 1996, AM J PHYSIOL-HEART C, V271, pH1262, DOI 10.1152/ajpheart.1996.271.3.H1262; Wu KT, 2007, CHINESE J PHYSIOL, V50, P164; Wu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035508; Yan JC, 2014, PULM PHARMACOL THER, V28, P9, DOI 10.1016/j.pupt.2013.11.004; YUE P, 1995, CIRCULATION, V91, P1154, DOI 10.1161/01.CIR.91.4.1154; Zebrowska A., 2014, EUR J SPORT SCI, P1; Zhao HT, 2003, FREE RADICAL BIO MED, V34, P1359, DOI 10.1016/S0891-5849(03)00142-4	69	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142039	10.1371/journal.pone.0142039	http://dx.doi.org/10.1371/journal.pone.0142039			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540339	Green Published, Green Submitted, gold			2022-12-26	WOS:000364303800047
J	Liu, LL; Li, F; Pao, W; Michor, F				Liu, Lin L.; Li, Fei; Pao, William; Michor, Franziska			Dose-Dependent Mutation Rates Determine Optimum Erlotinib Dosing Strategies for EGFR Mutant Non-Small Cell Lung Cancer Patients	PLOS ONE			English	Article							DRUG-RESISTANCE; MATHEMATICAL-MODEL; TARGETED THERAPIES; STOCHASTIC-MODEL; CHEMOTHERAPY; EVOLUTION; IMATINIB; QUIESCENCE; GENERATION; APOPTOSIS	Background The advent of targeted therapy for cancer treatment has brought about a paradigm shift in the clinical management of human malignancies. Agents such as erlotinib used for EGFR-mutant non-small cell lung cancer or imatinib for chronic myeloid leukemia, for instance, lead to rapid tumor responses. Unfortunately, however, resistance often emerges and renders these agents ineffective after a variable amount of time. The FDA-approved dosing schedules for these drugs were not designed to optimally prevent the emergence of resistance. To this end, we have previously utilized evolutionary mathematical modeling of treatment responses to elucidate the dosing schedules best able to prevent or delay the onset of resistance. Here we expand on our approaches by taking into account dose-dependent mutation rates at which resistant cells emerge. The relationship between the serum drug concentration and the rate at which resistance mutations arise can lead to non-intuitive results about the best dose administration strategies to prevent or delay the emergence of resistance. Methods We used mathematical modeling, available clinical trial data, and different considerations of the relationship between mutation rate and drug concentration to predict the effectiveness of different dosing strategies. Results We designed several distinct measures to interrogate the effects of different treatment dosing strategies and found that a low-dose continuous strategy coupled with high-dose pulses leads to the maximal delay until clinically observable resistance. Furthermore, the response to treatment is robust against different assumptions of the mutation rate as a function of drug concentration. Conclusions For new and existing targeted drugs, our methodology can be employed to compare the effectiveness of different dose administration schedules and investigate the influence of changing mutation rates on outcomes.	[Liu, Lin L.; Li, Fei; Michor, Franziska] Harvard Univ, TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Liu, Lin L.; Michor, Franziska] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02215 USA; [Pao, William] Vanderbilt Ingram Canc Ctr, Nashville, TN 27232 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute; Vanderbilt University	Michor, F (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.	michor@jimmy.harvard.edu			Dana-Farber Cancer Institute Physical Sciences-Oncology Center [NCI U54CA143798]; US National Cancer Institute [R01CA121210, P01CA129243]; NATIONAL CANCER INSTITUTE [P01CA129243, U54CA143798, R01CA121210] Funding Source: NIH RePORTER	Dana-Farber Cancer Institute Physical Sciences-Oncology Center; US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors acknowledge support from the Dana-Farber Cancer Institute Physical Sciences-Oncology Center (NCI U54CA143798) and from US National Cancer Institute grants R01CA121210 and P01CA129243.	Agur Z, 1986, ANN NY ACAD SCI, V504, P274, DOI 10.1111/j.1749-6632.1987.tb48738.x; Allgayer H, 2008, ADV MED SCI-POLAND, V53, P130, DOI 10.2478/v10039-008-0025-9; Chmielecki J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002356; Citron ML, 2003, J CLIN ONCOL, V21, P1431, DOI 10.1200/JCO.2003.09.081; Coldman AJ, 2000, MATH BIOSCI, V168, P187, DOI 10.1016/S0025-5564(00)00045-6; COLDMAN AJ, 1986, B MATH BIOL, V48, P279, DOI 10.1016/S0092-8240(86)90028-5; Comen E, 2012, J MAMMARY GLAND BIOL, V17, P241, DOI 10.1007/s10911-012-9267-z; COSTA MIS, 1995, MATH BIOSCI, V125, P191, DOI 10.1016/0025-5564(94)00027-W; Davis W, 2001, J PHARMACOL EXP THER, V296, P1; DAY RS, 1986, CANCER RES, V46, P3876; de Pillis LG, 2005, CANCER RES, V65, P7950, DOI 10.1158/0008-5472.CAN-05-0564; de Pillis LG, 2001, J THEO MED, V24, P79, DOI [10.1080/10273660108833067, DOI 10.1080/10273660108833067]; DEMPSEY JL, 1985, CANCER RES, V45, P2873; DeVita V T Jr, 1975, CA Cancer J Clin, V25, P152; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; DIBROV BF, 1983, MATH BIOSCI, V66, P167, DOI 10.1016/0025-5564(83)90087-1; England K, 2006, FREE RADICAL RES, V40, P1124, DOI 10.1080/10715760600838209; Foo J, 2010, J THEOR BIOL, V263, P179, DOI 10.1016/j.jtbi.2009.11.022; Foo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000557; Gardner SN, 2003, MOL CANCER THER, V2, P1079; Gardner SN, 2002, J THEOR BIOL, V214, P181, DOI 10.1006/jtbi.2001.2459; Gerber DE, 2008, AM FAM PHYSICIAN, V77, P311; GHIBELLI L, 1995, BIOCHEM BIOPH RES CO, V216, P313, DOI 10.1006/bbrc.1995.2626; Haeno H, 2007, GENETICS, V177, P2209, DOI 10.1534/genetics.107.078915; Hahnfeldt P, 2003, J THEOR BIOL, V220, P545, DOI 10.1006/jtbi.2003.3162; Hofmann WK, 2003, BLOOD, V102, P659, DOI 10.1182/blood-2002-06-1756; Hug H, 1997, J BIOL CHEM, V272, P28191, DOI 10.1074/jbc.272.45.28191; Hutson TE, 2008, ONCOLOGIST, V13, P1084, DOI 10.1634/theoncologist.2008-0120; Iwasa Y, 2006, GENETICS, V172, P2557, DOI 10.1534/genetics.105.049791; Iwasa Y, 2003, P ROY SOC LOND B BIO, V270, P2572; Jia PL, 2013, GENOME RES, V23, P1434, DOI 10.1101/gr.152322.112; Kohandel M, 2006, J THEOR BIOL, V242, P62, DOI 10.1016/j.jtbi.2006.02.001; Komarova N, 2006, J THEOR BIOL, V239, P351, DOI 10.1016/j.jtbi.2005.08.003; Komarova NL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000990; Komarova NL, 2007, THEOR POPUL BIOL, V72, P523, DOI 10.1016/j.tpb.2007.08.003; Komarova NL, 2005, P NATL ACAD SCI USA, V102, P9714, DOI 10.1073/pnas.0501870102; Koptyra M, 2006, BLOOD, V108, P319, DOI 10.1182/blood-2005-07-2815; LEWIS PAW, 1979, NAV RES LOG, V26, P403, DOI 10.1002/nav.3800260304; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; Martin R. B., 1994, OPTIMAL CONTROL DRUG; NORTON L, 1986, CANCER TREAT REP, V70, P163; NORTON L, 1977, CANCER TREAT REP, V61, P1307; Panetta JC, 1996, B MATH BIOL, V58, P425, DOI 10.1016/0092-8240(95)00346-0; R Core Team, 2021, R LANGUAGE ENV STAT; Roche-Lestienne C, 2002, BLOOD, V100, P1014, DOI 10.1182/blood.V100.3.1014; Roche-Lestienne C, 2003, NEW ENGL J MED, V348, P2265, DOI 10.1056/NEJMc035089; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; SWAN GW, 1990, MATH BIOSCI, V101, P237, DOI 10.1016/0025-5564(90)90021-P; Tortora Giampaolo, 2011, Journal of the National Cancer Institute Monographs, P95, DOI 10.1093/jncimonographs/lgr026; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022	51	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141665	10.1371/journal.pone.0141665	http://dx.doi.org/10.1371/journal.pone.0141665			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536620	gold, Green Published, Green Submitted			2022-12-26	WOS:000364298400075
J	Wall, BT; Gorissen, SH; Pennings, B; Koopman, R; Groen, BBL; Verdijk, LB; van Loon, LJC				Wall, Benjamin Toby; Gorissen, Stefan H.; Pennings, Bart; Koopman, Rene; Groen, Bart B. L.; Verdijk, Lex B.; van Loon, Luc J. C.			Aging Is Accompanied by a Blunted Muscle Protein Synthetic Response to Protein Ingestion	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; ANABOLIC RESISTANCE; INSULIN-RESISTANCE; ABSORPTION; CARBOHYDRATE; MYOFIBRILLAR; DIGESTION; YOUNG; MEN; METABOLISM	Purpose Progressive loss of skeletal muscle mass with aging (sarcopenia) forms a global health concern. It has been suggested that an impaired capacity to increase muscle protein synthesis rates in response to protein intake is a key contributor to sarcopenia. We assessed whether differences in post-absorptive and/or post-prandial muscle protein synthesis rates exist between large cohorts of healthy young and older men. Procedures We performed a cross-sectional, retrospective study comparing in vivo post-absorptive muscle protein synthesis rates determined with stable isotope methodologies between 34 healthy young (22 +/- 1 y) and 72 older (75 +/- 1 y) men, and post-prandial muscle protein synthesis rates between 35 healthy young (22 +/- 1 y) and 40 older (74 +/- 1 y) men. Findings Post-absorptive muscle protein synthesis rates did not differ significantly between the young and older group. Post-prandial muscle protein synthesis rates were 16% lower in the older subjects when compared with the young. Muscle protein synthesis rates were >3 fold more responsive to dietary protein ingestion in the young. Irrespective of age, there was a strong negative correlation between post-absorptive muscle protein synthesis rates and the increase in muscle protein synthesis rate following protein ingestion. Conclusions Aging is associated with the development of muscle anabolic inflexibility which represents a key physiological mechanism underpinning sarcopenia.	[Wall, Benjamin Toby; Gorissen, Stefan H.; Pennings, Bart; Koopman, Rene; Groen, Bart B. L.; Verdijk, Lex B.; van Loon, Luc J. C.] Maastricht Univ, Med Ctr, NUTRIM Sch Nutr Toxicol & Metab, NL-6200 MD Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC)	van Loon, LJC (corresponding author), Maastricht Univ, Med Ctr, NUTRIM Sch Nutr Toxicol & Metab, NL-6200 MD Maastricht, Netherlands.	l.vanloon@maastrichtuniversity.nl	van Loon, Luc J.C./ABG-9158-2020; Gorissen, Stefan/ABA-1008-2021; van Loon, Luc J C/G-5920-2010; Verdijk, Lex B/H-4468-2016	van Loon, Luc J.C./0000-0002-6768-9231; Gorissen, Stefan/0000-0003-3737-9053; van Loon, Luc J C/0000-0002-6768-9231; Verdijk, Lex B/0000-0002-9196-8767				Areta JL, 2014, AM J PHYSIOL-ENDOC M, V306, pE989, DOI 10.1152/ajpendo.00590.2013; Balagopal P, 1997, AM J PHYSIOL-ENDOC M, V273, pE790, DOI 10.1152/ajpendo.1997.273.4.E790; Breen L, 2013, J CLIN ENDOCR METAB, V98, P2604, DOI 10.1210/jc.2013-1502; Burd NA, 2013, EXERC SPORT SCI REV, V41, P169, DOI 10.1097/JES.0b013e318292f3d5; Burd NA, 2012, J APPL PHYSIOL, V112, P1233, DOI 10.1152/japplphysiol.01343.2011; Chevalier S, 2011, J GERONTOL A-BIOL, V66, P681, DOI 10.1093/gerona/glr036; Cuthbertson D, 2004, FASEB J, V18, P422, DOI 10.1096/fj.04-2640fje; Denti L, 2000, J AM GERIATR SOC, V48, P51, DOI 10.1111/j.1532-5415.2000.tb03028.x; Dillon EL, 2011, AM J PHYSIOL-REG I, V301, pR1408, DOI 10.1152/ajpregu.00211.2011; Drummond MJ, 2012, AM J PHYSIOL-ENDOC M, V302, pE1113, DOI 10.1152/ajpendo.00603.2011; EVANS WJ, 1995, J GERONTOL A-BIOL, V50, P5, DOI 10.1093/gerona/50A.Special_Issue.5; Ferrando AA, 1996, AM J PHYSIOL-ENDOC M, V270, pE627, DOI 10.1152/ajpendo.1996.270.4.E627; GIBSON JNA, 1987, CLIN SCI, V72, P503, DOI 10.1042/cs0720503; Glover EI, 2008, J PHYSIOL-LONDON, V586, P6049, DOI 10.1113/jphysiol.2008.160333; Gorissen SHM, 2014, J CLIN ENDOCR METAB, V99, P2250, DOI 10.1210/jc.2013-3970; Guillet C, 2004, FASEB J, V18, P1586, DOI 10.1096/fj.03-1341fje; Guillet C, 2012, OBES REV, V13, P51, DOI 10.1111/j.1467-789X.2012.01037.x; Hasten DL, 2000, AM J PHYSIOL-ENDOC M, V278, pE620, DOI 10.1152/ajpendo.2000.278.4.E620; Hebert SL, 2010, CLIN NUTR, V29, P13, DOI 10.1016/j.clnu.2009.09.001; Katsanos CS, 2006, AM J PHYSIOL-ENDOC M, V291, pE381, DOI 10.1152/ajpendo.00488.2005; Katsanos CS, 2005, AM J CLIN NUTR, V82, P1065, DOI 10.1093/ajcn/82.5.1065; Kelley DE, 2000, DIABETES, V49, P677, DOI 10.2337/diabetes.49.5.677; Kelley DE, 2001, DIABETES CARE, V24, P933, DOI 10.2337/diacare.24.5.933; Kiskini A, 2013, AGE, V35, P2389, DOI 10.1007/s11357-013-9522-2; Koopman R, 2005, AM J PHYSIOL-ENDOC M, V288, pE645, DOI 10.1152/ajpendo.00413.2004; Koopman R, 2009, J NUTR, V139, P1707, DOI 10.3945/jn.109.109173; Koopman R, 2009, AM J CLIN NUTR, V90, P106, DOI 10.3945/ajcn.2009.27474; LUNDHOLM K, 1975, EXP GERONTOL, V10, P155, DOI 10.1016/0531-5565(75)90045-5; Manders RJ, 2008, J NUTR, V138, P1079, DOI 10.1093/jn/138.6.1079; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Moller N, 2008, DIABETES, V57, P3, DOI 10.2337/db07-1581; Moore D.R., 2014, J GERONTOL A; Moore DR, 2009, J PHYSIOL-LONDON, V587, P897, DOI 10.1113/jphysiol.2008.164087; Nilwik R, 2013, EXP GERONTOL, V48, P492, DOI 10.1016/j.exger.2013.02.012; Paddon-Jones D, 2004, AM J PHYSIOL-ENDOC M, V286, pE321, DOI 10.1152/ajpendo.00368.2003; Parr EB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088384; Pennings B, 2013, AM J CLIN NUTR, V98, P121, DOI 10.3945/ajcn.112.051201; Pennings B, 2012, AM J PHYSIOL-ENDOC M, V302, pE992, DOI 10.1152/ajpendo.00517.2011; Pennings B, 2011, AM J CLIN NUTR, V93, P997, DOI 10.3945/ajcn.110.008102; Pennings B, 2011, AM J CLIN NUTR, V93, P322, DOI 10.3945/ajcn.2010.29649; Petersen AMW, 2007, AM J PHYSIOL-ENDOC M, V293, pE843, DOI 10.1152/ajpendo.00301.2007; Phillips SM, 2009, J APPL PHYSIOL, V107, P645, DOI 10.1152/japplphysiol.00452.2009; Phillips SM, 2009, APPL PHYSIOL NUTR ME, V34, P403, DOI 10.1139/H09-042; RENNIE MJ, 1982, CLIN SCI, V63, P519, DOI 10.1042/cs0630519; Rooyackers OE, 1996, P NATL ACAD SCI USA, V93, P15364, DOI 10.1073/pnas.93.26.15364; Storlien L, 2004, P NUTR SOC, V63, P363, DOI 10.1079/PNS2004349; Symons TB, 2007, AM J CLIN NUTR, V86, P451, DOI 10.1093/ajcn/86.2.451; Volpi E, 1998, J CLIN INVEST, V101, P2000, DOI 10.1172/JCI939; Volpi E, 2001, JAMA-J AM MED ASSOC, V286, P1206, DOI 10.1001/jama.286.10.1206; Volpi E, 2000, J CLIN ENDOCR METAB, V85, P4481, DOI 10.1210/jc.85.12.4481; Volpi E, 1999, AM J PHYSIOL-ENDOC M, V277, pE513, DOI 10.1152/ajpendo.1999.277.3.E513; Wall BT, 2013, J CLIN ENDOCR METAB, V98, P4872, DOI 10.1210/jc.2013-2098; WELLE S, 1993, AM J PHYSIOL, V264, pE693, DOI 10.1152/ajpendo.1993.264.5.E693; WELLE S, 1995, AM J PHYSIOL-ENDOC M, V268, pE422, DOI 10.1152/ajpendo.1995.268.3.E422; YARASHESKI KE, 1993, AM J PHYSIOL, V265, pE210, DOI 10.1152/ajpendo.1993.265.2.E210; Yarasheski KE, 2011, AM J CLIN NUTR, V94, P172, DOI 10.3945/ajcn.110.010959	56	181	187	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140903	10.1371/journal.pone.0140903	http://dx.doi.org/10.1371/journal.pone.0140903			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536130	Green Published, gold			2022-12-26	WOS:000364298400043
J	Hwang, JI; Lee, SE; Kim, JE				Hwang, Jeong-In; Lee, Sung-Eun; Kim, Jang-Eok			Plant Uptake and Distribution of Endosulfan and Its Sulfate Metabolite Persisted in Soil	PLOS ONE			English	Article							ALPHA-ENDOSULFAN; PESTICIDES; DEGRADATION; FATE; BIODEGRADATION; ACCUMULATION; VEGETATION	The distributions of endosulfan (ED) residues (alpha-, beta-isomers, and sulfate-metabolite) in cucumbers grown in soils treated with ED at concentrations of 20 and 40 mg kg(-1) were assessed using indoor and outdoor experiments. In all treatments, degradation rates of the a-isomer in soils were higher than that of the beta-isomer. In the indoor tests, uptake amounts of total ED by cucumbers, after 15 d of growth, were 7.8 and 14.5 mg kg(-1) in 20 and 40 mg kg(-1)-treated pots, respectively. For growth time from 15 to 30 d, uptake amounts in 20 and 40 mg kg(-1)-treated pots were 3.8 and 7.9 mg kg(-1), respectively. Outdoor tests resulted in smaller ED residues in cucumbers than those in indoor tests. In both indoor and outdoor tests, ED residues absorbed were highest in roots, and the a-isomer was the more frequently absorbed isomer. These results will be useful for determining management criteria for soil persistent pesticides.	[Hwang, Jeong-In; Lee, Sung-Eun; Kim, Jang-Eok] Kyungpook Natl Univ, Sch Appl Biosci, Daegu, South Korea	Kyungpook National University	Kim, JE (corresponding author), Kyungpook Natl Univ, Sch Appl Biosci, Daegu, South Korea.	jekim@knu.ac.kr	Hwang, Jeong-In/D-8504-2017	Hwang, Jeong-In/0000-0002-3929-0688	grant (Research Cooperating for Agricultural Science & Technology Development), from Rural Development Administration, Republic of Korea [PJ011435]	grant (Research Cooperating for Agricultural Science & Technology Development), from Rural Development Administration, Republic of Korea	This work was funded by a grant (Research Cooperating for Agricultural Science & Technology Development; Project No. PJ011435), from the Rural Development Administration, Republic of Korea. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J. W., 2012, KOREAN J ENV AGR, V31, P164; Anderson JJ, 2013, J AGR FOOD CHEM, V61, P9027, DOI 10.1021/jf4025757; Awasthi N, 2000, SOIL BIOL BIOCHEM, V32, P1697, DOI 10.1016/S0038-0717(00)00087-0; Barriada-Pereira M, 2005, CHEMOSPHERE, V58, P1571, DOI 10.1016/j.chemosphere.2004.10.016; Pereira RC, 2006, ENVIRON POLLUT, V144, P210, DOI 10.1016/j.envpol.2005.12.030; El Bakouri H, 2007, WATER ENVIRON RES, V79, P2578, DOI 10.2175/106143007X184528; Esteve-Turrillas FA, 2005, J ENVIRON MONITOR, V7, P1093, DOI 10.1039/b507414b; Ihm JN, 2000, ANAL METHOD SOIL PLA, P103; Juraske R, 2008, CHEMOSPHERE, V70, P1748, DOI 10.1016/j.chemosphere.2007.08.047; Juraske R, 2011, ENVIRON SCI TECHNOL, V45, P651, DOI 10.1021/es102907v; Kim H. Y., 2011, KOREAN J ENV AGR, V30, P440; Ortiz-Hernandez ML, 2010, REV INT CONTAM AMBIE, V26, P27; Lee JB, 2006, J AGR FOOD CHEM, V54, P8824, DOI 10.1021/jf061276e; 황정인, 2014, [THE KOREAN JOURNAL OF PESTICIDE SCIENCE, 농약과학회지], V18, P148, DOI 10.7585/kjps.2014.18.3.148; 전상오, 2014, [THE KOREAN JOURNAL OF PESTICIDE SCIENCE, 농약과학회지], V18, P314, DOI 10.7585/kjps.2014.18.4.314; Leonard AW, 2001, J ENVIRON QUAL, V30, P750, DOI 10.2134/jeq2001.303750x; Liu YP, 2012, B ENVIRON CONTAM TOX, V88, P902, DOI 10.1007/s00128-012-0610-2; MACBEAN C, 2012, PESTICIDE MANUAL, P414; Ministry of Food and Drug Safety, 2015, PEST RES DAT; Rice CP, 1997, J AGR FOOD CHEM, V45, P2291, DOI 10.1021/jf960834u; Sethunathan N, 2004, J AGR FOOD CHEM, V52, P3030, DOI 10.1021/jf035173x; Shivaramaiah HM, 2006, J ENVIRON SCI HEAL B, V41, P895, DOI 10.1080/03601230600806004; SINGH NC, 1991, J AGR FOOD CHEM, V39, P575, DOI 10.1021/jf00003a028; Singh V, 2014, ECOTOX ENVIRON SAFE, V104, P189, DOI 10.1016/j.ecoenv.2014.02.025; Walse SS, 2003, J ENVIRON MONITOR, V5, P373, DOI 10.1039/b212165d; Wang CJ, 2007, PESTIC BIOCHEM PHYS, V87, P1, DOI 10.1016/j.pestbp.2006.04.004; Weber J, 2010, SCI TOTAL ENVIRON, V408, P2966, DOI 10.1016/j.scitotenv.2009.10.077; Xu XM, 2012, FOOD CHEM, V135, P161, DOI 10.1016/j.foodchem.2012.04.052	28	42	48	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141728	10.1371/journal.pone.0141728	http://dx.doi.org/10.1371/journal.pone.0141728			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529511	Green Published, Green Submitted, gold			2022-12-26	WOS:000364032600053
J	Lafferty, DJR; Laudenslager, ML; Mowat, G; Heard, D; Belant, JL				Lafferty, Diana J. R.; Laudenslager, Mark L.; Mowat, Garth; Heard, Doug; Belant, Jerrold L.			Sex, Diet, and the Social Environment: Factors Influencing Hair Cortisol Concentration in Free-Ranging Black Bears (Ursus americanus)	PLOS ONE			English	Article							LONG-TERM STRESS; POLAR BEARS; BIOMARKER; REPRODUCTION; RANK; GLUCOCORTICOIDS; CONSTRAINTS; ISOTOPES; SURVIVAL; ECOLOGY	Increasingly, measures of glucocorticoid levels (e.g., cortisol), key components of the neuroendocrine stress axis, are being used to measure past hypothalamic-pituitary-adrenal (HPA) activity to index psychological and physiological stress exhibited by wildlife for assessing individual and population-level well-being. However, many intrinsic and extrinsic factors affect HPA activity in animals. Using American black bears (Ursus americanus; n = 116) as an ecological model and hair cortisol concentration (HCC) as an integrative measure of past HPA activity, we evaluated the influence of diet, sex and the social environment on black bear HCC in a free-ranging population that spanned adjoining ecoregions with differing densities of potential conspecific and heterospecific competitors. HCC varied by sex, with female HCC ranging from 0.6 to 10.7 pg/mg (median = 4.5 +/- 1.2 mean absolute deviation [MAD]) and male HCC ranging from 0.5 to 35.1 pg/mg (median = 6.2 +/- 2.6 MAD). We also observed a three-way interaction among sex, delta C-14 and ecoregion, which may indicate that some differences in HCC between female and male black bears results from variability in the nutritional needs of larger-bodied males relative to smaller-bodied females, slight differences in food resources use between ecoregions as well as sex-based differences regarding the social environment. Once we understand what drives sex-specific differences in HCC, HCC may aid our understanding of the physiological responses by bears and other wildlife to diverse environmental challenges.	[Lafferty, Diana J. R.; Belant, Jerrold L.] Mississippi State Univ, Dept Wildlife Fisheries & Aquaculture, Carnivore Ecol Lab, Mississippi State, MS 39762 USA; [Laudenslager, Mark L.] Univ Colorado Denver, Dept Psychiat, Behav Immunol & Endocrinol Lab, Aurora, CO USA; [Mowat, Garth] British Columbia Minist Forests Lands & Nat Resou, Nelson, BC, Canada; [Heard, Doug] British Columbia Minist Forests Lands & Nat Resou, Prince George, BC, Canada; [Lafferty, Diana J. R.] N Carolina State Univ, Dept Forestry & Environm Resources, Fisheries Wildlife & Conservat Biol Program, Raleigh, NC 27695 USA	Mississippi State University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of North Carolina; North Carolina State University	Lafferty, DJR (corresponding author), Mississippi State Univ, Dept Wildlife Fisheries & Aquaculture, Carnivore Ecol Lab, Mississippi State, MS 39762 USA.	djr.lafferty@gmail.com	Belant, Jerrold/HDM-7749-2022; Laudenslager, Mark L/D-1057-2018	Laudenslager, Mark L/0000-0002-9815-3026	province of British Columbia; Hauser Bears	province of British Columbia; Hauser Bears	The province of British Columbia funded initial field work for this project. Funding for stable isotope and hair cortisol analysis was provided to DJRL, JLB and GM by Hauser Bears. Funders had no role in study design, data collection, data analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, MODEL SELECTION MULT; [Anonymous], DEMOGRAPHY HABITAT S; ATKINSON SN, 1995, FUNCT ECOL, V9, P559, DOI 10.2307/2390145; Ayers CR, 2013, POLAR BIOL, V36, P169, DOI 10.1007/s00300-012-1247-7; Barrett GM, 2002, HORM BEHAV, V42, P85, DOI 10.1006/hbeh.2002.1804; Bechshoft TO, 2012, ENVIRON INT, V45, P15, DOI 10.1016/j.envint.2012.04.005; Bechshoft TO, 2011, SCI TOTAL ENVIRON, V409, P831, DOI 10.1016/j.scitotenv.2010.10.047; Belant JL, 2006, ECOL APPL, V16, P2333, DOI 10.1890/1051-0761(2006)016[2333:IRPISU]2.0.CO;2; Ben-David M, 2004, OECOLOGIA, V138, P465, DOI 10.1007/s00442-003-1442-x; BOONSTRA R, 1993, GEN COMP ENDOCR, V91, P126, DOI 10.1006/gcen.1993.1113; Boonstra R, 2005, J MAMMAL, V86, P236, DOI 10.1644/BHE-001.1; Boonstra R, 2013, FUNCT ECOL, V27, P11, DOI 10.1111/1365-2435.12008; Bourbonnais ML, 2013, PLOS ONE, V8, DOI [10.1371/journal.po, 10.1371/journal.pone.0083768]; Bryan HM, 2014, CONSERV PHYSIOL, V2, DOI 10.1093/conphys/cou010; Bryan HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080537; Cattet M, 2014, CONSERV PHYSIOL, V2, DOI 10.1093/conphys/cou026; Cattet MRL, 2002, CAN J ZOOL, V80, P1156, DOI 10.1139/Z02-103; Charbonnel N, 2008, PHYSIOL BIOCHEM ZOOL, V81, P63, DOI 10.1086/523306; Chi DK, 1999, EFFECTS SALMON AVAIL; COY PL, 1992, CAN J ZOOL, V70, P2150, DOI 10.1139/z92-290; Creel S, 1997, BEHAV ECOL, V8, P298, DOI 10.1093/beheco/8.3.298; Creel S, 2002, CONSERV BIOL, V16, P809, DOI 10.1046/j.1523-1739.2002.00554.x; Creel S, 1996, SOCIAL STRESS DOMINA; Creel S, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot021; Creel S, 2013, FUNCT ECOL, V27, P66, DOI 10.1111/j.1365-2435.2012.02029.x; D'Anna-Hernandez KL, 2011, PHYSIOL BEHAV, V104, P348, DOI 10.1016/j.physbeh.2011.02.041; Dantzer B, 2014, CONSERV PHYSIOL, V2, DOI 10.1093/conphys/cou023; Dantzer B, 2010, GEN COMP ENDOCR, V167, P279, DOI 10.1016/j.ygcen.2010.03.024; Davenport MD, 2006, GEN COMP ENDOCR, V147, P255, DOI 10.1016/j.ygcen.2006.01.005; Derocher AE, 1996, CAN J ZOOL, V74, P1246, DOI 10.1139/z96-138; Derocher AE, 2010, BEHAV ECOL SOCIOBIOL, V64, P939, DOI 10.1007/s00265-010-0909-0; Dettmer AM, 2012, PSYCHONEUROENDOCRINO, V37, P191, DOI 10.1016/j.psyneuen.2011.06.003; Dettmer AM, 2009, DEV PSYCHOBIOL, V51, P706, DOI 10.1002/dev.20405; Fairbanks LA, 2011, PSYCHONEUROENDOCRINO, V36, P1201, DOI 10.1016/j.psyneuen.2011.02.013; Hilderbrand GV, 1996, CAN J ZOOL, V74, P2080, DOI 10.1139/z96-236; Hilderbrand GV, 1999, CAN J ZOOL, V77, P132, DOI 10.1139/cjz-77-1-132; Hoffman MC, 2014, CLIN INVEST MED, V37, pE252, DOI 10.25011/cim.v37i4.21731; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Jones ES, 2006, WILDLIFE SOC B, V34, P1320, DOI 10.2193/0091-7648(2006)34[1320:TVISCA]2.0.CO;2; KASWORM WF, 1994, BEARS - THEIR BIOLOGY AND MANAGEMENT, P223; Koren L, 2008, HORM BEHAV, V54, P212, DOI 10.1016/j.yhbeh.2008.02.020; Lafferty DJ, 2014, OIKOS; Lee JW, 2006, PHARM RES, V23, P312, DOI 10.1007/s11095-005-9045-3; Macbeth BJ, 2010, CAN J ZOOL, V88, P935, DOI 10.1139/Z10-057; Macbeth BJ, 2012, WILDLIFE SOC B, V36, P747, DOI 10.1002/wsb.219; Malcolm KD, 2013, GEN COMP ENDOCR, V185, P97, DOI 10.1016/j.ygcen.2013.01.014; Meyer JS, 2012, ENDOCRINOLOGY, V153, P4120, DOI 10.1210/en.2012-1226; MILLER SD, 1994, BEARS - THEIR BIOLOGY AND MANAGEMENT, P263; Moberg GP, 1999, DOES STRESS BECOME D; Mooring MS, 2006, HORM BEHAV, V49, P369, DOI 10.1016/j.yhbeh.2005.08.008; Mowat G, 2005, WILDLIFE BIOL, V11, P31, DOI 10.2981/0909-6396(2005)11[31:GUAABB]2.0.CO;2; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Rode KD, 2001, OECOLOGIA, V128, P62, DOI 10.1007/s004420100637; Romero LM, 2010, P ROY SOC B-BIOL SCI, V277, P3157, DOI 10.1098/rspb.2010.0678; Russell E, 2015, THER DRUG MONIT, V37, P71, DOI 10.1097/FTD.0000000000000148; SAPOLSKY RM, 1992, PSYCHONEUROENDOCRINO, V17, P701, DOI 10.1016/0306-4530(92)90029-7; Saudek CD, 2006, JAMA-J AM MED ASSOC, V295, P1688, DOI 10.1001/jama.295.14.1688; Sheriff MJ, 2011, OECOLOGIA, V166, P869, DOI 10.1007/s00442-011-1943-y; Van de Water PK, 2002, OECOLOGIA, V132, P332, DOI 10.1007/s00442-002-0973-x; Welch CA, 1997, ECOLOGY, V78, P1105, DOI 10.2307/2265862; Wingfield JC, 1998, AM ZOOL, V38, P191, DOI 10.1093/icb/38.1.191; Woods JG, 1999, WILDLIFE SOC B, V27, P616	62	28	28	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141489	10.1371/journal.pone.0141489	http://dx.doi.org/10.1371/journal.pone.0141489			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529405	Green Submitted, Green Published, gold			2022-12-26	WOS:000364032600032
J	Chiang, CY; Yu, MC; Yang, SL; Yen, MY; Bai, KJ				Chiang, Chen-Yuan; Yu, Ming-Chih; Yang, Shiang-Lin; Yen, Muh-Yong; Bai, Kuan-Jen			Surveillance of Tuberculosis in Taipei: The Influence of Nontuberculous Mycobacteria	PLOS ONE			English	Article							HUMAN TRANSMISSION; CYSTIC-FIBROSIS; LUNG-DISEASE; ABSCESSUS	Background Notification of tuberculosis (TB) but not nontuberculous mycobacteria (NTM) is mandatory in Taiwan. Partly due to the strict regulation on TB notification, several patients infected with NTM were notified as TB cases. Notification of patients infected with NTM as TB cases can trigger public health actions and impose additional burdens on the public health system. We conducted a study to assess the influence of NTM infection on surveillance of TB in Taipei. Methodology/Principal Findings The study population included all individuals with a positive culture for Mycobacterium who were citizens of Taipei City and notified as TB cases in the calendar years 2007-2010. Of the 4216 notified culture-positive tuberculosis (TB) cases, 894 (21.2%) were infected with NTM. The average annual reported case rate of infection with NTM was 8.6 (95% confidence interval 7.7-9.4) per 100,000 people. The reported case rate of NTM increased with age in both males and females. The proportion of reported TB cases infected with NTM was significantly higher in females than in males (27.6% vs 17.8%, adjusted OR (adjOR) 1.93, 95% confidence interval (CI) 1.63-2.28); in smear-positive than in smear-negative (23.1% vs 19.2%, adjOR 1.26, 95% CI 1.08-1.47); and in previously treated cases than in new cases (35.7% vs 19.1%, adjOR 2.30, 95% CI 1.88-2.82). The most frequent species was M. avium complex (32.4%), followed by M. chelonae complex (17.6%), M. fortuitum complex (17.0%) and M. kansasii (9.8%). Of the 890 notified NTM cases assessed, 703 (79.0%) were treated with anti-TB drugs, and 730 (82.0%) were de-notified. Conclusions/Significance The influence of NTM on surveillance of TB in Taipei was substantial. Health authorities should take action to ensure that nucleic acid amplification tests are performed in all smear-positive cases in a timely manner to reduce the misdiagnosis of patients infected with NTM as TB cases.	[Chiang, Chen-Yuan] Int Union TB & Lung Dis, Paris, France; [Chiang, Chen-Yuan; Yu, Ming-Chih; Bai, Kuan-Jen] Taipei Med Univ, Wan Fang Hosp, Dept Internal Med, Div Pulm Med, Taipei, Taiwan; [Chiang, Chen-Yuan] Taipei Med Univ, Coll Med, Sch Med, Dept Internal Med, Taipei, Taiwan; [Yu, Ming-Chih; Bai, Kuan-Jen] Taipei Med Univ, Coll Med, Sch Resp Therapy, Taipei, Taiwan; [Yang, Shiang-Lin] Ctr Dis Control, Dept Hlth, Taipei, Taiwan; [Yen, Muh-Yong] Taipei City Govt, Taipei City Hosp, Dept Dis Control & Prevent, Taipei, Taiwan	Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Medical University; Centers For Disease Control - Taiwan; Taipei City Hospital	Bai, KJ (corresponding author), Taipei Med Univ, Wan Fang Hosp, Dept Internal Med, Div Pulm Med, Taipei, Taiwan.	kjbai@w.tmu.edu.tw						Adjemian J, 2012, AM J RESP CRIT CARE, V185, P881, DOI 10.1164/rccm.201111-2016OC; Aitken ML, 2012, AM J RESP CRIT CARE, V185, P231, DOI 10.1164/ajrccm.185.2.231; Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P7; Brode SK, 2014, INT J TUBERC LUNG D, V18, P1370, DOI 10.5588/ijtld.14.0120; Bryant JM, 2013, LANCET, V381, P1551, DOI 10.1016/S0140-6736(13)60632-7; Canadian Thoracic Society, 2013, CAN RESP J SA, V20, p1A; Chiang CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044133; Chiang CY, 2002, INT J TUBERC LUNG D, V6, P974; Daley CL, 2010, INT J TUBERC LUNG D, V14, P665; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Hoefsloot W, 2013, EUR RESPIR J, V42, P1604, DOI 10.1183/09031936.00149212; Hoefsloot W, 2012, EUR RESPIR J, V40, P1576, DOI 10.1183/09031936.00096312; Kendall BA, 2011, EMERG INFECT DIS, V17, P506, DOI 10.3201/eid1703.101164; Khan K, 2007, AM J RESP CRIT CARE, V176, P306, DOI 10.1164/rccm.200702-201OC; Kim YK, 2014, INT J TUBERC LUNG D, V18, P725, DOI 10.5588/ijtld.13.0871; Lai CC, 2010, EMERG INFECT DIS, V16, P294, DOI 10.3201/eid1602.090675; Lo HY, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-915; Maiga M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036902; Marras TK, 2013, EMERG INFECT DIS, V19, P1889, DOI 10.3201/eid1911.130737; Moore JE, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-612; Philley JV, 2013, SEMIN RESP CRIT CARE, V34, P135, DOI 10.1055/s-0033-1333575; Ricketts WM, 2014, EUR RESPIR J, V44, P1085, DOI 10.1183/09031936.00066614; Ringshausen FC, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-231; Stanford J, 2012, INT J MYCOBACT, V1, P3, DOI 10.1016/j.ijmyco.2012.01.001; Thomson RM, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-89; van der Werf MJ, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-62; van Ingen J, 2012, EUR RESPIR MONOGR, P25, DOI 10.1183/1025448x.10022511; Wu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109736; Xu KJ, 2014, EMERG INFECT DIS, V20, P1060, DOI 10.3201/eid2006.130700	29	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142324	10.1371/journal.pone.0142324	http://dx.doi.org/10.1371/journal.pone.0142324			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544554	Green Published, Green Submitted, gold			2022-12-26	WOS:000364398700111
J	Moffa, EB; Machado, MAAM; Mussi, MCM; Xiao, YZ; Garrido, SS; Giampaolo, ET; Siqueira, WL				Moffa, Eduardo B.; Machado, Maria A. A. M.; Mussi, Maria C. M.; Xiao, Yizhi; Garrido, Saulo S.; Giampaolo, Eunice T.; Siqueira, Walter L.			In Vitro Identification of Histatin 5 Salivary Complexes	PLOS ONE			English	Article							PROLINE-RICH PROTEINS; WHOLE SALIVA; PROTEOME; STATHERIN; PEPTIDE; LACTOFERRIN; DOMAINS; AMYLASE; BINDING; MG2	With recent progress in the analysis of the salivary proteome, the number of salivary proteins identified has increased dramatically. However, the physiological functions of many of the newly discovered proteins remain unclear. Closely related to the study of a protein's function is the identification of its interaction partners. Although in saliva some proteins may act primarily as single monomeric units, a significant percentage of all salivary proteins, if not the majority, appear to act in complexes with partners to execute their diverse functions. Coimmunoprecipitation (Co-IP) and pull-down assays were used to identify the heterotypic complexes between histatin 5, a potent natural antifungal protein, and other salivary proteins in saliva. Classical protein-protein interaction methods in combination with high-throughput mass spectrometric techniques were carried out. Co-IP using protein G magnetic Sepharose TM beads suspension was able to capture salivary complexes formed between histatin 5 and its salivary protein partners. Pull-down assay was used to confirm histatin 5 protein partners. A total of 52 different proteins were identified to interact with histatin 5. The present study used proteomic approaches in conjunction with classical biochemical methods to investigate protein-protein interaction in human saliva. Our study demonstrated that when histatin 5 is complexed with salivary amylase, one of the 52 proteins identified as a histatin 5 partner, the antifungal activity of histatin 5 is reduced. We expected that our proteomic approach could serve as a basis for future studies on the mechanism and structural-characterization of those salivary protein interactions to understand their clinical significance.	[Moffa, Eduardo B.; Mussi, Maria C. M.; Xiao, Yizhi; Siqueira, Walter L.] Univ Western Ontario, Dept Dent & Biochem, Schulich Sch Med & Dent, London, ON, Canada; [Moffa, Eduardo B.; Giampaolo, Eunice T.] UNESP Univ Estadual Paulista, Araraquara Dent Sch, Dept Dent Mat & Prosthodont, Sao Paulo, Brazil; [Moffa, Eduardo B.] CEUMA Univ, Dept Prosthodont, Sao Luis, MA, Brazil; [Moffa, Eduardo B.; Machado, Maria A. A. M.] Univ Sao Paulo, Bauru Dent Sch, Dept Pediat Dent Orthodont & Publ Hlth, Bauru, SP, Brazil; [Mussi, Maria C. M.] Univ Sao Paulo, Sch Dent, Sao Paulo, SP, Brazil; [Garrido, Saulo S.] UNESP Univ Estadual Paulista, Inst Chem, Dept Biochem & Technol Chem, Sao Paulo, Brazil	Western University (University of Western Ontario); Universidade Estadual Paulista; Universidade Ceuma; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual Paulista	Siqueira, WL (corresponding author), Univ Western Ontario, Dept Dent & Biochem, Schulich Sch Med & Dent, London, ON, Canada.	walter.siqueira@uwo.ca	Siqueira, Walter/ABE-8924-2020; Moffa, Eduardo B/N-4260-2015; Machado, Maria Aparecida Andrade Moreira/D-8224-2012; Garrido, Saulo S Santesso/D-4267-2012; Mussi, Maria Carolina Martins/AAE-3128-2021; Siqueira, Walter/ABE-4069-2021	Siqueira, Walter/0000-0003-1921-3658; Moffa, Eduardo B/0000-0002-0372-6830; Machado, Maria Aparecida Andrade Moreira/0000-0003-3778-7444; Garrido, Saulo S Santesso/0000-0001-7122-1132; 	FAPESP [2011/23540-5, 2011/23543-4, 2012/01528-6, 2013/15412-2]; NSERC [371813]; CIHR [106657, 97577]; Canada Foundation for Innovation [25116]; CIHR New Investigator Award [113166]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); CIHR New Investigator Award(Canadian Institutes of Health Research (CIHR))	Support was provided by FAPESP Grants 2011/23540-5, 2011/23543-4, 2012/01528-6 and 2013/15412-2, NSERC grant#371813, CIHR grants #106657/#97577, and Canada Foundation for Innovation grant #25116. WLS is recipient of a CIHR New Investigator Award grant#113166.	Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; BAUM BJ, 1977, J DENT RES, V56, P1115, DOI 10.1177/00220345770560091801; BENNICK A, 1971, BIOCHEM J, V123, P455, DOI 10.1042/bj1230455; Bruno LS, 2005, BBA-MOL CELL RES, V1746, P65, DOI 10.1016/j.bbamcr.2005.08.007; Castagnola M, 2004, J BIOL CHEM, V279, P41436, DOI 10.1074/jbc.M404322200; Castagnola M, 2012, J MATERN-FETAL NEO M, V25, P27, DOI 10.3109/14767058.2012.714647; Castagnola M, 2012, EXPERT REV PROTEOMIC, V9, P33, DOI [10.1586/EPR.11.77, 10.1586/epr.11.77]; CSERHATI T, 1995, PEPTIDES, V16, P165, DOI 10.1016/0196-9781(94)00134-R; DAWES C, 1972, J PHYSIOL-LONDON, V220, P529, DOI 10.1113/jphysiol.1972.sp009721; Denny P, 2008, J PROTEOME RES, V7, P1994, DOI 10.1021/pr700764j; DICKINSON DP, 1987, BIOCHEM BIOPH RES CO, V149, P784, DOI 10.1016/0006-291X(87)90436-0; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gibbins HL, 2014, ORAL DIS, V20, P707, DOI 10.1111/odi.12194; Gibbins HL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119677; Gyurko C, 2001, ANTON LEEUW INT J G, V79, P297, DOI 10.1023/A:1012070600340; Helmerhorst EJ, 2006, ARCH ORAL BIOL, V51, P1061, DOI 10.1016/j.archoralbio.2006.06.005; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Iontcheva I, 1997, J DENT RES, V76, P734, DOI 10.1177/00220345970760030501; Iontcheva I, 2000, J DENT RES, V79, P732; KELLER PJ, 1971, BIOCHEMISTRY-US, V10, P4867, DOI 10.1021/bi00802a006; KOUSVELARI EE, 1979, BIOCHIM BIOPHYS ACTA, V578, P76, DOI 10.1016/0005-2795(79)90115-6; McDonald EE, 2011, J DENT RES, V90, P268, DOI 10.1177/0022034510388653; OPPENHEIM FG, 1988, J BIOL CHEM, V263, P7472; OPPENHEIM FG, 1971, BIOCHEMISTRY-US, V10, P4233, DOI 10.1021/bi00799a013; Oppenheim FG, 2007, ANN NY ACAD SCI, V1098, P22, DOI 10.1196/annals.1384.030; PLOS ONE Staff, 2015, PLoS One, V10, pe0126887, DOI 10.1371/journal.pone.0126887; POLLOCK JJ, 1984, INFECT IMMUN, V44, P702, DOI 10.1128/IAI.44.3.702-707.1984; RAJ PA, 1990, J BIOL CHEM, V265, P3898; Ramani AK, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-R40; Ruhl S, 2005, J DENT RES, V84, P29, DOI 10.1177/154405910508400104; Ruhl S, 2012, EXPERT REV PROTEOMIC, V9, P85, DOI [10.1586/epr.11.80, 10.1586/EPR.11.80]; Salih E, 2010, ANAL BIOCHEM, V407, P19, DOI 10.1016/j.ab.2010.07.012; SCHLESINGER DH, 1977, J BIOL CHEM, V252, P1689; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Siqueira WL, 2008, J DENT RES, V87, P445, DOI 10.1177/154405910808700508; Siqueira WL, 2007, ANN NY ACAD SCI, V1098, P504, DOI 10.1196/annals.1384.023; Siqueira WL, 2010, J DENT RES, V89, P626, DOI 10.1177/0022034510363384; Siqueira WL, 2012, PROTEOMICS, V12, P3426, DOI 10.1002/pmic.201100665; Siqueira WL, 2004, ORAL SURG ORAL MED O, V98, P76, DOI 10.1016/j.tripleo.2004.04.007; Soares RV, 2004, ARCH ORAL BIOL, V49, P337, DOI 10.1016/j.archoralbio.2003.11.007; Soares RV, 2003, J DENT RES, V82, P471, DOI 10.1177/154405910308200613; Sun XL, 2009, FASEB J, V23, P2691, DOI 10.1096/fj.09-131045; Vitorino R, 2012, J PROTEOMICS, V75, P5140, DOI 10.1016/j.jprot.2012.05.045; Wang GS, 2014, PHARMACEUTICALS-BASE, V7, P545, DOI 10.3390/ph7050545; XU T, 1991, INFECT IMMUN, V59, P2549, DOI 10.1128/IAI.59.8.2549-2554.1991	46	12	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142517	10.1371/journal.pone.0142517	http://dx.doi.org/10.1371/journal.pone.0142517			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544073	Green Published, Green Submitted, gold			2022-12-26	WOS:000364398700149
J	Buckley, M; Farina, RA; Lawless, C; Tambusso, PS; Varela, L; Carlini, AA; Powell, JE; Martinez, JG				Buckley, Michael; Farina, Richard A.; Lawless, Craig; Sebastian Tambusso, P.; Varela, Luciano; Carlini, Alfredo A.; Powell, Jaime E.; Martinez, Jorge G.			Collagen Sequence Analysis of the Extinct Giant Ground Sloths Lestodon and Megatherium	PLOS ONE			English	Article							AMERICAN BIOTIC INTERCHANGE; MOLECULAR PHYLOGENY; XENARTHRA; MITOCHONDRIAL; DIET; DIVERSIFICATION; PLEISTOCENE; TARDIGRADA; ARMADILLOS; RADIATION	For over 200 years, fossils of bizarre extinct creatures have been described from the Americas that have ranged from giant ground sloths to the 'native' South American ungulates, groups of mammals that evolved in relative isolation on South America. Ground sloths belong to the South American xenarthrans, a group with modern although morphologically and ecologically very different representatives (anteaters, armadillos and sloths), which has been proposed to be one of the four main eutherian clades. Recently, proteomics analyses of bone collagen have recently been used to yield a molecular phylogeny for a range of mammals including the unusual 'Malagasy aardvark' shown to be most closely related to the afrotherian tenrecs, and the south American ungulates supporting their morphological association with condylarths. However, proteomics results generate partial sequence information that could impact upon the phylogenetic placement that has not been appropriately tested. For comparison, this paper examines the phylogenetic potential of proteomics-based sequencing through the analysis of collagen extracted from two extinct giant ground sloths, Lestodon and Megatherium. The ground sloths were placed as sister taxa to extant sloths, but with a closer relationship between Lestodon and the extant sloths than the basal Megatherium. These results highlight that proteomics methods could yield plausible phylogenies that share similarities with other methods, but have the potential to be more useful in fossils beyond the limits of ancient DNA survival.	[Buckley, Michael] Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, Manchester, Lancs, England; [Farina, Richard A.; Sebastian Tambusso, P.; Varela, Luciano] Univ Republica, Secc Paleontol, Fac Ciencias, Montevideo, Uruguay; [Lawless, Craig] Univ Manchester, Manchester, Lancs, England; [Carlini, Alfredo A.] Museo La Plata, Fac Ciencias Nat & Museo, Buenos Aires, DF, Argentina; [Powell, Jaime E.] Univ Nacl Tucuman, Fac Ciencias Nat, RA-4000 San Miguel De Tucuman, Tucuman, Argentina; [Martinez, Jorge G.] Inst Arqueol & Museo UNT, Inst Super Estudios Sociales CONICET, San Miguel De Tucuman, Argentina	University of Manchester; Universidad de la Republica, Uruguay; University of Manchester; National University of La Plata; Museo La Plata; Universidad Nacional de Tucuman	Buckley, M (corresponding author), Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, Manchester, Lancs, England.	m.buckley@manchester.ac.uk	Fariña, Richard/GRF-6009-2022; Varela, Luciano/R-2111-2018	Varela, Luciano/0000-0002-9481-6558; Tambusso, Pablo Sebastian/0000-0001-7349-5292; Martinez, Jorge Gabriel/0000-0001-6642-4074; Buckley, Michael/0000-0002-4166-8213	Royal Society; Comision Sectorial de Investigacion Cientifica; Universidad de la Republica; Comuna Canaria; Municipio de Sauce;  [CIUNT 26G522]; Natural Environment Research Council [NE/K000799/1] Funding Source: researchfish; NERC [NE/K000799/1] Funding Source: UKRI	Royal Society(Royal Society of London); Comision Sectorial de Investigacion Cientifica; Universidad de la Republica; Comuna Canaria; Municipio de Sauce; ; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The authors gratefully acknowledge the Royal Society for fellowship funding to MB. This is a contribution to the project "Prospeccion de nuevos sitios fosiliferos y arqueologicos en el area del Arroyo del Vizcaino" funded by the Comision Sectorial de Investigacion Cientifica, Universidad de la Republica and both Comuna Canaria and Municipio de Sauce partially funded the excavations of RF and his team. The authors are grateful to funding for recovery of one of the Megatherium specimens under the grant CIUNT 26G522 to JP.	Barros MC, 2003, GENET MOL BIOL, V26, P5, DOI 10.1590/S1415-47572003000100002; Buckley M, 2014, PALAEOGEOGR PALAEOCL, V416, P69, DOI 10.1016/j.palaeo.2014.06.026; Buckley M, 2011, GEOCHIM COSMOCHIM AC, V75, P2007, DOI 10.1016/j.gca.2011.01.022; Buckley M, 2008, SCIENCE, V319; Buckley M, 2015, P ROYAL SOC B, V282; Buckley M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059614; Buckley M, 2013, RAPID COMMUN MASS SP, V27, P531, DOI 10.1002/rcm.6481; Buckley M, 2009, RAPID COMMUN MASS SP, V23, P3843, DOI 10.1002/rcm.4316; Buckley M, 2008, SCIENCE, V319, DOI 10.1126/science.1147046; Cappellini E, 2012, J PROTEOME RES, V11, P917, DOI 10.1021/pr200721u; Clack AA, 2012, METHODS MOL BIOL, V840, P51, DOI 10.1007/978-1-61779-516-9_7; Cuvier G., 1796, MAGASIN ENCY J SCI L, V7, P303; Delsuc F, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-11; Delsuc F, 2003, MOL PHYLOGENET EVOL, V28, P261, DOI 10.1016/S1055-7903(03)00111-8; Delsuc F, 2001, P ROY SOC B-BIOL SCI, V268, P1605, DOI 10.1098/rspb.2001.1702; Engelmann G.F., 1985, P51; Faria RA., 2013, MEGAFAUNA GIANT BEAS; Farina Richard A., 2003, Senckenbergiana Biologica, V83, P3; Farina RA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2211; Gaudin Timothy J., 2003, Senckenbergiana Biologica, V83, P27; Gaudin Timothy J., 2008, P24; Gaudin TJ, 2004, ZOOL J LINN SOC-LOND, V140, P255, DOI 10.1111/j.1096-3642.2003.00100.x; Gervais P., 1855, RECHARCHES MAMMIFERE; Greenwood AD, 2001, MOL PHYLOGENET EVOL, V18, P94, DOI 10.1006/mpev.2000.0860; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hallstrom BM, 2007, MOL BIOL EVOL, V24, P2059, DOI 10.1093/molbev/msm136; Hofreiter M, 2003, QUATERNARY RES, V59, P364, DOI 10.1016/S0033-5894(03)00030-9; Hofreiter M, 2000, MOL ECOL, V9, P1975, DOI 10.1046/j.1365-294X.2000.01106.x; Hoss M, 1996, P NATL ACAD SCI USA, V93, P181, DOI 10.1073/pnas.93.1.181; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jiang XG, 2007, J PROTEOME RES, V6, P2287, DOI 10.1021/pr070056t; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lessa EP, 1996, PALAEONTOLOGY, V39, P651; LOWENSTEIN JM, 1981, NATURE, V291, P409, DOI 10.1038/291409a0; Martinez J, 2005, SERIE MONOGR DID FCN, V45, P25; McDonald H. Gregory, 2008, P39; Nielsen-Marsh C., 2002, BIOCHEMISTRY-US, V24, P12, DOI [10.1042/BIO02403012, DOI 10.1042/BIO02403012]; O'Leary MA, 2013, SCIENCE, V339, P662, DOI 10.1126/science.1229237; Poinar HN, 1998, SCIENCE, V281, P402, DOI 10.1126/science.281.5375.402; Pujos F, 2007, J VERTEBR PALEONTOL, V27, P132, DOI 10.1671/0272-4634(2007)27[132:LOMFMX]2.0.CO;2; Pujos F, 2007, ZOOL J LINN SOC-LOND, V149, P179, DOI 10.1111/j.1096-3642.2007.00240.x; Rybczynski N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2516; Sarich V.M., 1985, P77; SHOSHANI J, 1985, PALEOBIOLOGY, V11, P429, DOI 10.1017/S0094837300011714; Springer MS, 2003, P NATL ACAD SCI USA, V100, P1056, DOI 10.1073/pnas.0334222100; van Dijk MAM, 1999, SYST BIOL, V48, P94, DOI 10.1080/106351599260463; Vizcaino Sergio F., 2008, P1; Wadsworth C, 2014, RAPID COMMUN MASS SP, V28, P605, DOI 10.1002/rcm.6821; Webb SD, 2006, ANN MO BOT GARD, V93, P245; Woodburne MO, 2010, J MAMM EVOL, V17, P245, DOI 10.1007/s10914-010-9144-8	50	27	27	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0139611	10.1371/journal.pone.0139611	http://dx.doi.org/10.1371/journal.pone.0139611			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540101	Green Published, gold, Green Submitted			2022-12-26	WOS:000364303800002
J	He, M; Zhang, YN; He, P				He, Ming; Zhang, Ya-Nan; He, Peng			Molecular Characterization and Differential Expression of an Olfactory Receptor Gene Family in the White-Backed Planthopper Sogatella furcifera Based on Transcriptome Analysis	PLOS ONE			English	Article							IONOTROPIC GLUTAMATE RECEPTORS; DROSOPHILA ODORANT RECEPTORS; SEX-PHEROMONE RECEPTORS; STREAKED DWARF VIRUS; FUNCTIONAL-CHARACTERIZATION; ANTENNAL TRANSCRIPTOME; BINDING-PROTEINS; IDENTIFICATION; SUPERFAMILY; SPECIATION	The white-backed planthopper, Sogatella furcifera, a notorious rice pest in Asia, employs host plant volatiles as cues for host location. In insects, odor detection is mediated by two types of olfactory receptors: odorant receptors (ORs) and ionotropic receptors (IRs). In this study, we identified 63 SfurORs and 14 SfurIRs in S. furcifera based on sequences obtained from the head transcriptome and bioinformatics analysis. The motif-pattern of 130 hemiptera ORs indicated an apparent differentiation in this order. Phylogenetic trees of the ORs and IRs were constructed using neighbor-joining estimates. Most of the ORs had orthologous genes, but a specific OR clade was identified in S. furcifera, which suggests that these ORs may have specific olfactory functions in this species. Our results provide a basis for further investigations of how S. furcifera coordinates its olfactory receptor genes with its plant hosts, thereby providing a foundation for novel pest management approaches based on these genes.	[He, Ming; He, Peng] Guizhou Univ, Minist Educ, State Key Lab Breeding Base Green Pesticide & Agr, Key Lab Green Pesticide & Agr Bioengn, Guiyang 550003, Peoples R China; [Zhang, Ya-Nan] Huaibei Normal Univ, Coll Life Sci, Huaibei, Peoples R China	Guizhou University; Huaibei Normal University	He, P (corresponding author), Guizhou Univ, Minist Educ, State Key Lab Breeding Base Green Pesticide & Agr, Key Lab Green Pesticide & Agr Bioengn, Guiyang 550003, Peoples R China.	fcc.phe@gzu.edu.cn			Natural Science Foundation of China [31360528, 31401750]; Natural Science Foundation of Guizhou Province of China [QKH-J [2014]2062]; Scientific Research Foundation of Guizhou University, China (RJH Project) [2013-28]; Brainstorm Project on Social Development by Department of Science and Technology of Guizhou Province [SY [2010]3004]; Science and Technology Project of Guizhou Province (QKH Major Project) [(2012) 6012]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guizhou Province of China; Scientific Research Foundation of Guizhou University, China (RJH Project); Brainstorm Project on Social Development by Department of Science and Technology of Guizhou Province; Science and Technology Project of Guizhou Province (QKH Major Project)	Support was provided by Natural Science Foundation of China (Grant Nos. 31360528 and 31401750 for PH), Natural Science Foundation of Guizhou Province of China (Grant No. QKH-J [2014]2062 for PH), Scientific Research Foundation of Guizhou University, China (RJH Project Grant No. 2013-28 for PH), Brainstorm Project on Social Development by Department of Science and Technology of Guizhou Province (Grant No. SY [2010]3004 for MH), and Science and Technology Project of Guizhou Province (QKH Major Project Grant No. (2012) 6012 for MH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuin L, 2011, NEURON, V69, P44, DOI 10.1016/j.neuron.2010.11.042; Bengtsson JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031620; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Cao DP, 2014, INT J BIOL SCI, V10, P846, DOI 10.7150/ijbs.9297; Cao DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101187; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; Dasmahapatra KK, 2012, NATURE, V487, P94, DOI 10.1038/nature11041; Engsontia P, 2008, INSECT BIOCHEM MOLEC, V38, P387, DOI 10.1016/j.ibmb.2007.10.005; Fox AN, 2001, P NATL ACAD SCI USA, V98, P14693, DOI 10.1073/pnas.261432998; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; Glaser N, 2013, INT J BIOL SCI, V9, P481, DOI 10.7150/ijbs.6109; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grosse-Wilde E, 2011, P NATL ACAD SCI USA, V108, P7449, DOI 10.1073/pnas.1017963108; He P, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-136; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; Jacquin-Joly E, SHORT VIEWS INSECT M, P147; Jiang XJ, 2014, INSECT BIOCHEM MOLEC, V48, P63, DOI 10.1016/j.ibmb.2014.02.010; Jordan MD, 2009, CHEM SENSES, V34, P383, DOI 10.1093/chemse/bjp010; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Liu C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000467; Liu CC, 2013, INSECT BIOCHEM MOLEC, V43, P747, DOI 10.1016/j.ibmb.2013.05.009; Liu NY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-597; Liu YD, 2013, PLANT SIGNAL BEHAV, V8, DOI [10.4161/psb.25079, 10.4161/psb.23864, 10.1371/journal.pone.0065361]; Madden DR, 2002, NAT REV NEUROSCI, V3, P91, DOI 10.1038/nrn725; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; OBATA T, 1981, JPN J APPL ENTOMOL Z, V25, P47, DOI 10.1303/jjaez.25.47; OBATA T, 1983, APPL ENTOMOL ZOOL, V18, P161, DOI 10.1303/aez.18.161; Olivier V, 2011, INSECT MOL BIOL, V20, P189, DOI 10.1111/j.1365-2583.2010.01057.x; Pelosi P, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00320; Poivet E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060263; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Robertson HM, 2006, GENOME RES, V16, P1395, DOI 10.1101/gr.5057506; Rytz R, 2013, INSECT BIOCHEM MOLEC, V43, P888, DOI 10.1016/j.ibmb.2013.02.007; Sakurai T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002115; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Schwarz D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-633; Silbering AF, 2011, J NEUROSCI, V31, P13357, DOI 10.1523/JNEUROSCI.2360-11.2011; Smadja C, 2009, MOL BIOL EVOL, V26, P2073, DOI 10.1093/molbev/msp116; Smadja CM, 2012, EVOLUTION, V66, P2723, DOI 10.1111/j.1558-5646.2012.01612.x; Smart R, 2008, INSECT BIOCHEM MOLEC, V38, P770, DOI 10.1016/j.ibmb.2008.05.002; Sun MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062098; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vogt RG, COMPREHENSIVE INSECT, V3, P753; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Xu YL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-632; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhan S, 2011, CELL, V147, P1171, DOI 10.1016/j.cell.2011.09.052; Zhang YN, 2014, INSECT MOL BIOL, V23, P611, DOI 10.1111/imb.12109; Zhang YD, 2013, SCI WORLD J, DOI 10.1155/2013/130134; Zhou GH, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00270; Zhou YL, 2014, J INSECT PHYSIOL, V60, P31, DOI 10.1016/j.jinsphys.2013.10.006	55	21	25	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0140605	10.1371/journal.pone.0140605	http://dx.doi.org/10.1371/journal.pone.0140605			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540266	Green Published, Green Submitted, gold			2022-12-26	WOS:000364303800005
J	Hou, JC; Fu, JH; Li, D; Han, X; Li, L; Song, WT; Yao, MJ; Liu, JX				Hou, Jincai; Fu, Jianhua; Li, Dan; Han, Xiao; Li, Lei; Song, Wenting; Yao, Mingjiang; Liu, Jianxun			Transcriptomic Analysis of Myocardial Ischemia Using the Blood of Rat	PLOS ONE			English	Article							GENE-EXPRESSION; RNA-SEQ; REPERFUSION INJURY; ISCHEMIA/REPERFUSION INJURY; HEART; ULTRAFAST; SEQUENCES; ALIGNMENT; PROTECTS; GENOME	Myocardial ischemia is a pathological state of heart with reduced blood flow to heart and abnormal myocardial energy metabolism. This disease occurs commonly in middle aged and elderly people. Several studies have indicated that the rat was an appropriate animal model used to study myocardial ischemia. In this study, in order to gain insights into the pathogenesis of myocardial ischemia, we sequenced the transcriptomes of three normal rats as control and the same number of myocardial ischemia rats. We sequenced the genomes of 6 rats, including 3 cases (myocardial ischemia) and 3 controls using Illumina HiSeq 2000. Then we calculated the gene expression values and identified differentially expressed genes based on reads per kilobase transcriptome per million (RPKM). Meanwhile we performed a GO enrichment analysis and predicted novel transcripts. In our study, we found that 707 genes were up-regulated and 21 genes were down-regulated in myocardial ischemia rats by at least 2-fold compared with controls. By the distribution of reads and the annotation of reference genes, we found 1,703 and 1,552 novel transcripts in cases and controls, respectively. At the same time, we refined the structure of 9,587 genes in controls and 10,301 in cases. According to the results of GO term and pathway analysis of differentially expressed genes, we found that the immune response, stimulus response, response to stress and some diseases may be associated with myocardial ischemia. Since many diseases, especially immune diseases, are associated with myocardial ischemia, we should pay more attention to the complications which might result from myocardial ischemia.	[Hou, Jincai; Fu, Jianhua; Li, Dan; Han, Xiao; Li, Lei; Song, Wenting; Yao, Mingjiang; Liu, Jianxun] China Acad Chinese Med Sci, Inst Basic Med Sci, Xiyuan Hosp, Beijing, Peoples R China; [Hou, Jincai; Fu, Jianhua; Li, Dan; Han, Xiao; Li, Lei; Song, Wenting; Yao, Mingjiang; Liu, Jianxun] Beijing Key Lab Pharmacol Chinese Mat Med, Beijing, Peoples R China	China Academy of Chinese Medical Sciences; Xiyuan Hospital, CACMS	Liu, JX (corresponding author), China Acad Chinese Med Sci, Inst Basic Med Sci, Xiyuan Hosp, Beijing, Peoples R China.	liujx0324@sina.com			National Natural Science Foundation of China [81173582]; National Science & Technology Major Project of China [2012ZX09103201-049, 2012zx09301002-004-002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science & Technology Major Project of China	This work was funded by National Natural Science Foundation of China (No. 81173582), National Science & Technology Major Project of China (Nos. 2012ZX09103201-049), and National Science & Technology Major Project of China (2012zx09301002-004-002).	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Benjamini Y, 2001, ANN STAT, V29, P1165; Cock PJA, 2010, NUCLEIC ACIDS RES, V38, P1767, DOI 10.1093/nar/gkp1137; DAS DK, 1995, J MOL CELL CARDIOL, V27, P181, DOI 10.1016/S0022-2828(08)80017-X; Ferrari R, 1998, AM J CARDIOL, V82, p2K, DOI 10.1016/S0002-9149(98)00531-1; Fullwood MJ, 2009, GENOME RES, V19, P521, DOI 10.1101/gr.074906.107; Goldman S, 1995, J Card Fail, V1, P169, DOI 10.1016/1071-9164(95)90019-5; Gottlieb RA, 1999, ANN NY ACAD SCI, V874, P412, DOI 10.1111/j.1749-6632.1999.tb09255.x; Guzel S, 2013, DIABETES VASC DIS RE, V10, P25, DOI 10.1177/1479164112440815; Ha TZ, 2011, ANTIOXID REDOX SIGN, V15, P1875, DOI 10.1089/ars.2010.3723; Kelle I, 2015, EUR REV MED PHARMACO, V19, P2468; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2013, CARDIOVASC DIABETOL, V12, DOI [10.1186/1475-2840-12-133, 10.1186/1475-2840-12-91]; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li TC, 2014, PHARMAZIE, V69, P850, DOI 10.1691/ph.2014.4598; Li Y, 2011, J BIOL CHEM, V286, P31308, DOI 10.1074/jbc.M111.246124; Lin YL, 2015, EXP THER MED, V9, P1537, DOI 10.3892/etm.2015.2290; Liu PY, 2014, J GERIATR CARDIOL, V11, P303, DOI 10.11909/j.issn.1671-5411.2014.04.005; Liu Qian-Ping, 2013, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V29, P326; Lyn D, 2000, PHYSIOL GENOMICS, V2, P93, DOI 10.1152/physiolgenomics.2000.2.3.93; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Michael LH, 1995, AM J PHYSIOL-HEART C, V269, pH2147, DOI 10.1152/ajpheart.1995.269.6.H2147; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Raz T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019287; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Tarzami ST, 2002, J MOL CELL CARDIOL, V34, P209, DOI 10.1006/jmcc.2001.1503; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Xiang SY, 2011, J CLIN INVEST, V121, P3269, DOI 10.1172/JCI44371; Yu LM, 2015, J PINEAL RES, V59, P420, DOI 10.1111/jpi.12272; Zhang Y, 2011, CIRC-HEART FAIL, V4, P659, DOI 10.1161/CIRCHEARTFAILURE.111.962563; Zhou MJ, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/481405	31	2	2	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141915	10.1371/journal.pone.0141915	http://dx.doi.org/10.1371/journal.pone.0141915			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540270	gold, Green Published, Green Submitted			2022-12-26	WOS:000364303800036
J	Huang, D; Peng, WJ; Ye, Q; Liu, XP; Zhao, L; Fan, L; Xia-Hou, K; Jia, HJ; Luo, J; Zhou, LT; Li, BB; Wang, SL; Xu, WT; Chen, Z; Tan, WS				Huang, Ding; Peng, Wen-Juan; Ye, Qian; Liu, Xu-Ping; Zhao, Liang; Fan, Li; Xia-Hou, Kang; Jia, Han-Jing; Luo, Jian; Zhou, Lin-Ting; Li, Bei-Bei; Wang, Shi-Lei; Xu, Wen-Ting; Chen, Ze; Tan, Wen-Song			Serum-Free Suspension Culture of MDCK Cells for Production of Influenza H1N1 Vaccines	PLOS ONE			English	Article							SCALE MICROCARRIER CULTURE; VIRUS PRODUCTION; VERO CELLS; FREE MEDIA; A-VIRUS; GROWTH; LINE; APOPTOSIS; ADHERENT; SYSTEM	Development of serum-free suspension cell culture processes is very important for influenza vaccine production. Previously, we developed a MDCK suspension cell line in a serum-free medium. In the present study, the growth kinetics of suspension MDCK cells and influenza virus production in the serum-free medium were investigated, in comparison with those of adherent MDCK cells in both serum-containing and serum-free medium. It was found that the serum-free medium supported the stable subculture and growth of both adherent and suspension cells. In batch culture, for both cell lines, the growth kinetics in the serum-free medium was comparable with those in the serum-containing medium and a commercialized serum-free medium. In the serum-free medium, peak viable cell density (VCD), haemagglutinin (HA) and median tissue culture infective dose (TCID50) titers of the two cell lines reached 4.51x10(6) cells/mL, 2.94Log(10)(HAU/50 mu L) and 8.49Log(10)(virions/mL), and 5.97x10(6) cells/mL, 3.88Log(10)(HAU/50 mu L), and 10.34Log(10)(virions/mL), respectively. While virus yield of adherent cells in the serum-free medium was similar to that in the serum-containing medium, suspension culture in the serum-free medium showed a higher virus yield than adherent cells in the serum-containing medium and suspension cells in the commercialized serum-free medium. However, the percentage of infectious viruses was lower for suspension culture in the serum-free medium. These results demonstrate the great potential of this suspension MDCK cell line in serum-free medium for influenza vaccine production and further improvements are warranted.	[Huang, Ding; Peng, Wen-Juan; Ye, Qian; Liu, Xu-Ping; Zhao, Liang; Fan, Li; Xia-Hou, Kang; Jia, Han-Jing; Tan, Wen-Song] E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China; [Luo, Jian; Zhou, Lin-Ting; Li, Bei-Bei; Wang, Shi-Lei; Xu, Wen-Ting; Chen, Ze] Shanghai Inst Biol Prod Co Ltd, Shanghai 200052, Peoples R China	East China University of Science & Technology	Liu, XP (corresponding author), E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China.	xupingliu@ecust.edu.cn; wstan@ecust.edu.cn	Zhao, Liang/J-6986-2012	Zhao, Liang/0000-0001-8077-3617	National Natural Science Foundation of China [21206040, 21406066]; National High Technology Research and Development Program of China (863 Program) [2012AA02A303]; National Science and Technology Major Project [2013ZX10004003-003-003]; Fundamental Research Funds for the Central Universities [WF1214035]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Science and Technology Major Project; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (Nos. 21206040, 21406066)(http://www.nsfc.gov.cn/), the National High Technology Research and Development Program of China (863 Program) (No. 2012AA02A303) (http://www.863.gov.cn/), the National Science and Technology Major Project (No. 2013ZX10004003-003-003) (http://www.nmp.gov.cn/), and the Fundamental Research Funds for the Central Universities (WF1214035) (http://jkw.mof.gov.cn/).	ALTMAN SA, 1993, BIOTECHNOL PROGR, V9, P671, DOI 10.1021/bp00024a017; Bock A, 2011, BIOTECHNOL PROGR, V27, P241, DOI 10.1002/btpr.539; Bock A, 2009, BIOTECHNOL PROGR, V25, P1717, DOI 10.1002/btpr.262; Butler M, 2000, BIOTECHNOL PROGR, V16, P854, DOI 10.1021/bp000110+; Chen A, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-81; Chen MQ, 2011, BIOMATERIALS, V32, P7532, DOI 10.1016/j.biomaterials.2011.06.054; Chu C, 2009, P NATL ACAD SCI USA, V106, P14802, DOI 10.1073/pnas.0905912106; FISHBEIN DB, 1993, VACCINE, V11, P1390, DOI 10.1016/0264-410X(93)90167-V; Frensing T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072288; Genzel Y, 2006, VACCINE, V24, P3261, DOI 10.1016/j.vaccine.2006.01.019; Genzel Y, 2014, VACCINE; Genzel Y, 2013, APPL MICROBIOL BIOT, V97, P111, DOI 10.1007/s00253-012-4238-2; Genzel Y, 2010, APPL MICROBIOL BIOT, V88, P461, DOI 10.1007/s00253-010-2742-9; Genzel Y, 2009, EXPERT REV VACCINES, V8, P1681, DOI [10.1586/erv.09.128, 10.1586/ERV.09.128]; Hatakeyama S, 2005, J CLIN MICROBIOL, V43, P4139, DOI 10.1128/JCM.43.8.4139-4146.2005; Henry O, 2004, BIOTECHNOL BIOENG, V86, P765, DOI 10.1002/bit.20074; Hu AYC, 2008, VACCINE, V26, P5736, DOI 10.1016/j.vaccine.2008.08.015; Hu AYC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0014578, 10.1371/journal.pone.0029229]; Huang D, 2014, VACCINE, V32, P7091, DOI 10.1016/j.vaccine.2014.10.067; Huang Ding, 2011, Sheng Wu Gong Cheng Xue Bao, V27, P645; Hussain AI, 2010, VACCINE, V28, P3848, DOI 10.1016/j.vaccine.2010.03.005; INFL WA, WHO MAN AN INFL DIAG; Isken B, 2012, VACCINE, V30, P5253, DOI 10.1016/j.vaccine.2012.05.065; Kalbfuss B, 2008, BIOLOGICALS, V36, P145, DOI 10.1016/j.biologicals.2007.10.002; Lee J-S, 2009, Google Patents, Patent No. [WO 2009152181A12009, 2009152181]; Li N, 2011, ACTA VIROL, V55, P147, DOI 10.4149/av_2011_02_147; Lohr V, 2009, VACCINE, V27, P4975, DOI 10.1016/j.vaccine.2009.05.083; Lohr V, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-79; Mehtali M, 2006, WO Patent, Patent No. [2,006,108,846, 20006108846]; Mohler L, 2005, BIOTECHNOL BIOENG, V90, P46, DOI 10.1002/bit.20363; Ngunjiri JM, 2008, J VIROL, V82, P2673, DOI 10.1128/JVI.02221-07; Pau MG, 2001, VACCINE, V19, P2716, DOI 10.1016/S0264-410X(00)00508-9; Peschel B, 2013, VACCINE, V31, P5693, DOI 10.1016/j.vaccine.2013.09.051; Petiot E, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-84; Pohscheidt M, 2008, VACCINE, V26, P1552, DOI 10.1016/j.vaccine.2008.01.032; Reisinger KS, 2009, J INFECT DIS, V200, P849, DOI 10.1086/605506; Tan W, 2010, Serum-free medium for large-scale adherent and single-cell culture of MDCK cells2010, Patent No. [ZL 201010022834.4, 201010022834]; Tapia F, 2014, VACCINE, V32, P1003, DOI 10.1016/j.vaccine.2013.11.044; van Wielink R, 2011, J VIROL METHODS, V171, P53, DOI 10.1016/j.jviromet.2010.09.029; Wu SC, 2004, VACCINE, V22, P3858, DOI 10.1016/j.vaccine.2004.05.037	40	28	36	5	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141686	10.1371/journal.pone.0141686	http://dx.doi.org/10.1371/journal.pone.0141686			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540170	Green Submitted, gold, Green Published			2022-12-26	WOS:000364303800023
J	Komoto, S; Tacharoenmuang, R; Guntapong, R; Ide, T; Haga, K; Katayama, K; Kato, T; Ouchi, Y; Kurahashi, H; Tsuji, T; Sangkitporn, S; Taniguchi, K				Komoto, Satoshi; Tacharoenmuang, Ratana; Guntapong, Ratigorn; Ide, Tomihiko; Haga, Kei; Katayama, Kazuhiko; Kato, Takema; Ouchi, Yuya; Kurahashi, Hiroki; Tsuji, Takao; Sangkitporn, Somchai; Taniguchi, Koki			Emergence and Characterization of Unusual DS-1-Like G1P[8] Rotavirus Strains in Children with Diarrhea in Thailand	PLOS ONE			English	Article							WHOLE-GENOMIC ANALYSIS; GENOTYPE CONSTELLATION; PORCINE; CLASSIFICATION; IDENTIFICATION; PREVALENCE; SPREAD; JAPAN; NSP4; GENE	The emergence and rapid spread of unusual DS-1-like G1P[8] rotaviruses in Japan have been recently reported. During rotavirus surveillance in Thailand, three DS-1-like G1P[8] strains (RVA/Human-wt/THA/PCB-180/2013/G1P[8], RVA/Human-wt/THA/SKT-109/2013/G1P[8], and RVA/Human-wt/THA/SSKT-41/2013/G1P[8]) were identified in stool specimens from hospitalized children with severe diarrhea. In this study, we sequenced and characterized the complete genomes of strains PCB-180, SKT-109, and SSKT-41. On whole genomic analysis, all three strains exhibited a unique genotype constellation including both genogroup 1 and 2 genes: G1-P[8]-I2-R2-C2-M2-A2-N2-T2-E2-H2. This novel genotype constellation is shared with Japanese DS-1-like G1P[8] strains. Phylogenetic analysis revealed that the G/P genes of strains PCB-180, SKT-109, and SSKT-41 appeared to have originated from human Wa-like G1P[8] strains. On the other hand, the non-G/P genes of the three strains were assumed to have originated from human DS-1-like strains. Thus, strains PCB-180, SKT-109, and SSKT-41 appeared to be derived through reassortment event(s) between Wa-like G1P[8] and DS-1-like human rotaviruses. Furthermore, strains PCB-180, SKT-109, and SSKT-41 were found to have the 11-segment genome almost indistinguishable from one another in their nucleotide sequences and phylogenetic lineages, indicating the derivation of the three strains from a common origin. Moreover, all the 11 genes of the three strains were closely related to those of Japanese DS-1-like G1P[8] strains. Therefore, DS-1-like G1P[8] strains that have emerged in Thailand and Japan were assumed to have originated from a recent common ancestor. To our knowledge, this is the first report on whole genome-based characterization of DS-1-like G1P[8] strains that have emerged in an area other than Japan. Our observations will provide important insights into the evolutionary dynamics of emerging DS-1-like G1P[8] rotaviruses.	[Komoto, Satoshi; Ide, Tomihiko; Taniguchi, Koki] Fujita Hlth Univ, Sch Med, Dept Virol & Parasitol, Toyoake, Aichi 47011, Japan; [Tacharoenmuang, Ratana; Guntapong, Ratigorn; Sangkitporn, Somchai] Natl Inst Hlth, Dept Med Sci, Nonthaburi, Thailand; [Haga, Kei; Katayama, Kazuhiko] Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan; [Kato, Takema; Kurahashi, Hiroki] Fujita Hlth Univ, Div Mol Genet, Inst Comprehens Med Sci, Toyoake, Aichi, Japan; [Ouchi, Yuya; Kurahashi, Hiroki] Fujita Hlth Univ, Genome & Transcriptome Anal Ctr, Toyoake, Aichi, Japan; [Tsuji, Takao] Fujita Hlth Univ, Sch Med, Dept Microbiol, Toyoake, Aichi 47011, Japan	Fujita Health University; Ministry of Public Health - Thailand; National Institute of Infectious Diseases (NIID); Fujita Health University; Fujita Health University; Fujita Health University	Komoto, S (corresponding author), Fujita Hlth Univ, Sch Med, Dept Virol & Parasitol, Toyoake, Aichi 47011, Japan.	satoshik@fujita-hu.ac.jp		Katayama, Kazuhiko/0000-0002-7692-1151	MEXT-Supported Program for the Strategic Research Foundation at Private Universities; Japan Agency for Medical Research and Development, AMED; Original Rotavirus Vaccine Effectiveness Study Program of the Ministry of Public Health of Thailand	MEXT-Supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED)); Original Rotavirus Vaccine Effectiveness Study Program of the Ministry of Public Health of Thailand	This study was supported in part by the MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2010-2014 (KT), the Research Program on Emerging and Re-emerging Infectious Diseases from the Japan Agency for Medical Research and Development, AMED (KT), and the Original Rotavirus Vaccine Effectiveness Study Program of the Ministry of Public Health of Thailand (SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dennis FE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100699; Doro R, 2014, INFECT GENET EVOL, V28, P495, DOI 10.1016/j.meegid.2014.09.016; Estes M.K., 2013, FIELDS VIROLOGY, V6th, P1347; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fujii Y, 2014, INFECT GENET EVOL, V28, P426, DOI 10.1016/j.meegid.2014.08.001; Ghosh S, 2011, FUTURE MICROBIOL, V6, P1049, DOI [10.2217/FMB.11.90, 10.2217/fmb.11.90]; Ghosh S, 2011, J GEN VIROL, V92, P1222, DOI 10.1099/vir.0.029868-0; Giammanco GM, 2014, J GEN VIROL, V95, P91, DOI 10.1099/vir.0.056788-0; Heiman EM, 2008, J VIROL, V82, P11106, DOI 10.1128/JVI.01402-08; Ide T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124965; Khananurak K, 2010, INFECT GENET EVOL, V10, P537, DOI 10.1016/j.meegid.2010.02.003; Komoto S, 2006, P NATL ACAD SCI USA, V103, P4646, DOI 10.1073/pnas.0509385103; Komoto S, 2014, VET MICROBIOL, V174, P577, DOI 10.1016/j.vetmic.2014.09.033; Komoto S, 2014, INFECT GENET EVOL, V27, P277, DOI 10.1016/j.meegid.2014.08.002; Kuzuya M, 2014, J MED VIROL, V86, P1056, DOI 10.1002/jmv.23746; Maes P, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-238; Malasao R, 2015, VIRUS GENES, V50, P129, DOI 10.1007/s11262-014-1135-z; Matthijnssens J, 2008, J VIROL, V82, P3204, DOI 10.1128/JVI.02257-07; Matthijnssens J, 2011, ARCH VIROL, V156, P1397, DOI 10.1007/s00705-011-1006-z; Matthijnssens J, 2010, MOL BIOL EVOL, V27, P2431, DOI 10.1093/molbev/msq137; McDonald SM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000634; Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448; Tacharoenmuang R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139381; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Theamboonlers A, 2014, INFECT GENET EVOL, V21, P295, DOI 10.1016/j.meegid.2013.11.020; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trojnar E, 2013, J GEN VIROL, V94, P136, DOI 10.1099/vir.0.047381-0; Wang Y., 2014, INT J DISTRIB SENS N, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0110024; Yamamoto SP, 2014, EMERG INFECT DIS, V20, P1030, DOI 10.3201/eid2006.131326	30	44	46	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141739	10.1371/journal.pone.0141739	http://dx.doi.org/10.1371/journal.pone.0141739			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540260	gold, Green Submitted, Green Published			2022-12-26	WOS:000364303800025
J	Fonseca, SAS; Costas, RM; Morato-Marques, M; Costa, S; Alegretti, JR; Rosenberg, C; da Motta, ELA; Serafini, PC; Pereira, LV				Siqueira Fonseca, Simone Aparecida; Costas, Roberta Montero; Morato-Marques, Mariana; Costa, Silvia; Alegretti, Jose Roberto; Rosenberg, Carla; Alves da Motta, Eduardo Leme; Serafini, Paulo C.; Pereira, Lygia V.			A Euploid Line of Human Embryonic Stem Cells Derived from a 43,XX,dup(9q),+12,-14,-15,-18,-21 Embryo	PLOS ONE			English	Article							X-CHROMOSOME INACTIVATION; SELF-CORRECTION; DERIVATION; ANEUPLOIDY; PGD	Aneuploid embryos diagnosed by FISH-based preimplantation genetic screening (PGS) have been shown to yield euploid lines of human embryonic stem cells (hESCs) with a relatively high frequency. Given that the diagnostic procedure is usually based on the analysis of 1-2 blastomeres of 5 to 10-cell cleavage-stage embryos, mosaicism has been a likely explanation for the phenomena. However, FISH-based PGS can have a significant rate of misdiagnosis, and therefore some of those lines may have been derived from euploid embryos misdiagnosed as aneuploid. More recently, coupling of trophectoderm (TE) biopsy at the blastocyst stage and array-CGH lead to a more informative form of PGS. Here we describe the establishment of a new line of hESCs from an embryo with a 43, XX, dup(9q), +12,-14,-15,-18,-21 chromosomal content based on array-CGH of TE biopsy. We show that, despite the complex chromosomal abnormality, the corresponding hESC line BR-6 is euploid (46, XX). Single nucleotide polymorphism analysis showed that the embryo's missing chromosomes were not duplicated in BR-6, suggesting the existence of extensive mosaicism in the TE lineage.	[Siqueira Fonseca, Simone Aparecida; Costas, Roberta Montero; Morato-Marques, Mariana; Pereira, Lygia V.] Univ Sao Paulo, Natl Lab Embryon Stem Cell LaNCE, Sao Paulo, Brazil; [Siqueira Fonseca, Simone Aparecida; Morato-Marques, Mariana; Costa, Silvia; Rosenberg, Carla; Pereira, Lygia V.] Univ Sao Paulo, Dept Genet & Evolutionary Biol, Sao Paulo, Brazil; [Alegretti, Jose Roberto; Alves da Motta, Eduardo Leme; Serafini, Paulo C.] Huntington Ctr Human Reprod, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Pereira, LV (corresponding author), Univ Sao Paulo, Natl Lab Embryon Stem Cell LaNCE, Sao Paulo, Brazil.	lpereira@usp.br	Fonseca, Simone/AAD-7393-2019; rosenberg, carla/N-4148-2015; Pereira, Lygia V/C-1049-2012; Costa, Silvia F/K-4768-2012; Motta, Eduardo/M-1264-2014	rosenberg, carla/0000-0003-3253-4448; Pereira, Lygia V/0000-0002-0002-725X; Costa, Silvia F/0000-0003-1087-752X; Fonseca, Simone/0000-0003-3301-222X; Motta, Eduardo/0000-0001-9029-9138	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP-CEPID) Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Departamento de Ciencia e Tecnologia do Ministerio da Saude (CNPq/MS/DECIT) [13/08135-2]; Banco Nacional de Desenvolvimento Economico e Social (BNDES); Financiadora de Estudos e Projetos (FINEP)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP-CEPID) Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Departamento de Ciencia e Tecnologia do Ministerio da Saude (CNPq/MS/DECIT); Banco Nacional de Desenvolvimento Economico e Social (BNDES); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep))	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP-CEPID 13/08135-2) Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Departamento de Ciencia e Tecnologia do Ministerio da Saude (CNPq/MS/DECIT), Banco Nacional de Desenvolvimento Economico e Social (BNDES) and Financiadora de Estudos e Projetos (FINEP).	Barbash-Hazan S, 2009, FERTIL STERIL, V92, P890, DOI 10.1016/j.fertnstert.2008.07.1761; Bazrgar M, 2013, STEM CELLS DEV, V22, P2449, DOI 10.1089/scd.2013.0053; Chen H, 2005, HUM REPROD, V20, P2201, DOI 10.1093/humrep/dei010; Georges JAD, 2014, STEM CELL REV REP, V10, P472, DOI 10.1007/s12015-014-9505-4; Doss MX, 2004, J CELL MOL MED, V8, P465, DOI 10.1111/j.1582-4934.2004.tb00471.x; Fraga AM, 2011, CELL TRANSPLANT, V20, P431, DOI 10.3727/096368910X522261; Fragouli E, 2008, HUM REPROD, V23, P2596, DOI 10.1093/humrep/den287; Fritz MA, 2008, HUM REPROD, V23, P2617, DOI 10.1093/humrep/den400; Gardner DK, 1999, TOWARDS REPRODUCTIVE CERTAINTY, P378; Gosden C., 1992, HUMAN CYTOGENETICS, P37; Hansis C, 2006, REPROD BIOMED ONLINE, V6, P215; Lavon N, 2008, STEM CELLS, V26, P1874, DOI 10.1634/stemcells.2008-0156; Lerou PH, 2008, NAT BIOTECHNOL, V26, P212, DOI 10.1038/nbt1378; Li M, 2005, FERTIL STERIL, V84, P1395, DOI 10.1016/j.fertnstert.2005.04.068; Mateizel I, 2006, HUM REPROD, V21, P503, DOI 10.1093/humrep/dei345; Mitalipova M, 2006, METH MOL B, V331, P55; Munne S, 2005, FERTIL STERIL, V84, P1328, DOI 10.1016/j.fertnstert.2005.06.025; Northrop LE, 2010, MOL HUM REPROD, V16, P590, DOI 10.1093/molehr/gaq037; Peura T, 2008, CLONING STEM CELLS, V10, P203, DOI 10.1089/clo.2007.0062; Rodin S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4195; Scott R, 2008, FERTIL STERIL, V90, P77, DOI 10.1016/j.fertnstert.2007.11.058; Shetty Ronak, 2012, Methods Mol Biol, V873, P151, DOI 10.1007/978-1-61779-794-1_9; Silva SS, 2008, P NATL ACAD SCI USA, V105, P4820, DOI 10.1073/pnas.0712136105; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Treff NR, 2010, MOL HUM REPROD, V16, P583, DOI 10.1093/molehr/gaq039; Tropel P, 2010, IN VITRO CELL DEV-AN, V46, P376, DOI 10.1007/s11626-010-9300-8; Vajta G, 2006, THERIOGENOLOGY, V65, P236, DOI 10.1016/j.theriogenology.2005.09.026	27	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0140999	10.1371/journal.pone.0140999	http://dx.doi.org/10.1371/journal.pone.0140999			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540511	Green Published, Green Submitted, gold			2022-12-26	WOS:000364303800008
J	Geuskens, RREG; Borst, J; Lucas, M; Boers, AMM; Berkhemer, OA; Roos, YBWEM; van Walderveen, MAA; Jenniskens, SFM; van Zwam, WH; Dippel, DWJ; Majoie, CBLM; Marquering, HA				Geuskens, Ralph R. E. G.; Borst, Jordi; Lucas, Marit; Boers, A. M. Merel; Berkhemer, Olvert A.; Roos, Yvo B. W. E. M.; van Walderveen, Marianne A. A.; Jenniskens, Sjoerd F. M.; van Zwam, Wim H.; Dippel, Diederik W. J.; Majoie, Charles B. L. M.; Marquering, Henk A.		MR CLEAN Trial Investigators	Characteristics of Misclassified CT Perfusion Ischemic Core in Patients with Acute Ischemic Stroke	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY PERFUSION; CEREBRAL-BLOOD-FLOW; TECHNICAL IMPLEMENTATIONS; ENDOVASCULAR THERAPY; IMAGING SELECTION; BRAIN PERFUSION; THEORETIC BASIS; INFARCT VOLUME; PART 1; PENUMBRA	Background CT perfusion (CTP) is used to estimate the extent of ischemic core and penumbra in patients with acute ischemic stroke. CTP reliability, however, is limited. This study aims to identify regions misclassified as ischemic core on CTP, using infarct on follow-up noncontrast CT. We aim to assess differences in volumetric and perfusion characteristics in these regions compared to areas that ended up as infarct on follow-up. Materials and Methods This study included 35 patients with >100 mm brain coverage CTP. CTP processing was performed using Philips software (IntelliSpace 7.0). Final infarct was automatically segmented on follow-up noncontrast CT and used as reference. CTP and follow-up noncontrast CT image data were registered. This allowed classification of ischemic lesion agreement (core on CTP: rMTT >= 145%, aCBV<2.0 ml/100g and infarct on follow-up noncontrast CT) and misclassified ischemic core (core on CTP, not identified on follow-up noncontrast CT) regions. False discovery ratio (FDR), defined as misclassified ischemic core volume divided by total CTP ischemic core volume, was calculated. Absolute and relative CTP parameters (CBV, CBF, and MTT) were calculated for both misclassified CTP ischemic core and ischemic lesion agreement regions and compared using paired rank-sum tests. Results Median total CTP ischemic core volume was 49.7ml (IQR: 29.9ml-132ml); median misclassified ischemic core volume was 30.4ml (IQR: 20.9ml-77.0ml). Median FDR between patients was 62% (IQR: 49%-80%). Median relative mean transit time was 243% (IQR: 198%-289%) and 342% (IQR: 249%-432%) for misclassified and ischemic lesion agreement regions, respectively. Median absolute cerebral blood volume was 1.59 (IQR: 1.43-1.79) ml/100g (P<0.01) and 1.38 (IQR: 1.15-1.49) ml/100g (P<0.01) for misclassified ischemic core and ischemic lesion agreement, respectively. All CTP parameter values differed significantly. Conclusion For all patients a considerable region of the CTP ischemic core is misclassified. CTP parameters significantly differed between ischemic lesion agreement and misclassified CTP ischemic core, suggesting that CTP analysis may benefit from revisions.	[Geuskens, Ralph R. E. G.; Lucas, Marit; Boers, A. M. Merel; Marquering, Henk A.] Univ Amsterdam, Acad Med Ctr, Dept Biomed Engn & Phys, NL-1105 AZ Amsterdam, Netherlands; [Borst, Jordi; Berkhemer, Olvert A.; Majoie, Charles B. L. M.; Marquering, Henk A.] Univ Amsterdam, Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands; [Roos, Yvo B. W. E. M.] Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands; [van Walderveen, Marianne A. A.] Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands; [Jenniskens, Sjoerd F. M.] Radboud Univ Nijmegen, Med Ctr, Dept Radiol, NL-6525 ED Nijmegen, Netherlands; [van Zwam, Wim H.] Maastricht Univ, Med Ctr, Dept Radiol, NL-6200 MD Maastricht, Netherlands; [Dippel, Diederik W. J.] Erasmus MC, Dept Neurol, Rotterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen; Maastricht University; Erasmus University Rotterdam; Erasmus MC	Geuskens, RREG (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Biomed Engn & Phys, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	r.r.geuskens@amc.uva.nl	Roos, Yvo BWEM/B-9843-2013; Jenniskens, S.F.M./L-4415-2015; Dippel, Diederik/AAJ-2192-2020	Dippel, Diederik/0000-0002-9234-3515; Marquering, Henk/0000-0002-1414-6313	ITEA2 project; Dutch Heart Foundation; AngioCare; Covidien/ev3; Medac/Lamepro; Penumbra	ITEA2 project; Dutch Heart Foundation(Netherlands Heart Foundation); AngioCare; Covidien/ev3; Medac/Lamepro; Penumbra	Part of this research has been sponsored by the ITEA2 project, label 10004: MEDUSA - Medical Distributed Utilization of Services & Applications (https://itea3.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The MRCLEAN trial is supported by the Dutch Heart Foundation and by unrestricted grants from AngioCare, Covidien/ev3, Medac/Lamepro, and Penumbra.	Allmendinger AM, 2012, AM J ROENTGENOL, V198, P52, DOI 10.2214/AJR.10.7255; Benson J, 2015, EUR J RADIOL, V84, P682, DOI 10.1016/j.ejrad.2014.12.026; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Best AC, 2012, RADIOGRAPHICS, V32, P1179, DOI 10.1148/rg.324105742; Boers AM, 2013, AM J NEURORADIOL, V34, P1522, DOI 10.3174/ajnr.A3463; Borst J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119409; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Campbell BCV, 2015, INT J STROKE, V10, P51, DOI 10.1111/ijs.12381; Campbell BCV, 2012, STROKE, V43, P2648, DOI 10.1161/STROKEAHA.112.660548; Campbell BCV, 2012, ARCH NEUROL-CHICAGO, V69, P46, DOI 10.1001/archneurol.2011.232; Campbell BCV, 2011, STROKE, V42, P3435, DOI 10.1161/STROKEAHA.111.618355; Dani KA, 2011, ANN NEUROL, V70, P384, DOI 10.1002/ana.22500; Fahmi F, 2013, EUR J RADIOL, V82, P2334, DOI 10.1016/j.ejrad.2013.08.039; Fahmi F, 2012, AM J NEURORADIOL, V33, P2074, DOI 10.3174/ajnr.A3110; Finitsis S, 2014, NEURORADIOLOGY, V56, P325, DOI 10.1007/s00234-014-1329-z; Gonzalez RG, 2012, J NEUROINTERV SURG, V4, P242, DOI 10.1136/neurintsurg-2012-010404; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; Grand S, 2013, Diagn Interv Imaging, V94, P1241, DOI 10.1016/j.diii.2013.06.009; Hacke W, 2008, NEW ENGL J MED, V359, P877; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Jovin TG, 2015, THROMBECTOMY 8 HOURS, P1, DOI [10.1056/NEJMoa1503780, DOI 10.1056/NEJM0A1503780]; Kamalian S, 2011, STROKE, V42, P1923, DOI 10.1161/STROKEAHA.110.610618; Kaufmann AM, 1999, STROKE, V30, P93, DOI 10.1161/01.STR.30.1.93; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Konstas AA, 2009, AM J NEURORADIOL, V30, P885, DOI 10.3174/ajnr.A1492; Konstas AA, 2009, AM J NEURORADIOL, V30, P662, DOI 10.3174/ajnr.A1487; Konstas AA, 2010, RADIOLOGY, V254, P22, DOI 10.1148/radiol.09091610; Kudo K, 2010, RADIOLOGY, V254, P200, DOI 10.1148/radiol.254082000; Lui YW, 2010, AM J NEURORADIOL, V31, P1552, DOI 10.3174/ajnr.A2026; Man FY, 2015, NEURORADIOLOGY, V57, P573, DOI 10.1007/s00234-015-1507-7; Mangla R, 2014, EMERG RADIOL, V21, P49, DOI 10.1007/s10140-013-1125-9; Olivot JM, 2009, STROKE, V40, P469, DOI 10.1161/STROKEAHA.108.526954; Rosso C, 2009, RADIOLOGY, V250, P184, DOI 10.1148/radiol.2493080107; Saver JL, 2006, STROKE, V37, P263, DOI 10.1161/01.STR.0000196957.55928.ab; Saver JL, 1999, STROKE, V30, P293, DOI 10.1161/01.STR.30.2.293; Saver JL, 2015, STENT RETRIVER THROM, P1, DOI [10.1056/NEJMoa1415061, DOI 10.1056/NEJM0A1415061]; SCHAEFER PW, 2015, LTD RELIABILITY COMP, V46, P419, DOI DOI 10.1161/STR0KEAHA.114.007117; Song SS, 2013, SEMIN NEUROL, V33, P436, DOI 10.1055/s-0033-1364214; Tarpley J, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0336-6; Wintermark M, 2007, NEUROLOGY, V68, P694, DOI 10.1212/01.wnl.0000255959.30107.08; Wintermark M, 2006, STROKE, V37, P979, DOI 10.1161/01.STR.0000209238.61459.39; Wintermark M, 2001, EUR RADIOL, V11, P1220, DOI 10.1007/s003300000707; Wintermark M, 2013, STROKE, V44, P2628, DOI 10.1161/STROKEAHA.113.002015; Yoo AJ, 2013, J NEUROINTERV SURG, V5, P1, DOI 10.1136/neurintsurg-2013-010741; Zhao LM, 2011, INT J STROKE, V6, P544, DOI 10.1111/j.1747-4949.2011.00681.x; Zhu GM, 2013, STROKE, V44, P1014, DOI 10.1161/STROKEAHA.111.000229	46	30	30	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141571	10.1371/journal.pone.0141571	http://dx.doi.org/10.1371/journal.pone.0141571			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536226	Green Published, Green Submitted, gold			2022-12-26	WOS:000364298400071
J	Kong, WW; Chen, N; Liu, TT; Zhu, J; Wang, JQ; He, XQ; Jin, Y				Kong, Weiwen; Chen, Nan; Liu, Tingting; Zhu, Jing; Wang, Jingqi; He, Xiaoqing; Jin, Yi			Large-Scale Transcriptome Analysis of Cucumber and Botrytis cinerea during Infection	PLOS ONE			English	Article							OXIDATIVE BURST; PLANT IMMUNITY; BIOTIC STRESS; ABSCISIC-ACID; RESISTANCE; ARABIDOPSIS; JASMONATE; ETHYLENE; DEFENSE; GENE	Cucumber gray mold caused by Botrytis cinerea is considered one of the most serious cucumber diseases. With the advent of Hi-seq technology, it is possible to study the plant-pathogen interaction at the transcriptome level. To the best of our knowledge, this is the first application of RNA-seq to identify cucumber and B. cinerea differentially expressed genes (DEGs) before and after the plant-pathogen interaction. In total, 248,908,688 raw reads were generated; after removing low-quality reads and those containing adapter and poly-N, 238,341,648 clean reads remained to map the reference genome. There were 3,512 cucumber DEGs and 1,735 B. cinerea DEGs. GO enrichment and KEGG enrichment analysis were performed on these DEGs to study the interaction between cucumber and B. cinerea. To verify the reliability and accuracy of our transcriptome data, 5 cucumber DEGs and 5 B. cinerea DEGs were chosen for RT-PCR verification. This is the first systematic transcriptome analysis of components related to the B. cinerea-cucumber interaction. Functional genes and putative pathways identified herein will increase our understanding of the mechanism of the pathogen-host interaction.	[Kong, Weiwen; Chen, Nan; Liu, Tingting; Zhu, Jing; Wang, Jingqi; He, Xiaoqing; Jin, Yi] Beijing Forestry Univ, Coll Biol Sci & Technol, Beijing 100083, Peoples R China	Beijing Forestry University	He, XQ (corresponding author), Beijing Forestry Univ, Coll Biol Sci & Technol, POB 162, Beijing 100083, Peoples R China.	lenahe@bjfu.edu.cn; wizard.jin@163.com	He, Xiaoqing/AGM-1178-2022	He, Xiaoqing/0000-0001-9098-9980	Fundamental Research Funds for the Central University [TD2012-03]; non-profit Industry Financial Program of Ministry Of Water Resources [201201032]; Natural Science Foundation of China [51108029]	Fundamental Research Funds for the Central University; non-profit Industry Financial Program of Ministry Of Water Resources; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Fundamental Research Funds for the Central University (TD2012-03), non-profit Industry Financial Program of Ministry Of Water Resources (201201032), and Natural Science Foundation of China (51108029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuQamar S, 2006, PLANT J, V48, P28, DOI 10.1111/j.1365-313X.2006.02849.x; Adie BAT, 2007, PLANT CELL, V19, P1665, DOI 10.1105/tpc.106.048041; Anders S., HTSEQ ANAL HIGH THRO; Asselbergh B, 2007, PLANT PHYSIOL, V144, P1863, DOI 10.1104/pp.107.099226; Balint-Kurti PJ, 2015, NAT GENET, V47, P101, DOI 10.1038/ng.3203; Bilgin DD, 2010, PLANT CELL ENVIRON, V33, P1597, DOI 10.1111/j.1365-3040.2010.02167.x; Blanco-Ulate B, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00435; Bolwell GP, 2002, J EXP BOT, V53, P1367, DOI 10.1093/jexbot/53.372.1367; BROEKAERT WF, 1990, FEMS MICROBIOL LETT, V69, P55, DOI [10.1111/j.1574-6968.1990.tb04174.x, 10.1016/S0378-1097(98)00477-7]; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cui XG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-226; De Cremer K, 2013, PLANT CELL ENVIRON, V36, P1992, DOI 10.1111/pce.12106; De Gara L, 2003, PLANT PHYSIOL BIOCH, V41, P863, DOI 10.1016/S0981-9428(03)00135-9; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Elad Y, 1997, BIOL REV, V72, P381, DOI 10.1017/S0006323197005057; Elad Y, 2007, BOTRYTIS BIOL PATHOL, P1, DOI DOI 10.1007/978-1-4020-2626-3_1; Esquinas-Alcazar J.T., 1983, GENETIC RESOURCES CU; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Govrin EM, 2006, PHYTOPATHOLOGY, V96, P299, DOI 10.1094/PHYTO-96-0299; GUO Z, 1993, PLANT PHYSIOL, V102, P45, DOI 10.1104/pp.102.1.45; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Leroux P., 2007, BOTRYTIS BIOL PATHOL, P195, DOI [10.1007/978-1-4020-2626-3_12, DOI 10.1007/978-1-4020-2626-3_12]; Li XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068233; Lorenzo O, 2005, CURR OPIN PLANT BIOL, V8, P532, DOI 10.1016/j.pbi.2005.07.003; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Mauch-Mani B, 2005, CURR OPIN PLANT BIOL, V8, P409, DOI 10.1016/j.pbi.2005.05.015; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Siewers V, 2005, MOL PLANT MICROBE IN, V18, P602, DOI 10.1094/MPMI-18-0602; Smith JE, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-334; ten Have A, 1998, MOL PLANT MICROBE IN, V11, P1009, DOI 10.1094/MPMI.1998.11.10.1009; ten Have A, 2001, FUNGAL GENET BIOL, V33, P97, DOI 10.1006/fgbi.2001.1269; Thomma BPHJ, 1999, PLANT PHYSIOL, V121, P1093, DOI 10.1104/pp.121.4.1093; Thomma BPHJ, 1998, P NATL ACAD SCI USA, V95, P15107, DOI 10.1073/pnas.95.25.15107; van Kan JAL, 2006, TRENDS PLANT SCI, V11, P247, DOI 10.1016/j.tplants.2006.03.005; van Loon LC, 2006, TRENDS PLANT SCI, V11, P184, DOI 10.1016/j.tplants.2006.02.005; Wang H, 2013, MOL PLANT PATHOL, V14, P453, DOI 10.1111/mpp.12017; Weiberg A, 2013, SCIENCE, V342, P118, DOI 10.1126/science.1239705; Wilhelm BT, 2009, METHODS, V48, P249, DOI 10.1016/j.ymeth.2009.03.016; Wojtaszek P, 1997, BIOCHEM J, V322, P681, DOI 10.1042/bj3220681; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang L., 2013, AGR APPL, P361, DOI [10.1007/978-3-642-36821-9_14, DOI 10.1007/978-3-642-36821-9_14]; Zhu S, 2013, BRIEF BIOINFORM, V14, P713, DOI 10.1093/bib/bbs047	43	37	41	6	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142221	10.1371/journal.pone.0142221	http://dx.doi.org/10.1371/journal.pone.0142221			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536465	Green Published, Green Submitted, gold			2022-12-26	WOS:000364298400145
J	Lee, YT; Nfor, ON; Tantoh, DM; Huang, JY; Ku, WY; Hsu, SY; Ko, PC; Hung, HC; Jan, CF; Liaw, YP				Lee, Yuan-Ti; Nfor, Oswald Ndi; Tantoh, Disline Manli; Huang, Jing-Yang; Ku, Wen-Yuan; Hsu, Shu-Yi; Ko, Pei-Chieh; Hung, Hung-Chang; Jan, Cheng-Feng; Liaw, Yung-Po			Herpes Zoster as a Predictor of HIV Infection in Taiwan: A Population-Based Study	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION	This study aimed to investigate the association between herpes zoster (HZ) and human immunodeficiency virus (HIV). Data were retrieved from the Longitudinal Health Insurance Databases (LHID 2005 and 2010), Taiwan. The International Classification of Diseases, 9th Revision, Clinical Modification [ICD-9-CM] codes were used to identify Hz from 2001-2004. Identification of HIV infection was from 2005-2010. The hazard ratios of HIV among herpes zoster infected and non-herpes zoster infected patients were estimated using multiple Cox proportional hazard model. In general, 19685 participants were identified with Hz. The HIV incidence rates (per 104 person-months) in herpes zoster infected and non-infected patients were 0.191(95% CI 0.130-0.280) and 0.079 (95% CI 0.074-0.084), respectively while the hazard ratio (HR) of HIV among infected individuals was 3.518 (95% CI 2.375-5.211). This study concludes that herpes zoster could be considered as a predictor of HIV infection especially among Asian populations, hence it is vital to test herpes zoster infected individuals for HIV antibodies.	[Lee, Yuan-Ti] Chung Shan Med Univ Hosp, Dept Internal Med, Div Infect Dis, Taichung 40201, Taiwan; [Lee, Yuan-Ti] Chung Shan Med Univ, Sch Med, Taichung 40201, Taiwan; [Lee, Yuan-Ti] Chung Shan Med Univ, Inst Med, Taichung 40201, Taiwan; [Nfor, Oswald Ndi; Tantoh, Disline Manli; Huang, Jing-Yang; Ku, Wen-Yuan; Hsu, Shu-Yi; Ko, Pei-Chieh; Liaw, Yung-Po] Chung Shan Med Univ, Dept Publ Hlth, Taichung 40201, Taiwan; [Nfor, Oswald Ndi; Tantoh, Disline Manli; Huang, Jing-Yang; Ku, Wen-Yuan; Hsu, Shu-Yi; Ko, Pei-Chieh; Liaw, Yung-Po] Chung Shan Med Univ, Inst Publ Hlth, Taichung 40201, Taiwan; [Hung, Hung-Chang] Nantou Hosp, Dept Internal Med, Div Gastroenterol, Minist Hlth & Welf, Nantou, Taiwan; [Jan, Cheng-Feng] Chung Yuan Christian Univ, Off Phys Educ, Chungli, Taiwan; [Liaw, Yung-Po] Chung Shan Med Univ Hosp, Dept Family & Community Med, Taichung 40201, Taiwan	Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Yuan Christian University; Chung Shan Medical University; Chung Shan Medical University Hospital	Liaw, YP (corresponding author), Chung Shan Med Univ, Dept Publ Hlth, Taichung 40201, Taiwan.	Liawyp@csmu.edu.tw	Liaw, Yung Po/AAV-6746-2021; Lee, Yuan-Ti/ABH-7837-2020	Lee, Yuan-Ti/0000-0003-4577-4379; Huang, Jing-Yang/0000-0002-0794-9388				BUCHBINDER SP, 1992, J INFECT DIS, V166, P1153, DOI 10.1093/infdis/166.5.1153; COLEBUNDERS R, 1988, J INFECT DIS, V157, P314, DOI 10.1093/infdis/157.2.314; Gnann JW, 2002, NEW ENGL J MED, V347, P340, DOI 10.1056/NEJMcp1302674; HELGASON S, 1996, EUR J GEN PRACT, V2, P12; HIRA SK, 1990, J ACQ IMMUN DEF SYND, V3, P87; Hope-Simpson RE, 1965, J ROY SOC MED, V58, P9; Laskin OL, 1986, AM J MED, V81; LINDAN CP, 1992, ANN INTERN MED, V116, P320, DOI 10.7326/0003-4819-116-4-320; Moanna A, 2013, CLIN INFECT DIS, V57, P122, DOI 10.1093/cid/cit165; RAGOZZINO MW, 1982, MEDICINE, V61, P310, DOI 10.1097/00005792-198209000-00003; Rubben A, 1997, BRIT J DERMATOL, V137, P259, DOI 10.1046/j.1365-2133.1997.18161913.x; TYNDALL MW, 1995, CLIN INFECT DIS, V21, P1035, DOI 10.1093/clinids/21.4.1035; VEENSTRA J, 1995, AIDS, V9, P1153, DOI 10.1097/00002030-199510000-00006	13	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142254	10.1371/journal.pone.0142254	http://dx.doi.org/10.1371/journal.pone.0142254			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26535574	Green Submitted, Green Published, gold			2022-12-26	WOS:000364298400148
J	Jackson, MM; Gergel, SE; Martin, K				Jackson, Michelle M.; Gergel, Sarah E.; Martin, Kathy			Effects of Climate Change on Habitat Availability and Configuration for an Endemic Coastal Alpine Bird	PLOS ONE			English	Article							VANCOUVER-ISLAND; MODEL PROJECTIONS; ENVELOPE MODELS; PTARMIGAN; RANGE; IMPACTS; NICHE; CLASSIFICATION; DISTRIBUTIONS; CONTRACTIONS	North America's coastal mountains are particularly vulnerable to climate change, yet harbour a number of endemic species. With little room "at the top" to track shifting climate envelopes, alpine species may be especially negatively affected by climate-induced habitat fragmentation. We ask how climate change will affect the total amount, mean patch size, and number of patches of suitable habitat for Vancouver Island White-tailed Ptarmigan (Lagopus leucura saxatilis; VIWTP), a threatened, endemic alpine bird. Using a Random Forest model and a unique dataset consisting of citizen science observations combined with field surveys, we predict the distribution and configuration of potential suitable summer habitat for VIWTP under baseline and future (2020s, 2050s, and 2080s) climates using three general circulation models and two greenhouse gas scenarios. VIWTP summer habitat is predicted to decline by an average of 25%, 44%, and 56% by the 2020s, 2050s, and 2080s, respectively, under the low greenhouse gas scenario and 27%, 59%, and 74% under the high scenario. Habitat patches are predicted to become fragmented, with a 5279% reduction in mean patch size. The average elevation of suitable habitat patches is expected to increase, reflecting a loss of patches at lower elevations. Thus ptarmigan are in danger of being "squeezed off the mountain", as their remaining suitable habitat will be increasingly confined to mountaintops in the center of the island. The extent to which ptarmigan will be able to persist in increasingly fragmented habitat is unclear. Much will depend on their ability to move throughout a more heterogeneous landscape, utilize smaller breeding areas, and survive increasingly variable climate extremes. Our results emphasize the importance of continued monitoring and protection for high elevation specialist species, and suggest that White-tailed Ptarmigan should be considered an indicator species for alpine ecosystems in the face of climate change.	[Jackson, Michelle M.; Gergel, Sarah E.; Martin, Kathy] Univ British Columbia, Dept Forest & Conservat Sci, Vancouver, BC V6T 1Z4, Canada; [Martin, Kathy] Environm Canada, Delta, BC V4K 3N2, Canada	University of British Columbia; Environment & Climate Change Canada	Jackson, MM (corresponding author), Univ British Columbia, Dept Forest & Conservat Sci, 2424 Main Mall, Vancouver, BC V6T 1Z4, Canada.	michellegooch@gmail.com	Jackson, Michelle/AAA-8442-2021		TerreWEB; Natural Sciences and Engineering Research Council of Canada (NSERC); Collaborative Research and Training Experience (CREATE) fellowship program at the University of British Columbia; NSERC [147390-2010]; Forest Renewal British Columbia [16R81811]; Environment Canada [16R31929]	TerreWEB; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Collaborative Research and Training Experience (CREATE) fellowship program at the University of British Columbia; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Forest Renewal British Columbia; Environment Canada(CGIAR)	Funding for this research was provided by TerreWEB (http://terreweb.ubc.ca), a Natural Sciences and Engineering Research Council of Canada (NSERC; http://www.nserc-crsng.gc.ca) Collaborative Research and Training Experience (CREATE) fellowship program at the University of British Columbia to M.J. NSERC provided support to several undergraduate student technicians (Undergraduate Research Student Assistantships). Additional support came from NSERC Discovery Grants (147390-2010), Forest Renewal British Columbia (16R81811) and Environment Canada support (16R31929) to K.M. and an NSERC Discovery Grant to S.G.	Archer KJ, 2008, COMPUT STAT DATA AN, V52, P2249, DOI 10.1016/j.csda.2007.08.015; Ashcroft MB, 2010, J BIOGEOGR, V37, P1407, DOI 10.1111/j.1365-2699.2010.02300.x; Botts EA, 2013, GLOBAL ECOL BIOGEOGR, V22, P567, DOI 10.1111/geb.12027; Boyle WA, 2016, BIOL REV, V91, P469, DOI 10.1111/brv.12180; Bradbury W. C., 1915, Condor Hollywood, V17, DOI 10.2307/1362307; Braunisch V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097718; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Campbell RW, 1990, NONPASSERINES DIURNA; Chefaoui RM, 2008, ECOL MODEL, V210, P478, DOI 10.1016/j.ecolmodel.2007.08.010; Coppack T, 2002, ARDEA, V90, P369; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Daly C, 2002, CLIM RES, V22, P99, DOI 10.3354/cr022099; Dirnbock T, 2011, GLOBAL CHANGE BIOL, V17, P990, DOI 10.1111/j.1365-2486.2010.02266.x; Duursma DE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084222; Elsen PR, 2015, NAT CLIM CHANGE, V5, P772, DOI [10.1038/nclimate2656, 10.1038/NCLIMATE2656]; Essl F, 2009, BIOL CONSERV, V142, P2547, DOI 10.1016/j.biocon.2009.05.027; Fedy BC, 2008, MOL ECOL, V17, P1905, DOI 10.1111/j.1365-294X.2008.03720.x; Fedy B, 2011, CONDOR, V113, P306, DOI 10.1525/cond.2011.100070; Fitzpatrick MC, 2009, BIODIVERS CONSERV, V18, P2255, DOI 10.1007/s10531-009-9584-8; Flower A, 2013, ENVIRON SCI POLICY, V26, P63, DOI 10.1016/j.envsci.2012.07.024; Fraser D, 1999, RARE BIRDS BRIT COLU; Gage GS, 2004, ANIM CONSERV, V7, P161, DOI 10.1017/S1367943004001246; Galbreath KE, 2009, EVOLUTION, V63, P2848, DOI 10.1111/j.1558-5646.2009.00803.x; GESSLER PE, 1995, INT J GEOGR INF SYST, V9, P421, DOI 10.1080/02693799508902047; Green RE, 2008, BIOL LETTERS, V4, P599, DOI 10.1098/rsbl.2008.0052; Gregory RD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004678; Hallinger M, 2010, NEW PHYTOL, V186, P890, DOI 10.1111/j.1469-8137.2010.03223.x; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Host P., 1942, Auk, V59, P388; Jackson MM, 2015, BIOL CONSERV, V181, P162, DOI 10.1016/j.biocon.2014.11.010; Jankowski JE, 2010, ECOLOGY, V91, P1877, DOI 10.1890/09-2063.1; JANZ DW, 2000, 19 REC NAT END WILDL; Jiguet F, 2013, BIRD STUDY, V60, P60, DOI 10.1080/00063657.2012.733337; JOHNSON RE, 1968, COMP BIOCHEM PHYSIOL, V24, P1003, DOI 10.1016/0010-406X(68)90813-X; Korner C, 2002, MOUNTAIN BIODIVERSITY: A GLOBAL ASSESSMENT, P3; Kullman L, 2009, J ECOL, V97, P415, DOI 10.1111/j.1365-2745.2009.01488.x; Laroque CP, 2003, FOREST ECOL MANAG, V183, P313, DOI 10.1016/S0378-1127(03)00110-5; LAROQUE CP, 2000, W GEOGRAPHY, V10, P43; Larsen JN, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1567; Le Viol I, 2012, BIOL LETTERS, V8, P780, DOI 10.1098/rsbl.2012.0496; Liu CR, 2013, J BIOGEOGR, V40, P778, DOI 10.1111/jbi.12058; Martin K, 2000, CONDOR, V102, P503, DOI 10.1650/0010-5422(2000)102[0503:RDADRI]2.0.CO;2; Martin K, 2004, J FIELD ORNITHOL, V75, P239, DOI 10.1648/0273-8570-75.3.239; Martin K, 1998, USE ALPINE HABITATS; McTaggart-Cowan, 1939, CONDOR, V41, P82; Mignatti A, 2012, WILDLIFE BIOL, V18, P318, DOI 10.2981/11-084; MONSERUD RA, 1992, ECOL MODEL, V62, P275, DOI 10.1016/0304-3800(92)90003-W; Mote PW, 2010, CLIMATIC CHANGE, V102, P29, DOI 10.1007/s10584-010-9848-z; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Myers-Smith IH, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/045509; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pauli H, 2007, GLOBAL CHANGE BIOL, V13, P147, DOI 10.1111/j.1365-2486.2006.01282.x; Pearson RG, 2006, TRENDS ECOL EVOL, V21, P111, DOI 10.1016/j.tree.2005.11.022; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pedersen AO, 2014, J ORNITHOL, V155, P195, DOI 10.1007/s10336-013-1001-0; Pimm S, 2006, P NATL ACAD SCI USA, V103, P10941, DOI 10.1073/pnas.0604181103; Randin CF, 2009, GLOBAL CHANGE BIOL, V15, P1557, DOI 10.1111/j.1365-2486.2008.01766.x; Rodenhuis D, 2007, CLIMATE OVERVIEW 200; Rull V, 2009, J BIOGEOGR, V36, P481, DOI 10.1111/j.1365-2699.2008.02023.x; Sappington JM, 2007, J WILDLIFE MANAGE, V71, P1419, DOI 10.2193/2005-723; Saunders DA, 2005, CONSERV BIOL, V5, P18; Schwartz MW, 2012, BIOL CONSERV, V155, P149, DOI 10.1016/j.biocon.2012.06.011; Sekercioglu CH, 2008, CONSERV BIOL, V22, P140, DOI 10.1111/j.1523-1739.2007.00852.x; Senay SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071218; Snall T, 2011, BIOL CONSERV, V144, P804, DOI 10.1016/j.biocon.2010.11.010; Suggitt AJ, 2011, OIKOS, V120, P1, DOI 10.1111/j.1600-0706.2010.18270.x; Sullivan BL, 2009, BIOL CONSERV, V142, P2282, DOI 10.1016/j.biocon.2009.05.006; Tingley MW, 2009, P NATL ACAD SCI USA, V106, P19637, DOI 10.1073/pnas.0901562106; Topp E, 2014, THESIS U PADOVA BRIT; Trivedi MR, 2008, GLOBAL CHANGE BIOL, V14, P1089, DOI 10.1111/j.1365-2486.2008.01553.x; VEGHTE JH, 1965, PHYSIOL ZOOL, V38, P267, DOI 10.1086/physzool.38.3.30152838; Virkkala R, 2008, BIOL CONSERV, V141, P1343, DOI 10.1016/j.biocon.2008.03.007; Wang TL, 2012, FOREST ECOL MANAG, V279, P128, DOI 10.1016/j.foreco.2012.05.034; Wang TL, 2012, J APPL METEOROL CLIM, V51, P16, DOI 10.1175/JAMC-D-11-043.1; Warton DI, 2010, ANN APPL STAT, V4, P1383, DOI 10.1214/10-AOAS331; Whittington J, 2005, ECOL APPL, V15, P543, DOI 10.1890/03-5317; Wiebe KL, 1998, ANIM BEHAV, V56, P1137, DOI 10.1006/anbe.1998.0862; Wilson S, 2011, POPUL ECOL, V53, P459, DOI 10.1007/s10144-011-0261-x; Wisz Mary S., 2009, BMC Ecology, V9, P8, DOI 10.1186/1472-6785-9-8; Zarnetske PL, 2007, ECOL APPL, V17, P1714, DOI 10.1890/06-1312.1; ZWICKEL FC, 1967, J WILDLIFE MANAGE, V31, P202, DOI 10.2307/3798382	81	23	24	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0142110	10.1371/journal.pone.0142110	http://dx.doi.org/10.1371/journal.pone.0142110			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529306	Green Published, Green Submitted, gold			2022-12-26	WOS:000364032600101
J	Zhao, WJ; Yu, XY; Ma, H; Zhu, QK; Zhang, Y; Qin, W; Ai, N; Wang, Y				Zhao, Weijun; Yu, Xinyang; Ma, Huan; Zhu, Qingke; Zhang, Yan; Qin, Wei; Ai, Ning; Wang, Yu			Analysis of Precipitation Characteristics during 1957-2012 in the Semi-Arid Loess Plateau, China	PLOS ONE			English	Article							RAINFALL TRENDS; DROUGHT; PREDICTION	Precipitation is the only water supply and most important factor affecting vegetation growth on the slopes of semi-arid Loess Plateau of China. Based on precipitation data from 7 synoptic stations in the study area over the period 1957-2012, the trends of precipitation and standardized precipitation index (SPI) were analyzed by using linear regression, Mann-Kendall, and Spearman's Rho tests at the 5% significance level. The results show that (1) the precipitation fluctuation of monthly precipitation was intense (coefficients of variation>100%), and the drier years were recorded as 1965 and 1995 at all stations. (2) The significant change trend of different stations varied on different time scales: the Changwu station had a significant decreasing trend in April (-0.488 mm/year) and November (-0.249 mm/year), while Luochuan station was in April (-0.457 mm/year); Changwu station displayed a significant increasing trends in winter (0.220 mm/year) and a significant decreasing trends in spring (-0.770 mm/year). The significant decreasing trends in annual precipitation were detected at the Suide (-2.034 mm/year) and Yan'an (-2.129 mm/year) stations. (3) The SPI-12 series analysis suggests that the drought degree of Yulin and Changwu was the lowest and that of Hengshan was the highest among the 7 synoptic stations.	[Zhao, Weijun] Taishan Univ, Key Lab Tourism & Resources Environm Coll & Univ, Tai An 271021, Shandong, Peoples R China; [Zhao, Weijun; Ma, Huan; Zhu, Qingke; Zhang, Yan; Ai, Ning; Wang, Yu] Beijing Forestry Univ, Forestry Ecol Engn Res Ctr, Minist Educ, Beijing, Peoples R China; [Yu, Xinyang] Shandong Agr Univ, Coll Resources & Environm, Tai An, Shandong, Peoples R China; [Qin, Wei] China Inst Water Resources & Hydropower Res, Dept Sedimentat, Beijing 100044, Peoples R China	Taishan University; Beijing Forestry University; Shandong Agricultural University; China Institute of Water Resources & Hydropower Research	Zhu, QK (corresponding author), Beijing Forestry Univ, Forestry Ecol Engn Res Ctr, Minist Educ, Beijing, Peoples R China.	zhuqingke@sohu.com	Ma, Huan/AAA-9466-2021		China National Scientific and Technical Innovation Research Project for 12th Five Year Plan [2011BAD38B0601]; National Natural Science Foundation of China [41472313]; Natural Science Foundation of Shandong Province [ZR2011DM012, ZR2014DL002]	China National Scientific and Technical Innovation Research Project for 12th Five Year Plan; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	The financial support for the study was from China National Scientific and Technical Innovation Research Project for 12th Five Year Plan (2011BAD38B0601), the National Natural Science Foundation of China (41472313), and the Natural Science Foundation of Shandong Province (ZR2011DM012, ZR2014DL002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006887; Allen R. G., 1998, FAO Irrigation and Drainage Paper; [傅朝 Fu Zhu], 2008, [干旱区研究, Arid Zone Research], V25, P447; Gemmer M, 2004, THEOR APPL CLIMATOL, V77, P39, DOI 10.1007/s00704-003-0018-3; Gocic M, 2013, J HYDROL, V494, P32, DOI 10.1016/j.jhydrol.2013.04.044; GRIGG NS, 1993, J WATER RES PL-ASCE, V119, P531, DOI 10.1061/(ASCE)0733-9496(1993)119:5(531); Guhathakurta P, 2008, INT J CLIMATOL, V28, P1453, DOI 10.1002/joc.1640; Helsel D. R., 1992, STAT METHODS WATER R; Hisdal H, 2001, INT J CLIMATOL, V21, P317, DOI 10.1002/joc.619; Huang WanHua, 2010, Transactions of the Chinese Society of Agricultural Engineering, V26, P50; KENDALL M. G., 1948, Rank correlation methods.; Kendall MG, 1968, ADV THEORY STAT DESI, V3; Khalili D, 2011, WATER RESOUR MANAG, V25, P1737, DOI 10.1007/s11269-010-9772-z; KOHLER M. A., 1949, BULL AMER METEOROL SOC, V30, P188; Krishnakumar KN, 2009, ATMOS ENVIRON, V43, P1940, DOI 10.1016/j.atmosenv.2008.12.053; [李春晖 Li Chunhui], 2004, [地理研究, Geographical Research], V23, P753; Liu Q, 2008, J HYDROL, V361, P330, DOI 10.1016/j.jhydrol.2008.08.002; [刘艳丽 Liu Yanli], 2013, [干旱区资源与环境, Journal of Arid Land Resources and Environment], V27, P75; [刘引鸽 LIU Yinge], 2007, [干旱区研究, Arid Zone Research], V24, P49; Lloyd-Hughes B, 2002, INT J CLIMATOL, V22, P1571, DOI 10.1002/joc.846; Mann HB, 1945, ECONOMETRICA, V13, P245, DOI 10.2307/1907187; MCKEE TB, 1993, P 8 C APPL CLIM AN C; MCKEE TB, 1995, NINTH CONFERENCE ON APPLIED CLIMATOLOGY, P233; Mishra AK, 2010, J HYDROL, V391, P204, DOI 10.1016/j.jhydrol.2010.07.012; Moreira EE, 2008, J HYDROL, V354, P116, DOI 10.1016/j.jhydrol.2008.03.002; Naidu CV, 1999, METEOROL APPL, V6, P395, DOI 10.1017/S1350482799001358; Oguntunde PG, 2011, J HYDROL, V411, P207, DOI 10.1016/j.jhydrol.2011.09.037; Partal T, 2006, HYDROL PROCESS, V20, P2011, DOI 10.1002/hyp.5993; Paulo AA, 2012, NAT HAZARD EARTH SYS, V12, P1481, DOI 10.5194/nhess-12-1481-2012; Paulo AA, 2008, WATER RESOUR MANAG, V22, P1277, DOI 10.1007/s11269-007-9225-5; Pereira L.S., 2009, COPING WATER SCARCIT; Phillips CL., 2008, SIGNALS SYSTEMS TRAN, V4; Rosa RD, 2010, TRATAMENTO QUALIDADE, P119; Sales JD, 1980, APPL MODELING HYDROL; Shahid S, 2008, HYDROL PROCESS, V22, P2235, DOI 10.1002/hyp.6820; She DongLi, 2011, Nongye Jixie Xuebao = Transactions of the Chinese Society for Agricultural Machinery, V42, P73; Sneyers R., STAT ANAL SERIES OBS; Storch HV, ANAL CLIMATE VARIABI; [孙智辉 Sun Zhihui], 2013, [中国沙漠, Journal of Desert Research], V33, P1560; Tabari H, 2012, HYDROL PROCESS, V26, P3351, DOI 10.1002/hyp.8460; Tabari H, 2011, J HYDROL, V396, P313, DOI 10.1016/j.jhydrol.2010.11.034; [王媛媛 Wang Yuanyuan], 2012, [自然资源学报, Journal of Natural Resources], V27, P2135; [姚雪玲 Yao Xueling], 2012, [生态学报, Acta Ecologica Sinica], V32, P4961; Zou WenXiu, 2011, Transactions of the Chinese Society of Agricultural Engineering, V27, P196	45	15	16	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141662	10.1371/journal.pone.0141662	http://dx.doi.org/10.1371/journal.pone.0141662			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528917	Green Submitted, gold, Green Published			2022-12-26	WOS:000364032600048
J	Albesa-Jove, D; Comino, N; Tersa, M; Mohorko, E; Urresti, S; Dainese, E; Chiarelli, LR; Pasca, MR; Manganelli, R; Makarov, V; Riccardi, G; Svergun, DI; Glockshuber, R; Guerin, ME				Albesa-Jove, David; Comino, Natalia; Tersa, Montse; Mohorko, Elisabeth; Urresti, Saioa; Dainese, Elisa; Chiarelli, Laurent R.; Pasca, Maria Rosalia; Manganelli, Riccardo; Makarov, Vadim; Riccardi, Giovanna; Svergun, Dmitri I.; Glockshuber, Rudi; Guerin, Marcelo E.			The Redox State Regulates the Conformation of Rv2466c to Activate the Antitubercular Prodrug TP053	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-DISULFIDE-ISOMERASE; HIGH-RESOLUTION; INFLUENZA HEMAGGLUTININ; THIOREDOXIN; TUBERCULOSIS; SCATTERING; MECHANISM; SYSTEM; DSBA; TRANSFERASES	Rv2466c is a key oxidoreductase that mediates the reductive activation of TP053, a thienopyrimidine derivative that kills replicating and non-replicating Mycobacterium tuberculosis, but whose mode of action remains enigmatic. Rv2466c is a homodimer in which each subunit displays a modular architecture comprising a canonical thioredoxin-fold with a Cys(19)-Pro(20)-Trp(21)-Cys(22) motif, and an insertion consisting of a four alpha-helical bundle and a short alpha-helical hairpin. Strong evidence is provided for dramatic conformational changes during the Rv2466c redox cycle, which are essential for TP053 activity. Strikingly, a new crystal structure of the reduced form of Rv2466c revealed the binding of a C-terminal extension in alpha-helical conformation to a pocket next to the active site cysteine pair at the interface between the thioredoxin domain and the helical insertion domain. The ab initio low-resolution envelopes obtained from small angle x-ray scattering showed that the fully reduced form of Rv2466c adopts a "closed" compact conformation in solution, similar to that observed in the crystal structure. In contrast, the oxidized form of Rv2466c displays an "open" conformation, where tertiary structural changes in the alpha-helical subdomain suffice to account for the observed conformational transitions. Altogether our structural, biochemical, and biophysical data strongly support a model in which the formation of the catalytic disulfide bond upon TP053 reduction triggers local structural changes that open the substrate binding site of Rv2466c allowing the release of the activated, reduced form of TP053. Our studies suggest that similar structural changes might have a functional role in other members of the thioredoxin-fold superfamily.	[Albesa-Jove, David; Comino, Natalia; Tersa, Montse; Urresti, Saioa; Guerin, Marcelo E.] Univ Basque Country, Ctr Mixto Consejo Super Invest Cientif, Euskal Herriko Unibertsitatea, CSIC,Unidad Biofis, Leioa 48940, Bizkaia, Spain; [Albesa-Jove, David; Comino, Natalia; Tersa, Montse; Urresti, Saioa; Guerin, Marcelo E.] Univ Basque Country, Dept Bioquim, Leioa 48940, Bizkaia, Spain; [Albesa-Jove, David; Guerin, Marcelo E.] Ikerbasque, Basque Fdn Sci, Bilbao 48013, Spain; [Mohorko, Elisabeth; Glockshuber, Rudi] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; [Dainese, Elisa; Manganelli, Riccardo] Univ Pavia, Dept Mol Med, I-27100 Pavia, Italy; [Chiarelli, Laurent R.; Pasca, Maria Rosalia; Riccardi, Giovanna] Univ Pavia, Dept Biol & Biotechnol Lazzaro Spallanzani, I-27100 Pavia, Italy; [Makarov, Vadim] Russian Acad Sci, AN Bakh Inst Biochem, Moscow 119071, Russia; [Svergun, Dmitri I.] DESY, Hamburg Outstn, European Mol Biol Lab, D-22603 Hamburg, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country; Basque Foundation for Science; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Pavia; University of Pavia; Research Center of Biotechnology RAS; Russian Academy of Sciences; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY)	Guerin, ME (corresponding author), Univ Basque Country, Ctr Mixto Consejo Super Invest Cientif, Euskal Herriko Unibertsitatea, CSIC,Unidad Biofis, Barrio Sarriena S-N, Leioa 48940, Bizkaia, Spain.	mrcguerin@gmail.com	Pasca, Maria Rosalia/J-8752-2016; Albesa-Jové, David/F-5683-2016; Albesa-Jové, David/O-3822-2019; Makarov, Vadim/HGB-7756-2022; Makarov, Vadim/AAE-5483-2021; Manganelli, Riccardo/A-7361-2009; Chiarelli, Laurent Roberto/J-8368-2016; Guerin, Marcelo M/N-7245-2016	Pasca, Maria Rosalia/0000-0002-8906-4937; Albesa-Jové, David/0000-0003-2904-8203; Albesa-Jové, David/0000-0003-2904-8203; Makarov, Vadim/0000-0001-8746-2694; Makarov, Vadim/0000-0001-8746-2694; Manganelli, Riccardo/0000-0003-0940-7336; Chiarelli, Laurent Roberto/0000-0003-0348-9764; Guerin, Marcelo M/0000-0001-9524-3184; Comino, Natalia/0000-0001-8924-8819; Tersa, Montse/0000-0002-2370-7776; RICCARDI, Giovanna/0000-0003-3295-0070; Urresti, Saioa/0000-0002-8678-8358	European Commission [HEALTH-F3-2011-260872, 283570]; Spanish Ministry of Economy and Competitiveness [BIO2013-49022-C2-2-R]; Basque Government	European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish Ministry of Economy and Competitiveness(Spanish Government); Basque Government(Basque Government)	This work was supported by European Commission Contract HEALTH-F3-2011-260872, the Spanish Ministry of Economy and Competitiveness Contract BIO2013-49022-C2-2-R, and the Basque Government (to M. E. G.), the European Commission FP7 Programme under BioStruct-X Grant 283570, Diamond Light Source Proposals mx8302/10130, and SOLEIL Proposal 20140843. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Albesa-Jove D, 2014, ACS CHEM BIOL, V9, P1567, DOI 10.1021/cb500149m; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Blanchet CE, 2013, ANNU REV PHYS CHEM, V64, P37, DOI 10.1146/annurev-physchem-040412-110132; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; Carr CM, 1997, P NATL ACAD SCI USA, V94, P14306, DOI 10.1073/pnas.94.26.14306; CARR CM, 1993, CELL, V73, P823, DOI 10.1016/0092-8674(93)90260-W; CARR CM, 1994, SCIENCE, V266, P234, DOI 10.1126/science.7939658; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cohen J, 2013, SCIENCE, V339, P130, DOI 10.1126/science.339.6116.130; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; DIRR H, 1994, EUR J BIOCHEM, V220, P645, DOI 10.1111/j.1432-1033.1994.tb18666.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fan DP, 2003, J BIOL CHEM, V278, P21212, DOI 10.1074/jbc.M208486200; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Giganti D, 2013, J BIOL CHEM, V288, P29797, DOI 10.1074/jbc.M113.462705; Gorner K, 2007, J BIOL CHEM, V282, P13680, DOI 10.1074/jbc.M609821200; Guinier A., 1939, ANN PHYS-LEIPZIG, DOI DOI 10.1051/ANPHYS/193911120161; Han X, 2001, NAT STRUCT BIOL, V8, P715, DOI 10.1038/90434; Hanschmann EM, 2013, ANTIOXID REDOX SIGN, V19, P1539, DOI 10.1089/ars.2012.4599; Hartkoorn RC, 2012, EMBO MOL MED, V4, P1032, DOI 10.1002/emmm.201201689; HOLMGREN A, 1995, STRUCTURE, V3, P239, DOI 10.1016/S0969-2126(01)00153-8; Inaba K, 2008, BBA-MOL CELL RES, V1783, P520, DOI 10.1016/j.bbamcr.2007.11.006; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; Jackson M, 2013, FUTURE MICROBIOL, V8, P855, DOI 10.2217/fmb.13.52; JENG MF, 1994, STRUCTURE, V2, P853, DOI 10.1016/S0969-2126(94)00086-7; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Khan HA, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00070; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Koul A, 2007, NAT CHEM BIOL, V3, P323, DOI 10.1038/nchembio884; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Lechartier B, 2014, EMBO MOL MED, V6, P158, DOI 10.1002/emmm.201201772; Malojcic G, 2008, FEBS LETT, V582, P3301, DOI 10.1016/j.febslet.2008.07.063; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X; Mazon H, 2007, J BIOL CHEM, V282, P11281, DOI 10.1074/jbc.M611177200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mossner E, 1998, PROTEIN SCI, V7, P1233; Mossner E, 1999, J BIOL CHEM, V274, P25254, DOI 10.1074/jbc.274.36.25254; Narayanaswami V, 2010, COMP BIOCHEM PHYS A, V155, P123, DOI 10.1016/j.cbpa.2009.09.009; Neres J, 2015, ACS CHEM BIOL, V10, P705, DOI 10.1021/cb5007163; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qi Y, 2005, PROTEINS, V58, P376, DOI 10.1002/prot.20329; QIN J, 1994, STRUCTURE, V2, P503, DOI 10.1016/S0969-2126(00)00051-4; Raman S, 2001, J BACTERIOL, V183, P6119, DOI 10.1128/JB.183.20.6119-6125.2001; SINGH R, 1990, J AM CHEM SOC, V112, P1190, DOI 10.1021/ja00159a046; Sotomayor-Perez AC, 2013, J AM CHEM SOC, V135, P11929, DOI 10.1021/ja404790f; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tian G, 2008, J BIOL CHEM, V283, P33630, DOI 10.1074/jbc.M806026200; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang JJ, 2002, P NATL ACAD SCI USA, V99, P1188, DOI 10.1073/pnas.032565999; WHO, 2014, GLOB TUB REP 2013; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu BJ, 2012, TRENDS PHARMACOL SCI, V33, P656, DOI 10.1016/j.tips.2012.09.007; WUNDERLICH M, 1993, J MOL BIOL, V233, P559, DOI 10.1006/jmbi.1993.1535; Zumla A, 2013, NAT REV DRUG DISCOV, V12, P388, DOI 10.1038/nrd4001; Zumla A, 2013, NEW ENGL J MED, V368, P745, DOI 10.1056/NEJMra1200894	59	14	14	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					31077	31089		10.1074/jbc.M115.677039	http://dx.doi.org/10.1074/jbc.M115.677039			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26546681	hybrid, Green Published			2022-12-26	WOS:000367199000036
J	Brotnow, L; Reiss, D; Stover, CS; Ganiban, J; Leve, LD; Neiderhiser, JM; Shaw, DS; Stevens, HE				Brotnow, Line; Reiss, David; Stover, Carla S.; Ganiban, Jody; Leve, Leslie D.; Neiderhiser, Jenae M.; Shaw, Daniel S.; Stevens, Hanna E.			Expectant Mothers Maximizing Opportunities: Maternal Characteristics Moderate Multifactorial Prenatal Stress in the Prediction of Birth Weight in a Sample of Children Adopted at Birth	PLOS ONE			English	Article							RISK-FACTORS; PSYCHOSOCIAL STRESS; SOCIAL SUPPORT; EMOTIONAL DISTRESS; GENETIC INFLUENCES; PRETERM BIRTH; PARTNER ABUSE; EARLY GROWTH; LIFE EVENTS; PREGNANCY	Background Mothers' stress in pregnancy is considered an environmental risk factor in child development. Multiple stressors may combine to increase risk, and maternal personal characteristics may offset the effects of stress. This study aimed to test the effect of 1) multifactorial prenatal stress, integrating objective "stressors" and subjective "distress" and 2) the moderating effects of maternal characteristics (perceived social support, self-esteem and specific personality traits) on infant birthweight. Method Hierarchical regression modeling was used to examine cross-sectional data on 403 birth mothers and their newborns from an adoption study. Results Distress during pregnancy showed a statistically significant association with birthweight (R-2 = 0.032, F-(2,F- 398) = 6.782, p = .001). The hierarchical regression model revealed an almost two-fold increase in variance of birthweight predicted by stressors as compared with distress measures (R-2 Delta = 0.049, F-(4,F- 394) = 5.339, p <.001). Further, maternal characteristics moderated this association (R-2 Delta = 0.031, F-(4,F- 389) = 3.413, p = .009). Specifically, the expected benefit to birthweight as a function of higher SES was observed only for mothers with lower levels of harm-avoidance and higher levels of perceived social support. Importantly, the results were not better explained by prematurity, pregnancy complications, exposure to drugs, alcohol or environmental toxins. Conclusions The findings support multidimensional theoretical models of prenatal stress. Although both objective stressors and subjectively measured distress predict birthweight, they should be considered distinct and cumulative components of stress. This study further highlights that jointly considering risk factors and protective factors in pregnancy improves the ability to predict birthweight.	[Brotnow, Line; Stevens, Hanna E.] Univ Iowa, Coll Med, Dept Psychiat, Iowa City, IA 52242 USA; [Brotnow, Line; Reiss, David; Stevens, Hanna E.] Yale Univ, Sch Med, Yale Child Study Ctr, New Haven, CT USA; [Stover, Carla S.] Univ S Florida, Dept Mental Hlth Law & Policy, Tampa, FL USA; [Ganiban, Jody] George Washington Univ, Dept Psychol, Washington, DC 20052 USA; [Leve, Leslie D.] Univ Oregon, Dept Counseling Psychol & Human Serv, Eugene, OR 97403 USA; [Neiderhiser, Jenae M.] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA; [Shaw, Daniel S.] Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA	University of Iowa; Yale University; State University System of Florida; University of South Florida; George Washington University; University of Oregon; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Stevens, HE (corresponding author), Univ Iowa, Coll Med, Dept Psychiat, Iowa City, IA 52242 USA.	hanna-stevens@uiowa.edu	Stevens, Hanna/M-4104-2016	Stevens, Hanna/0000-0002-3906-0786	Klingenstein Third Generation Foundation; National Center for Advancing Translational Science [CTSA UL1 TR000142]; National Institute of Child Health and Human Development [R01 HD042608]; National Institute on Drug Abuse, NIH, U.S. PHS; National Institute on Drug Abuse [R01 DA020585]; National Institute of Mental Health and OBSSR, NIH, U.S. PHS; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R56HD042608] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042608] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH077823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020585] Funding Source: NIH RePORTER	Klingenstein Third Generation Foundation(Klingenstein Philanthropies); National Center for Advancing Translational Science; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Drug Abuse, NIH, U.S. PHS; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Mental Health and OBSSR, NIH, U.S. PHS; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This project was supported by the Klingenstein Third Generation Foundation Fellowship in ADHD (P.I.: Hanna Stevens, M.D., Ph.D), support to Hanna Stevens from CTSA UL1 TR000142 from the National Center for Advancing Translational Science, R01 HD042608 from the National Institute of Child Health and Human Development and the National Institute on Drug Abuse, NIH, U.S. PHS (PI Years 1-5: David Reiss, M.D.; PI Years 6-10: Leslie Leve, PhD) and grant R01 DA020585 from the National Institute on Drug Abuse, the National Institute of Mental Health and OBSSR, NIH, U.S. PHS (PI: Jenae Neiderhiser, Ph.D.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health and Human Development or the National Institutes of Health.	Alderdice F, 2012, J PSYCHOSOM OBST GYN, V33, P62, DOI 10.3109/0167482X.2012.673040; Aldwin C., 2007, STRESS COPING DEV IN; ANDREASEN NC, 1977, ARCH GEN PSYCHIAT, V34, P1229; Bale TL, 2010, BIOL PSYCHIAT, V68, P314, DOI 10.1016/j.biopsych.2010.05.028; Barker DJP, 1997, NUTRITION, V13, P807, DOI 10.1016/S0899-9007(97)00193-7; Beck A, 1993, MANUAL BECK DEPRESSI; Beck A.T., 1990, BECK SCALE SUICIDE I; Bell S, 2012, SOC SCI MED, V74, P1324, DOI 10.1016/j.socscimed.2012.01.019; BELSKY J, 1984, CHILD DEV, V55, P83, DOI 10.2307/1129836; Betts KS, 2014, DEPRESS ANXIETY, V31, P9, DOI 10.1002/da.22210; Beydoun H, 2008, PAEDIATR PERINAT EP, V22, P438, DOI 10.1111/j.1365-3016.2008.00951.x; Bolten MI, 2012, J PEDIATR-US, V161, P104, DOI 10.1016/j.jpeds.2011.12.044; Borcherding K, 2005, J FAM NURS, V11, P289, DOI 10.1177/1074840705278582; Boulet SL, 2011, MATERN CHILD HLTH J, V15, P836, DOI 10.1007/s10995-009-0538-2; BRONFENBRENNER U, 1994, PSYCHOL REV, V101, P568, DOI 10.1037/0033-295X.101.4.568; Brown SJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-196; Campbell J, 1999, AM J EPIDEMIOL, V150, P714; Campos B, 2008, CULT DIVERS ETHN MIN, V14, P155, DOI 10.1037/1099-9809.14.2.155; Caspi A, 1996, INT J METHOD PSYCH, V6, P101, DOI 10.1002/(SICI)1234-988X(199607)6:2<101::AID-MPR156>3.3.CO;2-E; Chen MJ, 2011, AM J OBSTET GYNECOL, V205, P402, DOI 10.1016/j.ajog.2011.05.003; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; Cohen J., 2003, APPL MULTIPLE REGRES; CONGER RD, 1994, CHILD DEV, V65, P541, DOI 10.1111/j.1467-8624.1994.tb00768.x; Costello EJ, 2007, ARCH GEN PSYCHIAT, V64, P338, DOI 10.1001/archpsyc.64.3.338; DOHRENWEND BS, 1978, J HEALTH SOC BEHAV, V19, P205, DOI 10.2307/2136536; Dunkel Schetter C, 2013, HLTH PSYCHOL REV, P1; Dyer JM, 2011, J IMMIGR MINOR HEALT, V13, P487, DOI 10.1007/s10903-010-9331-y; Entringer S, 2010, CURR OPIN ENDOCRINOL, V17, P507, DOI 10.1097/MED.0b013e3283405921; Entringer S, 2009, HORM BEHAV, V55, P292, DOI 10.1016/j.yhbeh.2008.11.006; Feldman PJ, 2000, PSYCHOSOM MED, V62, P715, DOI 10.1097/00006842-200009000-00016; Field T, 2011, INFANT BEHAV DEV, V34, P1, DOI 10.1016/j.infbeh.2010.09.008; Glazier RH, 2004, J PSYCHOSOM OBST GYN, V25, P247, DOI 10.1080/01674820400024406; Gofin R, 2000, PUBLIC HEALTH, V114, P161, DOI 10.1016/S0033-3506(00)00328-0; Graignic-Philippe R, 2014, NEUROSCI BIOBEHAV R, V43, P137, DOI 10.1016/j.neubiorev.2014.03.022; Grote NK, 2010, ARCH GEN PSYCHIAT, V67, P1012, DOI 10.1001/archgenpsychiatry.2010.111; Hamilton JG, 2008, J PSYCHOSOM OBST GYN, V29, P97, DOI 10.1080/01674820701690624; Harden KP, 2007, BEHAV GENET, V37, P273, DOI 10.1007/s10519-006-9113-4; Harris A, 2011, HORM BEHAV, V59, P279, DOI 10.1016/j.yhbeh.2010.06.007; Hayes AF, 2009, BEHAV RES METHODS, V41, P924, DOI 10.3758/BRM.41.3.924; Hobel CJ, 2008, CLIN OBSTET GYNECOL, V51, P333, DOI 10.1097/GRF.0b013e31816f2709; Kendler KS, 2007, PSYCHOL MED, V37, P615, DOI 10.1017/S0033291706009524; Kendler KS, 2008, ARCH GEN PSYCHIAT; Kenny LC, 2014, RES PERSPECT END INT, V12, P41, DOI 10.1007/978-3-319-02591-9_4; Khashan AS, 2008, ARCH GEN PSYCHIAT, V65, P146, DOI 10.1001/archgenpsychiatry.2007.20; King S, 2012, BIRTH DEFECTS RES C, V96, P273, DOI 10.1002/bdrc.21026; Lazarus R.S., 1984, EMOTION ADAPTATION; Lazarus RS., 2006, STRESS EMOTION NEW S; Lazinski M, 2008, ARCH WOMEN MENT HLTH, V11, P363, DOI 10.1007/s00737-008-0035-4; LeCuyer-Maus EA, 2003, PUBLIC HEALTH NURS, V20, P132, DOI 10.1046/j.1525-1446.2003.20207.x; Leve LD, 2007, TWIN RES HUM GENET, V10, P84, DOI 10.1375/twin.10.1.84; Leve LD, 2013, TWIN RES HUM GENET, V16, P412, DOI 10.1017/thg.2012.126; Levy-Shiff R, 1998, DEV PSYCHOL, V34, P1417, DOI 10.1037/0012-1649.34.6.1417; Lobel M, 2000, HEALTH PSYCHOL, V19, P544, DOI 10.1037/0278-6133.19.6.544; LOBEL M, 1994, J BEHAV MED, V17, P225, DOI 10.1007/BF01857952; LOBEL M, 1992, HEALTH PSYCHOL, V11, P32, DOI 10.1037/0278-6133.11.1.32; Lucassen PJ, 2013, TRENDS NEUROSCI, V36, P621, DOI 10.1016/j.tins.2013.08.002; Marceau K, 2013, INT J BEHAV DEV, V37, P366, DOI 10.1177/0165025413489378; McFarlane J, 1996, NURS RES, V45, P37, DOI 10.1097/00006199-199601000-00007; McKelvey LM, 2002, INFANT MENT HEALTH J, V23, P164, DOI 10.1002/imhj.10010; Messer B., 1986, MANUAL ADULT SELF PE; Monk C, 2013, J CHILD PSYCHOL PSYC, V54, P115, DOI 10.1111/jcpp.12000; Nast I, 2013, PEDIAT PERINATAL EPI; Nylen KJ, 2012, J BEHAV MED; Pettersson E, 2014, J CHILD PSYCHOL PSYC; Pluess M, 2010, BIOL PSYCHOL, V83, P169, DOI 10.1016/j.biopsycho.2009.12.005; Raphael-Left J, 2005, PSYCHOL PROCESSES CH; Rice F, 2010, PSYCHOL MED, V40, P335, DOI 10.1017/S0033291709005911; Rini CK, 1999, HEALTH PSYCHOL, V18, P333, DOI 10.1037/0278-6133.18.4.333; Rogers E, 2009, NEOREVIEWS, V3, P100; Roy-Matton N, 2011, OBSTET GYNECOL SURV, V66, P475, DOI 10.1097/OGX.0b013e31822954c0; Schetter CD, 2011, ANNU REV PSYCHOL, V62, P531, DOI 10.1146/annurev.psych.031809.130727; Schofield TJ, 2012, MERRILL PALMER QUART, V58, P255, DOI 10.1353/mpq.2012.0008; Swickert RJ, 2010, PERS INDIV DIFFER, V48, P736, DOI 10.1016/j.paid.2010.01.018; Thapar A, 2009, BRIT J PSYCHIAT, V195, P100, DOI 10.1192/bjp.bp.109.062828; Valladares E, 2002, OBSTET GYNECOL, V100, P700, DOI 10.1016/S0029-7844(02)02093-8; van den Oord EJCG, 2003, J CHILD PSYCHOL PSYC, V44, P180; Wadhwa PD, 2005, PSYCHONEUROENDOCRINO, V30, P724, DOI 10.1016/j.psyneuen.2005.02.004; Wainstock T, 2013, J MATERN-FETAL NEO M, P1; Weinstock M, 2008, NEUROSCI BIOBEHAV R, V32, P1073, DOI 10.1016/j.neubiorev.2008.03.002; Yali AM, 1999, J PSYCHOSOM OBST GYN, V20, P39, DOI 10.3109/01674829909075575; Zhu P, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.02.023	81	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141881	10.1371/journal.pone.0141881	http://dx.doi.org/10.1371/journal.pone.0141881			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV6RT	26544958	Green Published, gold, Green Accepted			2022-12-26	WOS:000364398700058
J	Brown, TA; Tkachuk, AN; Clayton, DA				Brown, Timothy A.; Tkachuk, Ariana N.; Clayton, David A.			Mitochondrial Transcription Factor A (TFAM) Binds to RNA Containing 4-Way Junctions and Mitochondrial tRNA	PLOS ONE			English	Article							DNA COPY NUMBER; MOBILITY GROUP BOX; PROTEIN; POLYMERASE; INNATE; IDENTIFICATION; REPLICATION; NUCLEOIDS; DEGRADATION; BIOGENESIS	Mitochondrial DNA (mtDNA) is maintained within nucleoprotein complexes known as nucleoids. These structures are highly condensed by the DNA packaging protein, mitochondrial Transcription Factor A (TFAM). Nucleoids also include RNA, RNA: DNA hybrids, and are associated with proteins involved with RNA processing and mitochondrial ribosome biogenesis. Here we characterize the ability of TFAM to bind various RNA containing substrates in order to determine their role in TFAM distribution and function within the nucleoid. We find that TFAM binds to RNA-containing 4-way junctions but does not bind appreciably to RNA hairpins, internal loops, or linear RNA: DNA hybrids. Therefore the RNA within nucleoids largely excludes TFAM, and its distribution is not grossly altered with removal of RNA. Within the cell, TFAM binds to mitochondrial tRNAs, consistent with our RNA 4-way junction data. Kinetic binding assays and RNase-insensitive TFAM distribution indicate that DNA remains the preferred substrate within the nucleoid. However, TFAM binds to tRNA with nanomolar affinity and these complexes are not rare. TFAM-immunoprecipitated tRNAs have processed ends, suggesting that binding is not specific to RNA precursors. The amount of each immunoprecipitated tRNA is not well correlated with tRNA celluar abundance, indicating unequal TFAM binding preferences. TFAM-mt-tRNA interaction suggests potentially new functions for this protein.	[Brown, Timothy A.; Tkachuk, Ariana N.; Clayton, David A.] Howard Hughes Med Inst, Ashburn, VA 20147 USA	Howard Hughes Medical Institute	Brown, TA (corresponding author), Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA.	brownt@janelia.hhmi.org		Tkachuk, Ariana/0000-0001-8991-9643; Brown, Timothy/0000-0001-8941-7678	Howard Hughes Medical Institute; Janelia Research Campus	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Janelia Research Campus	This work was funded entirely by the Howard Hughes Medical Institute through full and direct support of the Janelia Research Campus (www.janelia.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonicka H, 2013, CELL METAB, V17, P386, DOI 10.1016/j.cmet.2013.02.006; Arnoult D, 2011, EMBO REP, V12, P901, DOI 10.1038/embor.2011.157; Balandina A, 2002, J BIOL CHEM, V277, P27622, DOI 10.1074/jbc.M201978200; Bell AJ, 2008, BIOCHEM BIOPH RES CO, V377, P262, DOI 10.1016/j.bbrc.2008.09.131; Bianchi ME, 2007, IMMUNOL REV, V220, P35, DOI 10.1111/j.1600-065X.2007.00574.x; Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200; Bogenhagen DF, 2014, CELL METAB, V19, P618, DOI 10.1016/j.cmet.2014.03.013; BONNEFOY E, 1994, J MOL BIOL, V242, P116, DOI 10.1006/jmbi.1994.1563; Brown A, 2014, SCIENCE, V346, P718, DOI 10.1126/science.1258026; Brown TA, 2002, NUCLEIC ACIDS RES, V30, P2004, DOI 10.1093/nar/30.9.2004; Brown TA, 2011, MOL CELL BIOL, V31, P4994, DOI 10.1128/MCB.05694-11; Brown TA, 2008, J BIOL CHEM, V283, P36743, DOI 10.1074/jbc.M806174200; Brzezniak LK, 2011, RNA BIOL, V8, P616, DOI 10.4161/rna.8.4.15393; Cotney J, 2007, NUCLEIC ACIDS RES, V35, P4042, DOI 10.1093/nar/gkm424; Damas J, 2012, NUCLEIC ACIDS RES, V40, P7606, DOI 10.1093/nar/gks500; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; Farge G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2001; Fender A, 2012, BIOCHIMIE, V94, P1090, DOI 10.1016/j.biochi.2012.02.030; Fernandez-Vizarra E, 2002, METHODS, V26, P292, DOI 10.1016/S1046-2023(02)00034-8; FISHER RP, 1988, MOL CELL BIOL, V8, P3496, DOI 10.1128/MCB.8.8.3496; FISHER RP, 1989, GENE DEV, V3, P2202, DOI 10.1101/gad.3.12b.2202; Gangelhoff TA, 2009, NUCLEIC ACIDS RES, V37, P3153, DOI 10.1093/nar/gkp157; Gilbert SL, 2000, J BIOL CHEM, V275, P36491, DOI 10.1074/jbc.C000409200; He J, 2012, NUCLEIC ACIDS RES, V40, P6109, DOI 10.1093/nar/gks266; He J, 2012, NUCLEIC ACIDS RES, V40, P6097, DOI 10.1093/nar/gks257; Holzmann J, 2008, CELL, V135, P462, DOI 10.1016/j.cell.2008.09.013; Hue THD, 2014, EMBO MOL MED, V6, P183, DOI 10.1002/emmm.201303202; Hunter SE, 2004, MITOCHONDRION, V4, P21, DOI 10.1016/j.mito.2004.04.003; Iborra FJ, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-9; Jourdain AA, 2013, CELL METAB, V17, P399, DOI 10.1016/j.cmet.2013.02.005; Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404; KING MP, 1993, J BIOL CHEM, V268, P10228; Kolesar JE, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1324; Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108; Lee KW, 2013, J BIOL CHEM, V288, P31386, DOI 10.1074/jbc.M113.515692; Lu B, 2013, MOL CELL, V49, P121, DOI 10.1016/j.molcel.2012.10.023; Malarkey CS, 2012, TRENDS BIOCHEM SCI, V37, P553, DOI 10.1016/j.tibs.2012.09.003; Malarkey CS, 2012, NUCLEIC ACIDS RES, V40, P614, DOI 10.1093/nar/gkr787; Markov DA, 2009, YEAST, V26, P423, DOI 10.1002/yea.1672; Matsushima Y, 2010, P NATL ACAD SCI USA, V107, P18410, DOI 10.1073/pnas.1008924107; Mei YD, 2010, MOL CELL, V37, P668, DOI 10.1016/j.molcel.2010.01.023; Nagaike T, 2001, J BIOL CHEM, V276, P40041, DOI 10.1074/jbc.M106202200; Ngo Huu B, 2014, Nat Commun, V5, P3077, DOI 10.1038/ncomms4077; Ohno T, 2000, BIOCHEM BIOPH RES CO, V271, P492, DOI 10.1006/bbrc.2000.2656; OJALA D, 1980, CELL, V22, P393, DOI 10.1016/0092-8674(80)90350-5; Ozawa T, 2007, NAT METHODS, V4, P413, DOI 10.1038/NMETH1030; Perli E, 2014, EMBO MOL MED, V6, P169, DOI 10.1002/emmm.201303198; Pohjoismaki JLO, 2006, NUCLEIC ACIDS RES, V34, P5815, DOI 10.1093/nar/gkl703; Pohjoismaki JLO, 2010, J MOL BIOL, V397, P1144, DOI 10.1016/j.jmb.2010.02.029; Rodeheffer MS, 2003, J BIOL CHEM, V278, P18695, DOI 10.1074/jbc.M301399200; Rorbach J, 2008, NUCLEIC ACIDS RES, V36, P5787, DOI 10.1093/nar/gkn576; Shi YH, 2012, P NATL ACAD SCI USA, V109, P16510, DOI 10.1073/pnas.1119738109; Surovtseva YV, 2013, NUCLEIC ACIDS RES, V41, P2479, DOI 10.1093/nar/gks1447; Surovtseva YV, 2011, P NATL ACAD SCI USA, V108, P17921, DOI 10.1073/pnas.1108852108; Suzuki T, 2007, METHOD ENZYMOL, V425, P231, DOI 10.1016/S0076-6879(07)25010-4; Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258; WANG Y, 2013, PLOS ONE, V2013; Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200; West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156; Yanai H, 2011, J INTERN MED, V270, P301, DOI 10.1111/j.1365-2796.2011.02433.x; Ylikallio E, 2010, HUM MOL GENET, V19, P2695, DOI 10.1093/hmg/ddq163	61	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142436	10.1371/journal.pone.0142436	http://dx.doi.org/10.1371/journal.pone.0142436			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545237	Green Submitted, Green Published, gold			2022-12-26	WOS:000364398700140
J	Fu, J; Sharma, P; Spicer, V; Krokhin, OV; Zhang, XL; Fristensky, B; Cicek, N; Sparling, R; Levin, DB				Fu, Jilagamazhi; Sharma, Parveen; Spicer, Vic; Krokhin, Oleg V.; Zhang, Xiangli; Fristensky, Brian; Cicek, Nazim; Sparling, Richard; Levin, David. B.			Quantitative 'Omics Analyses of Medium Chain Length Polyhydroxyalkanaote Metabolism in Pseudomonas putida LS46 Cultured with Waste Glycerol and Waste Fatty Acids	PLOS ONE			English	Article							ENHANCED PRODUCTION; TREHALOSE SYNTHASE; ESCHERICHIA-COLI; BIOSYNTHESIS; AERUGINOSA; EXPRESSION; GENOME; KT2440; GROWTH; POLY(3-HYDROXYBUTYRATE-CO-3-HYDROXYHEXANOATE)	Transcriptomes and proteomes of Pseudomonas putida LS46 cultured with biodiesel-derived waste glycerol or waste free fatty acids, as sole carbon sources, were compared under conditions that were either permissive or non-permissive for synthesis of medium chain length polyhydroxyalkanoates (mcl-PHA). The objectives of this study were to elucidate mechanisms that influence activation of biopolymer synthesis, intra-cellular accumulation, and monomer composition, and determine if these were physiologically specific to the carbon sources used for growth of P. putida LS46. Active mcl-PHA synthesis by P. putida LS46 was associated with high expression levels of key mcl-PHA biosynthesis genes and/or gene products including monomer-supplying proteins, PHA synthases, and granule-associated proteins. 'Omics data suggested that expression of these genes were regulated by different genetic mechanisms in P. putida LS46 cells in different physiological states, when cultured on the two waste carbon sources. Optimal polymer production by P. putida LS46 was primarily limited by less efficient glycerol metabolism during mcl-PHA synthesis on waste glycerol. Mapping the 'Omics data to the mcl-PHA biosynthetic pathway revealed significant variations in gene expression, primarily involved in: 1) glycerol transportation; 2) enzymatic reactions that recycle reducing equivalents and produce key mcl-PHA biosynthesis pathway intermediates (e.g. NADH/NADPH, acetyl-CoA). Active synthesis of mcl-PHAs was observed during exponential phase in cultures with waste free fatty acids, and was associated with the fatty acid beta-oxidation pathway. A putative Thioesterase in the beta-oxidation pathway that may regulate the level of fatty acid beta-oxidation intermediates, and thus carbon flux to mcl-PHA biosynthesis, was highly up-regulated. Finally, the data suggested that differences in expression of selected fatty acid metabolism and mcl-PHA monomer-supplying enzymes may play a role in determining the monomer composition of mcl-PHA polymers. Understanding the relationships between genome content, gene and gene product expression, and how these factors influence polymer synthesis, will aid in optimization of mcl-PHA production by P. putida LS46 using biodiesel waste streams.	[Fu, Jilagamazhi; Sharma, Parveen; Cicek, Nazim; Levin, David. B.] Univ Manitoba, Dept Biosyst Engn, Winnipeg, MB, Canada; [Spicer, Vic; Krokhin, Oleg V.] Univ Manitoba, Dept Internal Med, Winnipeg, MB, Canada; [Spicer, Vic; Krokhin, Oleg V.] Univ Manitoba, Manitoba Ctr Prote & Syst Biol, Winnipeg, MB, Canada; [Zhang, Xiangli; Fristensky, Brian] Univ Manitoba, Dept Plant Sci, Winnipeg, MB R3T 2N2, Canada; [Sparling, Richard] Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada	University of Manitoba; University of Manitoba; University of Manitoba; University of Manitoba; University of Manitoba	Levin, DB (corresponding author), Univ Manitoba, Dept Biosyst Engn, Winnipeg, MB, Canada.	david.levin@umanitoba.ca		Cicek, Nazim/0000-0002-3929-2536; Fristensky, Brian/0000-0002-1554-3492	Genome Canada, through the Applied Genomics Research in Bioproducts or Crops (ABC) program; government of the Province of Manitoba through the Manitoba Research Innovation Fund (MRIF); Manitoba Rural Adaptation Council (MRAC)	Genome Canada, through the Applied Genomics Research in Bioproducts or Crops (ABC) program; government of the Province of Manitoba through the Manitoba Research Innovation Fund (MRIF); Manitoba Rural Adaptation Council (MRAC)	This work was funded by Genome Canada, through the Applied Genomics Research in Bioproducts or Crops (ABC) program for the grant titled, "Microbial Genomics for Biofuels and Co-Products from Biorefining Processes", and by the government of the Province of Manitoba through the Manitoba Research Innovation Fund (MRIF) and the Manitoba Rural Adaptation Council (MRAC).	Akaraonye E, 2010, J CHEM TECHNOL BIOT, V85, P732, DOI 10.1002/jctb.2392; Borrero-de Acuna JM, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-88; Cavalheiro JMBT, 2009, PROCESS BIOCHEM, V44, P509, DOI 10.1016/j.procbio.2009.01.008; Cerrate S, 2006, INT J POULT SCI, V11, P1001, DOI [10.3923/ijps.2006.1001.1007, DOI 10.3923/IJPS.2006.1001.1007]; Deziel E, 2003, MICROBIOL-SGM, V149, P2005, DOI 10.1099/mic.0.26154-0; Escapa IF, 2013, ENVIRON MICROBIOL, V15, P93, DOI 10.1111/j.1462-2920.2012.02790.x; Escapa IF, 2012, ENVIRON MICROBIOL, V14, P1049, DOI 10.1111/j.1462-2920.2011.02684.x; Follonier S, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-25; Freeman BC, 2010, ENVIRON MICROBIOL, V12, P1486, DOI 10.1111/j.1462-2920.2010.02171.x; Fu J, 2014, CAN J MICROBIOL, V60, P461, DOI 10.1139/cjm-2014-0108; Fukui T, 1998, J BACTERIOL, V180, P667, DOI 10.1128/JB.180.3.667-673.1998; Galan B, 2011, MOL MICROBIOL, V79, P402, DOI 10.1111/j.1365-2958.2010.07450.x; Gungormusler-Yilmaz M, 2014, AMB EXPRESS, V4, DOI 10.1186/s13568-014-0063-6; Guzik MW, 2014, MICROBIOL-SGM, V160, P1760, DOI 10.1099/mic.0.078758-0; Hoang TT, 1997, J BACTERIOL, V179, P5326, DOI 10.1128/jb.179.17.5326-5332.1997; Hoffmann N, 2004, FEMS MICROBIOL LETT, V237, P1, DOI 10.1111/j.1574-6968.2004.tb09671.x; Hunt MC, 2002, PROG LIPID RES, V41, P99, DOI 10.1016/S0163-7827(01)00017-0; de Eugenio LI, 2010, ENVIRON MICROBIOL, V12, P207, DOI [10.1111/j.1462-2920.2009.02061.x, 10.1111/j.1462-2920.2010.02199.x]; Javidpour P, 2014, APPL ENVIRON MICROB, V80, P497, DOI 10.1128/AEM.03194-13; Joyce AR, 2006, NAT REV MOL CELL BIO, V7, P198, DOI 10.1038/nrm1857; Kang Y, 2008, MICROBIOL-SGM, V154, P1584, DOI 10.1099/mic.0.2008/018135-0; Karine L, 2008, MOL MICROBIOL, V67, P241; Kenny ST, 2012, APPL MICROBIOL BIOT, V95, P623, DOI 10.1007/s00253-012-4058-4; Kim J, 2013, ENV MICROBIOL REP, V5, P883, DOI 10.1111/1758-2229.12090; Kimber MS, 2004, J BIOL CHEM, V279, P52593, DOI 10.1074/jbc.M408105200; Koller M, 2005, BIOMACROMOLECULES, V6, P561, DOI 10.1021/bm049478b; La Rosa R, 2014, ENVIRON MICROBIOL, V16, P278, DOI 10.1111/1462-2920.12303; Lee IY, 1996, BIOTECHNOL BIOENG, V52, P707, DOI 10.1002/(SICI)1097-0290(19961220)52:6<707::AID-BIT8>3.0.CO;2-S; LEE IY, 1995, FEMS MICROBIOL LETT, V131, P35, DOI 10.1111/j.1574-6968.1995.tb07750.x; Li C, 2013, ENERGIES, V6, P4739, DOI 10.3390/en6094739; Lu XY, 2003, FEMS MICROBIOL LETT, V221, P97, DOI 10.1016/S0378-1097(03)00173-3; Ma Y, 2006, J FOOD ENG, V77, P342, DOI 10.1016/j.jfoodeng.2005.06.042; MALOY SR, 1980, J BACTERIOL, V143, P720, DOI 10.1128/JB.143.2.720-725.1980; McMahon B, 2007, FEMS MICROBIOL LETT, V273, P50, DOI 10.1111/j.1574-6968.2007.00780.x; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; Nikel PI, 2014, ENVIRON MICROBIOL, V16, P239, DOI 10.1111/1462-2920.12224; Poblete-Castro I, 2013, METAB ENG, V15, P113, DOI 10.1016/j.ymben.2012.10.004; Poblete-Castro I, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-34; Qiu YZ, 2005, BIOTECHNOL LETT, V27, P1381, DOI 10.1007/s10529-005-3685-6; Regine HA, 1991, J BACTERIOL, V173, P7918; Rehm BHA, 2001, APPL ENVIRON MICROB, V67, P3102, DOI 10.1128/AEM.67.7.3102-3109.2001; Ren Q, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-254; Ren Q, 2009, BIOMACROMOLECULES, V10, P916, DOI 10.1021/bm801431c; Roca A, 2013, ENVIRON MICROBIOL, V15, P780, DOI 10.1111/1462-2920.12037; Ryan WJ, 2013, APPL ENVIRON MICROB, V79, P1795, DOI 10.1128/AEM.02962-12; Sabirova JS, 2006, J BACTERIOL, V188, P8452, DOI 10.1128/JB.01321-06; Sato S, 2011, APPL MICROBIOL BIOT, V90, P951, DOI 10.1007/s00253-011-3150-5; Schweizer HP, 1997, MICROBIOL-SGM, V143, P1287, DOI 10.1099/00221287-143-4-1287; Sharma PK, 2012, CAN J MICROBIOL, V58, P982, DOI [10.1139/w2012-074, 10.1139/W2012-074]; Simon O, 2014, J PROTEOMICS, V109, P212, DOI 10.1016/j.jprot.2014.07.006; Singh R, 2007, J BACTERIOL, V189, P6665, DOI 10.1128/JB.00555-07; SPENCER AK, 1978, J BIOL CHEM, V253, P5922; Su J, 2014, BIOTECHNOL LETT, V36, P1009, DOI 10.1007/s10529-013-1450-9; Sun ZY, 2007, APPL MICROBIOL BIOT, V74, P69, DOI 10.1007/s00253-006-0655-4; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Trotschel C, 2013, MICROB BIOTECHNOL, V6, P708, DOI 10.1111/1751-7915.12035; Tuleva BK, 2002, Z NATURFORSCH C, V57, P356; Verbeke TJ, 2014, APPL ENVIRON MICROB, V80, P1602, DOI 10.1128/AEM.03555-13; Verhoef S, 2014, NEW BIOTECHNOL, V31, P114, DOI 10.1016/j.nbt.2013.08.006; Wang P, 2015, SCI REP-UK, V5, DOI 10.1038/srep09150; Wang Q, 2012, APPL ENVIRON MICROB, V78, P519, DOI 10.1128/AEM.07020-11; Wang TF, 2014, CAN J MICROBIOL, V60, P599, DOI 10.1139/cjm-2014-0330; Yang FX, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-13	63	17	17	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142322	10.1371/journal.pone.0142322	http://dx.doi.org/10.1371/journal.pone.0142322			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544181	Green Published, Green Submitted, gold			2022-12-26	WOS:000364398700110
J	Gu, QY; Zhang, J; Hu, HF; Tan, YE; Shi, SM; Nian, YY				Gu, Qiaoyan; Zhang, Jun; Hu, Haifeng; Tan, Yu-e; Shi, Shengmei; Nian, Yuanyuan			Clinical Significance of MiR-137 Expression in Patients with Gastric Cancer After Radical Gastrectomy	PLOS ONE			English	Article							PROMOTER; PATHOGENESIS; MIRNAS	The dysregulation of miR-137 plays vital roles in the oncogenesis and progression of various types of cancer, but its role in prognosis of gastric cancer patients remains unknown. This study was designed to investigate the expression and prognostic significance of miR-137 in gastric cancer patients after radical gastrectomy. Quantitative real-time PCR (qRT-PCR) was performed to evaluate the expression of miR-137 in human gastric cancer cell lines and tissues in patients with gastric adenocarcinoma. Results were assessed for association with clinical factors and overall survival by using Kaplan-Meier analysis. Prognostic values of miR-137 expression and clinical outcomes were evaluated by Cox regression analysis. The results exhibited that the expression level of miR-137 was decreased in human gastric cancer cell lines and tissues, and down-regulated expression of miR-137 was associated with tumor cell differentiation, N stage, and TNM stage. Decreased miR-137 expression in gastric cancer tissues was positively correlated with poor overall survival of gastric cancer patients. Further multivariate Cox regression analysis suggested that miR-137 expression was an independent prognostic indicator for gastric cancer except for TNM stage. Applying the prognostic value of miR-137 expression to TNM stage III group showed a better risk stratification for overall survival. In conclusion, the results reinforced the critical role for the down-regulated miR-137 expression in gastric cancer and suggested that miR-137 expression could be a prognostic indicator for this disease. In addition, these patients with TNM stage III gastric cancer and low miR-137 expression might need more aggressive postoperative treatment and closer follow-up.	[Gu, Qiaoyan; Zhang, Jun; Nian, Yuanyuan] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Gastroenterol, Xian 710049, Peoples R China; [Gu, Qiaoyan; Hu, Haifeng; Tan, Yu-e; Shi, Shengmei] Yanan Univ, Affiliated Hosp, Dept Gastroenterol, Yanan, Peoples R China	Xi'an Jiaotong University; Yanan University	Zhang, J (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Gastroenterol, Xian 710049, Peoples R China.	zhangjun_2016@sina.com						Chakrabarti M, 2015, GENE, V573, P141, DOI 10.1016/j.gene.2015.07.034; Chen DL, 2013, CARCINOGENESIS, V34, P803, DOI 10.1093/carcin/bgs400; Chen WQ, 2014, CHIN J CANCER, V33, P402, DOI 10.5732/cjc.014.10084; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Figueiredo C, 2013, HELICOBACTER, V18, P28, DOI 10.1111/hel.12083; Guo JL, 2013, BIOCHEM BIOPH RES CO, V441, P357, DOI 10.1016/j.bbrc.2013.10.052; Kang N, 2015, LUNG CANCER, V89, P99, DOI 10.1016/j.lungcan.2015.05.011; Langevin SM, 2010, CARCINOGENESIS, V31, P864, DOI 10.1093/carcin/bgq051; Liu M, 2011, INT J CANCER, V128, P1269, DOI 10.1002/ijc.25452; Liu S, 2014, TUMOR BIOL, V35, P9131, DOI 10.1007/s13277-014-2177-5; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Stadtlander CTKH, 1999, CARCINOGENESIS, V20, P2195, DOI 10.1093/carcin/20.12.2195; Stanitz E, 2013, ANTICANCER RES, V33, P3195; Steponaitiene R, 2016, MOL CARCINOGEN, V55, P376, DOI 10.1002/mc.22287; Thrumurthy SG, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6367; Washington K, 2010, ANN SURG ONCOL, V17, P3077, DOI 10.1245/s10434-010-1362-z; Wu LP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130124; Yang L, 2006, WORLD J GASTROENTERO, V12, P17, DOI 10.3748/wjg.v12.i1.17; Yang YJ, 2015, CLIN CANCER RES, V21, P2399, DOI 10.1158/1078-0432.CCR-14-1437; Yao Y, 2009, MOL MED REP, V2, P963, DOI 10.3892/mmr_00000199; Zhao YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039102; Zheng XS, 2015, J CANCER RES CLIN, V141, P785, DOI 10.1007/s00432-014-1847-4	23	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142377	10.1371/journal.pone.0142377	http://dx.doi.org/10.1371/journal.pone.0142377			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545111	Green Submitted, Green Published, gold			2022-12-26	WOS:000364398700123
J	Lopez-Rull, I; Hornero-Mendez, D; Frias, O; Blanco, G				Lopez-Rull, Isabel; Hornero-Mendez, Damaso; Frias, Oscar; Blanco, Guillermo			Age-Related Relationships between Innate Immunity and Plasma Carotenoids in an Obligate Avian Scavenger	PLOS ONE			English	Article							VULTURES GYPS-FULVUS; COLONIAL GRIFFON VULTURES; LIFE-HISTORY; TRADE-OFFS; ACQUIRED-IMMUNITY; SEXUAL SIGNALS; TREE SWALLOWS; BIRDS; NESTLINGS; DEFENSE	Variation in immunity is influenced by allocation trade-offs that are expected to change between age-classes as a result of the different environmental and physiological conditions that individuals encounter over their lifetime. One such trade-off occurs with carotenoids, which must be acquired with food and are involved in a variety of physiological functions. Nonetheless, relationships between immunity and carotenoids in species where these micronutrients are scarce due to diet are poorly studied. Among birds, vultures show the lowest concentrations of plasma carotenoids due to a diet based on carrion. Here, we investigated variations in the relationships between innate immunity (hemagglutination by natural antibodies and hemolysis by complement proteins), pathogen infection and plasma carotenoids in nestling and adult griffon vultures (Gyps fulvus) in the wild. Nestlings showed lower hemolysis, higher total carotenoid concentration and higher pathogen infection than adults. Hemolysis was negatively related to carotenoid concentration only in nestlings. A differential carotenoid allocation to immunity due to the incomplete development of the immune system of nestlings compared with adults is suggested linked to, or regardless of, potential differences in parasite infection, which requires experimental testing. We also found that individuals with more severe pathogen infections showed lower hemagglutination than those with a lower intensity infection irrespective of their age and carotenoid level. These results are consistent with the idea that intraspecific relationships between innate immunity and carotenoids may change across ontogeny, even in species lacking carotenoid-based coloration. Thus, even low concentrations of plasma carotenoids due to a scavenger diet can be essential to the development and activation of the immune system in growing birds.	[Lopez-Rull, Isabel; Frias, Oscar; Blanco, Guillermo] CSIC, Museo Nacl Ciencias Nat, Dept Ecol Evolut, E-28006 Madrid, Spain; [Hornero-Mendez, Damaso] CSIC, Inst Grasa, Dept Biotecnol Alimentos, E-41080 Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de la Grasa (IG)	Lopez-Rull, I (corresponding author), CSIC, Museo Nacl Ciencias Nat, Dept Ecol Evolut, E-28006 Madrid, Spain.	isalorull@gmail.com	Blanco, Guillermo/L-3170-2014; Hornero-Mendez, Damaso/H-2507-2012; Lopez-Rull, Isabel/AAB-1097-2019	Blanco, Guillermo/0000-0001-5742-4929; Hornero-Mendez, Damaso/0000-0002-1781-5703; Lopez-Rull, Isabel/0000-0002-3255-0459	Spanish Ministerio of Economia y Competitividad [CGL2009-12753-C02-01/BOS, CGL2010-15726]; CYTED [112RT0445]	Spanish Ministerio of Economia y Competitividad(Spanish Government); CYTED	Funds were provided by the projects CGL2009-12753-C02-01/BOS and CGL2010-15726 of Spanish Ministerio of Economia y Competitividad. DHM is member of the IBERCAROT Network, funded by CYTED (ref. 112RT0445).	Aguilera E, 2007, NATURWISSENSCHAFTEN, V94, P895, DOI 10.1007/s00114-007-0268-5; Alonso-Alvarez C, 2004, AM NAT, V164, P651, DOI 10.1086/424971; [Anonymous], 1993, LOS BUITRES IBERICOS; Apanius V, 1998, AVIAN GROWTH DEV EVO, V8, P203; Baeta R, 2008, P ROY SOC B-BIOL SCI, V275, P427, DOI 10.1098/rspb.2007.1383; Biard C, 2009, J EXP BIOL, V212, P1336, DOI 10.1242/jeb.028449; Biard C, 2006, J EXP BIOL, V209, P1004, DOI 10.1242/jeb.02089; Blanco G, 1997, IBIS, V139, P180, DOI 10.1111/j.1474-919X.1997.tb04522.x; Blanco G, 2005, P ROY SOC B-BIOL SCI, V272, P1893, DOI 10.1098/rspb.2005.3157; Blanco G, 1996, AUK, V113, P247, DOI 10.2307/4088957; Blanco G, 2006, BIOL J LINN SOC, V88, P383, DOI 10.1111/j.1095-8312.2006.00625.x; Blanco G, 2014, POPUL ECOL, V56, P593, DOI 10.1007/s10144-014-0445-2; Blanco G, 2014, POPUL ECOL, V56, P203, DOI 10.1007/s10144-013-0404-3; Blanco G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065562; Blount JD, 2003, OIKOS, V102, P340, DOI 10.1034/j.1600-0706.2003.12413.x; Blount JD, 2003, SCIENCE, V300, P125, DOI 10.1126/science.1082142; Bonneaud C, 2003, AM NAT, V161, P367, DOI 10.1086/346134; Bortolotti GR, 2002, J ANIM ECOL, V71, P333, DOI 10.1046/j.1365-2656.2002.00602.x; Butler MW, 2012, FUNCT ECOL, V26, P406, DOI 10.1111/j.1365-2435.2011.01942.x; Chew BP, 2009, CAROTENOIDS SER, V5, P363, DOI 10.1007/978-3-7643-7501-0_17; Chew BP, 2004, J NUTR, V134, p257S, DOI 10.1093/jn/134.1.257S; Cucco M, 2006, BEHAV PROCESS, V73, P325, DOI 10.1016/j.beproc.2006.08.002; De Coster G, 2010, J EXP BIOL, V213, P3012, DOI 10.1242/jeb.042721; DONAZAR JA, 1989, ARDEA, V77, P217; Elosegui I., 1989, ACTA BIOL MONTANA, V3; Fellah JS, 2008, AVIAN IMMUNOLOGY, P51, DOI 10.1016/B978-012370634-8.50006-8; Fenoglio S, 2002, ETHOL ECOL EVOL, V14, P149; Fitze PS, 2007, AM NAT, V169, pS137, DOI 10.1086/510094; Friend M., 1999, FIELD MANUAL WILDLIF; Goodwin TW, 1984, BIOCH CAROTENOIDS, VII; Hill GE, 2012, AM NAT, V180, pE127, DOI 10.1086/667861; Killpack TL, 2013, J AVIAN BIOL, V44, P513, DOI 10.1111/j.1600-048X.2013.00239.x; Killpack TL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047294; Klasing Kirk C., 2004, Acta Zoologica Sinica, V50, P961; Koutsos EA, 2003, COMP BIOCHEM PHYS A, V135, P635, DOI 10.1016/S1095-6433(03)00158-2; Leclaire S, 2015, BEHAV ECOL SOCIOBIOL; Lee KA, 2008, J ANIM ECOL, V77, P356, DOI 10.1111/j.1365-2656.2007.01347.x; Lee KA, 2006, INTEGR COMP BIOL, V46, P1000, DOI 10.1093/icb/icl049; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Lopez-Rull I, 2015, NESTS, EGGS, AND INCUBATION: NEW IDEAS ABOUT AVIAN REPRODUCTION, P82; LOZANO GA, 1994, OIKOS, V70, P309, DOI 10.2307/3545643; Lucas A, 2014, J EXP BIOL, V217, P1253, DOI 10.1242/jeb.098004; Martinez F, 1997, J FIELD ORNITHOL, V68, P392; Martinez F, 1998, ORNIS FENNICA, V75, P145; Matson KD, 2005, DEV COMP IMMUNOL, V29, P275, DOI 10.1016/j.dci.2004.07.006; Mauck RA, 2005, FUNCT ECOL, V19, P1001, DOI 10.1111/j.1365-2435.2005.01060.x; McGraw KJ, 2011, BIOL J LINN SOC, V102, P560, DOI 10.1111/j.1095-8312.2010.01594.x; McGraw KJ, 2003, AM NAT, V162, P704, DOI 10.1086/378904; MINGUEZMOSQUERA MI, 1993, J AGR FOOD CHEM, V41, P1616, DOI 10.1021/jf00034a018; Negro JJ, 2002, NATURE, V416, P807, DOI 10.1038/416807a; Norris K, 2000, BEHAV ECOL, V11, P19, DOI 10.1093/beheco/11.1.19; Noziere P, 2006, ANIM FEED SCI TECH, V131, P418, DOI 10.1016/j.anifeedsci.2006.06.018; Ochsenbein AF, 2000, IMMUNOL TODAY, V21, P624, DOI 10.1016/S0167-5699(00)01754-0; Olson VA, 1998, TRENDS ECOL EVOL, V13, P510, DOI 10.1016/S0169-5347(98)01484-0; Palacios MG, 2009, DEV COMP IMMUNOL, V33, P456, DOI 10.1016/j.dci.2008.09.006; Parejo D, 2007, J AVIAN BIOL, V38, P717, DOI 10.1111/j.2007.0908-8857.04081.x; Parejo D, 2009, NATURWISSENSCHAFTEN, V96, P1193, DOI 10.1007/s00114-009-0584-z; Peig J, 2010, FUNCT ECOL, V24, P1323, DOI 10.1111/j.1365-2435.2010.01751.x; Perez-Rodriguez L, 2008, J EXP BIOL, V211, P2155, DOI 10.1242/jeb.017178; Peters A, 2004, AM NAT, V164, P51, DOI 10.1086/421302; Peters A, 2011, OECOLOGIA, V166, P35, DOI 10.1007/s00442-011-1921-4; Ritchie V.W., 1994, AVIAN MED PRINCIPLES; Saino N, 2003, P ROY SOC B-BIOL SCI, V270, P2485, DOI 10.1098/rspb.2003.2534; Sandland GJ, 2003, TRENDS PARASITOL, V19, P571, DOI 10.1016/j.pt.2003.10.006; Simons MJP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043088; Smits JEG, 2008, COMP BIOCHEM PHYS A, V151, P711, DOI 10.1016/j.cbpa.2008.08.025; Stambaugh T, 2011, WILSON J ORNITHOL, V123, P779, DOI 10.1676/10-197.1; Surai PF, 2011, J POULT SCI, V38, P1; Wink M, 1998, MOL ECOL, V7, P779, DOI 10.1046/j.1365-294x.1998.00377.x	69	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141759	10.1371/journal.pone.0141759	http://dx.doi.org/10.1371/journal.pone.0141759			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544885	Green Submitted, gold, Green Published			2022-12-26	WOS:000364398700041
J	Regmi, SC; Park, SY; Kim, SJ; Banskota, S; Shah, S; Kim, DH; Kim, JA				Regmi, Sushil C.; Park, Su Young; Kim, Seung Joo; Banskota, Suhrid; Shah, Sajita; Kim, Dong-Hee; Kim, Jung-Ae			The Anti-Tumor Activity of Succinyl Macrolactin A Is Mediated through the beta-Catenin Destruction Complex via the Suppression of Tankyrase and PI3K/Akt	PLOS ONE			English	Article							CANCER STEM-CELLS; COLORECTAL-CANCER; COLON-CANCER; WNT PATHWAY; INHIBITION; PROLIFERATION; MUTATIONS; PROGRESSION; MACROLIDES; GROWTH	Accumulated gene mutations in cancer suggest that multi-targeted suppression of affected signaling networks is a promising strategy for cancer treatment. In the present study, we report that 7-O-succinyl macrolactin A (SMA) suppresses tumor growth by stabilizing the beta-catenin destruction complex, which was achieved through inhibition of regulatory components associated with the complex. SMA significantly reduced the activities of PI3K/Akt, which corresponded with a decrease in GSK3 beta phosphorylation, an increase in beta-catenin phosphorylation, and a reduction in nuclear beta-catenin content in HT29 human colon cancer cells. At the same time, the activity of tankyrase, which inhibits the beta-catenin destruction complex by destabilizing the axin level, was suppressed by SMA. Despite the low potency of SMA against tankyrase activity (IC50 of 50.1 mu M and 15.5 mu M for tankyrase 1 and 2, respectively) compared to XAV939 (IC50 of 11 nM for tankyrase 1), a selective and potent tankyrase inhibitor, SMA had strong inhibitory effects on beta-catenin-dependent TCF/LEF1 transcriptional activity (IC50 of 39.8 nM), which were similar to that of XAV939 (IC50 of 28.1 nM). In addition to suppressing the colony forming ability of colon cancer cells in vitro, SMA significantly inhibited tumor growth in CT26 syngenic and HT29 xenograft mouse tumor models. Furthermore, treating mice with SMA in combination with 5-FU in a colon cancer xenograft model or with cisplatin in an A549 lung cancer xenograft model resulted in greater anti-tumor activity than did treatment with the drugs alone. In the xenograft tumor tissues, SMA dose-dependently inhibited nuclear beta-catenin along with reductions in GSK3 beta phosphorylation and increases in axin levels. These results suggest that SMA is a possible candidate as an effective anti-cancer agent alone or in combination with cytotoxic chemotherapeutic drugs, such as 5-FU and cisplatin, and that the mode of action for SMA involves stabilization of the beta-catenin destruction complex through inhibition of tankyrase and the PI3K/Akt signaling pathway.	[Regmi, Sushil C.; Park, Su Young; Kim, Seung Joo; Banskota, Suhrid; Shah, Sajita; Kim, Jung-Ae] Yeungnam Univ, Coll Pharm, Gyongsan, South Korea; [Kim, Dong-Hee] Daewoo Pharm Co Ltd, Ctr Res & Dev, Busan, South Korea	Yeungnam University	Kim, JA (corresponding author), Yeungnam Univ, Coll Pharm, Gyongsan, South Korea.	jakim@yu.ac.kr	Banskota, Suhrid/AAF-2315-2020; Banskota, Suhrid/Q-8485-2016; Regmi, Sushil/M-6385-2017	Banskota, Suhrid/0000-0003-3183-6268; Banskota, Suhrid/0000-0003-3183-6268; 	Yeungnam University Research Grant; Daewoo Pharmaceutical Co., Ltd	Yeungnam University Research Grant; Daewoo Pharmaceutical Co., Ltd	This work was supported by a Yeungnam University Research Grant (2014). Daewoo Pharmaceutical Co., Ltd provided the material, SMA, and support in the form of salary for author DHK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinleye A, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-88; Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Casas-Selves M, 2012, CANCER RES, V72, P4154, DOI 10.1158/0008-5472.CAN-11-2848; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Ewan K, 2010, CANCER RES, V70, P5963, DOI 10.1158/0008-5472.CAN-10-1028; Gelmini S, 2004, CANCER LETT, V216, P81, DOI 10.1016/j.canlet.2004.05.010; Gelmini S, 2006, ONCOL REP, V16, P1261; GUSTAFSON K, 1989, J AM CHEM SOC, V111, P7519, DOI 10.1021/ja00201a036; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Ihle NT, 2009, CANCER RES, V69, P143, DOI 10.1158/0008-5472.CAN-07-6656; Ishibe S, 2006, MOL CELL BIOL, V26, P9232, DOI 10.1128/MCB.01312-06; Kang Y, 2015, ARCH PHARM RES, V38, P249, DOI 10.1007/s12272-014-0535-x; Kanoh S, 2010, CLIN MICROBIOL REV, V23, P590, DOI 10.1128/CMR.00078-09; Kolligs FT, 2002, DIGESTION, V66, P131, DOI 10.1159/000066755; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Li XQ, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-114; McNeill H, 2010, NAT REV MOL CELL BIO, V11, P404, DOI 10.1038/nrm2902; Nakashima T, 2008, ONCOL REP, V19, P203; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Ng SW, 2009, J BIOL CHEM, V284, P24767, DOI 10.1074/jbc.M109.011692; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; Park S, 2014, EUR J PHARMACOL, V735, P184, DOI 10.1016/j.ejphar.2014.04.024; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; RISIO M, 1991, CANCER RES, V51, P1917; RISIO M, 1992, J CELL BIOCHEM, P79; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Shebzukhov YV, 2008, CANCER IMMUNOL IMMUN, V57, P871, DOI 10.1007/s00262-007-0423-z; Stewart DJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt356; Stewart DJ, 2010, CRIT REV ONCOL HEMAT, V75, P173, DOI 10.1016/j.critrevonc.2009.11.006; Teng Y, 2010, BIOCHEM BIOPH RES CO, V392, P373, DOI 10.1016/j.bbrc.2010.01.028; Tian XH, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-100; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Voskas Daniel, 2010, F1000 Biol Rep, V2, P82, DOI 10.3410/B2-82; Zhang J, 2011, GASTROENTEROLOGY, V141, P50, DOI 10.1053/j.gastro.2011.05.010	40	17	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141753	10.1371/journal.pone.0141753	http://dx.doi.org/10.1371/journal.pone.0141753			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544726	Green Published, gold, Green Submitted			2022-12-26	WOS:000364398700040
J	Roy, S; Basu, S; Dasgupta, D; Bhattacharyya, D; Banerjee, R				Roy, Sourav; Basu, Sankar; Dasgupta, Dipak; Bhattacharyya, Dhananjay; Banerjee, Rahul			The Unfolding MD Simulations of Cyclophilin: Analyzed by Surface Contact Networks and Their Associated Metrics	PLOS ONE			English	Article							TRANSFER-RNA SYNTHETASE; FREE-ENERGY LANDSCAPE; MOLECULAR-DYNAMICS; LEISHMANIA-DONOVANI; PROTEIN STRUCTURES; MOLTEN GLOBULES; RIBONUCLEASE-A; KEY RESIDUES; PACKING; COMPLEMENTARITY	Currently, considerable interest exists with regard to the dissociation of close packed aminoacids within proteins, in the course of unfolding, which could result in either wet or dry moltenglobules. The progressive disjuncture of residues constituting the hydrophobic core ofcyclophilin from L. donovani (LdCyp) has been studied during the thermal unfolding of the molecule, by molecular dynamics simulations. LdCyp has been represented as a surface contactnetwork (SCN) based on the surface complementarity (S-m) of interacting residues within themolecular interior. The application of Sm to side chain packing within proteins make it a very sensitive indicator of subtle perturbations in packing, in the thermal unfolding of the protein. Network based metrics have been defined to track the sequential changes in the disintegration ofthe SCN spanning the hydrophobic core of LdCyp and these metrics prove to be highly sensitive compared to traditional metrics in indicating the increased conformational (and dynamical) flexibility in the network. These metrics have been applied to suggest criteria distinguishing DMG, WMG and transition state ensembles and to identify key residues involved in crucial conformational/topological events during the unfolding process.	[Roy, Sourav; Basu, Sankar; Dasgupta, Dipak; Bhattacharyya, Dhananjay; Banerjee, Rahul] Saha Inst Nucl Phys, Kolkata 700064, India	Saha Institute of Nuclear Physics	Bhattacharyya, D (corresponding author), Saha Inst Nucl Phys, Sect 1,Block AF, Kolkata 700064, India.	dhananjay.bhattacharyya@saha.ac.in; rahul.banerjee@saha.ac.in	Basu, Sankar/AAD-7202-2019; ROY, SOURAV/ABE-1206-2020	Basu, Sankar/0000-0003-1393-1982; ROY, SOURAV/0000-0001-5354-3824	Department of Atomic Energy (Government of India) [XII-RD-SIN-5.04-0102, XII-RD-SIN-5.04-0103]	Department of Atomic Energy (Government of India)(Department of Atomic Energy (DAE))	This project was funded by Department of Atomic Energy (Government of India) Projects of SINP: MSACR [XII-R&D-SIN-5.04-0102] and BARD -[XII-R&D-SIN-5.04-0103].	Amitai G, 2004, J MOL BIOL, V344, P1135, DOI 10.1016/j.jmb.2004.10.055; Atilgan AR, 2004, BIOPHYS J, V86, P85, DOI 10.1016/S0006-3495(04)74086-2; Baldwin RL, 2013, PROTEIN-STRUCT FUNCT, V78, P2725; Baldwin RL, 2013, CURR OPIN STRUC BIOL, V23, P4, DOI 10.1016/j.sbi.2012.11.004; Banerjee R, 2003, J MOL BIOL, V333, P211, DOI 10.1016/j.jmb.2003.08.013; Basu S, 2014, INDIAN J BIOCHEM BIO, V51, P188; Basu S, 2012, BIOPHYS J, V102, P2605, DOI 10.1016/j.bpj.2012.04.029; Basu S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-195; BEHE MJ, 1991, P NATL ACAD SCI USA, V88, P4195, DOI 10.1073/pnas.88.10.4195; Bhattacharyya M, 2013, PROTEIN SCI, V22, P1399, DOI 10.1002/pro.2333; Bhattacharyya M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051676; Bhattacharyya M, 2011, BIOCHEMISTRY-US, V50, P6225, DOI 10.1021/bi200306u; Bhattacharyya M, 2010, PROTEINS, V78, P506, DOI 10.1002/prot.22573; Bhattacharyya S, 2013, CURR OPIN STRUC BIOL, V23, P11, DOI 10.1016/j.sbi.2012.10.010; Borg I, 2010, MODERN MULTIDIMENSIO; Brinda KV, 2005, BIOPHYS J, V89, P4159, DOI 10.1529/biophysj.105.064485; BROCCHIERI L, 1994, P NATL ACAD SCI USA, V91, P9297, DOI 10.1073/pnas.91.20.9297; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; Dasgupta A, 2014, J PHYS CHEM B, V118, P6380, DOI 10.1021/jp410019f; Dokholyan NV, 2002, P NATL ACAD SCI USA, V99, P8637, DOI 10.1073/pnas.122076099; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Gao M, 2010, J PHYS CHEM B, V114, P15687, DOI 10.1021/jp1052453; Ghosh A, 2007, P NATL ACAD SCI USA, V104, P15711, DOI 10.1073/pnas.0704459104; Ghosh A, 2007, BIOPHYS J, V92, P2523, DOI 10.1529/biophysj.106.099903; Glassner NC, 1996, P NATL ACAD SCI USA, V93, P12155; Greene LH, 2003, J MOL BIOL, V334, P781, DOI 10.1016/j.jmb.2003.08.061; HOELTZLI SD, 1995, P NATL ACAD SCI USA, V92, P9318, DOI 10.1073/pnas.92.20.9318; Hua L, 2008, P NATL ACAD SCI USA, V105, P16928, DOI 10.1073/pnas.0808427105; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jacobs DJ, 2001, PROTEINS, V44, P150, DOI 10.1002/prot.1081; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; Jha SK, 2009, P NATL ACAD SCI USA, V106, P12289, DOI 10.1073/pnas.0905744106; Joo H, 2014, PROTEINS, V82, P2128, DOI 10.1002/prot.24569; Joo H, 2012, J MOL BIOL, V419, P234, DOI 10.1016/j.jmb.2012.03.004; Juneja J, 2002, BIOCHEMISTRY-US, V41, P2641, DOI 10.1021/bi011480p; Jung JW, 2005, PROTEINS, V58, P389, DOI 10.1002/prot.20324; KIEFHABER T, 1995, NATURE, V375, P513, DOI 10.1038/375513a0; KIEFHABER T, 1995, P NATL ACAD SCI USA, V92, P2657, DOI 10.1073/pnas.92.7.2657; Krishnan A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002149; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Mitchell JBO, 1999, PROTEIN-STRUCT FUNCT, V29, P359; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Prajapati RS, 2007, BIOCHEMISTRY-US, V46, P10339, DOI 10.1021/bi700577m; Rami BR, 2002, BIOCHEMISTRY-US, V41, P1710, DOI 10.1021/bi0120300; Reiner A, 2010, P NATL ACAD SCI USA, V107, P4955, DOI 10.1073/pnas.0910001107; Roy S, 2014, INT J BIOL MACROMOL, V69, P353, DOI 10.1016/j.ijbiomac.2014.05.063; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Salimi NL, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000689; Samanta U, 1999, ACTA CRYSTALLOGR D, V55, P1421, DOI 10.1107/S090744499900726X; SHAKHNOVICH EI, 1989, BIOPOLYMERS, V28, P1667, DOI 10.1002/bip.360281003; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; SINGH J, 1985, FEBS LETT, V191, P1, DOI 10.1016/0014-5793(85)80982-0; Sukhwal A, 2011, ACTA CRYSTALLOGR D, V67, P429, DOI 10.1107/S0907444911007062; Thorpe MF, 2001, J MOL GRAPH MODEL, V19, P60, DOI 10.1016/S1093-3263(00)00122-4; Vendruscolo M, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.061910; Vendruscolo M, 2001, NATURE, V409, P641, DOI 10.1038/35054591; Venugopal V, 2007, ACTA CRYSTALLOGR F, V63, P60, DOI 10.1107/S1744309106056351; Vishveshwara S., 2002, J THEOR COMPUT CHEM, V1, P187, DOI DOI 10.1142/S0219633602000117; Zhou RH, 2003, P NATL ACAD SCI USA, V100, P13280, DOI 10.1073/pnas.2233312100; Zhou RH, 2001, P NATL ACAD SCI USA, V98, P14931, DOI 10.1073/pnas.201543998	61	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142173	10.1371/journal.pone.0142173	http://dx.doi.org/10.1371/journal.pone.0142173			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545107	Green Submitted, Green Published, gold			2022-12-26	WOS:000364398700091
J	Zhang, K; Yun, SD; Shah, NJ				Zhang, Ke; Yun, Seong Dae; Shah, N. Jon			Tripled Readout Slices in Multi Time-Point pCASL Using Multiband Look-Locker EPI	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; WHOLE-BRAIN; ARTERIAL; PERFUSION; VOLUME; MODEL	Multi time-point pseudo-continuous arterial spin labelling (pCASL) with a Look-Locker EPI readout can sample the signal curve of blood kinetics at multiple time points after the labelling pulse. However, due to signal relaxation of labelled blood, the number of readout slices is limited. The aim of this study is to employ a multiband excitation technique to triple the number of readout slices in multi time-point pCASL. The multiband technique, along with 2fold in-plane parallel imaging, was incorporated into the Look-Locker EPI for the multi timepoint sampling of blood kinetic behaviour following the pCASL labelling scheme. The performance evaluation of the multiband and the single-band techniques were performed on four healthy subjects using a 32-channel head RF coil at 3T. Quantitative perfusion maps were analysed using a combination of labelling with and without flow suppression gradients. The perfusion maps provided by the multiband accelerated multi time-point pCASL were in good agreement with the conventional single-band technique. Multiband acceleration caused SNR loss but offered quantitative perfusion maps in 6.23 min with 18 slices compared with 6 slices within the same time period for the single-band method. As conclusion, the multiband technique can successfully triple the number of readout slices while achieving comparable perfusion data in the same measurement time as the conventional single-band readout.	[Zhang, Ke; Yun, Seong Dae; Shah, N. Jon] Forschungszentrum Julich, Med Imaging Phys, Inst Neurosci & Med 4, D-52425 Julich, Germany; [Shah, N. Jon] Rhein Westfal TH Aachen, JARA, Fac Med, Dept Neurol, Aachen, Germany	Helmholtz Association; Research Center Julich; RWTH Aachen University	Shah, NJ (corresponding author), Forschungszentrum Julich, Med Imaging Phys, Inst Neurosci & Med 4, D-52425 Julich, Germany.	n.j.shah@fz-juelich.de	Shah, N. Jon/H-5849-2013	Shah, N. Jon/0000-0002-8151-6169; Yun, Seong Dae/0000-0001-7398-1899				Alsop DC, 1996, J CEREBR BLOOD F MET, V16, P1236, DOI 10.1097/00004647-199611000-00019; Blaimer Martin, 2004, Top Magn Reson Imaging, V15, P223, DOI 10.1097/01.rmr.0000136558.09801.dd; Brookes MJ, 2007, MAGN RESON MED, V58, P41, DOI 10.1002/mrm.21199; Buxton RB, 1998, MAGNET RESON MED, V40, P383, DOI 10.1002/mrm.1910400308; Chappell MA, 2010, MAGN RESON MED, V63, P1357, DOI 10.1002/mrm.22320; Chen YF, 2012, MAGN RESON MATER PHY, V25, P135, DOI 10.1007/s10334-011-0276-5; Dai WY, 2013, MAGN RESON MED, V69, P1014, DOI 10.1002/mrm.24335; Dai WY, 2008, MAGN RESON MED, V60, P1488, DOI 10.1002/mrm.21790; DETRE JA, 1992, MAGNET RESON MED, V23, P37, DOI 10.1002/mrm.1910230106; Feinberg DA, 2013, MAGN RESON MED, V70, P1500, DOI 10.1002/mrm.24994; Feinberg DA, 2013, J MAGN RESON, V229, P90, DOI 10.1016/j.jmr.2013.02.002; Feinberg DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015710; Gunther M, 2005, MAGN RESON MED, V54, P491, DOI 10.1002/mrm.20580; Gunther M, 2001, MAGNET RESON MED, V46, P974, DOI 10.1002/mrm.1284; Gunther M., 2007, P 15 ANN M ISMRM, V15, P380; Hendrikse J, 2003, MAGNET RESON MED, V50, P429, DOI 10.1002/mrm.10525; HERSCOVITCH P, 1985, J CEREBR BLOOD F MET, V5, P65, DOI 10.1038/jcbfm.1985.9; Kim T, 2013, MAGN RESON MED, V70, P1653, DOI 10.1002/mrm.24880; Koopmans PJ, 2012, NEUROIMAGE, V62, P1939, DOI 10.1016/j.neuroimage.2012.05.080; Larkman DJ, 2001, J MAGN RESON IMAGING, V13, P313, DOI 10.1002/1522-2586(200102)13:2<313::AID-JMRI1045>3.0.CO;2-W; LEENDERS KL, 1990, BRAIN, V113, P27, DOI 10.1093/brain/113.1.27; Moeller S, 2010, MAGN RESON MED, V63, P1144, DOI 10.1002/mrm.22361; Ostergaard L, 1996, MAGN RESON MED, V36, P715, DOI 10.1002/mrm.1910360510; Ozyurt O., 2010, P 18 ANN M ISMRM, V18, P4065; Paling D, 2014, J CEREBR BLOOD F MET, V34, P34, DOI 10.1038/jcbfm.2013.161; Petersen ET, 2010, NEUROIMAGE, V49, P104, DOI 10.1016/j.neuroimage.2009.07.068; Petersen ET, 2006, MAGN RESON MED, V55, P219, DOI 10.1002/mrm.20784; Setsompop K, 2012, MAGN RESON MED, V67, P1210, DOI 10.1002/mrm.23097; Lawrence KS, 2012, MAGN RESON MED, V67, P1275, DOI 10.1002/mrm.23104; Teeuwisse WM, 2014, MAGN RESON MED, V72, P1712, DOI 10.1002/mrm.25083; Wu WC, 2007, MAGN RESON MED, V58, P1020, DOI 10.1002/mrm.21403; Zhang K, 2014, J CEREBR BLOOD F MET, V34, P1373, DOI 10.1038/jcbfm.2014.92	32	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141108	10.1371/journal.pone.0141108	http://dx.doi.org/10.1371/journal.pone.0141108			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544715	Green Published, gold			2022-12-26	WOS:000364398700016
J	Akiyama, Y; Agata, K; Inoue, T				Akiyama, Yoshitaro; Agata, Kiyokazu; Inoue, Takeshi			Spontaneous Behaviors and Wall-Curvature Lead to Apparent Wall Preference in Planarian	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; DUGESIA-JAPONICA; SIGNALING SYSTEM; NEURAL-NETWORK; REGENERATION; LOCOMOTION; BRAIN; CELLS; IDENTIFICATION; REPRODUCTION	The planarian Dugesia japonica tends to stay near the walls of its breeding containers and experimental dishes in the laboratory, a phenomenon called "wall preference". This behavior is thought to be important for environmental adaptation, such as hiding by planarians in nature. However, the mechanisms regulating wall-preference behavior are not well understood, since this behavior occurs in the absence of any particular stimulation. Here we show the mechanisms of wall-preference behavior. Surprisingly, planarian wall-preference behavior was also shown even by the head alone and by headless planarians. These results indicate that planarian "wall-preference" behavior only appears to be a "preference" behavior, and is actually an outcome of spontaneous behaviors, rather than of brain function. We found that in the absence of environmental cues planarians moved basically straight ahead until they reached a wall, and that after reaching a wall, they changed their direction of movement to one tangential to the wall, suggesting that this spontaneous behavior may play a critical role in the wall preference. When we tested another spontaneous behavior, the wigwag movement of the planarian head, using computer simulation with various wigwag angles and wigwag intervals, large wigwag angle and short wigwag interval reduced wall-preference behavior. This indicated that wigwag movement may determine the probability of staying near the wall or leaving the wall. Furthermore, in accord with this simulation, when we tested planarian wall-preference behavior using several assay fields with different curvature of the wall, we found that concavity and sharp curvature of walls negatively impacted wall preference by affecting the permissible angle of the wigwag movement. Together, these results indicate that planarian wall preference may be involuntarily caused by the combination of two spontaneous planarian behaviors: moving straight ahead until reaching a wall and then moving along it in the absence of environmental cues, and wigwag movements of the head.	[Akiyama, Yoshitaro; Agata, Kiyokazu; Inoue, Takeshi] Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto, Japan	Kyoto University	Inoue, T (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto, Japan.	inoue@mdb.biophys.kyoto-u.ac.jp	Inoue, Takeshi/S-5623-2019	Inoue, Takeshi/0000-0003-3289-4478; Agata, Kiyokazu/0000-0002-5195-2576	Takeda Science Foundation funds;  [22124001];  [22124002];  [22700336];  [15K07];  [148]	Takeda Science Foundation funds; ; ; ; ; 	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas (22124001, 22124002) to KA, a Grant-in-Aid for Scientific Research (22700336, 15K07 and148) to TI, and The Takeda Science Foundation funds to TI.	Agata K, 1999, SEMIN CELL DEV BIOL, V10, P377, DOI 10.1006/scdb.1999.0324; Agata K, 1998, ZOOL SCI, V15, P433, DOI 10.2108/zsj.15.433; Arrieumerlou C, 2005, DEV CELL, V8, P215, DOI 10.1016/j.devcel.2004.12.007; Blackiston D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014370; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Elliott SA, 2013, WIRES DEV BIOL, V2, P301, DOI 10.1002/wdev.82; Hoshi M, 2003, INTEGR COMP BIOL, V43, P242, DOI 10.1093/icb/43.2.242; Inoue T, 2004, ZOOL SCI, V21, P275, DOI 10.2108/zsj.21.275; Inoue T, 2007, DEVELOPMENT, V134, P1679, DOI 10.1242/dev.02835; Inoue T, 2015, ZOOL LETT, V1, DOI 10.1186/s40851-014-0010-z; Inoue T, 2014, J NEUROSCI, V34, P15701, DOI 10.1523/JNEUROSCI.5379-13.2014; Kirkby LA, 2013, NEURON, V80, P1129, DOI 10.1016/j.neuron.2013.10.030; Mineta K, 2003, P NATL ACAD SCI USA, V100, P7666, DOI 10.1073/pnas.1332513100; Nishimura K, 2008, NEUROSCIENCE, V153, P1103, DOI 10.1016/j.neuroscience.2008.03.026; Nishimura K, 2010, NEUROSCIENCE, V168, P18, DOI 10.1016/j.neuroscience.2010.03.038; Nishimura K, 2007, NEUROSCI RES, V59, P101, DOI 10.1016/j.neures.2007.05.014; Nishimura K, 2007, DEV NEUROBIOL, V67, P1059, DOI 10.1002/dneu.20377; Nishimura K, 2008, NEUROCHEM INT, V53, P184, DOI 10.1016/j.neuint.2008.09.006; O'Donovan MJ, 1999, CURR OPIN NEUROBIOL, V9, P94, DOI 10.1016/S0959-4388(99)80012-9; Paskin TR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114708; Pearl R, 1903, Q J MICROSC SCI, V46, P509; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P725, DOI 10.1146/annurev.cellbio.20.010403.095114; Rink JC, 2013, DEV GENES EVOL, V223, P67, DOI 10.1007/s00427-012-0426-4; Rompolas P, 2010, MOL BIOL CELL, V21, P3669, DOI 10.1091/mbc.E10-04-0373; Sakurai T, 2012, INT J DEV BIOL, V56, P173, DOI 10.1387/ijdb.113439ts; Shibata N, 2010, DEV GROWTH DIFFER, V52, P27, DOI 10.1111/j.1440-169X.2009.01155.x; Shibata T, 2013, BIOPHYS J, V105, P2199, DOI 10.1016/j.bpj.2013.09.024; Shibata T, 2012, J CELL SCI, V125, P5138, DOI 10.1242/jcs.108373; Stringer CE, 1917, P NATL ACAD SCI USA, V3, P691, DOI 10.1073/pnas.3.12.691; Takano T, 2007, DEV GROWTH DIFFER, V49, P383, DOI 10.1111/j.1440-169x.2007.00936.x; Talbot J, 2011, J EXP BIOL, V214, P1063, DOI 10.1242/jeb.052290; Taliaferro WH, 1920, J EXP ZOOL, V31, P59; Tazaki A, 1999, BIOCHEM BIOPH RES CO, V260, P426, DOI 10.1006/bbrc.1999.0933; Tecott LH, 2004, NAT NEUROSCI, V7, P462, DOI 10.1038/nn1225; Umesono Y, 2013, NATURE, V500, P73, DOI 10.1038/nature12359; Umesono Y, 2011, EUR J NEUROSCI, V34, P863, DOI 10.1111/j.1460-9568.2011.07819.x; Umesono Y, 2009, DEV GROWTH DIFFER, V51, P185, DOI 10.1111/j.1440-169X.2009.01099.x; Walter HE, 1907, J EXP ZOOL, V5, P35, DOI 10.1002/jez.1400050104; Weiner OD, 2007, PLOS BIOL, V5, P2053, DOI 10.1371/journal.pbio.0050221	39	11	11	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142214	10.1371/journal.pone.0142214	http://dx.doi.org/10.1371/journal.pone.0142214			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26539715	gold, Green Published, Green Submitted			2022-12-26	WOS:000364303800069
J	Jackrel, SL; Wootton, JT				Jackrel, Sara L.; Wootton, J. Timothy			Diversity of Riparian Plants among and within Species Shapes River Communities	PLOS ONE			English	Article							LEAF-LITTER; DECOMPOSITION; ECOSYSTEM; BIODIVERSITY; TRAITS	Organismal diversity among and within species may affect ecosystem function with effects transmitting across ecosystem boundaries. Whether recipient communities adjust their composition, in turn, to maximize their function in response to changes in donor composition at these two scales of diversity is unknown. We use small stream communities that rely on riparian subsidies as a model system. We used leaf pack experiments to ask how variation in plants growing beside streams in the Olympic Peninsula of Washington State, USA affects stream communities via leaf subsidies. Leaves from red alder (Alnus rubra), vine maple (Acer cinereus), bigleaf maple (Acer macrophyllum) and western hemlock (Tsuga heterophylla) were assembled in leaf packs to contrast low versus high diversity, and deployed in streams to compare local versus non-local leaf sources at the among and within species scales. Leaves from individuals within species decomposed at varying rates; most notably thin leaves decomposed rapidly. Among deciduous species, vine maple decomposed most rapidly, harbored the least algal abundance, and supported the greatest diversity of aquatic invertebrates, while bigleaf maple was at the opposite extreme for these three metrics. Recipient communities decomposed leaves from local species rapidly: leaves from early successional plants decomposed rapidly in stream reaches surrounded by early successional forest and leaves from later successional plants decomposed rapidly adjacent to later successional forest. The species diversity of leaves inconsistently affected decomposition, algal abundance and invertebrate metrics. Intraspecific diversity of leaf packs also did not affect decomposition or invertebrate diversity. However, locally sourced alder leaves decomposed more rapidly and harbored greater levels of algae than leaves sourced from conspecifics growing in other areas on the Olympic Peninsula, but did not harbor greater aquatic invertebrate diversity. In contrast to alder, local intraspecific differences via decomposition, algal or invertebrate metrics were not observed consistently among maples. These results emphasize that biodiversity of riparian subsidies at the within and across species scale have the potential to affect aquatic ecosystems, although there are complex species- specific effects.	[Jackrel, Sara L.; Wootton, J. Timothy] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA	University of Chicago	Jackrel, SL (corresponding author), Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA.	sjackrel@uchicago.edu	Wootton, J. Timothy/F-3191-2015	Wootton, J. Timothy/0000-0002-7715-0344; Jackrel, Sara/0000-0001-7326-4996	National Science Foundation Graduate Research Fellowship Program fellowship; University of Chicago Hinds Fund grant; ARCS1 (Achievement Rewards for College Scientists) Foundation, Inc.'s Scholar Illinois Chapter; Olympic National Resources Grant; NSF [DEB 09-19420]	National Science Foundation Graduate Research Fellowship Program fellowship; University of Chicago Hinds Fund grant; ARCS1 (Achievement Rewards for College Scientists) Foundation, Inc.'s Scholar Illinois Chapter; Olympic National Resources Grant; NSF(National Science Foundation (NSF))	This work was supported by a National Science Foundation Graduate Research Fellowship Program fellowship, University of Chicago Hinds Fund grant, and ARCS1 (Achievement Rewards for College Scientists) Foundation, Inc.'s Scholar Illinois Chapter [2014 and 2015] to S.L. Jackrel and an Olympic National Resources Grant and NSF grant DEB 09-19420 to J.T. Wootton. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boege K, 2005, TRENDS ECOL EVOL, V20, P441, DOI 10.1016/j.tree.2005.05.001; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; COLEY PD, 1983, ECOL MONOGR, V53, P209, DOI 10.2307/1942495; Crutsinger GM, 2006, SCIENCE, V313, P966, DOI 10.1126/science.1128326; Fonte SJ, 2004, BIOTROPICA, V36, P474, DOI 10.1111/j.1744-7429.2004.tb00343.x; Gartner TB, 2004, OIKOS, V104, P230, DOI 10.1111/j.0030-1299.2004.12738.x; Gessner MO, 2010, TRENDS ECOL EVOL, V25, P372, DOI 10.1016/j.tree.2010.01.010; Hutchens JJ, 2000, AM MIDL NAT, V143, P397, DOI 10.1674/0003-0031(2000)143[0397:EOFDBT]2.0.CO;2; IRONS JG, 1991, CAN J FISH AQUAT SCI, V48, P442, DOI 10.1139/f91-058; Jackrel SL, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2522; Jackrel SL, 2014, ECOLOGY, V95, P37, DOI 10.1890/13-0804.1; Kominoski JS, 2011, ECOLOGY, V92, P151, DOI 10.1890/10-0028.1; Lecerf A, 2008, BASIC APPL ECOL, V9, P598, DOI 10.1016/j.baae.2007.11.003; Lecerf A, 2011, ECOLOGY, V92, P160, DOI 10.1890/10-0315.1; Magurran A.E., 1988, ECOLOGICAL DIVERSITY; Merritt R. W., 2008, INTRO AQUATIC INSECT; Schindler MH, 2009, ECOLOGY, V90, P1641, DOI 10.1890/08-1597.1; Swan CM, 2009, ECOLOGY, V90, P1650, DOI 10.1890/08-0329.1; TRISKA FJ, 1976, ECOLOGY, V57, P783, DOI 10.2307/1936191; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; WARD GM, 1979, ECOLOGY, V60, P57, DOI 10.2307/1936468; Wootton JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051839; Wootton JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043561	23	8	8	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142362	10.1371/journal.pone.0142362	http://dx.doi.org/10.1371/journal.pone.0142362			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26539714	Green Published, gold			2022-12-26	WOS:000364303800089
J	Kaiser, A; Langer, B; Przyborski, J; Kersting, D; Kruger, M				Kaiser, Annette; Langer, Barbara; Przyborski, Jude; Kersting, David; Krueger, Mirko			A Putative Non-Canonical Ras-Like GTPase from P. falciparum: Chemical Properties and Characterization of the Protein	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; SCHISTOSOMA-MANSONI; COUPLED RECEPTOR; BINDING PROTEINS; IDENTIFICATION; COMMITMENT; EXPRESSION	During its development the malaria parasite P. falciparum has to adapt to various different environmental contexts. Key cellular mechanisms involving G-protein coupled signal transduction chains are assumed to act at these interfaces. Heterotrimeric G-proteins are absent in Plasmodium. We here describe the first cloning and expression of a putative, non-canonical Ras-like G protein (acronym PfG) from Plasmodium. PfG reveals an open reading frame of 2736 bp encoding a protein of 912 amino acids with a theoretical pI of 8.68 and a molecular weight of 108.57 kDa. Transcript levels and expression are significantly increased in the erythrocytic phase in particular during schizont and gametocyte formation. Most notably, PfG has GTP binding capacity and GTPase activity due to an EngA2 domain present in small Ras-like GTPases in a variety of Bacillus species and Mycobacteria. By contrast, plasmodial PfG is divergent from any human alpha-subunit. PfG was expressed in E. coli as a histidine-tagged fusion protein and was stable only for 3.5 hours. Purification was only possible under native conditions by Nickel-chelate chromatography and subsequent separation by Blue Native PAGE. Binding of a fluorescent GTP analogue BODIPY1FL guanosine 5'O-(thiotriphosphate) was determined by fluorescence emission. Mastoparan stimulated GTP binding in the presence of Mg2+. GTPase activity was determined colorimetrically. Activity expressed as absolute fluorescence was 50% higher for the human paralogue than the activity of the parasitic enzyme. The PfG protein is expressed in the erythrocytic stages and binds GTP after immunoprecipitation. Immunofluorescence using specific antiserum suggests that PfG localizes to the parasite cytosol. The current data suggest that the putitative, Ras-like G-protein might be involved in a non-canonical signaling pathway in Plasmodium. Research on the function of PfG with respect to pathogenesis and antimalarial chemotherapy is currently under way.	[Kaiser, Annette; Langer, Barbara; Kersting, David; Krueger, Mirko] Univ Duisburg Essen, Inst Pharmacogenet, Med Res Ctr, D-45147 Essen, Germany; [Langer, Barbara] Inst Pharmacol, D-45147 Essen, Germany; [Przyborski, Jude] Univ Marburg, Dept Parasitol, FB Biol, D-34043 Marburg, Germany	University of Duisburg Essen; Philipps University Marburg	Kaiser, A (corresponding author), Univ Duisburg Essen, Inst Pharmacogenet, Med Res Ctr, Hufelandstr 55, D-45147 Essen, Germany.	kaiser@microbiology-bonn.de	Kersting, David/ABA-5198-2020; Przyborski, Jude/ABC-9498-2021	Kersting, David/0000-0002-8451-1830; Przyborski, Jude/0000-0002-3494-7767; Kaiser, Annette/0000-0001-7873-3958	DAAD, Hans und Gertie Fischer Stiftung [56154387]	DAAD, Hans und Gertie Fischer Stiftung	DAAD No. 56154387, Hans und Gertie Fischer Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034571; Alaganan A, 2014, P NATL ACAD SCI USA, V111, P1126, DOI 10.1073/pnas.1313501111; Auburn S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010017; Baker DA, 2011, CELL MICROBIOL, V13, P331, DOI 10.1111/j.1462-5822.2010.01561.x; Billker O, 2004, CELL, V117, P503, DOI 10.1016/S0092-8674(04)00449-0; Blisnick T, 2005, MOL BIOCHEM PARASIT, V141, P39, DOI 10.1016/j.molbiopara.2005.01.013; Bosch ED, 2012, PLOS PATHOG, V8; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; Doerig C, 2009, PARASITE, V16, P169, DOI 10.1051/parasite/2009163169; Dyer M, 2000, MOL BIOCHEM PARASIT, V110, P435, DOI 10.1016/S0166-6851(00)00312-1; El-Shehabi F, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001523; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gilchrist A, 2007, TRENDS PHARMACOL SCI, V28, P431, DOI 10.1016/j.tips.2007.06.012; GILLISON SL, 1994, DIABETES, V43, P24, DOI 10.2337/diabetes.43.1.24; Hall A, GTPASES FRONTIERS MO; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Harrison T, 2003, SCIENCE, V301, P1734, DOI 10.1126/science.1089324; Haste NM, 2012, MICROBES INFECT, V14, P838, DOI 10.1016/j.micinf.2012.05.004; Hayward RE, 2000, MOL MICROBIOL, V35, P6, DOI 10.1046/j.1365-2958.2000.01730.x; HIGASHIJIMA T, 1990, J BIOL CHEM, V265, P14176; Huber SM, 2004, J BIOL CHEM, V279, P41444, DOI 10.1074/jbc.M407618200; Huber SM, 2012, MICROBES INFECT, V14, P779, DOI 10.1016/j.micinf.2012.04.009; Jameson EE, 2005, J BIOL CHEM, V280, P7712, DOI 10.1074/jbc.M413810200; Kimple AJ, 2011, PHARMACOL REV, V63, P728, DOI 10.1124/pr.110.003038; Kremer K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003213; Kumar A, 2004, J BIOL CHEM, V279, P24255, DOI 10.1074/jbc.M312855200; Lolupiman S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089424; MANSOUR JM, 1989, MOL BIOCHEM PARASIT, V36, P11, DOI 10.1016/0166-6851(89)90195-3; McNamara CW, 2013, NATURE, V504, P248, DOI 10.1038/nature12782; McRobert L, 2008, PLOS BIOL, V6, P1243, DOI 10.1371/journal.pbio.0060139; Miao J, 2013, EXP PARASITOL, V135, P541, DOI 10.1016/j.exppara.2013.09.010; Millholland MG, 2013, CELL HOST MICROBE, V13, P15, DOI 10.1016/j.chom.2012.12.001; Moon RW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000599; Murphy SC, 2006, PLOS MED, V3, P2403, DOI 10.1371/journal.pmed.0030528; Nicastro G, 2015, CURR OPIN STRUC BIOL, V30, P63, DOI 10.1016/j.sbi.2015.01.002; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pantages E, 2000, NEURON, V28, P835, DOI 10.1016/S0896-6273(00)00157-4; Peatey CL, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-134; Salazar E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039769; Schwank S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014470; Scita G, 1999, NATURE, V401, P290, DOI 10.1038/45822; Shields MJ, 2009, BIOCHEMISTRY-US, V48, P10793, DOI 10.1021/bi901074h; Sinha A, 2014, NATURE, V507, P253, DOI 10.1038/nature12970; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Sluyter R, 2004, J BIOL CHEM, V279, P44749, DOI 10.1074/jbc.M405631200; Spork S, 2009, EUKARYOT CELL, V8, P1134, DOI 10.1128/EC.00083-09; Sprague RS, 2011, ACTA PHYSIOL, V202, P285, DOI 10.1111/j.1748-1716.2010.02182.x; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Susa MH, 1992, INT J MOL MED, V3, P115; Tasken K, 2004, PHYSIOL REV, V84, P137, DOI 10.1152/physrev.00021.2003; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Wang JY, 2003, P NATL ACAD SCI USA, V100, P3035, DOI 10.1073/pnas.262792899; Williams M, 2011, MOL BIOCHEM PARASIT, V180, P17, DOI 10.1016/j.molbiopara.2011.07.004	54	10	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0140994	10.1371/journal.pone.0140994	http://dx.doi.org/10.1371/journal.pone.0140994			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540393	Green Submitted, Green Published, gold			2022-12-26	WOS:000364303800007
J	Mahdi, LK; Van der Hoek, MB; Ebrahimie, E; Paton, JC; Ogunniyi, AD				Mahdi, Layla K.; Van der Hoek, Mark B.; Ebrahimie, Esmaeil; Paton, James C.; Ogunniyi, Abiodun D.			Characterization of Pneumococcal Genes Involved in Bloodstream Invasion in a Mouse Model	PLOS ONE			English	Article							SERINE-PROTEASE PRTA; STREPTOCOCCUS-PNEUMONIAE; SURFACE PROTEIN; VIRULENCE PROTEINS; NASOPHARYNGEAL COLONIZATION; CAPSULAR POLYSACCHARIDE; COMPARATIVE EFFICACY; OXIDATIVE STRESS; MICROARRAY DATA; PHASE VARIATION	Streptococcus pneumoniae (the pneumococcus) continues to account for significant morbidity and mortality worldwide, causing life-threatening diseases such as pneumonia, bacteremia and meningitis, as well as less serious infections such as sinusitis, conjunctivitis and otitis media. Current polysaccharide vaccines are strictly serotype-specific and also drive the emergence of non-vaccine serotype strains. In this study, we used microarray analysis to compare gene expression patterns of either serotype 4 or serotype 6A pneumococci in the nasopharynx and blood of mice, as a model to identify genes involved in invasion of blood in the context of occult bacteremia in humans. In this manner, we identified 26 genes that were significantly up-regulated in the nasopharynx and 36 genes that were significantly up-regulated in the blood that were common to both strains. Gene Ontology classification revealed that transporter and DNA binding (transcription factor) activities constitute the significantly different molecular functional categories for genes up-regulated in the nasopharynx and blood. Targeted mutagenesis of selected genes from both niches and subsequent virulence and pathogenesis studies identified the manganese-dependent superoxide dismutase (SodA) as most likely to be essential for colonization, and the cell wall-associated serine protease (PrtA) as important for invasion of blood. This work extends our previous analyses and suggests that both PrtA and SodA warrant examination in future studies aimed at prevention and/or control of pneumococcal disease.	[Mahdi, Layla K.; Paton, James C.; Ogunniyi, Abiodun D.] Univ Adelaide, Sch Biol Sci, Res Ctr Infect Dis, Adelaide, SA, Australia; [Van der Hoek, Mark B.] Univ Adelaide, Adelaide Microarray Ctr, Adelaide, SA, Australia; [Van der Hoek, Mark B.] SA Pathol, Adelaide, SA, Australia; [Ebrahimie, Esmaeil] Univ Adelaide, Sch Biol Sci, Dept Genet & Evolut, Adelaide, SA, Australia	University of Adelaide; University of Adelaide; SA Pathology; University of Adelaide	Ogunniyi, AD (corresponding author), Univ Adelaide, Sch Anim & Vet Sci, Adelaide, SA, Australia.	david.ogunniyi@adelaide.edu.au	Ebrahimie, Esmaeil/AAN-2611-2020; Ebrahimi, Mansour/AAO-9096-2021	Ebrahimie, Esmaeil/0000-0002-4431-2861; Ebrahimi, Mansour/0000-0001-7011-2567; Ogunniyi, Abiodun/0000-0001-9308-5629; Mahdi, Layla/0000-0002-5878-8385	Meningitis Research Foundation [0802.0]; National Health and Medical Research Council of Australia (NHMRC) [565526, 627142]; Wellcome Trust	Meningitis Research Foundation(Meningitis Research Foundation (MRF)); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Meningitis Research Foundation (GB; www.meningitis.org) Research Grant 0802.0 to ADO, JCP and LKM, as well as by National Health and Medical Research Council of Australia (NHMRC; http://www.nhmrc.gov.au) Program Grant 565526 to JCP, a Senior Principal Research Fellow, and Project Grant 627142 to JCP and ADO. The authors acknowledge B mu G@S (the Bacterial Microarray Group at St George's, University of London; www.bugs.sgul.ac.uk) for supply of the microarray slides and advice and The Wellcome Trust for funding the multi-collaborative microbial pathogen microarray facility under its Functional Genomics Resources Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamou JE, 2001, INFECT IMMUN, V69, P949, DOI 10.1128/IAI.69.2.949-958.2001; ARTHUR M, 1995, GENE, V154, P87, DOI 10.1016/0378-1119(94)00851-I; Balachandran P, 2002, INFECT IMMUN, V70, P2526, DOI 10.1128/IAI.70.5.2526-2534.2002; Berry AM, 2000, INFECT IMMUN, V68, P133, DOI 10.1128/IAI.68.1.133-140.2000; Bethe G, 2001, FEMS MICROBIOL LETT, V205, P99, DOI 10.1016/S0378-1097(01)00453-0; Briles DE, 2005, INFECT IMMUN, V73, P6945, DOI 10.1128/IAI.73.10.6945-6951.2005; Briles DE, 2003, J INFECT DIS, V188, P339, DOI 10.1086/376571; Brooks-Walter A, 1999, INFECT IMMUN, V67, P6533; Brown JS, 2001, INFECT IMMUN, V69, P6702, DOI 10.1128/IAI.69.11.6702-6706.2001; Brueggemann AB, 2007, PLOS PATHOG, V3, P1628, DOI 10.1371/journal.ppat.0030168; de Stoppelaar SF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080062; Eijkelkamp BA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089427; Fox RJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-126; Fruzangohar M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058759; Giefing C, 2008, J EXP MED, V205, P117, DOI 10.1084/jem.20071168; Hamel J, 2004, INFECT IMMUN, V72, P2659, DOI 10.1128/IAI.72.5.2659-2670.2004; Hammerschmidt S, 1997, MOL MICROBIOL, V25, P1113, DOI 10.1046/j.1365-2958.1997.5391899.x; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.03106.x; Hendriksen WT, 2009, MICROBIOL-SGM, V155, P1569, DOI 10.1099/mic.0.025072-0; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; Iannelli F, 2004, INFECT IMMUN, V72, P3077, DOI 10.1128/IAI.72.5.3077-3080.2004; Kim JO, 1998, J INFECT DIS, V177, P368, DOI 10.1086/514205; Kuppermann N, 1999, PEDIATR CLIN N AM, V46, P1073, DOI 10.1016/S0031-3955(05)70176-0; Kwon HY, 2004, INFECT IMMUN, V72, P5646, DOI 10.1128/IAI.72.10.5646-5653.2004; LeMessurier KS, 2006, MICROBIOL-SGM, V152, P305, DOI 10.1099/mic.0.28438-0; LOCK RA, 1988, MICROB PATHOGENESIS, V5, P461, DOI 10.1016/0882-4010(88)90007-1; LOCK RA, 1992, MICROB PATHOGENESIS, V12, P137, DOI 10.1016/0882-4010(92)90116-6; Mahdi LK, 2008, INFECT IMMUN, V76, P646, DOI 10.1128/IAI.01161-07; Mandi LK, 2012, J CLIN INVEST, V122, P2208, DOI 10.1172/JCI45850; McCluskey J, 2004, MOL MICROBIOL, V51, P1661, DOI 10.1111/j.1365-2958.2003.03917.x; Mirza S, 2011, INFECT IMMUN, V79, P2440, DOI 10.1128/IAI.00489-10; Moffitt KL, 2011, CELL HOST MICROBE, V9, P158, DOI 10.1016/j.chom.2011.01.007; Moschioni M, 2012, VACCINE, V30, P1349, DOI 10.1016/j.vaccine.2011.12.080; Ogunniyi AD, 2007, INFECT IMMUN, V75, P1843, DOI 10.1128/IAI.01384-06; Ogunniyi AD, 2007, INFECT IMMUN, V75, P350, DOI 10.1128/IAI.01103-06; Ogunniyi AD, 2012, INFECT IMMUN, V80, P3268, DOI 10.1128/IAI.00295-12; Ogunniyi AD, 2010, J BACTERIOL, V192, P4489, DOI 10.1128/JB.00064-10; Ogunniyi AD, 2000, INFECT IMMUN, V68, P3028, DOI 10.1128/IAI.68.5.3028-3033.2000; Orihuela CJ, 2009, J CLIN INVEST, V119, P1638, DOI 10.1172/JCI36759; Orihuela CJ, 2004, J INFECT DIS, V190, P1661, DOI 10.1086/424596; Orihuela CJ, 2004, INFECT IMMUN, V72, P5582, DOI 10.1128/IAI.72.10.5582-5596.2004; PATON JC, 1983, INFECT IMMUN, V40, P548, DOI 10.1128/IAI.40.2.548-552.1983; Paton JC, 2004, PNEUMOCCOCUS, P382; Pettigrew MM, 2014, INFECT IMMUN, V82, P4607, DOI 10.1128/IAI.02225-14; Plumptre CD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078916; Rosenow C, 1997, MOL MICROBIOL, V25, P819, DOI 10.1111/j.1365-2958.1997.mmi494.x; Shah P, 2006, INFECT IMMUN, V74, P5888, DOI 10.1128/IAI.00553-06; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; STEPHENS MA, 1974, J AM STAT ASSOC, V69, P730, DOI 10.2307/2286009; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tong HH, 2005, INFECT IMMUN, V73, P7775, DOI 10.1128/IAI.73.11.7775-7778.2005; Weiser JN, 2010, J MOL MED, V88, P97, DOI 10.1007/s00109-009-0557-x; WEISER JN, 1994, INFECT IMMUN, V62, P2582, DOI 10.1128/IAI.62.6.2582-2589.1994; World Health Organization, 2014, ANT RES GLOB REP SUR; World Health Organization Media Centre, 2013, PNEUMONIA; Yesilkaya H, 2000, INFECT IMMUN, V68, P2819, DOI 10.1128/IAI.68.5.2819-2826.2000; Zysk G, 2000, INFECT IMMUN, V68, P3740, DOI 10.1128/IAI.68.6.3740-3743.2000; Zysk G, 2003, J INFECT DIS, V187, P330, DOI 10.1086/367701	60	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141816	10.1371/journal.pone.0141816	http://dx.doi.org/10.1371/journal.pone.0141816			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26539717	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000364303800029
J	Mrakic-Sposta, S; Gussoni, M; Moretti, S; Pratali, L; Giardini, G; Tacchini, P; Dellanoce, C; Tonacci, A; Mastorci, F; Borghini, A; Montorsi, M; Vezzoli, A				Mrakic-Sposta, Simona; Gussoni, Maristella; Moretti, Sarah; Pratali, Lorenza; Giardini, Guido; Tacchini, Philippe; Dellanoce, Cinzia; Tonacci, Alessandro; Mastorci, Francesca; Borghini, Andrea; Montorsi, Michela; Vezzoli, Alessandra			Effects of Mountain Ultra-Marathon Running on ROS Production and Oxidative Damage by Micro-Invasive Analytic Techniques	PLOS ONE			English	Article							ENDURANCE EXERCISE; SKELETAL-MUSCLE; IMMUNE-SYSTEM; REDOX BIOLOGY; STRESS; NITRITE; PLASMA; MECHANISMS; NEOPTERIN; RUN	Purpose Aiming to gain a detailed insight into the physiological mechanisms involved under extreme conditions, a group of experienced ultra-marathon runners, performing the mountain Tor des Geants (R) ultra-marathon: 330 km trail-run in Valle d'Aosta, 24000 m of positive and negative elevation changes, was monitored. ROS production rate, antioxidant capacity, oxidative damage and inflammation markers were assessed, adopting micro-invasive analytic techniques. Methods Forty-six male athletes (45.04 +/- 8.75 yr, 72.6 +/- 8.4 kg, 1.76 +/- 0.05 m) were tested. Capillary blood and urine were collected before (Pre-), in the middle (Middle-) and immediately after (Post-) Race. Samples were analyzed for: Reactive Oxygen Species (ROS) production by Electron Paramagnetic Resonance; Antioxidant Capacity by Electrochemistry; oxidative damage (8-hydroxy-2-deoxy Guanosine: 8-OH-dG; 8-isoprostane: 8-isoPGF2 alpha) and nitric oxide metabolites by enzymatic assays; inflammatory biomarkers (plasma and urine interleukin-6: IL-6-P and IL-6-U) by enzyme-linked immunosorbent assays (ELISA); Creatinine and Neopterin by HPLC, hematologic (lactate, glucose and hematocrit) and urine parameters by standard analyses. Results Twenty-five athletes finished the race, while twenty-one dropped out of it. A significant increase (Post-Race vs Pre) of the ROS production rate (2.20 +/- 0.27 vs 1.65 +/- 0.22 mu mol. min-1), oxidative damage biomarkers (8-OH-dG: 6.32 +/- 2.38 vs 4.16 +/- 1.25 ng.mg(-1) Creatinine and 8-isoPGF2 alpha: 1404.0 +/- 518.30 vs 822.51 +/- 448.91 pg.mg(-1)Creatinine), inflammatory state (IL-6-P: 66.42 +/- 36.92 vs 1.29 +/- 0.54 pg.mL(-1) and IL-6-U: 1.33 +/- 0.56 vs 0.71 +/- 0.17 pg.mL(-1)) and lactate production (+190%), associated with a decrease of both antioxidant capacity (-7%) and renal function (i.e. Creatinine level +76%) was found. Conclusions The used micro-invasive analytic methods allowed us to perform most of them before, during and immediately after the race directly in the field, by passing the need of storing and transporting samples for further analysis. Considered altogether the investigated variables showed up that exhaustive and prolonged exercise not only promotes the generation of ROS but also induces oxidative stress, transient renal impairment and inflammation.	[Mrakic-Sposta, Simona; Moretti, Sarah; Vezzoli, Alessandra] CNR, Inst Bioimaging & Mol Physiol, I-20133 Milan, Italy; [Gussoni, Maristella] Univ Milan, Dept Pathophysiol & Transplantat, Physiol Sect, Milan, Italy; [Pratali, Lorenza; Dellanoce, Cinzia; Tonacci, Alessandro; Mastorci, Francesca; Borghini, Andrea] CNR, Inst Clin Physiol, I-56100 Pisa, Italy; [Giardini, Guido] Valle dAosta Reg Hosp Umberto Parini, Neurol & Neurophysiol Dept, Mt Med Ctr, Aosta, Italy; [Tacchini, Philippe] EDEL Therapeut SA, PSE EPFL B, CH-1015 Lausanne, Switzerland; [Montorsi, Michela] Univ Telemat S Raffaele Roma, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); University of Milan; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); Universita Telematica San Raffaele	Vezzoli, A (corresponding author), CNR, Inst Bioimaging & Mol Physiol, I-20133 Milan, Italy.	alessandra.vezzoli@ibfm.cnr.it	Montorsi, Michela/K-7299-2016; moretti, sarah/K-9953-2016; Mrakic-Sposta, Simona/AAA-2991-2019; Tonacci, Alessandro/J-7996-2016; Pratali, Lorenza/AAQ-6094-2020	Montorsi, Michela/0000-0001-5152-761X; moretti, sarah/0000-0002-4260-7404; Mrakic-Sposta, Simona/0000-0001-7359-2690; Tonacci, Alessandro/0000-0001-8335-5541; Borghini, Andrea/0000-0003-1061-8309				Bailey DM, 2007, FREE RADICAL RES, V41, P182, DOI 10.1080/10715760601028867; Basu S, 2008, ANTIOXID REDOX SIGN, V10, P1405, DOI 10.1089/ars.2007.1956; Brun JF, 2010, BIORHEOLOGY, V47, P95, DOI 10.3233/BIR-2010-0563; Collins Y, 2012, J CELL SCI, V125, P801, DOI 10.1242/jcs.098475; Comassi M, 2015, INTERN MED J, V45, P74, DOI 10.1111/imj.12625; Degache F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084554; Dejam A, 2005, BLOOD, V106, P734, DOI 10.1182/blood-2005-02-0567; Dikalov SI, 2002, ARCH BIOCHEM BIOPHYS, V402, P218, DOI 10.1016/S0003-9861(02)00064-4; Febbraio MA, 2002, FASEB J, V16, P1335, DOI 10.1096/fj.01-0876rev; Fernstrom M, 2007, J APPL PHYSIOL, V102, P1844, DOI 10.1152/japplphysiol.01173.2006; Finaud J, 2006, SPORTS MED, V36, P327, DOI 10.2165/00007256-200636040-00004; Gomes EC, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/756132; Halliwell B., 2007, FREE RADICALS BIOL M; HOLLEY AE, 1993, BRIT MED BULL, V49, P494, DOI 10.1093/oxfordjournals.bmb.a072626; HUBER C, 1984, J EXP MED, V160, P310, DOI 10.1084/jem.160.1.310; KANTER MM, 1993, J APPL PHYSIOL, V74, P965, DOI 10.1152/jappl.1993.74.2.965; Keller C, 2001, FASEB J, V15, P2748, DOI 10.1096/fj.01-0507fje; Klapcinska B, 2013, EUR J APPL PHYSIOL, V113, P2781, DOI 10.1007/s00421-013-2714-8; Larsen FJ, 2012, FREE RADICAL BIO MED, V53, P1919, DOI 10.1016/j.freeradbiomed.2012.08.580; Lippi G, 2012, BLOOD TRANSFUS-ITALY, V10, P377, DOI 10.2450/2012.0167-11; Liu JF, 2005, ANAL CHEM, V77, P7687, DOI 10.1021/ac0509298; Liu JF, 2006, ANAL CHEM, V78, P6879, DOI 10.1021/ac0608624; Liu ML, 1999, AM J PHYSIOL-ENDOC M, V276, pE1083, DOI 10.1152/ajpendo.1999.276.6.E1083; Michailidis Y, 2007, MED SCI SPORT EXER, V39, P1107, DOI 10.1249/01.mss.0b013e318053e7ba; Mrakic-Sposta S, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/804794; Mrakic-Sposta S, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/306179; Mrakic-Sposta S, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/973927; Murr C, 2002, CURR DRUG METAB, V3, P175, DOI 10.2174/1389200024605082; Nieman DC, 2003, INT J SPORTS MED, V24, P541; Nikolaidis MG, 2008, SPORTS MED, V38, P579, DOI 10.2165/00007256-200838070-00005; Nikolaidis MG, 2012, J EXP BIOL, V215, P1615, DOI 10.1242/jeb.067470; Nyska A, 2002, TOXICOL PATHOL, V30, P620, DOI 10.1080/01926230290166724; Ostrowski K, 2000, EUR J APPL PHYSIOL, V83, P512, DOI 10.1007/s004210000312; Pedersen BK, 2000, PHYSIOL REV, V80, P1055, DOI 10.1152/physrev.2000.80.3.1055; POORTMANS JR, 1984, SPORTS MED, V1, P125, DOI 10.2165/00007256-198401020-00003; Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007; Radak Z, 2003, EUR J CLIN INVEST, V33, P726, DOI 10.1046/j.1365-2362.2003.01202.x; Reichhold S, 2009, MUTAT RES-REV MUTAT, V682, P28, DOI 10.1016/j.mrrev.2009.02.002; REID RI, 1987, BRIT J UROL, V59, P133, DOI 10.1111/j.1464-410X.1987.tb04803.x; Robach P, 2014, SCAND J MED SCI SPOR, V24, P18, DOI 10.1111/j.1600-0838.2012.01481.x; Rodriguez-Plaza L G, 1997, J Cardiovasc Risk, V4, P367, DOI 10.1097/00043798-199710000-00009; Sajfutdinov R.G., 2001, ELECT PARAMAGNETIC R; Scotney B, 2014, CLIN J SPORT MED; Shao ZL, 2014, AM J CARDIOL, V113, P1839, DOI 10.1016/j.amjcard.2014.03.016; Steensberg A, 2002, EUR J APPL PHYSIOL, V87, P38, DOI 10.1007/s00421-002-0584-6; Steinbacher P, 2015, BIOMOLECULES, V5, P356, DOI 10.3390/biom5020356; Sugama K, 2015, EXERC IMMUNOL REV, V21, P130; Sugama K, 2013, EXERC IMMUNOL REV, V19, P29; Tacchini P, 2013, ELECTROANAL, V25, P922, DOI 10.1002/elan.201200590; Totzeck M, 2012, NITRIC OXIDE-BIOL CH, V27, P75, DOI 10.1016/j.niox.2012.05.003; Tsikas D, 2005, FREE RADICAL RES, V39, P797, DOI 10.1080/10715760500053651; TSIKAS D, 1994, J CHROMATOGR B, V661, P185, DOI 10.1016/0378-4347(94)00374-2; Turner JE, 2014, BIOCHEM SOC T, V42, P989, DOI 10.1042/BST20140120; Turner JE, 2011, MED SCI SPORT EXER, V43, P1770, DOI 10.1249/MSS.0b013e31821240bb; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Vassalle C, 2014, BIOMARK MED, V8, P881, DOI [10.2217/BMM.13.152, 10.2217/bmm.13.152]	56	68	69	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141780	10.1371/journal.pone.0141780	http://dx.doi.org/10.1371/journal.pone.0141780			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540518	gold, Green Submitted, Green Published			2022-12-26	WOS:000364303800028
J	Siman, R; Cocca, R; Dong, Y				Siman, Robert; Cocca, Ryan; Dong, Yina			The mTOR Inhibitor Rapamycin Mitigates Perforant Pathway Neurodegeneration and Synapse Loss in a Mouse Model of Early-Stage Alzheimer-Type Tauopathy	PLOS ONE			English	Article							ENTORHINAL CORTEX NEURONS; MAMMALIAN TARGET; MEMORY IMPAIRMENT; IN-VITRO; TAU; AUTOPHAGY; DISEASE; PATHOLOGY; TOXICITY; STIMULATION	The perforant pathway projection from layer II of the entorhinal cortex to the hippocampal dentate gyrus is especially important for long-term memory formation, and is preferentially vulnerable to developing a degenerative tauopathy early in Alzheimer's disease (AD) that may spread over time trans-synaptically. Despite the importance of the perforant pathway to the clinical onset and progression of AD, a therapeutic has not been identified yet that protects it from tau-mediated toxicity. Here, we used an adeno-associated viral vector-based mouse model of early-stage AD-type tauopathy to investigate effects of the mTOR inhibitor and autophagy stimulator rapamycin on the tau-driven loss of perforant pathway neurons and synapses. Focal expression of human tau carrying a P301L mutation but not eGFP as a control in layer II of the lateral entorhinal cortex triggered rapid degeneration of these neurons, loss of lateral perforant pathway synapses in the dentate gyrus outer molecular layer, and activation of neuroinflammatory microglia and astroglia in the two locations. Chronic systemic rapamycin treatment partially inhibited phosphorylation of a mechanistic target of rapamycin substrate in brain and stimulated LC3 cleavage, a marker of autophagic flux. Compared with vehicle-treated controls, rapamycin protected against the tau-induced neuronal loss, synaptotoxicity, reactive microgliosis and astrogliosis, and activation of innate neuroimmunity. It did not alter human tau mRNA or total protein levels. Finally, rapamycin inhibited trans-synaptic transfer of human tau expression to the dentate granule neuron targets for the perforant pathway, likely by preventing the synaptic spread of the AAV vector in response to pathway degeneration. These results identify systemic rapamycin as a treatment that protects the entorhinal cortex and perforant pathway projection from tau-mediated neurodegeneration, axonal and synapse loss, and neuroinflammatory reactive gliosis. The findings support the potential for slowing the progression of AD by abrogating tau-mediated neurotoxicity at its earliest neuropathological stages.	[Siman, Robert; Cocca, Ryan; Dong, Yina] Univ Penn, Perelman Sch Med, Ctr Brain Injury & Repair, Dept Neurosurg, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Siman, R (corresponding author), Univ Penn, Perelman Sch Med, Ctr Brain Injury & Repair, Dept Neurosurg, Philadelphia, PA 19104 USA.	siman@mail.med.upenn.edu			Alzheimer's Association [ZEN-12-239284]; NIH [DK019525]	Alzheimer's Association(Alzheimer's Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was funded by a grant from the Alzheimer's Association to RS (ZEN-12-239284). The Penn Viral Vector Core facility generated, purified, sequenced, and titrated the AAV vectors. The Core is supported in part by NIH grant DK019525 to Dr. Mitchell Lazar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA H, 1990, J NEUROIMMUNOL, V30, P81, DOI 10.1016/0165-5728(90)90055-R; Amaral DaL P, 2007, HIPPOCAMPUS BOOK, P37; Ashe KH, 2010, NEURON, V66, P631, DOI 10.1016/j.neuron.2010.04.031; Bove J, 2011, NAT REV NEUROSCI, V12, P437, DOI 10.1038/nrn3068; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Caccamo A, 2014, J NEUROSCI, V34, P7988, DOI 10.1523/JNEUROSCI.0777-14.2014; COLEMAN PD, 1987, J COMP NEUROL, V266, P300, DOI 10.1002/cne.902660213; Congdon EE, 2012, AUTOPHAGY, V8, P609, DOI 10.4161/auto.19048; Cortes CJ, 2012, J NEUROSCI, V32, P12396, DOI 10.1523/JNEUROSCI.6189-11.2012; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Dehay B, 2010, J NEUROSCI, V30, P12535, DOI 10.1523/JNEUROSCI.1920-10.2010; EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X; Fath T, 2002, J NEUROSCI, V22, P9733; Gertig U, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00101; GomezIsla T, 1996, J NEUROSCI, V16, P4491; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; HYMAN BT, 1984, SCIENCE, V225, P1168, DOI 10.1126/science.6474172; HYMAN BT, 1986, ANN NEUROL, V20, P472, DOI 10.1002/ana.410200406; Jaturapatporn D, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006378.pub2; Jiang T, 2014, NEUROPHARMACOLOGY, V85, P121, DOI 10.1016/j.neuropharm.2014.05.032; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Kirkby DL, 1998, EUR J NEUROSCI, V10, P823, DOI 10.1046/j.1460-9568.1998.00087.x; Kordower JH, 2001, ANN NEUROL, V49, P202, DOI 10.1002/1531-8249(20010201)49:2<202::AID-ANA40>3.3.CO;2-V; Kraemer BC, 2003, P NATL ACAD SCI USA, V100, P9980, DOI 10.1073/pnas.1533448100; Lee VMY, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006437; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; MATTHEWS DA, 1976, BRAIN RES, V115, P23, DOI 10.1016/0006-8993(76)90820-9; McGeer EG, 2003, PROG NEURO-PSYCHOPH, V27, P741, DOI 10.1016/S0278-5846(03)00124-6; McLeland CB, 2011, METHODS MOL BIOL, V697, P199, DOI 10.1007/978-1-60327-198-1_21; Meikle L, 2008, J NEUROSCI, V28, P5422, DOI 10.1523/JNEUROSCI.0955-08.2008; Menzies FM, 2010, BRAIN, V133, P93, DOI 10.1093/brain/awp292; Nixon RA, 2011, NEUROBIOL DIS, V43, P38, DOI 10.1016/j.nbd.2011.01.021; Ozcelik S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062459; Page G, 2006, NEUROCHEM INT, V49, P413, DOI 10.1016/j.neuint.2006.01.020; PEARSON RCA, 1985, P NATL ACAD SCI USA, V82, P4531, DOI 10.1073/pnas.82.13.4531; Price JL, 2001, ARCH NEUROL-CHICAGO, V58, P1395, DOI 10.1001/archneur.58.9.1395; Ramsden M, 2005, J NEUROSCI, V25, P10637, DOI 10.1523/JNEUROSCI.3279-05.2005; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Robinson JL, 2014, BRAIN, V137, P2578, DOI 10.1093/brain/awu190; Schaeffer V, 2012, BRAIN, V135, P2169, DOI 10.1093/brain/aws143; Scheff SW, 2006, NEUROBIOL AGING, V27, P1372, DOI 10.1016/j.neurobiolaging.2005.09.012; Schneider A, 2008, NEUROTHERAPEUTICS, V5, P443, DOI 10.1016/j.nurt.2008.05.006; Schultz H, 2012, J NEUROSCI, V32, P4716, DOI 10.1523/JNEUROSCI.5126-11.2012; Siman R, 2004, NEUROSCIENCE, V129, P615, DOI 10.1016/j.neuroscience.2004.08.028; Siman R, 2013, J NEUROPATH EXP NEUR, V72, P1062, DOI 10.1097/NEN.0000000000000006; Spilman P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009979; Spires TL, 2006, AM J PATHOL, V168, P1598, DOI 10.2353/ajpath.2006.050840; Squire LR, 2007, NAT REV NEUROSCI, V8, P872, DOI 10.1038/nrn2154; STAUBLI U, 1984, P NATL ACAD SCI-BIOL, V81, P5885, DOI 10.1073/pnas.81.18.5885; Tanaka M, 2004, NAT MED, V10, P148, DOI 10.1038/nm985; Tanemura K, 2002, J NEUROSCI, V22, P133, DOI 10.1523/JNEUROSCI.22-01-00133.2002; TIMM F, 1958, Z ZELLFORSCH MIK ANA, V48, P548, DOI 10.1007/BF00342730; Viscomi MT, 2012, AUTOPHAGY, V8, P222, DOI 10.4161/auto.8.2.18599; Wang IF, 2012, P NATL ACAD SCI USA, V109, P15024, DOI 10.1073/pnas.1206362109; Ward SM, 2012, BIOCHEM SOC T, V40, P667, DOI 10.1042/BST20120134; Wischik CM, 1996, P NATL ACAD SCI USA, V93, P11213, DOI 10.1073/pnas.93.20.11213; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382; Zhang C, 2007, EXP NEUROL, V204, P77, DOI 10.1016/j.expneurol.2006.09.018	59	85	86	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142340	10.1371/journal.pone.0142340	http://dx.doi.org/10.1371/journal.pone.0142340			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540269	gold, Green Submitted, Green Published			2022-12-26	WOS:000364303800086
J	Wang, J; Jiang, ZL; Lam, W; Gullen, EA; Yu, Z; Wei, Y; Wang, LH; Zeiss, C; Beck, A; Cheng, EC; Wu, CF; Cheng, YC; Zhang, YX				Wang, Jing; Jiang, Zaoli; Lam, Wing; Gullen, Elizabeth A.; Yu, Zhe; Wei, Ying; Wang, Lihui; Zeiss, Caroline; Beck, Amanda; Cheng, Ee-Chun; Wu, Chunfu; Cheng, Yung-Chi; Zhang, Yixuan			Study of Malformin C, a Fungal Source Cyclic Pentapeptide, as an Anti-Cancer Drug	PLOS ONE			English	Article							DNA-DAMAGE; CELLS; TROXACITABINE; ACTIVATION; METABOLITE; EXPRESSION; CANCER; KINASE	Malformin C, a fungal cyclic pentapeptide, has been claimed to have anti-cancer potential, but no in vivo study was available to substantiate this property. Therefore, we conducted in vitro and in vivo experiments to investigate its anti-cancer effects and toxicity. Our studies showed Malformin C inhibited Colon 38 and HCT 116 cell growth dose-dependently with an IC50 of 0.27 +/- 0.07 mu M and 0.18 +/- 0.023 mu M respectively. This inhibition was explicated by Malformin C's effect on G2/M arrest. Moreover, we observed up-regulated expression of phospho-histone H2A.X, p53, cleaved CASPASE 3 and LC3 after Malformin C treatment, while the apoptosis assay indicated an increased population of necrotic and late apoptotic cells. In vivo, the pathological study exhibited the acute toxicity of Malformin C at lethal dosage in BDF1 mice might be caused by an acute yet subtle inflammatory response, consistent with elevated IL-6 in the plasma cytokine assay. Further anti-tumor and toxicity experiments proved that 0.3mg/kg injected weekly was the best therapeutic dosage of Malformin C in Colon 38 xenografted BDF1 mice, whereas 0.1mg/kg every other day showed no effect with higher resistance, and 0.9mg/kg per week either led to fatal toxicity in seven-week old mice or displayed no advantage over 0.3mg/kg group in nine-week old mice. Overall, we conclude that Malformin C arrests Colon 38 cells in G2/M phase and induces multiple forms of cell death through necrosis, apoptosis and autophagy. Malformin C has potent cell growth inhibition activity, but the therapeutic index is too low to be an anti-cancer drug.	[Wang, Jing; Jiang, Zaoli; Lam, Wing; Gullen, Elizabeth A.; Cheng, Ee-Chun; Cheng, Yung-Chi] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Yu, Zhe; Wei, Ying; Wang, Lihui; Wu, Chunfu; Zhang, Yixuan] Shenyang Pharmaceut Univ, Sch Life Sci & Biopharmaceut, Shenyang, Peoples R China; [Zeiss, Caroline; Beck, Amanda] Yale Univ, Sch Med, Comparat Med Sect, New Haven, CT 06510 USA; [Wang, Jing] Beijing Univ Chinese Med, Dept Hematol & Oncol, Dongzhimen Hosp, Beijing, Peoples R China	Yale University; Shenyang Pharmaceutical University; Yale University; Beijing University of Chinese Medicine	Cheng, YC (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA.	yccheng@yale.edu; zhangyxzsh@163.com	Beck, Amanda P/H-9573-2017	Beck, Amanda P/0000-0003-1867-4110; Wang, Jing/0000-0002-2735-7283	NCI [CA-154295]; Yung-Chi Cheng's lab at Yale University; NATIONAL CANCER INSTITUTE [P01CA154295] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Yung-Chi Cheng's lab at Yale University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Yung-Chi Cheng is a Fellow of the National Foundation for Cancer Research, USA. Part of his salary is from the NCI grant from CA-154295. Most of the research support is funded by a trust fund to Yung-Chi Cheng's lab at Yale University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderegg RJ, 1976, J AM CHEM SOC, V26, P6; Beidler DR, 1996, CANCER RES, V56, P9; BODANSZK.M, 1974, P NATL ACAD SCI USA, V71, P2791, DOI 10.1073/pnas.71.7.2791; Chen HX, 1993, CANCER RES, V53, P4; CURTIS RW, 1958, PLANT PHYSIOL, V33, P17, DOI 10.1104/pp.33.1.17; CURTIS RW, 1958, SCIENCE, V128, P661, DOI 10.1126/science.128.3325.661; Ferguson PJ, 1988, CANCER RES, V48, P9; Gaj CL, 1998, BIOCHEM PHARMACOL, V55, P13; Gao W, 2011, CELL DEATH DIFFER, V18, P1598, DOI 10.1038/cdd.2011.33; Gao WL, 2004, CANCER RES, V64, P678, DOI 10.1158/0008-5472.CAN-03-1904; Giles FJ, 2002, J CLIN ONCOLOGY OFFI, V20, P8; Grove KL, 1996, CANCER RES, V56, P5; Hagimori K, 2007, BIOL PHARM BULL, V30, P1379, DOI 10.1248/bpb.30.1379; Harrington HA, 2008, THEOR BIOL MED MODEL, V5, DOI 10.1186/1742-4682-5-26; HERBERT JM, 1994, BIOCHEM PHARMACOL, V48, P1211, DOI 10.1016/0006-2952(94)90158-9; JOHN WW, 1974, EXPERIENTIA, V30, P1392, DOI 10.1007/BF01919652; KIM KW, 1993, BIOSCI BIOTECH BIOCH, V57, P787, DOI 10.1271/bbb.57.787; KOBBE B, 1977, APPL ENVIRON MICROB, V33, P996, DOI 10.1128/AEM.33.4.996-997.1977; Koizumi Y, 2002, J ANTIBIOT, V55, P78, DOI 10.7164/antibiotics.55.78; Koizumi Y, 2011, BIOL PHARM BULL, V34, P1426, DOI 10.1248/bpb.34.1426; Kojima Y, 2008, J ANTIBIOT, V61, P297, DOI 10.1038/ja.2008.42; Kojima Y, 2009, J ANTIBIOT, V62, P681, DOI 10.1038/ja.2009.100; Lam W, 2009, MOL CANCER THER, V8, P415, DOI 10.1158/1535-7163.MCT-08-0692; Lapointe R, 2005, ANN ONCOL, V16, P289, DOI 10.1093/annonc/mdi061; Lee Y, 2004, J MED CHEM, V47, P5555, DOI 10.1021/jm049949c; Medema RH, 2012, ONCOGENE, V31, P2601, DOI 10.1038/onc.2011.451; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Morimoto-Tomita M, 2005, CLIN EXP METASTAS, V22, P513, DOI 10.1007/s10585-005-3585-0; Park SY, 2002, CANCER RES, V62, P7; Rodriguez-Rocha H, 2011, MUTAT RES-FUND MOL M, V711, P158, DOI 10.1016/j.mrfmmm.2011.03.007; Rufini A, 2013, ONCOGENE, V32, P5129, DOI 10.1038/onc.2012.640; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; SUDA S, 1966, APPL MICROBIOL, V14, P475, DOI 10.1128/AEM.14.3.475-476.1966; Wahl GM, 2001, NAT CELL BIOL, V3, pE277, DOI 10.1038/ncb1201-e277; Yuan JS, 2010, FEBS LETT, V584, P3717, DOI 10.1016/j.febslet.2010.05.021; Zhan JX, 2007, PHYTOCHEMISTRY, V68, P368, DOI 10.1016/j.phytochem.2006.09.038	36	15	27	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0140069	10.1371/journal.pone.0140069	http://dx.doi.org/10.1371/journal.pone.0140069			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540166	gold, Green Published, Green Submitted			2022-12-26	WOS:000364303800003
J	Allie, E; Pelissier, R; Engel, J; Petronelli, P; Freycon, V; Deblauwe, V; Soucemarianadin, L; Weigel, J; Baraloto, C				Allie, Elodie; Pelissier, Raphael; Engel, Julien; Petronelli, Pascal; Freycon, Vincent; Deblauwe, Vincent; Soucemarianadin, Laure; Weigel, Jean; Baraloto, Christopher			Pervasive Local-Scale Tree-Soil Habitat Association in a Tropical Forest Community	PLOS ONE			English	Article							RAIN-FOREST; FUNCTIONAL TRAITS; SPATIAL VARIATION; PLANT DIVERSITY; HETEROGENEITY; DISTRIBUTIONS; GRADIENT; AMAZON; TOPOGRAPHY; DISPERSAL	We examined tree-soil habitat associations in lowland forest communities at Paracou, French Guiana. We analyzed a large dataset assembling six permanent plots totaling 37.5 ha, in which extensive LIDAR-derived topographical data and soil chemical and physical data have been integrated with precise botanical determinations. Map of relative elevation from the nearest stream summarized both soil fertility and hydromorphic characteristics, with seasonally inundated bottomlands having higher soil phosphate content and base saturation, and plateaus having higher soil carbon, nitrogen and aluminum contents. We employed a statistical test of correlations between tree species density and environmental maps, by generating Monte Carlo simulations of random raster images that preserve auto-correlation of the original maps. Nearly three fourths of the 94 taxa with at least one stem per ha showed a significant correlation between tree density and relative elevation, revealing contrasted species-habitat associations in term of abundance, with seasonally inundated bottomlands (24.5% of species) and well-drained plateaus (48.9% of species). We also observed species preferences for environments with or without steep slopes (13.8% and 10.6%, respectively). We observed that closely-related species were frequently associated with different soil habitats in this region (70% of the 14 genera with congeneric species that have a significant association test) suggesting species-habitat associations have arisen multiple times in this tree community. We also tested if species with similar habitat preferences shared functional strategies. We found that seasonally inundated forest specialists tended to have smaller stature (maximum diameter) than species found on plateaus. Our results underline the importance of tree-soil habitat associations in structuring diverse communities at fine spatial scales and suggest that additional studies are needed to disentangle community assembly mechanisms related to dispersal limitation, biotic interactions and environmental filtering from species-habitat associations. Moreover, they provide a framework to generalize across tropical forest sites.	[Allie, Elodie] Univ Antilles Guyane, UMR EcoFoG, Kourou, France; [Pelissier, Raphael] IRD, UMR AMAP, Montpellier, France; [Engel, Julien] CNRS, UMR EcoFoG, Kourou, France; [Petronelli, Pascal; Soucemarianadin, Laure] Cirad, UMR EcoFoG, Kourou, France; [Freycon, Vincent] Cirad, UPR BSEF, Montpellier, France; [Deblauwe, Vincent] UMR Diade, Montpellier, France; [Weigel, Jean] AgroParisTech, UMR EcoFoG, Kourou, France; [Baraloto, Christopher] INRA, UMR EcoFoG, Kourou, France; [Baraloto, Christopher] Florida Int Univ, Dept Biol Sci, Int Ctr Trop Bot, Miami, FL 33199 USA	AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; CIRAD; Universite de Montpellier; AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; INRAE; State University System of Florida; Florida International University	Allie, E (corresponding author), Univ Antilles Guyane, UMR EcoFoG, Kourou, France.	elodie.allie@ecofog.gf	Deblauwe, Vincent/E-5683-2010; Pélissier, Raphaël/C-1224-2008; Baraloto, Christopher/ABG-2500-2020; Soucemarianadin, Laure N./E-2978-2019	Deblauwe, Vincent/0000-0001-9881-1052; Pélissier, Raphaël/0000-0003-4845-5090; Baraloto, Christopher/0000-0001-7322-8581; Soucemarianadin, Laure N./0000-0002-9340-3268; Allie, Elodie/0000-0001-8807-7982; Engel, Julien/0000-0002-8078-9309	European Social Fund; French Guiana region; Centre National d'Etudes Spatiales (CNES); Universite des Antilles et de la Guyane; "Investissement d'Avenir" grant Agence Nationale de la Recherche (CEBA) [ANR-10-LABX-25-01]	European Social Fund(European Social Fund (ESF)); French Guiana region; Centre National d'Etudes Spatiales (CNES)(Centre National D'etudes Spatiales); Universite des Antilles et de la Guyane; "Investissement d'Avenir" grant Agence Nationale de la Recherche (CEBA)(French National Research Agency (ANR))	This study was carried out within the framework of EA's PhD project co-funded by European Social Fund, French Guiana region, Centre National d'Etudes Spatiales (CNES) and Universite des Antilles et de la Guyane. It is a contribution to Centre d'Etude de la Biodiversite Amazonienne (CEBA) biodiscovery program funded by an "Investissement d'Avenir" grant Agence Nationale de la Recherche (CEBA, ANR-10-LABX-25-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, HEXAGON BINNING OVER; Bagchi R, 2014, NATURE, V506, P85, DOI 10.1038/nature12911; Baldeck CA, 2013, OECOLOGIA, V173, P1491, DOI 10.1007/s00442-013-2709-5; Baldwin DS, 2000, REGUL RIVER, V16, P457, DOI 10.1002/1099-1646(200009/10)16:5&lt;457::AID-RRR597&gt;3.0.CO;2-B; Baraloto C, 2004, OECOLOGIA, V141, P701, DOI 10.1007/s00442-004-1691-3; Baraloto C, 2007, ECOLOGY, V88, P478, DOI 10.1890/0012-9658(2007)88[478:SWSTAH]2.0.CO;2; Baraloto C, 2012, J ECOL, V100, P690, DOI 10.1111/j.1365-2745.2012.01966.x; Bivand R, 2013, R PACKAGE VERSION, V1; Boehner J, 2006, GOETTINGER GEOGRAPHI, P130; Bohlman SA, 2008, J VEG SCI, V19, P863, DOI 10.3170/2008-8-18463; Bohner J., 2006, GOTTINGER GEOGRAPHIS, V115, P13; Bonal D, 2000, OECOLOGIA, V124, P454, DOI 10.1007/PL00008871; Brown C, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0502; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Comita LS, 2010, SCIENCE, V329, P330, DOI 10.1126/science.1190772; Comita LS, 2009, ECOLOGY, V90, P2755, DOI 10.1890/08-1482.1; Condit R, 2000, SCIENCE, V288, P1414, DOI 10.1126/science.288.5470.1414; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; Couteron P, 2003, FOREST ECOL MANAG, V172, P89, DOI 10.1016/S0378-1127(02)00310-9; Daws MI, 2002, PLANT SOIL, V238, P79, DOI 10.1023/A:1014289930621; Deblauwe V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048766; Dray S, 2012, ECOL MONOGR, V82, P257, DOI 10.1890/11-1183.1; Engelbrecht BMJ, 2007, NATURE, V447, P80, DOI 10.1038/nature05747; Epron D, 2006, J TROP ECOL, V22, P565, DOI 10.1017/S0266467406003415; FAO, 2020, SOILS PORTAL WORLD R; Ferry B, 2010, J ECOL, V98, P106, DOI 10.1111/j.1365-2745.2009.01604.x; Fine PVA, 2006, AM NAT, V168, P796, DOI 10.1086/508635; Fine PVA, 2006, ECOLOGY, V87, pS150, DOI 10.1890/0012-9658(2006)87[150:TGTAHS]2.0.CO;2; Fine PVA, 2014, EVOLUTION, V68, P1988, DOI 10.1111/evo.12414; Fortunel C, 2014, NEW PHYTOL, V202, P79, DOI 10.1111/nph.12632; Garzon-Lopez CX, 2014, J VEG SCI, V25, P349, DOI 10.1111/jvs.12090; Gruber S, 2009, DEV SOIL SCI, V33, P171, DOI 10.1016/S0166-2481(08)00007-X; Guitet S, 2015, BIODIVERS CONSERV, V24, P1215, DOI 10.1007/s10531-014-0854-8; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1111/j.1365-2745.2001.00615.x; Herault B, 2011, J ECOL, V99, P1431, DOI 10.1111/j.1365-2745.2011.01883.x; Hijmans R. J, 2014, GEOGRAPHIC DATA ANAL; HilleRisLambers J, 2012, ANNU REV ECOL EVOL S, V43, P227, DOI 10.1146/annurev-ecolsys-110411-160411; Horn S, 2015, ACTA OECOL, V63, P56, DOI 10.1016/j.actao.2015.01.004; IncTM, 2010, MATLAB; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; Kraft NJB, 2008, SCIENCE, V322, P580, DOI 10.1126/science.1160662; Mangan SA, 2010, NATURE, V466, P752, DOI 10.1038/nature09273; Miyamoto K, 2003, J TROP ECOL, V19, P43, DOI 10.1017/S0266467403003067; Murtaugh PA, 2014, ECOLOGY, V95, P611, DOI 10.1890/13-0590.1; Pelissier R, 2002, PLANT ECOL, V162, P143, DOI 10.1023/A:1020399603500; Phillips OL, 2003, J ECOL, V91, P757, DOI 10.1046/j.1365-2745.2003.00815.x; Pitman NCA, 2001, ECOLOGY, V82, P2101, DOI 10.1890/0012-9658(2001)082[2101:DADOTS]2.0.CO;2; Plotkin JB, 2000, J THEOR BIOL, V207, P81, DOI 10.1006/jtbi.2000.2158; Quesada CA, 2012, BIOGEOSCIENCES, V9, P2203, DOI 10.5194/bg-9-2203-2012; Quesada CA, 2010, BIOGEOSCIENCES, V7, P1515, DOI 10.5194/bg-7-1515-2010; R Core Team, 2021, R LANGUAGE ENV STAT; Renard D., 2014, RGEOSTATS MANUAL; Russo SE, 2010, AM J BOT, V97, P1109, DOI 10.3732/ajb.0900344; Russo SE, 2005, J ECOL, V93, P879, DOI 10.1111/j.1365-2745.2005.01030.x; Sabatier D, 1997, PLANT ECOL, V131, P81, DOI 10.1023/A:1009775025850; Sollins P, 1998, ECOLOGY, V79, P23, DOI 10.1890/0012-9658(1998)079[0023:FISCIT]2.0.CO;2; Swenson NG, 2007, ECOLOGY, V88, P1770, DOI 10.1890/06-1499.1; ter Steege H, 2013, SCIENCE, V342, P325, DOI 10.1126/science.1243092; Townsend AR, 2008, TRENDS ECOL EVOL, V23, P424, DOI 10.1016/j.tree.2008.04.009; Traissac S, 2014, J VEG SCI, V25, P491, DOI 10.1111/jvs.12080; Tuomisto H, 2003, SCIENCE, V299, P241, DOI 10.1126/science.1078037; Uriarte M, 2010, ECOL LETT, V13, P1503, DOI 10.1111/j.1461-0248.2010.01541.x; Valencia R, 2004, J ECOL, V92, P214, DOI 10.1111/j.0022-0477.2004.00876.x; van Scholl L, 2004, FOREST ECOL MANAG, V195, P301, DOI 10.1016/j.foreco.2004.03.020; Vincent G, 2011, ANN FOREST SCI, V68, P357, DOI 10.1007/s13595-011-0024-z; Vleminckx J, 2015, J VEG SCI, V26, P134, DOI 10.1111/jvs.12209; WEIHER E, 1995, OIKOS, V74, P159, DOI 10.2307/3545686; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809; Xia SW, 2015, PLANT SOIL, V391, P51, DOI 10.1007/s11104-015-2402-z	69	30	31	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141488	10.1371/journal.pone.0141488	http://dx.doi.org/10.1371/journal.pone.0141488			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26535570	Green Published, gold, Green Submitted			2022-12-26	WOS:000364298400067
J	Burgi, R; Tomatis, L; Murer, K; de Bruin, ED				Buergi, Rahel; Tomatis, Laura; Murer, Kurt; de Bruin, Eling D.			Localization of Physical Activity in Primary School Children Using Accelerometry and Global Positioning System	PLOS ONE			English	Article							UNITED-STATES; HEALTH; ENVIRONMENT; TIME; GPS; YOUTH; ADOLESCENTS; PEOPLE; RECESS	Background Ecological approaches have highlighted the importance of the built environment as a factor affecting physical activity. However, knowledge on children's activity patterns is still incomplete. Particularly, data on the spatial context of physical activity is limited, which limits the potential to design location-based interventions effectively. Using global positioning system (GPS) and accelerometry, this study aimed to identify locations where children engage in moderate-vigorous physical activity (MVPA). Methods Participants included 119 children (11-14 years, 57% girls) from public schools in Winterthur, Switzerland. During a regular school week between February and April 2013, children wore an accelerometer and GPS sensor for seven consecutive days. Time-matched accelerometer and GPS data was mapped with a geographic information system and each data point was assigned to one of seven defined activity settings. Both the absolute amount of MVPA and proportion of time in MVPA were calculated for every setting. Multilevel analyses accounting for the hierarchical structure of the data were conducted to investigate any gender differences. Results Children achieved most MVPA on streets (34.5%) and on school grounds (33.4%). The proportion children spent in MVPA was highest in recreational facilities (19.4%), at other schools (19.2%) and on streets (18.6%). Boys accumulated significantly more MVPA overall and on other school grounds (p < 0.05) and showed a significantly higher proportion of time in MVPA at own school and outside of Winterthur (p < 0.05). Conclusions The results indicate the importance of streets and school grounds as activity-promoting environments. The high use of streets may be an indicator for active transportation, which appears to contribute to an active lifestyle in both genders. In contrast, the school setting is more likely to encourage physical activity in boys. Recreational facilities seem to be conducive for MVPA among both genders, although infrequently visited during the week of measurement.	[Buergi, Rahel; Tomatis, Laura; Murer, Kurt; de Bruin, Eling D.] Swiss Fed Inst Technol, Inst Human Movement Sci & Sport, Dept Hlth Sci & Technol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Burgi, R (corresponding author), Swiss Fed Inst Technol, Inst Human Movement Sci & Sport, Dept Hlth Sci & Technol, Zurich, Switzerland.	rahel.buergi@hest.ethz.ch	de Bruin, Eling D./A-4751-2011	de Bruin, Eling D./0000-0002-6542-7385				Almanza E, 2012, HEALTH PLACE, V18, P46, DOI 10.1016/j.healthplace.2011.09.003; Andersen HB, 2015, LANDSCAPE URBAN PLAN, V134, P83, DOI 10.1016/j.landurbplan.2014.10.005; Andersen LB, 2011, BRIT J SPORT MED, V45, P871, DOI 10.1136/bjsports-2011-090333; Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; Biddle SJH, 2011, BRIT J SPORT MED, V45, P886, DOI 10.1136/bjsports-2011-090185; Blatchford P, 2003, BRIT J DEV PSYCHOL, V21, P481, DOI 10.1348/026151003322535183; Bringolf-Isler B, 2008, PREV MED, V46, P67, DOI 10.1016/j.ypmed.2007.06.015; Bringolf-Isler B, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-50; Brownson RC, 2005, ANNU REV PUBL HEALTH, V26, P421, DOI 10.1146/annurev.publhealth.26.021304.144437; Cerin E, 2011, J PLAN LIT, V26, P151, DOI 10.1177/0885412210386229; Corder K, 2008, J APPL PHYSIOL, V105, P977, DOI 10.1152/japplphysiol.00094.2008; Currie C., 2012, SOCIAL DETERMINANTS; Dessing D, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-97; Ding D, 2011, AM J PREV MED, V41, P442, DOI 10.1016/j.amepre.2011.06.036; Dossegger A, 2014, MED SCI SPORT EXER, V46, P1140, DOI 10.1249/MSS.0000000000000215; Ekelund U, 2011, BRIT J SPORT MED, V45, P859, DOI 10.1136/bjsports-2011-090190; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Federal Statistical Office, 2015, SWISS STAT 2015; Hallal PC, 2006, SPORTS MED, V36, P1019, DOI 10.2165/00007256-200636120-00003; Jankowska MM, 2015, EXERC SPORT SCI REV, V43, P48, DOI 10.1249/JES.0000000000000035; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Jones AP, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-42; Kerr J, 2011, AM J PREV MED, V41, P532, DOI 10.1016/j.amepre.2011.07.017; Kjonniksen L, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-69; Klinker Charlotte D, 2014, Int J Behav Nutr Phys Act, V11, P8, DOI 10.1186/1479-5868-11-8; Krenn PJ, 2011, AM J PREV MED, V41, P508, DOI 10.1016/j.amepre.2011.06.046; Lachowycz K, 2012, HEALTH PLACE, V18, P586, DOI 10.1016/j.healthplace.2012.01.006; Lamprecht M., 2015, SPORT SCHWEIZ 2014 K; Maas J, 2013, NEIGHBOURHOOD STRUCT, P153; Maddison R, 2010, PEDIATR EXERC SCI, V22, P392, DOI 10.1123/pes.22.3.392; McCrorie PRW, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0093-0; Murer SB, 2014, EUR J NUTR, V53, P865, DOI 10.1007/s00394-013-0590-y; Nettlefold L, 2011, BRIT J SPORT MED, V45, P813, DOI 10.1136/bjsm.2009.068072; Nilsson A, 2002, PEDIATR EXERC SCI, V14, P87, DOI 10.1123/pes.14.1.87; Ogden CL, 2010, JAMA-J AM MED ASSOC, V303, P242, DOI 10.1001/jama.2009.2012; Oreskovic NM, 2012, GEOSPATIAL HEALTH, V6, P263, DOI 10.4081/gh.2012.144; Pawlowski CS, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-639; Quigg R, 2010, PREV MED, V50, P235, DOI 10.1016/j.ypmed.2010.02.002; Rainham DG, 2012, AM J PREV MED, V42, pE87, DOI 10.1016/j.amepre.2012.02.011; Richard L, 2011, ANNU REV PUBL HEALTH, V32, P307, DOI 10.1146/annurev-publhealth-031210-101141; Rodriguez DA, 2005, MED SCI SPORT EXER, V37, pS572, DOI 10.1249/01.mss.0000185297.72328.ce; Schipperijn J, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00021; Thompson AM, 2003, MED SCI SPORT EXER, V35, P1684, DOI 10.1249/01.MSS.0000089244.44914.1F; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Trost SG, 2011, MED SCI SPORT EXER, V43, P1360, DOI 10.1249/MSS.0b013e318206476e; van Sluijs EMF, 2009, PREV MED, V48, P519, DOI 10.1016/j.ypmed.2009.03.002; Verloigne M, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-34; Wang YF, 2012, INT REV PSYCHIATR, V24, P176, DOI 10.3109/09540261.2012.688195; WELK GJ, 2002, PHYS ACTIVITY ASSESS, P125	49	14	14	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142223	10.1371/journal.pone.0142223	http://dx.doi.org/10.1371/journal.pone.0142223			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536595	gold, Green Published, Green Submitted			2022-12-26	WOS:000364298400146
J	Feng, SQ; Sun, SS; Chen, XL; Wu, SJ; Wang, DY; Chen, XS				Feng, Shouqian; Sun, Shasha; Chen, Xiaoliu; Wu, Shujing; Wang, Deyun; Chen, Xuesen			PyMYB10 and PyMYB10.1 Interact with bHLH to Enhance Anthocyanin Accumulation in Pears	PLOS ONE			English	Article							MYB TRANSCRIPTION FACTORS; ARABIDOPSIS-THALIANA; FLAVONOL ACCUMULATION; TRANSGENIC TOBACCO; REGULATORY GENES; PYRUS-COMMUNIS; RED APPLES; BIOSYNTHESIS; EXPRESSION; PATHWAY	Color is an important agronomic trait of pears, and the anthocyanin content of fruit is immensely significant for pear coloring. In this study, an anthocyanin-activating R2R3-MYB transcription factor gene, PyMYB10.1, was isolated from fruits of red sand pear (Pyrus pyrifolia cv. Aoguan). Alignments of the nucleotide and amino acid sequences suggested that PyMYB10.1 was involved in anthocyanin regulation. Similar to PyMYB10, PyMYB10.1 was predominantly expressed in red tissues, including the skin, leaf and flower, but it was minimally expressed in non-red fruit flesh. The expression of this gene could be induced by light. Dual-luciferase assays indicated that both PyMYB10 and PyMYB10.1 activated the AtDFR promoter. The activation of AtDFR increased to a greater extent when combined with a bHLH co-factor, such as PybHLH, MrbHLH1, MrbHLH2, or AtbHLH2. However, the response of this activation depended on the protein complex formed. PyMYB10-AtbHLH2 activated the AtDFR promoter to a greater extent than other combinations of proteins. PyMYB10-AtbHLH2 also induced the highest anthocyanin accumulation in tobacco transient-expression assays. Moreover, PybHLH interacted with PyMYB10 and PyMYB10.1. These results suggest that both PyMYB10 and PyMYB10.1 are positive anthocyanin biosynthesis regulators in pears that act via the formation of a ternary complex with PybHLH. The functional characterization of PyMYB10 and PyMYB10.1 will aid further understanding of the anthocyanin regulation in pears.	[Feng, Shouqian; Sun, Shasha; Chen, Xiaoliu; Wu, Shujing; Wang, Deyun; Chen, Xuesen] Shandong Agr Univ, State Key Lab Crop Biol, Coll Hort Sci & Engn, Tai An, Shandong, Peoples R China	Shandong Agricultural University	Chen, XS (corresponding author), Shandong Agr Univ, State Key Lab Crop Biol, Coll Hort Sci & Engn, Tai An, Shandong, Peoples R China.	chenxs@sdau.edu.cn	shi, zhensheng/GXN-3967-2022		National Natural Science Foundation of China [31201593]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant No. 31201593).	Aharoni A, 2001, PLANT J, V28, P319, DOI 10.1046/j.1365-313X.2001.01154.x; Albert NW, 2011, PLANT J, V65, P771, DOI 10.1111/j.1365-313X.2010.04465.x; Azuma A, 2008, THEOR APPL GENET, V117, P1009, DOI 10.1007/s00122-008-0840-1; Bruce W, 2000, PLANT CELL, V12, P65, DOI 10.1105/tpc.12.1.65; Cheng S, 1993, PLANT MOL BIOL REP, V11, P113, DOI DOI 10.1007/BF02670468; Chiu LW, 2012, PLANTA, V236, P1153, DOI 10.1007/s00425-012-1665-3; DAYTON DF, 1966, P AM SOC HORTIC SCI, V89, P110; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; DUSSI MC, 1995, J AM SOC HORTIC SCI, V120, P785, DOI 10.21273/JASHS.120.5.785; Espley RV, 2007, PLANT J, V49, P414, DOI 10.1111/j.1365-313X.2006.02964.x; Espley RV, 2009, PLANT CELL, V21, P168, DOI 10.1105/tpc.108.059329; Feng SQ, 2010, PLANTA, V232, P245, DOI 10.1007/s00425-010-1170-5; Fischer TC, 2007, TREES-STRUCT FUNCT, V21, P521, DOI 10.1007/s00468-007-0145-z; Fornale S, 2014, PLANT CELL PHYSIOL, V55, P507, DOI 10.1093/pcp/pct187; Gonzalez A, 2008, PLANT J, V53, P814, DOI 10.1111/j.1365-313X.2007.03373.x; Grotewold E, 1998, PLANT CELL, V10, P721, DOI 10.1105/tpc.10.5.721; Hellens RP, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-13; Hichri I, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-117; Hichri I, 2010, MOL PLANT, V3, P509, DOI 10.1093/mp/ssp118; Huang WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070778; Jin HL, 2000, EMBO J, V19, P6150, DOI 10.1093/emboj/19.22.6150; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Li M, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058745, 10.1371/journal.pone.0078500, 10.1371/journal.pone.0059582, 10.1371/journal.pone.0079955]; Lin-Wang Kui, 2010, BMC Plant Biol, V10, P50, DOI 10.1186/1471-2229-10-50; Liu XF, 2013, PLANT CELL TISS ORG, V115, P285, DOI 10.1007/s11240-013-0361-8; Mano H, 2007, PLANT PHYSIOL, V143, P1252, DOI 10.1104/pp.106.094425; Matsui K, 2008, PLANT J, V55, P954, DOI 10.1111/j.1365-313X.2008.03565.x; Nesi N, 2001, PLANT CELL, V13, P2099, DOI 10.1105/tpc.13.9.2099; PIRIE A, 1976, PLANT PHYSIOL, V58, P468, DOI 10.1104/pp.58.4.468; Schwinn K, 2006, PLANT CELL, V18, P831, DOI 10.1105/tpc.105.039255; Steyn WJ, 2005, ACTA HORTIC, P79, DOI 10.17660/ActaHortic.2005.671.9; Stracke R, 2007, PLANT J, V50, P660, DOI 10.1111/j.1365-313X.2007.03078.x; Takos AM, 2006, PLANT PHYSIOL, V142, P1216, DOI 10.1104/pp.106.088104; Tamagnone L, 1998, PLANT CELL, V10, P135, DOI 10.1105/tpc.10.2.135; Tao B, 2004, SW CHIN J AGR SCI, V47, P409; Walker AR, 2007, PLANT J, V49, P772, DOI 10.1111/j.1365-313X.2006.02997.x; Wang HuiCong, 2004, Scientia Agricultura Sinica, V37, P2028; Wu BH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105959; Wu J, 2013, GENOME RES, V23, P396, DOI 10.1101/gr.144311.112; Yang YN, 2013, TREE GENET GENOMES, V9, P1351, DOI 10.1007/s11295-013-0644-6; Zhang XD, 2011, PLANT MOL BIOL REP, V29, P305, DOI 10.1007/s11105-010-0231-z; Zimmermann IM, 2004, PLANT J, V40, P22, DOI 10.1111/j.1365-313X.2004.02183.x	42	31	34	6	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142112	10.1371/journal.pone.0142112	http://dx.doi.org/10.1371/journal.pone.0142112			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536358	Green Published, Green Submitted, gold			2022-12-26	WOS:000364298400135
J	Foygel, K; Sekar, TV; Paulmurugan, R				Foygel, Kira; Sekar, Thillai V.; Paulmurugan, Ramasamy			Monitoring the Antioxidant Mediated Chemosensitization and ARE-Signaling in Triple Negative Breast Cancer Therapy	PLOS ONE			English	Article							POLY(ADP-RIBOSE) POLYMERASE; NRF2 ACTIVATORS; DARK SIDE; CELLS; PATHWAY; GROWTH; OVEREXPRESSION; SULFASALAZINE; TRANSFERASE; GATEKEEPER	Chemotherapy often fails due to cellular detoxifying mechanisms, including phase-II enzymes. Activation of Nrf2-Keap1 pathway induces phase-II enzymes expression through ARE-signaling and prevents cancer development. Nrf2-overexpression in cancer cells results in chemo- and/or radioresistance. This necessitates understanding of Nrf2-regulation, and identification of Nrf2 activators/inhibitors sensitizing cancer cells to improve chemotherapy. N-terminal 435-amino acids of Nrf2 are crucial for Keap1 binding during ubiquitination. Identification of a minimum Nrf2-domain required for Keap1 binding without altering endogenous ARE-signaling would be a novel tool to study Nrf2-signaling. Current study developed firefly-luciferase reporter fusion with N-terminal Nrf2-domain of different lengths and examined its response to Nrf2-activators in cells. The results identified FLuc2 fusion with N-terminal 100-aa of Nrf2 is sufficient for measuring Nrf2-activation in cancer cells. We used MDA-MB231 cells expressing this particular construct for studying antioxidant induced Nrf2-activation and chemosensitization in triple-negative breast cancer therapy. While antioxidant EGCG showed chemosensitization of MDA-MB231 cells to cisplatin by activating Nrf2-ARE signaling, PTS, another antioxidant showed chemoprotection. Tumor xenograft study in mouse demonstrates that combinational treatment by cisplatin/EGCG resulted in tumor growth reduction, compared to cisplatin alone treatment. The results of this study highlight the importance of identifying selective combination of antioxidants/chemotherapeutic agents for customized treatment strategy.	[Foygel, Kira; Sekar, Thillai V.; Paulmurugan, Ramasamy] Stanford Univ, Sch Med, BioX Program, Mol Imaging Program Stanford, Stanford, CA 94305 USA	Stanford University	Paulmurugan, R (corresponding author), Stanford Univ, Sch Med, BioX Program, Mol Imaging Program Stanford, Stanford, CA 94305 USA.	paulmur8@stanford.edu		Paulmurugan, Ramasamy/0000-0001-7155-4738	National Institute of Health-National Cancer Institute [RO1CA161091]; NATIONAL CANCER INSTITUTE [R01CA161091] Funding Source: NIH RePORTER	National Institute of Health-National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding provided by National Institute of Health-National Cancer Institute grant RO1CA161091 awarded to Ramasamy Paulmurugan.	BACH MK, 1985, BIOCHEM PHARMACOL, V34, P2695, DOI 10.1016/0006-2952(85)90570-2; BATIST G, 1986, J BIOL CHEM, V261, P5544; Canning P, 2015, FREE RADICAL BIO MED, V88, P101, DOI 10.1016/j.freeradbiomed.2015.05.034; Canning P, 2013, J BIOL CHEM, V288, P7803, DOI 10.1074/jbc.M112.437996; CHAO CCK, 1992, MOL PHARMACOL, V41, P69; Cheng XH, 2013, DIABETES, V62, P4088, DOI 10.2337/db13-0169; Chung WJ, 2009, J NEUROCHEM, V110, P182, DOI 10.1111/j.1471-4159.2009.06129.x; DIASIO RB, 1989, CLIN PHARMACOKINET, V16, P215, DOI 10.2165/00003088-198916040-00002; Duriez PJ, 1997, BIOCHEM CELL BIOL, V75, P337, DOI 10.1139/bcb-75-4-337; Gupta SC, 2011, ANN NY ACAD SCI, V1215, P150, DOI 10.1111/j.1749-6632.2010.05852.x; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Huang Y, 2004, CANCER RES, V64, P4294, DOI 10.1158/0008-5472.CAN-03-3884; Khan K, 2010, HEAD NECK-J SCI SPEC, V32, P381, DOI 10.1002/hed.21195; Kobayashi M, 2005, ANTIOXID REDOX SIGN, V7, P385, DOI 10.1089/ars.2005.7.385; Kobayashi M, 2006, ADV ENZYME REGUL, V46, P113, DOI 10.1016/j.advenzreg.2006.01.007; Lau A, 2008, PHARMACOL RES, V58, P262, DOI 10.1016/j.phrs.2008.09.003; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lewis KN, 2010, INTEGR COMP BIOL, V50, P829, DOI 10.1093/icb/icq034; Li N, 2006, ANTIOXID REDOX SIGN, V8, P88, DOI 10.1089/ars.2006.8.88; Liu L, 1999, CLIN CANCER RES, V5, P2908; Marchan R, 2013, ARCH TOXICOL, V87, P2047, DOI 10.1007/s00204-013-1165-7; Ning SC, 2012, CANCER RES, V72, P2600, DOI 10.1158/0008-5472.CAN-11-2303; OConnor PM, 1997, CANCER RES, V57, P4285; Ramkumar KM, 2013, ANAL CHEM, V85, P7542, DOI 10.1021/ac401569j; Sayin VI, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007653; Theodore M, 2008, J BIOL CHEM, V283, P8984, DOI 10.1074/jbc.M709040200; Wang XJ, 2008, CARCINOGENESIS, V29, P1235, DOI 10.1093/carcin/bgn095; Zhang DD, 2010, ANTIOXID REDOX SIGN, V13, P1623, DOI 10.1089/ars.2010.3301; Zheng HT, 2011, DIABETES, V60, P3055, DOI 10.2337/db11-0807	29	13	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141913	10.1371/journal.pone.0141913	http://dx.doi.org/10.1371/journal.pone.0141913			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536456	Green Submitted, Green Published, gold			2022-12-26	WOS:000364298400100
J	Rabago, CA; Dingwell, JB; Wilken, JM				Rabago, Christopher A.; Dingwell, Jonathan B.; Wilken, Jason M.			Reliability and Minimum Detectable Change of Temporal-Spatial, Kinematic, and Dynamic Stability Measures during Perturbed Gait	PLOS ONE			English	Article							TRANSTIBIAL AMPUTATION WALKING; RETEST RELIABILITY; DIVIDED ATTENTION; HEALTHY-YOUNG; OLDER-ADULTS; TASK; VARIABILITY; TREADMILL; INDIVIDUALS; AGE	Temporal-spatial, kinematic variability, and dynamic stability measures collected during perturbation-based assessment paradigms are often used to identify dysfunction associated with gait instability. However, it remains unclear which measures are most reliable for detecting and tracking responses to perturbations. This study systematically determined the between-session reliability and minimum detectable change values of temporal-spatial, kinematic variability, and dynamic stability measures during three types of perturbed gait. Twenty young healthy adults completed two identical testing sessions two weeks apart, comprised of an unperturbed and three perturbed (cognitive, physical, and visual) walking conditions in a virtual reality environment. Within each session, perturbation responses were compared to unperturbed walking using paired t-tests. Between-session reliability and minimum detectable change values were also calculated for each measure and condition. All temporal-spatial, kinematic variability and dynamic stability measures demonstrated fair to excellent between-session reliability. Minimal detectable change values, normalized to mean values ranged from 1-50%. Step width mean and variability measures demonstrated the greatest response to perturbations with excellent between-session reliability and low minimum detectable change values. Orbital stability measures demonstrated specificity to perturbation direction and sensitivity with excellent between-session reliability and low minimum detectable change values. We observed substantially greater between-session reliability and lower minimum detectable change values for local stability measures than previously described which may be the result of averaging across trials within a session and using velocity versus acceleration data for reconstruction of state spaces. Across all perturbation types, temporal-spatial, orbital and local measures were the most reliable measures with the lowest minimum detectable change values, supporting their use for tracking changes over multiple testing sessions. The between-session reliability and minimum detectable change values reported here provide an objective means for interpreting changes in temporal-spatial, kinematic variability, and dynamic stability measures during perturbed walking which may assist in identifying instability.	[Rabago, Christopher A.; Wilken, Jason M.] Brooke Army Med Ctr, Dept Orthopaed & Rehabil, Ctr Intrepid, Jbsa Ft Sam Houston, TX 78234 USA; [Rabago, Christopher A.; Wilken, Jason M.] Dept Def & Vet Affairs Extrem Trauma, Jbsa Ft Sam Houston, TX USA; [Rabago, Christopher A.; Wilken, Jason M.] Amputat Ctr Excellence, Jbsa Ft Sam Houston, TX USA; [Dingwell, Jonathan B.] Univ Texas Austin, Dept Kinesiol & Hlth Educ, Austin, TX 78712 USA	San Antonio Military Medical Center; United States Department of Defense; United States Army; University of Texas System; University of Texas Austin	Rabago, CA (corresponding author), Brooke Army Med Ctr, Dept Orthopaed & Rehabil, Ctr Intrepid, Jbsa Ft Sam Houston, TX 78234 USA.	Christopher.A.Rabago.civ@mail.mil	Wilken, Jason/ABA-3309-2021	Wilken, Jason/0000-0002-5556-7667; Dingwell, Jonathan/0000-0001-6990-4153; Rabago, Christopher/0000-0002-4484-0613	Medical Research and Materiel Command's Military Operational Medicine Research Program [W81XWH-09-P-0874]	Medical Research and Materiel Command's Military Operational Medicine Research Program	Support provided by Medical Research and Materiel Command's Military Operational Medicine Research Program, http://mrmc.amedd.army.mil, Grant W81XWH-09-P-0874 (to JMW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Yahya E, 2011, NEUROSCI BIOBEHAV R, V35, P715, DOI 10.1016/j.neubiorev.2010.08.008; Arellano CJ, 2009, MED SCI SPORT EXER, V41, P620, DOI 10.1249/MSS.0b013e31818a0ea4; Beauchet O, 2005, J MOTOR BEHAV, V37, P259; Beltran EJ, 2014, J BIOMECH, V47, P1138, DOI 10.1016/j.jbiomech.2013.12.011; Beurskens R, 2014, J BIOMECH, V47, P3072, DOI 10.1016/j.jbiomech.2014.06.041; Beurskens R, 2014, J BIOMECH, V47, P1675, DOI 10.1016/j.jbiomech.2014.02.033; Bock O, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-27; Bruijn SM, 2009, J NEUROSCI METH, V178, P327, DOI 10.1016/j.jneumeth.2008.12.015; Brunnekreef JJ, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-17; Oliveira ASC, 2012, GAIT POSTURE, V36, P301, DOI 10.1016/j.gaitpost.2012.03.016; Cohen J.E., 1988, STAT POWER ANAL BEHA; Decker LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041306; Dingwell JB, 2006, J BIOMECH, V39, P444, DOI 10.1016/j.jbiomech.2004.12.014; Dingwell JB, 2000, CHAOS, V10, P848, DOI 10.1063/1.1324008; Dingwell JB., 2006, WILEY ENCY BIOMEDICA; Dingwell JB, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-12; Dingwell JB, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000856; Dunlap WP, 1996, PSYCHOL METHODS, V1, P170, DOI 10.1037/1082-989X.1.2.170; EBERSBACH G, 1995, PERCEPT MOTOR SKILL, V81, P107, DOI 10.2466/pms.1995.81.1.107; England SA, 2007, GAIT POSTURE, V25, P172, DOI 10.1016/j.gaitpost.2006.03.003; Gates DH, 2009, J BIOMECH, V42, P1345, DOI 10.1016/j.jbiomech.2009.03.015; Gottshall KR, 2010, J NEUROL PHYS THER, V34, P94, DOI 10.1097/NPT.0b013e3181dead12; Grabiner Mark D, 2005, J Neuroeng Rehabil, V2, P25, DOI 10.1186/1743-0003-2-25; Granata KP, 2008, J ELECTROMYOGR KINES, V18, P172, DOI 10.1016/j.jelekin.2007.06.008; Hak L, 2012, GAIT POSTURE, V36, P260, DOI 10.1016/j.gaitpost.2012.03.005; Haley SM, 2006, PHYS THER, V86, P735, DOI 10.1093/ptj/86.5.735; Hausdorff JM, 2003, J GERIATR PSYCH NEUR, V16, P53, DOI 10.1177/0891988702250580; Hollman JH, 2010, GAIT POSTURE, V32, P23, DOI 10.1016/j.gaitpost.2010.02.017; HOLM S, 1979, SCAND J STAT, V6, P65; Hurmuzlu Y, 1996, J BIOMECH ENG-T ASME, V118, P405, DOI 10.1115/1.2796024; HURMUZLU Y, 1994, J BIOMECH ENG-T ASME, V116, P30, DOI 10.1115/1.2895701; Kang HG, 2008, GAIT POSTURE, V27, P572, DOI 10.1016/j.gaitpost.2007.07.009; Kim H, 2012, J BIOMECH, V45, P1850, DOI 10.1016/j.jbiomech.2012.05.003; Lamoth CJ, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-2; Maki BE, 1997, J AM GERIATR SOC, V45, P313, DOI 10.1111/j.1532-5415.1997.tb00946.x; Mayer-Kress G, 1986, DIMENSIONS ENTROPIES, P82, DOI DOI 10.1007/978-3-642-71001-8_11; McAndrew PM, 2011, J BIOMECH, V44, P644, DOI 10.1016/j.jbiomech.2010.11.007; McAndrew PM, 2010, J BIOMECH, V43, P1470, DOI 10.1016/j.jbiomech.2010.02.003; McFadyen BJ, 2007, EXP BRAIN RES, V179, P235, DOI 10.1007/s00221-006-0784-0; McFadyen BJ, 2009, ARCH PHYS MED REHAB, V90, P1596, DOI 10.1016/j.apmr.2009.03.010; Melnyk BM, 2005, EVIDENCE BASED PRACT; Mersmann F, 2013, GAIT POSTURE, V37, P373, DOI 10.1016/j.gaitpost.2012.08.005; Nayfeh A.H., 2008, APPL NONLINEAR DYNAM; Nnodim JO, 2013, GAIT POSTURE, V37, P61, DOI 10.1016/j.gaitpost.2012.06.002; O'Connor SM, 2012, GAIT POSTURE, V36, P102, DOI 10.1016/j.gaitpost.2012.01.014; O'Connor SM, 2012, J NEUROPHYSIOL, V107, P2549, DOI 10.1152/jn.00866.2011; O'Shea S, 2002, PHYS THER, V82, P888, DOI 10.1093/ptj/82.9.888; Olivier I, 2010, GAIT POSTURE, V32, P494, DOI 10.1016/j.gaitpost.2010.07.008; Owings TM, 2004, J BIOMECH, V37, P935, DOI 10.1016/j.jbiomech.2003.11.012; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; Plummer-D'Amato P, 2008, GAIT POSTURE, V27, P683, DOI 10.1016/j.gaitpost.2007.09.001; Rabago CA, 2011, J NEUROL PHYS THER, V35, P185, DOI 10.1097/NPT.0b013e318235d7e6; Regnaux JP, 2006, J NEUROENG REHABIL, V3, DOI 10.1186/1743-0003-3-19; Reynard P, 2014, J BIOMECH, V47, P74, DOI 10.1016/j.jbiomech.2013.10.011; ROSENSTEIN MT, 1993, PHYSICA D, V65, P117, DOI 10.1016/0167-2789(93)90009-P; Sheehan RC, 2015, GAIT POSTURE, V41, P795, DOI 10.1016/j.gaitpost.2015.02.008; Shrout P E, 1998, Stat Methods Med Res, V7, P301, DOI 10.1191/096228098672090967; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Sinitksi EH, 2012, J BIOMECH, V45, P2084, DOI 10.1016/j.jbiomech.2012.05.039; Stolze H, 1998, GAIT POSTURE, V7, P125, DOI 10.1016/S0966-6362(97)00043-X; Szturm T, 2013, GAIT POSTURE, V38, P596, DOI 10.1016/j.gaitpost.2013.02.004; Terrier P, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-94; Terrier P, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-12; Terry K, 2012, J BIOMECH, V45, P1979, DOI 10.1016/j.jbiomech.2012.05.006; van Schooten KS, 2014, GAIT POSTURE, V39, P695, DOI 10.1016/j.gaitpost.2013.09.020; van Schooten KS, 2013, J BIOMECH, V46, P137, DOI 10.1016/j.jbiomech.2012.10.032; Vaughan CL, 2005, GAIT POSTURE, V21, P350, DOI 10.1016/j.gaitpost.2004.01.011; Verghese J, 2002, J AM GERIATR SOC, V50, P1572, DOI 10.1046/j.1532-5415.2002.50415.x; Warren WH, 2001, NAT NEUROSCI, V4, P213, DOI 10.1038/84054; Yogev-Seligmann G, 2010, PHYS THER, V90, P177, DOI 10.2522/ptj.20090043; Zeni JA, 2008, GAIT POSTURE, V27, P710, DOI 10.1016/j.gaitpost.2007.07.007	71	14	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142083	10.1371/journal.pone.0142083	http://dx.doi.org/10.1371/journal.pone.0142083			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26535580	Green Published, gold			2022-12-26	WOS:000364298400130
J	Tropea, T; De Francesco, EM; Rigiracciolo, D; Maggiolini, M; Wareing, M; Osol, G; Mandala, M				Tropea, Teresa; De Francesco, Ernestina Marianna; Rigiracciolo, Damiano; Maggiolini, Marcello; Wareing, Mark; Osol, George; Mandala, Maurizio			Pregnancy Augments G Protein Estrogen Receptor (GPER) Induced Vasodilation in Rat Uterine Arteries via the Nitric Oxide - cGMP Signaling Pathway	PLOS ONE			English	Article							BREAST-CANCER CELLS; SMOOTH-MUSCLE; GPR30 ANTAGONIST; EXPRESSION; AGONISTS; ALPHA; ENDOTHELIUM; ACTIVATION; GENE; BETA	Background The regulation of vascular tone in the uterine circulation is a key determinant of appropriate uteroplacental blood perfusion and successful pregnancy outcome. Estrogens, which increase in the maternal circulation throughout pregnancy, can exert acute vasodilatory actions. Recently a third estrogen receptor named GPER (G protein-coupled estrogen receptor) was identified and, although several studies have shown vasodilatory effects in several vascular beds, nothing is known about its role in the uterine vasculature. Aim The aim of this study was to determine the function of GPER in uterine arteries mainly during pregnancy. Uterine arteries were isolated from nonpregnant and pregnant rats. Methods Vessels were contracted with phenylephrine and then incubated with incremental doses (10(-12)-10(-5) M) of the selective GPER agonist G1. Results G1 induced a dose-dependent vasodilation which was: 1) significantly increased in pregnancy, 2) endothelium-dependent, 3) primarily mediated by NO/cGMP pathway and 4) unaffected by BKca channel inhibition. Conclusion This is the first study to show the potential importance of GPER signaling in reducing uterine vascular tone during pregnancy. GPER may therefore play a previously unrecognized role in the regulation of uteroplacental blood flow and normal fetus growth.	[Tropea, Teresa; Mandala, Maurizio] Univ Calabria, Dept Biol Ecol & Earth Sci, I-87036 Arcavacata Di Rende, Italy; [De Francesco, Ernestina Marianna; Rigiracciolo, Damiano; Maggiolini, Marcello] Univ Calabria, Dept Pharm Hlth & Nutr Sci, I-87036 Arcavacata Di Rende, Italy; [Wareing, Mark] Univ Manchester, Maternal & Fetal Hlth Res Ctr, Manchester, Lancs, England; [Osol, George] Univ Vermont, Dept Obstet Gynecol & Reprod Sci, Burlington, VT USA	University of Calabria; University of Calabria; University of Manchester; University of Vermont	Mandala, M (corresponding author), Univ Calabria, Dept Biol Ecol & Earth Sci, I-87036 Arcavacata Di Rende, Italy.	m.mandala@unical.it	Maggiolini, Marcello/Z-4729-2019; Rigiracciolo, Damiano Cosimo/GRS-9234-2022	Tropea, Teresa/0000-0003-3972-3313; Rigiracciolo, Damiano Cosimo/0000-0003-1161-6380	University of Calabria	University of Calabria	This work was supported by the University of Calabria with a contribution named "ex 60%" to MM. The funder had a role in study design and in analysis and interpretation of data.	Albanito L, 2015, ENV HLTH PE IN PRESS; Arefin S, 2014, MATURITAS, V78, P123, DOI 10.1016/j.maturitas.2014.04.002; Bologa CG, 2006, NAT CHEM BIOL, V2, P207, DOI 10.1038/nchembio775; Broughton BRS, 2010, AM J PHYSIOL-HEART C, V298, pH1055, DOI 10.1152/ajpheart.00878.2009; Byers MJ, 2005, J PHYSIOL-LONDON, V565, P85, DOI 10.1113/jphysiol.2005.085753; Carmeci C, 1997, GENOMICS, V45, P607, DOI 10.1006/geno.1997.4972; Carroll JS, 2006, MOL ENDOCRINOL, V20, P1707, DOI 10.1210/me.2005-0334; Colton I, 2012, CELL PHYSIOL BIOCHEM, V29, P883, DOI 10.1159/000178465; Corcoran JJ, 2014, MOL HUM REPROD, V20, P433, DOI 10.1093/molehr/gat095; De Francesco EM, 2014, CANCER RES, V74, P4053, DOI 10.1158/0008-5472.CAN-13-3590; De Francesco EM, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3458; Dennis MK, 2009, NAT CHEM BIOL, V5, P421, DOI 10.1038/nchembio.168; Haas E, 2007, HYPERTENSION, V49, P1358, DOI 10.1161/HYPERTENSIONAHA.107.089995; Haas E, 2009, CIRC RES, V104, P288, DOI 10.1161/CIRCRESAHA.108.190892; Isensee J, 2009, ENDOCRINOLOGY, V150, P1722, DOI 10.1210/en.2008-1488; Kvingedal AM, 1997, FEBS LETT, V407, P59, DOI 10.1016/S0014-5793(97)00278-0; Lappano R, 2010, MOL CELL ENDOCRINOL, V320, P162, DOI 10.1016/j.mce.2010.02.006; Lindsey SH, 2014, STEROIDS, V81, P99, DOI 10.1016/j.steroids.2013.10.017; Lindsey SH, 2011, J CARDIOVASC PHARM, V57, P598, DOI 10.1097/FJC.0b013e3182135f1c; Maggiolini M, 2010, J ENDOCRINOL, V204, P105, DOI 10.1677/JOE-09-0242; MAGNESS RR, 1986, AM J OBSTET GYNECOL, V155, P897, DOI 10.1016/S0002-9378(86)80047-3; Mandala M, 2012, BASIC CLIN PHARMACOL, V110, P12, DOI 10.1111/j.1742-7843.2011.00793.x; Meyer MR, 2011, VASC PHARMACOL, V55, P17, DOI 10.1016/j.vph.2011.06.003; Meyer MR, 2010, PHARMACOLOGY, V86, P58, DOI 10.1159/000315497; O'Dowd BF, 1998, GENOMICS, V47, P310, DOI 10.1006/geno.1998.5095; Osol G, 2009, PHYSIOLOGY, V24, P58, DOI 10.1152/physiol.00033.2008; Owman C, 1996, BIOCHEM BIOPH RES CO, V228, P285, DOI 10.1006/bbrc.1996.1654; Pastore MB, 2012, SEMIN REPROD MED, V30, P46, DOI 10.1055/s-0031-1299597; Patkar S, 2011, NEUROSCI RES, V71, P78, DOI 10.1016/j.neures.2011.05.006; Pupo M, 2012, ENVIRON HEALTH PERSP, V120, P1177, DOI 10.1289/ehp.1104526; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Takada Y, 1997, BIOCHEM BIOPH RES CO, V240, P737, DOI 10.1006/bbrc.1997.7734; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; van der Heijden OWH, 2005, BIOL REPROD, V73, P1289, DOI 10.1095/biolreprod.105.044438; Yu X, 2011, AM J PHYSIOL-ENDOC M, V301, pE882, DOI 10.1152/ajpendo.00037.2011	35	40	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141997	10.1371/journal.pone.0141997	http://dx.doi.org/10.1371/journal.pone.0141997			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536245	Green Published, Green Submitted, gold			2022-12-26	WOS:000364298400116
J	Cho, KH; Kim, YS; Nam, CM; Kim, TH; Kim, SJ; Han, KT; Park, EC				Cho, Kyoung Hee; Kim, Young Sam; Nam, Chung Mo; Kim, Tae Hyun; Kim, Sun Jung; Han, Kyu-Tae; Park, Eun-Cheol			The Association between Continuity of Care and All-Cause Mortality in Patients with Newly Diagnosed Obstructive Pulmonary Disease: A Population-Based Retrospective Cohort Study, 2005-2012	PLOS ONE			English	Article							AMBULATORY-CARE; ADULT PATIENTS; PREDICTORS; SURVIVAL; OUTCOMES; KOREA; COSTS; COPD	Background The disease burden is increasing for chronic obstructive pulmonary disease (COPD) due to increasing of the growth rate of prevalence and mortality. But the empirical researches are a little for COPD that studied the association between continuity of care and death and about predictors effect on mortality. Objective To investigate the association between continuity of care (COC) and chronic obstructive pulmonary disease (COPD) mortality and to identify other mortality-related factors in COPD patients. Methods We conducted a longitudinal, population-based retrospective cohort study in adult patients with COPD from 2002 to 2012 using a nationwide health insurance claims database. The study sample included individuals aged 40 years and over who developed COPD in 2005 and survived until 2006. We performed a Cox proportional hazard regression analysis with COC analyzed as a time-dependent covariate. Results Of the 3,090 participants, 60.8% died before the end of study (N = 1,879). The median years of survival for individuals with high COC (COC index >= 0.75) was 3.92, and that for patients with low COC (COC index<0.75) was 2.58 in a Kaplan Meier analysis. In a multivariate, time-dependent analysis, low COC was associated with a 22% increased risk of all-cause mortality (HR, 1.22; 95% CI, 1.09-1.36). Not receiving oxygen therapy at home was associated with a 23% increased risk of all-cause mortality (HR, 1.23; 95% CI, 1.01-1.49). Moreover, the risk of all-cause mortality for individuals who admitted one time increased 38%(HR, 1.38; 95% CI, 1.21-1.59), two times was 63%(HR, 1.63; 95% CI, 1.34-1.99) and 3+times was 96%(HR, 1.96; 95% CI, 1.63-2.36) relative to the reference group (no admission). Conclusions High COC was associated with a decreased risk of all-cause mortality. In addition, home oxygen therapy and number of hospital admissions may predict mortality in patients with COPD.	[Cho, Kyoung Hee; Kim, Sun Jung; Han, Kyu-Tae] Yonsei Univ, Grad Sch, Dept Publ Hlth, Seoul 120749, South Korea; [Cho, Kyoung Hee; Kim, Tae Hyun; Kim, Sun Jung; Han, Kyu-Tae; Park, Eun-Cheol] Yonsei Univ, Coll Med, Inst Hlth Serv Res, Seoul, South Korea; [Kim, Young Sam] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Nam, Chung Mo] Yonsei Univ, Coll Med, Dept Biostat, Seoul, South Korea; [Kim, Tae Hyun] Yonsei Univ, Grad Sch Publ Hlth, Seoul 120749, South Korea; [Park, Eun-Cheol] Yonsei Univ, Coll Med, Dept Prevent Med, Seoul, South Korea	Yonsei University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Park, EC (corresponding author), Yonsei Univ, Coll Med, Inst Hlth Serv Res, Seoul, South Korea.	ECPARK@yuhs.ac	Kim, Sun Jung/AAM-7334-2020; Park, Eun-Cheol/O-5644-2019	Kim, Sun Jung/0000-0003-1756-1376; Park, Eun-Cheol/0000-0002-2306-5398; Nam, Chung Mo/0000-0003-0985-0928; Cho, Kyoung Hee/0000-0003-0753-1560; Kim, Tae Hyun/0000-0003-1053-8958; Han, Kyu-Tae/0000-0002-5817-1203; Kim, Young Sam/0000-0001-9656-8482				Atlas SJ, 2009, ANN INTERN MED, V150, P325, DOI 10.7326/0003-4819-150-5-200903030-00008; BICE TW, 1977, MED CARE, V15, P347, DOI 10.1097/00005650-197704000-00010; Cabana MD, 2004, J FAM PRACTICE, V53, P974; Celli BR, 2008, RESP MED, V102, pS27, DOI 10.1016/S0954-6111(08)70005-2; Chen CC, 2012, BMC HEALTH SERV RES, V12, P405; Dela Coleta K, 2008, RESP MED, V102, P512, DOI 10.1016/j.rmed.2007.12.003; Esteban C, 2008, J GEN INTERN MED, V23, P1829, DOI 10.1007/s11606-008-0783-x; Gill James M, 2003, Ann Fam Med, V1, P162, DOI 10.1370/afm.22; Gray DP, 2003, J ROY SOC MED, V96, P160, DOI 10.1258/jrsm.96.4.160; Haggerty JL, 2003, BRIT MED J, V327, P1219, DOI 10.1136/bmj.327.7425.1219; Hjalmarsen A, 1999, INT J TUBERC LUNG D, V3, P1120; Hong JS, 2014, MED CARE, V52, P446, DOI 10.1097/MLR.0000000000000110; Hong JS, 2013, HEALTH POLICY, V109, P158, DOI 10.1016/j.healthpol.2012.09.009; Hussey PS, 2014, JAMA INTERN MED, V174, P742, DOI 10.1001/jamainternmed.2014.245; Hussey PS, 2014, JAMA INTER MED, P17; Kim RY, 2011, INTRO NATL PATIENTS; Knight JC, 2009, POPUL HEALTH MANAG, V12, P81, DOI 10.1089/pop.2008.0020; Korea National Statistical Office, 2013, STAT ALL CAUS MORT 2; Mainous AG, 1998, AM J PUBLIC HEALTH, V88, P1539, DOI 10.2105/AJPH.88.10.1539; Malcolm JC, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-303; Menec Verena H, 2006, J Health Serv Res Policy, V11, P196, DOI 10.1258/135581906778476562; 김재용, 2006, Diabetes and Metabolism Journal, V30, P377; Parchman ML, 2002, MED CARE, V40, P137, DOI 10.1097/00005650-200202000-00008; Saultz John W, 2003, Ann Fam Med, V1, P134, DOI 10.1370/afm.23; Sharma G, 2010, ARCH INTERN MED, V170, P1664, DOI 10.1001/archinternmed.2010.345; Uijen AA, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X649115; van Walraven C, 2004, J CLIN EPIDEMIOL, V57, P672, DOI 10.1016/j.jclinepi.2003.12.008; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; WASSON JH, 1984, JAMA-J AM MED ASSOC, V252, P2413; Weiss LJ, 1996, AM J PUBLIC HEALTH, V86, P1742, DOI 10.2105/AJPH.86.12.1742	30	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141465	10.1371/journal.pone.0141465	http://dx.doi.org/10.1371/journal.pone.0141465			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV1QH	26529224	gold, Green Published			2022-12-26	WOS:000364032600030
J	Tokuyama, E; Nagai, Y; Takahashi, K; Kimata, Y; Naruse, K				Tokuyama, Eijiro; Nagai, Yusuke; Takahashi, Ken; Kimata, Yoshihiro; Naruse, Keiji			Mechanical Stretch on Human Skin Equivalents Increases the Epidermal Thickness and Develops the Basement Membrane	PLOS ONE			English	Article							UNIAXIAL CYCLIC STRETCH; KERATINOCYTES IN-VITRO; FIBROBLAST PROLIFERATION; DERMAL FIBROBLASTS; ENDOTHELIAL-CELLS; UP-REGULATION; STRAIN; MODEL; EXPRESSION; TENSILE	All previous reports concerning the effect of stretch on cultured skin cells dealt with experiments on epidermal keratinocytes or dermal fibroblasts alone. The aim of the present study was to develop a system that allows application of stretch stimuli to human skin equivalents (HSEs), prepared by coculturing of these two types of cells. In addition, this study aimed to analyze the effect of a stretch on keratinization of the epidermis and on the basement membrane. HSEs were prepared in a gutter-like structure created with a porous silicone sheet in a silicone chamber. After 5-day stimulation with stretching, HSEs were analyzed histologically and immunohistologically. Stretch-stimulated HSEs had a thicker epidermal layer and expressed significantly greater levels of laminin 5 and collagen IV/VII in the basal layer compared with HSEs not subjected to stretch stimulation. Transmission electron microscopy revealed that the structure of the basement membrane was more developed in HSEs subjected to stretching. Our model may be relevant for extrapolating the effect of a stretch on the skin in a state similar to an in vivo system. This experimental system may be useful for analysis of the effects of stretch stimuli on skin properties and wound healing and is also expected to be applicable to an in vitro model of a hypertrophic scar in the future.	[Tokuyama, Eijiro; Kimata, Yoshihiro] Okayama Univ, Dept Plast & Reconstruct Surg, Grad Sch Med, Okayama, Japan; [Nagai, Yusuke] Menicon Co Ltd, Aichi, Japan; [Naruse, Keiji] Okayama Univ, Dept Cardiovasc Physiol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan	Okayama University; Okayama University	Tokuyama, E (corresponding author), Okayama Univ, Dept Plast & Reconstruct Surg, Grad Sch Med, Okayama, Japan.	tokuyamaeijiro@gmail.com	TAKAHASHI, Ken/B-1622-2011; Sokabe, Masahiro/I-1565-2012	TAKAHASHI, Ken/0000-0002-7580-8691; naruse, keiji/0000-0003-4100-6444	Japan Society for the Promotion of Science (JSPS) [24592713]; Menicon Co., Ltd.	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Menicon Co., Ltd.	This study was supported by a Grant-in-Aid for Scientific Research (C), 24592713 provided by the Japan Society for the Promotion of Science (JSPS) and Menicon Co., Ltd. provided support in the form of salaries for authors YN and KN (who is a research/adviser for Menicon Co., Ltd). These funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Amano S, 2001, EXP CELL RES, V271, P249, DOI 10.1006/excr.2001.5387; Balestrini JL, 2006, J BIOMECH, V39, P2983, DOI 10.1016/j.jbiomech.2005.10.025; BELL E, 1981, SCIENCE, V211, P1052, DOI 10.1126/science.7008197; BOXMAN I, 1993, J INVEST DERMATOL, V101, P316, DOI 10.1111/1523-1747.ep12365474; Del Bino S, 2004, BRIT J DERMATOL, V150, P658, DOI 10.1111/j.0007-0963.2004.05886.x; Deng D, 2009, BIOMATERIALS, V30, P6724, DOI 10.1016/j.biomaterials.2009.08.054; Derderian CA, 2005, ANN PLAS SURG, V55, P69, DOI 10.1097/01.sap.0000168160.86221.e9; Eagan TS, 2007, J MANIP PHYSIOL THER, V30, P584, DOI 10.1016/j.jmpt.2007.07.013; El-Ghalbzouri A, 2002, BRIT J DERMATOL, V147, P230, DOI 10.1046/j.1365-2133.2002.04871.x; Florin L, 2005, J CELL SCI, V118, P1981, DOI 10.1242/jcs.02303; Gauvin R, 2011, ACTA BIOMATER, V7, P3294, DOI 10.1016/j.actbio.2011.05.034; GAY R, 1992, TOXICOL IN VITRO, V6, P303, DOI 10.1016/0887-2333(92)90020-R; Grymes RA, 1997, IN VITRO CELL DEV-AN, V33, P392, DOI 10.1007/s11626-997-0011-8; Hirano Y, 2008, J BIOTECHNOL, V133, P245, DOI 10.1016/j.jbiotec.2007.07.955; Huang CY, 2013, J PLAST RECONSTR AES, V66, pE351, DOI 10.1016/j.bjps.2013.08.002; HUNT CC, 1975, J PHYSIOL-LONDON, V252, P259, DOI 10.1113/jphysiol.1975.sp011143; Kato T, 1998, BIOCHEM BIOPH RES CO, V244, P615, DOI 10.1006/bbrc.1998.8335; Kessler D, 2001, J BIOL CHEM, V276, P36575, DOI 10.1074/jbc.M101602200; Kippenberger S, 2000, J INVEST DERMATOL, V114, P408, DOI 10.1046/j.1523-1747.2000.00915.x; Kippenberger S, 2005, J BIOL CHEM, V280, P3060, DOI 10.1074/jbc.M409590200; Knies Y, 2006, EXP DERMATOL, V15, P347, DOI 10.1111/j.0906-6705.2006.00422.x; Kurita M, 2011, BIOCHEM BIOPH RES CO, V409, P103, DOI 10.1016/j.bbrc.2011.04.118; Maas-Szabowski N, 1999, J CELL SCI, V112, P1843; Marionnet C, 2006, J INVEST DERMATOL, V126, P971, DOI 10.1038/sj.jid.5700230; Nagai Y, 2012, BIOMATERIALS, V33, P1044, DOI 10.1016/j.biomaterials.2011.10.049; Naruse K, 1998, AM J PHYSIOL-HEART C, V274, pH1532; Naruse K, 1998, FEBS LETT, V441, P111, DOI 10.1016/S0014-5793(98)01528-2; Netzlaff F, 2007, EUR J PHARM BIOPHARM, V66, P127, DOI 10.1016/j.ejpb.2006.08.012; Nishimura K, 2007, WOUND REPAIR REGEN, V15, P646, DOI 10.1111/j.1524-475X.2007.00295.x; Nishimura K, 2009, J SURG RES, V155, P125, DOI 10.1016/j.jss.2008.07.029; Ogura Y, 2008, BRIT J DERMATOL, V159, P49, DOI 10.1111/j.1365-2133.2008.08576.x; Russell D, 2004, J CELL SCI, V117, P5233, DOI 10.1242/jcs.01407; Segal N, 2008, MATRIX BIOL, V27, P163, DOI 10.1016/j.matbio.2007.09.002; STOCKBRIDGE LL, 1988, BIOPHYS J, V54, P187, DOI 10.1016/S0006-3495(88)82944-8; Syedain ZH, 2009, BIOMATERIALS, V30, P4078, DOI 10.1016/j.biomaterials.2009.04.027; Szabowski A, 2000, CELL, V103, P745, DOI 10.1016/S0092-8674(00)00178-1; Takei T, 1997, J CELL BIOCHEM, V67, P327, DOI 10.1002/(SICI)1097-4644(19971201)67:3<327::AID-JCB5>3.0.CO;2-Y; Takei T, 1997, J CELL PHYSIOL, V173, P64, DOI 10.1002/(SICI)1097-4652(199710)173:1<64::AID-JCP8>3.0.CO;2-H; Tsunenaga M, 1998, MATRIX BIOL, V17, P603, DOI 10.1016/S0945-053X(98)90111-1; Wang ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040951; Wen HA, 2009, INT WOUND J, V6, P149, DOI 10.1111/j.1742-481X.2009.00591.x; Yang GG, 2004, J BIOMECH, V37, P1543, DOI 10.1016/j.jbiomech.2004.01.005; Yang LJ, 2009, J DERMATOL SCI, V56, P188, DOI 10.1016/j.jdermsci.2009.09.009; Yano S, 2004, J INVEST DERMATOL, V122, P783, DOI 10.1111/j.0022-202X.2004.22328.x	44	31	35	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141989	10.1371/journal.pone.0141989	http://dx.doi.org/10.1371/journal.pone.0141989			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528823	Green Published, Green Submitted, gold			2022-12-26	WOS:000364032600087
J	Wang, RS; Ding, Q; Yaqoob, U; de Assuncao, TM; Verma, VK; Hirsova, P; Cao, S; Mukhopadhyay, D; Huebert, RC; Shah, VH				Wang, Ruisi; Ding, Qian; Yaqoob, Usman; de Assuncao, Thiago M.; Verma, Vikas K.; Hirsova, Petra; Cao, Sheng; Mukhopadhyay, Debabrata; Huebert, Robert C.; Shah, Vijay H.			Exosome Adherence and Internalization by Hepatic Stellate Cells Triggers Sphingosine 1-Phosphate-dependent Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-CELLS; LIVER FIBROSIS; EXTRACELLULAR EXPORT; MEDIATED ENDOCYTOSIS; GROWTH; MICROPARTICLES; MICROVESICLES; ROLES; PATHOGENESIS; ACTIVATION	Exosomes are cell-derived extracellular vesicles thought to promote intercellular communication by delivering specific content to target cells. The aim of this study was to determine whether endothelial cell (EC)-derived exosomes could regulate the phenotype of hepatic stellate cells (HSCs). Initial microarray studies showed that fibroblast growth factor 2 induced a 2.4-fold increase in mRNA levels of sphingosine kinase 1 (SK1). Exosomes derived from an SK1-overexpressing EC line increased HSC migration 3.2-fold. Migration was not conferred by the dominant negative SK1 exosome. Incubation of HSCs with exosomes was also associated with an 8.3-fold increase in phosphorylation of AKT and 2.5-fold increase in migration. Exosomes were found to express the matrix protein and integrin ligand fibronectin (FN) by Western blot analysis and transmission electron microscopy. Blockade of the FN-integrin interaction with a CD29 neutralizing antibody or the RGD peptide attenuated exosome-induced HSC AKT phosphorylation and migration. Inhibition of endocytosis with transfection of dynamin siRNA, the dominant negative dynamin GTPase construct Dyn2K44A, or the pharmacological inhibitor Dynasore significantly attenuated exosome-induced AKT phosphorylation. SK1 levels were increased in serum exosomes derived from mice with experimental liver fibrosis, and SK1 mRNA levels were up-regulated 2.5-fold in human liver cirrhosis patient samples. Finally, S1PR2 inhibition protected mice from CCl4-induced liver fibrosis. Therefore, EC-derived SK1-containing exosomes regulate HSC signaling and migration through FN-integrin-dependent exosome adherence and dynamin-dependent exosome internalization. These findings advance our understanding of EC/HSC cross-talk and identify exosomes as a potential target to attenuate pathobiology signals.	[Wang, Ruisi] Mayo Clin, Dept Mol Pharmacol, Rochester, MN 55902 USA; [Wang, Ruisi] Mayo Clin, Dept Expt Therapeut, Rochester, MN 55902 USA; [Mukhopadhyay, Debabrata] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55902 USA; [Ding, Qian; Yaqoob, Usman; de Assuncao, Thiago M.; Verma, Vikas K.; Hirsova, Petra; Cao, Sheng; Huebert, Robert C.; Shah, Vijay H.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55902 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Shah, VH (corresponding author), Mayo Clin, 200 First St SW, Rochester, MN 55905 USA.	shah.vijay@mayo.edu	Hirsova, Petra/B-8943-2018; Verma, Vikas/I-6593-2018; Regan, Clinton/E-6250-2012	Hirsova, Petra/0000-0003-0494-0924; Verma, Vikas/0000-0003-2890-9200; 	National Institutes of Health [R01 DK59615, R01 AA021171, P30 DK84567, U01 AA21788]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK100575, P30DK084567, R01DK059615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA021171, R01AA021171, U01AA021788] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK59615 and R01 AA021171 (to V. H. S.). Patient samples were obtained through the support of National Institutes of Health Grants P30 DK84567 (to N. F. L.) and U01 AA21788 (to V. H. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ancellin N, 2002, J BIOL CHEM, V277, P6667, DOI 10.1074/jbc.M102841200; Arendt BK, 2014, ONCOTARGET, V5, P5686, DOI 10.18632/oncotarget.2159; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bobrie A, 2011, TRAFFIC, V12, P1659, DOI 10.1111/j.1600-0854.2011.01225.x; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Calzolari A, 2006, J CELL SCI, V119, P4486, DOI 10.1242/jcs.03228; Cao S, 2010, J CLIN INVEST, V120, P2379, DOI 10.1172/JCI41203; Cao Y, 2010, J BIOL CHEM, V285, P31840, DOI 10.1074/jbc.M110.151696; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Damke H, 2001, MOL BIOL CELL, V12, P2578, DOI 10.1091/mbc.12.9.2578; de Assuncao TM, 2014, J BIOL CHEM, V289, P15798, DOI 10.1074/jbc.M113.544346; El-Sayed A, 2013, MOL THER, V21, P1118, DOI 10.1038/mt.2013.54; Fitzner D, 2011, J CELL SCI, V124, P447, DOI 10.1242/jcs.074088; Giugliano S, 2015, GASTROENTEROLOGY, V148, P392, DOI 10.1053/j.gastro.2014.10.040; Henderson NC, 2013, BBA-MOL BASIS DIS, V1832, P891, DOI 10.1016/j.bbadis.2012.10.005; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Higuchi M, 2008, NAT CELL BIOL, V10, P1356, DOI 10.1038/ncb1795; Huebert RC, 2010, LAB INVEST, V90, P1770, DOI 10.1038/labinvest.2010.132; Huebert RC, 2010, HEPATOLOGY, V52, P238, DOI 10.1002/hep.23628; Kageyama Y, 2012, HEPATOLOGY, V56, P1427, DOI 10.1002/hep.25780; Kang NL, 2011, HEPATOLOGY, V54, P707, DOI 10.1002/hep.24384; Kornek M, 2012, GASTROENTEROLOGY, V143, P448, DOI 10.1053/j.gastro.2012.04.031; Kornek M, 2011, HEPATOLOGY, V53, P230, DOI 10.1002/hep.23999; Lalor PF, 2002, J IMMUNOL, V169, P983, DOI 10.4049/jimmunol.169.2.983; Lee HD, 2014, EUR J IMMUNOL, V44, P1156, DOI 10.1002/eji.201343660; Lemoinne S, 2015, HEPATOLOGY, V61, P1041, DOI 10.1002/hep.27318; Lemoinne S, 2014, NAT REV GASTRO HEPAT, V11, DOI 10.1038/nrgastro.2014.7; Li CY, 2011, J HEPATOL, V54, P1205, DOI 10.1016/j.jhep.2010.08.028; Liu CS, 2013, J CLIN INVEST, V123, P1138, DOI 10.1172/JCI63836; Looze C, 2009, BIOCHEM BIOPH RES CO, V378, P433, DOI 10.1016/j.bbrc.2008.11.050; Luga V, 2012, CELL, V151, P1542, DOI 10.1016/j.cell.2012.11.024; Maceyka M, 2009, J LIPID RES, V50, pS272, DOI 10.1194/jlr.R800065-JLR200; Marimpietri D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075054; Masyuk AI, 2013, J HEPATOL, V59, P621, DOI 10.1016/j.jhep.2013.03.028; Melo SA, 2015, NATURE, V523, P177, DOI 10.1038/nature14581; Moreira RK, 2007, ARCH PATHOL LAB MED, V131, P1728; Nojima H, 2016, J HEPATOL, V64, P60, DOI 10.1016/j.jhep.2015.07.030; Pitson SM, 2001, FEBS LETT, V509, P169; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Schrage A, 2008, HISTOCHEM CELL BIOL, V129, P441, DOI 10.1007/s00418-008-0379-x; Senger DR, 2002, AM J PATHOL, V160, P195, DOI 10.1016/S0002-9440(10)64363-5; Serriere-Lanneau V, 2007, FASEB J, V21, P2005, DOI 10.1096/fj.06-6889com; Simonetto DA, 2015, HEPATOLOGY, V61, P648, DOI 10.1002/hep.27387; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; Svensson KJ, 2013, J BIOL CHEM, V288, P17713, DOI 10.1074/jbc.M112.445403; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tian T, 2014, J BIOL CHEM, V289, P22258, DOI 10.1074/jbc.M114.588046; Tu KS, 2015, HEPATOLOGY, V61, P361, DOI 10.1002/hep.27251; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van Beijnum JR, 2008, NAT PROTOC, V3, P1085, DOI 10.1038/nprot.2008.71; Venkataraman K, 2006, BIOCHEM J, V397, P461, DOI 10.1042/BJ20060251; Wang Z, 2013, STRUCTURE, V21, P798, DOI 10.1016/j.str.2013.02.025; Witek RP, 2009, GASTROENTEROLOGY, V136, P320, DOI 10.1053/j.gastro.2008.09.066; Yang L, 2013, J HEPATOL, V59, P114, DOI 10.1016/j.jhep.2013.02.021; Yang L, 2014, GASTROENTEROLOGY, V146, P1339, DOI 10.1053/j.gastro.2014.01.061; Yang L, 2012, HEPATOLOGY, V56, p768A; Yaqoob U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098130; Yaqoob U, 2012, CANCER RES, V72, P4047, DOI 10.1158/0008-5472.CAN-11-3907; Zhu Q, 2012, J HEPATOL, V56, P893, DOI 10.1016/j.jhep.2011.11.013; Zou L, 2012, J BIOL CHEM, V287, P7190, DOI 10.1074/jbc.M111.304972	60	136	148	2	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					30684	U51		10.1074/jbc.M115.671735	http://dx.doi.org/10.1074/jbc.M115.671735			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26534962	Green Published, hybrid			2022-12-26	WOS:000367199000003
J	Dean, GS; Clifford, D; Whelan, AO; Tchilian, EZ; Beverley, PCL; Salguero, FJ; Xing, Z; Vordermeier, HM; Villarreal-Ramos, B				Dean, Gillian S.; Clifford, Derek; Whelan, Adam O.; Tchilian, Elma Z.; Beverley, Peter C. L.; Salguero, Francisco J.; Xing, Zhou; Vordermeier, Hans M.; Villarreal-Ramos, Bernardo			Protection Induced by Simultaneous Subcutaneous and Endobronchial Vaccination with BCG/BCG and BCG/Adenovirus Expressing Antigen 85A against Mycobacterium bovis in Cattle	PLOS ONE			English	Article							BCG; TUBERCULOSIS; IMMUNIZATION; RESPONSES; VACCINES; MUCOSAL	The incidence of bovine tuberculosis (bTB) in the GB has been increasing since the 1980s. Immunisation, alongside current control measures, has been proposed as a sustainable measure to control bTB. Immunisation with Mycobacterium bovis bacillus Calmette-Guerin (BCG) has been shown to protect against bTB. Furthermore, much experimental data indicates that pulmonary local immunity is important for protection against respiratory infections including Mycobacterium tuberculosis and that pulmonary immunisation is highly effective. Here, we evaluated protection against M. bovis, the main causative agent of bTB, conferred by BCG delivered subcutaneously, endobronchially or by the new strategy of simultaneous immunisation by both routes. We also tested simultaneous subcutaneous immunisation with BCG and endobronchial delivery of a recombinant type 5 adenovirus expressing mycobacterial antigen 85A. There was significantly reduced visible pathology in animals receiving the simultaneous BCG/BCG or BCG/Ad85 treatment compared to naive controls. Furthermore, there were significantly fewer advanced microscopic granulomata in animals receiving BCG/Ad85A compared to naive controls. Thus, combining local and systemic immunisation limits the development of pathology, which in turn could decrease bTB transmission.	[Dean, Gillian S.; Clifford, Derek; Whelan, Adam O.; Salguero, Francisco J.; Vordermeier, Hans M.; Villarreal-Ramos, Bernardo] APHA Weybridge, TB Res Grp, New Haw KT15 3NB, Surrey, England; [Xing, Zhou] McMaster Univ, McMaster Immunol Res Ctr, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Tchilian, Elma Z.; Beverley, Peter C. L.] Univ Oxford, Peter Medawar Bldg Pathogen Res, Oxford, England	McMaster University; University of Oxford	Villarreal-Ramos, B (corresponding author), APHA Weybridge, TB Res Grp, Woodham Lane, New Haw KT15 3NB, Surrey, England.	Bernardo.Villarreal-Ramos@apha.gsi.gov.uk	Tchilian, Elma Z/Q-5976-2017; Salguero, Francisco J/A-7336-2010; Vordermeier, H Martin/C-6936-2011	Tchilian, Elma Z/0000-0002-4869-5118; Beverley, Peter/0000-0003-0481-2180; Salguero, Francisco Javier/0000-0002-5315-3882	 [SE3266];  [60701235]; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001932] Funding Source: researchfish; Medical Research Council [G1100085, G0701235] Funding Source: researchfish; BBSRC [BBS/E/I/00001932] Funding Source: UKRI; MRC [G1100085, G0701235] Funding Source: UKRI	; ; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	SE3266 (https://www.gov.uk/government/organisations/department-for-environment-food-ruralaffairs) HMV BVR AOW GSD DC FJS, 60701235 (http://www.mrc.ac.uk/) EZT PCLB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranday-Cortes E, 2012, TRANSBOUND EMERG DIS, DOI [10.1111/tbed.12035, DOI 10.1111/TBED.12035]; Calmette A, 1931, Proc R Soc Med, V24, P1481; Dean G, 2014, VACCINE, V32, P1304, DOI 10.1016/j.vaccine.2013.11.045; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; Forbes EK, 2008, J IMMUNOL, V181, P4955, DOI 10.4049/jimmunol.181.7.4955; Griffin JFT, 2001, TUBERCULOSIS, V81, P133, DOI 10.1054/tube.2000.0271; Krebs J., 1997, PB3423 HMSO; Lightbody KA, 1998, VET REC, V142, P295, DOI 10.1136/vr.142.12.295; Ronan EO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008235; Santosuosso M, 2006, INFECT IMMUN, V74, P4634, DOI 10.1128/IAI.00517-06; Smaill F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006843; Tchilian EZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027477; Villarreal-Ramos B, 2006, VACCINE, V24, P6850, DOI 10.1016/j.vaccine.2006.06.034; Vordermeier HM, 2009, INFECT IMMUN, V77, P3364, DOI 10.1128/IAI.00287-09; Vordermeier HM, 2004, IMMUNOLOGY, V112, P461, DOI 10.1111/j.1365-2567.2004.01903.x; Vordermeier HM, 2002, INFECT IMMUN, V70, P3026, DOI 10.1128/IAI.70.6.3026-3032.2002; Vordermeier HM, 2006, VET J, V171, P229, DOI 10.1016/j.tvjl.2004.11.001; Wang J, 2004, J IMMUNOL, V173, P6357, DOI 10.4049/jimmunol.173.10.6357; Wangoo A, 2005, J COMP PATHOL, V133, P223, DOI 10.1016/j.jcpa.2005.05.001; Whelan A, 2012, VACCINE, V30, P6294, DOI 10.1016/j.vaccine.2012.07.086; Wood PR, 2001, TUBERCULOSIS, V81, P147, DOI 10.1054/tube.2000.0272; Xing Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005856	22	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142270	10.1371/journal.pone.0142270	http://dx.doi.org/10.1371/journal.pone.0142270			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544594	Green Published, Green Submitted, gold			2022-12-26	WOS:000364398700103
J	Natarelli, L; Ranaldi, G; Leoni, G; Roselli, M; Guantario, B; Comitato, R; Ambra, R; Cimino, F; Speciale, A; Virgili, F; Canali, R				Natarelli, Lucia; Ranaldi, Giulia; Leoni, Guido; Roselli, Marianna; Guantario, Barbara; Comitato, Raffaella; Ambra, Roberto; Cimino, Francesco; Speciale, Antonio; Virgili, Fabio; Canali, Raffaella			Nanomolar Caffeic Acid Decreases Glucose Uptake and the Effects of High Glucose in Endothelial Cells	PLOS ONE			English	Article							NF-KAPPA-B; NATURAL PROTECTIVE MECHANISM; INDUCED APOPTOSIS; COFFEE CONSUMPTION; HYPERGLYCEMIA; INHIBITION; PATHWAY; DEATH; RISK; PHOSPHORYLATION	Epidemiological studies suggest that moderate and prolonged consumption of coffee is associated with a reduced risk of developing type 2 diabetes but the molecular mechanisms underlying this effect are not known. In this study, we report the effects of physiological concentrations of caffeic acid, easily achievable by normal dietary habits, in endothelial cells cultured in 25 mM of glucose (high glucose, HG). In HG, the presence of 10 nM caffeic acid was associated with a decrease of glucose uptake but not to changes of GLUT-1 membrane localization or mRNA levels. Moreover, caffeic acid countered HG-induced loss of barrier integrity, reducing actin rearrangement and FITC-dextran passage. The decreased flux of glucose associated to caffeic acid affected HG induced apoptosis by down-regulating the expression of initiator (caspase 8 and 9) and effector caspases (caspase 7 and 3) and by increasing the levels of phosphorylated Bcl-2. We also observed that caffeic acid in HG condition was associated to a reduction of p65 subunit nuclear levels with respect to HG alone. NF-kappa B activation has been shown to lead to apoptosis in HG treated cells and the analysis of the expression of a panel of about 90 genes related to NF-kappa B signaling pathway revealed that caffeic acid significantly influenced gene expression changes induced by HG. In conclusion, our results suggest that caffeic acid, decreasing the metabolic stress induced by HG, allows the activation of survival mechanisms mediated by a different modulation of NF-kappa B-related signaling pathways and to the activation of anti-apoptotic proteins.	[Natarelli, Lucia; Ranaldi, Giulia; Roselli, Marianna; Guantario, Barbara; Comitato, Raffaella; Ambra, Roberto; Virgili, Fabio; Canali, Raffaella] Council Agr Res & Econ, Food & Nutr Res Ctr, Rome, Italy; [Leoni, Guido] Univ Roma La Sapienza, Dept Phys, I-00185 Rome, Italy; [Cimino, Francesco; Speciale, Antonio] Univ Messina, Dept Drug Sci & Hlth Prod, Messina, Italy	Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Sapienza University Rome; University of Messina	Canali, R (corresponding author), Council Agr Res & Econ, Food & Nutr Res Ctr, Rome, Italy.	raffaella.canali@entecra.it	Roselli, Marianna/L-6501-2019; Ranaldi, Giulia/ABC-4934-2020; Speciale, Antonio/C-2846-2011; Natarelli, Lucia/AAY-6449-2020; Canali, Raffaella/AAA-3965-2020; Leoni, Guido/AAX-6544-2020	Roselli, Marianna/0000-0003-2355-3241; Speciale, Antonio/0000-0002-6135-3892; Canali, Raffaella/0000-0003-0012-4831; Leoni, Guido/0000-0003-0502-1962; Ambra, Roberto/0000-0002-1120-3976; Natarelli, Lucia/0000-0002-9725-6576; RANALDI, GIULIA/0000-0002-6889-144X; Guantario, Barbara/0000-0002-1759-5253; Virgili, Fabio/0000-0002-9691-8742	Italian Ministry of Agricultural and Nutritional Policies and Forestry	Italian Ministry of Agricultural and Nutritional Policies and Forestry	This work was supported by the Italian Ministry of Agricultural and Nutritional Policies and Forestry (Special Research Projects MiPAAF - NUME and MiPAAF - MEDITO). The authors are grateful to the Epigenomics Flagship Project-EPIGEN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliprantis AO, 2000, EMBO J, V19, P3325, DOI 10.1093/emboj/19.13.3325; Alpert E, 2005, DIABETOLOGIA, V48, P752, DOI 10.1007/s00125-005-1681-y; Alpert E, 2002, BIOCHEM J, V362, P413, DOI 10.1042/0264-6021:3620413; BAUER J, 1992, J CELL PHYSIOL, V153, P437, DOI 10.1002/jcp.1041530302; BAUMGARTNERPARZER SM, 1995, DIABETES, V44, P1323, DOI 10.2337/diabetes.44.11.1323; Bhupathiraju SN, 2013, AM J CLIN NUTR, V97, P155, DOI 10.3945/ajcn.112.048603; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Busik JV, 2002, INVEST OPHTH VIS SCI, V43, P2356; Cerami EG, 2011, NUCLEIC ACIDS RES, V39, pD685, DOI 10.1093/nar/gkq1039; Chang WC, 2010, TAIWAN J OBSTET GYNE, V49, P419, DOI 10.1016/S1028-4559(10)60092-7; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Cohen G., 2007, Archives of Physiology and Biochemistry, V113, P259, DOI 10.1080/13813450701783513; Davidson SM, 2006, AM J PHYSIOL-HEART C, V291, pH1486, DOI 10.1152/ajpheart.00301.2006; de Jongh RT, 2004, CIRCULATION, V109, P2529, DOI 10.1161/01.CIR.0000129772.26647.6F; Duffy A, 2006, ENDOTHELIUM-J ENDOTH, V13, P9, DOI 10.1080/10623320600659997; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Frustaci A, 2000, CIRC RES, V87, P1123, DOI 10.1161/01.RES.87.12.1123; Goldin A, 2006, CIRCULATION, V114, P597, DOI 10.1161/CIRCULATIONAHA.106.621854; Handa P, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-16; Hempel A, 1997, CIRC RES, V81, P363, DOI 10.1161/01.RES.81.3.363; Hindley A, 2002, J CELL SCI, V115, P1575; Ho FM, 2006, CELL SIGNAL, V18, P391, DOI 10.1016/j.cellsig.2005.05.009; Huang DW, 2009, J AGR FOOD CHEM, V57, P7687, DOI 10.1021/jf901376x; KAISER N, 1993, DIABETES, V42, P80, DOI 10.2337/diabetes.42.1.80; Kaiser WJ, 2004, J IMMUNOL, V172, P1699, DOI 10.4049/jimmunol.172.3.1699; Kang NJ, 2009, CARCINOGENESIS, V30, P321, DOI 10.1093/carcin/bgn282; Kishimoto Y, 2013, EUR J CLIN NUTR, V67, P532, DOI 10.1038/ejcn.2013.29; Lee HZ, 2004, LIFE SCI, V74, P2085, DOI 10.1016/j.lfs.2003.06.046; McIlwain DR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008656; Miele C, 2007, J BIOL CHEM, V282, P31835, DOI 10.1074/jbc.M702481200; Munshi N, 2002, J IMMUNOL, V168, P5860, DOI 10.4049/jimmunol.168.11.5860; Nakagami H, 2001, DIABETES, V50, P1472, DOI 10.2337/diabetes.50.6.1472; Nardini M, 2002, J AGR FOOD CHEM, V50, P5735, DOI 10.1021/jf0257547; Natella F, 2012, NUTR REV, V70, P207, DOI 10.1111/j.1753-4887.2012.00470.x; Nobe K, 2006, J PHARMACOL EXP THER, V318, P530, DOI 10.1124/jpet.106.105015; Nourbakhsh M, 1999, EMBO J, V18, P6415, DOI 10.1093/emboj/18.22.6415; Ranaldi G, 2013, J NUTR BIOCHEM, V24, P967, DOI 10.1016/j.jnutbio.2012.06.020; Riahi Y, 2010, DIABETES, V59, P808, DOI 10.2337/db09-1207; Ruvolo PP, 2001, LEUKEMIA, V15, P515, DOI 10.1038/sj.leu.2402090; Salameh A, 1997, J CARDIOVASC PHARM, V30, P182, DOI 10.1097/00005344-199708000-00006; Salaun B, 2007, EUR J IMMUNOL, V37, P3311, DOI 10.1002/eji.200737744; Sheu ML, 2005, ARTERIOSCL THROM VAS, V25, P539, DOI 10.1161/01.ATV.0000155462.24263.e4; Sprick MR, 2004, BBA-MOL CELL RES, V1644, P125, DOI 10.1016/j.bbamcr.2003.11.002; Sun RL, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.178798; Swanton E, 1999, ONCOGENE, V18, P1781, DOI 10.1038/sj.onc.1202490; Tobin NP, 2008, AM J PHYSIOL-HEART C, V295, pH1403, DOI 10.1152/ajpheart.00240.2008; Tunnicliffe JM, 2008, APPL PHYSIOL NUTR ME, V33, P1290, DOI 10.1139/H08-123; Vacaresse N, 2001, BRIT J PHARMACOL, V132, P1777, DOI 10.1038/sj.bjp.0703981; van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97; Van Dam RM, 2004, DIABETES CARE, V27, P2990, DOI 10.2337/diacare.27.12.2990; Vauzour D, 2010, NUTRIENTS, V2, P1106, DOI 10.3390/nu2111106; Wegener Elmar, 2007, Sci STKE, V2007, ppe21, DOI 10.1126/stke.3842007pe21; WELSCH CA, 1989, J NUTR, V119, P1698, DOI 10.1093/jn/119.11.1698; Yochum L, 1999, AM J EPIDEMIOL, V149, P943, DOI 10.1093/oxfordjournals.aje.a009738	54	10	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142421	10.1371/journal.pone.0142421	http://dx.doi.org/10.1371/journal.pone.0142421			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544184	Green Submitted, Green Published, gold			2022-12-26	WOS:000364398700134
J	Park, SJ; Ahn, HS; Kim, JS; Lee, C				Park, Seong-Jun; Ahn, Hee-Sung; Kim, Jun Seok; Lee, Cheolju			Evaluation of Multi-tRNA Synthetase Complex by Multiple Reaction Monitoring Mass Spectrometry Coupled with Size Exclusion Chromatography	PLoS One			English	Article							PROTEIN-PROTEIN INTERACTIONS; ELONGATION FACTOR-I; MACROMOLECULAR ASSEMBLAGE; CANCER; PURIFICATION; CELLS; QUANTIFICATION; TRANSLATION; DISSECTION; PROTEOMICS	Eight aminoacyl-tRNA synthetases (M, K, Q, D, R, I, EP and LARS) and three auxiliary proteins (AIMP1, 2 and 3) are known to form a multi-tRNA synthetase complex (MSC) in mammalian cells. We combined size exclusion chromatography (SEC) with reversed-phase liquid chromatography multiple reaction monitoring mass spectrometry (RPLC-MRM-MS) to characterize MSC components and free ARS proteins in human embryonic kidney (HEK 293T) cells. Crude cell extract and affinity-purified proteins were fractionated by SEC in non-denaturing state and ARSs were monitored in each fraction by MRM-MS. The eleven MSC components appeared mostly in earlier SEC fractions demonstrating their participation in complex formation. TARSL2 and AIMP2-DX2, despite their low abundance, were co-purified with KARS and detected in the SEC fractions, where MSC appeared. Moreover, other large complex-forming ARS proteins, such as VARS and FARS, were detected in earlier fractions. The MRM-MS results were further confirmed by western blot analysis. Our study demonstrates usefulness of combined SEC-MRM analysis for the characterization of protein complexes and in understanding the behavior of minor isoforms or variant proteins.	[Park, Seong-Jun; Ahn, Hee-Sung; Kim, Jun Seok; Lee, Cheolju] Korea Inst Sci & Technol, Biomed Res Inst, Ctr Theragnosis, Seoul 136791, South Korea; [Ahn, Hee-Sung; Lee, Cheolju] Univ Sci & Technol, Dept Biol Chem, Daejeon 305333, South Korea	Korea Institute of Science & Technology (KIST); University of Science & Technology (UST)	Lee, C (corresponding author), Korea Inst Sci & Technol, Biomed Res Inst, Ctr Theragnosis, Seoul 136791, South Korea.	clee270@kist.re.kr		Ahn, Hee-Sung/0000-0003-2241-6536	National Research Foundation - Korean Ministry of Science, ICT and Future Planning [2013M3A9B6076414]; Korea Health Industry Development Institute - Korean Ministry of Health Welfare [HI14C3484]; National Research Council of Science and Technology; intramural program of the Korea Institute of Science and Technology	National Research Foundation - Korean Ministry of Science, ICT and Future Planning; Korea Health Industry Development Institute - Korean Ministry of Health Welfare; National Research Council of Science and Technology; intramural program of the Korea Institute of Science and Technology	The study was supported by a grant from the National Research Foundation (Next-Generation Applied Omics program: 2013M3A9B6076414) funded by the Korean Ministry of Science, ICT and Future Planning, a grant from the Korea Health Industry Development Institute (Research Hospital program: HI14C3484) funded by the Korean Ministry of Health & Welfare, and a grant for the Joint Research Project funded by National Research Council of Science and Technology. The study was also supported by an intramural program of the Korea Institute of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEC G, 1989, J BIOL CHEM, V264, P21131; Choi JW, 2012, J MOL CELL BIOL, V4, P164, DOI 10.1093/jmcb/mjs018; Choi JW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001351; Dias J, 2013, J BIOL CHEM, V288, P23979, DOI 10.1074/jbc.M113.489922; Fu YY, 2014, P NATL ACAD SCI USA, V111, P15084, DOI 10.1073/pnas.1408836111; Guo M, 2013, NAT CHEM BIOL, V9, P145, DOI [10.1038/nchembio.1158, 10.1038/NCHEMBIO.1158]; Havugimana PC, 2012, CELL, V150, P1068, DOI 10.1016/j.cell.2012.08.011; Hooper J, 1997, J ROY SOC MED, V90, P706; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Kaminska M, 2009, J BIOL CHEM, V284, P6053, DOI 10.1074/jbc.M809636200; Keefe AD, 2001, PROTEIN EXPRES PURIF, V23, P440, DOI 10.1006/prep.2001.1515; Kennedy JJ, 2014, NAT METHODS, V11, P149, DOI [10.1038/NMETH.2763, 10.1038/nmeth.2763]; Kim JS, 2014, ANAL CHIM ACTA, V840, P1, DOI 10.1016/j.aca.2014.06.024; Kim JS, 2013, J PROTEOME RES, V12, P2582, DOI 10.1021/pr3011414; Kim JY, 2002, P NATL ACAD SCI USA, V99, P7912, DOI 10.1073/pnas.122110199; Kim K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081734; Kirkwood KJ, 2013, MOL CELL PROTEOMICS, V12, P3851, DOI 10.1074/mcp.M113.032367; Kristensen AR, 2012, NAT METHODS, V9, P907, DOI 10.1038/nmeth.2131; Kuzyk MA, 2009, MOL CELL PROTEOMICS, V8, P1860, DOI 10.1074/mcp.M800540-MCP200; Lee SW, 2004, J CELL SCI, V117, P3725, DOI 10.1242/jcs.01342; Liu XQ, 2013, METHODS, V61, P304, DOI 10.1016/j.ymeth.2013.03.006; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Martinez-Aguilar J, 2013, J PROTEOME RES, V12, P3679, DOI 10.1021/pr400251t; MOSYAK L, 1995, NAT STRUCT BIOL, V2, P537, DOI 10.1038/nsb0795-537; MOTORIN YA, 1991, EUR J BIOCHEM, V201, P325, DOI 10.1111/j.1432-1033.1991.tb16289.x; Nathanson L, 2000, J BIOL CHEM, V275, P31559, DOI 10.1074/jbc.C000385200; Negrutskii BS, 1999, J BIOL CHEM, V274, P4545, DOI 10.1074/jbc.274.8.4545; Olinares PDB, 2010, MOL CELL PROTEOMICS, V9, P1594, DOI 10.1074/mcp.M000038-MCP201; Pan S, 2012, J PROTEOME RES, V11, P1937, DOI 10.1021/pr201117w; Pardo M, 2012, J PROTEOME RES, V11, P1462, DOI 10.1021/pr2011632; Park SG, 2005, TRENDS BIOCHEM SCI, V30, P569, DOI 10.1016/j.tibs.2005.08.004; Quevillon S, 1999, J MOL BIOL, V285, P183, DOI 10.1006/jmbi.1998.2316; Rho SB, 1999, P NATL ACAD SCI USA, V96, P4488, DOI 10.1073/pnas.96.8.4488; Robinson JC, 2000, J MOL BIOL, V304, P983, DOI 10.1006/jmbi.2000.4242; Rodova M, 1999, BIOCHEM BIOPH RES CO, V255, P765, DOI 10.1006/bbrc.1999.0141; Schimmel P, 2008, PROTEIN SCI, V17, P1643, DOI 10.1110/ps.037242.108; Trinkle-Mulcahy L, 2008, J CELL BIOL, V183, P223, DOI 10.1083/jcb.200805092; Yao P, 2013, EMBO MOL MED, V5, P332, DOI 10.1002/emmm.201100626	38	12	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142253	10.1371/journal.pone.0142253	http://dx.doi.org/10.1371/journal.pone.0142253			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544075	Green Submitted, gold, Green Published			2022-12-26	WOS:000364398700101
J	Reid, JP; Schnitzer, SA; Powers, JS				Reid, Joseph Pignatello; Schnitzer, Stefan A.; Powers, Jennifer S.			Short and Long-Term Soil Moisture Effects of Liana Removal in a Seasonally Moist Tropical Forest	PLOS ONE			English	Article							TREE REGENERATION; SECONDARY FOREST; GROWTH; DYNAMICS; PATTERNS; ABUNDANCE; DROUGHT; WATER; ECOLOGY; BIOMASS	Lianas (woody vines) are particularly abundant in tropical forests, and their abundance is increasing in the neotropics. Lianas can compete intensely with trees for above-and below-ground resources, including water. As tropical forests experience longer and more intense dry seasons, competition for water is likely to intensify. However, we lack an understanding of how liana abundance affects soil moisture and hence competition with trees for water in tropical forests. To address this critical knowledge gap, we conducted a large-scale liana removal experiment in a seasonal tropical moist forest in central Panama. We monitored shallow and deep soil moisture over the course of three years to assess the effects of lianas in eight 0.64 ha removal plots and eight control plots. Liana removal caused short-term effects in surface soils. Surface soils (10 cm depth) in removal plots dried more slowly during dry periods and accumulated water more slowly after rainfall events. These effects disappeared within four months of the removal treatment. In deeper soils (40 cm depth), liana removal resulted in a multi-year trend towards 5-25% higher soil moisture during the dry seasons with the largest significant effects occurring in the dry season of the third year following treatment. Liana removal did not affect surface soil temperature. Multiple and mutually occurring mechanisms may be responsible for the effects of liana removal on soil moisture, including competition with trees, and altered microclimate, and soil structure. These results indicate that lianas influence hydrologic processes, which may affect tree community dynamics and forest carbon cycling.	[Reid, Joseph Pignatello; Powers, Jennifer S.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Schnitzer, Stefan A.] Marquette Univ, Dept Biol Sci, Milwaukee, WI 53201 USA; [Schnitzer, Stefan A.; Powers, Jennifer S.] Smithsonian Trop Res Inst, Balboa, Panama; [Powers, Jennifer S.] Univ Minnesota, Dept Plant Biol, St Paul, MN USA	University of Minnesota System; University of Minnesota Twin Cities; Marquette University; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Minnesota System; University of Minnesota Twin Cities	Powers, JS (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA.	powers@umn.edu	Reid, Joseph/I-3292-2012	Reid, Joseph/0000-0001-6905-5235	National Science Foundation [DEB 0845071]; NSF [DEB 1019436, DEB 1019441]; Direct For Biological Sciences [1019436] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was made possible by National Science Foundation Grants DEB 0845071 and NSF DEB 1019436 to S.A.S, and NSF DEB 1019441 to J.S.P. The website for the US National Science Foundation is: http://www.nsf.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Cansino L, 2015, ECOLOGY, V96, P39, DOI 10.1890/14-1002.1; Andrade JL, 2005, TREES-STRUCT FUNCT, V19, P282, DOI 10.1007/s00468-004-0388-x; Asner GP, 2012, ECOL LETT, V15, P1001, DOI 10.1111/j.1461-0248.2012.01821.x; Barry KE, BIOTROPICA IN PRESS; Bruno RD, 2006, HYDROL PROCESS, V20, P2477, DOI 10.1002/hyp.6211; Cai ZQ, 2009, OECOLOGIA, V161, P25, DOI 10.1007/s00442-009-1355-4; Carnpanello PI, 2007, FOREST ECOL MANAG, V252, P108, DOI 10.1016/j.foreco.2007.06.032; Chen LJ, 2015, IEEE SYST J, V9, P1091, DOI 10.1109/JSYST.2013.2296979; Coenders-Gerrits AMJ, 2013, HYDROL EARTH SYST SC, V17, P1749, DOI 10.5194/hess-17-1749-2013; DeWalt SJ, 2004, BIOTROPICA, V36, P7, DOI 10.1646/02115; Duran SM, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0301; EWERS FW, 1990, OECOLOGIA, V84, P544, DOI 10.1007/BF00328172; Ewers FW, 1997, OECOLOGIA, V110, P191, DOI 10.1007/s004420050149; Fu R, 2013, P NATL ACAD SCI USA, V110, P18110, DOI 10.1073/pnas.1302584110; GENTRY A H, 1983, Tropical Ecology, V24, P63; Grauel WT, 2004, FOREST ECOL MANAG, V190, P99, DOI 10.1016/j.foreco.2003.10.009; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoffman MD, 2014, J MACH LEARN RES, V15, P1593; Jacobsen AL, 2012, AM J BOT, V99, P1583, DOI 10.3732/ajb.1200140; Laurance WF, 2014, ECOLOGY, V95, P1604, DOI 10.1890/13-1571.1; Lewis SL, 2009, ANNU REV ECOL EVOL S, V40, P529, DOI 10.1146/annurev.ecolsys.39.110707.173345; da Costa ACL, 2010, NEW PHYTOL, V187, P579, DOI 10.1111/j.1469-8137.2010.03309.x; Perez-Salicrup DR, 2000, OECOLOGIA, V124, P469, DOI 10.1007/PL00008872; Perez-Salicrup DR, 2001, ECOLOGY, V82, P389, DOI 10.1890/0012-9658(2001)082[0389:EOLCOT]2.0.CO;2; Phillips OL, 2002, NATURE, V418, P770, DOI 10.1038/nature00926; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Powers JS, 2005, NEW PHYTOL, V165, P913, DOI 10.1111/j.1469-8137.2004.01279.x; Powers JS, 2014, ECOLOGY OF LIANAS; R Core Team, 2021, R LANGUAGE ENV STAT; Restom TG, 2004, FOREST ECOL MANAG, V190, P109, DOI 10.1016/j.foreco.2003.10.010; Restom TG, 2001, PLANT SOIL, V236, P155, DOI 10.1023/A:1012776532147; Schnitzer SA, 2002, TRENDS ECOL EVOL, V17, P223, DOI 10.1016/S0169-5347(02)02491-6; Schnitzer SA, 2005, AM NAT, V166, P262, DOI 10.1086/431250; Schnitzer SA, 2015, ECOLOGY OF LIANAS, P451; Schnitzer SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052114; Schnitzer SA, 2011, ECOL LETT, V14, P397, DOI 10.1111/j.1461-0248.2011.01590.x; Schnitzer SA, 2010, ECOL LETT, V13, P849, DOI 10.1111/j.1461-0248.2010.01480.x; Team SD, 2013, STAN MODELING LANGUA; Team SD, 2013, STAN A C LIB PROBABI; Tobin MF, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00322.1; Townsend AR, 2011, FRONT ECOL ENVIRON, V9, P9, DOI 10.1890/100047; van der Heijden GM, 2013, BIOTROPICA, V45, P682, DOI 10.1111/btp.12060; van der Heijden GMF, 2015, P NATL ACAD SCI USA, V112, P13267, DOI 10.1073/pnas.1504869112; van der Sande MT, 2013, OECOLOGIA, V172, P961, DOI 10.1007/s00442-012-2563-x; Wyka TP, 2013, ANN BOT-LONDON, V112, P1667, DOI 10.1093/aob/mct236; Yavitt JB, 2009, AUST J SOIL RES, V47, P674, DOI 10.1071/SR08258; Yavitt JB, 2008, J TROP ECOL, V24, P19, DOI 10.1017/S0266467407004713; Zhu SD, 2009, PLANT ECOL, V204, P295, DOI 10.1007/s11258-009-9592-5	48	17	18	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141891	10.1371/journal.pone.0141891	http://dx.doi.org/10.1371/journal.pone.0141891			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545205	Green Submitted, Green Published, gold			2022-12-26	WOS:000364398700060
J	Zhang, J; Chen, BB; Wu, T; Wang, Q; Zhuang, L; Zhu, C; Fan, N; Qing, WJ; Ma, Y; Xu, XP				Zhang, Jing; Chen, Bobin; Wu, Ting; Wang, Qian; Zhuang, Lin; Zhu, Chen; Fan, Ni; Qing, Wenjiao; Ma, Yan; Xu, Xiaoping			Synergistic Effect and Molecular Mechanism of Homoharringtonine and Bortezomib on SKM-1 Cell Apoptosis	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; NF-KAPPA-B; RISK MYELODYSPLASTIC SYNDROME; LOW-DOSE CYTARABINE; INTENSIVE CHEMOTHERAPY; IN-VITRO; CANCER; COMBINATION; MICRORNAS; REGIMENS	Background Myelodysplastic syndromes (MDS) are clonal marrow stem-cell disorders with a high risk of progression to acute myeloid leukemia (AML). Treatment options are limited and targeted therapies are not available for MDS. In the present study, we investigated the cytotoxicity and the molecular mechanism of Homoharringtonine (HHT) and Bortezomib towards highrisk MDS cell line SKM-1 in vitro and the role of miR-3151 was first evaluated in SKM-1 cells. Methods SKM-1 cells were treated with different concentrations of HHT or Bortezomib, and cell viability was analyzed with CCK-8 assay. The influence on cell proliferation, cell cycle distribution and the percentage of apoptosis cells were analyzed by flow cytometry. Calcusyn software was used to calculate combination index (CI) values. Western blot was used to analysis phosphorylation of Akt and nuclear NF-kappa B protein expression in SKM-1 cells. Mature miR-3151 level and p53 protein level were detected after HHT or Bortezomib treatment. The cell proliferation and p53 protein level were reassessed in SKM-1 cells infected with lentivirus to overexpress miR-3151. Results Simultaneous exposure to HHT and Bortezomib (10.4: 1) resulted in a significant reduction of cell proliferation in SKM-1 cells (P < 0.05). Cell cycle arrest at G0/ G1 and G2/M phase was observed (P < 0.05). HHT and Bortezomib synergistically induced cell apoptosis by regulating members of caspase 9, caspase 3 and Bcl-2 family (P < 0.01). The mechanisms of the synergy involved Akt and NF-kappa B signaling pathway inhibition, downregulation of mature miR-3151 and increment of downstream p53 protein level. Overexpression of miR-3151 promoted cell proliferation and inhibited p53 protein expression in SKM-1 (P < 0.01). Conclusions HHT and Bortezomib synergistically inhibit SKM-1 cell proliferation and induce apoptosis in vitro. Inhibition of Akt and NF-kappa B pathway signaling contribute to molecular mechanism of HHT and Bortezomib. miR-3151 abundance is implicated in SKM-1 cell viability, cell proliferation and p53 protein expression.	[Zhang, Jing; Chen, Bobin; Wu, Ting; Wang, Qian; Zhuang, Lin; Zhu, Chen; Fan, Ni; Qing, Wenjiao; Ma, Yan; Xu, Xiaoping] Fudan Univ, Huashan Hosp, Shanghai Med Coll, Dept Hematol, Shanghai 200433, Peoples R China	Fudan University	Xu, XP (corresponding author), Fudan Univ, Huashan Hosp, Shanghai Med Coll, Dept Hematol, Shanghai 200433, Peoples R China.	xpxu1111@163.com	MA, YAN/HHN-2912-2022		National Natural Science Foundation of China [81070404]; Sub-topic of National Science and Technology Major Project [2012ZX0903004-001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sub-topic of National Science and Technology Major Project	The study was supported by the National Natural Science Foundation of China (Grant No. 81070404) and the Sub-topic of National Science and Technology Major Project (Grant No. 2012ZX0903004-001). The funder conceived and designed the experiments.	Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Braun T, 2006, BLOOD, V107, P1156; CHEN JYZDL, 1990, CANCER RES, V50, P2031; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Crawford LJ, 2013, BLOOD REV, V27, P297, DOI 10.1016/j.blre.2013.10.002; Dlugosz PJ, 2006, EMBO J, V25, P2287, DOI 10.1038/sj.emboj.7601126; Eisfeld AK, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004762; Eisfeld AK, 2012, BLOOD, V120, P249, DOI 10.1182/blood-2012-02-408492; He L, 2007, NAT REV CANCER, V7, P819, DOI 10.1038/nrc2232; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hermeking H, 2007, CANCER CELL, V12, P414, DOI 10.1016/j.ccr.2007.10.028; Huang J, 2011, INT J HEMATOL, V93, P482, DOI 10.1007/s12185-011-0821-z; Jin J, 2006, LEUKEMIA, V20, P1361, DOI 10.1038/sj.leu.2404287; Jin J, 2013, LANCET ONCOL, V14, P599, DOI 10.1016/S1470-2045(13)70152-9; Kantarjian H, 2006, CANCER-AM CANCER SOC, V106, P1099, DOI 10.1002/cncr.21699; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Knipp S, 2007, CANCER-AM CANCER SOC, V110, P345, DOI 10.1002/cncr.22779; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Li S, 2013, ZHEJIANG MED J, V35, P105; Meng HT, 2008, LEUKEMIA LYMPHOMA, V49, P1954, DOI 10.1080/10428190802320368; Nyakern M, 2006, LEUKEMIA, V20, P230, DOI 10.1038/sj.leu.2404057; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Riccioni R, 2007, BRIT J HAEMATOL, V139, P194, DOI 10.1111/j.1365-2141.2007.06757.x; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Ryningen A, 2006, LEUKEMIA RES, V30, P1531, DOI 10.1016/j.leukres.2006.02.014; Shu HE, 2007, ZHONGGUO WU ZHEN XUE, V7, P331; Su Ji-Ying, 2009, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V17, P459; Wu LY, 2011, J CANCER RES CLIN, V137, P1563, DOI 10.1007/s00432-011-1020-2; Wu LY, 2009, LEUKEMIA LYMPHOMA, V50, P1461, DOI 10.1080/10428190903096719; XU B, 1981, AM J CHINESE MED, V9, P268, DOI 10.1142/S0192415X81000354; XU B, 1981, TRENDS PHARMACOL SCI, V2, P271, DOI 10.1016/0165-6147(81)90337-0; Yao Y, 1999, ACTA ACAD MED XUZHOU, V19, P221	34	3	4	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142422	10.1371/journal.pone.0142422	http://dx.doi.org/10.1371/journal.pone.0142422			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544558	Green Published, Green Submitted, gold			2022-12-26	WOS:000364398700135
J	Cossu-Rocca, P; Orru, S; Muroni, MR; Sanges, F; Sotgiu, G; Ena, S; Pira, G; Murgia, L; Manca, A; Uras, MG; Sarobba, MG; Urru, S; De Miglio, MR				Cossu-Rocca, Paolo; Orru, Sandra; Muroni, Maria Rosaria; Sanges, Francesca; Sotgiu, Giovanni; Ena, Sara; Pira, Giovanna; Murgia, Luciano; Manca, Alessandra; Uras, Maria Gabriela; Sarobba, Maria Giuseppina; Urru, Silvana; De Miglio, Maria Rosaria			Analysis of PIK3CA Mutations and Activation Pathways in Triple Negative Breast Cancer	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; ONCOGENIC MUTATIONS; TARGETED THERAPIES; SIGNALING PATHWAY; HIGH-FREQUENCY; PTEN LOSS; GENE; EXPRESSION; CARCINOMA; SUBTYPES	Background Triple Negative Breast Cancer (TNBC) accounts for 12-24% of all breast carcinomas, and shows worse prognosis compared to other breast cancer subtypes. Molecular studies demonstrated that TNBCs are a heterogeneous group of tumors with different clinical and pathologic features, prognosis, genetic-molecular alterations and treatment responsivity. The PI3K/AKT is a major pathway involved in the regulation of cell survival and proliferation, and is the most frequently altered pathway in breast cancer, apparently with different biologic impact on specific cancer subtypes. The most common genetic abnormality is represented by PIK3CA gene activating mutations, with an overall frequency of 20-40%. The aims of our study were to investigate PIK3CA gene mutations on a large series of TNBC, to perform a wider analysis on genetic alterations involving PI3K/AKT and BRAF/RAS/MAPK pathways and to correlate the results with clinical-pathologic data. Materials and Methods PIK3CA mutation analysis was performed by using cobas (R) PIK3CA Mutation Test. EGFR, AKT1, BRAF, and KRAS genes were analyzed by sequencing. Immunohistochemistry was carried out to identify PTEN loss and to investigate for PI3K/AKT pathways components. Results PIK3CA mutations were detected in 23.7% of TNBC, whereas no mutations were identified in EGFR, AKT1, BRAF, and KRAS genes. Moreover, we observed PTEN loss in 11.3% of tumors. Deregulation of PI3K/AKT pathways was revealed by consistent activation of pAKT and p-p44/42 MAPK in all PIK3CA mutated TNBC. Conclusions Our data shows that PIK3CA mutations and PI3K/AKT pathway activation are common events in TNBC. A deeper investigation on specific TNBC genomic abnormalities might be helpful in order to select patients who would benefit from current targeted therapy strategies.	[Cossu-Rocca, Paolo; Muroni, Maria Rosaria; Sanges, Francesca; Murgia, Luciano; De Miglio, Maria Rosaria] Univ Sassari, Dept Clin & Expt Med, I-07100 Sassari, Italy; [Orru, Sandra] A Businco Oncol Hosp, Dept Pathol, ASL Cagliari, Cagliari, Italy; [Sotgiu, Giovanni] Univ Sassari, Epidemiol & Med Stat Unit, Dept Biomed Sci, Res Med Educ & Profess Dev Unit,AOU Sassari, I-07100 Sassari, Italy; [Ena, Sara; Pira, Giovanna] Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy; [Manca, Alessandra; Uras, Maria Gabriela] AOU Sassari, Dept Pathol, Sassari, Italy; [Sarobba, Maria Giuseppina] ASL Nuoro, Dept Med Oncol, Nuoro, Italy; [Urru, Silvana] Ctr Adv Studies Res & Dev Sardinia Technol Pk Pol, Biomed Sect, Cagliari, Italy	University of Sassari; University of Sassari; University of Sassari	Cossu-Rocca, P (corresponding author), Giovanni Paolo II Hosp, Dept Diagnost Serv, Surg Pathol Unit, ASL Olbia, Olbia, Italy.	pcossurocca@yahoo.it	Sotgiu, Giovanni/N-1032-2017	Sotgiu, Giovanni/0000-0002-1600-4474; COSSU ROCCA, Paolo Alessandro/0000-0002-8472-6946; urru, silvana anna maria/0000-0001-6213-1290; Ena, Sara/0000-0003-1861-7845	Fondazione Banco di Sardegna, Italy; Regione Autonoma della Sardegna, Italy - Anno	Fondazione Banco di Sardegna, Italy(Fondazione Banco di Sardegna); Regione Autonoma della Sardegna, Italy - Anno	This work was supported in part by grants from Fondazione Banco di Sardegna, Italy and from Regione Autonoma della Sardegna, Italy - Anno 2011, Legge Regionale 7 agosto 2007, n.7: "Promozione della Ricerca Scientifica e dell'Innovazione Tecnologica in Sardegna". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson VG, 2014, BREAST CANCER RES TR, V145, P389, DOI 10.1007/s10549-014-2945-3; Arsenic R, 2014, APPL IMMUNOHISTO M M, V22, P50, DOI 10.1097/PDM.0b013e318297afea; Baccarini M, 2005, FEBS LETT, V579, P3271, DOI 10.1016/j.febslet.2005.03.024; Bachman KE, 2004, CANCER BIOL THER, V3, P772, DOI 10.4161/cbt.3.8.994; Ban KA, 2014, SURG ONCOL CLIN N AM, V23, P409, DOI 10.1016/j.soc.2014.03.011; Barbareschi M, 2007, CLIN CANCER RES, V13, P6064, DOI 10.1158/1078-0432.CCR-07-0266; Boyault S, 2012, BREAST CANCER RES TR, V132, P29, DOI 10.1007/s10549-011-1518-y; Buttitta F, 2006, J PATHOL, V208, P350, DOI 10.1002/path.1908; Carey L, 2010, NAT REV CLIN ONCOL, V7, P683, DOI 10.1038/nrclinonc.2010.154; CARPENTER G, 1990, J BIOL CHEM, V265, P7709; Cizkova M, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3113; De Abreu FB, 2013, AM J PATHOL, V183, P1075, DOI 10.1016/j.ajpath.2013.07.002; De Miglio MR, 2010, DIAGN MOL PATHOL, V19, P201, DOI 10.1097/PDM.0b013e3181db67d5; Fink LS, 2015, MOL CANCER THER, V14, P298, DOI 10.1158/1535-7163.MCT-14-0529; Gonzalez-Angulo AM, 2013, CANCER-AM CANCER SOC, V119, P7, DOI 10.1002/cncr.27608; Gordon V, 2013, CLIN CANCER RES, V19, P3738, DOI 10.1158/1078-0432.CCR-12-0274; Grob TJ, 2012, BREAST CANCER RES TR, V134, P561, DOI 10.1007/s10549-012-2092-7; Hammond MEH, 2010, J ONCOL PRACT, V6, P195, DOI 10.1200/JOP.777003; Hashimoto K, 2014, ANN ONCOL, V25, P1973, DOI 10.1093/annonc/mdu247; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Higgins MJ, 2011, J CLIN INVEST, V121, P3797, DOI 10.1172/JCI57152; Janku F, 2013, CANCER RES, V73, P276, DOI 10.1158/0008-5472.CAN-12-1726; Janku F, 2012, J CLIN ONCOL, V30, P777, DOI 10.1200/JCO.2011.36.1196; Jensen JD, 2011, CLIN CANCER RES, V17, P667, DOI 10.1158/1078-0432.CCR-10-1133; Kalinsky K, 2009, CLIN CANCER RES, V15, P5049, DOI 10.1158/1078-0432.CCR-09-0632; Kandula M, 2013, ASIAN PAC J CANCER P, V14, P5067, DOI 10.7314/APJCP.2013.14.9.5067; Kim Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079014; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kriegsmann M, 2014, ONCOTARGET, V5, P9952, DOI 10.18632/oncotarget.2481; Lai YL, 2008, ANN SURG ONCOL, V15, P1064, DOI 10.1245/s10434-007-9751-7; Lakhani SR., 2012, WHO CLASSIFICATION T, P14; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Li SY, 2006, BREAST CANCER RES TR, V96, P91, DOI 10.1007/s10549-005-9048-0; Loi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053292; Martin V, 2012, HISTOL HISTOPATHOL, V27, P785, DOI 10.14670/HH-27.785; Maruyama N, 2007, CLIN CANCER RES, V13, P408, DOI 10.1158/1078-0432.CCR-06-0267; Metzger O, 2012, J CLIN ONCOL, V30, P1879, DOI 10.1200/JCO.2011.38.2010; Miller TW, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3039; Millis SZ, 2015, CLIN BREAST CANCER, V15, P473, DOI 10.1016/j.clbc.2015.04.008; Moulder SL, 2010, CLIN BREAST CANCER, V10, pS66, DOI 10.3816/CBC.2010.s.014; Mutter GL, 2000, JNCI-J NATL CANCER I, V92, P924, DOI 10.1093/jnci/92.11.924; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Oakman C, 2010, BREAST, V19, P312, DOI 10.1016/j.breast.2010.03.026; Ordonez NG, 1998, AM J SURG PATHOL, V22, P1215, DOI 10.1097/00000478-199810000-00006; Perez-Tenorio G, 2007, CLIN CANCER RES, V13, P3577, DOI 10.1158/1078-0432.CCR-06-1609; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Reis-Filho JS, 2008, HISTOPATHOLOGY, V52, P108, DOI 10.1111/j.1365-2559.2007.02889.x; Saal LH, 2005, CANCER RES, V65, P2554, DOI 10.1158/0008-5472-CAN-04-3913; Sanchez-Munoz A, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-136; SAR M, 1990, ENDOCRINOLOGY, V127, P3180, DOI 10.1210/endo-127-6-3180; Secq V, 2014, BRIT J CANCER, V110, P1045, DOI 10.1038/bjc.2013.794; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Tanaka Y, 2006, ONCOGENE, V25, P2950, DOI 10.1038/sj.onc.1209311; Tilch E, 2014, BREAST CANCER RES TR, V143, P385, DOI 10.1007/s10549-013-2798-1; Tokunaga E, 2008, CURR CANCER DRUG TAR, V8, P27, DOI 10.2174/156800908783497140; Weigelt B, 2008, J PATHOL, V216, P141, DOI 10.1002/path.2407	59	64	65	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141763	10.1371/journal.pone.0141763	http://dx.doi.org/10.1371/journal.pone.0141763			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540293	Green Published, Green Submitted, gold			2022-12-26	WOS:000364303800026
J	Delobel-Ayoub, M; Ehlinger, V; Klapouszczak, D; Maffre, T; Raynaud, JP; Delpierre, C; Arnaud, C				Delobel-Ayoub, Malika; Ehlinger, Virginie; Klapouszczak, Dana; Maffre, Thierry; Raynaud, Jean-Philippe; Delpierre, Cyrille; Arnaud, Catherine			Socioeconomic Disparities and Prevalence of Autism Spectrum Disorders and Intellectual Disability	PLOS ONE			English	Article							SOCIODEMOGRAPHIC RISK-FACTORS; NON-HISPANIC WHITE; MENTAL-RETARDATION; CHILDREN; POPULATION; EPIDEMIOLOGY; ASSOCIATION; DEPRIVATION; DIAGNOSIS; ETHNICITY	Background and Objectives Study of the impact of socioeconomic status on autism spectrum disorders (ASD) and severe intellectual disabilities (ID) has yielded conflicting results. Recent European studies suggested that, unlike reports from the United States, low socioeconomic status is associated with an increased risk of ASD. For intellectual disabilities, the links with socioeconomic status vary according to the severity. We wished to clarify the links between socioeconomic status and the prevalence of ASD (with or without ID) and isolated severe ID. Methods 500 children with ASD and 245 children with severe ID (IQ <50) aged 8 years, born 1995 to 2004, were recruited from a French population-based registry. Inclusions were based on clinical diagnoses reported in medical records according to the International Classification of Diseases, 10th Revision. Socioeconomic status was measured by indicators available at block census level which characterize the population of the child's area of residence. Measures of deprivation, employment, occupation, education, immigration and family structure were used. Prevalences were compared between groups of census units defined by the tertiles of socioeconomic level in the general population. Results Prevalence of ASD with associated ID was higher in areas with the highest level of deprivation and the highest percentage of unemployed adults, persons with no diploma, immigrants and single-parent families. No association was found when using occupational class. Regarding ASD without associated ID, a higher prevalence was found in areas with the highest percentage of immigrants. No association was found for other socioeconomic indicators. The prevalence of isolated severe ID was likely to be higher in the most disadvantaged groups defined by all indicators. Conclusion The prevalence of ASD with associated ID and of severe isolated ID is more likely to be higher in areas with the highest level of deprivation.	[Delobel-Ayoub, Malika; Ehlinger, Virginie; Klapouszczak, Dana; Arnaud, Catherine] CHU Toulouse, Registre Handicaps Enfant Haute Garonne, Toulouse, France; [Delobel-Ayoub, Malika; Ehlinger, Virginie; Klapouszczak, Dana; Raynaud, Jean-Philippe; Delpierre, Cyrille; Arnaud, Catherine] Fac Med Toulouse, INSERM, U1027, F-31073 Toulouse, France; [Delobel-Ayoub, Malika; Ehlinger, Virginie; Klapouszczak, Dana; Raynaud, Jean-Philippe; Delpierre, Cyrille; Arnaud, Catherine] Univ Toulouse 3, F-31062 Toulouse, France; [Maffre, Thierry; Raynaud, Jean-Philippe] Hop La Grave, Serv Univ Psychiat Enfant & Adolescent, CHU Toulouse, Toulouse, France; [Maffre, Thierry] Hop La Grave, Ctr Ressources Autisme Midipyrenees, Toulouse, France; [Arnaud, Catherine] CHU Purpan, Dept Epidemiol Clin, Toulouse, France	CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; CHU de Toulouse; CHU de Toulouse	Delobel-Ayoub, M (corresponding author), CHU Toulouse, Registre Handicaps Enfant Haute Garonne, Toulouse, France.	delobel.m@chu-toulouse.fr	Delobel-Ayoub, Malika/AAC-2047-2020; Romanova, Raisa/O-5724-2018; KLAPOUSZCZAK, DANA/AAC-8311-2019; ARNAUD, Catherine/AAC-5646-2019; Delobel-Ayoub, Malika/AAC-4341-2019	ARNAUD, Catherine/0000-0002-4002-802X; Delobel-Ayoub, Malika/0000-0002-0090-8313; delpierre, cyrille/0000-0002-0831-080X; Raynaud, Jean-Philippe/0000-0002-6101-7370				Baird G, 2006, LANCET, V368, P210, DOI 10.1016/S0140-6736(06)69041-7; Bhasin TK, 2007, J AUTISM DEV DISORD, V37, P667, DOI 10.1007/s10803-006-0194-y; Bilder D, 2009, PEDIATRICS, V123, P1293, DOI 10.1542/peds.2008-0927; Burd L, 1999, J PERINAT MED, V27, P441, DOI 10.1515/JPM.1999.059; Chakrabarti S, 2005, AM J PSYCHIAT, V162, P1133, DOI 10.1176/appi.ajp.162.6.1133; Croen LA, 2002, J AUTISM DEV DISORD, V32, P217, DOI 10.1023/A:1015405914950; Croen LA, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.6.e86; Decoufle Pierre, 1995, Annals of Epidemiology, V5, P347, DOI 10.1016/1047-2797(95)00031-2; Delobel-Ayoub M., 2010, Bulletin Epidemiologique Hebdomadaire, P180; Dodds L, 2011, J AUTISM DEV DISORD, V41, P891, DOI 10.1007/s10803-010-1114-8; DREWS CD, 1995, AM J PUBLIC HEALTH, V85, P329, DOI 10.2105/AJPH.85.3.329; Durkin MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011551; Emerson E, 2012, J EPIDEMIOL COMMUN H, V66, P218, DOI 10.1136/jech.2010.111773; Fountain C, 2011, J EPIDEMIOL COMMUN H, V65, P503, DOI 10.1136/jech.2009.104588; Harrison MJ, 2006, ARCH DIS CHILD, V91, P16, DOI 10.1136/adc.2004.049601; Hultman CM, 2002, EPIDEMIOLOGY, V13, P417, DOI 10.1097/00001648-200207000-00009; Keen DV, 2010, BRIT J PSYCHIAT, V196, P274, DOI 10.1192/bjp.bp.109.065490; Kim YS, 2011, AM J PSYCHIAT, V168, P904, DOI 10.1176/appi.ajp.2011.10101532; Larsson HJ, 2005, AM J EPIDEMIOL, V161, P916, DOI 10.1093/aje/kwi123; Lauritsen MB, 2005, J CHILD PSYCHOL PSYC, V46, P963, DOI 10.1111/j.1469-7610.2004.00391.x; Leonard H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017875; Maenner Matthew J, 2009, WMJ, V108, P253; Magnusson C, 2012, BRIT J PSYCHIAT, V201, P109, DOI 10.1192/bjp.bp.111.095125; Nassar N, 2009, INT J EPIDEMIOL, V38, P1245, DOI 10.1093/ije/dyp260; Nicholas JS, 2009, ANN EPIDEMIOL, V19, P808, DOI 10.1016/j.annepidem.2009.04.005; Ouellette-Kuntz H., 2006, J POLICY PRACT INTEL, V3, P164, DOI [10.1111/j.1741-1130.2006.00076.x, DOI 10.1111/J.1741-1130.2006.00076.X]; Pedersen A, 2012, PEDIATRICS, V129, pE629, DOI 10.1542/peds.2011-1145; Pornet C, 2012, J EPIDEMIOL COMMUN H, V66, P982, DOI 10.1136/jech-2011-200311; Rai D, 2012, J AM ACAD CHILD PSY, V51, P467, DOI 10.1016/j.jaac.2012.02.012; Russell G, 2011, SOC PSYCH PSYCH EPID, V46, P1283, DOI 10.1007/s00127-010-0294-z; Saint-Georges C., 2013, NEUROPSYCHIAT ENFAN, V61, P400, DOI DOI 10.1016/J.NEURENF.2013.05.005; Schieve LA, 2012, DISABIL HEALTH J, V5, P18, DOI 10.1016/j.dhjo.2011.09.001; Stromme P, 2000, SOC PSYCH PSYCH EPID, V35, P12, DOI 10.1007/s001270050003; Thomas P, 2012, AUTISM, V16, P201, DOI 10.1177/1362361311413397; TOWNSEND P, 1987, J SOC POLICY, V16, P125, DOI 10.1017/S0047279400020341; van Bakel MME, 2015, J AUTISM DEV DISORD, V45, P3255, DOI 10.1007/s10803-015-2486-6; Windham GC, 2011, J AUTISM DEV DISORD, V41, P1362, DOI 10.1007/s10803-010-1160-2; Wingate M, 2014, MMWR SURVEILL SUMM, V63; YEARGINALLSOPP M, 1995, AM J PUBLIC HEALTH, V85, P324, DOI 10.2105/AJPH.85.3.324	39	84	86	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141964	10.1371/journal.pone.0141964	http://dx.doi.org/10.1371/journal.pone.0141964			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV5IS	26540408	gold, Green Submitted, Green Published			2022-12-26	WOS:000364303800038
J	Lu, JY; Yu, HY; Mo, YF; Ma, XJ; Hao, YP; Lu, W; Li, HT; Bao, YQ; Zhou, J; Jia, WP				Lu, Jingyi; Yu, Haoyong; Mo, Yifei; Ma, Xiaojing; Hao, Yaping; Lu, Wei; Li, Huating; Bao, Yuqian; Zhou, Jian; Jia, Weiping			Patterns of Circulating Fibroblast Growth Factor 21 in Subjects with and without Type 2 Diabetes	PLoS One			English	Article							SERUM FGF21 LEVELS; METABOLIC REGULATOR; FATTY-ACIDS; DISEASE; OBESITY; HUMANS; MICE; MELLITUS	Background Fibroblast growth factor 21 (FGF21) exerts wide-range effects on carbohydrate and lipid metabolism. However, its perturbation in type 2 diabetes mellitus (T2DM) remains elusive. Besides, previous human studies in T2DM simply investigated fasting or stimulated levels of FGF21. The current study sought to evaluate the temporal changes of circulating FGF21 in subjects with and without T2DM. Methods Ten patients with T2DM and 16 normal controls (NC) were recruited. Participants were categorized as obese (BMI >= 25 kg/m(2)) or lean (BMI<25 kg/m(2)). Blood samples were drawn every 30 min within 7 hours (8 a. m.-3 p.m.). Serum FGF21, blood glucose, insulin, free fatty acids (FFAs) and adiponectin were measured in all subjects. Results The peak levels of FGF21 were observed in the fasting state (8 a.m.) both in T2DM and NC groups (267.35 +/- 158.72 ng/L vs. 178.93 +/- 121.37 ng/L, P = 0.096). FGF21 AUC did not differ significantly between the two groups (T2DM: 949.4 +/- 471.47 ng/L; NC: 883.13 +/- 561.40 ng/L, P = 0.770). Obese subjects had higher FGF21 levels than lean ones in patients either with or without T2DM. The pattern of FFAs closely resembled that of FGF21. Correlation analysis showed that temporal levels of FGF21 were significantly related to FFAs (r = 0.749, P = 0.002), but not blood glucose, insulin or adiponectin (all P> 0.05). Conclusions These findings suggest that the pattern of circulating FGF21 does not differ significantly between T2DM and NC, although T2DM patients showed a trend toward higher fasting FGF21 than healthy subjects. The pattern of circulating FFAs is significantly associated with that of FGF21.	[Lu, Jingyi; Yu, Haoyong; Mo, Yifei; Ma, Xiaojing; Hao, Yaping; Lu, Wei; Li, Huating; Bao, Yuqian; Zhou, Jian; Jia, Weiping] Shanghai Jiao Tong Univ, Dept Endocrinol & Metab, Shanghai Key Lab Diabet Mellitus, Affiliated Peoples Hosp 6,Shanghai Diabet Inst,Sh, Shanghai 200030, Peoples R China; [Zhou, Jian] Kashgar Prefecture Second Peoples Hosp, Dept Endocrinol & Metab, Kashi, Xinjiang, Peoples R China	Shanghai Jiao Tong University	Zhou, J (corresponding author), Shanghai Jiao Tong Univ, Dept Endocrinol & Metab, Shanghai Key Lab Diabet Mellitus, Affiliated Peoples Hosp 6,Shanghai Diabet Inst,Sh, Shanghai 200030, Peoples R China.	zhoujian@sjtu.edu.cn; wpjia@sjtu.edu.cn			National Natural Science Foundation of China [81300666, 81100590]; Shanghai Rising-Star Program [12QA1402500]; Shanghai Medical Program for Outstanding Young Talent [XYQ2011013]; MSD China Holding Co., Ltd.	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Rising-Star Program; Shanghai Medical Program for Outstanding Young Talent; MSD China Holding Co., Ltd.	This work was supported by grants from the National Natural Science Foundation of China (http://www.nsfc.gov.cn/, 81300666 to JL and 81100590 to JZ), Shanghai Rising-Star Program (12QA1402500), Shanghai Medical Program for Outstanding Young Talent (XYQ2011013) and MSD China Holding Co., Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Berti L, 2015, MOL METAB, V4, P519, DOI 10.1016/j.molmet.2015.04.002; Chavez AO, 2009, DIABETES CARE, V32, P1542, DOI 10.2337/dc09-0684; Chen C, 2011, DIABETES CARE, V34, P2113, DOI 10.2337/dc11-0294; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Dutchak PA, 2012, CELL, V148, P556, DOI 10.1016/j.cell.2011.11.062; Galman C, 2008, CELL METAB, V8, P169, DOI 10.1016/j.cmet.2008.06.014; Gaich G, 2013, CELL METAB, V18, P333, DOI 10.1016/j.cmet.2013.08.005; Holland WL, 2013, CELL METAB, V17, P790, DOI 10.1016/j.cmet.2013.03.019; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168; Kharitonenkov A, 2009, CURR OPIN PHARMACOL, V9, P805, DOI 10.1016/j.coph.2009.07.001; Kok SW, 2002, J CLIN ENDOCR METAB, V87, P805, DOI 10.1210/jc.87.2.805; Lee CH, 2015, J CLIN ENDOCR METAB, V100, P1368, DOI 10.1210/jc.2014-3465; Li XS, 2011, DIABETES RES CLIN PR, V93, P10, DOI 10.1016/j.diabres.2011.02.034; Lin ZF, 2013, CELL METAB, V17, P779, DOI 10.1016/j.cmet.2013.04.005; Mai K, 2009, DIABETES, V58, P1532, DOI 10.2337/db08-1775; Maury E, 2010, CIRC RES, V106, P447, DOI 10.1161/CIRCRESAHA.109.208355; Mraz M, 2009, CLIN ENDOCRINOL, V71, P369, DOI 10.1111/j.1365-2265.2008.03502.x; Roesch SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116928; Xiao Y, 2012, J CLIN ENDOCR METAB, V97, pE54, DOI 10.1210/jc.2011-1930; Yu HY, 2011, CLIN CHEM, V57, P691, DOI 10.1373/clinchem.2010.155184; Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476; Zibar K, 2015, ENDOCRINE, V48, P848, DOI 10.1007/s12020-014-0413-9	24	6	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142207	10.1371/journal.pone.0142207	http://dx.doi.org/10.1371/journal.pone.0142207			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540514	Green Submitted, Green Published, gold			2022-12-26	WOS:000364303800068
J	Neuberger, A; van Veen, HW				Neuberger, Arthur; van Veen, Hendrik W.			Hoechst 33342 Is a Hidden "Janus" amongst Substrates for the Multidrug Efflux Pump LmrP	PLoS One			English	Article							TRANSPORTER LMRP; RESISTANCE; BINDING; MEMBRANES; SYSTEMS; PROTEIN	Multidrug transporters mediate the active extrusion of antibiotics and toxic ions from the cell. This reaction is thought to be based on a switch of the transporter between two conformational states, one in which the interior substrate binding cavity is available for substrate binding at the inside of the cell, and another in which the cavity is exposed to the outside of the cell to enable substrate release. Consistent with this model, cysteine cross-linking studies with the Major Facilitator Superfamily drug/proton antiporter LmrP from Lactococcus lactis demonstrated binding of transported benzalkonium to LmrP in its inward-facing state. The fluorescent dye Hoechst 33342 is a substrate for many multidrug transporters and is extruded by efflux pumps in microbial and mammalian cells. Surprisingly, and in contrast to other multidrug transporters, LmrP was found to actively accumulate, rather than extrude, Hoechst 33342 in lactococcal cells. Consistent with this observation, LmrP expression was associated with cellular sensitivity, rather than resistance to Hoechst 33342. Thus, we discovered a hidden "Janus" amongst LmrP substrates that is translocated in reverse direction across the membrane by binding to outward-facing LmrP followed by release from inward-facing LmrP. These findings are in agreement with distance measurements by electron paramagnetic resonance in which Hoechst 33342 binding was found to stabilize LmrP in its outward-facing conformation. Our data have important implications for the use of multidrug exporters in selective targeting of "Hoechst 33342-like" drugs to cells and tissues in which these transporters are expressed.	[Neuberger, Arthur; van Veen, Hendrik W.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1QJ, England	University of Cambridge	van Veen, HW (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1QJ, England.	hwv20@cam.ac.uk	van Veen, Hendrik W./A-4162-2008	van Veen, Hendrik W./0000-0002-9658-8077; Neuberger, Arthur/0000-0002-7744-6559	Herchel-Smith Scholarship; Biotechnology and Biological Sciences Research Council (BBSRC); Medical Research Council (MRC); Human Frontier Science Program (HFSP); British Society for Antimicrobial Chemotherapy (BSAC); Commonwealth Trust; BBSRC [BB/I002383/1, BB/K017713/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K017713/1, BB/I002383/1] Funding Source: researchfish	Herchel-Smith Scholarship; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Human Frontier Science Program (HFSP)(Human Frontier Science Program); British Society for Antimicrobial Chemotherapy (BSAC); Commonwealth Trust; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	AN is a recipient of a Herchel-Smith Scholarship. Research in the Van Veen group is also supported by the Biotechnology and Biological Sciences Research Council (BBSRC), the Medical Research Council (MRC), the Human Frontier Science Program (HFSP), the British Society for Antimicrobial Chemotherapy (BSAC), and the Commonwealth Trust.	Aleman C, 2005, J BIOMOL STRUCT DYN, V23, P29, DOI 10.1080/07391102.2005.10507044; Balakrishnan L, 2004, J BIOL CHEM, V279, P11273, DOI 10.1074/jbc.M308494200; Bapna A, 2007, J MOL MICROB BIOTECH, V12, P197, DOI 10.1159/000099641; Barrera NP, 2009, NAT METHODS, V6, P585, DOI 10.1038/nmeth.1347; Bolhuis H, 1996, J BIOL CHEM, V271, P24123, DOI 10.1074/jbc.271.39.24123; Borges-Walmsley MI, 2003, BIOCHEM J, V376, P313, DOI 10.1042/BJ20020957; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; Fluman N, 2012, MOL CELL, V47, P777, DOI 10.1016/j.molcel.2012.06.018; Gbaguidi B, 2007, CELL MOL LIFE SCI, V64, P1571, DOI 10.1007/s00018-007-7031-0; Gbaguidi B, 2004, CELL MOL LIFE SCI, V61, P2646, DOI 10.1007/s00018-004-4298-2; Kaback HR, 2011, J MEMBRANE BIOL, V239, P85, DOI 10.1007/s00232-010-9327-5; Masureel M, 2014, NAT CHEM BIOL, V10, P149, DOI 10.1038/nchembio.1408; Paulsen IT, 1996, MICROBIOL REV, V60, P575, DOI 10.1128/MMBR.60.4.575-608.1996; Penmatsa A, 2014, J PHYSIOL-LONDON, V592, P863, DOI 10.1113/jphysiol.2013.259051; Poole K, 2005, J ANTIMICROB CHEMOTH, V56, P20, DOI 10.1093/jac/dki171; Putman M, 1999, BIOCHEMISTRY-US, V38, P13900, DOI 10.1021/bi991262k; Putman M, 2001, MICROBIOL-SGM, V147, P2873, DOI 10.1099/00221287-147-10-2873; Putman M, 2000, MICROBIOL MOL BIOL R, V64, P672, DOI 10.1128/MMBR.64.4.672-693.2000; Schaedler TA, 2012, J BIOL CHEM, V287, P27682, DOI 10.1074/jbc.M112.372334; Schaedler TA, 2010, FASEB J, V24, P3653, DOI 10.1096/fj.10-156927; Shapiro AB, 1997, EUR J BIOCHEM, V250, P122, DOI 10.1111/j.1432-1033.1997.00122.x; Siarheyeva A, 2006, BIOCHEMISTRY-US, V45, P6203, DOI 10.1021/bi0524870; Venter H, 2008, BIOCHEM PHARMACOL, V75, P866, DOI 10.1016/j.bcp.2007.10.022; WALTER A, 1986, J MEMBRANE BIOL, V90, P207, DOI 10.1007/BF01870127; Wang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038715; Woebking B, 2008, BIOCHEMISTRY-US, V47, P10904, DOI 10.1021/bi800778d	26	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141991	10.1371/journal.pone.0141991	http://dx.doi.org/10.1371/journal.pone.0141991			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540112	Green Published, Green Submitted, gold			2022-12-26	WOS:000364303800042
J	White, SR; Bird, SM; Merrall, ELC; Hutchinson, SJ				White, Simon R.; Bird, Sheila M.; Merrall, Elizabeth L. C.; Hutchinson, Sharon J.			Drugs-Related Death Soon after Hospital-Discharge among Drug Treatment Clients in Scotland: Record Linkage, Validation, and Investigation of Risk-Factors	PLOS ONE			English	Article							MORTALITY; SUICIDE; INFECTION; DIAGNOSIS; PRISONERS; OVERDOSE; NALOXONE; RELEASE	We validate that the 28 days after hospital-discharge are high-risk for drugs-related death (DRD) among drug users in Scotland and investigate key risk-factors for DRDs soon after hospital-discharge. Using data from an anonymous linkage of hospitalisation and death records to the Scottish Drugs Misuse Database (SDMD), including over 98,000 individuals registered for drug treatment during 1 April 1996 to 31 March 2010 with 705,538 person-years, 173,107 hospital-stays, and 2,523 DRDs. Time-at-risk of DRD was categorised as: during hospitalization, within 28 days, 29-90 days, 91 days-1 year, >1 year since most recent hospital discharge versus 'never admitted'. Factors of interest were: having ever injected, misuse of alcohol, length of hospital-stay (0-1 versus 2+ days), and main discharge-diagnosis. We confirm SDMD clients' high DRD-rate soon after hospital-discharge in 2006-2010. DRD-rate in the 28 days after hospital-discharge did not vary by length of hospital-stay but was significantly higher for clients who had ever-injected versus otherwise. Three leading discharge-diagnoses accounted for only 150/290 DRDs in the 28 days after hospital-discharge, but ever-injectors for 222/290. Hospital-discharge remains a period of increased DRD-vulnerability in 2006-2010, as in 1996-2006, especially for those with a history of injecting.	[White, Simon R.; Bird, Sheila M.] Cambridge Inst Publ Hlth, Med Res Council Biostat Unit, Cambridge, England; [Merrall, Elizabeth L. C.] Novartis Vaccines & Diagnost, Novartis Pharam BV, NL-1101 CL Amsterdam, Netherlands; [Hutchinson, Sharon J.] Hlth Protect Scotland, Glasgow G3 7LN, Lanark, Scotland	MRC Biostatistics Unit; University of Cambridge; Novartis	White, SR (corresponding author), Cambridge Inst Publ Hlth, Med Res Council Biostat Unit, Cambridge, England.	Simon.White@mrc-bsu.cam.ac.uk	Hutchinson, Sharon/Y-3949-2019	Hutchinson, Sharon/0000-0002-6891-6758; White, Simon/0000-0001-8642-7037	Medical Research Council [MC_US_A030_0007 / 01]; Chief Scientist Office of the Scottish Executive; MRC [MC_U105260794, MC_U105292687] Funding Source: UKRI; Medical Research Council [MC_U105292687, MC_U105260794] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chief Scientist Office of the Scottish Executive; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Medical Research Council (reference: MC_US_A030_0007 / 01). The data for this work were made available as a result of research funded by a grant from the Chief Scientist Office of the Scottish Executive. No sponsor had any role in the study design, data collection, data analysis, data interpretation, or writing of the report.; The authors are grateful to Information Services Division for provision of the linked data. The data for this work were made available as a result of research funded by a grant from the Chief Scientist Office of the Scottish Executive.	Amin J, 2006, LANCET, V368, P938, DOI 10.1016/S0140-6736(06)69374-4; Cornish R, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5475; COX DR, 1972, J R STAT SOC B, V34, P187; Davoli M, 2007, ADDICTION, V102, P1954, DOI 10.1111/j.1360-0443.2007.02025.x; Degenhardt L, 2009, DRUG ALCOHOL DEPEN, V105, P9, DOI 10.1016/j.drugalcdep.2009.05.021; Hall W, 2010, ADDICTION, V105, P1332, DOI 10.1111/j.1360-0443.2010.02919.x; Hunt IM, 2009, PSYCHOL MED, V39, P443, DOI 10.1017/S0033291708003644; Information Services Division, 2009, IMP CHANG WE PRES OU; Information Services Division, 2014, NAT NAL PROGR SCOTL; Jackson G. W. L., 2001, 5 GEN REG OFF SCOTL; Kariminia A, 2007, INT J EPIDEMIOL, V36, P310, DOI 10.1093/ije/dyl225; Kariminia A, 2007, MED J AUSTRALIA, V187, P387, DOI 10.5694/j.1326-5377.2007.tb01307.x; Kendrick Stephen, 1993, Health Bulletin (Edinburgh), V51, P72; McAuley A, 2012, DRUG-EDUC PREV POLIC, V19, P309, DOI 10.3109/09687637.2012.682232; McDonald SA, 2010, EPIDEMIOL INFECT, V138, P393, DOI 10.1017/S0950268809990616; McDonald SA, 2009, STAT METHODS MED RES, V18, P271, DOI 10.1177/0962280208094690; Merrall E. L. C., 2012, THESIS U CAMBRIDGE; Merrall E, 2013, ADDICT RES THEORY, V21, P52, DOI 10.3109/16066359.2012.690052; Merrall ELC, 2012, INT J DRUG POLICY, V23, P24, DOI 10.1016/j.drugpo.2011.05.010; Merrall ELC, 2010, ADDICTION, V105, P1545, DOI 10.1111/j.1360-0443.2010.02990.x; Merralll ELC, 2013, ADDICTION, V108, P377, DOI 10.1111/j.1360-0443.2012.04066.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rome A., 2008, REDUCING DRUG USERS; Strang J, 2013, J URBAN HEALTH, V90, P983, DOI 10.1007/s11524-013-9803-1; Workshop C, 2010, ADDICT RES THEORY, V18, P194, DOI 10.3109/16066350902825948	25	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141073	10.1371/journal.pone.0141073	http://dx.doi.org/10.1371/journal.pone.0141073			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV5IS	26539701	gold, Green Published, Green Submitted			2022-12-26	WOS:000364303800009
J	Narvaez, I; Brochu, CA; Escaso, F; Perez-Garcia, A; Ortega, F				Narvaez, Ivan; Brochu, Christopher A.; Escaso, Fernando; Perez-Garcia, Adan; Ortega, Francisco			New Crocodyliforms from Southwestern Europe and Definition of a Diverse Clade of European Late Cretaceous Basal Eusuchians	PLOS ONE			English	Article							SOUTHERN FRANCE; BIOGEOGRAPHY; MORPHOLOGY; CUENCA; ORIGIN; MARSH; BIOTA	The late Campanian-early Maastrichtian site of Lo Hueco (Cuenca, Spain) has provided a set of well-preserved crocodyliform skull and lower jaw remains, which are described here and assigned to a new basal eusuchian taxon, Lohuecosuchus megadontos gen. et sp. nov. The reevaluation of a complete skull from the synchronous site of Fox-Amphoux (Department of Var, France) allows us to define a second species of this new genus. Phylogenetic analysis places Lohuecosuchus in a clade exclusively composed by European Late Cretaceous taxa. This new clade, defined here as Allodaposuchidae, is recognized as the sister group of Hylaeochampsidae, also comprised of European Cretaceous forms. Allodaposuchidae and Hylaeochampsidae are grouped in a clade identified as the sister group of Crocodylia, the only crocodyliform lineage that reaches our days. Allodaposuchidae shows a vicariant distribution pattern in the European Late Cretaceous archipelago, with several Ibero-Armorican forms more closely related to each other than with to Romanian Allodaposuchus precedens.	[Narvaez, Ivan; Escaso, Fernando; Perez-Garcia, Adan; Ortega, Francisco] Univ Nacl Educ Distancia, Grp Biol Evolut, E-28040 Madrid, Spain; [Brochu, Christopher A.] Univ Iowa, Dept Earth & Environm Sci, Iowa City, IA USA	Universidad Nacional de Educacion a Distancia (UNED); University of Iowa	Narvaez, I (corresponding author), Univ Nacl Educ Distancia, Grp Biol Evolut, E-28040 Madrid, Spain.	inarvaez@ccia.uned.es	Escaso, Fernando/H-9782-2015; García, Adán Pérez/AAM-6680-2021; Narvaez, Ivan/D-8147-2018; Ortega, Francisco/B-5760-2009; Ortega, Francisco/K-3255-2015	Escaso, Fernando/0000-0001-7642-1555; García, Adán Pérez/0000-0002-9074-6855; Narvaez, Ivan/0000-0003-0114-7058; Ortega, Francisco/0000-0002-7431-354X; Ortega, Francisco/0000-0002-7431-354X	Spanish Ministerio de Economia y Competitividad [CGL2012-35199]; US National Science Foundation [DEB 1257786-125748]; project "Estudio paleoambiental, faunistico y floristico del yacimiento del Cretacico Superior de Lo Hueco (Fuentes, Cuenca)" [CGL2012-35199]; SYNTHESYS Project - European Community	Spanish Ministerio de Economia y Competitividad(Spanish Government); US National Science Foundation(National Science Foundation (NSF)); project "Estudio paleoambiental, faunistico y floristico del yacimiento del Cretacico Superior de Lo Hueco (Fuentes, Cuenca)"; SYNTHESYS Project - European Community	Funding: This work was supported by the Spanish Ministerio de Economia y Competitividad CGL2012-35199: IN, FE, APG, FO (http://www.mineco.gob.es/portal/site/mineco/), US National Science Foundation DEB 1257786-125748: CAB (http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the project "Estudio paleoambiental, faunistico y floristico del yacimiento del Cretacico Superior de Lo Hueco (Fuentes, Cuenca)" (CGL2012-35199). We thank J.M. Gasca, I. Canudo and E. Puertolas (Museo Paleontologico Universidad de Zaragoza); J. Le Loeuff (Musee des Dinosaures d'Esperaza, France); A. D. Buscalioni and J.L. Sanz (Universidad Autonoma de Madrid); T. Tortosa (Museum d'Histoire Naturelle d'Aix-en-Provence); E. Buffetaut, F. Fages, D. Clavel and members of Association Culturelle Archeologique et Paleontologique (Musee de Cruzy); A. and P. Mechin (Vitrolles); M. Padilla (Museo de Anatomia de Vertebrados Universidad Complutense de Madrid); S. Bailon (Museum national d'Histoire naturelle, Paris); L. Steel and S. Chapman (Natural History Museum, London), A. Osi and M. Rabi (Magyar Termeszettudomanyi Muzeum, Budapest), and L. Makadi (Magyar Allami Foldtani Intezet, Budapest) for access to collections. We thank the editor T. Smith and the reviewers M. Delfino and S. Jouve for comments and suggestions. Special thanks to members of Grupo de Biologia Evolutiva UNED: F. Marcos for preparation of the specimens and P. Mocho and A. Paramo for their suggestions. The comparative studies have been supported by the SYNTHESYS Project (http://www.synthesys.info), financed by the European Community Research Infrastructure Action under the FP7 Integrating Activities Programme. CAB was supported by US National Science Foundation DEB 1257786-125748.	Barroso-Barcenilla F, 2009, CRETACEOUS RES, V30, P1268, DOI 10.1016/j.cretres.2009.07.010; Blanco A, 2015, PEERJ, V3, DOI 10.7717/peerj.1171; Blanco A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115837; Brochu CA, 2006, J PALEONTOL, V80, P162, DOI 10.1666/0022-3360(2006)080[0162:OAPSOE]2.0.CO;2; Brochu CA, 1999, J VERTEBR PALEONTOL, V19, P9, DOI 10.1080/02724634.1999.10011201; Brochu CA, 2012, J VERTEBR PALEONTOL, V32, P587, DOI 10.1080/02724634.2012.652324; Brochu CA, 2012, J VERTEBR PALEONTOL, V32, P105, DOI 10.1080/02724634.2012.633585; Brochu CA, 2011, ZOOL J LINN SOC-LOND, V163, pS228, DOI 10.1111/j.1096-3642.2011.00716.x; Buscalioni AD, 1997, CR ACAD SCI II A, V325, P525, DOI 10.1016/S1251-8050(97)89872-2; Buscalioni AD, 2011, ZOOL J LINN SOC-LOND, V163, pS199, DOI 10.1111/j.1096-3642.2011.00718.x; Buscalioni Angela D., 1999, Estudios del Museo de Ciencias Naturales de Alava, V14, P213; CLARK J M, 1992, American Museum Novitates, P1; Csiki-Sava Z, 2015, ZOOKEYS, P1, DOI 10.3897/zookeys.469.8439; Delfino M, 2008, PALAEONTOLOGY, V51, P1091, DOI 10.1111/j.1475-4983.2008.00800.x; Delfino M, 2008, J VERTEBR PALEONTOL, V28, P111, DOI 10.1671/0272-4634(2008)28[111:ACSOAP]2.0.CO;2; Escaso F, 2012, FUNDAMENTAL, V20, P71; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Hay O.P., 1930, CARNEGIE I WASHINGTO, V390, P1; Houssaye A, 2013, PALAEONTOL Z, V87, P415, DOI 10.1007/s12542-013-0164-6; Huxley TH, 1875, Q J GEOL SOC LOND, V3, P423; Iordansky N.N., 1973, P201; Koken E., 1888, Z DTSCH GEOLOGISCHEN, P754; Laurent Y., 2001, Developments in Palaeontology and Stratigraphy, V19, P657; Laurent Yves, 2000, Oryctos, V3, P19; Leidy J., 1852, P ACAD NAT SCI PHILA, V6, P35; LELOEUFF J, 1991, CRETACEOUS RES, V12, P93, DOI 10.1016/S0195-6671(05)80019-9; Martin JE, 2015, ZOOLOGICAL J LINNEAN, DOI [10.1111/zoj.12331, DOI 10.1111/Z0J.12331]; Martin JE, 2008, ZOOL J LINN SOC-LOND, V152, P567, DOI 10.1111/j.1096-3642.2007.00358.x; Martin JE, 2007, J VERTEBR PALEONTOL, V27, P362, DOI 10.1671/0272-4634(2007)27[362:NMOTLC]2.0.CO;2; Martin JE, 2010, PALAEOGEOGR PALAEOCL, V293, P406, DOI 10.1016/j.palaeo.2009.10.021; Martin JE, 2010, J VERTEBR PALEONTOL, V30, P756, DOI 10.1080/02724631003758318; Matheron P., 1869, MEMOIRES ACAD IMPERI, P1; Mook C.C., 1924, AM MUS NOVIT, V117, P1; Narvaez I., 2015, THESIS; Narvaez I, 2014, 74 ANN M SOC VERT PA, P194; Narvaez I., 2013, 6 JORN INT PAL DIN E, P96; Narvaez I., 2011, VIAJANDO MUNDOS PRET, P75; Narvaez Ivan, 2010, Cidaris, V30, P205; Nopcsa F., 1928, GEOL HUNG SER PALAEO, V1, P75; Ortega F, 2015, J IBER GEOL, V41, P83, DOI 10.5209/rev_JIGE.2015.v41.n1.48657; Ortega F., 2008, PUBLICACIONES SEMINA, V8, P331; Osi A, 2007, NEUES JAHRB GEOL P-A, V243, P169, DOI 10.1127/0077-7749/2007/0243-0169; Owen R., 1874, PALAEONTOGRAPHICAL S, VXXVII, P1; Pereda-Suberbiola X, 2009, B SOC GEOL FR, V180, P57, DOI 10.2113/gssgfbull.180.1.57; Perez-Garcia A, 2012, GEOBIOS-LYON, V45, P219, DOI 10.1016/j.geobios.2011.03.001; Pol D, 2009, B AM MUS NAT HIST, P1; Puertolas E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020011; Puertolas-Pascual E, 2014, HIST BIOL, V26, P91, DOI 10.1080/08912963.2012.763034; Rogers JV, 2003, J VERTEBR PALEONTOL, V23, P128, DOI 10.1671/0272-4634(2003)23[128:PTANPC]2.0.CO;2; Salisbury SW, 2006, P ROY SOC B-BIOL SCI, V273, P2439, DOI 10.1098/rspb.2006.3613; Serrano H, 2012, FUNDAMENTAL, V20, P237; Smith T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132550; Storrs Glenn W., 2000, P402; Torices A, 2010, MESOGEE, V66, P74; Turner AH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118116; WALKER AD, 1970, PHILOS T ROY SOC B, V257, P323, DOI 10.1098/rstb.1970.0028; Weishampel DB, 2010, PALAEOGEOGR PALAEOCL, V293, P419, DOI 10.1016/j.palaeo.2010.03.024	57	40	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140679	10.1371/journal.pone.0140679	http://dx.doi.org/10.1371/journal.pone.0140679			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26535893	Green Published, gold, Green Submitted			2022-12-26	WOS:000364298400032
J	Tu, XY; Kuang, ZC; Gong, X; Shi, Y; Yu, L; Shi, HJ; Wang, J; Sun, ZG				Tu, Xiaoyu; Kuang, Zhichao; Gong, Xia; Shi, Yan; Yu, Lin; Shi, Huijuan; Wang, Jian; Sun, Zhaogui			The Influence of LepR Tyrosine Site Mutations on Mouse Ovary Development and Related Gene Expression Changes	PLOS ONE			English	Article							LEPTIN RECEPTOR; C-KIT; CELL PROLIFERATION; MEDICAL PROGRESS; IDENTIFICATION; LOCALIZATION; PROTEIN; OBESITY; CLONING; TARGET	Leptin exerts many biological functions, such as in metabolism and reproduction, through binding to and activating the leptin receptor, LepRb, which is expressed in many regions of the brain. To better understand the roles of LepR downstream signaling pathways, Y123F mice, which expressed mutant leptin receptors with phenylalanine (F) substituted for three tyrosines (Y) (Tyr985, Tyr1077 and Tyr1138), were generated. The body weight and abdominal fat deposits of Y123F homozygous mice (HOM) were higher than those of wildtype mice (WT). HOM ovaries were atrophic and the follicles developed abnormally; however, the HOM ovaries did not exhibit polycystic phenotypes. Moreover, Y123F HOM adults had no estrous cycle and the blood estrogen concentration remained stable at a low level below detection limit of 5 pg/ml. LepR expression in HOM ovaries was higher than in WT ovaries. Using cDNA Microarrays, the mRNA expressions of 41 genes were increased, and 100 were decreased in HOM vs. WT ovaries, and many signaling pathways were evaluated to be involved significantly. The expressions of 19 genes were validated by real-time quantitative PCR, most of which were consistent with the microarray results. Thus, Y123F HOM mice were suggested as a new animal model of PCOS for research that mainly emphasizes metabolic disorders and anovulation, but not the polycystic phenotype. Meanwhile, using the model, we found that JAK-STAT and hormone biosynthesis pathways were involved in the follicular development and ovulation disorders caused by LepR deficiency in ovaries, although we could not exclude indirect actions from the brain.	[Tu, Xiaoyu; Kuang, Zhichao] Fudan Univ, Shanghai Med Coll, Inst Reprod & Dev, Shanghai 200433, Peoples R China; [Shi, Yan; Yu, Lin; Shi, Huijuan; Wang, Jian; Sun, Zhaogui] Shanghai Inst Planned Parenthood Res, Key Lab Contracept Drugs & Devices Natl Populat &, Shanghai, Peoples R China; [Gong, Xia] Shanghai Business Sch, Dept Food Sci, Shanghai, Peoples R China	Fudan University; Shanghai Business School	Sun, ZG (corresponding author), Shanghai Inst Planned Parenthood Res, Key Lab Contracept Drugs & Devices Natl Populat &, Shanghai, Peoples R China.	sunzgbio@126.com			National Natural Science Foundation of China [81170569, 81370682]; Project from Science and Technology Commission of Shanghai Municipality [14140901301]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project from Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by the National Natural Science Foundation of China (No. 81170569 and 81370682) and Project from Science and Technology Commission of Shanghai Municipality (14140901301). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre C, 1997, GENOMICS, V39, P216, DOI 10.1006/geno.1996.4482; Bates SH, 2003, TRENDS ENDOCRIN MET, V14, P447, DOI 10.1016/j.tem.2003.10.003; Baumann H, 1996, P NATL ACAD SCI USA, V93, P8374, DOI 10.1073/pnas.93.16.8374; Cirmanova V, 2008, PHYSIOL RES, V57, pS143, DOI 10.33549/physiolres.931499; Ehrmann DA, 2005, NEW ENGL J MED, V352, P1223, DOI 10.1056/NEJMra041536; Elmquist JK, 2000, FRONT HORM RES, V26, P21; Fei H, 1997, P NATL ACAD SCI USA, V94, P7001, DOI 10.1073/pnas.94.13.7001; FRANKS S, 1995, NEW ENGL J MED, V333, P853, DOI 10.1056/NEJM199509283331307; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; GARRIS DR, 1989, ANAT RECORD, V225, P310, DOI 10.1002/ar.1092250407; Ghizzoni L, 2001, HORM METAB RES, V33, P323, DOI 10.1055/s-2001-15419; Gorska E, 2010, EUR J MED RES, V15, P50; Guillemette C, 2004, BREAST CANCER RES, V6, P246, DOI 10.1186/bcr936; Hamm ML, 2004, BIOL REPROD, V71, P66, DOI 10.1095/biolreprod.104.027292; Hiney JK, 1996, ENDOCRINOLOGY, V137, P3717, DOI 10.1210/en.137.9.3717; HORIE K, 1993, HUM REPROD, V8, P1955, DOI 10.1093/oxfordjournals.humrep.a137967; Hoyer PE, 2005, MOL CELL ENDOCRINOL, V234, P1, DOI 10.1016/j.mce.2004.09.012; Hutt KJ, 2006, MOL HUM REPROD, V12, P61, DOI 10.1093/molehr/gal010; Israel D, 2010, TRENDS ENDOCRIN MET, V21, P10, DOI 10.1016/j.tem.2009.07.004; Jiang L, 2008, P NATL ACAD SCI USA, V105, P18619, DOI 10.1073/pnas.0804589105; Jiao Y, 2013, DIABETOLOGIA, V56, P2435, DOI 10.1007/s00125-013-3014-x; Jungheim ES, 2012, OBSTET GYN CLIN N AM, V39, P479, DOI 10.1016/j.ogc.2012.09.002; Kendall NR, 2004, REPRODUCTION, V128, P757, DOI 10.1530/rep.1.00256; Klinge CM, 2000, STEROIDS, V65, P227, DOI 10.1016/S0039-128X(99)00107-5; Lavens D, 2006, J CELL SCI, V119, P2214, DOI 10.1242/jcs.02947; Matsumoto A, 1997, BLOOD, V89, P3148, DOI 10.1182/blood.V89.9.3148; Moeller G, 2009, MOL CELL ENDOCRINOL, V301, P7, DOI 10.1016/j.mce.2008.10.040; Morton GJ, 2011, PHYSIOL REV, V91, P389, DOI 10.1152/physrev.00007.2010; Moschos S, 2002, FERTIL STERIL, V77, P433, DOI 10.1016/S0015-0282(01)03010-2; Nokelainen P, 2000, ENDOCRINOLOGY, V141, P772, DOI 10.1210/en.141.2.772; Schedin P, 2000, J MAMMARY GLAND BIOL, V5, P211, DOI 10.1023/A:1026447506666; Schwartz MW, 1996, J CLIN INVEST, V98, P1101, DOI 10.1172/JCI118891; Spicer LJ, 1997, ENDOCRINOLOGY, V138, P3374, DOI 10.1210/en.138.8.3374; Starlard-Davenport A, 2008, STEROIDS, V73, P139, DOI 10.1016/j.steroids.2007.09.007; Starlard-Davenport A, 2007, STEROIDS, V72, P85, DOI 10.1016/j.steroids.2006.11.016; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Swain JE, 2004, BIOL REPROD, V71, P1446, DOI 10.1095/biolreprod.104.033035; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Torn S, 2003, BIOCHEM BIOPH RES CO, V305, P37, DOI 10.1016/S0006-291X(03)00694-6; Walters KA, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097808; Wang N, 2014, METABOLISM, V63, P94, DOI 10.1016/j.metabol.2013.09.001; You J, 2010, MOL CELL BIOL, V30, P1650, DOI 10.1128/MCB.01307-09; Zabeau L, 2015, CELL MOL LIFE SCI, V72, P629, DOI 10.1007/s00018-014-1697-x; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zhou YJ, 2013, FRONT MED-PRC, V7, P207, DOI 10.1007/s11684-013-0263-5	45	13	14	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141800	10.1371/journal.pone.0141800	http://dx.doi.org/10.1371/journal.pone.0141800			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529315	Green Published, gold, Green Submitted			2022-12-26	WOS:000364032600061
J	Rybaczek, D; Musialek, MW; Balcerczyk, A				Rybaczek, Dorota; Musialek, Marcelina Weronika; Balcerczyk, Aneta			Caffeine-Induced Premature Chromosome Condensation Results in the Apoptosis-Like Programmed Cell Death in Root Meristems of Vicia faba	PLOS ONE			English	Article							MITOTIC CATASTROPHE; DNA FRAGMENTATION; MINOR SEEDLINGS; H2AX HISTONES; PISUM-SATIVUM; CYCLE PHASE; PLANT; INDUCTION; STRESS; PHOSPHORYLATION	We have demonstrated that the activation of apoptosis-like programmed cell death (ALPCD) was a secondary result of caffeine (CF) induced premature chromosome condensation (PCC) in hydroxyurea-synchronized Vicia faba root meristem cells. Initiation of the apoptotic-like cell degradation pathway seemed to be the result of DNA damage generated by treatment with hydroxyurea (HU) [double-stranded breaks (DSBs) mostly] and co-treatment with HU/CF [single-stranded breaks (SSBs) mainly]. A single chromosome comet assay was successfully used to study different types of DNA damage (neutral variant-DSBs versus alkaline-DSBs or SSBs). The immunocytochemical detection of H2AXS139Ph and PARP-2 were used as markers for DSBs and SSBs, respectively. Acridine orange and ethidium bromide (AO/EB) were applied for quantitative immunofluorescence measurements of dead, dying and living cells. Apoptotic-type DNA fragmentation and positive TUNEL reaction finally proved that CF triggers AL-PCD in stressed V. faba root meristem cells. In addition, the results obtained under transmission electron microscopy (TEM) further revealed apoptotic-like features at the ultrastructural level of PCC-type cells: (i) extensive vacuolization; (ii) abnormal chromatin condensation, its marginalization and concomitant degradation; (iii) formation of autophagy-like vesicles (iv) protoplast shrinkage (v) fragmentation of cell nuclei and (vi) extensive degeneration of the cells. The results obtained have been discussed with respect to the vacuolar/autolytic type of plant-specific AL-PCD.	[Rybaczek, Dorota; Musialek, Marcelina Weronika] Univ Lodz, Dept Cytophysiol, Inst Expt Biol, Fac Biol & Environm Protect, PL-90131 Lodz, Poland; [Balcerczyk, Aneta] Univ Lodz, Dept Mol Biophys, Fac Biol & Environm Protect, PL-90131 Lodz, Poland	University of Lodz; University of Lodz	Rybaczek, D (corresponding author), Univ Lodz, Dept Cytophysiol, Inst Expt Biol, Fac Biol & Environm Protect, PL-90131 Lodz, Poland.	dorota.rybaczek@gmail.com	Rybaczek, Dorota/ABC-7091-2020	Rybaczek, Dorota/0000-0002-9020-3391; Balcerczyk, Aneta/0000-0001-8544-5778; Musialek, Marcelina/0000-0003-4014-7915	Foundation for Polish Science [POMOST/2011-4/8]	Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission)	The work was funded by 'POMOST' fellowship from the Foundation for Polish Science (contract no. POMOST/2011-4/8).; The work was funded by 'POMOST' fellowship from the Foundation for Polish Science (grant number: POMOST/2011-4/8; DR: author who received the funding); this funding source had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Affenzeller MJ, 2009, J EXP BOT, V60, P939, DOI 10.1093/jxb/ern348; Babula P, 2009, ENVIRON EXP BOT, V65, P330, DOI 10.1016/j.envexpbot.2008.11.007; Banfalvi G, 2005, APOPTOSIS, V10, P631, DOI 10.1007/s10495-005-1897-9; Barciszewski J, 2007, INT J BIOL MACROMOL, V40, P182, DOI 10.1016/j.ijbiomac.2006.06.024; Borek S, 2009, J EXP BOT, V60, P3453, DOI 10.1093/jxb/erp186; Brown EJ, 2000, GENE DEV, V14, P397; BRUNI A, 1976, HISTOCHEMISTRY, V48, P269, DOI 10.1007/BF00499244; Byczkowska A, 2013, PROTOPLASMA, V250, P121, DOI 10.1007/s00709-012-0383-9; Carimi F, 2003, PLANTA, V216, P413, DOI 10.1007/s00425-002-0862-x; Cassab GI, 1992, TISSUE PRINTING, P23; Collazo C., 2006, BIOTECNOL APL, V23, P1; Della Mea M, 2007, AMINO ACIDS, V33, P395, DOI 10.1007/s00726-007-0530-3; Diaz-Tielas C, 2012, PLANT CELL ENVIRON, V35, P1500, DOI 10.1111/j.1365-3040.2012.02506.x; Dominguez F, 2004, J BIOL CHEM, V279, P11530, DOI 10.1074/jbc.M308082200; Dominguez F, 2001, PLANTA, V213, P352, DOI 10.1007/s004250000517; Dominguez F, 2006, BIOCHEM J, V397, P529, DOI 10.1042/BJ20051809; Dominguez F, 2012, PLANT SCI, V197, P114, DOI 10.1016/j.plantsci.2012.09.009; Doniak M, 2014, PLANT CELL REP, V33, P2063, DOI 10.1007/s00299-014-1681-9; Dunn SR, 2004, CELL DEATH DIFFER, V11, P1213, DOI 10.1038/sj.cdd.4401484; El-Maarouf-Bouteau H, 2011, J EXP BOT, V62, P5003, DOI 10.1093/jxb/err198; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fragkos M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022946; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Gladish DK, 2006, ANN BOT-LONDON, V97, P895, DOI 10.1093/aob/mcl040; Gohring F, 1997, EMBO J, V16, P7361, DOI 10.1093/emboj/16.24.7361; Groover A, 1999, PLANT PHYSIOL, V119, P375, DOI 10.1104/pp.119.2.375; Huang XA, 2006, CYTOM PART A, V69A, P222, DOI 10.1002/cyto.a.20257; Hubner B, 2009, EUR BIOPHYS J BIOPHY, V38, P729, DOI 10.1007/s00249-009-0496-z; Iglesias-Guimarais V, 2013, J BIOL CHEM, V288, P9200, DOI 10.1074/jbc.M112.411371; Jones A, 2000, TRENDS PLANT SCI, V5, P225, DOI 10.1016/S1360-1385(00)01605-8; Jones AM, 2001, METHOD CELL BIOL, V66, P437; Kobori S, 2007, PLANT BIOTECHNOL-NAR, V24, P375, DOI 10.5511/plantbiotechnology.24.375; Kolodziejek I, 2007, PROTOPLASMA, V232, P97, DOI 10.1007/s00709-007-0271-x; Kontek R, 2014, TOXICOL IN VITRO, V28, P282, DOI 10.1016/j.tiv.2013.11.007; Krantic S, 2005, TRENDS NEUROSCI, V28, P670, DOI 10.1016/j.tins.2005.09.011; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Kunikowska A, 2013, PROTOPLASMA, V250, P851, DOI 10.1007/s00709-012-0466-7; Kuthanova A, 2008, PLANT CELL ENVIRON, V31, P1634, DOI 10.1111/j.1365-3040.2008.01876.x; Lang FF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129196; Lockshin RA, 2004, INT J BIOCHEM CELL B, V36, P2405, DOI 10.1016/j.biocel.2004.04.011; Mazurczyk M, 2015, BIOCHIMIE, V108, P25, DOI 10.1016/j.biochi.2014.10.026; MEIKRANTZ W, 1994, P NATL ACAD SCI USA, V91, P3754, DOI 10.1073/pnas.91.9.3754; Minina EA, 2013, J CELL BIOL, V203, P917, DOI 10.1083/jcb.201307082; Nishawar Jan, 2008, Biotechnology and Molecular Biology Reviews, V3, P111; OLIVE MR, 1990, PLANT MOL BIOL, V15, P593, DOI 10.1007/BF00017834; Ovejero-Benito MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064890; Potocki L, 2014, BIOCHIMIE, V97, P163, DOI 10.1016/j.biochi.2013.10.010; Reape TJ, 2008, J EXP BOT, V59, P435, DOI 10.1093/jxb/erm258; Reape TJ, 2010, APOPTOSIS, V15, P249, DOI 10.1007/s10495-009-0447-2; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Ribble D, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-12; Rybaczek D, 2007, BIOL PLANTARUM, V51, P443, DOI 10.1007/s10535-007-0094-9; Rybaczek D, 2002, FOLIA HISTOCHEM CYTO, V40, P51; Rybaczek D, 2011, DNA REPAIR, P185; Rybaczek D, 2013, NEW RES DIRECTIONS D, P231, DOI [10.5772/54020, DOI 10.5772/54020]; Rybaczek D, 2008, ACTA PHYSIOL PLANT, V30, P663, DOI 10.1007/s11738-008-0163-5; Rybaczek D, 2007, HISTOCHEM CELL BIOL, V128, P227, DOI 10.1007/s00418-007-0311-9; Rybaczek D, 2007, PROTOPLASMA, V230, P31, DOI 10.1007/s00709-006-0192-0; Rybaczek D, 2014, PLANT CELL REP, V33, P1547, DOI 10.1007/s00299-014-1637-0; Rybaczek D, 2011, HISTOCHEM CELL BIOL, V135, P263, DOI 10.1007/s00418-011-0793-3; SCHLEGEL R, 1986, SCIENCE, V232, P1264, DOI 10.1126/science.2422760; Serafini-Fracassini D, 2010, PLANT PHYSIOL BIOCH, V48, P602, DOI 10.1016/j.plaphy.2010.03.005; Smetana O, 2012, J EXP BOT, V63, P2631, DOI 10.1093/jxb/err439; Tegeder M, 1995, PLANT CELL REP, V15, P164, DOI 10.1007/BF00193712; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Vakifahmetoglu H, 2008, CELL DEATH DIFFER, V15, P1153, DOI 10.1038/cdd.2008.47; van Doorn WG, 2011, CELL DEATH DIFFER, V18, P1241, DOI 10.1038/cdd.2011.36; van Doorn WG, 2005, TRENDS PLANT SCI, V10, P478, DOI 10.1016/j.tplants.2005.08.003; van Doorn WG, 2005, TRENDS PLANT SCI, V10, P117, DOI 10.1016/j.tplants.2005.01.006; van Doorn WG, 2011, J EXP BOT, V62, P4749, DOI 10.1093/jxb/err196; Vanyushin BF, 2004, INT REV CYTOL, V233, P135, DOI 10.1016/S0074-7696(04)33004-4; VAUX DL, 1994, CELL, V76, P777, DOI 10.1016/0092-8674(94)90350-6; Vitale I, 2011, NAT REV MOL CELL BIO, V12, P384, DOI 10.1038/nrm3115; Wang JH, 2013, TRENDS PLANT SCI, V18, P133, DOI 10.1016/j.tplants.2012.09.004; Yamada T, 2006, J EXP BOT, V57, P3543, DOI 10.1093/jxb/erl100; Yoshida M, 1997, EXP CELL RES, V232, P225, DOI 10.1006/excr.1997.3538	77	14	15	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142307	10.1371/journal.pone.0142307	http://dx.doi.org/10.1371/journal.pone.0142307			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545248	gold, Green Submitted, Green Published			2022-12-26	WOS:000364398700108
J	Urayama, A; Dohgu, S; Robinson, SM; Sly, WS; Grubb, JH; Banks, WA				Urayama, Akihiko; Dohgu, Shinya; Robinson, Sandra M.; Sly, William S.; Grubb, Jeffery H.; Banks, William A.			Alpha Adrenergic Induction of Transport of Lysosomal Enzyme across the Blood-Brain Barrier	PLoS One			English	Article							MANNOSE 6-PHOSPHATE RECEPTOR; MEDIATED TRANSPORT; INTERNALIZATION; SUBTYPES; STORAGE; VII	The impermeability of the adult blood-brain barrier (BBB) to lysosomal enzymes impedes the ability to treat the central nervous system manifestations of lysosomal storage diseases. Here, we found that simultaneous stimulation of the alpha1 and alpha2 adrenoreceptor restores in adult mice the high rate of transport for the lysosomal enzyme P-GUS that is seen in neonates but lost with development. Beta adrenergics, other monoamines, and acetylcholine did not restore this transport. A high dose (500 microg/mouse) of clonidine, a strong alpha2 and weak alpha1 agonist, was able to act as monotherapy in the stimulation of P-GUS transport. Neither use of alpha1 plus alpha2 agonists nor the high dose clonidine disrupted the BBB to albumin. In situ brain perfusion and immunohistochemistry studies indicated that adrengerics act on transporters already at the luminal surface of brain endothelial cells. These results show that adrenergic stimulation, including monotherapy with clonidine, could be key for CNS enzyme replacement therapy.	[Urayama, Akihiko] Univ Texas Med Sch Houston, Dept Neurol, Houston, TX USA; [Dohgu, Shinya] Fac Pharmaceut Sci, Dept Pharmaceut Care & Hlth Sci, Fukuoka, Japan; [Robinson, Sandra M.] St Louis Univ, Div Geriatr Med, Dept Internal Med, St Louis, MO 63103 USA; [Sly, William S.; Grubb, Jeffery H.] St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO USA; [Banks, William A.] Vet Affairs Puget Sound Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Seattle, WA 98493 USA; [Banks, William A.] Univ Washington, Sch Med, Dept Med, Div Gerontol & Geriatr Med, Seattle, WA 98195 USA	University of Texas System; University of Texas Health Science Center Houston; Saint Louis University; Saint Louis University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle	Banks, WA (corresponding author), Vet Affairs Puget Sound Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Seattle, WA 98493 USA.	wabanks1@uw.edu	Dohgu, Shinya/AAK-9992-2020; Banks, William A/K-1330-2017	Banks, William A/0000-0002-0496-3619	National Institutes of Health [Ro1 NS081134]; Veterans Affairs; Shire; NIH [R01 NS081134]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs); Shire; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Institutes of Health (WAB) Ro1 NS081134, Veterans Affairs (WAB) (no number), Shire (WAB; WSS) (no number). The funders had no role in the study, design, data collection and analysis, decision to publish, or preparation of the manuscript.; Supported by Veterans Affairs (WAB), Shire, and NIH R01 NS081134 (WAB). The contents do not represent the views of the US Department of Veterans Affairs or the United States Government.	Banks WA, 2001, BRAIN RES, V899, P209, DOI 10.1016/S0006-8993(01)02242-9; BANKS WA, 1986, J PHARMACOL EXP THER, V239, P668; BANKS WA, 1988, J PHARMACOL EXP THER, V244, P579; Begley DJ, 2008, CURR PHARM DESIGN, V14, P1566, DOI 10.2174/138161208784705504; BLASBERG RG, 1983, J CEREBR BLOOD F MET, V3, P8, DOI 10.1038/jcbfm.1983.2; Calias P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030341; Dohgu S, 2008, EXP NEUROL, V210, P740, DOI 10.1016/j.expneurol.2007.12.028; Georgieva JV, 2011, MOL THER, V19, P318, DOI 10.1038/mt.2010.236; Grubb JH, 2008, P NATL ACAD SCI USA, V105, P2616, DOI 10.1073/pnas.0712147105; KALARIA RN, 1989, NEUROSCI LETT, V106, P233, DOI 10.1016/0304-3940(89)90231-0; LOSSINSKY AS, 1983, ACTA NEUROPATHOL, V61, P239, DOI 10.1007/BF00691992; MURPHY VA, 1985, J CEREBR BLOOD F MET, V5, P401, DOI 10.1038/jcbfm.1985.55; PATLAK CS, 1983, J CEREBR BLOOD F MET, V3, P1, DOI 10.1038/jcbfm.1983.1; Perez-Aso M, 2013, BBA-MOL CELL RES, V1833, P2322, DOI 10.1016/j.bbamcr.2013.06.013; Preston Jane E, 2014, Adv Pharmacol, V71, P147, DOI 10.1016/bs.apha.2014.06.001; REESE TS, 1967, J CELL BIOL, V34, P207, DOI 10.1083/jcb.34.1.207; SANDS MS, 1994, J CLIN INVEST, V93, P2324, DOI 10.1172/JCI117237; Shi T, 2006, MOL PHARMACOL, V70, P129, DOI 10.1124/mol.105.020735; Stanasila L, 2008, MOL PHARMACOL, V74, P562, DOI 10.1124/mol.107.043422; Tomatsu S, 2007, HUMAN MOL GENETICS; Urayama A, 2004, P NATL ACAD SCI USA, V101, P12658, DOI 10.1073/pnas.0405042101; Urayama A, 2008, MOL THER, V16, P1261, DOI 10.1038/mt.2008.84; Urayama A, 2007, P NATL ACAD SCI USA, V104, P12873, DOI 10.1073/pnas.0705611104; VANDEURS B, 1978, MICROVASC RES, V16, P280, DOI 10.1016/0026-2862(78)90061-4; Wheway J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052586	25	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142347	10.1371/journal.pone.0142347	http://dx.doi.org/10.1371/journal.pone.0142347			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545208	gold, Green Published, Green Submitted			2022-12-26	WOS:000364398700116
J	Zeng, XF; Zhao, N; Sun, HW; Ye, L; Zhai, JQ				Zeng, Xiaofan; Zhao, Na; Sun, Huaiwei; Ye, Lei; Zhai, Jianqing			Changes and Relationships of Climatic and Hydrological Droughts in the Jialing River Basin, China	PLOS ONE			English	Article							TRENDS; INDEX; CIRCULATION; IRAN	The comprehensive assessment of climatic and hydrological droughts in terms of their temporal and spatial evolutions is very important for water resources management and social development in the basin scale. To study the spatial and temporal changes of climatic and hydrological droughts and the relationships between them, the SPEI and SDI are adopted to assess the changes and the correlations of climatic and hydrological droughts by selecting the Jialing River basin, China as the research area. The SPEI and SDI at different time scales are assessed both at the entire Jialing River basin and at the regional levels of the three sub basins. The results show that the SPEI and SDI are very suitable for assessing the changes and relationships of climatic and hydrological droughts in large basins. Based on the assessment, for the Jialing River basin, climatic and hydrological droughts have the increasing tendency during recent several decades, and the increasing trend of climatic droughts is significant or extremely significant in the western and northern basin, while hydrological drought has a less significant increasing trend. Additionally, climatic and hydrological droughts tend to increase in the next few years. The results also show that on short time scales, climatic droughts have one or two months lag impact on hydrological droughts in the north-west area of the basin, and have one month lag impact in south-east area of the basin. The assessment of climatic and hydrological droughts based on the SPEI and SDI could be very useful for water resources management and climate change adaptation at large basin scale.	[Zeng, Xiaofan; Zhao, Na] Inst Water Resources Hydropower Res, State Key Lab Simulat & Regulat Water Cycle River, Beijing, Peoples R China; [Zeng, Xiaofan; Zhao, Na; Sun, Huaiwei; Ye, Lei] Huazhong Univ Sci & Technol, Sch Hydropower & Informat Engn, Wuhan 430074, Peoples R China; [Zhai, Jianqing] China Meteorol Adm, Natl Climate Ctr, Beijing, Peoples R China	China Institute of Water Resources & Hydropower Research; Huazhong University of Science & Technology; China Meteorological Administration	Zhao, N (corresponding author), Inst Water Resources Hydropower Res, State Key Lab Simulat & Regulat Water Cycle River, Beijing, Peoples R China.	na.zhao.2011@hust.edu.cn	Sun, Huaiwei/AAB-4063-2019	Sun, Huaiwei/0000-0003-4873-0697	National Natural Science Foundation of China [51309105, 51409109]; Open Research Foundation of State Key Laboratory of Simulation and Regulation of Water Cycle in River Basin, China [IWHR-SKL-201307, IWHR-SKL-201308]; Fundamental Research Funds for the Central Universities, HUST [2014QN233, 2014QN234]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Research Foundation of State Key Laboratory of Simulation and Regulation of Water Cycle in River Basin, China; Fundamental Research Funds for the Central Universities, HUST(Fundamental Research Funds for the Central Universities)	Support was provided by: 1) National Natural Science Foundation of China (No. 51309105), to XFZ [http://www.nsfc.gov.cn/]; 2) National Natural Science Foundation of China (No. 51409109), to NZ [http://www.nsfc.gov.cn/]; 3) Open Research Foundation of State Key Laboratory of Simulation and Regulation of Water Cycle in River Basin, China (IWHR-SKL-201307), to XFZ [http://www.skl-wac.cn/sklsr/kfjj/A4505index_1.htm]; 4) Open Research Foundation of State Key Laboratory of Simulation and Regulation of Water Cycle in River Basin, China (IWHR-SKL-201308), to NZ [http://www.skl-wac.cn/sklsr/kfjj/A4505index_1.htm]; 5) Fundamental Research Funds for the Central Universities, HUST (No. 2014QN233), to XFZ; 6) Fundamental Research Funds for the Central Universities, HUST (No. 2014QN234), NZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreadis KM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025711; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Dai A, 2004, J HYDROMETEOROL, V5, P1117, DOI 10.1175/JHM-386.1; [杜华明 Du Huaming], 2015, [自然资源学报, Journal of Natural Resources], V30, P836; [段文明 Duan Wenming], 2012, [水土保持研究, Research of Soil and Water Conservation], V19, P97; Fu GB, 2004, CLIMATIC CHANGE, V65, P149, DOI 10.1023/B:CLIM.0000037491.95395.bb; Gan TY, 1998, WATER RESOUR RES, V34, P3009, DOI 10.1029/98WR01265; IPCC, 2011, MAN RISKS EXTR EV DI; KENDALL M. G., 1948, Rank correlation methods.; Lopez-Moreno JI, 2013, J HYDROL, V477, P175, DOI 10.1016/j.jhydrol.2012.11.028; MCKEE TB, 1995, NINTH CONFERENCE ON APPLIED CLIMATOLOGY, P233; Mishra AK, 2010, J HYDROL, V391, P204, DOI 10.1016/j.jhydrol.2010.07.012; Nalbantis I, 2009, WATER RESOUR MANAG, V23, P881, DOI 10.1007/s11269-008-9305-1; Palmer W.C., 1965, 45 US DEP COMM WEATH, P45; Rodier JA, 1985, UNESCO WMO STUDIES R, P149; Seager R, 2007, SCIENCE, V316, P1181, DOI 10.1126/science.1139601; Shafer B. A., 1982, P W SNOW C COL STAT, P164; SINGH VP, 1993, STOCH HYDROL HYDRAUL, V7, P163, DOI 10.1007/BF01585596; Sneyers R., 1991, Technical Note - World Meteorological Organization; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sterl A, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034071; Tabari H, 2013, WATER RESOUR MANAG, V27, P137, DOI 10.1007/s11269-012-0173-3; Talaee PH, 2014, HYDROL PROCESS, V28, P764, DOI 10.1002/hyp.9586; Thornthwaite CW, 1948, GEOGR REV, V38, P55, DOI 10.2307/210739; Tian D, 2012, J HYDROL, V475, P350, DOI 10.1016/j.jhydrol.2012.10.009; Tsakiris G, 2007, WATER RESOUR MANAG, V21, P821, DOI 10.1007/s11269-006-9105-4; Vicente-Serrano SM, 2010, J CLIMATE, V23, P1696, DOI 10.1175/2009JCLI2909.1; Wang HJ, 2001, ADV ATMOS SCI, V18, P376; Wilhite DA, 1992, ENCY EARTH SYSTEM SC, V2, P81, DOI DOI 10.4324/9781315298917-26; Wilhite DA, 2007, WATER RESOUR MANAG, V21, P763, DOI 10.1007/s11269-006-9076-5; [叶磊 Ye Lei], 2015, [长江流域资源与环境, Resources and Environment in the Yangtze Basin], V24, P943; Zhang Q., 2003, CHINA CLIMATE IMPACT, P12; Zou XK, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021853	33	16	18	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141648	10.1371/journal.pone.0141648	http://dx.doi.org/10.1371/journal.pone.0141648			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544070	gold, Green Published, Green Submitted			2022-12-26	WOS:000364398700037
J	Castagnola, P; Zoppoli, G; Gandolfo, S; Monticone, M; Malacarne, D; Cirmena, G; Brown, D; Aiello, C; Maffei, M; Marino, R; Giaretti, W; Pentenero, M				Castagnola, Patrizio; Zoppoli, Gabriele; Gandolfo, Sergio; Monticone, Massimiliano; Malacarne, Davide; Cirmena, Gabriella; Brown, David; Aiello, Cinzia; Maffei, Massimo; Marino, Roberto; Giaretti, Walter; Pentenero, Monica			Genomic DNA Copy Number Aberrations, Histological Diagnosis, Oral Subsite and Aneuploidy in OPMDs/OSCCs	PLOS ONE			English	Article							POTENTIALLY MALIGNANT LESIONS; FALSE DISCOVERY RATE; CHROMOSOMAL INSTABILITY; EPITHELIAL DYSPLASIA; HIGH-RISK; PROGRESSION; HEAD; LEUKOPLAKIA; ALGORITHMS; EVOLUTION	Oral potentially malignant disorders (OPMDs) characterized by the presence of dysplasia and DNA copy number aberrations (CNAs), may reflect chromosomal instability (CIN) and predispose to oral squamous cell carcinoma (OSCC). Early detection of OPMDs with such characteristics may play a crucial role in OSCC prevention. The aim of this study was to explore the relationship between CNAs, histological diagnosis, oral subsite and aneuploidy in OPMDs/OSCCs. Samples from OPMDs and OSCCs were processed by high-resolution DNA flow cytometry (hr DNA-FCM) to determine the relative nuclear DNA content. Additionally, CNAs were obtained for a subset of these samples by genome-wide array comparative genomic hybridization (aCGH) using DNA extracted from either diploid or aneuploid nuclei suspension sorted by FCM. Our study shows that: i) aneuploidy, global genomic imbalance (measured as the total number of CNAs) and specific focal CNAs occur early in the development of oral cancer and become more frequent at later stages; ii) OPMDs limited to tongue (TNG) mucosa display a higher frequency of aneuploidy compared to OPMDs confined to buccal mucosa (BM) as measured by DNA-FCM; iii) TNG OPMDs/OSCCs show peculiar features of CIN compared to BM OPMDs/OSCCs given the preferential association with total broad and specific focal CNA gains. Follow-up studies are warranted to establish whether the presence of DNA aneuploidy and specific focal or broad CNAs may predict cancer development in non-dysplastic OPMDs.	[Castagnola, Patrizio; Zoppoli, Gabriele; Monticone, Massimiliano; Malacarne, Davide; Aiello, Cinzia; Giaretti, Walter] IRCCS AOU San Martino IST, Genoa, Italy; [Zoppoli, Gabriele; Cirmena, Gabriella; Maffei, Massimo] Univ Genoa, Dept Internal Med, I-16126 Genoa, Italy; [Gandolfo, Sergio; Marino, Roberto; Pentenero, Monica] Univ Turin, Dept Oncol, Oral Med & Oral Oncol Unit, Turin, Italy; [Brown, David] Univ Libre Bruxelles, Inst Jules Bordet, JC Heuson Breast Canc Translat Res Lab, Brussels, Belgium	University of Genoa; IRCCS AOU San Martino IST; University of Genoa; University of Turin; Institut Jules Bordet; Universite Libre de Bruxelles	Castagnola, P (corresponding author), IRCCS AOU San Martino IST, Genoa, Italy.	patrizio.castagnola@hsanmartino.it	Castagnola, Patrizio/H-2029-2012; Maffei, Massimo/AAC-1669-2020; Zoppoli, Gabriele/B-6935-2016; Pentenero, Monica/F-8797-2013; Zoppoli, Gabriele/B-6935-2016	Castagnola, Patrizio/0000-0003-2008-9199; Maffei, Massimo/0000-0002-2453-9065; Zoppoli, Gabriele/0000-0003-3890-5588; Pentenero, Monica/0000-0003-3972-1203; Maffei, Massimo/0000-0001-6814-2353; Cirmena, Gabriella/0000-0002-5794-2766; Zoppoli, Gabriele/0000-0002-1619-1708	Compagnia di San Paolo [2011.0173]; AIRC [MFAG10570]; Ministero della Salute-Fondi Ministero della Salute	Compagnia di San Paolo(Compagnia di San Paolo); AIRC(Fondazione AIRC per la ricerca sul cancro); Ministero della Salute-Fondi Ministero della Salute	This work was supported by Compagnia di San Paolo-2011.0173- (http://www.compagniadisanpaolo.it), AIRC -MFAG10570- (http://www.airc.it), and Ministero della Salute-Fondi Ministero della Salute - 5 per mille 2011- (http://www.salute.gov.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amati Bruno, 1998, Frontiers in Bioscience, V3, pD250; Arduino PG, 2013, ORAL DIS, V19, P642, DOI 10.1111/odi.12065; Awan Kh, 2014, J Int Oral Health, V6, pi; Baker DJ, 2009, CANCER CELL, V16, P475, DOI 10.1016/j.ccr.2009.10.023; Benjamini Y, 2005, GENETICS, V171, P783, DOI 10.1534/genetics.104.036699; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bloebaum M, 2014, J CRANIO MAXILL SURG, V42, P1572, DOI 10.1016/j.jcms.2014.01.046; Borkosky SS, 2009, J CANCER RES CLIN, V135, P703, DOI 10.1007/s00432-008-0507-y; Bradley G, 2010, BRIT J CANCER, V103, P1432, DOI 10.1038/sj.bjc.6605905; Brennan M, 2007, ORAL SURG ORAL MED O, V103, pS19, DOI 10.1016/j.tripleo.2006.10.015; Buffart TE, 2007, CELL ONCOL, V29, P351; BUNDGAARD T, 1992, CANCER-AM CANCER SOC, V70, P1, DOI 10.1002/1097-0142(19920701)70:1<1::AID-CNCR2820700102>3.0.CO;2-S; Carlson JM HD, 2009, MICROSOFT RESEARCH T; Castagnola P, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-445; Donadini A, 2010, CELL ONCOL, V32, P373, DOI 10.3233/CLO-2010-0525; Giaretti W, 2012, CELL ONCOL, V35, P43, DOI 10.1007/s13402-011-0064-2; Giaretti W, 2013, CANCER EPIDEM BIOMAR, V22, P1133, DOI 10.1158/1055-9965.EPI-13-0147; Giaretti W, 2012, FUTURE ONCOL, V8, P1257, DOI [10.2217/fon.12.116, 10.2217/FON.12.116]; Gordon DJ, 2012, NAT REV GENET, V13, P189, DOI 10.1038/nrg3123; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Kresty LA, 2002, CANCER RES, V62, P5295; Ledet EM, 2013, PROSTATE, V73, P614, DOI 10.1002/pros.22602; Lee H, 2002, GENETICS, V161, P905; Lin M, 2006, ONCOGENE, V25, P1424, DOI 10.1038/sj.onc.1209166; Lippman SM, 2001, NEW ENGL J MED, V344, P1323, DOI 10.1056/NEJM200104263441710; Louhimo R, 2012, NAT METHODS, V9, P351, DOI [10.1038/NMETH.1893, 10.1038/nmeth.1893]; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Nankivell P, 2013, OR SURG OR MED OR PA, V115, P87, DOI 10.1016/j.oooo.2012.10.015; Navone R, 2008, J ORAL PATHOL MED, V37, P358, DOI 10.1111/j.1600-0714.2008.00636.x; Nilsen G, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-591; OTTO FJ, 1994, METHOD CELL BIOL, V41, P211; Peng CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023452; Potapova TA, 2013, CANCER METAST REV, V32, P377, DOI 10.1007/s10555-013-9436-6; Reibel J, 2003, CRIT REV ORAL BIOL M, V14, P47, DOI 10.1177/154411130301400105; SAITO T, 1991, INT J ORAL MAX SURG, V20, P259, DOI 10.1016/S0901-5027(05)80148-1; SAITO T, 1995, INT J ORAL MAX SURG, V24, P44, DOI 10.1016/S0901-5027(05)80855-0; Salahshourifar I, 2014, ORAL ONCOL, V50, P404, DOI 10.1016/j.oraloncology.2014.02.005; SCULLY C, 1993, J ORAL PATHOL MED, V22, P246, DOI 10.1111/j.1600-0714.1993.tb01066.x; Scully C, 2014, ORAL DIS, V20, P1, DOI 10.1111/odi.12208; Sheltzer JM, 2011, SCIENCE, V333, P1026, DOI 10.1126/science.1206412; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Sklenicka S, 2010, J ORAL MAXIL SURG, V68, P1270, DOI 10.1016/j.joms.2009.11.016; Smeets SJ, 2006, ONCOGENE, V25, P2558, DOI 10.1038/sj.onc.1209275; Sotillo R, 2009, CANCER CELL, V16, P451, DOI 10.1016/j.ccr.2009.11.014; Sperandio M, 2013, CANCER PREV RES, V6, P822, DOI 10.1158/1940-6207.CAPR-13-0001; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Thompson Lester, 2006, Ear Nose Throat J, V85, P74; Thompson SL, 2010, CURR BIOL, V20, pR285, DOI 10.1016/j.cub.2010.01.034; Torres-Rendon A, 2009, ORAL ONCOL, V45, P468, DOI 10.1016/j.oraloncology.2008.07.006; Towle R, 2014, CANCER MED-US, V3, P1170, DOI 10.1002/cam4.307; van der Waal I, 2009, ORAL ONCOL, V45, P317, DOI 10.1016/j.oraloncology.2008.05.016; WALDRON CA, 1975, CANCER-AM CANCER SOC, V36, P1386, DOI 10.1002/1097-0142(197510)36:4<1386::AID-CNCR2820360430>3.0.CO;2-7; Weaver BAA, 2009, J CELL BIOL, V185, P934, DOI 10.1083/jcb.200905098; Yates LR, 2012, NAT REV GENET, V13, P795, DOI 10.1038/nrg3317; Yong ZWE, 2014, SCI REP-UK, V4, DOI 10.1038/srep06073; Yoshioka S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056165; Zhang LW, 2012, CANCER PREV RES, V5, P1081, DOI 10.1158/1940-6207.CAPR-12-0173	57	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142294	10.1371/journal.pone.0142294	http://dx.doi.org/10.1371/journal.pone.0142294			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540282	Green Published, Green Submitted, gold			2022-12-26	WOS:000364303800076
J	Jackson, EE; Rendina-Ruedy, E; Smith, BJ; Lacombe, VA				Jackson, Ellen E.; Rendina-Ruedy, Elisabeth; Smith, Brenda J.; Lacombe, Veronique A.			Loss of Toll-Like Receptor 4 Function Partially Protects against Peripheral and Cardiac Glucose Metabolic Derangements During a Long-Term High-Fat Diet	PLOS ONE			English	Article							INDUCED INSULIN-RESISTANCE; PROLONGED HYPERINSULINEMIA; SKELETAL-MUSCLE; TLR4 EXPRESSION; PLASMA-GLUCOSE; MICE; INFLAMMATION; TRANSPORTER; GLUT8; OBESITY	Diabetes is a chronic inflammatory disease that carries a high risk of cardiovascular disease. However, the pathophysiological link between these disorders is not well known. We hypothesize that TLR4 signaling mediates high fat diet (HFD)-induced peripheral and cardiac glucose metabolic derangements. Mice with a loss-of-function mutation in TLR4 (C3H/HeJ) and age-matched control (C57BL/6) mice were fed either a high-fat diet or normal diet for 16 weeks. Glucose tolerance and plasma insulin were measured. Protein expression of glucose transporters (GLUT), AKT (phosphorylated and total), and proinflammatory cytokines (IL-6, TNF-alpha and SOCS-3) were quantified in the heart usingWestern Blotting. Both groups fed a long-term HFD had increased body weight, blood glucose and insulin levels, as well as impaired glucose tolerance compared to mice fed a normal diet. TLR4-mutant mice were partially protected against long-term HFD-induced insulin resistance. In control mice, feeding a HFD decreased cardiac crude membrane GLUT4 protein content, which was partially rescued in TLR4-mutant mice. TLR4-mutant mice fed a HFD also had increased expression of GLUT8, a novel isoform, compared to mice fed a normal diet. GLUT8 content was positively correlated with SOCS-3 and IL-6 expression in the heart. No significant differences in cytokine expression were observed between groups, suggesting a lack of inflammation in the heart following a HFD. Loss of TLR4 function partially restored a healthy metabolic phenotype, suggesting that TLR4 signaling is a key mechanism in HFD-induced peripheral and cardiac insulin resistance. Our data further suggest that TLR4 exerts its detrimental metabolic effects in the myocardium through a cytokine-independent pathway.	[Jackson, Ellen E.; Lacombe, Veronique A.] Oklahoma State Univ, Dept Physiol Sci, Stillwater, OK 74078 USA; [Rendina-Ruedy, Elisabeth; Smith, Brenda J.] Oklahoma State Univ, Dept Nutr Sci, Stillwater, OK 74078 USA; [Lacombe, Veronique A.] Univ Oklahoma, Hlth Sci Ctr, Harold Hamm Diabet Ctr, Oklahoma City, OK USA	Oklahoma State University System; Oklahoma State University - Stillwater; Oklahoma State University System; Oklahoma State University - Stillwater; University of Oklahoma System; University of Oklahoma Health Sciences Center	Lacombe, VA (corresponding author), Oklahoma State Univ, Dept Physiol Sci, Stillwater, OK 74078 USA.	veronique.lacombe@okstate.edu		Jackson, Ellen/0000-0001-6866-2105	NIH [T35OD011186]; American Veterinary Medical Foundation; Oklahoma State University Center for Veterinary Health Sciences; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T35OD011186] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Veterinary Medical Foundation; Oklahoma State University Center for Veterinary Health Sciences; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We acknowledge funding from NIH grant T35OD011186, the American Veterinary Medical Foundation, and the Oklahoma State University Center for Veterinary Health Sciences.	Aerni-Flessner L, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-63; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Carayannopoulos MO, 2000, P NATL ACAD SCI USA, V97, P7313, DOI 10.1073/pnas.97.13.7313; CDC National Diabetes Fact Sheet, 2014, NAT ENT DIS SURV LIS, P1, DOI [10.1002/ejoc.201200111, DOI 10.1002/EJOC.201200111]; Chao W, 2009, AM J PHYSIOL-HEART C, V296, pH1, DOI 10.1152/ajpheart.00995.2008; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; de Laat MA, 2015, VET J, V205, P381, DOI 10.1016/j.tvjl.2015.05.018; de Laat MA, 2015, EQUINE VET J, V47, P494, DOI 10.1111/evj.12320; de Laat MA, 2014, VET IMMUNOL IMMUNOP, V157, P78, DOI 10.1016/j.vetimm.2013.10.010; de Laat MA, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00120; DeBosch BJ, 2013, MOL ENDOCRINOL, V27, P1887, DOI 10.1210/me.2013-1137; Dong BJ, 2012, AM J PHYSIOL-HEART C, V303, pH732, DOI 10.1152/ajpheart.00948.2011; Fuentes-Antras J, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/847827; Gray S, 2011, TRENDS ENDOCRIN MET, V22, P394, DOI 10.1016/j.tem.2011.05.001; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Holland WL, 2011, J CLIN INVEST, V121, P1858, DOI 10.1172/JCI43378; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Huang JP, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-77; Ibberson M, 2000, J BIOL CHEM, V275, P4607, DOI 10.1074/jbc.275.7.4607; KATZ EB, 1995, NATURE, V377, P151, DOI 10.1038/377151a0; Kim HJ, 2004, DIABETES, V53, P1060, DOI 10.2337/diabetes.53.4.1060; Kim J. J., 2010, GASTROENTEROL RES PR, V2010; Kim JK, 2006, CELL METAB, V4, P417, DOI 10.1016/j.cmet.2006.11.008; Kim JK, 2001, J CLIN INVEST, V108, P437, DOI 10.1172/JCI11559; Ko HJ, 2009, DIABETES, V58, P2536, DOI 10.2337/db08-1361; Konner AC, 2011, TRENDS ENDOCRIN MET, V22, P16, DOI 10.1016/j.tem.2010.08.007; Kowalski GM, 2015, BIOCHEM BIOPH RES CO, V463, P818, DOI 10.1016/j.bbrc.2015.06.019; Lacombe VA, 2003, AM J VET RES, V64, P1500, DOI 10.2460/ajvr.2003.64.1500; Lacombe Veronique A, 2014, ISRN Vet Sci, V2014, P409547, DOI 10.1155/2014/409547; Lorenzo O, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/652097; Lucas EA, 2011, BRIT J NUTR, V106, P1495, DOI 10.1017/S0007114511002066; Manolakis AC, 2011, EUR J ENDOCRINOL, V165, P261, DOI 10.1530/EJE-11-0280; Mueckler M, 2013, MOL ASPECTS MED, V34, P121, DOI 10.1016/j.mam.2012.07.001; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Park SY, 2005, DIABETES, V54, P3530, DOI 10.2337/diabetes.54.12.3530; Pasare C, 2005, ADV EXP MED BIOL, V560, P11; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Razolli DS, 2015, ENDOCRINOLOGY, V156, P103, DOI 10.1210/en.2014-1552; Rendina-Ruedy E, 2015, J BONE MINER METAB; Schaeffler A, 2009, IMMUNOLOGY, V126, P233, DOI 10.1111/j.1365-2567.2008.02892.x; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Song MJ, 2006, BIOCHEM BIOPH RES CO, V346, P739, DOI 10.1016/j.bbrc.2006.05.170; Suganami T, 2007, BIOCHEM BIOPH RES CO, V354, P45, DOI 10.1016/j.bbrc.2006.12.190; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Waller AP, 2012, VET IMMUNOL IMMUNOP, V149, P208, DOI 10.1016/j.vetimm.2012.07.003; Waller AP, 2011, J VET INTERN MED, V25, P315, DOI 10.1111/j.1939-1676.2010.0674.x; Waller AP, 2013, BBA-MOL BASIS DIS, V1832, P121, DOI 10.1016/j.bbadis.2012.09.013; Waller APK A., 2015, BIOCHIM BIOPHYS ACTA, V1852, P9	50	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142077	10.1371/journal.pone.0142077	http://dx.doi.org/10.1371/journal.pone.0142077			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26539824	Green Published, Green Submitted, gold			2022-12-26	WOS:000364303800050
J	Lin, DR; Chen, JJ; Lin, ZL; Li, XY; Wu, XH; Long, EP; Luo, LX; Zhang, B; Chen, H; Chen, W; Zhang, L; Lin, HT; Chen, WR; Liu, YZ				Lin, Duoru; Chen, Jingjing; Lin, Zhuoling; Li, Xiaoyan; Wu, Xiaohang; Long, Erping; Luo, Lixia; Zhang, Bo; Chen, Hui; Chen, Wan; Zhang, Li; Lin, Haotian; Chen, Weirong; Liu, Yizhi			10-Year Overview of the Hospital-Based Prevalence and Treatment of Congenital Cataracts: The CCPMOH Experience	PLOS ONE			English	Article							PEDIATRIC CATARACT; VISUAL IMPAIRMENT; DISEASES; CHILDREN; SURGERY	A review of 6 years of hospitalization charts from Zhongshan Ophthalmic Center (ZOC) revealed that congenital cataracts (CC) accounted for 2.39% of all cataract in-patient cases and that the age at surgery was decreasing before the establishment of the Childhood Cataract Program of the Chinese Ministry of Health (CCPMOH) in December 2010. We aimed to investigate data from the 4 years (January 2011 to December 2014) following the establishment of the CCPMOH, compared, and combined with data from the previous study period (January 2005 to December 2010) to generate a 10-year overview of the hospital-based prevalence and treatment of CC. In the 4-year period after CCPMOH establishment, the prevalence of CC was 2.01% in all hospitalizations, and was 2.78% in all cataract inpatients. Most of the eligible CC in-patients (71%) lived in south China. The ratio of boys to girls was 1.42:1. Nearly 2/3 of the patients underwent cataract extraction with primary intraocular lens (IOL) implantation at a mean age of 78.40 +/- 51.45 months, and cataract extraction surgeries without IOL implantation were performed in the remaining 1/3 of patients at a mean age of 10.03 +/- 15.92 months. After CCPMOH establishment, an increased incidence of CC was revealed, and the CC in-patients were younger than the patients in the previous period. The 10-year overview (2421 CC in-patients from 206630 hospitalizations) revealed upward trends in both the number and the prevalence of CC and a further reduction in age at surgery. In conclusion, the data from 4-year period after CCPMOH establishment and the 10-year overview showed upward trends in the hospital-based prevalence of CC cases and a further reduction in age at surgery, likely reflecting the effects of the CCPMOH establishment and providing useful information for further CC studies and a valuable foundation for the prevention and treatment of this cause of childhood blindness.	[Lin, Duoru; Chen, Jingjing; Lin, Zhuoling; Li, Xiaoyan; Wu, Xiaohang; Long, Erping; Luo, Lixia; Zhang, Bo; Chen, Hui; Chen, Wan; Zhang, Li; Lin, Haotian; Chen, Weirong; Liu, Yizhi] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Lin, HT (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	gddlht@aliyun.com; chenwr_q@aliyun.com; yizhi_liu@aliyun.com	liu, yi/GXE-9662-2022; Chen, Wei/GZK-7348-2022	Long, Erping/0000-0002-3502-5596	Ministry of Science and Technology of China [2015CB964600]; Key Projects for Hospital Clinical Disciplines of the Ministry of Health of China [175]; Pearl River Science and Technology New Star Project of Guangzhou City [2014J2200060]; Guangdong Provincial Natural Science Foundation for Distinguished Young Scholars of China [2014A030306030]; Youth Science and Technology Innovation Talents Funds in the Special Support Plan for High Level Talents in Guangdong Province [2014TQ01R573]; Cultivation Projects [12ykpy61]; Intensive Cultivation Projects [2015ykzd11]; Fundamental Research Funds for the Central Universities; Fundamental Research Funds of State Key Laboratory of Ophthalmology [2015QN01]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Key Projects for Hospital Clinical Disciplines of the Ministry of Health of China; Pearl River Science and Technology New Star Project of Guangzhou City; Guangdong Provincial Natural Science Foundation for Distinguished Young Scholars of China; Youth Science and Technology Innovation Talents Funds in the Special Support Plan for High Level Talents in Guangdong Province; Cultivation Projects; Intensive Cultivation Projects; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Fundamental Research Funds of State Key Laboratory of Ophthalmology	This clinical study was supported by the Ministry of Science and Technology of China Grants (973 program, 2015CB964600), the Key Projects for Hospital Clinical Disciplines of the Ministry of Health of China in 2010- 2012 (Project No. 175 in Document 439 of the Planning and Finance Secretary of the Ministry of Health), the Pearl River Science and Technology New Star (Grant No. 2014J2200060) Project of Guangzhou City, the Guangdong Provincial Natural Science Foundation for Distinguished Young Scholars of China (Grant No. 2014A030306030), Youth Science and Technology Innovation Talents Funds in the Special Support Plan for High Level Talents in Guangdong Province (Grant No. 2014TQ01R573), the Cultivation Projects (12ykpy61) and Intensive Cultivation Projects (2015ykzd11) for Young Teaching Staff of Sun Yat-sen University, the Fundamental Research Funds for the Central Universities and the Fundamental Research Funds of State Key Laboratory of Ophthalmology (Grant No. 2015QN01). The sponsors of the study played no role in the study protocol design, data collection, data analysis, data interpretation, manuscript preparation, or the decision to submit the manuscript for publication.	Bayoumi NHL, 2015, J PEDIAT OPHTH STRAB, V52, P214, DOI 10.3928/01913913-20150414-11; Chak M, 2006, INVEST OPHTH VIS SCI, V47, P4262, DOI 10.1167/iovs.05-1160; Chen WK, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056540, 10.1371/journal.pone.0053985, 10.1371/journal.pone.0073764]; Foster A, 1997, J CATARACT REFR SURG, V23, P601, DOI 10.1016/S0886-3350(97)80040-5; Haargaard B, 2015, ACTA OPHTHALMOL, V93, P24, DOI 10.1111/aos.12445; He JN, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1312; Katibeh Marzieh, 2013, J Ophthalmic Vis Res, V8, P308; Lim Z, 2010, AM J OPHTHALMOL, V149, P887, DOI 10.1016/j.ajo.2010.01.012; Lin H.C., 2014, PLOS ONE, V9; Lin HT, 2012, INT J OPHTHALMOL-CHI, V5, P638, DOI 10.3980/j.issn.2222-3959.2012.05.19; Lin HT, 2012, OPHTHALMOLOGY, V119, P2463, DOI 10.1016/j.ophtha.2012.06.046; Muir KW, 2013, JAMA OPHTHALMOL, V131, P119, DOI 10.1001/jamaophthalmol.2013.577; Pi LH, 2012, J EPIDEMIOL, V22, P37, DOI 10.2188/jea.JE20110063; Rahi JS, 2000, INVEST OPHTH VIS SCI, V41, P2108; Sisk RA, 2010, OPHTHALMOLOGY, V117, P2178, DOI 10.1016/j.ophtha.2010.03.062; Trumler AA, 2011, CURR OPIN OPHTHALMOL, V22, P365, DOI 10.1097/ICU.0b013e32834994dc; Umar MM, 2015, MIDDLE EAST AFR J OP, V22, P92, DOI 10.4103/0974-9233.148356; You CY, 2011, OPHTHALMOLOGY, V118, P17, DOI 10.1016/j.ophtha.2010.04.014	18	20	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142298	10.1371/journal.pone.0142298	http://dx.doi.org/10.1371/journal.pone.0142298			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540510	Green Published, Green Submitted, gold			2022-12-26	WOS:000364303800078
J	Song, YZ; Yang, HL; Peng, JH; Song, YR; Sun, Q; Li, Y				Song, Yong-Ze; Yang, Hong-Lei; Peng, Jun-Huan; Song, Yi-Rong; Sun, Qian; Li, Yuan			Estimating PM2.5 Concentrations in Xi'an City Using a Generalized Additive Model with Multi-Source Monitoring Data	PLOS ONE			English	Article							AEROSOL OPTICAL DEPTH; GROUND-LEVEL PM2.5; AIR-POLLUTANT CONCENTRATIONS; PARTICULATE MATTER PM2.5; UNITED-STATES; SOURCE APPORTIONMENT; EMPIRICAL RELATIONSHIP; SEASONAL-VARIATIONS; ELEMENTAL CARBON; THICKNESS	Particulate matter with an aerodynamic diameter <2.5 mu m (PM2.5) represents a severe environmental problem and is of negative impact on human health. Xi'an City, with a population of 6.5 million, is among the highest concentrations of PM2.5 in China. In 2013, in total, there were 191 days in Xi'an City on which PM2.5 concentrations were greater than 100 mu g/m(3). Recently, a few studies have explored the potential causes of high PM2.5 concentration using remote sensing data such as the MODIS aerosol optical thickness (AOT) product. Linear regression is a commonly used method to find statistical relationships among PM2.5 concentrations and other pollutants, including CO, NO2, SO2, and O-3, which can be indicative of emission sources. The relationships of these variables, however, are usually complicated and non-linear. Therefore, a generalized additive model (GAM) is used to estimate the statistical relationships between potential variables and PM2.5 concentrations. This model contains linear functions of SO2 and CO, univariate smoothing non-linear functions of NO2, O-3, AOT and temperature, and bivariate smoothing non-linear functions of location and wind variables. The model can explain 69.50% of PM2.5 concentrations, with R-2 = 0.691, which improves the result of a stepwise linear regression (R-2 = 0.582) by 18.73%. The two most significant variables, CO concentration and AOT, represent 20.65% and 19.54% of the deviance, respectively, while the three other gas-phase concentrations, SO2, NO2, and O-3 account for 10.88% of the total deviance. These results show that in Xi'an City, the traffic and other industrial emissions are the primary source of PM2.5. Temperature, location, and wind variables also non-linearly related with PM2.5.	[Song, Yong-Ze; Yang, Hong-Lei; Peng, Jun-Huan] China Univ Geosci, Sch Land Sci & Technol, Beijing, Peoples R China; [Song, Yi-Rong] Qinghai Univ, Dept Geol Engn, Xining, Qinghai, Peoples R China; [Sun, Qian] China Univ Geosci, Sch Water Resources & Environm, Beijing, Peoples R China; [Li, Yuan] China Univ Geosci, Sch Geophys & Informat Technol, Beijing, Peoples R China	China University of Geosciences; Qinghai University; China University of Geosciences; China University of Geosciences	Yang, HL (corresponding author), China Univ Geosci, Sch Land Sci & Technol, Beijing, Peoples R China.	yanghonglei226@126.com	Song, Yongze/F-1940-2018	Song, Yongze/0000-0003-3420-9622	National Natural Science Foundation of China [41304012, 61427802, 41330634, 41374016]; National High-tech R&D Program of China [SS2012AA120804]; Doctoral Fund of Ministry of Education of China [20100022110008]; Open Research Fund of Key Laboratory of Digital Earth Science, Center for Earth Observation and Digital Earth, Chinese Academy of Sciences [2010LDE002]; Fundamental Research Funds for the Central Universities [2652015180]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-tech R&D Program of China(National High Technology Research and Development Program of China); Doctoral Fund of Ministry of Education of China(Ministry of Education, China); Open Research Fund of Key Laboratory of Digital Earth Science, Center for Earth Observation and Digital Earth, Chinese Academy of Sciences; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the following research projects: the National Natural Science Foundation of China (41304012, 61427802, 41330634, 41374016); the National High-tech R&D Program of China (SS2012AA120804); the Doctoral Fund of Ministry of Education of China (20100022110008); the Open Research Fund of Key Laboratory of Digital Earth Science, Center for Earth Observation and Digital Earth, Chinese Academy of Sciences (2010LDE002); the Fundamental Research Funds for the Central Universities (2652015180). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBEY DE, 1995, J EXPO ANAL ENV EPID, V5, P137; Bell ML, 2007, ENVIRON HEALTH PERSP, V115, P989, DOI 10.1289/ehp.9621; Bhaskar BV, 2010, AEROSOL AIR QUAL RES, V10, P301, DOI 10.4209/aaqr.2009.10.0069; Bian HS, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012781; Boys BL, 2014, ENVIRON SCI TECHNOL, V48, P11109, DOI 10.1021/es502113p; Cao JJ, 2005, ATMOS CHEM PHYS, V5, P3127, DOI 10.5194/acp-5-3127-2005; Carslaw DC, 2007, ATMOS ENVIRON, V41, P5289, DOI 10.1016/j.atmosenv.2007.02.032; Chen LWA, 2001, GEOPHYS RES LETT, V28, P1711, DOI 10.1029/2000GL012354; Chi X, 2013, ATMOS CHEM PHYS, V13, P12271, DOI 10.5194/acp-13-12271-2013; Chu D.A., 2002, GEOPHYS RES LETT, V29, DOI [10.1029/2001GL013205, DOI 10.1029/2001GL013205]; Costabile F, 2006, JSME INT J B-FLUID T, V49, P35, DOI 10.1299/jsmeb.49.35; Deshmukh DK, 2011, AEROSOL AIR QUAL RES, V11, P696, DOI 10.4209/aaqr.2010.04.0025; Dogruparmak SC, 2011, CLEAN-SOIL AIR WATER, V39, P597, DOI 10.1002/clen.201000478; Edwards DP, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004727; Federal R, 1987, FED REG, V52; Federal R, 2013, FED REG, V78; Fumo Yang, 2002, Journal of Tsinghua University (Science and Technology), V42, P1605; Gao B, 2013, ENVIRON SCI POLLUT R, V20, P2398, DOI 10.1007/s11356-012-1129-0; Glantz P, 2009, ATMOS ENVIRON, V43, P5838, DOI 10.1016/j.atmosenv.2009.05.017; Glasser L, 2007, J CHEM EDUC, V84, P533, DOI 10.1021/ed084p533; Guo YM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7139; Gupta P, 2006, ATMOS ENVIRON, V40, P5880, DOI 10.1016/j.atmosenv.2006.03.016; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Ho KF, 2014, ENVIRON MONIT ASSESS, V186, P2835, DOI 10.1007/s10661-013-3584-6; Hoff RM, 2009, J AIR WASTE MANAGE, V59, P645, DOI 10.3155/1047-3289.59.6.645; Hu XF, 2014, REMOTE SENS ENVIRON, V140, P220, DOI 10.1016/j.rse.2013.08.032; Hu ZY, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-27; Huang Y, 2014, ENVIRON SCI TECHNOL, V48, P13834, DOI 10.1021/es503696k; Khodeir M, 2012, ATMOS POLLUT RES, V3, P331, DOI 10.5094/APR.2012.037; Kim HS, 2014, ASIA-PAC J ATMOS SCI, V50, P191, DOI 10.1007/s13143-014-0007-8; Koelemeijer RBA, 2006, ATMOS ENVIRON, V40, P5304, DOI 10.1016/j.atmosenv.2006.04.044; Kumar N, 2007, ATMOS ENVIRON, V41, P4492, DOI 10.1016/j.atmosenv.2007.01.046; Li Guo-xing, 2013, Zhonghua Yi Xue Za Zhi, V93, P2703; Li LF, 2013, ENVIRON SCI TECHNOL, V47, P9291, DOI 10.1021/es401281r; Li Z, 2010, ADV ATMOS SCI, V27, P777, DOI 10.1007/s00376-009-9052-0; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lin CQ, 2015, REMOTE SENS ENVIRON, V156, P117, DOI 10.1016/j.rse.2014.09.015; Lin G, 2014, INT J ENV RES PUB HE, V11, P173, DOI 10.3390/ijerph110100173; Liousse C, 1996, J GEOPHYS RES-ATMOS, V101, P19411, DOI 10.1029/95JD03426; Liu Y, 2004, J GEOPHYS RES-ATMOS, V109, DOI [10.1029/2004JD005025, 10.1029/2003JD003981]; Liu Y, 2007, REMOTE SENS ENVIRON, V107, P33, DOI 10.1016/j.rse.2006.05.022; Liu Y, 2009, ENVIRON HEALTH PERSP, V117, P886, DOI 10.1289/ehp.0800123; Lu YP DJ, 2006, J SHAANXI METEOROLOG, V01, P1; Ma ZW, 2014, ENVIRON SCI TECHNOL, V48, P7436, DOI 10.1021/es5009399; Meng Z, 2007, FOOD CHEM TOXICOL, V45, P1368, DOI 10.1016/j.fct.2007.01.014; Moyeed RA, 2002, MATH GEOL, V34, P365, DOI 10.1023/A:1015085810154; Notario A, 2014, ATMOS RES, V145, P92, DOI 10.1016/j.atmosres.2014.03.021; Paciorek CJ, 2008, ENVIRON SCI TECHNOL, V42, P5800, DOI 10.1021/es703181j; POPE CA, 1995, AM J RESP CRIT CARE, V151, P669, DOI 10.1164/ajrccm/151.3_Pt_1.669; Pui DYH, 2014, PARTICUOLOGY, V13, P1, DOI 10.1016/j.partic.2013.11.001; Saiz-Lopez A, 2009, WATER AIR SOIL POLL, V200, P277, DOI 10.1007/s11270-008-9912-8; Schaap M, 2009, ATMOS CHEM PHYS, V9, P909, DOI 10.5194/acp-9-909-2009; Schlesinger RB, 2007, INHAL TOXICOL, V19, P811, DOI 10.1080/08958370701402382; Schwartz J, 1996, J AIR WASTE MANAGE, V46, P927, DOI 10.1080/10473289.1996.10467528; SEINFELD JH, 1989, SCIENCE, V243, P745, DOI 10.1126/science.243.4892.745; Shen ZX, 2009, ATMOS ENVIRON, V43, P2911, DOI 10.1016/j.atmosenv.2009.03.005; Song WZ, 2014, REMOTE SENS ENVIRON, V154, P1, DOI 10.1016/j.rse.2014.08.008; Sorek-Hamer M, 2013, ENVIRON POLLUT, V182, P417, DOI 10.1016/j.envpol.2013.08.002; Strawa A. W., 2011, ATMOSPHERIC CHEM PHY, P30563, DOI DOI 10.5194/ACPD-11-30563-2011; Sun YL, 2004, ATMOS ENVIRON, V38, P5991, DOI 10.1016/j.atmosenv.2004.07.009; Sun Z, 2013, ENVIRON SCI TECHNOL, V26, P75; Tai APK, 2010, ATMOS ENVIRON, V44, P3976, DOI 10.1016/j.atmosenv.2010.06.060; Tao J, 2009, PARTICUOLOGY, V7, P68, DOI 10.1016/j.partic.2008.11.002; Tao L, 2011, ENVIRON SCI TECHNOL, V24, P63; Tian J, 2010, REMOTE SENS ENVIRON, V114, P221, DOI 10.1016/j.rse.2009.09.011; Wang GengChen, 2014, Science & Technology Review, V32, P72; Wang J., 2003, GEOPHYS RES LETT, V30; Wang J, 2011, J ARID METEOROLOGY, V29, P174; Wang Y, 2005, ATMOS ENVIRON, V39, P3771, DOI 10.1016/j.atmosenv.2005.03.013; Wang YS, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015376; Wang ZF, 2010, REMOTE SENS ENVIRON, V114, P50, DOI 10.1016/j.rse.2009.08.009; Watson JG, 2008, J AIR WASTE MANAGE, V58, P265, DOI 10.3155/1047-3289.58.2.265; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Xin JY, 2014, ATMOS RES, V138, P179, DOI 10.1016/j.atmosres.2013.11.001; Yan ZW, 2010, INT J CLIMATOL, V30, P1226, DOI 10.1002/joc.1971; Yang ChunXue, 2011, Journal of Environment and Health, V28, P735; [张承中 Zhang Chengzhong], 2013, [环境工程学报, Chinese Journal of Environmental Engineering], V7, P1477; Zhang K, 2010, ATMOS ENVIRON, V44, P1740, DOI 10.1016/j.atmosenv.2010.02.008; [张凯 ZHANG Kai], 2007, [环境科学学报, Acta Scientiae Circumstantiae], V27, P459	79	37	39	3	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142149	10.1371/journal.pone.0142149	http://dx.doi.org/10.1371/journal.pone.0142149			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540446	Green Published, gold, Green Submitted			2022-12-26	WOS:000364303800058
J	Provence, A; Hristov, KL; Parajuli, SP; Petkov, GV				Provence, Aaron; Hristov, Kiril L.; Parajuli, Shankar P.; Petkov, Georgi V.			Regulation of Guinea Pig Detrusor Smooth Muscle Excitability by 17 beta-Estradiol: The Role of the Large Conductance Voltage- and Ca2+-Activated K+ Channels	PLOS ONE			English	Article							LOWER URINARY-TRACT; BK CHANNEL; RELAXATION; ESTRADIOL; ESTROGENS; ACTIVATION; PROGESTERONE; MODULATION; PHYSIOLOGY; BINDING	Estrogen replacement therapies have been suggested to be beneficial in alleviating symptoms of overactive bladder. However, the precise regulatory mechanisms of estrogen in urinary bladder smooth muscle (UBSM) at the cellular level remain unknown. Large conductance voltage- and Ca2+-activated K+ (BK) channels, which are key regulators of UBSM function, are suggested to be non-genomic targets of estrogens. This study provides an electrophysiological investigation into the role of UBSM BK channels as direct targets for 17 beta-estradiol, the principle estrogen in human circulation. Single BK channel recordings on inside-out excised membrane patches and perforated whole cell patch-clamp were applied in combination with the BK channel selective inhibitor paxilline to elucidate the mechanism of regulation of BK channel activity by 17 beta-estradiol in freshly-isolated guinea pig UBSM cells. 17 beta-Estradiol (100 nM) significantly increased the amplitude of depolarization-induced whole cell steady-state BK currents and the frequency of spontaneous transient BK currents in freshly-isolated UBSM cells. The increase in whole cell BK currents by 17 beta-estradiol was eliminated upon blocking BK channels with paxilline. 17 beta-Estradiol (100 nM) significantly increased (similar to 3-fold) the single BK channel open probability, indicating direct 17 beta-estradiol-BK channel interactions. 17 beta-Estradiol (100 nM) caused a significant hyperpolarization of the membrane potential of UBSM cells, and this hyperpolarization was reversed by blocking the BK channels with paxilline. 17 beta-Estradiol (100 nM) had no effects on L-type voltage-gated Ca2+ channel currents recorded under perforated patch-clamp conditions. This study reveals a new regulatory mechanism in the urinary bladder whereby BK channels are directly activated by 17 beta-estradiol to reduce UBSM cell excitability.	[Provence, Aaron; Hristov, Kiril L.; Parajuli, Shankar P.; Petkov, Georgi V.] Univ S Carolina, South Carolina Coll Pharm, Dept Drug Discovery & Biomed Sci, Columbia, SC 29208 USA	Medical University of South Carolina; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Petkov, GV (corresponding author), Univ S Carolina, South Carolina Coll Pharm, Dept Drug Discovery & Biomed Sci, Columbia, SC 29208 USA.	petkov@cop.sc.edu			NIH [R01-DK084284, R01-DK106964]; National Institutes of Health [F31-DK104528]; SPARC Graduate Research Grant from the Office of the Vice President for Research at the University of South Carolina; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK106964, F31DK104528, R01DK084284] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SPARC Graduate Research Grant from the Office of the Vice President for Research at the University of South Carolina; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by grants from the NIH R01-DK084284 and R01-DK106964 to Georgi V. Petkov. Aaron Provence was supported by National Institutes of Health pre-doctoral fellowship F31-DK104528 and a SPARC Graduate Research Grant from the Office of the Vice President for Research at the University of South Carolina.	Andersson KE, 2004, PHARMACOL REV, V56, P581, DOI 10.1124/pr.56.4.4; Broughton BRS, 2010, AM J PHYSIOL-HEART C, V298, pH1055, DOI 10.1152/ajpheart.00878.2009; Cairrao E, 2012, ACTA PHARMACOL SIN, V33, P615, DOI 10.1038/aps.2012.4; Cardozo L, 2004, ACTA OBSTET GYN SCAN, V83, P892, DOI 10.1111/j.0001-6349.2004.00581.x; Dambros M, 2004, PHARMACOLOGY, V72, P121, DOI 10.1159/000080184; De Wet H, 2006, MOL MEMBR BIOL, V23, P420, DOI 10.1080/09687860600802803; de Wet Heidi, 2008, V491, P177, DOI 10.1007/978-1-59745-526-8_14; Dick GM, 2001, J BIOL CHEM, V276, P44835, DOI 10.1074/jbc.M106851200; Game X, 2013, PROG UROL, V23, P502, DOI 10.1016/j.purol.2013.03.012; Hanna-Mitchell AT, 2014, NEUROUROL URODYNAM, V33, P611, DOI 10.1002/nau.22582; Hanna-Mitchell AT, 2015, NEUROUROL U IN PRESS; Kelly MJ, 1999, STEROIDS, V64, P64, DOI 10.1016/S0039-128X(98)00095-6; Koski Michelle E, 2011, Curr Urol Rep, V12, P345, DOI 10.1007/s11934-011-0208-y; Maher J, 2013, BRIT J PHARMACOL, V169, P1153, DOI 10.1111/bph.12211; Malysz J, 2014, AM J PHYSIOL-CELL PH, V306, pC45, DOI 10.1152/ajpcell.00047.2013; Morrow JP, 2006, P NATL ACAD SCI USA, V103, P5096, DOI 10.1073/pnas.0600907103; Ogata R, 1996, BRIT J PHARMACOL, V117, P351, DOI 10.1111/j.1476-5381.1996.tb15198.x; Patra PB, 2009, UROLOGY, V74, P463, DOI 10.1016/j.urology.2008.12.046; Petkov GV, 2014, AM J PHYSIOL-REG I, V307, pR571, DOI 10.1152/ajpregu.00142.2014; Petkov GV, 2012, NAT REV UROL, V9, P30, DOI 10.1038/nrurol.2011.194; Robinson D, 2014, NEUROUROL URODYNAM, V33, P1086, DOI 10.1002/nau.22464; Robinson Dudley, 2013, Menopause Int, V19, P155, DOI 10.1177/1754045313511398; Rosenfeld CR, 2012, ENDOCRINOLOGY, V153, P6012, DOI 10.1210/en.2012-1717; SHELDON JH, 1995, J PHARMACOL EXP THER, V274, P723; Valeri A, 2009, EXP PHYSIOL, V94, P834, DOI 10.1113/expphysiol.2009.047118; Valverde MA, 1999, SCIENCE, V285, P1929, DOI 10.1126/science.285.5435.1929; YASAY GD, 1995, PHARMACOLOGY, V51, P273, DOI 10.1159/000139336	27	14	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141950	10.1371/journal.pone.0141950	http://dx.doi.org/10.1371/journal.pone.0141950			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536038	Green Published, Green Submitted, gold			2022-12-26	WOS:000364298400105
J	Roberts, AI; Roberts, SGB				Roberts, Anna Ilona; Roberts, Sam George Bradley			Gestural Communication and Mating Tactics in Wild Chimpanzees	PLOS ONE			English	Article							PAN-TROGLODYTES-SCHWEINFURTHII; REPRODUCTIVE STRATEGIES; FEMALE CHIMPANZEES; PRIMATE; REPERTOIRE; COPULATION; EVOLUTION; PATERNITY; RESPONSES; COGNITION	The extent to which primates can flexibly adjust the production of gestural communication according to the presence and visual attention of the audience provides key insights into the social cognition underpinning gestural communication, such as an understanding of third party relationships. Gestures given in a mating context provide an ideal area for examining this flexibility, as frequently the interests of a male signaller, a female recipient and a rival male bystander conflict. Dominant chimpanzee males seek to monopolize matings, but subordinate males may use gestural communication flexibly to achieve matings despite their low rank. Here we show that the production of mating gestures in wild male East African chimpanzees (Pan troglodytes schweunfurthii) was influenced by a conflict of interest with females, which in turn was influenced by the presence and visual attention of rival males. When the conflict of interest was low (the rival male was present and looking away), chimpanzees used visual/tactile gestures over auditory gestures. However, when the conflict of interest was high (the rival male was absent, or was present and looking at the signaller) chimpanzees used auditory gestures over visual/tactile gestures. Further, the production of mating gestures was more common when the number of oestrous and non-oestrus females in the party increased, when the female was visually perceptive and when there was no wind. Females played an active role in mating behaviour, approaching for copulations more often when the number of oestrus females in the party increased and when the rival male was absent, or was present and looking away. Examining how social and ecological factors affect mating tactics in primates may thus contribute to understanding the previously unexplained reproductive success of subordinate male chimpanzees.	[Roberts, Anna Ilona; Roberts, Sam George Bradley] Univ Chester, Dept Psychol, Chester, Cheshire, England	University of Chester	Roberts, AI (corresponding author), Univ Chester, Dept Psychol, Parkgate Rd, Chester, Cheshire, England.	anna.roberts@chester.ac.uk		Roberts, Sam/0000-0003-3986-0254; Roberts, Anna/0000-0003-1185-7897	Economic and Social Research Council; University of Chester	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); University of Chester	Economic and Social Research Council funded data collection. University of Chester funded write up and data analyses.; We would like to thank the BCFS, NSCT, UWA for permission to conduct this project. We thank Geresomu Muhumuza for providing excellent support in the field. The fieldwork for this study was funded by Economic and Social Research Council, UK. A. R., S. R. designed the study, analysed the data, wrote the manuscript. A. R. collected the data, coded the footage. We are grateful to two anonymous reviewers for making a valuable contribution to this paper.	Bard KA, 2014, AM J PRIMATOL, V76, P14, DOI 10.1002/ajp.22189; Barrett L, 2005, P ROY SOC B-BIOL SCI, V272, P1865, DOI 10.1098/rspb.2005.3200; Beerda B, 1998, APPL ANIM BEHAV SCI, V58, P365, DOI 10.1016/S0168-1591(97)00145-7; Blute M, 2006, GESTURE, V6, P177; Bryant Gregory A, 2013, Front Psychol, V4, P990, DOI 10.3389/fpsyg.2013.00990; Clark A, 1997, BEHAV BRAIN SCI, V20, P57, DOI 10.1017/S0140525X97000022; Connor R. C., 2009, SEXUAL COERCION PRIM; Crockford C, 2012, CURR BIOL, V22, P142, DOI 10.1016/j.cub.2011.11.053; de Langre E, 2008, ANNU REV FLUID MECH, V40, P141, DOI 10.1146/annurev.fluid.40.111406.102135; de Waal F., 1986, P221; de Waal Frans B.M., 1992, Evolutionary Anthropology, V1, P86, DOI 10.1002/evan.1360010306; DEWAAL F, 1982, CHIMPANZEE POLITICS; EGGELING WJ, 1947, J ECOL, V34, P20, DOI 10.2307/2256760; Feldblum JT, 2014, CURR BIOL, V24, P2855, DOI 10.1016/j.cub.2014.10.039; Gilby IC, 2008, BEHAV ECOL SOCIOBIOL, V62, P1831, DOI 10.1007/s00265-008-0612-6; Goodall J., 1986, CHIMPANZEES GOMBE PA; Hare B, 2000, ANIM BEHAV, V59, P771, DOI 10.1006/anbe.1999.1377; Hasegawa T., 1983, J ETHOL, V1, P75, DOI DOI 10.1007/BF02347833; HEWES GW, 1992, CURR ANTHROPOL, V33, P65, DOI 10.1086/204019; Heyes C, 2012, PHILOS T R SOC B, V367, P2091, DOI 10.1098/rstb.2012.0111; Heyes CM, 1998, BEHAV BRAIN SCI, V21, P101, DOI 10.1017/S0140525X98000703; Hopkins WD, 2007, ANIM BEHAV, V73, P281, DOI 10.1016/j.anbehav.2006.08.004; Hosken DJ, 2001, CURR BIOL, V11, P489, DOI 10.1016/S0960-9822(01)00146-4; le Roux A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2468; Lovegrove BG, 2003, J COMP PHYSIOL B, V173, P87, DOI 10.1007/s00360-002-0309-5; Matsumoto-Oda A, 1999, BEHAV ECOL SOCIOBIOL, V46, P258, DOI 10.1007/s002650050618; MAYNARD-SMITH J., 2003, ANIMAL SIGNALS; MORLAND HS, 1993, LEMUR SOCIAL SYSTEMS AND THEIR ECOLOGICAL BASIS, P193; Muller MN, 2007, P ROY SOC B-BIOL SCI, V274, P1009, DOI 10.1098/rspb.2006.0206; Muller Martin N., 2009, P184; Muller MN, 2004, BEHAV ECOL SOCIOBIOL, V55, P332, DOI 10.1007/s00265-003-0713-1; Newton-Fisher NE, 2010, AM J PHYS ANTHROPOL, V142, P417, DOI 10.1002/ajpa.21241; NIEMEYER CL, 1983, ETHOL SOCIOBIOL, V4, P205, DOI 10.1016/0162-3095(83)90010-9; Nunn CL, 1999, ANIM BEHAV, V58, P229, DOI 10.1006/anbe.1999.1159; Pawlowski B, 1998, BEHAVIOUR, V135, P357, DOI 10.1163/156853998793066285; Penn DC., 2013, AGENCY JOINT ATTENTI, P62, DOI [10.1093/acprof%3Aoso/9780199988341.003.0004, DOI 10.1093/ACPROF%3AOSO/9780199988341.003.0004, DOI 10.1093/ACPROF:OSO/9780199988341.001.0001]; Peters RA, 2007, CURR BIOL, V17, P1231, DOI 10.1016/j.cub.2007.06.035; Pika S, 2003, AM J PRIMATOL, V60, P95, DOI 10.1002/ajp.10097; Rendall D, 2009, ANIM BEHAV, V78, P233, DOI 10.1016/j.anbehav.2009.06.007; Reynolds V., 2005, CHIMPANZEES BUDONGO; Roberts AI, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4088; Roberts AI, 2014, ANIM COGN, V17, P317, DOI 10.1007/s10071-013-0664-5; Roberts AI, 2013, ANIM COGN, V16, P187, DOI 10.1007/s10071-012-0563-1; Roberts AI, 2012, EVOL HUM BEHAV, V33, P578, DOI 10.1016/j.evolhumbehav.2012.05.006; Roberts AI, 2012, ANIM BEHAV, V84, P459, DOI 10.1016/j.anbehav.2012.05.022; Shanker SG, 2002, BEHAV BRAIN SCI, V25, P646, DOI 10.1017/S0140525X02510116; Soltis J, 2001, ANIM BEHAV, V62, P485, DOI 10.1006/anbe.2001.1774; Tomasello M, 2002, COGNITIVE ANIMAL EMP; Townsend SW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002431; Tutin C.E.G., 1981, P239; TUTIN CEG, 1979, ANIM BEHAV, V27, P845, DOI 10.1016/0003-3472(79)90022-8; TUTIN CEG, 1979, BEHAV ECOL SOCIOBIOL, V6, P29, DOI 10.1007/BF00293242; TUTIN CEG, 1973, FOLIA PRIMATOL, V19, P237, DOI 10.1159/000155542; Watts DP, 1998, BEHAV ECOL SOCIOBIOL, V44, P43, DOI 10.1007/s002650050513; Wilczynski W, 1999, GEOGRAPHIC VARIATION IN BEHAVIOR, P234; Wroblewski EE, 2009, ANIM BEHAV, V77, P873, DOI 10.1016/j.anbehav.2008.12.014; Zahavi A, 1997, HANDICAP PRINCIPLE M; Zuberbuhler K, 2008, CURR BIOL, V18, pR189, DOI 10.1016/j.cub.2007.12.041	58	15	15	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0139683	10.1371/journal.pone.0139683	http://dx.doi.org/10.1371/journal.pone.0139683			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536467	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000364298400010
J	Simpson, HM; Khan, RZ; Song, C; Sharma, D; Sadashivaiah, K; Furusawa, A; Liu, XY; Nagaraj, S; Sengamalay, N; Sadzewicz, L; Tallon, LJ; Chen, QC; Livak, F; Rapoport, AP; Kimball, A; Banerjee, A				Simpson, Haley M.; Khan, Rashid Z.; Song, Chang; Sharma, Deva; Sadashivaiah, Kavitha; Furusawa, Aki; Liu, Xinyue; Nagaraj, Sushma; Sengamalay, Naomi; Sadzewicz, Lisa; Tallon, Luke J.; Chen, Qing C.; Livak, Ferenc; Rapoport, Aaron P.; Kimball, Amy; Banerjee, Arnob			Concurrent Mutations in ATM and Genes Associated with Common gamma Chain Signaling in Peripheral T Cell Lymphoma	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; STAT5B N642H MUTATION; MISSENSE MUTATIONS; SOMATIC MUTATION; CANCER; REVEALS; KINASE; INACTIVATION; LANDSCAPE; ACTIVATION	Peripheral T cell lymphoma (PTCL) is a heterogeneous malignancy with poor response to current therapeutic strategies and incompletely characterized genetics. We conducted whole exome sequencing of matched PTCL and non-malignant samples from 12 patients, spanning 8 subtypes, to identify potential oncogenic mutations in PTCL. Analysis of the mutations identified using computational algorithms, CHASM, PolyPhen2, PROVEAN, and MutationAssessor to predict the impact of these mutations on protein function and PTCL tumorigenesis, revealed 104 somatic mutations that were selected as high impact by all four algorithms. Our analysis identified recurrent somatic missense or nonsense mutations in 70 genes, 9 of which contained mutations predicted significant by all 4 algorithms: ATM, RUNX1T1, WDR17, NTRK3, TP53, TRMT12, CACNA2D1, INTS8, and KCNH8. We observed somatic mutations in ATM (ataxia telangiectasia-mutated) in 5 out of the 12 samples and mutations in the common gamma chain (gamma(c)) signaling pathway (JAK3, IL2RG, STAT5B) in 3 samples, all of which also harbored mutations in ATM. Our findings contribute insights into the genetics of PTCL and suggest a relationship between gamma(c) signaling and ATM in T cell malignancy.	[Simpson, Haley M.; Khan, Rashid Z.; Song, Chang; Sharma, Deva; Sadashivaiah, Kavitha; Furusawa, Aki; Livak, Ferenc; Rapoport, Aaron P.; Kimball, Amy; Banerjee, Arnob] Univ Maryland, Sch Med, Dept Med, Program Oncol,Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Simpson, Haley M.; Khan, Rashid Z.; Song, Chang; Sharma, Deva; Sadashivaiah, Kavitha; Furusawa, Aki; Banerjee, Arnob] Univ Maryland, Sch Med, Ctr Stem Cell Res & Regenerat Med, Baltimore, MD 21201 USA; [Liu, Xinyue; Nagaraj, Sushma; Sengamalay, Naomi; Sadzewicz, Lisa; Tallon, Luke J.] Univ Maryland, Sch Med, Inst Genome Sci, Genome Resource Ctr, Baltimore, MD 21201 USA; [Chen, Qing C.] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Livak, Ferenc] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Banerjee, A (corresponding author), Univ Maryland, Sch Med, Dept Med, Program Oncol,Greenebaum Canc Ctr, Baltimore, MD 21201 USA.	abanerjee@som.umaryland.edu	Khan, Rashid/HHZ-3812-2022		National Institute of Health [P30CA134272, K08HL93207]; Gabrielle's Angel Foundation for Cancer Research; American Cancer Society; Marlene and Stewart Greenebaum Cancer Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL093027] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gabrielle's Angel Foundation for Cancer Research; American Cancer Society(American Cancer Society); Marlene and Stewart Greenebaum Cancer Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by National Institute of Health grants (P30CA134272, K08HL93207) (AB) (http://www.nih.gov/), the Gabrielle's Angel Foundation for Cancer Research (AB) (http://www.gabriellesangels.org/), the American Cancer Society (AB) (http://www.cancer.org/), and the Marlene and Stewart Greenebaum Cancer Center (http://umm.edu/programs/cancer). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Agarwal A, 2015, ONCOGENE, V34, P2991, DOI 10.1038/onc.2014.243; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Ariyoshi K, 2000, J BIOL CHEM, V275, P24407, DOI 10.1074/jbc.M909771199; Babushok DV, 2015, CANC GENET; Bandapalli OR, 2014, HAEMATOLOGICA, V99, pE188, DOI 10.3324/haematol.2014.104992; Bergmann AK, 2014, GENE CHROMOSOME CANC, V53, P309, DOI 10.1002/gcc.22141; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Bullrich F, 1999, CANCER RES, V59, P24; Camacho E, 2002, BLOOD, V99, P238, DOI 10.1182/blood.V99.1.238; Carter H, 2010, CANCER BIOL THER, V10, P582, DOI 10.4161/cbt.10.6.12537; Choi YH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039927, 10.1371/journal.pone.0046688]; Degryse S, 2014, BLOOD, V124, P3092, DOI 10.1182/blood-2014-04-566687; Fang NY, 2003, P NATL ACAD SCI USA, V100, P5372, DOI 10.1073/pnas.0831102100; Foss FM, 2011, BLOOD, V117, P6756, DOI 10.1182/blood-2010-05-231548; Gandhi MK, 2015, BLOOD REV; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Gronbaek K, 2002, BLOOD, V100, P1430, DOI 10.1182/blood-2002-02-0382; Hong S, 2013, J NANOMATER, V2013, DOI [10.1155/2013/246328, 10.1155/2013/790323]; Huang YL, 2013, BEST PRACT RES CL HA, V26, P57, DOI 10.1016/j.beha.2013.04.006; Huang YL, 2010, BLOOD, V115, P1226, DOI 10.1182/blood-2009-05-221275; Intlekofer AM, 2014, INT J HEMATOL, V99, P249, DOI 10.1007/s12185-014-1521-2; Jerez A, 2012, BLOOD, V120, P3048, DOI 10.1182/blood-2012-06-435297; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kiel MJ, 2014, BLOOD, V124, P1460, DOI 10.1182/blood-2014-03-559542; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kleppe M, 2011, HAEMATOL-HEMATOL J, V96, P1723, DOI 10.3324/haematol.2011.041921; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kontro M, 2014, LEUKEMIA, V28, P1738, DOI 10.1038/leu.2014.89; Koo GC, 2012, CANCER DISCOV, V2, P591, DOI 10.1158/2159-8290.CD-12-0028; Koskela HLM, 2012, NEW ENGL J MED, V366, P1905, DOI 10.1056/NEJMoa1114885; Kucuk C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7025; Lindemann MJ, 2003, J BIOL CHEM, V278, P10239, DOI 10.1074/jbc.M209471200; Ma XL, 2015, CANCER GENET-NY, V208, P52, DOI 10.1016/j.cancergen.2014.12.001; Manso R, 2015, HAEMATOLOGICA, V100, pE25, DOI 10.3324/haematol.2014.113696; Manso R, 2014, BLOOD, V123, P2893, DOI 10.1182/blood-2014-02-555946; Nakamoto-Matsubara R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109714; Navrkalova V, 2013, HAEMATOLOGICA, V98, P1124, DOI 10.3324/haematol.2012.081620; Nelson Erik A, 2012, Genes Cancer, V3, P503, DOI 10.1177/1947601912466555; Nicolae A, 2014, LEUKEMIA, V28, P2244, DOI 10.1038/leu.2014.200; Odejide O, 2014, BLOOD, V123, P1293, DOI 10.1182/blood-2013-10-531509; Palomero T, 2014, NAT GENET, V46, P166, DOI 10.1038/ng.2873; Rajala HLM, 2013, BLOOD, V121, P4541, DOI 10.1182/blood-2012-12-474577; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Savage KJ, 2011, CURR HEMATOL MALIG R, V6, P222, DOI 10.1007/s11899-011-0100-3; Shimizu D, 2007, INT J HEMATOL, V85, P212, DOI 10.1532/IJH97.06165; Shyr C, 2014, BMC MED GENOMICS, V7, DOI 10.1186/s12920-014-0064-y; Skarbnik AP, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00138; Stankovic T, 2002, LEUKEMIA LYMPHOMA, V43, P1563, DOI 10.1080/1042819021000002884; Stankovic T, 1998, AM J HUM GENET, V62, P334, DOI 10.1086/301706; Stilgenbauer S, 1997, NAT MED, V3, P1155, DOI 10.1038/nm1097-1155; Stoppa-Lyonnet D, 1998, BLOOD, V91, P3920, DOI 10.1182/blood.V91.10.3920.3920_3920_3926; Thoma G, 2014, BIOORG MED CHEM LETT, V24, P4617, DOI 10.1016/j.bmcl.2014.08.046; Vaque JP, 2014, BLOOD, V123, P2034, DOI 10.1182/blood-2013-05-504308; Vasmatzis G, 2012, BLOOD, V120, P2280, DOI 10.1182/blood-2012-03-419937; Vorechovsky I, 1997, NAT GENET, V17, P96, DOI 10.1038/ng0997-96; Achatz MIW, 2007, CANCER LETT, V245, P96, DOI 10.1016/j.canlet.2005.12.039; Wang C, 2014, BIOINFORMATICS, V30, P2678, DOI 10.1093/bioinformatics/btu363; Weston VJ, 2010, BLOOD, V116, P4578, DOI 10.1182/blood-2010-01-265769; Wong WC, 2011, BIOINFORMATICS, V27, P2147, DOI 10.1093/bioinformatics/btr357; Yamane H, 2012, NAT IMMUNOL, V13, P1037, DOI 10.1038/ni.2431; Yamashita Y, 2010, ONCOGENE, V29, P3723, DOI 10.1038/onc.2010.117; Yuille MAR, 1998, ONCOGENE, V16, P789, DOI 10.1038/sj.onc.1201603; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725	64	15	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141906	10.1371/journal.pone.0141906	http://dx.doi.org/10.1371/journal.pone.0141906			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536348	Green Published, gold, Green Submitted			2022-12-26	WOS:000364298400099
J	Youngsteadt, E; Appler, RH; Lopez-Uribe, MM; Tarpy, DR; Frank, SD				Youngsteadt, Elsa; Appler, R. Holden; Lopez-Uribe, Margarita M.; Tarpy, David R.; Frank, Steven D.			Urbanization Increases Pathogen Pressure on Feral and Managed Honey Bees	PLOS ONE			English	Article							APIS-MELLIFERA; NOSEMA-CERANAE; IMMUNE-RESPONSE; VARROA-JACOBSONI; N. CERANAE; INFECTION; COLONIES; BIODIVERSITY; PREVALENCE; PATTERNS	Given the role of infectious disease in global pollinator decline, there is a need to understand factors that shape pathogen susceptibility and transmission in bees. Here we ask how urbanization affects the immune response and pathogen load of feral and managed colonies of honey bees (Apis mellifera Linnaeus), the predominant economically important pollinator worldwide. Using quantitative real-time PCR, we measured expression of 4 immune genes and relative abundance of 10 honey bee pathogens. We also measured worker survival in a laboratory bioassay. We found that pathogen pressure on honey bees increased with urbanization and management, and the probability of worker survival declined 3-fold along our urbanization gradient. The effect of management on pathogens appears to be mediated by immunity, with feral bees expressing immune genes at nearly twice the levels of managed bees following an immune challenge. The effect of urbanization, however, was not linked with immunity; instead, urbanization may favor viability and transmission of some disease agents. Feral colonies, with lower disease burdens and stronger immune responses, may illuminate ways to improve honey bee management. The previously unexamined effects of urbanization on honey-bee disease are concerning, suggesting that urban areas may favor problematic diseases of pollinators.	[Youngsteadt, Elsa; Appler, R. Holden; Lopez-Uribe, Margarita M.; Tarpy, David R.; Frank, Steven D.] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Lopez-Uribe, Margarita M.; Tarpy, David R.] N Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Tarpy, DR (corresponding author), N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA.	drtarpy@ncsu.edu		Youngsteadt, Elsa/0000-0003-2032-9674; Tarpy, David/0000-0001-8601-6094	Agriculture and Food Research Initiative Competitive [2013-02476]; United States Department of Agriculture National Institute of Food and Agriculture; North Carolina State University College of Agriculture and Life Sciences Dean's Enrichment Grant; North Carolina Department of Agriculture and Consumer Services; North Carolina State Beekeepers Association; North Carolina State University Department of Entomology; United States Geological Survey [G11AC20471, G13AC00405]	Agriculture and Food Research Initiative Competitive; United States Department of Agriculture National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); North Carolina State University College of Agriculture and Life Sciences Dean's Enrichment Grant; North Carolina Department of Agriculture and Consumer Services; North Carolina State Beekeepers Association; North Carolina State University Department of Entomology; United States Geological Survey(United States Geological Survey)	This research was supported by Agriculture and Food Research Initiative Competitive Grant no. 2013-02476 from the United States Department of Agriculture National Institute of Food and Agriculture to SDF and EY (http://nifa.usda.gov/); a North Carolina State University College of Agriculture and Life Sciences Dean's Enrichment Grant to DRT and SDF (http://harvest.cals.ncsu.edu/); the North Carolina Department of Agriculture and Consumer Services (DRT) (http://www.ncagr.gov/); a gift from the North Carolina State Beekeepers Association to RHA and DRT (http://www.ncbeekeepers.org/); support from the North Carolina State University Department of Entomology to RHA (http://www.cals.ncsu.edu/entomology/); and by Cooperative Agreement No. G11AC20471 and G13AC00405 from the United States Geological Survey to SDF (http://www.usgs.gov/). Its contents are solely the responsibility of the authors and do not necessarily represent the views of the Department of the Interior Southeast Climate Science Center or the USGS. This manuscript is submitted for publication with the understanding that the United States Government is authorized to reproduce and distribute reprints for Governmental purposes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2008, CURR BIOL, V18, P1572, DOI 10.1016/j.cub.2008.08.066; Alaux C, 2010, BIOL LETTERS, V6, P562, DOI 10.1098/rsbl.2009.0986; Alirol E, 2011, LANCET INFECT DIS, V11, P131, DOI 10.1016/S1473-3099(10)70223-1; [Anonymous], 2013, R LANG ENV STAT COMP; Antunez K, 2009, ENVIRON MICROBIOL, V11, P2284, DOI 10.1111/j.1462-2920.2009.01953.x; Ardia DR, 2012, FUNCT ECOL, V26, P732, DOI 10.1111/j.1365-2435.2012.01989.x; Aufauvre J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091686; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Borowska J, 2011, J INSECT PHYSIOL, V57, P760, DOI 10.1016/j.jinsphys.2011.02.012; Bradley CA, 2007, TRENDS ECOL EVOL, V22, P95, DOI 10.1016/j.tree.2006.11.001; Brearley G, 2013, BIOL REV, V88, P427, DOI 10.1111/brv.12009; Bulet P, 1999, DEV COMP IMMUNOL, V23, P329, DOI 10.1016/S0145-305X(99)00015-4; Burkle LA, 2013, SCIENCE, V339, P1611, DOI 10.1126/science.1232728; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Cassell DL, 2002, RANDOMIZATION TEST W; Chaimanee V, 2012, J INSECT PHYSIOL, V58, P1090, DOI 10.1016/j.jinsphys.2012.04.016; Chen YP, 2007, ADV VIRUS RES, V70, P33, DOI 10.1016/S0065-3527(07)70002-7; Chen Y, 2008, J INVERTEBR PATHOL, V97, P186, DOI 10.1016/j.jip.2007.07.010; Cornman RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043562; Couvillon M, 2015, APIDOLOGIE, V46, P61, DOI 10.1007/s13592-014-0302-5; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Faeth SH, 2011, ANN NY ACAD SCI, V1223, P69, DOI 10.1111/j.1749-6632.2010.05925.x; Fenoy S, 2009, APPL ENVIRON MICROB, V75, P6886, DOI 10.1128/AEM.01025-09; Furst MA, 2014, NATURE, V506, P364, DOI 10.1038/nature12977; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; George K, 2007, ATMOS ENVIRON, V41, P7654, DOI 10.1016/j.atmosenv.2007.08.018; Giersch T, 2009, APIDOLOGIE, V40, P117, DOI 10.1051/apido/2008065; Gilbert B, 2010, J APPL ECOL, V47, P1071, DOI 10.1111/j.1365-2664.2010.01861.x; GILLIAM M, 1991, J INVERTEBR PATHOL, V58, P286, DOI 10.1016/0022-2011(91)90077-4; Giraudeau M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086747; Gisder S, 2010, APPL ENVIRON MICROB, V76, P3032, DOI 10.1128/AEM.03097-09; Gonzalez-Santoyo I, 2012, ENTOMOL EXP APPL, V142, P1, DOI 10.1111/j.1570-7458.2011.01187.x; Goulson D, 2002, OECOLOGIA, V130, P267, DOI 10.1007/s004420100803; Goulson D, 2012, ECOL ENTOMOL, V37, P83, DOI 10.1111/j.1365-2311.2011.01334.x; Higes M, 2008, ENVIRON MICROBIOL, V10, P2659, DOI 10.1111/j.1462-2920.2008.01687.x; Higes M, 2013, ENV MICROBIOL REP, V5, P17, DOI 10.1111/1758-2229.12024; Highfield AC, 2009, APPL ENVIRON MICROB, V75, P7212, DOI 10.1128/AEM.02227-09; Huang Q, 2012, J INVERTEBR PATHOL, V109, P297, DOI 10.1016/j.jip.2012.01.004; Kraus B, 1995, ENVIRON ENTOMOL, V24, P1473, DOI 10.1093/ee/24.6.1473; Kuhnholz S, 1997, BEHAV ECOL SOCIOBIOL, V41, P407, DOI 10.1007/s002650050402; Le Conte Y, 2007, APIDOLOGIE, V38, P566, DOI 10.1051/apido:2007040; Lecocq A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132473; Lee KV, 2013, APIDOLOGIE IN PRESS; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Leong M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086357; Lowe EC, 2011, AUST J ZOOL, V59, P73, DOI 10.1071/ZO11041; Magnus R, 2010, SOCIOBIOLOGY, V55, P285; Magnus RM, 2014, BIOCHEM GENET, V52, P245, DOI 10.1007/s10528-014-9644-y; Manning R, 2007, AUST J EXP AGR, V47, P883, DOI 10.1071/EA04222; Martin SJ, 2013, ENV MICROBIOL REP, V5, P506, DOI 10.1111/1758-2229.12052; Martin SJ, 2012, SCIENCE, V336, P1304, DOI 10.1126/science.1220941; Natsopoulou ME, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.1896; Oksanen J., **DATA OBJECT**; Oldroyd BP, 1999, TRENDS ECOL EVOL, V14, P312, DOI 10.1016/S0169-5347(99)01613-4; Patz JA, 2004, ENVIRON HEALTH PERSP, V112, P1092, DOI 10.1289/ehp.6877; Polkki M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038832; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seehuus SC, 2006, P NATL ACAD SCI USA, V103, P962, DOI 10.1073/pnas.0502681103; Seto KC, 2012, P NATL ACAD SCI USA, V109, P16083, DOI 10.1073/pnas.1211658109; Singh R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014357; Smith M. L., APIDOLOGIE IN PRESS; Sponsler DB, 2015, PEERJ, V3, DOI 10.7717/peerj.838; Steffan-Dewenter I, 2003, P ROY SOC B-BIOL SCI, V270, P569, DOI 10.1098/rspb.2002.2292; Stevenson M., EPIR TOOLS ANAL EPID; Szalanski AL, 2014, FLA ENTOMOL, V97, P585, DOI 10.1653/024.097.0233; Therneau TM, 2014, PACKAGE SURVIVAL ANA; Thompson CE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105164; Traver BE, 2011, J INVERTEBR PATHOL, V107, P43, DOI 10.1016/j.jip.2011.02.003; Williams JB, 2008, EXP GERONTOL, V43, P538, DOI 10.1016/j.exger.2008.02.001; Xian G, 2011, PHOTOGRAMM ENG REM S, V77, P758	71	45	47	1	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142031	10.1371/journal.pone.0142031	http://dx.doi.org/10.1371/journal.pone.0142031			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536606	Green Published, Green Submitted, gold			2022-12-26	WOS:000364298400119
J	Wu, ZY; Milne, RI; Chen, CJ; Liu, J; Wang, H; Li, DZ				Wu, Zeng-Yuan; Milne, Richard I.; Chen, Chia-Jui; Liu, Jie; Wang, Hong; Li, De-Zhu			Ancestral State Reconstruction Reveals Rampant Homoplasy of Diagnostic Morphological Characters in Urticaceae, Conflicting with Current Classification Schemes	PLOS ONE			English	Article							ELATOSTEMA URTICACEAE; REPEATED EVOLUTION; NOV URTICACEAE; PHYLOGENY; FAMILY; DIVERSITY; RADIATION; ANATOMY	Urticaceae is a family with more than 2000 species, which contains remarkable morphological diversity. It has undergone many taxonomic reorganizations, and is currently the subject of further systematic studies. To gain more resolution in systematic studies and to better understand the general patterns of character evolution in Urticaceae, based on our previous phylogeny including 169 accessions comprising 122 species across 47 Urticaceae genera, we examined 19 diagnostic characters, and analysed these employing both maximum-parsimony and maximum-likelihood approaches. Our results revealed that 16 characters exhibited multiple state changes within the family, with ten exhibiting >eight changes and three exhibiting between 28 and 40. Morphological synapomorphies were identified for many clades, but the diagnostic value of these was often limited due to reversals within the clade and/or homoplasies elsewhere. Recognition of the four clades comprising the family at subfamily level can be supported by a small number carefully chosen defining traits for each. Several non-monophyletic genera appear to be defined only by characters that are plesiomorphic within their clades, and more detailed work would be valuable to find defining traits for monophyletic clades within these. Some character evolution may be attributed to adaptive evolution in Urticaceae due to shifts in habitat or vegetation type. This study demonstrated the value of using phylogeny to trace character evolution, and determine the relative importance of morphological traits for classification.	[Wu, Zeng-Yuan; Liu, Jie; Li, De-Zhu] Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant & Biodivers East Asia, Kunming 650201, Yunnan, Peoples R China; [Wu, Zeng-Yuan; Liu, Jie; Wang, Hong; Li, De-Zhu] Chinese Acad Sci, Kunming Inst Bot, Germplasm Bank Wild Species, Kunming 650201, Yunnan, Peoples R China; [Milne, Richard I.] Univ Edinburgh, Inst Mol Plant Sci, Sch Biol Sci, Edinburgh EH9 3JH, Midlothian, Scotland; [Chen, Chia-Jui] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing 100093, Peoples R China; [Wu, Zeng-Yuan] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; University of Edinburgh; Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, H (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Germplasm Bank Wild Species, Kunming 650201, Yunnan, Peoples R China.	wanghong@mail.kib.ac.cn; dzl@mail.kib.ac.cn	Wu, Zeng-Yuan/ABD-4758-2021; Li, De-Zhu/G-8203-2011	Li, De-Zhu/0000-0002-4990-724X; jie, liu/0000-0003-4356-1943; Wu, Zeng-Yuan/0000-0003-4652-0194	National Natural Science Foundation of China [40830209, 41571059]; National Key Basic Research Program of China [2014CB954100]; Ministry of Science and Technology, China [2013FY112600]; Applied Fundamental Research Foundation of Yunnan Province [2014GA003]; China Scholarship Council	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); Ministry of Science and Technology, China(Ministry of Science and Technology, China); Applied Fundamental Research Foundation of Yunnan Province; China Scholarship Council(China Scholarship Council)	(1) National Natural Science Foundation of China (40830209), http://www.nsfc.gov.cn/, De-Zhu Li. The role of this sponsor is design, data collection. (2) The National Key Basic Research Program of China (2014CB954100), http://www.nsfc.gov.cn/, De-Zhu Li. The role of this sponsor is analysis. (3) Ministry of Science and Technology, China, Basic Research Project (No. 2013FY112600), http://www.most.gov.cn/, Hong Wang. The role of this sponsor is analysis. (4) National Natural Science Foundation of China (41571059), http://www.nsfc.gov.cn/, Jie Liu. The role of this sponsor is materials collection. (5) Applied Fundamental Research Foundation of Yunnan Province (2014GA003), http://www.nsfc.gov.cn/, De-Zhu Li. The role of this sponsor is decision to publish. (6) China Scholarship Council, http://www.csc.edu.cn/, Zeng-Yuan Wu. The role of this sponsor is preparation of the manuscript.	[Anonymous], 1989, EVOLUTION SYSTEMATIC; [Anonymous], 2003, FLORA CHINA; Banks H, 2014, TAXON, V63, P299, DOI 10.12705/632.37; Bechtel ARI, 1921, AM J BOT, V8, P386, DOI 10.2307/2435455; Beentje HJ, 2010, ROYAL BOT GARDENS, P147; BERG CC, 1978, TAXON, V27, P39, DOI 10.2307/1220477; Berg CC., 1989, EVOLUTION SYSTEMATIC, V2, P193; BIGALKE HILDEGARD, 1933, BEITR BIOL PFLANZEN, V21, P1; Chen C.J., 1985, ACTA PHYTOTAX SINICA, V23, P444; Chew W. L., 1963, Gardens' Bulletin, V20, P1; Conn Barry J., 2009, Kew Bulletin, V64, P349; Couvreur TLP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010473; Cunha AF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117553; Cunningham CW, 1998, TRENDS ECOL EVOL, V13, P361, DOI 10.1016/S0169-5347(98)01382-2; de Oliveira LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089701; Divakar PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083115; Ekman S, 2008, SYST BIOL, V57, P141, DOI 10.1080/10635150801910451; Finarelli JA, 2006, SYST BIOL, V55, P301, DOI 10.1080/10635150500541698; FRIIS I, 1988, NORD J BOT, V8, P25, DOI 10.1111/j.1756-1051.1988.tb01705.x; Friis I., 1993, FAMILIES GENERA VASC, VII, P612, DOI DOI 10.2307/1222750; Gaudichaud C., 1830, VOYAGE AUTOUR MONDE, P111; Gavrilets S, 2009, SCIENCE, V323, P732, DOI 10.1126/science.1157966; Givnish TJ, 2005, P ROY SOC B-BIOL SCI, V272, P1481, DOI 10.1098/rspb.2005.3067; Hadiah JT, 2009, BLUMEA BIODIVERS ECO, V54, P1; Hadiah Julisasi T., 2003, Telopea, V10, P235; Hadiah JT, 2008, AUST SYST BOT, V21, P375, DOI 10.1071/SB08041; Hanson-Smith V, 2010, MOL BIOL EVOL, V27, P1988, DOI 10.1093/molbev/msq081; Harris J.G., 1994, PLANT IDENTIFICATION; Horn JW, 2009, AM J BOT, V96, P1462, DOI 10.3732/ajb.0800396; Kato T, 2008, ECOL RES, V23, P339, DOI 10.1007/s11284-007-0387-7; Kim C, 2015, TAXON, V64, P65, DOI 10.12705/641.20; Kravtsova TI, 2009, COMP CARPOLOGY URTIC, P136; Lu L, 2010, BOT J LINN SOC, V162, P477, DOI 10.1111/j.1095-8339.2009.01024.x; Maddison WP, 2011, MESQUITE MODULAR SYS; Nurk NM, 2013, MOL PHYLOGENET EVOL, V66, P1, DOI 10.1016/j.ympev.2012.08.022; Ricklefs RE, 2007, TRENDS ECOL EVOL, V22, P601, DOI 10.1016/j.tree.2007.06.013; Robinson CB., 1910, PHILIPP J SCI, V5, P465; Ronquist F, 2004, TRENDS ECOL EVOL, V19, P475, DOI 10.1016/j.tree.2004.07.002; Schaffer S, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-246; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Simpson G. G., 1953, MAJOR FEATURES EVOLU, DOI DOI 10.7312/SIMP93764; Simpson MG, 2010, PLANT SYSTEMATICS, 2ND EDITION, P1; Soltis DE, 2013, AM J BOT, V100, P916, DOI 10.3732/ajb.1300044; STEVENS PF, 2001, ANGIOSPERM PHYLOGENY; Sun YS, 2012, MOL PHYLOGENET EVOL, V63, P150, DOI 10.1016/j.ympev.2012.01.002; Takhtajan A, 2009, FLOWERING PLANTS, P281; THURSTON EL, 1974, AM J BOT, V61, P809, DOI 10.2307/2441617; Thurston EL, 1969, BOT REV, V65, P393, DOI DOI 10.1007/BF02858878; Vanderpoorten A, 2006, SYSTEMATIC BIOL, V55, P957, DOI 10.1080/10635150601088995; Wang W.T., 1995, FLORA REIPUBLICAE PO, V23, P187; [王文采 Wang Wentsai], 2010, [广西植物, Guihaia], V30, P571; Wang WT, 1980, B BOT LAB N E FOREST, V7, P1; Wang WT, 2012, PAPER COLLECTION WT; Wang WT, 1995, FLORA REIPUBLICAE PO, V23, P1; Wang WT, 1980, B BOT LAB N E FOREST, V6, P45; Webster NB, 2012, MOL PHYLOGENET EVOL, V63, P625, DOI 10.1016/j.ympev.2012.02.004; Weddell H.A., 1869, PRODROMUS SYSTEMATIS, V16, P32, DOI [10.5962/bhl.title.286, DOI 10.5962/BHL.TITLE.286]; Weddell HA, 1854, ANN SCI NAT BOT 4, V4, P173; Weddell HA., 1856, ARCH MUSEUM HIST NAT, V9, P1; Wiens JJ, 2006, EVOLUTION, V60, P123, DOI 10.1111/j.0014-3820.2006.tb01088.x; Wilmot-Dear C. M., 2012, Edinburgh Journal of Botany, V69, P301, DOI 10.1017/S096042861200011X; Wilmot-Dear CM, 2004, NORD J BOT, V24, P5, DOI 10.1111/j.1756-1051.2004.tb00825.x; Wilmot-Dear C.M., 1996, OPERA BOT, V129, P1; Wu ZY, 2013, MOL PHYLOGENET EVOL, V69, P814, DOI 10.1016/j.ympev.2013.06.022; Wu ZY, 2013, ANN BOT FENN, V50, P75, DOI 10.5735/085.050.0113; Wu Zeng-Yuan, 2011, PhytoKeys, V7, P57, DOI 10.3897/phytokeys.7.2022; Wu ZY, 2011, NORD J BOT, V29, P227, DOI 10.1111/j.1756-1051.2011.01076.x	67	19	19	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141821	10.1371/journal.pone.0141821	http://dx.doi.org/10.1371/journal.pone.0141821			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529598	gold, Green Submitted, Green Published			2022-12-26	WOS:000364032600064
J	Londino, JD; Gulick, D; Isenberg, JS; Mallampalli, RK				Londino, James D.; Gulick, Dexter; Isenberg, Jeffrey S.; Mallampalli, Rama K.			Cleavage of Signal Regulatory Protein alpha (SIRP alpha) Enhances Inflammatory Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; C-TERMINAL FRAGMENT; NF-KAPPA-B; CELL-MIGRATION; SECRETASE; ACTIVATION; CD47; SHPS-1; ADAM10; GROWTH	Signal regulatory protein alpha (SIRP alpha) is a membrane glycoprotein immunoreceptor abundant in cells of monocyte lineage. SIRP alpha ligation by a broadly expressed transmembrane protein, CD47, results in phosphorylation of the cytoplasmic immunoreceptor tyrosine-based inhibitory motifs, resulting in the inhibition of NF-kappa B signaling in macrophages. Here we observed that proteolysis of SIRP alpha during inflammation is regulated by a disintegrin and metalloproteinase domain-containing protein 10 (ADAM10), resulting in the generation of a membrane-associated cleavage fragment in both THP-1 monocytes and human lung epithelia. We mapped a charge-dependent putative cleavage site near the membrane-proximal domain necessary for ADAM10-mediated cleavage. In addition, a secondary proteolytic cleavage within the membrane-associated SIRP alpha fragment by gamma-secretase was identified. Ectopic expression of a SIRP alpha mutant plasmid encoding a proteolytically resistant form in HeLa cells inhibited activation of the NF-kappa B pathway and suppressed STAT1 phosphorylation in response to TNF alpha to a greater extent than expression of wild-type SIRP alpha. Conversely, overexpression of plasmids encoding the proteolytically cleaved SIRP alpha fragments in cells resulted in enhanced STAT-1 and NF-kappa B pathway activation. Thus, the data suggest that combinatorial actions of ADAM10 and gamma-secretase on SIRP alpha cleavage promote inflammatory signaling.	[Londino, James D.; Gulick, Dexter; Isenberg, Jeffrey S.; Mallampalli, Rama K.] Univ Pittsburgh, Dept Med, Div Pulm Allergy & Crit Care Med, Acute Lung Injury Ctr Excellence, Pittsburgh, PA 15213 USA; [Mallampalli, Rama K.] Univ Pittsburgh, Dept Cell Biol & Physiol & Bioengn, Pittsburgh, PA 15213 USA; [Mallampalli, Rama K.] Vet Affairs Pittsburgh Healthcare Syst, Med Specialty Serv Line, Pittsburgh, PA 15213 USA; [Isenberg, Jeffrey S.] Univ Pittsburgh, Sch Med, Div Pulm,Allergy & Crit Care Med, Vasc Med Inst,Starzl Transplantat Inst,Dept Pharm, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Mallampalli, RK (corresponding author), Univ Pittsburgh, UPMC Montefiore, Pulm Allergy & Crit Care Med, Dept Med, NW628, Pittsburgh, PA 15213 USA.	mallampallirk@upmc.edu	Londino, James/GXH-2306-2022; Londino, James/GXH-4404-2022; Regan, Clinton/E-6250-2012	Londino, James/0000-0001-7647-6927; 	United States Department of Veterans Affairs Merit Review Award; National Institutes of Health [HL096376, HL097376, HL098174, HL081784, 1UH2HL123502, HL114453, T32 5T32HL007563-28]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UH2HL123502, R01HL098174, T32HL007563, P01HL114453, R01HL096376, R01HL112914, R01HL081784, R01HL097376] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002200] Funding Source: NIH RePORTER	United States Department of Veterans Affairs Merit Review Award(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was partially supported by a United States Department of Veterans Affairs Merit Review Award and partially by National Institutes of Health R01 Grants HL096376, HL097376, HL098174, HL081784, and 1UH2HL123502 and P01 Grant HL114453 (to R. K. M.) and Grant T32 5T32HL007563-28 (to J. D. L.). The authors declare no conflict of interests. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams S, 1998, J IMMUNOL, V161, P1853; Alblas J, 2005, MOL CELL BIOL, V25, P7181, DOI 10.1128/MCB.25.16.7181-7192.2005; Anders L, 2006, MOL CELL BIOL, V26, P3917, DOI 10.1128/MCB.26.10.3917-3934.2006; Baba N, 2013, J EXP MED, V210, P1251, DOI 10.1084/jem.20122037; Chen BB, 2011, MOL CELL BIOL, V31, P1905, DOI 10.1128/MCB.00723-10; Chen BB, 2009, MOL CELL BIOL, V29, P3062, DOI 10.1128/MCB.01824-08; Ding DR, 2014, MEDCHEMCOMM, V5, P1381, DOI 10.1039/c4md00172a; Dong LW, 2008, MOL IMMUNOL, V45, P3025, DOI 10.1016/j.molimm.2008.03.012; Fournier B, 2012, J BIOL CHEM, V287, P19386, DOI 10.1074/jbc.M111.324533; Gao YH, 2001, P NATL ACAD SCI USA, V98, P14979, DOI 10.1073/pnas.261463298; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; Hinz M, 2014, EMBO REP, V15, P46, DOI 10.1002/embr.201337983; Janssen WJ, 2008, AM J RESP CRIT CARE, V178, P158, DOI 10.1164/rccm.200711-1661OC; Jiang DS, 2014, HYPERTENSION, V63, P96, DOI 10.1161/HYPERTENSIONAHA.113.01506; Johansen ML, 2007, J BIOL CHEM, V282, P24219, DOI 10.1074/jbc.M701565200; Kim EJ, 2013, INFLAMM RES, V62, P377, DOI 10.1007/s00011-013-0589-0; Kong XN, 2007, J EXP MED, V204, P2719, DOI 10.1084/jem.20062611; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Le Gall SM, 2010, J CELL SCI, V123, P3913, DOI 10.1242/jcs.069997; Lee EJ, 2014, J IMMUNOL, V193, P2384, DOI 10.4049/jimmunol.1303240; Lin Y, 2012, PROTEIN EXPRES PURIF, V85, P109, DOI 10.1016/j.pep.2012.07.002; Maatta JA, 2006, MOL BIOL CELL, V17, P67, DOI 10.1091/mbc.E05-05-0402; Maretzky T, 2015, J BIOL CHEM, V290, P7416, DOI 10.1074/jbc.M114.603753; Morohashi Y, 2006, J BIOL CHEM, V281, P14670, DOI 10.1074/jbc.M513012200; Murai-Takebe R, 2004, J BIOL CHEM, V279, P11616, DOI 10.1074/jbc.M311463200; Neznanov N, 2003, J BIOL CHEM, V278, P3809, DOI 10.1074/jbc.M210698200; Ohnishi H, 2004, J BIOL CHEM, V279, P27878, DOI 10.1074/jbc.M313085200; Pan Y, 2012, J MOL ENDOCRINOL, V49, P21, DOI 10.1530/JME-11-0174; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Raymond M, 2010, EUR J IMMUNOL, V40, P3510, DOI 10.1002/eji.201040797; Shen XC, 2009, MOL CELL PROTEOMICS, V8, P1539, DOI 10.1074/mcp.M800543-MCP200; Skovronsky DM, 2000, BIOCHEMISTRY-US, V39, P810, DOI 10.1021/bi991728z; Steevels TAM, 2011, EUR J IMMUNOL, V41, P575, DOI 10.1002/eji.201041179; Stenberg A, 2013, J LEUKOCYTE BIOL, V93, P403, DOI 10.1189/jlb.1110637; Stofega MR, 2000, J BIOL CHEM, V275, P28222; Toth AB, 2013, NAT NEUROSCI, V16, P1417, DOI 10.1038/nn.3516; Tsai RK, 2010, BLOOD CELL MOL DIS, V45, P67, DOI [10.1016/j.bcmd.2010.02.016, 10.1016/j.hcmd.2010.02.016]; van Beek EM, 2005, J IMMUNOL, V175, P7781, DOI 10.4049/jimmunol.175.12.7781; Wang L, 2012, J NEUROCHEM, V122, P834, DOI 10.1111/j.1471-4159.2012.07818.x; Yao MY, 2014, J AM SOC NEPHROL, V25, P1171, DOI 10.1681/ASN.2013040433; Zen K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3436; Zhang X, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00427	42	24	24	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					31113	31125		10.1074/jbc.M115.682914	http://dx.doi.org/10.1074/jbc.M115.682914			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26534964	Green Published, hybrid			2022-12-26	WOS:000367199000039
J	Chen, CH; Liao, WC; Wu, BR; Chen, CY; Chen, WC; Hsia, TC; Cheng, WC; Tu, CY; Hsu, WH				Chen, Chia-Hung; Liao, Wei-Chih; Wu, Biing-Ru; Chen, Chih-Yu; Chen, Wei-Chun; Hsia, Te-Chun; Cheng, Wen-Chien; Tu, Chih-Yen; Hsu, Wu-Huei			Endobronchial Ultrasound Changed the World of Lung Cancer Patients: A 11-Year Institutional Experience	PLOS ONE			English	Article							TRANSBRONCHIAL NEEDLE ASPIRATION; PERIPHERAL PULMONARY-LESIONS; GUIDE-SHEATH; DIAGNOSIS; CT; BRONCHOSCOPY; BIOPSY; ULTRASONOGRAPHY; PNEUMOTHORAX; METAANALYSIS	Objectives The role of advanced bronchoscopic diagnostic techniques in the detection and staging of lung cancer has increased sharply in recent years. The development of endobronchial ultrasound (EBUS) improved minimally invasive mediastinal staging and diagnosis of peripheral lung lesions (PLLs). We investigated the impact of using EBUS as a diagnostic method for tissue acquisition in lung cancer patients. Methods In a single center observational retrospective study, 3712 subjects were diagnosed with lung cancer from 2003 to 2013 (EBUS was introduced in 2008). Thus, we divided the data into two periods: the conventional bronchoscopy period (2003 to 2007) and the EBUS period (2008 to 2013). Results A total of 3712 patients were included in the analysis. Comparing the conventional bronchoscopy period with the EBUS period data, there has been a significant reduction in the use of diagnostic modalities: CT-guided biopsy (P < 0.0001) and pleural effusion cytology (P < 0.0001). The proportion of subjects diagnosed using bronchoscopy significantly increased from 39.4% in the conventional period to 47.4% in the EBUS period (P < 0.0001). In the EBUS period, there has also been a significant increase in the proportion of patients proceeding directly to diagnostic surgery (P < 0.0001). Compared to bronchoscopy, the incidence of complications was higher in those who underwent CT guide biopsy. The incidence of iatrogenic pneumothorax significantly decreased in the EBUS period. Conclusions Advanced bronchoscopic techniques are widely used in the diagnosis of lung cancer. At our institution, the increasing use of EBUS for providing lung cancer diagnosis has led to a significant reduction in other diagnostic modalities, namely CT-guided biopsy and pleural effusion cytology. These changes in practice also led to a reduction in the incidence of complications.	[Chen, Chia-Hung; Liao, Wei-Chih; Wu, Biing-Ru; Chen, Chih-Yu; Chen, Wei-Chun; Hsia, Te-Chun; Cheng, Wen-Chien; Tu, Chih-Yen; Hsu, Wu-Huei] China Med Univ Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Taichung, Taiwan; [Wu, Biing-Ru; Chen, Chih-Yu; Chen, Wei-Chun; Cheng, Wen-Chien; Tu, Chih-Yen; Hsu, Wu-Huei] China Med Univ, Sch Med, Taichung, Taiwan; [Tu, Chih-Yen] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Chen, Chia-Hung; Hsia, Te-Chun] China Med Univ, Dept Resp Therapy, Taichung, Taiwan; [Chen, Chia-Hung; Liao, Wei-Chih] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Liao, Wei-Chih; Chen, Wei-Chun; Hsia, Te-Chun; Cheng, Wen-Chien] China Med Univ, Hyperbar Oxygen Therapy Ctr, Dept Internal Med, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; National Chung Hsing University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan	Cheng, WC (corresponding author), China Med Univ Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Taichung, Taiwan.	chesttu@gmail.com; wcchengdr@gmail.com						Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Alberts WM, 2013, CHEST, V143, p38S, DOI 10.1378/chest.12-2342; Asano F, 2012, RESPIROLOGY, V17, P478, DOI 10.1111/j.1440-1843.2011.02123.x; Baaklini WA, 2000, CHEST, V117, P1049, DOI 10.1378/chest.117.4.1049; Cancer Care Ontario, 2013, CANCER FACT LUNG CAN; Chen Alexander, 2014, Ann Am Thorac Soc, V11, P578, DOI 10.1513/AnnalsATS.201311-384OC; Figueiredo VR, 2013, J BRAS PNEUMOL, V39, P226, DOI 10.1590/S1806-37132013000200015; Gu P, 2009, EUR J CANCER, V45, P1389, DOI 10.1016/j.ejca.2008.11.043; Herth FJF, 2009, J THORAC ONCOL, V4, P1060, DOI 10.1097/JTO.0b013e3181b24100; Holty JEC, 2005, THORAX, V60, P949, DOI 10.1136/thx.2005.041525; Izumo T, 2013, J THORAC DIS, V5, P745, DOI 10.3978/j.issn.2072-1439.2013.11.30; Kikuchi E, 2004, EUR RESPIR J, V24, P533, DOI 10.1183/09031936.04.00138603; Lam B, 2006, EUR RESPIR J, V28, P915, DOI 10.1183/09031936.06.00131405; Navani N, 2012, AM J RESP CRIT CARE, V185, P1316, DOI 10.1164/rccm.201202-0294OC; Navani N, 2011, THORAX, V66, P352, DOI 10.1136/thx.2010.146407; NICE (National Institute for Health and Care Excellence), 2011, LUNG CANC DIAGN MAN; Rivera MP, 2007, CHEST, V132, p131S, DOI 10.1378/chest.07-1357; Roth Kjetil, 2008, BMC Pulm Med, V8, P2, DOI 10.1186/1471-2466-8-2; Saji H, 2002, CHEST, V121, P1521, DOI 10.1378/chest.121.5.1521; Sakairi Y, 2013, GEN THORAC CARDIOVAS, V61, P522, DOI 10.1007/s11748-013-0263-z; Seidelman JL, 2013, CANCER IMAGING, V13, P365, DOI 10.1102/1470-7330.2013.9025; Sharma C P, 2002, Indian J Chest Dis Allied Sci, V44, P25; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Steinfort DP, 2011, EUR RESPIR J, V37, P902, DOI 10.1183/09031936.00075310; Steinfort DP, 2013, EUR RESPIR J, V41, P539, DOI 10.1183/09031936.00044612; Steinfort DP, 2011, RESP MED, V105, P1704, DOI 10.1016/j.rmed.2011.08.008; Steinfort DP, 2010, RESP CARE, V55, P702; Tournoy KG, 2009, LUNG CANCER, V63, P45, DOI 10.1016/j.lungcan.2008.04.004; Varela-Lema L, 2009, EUR RESPIR J, V33, P1156, DOI 10.1183/09031936.00097908; Verma A, 2013, YONSEI MED J, V54, P672, DOI 10.3349/ymj.2013.54.3.672; Yasufuku K, 2006, CHEST, V130, P710, DOI 10.1378/chest.130.3.710; Yasufuku K, 2011, J THORAC CARDIOV SUR, V142, P1393, DOI 10.1016/j.jtcvs.2011.08.037; Yeow KM, 2004, CHEST, V126, P748, DOI 10.1378/chest.126.3.748; Zaric B, 2013, J THORAC DIS, V5, pS359, DOI 10.3978/j.issn.2072-1439.2013.05.15	34	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142336	10.1371/journal.pone.0142336	http://dx.doi.org/10.1371/journal.pone.0142336			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545094	gold, Green Published, Green Submitted			2022-12-26	WOS:000364398700115
J	Gobl, CS; Bozkurt, L; Tura, A; Pacini, G; Kautzky-Willer, A; Mittlbock, M				Goebl, Christian S.; Bozkurt, Latife; Tura, Andrea; Pacini, Giovanni; Kautzky-Willer, Alexandra; Mittlboeck, Martina			Application of Penalized Regression Techniques in Modelling Insulin Sensitivity by Correlated Metabolic Parameters	PLOS ONE			English	Article							VARIABLE SELECTION; PROGNOSTIC MODELS; IDENTIFICATION; PREDICTORS; SHRINKAGE; LASSO	This paper aims to introduce penalized estimation techniques in clinical investigations of diabetes, as well as to assess their possible advantages and limitations. Data from a previous study was used to carry out the simulations to assess: a) which procedure results in the lowest prediction error of the final model in the setting of a large number of predictor variables with high multicollinearity (of importance if insulin sensitivity should be predicted) and b) which procedure achieves the most accurate estimate of regression coefficients in the setting of fewer predictors with small unidirectional effects and moderate correlation between explanatory variables (of importance if the specific relation between an independent variable and insulin sensitivity should be examined). Moreover a special focus is on the correct direction of estimated parameter effects, a non-negligible source of error and misinterpretation of study results. The simulations were performed for varying sample size to evaluate the performance of LASSO, Ridge as well as different algorithms for Elastic Net. These methods were also compared with automatic variable selection procedures (i. e. optimizing AIC or BIC). We were not able to identify one method achieving superior performance in all situations. However, the improved accuracy of estimated effects underlines the importance of using penalized regression techniques in our example (e.g. if a researcher aims to compare relations of several correlated parameters with insulin sensitivity). However, the decision which procedure should be used depends on the specific context of a study (accuracy versus complexity) and moreover should involve clinical prior knowledge.	[Goebl, Christian S.] Med Univ Vienna, Div Feto Maternal Med, Dept Gynecol & Obstet, Vienna, Austria; [Bozkurt, Latife; Kautzky-Willer, Alexandra] Med Univ Vienna, Div Endocrinol & Metab, Dept Internal Med 3, Unit Gender Med, Vienna, Austria; [Tura, Andrea; Pacini, Giovanni] CNR, Inst Neurosci, Metab Unit, Padua, Italy; [Mittlboeck, Martina] Med Univ Vienna, Sect Clin Biometr, Ctr Med Stat Informat & Intelligent Syst, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Consiglio Nazionale delle Ricerche (CNR); Medical University of Vienna	Mittlbock, M (corresponding author), Med Univ Vienna, Sect Clin Biometr, Ctr Med Stat Informat & Intelligent Syst, Vienna, Austria.	martina.mittlboeck@meduniwien.ac.at		Kautzky-Willer, Alexandra/0000-0002-3520-4105; Mittlboeck, Martina/0000-0003-1097-4047	Austrian Science Fund [P14515 MED]	Austrian Science Fund(Austrian Science Fund (FWF))	The study was supported by the Austrian Science Fund (P14515 MED) to AKW.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Ambler G, 2012, STAT MED, V31, P1150, DOI 10.1002/sim.4371; Bi J, 2012, J SENS STUD, V27, P87, DOI 10.1111/j.1745-459X.2012.00370.x; Borai A, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-158; Efron B, 2004, J AM STAT ASSOC, V99, P619, DOI 10.1198/016214504000000692; Gobi CS, 2013, AM J PHYSIOL-ENDOC M, V304, pE524, DOI [10.1152/ajpendo.00461.2012, DOI 10.1152/AJPEND0.00461.2012]; Gobl CS, 2015, AM J PHYSIOL-REG I, V309, pR13, DOI 10.1152/ajpregu.00059.2015; Goeman J., 2018, PENALIZED L1 LASO FU; Goeman JJ, 2010, BIOMETRICAL J, V52, P70, DOI 10.1002/bimj.200900028; Hammami D, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD017864; Hastie T., 2009, UNSUPERVISED LEARNIN; Hocking RR., 2003, METHODS APPL LINEAR, DOI 10.1002/0471434159; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; LECESSIE S, 1992, J R STAT SOC C-APPL, V41, P191, DOI DOI 10.2307/2347628; LILLIOJA S, 1993, NEW ENGL J MED, V329, P1988, DOI 10.1056/NEJM199312303292703; Pacini G, 1998, AM J PHYSIOL-ENDOC M, V274, pE592, DOI 10.1152/ajpendo.1998.274.4.E592; Porzelius C, 2010, STAT COMPUT, V20, P151, DOI 10.1007/s11222-009-9155-6; Sauerbrei W, 1999, J ROY STAT SOC C-APP, V48, P313, DOI 10.1111/1467-9876.00155; Sauerbrei W, 2007, STAT MED, V26, P5512, DOI 10.1002/sim.3148; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Steyerberg E., 2009, CLIN PREDICTION MODE; Steyerberg EW, 2000, STAT MED, V19, P1059, DOI 10.1002/(SICI)1097-0258(20000430)19:8<1059::AID-SIM412>3.0.CO;2-0; Tibshirani R, 1997, STAT MED, V16, P385, DOI 10.1002/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tura A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050419; Vach K, 2001, STAT NEERL, V55, P53, DOI 10.1111/1467-9574.00156; Van Houwelingen H. C., 2013, OPEN J STAT, V3, P79, DOI DOI 10.4236/OJS.2013.32011; Venables WN., 2002, MODERN APPL STAT S 4; Vidaurre D, 2013, INT STAT REV, V81, P361, DOI 10.1111/insr.12023; Waldron L, 2011, BIOINFORMATICS, V27, P3399, DOI 10.1093/bioinformatics/btr591; WYATT JC, 1995, BMJ-BRIT MED J, V311, P1539, DOI 10.1136/bmj.311.7019.1539; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	32	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141524	10.1371/journal.pone.0141524	http://dx.doi.org/10.1371/journal.pone.0141524			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544569	Green Published, Green Submitted, gold			2022-12-26	WOS:000364398700031
J	Gonzalez-Bulnes, A; Torres-Rovira, L; Astiz, S; Ovilo, C; Sanchez-Sanchez, R; Gomez-Fidalgo, E; Perez-Solana, M; Martin-Lluch, M; Garcia-Contreras, C; Vazquez-Gomez, M				Gonzalez-Bulnes, Antonio; Torres-Rovira, Laura; Astiz, Susana; Ovilo, Cristina; Sanchez-Sanchez, Raul; Gomez-Fidalgo, Ernesto; Perez-Solana, Mariluz; Martin-Lluch, Mercedes; Garcia-Contreras, Consuelo; Vazquez-Gomez, Marta			Fetal Sex Modulates Developmental Response to Maternal Malnutrition	PLOS ONE			English	Article							INTRAUTERINE GROWTH-RETARDATION; ANIMAL-MODELS; GESTATIONAL-AGE; BLOOD-PRESSURE; BIRTH-WEIGHT; SWINE; RESTRICTION; PIG; CHOLESTEROL; OBESITY	The incidence of obesity and metabolic diseases is dramatically high in rapidly developing countries. Causes have been related to intrinsic ethnic features with development of a thrifty genotype for adapting to food scarcity, prenatal programming by undernutrition, and postnatal exposure to obesogenic lifestyle. Observational studies in humans and experimental studies in animal models evidence that the adaptive responses of the offspring may be modulated by their sex. In the contemporary context of world globalization, the new question arising is the existence and extent of sex-related differences in developmental and metabolic traits in case of mixed-race. Hence, in the current study, using a swine model, we compared male and female fetuses that were crossbred from mothers with thrifty genotype and fathers without thrifty genotype. Female conceptuses evidence stronger protective strategies for their adequate growth and postnatal survival. In brief, both male and female fetuses developed a brain-sparing effect but female fetuses were still able to maintain the development of other viscerae than the brain (mainly liver, intestine and kidneys) at the expense of carcass development. Furthermore, these morphometric differences were reinforced by differences in nutrient availability (glucose and cholesterol) favoring female fetuses with severe developmental predicament. These findings set the basis for further studies aiming to increase the knowledge on the interaction between genetic and environmental factors in the determination of adult phenotype	[Gonzalez-Bulnes, Antonio; Astiz, Susana; Ovilo, Cristina; Sanchez-Sanchez, Raul; Gomez-Fidalgo, Ernesto; Perez-Solana, Mariluz; Martin-Lluch, Mercedes; Garcia-Contreras, Consuelo] INIA, Madrid, Spain; [Gonzalez-Bulnes, Antonio; Torres-Rovira, Laura] Univ Sassari, I-07100 Sassari, Italy; [Vazquez-Gomez, Marta] UCM, Fac Vet, Madrid, Spain	University of Sassari; Complutense University of Madrid	Gonzalez-Bulnes, A (corresponding author), INIA, Madrid, Spain.	bulnes@inia.es	Garcia Contreras, Consolacion/AAX-2057-2021; Astiz, Susana/AAN-8769-2021; Garcia-Contreras, Consolacion/GSE-0766-2022; Ovilo, Cristina/N-9931-2014; Vázquez-Gómez, Marta/L-7054-2014; Gonzalez-Bulnes, Antonio/K-7691-2015; Sánchez, Raúl Sánchez/M-8694-2019	Garcia-Contreras, Consolacion/0000-0003-4624-2585; Ovilo, Cristina/0000-0002-5738-8435; Vázquez-Gómez, Marta/0000-0002-8916-2086; Gonzalez-Bulnes, Antonio/0000-0002-0917-4475; Sánchez, Raúl Sánchez/0000-0002-2987-5906; Torres-Rovira, Laura/0000-0003-1467-7533; Martin, Mercedes/0000-0003-4734-4196	Ministry of Science and Innovation [AGL2010-21991-C03-03]; Ministry of Economy and Competitiveness [AGL2013-48121-C3-2-R]; FEDER	Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministry of Economy and Competitiveness; FEDER(European Commission)	The experimental work was supported by funds from the Ministry of Science and Innovation (project AGL2010-21991-C03-03) and the Ministry of Economy and Competitiveness (project AGL2013-48121-C3-2-R to AGB), co-funded by FEDER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken CE, 2013, REPRODUCTION, V145, pR1, DOI 10.1530/REP-11-0489; Antipatis C, 2000, BRIT J NUTR, V84, P125; Bahr A, 2012, REPROD DOMEST ANIM, V47, P59, DOI 10.1111/j.1439-0531.2012.02056.x; Barbaux S, 2015, PLACENTA, V36, pS5, DOI 10.1016/j.placenta.2015.01.196; Barbero A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078424; Bauer R, 2000, AM J PHYSIOL-REG I, V279, pR1010, DOI 10.1152/ajpregu.2000.279.3.R1010; Bavdekar A, 1999, DIABETES, V48, P2422, DOI 10.2337/diabetes.48.12.2422; Bee G, 2004, J ANIM SCI, V82, P826; British Society of Animal Science, 2003, NUTR REQ STAND PIGS; D'Inca R, 2010, J NUTR, V140, P925, DOI 10.3945/jn.109.116822; DAWKINS MJR, 1966, BRIT MED BULL, V22, P27, DOI 10.1093/oxfordjournals.bmb.a070432; DOUGLAS WR, 1972, SPACE LIFE SCI, V3, P226, DOI 10.1007/BF00928167; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Gonzalez-Bulnes A, 2012, REPRODUCTION, V144, P269, DOI 10.1530/REP-12-0105; Gonzalez-Bulnes A, 2012, GEN COMP ENDOCR, V176, P94, DOI 10.1016/j.ygcen.2011.12.038; Guilloteau P, 2010, NUTR RES REV, V23, P4, DOI 10.1017/S0954422410000077; Haugen G, 2005, CIRC RES, V96, P12, DOI 10.1161/01.RES.0000152391.45273.A2; HOUPT KA, 1979, YALE J BIOL MED, V52, P307; HUHN RG, 1969, LAB ANIM CARE, V19, P403; Kong APS, 2013, NAT REV ENDOCRINOL, V9, P537, DOI 10.1038/nrendo.2013.102; Krishnaveni GV, 2014, CLIN ENDOCRINOL, V80, P73, DOI 10.1111/cen.12143; Kuhn G, 2002, FLEISCHWIRTSCHAFT, V82, P128; Kurome M, 2015, METHODS MOL BIOL, V1222, P37, DOI 10.1007/978-1-4939-1594-1_4; Latini G, 2004, ACTA PAEDIATR, V93, P1635, DOI 10.1080/08035250410023106; Lesage J, 2001, ENDOCRINOLOGY, V142, P1692, DOI 10.1210/en.142.5.1692; Lunney JK, 2007, INT J BIOL SCI, V3, P179, DOI 10.7150/ijbs.3.179; Metges CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031390; MOHAN M, 1990, Indian Pediatrics, V27, P43; Myatt L, 2006, J PHYSIOL-LONDON, V572, P25, DOI 10.1113/jphysiol.2006.104968; Nijland MJ, 2010, J PHYSIOL-LONDON, V588, P1349, DOI 10.1113/jphysiol.2009.184168; Ovilo C, 2005, GENET RES, V85, P57, DOI 10.1017/S0016672305007330; Ovilo C, 2014, BRIT J NUTR, V111, P735, DOI 10.1017/S0007114513002948; Paixao AD, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.111823; Palinski W, 2009, CIRC RES, V104, P569, DOI 10.1161/CIRCRESAHA.109.194191; Pandey A, 2015, IUBMB LIFE, V67, P506, DOI 10.1002/iub.1396; Perry B, 2002, BRAIN MIND, V3, P79, DOI DOI 10.1023/A:1016557824657; Prentice Andrew M, 2014, Nestle Nutr Inst Workshop Ser, V78, P155, DOI 10.1159/000354957; Prentice AM, 2009, NESTLE NUTR WORKS SE, V63, P47, DOI 10.1159/000209972; Quiniou N, 2002, LIVEST PROD SCI, V78, P63, DOI 10.1016/S0301-6226(02)00181-1; RANDALL GCB, 1983, BIOL REPROD, V29, P1077, DOI 10.1095/biolreprod29.5.1077; Rehfeldt C, 2006, J Anim Sci, V84 Suppl, pE113; Rexhepaj R, 2008, AM J PHYSIOL-REG I, V294, pR2008, DOI 10.1152/ajpregu.00737.2007; Ritz E, 2011, NAT REV NEPHROL, V7, P137, DOI 10.1038/nrneph.2011.1; RUDOLPH AM, 1984, J DEV PHYSIOL, V6, P11; Schmidt W, 1992, Adv Anat Embryol Cell Biol, V127, P1; Scully Tony, 2012, Nature, V485, pS2; SHELLEY HJ, 1975, BRIT MED BULL, V31, P37, DOI 10.1093/oxfordjournals.bmb.a071239; SHELLEY HJ, 1961, BRIT MED BULL, V17, P137, DOI 10.1093/oxfordjournals.bmb.a069888; Shetty P, 2012, NATURE, V485, pS14, DOI 10.1038/485S14a; Spurlock ME, 2008, J NUTR, V138, P397, DOI 10.1093/jn/138.2.397; Thomas Nihal, 2012, Indian J Endocrinol Metab, V16, pS142, DOI 10.4103/2230-8210.104024; Torres-Rovira L, 2012, SCI WORLD J, DOI 10.1100/2012/510149; Torres-Rovira L, 2013, ENDOCR METAB IMMUNE, V13, P143, DOI 10.2174/1871530311313020002; Torres-Rovira L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066728; Trahair J F, 1997, Equine Vet J Suppl, P40; Vuguin PM, 2007, HORM RES, V68, P113, DOI 10.1159/000100545; Wells JCK, 2009, INT J EPIDEMIOL, V38, P63, DOI 10.1093/ije/dyn183; Wise T, 1997, J ANIM SCI, V75, P2197; WISE T, 1993, J ANIM SCI, V71, P2732, DOI 10.2527/1993.71102732x; Wolf E, 2014, TRANSGENIC RES, V23, P27, DOI 10.1007/s11248-013-9755-y; Woollett LA, 2001, CURR OPIN LIPIDOL, V12, P305, DOI 10.1097/00041433-200106000-00010; Wu G, 2006, J ANIM SCI, V84, P2316, DOI 10.2527/jas.2006-156	62	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142158	10.1371/journal.pone.0142158	http://dx.doi.org/10.1371/journal.pone.0142158			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544862	Green Published, gold, Green Submitted			2022-12-26	WOS:000364398700089
J	Hudson, BD; Hum, NR; Thomas, CB; Kohlgruber, A; Sebastian, A; Collette, NM; Coleman, MA; Christiansen, BA; Loots, GG				Hudson, Bryan D.; Hum, Nicholas R.; Thomas, Cynthia B.; Kohlgruber, Ayano; Sebastian, Aimy; Collette, Nicole M.; Coleman, Matthew A.; Christiansen, Blaine A.; Loots, Gabriela G.			SOST Inhibits Prostate Cancer Invasion	PLOS ONE			English	Article							RECEPTOR-RELATED PROTEIN-5; SECRETED WNT ANTAGONIST; VAN-BUCHEM-DISEASE; IN-VITRO; BETA-CATENIN; SIGNALING PATHWAY; BONE METASTASIS; COLON-CANCER; CELL-GROWTH; GENE	Inhibitors of Wnt signaling have been shown to be involved in prostate cancer (PC) metastasis; however the role of Sclerostin (Sost) has not yet been explored. Here we show that elevated Wnt signaling derived from Sost deficient osteoblasts promotes PC invasion, while rhSOST has an inhibitory effect. In contrast, rhDKK1 promotes PC elongation and filopodia formation, morphological changes characteristic of an invasive phenotype. Furthermore, rhDKK1 was found to activate canonical Wnt signaling in PC3 cells, suggesting that SOST and DKK1 have opposing roles on Wnt signaling in this context. Gene expression analysis of PC3 cells co-cultured with OBs exhibiting varying amounts of Wnt signaling identified CRIM1 as one of the transcripts upregulated under highly invasive conditions. We found CRIM1 overexpression to also promote cell-invasion. These findings suggest that bonederived Wnt signaling may enhance PC tropism by promoting CRIM1 expression and facilitating cancer cell invasion and adhesion to bone. We concluded that SOST and DKK1 have opposing effects on PC3 cell invasion and that bone-derived Wnt signaling positively contributes to the invasive phenotypes of PC3 cells by activating CRIM1 expression and facilitating PC-OB physical interaction. As such, we investigated the effects of high concentrations of SOST in vivo. We found that PC3-cells overexpressing SOST injected via the tail vein in NSG mice did not readily metastasize, and those injected intrafemorally had significantly reduced osteolysis, suggesting that targeting the molecular bone environment may influence bone metastatic prognosis in clinical settings.	[Hudson, Bryan D.; Hum, Nicholas R.; Thomas, Cynthia B.; Kohlgruber, Ayano; Sebastian, Aimy; Collette, Nicole M.; Coleman, Matthew A.; Loots, Gabriela G.] Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Biol & Biotechnol Div, Livermore, CA 94550 USA; [Sebastian, Aimy; Loots, Gabriela G.] Univ Calif Merced, Sch Nat Sci, Merced, CA USA; [Coleman, Matthew A.] Univ Calif Davis, Med Ctr, Dept Radiat Oncol, Sacramento, CA 95817 USA; [Christiansen, Blaine A.] Univ Calif Davis, Med Ctr, Dept Orthopaed Surg, Sacramento, CA 95817 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California Merced; University of California System; University of California Davis; University of California System; University of California Davis	Loots, GG (corresponding author), Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Biol & Biotechnol Div, Livermore, CA 94550 USA.	loots1@llnl.gov	Sebastian, Aimy/S-5230-2017; Loots, Gabriela G/AGA-4868-2022	Sebastian, Aimy/0000-0002-7822-7040; Loots, Gabriela G/0000-0001-9546-5561; Coleman, Matthew/0000-0003-1389-4018; Christiansen, Blaine/0000-0002-0105-6458; Hum, Nicholas/0000-0003-1605-3193; Collette, Nicole/0000-0002-9068-8712	National Institute of Health [DK075730, P41MI03483]; Lawrence Livermore National Laboratory [LDRD-10-ERD-020]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103483] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of Health Grant No. DK075730 and P41MI03483 Lawrence Livermore National Laboratory Grant No. LDRD-10-ERD-020. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arjonen A, 2014, J CLIN INVEST, V124, P1069, DOI 10.1172/JCI67280; Balemans W, 2002, J MED GENET, V39, P91, DOI 10.1136/jmg.39.2.91; Balemans W, 2001, HUM MOL GENET, V10, P537, DOI 10.1093/hmg/10.5.537; BELLOWS CG, 1986, J CELL BIOCHEM, V31, P153, DOI 10.1002/jcb.240310207; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; Chesire DR, 2002, ONCOGENE, V21, P2679, DOI 10.1038/sj.onc.1205352; Chung LWK, 2005, J UROLOGY, V173, P10, DOI 10.1097/01.ju.0000141582.15218.10; Collette NM, 2012, P NATL ACAD SCI USA, V109, P14092, DOI 10.1073/pnas.1207188109; Collette NM, 2013, DEV BIOL, DOI [10.1016/j.ydbio.2013.08.015, DOI 10.1016/J.YDBI0.2013.08.015]; Cruciat CM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a015081; Daimon E, 2013, ARCH DERMATOL RES, V305, P571, DOI 10.1007/s00403-013-1343-8; Dhar S, 2011, P NATL ACAD SCI USA, V108, P1850, DOI 10.1073/pnas.1011379108; Festuccia C, 2000, INT J CANCER, V85, P407, DOI 10.1002/(SICI)1097-0215(20000201)85:3<407::AID-IJC18>3.0.CO;2-8; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Gonzalex-Sancho JM, 2005, ONCOGENE, V24, P1098, DOI 10.1038/sj.onc.1208303; Guo Y, 2008, CANCER RES, V68, P3350, DOI 10.1158/0008-5472.CAN-07-3220; HODGES GM, 1970, EUR J CANCER, V6, P235, DOI 10.1016/0014-2964(70)90026-5; Holmen SL, 2004, J BONE MINER RES, V19, P2033, DOI 10.1359/JBMR.040907; Jenkins ZA, 2009, NAT GENET, V41, P95, DOI 10.1038/ng.270; Jung K, 2014, BBA-REV CANCER, V1846, P425, DOI 10.1016/j.bbcan.2014.09.001; Kapinas K, 2012, MATRIX BIOL, V31, P299, DOI 10.1016/j.matbio.2012.03.002; Keil R, 2013, BIOL CHEM, V394, P1005, DOI 10.1515/hsz-2013-0114; Khaja ASS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026539; Kim H, 2013, INT J ONCOL, V43, P1319, DOI 10.3892/ijo.2013.2036; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Li SJ, 2011, J MOL HISTOL, V42, P491, DOI 10.1007/s10735-011-9347-1; Li XQ, 2015, CANCER RES, V75, P3302, DOI 10.1158/0008-5472.CAN-15-0240; Lu Y, 2007, INT J CANCER, V121, P724, DOI 10.1002/ijc.22704; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; Matsuura I, 2010, BIOCHEM J, V426, P327, DOI 10.1042/BJ20090990; Mencej-Bedrac S, 2009, CALCIFIED TISSUE INT, V85, P501, DOI 10.1007/s00223-009-9306-y; Meyer M, 2012, J CELL SCI, V125, P5690, DOI 10.1242/jcs.108167; Nagaoka T, 2013, CELL SIGNAL, V25, P178, DOI 10.1016/j.cellsig.2012.09.024; Ongkeko WM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085803; Perdu B, 2010, J BONE MINER RES, V25, P82, DOI 10.1359/jbmr.090707; Polakis P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008052; Ponferrada VG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032635; Qi LS, 2012, CANCER SCI, V103, P828, DOI 10.1111/j.1349-7006.2012.02222.x; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; Sarahrudi K, 2012, J ORTHOP RES, V30, P1549, DOI 10.1002/jor.22129; Sato N, 2010, CANCER RES, V70, P5326, DOI 10.1158/0008-5472.CAN-09-3879; Scatton O, 2006, ONCOGENE, V25, P4067, DOI 10.1038/sj.onc.1209430; Shindo A, 2014, SCIENCE, V343, P649, DOI 10.1126/science.1243126; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sims AM, 2008, J BONE MINER RES, V23, P499, DOI 10.1359/JBMR.071113; Staehling-Hampton K, 2002, AM J MED GENET, V110, P144, DOI 10.1002/ajmg.10401; Tang YX, 2009, MOL CANCER THER, V8, P458, DOI 10.1158/1535-7163.MCT-08-0885; Tao YM, 2013, DIGEST LIVER DIS, V45, P251, DOI 10.1016/j.dld.2012.10.020; Uysal-Onganer P, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-55; Verras M, 2006, CANCER LETT, V237, P22, DOI 10.1016/j.canlet.2005.06.004; Wang BE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002186; Wang YK, 1999, GENOMICS, V57, P235, DOI 10.1006/geno.1999.5773; Yee DS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-162; Yu B, 2009, J HEPATOL, V50, P948, DOI 10.1016/j.jhep.2008.11.020; Zi XL, 2005, CANCER RES, V65, P9762, DOI 10.1158/0008-5472.CAN-05-0103	56	21	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142058	10.1371/journal.pone.0142058	http://dx.doi.org/10.1371/journal.pone.0142058			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545120	Green Published, Green Submitted, gold			2022-12-26	WOS:000364398700075
J	Liu, B; Taioli, E				Liu, Bian; Taioli, Emanuela			Seasonal Variations of Complete Blood Count and Inflammatory Biomarkers in the US Population - Analysis of NHANES Data	PLOS ONE			English	Article							C-REACTIVE PROTEIN; MYOCARDIAL-INFARCTION; PHYSICAL-ACTIVITY; RISK-FACTORS; AIR-TEMPERATURE; HEART-FAILURE; PLATELET; DISEASE; MECHANISMS; FIBRINOGEN	Background Recent studies reported seasonal differences in gene expression in white blood cells, adipose tissue, and inflammatory biomarkers of the immune system. There is no data on the seasonal variations of these biomarkers in the US general population of both children and adults. Then aim of this study is to explore the seasonal trends in complete blood count (CBC), and C-reactive protein (CRP) in a large non- institutionalized US population. Methods Seven cross-sectional data collected in the National Health and Nutrition Examination Survey (NHANES) during 1999-2012 were aggregated; participants reporting recent use of prescribed steroids, chemotherapy, immunomodulators and antibiotics were excluded. Linear regression models were used to compare levels of CBC and CRP between winter-spring (November-April) and summer-fall (May-October), adjusting for demographics, personal behavioral factors, and chronic disease conditions. Results A total of 27,478 children and 36,644 adults (>= 18 years) were included in the study. Levels of neutrophils, white blood cell count (WBC), and CRP were higher in winter-spring than summer-fall (p <= 0.05). Red blood cell components were lower in winter-spring than in summer-fall, while the opposite was seen for platelets. Conclusions This large population-based study found notable seasonal variations in blood cell composition and inflammatory biomarkers, with a more pro-inflammatory immune system seen in winter-spring than summer-fall. The red blood cell patterns could have implications for the observed cardio-vascular seasonality.	[Taioli, Emanuela] Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, New York, NY 10029 USA; Inst Translat Epidemiol, New York, NY USA	Icahn School of Medicine at Mount Sinai	Taioli, E (corresponding author), Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, New York, NY 10029 USA.	emanuela.taioli@mountsinai.org		Liu, Bian/0000-0001-9166-693X				Abramson JL, 2002, ARCH INTERN MED, V162, P1286, DOI 10.1001/archinte.162.11.1286; Anand IS, 2006, EUR HEART J, V27, P485; Anand IS, 2008, HEART FAIL REV, V13, P379, DOI 10.1007/s10741-008-9088-8; Azab B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112361; Braga ALF, 2002, ENVIRON HEALTH PERSP, V110, P859, DOI 10.1289/ehp.02110859; Crawford VLS, 2000, QJM-MON J ASSOC PHYS, V93, P745, DOI 10.1093/qjmed/93.11.745; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; De Jong S, 2014, HUM MOL GENET, V23, P2721, DOI 10.1093/hmg/ddt665; Dopico XC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8000; ELWOOD PC, 1993, BRIT HEART J, V70, P520; Fares Auda, 2013, N Am J Med Sci, V5, P266, DOI 10.4103/1947-2714.110430; Ferreira RC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003444; Gallerani M, 1999, RHEUMATOLOGY, V38, P1003, DOI 10.1093/rheumatology/38.10.1003; Gallerani M, 2013, EUR J MED RES, V18, DOI 10.1186/2047-783X-18-31; Gasparyan AY, 2011, RHEUMATOL INT, V31, P153, DOI 10.1007/s00296-010-1446-x; Goldinger A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126995; KEATINGE WR, 1984, BMJ-BRIT MED J, V289, P1405, DOI 10.1136/bmj.289.6456.1405; Khera A, 2009, J CLIN ENDOCR METAB, V94, P3251, DOI 10.1210/jc.2008-2406; KRISTALBONEH E, 1993, BRIT J HAEMATOL, V85, P603; Lewington S, 2012, J HYPERTENS, V30, P1383, DOI 10.1097/HJH.0b013e32835465b5; Marti-Soler H, 2014, HEART, V100, P1517, DOI 10.1136/heartjnl-2014-305623; Matthews CE, 2001, AM J EPIDEMIOL, V153, P172, DOI 10.1093/aje/153.2.172; Mavri A, 2001, BLOOD COAGUL FIBRIN, V12, P359, DOI 10.1097/00001721-200107000-00004; NCHS, 2013, SPEC WEIGHT PAR; Newman MA, 2009, MED SCI SPORT EXER, V41, P322, DOI 10.1249/MSS.0b013e3181864c05; Ornato JP, 1996, J AM COLL CARDIOL, V28, P1684, DOI 10.1016/S0735-1097(96)00411-1; ROSENTHAL NE, 1984, ARCH GEN PSYCHIAT, V41, P72; Rudnicka AR, 2007, CIRCULATION, V115, P996, DOI 10.1161/CIRCULATIONAHA.106.635169; Schneider A, 2008, EPIDEMIOLOGY, V19, P391, DOI 10.1097/EDE.0b013e31816a4325; Sung KC, 2006, INT J CARDIOL, V107, P338, DOI 10.1016/j.ijcard.2005.03.045; Thirup P, 2003, SPORTS MED, V33, P231, DOI 10.2165/00007256-200333030-00005; Wolf K, 2009, CIRCULATION, V120, P735, DOI 10.1161/CIRCULATIONAHA.108.815860; Woloshin S, 2005, NEW ENGL J MED, V352, P1611, DOI 10.1056/NEJM200504143521525; Zipf G, 2013, NATL CTR HLTH STAT V, V1	34	36	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142382	10.1371/journal.pone.0142382	http://dx.doi.org/10.1371/journal.pone.0142382			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544180	Green Published, gold, Green Submitted			2022-12-26	WOS:000364398700126
J	Zhu, MZ; Lu, YP; Wang, JF; Li, S; Wang, XN				Zhu, Muzi; Lu, Yanping; Wang, Jufang; Li, Shuang; Wang, Xiaoning			Carbon Catabolite Repression and the Related Genes of ccpA, ptsH and hprK in Thermoanaerobacterium aotearoense	PLOS ONE			English	Article							BACILLUS-SUBTILIS; MOLECULAR CHARACTERIZATION; PHOSPHOTRANSFERASE SYSTEM; DEPENDENT PHOSPHORYLATION; PHOSPHOCARRIER PROTEIN; HYDROGEN-PRODUCTION; 2-DEOXYGLUCOSE; EXPRESSION; PHOSPHOENOLPYRUVATE; RESISTANCE	The strictly anaerobic, Gram-positive bacterium, Thermoanaerobacterium aotearoense SCUT27, is capable of producing ethanol, hydrogen and lactic acid by directly fermenting glucan, xylan and various lignocellulosically derived sugars. By using non-metabolizable and metabolizable sugars as substrates, we found that cellobiose, galactose, arabinose and starch utilization was strongly inhibited by the existence of 2-deoxyglucose (2-DG). However, the xylose and mannose consumptions were not markedly affected by 2-DG at the concentration of one-tenth of the metabolizable sugar. Accordingly, T. aotearoense SCUT27 could consume xylose and mannose in the presence of glucose. The carbon catabolite repression (CCR) related genes, ccpA, ptsH and hprK were confirmed to exist in T. aotearoense SCUT27 through gene cloning and protein characterization. The highly purified Histidine-containing Protein (HPr) could be specifically phosphorylated at Serine 46 by HPr kinase/phosphatase (HPrK/P) with no need to add fructose-1,6-bisphosphate (FBP) or glucose-6-phosphate (Glc-6-P) in the reaction mixture. The specific protein-interaction of catabolite control protein A (CcpA) and phosphorylated HPr was proved via affinity chromatography in the absence of formaldehyde. The equilibrium binding constant (K-D) of CcpA and HPrSerP was determined as 2.22 +/- 0.36 nM by surface plasmon resonance (SPR) analysis, indicating the high affinity between these two proteins.	[Zhu, Muzi; Lu, Yanping; Wang, Jufang; Li, Shuang] S China Univ Technol, Sch Biosci & Bioengn, Prov Key Lab Fermentat & Enzyme Engn, Guangzhou 510641, Guangdong, Peoples R China; [Wang, Xiaoning] Chinese Peoples Liberat Army Gen Hosp, Inst Life Sci, State Key Lab Kidney, Beijing 100853, Peoples R China	South China University of Technology; Chinese People's Liberation Army General Hospital	Li, S (corresponding author), S China Univ Technol, Sch Biosci & Bioengn, Prov Key Lab Fermentat & Enzyme Engn, Guangzhou 510641, Guangdong, Peoples R China.	shuangli@scut.edu.cn	Wang, Jufang/AAH-8068-2019		National Natural Science Foundation of China [21276096]; International Cooperation Research Program of Guangdong, China [2014A050503024]; Natural Science Foundation of Guangdong, China [2014A030313258]; Fundamental Research Funds for the Central Universities, SCUT; Pearl River New-Star of Science Technology; Guangzhou City [2012J2200012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Cooperation Research Program of Guangdong, China; Natural Science Foundation of Guangdong, China(National Natural Science Foundation of Guangdong Province); Fundamental Research Funds for the Central Universities, SCUT(Fundamental Research Funds for the Central Universities); Pearl River New-Star of Science Technology; Guangzhou City	This study was supported by research grants from the National Natural Science Foundation of China (21276096), International Cooperation Research Program of Guangdong, China (2014A050503024), the Natural Science Foundation of Guangdong, China (2014A030313258) and the Fundamental Research Funds for the Central Universities, SCUT. Shuang Li was funded by the Pearl River New-Star of Science & Technology supported by Guangzhou City (2012J2200012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asanuma N, 2004, APPL ENVIRON MICROB, V70, P5244, DOI 10.1128/AEM.70.9.5244-5251.2004; Asanuma N, 2003, ARCH MICROBIOL, V179, P205, DOI 10.1007/s00203-003-0516-9; BARBAN S, 1961, J BIOL CHEM, V236, P1887; Colabardini AC, 2012, FUNGAL GENET BIOL, V49, P130, DOI 10.1016/j.fgb.2011.11.004; Dahl MK, 2002, J MOL MICROB BIOTECH, V4, P315; DEUTSCHER J, 1994, J BACTERIOL, V176, P3336, DOI 10.1128/jb.176.11.3336-3344.1994; Filho SA, 1986, NAT BIOTECHNOL, V4, P311; Foudeh AM, 2014, BIOSENS BIOELECTRON, V52, P129, DOI 10.1016/j.bios.2013.08.032; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; HENKIN TM, 1991, MOL MICROBIOL, V5, P575, DOI 10.1111/j.1365-2958.1991.tb00728.x; HUECK CJ, 1995, MOL MICROBIOL, V15, P395, DOI 10.1111/j.1365-2958.1995.tb02252.x; Jankovic I, 2002, J MOL MICROB BIOTECH, V4, P309; Kinoshita E, 2009, NAT PROTOC, V4, P1513, DOI 10.1038/nprot.2009.154; KORNBERG H, 1994, P NATL ACAD SCI USA, V91, P11080, DOI 10.1073/pnas.91.23.11080; KRAUS A, 1994, J BACTERIOL, V176, P1738, DOI 10.1128/jb.176.6.1738-1745.1994; Kravanja M, 1999, MOL MICROBIOL, V31, P59, DOI 10.1046/j.1365-2958.1999.01146.x; Lai ZC, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/s13068-014-0119-5; Leiba J, 2012, J BIOL CHEM, V287, P43607, DOI 10.1074/jbc.M112.418913; Li SA, 2010, BIORESOURCE TECHNOL, V101, P8718, DOI 10.1016/j.biortech.2010.06.111; Lin L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002318; Lorca GL, 2005, J BACTERIOL, V187, P7826, DOI 10.1128/JB.187.22.7826-7839.2005; Miwa Y, 2000, NUCLEIC ACIDS RES, V28, P1206, DOI 10.1093/nar/28.5.1206; Nguyen HD, 2005, PLASMID, V54, P241, DOI 10.1016/j.plasmid.2005.05.001; Park YH, 2006, J BIOL CHEM, V281, P6448, DOI 10.1074/jbc.M512672200; PARNIAK M, 1985, CAN J BIOCHEM CELL B, V63, P333, DOI 10.1139/o85-049; Ralser M, 2008, P NATL ACAD SCI USA, V105, P17807, DOI 10.1073/pnas.0803090105; Reizer J, 1996, J BACTERIOL, V178, P5480, DOI 10.1128/jb.178.18.5480-5486.1996; Ren C, 2010, METAB ENG, V12, P446, DOI 10.1016/j.ymben.2010.05.002; SANZ P, 1994, YEAST, V10, P1195, DOI 10.1002/yea.320100907; Schumacher MA, 2007, J MOL BIOL, V368, P1042, DOI 10.1016/j.jmb.2007.02.054; Schumacher MA, 2011, NUCLEIC ACIDS RES, V39, P2931, DOI 10.1093/nar/gkq1177; Shaw AJ, 2008, P NATL ACAD SCI USA, V105, P13769, DOI 10.1073/pnas.0801266105; Shaw AJ, 2012, METAB ENG, V14, P528, DOI 10.1016/j.ymben.2012.06.004; Sun XS, 2011, PROTEOMICS, V11, P3288, DOI 10.1002/pmic.201000396; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THEVENOT T, 1995, J BACTERIOL, V177, P2751, DOI 10.1128/jb.177.10.2751-2759.1995; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Titgemeyer F, 2002, ANTON LEEUW INT J G, V82, P59, DOI 10.1023/A:1020628909429; Tsakraklides V, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-85; Vadeboncoeur C, 1997, FEMS MICROBIOL REV, V19, P187, DOI 10.1016/S0168-6445(96)00029-0; Warner JB, 2003, MICROBIOL MOL BIOL R, V67, P475, DOI 10.1128/MMBR.67.4.475-490.2003; WEICKERT MJ, 1992, J BIOL CHEM, V267, P15869; Wunsche A, 2012, FEBS J, V279, P2201, DOI 10.1111/j.1742-4658.2012.08604.x; Yang XF, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-124; Ye JJ, 1996, J BACTERIOL, V178, P3557, DOI 10.1128/jb.178.12.3557-3563.1996; Zhong DS, 2008, MOL CANCER THER, V7, P809, DOI 10.1158/1535-7163.MCT-07-0559; Zhou Y, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-138	47	7	7	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142121	10.1371/journal.pone.0142121	http://dx.doi.org/10.1371/journal.pone.0142121			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540271	Green Published, gold, Green Submitted			2022-12-26	WOS:000364303800056
J	Arsenault, D; Coulombe, K; Zhu, AJ; Gong, CY; Kil, KE; Choi, JK; Poutiainen, P; Brownell, AL				Arsenault, Dany; Coulombe, Katherine; Zhu, Aijun; Gong, Chunyu; Kil, Kun-Eek; Choi, Ji-Kyung; Poutiainen, Pekka; Brownell, Anna-Liisa			Loss of Metabotropic Glutamate Receptor 5 Function on Peripheral Benzodiazepine Receptor in Mice Prenatally Exposed to LPS	PLOS ONE			English	Article							POSITIVE ALLOSTERIC MODULATOR; MICROGLIAL ACTIVATION; MGLUR5 ANTAGONIST; RAT-BRAIN; PSYCHIATRIC-DISORDERS; MULTIPLE-SCLEROSIS; VIRAL-INFECTION; PROTEIN; SCHIZOPHRENIA; EXPRESSION	Parental microglial induced neuroinflammation, triggered by bacterial-or viral infections, can induce neuropsychiatric disorders like schizophrenia and autism to offspring in animal models. Recent investigations suggest that microglia, the resident immune cells of the brain, provides a link between neurotransmission, immune cell activation, brain inflammation and neuronal dysfunction seen with the offspring. Relatively little is known about how reduction of brain inflammation and restoration of glial function are associated with diminution of brain degeneration and behavioral deficits in offspring. Increased mGluR5 expression and the long-lasting excitotoxic effects of the neurotoxin during brain development are associated with the glial dysfunctions. We investigated the relationship of mGluR5 and PBR and how they regulate glial function and inflammatory processes in mice prenatally exposed to LPS (120 mu g/kg, between gestational days 15 and 17), an inflammatory model of a psychiatric disorder. Using PET imaging, we showed that pharmacological activation of mGluR5 during 5 weeks reduced expression of classic inflammation marker PBR in many brain areas and that this molecular association was not present in LPS-exposed offspring. The post-mortem analysis revealed that the down regulation of PBR was mediated through activation of mGluR5 in astrocytes. In addition, we demonstrated that this interaction is defective in a mouse model of the psychiatric deficit offering a novel insight of mGluR5 involvement to brain related disorders and PBR related imaging studies. In conclusion, mGluR5 driven glutamatergic activity regulates astrocytic functions associated with PBR (cholesterol transport, neurosteroidogenesis, glial phenotype) during maturation and could be associated with neuropsychiatric disorders in offspring.	[Arsenault, Dany; Zhu, Aijun; Gong, Chunyu; Kil, Kun-Eek; Choi, Ji-Kyung; Poutiainen, Pekka; Brownell, Anna-Liisa] Harvard Univ, Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging,Med Sch, Charlestown, MA 02129 USA; [Coulombe, Katherine] Univ Laval, Ctr Rech, CHU Quebec, Axe Neurosci Fac Pharm, Quebec City, PQ, Canada	Harvard University; Massachusetts General Hospital; Laval University	Brownell, AL (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging,Med Sch, Charlestown, MA 02129 USA.	abrownell@partners.org	Kil, Kun-Eek/ABD-7285-2020	Kil, Kun-Eek/0000-0002-1113-2469; Poutiainen, Pekka/0000-0001-8148-9909	National Institute of Mental Health [1R01MH091684]; Fonds de la Recherche en Sante du Quebec (FRSQ); Orion Farmos Research Foundation; Saastamoinen Foundation; Sigrid Juselius Foundation; Osk Huttunen Foundation; Kuopio University Foundation; National Center of Research Resources [S10RR029495, S10RR026666]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091684] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Orion Farmos Research Foundation; Saastamoinen Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Osk Huttunen Foundation; Kuopio University Foundation; National Center of Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institute of Mental Health [grant 1R01MH091684]. Dany Arsenault was supported by scholarship from Fonds de la Recherche en Sante du Quebec (FRSQ). The authors would like to express their appreciation of the financial support for PP from The Orion Farmos Research Foundation, Saastamoinen Foundation, Sigrid Juselius Foundation, Osk Huttunen Foundation and Kuopio University Foundation. The used instrumentation in the experiments was supported by the grants from the National Center of Research Resources (grants S10RR029495 and S10RR026666].	Anderson JJ, 2003, EUR J PHARMACOL, V473, P35, DOI 10.1016/S0014-2999(03)01935-6; Arsenault Dany, 2014, Open J Med Psychol, V3, P202; Arsenault D, 2014, BRAIN BEHAV IMMUN, V38, P77, DOI 10.1016/j.bbi.2013.12.016; Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658; Ayala JE, 2009, NEUROPSYCHOPHARMACOL, V34, P2057, DOI 10.1038/npp.2009.30; Bae KR, 2014, J NEUROIMMUNE PHARM, V9, P424, DOI 10.1007/s11481-014-9540-6; Baharnoori M, 2009, SCHIZOPHR RES, V107, P99, DOI 10.1016/j.schres.2008.10.003; Banati RB, 2000, BRAIN, V123, P2321, DOI 10.1093/brain/123.11.2321; Brahmachari S, 2006, J NEUROSCI, V26, P4930, DOI 10.1523/JNEUROSCI.5480-05.2006; Brodkin J, 2002, PHARMACOL BIOCHEM BE, V73, P359, DOI 10.1016/S0091-3057(02)00828-6; Brown AS, 2010, AM J PSYCHIAT, V167, P261, DOI 10.1176/appi.ajp.2009.09030361; Busse CS, 2004, NEUROPSYCHOPHARMACOL, V29, P1971, DOI 10.1038/sj.npp.1300540; Byrnes KR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-43; Byrnes KR, 2009, GLIA, V57, P550, DOI 10.1002/glia.20783; Cagnin A, 2001, LANCET, V358, P461, DOI 10.1016/S0140-6736(01)05625-2; Cagnin A, 2007, NEUROTHERAPEUTICS, V4, P443, DOI 10.1016/j.nurt.2007.04.006; CATANIA MV, 1994, NEUROSCIENCE, V61, P481, DOI 10.1016/0306-4522(94)90428-6; CATANIA MV, 1994, MOL PHARMACOL, V45, P626; Chen MK, 2008, PHARMACOL THERAPEUT, V118, P1, DOI 10.1016/j.pharmthera.2007.12.004; Chen MK, 2006, TOXICOL SCI, V91, P532, DOI 10.1093/toxsci/kfj172; Chen MK, 2004, BRAIN, V127, P1379, DOI 10.1093/brain/awh161; Choi J, 2011, GLIA, V59, P219, DOI 10.1002/glia.21091; Clarke MC, 2006, SCHIZOPHRENIA BULL, V32, P3, DOI 10.1093/schbul/sbj028; Conn PJ, 2009, TRENDS PHARMACOL SCI, V30, P25, DOI 10.1016/j.tips.2008.10.006; D'Ascenzo M, 2007, P NATL ACAD SCI USA, V104, P1995, DOI 10.1073/pnas.0609408104; Da Pozzo E, 2012, CURR MOL MED, V12, P426; Debruyne JC, 2003, EUR J NEUROL, V10, P257, DOI 10.1046/j.1468-1331.2003.00571.x; Diaz-Cabiale Z, 2002, NEUROSCI LETT, V324, P154, DOI 10.1016/S0304-3940(02)00179-9; Dickerson JW, 2012, NEURODEGENER DIS MAN, V2, P221, DOI 10.2217/NMT.12.6; Drouin-Ouellet J, 2011, GLIA, V59, P188, DOI 10.1002/glia.21086; ENG LF, 1994, BRAIN PATHOL, V4, P229, DOI 10.1111/j.1750-3639.1994.tb00838.x; Fatemi SH, 2015, SCHIZOPHR RES, V167, P42, DOI 10.1016/j.schres.2014.10.010; Fatemi SH, 2014, SCHIZOPHR RES, V158, P270, DOI 10.1016/j.schres.2014.06.029; Fatemi SH, 2005, SYNAPSE, V57, P91, DOI 10.1002/syn.20162; Ferraguti F, 2001, EXP BRAIN RES, V137, P1, DOI 10.1007/s002210000633; Fortier ME, 2007, BEHAV BRAIN RES, V181, P270, DOI 10.1016/j.bbr.2007.04.016; Gerhard A, 2006, MOVEMENT DISORD, V21, P89, DOI 10.1002/mds.20668; Gerhard A, 2005, NEUROIMAGE, V24, P591, DOI 10.1016/j.neuroimage.2004.09.034; Golan H, 2006, NEUROSCIENCE, V141, P1909, DOI 10.1016/j.neuroscience.2006.05.045; Golan HM, 2005, NEUROPHARMACOLOGY, V48, P903, DOI 10.1016/j.neuropharm.2004.12.023; Guilarte TR, 2003, NEUROSCIENCE, V122, P499, DOI 10.1016/S0306-4522(03)00476-7; Haidan A, 2000, MOL CELL ENDOCRINOL, V165, P25, DOI 10.1016/S0303-7207(00)00267-7; Hermans E, 2001, BIOCHEM J, V359, P465, DOI 10.1042/0264-6021:3590465; Higashimori H, 2013, HUM MOL GENET, V22, P2041, DOI 10.1093/hmg/ddt055; Hovelso N, 2012, CURR NEUROPHARMACOL, V10, P12, DOI 10.2174/157015912799362805; Kinney GG, 2005, J PHARMACOL EXP THER, V313, P199, DOI 10.1124/jpet.104.079244; Klodzinska A, 2004, NEUROPHARMACOLOGY, V47, P342, DOI 10.1016/j.neuropharm.2004.04.013; Kneeland RE, 2013, PROG NEURO-PSYCHOPH, V42, P35, DOI 10.1016/j.pnpbp.2012.02.001; Kozlowski C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031814; Kuhlmann AC, 2000, J NEUROCHEM, V74, P1694, DOI 10.1046/j.1471-4159.2000.0741694.x; Lin CW, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00087; Loane DJ, 2009, J BIOL CHEM, V284, P15629, DOI 10.1074/jbc.M806139200; Maelfait J, 2008, J EXP MED, V205, P1967, DOI 10.1084/jem.20071632; Mikulecka A, 2009, BEHAV BRAIN RES, V204, P133, DOI 10.1016/j.bbr.2009.05.032; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; NOVAIS ARB, 2013, PEDIATR RES, V73, P750, DOI DOI 10.1038/PR.2013.40; O'Connor EC, 2010, NEUROPSYCHOPHARMACOL, V35, P1807, DOI 10.1038/npp.2010.48; Ouchi Y, 2005, ANN NEUROL, V57, P168, DOI 10.1002/ana.20338; Palucha A, 2005, PHARMACOL BIOCHEM BE, V81, P901, DOI 10.1016/j.pbb.2005.06.015; Panchision DM, 2002, CURR OPIN GENET DEV, V12, P478, DOI 10.1016/S0959-437X(02)00329-5; Papadopoulos V., 2003, Annales Pharmaceutiques Francaises, V61, P30; Papadopoulos V, 1997, STEROIDS, V62, P21, DOI 10.1016/S0039-128X(96)00154-7; Patel S, 2007, NUCL MED BIOL, V34, P1009, DOI 10.1016/j.nucmedbio.2007.07.009; Patterson PH, 2009, BEHAV BRAIN RES, V204, P313, DOI 10.1016/j.bbr.2008.12.016; PECKNOLD JC, 1982, J CLIN PSYCHOPHARM, V2, P129; Pellegrino D, 2007, J NUCL MED, V48, P1147, DOI 10.2967/jnumed.106.037796; Piers TM, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00199; Porter RHP, 2005, J PHARMACOL EXP THER, V315, P711, DOI 10.1124/jpet.105.089839; Romano C, 1996, J COMP NEUROL, V367, P403, DOI 10.1002/(SICI)1096-9861(19960408)367:3<403::AID-CNE6>3.0.CO;2-9; Romano C, 1996, J BIOL CHEM, V271, P28612, DOI 10.1074/jbc.271.45.28612; Rosenbrock H, 2010, EUR J PHARMACOL, V639, P40, DOI 10.1016/j.ejphar.2010.02.057; Rousset CI, 2013, DEV NEUROSCI-BASEL, V35, P172, DOI 10.1159/000346579; SHIGEMOTO R, 1993, NEUROSCI LETT, V163, P53, DOI 10.1016/0304-3940(93)90227-C; Sullivan JM, 2013, J CEREBR BLOOD F MET, V33, P532, DOI 10.1038/jcbfm.2012.195; Versijpt JJ, 2003, EUR NEUROL, V50, P39, DOI 10.1159/000070857; Wei XH, 2013, J NEUROSCI, V33, P1540, DOI 10.1523/JNEUROSCI.0324-12.2013	76	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142093	10.1371/journal.pone.0142093	http://dx.doi.org/10.1371/journal.pone.0142093			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536027	Green Published, gold, Green Submitted			2022-12-26	WOS:000364298400132
J	Van Zee, J; Piesman, JF; Hojgaard, A; Black, WC				Van Zee, Janice; Piesman, Joseph F.; Hojgaard, Andrias; Black, William Cormack			Nuclear Markers Reveal Predominantly North to South Gene Flow in Ixodes scapularis, the Tick Vector of the Lyme Disease Spirochete	PLOS ONE			English	Article							BORRELIA-BURGDORFERI; POPULATION-GENETICS; MAXIMUM-LIKELIHOOD; STATISTICAL-METHOD; RANGE EXPANSION; MOLECULAR CLOCK; DAMMINI ACARI; IXODIDAE; INFERENCE; SOFTWARE	Ixodes scapularis, the tick vector of the Lyme disease spirochete, is distributed over most of the eastern United States, but >80% of all Lyme disease cases occur in the northeast. The role that genetic differences between northern and southern tick populations play in explaining this disparate distribution of Lyme disease cases is unclear. The present study was conducted with 1,155 SNP markers in eight nuclear genes; the 16S mitochondrial gene was examined for comparison with earlier studies. We examined 350 I. scapularis from 7 states covering a representative area of the species. A demographic analysis using Bayesian Extended Skyline Analysis suggested that I. scapularis populations in Mississippi and Georgia began expanding 500,000 years ago, those in Florida and North Carolina 200,000 years ago and those from Maryland and New Jersey only during the past 50,000 years with an accompanying bottleneck. Wisconsin populations only began expanding in the last 20,000 years. Analysis of current migration patterns suggests large amounts of gene flow in northern collections and equally high rates of gene flow among southern collections. In contrast there is restricted and unidirectional gene flow between northern and southern collections, mostly occurring from northern into southern populations. Northern populations are characterized by nymphs that quest above the leaf litter, are easy to collect by flagging, frequently feed on mammals such as rodents and shrews, commonly attach to people, and about 25% of which are infected with B. burgdorferi. If there is a genetic basis for these behaviors, then the patterns detected in this study are of concern because they suggest that northern I. scapularis populations with a greater ability to vector B. burgdorferi to humans are expanding south.	[Van Zee, Janice; Piesman, Joseph F.; Hojgaard, Andrias] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO 80521 USA; [Black, William Cormack] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA	Centers for Disease Control & Prevention - USA; Colorado State University	Black, WC (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	wcb4@lamar.colostate.edu			American Society of Microbiology post doctorate fellowship program; Centers for Disease Control and Prevention	American Society of Microbiology post doctorate fellowship program; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was financially supported by American Society of Microbiology post doctorate fellowship program and Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Chas Apperson (North Carolina), Katherine Feldman (Maryland), Michael Levin (Florida and Georgia), Marc Dolan and Terry Schulze (New Jersey), Jerome Goddard (Mississippi) and Susan Paskewicz (Wisconsin) for providing us with ticks. This work was financially supported by American Society of Microbiology post doctorate fellowship program and Centers for Disease Control and Prevention.	Araya-Anchetta A, 2015, INFECT GENET EVOL, V29, P164, DOI 10.1016/j.meegid.2014.11.008; Brinkerhoff RJ, 2014, EMERG INFECT DIS, V20, P1661, DOI 10.3201/eid2010.130782; Caporale DA, 1995, MOL PHYLOGENET EVOL, V4, P361, DOI 10.1006/mpev.1995.1033; Dennis DT, 1998, J MED ENTOMOL, V35, P629, DOI 10.1093/jmedent/35.5.629; Dennis DT, 2005, CLIN INFECT DIS, V41, P966, DOI 10.1086/432958; Diuk-Wasser MA, 2012, AM J TROP MED HYG, V86, P320, DOI 10.4269/ajtmh.2012.11-0395; Diuk-Wasser MA, 2010, GLOBAL ECOL BIOGEOGR, V19, P504, DOI 10.1111/j.1466-8238.2010.00526.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gatewood AG, 2009, APPL ENVIRON MICROB, V75, P2476, DOI 10.1128/AEM.02633-08; Gilbert KJ, 2012, MOL ECOL, V21, P4925, DOI 10.1111/j.1365-294X.2012.05754.x; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Heled J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-289; Humphrey PT, 2010, EVOLUTION, V64, P2653, DOI 10.1111/j.1558-5646.2010.01001.x; Kelly RR, 2014, INFECT GENET EVOL, V27, P543, DOI 10.1016/j.meegid.2014.05.022; Khatchikian CE, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00134.1; Kingman JFC, 2000, GENETICS, V156, P1461; Koffi JK, 2012, J MED ENTOMOL, V49, P400, DOI 10.1603/ME11210; Kuehn BM, 2013, JAMA-J AM MED ASSOC, V310, P1110, DOI 10.1001/jama.2013.278331; Kuhner MK, 2009, TRENDS ECOL EVOL, V24, P86, DOI 10.1016/j.tree.2008.09.007; Kuhner MK, 2006, BIOINFORMATICS, V22, P768, DOI 10.1093/bioinformatics/btk051; Leighton PA, 2012, J APPL ECOL, V49, P457, DOI 10.1111/j.1365-2664.2012.02112.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MCLAIN DK, 1995, HEREDITY, V75, P303, DOI 10.1038/hdy.1995.139; Norris DE, 1996, J MED ENTOMOL, V33, P78, DOI 10.1093/jmedent/33.1.78; Ogden NH, 2008, APPL ENVIRON MICROB, V74, P3919, DOI 10.1128/AEM.00857-08; Ogden NH, 2006, INT J PARASITOL, V36, P63, DOI 10.1016/j.ijpara.2005.08.016; OLIVER JH, 1993, J MED ENTOMOL, V30, P54, DOI 10.1093/jmedent/30.1.54; Oliver JH, 1996, J PARASITOL, V82, P926, DOI 10.2307/3284201; Orloski K A, 2000, MMWR CDC Surveill Summ, V49, P1; Papadopoulou A, 2010, MOL BIOL EVOL, V27, P1659, DOI 10.1093/molbev/msq051; Pepin KM, 2012, AM J TROP MED HYG, V86, P1062, DOI 10.4269/ajtmh.2012.11-0630; Piesman J., 2002, LYME BORRELIOSIS BIO; Pritchard JK, 2000, GENETICS, V155, P945; Qiu WG, 2002, GENETICS, V160, P833; RICH SM, 1995, P NATL ACAD SCI USA, V92, P6284, DOI 10.1073/pnas.92.14.6284; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Sakamoto JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101389; Schauber EM, 1998, J MED ENTOMOL, V35, P901, DOI 10.1093/jmedent/35.5.901; SPIELMAN A, 1985, ANNU REV ENTOMOL, V30, P439, DOI 10.1146/annurev.en.30.010185.002255; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; TAJIMA F, 1989, GENETICS, V123, P585; Telford SR, 1997, EMERG INFECT DIS, V3, P165, DOI 10.3201/eid0302.970209; Van Zee J, 2013, TICKS TICK-BORNE DIS, V4, P63, DOI 10.1016/j.ttbdis.2012.07.005; WESSON DM, 1993, P NATL ACAD SCI USA, V90, P10221, DOI 10.1073/pnas.90.21.10221	50	24	24	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0139630	10.1371/journal.pone.0139630	http://dx.doi.org/10.1371/journal.pone.0139630			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536360	Green Published, gold, Green Submitted			2022-12-26	WOS:000364298400009
J	Habota, T; McLennan, SN; Cameron, J; Ski, CF; Thompson, DR; Rendell, PG				Habota, Tina; McLennan, Skye N.; Cameron, Jan; Ski, Chantal F.; Thompson, David R.; Rendell, Peter G.			An Investigation of Emotion Recognition and Theory of Mind in People with Chronic Heart Failure	PLOS ONE			English	Article							FACIAL AFFECT RECOGNITION; COGNITIVE TEST BATTERY; QUALITY-OF-LIFE; SOCIAL COGNITION; ASPERGER-SYNDROME; NORMAL ADULTS; BRAIN-INJURY; IMPAIRMENT; DEPRESSION; VOICE	Objectives Cognitive deficits are common in patients with chronic heart failure (CHF), but no study has investigated whether these deficits extend to social cognition. The present study provided the first empirical assessment of emotion recognition and theory of mind (ToM) in patients with CHF. In addition, it assessed whether each of these social cognitive constructs was associated with more general cognitive impairment. Methods A group comparison design was used, with 31 CHF patients compared to 38 demographically matched controls. The Ekman Faces test was used to assess emotion recognition, and the Mind in the Eyes test to measure ToM. Measures assessing global cognition, executive functions, and verbal memory were also administered. Results There were no differences between groups on emotion recognition or ToM. The CHF group's performance was poorer on some executive measures, but memory was relatively preserved. In the CHF group, both emotion recognition performance and ToM ability correlated moderately with global cognition (r = .38, p = .034; r = .49, p = .005, respectively), but not with executive function or verbal memory. Conclusion CHF patients with lower cognitive ability were more likely to have difficulty recognizing emotions and inferring the mental states of others. Clinical implications of these findings are discussed.	[Habota, Tina; McLennan, Skye N.; Rendell, Peter G.] Australian Catholic Univ, Cognit & Emot Res Ctr, Melbourne, Vic, Australia; [Cameron, Jan; Ski, Chantal F.; Thompson, David R.] Australian Catholic Univ, Ctr Heart & Mind, Melbourne, Vic, Australia	Australian Catholic University; Australian Catholic University	Habota, T (corresponding author), Australian Catholic Univ, Cognit & Emot Res Ctr, Melbourne, Vic, Australia.	tina.habota@acu.edu.au	Cameron, Jan/GPC-8933-2022; Cameron, Jan/AAE-4937-2019; Ski, Chantal/AAJ-6595-2020; Rendell, Peter/E-7539-2010; Thompson, David R/E-2431-2018	Cameron, Jan/0000-0002-3335-904X; Ski, Chantal/0000-0003-1324-2933; Rendell, Peter/0000-0002-4829-4322; Thompson, David R/0000-0001-8518-6307; Habota, Tina/0000-0002-5596-5139	Mona Menzies Post-Doctoral Nursing Research Grant from the Nurses Board Victoria Legacy Ltd; Discovery Project Grant from the Australian Research Council; Australian Postgraduate Award scholarship	Mona Menzies Post-Doctoral Nursing Research Grant from the Nurses Board Victoria Legacy Ltd; Discovery Project Grant from the Australian Research Council(Australian Research Council); Australian Postgraduate Award scholarship	The study was funded by a Mona Menzies Post-Doctoral Nursing Research Grant from the Nurses Board Victoria Legacy Ltd, Discovery Project Grant from the Australian Research Council, and an Australian Postgraduate Award scholarship.	Adolphs R, 2000, J NEUROSCI, V20, P2683; Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Alvarez JA, 2006, NEUROPSYCHOL REV, V16, P17, DOI 10.1007/s11065-006-9002-x; Apperly IA, 2004, J COGNITIVE NEUROSCI, V16, P1773, DOI 10.1162/0898929042947928; Arestedt K, 2013, EUR J CARDIOVASC NUR, V12, P69, DOI 10.1177/1474515111432997; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Bailey PE, 2008, J GERONTOL B-PSYCHOL, V63, pP219, DOI 10.1093/geronb/63.4.P219; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Baron-Cohen S, 2001, INT REV RES MENT RET, V23, P169; Bennett JA, 2002, HEART LUNG, V31, P262, DOI 10.1067/mhl.2002.124554; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Burgess P.W., 1997, HAYLING BRIXTON TEST; Cameron J, 2010, EUR J HEART FAIL, V12, P508, DOI 10.1093/eurjhf/hfq042; Cannon JA, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0106-5; Carrington SJ, 2009, HUM BRAIN MAPP, V30, P2313, DOI 10.1002/hbm.20671; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cohen J.E., 1988, STAT POWER ANAL BEHA; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; Edwards J, 2002, CLIN PSYCHOL REV, V22, P1267, DOI 10.1016/S0272-7358(02)00162-9; Ekman I, 2001, J Cardiovasc Nurs, V16, P47; EKMAN P, 1976, ENVIRON PSYCH NONVER, V1, P56, DOI 10.1007/BF01115465; Fett AKJ, 2011, NEUROSCI BIOBEHAV R, V35, P573, DOI 10.1016/j.neubiorev.2010.07.001; Martin-Rodriguez JF, 2010, NEUROPSYCHOLOGIA, V48, P1181, DOI 10.1016/j.neuropsychologia.2010.02.009; Friedmann E, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.05.009; Frith C, 2005, CURR BIOL, V15, pR644, DOI 10.1016/j.cub.2005.08.041; Golan O, 2007, J AUTISM DEV DISORD, V37, P1096, DOI 10.1007/s10803-006-0252-5; Golan O, 2006, J AUTISM DEV DISORD, V36, P169, DOI 10.1007/s10803-005-0057-y; Grossmann T, 2010, RESTOR NEUROL NEUROS, V28, P219, DOI 10.3233/RNN-2010-0499; Habota T, 2015, J INT NEUROPSYCH SOC, V21, P183, DOI 10.1017/S1355617715000119; Harms MB, 2010, NEUROPSYCHOL REV, V20, P290, DOI 10.1007/s11065-010-9138-6; Hawkins MAW, 2015, J CARDIOVASC NURS, V30, pE9, DOI 10.1097/JCN.0000000000000178; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1623, DOI 10.1016/j.neuropsychologia.2006.03.020; Henry JD, 2009, J INT NEUROPSYCH SOC, V15, P277, DOI 10.1017/S1355617709090195; Insel KC, 2002, J ADV NURS, V38, P360, DOI 10.1046/j.1365-2648.2002.02196.x; Isaacowitz DM, 2006, PSYCHOL AGING, V21, P40, DOI 10.1037/0882-7974.21.1.40; Jokinen H, 2006, J NEUROL NEUROSUR PS, V77, P28, DOI 10.1136/jnnp.2005.069120; Kohler Christian G, 2010, Schizophr Bull, V36, P1009, DOI 10.1093/schbul/sbn192; Kret ME, 2015, NEUROSCI BIOBEHAV R, V52, P153, DOI 10.1016/j.neubiorev.2015.02.011; Krum H, 2006, MED J AUSTRALIA, V185, P549, DOI 10.5694/j.1326-5377.2006.tb00690.x; LAMBERTY GJ, 1994, NEUROPSY NEUROPSY BE, V7, P230; Li YS, 2001, INT J GERIATR PSYCH, V16, P455, DOI 10.1002/gps.360; Luttik Marie Louise, 2005, J Cardiovasc Nurs, V20, P162; Mathuranath PS, 2000, NEUROLOGY, V55, P1613, DOI 10.1212/01.wnl.0000434309.85312.19; Mioshi E, 2006, INT J GERIATR PSYCH, V21, P1078, DOI 10.1002/gps.1610; Moser DK, 2008, J CARDIOVASC NURS, V23, P205, DOI 10.1097/01.JCN.0000305097.09710.a5; Murberg TA, 2004, INT J PSYCHIAT MED, V34, P207, DOI 10.2190/GKJ2-P8BD-V59X-MJNQ; Nelson HE., 1982, NATL ADULT READING T; O'Loughlin C, 2010, INT J CARDIOL, V139, P60, DOI 10.1016/j.ijcard.2008.09.003; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Phillips LH, 2011, NEUROPSYCHOLOGY, V25, P131, DOI 10.1037/a0020752; Pinkham AE, 2003, AM J PSYCHIAT, V160, P815, DOI 10.1176/appi.ajp.160.5.815; Pottgen J, 2013, J NEUROL NEUROSUR PS, V84, P523, DOI 10.1136/jnnp-2012-304157; Pressler SJ, 2008, J CARDIOVASC NURS, V23, P239, DOI 10.1097/01.JCN.0000305096.09710.ec; Pressler SJ, 2010, NURS RES, V59, P127, DOI 10.1097/NNR.0b013e3181d1a747; Radice-Neumann D, 2007, BRAIN INJURY, V21, P807, DOI 10.1080/02699050701504281; Reitan RM, 1992, TRAIL MAKING TEST MA; Rey A., 1958, EXAMEN CLIN PSYCHOL; Ruffman T, 2008, NEUROSCI BIOBEHAV R, V32, P863, DOI 10.1016/j.neubiorev.2008.01.001; Rutherford MD, 2002, J AUTISM DEV DISORD, V32, P189, DOI 10.1023/A:1015497629971; Schmidt SJ, 2011, SCHIZOPHRENIA BULL, V37, pS41, DOI 10.1093/schbul/sbr079; Sprong M, 2007, BRIT J PSYCHIAT, V191, P5, DOI 10.1192/bjp.bp.107.035899; Tabachnick BG., 2013, USING MULTIVARIATE S, V6th; Vellante M, 2013, COGN NEUROPSYCHIATRY, V18, P326, DOI 10.1080/13546805.2012.721728; Vogels RLC, 2007, J AM GERIATR SOC, V55, P1764, DOI 10.1111/j.1532-5415.2007.01395.x; Vogels RLC, 2007, EUR J HEART FAIL, V9, P1003, DOI 10.1016/j.ejheart.2007.07.006; Vogels RLC, 2007, EUR J HEART FAIL, V9, P440, DOI 10.1016/j.ejheart.2006.11.001; Volz A, 2011, J BEHAV MED, V34, P13, DOI 10.1007/s10865-010-9282-8; Woo MA, 2003, J APPL PHYSIOL, V95, P677, DOI 10.1152/japplphysiol.00101.2003; Yohannes AM, 2010, INT J GERIATR PSYCH, V25, P1209, DOI 10.1002/gps.2463; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	70	5	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141607	10.1371/journal.pone.0141607	http://dx.doi.org/10.1371/journal.pone.0141607			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV1QH	26529409	Green Published, gold			2022-12-26	WOS:000364032600042
J	Koudelkova, P; Weber, G; Mikulits, W				Koudelkova, Petra; Weber, Gerhard; Mikulits, Wolfgang			Liver Sinusoidal Endothelial Cells Escape Senescence by Loss of p19ARF	PLOS ONE			English	Article							PHENOTYPIC HETEROGENEITY; EXPRESSION; CULTURE; PECAM-1	Liver sinusoidal endothelial cells (LSECs) represent a highly differentiated cell type that lines hepatic sinusoids. LSECs form a discontinuous endothelium due to fenestrations under physiological conditions, which are reduced upon chronic liver injury. Cultivation of rodent LSECs associates with a rapid onset of stress-induced senescence a few days post isolation, which limits genetic and biochemical studies ex vivo. Here we show the establishment of LSECs isolated from p19(ARF-/-) mice which undergo more than 50 cell doublings in the absence of senescence. Isolated p19(ARF-/-) LSECs display a cobblestone-like morphology and show the ability of tube formation. Analysis of DNA content revealed a stable diploid phenotype after long-term passaging without a gain of aneuploidy. Notably, p19(ARF-/-) LSECs express the endothelial markers CD31, vascular endothelial growth factor receptor (VEGFR)-2, VE-cadherin, von Willebrand factor, stabilin-2 and CD146 suggesting that these cells harbor and maintain an endothelial phenotype. In line, treatment with small molecule inhibitors against VEGFR-2 caused cell death, demonstrating the sustained ability of p19(ARF-/-) LSECs to respond to anti-angiogenic therapeutics. From these data we conclude that loss of p19(ARF) overcomes senescence of LSECs, allowing immortalization of cells without losing endothelial characteristics. Thus, p19(ARF-/-) LSECs provide a novel cellular model to study endothelial cell biology.	[Koudelkova, Petra; Weber, Gerhard; Mikulits, Wolfgang] Med Univ Vienna, Ctr Comprehens Canc, Div Inst Canc Res, Dept Med 1, Vienna, Austria	Medical University of Vienna	Mikulits, W (corresponding author), Med Univ Vienna, Ctr Comprehens Canc, Div Inst Canc Res, Dept Med 1, Vienna, Austria.	wolfgang.mikulits@meduniwien.ac.at	Mikulits, Wolfgang/AAH-4043-2021	Mikulits, Wolfgang/0000-0003-4612-7106	People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme, Spain (FP7) under Research Executive Agency Grant [PITN-GA-2012-316549-(IT-LIVER)]	People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme, Spain (FP7) under Research Executive Agency Grant	People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme, Spain (FP7/2007-2013) under Research Executive Agency Grant agreement no. PITN-GA-2012-316549-(IT-LIVER) to WM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae; Angst BD, 2001, J CELL SCI, V114, P629; Arnaoutova I, 2010, NAT PROTOC, V5, P628, DOI 10.1038/nprot.2010.6; Bian Chang, 2005, J Zhejiang Univ Sci B, V6, P631, DOI 10.1631/jzus.2005.B0631; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Braet Filip, 2002, Comp Hepatol, V1, P1, DOI 10.1186/1476-5926-1-1; Daneker GW, 1998, IN VITRO CELL DEV-AN, V34, P370, DOI 10.1007/s11626-998-0018-9; Dave JM, 2014, MICROCIRCULATION, V21, P333, DOI 10.1111/micc.12111; DeLeve LD, 2006, AM J PHYSIOL-GASTR L, V291, pG1187, DOI 10.1152/ajpgi.00229.2006; DeLeve LD, 2013, J CLIN INVEST, V123, P1861, DOI 10.1172/JCI66025; Ferreri DM, 2008, CELL COMMUN ADHES, V15, P333, DOI 10.1080/15419060802440377; Geraud C, 2013, LIVER INT, V33, P1428, DOI 10.1111/liv.12262; Geraud C, 2010, HEPATOLOGY, V52, P313, DOI 10.1002/hep.23618; Gotzmann J, 2002, J CELL SCI, V115, P1189; Huebert RC, 2010, LAB INVEST, V90, P1770, DOI 10.1038/labinvest.2010.132; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Lalor PF, 2006, WORLD J GASTROENTERO, V12, P5429, DOI 10.3748/wjg.v12.i34.5429; March S, 2009, HEPATOLOGY, V50, P920, DOI 10.1002/hep.23085; Mikula M, 2004, HEPATOLOGY, V39, P628, DOI 10.1002/hep.20084; NEWMAN PJ, 1994, ANN NY ACAD SCI, V714, P165, DOI 10.1111/j.1749-6632.1994.tb12041.x; Nisato RE, 2004, AM J PATHOL, V165, P11, DOI 10.1016/S0002-9440(10)63271-3; Oommen S, 2011, J BIOL CHEM, V286, P1083, DOI 10.1074/jbc.M110.175158; Palmero I, 1998, NATURE, V395, P125, DOI 10.1038/25870; Petz M, 2012, NUCLEIC ACIDS RES, V40, P290, DOI 10.1093/nar/gkr717; Ponnuchamy B, 2008, CIRC RES, V102, P1139, DOI 10.1161/CIRCRESAHA.108.177394; Proell V, 2005, BBA-MOL CELL RES, V1744, P76, DOI 10.1016/j.bbamcr.2004.12.009; QUELLE DE, 1995, CELL, V83, P993; Sano M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089830; Schneider GP, 2002, CLIN CANCER RES, V8, P3955; Schrage A, 2008, HISTOCHEM CELL BIOL, V129, P441, DOI 10.1007/s00418-008-0379-x; Sherr CJ, 2005, COLD SH Q B, V70, P129, DOI 10.1101/sqb.2005.70.004; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; Siow RCM, 2012, METHODS MOL BIOL, V806, P265, DOI 10.1007/978-1-61779-367-7_18; Witmer AN, 2002, J HISTOCHEM CYTOCHEM, V50, P767, DOI 10.1177/002215540205000603; Woodfin A, 2007, ARTERIOSCL THROM VAS, V27, P2514, DOI 10.1161/ATVBAHA.107.151456; Wu WC, 2003, ONCOGENE, V22, P3361, DOI 10.1038/sj.onc.1206285; Xie GH, 2013, GUT, V62, P299, DOI 10.1136/gutjnl-2011-301494	39	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0142134	10.1371/journal.pone.0142134	http://dx.doi.org/10.1371/journal.pone.0142134			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528722	Green Published, gold, Green Submitted			2022-12-26	WOS:000364032600106
J	Stillova, K; Jurak, P; Chladek, J; Chrastina, J; Halamek, J; Bockova, M; Goldemundova, S; Riha, I; Rektor, I				Stillova, Klara; Jurak, Pavel; Chladek, Jan; Chrastina, Jan; Halamek, Josef; Bockova, Martina; Goldemundova, Sabina; Riha, Ivo; Rektor, Ivan			The Role of Anterior Nuclei of the Thalamus: A Subcortical Gate in Memory Processing: An Intracerebral Recording Study	PLOS ONE			English	Article							DEEP BRAIN-STIMULATION; ELECTRICAL-STIMULATION; MAMMILLARY BODIES; SPATIAL MEMORY; CORTEX; CONNECTIVITY; HIPPOCAMPUS; AMNESIA; PET; PERFORMANCE	Objective To study the involvement of the anterior nuclei of the thalamus (ANT) as compared to the involvement of the hippocampus in the processes of encoding and recognition during visual and verbal memory tasks. Methods We studied intracerebral recordings in patients with pharmacoresistent epilepsy who underwent deep brain stimulation (DBS) of the ANT with depth electrodes implanted bilaterally in the ANT and compared the results with epilepsy surgery candidates with depth electrodes implanted bilaterally in the hippocampus. We recorded the event-related potentials (ERPs) elicited by the visual and verbal memory encoding and recognition tasks. Results P300-like potentials were recorded in the hippocampus by visual and verbal memory encoding and recognition tasks and in the ANT by the visual encoding and visual and verbal recognition tasks. No significant ERPs were recorded during the verbal encoding task in the ANT. In the visual and verbal recognition tasks, the P300-like potentials in the ANT preceded the P300-like potentials in the hippocampus. Conclusions The ANT is a structure in the memory pathway that processes memory information before the hippocampus. We suggest that the ANT has a specific role in memory processes, especially memory recognition, and that memory disturbance should be considered in patients with ANT-DBS and in patients with ANT lesions.	[Stillova, Klara; Chrastina, Jan; Bockova, Martina; Goldemundova, Sabina; Riha, Ivo; Rektor, Ivan] Cent European Inst Technol CEITEC, Brain & Mind Res Program, Brno, Czech Republic; [Stillova, Klara; Bockova, Martina; Goldemundova, Sabina; Rektor, Ivan] Masaryk Univ, St Annes Teaching Hosp, Dept Neurol, Sch Med, Brno, Czech Republic; [Chrastina, Jan; Riha, Ivo] Masaryk Univ, St Annes Teaching Hosp, Dept Neurosurg, Sch Med, Brno, Czech Republic; [Jurak, Pavel; Chladek, Jan; Halamek, Josef] Acad Sci Czech Republ, Inst Sci Instruments, CS-61264 Brno, Czech Republic	Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC); Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC); Czech Academy of Sciences; Institute of Scientific Instruments of the Czech Academy of Sciences	Rektor, I (corresponding author), Cent European Inst Technol CEITEC, Brain & Mind Res Program, Brno, Czech Republic.	irektor@med.muni.cz	Halamek, Josef/M-3836-2019; Chladek, Jan/AAK-2231-2021; Halamek, Josef/D-5110-2012; Jurak, Pavel/AAO-3084-2020; Jurák, Pavel/G-1466-2014; Chladek, Jan/B-2600-2009	Halamek, Josef/0000-0001-8986-796X; Chladek, Jan/0000-0002-9500-0657; Halamek, Josef/0000-0001-8986-796X; Jurak, Pavel/0000-0002-3793-5075; Jurák, Pavel/0000-0002-3793-5075; Chladek, Jan/0000-0002-9500-0657; Bockova, Martina/0000-0003-2691-9122	research project CEITEC MU-Central European Institute of Technology Masaryk University; "Research and Development for Innovations" Operational Programme the European Regional Development Fund; Application Laboratories of Advanced Microtechnologies and Nanotechnologies [CZ.1.05/2.1.00/01.0017];  [GACR P103/11/0933]	research project CEITEC MU-Central European Institute of Technology Masaryk University; "Research and Development for Innovations" Operational Programme the European Regional Development Fund; Application Laboratories of Advanced Microtechnologies and Nanotechnologies; 	This work was supported by the research project CEITEC MU-Central European Institute of Technology Masaryk University. The technical part of the study was also supported by the projects GA GACR P103/11/0933 and Application Laboratories of Advanced Microtechnologies and Nanotechnologies, CZ.1.05/2.1.00/01.0017, co-funded by the "Research and Development for Innovations" Operational Programme the European Regional Development Fund and the state budget. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggleton JP, 2010, EUR J NEUROSCI, V31, P2292, DOI 10.1111/j.1460-9568.2010.07251.x; Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; Bockova M, 2014, BRAIN TOPOGRAPHY, P1; Cihak R, 1997, ANATOMIE; CLARKE S, 1994, J NEUROL NEUROSUR PS, V57, P27, DOI 10.1136/jnnp.57.1.27; FAZIO F, 1992, J CEREBR BLOOD F MET, V12, P353, DOI 10.1038/jcbfm.1992.52; Fisher R, 2010, EPILEPSIA, V51, P899, DOI 10.1111/j.1528-1167.2010.02536.x; Garden DLF, 2009, BRAIN, V132, P1847, DOI 10.1093/brain/awp090; HALGREN E, 1978, ELECTROEN CLIN NEURO, V45, P585, DOI 10.1016/0013-4694(78)90159-1; Hamani C, 2010, EXP NEUROL, V225, P154, DOI 10.1016/j.expneurol.2010.06.007; Harding A, 2000, BRAIN, V123, P141, DOI 10.1093/brain/123.1.141; Hodaie M, 2002, EPILEPSIA, V43, P603, DOI 10.1046/j.1528-1157.2002.26001.x; Hu R, 2009, NEUROSURG FOCUS, V27, DOI 10.3171/2009.4.FOCUS0975; Jankowski MM, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00045; JONESGOTMAN M, 1994, EPILEPSIA, V35, P61, DOI 10.1111/j.1528-1157.1994.tb02913.x; Kopelman MD, 2014, NEUROSCI BIOBEHAV RE; Kubota Y, 2013, CLIN NEUROPHYSIOL, V124, P1547, DOI 10.1016/j.clinph.2013.01.024; Lim SN, 2007, EPILEPSIA, V48, P342, DOI 10.1111/j.1528-1167.2006.00898.x; Muller RU, 1996, J GEN PHYSIOL, V107, P663, DOI 10.1085/jgp.107.6.663; O'keefe J, 1978, HIPPOCAMPUS COGNITIV, V3, P483; Oedekoven CS, 2014, BRAIN IMAGING BEHAV, P1; Oh YS, 2012, SEIZURE-EUR J EPILEP, V21, P183, DOI 10.1016/j.seizure.2011.12.003; Parker A, 1997, NEUROPSYCHOLOGIA, V35, P1093, DOI 10.1016/S0028-3932(97)00042-0; Parvizi J, 2009, TRENDS COGN SCI, V13, P354, DOI 10.1016/j.tics.2009.04.008; Pergola G, 2013, NEUROIMAGE, V74, P195, DOI 10.1016/j.neuroimage.2013.02.017; Rabin ML, 2004, BRAIN, V127, P2286, DOI 10.1093/brain/awh281; Reed LJ, 2003, CORTEX, V39, P1027, DOI 10.1016/S0010-9452(08)70876-1; Rubin RD, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00742; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Stillova K, 2013, J NEURAL TRANSM, V120, P391, DOI 10.1007/s00702-012-0890-z; Talairach J, 1967, ATLAS ANATOMIE STERE; Van der Werf YD, 2000, NEUROPSYCHOLOGIA, V38, P613, DOI 10.1016/S0028-3932(99)00104-9; Van der Werf YD, 2003, NEUROPSYCHOLOGIA, V41, P1330, DOI 10.1016/S0028-3932(03)00059-9; Vann SD, 2004, NAT REV NEUROSCI, V5, P35, DOI 10.1038/nrn1299; Vann SD, 2007, EUR J NEUROSCI, V26, P1575, DOI 10.1111/j.1460-9568.2007.05773.x; Vincent JL, 2006, J NEUROPHYSIOL, V96, P3517, DOI 10.1152/jn.00048.2006; Wang L, 2006, NEUROIMAGE, V31, P496, DOI 10.1016/j.neuroimage.2005.12.033; Wang L, 2010, NEUROIMAGE, V51, P910, DOI 10.1016/j.neuroimage.2010.02.046; Warburton EC, 2000, EUR J NEUROSCI, V12, P1714, DOI 10.1046/j.1460-9568.2000.00039.x; Wennberg R, 2006, CLIN NEUROPHYSIOL, V117, P474, DOI 10.1016/j.clinph.2005.09.020; Wennberg RA, 2003, CLIN NEUROPHYSIOL, V114, P1403, DOI 10.1016/S1388-2457(03)00152-4; Wolff M, 2006, J NEUROSCI, V26, P2907, DOI 10.1523/JNEUROSCI.5481-05.2006; WU CFJ, 1986, ANN STAT, V14, P1261, DOI 10.1214/aos/1176350142	43	23	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0140778	10.1371/journal.pone.0140778	http://dx.doi.org/10.1371/journal.pone.0140778			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529407	gold, Green Published			2022-12-26	WOS:000364032600012
J	Kotani, H; Ebi, H; Kitai, H; Nanjo, S; Kita, K; Huynh, TG; Ooi, A; Faber, AC; Mino-Kenudson, M; Yano, S				Kotani, H.; Ebi, H.; Kitai, H.; Nanjo, S.; Kita, K.; Huynh, T. G.; Ooi, A.; Faber, A. C.; Mino-Kenudson, M.; Yano, S.			Co-active receptor tyrosine kinases mitigate the effect of FGFR inhibitors in FGFR1-amplified lung cancers with low FGFR1 protein expression	ONCOGENE			English	Article							IN-SITU HYBRIDIZATION; ACQUIRED-RESISTANCE; GENE AMPLIFICATION; TARGETED THERAPIES; BREAST-CANCER; GROWTH; SENSITIVITY; ACTIVATION; GENOMICS; AZD4547	Targeted therapies are effective in subsets of lung cancers with EGFR mutations and anaplastic lymphoma kinase (ALK) translocations. Large-scale genomics have recently expanded the lung cancer landscape with FGFR1 amplification found in 10-20% of squamous cell carcinomas (SCCs). However, the response rates have been low for biomarker-directed fibroblast growth factor receptor (FGFR) inhibitor therapy in SCC, which contrasts to the relatively high rates of response seen in EGFR mutant and ALK-translocated lung cancers treated with epidermal growth factor receptor (EGFR) inhibitors and ALK inhibitors, respectively. In order to better understand the low response rates of FGFR1-amplified lung cancers to FGFR inhibitors, relationships between gene copy number, mRNA expression and protein expression of FGFR1 were assessed in cell lines, tumor specimens and data from The Cancer Genome Atlas. The importance of these factors for the sensitivity to FGFR inhibitors was determined by analyzing drug screen data and conducting in vitro and in vivo experiments. We report that there was a discrepancy between FGFR1 amplification level and FGFR1 protein expression in a number of these cell lines, and the cancers with unexpectedly low FGFR1 expression were uniformly resistant to the different FGFR inhibitors. Further interrogation of the receptor tyrosine kinase activity in these discordant cell lines revealed co-activation of HER2 and platelet-derived growth factor receptor-a (PDGFRa) caused by gene amplification or ligand overexpression maintained phosphoinositide 3-kinase (PI3K) and MEK/ERK signaling even in the presence of FGFR inhibitor. Accordingly, co-inhibition of FGFR1 and HER2 or PDGFRa led to enhanced drug responses. In contrast, FGFR1-amplified high FGFR1 protein-expressing lung cancers are sensitive to FGFR inhibitor monotherapy by downregulating ERK signaling. Addition of a PI3K inhibitor to these high FGFR1 protein-expressing cancers further sensitized them to FGFR inhibitor. These data reveal that biomarker-directed trials for FGFR1-amplified SCC require assessment of FGFR1 protein expression and uncover novel therapeutic strategies for FGFR1-amplified SCC with low FGFR1 protein expression.	[Kotani, H.; Ebi, H.; Kitai, H.; Nanjo, S.; Kita, K.; Yano, S.] Kanazawa Univ, Canc Res Inst, Div Med Oncol, 13-1 Takaramachi, Kanazawa, Ishikawa 9200934, Japan; [Huynh, T. G.; Mino-Kenudson, M.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Ooi, A.] Kanazawa Univ, Grad Sch Med Sci, Dept Mol & Cellular Pathol, Kanazawa, Ishikawa, Japan; [Faber, A. C.] Virginia Commonwealth Univ, Sch Dent, VCU Philips Inst Oral Hlth Res, Richmond, VA USA; [Faber, A. C.] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA USA	Kanazawa University; Harvard University; Massachusetts General Hospital; Kanazawa University; Virginia Commonwealth University; Virginia Commonwealth University	Ebi, H; Yano, S (corresponding author), Kanazawa Univ, Canc Res Inst, Div Med Oncol, 13-1 Takaramachi, Kanazawa, Ishikawa 9200934, Japan.	hebi@staff.kanazawa-u.ac.jp; syano@staff.kanazawa-u.ac.jp	Ebi, Hiromichi/AAA-7358-2019; Kitai, Hidenori/AAD-4168-2022; KITA, Kenji/D-8437-2015	Ebi, Hiromichi/0000-0003-3155-7576; KITA, Kenji/0000-0002-4622-6633; Kotani, Hiroshi/0000-0002-6001-0636; KITAI, HIDENORI/0000-0001-6372-846X	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [26830105, 22112010A01]	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank Dr Shuta Tomida at Okayama University for his assistance with the statistics. This work was supported by Grants-in-Aid for Scientific Research (H Ebi, 26830105 and S Yano, 21390256), Scientific Research on Innovative Areas 'Integrative Research on Cancer Microenvironment Network' (H Ebi and S Yano, 22112010A01) and Grant-in-Aid for Project for Development of Innovative Research on Cancer Therapeutics (P-Direct) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan.	Brooks AN, 2012, CLIN CANCER RES, V18, P1855, DOI 10.1158/1078-0432.CCR-11-0699; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Dieci MV, 2013, CANCER DISCOV, V3, P264, DOI 10.1158/2159-8290.CD-12-0362; Dienstmann R, 2014, ANN ONCOL, V25, P552, DOI 10.1093/annonc/mdt419; Dutt A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020351; Ebi H, 2011, J CLIN INVEST, V121, P4311, DOI 10.1172/JCI57909; Engelman JA, 2008, CLIN CANCER RES, V14, P2895, DOI 10.1158/1078-0432.CCR-07-2248; Faber AC, 2009, P NATL ACAD SCI USA, V106, P19503, DOI 10.1073/pnas.0905056106; Gandara DR, 2015, CLIN CANCER RES, V21, P2236, DOI 10.1158/1078-0432.CCR-14-3039; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gavine PR, 2012, CANCER RES, V72, P2045, DOI 10.1158/0008-5472.CAN-11-3034; Guagnano V, 2012, CANCER DISCOV, V2, P1118, DOI 10.1158/2159-8290.CD-12-0210; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Harbinski F, 2012, CANCER DISCOV, V2, P948, DOI 10.1158/2159-8290.CD-12-0237; Hata AN, 2015, CANCER DISCOV, V5, P475, DOI 10.1158/2159-8290.CD-15-0011; Heist RS, 2012, J THORAC ONCOL, V7, P1775, DOI 10.1097/JTO.0b013e31826aed28; Helsten T, 2015, CLIN CANC RES; Herbst RS, 2015, CLIN CANCER RES, V21, P1514, DOI 10.1158/1078-0432.CCR-13-3473; Kim HR, 2013, J CLIN ONCOL, V31, P731, DOI 10.1200/JCO.2012.43.8622; Kohler LH, 2012, VIRCHOWS ARCH, V461, P49, DOI 10.1007/s00428-012-1250-y; Kunii K, 2008, CANCER RES, V68, P2340, DOI 10.1158/0008-5472.CAN-07-5229; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Malchers F, 2014, CANCER DISCOV, V4, P246, DOI 10.1158/2159-8290.CD-13-0323; McDermott U, 2009, CANCER RES, V69, P3937, DOI 10.1158/0008-5472.CAN-08-4327; Meador CB, 2014, CLIN CANCER RES, V20, P2264, DOI 10.1158/1078-0432.CCR-13-1591; Montenegro MF, 2015, ONCOGENE, V34, P135, DOI 10.1038/onc.2013.605; Niederst MJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7377; Nogova L, 2014, ASCO M, V32, P8034; O'Hare T, 2009, CANCER CELL, V16, P401, DOI 10.1016/j.ccr.2009.09.028; Ooi A, 2012, J PATHOL, V227, P8, DOI 10.1002/path.3974; Paik PK, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.8035; Phillips GDL, 2008, CANCER RES, V68, P9280, DOI 10.1158/0008-5472.CAN-08-1776; Pros E, 2013, INT J CANCER, V133, P898, DOI 10.1002/ijc.28090; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Robertson KD, 2001, ONCOGENE, V20, P3139, DOI 10.1038/sj.onc.1204341; Schildhaus HU, 2012, MODERN PATHOL, V25, P1473, DOI 10.1038/modpathol.2012.102; Seo AN, 2014, VIRCHOWS ARCH, V465, P547, DOI 10.1007/s00428-014-1634-2; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Terai H, 2013, MOL CANCER RES, V11, P759, DOI 10.1158/1541-7786.MCR-12-0652; Tran TN, 2013, LUNG CANCER, V81, P462, DOI 10.1016/j.lungcan.2013.05.015; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Wang J, 2015, ONCOGENE, V34, P2167, DOI 10.1038/onc.2014.161; Weiss J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001451; Wilson TR, 2011, CANCER CELL, V20, P158, DOI 10.1016/j.ccr.2011.07.011; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Wynes MW, 2014, CLIN CANCER RES, V20, P3299, DOI 10.1158/1078-0432.CCR-13-3060; Zhang JC, 2012, CLIN CANCER RES, V18, P6658, DOI 10.1158/1078-0432.CCR-12-2694	49	29	30	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 7	2016	35	27					3587	3597		10.1038/onc.2015.426	http://dx.doi.org/10.1038/onc.2015.426			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DR0UD	26549034	Green Submitted			2022-12-26	WOS:000379621500011
J	Lavallard, V; Armanet, M; Parnaud, G; Meyer, J; Barbieux, C; Montanari, E; Meier, R; Morel, P; Berney, T; Bosco, D				Lavallard, Vanessa; Armanet, Mathieu; Parnaud, Geraldine; Meyer, Jeremy; Barbieux, Charlotte; Montanari, Elisa; Meier, Raphael; Morel, Philippe; Berney, Thierry; Bosco, Domenico			Cell rearrangement in transplanted human islets	FASEB JOURNAL			English	Article						architecture; vascularization; extracellular matrix	HUMAN PANCREATIC-ISLETS; INDIVIDUAL B-CELLS; HUMAN BETA-CELLS; INSULIN-SECRETION; BASEMENT-MEMBRANE; LANGERHANS; ADHESION; MICE; CA2+; HETEROGENEITY	The major feature of the human pancreatic islet architecture is the organization of endocrine cells into clusters comprising central beta cells and peripheral a cells surrounded by vasculature. To have an insight into the mechanisms that govern this unique islet architecture, islet cells were isolated, and reaggregation of a and b cells into islet-like structures (pseudoislets) after culture or transplantation into mice was studied by immunohistology. The pseudoislets formed in culture displayed an unusual cell arrangement, contrasting with the transplanted pseudoislets, which exhibited a cell arrangement similar to that observed in native pancreatic islet subunits. The pattern of revascularization and the distribution of extracellular matrix around transplanted pseudoislets were alike to those observed in native pancreatic islets. This organization of transplanted pseudoislets occurred also when revascularization was abolished by treating mice with an anti-VEGF antibody, but not when contact with extracellular matrix was prevented by encapsulation of pseudoislets within alginate hydrogel. These results indicate that the maintenance of islet cell arrangement is dependent on in vivo features such as extracellular matrix but independent of vascularization.	[Lavallard, Vanessa; Parnaud, Geraldine; Meyer, Jeremy; Barbieux, Charlotte; Montanari, Elisa; Meier, Raphael; Morel, Philippe; Berney, Thierry; Bosco, Domenico] Univ Hosp Geneva, Dept Surg, Cell Isolat & Transplantat Ctr, Geneva, Switzerland; [Lavallard, Vanessa; Parnaud, Geraldine; Meyer, Jeremy; Barbieux, Charlotte; Montanari, Elisa; Meier, Raphael; Morel, Philippe; Berney, Thierry; Bosco, Domenico] Univ Geneva, Geneva, Switzerland; [Armanet, Mathieu] Hop St Louis, AP HP, Cell Therapy Unit, Paris, France; [Armanet, Mathieu] Univ Paris 07, Paris, France; [Armanet, Mathieu] Ctr Rech Cordeliers, INSERM, Unite Mixte Rech Sci 1138, Paris, France	University of Geneva; University of Geneva; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Lavallard, V (corresponding author), Cell Isolat & Transplantat Ctr, Rue Michel Servet 1, CH-1211 Geneva 4, Switzerland.	vanessa.lavallard@unige.ch	Berney, Thierry/ABE-9450-2021; Meier, Raphaël P H/AAR-7882-2021; Meyer, Jeremy/AAP-3367-2020	Berney, Thierry/0000-0002-4230-9378; Meier, Raphaël P H/0000-0001-9050-0436; Bosco, Domenico/0000-0003-3453-9613; Meyer, Jeremy/0000-0003-3381-9146; Lavallard, Vanessa/0000-0001-7328-7549	Swiss National Science Foundation [310030_143462/1]; Insuleman Foundation; Juvenile Diabetes Research Foundation [31-2012-783]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Insuleman Foundation; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation)	The authors thank Corinne Sinigaglia, David Matthey-Doret, Caroline Rouget, Solange Masson, and Nadine Pernin for their excellent technical work (Geneva University Hospitals and Department of Surgery, University of Geneva, Geneva, Switzerland). This work was supported by a grant from the Swiss National Science Foundation (310030_143462/1) and a grant from the Insuleman Foundation. Human islets for research were provided thanks to the European Consortium for Islet Transplantation funded by Juvenile Diabetes Research Foundation (31-2012-783). D.B. is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. V.L. researched data and wrote the manuscript. J.M. and C.B. reviewed the manuscript. G.P., M.A., E.M., and R.M. researched data. P.M. and T.B. contributed to discussion and reviewed the manuscript. D.B. designed the study, researched data, and reviewed the manuscript. The authors declare no conflicts of interest.	Armanet M, 2009, FASEB J, V23, P4046, DOI 10.1096/fj.08-127142; BAETENS D, 1978, DIABETES, V27, P1, DOI 10.2337/diabetes.27.1.1; BERGSTEN P, 1994, J BIOL CHEM, V269, P8749; Bonner-Weir S, 2008, DIABETES, V57, P2899, DOI 10.2337/db07-1842; BOSCO D, 1989, EXP CELL RES, V184, P72, DOI 10.1016/0014-4827(89)90365-0; BOSCO D, 1995, AM J PHYSIOL-CELL PH, V268, pC611, DOI 10.1152/ajpcell.1995.268.3.C611; Bosco D, 2000, DIABETES, V49, P233, DOI 10.2337/diabetes.49.2.233; Bosco D, 2010, DIABETES, V59, P1202, DOI 10.2337/db09-1177; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; Bucher P, 2005, TRANSPLANTATION, V79, P91, DOI 10.1097/01.TP.0000147344.73915.C8; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Cirulli V, 1998, J CELL BIOL, V140, P1519, DOI 10.1083/jcb.140.6.1519; CIRULLI V, 1993, J CLIN INVEST, V91, P1868, DOI 10.1172/JCI116403; EMONARD H, 1987, J CELL PHYSIOL, V133, P95, DOI 10.1002/jcp.1041330112; ERLANDSEN SL, 1976, J HISTOCHEM CYTOCHEM, V24, P883, DOI 10.1177/24.7.60437; GRUBE D, 1983, ARCH HISTOL JAPON, V46, P327, DOI 10.1679/aohc.46.327; HALBAN PA, 1987, DIABETES, V36, P783, DOI 10.2337/diabetes.36.7.783; Hauge-Evans AC, 1999, DIABETES, V48, P1402, DOI 10.2337/diabetes.48.7.1402; HIRIART M, 1991, ENDOCRINOLOGY, V128, P3193, DOI 10.1210/endo-128-6-3193; Hughes SJ, 2006, TRANSPLANTATION, V81, P423, DOI 10.1097/01.tp.0000197482.91227.df; Kantengwa S, 1997, EXP CELL RES, V237, P394, DOI 10.1006/excr.1997.3803; Koma YI, 2008, GASTROENTEROLOGY, V134, P1544, DOI 10.1053/j.gastro.2008.01.081; Maffi Paola, 2011, Rev Diabet Stud, V8, P44, DOI 10.1900/RDS.2011.8.44; Merani S, 2006, TRANSPLANTATION, V82, P1472, DOI 10.1097/01.tp.0000243166.64244.3d; MONTESANO R, 1983, J CELL BIOL, V97, P935, DOI 10.1083/jcb.97.3.935; Muller YD, 2013, AM J TRANSPLANT, V13, P1093, DOI 10.1111/ajt.12138; Nyman LR, 2008, J CLIN INVEST, V118, P3790, DOI 10.1172/JCI36209; Parnaud G, 2011, ENDOCRINOLOGY, V152, P4601, DOI 10.1210/en.2011-1286; Pedersen MG, 2005, BIOPHYS J, V89, P107, DOI 10.1529/biophysj.104.055681; PIPELEERS D, 1994, DIABETOLOGIA, V37, pS57, DOI 10.1007/BF00400827; PRALONG WF, 1990, EMBO J, V9, P53, DOI 10.1002/j.1460-2075.1990.tb08079.x; Rackham CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057844; RICORDI C, 1988, DIABETES, V37, P413, DOI 10.2337/diabetes.37.4.413; Ris F, 2010, CELL TRANSPLANT, V19, P1573, DOI 10.3727/096368910X515863; SALOMON D, 1986, EXP CELL RES, V162, P507, DOI 10.1016/0014-4827(86)90354-X; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; STARICH GH, 1991, ACTA HISTOCHEM, V90, P93, DOI 10.1016/S0065-1281(11)80167-4; Virtanen I, 2008, DIABETOLOGIA, V51, P1181, DOI 10.1007/s00125-008-0997-9; Wojtusciszyn A, 2008, DIABETOLOGIA, V51, P1843, DOI 10.1007/s00125-008-1103-z	39	20	20	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					748	760		10.1096/fj.15-273805	http://dx.doi.org/10.1096/fj.15-273805			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26534832				2022-12-26	WOS:000369391900025
J	Baerts, L; Waumans, Y; Brandt, I; Jungraithmayr, W; Van der Veken, P; Vanderheyden, M; De Meester, I				Baerts, Lesley; Waumans, Yannick; Brandt, Inger; Jungraithmayr, Wolfgang; Van der Veken, Pieter; Vanderheyden, Marc; De Meester, Ingrid			Circulating Stromal Cell-Derived Factor 1 alpha Levels in Heart Failure: A Matter of Proper Sampling	PLoS One			English	Article							ENDOTHELIAL PROGENITOR CELLS; ACUTE MYOCARDIAL-INFARCTION; FACTOR-I; ADENOSINE-DEAMINASE; CXCR4; INHIBITION; CD26; FACTOR-1-ALPHA; RECRUITMENT; DYSFUNCTION	Background The chemokine Stromal cell-derived factor 1 alpha (SDF1 alpha, CXCL12) is currently under investigation as a biomarker for various cardiac diseases. The correct interpretation of SDF1 alpha levels is complicated by the occurrence of truncated forms that possess an altered biological activity. Methodology We studied the immunoreactivities of SDF1 alpha forms and evaluated the effect of adding a DPP4 inhibitor in sampling tubes on measured SDF1 alpha levels. Using optimized sampling, we measured DPP4 activity and SDF1 alpha levels in patients with varying degrees of heart failure. Results The immunoreactivities of SDF1 alpha and its degradation products were determined with three immunoassays. A one hour incubation of SDF1 alpha with DPP4 at 37 degrees C resulted in 2/3 loss of immunoreactivity in each of the assays. Incubation with serum gave a similar result. Using appropriate sampling, SDF1 alpha levels were found to be significantly higher in those heart failure patients with a severe loss of left ventricular function. DPP4 activity in serum was not altered in the heart failure population. However, the DPP4 activity was found to be significantly decreased in patients with high SDF1 alpha levels Conclusions We propose that all samples for SDF1 alpha analysis should be collected in the presence of at least a DPP4 inhibitor. In doing so, we found higher SDF1 alpha levels in subgroups of patients with heart failure. Our work supports the need for further research on the clinical relevance of SDF1 alpha levels in cardiac disease.	[Baerts, Lesley; Waumans, Yannick; De Meester, Ingrid] Univ Antwerp, Med Biochem Lab, B-2020 Antwerp, Belgium; [Brandt, Inger] OLV Hosp Aalst, Clin Chem Lab, Aalst, Belgium; [Jungraithmayr, Wolfgang] Univ Zurich Hosp, Div Thorac Surg, CH-8091 Zurich, Switzerland; [Van der Veken, Pieter] Univ Antwerp, Med Chem Lab, B-2020 Antwerp, Belgium; [Vanderheyden, Marc] OLV Hosp Aalst, Cardiovasc Ctr, Aalst, Belgium	University of Antwerp; University of Zurich; University Zurich Hospital; University of Antwerp; Cardiovascular Center Aalst	De Meester, I (corresponding author), Univ Antwerp, Med Biochem Lab, B-2020 Antwerp, Belgium.	ingrid.demeester@uantwerpen.be	De Meester, Ingrid/A-6881-2017; Jungraithmayr, Wolfgang/F-3882-2015; Van der Veken, Pieter/P-5819-2016	De Meester, Ingrid/0000-0002-3421-0124; Jungraithmayr, Wolfgang/0000-0002-1442-4862; Van der Veken, Pieter/0000-0003-1208-3571	University of Antwerp Special research Fund (BOF) [FFB3551]; Flanders Research Foundation (FWO) [G0141.12]	University of Antwerp Special research Fund (BOF); Flanders Research Foundation (FWO)(FWO)	This work was supported by the University of Antwerp Special research Fund (BOF; Grant FFB3551, https://www.uantwerpen.be/nl/) and the Flanders Research Foundation (FWO; Grant G0141.12, http://www.fwo.be/en/).	Abbott JD, 2004, CIRCULATION, V110, P3300, DOI 10.1161/01.CIR.0000147780.30124.CF; Aiuti BA, 1997, J EXP MED, V185, P111; Baggiolini M, 2001, J INTERN MED, V250, P91, DOI 10.1046/j.1365-2796.2001.00867.x; Christopherson KW, 2004, SCIENCE, V305, P1000, DOI 10.1126/science.1097071; Chung ES, 2015, EUR HEART J, V36, P2228, DOI 10.1093/eurheartj/ehv254; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; Delgado MB, 2001, EUR J IMMUNOL, V31, P699, DOI 10.1002/1521-4141(200103)31:3<699::AID-IMMU699>3.0.CO;2-6; DeMeester I, 1996, J IMMUNOL METHODS, V189, P99, DOI 10.1016/0022-1759(95)00239-1; dos Santos L, 2013, CIRC-HEART FAIL, V6, P1029, DOI 10.1161/CIRCHEARTFAILURE.112.000057; Eltzschig HK, 2006, BLOOD, V108, P1602, DOI 10.1182/blood-2006-02-001016; Fadini GP, 2010, DIABETES CARE, V33, P1607, DOI 10.2337/dc10-0187; Ghasemzadeh N, 2014, ATHEROSCLEROSIS; Heymes C, 1999, CIRCULATION, V99, P3009, DOI 10.1161/01.CIR.99.23.3009; Huang CY, 2012, BRIT J PHARMACOL, V167, P1506, DOI 10.1111/j.1476-5381.2012.02102.x; Jungraithmayr W, 2012, EUR J CARDIO-THORAC, V41, P1166, DOI 10.1093/ejcts/ezr180; Kanki S, 2011, CIRC-HEART FAIL, V4, P509, DOI 10.1161/CIRCHEARTFAILURE.110.960302; Lambeir AM, 2001, J BIOL CHEM, V276, P29839, DOI 10.1074/jbc.M103106200; LaRocca TJ, 2012, J MOL CELL CARDIOL, V53, P223, DOI 10.1016/j.yjmcc.2012.05.016; Lee BC, 2009, EUR J HEART FAIL, V11, P238, DOI 10.1093/eurjhf/hfn035; Matheeussen V, 2011, BIOL CHEM, V392, P189, DOI 10.1515/BC.2011.002; McQuibban GA, 2001, J BIOL CHEM, V276, P43503, DOI 10.1074/jbc.M107736200; Mortier A, 2008, PHARMACOL THERAPEUT, V120, P197, DOI 10.1016/j.pharmthera.2008.08.006; Pala L, 2012, ACTA DIABETOL, V49, pS59, DOI 10.1007/s00592-010-0195-3; Penn MS, 2013, CIRC RES, V112, P816, DOI 10.1161/CIRCRESAHA.111.300440; Pyo RT, 2006, J MOL CELL CARDIOL, V41, P834, DOI 10.1016/j.yjmcc.2006.08.008; Segers VFM, 2010, J CARDIOVASC TRANSL, V3, P469, DOI 10.1007/s12265-010-9207-5; Shigeta T, 2012, CIRCULATION, V126, P1838, DOI 10.1161/CIRCULATIONAHA.112.096479; Shioda T, 1998, P NATL ACAD SCI USA, V95, P6331, DOI 10.1073/pnas.95.11.6331; Subramanian S, 2014, ARTERIOSCL THROM VAS, V34, P2100, DOI 10.1161/ATVBAHA.114.303579; Theiss HD, 2013, INT J CARDIOL, V168, P3359, DOI 10.1016/j.ijcard.2013.04.121; Valenzuela-Fernandez A, 2002, J BIOL CHEM, V277, P15677, DOI 10.1074/jbc.M111388200; Yancy CW, 2013, CIRCULATION, V128, pE240, DOI 10.1161/CIR.0b013e31829e8776; Yang T, 2014, HEART LUNG, V43, P322, DOI 10.1016/j.hrtlng.2014.04.016; Zaruba MM, 2009, CELL STEM CELL, V4, P313, DOI 10.1016/j.stem.2009.02.013	34	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141408	10.1371/journal.pone.0141408	http://dx.doi.org/10.1371/journal.pone.0141408			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544044	Green Published, gold, Green Submitted			2022-12-26	WOS:000364398700021
J	El-Serafi, I; Afsharian, P; Moshfegh, A; Hassan, M; Terelius, Y				El-Serafi, Ibrahim; Afsharian, Parvaneh; Moshfegh, Ali; Hassan, Moustapha; Terelius, Ylva			Cytochrome P450 Oxidoreductase Influences CYP2B6 Activity in Cyclophosphamide Bioactivation	PLOS ONE			English	Article							P450 OXIDOREDUCTASE; INTERINDIVIDUAL VARIABILITY; ALLELE FREQUENCIES; GENE POLYMORPHISMS; IN-VITRO; METABOLISM; VARIANTS; 4-HYDROXYCYCLOPHOSPHAMIDE; PHARMACOKINETICS; EXPRESSION	Introduction Cyclophosphamide is commonly used as an important component in conditioning prior to hematopoietic stem cell transplantation, a curative treatment for several hematological diseases. Cyclophosphamide is a prodrug activated mainly by cytochrome P450 2B6 (CYP2B6) in the liver. A high degree of inter-and intra-individual variation in cyclophosphamide kinetics has been reported in several studies. Materials and Methods Hydroxylation of cyclophosphamide was investigated in vitro using three microsomal batches of CYP2B6*1 with different ratios of POR/CYP expression levels. Twenty patients undergoing hematopoietic stem cell transplantation were also included in the study. All patients received an i.v. infusion of cyclophosphamide (60 mg/kg/day, for two days) as a part of their conditioning. Blood samples were collected from each patient before cyclophosphamide infusion, 6 h after the first dose and before and 6 h after the second dose. POR gene expression was measured by mRNA analysis and the pharmacokinetics of cyclophosphamide and its active metabolite were determined. Results A strong correlation between the in vitro intrinsic clearance of cyclophosphamide and the POR/CYP ratio was found. The apparent K-m for CYP2B6.1 was almost constant (3-4 mM), while the CLint values were proportional to the POR/CYP ratio (3-34 mu L/min/nmol CYP). In patients, the average expression of the POR gene in blood was significantly (P < 0.001) up-regulated after cyclophosphamide infusion, with high inter-individual variations and significant correlation with the concentration ratio of the active metabolite 4-hydroxy-cyclophosphamide/cyclophosphamide. Nine patients were carriers for POR*28; four patients had relatively high POR expression. Conclusions This investigation shows for the first time that POR besides CYP2B6 can influence cyclophosphamide metabolism. Our results indicate that not only CYPs are important, but also POR expression and/or activity may influence cyclophosphamide bioactivation, affecting therapeutic efficacy and treatment related toxicity and hence on clinical outcome. Thus, both POR and CYP genotype and expression levels may have to be taken into account when personalizing treatment schedules to achieve optimal therapeutic drug plasma concentrations of cyclophosphamide.	[El-Serafi, Ibrahim; Afsharian, Parvaneh; Hassan, Moustapha] Karolinska Inst, Dept Lab Med, ECM, Stockholm, Sweden; [Moshfegh, Ali] Karolinska Inst, Dept Oncol Pathol, CCK, Stockholm, Sweden; [Hassan, Moustapha] Karolinska Univ Hosp Huddinge, Dept Clin Res Ctr, Stockholm, Sweden; [Terelius, Ylva] Medivir AB, Dept Discovery Res, Huddinge, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Medivir	Hassan, M (corresponding author), Karolinska Inst, Dept Lab Med, ECM, Stockholm, Sweden.	Moustapha.Hassan@ki.se	Hassan, Moustapha/H-9260-2015	Hassan, Moustapha/0000-0003-1927-5859; El-Serafi, Ibrahim/0000-0002-0463-1518	Swedish Childhood Cancer Society; Swedish Cancer Foundation; Karolinska Institute	Swedish Childhood Cancer Society; Swedish Cancer Foundation; Karolinska Institute(Karolinska Institutet)	The study was supported by grants from the Swedish Childhood Cancer Society, Swedish Cancer Foundation and The Karolinska Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Medivir provided support in the form of salary for author YT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Afsar NA, 2012, EUR J CLIN PHARMACOL, V68, P389, DOI 10.1007/s00228-011-1134-0; Afsharian P, 2005, EUR J HAEMATOL, V75, P206, DOI 10.1111/j.1600-0609.2005.00492.x; Agrawal V, 2008, PHARMACOGENET GENOM, V18, P569, DOI 10.1097/FPC.0b013e32830054ac; Ariyoshi N, 2001, BIOCHEM BIOPH RES CO, V281, P1256, DOI 10.1006/bbrc.2001.4524; Ariyoshi N, 2011, DRUG METAB DISPOS, V39, P2045, DOI 10.1124/dmd.111.039586; Binotto G, 2003, ONCOLOGY-BASEL, V65, P17, DOI 10.1159/000073353; Burt RK, 2008, JAMA-J AM MED ASSOC, V299, P925, DOI 10.1001/jama.299.8.925; CHANG TKH, 1993, CANCER RES, V53, P5629; Chen X, 2012, PLOS ONE, V7; Cho JY, 2004, DRUG METAB DISPOS, V32, P1341, DOI 10.1124/dmd.104.001107; de Jonge H, 2011, PHARMACOGENOMICS, V12, P1281, DOI [10.2217/PGS.11.77, 10.2217/pgs.11.77]; Fernandes BJD, 2011, CANCER CHEMOTH PHARM, V68, P897, DOI 10.1007/s00280-011-1554-7; El-Serafi I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086619; Fluck CE, 2004, NAT GENET, V36, P228, DOI 10.1038/ng1300; Gomes AM, 2009, PHARMACOGENOMICS, V10, P579, DOI [10.2217/pgs.09.7, 10.2217/PGS.09.7]; GORDON MY, 1985, LEUKEMIA RES, V9, P1017, DOI 10.1016/0145-2126(85)90072-4; Griskevicius L, 2002, THER DRUG MONIT, V24, P405, DOI 10.1097/00007691-200206000-00013; Hart SN, 2008, EXPERT OPIN DRUG MET, V4, P439, DOI [10.1517/17425255.4.4.439, 10.1517/17425255.4.4.439 ]; Hesse LM, 2004, PHARMACOGENETICS, V14, P225, DOI 10.1097/00008571-200404000-00002; Huang NW, 2005, AM J HUM GENET, V76, P729, DOI 10.1086/429417; Klein K, 2005, PHARMACOGENET GENOM, V15, P861, DOI 10.1097/01213011-200512000-00004; Lang T, 2004, J PHARMACOL EXP THER, V311, P34, DOI 10.1124/jpet.104.068973; Lang T, 2001, PHARMACOGENETICS, V11, P399, DOI 10.1097/00008571-200107000-00004; Merla G, 2006, AM J HUM GENET, V79, P332, DOI 10.1086/506371; Pandey AV, 2010, BIOCHEM BIOPH RES CO, V400, P374, DOI 10.1016/j.bbrc.2010.08.072; Raccor BS, 2012, DRUG METAB DISPOS, V40, P54, DOI 10.1124/dmd.111.039347; Ren S, 1997, CANCER RES, V57, P4229; REYNOLDS M, 1989, EUR J HAEMATOL, V43, P314; RODRIGUEZ G, 1994, INVEST NEW DRUG, V12, P75, DOI 10.1007/BF00874436; Rotger Margalida, 2005, Pharmacogenet Genomics, V15, P1, DOI 10.1097/01213011-200501000-00001; Sandee D, 2010, PHARMACOGENET GENOM, V20, P677, DOI 10.1097/FPC.0b013e32833f4f9b; SINGER CRJ, 1987, LEUKEMIA RES, V11, P953, DOI 10.1016/0145-2126(87)90112-3; SLADEK NE, 1988, PHARMACOL THERAPEUT, V37, P301, DOI 10.1016/0163-7258(88)90004-6; Subramanian M, 2012, PHARMACOGENET GENOM, V22, P590, DOI 10.1097/FPC.0b013e3283544062; Tsuchiya K, 2004, BIOCHEM BIOPH RES CO, V319, P1322, DOI 10.1016/j.bbrc.2004.05.116; Wang SL, 2007, DRUG METAB DISPOS, V35, P176, DOI 10.1124/dmd.106.011056; Wortham M, 2007, DRUG METAB DISPOS, V35, P1700, DOI 10.1124/dmd.107.016436; Xie HJ, 2006, EUR J PHARM SCI, V27, P54, DOI 10.1016/j.ejps.2005.08.008; Xie HJ, 2003, PHARMACOGENOMICS J, V3, P53, DOI 10.1038/sj.tpj.6500157; Xie HJ, 2003, BONE MARROW TRANSPL, V31, P197, DOI 10.1038/sj.bmt.1703815; Yao S, 2010, CLIN CANCER RES, V16, P6169, DOI 10.1158/1078-0432.CCR-10-0281; Zhang HM, 2011, J PHARMACOL EXP THER, V338, P803, DOI 10.1124/jpet.111.183111; Zhang JJ, 2012, EUR J CLIN PHARM	43	22	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141979	10.1371/journal.pone.0141979	http://dx.doi.org/10.1371/journal.pone.0141979			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544874	Green Submitted, gold, Green Published			2022-12-26	WOS:000364398700065
J	Giri, A; Wu, JM; Ward, RM; Hartmann, KE; Park, AJ; North, KE; Graff, M; Wallace, RB; Bareh, G; Qi, LH; O'Sullivan, MJ; Reiner, AP; Edwards, TL; Edwards, DRV				Giri, Ayush; Wu, Jennifer M.; Ward, Renee M.; Hartmann, Katherine E.; Park, Amy J.; North, Kari E.; Graff, Mariaelisa; Wallace, Robert B.; Bareh, Gihan; Qi, Lihong; O'Sullivan, Mary J.; Reiner, Alexander P.; Edwards, Todd L.; Edwards, Digna R. Velez			Genetic Determinants of Pelvic Organ Prolapse among African American and Hispanic Women in the Women's Health Initiative	PLOS ONE			English	Article							TIBIAL NERVE-STIMULATION; GENOME-WIDE ASSOCIATION; NATURAL-HISTORY; LAMININ GAMMA-1; FAMILY-HISTORY; RISK; DISORDERS; INCONTINENCE; METAANALYSIS; EXPRESSION	Current evidence suggests a multifactorial etiology to pelvic organ prolapse (POP), including genetic predisposition. We conducted a genome-wide association study of POP in African American (AA) and Hispanic (HP) women from the Women's Health Initiative Hormone Therapy study. Cases were defined as any POP (grades 1-3) or moderate/severe POP (grades 2-3), while controls had grade 0 POP. We performed race-specific multiple logistic regression analyses between SNPs imputed to 1000 genomes in relation to POP (grade 0 vs 1-3; grade 0 vs 2-3) adjusting for age at diagnosis, body mass index, parity, and genetic ancestry. There were 1274 controls and 1427 cases of any POP and 317 cases of moderate/severe POP. Although none of the analyses reached genome-wide significance (p < 5 x 10(-8)), we noted variants in several loci that met p < 10(-6). In race-specific analysis of grade 0 vs 2-3, intronic SNPs in the CPE gene (rs28573326, OR: 2.14; 95% CI 1.62-2.83; p = 1.0 x 10(-7)) were associated with POP in AAs, and SNPs in the gene AL132709.5 (rs1950626, OR: 2.96; 95% CI 1.96-4.48, p = 2.6 x 10(-7)) were associated with POP in HPs. Inverse variance fixed-effect meta-analysis of the race-specific results showed suggestive signals for SNPs in the DPP6 gene (rs11243354, OR: 1.36; p = 4.2 x 10(-7)) in the grade 0 vs 1-3 analyses and for SNPs around PGBD5 (rs740494, OR: 2.17; p = 8.6 x 10(-7)) and SHC3 (rs2209875, OR: 0.60; p = 9.3 x 10(-7)) in the grade 0 vs 2-3 analyses. While we did not identify genome-wide significant findings, we document several SNPs reaching suggestive statistical significance. Further interrogation of POP in larger minority samples is warranted.	[Giri, Ayush; Hartmann, Katherine E.; Reiner, Alexander P.; Edwards, Todd L.; Edwards, Digna R. Velez] Vanderbilt Univ, Vanderbilt Epidemiol Ctr, Inst Med & Publ Hlth, Nashville, TN 37235 USA; [Wu, Jennifer M.] Univ N Carolina, Ctr Womens Hlth Res, Dept Obstet & Gynecol, Chapel Hill, NC USA; [Ward, Renee M.; Hartmann, Katherine E.; Edwards, Digna R. Velez] Vanderbilt Univ, Med Ctr, Dept Obstet & Gynecol, Nashville, TN 37232 USA; [Hartmann, Katherine E.; Edwards, Todd L.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Park, Amy J.] Georgetown Univ, Med Ctr, Dept Obstet & Gynecol & Urol, Washington, DC 20007 USA; [North, Kari E.; Graff, Mariaelisa] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Wallace, Robert B.] Univ Iowa, Dept Epidemiol, Iowa City, IA USA; [Bareh, Gihan] Loma Linda Univ, Dept Obstet & Gynecol, Loma Linda, CA 92350 USA; [Qi, Lihong] Univ Calif Davis, Dept Publ Hlth Sci, Davis, CA 95616 USA; [O'Sullivan, Mary J.] Univ Miami, Dept Obstet & Gynecol, Miami, FL USA; [Reiner, Alexander P.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Edwards, Todd L.; Edwards, Digna R. Velez] Vanderbilt Univ, Vanderbilt Genet Inst, Nashville, TN 37235 USA	Vanderbilt University; University of North Carolina; University of North Carolina Chapel Hill; Vanderbilt University; Vanderbilt University; Georgetown University; University of North Carolina; University of North Carolina Chapel Hill; University of Iowa; Loma Linda University; University of California System; University of California Davis; University of Miami; University of Washington; University of Washington Seattle; Vanderbilt University	Edwards, TL (corresponding author), Vanderbilt Univ, Vanderbilt Epidemiol Ctr, Inst Med & Publ Hlth, 221 Kirkland Hall, Nashville, TN 37235 USA.	todd.l.edwards@vanderbilt.edu; digna.r.velez.edwards@vanderbilt.edu	Wu, Jennifer/GRX-1831-2022; Qi, LI/AAF-3389-2019; Hartmann, Katherine Eubanks/AAV-5288-2020	Wu, Jennifer/0000-0002-4477-3932; Wu, Jennifer/0000-0002-3171-1054; Hartmann, Katherine/0000-0002-7051-8185	National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services [N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, 44221]; NHLBI [N02-HL-64278]; Vanderbilt Clinical and Translational Research Scholar award [5KL2RR024975]; Building Interdisciplinary Research Careers in Women's Health career development program [5K12HD04383-11]; Eunice Kennedy Shriver National Institute of Child Health & Human Development [K23HD068404]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K23HD068404] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064278] Funding Source: NIH RePORTER; WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH [N01WH042129, N01WH042107, N01WH032122, N01WH032100, N01WH032118, N01WH032111, N01WH032108, N01WH022110, N01WH032105, N01WH032115] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Vanderbilt Clinical and Translational Research Scholar award; Building Interdisciplinary Research Careers in Women's Health career development program; Eunice Kennedy Shriver National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The Women's Health Initiative program is funded by the National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services through contracts N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, and 44221. Funding for Women's Health Initiative SHARe genotyping was provided by NHLBI Contract N02-HL-64278. This work was funded by Vanderbilt Clinical and Translational Research Scholar award (5KL2RR024975) to Todd Edwards and by the Building Interdisciplinary Research Careers in Women's Health career development program (5K12HD04383-11) to Digna R. Velez Edwards. Dr. Jennifer Wu is supported by K23HD068404, Eunice Kennedy Shriver National Institute of Child Health & Human Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen-Brady K, 2014, AM J OBSTET GYNECOLO; Allen-Brady K, 2011, OBSTET GYNECOL, V118, P1345, DOI 10.1097/AOG.0b013e318236f4b5; Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; Biemans JMAE, 2013, NEUROMODULATION, V16, P25, DOI 10.1111/j.1525-1403.2012.00504.x; Bortolini MAT, 2012, NEUROUROL URODYNAM, V31, P109, DOI 10.1002/nau.21175; Bradley CS, 2007, OBSTET GYNECOL, V109, P848, DOI 10.1097/01.AOG.0000255977.91296.5d; Buchsbaum GM, 2006, OBSTET GYNECOL, V108, P1388, DOI 10.1097/01.AOG.0000245784.31082.ed; Chen C, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.014; Chen H, 2001, HUM MUTAT, V18, P120, DOI 10.1002/humu.1161; Chen HY, 2010, EUR J OBSTET GYN R B, V149, P222, DOI 10.1016/j.ejogrb.2009.12.014; Chiaffarino F, 1999, EUR J OBSTET GYN R B, V82, P63, DOI 10.1016/S0301-2115(98)00175-4; Chu KF, 2013, POSTGRAD MED, V125, P53, DOI 10.3810/pgm.2013.07.2679; Cronin S, 2009, EUR J HUM GENET, V17, P213, DOI 10.1038/ejhg.2008.194; Cronin S, 2008, HUM MOL GENET, V17, P768, DOI 10.1093/hmg/ddm361; Curb JD, 2003, ANN EPIDEMIOL, V13, pS122, DOI 10.1016/S1047-2797(03)00048-6; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Edenfield AL, 2015, OBSTET GYNECOL SURV, V70, P329, DOI 10.1097/OGX.0000000000000171; Glazener C, 2013, BJOG-INT J OBSTET GY, V120, P161, DOI 10.1111/1471-0528.12075; Han B, 2011, AM J HUM GENET, V88, P586, DOI 10.1016/j.ajhg.2011.04.014; Hays J, 2003, ANN EPIDEMIOL, V13, pS18, DOI 10.1016/S1047-2797(03)00042-5; Hendrix SL, 2002, AM J OBSTET GYNECOL, V186, P1160, DOI 10.1067/mob.2002.123819; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303; Kluivers KB, 2009, INT UROGYNECOL J, V20, P1113, DOI 10.1007/s00192-009-0913-y; Koch WF, 2014, INNERVATION MATURE H, P337; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Kudish BI, 2009, OBSTET GYNECOL, V113, P81, DOI 10.1097/AOG.0b013e318190a0dd; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Low SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011824; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; McLennan MT, 2008, INT UROGYNECOL J, V19, P1063, DOI 10.1007/s00192-008-0591-1; Morris AP, 2011, GENET EPIDEMIOL, V35, P809, DOI 10.1002/gepi.20630; NAGGERT JK, 1995, NAT GENET, V10, P135, DOI 10.1038/ng0695-135; Nikolova G, 2007, HUM GENET, V120, P847, DOI 10.1007/s00439-006-0267-1; Norton PA, 2013, INT UROGYNECOL J, V24, P413, DOI 10.1007/s00192-012-1866-0; Nygaard I, 2008, JAMA-J AM MED ASSOC, V300, P1311, DOI 10.1001/jama.300.11.1311; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rortveit G, 2007, OBSTET GYNECOLOGY, V109; Tanaka S, 2013, PHARMACOGENOMICS J, V13, P27, DOI 10.1038/tpj.2011.36; van Balken MR, 2001, J UROLOGY, V166, P914, DOI 10.1016/S0022-5347(05)65863-6; van Es MA, 2008, NAT GENET, V40, P29, DOI 10.1038/ng.2007.52; Wang X, 2013, HUM MOL GENET; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Ward RM, 2014, AM J OBSTET GYNECOL, V211, P326, DOI 10.1016/j.ajog.2014.04.006; Whitcomb EL, 2009, OBSTET GYNECOL, V114, P1271, DOI 10.1097/AOG.0b013e3181bf9cc8; Wu JM, 2014, OBSTET GYNECOL, V123, P1201, DOI 10.1097/AOG.0000000000000286; Wu JM, 2013, AM J OBSTET GYNECOL, V208, P360, DOI 10.1016/j.ajog.2012.11.030; Wu JM, 2012, OBSTET GYNECOL, V120, P587, DOI 10.1097/AOG.0b013e318262234b; Wu JM, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.01.033	50	12	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141647	10.1371/journal.pone.0141647	http://dx.doi.org/10.1371/journal.pone.0141647			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545240	Green Published, gold, Green Submitted			2022-12-26	WOS:000364398700036
J	Larmuseau, MHD; Vessi, A; Jobling, MA; Van Geystelen, A; Primativo, G; Biondi, G; Martinez-Labarga, C; Ottoni, C; Decorte, R; Rickards, O				Larmuseau, Maarten H. D.; Vessi, Andrea; Jobling, Mark A.; Van Geystelen, Anneleen; Primativo, Giuseppina; Biondi, Gianfranco; Martinez-Labarga, Cristina; Ottoni, Claudio; Decorte, Ronny; Rickards, Olga			The Paternal Landscape along the Bight of Benin - Testing Regional Representativeness of West-African Population Samples Using Y-Chromosomal Markers	PLOS ONE			English	Article							PHYLOGENETIC TREE; MITOCHONDRIAL-DNA; GENETIC-VARIATION; HAPLOGROUP TREE; DIVERSITY; POLYMORPHISMS; EXPANSION; SCALE; LINEAGES; PHYLOGEOGRAPHY	Patterns of genetic variation in human populations across the African continent are still not well studied in comparison with Eurasia and America, despite the high genetic and cultural diversity among African populations. In population and forensic genetic studies a single sample is often used to represent a complete African region. In such a scenario, inappropriate sampling strategies and/or the use of local, isolated populations may bias interpretations and pose questions of representativeness at a macrogeographic-scale. The non-recombining region of the Y-chromosome (NRY) has great potential to reveal the regional representation of a sample due to its powerful phylogeographic information content. An area poorly characterized for Y-chromosomal data is the West-African region along the Bight of Benin, despite its important history in the trans-Atlantic slave trade and its large number of ethnic groups, languages and lifestyles. In this study, Y-chromosomal haplotypes from four Beninese populations were determined and a global meta-analysis with available Y-SNP and YSTR data from populations along the Bight of Benin and surrounding areas was performed. A thorough methodology was developed allowing comparison of population samples using Y-chromosomal lineage data based on different Y-SNP panels and phylogenies. Geographic proximity turned out to be the best predictor of genetic affinity between populations along the Bight of Benin. Nevertheless, based on Y-chromosomal data from the literature two population samples differed strongly from others from the same or neighbouring areas and are not regionally representative within large-scale studies. Furthermore, the analysis of the HapMap sample YRI of a Yoruban population from South-western Nigeria based on Y-SNPs and Y-STR data showed for the first time its regional representativeness, a result which is important for standard population and forensic genetic applications using the YRI sample. Therefore, the uniquely and powerful geographical information carried by the Y-chromosome makes it an important locus to test the representativeness of a certain sample even in the genomic era, especially in poorly investigated areas like Africa.	[Larmuseau, Maarten H. D.; Vessi, Andrea; Ottoni, Claudio; Decorte, Ronny] Katholieke Univ Leuven, Forens Biomed Sci, Dept Imaging & Pathol, Leuven, Belgium; [Larmuseau, Maarten H. D.; Van Geystelen, Anneleen] Katholieke Univ Leuven, Lab Socioecol & Social Evolut, Dept Biol, Leuven, Belgium; [Larmuseau, Maarten H. D.; Jobling, Mark A.] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Vessi, Andrea; Primativo, Giuseppina; Martinez-Labarga, Cristina; Ottoni, Claudio; Rickards, Olga] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy; [Biondi, Gianfranco] Univ Laquila, Dept Clin Med Publ Hlth Life & Environm, Laquila, Italy; [Ottoni, Claudio] Katholieke Univ Leuven, Ctr Archaeol Sci, Dept Earth & Environm Sci, Leuven, Belgium; [Decorte, Ronny] UZ Leuven, Lab Forens Genet & Mol Archaeol, Leuven, Belgium	KU Leuven; KU Leuven; University of Leicester; University of Rome Tor Vergata; University of L'Aquila; KU Leuven; KU Leuven; University Hospital Leuven	Larmuseau, MHD (corresponding author), Katholieke Univ Leuven, Forens Biomed Sci, Dept Imaging & Pathol, Leuven, Belgium.	maarten.larmuseau@bio.kuleuven.be	Decorte, Ronny/AAG-1365-2021; Ottoni, Claudio/AFM-1230-2022; MARTINEZ-LABARGA, CRISTINA M/K-6011-2014; Larmuseau, Maarten/GSJ-0393-2022; Ottoni, Claudio/AFM-1348-2022; RICKARDS, OLGA/L-7878-2015	MARTINEZ-LABARGA, CRISTINA M/0000-0003-0439-0379; Ottoni, Claudio/0000-0001-8870-1589; RICKARDS, OLGA/0000-0003-2880-7466; Decorte, Ronny/0000-0002-0001-386X; Jobling, Mark/0000-0002-8061-1308; Larmuseau, Maarten H.D./0000-0002-5974-7235	Wellcome Trust [087576]; KU Leuven BOF Centre of Excellence [PF/2010/07]	Wellcome Trust(Wellcome TrustEuropean Commission); KU Leuven BOF Centre of Excellence	MHDL is a postdoctoral fellow of the FWO Vlaanderen (Research Foundation Flanders). MAJ was supported by a Wellcome Trust Senior Fellowship (grant no. 087576). This study was funded in the context of the KU Leuven BOF Centre of Excellence Financing on 'Eco and socio evolutionary dynamics' (Project number PF/2010/07) and on 'Centre for Archaeological Sciences 2 - New methods for research in demography and interregional exchange'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; [Anonymous], 2011, R FDN STAT COMP R R; Argyle WJ, 1966, THE FON OF DAHOMEY A; Ballantyne KN, 2010, AM J HUM GENET, V87, P341, DOI 10.1016/j.ajhg.2010.08.006; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Batini C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8152; Batini C, 2011, MOL BIOL EVOL, V28, P2603, DOI 10.1093/molbev/msr089; Biondi G, 1996, AM J PHYS ANTHROPOL, V99, P519; Blench R. M., 2006, ARCHAEOLOGY LANGUAGE; Brucato N, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-314; Caratti S, 2009, INT J LEGAL MED, V123, P357, DOI 10.1007/s00414-009-0350-y; Chiaroni J, 2009, P NATL ACAD SCI USA, V106, P20174, DOI 10.1073/pnas.0910803106; Corbo RM, 1999, AM J HUM BIOL, V11, P297, DOI 10.1002/(SICI)1520-6300(1999)11:3<297::AID-AJHB2>3.0.CO;2-B; Cruciani F, 2011, AM J HUM GENET, V88, P814, DOI 10.1016/j.ajhg.2011.05.002; Cruciani F, 2010, EUR J HUM GENET, V18, P800, DOI 10.1038/ejhg.2009.231; de Filippo C, 2011, MOL BIOL EVOL, V28, P1255, DOI 10.1093/molbev/msq312; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Eltis D., 2010, ATLAS TRANSATLANTIC; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Hallast P, 2015, MOL BIOL EVOL, V32, P661, DOI 10.1093/molbev/msu327; Hammer MF, 2002, ANNU REV ANTHROPOL, V31, P303, DOI 10.1146/annurev.anthro.31.040402.085413; He M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004684; Heine B, 2000, AFRICAN LANGUAGES; Helgason A, 2003, AM J HUM GENET, V72, P1370, DOI 10.1086/375453; Jobling M, 2014, HUMAN EVOLUTIONARY GENETICS, SECOND EDITION, P1; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Kayser M, 2014, FORENSIC DNA APPL IN; Klein Herbert S, 1999, ATLANTIC SLAVE TRADE; Larmuseau MHD, 2015, HEREDITY, V115, P3, DOI 10.1038/hdy.2015.5; Larmuseau MHD, 2014, FORENSIC SCI INT-GEN, V9, P179, DOI 10.1016/j.fsigen.2013.04.002; Larmuseau MHD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2400; Larmuseau MHD, 2012, HEREDITY, V109, P90, DOI 10.1038/hdy.2012.17; Larmuseau MHD, 2015, FORENSIC SCI INT-GEN, V15, P39, DOI 10.1016/j.fsigen.2014.11.012; Larmuseau MHD, 2014, EUR J HUM GENET, V22, P681, DOI 10.1038/ejhg.2013.211; Larmuseau MHD, 2012, EUR J HUM GENET, V20, P434, DOI 10.1038/ejhg.2011.218; Larmuseau MHD, 2011, FORENSIC SCI INT-GEN, V5, P95, DOI 10.1016/j.fsigen.2010.08.020; Law Robin, 2005, OUIDAH SOCIAL HIST W; MANTEL N, 1967, CANCER RES, V27, P209; Marks SJ, 2012, MOL ECOL, V21, P4958, DOI 10.1111/j.1365-294X.2012.05689.x; Mendez FL, 2013, AM J HUM GENET, V92, P637, DOI 10.1016/j.ajhg.2013.03.006; Montano V, 2011, MOL ECOL, V20, P2693, DOI 10.1111/j.1365-294X.2011.05130.x; Ottoni C, 2011, AM J PHYS ANTHROPOL, V145, P118, DOI 10.1002/ajpa.21473; Pour NA, 2013, EUR J HUM GENET, V21, P423, DOI 10.1038/ejhg.2012.176; Purps J, 2014, FORENSIC SCI INT-GEN, V12, P12, DOI 10.1016/j.fsigen.2014.04.008; Qamar R, 2002, AM J HUM GENET, V70, P1107, DOI 10.1086/339929; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rickards O., 1994, CONTRIBUTIONS ANIMAL, P355; Sanchez-Faddeev H, 2013, EUR J HUM GENET, V21, P1134, DOI 10.1038/ejhg.2013.12; Schroeder H, 2015, P NATL ACAD SCI USA, V112, P3669, DOI 10.1073/pnas.1421784112; Scozzari R, 1999, AM J HUM GENET, V65, P829, DOI 10.1086/302538; Scozzari R, 2014, GENOME RES, V24, P535, DOI 10.1101/gr.160788.113; Strassmann BI, 2012, P NATL ACAD SCI USA, V109, P9781, DOI 10.1073/pnas.1110442109; Trombetta B, 2015, GENOME BIOL EVOL, V7, P1940, DOI 10.1093/gbe/evv118; Trombetta B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016073; Valverde L, EUROPEAN J IN PRESS; Van Geystelen A, 2013, FORENSIC SCI INT-GEN, V7, P573, DOI 10.1016/j.fsigen.2013.03.010; Van Geystelen A, 2014, ELECTROPHORESIS, V35, P3102, DOI 10.1002/elps.201300459; Van Geystelen A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-101; van Oven M, 2014, HUM MUTAT, V35, P187, DOI 10.1002/humu.22468; van Oven M, 2011, INT J LEGAL MED, V125, P879, DOI 10.1007/s00414-011-0605-2; Wilder JA, 2004, NAT GENET, V36, P1122, DOI 10.1038/ng1428; Willuweit S, 2007, FORENSIC SCI INT-GEN, V1, P83, DOI 10.1016/j.fsigen.2007.01.017	65	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141510	10.1371/journal.pone.0141510	http://dx.doi.org/10.1371/journal.pone.0141510			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544036	Green Submitted, Green Published, gold			2022-12-26	WOS:000364398700029
J	Vargas, CL; Espinoza, MA; Giglio, A; Soza, A				Vargas, Constanza L.; Espinoza, Manuel A.; Giglio, Andres; Soza, Alejandro			Cost Effectiveness of Daclatasvir/Asunaprevir Versus Peginterferon/Ribavirin and Protease Inhibitors for the Treatment of Hepatitis c Genotype 1b Naive Patients in Chile	PLOS ONE			English	Article							DACLATASVIR PLUS ASUNAPREVIR; HEPATOCELLULAR-CARCINOMA; NATURAL-HISTORY; LIVER-DISEASE; UNITED-STATES; CIRRHOSIS; THERAPY; TRANSPLANTATION; RIBAVIRIN; SURVIVAL	Introduction Daclatasvir and Asunaprevir (DCV/ASV) have recently been approved for the treatment of chronic hepatitis C virus infection. In association, they are more effective and safer than previous available treatments, but more expensive. It is unclear if paying for the additional costs is an efficient strategy considering limited resources. Methods A Markov model was built to estimate the expected costs in Chilean pesos (CL$) and converted to US dollars (US$) and benefits in quality adjusted life years (QALYs) in a hypothetic cohort of naive patients receiving DCV/ASV compared to protease inhibitors (PIs) and Peginterferon plus Ribavirin (PR). Efficacy was obtained from a mixed-treatment comparison study and costs were estimated from local sources. Utilities were obtained applying the EQ-5D survey to local patients and then valued with the Chilean tariff. A time horizon of 46 years and a discount rate of 3% for costs and outcomes was considered. The ICERs were estimated for a range of DCV/ASV prices. Deterministic and probabilistic sensitivity analyses were performed. Results PIs were extendedly dominated by DCV/ASV. The ICER of DCV/ASV compared to PR was US$ 16,635/QALY at a total treatment price of US$ 77,419; US$ 11,581/QALY at a price of US$ 58,065; US$ 6,375/QALY at a price of US$ 38,710; and US$ 1,364 /QALY at a price of US$ 19,355. The probability of cost-effectiveness at a price of US$ 38,710 was 91.6% while there is a 21.43% probability that DCV/ASV dominates PR if the total treatment price was US$ 19,355. Although the results are sensitive to certain parameters, the ICER did not increase above the suggested threshold of 1 GDP per capita. Conclusions DCV/ASV can be considered cost-effective at any price of the range studied. These results provide decision makers useful information about the value of incorporating these drugs into the public Chilean healthcare system.	[Vargas, Constanza L.; Espinoza, Manuel A.; Soza, Alejandro] Pontificia Univ Catolica Chile, Clin Res Ctr, Hlth Technol Assessment Unit, Santiago, Chile; [Espinoza, Manuel A.] Pontificia Univ Catolica Chile, Dept Publ Hlth, Santiago, Chile; [Giglio, Andres] Hosp Dr Sotero del Rio, Santiago, Chile; [Soza, Alejandro] Pontificia Univ Catolica Chile, Dept Gastroenterol, Santiago, Chile	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Universidad de Chile; Pontificia Universidad Catolica de Chile	Espinoza, MA (corresponding author), Pontificia Univ Catolica Chile, Clin Res Ctr, Hlth Technol Assessment Unit, Alameda 340, Santiago, Chile.	maespinoza@med.puc.cl	Espinoza, Manuel/AAU-5178-2020	Espinoza, Manuel/0000-0001-9564-9512; Vargas, Constanza/0000-0002-8667-1926	Bristol Meyers Squib	Bristol Meyers Squib	Bristol Meyers Squib provided the funding of this study to the Centre for Clinical Research, Pontificia Universidad Catolica de Chile. The study was performed under strict clauses of independence of the authors regarding matters of study design, data collection, interpretation of data, analysis of the results and elaboration of the manuscript. This manuscript did not require the approval of BMS for its submission.	Abrarira G L, 2013, SANTIAGO COMPOSTELA; [Anonymous], 2015, HEPATOLOGY BALTIMORE; Benvegnu L, 2001, GUT, V48, P110, DOI 10.1136/gut.48.1.110; Booth J, 2001, CLIN GUIDELINES MANA; CANTOR SB, 1994, MED DECIS MAKING, V14, P259, DOI 10.1177/0272989X9401400308; Cardoso AC, 2010, J HEPATOL, V52, P652, DOI 10.1016/j.jhep.2009.12.028; CENABAST, 2014, INF COMP MERC TEL BO; Chhatwal J, 2015, ANN INTERN MED, V162, P397, DOI 10.7326/M14-1336; D'Amico G, 2006, J HEPATOL, V44, P217, DOI 10.1016/j.jhep.2005.10.013; Fattovich G, 1997, GASTROENTEROLOGY, V112, P463, DOI 10.1053/gast.1997.v112.pm9024300; FONASA, 2014, DECR LEY INF PREC 20; FONASA, 2014, AR FONASA MOD AT I M; Gao M, 2013, CURR OPIN VIROL, V3, P514, DOI 10.1016/j.coviro.2013.06.014; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; INE D, 2014, AN EST VIT 2012; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Kumada H, 2014, HEPATOLOGY, V59, P2083, DOI 10.1002/hep.27113; Lang K, 2009, J HEPATOL, V50, P89, DOI 10.1016/j.jhep.2008.07.029; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Leidner AJ, 2015, HEPATOLOGY BALTIMORE; Ltda BA, 2009, ESTUDIO VERIFICACION; Manns M, 2014, LANCET, V384, P1597, DOI 10.1016/S0140-6736(14)61059-X; Martin NK, 2012, HEPATOLOGY, V55, P49, DOI 10.1002/hep.24656; McEwan P, 2013, APPL HEALTH ECON HEA, V11, P53, DOI 10.1007/s40258-012-0002-0; McLernon DJ, 2008, MED DECIS MAKING, V28, P582, DOI 10.1177/0272989X08315240; McPhee F, 2012, ANTIMICROB AGENTS CH, V56, P5387, DOI 10.1128/AAC.01186-12; MINSAL, 2013, AN CAN VAL EST VER C; [MINSAL salud Edl], 2013, SAL EDL; [MINSAL Publica SdS], 2010, PUBL SDS; Najafzadeh M, 2015, ANN INTERN MED, V162, P407, DOI 10.7326/M14-1152; NICE, 2013, PEG ALF RIB TREATM M; Pawlotsky JM, 2015, J HEPATOL, V63, P199, DOI 10.1016/j.jhep.2015.03.025; Perez R, TRANSPLANTE HEPATICO; Planas R, 2004, J HEPATOL, V40, P823, DOI 10.1016/j.jhep.2004.01.005; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Ryder SD, 2015, CLIN MED, V15, P197, DOI 10.7861/clinmedicine.15-2-197; Saab S, 2010, LIVER TRANSPLANT, V16, P748, DOI 10.1002/lt.22072; Shepherd J, 2007, HEALTH TECHNOL ASSES, V11, P1; Signorovitch JE, 2015, J COMP EFFECT RES, P1; Soza Alejandro, 2004, Ann Hepatol, V3, P146; Thein HH, 2008, HEPATOLOGY, V48, P418, DOI 10.1002/hep.22375; Thuluvath PJ, 2010, AM J TRANSPLANT, V10, P1003, DOI 10.1111/j.1600-6143.2010.03037.x; Townsend R, 2011, VALUE HEALTH, V14, P1068, DOI 10.1016/j.jval.2011.06.006; WHO, 2014, GUID SCREEN CAR TREA; Wolfe RA, 2010, AM J TRANSPLANT, V10, P961, DOI 10.1111/j.1600-6143.2010.03021.x; Zarate V, 2011, VALUE HEALTH, V14, P1135, DOI 10.1016/j.jval.2011.09.002	46	8	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141660	10.1371/journal.pone.0141660	http://dx.doi.org/10.1371/journal.pone.0141660			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544203	Green Published, gold, Green Submitted			2022-12-26	WOS:000364398700038
J	Gatticchi, L; Bellezza, I; Del Sordo, R; Peirce, MJ; Sidoni, A; Roberti, R; Minelli, A				Gatticchi, Leonardo; Bellezza, Ilaria; Del Sordo, Rachele; Peirce, Matthew J.; Sidoni, Angelo; Roberti, Rita; Minelli, Alba			The Tm7sf2 Gene Deficiency Protects Mice against Endotoxin-Induced Acute Kidney Injury	PLOS ONE			English	Article							TNF-ALPHA; PROXIMAL TUBULE; INDUCED LIPOTOXICITY; LIPID-METABOLISM; RENAL-FAILURE; FATTY-ACID; CHOLESTEROL; INFLAMMATION; AUTOPHAGY; CELLS	Cholesterol is essential for diverse cellular functions and cellular and whole-body cholesterol homeostasis is highly controlled. Cholesterol can also influence cellular susceptibility to injury. The connection between cholesterol metabolism and inflammation is exemplified by the Tm7sf2 gene, the absence of which reveals an essential role in cholesterol biosynthesis under stress conditions but also results in an inflammatory phenotype, i.e. NF-kappa B activation and TNF alpha up-regulation. Here, by using Tm7sf2(+/+) and Tm7sf2(-/-) mice, we investigated whether the Tm7sf2 gene, through its role in cholesterol biosynthesis under stress conditions, is involved in the renal failure induced by the administration of LPS. We found that the loss of Tm7sf2 gene results in significantly reduced blood urea nitrogen levels accompanied by decreased renal inflammatory response and neutral lipid accumulation. The increased expression of fatty acids catabolic enzymes reduces the need of the renal autophagy, a known crucial nutrient-sensing pathway in lipid metabolism. Moreover, we observed that the Tm7sf2 insufficiency is responsible for the inhibition of the NF-kappa B signalling thus dampening the inflammatory response and leading to a reduced renal damage. These results suggest a pivotal role for Tm7sf2 in renal inflammatory and lipotoxic response under endotoxemic conditions.	[Gatticchi, Leonardo; Bellezza, Ilaria; Del Sordo, Rachele; Peirce, Matthew J.; Sidoni, Angelo; Roberti, Rita; Minelli, Alba] Univ Perugia, Dept Expt Med, I-06124 Perugia, Italy	University of Perugia	Minelli, A (corresponding author), Univ Perugia, Dept Expt Med, Piazzale Gambuli, I-06124 Perugia, Italy.	alba.minelli@unipg.it	Peirce, Matthew/ABB-9577-2021; Gatticchi, Leonardo/AAX-2811-2020; BELLEZZA, ILARIA/AAA-8099-2022	Peirce, Matthew/0000-0003-3648-5639; BELLEZZA, ILARIA/0000-0002-8106-1600; Gatticchi, Leonardo/0000-0002-0098-7840	PRIN (Progetti di Ricerca di Interesse Nazionele) [20092BE97Y_005]; Fondazione Cassa di Risparmio di Perugia [2011.0184.021, 2011.0099.021]	PRIN (Progetti di Ricerca di Interesse Nazionele)(Ministry of Education, Universities and Research (MIUR)); Fondazione Cassa di Risparmio di Perugia(Fondazione Cassa Risparmio Perugia)	This work was supported by PRIN (Progetti di Ricerca di Interesse Nazionele) (20092BE97Y_005), and Fondazione Cassa di Risparmio di Perugia (2011.0184.021 and 2011.0099.021) to RR and IB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba M, 2010, MITOCHONDRION, V10, P369, DOI 10.1016/j.mito.2010.03.004; BALABAN RS, 1988, AM J PHYSIOL, V254, pF407, DOI 10.1152/ajprenal.1988.254.3.F407; Bascands JL, 2009, BIOCHEM BIOPH RES CO, V386, P407, DOI 10.1016/j.bbrc.2009.06.063; Bellezza I, 2015, SCI REP-UK, V5, DOI 10.1038/srep09471; Bellezza I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068017; Bennati AM, 2008, FEBS J, V275, P5034, DOI 10.1111/j.1742-4658.2008.06637.x; Cunningham PN, 2002, J IMMUNOL, V168, P5817, DOI 10.4049/jimmunol.168.11.5817; Czaja MJ, 2010, AM J PHYSIOL-CELL PH, V298, pC973, DOI 10.1152/ajpcell.00527.2009; Distler JHW, 2008, ARTHRITIS RHEUM, V58, P2228, DOI 10.1002/art.23645; Dupont N, 2014, CURR BIOL, V24, P609, DOI 10.1016/j.cub.2014.02.008; Ernandez T, 2009, KIDNEY INT, V76, P262, DOI 10.1038/ki.2009.142; Feingold KR, 2008, J LIPID RES, V49, P2179, DOI 10.1194/jlr.M800233-JLR200; FOLCH J, 1957, J BIOL CHEM, V226, P497; Garbarino J, 2009, CURR OPIN CLIN NUTR, V12, P110, DOI 10.1097/MCO.0b013e32832182ee; Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940; GULLANS SR, 1984, AM J PHYSIOL, V247, pF582, DOI 10.1152/ajprenal.1984.247.4.F582; He K, 2014, KIDNEY INT, V85, P276, DOI 10.1038/ki.2013.342; Heemskerk S, 2006, CLIN J AM SOC NEPHRO, V1, P853, DOI 10.2215/CJN.00490206; Howell GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069520; Huang LH, 2011, KIDNEY INT, V79, P613, DOI 10.1038/ki.2010.469; Hunter I, 2006, J BIOL CHEM, V281, P34705, DOI 10.1074/jbc.M605738200; Johnson ACM, 2005, KIDNEY INT, V67, P2196, DOI 10.1111/j.1523-1755.2005.00325.x; Knotek M, 2001, KIDNEY INT, V59, P2243, DOI 10.1046/j.1523-1755.2001.00740.x; MACALA LJ, 1983, J LIPID RES, V24, P1243; Meldrum KK, 2002, AM J PHYSIOL-HEART C, V282, pH540, DOI 10.1152/ajpheart.00072.2001; MOORHEAD JF, 1982, LANCET, V2, P1309; Proctor G, 2006, DIABETES, V55, P2502, DOI 10.2337/db05-0603; Savary S, 2012, CURR DRUG METAB, V13, P1358, DOI 10.2174/138920012803762729; Schroeder S, 2014, AUTOPHAGY, V10, P1335, DOI 10.4161/auto.28919; Shpilka T., 2015, EMBO J; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Takahashi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030134; van Diepen JA, 2013, ATHEROSCLEROSIS, V228, P306, DOI 10.1016/j.atherosclerosis.2013.02.028; van Zutphen T, 2014, MOL BIOL CELL, V25, P290, DOI 10.1091/mbc.E13-08-0448; Vasko R, 2013, ANTIOXID REDOX SIGN, V19, P211, DOI 10.1089/ars.2012.4768; Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430; Wang CW, 2014, J CELL BIOL, V206, P357, DOI 10.1083/jcb.201404115; Weinberg JM, 2006, KIDNEY INT, V70, P1560, DOI 10.1038/sj.ki.5001834; Xin W, 2015, BIOCHEM BIOPH RES CO, V463, P364, DOI 10.1016/j.bbrc.2015.05.070; Zager RA, 2007, KIDNEY INT, V71, P496, DOI 10.1038/sj.ki.5002092; Zager RA, 2006, KIDNEY INT, V69, P1181, DOI 10.1038/sj.ki.5000022; Zager RA, 2002, AM J PATHOL, V161, P681, DOI 10.1016/S0002-9440(10)64224-1; Zager RA, 2001, AM J PATHOL, V159, P743, DOI 10.1016/S0002-9440(10)61745-2; Zager RA, 2000, KIDNEY INT, V58, P193, DOI 10.1046/j.1523-1755.2000.00154.x; Zager RA, 2000, AM J PATHOL, V157, P1007, DOI 10.1016/S0002-9440(10)64613-5; Zager RA, 1999, KIDNEY INT, V56, P1788, DOI 10.1046/j.1523-1755.1999.00745.x; Zager RA, 2006, KIDNEY INT, V67, P111; Zarbock A, 2014, CURR OPIN CRIT CARE, V20, P588, DOI 10.1097/MCC.0000000000000153	48	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141885	10.1371/journal.pone.0141885	http://dx.doi.org/10.1371/journal.pone.0141885			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540160	Green Submitted, Green Published, gold			2022-12-26	WOS:000364303800033
J	Kang, HB; Ji, WJ; Qian, ZH; Li, YX; Jiang, CH; Wu, ZX; Wen, XL; Xu, WJ; Liu, AH				Kang, Huibin; Ji, Wenjun; Qian, Zenghui; Li, Youxiang; Jiang, Chuhan; Wu, Zhongxue; Wen, Xiaolong; Xu, Wenjuan; Liu, Aihua			Aneurysm Characteristics Associated with the Rupture Risk of Intracranial Aneurysms: A Self-Controlled Study	PLOS ONE			English	Article							UNRUPTURED CEREBRAL ANEURYSMS; SUBARACHNOID HEMORRHAGE; NATURAL-HISTORY; ASPECT RATIO; SACCULAR ANEURYSMS; BOTTLENECK FACTOR; SIZE; SHAPE; HEMODYNAMICS; POPULATION	This study analyzed the rupture risk of intracranial aneurysms (IAs) according to aneurysm characteristics by comparing the differences between two aneurysms in different locations within the same patient. We utilized this self-controlled model to exclude potential interference from all demographic factors to study the risk factors related to IA rupture. A total of 103 patients were diagnosed with IAs between January 2011 and April 2015 and were enrolled in this study. All enrolled patients had two IAs. One IA (the case) was ruptured, and the other (the control) was unruptured. Aneurysm characteristics, including the presence of a daughter sac, the aneurysm neck, the parent artery diameter, the maximum aneurysm height, the maximum aneurysm width, the location, the aspect ratio (AR, maximum perpendicular height/average neck diameter), the size ratio (SR, maximum aneurysm height/average parent diameter) and the width/height ratio (WH ratio, maximum aneurysm width/maximum aneurysm height), were collected and analyzed to evaluate the rupture risks of the two IAs within each patient and to identify the independent risk factors associated with IA rupture. Multivariate, conditional, backward, stepwise logistic regression analysis was performed to identify the independent risk factors associated with IA rupture. The multivariate analysis identified the presence of a daughter sac (odds ratio [OR], 13.80; 95% confidence interval [CI], 1.65-115.87), a maximum aneurysm height >= 7 mm (OR, 4.80; 95% CI, 1.21-18.98), location on the posterior communicating artery (PCOM) or anterior communicating artery (ACOM; OR, 3.09; 95% CI, 1.34-7.11) and SR (OR, 2.13; 95% CI, 1.16-3.91) as factors that were significantly associated with IA rupture. The presence of a daughter sac, the maximum aneurysm height, PCOM or ACOM locations and SR (>1.5 +/- 0.7) of unruptured IAs were significantly associated with IA rupture.	[Kang, Huibin; Ji, Wenjun; Qian, Zenghui; Li, Youxiang; Jiang, Chuhan; Wu, Zhongxue; Wen, Xiaolong; Xu, Wenjuan; Liu, Aihua] Capital Med Univ, Beijing Tiantan Hosp, Beijing Neurosurg Inst, Dept Intervent Neuroradiol, Beijing, Peoples R China	Beijing Neurosurgical Institute; Capital Medical University	Liu, AH (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Beijing Neurosurg Inst, Dept Intervent Neuroradiol, Beijing, Peoples R China.	liuaihuadoctor@163.com			National Natural Science Foundation [81441038]; Natural Science Foundation of Beijing, China [7142032]; Specific Research Projects for Capital Health Development [2014-3-2044]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing, China(Beijing Natural Science Foundation); Specific Research Projects for Capital Health Development	This research was supported by the National Natural Science Foundation (81441038), Natural Science Foundation of Beijing, China (No. 7142032), and Specific Research Projects for Capital Health Development (2014-3-2044).	Anderson C, 2003, STROKE, V34, P1771, DOI 10.1161/01.STR.0000077015.90334.A7; Backes D, 2014, STROKE, V45, P1299, DOI 10.1161/STROKEAHA.113.004421; Beck J, 2003, ACTA NEUROCHIR, V145, P861, DOI 10.1007/s00701-003-0124-0; Dhar S, 2008, NEUROSURGERY, V63, P185, DOI 10.1227/01.NEU.0000316847.64140.81; Etminan N, 2015, NEUROLOGY, V85, P881, DOI 10.1212/WNL.0000000000001891; Feigin VL, 2005, STROKE, V36, P2773, DOI 10.1161/01.STR.0000190838.02954.e8; Greving JP, 2014, LANCET NEUROL, V13, P59, DOI 10.1016/S1474-4422(13)70263-1; Hoh BL, 2007, NEUROSURGERY, V61, P716, DOI 10.1227/01.NEU.0000298899.77097.BF; Hop JW, 1997, STROKE, V28, P660, DOI 10.1161/01.STR.28.3.660; Inagawa T, 2010, WORLD NEUROSURG, V73, P155, DOI 10.1016/j.surneu.2009.03.007; Ishibashi T, 2009, STROKE, V40, P313, DOI 10.1161/STROKEAHA.108.521674; Juvela S, 2013, STROKE, V44, P2414, DOI 10.1161/STROKEAHA.113.001838; Juvela S, 2008, J NEUROSURG, V108, P1052, DOI 10.3171/JNS/2008/108/5/1052; Korja M, 2014, STROKE, V45, P1958, DOI 10.1161/STROKEAHA.114.005318; Laaksamo E, 2012, NEUROSURGERY, V70, P1565, DOI 10.1227/NEU.0b013e31824c057e; Lai H. P., 2009, Hong Kong Medical Journal, V15, P262; Lauric A, 2012, NEUROSURGERY, V71, P38, DOI 10.1227/NEU.0b013e3182503bf9; Ma D, 2010, NEUROL RES, V32, P482, DOI 10.1179/016164109X12581096796558; Morita A, 2012, NEW ENGL J MED, V366, P2474, DOI 10.1056/NEJMoa1113260; Muller TB, 2013, NEUROSURGERY, V73, P256, DOI 10.1227/01.neu.0000430295.23799.16; Nahed BV, 2005, NEUROSURGERY, V57, P676, DOI 10.1227/01.NEU.0000175549.96530.59; Raghavan ML, 2005, J NEUROSURG, V102, P355, DOI 10.3171/jns.2005.102.2.0355; Rahman M, 2011, NEUROSURGERY, V68, P155, DOI 10.1227/NEU.0b013e3181ff357c; Rahman M, 2010, STROKE, V41, P916, DOI 10.1161/STROKEAHA.109.574244; Rinkel GJE, 1998, STROKE, V29, P251, DOI 10.1161/01.STR.29.1.251; Schnell S, 2014, J MAGN RESON IMAGING, V39, P120, DOI 10.1002/jmri.24110; Sonobe M, 2010, STROKE, V41, P1969, DOI 10.1161/STROKEAHA.110.585059; Steiner T, 2013, CEREBROVASC DIS, V35, P93, DOI 10.1159/000346087; Thompson BG, 2015, STROKE, V46, P2368, DOI 10.1161/STR.0000000000000070; Tominari S, 2015, ANN NEUROL, V77, P1050, DOI 10.1002/ana.24400; Ujiie H, 2001, NEUROSURGERY, V48, P495, DOI 10.1097/00006123-200103000-00007; Ujiie H, 1999, NEUROSURGERY, V45, P119, DOI 10.1097/00006123-199907000-00028; Villablanca JP, 2013, RADIOLOGY, V269, P258, DOI 10.1148/radiol.13121188; Vlak MHM, 2013, STROKE, V44, P1256, DOI 10.1161/STROKEAHA.111.000679; Vlak MHM, 2011, LANCET NEUROL, V10, P626, DOI 10.1016/S1474-4422(11)70109-0; Wermer MJH, 2007, STROKE, V38, P1404, DOI 10.1161/01.STR.0000260955.51401.cd; Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3; Williams Lindsy N, 2013, Neurol Clin Pract, V3, P99; Yu SCH, 2004, AM J NEURORADIOL, V25, P307; Zhao L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085668	40	38	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142330	10.1371/journal.pone.0142330	http://dx.doi.org/10.1371/journal.pone.0142330			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540158	Green Published, Green Submitted, gold			2022-12-26	WOS:000364303800083
J	Poli, E; Zhang, J; Nwachukwu, C; Zheng, YL; Adedokun, B; Olopade, OI; Han, YJ				Poli, Elizabeth; Zhang, Jing; Nwachukwu, Chika; Zheng, Yonglan; Adedokun, Babatunde; Olopade, Olufunmilayo I.; Han, Yoo-Jeong			Molecular Subtype-Specific Expression of MicroRNA-29c in Breast Cancer Is Associated with CpG Dinucleotide Methylation of the Promoter	PLOS ONE			English	Article							DNA METHYLATION; TUMORS; MIR-29C; HYPERMETHYLATION; CARCINOMAS; PORTRAITS	Basal-like breast cancer is a molecularly distinct subtype of breast cancer that is highly aggressive and has a poor prognosis. MicroRNA-29c (miR-29c) has been shown to be significantly down-regulated in basal-like breast tumors and to be involved in cell invasion and sensitivity to chemotherapy. However, little is known about the genetic and regulatory factors contributing to the altered expression of miR-29c in basal-like breast cancer. We here report that epigenetic modifications at the miR-29c promoter, rather than copy number variation of the gene, may drive the lower expression of miR-29c in basal-like breast cancer. Bisulfite sequencing of CpG sites in the miR-29c promoter region showed higher methylation in basal-like breast cancer cell lines compared to luminal subtype cells with a significant inverse correlation between expression and methylation of miR-29c. Analysis of primary breast tumors using The Cancer Genome Atlas (TCGA) dataset confirmed significantly higher levels of methylation of the promoter in basal-like breast tumors compared to all other subtypes. Furthermore, inhibition of CpG methylation with 5-aza-CdR increases miR-29c expression in basal-like breast cancer cells. Flourescent In Situ Hybridization (FISH) revealed chromosomal abnormalities at miR-29c loci in breast cancer cell lines, but with no correlation between copy number variation and expression of miR-29c. Our data demonstrated that dysregulation of miR-29c in basal-like breast cancer cells may be in part driven by methylation at CpG sites. Epigenetic control of the miR-29c promoter by epigenetic modifiers may provide a potential therapeutic target to overcome the aggressive behavior of these cancers.	[Poli, Elizabeth; Zhang, Jing; Nwachukwu, Chika; Zheng, Yonglan; Adedokun, Babatunde; Olopade, Olufunmilayo I.; Han, Yoo-Jeong] Univ Chicago, Dept Med, Ctr Clin Canc Genet & Global Hlth, Sect Hematol Oncol, Chicago, IL 60637 USA	University of Chicago	Han, YJ (corresponding author), Univ Chicago, Dept Med, Ctr Clin Canc Genet & Global Hlth, Sect Hematol Oncol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	yjhan@medicine.bsd.uchicago.edu	Zheng, Yonglan/O-4112-2019	Zheng, Yonglan/0000-0001-6597-7072	Howard Hughes Medical Fellows Program; Breast Cancer Research Foundation; Ralph and Marion Falk Medical Research Trust; National Institute of Health-Specialized Program of Research Excellence in Breast Cancer [(P50 CA125183]; FOGARTY INTERNATIONAL CENTER [D43TW009112] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P50CA125183] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER	Howard Hughes Medical Fellows Program; Breast Cancer Research Foundation; Ralph and Marion Falk Medical Research Trust; National Institute of Health-Specialized Program of Research Excellence in Breast Cancer; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by funding to E. P. from Howard Hughes Medical Fellows Program, O. I. O. and Y.H from the Breast Cancer Research Foundation and the Ralph and Marion Falk Medical Research Trust. This research was also supported by the National Institute of Health-Specialized Program of Research Excellence in Breast Cancer (P50 CA125183 to OIO). OIO is American Cancer Society Clinical Research Professor.	American Cancer Society, 2013, BREAST CANC FACTS FI; Baer C, 2013, CANCER RES, V73, P473, DOI 10.1158/0008-5472.CAN-12-3731; Baer C, 2012, CANCER RES, V72, P3775, DOI 10.1158/0008-5472.CAN-12-0803; Barch MJ, 1997, AGT CYTOGENETICS LAB; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dawson K, 2013, CIRCULATION, V127, P1466, DOI 10.1161/CIRCULATIONAHA.112.001207; Ding DP, 2011, CARCINOGENESIS, V32, P1025, DOI 10.1093/carcin/bgr078; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Erson AE, 2008, CLIN GENET, V74, P296, DOI 10.1111/j.1399-0004.2008.01076.x; Foulks JM, 2012, J BIOMOL SCREEN, V17, P2, DOI 10.1177/1087057111421212; Gluz O, 2009, ANN ONCOL, V20, P1913, DOI 10.1093/annonc/mdp492; Hawkins SM, 2011, MOL ENDOCRINOL, V25, P821, DOI 10.1210/me.2010-0371; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072287; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Huang YW, 2014, GYNECOL ONCOL, V133, P340, DOI 10.1016/j.ygyno.2014.02.009; Jia HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088057; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kogure T, 2012, J CELL MOL MED, V16, P2647, DOI 10.1111/j.1582-4934.2012.01578.x; Kulis M, 2010, ADV GENET, V70, P27, DOI [10.1016/S0065-2660(10)70002-X, 10.1016/B978-0-12-380866-0.60002-2]; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Matsuo M, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-15; Millikan RC, 2008, BREAST CANCER RES TR, V109, P123, DOI 10.1007/s10549-007-9632-6; Mott JL, 2010, J CELL BIOCHEM, V110, P1155, DOI 10.1002/jcb.22630; Nguyen T, 2011, EPIGENETICS-US, V6, P388, DOI 10.4161/epi.6.3.14056; Nygren MK, 2014, BRIT J CANCER, V110, P2072, DOI 10.1038/bjc.2014.113; Pandi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058039; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Presneau N, 2013, BRIT J CANCER, V108, P964, DOI 10.1038/bjc.2012.518; Roll JD, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-15; Ruan K, 2009, CANCER LETT, V285, P116, DOI 10.1016/j.canlet.2009.04.031; Saito Y, 2013, INT J CANCER, V132, P1751, DOI 10.1002/ijc.27862; Sandhu R, 2014, INT J ONCOL, V44, P563, DOI 10.3892/ijo.2013.2197; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stewart DJ, 2009, CLIN CANCER RES, V15, P3881, DOI 10.1158/1078-0432.CCR-08-2196; Voduc KD, 2010, J CLIN ONCOL, V28, P1684, DOI 10.1200/JCO.2009.24.9284; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028	40	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142224	10.1371/journal.pone.0142224	http://dx.doi.org/10.1371/journal.pone.0142224			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26539832	Green Published, Green Submitted, gold			2022-12-26	WOS:000364303800070
J	Sun, LJ; Wang, F; Liu, A; Xin, RL; Zhu, YX; Li, JW; Shao, Y; Ye, JZ; Chen, DQ; Li, ZC				Sun, Lijun; Wang, Fang; Liu, An; Xin, Ruolei; Zhu, Yunxia; Li, Jianwei; Shao, Ying; Ye, Jiangzhu; Chen, Danqing; Li, Zaicun			Natural Conception May Be an Acceptable Option in HIV-Serodiscordant Couples in Resource Limited Settings	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL THERAPY; ASSISTED REPRODUCTION; TRANSMISSION; CARE; INSEMINATION; CONCEIVE; DESIRE; KENYA; WOMEN	Many HIV serodiscordant couples have a strong desire to have their own biological children. Natural conception may be the only choice in some resource limited settings but data about natural conception is limited. Here, we reported our findings of natural conception in HIV serodiscordant couples. Between January 2008 and June 2014, we retrospectively collected data on 91 HIV serodiscordant couples presenting to Beijing Youan Hospital with childbearing desires. HIV counseling, effective ART on HIV infected partners, pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) in negative female partners and timed intercourse were used to maximally reduce the risk of HIV transmission. Of the 91 HIV serodiscordant couples, 43 were positive in male partners and 48 were positive in female partners. There were 196 unprotected vaginal intercourses, 100 natural conception and 97 newborns. There were no cases of HIV seroconversion in uninfected sexual partners. Natural conception may be an acceptable option in HIV-serodiscordant couples in resource limited settings if HIV-positive individuals have undetectable viremia on HAART, combined with HIV counseling, PrEP, PEP and timed intercourse.	[Sun, Lijun; Liu, An; Li, Jianwei; Shao, Ying; Ye, Jiangzhu; Li, Zaicun] Capital Med Univ, Beijing Youan Hosp, Ctr Infect Dis, Beijing 100069, Peoples R China; [Wang, Fang] China CDC, Natl Ctr Women & Childrens Hlth, Beijing 100081, Peoples R China; [Xin, Ruolei] Beijing Ctr Prevent Med Res, Beijing 100013, Peoples R China; [Zhu, Yunxia] Capital Med Univ, Beijing Youan Hosp, Dept Gynecol, Beijing 100069, Peoples R China; [Chen, Danqing] Zhejiang Univ, Sch Med, Womens Hosp, Hangzhou 310006, Zhejiang, Peoples R China	Capital Medical University; Chinese Center for Disease Control & Prevention; National Center for Women & Children's Health, Chinese Center for Disease Control & Prevention; Capital Medical University; Zhejiang University	Chen, DQ (corresponding author), Zhejiang Univ, Sch Med, Womens Hosp, Hangzhou 310006, Zhejiang, Peoples R China.	chendq@zju.edu.cn; cun521@vip.163.com	LI, JIAN/GRY-2197-2022; li, jian/GSE-0245-2022		National Natural Science Foundation of China [81273136]; Development and Application Research of Beijing AIDS Clinical Data and Sample Repository [D13110700530000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Development and Application Research of Beijing AIDS Clinical Data and Sample Repository	This study was supported by the National Natural Science Foundation of China (81273136) and Development and Application Research of Beijing AIDS Clinical Data and Sample Repository (D13110700530000).	Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Barreiro P, 2007, HUM REPROD, V22, P2353, DOI 10.1093/humrep/dem226; Barreiro P, 2006, JAIDS-J ACQ IMM DEF, V43, P324, DOI 10.1097/01.qai.0000243091.40490.fd; Bauni EK, 2000, STUD FAMILY PLANN, V31, P69, DOI 10.1111/j.1728-4465.2000.00069.x; Beyeza-Kashesya J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-247; Louis B, 2007, EUR J OBSTET GYN R B, V135, P76, DOI 10.1016/j.ejogrb.2007.04.011; Castilla J, 2005, JAIDS-J ACQ IMM DEF, V40, P96, DOI 10.1097/01.qai.0000157389.78374.45; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Gosselin JT, 2011, AIDS BEHAV, V15, P469, DOI 10.1007/s10461-010-9830-9; Guzick DS, 1999, NEW ENGL J MED, V340, P177, DOI 10.1056/NEJM199901213400302; Hall HI, 2013, JAMA INTERN MED, V173, P1337, DOI 10.1001/jamainternmed.2013.6841; He N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077981; Leggett Hadley, 2011, BETA, V23, P43; Loutfy MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055747; Mandelbrot L, 1997, LANCET, V349, P850, DOI 10.1016/S0140-6736(05)61754-0; Mmeje O, 2015, AIDS CARE, V27, P10, DOI 10.1080/09540121.2014.946385; Ogilvie GS, 2007, AIDS, V21, pS83, DOI 10.1097/01.aids.0000255090.51921.60; Oladapo Olufemi T, 2005, J Natl Med Assoc, V97, P1672; PoAGfAa A, 2013, GUIDELINES USE ANTIR; Transmission PoToH-IPWaPoP, 2014, REC US ANT DRUGS PRE; Vernazza PL, 2011, AIDS, V25, P2005, DOI 10.1097/QAD.0b013e32834a36d0; Vitorino RL, 2011, FERTIL STERIL, V95, P1684, DOI 10.1016/j.fertnstert.2011.01.127	23	4	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142085	10.1371/journal.pone.0142085	http://dx.doi.org/10.1371/journal.pone.0142085			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540103	Green Submitted, Green Published, gold			2022-12-26	WOS:000364303800052
J	Ni, ZQ; Zhou, LX; Li, X; Zhang, J; Dong, SL				Ni, Zhongqiu; Zhou, Lanxia; Li, Xu; Zhang, Jing; Dong, Shouliang			Tetrazine-Containing Amino Acid for Peptide Modification and Live Cell Labeling	PLOS ONE			English	Article							DIELS-ALDER REACTIONS; SUBSTANCE-P; TRANS-CYCLOOCTENES; MAMMALIAN-CELLS; CANCER-CELLS; LIGATION; REACTIVITY; PROTEINS; CYCLOADDITIONS; DIENOPHILE	A novel amino acid derivative 3-(4-(1, 2, 4, 5-tetrazine-3-yl) phenyl)-2-aminopropanoic acid was synthesized in this study. The compound possessed better water-solubility and was synthesized more easily compared with the well-known and commercially available 3-(p-benzylamino)-1, 2, 4, 5-tetrazine. Tetrazine-containing amino acid showed excellent stability in biological media and might be used for cancer cell labeling. Moreover, the compound remained relatively stable in 50% TFA/DCM with little decomposition after prolonged exposure at room temperature. The compound could be utilized as phenylalanine or tyrosine analogue in peptide modification, and the tetrazine-containing peptide demonstrated more significant biological activity than that of the parent peptide. The combination of tetrazine group and amino acid offered broad development prospects of the bioorthogonal labeling and peptide synthesis.	[Ni, Zhongqiu; Li, Xu; Zhang, Jing; Dong, Shouliang] Lanzhou Univ, Sch Life Sci, Inst Biochem & Mol Biol, Lanzhou 730000, Peoples R China; [Zhou, Lanxia] Lanzhou Univ, Affiliated Hosp 1, Core Lab, Lanzhou 730000, Peoples R China; [Zhou, Lanxia] Lanzhou Univ, Key Lab Gastrointestinal Dis, Lanzhou 730000, Peoples R China; [Dong, Shouliang] Lanzhou Univ, Key Lab Preclin Study New Drugs Gansu Prov, Lanzhou 730000, Peoples R China	Lanzhou University; Lanzhou University; Lanzhou University; Lanzhou University	Dong, SL (corresponding author), Lanzhou Univ, Sch Life Sci, Inst Biochem & Mol Biol, Lanzhou 730000, Peoples R China.	dongsl@lzu.edu.cn			Fundamental Research Funds for the Central Universities [lzujbky-2013-154]; Health Industry Research Project of Gansu Province [GWGL2014-54]; Foundation of Key Laboratory for Gastrointestinal Diseases of Gansu Province [gswcky-2012-006]; National Natural Science Foundation of China [30870526]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Health Industry Research Project of Gansu Province; Foundation of Key Laboratory for Gastrointestinal Diseases of Gansu Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Fundamental Research Funds for the Central Universities (lzujbky-2013-154), Health Industry Research Project of Gansu Province (GWGL2014-54), partially the Foundation of Key Laboratory for Gastrointestinal Diseases of Gansu Province (gswcky-2012-006), and the grant from National Natural Science Foundation of China (No. 30870526). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALCAR J, 1983, TETRAHEDRON LETT, V24, P1481, DOI 10.1016/S0040-4039(00)81687-1; Beatty KE, 2006, ANGEW CHEM INT EDIT, V45, P7364, DOI 10.1002/anie.200602114; Bhushan R, 2004, AMINO ACIDS, V27, P231, DOI 10.1007/s00726-004-0118-0; Blackman ML, 2008, J AM CHEM SOC, V130, P13518, DOI 10.1021/ja8053805; Borrmann A, 2012, CHEMBIOCHEM, V13, P2094, DOI 10.1002/cbic.201200407; BURY RW, 1976, J MED CHEM, V19, P854, DOI 10.1021/jm00228a028; Canalle LA, 2010, CHEM SOC REV, V39, P329, DOI 10.1039/b807871h; COUTURE R, 1982, PHARMACOLOGY, V24, P1, DOI 10.1159/000137572; Devaraj NK, 2011, ACCOUNTS CHEM RES, V44, P816, DOI 10.1021/ar200037t; Devaraj NK, 2009, ANGEW CHEM INT EDIT, V48, P7013, DOI 10.1002/anie.200903233; Devaraj NK, 2008, BIOCONJUGATE CHEM, V19, P2297, DOI 10.1021/bc8004446; INADA Y, 1995, TRENDS BIOTECHNOL, V13, P86, DOI 10.1016/S0167-7799(00)88912-X; Jiang JB, 2013, CHEM-EUR J, V19, P17679, DOI 10.1002/chem.201303290; Kim CH, 2013, CURR OPIN CHEM BIOL, V17, P412, DOI 10.1016/j.cbpa.2013.04.017; Lang K, 2014, CHEM REV, V114, P4764, DOI 10.1021/cr400355w; Lang K, 2012, J AM CHEM SOC, V134, P10317, DOI 10.1021/ja302832g; Lang K, 2012, NAT CHEM, V4, P298, DOI 10.1038/nchem.1250; LEMBECK F, 1979, N-S ARCH PHARMACOL, V310, P175, DOI 10.1007/BF00500282; Li H, 2011, PROG CRYST GROWTH CH, V57, P117, DOI 10.1016/j.pcrysgrow.2011.10.006; Liu DS, 2012, J AM CHEM SOC, V134, P792, DOI 10.1021/ja209325n; LUNDBERG JM, 1984, ACTA PHYSIOL SCAND, V120, P217, DOI 10.1111/j.1748-1716.1984.tb00127.x; Niederwieser A, 2013, ANGEW CHEM INT EDIT, V52, P4265, DOI 10.1002/anie.201208991; Nilsson BL, 2000, ORG LETT, V2, P1939, DOI 10.1021/ol0060174; Park S, 2011, CARBON, V49, P3019, DOI 10.1016/j.carbon.2011.02.071; Pipkorn R, 2009, J PEPT SCI, V15, P235, DOI 10.1002/psc.1108; Plass T, 2012, ANGEW CHEM INT EDIT, V51, P4166, DOI 10.1002/anie.201108231; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Sauer J, 1998, EUR J ORG CHEM, V1998, P2885; Schneider S, 2013, CHEMBIOCHEM, V14, P2114, DOI 10.1002/cbic.201300435; Seitchik JL, 2012, J AM CHEM SOC, V134, P2898, DOI 10.1021/ja2109745; Selvaraj R, 2013, CURR OPIN CHEM BIOL, V17, P753, DOI 10.1016/j.cbpa.2013.07.031; SIEBER P, 1987, TETRAHEDRON LETT, V28, P2107, DOI 10.1016/S0040-4039(00)96055-6; Sletten EM, 2009, ANGEW CHEM INT EDIT, V48, P6974, DOI 10.1002/anie.200900942; Tucker MJ, 2010, ANGEW CHEM INT EDIT, V49, P3612, DOI 10.1002/anie.201000500; Vrabel M, 2013, CHEM-EUR J, V19, P13309, DOI 10.1002/chem.201301838; Zhang WH, 2013, CURR OPIN STRUC BIOL, V23, P581, DOI 10.1016/j.sbi.2013.06.009	36	14	14	4	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141918	10.1371/journal.pone.0141918	http://dx.doi.org/10.1371/journal.pone.0141918			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536589	gold, Green Published, Green Submitted			2022-12-26	WOS:000364298400101
J	Coker, DJ; Hoey, AS; Wilson, SK; Depczynski, M; Graham, NAJ; Hobbs, JPA; Holmes, TH; Pratchett, MS				Coker, Darren J.; Hoey, Andrew S.; Wilson, Shaun K.; Depczynski, Martial; Graham, Nicholas A. J.; Hobbs, Jean-Paul A.; Holmes, Thomas H.; Pratchett, Morgan S.			Habitat Selectivity and Reliance on Live Corals for Indo-Pacific Hawkfishes (Family: Cirrhitidae)	PLOS ONE			English	Article							GREAT-BARRIER-REEF; SOCIAL-ORGANIZATION; REPRODUCTIVE-BEHAVIOR; FISHES; DEGRADATION; EVOLUTION; PREDATION; SPECIALIZATION; SUSCEPTIBILITY; DISTURBANCES	Hawkfishes (family: Cirrhitidae) are small conspicuous reef predators that commonly perch on, or shelter within, the branches of coral colonies. This study examined habitat associations of hawkfishes, and explicitly tested whether hawkfishes associate with specific types of live coral. Live coral use and habitat selectivity of hawkfishes was explored at six locations from Chagos in the central Indian Ocean extending east to Fiji in the Pacific Ocean. A total of 529 hawkfishes from seven species were recorded across all locations with 63% of individuals observed perching on, or sheltering within, live coral colonies. Five species (all except Cirrhitus pinnulatus and Cirrhitichthys oxycephalus) associated with live coral habitats. Cirrhitichthys falco selected for species of Pocillopora while Paracirrhites arcatus and P. forsteri selected for both Pocillopora and Acropora, revealing that these habitats are used disproportionately more than expected based on the local cover of these coral genera. Habitat selection was consistent across geographic locations, and species of Pocillopora were the most frequently used and most consistently selected even though this coral genus never comprised more than 6% of the total coral cover at any of the locations. Across locations, Paracirrhites arcatus and P. forsteri were the most abundant species and variation in their abundance corresponded with local patterns of live coral cover and abundance of Pocilloporid corals, respectively. These findings demonstrate the link between small predatory fishes and live coral habitats adding to the growing body of literature highlighting that live corals (especially erect branching corals) are critically important for sustaining high abundance and diversity of fishes on coral reefs.	[Coker, Darren J.; Hoey, Andrew S.; Graham, Nicholas A. J.; Pratchett, Morgan S.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Coker, Darren J.] King Abdullah Univ Sci & Technol, Div Biol & Environm Sci & Engn, Red Sea Res Ctr, Thuwal, Saudi Arabia; [Wilson, Shaun K.; Depczynski, Martial; Holmes, Thomas H.] Univ Western Australia, Oceans Inst, Crawley, Australia; [Wilson, Shaun K.; Holmes, Thomas H.] Dept Pk & Wildlife, Marine Sci Program, Perth, WA, Australia; [Depczynski, Martial] Univ Western Australia, Australian Inst Marine Sci, Oceans Inst, Crawley, Australia; [Graham, Nicholas A. J.] Univ Lancaster, Lancaster Environm Ctr, Lancaster, England; [Hobbs, Jean-Paul A.] Curtin Univ, Dept Environm & Agr, Perth, WA 6845, Australia	James Cook University; King Abdullah University of Science & Technology; University of Western Australia; Australian Institute of Marine Science; University of Western Australia; Lancaster University; Curtin University	Coker, DJ (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	Darren.coker@kaust.edu.sa	Hoey, Andrew S/B-5457-2015; Pratchett, Morgan/AAW-5179-2020; Graham, Nicholas AJ/C-8360-2014; Pratchett, Morgan S/A-9256-2010; Hobbs, Jean-Paul/I-8743-2012; depczynski, martial/B-7689-2008	Pratchett, Morgan/0000-0002-1862-8459; Graham, Nicholas AJ/0000-0002-0304-7467; Pratchett, Morgan S/0000-0002-1862-8459; Hobbs, Jean-Paul/0000-0003-0331-354X; depczynski, martial/0000-0001-8723-0076; Hoey, Andrew/0000-0002-4261-5594; Wilson, Shaun/0000-0002-4590-0948	ARC Centre of Excellence for Coral Reef Studies; Natural Environment Research Council [ceh010010] Funding Source: researchfish	ARC Centre of Excellence for Coral Reef Studies(Australian Research Council); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	THis work was supported by the ARC Centre of Excellence for Coral Reef Studies. MSP received the finds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen G.R., 2003, REEF FISH IDENTIFICA; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; BELL JD, 1984, MAR ECOL PROG SER, V15, P265, DOI 10.3354/meps015265; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Coker DJ, 2014, REV FISH BIOL FISHER, V24, P89, DOI 10.1007/s11160-013-9319-5; Coker DJ, 2009, BEHAV ECOL, V20, P1204, DOI 10.1093/beheco/arp113; COLES SL, 1980, MAR ECOL PROG SER, V2, P281, DOI 10.3354/meps002281; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; DeMartini EE, 1996, COPEIA, P362, DOI 10.2307/1446852; DeMartini EE, 1996, B MAR SCI, V58, P826; DONALDSON TJ, 1990, JPN J ICHTHYOL, V36, P439, DOI 10.1007/BF02905464; DONALDSON TJ, 1989, ENVIRON BIOL FISH, V24, P295, DOI 10.1007/BF00001403; DONALDSON TJ, 1987, B MAR SCI, V41, P531; DONALDSON TJ, 1986, JPN J ICHTHYOL, V33, P329, DOI 10.1007/BF02904172; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; FOWLER AJ, 1987, CORAL REEFS, V6, P49, DOI 10.1007/BF00302212; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Gaston KJ, 1997, J ANIM ECOL, V66, P579, DOI 10.2307/5951; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Graham NAJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003039; Hanski I, 1993, 3 EXPLANATIONS POSIT, P108; Hiatt R. H., 1960, Ecological Monographs, V30, P65, DOI 10.2307/1942181; HOBSON ES, 1974, FISH B-NOAA, V72, P915; HOBSON ES, 1994, ENVIRON BIOL FISH, V40, P49, DOI 10.1007/BF00002182; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Kadota T, 2011, ENVIRON BIOL FISH, V92, P79, DOI 10.1007/s10641-011-9817-z; Kane C, 2009, ENVIRON BIOL FISH, V84, P1, DOI 10.1007/s10641-008-9377-z; Madin JS, 2006, NATURE, V444, P477, DOI 10.1038/nature05328; Manly B.F.J., 2002, RESOURCE SELECTION A; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; Morin PJ, 2011, COMMUNITY ECOLOGY, 2ND EDITION, P1, DOI 10.1002/9781444341966; Munday PL, 1998, OCEANOGR MAR BIOL<D>, V36, P373; Munday PL, 2000, ENVIRON BIOL FISH, V58, P355, DOI 10.1023/A:1007689314926; Munday PL, 1997, MAR ECOL PROG SER, V152, P227, DOI 10.3354/meps152227; Myers RF, 1989, CORAL GRAPHICS GUAM; Onton K, 2011, MAR ECOL PROG SER, V433, P75, DOI 10.3354/meps09156; PIMM SL, 1981, OIKOS, V37, P1, DOI 10.2307/3544067; Pratchett MS, 2009, MAR ENVIRON RES, V67, P230, DOI 10.1016/j.marenvres.2009.03.001; Pratchett MS, 2008, OCEANOGR MAR BIOL, V46, P251, DOI 10.1201/9781420065756.ch6; Pratchett MS, 2014, OCEANOGR MAR BIOL, V52, P133; Pratchett MS, 2012, ECOL EVOL, V2, P2168, DOI 10.1002/ece3.321; Pratchett Morgan S., 2011, Diversity, V3, P424, DOI 10.3390/d3030424; RCore Team, 2020, R LANG ENV STAT COMP; Rosenzweig ML, 1997, EVOL ECOL, V11, P733, DOI 10.1023/A:1018490419885; SADOVY Y, 1995, ENVIRON BIOL FISH, V42, P143, DOI 10.1007/BF00001992; SALE PF, 1971, COPEIA, P324; Schmitt RJ, 2009, ECOLOGY, V90, P2434, DOI 10.1890/08-1225.1; Sheppard CRC, 2002, AMBIO, V31, P40, DOI 10.1639/0044-7447(2002)031[0040:EVROCR]2.0.CO;2; Slatyer RA, 2013, ECOL LETT, V16, P1104, DOI 10.1111/ele.12140; SMITH EP, 1982, ECOLOGY, V63, P1675, DOI 10.2307/1940109; Stella JS, 2010, CORAL REEFS, V29, P957, DOI 10.1007/s00338-010-0648-8; Stella JS, 2011, OCEANOGR MAR BIOL, V49, P43; Turner SJ, 1999, FISHERIES MANAG ECOL, V6, P401, DOI 10.1046/j.1365-2400.1999.00167.x; WERNER EE, 1983, ECOLOGY, V64, P1540, DOI 10.2307/1937508; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x; Wilson SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015185	62	8	8	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0138136	10.1371/journal.pone.0138136	http://dx.doi.org/10.1371/journal.pone.0138136			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529406	Green Published, Green Accepted, gold			2022-12-26	WOS:000364032600002
J	Harris, C; Abubeker, S; Yu, MM; Leskey, T; Zhang, AJ				Harris, Christina; Abubeker, Sitra; Yu, Mengmeng; Leskey, Tracy; Zhang, Aijun			Semiochemical Production and Laboratory Behavior Response of the Brown Marmorated Stink Bug, Halyomorpha Halys	PLOS ONE			English	Article							SUBSTRATE-BORNE SIGNALS; SEX-PHEROMONE; HETEROPTERA-PENTATOMIDAE; AGGREGATION PHEROMONE; MOTH; IDENTIFICATION; COMMUNICATION; ATTRACTION; HEMIPTERA	Background The brown marmorated stink bug (BMSB) is an exotic insect pest that was first recognized in the United States in 2001. As of today, it has been found in more than 42 states. BMSB has a very broad host plant range and damage to crops in mid-Atlantic States has reached a critical level. A reliable and accurate tool for infestation detection and population monitoring is urgently needed to provide better and more timely interventions. Pheromones produced by male BMSB have been previously identified and are currently used in BMSB infestation detection. However, the conditions affecting BMSB production of these pheromones were unknown. Methodology/Principal Findings In this study, we collected headspace volatiles from male BMSB under laboratory conditions, measured the temporal patterns of release of these pheromones, and assayed the attractiveness to conspecifics. In addition to the pheromone components, tridecane (C13) and E-2-decenal (an alarm compound) were observed in headspace collections of males, as well as in females and nymphs. Exposure of pheromone-emitting adult males to synthetic C13 greatly reduced pheromone emission. Conclusions/Significance This information should lead to a better understanding of the biology, physiology, and chemical ecology of BMSB, which will help scientists and growers develop more efficient strategies based on natural products to manage BMSB population, therefore, reducing pesticide usage and protecting the crops from BMSB damage.	[Harris, Christina; Abubeker, Sitra; Yu, Mengmeng; Zhang, Aijun] ARS, Invas Insect Biocontrol & Behav Lab, USDA, Beltsville, MD 20705 USA; [Harris, Christina] Virginia Tech Univ, Dept Entomol, Blacksburg, VA 24060 USA; [Leskey, Tracy] ARS, Appalachian Fruit Res Stn, USDA, Kearneysville, WV 25430 USA	United States Department of Agriculture (USDA); Virginia Polytechnic Institute & State University; United States Department of Agriculture (USDA)	Zhang, AJ (corresponding author), ARS, Invas Insect Biocontrol & Behav Lab, USDA, Beltsville, MD 20705 USA.	aijun.zhang@ars.usda.gov			USDA	USDA(United States Department of Agriculture (USDA))	This research was fully funded by USDA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich JR, 2009, FLA ENTOMOL, V92, P483, DOI 10.1653/024.092.0310; Aldrich JR, 2007, J CHEM ECOL, V33, P801, DOI 10.1007/s10886-007-9270-9; ALDRICH JR, 1988, ANNU REV ENTOMOL, V33, P211, DOI 10.1146/annurev.en.33.010188.001235; BAKER TC, 1979, J INSECT PHYSIOL, V25, P943, DOI 10.1016/0022-1910(79)90107-0; Cokl A, 2003, ANNU REV ENTOMOL, V48, P29, DOI 10.1146/annurev.ento.48.091801.112605; Hoebeke ER, 2003, P ENTOMOL SOC WASH, V105, P225; KAWADA H, 1983, APPL ENTOMOL ZOOL, V18, P234, DOI 10.1303/aez.18.234; Khrimian A, 2014, J NAT PROD, V77, P1708, DOI 10.1021/np5003753; Krupke CH, 2006, ANN ENTOMOL SOC AM, V99, P169, DOI 10.1603/0013-8746(2006)099[0169:DPOECH]2.0.CO;2; Leskey T. C., 2012, Outlooks on Pest Management, V23, P218, DOI 10.1564/23oct07; Leskey Tracy C., 2012, Psyche (Cambridge), V2012, P1, DOI 10.1155/2012/535062; Leskey TC, 2012, J ENTOMOL SCI, V47, P76; Levi-Zada A, 2014, J CHEM ECOL, V40, P236, DOI 10.1007/s10886-014-0391-7; McBrien HL, 2001, J CHEM ECOL, V27, P1821, DOI 10.1023/A:1010460709535; MORIYA S, 1984, APPL ENTOMOL ZOOL, V19, P317, DOI 10.1303/aez.19.317; Nielsen AL, 2008, J ECON ENTOMOL, V101, P1439, DOI 10.1603/0022-0493(2008)101[1439:TOITHH]2.0.CO;2; Nielsen AL, 2009, ANN ENTOMOL SOC AM, V102, P608, DOI 10.1603/008.102.0405; OTA D, 1991, J INSECT BEHAV, V4, P441, DOI 10.1007/BF01049329; PRESTWICH GD, 1990, J CHEM ECOL, V16, P1761, DOI 10.1007/BF01020493; Ryan MF., 2002, INSECT CHEMORECEPTIO, P113, DOI DOI 10.1007/0-306-47581-2; Silvegren G, 2005, J INSECT PHYSIOL, V51, P277, DOI 10.1016/j.jinsphys.2004.11.013; Zahn DK, 2008, J CHEM ECOL, V34, P238, DOI 10.1007/s10886-007-9415-x; Zhang AJ, 2004, P NATL ACAD SCI USA, V101, P9601, DOI 10.1073/pnas.0401298101; ZHANG AJ, 1994, J CHEM ECOL, V20, P2415, DOI 10.1007/BF02033210; Zunic A, 2008, ANN ENTOMOL SOC AM, V101, P1169, DOI 10.1603/0013-8746-101.6.1169	25	30	30	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0140876	10.1371/journal.pone.0140876	http://dx.doi.org/10.1371/journal.pone.0140876			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528717	Green Published, Green Submitted, gold			2022-12-26	WOS:000364032600016
J	Marchant, I; Boissel, JP; Nony, P; Gueyffier, F				Marchant, Ivanny; Boissel, Jean-Pierre; Nony, Patrice; Gueyffier, Francois			High Risk versus Proportional Benefit: Modelling Equitable Strategies in Cardiovascular Prevention	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; EUROPEAN GUIDELINES; CLINICAL-PRACTICE; HEALTH-CARE; FRAMINGHAM; SCORE; ENGINE; METAANALYSIS; POPULATION; VALIDATION	Objective To examine the performances of an alternative strategy to decide initiating BP-lowering drugs called Proportional Benefit (PB). It selects candidates addressing the inequity induced by the high-risk approach since it distributes the gains proportionally to the burden of disease by genders and ages. Study Design and Setting Mild hypertensives from a Realistic Virtual Population by genders and 10-year age classes (range 35-64 years) received simulated treatment over 10 years according to the PB strategy or the 2007 ESH/ESC guidelines (ESH/ESC). Primary outcomes were the relative lifeyear gain (life-years gained-to-years of potential life lost ratio) and the number needed to treat to gain a life-year. A sensitivity analysis was performed to assess the impact of changes introduced by the ESH/ESC guidelines appeared in 2013 on these outcomes. Results The 2007 ESH/ESC relative life-year gains by ages were 2%; 10%; 14% in men, and 0%; 2%; 11% in women, this gradient being abolished by the PB (relative gain in all categories = 10%), while preserving the same overall gain in life-years. The redistribution of benefits improved the profile of residual events in younger individuals compared to the 2007 ESH/ESC guidelines. The PB strategy was more efficient (NNT = 131) than the 2013 ESH/ESC guidelines, whatever the level of evidence of the scenario adopted (NNT = 139 and NNT = 179 with the evidence-based scenario and the opinion-based scenario, respectively), although the 2007 ESH/ESC guidelines remained the most efficient strategy (NNT = 114). Conclusion The Proportional Benefit strategy provides the first response ever proposed against the inequity of resource use when treating highest risk people. It occupies an intermediate position with regards to the efficiency expected from the application of historical and current ESH/ESC hypertension guidelines. Our approach allows adapting recommendations to the risk and resources of a particular country.	[Marchant, Ivanny] Univ Valparaiso, Escuela Med, Valparaiso, Chile; [Boissel, Jean-Pierre] NovaDiscovery, Biomodelling Dept, Lyon, France; [Nony, Patrice; Gueyffier, Francois] CNRS, Lab Biometrie & Biol Evolut, Serv Pharmacol Clin & Essais Therapeut, UMR 5558, Lyon, France; [Gueyffier, Francois] INSERM, EPICIME, CIC 201, F-69008 Lyon, France; [Gueyffier, Francois] CHU Lyon, Hop L Pradel, Lyon, France	Universidad de Valparaiso; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); VetAgro Sup; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon	Marchant, I (corresponding author), Univ Valparaiso, Escuela Med, Valparaiso, Chile.	ivanny.marchant@uv.cl	Gueyffier, François/B-8545-2008	Gueyffier, François/0000-0002-9921-0977	Fondo Nacional de Desarrollo Cientifico y Tecnologico-FONDECYT Iniciacion a la investigacion at CONICYT Chile [11110399]; Agence Nationale de la Recherche France [SYSCOMM 002]; NovaDiscovery	Fondo Nacional de Desarrollo Cientifico y Tecnologico-FONDECYT Iniciacion a la investigacion at CONICYT Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Agence Nationale de la Recherche France(French National Research Agency (ANR)); NovaDiscovery	This study was supported by the Fondo Nacional de Desarrollo Cientifico y Tecnologico-FONDECYT Iniciacion a la investigacion at CONICYT Chile [11110399] (http://www.conicyt.cl/fondecyt/), and the Agence Nationale de la Recherche France [SYSCOMM 002] (http://www.agence-nationale-recherche.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. NovaDiscovery provided support in the form of a salary for author JPB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Almeda-Valdes P, 2010, CURR DIABETES REV, V6, P1, DOI 10.2174/157339910790442646; [Anonymous], 2010, INSEE POPULATION EVO; [Anonymous], WHO DEF OLD ELD PERS; Athanasakis K, 2012, J HYPERTENS, V30, P227, DOI 10.1097/HJH.0b013e32834d9f18; Boissel JP, 2011, PERS MED, V8, P581, DOI [10.2217/pme.11.54, 10.2217/PME.11.54]; Capewell S, 2009, AM J EPIDEMIOL, V170, P229, DOI 10.1093/aje/kwp150; Claxton K, 2011, HEALTH ECON, V20, P2, DOI 10.1002/hec.1612; Coleman RL, 2007, DIABETES CARE, V30, P1292, DOI 10.2337/dc06-1358; Coleman RL, 2012, DIABETES, V61, pA103; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; De Backer G, 2003, EUR J CARDIOV PREV R, V10, pS1, DOI 10.1097/01.hjr.0000087913.96265.e2; Diao D, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006742.pub2; Earnshaw J, 2008, PHARMACOECONOMICS, V26, P725, DOI 10.2165/00019053-200826090-00002; Erhardt LR, 2006, ATHEROSCLEROSIS, V185, P12, DOI 10.1016/j.atherosclerosis.2005.10.001; Goldman DP, 2009, AM J PUBLIC HEALTH, V99, P2096, DOI 10.2105/AJPH.2009.172627; Graham I, 2007, EUR HEART J, V28, P2375, DOI 10.1093/eurheartj/ehm316; Granstrom O, 2012, CLINICOECONOMIC OUTC, V4, P313, DOI 10.2147/CEOR.S35824; Gravelle H, 2007, HEALTH ECON, V16, P307, DOI 10.1002/hec.1168; Gueyffier F, 1996, J HUM HYPERTENS, V10, P1; Guzder RN, 2005, DIABETIC MED, V22, P554, DOI 10.1111/j.1464-5491.2005.01494.x; Hense HW, 2003, EUR HEART J, V24, P937, DOI 10.1016/S0195-668X(03)00081-2; Hippisley-Cox J, 2007, BMJ-BRIT MED J, V335, P136, DOI 10.1136/bmj.39261.471806.55; Kahn R, 2008, DIABETES CARE, V31, P1686, DOI 10.2337/dc08-9022; Kengne AP, 2010, DIABETOLOGIA, V53, P821, DOI 10.1007/s00125-010-1681-4; Liew SM, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000728; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/eht151, 10.1093/eurheartj/ehm236]; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; Marchant I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017508; Marchant I, 2009, EUR J CARDIOV PREV R, V16, P609, DOI 10.1097/HJR.0b013e32832da006; Nord E, 2011, HEALTH ECON, V20, P16, DOI 10.1002/hec.1687; PAHO's Area of Health Analysis and Information Systems (AIS), 2003, Epidemiol Bull, V24, P1; Perk Joep, 2012, Int J Behav Med, V19, P403, DOI [10.1016/j.atherosclerosis.2012.05.007, 10.1093/eurheartj/ehs092, 10.1007/s12529-012-9242-5]; R Core Team, 2021, R LANGUAGE ENV STAT; ROSE G, 1981, BMJ-BRIT MED J, V282, P1847, DOI 10.1136/bmj.282.6279.1847; Sozou PD, 2009, P R SOC B, V276, P2955, DOI 10.1098/rspb.2009.0401; SPIEGELHALTER DJ, 1992, BRIT MED J, V305, P1205, DOI 10.1136/bmj.305.6863.1205; Sundstrom J, 2014, LANCET, V384, P591, DOI 10.1016/S0140-6736(14)61212-5; Thomopoulos C, 2014, J HYPERTENS, V32, P2305, DOI 10.1097/HJH.0000000000000380; Thomsen TF, 2002, INT J EPIDEMIOL, V31, P817, DOI 10.1093/ije/31.4.817; Torgerson DJ, 1999, BRIT MED J, V319, P914, DOI 10.1136/bmj.319.7214.914; van der Heijden AAWA, 2009, DIABETES CARE, V32, P2094, DOI 10.2337/dc09-0745	41	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0140793	10.1371/journal.pone.0140793	http://dx.doi.org/10.1371/journal.pone.0140793			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529507	Green Published, Green Submitted, gold			2022-12-26	WOS:000364032600013
J	Richardson, MF; Sherman, CDH				Richardson, Mark F.; Sherman, Craig D. H.			De Novo Assembly and Characterization of the Invasive Northern Pacific Seastar Transcriptome	PLOS ONE			English	Article							GENERATION SEQUENCING DATA; MUSSELS GENUS MYTILUS; TRANSPOSABLE ELEMENTS; RAPID TRANSCRIPTOME; POPULATION GENOMICS; ASTERIAS-AMURENSIS; ERROR-CORRECTION; HEAT-STRESS; RNA-SEQ; CD-HIT	Invasive species are a major threat to global biodiversity but can also serve as valuable model systems to examine important evolutionary processes. While the ecological aspects of invasions have been well documented, the genetic basis of adaptive change during the invasion process has been hampered by a lack of genomic resources for the majority of invasive species. Here we report the first larval transcriptomic resource for the Northern Pacific Seastar, Asterias amurensis, an invasive marine predator in Australia. Approximately 117.5 million 100 base-pair (bp) paired-end reads were sequenced from a single RNA-Seq library from a pooled set of full-sibling A. amurensis bipinnaria larvae. We evaluated the efficacy of a pre-assembly error correction pipeline on subsequent de novo assembly. Error correction resulted in small but important improvements to the final assembly in terms of mapping statistics and core eukaryotic genes representation. The error-corrected de novo assembly resulted in 115,654 contigs after redundancy clustering. 41,667 assembled contigs were homologous to sequences from NCBI's non-redundant protein and Uni-Prot databases. We assigned Gene Ontology, KEGG Orthology, Pfam protein domain terms and predicted protein-coding sequences to > 36,000 contigs. The final transcriptome dataset generated here provides functional information for 18,319 unique proteins, comprising at least 11,355 expressed genes. Furthermore, we identified 9,739 orthologs to P. miniata proteins, evaluated our annotation pipeline and generated a list of 150 candidate genes for responses to several environmental stressors that may be important for adaptation of A. amurensis in the invasive range. Our study has produced a large set of A. amurensis RNA contigs with functional annotations that can serve as a resource for future comparisons to other echinoderm transcriptomes and gene expression studies. Our data can be used to study the genetic basis of adaptive change and other important evolutionary processes during a successful invasion.	[Richardson, Mark F.] Deakin Univ, Geelong, Vic 3217, Australia; Ctr Integrat Ecol, Sch Life & Environm Sci, Geelong, Vic 3220, Australia	Deakin University	Richardson, MF (corresponding author), Deakin Univ, Geelong, Vic 3217, Australia.	m.richardson@deakin.edu.au	Sherman, Craig/A-2484-2010	Sherman, Craig/0000-0003-2099-0462	Holsworth Wildlife Research Endowment Award [RM23514]; Centre for Integrative Ecology (Deakin University); Deakin University International Postgraduate Research Scholarship	Holsworth Wildlife Research Endowment Award; Centre for Integrative Ecology (Deakin University); Deakin University International Postgraduate Research Scholarship	Research was supported by a Holsworth Wildlife Research Endowment Award (RM23514) and funding from the Centre for Integrative Ecology (Deakin University). MFR is supported by a Deakin University International Postgraduate Research Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allhoff M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S5-S1; Arthofer W, 2015, MOL ECOL RESOUR, V15, P228, DOI 10.1111/1755-0998.12340; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barron MG, 2014, ANNU REV GENET, V48, P561, DOI 10.1146/annurev-genet-120213-092359; Bock DG, 2014, MOL ECOL; Brayer KJ, 2008, CELL BIOCHEM BIOPHYS, V50, P111, DOI 10.1007/s12013-008-9008-5; Brown C. T., 2012, ARXIV12034802QBICOGN, V1203, P4802; BRUCE BD, 1995, LAB FIELD STUDIES LA; BYRNE M, 1992, MAR BIOL, V114, P297, DOI 10.1007/BF00349533; Cahais V, 2012, MOL ECOL RESOUR, V12, P834, DOI 10.1111/j.1755-0998.2012.03148.x; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cameron RA, 2009, NUCLEIC ACIDS RES, V37, pD750, DOI 10.1093/nar/gkn887; Casacuberta E, 2013, MOL ECOL, V22, P1503, DOI 10.1111/mec.12170; Chu JH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-149; De Wit P, 2012, MOL ECOL RESOUR, V12, P1058, DOI 10.1111/1755-0998.12003; Dlugosch KM, 2008, ECOL LETT, V11, P701, DOI 10.1111/j.1461-0248.2008.01181.x; Du HX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033311; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Francis WR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-167; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Gillard GB, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-45; Goggin LC., 1998, P M BIOL MAN INTR SE; Grosholz E, 2002, TRENDS ECOL EVOL, V17, P22, DOI 10.1016/S0169-5347(01)02358-8; Hansen KD, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq224; Harms L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-789; Hou R., 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021560, DOI 10.1371/J0URNAL.P0NE.0021560]; Ioannidis P, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-738; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kashenko SD., 2005, RUSS J MAR BIOL, V31, P294, DOI [10.1007/s11179-005-0091-9, DOI 10.1007/S11179-005-0091-9]; Keller SR, 2008, ECOL LETT, V11, P852, DOI 10.1111/j.1461-0248.2008.01188.x; Kolbe JJ, 2014, PHYSIOL BIOCHEM ZOOL, V87, P92, DOI 10.1086/672157; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0048156; Lockwood BL, 2011, MOL ECOL, V20, P517, DOI 10.1111/j.1365-294X.2010.04973.x; Lockwood BL, 2010, J EXP BIOL, V213, P3548, DOI 10.1242/jeb.046094; Logan CA, 2011, AM J PHYSIOL-REG I, V300, pR1373, DOI 10.1152/ajpregu.00689.2010; MacManes MD, 2013, PEERJ, V1, DOI 10.7717/peerj.113; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Mateo L, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004560; Minoche AE, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r112; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Nourisson C, 2014, MOL ECOLOGY RESOURCE, DOI [10.5061/dryad, DOI 10.5061/DRYAD]; Oliver KR, 2013, GENOME BIOL EVOL, V5, P1886, DOI 10.1093/gbe/evt141; Ometto L, 2013, GENOME BIOL EVOL, V5, P745, DOI 10.1093/gbe/evt034; Papenfuss AT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-261; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Prentis P, 2008, TRENDS PLANT SCI, V13, P1360; Rollins LA, 2015, MOL ECOL, V24, P2264, DOI 10.1111/mec.13184; Rollins LA, 2013, ECOL EVOL, V3, P4501, DOI 10.1002/ece3.824; Ross DJ, 2006, ESTUAR COAST SHELF S, V67, P695, DOI 10.1016/j.ecss.2005.11.038; Ross DJ, 2002, MAR ECOL PROG SER, V241, P99, DOI 10.3354/meps241099; Salzberg SL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-102; Schrader L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6495; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Shaw TI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048472; Smith CD, 2011, P NATL ACAD SCI USA, V108, P5673, DOI 10.1073/pnas.1008617108; Stapley J, 2015, MOL ECOL, V24, P2241, DOI 10.1111/mec.13089; Surget-Groba Y, 2010, GENOME RES, V20, P1432, DOI 10.1101/gr.103846.109; Tu Q, 2014, DEV BIOL, V385, P160, DOI 10.1016/j.ydbio.2013.11.019; Tulin S, 2013, EVODEVO, V4, DOI 10.1186/2041-9139-4-16; Vandepitte K, 2014, MOL ECOL, V23, P2157, DOI 10.1111/mec.12683; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wang H, 2010, PROTEOMICS, V10, P2972, DOI 10.1002/pmic.201000056; Wang XW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-529; Wang XW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-458; Yang XA, 2010, BIOINFORMATICS, V26, P2526, DOI 10.1093/bioinformatics/btq468; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	70	12	12	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0142003	10.1371/journal.pone.0142003	http://dx.doi.org/10.1371/journal.pone.0142003			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529321	gold, Green Submitted, Green Published			2022-12-26	WOS:000364032600091
J	Swartzwelder, HS; Acheson, SK; Miller, KM; Sexton, HG; Liu, W; Crews, FT; Risher, ML				Swartzwelder, H. Scott; Acheson, Shawn K.; Miller, Kelsey M.; Sexton, Hannah G.; Liu, Wen; Crews, Fulton T.; Risher, Mary-Louise			Adolescent Intermittent Alcohol Exposure: Deficits in Object Recognition Memory and Forebrain Cholinergic Markers	PLOS ONE			English	Article							ETHANOL EXPOSURE; HIPPOCAMPAL NEUROGENESIS; PERSISTENT LOSS; ADULT; RATS; CONSUMPTION; NEURONS; LESIONS; IMPACT; CORTEX	The long-term effects of intermittent ethanol exposure during adolescence (AIE) are of intensive interest and investigation. The effects of AIE on learning and memory and the neural functions that drive them are of particular interest as clinical findings suggest enduring deficits in those cognitive domains in humans after ethanol abuse during adolescence. Although studies of such deficits after AIE hold much promise for identifying mechanisms and therapeutic interventions, the findings are sparse and inconclusive. The present results identify a specific deficit in memory function after AIE and establish a possible neural mechanism of that deficit that may be of translational significance. Male rats (starting at PND-30) received exposure to AIE (5g/kg, i.g.) or vehicle and were allowed to mature into adulthood. At PND-71, one group of animals was assessed using the spatial-temporal object recognition (stOR) test to evaluate memory function. A separate group of animals was used to assess the density of cholinergic neurons in forebrain areas Ch1-4 using immunohistochemistry. AIE exposed animals manifested deficits in the temporal component of the stOR task relative to controls, and a significant decrease in the number of ChAT labeled neurons in forebrain areas Ch1-4. These findings add to the growing literature indicating long-lasting neural and behavioral effects of AIE that persist into adulthood and indicate that memory-related deficits after AIE depend upon the tasks employed, and possibly their degree of complexity. Finally, the parallel finding of diminished cholinergic neuron density suggests a possible mechanism underlying the effects of AIE on memory and hippocampal function as well as possible therapeutic or preventive strategies for AIE.	[Swartzwelder, H. Scott; Acheson, Shawn K.; Miller, Kelsey M.; Sexton, Hannah G.; Risher, Mary-Louise] Durham VA Med Ctr, Durham, NC 27705 USA; [Swartzwelder, H. Scott; Acheson, Shawn K.; Miller, Kelsey M.; Sexton, Hannah G.; Risher, Mary-Louise] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27705 USA; [Swartzwelder, H. Scott] Duke Univ, Med Ctr Durham, Dept Psychol & Neurosci, Durham, NC 27705 USA; [Liu, Wen; Crews, Fulton T.] Univ N Carolina, Bowles Ctr Alcohol Studies, Chapel Hill, NC 27514 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill	Swartzwelder, HS (corresponding author), Durham VA Med Ctr, Durham, NC 27705 USA.	hss@duke.edu	Crews, Fulton/T-1181-2019; Acheson, Shawn/A-3299-2016; Risher, Louise/AAP-2646-2020	Crews, Fulton/0000-0003-2393-4976; Risher, Louise/0000-0002-3139-4378	NIH/NIAAA NADIA [AA019925, AA020023, AA020024]; Department of Veterans Affairs Senior Research Career Scientist award; Department of Veterans Affairs Biomedical Laboratory Research and Development Career Development Award [IK2BX001267, 1IK2BX002505]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA019925, U24AA020024, U01AA020023] Funding Source: NIH RePORTER; Veterans Affairs [IK2BX002505] Funding Source: NIH RePORTER	NIH/NIAAA NADIA; Department of Veterans Affairs Senior Research Career Scientist award(US Department of Veterans Affairs); Department of Veterans Affairs Biomedical Laboratory Research and Development Career Development Award(US Department of Veterans Affairs); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the NIH/NIAAA NADIA AA019925 (to HSS), AA020023 and AA020024 (to FTC), a Department of Veterans Affairs Senior Research Career Scientist award (to HSS), a Department of Veterans Affairs Biomedical Laboratory Research and Development Career Development Award IK2BX001267 (to SKA), and a Department of Veterans Affairs Biomedical Laboratory Research and Development Career Development Award 1IK2BX002505 (to M-LR). The contents do not represent the views of the U.S. Department of Veteran Affairs or the United States Government.	Acheson SK, 2012, PLOS ONE, V8, P1; Boutros NN, 2014, INT J PSYCHIAT CLIN, V18, P2, DOI 10.3109/13651501.2013.873053; Broadwater M, 2013, BEHAV BRAIN RES, V256, P10, DOI 10.1016/j.bbr.2013.08.013; Broadwater MA, 2014, DEV NEUROSCI-BASEL, V36, P297, DOI 10.1159/000362874; Broadwater MA, 2014, DEV PSYCHOBIOL, V56, P1150, DOI 10.1002/dev.21186; Brown SA, 2008, PEDIATRICS, V121, pS290, DOI 10.1542/peds.2007-2243D; Cabrera SM, 2006, BEHAV NEUROSCI, V120, P298, DOI 10.1037/0735-7044.120.2.298; Clark RE, 2000, J NEUROSCI, V20, P8853; Clarke JR, 2010, P NATL ACAD SCI USA, V107, P2652, DOI 10.1073/pnas.0915059107; Desikan A, 2014, PHARMACOL BIOCHEM BE, V122, P279, DOI 10.1016/j.pbb.2014.04.011; Ehlers CL, 2011, NEUROSCIENCE, V199, P333, DOI 10.1016/j.neuroscience.2011.10.011; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Ennaceur A, 1997, EXP BRAIN RES, V113, P509, DOI 10.1007/PL00005603; Fleming RL, 2012, ALCOHOL CLIN EXP RES, V36, P279, DOI 10.1111/j.1530-0277.2011.01615.x; Fletcher BR, 2007, HIPPOCAMPUS, V17, P227, DOI 10.1002/hipo.20261; Kaneko N, 2006, GENES CELLS, V11, P1145, DOI 10.1111/j.1365-2443.2006.01010.x; Kanju PM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031073; Kart-Teke E, 2006, NEUROBIOL LEARN MEM, V85, P173, DOI 10.1016/j.nlm.2005.10.002; Lehmann O, 2003, EUR J NEUROSCI, V18, P651, DOI 10.1046/j.1460-9568.2003.02745.x; Little PJ, 1996, ALCOHOL CLIN EXP RES, V20, P1346, DOI 10.1111/j.1530-0277.1996.tb01133.x; Markwiese BJ, 1998, ALCOHOL CLIN EXP RES, V22, P416, DOI 10.1111/j.1530-0277.1998.tb03668.x; Matthews DB, 2010, ALCOHOL, V44, P1, DOI 10.1016/j.alcohol.2009.10.018; Mitchell JB, 1998, BEHAV BRAIN RES, V97, P107, DOI 10.1016/S0166-4328(98)00032-1; Mohapel P, 2005, NEUROBIOL AGING, V26, P939, DOI 10.1016/j.neurobiolaging.2004.07.015; Pascual M, 2007, EUR J NEUROSCI, V25, P541, DOI 10.1111/j.1460-9568.2006.05298.x; RILEY JN, 1978, SCIENCE, V201, P646, DOI 10.1126/science.566953; Risher ML, 2015, ALCOHOL CLIN EXP RES, V39, P989, DOI 10.1111/acer.12725; Risher ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062940; Silvers JM, 2006, ALCOHOL, V39, P151, DOI 10.1016/j.alcohol.2006.09.001; Silvers JM, 2003, ALCOHOL CLIN EXP RES, V27, P1606, DOI 10.1097/01.ALC.0000090141.66526.22; Sircar R, 2005, ALCOHOL CLIN EXP RES, V29, P1402, DOI 10.1097/01.alc.0000175012.77756.d9; Spear LP, 2014, NEUROSCI BIOBEHAV R, V45, P1, DOI 10.1016/j.neubiorev.2014.04.012; Squeglia LM, 2011, ALCOHOL CLIN EXP RES, V35, P1831, DOI 10.1111/j.1530-0277.2011.01527.x; Swartzwelder HS, 1995, ALCOHOL CLIN EXP RES, V19, P1480, DOI 10.1111/j.1530-0277.1995.tb01011.x; Teles-Grilo Ruivo Leonor M, 2013, Front Synaptic Neurosci, V5, P2, DOI 10.3389/fnsyn.2013.00002; Vetreno RP, 2012, NEUROSCIENCE, V226, P475, DOI 10.1016/j.neuroscience.2012.08.046; Vetreno RP, 2015, ADDICT BIOL, P12232; Vetreno RP, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00035; Vetreno RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113421; Vivar C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2101; WALKER DW, 1978, NEUROPSYCHOLOGIA, V16, P545, DOI 10.1016/0028-3932(78)90082-9; WALKER DW, 1980, SCIENCE, V209, P711, DOI 10.1126/science.7394532; White AM, 2000, ALCOHOL CLIN EXP RES, V24, P1251, DOI 10.1111/j.1530-0277.2000.tb02091.x; White AM, 2004, ANN NY ACAD SCI, V1021, P206, DOI 10.1196/annals.1308.026	44	32	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0140042	10.1371/journal.pone.0140042	http://dx.doi.org/10.1371/journal.pone.0140042			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529506	Green Published, Green Submitted, gold			2022-12-26	WOS:000364032600003
J	Mattera, R; Guardia, CM; Sidhu, SS; Bonifacino, JS				Mattera, Rafael; Guardia, Carlos M.; Sidhu, Sachdev S.; Bonifacino, Juan S.			Bivalent Motif-Ear Interactions Mediate the Association of the Accessory Protein Tepsin with the AP-4 Adaptor Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRESSIVE SPASTIC PARAPLEGIA; APPENDAGE DOMAIN; STRUCTURAL BASIS; SORTING SIGNALS; INTELLECTUAL DISABILITY; DEFICIENCY CAUSES; ALPHA-APPENDAGE; COATED VESICLES; CLATHRIN; BINDING	The heterotetrameric (epsilon-beta 4-mu 4-sigma 4) complex adaptor protein 4 (AP-4) is a component of a non-clathrin coat involved in protein sorting at the trans-Golgi network (TGN). Considerable interest in this complex has arisen from the recent discovery that mutations in each of its four subunits are the cause of a congenital intellectual disability and movement disorder in humans. Despite its physiological importance, the structure and function of this coat remain poorly understood. To investigate the assembly of the AP-4 coat, we dissected the determinants of interaction of AP-4 with its only known accessory protein, the ENTH/VHS-domain-containing protein tepsin. Using a variety of protein interaction assays, we found that tepsin comprises two phylogenetically conserved peptide motifs, [GS] LFXG [ML] X[LV] and S[AV] F[SA] FLN, within its C-terminal unstructured region, which interact with the C-terminal ear (or appendage) domains of the beta 4 and epsilon subunits of AP-4, respectively. Structure-based mutational analyses mapped the binding site for the [GS] LFXG[ML] X[LV] motif to a conserved, hydrophobic surface on the beta 4-ear platform fold. Both peptide-ear interactions are required for efficient association of tepsin with AP-4, and for recruitment of tepsin to the TGN. The bivalency of the interactions increases the avidity of tepsin for AP-4 and may enable cross-linking of multiple AP-4 heterotetramers, thus contributing to the assembly of the AP-4 coat. In addition to revealing critical aspects of this coat, our findings extend the paradigm of peptide-ear interactions, previously established for clathrin-AP-1/AP-2 coats, to a non-clathrin coat.	[Mattera, Rafael; Guardia, Carlos M.; Bonifacino, Juan S.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA; [Sidhu, Sachdev S.] Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Toronto	Bonifacino, JS (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Cell Biol & Metab Program, NIH, Bldg 35,Room 2F-226,35A Convent Dr,MSC 3758, Bethesda, MD 20892 USA.	bonifacinoj@helix.nih.gov	Guardia, Carlos M./ABC-8375-2020	Guardia, Carlos/0000-0002-4662-9360; Bonifacino, Juan S./0000-0002-5673-6370	Intramural Program of NICHD, National Institutes of Health [ZIA HD001607]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001607] Funding Source: NIH RePORTER	Intramural Program of NICHD, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by the Intramural Program of NICHD, National Institutes of Health (ZIA HD001607). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abou Jamra R, 2011, AM J HUM GENET, V88, P788, DOI 10.1016/j.ajhg.2011.04.019; Bauer P, 2012, NEUROGENETICS, V13, P73, DOI 10.1007/s10048-012-0314-0; Boehm M, 2001, EMBO J, V20, P6265, DOI 10.1093/emboj/20.22.6265; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Borner GHH, 2012, J CELL BIOL, V197, P141, DOI 10.1083/jcb.201111049; Brett TJ, 2002, STRUCTURE, V10, P797, DOI 10.1016/S0969-2126(02)00784-0; Burgos PV, 2010, DEV CELL, V18, P425, DOI 10.1016/j.devcel.2010.01.015; Collins BM, 2003, NAT STRUCT BIOL, V10, P607, DOI 10.1038/nsb955; Dell'Angelica EC, 1999, J BIOL CHEM, V274, P7278, DOI 10.1074/jbc.274.11.7278; Dell'Angelica EC, 1998, SCIENCE, V280, P431, DOI 10.1126/science.280.5362.431; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Duncan MC, 2003, NAT CELL BIOL, V5, P77, DOI 10.1038/ncb901; Edeling MA, 2006, DEV CELL, V10, P329, DOI 10.1016/j.devcel.2006.01.016; Eletsky A, 2013, SOLUTION NMR STRUCTU; Hardies K, 2015, HUM MOL GENET, V24, P2218, DOI 10.1093/hmg/ddu740; Hirst J, 1999, MOL BIOL CELL, V10, P2787, DOI 10.1091/mbc.10.8.2787; Hirst J, 2014, ELIFE, V3, DOI 10.7554/eLife.02866; Hirst J, 2013, TRAFFIC, V14, P153, DOI 10.1111/tra.12028; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jha A, 2004, J BIOL CHEM, V279, P2281, DOI 10.1074/jbc.M305644200; Jurgens MC, 2013, NAT CHEM BIOL, V9, P540, DOI [10.1038/NCHEMBIO.1294, 10.1038/nchembio.1294]; Kametaka S, 2007, MOL BIOL CELL, V18, P2991, DOI 10.1091/mbc.E06-12-1162; Kent HM, 2002, STRUCTURE, V10, P1139, DOI 10.1016/S0969-2126(02)00801-8; Kirchhausen T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016725; Legendre-Guillemin V, 2004, J CELL SCI, V117, P9, DOI 10.1242/jcs.00928; Mardones GA, 2013, J BIOL CHEM, V288, P9563, DOI 10.1074/jbc.M113.450775; Matsuda S, 2008, NEURON, V57, P730, DOI 10.1016/j.neuron.2008.02.012; Mattera R, 2003, EMBO J, V22, P78, DOI 10.1093/emboj/cdg015; Mattera R, 2004, J BIOL CHEM, V279, P8018, DOI 10.1074/jbc.M311873200; Miller GJ, 2003, NAT STRUCT BIOL, V10, P599, DOI 10.1038/nsb953; Mills IG, 2003, J CELL BIOL, V160, P213, DOI 10.1083/jcb.200208023; Mishra SK, 2005, J BIOL CHEM, V280, P19270, DOI 10.1074/jbc.M501029200; Mishra SK, 2004, J BIOL CHEM, V279, P46191, DOI 10.1074/jbc.M408095200; Moreno-De-Luca A, 2011, J MED GENET, V48, P141, DOI 10.1136/jmg.2010.082263; Nogi T, 2002, NAT STRUCT BIOL, V9, P527, DOI 10.1038/nsb808; Ohno H, 1996, J BIOL CHEM, V271, P29009, DOI 10.1074/jbc.271.46.29009; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Owen DJ, 2000, EMBO J, V19, P4216, DOI 10.1093/emboj/19.16.4216; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; Owen DJ, 1999, CELL, V97, P805, DOI 10.1016/S0092-8674(00)80791-6; Paczkowski JE, 2012, EMBO J, V31, P4191, DOI 10.1038/emboj.2012.268; Park SY, 2014, BIOSCI REP, V34; Praefcke GJK, 2004, EMBO J, V23, P4371, DOI 10.1038/sj.emboj.7600445; Pu J, 2015, DEV CELL, V33, P176, DOI 10.1016/j.devcel.2015.02.011; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Schmid EM, 2006, PLOS BIOL, V4, P1532, DOI 10.1371/journal.pbio.0040262; Sen Arpita, 2012, Biomol Concepts, V3, P117; Sidhu SS, 2000, METHOD ENZYMOL, V328, P333, DOI 10.1016/S0076-6879(00)28406-1; Simmen T, 2002, NAT CELL BIOL, V4, P154, DOI 10.1038/ncb745; Traub LM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016790; Verkerk AJMH, 2009, AM J HUM GENET, V85, P40, DOI 10.1016/j.ajhg.2009.06.004; Yap CC, 2003, MOL CELL NEUROSCI, V24, P283, DOI 10.1016/S1044-7431(03)00164-7	53	16	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					30736	30749		10.1074/jbc.M115.683409	http://dx.doi.org/10.1074/jbc.M115.683409			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26542808	Green Published, hybrid			2022-12-26	WOS:000367199000008
J	Alonso, A; Yu, B; Qureshi, WT; Grams, ME; Selvin, E; Soliman, EZ; Loehr, LR; Chen, LY; Agarwal, SK; Alexander, D; Boerwinkle, E				Alonso, Alvaro; Yu, Bing; Qureshi, Waqas T.; Grams, Morgan E.; Selvin, Elizabeth; Soliman, Elsayed Z.; Loehr, Laura R.; Chen, Lin Y.; Agarwal, Sunil K.; Alexander, Danny; Boerwinkle, Eric			Metabolomics and Incidence of Atrial Fibrillation in African Americans: The Atherosclerosis Risk in Communities (ARIC) Study	PLOS ONE			English	Article							HEART-FAILURE; BILE-ACIDS	Background Atrial fibrillation (AF) is a common arrhythmia. Application of metabolomic approaches, which may identify novel pathways and biomarkers of disease risk, to a longitudinal epidemiologic study of AF has been limited. Methods We determined the prospective association of 118 serum metabolites identified through untargeted metabolomics profiling with the incidence of newly-diagnosed AF in 1919 African-American men and women from the Atherosclerosis Risk in Communities study without AF at baseline (1987-1989). Incident AF cases through 2011 were ascertained from study electrocardiograms, hospital discharge codes, and death certificates. Results During a median follow-up of 22 years, we identified 183 incident AF cases. In Cox proportional hazards models adjusted for age, sex, smoking, body mass index, systolic blood pressure, use of antihypertensive medication, diabetes, prevalent heart failure, prevalent coronary heart disease, and kidney function, two conjugated bile acids (glycolithocholate sulfate and glycocholenate sulfate) were significantly associated with AF risk after correcting for multiple comparisons (p<0.0004). Multivariable-adjusted hazard ratios (95% confidence intervals) of AF were 1.22 (1.12-1.32) for glycolithocholate sulfate and 1.22 (1.10-1.35) for glycocholenate sulfate per 1-standard deviation higher levels. Associations were not appreciably different after additional adjustment for alcohol consumption or concentrations of circulating albumin and liver enzymes. Conclusion We found an association of higher levels of two bile acids with an increased risk of AF, pointing to a potential novel pathway in AF pathogenesis. Replication of results in independent studies is warranted.	[Alonso, Alvaro] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA; [Yu, Bing; Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA; [Qureshi, Waqas T.] Wake Forest Univ, Bowman Gray Sch Med, Div Cardiovasc Med, Winston Salem, NC USA; [Grams, Morgan E.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Grams, Morgan E.; Selvin, Elizabeth] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Selvin, Elizabeth] Johns Hopkins Univ, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA; [Soliman, Elsayed Z.] Wake Forest Sch Med, Dept Epidemiol & Prevent, Epidemiol Cardiol Res Ctr EPICARE, Winston Salem, NC USA; [Soliman, Elsayed Z.] Wake Forest Sch Med, Dept Med Cardiol, Winston Salem, NC USA; [Loehr, Laura R.] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Chen, Lin Y.] Univ Minnesota, Sch Med, Dept Med, Div Cardiovasc, Minneapolis, MN 55455 USA; [Agarwal, Sunil K.] Mt Sinai Heart Hosp, New York, NY USA; [Alexander, Danny] Metabolon Inc, Durham, NC USA; [Boerwinkle, Eric] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; University of Texas Health Science Center Houston; Wake Forest University; Wake Forest Baptist Medical Center; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Wake Forest University; Wake Forest University; University of North Carolina; University of North Carolina Chapel Hill; University of Minnesota System; University of Minnesota Twin Cities; Metabolon; Baylor College of Medicine	Alonso, A (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA.	alonso@umn.edu	Qureshi, Waqas/H-3498-2019; Alonso, Alvaro/A-4917-2010; Soliman, Elsayed Z/AAD-7135-2020	Qureshi, Waqas/0000-0002-5189-4417; Alonso, Alvaro/0000-0002-2225-8323; Soliman, Elsayed Z/0000-0001-5632-8150; Grams, Morgan/0000-0002-4430-6023; Loehr, Laura/0000-0002-9054-1825; Chen, Lin/0000-0002-0700-814X	National Heart, Lung, and Blood Institute [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HSN268201100012C, RC1HL099452]; National Human Genome Research Institute [3U01HG004402-02S1]; National Institute of Diabetes and Digestive and Kidney Diseases [R01DK089174, K24DK106414]; Metabolon, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL099452] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK089174, K24DK106414] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Metabolon, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HSN268201100012C). The metabolomics research was sponsored by the National Human Genome Research Institute (3U01HG004402-02S1). This work was additionally supported by National Heart, Lung, and Blood Institute grant RC1HL099452 to Dr. Alonso and by National Institute of Diabetes and Digestive and Kidney Diseases grant R01DK089174 and K24DK106414 to Dr. Selvin. The metabolomics measurements were sponsored by National Human Genome Research Institute (3U01HG004402-02S1). Reagents for the ALT, AST, and GGT assays were donated by Roche Diagnostics. Author DA is employed by Metabolon, Inc., a commercial entity. Metabolon, Inc. provided support in the form of salaries for this author [DA], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contribution' section. Similarly, the remaining funders did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Inizi S, 2006, INT J GYNECOL OBSTET, V93, P53, DOI 10.1016/j.ijgo.2005.12.030; Alnouti Y, 2009, TOXICOL SCI, V108, P225, DOI 10.1093/toxsci/kfn268; Alonso Alvaro, 2014, J Am Heart Assoc, V3, pe001211, DOI 10.1161/JAHA.114.001211; Alonso A, 2014, HEART, V100, P1511, DOI 10.1136/heartjnl-2014-305756; Alonso A, 2009, AM HEART J, V158, P111, DOI 10.1016/j.ahj.2009.05.010; BINAH O, 1987, N-S ARCH PHARMACOL, V335, P160; De Souza AI, 2010, J MOL CELL CARDIOL, V49, P851, DOI 10.1016/j.yjmcc.2010.07.008; Gorelik J, 2004, BJOG-INT J OBSTET GY, V111, P867, DOI 10.1111/j.1471-0528.2004.00166.x; Harrell FE, 2001, REGRESSION MODELING; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Jensen PN, 2012, PHARMACOEPIDEM DR S, V21, P141, DOI 10.1002/pds.2317; Kobayashi N, 2002, STEROIDS, V67, P827, DOI 10.1016/S0039-128X(02)00036-3; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Loehr LR, 2008, AM J CARDIOL, V101, P1016, DOI 10.1016/j.amjcard.2007.11.061; Lopez FL, 2012, CIRC-ARRHYTHMIA ELEC, V5, P155, DOI 10.1161/CIRCEP.111.966804; Mayr M, 2008, J AM COLL CARDIOL, V51, P585, DOI 10.1016/j.jacc.2007.09.055; MINDER EI, 1979, J LIPID RES, V20, P986; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Rainer PP, 2013, HEART, V99, P1685, DOI 10.1136/heartjnl-2013-304163; Rienstra M, 2012, CIRCULATION, V125, pE941, DOI 10.1161/CIRCULATIONAHA.112.112920; Roberts LD, 2013, CELL METAB, V18, P43, DOI 10.1016/j.cmet.2013.05.009; Sankoh AJ, 1997, STAT MED, V16, P2529, DOI 10.1002/(SICI)1097-0258(19971130)16:22<2529::AID-SIM692>3.0.CO;2-J; Schaap FG, 2014, NAT REV GASTRO HEPAT, V11, P55, DOI 10.1038/nrgastro.2013.151; Sinner MF, 2013, AM J CARDIOL, V111, P219, DOI 10.1016/j.amjcard.2012.09.021; Soliman EZ, 2009, STROKE, V40, P1204, DOI 10.1161/STROKEAHA.108.534735; Van Wagoner DR, 2015, HEART RHYTHM, V12, pE5, DOI 10.1016/j.hrthm.2014.11.011; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Zheng Y, 2014, OMICS, V18, P364, DOI 10.1089/omi.2014.0019; Zheng Y, 2013, AM J EPIDEMIOL, V178, P534, DOI 10.1093/aje/kwt004	29	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142610	10.1371/journal.pone.0142610	http://dx.doi.org/10.1371/journal.pone.0142610			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544570	Green Published, Green Submitted, gold			2022-12-26	WOS:000364398700159
J	Dominguez, LJ; Bes-Rastrollo, M; Basterra-Gortari, FJ; Gea, A; Barbagallo, M; Martinez-Gonzalez, MA				Dominguez, Ligia J.; Bes-Rastrollo, Maira; Javier Basterra-Gortari, Francisco; Gea, Alfredo; Barbagallo, Mario; Martinez-Gonzalez, Miguel A.			Association of a Dietary Score with Incident Type 2 Diabetes: The Dietary-Based Diabetes-Risk Score (DDS)	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; LIFE-STYLE INTERVENTION; FOOD-FREQUENCY QUESTIONNAIRE; ACTIVITY PROMOTION PROGRAMS; MEDITERRANEAN DIET; FOLLOW-UP; PREVENTION; MORTALITY; ADHERENCE; DISEASE	Background Strong evidence supports that dietary modifications may decrease incident type 2 diabetes mellitus (T2DM). Numerous diabetes risk models/scores have been developed, but most do not rely specifically on dietary variables or do not fully capture the overall dietary pattern. We prospectively assessed the association of a dietary-based diabetes-risk score (DDS), which integrates optimal food patterns, with the risk of developing T2DM in the SUN ("Seguimiento Universidad de Navarra") longitudinal study. Methods We assessed 17,292 participants initially free of diabetes, followed-up for a mean of 9.2 years. A validated 136-item FFQ was administered at baseline. Taking into account previous literature, the DDS positively weighted vegetables, fruit, whole cereals, nuts, coffee, low-fat dairy, fiber, PUFA, and alcohol in moderate amounts; while it negatively weighted red meat, processed meats and sugar-sweetened beverages. Energy-adjusted quintiles of each item (with exception of moderate alcohol consumption that received either 0 or 5 points) were used to build the DDS (maximum: 60 points). Incident T2DM was confirmed through additional detailed questionnaires and review of medical records of participants. We used Cox proportional hazards models adjusted for socio-demographic and anthropometric parameters, health-related habits, and clinical variables to estimate hazard ratios (HR) of T2DM. Results We observed 143 T2DM confirmed cases during follow-up. Better baseline conformity with the DDS was associated with lower incidence of T2DM (multivariable-adjusted HR for intermediate (25-39 points) vs. low (11-24) category 0.43 [95% confidence interval (CI) 0.21, 0.89]; and for high (40-60) vs. low category 0.32 [95% CI: 0.14, 0.69]; p for linear trend: 0.019). Conclusions The DDS, a simple score exclusively based on dietary components, showed a strong inverse association with incident T2DM. This score may be applicable in clinical practice to improve dietary habits of subjects at high risk of T2DM and also as an educational tool for laypeople to help them in self-assessing their future risk for developing diabetes.	[Dominguez, Ligia J.; Barbagallo, Mario] Univ Palermo, Dept Internal Med & Geriatr, Geriatr Unit, Palermo, Italy; [Bes-Rastrollo, Maira; Javier Basterra-Gortari, Francisco; Gea, Alfredo; Martinez-Gonzalez, Miguel A.] Univ Navarra, IDISNA, Dept Prevent Med & Publ Hlth, E-31080 Pamplona, Spain; [Bes-Rastrollo, Maira; Javier Basterra-Gortari, Francisco; Gea, Alfredo; Martinez-Gonzalez, Miguel A.] Inst Salud Carlos III, CIBER Fisiopatol Obesidad Nutr CIBERobn, Madrid, Spain; [Javier Basterra-Gortari, Francisco] Osasunbidea IDISNA, Hosp Reina Sofia, Dept Internal Med Endocrinol, Tudela, Spain	University of Palermo; University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Servicio Navarro de Salud - Osasunbidea	Dominguez, LJ (corresponding author), Univ Palermo, Dept Internal Med & Geriatr, Geriatr Unit, Palermo, Italy.	ligia.dominguez@unipa.it	Bes-Rastrollo, Maira/A-1329-2009; Martinez-Gonzalez, Miguel A./AAE-7669-2019; BARBAGALLO, MARIO/K-4794-2017	Bes-Rastrollo, Maira/0000-0002-9139-4206; BARBAGALLO, MARIO/0000-0002-1349-6530; Gea, Alfredo/0000-0002-2229-4690	Spanish Ministry of Health and European Regional Development Fund (FEDER) [PI10/02993, PI10/02658, PI13/00615, PI14/01668, PI14/01798, PI14/1764, RD06/0045, G03/140]; Navarra Regional Government [45/2011, 122/2014]; FPU fellowship from the Spanish Government	Spanish Ministry of Health and European Regional Development Fund (FEDER); Navarra Regional Government; FPU fellowship from the Spanish Government(Spanish Government)	The Seguimiento Universidad de Navarra (SUN) study has received funding from the Spanish Ministry of Health and European Regional Development Fund (FEDER) (grants PI10/02993, PI10/02658, PI13/00615, PI14/01668, PI14/01798, PI14/1764, RD06/0045, G03/140), and the Navarra Regional Government (45/2011, 122/2014). AG is supported by a FPU fellowship from the Spanish Government.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Ardisson Korat Andres V, 2014, Curr Nutr Rep, V3, P345; Balk EM, 2015, ANN INTERN MED, V163, P437, DOI 10.7326/M15-0452; Bes-Rastrollo M., 2005, REV ESP OBES, V3, P352; Bhupathiraju SN, 2014, DIABETOLOGIA, V57, P1346, DOI 10.1007/s00125-014-3235-7; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Ciulla TA, 2003, DIABETES CARE, V26, P2653, DOI 10.2337/diacare.26.9.2653; COLDITZ GA, 1995, ANN INTERN MED, V122, P481, DOI 10.7326/0003-4819-122-7-199504010-00001; Cuadrado C., 2013, TABLAS COMPOSICION A, V16th; de la Fuente-Arrillaga C, 2010, PUBLIC HEALTH NUTR, V13, P1364, DOI 10.1017/S1368980009993065; DiPreta JA, 2014, MED CLIN N AM, V98, P353, DOI 10.1016/j.mcna.2013.10.010; Dominguez LJ, 2013, NUTR METAB CARDIOVAS, V23, P451, DOI 10.1016/j.numecd.2011.10.009; Donin AS, 2015, DIABETOLOGIA; Fernandez-Ballarth JD, 2010, BRIT J NUTR, V103, P1808, DOI 10.1017/S0007114509993837; Greenland S, 2008, MODERN EPIDEMIOLOGY, P303; Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849; Hu FB, 2015, JAMA-J AM MED ASSOC, V313, P2319, DOI 10.1001/jama.2015.5287; Imamura F, 2015, LANCET GLOB HEALTH, V3, pE132, DOI 10.1016/S2214-109X(14)70381-X; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Joseph JJ, 2014, CURR OPIN ENDOCRINOL, V21, P109, DOI 10.1097/MED.0000000000000044; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kroger J, 2014, DIABETOLOGIA, V57, P321, DOI 10.1007/s00125-013-3092-9; Li GW, 2014, LANCET DIABETES ENDO, V2, P474, DOI 10.1016/S2213-8587(14)70057-9; Li R, 2015, ANN INTERN MED, V163, P452, DOI 10.7326/M15-0469; Lindstrom J, 2006, LANCET, V368, P1673, DOI 10.1016/S0140-6736(06)69701-8; Martinez-Gonzalez MA, 2008, BMJ-BRIT MED J, V336, P1348, DOI 10.1136/bmj.39561.501007.BE; Martinez-Gonzalez MA, 2005, PUBLIC HEALTH NUTR, V8, P920, DOI 10.1079/PHN2005745; Martinez-Gonzalez MA, 2002, NUTR NEUROSCI, V5, P65, DOI 10.1080/10284150290007047; MARTINMORENO JM, 1993, INT J EPIDEMIOL, V22, P512, DOI 10.1093/ije/22.3.512; Mataix Verdu J., 2009, TABLA COMPOSICION AL, V5th; Morley JE, 2013, J AM MED DIR ASSOC, V14, P392, DOI 10.1016/j.jamda.2013.03.022; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Noble D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7163; Nowak C, 2015, LANCET DIABETES ENDO, V3, P166, DOI 10.1016/S2213-8587(14)70261-X; O'Connor LM, 2014, DIABETOLOGIA, V57, P909, DOI 10.1007/s00125-014-3176-1; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Phillips CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078950; Ramachandran A, 2006, DIABETOLOGIA, V49, P289, DOI 10.1007/s00125-005-0097-z; Schmid R, 2011, DIABETES CARE, V34, P1863, DOI 10.2337/dc11-0206; Schroder H, 2011, J NUTR, V141, P1140, DOI 10.3945/jn.110.135566; Seaquist ER, 2014, JAMA-J AM MED ASSOC, V311, P2267, DOI 10.1001/jama.2014.6451; Segui-Gomez M, 2006, INT J EPIDEMIOL, V35, P1417, DOI 10.1093/ije/dyl223; Sinclair A, 2015, LANCET DIABETES ENDO, V3, P275, DOI 10.1016/S2213-8587(14)70176-7; Tobias DK, 2014, NEW ENGL J MED, V370, P233, DOI 10.1056/NEJMoa1304501; Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Willet W., 1998, NUTR EPIDEMIOLOGY, P74, DOI DOI 10.1093/ACPROF:OSO/9780195122978.001.0001; Zimmet PZ, 2014, LANCET DIABETES ENDO, V2, P56, DOI 10.1016/S2213-8587(13)70112-8	48	14	14	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141760	10.1371/journal.pone.0141760	http://dx.doi.org/10.1371/journal.pone.0141760			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544985	gold, Green Published, Green Submitted			2022-12-26	WOS:000364398700042
J	Gaykalova, DA; Vatapalli, R; Wei, YY; Tsai, HL; Wang, H; Zhang, C; Hennessey, PT; Guo, T; Tan, M; Li, R; Ahn, J; Khan, Z; Westra, WH; Bishop, JA; Zaboli, D; Koch, WM; Khan, T; Ochs, MF; Califano, JA				Gaykalova, Daria A.; Vatapalli, Rajita; Wei, Yingying; Tsai, Hua-Ling; Wang, Hao; Zhang, Chi; Hennessey, Patrick T.; Guo, Theresa; Tan, Marietta; Li, Ryan; Ahn, Julie; Khan, Zubair; Westra, William H.; Bishop, Justin A.; Zaboli, David; Koch, Wayne M.; Khan, Tanbir; Ochs, Michael F.; Califano, Joseph A.			Outlier Analysis Defines Zinc Finger Gene Family DNA Methylation in Tumors and Saliva of Head and Neck Cancer Patients	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; PROMOTER HYPERMETHYLATION; GLOBAL HYPOMETHYLATION; PROTEIN; ACTIVATION; EXPRESSION; BIOMARKER; BIOLOGY; RINSES; EDNRB	Head and Neck Squamous Cell Carcinoma (HNSCC) is the fifth most common cancer, annually affecting over half a million people worldwide. Presently, there are no accepted biomarkers for clinical detection and surveillance of HNSCC. In this work, a comprehensive genome-wide analysis of epigenetic alterations in primary HNSCC tumors was employed in conjunction with cancer-specific outlier statistics to define novel biomarker genes which are differentially methylated in HNSCC. The 37 identified biomarker candidates were top-scoring outlier genes with prominent differential methylation in tumors, but with no signal in normal tissues. These putative candidates were validated in independent HNSCC cohorts from our institution and TCGA (The Cancer Genome Atlas). Using the top candidates, ZNF14, ZNF160, and ZNF420, an assay was developed for detection of HNSCC cancer in primary tissue and saliva samples with 100% specificity when compared to normal control samples. Given the high detection specificity, the analysis of ZNF DNA methylation in combination with other DNA methylation biomarkers may be useful in the clinical setting for HNSCC detection and surveillance, particularly in high-risk patients. Several additional candidates identified through this work can be further investigated toward future development of a multi-gene panel of biomarkers for the surveillance and detection of HNSCC.	[Gaykalova, Daria A.; Vatapalli, Rajita; Zhang, Chi; Hennessey, Patrick T.; Guo, Theresa; Tan, Marietta; Li, Ryan; Ahn, Julie; Khan, Zubair; Westra, William H.; Bishop, Justin A.; Zaboli, David; Koch, Wayne M.; Khan, Tanbir; Califano, Joseph A.] Johns Hopkins Med Inst, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; [Vatapalli, Rajita] Northwestern Univ, Dept Urol, Chicago, IL 60611 USA; [Wei, Yingying; Tsai, Hua-Ling; Wang, Hao; Ochs, Michael F.] Johns Hopkins Med Inst, Dept Oncol, Div Oncol Biostat, Baltimore, MD 21205 USA; [Wei, Yingying] Chinese Univ Hong Kong, Dept Stat, Shatin, Hong Kong, Peoples R China; [Zhang, Chi] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA; [Westra, William H.; Bishop, Justin A.] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA; [Ochs, Michael F.] Coll New Jersey, Dept Math & Stat, Ewing, NJ USA; [Califano, Joseph A.] Greater Baltimore Med Ctr, Milton J Dance Head & Neck Ctr, Baltimore, MD USA; [Califano, Joseph A.] Univ Calif San Diego, Dept Surg, Div Otolaryngol Head & Neck Surg, La Jolla, CA 92093 USA	Johns Hopkins University; Johns Hopkins Medicine; Northwestern University; Johns Hopkins University; Johns Hopkins Medicine; Chinese University of Hong Kong; University of Virginia; Johns Hopkins University; Johns Hopkins Medicine; College of New Jersey; Greater Baltimore Medical Center; University of California System; University of California San Diego	Califano, JA (corresponding author), Johns Hopkins Med Inst, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA.	jcalifano@ucsd.edu	Wei, Yingying/S-8001-2018; Vatapalli, Rajita/AAN-1397-2021; Guo, Theresa/AFU-3555-2022; Guo, Theresa/AAF-2216-2021	Wei, Yingying/0000-0003-3826-336X; Zhang, Chi/0000-0002-9297-0690; Ahn, Julie/0000-0001-5168-6717	National Institute of Dental and Craniofacial Research and National Institute of Health Challenge Grant [RC1DE020324]; National Institute of Dental and Craniofacial Research and National Cancer Institute grant [P50 DE 019032]; NATIONAL CANCER INSTITUTE [P50CA096784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [P50DE019032, R01DE023347] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC1DE020324] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM011000] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research and National Institute of Health Challenge Grant; National Institute of Dental and Craniofacial Research and National Cancer Institute grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the National Institute of Dental and Craniofacial Research and National Institute of Health Challenge Grant (RC1DE020324); National Institute of Dental and Craniofacial Research and National Cancer Institute grant (P50 DE 019032 Head and Neck Cancer SPORE) to JAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Arantes LMRB, 2014, ORAL ONCOL, V50, P587, DOI 10.1016/j.oraloncology.2014.02.015; Belbin TJ, 2008, HEAD NECK PATHOL, V2, P243, DOI 10.1007/s12105-008-0071-4; Bhan S, 2011, CLIN CANCER RES, V17, P4267, DOI 10.1158/1078-0432.CCR-11-0653; Calmon MF, 2009, NEOPLASIA, V11, P1329, DOI 10.1593/neo.91110; Carvalho AL, 2008, CLIN CANCER RES, V14, P97, DOI 10.1158/1078-0432.CCR-07-0722; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; Demokan S, 2010, INT J CANCER, V127, P2351, DOI 10.1002/ijc.25248; Fertig EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078127; Gaykalova D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040389; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghosh Debashis, 2013, Methods Mol Biol, V972, P141, DOI 10.1007/978-1-60327-337-4_9; Ghosh D, 2010, J BIOPHARM STAT, V20, P193, DOI 10.1080/10543400903572704; Grimwood J, 2004, NATURE, V428, P529, DOI 10.1038/nature02399; Guerrero-Preston R, 2011, CANCER PREV RES, V4, P1061, DOI 10.1158/1940-6207.CAPR-11-0006; Guerrero-Preston R, 2014, EPIGENETICS, V9; Ha PK, 2006, LANCET ONCOL, V7, P77, DOI 10.1016/S1470-2045(05)70540-4; Hartmann S, 2012, J APPL GENET, V53, P167, DOI 10.1007/s13353-011-0079-4; Hayashi M, 2014, ANN SURG ONCOL, V21, P3124, DOI 10.1245/s10434-014-3661-2; He Q, 2011, ONCOL LETT, V2, P725, DOI 10.3892/ol.2011.297; Kim MS, 2006, CANCER RES, V66, P3409, DOI 10.1158/0008-5472.CAN-05-1608; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Li R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091263; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lleras RA, 2013, CLIN CANCER RES, V19, P5444, DOI 10.1158/1078-0432.CCR-12-3280; Lleras RA, 2011, AM J PATHOL, V178, P1965, DOI 10.1016/j.ajpath.2011.01.049; Carvalho AL, 2011, CLIN CANCER RES, V17, P4782, DOI 10.1158/1078-0432.CCR-11-0324; Lukic S, 2014, CELL DEATH DIFFER, V21, P381, DOI 10.1038/cdd.2013.150; MacDonald JW, 2006, BIOINFORMATICS, V22, P2950, DOI 10.1093/bioinformatics/btl433; Marur S, 2008, MAYO CLIN PROC, V83, P489, DOI 10.4065/83.4.489; Ochs MF, 2013, IEEE ACM T COMPUTATI; Ovchinnikov DA, 2012, TRANSL ONCOL, V5, P321, DOI 10.1593/tlo.12232; Pattani KM, 2010, CANCER PREV RES, V3, P1093, DOI 10.1158/1940-6207.CAPR-10-0115; Pepe M. S., 2003, STAT EVALUATION MED; Poage GM, 2011, CLIN CANCER RES, V17, P3579, DOI 10.1158/1078-0432.CCR-11-0044; Rathi KS, 2014, DRUG DEV RE IN PRESS; Schussel J, 2013, CLIN CANCER RES, V19, P3268, DOI 10.1158/1078-0432.CCR-12-3496; Shao CB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048582; Shao CB, 2011, ORAL ONCOL, V47, P251, DOI 10.1016/j.oraloncology.2011.01.008; Sharma R, 2010, ORAL DIS, V16, P668, DOI 10.1111/j.1601-0825.2010.01676.x; Shaw RJ, 2006, BRIT J CANCER, V94, P561, DOI 10.1038/sj.bjc.6602972; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Smith IM, 2007, INT J CANCER, V121, P1724, DOI 10.1002/ijc.22889; Sun WY, 2014, CANCER RES, V74, P1091, DOI 10.1158/0008-5472.CAN-13-1259; Sun WY, 2012, CLIN CANCER RES, V18, P1082, DOI 10.1158/1078-0432.CCR-11-2392; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Viet CT, 2008, CANCER EPIDEM BIOMAR, V17, P3603, DOI 10.1158/1055-9965.EPI-08-0507; Worsham MJ, 2013, OTOLARYNG HEAD NECK, V149, P409, DOI 10.1177/0194599813490895; Yang Jing, 2011, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V46, P308	50	29	29	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142148	10.1371/journal.pone.0142148	http://dx.doi.org/10.1371/journal.pone.0142148			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544568	Green Published, gold, Green Submitted			2022-12-26	WOS:000364398700087
J	King, DFL; McKay, PF; Mann, JFS; Jones, CB; Shattock, RJ				King, Deborah F. L.; McKay, Paul F.; Mann, Jamie F. S.; Jones, C. Bryn; Shattock, Robin J.			Plasmid DNA Vaccine Co-Immunisation Modulates Cellular and Humoral Immune Responses Induced by Intranasal Inoculation in Mice	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-1/SIV CHIMERIC VIRUS; EPITHELIAL TRANSCYTOSIS; ENVELOPE GLYCOPROTEIN; RHESUS MACAQUES; MUCOSAL; PROTEIN; PROTECTION; CELLS; INDUCTION	Background An effective HIV vaccine will likely require induction of both mucosal and systemic cellular and humoral immune responses. We investigated whether intramuscular (IM) delivery of electroporated plasmid DNA vaccine and simultaneous protein vaccinations by intranasal (IN) and IM routes could be combined to induce mucosal and systemic cellular and humoral immune responses to a model HIV-1 CN54 gp140 antigen in mice. Results Co-immunisation of DNA with intranasal protein successfully elicited both serum and vaginal IgG and IgA responses, whereas DNA and IM protein co-delivery did not induce systemic or mucosal IgA responses. Cellular IFN gamma responses were preserved in co-immunisation protocols compared to protein-only vaccination groups. The addition of DNA to IN protein vaccination reduced the strong Th2 bias observed with IN protein vaccination alone. Luminex analysis also revealed that co-immunisation with DNA and IN protein induced expression of cytokines that promote B-cell function, generation of T-FH cells and CCR5 ligands that can reduce HIV infectivity. Significance These data suggest that while IN inoculation alone elicits both cellular and humoral responses, co-administration with homologous DNA vaccination can tailor these towards a more balanced Th1/Th2 phenotype modulating the cellular cytokine profile while eliciting high-levels of antigen-specific antibody. This work provides insights on how to generate differential immune responses within the same vaccination visit, and supports co-immunisation with DNA and protein by a mucosal route as a potential delivery strategy for HIV vaccines.	[King, Deborah F. L.; McKay, Paul F.; Mann, Jamie F. S.; Jones, C. Bryn; Shattock, Robin J.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis, Div Med, Mucosal Infect & Immun Grp, London, England	Imperial College London	Shattock, RJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis, Div Med, Mucosal Infect & Immun Grp, London, England.	r.shattock@imperial.ac.uk		Mann, Jamie/0000-0001-7037-1286; McKay, Paul/0000-0001-5195-6254	Center for HIV/AIDS Vaccine Immunology (CHAVI) [U19 AI067854-05]; Dormeur Investment Service Ltd; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067854] Funding Source: NIH RePORTER	Center for HIV/AIDS Vaccine Immunology (CHAVI); Dormeur Investment Service Ltd; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	DFLK was supported by a grant to RJS by the Center for HIV/AIDS Vaccine Immunology (CHAVI) # U19 AI067854-05. The authors gratefully acknowledge Dormeur Investment Service Ltd for providing funds to purchase equipment used in these studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfsen A, 2001, J IMMUNOL, V166, P6257, DOI 10.4049/jimmunol.166.10.6257; Arias MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041144; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Belakova J, 2007, ARCH IMMUNOL THER EX, V55, P387, DOI 10.1007/s00005-007-0044-4; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Bixler SL, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/852418; Buffa V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050529; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; El-Kamary SS, 2010, J INFECT DIS, V202, P1649, DOI 10.1086/657087; Fischer JE, 1997, J VIROL, V71, P8672, DOI 10.1128/JVI.71.11.8672-8677.1997; Fu TM, 2007, AIDS RES HUM RETROV, V23, P67, DOI 10.1089/aid.2006.0114; Geng SA, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-27; GRAHAM MB, 1994, J EXP MED, V180, P1273, DOI 10.1084/jem.180.4.1273; Hersperger AR, 2011, BLOOD, V117, P3799, DOI 10.1182/blood-2010-12-322727; Hersperger AR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000917; Hessell AJ, 2010, J VIROL, V84, P1302, DOI 10.1128/JVI.01272-09; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; HSIEH CS, 1995, J EXP MED, V181, P713, DOI 10.1084/jem.181.2.713; Hutnick NA, 2011, CURR OPIN VIROL, V1, P233, DOI 10.1016/j.coviro.2011.08.003; Jalah R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091550; Jin HL, 2005, VIROLOGY, V337, P183, DOI 10.1016/j.virol.2005.03.029; Jin HL, 2008, J IMMUNOL, V180, P5360, DOI 10.4049/jimmunol.180.8.5360; Kang YM, 2007, BIOCHEM BIOPH RES CO, V353, P1034, DOI 10.1016/j.bbrc.2006.12.124; Klein K, 2013, J VIROLOGY; Li JY, 2013, VACCINE, V31, P3747, DOI 10.1016/j.vaccine.2013.04.037; Mann JFS, 2014, J VIROL, V88, P6959, DOI 10.1128/JVI.00183-14; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; McKay PF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084707; Milpied PJ, 2013, NAT IMMUNOL, V14, P313, DOI 10.1038/ni.2567; Mitsdoerffer M, 2010, P NATL ACAD SCI USA, V107, P14292, DOI 10.1073/pnas.1009234107; Moran TM, 1996, J VIROL, V70, P5230, DOI 10.1128/JVI.70.8.5230-5235.1996; Naz RK, 2012, J REPROD IMMUNOL, V93, P1, DOI 10.1016/j.jri.2011.09.005; Pal R, 2006, VIROLOGY, V348, P341, DOI 10.1016/j.virol.2005.12.029; Patel V, 2013, P NATL ACAD SCI USA, V110, P2975, DOI 10.1073/pnas.1215393110; Patel V, 2010, VACCINE, V28, P4827, DOI 10.1016/j.vaccine.2010.04.064; Pissani F, 2014, VACCINE, V32, P507, DOI 10.1016/j.vaccine.2013.11.022; REINER SL, 1995, ANNU REV IMMUNOL, V13, P151, DOI 10.1146/annurev.iy.13.040195.001055; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rodenburg CM, 2001, AIDS RES HUM RETROV, V17, P161, DOI 10.1089/08892220150217247; Rosati M, 2009, P NATL ACAD SCI USA, V106, P15831, DOI 10.1073/pnas.0902628106; Shibata R, 1999, NAT MED, V5, P204, DOI 10.1038/5568; Trumpfheller C, 1998, CLIN EXP IMMUNOL, V112, P92; Tudor D, 2009, MUCOSAL IMMUNOL, V2, P412, DOI 10.1038/mi.2009.89; Tudor D, 2012, P NATL ACAD SCI USA, V109, P12680, DOI 10.1073/pnas.1200024109; Walker Bruce D, 2007, Top HIV Med, V15, P134; Watkins JD, 2013, AIDS, V27, pF13, DOI 10.1097/QAD.0b013e328360eac6; Yin JM, 2011, VACCINE, V29, P6763, DOI 10.1016/j.vaccine.2010.12.055	49	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141557	10.1371/journal.pone.0141557	http://dx.doi.org/10.1371/journal.pone.0141557			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544970	Green Published, Green Submitted, gold			2022-12-26	WOS:000364398700034
J	Otsuka, M; Kurihara, T; Isaka, T				Otsuka, Mitsuo; Kurihara, Toshiyuki; Isaka, Tadao			Effect of a Wide Stance on Block Start Performance in Sprint Running	PLOS ONE			English	Article							JOINT COORDINATE SYSTEM; SQUAT; PHASE; KINEMATICS; KNEE; SIZE; HIP	This study aimed to clarify the effect of widened stance width at the set position during the block start phase in sprint running on kinematics and kinetics at the hip joint and block-induced power. Fourteen male sprinters volunteered to participate in this study. They performed three block-start trials with a normal stance width (25 +/- 1 cm, normal condition) and a widened stance width (45 +/- 2 cm, widened condition) at the set position. The block start movements were recorded at 250 Hz with high-speed cameras and the ground reaction forces at 1250 Hz with force plates. During the block phase in the widened condition, the hip abduction and external rotation angles in both legs were significantly larger and smaller, respectively, than those in the normal condition. The positive peak value of the hip power in the rear leg was significantly greater in the widened condition than that in the normal condition. However, no significant difference was seen in the normalized block-induced power between the widened and normal conditions. We conclude that a widened stance width at the set position affects the hip-joint kinematics and rear hip power generation during the block start phase, but no effect on the block-induced power when considering sprinting performance during the whole block start phase.	[Otsuka, Mitsuo; Kurihara, Toshiyuki; Isaka, Tadao] Ritsumeikan Univ, Fac Sport & Hlth Sci, Kusatsu, Shiga 5258577, Japan	Ritsumeikan University	Otsuka, M (corresponding author), Ritsumeikan Univ, Fac Sport & Hlth Sci, 1-1-1 Nojihigashi, Kusatsu, Shiga 5258577, Japan.	otsuka-a@st.ritsumei.ac.jp	Otsuka, Mitsuo/AAB-4120-2019	Otsuka, Mitsuo/0000-0003-1391-4939	Kozuki Foundation [2011-9-1]; Grants-in-Aid for Scientific Research [26560361] Funding Source: KAKEN	Kozuki Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Kozuki Foundation 2011-9-1 to MO (http://www.kozuki.or.jp/jigyou/spresearch/list2011_09_spres.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bezodis NE, 2010, SPORT BIOMECH, V9, P258, DOI 10.1080/14763141.2010.538713; Bezodis NE, 2015, EUR J SPORT SCI, V15, P118, DOI 10.1080/17461391.2014.928915; Bradshaw EJ, 2007, SPORT BIOMECH, V6, P246, DOI 10.1080/14763140701489660; Clark DR, 2012, J STRENGTH COND RES, V26, P1169, DOI 10.1519/JSC.0b013e31822d533d; Debaere S, 2013, J SPORT SCI, V31, P137, DOI 10.1080/02640414.2012.722225; DEMPSTER WT, 1967, AM J ANAT, V120, P33, DOI 10.1002/aja.1001200104; Demura S, 2010, J STRENGTH COND RES, V24, P2742, DOI 10.1519/JSC.0b013e3181e27386; GROOD ES, 1983, J BIOMECH ENG-T ASME, V105, P136, DOI 10.1115/1.3138397; GUISSARD N, 1992, MED SCI SPORT EXER, V24, P1257; HANAVAN E P Jr, 1964, AMRL TR, P1; Harland MJ, 1997, SPORTS MED, V23, P11, DOI 10.2165/00007256-199723010-00002; HOF AL, 1996, GAIT POSTURE, V4, P222; International Association of Athletic Federations, 2013, COMP RUL 2014 2015, P154; Lieberman DE, 2010, NATURE, V463, P531, DOI 10.1038/nature08723; McCaw ST, 1999, MED SCI SPORT EXER, V31, P428, DOI 10.1097/00005768-199903000-00012; Mendoza L, 1993, J SPORT SCI, V11, P25, DOI 10.1080/02640419308729959; Mero A, 2006, J SPORT SCI, V24, P165, DOI 10.1080/02640410500131753; Milanese C, 2014, BIOL SPORT, V31, P209, DOI 10.5604/20831862.1111848; Mirakhorlo M, 2014, J RES HEALTH SCI, V14, P23; Okkonen O, 2013, J STRENGTH COND RES, V27, P2662, DOI 10.1519/JSC.0b013e31829992b0; Otsuka M, 2014, J APPL BIOMECH, V30, P390, DOI 10.1123/jab.2013-0017; Paoli A, 2009, J STRENGTH COND RES, V23, P246, DOI 10.1519/JSC.0b013e3181876811; Slawinski J, 2012, INT J SPORTS MED, V33, P555, DOI 10.1055/s-0032-1304587; Slawinski J, 2013, J SPORT SCI, V31, P256, DOI 10.1080/02640414.2012.729076; Winter D., 2009, BIOMECHANICS MOTOR C, V4th; Wu G, 2002, J BIOMECH, V35, P543, DOI 10.1016/S0021-9290(01)00222-6	27	13	13	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142230	10.1371/journal.pone.0142230	http://dx.doi.org/10.1371/journal.pone.0142230			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544719	Green Published, Green Submitted, gold			2022-12-26	WOS:000364398700096
J	Liu, J; Bai, J; Jiang, GQ; Li, XL; Wang, J; Wu, DC; Owusu, L; Zhang, ES; Li, WL				Liu, Jia; Bai, Jing; Jiang, Guoqiang; Li, Xinli; Wang, Jing; Wu, Dachang; Owusu, Lawrence; Zhang, Ershao; Li, Weiling			Anti-Tumor Effect of Pinus massoniana Bark Proanthocyanidins on Ovarian Cancer through Induction of Cell Apoptosis and Inhibition of Cell Migration	PLOS ONE			English	Article							KAPPA-B ACTIVATION; MMP-9 EXPRESSION; MAP KINASE; INVASION; PATHWAYS; EXTRACT; PROLIFERATION; MITOCHONDRIAL; PROGRESSION; METASTASIS	Pinus massoniana bark proanthocyanidins (PMBPs), an active component isolated from Pinus massoniana bark, has been reported to possess a wide range of biochemical properties. Here, we investigated the anti-tumor effect of PMBPs on ovarian cancer. The results indicated that PMBPs significantly reduced the growth of ovarian cancer cells and induced dose-dependent apoptosis. The underlying mechanisms involved were elucidated to include the loss of mitochondrial membrane potential, down-regulation of the anti-apoptotic protein Bcl-2 and the activation of Caspase 3/9, suggesting that PMBPs triggered apoptosis through activation of mitochondria-associated apoptotic pathway. In addition, wound healing and transwell chamber assays revealed that PMBPs could suppress migration and invasion of ovarian cancer cells. PMBPs dramatically inhibited MMP-9 activity and expression, blocked the activity of NF kappa B and the activation of ERK1/2 and p38 MAPK. Our findings suggest that PMBPs has the potential to be developed as an anti-tumor drug for ovarian cancer treatment and/or disease management.	[Liu, Jia; Bai, Jing; Jiang, Guoqiang; Li, Xinli; Wang, Jing; Wu, Dachang; Zhang, Ershao; Li, Weiling] Dalian Med Univ, Dept Biotechnol, Dalian, Liaoning, Peoples R China; [Owusu, Lawrence] Kwame Nkrumah Univ Sci & Technol, Dept Biochem & Biotechnol, Kumasi, Ghana; [Owusu, Lawrence] Univ S Florida, Dept Pharmaceut Sci, Tampa, FL USA	Dalian Medical University; Kwame Nkrumah University Science & Technology; State University System of Florida; University of South Florida	Li, WL (corresponding author), Dalian Med Univ, Dept Biotechnol, Dalian, Liaoning, Peoples R China.	liweiling2006@hotmail.com		liu, jia/0000-0002-1021-9271; li, weiling/0000-0001-6681-9156	National Natural Science Foundation of China [81302282]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by National Natural Science Foundation of China (No. 81302282) (URL: http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedi H, 2014, TUMOR BIOL, V35, P11027, DOI 10.1007/s13277-014-2396-9; Akl H, 2014, BBA-MOL CELL RES, V1843, P2240, DOI 10.1016/j.bbamcr.2014.04.017; Al Dhaheri Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068808; Barrantes ID, 2012, BIOCHEM SOC T, V40, P79, DOI 10.1042/BST20110676; Bond M, 2001, CARDIOVASC RES, V50, P556, DOI 10.1016/S0008-6363(01)00220-6; Chang C, 2013, INTEGR CANCER THER, V13, P249; Cui YY, 2005, WORLD J GASTROENTERO, V11, P5277, DOI 10.3748/wjg.v11.i34.5277; Cui YY, 2005, PHYTOTHER RES, V19, P34, DOI 10.1002/ptr.1619; Decker D G, 1972, Proc Natl Cancer Conf, V7, P223; Ebermann R, 1996, J PHOTOCH PHOTOBIO B, V36, P95, DOI 10.1016/S1011-1344(96)07353-8; Gatti L, 2014, J PHARMACOL EXP THER, V348, P360, DOI 10.1124/jpet.113.210054; Hu XX, 2012, ARCH GYNECOL OBSTET, V286, P1537, DOI 10.1007/s00404-012-2456-6; Hurst DR, 2011, INT REV CEL MOL BIO, V286, P107, DOI 10.1016/B978-0-12-385859-7.00003-3; Im NK, 2014, J MED FOOD, V17, P855, DOI 10.1089/jmf.2013.3077; Jelovac D, 2011, CA-CANCER J CLIN, V61, P183, DOI 10.3322/caac.20113; Kim JJ, 2014, BIOL PHARM BULL, V37, P158, DOI 10.1248/bpb.b13-00534; Kim YI, 2015, MOL MED REP, V12, P657, DOI 10.3892/mmr.2015.3460; Li L, 2014, ONCOL REP, V32, P1779, DOI 10.3892/or.2014.3422; Li YY, 2015, J PHARMACOL EXP THER, V353, P9, DOI 10.1124/jpet.114.220277; Lin F, 2014, J ORAL PATHOLOGY MED; Ma HL, 2010, INT J MOL MED, V25, P751, DOI 10.3892/ijmm_00000401; Ma HL, 2008, PHYTOTHER RES, V22, P1472, DOI 10.1002/ptr.2496; Marsden VS, 2004, J CELL BIOL, V165, P775, DOI 10.1083/jcb.200312030; Millimouno FM, 2014, CANCER PREV RES, V7, P1081, DOI 10.1158/1940-6207.CAPR-14-0136; Nandakumar V, 2008, CANCER LETT, V269, P378, DOI 10.1016/j.canlet.2008.03.049; Noh EM, 2015, EUR J PHARMACOL, V764, P79, DOI 10.1016/j.ejphar.2015.06.038; Ooi KK, 2015, J BIOL INORG CHEM, V20, P855, DOI 10.1007/s00775-015-1271-5; Ozols RF, 2003, J CLIN ONCOL, V21, P2451, DOI 10.1200/JCO.2003.03.039; Pal HC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086338; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Reddy KB, 2003, CANCER METAST REV, V22, P395, DOI 10.1023/A:1023781114568; Sak Katrin, 2012, Chemother Res Pract, V2012, P282570, DOI 10.1155/2012/282570; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Singh L, 2015, CLIN EXP OPHTHALMOL, V43, P259, DOI 10.1111/ceo.12397; Uchino R, 2010, BLOOD COAGUL FIBRIN, V21, P528, DOI 10.1097/MBC.0b013e32833a9b61; Wang XF, 2015, EXPERT OPIN THER TAR, V19, P577, DOI 10.1517/14728222.2015.1012156; Wei ZJ, 2015, INT J CLIN EXP PATHO, V8, P4481; Wrighton CJ, 1996, J EXP MED, V183, P1013, DOI 10.1084/jem.183.3.1013; [高晓文 XiaoWen Gao], 2008, [细胞生物学杂志, Chinese Journal of Cell Biology], V30, P642; Zhang JH, 2012, AM J CHINESE MED, V40, P861, DOI 10.1142/S0192415X12500644; Zhu L, 2012, J CELL PHYSIOL, V227, P1814, DOI 10.1002/jcp.22906	41	23	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142157	10.1371/journal.pone.0142157	http://dx.doi.org/10.1371/journal.pone.0142157			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26539720	Green Published, gold, Green Submitted			2022-12-26	WOS:000364303800059
J	Merkado, G; Titelboim, D; Hyams-Kaphzan, O; Holzmann, M; Pawlowski, J; Almogi-Labin, A; Abdu, U; Herut, B; Abramovich, S				Merkado, Gily; Titelboim, Danna; Hyams-Kaphzan, Orit; Holzmann, Maria; Pawlowski, Jan; Almogi-Labin, Ahuva; Abdu, Uri; Herut, Barak; Abramovich, Sigal			Molecular Phylogeny and Ecology of Textularia agglutinans d'Orbigny from the Mediterranean Coast of Israel: A Case of a Successful New Incumbent	PLOS ONE			English	Article							BENTHIC FORAMINIFERAL ASSEMBLAGES; MICROHABITAT SELECTION; SHELF; CHLOROPHYLL; DIVERSITY; TRANSECT; SEA	Textularia agglutinans d'Orbigny is a non-symbiont bearing and comparatively large benthic foraminiferal species with a widespread distribution across all oceans. In recent years, its populations have considerably expanded along the Israeli Mediterranean coast of the eastern Levantine basin. Despite its exceptionally widespread occurrence, no molecular data have yet been obtained. This study provides the first ribosomal DNA sequences of T. agglutinans complemented with morphological and ecological characterization, which are based on material collected during environmental monitoring of the hard bottom habitats along the Israeli Mediterranean coast, and from the Gulf of Elat (northern Red Sea). Our phylogenetic analyses reveal that all specimens from both provinces belong to the same genetic population, regardless their morphological variability. These results indicate that modern population of T. agglutinans found on the Mediterranean coast of Israel is probably Lessepsian. Our study also reveals that T. agglutinans has an epiphytic life mode, which probably enabled its successful colonization of the hard bottom habitats, at the Mediterranean coast of Israel, which consist of a diverse community of macroalgae. Our study further indicates that the species does not tolerate high SST (> 35 degrees C), which will probably prevent its future expansion in the easternmost Mediterranean in light of the expected rise in temperatures.	[Merkado, Gily; Titelboim, Danna; Abdu, Uri; Abramovich, Sigal] Ben Gurion Univ Negev, IL-84105 Beer Sheva, Israel; [Hyams-Kaphzan, Orit; Almogi-Labin, Ahuva] Geol Survey Israel, IL-95501 Jerusalem, Israel; [Holzmann, Maria; Pawlowski, Jan] Univ Geneva, Dept Genet & Evolut, Geneva, Switzerland; [Herut, Barak] Israel Oceanog & Limnol Res, Natl Inst Oceanog, Haifa, Israel	Ben Gurion University; Geological Survey Israel; University of Geneva; Israel Oceanographic & Limnological Research Institute	Abramovich, S (corresponding author), Ben Gurion Univ Negev, IL-84105 Beer Sheva, Israel.	sigalabr@bgu.ac.il	Pawlowski, Jan/AAO-3306-2021; Abramovich, Sigal/AAR-5034-2021	Pawlowski, Jan/0000-0003-2421-388X; Abramovich, Sigal/0000-0003-3124-1387; Herut, Barak/0000-0002-7093-8753; Almogi-Labin, Ahuva/0000-0002-4082-7120	Israel Science Foundation [587/2013]; BMBF-MOST German Israeli cooperation project [3-9054, 3-9055]; Swiss National Science Foundation [31003A_140766]; G. & A. Claraz Donation	Israel Science Foundation(Israel Science Foundation); BMBF-MOST German Israeli cooperation project; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); G. & A. Claraz Donation	The research was supported by the Israel Science Foundation grant No. 587/2013, by BMBF-MOST German Israeli cooperation project 3-9054, 3-9055, by the Swiss National Science Foundation grant 31003A_140766, and by a G. & A. Claraz Donation (JP, MH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albani A.D., 1990, Memorie di Scienze Geologiche, V42, P271; Almagor G, 1984, GEOL SURV ISR B, V77, P31; Arieli RN, 2011, MAR POLLUT BULL, V62, P1002, DOI 10.1016/j.marpolbul.2011.02.036; Aurahs R, 2009, MOL ECOL, V18, P1692, DOI 10.1111/j.1365-294X.2009.04136.x; Avital A, 2002, THESIS B GURION U NE; Avnaim-Katav S, 2015, J SEA RES, V99, P97, DOI 10.1016/j.seares.2015.02.006; Avnaim-Katav S, 2013, PALAEOGEOGR PALAEOCL, V386, P512, DOI 10.1016/j.palaeo.2013.06.019; BANNER F T, 1981, Journal of Foraminiferal Research, V11, P85; BARMAWIDJAJA DM, 1992, J FORAMIN RES, V22, P297, DOI 10.2113/gsjfr.22.4.297; Brady H.B., 1884, REPORTS SCI RESULTS, V9, P1; Buosi C, 2012, J FORAMIN RES, V42, P39; Coppa M. Grazia, 1995, Revista Espanola de Paleontologia, V10, P161; CULVER S J, 1980, Smithsonian Contributions to the Marine Sciences, P1; Culver SJ, 1987, DISTRIBUTION RECENT, P1, DOI [10.5479/si.01960768.30.1, DOI 10.5479/SI.01960768.30.1]; D'Orbigny A., 1839, HIT PHYS NATURELLE L, P144; d'Orbigny A.D., 1826, ANN SCI NATURELLES 1, V7, P245; D'Ortenzio F, 2009, BIOGEOSCIENCES, V6, P139, DOI 10.5194/bg-6-139-2009; Darling KF, 2008, MAR MICROPALEONTOL, V67, P216, DOI 10.1016/j.marmicro.2008.01.009; de Vargas C, 1999, P NATL ACAD SCI USA, V96, P2864, DOI 10.1073/pnas.96.6.2864; Debenay JP, 2012, GUIDE 1000 FORMINIFE; Defrance M, 1824, MOLLUSQUES VERS ZOOP, P32; Delage Y, 1896, TRAITE ZOOLOGIE CONC; Dorst S, 2013, J FORAMIN RES, V43, P238, DOI 10.2113/gsjfr.43.3.238; du Chatelet EA, 2013, MAR GEOL, V335, P114, DOI 10.1016/j.margeo.2012.10.013; Duchemin G, 2005, J FORAMIN RES, V35, P198, DOI 10.2113/35.3.198; Duijnstee I., 2001, THESIS UTRECHT U; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ehrenberg C, 1839, BILDING KREIDEFELSEN; Felder DL., 2009, GULF MEXICO ORIGIN W; Frontalini F, 2015, MAR BIODIVERS, V45, P549, DOI 10.1007/s12526-014-0238-z; Frontalini F, 2014, MICROPALEONTOLOGY, V60, P27; Gertman I, 2002, CIESM WORK SER, V16; Glazer A, 2010, MONITORING PROGRAM M; Goineau A, 2011, J SEA RES, V65, P58, DOI 10.1016/j.seares.2010.07.007; Herut B, 2000, OCEANOL ACTA, V23, P771, DOI 10.1016/S0399-1784(00)01118-X; Holzmann M, 2000, J MICROPALAEONTOL, V19, P85, DOI 10.1144/jm.19.1.85; Hottinger L., 1993, RECENT FORAMINIFERID; Hyams-Kaphzan O, 2014, GEOL SIRV ISR, P38; Hyams-Kaphzan O, 2008, NEUES JAHRB GEOL P-A, V248, P315, DOI 10.1127/0077-7749/2008/0248-0315; Jannink NT, 2001, THESIS UTECHT U; Javaux Emmanuelle J., 2003, Palaeontologia Electronica, V6, P1; Jorissen F, 1988, UTR MICROPALEONTOL B; JORISSEN FJ, 1987, MAR MICROPALEONTOL, V12, P21, DOI 10.1016/0377-8398(87)90012-0; Kucera M, 2002, PHILOS T ROY SOC A, V360, P695, DOI 10.1098/rsta.2001.0962; Langer M.R., 1991, MEDITERRANEAN FORAMI; Langer MR, 2013, NEUES JAHRB GEOL P-A, V267, P155, DOI 10.1127/0077-7749/2013/0302; LANGER MR, 1993, MAR MICROPALEONTOL, V20, P235, DOI 10.1016/0377-8398(93)90035-V; LANGER MR, 1993, J FORAMIN RES, V23, P40, DOI 10.2113/gsjfr.23.1.40; Lazzari P, 2012, BIOGEOSCIENCES, V9, P217, DOI 10.5194/bg-9-217-2012; Le Calvez Y, 1977, CAHIERS MICROPALEONT; Lecroq B, 2009, ZOOTAXA, P23, DOI 10.11646/zootaxa.2096.1.4; Loeblich A, 1994, FORAMINIFERA SAHUL S, P31; Macias D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081591; McCloskey B, 2009, THESIS U S FLORIDA; Meric E, 2007, J ASIAN EARTH SCI, V30, P353, DOI 10.1016/j.jseaes.2006.10.006; Milker Y, 2012, PALAEONTOL ELECTRON, V15; Mojtahid M, 2010, J FORAMIN RES, V40, P231, DOI 10.2113/gsjfr.40.3.231; Nomura R, 1981, MEM FAC ED SHIMANE U, V15, P31; Nomura R., 1997, MEM FAC EDU NAT SCI, V31, P1; Pawlowski J, 2000, MICROPALEONTOLOGY, V46, P1; Pawlowski J, 2008, BIODIVERS CONSERV, V17, P317, DOI 10.1007/s10531-007-9253-8; Pawlowski J, 2013, MAR MICROPALEONTOL, V100, P1, DOI 10.1016/j.marmicro.2013.04.002; Reiss Z, 1961, GEOLOGICAL SURVEY IS, V32, P10; Richardson Susan L., 2003, Micronesica, V35-36, P38; Rilov G, 2014, H322014 IOLR, V2014, pH32; Schonfeld J, 2012, MAR MICROPALEONTOL, V94-95, P1, DOI 10.1016/j.marmicro.2012.06.001; Sgarrella Franca, 1993, Bollettino della Societa Paleontologica Italiana, V32, P145; TAMURA K, 1992, MOL BIOL EVOL, V9, P678; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tapiero I, 2002, HIGH RESOLUTION PALE	70	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142263	10.1371/journal.pone.0142263	http://dx.doi.org/10.1371/journal.pone.0142263			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26539992	Green Published, gold, Green Submitted			2022-12-26	WOS:000364303800071
J	Sharma, NK; Kumar, A; Kumari, A; Tokar, EJ; Waalkes, MP; Bortner, CD; Williams, J; Ehrenshaft, M; Mason, RP; Sinha, BK				Sharma, Nilesh K.; Kumar, Ashutosh; Kumari, Amrita; Tokar, Erik J.; Waalkes, Michael P.; Bortner, Carl D.; Williams, Jason; Ehrenshaft, Marilyn; Mason, Ronald P.; Sinha, Birandra K.			Nitric Oxide Down-Regulates Topoisomerase I and Induces Camptothecin Resistance in Human Breast MCF-7 Tumor Cells	PLOS ONE			English	Article							COLON-CARCINOMA CELLS; S-NITROSYLATION; ANTICANCER ACTIVITY; MELANOMA-CELLS; P53 FUNCTION; DNA-DAMAGE; WILD-TYPE; CANCER; PROTEIN; SENSITIVITY	Camptothecin (CPT), a topoisomerase I poison, is an important drug for the treatment of solid tumors in the clinic. Nitric oxide ((NO)-N-center dot), a physiological signaling molecule, is involved in many cellular functions, including cell proliferation, survival and death. We have previously shown that (NO)-N-center dot plays a significant role in the detoxification of etoposide (VP-16), a topoisomerase II poison in vitro and in human melanoma cells. (NO)-N-center dot/(NO)-N-center dot-derived species are reported to modulate activity of several important cellular proteins. As topoisomerases contain a number of free sulfhydryl groups which may be targets of (NO)-N-center dot/(NO)-N-center dot-derived species, we have investigated the roles of (NO)-N-center dot/(NO)-N-center dot-derived species in the stability and activity of topo I. Here we show that (NO)-N-center dot/(NO)-N-center dot-derived species induces a significant down-regulation of topoisomerase I protein via the ubiquitin/26S proteasome pathway in human colon (HT29) and breast (MCF-7) cancer cell lines. Importantly, (NO)-N-center dot treatment induced a significant resistance to CPT only in MCF-7 cells. This resistance to CPT did not result from loss of topoisomerase I activity as there were no differences in topoisomerase I-induced DNA cleavage in vitro or in tumor cells, but resulted from the stabilization/induction of bcl2 protein. This up-regulation of bcl2 protein in MCF-7 cells was wtp53 dependent as pifithrine-alpha, a small molecule inhibitor of wtp53 function, completely reversed CPT resistance, suggesting that wtp53 and bcl2 proteins played important roles in CPT resistance. Because tumors in vivo are heterogeneous and contaminated by infiltrating macrophages, (NO)-N-center dot-induced down-regulation of topoisomerase I protein combined with bcl2 protein stabilization could render certain tumors highly resistant to CPT and drugs derived from it in the clinic.	[Sharma, Nilesh K.; Kumar, Ashutosh; Kumari, Amrita; Ehrenshaft, Marilyn; Mason, Ronald P.; Sinha, Birandra K.] NIEHS, Immun Inflammat & Dis Lab, NIH, Durham, NC 27713 USA; [Tokar, Erik J.; Waalkes, Michael P.] NIEHS, Natl Toxicol Program, NIH, Durham, NC USA; [Bortner, Carl D.] NIEHS, Lab Signal Transduct, NIH, Durham, NC USA; [Williams, Jason] NIEHS, Struct Biol Lab, NIH, Durham, NC USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Sinha, BK (corresponding author), NIEHS, Immun Inflammat & Dis Lab, NIH, Durham, NC 27713 USA.	sinha1@niehs.nih.gov	Sharma, Prof. Nilesh Kumar/ABA-5959-2020; Mason, Ronald P/G-5967-2019	Sharma, Prof. Nilesh Kumar/0000-0002-8774-3020; Mason, Ronald P/0000-0002-1859-9109	National Institute of Environmental Health Sciences, NIH; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102925, ZICES102488, ZIAES050139] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported [in part] by the intramural research program of the National Institute of Environmental Health Sciences, NIH.	BEIDLER DR, 1995, MOL PHARMACOL, V47, P907; Calmels S, 1997, CANCER RES, V57, P3365; Chanvorachote P, 2006, CANCER RES, V66, P6353, DOI 10.1158/0008-5472.CAN-05-4533; Chazotte-Aubert L, 2000, BIOCHEM BIOPH RES CO, V267, P609, DOI 10.1006/bbrc.1999.2003; Chazotte-Aubert L, 2001, BIOCHEM BIOPH RES CO, V281, P766, DOI 10.1006/bbrc.2001.4423; Chowdhury R, 2012, CHEM RES TOXICOL, V25, P2194, DOI 10.1021/tx300274a; Davis KL, 2001, ANNU REV PHARMACOL, V41, P203, DOI 10.1146/annurev.pharmtox.41.1.203; Davis PL, 1998, ANTICANCER RES, V18, P2919; Desai SD, 1997, J BIOL CHEM, V272, P24159, DOI 10.1074/jbc.272.39.24159; Desai SD, 2001, CANCER RES, V61, P5926; FAN SJ, 1995, CANCER RES, V55, P1649; Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116; FROELICHAMMON SJ, 1995, J BIOL CHEM, V270, P21429, DOI 10.1074/jbc.270.37.21429; GIOVANELLA BC, 1989, SCIENCE, V246, P1046, DOI 10.1126/science.2555920; Glynn SA, 2010, J CLIN INVEST, V120, P3843, DOI 10.1172/JCI42059; Gobert C, 1999, P NATL ACAD SCI USA, V96, P10355, DOI 10.1073/pnas.96.18.10355; Gobert C, 1996, BIOCHEMISTRY-US, V35, P5778, DOI 10.1021/bi952327w; Godoy LC, 2012, P NATL ACAD SCI USA, V109, P20373, DOI 10.1073/pnas.1218938109; Goldwasser F, 1996, CANCER RES, V56, P4430; Gupta M, 1997, CLIN CANCER RES, V3, P1653; Hall CN, 2009, NITRIC OXIDE-BIOL CH, V21, P92, DOI 10.1016/j.niox.2009.07.002; Hasinoff BB, 2005, MOL PHARMACOL, V67, P937, DOI 10.1124/mol.104.004416; Hawkins DS, 1996, CANCER RES, V56, P892; Heinecke JL, 2014, P NATL ACAD SCI USA, V111, P6323, DOI 10.1073/pnas.1401799111; Jaiswal M, 2000, CANCER RES, V60, P184; Jaiswal M, 2001, CANCER RES, V61, P6388; KOLIOS G, 1995, BRIT J PHARMACOL, V116, P2866, DOI 10.1111/j.1476-5381.1995.tb15938.x; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Lancaster JR, 2006, CHEM RES TOXICOL, V19, P1160, DOI 10.1021/tx060061w; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Li F, 2007, MOL CELL, V26, P63, DOI 10.1016/j.molcel.2007.02.024; LIU LF, 1983, J BIOL CHEM, V258, P5365; Loibl S, 2005, EUR J CANCER, V41, P265, DOI 10.1016/j.ejca.2004.07.010; Napoli C, 2013, J AM COLL CARDIOL, V62, P89, DOI 10.1016/j.jacc.2013.03.070; Nieves-Neira W, 1999, INT J CANCER, V82, P396, DOI 10.1002/(SICI)1097-0215(19990730)82:3<396::AID-IJC13>3.0.CO;2-Z; POMMIER Y, 1994, CANCER INVEST, V12, P530, DOI 10.3109/07357909409021413; Ridnour LA, 2006, ANTIOXID REDOX SIGN, V8, P1329, DOI 10.1089/ars.2006.8.1329; SAVILLE B, 1958, ANALYST, V83, P670, DOI 10.1039/an9588300670; Shih JY, 2006, J CANC MOL, V2, P101; Simon DI, 1996, P NATL ACAD SCI USA, V93, P4736, DOI 10.1073/pnas.93.10.4736; Sinha BK, 2013, J PHARMACOL EXP THER, V347, P607, DOI 10.1124/jpet.113.207928; Sinha BK, 2013, CHEM RES TOXICOL, V26, P379, DOI 10.1021/tx300480q; SINHA BK, 1995, DRUGS, V49, P11, DOI 10.2165/00003495-199549010-00002; Stewart L, 1998, SCIENCE, V279, P1534, DOI 10.1126/science.279.5356.1534; TANIZAWA A, 1994, J NATL CANCER I, V86, P836, DOI 10.1093/jnci/86.11.836; Tokar EJ, 2013, CHEM RES TOXICOL, V26, P96, DOI 10.1021/tx3004054; WANG JC, 1985, ANNU REV BIOCHEM, V54, P665, DOI 10.1146/annurev.biochem.54.1.665; Wang SW, 2004, J BIOL CHEM, V279, P25535, DOI 10.1074/jbc.M400944200; Wang YT, 2014, ACS CHEM BIOL, V9, P821, DOI 10.1021/cb400547u; Xu WM, 2002, CELL RES, V12, P311, DOI 10.1038/sj.cr.7290133; Xu WM, 2000, NAT CELL BIOL, V2, P339, DOI 10.1038/35014028; Zhou H, 2005, TOXICOLOGY, V208, P223, DOI 10.1016/j.tox.2004.11.021; Zhou J, 2004, CURR MOL MED, V4, P741, DOI 10.2174/1566524043359926	53	11	12	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141897	10.1371/journal.pone.0141897	http://dx.doi.org/10.1371/journal.pone.0141897			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540186	Green Published, gold, Green Submitted			2022-12-26	WOS:000364303800034
J	Dong, JL; Sun, BN; Ma, FJ; Wang, QJ; Jin, PH; Wang, WJ; Deng, P; Yang, Y; Li, XJ				Dong, Jun-Ling; Sun, Bai-Nian; Ma, Fu-Jun; Wang, Qiu-Jun; Jin, Pei-Hong; Wang, Wen-Jia; Deng, Peng; Yang, Yi; Li, Xiao-Jing			Paliurus Fruits from the Oligocene of South China and Their Phytogeographic Implications	PLOS ONE			English	Article							MORPHOLOGY; BIOGEOGRAPHY; GUANGXI	Paliurus favonii Unger is recognized and described based on fruits from the Oligocene Ningming flora of Guangxi, South China. Characteristics of the present specimens include circular winged fruits that are 10.0-11.5 mm in diameter with a central endocarp at 3.0 to 4.0 mm in diameter. The specimens fall into the morphological range of the fossil species P. favonii, which has been observed in other Cenozoic sites in the Northern Hemisphere. The present discovery represents the lowest latitude distribution of P. favonii in the world, and we are presenting the first P. favonii fossil described with detailed cuticular characteristics from China. Further, this finding demonstrates that the genus existed in the Oligocene Ningming region, South China, and provides new information for understanding the fossil history. The dispersal mode for winged fossils demonstrates that wind dispersal is well-represented in the Oligocene Ningming flora.	[Dong, Jun-Ling; Sun, Bai-Nian; Ma, Fu-Jun; Wang, Qiu-Jun; Jin, Pei-Hong; Wang, Wen-Jia; Deng, Peng; Yang, Yi; Li, Xiao-Jing] Lanzhou Univ, Sch Earth Sci, Lanzhou 730000, Peoples R China; [Dong, Jun-Ling; Sun, Bai-Nian; Ma, Fu-Jun; Wang, Qiu-Jun; Jin, Pei-Hong; Wang, Wen-Jia; Deng, Peng; Yang, Yi; Li, Xiao-Jing] Lanzhou Univ, Key Lab Mineral Resources Western China Gansu Pro, Lanzhou 730000, Peoples R China; [Dong, Jun-Ling; Sun, Bai-Nian] Chinese Acad Sci, Nanjing Inst Geol & Palaeontol, Key Lab Econ Stratig & Palaeogeog, Nanjing 210008, Jiangsu, Peoples R China	Lanzhou University; Lanzhou University; Chinese Academy of Sciences	Sun, BN (corresponding author), Lanzhou Univ, Sch Earth Sci, Lanzhou 730000, Peoples R China.	bnsun@lzu.edu.cn			National Natural Science Foundation of China [41172022]; National Basic Research Program of China (973 Program) [2012CB822003]; Key Laboratory of Economic Stratigraphy and Palaeogeography, Nanjing Institute of Geology and Palaeontology, CAS [Y421140303]; Fundamental Research Funds for the Central Universities [lzujbky-2014-285]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Key Laboratory of Economic Stratigraphy and Palaeogeography, Nanjing Institute of Geology and Palaeontology, CAS; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	Funding: This work was supported by the National Natural Science Foundation of China, grant 41172022 (http://www.nsfc.gov.cn/). This work was also supported by the National Basic Research Program of China (973 Program, number 2012CB822003), the Funds of Key Laboratory of Economic Stratigraphy and Palaeogeography, Nanjing Institute of Geology and Palaeontology, CAS (No. Y421140303), and the Fundamental Research Funds for the Central Universities (No. lzujbky-2014-285). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airy Shaw H. K., 1951, KEW B, V51, P327, DOI [10.2307/4118000, DOI 10.2307/4118000]; AUGSPURGER CK, 1988, NEW PHYTOL, V108, P357, DOI 10.1111/j.1469-8137.1988.tb04174.x; AUGSPURGER CK, 1986, AM J BOT, V73, P353, DOI 10.2307/2444078; Burge DO, 2008, INT J PLANT SCI, V169, P1066, DOI 10.1086/590453; Chen Geng-Jiao, 2004, Vertebrata Palasiatica, V42, P81; Chen GJ, 2011, SCI CHINA EARTH SCI, V54, P481, DOI 10.1007/s11430-011-4182-5; Chen GJ, 2005, J VERTEBR PALEONTOL, V25, P492, DOI 10.1671/0272-4634(2005)025[0492:ANCCRT]2.0.CO;2; Chen YF, 2005, BOT J LINN SOC, V147, P437, DOI 10.1111/j.1095-8339.2005.00373.x; Chen YF., 2014, INT J LATEST RES SCI, V3, P13; CONOVER MV, 1991, BOT J LINN SOC, V107, P295, DOI 10.1111/j.1095-8339.1991.tb00225b.x; Correa E, 2010, AM J BOT, V97, P71, DOI 10.3732/ajb.0900093; de Potascheff CD, 2014, BRITTONIA, V66, P191, DOI 10.1007/s12228-013-9314-0; Harris JG, 2001, PLANT IDENTIFICATION; Huzioka K., 1970, J MINING COLL AKITA, V4, P1; Kovar-Eder Johanna, 2004, Annalen des Naturhistorischen Museums in Wien A Mineralogie Petrologie Geologie Palaeontologie Archaeozoologie Anthropologie Praehistorie, V105A, P45; [李浩敏 Li Haomin], 2003, [古生物学报, Acta Palaeontologica Sinica], V42, P537; Li XC, 2014, ACTA GEOL SIN-ENGL, V88, P1364, DOI 10.1111/1755-6724.12304; Ma FJ, 2015, MYCOLOGIA, DOI [10.3852/38143270, DOI 10.3852/3814-3270]; Mai DH, 1991, ABH STAATL MUS MIN G, V38, P1; Manchester S. R., 2001, PROC DENVER MUS NAT, V4, P137; Manchester SR, 1999, ANN MO BOT GARD, V86, P472, DOI 10.2307/2666183; Manchester SR, 1987, MONOGRAPHS SYSTEMATI, V21, P91; Manchester SR, 2010, BOT REV, V76, P1, DOI 10.1007/s12229-010-9041-0; MIKI SHlGERU, 1933, BOT MAG [TOKYO], V47, P619; Morton CM, 1997, AM J BOT, V84, P530, DOI 10.2307/2446029; Pigg K. B., 2002, WASHINGTON GEOL, V30, P3; PRANCE GT, 1978, BRITTONIA, V30, P21, DOI 10.2307/2806452; Richardson J. E., 2000, Kew Bulletin, V55, P311, DOI 10.2307/4115645; Richardson JE, 2004, PHILOS T R SOC B, V359, P1495, DOI 10.1098/rstb.2004.1537; Schirarend C, 1996, GRANA, V35, P347, DOI 10.1080/00173139609429093; Schirarend C., 2007, FLORA CHINA HIPPOCAS, V12, P115; Schirarend Carsten, 1994, Botanische Jahrbuecher fuer Systematik Pflanzengeschichte und Pflanzengeographie, V116, P333; Shi GL, 2014, PALAEOWORLD, V23, P336, DOI 10.1016/j.palwor.2014.08.001; Shi GL, 2012, AM J BOT, V99, P108, DOI 10.3732/ajb.1100331; Shi GL, 2011, REV PALAEOBOT PALYNO, V166, P325, DOI 10.1016/j.revpalbo.2011.06.005; Shi GL, 2010, REV PALAEOBOT PALYNO, V161, P179, DOI 10.1016/j.revpalbo.2010.04.002; [宋柱秋 Song Zhuqiu], 2014, [古生物学报, Acta Palaeontologica Sinica], V53, P191; Sprague TA, 1916, DIONCOPHYLLUM B MISC, V4, P89; Unger F., 1847, CHLORIS PROTOGAEA, DOI [10.5962/bhl.title.141709, DOI 10.5962/BHL.TITLE.141709]; Wang Q, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-88; Wang QJ, 2015, CR PALEVOL, DOI [10.1016/j.crpv.2015.1003.1005, DOI 10.1016/J.CRPV.2015.1003.1005]; [王伟铭 Wang Weiming], 2003, [地层学杂志, Journal of Stratigraphy], V27, P324; Wilde V, 1998, REV PALAEOBOT PALYNO, V101, P7, DOI 10.1016/S0034-6667(97)00067-5; Wilde V, 2010, REV PALAEOBOT PALYNO, V159, P143, DOI 10.1016/j.revpalbo.2009.11.010; Work Group of 'Cenozoic Plant from China' (WGCPC), 1978, CENOZ PLANTS CHIN FO; Zhang Zhicheng, 1980, PALEONTOLOGICAL AT 2, P308	46	10	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140653	10.1371/journal.pone.0140653	http://dx.doi.org/10.1371/journal.pone.0140653			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536607	Green Submitted, Green Published, gold			2022-12-26	WOS:000364298400029
J	Rath, S; Salinas, M; Villegas, AG; Ramaswamy, S				Rath, Sasmita; Salinas, Manuel; Villegas, Ana G.; Ramaswamy, Sharan			Differentiation and Distribution of Marrow Stem Cells in Flex-Flow Environments Demonstrate Support of the Valvular Phenotype	PLOS ONE			English	Article							FLUID SHEAR-STRESS; CONGENITAL AORTIC-STENOSIS; TRILEAFLET HEART-VALVES; TIME RT-PCR; PULSATILE BIOREACTOR; ENDOTHELIAL-CELLS; TISSUE; DESIGN; IDENTIFICATION; REPLACEMENT	For treatment of critical heart valve diseases, prosthetic valves perform fairly well in most adults; however, for pediatric patients, there is the added requirement that the replacement valve grows with the child, thus extremely limiting current treatment options. Tissue engineered heart valves (TEHV), such as those derived from autologous bone marrow stem cells (BMSCs), have the potential to recapitulate native valve architecture and accommodate somatic growth. However, a fundamental pre-cursor in promoting directed integration with native tissues rather than random, uncontrolled growth requires an understanding of BMSC mechanobiological responses to valve-relevant mechanical environments. Here, we report on the responses of human BMSC-seeded polymer constructs to the valve-relevant stress states of: (i) steady flow alone, (ii) cyclic flexure alone, and (iii) the combination of cyclic flexure and steady flow (flex-flow). BMSCs were seeded onto a PGA: PLLA polymer scaffold and cultured in static culture for 8 days. Subsequently, the aforementioned mechanical conditions, (groups consisting of steady flow alone-850ml/min, cyclic flexure alone-1 Hz, and flex-flow-850ml/min and 1 Hz) were applied for an additional two weeks. We found samples from the flex-flow group exhibited a valve-like distribution of cells that expressed endothelial (preference to the surfaces) and myofibroblast (preference to the intermediate region) phenotypes. We interpret that this was likely due to the presence of both appreciable fluid-induced shear stress magnitudes and oscillatory shear stresses, which were concomitantly imparted onto the samples. These results indicate that flex-flow mechanical environments support directed in vitro differentiation of BMSCs uniquely towards a heart valve phenotype, as evident by cellular distribution and expression of specific gene markers. A priori guidance of BMSC-derived, engineered tissue growth under flex-flow conditions may serve to subsequently promote controlled, engineered to native tissue integration processes in vivo necessary for successful long-term valve remodeling.	[Rath, Sasmita; Salinas, Manuel; Villegas, Ana G.; Ramaswamy, Sharan] Florida Int Univ, Dept Biomed Engn, Miami, FL 33174 USA	State University System of Florida; Florida International University	Ramaswamy, S (corresponding author), Florida Int Univ, Dept Biomed Engn, Miami, FL 33174 USA.	sramaswa@fiu.edu	Sharan, Ramaswamy/H-4469-2019	Ramaswamy, Sharan/0000-0003-4108-7141	College of Engineering and Computing at Florida International University (FIU); university graduate school at FIU	College of Engineering and Computing at Florida International University (FIU); university graduate school at FIU	Financial support for this study was provided by the College of Engineering and Computing at Florida International University (FIU). Additionally, a Dissertation Year Fellowship to support Sasmita Rath, provided by the university graduate school at FIU, is gratefully acknowledged.	Aikawa E, 2006, CIRCULATION, V113, P1344, DOI 10.1161/CIRCULATIONAHA.105.591768; Alfonso AR, 2013, ACTA BIOMATER, V9, P8149, DOI 10.1016/j.actbio.2013.06.009; [Anonymous], KEY OP TRAIN KIT POW; Bancroft GN, 2003, TISSUE ENG, V9, P549, DOI 10.1089/107632703322066723; Barron V, 2003, ANN BIOMED ENG, V31, P1017, DOI 10.1114/1.1603260; Bilodeau K, 2006, TISSUE ENG, V12, P2367, DOI 10.1089/ten.2006.12.2367; Brand NJ, 2006, INT J BIOCHEM CELL B, V38, P30, DOI 10.1016/j.biocel.2005.06.018; Butcher JT, 2006, ARTERIOSCL THROM VAS, V26, P69, DOI 10.1161/01.ATV.0000196624.70507.0d; Butcher JT, 2004, ARTERIOSCL THROM VAS, V24, P1429, DOI 10.1161/01.ATV.0000130462.50769.5a; Dumont K, 2002, ARTIF ORGANS, V26, P710, DOI 10.1046/j.1525-1594.2002.06931_3.x; Engelmayr GC, 2008, ANN BIOMED ENG, V36, P700, DOI 10.1007/s10439-008-9447-6; Engelmayr GC, 2006, BIOMATERIALS, V27, P6083, DOI 10.1016/j.biomaterials.2006.07.045; Fisher AB, 2001, AM J PHYSIOL-LUNG C, V281, pL529, DOI 10.1152/ajplung.2001.281.3.L529; Flanagan TC, 2007, BIOMATERIALS, V28, P3388, DOI 10.1016/j.biomaterials.2007.04.012; Flanagan Thomas C., 2003, European Cells & Materials, V6, P28; Freed LE, 2006, TISSUE ENG, V12, P3285, DOI 10.1089/ten.2006.12.3285; Freeman WM, 1999, BIOTECHNIQUES, V26, P112, DOI 10.2144/99261rv01; GIRARD PR, 1995, J CELL PHYSIOL, V163, P179, DOI 10.1002/jcp.1041630121; He XJ, 1996, J BIOMECH ENG-T ASME, V118, P74, DOI 10.1115/1.2795948; Hildebrand DK, 2004, ANN BIOMED ENG, V32, P1039, DOI 10.1114/B:ABME.0000036640.11387.4b; Hoerstrup SP, 2000, CIRCULATION, V102, P44; Hoerstrup SP, 2002, CIRCULATION, V106, pI143, DOI 10.1161/01.cir.0000032872.55215.05; HORSTKOTTE D, 1988, EUR HEART J, V9, P57, DOI 10.1093/eurheartj/9.suppl_E.57; Justo RN, 1996, AM J CARDIOL, V77, P1332, DOI 10.1016/S0002-9149(96)00201-9; Kadner A, 2002, ANN THORAC SURG, V74, pS1422; KONNO S, 1975, J THORAC CARDIOV SUR, V70, P909; Li YSJ, 2005, J BIOMECH, V38, P1949, DOI 10.1016/j.jbiomech.2004.09.030; LINDROOS M, 1993, J AM COLL CARDIOL, V21, P1220, DOI 10.1016/0735-1097(93)90249-Z; Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035; Martinez C, 2013, MOL IMAGING, V12; Martinez C, 2013, TISSUE ENG PT A, V19, P458, DOI [10.1089/ten.tea.2012.0149, 10.1089/ten.TEA.2012.0149]; Mol A, 2005, ANN BIOMED ENG, V33, P1778, DOI 10.1007/s10439-005-8025-4; NAGEL T, 1994, J CLIN INVEST, V94, P885, DOI 10.1172/JCI117410; Ramaswamy S, NOVEL BIOREACT UNPUB; Ramaswamy S BS, 2014, J BIOMECHANICAL ENG; Ramaswamy S, 2010, BIOMATERIALS, V31, P1114, DOI 10.1016/j.biomaterials.2009.10.019; Rath S, 2015, J LONG-TERM EFF MED, V25; REYNOLDS JL, 1960, NEW ENGL J MED, V262, P276, DOI 10.1056/NEJM196002112620603; Sacks MS, 2007, PHILOS T R SOC B, V362, P1369, DOI 10.1098/rstb.2007.2122; Salinas M, 2014, J BIOMECH, V47, P3517, DOI 10.1016/j.jbiomech.2014.08.028; Schenke-Layland K, 2003, CARDIOVASC RES, V60, P497, DOI 10.1016/j.cardiores.2003.09.002; Schmidt D, 2007, CIRCULATION, V116, pI64, DOI 10.1161/CIRCULATIONAHA.106.6806637; Schmidt D, 2006, CIRCULATION, V114, pI125, DOI 10.1161/CIRCULATIONAHA.105.001040; Shinoka T, 1995, ANN THORAC SURG, V60, pS513, DOI 10.1016/0003-4975(95)00733-4; Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157; Steinhoff G, 2000, CIRCULATION, V102, P50; Stock UA, 2001, ANNU REV MED, V52, P443, DOI 10.1146/annurev.med.52.1.443; Sutherland FWH, 2005, CIRCULATION, V111, P2783, DOI 10.1161/CIRCULATIONAHA.104.498378; Topper JN, 1999, MOL MED TODAY, V5, P40, DOI 10.1016/S1357-4310(98)01372-0; Varga A, 2006, J VIROL METHODS, V132, P146, DOI 10.1016/j.jviromet.2005.10.004; Vermot J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000246; Vesely I, 2005, CIRC RES, V97, P743, DOI 10.1161/01.RES.0000185326.04010.9f; Wang H, 2005, ARTERIOSCL THROM VAS, V25, P1817, DOI 10.1161/01.ATV.0000175840.90510.a8; Yap CH, 2012, BIOMECH MODEL MECHAN, V11, P171, DOI 10.1007/s10237-011-0301-7; Yoganathan AP, 2004, ANNU REV BIOMED ENG, V6, P331, DOI 10.1146/annurev.bioeng.6.040803.140111; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	56	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141802	10.1371/journal.pone.0141802	http://dx.doi.org/10.1371/journal.pone.0141802			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536240	Green Published, gold, Green Submitted			2022-12-26	WOS:000364298400089
J	Salilew-Wondim, D; Fournier, E; Hoelker, M; Saeed-Zidane, M; Tholen, E; Looft, C; Neuhoff, C; Besenfelder, U; Havlicek, V; Rings, F; Gagne, D; Sirard, MA; Robert, C; Saadi, HAS; Gad, A; Schellander, K; Tesfaye, D				Salilew-Wondim, Dessie; Fournier, Eric; Hoelker, Michael; Saeed-Zidane, Mohammed; Tholen, Ernst; Looft, Christian; Neuhoff, Christiane; Besenfelder, Urban; Havlicek, Vita; Rings, Franca; Gagne, Dominic; Sirard, Marc-Andre; Robert, Claude; Saadi, Habib A. Shojaei; Gad, Ahmed; Schellander, Karl; Tesfaye, Dawit			Genome-Wide DNA Methylation Patterns of Bovine Blastocysts Developed In Vivo from Embryos Completed Different Stages of Development In Vitro	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; CPG-ISLANDS; BODY METHYLATION; MESSENGER-RNA; TRANSCRIPTOME; OOCYTES; TISSUE; DEMETHYLATION; EPIGENETICS; ERRORS	Early embryonic loss and altered gene expression in in vitro produced blastocysts are believed to be partly caused by aberrant DNA methylation. However, specific embryonic stage which is sensitive to in vitro culture conditions to alter the DNA methylation profile of the resulting blastocysts remained unclear. Therefore, the aim of this study was to investigate the stage specific effect of in vitro culture environment on the DNA methylation response of the resulting blastocysts. For this, embryos cultured in vitro until zygote (ZY), 4-cell (4C) or 16-cell (16C) were transferred to recipients and the blastocysts were recovery at day 7 of the estrous cycle. Another embryo group was cultured in vitro until blastocyst stage (IVP). Genome-wide DNA methylation profiles of ZY, 4C, 16C and IVP blastocyst groups were then determined with reference to blastocysts developed completely under in vivo condition (VO) using EmbryoGENE DNA Methylation Array. To assess the contribution of methylation changes on gene expression patterns, the DNA methylation data was superimposed to the transcriptome profile data. The degree of DNA methylation dysregulation in the promoter and/or gene body regions of the resulting blastocysts was correlated with successive stages of development the embryos advanced under in vitro culture before transfer to the in vivo condition. Genomic enrichment analysis revealed that in 4C and 16C blastocyst groups, hypermethylated loci were outpacing the hypomethylated ones in intronic, exonic, promoter and proximal promoter regions, whereas the reverse was observed in ZY blastocyst group. However, in the IVP group, as much hypermethylated as hypomethylated probes were detected in gene body and promoter regions. In addition, gene ontology analysis indicated that differentially methylated regions were found to affected several biological functions including ATP binding in the ZY group, programmed cell death in the 4C, glycolysis in 16C and genetic imprinting and chromosome segregation in IVP blastocyst groups. Furthermore, 1.6, 3.4, 3.9 and 9.4% of the differentially methylated regions that were overlapped to the transcriptome profile data were negatively correlated with the gene expression patterns in ZY, 4C, 16C and IVP blastocyst groups, respectively. Therefore, this finding indicated that suboptimal culture condition during preimplantation embryo development induced changes in the DNA methylation landscape of the resulting blastocysts in a stage dependent manner and the altered DNA methylation pattern was only partly explained the observed aberrant gene expression patterns of the blastocysts.	[Salilew-Wondim, Dessie; Hoelker, Michael; Saeed-Zidane, Mohammed; Tholen, Ernst; Looft, Christian; Neuhoff, Christiane; Rings, Franca; Schellander, Karl; Tesfaye, Dawit] Univ Bonn, Inst Anim Sci, Anim Breeding & Husb Grp, D-53115 Bonn, Germany; [Fournier, Eric; Gagne, Dominic; Sirard, Marc-Andre; Robert, Claude; Saadi, Habib A. Shojaei] Univ Laval Quebec, Fac Sci Agr & Alimentat, Ctr Rech Biol Reprod, INAF, Laval, PQ G1V 0A6, Canada; [Besenfelder, Urban; Havlicek, Vita] Univ Vet Med Vienna, Inst Anim Breeding & Genet, A-1210 Vienna, Austria; [Gad, Ahmed] Cairo Univ, Fac Agr, Dept Anim Prod, Giza 12613, Egypt	University of Bonn; Istituto Nazionale Astrofisica (INAF); Laval University; University of Veterinary Medicine Vienna; Egyptian Knowledge Bank (EKB); Cairo University	Salilew-Wondim, D (corresponding author), Univ Bonn, Inst Anim Sci, Anim Breeding & Husb Grp, D-53115 Bonn, Germany.	dsal@itw.uni-bonn.de	Sirard, Marc/A-9112-2011; Saadi, Habib A. Shojaei/U-6878-2019; Gad, Ahmed/M-7273-2013	Gad, Ahmed/0000-0001-9741-2105; Wondim, Dr. Dessie Salilew/0000-0002-8756-0865	EmbryoGENE Research Network, Canada	EmbryoGENE Research Network, Canada	Funding: This research was funded by EmbryoGENE Research Network, Canada.	Aksu DA, 2012, MOL REPROD DEV, V79, P613, DOI 10.1002/mrd.22068; Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; BARNES FL, 1991, MOL REPROD DEV, V29, P117, DOI 10.1002/mrd.1080290205; Betsha S, 2013, MOL REPROD DEV, V80, P315, DOI 10.1002/mrd.22165; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Bogliotti YS, 2015, ANIM REPROD, V12, P52; CAMOUS S, 1986, BIOL CELL, V58, P195, DOI 10.1111/j.1768-322X.1986.tb00506.x; Caraux G, 2005, BIOINFORMATICS, V21, P1280, DOI 10.1093/bioinformatics/bti141; Clemente M, 2011, BIOL REPROD, V85, P285, DOI 10.1095/biolreprod.111.091587; de Waal E, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.114785; Dean W, 2001, P NATL ACAD SCI USA, V98, P13734, DOI 10.1073/pnas.241522698; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Dessie SW, 2007, REPRODUCTION, V133, P931, DOI 10.1530/REP-06-0277; Dobbs KB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066230; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Elango N, 2011, GENETICS, V187, P1077, DOI 10.1534/genetics.110.126094; Ezura Y, 2009, ARTHRITIS RHEUM, V60, P1416, DOI 10.1002/art.24472; Farin PW, 2006, THERIOGENOLOGY, V65, P178, DOI 10.1016/j.theriogenology.2005.09.022; FREI RE, 1989, J REPROD FERTIL, V86, P637, DOI 10.1530/jrf.0.0860637; Gad A, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.099697; Guo HS, 2014, NATURE, V511, P606, DOI 10.1038/nature13544; Han L, 2007, CANCER BIOL THER, V6, P1284; Hiendleder S, 2006, BIOL REPROD, V75, P17, DOI 10.1095/biolreprod.105.043919; Hou J, 2007, SCI CHINA SER C, V50, P56, DOI 10.1007/s11427-007-0003-7; Huang YZ, 2014, SCI REP-UK, V4, P1, DOI 10.1038/srep06546; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; Ji H, 2010, NATURE, V467, P338, DOI 10.1038/nature09367; Jiang ZL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-756; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Katari S, 2009, HUM MOL GENET, V18, P3769, DOI 10.1093/hmg/ddp319; Klein CA, 1999, P NATL ACAD SCI USA, V96, P4494, DOI 10.1073/pnas.96.8.4494; Kues WA, 2008, P NATL ACAD SCI USA, V105, P19768, DOI 10.1073/pnas.0805616105; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Maher ER, 2003, HUM REPROD, V18, P2508, DOI 10.1093/humrep/deg486; Mamrut S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056869; Memili E, 1998, MOL REPROD DEV, V51, P36, DOI 10.1002/(SICI)1098-2795(199809)51:1&lt;36::AID-MRD4&gt;3.0.CO;2-X; Memili E, 1999, BIOL REPROD, V61, P1198, DOI 10.1095/biolreprod61.5.1198; Michels KB, 2013, NAT METHODS, V10, P949, DOI 10.1038/nmeth.2632; PARK JG, 1994, MOL CELL BIOL, V14, P7975, DOI 10.1128/MCB.14.12.7975; Park JS, 2007, DEV DYNAM, V236, P2523, DOI 10.1002/dvdy.21278; Silva ARRE, 2012, EPIGENETICS-US, V7, P440, DOI 10.4161/epi.19563; Rohde C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-230; Saadi HAS, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-451; Salilew-Wondim D, 2013, PHYSIOL GENOMICS, V45, P28, DOI 10.1152/physiolgenomics.00076.2012; Salilew-Wondim D, 2010, PHYSIOL GENOMICS, V42, P201, DOI 10.1152/physiolgenomics.00047.2010; Shen J, 2015, GASTROENT RES PRACT, V2015, DOI 10.1155/2015/230642; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Su JM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-12; Suzuki H, 2012, MOL ONCOL, V6, P567, DOI 10.1016/j.molonc.2012.07.007; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Tesfaye D, 2004, REPROD DOMEST ANIM, V39, P396, DOI 10.1111/j.1439-0531.2004.00531.x; Tesfaye D, 2003, MOL REPROD DEV, V66, P105, DOI 10.1002/mrd.10338; Vassena R, 2005, MOL REPROD DEV, V72, P430, DOI 10.1002/mrd.20375; Viuff D, 1996, MOL REPROD DEV, V43, P171, DOI 10.1002/(SICI)1098-2795(199602)43:2&lt;171::AID-MRD6&gt;3.0.CO;2-O; Wrenzycki Christine, 2003, Reprod Biomed Online, V7, P649; Yang XJ, 2014, CANCER CELL, V26, P577, DOI 10.1016/j.ccr.2014.07.028; Young LE, 2004, ANIM REPROD SCI, V82-3, P61, DOI 10.1016/j.anireprosci.2004.05.020	61	40	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140467	10.1371/journal.pone.0140467	http://dx.doi.org/10.1371/journal.pone.0140467			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536655	gold, Green Published, Green Submitted			2022-12-26	WOS:000364298400021
J	Winiecka-Klimek, M; Smolarz, M; Walczak, MP; Zieba, J; Hulas-Bigoszewska, K; Kmieciak, B; Piaskowski, S; Rieske, P; Grzela, DP; Stoczynska-Fidelus, E				Winiecka-Klimek, Marta; Smolarz, Maciej; Walczak, Maciej P.; Zieba, Jolanta; Hulas-Bigoszewska, Krystyna; Kmieciak, Blazej; Piaskowski, Sylwester; Rieske, Piotr; Grzela, Dawid P.; Stoczynska-Fidelus, Ewelina			SOX2 and SOX2-MYC Reprogramming Process of Fibroblasts to the Neural Stem Cells Compromised by Senescence	PLOS ONE			English	Article							DIRECT CONVERSION; MOUSE FIBROBLASTS; DEFINED FACTORS; SOMATIC-CELLS; DOPAMINERGIC-NEURONS; PROGENITOR CELLS; PRECURSOR CELLS; DIFFERENTIATION; EXPRESSION; BRAIN	Tumorigenic potential of induced pluripotent stem cells (iPSCs) infiltrating population of induced neural stem cells (iNSCs) generated from iPSCs may limit their medical applications. To overcome such a difficulty, direct reprogramming of adult somatic cells into iNSCs was proposed. The aim of this study was the systematic comparison of induced neural cells (iNc) obtained with different methods-direct reprogramming of human adult fibroblasts with either SOX2 (SiNSc-like) or SOX2 and c-MYC (SMiNSc-like) and induced pluripotent stem cells differentiation to ebiNSc-in terms of gene expression profile, differentiation potential as well as proliferation properties. Immunocytochemistry and real-time PCR analyses were used to evaluate gene expression profile and differentiation potential of various iNc types. Bromodeoxyuridine (BrdU) incorporation and senescence-associated beta-galactosidase (SA-beta-gal) assays were used to estimate proliferation potential. All three types of iNc were capable of neuronal differentiation; however, astrocytic differentiation was possible only in case of ebiNSc. Contrary to ebiNSc generation, the direct reprogramming was rarely a propitious process, despite 100% transduction efficiency. The potency of direct iNSCs-like cells generation was lower as compared to iNSCs obtained by iPSCs differentiation, and only slightly improved when c-MYC was added. Directly reprogrammed iNSCs-like cells were lacking the ability to differentiate into astrocytic cells and characterized by poor efficiency of neuronal cells formation. Such features indicated that these cells could not be fully reprogrammed, as confirmed mainly with senescence detection. Importantly, SiNSc-like and SMiNSc-like cells were unable to achieve the long-term survival and became senescent, which limits their possible therapeutic applicability. Our results suggest that iNSCs-like cells, generated in the direct reprogramming attempts, were either not fully reprogrammed or reprogrammed only into neuronal progenitors, mainly because of the inaccuracies of currently available protocols.	[Winiecka-Klimek, Marta; Smolarz, Maciej; Walczak, Maciej P.; Zieba, Jolanta; Hulas-Bigoszewska, Krystyna; Piaskowski, Sylwester; Rieske, Piotr; Grzela, Dawid P.; Stoczynska-Fidelus, Ewelina] Celther Polska, Dept Res & Dev, Lodz, Poland; [Winiecka-Klimek, Marta; Smolarz, Maciej; Zieba, Jolanta; Piaskowski, Sylwester; Rieske, Piotr; Stoczynska-Fidelus, Ewelina] Med Univ Lodz, Dept Tumor Biol, Lodz, Poland; [Kmieciak, Blazej] Med Univ Lodz, Chair Human Sci, Dept Med Law, Lodz, Poland	Medical University Lodz; Medical University Lodz	Winiecka-Klimek, M (corresponding author), Celther Polska, Dept Res & Dev, Lodz, Poland.	marta.winiecka-klimek@celther.com	Rieske, Piotr/M-4821-2015; Grzela, Dawid P/G-6395-2015; Stoczynska-Fidelus, Ewelina/S-9948-2016; Stoczynska-Fidelus, Ewelina/M-4871-2015	Rieske, Piotr/0000-0002-2970-0970; Grzela, Dawid P/0000-0002-0667-6488; Kmieciak, Blazej/0000-0002-6347-1796; Stoczynska-Fidelus, Ewelina/0000-0002-7779-3075	Polish Agency for Enterprise Development [POIG.01.04.00-10-011/11]	Polish Agency for Enterprise Development	This study was sponsored by Polish Agency for Enterprise Development, Grant No. POIG.01.04.00-10-011/11. ESF, PR, and SP participated in acquisition of funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiuti A, 1998, EXP HEMATOL, V26, P143; Banito A, 2009, GENE DEV, V23, P2134, DOI 10.1101/gad.1811609; Beguin PC, 2012, J CELL PHYSIOL, V227, P813, DOI 10.1002/jcp.22794; Bi D, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-46; Brambrink T, 2006, P NATL ACAD SCI USA, V103, P933, DOI 10.1073/pnas.0510485103; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Chandeck C, 2010, ADV ANAT PATHOL, V17, P42, DOI 10.1097/PAP.0b013e3181c66f4e; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Drozd AM, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0112-3; Glettig DL, 2013, BIORESEARCH OPEN ACC, V2, P179, DOI 10.1089/biores.2013.0006; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Han DW, 2012, CELL STEM CELL, V10, P465, DOI 10.1016/j.stem.2012.02.021; Hemmer K, 2014, STEM CELL REP, V3, P423, DOI 10.1016/j.stemcr.2014.06.017; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Kerosuo L, 2008, J CELL SCI, V121, P3941, DOI 10.1242/jcs.024802; Kerosuo L, 2010, DIFFERENTIATION, V80, P68, DOI 10.1016/j.diff.2010.04.003; KILPATRICK TJ, 1993, J NEUROSCI RES, V35, P147, DOI 10.1002/jnr.490350205; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kim K, 2011, NAT BIOTECHNOL, V29, P1117, DOI 10.1038/nbt.2052; Kim SM, 2014, NAT PROTOC, V9, P871, DOI 10.1038/nprot.2014.056; Kishaba Y, 2010, PATHOL INT, V60, P378, DOI 10.1111/j.1440-1827.2010.02532.x; Kodama S, 2001, RADIAT RES, V155, P254, DOI 10.1667/0033-7587(2001)155[0254:CCDSLG]2.0.CO;2; Kumar A, 2012, J MOL CELL BIOL, V4, P252, DOI 10.1093/jmcb/mjs015; Lujan E, 2012, P NATL ACAD SCI USA, V109, P2527, DOI 10.1073/pnas.1121003109; Mallanna SK, 2010, STEM CELLS, V28, P1715, DOI 10.1002/stem.494; Maucksch C, 2012, J STEM CELLS REGEN, V8, pP162; Oh J, 2010, J NEUROSCI RES, V88, P2798, DOI 10.1002/jnr.22447; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Park TIH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037742; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; Pinal CS, 1998, PERSPECT DEV NEUROBI, V5, P109; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Polouliakh N, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00007; Rieske P, 2007, EUR J NEUROSCI, V25, P31, DOI 10.1111/j.1460-9568.2006.05254.x; Rieske P, 2009, EXP CELL RES, V315, P462, DOI 10.1016/j.yexcr.2008.11.004; Ring KL, 2012, CELL STEM CELL, V11, P100, DOI 10.1016/j.stem.2012.05.018; Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761; Rosser AE, 1997, DEV BRAIN RES, V98, P291, DOI 10.1016/S0165-3806(96)00189-7; Rouhani F, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004432; Sansom SN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000511; Schnerch A, 2010, STEM CELLS, V28, P419, DOI 10.1002/stem.298; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Sun CK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5112; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TAKANASHI H, 1994, IN VITRO CELL DEV-AN, V30A, P384, DOI 10.1007/BF02634359; Tian N, 1999, P NATL ACAD SCI USA, V96, P12911, DOI 10.1073/pnas.96.22.12911; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wilson KD, 2009, STEM CELLS DEV, V18, P749, DOI 10.1089/scd.2008.0247; Yuan T, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt224	57	9	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141688	10.1371/journal.pone.0141688	http://dx.doi.org/10.1371/journal.pone.0141688			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26535892	Green Submitted, Green Published, gold			2022-12-26	WOS:000364298400077
J	Jang, H; Lee, JH; Braatz, RD				Jang, Hong; Lee, Jay H.; Braatz, Richard D.			State Estimation of the Time-Varying and Spatially Localized Concentration of Signal Molecules from the Stochastic Adsorption Dynamics on the Carbon Nanotube-Based Sensors and Its Application to Tumor Cell Detection	PLOS ONE			English	Article							NITRIC-OXIDE; FLUORESCENT-PROBES; HYDROGEN-PEROXIDE; PARTICLE FILTERS; SMOOTH-MUSCLE; GROWTH; ROLES; PROLIFERATION; DEATH; ASSAY	This paper addresses a problem of estimating time-varying, local concentrations of signal molecules with a carbon-nanotube (CNT)-based sensor array system, which sends signals triggered by monomolecular adsorption/desorption events of proximate molecules on the surfaces of the sensors. Such sensors work on nano-scale phenomena and show inherently stochastic non-Gaussian behavior, which is best represented by the chemical master equation (CME) describing the time evolution of the probabilities for all the possible number of adsorbed molecules. In the CME, the adsorption rate on each sensor is linearly proportional to the local concentration in the bulk phase. State estimators are proposed for these types of sensors that fully address their stochastic nature. For CNT-based sensors motivated by tumor cell detection, the particle filter, which is nonparametric and can handle non-Gaussian distributions, is compared to a Kalman filter that approximates the underlying distributions by Gaussians. In addition, the second-order generalized pseudo Bayesian estimation (GPB2) algorithm and the Markov chain Monte Carlo (MCMC) algorithm are incorporated into KF and PF respectively, for detecting latent drift in the concentration affected by different states of a cell.	[Jang, Hong; Lee, Jay H.] Korea Adv Inst Sci & Technol, Dept Chem & Biomol Engn, Taejon 305701, South Korea; [Braatz, Richard D.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA	Korea Advanced Institute of Science & Technology (KAIST); Massachusetts Institute of Technology (MIT)	Lee, JH (corresponding author), Korea Adv Inst Sci & Technol, Dept Chem & Biomol Engn, Taejon 305701, South Korea.	jayhlee@kaist.ac.kr	Lee, Jay Hyung/C-1808-2011; Braatz, Richard D/I-6725-2015	Lee, Jay Hyung/0000-0001-6134-6118; Braatz, Richard D/0000-0003-4304-3484	Advanced Biomass R&D Center(ABC) of Global Frontier Project - Ministry of Science, ICT and Future Planning [ABC-2011-0031354]	Advanced Biomass R&D Center(ABC) of Global Frontier Project - Ministry of Science, ICT and Future Planning	This work was supported by the Advanced Biomass R&D Center(ABC) of Global Frontier Project funded by the Ministry of Science, ICT and Future Planning (ABC-2011-0031354). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicher A, 2003, NAT MED, V9, P1370, DOI 10.1038/nm948; Arulampalam MS, 2002, IEEE T SIGNAL PROCES, V50, P174, DOI 10.1109/78.978374; Bar-Shalom Y, 1993, ESTIMATION TRACKING; Barone PW, 2005, NAT MATER, V4, P86, DOI 10.1038/nmat1276; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Boghossian AA, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3606496; Bracewell RN., 1986, FOURIER TRANSFORM IT; Casanova D, 2009, NAT NANOTECHNOL, V4, P581, DOI [10.1038/nnano.2009.200, 10.1038/NNANO.2009.200]; CATHCART R, 1983, ANAL BIOCHEM, V134, P111, DOI 10.1016/0003-2697(83)90270-1; Cognet L, 2007, SCIENCE, V316, P1465, DOI 10.1126/science.1141316; Czubryt MR, 2003, PROG EXP CARDIOL, V7, P249; Doucet A, 2001, IEEE T SIGNAL PROCES, V49, P613, DOI 10.1109/78.905890; FICHTHORN KA, 1991, J CHEM PHYS, V95, P1090, DOI 10.1063/1.461138; Fukumura D, 2006, NAT REV CANCER, V6, P521, DOI 10.1038/nrc1910; Garipcan B, 2011, ADV ENG MATER, V13, pB54, DOI 10.1002/adem.201080076; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Grau M, 2007, J CHROMATOGR B, V851, P106, DOI 10.1016/j.jchromb.2007.02.002; Hayter AJ., 2012, CENGAGE LEARNING; Heller DA, 2005, ADV MATER, V17, P2793, DOI 10.1002/adma.200500477; Heller DA, 2006, SCIENCE, V311, P508, DOI 10.1126/science.1120792; Irani K, 2000, CIRC RES, V87, P179, DOI 10.1161/01.RES.87.3.179; Jahnke T, 2007, J MATH BIOL, V54, P1, DOI 10.1007/s00285-006-0034-x; Jang H., 2015, P 2015 52 ACM EDAC I, P1, DOI DOI 10.1109/FCV.2015.7103755; JENKINS DC, 1995, P NATL ACAD SCI USA, V92, P4392, DOI 10.1073/pnas.92.10.4392; Jin H, 2010, NAT NANOTECHNOL, V5, P302, DOI [10.1038/nnano.2010.24, 10.1038/NNANO.2010.24]; Jin H, 2008, NANO LETT, V8, P4299, DOI 10.1021/nl802010z; Jones MK, 2004, BIOCHEM BIOPH RES CO, V318, P520, DOI 10.1016/j.bbrc.2004.04.055; Kelm M, 1997, J BIOL CHEM, V272, P9922; Kim J.H., 2010, ANGEW CHEM, V122, P1498; Kim JH, 2009, NAT CHEM, V1, P473, DOI [10.1038/NCHEM.332, 10.1038/nchem.332]; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; Li PF, 1997, CIRCULATION, V96, P3602; Lim MH, 2007, ACCOUNTS CHEM RES, V40, P41, DOI 10.1021/ar950149t; Lim MH, 2006, NAT CHEM BIOL, V2, P375, DOI 10.1038/nchembio794; Morbidelli L, 2004, CANC TREAT, V117, P155; Moses MA, 1995, INT REV CYTOL, V161, P1; O'Connell MJ, 2002, SCIENCE, V297, P593, DOI 10.1126/science.1072631; Robinson JK, 1999, ANAL CHEM, V71, P5131, DOI 10.1021/ac990646d; Saito S, 2008, CONT CONCEPT CONDENS, P1; Sasaki E, 2005, J AM CHEM SOC, V127, P3684, DOI 10.1021/ja042967z; Shizukuda Y, 1999, CIRC RES, V85, P247, DOI 10.1161/01.RES.85.3.247; Staniek K, 1999, BBA-BIOENERGETICS, V1413, P70, DOI 10.1016/S0005-2728(99)00083-3; Truskey G., 2009, TRANSPORT PHENOMENA; Ulissi ZW, 2013, COMPUT CHEM ENG, V51, P149, DOI 10.1016/j.compchemeng.2012.07.004; Ulissi ZW, 2011, J PHYS CHEM LETT, V2, P1690, DOI 10.1021/jz200572b; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Wong WC, 2010, IND ENG CHEM RES, V49, P7901, DOI 10.1021/ie9020655; Wong WC, 2009, J PROCESS CONTR, V19, P1438, DOI 10.1016/j.jprocont.2009.04.014; Zhang JQ, 2011, J AM CHEM SOC, V133, P567, DOI 10.1021/ja1084942	49	0	0	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141930	10.1371/journal.pone.0141930	http://dx.doi.org/10.1371/journal.pone.0141930			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528927	Green Published, gold, Green Submitted			2022-12-26	WOS:000364032600078
J	Nakatsuji, M; Inoue, H; Kohno, M; Saito, M; Tsuge, S; Shimizu, S; Ishida, A; Ishibashi, O; Inui, T				Nakatsuji, Masatoshi; Inoue, Haruka; Kohno, Masaki; Saito, Mayu; Tsuge, Syogo; Shimizu, Shota; Ishida, Atsuko; Ishibashi, Osamu; Inui, Takashi			Human Lipocalin-Type Prostaglandin D Synthase-Based Drug Delivery System for Poorly Water-Soluble Anti-Cancer Drug SN-38	PLOS ONE			English	Article							LIPOPHILIC LIGANDS; POLYMERIC MICELLES; CANCER; CPT-11; SN38; MODEL; TUMOR; CAMPTOTHECIN; IRINOTECAN; BINDING	Lipocalin-type prostaglandin D synthase (L-PGDS) is a member of the lipocalin superfamily, which is composed of secretory transporter proteins, and binds a wide variety of small hydrophobic molecules. Using this function, we have reported the feasibility of using L-PGDS as a novel drug delivery vehicle for poorly water-soluble drugs. In this study, we show the development of a drug delivery system using L-PGDS, one that enables the direct clinical use of 7-ethyl-10-hydroxy-camptothecin (SN-38), a poorly water-soluble anti-cancer drug. In the presence of 2 mM L-PGDS, the concentration of SN-38 in PBS increased 1,130-fold as compared with that in PBS. Calorimetric experiments revealed that L-PGDS bound SN-38 at a molecular ratio of 1: 3 with a dissociation constant value of 60 mu M. The results of an in vitro growth inhibition assay revealed that the SN-38/L-PGDS complexes showed high anti-tumor activity against 3 human cancer cell lines, i.e., Colo201, MDA-MB-231, and PC-3 with a potency similar to that of SN-38 used alone. The intravenous administration of SN-38/L-PGDS complexes to mice bearing Colo201 tumors showed a pronounced anti-tumor effect. Intestinal mucositis, which is one of the side effects of this drug, was not observed in mice administered SN-38/L-PGDS complexes. Taken together, L-PGDS enables the direct usage of SN-38 with reduced side effects.	[Nakatsuji, Masatoshi; Inoue, Haruka; Kohno, Masaki; Saito, Mayu; Tsuge, Syogo; Shimizu, Shota; Ishida, Atsuko; Ishibashi, Osamu; Inui, Takashi] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Dept Appl Life Sci, Naka Ku, Sakai, Osaka 5998531, Japan	Osaka Metropolitan University	Inui, T (corresponding author), Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Dept Appl Life Sci, Naka Ku, 1-1 Gakuen Cho, Sakai, Osaka 5998531, Japan.	inuit@bioinfo.osakafu-u.ac.jp	Ishibashi, Osamu/J-8413-2019; Inui, Takashi/G-1069-2011	Ishibashi, Osamu/0000-0003-4698-460X; 	Japan Society for the Promotion of Science [25242046, 21200076]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants 25242046 (to TI), and 21200076 (to TI) from Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/).	Abu Lila AS, 2013, J CONTROL RELEASE, V172, P38, DOI 10.1016/j.jconrel.2013.07.026; Al-Jamal WT, 2011, ACCOUNTS CHEM RES, V44, P1094, DOI 10.1021/ar200105p; Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377; Bae YH, 2011, J CONTROL RELEASE, V153, P198, DOI 10.1016/j.jconrel.2011.06.001; Bala V, 2013, J CONTROL RELEASE, V172, P48, DOI 10.1016/j.jconrel.2013.07.022; Cavadas M, 2011, NANOMED-NANOTECHNOL, V7, P730, DOI 10.1016/j.nano.2011.04.006; Chadha R, 2008, J SCI IND RES INDIA, V67, P185; Cho KJ, 2008, CLIN CANCER RES, V14, P1310, DOI 10.1158/1078-0432.CCR-07-1441; Curnis F, 2000, NAT BIOTECHNOL, V18, P1185, DOI 10.1038/81183; Dobrovolskaia MA, 2007, NAT NANOTECHNOL, V2, P469, DOI 10.1038/nnano.2007.223; Ebrahimnejad P, 2011, INT J PHARMACEUT, V406, P122, DOI 10.1016/j.ijpharm.2010.12.022; Fukuhara A, 2012, J CONTROL RELEASE, V159, P143, DOI 10.1016/j.jconrel.2011.12.020; Fukuhara A, 2012, BIOCHEM J, V443, P75, DOI 10.1042/BJ20111889; FUKUOKA M, 1992, J CLIN ONCOL, V10, P16, DOI 10.1200/JCO.1992.10.1.16; Garcia-Carbonero R, 2002, CLIN CANCER RES, V8, P641; Gong J, 2012, J CONTROL RELEASE, V159, P312, DOI 10.1016/j.jconrel.2011.12.012; Guichard S, 1999, BRIT J CANCER, V80, P364, DOI 10.1038/sj.bjc.6690364; Guo Q, 2012, COLLOID SURFACE B, V100, P138, DOI 10.1016/j.colsurfb.2012.04.041; Inoue K, 2009, J BIOCHEM, V145, P169, DOI 10.1093/jb/mvn154; Inui T, 2003, J BIOL CHEM, V278, P2845, DOI 10.1074/jbc.M209934200; Inui T, 2014, J CEREBR BLOOD F MET, V34, P1558, DOI 10.1038/jcbfm.2014.127; Jiskoot W, 2009, PHARM RES-DORDR, V26, P1303, DOI 10.1007/s11095-009-9855-9; Koizumi F, 2006, CANCER RES, V66, P10048, DOI 10.1158/0008-5472.CAN-06-1605; Kume S, 2012, BIOCHEM J, V446, P279, DOI 10.1042/BJ20120324; Melo MLP, 2008, CANCER CHEMOTH PHARM, V61, P775, DOI 10.1007/s00280-007-0534-4; Meyer-Losic F, 2008, CLIN CANCER RES, V14, P2145, DOI 10.1158/1078-0432.CCR-07-4580; Miyamoto Y, 2010, J STRUCT BIOL, V169, P209, DOI 10.1016/j.jsb.2009.10.005; Mizoguchi M, 2015, EUR J PHARM SCI, V74, P77, DOI 10.1016/j.ejps.2015.04.012; Peng CL, 2009, BIOMATERIALS, V30, P3614, DOI 10.1016/j.biomaterials.2009.03.048; ROTHENBERG ML, 1993, J CLIN ONCOL, V11, P2194, DOI 10.1200/JCO.1993.11.11.2194; Rothenberg ML, 1997, ANN ONCOL, V8, P837, DOI 10.1023/A:1008270717294; Sapra P, 2008, CLIN CANCER RES, V14, P1888, DOI 10.1158/1078-0432.CCR-07-4456; Sepehri N, 2014, INT J PHARMACEUT, V471, P485, DOI 10.1016/j.ijpharm.2014.05.046; Shimamoto S, 2007, J BIOL CHEM, V282, P31373, DOI 10.1074/jbc.M700123200; Sigurskjold BW, 2000, ANAL BIOCHEM, V277, P260, DOI 10.1006/abio.1999.4402; Slatter JG, 2000, DRUG METAB DISPOS, V28, P423; Svenson S, 2009, EUR J PHARM BIOPHARM, V71, P445, DOI 10.1016/j.ejpb.2008.09.023; Takasuna K, 1996, CANCER RES, V56, P3752; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Urade Y, 2000, BBA-PROTEIN STRUCT M, V1482, P259, DOI 10.1016/S0167-4838(00)00161-8; Vangara KK, 2014, AAPS PHARMSCITECH, V15, P472, DOI 10.1208/s12249-013-0068-5; Verhoef JJF, 2013, DRUG DELIV TRANSL RE, V3, P499, DOI 10.1007/s13346-013-0176-5; Zhao H, 2008, BIOCONJUGATE CHEM, V19, P849, DOI 10.1021/bc700333s; Zhou YY, 2010, FASEB J, V24, P4668, DOI 10.1096/fj.10-164863	44	6	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0142206	10.1371/journal.pone.0142206	http://dx.doi.org/10.1371/journal.pone.0142206			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529243	Green Published, Green Submitted, gold			2022-12-26	WOS:000364032600110
J	Zhao, X; Li, D; Pu, J; Mei, H; Yang, D; Xiang, X; Qu, H; Huang, K; Zheng, L; Tong, Q				Zhao, X.; Li, D.; Pu, J.; Mei, H.; Yang, D.; Xiang, X.; Qu, H.; Huang, K.; Zheng, L.; Tong, Q.			CTCF cooperates with noncoding RNA MYCNOS to promote neuroblastoma progression through facilitating MYCN expression	ONCOGENE			English	Article							MATRIX-METALLOPROTEINASE 14; GASTRIC-CANCER CELLS; HUMAN P53 GENE; N-MYC; TUMOR-SUPPRESSOR; NEURONAL DIFFERENTIATION; AMPLIFIED NEUROBLASTOMA; CONDITIONAL EXPRESSION; EPIGENETIC REGULATION; TRANSCRIPTION FACTOR	Previous studies have indicated the important roles of MYCN in tumorigenesis and progression of neuroblastoma (NB), the most common extracranial solid tumor derived from neural crest in childhood. However, the regulatory mechanisms of MYCN expression in NB still remain largely unknown. In this study, through mining public microarray databases and analyzing the cis-regulatory elements and chromatin immunoprecipitation data sets, we identified CCCTC-binding factor (CTCF) as a crucial transcription factor facilitating the MYCN expression in NB. RNA immunoprecipitation, RNA electrophoretic mobility shift assay, RNA pull down and in vitro binding assay indicated the physical interaction between CTCF and MYCN opposite strand (MYCNOS), a natural noncoding RNA surrounding the MYNC promoter. Gain- and loss-of-function studies revealed that MYCNOS facilitated the recruitment of CTCF to its binding sites within the MYCN promoter to induce chromatin remodeling, resulting in enhanced MYCN levels and altered downstream gene expression, in cultured NB cell lines. CTCF cooperated with MYCNOS to suppress the differentiation and promote the growth, invasion and metastasis of NB cells in vitro and in vivo. In clinical NB tissues and cell lines, CTCF and MYCNOS were upregulated and positively correlated with MYCN expression. CTCF was an independent prognostic factor for unfavorable outcome of NB, and patients with high MYCNOS expression had lower survival probability. Taken together, these results demonstrate that CTCF cooperates with noncoding RNA MYCNOS to exhibit oncogenic activity that affects the aggressiveness and progression of NB through transcriptional upregulation of MYCN.	[Zhao, X.; Li, D.; Pu, J.; Mei, H.; Yang, D.; Xiang, X.; Qu, H.; Tong, Q.] Huazhong Univ Sci & Technol, Union Hosp, Dept Pediat Surg, Tongji Med Coll, Wuhan 430022, Hubei Province, Peoples R China; [Huang, K.; Zheng, L.; Tong, Q.] Huazhong Univ Sci & Technol, Union Hosp, Clin Ctr Human Genom Res, Tongji Med Coll, Wuhan, Peoples R China; [Huang, K.] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Cardiol, Wuhan, Peoples R China; [Zheng, L.] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Pathol, Wuhan 430022, Hubei Province, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Tong, Q (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Dept Pediat Surg, Tongji Med Coll, Wuhan 430022, Hubei Province, Peoples R China.; Zheng, L (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Pathol, Wuhan 430022, Hubei Province, Peoples R China.	ld_zheng@hotmail.com; qs_tong@hotmail.com	Zhao, Xiang/AAL-6578-2020; Tong, Qiangsong/B-4500-2014	Zhao, Xiang/0000-0002-5332-4602; Tong, Qiangsong/0000-0002-2615-6404	National Natural Science Foundation of China [81272779, 81372667, 81372401, 81472363, 81402301, 81402408, 81572423]; Fundamental Research Funds for the Central Universities [2012QN224, 2013ZHYX003, 01-18-530112, 01-18-530115]; Natural Science Foundation of Hubei Province [2014CFA012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province)	We are grateful to Drs William L Carroll and Danny Reinberg for providing vectors. This work was supported by the National Natural Science Foundation of China (81272779, 81372667, 81372401, 81472363, 81402301, 81402408, 81572423), Fundamental Research Funds for the Central Universities (2012QN224, 2013ZHYX003, 01-18-530112, 01-18-530115) and Natural Science Foundation of Hubei Province (2014CFA012).	ARMSTRONG BC, 1992, CELL GROWTH DIFFER, V3, P385; Bell E, 2010, CANCER LETT, V293, P144, DOI 10.1016/j.canlet.2010.01.015; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chernukhin IV, 2000, J BIOL CHEM, V275, P29915, DOI 10.1074/jbc.M001538200; Chipumuro E, 2014, CELL, V159, P1126, DOI 10.1016/j.cell.2014.10.024; De la Rosa-Velazquez IA, 2007, CANCER RES, V67, P2577, DOI 10.1158/0008-5472.CAN-06-2024; Docquier F, 2005, CANCER RES, V65, P5112, DOI 10.1158/0008-5472.CAN-03-3498; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; Hasan MK, 2013, SCI REP-UK, V3, DOI 10.1038/srep03450; Henriksen JR, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-1; Huang KM, 2013, J BIOL CHEM, V288, P26067, DOI 10.1074/jbc.M113.486175; Inge TH, 2002, SURGERY, V132, P232, DOI 10.1067/msy.2002.125387; Jacobs JFM, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-239; Jiang GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031379; Kaneko Y, 2015, CANCER SCI, V106, P840, DOI 10.1111/cas.12677; Kramps C, 2004, J BIOL CHEM, V279, P5110, DOI 10.1074/jbc.M304758200; Li D, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0320-6; Li D, 2013, ONCOTARGET, V4, P2021, DOI 10.18632/oncotarget.1579; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Liu PY, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju113; Loven J, 2010, P NATL ACAD SCI USA, V107, P1553, DOI 10.1073/pnas.0913517107; Lutz W, 1996, ONCOGENE, V13, P803; Michel AM, 2014, NUCLEIC ACIDS RES, V42, pD859, DOI 10.1093/nar/gkt1035; Nutt SL, 1998, EMBO J, V17, P2319, DOI 10.1093/emboj/17.8.2319; Pandey GK, 2014, CANCER CELL, V26, P722, DOI 10.1016/j.ccell.2014.09.014; Pession A, 2005, CURR CANCER DRUG TAR, V5, P273, DOI 10.2174/1568009054064606; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Qu HX, 2015, HUM MOL GENET, V24, P2539, DOI 10.1093/hmg/ddv018; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Saldana-Meyer R, 2014, GENE DEV, V28, P723, DOI 10.1101/gad.236869.113; SCHWAB M, 1983, NATURE, V305, P245, DOI 10.1038/305245a0; Shoji W, 2015, BIOCHEM BIOPH RES CO, V461, P501, DOI 10.1016/j.bbrc.2015.04.050; Sivak LE, 1997, ONCOGENE, V15, P1937, DOI 10.1038/sj.onc.1201363; Soto-Reyes E, 2010, ONCOGENE, V29, P2217, DOI 10.1038/onc.2009.509; Suenaga Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1003996; Suenaga Y, 2009, BIOCHEM BIOPH RES CO, V390, P21, DOI 10.1016/j.bbrc.2009.09.044; Sun S, 2013, CELL, V153, P1537, DOI 10.1016/j.cell.2013.05.028; Tanaka N, 2008, INT J ONCOL, V33, P815, DOI 10.3892/ijo_00000069; Tee AE, 2014, ONCOTARGET, V5, P1793, DOI 10.18632/oncotarget.1785; Thomas WD, 2004, INT J BIOCHEM CELL B, V36, P771, DOI 10.1016/S1357-2725(03)00254-1; Vance KW, 2014, EMBO J, V33, P296, DOI 10.1002/embj.201386225; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985; Westermann F, 2002, CANCER LETT, V184, P127, DOI 10.1016/S0304-3835(02)00199-4; Witcher M, 2009, MOL CELL, V34, P271, DOI 10.1016/j.molcel.2009.04.001; Xiang JF, 2014, CELL RES, V24, P513, DOI 10.1038/cr.2014.35; Xiang X, 2015, CANCER LETT, V359, P187, DOI 10.1016/j.canlet.2015.01.008; Yang JH, 2013, NUCLEIC ACIDS RES, V41, pD177, DOI 10.1093/nar/gks1060; Yu M, 2009, INT J ONCOL, V34, P931, DOI 10.3892/ijo_00000219; Zhang H, 2014, ONCOGENE, V33, P387, DOI 10.1038/onc.2012.574; Zhang HY, 2012, MOL CANCER THER, V11, P1454, DOI 10.1158/1535-7163.MCT-12-0001; Zhang XH, 1999, ANTICANCER RES, V19, P1641; Zheng LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055719; Zheng LD, 2013, MOL CANCER RES, V11, P182, DOI 10.1158/1541-7786.MCR-12-0534; Zheng LD, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-74; Zheng LD, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-33	56	54	55	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 7	2016	35	27					3565	3576		10.1038/onc.2015.422	http://dx.doi.org/10.1038/onc.2015.422			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DR0UD	26549029				2022-12-26	WOS:000379621500009
J	Smilansky, A; Dangoor, L; Nakdimon, I; Ben-Hail, D; Mizrachi, D; Shoshan-Barmatz, V				Smilansky, Angela; Dangoor, Liron; Nakdimon, Itay; Ben-Hail, Danya; Mizrachi, Dario; Shoshan-Barmatz, Varda			The Voltage-dependent Anion Channel 1 Mediates Amyloid beta Toxicity and Represents a Potential Target for Alzheimer Disease Therapy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VDAC1 N-TERMINUS; MITOCHONDRIAL DYSFUNCTION; HEXOKINASE-ACTIVITY; CELL-DEATH; PROTEIN; EXPRESSION; APOPTOSIS; PEPTIDES; BINDING; LIFE	The voltage-dependent anion channel 1 (VDAC1), found in the mitochondrial outer membrane, forms the main interface between mitochondrial and cellular metabolisms, mediates the passage of a variety of molecules across the mitochondrial outer membrane, and is central to mitochondria-mediated apoptosis. VDAC1 is overexpressed in post-mortem brains of Alzheimer disease (AD) patients. The development and progress of AD are associated with mitochondrial dysfunction resulting from the cytotoxic effects of accumulated amyloid beta(A beta). In this study we demonstrate the involvement of VDAC1 and a VDAC1 N-terminal peptide (VDAC1-N-Ter) in A beta cell penetration and cell death induction. A beta directly interacted with VDAC1 and VDAC1-N-Ter, as monitored by VDAC1 channel conductance, surface plasmon resonance, and microscale thermophoresis. Preincubated A beta interacted with bilayer-reconstituted VDAC1 and increased its conductance similar to 2-fold. Incubation of cells with A beta resulted in mitochondria-mediated apoptotic cell death. However, the presence of non-cell-penetrating VDAC1-N-Ter peptide prevented A beta cellular entry and A beta-induced mitochondria-mediated apoptosis. Likewise, silencing VDAC1 expression by specific siRNA prevented A beta entry into the cytosol as well as A beta-induced toxicity. Finally, the mode of A beta-mediated action involves detachment of mitochondria-bound hexokinase, induction of VDAC1 oligomerization, and cytochrome c release, a sequence of events leading to apoptosis. As such, we suggest that A beta-mediated toxicity involves mitochondrial and plasma membrane VDAC1, leading to mitochondrial dysfunction and apoptosis induction. The VDAC1-N-Ter peptide targeting A beta cytotoxicity is thus a potential new therapeutic strategy for AD treatment.	[Smilansky, Angela; Dangoor, Liron; Nakdimon, Itay; Ben-Hail, Danya; Shoshan-Barmatz, Varda] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Smilansky, Angela; Dangoor, Liron; Nakdimon, Itay; Ben-Hail, Danya; Shoshan-Barmatz, Varda] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel; [Mizrachi, Dario] Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA	Ben Gurion University; Ben Gurion University; Cornell University	Shoshan-Barmatz, V (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.	vardasb@bgu.ac.il		Ben-Hail, Danya/0000-0002-8210-3446	National Institute for Biotechnology in the Negev (NIBN), Ben-Gurion University of the Negev	National Institute for Biotechnology in the Negev (NIBN), Ben-Gurion University of the Negev	This work was supported by a grant from the National Institute for Biotechnology in the Negev (NIBN), Ben-Gurion University of the Negev. This work was also financially supported by Phillip and Sima Needleman. The authors declare that they have no conflicts of interest with the contents of this article.	Abu-Hamad S, 2006, P NATL ACAD SCI USA, V103, P5787, DOI 10.1073/pnas.0600103103; Abu-Hamad S, 2008, J BIOL CHEM, V283, P13482, DOI 10.1074/jbc.M708216200; Abu-Hamad S, 2009, J CELL SCI, V122, P1906, DOI 10.1242/jcs.040188; Ahmad A, 2002, AM J PHYSIOL-LUNG C, V283, pL573, DOI 10.1152/ajplung.00410.2001; Akanda N, 2008, CELL CYCLE, V7, P3225, DOI 10.4161/cc.7.20.6831; Aleardi AM, 2005, J BIOENERG BIOMEMBR, V37, P207, DOI 10.1007/s10863-005-6631-3; Arbel N, 2012, J BIOL CHEM, V287, P23152, DOI 10.1074/jbc.M112.345918; Arbel N, 2010, J BIOL CHEM, V285, P6053, DOI 10.1074/jbc.M109.082990; Arzoine L, 2009, J BIOL CHEM, V284, P3946, DOI 10.1074/jbc.M803614200; Azoulay-Zohar H, 2004, BIOCHEM J, V377, P347, DOI 10.1042/BJ20031465; Benek O, 2015, CURR MED CHEM, V22, P1056, DOI 10.2174/0929867322666150114163051; Bryson JM, 2002, J BIOL CHEM, V277, P11392, DOI 10.1074/jbc.M110927200; Buettner R, 2000, P NATL ACAD SCI USA, V97, P3201, DOI 10.1073/pnas.060242297; Cabezas-Opazo FA, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/509654; Cardoso SM, 2002, BRAIN RES, V931, P117, DOI 10.1016/S0006-8993(02)02256-4; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; Clarke DD, 1999, BASIC NEUROCHEMISTRY; Cuadrado-Tejedor M, 2011, J ALZHEIMERS DIS, V23, P195, DOI 10.3233/JAD-2010-100966; Cunnane S, 2011, NUTRITION, V27, P3, DOI 10.1016/j.nut.2010.07.021; da-Silva WS, 2004, J BIOL CHEM, V279, P39846, DOI 10.1074/jbc.M403835200; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; De Pinto V, 2010, FEBS LETT, V584, P1793, DOI 10.1016/j.febslet.2010.02.049; Devi L, 2012, NEUROBIOL DIS, V45, P417, DOI 10.1016/j.nbd.2011.09.001; Elinder F, 2005, CELL DEATH DIFFER, V12, P1134, DOI 10.1038/sj.cdd.4401646; Ferrer I, 2009, J BIOENERG BIOMEMBR, V41, P425, DOI 10.1007/s10863-009-9243-5; FRACKOWIAK RSJ, 1981, BRAIN, V104, P753, DOI 10.1093/brain/104.4.753; Gao JH, 2009, AM J TRANSL RES, V1, P312; Gerber D, 2001, J BIOL CHEM, V276, P31229, DOI 10.1074/jbc.M101889200; Geula S, 2012, BIOCHEM J, V444, P475, DOI 10.1042/BJ20112079; Ghosh T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001170; Godbole A, 2003, BBA-MOL CELL RES, V1642, P87, DOI 10.1016/S0167-4889(03)00102-2; Godoy JA, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-23; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Han D, 2003, J BIOL CHEM, V278, P5557, DOI 10.1074/jbc.M210269200; Hardy J, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P151; Hertz L, 2015, J NEUROCHEM, V134, P7, DOI 10.1111/jnc.13107; Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Jenei ZA, 2009, J BIOL CHEM, V284, P6988, DOI 10.1074/jbc.M808487200; Keinan N, 2010, MOL CELL BIOL, V30, P5698, DOI 10.1128/MCB.00165-10; Kim T, 2013, SCIENCE, V341, P1399, DOI 10.1126/science.1242077; Kung HF, 2012, ACS MED CHEM LETT, V3, P265, DOI 10.1021/ml300058m; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lin H, 2001, FASEB J, V15, P2433, DOI 10.1096/fj.01-0377com; Lu AJ, 2007, FISH SHELLFISH IMMUN, V23, P601, DOI 10.1016/j.fsi.2007.01.007; Manczak M, 2004, NEUROMOL MED, V5, P147, DOI 10.1385/NMM:5:2:147; Manczak M, 2012, HUM MOL GENET, V21, P5131, DOI 10.1093/hmg/dds360; Marin R, 2007, MOL MEMBR BIOL, V24, P148, DOI 10.1080/09687860601055559; Mosconi L, 2008, ANN NY ACAD SCI, V1147, P180, DOI 10.1196/annals.1427.007; Pastorino JG, 2008, J BIOENERG BIOMEMBR, V40, P171, DOI 10.1007/s10863-008-9148-8; PIKE CJ, 1993, J NEUROSCI, V13, P1676; Prezma T, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.316; Ramirez CM, 2009, MOL CELL NEUROSCI, V42, P172, DOI 10.1016/j.mcn.2009.07.001; Readnower RD, 2011, INT J ALZHEIMERS DIS, V2011, DOI [10.4061/2011/104545, DOI 10.4061/2011/104545]; Reddy PH, 2013, BBA-MOL BASIS DIS, V1832, P1913, DOI 10.1016/j.bbadis.2013.06.012; Saddar S, 2005, J BIOL CHEM, V280, P24435, DOI 10.1074/jbc.M502804200; Shi Y, 2003, BIOCHEM BIOPH RES CO, V305, P989, DOI 10.1016/S0006-291X(03)00871-4; Shoshan-Barmatz V, 2012, CURR MED CHEM, V19, P714, DOI 10.2174/092986712798992110; Shoshan-Barmatz V, 2008, J BIOENERG BIOMEMBR, V40, P183, DOI 10.1007/s10863-008-9147-9; Shoshan-Barmatz V, 2015, BBA-BIOMEMBRANES, V1848, P2547, DOI 10.1016/j.bbamem.2014.10.040; Shoshan-Barmatz V, 2013, PROG MOL BIOL TRANSL, V117, P303, DOI 10.1016/B978-0-12-386931-9.00011-8; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; Shoshan-Barmatz V, 2009, BBA-BIOENERGETICS, V1787, P421, DOI 10.1016/j.bbabio.2008.11.009; Sultana R, 2006, NEUROBIOL DIS, V22, P76, DOI 10.1016/j.nbd.2005.10.004; Sun L, 2008, MOL CELL BIOL, V28, P1007, DOI 10.1128/MCB.00224-07; Thinnes FP, 2013, MOL GENET METAB, V108, P212, DOI 10.1016/j.ymgme.2013.01.008; Thinnes FP, 2011, WIEN MED WOCHENSCHR, V161, P274, DOI 10.1007/s10354-011-0887-5; Thinnes FP, 2009, MOL GENET METAB, V97, P241, DOI 10.1016/j.ymgme.2009.04.010; Wang XL, 2010, NEURODEGENER DIS, V7, P56, DOI 10.1159/000283484; Weisthal S, 2014, BBA-MOL CELL RES, V1843, P2270, DOI 10.1016/j.bbamcr.2014.03.021; Whittington DA, 2001, P NATL ACAD SCI USA, V98, P9545, DOI 10.1073/pnas.161301298; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Zaid H, 2005, CELL DEATH DIFFER, V12, P751, DOI 10.1038/sj.cdd.4401599	73	75	77	3	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					30670	30683		10.1074/jbc.M115.691493	http://dx.doi.org/10.1074/jbc.M115.691493			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26542804	hybrid, Green Published			2022-12-26	WOS:000367199000002
J	Brownley, RC; Agarwal, S; Loder, S; Eboda, O; Li, J; Peterson, J; Hwang, C; Breuler, C; Kaartinen, V; Zhou, B; Mishina, Y; Levi, B				Brownley, R. Cameron; Agarwal, Shailesh; Loder, Shawn; Eboda, Oluwatobi; Li, John; Peterson, Joshua; Hwang, Charles; Breuler, Christopher; Kaartinen, Vesa; Zhou, Bin; Mishina, Yuji; Levi, Benjamin			Characterization of Heterotopic Ossification Using Radiographic Imaging: Evidence for a Paradigm Shift	PLOS ONE			English	Article							BONE-FORMATION; CARTILAGE; MRI; INHIBITION; PREVENTION; MICROCT; RODENTS; INJURY; MOUSE; MODEL	Heterotopic ossification (HO) is the growth of extra- skeletal bone which occurs following trauma, burns, and in patients with genetic bone morphogenetic protein (BMP) receptor mutations. The clinical and laboratory evaluation of HO is dependent on radiographic imaging to identify and characterize these lesions. Here we show that despite its inadequacies, plain film radiography and single modality microCT continue to serve as a primary method of HO imaging in nearly 30% of published in vivo literature. Furthermore, we demonstrate that detailed microCT analysis is superior to plain film and single modality microCT radiography specifically in the evaluation of HO formed through three representative models due to its ability to 1) define structural relationships between growing extra- skeletal bone and normal, anatomic bone, 2) provide accurate quantification and growth rate based on volume of the space- occupying lesion, thereby facilitating assessments of therapeutic intervention, 3) identify HO at earlier times allowing for evaluation of early intervention, and 4) characterization of metrics of bone physiology including porosity, tissue mineral density, and cortical and trabecular volume. Examination of our trauma model using microCT demonstrated two separate areas of HO based on anatomic location and relationship with surrounding, normal bone structures. Additionally, microCT allows HO growth rate to be evaluated to characterize HO progression. Taken together, these data demonstrate the need for a paradigm shift in the evaluation of HO towards microCT as a standard tool for imaging.	[Brownley, R. Cameron; Agarwal, Shailesh; Loder, Shawn; Eboda, Oluwatobi; Li, John; Peterson, Joshua; Hwang, Charles; Breuler, Christopher; Levi, Benjamin] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Kaartinen, Vesa; Mishina, Yuji] Univ Michigan, Sch Dent, Ann Arbor, MI 48109 USA; [Zhou, Bin] Albert Einstein Coll Med, New York, NY USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Yeshiva University	Levi, B (corresponding author), Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA.	blevi@umich.edu	Kaartinen, Vesa/AAU-5396-2021		NIH/NIGMS [K08GM109105-0]; Plastic Surgery Foundation National Endowment Award; Association for Academic Surgery Roslyn Award; Research & Education Foundation Scholarship; American Association for the Surgery of Trauma Research & Education Foundation Scholarship [DOD: W81XWH-14- DMRDP-CRMRP- NMSIRA]; American Association of Plastic Surgery Research Fellowship; Coller Society Research Fellowship; NIH F32 Fellowship; Plastic Surgery Foundation; Howard Hughes Medical Institute (HHMI) Medical Fellows Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T35HL007690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K08GM109105] Funding Source: NIH RePORTER	NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Plastic Surgery Foundation National Endowment Award; Association for Academic Surgery Roslyn Award; Research & Education Foundation Scholarship; American Association for the Surgery of Trauma Research & Education Foundation Scholarship; American Association of Plastic Surgery Research Fellowship; Coller Society Research Fellowship; NIH F32 Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Plastic Surgery Foundation; Howard Hughes Medical Institute (HHMI) Medical Fellows Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	B.L. received funding from NIH/NIGMS -K08GM109105-0, Plastic Surgery Foundation National Endowment Award, the Association for Academic Surgery Roslyn Award, the Research & Education Foundation Scholarship, American Association for the Surgery of Trauma Research & Education Foundation Scholarship, DOD: W81XWH-14- DMRDP-CRMRP- NMSIRA, and American Association of Plastic Surgery Research Fellowship. S.A. was supported by the Coller Society Research Fellowship, NIH F32 Fellowship, and Plastic Surgery Foundation. S.L. was supported by the Howard Hughes Medical Institute (HHMI) Medical Fellows Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2015, DEV BIOL, V400, P202, DOI 10.1016/j.ydbio.2015.02.011; Baiker M, 2012, MOL IMAGING BIOL, V14, P420, DOI 10.1007/s11307-011-0522-2; Banovac K, 2001, SPINAL CORD, V39, P370, DOI 10.1038/sj.sc.3101166; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Buie HR, 2013, MED ENG PHYS, V35, P1645, DOI 10.1016/j.medengphy.2013.05.016; Cipriano C, 2009, ORTHOPEDICS, P32; Demontiero O, 2011, EXP GERONTOL, V46, P435, DOI 10.1016/j.exger.2011.01.001; Dijkstra AJ, 2010, CARTILAGE, V1, P328, DOI 10.1177/1947603510376819; Foldager CB, 2009, ACTA ORTHOP, V80, P737, DOI 10.3109/17453670903487040; Fransen M, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001160.PUB2; Fukuda T, 2009, J BIOL CHEM, V284, P7149, DOI 10.1074/jbc.M801681200; Imhof H, 2002, EUR RADIOL, V12, P2781, DOI 10.1007/s00330-001-1301-2; Lin L, 2010, BONE, V46, P425, DOI 10.1016/j.bone.2009.08.057; Mackie EJ, 2008, INT J BIOCHEM CELL B, V40, P46, DOI 10.1016/j.biocel.2007.06.009; Nishiyama KK, 2010, BONE, V46, P155, DOI 10.1016/j.bone.2009.09.023; Okagbare PI, 2012, ANALYST, V137, P77, DOI 10.1039/c1an15847c; Pavey GJ, 2015, CLIN ORTHOP RELAT R, V473, P2814, DOI 10.1007/s11999-015-4266-1; Peterson JR, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008810; Peterson JR, 2014, ANN SURG, V259, P993, DOI 10.1097/SLA.0b013e318291da85; Peterson JR, 2013, BONE, V54, P28, DOI 10.1016/j.bone.2013.01.002; Raghavan M, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3426310; Shimono K, 2011, NAT MED, V17, P454, DOI 10.1038/nm.2334; Shore EM, 2006, NAT GENET, V38, P525, DOI 10.1038/ng1783; Taha MA, 2013, J MAGN RESON IMAGING, V38, P231, DOI 10.1002/jmri.23876; Taiani JT, 2014, BONE, V64, P263, DOI 10.1016/j.bone.2014.04.019; Teo JCM, 2007, MAT SCI ENG C-BIO S, V27, P333, DOI 10.1016/j.msec.2006.05.003; THOMAS BJ, 1985, J BONE JOINT SURG AM, V67A, P400, DOI 10.2106/00004623-198567030-00008; van Kuijk AA, 2002, SPINAL CORD, V40, P313, DOI 10.1038/sj.sc.3101309; Yu PB, 2008, NAT MED, V14, P1363, DOI 10.1038/nm.1888	29	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141432	10.1371/journal.pone.0141432	http://dx.doi.org/10.1371/journal.pone.0141432			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544555	Green Published, gold, Green Submitted			2022-12-26	WOS:000364398700023
J	Perkins, BA; Cherney, DZI; Soleymanlou, N; Lee, JA; Partridge, H; Tschirhart, H; Zinman, B; Mazze, R; Fagan, N; Kaspers, S; Woerle, HJ; Broedl, UC; Johansen, OE				Perkins, Bruce A.; Cherney, David Z. I.; Soleymanlou, Nima; Lee, Justin A.; Partridge, Helen; Tschirhart, Holly; Zinman, Bernard; Mazze, Roger; Fagan, Nora; Kaspers, Stefan; Woerle, Hans-Juergen; Broedl, Uli C.; Johansen, Odd Erik			Diurnal Glycemic Patterns during an 8-Week Open-Label Proof-of-Concept Trial of Empagliflozin in Type 1 Diabetes	PLOS ONE			English	Article							COTRANSPORTER 2 INHIBITION; SGLT2 INHIBITOR; DOUBLE-BLIND; ADD-ON; GLUCOSE; DAPAGLIFLOZIN; METFORMIN; INSULIN; CANAGLIFLOZIN; IPRAGLIFLOZIN	Background We recently reported improved glycemic control with reduced insulin dose in subjects with type 1 diabetes treated with the sodium glucose co-transporter-2 inhibitor empagliflozin. To further characterize the effects, we analyzed diurnal glycemic patterns by continuous glucose monitoring (CGM). Methods In an 8-week single-arm open-label pilot study of empagliflozin, we compared ambulatory glucose profiles produced from CGM data during 2-week intervals in a placebo run-in baseline period, end-of-treatment, and post-treatment. Change in glycemic exposure was evaluated by area under the median curve according to time of day (AUC(TOTAL) 12:00am-11:55pm; AUC(DAY) 7:05am-10:55pm, AUC(NIGHT) 11:00pm-7:00am), as well as glycemic variability, glycemic stability and time-in-target (>= 70 to <= 140mg/dL). Results The 40 patients (26 on insulin pump) were aged 24 +/- 5 years and BMI 24.5 +/- 3.2 kg/m(2). Consistent with the observed HbA1c decrease (8.0 +/- 0.9% to 7.6 +/- 0.9%, p<0.0001), normalized AUC(TOTAL) CGM decreased from 153.7 +/- 25.4 to 149.0 +/- 30.2mg/dL.h at end-of-treatment (p = 0.31), and significantly increased post-treatment (164.1 +/- 29.5mg/dL.h, p = 0.02). The numerical decrease in normalized AUC(NIGHT) (152.0 +/- 36.6 to 141.9 +/- 34.4mg/dL.h, p = 0.13) exceeded AUC(DAY) (154.5 +/- 24.5 to 152.6 +/- 30.4mg/dL.h, p = 0.65). Trends toward lower glycemic variability (83.1 +/- 18.9 to 75.6 +/- 28.6mg/dL, p = 0.06) and little change in glycemic stability (10.8 +/- 3.6 to 10.3 +/- 4.5mg/dL/h, p = 0.51) were observed. When empagliflozin was discontinued, these worsened relative to baseline (89.3 +/- 19.3mg/dL, p = 0.04 and 11.8 +/- 3.7mg/dL/hr, p = 0.08). Time-in-target numerically increased (40.2 +/- 11.9 to 43.1 +/- 13.5%, p = 0.69) at end-of-treatment but reversed post-treatment. Findings were similar on stratification of pump and MDI subjects. Conclusions We observed that empagliflozin was associated with patterns of improved nighttime glycemia more prominent than daytime.	[Perkins, Bruce A.; Lee, Justin A.; Partridge, Helen; Tschirhart, Holly; Zinman, Bernard] Univ Toronto, Dept Med, Div Endocrinol & Metab, Toronto, ON, Canada; [Cherney, David Z. I.] Univ Toronto, Toronto Gen Hosp, Univ Hlth Network, Dept Med,Div Nephrol, Toronto, ON M5G 1L7, Canada; [Soleymanlou, Nima] Boehringer Ingelheim Canada Ltd Ltee, Burlington, ON, Canada; [Perkins, Bruce A.; Zinman, Bernard] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Mazze, Roger] WHO, Collaborating Ctr, Minneapolis, MN USA; [Fagan, Nora] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT USA; [Kaspers, Stefan; Woerle, Hans-Juergen; Broedl, Uli C.] Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany; [Johansen, Odd Erik] Boehringer Ingelheim Norway KS, Asker, Norway	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; Boehringer Ingelheim; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; World Health Organization; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim	Perkins, BA (corresponding author), Univ Toronto, Dept Med, Div Endocrinol & Metab, Toronto, ON, Canada.	bperkins@mtsinai.on.ca	Zinman, Bernard/E-7266-2013; Perkins, Bruce A/L-3726-2017; Woerle, Hans/ABE-1013-2021		Boehringer Ingelheim; Eli Lilly	Boehringer Ingelheim(Boehringer Ingelheim); Eli Lilly(Eli Lilly)	This study was funded by Boehringer Ingelheim and Eli Lilly. Boehringer Ingelheim's involvement included study design, data collection and data analysis. Eli Lilly's involvement was limited to co-funding of the study.	Bergenstal RM, 2013, DIABETES TECHNOL THE, V15, P198, DOI 10.1089/dia.2013.0051; Brand T, 2012, ADV THER, V29, P889, DOI 10.1007/s12325-012-0055-3; Cherney DZI, 2014, CAN J DIABETES, V38, P356, DOI 10.1016/j.jcjd.2014.05.006; Cherney DZI, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-28; Cherney DZI, 2014, CIRCULATION, V129, P587, DOI 10.1161/CIRCULATIONAHA.113.005081; Cuypers J, 2013, ACTA CLIN BELG, V68, P287, DOI 10.2143/ACB.3349; DCCT Res Grp, 1988, DIABETES CARE, V11, P567; DeFronzo RA, 2012, DIABETES OBES METAB, V14, P5, DOI 10.1111/j.1463-1326.2011.01511.x; Gerstl EM, 2008, EUR J PEDIATR, V167, P447, DOI 10.1007/s00431-007-0586-9; Heise T, 2013, DIABETES OBES METAB, V15, P613, DOI 10.1111/dom.12073; Henry RR, 2012, INT J CLIN PRACT, V66, P446, DOI 10.1111/j.1742-1241.2012.02911.x; Henry RR, 2015, DIABETES CARE, V38, P412, DOI 10.2337/dc13-2955; Imran SA, 2013, CAN J DIABETES, V37, pS31, DOI 10.1016/j.jcjd.2013.01.016; Kurosaki E, 2013, PHARMACOL THERAPEUT, V139, P51, DOI 10.1016/j.pharmthera.2013.04.003; Luippold G, 2012, DIABETES OBES METAB, V14, P601, DOI 10.1111/j.1463-1326.2012.01569.x; Mazze R, 2008, DIABETES TECHNOL THE, V10, pS93, DOI 10.1089/dia.2008.0006; Mazze RS, 2008, DIABETES TECHNOL THE, V10, P149, DOI 10.1089/dia.2007.0293; Mudaliar S, 2012, DIABETES CARE, V35, P2198, DOI 10.2337/dc12-0508; Musso G, 2012, ANN MED, V44, P375, DOI 10.3109/07853890.2011.560181; Nauck MA, 2011, DIABETES CARE, V34, P2015, DOI 10.2337/dc11-0606; Perkins BA, 2014, DIABETES CARE, V37, P1480, DOI 10.2337/dc13-2338; Polidori D, 2013, DIABETES CARE, V36, P2154, DOI 10.2337/dc12-2391; Rosenstock J, 2012, DIABETES CARE, V35, P1473, DOI 10.2337/dc11-1693; Rosenstock J, 2012, DIABETES CARE, V35, P1232, DOI 10.2337/dc11-1926; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Skrtic M, 2014, DIABETOLOGIA, V57, P2599, DOI 10.1007/s00125-014-3396-4; Wilding JPH, 2013, DIABETES OBES METAB, V15, P403, DOI 10.1111/dom.12038; Wilding JPH, 2009, DIABETES CARE, V32, P1656, DOI 10.2337/dc09-0517; Wood JR, 2013, DIABETES CARE, V36, P2035, DOI 10.2337/dc12-1959	29	28	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141085	10.1371/journal.pone.0141085	http://dx.doi.org/10.1371/journal.pone.0141085			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544192	gold, Green Published, Green Submitted			2022-12-26	WOS:000364398700014
J	Stone, VN; Parikh, HI; El-rami, F; Ge, XC; Chen, WH; Zhang, Y; Kellogg, GE; Xu, P				Stone, Victoria N.; Parikh, Hardik I.; El-rami, Fadi; Ge, Xiuchun; Chen, Weihau; Zhang, Yan; Kellogg, Glen E.; Xu, Ping			Identification of Small-Molecule Inhibitors against Meso-2, 6-Diaminopimelate Dehydrogenase from Porphyromonas gingivalis	PLOS ONE			English	Article							DIAMINOPIMELIC ACID DAP; STRUCTURE-BASED DESIGN; LYSINE BIOSYNTHESIS; PROTEIN STRUCTURES; DRUG DISCOVERY; FREE-ENERGY; ANTIBIOTICS; MICROBIOTA; TARGET; PERIODONTITIS	Species-specific antimicrobial therapy has the potential to combat the increasing threat of antibiotic resistance and alteration of the human microbiome. We therefore set out to demonstrate the beginning of a pathogen-selective drug discovery method using the periodontal pathogen Porphyromonas gingivalis as a model. Through our knowledge of metabolic networks and essential genes we identified a "druggable" essential target, meso-diaminopimelate dehydrogenase, which is found in a limited number of species. We adopted a high-throughput virtual screen method on the ZINC chemical library to select a group of potential small-molecule inhibitors. Meso-diaminopimelate dehydrogenase from P. gingivalis was first expressed and purified in Escherichia coli then characterized for enzymatic inhibitor screening studies. Several inhibitors with similar structural scaffolds containing a sulfonamide core and aromatic substituents showed dose-dependent inhibition. These compounds were further assayed showing reasonable whole-cell activity and the inhibition mechanism was determined. We conclude that the establishment of this target and screening strategy provides a model for the future development of new antimicrobials.	[Stone, Victoria N.; El-rami, Fadi; Ge, Xiuchun; Chen, Weihau; Xu, Ping] Virginia Commonwealth Univ, Philips Inst Oral Hlth Res, Richmond, VA 23284 USA; [Stone, Victoria N.; El-rami, Fadi; Xu, Ping] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA; [Parikh, Hardik I.; Zhang, Yan; Kellogg, Glen E.] Virginia Commonwealth Univ, Dept Med Chem, Richmond, VA 23298 USA; [Kellogg, Glen E.; Xu, Ping] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Xu, P (corresponding author), Virginia Commonwealth Univ, Philips Inst Oral Hlth Res, Richmond, VA 23284 USA.	pxu@vcu.edu	Parikh, Hardik/AAG-4963-2021	Kellogg, Glen/0000-0002-6282-6794; Parikh, Hardik/0000-0002-5621-7343	National Institutes of Health, US [R01DE018138, R01DE023078, F31DE024038]; NATIONAL CANCER INSTITUTE [P30CA016059] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023078, F31DE024038, R01DE018138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047463] Funding Source: NIH RePORTER	National Institutes of Health, US(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by the National Institutes of Health, US, grants R01DE018138 (PX), R01DE023078 (PX) and F31DE024038 (VS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT SD, 1994, J AM CHEM SOC, V116, P6513, DOI 10.1021/ja00094a004; Akita H, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-43; Amini S, 2011, CURR OPIN MICROBIOL, V14, P513, DOI 10.1016/j.mib.2011.07.017; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Avila M, 2009, DNA CELL BIOL, V28, P405, DOI 10.1089/dna.2009.0874; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bakheet TM, 2009, BIOINFORMATICS, V25, P451, DOI 10.1093/bioinformatics/btp002; Blount KF, 2007, NAT CHEM BIOL, V3, P44, DOI 10.1038/nchembio842; Burley SK, 2008, STRUCTURE, V16, P5, DOI 10.1016/j.str.2007.12.002; Cain R, 2014, BIOORG CHEM, V55, P69, DOI 10.1016/j.bioorg.2014.05.008; Chen T, 2010, DATABASE, V2010; Chen YY, 2011, MOL MICROBIOL, V79, P1380, DOI 10.1111/j.1365-2958.2010.07530.x; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; CLELAND WW, 1967, ADV ENZYMOL RAMB, V29, P1; Cozzini P, 2002, J MED CHEM, V45, P2469, DOI 10.1021/jm0200299; CREMER J, 1988, J GEN MICROBIOL, V134, P3221; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Darveau RP, 1998, INFECT IMMUN, V66, P1660, DOI 10.1128/IAI.66.4.1660-1665.1998; DESJARLAIS RL, 1990, P NATL ACAD SCI USA, V87, P6644, DOI 10.1073/pnas.87.17.6644; Detert J, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3106; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; Eke PI, 2015, J PERIODONTOL, V86, P611, DOI 10.1902/jop.2015.140520; Perez-Cobas AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080201; Fazius F, 2013, APPL MICROBIOL BIOT, V97, P3763, DOI 10.1007/s00253-013-4805-1; FLETCHER HM, 1995, INFECT IMMUN, V63, P1521, DOI 10.1128/IAI.63.4.1521-1528.1995; Gabanyi Margaret J., 2011, Journal of Structural and Functional Genomics, V12, P45, DOI 10.1007/s10969-011-9106-2; Gleeson MP, 2008, J MED CHEM, V51, P817, DOI 10.1021/jm701122q; Griffen AL, 1998, J CLIN MICROBIOL, V36, P3239, DOI 10.1128/JCM.36.11.3239-3242.1998; Gwynn MN, 2010, ANN NY ACAD SCI, V1213, P5, DOI 10.1111/j.1749-6632.2010.05828.x; Hajishengallis G, 2011, CELL HOST MICROBE, V10, P497, DOI 10.1016/j.chom.2011.10.006; Hudson AO, 2011, BBA-PROTEINS PROTEOM, V1814, P1162, DOI 10.1016/j.bbapap.2011.04.019; HURST T, 1994, J CHEM INF COMP SCI, V34, P190, DOI 10.1021/ci00017a025; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Hutton CA, 2003, MINI-REV MED CHEM, V3, P115, DOI 10.2174/1389557033405359; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Ishiguro I, 2009, FEMS MICROBIOL LETT, V292, P261, DOI 10.1111/j.1574-6968.2009.01489.x; Jernberg C, 2010, MICROBIOL-SGM, V156, P3216, DOI 10.1099/mic.0.040618-0; Johnson CL, 2012, PEDIATRICS, V129, P950, DOI 10.1542/peds.2011-2736; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Jorgensen JH, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P1152; Kassebaum NJ, 2014, J DENT RES, V93, P1045, DOI 10.1177/0022034514552491; Keller TH, 2006, CURR OPIN CHEM BIOL, V10, P357, DOI 10.1016/j.cbpa.2006.06.014; Kellogg GE, 2000, EUR J MED CHEM, V35, P651, DOI 10.1016/S0223-5234(00)00167-7; KLAINER AS, 1974, ANTIMICROB AGENTS CH, V6, P216, DOI 10.1128/AAC.6.2.216; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Koul A, 2011, NATURE, V469, P483, DOI 10.1038/nature09657; Leekha S, 2011, MAYO CLIN PROC, V86, P156, DOI 10.4065/mcp.2010.0639; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; McGovern SL, 2002, J MED CHEM, V45, P1712, DOI 10.1021/jm010533y; MISONO H, 1979, J BACTERIOL, V137, P22, DOI 10.1128/JB.137.1.22-27.1979; MISONO H, 1980, J BIOL CHEM, V255, P599; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Noverr MC, 2004, TRENDS MICROBIOL, V12, P562, DOI 10.1016/j.tim.2004.10.008; Paiva AM, 2001, BBA-PROTEIN STRUCT M, V1545, P67, DOI 10.1016/S0167-4838(00)00262-4; Pavelka MS, 1996, J BACTERIOL, V178, P6496, DOI 10.1128/jb.178.22.6496-6507.1996; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Sakamoto S, 2001, J MOL CATAL B-ENZYM, V12, P85, DOI 10.1016/S1381-1177(00)00207-1; Scapin G, 1996, BIOCHEMISTRY-US, V35, P13540, DOI 10.1021/bi961628i; Schobel F, 2010, EUKARYOT CELL, V9, P878, DOI 10.1128/EC.00020-10; Seidler J, 2003, J MED CHEM, V46, P4477, DOI 10.1021/jm030191r; Song Jae-Hoon, 2008, V416, P401, DOI 10.1007/978-1-59745-321-9_28; Spyrakis F, 2007, EUR J MED CHEM, V42, P921, DOI 10.1016/j.ejmech.2006.12.037; Sullivan A, 2001, Lancet Infect Dis, V1, P101, DOI 10.1016/S1473-3099(01)00066-4; Sutherland A, 1999, CHEM COMMUN, P555, DOI 10.1039/a900297i; Tonetti MS, 2015, J CLIN PERIODONT S16, V42, pS5, DOI [10.1111/jcpe.12368, DOI 10.1111/JCPE.12368]; WHITE PJ, 1983, J GEN MICROBIOL, V129, P739; Xu P, 2011, SCI REP-UK, V1, DOI 10.1038/srep00125	67	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141126	10.1371/journal.pone.0141126	http://dx.doi.org/10.1371/journal.pone.0141126			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544875	Green Published, gold, Green Submitted			2022-12-26	WOS:000364398700017
J	Alkooranee, JT; Yin, YT; Aledan, TR; Jiang, YF; Lu, GY; Wu, JS; Li, MT				Alkooranee, Jawadayn Talib; Yin, Yongtai; Aledan, Tamarah Raad; Jiang, Yingfen; Lu, Guangyuan; Wu, Jiangsheng; Li, Maoteng			Systemic Resistance to Powdery Mildew in Brassica napus (AACC) and Raphanus alboglabra (RRCC) by Trichoderma harzianum TH12	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; ERYSIPHE-CRUCIFERARUM; ACQUIRED-RESISTANCE; DISEASE RESISTANCE; DEFENSE RESPONSES; JUNCEA CHITINASE; PLANT-RESPONSES; SATIVUS L.; CELL-WALL; GENE	Trichoderma harzianum TH12 is a microbial pesticide for certain rapeseed diseases. The mechanism of systemic resistance induced by TH12 or its cell-free culture filtrate (CF) in Brassica napus (AACC) and Raphanus alboglabra (RRCC) to powdery mildew disease caused by ascomycete Erysiphe cruciferarum was investigated. In this study, we conducted the first large-scale global study on the cellular and molecular aspects of B. napus and R. alboglabra infected with E. cruciferarum. The histological study showed the resistance of R. alboglabra to powdery mildew disease. The growth of fungal colonies was not observed on R. alboglabra leaves at 1, 2, 4, 6, 8, and 10 days post-inoculation (dpi), whereas this was clearly observed on B. napus leaves after 6 dpi. In addition, the gene expression of six plant defense-related genes, namely, PR-1, PR-2 (a marker for SA signaling), PR-3, PDF 1.2 (a marker for JA/ET signaling), CHI620, and CHI570, for both genotypes were analyzed in the leaves of B. napus and R. alboglabra after treatment with TH12 or CF and compared with the non-treated ones. The qRT-PCR results showed that the PR-1 and PR-2 expression levels increased in E. cruciferarum-infected leaves, but decreased in the TH12-treated leaves compared with leaves treated with CF. The expression levels of PR-3 and PDF1.2 decreased in plants infected by E. cruciferarum. However, expression levels increased when the leaves were treated with TH12. For the first time, we disclosed the nature of gene expression in B. napus and R. alboglabra to explore the resistance pathways in the leaves of both genotypes infected and non-infected by powdery mildew and inoculated or non-inoculated with elicitor factors. Results suggested that R. alboglabra exhibited resistance to powdery mildew disease, and the application of T. harzianum and its CF are a useful tool to facilitate new protection methods for resist or susceptible plants.	[Alkooranee, Jawadayn Talib; Yin, Yongtai; Aledan, Tamarah Raad; Li, Maoteng] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Dept Biotechnol, Wuhan 430074, Peoples R China; [Alkooranee, Jawadayn Talib] Univ Basrah, Dept Plant Protect, Coll Agr, Basrah, Iraq; [Alkooranee, Jawadayn Talib; Li, Maoteng] Huanggang Normal Univ, Hubei Collaborat Innovat Ctr Characterist Resourc, Huanggang, Peoples R China; [Jiang, Yingfen] Anhui Acad Agr Sci, Crops Inst, Hefei, Anhui, Peoples R China; [Lu, Guangyuan] Chinese Acad Agr Sci, Oil Crops Res Inst, Wuhan, Hubei, Peoples R China; [Wu, Jiangsheng] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China	Huazhong University of Science & Technology; University of Basrah; Huanggang Normal University; Anhui Academy of Agricultural Sciences; Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Huazhong Agricultural University	Lu, GY (corresponding author), Chinese Acad Agr Sci, Oil Crops Res Inst, Wuhan, Hubei, Peoples R China.	luwiz@oilcrops.cn; limaoteng426@mail.hust.edu.cn	Alkooranee, Jawadayn Talib/ABG-4193-2020	Alkooranee, Jawadayn Talib/0000-0003-2997-4637	National Natural Science Foundation of China [31201267]; National 863 projects of China [2011AA10A104, 2009AA101105]; scientific research project of Hubei Collaborative Innovation Center for the Characteristic Resources Exploitation of Dabie Mountains [2015TD03]; New Century Talents Support Program of the Ministry of Education of China [NCET110172]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 863 projects of China(National High Technology Research and Development Program of China); scientific research project of Hubei Collaborative Innovation Center for the Characteristic Resources Exploitation of Dabie Mountains; New Century Talents Support Program of the Ministry of Education of China	The work was supported by the National Natural Science Foundation of China (31201267), the National 863 projects of China (2011AA10A104, 2009AA101105), the scientific research project of Hubei Collaborative Innovation Center for the Characteristic Resources Exploitation of Dabie Mountains (2015TD03), and New Century Talents Support Program of the Ministry of Education of China (NCET110172).	Adam L, 1999, MOL PLANT MICROBE IN, V12, P1031, DOI 10.1094/MPMI.1999.12.12.1031; Ahmed NU, 2012, MOL BIOL REP, V39, P3649, DOI 10.1007/s11033-011-1139-x; Alkooranee J. T., 2015, American Journal of Plant Sciences, V6, P1662, DOI 10.4236/ajps.2015.610166; Alkooranee JT, 2015, PLANT DIS; Barilli E, 2014, EUPHYTICA, V198, P13, DOI 10.1007/s10681-014-1062-z; Chen HG, 2008, GENET RESOUR CROP EV, V55, P143, DOI 10.1007/s10722-007-9223-8; Cheng YL, 2015, PROTOPLASMA, V252, P1167, DOI 10.1007/s00709-014-0750-9; Choi HW, 2009, PLANT PATHOLOGY J, V25, P86, DOI 10.5423/PPJ.2009.25.1.086; De Meyer G, 1998, EUR J PLANT PATHOL, V104, P279, DOI 10.1023/A:1008628806616; DeSamblanx GW, 1997, J BIOL CHEM, V272, P1171, DOI 10.1074/jbc.272.2.1171; Ellinger D, 2013, PLANT PHYSIOL, V161, P1433, DOI 10.1104/pp.112.211011; Ellis J, 2006, PLANT CELL, V18, P523, DOI 10.1105/tpc.105.040584; Enright SM, 2007, AM J BOT, V94, P1813, DOI 10.3732/ajb.94.11.1813; Fondevilla S, 2011, PLANT BREEDING, V130, P281, DOI 10.1111/j.1439-0523.2010.01769.x; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Gomez K.A., 1984, STAT PROCEDURES AGR, P13; Gu YQ, 2002, PLANT CELL, V14, P817, DOI 10.1105/tpc.000794; Guan Y, 2008, PLANT SIGNAL BEHAV, V3, P1103, DOI 10.4161/psb.3.12.7006; Guan Y, 2008, J EXP BOT, V59, P3475, DOI 10.1093/jxb/ern197; Gurjar SG, 2012, AM J PLANT SCI, V3, P190; Gus-Mayer S, 1998, P NATL ACAD SCI USA, V95, P8398, DOI 10.1073/pnas.95.14.8398; Hafez YM, 2011, EGYPTIAN J PHYTOPATH, V39, P180; Hardham AR, 2007, CURR OPIN PLANT BIOL, V10, P342, DOI 10.1016/j.pbi.2007.05.001; Harel YM, 2014, PHYTOPATHOLOGY, V104, P150, DOI 10.1094/PHYTO-02-13-0043-R; Hermosa R, 2012, MICROBIOL-SGM, V158, P17, DOI 10.1099/mic.0.052274-0; Hossain MM, 2008, PLANT SOIL, V304, P227, DOI 10.1007/s11104-008-9542-3; Huckelhoven R, 2007, ANNU REV PHYTOPATHOL, V45, P101, DOI 10.1146/annurev.phyto.45.062806.094325; Iglesias-Garcia R, 2015, EUPHYTICA, V201, P381, DOI 10.1007/s10681-014-1221-2; Ji JH, 2008, EUPHYTICA, V163, P159, DOI 10.1007/s10681-007-9578-0; Karossi AT, 2009, TEKNOLOGI INDONESIA, V32, P91; Kessler A, 2002, ANNU REV PLANT BIOL, V53, P299, DOI 10.1146/annurev.arplant.53.100301.135207; Khan AM, 1972, PL480; Khanal P, 2014, J CLIN DIAGN RES, V8, P112, DOI 10.7860/JCDR/2014/6788.3956; KOCH E, 1990, BOT HELV, V100, P257; Kokina A., 2008, Agronomijas Vestis, P77; Korolev N, 2008, BIOCONTROL, V53, P667, DOI 10.1007/s10526-007-9103-3; Kumar Sudheer, 2002, Journal of Mycology and Plant Pathology, V32, P184; Leflon M, 2006, THEOR APPL GENET, V113, P1467, DOI 10.1007/s00122-006-0393-0; Li XL, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-207; Long H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117198; Maksimov IV, 2011, APPL BIOCHEM MICRO+, V47, P333, DOI 10.1134/S0003683811040090; Martinez-Medina A, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00206; Meena PD, 2013, CROP PROT, V53, P169, DOI 10.1016/j.cropro.2013.07.006; Mei JQ, 2013, THEOR APPL GENET, V126, P549, DOI 10.1007/s00122-012-2000-x; Mora-Aviles M. A., 2004, Revista Chapingo. Serie Horticultura, V10, P141; Narusaka M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115864; Penaud A, 1999, P 10 INT RAP C REG I; Perazzolli M, 2008, BIOL CONTROL, V47, P228, DOI 10.1016/j.biocontrol.2008.08.008; Peterhansel C, 1997, PLANT CELL, V9, P1397, DOI 10.1105/tpc.9.8.1397; Pombo MA, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0492-1; Potlakayala SD, 2007, PHYTOPATHOLOGY, V97, P794, DOI 10.1094/PHYTO-97-7-0794; Sasek V, 2012, MOL PLANT MICROBE IN, V25, P1238, DOI 10.1094/MPMI-02-12-0033-R; Schuster A, 2010, APPL MICROBIOL BIOT, V87, P787, DOI 10.1007/s00253-010-2632-1; Sharma Pratibha, 2004, Journal of Biological Control, V18, P21; Shoresh M, 2010, ANNU REV PHYTOPATHOL, V48, P21, DOI 10.1146/annurev-phyto-073009-114450; Sisti M, 2003, FITOTERAPIA, V74, P453, DOI 10.1016/S0367-326X(03)00108-4; Spoel SH, 2003, PLANT CELL, V15, P760, DOI 10.1105/tpc.009159; TERRAS FRG, 1992, J BIOL CHEM, V267, P15301; Thaler JS, 2004, PLANT PHYSIOL, V135, P530, DOI 10.1104/pp.104.041566; Thomma BPHJ, 2001, CURR OPIN IMMUNOL, V13, P63, DOI 10.1016/S0952-7915(00)00183-7; Thomma BPHJ, 1998, P NATL ACAD SCI USA, V95, P15107, DOI 10.1073/pnas.95.25.15107; UKNES S, 1992, PLANT CELL, V4, P645, DOI 10.1105/tpc.4.6.645; Van Wees SCM, 2008, CURR OPIN PLANT BIOL, V11, P443, DOI 10.1016/j.pbi.2008.05.005; Verhagen BWM, 2004, MOL PLANT MICROBE IN, V17, P895, DOI 10.1094/MPMI.2004.17.8.895; Walters DR, 2013, J EXP BOT, V64, P1263, DOI 10.1093/jxb/ert026; Wang XL, 2014, EUPHYTICA, V198, P289, DOI 10.1007/s10681-014-1105-5; Wang Z, 2009, MOL PLANT MICROBE IN, V22, P235, DOI 10.1094/MPMI-22-3-0235; WARD ER, 1991, PLANT CELL, V3, P1085, DOI 10.1105/tpc.3.10.1085; WILLIAMSON CJ, 1986, J AGR SCI, V107, P385, DOI 10.1017/S0021859600087190; Xiao SY, 1997, PLANT J, V12, P757, DOI 10.1046/j.1365-313X.1997.12040757.x; Yedidia I, 1999, APPL ENVIRON MICROB, V65, P1061; Yoshioka Y, 2012, PEST MANAG SCI, V68, P60, DOI 10.1002/ps.2220; Yu X, 2013, THEOR APPL GENET, V126, P2553, DOI 10.1007/s00122-013-2154-1; Zhan HX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113455; Zhu WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053901	75	19	19	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142177	10.1371/journal.pone.0142177	http://dx.doi.org/10.1371/journal.pone.0142177			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540161	gold, Green Published, Green Submitted			2022-12-26	WOS:000364303800063
J	Li, GW; Du, J; Li, YP; Wu, JX				Li, Guangwei; Du, Juan; Li, Yiping; Wu, Junxiang			Identification of Putative Olfactory Genes from the Oriental Fruit Moth Grapholita molesta via an Antennal Transcriptome Analysis	PLOS ONE			English	Article							ODORANT-BINDING-PROTEINS; SEX-PHEROMONE; HELICOVERPA-ARMIGERA; CYDIA-MOLESTA; HOST PLANTS; HONEY-BEE; EXPRESSION; RECEPTORS; GENOME; LEPIDOPTERA	Background The oriental fruit moth, Grapholita molesta, is an extremely important oligophagous pest species of stone and pome fruits throughout the world. As a host-switching species, adult moths, especially females, depend on olfactory cues to a large extent in locating host plants, finding mates, and selecting oviposition sites. The identification of olfactory genes can facilitate investigation on mechanisms for chemical communications. Methodology/Principal Finding We generated transcriptome of female antennae of G. molesta using the next-generation sequencing technique, and assembled transcripts from RNA-seq reads using Trinity, SOAPdenovo-trans and Abyss-trans assemblers. We identified 124 putative olfactory genes. Among the identified olfactory genes, 118 were novel to this species, including 28 transcripts encoding for odorant binding proteins, 17 chemosensory proteins, 48 odorant receptors, four gustatory receptors, 24 ionotropic receptors, two sensory neuron membrane proteins, and one odor degrading enzyme. The identified genes were further confirmed through semi-quantitative reverse transcription PCR for transcripts coding for 26 OBPs and 17 CSPs. OBP transcripts showed an obvious antenna bias, whereas CSP transcripts were detected in different tissues. Conclusion Antennal transcriptome data derived from the oriental fruit moth constituted an abundant molecular resource for the identification of genes potentially involved in the olfaction process of the species. This study provides a foundation for future research on the molecules involved in olfactory recognition of this insect pest, and in particular, the feasibility of using semiochemicals to control this pest.	[Li, Guangwei; Du, Juan; Li, Yiping; Wu, Junxiang] Northwest A&F Univ, Key Lab Plant Protect Resources & Pest Management, Minist Educ, Yangling, Shaanxi, Peoples R China; [Li, Guangwei; Du, Juan; Li, Yiping; Wu, Junxiang] Northwest A&F Univ, Key Lab Appl Entomol, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	Wu, JX (corresponding author), Northwest A&F Univ, Key Lab Plant Protect Resources & Pest Management, Minist Educ, Yangling, Shaanxi, Peoples R China.	junxw@nwsuaf.edu.cn			National Natural Science Foundation of China [31272043]; Public Welfare Project from Ministry of Agriculture of the People's Republic of China [201103024]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Public Welfare Project from Ministry of Agriculture of the People's Republic of China	This work was supported by National Natural Science Foundation of China (Grant No. 31272043) and Public Welfare Project from Ministry of Agriculture of the People's Republic of China (Grant No. 201103024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuin L, 2011, NEURON, V69, P44, DOI 10.1016/j.neuron.2010.11.042; Bengtsson JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031620; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Cao DP, 2014, INT J BIOL SCI, V10, P846, DOI 10.7150/ijbs.9297; CARDE AM, 1979, J CHEM ECOL, V5, P423, DOI 10.1007/BF00987927; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; de Bruyne M, 2008, J CHEM ECOL, V34, P882, DOI 10.1007/s10886-008-9485-4; Dorn Silvia, 2001, IOBC-WPRS Bulletin, V24, P133; DU GH, 1995, BIOCHEMISTRY-US, V34, P8726, DOI 10.1021/bi00027a023; Foret S, 2007, INSECT BIOCHEM MOLEC, V37, P19, DOI 10.1016/j.ibmb.2006.09.009; Galindo K, 2001, GENETICS, V159, P1059; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; Garczynski SF, 2013, INSECT SCI, V20, P559, DOI 10.1111/j.1744-7917.2012.01560.x; Garczynski SF, 2012, INSECT SCI, V19, P64, DOI 10.1111/j.1744-7917.2011.01423.x; Gong DP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-332; Gong L, 2012, B ENTOMOL RES, V102, P600, DOI 10.1017/S0007485312000168; Grosse-Wilde E, 2011, P NATL ACAD SCI USA, V108, P7449, DOI 10.1073/pnas.1017963108; Gu SH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-636; Gu SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042871; Guo W, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001291; He XL, 2010, J CHEM ECOL, V36, P1293, DOI 10.1007/s10886-010-9870-7; Hekmat-Scafe DS, 2002, GENOME RES, V12, P1357, DOI 10.1101/gr.239402; Il'ichev AL, 2009, J PLANT INTERACT, V4, P289, DOI 10.1080/17429140903267814; KLEIN U, 1987, INSECT BIOCHEM, V17, P1193, DOI 10.1016/0020-1790(87)90093-X; Krieger J, 2002, EUR J NEUROSCI, V16, P619, DOI 10.1046/j.1460-9568.2002.02109.x; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; Leal WS, 1999, FEBS LETT, V464, P85, DOI 10.1016/S0014-5793(99)01683-X; Legeai F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-86; Li B, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0553-5; Liu Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036949, 10.1371/journal.pone.0032127, 10.1371/journal.pone.0040003, 10.1186/1746-1596-7-49]; Lombarkia N, 2008, ENTOMOL EXP APPL, V128, P57, DOI 10.1111/j.1570-7458.2008.00741.x; Madden DR, 2002, NAT REV NEUROSCI, V3, P91, DOI 10.1038/nrn725; Maleszka J, 2007, DEV GENES EVOL, V217, P189, DOI 10.1007/s00427-006-0127-y; Mazzi D, 2012, ANN APPL BIOL, V160, P97, DOI 10.1111/j.1744-7348.2012.00533.x; Myers CT, 2007, J ECON ENTOMOL, V100, P421, DOI 10.1603/0022-0493(2007)100[421:EOOHPA]2.0.CO;2; Najar-Rodriguez A, 2013, J CHEM ECOL, V39, P418, DOI 10.1007/s10886-013-0262-7; Najar-Rodriguez AJ, 2011, J EXP BIOL, V214, P162, DOI 10.1242/jeb.054262; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; Natale D, 2004, J APPL ENTOMOL, V128, P22, DOI 10.1046/j.1439-0418.2003.00802.x; Natale D, 2003, B ENTOMOL RES, V93, P335, DOI 10.1079/BER2003250; NOMURA A, 1992, INT J DEV BIOL, V36, P391; PELOSI P, 1995, COMP BIOCHEM PHYS B, V111, P503, DOI 10.1016/0305-0491(95)00019-5; Picimbon JF, 2001, INSECT BIOCHEM MOLEC, V31, P1173, DOI 10.1016/S0965-1748(01)00063-7; Pinero JC, 2008, J INSECT PHYSIOL, V54, P333, DOI 10.1016/j.jinsphys.2007.10.002; Pinero JC, 2009, ENTOMOL EXP APPL, V131, P67, DOI 10.1111/j.1570-7458.2009.00832.x; Rajapakse CNK, 2006, PHYSIOL ENTOMOL, V31, P270, DOI 10.1111/j.1365-3032.2006.00517.x; RICE RE, 1972, J ECON ENTOMOL, V65, P1212, DOI 10.1093/jee/65.4.1212; Sato K., 2009, RESULTS PROBL CELL D, P203; Sato K, 2011, P NATL ACAD SCI USA, V108, P11680, DOI 10.1073/pnas.1019622108; Shanbhag SR, 2001, CELL TISSUE RES, V304, P423, DOI 10.1007/s004410100388; Song YQ, 2014, J INTEGR AGR, V13, P2709, DOI 10.1016/S2095-3119(13)60686-3; STEINER L. F., 1933, JOUR ECON ENT, V26, P774, DOI 10.1093/jee/26.4.774; Tanaka K, 2009, CURR BIOL, V19, P881, DOI 10.1016/j.cub.2009.04.035; Varela N, 2009, CELL TISSUE RES, V337, P513, DOI 10.1007/s00441-009-0839-1; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wang G, 2011, INSECT MOL BIOL, V20, P125, DOI 10.1111/j.1365-2583.2010.01045.x; Wanner KW, 2007, P NATL ACAD SCI USA, V104, P14383, DOI 10.1073/pnas.0705459104; Wanner KW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008685; Wetzel CH, 2001, P NATL ACAD SCI USA, V98, P9377, DOI 10.1073/pnas.151103998; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Yang J, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021128, 10.1371/journal.pone.0024111]; Zhan S, 2011, CELL, V147, P1171, DOI 10.1016/j.cell.2011.09.052; Zhang TT, 2012, J INSECT PHYSIOL, V58, P941, DOI 10.1016/j.jinsphys.2012.04.010; Zhao QY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S14-S2; Zhao Z. R., 1989, Insect Knowledge, V26, P17; Zhou JJ, 2008, INSECT MOL BIOL, V17, P147, DOI 10.1111/j.1365-2583.2007.00789.x; Zhou JJ, 2006, CHEM SENSES, V31, P453, DOI 10.1093/chemse/bjj050; Zhou XF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002930	70	29	48	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142193	10.1371/journal.pone.0142193	http://dx.doi.org/10.1371/journal.pone.0142193			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540284	Green Published, Green Submitted, gold			2022-12-26	WOS:000364303800066
J	Cornu, A; Farruggia, A; Leppik, E; Pinier, C; Fournier, F; Genoud, D; Frerot, B				Cornu, Agnes; Farruggia, Anne; Leppik, Ene; Pinier, Centina; Fournier, Florence; Genoud, David; Frerot, Brigitte			Trapping the Pasture Odorscape Using Open-Air Solid-Phase Micro Extraction, a Tool to Assess Grassland Value	PLOS ONE			English	Article							GRAZING INTENSITY; PLANTS; DIVERSITY; MICROEXTRACTION; VOLATILES; EMISSIONS; RESPONSES; INSECTS	Besides supporting cattle feeding, grasslands are home to a diversity of plants and insects that interact with each other by emitting volatile compounds. The aim of this work was to develop a method to determine permanent grassland odorscape and relate it to flower-visiting insects. Two grasslands were chosen for their contrasting levels of botanical diversity, resulting from differing grazing managements. Measurements were made over two periods of three consecutive days at the beginning of grazing, and just after the cows had left the plots. Volatile compounds were trapped using solid-phase microextraction (SPME) fibers exposed eight hours a day in three exclosures per plot, and then analyzed by gas-chromatography-mass spectrometry (GC-MS). Insects were trapped using pan traps and a net, sorted and counted. The open air SPME method yielded volatile compound profiles that were richer than maize field profiles, comprising the common green leaf volatiles (GLV) and more specific ones. Differences between the odorscapes of the two grasslands were found, but they were not as marked as expected from their botanical composition. By contrast, there were sharp differences between the two periods, resulting from the combined effects of changes in weather conditions, plant phenological stage and grazing progress. Several correlations between insect counts and volatile compounds were found. Although their correlation coefficients were low, some of them were confirmed when tested by Spearman rank correlation, and could be logically explained. This method of grassland odorscape deserves to be developed because it can provide information on many aspects of grassland function and on the stresses that grassland plants undergo.	[Cornu, Agnes; Farruggia, Anne] Clermont Univ, VetAgro Sup, INRA, Herbivores UMR1213, St Genes Champanelle, France; [Leppik, Ene; Pinier, Centina; Frerot, Brigitte] INRA, Inst Ecol & Sci Environm Paris, UMR1392, F-78026 Versailles, France; [Fournier, Florence] INRA, Unite Expt Monts Auvergne UE1296, Laqueuille, France; [Genoud, David] Diagnost Gest Environm, Arzens, France; [Genoud, David] Observ Abeilles, Arzens, France	INRAE; VetAgro Sup; INRAE; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Universite Paris Saclay; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); INRAE	Cornu, A (corresponding author), Clermont Univ, VetAgro Sup, INRA, Herbivores UMR1213, St Genes Champanelle, France.	agnes.cornu@clermont.inra.fr	Cornu, Agnès/ABA-6876-2021	Cornu, Agnès/0000-0001-5954-8896; GENOUD, David/0000-0001-8564-040X	INRA; Diagnostic Gestion Environnement and Observatoire des Abeilles	INRA; Diagnostic Gestion Environnement and Observatoire des Abeilles	Funding: This work was funded by INRA. David Genoud is affiliated with Diagnostic Gestion Environnement and Observatoire des Abeilles. Diagnostic Gestion Environnement and Observatoire des Abeilles provided support in the form of salary to David Genoud, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Cornu A, 2001, J AGR FOOD CHEM, V49, P203, DOI 10.1021/jf0008341; Davis TS, 2013, J CHEM ECOL, V39, P840, DOI 10.1007/s10886-013-0306-z; Dellicour S, 2013, J SEP SCI, V36, P3206, DOI 10.1002/jssc.201300388; Dumont B, 2009, GRASS FORAGE SCI, V64, P92, DOI 10.1111/j.1365-2494.2008.00674.x; Feng L, 2008, J CHROMATOGR SCI, V46, P577, DOI 10.1093/chromsci/46.7.577; Hales KE, 2012, ATMOS ENVIRON, V60, P292, DOI 10.1016/j.atmosenv.2012.06.080; Hegland SJ, 2006, ECOL ENTOMOL, V31, P532, DOI 10.1111/j.1365-2311.2006.00812.x; Kruess A, 2002, BIOL CONSERV, V106, P293, DOI 10.1016/S0006-3207(01)00255-5; Leppik E., 2014, American Journal of Plant Sciences, V5, P811, DOI 10.4236/ajps.2014.56095; Leppik E, 2014, CHEMOECOLOGY, V24, P221, DOI 10.1007/s00049-014-0165-2; Lu M, 2007, IDENTIFICATION ODOR; Lucas-Barbosa D, 2011, PHYTOCHEMISTRY, V72, P1647, DOI 10.1016/j.phytochem.2011.03.013; Maffei ME, 2010, S AFR J BOT, V76, P612, DOI 10.1016/j.sajb.2010.03.003; Scala A, 2013, INT J MOL SCI, V14, P17781, DOI 10.3390/ijms140917781; Sharkey TD, 1996, TRENDS PLANT SCI, V1, P78, DOI 10.1016/S1360-1385(96)80038-0; Sjodin NE, 2007, BIODIVERS CONSERV, V16, P2103, DOI 10.1007/s10531-006-9103-0; Thomas D.B., 2010, SUBTROP PLANT SCI, V62, P34; Westphal C, 2008, ECOL MONOGR, V78, P653, DOI 10.1890/07-1292.1	18	3	3	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140600	10.1371/journal.pone.0140600	http://dx.doi.org/10.1371/journal.pone.0140600			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536369	Green Published, gold, Green Submitted			2022-12-26	WOS:000364298400027
J	Fairbridge, NA; Southall, TM; Ayre, DC; Komatsu, Y; Raquet, PI; Brown, RJ; Randell, E; Kovacs, CS; Christian, SL				Fairbridge, Nicholas A.; Southall, Thomas M.; Ayre, D. Craig; Komatsu, Yumiko; Raquet, Paula I.; Brown, Robert J.; Randell, Edward; Kovacs, Christopher S.; Christian, Sherri L.			Loss of CD24 in Mice Leads to Metabolic Dysfunctions and a Reduction in White Adipocyte Tissue	PLOS ONE			English	Article							HIGH-FAT DIET; ADIPOSE-TISSUE; IN-VIVO; INSULIN-RESISTANCE; GLUT4 TRANSLOCATION; GLUCOSE-TRANSPORT; GENE-EXPRESSION; CELLS; DIFFERENTIATION; PROTEIN	CD24 is a glycophosphatidylinositol (GPI)-linked cell surface receptor that is involved in regulating the survival or differentiation of several different cell types. CD24 has been used to identify pre-adipocytes that are able to reconstitute white adipose tissue (WAT) in vivo. Moreover, we recently found that the dynamic upregulation of CD24 in vitro during early phases of adipogenesis is necessary for mature adipocyte development. To determine the role of CD24 in adipocyte development in vivo, we evaluated the development of the inguinal and interscapular subcutaneous WAT and the epididymal visceral WAT in mice with a homozygous deletion of CD24 (CD24KO). We observed a significant decrease in WAT mass of 40% to 74% in WAT mass from both visceral and subcutaneous depots in male mice, with no significant effect in female mice, compared to wild-type (WT) sex-and age-matched controls. We also found that CD24KO mice had increased fasting glucose and free fatty acids, decreased fasting insulin, and plasma leptin. No major differences were observed in the sensitivity to insulin or glucose, or in circulating triglycerides, total cholesterol, HDL-cholesterol, or LDL-cholesterol levels between WT and CD24KO mice. Challenging the CD24KO mice with either high sucrose (35%) or high fat (45%) diets that promote increased adiposity, increased WAT mass and fasting insulin, adiponectin and leptin levels, as well as reduced the sensitivity to insulin and glucose, to the levels of WT mice on the same diets. The CD24-mediated reduction in fat pad size was due to a reduction in adipocyte cell size in all depots with no significant reduction pre-adipocyte or adipocyte cell number. Thus, we have clearly demonstrated that the global absence of CD24 affects adipocyte cell size in vivo in a sex-and diet-dependent manner, as well as causing metabolic disturbances in glucose homeostasis and free fatty acid levels.	[Fairbridge, Nicholas A.; Southall, Thomas M.; Ayre, D. Craig; Raquet, Paula I.; Brown, Robert J.; Christian, Sherri L.] Mem Univ Newfoundland, Dept Biochem, Fac Sci, St John, NF, Canada; [Komatsu, Yumiko] Mem Univ Newfoundland, Fac Med, Div Biomed Sci, St John, NF, Canada; [Randell, Edward] Mem Univ Newfoundland, Fac Med, Dept Lab Med, St John, NF, Canada; [Kovacs, Christopher S.] Mem Univ Newfoundland, Fac Med, Div Med Endocrinol, St John, NF, Canada	Memorial University Newfoundland; Memorial University Newfoundland; Memorial University Newfoundland; Memorial University Newfoundland	Christian, SL (corresponding author), Mem Univ Newfoundland, Dept Biochem, Fac Sci, St John, NF, Canada.	sherri.christian@mun.ca		Ayre, D. Craig/0000-0003-0345-4764; Brown, Robert/0000-0002-1875-1537; Christian, Sherri/0000-0002-4289-4386	Canadian Institutes of Health Research Institute of Nutrition, Metabolism, and Diabetes [126614, 126754]; Research and Development Corporation of Newfoundland [5404.1090.103]; Beatrice Hunter Cancer Research Institute; Terry Fox Strategic Health Research Training Program in Cancer Research at CIHR and Memorial University of Newfoundland	Canadian Institutes of Health Research Institute of Nutrition, Metabolism, and Diabetes(Canadian Institutes of Health Research (CIHR)); Research and Development Corporation of Newfoundland; Beatrice Hunter Cancer Research Institute; Terry Fox Strategic Health Research Training Program in Cancer Research at CIHR and Memorial University of Newfoundland	This study was funded by the Canadian Institutes of Health Research Institute of Nutrition, Metabolism, and Diabetes (www.cihr-irsc.gc.ca, grant no. 126614 and 126754) and the Research and Development Corporation of Newfoundland (www.rdc.org, grant no. 5404.1090.103). DCA is supported by a trainee award from the Beatrice Hunter Cancer Research Institute, with funds provided by The Terry Fox Strategic Health Research Training Program in Cancer Research at CIHR and Memorial University of Newfoundland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An YP, 2013, J PROTEOME RES, V12, P3755, DOI 10.1021/pr400398b; Asterholm Ingrid Wernstedt, 2007, Drug Discov Today Dis Models, V4, P17; Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Ayre DC, 2015, IMMUNOLOGY; Bederman IR, 2009, J BIOL CHEM, V284, P6101, DOI 10.1074/jbc.M808668200; Berry DC, 2013, DEVELOPMENT, V140, P3939, DOI 10.1242/dev.080549; Berry R, 2013, NAT CELL BIOL, V15, P302, DOI 10.1038/ncb2696; Byrne MF, 2002, CAN J GASTROENTEROL, V16, P849, DOI 10.1155/2002/836012; Capeau J, 2010, ENDOCR DEV, V19, P1, DOI 10.1159/000316893; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cawthorn WP, 2012, J LIPID RES, V53, P227, DOI 10.1194/jlr.R021089; Chaput JP, 2012, OBES REV, V13, P681, DOI 10.1111/j.1467-789X.2012.00992.x; Chen GY, 2009, SCIENCE, V323, P1722, DOI 10.1126/science.1168988; Chiang SH, 2001, NATURE, V410, P944, DOI 10.1038/35073608; Cram DS, 1999, DIFFERENTIATION, V64, P237, DOI 10.1046/j.1432-0436.1999.6440237.x; Delarue J, 2007, CURR OPIN CLIN NUTR, V10, P142, DOI 10.1097/MCO.0b013e328042ba90; Fang XF, 2010, CELL MOL IMMUNOL, V7, P100, DOI 10.1038/cmi.2009.119; Fernandes AB, 2011, J NEUROENDOCRINOL, V23, P1288, DOI 10.1111/j.1365-2826.2011.02226.x; Forest C, 2003, BIOCHEM SOC T, V31, P1125; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Heinrichsen ET, 2014, MOL METAB, V3, P42, DOI 10.1016/j.molmet.2013.10.003; HERZBERG GR, 1982, CAN J PHYSIOL PHARM, V60, P912, DOI 10.1139/y82-128; Hyun CK, 2010, BIOCHEM BIOPH RES CO, V399, P480, DOI 10.1016/j.bbrc.2010.07.072; Inoue M, 2006, MOL BIOL CELL, V17, P2303, DOI 10.1091/mbc.E06-01-0030; JAMES DE, 1988, NATURE, V333, P183, DOI 10.1038/333183a0; Jeffery E, 2015, NAT CELL BIOL, V17, P376, DOI 10.1038/ncb3122; Jo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000324; Joe AWB, 2009, STEM CELLS, V27, P2563, DOI 10.1002/stem.190; Kaipparettu BA, 2008, INT J CANCER, V123, P66, DOI 10.1002/ijc.23480; Kim JI, 2015, MOL CELL BIOL, V35, P1686, DOI 10.1128/MCB.01321-14; LEMONNIER D, 1972, J CLIN INVEST, V51, P2907, DOI 10.1172/JCI107115; Leto D, 2012, NAT REV MOL CELL BIO, V13, P383, DOI 10.1038/nrm3351; LIN FT, 1994, P NATL ACAD SCI USA, V91, P8757, DOI 10.1073/pnas.91.19.8757; LIN FT, 1992, GENE DEV, V6, P533, DOI 10.1101/gad.6.4.533; Lisiansky V, 2014, INT J BIOL MARKER, V29, pE62, DOI 10.5301/jbm.5000072; Martin S, 2013, HORM MOL BIOL CLIN I, V15, P11, DOI 10.1515/hmbci-2013-0035; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Nielsen PJ, 1997, BLOOD, V89, P1058, DOI 10.1182/blood.V89.3.1058; Nielsen TS, 2014, J MOL ENDOCRINOL, V52, pR199, DOI 10.1530/JME-13-0277; Nye CK, 2008, J BIOL CHEM, V283, P27565, DOI 10.1074/jbc.M804393200; Parks EJ, 2002, P NUTR SOC, V61, P281, DOI 10.1079/PNS2002148; Peyot ML, 2010, DIABETES, V59, P2178, DOI 10.2337/db09-1452; RCore Team, 2020, R LANG ENV STAT COMP; Rochford JJ, 2014, CURR TOP DEV BIOL, V109, P53, DOI 10.1016/B978-0-12-397920-9.00005-6; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Rungaldier S, 2013, BBA-BIOMEMBRANES, V1828, P956, DOI 10.1016/j.bbamem.2012.11.030; Runz S, 2008, BIOCHEM BIOPH RES CO, V365, P35, DOI 10.1016/j.bbrc.2007.10.139; Rutkowski JM, 2015, J CELL BIOL, V208, P501, DOI 10.1083/jcb.201409063; Sadie-Van Gijsen H, 2013, CELL MOL LIFE SCI, V70, P2331, DOI 10.1007/s00018-012-1211-2; SALANS LB, 1968, J CLIN INVEST, V47, P153, DOI 10.1172/JCI105705; Schabath H, 2006, J CELL SCI, V119, P314, DOI 10.1242/jcs.02741; Scherer T, 2011, REV ENDOCR METAB DIS, V12, P235, DOI 10.1007/s11154-011-9190-4; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Smith NC, 2015, ADIPOCYTE, V4, P89, DOI 10.4161/21623945.2014.985015; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Strable MS, 2010, CRIT REV BIOCHEM MOL, V45, P199, DOI 10.3109/10409231003667500; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Team RC, 2014, NLME LINEAR NONLINEA; Temple KA, 2007, FEBS LETT, V581, P469, DOI 10.1016/j.febslet.2007.01.007; Wang LZ, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030049; Watson RT, 2001, J CELL BIOL, V154, P829, DOI 10.1083/jcb.200102078; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Zhou QM, 2003, P NATL ACAD SCI USA, V100, P15041, DOI 10.1073/pnas.2533866100	65	14	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141966	10.1371/journal.pone.0141966	http://dx.doi.org/10.1371/journal.pone.0141966			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536476	Green Submitted, Green Published, gold			2022-12-26	WOS:000364298400109
J	Fortunato, CS; Crump, BC				Fortunato, Caroline S.; Crump, Byron C.			Microbial Gene Abundance and Expression Patterns across a River to Ocean Salinity Gradient	PLOS ONE			English	Article							LIVING BACTERIAL COMMUNITIES; ANOXYGENIC PHOTOTROPHIC BACTERIA; COLUMBIA RIVER; MARINE-BACTERIA; ESTUARY; DIVERSITY; ASSEMBLAGES; VARIABILITY; DELAWARE; SEQUENCE	Microbial communities mediate the biogeochemical cycles that drive ecosystems, and it is important to understand how these communities are affected by changing environmental conditions, especially in complex coastal zones. As fresh and marine waters mix in estuaries and river plumes, the salinity, temperature, and nutrient gradients that are generated strongly influence bacterioplankton community structure, yet, a parallel change in functional diversity has not been described. Metagenomic and metatranscriptomic analyses were conducted on five water samples spanning the salinity gradient of the Columbia River coastal margin, including river, estuary, plume, and ocean, in August 2010. Samples were pre-filtered through 3 mu m filters and collected on 0.2 mu m filters, thus results were focused on changes among free-living microbial communities. Results from metagenomic 16S rRNA sequences showed taxonomically distinct bacterial communities in river, estuary, and coastal ocean. Despite the strong salinity gradient observed over sampling locations (0 to 33), the functional gene profiles in the metagenomes were very similar from river to ocean with an average similarity of 82%. The metatranscriptomes, however, had an average similarity of 31%. Although differences were few among the metagenomes, we observed a change from river to ocean in the abundance of genes encoding for catabolic pathways, osmoregulators, and metal transporters. Additionally, genes specifying both bacterial oxygenic and anoxygenic photosynthesis were abundant and expressed in the estuary and plume. Denitrification genes were found throughout the Columbia River coastal margin, and most highly expressed in the estuary. Across a river to ocean gradient, the free-living microbial community followed three different patterns of diversity: 1) the taxonomy of the community changed strongly with salinity, 2) metabolic potential was highly similar across samples, with few differences in functional gene abundance from river to ocean, and 3) gene expression was highly variable and generally was independent of changes in salinity.	[Fortunato, Caroline S.] Marine Biol Lab, Josephine Bay Paul Ctr, Woods Hole, MA 02543 USA; [Crump, Byron C.] Oregon State Univ, Coll Earth Oceans & Atmospher Sci, Corvallis, OR 97331 USA	Marine Biological Laboratory - Woods Hole; Oregon State University	Fortunato, CS (corresponding author), Marine Biol Lab, Josephine Bay Paul Ctr, Woods Hole, MA 02543 USA.	cfortunato@mbl.edu	Crump, Byron/ABF-3711-2020	Crump, Byron/0000-0001-7062-1273	National Science Foundation [OCE-0424602]	National Science Foundation(National Science Foundation (NSF))	Funding: This study was carried out within the context of the Science and Technology Center for Coastal Margin Observation & Prediction (CMOP) supported by the National Science Foundation, grant number OCE-0424602 to Antonio Baptista (http://www.stccmop.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beja O, 2002, NATURE, V415, P630, DOI 10.1038/415630a; Bernhard AE, 2005, ENVIRON MICROBIOL, V7, P1289, DOI 10.1111/j.1462-2920.2005.00808.x; Bouvier TC, 2002, LIMNOL OCEANOGR, V47, P453, DOI 10.4319/lo.2002.47.2.0453; Brauer SL, 2013, ESTUAR COAST, V36, P1073, DOI 10.1007/s12237-013-9603-6; Cottrell MT, 2010, ISME J, V4, P945, DOI 10.1038/ismej.2010.13; Crump BC, 1999, APPL ENVIRON MICROB, V65, P3192; Crump BC, 2003, APPL ENVIRON MICROB, V69, P2253, DOI 10.1128/AEM.69.4.2253-2268.2003; Crump BC, 2004, APPL ENVIRON MICROB, V70, P1494, DOI 10.1128/AEM.70.3.1494-1505.2004; Crump BC, 1998, AQUAT MICROB ECOL, V14, P7, DOI 10.3354/ame014007; Dupont CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089549; Eiler A, 2014, ENVIRON MICROBIOL, V16, P2682, DOI 10.1111/1462-2920.12301; Flamholz A, 2013, P NATL ACAD SCI USA, V110, P10039, DOI 10.1073/pnas.1215283110; Fortunato CS, 2013, ISME J, V7, P1899, DOI 10.1038/ismej.2013.79; Fortunato CS, 2012, ISME J, V6, P554, DOI 10.1038/ismej.2011.135; Fortunato CS, 2011, MICROB ECOL, V62, P374, DOI 10.1007/s00248-011-9805-z; Ganesh S, 2014, ISME J, V8, P187, DOI 10.1038/ismej.2013.144; Ghai R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023785; Green RT, 2013, ISME J, V7, P581, DOI 10.1038/ismej.2012.140; Grote J, 2011, STAND GENOMIC SCI, V5, P269, DOI 10.4056/sigs.1854551; Herlemann DPR, 2011, ISME J, V5, P1571, DOI 10.1038/ismej.2011.41; Hewson I, 2004, APPL ENVIRON MICROB, V70, P3425, DOI 10.1128/AEM.70.6.3425-3433.2004; Hewson I, 2014, APPL ENVIRON MICROB, V80, P328, DOI 10.1128/AEM.02680-13; Hickey BM, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005452; Hickey BM, 1998, J GEOPHYS RES-OCEANS, V103, P10339, DOI 10.1029/97JC03290; Karl DM, 2002, NATURE, V415, P590, DOI 10.1038/415590b; Kempf B, 1998, ARCH MICROBIOL, V170, P319, DOI 10.1007/s002030050649; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Logares R, 2009, TRENDS MICROBIOL, V17, P414, DOI 10.1016/j.tim.2009.05.010; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD123, DOI 10.1093/nar/gkr975; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Moran MA, 2007, APPL ENVIRON MICROB, V73, P4559, DOI 10.1128/AEM.02580-06; Mou XZ, 2007, ENVIRON MICROBIOL, V9, P2025, DOI 10.1111/j.1462-2920.2007.01318.x; Newton RJ, 2011, MICROBIOL MOL BIOL R, V75, P14, DOI 10.1128/MMBR.00028-10; Oh HM, 2010, J BACTERIOL, V192, P3240, DOI 10.1128/JB.00347-10; Oh S, 2011, APPL ENVIRON MICROB, V77, P6000, DOI 10.1128/AEM.00107-11; PORETSKY RS, 2009, JOVE-J VIS EXP, DOI DOI 10.3791/1086; Prahl FG, 1998, HYDROBIOLOGIA, V361, P37; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Selje N, 2003, AQUAT MICROB ECOL, V30, P221, DOI 10.3354/ame030221; SIMENSTAD CA, 1990, PROG OCEANOGR, V25, P1, DOI 10.1016/0079-6611(90)90002-J; Sleator RD, 2002, FEMS MICROBIOL REV, V26, P49, DOI 10.1111/j.1574-6976.2002.tb00598.x; SMALL LF, 1990, PROG OCEANOGR, V25, P175, DOI 10.1016/0079-6611(90)90007-O; Smith MW, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00120; Smith MW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013312; Stewart FJ, 2012, ENVIRON MICROBIOL, V14, P23, DOI 10.1111/j.1462-2920.2010.02400.x; Stewart FJ, 2010, ISME J, V4, P896, DOI 10.1038/ismej.2010.18; Stingl U, 2007, ISME J, V1, P361, DOI 10.1038/ismej.2007.49; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Waidner LA, 2005, ENVIRON MICROBIOL, V7, P1896, DOI 10.1111/j.1462-2920.2005.00883.x; Waidner LA, 2007, APPL ENVIRON MICROB, V73, P3936, DOI 10.1128/AEM.00592-07; Xu HB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052249; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996	57	48	50	8	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140578	10.1371/journal.pone.0140578	http://dx.doi.org/10.1371/journal.pone.0140578			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536246	Green Submitted, Green Published, gold			2022-12-26	WOS:000364298400026
J	Heinrichs, J; Scheben, A; Lee, GE; Vana, J; Schafer-Verwimp, A; Krings, M; Schmidt, AR				Heinrichs, Jochen; Scheben, Armin; Lee, Gaik Ee; Vana, Jiri; Schaefer-Verwimp, Alfons; Krings, Michael; Schmidt, Alexander R.			Molecular and Morphological Evidence Challenges the Records of the Extant Liverwort Ptilidium pulcherrimum in Eocene Baltic Amber	PLOS ONE			English	Article							LAND PLANTS; MARCHANTIOPHYTA; ORIGIN; FOSSIL; DIVERSIFICATION; PHYLOGENY; EVOLUTION; JUNGERMANNIOPSIDA; CLASSIFICATION; DISJUNCTIONS	Preservation of liverworts in amber, a fossilized tree resin, is often exquisite. Twenty-three fossil species of liverworts have been described to date from Eocene (35-50 Ma) Baltic amber. In addition, two inclusions have been assigned to the extant species Ptilidium pulcherrimum (Ptilidiales or Porellales). However, the presence of the boreal P. pulcherrimum in the subtropical or warm-temperate Baltic amber forest challenges the phytogeographical interpretation of the Eocene flora. A re-investigation of one of the fossils believed to be P. pulcherrimum reveals that this specimen in fact represents the first fossil evidence of the genus Tetralophozia, and thus is re-described here as Tetralophozia groehnii sp. nov. A second fossil initially assigned to P. pulcherrimum is apparently lost, and can be reassessed only based on the original description and illustrations. This fossil is morphologically similar to the extant North Pacific endemic Ptilidium californicum, rather than P. pulcherrimum. Divergence time estimates based on chloroplast DNA sequences provide evidence of a Miocene origin of P. pulcherrimum, and thus also argue against the presence of this taxon in the Eocene. Ptilidium californicum originated 25-43 Ma ago. As a result, we cannot rule out that the Eocene fossil belongs to P. californicum. Alternatively, the fossil might represent a stem lineage element of Ptilidium or an early crown group species with morphological similarities to P. californicum.	[Heinrichs, Jochen; Scheben, Armin; Lee, Gaik Ee] Univ Munich LMU, Dept Biol, Munich, Germany; [Heinrichs, Jochen; Scheben, Armin; Lee, Gaik Ee] Univ Munich LMU, Geobioctr, Munich, Germany; [Vana, Jiri] Charles Univ Prague, Dept Bot, Prague, Czech Republic; [Krings, Michael] Univ Munich LMU, Dept Earth & Environm Sci, Munich, Germany; [Krings, Michael] Bavarian State Collect Palaeontol & Geol, Munich, Germany; [Schmidt, Alexander R.] Univ Gottingen, Dept Geobiol, D-37073 Gottingen, Germany	University of Munich; University of Munich; Charles University Prague; University of Munich; University of Gottingen	Heinrichs, J (corresponding author), Univ Munich LMU, Dept Biol, Munich, Germany.	jheinrichs@lmu.de; alexander.schmidt@geo.uni-goettingen.de	Lee, Gaik Ee G/W-3683-2018; Krings, Michael/AAM-6436-2020; Váňa, Jiří/I-5979-2016; Lee, Gaik Ee/O-8353-2019; Scheben, Armin/AAS-2136-2020	Lee, Gaik Ee G/0000-0001-5161-6196; Váňa, Jiří/0000-0001-5532-3286; Lee, Gaik Ee/0000-0001-5161-6196; Scheben, Armin/0000-0002-2230-2013	Alexander von Humboldt foundation; German Research Foundation (DFG); University of Gottingen	Alexander von Humboldt foundation(Alexander von Humboldt Foundation); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Gottingen	Funding: This work was supported by the Alexander von Humboldt foundation (fellowship to GEL): The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. It also received support from the Open Access Grant Program of the German Research Foundation (DFG) and the Open Access Publication Fund of the University of Gottingen: The publication fee in an open access publication will be covered by the funders.	Berendt GC, 1845, BERNSTEIN IHM BEFIND; Botting RS, 2006, CAN J BOT, V84, P120, DOI [10.1139/B05-146, 10.1139/b05-146]; Caspary R., 1907, ABHANDLUNGEN KONIGLI, V4, P11; Caspary R., 1887, SCHRIFTEN KONIGLICHE, V27, P1; Clarke JT, 2011, NEW PHYTOL, V192, P266, DOI 10.1111/j.1469-8137.2011.03794.x; Conwentz H., 1890, MONOGRAPHIE BALTISCH; Cooper ED, 2012, BIOL J LINN SOC, V107, P425, DOI 10.1111/j.1095-8312.2012.01946.x; Cox CJ, 2014, SYST BIOL, V63, P272, DOI 10.1093/sysbio/syt109; Crandall-Stotler B., 2009, Edinburgh Journal of Botany, V66, P155, DOI 10.1017/S0960428609005393; Doyle William T., 2006, Madrono, V53, P89, DOI 10.3120/0024-9637(2006)53[89:CTABOC]2.0.CO;2; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Feldberg K, 2014, SCI REP-UK, V4, DOI 10.1038/srep05974; Feldberg K, 2013, PLANT SYST EVOL, V299, P585, DOI 10.1007/s00606-012-0745-y; Fiz-Palacios O, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-341; Frahm J.-P., 2013, ARCH BRYOLOGY, V175, P1; Frahm J-P., 2010, LAUBMOOSFLORA BALTIS; Garrett RM, 1909, PRECIOUS STONES OLD; Goremykin VV, 2005, PLANT SYST EVOL, V254, P93, DOI 10.1007/s00606-005-0337-1; GROLLE R, 1980, Feddes Repertorium, V91, P183; Grolle R., 1993, J HATTORI BOT LAB, V74, P71; Groth-Malonek M, 2005, MOL BIOL EVOL, V22, P117, DOI 10.1093/molbev/msh259; GUSTAFSSON L, 1995, J APPL ECOL, V32, P412, DOI 10.2307/2405107; Hall T.A., 1999, SYMPOSIUM, V41, P95; Hartmann FA, 2006, INT J PLANT SCI, V167, P1205, DOI 10.1086/508023; Heinrichs J, 2005, CRYPTOGAMIE BRYOL, V26, P131; Heinrichs J, 2007, TAXON, V56, P31, DOI 10.2307/25065733; Heinrichs J, 2015, REV PALAEOBOT PALYNO, V221, P59, DOI 10.1016/j.revpalbo.2015.05.007; Heinrichs J, 2015, REV PALAEOBOT PALYNO, V217, P39, DOI 10.1016/j.revpalbo.2015.02.006; Heinrichs J, 2014, REV PALAEOBOT PALYNO, V203, P48, DOI 10.1016/j.revpalbo.2014.01.004; J-P Frahm, 2006, LIMPRICHTIA, V29, P119; Katagiri T., 2015, NOVA HEDWIGIA, DOI [10.1127/novaHedwigia/2015/0276, DOI 10.1127/NOVAHEDWIGIA/2015/0276]; Kenrick P, 1997, NATURE, V389, P33, DOI 10.1038/37918; Kenrick P, 2012, PHILOS T R SOC B, V367, P519, DOI 10.1098/rstb.2011.0271; Kiraly I, 2013, BIODIVERS CONSERV, V22, P209, DOI 10.1007/s10531-012-0415-y; Krassilov VA, 1984, NEW MANUAL BRYOLOGY, VII, P1172; Kreier HP, 2010, MOL PHYLOGENET EVOL, V57, P1260, DOI 10.1016/j.ympev.2010.10.002; Kuusinen M, 1999, ECOGRAPHY, V22, P729, DOI 10.1111/j.1600-0587.1999.tb00522.x; Laenen B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6134; Liu Y, 2008, ANN MO BOT GARD, V95, P459, DOI 10.3417/2006071; Loriga J, 2014, AM J BOT, V101, P1466, DOI 10.3732/ajb.1400262; MAGDEFRAU KARL, 1957, BER DUTCH BOT GES, V70, P433; Meister, 2004, LIVERWORTS BALTIC BI; Nascimbene J, 2009, CAN J FOREST RES, V39, P785, DOI 10.1139/X09-013; Nishiyama T, 2004, MOL BIOL EVOL, V21, P1813, DOI 10.1093/molbev/msh203; Oostendorp C., 1987, BRYOPHYTORUM BIBLIOT, V34, P5; Parham JF, 2012, SYST BIOL, V61, P346, DOI 10.1093/sysbio/syr107; Paton J. A., 1999, LIVERWORT FLORA BRIT; Pearson PN, 2007, GEOLOGY, V35, P211, DOI 10.1130/G23175A.1; Penney D., 2010, BIODIVERSITY FOSSILS; Qiu YL, 2006, P NATL ACAD SCI USA, V103, P15511, DOI 10.1073/pnas.0603335103; Rambaut A, 2014, FIGTREE V 1 4 2; Rambaut A., 2014, TRACER V1 6; Renner MAM, 2015, BOT J LINN SOC, V178, P222, DOI 10.1111/boj.12279; Schneider H, 2015, ORG DIVERS EVOL, V15, P277, DOI 10.1007/s13127-015-0200-3; Schofield W. B., 2002, FIELD GUIDE LIVERWOR; SCHUSTER RM, 1989, REV PALAEOBOT PALYNO, V57, P277, DOI 10.1016/0034-6667(89)90025-0; Schuster RM, 2002, NOVA HEDWIGIA, V74, P465, DOI 10.1127/0029-5035/2002/0074-0465; Schuster RM., 1966, HEPATICAE ANTHOCEROT; Schuwirth Rainer, 2002, NOVA HEDWIGIA S, P1; Sendel N., 1742, HIST SUCCINORUM CORP; Soderstrom L, 2010, PHYTOTAXA, V3, P47; Standke G., 2008, EXKURSIONSF HRER VER, V236, P11; Standke G., 1998, SCHRIFTENREIHE F R G, V7, P93; Sun Y, 2014, MOL PHYLOGENET EVOL, V76, P189, DOI 10.1016/j.ympev.2014.03.018; Taylor T. N., 2009, BIOL EVOLUTION FOSSI; URMI E, 1983, J BRYOL, V12, P393, DOI 10.1179/jbr.1983.12.3.393; Vana J., 1993, TROP BRYOL, V8, P99, DOI [10.11646/bde.8.1.12, DOI 10.11646/BDE.8.1.12]; Villarreal JC, 2014, MOL PHYLOGENET EVOL, V78, P25, DOI 10.1016/j.ympev.2014.04.014; Weitschat Wolfgang, 2010, P80; Wellman CH, 2003, NATURE, V425, P282, DOI 10.1038/nature01884; Wickett NJ, 2014, P NATL ACAD SCI USA, V111, pE4859, DOI 10.1073/pnas.1323926111; Willerslev E, 2003, SCIENCE, V300, P791, DOI 10.1126/science.1084114; WILLMANN R, 1985, ART RAUM Z; Wilson R, 2007, BIOLOGY LETT, V3, P566, DOI 10.1098/rsbl.2007.0287; Wodniok S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-104; Wolfe AP, 2009, P R SOC B, V276, P3403, DOI 10.1098/rspb.2009.0806	76	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140977	10.1371/journal.pone.0140977	http://dx.doi.org/10.1371/journal.pone.0140977			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536603	gold, Green Published, Green Submitted			2022-12-26	WOS:000364298400047
J	Magris, RA; Heron, SF; Pressey, RL				Magris, Rafael A.; Heron, Scott F.; Pressey, Robert L.			Conservation Planning for Coral Reefs Accounting for Climate Warming Disturbances	PLOS ONE			English	Article							SEA-SURFACE TEMPERATURE; EL-NINO; OCEAN ACIDIFICATION; GLOBAL TREND; RESILIENCE; MANAGEMENT; FUTURE; IMPACTS; STRESS; VULNERABILITY	Incorporating warming disturbances into the design of marine protected areas (MPAs) is fundamental to developing appropriate conservation actions that confer coral reef resilience. We propose an MPA design approach that includes spatially-and temporally-varying sea-surface temperature (SST) data, integrating both observed (1985-2009) and projected (2010-2099) time-series. We derived indices of acute (time under reduced ecosystem function following short-term events) and chronic thermal stress (rate of warming) and combined them to delineate thermal-stress regimes. Coral reefs located on the Brazilian coast were used as a case study because they are considered a conservation priority in the southwestern Atlantic Ocean. We show that all coral reef areas in Brazil have experienced and are projected to continue to experience chronic warming, while acute events are expected to increase in frequency and intensity. We formulated quantitative conservation objectives for regimes of thermal stress. Based on these objectives, we then evaluated if/how they are achieved in existing Brazilian MPAs and identified priority areas where additional protection would reinforce resilience. Our results show that, although the current system of MPAs incorporates locations within some of our thermal-stress regimes, historical and future thermal refugia along the central coast are completely unprotected. Our approach is applicable to other marine ecosystems and adds to previous marine planning for climate change in two ways: (i) by demonstrating how to spatially configure MPAs that meet conservation objectives for warming disturbance using spatially-and temporally-explicit data; and (ii) by strategically allocating different forms of spatial management (MPA types) intended to mitigate warming impacts and also enhance future resistance to climate warming.	[Magris, Rafael A.; Pressey, Robert L.] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia; [Heron, Scott F.] Natl Ocean & Atmospher Adm Coral Reef Watch, Townsville, Qld, Australia; [Heron, Scott F.] James Cook Univ, Dept Phys, Marine Geophys Lab, Coll Sci Technol & Engn, Townsville, Qld 4811, Australia	James Cook University; National Oceanic Atmospheric Admin (NOAA) - USA; James Cook University	Magris, RA (corresponding author), James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia.	Rafael.magris@my.jcu.edu.au	Heron, Scott F/E-7928-2011; /AAL-3738-2021	Heron, Scott/0000-0001-5262-6978	Australian Research Council; NOAA Coral Reef Conservation Program; Brazilian Ministry of Environment; CNPq-Brazil	Australian Research Council(Australian Research Council); NOAA Coral Reef Conservation Program(National Oceanic Atmospheric Admin (NOAA) - USA); Brazilian Ministry of Environment; CNPq-Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding: RAM and RLP are supported by Australian Research Council; SFH is supported by NOAA Coral Reef Conservation Program. RAM is also supported by Brazilian Ministry of Environment. RAM thanks CNPq-Brazil for financial support.	Alagador D, 2014, J APPL ECOL, V51, P703, DOI 10.1111/1365-2664.12230; Allison GW, 2003, ECOL APPL, V13, pS8; Allnutt TF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028969; Amaral Fernanda D., 2006, Arquivos de Ciencias do Mar, V39, P138; Anthony KRN, 2015, GLOBAL CHANGE BIOL, V21, P48, DOI 10.1111/gcb.12700; Baird AH, 2009, ANNU REV ECOL EVOL S, V40, P551, DOI 10.1146/annurev.ecolsys.110308.120220; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Ban NC, 2012, CONSERV BIOL, V26, P799, DOI 10.1111/j.1523-1739.2012.01894.x; Ban NC, 2009, CONSERV LETT, V2, P206, DOI 10.1111/j.1755-263X.2009.00071.x; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Berkelmans R, 2004, CORAL REEFS, V23, P74, DOI 10.1007/s00338-003-0353-y; Brown CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065765; Carroll C, 2010, GLOBAL CHANGE BIOL, V16, P891, DOI 10.1111/j.1365-2486.2009.01965.x; Casey KS, 2010, OCEANOGRAPHY FROM SPACE: REVISITED, P273, DOI 10.1007/978-90-481-8681-5_16; Chollett I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110634; Chollett I, 2013, BIOL CONSERV, V167, P179, DOI 10.1016/j.biocon.2013.08.010; Chollett I, 2012, MAR POLLUT BULL, V64, P956, DOI 10.1016/j.marpolbul.2012.02.016; Comeaux RS, 2012, ESTUAR COAST SHELF S, V96, P81, DOI 10.1016/j.ecss.2011.10.003; Connell JH, 1997, ECOL MONOGR, V67, P461, DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; Cote IM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000438; Day JC, 2002, OCEAN COAST MANAGE, V45, P139, DOI 10.1016/S0964-5691(02)00052-2; Donner SD, 2005, GLOBAL CHANGE BIOL, V11, P2251, DOI 10.1111/j.1365-2486.2005.01073.x; Donner SD, 2007, P NATL ACAD SCI USA, V104, P5483, DOI 10.1073/pnas.0610122104; Donner SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005712; Donner Simon D., 2009, V205, P159; Dunne JP, 2013, NAT CLIM CHANGE, V3, P563, DOI 10.1038/NCLIMATE1827; Eakin CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013969; Ferreira BP, 2013, CORAL REEFS, V32, P441, DOI 10.1007/s00338-012-0992-y; Francini RB, 2008, MAR POLLUT BULL, V56, P1008, DOI 10.1016/j.marpolbul.2008.02.013; Frieler K, 2013, NAT CLIM CHANGE, V3, P165, DOI 10.1038/NCLIMATE1674; Game ET, 2008, ECOL APPL, V18, P670, DOI 10.1890/07-1027.1; Game ET, 2008, CONSERV BIOL, V22, P1619, DOI 10.1111/j.1523-1739.2008.01037.x; Game ET, 2009, TRENDS ECOL EVOL, V24, P360, DOI 10.1016/j.tree.2009.01.011; Gerhardinger LC, 2011, ENVIRON MANAGE, V47, P630, DOI 10.1007/s00267-010-9554-7; GLYNN PW, 1990, CORAL REEFS, V8, P181, DOI 10.1007/BF00265009; Golbuu Y, 2007, CORAL REEFS, V26, P319, DOI 10.1007/s00338-007-0200-7; Good SA, 2007, J CLIMATE, V20, P1255, DOI 10.1175/JCLI4049.1; Hallock P, 2005, SEDIMENT GEOL, V175, P19, DOI 10.1016/j.sedgeo.2004.12.027; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hansen L, 2010, CONSERV BIOL, V24, P63, DOI 10.1111/j.1523-1739.2009.01404.x; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; Heron Scott F., 2013, P285; Heron SF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012210; Hobday AJ, 2011, MAR ECOL-EVOL PERSP, V32, P392, DOI 10.1111/j.1439-0485.2011.00459.x; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hughes TP, 2012, CURR BIOL, V22, P736, DOI 10.1016/j.cub.2012.02.068; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Hughes TP, 1999, LIMNOL OCEANOGR, V44, P932, DOI 10.4319/lo.1999.44.3_part_2.0932; Jorda G, 2012, NAT CLIM CHANGE, V2, P821, DOI [10.1038/NCLIMATE1533, 10.1038/nclimate1533]; Keller BD, 2009, ENVIRON MANAGE, V44, P1069, DOI 10.1007/s00267-009-9346-0; Kelmo F, 2003, CORAL REEFS, V22, P541, DOI 10.1007/s00338-003-0343-0; Kerr RA, 2000, SCIENCE, V288, P1984, DOI 10.1126/science.288.5473.1984; Klein CJ, 2014, CONSERV LETT, DOI [10.1111/econl.12147, DOI 10.1111/C0NL.12147]; Krug LA, 2013, ENVIRON MODELL SOFTW, V42, P157, DOI 10.1016/j.envsoft.2013.01.003; Leao Z.M.A.N., 2010, Pan-American Journal of Aquatic Sciences, V5, P224; Leão Zelinda Margarida Andrade Nery, 2008, Biota Neotrop., V8, P0, DOI 10.1590/S1676-06032008000300006; Levy JS, 2013, MAR POLICY, V38, P16, DOI 10.1016/j.marpol.2012.05.015; Linares C, 2011, MAR ECOL PROG SER, V438, P97, DOI 10.3354/meps09272; Liu G, 2006, 10 INT COR REEF S OK; Logan CA, 2014, GLOBAL CHANGE BIOL, V20, P125, DOI 10.1111/gcb.12390; Magris RA, 2013, NAT CONSERVACAO, V11, P81, DOI 10.4322/natcon.2013.013; Magris RA, 2016, ECOGRAPHY, V39, P649, DOI 10.1111/ecog.01507; Magris RA, 2014, BIOL CONSERV, V170, P207, DOI 10.1016/j.biocon.2013.12.032; Maina J, 2008, ECOL MODEL, V212, P180, DOI 10.1016/j.ecolmodel.2007.10.033; Maina J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023064; Makino A, 2014, DIVERS DISTRIB, V20, P859, DOI 10.1111/ddi.12184; Maynard JA, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032175; McAvaney BJ, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P471; McClanahan TR, 2007, CORAL REEFS, V26, P695, DOI 10.1007/s00338-006-0193-7; McClanahan TR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042884; McClanahan TR, 2007, ECOL MONOGR, V77, P503, DOI 10.1890/06-1182.1; McCook LJ, 2009, CORAL REEFS, V28, P353, DOI 10.1007/s00338-008-0463-7; McLeod E, 2012, COAST MANAGE, V40, P651, DOI 10.1080/08920753.2012.728123; McLeod E, 2010, COAST MANAGE, V38, P518, DOI 10.1080/08920753.2010.509466; McLeod E, 2009, FRONT ECOL ENVIRON, V7, P362, DOI 10.1890/070211; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; Miranda RJ, 2013, LAT AM J AQUAT RES, V41, P351, DOI 10.3856/vol41-issue2-fulltext-14; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Mumby PJ, 2014, CONSERV LETT, V7, P176, DOI 10.1111/conl.12047; Mumby PJ, 2011, ECOL LETT, V14, P132, DOI 10.1111/j.1461-0248.2010.01562.x; Munday PL, 2009, MAR ECOL PROG SER, V388, P235, DOI 10.3354/meps08137; Nakicenovic N., 2000, IPCC SPECIAL REPORT; Penaflor EL, 2009, CORAL REEFS, V28, P841, DOI 10.1007/s00338-009-0522-8; Pressey RL, 2013, BIOL CONSERV, V166, P155, DOI 10.1016/j.biocon.2013.06.025; Rezende EL, 2011, FUNCT ECOL, V25, P111, DOI 10.1111/j.1365-2435.2010.01778.x; Rondinini C, 2006, ECOL LETT, V9, P1136, DOI 10.1111/j.1461-0248.2006.00970.x; Russell BD, 2009, GLOBAL CHANGE BIOL, V15, P2153, DOI 10.1111/j.1365-2486.2009.01886.x; Salm R.V., 2006, CORAL REEFS CLIMATE, DOI 10.1029/61CE12; Selig ER, 2012, GLOBAL CHANGE BIOL, V18, P1561, DOI 10.1111/j.1365-2486.2012.02658.x; Selig ER, 2010, GLOBAL ECOL BIOGEOGR, V19, P397, DOI 10.1111/j.1466-8238.2009.00522.x; Sheppard CRC, 2003, NATURE, V425, P294, DOI 10.1038/nature01987; Spillman CM, 2011, B AM METEOROL SOC, V92, P1581, DOI 10.1175/BAMS-D-11-00009.1; Strange N, 2011, BIOL CONSERV, V144, P2968, DOI 10.1016/j.biocon.2011.08.022; van Hooidonk R, 2012, CORAL REEFS, V31, P121, DOI 10.1007/s00338-011-0825-4; van Hooidonk R, 2015, GLOBAL CHANGE BIOL, V21, P3389, DOI 10.1111/gcb.12901; van Hooidonk R, 2014, GLOBAL CHANGE BIOL, V20, P103, DOI 10.1111/gcb.12394; Weatherhead EC, 1998, J GEOPHYS RES-ATMOS, V103, P17149, DOI 10.1029/98JD00995; Wernberg T, 2011, J EXP MAR BIOL ECOL, V400, P7, DOI 10.1016/j.jembe.2011.02.021; West JM, 2003, CONSERV BIOL, V17, P956, DOI 10.1046/j.1523-1739.2003.02055.x; Wilson KA, 2009, ANN NY ACAD SCI, V1162, P237, DOI 10.1111/j.1749-6632.2009.04149.x; Wu Q, 2008, GEOPHYS RES LETT, V35; Yang JS, 2012, HYDROL EARTH SYST SC, V16, P801, DOI 10.5194/hess-16-801-2012; Zhang J, 2010, ATMOS CHEM PHYS, V10, P10949, DOI 10.5194/acp-10-10949-2010	105	28	31	0	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140828	10.1371/journal.pone.0140828	http://dx.doi.org/10.1371/journal.pone.0140828			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26535586	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000364298400040
J	Nigorikawa, K; Hazeki, K; Sasaki, J; Omori, Y; Miyake, M; Morioka, S; Guo, Y; Sasaki, T; Hazeki, O				Nigorikawa, Kiyomi; Hazeki, Kaoru; Sasaki, Junko; Omori, Yumio; Miyake, Mikiko; Morioka, Shin; Guo, Ying; Sasaki, Takehiko; Hazeki, Osamu			Inositol Polyphosphate-4-Phosphatase Type I Negatively Regulates Phagocytosis via Dephosphorylation of Phagosomal PtdIns (3,4)P-2	PLOS ONE			English	Article							MYOSIN-X; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHOINOSITIDE 3-KINASE; ROLES; MEMBRANE; RAB5; MACROPINOCYTOSIS; PHOSPHATASES; ENDOCYTOSIS; ACTIVATION	Phagocytosis is a highly conserved process whereby phagocytic cells engulf pathogens and apoptotic bodies. The present study focused on the role of inositol polyphosphate-4-phosphatase type I (Inpp4a) in phagocytosis. Raw264.7 cells that express shRNA against Inpp4a (shInpp4a cells) showed significantly increased phagocytic activity. The introduction of shRNA-resistant human Inpp4a abolished this increase. Macrophages from Inpp4a knockout mice showed similar increases in the phagocytic activity. Inpp4a was recruited to the phagosome membrane by a mechanism other than the direct interaction with Rab5. PtdIns(3,4)P-2 increased on the phagosome of shInpp4a cells, while PtdIns(3) P significantly decreased. The results indicate that Inpp4a negatively regulates the phagocytic activity of macrophages as a member of the sequential dephosphorylation system that metabolizes phagosomal PtdIns(3,4,5)P-3 to PtdIns(3)P.	[Nigorikawa, Kiyomi; Hazeki, Kaoru; Omori, Yumio; Miyake, Mikiko; Morioka, Shin; Guo, Ying; Hazeki, Osamu] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Hiroshima 7348553, Japan; [Sasaki, Junko; Sasaki, Takehiko] Akita Univ, Dept Pathol & Immunol, Sch Med, Akita 0108543, Japan	Hiroshima University; Akita University	Hazeki, K (corresponding author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Hiroshima 7348553, Japan.	khazeki@hiroshima-u.ac.jp		Sasaki, Takehiko/0000-0003-1837-3748				Beemiller P, 2006, PLOS BIOL, V4, P987, DOI 10.1371/journal.pbio.0040162; Billcliff PG, 2014, BIOCHEM J, V461, P159, DOI 10.1042/BJ20140361; Bohdanowicz M, 2013, PHYSIOL REV, V93, P69, DOI 10.1152/physrev.00002.2012; Bohdanowicz M, 2012, MOL BIOL CELL, V23, P176, DOI 10.1091/mbc.E11-06-0489; Botelho RJ, 2000, J CELL BIOL, V151, P1353, DOI 10.1083/jcb.151.7.1353; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Cox D, 2002, NAT CELL BIOL, V4, P469, DOI 10.1038/ncb805; Fairn GD, 2012, TRENDS IMMUNOL, V33, P397, DOI 10.1016/j.it.2012.03.003; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Hazeki K, 2012, FEBS LETT, V586, P4010, DOI 10.1016/j.febslet.2012.09.043; Huang ZY, 2003, J LEUKOCYTE BIOL, V73, P823, DOI 10.1189/jlb.0902454; Ivetac I, 2005, MOL BIOL CELL, V16, P2218, DOI 10.1091/mbc.e04-09-0799; Jean S, 2012, NAT REV MOL CELL BIO, V13, P463, DOI 10.1038/nrm3379; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; Lu Q, 2011, MOL BIOL CELL, V22, P4268, DOI 10.1091/mbc.E11-04-0354; Maekawa M, 2014, P NATL ACAD SCI USA, V111, pE978, DOI 10.1073/pnas.1311029111; NINOMIYA N, 1994, J BIOL CHEM, V269, P22732; Peng QS, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000500; Plantard L, 2010, J CELL SCI, V123, P3525, DOI 10.1242/jcs.069609; Posor Y, 2013, NATURE, V499, P233, DOI 10.1038/nature12360; Sasaki J, 2010, NATURE, V465, P497, DOI 10.1038/nature09023; Scott CC, 2005, J CELL BIOL, V169, P139, DOI 10.1083/jcb.200412162; Segawa T, 2014, BIOCHEM J, V464, P365, DOI 10.1042/BJ20140916; Shin HW, 2005, J CELL BIOL, V170, P607, DOI 10.1083/jcb.200505128; Tamura N, 2009, BIOCHEM J, V423, P99, DOI 10.1042/BJ20090687; Thi EP, 2012, J LEUKOCYTE BIOL, V92, P553, DOI 10.1189/jlb.0212053; Tsukamoto K, 2008, J IMMUNOL, V180, P2054, DOI 10.4049/jimmunol.180.4.2054; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069	28	11	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142091	10.1371/journal.pone.0142091	http://dx.doi.org/10.1371/journal.pone.0142091			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26535897	Green Published, gold, Green Submitted			2022-12-26	WOS:000364298400131
J	Qureshi, R; Yildirim, O; Gasser, A; Basmadjian, C; Zhao, Q; Wilmet, JP; Desaubry, L; Nebigil, CG				Qureshi, Rehana; Yildirim, Onur; Gasser, Adeline; Basmadjian, Christine; Zhao, Qian; Wilmet, Jean-Philippe; Desaubry, Laurent; Nebigil, Canan G.			FL3, a Synthetic Flavagline and Ligand of Prohibitins, Protects Cardiomyocytes via STAT3 from Doxorubicin Toxicity	PLOS ONE			English	Article							POTENT ANTICANCER; SIGNAL TRANSDUCER; INDUCED APOPTOSIS; CARDIAC FIBROSIS; TRANSCRIPTION 3; HEART-FAILURE; PATHWAY; CELLS; SURVIVAL; INHIBITION	Aims The clinical use of doxorubicin for the treatment of cancer is limited by its cardiotoxicity. Flavaglines are natural products that have both potent anticancer and cardioprotective properties. A synthetic analog of flavaglines, FL3, efficiently protectsmice from the cardiotoxicity of doxorubicin. The mechanism underlying this cardioprotective effect has yet to be elucidated. Methods and Results Here, we show that FL3 binds to the scaffold proteins prohibitins (PHBs) and thus promotes their translocation to mitochondria in the H9c2 cardiomyocytes. FL3 induces heterodimerization of PHB1 with STAT3, thereby ensuring cardioprotection from doxorubicin toxicity. This interaction is associated with phosphorylation of STAT3. A JAK2 inhibitor, WP1066, suppresses both the phosphorylation of STAT3 and the protective effect of FL3 in cardiomyocytes. The involvement of PHBs in the FL3-mediated cardioprotection was confirmed by means of small interfering RNAs (siRNAs) targeting PHB1 and PHB2. The siRNA knockdown of PHBs inhibits both phosphorylation of STAT3 and the cardioprotective effect of FL3. Conclusion Activation of mitochondrial STAT3/PHB1 complex by PHB ligands may be a new strategy against doxorubicin-induced cardiotoxicity and possibly other cardiac problems.	[Qureshi, Rehana; Yildirim, Onur; Gasser, Adeline; Wilmet, Jean-Philippe; Nebigil, Canan G.] Univ Strasbourg, CNRS, GPCRs Cardiobiol & Metab Team, UMR 7242,LabEx Medalis,Strasbourg Sch Biotechnol, Illkirch Graffenstaden, France; [Basmadjian, Christine; Zhao, Qian; Desaubry, Laurent] Univ Strasbourg, CNRS, Lab Therapeut Innovat, UMR 7200,Fac Pharm, Illkirch Graffenstaden, France; [Desaubry, Laurent] Tianjin Univ Sci & Technol, Coll Biotechnol, Sino French Joint Lab Food Nutr Safety & Med Chem, Tianjin 300457, Peoples R China	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Tianjin University Science & Technology	Desaubry, L (corresponding author), Univ Strasbourg, CNRS, Lab Therapeut Innovat, UMR 7200,Fac Pharm, Illkirch Graffenstaden, France.	desaubry@unistra.fr; nebigil@unistra.fr	YILDIRIM, Onur Gokhan/AAA-9156-2022; Nebigil, Canan/AAK-7162-2021; Desaubry, Laurent G/R-5446-2017; YILDIRIM, ONUR GOKHAN/ABF-4347-2021	Nebigil, Canan/0000-0002-2035-5795; Desaubry, Laurent G/0000-0002-1192-2970; YILDIRIM, ONUR GOKHAN/0000-0003-0090-7369; GASSER, Adeline/0000-0003-2678-327X	"Association pour la Recherche sur le Cancer" (ARC) [3940, SFI20111204054, PJA 20141201909]; "Agence National la Recherche" (ANR) [ANR-11-EMMA-021]; French government; AAREC Filia Research; Association Nationale de la Recherche et de la Technologie; Erasmus fellowship; Centre National de la Recherche Scientifique; Universite de Strasbourg	"Association pour la Recherche sur le Cancer" (ARC)(Fondation ARC pour la Recherche sur le Cancer); "Agence National la Recherche" (ANR)(French National Research Agency (ANR)); French government; AAREC Filia Research; Association Nationale de la Recherche et de la Technologie(French National Research Agency (ANR)); Erasmus fellowship; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite de Strasbourg	This work was supported by the "Association pour la Recherche sur le Cancer" (ARC, grant numbers 3940, SFI20111204054 and PJA 20141201909) and the "Agence National la Recherche" (ANR, grant number ANR-11-EMMA-021). This work has also been published within the LABEX ANR-10-LABX-0034_Medalis and received a financial support from the French government managed by Agence Nationale de la recherche under Programme d'investissement d'avenir. Christine Basmadjian and Qian Zhao were supported by AAREC Filia Research and the Association Nationale de la Recherche et de la Technologie. Onur Yildirim received an Erasmus fellowship. This work was supported by grants from Centre National de la Recherche Scientifique, and Universite de Strasbourg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artal-Sanz M, 2009, NATURE, V461, P793, DOI 10.1038/nature08466; Basmadjian C, 2013, FUTURE MED CHEM, V5, P2185, DOI 10.4155/fmc.13.177; Becker MS, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.528; Bernard Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025302; Boengler K, 2008, PHARMACOL THERAPEUT, V120, P172, DOI 10.1016/j.pharmthera.2008.08.002; Bolli R, 2003, TRENDS CARDIOVAS MED, V13, P72, DOI 10.1016/S1050-1738(02)00230-X; Chowdhury I, 2014, J CELL PHYSIOL, V229, P998, DOI 10.1002/jcp.24531; Chowdhury I, 2013, APOPTOSIS, V18, P1513, DOI 10.1007/s10495-013-0901-z; Chowdhury I, 2011, LIFE SCI, V89, P295, DOI 10.1016/j.lfs.2011.06.022; Destouches D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002518; Frias MA, 2008, CARDIOVASC RES, V80, P69, DOI 10.1093/cvr/cvn171; Gratia S, 2012, J PROTEOMICS, V75, P4705, DOI 10.1016/j.jprot.2012.02.004; Han J, 2014, CELL SIGNAL, V26, P2086, DOI 10.1016/j.cellsig.2014.06.006; Harada M, 2005, NAT MED, V11, P305, DOI 10.1038/nm1199; Hilfiker-Kleiner D, 2005, PHARMACOL THERAPEUT, V107, P131, DOI 10.1016/j.pharmthera.2005.02.003; Hoch M, 2011, CELL STEM CELL, V9, P131, DOI 10.1016/j.stem.2011.07.001; Iwamaru A, 2007, ONCOGENE, V26, P2435, DOI 10.1038/sj.onc.1210031; Jacoby JJ, 2003, P NATL ACAD SCI USA, V100, P12929, DOI 10.1073/pnas.2134694100; Jia YH, 2012, CELL BIOCHEM FUNCT, V30, P426, DOI 10.1002/cbf.2820; Kunisada K, 2000, P NATL ACAD SCI USA, V97, P315, DOI 10.1073/pnas.97.1.315; Lee JH, 2010, FEBS J, V277, P488, DOI 10.1111/j.1742-4658.2009.07505.x; Liu XH, 2004, PROTEOMICS, V4, P3167, DOI 10.1002/pmic.200300845; Liu XH, 2009, CELL STRESS CHAPERON, V14, P311, DOI 10.1007/s12192-008-0086-5; Liu YH, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/605154; Obana M, 2010, CIRCULATION, V121, P684, DOI 10.1161/CIRCULATIONAHA.109.893677; Polier G, 2012, CHEM BIOL, V19, P1093, DOI 10.1016/j.chembiol.2012.07.012; Ribeiro N, 2012, J MED CHEM, V55, P10064, DOI 10.1021/jm301201z; Song W, 2014, FEBS LETT, V588, P422, DOI 10.1016/j.febslet.2013.12.021; Sripathi SR, 2011, BIOCHEMISTRY-US, V50, P8342, DOI 10.1021/bi2008933; Szczepanek K, 2012, MITOCHONDRION, V12, P180, DOI 10.1016/j.mito.2011.08.011; Tebbi CK, 2007, J CLIN ONCOL, V25, P493, DOI 10.1200/JCO.2005.02.3879; Theiss AL, 2011, BBA-MOL CELL RES, V1813, P1137, DOI 10.1016/j.bbamcr.2011.01.033; Thuaud F, 2013, CHEM BIOL, V20, P316, DOI 10.1016/j.chembiol.2013.02.006; Thuaud F, 2009, J MED CHEM, V52, P5176, DOI 10.1021/jm900365v; Vejpongsa P, 2014, J AM COLL CARDIOL, V64, P938, DOI 10.1016/j.jacc.2014.06.1167; Wang K, 2015, CELL DEATH DIFFER, V22, P1058, DOI 10.1038/cdd.2014.200; Yano N, 2008, ENDOCRINOLOGY, V149, P6449, DOI 10.1210/en.2008-0292; Zhu WQ, 2014, CARDIOVASC RES, V103, P81, DOI 10.1093/cvr/cvu118	38	26	26	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141826	10.1371/journal.pone.0141826	http://dx.doi.org/10.1371/journal.pone.0141826			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536361	gold, Green Submitted, Green Published			2022-12-26	WOS:000364298400090
J	Scarlet, D; Ertl, R; Aurich, C; Steinborn, R				Scarlet, Dragos; Ertl, Reinhard; Aurich, Christine; Steinborn, Ralf			The Orthology Clause in the Next Generation Sequencing Era: Novel Reference Genes Identified by RNA-seq in Humans Improve Normalization of Neonatal Equine Ovary RT-qPCR Data	PLOS ONE			English	Article							REAL-TIME PCR; RELIABLE REFERENCE GENES; HOUSEKEEPING GENES; EXPRESSION ANALYSIS; MESSENGER-RNA; COEXPRESSION; TISSUES; INFORMATION; VALIDATION; PREDICTION	Background Vertebrate evolution is accompanied by a substantial conservation of transcriptional programs with more than a third of unique orthologous genes showing constrained levels of expression. Moreover, there are genes and exons exhibiting excellent expression stability according to RNA-seq data across a panel of eighteen tissues including the ovary (Human Body Map 2.0). Results We hypothesized that orthologs of these exons would also be highly uniformly expressed across neonatal ovaries of the horse, which would render them appropriate reference genes (RGs) for normalization of reverse transcription quantitative PCR (RT-qPCR) data in this context. The expression stability of eleven novel RGs (C1orf43, CHMP2A, EMC7, GPI, PSMB2, PSMB4, RAB7A, REEP5, SNRPD3, VCP and VPS29) was assessed by RT-qPCR in ovaries of seven neonatal fillies and compared to that of the expressed repetitive element ERE-B, two universal (OAZ1 and RPS29) and four traditional RGs (ACTB, GAPDH, UBB and B2M). Expression stability analyzed with the software tool RefFinder top ranked the normalization factor constituted of the genes SNRPD3 and VCP, a gene pair that is not co-expressed according to COEXPRESdb and GeneMANIA. The traditional RGs GAPDH, B2M, ACTB and UBB were only ranked 3rd and 12th to 14th, respectively. Conclusions The functional diversity of the novel RGs likely facilitates expression studies over a wide range of physiological and pathological contexts related to the neonatal equine ovary. In addition, this study augments the potential for RT-qPCR-based profiling of human samples by introducing seven new human RG assays (C1orf43, CHMP2A, EMC7, GPI, RAB7A, VPS29 and UBB).	[Scarlet, Dragos; Aurich, Christine] Univ Vet Med, Ctr Artificial Inseminat & Embryo Transfer, Vienna, Austria; [Ertl, Reinhard; Steinborn, Ralf] Univ Vet Med, VetCore, Genom Core Facil, Vienna, Austria	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna	Scarlet, D (corresponding author), Univ Vet Med, Ctr Artificial Inseminat & Embryo Transfer, Vienna, Austria.	dragos.scarlet@vetmeduni.ac.at	Scarlet, Dragos/AAU-5766-2021	Scarlet, Dragos/0000-0002-9599-0830; Ertl, Reinhard/0000-0001-7485-3661				Ahn K, 2011, GENES GENOM, V33, P245, DOI 10.1007/s13258-010-0114-6; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Aoki K, 2007, PLANT CELL PHYSIOL, V48, P381, DOI 10.1093/pcp/pcm013; Beekman L, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-5; BHATIA P, 1994, ANAL BIOCHEM, V216, P223, DOI 10.1006/abio.1994.1028; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cai J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095974; Carnevale EM, 2008, THERIOGENOLOGY, V69, P23, DOI 10.1016/j.theriogenology.2007.09.011; Chen DL, 2011, J CELL PHYSIOL, V226, P2469, DOI 10.1002/jcp.22725; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; De Keyser E, 2013, BMC MOL BIOL, V14, DOI 10.1186/1471-2199-14-13; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Dijkstra JR, 2014, MOL ONCOL, V8, P813, DOI 10.1016/j.molonc.2013.12.016; Eisenberg E, 2013, TRENDS GENET, V29, P569, DOI 10.1016/j.tig.2013.05.010; Ferguson BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015208; Fox-Walsh KL, 2005, P NATL ACAD SCI USA, V102, P16176, DOI 10.1073/pnas.0508489102; GOLDSWORTHY SM, 1993, CELL PROLIFERAT, V26, P511, DOI 10.1111/j.1365-2184.1993.tb00029.x; Hallegger M, 2010, FEBS J, V277, P856, DOI 10.1111/j.1742-4658.2009.07521.x; Hao XY, 2014, INT J MOL SCI, V15, P22155, DOI 10.3390/ijms151222155; Herrera-Luna CV, 2012, REPROD DOMEST ANIM, V47, P928, DOI 10.1111/j.1439-0531.2012.01993.x; HIGUCHI R, 1993, BIO-TECHNOL, V11, P1026, DOI 10.1038/nbt0993-1026; Hoque M, 2013, NAT METHODS, V10, P133, DOI [10.1038/NMETH.2288, 10.1038/nmeth.2288]; Hruz T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-156; Kenkel CD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026914; Kwon MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006162; Laurell H, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1259; Martinez-Beamonte R, 2011, J BIOTECHNOL, V151, P325, DOI 10.1016/j.jbiotec.2010.12.017; Meyer FRL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063125; Mutwil M, 2011, PLANT CELL, V23, P895, DOI 10.1105/tpc.111.083667; Obayashi T, 2009, DNA RES, V16, P249, DOI 10.1093/dnares/dsp016; Okamura Y, 2015, NUCLEIC ACIDS RES, V43, pD82, DOI 10.1093/nar/gku1163; Omondi BA, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0862-x; Pan HP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125868; Pervouchine DD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6903; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Reddy DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078555; Saint-Marcoux D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118678; Savonet V, 1997, ANAL BIOCHEM, V247, P165, DOI 10.1006/abio.1997.2055; Scarlet D, 2015, REPROD FERTILITY DEV; Smits Katrien, 2009, BMC Res Notes, V2, P246, DOI 10.1186/1756-0500-2-246; Sterner DA, 1996, P NATL ACAD SCI USA, V93, P15081, DOI 10.1073/pnas.93.26.15081; Sun M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115979; Svingen T, 2015, PEERJ, V3, DOI 10.7717/peerj.855; Thomas KC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088653; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vassetzky NS, 2013, NUCLEIC ACIDS RES, V41, pD83, DOI 10.1093/nar/gks1263; Walt M L, 1979, J Reprod Fertil Suppl, P471; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	51	13	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142122	10.1371/journal.pone.0142122	http://dx.doi.org/10.1371/journal.pone.0142122			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536597	Green Published, gold, Green Submitted			2022-12-26	WOS:000364298400137
J	Zilelidou, EA; Rychli, K; Manthou, E; Ciolacu, L; Wagner, M; Skandamis, PN				Zilelidou, Evangelia A.; Rychli, Kathrin; Manthou, Evanthia; Ciolacu, Luminita; Wagner, Martin; Skandamis, Panagiotis N.			Highly Invasive Listeria monocytogenes Strains Have Growth and Invasion Advantages in Strain Competition	PLOS ONE			English	Article							ESCHERICHIA-COLI; PSEUDOMONAS-FLUORESCENS; STRESS-ADAPTATION; BIOFILM FORMATION; SEROTYPE 1/2A; 4B STRAINS; BACTERIA; FOOD; ENRICHMENT; INHIBITION	Multiple Listeria monocytogenes strains can be present in the same food sample; moreover, infection with more than one L. monocytogenes strain can also occur. In this study we investigated the impact of strain competition on the growth and in vitro virulence potential of L. monocytogenes. We identified two strong competitor strains, whose growth was not (or only slightly) influenced by the presence of other strains and two weak competitor strains, which were outcompeted by other strains. Cell contact was essential for growth inhibition. In vitro virulence assays using human intestinal epithelial Caco2 cells showed a correlation between the invasion efficiency and growth inhibition: the strong growth competitor strains showed high invasiveness. Moreover, invasion efficiency of the highly invasive strain was further increased in certain combinations by the presence of a low invasive strain. In all tested combinations, the less invasive strain was outcompeted by the higher invasive strain. Studying the effect of cell contact on in vitro virulence competition revealed a complex pattern in which the observed effects depended only partially on cell-contact suggesting that competition occurs at two different levels: i) during co-cultivation prior to infection, which might influence the expression of virulence factors, and ii) during infection, when bacterial cells compete for the host cell. In conclusion, we show that growth of L. monocytogenes can be inhibited by strains of the same species leading potentially to biased recovery during enrichment procedures. Furthermore, the presence of more than one L. monocytogenes strain in food can lead to increased infection rates due to synergistic effects on the virulence potential.	[Zilelidou, Evangelia A.; Manthou, Evanthia; Skandamis, Panagiotis N.] Agr Univ Athens, Dept Food Sci & Human Nutr, Lab Food Qual Control & Hyg, GR-11855 Athens, Greece; [Rychli, Kathrin; Ciolacu, Luminita; Wagner, Martin] Univ Vet Med Vienna, Inst Milk Hyg, Vienna, Austria; [Ciolacu, Luminita] Dunarea de Jos Univ Galati, Galati, Romania	Agricultural University of Athens; University of Veterinary Medicine Vienna; Dunarea De Jos University Galati	Rychli, K (corresponding author), Univ Vet Med Vienna, Inst Milk Hyg, Vienna, Austria.	Kathrin.rychli@vetmeduni.ac.at	Nychas, George/B-2734-2009	Nychas, George/0000-0002-2673-6425; Ciolacu, Luminita/0000-0003-4123-7859; Kober-Rychli, Kathrin/0000-0001-6147-577X	European Union: 7th Framework Programme projects PROMISE [265877]; University of Veterinary Medicine Vienna, Austria [PL4]	European Union: 7th Framework Programme projects PROMISE; University of Veterinary Medicine Vienna, Austria	Support was provided by the European Union: 7th Framework Programme projects PROMISE, project number 265877 (to MW and PNS), and by an internal start-up project from the University of Veterinary Medicine Vienna, Austria; PL4 (to KR).	Al-Zeyara SA, 2011, INT J FOOD MICROBIOL, V145, P98, DOI 10.1016/j.ijfoodmicro.2010.11.036; Amezquita A, 2002, J FOOD PROTECT, V65, P316, DOI 10.4315/0362-028X-65.2.316; Andritsos ND, 2013, FOOD MICROBIOL, V36, P395, DOI 10.1016/j.fm.2013.06.020; Aoki SK, 2005, SCIENCE, V309, P1245, DOI 10.1126/science.1115109; Bassler BL, 2002, CELL, V109, P421, DOI 10.1016/S0092-8674(02)00749-3; Bassler BL, 2006, CELL, V125, P237, DOI 10.1016/j.cell.2006.04.001; Belval SC, 2006, APPL ENVIRON MICROB, V72, P2644, DOI 10.1128/AEM.72.4.2644-2650.2006; Besse NG, 2005, INT J FOOD MICROBIOL, V104, P123, DOI 10.1016/j.ijfoodmicro.2005.01.012; Bruhn JB, 2005, APPL ENVIRON MICROB, V71, P961, DOI 10.1128/AEM.71.2.961-967.2005; Bruno JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015138; Buchanan RL, 1999, FOOD MICROBIOL, V16, P523, DOI 10.1006/fmic.1998.0264; Carvalheira A, 2010, FOOD CONTROL, V21, P1492, DOI 10.1016/j.foodcont.2010.04.021; COCONNIER MH, 1993, FEMS MICROBIOL LETT, V110, P299, DOI 10.1016/0378-1097(93)90119-M; Cooley MB, 2006, J FOOD PROTECT, V69, P2329, DOI 10.4315/0362-028X-69.10.2329; Cornforth DM, 2013, NAT REV MICROBIOL, V11, P285, DOI 10.1038/nrmicro2977; Cornu M, 2002, INT J FOOD MICROBIOL, V73, P261, DOI 10.1016/S0168-1605(01)00658-4; Dailey RC, 2014, FOOD MICROBIOL, V44, P173, DOI 10.1016/j.fm.2014.05.004; De Blackburn WC, 1994, INT J FOOD MICROBIOL, V24, P125, DOI [10.1016/0168-1605(94)90112-0, DOI 10.1016/0168-1605(94)90112-0]; Doumith M, 2004, J CLIN MICROBIOL, V42, P3819, DOI 10.1128/JCM.42.8.3819-3822.2004; Eisenreich W, 2010, NAT REV MICROBIOL, V8, P401, DOI 10.1038/nrmicro2351; Fleet GH, 1999, INT J FOOD MICROBIOL, V50, P101, DOI 10.1016/S0168-1605(99)00080-X; Fox E, 2009, J FOOD PROTECT, V72, P1450, DOI 10.4315/0362-028X-72.7.1450; Fox EM, 2011, APPL ENVIRON MICROB, V77, P6559, DOI 10.1128/AEM.05529-11; FRETZ R, 2010, EUROSURVEILLANCE, V15, P2; Galvez A, 2010, CURR OPIN BIOTECH, V21, P142, DOI 10.1016/j.copbio.2010.01.005; Gandhi M, 2007, INT J FOOD MICROBIOL, V113, P1, DOI 10.1016/j.ijfoodmicro.2006.07.008; Garmyn Dominique, 2009, Commun Integr Biol, V2, P371; Giaouris E, 2014, MEAT SCI, V97, P298, DOI 10.1016/j.meatsci.2013.05.023; Gilmour MW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-120; Gnanou Besse N., 2010, International Journal of Food Microbiology, V136, P345; Gorski L, 2006, APPL ENVIRON MICROB, V72, P776, DOI 10.1128/AEM.72.1.776-783.2006; Gram L, 2002, INT J FOOD MICROBIOL, V78, P79, DOI 10.1016/S0168-1605(02)00233-7; Gray MJ, 2006, INFECT IMMUN, V74, P2505, DOI 10.1128/IAI.74.5.2505-2512.2006; Gueimonde M, 2006, FOOD RES INT, V39, P467, DOI 10.1016/j.foodres.2005.10.003; Haruta S, 2009, ENVIRON MICROBIOL, V11, P2963, DOI 10.1111/j.1462-2920.2009.01956.x; Hayes CS, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a010025; Keller L, 2006, NAT REV MICROBIOL, V4, P249, DOI 10.1038/nrmicro1383; Koskiniemi S, 2013, P NATL ACAD SCI USA, V110, P7032, DOI 10.1073/pnas.1300627110; Laksanalamai P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042448; Leverentz B, 2006, APPL ENVIRON MICROB, V72, P1135, DOI 10.1128/AEM.72.2.1135-1140.2006; McCollum JT, 2013, NEW ENGL J MED, V369, P944, DOI 10.1056/NEJMoa1215837; Moroni O, 2006, APPL ENVIRON MICROB, V72, P6894, DOI 10.1128/AEM.00928-06; Nadell Carey D, 2008, J Biol, V7, P27, DOI 10.1186/jbiol87; O'Byrne CP, 2008, ADV APPL MICROBIOL, V65, P115, DOI 10.1016/S0065-2164(08)00605-9; Oliveira M, 2012, FOOD CONTROL, V25, P678, DOI 10.1016/j.foodcont.2011.12.002; Pan YW, 2009, APPL ENVIRON MICROB, V75, P5846, DOI 10.1128/AEM.00816-09; Poole SJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002217; Pricope-Ciolacu L, 2013, INT J FOOD MICROBIOL, V166, P59, DOI 10.1016/j.ijfoodmicro.2013.05.027; Riedel CU, 2009, MOL MICROBIOL, V71, P1177, DOI 10.1111/j.1365-2958.2008.06589.x; Ruhe ZC, 2013, TRENDS MICROBIOL, V21, P230, DOI 10.1016/j.tim.2013.02.003; Ruhe ZC, 2013, MBIO, P4; Rychli K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089964; Schmitz-Esser S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00380; Schvartzman MS, 2011, J FOOD PROTECT, V74, P1805, DOI 10.4315/0362-028X.JFP-11-102; Simos M, 2008, INT J FOOD MICROBIOL, V128, P309, DOI 10.1016/j.ijfoodmicro.2008.09.003; Soni KA, 2011, FOODBORNE PATHOG DIS, V8, P843, DOI 10.1089/fpd.2010.0746; Tan QL, 2012, BIOSCI BIOTECH BIOCH, V76, P699, DOI 10.1271/bbb.110832; Tham W, 2002, EPIDEMIOL INFECT, V128, P105, DOI 10.1017/S0950268801006379; Thomas LV, 1996, INT J FOOD MICROBIOL, V29, P361, DOI 10.1016/0168-1605(95)00077-1; Vivant AL, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00160; Xayarath B, 2012, FUTURE MICROBIOL, V7, P839, DOI [10.2217/fmb.12.57, 10.2217/FMB.12.57]; Zitz U, 2011, J FOOD PROTECT, V74, P1282, DOI 10.4315/0362-028X.JFP-11-045	62	21	21	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141617	10.1371/journal.pone.0141617	http://dx.doi.org/10.1371/journal.pone.0141617			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529510	gold, Green Submitted, Green Published			2022-12-26	WOS:000364032600043
J	Stewart, SE; Bird, CH; Tabor, RF; D'Angelo, ME; Piantavigna, S; Whisstock, JC; Trapani, JA; Martin, LL; Bird, PI				Stewart, Sarah E.; Bird, Catherina H.; Tabor, Rico F.; D'Angelo, Michael E.; Piantavigna, Stefania; Whisstock, James C.; Trapani, Joseph A.; Martin, Lisandra L.; Bird, Phillip I.			Analysis of Perforin Assembly by Quartz Crystal Microbalance Reveals a Role for Cholesterol and Calcium-independent Membrane Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATURAL-KILLER-CELLS; PORE-FORMING PROTEIN; STREPTOLYSIN-O; TARGET MEMBRANES; PLASMA-MEMBRANE; C2 DOMAIN; GRANZYMES; LYMPHOCYTES; MECHANISM; CYTOLYSIN	Perforin is an essential component in the cytotoxic lymphocyte-mediated cell death pathway. The traditional view holds that perforin monomers assemble into pores in the target cell membrane via a calcium-dependent process and facilitate translocation of cytotoxic proteases into the cytoplasm to induce apoptosis. Although many studies have examined the structure and role of perforin, the mechanics of pore assembly and granzyme delivery remain unclear. Here we have employed quartz crystal microbalance with dissipation monitoring (QCM-D) to investigate binding and assembly of perforin on lipid membranes, and show that perforin monomers bind to the membrane in a cooperative manner. We also found that cholesterol influences perforin binding and activity on intact cells and model membranes. Finally, contrary to current thinking, perforin efficiently binds membranes in the absence of calcium. When calcium is added to perforin already on the membrane, the QCM-D response changes significantly, indicating that perforin becomes membranolytic only after calcium binding.	[Stewart, Sarah E.; Bird, Catherina H.; D'Angelo, Michael E.; Whisstock, James C.; Bird, Phillip I.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Tabor, Rico F.; Piantavigna, Stefania; Martin, Lisandra L.] Monash Univ, Sch Chem, Clayton, Vic 3800, Australia; [Whisstock, James C.] Monash Univ, Australian Res Council, Ctr Excellence Adv Mol Imaging, Clayton, Vic 3800, Australia; [Trapani, Joseph A.] Peter MacCallum Canc Ctr, Canc Immunol Program, Canc Cell Death Lab, East Melbourne, Vic 3002, Australia	Monash University; Monash University; Monash University; Peter Maccallum Cancer Center	Bird, PI (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.	phil.bird@monash.edu	Martin, Lisandra L/E-4482-2010	Martin, Lisandra L/0000-0003-0486-5813; D'Angelo, Michael/0000-0001-9342-0132; Tabor, Rico/0000-0003-2926-0095; Whisstock, James/0000-0003-4200-5611; Bird, Phillip/0000-0002-6695-606X; Trapani, Joseph/0000-0003-0983-1532; Stewart, Sarah E/0000-0003-3712-9898	National Health and Medical Research Council (Australia); Australian Research Council	National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by grants from the National Health and Medical Research Council (Australia) (to P. I. B. and J. C. W.) and by grants from the Australian Research Council (to L. L. M R. F. T., and J. C. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Baran K, 2009, IMMUNITY, V30, P684, DOI 10.1016/j.immuni.2009.03.016; BHAKDI S, 1985, INFECT IMMUN, V47, P52; BLUMENTHAL R, 1984, P NATL ACAD SCI-BIOL, V81, P5551, DOI 10.1073/pnas.81.17.5551; CRIADO M, 1985, J IMMUNOL, V135, P4245; DENNERT G, 1983, J EXP MED, V157, P1483, DOI 10.1084/jem.157.5.1483; DOURMASHKIN RR, 1980, CLIN EXP IMMUNOL, V42, P554; Dunstone MA, 2012, CURR OPIN STRUC BIOL, V22, P342, DOI 10.1016/j.sbi.2012.04.008; Flanagan JJ, 2009, BIOCHEMISTRY-US, V48, P3977, DOI 10.1021/bi9002309; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Harris JR, 1998, J STRUCT BIOL, V121, P343, DOI 10.1006/jsbi.1998.3989; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; Krasilnikov OV, 2007, BIOCHIMIE, V89, P271, DOI 10.1016/j.biochi.2006.12.003; Law RHP, 2010, NATURE, V468, P447, DOI 10.1038/nature09518; Leung C, 2014, ELIFE, V3, DOI 10.7554/eLife.04247; LICHTENHELD MG, 1988, NATURE, V335, P448, DOI 10.1038/335448a0; Lopez JA, 2013, BLOOD, V121, P2659, DOI 10.1182/blood-2012-07-446146; MASSON D, 1985, J BIOL CHEM, V260, P9069; McCubbin GA, 2011, EUR BIOPHYS J BIOPHY, V40, P437, DOI 10.1007/s00249-010-0652-5; Mechler A, 2009, BIOMATERIALS, V30, P682, DOI 10.1016/j.biomaterials.2008.10.016; Metkar SS, 2015, CELL DEATH DIFFER, V22, P74, DOI 10.1038/cdd.2014.110; Metkar SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024286; NIEDERMEYER W, 1985, TOXICON, V23, P425, DOI 10.1016/0041-0101(85)90026-1; Palmer M, 1998, EMBO J, V17, P1598, DOI 10.1093/emboj/17.6.1598; PETERS PJ, 1991, J EXP MED, V173, P1099, DOI 10.1084/jem.173.5.1099; Piantavigna S, 2011, BBA-BIOMEMBRANES, V1808, P1811, DOI 10.1016/j.bbamem.2011.03.002; PODACK ER, 1983, NATURE, V302, P442, DOI 10.1038/302442a0; Ponting CP, 1996, PROTEIN SCI, V5, P162; Praper T, 2011, J BIOL CHEM, V286, P2946, DOI 10.1074/jbc.M110.169417; Praporski S, 2009, J BIOL CHEM, V284, P33224, DOI 10.1074/jbc.M109.006064; SAUERBREY G, 1959, Z PHYS, V155, P155; Sekiya K, 1993, Kansenshogaku Zasshi, V67, P736; Stepp SE, 1999, SCIENCE, V286, P1957, DOI 10.1126/science.286.5446.1957; Stewart SE, 2015, BBA-BIOMEMBRANES, V1848, P115, DOI 10.1016/j.bbamem.2014.10.012; Stewart SE, 2014, J BIOL CHEM, V289, P9172, DOI 10.1074/jbc.M113.544890; Stewart SE, 2012, BBA-PROTEINS PROTEOM, V1824, P59, DOI 10.1016/j.bbapap.2011.05.020; Sutton VR, 2008, METHODS, V44, P241, DOI 10.1016/j.ymeth.2007.11.011; Tabor RF, 2010, J COLLOID INTERF SCI, V346, P424, DOI 10.1016/j.jcis.2010.03.047; Tomita T, 2004, J BIOL CHEM, V279, P26975, DOI 10.1074/jbc.M402676200; Torn LH, 2005, LANGMUIR, V21, P7768, DOI 10.1021/la051102b; Traore DAK, 2013, BIOCHEM J, V456, P323, DOI 10.1042/BJ20130999; Voskoboinik I, 2005, J BIOL CHEM, V280, P8426, DOI 10.1074/jbc.M413303200; Walev I, 2001, P NATL ACAD SCI USA, V98, P3185, DOI 10.1073/pnas.051429498; Weller U, 1996, EUR J BIOCHEM, V236, P34, DOI 10.1111/j.1432-1033.1996.00034.x; YOUNG JDE, 1986, CELL, V44, P849, DOI 10.1016/0092-8674(86)90007-3	45	5	5	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					31101	31112		10.1074/jbc.M115.683078	http://dx.doi.org/10.1074/jbc.M115.683078			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26542805	Green Published, hybrid			2022-12-26	WOS:000367199000038
J	Bhattacharjee, P; Bhattacharyya, D				Bhattacharjee, Payel; Bhattacharyya, Debasish			An Enzyme from Aristolochia indica Destabilizes Fibrin-beta Amyloid Co-Aggregate: Implication in Cerebrovascular Diseases	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR; FRAGMENT-D; BINDING; THROMBOSIS; VENOM	Fibrinogen and beta-amyloid (A beta) peptide independently form ordered aggregates but in combination, they form disordered structures which are resistant to fibrinolytic enzymes like plasmin and cause severity in cerebral amyloid angiopathy (CAA). A novel enzyme of 31.3 kDa has been isolated from the root of the medicinal plant Aristolochia indica that showed fibrinolytic as well as fibrin-A beta co-aggregate destabilizing properties. This enzyme is functionally distinct from plasmin. Thrombolytic action of the enzyme was demonstrated in rat model. The potency of the plant enzyme in degrading fibrin and fibrin-plasma protein (A beta, human serum albumin, lysozyme, transthyretin and fibronectin) co-aggregates was demonstrated by atomic force microscopy, scanning electron microscopy and confocal microscopy that showed better potency of the plant enzyme as compared to plasmin. Moreover, the plant enzyme inhibited localization of the co-aggregate inside SH-SY5Y human neuroblastoma cells and also co-aggregate induced cytotoxicity. Plasmin was inefficient in this respect. In the background of limited options for fragmentation of these co-aggregates, the plant enzyme may appear as a potential proteolytic enzyme.	[Bhattacharjee, Payel; Bhattacharyya, Debasish] Indian Inst Chem Biol, CSIR, Div Struct Biol & Bioinformat, Kolkata 700032, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Bhattacharjee, P (corresponding author), Indian Inst Chem Biol, CSIR, Div Struct Biol & Bioinformat, Kolkata 700032, India.	payel.iicb@gmail.com; debasish@iicb.res.in			CSIR-Net Work Project [miND BSC0115]; Department of Science and Technology, Cognition Science Initiative, Project [SR/CSI/07/2009(G)]; UGC-NET fellowship	CSIR-Net Work Project(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology, Cognition Science Initiative, Project; UGC-NET fellowship	This work is supported by CSIR-Net Work Project (miND BSC0115) and the Department of Science and Technology, Cognition Science Initiative, Project No. SR/CSI/07/2009(G). P.B. was supported by UGC-NET fellowship.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Adams RA, 2004, MOL INTERV, V4, P163; Ahn HJ, 2014, J EXP MED, V211, P1049, DOI 10.1084/jem.20131751; Ahn HJ, 2010, P NATL ACAD SCI USA, V107, P21812, DOI 10.1073/pnas.1010373107; ASTRUP T, 1952, ARCH BIOCHEM BIOPHYS, V40, P346, DOI 10.1016/0003-9861(52)90121-5; Bhattacharjee P, 2013, J BIOL CHEM, V288, P30559, DOI 10.1074/jbc.M113.511410; Bhattacharjee P, 2013, J ETHNOPHARMACOL, V145, P220, DOI 10.1016/j.jep.2012.10.056; Buchmann K, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00459; Charidimou A, 2012, J NEUROL NEUROSUR PS, V83, P124, DOI 10.1136/jnnp-2011-301308; Cortes-Canteli M, 2009, J THROMB HAEMOST, V7, P146, DOI 10.1111/j.1538-7836.2009.03376.x; Furie B, 2005, J CLIN INVEST, V115, P3355, DOI 10.1172/JCI26987; GOLDENBERG DP, 1984, ANAL BIOCHEM, V138, P1, DOI 10.1016/0003-2697(84)90761-9; Hawkes C, 2012, J ADDICT RES THER S, VS5, pe001; Hoffman R, 1998, J INVEST DERMATOL, V111, P1140, DOI 10.1046/j.1523-1747.1998.00429.x; Johnson SM, 2012, J MOL BIOL, V421, P185, DOI 10.1016/j.jmb.2011.12.060; KACZMAREK E, 1993, J BIOL CHEM, V268, P2474; Killer M, 2010, DRUG DISCOV TODAY, V15, P640, DOI 10.1016/j.drudis.2010.04.007; Kim SH, 1998, ANAL BIOCHEM, V263, P115, DOI 10.1006/abio.1998.2816; Kolev K., 2014, FIBRINOLYSIS THROMBO, P3, DOI [10.5772/57353., DOI 10.5772/57353]; Lai Aaron Y, 2010, Int J Alzheimers Dis, V2011, P548380, DOI 10.4061/2011/548380; Levi M, 2001, THROMB HAEMOSTASIS, V86, P1331; Liu RM, 2011, NEUROBIOL AGING, V32, P1079, DOI 10.1016/j.neurobiolaging.2009.06.003; Longstaff C, 2011, BLOOD, V117, P661, DOI 10.1182/blood-2010-06-290338; Lord ST, 2011, ARTERIOSCL THROM VAS, V31, P494, DOI 10.1161/ATVBAHA.110.213389; Maity G, 2011, TOXICON, V57, P747, DOI 10.1016/j.toxicon.2011.02.008; McCarty SM, 2013, ADV WOUND CARE, V2, P438, DOI 10.1089/wound.2012.0370; Oliveira SB, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-21; OPRANDY JJ, 1988, AM J TROP MED HYG, V38, P181, DOI 10.4269/ajtmh.1988.38.181; Pontes-Neto Octavio M, 2012, Eur Neurol Rev, V7, P134; PRINCEN HMG, 1985, THROMB HAEMOSTASIS, V53, P212; Rego ROM, 2005, INSECT BIOCHEM MOLEC, V35, P991, DOI 10.1016/j.ibmb.2005.04.001; Sakono M, 2010, FEBS J, V277, P1348, DOI 10.1111/j.1742-4658.2010.07568.x; SHEARMAN MS, 1995, J NEUROCHEM, V65, P218, DOI 10.1046/j.1471-4159.1995.65010218.x; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Simkhada JR, 2010, PROCESS BIOCHEM, V45, P88, DOI 10.1016/j.procbio.2009.08.010; Smith EE, 2009, STROKE, V40, P2601, DOI 10.1161/STROKEAHA.108.536839; Stoffels JMJ, 2013, BRAIN, V136, P116, DOI 10.1093/brain/aws313; Talens S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041966; Taylor D, 2012, DRUG TREATMENTS ALZH, P1; Tucker HM, 2000, J NEUROSCI, V20, P3937; van Rooden S, 2009, STROKE, V40, P3022, DOI 10.1161/STROKEAHA.109.554378; Vieira MNN, 2006, CELL BIOCHEM BIOPHYS, V44, P549, DOI 10.1385/CBB:44:3:549; WILCHEK M, 1984, METHOD ENZYMOL, V104, P3; Yakovlev S, 2000, BIOCHEMISTRY-US, V39, P15730, DOI 10.1021/bi001847a; Yang Z, 2002, BIOCHEMISTRY-US, V41, P10218, DOI 10.1021/bi020299t; Zamolodchikov D, 2012, BLOOD, V119, P3342, DOI 10.1182/blood-2011-11-389668; ZHANG Y, 1995, J BIOL CHEM, V270, P10246, DOI 10.1074/jbc.270.17.10246	47	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141986	10.1371/journal.pone.0141986	http://dx.doi.org/10.1371/journal.pone.0141986			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545113	Green Submitted, Green Published, gold			2022-12-26	WOS:000364398700067
J	Fontinha, D; Lopes, FB; Marques, S; Simas, JP				Fontinha, Diana; Lopes, Filipa B.; Marques, Sofia; Pedro Simas, J.			Murid Gammaherpesvirus Latency-Associated Protein M2 Promotes the Formation of Conjugates between Transformed B Lymphoma Cells and T Helper Cells	PLoS One			English	Article							EPSTEIN-BARR-VIRUS; IMMUNOLOGICAL SYNAPSE; GERMINAL-CENTER; TARGET-CELLS; HIV-1 NEF; IN-VIVO; INFECTION; PATHOGENESIS; LYMPHOCYTES; ACTIVATION	Establishment of persistent infection in memory B cells by murid herpesvirus-4 (MuHV-4) depends on the proliferation of latently infected germinal center B cells, for which T cell help is essential. Whether the virus is capable of modulating B-T helper cell interaction for its own benefit is still unknown. Here, we investigate if the MuHV-4 latency associated M2 protein, which assembles multiprotein complexes with B cell signaling proteins, plays a role. We observed that M2 led to the upregulation of adhesion and co-stimulatory molecules in transduced B cell lines. In an MHC-II restricted OVA peptide-specific system, M2 polarized to the B-T helper contact zone. Furthermore, it promoted B cell polarization, as demonstrated by the increased proximity of the B cell microtubule organizing center to the interface. Consistent with these data, M2 promoted the formation of B-T helper cell conjugates. In an in vitro competition assay, this translated into a competitive advantage, as T cells preferentially conjugated with M2-expressing B cells. However, expression of M2 alone in B cells was not sufficient to lead to T cell activation, as it only occurred in the presence of specific peptide. Taken together, these findings support that M2 promotes the formation of B-T helper cell conjugates. In an in vivo context this may confer a competitive advantage to the infected B cell in acquisition of T cell help and initiation of a germinal center reaction, hence host colonization.	[Pedro Simas, J.] Univ Lisbon, Fac Med, Inst Mol Med, P-1699 Lisbon, Portugal; Univ Lisbon, Fac Med, Inst Microbiol, P-1699 Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa	Simas, JP (corresponding author), Univ Lisbon, Fac Med, Inst Mol Med, P-1699 Lisbon, Portugal.	psimas@medicina.ulisboa.pt	Simas, J Pedro/M-5157-2013	Simas, J Pedro/0000-0001-6982-9253; Alenquer, Marta/0000-0003-3062-1222; Marques, Sofia/0000-0003-1467-1529; Fontinha, Diana/0000-0002-0046-648X	Fundacao para a Ciencia e a Tecnologia [PTDC/SAU-MII/099314/2008]	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	The authors received funding for this work from Fundacao para a Ciencia e a Tecnologia (PTDC/SAU-MII/099314/2008).	Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Barton E, 2011, ANNU REV IMMUNOL, V29, P351, DOI 10.1146/annurev-immunol-072710-081639; Cho NH, 2004, J EXP MED, V200, P681, DOI 10.1084/jem.20040924; Collins CM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004106; Collins CM, 2009, J VIROL, V83, P6484, DOI 10.1128/JVI.00297-09; Coscoy L, 2001, J CLIN INVEST, V107, P1599, DOI 10.1172/JCI12432; de Miranda MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001654; de Miranda MP, 2013, J BIOL CHEM, V288, P3858, DOI 10.1074/jbc.M112.439810; Decalf J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004269; Depoil D, 2005, IMMUNITY, V22, P185, DOI 10.1016/j.immuni.2004.12.010; Duchez S, 2011, J IMMUNOL, V187, P4571, DOI 10.4049/jimmunol.1100600; EHTISHAM S, 1993, J VIROL, V67, P5247, DOI 10.1128/JVI.67.9.5247-5252.1993; Evans AG, 2008, J EXP MED, V205, P669, DOI 10.1084/jem.20071135; Flano E, 2002, J EXP MED, V196, P1363, DOI 10.1084/jem.20020890; Frederico B, 2014, CELL HOST MICROBE, V15, P457, DOI 10.1016/j.chom.2014.03.010; Friedl P, 2005, NAT REV IMMUNOL, V5, P532, DOI 10.1038/nri1647; GEIGER B, 1982, J CELL BIOL, V95, P137, DOI 10.1083/jcb.95.1.137; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Haller C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001212; Haller C, 2006, J BIOL CHEM, V281, P19618, DOI 10.1074/jbc.M513802200; Huppa JB, 2003, NAT REV IMMUNOL, V3, P973, DOI 10.1038/nri1245; Jacoby MA, 2002, J VIROL, V76, P1790, DOI 10.1128/JVI.76.4.1790-1801.2002; Kim IJ, 2003, J IMMUNOL, V171, P886, DOI 10.4049/jimmunol.171.2.886; KUPFER A, 1986, P NATL ACAD SCI USA, V83, P6080, DOI 10.1073/pnas.83.16.6080; KUPFER A, 1984, J IMMUNOL, V133, P2762; Liang XZ, 2004, J VIROL, V78, P12416, DOI 10.1128/JVI.78.22.12416-12427.2004; Macrae AI, 2003, J VIROL, V77, P9700, DOI 10.1128/JVI.77.17.9700-9709.2003; Madureira PA, 2005, J BIOL CHEM, V280, P37310, DOI 10.1074/jbc.M507478200; Marques S, 2003, J VIROL, V77, P7308, DOI 10.1128/JVI.77.13.7308-7318.2003; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Rangaswamy US, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105197; Rangaswamy US, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003858; Robertson JM, 2000, J IMMUNOL, V164, P4706, DOI 10.4049/jimmunol.164.9.4706; Rodrigues L, 2006, J VIROL, V80, P6123, DOI 10.1128/JVI.02700-05; Roughan JE, 2009, J VIROL, V83, P3968, DOI 10.1128/JVI.02609-08; Saxena SK, 2012, FUTURE VIROL, V7, P609, DOI 10.2217/FVL.12.42; Siegel AM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000039; Simas JP, 2004, J GEN VIROL, V85, P2789, DOI 10.1099/vir.0.80138-0; Simas JP, 1998, TRENDS MICROBIOL, V6, P276; Stevenson PG, 1999, J VIROL, V73, P1075, DOI 10.1128/JVI.73.2.1075-1079.1999; Thorley-Lawson DA, 2013, CURR OPIN VIROL, V3, P227, DOI 10.1016/j.coviro.2013.04.005; Thoulouze MI, 2006, IMMUNITY, V24, P547, DOI 10.1016/j.immuni.2006.02.016; Usherwood EJ, 1996, J GEN VIROL, V77, P627, DOI 10.1099/0022-1317-77-4-627; VALITUTTI S, 1993, EUR J IMMUNOL, V23, P790, DOI 10.1002/eji.1830230403; Valitutti S, 2000, METH MOL B, V121, P305; Willer DO, 2003, J VIROL, V77, P8310, DOI 10.1128/JVI.77.15.8310-8321.2003	46	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142540	10.1371/journal.pone.0142540	http://dx.doi.org/10.1371/journal.pone.0142540			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544979	gold, Green Published, Green Submitted			2022-12-26	WOS:000364398700154
J	Gepner, AD; Colangelo, LA; Reilly, N; Korcarz, CE; Kaufman, JD; Stein, JH				Gepner, Adam D.; Colangelo, Laura A.; Reilly, Nicole; Korcarz, Claudia E.; Kaufman, Joel D.; Stein, James H.			Carotid Artery Longitudinal Displacement, Cardiovascular Disease and Risk Factors: The Multi-Ethnic Study of Atherosclerosis	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; BLOOD-PRESSURE; SHEAR STRAIN; WALL; ASSOCIATIONS; MOVEMENTS; DISTENSIBILITY; ELASTICITY; STIFFNESS	Background Associations between carotid artery longitudinal displacement, cardiovascular disease risk factors, and events were evaluated in a large, multi-ethnic cohort. Materials and Methods A novel, reproducible protocol was developed for measuring right common carotid artery longitudinal displacement using ultrasound speckle-tracking. Total longitudinal displacement was measured in 389 randomly selected participants from the Multi-Ethnic Study of Atherosclerosis that were free of cardiovascular disease at baseline. Univariate analyses and Pearson Correlations were used to define relationships between longitudinal displacement with traditional cardiovascular risk factors and traditional measures of arterial stiffness. Hazard ratios of longitudinal displacement for cardiovascular disease and coronary heart disease events were compared using Cox proportional hazards models. Results Participants were a mean (standard deviation) 59.0 (8.7) years old, 48% female, 39% White, 26% Black, 22% Hispanic, and 14% Chinese. They had 19 (4.9%) cardiovascular disease and 14 (3.6%) coronary heart disease events over a mean 9.5 years of follow-up. Less longitudinal displacement was associated with Chinese (beta = -0.11, p = 0.02) compared to White race/ethnicity and greater longitudinal displacement was associated with higher carotid intima-media thickness (beta = 0.26, p = 0.004). Longitudinal displacement was not associated with other cardiovascular disease risk factors or markers of arterial stiffness. After adjustment for age and sex, and heart rate, Chinese race/ethnicity (beta = -0.10, p = 0.04) and carotid intima-media thickness (beta = 0.30 p = 0.003) were associated independently with longitudinal displacement. Longitudinal displacement predicted coronary heart disease (Hazard ratio [HR] 3.3, 95% Confidence intervals [CI] 0.96-11.14, p = 0.06) and cardiovascular disease (HR 2.1, 95% CI 0.6-7.3, p = 0.23) events. Conclusions Less longitudinal displacement is associated with Chinese ethnicity and greater carotid artery longitudinal displacement is associated with thicker intima-media thickness. Longitudinal displacement may predict adverse coronary heart disease and cardiovascular disease events.	[Gepner, Adam D.; Reilly, Nicole; Korcarz, Claudia E.; Stein, James H.] Univ Wisconsin, Dept Med, Div Cardiovasc Med, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Colangelo, Laura A.] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Kaufman, Joel D.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA	University of Wisconsin System; University of Wisconsin Madison; Northwestern University; Feinberg School of Medicine; University of Washington; University of Washington Seattle	Stein, JH (corresponding author), Univ Wisconsin, Dept Med, Div Cardiovasc Med, Sch Med & Publ Hlth, Madison, WI 53706 USA.	jhs@medicine.wisc.edu	Kaufman, Joel D/B-5761-2008; Korcarz, Claudia/A-5728-2018	Kaufman, Joel D/0000-0003-4174-9037; Stein, James/0000-0002-2770-8223; Korcarz, Claudia/0000-0001-9691-9027	National Heart, Lung, and Blood Institute [HC95159-HC95169, HL07936]; National Institute of Environmental Health Sciences [ES015915]; National Center for Research Resources [RR024156, RR025005]; Ruth L. Kirschstein National Research Service Award from the National Heart, Lung, and Blood Institute [HL07936]; Alpha Omega Alpha Postgraduate Award; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095162, N01HC095160, N01HC095163, N01HC095164, N01HC095169, N01HC095166, N01HC095161, N01HC095159, N01HC095168, N01HC095167, N01HC095165] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P50ES015915] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Ruth L. Kirschstein National Research Service Award from the National Heart, Lung, and Blood Institute; Alpha Omega Alpha Postgraduate Award; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Grants HC95159-HC95169 and HL07936 from the National Heart, Lung, and Blood Institute www.nhlbi.nih.gov, Grant ES015915 from the National Institute of Environmental Health Sciences www.niehs.nih.gov, Grants RR024156 and RR025005 from the National Center for Research Resources http://dnrc.nih.gov/reports/programs/ncrr.asp, Ruth L. Kirschstein National Research Service Award from the National Heart, Lung, and Blood Institute to the University of Wisconsin-Madison Cardiovascular Research Center (HL07936) http://www.nhlbi.nih.gov/research/training/programs/predoctoral/nrsa-parent-f31, Alpha Omega Alpha Postgraduate Award http://alphaomegaalpha.org/postgrad_award.html.	Ahlgren AR, 2009, CLIN PHYSIOL FUNCT I, V29, P353, DOI 10.1111/j.1475-097X.2009.00875.x; BRANDS PJ, 1995, ULTRASOUND MED BIOL, V21, P171, DOI 10.1016/S0301-5629(94)00111-1; Catalano M, 2011, EUR J ECHOCARDIOGR, V12, P528, DOI 10.1093/ejechocard/jer078; Cinthio M, 2006, AM J PHYSIOL-HEART C, V291, pH394, DOI 10.1152/ajpheart.00988.2005; Folsom AR, 2008, ARCH INTERN MED, V168, P1333, DOI 10.1001/archinte.168.12.1333; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gepner AD, 2014, STROKE, V45, P48, DOI 10.1161/STROKEAHA.113.002649; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Ma XJ, 2012, EUR J OBSTET GYN R B, V160, P30, DOI 10.1016/j.ejogrb.2011.09.038; Nichols W, 2011, THEORETICAL EXPT CLI; Oyre S, 1998, J AM COLL CARDIOL, V32, P128, DOI 10.1016/S0735-1097(98)00207-1; Pannier BM, 2002, AM J HYPERTENS, V15, P743, DOI 10.1016/S0895-7061(02)02962-X; Park HE, 2012, J ATHEROSCLER THROMB, V19, P349, DOI 10.5551/jat.10686; Persson M, 2003, CLIN PHYSIOL FUNCT I, V23, P247, DOI 10.1046/j.1475-097X.2003.00504.x; Reneman RS, 2005, EUR HEART J, V26, P960, DOI 10.1093/eurheartj/ehi177; Shimbo D, 2013, AM J HYPERTENS, V26, P896, DOI 10.1093/ajh/hpt040; Svedlund S, 2011, ARTERIOSCL THROM VAS, V31, P1668, DOI 10.1161/ATVBAHA.111.222901; Svedlund S, 2011, CLIN PHYSIOL FUNCT I, V31, P32, DOI 10.1111/j.1475-097X.2010.00976.x; Tattersall MC, 2014, STROKE, V45, P3257, DOI 10.1161/STROKEAHA.114.005669; Weber T, 2004, CIRCULATION, V109, P184, DOI 10.1161/01.CIR.0000105767.94169.E3; WEIZSACKER HW, 1983, J BIOMECH, V16, P703, DOI 10.1016/0021-9290(83)90080-5; Wilkins JT, 2012, AM J HYPERTENS, V25, P535, DOI 10.1038/ajh.2012.13; Yang WI, 2011, J HYPERTENS, V29, P2404, DOI 10.1097/HJH.0b013e32834c46dd; Zahnd G VD, 2012, LONGITUDINAL DISPLAC; Zahnd G, 2012, ULTRASOUND MED BIOL, V38, P1705, DOI 10.1016/j.ultrasmedbio.2012.05.004; Zhang L, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-39	26	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142138	10.1371/journal.pone.0142138	http://dx.doi.org/10.1371/journal.pone.0142138			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545210	gold, Green Published, Green Submitted			2022-12-26	WOS:000364398700084
J	Ismail, NA; Said, HM; Pinini, Z; Omar, SV; Beyers, N; Naidoo, P				Ismail, N. A.; Said, H. M.; Pinini, Z.; Omar, S. V.; Beyers, N.; Naidoo, P.			Optimizing Mycobacterial Culture in Smear-Negative, Human Immunodeficiency Virus-Infected Tuberculosis Cases	PLoS One			English	Article							PULMONARY TUBERCULOSIS; DIAGNOSIS; HIV; SPUTUM; YIELD; MICROSCOPY; SETTINGS; PROGRAM; PEOPLE; TIME	Introduction Tuberculosis (TB) is a significant public health problem and the diagnosis in human immunodeficiency virus (HIV)-infected individuals is challenging. The use of mycobacterial culture remains an important complementary tool and optimizing it has important benefits. We sought to determine the effect of an increase in the number of specimens evaluated, addition of nutritional supplementation to the culture medium, sputum appearance and volume on diagnostic yield and time to detection of pulmonary TB among smear-negative, HIV-infected adults. Methods In this prospective study conducted at the Tshwane District Hospital and Academic TB Laboratory, Pretoria, South Africa we collected three sputum specimens an hour apart from presumptive TB cases at an antiretroviral treatment site. We analysed specimens from 236 patients. Specimen appearance and volume were recorded. All specimens were processed for culture using both standard and supplemented media. Results A single specimen identified 79% of PTB cases using standard media; the second and third specimens added 12.5% and 8.3% respectively. Media supplementation, sputum appearance and specimen volume had no effect on culture yield or contamination rates. The mean time to detection was reduced from 19.8 days in standard cultures to 11.8 days in nutrient supplemented cultures (p = 0.002). For every 1 ml increase in sputum volume, time to detection was decreased by a factor of 0.797 (p = 0.011). Conclusion Use of an inexpensive culture supplement substantially reduced time to detection and could contribute to reducing treatment delay among HIV-infected cases.	[Ismail, N. A.] Univ Pretoria, Fac Hlth Sci, Dept Med Microbiol, ZA-0002 Pretoria, South Africa; [Ismail, N. A.; Said, H. M.; Omar, S. V.] Natl Inst Communicable Dis, Ctr TB, Johannesburg, South Africa; [Said, H. M.] Univ Free State, Dept Med Microbiol, Bloemfontein, South Africa; [Pinini, Z.] Gauteng Dept Hlth, TB HIV Directorate, Johannesburg, South Africa; [Beyers, N.; Naidoo, P.] Univ Stellenbosch, Dept Paediat & Child Hlth, Desmond Tutu TB Ctr, Cape Town, South Africa	University of Pretoria; National Institute for Communicable Diseases (NICD); University of the Free State; Stellenbosch University	Ismail, NA (corresponding author), Univ Pretoria, Fac Hlth Sci, Dept Med Microbiol, ZA-0002 Pretoria, South Africa.	naziri@nicd.ac.za	Omar, Shaheed Vally/AAB-5071-2020; Said, Halima/GWV-3962-2022	Omar, Shaheed Vally/0000-0001-6983-1636; Said, Halima/0000-0003-4843-9541	United States Agency for International Development (USAID) [GHN-A-00-08-00004-00]	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR)	This research was supported by a United States Agency for International Development (USAID) Cooperative Agreement (TREAT TB Agreement No. GHN-A-00-08-00004-00). The contents are the responsibility of the author(s) and do not necessarily reflect the views of USAID.	Brittle W, 2009, J CLIN MICROBIOL, V47, P1287, DOI 10.1128/JCM.02320-08; Cain KP, 2010, NEW ENGL J MED, V362, P707, DOI 10.1056/NEJMoa0907488; Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0; Hargreaves NJ, 2001, INT J TUBERC LUNG D, V5, P847; Harries AD, 1999, T ROY SOC TROP MED H, V93, P443, DOI 10.1016/S0035-9203(99)90153-0; Havlir DV, 2008, JAMA-J AM MED ASSOC, V300, P423, DOI 10.1001/jama.300.4.423; Hopewell PC, 2006, LANCET INFECT DIS, V6, P710, DOI 10.1016/S1473-3099(06)70628-4; Kik SV, 2014, EUR RESPIR J, V43, P1793, DOI 10.1183/09031936.00217313; KUBICA GP, 1963, AM REV RESPIR DIS, V87, P775; Mase SR, 2007, INT J TUBERC LUNG D, V11, P485; Monkongdee P, 2009, AM J RESP CRIT CARE, V180, P903, DOI 10.1164/rccm.200905-0692OC; Padmapriyadarsini C, 2011, INDIAN J MED RES, V134, P850, DOI 10.4103/0971-5916.92630; Peter JG, 2014, EUR RESPIR J, V43, P185, DOI 10.1183/09031936.00198012; Peter JG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039966; Pheiffer C, 2008, INT J TUBERC LUNG D, V12, P792; Schoch OD, 2007, AM J RESP CRIT CARE, V175, P80, DOI 10.1164/rccm.200608-1092OC; STATSSA, 2013, MORT CAUS DEATH S AF; Steingart KR, 2006, LANCET INFECT DIS, V6, P664, DOI 10.1016/S1473-3099(06)70602-8; Steingart KR, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009593.pub2; WHO, 2012, WHO POL COLL TB HIV; World Health Organization, 2014, WHO MON XPERT MTB RI; World Health Organization, 2014, XPERT MTB RIF IMPL M	22	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141851	10.1371/journal.pone.0141851	http://dx.doi.org/10.1371/journal.pone.0141851			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544183	Green Published, gold			2022-12-26	WOS:000364398700054
J	Kumazaki, M; Usuku, S				Kumazaki, Makoto; Usuku, Shuzo			Genetic Analysis of Norovirus GII.4 Variant Strains Detected in Outbreaks of Gastroenteritis in Yokohama, Japan, from the 2006-2007 to the 2013-2014 Seasons	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; SPORADIC GASTROENTERITIS; EMERGENCE; EVOLUTION; CHILDREN; GENOTYPES; IMMUNITY; ESCAPE	Noroviruses (NoVs) are the leading cause of acute gastroenteritis, both in sporadic cases and outbreaks. Since the 1990s, the emergence of several GII.4 variants has been reported worldwide. To investigate the epidemic status of NoV, 6,724 stool samples collected from outbreaks in Yokohama, Japan, from the 2006-2007 to 2013-2014 seasons were assessed for NoVs. We genotyped one specimen from each GII outbreak and conducted a sequence analysis of the VP1 gene for several GII.4 strains. Of the 947 NoV outbreaks during our study, GII was detected in 835, and GII.4 was the predominant genotype of GII. Five different GII.4 variants, Yerseke 2006a, Den Haag 2006b (2006b), Apeldoorn 2007, New Orleans 2009, and Sydney 2012, were detected. During this study period, the most prevalent variant of GII.4 was 2006b, and in each individual season, either 2006b or Sydney 2012 was the predominant variant. Out of the 16 detected 2006b strains, 12 had some amino acid substitutions in their blockade epitope, and these substitutions were concentrated in three residues. Two of the 2006b strains detected in the 2012-2013 season had a S368E substitution, which is consistent with the amino acid residues at same site of NSW0514 (Sydney 2012 prototype). Among the 16 detected strains of Sydney 2012, a phylogenetic analysis showed that all five strains detected in Yokohama during the 2011-2012 season clustered away from the other Sydney 2012 strains that were detected in the 2012-2013 and 2013-2014 seasons. These five strains and other Sydney 2012 strains in Yokohama had a few amino acid differences in the blockade epitopes compared with NSW0514. The amino acid substitutions observed in this study provide informative data about the evolution of a novel GII.4 variant.	[Kumazaki, Makoto; Usuku, Shuzo] Yokohama City Inst Publ Hlth, Microbiol Testing & Res Div, Yokohama, Kanagawa, Japan		Kumazaki, M (corresponding author), Yokohama City Inst Publ Hlth, Microbiol Testing & Res Div, Yokohama, Kanagawa, Japan.	ma00-kumazaki@city.yokohama.jp						Boon D, 2011, J VIROL, V85, P8656, DOI 10.1128/JVI.00472-11; Bull RA, 2006, J CLIN MICROBIOL, V44, P327, DOI 10.1128/JCM.44.2.327-333.2006; Cao S, 2007, J VIROL, V81, P5949, DOI 10.1128/JVI.00219-07; Chan-It W, 2012, J MED VIROL, V84, P1089, DOI 10.1002/jmv.23309; Cho HG, 2014, J CLIN VIROL, V61, P340, DOI 10.1016/j.jcv.2014.08.018; Debbink K, 2013, J INFECT DIS, V208, P1877, DOI 10.1093/infdis/jit370; Debbink K, 2012, J VIROL, V86, P1214, DOI 10.1128/JVI.06189-11; Desai R, 2012, CLIN INFECT DIS, V55, P189, DOI 10.1093/cid/cis372; Donaldson EF, 2010, NAT REV MICROBIOL, V8, P231, DOI 10.1038/nrmicro2296; Eden JS, 2014, VIROLOGY, V450, P106, DOI 10.1016/j.virol.2013.12.005; Fioretti JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092988; Giammanco GM, 2014, VIROLOGY, V450, P355, DOI 10.1016/j.virol.2013.12.007; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Green K., 2013, FIELDS VIROLOGY, V1, P583; Hasing ME, 2014, INFECT GENET EVOL, V27, P181, DOI 10.1016/j.meegid.2014.07.016; Hasing ME, 2013, J CLIN MICROBIOL, V51, P2204, DOI 10.1128/JCM.00663-13; Hoehne M, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-69; Huhti L, 2011, J INFECT DIS, V203, P1442, DOI 10.1093/infdis/jir039; Jothikumar N, 2005, APPL ENVIRON MICROB, V71, P1870, DOI 10.1128/AEM.71.4.1870-1875.2005; Kageyama T, 2004, J CLIN MICROBIOL, V42, P2988, DOI 10.1128/JCM.42.7.2988-2995.2004; Kojima S, 2002, J VIROL METHODS, V100, P107, DOI 10.1016/S0166-0934(01)00404-9; Kroneman A, 2011, J CLIN VIROL, V51, P121, DOI 10.1016/j.jcv.2011.03.006; Kroneman A, 2013, ARCH VIROL, V158, P2059, DOI 10.1007/s00705-013-1708-5; Kumazaki M, 2014, ARCH VIROL, V159, P761, DOI 10.1007/s00705-013-1894-1; Lindesmith LC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002705; Motomura K, 2008, J VIROL, V82, P11247, DOI 10.1128/JVI.00897-08; Okada M, 2005, J CLIN MICROBIOL, V43, P4391, DOI 10.1128/JCM.43.9.4391-4401.2005; Prasad BVV, 1999, SCIENCE, V286, P287, DOI 10.1126/science.286.5438.287; Sakon N, 2015, J INFECT DIS, V211, P879, DOI 10.1093/infdis/jiu496; Siebenga JJ, 2007, J VIROL, V81, P9932, DOI 10.1128/JVI.00674-07; Siebenga JJ, 2009, J INFECT DIS, V200, P802, DOI 10.1086/605127; Simmons K, 2013, EMERG INFECT DIS, V19, P1260, DOI 10.3201/eid1908.130472; Thongprachum A, 2014, INFECT GENET EVOL, V23, P65, DOI 10.1016/j.meegid.2014.01.030; Tran TNH, 2013, J CLIN VIROL, V56, P185, DOI 10.1016/j.jcv.2012.11.011; Vega E, 2014, J CLIN MICROBIOL, V52, P147, DOI 10.1128/JCM.02680-13; Yu YX, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/196169; Zhirakovskaia EV, 2015, J MED VIROL, V87, P740, DOI 10.1002/jmv.24068	37	18	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142568	10.1371/journal.pone.0142568	http://dx.doi.org/10.1371/journal.pone.0142568			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544040	Green Published, Green Submitted, gold			2022-12-26	WOS:000364398700157
J	Mansell, H; Soliman, M; Elmoselhi, H; Shoker, A				Mansell, Holly; Soliman, Mahmoud; Elmoselhi, Hamdi; Shoker, Ahmed			Elevated Circulating Interleukin 33 Levels in Stable Renal Transplant Recipients at High Risk for Cardiovascular Events	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; CORONARY-ARTERY-DISEASE; ACUTE REJECTION; HEART-DISEASE; IFN-GAMMA; IL-33; ATHEROSCLEROSIS; INFLAMMATION; SERUM; CYTOKINE	Background The Major Adverse Cardiovascular Events calculator (CRCRTR-MACE) estimates the burden of cardiovascular risk in renal transplant recipients (RTR). Our recent study of 95 RTR reported the 7-year median risk of cardiovascular events (CVE) to be 9.97%, ranging from 1.93 to 84.27%. Nearly a third (28.4%) of the cohort was above 20% risk for a CVE. Since interleukins (ILs) as part of the inflammatory response may play a role in the pathogenesis of cardiovascular disease (CVD), we extended this study to identify which ILs are associated with high cardiovascular risk in this population. Methods Twenty-two ILs were measured by multiplexed fluorescent bead-based immunoassay in 95 RTR and 56 normal controls. Stepwise analysis after multivariate determination of significant demographic and inflammatory variables was performed between the high and low-CVD risk groups (which were arbitrarily set at scores <10% and >= 20%, respectively). Normalized data was presented as mean +/- SD and non-normalized data as median (minimum-maximum). Significance was measured at <0.05. Results 27.5% of the low-risk and 31.3% of the high-risk groups had mean IL levels above the 95 percentile of the normal control levels. In the non-parametric analysis IL-6, 9, 16, 17 and 33 were significantly higher in the high-risk group compared to the control. Univariate analysis (UVA) of the high-risk group identified IL-33 as the only IL that remained significantly higher than the control and low-risk groups (p = 0.000). The percentage of patients with IL-33 levels above the 90 percentile of control value in the low and high-risk groups were 15.6% and 52.0%, respectively (p<0.002). UVA of factors significant to high IL-33 levels included estimated glomerular filtration rate (eGFR), while diabetes mellitus, serum phosphorus, microalbuminuria and age also remained significant in the multivariate analysis. Conclusion Circulating IL-33 level is positively associated with high CRCRTR-MACE score. Diminished eGFR, age, diabetes, serum phosphorus and microalbuminurea demonstrate significant relationship with elevated IL-33 levels, supporting the possible pathognomonic role of IL-33 in the cardiovascular burden in RTR.	[Mansell, Holly] Univ Saskatchewan, Coll Pharm & Nutr, Saskatoon, SK S7N 0W0, Canada; [Soliman, Mahmoud; Elmoselhi, Hamdi; Shoker, Ahmed] St Pauls Hosp, Saskatchewan Renal Transplant Program, Saskatoon, SK, Canada; [Shoker, Ahmed] Univ Saskatchewan, Dept Med, Saskatoon, SK S7N 0W0, Canada	University of Saskatchewan; St. Paul's Hospital; University of Saskatchewan; University of Saskatchewan	Shoker, A (corresponding author), St Pauls Hosp, Saskatchewan Renal Transplant Program, Saskatoon, SK, Canada.	ahmed.shoker@usask.ca			Astellas Pharma Canada	Astellas Pharma Canada(Astellas Pharmaceuticals)	http://www.astellas.ca/ Astellas Pharma Canada to A.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedini S, 2009, CLIN J AM SOC NEPHRO, V4, P1246, DOI 10.2215/CJN.00930209; Akcay A, 2011, J AM SOC NEPHROL, V22, P2057, DOI 10.1681/ASN.2010091011; Arnlov J, 2005, CIRCULATION, V112, P969, DOI 10.1161/CIRCULATIONAHA.105.538132; Bao YS, 2012, J CLIN IMMUNOL, V32, P587, DOI 10.1007/s10875-011-9622-7; Barbour M, 2014, EUR J IMMUNOL, V44, P3320, DOI 10.1002/eji.201444671; Brunner SM, 2011, TRANSPL INT, V24, P1027, DOI 10.1111/j.1432-2277.2011.01306.x; Calvo MS, 2013, AM J CLIN NUTR, V98, P6, DOI 10.3945/ajcn.112.053934; Cayrol C, 2014, CURR OPIN IMMUNOL, V31, P31, DOI 10.1016/j.coi.2014.09.004; Choi YS, 2009, BLOOD, V114, P3117, DOI 10.1182/blood-2009-02-203372; Cortez-Cooper M, 2013, VASC MED, V18, P282, DOI 10.1177/1358863X13508336; De Serres SA, 2012, CLIN J AM SOC NEPHRO, V7, P1018, DOI 10.2215/CJN.11051011; DECKERT T, 1989, DIABETOLOGIA, V32, P219, DOI 10.1007/BF00285287; Demyanets S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095055; Dhillon OS, 2013, INT J CARDIOL, V167, P2182, DOI 10.1016/j.ijcard.2012.05.073; Foley RN, 2009, J AM SOC NEPHROL, V20, P397, DOI 10.1681/ASN.2008020141; Fontes JA, 2015, CYTOKINE, V74, P62, DOI 10.1016/j.cyto.2014.12.024; Frostegard J, 1999, ATHEROSCLEROSIS, V145, P33, DOI 10.1016/S0021-9150(99)00011-8; Garg AX, 2002, KIDNEY INT, V61, P1486, DOI 10.1046/j.1523-1755.2002.00270.x; Gibson CM, 2006, AM J CARDIOL, V97, P1473, DOI 10.1016/j.amjcard.2005.12.037; Gregersen I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072769; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Hasan A, 2014, BMC IMMUNOL, V15, DOI 10.1186/1471-2172-15-19; Israni AK, 2010, AM J TRANSPLANT, V10, P338, DOI 10.1111/j.1600-6143.2009.02949.x; Jiang HR, 2012, EUR J IMMUNOL, V42, P1804, DOI 10.1002/eji.201141947; Kidd Parris, 2003, Altern Med Rev, V8, P223; Kritchevsky SB, 2005, CARDIOVASC RES, V66, P265, DOI 10.1016/j.cardiores.2004.12.026; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Libby P, 2010, CIRC J, V74, P213, DOI 10.1253/circj.CJ-09-0706; Lindmark E, 2001, JAMA-J AM MED ASSOC, V286, P2107, DOI 10.1001/jama.286.17.2107; Liu CL, 2014, CORONARY ARTERY DIS, V25, P498, DOI 10.1097/MCA.0000000000000117; Liu JY, 2014, J CLIN NEUROSCI, V21, P298, DOI 10.1016/j.jocn.2013.04.036; Liu Q, 2013, CYTOKINE, V62, P183, DOI 10.1016/j.cyto.2013.02.026; Lloyd-Jones DM, 2010, CIRCULATION, V121, P1768, DOI 10.1161/CIRCULATIONAHA.109.849166; Mansell H, 2015, AM J NEPHROL, V41, P147, DOI 10.1159/000377641; Mansell H, 2014, SCI WORLD J, DOI 10.1155/2014/750579; Mansell H, 2013, CLIN TRANSPLANT, V27, pE391, DOI 10.1111/ctr.12159; Matta BM, 2014, J IMMUNOL, V193, P4010, DOI 10.4049/jimmunol.1400481; McLaren JE, 2010, J IMMUNOL, V185, P1222, DOI 10.4049/jimmunol.1000520; Menon MC, 2013, ANN NY ACAD SCI, V1301, P21, DOI 10.1111/nyas.12283; Millan O, 2014, CLIN IMMUNOL, V154, P141, DOI 10.1016/j.clim.2014.07.007; Miller AM, 2008, J EXP MED, V205, P339, DOI 10.1084/jem.20071868; Miller AM, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-22; Milovanovic M, 2012, IMMUNOL RES, V52, P89, DOI 10.1007/s12026-012-8283-9; Murphy GEJ, 2010, ANN RHEUM DIS, V69, P43, DOI 10.1136/ard.2009.120113; Packard RRS, 2008, CLIN CHEM, V54, P24, DOI 10.1373/clinchem.2007.097360; Pomeshchik Y, 2015, BRAIN BEHAV IMMUN, V44, P68, DOI 10.1016/j.bbi.2014.08.002; Saini D, 2011, J HEART LUNG TRANSPL, V30, P624, DOI 10.1016/j.healun.2011.01.708; Salas A, 2013, GUT, V62, P1392, DOI 10.1136/gutjnl-2012-303920; Sanada S, 2007, J CLIN INVEST, V117, P1538, DOI 10.1172/JCI30634; Sanchez-Escuredo A, 2010, TRANSPL P, V42, P2905, DOI 10.1016/j.transproceed.2010.07.076; Schiffrin EL, 2007, CIRCULATION, V116, P85, DOI 10.1161/CIRCULATIONAHA.106.678342; Schuett H, 2009, THROMB HAEMOSTASIS, V102, P215, DOI 10.1160/TH09-05-0297; Shabgah AG, 2014, POSTEP DERM ALERGOL, V31, P256, DOI 10.5114/pdia.2014.40954; Shimpo M, 2004, CIRCULATION, V109, P2186, DOI 10.1161/01.CIR.0000127958.21003.5A; Shin WS, 2002, ATHEROSCLEROSIS, V160, P91, DOI 10.1016/S0021-9150(01)00571-8; Soveri I, 2012, TRANSPLANTATION, V94, P57, DOI 10.1097/TP.0b013e3182516cdc; Stenvinkel P, 2005, KIDNEY INT, V67, P1216, DOI 10.1111/j.1523-1755.2005.00200.x; Thierry A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088742; Tonelli M, 2005, CIRCULATION, V112, P2627, DOI 10.1161/CIRCULATIONAHA.105.553198; Tsimikas S, 2014, J AM COLL CARDIOL, V63, P1724, DOI 10.1016/j.jacc.2013.12.030; Yin H, 2010, TRANSPLANTATION, V89, P1189, DOI 10.1097/TP.0b013e3181d720af; Zhang K, 2013, CHINESE MED J-PEKING, V126, P3628, DOI 10.3760/cma.j.issn.0366-6999.20130145; Zhao Q, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/587376	64	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142141	10.1371/journal.pone.0142141	http://dx.doi.org/10.1371/journal.pone.0142141			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544186	Green Submitted, Green Published, gold			2022-12-26	WOS:000364398700086
J	Naidoo, K; Malindisa, ST; Otgaar, TC; Bernert, M; Dias, BD; Ferreira, E; Reusch, U; Knackmuss, S; Little, M; Weiss, SFT; Letsolo, BT				Naidoo, Kerrilyn; Malindisa, Sibusiso T.; Otgaar, Tyrone C.; Bernert, Martin; Dias, Bianca Da Costa; Ferreira, Eloise; Reusch, Uwe; Knackmuss, Stefan; Little, Melvyn; Weiss, Stefan F. T.; Letsolo, Boitelo T.			Knock-Down of the 37kDa/67kDa Laminin Receptor LRP/LR Impedes Telomerase Activity	PLOS ONE			English	Article							INFECTED NEURONAL CELLS; CELLULAR SENESCENCE; MAMMALIAN TELOMERES; ANTIBODY IGG1-IS18; PRPSC PROPAGATION; PRION PROTEIN; CANCER CELLS; ACTS; IMMORTALIZATION; SHELTERIN	Cancer has become a major problem worldwide due to its increasing incidence and mortality rates. Both the 37kDa/67kDa laminin receptor (LRP/LR) and telomerase are overexpressed in cancer cells. LRP/LR enhances the invasiveness of cancer cells thereby promoting metastasis, supporting angiogenesis and hampering apoptosis. An essential component of telomerase, hTERT is overexpressed in 85-90% of most cancers. hTERT expression and increased telomerase activity are associated with tumor progression. As LRP/LR and hTERT both play a role in cancer progression, we investigated a possible correlation between LRP/LR and telomerase. LRP/LR and hTERT co-localized in the perinuclear compartment of tumorigenic breast cancer (MDA_MB231) cells and non-tumorigenic human embryonic kidney (HEK293) cells. FLAG (R) Co-immunoprecipitation assays confirmed an interaction between LRP/LR and hTERT. In addition, flow cytometry revealed that both cell lines displayed high cell surface and intracellular LRP/LR and hTERT levels. Knock-down of LRP/LR by RNAi technology significantly reduced telomerase activity. These results suggest for the first time a novel function of LRP/LR in contributing to telomerase activity. siRNAs targeting LRP/LR may act as a potential alternative therapeutic tool for cancer treatment by (i) blocking metastasis (ii) promoting angiogenesis (iii) inducing apoptosis and (iv) impeding telomerase activity.	[Naidoo, Kerrilyn; Malindisa, Sibusiso T.; Otgaar, Tyrone C.; Bernert, Martin; Dias, Bianca Da Costa; Ferreira, Eloise; Weiss, Stefan F. T.; Letsolo, Boitelo T.] Univ Witwatersrand, Sch Mol & Cell Biol, ZA-2050 Johannesburg, South Africa; [Reusch, Uwe; Knackmuss, Stefan; Little, Melvyn] Affimed GmbH, D-69120 Heidelberg, Germany	University of Witwatersrand	Weiss, SFT (corresponding author), Univ Witwatersrand, Sch Mol & Cell Biol, Private Bag 3, ZA-2050 Johannesburg, South Africa.	Stefan.weiss@wits.ac.za; Boitelo.Letsolo@wits.ac.za	Malindisa, Sibusiso Tebogo/M-4359-2019; Malindisa, Sibusiso/GQQ-0761-2022; Malindisa, Sibusiso Tebogo T/G-5419-2019	Malindisa, Sibusiso Tebogo/0000-0002-9287-9408; Malindisa, Sibusiso Tebogo T/0000-0002-9287-9408; van der Merwe (nee Ferreira), Eloise/0000-0001-5985-4885	National Research Foundation; Republic of South Africa; South African Medical Research Council (SAMRC)	National Research Foundation; Republic of South Africa; South African Medical Research Council (SAMRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the National Research Foundation, the Republic of South Africa. Any opinions, findings and conclusions or recommendations expressed in this material are those of the authors, and therefore, the National Research Foundation does not accept any liability in this regard thereto. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The research from which this publication emanated was co-funded by the South African Medical Research Council (SAMRC). The specific roles of these authors are articulated in the "author contributions" section.	ALLSOPP RC, 1995, EXP CELL RES, V220, P194, DOI 10.1006/excr.1995.1306; Baumer Y, 2010, CELL MOL LIFE SCI, V67, P2451, DOI 10.1007/s00018-010-0349-z; de Jesus BB, 2012, EMBO MOL MED, V4, P691, DOI 10.1002/emmm.201200245; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Capper R, 2007, GENE DEV, V21, P2495, DOI 10.1101/gad.439107; Chetty C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096268; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Dias BD, 2014, SCI REP-UK, V4, DOI 10.1038/srep05556; Dias BD, 2013, SCI REP-UK, V3, DOI 10.1038/srep02702; Gauczynski S, 2001, EMBO J, V20, P5863, DOI 10.1093/emboj/20.21.5863; Gauczynski S, 2006, J INFECT DIS, V194, P702, DOI 10.1086/505914; Greider CW, 1996, SCI AM, V274, P92, DOI 10.1038/scientificamerican0296-92; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; HARLEY CB, 1994, COLD SPRING HARB SYM, V59, P307, DOI 10.1101/SQB.1994.059.01.035; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HARLEY CB, 1992, EXP GERONTOL, V27, P375, DOI 10.1016/0531-5565(92)90068-B; Holt SE, 1996, MOL CELL BIOL, V16, P2932; Hundt C, 2001, EMBO J, V20, P5876, DOI 10.1093/emboj/20.21.5876; Jovanovic K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100373; Jovanovic K, 2013, SCI REP-UK, V3, DOI 10.1038/srep02699; Khumalo T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139584; Khumalo T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066297; Khusal R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058888; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Langlade-Demoyen P, 2010, Patent US, Patent No. [20140056932.2010, 20140056932]; Letsolo BT, 2010, NUCLEIC ACIDS RES, V38, P1841, DOI 10.1093/nar/gkp1183; Leucht C, 2003, EMBO REP, V4, P290, DOI 10.1038/sj.embor.embor768; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Lu LG, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2893; Mbazima V, 2010, FRONT BIOSCI-LANDMRK, V15, P1150, DOI 10.2741/3667; Moodley K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057409; Omar A, 2012, J MOL BIOL, V419, P102, DOI 10.1016/j.jmb.2012.02.035; Omar A, 2011, EXPERT OPIN THER PAT, V21, P35, DOI 10.1517/13543776.2011.539203; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Pinnock EC, 2016, J ALZHEIMERS DIS; Rieger R, 1997, NAT MED, V3, P1383, DOI 10.1038/nm1297-1383; Shay JW, 2005, CARCINOGENESIS, V26, P867, DOI 10.1093/carcin/bgh296; SHAY JW, 1991, EXP CELL RES, V196, P33, DOI 10.1016/0014-4827(91)90453-2; Tomas-Loba A, 2008, CELL, V135, P609, DOI 10.1016/j.cell.2008.09.034; Vana K, 2006, J MOL BIOL, V358, P57, DOI 10.1016/j.jmb.2006.02.011; WRIGHT WE, 1992, EXP GERONTOL, V27, P383, DOI 10.1016/0531-5565(92)90069-C; Zuber C, 2008, J MOL BIOL, V378, P530, DOI 10.1016/j.jmb.2008.02.004	42	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141618	10.1371/journal.pone.0141618	http://dx.doi.org/10.1371/journal.pone.0141618			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545108	gold, Green Submitted, Green Published			2022-12-26	WOS:000364398700035
J	Ogura, Y; Miyake, N; Kou, I; Iida, A; Nakajima, M; Takeda, K; Fujibayashi, S; Shiina, M; Okada, E; Toyama, Y; Iwanami, A; Ishii, K; Ogata, K; Asahara, H; Matsumoto, N; Nakamura, M; Matsumoto, M; Ikegawa, S				Ogura, Yoji; Miyake, Noriko; Kou, Ikuyo; Iida, Aritoshi; Nakajima, Masahiro; Takeda, Kazuki; Fujibayashi, Shunsuke; Shiina, Masaaki; Okada, Eijiro; Toyama, Yoshiaki; Iwanami, Akio; Ishii, Ken; Ogata, Kazuhiro; Asahara, Hiroshi; Matsumoto, Naomichi; Nakamura, Masaya; Matsumoto, Morio; Ikegawa, Shiro			Identification of HOXD4 Mutations in Spinal Extradural Arachnoid Cyst	PLoS One			English	Article							LYMPHEDEMA-DISTICHIASIS SYNDROME; HOMEOBOX GENES; MFH-1; FAMILY	Spinal extradural arachnoid cyst (SEDAC) is a cyst in the spinal canal that protrudes into the epidural space from a defect in the dura mater and leads to neurological disturbances. We previously showed that familial SEDAC is caused by FOXC2 mutation; however, the causal gene of sporadic SEDAC has not been identified. To identify the causal gene of sporadic SEDAC, we performed whole exome sequencing for 12 subjects with sporadic SEDAC and identified heterozygous HOXD4 loss-of-function mutations in three subjects. HOXD4 haplo-insufficiency causes SEDAC and a transcriptional network containing HOXD4 and FOXC2 is involved in the development of the dura mater and the etiology of SEDAC.	[Ogura, Yoji; Kou, Ikuyo; Iida, Aritoshi; Nakajima, Masahiro; Takeda, Kazuki; Ikegawa, Shiro] RIKEN Ctr Integrat Med Sci, Lab Bone & Joint Dis, Tokyo 1088639, Japan; [Ogura, Yoji; Takeda, Kazuki; Toyama, Yoshiaki; Iwanami, Akio; Ishii, Ken; Nakamura, Masaya; Matsumoto, Morio] Keio Univ, Sch Med, Dept Orthopaed Surg, Tokyo 1608582, Japan; [Miyake, Noriko; Matsumoto, Naomichi] Yokohama City Univ, Dept Human Genet, Grad Sch Med, Yokohama, Kanagawa 2360004, Japan; [Fujibayashi, Shunsuke] Kyoto Univ, Dept Orthopaed Surg, Kyoto 6068507, Japan; [Shiina, Masaaki; Ogata, Kazuhiro] Yokohama City Univ, Grad Sch Med, Dept Biochem, Yokohama, Kanagawa 2360004, Japan; [Okada, Eijiro] Saiseikai Cent Hosp, Dept Orthopaed Surg, Tokyo 1080073, Japan; [Asahara, Hiroshi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Syst BioMed, Tokyo 1138510, Japan	RIKEN; Keio University; Yokohama City University; Kyoto University; Yokohama City University; Tokyo Saiseikai Central Hospital; Tokyo Medical & Dental University (TMDU)	Ikegawa, S (corresponding author), RIKEN Ctr Integrat Med Sci, Lab Bone & Joint Dis, Tokyo 1088639, Japan.	sikegawa@ims.u-tokyo.ac.jp	Ikegawa, Shiro/N-6895-2015; Iida, Aritoshi/CAA-1373-2022; Ogura, Yoji/V-2740-2019; Nakamura, Masaya/K-4111-2013	Ikegawa, Shiro/0000-0003-0316-2147; Iida, Aritoshi/0000-0001-7538-1651; 	Japan Agency For Medical Research and Development (AMED) [14525125]	Japan Agency For Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This study is supported by research grants from Japan Agency For Medical Research and Development (AMED) (contract No. 14525125). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang IC, 2004, PEDIATR NEUROSURG, V40, P70, DOI 10.1159/000078911; CILLUFFO JM, 1981, MAYO CLIN PROC, V56, P93; Fang JM, 2000, AM J HUM GENET, V67, P1382, DOI 10.1086/316915; Kaestner KH, 1996, DEVELOPMENT, V122, P1751; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Mark M, 1997, PEDIATR RES, V42, P421, DOI 10.1203/00006450-199710000-00001; MAVILIO F, 1986, NATURE, V324, P664, DOI 10.1038/324664a0; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; Miravet E, 2002, J CHILD NEUROL, V17, P770, DOI 10.1177/08830738020170101802; MIURA N, 1993, FEBS LETT, V326, P171, DOI 10.1016/0014-5793(93)81785-X; Ogura Y, 2012, PLOS ONE; Ogura Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080548; POPPERL H, 1992, EMBO J, V11, P3673, DOI 10.1002/j.1460-2075.1992.tb05452.x; Sanchez-Carpintero R, 2010, GENET MED, V12, P532, DOI 10.1097/GIM.0b013e3181e5c7ea; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Thim VV, 2005, HUM MUTAT, V25, P384, DOI 10.1002/humu.20155; Yabuki S, 2007, AM J MED GENET A, V143A, P884, DOI 10.1002/ajmg.a.31669	17	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142126	10.1371/journal.pone.0142126	http://dx.doi.org/10.1371/journal.pone.0142126			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545093	Green Submitted, gold, Green Published			2022-12-26	WOS:000364398700083
J	Sun, X; Ban, JH; Sha, XJ; Wang, WG; Jiao, Y; Wang, WS; Yang, YW; Wei, JJ; Shen, LJ; Chen, JH				Sun, Xiang; Ban, Jinghao; Sha, Xinjia; Wang, Weiguo; Jiao, Yang; Wang, Wanshan; Yang, Yanwei; Wei, Jingjing; Shen, Lijuan; Chen, Jihua			Effect of Er,Cr:YSGG Laser at Different Output Powers on the Micromorphology and the Bond Property of Non-Carious Sclerotic Dentin to Resin Composites	PLOS ONE			English	Article							SELF-ETCH ADHESIVES; SURFACE-ROUGHNESS; BOVINE DENTIN; HYBRID LAYER; STRENGTH; ENAMEL; ERBIUM; PERFORMANCE; CEMENTS; SYSTEMS	Background The objective of this study was to investigate the influence of Er, Cr:YSGG laser irradiated at different powers on the micromorphology and the bonding property of non-carious sclerotic dentin to resin composites. Methods Two hundred bovine incisors characterized by non-carious sclerotic dentin were selected, and the seventy-two teeth of which for surface morphological analysis were divided into nine groups according to various treatments (A: the control group, B: only treated with the adhesive Adper Easy One, C: diamond bur polishing followed by Adper Easy One, D-I: Er, Cr: YSGG laser irradiating at 1W, 2W, 3W, 4W, 5W, 6W output power, respectively, followed by Adper Easy One). The surface roughness values were measured by the non-contact three-dimensional morphology scanner, then the surface micromorphologies of surfaces in all groups were assessed by scanning electron microscopy (SEM); meanwhile, Image Pro-Plus 6.0 software was used to measure the relative percentage of open tubules on SEM images. The rest, one hundred twenty-eight teeth for bond strength test, were divided into eight groups according to the different treatments (A: only treated with the adhesive Adper Easy One, B: diamond bur polishing followed by the above adhesive, C-H: Er, Cr: YSGG laser irradiating at 1W, 2 W, 3W, 4 W, 5W, 6W output power, respectively, followed by the above adhesive), and each group was subsequently divided into two subgroups according to whether aging is performed (immediately tested and after thermocycling). Micro-shear bond strength test was used to evaluate the bond strength. Results The 4W laser group showed the highest roughness value (30.84 +/- 1.93 mu m), which was statistically higher than the control group and the diamond bur groups (p<0.05). The mean percentages ((27.8 +/- 1.8)%, (28.0 +/- 2.2)%, (30.0 +/- 1.9)%) of open tubules area in the 4W, 5W, 6W group were higher than other groups (p<0.05). The 4W laser group showed the highest micro-shear bond strength not only in immediately tested (17.60 +/- 2.55 PMa) but after thermocycling (14.35 +/- 2.08MPa). Conclusion The Er,Cr:YSGG laser at 4W power can effectively improve the bonding property between non-carious sclerotic dentin and resin composites by increasing the roughness and mean percentage area of open tubules.	[Sun, Xiang; Sha, Xinjia] Fourth Mil Med Univ, Sch Stomatol, Dept VIP Dent Care, State Key Lab Mil Stomatol, Xian 710032, Peoples R China; [Ban, Jinghao] Fourth Mil Med Univ, State Key Lab Mil Stomatol, Dept Prevent Dent, Sch Stomatol, Xian 710032, Peoples R China; [Wang, Weiguo] PLA, Hosp 117, Dept Stomatol, Hangzhou, Zhejiang, Peoples R China; [Jiao, Yang; Wei, Jingjing; Shen, Lijuan; Chen, Jihua] Fourth Mil Med Univ, State Key Lab Mil Stomatol, Dept Prosthodont, Sch Stomatol, Xian 710032, Peoples R China; [Jiao, Yang; Wei, Jingjing; Shen, Lijuan; Chen, Jihua] Shaanxi Key Lab Stomatol, Xian, Peoples R China; [Wang, Wanshan] Fourth Mil Med Univ, State Key Lab Mil Stomatol, Dept Dent Mat, Sch Stomatol, Xian 710032, Peoples R China; [Yang, Yanwei] PLA, Lanzhou Gen Hosp, Lanzhou Command, Dept Stomatol, Lanzhou, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Chen, JH (corresponding author), Fourth Mil Med Univ, State Key Lab Mil Stomatol, Dept Prosthodont, Sch Stomatol, Xian 710032, Peoples R China.	jhchen@fmmu.edu.cn	wei, jing/GXA-1455-2022	Chen, Ji-hua/0000-0002-1151-0693	National Natural Science Foundation of China [81130078, 81371187]; program for Changjiang Scholars and Innovative Research Team in University [IRT13051]; Specialized Research Project for Military health care [14BJZ56]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Specialized Research Project for Military health care	This work was financially supported by grants from the National Natural Science Foundation of China (No. 81130078 and No. 81371187), by the program for Changjiang Scholars and Innovative Research Team in University (No. IRT13051) and by the Specialized Research Project for Military health care (No. 14BJZ56).	Amaral RC, 2010, OPER DENT, V35, P211, DOI 10.2341/09-198-L; Ansari ZJ, 2012, LASER MED SCI, V27, P761, DOI 10.1007/s10103-011-0961-7; ARCORIA CJ, 1993, J ORAL REHABIL, V20, P213, DOI 10.1111/j.1365-2842.1993.tb01603.x; Bahrololoomi Zahra, 2014, J Dent (Tehran), V11, P172; Baygin O, 2012, LASER MED SCI, V27, P153, DOI 10.1007/s10103-011-0918-x; Botta SB, 2011, PHOTOMED LASER SURG, V29, P261, DOI 10.1089/pho.2010.2812; Camargo MA, 2008, J DENT, V36, P922, DOI 10.1016/j.jdent.2008.07.009; Camargo MA, 2008, ARCH ORAL BIOL, V53, P105, DOI 10.1016/j.archoralbio.2007.09.005; De Munck J, 2002, EUR J ORAL SCI, V110, P322, DOI 10.1034/j.1600-0722.2002.21281.x; Ding M, 2014, J ADV PROSTHODONT, V6, P165, DOI 10.4047/jap.2014.6.3.165; Eckert GJ, 2007, DENT MATER, V23, P385, DOI 10.1016/j.dental.2006.02.007; Eliguzeloglu E, 2008, OPER DENT, V33, P338, DOI 10.2341/07-96; Eversole LR, 1997, J AM DENT ASSOC, V128, P1099, DOI 10.14219/jada.archive.1997.0367; Giray FE, 2014, PHOTOMED LASER SURG, V32, P413, DOI 10.1089/pho.2013.3701; Gisler G, 2014, LASER MED SCI, V29, P77, DOI 10.1007/s10103-012-1243-8; HEYMANN HO, 1993, J AM DENT ASSOC, V124, P27; Hoshing Upendra A, 2014, J Conserv Dent, V17, P320, DOI 10.4103/0972-0707.136438; Hossain M, 2001, J CLIN LASER MED SUR, V19, P297, DOI 10.1089/104454701753342749; Jordehi AY, 2007, PHOTOMED LASER SURG, V25, P402, DOI 10.1089/pho.2006.2074; Kenshima S, 2006, J DENT, V34, P775, DOI 10.1016/j.jdent.2006.03.001; Koase K, 2004, J ADHES DENT, V6, P97; Kuscer L, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.10.108002; Kusunoki M, 2002, J DENT, V30, P91, DOI 10.1016/S0300-5712(02)00003-9; Loguercio AD, 2005, DENT MATER, V21, P224, DOI 10.1016/j.dental.2004.03.012; Loguercio AD, 2011, J DENT, V39, P578, DOI 10.1016/j.jdent.2011.06.005; Luque-Martinez IV, 2013, OPER DENT, V38, P39, DOI 10.2341/11-390-L; McDonough WG, 2001, DENT MATER, V17, P492, DOI 10.1016/S0109-5641(01)00008-2; Mena-Serrano AP, 2013, J APPL ORAL SCI, V21, P196, DOI 10.1590/1678-7757201302136; Nishiyama N, 2006, J DENT RES, V85, P422, DOI 10.1177/154405910608500505; Rizoiu loana M, 1995, JCDA, V12, P41; Shahabi S, 2013, LASER MED SCI, V28, P139, DOI 10.1007/s10103-012-1086-3; Sudsangiam S, 1999, J Adhes Dent, V1, P57; Tsai YL, 2011, DENT MATER J, V30, P941, DOI 10.4012/dmj.2011-111; Turkmen C, 2010, QUINTESSENCE INT, V41, pE119; Uekusa Satoshi, 2007, J Oral Sci, V49, P183; van Dijken JWV, 2004, AM J DENT, V17, P27; Visuri SR, 1996, J DENT RES, V75, P599, DOI 10.1177/00220345960750011401; Wegehaupt F, 2008, J ORAL REHABIL, V35, P390, DOI 10.1111/j.1365-2842.2007.01843.x; Xie C, 2010, OPER DENT, V35, P547, DOI 10.2341/10-025-L	39	4	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142311	10.1371/journal.pone.0142311	http://dx.doi.org/10.1371/journal.pone.0142311			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544034	Green Published, Green Submitted, gold			2022-12-26	WOS:000364398700109
J	Henzi, T; Schwaller, B				Henzi, Thomas; Schwaller, Beat			Antagonistic Regulation of Parvalbumin Expression and Mitochondrial Calcium Handling Capacity in Renal Epithelial Cells	PLOS ONE			English	Article							FAST-TWITCH MUSCLES; CA2+ UPTAKE; COTRANSPORTER NCC; SKELETAL-MUSCLE; MOUSE MODEL; DEFICIENCY; PROTEIN; REABSORPTION; ABSORPTION; GENES	Parvalbumin (PV) is a cytosolic Ca2+-binding protein acting as a slow-onset Ca2+ buffer modulating the shape of Ca2+ transients in fast-twitch muscles and a subpopulation of neurons. PV is also expressed in non-excitable cells including distal convoluted tubule (DCT) cells of the kidney, where it might act as an intracellular Ca2+ shuttle facilitating transcellular Ca2+ resorption. In excitable cells, upregulation of mitochondria in "PV-ergic" cells in PV-/- mice appears to be a general hallmark, evidenced in fast-twitch muscles and cerebellar Purkinje cells. Using Gene Chip Arrays and qRT-PCR, we identified differentially expressed genes in the DCT of PV-/- mice. With a focus on genes implicated in mitochondrial Ca2+ transport and membrane potential, uncoupling protein 2 (Ucp2), mitocalcin (Efhd1), mitochondrial calcium uptake 1 (Micu1), mitochondrial calcium uniporter (Mcu), mitochondrial calcium uniporter regulator 1 (Mcur1), cytochrome c oxidase subunit 1 (COX1), and ATP synthase subunit beta (Atp5b) were found to be up-upregulated. At the protein level, COX1 was increased by 31 +/- 7%, while ATP-synthase subunit beta was unchanged. This suggested that these mitochondria were better suited to uphold the electrochemical potential across the mitochondrial membrane, necessary for mitochondrial Ca2+ uptake. Ectopic expression of PV in PV-negative Madin-Darby canine kidney (MDCK) cells decreased COX1 and concomitantly mitochondrial volume, while ATP synthase subunit beta levels remained unaffected. Suppression of PV by shRNA in PV-expressing MDCK cells led subsequently to an increase in COX1 expression. The collapsing of the mitochondrial membrane potential by the uncoupler CCCP occurred at lower concentrations in PV-expressing MDCK cells than in control cells. In support, a reduction of the relative mitochondrial mass was observed in PV-expressing MDCK cells. Deregulation of the cytoplasmic Ca2+ buffer PV in kidney cells was counterbalanced in vivo and in vitro by adjusting the relative mitochondrial volume and modifying the mitochondrial protein composition conceivably to increase their Ca2+-buffering/sequestration capacity.	[Henzi, Thomas; Schwaller, Beat] Univ Fribourg, Dept Med, Anat, CH-1700 Fribourg, Switzerland	University of Fribourg	Schwaller, B (corresponding author), Univ Fribourg, Dept Med, Anat, CH-1700 Fribourg, Switzerland.	beat.schwaller@unifr.ch		Schwaller, Beat/0000-0002-8277-7555	Swiss National Science Foundation (SNSF) [130680, 10A22]	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF))	The project was supported by funding from the Swiss National Science Foundation (SNSF grant #130680 to B.S.) and a Novartis grant #10A22 to B.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge GM, 2008, J NEUROSCI METH, V172, P250, DOI 10.1016/j.jneumeth.2008.05.003; Belge H, 2007, P NATL ACAD SCI USA, V104, P14849, DOI 10.1073/pnas.0702810104; Berridge M, 1999, CURR BIOL, V9, pR157, DOI 10.1016/S0960-9822(99)80101-8; Bianchi K, 2006, CELL DEATH DIFFER, V13, P586, DOI 10.1038/sj.cdd.4401784; Blum W, 2013, INT J CANCER, V133, P2077, DOI 10.1002/ijc.28218; Calvo AC, 2008, PROTEOMICS, V8, P4338, DOI 10.1002/pmic.200701091; Carafoli E, 2010, BBA-BIOENERGETICS, V1797, P595, DOI 10.1016/j.bbabio.2010.03.024; Chen G, 2006, NEUROSCIENCE, V142, P97, DOI 10.1016/j.neuroscience.2006.06.008; Chen GP, 2001, AM J PHYSIOL-CELL PH, V281, pC114, DOI 10.1152/ajpcell.2001.281.1.C114; de Baaij JHF, 2013, AM J PHYSIOL-RENAL, V305, pF1563, DOI 10.1152/ajprenal.00322.2013; Drago I, 2012, P NATL ACAD SCI USA, V109, P12986, DOI 10.1073/pnas.1210718109; Ducreux S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044837; Gailly P, 2014, PFLUG ARCH EUR J PHY, V466, P2035, DOI 10.1007/s00424-013-1438-2; Gustavsson N, 2006, BIOCHEM BIOPH RES CO, V340, P1119, DOI 10.1016/j.bbrc.2005.12.119; Hoenderop JGJ, 2005, PHYSIOL REV, V85, P373, DOI 10.1152/physrev.00003.2004; Hsu YJ, 2015, J BONE MINER RES, V30, P116, DOI 10.1002/jbmr.2306; Kuznetsov AV, 2009, INT J BIOCHEM CELL B, V41, P1928, DOI 10.1016/j.biocel.2009.03.007; LANG F, 1995, KIDNEY INT, V48, P1200, DOI 10.1038/ki.1995.403; Loffing J, 2004, J AM SOC NEPHROL, V15, P2276, DOI 10.1097/01.ASN.0000138234.18569.63; Loffing J, 2001, AM J PHYSIOL-RENAL, V281, pF1021, DOI 10.1152/ajprenal.0085.2001; Maetzler W, 2004, EXP NEUROL, V186, P78, DOI 10.1016/j.expneurol.2003.10.014; Markadieu N, 2012, AM J PHYSIOL-RENAL, V303, pF886, DOI 10.1152/ajprenal.00114.2012; Meyer AH, 2002, J NEUROSCI, V22, P7055; Miller RL, 2006, AM J PHYSIOL-RENAL, V291, pF236, DOI 10.1152/ajprenal.00273.2005; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Nicolet-Barousse L, 2005, J BONE MINER RES, V20, P799, DOI 10.1359/JBMR.041238; Nijenhuis T, 2005, J CLIN INVEST, V115, P1651, DOI 10.1172/JCI24134; Olinger E, 2012, NEPHROL DIAL TRANSPL, V27, P3988, DOI 10.1093/ndt/gfs457; Orduz D, 2013, J PHYSIOL-LONDON, V591, P3215, DOI 10.1113/jphysiol.2012.250795; Pendergrass W, 2004, CYTOM PART A, V61A, P162, DOI 10.1002/cyto.a.20033; Racay P, 2006, FEBS J, V273, P96, DOI 10.1111/j.1742-4658.2005.05046.x; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; Rudolf R, 2004, J CELL BIOL, V166, P527, DOI 10.1083/jcb.200403102; Schmidt H, 2003, J PHYSIOL-LONDON, V551, P13, DOI 10.1113/jphysiol.2002.035824; Schoeber JPH, 2007, BIOCHEM SOC T, V35, P115, DOI 10.1042/BST0350115; Schwaller B, 2004, MOL CELL NEUROSCI, V25, P650, DOI 10.1016/j.mcn.2003.12.006; Schwaller B, 1999, AM J PHYSIOL-CELL PH, V276, pC395, DOI 10.1152/ajpcell.1999.276.2.C395; Schwaller B, 2009, CELL MOL LIFE SCI, V66, P275, DOI 10.1007/s00018-008-8564-6; Schwaller B, 2012, ADV EXP MED BIOL, V740, P1, DOI 10.1007/978-94-007-2888-2_1; Simon DB, 1996, NAT GENET, V12, P24, DOI 10.1038/ng0196-24; Smets I, 2004, AM J PHYSIOL-RENAL, V286, pF784, DOI 10.1152/ajprenal.00284.2003; Szabadkai G, 2008, PHYSIOLOGY, V23, P84, DOI 10.1152/physiol.00046.2007; van Angelen AA, 2013, NEPHROL DIAL TRANSPL, V28, P2983, DOI 10.1093/ndt/gft358; Vecellio M, 2000, EUR J NEUROSCI, V12, P945, DOI 10.1046/j.1460-9568.2000.00986.x; Voets T, 2004, J BIOL CHEM, V279, P19, DOI 10.1074/jbc.M311201200; Wohr M, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.19; Wu H, 2002, SCIENCE, V296, P349, DOI 10.1126/science.1071163; Xi Q, 2009, PFLUG ARCH EUR J PHY, V458, P89, DOI 10.1007/s00424-008-0601-7	48	21	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142005	10.1371/journal.pone.0142005	http://dx.doi.org/10.1371/journal.pone.0142005			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540196	Green Published, Green Submitted, gold			2022-12-26	WOS:000364303800044
J	Miramontes, R; Hill, AN; Woodruff, RSY; Lambert, LA; Navin, TR; Castro, KG; LoBue, PA				Miramontes, Roque; Hill, Andrew N.; Woodruff, Rachel S. Yelk; Lambert, Lauren A.; Navin, Thomas R.; Castro, Kenneth G.; LoBue, Philip A.			Tuberculosis Infection in the United States: Prevalence Estimates from the National Health and Nutrition Examination Survey, 2011-2012	PLOS ONE			English	Article							GAMMA RELEASE ASSAYS; SKIN-TEST; LATENT TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; TB; IMPLEMENTATION; TRANSMISSION; GUIDELINES; HOMELESS	Background Reexamining the prevalence of persons infected with tuberculosis (TB) is important to determine trends over time. In 2011-2012 a TB component was included in the National Health and Nutrition Examination Survey (NHANES) to estimate the reservoir of persons infected with TB. Methods Civilian, noninstitutionalized U.S. population survey participants aged 6 years and older were interviewed regarding their TB history and eligibility for the tuberculin skin test (TST) and interferon gamma release assay (IGRA) blood test. Once eligibility was confirmed, both tests were conducted. Prevalence and numbers of TST positive (10 mm or greater), IGRA positive, and both TST and IGRA positive were calculated by adjusting for the complex survey design after applying corrections for item nonresponse and digit preference in TST induration measurements. To examine TST positivity over time, data from NHANES 1999-2000 were reanalyzed using the same statistical methods. The TST was performed using Tubersol, a commercially available purified protein derivative (PPD), rather than PPD-S, which was the antigen used in NHANES 1999-2000. Prior patient history of TB vaccination was not collected in this study nor were patients examined for the presence of a Bacillus of Calmette and Guerin (BCG) vaccine scar. Results For NHANES 2011-2012, TST and IGRA results were available for 6,128 (78.4%) and 7,107 (90.9%) eligible participants, respectively. There was no significant difference between the percentage of the U.S. population that was TST positive in 2011-2012 (4.7% [95% CI 3.4-6.3]; 13,276,000 persons) compared with 1999-2000 (4.3%; 3.5-5.3). In 2011-2012 the percentage that was IGRA positive was 5.0% (4.2-5.8) and double TST and IGRA positivity was 2.1% (1.5-2.8). The point estimate of IGRA positivity prevalence in foreign-born persons (15.9%; 13.5-18.7) was lower than for TST (20.5%; 16.1-25.8) in 2011-2012. The point estimate of IGRA positivity prevalence in U.S.-born persons (2.8%; 2.0-3.8) was higher than for TST (1.5%; 0.9-2.6). Conclusions No statistically significant decline in the overall estimated prevalence of TST positivity was detected from 1999-2000 to 2011-2012. The prevalence of TB infection, whether measured by TST or IGRA, remains lower among persons born in the United States compared with foreign-born persons.	[Miramontes, Roque; Hill, Andrew N.; Woodruff, Rachel S. Yelk; Lambert, Lauren A.; Navin, Thomas R.; Castro, Kenneth G.; LoBue, Philip A.] Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Miramontes, R (corresponding author), Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA 30333 USA.	rmiramontes@cdc.gov	Castro, Kenneth G/P-1882-2018	Castro, Kenneth G/0000-0001-7964-6354; Miramontes, Roque/0000-0001-9535-460X				Affronti L F, 1969, Am Rev Respir Dis, V99, P460; Alami NN, 2014, MMWR-MORBID MORTAL W, V63, P229; [Anonymous], 1995, MMWR Recomm Rep, V44, P19; [Anonymous], 2013, TUB PUR PROT DER; [Anonymous], 2013, REP TUB US; [Anonymous], 2010, MMWR-MORBID MORTAL W; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 1974, WHO TECHN REP SER, V552, P16; Arend SM, 2007, AM J RESP CRIT CARE, V175, P618, DOI 10.1164/rccm.200608-1099OC; Baillargeon J, 2000, ANN EPIDEMIOL, V10, P74, DOI 10.1016/S1047-2797(99)00033-2; Bennett DE, 2008, AM J RESP CRIT CARE, V177, P348, DOI 10.1164/rccm.200701-057OC; Bennett RJ, 2014, AM J PUBLIC HEALTH, V104, pE95, DOI 10.2105/AJPH.2013.301637; Brown A, 2012, STAT PORTRAIT FOREIG; Cain KP, 2012, AM J RESP CRIT CARE, V186, P273, DOI 10.1164/rccm.201111-2076OC; Camarda CG, 2008, STAT MODEL, V8, P385, DOI 10.1177/1471082X0800800404; Centers for Disease Control and Prevention, 2015, NHANES 1999 2000 PUB; Centers for Disease Control and Prevention, 2014, NHANES 2011 2012 OV; Centers for Disease Control and Prevention (CDC), 2014, NAT HLTH NUTR EX SUR; Chin DP, 1998, AM J RESP CRIT CARE, V158, P1797, DOI 10.1164/ajrccm.158.6.9804029; Choi JC, 2008, CHEST, V133, P1415, DOI 10.1378/chest.07-2193; Connell TG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002624; Dorman SE, 2014, AM J RESP CRIT CARE, V189, P77, DOI 10.1164/rccm.201302-0365OC; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; Dye C, 2013, ANNU REV PUBL HEALTH, V34, P271, DOI 10.1146/annurev-publhealth-031912-114431; Eilers RHC, 2004, INT J TUBERC LUNG D, V8, P232; Engel A, 1977, Vital Health Stat 11, P1; Esmail H, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0437; Goodwin DJ, 2014, MIL MED, V179, P333, DOI 10.7205/MILMED-D-13-00364; Hill AN, 2012, EPIDEMIOL INFECT, V140, P1862, DOI 10.1017/S095026881100286X; Jensen Paul A., 2005, Morbidity and Mortality Weekly Report, V54, P1; Kimerling Michael E., 2006, Morbidity and Mortality Weekly Report, V55, P1; Kong PM, 2002, EMERG INFECT DIS, V8, P1280; Lashley M, 2007, PUBLIC HEALTH NURS, V24, P34, DOI 10.1111/j.1525-1446.2006.00605.x; Lee D P R, 2009, MMWR REP, V62, P1; Lumley T., 2004, J STAT SOFTW, V9, P1, DOI [10.18637/jss.v009.i08, DOI 10.18637/JSS.V009.I08]; Mazurek GH, 2007, CLIN INFECT DIS, V45, P837, DOI 10.1086/521107; McAdam JM, 2009, EMERG INFECT DIS, V15, P1109, DOI 10.3201/eid1507.080410; Mirel L.B., 2013, VITAL HLTH STAT, V2; Onozaki I, 2010, RESPIROLOGY, V15, P32, DOI 10.1111/j.1440-1843.2009.01673.x; Posey DL, 2014, MMWR-MORBID MORTAL W, V63, P234; Smieja MJ, 2000, COCHRANE DB SYST REV, V1999, DOI DOI 10.1002/14651858.CD001363; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; WHO, 2014, GLOB TUB REP 2014; Winston CA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-206; Woodruff RSY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065276; World Health Organization, SYST SCREEN ACT TUB; World Health Organization, 2013, 13 M WHO STRAT TECHN; Zhao XR, 2009, AM J CLIN PATHOL, V132, P678, DOI 10.1309/AJCPUHC34NBDGKKL	48	107	108	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140881	10.1371/journal.pone.0140881	http://dx.doi.org/10.1371/journal.pone.0140881			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV5GZ	26536035	Green Published, gold, Green Submitted			2022-12-26	WOS:000364298400042
J	Nishijima, T; Hayashida, T; Kurosawa, T; Tanaka, N; Oka, S; Gatanaga, H				Nishijima, Takeshi; Hayashida, Tsunefusa; Kurosawa, Takuma; Tanaka, Noriko; Oka, Shinichi; Gatanaga, Hiroyuki			Drug Transporter Genetic Variants Are Not Associated with TDF-Related Renal Dysfunction in Patients with HIV-1 Infection: A Pharmacogenetic Study	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; TENOFOVIR DISOPROXIL FUMARATE; KIDNEY TUBULAR DYSFUNCTION; FUNCTION DECLINE; IMPAIRMENT; DISEASE; REGIMEN; SAFETY; ADULTS; ABCC2	Objective To investigate whether single nucleotide polymorphisms (SNP) of drug transporter proteins for TDF is a risk factor for TDF-related renal function decrement. Methods This study investigated the association between 3 SNPs (ABCC2-24, 1249, and ABCB1 2677), which are shown to be associated with TDF-induced tubulopathy, and clinically important renal outcomes (>10ml/min/1.73m(2) decrement in eGFR relative to baseline, >25% decrement in eGFR, and eGFR <60ml/min/1.73m(2)) in 703 HIV-1-infected Japanese patients who initiated TDF-containing antiretroviral therapy (ART). Genotyping was performed by allelic discrimination using TaqMan 5'-nuclease assays. Results 95% of the study patients were males and 66% were treatment-naive, with median CD4 count of 249/mu l, median baseline eGFR of 96ml/min/1.73m(2) (IQR 84.6-109.2), and median exposure to TDF of 3.66 years (IQR 1.93-5.59). The frequencies of genotypes at -24, 1249 of ABCC2, and 2677 of ABCB1 were neither different between patients with decrement in eGFR of >10ml/min/1.73m(2) and those without such decrement (ABCC2: -24, p = 0.53, 1249, p = 0.68; ABCB1: 2677, p = 0.74), nor between those without and with the other two renal outcomes (>25% decrement: ABCC2: -24, p = 0.83, 1249, p = 0.97, ABCB1: 2677, p = 0.40; eGFR <60ml/min/1.73m(2): ABCC2: -24, p = 0.51, 1249, p = 0.81, ABCB1: 2677, p = 0.94). Logistic regression analysis showed that the risk genotype of the three SNPs were not associated with any of the three renal outcomes, respectively. Logistic regression model that applied either dominant, recessive, or additive model yielded the same results. Conclusions SNPs of the drug transporters for TDF are not associated with clinically important renal outcomes in patients who initiated TDF-containing ART.	[Nishijima, Takeshi; Hayashida, Tsunefusa; Oka, Shinichi; Gatanaga, Hiroyuki] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan; [Nishijima, Takeshi; Oka, Shinichi; Gatanaga, Hiroyuki] Kumamoto Univ, Ctr AIDS Res, Kumamoto, Japan; [Kurosawa, Takuma] Tokyo Univ Sci, Grad Sch Sci, Dept Math Sci Informat Sci, Tokyo 162, Japan; [Kurosawa, Takuma; Tanaka, Noriko] Natl Ctr Global Hlth & Med, Ctr Clin Sci, Dept Clin Res & Informat, Biostat Sect, Tokyo, Japan	National Center for Global Health & Medicine - Japan; Kumamoto University; Tokyo University of Science; National Center for Global Health & Medicine - Japan	Gatanaga, H (corresponding author), Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan.	higatana@acc.ncgm.go.jp	Tanaka, Noriko/AAP-8984-2021; Tanaka, Noriko/J-7811-2018	Tanaka, Noriko/0000-0003-3025-1591; Tanaka, Noriko/0000-0003-3025-1591	Japanese Ministry of Health, Labour, and Welfare [H23-AIDS-001]; Grant for National Center for Global Health and Medicine [25-106, 27-6001]; IMAI MEMORIAL TRUST FOR AIDS RESEARCH	Japanese Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan); Grant for National Center for Global Health and Medicine; IMAI MEMORIAL TRUST FOR AIDS RESEARCH	This work was supported by a Grant-in Aid for AIDS research from the Japanese Ministry of Health, Labour, and Welfare (H23-AIDS-001), The Grant for National Center for Global Health and Medicine (25-106 and 27-6001), and a grants-in-aid of The IMAI MEMORIAL TRUST FOR AIDS RESEARCH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], PREEXP PROPH PREV HI; [Anonymous], GUIDELINES USE ANTIR; Brennan A, 2011, AIDS, V25, P1603, DOI 10.1097/QAD.0b013e32834957da; Chaisiri K, 2010, CURR HIV RES, V8, P504, DOI 10.2174/157016210793499259; Choi AI, 2007, KIDNEY INT, V72, P1380, DOI 10.1038/sj.ki.5002541; Fung S, 2013, GASTROENTEROLOGY; Gallant JE, 2008, AIDS, V22, P2155, DOI 10.1097/QAD.0b013e3283112b8e; Gatanaga H, 2006, AIDS RES HUM RETROV, V22, P744, DOI 10.1089/aid.2006.22.744; Goicoechea M, 2008, J INFECT DIS, V197, P102, DOI 10.1086/524061; Horio M, 2013, CLIN EXP NEPHROL, V17, P352, DOI 10.1007/s10157-012-0704-5; Horio M, 2010, AM J KIDNEY DIS, V56, P32, DOI 10.1053/j.ajkd.2010.02.344; Izzedine H, 2006, J INFECT DIS, V194, P1481, DOI 10.1086/508546; Kearney BP, 2006, JAIDS-J ACQ IMM DEF, V43, P278, DOI 10.1097/01.qai.0000243103.03265.2b; Kiser JJ, 2008, CLIN PHARMACOL THER, V83, P265, DOI 10.1038/sj.clpt.6100269; Kiser JJ, 2008, JAIDS-J ACQ IMM DEF, V47, P298, DOI 10.1097/QAI.0b013e31815e7478; Kohler JJ, 2009, LAB INVEST, V89, P513, DOI 10.1038/labinvest.2009.14; Kurata Y, 2002, CLIN PHARMACOL THER, V72, P209, DOI 10.1067/mcp.2002.126177; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lucas GM, 2014, CLIN INFECT DIS; Lucas GM, 2014, CLIN INFECT DIS, V59, pE96, DOI 10.1093/cid/ciu617; Manosuthi W, 2014, J ANTIMICROB CHEMOTH, V69, P2195, DOI 10.1093/jac/dku129; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Mocroft A, 2010, AIDS, V24, P1667, DOI 10.1097/QAD.0b013e328339fe53; Moss DM, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00248; Nelson MR, 2007, AIDS, V21, P1273, DOI 10.1097/QAD.0b013e3280b07b33; Neumanova Z, 2014, AIDS, V28, P9, DOI 10.1097/QAD.0000000000000112; Nishijima T, 2014, AIDS, V28, P1903, DOI 10.1097/QAD.0000000000000347; Nishijima T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029977; Nishijima T, 2012, CLIN INFECT DIS, V55, P1558, DOI 10.1093/cid/cis772; Nishijima T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022661; Poizot-Martin I, 2013, JAIDS-J ACQ IMM DEF, V62, P375, DOI 10.1097/QAI.0b013e31827ce4ee; Pushpakom SP, 2011, J INFECT DIS, V204, P145, DOI 10.1093/infdis/jir215; Ray AS, 2006, ANTIMICROB AGENTS CH, V50, P3297, DOI 10.1128/AAC.00251-06; Rodriguez-Novoa S, 2009, PHARMACOGENOMICS, V10, P1675, DOI 10.2217/PGS.09.115; Rodriguez-Novoa S, 2009, CLIN INFECT DIS, V48, pE108, DOI 10.1086/598507; Roldan V, 2013, AM J CARDIOL, V111, P1159, DOI 10.1016/j.amjcard.2012.12.045; Ryom L, 2013, J INFECT DIS, V207, P1359, DOI 10.1093/infdis/jit043; Sirirungsi W, 2015, JAIDS-J ACQ IMM DEF, V68, pE56, DOI 10.1097/QAI.0000000000000504; Verhelst D, 2002, AM J KIDNEY DIS, V40, P1331, DOI 10.1053/ajkd.2002.36924; World Health Organization, CONS GUID US ANT DRU; World Health Organization, 2014, POL BRIEF CONS GUID	41	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141931	10.1371/journal.pone.0141931	http://dx.doi.org/10.1371/journal.pone.0141931			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26535588	Green Published, gold, Green Submitted			2022-12-26	WOS:000364298400103
J	Ponnusamy, D; Clinkenbeard, KD				Ponnusamy, Duraisamy; Clinkenbeard, Kenneth D.			Role of Tellurite Resistance Operon in Filamentous Growth of Yersinia pestis in Macrophages	PLOS ONE			English	Article							ESCHERICHIA-COLI; SURVIVAL; REPLICATION; VIRULENCE; PLASMID; REGION; GENES; PERSISTENCE; DIVISION; STRESS	Background Yersinia pestis initiates infection by parasitism of host macrophages. In response to macrophage infections, intracellular Y. pestis can assume a filamentous cellular morphology which may mediate resistance to host cell innate immune responses. We previously observed the expression of Y. pestis tellurite resistance proteins TerD and TerE from the terZABCDE operon during macrophage infections. Others have observed a filamentous response associated with expression of tellurite resistance operon in Escherichia coli exposed to tellurite. Therefore, in this study we examine the potential role of Y. pestis tellurite resistance operon in filamentous cellular morphology during macrophage infections. Principal Findings In vitro treatment of Y. pestis culture with sodium tellurite (Na2TeO3) caused the bacterial cells to assume a filamentous phenotype similar to the filamentous phenotype observed during macrophage infections. A deletion mutant for genes terZAB abolished the filamentous morphologic response to tellurite exposure or intracellular parasitism, but without affecting tellurite resistance. However, a terZABCDE deletion mutant abolished both filamentous morphologic response and tellurite resistance. Complementation of the terZABCDE deletion mutant with terCDE, but not terZAB, partially restored tellurite resistance. When the terZABCDE deletion mutant was complemented with terZAB or terCDE, Y. pestis exhibited filamentous morphology during macrophage infections as well as while these complemented genes were being expressed under an in vitro condition. Further in E. coli, expression of Y. pestis terZAB, but not terCDE, conferred a filamentous phenotype. Conclusions These findings support the role of Y. pestis terZAB mediation of the filamentous response phenotype; whereas, terCDE confers tellurite resistance. Although the beneficial role of filamentous morphological responses by Y. pestis during macrophage infections is yet to be fully defined, it may be a bacterial adaptive strategy to macrophage associated stresses.	[Ponnusamy, Duraisamy; Clinkenbeard, Kenneth D.] Oklahoma State Univ, Ctr Vet Hlth Sci, Dept Vet Pathobiol, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater	Clinkenbeard, KD (corresponding author), Oklahoma State Univ, Ctr Vet Hlth Sci, Dept Vet Pathobiol, Stillwater, OK 74078 USA.	ken.clinkenbeard@okstate.edu			Center for Veterinary Heath Sciences, Oklahoma State University	Center for Veterinary Heath Sciences, Oklahoma State University	The study was funded by the Center for Veterinary Heath Sciences, Oklahoma State University.	Anantharaman V, 2012, MOL BIOSYST, V8, P3142, DOI 10.1039/c2mb25239b; Aradska J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078010; Bearden SW, 1997, INFECT IMMUN, V65, P1659, DOI 10.1128/IAI.65.5.1659-1668.1997; BRUBAKER RR, 1964, J INFECT DIS, V114, P13, DOI 10.1093/infdis/114.1.13; Chauhan A, 2006, J BACTERIOL, V188, P1856, DOI 10.1128/JB.188.5.1856-1865.2006; Comer JE, 2010, INFECT IMMUN, V78, P5086, DOI 10.1128/IAI.00256-10; Derbise A, 2003, FEMS IMMUNOL MED MIC, V38, P113, DOI 10.1016/S0928-8244(03)00181-0; Diacovich L, 2010, NAT REV MICROBIOL, V8, P117, DOI 10.1038/nrmicro2295; Flannagan RS, 2012, ANNU REV PATHOL-MECH, V7, P61, DOI 10.1146/annurev-pathol-011811-132445; Franks SE, 2014, INFECT IMMUN, V82, P1132, DOI 10.1128/IAI.01614-13; Grabenstein JP, 2006, INFECT IMMUN, V74, P3727, DOI 10.1128/IAI.00255-06; HALL PJ, 1974, INFECT IMMUN, V9, P1105, DOI 10.1128/IAI.9.6.1105-1113.1974; JANSSEN WA, 1969, SCIENCE, V163, P950, DOI 10.1126/science.163.3870.950; Justice SS, 2008, NAT REV MICROBIOL, V6, P162, DOI 10.1038/nrmicro1820; Khlebnikov A, 2000, J BACTERIOL, V182, P7029, DOI 10.1128/JB.182.24.7029-7034.2000; Kumar Y, 2009, CELL HOST MICROBE, V5, P593, DOI 10.1016/j.chom.2009.05.014; Liu MF, 1999, FEMS MICROBIOL LETT, V174, P385; Lukaszewski RA, 2005, INFECT IMMUN, V73, P7142, DOI 10.1128/IAI.73.11.7142-7150.2005; Oyston PCF, 2000, INFECT IMMUN, V68, P3419, DOI 10.1128/IAI.68.6.3419-3425.2000; Perez JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000211; Ponnusamy D, 2011, THESIS; Ponnusamy D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042211; Ponnusamy D, 2011, VET MICROBIOL, V150, P146, DOI 10.1016/j.vetmic.2010.12.025; Pujol C, 2005, P NATL ACAD SCI USA, V102, P12909, DOI 10.1073/pnas.0502849102; Pujol C, 2009, INFECT IMMUN, V77, P2251, DOI 10.1128/IAI.00068-09; Pujol U, 2005, CLIN IMMUNOL, V114, P216, DOI 10.1016/j.clim.2004.07.013; Rosenberger CM, 2002, J BIOL CHEM, V277, P18753, DOI 10.1074/jbc.M110649200; Sebbane F, 2005, AM J PATHOL, V166, P1427, DOI 10.1016/S0002-9440(10)62360-7; SLATER M, 1974, BACTERIOL REV, V38, P199, DOI 10.1128/MMBR.38.2.199-221.1974; Spinner JL, 2014, J LEUKOCYTE BIOL, V95, P389, DOI 10.1189/jlb.1112551; STRALEY SC, 1984, INFECT IMMUN, V45, P649, DOI 10.1128/IAI.45.3.649-654.1984; Taylor DE, 1999, TRENDS MICROBIOL, V7, P111, DOI 10.1016/S0966-842X(99)01454-7; Toptchieva A, 2003, MICROBIOL-SGM, V149, P1285, DOI 10.1099/mic.0.25981-0; Tremaroli V, 2009, APPL ENVIRON MICROB, V75, P719, DOI 10.1128/AEM.01771-08; Trutko SM, 2000, ARCH MICROBIOL, V173, P178, DOI 10.1007/s002039900123; Valkova D, 2007, CENT EUR J BIOL, V2, P182, DOI 10.2478/s11535-007-0019-9; Valkovicova L, 2013, ANTON LEEUW INT J G, V104, P899, DOI 10.1007/s10482-013-0009-z; Vavrova S, 2006, BIOMETALS, V19, P453, DOI 10.1007/s10534-005-4862-8; WALTER EG, 1991, J BACTERIOL, V173, P1111, DOI 10.1128/jb.173.3.1111-1119.1991; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; Whelan KF, 1997, J BACTERIOL, V179, P63, DOI 10.1128/jb.179.1.63-71.1997; Wimsatt J, 2009, J VECTOR DIS, V46, P85; Zannoni D, 2008, ADV MICROB PHYSIOL, V53, P1, DOI 10.1016/S0065-2911(07)53001-8; Zhou DS, 2006, MICROBES INFECT, V8, P2669, DOI 10.1016/j.micinf.2006.07.015	44	15	15	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141984	10.1371/journal.pone.0141984	http://dx.doi.org/10.1371/journal.pone.0141984			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536670	Green Published, Green Submitted, gold			2022-12-26	WOS:000364298400111
J	Tian, M; Miao, HM; Shen, Y; Gao, J; Mo, XF; Zhou, XT				Tian, Mi; Miao, Huamao; Shen, Yang; Gao, Jian; Mo, Xiaofen; Zhou, Xingtao			Intra- and Intersession Repeatability of an Optical Quality and Intraocular Scattering Measurement System in Children	PLOS ONE			English	Article							IN-SITU KERATOMILEUSIS; RETINAL IMAGE QUALITY; CLINICAL-EVALUATION; GRADING NUCLEAR; PENTACAM; ABERRATIONS; OPACITY; EYES	Purpose To evaluate intra-and intersession repeatability of objective optical quality and intraocular scattering measurements with a double-pass system in children. Methods Forty-two eyes of 42 children were included in the study. An optical quality analysis system (OQAS) was used to measure optical quality parameters, including modulation transfer function cutoff frequency (MTFcutoff), Strehl ratio (SR), OQAS values (OV) at 3 different contrasts and objective scatter index (OSI). Three measurement sessions with 10-min intervals were operated by the same technician, and in each session four consecutive measurements were obtained. Results Mean values for MTFcutoff, SR and OSI were 46.85 +/- 7.45cpd, 0.27 +/- 0.06 and 0.34 +/- 0.22 respectively. 1) The intraclass correlation coefficients were ranged from 0.89 to 0.97 and coefficients of variation from 0.06 to 0.16 for all the parameters in the first session; the relative repeatability were 11.1% (MTFcutoff), 22.5% (SR), 10.9% (OV100%), 16.6% (OV2%), 22.4% (OV9%) and 56.3% (OSI). Similar results were found in the second and third sessions. 2) Bland-Altman analysis showed that narrow 95% confidence intervals (compared between the first and second sessions) ranged from -5.42 to 5.28 (MTFcutoff), -0.05 to 0.07 (SR), -0.18 to 0.18 (OV100%), -0.26 to 0.29 (OV20%), -0.33 to 0.39 (OV9%) and -0.11 to 0.09 (OSI); the comparison between any two of the three sessions showed similar results. Conclusion Measurements of optical quality and intraocular scattering in children by the double-pass system showed good intra- and intersession repeatability. Retinal image quality is high and intraocular scattering is low in children.	[Tian, Mi; Miao, Huamao; Shen, Yang; Mo, Xiaofen; Zhou, Xingtao] Fudan Univ, Dept Ophthalmol, Eye & ENT Hosp, Myopia Key Lab,Hlth Minist, Shanghai 200433, Peoples R China; [Gao, Jian] Fudan Univ, Ctr Clin Epidemiol & Evidence Based Med, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Mo, XF (corresponding author), Fudan Univ, Dept Ophthalmol, Eye & ENT Hosp, Myopia Key Lab,Hlth Minist, Shanghai 200433, Peoples R China.	xfmo@fudan.edu.cn; xingtaozhou@163.com	Shen, Yang/R-3539-2016; zhou, xt/GWZ-9212-2022	Shen, Yang/0000-0002-5859-0790; 	Key Project of Science and Technology of Shanghai [11JC1402000]; Shanghai Municipal Education Comission [12SG04]	Key Project of Science and Technology of Shanghai; Shanghai Municipal Education Comission(Shanghai Municipal Education Commission (SHMEC))	This work was funded by the Key Project of Science and Technology of Shanghai (Grant No. 11JC1402000) and the Shanghai Municipal Education Comission (Grant No. 12SG04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldebasi HI, 2013, SAUDI J OPHTHALMOL, V27, P253, DOI 10.1016/j.sjopt.2013.07.007; Anera RG, 2011, J REFRACT SURG, V27, P597, DOI 10.3928/1081597X-20110303-01; Artal P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016823; Bland JM, 1996, BRIT MED J, V313, P41, DOI 10.1136/bmj.313.7048.41; Bland JM, 1996, BRIT MED J, V313, P744; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Cabot F, 2013, AM J OPHTHALMOL, V155, P629, DOI 10.1016/j.ajo.2012.11.005; Chen D, 2009, CLIN EXP OPTOM, V92, P110, DOI 10.1111/j.1444-0938.2008.00336.x; de Juan V, 2014, CONTACT LENS ANTERIO, V37, P278, DOI 10.1016/j.clae.2014.02.003; Diaz-Douton F, 2006, INVEST OPHTH VIS SCI, V47, P1710, DOI 10.1167/iovs.05-1049; Gispets J, 2002, OPHTHAL PHYSL OPT, V22, P221, DOI 10.1046/j.1475-1313.2002.00021.x; Gobbe M, 2002, J REFRACT SURG, V18, pS567; Guell JL, 2004, J CATARACT REFR SURG, V30, P1598, DOI 10.1016/j.jcrs.2004.04.031; He JC, 2002, VISION RES, V42, P1063, DOI 10.1016/S0042-6989(02)00035-4; Kamiya K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066846; Kamiya K, 2012, CURR EYE RES, V37, P884, DOI 10.3109/02713683.2012.688164; Kamiya K, 2012, INVEST OPHTH VIS SCI, V53, P3161, DOI 10.1167/iovs.12-9650; Kobashi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082427; Lackner B, 2005, OPTOMETRY VISION SCI, V82, P892, DOI 10.1097/01.opx.0000180817.46312.0a; Li T, 2012, CLIN EXP OPTOM, V95, P399, DOI 10.1111/j.1444-0938.2012.00739.x; Martinez-Roda JA, 2011, CLIN EXP OPTOM, V94, P223, DOI 10.1111/j.1444-0938.2010.00535.x; Miao HM, 2014, J REFRACT SURG, V30, P296, DOI 10.3928/1081597X-20140415-02; Ondategui JC, 2012, J CATARACT REFR SURG, V38, P16, DOI 10.1016/j.jcrs.2011.07.037; Ortiz D, 2008, J CATARACT REFR SURG, V34, P1345, DOI 10.1016/j.jcrs.2008.04.022; Saad A, 2010, J CATARACT REFR SURG, V36, P28, DOI 10.1016/j.jcrs.2009.07.033; Shankar H, 2008, J CATARACT REFR SURG, V34, P103, DOI 10.1016/j.jcrs.2007.09.013; Tomas J, 2012, CLIN EXP OPTOM, V95, P60, DOI 10.1111/j.1444-0938.2011.00660.x; Torrents A, 1997, OPHTHAL PHYSL OPT, V17, P357, DOI 10.1111/j.1475-1313.1997.tb00067.x; Vilaseca M, 2012, BRIT J OPHTHALMOL, V96, P1204, DOI 10.1136/bjophthalmol-2011-301055; Vilaseca M, 2010, J CATARACT REFR SURG, V36, P1945, DOI 10.1016/j.jcrs.2010.05.029; Vilaseca M, 2010, OPTOMETRY VISION SCI, V87, P675, DOI 10.1097/OPX.0b013e3181ea1ad3	31	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142189	10.1371/journal.pone.0142189	http://dx.doi.org/10.1371/journal.pone.0142189			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536120	gold, Green Submitted, Green Published			2022-12-26	WOS:000364298400142
J	Collinson, S; Khan, K; Heffernan, JM				Collinson, Shannon; Khan, Kamran; Heffernan, Jane M.			The Effects of Media Reports on Disease Spread and Important Public Health Measurements	PLOS ONE			English	Article							EPIDEMIC; TRANSMISSION; MODEL; DESENSITIZATION; COMMUNICATION; VACCINATION; VIOLENCE	Controlling the spread of influenza to reduce the effects of infection on a population is an important mandate of public health. Mass media reports on an epidemic or pandemic can provide important information to the public, and in turn, can induce positive healthy behaviour practices (i.e., handwashing, social distancing) in the individuals, that will reduce the probability of contracting the disease. Mass media fatigue, however, can dampen these effects. Mathematical models can be used to study the effects of mass media reports on epidemic/pandemic outcomes. In this study we employ a stochastic agent based model to provide a quantification of mass media reports on the variability in important public health measurements. We also include mass media report data compiled by the Global Public Health Intelligence Network, to study the effects of mass media reports in the 2009 H1N1 pandemic. We find that the report rate and the rate at which individuals relax their healthy behaviours (media fatigue) greatly affect the variability in important public health measurements. When the mass media reporting data is included in the model, two peaks of infection result.	[Collinson, Shannon; Heffernan, Jane M.] York Univ, Ctr Dis Modelling, Modelling Infect & Immun Lab, Toronto, ON M3J 2R7, Canada; [Collinson, Shannon; Heffernan, Jane M.] York Univ, Math & Stat, Toronto, ON M3J 2R7, Canada; [Khan, Kamran] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Khan, Kamran] Univ Toronto, Dept Med, Div Infect Dis, Toronto, ON, Canada	York University - Canada; York University - Canada; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Heffernan, JM (corresponding author), York Univ, Ctr Dis Modelling, Modelling Infect & Immun Lab, Toronto, ON M3J 2R7, Canada.	jmheffer@yorku.ca			Natural Science and Engineering Research Council of Canada; Ontario Ministry of Research and Innovation; Mitacs	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Mitacs	This study was supported by the Natural Science and Engineering Research Council of Canada, the Ontario Ministry of Research and Innovation, and Mitacs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LJS, 2008, LECT NOTES MATH, V1945, P81, DOI 10.1007/978-3-540-78911-6_3; [Anonymous], 2006, HIGHLIGHTS CANADIAN; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; Breban R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028300; Catalan-Matamoros D., 2011, HLTH MANAGEMENT DIFF, P296; Collinson S, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-376; Cui JA, 2008, ROCKY MT J MATH, V38, P1323, DOI 10.1216/RMJ-2008-38-5-1323; Cui JG, 2008, J DYN DIFFER EQU, V20, P31, DOI 10.1007/s10884-007-9075-0; Fanti KA, 2009, AGGRESSIVE BEHAV, V35, P179, DOI 10.1002/ab.20295; Funk S, 2014, NATURE, V515, P493, DOI 10.1038/515492b; Gojovic MZ, 2009, CAN MED ASSOC J, V181, P673, DOI 10.1503/cmaj.091641; GRIFFITHS MD, 1989, NEW IDEAS PSYCHOL, V7, P85, DOI 10.1016/0732-118X(89)90039-1; Heffernan JM, 2005, J R SOC INTERFACE, V2, P281, DOI 10.1098/rsif.2005.0042; Hornik R.C., 2002, PUBLIC HLTH COMMUNIC; Husemann S, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1742-1; Jackson C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097297; Jung M, 2013, VACCINE, V31, P4860, DOI 10.1016/j.vaccine.2013.07.068; Kelso JK, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-117; Kerho S, 2010, MACROSOCIAL DETERMIN; Khan K, 2013, B WORLD HEALTH ORGAN, V91, P368, DOI 10.2471/BLT.12.114777; Kinnick KN, 1996, JOURNALISM MASS COMM, V73, P687, DOI 10.1177/107769909607300314; Laskowski M., 2015, BIOMAT 2014 P; Lau JTF, 2003, J EPIDEMIOL COMMUN H, V57, P864, DOI 10.1136/jech.57.11.864; Li YF, 2008, ROCKY MT J MATH, V38, P1437, DOI 10.1216/RMJ-2008-38-5-1437; Liu R., 2007, COMP MATH MATH PHYS, V8, P153, DOI [10.1080/17486700701425870, DOI 10.1080/17486700701425870]; Majumder Maimuna S, 2015, PLoS Curr, V7, DOI 10.1371/currents.outbreaks.e6659013c1d7f11bdab6a20705d1e865; McBurney DH, 1997, PHYSIOL BEHAV, V61, P181, DOI 10.1016/S0031-9384(96)00366-6; Merler S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002205; Misra AK, 2011, MATH COMPUT MODEL, V53, P1221, DOI 10.1016/j.mcm.2010.12.005; Mostaco-Guidolin LC, 2011, CANADIAN APPL MATH Q, P19; National Advisory Committee on Immunization (NACI), 2011, STAT SEAS INFL VACC; Pang JH, 2009, ICIC 2009: SECOND INTERNATIONAL CONFERENCE ON INFORMATION AND COMPUTING SCIENCE, VOL 3, PROCEEDINGS, P116, DOI 10.1109/ICIC.2009.235; Pourbohloul B, 2009, INFLUENZA OTHER RESP, V3, P215, DOI 10.1111/j.1750-2659.2009.00100.x; Public Health Agency of Canada (PHAC), FLUWATCH REP; Roth D., 2011, SOCIAL DISTANCING PA; Samanta S, 2013, APPL MATH COMPUT, V219, P6965, DOI 10.1016/j.amc.2013.01.009; Schabas R, 2009, THE GLOBE AND MAIL; Schweitzer F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001458; Smith KC, 2013, INFLUENZA OTHER RESP, V7, P847, DOI 10.1111/irv.12073; Sun CJ, 2011, MATH BIOSCI, V230, P87, DOI 10.1016/j.mbs.2011.01.005; Tchuenche JM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S1-S5; Viswanath K., 2007, MACROSOCIAL DETERMIN, P275, DOI DOI 10.1007/978-0-387-70812-6_13; Wakefield MA, 2011, HEALTH EDUC RES, V26, P988, DOI 10.1093/her/cyr054; Wakefield MA, 2010, LANCET, V376, P1261, DOI 10.1016/S0140-6736(10)60809-4; Wang Q, 2015, DISCRETE CONT DYN-B, V20, P215, DOI 10.3934/dcdsb.2015.20.215; Weaver LR, 2003, CHINA SARS NUMBERS P; Xiao DM, 2007, MATH BIOSCI, V208, P419, DOI 10.1016/j.mbs.2006.09.025; Xiao YN, 2015, SCI REP-UK, V5, DOI 10.1038/srep07838; Yuan XP, 2013, CHAOS SOLITON FRACT, V48, P1, DOI 10.1016/j.chaos.2012.12.001	49	68	73	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141423	10.1371/journal.pone.0141423	http://dx.doi.org/10.1371/journal.pone.0141423			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV1QH	26528909	Green Submitted, Green Published, gold			2022-12-26	WOS:000364032600028
J	Duran, BOD; Fernandez, GJ; Mareco, EA; Moraes, LN; Salomao, RAS; de Paula, TG; Santos, VB; Carvalho, RF; Dal-Pai-Silvca, M				da Silva Duran, Bruno Oliveira; Fernandez, Geysson Javier; Mareco, Edson Assuncao; Moraes, Leonardo Nazario; Simoes Salomao, Rondinelle Artur; de Paula, Tassiana Gutierrez; Santos, Vander Bruno; Carvalho, Robson Francisco; Dal-Pai-Silvca, Maeli			Differential microRNA Expression in Fast- and Slow-Twitch Skeletal Muscle of Piaractus mesopotamicus during Growth	PLOS ONE			English	Article							QUANTITATIVE EXPRESSION; GENE-EXPRESSION; PROLIFERATION; PAX7; PREDICTION; MYOGENIN; CELLS; MYOD; ACT	Pacu (Piaractus mesopotamicus) is a Brazilian fish with a high economic value in pisciculture due to its rusticity and fast growth. Postnatal growth of skeletal muscle in fish occurs by hyperplasia and/or hypertrophy, processes that are dependent on the proliferation and differentiation of myoblasts. A class of small noncoding RNAs, known as microRNAs (miRNAs), represses the expression of target mRNAs, and many studies have demonstrated that miR-1, miR-133, miR-206 and miR-499 regulate different processes in skeletal muscle through the mRNA silencing of hdac4 (histone deacetylase 4), srf (serum response factor), pax7 (paired box 7) and sox6 ((sex determining region Y)-box 6), respectively. The aim of our work was to evaluate the expression of these miRNAs and their putative target mRNAs in fast-and slow-twitch skeletal muscle of pacu during growth. We used pacus in three different development stages: larval (aged 30 days), juvenile (aged 90 days and 150 days) and adult (aged 2 years). To complement our study, we also performed a pacu myoblast cell culture, which allowed us to investigate miRNA expression in the progression from myoblast proliferation to differentiation. Our results revealed an inverse correlation between the expression of the miRNAs and their target mRNAs, and there was evidence that miR-1 and miR-206 may regulate the differentiation of myoblasts, whereas miR-133 may regulate the proliferation of these cells. miR-499 was highly expressed in slow-twitch muscle, which suggests its involvement in the specification of the slow phenotype in muscle fibers. The expression of these miRNAs exhibited variations between different development stages and between distinct muscle twitch phenotypes. This work provides the first identification of miRNA expression profiles in pacu skeletal muscle and suggests an important role of these molecules in muscle growth and in the maintenance of the muscle phenotype.	[da Silva Duran, Bruno Oliveira; Fernandez, Geysson Javier; Mareco, Edson Assuncao; Moraes, Leonardo Nazario; de Paula, Tassiana Gutierrez; Carvalho, Robson Francisco; Dal-Pai-Silvca, Maeli] Sao Paulo State Univ, Inst Biosci Botucatu, Dept Morphol, Botucatu, SP, Brazil; [Simoes Salomao, Rondinelle Artur] Sao Paulo State Univ, Aquaculture Ctr, Jaboticabal, SP, Brazil; [Santos, Vander Bruno] Sao Paulo Agcy Agribusiness Technol, Presidente Prudente, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista	Dal-Pai-Silvca, M (corresponding author), Sao Paulo State Univ, Inst Biosci Botucatu, Dept Morphol, Botucatu, SP, Brazil.	maeli@ibb.unesp.br	de Paula, Tassiana Gutierrez/L-2867-2017; de Moraes, Leonardo Nazario/F-8621-2012; Dal-Pai-Silva, Maeli/GLR-1413-2022; Fernandez, geysson javier/O-2783-2017; Carvalho, Robson Francisco/AAE-4134-2020; Fernandez, Geysson/AAT-9495-2021; Duran, Bruno/AAA-9977-2020	Fernandez, geysson javier/0000-0002-7982-9940; Carvalho, Robson Francisco/0000-0002-4901-7714; Duran, Bruno/0000-0002-7920-8175; Santos, Vander Bruno/0000-0003-1816-169X; Mareco, Edson/0000-0002-3504-6936; Dal Pai, Maeli/0000-0001-7269-9197; Fernandez, Geysson Javier/0000-0002-8493-1587; Moraes, Leonardo/0000-0003-4515-4137	Sao Paulo Research Foundation [2013/01892-2, 2013/10196-0]	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by grants from Sao Paulo Research Foundation (Process no 2013/01892-2 and Process no 2013/10196-0), http://www.fapesp.br/, to BOSD and MDPS.	Aguiar DH, 2008, AQUAC RES, V39, P1673, DOI 10.1111/j.1365-2109.2008.02042.x; de Almeida FLA, 2010, MICRON, V41, P997, DOI 10.1016/j.micron.2010.06.012; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bower NI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011100; Bower NI, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-80; Castagnolli N, 1986, PISCICULTURA NOS TRO; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen JF, 2010, J CELL BIOL, V190, P867, DOI 10.1083/jcb.200911036; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Froehlich JM, 2013, IN VITRO CELL DEV-AN, V49, P371, DOI 10.1007/s11626-013-9616-2; Gabillard JC, 2010, CELL TISSUE RES, V342, P471, DOI 10.1007/s00441-010-1071-8; Ge YJ, 2011, CELL CYCLE, V10, P441, DOI 10.4161/cc.10.3.14710; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hitachi Keisuke, 2013, Front Physiol, V4, P408, DOI 10.3389/fphys.2013.00408; Johansen KA, 2005, MAR BIOTECHNOL, V7, P576, DOI 10.1007/s10126-004-5133-3; Johnston IA, 2011, J EXP BIOL, V214, P1617, DOI 10.1242/jeb.038620; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McCarthy JJ, 2011, EXERC SPORT SCI REV, V39, P150, DOI 10.1097/JES.0b013e31821c01e1; Miska EA, 2001, NUCLEIC ACIDS RES, V29, P3439, DOI 10.1093/nar/29.16.3439; Miska EA, 1999, EMBO J, V18, P5099, DOI 10.1093/emboj/18.18.5099; Nachtigall PG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119804; Olson EN, 2000, CELL, V101, P689, DOI 10.1016/S0092-8674(00)80880-6; Oustanina S, 2004, EMBO J, V23, P3430, DOI 10.1038/sj.emboj.7600346; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Rowlerson A., 2001, Fish Physiology, V18, P103; Saenger A.M., 2001, Fish Physiology, V18, P187; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Soulez M, 1996, MOL CELL BIOL, V16, P6065; TREISMAN R, 1987, EMBO J, V6, P2711, DOI 10.1002/j.1460-2075.1987.tb02564.x; Urbinati E.C., 2005, ESPECIES NATIVAS PIS, P225; van Rooij E, 2008, TRENDS GENET, V24, P159, DOI 10.1016/j.tig.2008.01.007; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Vejnar CE, 2012, NUCLEIC ACIDS RES, V40, P11673, DOI 10.1093/nar/gks901; von Hofsten J, 2008, EMBO REP, V9, P683, DOI 10.1038/embor.2008.73; Wang XNH, 2013, CURR OPIN CLIN NUTR, V16, P258, DOI 10.1097/MCO.0b013e32835f81b9; Wang XG, 2011, DEVELOPMENT, V138, P4399, DOI 10.1242/dev.070516; Yan B, 2012, AQUACULTURE, V364, P240, DOI 10.1016/j.aquaculture.2012.08.018; Yan XC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030925; Zammit PS, 2006, J CELL SCI, V119, P1824, DOI 10.1242/jcs.02908	42	21	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141967	10.1371/journal.pone.0141967	http://dx.doi.org/10.1371/journal.pone.0141967			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529415	Green Published, Green Submitted, gold			2022-12-26	WOS:000364032600082
J	de Oliveira, RR; Melo, EC; Falavina, LP; Mathias, TAD				de Oliveira, Rosana Rosseto; Melo, Emiliana Cristina; Falavina, Larissa Pereira; de Freitas Mathias, Thais Aidar			The Growing Trend of Moderate Preterm Births: An Ecological Study in One Region of Brazil	PLOS ONE			English	Article							EPIDEMIOLOGY; RATES; STATE; RISK	Background Preterm birth is a serious public health problem, as it is linked to high rates of neonatal and child morbidity and mortality, with Brazil listed among the countries with the ten highest numbers of premature births. Nonetheless, knowledge is scarce regarding prematurity and associated factors in mid-sized cities. The objective of this study was to analyze the trend of preterm births and associated factors in a municipality located in the state of Parana, Brazil. Methods This was an ecological time series study of births recorded into the Live Birth Information System for residents of Maringa, Parana, Brazil, between 2000 and 2013. The polynomial regression model was used for trend analysis of preterm birth, characteristics of the mother, gestation and delivery, and newborn. The association with preterm birth was analyzed using odds ratio (OR). Results A total of 61,634 live births were analyzed, of which 5,632 were preterm births. Prematurity increased from 7.9% in 2000 to 11.2% in 2013-an average increase of 0.54% per year (r(2) = 0.93)-with a growing share of moderate preterm births (32 to < 37 weeks), which rose from 7.0% in 2000 to 9.7% in 2013. Between 2011 and 2013, multiple pregnancy (OR = 16.64; CI = 13.24-20.92), inadequate number of prenatal visits (OR = 2.81; CI = 2.51-3.15), Apgar score below 7 at 1 (OR = 4.07; CI = 3.55-4.67) and 5 minutes (OR = 10.88; CI = 7.71-15.36), low birth weight (OR = 38.75; CI = 33.72-44.55) and congenital malformations (OR = 3.18; CI = 2.14-4.74) were associated with preterm birth. A growing trend was observed for multiple pregnancies, with an average annual increase of 0.32% (r(2) = 0.90), as well as for C-section birth (2.38% yearly increase). Of all newborn characteristics, Apgar score below 7 at 5 minutes (-0.19% per year) and low birth weight (-1.43%) decreased, whereas congenital malformations rose (0.20% per year). Conclusions Efforts are required to prevent premature delivery, particularly during the moderate period, as well as greater care during the prenatal period towards expectant mothers bearing multiple pregnancies, birth defects, in addition to reducing C-section birth as it may be linked to preterm birth.	[de Oliveira, Rosana Rosseto] Univ Estadual Maringa, Grad Nursing Program, Dept Nursing, Maringa, Parana, Brazil; [Melo, Emiliana Cristina] Northern Parana State Univ, Dept Nursing, Bandeirantes, Parana, Brazil; [Falavina, Larissa Pereira] Univ Estadual Maringa, Sch Nursing, Nursing Program, Maringa, Parana, Brazil; [de Freitas Mathias, Thais Aidar] Univ Estadual Maringa, Dept Nursing, Publ Hlth, Maringa, Parana, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Maringa; Universidade Estadual de Maringa	de Oliveira, RR (corresponding author), Univ Estadual Maringa, Dept Nursing, Maringa, Parana, Brazil.	rosanarosseto@gmail.com	Falavina, Larissa Pereira/AAS-8519-2021; Oliveira, Rosana Rosseto/E-6193-2017	Falavina, Larissa Pereira/0000-0001-9158-6673; Oliveira, Rosana Rosseto/0000-0003-3373-1654	National Council for Scientific and Technological Development (CNPq) [473708/2012-4]	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was financed by the National Council for Scientific and Technological Development (CNPq), call 14/2012, process 473708/2012-4. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1985, LANCET, V2, P436; Brito VRS, 2010, REV RENE, V11, P27; Cheong JLY, 2012, J PAEDIATR CHILD H, V48, P784, DOI 10.1111/j.1440-1754.2012.02536.x; da Saude Ministerio, 2006, PRENATAL PUERPERIO A; da Saude Misterio, 2011, SECR VIG SAUD MAN IN; da Silva Gisele Ferreira, 2011, Rev Esc Enferm USP, V45, P79; Fujimori E, 2013, CAD SAUDE PUBLICA, V29, P145, DOI 10.1590/S0102-311X2013000100017; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Howson C, 2012, BORN TOO SOON GLOBAL; Instituto Paranaense de Desenvolvimento Economico e Social, 2014, PAR EM NUM; Johnson S, 2009, PEDIATRICS, V124, pE249, DOI 10.1542/peds.2008-3743; Lantos JD, 2011, ARAMBAM MAIMONIDES M, V2, pe0065; Lee SH, 2010, INT J NURS STUD, V47, P1159, DOI 10.1016/j.ijnurstu.2010.02.006; Moreira MEL, 2014, CIENC SAUDE COLETIVA, V19, P1981, DOI 10.1590/1413-81232014194.10182012; Lopez PO, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-26; Mcnally LZ, 2011, PERINATAL STAT SERIE, V25; Melo EC, 2013, CIENC CUID SAUDE, V12, P415; Ministerio da Saude, 2012, EST VIT NASC VIV; Vasconcelos AMN, 2012, EPIDEMIOL SERV SAUDE, V21, P539, DOI 10.5123/S1679-49742012000400003; Oliveira RR, REV PESQ CU IN PRESS; Ramos Helena Ângela de Camargo, 2009, Esc. Anna Nery, V13, P297; Silva AMR, 2009, CAD SAUDE PUBLICA, V25, P2125, DOI 10.1590/S0102-311X2009001000004; Shapiro-Mendoza CK, 2012, SEMIN FETAL NEONAT M, V17, P120, DOI 10.1016/j.siny.2012.01.007; Silveira Mariângela F, 2008, Rev. Saúde Pública, V42, P957, DOI 10.1590/S0034-89102008000500023; VanderWeele TJ, 2012, SOC SCI MED, V74, P196, DOI 10.1016/j.socscimed.2011.10.031; Victora CG, 2012, LANCET, V380, P1149, DOI 10.1016/S0140-6736(12)61427-5	26	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141852	10.1371/journal.pone.0141852	http://dx.doi.org/10.1371/journal.pone.0141852			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529097	Green Published, Green Submitted, gold			2022-12-26	WOS:000364032600069
J	Srinivas, C; Ramaiah, MJ; Lavanya, A; Yerramsetty, S; Kishor, PBK; Basha, SA; Kamal, A; Bhadra, U; Bhadra, MP				Srinivas, Chatla; Ramaiah, M. Janaki; Lavanya, A.; Yerramsetty, Suresh; Kishor, P. B. Kavi; Basha, Shaik Anver; Kamal, Ahmed; Bhadra, Utpal; Bhadra, Manika-Pal			Novel Etoposide Analogue Modulates Expression of Angiogenesis Associated microRNAs and Regulates Cell Proliferation by Targeting STAT3 in Breast Cancer	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; TUMOR ANGIOGENESIS; THERAPEUTIC TARGET; SIGNAL TRANSDUCER; MIR-16 INDUCE; COLON-CANCER; IN-VITRO; VEGF; BCL-2; APOPTOSIS	Tumor microenvironment play role in angiogenesis and carcinogenesis. Etoposide, a known topoisomerase II inhibitor induces DNA damage resulting in cell cycle arrest. We developed a novel Etoposide analogue, Quinazolino-4 beta-amidopodophyllotoxin (C-10) that show better efficacy in regulating cell proliferation and angiogenesis. We evaluated its role on expression of microRNAs-15, 16, 17 and 221 and its targets Bcl-2, STAT3 and VEGF that dictate cell proliferation and angiogenesis. Docking studies clearly demonstrated the binding of Etoposide and C-10 to STAT3. We conclude that combination of Etoposide or C-10 with miR-15, 16, 17 and 221 as a new approach to induce apoptosis and control angiogenesis in breast cancer.	[Srinivas, Chatla; Ramaiah, M. Janaki; Lavanya, A.; Yerramsetty, Suresh; Bhadra, Manika-Pal] CSIR Indian Inst Chem Technol, Ctr Chem Biol, Hyderabad, Andhra Pradesh, India; [Ramaiah, M. Janaki] SASTRA Univ, Sch Chem & Biotechnol, Thanjavur, India; [Kishor, P. B. Kavi] Osmania Univ, Dept Genet, Hyderabad 500007, Andhra Pradesh, India; [Basha, Shaik Anver; Kamal, Ahmed] CSIR Indian Inst Chem Technol, Med Chem & Pharmacol, Hyderabad, Andhra Pradesh, India; [Bhadra, Utpal] CSIR Ctr Cellular & Mol Biol, Funct Genom & Gene Silencing Grp, Hyderabad, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Shanmugha Arts, Science, Technology & Research Academy (SASTRA); Osmania University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Bhadra, MP (corresponding author), CSIR Indian Inst Chem Technol, Ctr Chem Biol, Hyderabad, Andhra Pradesh, India.	manika@iict.res.in	Chatla, Srinivas/AAA-9299-2020; RAMAIAH, JANAKI/AAL-9074-2020	Chatla, Srinivas/0000-0002-8509-8494; Ramaiah, Janaki/0000-0003-1814-2819	CSIR [CSC-0111]	CSIR(Council of Scientific & Industrial Research (CSIR) - India)	Funding: The entire work was supported by CSIR 12th Five Year Plan, Project-SMILE (CSC-0111). CS and AL thank CSIR for their fellowship.	Aggarwal BB, 2009, ANN NY ACAD SCI, V1171, P59, DOI 10.1111/j.1749-6632.2009.04911.x; Albasanz-Puig A, 2012, BIOCHEM BIOPH RES CO, V428, P179, DOI 10.1016/j.bbrc.2012.10.037; Ando H, 2013, J GENE MED, V15, P20, DOI 10.1002/jgm.2690; Auyeung KKW, 2012, ONCOL REP, V28, P2188, DOI 10.3892/or.2012.2056; Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Bellou S, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-35; Bhattacharya R, 2009, CANCER RES, V69, P9090, DOI 10.1158/0008-5472.CAN-09-2552; Bid HK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035513; Bossung V, 2010, CURR OPIN OBSTET GYN, V22, P79, DOI 10.1097/GCO.0b013e328334e462; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Chen HX, 2009, NAT REV CLIN ONCOL, V6, P465, DOI 10.1038/nrclinonc.2009.94; Choi HJ, 2012, BBA-MOL CELL RES, V1823, P1082, DOI 10.1016/j.bbamcr.2012.03.015; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Claesson-Welsh L, 2013, J INTERN MED, V273, P114, DOI 10.1111/joim.12019; Cohen SM, 2006, GENE DEV, V20, P2769, DOI 10.1101/gad.1484606; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fossey SL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-81; Gerber HP, 1998, J BIOL CHEM, V273, P13313, DOI 10.1074/jbc.273.21.13313; Guo CJ, 2009, J HEPATOL, V50, P766, DOI 10.1016/j.jhep.2008.11.025; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Huang W, 2014, ACS CHEM BIOL, V9, P1188, DOI 10.1021/cb500071v; Ihle MA, 2015, MOL ONCOL, V9, P1421, DOI 10.1016/j.molonc.2015.03.013; Jain RK, 2006, NAT CLIN PRACT ONCOL, V3, P24, DOI 10.1038/ncponc0403; Kamal A, 2013, BIOORGAN MED CHEM, V21, P6414, DOI 10.1016/j.bmc.2013.08.051; Kaneko T, 2007, CANCER RES, V67, P9685, DOI 10.1158/0008-5472.CAN-07-1497; Key TJ, 2001, LANCET ONCOL, V2, P133, DOI 10.1016/S1470-2045(00)00254-0; Kim Y, 2002, PLANTA MED, V68, P271, DOI 10.1055/s-2002-23140; Kumar A, 2012, BIOINFORMATION, V8, P988, DOI 10.6026/97320630008988; Li Haoran, 2014, Oncoscience, V1, P531; Melo S, 2011, P NATL ACAD SCI USA, V108, P4394, DOI 10.1073/pnas.1014720108; Mueller MD, 2000, P NATL ACAD SCI USA, V97, P10972, DOI 10.1073/pnas.200377097; Nahar S, 2014, CHEM COMMUN, V50, P4639, DOI 10.1039/c3cc49337g; Nathwani SM, 2013, ONCOL REP, V29, P585, DOI 10.3892/or.2012.2181; Nicoli S, 2012, DEV CELL, V22, P418, DOI 10.1016/j.devcel.2012.01.008; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; Panigrahy D, 2010, EXP THER MED, V1, P739, DOI 10.3892/etm.2010.127; Pidgeon GP, 2001, BRIT J CANCER, V85, P273, DOI 10.1054/bjoc.2001.1876; Porcu E, 2013, ANGIOGENESIS, V16, P647, DOI 10.1007/s10456-013-9343-z; Prudent R, 2013, BRIT J PHARMACOL, V168, P673, DOI 10.1111/j.1476-5381.2012.02230.x; Regis G, 2008, SEMIN CELL DEV BIOL, V19, P351, DOI 10.1016/j.semcdb.2008.06.004; Ren XA, 2009, BRIT J PHARMACOL, V156, P1228, DOI 10.1111/j.1476-5381.2009.00112.x; Repovic P, 2003, ONCOGENE, V22, P8117, DOI 10.1038/sj.onc.1206922; Scherr M, 2014, LEUKEMIA, V28, P554, DOI 10.1038/leu.2013.361; Schneider BP, 2007, NAT CLIN PRACT ONCOL, V4, P181, DOI 10.1038/ncponc0740; Shan G, 2008, NAT BIOTECHNOL, V26, P933, DOI 10.1038/nbt.1481; Shen J, 2012, PANCREATOLOGY, V12, P91, DOI 10.1016/j.pan.2012.02.008; Shi M, 2010, CANCER METAST REV, V29, P785, DOI 10.1007/s10555-010-9265-9; Shi Q, 2001, CANCER RES, V61, P4143; Shinkaruk S., 2003, Current Medicinal Chemistry - Anti-Cancer Agents, V3, P95, DOI 10.2174/1568011033353452; Spinetti G, 2013, CIRC RES, V112, DOI 10.1161/CIRCRESAHA.111.300418; Sun CY, 2013, CARCINOGENESIS, V34, P426, DOI 10.1093/carcin/bgs333; Takahashi Y, 1997, ARCH SURG-CHICAGO, V132, P541; TISCHER E, 1991, J BIOL CHEM, V266, P11947; van Schooneveld E, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0526-y; Vangala JR, 2014, J BIOL CHEM, V289, P12612, DOI 10.1074/jbc.M113.542829; Wei DY, 2003, ONCOGENE, V22, P319, DOI 10.1038/sj.onc.1206122; Xia L, 2008, INT J CANCER, V123, P372, DOI 10.1002/ijc.23501; Zushi SI, 1998, INT J CANCER, V78, P326, DOI 10.1002/(SICI)1097-0215(19981029)78:3<326::AID-IJC12>3.0.CO;2-4	60	15	16	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2015	10	11							e0142006	10.1371/journal.pone.0142006	http://dx.doi.org/10.1371/journal.pone.0142006			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7AC	26551008	gold, Green Submitted, Green Published			2022-12-26	WOS:000364422800013
J	Harasti, D; Lee, KA; Gallen, C; Hughes, JM; Stewart, J				Harasti, David; Lee, Kate A.; Gallen, Christopher; Hughes, Julian M.; Stewart, John			Movements, Home Range and Site Fidelity of Snapper (Chrysophrys auratus) within a Temperate Marine Protected Area	PLOS ONE			English	Article							NEW-SOUTH-WALES; PAGRUS-AURATUS; HABITAT UTILIZATION; REEF FISH; TEMPORAL VARIATION; ACOUSTIC TRACKING; PATTERNS; RESERVES; SPARIDAE; BEHAVIOR	Understanding the movement dynamics of marine fish provides valuable information that can assist with species management, particularly regarding protection within marine protected areas (MPAs). We performed an acoustic tagging study implemented within the Port Stephens-Great Lakes Marine Park on the mid-north coast of New South Wales, Australia, to assess the movement patterns, home range and diel activity of snapper (Chrysophrys auratus; Sparidae); a species of significant recreational and commercial fishing importance in Australia. The study focused on C. auratus movements around Cabbage Tree Island, which is predominantly a no-take sanctuary zone (no fishing), with an array of acoustic stations deployed around the island and adjacent reefs and islands. Thirty C. auratus were tagged with internal acoustic tags in November 2010 with their movements recorded until September 2014. Both adult and juvenile C. auratus were observed to display strong site fidelity to Cabbage Tree Island with a mean 12-month residency index of 0.83 (range = 0 low to 1 high). Only three fish were detected on acoustic receivers away from Cabbage Tree Island, with one fish moving a considerable distance of similar to 290 kms over a short time frame (46 days). The longest period of residency recorded at the island was for three fish occurring regularly at the site for a period of 1249 days. Chrysophrys auratus displayed strong diurnal behaviour and detection frequency was significantly higher during the day than at night; however, there was no significant difference in detection frequency between different hours. This study demonstrates that even small-scale protected areas can benefit C. auratus during multiple life-history stages as it maintains a small home range and displays strong site fidelity over a period of 3 years.	[Harasti, David; Gallen, Christopher] NSW Dept Primary Ind, Fisheries Res, Nelson Bay, NSW 2315, Australia; [Lee, Kate A.] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Hughes, Julian M.; Stewart, John] Sydney Inst Marine Sci, New South Wales Dept Primary Ind, Mosman, NSW 2088, Australia	NSW Department of Primary Industries; Macquarie University; NSW Department of Primary Industries; Sydney Institute of Marine Science	Harasti, D (corresponding author), NSW Dept Primary Ind, Fisheries Res, Nelson Bay, NSW 2315, Australia.	david.harasti@dpi.nsw.gov.au	Harasti, David/I-1266-2019; Stewart, John/N-7330-2016; Hughes, Julian/D-2695-2017	Harasti, David/0000-0002-2851-9838; Stewart, John/0000-0002-1435-0082; Hughes, Julian/0000-0002-0884-8386	NSW Recreational Fishing Trust [DPI60]	NSW Recreational Fishing Trust	This study was supported by NSW Recreational Fishing Trust (Project DPI60) (to JS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis D, 2012, J APPL ICHTHYOL, V28, P126, DOI 10.1111/j.1439-0426.2011.01795.x; Abecasis D, 2015, MAR ECOL PROG SER, V518, P255, DOI 10.3354/meps11054; Abecasis D, 2009, ESTUAR COAST SHELF S, V85, P525, DOI 10.1016/j.ecss.2009.09.001; Afonso P, 2008, MAR ECOL PROG SER, V359, P215, DOI 10.3354/meps07272; Afonso P, 2011, BIOL CONSERV, V144, P2739, DOI 10.1016/j.biocon.2011.07.028; Afonso P, 2009, MAR ECOL PROG SER, V381, P273, DOI 10.3354/meps07946; AGARDY MT, 1994, TRENDS ECOL EVOL, V9, P267, DOI 10.1016/0169-5347(94)90297-6; Alos J, 2011, MAR ECOL PROG SER, V427, P173, DOI 10.3354/meps09042; Babcock RC, 2010, P NATL ACAD SCI USA, V107, P18256, DOI 10.1073/pnas.0908012107; Banks SA, 2010, MAR POLICY, V34, P197, DOI 10.1016/j.marpol.2009.06.006; Barton K., 2012, MUMIN MULTIMODEL INF; Bates D., 2013, LME4 LINEAR MIXED EF; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Bond ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032983; Bruce BD, 2006, MAR BIOL, V150, P161, DOI 10.1007/s00227-006-0325-1; Bruce B. D., 2013, ACOUSTIC TRACKING AE; Bruce Barry D., 2012, P225; Bruce T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036687; Bryars S, 2012, MAR FRESHWATER RES, V63, P552, DOI 10.1071/MF12016; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Christie MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015715; Christie P, 2007, CORAL REEFS, V26, P1047, DOI 10.1007/s00338-007-0235-9; Coleman MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020168; CROSSLAND J, 1977, NEW ZEAL J MAR FRESH, V11, P37, DOI 10.1080/00288330.1977.9515660; Curley BG, 2013, REV FISH BIOL FISHER, V23, P435, DOI 10.1007/s11160-013-9309-7; Currey LM, 2014, MAR BIOL, V161, P2155, DOI 10.1007/s00227-014-2497-4; da Silva IM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0111774; Denny CM, 2004, MAR ECOL PROG SER, V272, P183, DOI 10.3354/meps272183; Di Franco A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031681; Edgar GJ, 2004, ENVIRON BIOL FISH, V70, P273, DOI 10.1023/B:EBFI.0000033342.89719.39; Edgar GJ, 2012, AUSTR MARINE LIFE; Edgar GJ, 2014, NATURE, V506, P216, DOI 10.1038/nature13022; Egli DP, 2004, ICES J MAR SCI, V61, P1137, DOI 10.1016/j.icesjms.2004.07.004; Ferguson AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065838; Ferrell D, 1996, ASSESSMENT FISHERY S; Francis M., 2012, COASTAL FISHES NZ; Gell FR, 2003, TRENDS ECOL EVOL, V18, P448, DOI 10.1016/S0169-5347(03)00189-7; Halpern BS, 2003, ECOL APPL, V13, pS117; HANSEN LP, 1993, ANIM BEHAV, V45, P927, DOI 10.1006/anbe.1993.1112; Harasti D, 2014, J APPL ICHTHYOL, V30, P1007, DOI 10.1111/jai.12446; Harasti D, 2014, J FISH BIOL, V85, P1413, DOI 10.1111/jfb.12492; Harasti D, 2015, J EXP MAR BIOL ECOL, V463, P173, DOI 10.1016/j.jembe.2014.12.003; Harrison HB, 2012, CURR BIOL, V22, P1023, DOI 10.1016/j.cub.2012.04.008; Hartill BW, 2003, MAR FRESHWATER RES, V54, P931, DOI 10.1071/MF02095; Heupel MR, 2006, MAR FRESHWATER RES, V57, P1, DOI 10.1071/MF05091; HILBORN R, 1990, CAN J FISH AQUAT SCI, V47, P635, DOI 10.1139/f90-071; HOLLAND KN, 1993, B MAR SCI, V52, P982; Hothorn T., 2010, MULTCOMP SIMULTANEOU; How JR, 2012, MAR FRESHWATER RES, V63, P312, DOI 10.1071/MF11194; Kelaher BP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085825; La Mesa G, 2013, HYDROBIOLOGIA, V720, P129, DOI 10.1007/s10750-013-1631-5; Lee KA, 2015, AQUAT CONSERV, V25, P174, DOI 10.1002/aqc.2431; Lester SE, 2008, MAR ECOL PROG SER, V367, P49, DOI 10.3354/meps07599; Lowe CG, 2003, MAR ECOL PROG SER, V256, P205, DOI 10.3354/meps256205; Lutcavage ME, 1999, CAN J FISH AQUAT SCI, V56, P173, DOI 10.1139/cjfas-56-2-173; Malcolm HA, 2007, MAR ECOL PROG SER, V350, P277, DOI 10.3354/meps07195; Malcolm HA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127616; Meyer CG, 2007, MAR ECOL PROG SER, V333, P13, DOI 10.3354/meps333013; Meyer CG, 2000, ENVIRON BIOL FISH, V59, P235, DOI 10.1023/A:1007664813814; Meyer CG, 2005, ENVIRON BIOL FISH, V73, P201, DOI 10.1007/s10641-005-0559-7; Molloy PP, 2009, J APPL ECOL, V46, P743, DOI 10.1111/j.1365-2664.2009.01662.x; Moran M, 2003, MAR FRESHWATER RES, V54, P913, DOI 10.1071/MF03012; Mumby PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008657; Nielsen JL, 2009, TAGGING TRACKING MAR; Norriss JV, 2012, MAR FRESHWATER RES, V63, P1191, DOI 10.1071/MF12077; Parsons DM, 2014, NEW ZEAL J MAR FRESH, V48, P256, DOI 10.1080/00288330.2014.892013; Parsons DM, 2011, CAN J FISH AQUAT SCI, V68, P632, DOI 10.1139/F11-005; Parsons DM, 2010, BIOL CONSERV, V143, P2039, DOI 10.1016/j.biocon.2010.05.009; Parsons DM, 2003, MAR ECOL PROG SER, V262, P253, DOI 10.3354/meps262253; Pastor J, 2009, CR BIOL, V332, P732, DOI 10.1016/j.crvi.2009.03.010; Pincock DG, 2011, FALSE DETECTIONS WHA; Pinheiro J, 2001, MIXED EFFECTS MODELS; Poulos DE, 2013, AQUAT CONSERV, V23, P838, DOI 10.1002/aqc.2362; R Core Development Team, 2009, R LANG ENV STAT COMP; Read AD, 2010, OCEAN COAST MANAGE, V53, P636, DOI 10.1016/j.ocecoaman.2010.08.003; Roberts C.M., 1991, Reviews in Fish Biology and Fisheries, V1, P65, DOI 10.1007/BF00042662; Roberts CM, 2001, SCIENCE, V294, P1920, DOI 10.1126/science.294.5548.1920; Russ GR, 2004, ECOL APPL, V14, P597, DOI 10.1890/03-5076; SCOTT SG, 1993, ENVIRON BIOL FISH, V36, P149, DOI 10.1007/BF00002794; Selig ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009278; Simpfendorfer CA, 2002, CAN J FISH AQUAT SCI, V59, P23, DOI 10.1139/F01-191; Smith ANH, 2014, MAR ECOL PROG SER, V499, P203, DOI 10.3354/meps10653; Squire Jr JL, 1974, REV CONTRIBUTED PA 2, P226; Stewart J, 2009, SIZE AGE SEXUAL MATU; Sumpton WD, 2003, MAR FRESHWATER RES, V54, P923, DOI 10.1071/MF02119; Terres MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136799; Topping DT, 2005, MAR BIOL, V147, P301, DOI 10.1007/s00227-005-1573-1; Villegas-Rios D, 2013, J SEA RES, V80, P61, DOI 10.1016/j.seares.2013.02.009; Wakefield CB, 2011, FISH RES, V109, P243, DOI 10.1016/j.fishres.2011.02.008; Willis TJ, 2001, NEW ZEAL J MAR FRESH, V35, P581, DOI 10.1080/00288330.2001.9517024; Zeller DC, 1998, CAN J FISH AQUAT SCI, V55, P917, DOI 10.1139/cjfas-55-4-917; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x; Zuur Alain F., 2009, P1	94	25	25	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142454	10.1371/journal.pone.0142454	http://dx.doi.org/10.1371/journal.pone.0142454			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544185	Green Submitted, Green Published, gold			2022-12-26	WOS:000364398700142
J	Manni, M; Gupta, S; Nixon, BG; Weaver, CT; Jessberger, R; Pernis, AB				Manni, Michela; Gupta, Sanjay; Nixon, Briana G.; Weaver, Casey T.; Jessberger, Rolf; Pernis, Alessandra B.			IRF4-Dependent and IRF4-Independent Pathways Contribute to DC Dysfunction in Lupus	PLOS ONE			English	Article							INTERFERON-REGULATORY FACTOR-4; HELPER-CELL-DIFFERENTIATION; DENDRITIC CELLS; TRANSCRIPTION-FACTOR; T-CELLS; B-CELLS; IRF4; AUTOIMMUNITY; SWAP-70; ERYTHEMATOSUS	Interferon Regulatory Factors (IRFs) play fundamental roles in dendritic cell (DC) differentiation and function. In particular, IRFs are critical transducers of TLR signaling and dysregulation in this family of factors is associated with the development of autoimmune disorders such as Systemic Lupus Erythematosus (SLE). While several IRFs are expressed in DCs their relative contribution to the aberrant phenotypic and functional characteristics that DCs acquire in autoimmune disease has not been fully delineated. Mice deficient in both DEF6 and SWAP-70 (= Double-knock-out or DKO mice), two members of a unique family of molecules that restrain IRF4 function, spontaneously develop a lupus-like disease. Although autoimmunity in DKO mice is accompanied by dysregulated IRF4 activity in both T and B cells, SWAP-70 is also known to regulate multiple aspects of DC biology leading us to directly evaluate DC development and function in these mice. By monitoring Blimp1 expression and IL-10 competency in DKO mice we demonstrate that DCs in these mice exhibit dysregulated IL-10 production, which is accompanied by aberrant Blimp1 expression in the spleen but not in the peripheral lymph nodes. We furthermore show that DCs from these mice are hyper-responsive to multiple TLR ligands and that IRF4 plays a differential role in in these responses by being required for the TLR4-mediated but not the TLR9-mediated upregulation of IL-10 expression. Thus, DC dysfunction in lupus-prone mice relies on both IRF4-dependent and IRF4-independent pathways.	[Manni, Michela; Gupta, Sanjay; Pernis, Alessandra B.] Hosp Special Surg, Autoimmun & Inflammat Program, New York, NY 10021 USA; [Nixon, Briana G.; Pernis, Alessandra B.] Weill Cornell Grad Sch Med Sci, Grad Program Immunol & Microbial Pathogenesis, New York, NY USA; [Weaver, Casey T.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Jessberger, Rolf] Tech Univ Dresden, Inst Physiol Chem, D-01062 Dresden, Germany; [Pernis, Alessandra B.] Cornell Univ, Weill Cornell Med Coll, Dept Med, New York, NY 10021 USA	Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; University of Alabama System; University of Alabama Birmingham; Technische Universitat Dresden; Cornell University	Pernis, AB (corresponding author), Hosp Special Surg, Autoimmun & Inflammat Program, 535 E 70th St, New York, NY 10021 USA.	pernisa@hss.edu		Nixon, Briana/0000-0001-7334-9404	National Institutes of Health [1R01AI083440, 1R01AR064883]; Alliance for Lupus Research; Peter Jay Sharp Foundation; David Z. Rosensweig Genomics Research Center; Kadmon Corporation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064883] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alliance for Lupus Research; Peter Jay Sharp Foundation; David Z. Rosensweig Genomics Research Center; Kadmon Corporation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institutes of Health 1R01AI083440 and 1R01AR064883, the Alliance for Lupus Research, the Peter Jay Sharp Foundation, and the David Z. Rosensweig Genomics Research Center (ABP). ABP also received funding from the Kadmon Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajana S, 2012, J IMMUNOL, V189, P3368, DOI 10.4049/jimmunol.1102613; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Biswas PS, 2012, J EXP MED, V209, P581, DOI 10.1084/jem.20111195; Biswas PS, 2010, J CLIN INVEST, V120, P3280, DOI 10.1172/JCI42856; Bollig N, 2012, P NATL ACAD SCI USA, V109, P8664, DOI 10.1073/pnas.1205834109; Boule MW, 2004, J EXP MED, V199, P1631, DOI 10.1084/jem.20031942; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Chen QZ, 2008, IMMUNITY, V29, P899, DOI 10.1016/j.immuni.2008.10.011; Cretney E, 2011, NAT IMMUNOL, V12, P304, DOI 10.1038/ni.2006; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Feng YB, 2014, EXPERT OPIN THER PAT, V24, P295, DOI 10.1517/13543776.2014.863279; Gao Y, 2013, IMMUNITY, V39, P722, DOI 10.1016/j.immuni.2013.08.028; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Glasmacher E, 2012, SCIENCE, V338, P975, DOI 10.1126/science.1228309; Gotz A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060642; Groux H, 2003, J AUTOIMMUN, V20, P281, DOI 10.1016/S0896-8411(03)00044-1; Helft J, 2015, IMMUNITY, V42, P1197, DOI 10.1016/j.immuni.2015.05.018; Honma K, 2008, P NATL ACAD SCI USA, V105, P15890, DOI 10.1073/pnas.0803171105; Isgro J, 2013, ARTHRITIS RHEUM-US, V65, P1592, DOI 10.1002/art.37934; Kim SJ, 2011, J EXP MED, V208, P2193, DOI 10.1084/jem.20110658; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Lech M, 2011, J AM SOC NEPHROL, V22, P1443, DOI 10.1681/ASN.2010121260; Li P, 2012, NATURE, V490, P543, DOI 10.1038/nature11530; Lohoff M, 2005, NAT REV IMMUNOL, V5, P125, DOI 10.1038/nri1552; Lohoff M, 2002, P NATL ACAD SCI USA, V99, P11808, DOI 10.1073/pnas.182425099; Lugt BV, 2014, NAT IMMUNOL, V15, P161, DOI 10.1038/ni.2795; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Maynard CL, 2007, NAT IMMUNOL, V8, P931, DOI 10.1038/ni1504; Oberbanscheidt P, 2007, EUR J CELL BIOL, V86, P13, DOI 10.1016/j.ejcb.2006.08.005; Ocana-Morgner C, 2013, J IMMUNOL, V190, P5545, DOI 10.4049/jimmunol.1203095; Ocana-Morgner C, 2011, J IMMUNOL, V186, P5345, DOI 10.4049/jimmunol.1003461; Ocana-Morgner C, 2009, BLOOD, V113, P1474, DOI 10.1182/blood-2008-04-152587; Persson EK, 2013, IMMUNITY, V38, P958, DOI 10.1016/j.immuni.2013.03.009; Rengarajan J, 2002, J EXP MED, V195, P1003, DOI 10.1084/jem.20011128; Rogatsky I, 2014, AUTOIMMUNITY, V47, P242, DOI 10.3109/08916934.2013.853050; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Salloum R, 2011, TRANSL RES, V157, P326, DOI 10.1016/j.trsl.2011.01.006; Santana-de Anda K, 2011, AUTOIMMUN REV, V11, P98, DOI 10.1016/j.autrev.2011.08.006; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Sciammas R, 2006, IMMUNITY, V25, P225, DOI 10.1016/j.immuni.2006.07.009; Sisirak V, 2014, J EXP MED, V211, P1969, DOI 10.1084/jem.20132522; Staudt V, 2010, IMMUNITY, V33, P192, DOI 10.1016/j.immuni.2010.07.014; Stirzaker RA, 2012, LUPUS, V21, P656, DOI 10.1177/0961203312436862; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Teichmann LL, 2015, IMMUNITY, V42, P552, DOI 10.1016/j.immuni.2015.02.015; Teichmann LL, 2012, J IMMUNOL, V188, P678, DOI 10.4049/jimmunol.1102456; Teichmann LL, 2010, IMMUNITY, V33, P967, DOI 10.1016/j.immuni.2010.11.025; Vistica BP, 2012, MOL VIS, V18, P1858; Watchmaker PB, 2014, NAT IMMUNOL, V15, P98, DOI 10.1038/ni.2768; Watkins AA, 2015, J IMMUNOL, V194, P1467, DOI 10.4049/jimmunol.1402807; Williams JW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3990; Yamamoto M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025812	53	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141927	10.1371/journal.pone.0141927	http://dx.doi.org/10.1371/journal.pone.0141927			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544714	Green Published, gold, Green Submitted			2022-12-26	WOS:000364398700064
J	Szigeti, A; Tatrai, E; Varga, BE; Szamosi, A; DeBuc, DC; Nagy, ZZ; Nemeth, J; Somfai, GM				Szigeti, Andrea; Tatrai, Erika; Varga, Boglarka Eniko; Szamosi, Anna; DeBuc, Delia Cabrera; Nagy, Zoltan Zsolt; Nemeth, Janos; Somfai, Gabor Mark			The Effect of Axial Length on the Thickness of Intraretinal Layers of the Macula	PLoS One			English	Article							OPTICAL COHERENCE TOMOGRAPHY; NERVE HEAD; CHOROIDAL THICKNESS; RETINAL THICKNESS; SEX; AGE; EYE; OCT; DETERMINANTS; PARAMETERS	Purpose The aim of this study was to evaluate the effect of axial length (AL) on the thickness of intraretinal layers in the macula using optical coherence tomography (OCT) image analysis. Methods Fifty three randomly selected eyes of 53 healthy subjects were recruited for this study. The median age of the participants was 29 years (range: 6 to 67 years). AL was measured for each eye using a Lenstar LS 900 device. OCT imaging of the macula was also performed by Stratus OCT. OCTRIMA software was used to process the raw OCT scans and to determine the weighted mean thickness of 6 intraretinal layers and the total retina. Partial correlation test was performed to assess the correlation between the AL and the thickness values. Results Total retinal thickness showed moderate negative correlation with AL (r = -0.378, p = 0.0007), while no correlation was observed between the thickness of the retinal nerve fiber layer (RNFL), ganglion cell layer (GCC), retinal pigment epithelium (RPE) and AL. Moderate negative correlation was observed also between the thickness of the ganglion cell layer and inner plexiform layer complex (GCL+ IPL), inner nuclear layer (INL), outer plexiform layer (OPL), outer nuclear layer (ONL) and AL which were more pronounced in the peripheral ring (r = -0.402, p = 0.004; r = -0.429, p = 0.002; r = -0.360, p = 0.01; r = -0.448, p = 0.001). Conclusions Our results have shown that the thickness of the nuclear layers and the total retina is correlated with AL. The reason underlying this could be the lateral stretching capability of these layers; however, further research is warranted to prove this theory. Our results suggest that the effect of AL on retinal layers should be taken into account in future studies.	[Szigeti, Andrea; Tatrai, Erika; Varga, Boglarka Eniko; Szamosi, Anna; Nagy, Zoltan Zsolt; Nemeth, Janos; Somfai, Gabor Mark] Semmelweis Univ, Dept Ophthalmol, H-1085 Budapest, Hungary; [DeBuc, Delia Cabrera; Somfai, Gabor Mark] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA	Semmelweis University; Bascom Palmer Eye Institute; University of Miami	Somfai, GM (corresponding author), Semmelweis Univ, Dept Ophthalmol, H-1085 Budapest, Hungary.	somfaigm@yahoo.com	Nagy, Zoltan Zsolt/T-6180-2017	Cabrera DeBuc, Delia/0000-0002-4726-894X; Somfai, Gabor Mark/0000-0001-6329-442X; Nemeth, Janos/0000-0001-8575-4888	Juvenile Diabetes Research Foundation Grant; NIH [NIH R01EY020607]; NIH Center [P30-EY014801]; Research to Prevent Blindness, Inc.; Helen Keller Foundation for Research and Education; Eotvos Scholarship of the Hungarian Scholarship Fund; Zsigmond Diabetes Fund of the Hungarian Academy of Sciences; NATIONAL EYE INSTITUTE [R01EY020607, P30EY014801] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation Grant(Juvenile Diabetes Research Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); Helen Keller Foundation for Research and Education; Eotvos Scholarship of the Hungarian Scholarship Fund; Zsigmond Diabetes Fund of the Hungarian Academy of Sciences; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported in part by a Juvenile Diabetes Research Foundation Grant, a NIH Grant No. NIH R01EY020607, a NIH Center Grant No. P30-EY014801, by an unrestricted grant to the University of Miami from Research to Prevent Blindness, Inc., by a research fellowship of the Helen Keller Foundation for Research and Education (GMS), the Eotvos Scholarship of the Hungarian Scholarship Fund, and by the Zsigmond Diabetes Fund of the Hungarian Academy of Sciences.	Abbott CJ, 2011, VISION RES, V51, P376, DOI 10.1016/j.visres.2010.12.005; ABDALLA MI, 1970, BRIT J OPHTHALMOL, V54, P122, DOI 10.1136/bjo.54.2.122; Amar Agarwal, 2012, PHACOEMULSIFICATION; ANDREASSEN TT, 1980, EXP EYE RES, V31, P435, DOI 10.1016/S0014-4835(80)80027-3; [Anonymous], 1991, OPHTHALMOL, V98, P741; Cheung CY, 2011, INVEST OPHTH VIS SCI, V52, P9629, DOI 10.1167/iovs.11-7481; Chou T, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/4/046001; DeBuc C., 2011, IMAGE SEG, V1, P15, DOI DOI 10.5772/628; Debuc DC, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3470116; DeBuc DC, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3268773; Demirkaya N, 2013, INVEST OPHTH VIS SCI, V54, P4934, DOI 10.1167/iovs.13-11913; Fernandez DC, 2005, OPT EXPRESS, V13, P10200, DOI 10.1364/OPEX.13.010200; Fledelius HC, 2014, ACTA OPHTHALMOL, V92, P259, DOI 10.1111/aos.12107; Franze K, 2011, SOFT MATTER, V7, P3147, DOI 10.1039/c0sm01017k; GUTHOFF R, 1984, OPHTHALMIC RES, V16, P289, DOI 10.1159/000265331; Huang D, 2012, INVEST OPHTH VIS SCI, V53, P4990, DOI 10.1167/iovs.11-8214; Huang JJ, 2011, OPHTHAL SURG LAS IM, V42, P216, DOI 10.3928/15428877-20110324-01; Ishikawa H, 2005, INVEST OPHTH VIS SCI, V46, P2012, DOI 10.1167/iovs.04-0335; Kashani AH, 2010, AM J OPHTHALMOL, V149, P496, DOI 10.1016/j.ajo.2009.09.025; Kelty PJ, 2008, INVEST OPHTH VIS SCI, V49, P2668, DOI 10.1167/iovs.07-1000; Knight OJ, 2012, ARCH OPHTHALMOL-CHIC, V130, P312, DOI 10.1001/archopthalmol.2011.1576; Koh VT, 2012, INVEST OPHTH VIS SCI, V53, P5853, DOI 10.1167/iovs.12-10414; Li XQ, 2011, INVEST OPHTH VIS SCI, V52, P8438, DOI 10.1167/iovs.11-8108; Massin P, 2001, ARCH OPHTHALMOL-CHIC, V119, P1135, DOI 10.1001/archopht.119.8.1135; Mwanza JC, 2011, INVEST OPHTH VIS SCI, V52, P7872, DOI 10.1167/iovs.11-7896; NEMETH J, 1992, ACTA OPHTHALMOL, V70, P353; Ooto S, 2011, INVEST OPHTH VIS SCI, V52, P8769, DOI 10.1167/iovs.11-8388; Puliafito Carmen A, 2010, Ophthalmic Surg Lasers Imaging, V41 Suppl, pS5, DOI 10.3928/15428877-20101031-20; Rao HL, 2011, INVEST OPHTH VIS SCI, V52, P1103, DOI 10.1167/iovs.10-5997; Read SA, 2011, OPTOMETRY VISION SCI, V88, P855, DOI 10.1097/OPX.0b013e3182186a36; Samarawickrama C, 2010, INVEST OPHTH VIS SCI, V51, P4471, DOI 10.1167/iovs.09-3892; Shahidi M, 2005, AM J OPHTHALMOL, V139, P1056, DOI 10.1016/j.ajo.2005.01.012; Silverman RH, 2009, CLIN EXP OPHTHALMOL, V37, P54, DOI 10.1111/j.1442-9071.2008.01892.x; Sogawa K, 2012, AM J OPHTHALMOL, V153, P1129, DOI 10.1016/j.ajo.2011.11.005; Somfai GM, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2774827; Song WK, 2010, INVEST OPHTH VIS SCI, V51, P3913, DOI 10.1167/iovs.09-4189; Tanna H, 2010, BRIT J OPHTHALMOL, V94, P372, DOI 10.1136/bjo.2009.163501; Tatrai E, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3573817; Tranquart F, 2003, J CLIN ULTRASOUND, V31, P258, DOI 10.1002/jcu.10169; Wagner-Schuman M, 2011, INVEST OPHTH VIS SCI, V52, P625, DOI 10.1167/iovs.10-5886; Wexler A, 2010, BMC OPHTHALMOL, V10, DOI 10.1186/1471-2415-10-13; Wolsley CJ, 2008, VISION RES, V48, P1554, DOI 10.1016/j.visres.2008.04.013; Wong ACM, 2005, EYE, V19, P292, DOI 10.1038/sj.eye.6701466	43	18	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142383	10.1371/journal.pone.0142383	http://dx.doi.org/10.1371/journal.pone.0142383			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544553	Green Published, gold, Green Submitted			2022-12-26	WOS:000364398700127
J	Chatterjee, T; Sheikh, IA; Chakravarty, D; Chakrabarti, P; Sarkar, P; Saha, T; Chakrabarti, MK; Hoque, KM				Chatterjee, Tanaya; Sheikh, Irshad Ali; Chakravarty, Devlina; Chakrabarti, Pinak; Sarkar, Paramita; Saha, Tultul; Chakrabarti, Manoj K.; Hoque, Kazi Mirajul			Effects of Small Molecule Calcium-Activated Chloride Channel Inhibitors on Structure and Function of Accessory Cholera Enterotoxin (Ace) of Vibrio cholerae	PLOS ONE			English	Article							SECRETION; DEGRADATION; TOXIN	Cholera pathogenesis occurs due to synergistic pro-secretory effects of several toxins, such as cholera toxin (CTX) and Accessory cholera enterotoxin (Ace) secreted by Vibrio cholerae strains. Ace activates chloride channels stimulating chloride/bicarbonate transport that augments fluid secretion resulting in diarrhea. These channels have been targeted for drug development. However, lesser attention has been paid to the interaction of chloride channel modulators with bacterial toxins. Here we report the modulation of the structure/function of recombinant Ace by small molecule calcium-activated chloride channel (CaCC) inhibitors, namely CaCCinh-A01, digallic acid (DGA) and tannic acid. Biophysical studies indicate that the unfolding (induced by urea) free energy increases upon binding CaCCinh-A01 and DGA, compared to native Ace, whereas binding of tannic acid destabilizes the protein. Far-UV CD experiments revealed that the alpha-helical content of Ace-CaCCinh-A01 and Ace-DGA complexes increased relative to Ace. In contrast, binding to tannic acid had the opposite effect, indicating the loss of protein secondary structure. The modulation of Ace structure induced by CaCC inhibitors was also analyzed using docking and molecular dynamics (MD) simulation. Functional studies, performed using mouse ileal loops and Ussing chamber experiments, corroborate biophysical data, all pointing to the fact that tannic acid destabilizes Ace, inhibiting its function, whereas DGA stabilizes the toxin with enhanced fluid accumulation in mouse ileal loop. The efficacy of tannic acid in mouse model suggests that the targeted modulation of Ace structure may be of therapeutic benefit for gastrointestinal disorders.	[Chatterjee, Tanaya; Chakravarty, Devlina; Chakrabarti, Pinak] Bose Inst, Dept Biochem, Kolkata 700054, India; [Sheikh, Irshad Ali; Sarkar, Paramita; Saha, Tultul; Chakrabarti, Manoj K.; Hoque, Kazi Mirajul] Natl Inst Cholera & Enter Dis, Div Mol Pathophysiol, Kolkata 700010, India	Department of Science & Technology (India); Bose Institute; Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED)	Chatterjee, T (corresponding author), Bose Inst, Dept Biochem, P1-12 CIT Scheme VIIM, Kolkata 700054, India.	tanaya_chatterjee@yahoo.com	Sheikh, Irshad/AAD-6196-2022; Kazi, Mirajul Hoque/AAR-5291-2021; CHAKRAVARTY, DEVLINA/E-2676-2018	CHAKRAVARTY, DEVLINA/0000-0002-7499-9553; Saha, Tultul/0000-0002-7913-9640	Department of Science and Technology, India [SR/WOS-A/LS-390/2011]; JC Bose National Fellowship [SR/S2/JCB-12/2006]; Department of Biotechnology [BT/HRD/35/02/07/2009]; Indian Council of Medical Research [3/1/3/JRF-2010/HRD-58(42194), 3/1/3/JRF-2013/HRD-045(4025)]	Department of Science and Technology, India(Department of Science & Technology (India)); JC Bose National Fellowship; Department of Biotechnology; Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	TC is supported by a DST Woman Scientist Grant from the Department of Science and Technology, India [SR/WOS-A/LS-390/2011] and PC by the JC Bose National Fellowship [SR/S2/JCB-12/2006]. KMH gratefully acknowledges financial support by Department of Biotechnology as a Ramalingaswami Fellow [BT/HRD/35/02/07/2009]. IAS thanka Indian Council of Medical Research for their funding [3/1/3/JRF-2010/HRD-58(42194), No. 3/1/3/JRF-2013/HRD-045(4025)].	Adcock SA, 2006, CHEM REV, V106, P1589, DOI 10.1021/cr040426m; Ai-Awqati Q, 2002, J CLIN INVEST, V110, P1599, DOI 10.1172/JCI200217301; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Barrett KE, 2000, ANNU REV PHYSIOL, V62, P535, DOI 10.1146/annurev.physiol.62.1.535; Bill A, 2014, J BIOL CHEM, V289, P11029, DOI 10.1074/jbc.M114.549188; Cantor C.R., 1980, BIOPHYSICAL CHEM 2; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chatterjee T, 2011, BIOCHEMISTRY-US, V50, P2962, DOI 10.1021/bi101673x; De la Fuente R, 2008, MOL PHARMACOL, V73, P758, DOI 10.1124/mol.107.043208; De SN, 2010, B WORLD HEALTH ORGAN, V88, P239, DOI 10.1002/path.1700660228; Field M, 2003, J CLIN INVEST, V111, P931, DOI 10.1172/JCI200318326; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; HERRINGTON DA, 1988, J EXP MED, V168, P1487, DOI 10.1084/jem.168.4.1487; Karaolis DK, 1988, P NATL ACAD SCI USA, V95, P3134; Li Y, 2006, BIOORGAN MED CHEM, V14, P1431, DOI 10.1016/j.bmc.2005.09.066; LINS L, 1995, FASEB J, V9, P535, DOI 10.1096/fasebj.9.7.7737462; McDonald I, 1993, HBPLUS COMPUTER PROG; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Namkung W, 2011, J BIOL CHEM, V286, P2365, DOI 10.1074/jbc.M110.175109; Namkung W, 2010, FASEB J, V24, P4178, DOI 10.1096/fj.10-160648; Neklesa TK, 2011, NAT CHEM BIOL, V7, P538, DOI [10.1038/NCHEMBIO.597, 10.1038/nchembio.597]; PACE CN, 1990, TRENDS BIOTECHNOL, V8, P93, DOI 10.1016/0167-7799(90)90146-O; Rastelli G, 2010, J COMPUT CHEM, V31, P797, DOI 10.1002/jcc.21372; Ren AX, 2012, DIGEST DIS SCI, V57, P99, DOI 10.1007/s10620-011-1821-9; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shahlaei M, 2011, BBA-BIOMEMBRANES, V1808, P802, DOI 10.1016/j.bbamem.2010.12.004; Sheikh IA, 2013, J BIOL CHEM, V288, P20404, DOI 10.1074/jbc.M113.467860; Thiagarajah JR, 2012, CLIN PHARMACOL THER, V92, P287, DOI 10.1038/clpt.2012.114; TRUCKSIS M, 1993, P NATL ACAD SCI USA, V90, P5267, DOI 10.1073/pnas.90.11.5267; Trucksis M, 2000, AM J PHYSIOL-CELL PH, V279, pC567, DOI 10.1152/ajpcell.2000.279.3.C567; Trucksis M., 2009, US Patent, Patent No. [US 7, 582, 424 B2, 7582424]; Verkman AS, 2009, NAT REV DRUG DISCOV, V8, P153, DOI 10.1038/nrd2780; Wachsmuth K., 1994, VIBRIO CHOLERAE CHOL; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005	35	5	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141283	10.1371/journal.pone.0141283	http://dx.doi.org/10.1371/journal.pone.0141283			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540279	Green Submitted, Green Published, gold			2022-12-26	WOS:000364303800015
J	Chen, YX; Zhou, T; Zhang, CC; Wang, K; Liu, J; Lu, JY; Xu, KW				Chen, Yuanxue; Zhou, Tao; Zhang, Chaochun; Wang, Ke; Liu, Jing; Lu, Junyu; Xu, Kaiwei			Rational Phosphorus Application Facilitates the Sustainability of the Wheat/Maize/Soybean Relay Strip Intercropping System	PLOS ONE			English	Article							INTERSPECIFIC INTERACTIONS; YIELD ADVANTAGE; MAIZE; WHEAT; PRODUCTIVITY; MANAGEMENT; ROTATIONS; RECOVERY; QUALITY; GROWTH	Wheat (Triticum aestivum L.)/maize (Zea mays L.)/soybean (Glycine max L.) relay strip intercropping (W/M/S) system is commonly used by the smallholders in the Southwest of China. However, little known is how to manage phosphorus (P) to enhance P use efficiency of the W/M/S system and to mitigate P leaching that is a major source of pollution. Field experiments were carried out in 2011, 2012, and 2013 to test the impact of five P application rates on yield and P use efficiency of the W/M/S system. The study measured grain yield, shoot P uptake, apparent P recovery efficiency (PRE) and soil P content. A linear-plateau model was used to determine the critical P rate that maximizes gains in the indexes of system productivity. The results show that increase in P application rates aggrandized shoot P uptake and crops yields at threshold rates of 70 and 71.5 kg P ha(-1) respectively. With P application rates increasing, the W/M/S system decreased the PRE from 35.9% to 12.3% averaged over the three years. A rational P application rate, 72 kg P ha(-1), or an appropriate soil Olsen-P level, 19.1 mg kg(-1), drives the W/M/S system to maximize total grain yield while minimizing P surplus, as a result of the PRE up to 28.0%. We conclude that rational P application is an important approach for relay intercropping to produce high yield while mitigating P pollution and the rational P application-based integrated P fertilizer management is vital for sustainable intensification of agriculture in the Southwest of China.	[Chen, Yuanxue; Zhou, Tao; Wang, Ke; Liu, Jing; Xu, Kaiwei] Sichuan Agr Univ, Coll Resource Sci, Dept Plant Nutr & Microbiol, Chengdu, Peoples R China; [Zhang, Chaochun] China Agr Univ, Dept Plant Nutr, Coll Resource & Environm Sci, Beijing 100094, Peoples R China; [Lu, Junyu] Yaan Agr Bur, Yaan, Peoples R China	Sichuan Agricultural University; China Agricultural University	Chen, YX (corresponding author), Sichuan Agr Univ, Coll Resource Sci, Dept Plant Nutr & Microbiol, Chengdu, Peoples R China.	cyxue2002@aliyun.com; xkwei@126.com			National Natural Science Foundation of China [31210103906]; National Maize Production System in China [CARS-02-24]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Maize Production System in China	This work was supported by the National Natural Science Foundation of China (31210103906) and the National Maize Production System in China (CARS-02-24).	Aulakh MS, 2003, FIELD CROP RES, V80, P99, DOI 10.1016/S0378-4290(02)00172-7; Blake G.R., 1986, METHODS SOIL ANAL, V5, P363, DOI DOI 10.2136/SSSABOOKSER5.1.2ED.C13; [陈晓辉 Chen Xiaohui], 2014, [植物营养与肥料学报, Journal of Plant Nutrition and Fertitizer], V20, P1127; Chen YuanXue, 2014, Acta Prataculturae Sinica, V23, P73; Cui ZL, 2013, GLOBAL CHANGE BIOL, V19, P2467, DOI 10.1111/gcb.12213; Erisman JW, 2008, ATMOS ENVIRON, V42, P3209, DOI 10.1016/j.atmosenv.2007.04.004; FAO, 2011, FAOSTAT DAT AGR PROD; Gao YJ, 2009, NUTR CYCL AGROECOSYS, V85, P109, DOI 10.1007/s10705-009-9252-0; Kihara J, 2010, EXP AGR, V46, P35, DOI 10.1017/S0014479709990810; Le C, 2010, ENVIRON MANAGE, V45, P662, DOI 10.1007/s00267-010-9440-3; Li H, 2011, PLANT SOIL, V349, P157, DOI 10.1007/s11104-011-0909-5; Li HG, 2010, BIOL FERT SOILS, V46, P79, DOI 10.1007/s00374-009-0411-x; Li L, 2006, OECOLOGIA, V147, P280, DOI 10.1007/s00442-005-0256-4; Li L, 2001, FIELD CROP RES, V71, P123, DOI 10.1016/S0378-4290(01)00156-3; Li L, 2007, P NATL ACAD SCI USA, V104, P11192, DOI 10.1073/pnas.0704591104; Li L, 2011, SOIL SCI PLANT NUTR, V57, P61, DOI 10.1080/00380768.2010.548307; Li QZ, 2011, PLANT SOIL, V339, P147, DOI 10.1007/s11104-010-0561-5; Ma L, 2010, J ENVIRON QUAL, V39, P1279, DOI 10.2134/jeq2009.0403; Ma WQ, 2011, CHEMOSPHERE, V84, P814, DOI 10.1016/j.chemosphere.2011.04.055; Mao LL, 2012, FIELD CROP RES, V138, P11, DOI 10.1016/j.fcr.2012.09.019; Mei PP, 2012, FIELD CROP RES, V130, P19, DOI 10.1016/j.fcr.2012.02.007; Motta SR, 2013, EUR J AGRON, V45, P59, DOI 10.1016/j.eja.2012.10.007; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Robertson GP, 2009, ANNU REV ENV RESOUR, V34, P97, DOI 10.1146/annurev.environ.032108.105046; Schindler DW, 2008, P NATL ACAD SCI USA, V105, P11254, DOI 10.1073/pnas.0805108105; Tang X, 2009, PLANT SOIL, V323, P143, DOI 10.1007/s11104-009-9919-y; Vandamme E, 2014, NUTR CYCL AGROECOSYS, V98, P187, DOI 10.1007/s10705-014-9605-1; Vitousek PM, 2009, SCIENCE, V324, P1519, DOI 10.1126/science.1170261; Xia HY, 2013, FIELD CROP RES, V154, P53, DOI 10.1016/j.fcr.2013.07.011; Xu JZ, 2013, SOIL TILL RES, V126, P169, DOI 10.1016/j.still.2012.07.005; Yang F, 2014, FIELD CROP RES, V155, P245, DOI 10.1016/j.fcr.2013.08.011; Yong TW, 2009, THESIS SICHUAN AGR U; Zhang FS, 2012, ADV AGRON, V116, P1, DOI 10.1016/B978-0-12-394277-7.00001-4; Zhang HM, 2010, NUTR CYCL AGROECOSYS, V88, P341, DOI 10.1007/s10705-010-9359-3; Zhang L, 2008, FIELD CROP RES, V107, P29, DOI 10.1016/j.fcr.2007.12.014; Zhang WF, 2008, NUTR CYCL AGROECOSYS, V80, P131, DOI 10.1007/s10705-007-9126-2; Zhang XB, 2004, CHINESE SCI BULL, V49, P1953, DOI 10.1360/04wd0106; [钟晓英 Zhong Xiaoying], 2004, [生态学报, Acta Ecologica Sinica], V24, P2275; Zingore S, 2008, NUTR CYCL AGROECOSYS, V80, P1, DOI 10.1007/s10705-007-9117-3	40	13	13	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141725	10.1371/journal.pone.0141725	http://dx.doi.org/10.1371/journal.pone.0141725			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540207	Green Submitted, Green Published, gold			2022-12-26	WOS:000364303800024
J	Jin, J; Kim, J				Jin, Junghwan; Kim, Jinsoo			Forecasting Natural Gas Prices Using Wavelets, Time Series, and Artificial Neural Networks	PLOS ONE			English	Article							CRUDE-OIL PRICE; TRANSFORM; ARIMA; MODEL; DECOMPOSITION; PERFORMANCE; PREDICTION	Following the unconventional gas revolution, the forecasting of natural gas prices has become increasingly important because the association of these prices with those of crude oil has weakened. With this as motivation, we propose some modified hybrid models in which various combinations of the wavelet approximation, detail components, autoregressive integrated moving average, generalized autoregressive conditional heteroskedasticity, and artificial neural network models are employed to predict natural gas prices. We also emphasize the boundary problem in wavelet decomposition, and compare results that consider the boundary problem case with those that do not. The empirical results show that our suggested approach can handle the boundary problem, such that it facilitates the extraction of the appropriate forecasting results. The performance of the wavelet-hybrid approach was superior in all cases, whereas the application of detail components in the forecasting was only able to yield a small improvement in forecasting performance. Therefore, forecasting with only an approximation component would be acceptable, in consideration of forecasting efficiency.	[Jin, Junghwan; Kim, Jinsoo] Hanyang Univ, Dept Nat Resources & Environm Engn, Seoul 133791, South Korea	Hanyang University	Kim, J (corresponding author), Hanyang Univ, Dept Nat Resources & Environm Engn, Seoul 133791, South Korea.	jinsookim@hanyang.ac.kr	Kim, Jinsoo/P-9559-2015	Kim, Jinsoo/0000-0001-6496-1714	Energy Efficiency & Resources Core Technology Program of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) from the Ministry of Trade, Industry & Energy, Republic of Korea [20152510101880]	Energy Efficiency & Resources Core Technology Program of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) from the Ministry of Trade, Industry & Energy, Republic of Korea	This work was supported by the Energy Efficiency & Resources Core Technology Program of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) granted financial resource from the Ministry of Trade, Industry & Energy, Republic of Korea (No. 20152510101880).	Ahmad S, WAVELET BASED MULTIR; Amjady N, 2009, ENERGY, V34, P46, DOI 10.1016/j.energy.2008.09.020; [Anonymous], 2010, GARCH MODELS; Barucci E., 2001, J INT FINANC MARK I, V12, P183, DOI DOI 10.1016/S1042-4431(02); Cao JC, 2006, ENERGY, V31, P3435, DOI 10.1016/j.energy.2006.04.001; Chen KY, 2011, EXPERT SYST APPL, V38, P10368, DOI 10.1016/j.eswa.2011.02.049; Ching-Lai H, 2006, PROB METH APPL POW S; Conejo AJ, 2005, IEEE T POWER SYST, V20, P1035, DOI 10.1109/TPWRS.2005.846054; Cooper JCB, 1999, J APPL STAT, V26, P909, DOI 10.1080/02664769921927; ENGLE RF, 1982, ECONOMETRICA, V50, P987, DOI 10.2307/1912773; Garcia RC, 2005, IEEE T POWER SYST, V20, P867, DOI 10.1109/TPWRS.2005.846044; Giovanni Petris SP, 2009, DYNAMIC LINEAR MODEL; Hamzacebi C, 2008, INFORM SCIENCES, V178, P4550, DOI 10.1016/j.ins.2008.07.024; Hartley P, THE FUTURE OF LONG T; Hong C, 2001, POWER ENGINEERING SO; Hwang Y, 2012, JOURNAL OF KOREA TRA, V37, P217; IEA, 2013, GAS MEDIUM TERM MARK; IEA, 2013, DEVELOPING A NATURAL; IEA, 2012, WORLD EN OUTL 2012; IHS, 2013, AMERICAS NEW ENERGY, V3; International Energy Agency (IEA), 2011, WORLD ENERGY OUTLOOK; Jakasa T, 2011, 2011 8TH INTERNATION; 황광수, 2012, [Journal of the Korean Society of Mineral and Energy Resources Engineers, 한국자원공학회지], V49, P338; Kandil N, 2006, INT J ELEC POWER, V28, P525, DOI 10.1016/j.ijepes.2006.02.014; Kim D, 2005, NEURAL NETWORKS THEO; Lee D, THE EFFIECT OF OIL P, V12; Liu H, 2013, APPL ENERG, V107, P191, DOI 10.1016/j.apenergy.2013.02.002; Malik F, 2006, J ECON BUS, V58, P168, DOI 10.1016/j.jeconbus.2005.09.004; MathWorks, 2005, GARCH TOOLB US MATLA; Mazighi AEH, 2005, OPEC ENERGY REV, V29, P219, DOI 10.1111/j.0277-0180.2005.00152.x; Mellit A, 2006, APPL ENERG, V83, P705, DOI 10.1016/j.apenergy.2005.06.003; Meulenkamp F, 1999, INT J ROCK MECH MIN, V36, P29, DOI 10.1016/S0148-9062(98)00173-9; Moazzami M, 2013, APPL ENERG, V101, P489, DOI 10.1016/j.apenergy.2012.06.009; Nguyen HT, 2010, ENERGY, V35, P3674, DOI 10.1016/j.energy.2010.05.013; Pindoriya NM, 2008, IEEE T POWER SYST, V23, P1423, DOI 10.1109/TPWRS.2008.922251; Ramberg DJ, 2012, ENERG J, V33, P13, DOI 10.5547/01956574.33.2.2; Reboredo JC, 2013, ECON MODEL, V32, P42, DOI 10.1016/j.econmod.2012.12.028; Secretariat EC, 2007, PUTTING A PRICE ON E; Shafie-khah M, 2011, ENERG CONVERS MANAGE, V52, P2165, DOI 10.1016/j.enconman.2010.10.047; SHENSA MJ, 1992, IEEE T SIGNAL PROCES, V40, P2464, DOI 10.1109/78.157290; Shumway H-R, 2010, TIME SERIES ANAL ITS; Soltani S, 2002, NEUROCOMPUTING, V48, P267, DOI 10.1016/S0925-2312(01)00648-8; Suseelatha A, 2013, J ENG; Tan ZF, 2010, APPL ENERG, V87, P3606, DOI 10.1016/j.apenergy.2010.05.012; Terui N, 2002, INT J FORECASTING, V18, P421, DOI 10.1016/S0169-2070(01)00120-0; Tseng FM, 2001, FUZZY SET SYST, V118, P9, DOI 10.1016/S0165-0114(98)00286-3; vanderVoort M, 1996, TRANSPORT RES C-EMER, V4, P307, DOI 10.1016/S0968-090X(97)82903-8; Wilhelmsson A, 2006, J FORECASTING, V25, P561, DOI 10.1002/for.1009; Yao SJ, 2000, ENERG CONVERS MANAGE, V41, P1975, DOI 10.1016/S0196-8904(00)00035-2; Yousefi S, 2005, CHAOS SOLITON FRACT, V25, P265, DOI 10.1016/j.chaos.2004.11.015; Yu LA, 2008, ENERG ECON, V30, P2623, DOI 10.1016/j.eneco.2008.05.003; Zhang GQ, 1998, INT J FORECASTING, V14, P35, DOI 10.1016/S0169-2070(97)00044-7	52	14	14	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142064	10.1371/journal.pone.0142064	http://dx.doi.org/10.1371/journal.pone.0142064			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV5IS	26539722	gold, Green Published, Green Submitted			2022-12-26	WOS:000364303800049
J	Peng, YC; Yu, K; Zhang, YJ; Islam, S; Sun, DF; Ma, WJ				Peng, Yanchun; Yu, Kan; Zhang, Yujuan; Islam, Shahidul; Sun, Dongfa; Ma, Wujun			Two Novel Y-Type High Molecular Weight Glutenin Genes in Chinese Wheat Landraces of the Yangtze-River Region	PLOS ONE			English	Article							DESORPTION/IONIZATION MASS-SPECTROMETRY; BREAD-MAKING QUALITY; SUBUNIT GENE; HETEROLOGOUS EXPRESSION; ALLELIC VARIATION; STORAGE PROTEINS; SDS-PAGE; PERFORMANCE; SEQUENCE; GENOME	High molecular weight glutenin subunits (HMW-GSs) are key determinants for the end-use quality of wheat. Chinese wheat landraces are an important resource for exploring novel HMW-GS genes to improve the wheat baking quality. Two novel Glu-1Dy HMW-GSs (designated as 1Dy12.6 and 1Dy12.7) were identified and cloned from two Chinese wheat landraces Huazhong830 and Luosimai. The 1Dy12.6 and 1Dy12.7 subunits were deposited as the NCBInr Acc. No KR262518, and KR262519, respectively. The full open reading frames (ORFs) of 1Dy12.6 and 1Dy12.7 were 2022 bp and 1977 bp, encoding for proteins of 673 and 658 amino acid residues, respectively. Each contains four typical primary regions of HMW-GSs (a signal peptide, N-and C-terminal regions, and a central repetitive region). Their deduced molecular masses (70,165 Da and 68,400 Da) were strikingly consistent with those identified by MALDI-TOF-MS (69,985Da and 68,407 Da). The 1Dy12.6 is the largest 1Dy glutenin subunits cloned in common wheat up to date, containing longer repetitive central domains than other 1Dy encoded proteins. In comparison with the most similar active 1Dy alleles previously reported, the newly discovered alleles contained a total of 20 SNPs and 3 indels. The secondary structure prediction indicated that 1Dy12.6 and 1Dy12.7 have similar proportion of alpha-helix, beta-turn, and beta-bend to those of 1Dy10 (X12929). The phylogenetic analysis illustrated that the x-and y-type subunits of glutenins were well separated, but both 1Dy12.6 and 1Dy12.7 were clustered with the other Glu-1Dy alleles. Our results revealed that the 1Dy12.6 and 1Dy12.7 subunit have potential to strengthen gluten polymer interactions, and are valuable genetic resources for wheat quality improvement.	[Peng, Yanchun; Yu, Kan; Sun, Dongfa] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan 430070, Peoples R China; [Peng, Yanchun; Zhang, Yujuan; Islam, Shahidul; Ma, Wujun] Murdoch Univ, Sch Vet & Life Sci, State Agr Biotechnol Ctr, Perth, WA 6150, Australia; [Peng, Yanchun; Zhang, Yujuan; Islam, Shahidul; Ma, Wujun] AEGIC, Perth, WA 6150, Australia; [Sun, Dongfa] Grain Ind, Hubei Collaborat Innovat Ctr, Jingzhou 434025, Peoples R China	Huazhong Agricultural University; Murdoch University	Sun, DF (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan 430070, Peoples R China.	sundongfa1@mail.hzau.edu.cn; w.ma@murdoch.edu.au	Ma, Wujun/F-5957-2010	Ma, Wujun/0000-0002-1264-866X; Islam, Shahidul/0000-0001-5994-0521; Zhang, Yujuan/0000-0002-3243-1644	"863" China High-Tech Research Program [2011AA10A106]	"863" China High-Tech Research Program(National High Technology Research and Development Program of China)	Funded by the "863" China High-Tech Research Program grant #2011AA10A106 DFS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altpeter F, 1996, NAT BIOTECHNOL, V14, P1155, DOI 10.1038/nbt0996-1155; ANDERSON OD, 1989, THEOR APPL GENET, V77, P689, DOI 10.1007/BF00261246; ANDERSON OD, 1989, NUCLEIC ACIDS RES, V17, P461, DOI 10.1093/nar/17.1.461; Belton PS, 1998, SPECTROCHIM ACTA A, V54, P955, DOI 10.1016/S1386-1425(98)00025-0; BELTON PS, 1995, INT J BIOL MACROMOL, V17, P74, DOI 10.1016/0141-8130(95)93520-8; Belton PS, 1999, J CEREAL SCI, V29, P103, DOI 10.1006/jcrs.1998.0227; Butow BJ, 2003, THEOR APPL GENET, V107, P1524, DOI 10.1007/s00122-003-1396-8; Chen J, 2007, RAPID COMMUN MASS SP, V21, P2913, DOI 10.1002/rcm.3151; Cornish GB, 2001, AUST J AGR RES, V52, P1339, DOI 10.1071/AR01060; Cunsolo V, 2004, J MASS SPECTROM, V39, P66, DOI 10.1002/jms.558; Cunsolo V, 2003, RAPID COMMUN MASS SP, V17, P442, DOI 10.1002/rcm.938; D'Ovidio R, 1997, PLANT BREEDING, V116, P525, DOI 10.1111/j.1439-0523.1997.tb02184.x; DOVIDIO R, 1995, THEOR APPL GENET, V91, P189, DOI 10.1007/BF00220876; DOvidio R, 1996, THEOR APPL GENET, V93, P1048, DOI 10.1007/BF00230123; DOVIDIO R, 1995, CEREAL CHEM, V72, P443; Gao LY, 2010, J AGR FOOD CHEM, V58, P2777, DOI 10.1021/jf903363z; Gianibelli MC, 2001, J CEREAL SCI, V33, P39, DOI 10.1006/jcrs.2000.0328; Gianibelli MC, 2001, CEREAL CHEM, V78, P635, DOI 10.1094/CCHEM.2001.78.6.635; Gilbert SM, 2000, BBA-PROTEIN STRUCT M, V1479, P135, DOI 10.1016/S0167-4838(00)00059-5; GUPTA RB, 1994, J CEREAL SCI, V19, P9, DOI 10.1006/jcrs.1994.1003; Kohler P, 1994, WHEAT KERNEL PROTEIN, P45; Kussmann M, 1997, J MASS SPECTROM, V32, P593; LAFIANDRA D, 1993, J CEREAL SCI, V18, P197, DOI 10.1006/jcrs.1993.1046; LAWRENCE GJ, 1981, THEOR APPL GENET, V59, P25, DOI 10.1007/BF00275771; Lei ZS, 2006, J CEREAL SCI, V43, P94, DOI 10.1016/j.jcs.2005.08.003; Li X, 2007, GENOME, V50, P1130, DOI 10.1139/G07-089; Liu L, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-124; Liu L, 2009, J CEREAL SCI, V50, P295, DOI 10.1016/j.jcs.2009.05.006; LUKOW O M, 1992, Journal of Genetics and Breeding, V46, P187; LUKOW OM, 1989, J SCI FOOD AGR, V46, P451, DOI 10.1002/jsfa.2740460407; Ma W, 2003, EUPHYTICA, V134, P51, DOI 10.1023/A:1026191918704; MARCHYLO BA, 1992, J CEREAL SCI, V15, P29, DOI 10.1016/S0733-5210(09)80054-4; Masci S, 2000, THEOR APPL GENET, V100, P396, DOI 10.1007/s001220050052; Mihalik D, 2013, FOOD SCI BIOTECHNOL, V22, P33, DOI 10.1007/s10068-013-0045-5; Muccilli V, 2005, PROTEOMICS, V5, P719, DOI 10.1002/pmic.200401029; Pandey R, 2008, MOL BIOL REP, V35, P153, DOI 10.1007/s11033-007-9065-7; Payne P. I., 1983, Cereal Research Communications, V11, P29; PAYNE PI, 1987, ANNU REV PLANT PHYS, V38, P141, DOI 10.1146/annurev.pp.38.060187.001041; PAYNE PI, 1981, J SCI FOOD AGR, V32, P51, DOI 10.1002/jsfa.2740320109; PAYNE PI, 1987, J SCI FOOD AGR, V40, P51, DOI 10.1002/jsfa.2740400108; Pierucci VRM, 2009, J AGR FOOD CHEM, V57, P6318, DOI 10.1021/jf900629s; Shewry Peter R, 2003, Adv Food Nutr Res, V45, P219; Shewry PR, 2006, THEOR APPL GENET, V113, P128, DOI 10.1007/s00122-006-0279-1; Shewry PR, 2003, THEOR APPL GENET, V106, P744, DOI 10.1007/s00122-002-1135-6; SHEWRY PR, 1995, BIO-TECHNOL, V13, P1185, DOI 10.1038/nbt1195-1185; SHEWRY PR, 1992, J CEREAL SCI, V15, P105, DOI 10.1016/S0733-5210(09)80062-3; Shewry PR, 2002, J EXP BOT, V53, P947, DOI 10.1093/jexbot/53.370.947; Subburaj S, 2014, J APPL GENET, V55, P27, DOI 10.1007/s13353-013-0187-4; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TATHAM AS, 1990, J CEREAL SCI, V11, P189, DOI 10.1016/S0733-5210(09)80163-X; TATHAM AS, 1985, CEREAL CHEM, V62, P405; Wang JR, 2007, BIOCHEM SYST ECOL, V35, P421, DOI 10.1016/j.bse.2006.12.002; Wang K, 2012, HEREDITAS, V149, P41, DOI 10.1111/j.1601-5223.2011.02215.x; Wrigley CW, 1996, NATURE, V381, P738, DOI 10.1038/381738a0; Yan YM, 2009, J CEREAL SCI, V50, P398, DOI 10.1016/j.jcs.2009.08.004; Yan ZH, 2002, CHINESE SCI BULL, V47, P220, DOI 10.1360/02tb9053; Zhao XL, 2006, THEOR APPL GENET, V113, P1247, DOI 10.1007/s00122-006-0379-y; Zheng W, 2011, J CEREAL SCI, V54, P401, DOI 10.1016/j.jcs.2011.08.004	58	13	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142348	10.1371/journal.pone.0142348	http://dx.doi.org/10.1371/journal.pone.0142348			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540300	Green Published, gold, Green Submitted			2022-12-26	WOS:000364303800087
J	Renga, B; Cipriani, S; Carino, A; Simonetti, M; Zampella, A; Fiorucci, S				Renga, Barbara; Cipriani, Sabrina; Carino, Adriana; Simonetti, Michele; Zampella, Angela; Fiorucci, Stefano			Reversal of Endothelial Dysfunction by GPBAR1 Agonism in Portal Hypertension Involves a AKT/FOXOA1 Dependent Regulation of H2S Generation and Endothelin-1	PLoS One			English	Article							FARNESOID-X-RECEPTOR; HEPATIC STELLATE CELLS; NORMAL RAT-LIVER; NITRIC-OXIDE; HYDROGEN-SULFIDE; MOLECULAR TARGETS; BILE-ACIDS; CIRRHOSIS; MICROCIRCULATION; HOMOCYSTEINE	Background GPBAR1 is a bile acids activated receptor expressed in entero-hepatic tissues. In the liver expression of GPBAR1 is restricted to sinusoidal and Kuppfer cells. In the systemic circulation vasodilation caused by GPBAR1 agonists is abrogated by inhibition of cystathione-gamma-liase (CSE), an enzyme essential to the generation of hydrogen sulfide (H2S), a vasodilatory agent. Portal BAR501 is a semisynthetic bile acid derivative endowed with a potent and selective agonistic activity toward GPBAR1. Methods Cirrhosis was induced in mice by carbon tetrachloride (CCL4) administration for 9 weeks. Liver endothelial dysfunction was induced by feeding wild type and Gpbar1(-/-) mice with methionine for 4 weeks. In both models, mice were administered BAR501, 15 mg/kg/day. Results By transactivation assay we demonstrate that BAR501 is a selective GPBAR1 agonist devoid of any FXR agonistic activity. In naive rats, BAR501 effectively reduced hepatic perfusion pressure and counteracted the vasoconstriction activity of norepinephrine. In the CCl4 model, 9 weeks treatment with BAR501 effectively protected against development of endothelial dysfunction by increasing liver CSE expression and activity and by reducing endothelin (ET)-1 gene expression. In mice feed methionine, treatment with BAR501 attenuated endothelial dysfunction and caused a GPBAR1-dependent regulation of CSE. Using mediated by both genomic (recruitment of CREB to CRE in the CSE promoter) and non-genomic effects, involving a Akt-dependent phosporylation of CSE and endothelial nitric oxide (NO) synthase (eNOS). BAR501, phosphorylates FOXO1 and inhibits ET-1 transcription in liver sinusoidal cells. Conclusions BAR501, a UDCA-like GPBAR1 agonist, rescues from endothelial dysfunction in rodent models of portal hypertension by exerting genomic and non-genomic effects on CSE, eNOS and ET-1 in liver sinusoidal cells.	[Renga, Barbara; Carino, Adriana; Simonetti, Michele; Fiorucci, Stefano] Univ Perugia, Dept Surg & Biomed Sci, I-06100 Perugia, Italy; [Cipriani, Sabrina] Univ Perugia, Dept Med, I-06100 Perugia, Italy; [Zampella, Angela] Univ Naples Federico II, Dept Pharm, Naples, Italy	University of Perugia; University of Perugia; University of Naples Federico II	Fiorucci, S (corresponding author), Univ Perugia, Dept Surg & Biomed Sci, I-06100 Perugia, Italy.	Stefano.Fiorucci@unipg.it		Carino, Adriana/0000-0003-2341-9528	BAR Pharmaceuticals; Department of Surgery and Biomedical Sciences	BAR Pharmaceuticals; Department of Surgery and Biomedical Sciences	This study was partially supported by a grant by BAR Pharmaceuticals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Additional funds were intramural from Department of Surgery and Biomedical Sciences.	Bolognesi M, 2014, WORLD J GASTROENTERO, V20, P2555, DOI 10.3748/wjg.v20.i10.2555; Bosy-Westphal A, 2001, HEPATOL RES, V20, P28, DOI 10.1016/S1386-6346(00)00119-4; Carbajo-Pescador S, 2014, CURR MED CHEM, V21, P1231, DOI 10.2174/0929867321666131228205703; Distrutti E, 2008, HEPATOLOGY, V47, P659, DOI 10.1002/hep.22037; Festa C, 2014, J MED CHEM, V57, P8477, DOI 10.1021/jm501273r; Fiorucci S, 2005, J PHARMACOL EXP THER, V315, P58, DOI 10.1124/jpet.105.085597; Fiorucci S, 2005, HEPATOLOGY, V42, P539, DOI 10.1002/hep.20817; Fiorucci S, 2005, J PHARMACOL EXP THER, V314, P584, DOI 10.1124/jpet.105.084905; Fiorucci S, 2004, GASTROENTEROLOGY, V127, P1497, DOI 10.1053/j.gastro.2004.08.001; Fiorucci S, 2006, GASTROENTEROLOGY, V131, P259, DOI 10.1053/j.gastro.2006.02.033; Fiorucci S, 2009, TRENDS PHARMACOL SCI, V30, P570, DOI 10.1016/j.tips.2009.08.001; Gracia-Sancho J, 2015, HEPATOL INT, V9, P183, DOI 10.1007/s12072-015-9613-5; GROSSMAN HJ, 1995, HEPATOLOGY, V21, P162; Gupta TK, 1998, HEPATOLOGY, V28, P926, DOI 10.1002/hep.510280405; Hendrickson H, 2003, AM J PHYSIOL-GASTR L, V285, pG652, DOI 10.1152/ajpgi.00143.2003; HOROWITZ JH, 1981, GASTROENTEROLOGY, V81, P668; Keitel V, 2007, HEPATOLOGY, V45, P695, DOI 10.1002/hep.21458; Kida T, 2013, ARTERIOSCL THROM VAS, V33, P1663, DOI 10.1161/ATVBAHA.113.301565; Leon J, 2014, J PINEAL RES, V56, P415, DOI 10.1111/jpi.12131; Lieu T, 2014, BRIT J PHARMACOL, V171, P1156, DOI 10.1111/bph.12426; Martin-Duce A, 1988, HEPATOLOGY, V8, P65; MITTAL MK, 1994, AM J PHYSIOL, V267, pG416, DOI 10.1152/ajpgi.1994.267.3.G416; Parker HE, 2012, BRIT J PHARMACOL, V165, P414, DOI 10.1111/j.1476-5381.2011.01561.x; Poupon R, 2012, CLIN RES HEPATOL GAS, V36, pS3, DOI 10.1016/S2210-7401(12)70015-3; Reiter CEN, 2010, ENDOCRINOLOGY, V151, P103, DOI 10.1210/en.2009-0997; Renga B, 2015, AM J PHYSIOL-HEART C, V309, pH114, DOI 10.1152/ajpheart.00087.2015; Renga B, 2012, FASEB J, V26, P3021, DOI 10.1096/fj.11-195701; Renga B, 2009, WORLD J GASTROENTERO, V15, P2097, DOI 10.3748/wjg.15.2097; Rockey DC, 2000, GASTROENTEROLOGY, V118, P1261, DOI 10.1016/S0016-5085(00)70379-9; Shah V, 2001, AM J PHYSIOL-GASTR L, V280, pG1209, DOI 10.1152/ajpgi.2001.280.6.G1209; Shah V, 1999, GASTROENTEROLOGY, V117, P1222, DOI 10.1016/S0016-5085(99)70408-7; Shah V, 1997, J CLIN INVEST, V100, P2923, DOI 10.1172/JCI119842; Stipanuk MH, 2004, ANNU REV NUTR, V24, P539, DOI 10.1146/annurev.nutr.24.012003.132418; Vassileva G, 2006, BIOCHEM J, V398, P423, DOI 10.1042/BJ20060537; Wang Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/925350; Wiest R, 2002, HEPATOLOGY, V35, P478, DOI 10.1053/jhep.2002.31432; Woods M, 2003, MOL PHARMACOL, V64, P923, DOI 10.1124/mol.64.4.923	37	41	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141082	10.1371/journal.pone.0141082	http://dx.doi.org/10.1371/journal.pone.0141082			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26539823	Green Published, Green Submitted, gold			2022-12-26	WOS:000364303800010
J	Rutkowski, R; Krofel, M; Giannatos, G; Cirovic, D; Mannil, P; Volokh, AM; Lanszki, J; Heltai, M; Szabo, L; Banea, OC; Yavruyan, E; Hayrapetyan, V; Kopaliani, N; Miliou, A; Tryfonopoulos, GA; Lymberakis, P; Penezic, A; Pakeltyte, G; Suchecka, E; Bogdanowicz, W				Rutkowski, Robert; Krofel, Miha; Giannatos, Giorgos; Cirovic, Dusko; Maennil, Peep; Volokh, Anatoliy M.; Lanszki, Jozsef; Heltai, Miklos; Szabo, Laszlo; Banea, Ovidiu C.; Yavruyan, Eduard; Hayrapetyan, Vahram; Kopaliani, Natia; Miliou, Anastasia; Tryfonopoulos, George A.; Lymberakis, Petros; Penezic, Aleksandra; Pakeltyte, Giedre; Suchecka, Ewa; Bogdanowicz, Wieslaw			A European Concern? Genetic Structure and Expansion of Golden Jackals (Canis aureus) in Europe and the Caucasus	PLOS ONE			English	Article							RAPID RANGE EXPANSION; BEAR URSUS-ARCTOS; MITOCHONDRIAL-DNA; POPULATION-STRUCTURE; WOLF POPULATION; CONSERVATION GENETICS; DIET COMPOSITION; VULPES-VULPES; RED FOX; DIVERSITY	In the first continent-wide study of the golden jackal (Canis aureus), we characterised its population genetic structure and attempted to identify the origin of European populations. This provided a unique insight into genetic characteristics of a native carnivore population with rapid large-scale expansion. We analysed 15 microsatellite markers and a 406 basepair fragment of the mitochondrial control region. Bayesian-based and principal components methods were applied to evaluate whether the geographical grouping of samples corresponded with genetic groups. Our analysis revealed low levels of genetic diversity, reflecting the unique history of the golden jackal among Europe's native carnivores. The results suggest ongoing gene flow between south-eastern Europe and the Caucasus, with both contributing to the Baltic population, which appeared only recently. The population from the Peloponnese Peninsula in southern Greece forms a common genetic cluster with samples from south-eastern Europe (Delta K approach in STRUCTURE, Principal Components Analysis [PCA]), although the results based on BAPS and the estimated likelihood in STRUCTURE indicate that Peloponnesian jackals may represent a distinct population. Moreover, analyses of population structure also suggest either genetic distinctiveness of the island population from Samos near the coast of Asia Minor (BAPS, most STRUCTURE, PCA), or possibly its connection with the Caucasus population (one analysis in STRUCTURE). We speculate from our results that ancient Mediterranean jackal populations have persisted to the present day, and have merged with jackals colonising from Asia. These data also suggest that new populations of the golden jackal may be founded by long-distance dispersal, and thus should not be treated as an invasive alien species, i.e. an organism that is "non-native to an ecosystem, and which may cause economic or environmental harm or adversely affect human health". These insights into the genetic structure and ancestry of Baltic jackals have important implications for management and conservation of jackals in Europe. The golden jackal is listed as an Annex V species in the EU Habitats Directive and as such, considering also the results presented here, should be legally protected in all EU member states.	[Rutkowski, Robert; Suchecka, Ewa; Bogdanowicz, Wieslaw] Polish Acad Sci, Museum & Inst Zool, PL-00679 Warsaw, Poland; [Krofel, Miha] Univ Ljubljana, Wildlife Ecol Res Grp, Dept Forestry, Biotech Fac, Ljubljana, Slovenia; [Giannatos, Giorgos] Univ Athens, Sch Biol, Dept Zool Marine Biol, Athens, Greece; [Cirovic, Dusko; Penezic, Aleksandra] Univ Belgrade, Fac Biol, Inst Zool, Belgrade, Serbia; [Maennil, Peep] Estonian Environm Agcy, Tartu, Estonia; [Volokh, Anatoliy M.] Tauride Agrotechnol State Univ, Melitopol, Ukraine; [Lanszki, Jozsef] Univ Kaposvar, Nat Conservat Dept, Kaposvar, Hungary; [Heltai, Miklos; Szabo, Laszlo] Szent Istvan Univ, Inst Wildlife Conservat, Godollo, Hungary; [Banea, Ovidiu C.] Ecol Dept Crispus NGO Sibiu, Sibiu, Romania; [Yavruyan, Eduard] Natl Acad Sci Armenia, Sci Ctr Zool & Hydroecol, Yerevan, Armenia; [Hayrapetyan, Vahram] Armenian Natl Agrarian Univ, Stepanakert Branch, Stepanakert, Armenia; [Kopaliani, Natia] Ilia State Univ, Inst Ecol, Tbilisi, Georgia; [Miliou, Anastasia] Archipelagos Inst Marine Conservat, Pythagorio, Samos, Greece; [Tryfonopoulos, George A.] Management Body Mt Parnon & Moustos Wetland, Arkadia, Astros, Greece; [Lymberakis, Petros] Univ Crete, Nat Hist Museum Crete, Iraklion, Crete, Greece; [Pakeltyte, Giedre] Kaunas T Ivanauskas Zool Museum, Kaunas, Lithuania	Polish Academy of Sciences; Museum & Institute of Zoology of the Polish Academy of Sciences; University of Ljubljana; National & Kapodistrian University of Athens; University of Belgrade; Ministry of Education & Science of Ukraine; Dmytro Motornyi Tavria State Agrotechnological University; Kaposvar University; Hungarian University of Agriculture & Life Sciences; National Academy of Sciences of Armenia; Ilia State University; University of Crete	Bogdanowicz, W (corresponding author), Polish Acad Sci, Museum & Inst Zool, PL-00679 Warsaw, Poland.	wieslawb@miiz.waw.pl	Krofel, Miha/I-4495-2019; BANEA, Ovidiu/AAE-3234-2021; Cirovic, Dusko/AAM-6303-2020; Lanszki, Jozsef/AAN-1013-2020	Krofel, Miha/0000-0002-2010-5219; Cirovic, Dusko/0000-0001-9468-0948; Penezic, Aleksandra/0000-0002-3033-1658; Rutkowski, Robert/0000-0003-0265-7455; Lanszki, Jozsef/0000-0002-2067-6601; Lymberakis, Petros/0000-0002-5067-9600; Banea, Ovidiu Constantin/0000-0002-0074-7011; Bogdanowicz, Wieslaw/0000-0003-1196-2494	Ministry of Science and Higher Education, Poland [N N303 566339]; Slovenian Research Agency [P4-0059]; Ministry of Education and Science and Technological Development, Serbia [TR 31009]; Research Centre of Excellence [9878/2015/FEKUT]	Ministry of Science and Higher Education, Poland(Ministry of Science and Higher Education, Poland); Slovenian Research Agency(Slovenian Research Agency - Slovenia); Ministry of Education and Science and Technological Development, Serbia; Research Centre of Excellence	This study was supported by the Ministry of Science and Higher Education, Poland (grant no. N N303 566339 to WB); the Slovenian Research Agency (grant no. P4-0059 to MK); the Ministry of Education and Science and Technological Development, Serbia (grant no. TR 31009 to DC); and the Research Centre of Excellence (grant no. 9878/2015/FEKUT to MH and LS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal RK, 2007, J ZOOL SYST EVOL RES, V45, P163, DOI 10.1111/j.1439-0469.2006.00400.x; Andersen LW, 2015, MAMMAL RES, V60, P163, DOI 10.1007/s13364-015-0220-6; [Anonymous], 2012, KORA NEWS       0908; Arnold J, 2012, MAMMAL REV, V42, P1, DOI 10.1111/j.1365-2907.2011.00185.x; Aspi J, 2009, CONSERV GENET, V10, P815, DOI 10.1007/s10592-008-9642-x; Austerlitz F, 1997, THEOR POPUL BIOL, V51, P148, DOI 10.1006/tpbi.1997.1302; Avise JC, 2002, ANNU REV GENET, V36, P19, DOI 10.1146/annurev.genet.36.030602.090831; Avise JC, 2010, CONSERV GENET, V11, P665, DOI 10.1007/s10592-009-0006-y; Baltrunaite L, 2013, CENT EUR J BIOL, V8, P440, DOI 10.2478/s11535-013-0154-9; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Banea O, 2013, GOJAGE BLOG     0301; Banks SC, 2010, MOL ECOL, V19, P2011, DOI 10.1111/j.1365-294X.2010.04627.x; Boskovic Ivica, 2013, Agriculturae Conspectus Scientificus, V78, P245; Brelih S., 1955, BIOL VESTNIK, V4, P56; Broquet T, 2009, ANNU REV ECOL EVOL S, V40, P193, DOI 10.1146/annurev.ecolsys.110308.120324; Buckley J, 2012, MOL ECOL, V21, P267, DOI 10.1111/j.1365-294X.2011.05388.x; Carty J, 2009, J CONSERV BIOL, V1, P38; Chapron G, 2014, SCIENCE, V346, P1517, DOI 10.1126/science.1257553; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Cirovic D, 2015, J HELMINTHOL, V89, P28, DOI 10.1017/S0022149X13000552; Cirovic D, 2015, ACTA VET HUNG, V63, P189, DOI 10.1556/AVet.2015.016; Cirovic D, 2014, ACTA VET HUNG, V62, P481, DOI 10.1556/AVet.2014.021; Cirovic D, 2014, MAMM BIOL, V79, P132, DOI 10.1016/j.mambio.2013.11.003; Cohen TM, 2013, CONSERV GENET, V14, P55, DOI 10.1007/s10592-012-0423-1; Convention on Biological Diversity, 2015, WHAT AR INV AL SPEC; Corander J, 2008, COMPUTATION STAT, V23, P111, DOI 10.1007/s00180-007-0072-x; Corander J, 2006, MOL ECOL, V15, P2833, DOI 10.1111/j.1365-294X.2006.02994.x; Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; DEMETER A., 1993, HDB SAUGETIERE EUROP, P107; Djan M, 2014, MAMM BIOL, V79, P277, DOI 10.1016/j.mambio.2014.03.001; Dolf G, 2000, GENET SEL EVOL, V32, P533, DOI 10.1051/gse:2000135; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Edwards CJ, 2012, QUATERNARY SCI REV, V57, P95, DOI 10.1016/j.quascirev.2012.10.010; Emel SL, 2012, CONSERV GENET, V13, P1685, DOI 10.1007/s10592-012-0407-1; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Fabbri E, 2014, MAMM BIOL, V79, P138, DOI 10.1016/j.mambio.2013.10.002; Fabbri E, 2014, CONSERV GENET, V15, P187, DOI 10.1007/s10592-013-0530-7; Flagstad O, 2003, MOL ECOL, V12, P869, DOI 10.1046/j.1365-294X.2003.01784.x; Francisco LV, 1996, MAMM GENOME, V7, P359, DOI 10.1007/s003359900104; Francois O, 2010, MOL ECOL RESOUR, V10, P773, DOI 10.1111/j.1755-0998.2010.02868.x; Frankham R, 1997, HEREDITY, V78, P311, DOI 10.1038/hdy.1997.46; FREDHOLM M, 1995, MAMM GENOME, V6, P11, DOI 10.1007/BF00350887; Galov A, 2014, MAMM BIOL, V79, P77, DOI 10.1016/j.mambio.2013.10.003; Garroway CJ, 2011, GLOBAL CHANGE BIOL, V17, P1760, DOI 10.1111/j.1365-2486.2010.02384.x; Giannatos G, 2005, BELG J ZOOL, V135, P145; Giannatos G., 2004, POPULATION STATUS CO; Gompert Z, 2012, MOL ECOL, V21, P1542, DOI 10.1111/j.1365-294X.2012.05471.x; Goudet J., 2001, FSTAT V2 9 3 PROGRAM; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; Gugolz D, 2008, J ZOOL, V275, P201, DOI 10.1111/j.1469-7998.2008.00428.x; Hagen SB, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0092; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hedrick PW, 2001, TRENDS ECOL EVOL, V16, P629, DOI 10.1016/S0169-5347(01)02282-0; Hellborg L, 2002, CONSERV GENET, V3, P97, DOI 10.1023/A:1015217723287; Heltai M., 2012, INT S HUNT MOD ASP S, P13; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hindrikson M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075765; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; Ibrahim KM, 1996, HEREDITY, V77, P282, DOI 10.1038/hdy.1996.142; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jansson E, 2012, MOL ECOL, V21, P5178, DOI 10.1111/mec.12010; Jedrzejewski W, 2012, J MAMMAL, V93, P1480, DOI 10.1644/10-MAMM-A-132.1; Jhala Y, 2015, CANIS AUREUS IUCN RE; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; KAREIVA P, 1990, PHILOS T R SOC B, V330, P175, DOI 10.1098/rstb.1990.0191; Keyghobadi N, 2007, CAN J ZOOL, V85, P1049, DOI 10.1139/Z07-095; Kocijan I, 2011, MAMM BIOL, V76, P615, DOI 10.1016/j.mambio.2010.12.003; Koepfli KP, 2015, CURR BIOL, V25, P2158, DOI 10.1016/j.cub.2015.06.060; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; Kopatz A, 2012, CONSERV GENET, V13, P681, DOI 10.1007/s10592-012-0317-2; Koskinen MT, 2004, HEREDITAS, V141, P61, DOI 10.1111/j.1601-5223.2004.01804.x; Kowalczyk R, 2015, MAMMAL RES, V60, P411, DOI 10.1007/s13364-015-0238-9; Krehenwinkel H, 2013, MOL ECOL, V22, P2232, DOI 10.1111/mec.12223; KRYSTUFEK B, 1990, FOLIA ZOOL, V39, P291; Krystufek B., 1990, Annalen des Naturhistorischen Museums in Wien Serie B Botanik und Zoologie, V91, P7; Kuhn W., 1935, Zeitschrift fuer Saugietierkunde, V10, P144; Lanszki J, 2015, ANN ZOOL FENN, V52, P243, DOI 10.5735/086.052.0403; Levickait R, 2015, LIETUVOJE SUMEDZIOTA; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Linnell J., 2008, GUIDELINES POPULATIO; LODGE DM, 1993, TRENDS ECOL EVOL, V8, P133, DOI 10.1016/0169-5347(93)90025-K; Lombaert E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009743; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; Lucchini V, 2004, MOL ECOL, V13, P523, DOI 10.1046/j.1365-294X.2004.02077.x; Mackel R., 2000, SAUGETIERKUNDLICHE I, V4, P477; Malez V., 1984, 9 YUG SPEL C C P, P617; Mason RAB, 2011, CONSERV GENET, V12, P91, DOI 10.1007/s10592-009-9993-y; McVean G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000686; Mehora M., 1953, LOVEC, V36, P470; Mihelic Miha, 2012, Natura Sloveniae, V14, P51; Miller N, 2005, SCIENCE, V310, P992, DOI 10.1126/science.1115871; Murtskhvaladze M, 2010, MOL ECOL, V19, P1829, DOI 10.1111/j.1365-294X.2010.04610.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; NEI M, 1974, GENETICS, V76, P379; OSTRANDER EA, 1993, GENOMICS, V16, P207, DOI 10.1006/geno.1993.1160; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; PEAKALL R, 2001, GENAIEX V5 GENETIC A; Penezic A, 2014, PARASITOL RES, V113, P3281, DOI 10.1007/s00436-014-3991-9; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Pilot M, 2006, MOL ECOL, V15, P4533, DOI 10.1111/j.1365-294X.2006.03110.x; Pilot M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093828; Pilot M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039341; Pritchard JK, 2000, GENETICS, V155, P945; Ramakrishnan AP, 2010, MOL ECOL, V19, P1134, DOI 10.1111/j.1365-294X.2010.04543.x; Randi E, 2000, CONSERV BIOL, V14, P464, DOI 10.1046/j.1523-1739.2000.98280.x; Randi E, 2011, MAMMAL REV, V41, P99, DOI 10.1111/j.1365-2907.2010.00176.x; Ratkiewicz M, 2012, ANIM CONSERV, V15, P603, DOI 10.1111/j.1469-1795.2012.00556.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rozenko Nikolaj, 2010, Beitraege zur Jagd- und Wildforschung, V35, P237; Rueness EK, 2003, MOL ECOL, V12, P2623, DOI 10.1046/j.1365-294X.2003.01952.x; Rueness EK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016385; Salek M, 2014, EUR J WILDLIFE RES, V60, P193, DOI 10.1007/s10344-013-0765-0; Sarre SD, 2009, WILDLIFE RES, V36, P70, DOI 10.1071/WR08066; Schmidt K, 2009, CONSERV GENET, V10, P497, DOI 10.1007/s10592-008-9795-7; Schmitt T, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-11; Sommer R, 2005, MAMM BIOL, V70, P227, DOI 10.1016/j.mambio.2004.12.001; Spassov N., 1989, Historia Naturalis Bulgarica, V1, P44; Stoyanov S., 2012, INT S HUNT MOD ASP S, V1, P48; Stratford Jos, 2015, Zoology and Ecology, V25, P277, DOI 10.1080/21658005.2015.1073894; STV, 2012, ZIT IZ DER TOM BREST; Swaegers J, 2013, HEREDITY, V111, P422, DOI 10.1038/hdy.2013.64; Szabo L, 2009, MAMMALIA, V73, P307, DOI 10.1515/MAMM.2009.048; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; TABERLET P, 1994, P ROY SOC B-BIOL SCI, V255, P195, DOI 10.1098/rspb.1994.0028; Thibault I, 2009, DIVERS DISTRIB, V15, P1060, DOI 10.1111/j.1472-4642.2009.00606.x; Toom M, 2014, THESIS ESTONIAN U LI; Toth T, 2009, NORTH-WEST J ZOOL, V5, P386; Trouwborst A, 2015, BIODIVERS CONSERV, V24, P1567, DOI 10.1007/s10531-015-0894-8; Vuletic-Vukasovic V, 1908, CAGALJ NA KORCULI; Wandeler P, 2003, MOL ECOL, V12, P647, DOI 10.1046/j.1365-294X.2003.01768.x; Wang SP, 2014, MOL ECOL, V23, P637, DOI 10.1111/mec.12634; Watts PC, 2010, BIOL INVASIONS, V12, P3887, DOI 10.1007/s10530-010-9779-7; Weingarth Kirsten, 2012, Saeugetierkundliche Informationen, V8, P443; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Yom-Tov Y., 1995, ISR BIOL CONS, V73, P19, DOI DOI 10.1016/0006-3207(95)90051-9; Zachos FE, 2009, BIOCHEM GENET, V47, P241, DOI 10.1007/s10528-009-9221-y; Zila S., 2014, SAKAL UKRAINI STRATI	144	55	58	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141236	10.1371/journal.pone.0141236	http://dx.doi.org/10.1371/journal.pone.0141236			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540195	Green Submitted, gold, Green Published			2022-12-26	WOS:000364303800014
J	Stoffers, D; Diaz, BA; Chen, G; den Braber, A; van 't Ent, D; Boomsma, DI; Mansvelder, HD; de Geus, E; Van Someren, EJW; Linkenkaer-Hansen, K				Stoffers, Diederick; Diaz, B. Alexander; Chen, Gang; den Braber, Anouk; van 't Ent, Dennis; Boomsma, Dorret I.; Mansvelder, Huibert D.; de Geus, Eco; Van Someren, Eus J. W.; Linkenkaer-Hansen, Klaus			Resting-State fMRI Functional Connectivity Is Associated with Sleepiness, Imagery, and Discontinuity of Mind	PLOS ONE			English	Article							DEFAULT-MODE; CORRELATED FLUCTUATIONS; WANDERING MINDS; BRAIN ACTIVITY; VISUAL-CORTEX; BASE-LINE; NETWORK; DYNAMICS; PATTERNS; NEUROSCIENCE	Resting-state functional magnetic resonance imaging (rs-fMRI) is widely used to investigate the functional architecture of the healthy human brain and how it is affected by learning, life-long development, brain disorders or pharmacological intervention. Non-sensory experiences are prevalent during rest and must arise from ongoing brain activity, yet little is known about this relationship. Here, we used two runs of rs-fMRI both immediately followed by the Amsterdam Resting-State Questionnaire (ARSQ) to investigate the relationship between functional connectivity within ten large-scale functional brain networks and ten dimensions of thoughts and feelings experienced during the scan in 106 healthy participants. We identified 11 positive associations between brain-network functional connectivity and ARSQ dimensions. 'Sleepiness' exhibited significant associations with functional connectivity within Visual, Sensorimotor and Default Mode networks. Similar associations were observed for 'Visual Thought' and 'Discontinuity of Mind', which may relate to variation in imagery and thought control mediated by arousal fluctuations. Our findings show that selfreports of thoughts and feelings experienced during a rs-fMRI scan help understand the functional significance of variations in functional connectivity, which should be of special relevance to clinical studies.	[Stoffers, Diederick; Diaz, B. Alexander; Mansvelder, Huibert D.; Van Someren, Eus J. W.; Linkenkaer-Hansen, Klaus] Vrije Univ Amsterdam, Dept Integrat Neurophysiol, CNCR, Amsterdam, Netherlands; [Stoffers, Diederick; Van Someren, Eus J. W.] Netherlands Inst Neurosci, Dept Sleep & Cognit, Amsterdam, Netherlands; [Chen, Gang] NIMH, Sci & Stat Comp Core, Bethesda, MD 20892 USA; [den Braber, Anouk; van 't Ent, Dennis; Boomsma, Dorret I.; de Geus, Eco] Vrije Univ Amsterdam, Fac Psychol & Educ, Dept Biol Psychol, Amsterdam, Netherlands; [Van Someren, Eus J. W.] Vrije Univ Amsterdam, Dept Med Psychol, Med Ctr, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Linkenkaer-Hansen, K (corresponding author), Vrije Univ Amsterdam, Dept Integrat Neurophysiol, CNCR, Amsterdam, Netherlands.	klaus.linkenkaer@cncr.vu.nl	Van Someren, Eus/AAA-6789-2020; Mansvelder, Huibert/N-6138-2018; Boomsma, Dorret I/AAX-4470-2020; Linkenkaer-Hansen, Klaus/A-6757-2009; de Geus, Eco J.C./M-9318-2015	Mansvelder, Huibert/0000-0003-1365-5340; Linkenkaer-Hansen, Klaus/0000-0003-2140-9780; de Geus, Eco J.C./0000-0001-6022-2666; van 't Ent, Dennis/0000-0003-2001-1375; den Braber, A./0000-0002-3377-2627	Netherlands Organization for Scientific Research [400-07-080, 433-08-121]; Neuroscience Campus Amsterdam [AC-2009-F2-3]; VU University Amsterdam (VU-CvB Financial Incentive Scheme)	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Neuroscience Campus Amsterdam; VU University Amsterdam (VU-CvB Financial Incentive Scheme)	This work was supported by the Netherlands Organization for Scientific Research (MaGW-nr: 400-07-080 and 433-08-121), the Neuroscience Campus Amsterdam (AC-2009-F2-3), and VU University Amsterdam (VU-CvB Financial Incentive Scheme to KL-H).	Aldao A, 2010, CLIN PSYCHOL REV, V30, P217, DOI 10.1016/j.cpr.2009.11.004; Allen EA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00002; Andrews-Hanna JR, 2010, J NEUROPHYSIOL, V104, P322, DOI 10.1152/jn.00830.2009; Bartels A, 2005, NEUROIMAGE, V24, P339, DOI 10.1016/j.neuroimage.2004.08.044; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Borsboom D, 2013, ANNU REV CLIN PSYCHO, V9, P91, DOI 10.1146/annurev-clinpsy-050212-185608; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Chang C, 2013, NEUROIMAGE, V72, P227, DOI 10.1016/j.neuroimage.2013.01.049; Chen G, 2013, NEUROIMAGE, V73, P176, DOI 10.1016/j.neuroimage.2013.01.047; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; de Bie HMA, 2012, HUM BRAIN MAPP, V33, P1189, DOI 10.1002/hbm.21280; Deco G, 2011, NAT REV NEUROSCI, V12, P43, DOI 10.1038/nrn2961; Diaz BA, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00271; Diaz B Alexander, 2013, Front Hum Neurosci, V7, P446, DOI 10.3389/fnhum.2013.00446; Donner TH, 2013, J NEUROSCI, V33, P2188, DOI 10.1523/JNEUROSCI.3388-12.2013; Doucet G, 2012, NEUROIMAGE, V59, P3194, DOI 10.1016/j.neuroimage.2011.11.059; Esposito F, 2013, BRAIN, V136, P710, DOI 10.1093/brain/awt007; Fell J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00409; Ferreira LK, 2013, NEUROSCI BIOBEHAV R, V37, P384, DOI 10.1016/j.neubiorev.2013.01.017; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fukunaga M, 2006, MAGN RESON IMAGING, V24, P979, DOI 10.1016/j.mri.2006.04.018; Gordon EM, 2014, HUM BRAIN MAPP, V35, P1004, DOI 10.1002/hbm.22230; Gorgolewski KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097176; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; Greicius MD, 2008, HUM BRAIN MAPP, V29, P839, DOI 10.1002/hbm.20537; Griffanti L, 2014, NEUROIMAGE, V95, P232, DOI 10.1016/j.neuroimage.2014.03.034; Gruberger M, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00056; Hardstone R, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00450; Heavey CL, 2008, CONSCIOUS COGN, V17, P798, DOI 10.1016/j.concog.2007.12.006; Hutchison RM, 2013, NEUROIMAGE, V80, P360, DOI 10.1016/j.neuroimage.2013.05.079; Jenkinson M., 2000, TR00MJ3 U OXF DEP CL; Khalili-Mahani N, 2012, HUM BRAIN MAPP, V33, P1003, DOI 10.1002/hbm.21265; Killingsworth MA, 2010, SCIENCE, V330, P932, DOI 10.1126/science.1192439; Klumpers LE, 2012, NEUROIMAGE, V63, P1701, DOI 10.1016/j.neuroimage.2012.07.051; Laird AR, 2011, J COGNITIVE NEUROSCI, V23, P4022, DOI 10.1162/jocn_a_00077; Laird Angela R, 2011, BMC Res Notes, V4, P349, DOI 10.1186/1756-0500-4-349; Larson-Prior LJ, 2009, P NATL ACAD SCI USA, V106, P4489, DOI 10.1073/pnas.0900924106; Lewisa CM, 2009, P NATL ACAD SCI USA, V106, P17558, DOI 10.1073/pnas.0902455106; Locke DEC, 2009, DEMENT GERIATR COGN, V27, P260, DOI 10.1159/000203890; Lowe MJ, 2012, NEUROIMAGE, V62, P1146, DOI 10.1016/j.neuroimage.2012.01.014; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Mor N, 2002, PSYCHOL BULL, V128, P638, DOI 10.1037//0033-2909.128.4.638; Morcom AM, 2007, NEUROIMAGE, V37, P1073, DOI 10.1016/j.neuroimage.2006.09.013; Nir Y, 2006, NEUROIMAGE, V30, P1313, DOI 10.1016/j.neuroimage.2005.11.018; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Reichle ME, 2010, TRENDS COGN SCI, V14, P180, DOI 10.1016/j.tics.2010.01.008; Richiardi J, 2011, NEUROIMAGE, V56, P616, DOI 10.1016/j.neuroimage.2010.05.081; Salimi-Khorshidi G, 2014, NEUROIMAGE, V90, P449, DOI 10.1016/j.neuroimage.2013.11.046; Sammer G, 2007, HUM BRAIN MAPP, V28, P793, DOI 10.1002/hbm.20309; Scheeringa R, 2012, BRAIN CONNECT, V2, P254, DOI 10.1089/brain.2012.0088; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Seeley William W., 2009, V24, P160, DOI 10.1159/000197895; Singer W, 2013, TRENDS COGN SCI, V17, P616, DOI 10.1016/j.tics.2013.09.006; Smallwood J, 2006, PSYCHOL BULL, V132, P946, DOI 10.1037/0033-2909.132.6.946; Smallwood J, 2009, EMOTION, V9, P271, DOI 10.1037/a0014855; Smith DV, 2014, NEUROIMAGE, V95, P1, DOI 10.1016/j.neuroimage.2014.03.042; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Stam CJ, 2006, NEUROIMAGE, V32, P1335, DOI 10.1016/j.neuroimage.2006.05.033; Tagliazucchi E, 2014, NEURON, V82, P695, DOI 10.1016/j.neuron.2014.03.020; Tambini A, 2010, NEURON, V65, P280, DOI 10.1016/j.neuron.2010.01.001; Tusche A, 2014, NEUROIMAGE, V97, P107, DOI 10.1016/j.neuroimage.2014.03.076; Veer IM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00041; Washington SD, 2014, HUM BRAIN MAPP, V35, P1284, DOI 10.1002/hbm.22252; Woolrich Mark W, 2009, Neuroimage, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Wu CWW, 2011, BRAIN CONNECT, V1, P401, DOI 10.1089/brain.2011.0018; Yang CM, 2010, CONSCIOUS COGN, V19, P1084, DOI 10.1016/j.concog.2009.12.017; Yarkoni T, 2010, TRENDS COGN SCI, V14, P489, DOI 10.1016/j.tics.2010.08.004; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198	74	33	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142014	10.1371/journal.pone.0142014	http://dx.doi.org/10.1371/journal.pone.0142014			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540239	gold, Green Submitted, Green Published			2022-12-26	WOS:000364303800045
J	Deliens, G; Stercq, F; Mary, A; Slama, H; Cleeremans, A; Peigneux, P; Kissine, M				Deliens, Gaetane; Stercq, Fanny; Mary, Alison; Slama, Hichem; Cleeremans, Axel; Peigneux, Philippe; Kissine, Mikhail			Impact of Acute Sleep Deprivation on Sarcasm Detection	PLOS ONE			English	Article							PSYCHOMOTOR VIGILANCE PERFORMANCE; PERSPECTIVE-TAKING; VERBAL IRONY; INDIVIDUAL-DIFFERENCES; HEALTHY-ADULTS; WORKING-MEMORY; REACTION-TIME; ONE NIGHT; TASK; STROOP	There is growing evidence that sleep plays a pivotal role on health, cognition and emotional regulation. However, the interplay between sleep and social cognition remains an uncharted research area. In particular, little is known about the impact of sleep deprivation on sarcasm detection, an ability which, once altered, may hamper everyday social interactions. The aim of this study is to determine whether sleep-deprived participants are as able as sleep-rested participants to adopt another perspective in gauging sarcastic statements. At 9am, after a whole night of sleep (n = 15) or a sleep deprivation night (n = 15), participants had to read the description of an event happening to a group of friends. An ambiguous voicemail message left by one of the friends on another's phone was then presented, and participants had to decide whether the recipient would perceive the message as sincere or as sarcastic. Messages were uttered with a neutral intonation and were either: (1) sarcastic from both the participant's and the addressee's perspectives (i.e. both had access to the relevant background knowledge to gauge the message as sarcastic), (2) sarcastic from the participant's but not from the addressee's perspective (i.e. the addressee lacked context knowledge to detect sarcasm) or (3) sincere. A fourth category consisted in messages sarcastic from both the participant's and from the addressee's perspective, uttered with a sarcastic tone. Although sleep-deprived participants were as accurate as sleep-rested participants in interpreting the voice message, they were also slower. Blunted reaction time was not fully explained by generalized cognitive slowing after sleep deprivation; rather, it could reflect a compensatory mechanism supporting normative accuracy level in sarcasm understanding. Introducing prosodic cues compensated for increased processing difficulties in sarcasm detection after sleep deprivation. Our findings support the hypothesis that sleep deprivation might damage the flow of social interactions by slowing perspective-taking processes.	[Deliens, Gaetane; Cleeremans, Axel] Univ Libre Bruxelles, CRCN, CO3, Brussels, Belgium; [Deliens, Gaetane; Mary, Alison; Slama, Hichem; Cleeremans, Axel; Peigneux, Philippe] Univ Libre Bruxelles, UNI ULB Neurosci Inst, Brussels, Belgium; [Deliens, Gaetane; Mary, Alison; Slama, Hichem; Peigneux, Philippe] Univ Libre Bruxelles, Neuropsychol & Funct Neuroimaging Res Grp UR2NF, CRCN, Brussels, Belgium; [Deliens, Gaetane; Stercq, Fanny; Kissine, Mikhail] Univ Libre Bruxelles, ACTE, LaDisco Ctr Res Linguist, Brussels, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles	Deliens, G (corresponding author), Univ Libre Bruxelles, CRCN, CO3, Brussels, Belgium.	Gaetane.Deliens@ulb.ac.be	Slama, Hichem/HGA-3213-2022; Kissine, Mikhail/AAE-9184-2020	Slama, Hichem/0000-0003-3856-4488; Kissine, Mikhail/0000-0001-6693-9772; Mary, Alison/0000-0002-4298-1922; Peigneux, Philippe/0000-0003-4745-1434	Departement du developpement technologique", Region Wallonne (Belgium) [DGO6]; FNRSCC [1.5.184.10.F]; FRSM [3.4.594.08.F]; MIS grant F.R.S.-FNRS [F.4502.15]	Departement du developpement technologique", Region Wallonne (Belgium); FNRSCC(Fonds de la Recherche Scientifique - FNRS); FRSM(Fonds de la Recherche Scientifique - FNRS); MIS grant F.R.S.-FNRS	Funding: GD is a postdoctoral researcher supported by a "Greentic" grant from the "Departement du developpement technologique" (DGO6), Region Wallonne (Belgium). FS and AM are Research Fellows at the Belgian Fond National de la Recherche Scientifique (FNRS). AC is a Research Director with the same institution. PP is Francqui Research Professor 2013-2016. This study has been conducted with support of FNRSCC grant 1.5.184.10.F, FRSM grant 3.4.594.08.F and MIS grant F.4502.15 F.R.S.-FNRS.	AKERSTEDT T, 1990, INT J NEUROSCI, V52, P29, DOI 10.3109/00207459008994241; Akimoto Y, 2012, METAPHOR SYMBOL, V27, P217, DOI 10.1080/10926488.2012.691750; Axelsson J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6614; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Basner M., 2015, J SLEEP RES; Basner M, 2011, SLEEP, V34, P581, DOI 10.1093/sleep/34.5.581; Bazydlo R, 2001, PSYCHOSOM MED, V63, P56, DOI 10.1097/00006842-200101000-00007; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Berger RH, 2012, J SLEEP RES, V21, P235, DOI 10.1111/j.1365-2869.2011.00962.x; Blatter K, 2006, BEHAV BRAIN RES, V168, P312, DOI 10.1016/j.bbr.2005.11.018; Brown-Schmidt S, 2009, PSYCHON B REV, V16, P893, DOI 10.3758/PBR.16.5.893; Bryant GA, 2005, LANG SPEECH, V48, P257, DOI 10.1177/00238309050480030101; Bryant GA, 2002, METAPHOR SYMBOL, V17, P99, DOI 10.1207/S15327868MS1702_2; Bryant GA, 2010, DISCOURSE PROCESS, V47, P545, DOI 10.1080/01638530903531972; Butt M, 2015, SLEEP BREATH, V19, P255, DOI 10.1007/s11325-014-1005-x; Buysse DJ, 2014, SLEEP, V37, P9, DOI 10.5665/sleep.3298; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cacioppo JT, 2002, PSYCHOL SCI, V13, P384, DOI 10.1111/j.0956-7976.2002.00469.x; Cain SW, 2011, BRAIN COGNITION, V76, P37, DOI 10.1016/j.bandc.2011.03.005; Cheang HS, 2011, PRAGMAT COGN, V19, P203, DOI 10.1075/pc.19.2.02che; Couyoumdjian A, 2010, J SLEEP RES, V19, P64, DOI 10.1111/j.1365-2869.2009.00774.x; Curcio G, 2006, SLEEP MED REV, V10, P323, DOI 10.1016/j.smrv.2005.11.001; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Deliens G, 2015, RJAD, P1; Deliens G, 2014, EXP BRAIN RES, V232, P1403, DOI 10.1007/s00221-014-3832-1; Deltour JJ, 1993, MANUEL ET ANNEXES; DEWS S, 1995, METAPHOR SYMB ACT, V10, P3, DOI 10.1207/s15327868ms1001_2; Dinges DF, 1997, SLEEP, V20, P267; DINGES DF, 1985, BEHAV RES METH INSTR, V17, P652, DOI 10.3758/BF03200977; Doran SM, 2001, ARCH ITAL BIOL, V139, P253; Dress ML, 2008, J LANG SOC PSYCHOL, V27, P71, DOI 10.1177/0261927X07309512; Durmer JS, 2005, SEMIN NEUROL, V25, P117, DOI 10.1055/s-0029-1237117; Engle-Friedman M, 2003, J SLEEP RES, V12, P113, DOI 10.1046/j.1365-2869.2003.00351.x; Epley N, 2004, J PERS SOC PSYCHOL, V87, P327, DOI 10.1037/0022-3514.87.3.327; German TP, 2006, COGNITION, V101, P129, DOI 10.1016/j.cognition.2005.05.007; Gibbs R.W., 2000, METAPHOR SYMBOL, V15, P5, DOI [DOI 10.1080/10926488.2000.9678862, 10.1207/S15327868MS1512_2, DOI 10.1207/S15327868MS1512_2]; Griffin AM, 2006, SOC COGNITION, V24, P187, DOI 10.1521/soco.2006.24.2.187; Harrison Y, 2000, Q J EXP PSYCHOL-A, V53, P271, DOI 10.1080/027249800390772; Hayes AF., 2003, INTRO MEDIATION MODE; Henry M, 2012, J NEUROSCI METH, V210, P125, DOI 10.1016/j.jneumeth.2012.07.025; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Kahn-Greene ET, 2006, PERS INDIV DIFFER, V41, P1433, DOI 10.1016/j.paid.2006.06.002; KEYSAR B, 1994, COGNITIVE PSYCHOL, V26, P165, DOI 10.1006/cogp.1994.1006; Killgore WDS, 2008, SLEEP MED, V9, P517, DOI 10.1016/j.sleep.2007.07.003; Killgore WDS, 2007, PERCEPT MOTOR SKILL, V105, P276; Killgore WDS, 2010, PROG BRAIN RES, V185, P105, DOI 10.1016/B978-0-444-53702-7.00007-5; Kreuz RJ, 1999, J PRAGMATICS, V31, P1685, DOI 10.1016/S0378-2166(99)00010-7; Laval V, 2005, J SPEECH LANG HEAR R, V48, P610, DOI 10.1044/1092-4388(2005/042); Lim JL, 2008, ANN NY ACAD SCI, V1129, P305, DOI 10.1196/annals.1417.002; LINGENFELSER T, 1994, MED EDUC, V28, P566, DOI 10.1111/j.1365-2923.1994.tb02737.x; Luyster FS, 2012, SLEEP, V35, P727, DOI 10.5665/sleep.1846; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Mary A, 2015, CHILD NEUROPSYCHOL, V12, P1; Monti JM, 2013, PROG NEURO-PSYCHOPH, V43, P209, DOI 10.1016/j.pnpbp.2012.12.021; Morris Charles W., 1934, MIND SELF SOC STANDP, V18, P1972; National Sleep Foundation, 2013, INT BEDR POLL SUMM F; Nichols Shaun, 2003, MINDREADING INTEGRAT; Nickerson RS, 1999, PSYCHOL BULL, V125, P737, DOI 10.1037/0033-2909.125.6.737; Pallesen S, 2004, PERCEPT MOTOR SKILL, V98, P1305, DOI 10.2466/PMS.98.3.1305-1314; Pexman PM, 2004, METAPHOR SYMBOL, V19, P143, DOI 10.1207/s15327868ms1902_3; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Ruby P, 2003, EUR J NEUROSCI, V17, P2475, DOI 10.1046/j.1460-9568.2003.02673.x; Russell J., 1997, AUTISM EXECUTIVE DIS, P256, DOI DOI 10.1093/MED:PSYCH/9780198523499.003.0008; Sagaspe P, 2006, BRAIN COGNITION, V60, P76, DOI 10.1016/j.bandc.2005.10.001; Sagaspe P, 2003, CAN J EXP PSYCHOL, V57, P265, DOI 10.1037/h0087430; Schwarz JFA, 2013, BIOL PSYCHOL, V93, P41, DOI 10.1016/j.biopsycho.2013.01.008; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Stuss DT, 2011, J INT NEUROPSYCH SOC, V17, P759, DOI 10.1017/S1355617711000695; Toplak M, 2000, J PRAGMATICS, V32, P1467, DOI 10.1016/S0378-2166(99)00101-0; Tucker AM, 2010, SLEEP, V33, P47, DOI 10.1093/sleep/33.1.47; van der Helm E, 2010, SLEEP, V33, P335, DOI 10.1093/sleep/33.3.335; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Vriend JL, 2013, J PEDIAT PSYCHOL; Wardlow L, 2013, PSYCHON B REV, V20, P766, DOI 10.3758/s13423-013-0396-1; Wilcox R. R., 1987, NEW STAT PROCEDURES; Winner E, 1998, BRAIN LANG, V62, P89, DOI 10.1006/brln.1997.1889; Woodland J, 2011, METAPHOR SYMBOL, V26, P227, DOI 10.1080/10926488.2011.583197; Zohar D, 2005, SLEEP, V28, P47, DOI 10.1093/sleep/28.1.47	78	9	10	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140527	10.1371/journal.pone.0140527	http://dx.doi.org/10.1371/journal.pone.0140527			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV5GZ	26535906	Green Published, gold, Green Submitted			2022-12-26	WOS:000364298400023
J	Kojima, W				Kojima, Wataru			Attraction to Carbon Dioxide from Feeding Resources and Conspecific Neighbours in Larvae of the Rhinoceros Beetle Trypoxylus dichotomus	PLOS ONE			English	Article							HOST-PLANT LOCATION; MICROBIAL ACTIVITY; COLEOPTERA; PHYSIOLOGY; SIZE; AGGREGATION; PLASTICITY; RECEPTORS; EVOLUTION; RESPONSES	Saprophagous (feeding on decaying matter) insects often use carbon dioxide (CO2) as a cue for finding food. Humus-feeding larvae of the giant rhinoceros beetle Trypoxylus dichotomus exhibit a clumped distribution in natural microhabitats, but the mechanisms driving the distribution were unknown. Herein, I examined whether larvae use CO2 as a cue for fermented humus and aggregate in the vicinity of the food. I found that (i) larvae of T. dichotomus are strongly attracted to CO2, (ii) larvae orient toward highly fermented humus when given a choice between highly and poorly fermented humus, (iii) the highly fermented humus emits more CO2 than the poorly fermented humus, and (iv) larvae grow larger when fed highly fermented humus rather than poorly fermented humus. The clumped distribution of larvae is probably formed along the concentration gradient of CO2 induced by heterogeneity of fermented organic materials in soil. My laboratory experiments also revealed that larvae are chemically attracted to each other. Moreover, CO2 concentrations in soil were increased by the larval respiration, and small amounts of CO2 (much less than emitted during respiration by a single larva) were sufficient for larval attraction. These results suggest that not only response to fermented food resources, but also respiratory CO2 from conspecifics may lead to aggregation. Enhanced densities resulted in reduced weight gain under experimental conditions. However, exploiting a high-value resource at enhanced densities still led to greater body weight compared to individually exploiting a low-value resource. This demonstrates the adaptive value of the response to CO2 sources in this species.	Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, Tokyo 1538902, Japan	University of Tokyo	Kojima, W (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.	koj.wataru@gmail.com			Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [13J08975] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study is funded by Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R.D., 1974, Annual Rev Ecol Syst, V5, P325, DOI 10.1146/annurev.es.05.110174.001545; AVERILL AL, 1987, ECOLOGY, V68, P878, DOI 10.2307/1938359; Barrozo RB, 2004, CHEM SENSES, V29, P319, DOI 10.1093/chemse/bjh035; Bernklau EJ, 2005, J ECON ENTOMOL, V98, P476, DOI 10.1603/0022-0493-98.2.476; Bernklau EJ, 1998, J ECON ENTOMOL, V91, P444, DOI 10.1093/jee/91.2.444; Binet F, 1998, BIOL FERT SOILS, V27, P79, DOI 10.1007/s003740050403; BOGNER F, 1986, J COMP PHYSIOL A, V158, P741, DOI 10.1007/BF01324818; Brown GG, 2000, EUR J SOIL BIOL, V36, P177, DOI 10.1016/S1164-5563(00)01062-1; Denno RF, 1997, ECOL ENTOMOL, V22, P133, DOI 10.1046/j.1365-2311.1997.t01-1-00063.x; DOANE JF, 1975, CAN ENTOMOL, V107, P1233, DOI 10.4039/Ent1071233-12; Eilers EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041357; Erb M, 2013, ADV INSECT PHYSIOL, V45, P53, DOI 10.1016/B978-0-12-417165-7.00002-7; Fordyce JA, 2003, OECOLOGIA, V135, P250, DOI 10.1007/s00442-003-1177-8; GRANT AJ, 1995, J COMP PHYSIOL A, V177, P389, DOI 10.1007/BF00187475; Guerenstein PG, 2008, ANNU REV ENTOMOL, V53, P161, DOI 10.1146/annurev.ento.53.103106.093402; Hongo Y, 2007, BEHAV ECOL SOCIOBIOL, V62, P245, DOI 10.1007/s00265-007-0459-2; Johnson SN, 2006, B ENTOMOL RES, V96, P361, DOI 10.1079/BER2006436; Johnson SN, 2012, J CHEM ECOL, V38, P604, DOI 10.1007/s10886-012-0106-x; Johnson SN, 2006, PHYSIOL ENTOMOL, V31, P1, DOI 10.1111/j.1365-3032.2005.00487.x; JONES OT, 1978, ENTOMOL EXP APPL, V24, P472, DOI 10.1007/BF02385099; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Kojima W, 2015, ECOL ENTOMOL, V40, P420, DOI 10.1111/een.12205; Kojima W, 2014, NATURWISSENSCHAFTEN, V101, P687, DOI 10.1007/s00114-014-1199-6; Krause J, 2002, LIVING GROUPS; Lavelle P, 1997, EUR J SOIL BIOL, V33, P159; LYIMO EO, 1992, ENTOMOL EXP APPL, V63, P265, DOI 10.1007/BF00192775; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rogers CD, 2013, B ENTOMOL RES, V103, P675, DOI 10.1017/S0007485313000382; Stillwell RC, 2010, ANNU REV ENTOMOL, V55, P227, DOI 10.1146/annurev-ento-112408-085500; Tanahashi M, 2009, J INSECT PHYSIOL, V55, P983, DOI 10.1016/j.jinsphys.2009.07.002; Tsurumaki H, 1987, SAISHU TO SHIIKU, V49, P254; Walzer A, 2011, BIOL J LINN SOC, V102, P650, DOI 10.1111/j.1095-8312.2010.01593.x; Wang CL, 2009, J ECON ENTOMOL, V102, P1580, DOI 10.1603/029.102.0423; Wertheim B, 2005, ANNU REV ENTOMOL, V50, P321, DOI 10.1146/annurev.ento.49.061802.123329	34	14	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141733	10.1371/journal.pone.0141733	http://dx.doi.org/10.1371/journal.pone.0141733			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536591	gold, Green Submitted, Green Published			2022-12-26	WOS:000364298400083
J	Taciak, M; Barszcz, M; Tusnio, A; Pastuszewska, B				Taciak, Marcin; Barszcz, Marcin; Tusnio, Anna; Pastuszewska, Barbara			Interactive Effects of Indigestible Carbohydrates, Protein Type, and Protein Level on Biomarkers of Large Intestine Health in Rats	PLOS ONE			English	Article							BETA-GLUCURONIDASE ACTIVITY; COLONIC DNA-DAMAGE; RESISTANT STARCH; DIETARY FIBER; POTATO FIBER; BACTERIAL METABOLITES; CECAL FERMENTATION; ACID; MORPHOLOGY; CASEIN	The effects of indigestible carbohydrates, protein type, and protein level on large intestine health were examined in rats. For 21 days, 12 groups of six 12-week-old male Wistar rats were fed diets with casein (CAS), or potato protein concentrate (PPC), providing 14%(lower protein level; LP), or 20%(higher protein level; HP) protein, and containing cellulose, resistant potato starch, or pectin. Fermentation end-products, pH, and beta-glucuronidase levels in cecal digesta, and ammonia levels in colonic digesta were determined. Cecal digesta, tissue weights, cecal and colon morphology, and colonocyte DNA damage were also analyzed. Digesta pH was lower, whereas relative mass of cecal tissue and digesta were higher in rats fed pectin diets than in those fed cellulose. Cecal parameters were greater in rats fed PPC and HP diets than in those fed CAS and LP diets, respectively. Short-chain fatty acid (SCFA) concentrations were unaffected by protein or carbohydrate type. Total SCFA, acetic acid, and propionic acid concentrations were greater in rats fed LP diets than in those fed HP. Cecal pool of isobutyric and isovaleric acids was greater in rats fed PPC than in those fed CAS diets. PPC diets decreased phenol concentration and increased ammonia concentration in cecal and colonic digesta, respectively. Cecal crypt depth was greater in rats fed PPC and HP diets, and was unaffected by carbohydrates; whereas colonic crypt depth was greater in rats fed cellulose. Myenteron thickness in the cecum was unaffected by nutrition, but was greater in the colon of rats fed cellulose. Colonocyte DNA damage was greater in rats fed LP diets than in those fed HP diets, and was unaffected by carbohydrate or protein type. It was found that nutritional factors decreasing cecal digesta weight contribute to greater phenol production, increased DNA damage, and reduced ammonia concentration in the colon.	[Taciak, Marcin; Barszcz, Marcin; Tusnio, Anna; Pastuszewska, Barbara] Polish Acad Sci, Dept Monogastr Nutr, Kielanowski Inst Anim Physiol & Nutr, Jablonna, Poland	Polish Academy of Sciences; Kielanowski Institute of Animal Physiology & Nutrition of the Polish Academy of Sciences	Taciak, M (corresponding author), Polish Acad Sci, Dept Monogastr Nutr, Kielanowski Inst Anim Physiol & Nutr, Jablonna, Poland.	m.taciak@ifzz.pl	Taciak, Marcin/J-9425-2013; Tuśnio, Anna/AAI-1430-2019; Barszcz, Marcin/AAL-4761-2021; Taciak, Marcin/H-3751-2017	Taciak, Marcin/0000-0002-8963-9745; Barszcz, Marcin/0000-0002-3428-9805; Taciak, Marcin/0000-0002-8963-9745; Tusnio, Anna/0000-0001-7480-3592	Ministry of Science and Higher Education of Poland [N N311 046634]	Ministry of Science and Higher Education of Poland(Ministry of Science and Higher Education, Poland)	This study was financially supported by the Ministry of Science and Higher Education of Poland, Grant No. N N311 046634. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames BN, 1999, ANN NY ACAD SCI, V889, P87, DOI 10.1111/j.1749-6632.1999.tb08727.x; An C, 2014, APPL MICROBIOL BIOT, V98, P2779, DOI 10.1007/s00253-013-5271-5; Barszcz M, 2011, J ANIM FEED SCI, V20, P613, DOI 10.22358/jafs/66219/2011; Barszcz M, 2011, J ANIM FEED SCI, V20, P3, DOI 10.22358/jafs/66152/2011; Barth SW, 2005, CARCINOGENESIS, V26, P1414, DOI 10.1093/carcin/bgi082; Beaud D, 2005, MICROBIOL-SGM, V151, P2323, DOI 10.1099/mic.0.27712-0; Blachier F, 2007, AMINO ACIDS, V33, P547, DOI 10.1007/s00726-006-0477-9; Buraczewska L, 2007, LIVEST SCI, V109, P53, DOI 10.1016/j.livsci.2007.01.058; COLLINS AR, 1995, MUTAT RES-DNA REPAIR, V336, P69, DOI 10.1016/0921-8777(94)00043-6; CUMMINGS JH, 1979, AM J CLIN NUTR, V32, P2094, DOI 10.1093/ajcn/32.10.2094; de Vogel J, 2008, CARCINOGENESIS, V29, P398, DOI 10.1093/carcin/bgm278; Flint HJ, 2012, GUT MICROBES, V3, P289, DOI 10.4161/gmic.19897; Geypens B, 1997, GUT, V41, P70, DOI 10.1136/gut.41.1.70; Henningsson AM, 2002, J NUTR, V132, P3098, DOI 10.1093/jn/131.10.3098; Hughes R, 2000, Curr Issues Intest Microbiol, V1, P51; Juskiewicz J, 2009, J ANIM FEED SCI, V18, P709; Khattak M. M. A. K., 2002, Pakistan Journal of Nutrition, V1, P161; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Kuzmuk KN, 2005, J NUTR, V135, P1940, DOI 10.1093/jn/135.8.1940; Le Leu RK, 2007, CARCINOGENESIS, V28, P240, DOI 10.1093/carcin/bgl245; LUPTON JR, 1989, J NUTR, V119, P235, DOI 10.1093/jn/119.2.235; Macfarlane S, 2003, P NUTR SOC, V62, P67, DOI 10.1079/PNS2002207; Marques C, 2016, ADIPOCYTE, V5, P11, DOI 10.1080/21623945.2015.1061723; Martens JH, 2002, APPL MICROBIOL BIOT, V58, P275, DOI 10.1007/s00253-001-0902-7; Metzler BU, 2008, ASIAN AUSTRAL J ANIM, V21, P603, DOI 10.5713/ajas.2008.r.03; Morita T, 1998, J NUTR, V128, P1156, DOI 10.1093/jn/128.7.1156; Mouille B, 2004, AM J PHYSIOL-GASTR L, V287, pG344, DOI 10.1152/ajpgi.00445.2003; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Oberreuther-Moschner DL, 2005, TOXICOL LETT, V159, P212, DOI 10.1016/j.toxlet.2005.05.008; Pastuszewska B, 2010, ARCH ANIM NUTR, V64, P155, DOI 10.1080/17450390903478885; Paturi G, 2012, J FOOD SCI, V77, pH216, DOI 10.1111/j.1750-3841.2012.02911.x; Propst EL, 2003, J ANIM SCI, V81, P3057; SHIAU SY, 1983, J NUTR, V113, P138, DOI 10.1093/jn/113.1.138; Toden S, 2007, CANCER BIOL THER, V6, P253, DOI 10.4161/cbt.6.2.3627; Toden S, 2007, BRIT J NUTR, V97, P535, DOI 10.1017/S0007114507336817; Toden S, 2006, CANCER BIOL THER, V5, P267, DOI 10.4161/cbt.5.3.2382; Tusnio A, 2011, J ANIM FEED SCI, V20, P361, DOI 10.22358/jafs/66192/2011; Williams BA, 2001, NUTR RES REV, V14, P207, DOI 10.1079/NRR200127; Windey K, 2012, MOL NUTR FOOD RES, V56, P184, DOI 10.1002/mnfr.201100542	39	21	22	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142176	10.1371/journal.pone.0142176	http://dx.doi.org/10.1371/journal.pone.0142176			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536028	Green Published, gold, Green Submitted			2022-12-26	WOS:000364298400141
J	Tateno, C; Kawase, Y; Tobita, Y; Hamamura, S; Ohshita, H; Yokomichi, H; Sanada, H; Kakuni, M; Shiota, A; Kojima, Y; Ishida, Y; Shitara, H; Wada, NA; Tateishi, H; Sudoh, M; Nagatsuka, S; Jishage, K; Kohara, M				Tateno, Chise; Kawase, Yosuke; Tobita, Yoshimi; Hamamura, Satoko; Ohshita, Hiroki; Yokomichi, Hiroshi; Sanada, Harumi; Kakuni, Masakazu; Shiota, Akira; Kojima, Yuha; Ishida, Yuji; Shitara, Hiroshi; Wada, Naoko A.; Tateishi, Hiromi; Sudoh, Masayuki; Nagatsuka, Shin-ichiro; Jishage, Kou-ichi; Kohara, Michinori			Generation of Novel Chimeric Mice with Humanized Livers by Using Hemizygous cDNA-uPA/SCID Mice	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR TRANSGENE; MESSENGER-RNA EXPRESSION; HUMAN HEPATOCYTES; IN-VIVO; CYTOCHROME-P450; ENZYMES; INDUCTION; INFECTION; MOUSE; MODEL	We have used homozygous albumin enhancer/promoter-driven urokinase-type plasminogen activator/severe combined immunodeficient (uPA/SCID) mice as hosts for chimeric mice with humanized livers. However, uPA/SCID mice show four disadvantages: the human hepatocytes (h-heps) replacement index in mouse liver is decreased due to deletion of uPA transgene by homologous recombination, kidney disorders are likely to develop, body size is small, and hemizygotes cannot be used as hosts as more frequent homologous recombination than homozygotes. To solve these disadvantages, we have established a novel host strain that has a transgene containing albumin promoter/enhancer and urokinase-type plasminogen activator cDNA and has a SCID background (cDNA-uPA/SCID). We applied the embryonic stem cell technique to simultaneously generate a number of transgenic lines, and found the line with the most appropriate levels of uPA expression-not detrimental but with a sufficiently damaged liver. We transplanted h-heps into homozygous and hemizygous cDNA-uPA/SCID mice via the spleen, and monitored their human albumin (h-alb) levels and body weight. Blood h-alb levels and body weight gradually increased in the hemizygous cDNA-uPA/SCID mice and were maintained until they were approximately 30 weeks old. By contrast, blood h-alb levels and body weight in uPA/SCID chimeric mice decreased from 16 weeks of age onwards. A similar decrease in body weight was observed in the homozygous cDNA-uPA/SCID genotype, but h-alb levels were maintained until they were approximately 30 weeks old. Microarray analyses revealed identical h-heps gene expression profiles in homozygous and hemizygous cDNA-uPA/SCID mice were identical to that observed in the uPA/SCID mice. Furthermore, like uPA/SCID chimeric mice, homozygous and hemizygous cDNA-uPA/SCID chimeric mice were successfully infected with hepatitis B virus and C virus. These results indicate that hemizygous cDNA-uPA/SCID mice may be novel and useful hosts for producing chimeric mice for use in future long-term studies, including hepatitis virus infection analysis or drug toxicity studies.	[Tateno, Chise; Hamamura, Satoko; Ohshita, Hiroki; Yokomichi, Hiroshi; Sanada, Harumi; Kakuni, Masakazu; Shiota, Akira; Kojima, Yuha; Ishida, Yuji] PhoenixBio Co Ltd, Higashihiroshima, Hiroshima, Japan; [Tateno, Chise; Ishida, Yuji] Hiroshima Univ, Liver Res Project Ctr, Hiroshima, Japan; [Kawase, Yosuke; Wada, Naoko A.; Tateishi, Hiromi] Chugai Res Inst Med Sci Inc, Shizuoka, Japan; [Tobita, Yoshimi; Shitara, Hiroshi; Kohara, Michinori] Tokyo Metropolitan Inst Med Sci, Tokyo 113, Japan; [Sudoh, Masayuki; Jishage, Kou-ichi] Chugai Pharmaceut Co Ltd, Shizuoka, Japan; [Nagatsuka, Shin-ichiro] Sekisui Med Co Ltd, Tokyo, Japan	PHOENIXBIO CO. LTD.; Hiroshima University; Chugai Pharmaceutical Co., Ltd.; Chugai Research Institute for Medical Science, Inc.; Tokyo Metropolitan Institute of Medical Science; Chugai Pharmaceutical Co., Ltd.; Roche Holding; Sekisui Chemical Co Ltd	Tateno, C (corresponding author), PhoenixBio Co Ltd, Higashihiroshima, Hiroshima, Japan.	chise.mukaidani@phoenixbio.co.jp; kohara-mc@igakuken.or.jp	Yokomichi, Hiroshi/B-2816-2013	Yokomichi, Hiroshi/0000-0001-7369-155X	PhoenixBio, Co., Ltd.; Chugai Research Institute for Medical Science, Chugai Pharmaceutical Co., Ltd.; Sekisui Medical Co., Ltd.; Grants-in-Aid for Scientific Research [15H01272] Funding Source: KAKEN	PhoenixBio, Co., Ltd.; Chugai Research Institute for Medical Science, Chugai Pharmaceutical Co., Ltd.; Sekisui Medical Co., Ltd.; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was funded by PhoenixBio, Co., Ltd., Chugai Research Institute for Medical Science, Chugai Pharmaceutical Co., Ltd., and Sekisui Medical Co., Ltd., which provided support in the form of salaries for authors [CT, Y. Kawase, SH, HO, HY, H. Sanada, M. Kakuni, AS, Y. Kojima, YI, NAW, HT, MS, SN, KJ], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma H, 2007, NAT BIOTECHNOL, V25, P903, DOI 10.1038/nbt1326; Brezillon NM, 2008, CELL TRANSPLANT, V17, P803, DOI 10.3727/096368908786516800; Coleman MD, 2005, FACTORS AFFECTING DR; Hasegawa M, 2011, BIOCHEM BIOPH RES CO, V405, P405, DOI 10.1016/j.bbrc.2011.01.042; HECKEL JL, 1990, CELL, V62, P447, DOI 10.1016/0092-8674(90)90010-C; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kakuni M, 2014, INT J MOL SCI, V15, P58, DOI 10.3390/ijms15010058; Katoh M, 2005, DRUG METAB DISPOS, V33, P1333, DOI 10.1124/dmd.105.005157; Katoh M, 2005, DRUG METAB DISPOS, V33, P754, DOI 10.1124/dmd.104.002600; Katoh M, 2004, DRUG METAB DISPOS, V32, P1402, DOI 10.1124/dmd.104.001347; Mercer DF, 2001, NAT MED, V7, P927, DOI 10.1038/90968; Nishimura M, 2003, YAKUGAKU ZASSHI, V123, P369; Nishimura M, 2006, DRUG METAB PHARMACOK, V21, P357, DOI 10.2133/dmpk.21.357; Okumura H, 2007, TOXICOL SCI, V97, P533, DOI 10.1093/toxsci/kfm041; SANDGREN EP, 1991, CELL, V66, P245, DOI 10.1016/0092-8674(91)90615-6; SANDGREN EP, 1992, P NATL ACAD SCI USA, V89, P11523, DOI 10.1073/pnas.89.23.11523; Strom SC, 2010, METHODS MOL BIOL, V640, P491, DOI 10.1007/978-1-60761-688-7_27; Suemizu H, 2008, BIOCHEM BIOPH RES CO, V377, P248, DOI 10.1016/j.bbrc.2008.09.124; Takeuchi T, 1999, GASTROENTEROLOGY, V116, P636, DOI 10.1016/S0016-5085(99)70185-X; Tanaka T, 2004, J MED VIROL, V72, P223, DOI 10.1002/jmv.10566; Tateno C, 2004, AM J PATHOL, V165, P901, DOI 10.1016/S0002-9440(10)63352-4; Tateno C, 2013, LAB INVEST, V93, P54, DOI 10.1038/labinvest.2012.158; Yoshizato K, 2013, EXPERT OPIN DRUG MET, V9, P1419, DOI 10.1517/17425255.2013.826649	23	82	83	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142145	10.1371/journal.pone.0142145	http://dx.doi.org/10.1371/journal.pone.0142145			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536627	Green Submitted, Green Published, gold			2022-12-26	WOS:000364298400138
J	Lindholm, AK; Sandkam, B; Pohl, K; Breden, F				Lindholm, Anna K.; Sandkam, Ben; Pohl, Kristina; Breden, Felix			Poecilia picta, a Close Relative to the Guppy, Exhibits Red Male Coloration Polymorphism: A System for Phylogenetic Comparisons	PLOS ONE			English	Article							MATING PREFERENCES; RETICULATA PISCES; SEXUAL SELECTION; MATE PREFERENCE; RARE MALES; POPULATIONS; EVOLUTION; CHOICE; CYPRINODONTIFORMES; MAINTENANCE	Studies on the evolution of female preference and male color polymorphism frequently focus on single species since traits and preferences are thought to co-evolve. The guppy, Poecilia reticulata, has long been a premier model for such studies because female preferences and orange coloration are well known to covary, especially in upstream/downstream pairs of populations. However, focused single species studies lack the explanatory power of the comparative method, which requires detailed knowledge of multiple species with known evolutionary relationships. Here we describe a red color polymorphism in Poecilia picta, a close relative to guppies. We show that this polymorphism is restricted to males and is maintained in natural populations of mainland South America. Using tests of female preference we show female P. picta are not more attracted to red males, despite preferences for red/orange in closely related species, such as P. reticulata and P. parae. Male color patterns in these closely related species are different from P. picta in that they occur in discrete patches and are frequently Y chromosome-linked. P. reticulata have an almost infinite number of male patterns, while P. parae males occur in discrete morphs. We show the red male polymorphism in P. picta extends continuously throughout the body and is not a Y-linked trait despite the theoretical prediction that sexually-selected characters should often be linked to the heterogametic sex chromosome. The presence/absence of red male coloration of P. picta described here makes this an ideal system for phylogenetic comparisons that could reveal the evolutionary forces maintaining mate choice and color polymorphisms in this speciose group.	[Lindholm, Anna K.] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Sandkam, Ben; Pohl, Kristina; Breden, Felix] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada	University of Zurich; Simon Fraser University	Lindholm, AK (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland.	anna.lindholm@ieu.uzh.ch	Sandkam, Ben/A-1989-2013; Lindholm, Anna K/E-5207-2012	Sandkam, Ben/0000-0002-5043-9295; Lindholm, Anna K/0000-0001-8460-9769; Breden, Felix/0000-0001-9762-6314	Natural Sciences and Engineering Council of Canada; University of New South Wales; Field Museum of Natural History; National Geographic Society;  [163318]	Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of New South Wales; Field Museum of Natural History; National Geographic Society(National Geographic Society); 	The Natural Sciences and Engineering Council of Canada (www.nserc-crsng.gc.ca) provided funding through a postdoctoral fellowship to AL, and an operating grant to FB (#163318). Additional funding was provided by the University of New South Wales through a Vice-Chancellor's Postdoctoral Fellowship (AL; https://research.unsw.edu.au/unsw-internal-funding-opportunities#VC_Postdoc_Anchor), The Field Museum of Natural History (FB; www.fieldmuseum.org) and the National Geographic Society (FB; www.nationalgeographic.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander HJ, 2004, J EVOLUTION BIOL, V17, P1238, DOI 10.1111/j.1420-9101.2004.00788.x; Andersson Malte, 1994; BERRY AJ, 1986, ECOL ENTOMOL, V11, P251, DOI 10.1111/j.1365-2311.1986.tb00301.x; Breden F, 1999, MOL PHYLOGENET EVOL, V12, P95, DOI 10.1006/mpev.1998.0600; Breden F, 1999, ENVIRON BIOL FISH, V55, P449, DOI 10.1023/A:1007591926457; Breden F, 2011, ECOLOGY EVOLUTION PO; Dargent F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056789; ENDLER JA, 1995, TRENDS ECOL EVOL, V10, P22, DOI 10.1016/S0169-5347(00)88956-9; ENDLER JA, 1991, VISION RES, V31, P587, DOI 10.1016/0042-6989(91)90109-I; ENDLER JA, 1980, EVOLUTION, V34, P76, DOI 10.1111/j.1558-5646.1980.tb04790.x; EVANS J.P., 2011, ECOLOGY EVOLUTION PO; FARR JA, 1976, EVOLUTION, V30, P707, DOI 10.1111/j.1558-5646.1976.tb00951.x; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fisher RA, 1931, BIOL REV BIOL P CAMB, V6, P345, DOI 10.1111/j.1469-185X.1931.tb01030.x; Ford E.B., 1965, GENETIC POLYMORPHISM; Godin JGJ, 2003, BEHAV ECOL, V14, P194, DOI 10.1093/beheco/14.2.194; Gray SM, 2007, TRENDS ECOL EVOL, V22, P71, DOI 10.1016/j.tree.2006.10.005; GROSS MR, 1980, P NATL ACAD SCI-BIOL, V77, P6937, DOI 10.1073/pnas.77.11.6937; Hamilton A, 2001, MOL PHYLOGENET EVOL, V19, P277, DOI 10.1006/mpev.2000.0919; Haskins C. P., 1961, VERTEBRATE SPECIATIO, P320; HASKINS CP, 1949, EVOLUTION, V3, P160, DOI 10.2307/2405550; HAZEL WN, 1990, HEREDITY, V65, P449, DOI 10.1038/hdy.1990.116; Houde A.E., 1997, SEX COLOR MATE CHOIC; HOUDE AE, 1992, HEREDITY, V69, P229, DOI 10.1038/hdy.1992.120; Hughes KA, 2013, NATURE, V503, P108, DOI 10.1038/nature12717; Hurtado-Gonzales JL, 2010, J EVOLUTION BIOL, V23, P1293, DOI 10.1111/j.1420-9101.2010.01995.x; Hurtado-Gonzales JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101497; Hurtado-Gonzales JL, 2009, ANIM BEHAV, V77, P1187, DOI 10.1016/j.anbehav.2008.12.032; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; KANESHIRO KY, 1976, EVOLUTION, V30, P740, DOI 10.1111/j.1558-5646.1976.tb00954.x; KANESHIRO KY, 1980, EVOLUTION, V34, P437, DOI 10.1111/j.1558-5646.1980.tb04833.x; Keith P, 2000, PATRIMOINES NATURELS, V43, P1; KODRICBROWN A, 1989, BEHAV ECOL SOCIOBIOL, V25, P393, DOI 10.1007/BF00300185; Kokko H, 2006, PHILOS T R SOC B, V361, P319, DOI 10.1098/rstb.2005.1784; Liley N. R., 1966, Behaviour Suppl, V13, P1; Lindholm A, 2002, AM NAT, V160, pS214, DOI 10.1086/342898; Lindholm AK, 2014, J EVOLUTION BIOL, V27, P437, DOI 10.1111/jeb.12313; Lindholm AK, 2004, HEREDITY, V92, P156, DOI 10.1038/sj.hdy.6800386; Lucinda Paulo Henrique Franco, 2005, Neotrop. ichthyol., V3, P1, DOI 10.1590/S1679-62252005000100001; Magurran AE, 2005, CURR BIOL, V15, pR867, DOI 10.1016/j.cub.2005.10.034; Magurran AE, 2004, ANIM BEHAV, V67, P1077, DOI 10.1016/j.anbehav.2003.10.010; MAGURRAN AE, 2005, EVOLUTIONARY ECOLOGY; McKinnon JS, 2010, MOL ECOL, V19, P5101, DOI 10.1111/j.1365-294X.2010.04846.x; Meyer Manfred K., 1993, Zoologische Abhandlungen (Dresden), V47, P121; Morlon H, 2014, ECOL LETT, V17, P508, DOI 10.1111/ele.12251; R Development Core Team, 2014, R LANG ENV STAT COMP; Ravigne V, 2004, EVOL ECOL RES, V6, P125; REZNICK DN, 1992, COPEIA, P782, DOI 10.2307/1446155; Rodd FH, 2002, P ROY SOC B-BIOL SCI, V269, P475, DOI 10.1098/rspb.2001.1891; Rosen D. E., 1963, Bulletin of the American Museum of Natural History, V126, P1; Russell ST, 2006, BIOL J LINN SOC, V88, P397, DOI 10.1111/j.1095-8312.2006.00628.x; Sandkam B, 2015, MOL ECOL, V24, P596, DOI 10.1111/mec.13058; Sinervo B, 1996, NATURE, V380, P240, DOI 10.1038/380240a0; Torres-Dowdall J, 2013, BIOL J LINN SOC, V108, P790, DOI 10.1111/bij.12031; WINEMILLER KO, 1990, ENVIRON BIOL FISH, V29, P179, DOI 10.1007/BF00002218	55	2	2	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0142089	10.1371/journal.pone.0142089	http://dx.doi.org/10.1371/journal.pone.0142089			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529081	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000364032600099
J	Patten, ML; Welchman, AE				Patten, Matthew L.; Welchman, Andrew E.			fMRI Activity in Posterior Parietal Cortex Relates to the Perceptual Use of Binocular Disparity for Both Signal-In-Noise and Feature Difference Tasks	PLOS ONE			English	Article							HUMAN VISUAL-CORTEX; STEREOSCOPIC DEPTH-PERCEPTION; ANTERIOR INTRAPARIETAL AREA; MIDDLE TEMPORAL AREA; HUMAN BRAIN; SURFACE-ORIENTATION; 3-DIMENSIONAL SHAPE; OBJECT SHAPE; 3D SHAPE; MOTION	Visually guided action and interaction depends on the brain's ability to (a) extract and (b) discriminate meaningful targets from complex retinal inputs. Binocular disparity is known to facilitate this process, and it is an open question how activity in different parts of the visual cortex relates to these fundamental visual abilities. Here we examined fMRI responses related to performance on two different tasks (signal-in-noise "coarse" and feature difference "fine" tasks) that have been widely used in previous work, and are believed to differentially target the visual processes of signal extraction and feature discrimination. We used multi-voxel pattern analysis to decode depth positions (near vs. far) from the fMRI activity evoked while participants were engaged in these tasks. To look for similarities between perceptual judgments and brain activity, we constructed 'fMR-metric' functions that described decoding performance as a function of signal magnitude. Thereafter we compared fMRmetric and psychometric functions, and report an association between judged depth and fMRI responses in the posterior parietal cortex during performance on both tasks. This highlights common stages of processing during perceptual performance on these tasks.	[Patten, Matthew L.; Welchman, Andrew E.] Univ Birmingham, Sch Psychol, Edgbaston B15 2TT, England; [Patten, Matthew L.] UNSW Australia, Sch Psychol, Sydney, NSW, Australia; [Welchman, Andrew E.] Univ Cambridge, Dept Psychol, Cambridge CB2 3EB, England	University of Birmingham; University of New South Wales Sydney; University of Cambridge	Welchman, AE (corresponding author), Univ Birmingham, Sch Psychol, Edgbaston B15 2TT, England.	aew69@cam.ac.uk		Welchman, Andrew/0000-0002-7559-3299	European Community [PITN-GA-2008-214728, PIIF-GA-2011-299610]; Wellcome Trust [095183/Z/10/Z]	European Community(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	The research leading to these results received funding from the European Community's Seventh Framework Programme FP7/2007-2013 (grant agreements PITN-GA-2008-214728 and PIIF-GA-2011-299610) and the Wellcome Trust (095183/Z/10/Z).	Aguirre GK, 1998, NEUROIMAGE, V8, P360, DOI 10.1006/nimg.1998.0369; Anzai A, 2011, J NEUROSCI, V31, P10270, DOI 10.1523/JNEUROSCI.5956-10.2011; Backus BT, 2001, J NEUROPHYSIOL, V86, P2054, DOI 10.1152/jn.2001.86.4.2054; Ban H, 2015, J NEUROSCI, V35, P9823, DOI 10.1523/JNEUROSCI.1255-15.2015; Ban H, 2012, NAT NEUROSCI, V15, P636, DOI 10.1038/nn.3046; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bredfeldt CE, 2006, J NEUROSCI, V26, P7581, DOI 10.1523/JNEUROSCI.5308-05.2006; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Chandrasekaran C, 2007, J NEUROPHYSIOL, V97, P1553, DOI 10.1152/jn.01074.2006; Chang DHF, 2014, CURR BIOL, V24, P2445, DOI 10.1016/j.cub.2014.08.058; Chang DHF, 2013, J NEUROSCI, V33, P10962, DOI 10.1523/JNEUROSCI.0101-13.2013; Chowdhury SA, 2008, NEURON, V60, P367, DOI 10.1016/j.neuron.2008.08.023; Cottereau BR, 2012, J NEUROSCI, V32, P826, DOI 10.1523/JNEUROSCI.2709-11.2012; Cottereau BR, 2011, J NEUROSCI, V31, P954, DOI 10.1523/JNEUROSCI.3795-10.2011; Cumming BG, 1997, NATURE, V389, P280, DOI 10.1038/38487; Cumming BG, 2000, J NEUROSCI, V20, P4758, DOI 10.1523/JNEUROSCI.20-12-04758.2000; Cumming BG, 1998, PERCEPTION, V27, P1367, DOI 10.1068/p271367; DeAngelis GC, 1998, NATURE, V394, P677, DOI 10.1038/29299; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; Dosher BA, 1998, P NATL ACAD SCI USA, V95, P13988, DOI 10.1073/pnas.95.23.13988; Dosher BA, 2005, P NATL ACAD SCI USA, V102, P5286, DOI 10.1073/pnas.0500492102; Dosher BA, 2013, P NATL ACAD SCI USA, V110, P13678, DOI 10.1073/pnas.1312552110; Dupont P, 1997, CEREB CORTEX, V7, P283, DOI 10.1093/cercor/7.3.283; Durand JB, 2007, NEURON, V55, P493, DOI 10.1016/j.neuron.2007.06.040; Durand JB, 2009, NEUROIMAGE, V46, P1114, DOI 10.1016/j.neuroimage.2009.03.023; Georgieva S, 2009, J NEUROSCI, V29, P727, DOI 10.1523/JNEUROSCI.4753-08.2009; Heeger DJ, 2002, NAT REV NEUROSCI, V3, P142, DOI 10.1038/nrn730; Joachims T., 1999, ADV KERNEL METHODS S; Kourtzi Z, 2000, J NEUROSCI, V20, P3310, DOI 10.1523/JNEUROSCI.20-09-03310.2000; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; Li S, 2009, NEURON, V62, P441, DOI 10.1016/j.neuron.2009.03.016; Minini L, 2010, J NEUROPHYSIOL, V104, P169, DOI 10.1152/jn.00790.2009; Neri P, 2005, J NEUROPHYSIOL, V93, P1823, DOI 10.1152/jn.01068.2004; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; NORCIA AM, 1985, VISION RES, V25, P1603, DOI 10.1016/0042-6989(85)90130-0; Orban GA, 1999, NEURON, V24, P929, DOI 10.1016/S0896-6273(00)81040-5; Orban GA, 2006, NEUROPSYCHOLOGIA, V44, P2647, DOI 10.1016/j.neuropsychologia.2005.11.001; Palanca BJA, 2003, J NEUROSCI, V23, P7647; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Popple AV, 1998, VISION RES, V38, P319, DOI 10.1016/S0042-6989(97)00166-1; Preston TJ, 2008, J NEUROSCI, V28, P11315, DOI 10.1523/JNEUROSCI.2728-08.2008; Qiu FTT, 2005, NEURON, V47, P155, DOI 10.1016/j.neuron.2005.05.028; Sakata H, 1998, PHILOS T ROY SOC B, V353, P1363, DOI 10.1098/rstb.1998.0290; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; Shikata E, 1996, NEUROREPORT, V7, P2389, DOI 10.1097/00001756-199610020-00022; Shiozaki HM, 2012, J NEUROSCI, V32, P3830, DOI 10.1523/JNEUROSCI.5083-11.2012; Srivastava S, 2009, J NEUROSCI, V29, P10613, DOI 10.1523/JNEUROSCI.6016-08.2009; Taira M, 2000, J NEUROPHYSIOL, V83, P3140, DOI 10.1152/jn.2000.83.5.3140; Theys T, 2012, J NEUROPHYSIOL, V107, P995, DOI 10.1152/jn.00248.2011; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; Tootell RBH, 2001, CEREB CORTEX, V11, P298, DOI 10.1093/cercor/11.4.298; Tsao DY, 2003, NEURON, V39, P555, DOI 10.1016/S0896-6273(03)00459-8; Tsutsui KI, 2002, SCIENCE, V298, P409, DOI 10.1126/science.1074128; Tsutsui KI, 2001, J NEUROPHYSIOL, V86, P2856, DOI 10.1152/jn.2001.86.6.2856; TYLER CW, 1990, VISION RES, V30, P1877, DOI 10.1016/0042-6989(90)90165-H; Tyler CW, 2005, CURR MED IMAGING REV, V1, P319, DOI 10.2174/157340505774574772; Uka T, 2005, J NEUROSCI, V25, P10796, DOI 10.1523/JNEUROSCI.1637-05.2005; Uka T, 2004, NEURON, V42, P297, DOI 10.1016/S0896-6273(04)00186-2; Uka T, 2003, J NEUROSCI, V23, P3515; Uka T, 2006, J NEUROSCI, V26, P6791, DOI 10.1523/JNEUROSCI.5435-05.2006; Umeda K, 2007, J NEUROPHYSIOL, V98, P241, DOI 10.1152/jn.01336.2006; Vanduffel W, 2002, SCIENCE, V298, P413, DOI 10.1126/science.1073574; von der Heydt R, 2000, VISION RES, V40, P1955, DOI 10.1016/S0042-6989(00)00044-4; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Williams ZM, 2003, NAT NEUROSCI, V6, P616, DOI 10.1038/nn1055; ZEKI S, 1991, J NEUROSCI, V11, P641; Zeki S, 2003, CEREB CORTEX, V13, P189, DOI 10.1093/cercor/13.2.189	68	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0140696	10.1371/journal.pone.0140696	http://dx.doi.org/10.1371/journal.pone.0140696			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529314	Green Published, gold, Green Submitted			2022-12-26	WOS:000364032600011
J	Gao, NN; Zhai, QX; Li, YY; Huang, K; Bian, DL; Wang, XM; Liu, CG; Xu, H; Zhang, T				Gao, Ningning; Zhai, Qixi; Li, Yinyan; Huang, Kun; Bian, Donglin; Wang, Xuemei; Liu, Caigang; Xu, Hong; Zhang, Teng			Clinical Implications of T beta RII Expression in Breast Cancer	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; RECEPTOR-II; BONE METASTASIS; ESTROGEN; INVASIVENESS	Objective To explore the relationship between T beta RII [type II TGF beta (transforming growth factor beta) receptor] expression and clinicopathological characteristics, and to evaluate the prognostic significance of T beta RII expression in breast cancer. Methods Clinicopathological data and prognostic information of 108 patients with histologically confirmed breast cancer who were surgically treated at China Medical University between January 2007 and September 2008 were reviewed and the association between the clinicopathological characteristics and T beta RII expression was analyzed by chi-square test and multivariate analysis. The expression of T beta RII was assessed by immunohistochemistry. Results Of the 108 patients, 60 cases were T beta RII positive and 48 cases were negative. There was no significant association between T beta RII expression of the patients older than 40 years and that of the younger than 40 years (56.0% vs 50.0%; P = 0.742). The T beta RII expression rate was significantly increased in patients with lymph node metastasis compared to those without lymph node metastasis (67.40% vs 46.8%; P = 0.033). Statistically significant relationships were found between increasing tumor clinical stage and high T beta RII expression (P = 0.011). T beta RII expression was not associated with the expression of ER(estrogen receptor). PR, (progesterone receptor). Her-2 (human epidermal growth factor receptor 2) (P = 0.925, P = 0.861, and P = 0.840, respectively). Patients with high T beta RII expression showed poorer 5-year disease-free survival (DFS) compared to those with low expression (66.7% vs 45.6%; P = 0.028) by univariate analysis. Survival analysis demonstrated that T beta RII was associated with poor DFS (P = 0.011). Subgroup analysis revealed that T beta RII expression was associated with shorter DFS in patients with lymph node metastasis, ER-positive, PR-positive or Her-2-negative tumors (P = 0.006, P = 0.016, P = 0.022, and P = 0.033, respectively). Cox regression analysis revealed that high T beta RII expression was related to poor 5-year DFS, and it was an independent factor for predicting the poor outcome for breast cancer patients (P = 0.016). Conclusions High levels of T beta RII expression were associated with lymph node metastasis, increasing tumor clinical stage, and poorer 5-year DFS in patients with breast cancer. T beta RII may be a potential prognostic marker for breast cancer.	[Gao, Ningning; Zhai, Qixi; Li, Yinyan; Huang, Kun; Bian, Donglin; Wang, Xuemei] China Med Univ, Hosp 1, Ultrason Diag Dept, Shenyang 110001, Liaoning Provin, Peoples R China; [Liu, Caigang] Dalian Med Univ, Hosp 2, Dept Breast Surg, Dalian, Liaoning Provin, Peoples R China; [Xu, Hong; Zhang, Teng] Liaoning Prov Canc Hosp & Inst, Dept Breast Surg, Shenyang, Liaoning Provin, Peoples R China	China Medical University; Dalian Medical University	Wang, XM (corresponding author), China Med Univ, Hosp 1, Ultrason Diag Dept, Shenyang 110001, Liaoning Provin, Peoples R China.	wxmlmt@163.com	Wang, Xuemei/GXF-3702-2022; Liu, Caigang/C-7179-2018	Liu, Caigang/0000-0003-2083-235X				Arteaga CL, 1996, J MAMMARY GLAND BIOL, V1, P327, DOI 10.1007/BF02017388; Brattain MG, 1996, TYPE 2 TRANFORMING G, V8, P49; Buck MB, 2004, CLIN CANCER RES, V10, P491, DOI 10.1158/1078-0432.CCR-0320-03; Chen H, 2015, EXP THER MED, V9, P227, DOI 10.3892/etm.2014.2065; Chowdhury Sanjib, 2009, Mol Cell Pharmacol, V1, P57; de Kruijf EM, 2013, ANN ONCOL, V24, P384, DOI 10.1093/annonc/mds333; Deckers M, 2006, CANCER RES, V66, P2202, DOI 10.1158/0008-5472.CAN-05-3560; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Figueroa JD, 2010, BREAST CANCER RES TR, V121, P727, DOI 10.1007/s10549-009-0590-z; Gobbi H, 1999, J NATL CANCER I, V91, P2096, DOI 10.1093/jnci/91.24.2096; Gobbi H, 2000, HISTOPATHOLOGY, V36, P168; Goto N, 2014, J CANCER, V5, P336, DOI 10.7150/jca.7202; Goto N, 2011, CANCER SCI, V102, P1501, DOI 10.1111/j.1349-7006.2011.01977.x; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kang YB, 2005, P NATL ACAD SCI USA, V102, P13909, DOI 10.1073/pnas.0506517102; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Makris EA, 2011, BIOMATERIALS, V32, P7411, DOI 10.1016/j.biomaterials.2011.06.037; Mamiya T, 2010, LAB INVEST, V90, P1339, DOI 10.1038/labinvest.2010.105; Mishra S, 2014, ONCOGENE, V33, P4097, DOI 10.1038/onc.2013.374; Novitskiy SV, 2011, CANCER DISCOV, V1, P430, DOI 10.1158/2159-8290.CD-11-0100; Paiva CE, 2010, ANN ONCOL, V21, P734, DOI 10.1093/annonc/mdp518; Takanami I, 1997, J SURG ONCOL, V64, P262, DOI 10.1002/(SICI)1096-9098(199704)64:4<262::AID-JSO3>3.3.CO;2-0; Wakefield LM, 2002, CURR OPIN GENET DEV, V12, P22, DOI 10.1016/S0959-437X(01)00259-3; Wiercinska E, 2011, BREAST CANCER RES TR, V128, P657, DOI 10.1007/s10549-010-1147-x; Yu YJ, 2012, CARCINOGENESIS, V33, P68, DOI 10.1093/carcin/bgr246	26	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2015	10	11							e0141412	10.1371/journal.pone.0141412	http://dx.doi.org/10.1371/journal.pone.0141412			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7AC	26551005	gold, Green Submitted, Green Published			2022-12-26	WOS:000364422800004
J	Chantreau, V; Taddese, B; Munier, M; Gourdin, L; Henrion, D; Rodien, P; Chabbert, M				Chantreau, Vanessa; Taddese, Bruck; Munier, Mathilde; Gourdin, Louis; Henrion, Daniel; Rodien, Patrice; Chabbert, Marie			Molecular Insights into the Transmembrane Domain of the Thyrotropin Receptor	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; CRYSTAL-STRUCTURE; TSH RECEPTOR; ACTIVATION; DYNAMICS; HORMONE; COMPLEX; SWITCH; ANTAGONIST; MODULATION	The thyrotropin receptor (TSHR) is a G protein-coupled receptor (GPCR) that is member of the leucine-rich repeat subfamily (LGR). In the absence of crystal structure, the success of rational design of ligands targeting the receptor internal cavity depends on the quality of the TSHR models built. In this subfamily, transmembrane helices (TM) 2 and 5 are characterized by the absence of proline compared to most receptors, raising the question of the structural conformation of these helices. To gain insight into the structural properties of these helices, we carried out bioinformatics and experimental studies. Evolutionary analysis of the LGR family revealed a deletion in TM5 but provided no information on TM2. Wild type residues at positions 2.58, 2.59 or 2.60 in TM2 and/or at position 5.50 in TM5 were substituted to proline. Depending on the position of the proline substitution, different effects were observed on membrane expression, glycosylation, constitutive cAMP activity and responses to thyrotropin. Only proline substitution at position 2.59 maintained complex glycosylation and high membrane expression, supporting occurrence of a bulged TM2. The TSHR transmembrane domain was modeled by homology with the orexin 2 receptor, using a protocol that forced the deletion of one residue in the TM5 bulge of the template. The stability of the model was assessed by molecular dynamics simulations. TM5 straightened during the equilibration phase and was stable for the remainder of the simulations. Our data support a structural model of the TSHR transmembrane domain with a bulged TM2 and a straight TM5 that is specific of glycoprotein hormone receptors.	[Chantreau, Vanessa; Taddese, Bruck; Munier, Mathilde; Gourdin, Louis; Henrion, Daniel; Rodien, Patrice; Chabbert, Marie] Univ Angers, Lab Integrated Neurovasc & Mitochondrial Biol, INSERM 1083, UMR CNRS 6214, Angers, France; [Gourdin, Louis; Rodien, Patrice] CHU Angers, Dept Endocrinol, Reference Ctr Pathol Hormonal Recept, Angers, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Chabbert, M (corresponding author), Univ Angers, Lab Integrated Neurovasc & Mitochondrial Biol, INSERM 1083, UMR CNRS 6214, Angers, France.	marie.chabbert@univ-angers.fr	Henrion, Daniel/AAK-1995-2021; Henrion, Daniel/J-8141-2015; Rodien, Patrice/AAT-7909-2021; Henrion, Daniel/N-7023-2015; Munier, Mathilde/AAD-8239-2022; Munier, Mathilde/AAX-3770-2021	Henrion, Daniel/0000-0003-1094-0285; Henrion, Daniel/0000-0003-1094-0285; Henrion, Daniel/0000-0003-1094-0285; Munier, Mathilde/0000-0001-7194-6846; Taddese, Bruck/0000-0002-9884-4978	CNRS; INSERM; University of Angers; Conseil General de Maine-et-Loire; IBM; IFB; INRIA; SYSFERA	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University of Angers; Conseil General de Maine-et-Loire(Region Pays de la Loire); IBM(International Business Machines (IBM)); IFB; INRIA; SYSFERA	This work was supported by institutional grants from CNRS, INSERM and University of Angers. VC was supported by a fellowship from Conseil General de Maine-et-Loire. The authors thank NEC France SAS (Nanterre, France) for the kind provision of a multiprocessor server. The authors are grateful to CNRS, IBM, IFB, INRIA, and SYSFERA that provided access to the E-Biothon platform they are supporting. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti L, 2002, J CLIN ENDOCR METAB, V87, P2549, DOI 10.1210/jc.87.6.2549; Allen MD, 2011, FASEB J, V25, P3687, DOI 10.1096/fj.11-188961; Allen MD, 2011, THYROID, V21, P907, DOI 10.1089/thy.2011.0025; Biebermann H, 1998, FASEB J, V12, P1461, DOI 10.1096/fasebj.12.14.1461; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Cetani F, 1996, FEBS LETT, V378, P27, DOI 10.1016/0014-5793(95)01384-9; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Claus M, 2005, ENDOCRINOLOGY, V146, P5197, DOI 10.1210/en.2005-0713; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Davies TF, 2014, ENDOCRINOLOGY, V155, P1, DOI 10.1210/en.2013-2079; Derby MC, 2007, INT REV CYTOL, V261, P47, DOI 10.1016/S0074-7696(07)61002-X; Deupi X, 2010, PHYSIOLOGY, V25, P293, DOI 10.1152/physiol.00002.2010; Deville J, 2008, PROTEINS, V72, P115, DOI 10.1002/prot.21879; Deville J, 2009, J MOL EVOL, V68, P475, DOI 10.1007/s00239-009-9214-9; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; Govaerts C, 2001, J BIOL CHEM, V276, P22991, DOI 10.1074/jbc.M102244200; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Jo S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000880; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kleinau G, 2008, FASEB J, V22, P2798, DOI 10.1096/fj.07-104711; Kleinau Gunnar, 2014, Adv Pharmacol, V70, P81, DOI 10.1016/B978-0-12-417197-8.00003-1; Kleinau G, 2011, J BIOL CHEM, V286, P25859, DOI 10.1074/jbc.M110.196980; Kruse AC, 2013, NATURE, V504, P101, DOI 10.1038/nature12735; Kursawe R, 2007, TRENDS ENDOCRIN MET, V18, P199, DOI 10.1016/j.tem.2007.05.002; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Latif R, 2015, ENDOCRINOLOGY, V156, P488, DOI 10.1210/en.2014-1509; Laugwitz KL, 1996, P NATL ACAD SCI USA, V93, P116, DOI 10.1073/pnas.93.1.116; LAURENT E, 1987, MOL CELL ENDOCRINOL, V52, P273, DOI 10.1016/0303-7207(87)90055-4; Lee S, 2014, J PHYS CHEM B, V118, P547, DOI 10.1021/jp410344g; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mackerell AD, 2004, J COMPUT CHEM, V25, P1584, DOI 10.1002/jcc.20082; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Nagayama Y, 2000, J PHARMACOL EXP THER, V295, P404; Nagayama Y, 1998, J BIOL CHEM, V273, P33423, DOI 10.1074/jbc.273.50.33423; Neumann S, 2005, ENDOCRINOLOGY, V146, P477, DOI 10.1210/en.2004-1045; Neumann S, 2014, ENDOCRINOLOGY, V155, P310, DOI 10.1210/en.2013-1835; Neumann Susanne, 2009, Expert Rev Endocrinol Metab, V4, P669, DOI 10.1586/eem.09.36; Neumann S, 2008, ENDOCRINOLOGY, V149, P5945, DOI 10.1210/en.2008-0836; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pele J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019094; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rey J, 2010, J STRUCT BIOL, V171, P266, DOI 10.1016/j.jsb.2010.05.002; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanders J, 2007, THYROID, V17, P395, DOI 10.1089/thy.2007.0034; SEALFON SC, 1995, J BIOL CHEM, V270, P16683, DOI 10.1074/jbc.270.28.16683; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Urizar E, 2005, J BIOL CHEM, V280, P17135, DOI 10.1074/jbc.M414678200; van der Kant R, 2014, INT J MOL SCI, V15, P7841, DOI 10.3390/ijms15057841; VASSART G, 1992, ENDOCR REV, V13, P596, DOI 10.1210/er.13.3.596; Vassart G, 2004, TRENDS BIOCHEM SCI, V29, P119, DOI 10.1016/j.tibs.2004.01.006; Vlaeminck-Guillem V, 2002, MOL ENDOCRINOL, V16, P736, DOI 10.1210/me.16.4.736; Werry TD, 2003, BIOCHEM J, V374, P281, DOI 10.1042/BJ20030312; Wolf S, 2008, FEBS LETT, V582, P3335, DOI 10.1016/j.febslet.2008.08.022; Wolf S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123533; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Yin J, 2015, NATURE, V519, P247, DOI 10.1038/nature14035; Yohannan S, 2004, J MOL BIOL, V341, P1, DOI 10.1016/j.jmb.2004.06.025; Zhang DD, 2015, NATURE, V520, P317, DOI 10.1038/nature14287; Zhang KH, 2014, NATURE, V509, P115, DOI 10.1038/nature13083	66	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142250	10.1371/journal.pone.0142250	http://dx.doi.org/10.1371/journal.pone.0142250			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545118	Green Submitted, Green Published, gold			2022-12-26	WOS:000364398700099
J	Kaminski, R; Kosinski, A; Brala, M; Piwko, G; Lewicka, E; Dabrowska-Kugacka, A; Raczak, G; Kozlowski, D; Grzybiak, M				Kaminski, Rafal; Kosinski, Adam; Brala, Mariola; Piwko, Grzegorz; Lewicka, Ewa; Dabrowska-Kugacka, Alicja; Raczak, Grzegorz; Kozlowski, Dariusz; Grzybiak, Marek			Variability of the Left Atrial Appendage in Human Hearts	PLOS ONE			English	Article							TRANSESOPHAGEAL ECHOCARDIOGRAPHY; RISK-FACTORS; FIBRILLATION; STROKE; ANTICOAGULATION; PREVALENCE; MORPHOLOGY; WARFARIN; ANATOMY; CLOSURE	Atrial fibrillation increases the risk of thrombus formation. It is commonly responsible for cerebral stroke whereas less frequently for pulmonary embolism. The aim of the study was to describe the morphology of the left atrial appendage in the human heart with respect to sex, age and weight. Macroscopic examination was carried out on 100 left appendages taken from the hearts of the patients aged 18-77, both sexes. All hearts preserved in 4% water solution of formaldehyde carried neither marks of coronary artery disease nor congenital abnormalities. Three axes of appendage orientation were performed. After the appendage had been cut off, morphological examination was performed in long and perpendicular axes. Measurements of the appendages were taken from anatomical specimens and their silicone casts. We classified the left atrial appendage into 4 morphological groups according to the number of lobes. Most left atrial appendages in female population were composed of 2 lobes. In the male group typically 2 or 3-lobed appendages were observed. The mean left atrial appendage orifice ranged from 12.0 to 16.0 mm and the most significant difference in the orifices between males and females was observed in LAA type 2 (about 3.3 mm). A smaller orifice and narrower, tubular shape of the LAA lobes could explain a higher risk of thrombus formation during nonvalvular atrial fibrillation in women. Knowledge of anatomical variability of the LAA helps diagnose some undefined echoes in the appendage during transesophageal echocardiographic examination.	[Kaminski, Rafal; Kosinski, Adam; Piwko, Grzegorz; Grzybiak, Marek] Med Univ Gdansk, Dept Clin Anat, Gdansk, Poland; [Brala, Mariola; Lewicka, Ewa; Dabrowska-Kugacka, Alicja; Raczak, Grzegorz; Kozlowski, Dariusz] Med Univ Gdansk, Dept Cardiol & Electrotherapy, Hosp Med, Gdansk, Poland	Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk	Kaminski, R (corresponding author), Med Univ Gdansk, Dept Clin Anat, Gdansk, Poland.	rafal.kaminski@gumed.edu.pl	Dabrowska-Kugacka, Alicja/ABE-2997-2020; Lewicka, Ewa/T-9676-2018; Kosiński, Adam/N-6300-2018	Dabrowska-Kugacka, Alicja/0000-0002-5546-7818; Lewicka, Ewa/0000-0002-0162-2659; Kosiński, Adam/0000-0001-7507-2285; Grzybiak, Marek/0000-0002-3119-160X				Al-Saady NM, 1999, HEART, V82, P547, DOI 10.1136/hrt.82.5.547; Anderson RH, 2007, EUROPACE, V9, P3, DOI 10.1093/europace/eum200; Cappellari M, 2013, J NEUROL, V260, P2681, DOI 10.1007/s00415-013-7064-2; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Di Biase L, 2012, J AM COLL CARDIOL, V6; ERNST G, 1995, ANAT REC, V242, P553, DOI 10.1002/ar.1092420411; Giralt-Steinhauer E, 2012, J NEUROL, V259, P745, DOI 10.1007/s00415-011-6259-7; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Go AS, 1999, ANN INTERN MED, V131, P927, DOI 10.7326/0003-4819-131-12-199912210-00004; Ho SY, 2002, PACE, V25, P342, DOI 10.1046/j.1460-9592.2002.00342.x; Kaminski R, 2015, KARDIOL POL, V73, P183, DOI 10.5603/KP.a2014.0170; Kleczynski P, 2012, KARDIOL POL, V70, P965; MANNING WJ, 1995, ANN INTERN MED, V123, P817, DOI 10.7326/0003-4819-123-11-199512010-00001; Mizuguchi KA, 2009, ANESTH ANALG, V108, P70, DOI 10.1213/ane.0b013e3181857e53; Nucifora G, 2011, CIRC-CARDIOVASC IMAG, V4, P514, DOI 10.1161/CIRCIMAGING.111.963892; Plewka M, 2011, KARDIOL POL, V69, P85; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Shariff N, 2012, J ATRIAL FIBR, V3, P79; Sievert H, 2002, CIRCULATION, V105, P1887, DOI 10.1161/01.CIR.0000015698.54752.6D; Stewart S, 2001, HEART, V86, P516, DOI 10.1136/heart.86.5.516; Su P, 2008, HEART, V94, P1166, DOI 10.1136/hrt.2006.111989; Ucerler H, 2013, ANATOL J CARDIOL, V13, P566, DOI 10.5152/akd.2013.181; Veinot JP, 1997, CIRCULATION, V96, P3112, DOI 10.1161/01.CIR.96.9.3112; WANG K, 1995, BRIT HEART J, V73, P559; Wang Y, 2010, J CARDIOVASC ELECTR, V21, P973, DOI 10.1111/j.1540-8167.2010.01814.x; WOLF PA, 1987, ARCH INTERN MED, V147, P1561, DOI 10.1001/archinte.147.9.1561	26	19	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141901	10.1371/journal.pone.0141901	http://dx.doi.org/10.1371/journal.pone.0141901			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544191	Green Published, Green Submitted, gold			2022-12-26	WOS:000364398700062
J	Li, K; Liu, Y; Wang, QX; Wu, YL; Song, SM; Sun, Y; Liu, TC; Wang, J; Li, Y; Du, SY				Li, Ke; Liu, Yi; Wang, Quanxin; Wu, Yalei; Song, Shimin; Sun, Yi; Liu, Tengchong; Wang, Jun; Li, Yang; Du, Shaoyi			A Spacecraft Electrical Characteristics Multi-Label Classification Method Based on Off-Line FCM Clustering and On-Line WPSVM	PLOS ONE			English	Article							FAULT-TOLERANT CONTROL; PARITY SPACE; SYSTEM	This paper proposes a novel multi-label classification method for resolving the spacecraft electrical characteristics problems which involve many unlabeled test data processing, high-dimensional features, long computing time and identification of slow rate. Firstly, both the fuzzy c-means (FCM) offline clustering and the principal component feature extraction algorithms are applied for the feature selection process. Secondly, the approximate weighted proximal support vector machine (WPSVM) online classification algorithms is used to reduce the feature dimension and further improve the rate of recognition for electrical characteristics spacecraft. Finally, the data capture contribution method by using thresholds is proposed to guarantee the validity and consistency of the data selection. The experimental results indicate that the method proposed can obtain better data features of the spacecraft electrical characteristics, improve the accuracy of identification and shorten the computing time effectively.	[Li, Ke; Liu, Yi; Wang, Quanxin; Wu, Yalei; Wang, Jun] Beihang Univ, Ergon & Environm Control Lab, Beijing 100191, Peoples R China; [Song, Shimin; Sun, Yi; Liu, Tengchong] China Acad Space Technol, Beijing, Peoples R China; [Li, Yang] Beihang Univ, Sch Automat Sci & Elect Engn, Beijing, Peoples R China; [Du, Shaoyi] Xi An Jiao Tong Univ, Inst Artificial Intelligence & Robot, Xian 710049, Shanxi, Peoples R China	Beihang University; Beihang University; Xi'an Jiaotong University	Li, Y (corresponding author), Beihang Univ, Ergon & Environm Control Lab, Beijing 100191, Peoples R China.	like@buaa.edu.cn	Li, Yang/AAJ-2985-2020; Li, Yang/K-8907-2012		Aeronautical Science Foundation of China [2012ZD51043]; Fanzhou Youth Scientific Funds [20100504]; Chinese Government Fundamental Research Funds for Central Universities [YWF-14-HKXY-017, YWF-13-HKXY-033]; National Natural Science Foundation of China [61403016]	Aeronautical Science Foundation of China; Fanzhou Youth Scientific Funds; Chinese Government Fundamental Research Funds for Central Universities; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors are supported by the Aeronautical Science Foundation of China (No. 2012ZD51043), Fanzhou Youth Scientific Funds (No. 20100504), Chinese Government Fundamental Research Funds for the Central Universities (No. YWF-14-HKXY-017, YWF-13-HKXY-033), and the National Natural Science Foundation of China (61403016).	Bonivento C, 2004, AUTOMATICA, V40, P355, DOI 10.1016/j.automatica.2003.10.003; Chen L, 2008, WORLD C; Chew HG, 2001, INT CONF ACOUST SPEE, P1269; Chidambaram B, 2005, AEROSP CONF PROC, P3532; Chien S., 2005, J AEROS COMP INF COM, V2, P196, DOI [10.2514/1.12923, DOI 10.2514/1.12923]; Cordon O, 1999, INT J APPROX REASON, V20, P21, DOI 10.1016/S0888-613X(98)10021-X; DAVID AK, 1991, IEEE T POWER SYST, V6, P59, DOI 10.1109/59.131092; Debeljkovic DL, 2004, DYNAM CONT DIS SER A, V11, P691; Dietterich TG, 2000, MACH LEARN, V40, P139, DOI 10.1023/A:1007607513941; Ding SX, 2007, FAULT DETECTION SUPE, P378; Ding X, 1999, IEEE T AUTOMAT CONTR, V44, P337, DOI 10.1109/9.746262; Du Lin, 2008, High Voltage Engineering, V34, P1589; Duan K, 2003, NEUROCOMPUTING, V51, P41, DOI 10.1016/S0925-2312(02)00601-X; Gao HJ, 2003, IEEE T AUTOMAT CONTR, V48, P1661, DOI 10.1109/TAC.2003.817012; Gao ZW, 2007, AUTOMATICA, V43, P912, DOI 10.1016/j.automatica.2006.11.018; Gu J, 2008, P REL MAINT S, P484; Hamdi H, 2009, FAULT DETECTION SUPE, P438; Huang JS, 2002, IEEE T POWER DELIVER, V17, P609, DOI 10.1109/61.997947; Jiang T, 2007, SYST MAN CYB 2007 IS, P3146; Keerthi SS, 2001, NEURAL COMPUT, V13, P637, DOI 10.1162/089976601300014493; Keller K, 2006, IEEE AER C; Kishore W., 2006, P IEEE INT C IND TEC, P1054; Kobayashi Y, 2007, IEEE T AUTOMAT CONTR, V52, P318, DOI 10.1109/TAC.2006.887897; Kulatunge A, 2002, NETWORK FAULT PREDIC; Li K, 2014, CHINESE J AERONAUT, V27, P1390, DOI 10.1016/j.cja.2014.10.005; Li K, 2013, CHINESE J AERONAUT, V26, P1360, DOI 10.1016/j.cja.2013.07.006; Li WH, 2000, J PROCESS CONTR, V10, P471, DOI 10.1016/S0959-1524(00)00022-6; Li ZY, 2014, INT CONF INFO SCI, P1, DOI 10.1109/ICIST.2014.6920318; Liu Y, 2014, INT CONF SIGN PROCES, P1413, DOI 10.1109/ICOSP.2014.7015232; Mika S, 1999, ADV NEUR IN, V11, P536; Nguang SK, 2006, INT J ROBUST NONLIN, V16, P913, DOI 10.1002/rnc.1116; PATTON RJ, 1994, J GUID CONTROL DYNAM, V17, P278, DOI 10.2514/3.21194; Shaw SR, 2000, MASSACHUSETTS I TECH, P213; Simani S., 2003, ADV IND CON, DOI 10.1007/978-1-59259-405-4; Swearingen K, 2007, AER C MAR; Tuchb BA, 2007, P 32 GOMACTECH C; Utgoff P. E., 1989, Machine Learning, V4, P161, DOI 10.1023/A:1022699900025; Utgoff P.E., 1994, P 11 INT C MACH LEAR, P318; Wang LA, 1996, IEEE T SYST MAN CY B, V26, P100, DOI 10.1109/3477.484441; Witten IH, 2011, BIOMEDICAL ENG ONLIN, V5, P95; Wu Hao, 2007, High Voltage Engineering, V33, P64; Wu Q, 2006, AM CONTR C; Yang H, 2003, PATTERN RECOGN, V36, P563, DOI 10.1016/S0031-3203(02)00048-1; Yang J, 2004, PATTERN ANAL MACHINE, P131; Zhang YM, 2001, J GUID CONTROL DYNAM, V24, P133, DOI 10.2514/2.4687; Zhang YM, 2008, ANNU REV CONTROL, V32, P229, DOI 10.1016/j.arcontrol.2008.03.008; Zhou ZH, 2002, KNOWL-BASED SYST, V15, P515, DOI 10.1016/S0950-7051(02)00038-2	47	6	6	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0140395	10.1371/journal.pone.0140395	http://dx.doi.org/10.1371/journal.pone.0140395			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544549	gold, Green Published, Green Submitted			2022-12-26	WOS:000364398700007
J	Park, H; Imoto, S; Miyano, S				Park, Heewon; Imoto, Seiya; Miyano, Satoru			Recursive Random Lasso (RRLasso) for Identifying Anti-Cancer Drug Targets	PLOS ONE			English	Article							HUMAN BREAST-CANCER; LUNG-CANCER; GASTRIC-CANCER; EXPRESSION; GENE; PROLIFERATION; INVASION; MARKER; GROWTH; CELLS	Uncovering driver genes is crucial for understanding heterogeneity in cancer. L-1-type regularization approaches have been widely used for uncovering cancer driver genes based on genome-scale data. Although the existing methods have been widely applied in the field of bioinformatics, they possess several drawbacks: subset size limitations, erroneous estimation results, multicollinearity, and heavy time consumption. We introduce a novel statistical strategy, called a Recursive Random Lasso (RRLasso), for high dimensional genomic data analysis and investigation of driver genes. For time-effective analysis, we consider a recursive bootstrap procedure in line with the random lasso. Furthermore, we introduce a parametric statistical test for driver gene selection based on bootstrap regression modeling results. The proposed RRLasso is not only rapid but performs well for high dimensional genomic data analysis. Monte Carlo simulations and analysis of the "Sanger Genomics of Drug Sensitivity in Cancer dataset from the Cancer Genome Project" show that the proposed RRLasso is an effective tool for high dimensional genomic data analysis. The proposed methods provide reliable and biologically relevant results for cancer driver gene selection.	[Park, Heewon; Imoto, Seiya; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Tokyo, Japan	University of Tokyo	Park, H (corresponding author), Yamaguchi Univ, Fac Global & Sci Studies, Yamaguchi, Yamaguchi, Japan.	hwpark@yamaguchi-u.ac.jp		Miyano, Satoru/0000-0002-1753-6616	RIKEN Advanced Institute for Computational Science through the HPCI System Research project [hp140230]	RIKEN Advanced Institute for Computational Science through the HPCI System Research project	This research used computational resources of the K computer provided by the RIKEN Advanced Institute for Computational Science through the HPCI System Research project (Project ID:hp140230) and the Super Computer System, Human Genome Center, Institute of Medical Science, University of Tokyo. The authors would like to thank the associate editor and anonymous reviewers for the constructive and valuable comments that improved the quality of the paper.	Abou-Sharieha Samah, 2009, Chinese Journal of Clinical Oncology, V6, P1, DOI 10.1007/s11805-009-0001-6; Akino K, 2007, CANCER SCI, V98, P88, DOI 10.1111/j.1349-7006.2006.00351.x; Amaia G, 2007, DRUG DISCOVERY TECHN; Berlato C, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2838; Bhushan L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022484; Bilecova-Rabajdova M, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/156034; Buess M, 2004, NEOPLASIA, V6, P813, DOI 10.1593/neo.04307; Chan CWM, 2009, P NATL ACAD SCI USA, V106, P1936, DOI 10.1073/pnas.0812904106; Chen QR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105393; Chen YL, 2013, BIOCHEM BIOPH RES CO, V442, P56, DOI 10.1016/j.bbrc.2013.10.165; Chen YZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091104; Chiang S. F., 2014, SURG SCI, V5, P418, DOI DOI 10.4236/SS.2014.510067; Cho H, 2014, ONCOTARGET, V5, P3482, DOI 10.18632/oncotarget.1947; Chorawala MR, 2012, INT J PHARM SCI DRUG, V4, P1, DOI DOI 10.7243/2050-120x-1-1; Chung FH, INTEGRATION NETWORK; Coghlin C, 2006, J PATHOL, V210, P351, DOI 10.1002/path.2056; Colombo J, 2013, BIOL PROCED ONLINE, V15, DOI 10.1186/1480-9222-15-10; Drayton RM, 2014, CLIN CANCER RES, V20, P1990, DOI 10.1158/1078-0432.CCR-13-2805; Dupouy S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004223; Edwards YJK, 2011, PLOS ONE, V8; Frezza C, 2014, GAUDE FREZZA CANC ME, V2; Gemma A, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-174; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Huang HC, 2010, TECHNOL CANCER RES T, V9, P219, DOI 10.1177/153303461000900301; Iwao-Koizumi K, 2005, J CLIN ONCOL, V23, P422, DOI 10.1200/JCO.2005.09.078; Jarzab M, 2005, BREAST CANCER RES, V7; Jin YJ, 2014, INT J CANCER, V134, P2294, DOI 10.1002/ijc.28568; Kashiwagi K, 2012, PATHOL INT, V62, P232, DOI 10.1111/j.1440-1827.2011.02781.x; Kato M, 2012, CANCER SCI, V103, P1363, DOI 10.1111/j.1349-7006.2012.02298.x; Katoh M, 2012, INT J ONCOL, V41, P1913, DOI 10.3892/ijo.2012.1669; Khin SS, 2009, INT J CANCER, V125, P328, DOI 10.1002/ijc.24318; Kim BY, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/584604; Kohn KW, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035716, DOI 10.1371/J0URNAL.P0NE.0035716]; Kohno T, 2011, J THORAC ONCOL, V6, P813, DOI 10.1097/JTO.0b013e3181ee80ef; Kong CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022666; Kostianets O, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-161; Kundu J, 2012, INT J ONCOL, V41, P839, DOI 10.3892/ijo.2012.1517; Larriba Maria Jesus, 2013, Cancers (Basel), V5, P1242, DOI 10.3390/cancers5041242; Lee HJ, 2010, GASTROENTEROLOGY, V139, P213, DOI 10.1053/j.gastro.2010.04.008; Li CD, 2012, MOL CELL BIOCHEM, V370, P127, DOI 10.1007/s11010-012-1404-x; Lin H, 2012, CANCER GENE THER, V19, P845, DOI 10.1038/cgt.2012.70; Liu XX, 2011, FEBS LETT, V585, P1363, DOI 10.1016/j.febslet.2011.04.018; Llarena AM, 2009, J CLIN ONCOL, V27; Loberg RD, 2006, NEOPLASIA, V8, P69, DOI 10.1593/neo.05679; Miao LY, 2013, BIOCHEM BIOPH RES CO, V440, P792, DOI 10.1016/j.bbrc.2013.10.024; OKOCHI T, 1979, CANCER RES, V39, P1829; Ooe A, 2007, BREAST CANCER RES TR, V101, P305, DOI 10.1007/s10549-006-9293-x; Papapetropoulos S, 2006, GENE EXPRESSION, V13, P205, DOI 10.3727/000000006783991827; Pils D, 2010, GYNECOL ONCOL, V117, P189, DOI 10.1016/j.ygyno.2009.12.034; Samah NA, 2011, IIUM ENG J, V12, P213; Schulte Janin, 2011, BMC Med, V9, P137, DOI 10.1186/1741-7015-9-137; Sengupta D, 2014, BRIT J CANCER, V110, P2144, DOI 10.1038/bjc.2014.53; Shinojima T, 2012, EPIGENETICS-US, V7, P1279, DOI 10.4161/epi.22333; Spraggs CF, 2011, J CLIN ONCOL, V29, P667, DOI 10.1200/JCO.2010.31.3197; Stefanska B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068439; Sugiura T, 2007, CANCER BIOL THER, V6, P957, DOI 10.4161/cbt.6.6.4192; Suh KS, 2005, J INVEST DERM SYMP P, V10, P105, DOI 10.1111/j.1087-0024.2005.200402.x; Sun LG, 2014, CANCER GENET-NY, V207, P291, DOI 10.1016/j.cancergen.2014.07.003; TATA DB, 1993, ULTRASONICS, V31, P447, DOI 10.1016/0041-624X(93)90054-4; Tibshirani R, 2011, J R STAT SOC B, V73, P273, DOI 10.1111/j.1467-9868.2011.00771.x; Ummanni R, 2012, J PROTEOME RES, V11, P2452, DOI 10.1021/pr201172n; Velusamy T, 2013, P NATL ACAD SCI USA, V110, P3035, DOI 10.1073/pnas.1214326110; Wang SJ, 2011, ANN APPL STAT, V5, P468, DOI 10.1214/10-AOAS377; Wu GJ, 2006, CANCER RES, V66, P9829, DOI 10.1158/0008-5472.CAN-06-0506; Jiao Y, 2007, ACTA PHARMACOL SIN, V28, P1628, DOI 10.1111/j.1745-7254.2007.00647.x; Yao Q, 2009, ONCOL REP, V22, P541, DOI 10.3892/or_00000469; Yokomizo K, 2012, ANTICANCER RES, V32, P1319; Yun HM, 2014, FREE RADICAL BIO MED, V69, P367, DOI 10.1016/j.freeradbiomed.2014.02.001; Zhang J, 2011, MED ONCOL, V28, P494, DOI 10.1007/s12032-010-9489-0; Zhao Y, 2013, INT J MOL SCI, V14, P19670, DOI 10.3390/ijms141019670; Zhiying X, 2013, CENT EUR J IMMUNOL, V38, P416, DOI [10.5114/ceji.2013.39755, DOI 10.5114/CEJI.2013.39755]; Zhu R, 2013, ONCOL REP, V30, P2137, DOI 10.3892/or.2013.2697; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x; Zou H, 2009, ANN STAT, V37, P1733, DOI 10.1214/08-AOS625	74	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141869	10.1371/journal.pone.0141869	http://dx.doi.org/10.1371/journal.pone.0141869			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544691	gold, Green Published, Green Submitted			2022-12-26	WOS:000364398700056
J	Pokrzywa, M; Norum, M; Lengqvist, J; Ghobadpour, M; Abdul-Hussein, S; Moslemi, AR; Tajsharghi, H				Pokrzywa, Malgorzata; Norum, Michaela; Lengqvist, Johan; Ghobadpour, Mehrnaz; Abdul-Hussein, Saba; Moslemi, Ali-Reza; Tajsharghi, Homa			Developmental MYH3 Myopathy Associated with Expression of Mutant Protein and Reduced Expression Levels of Embryonic MyHC	PLOS ONE			English	Article							MYOSIN HEAVY-CHAIN; SKELETAL-MUSCLE; IIB-MYOSIN; IN-VIVO; GENE; MUTATIONS; HYPERTROPHY; ATROPHY; MOUSE; RING	Objective An essential role for embryonic MyHC in foetal development has been found from its association with distal arthrogryposis syndromes, a heterogeneous group of disorders characterised by congenital contractions. The latter probably result from severe myopathy during foetal development. Lack of embryonic muscle biopsy material and suitable animal models has hindered study of the pathomechanisms linking mutations in MYH3 to prenatal myopathy. Methods and Results We determined the pathomechanisms of developmental myopathy caused by recurrent p. Thr178Ile MYH3 heterozygosity, using patient-derived skeletal muscle cells in culture as an experimental disease model to emulate early embryonic development. These cultured cells were processed for discrimination and quantitative analysis of mutant and wild-type MYH3 alleles and MyHC transcripts, real-time RT-qPCR, sequence analysis, immunofluorescence microscopy, immunoblot, and proteomic assessments. Involvement of the ubiquitin proteasome system was investigated in patients with p. Thr178Ile mutations in MYH3 and MYH2. We found equal overall expression of mutant and wild-type MyHC mRNAs and proteins. Compared to the controls, however, expression of embryonic MyHC transcripts and proteins was reduced whereas expression of myosin-specific E3 ubiquitin ligase (MuRF1) was increased. We also found delayed myofibrillogenesis and atrophic myotubes but structured sarcomeres. Conclusion In conclusion, this study suggests that developmental p.Thr178Ile MYH3 myopathy is associated with a combined pathomechanism of insufficient dosage of functional embryonic MyHC and production of mutant protein.	[Pokrzywa, Malgorzata; Norum, Michaela; Ghobadpour, Mehrnaz; Tajsharghi, Homa] Univ Gothenburg, Dept Clin & Med Genet, Gothenburg, Sweden; [Lengqvist, Johan] Univ Gothenburg, Sahlgrenska Acad, Prote Core Facil, Gothenburg, Sweden; [Abdul-Hussein, Saba; Moslemi, Ali-Reza; Tajsharghi, Homa] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Pathol, Gothenburg, Sweden; [Tajsharghi, Homa] Univ Skovde, Sch Biomed, Syst Biol Res Ctr, Skovde, Sweden	University of Gothenburg; University of Gothenburg; University of Gothenburg; University of Skovde	Tajsharghi, H (corresponding author), Univ Gothenburg, Dept Clin & Med Genet, Gothenburg, Sweden.	homa.tajsharghi@gu.se	Pokrzywa, Małgorzata/GQA-6257-2022		Swedish Research Council; Swedish Society of Medicine; Ake Wiberg Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Society of Medicine; Ake Wiberg Foundation	This study was supported by research grants to HT from the Swedish Research Council, the Swedish Society of Medicine, and the Ake Wiberg Foundation. The funding bodies had no role in the design of the study, in data collection and analysis, in the decision to publish or in preparation of the manuscript.	Abdul-Hussein S, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-262; AcakpoSatchivi LJR, 1997, J CELL BIOL, V139, P1219, DOI 10.1083/jcb.139.5.1219; Allen DL, 2000, MICROSC RES TECHNIQ, V50, P492, DOI 10.1002/1097-0029(20000915)50:6<492::AID-JEMT6>3.3.CO;2-A; Allen DL, 2001, AM J PHYSIOL-CELL PH, V280, pC637, DOI 10.1152/ajpcell.2001.280.3.C637; Allen DL, 2001, DEV BIOL, V229, P383, DOI 10.1006/dbio.2000.9974; Alvarado DM, 2011, J BONE JOINT SURG AM, V93A, P1045, DOI 10.2106/JBJS.J.02004; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; FEGHALI R, 1989, J CELL BIOL, V108, P1791, DOI 10.1083/jcb.108.5.1791; Freemont PS, 2000, CURR BIOL, V10, pR84, DOI 10.1016/S0960-9822(00)00287-6; Glass D, 2010, ANN NY ACAD SCI, V1211, P25, DOI 10.1111/j.1749-6632.2010.05809.x; Glass DJ, 2003, NAT CELL BIOL, V5, P87, DOI 10.1038/ncb0203-87; KARSCHMIZRACHI I, 1989, NUCLEIC ACIDS RES, V17, P6167, DOI 10.1093/nar/17.15.6167; Mearini G, 2010, CARDIOVASC RES, V85, P357, DOI 10.1093/cvr/cvp348; Moslemi AR, 2010, NEW ENGL J MED, V362, P1203, DOI 10.1056/NEJMoa0900661; Oldfors A, 2012, ACTA NEUROPATHOLOGIC; Ruppel KM, 1996, MOL BIOL CELL, V7, P1123, DOI 10.1091/mbc.7.7.1123; Sartorius CA, 1998, J CELL BIOL, V141, P943, DOI 10.1083/jcb.141.4.943; Schiaffino S, 2010, ACTA PHYSIOL, V199, P451, DOI 10.1111/j.1748-1716.2010.02130.x; SCHIAFFINO S, 1994, J APPL PHYSIOL, V77, P493, DOI 10.1152/jappl.1994.77.2.493; Schiaffino S, 1996, PHYSIOL REV, V76, P371, DOI 10.1152/physrev.1996.76.2.371; SMERDU V, 1994, AM J PHYSIOL-CELL PH, V267, pC1723, DOI 10.1152/ajpcell.1994.267.6.C1723; Tajsharghi H, 2008, ARCH NEUROL-CHICAGO, V65, P1083, DOI 10.1001/archneur.65.8.1083; Tajsharghi H, 2014, EUR J HUM GENET, V22, P801, DOI 10.1038/ejhg.2013.250; Tajsharghi H, 2010, BRAIN, V133, P1451, DOI 10.1093/brain/awq083; Toydemir RM, 2006, NAT GENET, V38, P561, DOI 10.1038/ng1775; Weiss A, 1996, ANNU REV CELL DEV BI, V12, P417, DOI 10.1146/annurev.cellbio.12.1.417; Weiss A, 1999, P NATL ACAD SCI USA, V96, P2958, DOI 10.1073/pnas.96.6.2958; Willis MS, 2007, CIRC RES, V100, P456, DOI 10.1161/01.RES.0000259559.48597.32; Willis MS, 2009, AM J PHYSIOL-HEART C, V296, pH997, DOI 10.1152/ajpheart.00660.2008	29	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142094	10.1371/journal.pone.0142094	http://dx.doi.org/10.1371/journal.pone.0142094			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544689	Green Submitted, Green Published, gold			2022-12-26	WOS:000364398700080
J	Chauhan, A; Weiss, H; Koch, F; Ibrahim, SM; Vera, J; Wolkenhauer, O; Tiedge, M				Chauhan, Anuradha; Weiss, Heike; Koch, Franziska; Ibrahim, Saleh M.; Vera, Julio; Wolkenhauer, Olaf; Tiedge, Markus			Dissecting Long-Term Glucose Metabolism Identifies New Susceptibility Period for Metabolic Dysfunction in Aged Mice	PLoS One			English	Article							INSULIN REGULATORY SYSTEM; BODY-WEIGHT; ENERGY-BALANCE; MATHEMATICAL-MODELS; ADIPOSE-TISSUE; PLASMA LEPTIN; SECRETION; OBESITY; ACCUMULATION; HOMEOSTASIS	Metabolic disorders, like diabetes and obesity, are pathogenic outcomes of imbalance in glucose metabolism. Nutrient excess and mitochondrial imbalance are implicated in dysfunctional glucose metabolism with age. We used conplastic mouse strains with defined mitochondrial DNA (mtDNA) mutations on a common nuclear genomic background, and administered a high-fat diet up to 18 months of age. The conplastic mouse strain B6-mt(FVB), with a mutation in the mt-Atp8 gene, conferred beta-cell dysfunction and impaired glucose tolerance after high-fat diet. To our surprise, despite of this functional deficit, blood glucose levels adapted to perturbations with age. Blood glucose levels were particularly sensitive to perturbations at the early age of 3 to 6 months. Overall the dynamics consisted of a peak between 3-6 months followed by adaptation by 12 months of age. With the help of mathematical modeling we delineate how body weight, insulin and leptin regulate this non-linear blood glucose dynamics. The model predicted a second rise in glucose between 15 and 21 months, which could be experimentally confirmed as a secondary peak. We therefore hypothesize that these two peaks correspond to two sensitive periods of life, where perturbations to the basal metabolism can mark the system for vulnerability to pathologies at later age. Further mathematical modeling may perspectively allow the design of targeted periods for therapeutic interventions and could predict effects on weight loss and insulin levels under conditions of pre-diabetic obesity.	[Chauhan, Anuradha; Vera, Julio; Wolkenhauer, Olaf] Univ Rostock, Dept Syst Biol & Bioinformat, Inst Comp Sci, D-18055 Rostock, Germany; [Chauhan, Anuradha; Vera, Julio; Wolkenhauer, Olaf] Univ Stellenbosch, Stellenbosch Inst Adv Study STIAS, Wallenberg Res Ctr, ZA-7600 Stellenbosch, South Africa; [Weiss, Heike; Koch, Franziska; Tiedge, Markus] Univ Rostock, Dept Med Biochem & Mol Biol, D-18055 Rostock, Germany; [Ibrahim, Saleh M.] Med Univ Lubeck, Inst Expt Dermatol, D-23538 Lubeck, Germany	University of Rostock; Stellenbosch University; University of Rostock; University of Lubeck	Tiedge, M (corresponding author), Univ Rostock, Dept Med Biochem & Mol Biol, D-18055 Rostock, Germany.	markus.tiedge@med.uni-rostock.de	Koch, Franziska/AAF-2159-2021; Ibrahim, Saleh/AAO-9541-2020; Vera, Julio/O-4134-2015	Ibrahim, Saleh/0000-0001-7827-2290; Koch, Franziska/0000-0002-1798-5374; Vera, Julio/0000-0002-3076-5122	Bundesministerium fur Bildung und Forschung [0315892A]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	Support was provided by Bundesministerium fur Bildung und Forschung (Grant number: 0315892A) to JV and OW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren B, 1997, METABOLISM, V46, P1477, DOI 10.1016/S0026-0495(97)90152-9; ALPERT SS, 1990, AM J CLIN NUTR, V52, P784, DOI 10.1093/ajcn/52.5.784; ANTONETTI VW, 1973, AM J CLIN NUTR, V26, P64, DOI 10.1093/ajcn/26.1.64; Benoit SC, 2004, RECENT PROG HORM RES, V59, P267, DOI 10.1210/rp.59.1.267; Boutayeb A, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-43; BROCK N, 1961, ARZNEIMITTELFORSCH, V11, P1071; Cammisotto PG, 2002, AM J PHYSIOL-CELL PH, V283, pC244, DOI 10.1152/ajpcell.00033.2002; Chow CC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000045; Cobelli Claudio, 2009, IEEE Rev Biomed Eng, V2, P54, DOI 10.1109/RBME.2009.2036073; Collins S, 1996, NATURE, V380, P677, DOI 10.1038/380677a0; Gao AW, 2014, EMBO MOL MED, V6, P580, DOI 10.1002/emmm.201303782; GOLDBETER A, 1991, P NATL ACAD SCI USA, V88, P9107, DOI 10.1073/pnas.88.20.9107; Guo JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015961; Havel PJ, 2000, P NUTR SOC, V59, P359, DOI 10.1017/S0029665100000410; Johannesson B, 2015, EMBO J; Korolev KS, 2014, NAT REV CANCER, V14, P371, DOI 10.1038/nrc3712; Kozusko FP, 2001, B MATH BIOL, V63, P393, DOI 10.1006/bulm.2001.0229; Li JX, 2006, J THEOR BIOL, V242, P722, DOI 10.1016/j.jtbi.2006.04.002; Livingston EH, 2001, J SURG RES, V101, P216, DOI 10.1006/jsre.2001.6286; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Makroglou A, 2006, APPL NUMER MATH, V56, P559, DOI 10.1016/j.apnum.2005.04.023; Malmstrom R, 1996, DIABETOLOGIA, V39, P993; Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774; Naito M, 2011, DIABETES, V60, P2265, DOI 10.2337/db10-1795; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; Pattaranit R, 2008, J R SOC INTERFACE, V5, P1119, DOI 10.1098/rsif.2008.0216; PAYNE PR, 1977, ANN HUM BIOL, V4, P525, DOI 10.1080/03014467700002521; Sainsbury A, 1996, DIABETOLOGIA, V39, P353; Scheen AJ, 2005, DIABETES METAB, V31, pS27; SCHRAER WD, 1999, BIOL STUDY LIFE; Schwartz MW, 2005, SCIENCE, V307, P375, DOI 10.1126/science.1104344; Sethumadhavan S, 2012, J BIOL CHEM, V287, P22174, DOI 10.1074/jbc.M111.327866; Shimizu H, 1997, PEPTIDES, V18, P1263, DOI 10.1016/S0196-9781(97)00137-X; Tam J, 2009, CELL METAB, V9, P52, DOI 10.1016/j.cmet.2008.11.005; Thorens B, 2008, INT J OBESITY, V32, pA62, DOI 10.1038/ijo.2008.208; Varela L, 2012, EMBO REP, V13, P1079, DOI 10.1038/embor.2012.174; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Weiss H, 2012, ENDOCRINOLOGY, V153, P4666, DOI 10.1210/en.2012-1296; WESTERTERP KR, 1995, BRIT J NUTR, V73, P337, DOI 10.1079/BJN19950037; WOLFF SP, 1992, NATURE, V356, P375, DOI 10.1038/356375a0; Yu XH, 2009, HUM MOL GENET, V18, P4689, DOI 10.1093/hmg/ddp432; Yu X, 2009, GENOME RES, V19, P159, DOI 10.1101/gr.078865.108; Zhou B, 2012, P NATL ACAD SCI USA, V109, pE1201, DOI 10.1073/pnas.1119304109	43	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0140858	10.1371/journal.pone.0140858	http://dx.doi.org/10.1371/journal.pone.0140858			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540285	Green Published, Green Submitted, gold			2022-12-26	WOS:000364303800006
J	Huet, S; Gorre, H; Perrocheau, A; Picot, J; Cinier, M				Huet, Simon; Gorre, Harmony; Perrocheau, Anaelle; Picot, Justine; Cinier, Mathieu			Use of the Nanofitin Alternative Scaffold as a GFP-Ready Fusion Tag	PLOS ONE			English	Article							DNA-BINDING PROTEIN; RIBOSOME DISPLAY; SYSTEM; SAC7D; SELECTION; PCR; POLYMERASES; EXPRESSION; ANTIBODIES; EVOLUTION	With the continuous diversification of recombinant DNA technologies, the possibilities for new tailor-made protein engineering have extended on an on-going basis. Among these strategies, the use of the green fluorescent protein (GFP) as a fusion domain has been widely adopted for cellular imaging and protein localization. Following the lead of the direct head-to-tail fusion of GFP, we proposed to provide additional features to recombinant proteins by genetic fusion of artificially derived binders. Thus, we reported a GFP-ready fusion tag consisting of a small and robust fusion-friendly anti-GFP Nanofitin binding domain as a proof-of-concept. While limiting steric effects on the carrier, the GFP-ready tag allows the capture of GFP or its blue (BFP), cyan (CFP) and yellow (YFP) alternatives. Here, we described the generation of the GFP-ready tag from the selection of a Nanofitin variant binding to the GFP and its spectral variants with a nanomolar affinity, while displaying a remarkable folding stability, as demonstrated by its full resistance upon thermal sterilization process or the full chemical synthesis of Nanofitins. To illustrate the potential of the Nanofitin-based tag as a fusion partner, we compared the expression level in Escherichia coli and activity profile of recombinant human tumor necrosis factor alpha (TNF alpha) constructs, fused to a SUMO or GFP-ready tag. Very similar expression levels were found with the two fusion technologies. Both domains of the GFP-ready tagged TNFa were proved fully active in ELISA and interferometry binding assays, allowing the simultaneous capture by an antiTNFa antibody and binding to the GFP, and its spectral mutants. The GFP-ready tag was also shown inert in a L929 cell based assay, demonstrating the potent TNFa mediated apoptosis induction by the GFP-ready tagged TNFa. Eventually, we proposed the GFP-ready tag as a versatile capture and labeling system in addition to expected applications of antiGFP Nanofitins (as illustrated with previously described state-of-the-art anti-GFP binders applied to living cells and in vitro applications). Through a single fusion domain, the GFPready tagged proteins benefit from subsequent customization within a wide range of fluorescence spectra upon indirect binding of a chosen GFP variant.	[Huet, Simon; Gorre, Harmony; Perrocheau, Anaelle; Picot, Justine; Cinier, Mathieu] Affilogic SAS, Nantes, France		Cinier, M (corresponding author), Affilogic SAS, Nantes, France.	mathieu@affilogic.com	Homolka, Miloslav/F-9649-2014	Homolka, Miloslav/0000-0001-9650-1288	Affilogic SAS, Nantes, France	Affilogic SAS, Nantes, France	Affilogic SAS, Nantes, France, provided financial support in the form of salaries for authors SH HG AP JP MC, and participated in study design, conducted the study, and provided data collection, management and interpretation. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. The specific roles of the authors are articulated in the 'author contributions' section. Funder's website: http://www.affilogic.com/.	Behar G, 2013, PROTEIN ENG DES SEL, P1; Behar G, 2014, J BIOTECHNOL, V192, P123, DOI 10.1016/j.jbiotec.2014.10.006; Brauchle M, 2014, BIOL OPEN, V3, P1252, DOI 10.1242/bio.201410041; Buddelmeijer N, 2009, J BACTERIOL, V191, P161, DOI 10.1128/JB.01138-08; Caussinus E, 2012, NAT STRUCT MOL BIOL, V19, P117, DOI 10.1038/nsmb.2180; Chevrel A, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150080; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; Cinier M, 2012, J BIOL INORG CHEM, V17, P399, DOI 10.1007/s00775-011-0863-y; Cinier M, 2009, BIOCONJUGATE CHEM, V20, P2270, DOI 10.1021/bc9002597; Correa A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097438; Ekblad T, 2009, BIOPOLYMERS, V92, P116, DOI 10.1002/bip.21142; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FLICK DA, 1984, J IMMUNOL METHODS, V68, P167, DOI 10.1016/0022-1759(84)90147-9; Gebauer M, 2009, CURR OPIN CHEM BIOL, V13, P245, DOI 10.1016/j.cbpa.2009.04.627; GELLERT M, 1967, P NATL ACAD SCI USA, V57, P148, DOI 10.1073/pnas.57.1.148; Gera N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048928; Gera N, 2011, J MOL BIOL, V409, P601, DOI 10.1016/j.jmb.2011.04.020; Gibson DG, 2010, NAT METHODS, V7, P901, DOI 10.1038/nmeth.1515; Hanes J, 1997, P NATL ACAD SCI USA, V94, P4937, DOI 10.1073/pnas.94.10.4937; Herce HD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3660; Hoffmann A, 2010, PROTEIN EXPRES PURIF, V72, P238, DOI 10.1016/j.pep.2010.03.022; Hussain M, 2013, BIOTECHNOL PROGR, V29, P237, DOI 10.1002/btpr.1655; Izawa D, 2015, NATURE, V517, P631, DOI 10.1038/nature13911; Krehenbrink M, 2008, J MOL BIOL, V383, P1058, DOI 10.1016/j.jmb.2008.09.016; Lee JI, 2010, ENZYME MICROB TECH, V47, P147, DOI 10.1016/j.enzmictec.2010.06.003; Li M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105078; MCAFEE JG, 1995, BIOCHEMISTRY-US, V34, P10063, DOI 10.1021/bi00031a031; Miranda FF, 2011, BIOSENS BIOELECTRON, V26, P4184, DOI 10.1016/j.bios.2011.04.030; Mouratou B, 2007, P NATL ACAD SCI USA, V104, P17983, DOI 10.1073/pnas.0702963104; Mouratou B, 2012, METHODS MOL BIOL, V805, P315, DOI 10.1007/978-1-61779-379-0_18; Pacheco S, 2014, PROTEIN ENG DES SEL, V27, P431, DOI 10.1093/protein/gzu042; Patterson GH, 1997, BIOPHYS J, V73, P2782, DOI 10.1016/S0006-3495(97)78307-3; Ppyun H, 2013, J BIOTECHNOL, V164, P363, DOI 10.1016/j.jbiotec.2013.01.022; Qu M, 2013, MOL CELL, V51, P723, DOI 10.1016/j.molcel.2013.08.030; Robinson H, 1998, NATURE, V392, P202, DOI 10.1038/32455; ROEHM NW, 1991, J IMMUNOL METHODS, V142, P257, DOI 10.1016/0022-1759(91)90114-U; Schaffitzel C, 1999, J IMMUNOL METHODS, V231, P119, DOI 10.1016/S0022-1759(99)00149-0; Schaffitzel C, 2001, PROTEINPROTEIN INTER, P535; Schornack S, 2009, PLANT J, V60, P744, DOI 10.1111/j.1365-313X.2009.03982.x; Skrlec K, 2015, TRENDS BIOTECHNOL, V33, P408, DOI 10.1016/j.tibtech.2015.03.012; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; SMITH HO, 1970, J MOL BIOL, V51, P379, DOI 10.1016/0022-2836(70)90149-X; Tang JCY, 2013, CELL, V154, P928, DOI 10.1016/j.cell.2013.07.021; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Varga I, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-569; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Wang Y, 2004, NUCLEIC ACIDS RES, V32, P1197, DOI 10.1093/nar/gkh271; WEISS B, 1967, P NATL ACAD SCI USA, V57, P1021, DOI 10.1073/pnas.57.4.1021; WINTER G, 1994, ANNU REV IMMUNOL, V12, P433, DOI 10.1146/annurev.iy.12.040194.002245; Wu SW, 2005, PROTEINS, V60, P617, DOI 10.1002/prot.20524; Yang JM, 2004, J BIOMOL STRUCT DYN, V21, P513, DOI 10.1080/07391102.2004.10506945	51	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142304	10.1371/journal.pone.0142304	http://dx.doi.org/10.1371/journal.pone.0142304			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26539718	Green Published, gold, Green Submitted			2022-12-26	WOS:000364303800079
J	Song, YJ; Lim, J; Park, WS; Sohn, H; Lee, MS; Shin, DH; Kim, CB; Kim, H; Oh, GJ; Ki, M				Song, Yeong-Jun; Lim, Jiseun; Park, Woong-Sub; Sohn, Haesook; Lee, Moo-Sik; Shin, Dong-Hoon; Kim, Chun-Bae; Kim, Hwasung; Oh, Gyung-Jae; Ki, Moran			Seropositivity among Korean Young Adults Approximately 2 Years after a Single-Dose Vaccination against Hepatitis A Virus	PLOS ONE			English	Article							ANTIBODY-RESPONSE; IMMUNOGENICITY; VIROSOME; BOOSTER; EPAXAL(R); VACCINES; SAFETY; FEVER	We previously observed 80.7% seropositivity and a significant interaction between gender and hepatitis A virus (HAV) vaccine type (Havrix vs. Epaxal) on the seropositivity approximately 11 months after single-dose HAV vaccinations in Korean young adults. Our objective was to evaluate seropositivity approximately 2 years after a single-dose HAV vaccination and the influence of demographic characteristics on seropositivity, including the interaction between gender and vaccine type. Seronegative medical school students were randomly vaccinated with Havrix or Epaxal. Based on a total serum anti-HAV antibody titer cutoff of 20 IU/ mL, 338 participants (76.0%) of the 445 vaccinees were seropositive 20-25 months after a single-dose HAV vaccination. The seropositive rates were similar after vaccination with Havrix (77.0%) and Epaxal (74.9%). Univariate analysis indicated that female (p = 0.052) and less obese (p < 0.001) participants had a higher seropositive rate, whereas other characteristics such as age, alcohol use, smoking history, vaccine type, and follow-up duration were not associated with seropositivity. Multivariate analysis indicated that women (p = 0.026) and participants with moderate alcohol use (p < 0.001) showed significantly higher seropositive rates than men and participants with no or low alcohol use, respectively. The seropositive rates after vaccination with Havrix and Epaxal were 70.9% and 67.5% in men and 87.7% and 91.3% in women, respectively (p for interaction = 0.304). Compared with the seropositive rate approximately 11 months after vaccination, the seropositive rate decreased substantially only in men in the Havrix group (11.0% points), and consequently, the interaction between gender and vaccine type disappeared while seropositivity remained high (87.7% and 91.3% in Havrix and Epaxal groups, respectively) among women approximately 2 years after vaccination. Further studies are needed to assess whether the seropositive rate would be maintained in all groups more than 2 years after a single-dose HAV vaccination.	[Song, Yeong-Jun; Lim, Jiseun] Eulji Univ, Sch Med, Dept Prevent Med, Daejeon, South Korea; [Park, Woong-Sub] Kwandong Univ, Dept Prevent Med & Publ Hlth, Coll Med, Kangnung, South Korea; [Sohn, Haesook] Inje Univ, Sch Med, Dept Prevent Med, Busan, South Korea; [Lee, Moo-Sik] Konyang Univ, Dept Prevent Med, Coll Med, Daejeon, South Korea; [Shin, Dong-Hoon] Keimyung Univ, Sch Med, Dept Prevent Med, Daegu, South Korea; [Kim, Chun-Bae] Yonsei Univ, Wonju Coll Med, Inst Poverty Alleviat & Int Dev, Dept Prevent Med, Wonju, South Korea; [Kim, Hwasung] Soonchunhyang Univ, Coll Med, Dept Prevent Med, Cheonan, South Korea; [Oh, Gyung-Jae] Wonkwang Univ, Sch Med, Dept Prevent Med, Iksan, South Korea; [Ki, Moran] Natl Canc Ctr, Grad Sch Canc Sci & Policy, Dept Canc Control & Policy, Goyang, South Korea	Eulji University; Catholic Kwandong University; Inje University; Konyang University; Konyang University Hospital; Keimyung University; Yonsei University; Soonchunhyang University; Wonkwang University; National Cancer Center - Korea (NCC)	Ki, M (corresponding author), Natl Canc Ctr, Grad Sch Canc Sci & Policy, Dept Canc Control & Policy, Goyang, South Korea.	moranki@naver.com	Ki, Moran/R-6600-2019	Ki, Moran/0000-0002-8892-7104	National Research Foundation of Korea (KR) [2010-0022066]	National Research Foundation of Korea (KR)	This work was funded by National Research Foundation of Korea (KR) (http://www.nrf.re.kr/nrf_tot_cms/index.jsp?pmi-sso-return2=none), grant number 2010-0022066, to MK.	Ambrosch F, 2004, INFECTION, V32, P149, DOI 10.1007/s15010-004-3147-4; Baber TF H-BJ, 2001, ALCOHOL USE DISORDER; Beck BR, 2003, CLIN INFECT DIS, V37, pE126, DOI 10.1086/378890; Bovier PA, 1999, J TRAVEL MED, V6, P228, DOI 10.1111/j.1708-8305.1999.tb00523.x; Chun Sung-Soo, 2005, J Prev Med Public Health, V38, P307; D'Acremont V, 2006, J TRAVEL MED, V13, P78, DOI 10.1111/j.1708-8305.2006.00001.x; Hatz C, 2011, CLIN VACCINE IMMUNOL, V18, P885, DOI 10.1128/CVI.00358-10; Holzer BR, 1996, VACCINE, V14, P982, DOI 10.1016/0264-410X(96)00042-4; Kim SS, 2008, ARCH PSYCHIAT NURS, V22, P190, DOI 10.1016/j.apnu.2007.07.005; Landry P, 2000, VACCINE, V19, P399, DOI 10.1016/S0264-410X(00)00188-2; Lim J, 2014, YONSEI MED J, V55, P126, DOI 10.3349/ymj.2014.55.1.126; Maiwald H, 1997, VACCINE, V15, P346, DOI 10.1016/S0264-410X(97)00211-9; Ott JJ, 2013, INT J INFECT DIS, V17, pE939, DOI 10.1016/j.ijid.2013.04.012; Overbosch D, 2005, J TRAVEL MED, V12, P319, DOI 10.2310/7060.2005.12604; Park SH, 2012, SUBST ABUS, V33, P327, DOI 10.1080/08897077.2012.662209; WHO/IASO/IOTF, 2000, ASIA PACIFIC PERSPEC	16	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142297	10.1371/journal.pone.0142297	http://dx.doi.org/10.1371/journal.pone.0142297			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540392	Green Published, gold, Green Submitted			2022-12-26	WOS:000364303800077
J	Goh, S; Han, K; Ryu, J; Kim, S; Choi, M				Goh, Segun; Han, Kyungreem; Ryu, Jehkwang; Kim, Seonjin; Choi, MooYoung			Failure of Arm Movement Control in Stroke Patients, Characterized by Loss of Complexity	PLOS ONE			English	Article							PHYSIOLOGICAL TIME-SERIES; THEORETICAL-MODEL; POSTURAL TREMOR; ENTROPY; NETWORK; NONLINEARITY; TRANSITIONS; DYNAMICS	We study the mechanism of human arm-posture control by means of nonlinear dynamics and quantitative time series analysis methods. Utilizing linear and nonlinear measures in combination, we find that pathological tremors emerge in patient dynamics and serve as a main feature discriminating between normal and patient groups. The deterministic structure accompanied with loss of complexity inherent in the tremor dynamics is also revealed. To probe the underlying mechanism of the arm-posture dynamics, we further analyze the coupling patterns between joints and components, and discuss their roles in breaking of the organization structure. As a result, we elucidate the mechanisms in the arm-posture dynamics of normal subjects responding to the gravitational force and for the reduction of the dynamic degrees of freedom in the patient dynamics. This study provides an integrated framework for the origin of the loss of complexity in the dynamics of patients as well as the coupling structure in the arm-posture dynamics.	[Goh, Segun; Han, Kyungreem; Choi, MooYoung] Seoul Natl Univ, Dept Phys & Astron, Seoul 151747, South Korea; [Goh, Segun; Han, Kyungreem; Choi, MooYoung] Seoul Natl Univ, Ctr Theoret Phys, Seoul 151747, South Korea; [Ryu, Jehkwang] Seoul Natl Univ, Coll Humanities, Inst Cognit Sci, Seoul 151742, South Korea; [Kim, Seonjin] Seoul Natl Univ, Dept Phys Educ, Seoul 151748, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Choi, M (corresponding author), Seoul Natl Univ, Dept Phys & Astron, Seoul 151747, South Korea.	mychoi@snu.ac.kr	Goh, Segun/E-5471-2018	Goh, Segun/0000-0003-3027-8815; Choi, MooYoung/0000-0001-8070-7716	National Research Foundation of Korea [2012R1A2A4A01004419, 2011-0012331, 2014R1A6A3A01059467, 2010-0021103]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the National Research Foundation of Korea, through grants 2012R1A2A4A01004419 and 2011-0012331 (MYC), 2014R1A6A3A01059467 (SG), and 2010-0021103 (SK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MU, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.061918; Barnett L, 2014, J NEUROSCI METH, V223, P50, DOI 10.1016/j.jneumeth.2013.10.018; Bartsch R, 2007, PHYSICA A, V383, P455, DOI 10.1016/j.physa.2007.04.120; BOCK O, 1990, BEHAV BRAIN RES, V41, P167, DOI 10.1016/0166-4328(90)90106-O; Cabrera JL, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.158702; Cantu H, 2014, HUM MOVEMENT SCI, V35, P1, DOI 10.1016/j.humov.2014.02.003; Cavanaugh JT, 2005, SPORTS MED, V35, P935, DOI 10.2165/00007256-200535110-00002; Chen YQ, 1997, PHYS REV LETT, V79, P4501, DOI 10.1103/PhysRevLett.79.4501; COLLINS JJ, 1994, PHYS REV LETT, V73, P764, DOI 10.1103/PhysRevLett.73.764; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; Dingwell JB, 2000, CHAOS, V10, P848, DOI 10.1063/1.1324008; ECKMANN JP, 1992, PHYSICA D, V56, P185, DOI 10.1016/0167-2789(92)90023-G; Elble RJ, 1996, J CLIN NEUROPHYSIOL, V13, P133, DOI 10.1097/00004691-199603000-00004; Eurich CW, 1996, PHYS REV E, V54, P6681, DOI 10.1103/PhysRevE.54.6681; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Gao ZK, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/30005; Gao ZK, 2015, SCI REP-UK, V5, DOI 10.1038/srep08222; Gao ZK, 2015, EXP THERM FLUID SCI, V60, P157, DOI 10.1016/j.expthermflusci.2014.09.008; Gao ZK, 2012, NONLINEAR ANAL-REAL, V13, P947, DOI 10.1016/j.nonrwa.2011.08.029; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; GRASSBERGER P, 1983, PHYSICA D, V9, P189, DOI 10.1016/0167-2789(83)90298-1; GRASSBERGER P, 1983, PHYS REV A, V28, P2591, DOI 10.1103/PhysRevA.28.2591; HAKEN H, 1985, BIOL CYBERN, V51, P347, DOI 10.1007/BF00336922; HARWELL R C, 1983, Microsurgery, V4, P187, DOI 10.1002/micr.1920040310; Hirose A, 2008, NEURAL INFORM PROCES; Hsu WL, 2007, J NEUROPHYSIOL, V97, P3024, DOI 10.1152/jn.01142.2006; James EG, 2013, HUM MOVEMENT SCI, V32, P147, DOI 10.1016/j.humov.2012.11.003; Kantz H., 2005, NONLINEAR TIME SERIE, V2nd; Lakie M, 2010, EXP PHYSIOL, V95, P441, DOI 10.1113/expphysiol.2009.047555; McAuley JH, 2000, BRAIN, V123, P1545, DOI 10.1093/brain/123.8.1545; MORASSO P, 1981, EXP BRAIN RES, V42, P223; Morrison S, 2008, PARKINSONISM RELAT D, V14, P298, DOI 10.1016/j.parkreldis.2007.09.004; Patzelt F, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.238103; Pellegrini B, 2004, J NEUROSCI METH, V139, P185, DOI 10.1016/j.jneumeth.2004.04.025; Renyi A., 1961, MEASURES ENTROPY INF; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Ryu J, 2011, J SPORT EXERCISE PSY, V33, pS106; Schreiber T, 1996, PHYS REV LETT, V77, P635, DOI 10.1103/PhysRevLett.77.635; Shen Y, 2003, CLIN NEUROPHYSIOL, V114, P199, DOI 10.1016/S1388-2457(02)00338-3; Stam CJ, 2005, CLIN NEUROPHYSIOL, V116, P2266, DOI 10.1016/j.clinph.2005.06.011; Stergiou N, 2011, HUM MOVEMENT SCI, V30, P869, DOI 10.1016/j.humov.2011.06.002; Suzuki Y, 2012, J THEOR BIOL, V310, P55, DOI 10.1016/j.jtbi.2012.06.019; Takens F, 1981, DYNAMICAL SYSTEMS TU; TASS P, 1995, J BIOL PHYS, V21, P83, DOI 10.1007/BF00705593; THEILER J, 1986, PHYS REV A, V34, P2427, DOI 10.1103/PhysRevA.34.2427; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; UNO Y, 1989, BIOL CYBERN, V61, P89, DOI 10.1007/BF00204593; Vaillancourt DE, 2000, CLIN NEUROPHYSIOL, V111, P2046, DOI 10.1016/S1388-2457(00)00467-3; Winter DA, 1998, J NEUROPHYSIOL, V80, P1211, DOI 10.1152/jn.1998.80.3.1211; Yao W, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.021902	50	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141996	10.1371/journal.pone.0141996	http://dx.doi.org/10.1371/journal.pone.0141996			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536132	gold, Green Published, Green Submitted			2022-12-26	WOS:000364298400115
J	Stowe, C; Pizzey, A; Kalber, T; Badar, A; Lythgoe, M; Pule, M				Stowe, Cassandra; Pizzey, Arnold; Kalber, Tammy; Badar, Adam; Lythgoe, Mark; Pule, Martin			Flow-Based Single Cell Deposition for High-Throughput Screening of Protein Libraries	PLOS ONE			English	Article							RED-FLUORESCENT PROTEINS; LUCIFERASE MUTANTS; IMAGE-ANALYSIS; SELECTION; REPORTER; DESIGN	The identification and engineering of proteins having refined or novel characteristics is an important area of research in many scientific fields. Protein modelling has enabled the rational design of unique proteins, but high-throughput screening of large libraries is still required to identify proteins with potentially valuable properties. Here we report on the development and evaluation of a novel fluorescent activated cell sorting based screening platform. Single bacterial cells, expressing a protein library to be screened, are electronically sorted and deposited onto plates containing solid nutrient growth media in a dense matrix format of between 44 and 195 colonies/cm(2). We show that this matrix format is readily applicable to machine interrogation (<30 seconds per plate) and subsequent bioinformatic analysis (similar to 60 seconds per plate) thus enabling the high-throughput screening of the protein library. We evaluate this platform and show that bacteria containing a bioluminescent protein can be spectrally analysed using an optical imager, and a rare clone (0.5% population) can successfully be identified, picked and further characterised. To further enhance this screening platform, we have developed a prototype electronic sort stream multiplexer, that when integrated into a commercial flow cytometric sorter, increases the rate of colony deposition by 89.2% to 24 colonies per second. We believe that the screening platform described here is potentially the foundation of a new generation of high-throughput screening technologies for proteins.	[Stowe, Cassandra; Pizzey, Arnold; Pule, Martin] UCL, Dept Haematol, Inst Canc, Div Med, London, England; [Stowe, Cassandra; Kalber, Tammy; Badar, Adam; Lythgoe, Mark] UCL, Div Med, Ctr Adv Biomed Imaging, London, England	University of London; University College London; University of London; University College London	Pizzey, A (corresponding author), UCL, Dept Haematol, Inst Canc, Div Med, London, England.	a.pizzey@cancer.ucl.ac.uk		Lythgoe, Mark/0000-0002-4945-0171; Pule, Martin/0000-0002-8347-9867; Kalber, Tammy/0000-0002-3378-3748	EPSCR [EP/L006472/1]; King's College London and UCL Comprehensive Cancer Imaging Centre CR-UK; MRC; DoH (England); Medical Research Council [MR/J013110/1]; National Centre for the Replacement, Reduction and Refinement of Animal in Research (NC3Rs); UK Regenerative Medicine Platform Safety Hub [MRC: MR/K026739/1]; Eli Lilly and Company; EPSRC;  [BB/J012955/1]; Biotechnology and Biological Sciences Research Council [1331513] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/L006472/1] Funding Source: researchfish; Medical Research Council [MR/K026739/1] Funding Source: researchfish; EPSRC [EP/L006472/1] Funding Source: UKRI; MRC [MR/J013110/1, MR/K026739/1] Funding Source: UKRI	EPSCR; King's College London and UCL Comprehensive Cancer Imaging Centre CR-UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); DoH (England); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Centre for the Replacement, Reduction and Refinement of Animal in Research (NC3Rs)(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)); UK Regenerative Medicine Platform Safety Hub; Eli Lilly and Company(Eli Lilly); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); ; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding: TK is funded by an EPSCR Early Career Fellowship (EP/L006472/1). AB and ML receives funding from the King's College London and UCL Comprehensive Cancer Imaging Centre CR-UK & EPSRC, in association with the MRC and DoH (England): ML also receives funding from Medical Research Council (MR/J013110/1); the National Centre for the Replacement, Reduction and Refinement of Animal in Research (NC3Rs); UK Regenerative Medicine Platform Safety Hub (MRC: MR/K026739/1); Eli Lilly and Company. Funding was provided by BB/J012955/1 (http://www.bbsrc.ac.uk/); Biospace Laboratories provide the PhotonIMAGER (TM) Optima Optical imaging system. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam V, 2014, CURR OPIN CHEM BIOL, V20, P92, DOI 10.1016/j.cbpa.2014.05.016; Bean GJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085177; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Branchini BR, 2005, ANAL BIOCHEM, V345, P140, DOI 10.1016/j.ab.2005.07.015; Branchini BR, 2010, ANAL BIOCHEM, V396, P290, DOI 10.1016/j.ab.2009.09.009; Dahiyat BI, 1997, SCIENCE, V278, P82, DOI 10.1126/science.278.5335.82; Davidson MW, 2009, NAT METHODS, V6, P713, DOI 10.1038/nmeth1009-713; Dean KM, 2015, INTEGR BIOL-UK, V7, P263, DOI 10.1039/c4ib00251b; Hellinga HW, 1998, NAT STRUCT BIOL, V5, P525, DOI 10.1038/776; Kennedy D, 2011, APPL ENVIRON MICROB, V77, P4657, DOI 10.1128/AEM.00323-11; Keyaerts M, 2012, TRENDS MOL MED, V18, P164, DOI 10.1016/j.molmed.2012.01.005; Krutzik PO, 2006, NAT METHODS, V3, P361, DOI 10.1038/NMETH872; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; Law GHE, 2006, BIOCHEM J, V397, P305, DOI 10.1042/BJ20051847; Leader B, 2008, NAT REV DRUG DISCOV, V7, P21, DOI 10.1038/nrd2399; Loening AM, 2007, NAT METHODS, V4, P641, DOI 10.1038/NMETH1070; Lomenick B, 2011, ACS CHEM BIOL, V6, P34, DOI 10.1021/cb100294v; Luker KE, 2004, P NATL ACAD SCI USA, V101, P12288, DOI 10.1073/pnas.0404041101; Olsen M, 2000, CURR OPIN BIOTECH, V11, P331, DOI 10.1016/S0958-1669(00)00108-7; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Shapiro E, 2005, PROTEIN ENG DES SEL, V18, P581, DOI 10.1093/protein/gzi066; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Zhang MS, 2012, NAT METHODS, V9, P727, DOI [10.1038/NMETH.2021, 10.1038/nmeth.2021]	25	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140730	10.1371/journal.pone.0140730	http://dx.doi.org/10.1371/journal.pone.0140730			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536118	Green Published, gold, Green Submitted			2022-12-26	WOS:000364298400034
J	Kreitler, J; Schloss, CA; Soong, O; Hannah, L; Davis, FW				Kreitler, Jason; Schloss, Carrie A.; Soong, Oliver; Hannah, Lee; Davis, Frank W.			Conservation Planning for Offsetting the Impacts of Development: A Case Study of Biodiversity and Renewable Energy in the Mojave Desert	PLOS ONE			English	Article							NO NET LOSS; ENVIRONMENTAL IMPACTS; DISTRIBUTION MODELS; LAND; SCALE	Balancing society's competing needs of development and conservation requires careful consideration of tradeoffs. Renewable energy development and biodiversity conservation are often considered beneficial environmental goals. The direct footprint and disturbance of renewable energy, however, can displace species' habitat and negatively impact populations and natural communities if sited without ecological consideration. Offsets have emerged as a potentially useful tool to mitigate residual impacts after trying to avoid, minimize, or restore affected sites. Yet the problem of efficiently designing a set of offset sites becomes increasingly complex where many species or many sites are involved. Spatial conservation prioritization tools are designed to handle this problem, but have seen little application to offset siting and analysis. To address this need we designed an offset siting support tool for the Desert Renewable Energy Conservation Plan (DRECP) of California, and present a case study of hypothetical impacts from solar development in the Western Mojave subsection. We compare two offset scenarios designed to mitigate a hypothetical 15,331 ha derived from proposed utility-scale solar energy development (USSED) projects. The first scenario prioritizes offsets based precisely on impacted features, while the second scenario offsets impacts to maximize biodiversity conservation gains in the region. The two methods only agree on 28% of their prioritized sites and differ in meeting species-specific offset goals. Differences between the two scenarios highlight the importance of clearly specifying choices and priorities for offset siting and mitigation in general. Similarly, the effects of background climate and land use change may lessen the durability or effectiveness of offsets if not considered. Our offset siting support tool was designed specifically for the DRECP area, but with minor code modification could work well in other offset analyses, and could provide continuing support for a potentially innovative mitigation solution to environmental impacts.	[Kreitler, Jason; Schloss, Carrie A.] US Geol Survey, Western Geog Sci Ctr, Boise, ID 83702 USA; [Soong, Oliver; Hannah, Lee; Davis, Frank W.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Hannah, Lee] Conservat Int, Betty & Gordon Moore Ctr Sci & Oceans, Arlington, VA USA	United States Department of the Interior; United States Geological Survey; University of California System; University of California Santa Barbara; Conservation International	Kreitler, J (corresponding author), US Geol Survey, Western Geog Sci Ctr, Boise, ID 83702 USA.	jkreitler@usgs.gov	Davis, Frank W./B-7010-2009	Davis, Frank W./0000-0002-4643-5718	California Energy Commission [500-10-021]; U.S. Geological Survey Land Change Science program	California Energy Commission; U.S. Geological Survey Land Change Science program	This project was funded under California Energy Commission Contract#500-10-021 (http://www.energy.ca.gov/) and through the U.S. Geological Survey Land Change Science program (http://www.usgs.gov/climate_landuse/lcs/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi SA, 2000, APPL ENERG, V65, P121, DOI 10.1016/S0306-2619(99)00077-X; Ball I. R., 2009, SPATIAL CONSERVATION, P185, DOI DOI 10.1111/EVA.12631; BBOP (Business and Biodiversity Offsets Programme), 2012, NO NET LOSS LOSS GAI; Beier P, 2010, CONSERV BIOL, V24, P701, DOI 10.1111/j.1523-1739.2009.01422.x; Bull JW, 2014, CONSERV BIOL, V28, P799, DOI 10.1111/cobi.12243; Bull JW, 2013, FRONT ECOL ENVIRON, V11, P203, DOI 10.1890/120020; Cameron DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038437; Davis FW, 2006, ECOL SOC, V11; Davis FW, 2015, CEC5002015062; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Franklin J, 2013, DIVERS DISTRIB, V19, P1217, DOI 10.1111/ddi.12125; Franklin J, 2013, GLOBAL CHANGE BIOL, V19, P473, DOI 10.1111/gcb.12051; Gardner TA, 2013, CONSERV BIOL, V27, P1254, DOI 10.1111/cobi.12118; Gibbons Philip, 2007, Ecological Management & Restoration, V8, P26, DOI 10.1111/j.1442-8903.2007.00328.x; Gordon A, 2011, ENVIRON MODELL SOFTW, V26, P1481, DOI 10.1016/j.envsoft.2011.07.021; Goudey C.B., 1994, ECOLOGICAL UNITS CAL; Habib TJ, 2013, CONSERV BIOL, V27, P1313, DOI 10.1111/cobi.12098; Hannah L, 2005, BIOSCIENCE, V55, P231, DOI 10.1641/0006-3568(2005)055[0231:TVFTCE]2.0.CO;2; Heller NE, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00313.1; Hernandez RR, 2014, RENEW SUST ENERG REV, V29, P766, DOI 10.1016/j.rser.2013.08.041; Hernandez RR, 2015, NAT CLIM CHANGE, V5, P353, DOI 10.1038/nclimate2556; Kiesecker JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017566; Kiesecker JM, 2010, FRONT ECOL ENVIRON, V8, P261, DOI 10.1890/090005; Kiesecker JM, 2009, BIOSCIENCE, V59, P77, DOI 10.1525/bio.2009.59.1.11; Kreitler J, 2015, DRYAD DIGITAL REPOSI, DOI [10.5061/dryad.ks5dr, DOI 10.5061/DRYAD.KS5DR]; Laitila J, 2014, METHODS ECOL EVOL, V5, P1247, DOI 10.1111/2041-210X.12287; Lovich JE, 1999, ENVIRON MANAGE, V24, P309, DOI 10.1007/s002679900235; Lovich JE, 2011, BIOSCIENCE, V61, P982, DOI 10.1525/bio.2011.61.12.8; Madsen B., 2010, STATE BIODIVERSITY M; Maron M, 2013, CONSERV LETT, V6, P359, DOI 10.1111/conl.12007; Maron M, 2012, BIOL CONSERV, V155, P141, DOI 10.1016/j.biocon.2012.06.003; McKenney BA, 2010, ENVIRON MANAGE, V45, P165, DOI 10.1007/s00267-009-9396-3; Moilanen A., 2009, SPATIAL CONSERVATION, P28; Moilanen A., 2009, SPATIAL CONSERVATION; Moilanen A, 2007, BIOL CONSERV, V134, P571, DOI 10.1016/j.biocon.2006.09.008; Moilanen A, 2013, WILDLIFE RES, V40, P153, DOI 10.1071/WR12083; Moilanen A, 2009, RESTOR ECOL, V17, P470, DOI 10.1111/j.1526-100X.2008.00382.x; Overton JM, 2013, AMBIO, V42, P100, DOI 10.1007/s13280-012-0342-x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Quetier F, 2014, ENVIRON SCI POLICY, V38, P120, DOI 10.1016/j.envsci.2013.11.009; Quetier F, 2011, BIOL CONSERV, V144, P2991, DOI 10.1016/j.biocon.2011.09.002; R Core Team, 2012, R LANG ENV STAT COMP; Schloss CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028788; Spencer W, 2014, RECOMMENDATIONS INDE; Stoms DM, 2013, RENEW ENERG, V57, P289, DOI 10.1016/j.renene.2013.01.055; ten Kate K., 2004, BIODIVERSITY OFFSETS; Underwood JG, 2011, ENVIRON MANAGE, V47, P121, DOI 10.1007/s00267-010-9589-9; van Teeffelen AJA, 2014, LANDSCAPE URBAN PLAN, V130, P64, DOI 10.1016/j.landurbplan.2014.06.004; Watson JEM, 2013, NAT CLIM CHANGE, V3, P989, DOI [10.1038/NCLIMATE2007, 10.1038/nclimate2007]; Webb RH, 2009, MOJAVE DESERT, P343	51	14	14	1	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0140226	10.1371/journal.pone.0140226	http://dx.doi.org/10.1371/journal.pone.0140226			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529595	Green Published, gold			2022-12-26	WOS:000364032600004
J	Khandokar, YB; Srivastava, P; Sarker, S; Swarbrick, CMD; Aragao, D; Cowieson, N; Forwood, JK				Khandokar, Yogesh B.; Srivastava, Parul; Sarker, Subir; Swarbrick, Crystall M. D.; Aragao, David; Cowieson, Nathan; Forwood, Jade K.			Structural and Functional Characterization of the PaaI Thioesterase from Streptococcus pneumoniae Reveals a Dual Specificity for Phenylacetyl-CoA and Medium-chain Fatty Acyl-CoAs and a Novel CoA-induced Fit Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEGATIVE COOPERATIVITY; CATALYTIC MECHANISM; FOLD THIOESTERASE; SITES REACTIVITY; REFINEMENT; PURIFICATION; SELECTIVITY; SCATTERING; SYSTEM; HALF	PaaI thioesterases are members of the TE13 thioesterase family that catalyze the hydrolysis of thioester bonds between coenzyme A and phenylacetyl-CoA. In this study we characterize the PaaI thioesterase from Streptococcus pneumoniae (SpPaaI), including structural analysis based on crystal diffraction data to 1.8-angstrom resolution, to reveal two double hotdog domains arranged in a back to back configuration. Consistent with the crystallography data, both size exclusion chromatography and small angle x-ray scattering data support a tetrameric arrangement of thioesterase domains in solution. Assessment of SpPaaI activity against a range of acyl-CoA substrates showed activity for both phenylacetyl-CoA and medium-chain fatty-acyl CoA substrates. Mutagenesis of putative active site residues reveals Asn37, Asp52, and Thr68 are important for catalysis, and size exclusion chromatography analysis and x-ray crystallography confirm that these mutants retain the same tertiary and quaternary structures, establishing that the reduced activity is not a result of structural perturbations. Interestingly, the structure of SpPaaI in the presence of CoA provides a structural basis for the observed substrate specificity, accommodating a 10-carbon fatty acid chain, and a large conformational change of up to 38 angstrom in the N terminus, and a loop region involving Tyr(38)-Tyr(39). This is the first time PaaI thioesterases have displayed a dual specificity for medium-chain acyl-CoAs substrates and phenylacetyl-CoA substrates, and we provide a structural basis for this specificity, highlighting a novel induced fit mechanism that is likely to be conserved within members of this enzyme family.	[Khandokar, Yogesh B.; Srivastava, Parul; Swarbrick, Crystall M. D.; Forwood, Jade K.] Charles Sturt Univ, Sch Biomed Sci, Boorooma St, Wagga Wagga, NSW 2678, Australia; [Sarker, Subir] Charles Sturt Univ, Sch Anim & Vet Sci, Boorooma St, Wagga Wagga, NSW 2678, Australia; [Aragao, David; Cowieson, Nathan] Australian Synchrotron, Blackburn Rd, Clayton, Vic 3168, Australia	Charles Sturt University; Charles Sturt University	Forwood, JK (corresponding author), Charles Sturt Univ, Sch Biomed Sci, Boorooma St, Wagga Wagga, NSW 2678, Australia.	jforwood@csu.edu.au	Sarker, Subir/U-8444-2019; Aragao, David/A-1695-2012; Aragao, David/AAV-5514-2021	Sarker, Subir/0000-0002-2685-8377; Aragao, David/0000-0002-6551-4657; Aragao, David/0000-0002-6551-4657; KHANDOKAR, YOGESH/0000-0002-4630-8508; Swarbrick, Crystall/0000-0002-9337-3361; Forwood, Jade/0000-0003-3267-9997				ADAMS MJ, 1969, NATURE, V224, P491, DOI 10.1038/224491a0; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Cantu DC, 2014, CHEM-EUR J, V20, P9045, DOI 10.1002/chem.201304228; Cantu DC, 2011, NUCLEIC ACIDS RES, V39, pD342, DOI 10.1093/nar/gkq1072; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eschenfeldt William H., 2009, V498, P105, DOI 10.1007/978-1-59745-196-3_7; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Forwood JK, 2007, P NATL ACAD SCI USA, V104, P10382, DOI 10.1073/pnas.0700974104; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hunt MC, 2002, J BIOL CHEM, V277, P1128, DOI 10.1074/jbc.M106458200; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Koshland DE, 1996, CURR OPIN STRUC BIOL, V6, P757, DOI 10.1016/S0959-440X(96)80004-2; Kunishima N, 2005, J MOL BIOL, V352, P212, DOI 10.1016/j.jmb.2005.07.008; LEVITZKI A, 1971, BIOCHEMISTRY-US, V10, P3371, DOI 10.1021/bi00794a009; Marfori M, 2011, J BIOL CHEM, V286, P35643, DOI 10.1074/jbc.M111.225953; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Rodriguez-Guilbe M, 2013, J BIOL CHEM, V288, P10841, DOI 10.1074/jbc.M112.446765; Song F, 2006, J BIOL CHEM, V281, P11028, DOI 10.1074/jbc.M513896200; Song F, 2012, BIOCHEMISTRY-US, V51, P7000, DOI 10.1021/bi301059m; STALLCUP WB, 1973, J MOL BIOL, V80, P41, DOI 10.1016/0022-2836(73)90232-5; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Swarbrick CMD, 2014, J BIOL CHEM, V289, P24263, DOI 10.1074/jbc.M114.589408; Tilton GB, 2004, J BIOL CHEM, V279, P7487, DOI 10.1074/jbc.M309532200; Wei J, 2009, BIOCHEM J, V421, P311, DOI 10.1042/BJ20090039; Willis MA, 2008, BIOCHEMISTRY-US, V47, P2797, DOI 10.1021/bi702336d; Yamada J, 1996, ARCH BIOCHEM BIOPHYS, V326, P106, DOI 10.1006/abbi.1996.0053; Zhuang ZH, 2012, BIOCHEMISTRY-US, V51, P786, DOI 10.1021/bi2013917	36	6	6	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1866	1876		10.1074/jbc.M115.677484	http://dx.doi.org/10.1074/jbc.M115.677484			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26538563	Green Published, hybrid			2022-12-26	WOS:000368620700026
J	Kuruganti, S; Miersch, S; Deshpande, A; Speir, JA; Harris, BD; Schriewer, JM; Buller, RML; Sidhu, SS; Walter, MR				Kuruganti, Srilalitha; Miersch, Shane; Deshpande, Ashlesha; Speir, Jeffrey A.; Harris, Bethany D.; Schriewer, Jill M.; Buller, R. Mark L.; Sidhu, Sachdev S.; Walter, Mark R.			Cytokine Activation by Antibody Fragments Targeted to Cytokine-Receptor Signaling Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; conformational change; cytokine; interferon; phage display; protein structure; receptor; receptor	I-INTERFERON; BINDING-SITE; TUMOR MICROENVIRONMENT; ELECTRON-MICROSCOPY; ALPHA; RESPONSES; THERAPY; INNATE; APOPTOSIS; SUBTYPES	Background: Cytokines are administered to patients to eliminate viral infections and cancer yet often have side effects. Results: Antibody fragments have been designed that recognize cytokine-receptor complexes and change cytokine biological activity profiles. Conclusion: Designed proteins enhance interferon antiviral activity without inducing antiproliferative signaling pathways. Significance: Antibody fragments targeted to cytokine-receptor complexes provide new tools for manipulating cytokine signaling. Exogenous cytokine therapy can induce systemic toxicity, which might be prevented by activating endogenously produced cytokines in local cell niches. Here we developed antibody-based activators of cytokine signaling (AcCS), which recognize cytokines only when they are bound to their cell surface receptors. AcCS were developed for type I interferons (IFNs), which induce cellular activities by binding to cell surface receptors IFNAR1 and IFNAR2. As a potential alternative to exogenous IFN therapy, AcCS were shown to potentiate the biological activities of natural IFNs by approximate to 100-fold. Biochemical and structural characterization demonstrates that the AcCS stabilize the IFN-IFNAR2 binary complex by recognizing an IFN-induced conformational change in IFNAR2. Using IFN mutants that disrupt IFNAR1 binding, AcCS were able to enhance IFN antiviral potency without activating antiproliferative responses. This suggests AcCS can be used to manipulate cytokine signaling for basic science and possibly for therapeutic applications.	[Kuruganti, Srilalitha; Deshpande, Ashlesha; Harris, Bethany D.; Walter, Mark R.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Miersch, Shane; Sidhu, Sachdev S.] Univ Toronto, Donnelly Ctr, Banting & Best Dept Med Sci, Toronto, ON M5G 1L6, Canada; [Speir, Jeffrey A.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, Natl Resource Automated Mol Microscopy, La Jolla, CA 92037 USA; [Schriewer, Jill M.; Buller, R. Mark L.] St Louis Univ, Hlth Sci Ctr, Dept Microbiol & Immunol, St Louis, MO 63104 USA	University of Alabama System; University of Alabama Birmingham; University of Toronto; Scripps Research Institute; Saint Louis University	Walter, MR (corresponding author), Univ Alabama Birmingham, Dept Microbiol, 1025 18th St S, Birmingham, AL 35294 USA.	walter@uab.edu			NIGMS, National Institutes of Health [GM103310]; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097629, R01AI049342] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103310] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Access to the Biacore T-200 was made possible by the University of Alabama at Birmingham Multidisciplinary Molecular Interaction Core. EM work was performed at the National Resource for Automated Molecular Microscopy, which is supported by NIGMS, National Institutes of Health Grant GM103310. We thank Bridget Carragher and Carragher/Potter laboratory members for many helpful discussions regarding EM processing, Makoto Hijikata for HuS-E/2 cells and protocols for their growth, and Tamas Jilling for assistance with qPCR studies.	Akdis M, 2011, J ALLERGY CLIN IMMUN, V127, P701, DOI 10.1016/j.jaci.2010.11.050; Baldo BA, 2014, DRUG SAFETY, V37, P921, DOI 10.1007/s40264-014-0226-z; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Chawla-Sarkar M, 2003, APOPTOSIS, V8, P237, DOI 10.1023/A:1023668705040; Chill JH, 2002, BIOCHEMISTRY-US, V41, P3575, DOI 10.1021/bi011778f; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; de la Rosa-Trevin JM, 2013, J STRUCT BIOL, V184, P321, DOI 10.1016/j.jsb.2013.09.015; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Deshpande A, 2013, PROTEIN SCI, V22, P1100, DOI 10.1002/pro.2285; Espert L, 2003, J BIOL CHEM, V278, P16151, DOI 10.1074/jbc.M209628200; Fellouse FAS, 2007, MAKING USING ANTIBOD, P157; Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703; Garcin G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4016; George PM, 2012, PHARMACOL THERAPEUT, V135, P44, DOI 10.1016/j.pharmthera.2012.03.006; Gough DJ, 2012, IMMUNITY, V36, P166, DOI 10.1016/j.immuni.2012.01.011; Herzer K, 2009, CANCER RES, V69, P855, DOI 10.1158/0008-5472.CAN-08-2831; Honke N, 2012, NAT IMMUNOL, V13, P51, DOI 10.1038/ni.2169; Junttila IS, 2012, NAT CHEM BIOL, V8, P990, DOI [10.1038/NCHEMBIO.1096, 10.1038/nchembio.1096]; Kalie E, 2008, J BIOL CHEM, V283, P32925, DOI 10.1074/jbc.M806019200; Kuruganti S, 2014, PROTEIN EXPRES PURIF, V103, P75, DOI 10.1016/j.pep.2014.08.010; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Lavoie TB, 2011, CYTOKINE, V56, P282, DOI 10.1016/j.cyto.2011.07.019; Leonard JP, 1997, BLOOD, V90, P2541; Levin AM, 2012, NATURE, V484, P529, DOI 10.1038/nature10975; Levin D, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004998; Levin D, 2011, MOL CELL BIOL, V31, P3252, DOI 10.1128/MCB.05251-11; Lewerenz M, 1998, J MOL BIOL, V282, P585, DOI 10.1006/jmbi.1998.2026; Liu ZH, 2007, BLOOD, V110, P2408, DOI 10.1182/blood-2007-04-083998; Ludtke SJ, 2010, METHODS MOL BIOL, V673, P157, DOI 10.1007/978-1-60761-842-3_9; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Moraga I, 2015, CELL, V160, P1196, DOI 10.1016/j.cell.2015.02.011; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Pan MJ, 2008, BIOCHEMISTRY-US, V47, P12018, DOI 10.1021/bi801588g; Pasche N, 2012, DRUG DISCOV TODAY, V17, P583, DOI 10.1016/j.drudis.2012.01.007; Persson H, 2013, J MOL BIOL, V425, P803, DOI 10.1016/j.jmb.2012.11.037; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piehler J, 2012, IMMUNOL REV, V250, P317, DOI 10.1111/imr.12001; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; POCKAJ BA, 1994, J IMMUNOTHER, V15, P22, DOI 10.1097/00002371-199401000-00003; Radhakrishnan R, 1996, STRUCTURE, V4, P1453, DOI 10.1016/S0969-2126(96)00152-9; Roisman LC, 2005, J MOL BIOL, V353, P271, DOI 10.1016/j.jmb.2005.08.042; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sorzano COS, 2010, J STRUCT BIOL, V171, P197, DOI 10.1016/j.jsb.2010.03.011; Spangler JB, 2015, ANNU REV IMMUNOL, V33, P139, DOI 10.1146/annurev-immunol-032713-120211; Striz I, 2014, CLIN SCI, V126, P593, DOI 10.1042/CS20130497; Strunk JJ, 2008, J MOL BIOL, V377, P725, DOI 10.1016/j.jmb.2008.01.017; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Taniguchi T, 2001, NAT REV MOL CELL BIO, V2, P378, DOI 10.1038/35073080; Thomas C, 2011, CELL, V146, P621, DOI 10.1016/j.cell.2011.06.048; Tsugawa Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089869; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Weitzner BD, 2014, PROTEINS, V82, P1611, DOI 10.1002/prot.24534; Yang XM, 2014, CANCER CELL, V25, P37, DOI 10.1016/j.ccr.2013.12.004	55	9	10	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					447	461		10.1074/jbc.M115.665943	http://dx.doi.org/10.1074/jbc.M115.665943			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26546677	hybrid, Green Published			2022-12-26	WOS:000367589500040
J	Dumont, BL; Devlin, AA; Truempy, DM; Miller, JC; Singh, ND				Dumont, Beth L.; Devlin, Amy A.; Truempy, Dana M.; Miller, Jennifer C.; Singh, Nadia D.			No Evidence that Infection Alters Global Recombination Rate in House Mice	PLoS One			English	Article							CROSSING-OVER; DROSOPHILA-MELANOGASTER; MEIOTIC RECOMBINATION; ANTAGONISTIC COEVOLUTION; CHIASMA FREQUENCY; GENETIC-ANALYSIS; 3RD CHROMOSOME; HUMAN GENOME; RED QUEEN; TEMPERATURE	Recombination rate is a complex trait, with genetic and environmental factors shaping observed patterns of variation. Although recent studies have begun to unravel the genetic basis of recombination rate differences between organisms, less attention has focused on the environmental determinants of crossover rates. Here, we test the effect of one ubiquitous environmental pressure-bacterial infection-on global recombination frequency in mammals. We applied MLH1 mapping to assay global crossover rates in male mice infected with the pathogenic bacterium Borrelia burgdorferi, the causative agent of Lyme Disease, and uninfected control animals. Despite ample statistical power to identify biologically relevant differences between infected and uninfected animals, we find no evidence for a global recombination rate response to bacterial infection. Moreover, broad-scale patterns of crossover distribution, including the number of achiasmate bivalents, are not affected by infection status. Although pathogen exposure can plastically increase recombination in some species, our findings suggest that recombination rates in house mice may be resilient to at least some forms of infection stress. This negative result motivates future experiments with alternative house mouse pathogens to evaluate the generality of this conclusion.	[Dumont, Beth L.] N Carolina State Univ, Initiat Biol Complex, Raleigh, NC 27695 USA; [Dumont, Beth L.; Devlin, Amy A.; Truempy, Dana M.; Miller, Jennifer C.; Singh, Nadia D.] N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Dumont, BL (corresponding author), N Carolina State Univ, Initiat Biol Complex, Raleigh, NC 27695 USA.	bldumont@ncsu.edu; ndsingh@ncsu.edu			North Carolina State University (NCSU); Initiative in Biological Complexity at NCSU; National Institute of General Medical Sciences at the National Institutes of Health [1K99GM110332]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM110332] Funding Source: NIH RePORTER	North Carolina State University (NCSU); Initiative in Biological Complexity at NCSU; National Institute of General Medical Sciences at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: This work was supported by startup funds provided by North Carolina State University (NCSU) to NDS and JCM. BLD is supported by a distinguished postdoctoral research fellowship with the Initiative in Biological Complexity at NCSU and a K99/R00 Pathway to Independence Award from the National Institute of General Medical Sciences at the National Institutes of Health (1K99GM110332; http://www.nigms.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by North Carolina State University (NCSU) start-up funds to NDS and JCM. BLD is supported by a distinguished postdoctoral research fellowship with the Initiative in Biological Complexity at NCSU and a K99/R00 Pathway to Independence Award from the National Institute of General Medical Sciences (1K99GM110332).	Abdullah MFF, 2001, P NATL ACAD SCI USA, V98, P14524, DOI 10.1073/pnas.201529598; Agrawal AF, 2005, GENETICS, V171, P803, DOI 10.1534/genetics.105.041301; Anderson LK, 1999, GENETICS, V151, P1569; Andronic L, 2012, CAN J PLANT SCI, V92, P1083, DOI [10.4141/CJPS2011-197, 10.4141/cjps2011-197]; Auton A, 2012, SCIENCE, V336, P193, DOI 10.1126/science.1216872; Barthold S.W., 1992, LYME DIS MOL IMMUNOL, P223; BARTHOLD SW, 1990, J INFECT DIS, V162, P133, DOI 10.1093/infdis/162.1.133; BARTHOLD SW, 1991, AM J PATHOL, V139, P263; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Becker SD, 2007, LAB ANIM-UK, V41, P229, DOI 10.1258/002367707780378203; BELYAEV DK, 1982, BIOL ZBL, V101, P705; Borodin PM, 2008, GENETICS, V178, P621, DOI 10.1534/genetics.107.079665; Brick K, 2012, NATURE, V485, P642, DOI 10.1038/nature11089; Bridges CB, 1927, J GEN PHYSIOL, V8, P689, DOI 10.1085/jgp.8.6.689; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Busch JW, 2004, EVOLUTION, V58, P2584, DOI 10.1111/j.0014-3820.2004.tb00886.x; CHARLESWORTH B, 1985, HEREDITY, V54, P71, DOI 10.1038/hdy.1985.10; Cheng EY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000661; CHINNICI JP, 1971, GENETICS, V69, P85; Chowdhury R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000648; Coop G, 2008, SCIENCE, V319, P1395, DOI 10.1126/science.1151851; Coop G, 2007, NAT REV GENET, V8, P23, DOI 10.1038/nrg1947; DOWRICK G. J., 1957, HEREDITY, V11, P37, DOI 10.1038/hdy.1957.4; Dumont BL, 2008, EVOLUTION, V62, P276, DOI 10.1111/j.1558-5646.2007.00278.x; Dumont BL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002116; Dumont BL, 2011, GENETICS, V187, P643, DOI 10.1534/genetics.110.123851; Dumont BL, 2009, GENETICS, V182, P1345, DOI 10.1534/genetics.109.105114; Fledel-Alon A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020321; Fukuyama H, 2013, P NATL ACAD SCI USA, V110, P10717, DOI 10.1073/pnas.1304380110; HAMILTON WD, 1980, OIKOS, V35, P282, DOI 10.2307/3544435; HAMILTON WD, 1990, P NATL ACAD SCI USA, V87, P3566, DOI 10.1073/pnas.87.9.3566; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hastey CJ, 2012, J IMMUNOL, V188, P5612, DOI 10.4049/jimmunol.1103735; HENDERSON SA, 1988, HEREDITY, V60, P387, DOI 10.1038/hdy.1988.57; HENDERSON SA, 1968, NATURE, V218, P22, DOI 10.1038/218022a0; HENDERSON SA, 1989, HEREDITY, V62, P77, DOI 10.1038/hdy.1989.10; Holloway JK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000186; Hussin J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002251; Jaenlke J., 1978, EVOL THEORY, V94, P191; Jokela J, 2009, AM NAT, V174, pS43, DOI 10.1086/599080; Kauppi L, 2011, SCIENCE, V331, P916, DOI 10.1126/science.1195774; KIDWELL MG, 1972, GENETICS, V70, P419; Koehler KE, 2002, GENETICS, V162, P297; Kong A, 2004, NAT GENET, V36, P1203, DOI 10.1038/ng1445; Kong A, 2008, SCIENCE, V319, P1398, DOI 10.1126/science.1152422; Lucht JM, 2002, NAT GENET, V30, P311, DOI 10.1038/ng846; Lynch M, 2007, ORIGINS GENOME ARCHI; Ma Y, 1998, INFECT IMMUN, V66, P161, DOI 10.1128/IAI.66.1.161-168.1998; Miller JC, 2003, INFECT IMMUN, V71, P6943, DOI 10.1128/IAI.71.12.6943-6952.2003; Moro D, 2003, J WILDLIFE DIS, V39, P762, DOI 10.7589/0090-3558-39.4.762; Morran LT, 2011, SCIENCE, V333, P216, DOI 10.1126/science.1206360; Mostowy R, 2012, J EVOLUTION BIOL, V25, P2033, DOI 10.1111/j.1420-9101.2012.02584.x; Murdoch B, 2010, MAMM GENOME, V21, P550, DOI 10.1007/s00335-010-9303-5; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Neel JV, 1941, GENETICS, V26, P506; PARSONS PA, 1988, BIOL J LINN SOC, V35, P49, DOI 10.1111/j.1095-8312.1988.tb00458.x; Parvanov ED, 2010, SCIENCE, V327, P835, DOI 10.1126/science.1181495; Peters AD, 1999, AM NAT, V154, P393, DOI 10.1086/303247; Peters AHFM, 1997, CHROMOSOME RES, V5, P66, DOI 10.1023/A:1018445520117; Phillips D, 2015, NEW PHYTOL, V208, P421, DOI 10.1111/nph.13548; Plough HH, 1917, J EXP ZOOL, V24, P147, DOI 10.1002/jez.1400240202; Plough HH, 1921, J EXP ZOOL, V32, P187, DOI 10.1002/jez.1400320202; POWELL JERREL B., 1963, CROP SCI, V3, P11, DOI 10.2135/cropsci1963.0011183X000300010005x; R Core Team, 2018, R LANG ENV STAT COMP; Radolf JD, 2012, NAT REV MICROBIOL, V10, P87, DOI 10.1038/nrmicro2714; SAGE RD, 1986, NATURE, V324, P60, DOI 10.1038/324060a0; Sandor C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002854; Schmid-Hempel P, 2002, AM NAT, V160, P403, DOI 10.1086/341517; Singh ND, 2015, SCIENCE, V349, P747, DOI 10.1126/science.aab1768; Smith HF, 1936, NATURE, V138, P329, DOI 10.1038/138329b0; Smukowski CS, 2011, HEREDITY, V107, P496, DOI 10.1038/hdy.2011.44; Song J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004226; Soper DM, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2013.1091; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Stern C, 1926, P NATL ACAD SCI USA, V12, P530, DOI 10.1073/pnas.12.8.530; Stevison LS, 2010, J MOL EVOL, V71, P332, DOI 10.1007/s00239-010-9388-1; Sun F, 2004, AM J HUM GENET, V74, P521, DOI 10.1086/382138; Susiarjo M, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030005; Tedman-Aucoin K, 2012, EVOLUTION, V66, P575, DOI 10.1111/j.1558-5646.2011.01450.x; Thomsen H, 2001, MAMM GENOME, V12, P724, DOI 10.1007/s00335-001-2068-0; Vrooman LA, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004949; Webb AJ, 2008, P NATL ACAD SCI USA, V105, P10471, DOI 10.1073/pnas.0804933105; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322; Zuckert WR, 2005, CURR PROT MICROBIOL, V4	85	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2015	10	11							e0142266	10.1371/journal.pone.0142266	http://dx.doi.org/10.1371/journal.pone.0142266			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7AC	26550833	Green Submitted, gold, Green Published			2022-12-26	WOS:000364422800020
J	Cowell, WJ; Bellinger, DC; Coull, BA; Gennings, C; Wright, RO; Wright, RJ				Cowell, Whitney J.; Bellinger, David C.; Coull, Brent A.; Gennings, Chris; Wright, Robert O.; Wright, Rosalind J.			Associations between Prenatal Exposure to Black Carbon and Memory Domains in Urban Children: Modification by Sex and Prenatal Stress	PLOS ONE			English	Article							AIR-POLLUTION EXPOSURE; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; MATERNAL STRESS; DEVELOPMENTAL TOXICITY; PARTICULATE MATTER; POSTNATAL EXPOSURE; GENDER-DIFFERENCES; DEVELOPING BRAIN; BIRTH-WEIGHT; HEALTH	Background Whether fetal neurodevelopment is disrupted by traffic-related air pollution is uncertain. Animal studies suggest that chemical and non-chemical stressors interact to impact neurodevelopment, and that this association is further modified by sex. Objectives To examine associations between prenatal traffic-related black carbon exposure, prenatal stress, and sex with children's memory and learning. Methods Analyses included N = 258 mother-child dyads enrolled in a Boston, Massachusetts pregnancy cohort. Black carbon exposure was estimated using a validated spatiotemporal landuse regression model. Prenatal stress was measured using the Crisis in Family Systems-Revised survey of negative life events. The Wide Range Assessment of Memory and Learning (WRAML2) was administered at age 6 years; outcomes included the General Memory Index and its component indices [Verbal, Visual, and Attention Concentration]. Relationships between black carbon and WRAML2 index scores were examined using multivariable-adjusted linear regression including effect modification by stress and sex. Results Mothers were primarily minorities (60% Hispanic, 26% Black); 67% had <= 12 years of education. The main effect for black carbon was not significant for any WRAML2 index; however, in stratified analyses, among boys with high exposure to prenatal stress, Attention Concentration Index scores were on average 9.5 points lower for those with high compared to low prenatal black carbon exposure (P3-way interaction = 0.04). Conclusion The associations between prenatal exposure to black carbon and stress with children's memory scores were stronger in boys than in girls. Studies assessing complex interactions may more fully characterize health risks and, in particular, identify vulnerable subgroups.	[Cowell, Whitney J.] Columbia Univ, Mailman Sch Publ Hlth, Dept Environm Hlth Sci, New York, NY USA; [Bellinger, David C.] Childrens Hosp, Boston, MA 02115 USA; [Bellinger, David C.; Coull, Brent A.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Coull, Brent A.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Gennings, Chris; Wright, Robert O.] Icahn Sch Med Mt Sinai, Dept Prevent Med, New York, NY 10029 USA; [Wright, Robert O.; Wright, Rosalind J.] Icahn Sch Med Mt Sinai, Kravis Childrens Hosp, Dept Pediat, New York, NY 10029 USA; [Wright, Robert O.; Wright, Rosalind J.] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA	Columbia University; Harvard University; Boston Children's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Wright, RJ (corresponding author), Icahn Sch Med Mt Sinai, Kravis Childrens Hosp, Dept Pediat, New York, NY 10029 USA.	rosalind.wright@mssm.edu		Wright, Robert/0000-0003-1180-6459	National Institute of Environmental Health Science [R01ES010932, P30ES023515, P30ES000002, T32ES007322, R01ES013744]; National Heart, Lung and Blood Institute [U01HL072494, R01HL080674]; National Institute of Minority Health and Health Disparities [R01MD006086]; U.S. Environmental Protection Agency [RD-834798-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL072494, R01HL080674] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010932, P30ES023515, P30ES000002, T32ES007322] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD006086] Funding Source: NIH RePORTER	National Institute of Environmental Health Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); U.S. Environmental Protection Agency(United States Environmental Protection Agency); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The Asthma Coalition on Community, Environment and Social Stress (ACCESS) project has been funded by grants R01ES010932 (National Institute of Environmental Health Science http://www.niehs.nih.gov/), U01HL072494, R01HL080674 (National Heart, Lung and Blood Institute http://www.nhlbi.nih.gov/), and R01MD006086 (National Institute of Minority Health and Health Disparities http://www.nimhd.nih.gov/) (RJW, PI). Phenotyping and biostatistical support was funded by P30ES023515 CG, ROW, RJW) and P30ES000002 (BAC) (National Institute of Environmental Health Science http://www.niehs.nih.gov/). During preparation of this manuscript, authors were supported by T32ES007322 (WJC) and R01ES013744 (ROW) (National Institute of Environmental Health Science http://www.niehs.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CLEAN Air Center dedicated to air pollution estimates was funded by U.S. Environmental Protection Agency grant RD-834798-01 (http://www.epa.gov/). Its contents are solely the responsibility of the grantee and do not necessarily represent the official views of the USEPA. Further, USEPA does not endorse the purchase of any commercial products or services mentioned in the publication.	Adams W, 2008, ESSENTIALS WRAML2 TO; Aguiar A, 2010, ENVIRON HEALTH PERSP, V118, P1646, DOI 10.1289/ehp.1002326; Allen JL, 2014, ENVIRON HEALTH PERSP, V122, P939, DOI 10.1289/ehp.1307984; Arcangeli T, 2012, ULTRASOUND OBST GYN, V40, P267, DOI 10.1002/uog.11112; Berry CA, 2006, PSYCHOL REP, V98, P123, DOI 10.2466/PRO.98.1.123-132; Block ML, 2012, NEUROTOXICOLOGY, V33, P972, DOI 10.1016/j.neuro.2012.08.014; Bolton JL, 2014, BRAIN BEHAV IMMUN, V37, P30, DOI 10.1016/j.bbi.2013.10.029; Bolton JL, 2013, ENVIRON HEALTH PERSP, V121, P1075, DOI 10.1289/ehp.1306560; Bolton JL, 2012, FASEB J, V26, P4743, DOI 10.1096/fj.12-210989; Bowman RE, 2009, PHYSIOL BEHAV, V97, P21, DOI 10.1016/j.physbeh.2009.01.012; Bowman RE, 2005, J NEUROENDOCRINOL, V17, P526, DOI 10.1111/j.1365-2826.2005.01335.x; Bronson SL, 2014, ENDOCRINOLOGY, V155, P2635, DOI 10.1210/en.2014-1040; Chiu YHM, 2013, ENVIRON HEALTH PERSP, V121, P859, DOI 10.1289/ehp.1205940; Chiu YHM, 2012, AM J RESP CRIT CARE, V186, P147, DOI 10.1164/rccm.201201-0162OC; Clayton JA, 2014, NATURE, V509, P282, DOI 10.1038/509282a; Cordier S, 2002, ENVIRON RES, V89, P1, DOI 10.1006/enrs.2002.4349; Cory-Slechta DA, 2004, ENVIRON HEALTH PERSP, V112, P717, DOI 10.1289/ehp.6481; Cory-Slechta DA, 2008, BASIC CLIN PHARMACOL, V102, P218, DOI 10.1111/j.1742-7843.2007.00189.x; Davis EP, 2014, PSYCHONEUROENDOCRINO, V49, P11, DOI 10.1016/j.psyneuen.2014.06.014; Edwards SC, 2010, ENVIRON HEALTH PERSP, V118, P1326, DOI 10.1289/ehp.0901070; Ema M, 2013, REPROD TOXICOL, V42, P1, DOI 10.1016/j.reprotox.2013.06.074; Engel SM, 2010, ENVIRON HEALTH PERSP, V118, P565, DOI 10.1289/ehp.0901470; Erickson AC, 2014, J ENVIRON PUBLIC HEA, V2014, DOI 10.1155/2014/901017; Fougnie D., 2008, NEW RES SHORT TERM M, DOI 10.3389/conf.fnhum.2011.207.00576; Genc S, 2012, J TOXICOL-US, V2012, DOI 10.1155/2012/782462; Giedd JN, 1997, PROG NEURO-PSYCHOPH, V21, P1185, DOI 10.1016/S0278-5846(97)00158-9; Grahame TJ, 2014, J AIR WASTE MANAGE, V64, P620, DOI 10.1080/10962247.2014.912692; Grandjean P, 1997, NEUROTOXICOL TERATOL, V19, P417, DOI 10.1016/S0892-0362(97)00097-4; Green HF, 2014, NEUROSCI BIOBEHAV R, V40, P20, DOI 10.1016/j.neubiorev.2014.01.004; Gryparis A, 2007, J R STAT SOC C-APPL, V56, P183, DOI 10.1111/j.1467-9876.2007.00573.x; Gutteling BM, 2006, J ABNORM CHILD PSYCH, V34, P789, DOI 10.1007/s10802-006-9054-7; Guxens M, 2014, EPIDEMIOLOGY, V25, P636, DOI 10.1097/EDE.0000000000000133; Guxens M, 2012, ENVIRON HEALTH PERSP, V120, P144, DOI 10.1289/ehp.1103469; Hauser TU, 2014, JAMA PSYCHIAT, V71, P1165, DOI 10.1001/jamapsychiatry.2014.1093; Horton MK, 2012, NEUROTOXICOL TERATOL, V34, P534, DOI 10.1016/j.ntt.2012.07.004; Hougaard KS, 2007, NEUROTOXICOL TERATOL, V29, P425, DOI 10.1016/j.ntt.2007.02.003; Khandaker GM, 2013, PSYCHOL MED, V43, P239, DOI 10.1017/S0033291712000736; Kim E, 2014, SCI TOTAL ENVIRON, V481, P439, DOI 10.1016/j.scitotenv.2014.01.107; Knuesel I, 2014, NAT REV NEUROL, V10, P643, DOI 10.1038/nrneurol.2014.187; Lakshmanan A, 2015, ENVIRON RES, V137, P268, DOI 10.1016/j.envres.2014.10.035; Leal G, 2014, REGULATION HIPPOCAMP; Levesque S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-105; Llop S, 2013, TOXICOLOGY, V311, P3, DOI 10.1016/j.tox.2013.04.015; Luine V, 2002, STRESS, V5, P205, DOI 10.1080/1025389021000010549; Maccari S, 2007, PSYCHONEUROENDOCRINO, V32, pS10, DOI 10.1016/j.psyneuen.2007.06.005; Mueller BR, 2007, PHYSIOL BEHAV, V91, P55, DOI 10.1016/j.physbeh.2007.01.017; Myers HF, 2009, J BEHAV MED, V32, P9, DOI 10.1007/s10865-008-9181-4; Newman NC, 2013, ENVIRON HEALTH PERSP, V121, P731, DOI 10.1289/ehp.1205555; Oken Emily, 2003, BMC Pediatr, V3, P6, DOI 10.1186/1471-2431-3-6; Pedersen M, 2013, LANCET RESP MED, V1, P695, DOI 10.1016/S2213-2600(13)70192-9; Perera F, 2012, ENVIRON HEALTH PERSP, V120, P1190, DOI 10.1289/ehp.1104492; Perera FP, 2012, ENVIRON HEALTH PERSP, V120, P921, DOI 10.1289/ehp.1104315; Perera FP, 2009, PEDIATRICS, V124, pE195, DOI 10.1542/peds.2008-3506; Ramirez-Amaya V, 2001, J NEUROSCI, V21, P7340; Sacher J, 2013, MAGN RESON IMAGING, V31, P366, DOI 10.1016/j.mri.2012.06.007; Sagiv SK, 2012, ARCH PEDIAT ADOL MED, V166, P1123, DOI 10.1001/archpediatrics.2012.1286; Sagiv SK, 2012, ENVIRON HEALTH PERSP, V120, P904, DOI 10.1289/ehp.1104372; Schneider ML, 2002, PSYCHONEUROENDOCRINO, V27, P285, DOI 10.1016/S0306-4530(01)00050-6; Schwarz JM, 2008, J NEUROCHEM, V105, P1561, DOI 10.1111/j.1471-4159.2008.05384.x; Semmler A, 2005, J CHEM NEUROANAT, V30, P144, DOI 10.1016/j.jchemneu.2005.07.003; Shalowitz MU, 1998, HEALTH SERV RES, V33, P1381; Sheslow D, 2003, WIDE RANGE ASSESSMEN; Shors TJ, 2004, TRENDS NEUROSCI, V27, P250, DOI 10.1016/j.tins.2004.03.007; Suglia SF, 2008, AM J EPIDEMIOL, V167, P280, DOI 10.1093/aje/kwm308; Tau GZ, 2010, NEUROPSYCHOPHARMACOL, V35, P147, DOI 10.1038/npp.2009.115; Vahter M, 2007, ENVIRON RES, V104, P70, DOI 10.1016/j.envres.2006.10.001; Volk HE, 2011, ENVIRON HEALTH PERSP, V119, P873, DOI 10.1289/ehp.1002835; Wang SQ, 2009, ENVIRON HEALTH PERSP, V117, P1612, DOI 10.1289/ehp.0800023; Weinstock M., 2015, ADV NEUROBIOLOGY, V10; Weston HI, 2014, NEUROTOXICOLOGY, V44, P169, DOI 10.1016/j.neuro.2014.06.013; Wright RJ, 2008, CIENC SAUDE COLETIVA, V13, P1729, DOI 10.1590/S1413-81232008000600008; Wright RJ, 2009, CURR OPIN PEDIATR, V21, P222, DOI 10.1097/MOP.0b013e3283292629; Zanchi ACT, 2010, INHAL TOXICOL, V22, P910, DOI 10.3109/08958378.2010.494313	74	40	41	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142492	10.1371/journal.pone.0142492	http://dx.doi.org/10.1371/journal.pone.0142492			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544967	Green Published, Green Submitted, gold			2022-12-26	WOS:000364398700146
J	Dai, XX; Duan, X; Cui, XS; Kim, NH; Xiong, B; Sun, SC				Dai, Xiao-Xin; Duan, Xing; Cui, Xiang-Shun; Kim, Nam-Hyung; Xiong, Bo; Sun, Shao-Chen			Melamine Induces Oxidative Stress in Mouse Ovary	PLOS ONE			English	Article							CYANURIC ACID; IN-VITRO; APOPTOSIS; DAMAGE; CELL; PROLIFERATION; REPRODUCTION; FERTILITY; FOLLICLES; TOXICITY	Melamine is a nitrogen heterocyclic triazine compound which is widely used as an industrial chemical. Although melamine is not considered to be acutely toxic with a high LD50 in animals, food contaminated with melamine expose risks to the human health. Melamine has been reported to be responsible for the renal impairment in mammals, its toxicity on the reproductive system, however, has not been adequately assessed. In the present study, we examined the effect of melamine on the follicle development and ovary formation. The data showed that melamine increased reactive oxygen species (ROS) levels, and induced granulosa cell apoptosis as well as follicle atresia. To further analyze the mechanism by which melamine induces oxidative stress, the expression and activities of two key antioxidant enzymes superoxide dismutase (SOD) and glutathi-one peroxidase (GPX) were analyzed, and the concentration of malondialdehyde (MDA) were compared between control and melamine-treated ovaries. The result revealed that melamine changed the expression and activities of SOD and GPX in the melamine-treated mice. Therefore, we demonstrate that melamine causes damage to the ovaries via oxidative stress pathway.	[Dai, Xiao-Xin; Duan, Xing; Xiong, Bo; Sun, Shao-Chen] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing 210095, Jiangsu, Peoples R China; [Cui, Xiang-Shun; Kim, Nam-Hyung] Chungbuk Natl Univ, Dept Anim Sci, Cheongju 361763, South Korea	Nanjing Agricultural University; Chungbuk National University	Sun, SC (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing 210095, Jiangsu, Peoples R China.	sunsc@njau.edu.cn			Natural Science Foundation of Jiangsu Province [BK20140030]; Biogreen 21 Program, RDA, Republic of Korea [PJ011126]	Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Biogreen 21 Program, RDA, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was supported by the Natural Science Foundation of Jiangsu Province (BK20140030) and the Biogreen 21 Program (PJ011126), RDA, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Natural Science Foundation of Jiangsu Province (BK20140030) and the Biogreen 21 Program (PJ011126), RDA, Republic of Korea.	Agarwal A, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-28; Agarwal A, 2008, ANTIOXID REDOX SIGN, V10, P1375, DOI 10.1089/ars.2007.1964; Agarwal A, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-49; Al-Gubory KH, 2010, INT J BIOCHEM CELL B, V42, P1634, DOI 10.1016/j.biocel.2010.06.001; BOCK M, 1957, BRIT J PHARM CHEMOTH, V12, P1; Borgeest C, 2002, TOXICOL SCI, V68, P473, DOI 10.1093/toxsci/68.2.473; Chiu J, 2012, TRENDS CELL BIOL, V22, P592, DOI 10.1016/j.tcb.2012.08.002; Cook HA, 2005, ELECTROPHORESIS, V26, P1576, DOI 10.1002/elps.200410058; Cooke MS, 2006, CLIN CHIM ACTA, V365, P30, DOI 10.1016/j.cca.2005.09.009; Corn CM, 2005, FERTIL STERIL, V84, P627, DOI 10.1016/j.fertnstert.2005.03.061; Duan X, 2015, HUM REPROD, V30, P1643, DOI 10.1093/humrep/dev091; El Mouatassim S, 1999, MOL HUM REPROD, V5, P720, DOI 10.1093/molehr/5.8.720; Galazyn-Sidorczuk M, 2009, CHEM-BIOL INTERACT, V180, P31, DOI 10.1016/j.cbi.2009.01.014; GENEROSO WM, 1988, MUTAT RES, V199, P175, DOI 10.1016/0027-5107(88)90243-6; Guo CZ, 2012, CELL BIOL INT, V36, P183, DOI 10.1042/CBI20110036; Han YG, 2011, CELL MOL NEUROBIOL, V31, P65, DOI 10.1007/s10571-010-9554-4; Hau AKC, 2009, J AM SOC NEPHROL, V20, P245, DOI 10.1681/ASN.2008101065; Ingelfinger JR, 2008, NEW ENGL J MED, V359, P2745, DOI 10.1056/NEJMp0808410; Jewgenow K, 1999, THERIOGENOLOGY, V51, P745, DOI 10.1016/S0093-691X(99)00023-0; Lam HS, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2991; Lu X, 2015, FISH SHELLFISH IMMUN, V42, P58, DOI 10.1016/j.fsi.2014.10.027; Mates JM, 2012, ARCH TOXICOL, V86, P1649, DOI 10.1007/s00204-012-0906-3; Momose-Sato Y, 2009, EUR J NEUROSCI, V29, P1, DOI 10.1111/j.1460-9568.2008.06568.x; Neerman MF, 2004, INT J PHARMACEUT, V281, P129, DOI 10.1016/j.ijpharm.2004.04.023; Parry J, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1802; Puschner B, 2011, CLIN LAB MED, V31, P181, DOI 10.1016/j.cll.2010.10.003; Rashid K, 2013, FOOD CHEM TOXICOL, V62, P584, DOI 10.1016/j.fct.2013.09.026; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Skinner CG, 2010, J MED TOXICOL, V6, P50, DOI 10.1007/s13181-010-0038-1; TILLY JL, 1995, ENDOCRINOLOGY, V136, P242, DOI 10.1210/en.136.1.242; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Wang W, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102467; Xue M, 2011, REGUL TOXICOL PHARM, V61, P93, DOI 10.1016/j.yrtph.2011.06.005; Yin RH, 2013, RES VET SCI, V94, P618, DOI 10.1016/j.rvsc.2012.11.010	34	16	16	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142564	10.1371/journal.pone.0142564	http://dx.doi.org/10.1371/journal.pone.0142564			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545251	Green Submitted, Green Published, gold			2022-12-26	WOS:000364398700156
J	Golle, K; Muehlbauer, T; Wick, D; Granacher, U				Golle, Kathleen; Muehlbauer, Thomas; Wick, Ditmar; Granacher, Urs			Physical Fitness Percentiles of German Children Aged 9-12 Years: Findings from a Longitudinal Study	PLOS ONE			English	Article							CARDIORESPIRATORY FITNESS; METABOLIC RISK; FIELD-TESTS; LMS METHOD; VALUES; ADOLESCENTS; PERFORMANCE; STRENGTH; GROWTH; POWER	Background Generating percentile values is helpful for the identification of children with specific fitness characteristics (i. e., low or high fitness level) to set appropriate fitness goals (i. e., fitness/ health promotion and/or long-term youth athlete development). Thus, the aim of this longitudinal study was to assess physical fitness development in healthy children aged 9-12 years and to compute sex-and age-specific percentile values. Methods Two-hundred and forty children (88 girls, 152 boys) participated in this study and were tested for their physical fitness. Physical fitness was assessed using the 50-m sprint test (i. e., speed), the 1-kg ball push test, the triple hop test (i. e., upper-and lower-extremity muscular power), the stand-and-reach test (i. e., flexibility), the star run test (i. e., agility), and the 9-min run test (i. e., endurance). Age-and sex-specific percentile values (i. e., P-10 to P-90) were generated using the Lambda, Mu, and Sigma method. Adjusted (for change in body weight, height, and baseline performance) age-and sex-differences as well as the interactions thereof were expressed by calculating effect sizes (Cohen's d). Results Significant main effects of Age were detected for all physical fitness tests (d = 0.40-1.34), whereas significant main effects of Sex were found for upper-extremity muscular power (d = 0.55), flexibility (d = 0.81), agility (d = 0.44), and endurance (d = 0.32) only. Further, significant Sex by Age interactions were observed for upper-extremity muscular power (d = 0.36), flexibility (d = 0.61), and agility (d = 0.27) in favor of girls. Both, linear and curvilinear shaped curves were found for percentile values across the fitness tests. Accelerated (curvilinear) improvements were observed for upper-extremity muscular power (boys: 10-11 yrs; girls: 9-11 yrs), agility (boys: 9-10 yrs; girls: 9-11 yrs), and endurance (boys: 9-10 yrs; girls: 9-10 yrs). Tabulated percentiles for the 9-min run test indicated that running distances between 1,407-1,507 m, 1,479-1,597 m, 1,423-1,654 m, and 1,433-1,666 m in 9-to 12-year-old boys and 1,262-1,362 m, 1,329-1,434 m, 1,392-1,501 m, and 1,415-1,526 m in 9-to 12-year-old girls correspond to a "medium" fitness level (i. e., P-40 to P-60) in this population. Conclusions The observed differences in physical fitness development between boys and girls illustrate that age- and sex-specific maturational processes might have an impact on the fitness status of healthy children. Our statistical analyses revealed linear (e. g., lower-extremity muscular power) and curvilinear (e. g., agility) models of fitness improvement with age which is indicative of timed and capacity-specific fitness development pattern during childhood. Lastly, the provided age-and sex-specific percentile values can be used by coaches for talent identification and by teachers for rating/ grading of children's motor performance.	[Golle, Kathleen; Muehlbauer, Thomas; Granacher, Urs] Univ Potsdam, Res Focus Cognit Sci, Div Training & Movement Sci, Potsdam, Germany; [Wick, Ditmar] Univ Appl Sci Sport & Management, Potsdam, Germany	University of Potsdam	Golle, K (corresponding author), Univ Potsdam, Res Focus Cognit Sci, Div Training & Movement Sci, Potsdam, Germany.	kathleen.golle@uni-potsdam.de	Granacher, Urs/N-1963-2019; Granacher, Urs/GXM-3858-2022; Granacher, Urs/T-9900-2017	Granacher, Urs/0000-0002-7095-813X; Granacher, Urs/0000-0002-7095-813X; Granacher, Urs/0000-0002-7095-813X	Ministry of Education, Youth and Sport and the Sports Confederation of the federal state Brandenburg; Open Access Publication Fund of University of Potsdam	Ministry of Education, Youth and Sport and the Sports Confederation of the federal state Brandenburg; Open Access Publication Fund of University of Potsdam	The study was commissioned and supported by the Ministry of Education, Youth and Sport and the Sports Confederation of the federal state Brandenburg and by the Open Access Publication Fund of University of Potsdam." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN KL, 1976, EUR J APPL PHYSIOL O, V35, P49; Artero EG, 2011, PEDIATR DIABETES, V12, P704, DOI 10.1111/j.1399-5448.2011.00769.x; Balyi Istvan., 2013, LONG TERM ATHLETE DE; Bergmann GG, 2010, REV BRAS MED ESPORTE, V16, P339, DOI 10.1590/S1517-86922010000500004; Beunen G, 1988, Exerc Sport Sci Rev, V16, P503; Beunen G, 1997, INT J SPORTS MED, V18, pS171, DOI 10.1055/s-2007-972710; Beunen G, 2000, PEDIATR EXERC SCI, V12, P174, DOI 10.1123/pes.12.2.174; Bos K, 2009, DTSCH MOTORIK TEST 6; Bos K., 2009, BILD SPORT, P337, DOI [10.1007/978-3-531-94026-7_21, DOI 10.1007/978-3-531-94026-7_21]; CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V0100; Castro-Pineiro J, 2011, NUTR HOSP, V26, P572, DOI [10.1590/S0212-16112011000300021, 10.3305/nh.2011.26.3.4597]; Castro-Pinero J, 2013, EUR J SPORT SCI, V13, P139, DOI 10.1080/17461391.2011.606833; Castro-Pinero J, 2009, J STRENGTH COND RES, V23, P2295, DOI 10.1519/JSC.0b013e3181b8d5c1; Catley MJ, 2013, BRIT J SPORT MED, V47, P98, DOI 10.1136/bjsports-2011-090218; Cohen J.E., 1988, STAT POWER ANAL BEHA; COLE TJ, 1990, EUR J CLIN NUTR, V44, P45; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; De Miguel-Etayo P, 2014, INT J OBESITY, V38, pS57, DOI 10.1038/ijo.2014.136; Dollman J, 2002, PEDIATR EXERC SCI, V14, P297, DOI 10.1123/pes.14.3.297; ERBAUGH SJ, 1990, PERCEPT MOTOR SKILL, V71, P1123, DOI 10.2466/PMS.71.7.1123-1128; Golle K, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-499; Haywood K., 2020, HUMAN KINETICS; JACKSON AS, 1976, RES QUART, V47, P86, DOI 10.1080/10671315.1976.10615344; Llorente-Cantarero FJ, 2012, GENDER MED, V9, P436, DOI 10.1016/j.genm.2012.08.006; Lloyd RS, 2012, STRENGTH COND J, V34, P61, DOI 10.1519/SSC.0b013e31825760ea; Lopes VP, 2011, SCAND J MED SCI SPOR, V21, P663, DOI 10.1111/j.1600-0838.2009.01027.x; Lopes VP, 2012, EUR J SPORT SCI, V12, P384, DOI 10.1080/17461391.2011.566368; Lundgren SS, 2011, ACTA PAEDIATR, V100, P1359, DOI 10.1111/j.1651-2227.2011.02322.x; Malina R. M., 2004, GROWTH MATURATION PH, DOI DOI 10.5040/9781492596837; Martin JC, 1998, PEDIATRIC ANAEROBIC PERFORMANCE, P45; Ministerium fur Landwirtschaft UuRdLBME, 2002, LAND; Moll C, 2012, NEUROMOTION AUFM AUT, P22; Ortega FB, 2008, INT J OBESITY, V32, P1, DOI 10.1038/sj.ijo.0803774; Pan H, 2004, STAT MED, V23, P1749, DOI 10.1002/sim.1692; Pan H, 1997, USERS GUIDE LMSCHART; Reyes MEP, 2003, AM J HUM BIOL, V15, P800, DOI 10.1002/ajhb.10218; Rodrigues LP, 2013, J SCI MED SPORT, V16, P118, DOI 10.1016/j.jsams.2012.06.008; De Oliveira MSR, 2014, J SPORT MED PHYS FIT, V54, P780; Safrit MJ, 1990, PEDIATRIC EXERCISE S, V2, P9, DOI DOI 10.1123/PES.2.1.9; Santos R, 2014, J SPORT SCI, V32, P1510, DOI 10.1080/02640414.2014.906046; Schulz S., 2013, RELIABILITAT S UNPUB; Smith JJ, 2014, SPORTS MED, V44, P1209, DOI 10.1007/s40279-014-0196-4; Stark G., 2000, JUGEND TRAINIERT OLY; Tambalis KD, 2016, EUR J SPORT SCI, V16, P736, DOI 10.1080/17461391.2015.1088577; TANNER JM, 1966, ARCH DIS CHILD, V41, P613, DOI 10.1136/adc.41.220.613; Twisk JWR, 2000, MED SCI SPORT EXER, V32, P1455, DOI 10.1097/00005768-200008000-00014; Van Praagh E, 2002, SPORTS MED, V32, P701, DOI 10.2165/00007256-200232110-00003; Viru A, 1998, BIOL SPORT, V15, P211; Viru A., 1999, EUR J PHYS ED, V4, P75, DOI DOI 10.1080/1740898990040106; Woll A, 2011, EUR J PEDIATR, V170, P1129, DOI 10.1007/s00431-010-1391-4	50	44	46	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142393	10.1371/journal.pone.0142393	http://dx.doi.org/10.1371/journal.pone.0142393			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544848	Green Submitted, gold, Green Published			2022-12-26	WOS:000364398700129
J	Hirano, S; Kanno, S				Hirano, Seishiro; Kanno, Sanae			Macrophage Receptor with Collagenous Structure (MARCO) Is Processed by either Macropinocytosis or Endocytosis-Autophagy Pathway	PLOS ONE			English	Article							RECYCLING ENDOSOMES; SCAVENGER RECEPTORS; PLASMA-MEMBRANE; PHAGOCYTOSIS; BINDING; CELLS; TRAFFICKING; EXPRESSION; MACHINERY; PARTICLES	The Macrophage Receptor with COllagenous structure (MARCO) protein is a plasma membrane receptor for un-opsonized or environmental particles on phagocytic cells. Here, we show that MARCO was internalized either by ruffling of plasma membrane followed by macropinocytosis or by endocytosis followed by fusion with autophagosome in CHO-K1 cells stably transfected with GFP-MARCO. The macropinocytic process generated large vesicles when the plasma membrane subsided. The endocytosis/autophagosome (amphisome) generated small fluorescent puncta which were visible in the presence of glutamine, chloroquine, bafilomycin, ammonia, and other amines. The small puncta, but not the large vesicles, co-localized with LC3B and lysosomes. The LC3-II/LC3-I ratio increased in the presence of glutamine, ammonia, and chloroquine in various cells. The small puncta trafficked between the peri-nuclear region and the distal ends of cells back and forth at rates of up to 2-3 mu m/sec; tubulin, but not actin, regulated the trafficking of the small puncta. Besides phagocytosis MARCO, an adhesive plasma membrane receptor, may play a role in incorporation of various extracellular materials into the cell via both macropinocytic and endocytic pathways.	[Hirano, Seishiro] Natl Inst Environm Studies, NanoTox, RCER, Tsukuba, Ibaraki 3058506, Japan; [Kanno, Sanae] St Marianna Univ, Sch Med, Legal Med, Miyamae Ku, Kawasaki, Kanagawa 2168511, Japan	National Institute for Environmental Studies - Japan; Saint Marianna University	Hirano, S (corresponding author), Natl Inst Environm Studies, NanoTox, RCER, 16-2 Onogawa, Tsukuba, Ibaraki 3058506, Japan.	seishiro@nies.go.jp			Japan Society for the Promotion of Science [26670341]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Funding for this work came from #26670341 Japan Society for the Promotion of Science, https://www.jsps.go.jp/english/index.html.	Bonilla DL, 2013, IMMUNITY, V39, P537, DOI 10.1016/j.immuni.2013.08.026; Boya P, 2013, NAT CELL BIOL, V15, P713, DOI 10.1038/ncb2788; Cheong H, 2011, P NATL ACAD SCI USA, V108, P11121, DOI 10.1073/pnas.1107969108; Cherra SJ, 2010, J CELL BIOL, V190, P533, DOI 10.1083/jcb.201002108; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; ELOMAA O, 1995, CELL, V80, P603, DOI 10.1016/0092-8674(95)90514-6; Eng CH, 2010, AUTOPHAGY, V6, P968, DOI 10.4161/auto.6.7.13082; Eng CH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000911; Ferguson TA, 2014, AUTOPHAGY, V10, P165, DOI 10.4161/auto.26735; Florey O, 2011, NAT CELL BIOL, V13, P1335, DOI 10.1038/ncb2363; Gump JM, 2014, NAT CELL BIOL, V16, P47, DOI 10.1038/ncb2886; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910; Hirano S, 2012, TOXICOL APPL PHARM, V259, P96, DOI 10.1016/j.taap.2011.12.012; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Jahreiss L, 2008, TRAFFIC, V9, P574, DOI 10.1111/j.1600-0854.2008.00701.x; Kanno S, 2007, TOXICOL SCI, V97, P398, DOI 10.1093/toxsci/kfm050; Kerr MC, 2009, TRAFFIC, V10, P364, DOI 10.1111/j.1600-0854.2009.00878.x; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Klionsky DJ, 2005, J CELL SCI, V118, P7, DOI 10.1242/jcs.01620; Kobayashi S, 2010, AUTOPHAGY, V6, P36, DOI 10.4161/auto.6.1.10324; KOBZIK L, 1995, J IMMUNOL, V155, P367; Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204; Kvell K, 2006, BIOCHEM BIOPH RES CO, V341, P1193, DOI 10.1016/j.bbrc.2006.01.083; Palecanda A, 1999, J EXP MED, V189, P1497, DOI 10.1084/jem.189.9.1497; Pous C, 2011, NAT CELL BIOL, V13, P342, DOI 10.1038/ncb0411-342; Puri C, 2014, AUTOPHAGY, V10, P182, DOI 10.4161/auto.27174; Puri C, 2013, CELL, V154, P1285, DOI 10.1016/j.cell.2013.08.044; Ravikumar B, 2010, NAT CELL BIOL, V12, P747, DOI 10.1038/ncb2078; Sakiyama T, 2009, GASTROENTEROLOGY, V136, P924, DOI 10.1053/j.gastro.2008.12.002; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Sou Y, 2006, J BIOL CHEM, V281, P3017, DOI 10.1074/jbc.M505888200; Stolz A, 2014, NAT CELL BIOL, V16, P495, DOI 10.1038/ncb2979; Thakur SA, 2009, TOXICOL SCI, V107, P238, DOI 10.1093/toxsci/kfn210; Tooze SA, 2010, NAT CELL BIOL, V12, P831, DOI 10.1038/ncb0910-831; van der Vos KE, 2012, NAT CELL BIOL, V14, P829, DOI 10.1038/ncb2536; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Zavodszky E, 2013, FEBS LETT, V587, P1988, DOI 10.1016/j.febslet.2013.04.025	40	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142062	10.1371/journal.pone.0142062	http://dx.doi.org/10.1371/journal.pone.0142062			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545255	gold, Green Submitted, Green Published			2022-12-26	WOS:000364398700076
J	Saracco, F; Di Clemente, R; Gabrielli, A; Pietronero, L				Saracco, Fabio; Di Clemente, Riccardo; Gabrielli, Andrea; Pietronero, Luciano			From Innovation to Diversification: A Simple Competitive Model	PLOS ONE			English	Article							MUTUALISTIC NETWORKS; ECONOMIC COMPLEXITY; DISTRIBUTIONS; CAPABILITIES	Few attempts have been proposed in order to describe the statistical features and historical evolution of the export bipartite matrix countries/products. An important standpoint is the introduction of a products network, namely a hierarchical forest of products that models the formation and the evolution of commodities. In the present article, we propose a simple dynamical model where countries compete with each other to acquire the ability to produce and export new products. Countries will have two possibilities to expand their export: innovating, i.e. introducing new goods, namely new nodes in the product networks, or copying the productive process of others, i.e. occupying a node already present in the same network. In this way, the topology of the products network and the country-product matrix evolve simultaneously, driven by the countries push toward innovation.	[Saracco, Fabio; Di Clemente, Riccardo; Gabrielli, Andrea] Univ Roma, Dept Phys, ISC CNR UoS Sapienza, Ple Aldo Moro 5, I-00185 Rome, Italy; [Gabrielli, Andrea] Inst Adv Studies Lucca, IMT, I-55100 Lucca, Italy; [Pietronero, Luciano] Univ Roma La Sapienza, I-00185 Rome, Italy; [Pietronero, Luciano] London Inst Math Sci, London, England	Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR); Sapienza University Rome; University of Rome Tor Vergata; IMT School for Advanced Studies Lucca; Sapienza University Rome	Di Clemente, R (corresponding author), Univ Roma, Dept Phys, ISC CNR UoS Sapienza, Ple Aldo Moro 5, I-00185 Rome, Italy.	riccardo.diclemente@imtlucca.it	Di Clemente, Riccardo/N-9471-2014; Pietronero, Luciano/O-4473-2018; Saracco, Fabio/O-5295-2015; Gabrielli, Andrea/A-7175-2008	Di Clemente, Riccardo/0000-0001-8005-6351; Pietronero, Luciano/0000-0001-6424-8863; Saracco, Fabio/0000-0003-0812-5927; Gabrielli, Andrea/0000-0003-3705-7281				Aghion P., 1998, ENDOGENOUS GROWTH TH; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; BALASSA B, 1977, MANCH SCH ECON SOC, V45, P327, DOI 10.1111/j.1467-9957.1977.tb00701.x; Barbosa LA, 2009, THEOR BIOSCI, V128, P205, DOI 10.1007/s12064-009-0066-z; Barro R. J., 2003, EC GROWTH; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; Belmonte A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05301; Caldarelli G., 2007, SCALE FREE NETWORKS; Caldarelli G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047278; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Cristelli M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070726; Di Clemente R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112525; Feenstra RC, 2005, WORLD TRADE FLOWS 19; Hausmann R., 2007, CID WORKING PAPER SE, DOI [10.1111/j.1475-4932.1987.tb00650.x, DOI 10.1111/J.1475-4932.1987.TB00650.X]; Henisz W.J., 2000, ECON POLIT-OXFORD, V12, P1, DOI DOI 10.1111/1468-0343.00066; Hesse H, 2006, EXPORT DIVERSIFICATI; Hidalgo CA, 2007, SCIENCE, V317, P482, DOI 10.1126/science.1144581; Hidalgo CA, 2010, RWP10045 HKS; Hidalgo CA, 2009, P NATL ACAD SCI USA, V106, P10570, DOI 10.1073/pnas.0900943106; Johnson S, PREPRINT; Kauffman S., 1995, HOME UNIVERSE SEARCH; Krapivsky P, 2001, ORG GROWING RANDOM N; Maddison A., 2007, WORLD EC, V1; MURTHA TP, 1994, STRATEGIC MANAGE J, V15, P113; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Ostrom E., 1993, I INCENTIVES SUSTAIN; Pritchett L, 1997, J ECON PERSPECT, V11, P3, DOI 10.1257/jep.11.3.3; Pugliese E, 2016, EUR PHYS J-SPEC TOP, V225, P1893, DOI 10.1140/epjst/e2015-50118-1; Rogers Everett M., 2010, DIFFUSION INNOVATION; Saracco F, 2007, PREPRINT; Saracco F, 2015, SCI REP-UK, V5, DOI 10.1038/srep10595; STONE L, 1990, OECOLOGIA, V85, P74, DOI 10.1007/BF00317345; Suweis S, 2013, NATURE, V500, P449, DOI 10.1038/nature12438; Tacchella A, 2013, J ECON DYN CONTROL, V37, P1683, DOI 10.1016/j.jedc.2013.04.006; Tacchella A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00723; Tria F, 2014, SCI REP-UK, V4, DOI 10.1038/srep05890; Verona G, 2003, IND CORP CHANGE, V12, P577, DOI 10.1093/icc/12.3.577; Zaccaria A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113770	40	18	18	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0140420	10.1371/journal.pone.0140420	http://dx.doi.org/10.1371/journal.pone.0140420			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544685	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000364398700008
J	Al-Temaimi, RA; Al-Enezi, A; Al-Serri, A; Al-Roughani, R; Al-Mulla, F				Al-Temaimi, Rabeah Abbas; Al-Enezi, Anwar; Al-Serri, Ahmad; Al-Roughani, Raed; Al-Mulla, Fahd			The Association of Vitamin D Receptor Polymorphisms with Multiple Sclerosis in a Case-Control Study from Kuwait	PLOS ONE			English	Article							GENE POLYMORPHISMS; RISK; METAANALYSIS	Vitamin D deficiency is associated with several diseases including multiple sclerosis (MS). Several factors influence vitamin D levels and its optimal multi-function maintenance. Our objective was to assess quantifiable variables influencing vitamin D level and metabolism in MS patients from Kuwait. In a case-control study involving 50 MS patients, and 50 healthy control individuals for which plasma vitamin D levels, supplement use, vitamin D receptor (VDR) variants, and skin pigmentation indices were ascertained; we found overall vitamin D levels to be deficient in both groups, and supplement use to be common practice. VDR variants TaqI and BsmI associated with MS risk, and ApaI associated with low disease progression. VDR variant FokI associated with higher vitamin D levels in both groups. We conclude that several quantifiable variables related to vitamin D associate with MS suggesting a possible clinical immuno-modulatory application of vitamin D for MS patients in Kuwait.	[Al-Temaimi, Rabeah Abbas; Al-Serri, Ahmad] Kuwait Univ, Dept Pathol, Human Genet Unit, Fac Med, Jabriya, Kuwait; [Al-Enezi, Anwar] Kuwait Univ, Dept Pathol, Pathol Masters Program, Fac Med, Jabriya, Kuwait; [Al-Roughani, Raed] Amiri Hosp, Div Neurol, Dept Med, Kuwait, Kuwait; [Al-Roughani, Raed] Dasman Diabet Inst, Dept Med, Neurol Clin, Kuwait, Kuwait; [Al-Mulla, Fahd] Kuwait Univ, Fac Med, Dept Pathol, Mol Pathol Unit, Jabriya, Kuwait	Kuwait University; Kuwait University; Amiri Hospital; Kuwait University	Al-Temaimi, RA (corresponding author), Kuwait Univ, Dept Pathol, Human Genet Unit, Fac Med, Jabriya, Kuwait.	rabeah@hsc.edu.kw	Altemaimi, Rabeah/AAE-4726-2020; Al-Mulla, Fahd/E-2068-2015	Altemaimi, Rabeah/0000-0002-5662-7684; Al-Mulla, Fahd/0000-0001-5409-3829	Kuwait University College [212126150]; Kuwait Foundation [2012-1302-02]	Kuwait University College; Kuwait Foundation	This project was funded by the Kuwait University College of Graduate Studies grant no. 212126150, which was awarded to AAE, and in part by the Kuwait Foundation for the Advancement of Science (http://www.kfas.org/) grant no. 2012-1302-02 awarded to RAT.	Agliardi C, 2011, BRAIN BEHAV IMMUN, V25, P1460, DOI 10.1016/j.bbi.2011.05.015; Al-Temaimi R, 2015, J NEUROIMMUNOL, V285, P57, DOI 10.1016/j.jneuroim.2015.05.021; ALDIN ASN, 1990, J NEUROL SCI, V100, P137, DOI 10.1016/0022-510X(90)90024-H; Alimirah F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016024; Alroughani R, 2014, MULT SCLER J, V20, P543, DOI 10.1177/1352458513504328; Antico A, 2012, AUTOIMMUN REV, V12, P127, DOI 10.1016/j.autrev.2012.07.007; Asani FF, 2013, PLOS ONE, V8; Ascherio A, 2014, JAMA NEUROL, V71, P306, DOI 10.1001/jamaneurol.2013.5993; Autier P, 2014, LANCET DIABETES ENDO, V2, P76, DOI 10.1016/S2213-8587(13)70165-7; Ben-Selma W, 2015, INT J IMMUNOGENET; Christensen MHE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056019; Dickinson JL, 2009, MULT SCLER, V15, P563, DOI 10.1177/1352458509102459; Durrin LK, 1999, BBA-MOL BASIS DIS, V1453, P311, DOI 10.1016/S0925-4439(99)00007-1; Fernandes de Abreu D A, 2009, Psychoneuroendocrinology, V34 Suppl 1, pS265, DOI 10.1016/j.psyneuen.2009.05.023; Fields Jessica, 2011, Curr Osteoporos Rep, V9, P243, DOI 10.1007/s11914-011-0071-2; Fukazawa T, 1999, J NEUROL SCI, V166, P47, DOI 10.1016/S0022-510X(99)00112-4; Garcia-Martin E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065487; Hagenau T, 2009, OSTEOPOROSIS INT, V20, P133, DOI 10.1007/s00198-008-0626-y; Harms LR, 2011, BEST PRACT RES CL EN, V25, P657, DOI 10.1016/j.beem.2011.05.009; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Huang J, 2012, J NEUROL SCI, V313, P79, DOI 10.1016/j.jns.2011.09.024; Laaser U, 1985, PRIMARY HLTH CARE MA, Vxxiv; Lang PO, 2015, NUTRIENTS, V7, P2044, DOI 10.3390/nu7032044; Martinelli V, 2014, MULT SCLER J, V20, P147, DOI 10.1177/1352458513494959; Munger KL, 2014, ANN CLIN TRANSL NEUR, V1, P605, DOI 10.1002/acn3.91; Narooie-Nejad M, 2015, J MOL NEUROSCI; Narooie-Nejad M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/427519; Nessvi S, 2011, PHOTOCHEM PHOTOBIOL, V87, P1173, DOI 10.1111/j.1751-1097.2011.00956.x; Sioka C, 2011, J NEGAT RESULTS BIOM, V10, DOI 10.1186/1477-5751-10-3; Smolders J, 2009, ANN NY ACAD SCI, V1173, P515, DOI 10.1111/j.1749-6632.2009.04656.x; Smolders J, 2009, J NEUROIMMUNOL, V207, P117, DOI 10.1016/j.jneuroim.2008.12.011; Stocklin E, 2013, INT J VITAM NUTR RES, V83, P92, DOI 10.1024/0300-9831/a000151; Tajouri L, 2005, J NEUROGENET, V19, P25, DOI 10.1080/01677060590949692; Tizaoui K, 2015, CELL MOL IMMUNOL, V12, P243, DOI 10.1038/cmi.2014.47; Uitterlinden AG, 2004, GENE, V338, P143, DOI 10.1016/j.gene.2004.05.014; Uitterlinden AG, 2004, J STEROID BIOCHEM, V89-90, P187, DOI 10.1016/j.jsbmb.2004.03.083; VanAmerongen BM, 2004, EUR J CLIN NUTR, V58, P1095, DOI 10.1038/sj.ejcn.1601952; Webb AR, 2006, PROG BIOPHYS MOL BIO, V92, P17, DOI 10.1016/j.pbiomolbio.2006.02.004; Whitfield GK, 2001, MOL CELL ENDOCRINOL, V177, P145	39	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142265	10.1371/journal.pone.0142265	http://dx.doi.org/10.1371/journal.pone.0142265			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540116	Green Submitted, Green Published, gold			2022-12-26	WOS:000364303800072
J	Laine, N; Vaara, M; Anttila, VJ; Hoppu, K; Laaksonen, R; Airaksinen, M; Saxen, H				Laine, Niina; Vaara, Martti; Anttila, Veli-Jukka; Hoppu, Kalle; Laaksonen, Raisa; Airaksinen, Marja; Saxen, Harri			Evaluation of Antimicrobial Therapy of Blood Culture Positive Healthcare-Associated Infections in Children	PLoS One			English	Article							REPEATED PREVALENCE SURVEYS; FOR-DISEASE-CONTROL; NOSOCOMIAL INFECTIONS; STREAM INFECTIONS; APPROPRIATENESS; RESISTANCE; SURVIVAL; UNIT	Aim Knowledge of the quality of antimicrobial therapy (AMT) used for invasive healthcare-associated infections (HAIs) in paediatrics is scarce. Influence of the final information about the isolated pathogen on the subsequent targeted AMT was investigated in our study. Methods Data on 149 children (0-17 years) with blood culture positive HAIs were collected. The causative microbes under investigation were Staphylococcus aureus, Staphylococcus epidermidis, streptococci, Gram negative rods, and mixed infections were likewise included. For adjusting the antimicrobial regimen, an expert panel evaluated the quality of the targeted AMT and the delay of 72 hours after final microbiology results. AMT was regarded as inappropriate if the pathogen was totally resistant to the used antimicrobials (i) or if the chosen therapy was of not optimal efficacy against the pathogen (ii). Results 17% of the patients received inappropriate AMT. Half of these infections 13/26 (50%) were treated with an antimicrobial to which the isolate was resistant. Three (3/13, 23%) of these patients received antimicrobials which were totally ineffective according to in vitro data. Suboptimal or too broad spectrum AMT was administered to 13/26 (50%) patients. The most common causes of inappropriate use were the use of beta-lactams in oxacillin-resistant Staphylococcus epidermidis infections and vancomycin given in oxacillin-sensitive Staphylococcus aureus infections. Conclusion Approximately 17% of the selected cohort received inappropriate AMT. More attention should be paid to the appropriate use of antimicrobials, and training of prescribers should be urgently provided.	[Laine, Niina; Saxen, Harri] HUCH, Childrens Hosp, Helsinki, Finland; [Laine, Niina; Laaksonen, Raisa; Airaksinen, Marja] Univ Helsinki, Div Pharmacol & Pharmacotherapy, Fac Pharm, Helsinki, Finland; [Vaara, Martti] Helsinki Univ Cent HUCH Hosp, Div Clin Microbiol, HUSLAB, Helsinki, Finland; [Anttila, Veli-Jukka] HUCH, Dept Infect Dis, Helsinki, Finland; [Hoppu, Kalle] HUCH, Poison Informat Ctr, Helsinki, Finland	University of Helsinki	Laine, N (corresponding author), HUCH, Childrens Hosp, Helsinki, Finland.	niina.laine@helsinki.fi	Hoppu, Kalle/A-2811-2009	Hoppu, Kalle/0000-0001-6775-0453	University Pharmacy of Finland; Foundation of Paivikki ja Sakari Sohlberg; University of Helsinki, Finland	University Pharmacy of Finland; Foundation of Paivikki ja Sakari Sohlberg; University of Helsinki, Finland	The work was supported by The University Pharmacy of Finland (www.yliopistonapteekki.fi), The Foundation of Paivikki ja Sakari Sohlberg (www.psssaatio.fi) and The University of Helsinki, Finland. The funding was salary for PhD student Niina Laine. It was not used on other purposes besides working (i.e., no materials/computers etc.).	Balaban I, 2012, JPN J INFECT DIS, V65, P318, DOI 10.7883/yoken.65.318; Bartlett JM, 2014, AM J HEALTH-SYST PH, V71, P943, DOI 10.2146/ajhp130602; Burgner D, 1996, J HOSP INFECT, V34, P163, DOI 10.1016/S0195-6701(96)90062-6; Buyle FM, 2014, ACTA CLIN BELG; Cosgrove SE, 2007, INFECT CONT HOSP EP, V28, P641, DOI 10.1086/518345; Davey PG, 2008, CLIN MICROBIOL INFEC, V14, P15, DOI 10.1111/j.1469-0691.2008.01959.x; Erbay A, 2009, INT J ANTIMICROB AG, V34, P575, DOI 10.1016/j.ijantimicag.2009.07.006; Frank M, 2005, SCAND J INFECT DIS, V37, P177, DOI 10.1080/00365540410020956; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Harbarth S, 2003, AM J MED, V115, P529, DOI 10.1016/j.amjmed.2003.07.005; Kumar A, 2009, CHEST, V136, P1237, DOI 10.1378/chest.09-0087; Levy ER, 2012, INFECT CONT HOSP EP, V33, P346, DOI 10.1086/664761; Muhlemann K, 2004, INFECT CONT HOSP EP, V25, P765, DOI 10.1086/502474; Patel SJ, 2009, PEDIATR INFECT DIS J, V28, P1047, DOI 10.1097/INF.0b013e3181b12484; Raineri E, 2008, AM J INFECT CONTROL, V36, P283, DOI 10.1016/j.ajic.2007.06.009; Raymond J, 2000, INFECT CONT HOSP EP, V21, P260, DOI 10.1086/501755; Sarvikivi E, 2008, CLIN MICROBIOL INFEC, V14, P1072, DOI 10.1111/j.1469-0691.2008.02079.x; Shah PJ, 2014, J PHARM PRACT; Suppli M, 2011, CLIN MICROBIOL INFEC, V17, P1078, DOI 10.1111/j.1469-0691.2010.03394.x; WelshKerry J, 2010, J CLIN MICROBIOL, V48, P894, DOI [10.1128/JCM.01949-09, DOI 10.1128/JCM.01949-09]; Willemsen I, 2007, ANTIMICROB AGENTS CH, V51, P864, DOI 10.1128/AAC.00994-06; Yu K, 2014, AM J HEALTH-SYST PH, V71, P1019, DOI 10.2146/ajhp130612; Zaragoza R, 2003, CLIN MICROBIOL INFEC, V9, P412, DOI 10.1046/j.1469-0691.2003.00656.x	23	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141555	10.1371/journal.pone.0141555	http://dx.doi.org/10.1371/journal.pone.0141555			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26539831	Green Submitted, Green Published, gold			2022-12-26	WOS:000364303800020
J	Ostrovski, I; Lovblom, LE; Farooqi, MA; Scarr, D; Boulet, G; Hertz, P; Wu, T; Halpern, EM; Ngo, M; Ng, E; Orszag, A; Bril, V; Perkins, BA				Ostrovski, Ilia; Lovblom, Leif E.; Farooqi, Mohammed A.; Scarr, Daniel; Boulet, Genevieve; Hertz, Paul; Wu, Tong; Halpern, Elise M.; Ngo, Mylan; Ng, Eduardo; Orszag, Andrej; Bril, Vera; Perkins, Bruce A.			Reproducibility of In Vivo Corneal Confocal Microscopy Using an Automated Analysis Program for Detection of Diabetic Sensorimotor Polyneuropathy	PLOS ONE			English	Article							DISTAL SYMMETRIC POLYNEUROPATHY; PRACTICE PARAMETER EVALUATION; SUBBASAL NERVE PLEXUS; PERIPHERAL NEUROPATHY; ELECTRODIAGNOSTIC-MEDICINE; AMERICAN-ASSOCIATION; PHYSICAL-MEDICINE; FIBER DAMAGE; INDIVIDUALS; NEUROLOGY	Objective In vivo Corneal Confocal Microscopy (IVCCM) is a validated, non-invasive test for diabetic sensorimotor polyneuropathy (DSP) detection, but its utility is limited by the image analysis time and expertise required. We aimed to determine the inter-and intra-observer reproducibility of a novel automated analysis program compared to manual analysis. Methods In a cross-sectional diagnostic study, 20 non-diabetes controls (mean age 41.4 +/- 17.3y, HbA1c 5.5 +/- 0.4%) and 26 participants with type 1 diabetes (42.8 +/- 16.9y, 8.0 +/- 1.9%) underwent two separate IVCCM examinations by one observer and a third by an independent observer. Along with nerve density and branch density, corneal nerve fibre length (CNFL) was obtained by manual analysis (CNFLMANUAL), a protocol in which images were manually selected for automated analysis (CNFLSEMI-AUTOMATED), and one in which selection and analysis were performed electronically (CNFLFULLY-AUTOMATED). Reproducibility of each protocol was determined using intraclass correlation coefficients (ICC) and, as a secondary objective, the method of Bland and Altman was used to explore agreement between protocols. Results Mean CNFLManual was 16.7 +/- 4.0, 13.9 +/- 4.2 mm/mm(2) for non-diabetes controls and diabetes participants, while CNFLSemi-Automated was 10.2 +/- 3.3, 8.6 +/- 3.0 mm/mm(2) and CNFLFully-Automated was 12.5 +/- 2.8, 10.9 +/- 2.9 mm/mm(2). Inter-observer ICC and 95% confidence intervals (95%CI) were 0.73(0.56, 0.84), 0.75(0.59, 0.85), and 0.78(0.63, 0.87), respectively (p = NS for all comparisons). Intra-observer ICC and 95%CI were 0.72(0.55, 0.83), 0.74(0.57, 0.85), and 0.84(0.73, 0.91), respectively (p<0.05 for CNFLFully-Automated compared to others). The other IVCCM parameters had substantially lower ICC compared to those for CNFL. CNFLSemi-Automated and CNFL Fully-Automated underestimated CNFLManual by mean and 95%CI of 35.1(-4.5, 67.5)% and 21.0(-21.6, 46.1)%, respectively. Conclusions Despite an apparent measurement (underestimation) bias in comparison to the manual strategy of image analysis, fully-automated analysis preserves CNFL reproducibility. Future work must determine the diagnostic thresholds specific to the fully-automated measure of CNFL.	[Ostrovski, Ilia; Lovblom, Leif E.; Farooqi, Mohammed A.; Scarr, Daniel; Boulet, Genevieve; Hertz, Paul; Wu, Tong; Halpern, Elise M.; Orszag, Andrej; Perkins, Bruce A.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Perkins, Bruce A.] Univ Toronto, Dept Med, Div Endocrinol & Metab, Toronto, ON, Canada; [Ngo, Mylan; Ng, Eduardo; Bril, Vera] Univ Toronto, Dept Med, Div Neurol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto	Perkins, BA (corresponding author), Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada.	bperkins@mtsinai.on.ca	BRIL, vera/ABA-6509-2020; Perkins, Bruce A/L-3726-2017	Lovblom, Leif Erik/0000-0002-6774-8924; Farooqi, Mohammed/0000-0001-5282-4034; Orszag, Andrej/0000-0002-0027-1607	JDRF Operating Grant [17-2008-715]; Harvey and Annice Frisch Family Fund	JDRF Operating Grant; Harvey and Annice Frisch Family Fund	The study was funded by the JDRF Operating Grant No. 17-2008-715, website: http://www.jdrf.ca/ (Juvenile Diabetes Research Foundation). The authors wish to acknowledge the generous support of Randy and Jenny Frisch and The Harvey and Annice Frisch Family Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2012, DIABETES CARE, V35, P821, DOI 10.2337/dc11-1396; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Boulton AJM, 2005, DIABETES CARE, V28, P956, DOI 10.2337/diacare.28.4.956; Breiner A, 2014, DIABETES CARE, V37, P1418, DOI 10.2337/dc13-2005; Chen X, 2015, DIABETES CARE, V38, P1138, DOI 10.2337/dc14-2422; Dabbah MA, 2011, MED IMAGE ANAL, V15, P738, DOI 10.1016/j.media.2011.05.016; Dabbah MA, 2010, LECT NOTES COMPUT SC, V6361, P300; Dehghani C, 2014, INVEST OPHTH VIS SCI, V55, P7982, DOI 10.1167/iovs.14-15605; Dehghani C, 2014, CORNEA, V33, P696, DOI 10.1097/ICO.0000000000000152; Dehghani C, 2014, INVEST OPHTH VIS SCI, V55, P3195, DOI 10.1167/iovs.14-13959; Edwards K, 2012, CLIN EXP OPTOM, V95, P348, DOI 10.1111/j.1444-0938.2012.00740.x; Efron N, 2010, EYE CONTACT LENS, V36, P245, DOI 10.1097/ICL.0b013e3181eea915; England J. D., 2005, Neurology, V64, P199; England JD, 2009, NEUROLOGY, V72, P177, DOI 10.1212/01.wnl.0000336345.70511.0f; England JD, 2009, NEUROLOGY, V72, P185, DOI 10.1212/01.wnl.0000336370.51010.a1; Halpern EM, 2013, J DIABETES COMPLICAT, V27, P240, DOI 10.1016/j.jdiacomp.2012.10.011; Hertz P, 2011, DIABETIC MED, V28, P1253, DOI 10.1111/j.1464-5491.2011.03299.x; Hossain P, 2005, LANCET, V366, P1340, DOI 10.1016/S0140-6736(05)67546-0; Hume DA, 2012, DIABETES RES CLIN PR, V97, pE37, DOI 10.1016/j.diabres.2012.04.010; Jiang MS, 2016, BRIT J OPHTHALMOL, V100, P9, DOI 10.1136/bjophthalmol-2014-306038; Kim G, 2013, CORNEA, V32, P1331, DOI 10.1097/ICO.0b013e31829dd7f8; Malik RA, 2003, DIABETOLOGIA, V46, P683, DOI 10.1007/s00125-003-1086-8; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; Oh SJ, 2002, CLIN ELECTROMYOGRAPH, P86; Oremus M, 2012, BMJ OPEN, V4, P2, DOI DOI 10.1136/BMJ0PEN-2012-001368; Perkins BA, 2002, MUSCLE NERVE, V25, P212, DOI 10.1002/mus.10044; Petropoulos IN, 2015, INVEST OPHTH VIS SCI, V56, P2498, DOI 10.1167/iovs.14-15919; Petropoulos IN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123517; Petropoulos IN, 2014, INVEST OPHTH VIS SCI, V55, P2071, DOI 10.1167/iovs.13-13787; Petropoulos IN, 2013, CORNEA, V32, pE83, DOI 10.1097/ICO.0b013e3182749419; Pritchard N, 2015, DIABETES CARE, V38, P671, DOI 10.2337/dc14-2114; Quattrini C, 2007, DIABETES, V56, P2148, DOI 10.2337/db07-0285; Ruggeri Alfredo, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P4739; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Sivaskandarajah GA, 2013, DIABETES CARE, V36, P2748, DOI 10.2337/dc12-2075; Smith AG, 2008, NEUROLOGIST, V14, P23, DOI 10.1097/NRL.0b013e31815a3956; Sumner CJ, 2003, NEUROLOGY, V60, P108, DOI 10.1212/WNL.60.1.108; Tavakoli M, 2015, DIABETES CARE, V38, P838, DOI 10.2337/dc14-2311; Tavakoli M, 2012, CLIN EXP OPTOM, V95, P338, DOI 10.1111/j.1444-0938.2012.00743.x; Tavakoli M, 2011, JOVE-J VIS EXP, DOI 10.3791/2194; Tavakoli M, 2010, DIABETES CARE, V33, P1792, DOI 10.2337/dc10-0253; Tavakoli M, 2008, CLIN OPHTHALMOL, V2, P435; Vagenas D, 2012, OPTOMETRY VISION SCI, V89, P812, DOI 10.1097/OPX.0b013e31824ee8c9; Wu T, 2012, DIABETIC MED, V29, pE297, DOI 10.1111/j.1464-5491.2012.03678.x; Ziegler D, 2002, INT REV NEUROBIOL, V50, P431	45	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142309	10.1371/journal.pone.0142309	http://dx.doi.org/10.1371/journal.pone.0142309			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26539984	Green Published, gold, Green Submitted			2022-12-26	WOS:000364303800081
J	Shahbazi, S; Studnicki, J; Warner-Hillard, CW				Shahbazi, Sara; Studnicki, James; Warner-Hillard, Charles Wayne			A Cross-Sectional Retrospective Analysis of the Racial and Geographic Variations in Cataract Surgery	PLOS ONE			English	Article							HEALTH DISPARITIES; CARE; MORTALITY; BARRIERS	Background Cataract surgery is the most common surgery performed on beneficiaries of Medicare, accounting for more than $3.4 billion in annual expenditures. The purpose of this study is to examine racial and geographic variations in cataract surgery rates and determine the association between the racial composition of the community population and the racial disparity in the likelihood of receiving necessary cataract surgery. Methods Using the national prevalence rates from the National Institute of Eye Health and the 2010 Healthcare Cost and Utilization Project-Florida State Ambulatory Surgery Database, we determined the estimated cases of cataract and the actual number of cataract procedures performed, on four race/gender determined groups aged 65 and over in the state of Florida in 2010. The utilization rates and disparity ratios were also calculated for each Florida county. The counties were segmented into groups based on their racial composition. The association between racial composition and disparity ratios in receiving necessary cataract surgery was examined. The Geographic Information System was used to display county-level geospatial relationships. Results African-Americans have a lower gender-specific cataract prevalence (African-American male = 0.246, African-American female = 0.392, white male = 0.368, and white female = 0.457), but they are also less likely than whites to receive necessary cataract surgery (utilization rate: African-American male = 7.92%, African-American female = 6.17%, white male = 12.08%, and white female = 10.54%). The statistical results show no overall differences between the disparity ratios and the racial composition of the communities. However, our geospatial analyses revealed a concentration of high racial disparity/high white population counties largely along the West Coast and South Central portion of the state. Conclusions There are racial differences in the likelihood of receiving necessary cataract surgery. However, there is no significant statewide association between the racial composition of the community population and the racial disparity in the likelihood of receiving necessary cataract surgery. Geospatial techniques did, however, identify subpopulations of interest which were not otherwise identifiable with typical statistical approaches, nor consistent with their conclusions.	[Shahbazi, Sara] Univ N Carolina, Coll Hlth & Human Serv, Dept Hlth Serv Res, Charlotte, NC 28223 USA; [Studnicki, James; Warner-Hillard, Charles Wayne] Univ N Carolina, Coll Hlth & Human Serv, Dept Publ Hlth Sci, Charlotte, NC 28223 USA	University of North Carolina; University of North Carolina Charlotte; University of North Carolina; University of North Carolina Charlotte	Shahbazi, S (corresponding author), Univ N Carolina, Coll Hlth & Human Serv, Dept Hlth Serv Res, Charlotte, NC 28223 USA.	sshahbaz@uncc.edu						Baicker K, 2005, PERSPECT BIOL MED, V48, pS42; Baltussen R, 2004, B WORLD HEALTH ORGAN, V82, P338; Bhatt B. M., 2012, National Journal of Community Medicine, V3, P259; Broman AT, 2005, ARCH OPHTHALMOL-CHIC, V123, P1231, DOI 10.1001/archopht.123.9.1231; Centers for Disease Control and Prevention, VIS HLTH IN VHI COMM; Centers for Disease Control and Prevention, 1993, MMWR, V42; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P487; Cooper GS, 1997, J GEN INTERN MED, V12, P485, DOI 10.1046/j.1525-1497.1997.00087.x; Cooper RA, 2012, J URBAN HEALTH, V89, P828, DOI 10.1007/s11524-012-9689-3; Flood M, 14 OFR; Foster A, 2001, BRIT J OPHTHALMOL, V85, P635, DOI 10.1136/bjo.85.6.635; French DD, 2012, MIL MED, V177, P752, DOI 10.7205/MILMED-D-12-00046; Graves BA, 2009, ONLINE J RURAL NURS, V9; Gupta P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075584; Hayanga AJ, 2009, J AM COLL SURGEONS, V208, P1017, DOI 10.1016/j.jamcollsurg.2009.01.047; Healthcare Cost and Utilization Project, HCUP DAT US AGR TRAI; Healthcare Cost and Utilization Project, INTR HCUP STAT AMB S; JAVITT JC, 1995, MED CARE, V33, P90, DOI 10.1097/00005650-199501000-00008; Johnson JG, 1998, TROP DOCT, V28, P218, DOI 10.1177/004947559802800410; Keeffe JE, 2002, BRIT J OPHTHALMOL, V86, P24, DOI 10.1136/bjo.86.1.24; Klein BEK, 1997, OPHTHALMOLOGY, V104, P573, DOI 10.1016/S0161-6420(97)30267-X; Kohnen T, 2009, DTSCH ARZTEBL INT, V106, P695, DOI 10.3238/arztebl.2009.0695; Lewallen S, 2000, Community Eye Health, V13, P20; Lucas FL, 2006, ANN SURG, V243, P281, DOI 10.1097/01.sla.0000197560.92456.32; Martin P., 2013, EFFECT CATARACT SURG; Ntsoane MD, 2010, AFR VIS EYE HEALTH J, V69, P182; Ocampo VVD, 2002, CATARACT SENILE EMED; Ortman J. M., 2014, AGING NATION OLDER P, P25; Prevent Blindness America, 2012, PREV AD VIS IMP AG R; Roberts D, 2012, CAMB Q HEALTHC ETHIC, V21, P332, DOI 10.1017/S0963180112000059; United States Census Bureau, 2010, 2010 CENSUS BRIEFS; Wang F, 1997, Ophthalmic Epidemiol, V4, P89; West SK, 1998, AM J EPIDEMIOL, V148, P1033; Williams DR, 2005, HEALTH AFFAIR, V24, P325, DOI 10.1377/hlthaff.24.2.325; Women's Eye Health Task Force: Schepens Eye Research Institute Inc., 2003, EYE; Younan C, 2002, CLIN EXP OPHTHALMOL, V30, P163, DOI 10.1046/j.1442-9071.2002.00523.x; Zhang XZ, 2012, AM J OPHTHALMOL, V154, pS53, DOI 10.1016/j.ajo.2011.08.045	37	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142459	10.1371/journal.pone.0142459	http://dx.doi.org/10.1371/journal.pone.0142459			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540168	Green Submitted, Green Published, gold			2022-12-26	WOS:000364303800093
J	Aug, A; Altraja, S; Kilk, K; Porosk, R; Soomets, U; Altraja, A				Aug, Argo; Altraja, Siiri; Kilk, Kalle; Porosk, Rando; Soomets, Ursel; Altraja, Alan			E-Cigarette Affects the Metabolome of Primary Normal Human Bronchial Epithelial Cells	PLOS ONE			English	Article							SMOKE; IMPACT	E-cigarettes are widely believed to be safer than conventional cigarettes and have been even suggested as aids for smoking cessation. However, while reasonable with some regards, this judgment is not yet supported by adequate biomedical research data. Since bronchial epithelial cells are the immediate target of inhaled toxicants, we hypothesized that exposure to e-cigarettes may affect the metabolome of human bronchial epithelial cells (HBEC) and that the changes are, at least in part, induced by oxidant-driven mechanisms. Therefore, we evaluated the effect of e-cigarette liquid (ECL) on the metabolome of HBEC and examined the potency of antioxidants to protect the cells. We assessed the changes of the intracellular metabolome upon treatment with ECL in comparison of the effect of cigarette smoke condensate (CSC) with mass spectrometry and principal component analysis on air-liquid interface model of normal HBEC. Thereafter, we evaluated the capability of the novel antioxidant tetrapeptide O-methyl-L-tyrosinyl-.-L-glutamyl-L-cysteinylglycine (UPF1) to attenuate the effect of ECL. ECL caused a significant shift in the metabolome that gradually gained its maximum by the 5th hour and receded by the 7th hour. A second alteration followed at the 13th hour. Treatment with CSC caused a significant initial shift already by the 1st hour. ECL, but not CSC, significantly increased the concentrations of arginine, histidine, and xanthine. ECL, in parallel with CSC, increased the content of adenosine diphosphate and decreased that of three lipid species from the phosphatidylcholine family. UPF1 partially counteracted the ECL-induced deviations, UPF1's maximum effect occurred at the 5th hour. The data support our hypothesis that ECL profoundly alters the metabolome of HBEC in a manner, which is comparable and partially overlapping with the effect of CSC. Hence, our results do not support the concept of harmlessness of e-cigarettes.	[Aug, Argo; Kilk, Kalle; Porosk, Rando; Soomets, Ursel] Univ Tartu, Inst Biomed & Translat Med, Dept Biochem, Ctr Excellence Translat Med, EE-50090 Tartu, Estonia; [Altraja, Siiri] Univ Tartu, Dept Biomed, Inst Biomed & Translat Med, EE-50090 Tartu, Estonia; [Altraja, Alan] Univ Tartu, Dept Pulm Med, EE-50090 Tartu, Estonia; [Altraja, Alan] Tartu Univ Hosp, Lung Clin, Tartu, Estonia	University of Tartu; University of Tartu; University of Tartu	Altraja, A (corresponding author), Univ Tartu, Dept Pulm Med, Ulikooli 18, EE-50090 Tartu, Estonia.	alan@kliinikum.ee	Soomets, Ursel/H-5919-2015	Soomets, Ursel/0000-0002-3681-188X	Estonian Science Foundation [9043, 9103]; Institutional Research Support Project [IUT 20-42]; European Union through the European Social Fund	Estonian Science Foundation; Institutional Research Support Project; European Union through the European Social Fund	This work was supported by The Estonian Science Foundation (http://www.etag.ee/en/estonian-research-council/) grants No. 9043 (AlA) and 9103 (SA), by the Institutional Research Support Project IUT 20-42 (http://www.etag.ee/en/estonian-researchcouncil/), and by the European Union through the European Social Fund (http://www.doktorikool.ut.ee/kmdk/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abello N, 2008, ANAL CHEM, V80, P9171, DOI 10.1021/ac801215c; Altraja S, 2013, EXP TOXICOL PATHOL, V65, P711, DOI 10.1016/j.etp.2012.09.005; Aug A, 2014, AM J RESP CELL MOL, V51, P586, DOI 10.1165/rcmb.2013-0377OC; Brown J, 2014, ADDICTION, V109, P1531, DOI 10.1111/add.12623; Choi K, 2014, AM J PREV MED, V46, P175, DOI 10.1016/j.amepre.2013.10.007; Cobb NK, 2011, NEW ENGL J MED, V365, P193, DOI 10.1056/NEJMp1105249; Farsalinos KE, 2014, THER ADV DRUG SAF, V5, P67, DOI 10.1177/2042098614524430; Farsalinos KE, 2013, INT J ENV RES PUB HE, V10, P5146, DOI 10.3390/ijerph10105146; Flouris AD, 2013, INHAL TOXICOL, V25, P91, DOI 10.3109/08958378.2012.758197; Harrell PT, 2015, NICOTINE TOB RES, V17, P193, DOI 10.1093/ntr/ntu149; Pokhrel P, 2013, AM J PUBLIC HEALTH, V103, pE57, DOI 10.2105/AJPH.2013.301453; Polosa R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-786; Rahman I, 1996, FEBS LETT, V396, P21, DOI 10.1016/0014-5793(96)01027-7; Somborac-Bacura A, 2013, EXP PHYSIOL, V98, P316, DOI 10.1113/expphysiol.2012.067249; Soomets Ursel, 2005, V298, P241; Sutfin EL, 2013, DRUG ALCOHOL DEPEN, V131, P214, DOI 10.1016/j.drugalcdep.2013.05.001; Vardavas CI, 2012, CHEST, V141, P1400, DOI 10.1378/chest.11-2443; Vulimiri SV, 2009, CHEM RES TOXICOL, V22, P492, DOI 10.1021/tx8003246; World Health Organization, 2016, C PART WHO FRAM CONV; Zhu SH, 2014, TOB CONTROL, V23, P3, DOI 10.1136/tobaccocontrol-2014-051670	20	27	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142053	10.1371/journal.pone.0142053	http://dx.doi.org/10.1371/journal.pone.0142053			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536230	Green Published, Green Submitted, gold			2022-12-26	WOS:000364298400125
J	Kasparova, E; Van de Putte, AP; Marshall, C; Janko, K				Kasparova, Eva; Van de Putte, Anton P.; Marshall, Craig; Janko, Karel			Lifestyle and Ice: The Relationship between Ecological Specialization and Response to Pleistocene Climate Change	PLOS ONE			English	Article							ESTIMATING DEMOGRAPHIC HISTORY; HUMAN MITOCHONDRIAL-DNA; LAST GLACIAL MAXIMUM; SOUTHERN-OCEAN; POPULATION-GROWTH; NOTOTHENIOID FISHES; MOLECULAR VARIANCE; STATISTICAL-METHOD; GENETIC-STRUCTURE; ANTARCTIC FISHES	Major climatic changes in the Pleistocene had significant effects on marine organisms and the environments in which they lived. The presence of divergent patterns of demographic history even among phylogenetically closely-related species sharing climatic changes raises questions as to the respective influence of species-specific traits on population structure. In this work we tested whether the lifestyle of Antarctic notothenioid benthic and pelagic fish species from the Southern Ocean influenced the concerted population response to Pleistocene climatic fluctuations. This was done by a comparative analysis of sequence variation at the cyt b and S7 loci in nine newly sequenced and four re-analysed species. We found that all species underwent more or less intensive changes in population size but we also found consistent differences between demographic histories of pelagic and benthic species. Contemporary pelagic populations are significantly more genetically diverse and bear traces of older demographic expansions than less diverse benthic species that show evidence of more recent population expansions. Our findings suggest that the lifestyles of different species have strong influences on their responses to the same environmental events. Our data, in conjunction with previous studies showing a constant diversification tempo of these species during the Pleistocene, support the hypothesis that Pleistocene glaciations had a smaller effect on pelagic species than on benthic species whose survival may have relied upon ephemeral refugia in shallow shelf waters. These findings suggest that the interaction between lifestyle and environmental changes should be considered in genetic analyses.	[Kasparova, Eva; Janko, Karel] Acad Sci Czech Republic, Inst Anim Physiol & Genet, Lab Fish Genet, Libechov 27721, Czech Republic; [Kasparova, Eva; Janko, Karel] Acad Sci Czech Republic, Inst Vertebrate Biol, CS-60365 Brno, Czech Republic; [Van de Putte, Anton P.] Katholieke Univ Leuven, Lab Biodivers & Evolutionary Genom, B-3000 Leuven, Belgium; [Marshall, Craig] Univ Otago, Dept Biochem & Genet Otago, Dunedin, New Zealand; [Janko, Karel] Univ South Bohemia Ceske Budejovice, Ctr Polar Ecol, Ceske Budejovice 37005, Czech Republic; [Janko, Karel] Univ Ostrava, Fac Nat Sci, Dept Biol & Ecol, Life Sci Res Ctr, Ostrava 71000, Czech Republic	Czech Academy of Sciences; Institute of Animal Physiology & Genetics of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Vertebrate Biology of the Czech Academy of Sciences; KU Leuven; University of Otago; University of South Bohemia Ceske Budejovice; University of Ostrava	Kasparova, E (corresponding author), Acad Sci Czech Republic, Inst Anim Physiol & Genet, Lab Fish Genet, Rumburska 89, Libechov 27721, Czech Republic.	kasparova@iapg.cas.cz; janko@iapg.cas.cz	Marshall, Craig J./C-6668-2009; Van de Putte, Anton/S-3729-2019	Marshall, Craig J./0000-0003-4186-0368; Van de Putte, Anton/0000-0003-1336-5554; Stefkova Kasparova, Eva/0000-0003-4321-8213	Royal Belgian Institute for Natural Sciences, OD Nature, Brussels, Belgium [Vautierstraat 29, B-1000]; Grant Agency of Czech Academy of Sciences [KJB600450903]; European Centre of Ichtyoparasitology [P505/12/G112]; Ministry of Education, Youth and Sport of Czech Republic (Centre for Polar Ecology University of South Bohemia in Ceske Budejovice) [LM2010009, CZ.1.07/2.2.00/28.0190]; Belgian Science Policy (BELSPO) [BR/132/A1/vERSO]; Institute of Animal Physiology and Genetics [RVO: 67985904]	Royal Belgian Institute for Natural Sciences, OD Nature, Brussels, Belgium; Grant Agency of Czech Academy of Sciences; European Centre of Ichtyoparasitology; Ministry of Education, Youth and Sport of Czech Republic (Centre for Polar Ecology University of South Bohemia in Ceske Budejovice); Belgian Science Policy (BELSPO)(Belgian Federal Science Policy Office); Institute of Animal Physiology and Genetics	This work has been supported by the Royal Belgian Institute for Natural Sciences, OD Nature, Vautierstraat 29, B-1000 Brussels, Belgium. Grant Agency of the Czech Academy of Sciences (GA AS CR) (No. KJB600450903), European Centre of Ichtyoparasitology. (No. P505/12/G112), Ministry of Education, Youth and Sport of Czech Republic (Centre for Polar Ecology University of South Bohemia in Ceske Budejovice) (LM2010009, CZ.1.07/2.2.00/28.0190) and the Belgian Science Policy (BELSPO contract no BR/132/A1/vERSO). The authors' team receives continuous support from the Institute of Animal Physiology and Genetics (RVO: 67985904). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allcock AL, 2012, TRENDS ECOL EVOL, V27, P520, DOI 10.1016/j.tree.2012.05.009; Anderson RF, 2002, DEEP-SEA RES PT II, V49, P1909, DOI 10.1016/S0967-0645(02)00018-8; Arango CP, 2011, DEEP-SEA RES PT II, V58, P212, DOI 10.1016/j.dsr2.2010.05.019; Aronson RB, 2007, ANNU REV ECOL EVOL S, V38, P129, DOI 10.1146/annurev.ecolsys.38.091206.095525; Barnes DKA, 2001, J BIOGEOGR, V28, P359, DOI 10.1046/j.1365-2699.2001.00562.x; Bortolotto E, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-32; Buonaccorsi VP, 2001, MOL ECOL, V10, P1179, DOI 10.1046/j.1365-294X.2001.01270.x; Chown SL, 2004, PLOS BIOL, V2, P1701, DOI 10.1371/journal.pbio.0020406; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Dambach J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046283; Damerau M, 2012, POLAR BIOL, V35, P1073, DOI 10.1007/s00300-012-1155-x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Diaz A, 2011, DEEP-SEA RES PT II, V58, P205, DOI 10.1016/j.dsr2.2010.10.012; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Eastman J.T., 1985, P430; Eastman JT, 2005, POLAR BIOL, V28, P93, DOI 10.1007/s00300-004-0667-4; Eastman JT, 2000, J FISH BIOL, V57, P84, DOI 10.1111/j.1095-8649.2000.tb02246.x; Ehrich D, 2008, J BIOGEOGR, V35, P801, DOI 10.1111/j.1365-2699.2007.01864.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Eytan RI, 2010, EVOLUTION, V64, P3380, DOI 10.1111/j.1558-5646.2010.01071.x; Fauvelot C, 2003, EVOLUTION, V57, P1571; Fraser CI, 2009, P NATL ACAD SCI USA, V106, P3249, DOI 10.1073/pnas.0810635106; Fu YX, 1997, GENETICS, V147, P915; Gonzalez-Wevar CA, 2011, DEEP-SEA RES PT II, V58, P220, DOI 10.1016/j.dsr2.2010.05.026; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; Heemstra Gon, 1990, FISHES SO OCEAN; Heled J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-289; Hellberg ME, 2009, ANNU REV ECOL EVOL S, V40, P291, DOI 10.1146/annurev.ecolsys.110308.120223; Hemery LG, 2012, MOL ECOL, V21, P2502, DOI 10.1111/j.1365-294X.2012.05512.x; Hey J, 1997, GENETICS, V145, P833; Ho SYW, 2011, MOL ECOL RESOUR, V11, P423, DOI 10.1111/j.1755-0998.2011.02988.x; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; HUDSON RR, 1987, GENETICS, V116, P153; HUDSON RR, 1985, GENETICS, V111, P147; Janko K, 2011, MOL PHYLOGENET EVOL, V60, P305, DOI 10.1016/j.ympev.2011.03.008; Janko K, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-220; Kaiser S, 2013, MAR BIOL, V160, P2295, DOI 10.1007/s00227-013-2232-6; Kock KH, 2006, ANTARCT SCI, V18, P223, DOI 10.1017/S0954102006000265; Krosby M, 2009, P ROY SOC B-BIOL SCI, V276, P615, DOI 10.1098/rspb.2008.1310; Kuhner MK, 1998, GENETICS, V149, P429; Lessa EP, 2003, P NATL ACAD SCI USA, V100, P10331, DOI 10.1073/pnas.1730921100; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Marino IAM, 2013, MOL ECOL, V22, P5148, DOI 10.1111/mec.12458; Matschiner M, 2009, MOL ECOL, V18, P2574, DOI 10.1111/j.1365-294X.2009.04220.x; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; McGaughran A, 2010, J BIOGEOGR, V37, P103, DOI 10.1111/j.1365-2699.2009.02178.x; Near TJ, 2012, P NATL ACAD SCI USA, V109, P3434, DOI 10.1073/pnas.1115169109; Near TJ, 2004, ANTARCT SCI, V16, P37, DOI 10.1017/S0954102004001798; Papetti C, 2007, POLAR BIOL, V30, P1605, DOI 10.1007/s00300-007-0325-8; Papetti C, 2012, J BIOGEOGR, V39, P1361, DOI 10.1111/j.1365-2699.2011.02682.x; Patarnello T, 2011, BIOESSAYS, V33, P260, DOI 10.1002/bies.201000124; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Pybus OG, 2002, BIOINFORMATICS, V18, P1404, DOI 10.1093/bioinformatics/18.10.1404; RAFFI S, 1986, PALAEOGEOGR PALAEOCL, V52, P267, DOI 10.1016/0031-0182(86)90051-9; Raupach MJ, 2010, MAR BIOL, V157, P1783, DOI 10.1007/s00227-010-1451-3; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rogers Alex D., 2012, P417; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rutschmann S, 2011, MOL ECOL, V20, P4707, DOI 10.1111/j.1365-294X.2011.05279.x; Sabovljevic M, 2011, BIOLOGIA, V66, P42, DOI 10.2478/s11756-010-0129-0; Schneider S, 1999, GENETICS, V152, P1079; Smetacek V, 2005, NATURE, V437, P362, DOI 10.1038/nature04161; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Strimmer K, 2001, MOL BIOL EVOL, V18, P2298, DOI 10.1093/oxfordjournals.molbev.a003776; Strugnell JM, 2012, MOL ECOL, V21, P2775, DOI 10.1111/j.1365-294X.2012.05572.x; TAJIMA F, 1989, GENETICS, V123, P585; Thatje S, 2005, TRENDS ECOL EVOL, V20, P534, DOI 10.1016/j.tree.2005.07.010; Thatje S, 2008, ECOLOGY, V89, P682, DOI 10.1890/07-0498.1; Van de Putte AP, 2012, MAR GENOM, V8, P23, DOI 10.1016/j.margen.2012.05.002; Wilson NG, 2009, MOL ECOL, V18, P965, DOI 10.1111/j.1365-294X.2008.04071.x; Zane L, 2006, MOL ECOL, V15, P4499, DOI 10.1111/j.1365-294X.2006.03105.x	74	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0138766	10.1371/journal.pone.0138766	http://dx.doi.org/10.1371/journal.pone.0138766			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26535569	Green Published, Green Submitted, gold			2022-12-26	WOS:000364298400004
J	Omarova, EO; Nazarov, PA; Firsov, AM; Strakhovskaya, MG; Arkhipova, AY; Moisenovich, MM; Agapov, II; Ol'shevskaya, VA; Zaitsev, AV; Kalinin, VN; Kotova, EA; Antonenko, YN				Omarova, Elena O.; Nazarov, Pavel A.; Firsov, Alexander M.; Strakhovskaya, Marina G.; Arkhipova, Anastasia Yu.; Moisenovich, Mikhail M.; Agapov, Igor I.; Ol'shevskaya, Valentina A.; Zaitsev, Andrey V.; Kalinin, Valery N.; Kotova, Elena A.; Antonenko, Yuri N.			Carboranyl-Chlorin e(6) as a Potent Antimicrobial Photosensitizer	PLOS ONE			English	Article							NEUTRON-CAPTURE THERAPY; PHOTODYNAMIC INACTIVATION; ESCHERICHIA-COLI; MEMBRANE PERMEABILIZATION; BORON; BINDING; PHOTOINACTIVATION; DERIVATIVES; CHEMISTRY; PHTHALOCYANINES	Antimicrobial photodynamic inactivation is currently being widely considered as alternative to antibiotic chemotherapy of infective diseases, attracting much attention to design of novel effective photosensitizers. Carboranyl-chlorin-e(6) (the conjugate of chlorin e(6) with carborane), applied here for the first time for antimicrobial photodynamic inactivation, appeared to be much stronger than chlorin e(6) against Gram-positive bacteria, such as Bacillus subtilis, Staphyllococcus aureus and Mycobacterium sp. Confocal fluorescence spectroscopy and membrane leakage experiments indicated that bacteria cell death upon photodynamic treatment with carboranyl-chlorin-e(6) is caused by loss of cell membrane integrity. The enhanced photobactericidal activity was attributed to the increased accumulation of the conjugate by bacterial cells, as evaluated both by centrifugation and fluorescence correlation spectroscopy. Gram-negative bacteria were rather resistant to antimicrobial photodynamic inactivation mediated by carboranyl-chlorin-e(6). Unlike chlorin e(6), the conjugate showed higher (compared to the wild-type strain) dark toxicity with Escherichia coli Delta tolC mutant, deficient in TolC-requiring multidrug efflux transporters.	[Omarova, Elena O.; Nazarov, Pavel A.; Firsov, Alexander M.; Kotova, Elena A.; Antonenko, Yuri N.] Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow, Russia; [Strakhovskaya, Marina G.; Arkhipova, Anastasia Yu.; Moisenovich, Mikhail M.; Agapov, Igor I.] Moscow MV Lomonosov State Univ, Dept Biol, Moscow, Russia; [Strakhovskaya, Marina G.] FMBA, Fed Sci & Clin Ctr Specialized Med Serv & Med Tec, Moscow, Russia; [Agapov, Igor I.] Shumakov Res Ctr Transplantol & Artificial Organs, Moscow, Russia; [Ol'shevskaya, Valentina A.; Zaitsev, Andrey V.; Kalinin, Valery N.] Russian Acad Sci, Nesmeyanov Inst Organoelement Cpds, Moscow, Russia	Lomonosov Moscow State University; Lomonosov Moscow State University; V.I. Shumakov Federal Research Center of Transplantology & Artificial Organs; Russian Academy of Sciences; Nesmeyanov Institute of Organoelement Compounds	Kotova, EA (corresponding author), Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow, Russia.	kotova@genebee.msu.ru	Nazarov, Pavel A/G-7885-2018; Moisenovich, Michael/D-9428-2014; Zaitsev, Andrei/R-4081-2016; Strakhovskaya, Marina/I-5529-2012; Agapov, Igor/D-9450-2014; Arkhipova, Anastasiya Yur'evna/D-9432-2014; Ol'shevskaya, Valentina/ABA-9045-2020; Firsov, Alexander/AAD-1859-2019	Nazarov, Pavel A/0000-0003-1857-323X; Strakhovskaya, Marina/0000-0002-4571-0431; Agapov, Igor/0000-0002-0273-4601; Arkhipova, Anastasiya Yur'evna/0000-0001-6940-0406; Zaitsev, Andrei/0000-0001-6448-2561; Firsov, Alexander/0000-0001-5265-1348; Zaitsev, Artem/0000-0002-2314-0482	Russian Science Foundation [14-50-00029]	Russian Science Foundation(Russian Science Foundation (RSF))	This work was financially supported by the Russian Science Foundation (No. 14-50-00029).	Alves E, 2014, FUTURE MED CHEM, V6, P141, DOI 10.4155/fmc.13.211; Antonenko YN, 2014, BBA-BIOMEMBRANES, V1838, P793, DOI 10.1016/j.bbamem.2013.11.012; Asano R, 2014, J PHOTOCH PHOTOBIO B, V140, P140, DOI 10.1016/j.jphotobiol.2014.07.008; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BELLIN JS, 1969, ARCH BIOCHEM BIOPHYS, V132, P157, DOI 10.1016/0003-9861(69)90348-8; BERTOLONI G, 1990, FEMS MICROBIOL LETT, V71, P149; BERTOLONI G, 1985, J GEN MICROBIOL, V131, P2217; Demidova TN, 2005, ANTIMICROB AGENTS CH, V49, P2329, DOI 10.1128/AAC.49.6.2329-2335.2005; Denisov SS, 2014, CHEM COMMUN, V50, P15366, DOI 10.1039/c4cc04996a; Efremenko AV, 2014, PHOTOCH PHOTOBIO SCI, V13, P92, DOI 10.1039/c3pp50226k; Efremenko AV, 2012, PHOTOCH PHOTOBIO SCI, V11, P645, DOI 10.1039/c2pp05237g; Embleton ML, 2005, ANTIMICROB AGENTS CH, V49, P3690, DOI 10.1128/AAC.49.9.3690-3696.2005; Endo Y, 2001, CHEM BIOL, V8, P341, DOI 10.1016/S1074-5521(01)00016-3; Fanfrlik J, 2006, CHEMPHYSCHEM, V7, P1100, DOI 10.1002/cphc.200500648; Fomichev A Iu, 1991, Mikrobiologiia, V60, P507; Fuchs BB, 2007, ANTIMICROB AGENTS CH, V51, P2929, DOI 10.1128/AAC.00121-07; FUJITA H, 1970, Journal of Radiation Research, V11, P9, DOI 10.1269/jrr.11.9; Gad F, 2004, ANTIMICROB AGENTS CH, V48, P2173, DOI 10.1128/AAC.48.6.2173-2178.2004; Hamblin MR, 2002, J ANTIMICROB CHEMOTH, V49, P941, DOI 10.1093/jac/dkf053; HAMBLIN MR, 2004, PHOTOCH PHOTOBIO SCI, V3, P436, DOI DOI 10.1039/B311900A; Hao E, 2008, ORG BIOMOL CHEM, V6, P3732, DOI 10.1039/b807836j; HAWTHORNE MF, 1993, ANGEW CHEM INT EDIT, V32, P950, DOI 10.1002/anie.199309501; Horiyama T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108642; Huang L, 2010, ANTIMICROB AGENTS CH, V54, P3834, DOI 10.1128/AAC.00125-10; Issa F, 2011, CHEM REV, V111, P5701, DOI 10.1021/cr2000866; Julius RL, 2007, P NATL ACAD SCI USA, V104, P4808, DOI 10.1073/pnas.0700316104; Kato H, 2012, PHOTOCHEM PHOTOBIOL, V88, P423, DOI 10.1111/j.1751-1097.2012.01080.x; Kishen A, 2010, PHOTOCHEM PHOTOBIOL, V86, P1343, DOI 10.1111/j.1751-1097.2010.00792.x; Komagoe K, 2011, PHOTOCH PHOTOBIO SCI, V10, P1181, DOI 10.1039/c0pp00376j; Korbe S, 2006, CHEM REV, V106, P5208, DOI 10.1021/cr050548u; Kotova EA, 2011, BBA-BIOMEMBRANES, V1808, P2252, DOI 10.1016/j.bbamem.2011.05.018; Krishnamoorthy G, 2013, MOL MICROBIOL, V87, P982, DOI 10.1111/mmi.12143; Lambrechts SAG, 2005, ANTIMICROB AGENTS CH, V49, P2026, DOI 10.1128/AAC.49.5.2026-2034.2005; LIBERMAN EA, 1970, BIOCHIM BIOPHYS ACTA, V196, P221, DOI 10.1016/0005-2736(70)90010-6; Lopes D, 2014, J PHOTOCH PHOTOBIO B, V141, P145, DOI 10.1016/j.jphotobiol.2014.08.024; Luguya R, 2006, BIOORGAN MED CHEM, V14, P5890, DOI 10.1016/j.bmc.2006.05.026; MALIK Z, 1990, J PHOTOCH PHOTOBIO B, V5, P281, DOI 10.1016/1011-1344(90)85044-W; Mikula P, 2014, J PHOTOCH PHOTOBIO B, V138, P230, DOI 10.1016/j.jphotobiol.2014.04.014; Minnock A, 1996, J PHOTOCH PHOTOBIO B, V32, P159, DOI 10.1016/1011-1344(95)07148-2; Moisenovich MM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012717; Mojzisova H, 2009, PHOTOCH PHOTOBIO SCI, V8, P778, DOI 10.1039/b822269j; Nitzan Y, 2001, CURR MICROBIOL, V42, P408, DOI 10.1007/s002840010238; O'Riordan K, 2005, PHOTODIAGN PHOTODYN, V2, P247, DOI 10.1016/S1572-1000(05)00099-2; Ol'shevskaya VA, 2009, BIOORGAN MED CHEM, V17, P1297, DOI 10.1016/j.bmc.2008.12.016; Oros G, 1999, AMINO ACIDS, V17, P357, DOI 10.1007/BF01361661; Pashkovskaya A, 2010, LANGMUIR, V26, P5726, DOI 10.1021/la903867a; Pereira MA, 2014, PHOTOCH PHOTOBIO SCI, V13, P680, DOI 10.1039/c3pp50408e; Perevoshchikova IV, 2008, BBA-BIOMEMBRANES, V1778, P2182, DOI 10.1016/j.bbamem.2008.04.008; Pudziuvyte B, 2011, PHOTOCH PHOTOBIO SCI, V10, P1046, DOI 10.1039/c1pp05028a; Ratajski Michal, 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P159, DOI 10.2174/187152006776119126; Rokitskaya TI, 2012, BIOCHEMISTRY-MOSCOW+, V77, P975, DOI 10.1134/S0006297912090039; Rokitskaya TI, 2014, FEBS LETT, V588, P1590, DOI 10.1016/j.febslet.2014.02.046; Schafer M, 1998, INT J RADIAT BIOL, V74, P249, DOI 10.1080/095530098141636; Simon C, 2014, J PHOTOCH PHOTOBIO B, V141, P113, DOI 10.1016/j.jphotobiol.2014.09.015; Soukos NS, 1998, ANTIMICROB AGENTS CH, V42, P2595, DOI 10.1128/AAC.42.10.2595; Spesia MB, 2009, PHOTODIAGN PHOTODYN, V6, P52, DOI 10.1016/j.pdpdt.2009.01.003; Strakhovskaya MG, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1305, DOI 10.1134/S0006297909120025; Tegos GP, 2006, ANTIMICROB AGENTS CH, V50, P1402, DOI 10.1128/AAC.50.4.1402-1410.2006; Tegos GP, 2006, ANTIMICROB AGENTS CH, V50, P196, DOI 10.1128/AAC.50.1.196-203.2006; TOTANI T, 1981, J MED CHEM, V24, P1492, DOI 10.1021/jm00144a024; Uliana MP, 2014, PHOTOCH PHOTOBIO SCI, V13, P1137, DOI 10.1039/c3pp50376c; Valduga G, 1999, BIOCHEM BIOPH RES CO, V256, P84, DOI 10.1006/bbrc.1999.0190; Valliant JF, 2002, COORDIN CHEM REV, V232, P173, DOI 10.1016/S0010-8545(02)00087-5; Verma S, 2009, PHOTOCHEM PHOTOBIOL, V85, P111, DOI 10.1111/j.1751-1097.2008.00403.x; Wainwright M, 1998, J ANTIMICROB CHEMOTH, V42, P13, DOI 10.1093/jac/42.1.13	65	14	14	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141990	10.1371/journal.pone.0141990	http://dx.doi.org/10.1371/journal.pone.0141990			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26535905	gold, Green Published, Green Submitted			2022-12-26	WOS:000364298400113
J	Sengupta, A; McConkey, KR; Radhakrishna, S				Sengupta, Asmita; McConkey, Kim R.; Radhakrishna, Sindhu			Primates, Provisioning and Plants: Impacts of Human Cultural Behaviours on Primate Ecological Functions	PLOS ONE			English	Article							SEED DISPERSAL; FOOD; FOREST; MACAQUES; STRATEGIES; MONKEYS	Human provisioning of wildlife with food is a widespread global practice that occurs in multiple socio-cultural circumstances. Provisioning may indirectly alter ecosystem functioning through changes in the eco-ethology of animals, but few studies have quantified this aspect. Provisioning of primates by humans is known to impact their activity budgets, diets and ranging patterns. Primates are also keystone species in tropical forests through their role as seed dispersers; yet there is no information on how provisioning might affect primate ecological functions. The rhesus macaque is a major human-commensal species but is also an important seed disperser in the wild. In this study, we investigated the potential impacts of provisioning on the role of rhesus macaques as seed dispersers in the Buxa Tiger Reserve, India. We studied a troop of macaques which were provisioned for a part of the year and were dependent on natural resources for the rest. We observed feeding behaviour, seed handling techniques and ranging patterns of the macaques and monitored availability of wild fruits. Irrespective of fruit availability, frugivory and seed dispersal activities decreased when the macaques were provisioned. Provisioned macaques also had shortened daily ranges implying shorter dispersal distances. Finally, during provisioning periods, seeds were deposited on tarmac roads that were unconducive for germination. Provisioning promotes human-primate conflict, as commensal primates are often involved in aggressive encounters with humans over resources, leading to negative consequences for both parties involved. Preventing or curbing provisioning is not an easy task as feeding wild animals is a socio-cultural tradition across much of South and South-East Asia, including India. We recommend the initiation of literacy programmes that educate lay citizens about the ill-effects of provisioning and strongly caution them against the practice.	[Sengupta, Asmita; McConkey, Kim R.; Radhakrishna, Sindhu] Natl Inst Adv Studies, Sch Nat Sci & Engn, Bangalore, Karnataka, India		Sengupta, A (corresponding author), Natl Inst Adv Studies, Sch Nat Sci & Engn, Indian Inst Sci Campus, Bangalore, Karnataka, India.	asmita.sengupta@gmail.com	McConkey, Kim/AAP-5609-2021	McConkey, Kim/0000-0002-3793-7732	Department of Science and Technology, Government of India [SB/SO/AS-128/2012]	Department of Science and Technology, Government of India(Department of Science & Technology (India))	Funding: This study was supported by the Department of Science and Technology, Government of India [http://www.dst.gov.in/]: contract grant number SB/SO/AS-128/2012 awarded to SR. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert A, 2013, INT J PRIMATOL, V34, P170, DOI 10.1007/s10764-012-9649-5; Altmann J, 2005, BEHAV ECOL SOCIOBIOL, V57, P490, DOI 10.1007/s00265-004-0870-x; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; ALTMANN J, 1988, AM J PRIMATOL, V15, P213, DOI 10.1002/ajp.1350150304; Asaba N., 1984, ARASHIYAMA JAPANESE, V3, P55; ASQUITH PJ, 1989, YEARB PHYS ANTHROPOL, V32, P129; Becker DJ, 2015, ECOL LETT, V18, P483, DOI 10.1111/ele.12428; Becker DJ, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0309; Berman CM, 2007, INT J PRIMATOL, V28, P1123, DOI 10.1007/s10764-007-9199-4; Berman CM, 2002, INT J PRIMATOL, V23, P383, DOI 10.1023/A:1013891730061; BOUG A, 1994, REV ECOL-TERRE VIE, V49, P307; BRENNAN EJ, 1985, AFR J ECOL, V23, P35, DOI 10.1111/j.1365-2028.1985.tb00710.x; Chapman C.A., 2007, PRIMATES PERSPECTIVE, P510; Duncan RS, 2000, BIOTROPICA, V32, P33, DOI 10.1111/j.1744-7429.2000.tb00445.x; El Alami A, 2012, AM J PRIMATOL, V74, P210, DOI 10.1002/ajp.21989; Fooden J, 2000, FIELDIANA ZOOL, V96, P1, DOI DOI 10.5962/BHL.TITLE.7192; Fuentes A, 2007, HUMANS MONKEYS ROCK; Garber PA, 1998, AM J PRIMATOL, V45, P3, DOI 10.1002/(SICI)1098-2345(1998)45:1<3::AID-AJP2>3.0.CO;2-#; Goldberg JL, 2001, BEHAV ECOL, V12, P490, DOI 10.1093/beheco/12.4.490; Hammerschlag N, 2012, FUNCT ECOL, V26, P567, DOI 10.1111/j.1365-2435.2012.01973.x; Hemery Gwenael, 2005, Western Indian Ocean Journal of Marine Science, V4, P123; IUCN Red list, 2022, ZOOL, Patent No. [eT158085A760192, 158085760192]; Jefferies RL, 2004, INTEGR COMP BIOL, V44, P130, DOI 10.1093/icb/44.2.130; Julliot C, 1996, INT J PRIMATOL, V17, P239, DOI 10.1007/BF02735451; Kunz BK, 2008, J TROP ECOL, V24, P235, DOI 10.1017/S0266467408005014; Martin P., 1993, MEASURING BEHAV, V2nd, DOI [10.1017/CBO9781139168342, DOI 10.1017/CBO9781139168342]; McConkey KR, 2015, TRENDS ECOL EVOL, V30, P182, DOI 10.1016/j.tree.2015.01.006; McConkey KR, 2000, AM J PRIMATOL, V52, P13, DOI 10.1002/1098-2345(200009)52:1&lt;13::AID-AJP2&gt;3.0.CO;2-Y; McKinney T., 2010, AM J PRIMATOL, V71, P1; Medhi Rekha, 2007, Primate Conservation, V22, P135, DOI 10.1896/052.022.0114; Novacek MJ, 2008, P NATL ACAD SCI USA, V105, P11571, DOI 10.1073/pnas.0802599105; Oro D, 2013, ECOL LETT, V16, P1501, DOI 10.1111/ele.12187; PRISTON N.E.C, 2013, MACAQUE CONNECTION, V43, P225; R Core Team, 2014, LANG ENV STAT COMP; Radhakrishna S, INT J PRIMA IN PRESS; Ram S, 2003, CURR SCI INDIA, V84, P780; Robb GN, 2008, FRONT ECOL ENVIRON, V6, P476, DOI 10.1890/060152; Saj T, 1999, INT J PRIMATOL, V20, P977, DOI 10.1023/A:1020886820759; Schupp EW, 2010, NEW PHYTOL, V188, P333, DOI 10.1111/j.1469-8137.2010.03402.x; Sekercioglu CH, 2010, CONSERVATION BIOLOGY FOR ALL, P45, DOI 10.1093/acprof:oso/9780199554232.003.0004; Sengupta A, 2014, AM J PRIMATOL, V76, P1175, DOI 10.1002/ajp.22302; Sinha A, 2005, CURR SCI INDIA, V89, P1166; Sivakumar S., 2006, Forktail, V22, P128; Sukumar R., 2003, STUDY ELEPHANT UNPUB; Tsuji Y, 2011, MAMM BIOL, V76, P525, DOI 10.1016/j.mambio.2011.01.001; Wunderle JM, 1997, FOREST ECOL MANAG, V99, P223, DOI 10.1016/S0378-1127(97)00208-9; Zar JH., 2010, BIOSTAT ANAL, V5th	47	30	30	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140961	10.1371/journal.pone.0140961	http://dx.doi.org/10.1371/journal.pone.0140961			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536365	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000364298400045
J	Quan, JH; Chu, JQ; Kwon, J; Choi, IW; Ismail, HAHA; Zhou, W; Cha, GH; Zhou, Y; Yuk, JM; Jo, EK; Lee, YH				Quan, Juan-Hua; Chu, Jia-Qi; Kwon, Jaeyul; Choi, In-Wook; Ismail, Hassan Ahmed Hassan Ahmed; Zhou, Wei; Cha, Guang-Ho; Zhou, Yu; Yuk, Jae-Min; Jo, Eun-Kyeong; Lee, Young-Ha			Intracellular Networks of the PI3K/AKT and MAPK Pathways for Regulating Toxoplasma gondii-Induced IL-23 and IL-12 Production in Human THP-1 Cells	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; IMMUNE-RESPONSE; INFECTION; RESISTANCE; ACTIVATION; EXPRESSION; CYTOKINE; PROTEIN; INNATE; MICE	Interleukin (IL)-23 and IL-12 are closely related in structure, and these cytokines regulate both innate and adaptive immunity. However, the precise signaling networks that regulate the production of each in Toxoplasma gondii-infected THP-1 monocytic cells, particularly the PI3K/AKT and MAPK signaling pathways, remain unknown. In the present study, T. gondii infection upregulated the expression of IL-23 and IL-12 in THP-1 cells, and both cytokines increased with parasite dose. IL-23 secretion was strongly inhibited by TLR2 monoclonal antibody (mAb) treatment in a dose-dependent manner and by TLR2 siRNA transfection, whereas IL-12 secretion was strongly inhibited by TLR4 mAb treatment dose-dependently and by TLR4 siRNA transfection. IL-23 production was dose-dependently inhibited by the PI3K inhibitors LY294002 and wortmannin, whereas IL-12 production increased dose-dependently. THP- 1 cells exposed to live T. gondii tachyzoites underwent rapid p38 MAPK, ERK1/2 and JNK activation. IL-23 production was significantly upregulated by the p38 MAPK inhibitor SB203580 dose-dependently, whereas pretreatment with 10 mu M SB203580 significantly downregulated IL-12 production. ERK1/2 inhibition by PD98059 was significantly downregulated IL-23 production but upregulated IL-12 production. JNK inhibition by SP600125 upregulated IL-23 production, but IL-12 production was significantly downregulated dose-dependently. T. gondii infection resulted in AKT activation, and AKT phosphorylation was inhibited dose-dependently after pretreatment with PI3K inhibitors. In T. gondii-infected THP- 1 cells, ERK1/2 activation was regulated by PI3K; however, the phosphorylation of p38 MAPK and JNK was negatively modulated by the PI3K signaling pathway. Collectively, these results indicate that IL-23 production in T. gondii-infected THP-1 cells was regulated mainly by TLR2 and then by PI3K and ERK1/2; however, IL-12 production was mainly regulated by TLR4 and then by p38 MAPK and JNK. Our findings provide new insight concerning the intracellular networks of the PI3K/AKT and MAPK signaling cascades for regulating T. gondii- induced IL-23 and IL-12 secretion in human monocytic cells.	[Quan, Juan-Hua; Zhou, Yu] Guangdong Med Coll, Affiliated Hosp, Dept Gastroenterol, Zhanjiang 524001, Guangdong, Peoples R China; [Chu, Jia-Qi] Guangdong Med Coll, Affiliated Hosp, Stem Cell Res & Cellular Therapy Ctr, Zhanjiang 524001, Peoples R China; [Kwon, Jaeyul] Chungnam Natl Univ, Sch Med, Dept Med Educ, Taejon 301131, South Korea; [Choi, In-Wook; Ismail, Hassan Ahmed Hassan Ahmed; Zhou, Wei; Cha, Guang-Ho; Yuk, Jae-Min; Lee, Young-Ha] Chungnam Natl Univ, Sch Med, Dept Infect Biol, Taejon 301131, South Korea; [Jo, Eun-Kyeong] Chungnam Natl Univ, Sch Med, Dept Microbiol, Taejon 301131, South Korea; [Jo, Eun-Kyeong] Chungnam Natl Univ, Sch Med, Infect Signaling Network Res Ctr, Taejon 301131, South Korea	Guangdong Medical University; Guangdong Medical University; Chungnam National University; Chungnam National University; Chungnam National University; Chungnam National University	Lee, YH (corresponding author), Chungnam Natl Univ, Sch Med, Dept Infect Biol, Taejon 301131, South Korea.	yhalee@cnu.ac.kr		Kwon, Jaeyul/0000-0002-2452-4111; Yuk, Jae-Min/0000-0002-0630-9194; Cha, Guang-Ho/0000-0003-2639-1727; Eun-Kyeong, Jo/0000-0001-7191-0587; Ismail, Hassan Ahmed Hassan Ahmed/0000-0001-6554-9596	National Research Foundation of Korea (NRF) - Korean government (MSIP) [20070054932]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2014R1A1A2057655]; National Natural Science Foundation of China [81300368, 81301449]	National Research Foundation of Korea (NRF) - Korean government (MSIP); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Research Foundation of Korea (NRF) funded by the Korean government (MSIP) (No. 20070054932), and supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (No. NRF-2014R1A1A2057655). This study was also supported by grants from the National Natural Science Foundation of China (Grant No. 81300368 to Juan-Hua Quan and Grant No. 81301449 to Jia-Qi Chu).	Aldebert D, 2007, CYTOKINE, V37, P206, DOI 10.1016/j.cyto.2007.03.012; Debierre-Grockiego F, 2007, J IMMUNOL, V179, P1129, DOI 10.4049/jimmunol.179.2.1129; Del Rio L, 2004, J IMMUNOL, V172, P6954, DOI 10.4049/jimmunol.172.11.6954; Denkers EY, 1998, CLIN MICROBIOL REV, V11, P569, DOI 10.1128/CMR.11.4.569; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Drennan MB, 2004, AM J PATHOL, V164, P49, DOI 10.1016/S0002-9440(10)63095-7; Dunay IR, 2010, INFECT IMMUN, V78, P1564, DOI 10.1128/IAI.00472-09; Fukao T, 2003, TRENDS IMMUNOL, V24, P358, DOI 10.1016/S1471-4906(03)00139-X; Fukao T, 2002, NAT IMMUNOL, V3, P875, DOI 10.1038/ni825; Halonen Sandra K, 2013, Handb Clin Neurol, V114, P125, DOI 10.1016/B978-0-444-53490-3.00008-X; Holscher C, 2004, MED MICROBIOL IMMUN, V193, P1, DOI 10.1007/s00430-003-0186-x; Kawai T, 2005, CURR OPIN IMMUNOL, V17, P338, DOI 10.1016/j.coi.2005.02.007; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kim L, 2005, J IMMUNOL, V174, P4178, DOI 10.4049/jimmunol.174.7.4178; Kim L, 2006, J CELL SCI, V119, P2119, DOI 10.1242/jcs.02934; Langrish CL, 2004, IMMUNOL REV, V202, P96, DOI 10.1111/j.0105-2896.2004.00214.x; Lankford CSR, 2003, J LEUKOCYTE BIOL, V73, P49, DOI 10.1189/jlb.0602326; Lieberman LA, 2004, J IMMUNOL, V173, P1887, DOI 10.4049/jimmunol.173.3.1887; Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035; Manukyan MC, 2010, SHOCK, V34, P442, DOI 10.1097/SHK.0b013e3181e14ea9; Mason NJ, 2004, J IMMUNOL, V172, P3704, DOI 10.4049/jimmunol.172.6.3704; Miller CM, 2009, INT J PARASITOL, V39, P23, DOI 10.1016/j.ijpara.2008.08.002; Minns LA, 2006, J IMMUNOL, V176, P7589, DOI 10.4049/jimmunol.176.12.7589; Munoz M, 2009, J EXP MED, V206, P3047, DOI 10.1084/jem.20090900; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Quan JH, 2013, KOREAN J PARASITOL, V51, P85, DOI 10.3347/kjp.2013.51.1.85; Robben PM, 2005, J EXP MED, V201, P1761, DOI 10.1084/jem.20050054; Scanga CA, 2004, INFECT IMMUN, V72, P2400, DOI 10.1128/IAI.72.4.2400-2404.2004; Sher A, 2003, IMMUNOL RES, V27, P521, DOI 10.1385/IR:27:2-3:521; Sukhumayasi W, 2010, EXP PARASITOL, V126, P415, DOI 10.1016/j.exppara.2010.01.019; Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6; Valere A, 2003, PARASITE, V10, P59, DOI 10.1051/parasite/2003101p59; Xia LM, 2012, J IMMUNOL, V188, P753, DOI 10.4049/jimmunol.1101652; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893	35	29	30	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141550	10.1371/journal.pone.0141550	http://dx.doi.org/10.1371/journal.pone.0141550			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528819	Green Published, gold, Green Submitted			2022-12-26	WOS:000364032600037
J	Tansley, G; Schuurman, N; Amram, O; Yanchar, N				Tansley, Gavin; Schuurman, Nadine; Amram, Ofer; Yanchar, Natalie			Spatial Access to Emergency Services in Low- and Middle-Income Countries: A GIS-Based Analysis	PLOS ONE			English	Article							TRAUMA MORTALITY PATTERNS; PREHOSPITAL TIME; SYSTEMS; CARE; SURVIVAL	Injury is a leading cause of the global disease burden, accounting for 10 percent of all deaths worldwide. Despite 90 percent of these deaths occurring in low and middle-income countries (LMICs), the majority of trauma research and infrastructure development has taken place in high-income settings. Furthermore, although accessible services are of central importance to a mature trauma system, there remains a paucity of literature describing the spatial accessibility of emergency services in LMICs. Using data from the Service Provision Assessment component of the Demographic and Health Surveys of Namibia and Haiti we defined the capabilities of healthcare facilities in each country in terms of their preparedness to provide emergency services. A Geographic Information System-based network analysis method was used to define 5- 10- and 50-kilometer catchment areas for all facilities capable of providing 24-hour care, higher-level resuscitative services or tertiary care. The proportion of a country's population with access to each level of service was obtained by amalgamating the catchment areas with a population layer. A significant proportion of the population of both countries had poor spatial access to lower level services with 25% of the population of Haiti and 51% of the population of Namibia living further than 50 kilometers from a facility capable of providing 24-hour care. Spatial access to tertiary care was considerably lower with 51% of Haitians and 72% of Namibians having no access to these higher-level services within 50 kilometers. These results demonstrate a significant disparity in potential spatial access to emergency services in two LMICs compared to analogous estimates from high-income settings, and suggest that strengthening the capabilities of existing facilities may improve the equity of emergency services in these countries. Routine collection of georeferenced patient and facility data in LMICs will be important to understanding how spatial access to services influences outcomes.	[Tansley, Gavin; Yanchar, Natalie] Dalhousie Univ, Dept Epidemiol & Community Hlth, Halifax, NS, Canada; [Schuurman, Nadine; Amram, Ofer] Simon Fraser Univ, Dept Geog, Burnaby, BC V5A 1S6, Canada	Dalhousie University; Simon Fraser University	Schuurman, N (corresponding author), Simon Fraser Univ, Dept Geog, Burnaby, BC V5A 1S6, Canada.	nadine@sfu.ca		amram, ofer/0000-0002-8835-3104				Alegana VA, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-6; Branas CC, 2005, JAMA-J AM MED ASSOC, V293, P2626, DOI 10.1001/jama.293.21.2626; Central Intelligene Agency, WORLD FACTB ROADW; Deckelbaum DL, 2012, LANCET, V380, P713, DOI 10.1016/S0140-6736(11)61090-8; Dutton RP, 2010, J TRAUMA, V69, P620, DOI 10.1097/TA.0b013e3181bbfe2a; Gething PW, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-991; Hameed SM, 2010, J TRAUMA, V69, P1350, DOI 10.1097/TA.0b013e3181e751f7; Harmsen AMK, 2015, INJURY, V46, P602, DOI 10.1016/j.injury.2015.01.008; Henry JA, 2012, J TRAUMA ACUTE CARE, V73, P261, DOI 10.1097/TA.0b013e31824bde1e; Hsia RY, 2012, HEALTH POLICY PLANN, V27, P234, DOI 10.1093/heapol/czr023; Institut Haitien de l'Enfance II, 2013, EV PREST SERV SOINS; Linard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031743; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Mathers C, 2004, GLOB BURD DIS 2004 U; Meara JG, 2015, LANCET, V386, P569, DOI 10.1016/S0140-6736(15)60160-X; Ministry of Health and Social Services, 2009, NAM HLTH FAC CENS HF; Mitchell AD, 2007, CAN J SURG, V50, P129; Mock CN, 1998, J TRAUMA, V44, P804, DOI 10.1097/00005373-199805000-00011; Namibia Statistics Agency, 2011, POP CENS IND; Nathens AB, 2004, LANCET, V363, P1794, DOI 10.1016/S0140-6736(04)16307-1; Nations United Department of Economic and Social Affairs SD, 2014, WORLD STAT POCK; Nesbitt RC, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-25; Newgard CD, 2010, ANN EMERG MED, V55, P235, DOI 10.1016/j.annemergmed.2009.07.024; Norton R, 2013, NEW ENGL J MED, V368, P1723, DOI 10.1056/NEJMra1109343; Okwaraji YB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033564; Rogers FB, 2015, INJURY, V46, P525, DOI 10.1016/j.injury.2014.08.043; Sampalis JS, 1999, J TRAUMA, V46, P565, DOI 10.1097/00005373-199904000-00004; SAMPALIS JS, 1993, J TRAUMA, V34, P252, DOI 10.1097/00005373-199302000-00014; Whedon James M, 2013, J Emerg Trauma Shock, V6, P259, DOI 10.4103/0974-2700.120368; World Health Assembly 60, 2007, HLTH SYST EM CAR SYS; World Health Organization, INT MAN EM ESS SURG	31	32	32	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141113	10.1371/journal.pone.0141113	http://dx.doi.org/10.1371/journal.pone.0141113			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528911	Green Published, Green Submitted, gold			2022-12-26	WOS:000364032600018
J	Buczek, ME; Miles, AK; Green, W; Johnson, C; Boocock, DJ; Pockley, AG; Rees, RC; Hulman, G; van Schalkwyk, G; Parkinson, R; Hulman, J; Powe, DG; Regad, T				Buczek, M. E.; Miles, A. K.; Green, W.; Johnson, C.; Boocock, D. J.; Pockley, A. G.; Rees, R. C.; Hulman, G.; van Schalkwyk, G.; Parkinson, R.; Hulman, J.; Powe, D. G.; Regad, T.			Cytoplasmic PML promotes TGF-beta-associated epithelial-mesenchymal transition and invasion in prostate cancer	ONCOGENE			English	Article							PROMYELOCYTIC LEUKEMIA FUSES; MOLECULAR-MECHANISMS; SUPPRESSOR PML; NUCLEAR-BODIES; ALPHA; TRANSLOCATION; INTERFERON; EXPRESSION; T(15-17); TARGETS	Epithelial-mesenchymal transition (EMT) is a key event that is involved in the invasion and dissemination of cancer cells. Although typically considered as having tumour-suppressive properties, transforming growth factor (TGF)-beta signalling is altered during cancer and has been associated with the invasion of cancer cells and metastasis. In this study, we report a previously unknown role for the cytoplasmic promyelocytic leukaemia (cPML) tumour suppressor in TGF-beta signalling-induced regulation of prostate cancer-associated EMT and invasion. We demonstrate that cPML promotes a mesenchymal phenotype and increases the invasiveness of prostate cancer cells. This event is associated with activation of TGF-beta canonical signalling pathway through the induction of Sma and Mad related family 2 and 3 (SMAD2 and SMAD3) phosphorylation. Furthermore, the cytoplasmic localization of promyelocytic leukaemia (PML) is mediated by its nuclear export in a chromosomal maintenance 1 (CRM1)-dependent manner. This was clinically tested in prostate cancer tissue and shown that cytoplasmic PML and CRM1 co-expression correlates with reduced disease-specific survival. In summary, we provide evidence of dysfunctional TGF-beta signalling occurring at an early stage in prostate cancer. We show that this disease pathway is mediated by cPML and CRM1 and results in a more aggressive cancer cell phenotype. We propose that the targeting of this pathway could be therapeutically exploited for clinical benefit.	[Buczek, M. E.; Miles, A. K.; Johnson, C.; Boocock, D. J.; Pockley, A. G.; Rees, R. C.; Powe, D. G.; Regad, T.] Nottingham Trent Univ, John Van Geest Canc Res Ctr, Sch Sci & Technol, Clifton Lane, Nottingham NG11 8NS, England; [Green, W.; Parkinson, R.] City Hosp, Nottingham Univ Hosp NHS Trust, Dept Urol, Nottingham, England; [Hulman, G.; Hulman, J.; Powe, D. G.] Nottingham Univ Hosp Trust, Queens Med Ctr, Dept Cellular Pathol, Nottingham, England; [van Schalkwyk, G.] Royal Derby Hosp, Dept Histopathol, Derby, England	Nottingham Trent University; Nottingham University Hospital NHS Trust; University of Nottingham; Nottingham University Hospital NHS Trust; University of Nottingham; University of Nottingham	Regad, T (corresponding author), Nottingham Trent Univ, John Van Geest Canc Res Ctr, Sch Sci & Technol, Clifton Lane, Nottingham NG11 8NS, England.	tarik.regad@ntu.ac.uk	Regad, Tarik/A-6095-2012; Pockley, Alan G/I-4704-2015; Boocock, David/I-4666-2015	Regad, Tarik/0000-0003-4028-6368; Pockley, Alan G/0000-0001-9593-6431; Boocock, David/0000-0002-7333-3549; Miles, Amanda/0000-0002-5388-938X	John and Lucille van Geest Foundation; Cancer and Polio Research Fund	John and Lucille van Geest Foundation; Cancer and Polio Research Fund	This work was funded by the John and Lucille van Geest Foundation and Cancer and Polio Research Fund. We thank Mrs Anne Schneider, Mr Stephen Reeder, Mr Chris Nolan and Dr Claire Hawkes for their assistance in this study.	Altman DG, 2012, BMC MED, V10, DOI [10.1186/1741-7015-10-51, 10.1371/journal.pmed.1001216]; BORROW J, 1990, SCIENCE, V249, P1577, DOI 10.1126/science.2218500; Camp RL., 2004, CLIN CANCER RES, V10, P7252, DOI [DOI 10.1158/1078-0432.CCR-04-0713, 10.1158/1078-0432.CCR-04-0713]; Chan JYH, 1998, EUR J CANCER, V34, P1015, DOI 10.1016/S0959-8049(97)10138-1; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; DETHE H, 1990, NATURE, V347, P558, DOI 10.1038/347558a0; Grunert S, 2003, NAT REV MOL CELL BIO, V4, P657, DOI 10.1038/nrm1175; Gurrieri C, 2004, JNCI-J NATL CANCER I, V96, P269, DOI 10.1093/jnci/djh043; Heldin CH, 2012, FEBS LETT, V586, P1959, DOI 10.1016/j.febslet.2012.02.037; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825; Jin GX, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00147; KAKIZUKA A, 1991, CELL, V66, P663, DOI 10.1016/0092-8674(91)90112-C; Katakura Y, 1999, BIOCHEM BIOPH RES CO, V255, P110, DOI 10.1006/bbrc.1999.0129; Kubiczkova L, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-183; Lallemand-Breitenbach V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000661; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lin HK, 2004, NATURE, V431, P205, DOI 10.1038/nature02783; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Mathieu MG, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.29; Mazza M, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00174; MCCARTY KS, 1985, ARCH PATHOL LAB MED, V109, P716; Morrison CD, 2013, CANCER LETT, V341, P30, DOI 10.1016/j.canlet.2013.02.048; Nisole S, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00125; Principe DR, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt369; Regad T, 2001, ONCOGENE, V20, P7274, DOI 10.1038/sj.onc.1204854; Salomoni P, 2002, CELL, V108, P165, DOI 10.1016/S0092-8674(02)00626-8; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Son H, 2010, TOX RESEARCH, V26, P245, DOI 10.5487/TR.2010.26.4.245; TERRIS B, 1995, CANCER RES, V55, P1590; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Yuan WC, 2011, CANCER CELL, V20, P214, DOI 10.1016/j.ccr.2011.07.008	33	35	35	0	8	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 30	2016	35	26					3465	3475		10.1038/onc.2015.409	http://dx.doi.org/10.1038/onc.2015.409			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DQ5UI	26549027	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000379270100011
J	Abraham, A; Albulaihe, H; Alabdali, M; Qrimli, M; Breiner, A; Barnett, C; Katzberg, HD; Lovblom, LE; Perkins, BA; Bril, V				Abraham, Alon; Albulaihe, Hana; Alabdali, Majed; Qrimli, Mohammad; Breiner, Ari; Barnett, Carolina; Katzberg, Hans D.; Lovblom, Leif E.; Perkins, Bruce A.; Bril, Vera			Elevated Vibration Perception Thresholds in CIDP Patients Indicate More Severe Neuropathy and Lower Treatment Response Rates	PLOS ONE			English	Article							INFLAMMATORY DEMYELINATING POLYNEUROPATHY; PERIPHERAL NEUROPATHY; CRITERIA; POLYRADICULONEUROPATHY	Introduction Vibration perception threshold (VPT) examination using a neurothesiometer provides objective, sensitive and specific information, and has been utilized mainly in patients with diabetic polyneropathy. Objectives Explore the utility of VPT examination in CIDP patients. Methods CIDP subjects attending the Neuromuscular clinic between 01/2013 and 12/2014 were evaluated. Demographic data, clinical history, physical examination, VPT values, and electrophysiologic data from their charts were extracted. Results 70 charts were reviewed. 55 CIDP patients had elevated VPT, associated with higher frequency of abnormal sensory testing for various modalities (92.7% vs. 46.7%, p<0.0001), lower sensory and motor amplitudes and reduced conduction velocities on nerve conduction studies, and lower treatment response rates (54% vs. 93%, p = 0.01). Conclusion VPT examination is a simple tool, which is a reliable and sensitive measure not only for diabetic neuropathy, but also for CIDP. Moreover, in CIDP, elevated VPT values are also associated with lower treatment response rates.	[Abraham, Alon; Qrimli, Mohammad; Breiner, Ari; Barnett, Carolina; Katzberg, Hans D.; Bril, Vera] Univ Toronto, Univ Hlth Network, Div Neurol, Ellen & Martin Prosserman Ctr Neuromuscular Dis,D, Toronto, ON, Canada; [Albulaihe, Hana] King Saud Univ, King Khalid Univ Hosp, Dept Neurol, Riyadh, Saudi Arabia; [Alabdali, Majed] Univ Dammam, King Fahad Hosp Univ, Dept Neurol, Dammam, Saudi Arabia; [Lovblom, Leif E.; Perkins, Bruce A.] Mt Sinai Hosp, Dept Med, Div Endocrinol & Metab, Toronto, ON M5G 1X5, Canada; [Lovblom, Leif E.; Perkins, Bruce A.] Univ Toronto, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; King Saud University; King Khalid University Hospital; Imam Abdulrahman Bin Faisal University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Bril, V (corresponding author), Univ Toronto, Univ Hlth Network, Div Neurol, Ellen & Martin Prosserman Ctr Neuromuscular Dis,D, Toronto, ON, Canada.	vera.bril@utoronto.ca	Barnett, Carolina/AFM-9470-2022; Perkins, Bruce A/L-3726-2017; BRIL, vera/ABA-6509-2020; Abraham, Alon/H-9343-2019	Abraham, Alon/0000-0002-9020-2399; Lovblom, Leif Erik/0000-0002-6774-8924; Barnett, Carolina/0000-0001-5546-0221				Abraham A, 2015, EXPERT REV CLIN IMMU, V11, P537, DOI 10.1586/1744666X.2015.1018891; Amato A., 2008, NEUROMUSCULAR DISORD; Bolton CF, 2000, CANADIAN J NEUROLOGI, P288; Bril V, 2002, DIABETIC MED, V19, P661, DOI 10.1046/j.1464-5491.2002.00759.x; Bril V, 2010, MUSCLE NERVE, V42, P492, DOI 10.1002/mus.21733; Burns TM, 2002, J PERIPHER NERV SYST, V7, P112, DOI 10.1046/j.1529-8027.2002.02016.x; CLAUS D, 1993, MUSCLE NERVE, V16, P757, DOI 10.1002/mus.880160711; Cocito D, 2006, EUR J NEUROL, V13, P669, DOI 10.1111/j.1468-1331.2006.01259.x; Dimitrakoudis D, 2002, NEUROLOGY, V59, P611, DOI 10.1212/WNL.59.4.611; Dunnigan SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089344; Dyck PJ, 1999, MUSCLE NERVE, V22, P659, DOI 10.1002/(SICI)1097-4598(199906)22:6<659::AID-MUS1>3.0.CO;2-X; Hughes RAC, 2008, LANCET NEUROL, V7, P136, DOI 10.1016/S1474-4422(07)70329-0; Katz JS, 2000, NEUROLOGY, V54, P615, DOI 10.1212/WNL.54.3.615; Koski CL, 2009, J NEUROL SCI, V277, P1, DOI 10.1016/j.jns.2008.11.015; Kuwabara S, 2002, J NEUROL NEUROSUR PS, V72, P37, DOI 10.1136/jnnp.72.1.37; Magda P, 2003, ARCH NEUROL-CHICAGO, V60, P1755, DOI 10.1001/archneur.60.12.1755; Martin CL, 2010, DIABETES CARE, V33, P2635, DOI 10.2337/dc10-0616; Pestronk A, 2004, NEUROLOGY, V62, P461, DOI 10.1212/01.WNL.0000106939.41855.36; SIMMONS Z, 1993, NEUROLOGY, V43, P2202, DOI 10.1212/WNL.43.11.2202	19	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0139689	10.1371/journal.pone.0139689	http://dx.doi.org/10.1371/journal.pone.0139689			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545096	Green Published, gold, Green Submitted			2022-12-26	WOS:000364398700003
J	Beretov, J; Wasinger, VC; Millar, EKA; Schwartz, P; Graham, PH; Li, Y				Beretov, Julia; Wasinger, Valerie C.; Millar, Ewan K. A.; Schwartz, Peter; Graham, Peter H.; Li, Yong			Proteomic Analysis of Urine to Identify Breast Cancer Biomarker Candidates Using a Label-Free LC-MS/MS Approach	PLOS ONE			English	Article							ANNEXIN A1 EXPRESSION; PROSTATE-SPECIFIC ANTIGEN; MATRIX PROTEIN-1 ECM1; SPARC-LIKE PROTEIN-1; NERVE GROWTH-FACTOR; SERUM BIOMARKERS; NASOPHARYNGEAL CARCINOMA; TUMOR-SUPPRESSOR; DUCTAL CARCINOMA; DRUG-RESISTANCE	Introduction Breast cancer is a complex heterogeneous disease and is a leading cause of death in women. Early diagnosis and monitoring progression of breast cancer are important for improving prognosis. The aim of this study was to identify protein biomarkers in urine for early screening detection and monitoring invasive breast cancer progression. Method We performed a comparative proteomic analysis using ion count relative quantification label free LC-MS/MS analysis of urine from breast cancer patients (n = 20) and healthy control women (n = 20). Results Unbiased label free LC-MS/MS-based proteomics was used to provide a profile of abundant proteins in the biological system of breast cancer patients. Data analysis revealed 59 urinary proteins that were significantly different in breast cancer patients compared to the normal control subjects (p< 0.05, fold change > 3). Thirty-six urinary proteins were exclusively found in specific breast cancer stages, with 24 increasing and 12 decreasing in their abundance. Amongst the 59 significant urinary proteins identified, a list of 13 novel up-regulated proteins were revealed that may be used to detect breast cancer. These include stage specific markers associated with pre-invasive breast cancer in the ductal carcinoma in-situ (DCIS) samples (Leucine LRC36, MAST4 and Uncharacterized protein CI131), early invasive breast cancer (DYH8, HBA, PEPA, uncharacterized protein C4orf14 (CD014), filaggrin and MMRN2) and metastatic breast cancer (AGRIN, NEGR1, FIBA and Keratin KIC10). Preliminary validation of 3 potential markers (ECM1, MAST4 and filaggrin) identified was performed in breast cancer cell lines by Western blotting. One potential marker MAST4 was further validated in human breast cancer tissues as well as individual human breast cancer urine samples with immunohistochemistry and Western blotting, respectively. Conclusions Our results indicate that urine is a useful non-invasive source of biomarkers and the profile patterns (biomarkers) identified, have potential for clinical use in the detection of BC. Validation with a larger independent cohort of patients is required in the following study.	[Beretov, Julia; Graham, Peter H.; Li, Yong] St George Hosp, Canc Care Ctr, Kogarah, NSW, Australia; [Beretov, Julia; Graham, Peter H.; Li, Yong] UNSW, Fac Med, St George & Sutherland Clin Sch, Kensington, NSW, Australia; [Beretov, Julia; Millar, Ewan K. A.] St George Hosp, Anat Pathol, SEALS, Kogarah, NSW, Australia; [Wasinger, Valerie C.] UNSW, Mark Wainwright Analyt Ctr, Bioanalyt Mass Spectrometry Facil, Kensington, NSW, Australia; [Wasinger, Valerie C.; Millar, Ewan K. A.] UNSW, Sch Med Sci, Kensington, NSW, Australia; [Millar, Ewan K. A.] Kinghorn Canc Ctr, Canc Res Program, Darlinghurst, NSW, Australia; [Millar, Ewan K. A.] St Vincents Hosp, Garvan Inst Med Res, Darlinghurst, NSW 2010, Australia; [Millar, Ewan K. A.] Univ Western Sydney, Sch Med & Hlth Sci, Campbelltown, NSW, Australia; [Schwartz, Peter] St George Private Hosp, Breast Surg, Kogarah, NSW, Australia	St George Hospital; University of New South Wales Sydney; St George Hospital; University of New South Wales Sydney; University of New South Wales Sydney; Garvan Institute of Medical Research; St Vincents Hospital Sydney; Western Sydney University	Li, Y (corresponding author), St George Hosp, Canc Care Ctr, Kogarah, NSW, Australia.	y.li@unsw.edu.au	Millar, Ewan/ABE-9127-2020; Wasinger, Valerie/AAC-5004-2021	Millar, Ewan/0000-0002-9778-3253; Wasinger, Valerie/0000-0001-5338-0869; Li, Yong/0000-0002-8910-9787; Beretov, Julia/0000-0001-5582-0020	St George Cancer Care Centre Research Trust Fund	St George Cancer Care Centre Research Trust Fund	Funding provided by St George Cancer Care Centre Research Trust Fund.	Aaboe M, 2003, BBA-MOL BASIS DIS, V1638, P72, DOI 10.1016/S0925-4439(03)00059-0; Abdullah-Soheimi SS, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-58; Adachi J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r80; Ahn WS, 2005, CANCER SCI, V96, P197, DOI 10.1111/j.1349-7006.2005.00029.x; Antalis CJ, 2011, CLIN EXP METASTAS, V28, P733, DOI 10.1007/s10585-011-9405-9; BELLAHCENE A, 1995, AM J PATHOL, V146, P95; Beretov Julia, 2014, Biomark Cancer, V6, P21, DOI 10.4137/BIC.S17991; Beretov J, 2014, ADV CLIN CHEM, V63, P123, DOI 10.1016/B978-0-12-800094-6.00004-2; Black MH, 2000, BREAST CANCER RES TR, V59, P1, DOI 10.1023/A:1006380306781; Candiano G, 2010, J PROTEOMICS, V73, P829, DOI 10.1016/j.jprot.2009.12.003; Cao Y, 2008, APPL IMMUNOHISTO M M, V16, P530, DOI 10.1097/PAI.0b013e31817432c3; Caruso Joseph A, 2011, Clin Exp Metastasis, V28, P529, DOI 10.1007/s10585-011-9389-5; Chang KP, 2010, PROTEOMICS, V10, P2644, DOI 10.1002/pmic.200900620; Chang L, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.407; Cho W, 2010, J PROTEOME RES, V9, P5960, DOI 10.1021/pr100747p; Coffelt SB, 2015, NATURE; Coffelt SB, 2015, TRENDS IMMUNOL, V36, P198, DOI 10.1016/j.it.2015.02.006; Custodio A, 2012, J CANCER RES CLIN, V138, P867, DOI 10.1007/s00432-012-1161-y; Deng M, 2013, ONCOGENE, V32, P4273, DOI 10.1038/onc.2012.434; Descamps S, 1998, J BIOL CHEM, V273, P16659, DOI 10.1074/jbc.273.27.16659; Dolle L, 2004, CURR CANCER DRUG TAR, V4, P463, DOI 10.2174/1568009043332853; dos Santos CR, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-16; Dowling P, 2012, INT J CANCER, V131, P911, DOI 10.1002/ijc.26462; Esposito I, 2007, NEOPLASIA, V9, P8, DOI 10.1593/neo.06646; Goncalves A, 2006, ONCOGENE, V25, P981, DOI 10.1038/sj.onc.1209131; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Han ZQ, 2001, FASEB J, V15, P988, DOI 10.1096/fj.99-0934com; Hao J, 2010, BRIT J CANCER, V103, P1008, DOI 10.1038/sj.bjc.6605839; Hassanein M, 2012, CANCER PREV RES, V5, P992, DOI 10.1158/1940-6207.CAPR-11-0441; He P, 2005, PROTEOMICS, V5, P3442, DOI 10.1002/pmic.200401301; Husi H, 2011, PROTEOM CLIN APPL, V5, P289, DOI 10.1002/prca.201000107; Kadowaki M, 2011, J CANCER RES CLIN, V137, P1105, DOI 10.1007/s00432-010-0974-9; Karp NA, 2007, MOL CELL PROTEOMICS, V6, P1354, DOI 10.1074/mcp.M600274-MCP200; Khurana A, 2013, CLIN EXP METASTAS, V30, P407, DOI 10.1007/s10585-012-9546-5; Kim BK, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2247; Klein-Scory S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-70; Lakhani SR, 2012, WHO CLASSIFICATION T; Lal G, 2009, ANN SURG ONCOL, V16, P2280, DOI 10.1245/s10434-009-0533-2; Lee KM, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0479-6; Lei T, 2012, CLIN GENITOURINARY C; Leinonen T, 2007, J CLIN PATHOL, V60, P515, DOI 10.1136/jcp.2006.038711; Li JN, 2005, CLIN CHEM, V51, P2229, DOI 10.1373/clinchem.2005.052878; Linden M, 2012, PROTEOMICS, V12, P135, DOI 10.1002/pmic.201000810; Mohamed E, 2008, ELECTROPHORESIS, V29, P2645, DOI 10.1002/elps.200700828; Morimoto-Tomita M, 2005, NEOPLASIA, V7, P1001, DOI 10.1593/neo.05496; Myklebust MP, 2012, BRIT J CANCER, V106, P756, DOI 10.1038/bjc.2011.548; Nasim Faiz-Ul-Hassan, 2012, Biomark Cancer, V4, P19, DOI 10.4137/BIC.S10502; Nutter F, 2014, ENDOCR RELAT CANC; Opstal-van Winden AWJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-381; Pan S, 2011, MOL CELLULAR PROTEOM, V10; Parker BS, 2008, J PATHOL, V214, P337, DOI 10.1002/path.2265; Pavlova NN, 2013, ELIFE, V2, DOI 10.7554/eLife.00358; Peng L, 2013, EXP THER MED, V6, P1169, DOI 10.3892/etm.2013.1310; Profumo A, 2013, J PROTEOMICS, V85, P44, DOI 10.1016/j.jprot.2013.04.029; Provatopoulou X, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-390; Rho JH, 2008, J PROTEOME RES, V7, P2959, DOI 10.1021/pr8000892; Rittenhouse HG, 1998, CRIT REV CL LAB SCI, V35, P275, DOI 10.1080/10408369891234219; Robinson DR, 2011, NAT MED, V17, P1646, DOI 10.1038/nm.2580; Schulz DM, 2009, J PROTEOME RES, V8, P3430, DOI 10.1021/pr900071h; Semaan SM, 2012, J CANCER, V3, P269, DOI 10.7150/jca.4592; Shen DJ, 2005, BIOCHEM BIOPH RES CO, V326, P218, DOI 10.1016/j.bbrc.2004.10.214; Sloan KE, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-73; Solassol J, 2010, ONCOGENE, V29, P550, DOI 10.1038/onc.2009.341; Somiari RI, 2003, PROTEOMICS, V3, P1863, DOI 10.1002/pmic.200300560; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sun L, 2006, Mol Biol (Mosk), V40, P808; Takita J, 2011, CANCER SCI, V102, P1645, DOI 10.1111/j.1349-7006.2011.01995.x; Thongboonkerd V, 2002, KIDNEY INT, V62, P1461, DOI 10.1046/j.1523-1755.2002.00565.x; Turtoi A, 2012, J PROTEOME RES, V11, P5011, DOI 10.1021/pr3005698; Vafadar-Isfahani B, 2012, J ALZHEIMERS DIS, V28, P625, DOI 10.3233/JAD-2011-111505; VIZOSO F, 1995, J CLIN ONCOL, V13, P54, DOI 10.1200/JCO.1995.13.1.54; Wang LP, 2010, NEOPLASMA, V57, P253, DOI 10.4149/neo_2010_03_253; Wang LP, 2003, CANCER LETT, V200, P57, DOI 10.1016/S0304-3835(03)00350-1; Wenners AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045826; Whiteside TL, 2012, CLIN CANCER RES, V18, P2417, DOI 10.1158/1078-0432.CCR-12-0566; Wu QW, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-47; Yamanaka M, 2001, J UROLOGY, V166, P2495, DOI 10.1016/S0022-5347(05)65623-6; Yates JR, 2009, ANNU REV BIOMED ENG, V11, P49, DOI 10.1146/annurev-bioeng-061008-124934; Yi JK, 2009, CANCER EPIDEM BIOMAR, V18, P1357, DOI 10.1158/1055-9965.EPI-08-0696; Yin FQ, 2013, INT J ONCOL, V42, P1305, DOI 10.3892/ijo.2013.1819; Yom CK, 2011, J BREAST CANCER, V14, P262, DOI 10.4048/jbc.2011.14.4.262; Zeng Z, 2010, J CHROMATOGR A, V1217, P3307, DOI 10.1016/j.chroma.2009.09.029; Zhang Z, 2004, CANCER RES, V64, P5882, DOI 10.1158/0008-5472.CAN-04-0746; Zhu DJ, 2014, INT J CLIN EXP PATHO, V7, P1; Zoidakis J, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.009449	85	56	61	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141876	10.1371/journal.pone.0141876	http://dx.doi.org/10.1371/journal.pone.0141876			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544852	gold, Green Submitted, Green Published			2022-12-26	WOS:000364398700057
J	Blanton, C; He, ZC; Gottschall-Pass, KT; Sweeney, MI				Blanton, Cynthia; He, Zhengcheng; Gottschall-Pass, Katherine T.; Sweeney, Marva I.			Probiotics Blunt the Anti-Hypertensive Effect of Blueberry Feeding in Hypertensive Rats without Altering Hippuric Acid Production	PLOS ONE			English	Article							DIET VACCINIUM-ANGUSTIFOLIUM; INTESTINAL OXIDATIVE STRESS; BLOOD-PRESSURE; GUT MICROBIOTA; NITRIC-OXIDE; RISK-FACTORS; IN-VITRO; POLYPHENOLS; METABOLISM; CONSUMPTION	Previously we showed that feeding polyphenol-rich wild blueberries to hypertensive rats lowered systolic blood pressure. Since probiotic bacteria produce bioactive metabolites from berry polyphenols that enhance the health benefits of berry consumption, we hypothesized that adding probiotics to a blueberry-enriched diet would augment the anti-hypertensive effects of blueberry consumption. Groups (n = 8) of male spontaneously hypertensive rats were fed one of four AIN '93G-based diets for 8 weeks: Control (CON); 3% freeze-dried wild blueberry (BB); 1% probiotic bacteria (PRO); or 3% BB + 1% PRO (BB + PRO). Blood pressure was measured at weeks 0, 2, 4, 6, and 8 by the tail-cuff method, and urine was collected at weeks 4 and 8 to determine markers of oxidative stress (F2-isoprostanes), nitric oxide synthesis (nitrites), and polyphenol metabolism (hippuric acid). Data were analyzed using mixed models ANOVA with repeated measures. Diet had a significant main effect on diastolic blood pressure (p = 0.046), with significantly lower measurements in the BB-vs. CON-fed rats (p = 0.035). Systolic blood pressure showed a similar but less pronounced response to diet (p = 0.220), again with the largest difference between the BB and CON groups. Absolute increase in blood pressure between weeks 0 and 8 tended to be smaller in the BB and PRO vs. CON and BB + PRO groups (systolic increase, p = 0.074; diastolic increase, p = 0.185). Diet had a significant main effect on hippuric acid excretion (p < 0.0001), with 2- and similar to 1.5-fold higher levels at weeks 4 and 8, respectively, in the BB and BB + PRO vs. PRO and CON groups. Diet did not have a significant main effect on F2-iso-prostane (p = 0.159) or nitrite excretion (p = 0.670). Our findings show that adding probiotics to a blueberry-enriched diet does not enhance and actually may impair the anti-hypertensive effect of blueberry consumption. However, probiotic bacteria are not interfering with blueberry polyphenol metabolism into hippuric acid.	[Blanton, Cynthia] Idaho State Univ, Dept Nutr, Pocatello, ID 83209 USA; [He, Zhengcheng; Sweeney, Marva I.] Univ Prince Edward Isl, Dept Biol, Charlottetown, PE C1A 4P3, Canada; [Gottschall-Pass, Katherine T.] Univ Prince Edward Isl, Dept Appl Human Sci, Charlottetown, PE C1A 4P3, Canada	Idaho; Idaho State University; University of Prince Edward Island; University of Prince Edward Island	Blanton, C (corresponding author), Idaho State Univ, Dept Nutr, Pocatello, ID 83209 USA.	blancynt@isu.edu			Wild Blueberry Association of North America (WBANA)	Wild Blueberry Association of North America (WBANA)	The Wild Blueberry Association of North America (WBANA) provided $5000 USD to support this research. The financial support is not associated with a grant number. Marva Sweeney-Nixon has received funding from WBANA in the past and she was PI on this funding support (http://www.wildblueberries.com/health-research/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axling U, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-105; Basu A, 2010, J NUTR, V140, P1582, DOI 10.3945/jn.110.124701; Bohn T, 2015, MOL NUTR FOOD RES, V59, P1307, DOI 10.1002/mnfr.201400745; Borghi C, 2004, AM HEART J, V148, P285, DOI 10.1016/j.ahj.2004.02.003; Boto-Ordonez M, 2014, FOOD FUNCT, V5, P1932, DOI [10.1039/c4fo00029c, 10.1039/C4FO00029C]; Cassidy A, 2011, AM J CLIN NUTR, V93, P338, DOI 10.3945/ajcn.110.006783; Chen DW, 2015, J MICROBIOL BIOTECHN, V25, P687, DOI 10.4014/jmb.1409.09085; Chen HD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051001; Del Bo C, 2010, J AGR FOOD CHEM, V58, P2491, DOI 10.1021/jf903472x; Duda-Chodak A, 2015, EUR J NUTR, V54, P325, DOI 10.1007/s00394-015-0852-y; Elks CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024028; Erlund I, 2008, AM J CLIN NUTR, V87, P323, DOI 10.1093/ajcn/87.2.323; Esposito E, 2009, J NUTR, V139, P905, DOI 10.3945/jn.108.101808; Fortepiani LA, 2005, J HYPERTENS, V23, P801, DOI 10.1097/01.hjh.0000163149.05083.13; Gillespie C., 2011, Morbidity and Mortality Weekly Report, V60, P103; Haffner SM, 1996, ARCH INTERN MED, V156, P1994, DOI 10.1001/archinte.156.17.1994; Hakansson A, 2006, DIGEST DIS SCI, V51, P2094, DOI 10.1007/s10620-006-9170-9; Hakansson A, 2009, SCAND J GASTROENTERO, V44, P1213, DOI 10.1080/00365520903171268; Hidalgo M, 2012, J AGR FOOD CHEM, V60, P3882, DOI 10.1021/jf3002153; Hirata Y, 1996, HYPERTENSION, V27, P672, DOI 10.1161/01.HYP.27.3.672; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Queipo-Ortuno MI, 2012, AM J CLIN NUTR, V95, P1323, DOI 10.3945/ajcn.111.027847; Jakesevic M, 2013, J AGR FOOD CHEM, V61, P3468, DOI 10.1021/jf400203h; Jakesevic M, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-8; Johnson SA, 2015, J ACAD NUTR DIET, V115, P369, DOI 10.1016/j.jand.2014.11.001; Jose PA, 2015, CURR OPIN NEPHROL HY, V24, P403, DOI 10.1097/MNH.0000000000000149; Kalea AZ, 2010, J NUTR BIOCHEM, V21, P14, DOI 10.1016/j.jnutbio.2008.09.005; Khalesi S, 2014, HYPERTENSION, V64, P897, DOI 10.1161/HYPERTENSIONAHA.114.03469; Kristo AS, 2010, J AGR FOOD CHEM, V58, P11600, DOI 10.1021/jf101839u; Lacombe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067497; Landete JM, 2012, CRIT REV FOOD SCI, V52, P936, DOI 10.1080/10408398.2010.513779; Lopera YE, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/516727; Lye HS, 2009, INT J MOL SCI, V10, P3755, DOI 10.3390/ijms10093755; Mahboobi S, 2014, INT J PREVENTIVE MED, V5; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Manning RD, 2003, ACTA PHYSIOL SCAND, V179, P243, DOI 10.1046/j.0001-6772.2003.01204.x; Molan AL, 2009, WORLD J MICROB BIOT, V25, P1243, DOI 10.1007/s11274-009-0011-9; Mulder TP, 2005, AM J CLIN NUTR, V81, p256S, DOI 10.1093/ajcn/81.1.256S; Nabha L, 2005, CLIN EXP HYPERTENS, V27, P71, DOI 10.1081/CEH-200044267; Nair AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111976; Okrozub VV, 2015, EPMA J, V6, DOI 10.1186/s13167-015-0035-1; PANZA JA, 1993, CIRCULATION, V87, P1468, DOI 10.1161/01.CIR.87.5.1468; Peluso I, 2014, INT J FOOD SCI NUTR, V65, P259, DOI 10.3109/09637486.2014.880670; Phipps FC, 1994, NIOSH MANUAL ANAL ME; Public Health Agency of Canada, HYPERTENSION; Rashid Sherzad K, 2014, PLoS One, V9, pe97458, DOI 10.1371/journal.pone.0097458; Riso P, 2013, EUR J NUTR, V52, P949, DOI 10.1007/s00394-012-0402-9; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Russell WR, 2008, NUTR CANCER, V60, P636, DOI 10.1080/01635580801987498; Russell WR, 2007, MOL NUTR FOOD RES, V51, P726, DOI 10.1002/mnfr.200700022; Sanchez-Patan F, 2012, J AGR FOOD CHEM, V60, P2136, DOI 10.1021/jf2040115; Selma MV, 2009, J AGR FOOD CHEM, V57, P6485, DOI 10.1021/jf902107d; Shaughnessy KS, 2009, NUTR RES, V29, P130, DOI 10.1016/j.nutres.2009.01.001; Sun J, 2015, ANN MED, V47, P430, DOI 10.3109/07853890.2015.1071872; Sweeney MI, 2002, NUTR NEUROSCI, V5, P427, DOI 10.1080/1028415021000055970; Tabasco R, 2011, FOOD MICROBIOL, V28, P1345, DOI 10.1016/j.fm.2011.06.005; Toromanovic J, 2008, BOSNIAN J BASIC MED, V8, P38, DOI 10.17305/bjbms.2008.2994; Tzounis X, 2011, AM J CLIN NUTR, V93, P62, DOI 10.3945/ajcn.110.000075; VALLANCE P, 1989, LANCET, V2, P997; Vendrame S, 2011, J AGR FOOD CHEM, V59, P12815, DOI 10.1021/jf2028686; Wallen WJ, 2002, J NUTR, V132, P2246, DOI 10.1093/jn/132.8.2246; Williamson G, 2010, BRIT J NUTR, V104, pS48, DOI 10.1017/S0007114510003946; Yang T, 2015, HYPERTENSION, V65, P1331, DOI 10.1161/HYPERTENSIONAHA.115.05315; Yang Y, 2015, INT J CLIN EXP PATHO, V8, P2700	64	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142036	10.1371/journal.pone.0142036	http://dx.doi.org/10.1371/journal.pone.0142036			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544724	gold, Green Published, Green Submitted			2022-12-26	WOS:000364398700072
J	McNamara, JM; Houston, AI; Higginson, AD				McNamara, John M.; Houston, Alasdair I.; Higginson, Andrew D.			Costs of Foraging Predispose Animals to Obesity-Related Mortality when Food Is Constantly Abundant	PLoS One			English	Article							PSYCHOSOCIAL STRESS; ENERGY-BALANCE; PREDATION RISK; TRADE-OFF; STARVATION; EPIDEMIC; WEIGHT; FAT; METAANALYSIS; PERSPECTIVE	Obesity is an important medical problem affecting humans and animals in the developed world, but the evolutionary origins of the behaviours that cause obesity are poorly understood. The potential role of occasional gluts of food in determining fat-storage strategies for avoiding mortality have been overlooked, even though animals experienced such conditions in the recent evolutionary past and may follow the same strategies in the modern environment. Humans, domestic, and captive animals in the developed world are exposed to a surplus of calorie-rich food, conditions characterised as 'constant-glut'. Here, we use a mathematical model to demonstrate that obesity-related mortality from poor health in a constant-glut environment should equal the average mortality rate in the 'pre-modern' environment when predation risk was more closely linked with foraging. It should therefore not be surprising that animals exposed to abundant food often over-eat to the point of ill-health. Our work suggests that individuals tend to defend a given excessive level of reserves because this level was adaptive when gluts were short-lived. The model predicts that mortality rate in constant-glut conditions can increase as the assumed health cost of being overweight decreases, meaning that any adaptation that reduced such health costs would have counter-intuitively led to an increase in mortality in the modern environment. Taken together, these results imply that efforts to reduce the incidence of obesity that are focussed on altering individual behaviour are likely to be ineffective because modern, constant-glut conditions trigger previously adaptive behavioural responses.	[McNamara, John M.] Univ Bristol, Sch Math, Bristol BS8 1TW, Avon, England; [Houston, Alasdair I.; Higginson, Andrew D.] Univ Bristol, Sch Biol Sci, Bristol BS8 1TQ, Avon, England; [Higginson, Andrew D.] Univ Exeter, Coll Life & Environm Sci, Exeter EX4 4QG, Devon, England	University of Bristol; University of Bristol; University of Exeter	Higginson, AD (corresponding author), Univ Bristol, Sch Biol Sci, Life Sci Bldg,24 Tyndall Ave, Bristol BS8 1TQ, Avon, England.	adhigginson@gmail.com			European Research Council [250209]; NERC Independent Research Fellowship [NE/L011921/1]; NERC [NE/L011921/1, NE/L011921/2] Funding Source: UKRI; Natural Environment Research Council [NE/L011921/1, NE/L011921/2] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); NERC Independent Research Fellowship(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the European Research Council (Advanced Grant 250209 to Alasdair Houston). An NERC Independent Research Fellowship (NE/L011921/1) was awarded to A.D.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JW, 2001, AM J CLIN NUTR, V74, P579; Barker DJP, 1997, NUTRITION, V13, P807, DOI 10.1016/S0899-9007(97)00193-7; Benyshek DC, 2006, AM J PHYS ANTHROPOL, V131, P120, DOI 10.1002/ajpa.20334; Brodin A, 2001, ANIM BEHAV, V62, P993, DOI 10.1006/anbe.2001.1844; Davis C, 2010, EAT BEHAV, V11, P301, DOI 10.1016/j.eatbeh.2010.07.004; Fawcett TW, 2014, TRENDS COGN SCI, V18, P153, DOI 10.1016/j.tics.2013.12.012; Frankenhuis WE, 2012, DEV PSYCHOL, V48, P628, DOI 10.1037/a0025629; Garaulet M, 2010, INT J OBESITY, V34, P1667, DOI 10.1038/ijo.2010.118; Gariepy G, 2010, INT J OBESITY, V34, P407, DOI 10.1038/ijo.2009.252; Gazzola A, 2005, J ZOOL, V266, P205, DOI 10.1017/S0952836905006801; GOSLER AG, 1995, NATURE, V377, P621, DOI 10.1038/377621a0; Hayward AD, 2012, P ROY SOC B-BIOL SCI, V279, P4165, DOI 10.1098/rspb.2012.1190; Heymsfield SB, 2007, AM J CLIN NUTR, V85, P346, DOI 10.1093/ajcn/85.2.346; Higginson AD, 2012, AM NAT, V179, P338, DOI 10.1086/664457; Hocken AG, 2000, NEW ZEAL J ZOOL, V27, P305, DOI 10.1080/03014223.2000.9518239; James PT, 2004, CLIN DERMATOL, V22, P276, DOI 10.1016/j.clindermatol.2004.01.010; Kirchengast S, 1998, ANN HUM BIOL, V25, P541, DOI 10.1080/03014469800006782; Klenov VE, 2014, CURR OPIN OBSTET GYN, V26, P455, DOI 10.1097/GCO.0000000000000113; LIMA SL, 1986, ECOLOGY, V67, P377, DOI 10.2307/1938580; Marik PE, 2012, OBES REV, V13, P902, DOI 10.1111/j.1467-789X.2012.01014.x; McCue MD, 2010, COMP BIOCHEM PHYS A, V156, P1, DOI 10.1016/j.cbpa.2010.01.002; MCNAMARA JM, 1990, ACTA BIOTHEOR, V38, P37, DOI 10.1007/BF00047272; MCNAMARA JM, 1990, ADV APPL PROBAB, V22, P295, DOI 10.2307/1427537; Milner JJ, 2012, P NUTR SOC, V71, P298, DOI 10.1017/S0029665112000158; Morrison CD, 2007, NUTR REV, V65, P517, DOI 10.1111/j.1753-4887.2007.tb00277.x; Mysterud A, 2008, J ZOOL, V275, P407, DOI 10.1111/j.1469-7998.2008.00453.x; NEEL JV, 1962, AM J HUM GENET, V14, P353; Nikolopoulou A, 2012, EXPERT REV CARDIOVAS, V10, P933, DOI [10.1586/erc.12.74, 10.1586/ERC.12.74]; Obesity Strubbe JH., 1994, FOOD INTAKE ENERGY E; ODEA K, 1992, DIABETES METAB REV, V8, P373, DOI 10.1002/dmr.5610080405; PASQUET P, 1992, AM J CLIN NUTR, V56, P483, DOI 10.1093/ajcn/56.3.483; Pereira JA, 2010, EUR J WILDLIFE RES, V56, P939, DOI 10.1007/s10344-010-0423-8; Pickering TR, 2005, EVOL ANTHROPOL, V14, P159, DOI 10.1002/evan.20070; Pollock N J, 1995, Asia Pac J Clin Nutr, V4, P357; Popkin BM, 2004, INT J OBESITY, V28, pS2, DOI [10.1038/sj.ijo.0802804, 10.1038/sj.ijo.0802557]; Putaala A, 2001, WILDL BIOL, V18, P291; Raj Manu, 2012, Indian J Endocrinol Metab, V16, P13, DOI 10.4103/2230-8210.91176; Rius B, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00257; Rogers PJ, 1999, P NUTR SOC, V58, P59, DOI 10.1079/PNS19990009; Rowland NE, 2008, PHYSIOL BEHAV, V93, P97, DOI 10.1016/j.physbeh.2007.08.003; Schekkerman H, 2009, J ORNITHOL, V150, P133, DOI 10.1007/s10336-008-0328-4; Scott KA, 2008, J PSYCHOSOM RES, V64, P97, DOI 10.1016/j.jpsychores.2007.09.006; Sermondade N, 2013, HUM REPROD UPDATE, V19, P221, DOI 10.1093/humupd/dms050; Siervo M, 2009, HORM METAB RES, V41, P261, DOI 10.1055/s-0028-1119377; Siervo M, 2008, OBES METAB-MILAN, V4, P131; Speakman JR, 2008, INT J OBESITY, V32, P1611, DOI 10.1038/ijo.2008.161; Speakman JR, 2013, ANNU REV NUTR, V33, P289, DOI 10.1146/annurev-nutr-071811-150711; Treves A, 1999, J HUM EVOL, V36, P275, DOI 10.1006/jhev.1998.0268; Troiano RP, 1996, INT J OBESITY, V20, P63; Wells JCK, 2011, EUR J CLIN NUTR, V65, P1173, DOI 10.1038/ejcn.2011.132; Wells JCK, 2009, INT J OBESITY, V33, P1331, DOI 10.1038/ijo.2009.175; Wells J. C. K., 2010, EVOLUTIONARY BIOL HU; Wells JCK, 2006, BIOL REV, V81, P183, DOI 10.1017/S1464793105006974; White CL, 2010, PHYSIOL BEHAV, V100, P408, DOI 10.1016/j.physbeh.2010.04.006; WITTER MS, 1993, PHILOS T R SOC B, V340, P73, DOI 10.1098/rstb.1993.0050; Zafon C, 2007, OBES REV, V8, P525, DOI 10.1111/j.1467-789X.2007.00377.x; Zimmer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022352	57	5	5	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141811	10.1371/journal.pone.0141811	http://dx.doi.org/10.1371/journal.pone.0141811			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545121	Green Published, Green Submitted, gold			2022-12-26	WOS:000364398700051
J	Shuda, M; Guastafierro, A; Geng, XH; Shuda, Y; Ostrowski, SM; Lukianov, S; Jenkins, FJ; Honda, K; Maricich, SM; Moore, PS; Chang, Y				Shuda, Masahiro; Guastafierro, Anna; Geng, Xuehui; Shuda, Yoko; Ostrowski, Stephen M.; Lukianov, Stefan; Jenkins, Frank J.; Honda, Kord; Maricich, Stephen M.; Moore, Patrick S.; Chang, Yuan			Merkel Cell Polyomavirus Small T Antigen Induces Cancer and Embryonic Merkel Cell Proliferation in a Transgenic Mouse Model	PLOS ONE			English	Article							P53; CARCINOMA; EXPRESSION; MICE; RB; DIFFERENTIATION; TUMORIGENESIS; TRANSLATION; DEFICIENCY; VIRUSES	Merkel cell polyomavirus (MCV) causes the majority of human Merkel cell carcinomas (MCC) and encodes a small T (sT) antigen that transforms immortalized rodent fibroblasts in vitro. To develop a mouse model for MCV sT-induced carcinogenesis, we generated transgenic mice with a flox-stop-flox MCV sT sequence homologously recombined at the ROSA locus (ROSA(sT)), allowing Cre-mediated, conditional MCV sT expression. Standard tamoxifen (TMX) administration to adult Ubc(CreERT2); ROSA(sT) mice, in which Cre is ubiquitously expressed, resulted in MCV sT expression in multiple organs that was uniformly lethal within 5 days. Conversely, most adult UbcCreERT2; ROSAsT mice survived low-dose tamoxifen administration but developed ear lobe dermal hyperkeratosis and hypergranulosis. Simultaneous MCV sT expression and conditional homozygous p53 deletion generated multi-focal, poorly-differentiated, highly anaplastic tumors in the spleens and livers of mice after 60 days of TMX treatment. Mouse embryonic fibroblasts from these mice induced to express MCV sT exhibited anchorage-independent cell growth. To examine Merkel cell pathology, MCV sT expression was also induced during mid-embryogenesis in Merkel cells of Atoh1(CreERT2/+); ROSA(sT) mice, which lead to significantly increased Merkel cell numbers in touch domes at late embryonic ages that normalized postnatally. Tamoxifen administration to adult Atoh1(CreERT2/+); ROSA(sT) and Atoh1(CreERT2/+); ROSA(sT); p53(flox/flox) mice had no effects on Merkel cell numbers and did not induce tumor formation. Taken together, these results show that MCV sT stimulates progenitor Merkel cell proliferation in embryonic mice and is a bona fide viral oncoprotein that induces full cancer cell transformation in the p53-null setting.	[Shuda, Masahiro; Guastafierro, Anna; Shuda, Yoko; Lukianov, Stefan; Moore, Patrick S.; Chang, Yuan] Univ Pittsburgh, Inst Canc, Canc Virol Program, Pittsburgh, PA USA; [Geng, Xuehui; Maricich, Stephen M.] Univ Pittsburgh, Dept Pediat, Richard King Mellon Inst Pediat Res, Pittsburgh, PA 15260 USA; [Jenkins, Frank J.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA; [Ostrowski, Stephen M.; Honda, Kord] Case Western Reserve Univ, Sch Med, Dept Dermatol, Cleveland, OH USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Case Western Reserve University	Maricich, SM (corresponding author), Univ Pittsburgh, Dept Pediat, Richard King Mellon Inst Pediat Res, Pittsburgh, PA 15260 USA.	stephen.maricich@chp.edu; psm9@pitt.edu; yc70@pitt.edu	Chang, Yuan/F-4146-2011; SHUDA, MASAHIRO/F-5505-2011; Moore, Patrick/GVR-8294-2022; SHUDA, MASAHIRO/N-8239-2019; Moore, Patrick S./F-3960-2011	Chang, Yuan/0000-0003-1125-4041; SHUDA, MASAHIRO/0000-0003-0595-2572; SHUDA, MASAHIRO/0000-0003-0595-2572; Moore, Patrick S./0000-0002-8132-858X	NIH NCI [R01CA136806, CA136363, CA170354]; American Cancer Society Professorships; University of Pittsburgh Skin Cancer SPORE [CA12197305]; NIH NIAMS [R01AR05114, T32-AR007569]; Richard King Mellon Institute for Pediatric Research; Dermatology Foundation; University of Pittsburgh Cancer Institute [P30CA047904]; NATIONAL CANCER INSTITUTE [R01CA170354, R01CA136806, R01CA136363, P30CA047904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007569] Funding Source: NIH RePORTER	NIH NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society Professorships; University of Pittsburgh Skin Cancer SPORE(University of Pittsburgh); NIH NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Richard King Mellon Institute for Pediatric Research; Dermatology Foundation; University of Pittsburgh Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NIH NCI R01CA136806, CA136363, CA170354, and American Cancer Society Professorships to PSM and YC. MS was supported in part by the University of Pittsburgh Skin Cancer SPORE CA12197305. SMM was supported by NIH NIAMS R01AR05114, Richard King Mellon Institute for Pediatric Research. SMO was supported by the Dermatology Foundation and NIH NIAMS T32-AR007569. This project used the University of Pittsburgh Cancer Institute core facilities that are supported in part by award P30CA047904.	Allan LA, 2000, MOL CELL BIOL, V20, P1291, DOI 10.1128/MCB.20.4.1291-1298.2000; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; BLYTH K, 1995, ONCOGENE, V10, P1717; Borchert S, 2014, J VIROL, V88, P3144, DOI 10.1128/JVI.02916-13; Borozan I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076935; Bossuyt W, 2009, PLOS BIOL, V7, P311, DOI 10.1371/journal.pbio.1000039; Cheng JW, 2013, J VIROL, V87, P6118, DOI 10.1128/JVI.00385-13; Choi J, 2010, AM J PATHOL, V177, P2645, DOI 10.2353/ajpath.2010.100306; DeCaprio JA, 2013, NAT REV MICROBIOL, V11, P264, DOI 10.1038/nrmicro2992; DONEHOWER LA, 1995, GENE DEV, V9, P882, DOI 10.1101/gad.9.7.882; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Feng HC, 2007, J VIROL, V81, P11332, DOI 10.1128/JVI.00875-07; Fujiyama T, 2009, DEVELOPMENT, V136, P2049, DOI 10.1242/dev.033480; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Houben R, 2012, INT J CANCER, V130, P847, DOI 10.1002/ijc.26076; Houben R, 2010, J VIROL, V84, P7064, DOI 10.1128/JVI.02400-09; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kassem A, 2008, CANCER RES, V68, P5009, DOI 10.1158/0008-5472.CAN-08-0949; Khidr L, 2006, ONCOGENE, V25, P5210, DOI 10.1038/sj.onc.1209612; Kwun HJ, 2013, CELL HOST MICROBE, V14, P125, DOI 10.1016/j.chom.2013.06.008; Kwun HJ, 2009, J VIROL, V83, P12118, DOI 10.1128/JVI.01336-09; Maricich SM, 2009, SCIENCE, V324, P1580, DOI 10.1126/science.1172890; Moore PS, 2010, NAT REV CANCER, V10, P878, DOI 10.1038/nrc2961; Ostrowski SM, 2015, DEVELOPMENT ACCEPTED; Rodig SJ, 2012, J CLIN INVEST, V122, P4645, DOI 10.1172/JCI64116; Schmid M, 1997, VIRCHOWS ARCH, V430, P233, DOI 10.1007/BF01324807; Schmitt M, 2012, INT J CANCER, V131, P2863, DOI 10.1002/ijc.27607; SCHNEIDER JW, 1994, SCIENCE, V264, P1467, DOI 10.1126/science.8197461; Shuda M, 2008, P NATL ACAD SCI USA, V105, P16272, DOI 10.1073/pnas.0806526105; Shuda M, 2015, P NATL ACAD SCI USA, V112, P5875, DOI 10.1073/pnas.1505787112; Shuda M, 2014, J INVEST DERMATOL, V134, P1479, DOI 10.1038/jid.2013.483; Shuda M, 2011, J CLIN INVEST, V121, P3623, DOI 10.1172/JCI46323; Spurgeon ME, 2015, CANCER RES, V75, P1068, DOI 10.1158/0008-5472.CAN-14-2425; SYMONDS H, 1994, CELL, V78, P703, DOI 10.1016/0092-8674(94)90534-7; Verhaegen ME, 2014, THE JOURNAL OF INVES, DOI [10.1038/jid.2014.446, DOI 10.1038/JID.2014.446]; Wendzicki JA, 2015, CURR OPIN VIROL, V11, P38, DOI 10.1016/j.coviro.2015.01.009; Wright MC, 2015, J CELL BIOL, V208, P367, DOI 10.1083/jcb.201407101	37	58	59	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142329	10.1371/journal.pone.0142329	http://dx.doi.org/10.1371/journal.pone.0142329			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544690	Green Accepted, Green Submitted, gold, Green Published			2022-12-26	WOS:000364398700112
J	Valle, MS; Casabona, A; Cavallaro, C; Castorina, G; Cioni, M				Valle, Maria Stella; Casabona, Antonino; Cavallaro, Carlo; Castorina, Gabriele; Cioni, Matteo			Learning Upright Standing on a Multiaxial Balance Board	PLOS ONE			English	Article							POSTURAL CONTROL; APPROXIMATE ENTROPY; INTERNAL-MODELS; HEALTHY-YOUNG; MOTOR; SWAY; ADAPTATION; COORDINATION; MOVEMENTS; PERTURBATIONS	Upright stance on a balance board is a skill requiring complex rearrangement of the postural control. Despite the large use of these boards in training the standing posture, a comprehensive analysis of the learning process underlying the control of these devices is lacking. In this paper learning to maintain a stable stance on a multiaxial oscillating board was studied by analyzing performance changes over short and long periods. Healthy participants were asked to keep the board orientation as horizontal as possible for 20 sec, performing two sessions of 8 trials separated by 15-min pause. Memory consolidation was tested one week later. Amplitude and variability of the oscillations around horizontal plane and area and sway path of the board displacement decreased rapidly over the first session. The performance was stable during the second session, and retained after 1 week. A similar behavior was observed in the anterior-posterior and medial-lateral directions for amplitude and variability parameters, with less stable balance in the anterior-posterior direction. Approximate entropy and mean power frequency, assessing temporal dynamics and frequency content of oscillations, changed only in the anterior-posterior direction during the retention test. Overall, the ability to stand on a balance board is rapidly acquired, and retained for long time. The asymmetric stability between anterior-posterior and medial-lateral directions replicates a structure observed in other standing stances, suggesting a possible transfer from previous postural experiences. Conversely, changes in the temporal dynamics and the frequency content could be associated with new postural strategies developed later during memory consolidation.	[Valle, Maria Stella; Casabona, Antonino; Cioni, Matteo] Univ Catania, Dept Biomed & Biotechnol Sci, Catania, Italy; [Valle, Maria Stella; Casabona, Antonino; Cavallaro, Carlo; Castorina, Gabriele; Cioni, Matteo] Univ Catania, Gait & Posture Anal Lab, Catania, Italy; [Casabona, Antonino; Cavallaro, Carlo; Cioni, Matteo] Univ Catania, Phys Med & Rehabil Residency Program, Catania, Italy	University of Catania; University of Catania; University of Catania	Cioni, M (corresponding author), Univ Catania, Dept Biomed & Biotechnol Sci, Catania, Italy.	mcioni@unict.it		VALLE, Maria Stella/0000-0001-9728-3542; Casabona, Antonino/0000-0003-0180-4695	University of Catania	University of Catania	This work was supported by University of Catania.	Ahmed AA, 2007, J NEUROPHYSIOL, V97, P2439, DOI 10.1152/jn.00164.2006; Ahmed AA, 2009, J NEUROPHYSIOL, V102, P2816, DOI 10.1152/jn.00532.2009; Allum JHJ, 2003, IEEE ENG MED BIOL, V22, P37, DOI 10.1109/MEMB.2003.1195694; Almeida GL, 2006, GAIT POSTURE, V23, P17, DOI 10.1016/j.gaitpost.2004.11.020; ASSAIANTE C, 1995, HUM MOVEMENT SCI, V14, P13, DOI 10.1016/0167-9457(94)00048-J; Assaiante C, 2011, HUM MOVEMENT SCI, V30, P227, DOI 10.1016/j.humov.2010.05.007; Balasubramaniam R, 2000, GAIT POSTURE, V11, P12, DOI 10.1016/S0966-6362(99)00051-X; Bardy BG, 2007, J MOTOR BEHAV, V39, P326, DOI 10.3200/JMBR.39.4.326-336; Bloem BR, 2002, EXP BRAIN RES, V142, P91, DOI 10.1007/s00221-001-0926-3; Bottaro A, 2008, HUM MOVEMENT SCI, V27, P473, DOI 10.1016/j.humov.2007.11.005; Carpenter MG, 2001, EXP BRAIN RES, V138, P210, DOI 10.1007/s002210100681; Cavanaugh JT, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-42; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Chen CL, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-50; Chen FC, 2012, J EXP PSYCHOL-APPL, V18, P203, DOI 10.1037/a0026661; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cooper R L, 2005, Res Sports Med, V13, P163, DOI 10.1080/15438620590956197; Dettmer M, 2013, HUM MOVEMENT SCI, V32, P214, DOI 10.1016/j.humov.2012.12.002; Dougherty John, 2011, Mo Med, V108, P128; Doumas M, 2010, J NEUROPHYSIOL, V104, P1969, DOI 10.1152/jn.00345.2010; Duarte M, 2000, NEUROSCI LETT, V283, P173, DOI 10.1016/S0304-3940(00)00960-5; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Flanagan JR, 1997, J NEUROSCI, V17, P1519; Fransson PA, 1998, GAIT POSTURE, V7, P64, DOI 10.1016/S0966-6362(97)00030-1; Ganesan M, 2014, GAIT POSTURE, V39, P899, DOI 10.1016/j.gaitpost.2013.11.019; Genzel L, 2012, NEUROPSYCHOBIOLOGY, V66, P237, DOI 10.1159/000341878; Golomer E, 1999, NEUROSCI LETT, V267, P189, DOI 10.1016/S0304-3940(99)00356-0; Halicka Z, 2014, GAIT POSTURE, V39, P410, DOI 10.1016/j.gaitpost.2013.08.005; Haran F J, 2008, J Neurol Phys Ther, V32, P186, DOI 10.1097/NPT.0b013e31818dee39; HORAK FB, 1986, J NEUROPHYSIOL, V55, P1369, DOI 10.1152/jn.1986.55.6.1369; Hsu WL, 2007, J NEUROPHYSIOL, V97, P3024, DOI 10.1152/jn.01142.2006; Huisinga JM, 2012, NEUROSCI LETT, V524, P124, DOI 10.1016/j.neulet.2012.07.020; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; KESHNER EA, 1988, EXP BRAIN RES, V71, P455, DOI 10.1007/BF00248739; Krakauer JW, 2000, J NEUROSCI, V20, P8916, DOI 10.1523/jneurosci.20-23-08916.2000; Lakens Daniel, 2013, Front Psychol, V4, P863, DOI 10.3389/fpsyg.2013.00863; Latash ML, 2003, EXP BRAIN RES, V150, P314, DOI 10.1007/s00221-003-1419-3; Madureira MM, 2007, OSTEOPOROSIS INT, V18, P419, DOI 10.1007/s00198-006-0252-5; Mahboobin A, 2009, MED BIOL ENG COMPUT, V47, P921, DOI 10.1007/s11517-009-0477-5; MOORE SP, 1988, EXP BRAIN RES, V73, P648, DOI 10.1007/BF00406624; Morasso PG, 1999, NEURAL NETWORKS, V12, P1173, DOI 10.1016/S0893-6080(99)00058-1; Nagy E, 2004, EUR J APPL PHYSIOL, V92, P407, DOI 10.1007/s00421-004-1157-7; NASHNER LM, 1985, BEHAV BRAIN SCI, V8, P135, DOI 10.1017/S0140525X00020008; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; PINCUS SM, 1994, AM J PHYSIOL, V266, pH1643, DOI 10.1152/ajpheart.1994.266.4.H1643; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Podolski IYa, 1998, Membr Cell Biol, V11, P743; Prieto TE, 1996, IEEE T BIO-MED ENG, V43, P956, DOI 10.1109/10.532130; Prosperini L, 2010, MULT SCLER J, V16, P491, DOI 10.1177/1352458509359923; Rigoldi C, 2013, RES DEV DISABIL, V34, P840, DOI 10.1016/j.ridd.2012.11.007; Sabatini AM, 2000, MED BIOL ENG COMPUT, V38, P617, DOI 10.1007/BF02344866; Salaj S. S., 2007, KINESIOLOGY, V39, P131; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shadmehr R, 1997, J NEUROSCI, V17, P409, DOI 10.1523/JNEUROSCI.17-01-00409.1997; Shea CH, 2000, HUM MOVEMENT SCI, V19, P737, DOI 10.1016/S0167-9457(00)00021-X; Stoffregen TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066949; Tjernstrom F, 2005, J VESTIBUL RES-EQUIL, V15, P31; Tjernstrom F, 2010, J VESTIBUL RES-EQUIL, V20, P407, DOI 10.3233/VES-2010-0391; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; Torres-Oviedo G, 2007, J NEUROPHYSIOL, V98, P2144, DOI 10.1152/jn.01360.2006; Tseng YW, 2002, MOTOR CONTROL, V6, P183, DOI 10.1123/mcj.6.2.183; Wang Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085414; Wang Z, 2014, MOTOR CONTROL, V18, P165, DOI 10.1123/mc.2013-0064; Winter DA, 1996, J NEUROPHYSIOL, V75, P2334, DOI 10.1152/jn.1996.75.6.2334; Wolpert DM, 2011, NAT REV NEUROSCI, V12, P739, DOI 10.1038/nrn3112; Yaggie JA, 2006, J STRENGTH COND RES, V20, P422	66	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142423	10.1371/journal.pone.0142423	http://dx.doi.org/10.1371/journal.pone.0142423			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544694	Green Submitted, gold, Green Published			2022-12-26	WOS:000364398700136
J	Kigen, G; Busakhala, N; Ogaro, F; Chesire, E; Saat, N; Too, R; Nyandiko, W				Kigen, Gabriel; Busakhala, Naftali; Ogaro, Francis; Chesire, Emily; Saat, Nathan; Too, Robert; Nyandiko, Winstone			A Review of the Ingredients Contained in Over the Counter (OTC) Cough Syrup Formulations in Kenya. Are They Harmful to Infants?	PLOS ONE			English	Review							COLD MEDICATIONS; DIPHENHYDRAMINE MONOINTOXICATION; ADULT LITERATURE; PEDIATRIC COUGH; MEDICINE ABUSE; ADVERSE EVENTS; CHILDREN; ANTIHISTAMINES; PROMETHAZINE; WARNINGS	Background Cough syrups are widely used in the developing world, but safety of their use in infants and children less than two years has not been well documented. Some syrups contain multiple combinations of such drugs as promethazine, diphenhydramine and ephedrine; which are individually now contraindicated in children less than two years. Despite this, the syrups are available as over the counter drugs and may be dispensed to mothers who are unaware of the potentially hazardous effects to their infants. A descriptive cross-sectional study was used to investigate suitability of cough syrups sold within Eldoret municipality for use in children less than two years of age based on their formulations and available literature. Methods Two semi-structured questionnaires were administered to pharmacy attendants and mothers attending sick child clinic at a referral hospital to establish whether cough syrups containing more than one active ingredient of compounds, now contraindicated in children are administered to infants, and awareness of potential serious adverse effects. Data from labeled contents of cough syrups from retail pharmacies was recorded and corroborated with information from literature to determine those deemed to contain the ingredients. The second questionnaire was administered to mothers with children less than two years to ascertain whether they had used the identified syrups. A total of 260 mothers and 55 pharmacy attendants were interviewed. Results There was widespread use of the syrups in children, including infants, with 192 (74%) of the respondents having used identified syrups and over 90% of these on children less than 2 years including those less than three months. 146 (76%) mothers had administered the syrup at double the recommended dose. Conclusion The regulatory authorities should make concerted efforts to discourage use of cough syrups containing ingredients that pose adverse events to infants, including campaigns to educate pharmacy workers and mothers.	[Kigen, Gabriel; Busakhala, Naftali] Moi Univ, Dept Pharmacol & Toxicol, Sch Med, Eldoret, Kenya; [Ogaro, Francis; Chesire, Emily] Moi Teaching & Referral Hosp, Dept Paediat, Eldoret, Kenya; [Saat, Nathan] Moi Univ, Dept Pharm, Hlth Serv, Eldoret, Kenya; [Too, Robert] Moi Univ, Sch Publ Hlth, Dept Epidemiol & Nutr, Eldoret, Kenya; [Nyandiko, Winstone] Moi Univ, Sch Med, Dept Child Hlth & Pediat, Eldoret, Kenya	Moi University; Moi University; Moi University; Moi University	Kigen, G (corresponding author), Moi Univ, Dept Pharmacol & Toxicol, Sch Med, Eldoret, Kenya.	gkigen@mu.ac.ke	Kigen, Gabriel K/C-8494-2018	Kigen, Gabriel K/0000-0002-5047-4066				ACCP, 2006, PAT INF PAR CHILD CO; American Academy of Pediatrics, 2021, AAP AACAP CHA DECL N; [Anonymous], 1995, Pediatrics, V95, P598; Ashkin E, 2013, J FAM PRACTICE, V62, P145; Avois L, 2006, BRIT J SPORT MED, V40, DOI 10.1136/bjsm.2006.027557; Baker AM, 2003, J FORENSIC SCI, V48, P425; BENADRYL, 2013, BENADRYL DIPH HYDR I; Berg Ansgar, 2010, Tidsskr Nor Laegeforen, V130, P2474, DOI 10.4045/tidsskr.10.0503; Braude D, 2008, ACAD EMERG MED, V15, P209, DOI 10.1111/j.1553-2712.2008.00060.x; BRONCHODILATE, 2012, BRONCHO DILATE EPH H; BRONCHOLATE, 2007, BRONCHOLATE SYRUP PR; BRONKAID Bayer Corporation, BRONK EPH SULF 25 MG; Buck ML, 2010, MONTHLY NEWSLETTER H, V16; Chang CC, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006088.pub4; Church MK, 2010, ALLERGY, V65, P459, DOI 10.1111/j.1398-9995.2009.02325.x; Cooper R, 2013, HEALTH SOC CARE COMM, V21, P254, DOI 10.1111/hsc.12012; Cooper RJ, 2013, J SUBST USE, V18, P82, DOI 10.3109/14659891.2011.615002; Cote CJ, 2000, PEDIATRICS, V106, P633, DOI 10.1542/peds.106.4.633; Davila I, 2013, J INVEST ALLERG CLIN, V23, P1; del Cuvillo A, 2007, J INVEST ALLERG CLIN, V17, P28; Duggal HS, 2001, AUST NZ J PSYCHIAT, V35, P250; FDA, 2006, INF HEALTHC PROF PRO; Goldman RD, 2011, PAED CHILD HEALT-CAN, V16, P564, DOI 10.1093/pch/16.9.564; Isbister GK, 2012, J PAEDIATR CHILD H, V48, P91, DOI 10.1111/j.1440-1754.2010.01780.x; Knol K, 2000, ALLERGY, V55, P31, DOI 10.1034/j.1398-9995.2000.00005.x; Kuffner E, 2010, AM J FOREN MED PATH, V31, P106, DOI 10.1097/PAF.0b013e3181c2159c; Lazarus SG, 2013, CLIN PEDIATR, V52, P534, DOI 10.1177/0009922813482761; Lokker N, 2009, PEDIATRICS, V123, P1464, DOI 10.1542/peds.2008-0854; Maglione M, 2005, AM J PSYCHIAT, V162, P189, DOI 10.1176/appi.ajp.162.1.189; Morin CM, 2005, SLEEP, V28, P1465, DOI 10.1093/sleep/28.11.1465; Nine JS, 2006, AM J FOREN MED PATH, V27, P36, DOI 10.1097/01.paf.0000188093.45675.ee; Ostroff C, 2011, CHEST, V140, P295, DOI 10.1378/chest.11-0981; PHENERGAN, 2010, PHENERGAN PROM HYDR; PPB, 2014, CHILDR OV THE COUNT; Rimsza ME, 2008, PEDIATRICS, V122, pE318, DOI 10.1542/peds.2007-3813; Ryan Teresa, 2008, Pediatr Nurs, V34, P174; Salocks C, 2003, OFFICE ENV HLTH HAZA; Schaefer MK, 2008, PEDIATRICS, V121, P783, DOI 10.1542/peds.2007-3638; Sen EF, 2011, BRIT J CLIN PHARMACO, V71, P943, DOI 10.1111/j.1365-2125.2010.03860.x; Sharfstein JM, 2007, NEW ENGL J MED, V357, P2321, DOI 10.1056/NEJMp0707400; Shefrin AE, 2009, CAN FAM PHYSICIAN, V55, P1081; Simons FER, 2007, ARCH PEDIAT ADOL MED, V161, P105, DOI 10.1001/archpedi.161.1.105-a; Smith SM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001831.pub4; Standardmedia, 2014, WHY HON NOT COUGH SY; Starke PR, 2005, NEW ENGL J MED, V352, P2653, DOI 10.1056/NEJM200506233522522; Vassilev ZP, 2010, EXPERT OPIN DRUG SAF, V9, P233, DOI 10.1517/14740330903496410; Vernacchio L, 2008, PEDIATRICS, V122, pE323, DOI 10.1542/peds.2008-0498; Waris A, 2014, E AFRICAN MED J, V91	48	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142092	10.1371/journal.pone.0142092	http://dx.doi.org/10.1371/journal.pone.0142092			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540251	Green Submitted, Green Published, gold			2022-12-26	WOS:000364303800055
J	Zhai, YM; Yang, Q; Hou, MM				Zhai, Yaming; Yang, Qian; Hou, Maomao			The Effects of Saline Water Drip Irrigation on Tomato Yield, Quality, and Blossom-End Rot Incidence-A 3a Case Study in the South of China	PLOS ONE			English	Article							ROOT-ZONE; DEFICIT IRRIGATION; FRUIT-QUALITY; SOIL; GROWTH; CALCIUM; CULTIVARS; PRODUCTIVITY; HOMEOSTASIS; TOLERANCE	Saline water resources are abundant in the coastal areas of south China. Most of these resources still have not been effectively utilized. A 3-year study on the effects of saline water irrigation on tomato yield, quality and blossom-end rot (BER) was conducted at different lower limits of soil matric potential (-10 kPa, -20 kPa, -30 kPa, -40 kPa and -50 kPa). Saline water differing in electrical conductivity (EC) (3 dS/m, 4 dS/m, 4.5 dS/m, 5 dS/m and 5.5 dS/m) was supplied to the plant after the seedling establishment. In all three years, irrigation water with 5.5 dS/m salinity reduced the maximum leaf area index (LAIm) and chlorophyll content the most significantly when compared with other salinity treatments. However, compared with the control treatment (CK), a slight increase in LAIm and chlorophyll content was observed with 3 similar to 4 dS/m salinity. Saline water improved tomato quality, including fruit density, soluble solid, total acid, vitamin C and the sugar-acid ratio. There was a positive relationship between the overall tomato quality and salinity of irrigation water, as analyzed by principal component analysis (PCA). The tomato yield decreased with increased salinity. The 5.5 dS/m treatment reduced the tomato yield (Y-t) by 22.4 similar to 31.1%, 12.6 similar to 28.0% and 11.7 similar to 27.3%, respectively in 2012, 2013 and 2014, compared with CK. Moreover, a significant (P <= 0.01) coupling effect of salinity and soil matric potential on Yt was detected. Saline water caused Yt to increase more markedly when the lower limit of soil matric potential was controlled at a relatively lower level. The critical salinity level that produced significant increases in the BERi was 3 dS/m similar to 4 dS/m. Following the increase in BERi under saline water irrigation, marketable tomato yield (Y-m) decreased by 8.9%similar to 33.8% in 2012, 5.1% similar to 30.4% in 2013 and 10.1%similar to 32.3% in 2014 compared with CK. In terms of maintaining the Yt and Ym, the salinity of irrigation water should be controlled under 4 dS/m, and the lower limit of soil matric potential should be greater than -20 kPa.	[Zhai, Yaming; Hou, Maomao] Hohai Univ, Key Lab Efficient Irrigat Drainage & Agr Soil Wat, Minist Educ, Nanjing, Jiangsu, Peoples R China; [Zhai, Yaming] Hohai Univ, Coll Water Conservancy & Hydropower Engn, Nanjing, Jiangsu, Peoples R China; [Yang, Qian] Henan Vocat Coll Agr, Dept Gardening, Zhengzhou, Peoples R China; [Hou, Maomao] Fujian Agr & Forestry Univ, Coll Hort, Fuzhou, Fujian, Peoples R China	Hohai University; Hohai University; Fujian Agriculture & Forestry University	Hou, MM (corresponding author), Hohai Univ, Key Lab Efficient Irrigat Drainage & Agr Soil Wat, Minist Educ, Nanjing, Jiangsu, Peoples R China.	njhoumaomao@126.com			Open-up Fund of Key Laboratory of Efficient Irrigation-Drainage and Agricultural Soil-Water Environment in Southern China [E2015002]; Natural Science Foundation of Jiangsu province [BK20130838]; Natural Science Foundation of China [E090203]; basic research funds of Hohai University [2012B00914, 2014B04814]	Open-up Fund of Key Laboratory of Efficient Irrigation-Drainage and Agricultural Soil-Water Environment in Southern China; Natural Science Foundation of Jiangsu province(Natural Science Foundation of Jiangsu Province); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); basic research funds of Hohai University	This work was financed by Open-up Fund of Key Laboratory of Efficient Irrigation-Drainage and Agricultural Soil-Water Environment in Southern China (E2015002), Natural Science Foundation of Jiangsu province (BK20130838), Natural Science Foundation of China (E090203) and the basic research funds of Hohai University (2012B00914, 2014B04814).	Adams SR, 2001, ANN BOT-LONDON, V88, P869, DOI 10.1006/anbo.2001.1524; ALARCON JJ, 1994, PLANT SOIL, V166, P75, DOI 10.1007/BF02185483; Beckles DM, 2012, POSTHARVEST BIOL TEC, V63, P129, DOI 10.1016/j.postharvbio.2011.05.016; Ben Ahmed C, 2012, J ENVIRON MANAGE, V113, P538, DOI 10.1016/j.jenvman.2012.03.016; Chen LJ, 2014, AGR WATER MANAGE, V146, P24, DOI 10.1016/j.agwat.2014.07.021; Chen WP, 2010, AGR WATER MANAGE, V97, P2001, DOI 10.1016/j.agwat.2010.03.008; Cramer MD, 2001, SCI HORTIC-AMSTERDAM, V89, P269, DOI 10.1016/S0304-4238(00)00243-0; Cuartero J, 1999, SCI HORTIC-AMSTERDAM, V78, P83, DOI 10.1016/S0304-4238(98)00191-5; Cui NB, 2008, AGR WATER MANAGE, V95, P489, DOI 10.1016/j.agwat.2007.11.007; Dorais M., 2001, Horticultural Reviews, V26, P239; EHRET DL, 1986, ANN BOT-LONDON, V58, P679, DOI 10.1093/oxfordjournals.aob.a087230; Gawad GA, 2005, AGR WATER MANAGE, V78, P39, DOI 10.1016/j.agwat.2005.04.024; Hong-yun H, 2004, J EC WATER RESOURCES, V22, P54; Hou M. M., 2013, RES CROP, V14, P1232; Hou MM, 2014, SCI WORLD J, DOI 10.1155/2014/953675; Huang CH, 2012, EUR J AGRON, V43, P68, DOI 10.1016/j.eja.2012.05.008; Huang Z, 2010, AGR SCI CHINA, V9, P1150, DOI 10.1016/S1671-2927(09)60202-9; Jensen CR, 2010, AGR WATER MANAGE, V98, P403, DOI 10.1016/j.agwat.2010.10.018; Kamaluldeen J, 2014, AGR WATER MANAGE, V146, P95, DOI 10.1016/j.agwat.2014.07.027; Karin, 1997, NEW PHYTOL, V135, P213; Karlberg L, 2007, AGR WATER MANAGE, V89, P59, DOI 10.1016/j.agwat.2006.12.011; Katerji N, 1998, AGR WATER MANAGE, V38, P59, DOI 10.1016/S0378-3774(98)00051-1; Kumar P, 2015, AGR WATER MANAGE, V148, P72, DOI 10.1016/j.agwat.2014.09.014; Li CJ, 2015, SOIL TILL RES, V146, P99, DOI 10.1016/j.still.2014.03.013; Li XB, 2015, SOIL TILL RES, V146, P159, DOI 10.1016/j.still.2014.10.005; Li YL, 2002, SCI HORTIC-AMSTERDAM, V93, P267, DOI 10.1016/S0304-4238(01)00329-6; Liu J, 2004, JIANGXI COTTON, V26, p19~22; [刘友兆 Liu Youzhao], 2004, [地理与地理信息科学, Geography and geo-information science], V20, P57; Lu ShaoWei, 2012, China Vegetables, P56; Manai J, 2014, J PLANT PHYSIOL, V171, P1028, DOI 10.1016/j.jplph.2014.03.012; McGovern HJ, 2001, SOIL BIOL BIOCHEM, V33, P689, DOI 10.1016/S0038-0717(00)00185-1; Mestre TC, 2012, J PLANT PHYSIOL, V169, P1719, DOI 10.1016/j.jplph.2012.07.013; Nebauer SG, 2013, PLANT PHYSIOL BIOCH, V63, P61, DOI 10.1016/j.plaphy.2012.11.006; Patane C, 2011, SCI HORTIC-AMSTERDAM, V129, P590, DOI 10.1016/j.scienta.2011.04.030; Saure MC, 2001, SCI HORTIC-AMSTERDAM, V90, P193, DOI 10.1016/S0304-4238(01)00227-8; Savic S, 2008, SCI HORTIC-AMSTERDAM, V117, P15, DOI 10.1016/j.scienta.2008.03.009; Setia R, 2013, EUR J SOIL BIOL, V56, P95, DOI 10.1016/j.ejsobi.2013.02.003; Shao GC, 2014, SCI WORLD J, DOI 10.1155/2014/457937; Shao GC, 2014, EUR J AGRON, V53, P1, DOI 10.1016/j.eja.2013.10.005; Shao X, 2013, RES CROP, V14, P1159; Shao XH, 2012, ENRGY PROCED, V16, P747, DOI 10.1016/j.egypro.2012.01.120; SPURR ARTHUR R., 1959, HILGARDIA, V28, P269; Tabatabaie SJ, 2004, PLANT SOIL, V258, P169, DOI 10.1023/B:PLSO.0000016548.84566.62; TACHIBANA S, 1991, SCI HORTIC-AMSTERDAM, V45, P235, DOI 10.1016/0304-4238(91)90068-A; Taylor MD, 2004, HORTSCIENCE, V39, P1110, DOI 10.21273/HORTSCI.39.5.1110; Tuna AL, 2007, ENVIRON EXP BOT, V59, P173, DOI 10.1016/j.envexpbot.2005.12.007; Wan SQ, 2007, AGR WATER MANAGE, V90, P63, DOI 10.1016/j.agwat.2007.02.011; Wan ShuQin, 2008, Transactions of the Chinese Society of Agricultural Engineering, V24, P30; Wang FX, 2007, AGR WATER MANAGE, V88, P34, DOI 10.1016/j.agwat.2006.08.006; Wang W, 2014, J HOHAI U NATURAL SC, V42, P373; Zhang Z, 1999, J IRRIGATION DRAINAG, V18, P18; Zhao A, 1998, ACTA AGR U JIANGXIEN, V20, P523; Zheng JH, 2013, AGR WATER MANAGE, V129, P181, DOI 10.1016/j.agwat.2013.08.001; Zushi K, 2011, SCI HORTIC-AMSTERDAM, V129, P18, DOI 10.1016/j.scienta.2011.02.011	54	44	48	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142204	10.1371/journal.pone.0142204	http://dx.doi.org/10.1371/journal.pone.0142204			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540394	Green Submitted, Green Published, gold			2022-12-26	WOS:000364303800067
J	Bundela, S; Sharma, A; Bisen, PS				Bundela, Saurabh; Sharma, Anjana; Bisen, Prakash S.			Potential Compounds for Oral Cancer Treatment: Resveratrol, Nimbolide, Lovastatin, Bortezomib, Vorinostat, Berberine, Pterostilbene, Deguelin, Andrographolide, and Colchicine	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; NATURAL-PRODUCTS; DRUG DISCOVERY; CELL INVASION; SUPPRESSION; INHIBITION; APOPTOSIS; CURCUMIN; EXPRESSION; DELIVERY	Oral cancer is one of the main causes of cancer-related deaths in South-Asian countries. There are very limited treatment options available for oral cancer. Research endeavors focused on discovery and development of novel therapies for oral cancer, is necessary to control the ever rising oral cancer related mortalities. We mined the large pool of compounds from the publicly available compound databases, to identify potential therapeutic compounds for oral cancer. Over 84 million compounds were screened for the possible anti-cancer activity by custom build SVM classifier. The molecular targets of the predicted anti-cancer compounds were mined from reliable sources like experimental bioassays studies associated with the compound, and from protein-compound interaction databases. Therapeutic compounds from DrugBank, and a list of natural anti-cancer compounds derived from literature mining of published studies, were used for building partial least squares regression model. The regression model thus built, was used for the estimation of oral cancer specific weights based on the molecular targets. These weights were used to compute scores for screening the predicted anti-cancer compounds for their potential to treat oral cancer. The list of potential compounds was annotated with corresponding physicochemical properties, cancer specific bioactivity evidences, and literature evidences. In all, 288 compounds with the potential to treat oral cancer were identified in the current study. The majority of the compounds in this list are natural products, which are well-tolerated and have minimal side-effects compared to the synthetic counterparts. Some of the potential therapeutic compounds identified in the current study are resveratrol, nimbolide, lovastatin, bortezomib, vorinostat, berberine, pterostilbene, deguelin, andrographolide, and colchicine.	[Bundela, Saurabh; Bisen, Prakash S.] Govt India, Minist Def, Def Res Dev Org, Def Res Dev Estab, Gwalior, Madhya Pradesh, India; [Bundela, Saurabh; Sharma, Anjana] Rani Durgavati Univ, Dept Postgrad Studies & Res Biol Sci, Jabalpur 482001, Madhya Pradesh, India; [Bisen, Prakash S.] Jiwaji Univ, Sch Studies Biotechnol, Gwalior, Madhya Pradesh, India	Defence Research & Development Organisation (DRDO); Defence Research & Development Establishment (DRDE); Jiwaji University Gwalior	Bisen, PS (corresponding author), Govt India, Minist Def, Def Res Dev Org, Def Res Dev Estab, Gwalior, Madhya Pradesh, India.	psbisen@gmail.com	Bisen, Prakash S/H-3392-2019	Bisen, Prakash S/0000-0002-2818-7829				Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; Bisen P.S., 2012, J CANC SCI THER, V4, P23, DOI [DOI 10.4172/1948-5956.1000106, 10.4172/1948-5956.1000106]; Bisen PS, 2013, BIOL ORAL CANCER KEY; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; BRAMER G R, 1988, World Health Statistics Quarterly, V41, P32; Bundela S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102610; Butler MS, 2008, NAT PROD REP, V25, P475, DOI 10.1039/b514294f; Chang CM, 2012, ONCOL REP, V28, P1799, DOI 10.3892/or.2012.1991; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen HJ, 2013, INT J ONCOL, V43, P629, DOI 10.3892/ijo.2013.1977; Chen X, 2002, NUCLEIC ACIDS RES, V30, P412, DOI 10.1093/nar/30.1.412; Chen YY, 2010, ANTICANCER RES, V30, P945; Cheng YH, 2012, TOXICOL APPL PHARM, V263, P360, DOI 10.1016/j.taap.2012.07.010; Clark DE, 1999, J PHARM SCI-US, V88, P807, DOI 10.1021/js9804011; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Deng YT, 2011, ORAL ONCOL, V47, P256, DOI 10.1016/j.oraloncology.2011.01.005; Dudas J, 2013, EXP CELL RES, V319, P800, DOI 10.1016/j.yexcr.2012.12.001; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fung C, 2012, CANCER BIOL THER, V13, P1417, DOI 10.4161/cbt.22002; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; He ZS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009603; Ho YT, 2009, ANTICANCER RES, V29, P4063; Huang CY, 2013, J NUTR BIOCHEM, V24, P1596, DOI 10.1016/j.jnutbio.2013.01.010; Jaccard P., 1907, REV G N RALE SCI PUR, V18, P961; Keerthi SS, 2003, NEURAL COMPUT, V15, P1667, DOI 10.1162/089976603321891855; Krishnamoorthy Bhuvana, 2013, Dent Res J (Isfahan), V10, P527; Kuhn M, 2014, NUCLEIC ACIDS RES, V42, pD401, DOI 10.1093/nar/gkt1207; Kumar GH, 2010, INVEST NEW DRUG, V28, P392, DOI 10.1007/s10637-009-9263-3; Leeman-Neill RJ, 2011, CANCER PREV RES, V4, P230, DOI 10.1158/1940-6207.CAPR-10-0249; Li GH, 2012, BIOINFORMATICS, V28, P3334, DOI 10.1093/bioinformatics/bts625; Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243; Lin CW, 2014, EXPERT OPIN THER TAR, V18, P1109, DOI 10.1517/14728222.2014.947962; Lin HT, 2003, STUDY SIGMOID KERNEL, V3, P1, DOI DOI 10.1111/J.1945-1474.2005.TB00541.X; Lin HY, 2012, INT J NANOMED, V7, P941, DOI 10.2147/IJN.S28510; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Liu YP, 2016, HEAD NECK-J SCI SPEC, V38, pE524, DOI 10.1002/hed.24034; Mevik BH, 2007, J STAT SOFTW, V18, P1, DOI 10.18637/jss.v018.i02; Nagumo T, 2009, ORAL ONCOL, V45, P766, DOI 10.1016/j.oraloncology.2008.11.009; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; O'Boyle NM, 2008, CHEM CENT J, V2, DOI 10.1186/1752-153X-2-5; Park SJ, 2010, CANCER LETT, V292, P54, DOI 10.1016/j.canlet.2009.11.004; Priyadarsini RV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034628; ROSENBERG B, 1973, NATURWISSENSCHAFTEN, V60, P399, DOI 10.1007/BF00623551; Sarkar J, 2009, ORAL ONCOL, V45, P974, DOI 10.1016/j.oraloncology.2009.04.009; Schomburg K, 2010, J CHEM INF MODEL, V50, P1529, DOI 10.1021/ci100209a; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Suzuki M, 2009, CANCER CHEMOTH PHARM, V64, P1115, DOI 10.1007/s00280-009-0969-x; Tamatani T, 2013, INT J ONCOL, V42, P935, DOI 10.3892/ijo.2013.1786; Wang LJ, 2011, J DENT RES, V90, P1246, DOI 10.1177/0022034511418341; Wang YL, 2014, NUCLEIC ACIDS RES, V42, pD1075, DOI 10.1093/nar/gkt978; WEININGER D, 1988, J CHEM INF COMP SCI, V28, P31, DOI 10.1021/ci00057a005; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; WOOD P H N, 1990, World Health Statistics Quarterly, V43, P263; Yang SF, 2008, J DENT RES, V87, P401, DOI 10.1177/154405910808700413; Zhou GL, 2010, CANCER PREV RES, V3, P1493, DOI 10.1158/1940-6207.CAPR-10-0135; Zhou S, 2014, J CANCER RES CLIN, V140, P371, DOI 10.1007/s00432-013-1575-1	56	29	29	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141719	10.1371/journal.pone.0141719	http://dx.doi.org/10.1371/journal.pone.0141719			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536350	gold, Green Published, Green Submitted			2022-12-26	WOS:000364298400081
J	Darbani, B; Noeparvar, S; Borg, S				Darbani, Behrooz; Noeparvar, Shahin; Borg, Soren			Deciphering Mineral Homeostasis in Barley Seed Transfer Cells at Transcriptional Level	PLOS ONE			English	Article							TRANSPORTER 1 IRT1; PROTEIN 5 FBXL5; ARABIDOPSIS-THALIANA; IRON-DEFICIENCY; GENE-EXPRESSION; F-BOX; REPEAT PROTEIN; INTRACELLULAR TRAFFICKING; SALMONELLA-TYPHIMURIUM; CONJUGATE SENSITIVITY	In addition to the micronutrient inadequacy of staple crops for optimal human nutrition, a global downtrend in crop-quality has emerged from intensive breeding for yield. This trend will be aggravated by elevated levels of the greenhouse gas carbon dioxide. Therefore, crop bio-fortification is inevitable to ensure a sustainable supply of minerals to the large part of human population who is dietary dependent on staple crops. This requires a thorough understanding of plant-mineral interactions due to the complexity of mineral homeostasis. Employing RNA sequencing, we here communicate transfer cell specific effects of excess iron and zinc during grain filling in our model crop plant barley. Responding to alterations inmineral contents, we found a long range of different genes and transcripts. Among them, it is worth to highlight the auxin and ethylene signaling factors Arfs, Abcbs, Cand1, Hps4, Hac1, Ecr1, and Ctr1, diurnal fluctuation components Sdg2, Imb1, Lip1, and PhyC, retroelements, sulfur homeostasis components Amp1, Hmt3, Eil3, and Vip1, mineral trafficking components Med16, Cnnm4, Aha2, Clpc1, and Pcbps, and vacuole organization factors Ymr155W, RabG3F, Vps4, and Cbl3. Our analysis introduces new interactors and signifies a broad spectrum of regulatory levels from chromatin remodeling to intracellular protein sorting mechanisms active in the plant mineral homeostasis. The results highlight the importance of storage proteins in metal ion toxicity-resistance and chelation. Interestingly, the protein sorting and recycling factors Exoc7, Cdc1, Sec23A, and Rab11A contributed to the response as well as the polar distributors of metal-transporters ensuring the directional flow of minerals. Alternative isoform switching was found important for plant adaptation and occurred among transcripts coding for identical proteins as well as transcripts coding for protein isoforms. We also identified differences in the alternative-isoform preference between the treatments, indicating metal-affinity shifts among isoforms of metal transporters. Most important, we found the zinc treatment to impair both photosynthesis and respiration. A wide range of transcriptional changes including stress-related genes and negative feedback loops emphasize the importance to withhold mineral contents below certain cellular levels which otherwise might lead to agronomical impeding side-effects. By illustrating new mechanisms, genes, and transcripts, this report provides a solid platform towards understanding the complex network of plant mineral homeostasis.	[Darbani, Behrooz; Noeparvar, Shahin; Borg, Soren] Aarhus Univ, Dept Mol Biol & Genet, Res Ctr Flakkebjerg, Slagelse, Denmark; [Darbani, Behrooz] Univ Copenhagen, Dept Plant & Environm Sci, Frederiksberg, Denmark	Aarhus University; University of Copenhagen	Darbani, B (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Res Ctr Flakkebjerg, Slagelse, Denmark.	behroozdarbani@gmail.com; soren.borg@mbg.au.dk	darbani, behrooz/AAM-1641-2020	Darbani, Behrooz/0000-0003-0289-6392	Aarhus University; HarvestPlus	Aarhus University; HarvestPlus	This work was financially supported by Aarhus University and HarvestPlus.	Abadia J, 2011, PLANT PHYSIOL BIOCH, V49, P471, DOI 10.1016/j.plaphy.2011.01.026; Abdel-Ghany SE, 2005, PLANT CELL, V17, P1233, DOI 10.1105/tpc.104.030452; Atwood SE, 2014, PLANT CELL ENVIRON, V37, P213, DOI 10.1111/pce.12147; Bagley DC, 2012, J BIOL CHEM, V287, P25577, DOI 10.1074/jbc.M112.354043; Bamdad F, 2013, MOL NUTR FOOD RES, V57, P493, DOI 10.1002/mnfr.201200252; Barberon M, 2014, P NATL ACAD SCI USA, V111, P8293, DOI 10.1073/pnas.1402262111; Barberon M, 2011, P NATL ACAD SCI USA, V108, pE450, DOI 10.1073/pnas.1100659108; BARTEL B, 1995, SCIENCE, V268, P1745, DOI 10.1126/science.7792599; Becher M, 2004, PLANT J, V37, P251, DOI 10.1046/j.1365-313X.2003.01959.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernal M, 2012, PLANT CELL, V24, P738, DOI 10.1105/tpc.111.090431; Binder BM, 2007, PLANT CELL, V19, P509, DOI 10.1105/tpc.106.048140; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Cakmak I, 1996, PLANT SOIL, V180, P165, DOI 10.1007/BF00015299; Carbone R, 1997, CANCER RES, V57, P5498; Casacuberta E, 2013, MOL ECOL, V22, P1503, DOI 10.1111/mec.12170; Chen CC, 2011, PLANT PHYSIOL, V156, P2225, DOI 10.1104/pp.111.178996; Cheng YF, 2004, PLANT PHYSIOL, V135, P1020, DOI 10.1104/pp.104.044495; Cho M, 2012, PLANT PHYSIOL, V159, P642, DOI 10.1104/pp.112.196139; Chollangi S, 2012, J BIOL CHEM, V287, P23710, DOI 10.1074/jbc.M112.360404; Cui Y, 2014, PLANT CELL, V26, P2080, DOI 10.1105/tpc.114.123141; Curie C, 2000, BIOCHEM J, V347, P749, DOI 10.1042/0264-6021:3470749; Curie C, 2001, NATURE, V409, P346, DOI 10.1038/35053080; Darbani B, 2014, J BIOTECHNOL, V188, P100, DOI 10.1016/j.jbiotec.2014.08.012; Darbani B, 2014, J BIOL RES-THESSALON, V21, DOI 10.1186/2241-5793-21-3; Darbani B, 2013, BIOTECHNOL ADV, V31, P1292, DOI 10.1016/j.biotechadv.2013.05.003; del Pozo JC, 2002, PLANT CELL, V14, P421, DOI 10.1105/tpc.010282; Deng FL, 2013, PLANT PHYSIOL, V163, P1353, DOI 10.1104/pp.113.226225; Doskocilova A, 2011, PLANTA, V234, P459, DOI 10.1007/s00425-011-1419-7; Drdova EJ, 2013, PLANT J, V73, P709, DOI 10.1111/tpj.12074; Eguez L, 2004, GENETICS, V167, P107, DOI 10.1534/genetics.167.1.107; Ezaki B, 2007, J EXP BOT, V58, P497, DOI 10.1093/jxb/erl221; Fan HJ, 2014, PLANT J, V77, P209, DOI 10.1111/tpj.12380; Frey AG, 2014, P NATL ACAD SCI USA, V111, P8031, DOI 10.1073/pnas.1402732111; Fujimoto M, 2015, PLANT CELL PHYSIOL, V56, P287, DOI 10.1093/pcp/pcu195; Fujita M, 2009, CELL, V139, P352, DOI 10.1016/j.cell.2009.08.040; Gaillard S, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-22; Garcia MJ, 2010, J EXP BOT, V61, P3885, DOI 10.1093/jxb/erq203; GIBSON MM, 1991, MOL MICROBIOL, V5, P2753, DOI 10.1111/j.1365-2958.1991.tb01984.x; Giehl RFH, 2012, PLANT CELL, V24, P33, DOI 10.1105/tpc.111.092973; Gollhofer J, 2011, PLANT PHYSIOL BIOCH, V49, P557, DOI 10.1016/j.plaphy.2011.02.011; Grandbastien MA, 1998, TRENDS PLANT SCI, V3, P181, DOI 10.1016/S1360-1385(98)01232-1; Grotz N, 1998, P NATL ACAD SCI USA, V95, P7220, DOI 10.1073/pnas.95.12.7220; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Helliwell CA, 2001, PLANT CELL, V13, P2115, DOI 10.1105/tpc.13.9.2115; Huang CF, 2012, PLANT J, V69, P857, DOI 10.1111/j.1365-313X.2011.04837.x; Inoue H, 2009, J BIOL CHEM, V284, P3470, DOI 10.1074/jbc.M806042200; Jain Mukesh, 2006, Functional & Integrative Genomics, V6, P47, DOI 10.1007/s10142-005-0005-0; Kanter U, 2010, J EXP BOT, V61, P3995, DOI 10.1093/jxb/erq213; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim YY, 2009, PLANT J, V58, P737, DOI 10.1111/j.1365-313X.2009.03818.x; Klaus SMJ, 2005, J BIOL CHEM, V280, P38457, DOI 10.1074/jbc.M507432200; Kobayashi T, 2005, J EXP BOT, V56, P1305, DOI 10.1093/jxb/eri131; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lanquar V, 2005, EMBO J, V24, P4041, DOI 10.1038/sj.emboj.7600864; Lanquar V, 2010, PLANT PHYSIOL, V152, P1986, DOI 10.1104/pp.109.150946; Lapierre LA, 2001, MOL BIOL CELL, V12, P1843, DOI 10.1091/mbc.12.6.1843; Lasswell J, 2000, PLANT CELL, V12, P2395, DOI 10.1105/tpc.12.12.2395; Lee S, 2009, PLANT PHYSIOL, V150, P786, DOI 10.1104/pp.109.135418; Li C, 2014, PLANT CELL PHYSIOL, V55, P426, DOI 10.1093/pcp/pct180; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu WZ, 2013, P NATL ACAD SCI USA, V110, P1548, DOI 10.1073/pnas.1213235110; Loladze I, 2014, ELIFE, V3, DOI 10.7554/eLife.02245; Lubkowitz M, 2011, MOL PLANT, V4, P407, DOI 10.1093/mp/ssr004; Magidin M, 2003, PLANT J, V35, P523, DOI 10.1046/j.1365-313X.2003.01826.x; Malapeira J, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.24079; McCreedy RA, 2009, NUTR REV, V67, P607, DOI 10.1111/j.1753-4887.2009.00233.x; Michaillat L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054160; Milner MJ, 2013, J EXP BOT, V64, P369, DOI 10.1093/jxb/ers315; Morel M, 2009, PLANT PHYSIOL, V149, P894, DOI 10.1104/pp.108.130294; Muller M, 2004, PLANT PHYSIOL, V134, P409, DOI 10.1104/pp.103.029066; Narayanan NN, 2007, PLANT PHYSIOL BIOCH, V45, P277, DOI 10.1016/j.plaphy.2007.03.021; Neuteboom LW, 1999, PLANT MOL BIOL, V39, P273, DOI 10.1023/A:1006104205959; Nishino T, 2005, J BIOL CHEM, V280, P24888, DOI 10.1074/jbc.M501830200; Noh B, 2001, PLANT CELL, V13, P2441, DOI 10.1105/tpc.13.11.2441; Olmedo G, 2006, P NATL ACAD SCI USA, V103, P13286, DOI 10.1073/pnas.0605528103; Oomen RJFJ, 2009, NEW PHYTOL, V181, P637, DOI 10.1111/j.1469-8137.2008.02694.x; Parry DA, 2009, AM J HUM GENET, V84, P266, DOI 10.1016/j.ajhg.2009.01.009; Penalver E, 1999, J BACTERIOL, V181, P2555; Podar D, 2012, J BIOL CHEM, V287, P3185, DOI 10.1074/jbc.M111.305649; Qi YH, 2012, NEW PHYTOL, V193, P109, DOI 10.1111/j.1469-8137.2011.03910.x; Rampey RA, 2013, G3-GENES GENOM GENET, V3, P131, DOI 10.1534/g3.112.004655; Rangan P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/239621; Ranocha P, 2001, PLANT J, V25, P575, DOI 10.1046/j.1365-313x.2001.00988.x; Ravanel S, 2004, J BIOL CHEM, V279, P22548, DOI 10.1074/jbc.M313250200; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodriguez-Cazorla E, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004983; Rodriguez-Celma J, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00276; Ruiz JC, 2013, J BIOL CHEM, V288, P552, DOI 10.1074/jbc.M112.426171; Salahudeen AA, 2009, SCIENCE, V326, P722, DOI 10.1126/science.1176326; Santi S, 2009, NEW PHYTOL, V183, P1072, DOI 10.1111/j.1469-8137.2009.02908.x; Sauter M, 2013, BIOCHEM J, V451, P145, DOI 10.1042/BJ20121744; Schmidt W, 2000, PLANT PHYSIOL, V122, P1109, DOI 10.1104/pp.122.4.1109; Shahriari M, 2010, PLANT J, V64, P71, DOI 10.1111/j.1365-313X.2010.04310.x; Shi HF, 2008, SCIENCE, V320, P1207, DOI 10.1126/science.1157643; Sinclair SA, 2012, BBA-MOL CELL RES, V1823, P1553, DOI 10.1016/j.bbamcr.2012.05.016; Singh AK, 2003, PLANT PHYSIOL, V132, P1825, DOI 10.1104/pp.103.024018; Smith MR, 2013, APPL ENVIRON MICROB, V79, P728, DOI 10.1128/AEM.01737-12; SMITH RL, 1993, J BIOL CHEM, V268, P14071; Song WY, 2014, PLANT CELL ENVIRON, V37, P1192, DOI 10.1111/pce.12227; Song WY, 2010, P NATL ACAD SCI USA, V107, P21187, DOI 10.1073/pnas.1013964107; Staswick PE, 2005, PLANT CELL, V17, P616, DOI 10.1105/tpc.104.026690; STEPHAN UW, 1994, PLANT SOIL, V165, P181, DOI 10.1007/BF00008060; Sunkar R, 2000, PLANT J, V24, P533, DOI 10.1046/j.1365-313x.2000.00901.x; Tang RJ, 2015, P NATL ACAD SCI USA, V112, P3134, DOI 10.1073/pnas.1420944112; Tang SN, 2013, NUCLEIC ACIDS RES, V41, pW441, DOI 10.1093/nar/gkt428; Tauris B, 2009, J EXP BOT, V60, P1333, DOI 10.1093/jxb/erp023; Tiong J, 2014, NEW PHYTOL, V201, P131, DOI 10.1111/nph.12468; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trudeau MC, 2003, J BIOL CHEM, V278, P18705, DOI 10.1074/jbc.R300001200; van de Mortel JE, 2006, PLANT PHYSIOL, V142, P1127, DOI 10.1104/pp.106.082073; Vazquez HM, 2014, MOL BIOL CELL, V25, P3375, DOI 10.1091/mbc.E14-06-1033; Wang HY, 1997, GENE DEV, V11, P799, DOI 10.1101/gad.11.6.799; Waters BM, 2014, NEW PHYTOL, V203, P1128, DOI 10.1111/nph.12911; Wu HL, 2010, ANN BOT-LONDON, V105, P823, DOI 10.1093/aob/mcq051; Wu Y, 2010, J EXP BOT, V61, P3407, DOI 10.1093/jxb/erq161; Xu GR, 2011, SOURCE CODE BIOL MED, V6, DOI 10.1186/1751-0473-6-2; Yamaji N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3442; Yamaji N, 2013, PLANT PHYSIOL, V162, P927, DOI 10.1104/pp.113.216564; Yamazaki D, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003983; Yang TJW, 2010, PLANT PHYSIOL, V152, P2130, DOI 10.1104/pp.109.152728; Yu HL, 2012, J EXP BOT, V63, P4527, DOI 10.1093/jxb/ers131; Zargar SM, 2015, PLANT CELL REP, V34, P157, DOI 10.1007/s00299-014-1696-2; Zhang Y, 2014, NEW PHYTOL, V203, P770, DOI 10.1111/nph.12860; Zheng LQ, 2012, PLANT CELL, V24, P3767, DOI 10.1105/tpc.112.103820; Zientara K, 2009, J BIOTECHNOL, V139, P258, DOI 10.1016/j.jbiotec.2008.12.001; Zimmermann M, 2009, BIOCHEMISTRY-US, V48, P11640, DOI 10.1021/bi901573b	128	7	7	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141398	10.1371/journal.pone.0141398	http://dx.doi.org/10.1371/journal.pone.0141398			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536247	Green Submitted, Green Published, gold			2022-12-26	WOS:000364298400062
J	Dobay, A; Pilo, P; Lindholm, AK; Origgi, F; Bagheri, HC; Konig, B				Dobay, Akos; Pilo, Paola; Lindholm, Anna K.; Origgi, Francesco; Bagheri, Homayoun C.; Koenig, Barbara			Dynamics of a Tularemia Outbreak in a Closely Monitored Free-Roaming Population of Wild House Mice	PLOS ONE			English	Article							FRANCISELLA-TULARENSIS; DISEASES; MODELS	Infectious disease outbreaks can be devastating because of their sudden occurrence, as well as the complexity of monitoring and controlling them. Outbreaks in wildlife are even more challenging to observe and describe, especially when small animals or secretive species are involved. Modeling such infectious disease events is relevant to investigating their dynamics and is critical for decision makers to accomplish outbreak management. Tularemia, caused by the bacterium Francisella tularensis, is a potentially lethal zoonosis. Of the few animal outbreaks that have been reported in the literature, only those affecting zoo animals have been closely monitored. Here, we report the first estimation of the basic reproduction number R-0 of an outbreak in wildlife caused by F. tularensis using quantitative modeling based on a susceptible-infected-recovered framework. We applied that model to data collected during an extensive investigation of an outbreak of tularemia caused by F. tularensis subsp. holarctica (also designated as type B) in a closely monitored, free-roaming house mouse (Mus musculus domesticus) population in Switzerland. Based on our model and assumptions, the best estimated basic reproduction number R-0 of the current outbreak is 1.33. Our results suggest that tularemia can cause severe outbreaks in small rodents. We also concluded that the outbreak self-exhausted in approximately three months without administrating antibiotics.	[Dobay, Akos; Lindholm, Anna K.; Bagheri, Homayoun C.; Koenig, Barbara] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Pilo, Paola; Origgi, Francesco] Univ Bern, Vetsuisse Fac, Inst Vet Bacteriol, Bern, Switzerland; [Origgi, Francesco] Vetsuisse Fac, Ctr Fish & Wildlife Hlth FIWI, Bern, Switzerland	University of Zurich; University of Bern	Dobay, A (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland.	Akos.Dobay@uzh.ch	Dobay, Akos/N-3655-2019; Lindholm, Anna K/E-5207-2012	Dobay, Akos/0000-0001-6492-9298; Lindholm, Anna K/0000-0001-8460-9769; Bagheri, Homayoun/0000-0002-2495-7785; Konig, Barbara/0000-0001-7696-4736	canton of Zurich; Swiss Federal Office for the Environment [12.0003.KP/L121-0964]; Swiss Expert Committee for Biosafety [04.1240.PZ/L064-7521]; Swiss National Science Foundation [310030M-138389]	canton of Zurich; Swiss Federal Office for the Environment; Swiss Expert Committee for Biosafety; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the canton of Zurich (to HB, BK and AL) and by the Swiss Federal Office for the Environment (grant number 12.0003.KP/L121-0964, http://www.bafu.admin.ch, to PP), by the Swiss Expert Committee for Biosafety (grant number 04.1240.PZ/L064-7521, http://www.efbs.admin.ch, to PP) and the Swiss National Science Foundation (grant number 310030M-138389, http://www.snf.ch, to AL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akalin H, 2009, INT J INFECT DIS, V13, P547, DOI 10.1016/j.ijid.2008.09.020; Anda P, 2001, EMERG INFECT DIS, V7, P575; Attie O, 2013, J DATA MINING GENOMI, V4, P2153, DOI [10.4172/2153-0602.1000125, DOI 10.4172/2153-0602.1000125]; Auclair Y, 2014, BEHAV ECOL, V25, P1467, DOI 10.1093/beheco/aru143; Decors A, 2011, EUROSURVEILLANCE, V16; Desvars A, 2015, EMERG INFECT DIS, V21, P32, DOI 10.3201/eid2101.140916; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Farlow J, 2005, EMERG INFECT DIS, V11, P1835, DOI 10.3201/eid1112.050728; Ferrecchia CE, 2012, COMPARATIVE MED, V62, P316; Foley JE, 2010, VET MICROBIOL, V140, P332, DOI 10.1016/j.vetmic.2009.07.017; Gee K-F, 2012, TRANSWORLD RES NETWO, V37, P23; Gillard JJ, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00169; Helvaci S, 2000, EUR J EPIDEMIOL, V16, P271, DOI 10.1023/A:1007610724801; Hyman JM, 2000, MATH BIOSCI, V167, P65, DOI 10.1016/S0025-5564(00)00025-0; Jones R.M., 2005, APPL BIOSAF, V10, P227, DOI DOI 10.1177/153567600501000405; Kantardjiev T, 2006, EMERG INFECT DIS, V12, P678, DOI 10.3201/eid1204.050709; Kaysser P, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-157; Keeling MJ., 2007, MODELING INFECT DIS, VIllustrated edition; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Konig B., 2012, EVOLUTION HOUSE MOUS, P114, DOI [DOI 10.1017/CBO9781139044547.007, 10.1017/CBO9781139044547.007]; Lauriano CM, 2004, P NATL ACAD SCI USA, V101, P4246, DOI 10.1073/pnas.0307690101; Leander R, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002757; Matz-Rensing K, 2007, VET PATHOL, V44, P327, DOI 10.1354/vp.44-3-327; Marchette JN, 1960, THESIS; McClintock BT, 2010, ECOL LETT, V13, P659, DOI 10.1111/j.1461-0248.2010.01472.x; McClintock BT, 2009, ECOLOGY, V90, P313, DOI 10.1890/08-0973.1; Molins CR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010205; Moreau GB, 2013, VIRULENCE, V4, P826, DOI 10.4161/viru.25629; Morner T., 1992, Revue Scientifique et Technique Office International des Epizooties, V11, P1123; Morrison M.L., 2008, WILDLIFE STUDY DESIG; Origgi FC, 2015, EMERG INFECT DIS, V21, P133, DOI 10.3201/eid2101.140906; Runfola JK, 2015, MMWR-MORBID MORTAL W, V64, P429; Ryden P, 2012, J INFECT DIS, V205, P297, DOI 10.1093/infdis/jir732; Splettstoesser WD, 2007, EPIDEMIOL INFECT, V135, P1256, DOI 10.1017/S0950268807008035; Stundick MV, 2013, VET PATHOL, V50, P877, DOI 10.1177/0300985813486812; Vonkavaara M, 2008, CELL MICROBIOL, V10, P1327, DOI 10.1111/j.1462-5822.2008.01129.x; Weidt A, 2014, NATURWISSENSCHAFTEN, V101, P73, DOI 10.1007/s00114-013-1130-6	37	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141103	10.1371/journal.pone.0141103	http://dx.doi.org/10.1371/journal.pone.0141103			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536232	Green Accepted, Green Published, gold			2022-12-26	WOS:000364298400053
J	Sato, C; Sekiguchi, A; Kawai, M; Kotozaki, Y; Nouchi, R; Tada, H; Takeuchi, H; Ishida, T; Taki, Y; Kawashima, R; Ohuchi, N				Sato, Chiho; Sekiguchi, Atsushi; Kawai, Masaaki; Kotozaki, Yuka; Nouchi, Rui; Tada, Hiroshi; Takeuchi, Hikaru; Ishida, Takanori; Taki, Yasuyuki; Kawashima, Ryuta; Ohuchi, Noriaki			Postoperative Structural Brain Changes and Cognitive Dysfunction in Patients with Breast Cancer	PLOS ONE			English	Article							QUALITY-OF-LIFE; PREFRONTAL CORTEX; NEUROCOGNITIVE FUNCTION; GENERAL-ANESTHESIA; ATTENTION; SURGERY; SEVOFLURANE; NEUROINFLAMMATION; CHEMOTHERAPY; MECHANISMS	Objective The primary purpose of this study was to clarify the influence of the early response to surgery on brain structure and cognitive function in patients with breast cancer. It was hypothesized that the structure of the thalamus would change during the early response after surgery due to the effects of anesthesia and would represent one aspect of an intermediate phenotype of postoperative cognitive dysfunction (POCD). Methods We examined 32 postmenopausal females with breast cancer and 20 age-matched controls. We assessed their cognitive function (attention, memory, and executive function), and performed brain structural MRI 1.5 +/- 0.5 days before and 5.6 +/- 1.2 days after surgery. Results We found a significant interaction between regional grey matter volume (rGMV) in the thalamus (P < 0.05, familywise error (FWE), small volume correction (SVC)) and one attention domain subtest (P = 0.001, Bonferroni correction) after surgery in the patient group compared with the control group. Furthermore, the changes in attention were significantly associated with sevoflurane anesthetic dose (r(2) = 0.247, beta = -0.471, P = 0.032) and marginally associated with rGMV changes in the thalamus (P = 0.07, FWE, SVC) in the Pt group. Conclusion Our findings suggest that alterations in brain structure, particularly in the thalamus, may occur shortly after surgery and may be associated with attentional dysfunction. This early postoperative response to anesthesia may represent an intermediate phenotype of POCD. It was assumed that patients experiencing other risk factors of POCD, such as the severity of surgery, the occurrence of complications, and pre-existing cognitive impairments, would develop clinical POCD with broad and multiple types of cognitive dysfunction.	[Sato, Chiho; Sekiguchi, Atsushi; Kawashima, Ryuta] Tohoku Univ, IDAC, Dept Funct Brain Imaging, Sendai, Miyagi 980, Japan; [Sato, Chiho; Tada, Hiroshi; Ishida, Takanori; Ohuchi, Noriaki] Tohoku Univ, Grad Sch Med, Div Surg Oncol, Sendai, Miyagi 980, Japan; [Sekiguchi, Atsushi; Taki, Yasuyuki] Tohoku Univ, Tohoku Med Megabank Org, Dept Community Med Supports, Div Med Neuroimage Anal, Sendai, Miyagi 980, Japan; [Sekiguchi, Atsushi] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Adult Mental Hlth, Tokyo, Japan; [Kawai, Masaaki] Miyagi Canc Ctr Hosp, Dept Breast Oncol, Natori, Miyagi, Japan; [Kotozaki, Yuka] Fukushima Med Univ, Sch Med, Med Ind Translat Res Ctr, Div Clin Res, Fukushima, Japan; [Nouchi, Rui] Tohoku Univ, Frontier Res Inst Interdisciplinary Sci, Creat Interdisciplinary Res Div, Sendai, Miyagi 980, Japan; [Nouchi, Rui; Kawashima, Ryuta] Tohoku Univ, Dept Adv Brain Sci, Smart Ageing Int Res Ctr, IDAC, Sendai, Miyagi 980, Japan; [Nouchi, Rui] Tohoku Univ, Int Res Inst Disaster Sci, Human & Social Response Res Div, Sendai, Miyagi 980, Japan; [Takeuchi, Hikaru; Taki, Yasuyuki; Kawashima, Ryuta] Tohoku Univ, Div Dev Cognit Neurosci, IDAC, Sendai, Miyagi 980, Japan; [Taki, Yasuyuki] Tohoku Univ, Inst Dev Aging & Canc, Dept Nucl Med & Radiol, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Tohoku University; National Center for Neurology & Psychiatry - Japan; Miyagi Cancer Center; Fukushima Medical University; Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University	Sekiguchi, A (corresponding author), Tohoku Univ, IDAC, Dept Funct Brain Imaging, Sendai, Miyagi 980, Japan.	asekiguchi@ncnp.go.jp	Kotozaki, Yuka/ABA-2922-2020; Tada, Hiroshi/G-2551-2014; Nouchi, Rui/GQH-1608-2022; Kotozaki, Yuka/ABA-2267-2020; Takeuchi, Hikaru/D-1057-2011	Kotozaki, Yuka/0000-0002-4659-1200; Tada, Hiroshi/0000-0003-2670-8982; xing zhi, shi zhi/0000-0003-3289-5681; Takeuchi, Hikaru/0000-0002-8022-9694; Nouchi, Rui/0000-0002-2078-9518	International Research Institute of Disaster Science; Ministry of Education, Culture, Sports, Science and Technology in Japan [KAKENHI 24790653]	International Research Institute of Disaster Science; Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Funding: Financial support for this study was provided by a Grant for Special Project Research from the International Research Institute of Disaster Science, a Grant-in-Aid for Young Scientists (B) (KAKENHI 24790653) from the Ministry of Education, Culture, Sports, Science and Technology in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler LJ, 1997, ANESTH ANALG, V84, P120, DOI 10.1097/00000539-199701000-00023; Ahles TA, 2005, J CLIN ONCOL, V23, P4399, DOI 10.1200/JCO.2005.03.343; Ahles TA, 2012, J CLIN ONCOL, V30, P3675, DOI 10.1200/JCO.2012.43.0116; Alkire MT, 2000, CONSCIOUS COGN, V9, P370, DOI 10.1006/ccog.1999.0423; Bercker S, 2009, NEUROTOX RES, V16, P140, DOI 10.1007/s12640-009-9063-8; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Cao XZ, 2010, PROG NEURO-PSYCHOPH, V34, P1426, DOI 10.1016/j.pnpbp.2010.07.027; Carrasco M, 2001, P NATL ACAD SCI USA, V98, P5363, DOI 10.1073/pnas.081074098; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Chen MH, 2013, J ANESTH, V27, P487, DOI 10.1007/s00540-012-1548-6; Chun MM, 2007, CURR OPIN NEUROBIOL, V17, P177, DOI 10.1016/j.conb.2007.03.005; Correa DD, 2008, CANCER J, V14, P396, DOI 10.1097/PPO.0b013e31818d8769; Coull JT, 1998, PROG NEUROBIOL, V55, P343, DOI 10.1016/S0301-0082(98)00011-2; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fidalgo AR, 2011, NEUROSCIENCE, V190, P194, DOI 10.1016/j.neuroscience.2011.05.073; Fiset P, 1999, J NEUROSCI, V19, P5506; Fougnie D, 2008, RELATIONSHIP ATTENTI; Franks NP, 2011, CAN J ANESTH, V58, P139, DOI 10.1007/s12630-010-9420-3; Gaster C, 2011, VBM TOOLBOX SPM8; Guay J, 2011, INDIAN J ANAESTH, V55, P358, DOI 10.4103/0019-5049.84850; Hakoda Y, 1990, KYOIKUSHINRIGAKUKENK, P389; Hatta T, 2004, APPL NEUROPSYCHOL, V11, P153, DOI 10.1207/s15324826an1103_3; Hedayati E, 2011, ACTA ONCOL, V50, P1027, DOI 10.3109/0284186X.2011.572911; Hermelink K, 2007, CANCER, V109, P1905, DOI 10.1002/cncr.22610; Hofacer RD, 2013, ANN NEUROL, V73, P695, DOI 10.1002/ana.23892; HOLE A, 1980, ACTA ANAESTH SCAND, V24, P279, DOI 10.1111/j.1399-6576.1980.tb01549.x; Hovens IB, 2012, BRAIN BEHAV IMMUN, V26, P1169, DOI 10.1016/j.bbi.2012.06.004; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Ketz NA, 2015, TRENDS NEUROSCI, V38, P3, DOI 10.1016/j.tins.2014.09.007; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Kline RP, 2012, ANESTHESIOLOGY, V116, P603, DOI 10.1097/ALN.0b013e318246ec0b; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Moller JT, 1998, LANCET, V351, P857, DOI 10.1016/S0140-6736(97)07382-0; Nakane Y, 1997, WHOQOL 26 INFORM; Newman MF, 2001, STROKE, V32, P2874, DOI 10.1161/hs1201.099803; Newman S, 2007, ANESTHESIOLOGY, V106, P572, DOI 10.1097/00000542-200703000-00023; Nobre AC, 1997, BRAIN, V120, P515, DOI 10.1093/brain/120.3.515; Omura K, 2004, J CLIN EXP NEUROPSYC, V26, P645, DOI 10.1080/13803390490504272; Phillips-Bute B, 2006, PSYCHOSOM MED, V68, P369, DOI 10.1097/01.psy.0000221272.77984.e2; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Price CC, 2008, ANESTHESIOLOGY, V108, P8, DOI 10.1097/01.anes.0000296072.02527.18; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; Rasmussen LS, 2001, ACTA ANAESTH SCAND, V45, P275, DOI 10.1034/j.1399-6576.2001.045003275.x; Rosczyk HA, 2008, EXP GERONTOL, V43, P840, DOI 10.1016/j.exger.2008.06.004; Rossi AF, 2009, EXP BRAIN RES, V192, P489, DOI 10.1007/s00221-008-1642-z; Schlunzen L, 2004, ACTA ANAESTH SCAND, V48, P1268, DOI 10.1111/j.1399-6576.2004.00505.x; Schlunzen L, 2010, ACTA ANAESTH SCAND, V54, P603, DOI 10.1111/j.1399-6576.2010.02208.x; Sherman S.M., 2009, EXPLORING THALAMUS I, V2nd Edn; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Sugishita M, 2001, WECHSLER MEMORY SCAL; Tashiro M, 2005, BREAST CANC, V12; Taubert M, 2010, J NEUROSCI, V30, P11670, DOI 10.1523/JNEUROSCI.2567-10.2010; Terrando N, 2010, P NATL ACAD SCI USA, V107, P20518, DOI 10.1073/pnas.1014557107; Tuch DS, 2005, P NATL ACAD SCI USA, V102, P12212, DOI 10.1073/pnas.0407259102; Vardy J, 2008, ANN ONCOL, V19, P623, DOI 10.1093/annonc/mdm500; Wechsler D., 2008, WECHSLER ADULT INTEL; Wechsler D, 1987, WMS R WECHSLER MEMOR; White NS, 2003, NEUROIMAGE, V19, P402, DOI 10.1016/S1053-8119(03)00103-4; Yon JH, 2005, NEUROSCIENCE, V135, P815, DOI 10.1016/j.neuroscience.2005.03.064; Yoshizaki K, 2006, D CAT MANUAL SCREENI; Zehnder Antoinette E, 2007, Am J Alzheimers Dis Other Demen, V22, P416, DOI 10.1177/1533317507302448	64	22	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140655	10.1371/journal.pone.0140655	http://dx.doi.org/10.1371/journal.pone.0140655			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536672	Green Submitted, Green Published, gold			2022-12-26	WOS:000364298400030
J	Chung, YG; Seth, A; Doyle, C; Franck, D; Kim, D; Cristofaro, V; Benowitz, LI; Tu, DD; Estrada, CR; Mauney, JR; Sullivan, MP; Adam, RM				Chung, Yeun Goo; Seth, Abhishek; Doyle, Claire; Franck, Debra; Kim, Daniel; Cristofaro, Vivian; Benowitz, Larry I.; Tu, Duong D.; Estrada, Carlos R.; Mauney, Joshua R.; Sullivan, Maryrose P.; Adam, Rosalyn M.			Inosine Improves Neurogenic Detrusor Overactivity following Spinal Cord Injury	PLOS ONE			English	Article							PURINE-SENSITIVE MECHANISM; ADENOSINE RECEPTORS; PROMOTES RECOVERY; AFFERENT ACTIVITY; BLADDER; CELLS; MODEL; REGENERATION; OUTGROWTH; SUPPORT	Neurogenic detrusor overactivity and the associated loss of bladder control are among the most challenging complications of spinal cord injury (SCI). Anticholinergic agents are the mainstay for medical treatment of detrusor overactivity. However, their use is limited by significant side effects such that a search for new treatments is warranted. Inosine is a naturally occurring purine nucleoside with neuroprotective, neurotrophic and antioxidant effects that is known to improve motor function in preclinical models of SCI. However, its effect on lower urinary tract function has not been determined. The objectives of this study were to determine the effect of systemic administration of inosine on voiding function following SCI and to delineate potential mechanisms of action. Sprague-Dawley rats underwent complete spinal cord transection, or cord compression by application of an aneurysm clip at T8 for 30 sec. Inosine (225 mg/kg) or vehicle was administered daily via intraperitoneal injection either immediately after injury or after a delay of 8 wk. At the end of treatment, voiding behavior was assessed by cystometry. Levels of synaptophysin (SYP), neurofilament 200 (NF200) and TRPV1 in bladder tissues were measured by immunofluorescence imaging. Inosine administration decreased overactivity in both SCI models, with a significant decrease in the frequency of spontaneous non-voiding contractions during filling, compared to vehicle-treated SCI rats (p<0.05), including under conditions of delayed treatment. Immunofluorescence staining demonstrated increased levels of the pan-neuronal marker SYP and the Adelta fiber marker NF200, but decreased staining for the C-fiber marker, TRPV1 in bladder tissues from inosine-treated rats compared to those from vehicle-treated animals, including after delayed treatment. These findings demonstrate that inosine prevents the development of detrusor overactivity and attenuates existing overactivity following SCI, and may achieve its effects through modulation of sensory neurotransmission.	[Chung, Yeun Goo; Seth, Abhishek; Doyle, Claire; Franck, Debra; Tu, Duong D.; Estrada, Carlos R.; Mauney, Joshua R.; Adam, Rosalyn M.] Boston Childrens Hosp, Urol Dis Res Ctr, Boston, MA USA; [Chung, Yeun Goo; Seth, Abhishek; Doyle, Claire; Kim, Daniel; Cristofaro, Vivian; Benowitz, Larry I.; Tu, Duong D.; Estrada, Carlos R.; Mauney, Joshua R.; Sullivan, Maryrose P.; Adam, Rosalyn M.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Kim, Daniel; Benowitz, Larry I.] Boston Childrens Hosp, Dept Neurosurg, Boston, MA USA; [Cristofaro, Vivian; Sullivan, Maryrose P.] VA Boston Healthcare Syst, Div Urol, West Roxbury, MA USA; [Cristofaro, Vivian; Sullivan, Maryrose P.] Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Brigham & Women's Hospital	Sullivan, MP (corresponding author), Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA.	msullivan@rics.bwh.harvard.edu; rosalyn.adam@childrens.harvard.edu		Benowitz, Larry/0000-0002-0277-7222	Children's Urological Foundation; National Institutes of Health [R01 DK077195, P50 DK65298]; PVA Research Foundation [2909]; Department of Veterans Affairs Medical Research Service [BX001790]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077195, T32DK060442, P50DK065298] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001790] Funding Source: NIH RePORTER	Children's Urological Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PVA Research Foundation; Department of Veterans Affairs Medical Research Service(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	The authors acknowledge financial support from the Children's Urological Foundation, the National Institutes of Health (R01 DK077195, P50 DK65298, to R.M.A), the PVA Research Foundation (Grant 2909 to R.M.A) and Department of Veterans Affairs Medical Research Service, (BX001790 to M.P.S). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benowitz LI, 2002, PROG BRAIN RES, V137, P389; Benowitz LI, 2001, RESTOR NEUROL NEUROS, V19, P41; Benowitz LI, 1999, P NATL ACAD SCI USA, V96, P13486, DOI 10.1073/pnas.96.23.13486; Benowitz LI, 1998, J BIOL CHEM, V273, P29626, DOI 10.1074/jbc.273.45.29626; Bocklinger K, 2004, EUR J CELL BIOL, V83, P51, DOI 10.1078/0171-9335-00362; Chen P, 2002, P NATL ACAD SCI USA, V99, P9031, DOI 10.1073/pnas.132076299; Chung YG, 2014, BIOMATERIALS, V35, P7452, DOI 10.1016/j.biomaterials.2014.05.044; de Groat WC, 2006, PROG BRAIN RES, V152, P59, DOI 10.1016/S0079-6123(05)52005-3; de Groat WC, 2010, NEUROUROL URODYNAM, V29, P63, DOI 10.1002/nau.20761; del Popolo G, 2012, SPINAL CORD, V50, P8, DOI 10.1038/sc.2011.110; Gomez G, 2003, BLOOD, V102, P4472, DOI 10.1182/blood-2002-11-3624; Gopalakrishnan SM, 2002, J PHARMACOL EXP THER, V300, P910, DOI 10.1124/jpet.300.3.910; Hasko G, 2004, TRENDS PHARMACOL SCI, V25, P152, DOI 10.1016/j.tips.2004.01.006; Hou B, 2004, INVEST OPHTH VIS SCI, V45, P662, DOI 10.1167/iovs.03-0281; Juszczak K, 2009, J PHYSIOL PHARMACOL, V60, P85; Kim D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081948; Komiyama I, 1999, J UROLOGY, V161, P314, DOI 10.1016/S0022-5347(01)62138-4; Kuricova M, 2014, NEUROL SCI, V35, P1785, DOI 10.1007/s10072-014-1840-3; Liu F, 2006, SPINAL CORD, V44, P421, DOI 10.1038/sj.sc.3101878; Macedo SJ, 2013, PURINERG SIGNAL, V9, P51, DOI 10.1007/s11302-012-9327-2; Nascimento FP, 2010, J PHARMACOL EXP THER, V334, P590, DOI 10.1124/jpet.110.166058; Petrausch B, 2000, J NEUROSCI, V20, P8031; Schwarzschild MA, 2014, JAMA NEUROL, V71, P141, DOI 10.1001/jamaneurol.2013.5528; Seth A, 2013, BMC UROL, V13, DOI 10.1186/1471-2490-13-24; Shen H, 2005, STROKE, V36, P654, DOI 10.1161/01.STR.0000155747.15679.04; Shi M, 2002, NEUROREPORT, V13, P477, DOI 10.1097/00001756-200203250-00024; Smith JM, 2007, BRAIN, V130, P915, DOI 10.1093/brain/awl393; Zai LL, 2009, J NEUROSCI, V29, P8187, DOI 10.1523/JNEUROSCI.0414-09.2009	28	10	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141492	10.1371/journal.pone.0141492	http://dx.doi.org/10.1371/journal.pone.0141492			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529505	Green Submitted, gold, Green Published			2022-12-26	WOS:000364032600033
J	Gaidos, G; Panaitiu, AE; Guo, BQ; Pellegrini, M; Mierke, DF				Gaidos, Gabriel; Panaitiu, Alexandra E.; Guo, Bingqian; Pellegrini, Maria; Mierke, Dale F.			Identification and Characterization of the Interaction Site between cFLIP(L) and Calmodulin	PLOS ONE			English	Article							CANCER CELL-DEATH; C-FLIP; CHOLANGIOCARCINOMA CELLS; MOLECULAR-DYNAMICS; INDUCED APOPTOSIS; CRYSTAL-STRUCTURE; PEPTIDE COMPLEX; LUNG-CANCER; BINDING; TARGET	Overexpression of the cellular FLICE-like inhibitory protein (cFLIP) has been reported in a number of tumor types. As an inactive procaspase-8 homologue, cFLIP is recruited to the intracellular assembly known as the Death Inducing Signaling Complex (DISC) where it inhibits apoptosis, leading to cancer cell proliferation. Here we characterize the molecular details of the interaction between cFLIP(L) and calmodulin, a ubiquitous calcium sensing protein. By expressing the individual domains of cFLIP(L), we demonstrate that the interaction with calmodulin is mediated by the N-terminal death effector domain (DED1) of cFLIP(L). Additionally, we mapped the interaction to a specific region of the C-terminus of DED1, referred to as DED1 R4. By designing DED1/DED2 chimeric constructs in which the homologous R4 regions of the two domains were swapped, calmodulin binding properties were transferred to DED2 and removed from DED1. Furthermore, we show that the isolated DED1 R4 peptide binds to calmodulin and solve the structure of the peptide-protein complex using NMR and computational refinement. Finally, we demonstrate an interaction between cFLIP(L) and calmodulin in cancer cell lysates. In summary, our data implicate calmodulin as a potential player in DISC-mediated apoptosis and provide evidence for a specific interaction with the DED1 of cFLIP(L).	[Gaidos, Gabriel; Panaitiu, Alexandra E.; Guo, Bingqian; Pellegrini, Maria; Mierke, Dale F.] Dartmouth Coll, Dept Chem, Hanover, NH 03755 USA	Dartmouth College	Mierke, DF (corresponding author), Dartmouth Coll, Dept Chem, Hanover, NH 03755 USA.	Dale.F.Mierke@dartmouth.edu	Pellegrini, Maria/W-6005-2019	Pellegrini, Maria/0000-0003-3817-4412	National Institute of General Medical Sciences of the National Institutes of Health [P30GM106394]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM106394] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number P30GM106394 (to MP) (http://www.nigms.nih.gov/). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEREM A, 1992, TRENDS BIOCHEM SCI, V17, P438, DOI 10.1016/0968-0004(92)90016-3; Ahn EY, 2004, J BIOL CHEM, V279, P5661, DOI 10.1074/jbc.M311040200; Bagnoli M, 2010, INT J BIOCHEM CELL B, V42, P210, DOI 10.1016/j.biocel.2009.11.015; Bagnoli M, 2009, ENDOCR-RELAT CANCER, V16, P443, DOI 10.1677/ERC-08-0218; BAX A, 1985, J MAGN RESON, V63, P207, DOI 10.1016/0022-2364(85)90171-4; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; CAMPBELL AP, 1993, ANNU REV BIOPH BIOM, V22, P99, DOI 10.1146/annurev.bb.22.060193.000531; Carlomagno T, 2005, ANNU REV BIOPH BIOM, V34, P245, DOI 10.1146/annurev.biophys.34.040204.144419; Chen YB, 2008, J CELL BIOCHEM, V103, P788, DOI 10.1002/jcb.21447; Coggins BE, 2003, J BIOMOL NMR, V26, P93, DOI 10.1023/A:1023589029301; Egger Denise, 1994, Molecular Biotechnology, V1, P289, DOI 10.1007/BF02921696; FALCHETTO R, 1992, PROTEIN SCI, V1, P1613, DOI 10.1002/pro.5560011209; HAIT WN, 1986, J CLIN ONCOL, V4, P994, DOI 10.1200/JCO.1986.4.6.994; Havel T.F., 2002, ENCY COMPUTATIONAL C; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; HIDAKA H, 1981, P NATL ACAD SCI-BIOL, V78, P4354, DOI 10.1073/pnas.78.7.4354; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hwang MK, 2009, BIOCHEM CELL BIOL, V87, P919, DOI [10.1139/O09-058, 10.1139/o09-058]; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; ITO H, 1991, ANTICANCER RES, V11, P249; Kaminskyy VO, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.51; Kaufmann M, 2002, FEBS LETT, V527, P250, DOI 10.1016/S0014-5793(02)03146-0; Keller Rochus L. J., 1966, COMPUTER AIDED RESON; Kim HS, 2013, CELL, V155, P552, DOI 10.1016/j.cell.2013.09.041; Korkolopoulou P, 2004, UROLOGY, V63, P1198, DOI 10.1016/j.urology.2004.01.007; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Li FY, 2006, J BIOL CHEM, V281, P2960, DOI 10.1074/jbc.M511074200; Longley DB, 2006, ONCOGENE, V25, P838, DOI 10.1038/sj.onc.1209122; Majkut J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4350; McCourt C, 2012, CLIN CANCER RES, V18, P3822, DOI 10.1158/1078-0432.CCR-11-3277; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; MEADOR WE, 1993, SCIENCE, V262, P1718, DOI 10.1126/science.8259515; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; Menyhard DK, 2009, CURR COMPUT-AID DRUG, V5, P264, DOI 10.2174/157340909789577874; Ozturk S, 2012, EXP CELL RES, V318, P1324, DOI 10.1016/j.yexcr.2012.01.019; Ogura K, 1996, J BIOMOL NMR, V8, P492, DOI 10.1007/BF00228150; ONEIL KT, 1990, TRENDS BIOCHEM SCI, V15, P59, DOI 10.1016/0968-0004(90)90177-D; Pan G, 1999, AM J PATHOL, V155, P193, DOI 10.1016/S0002-9440(10)65113-9; Papoff G, 2010, BBA-MOL CELL RES, V1803, P898, DOI 10.1016/j.bbamcr.2010.04.006; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Pawar PS, 2008, BIOCHEM J, V412, P459, DOI 10.1042/BJ20071507; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Plati J, 2011, INTEGR BIOL-UK, V3, P279, DOI 10.1039/c0ib00144a; Rogers KMA, 2007, MOL CANCER THER, V6, P1544, DOI 10.1158/1535-7163.MCT-06-0673; Safa A. R., 2012, Experimental Oncology, V34, P176; SHAKA AJ, 1988, J MAGN RESON, V77, P274, DOI 10.1016/0022-2364(88)90178-3; Suever JD, 2008, BIOPHYS J, V95, P5913, DOI 10.1529/biophysj.108.130542; Tian F, 2012, CLIN EXP DERMATOL, V37, P259, DOI 10.1111/j.1365-2230.2011.04238.x; VORHERR T, 1993, BIOCHEMISTRY-US, V32, P6081, DOI 10.1021/bi00074a020; Wang ZC, 2010, THROMB RES, V125, P340, DOI 10.1016/j.thromres.2010.02.001; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Wilson TR, 2007, CANCER RES, V67, P5754, DOI 10.1158/0008-5472.CAN-06-3585; Wu XJ, 2005, J BIOL CHEM, V280, P29964, DOI 10.1074/jbc.M500710200; YAMAZAKI T, 1994, J AM CHEM SOC, V116, P11655, DOI 10.1021/ja00105a005; Yamniuk AP, 2004, MOL BIOTECHNOL, V27, P33, DOI 10.1385/MB:27:1:33; Yang JK, 2008, YONSEI MED J, V49, P19, DOI 10.3349/ymj.2008.49.1.19; Yang JK, 2005, MOL CELL, V20, P939, DOI 10.1016/j.molcel.2005.10.023; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Zuiderweg ERP, 2002, BIOCHEMISTRY-US, V41, P1, DOI 10.1021/bi011870b	62	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141692	10.1371/journal.pone.0141692	http://dx.doi.org/10.1371/journal.pone.0141692			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529318	Green Submitted, Green Published, gold			2022-12-26	WOS:000364032600051
J	Moon, BI; Kim, TH; Seoh, JY				Moon, Byung-In; Kim, Tae Hun; Seoh, Ju-Young			Functional Modulation of Regulatory T Cells by IL-2	PLOS ONE			English	Article							LOW-DOSE INTERLEUKIN-2; IMMUNOLOGICAL SELF-TOLERANCE; IN-VIVO; AUTOIMMUNE-DISEASE; CUTTING EDGE; INDUCTION; THERAPY; IMMUNITY; SUPPRESSION; ACTIVATION	The suppressive function of regulatory T cells (Tregs) is critical to the maintenance of immune homeostasis in vivo and yet, the specific identification of Tregs by phenotypic markers is not perfect. Tregs were originally identified in the CD4(+)CD25(+) fraction of T cells, but FoxP3 expression was later included as an additional marker of Tregs as FoxP3 expression was identified as being critical to the development and function of these cells. Intracellular expression of FoxP3 makes it difficult in using to isolate live and not permeabilized cells for functional assays. As such CD4(+)CD25(+) fraction is still frequently used for functional assays of Tregs. Although, the CD4(+)CD25(+) fraction substantially overlaps with the FoxP3(+) fraction, the minor mismatch between CD4(+)CD25(+) and FoxP3(+) fractions may confound the functional characteristics of Tregs. In this study, we isolated CD4(+)FoxP3(+) as well as CD4(+)CD25(+) fractions from Foxp3 knock-in mice, and compared their proliferative and suppressive activity in the presence or absence of various concentrations of IL-2. Our results showed comparable patterns of proliferative and suppressive responses for both fractions, except that contrary to the CD4(+)CD25(+) fraction the FoxP3+ fraction did not proliferate in an autocrine fashion even in response to a strong stimulation. In presence of exogenous IL-2, both CD4(+)CD25(+) and CD4(+)FoxP3(+) fractions were more sensitive than the CD4(+)CD25(-) responder cells in proliferative responsiveness. In addition, a low dose IL-2 enhanced whereas a high dose abrogated the suppressive activities of the CD4(+)CD25(+) and CD4(+)FoxP3(+) fractions. These results may provide an additional understanding of the characteristics of the various fractions of isolated Tregs based on phenotype and function and the role of varying levels of exogenous IL-2 on the suppressive activity of these cells.	[Moon, Byung-In] Ewha Womans Univ, Dept Surg, Grad Sch Med, Seoul, South Korea; [Kim, Tae Hun] Ewha Womans Univ, Dept Internal Med, Grad Sch Med, Seoul, South Korea; [Seoh, Ju-Young] Ewha Womans Univ, Grad Sch Med, Dept Microbiol, Seoul, South Korea	Ewha Womans University; Ewha Womans University; Ewha Womans University	Seoh, JY (corresponding author), Ewha Womans Univ, Grad Sch Med, Dept Microbiol, Seoul, South Korea.	jyseoh@ewha.ac.kr			Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI12C0050]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant of the Korean Health Technology R&D Project (https://www.htdream.kr/), Ministry of Health & Welfare, Republic of Korea (HI12C0050). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida ARM, 2006, J IMMUNOL, V177, P192, DOI 10.4049/jimmunol.177.1.192; Almeida ARM, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00125; Annunziato F, 2002, J EXP MED, V196, P379, DOI 10.1084/jem.20020110; Antony PA, 2006, J IMMUNOL, V176, P5255, DOI 10.4049/jimmunol.176.9.5255; Berntsen A, 2010, J IMMUNOTHER, V33, P425, DOI 10.1097/CJI.0b013e3181cd870f; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Cheng GY, 2011, IMMUNOL REV, V241, P63, DOI 10.1111/j.1600-065X.2011.01004.x; de la Rosa M, 2004, EUR J IMMUNOL, V34, P2480, DOI 10.1002/eji.200425274; Dooms H, 2010, EUR J IMMUNOL, V40, P1538, DOI 10.1002/eji.201040617; Givan AL, 1999, J IMMUNOL METHODS, V230, P99, DOI 10.1016/S0022-1759(99)00136-2; Grinberg-Bleyer Y, 2010, J EXP MED, V207, P1871, DOI 10.1084/jem.20100209; GUTIERREZRAMOS JC, 1992, EUR J IMMUNOL, V22, P2867, DOI 10.1002/eji.1830221117; He H, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-24; Hofer T, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00268; Jang MH, 2011, REGULATORY T CELLS, P201; Jilaveanu LB, 2009, CLIN DERMATOL, V27, P614, DOI 10.1016/j.clindermatol.2008.09.020; Jung YJ, 2009, IMMUNOBIOLOGY, V214, P291, DOI 10.1016/j.imbio.2008.09.004; Kim HR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091146; Klatzmann D, 2015, NAT REV IMMUNOL, V15, P283, DOI 10.1038/nri3823; Klein L, 2003, P NATL ACAD SCI USA, V100, P8886, DOI 10.1073/pnas.1533365100; KOLB H, 1986, EUR J IMMUNOL, V16, P209, DOI 10.1002/eji.1830160218; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; Levings MK, 2001, J EXP MED, V193, P1295, DOI 10.1084/jem.193.11.1295; Lim HW, 2005, J IMMUNOL, V175, P4180, DOI 10.4049/jimmunol.175.7.4180; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; Malek TR, 2004, NAT REV IMMUNOL, V4, P665, DOI 10.1038/nri1435; Margolin KA, 2000, SEMIN ONCOL, V27, P194; Nishikawa H, 2010, INT J CANCER, V127, P759, DOI 10.1002/ijc.25429; Oliveira V, 2006, TRANSPL IMMUNOL, V17, P7, DOI 10.1016/j.trim.2006.09.028; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Pereira-Santos MC, 2008, CLIN EXP ALLERGY, V38, P291, DOI 10.1111/j.1365-2222.2007.02887.x; Piccirillo CA, 2004, SEMIN IMMUNOL, V16, P81, DOI 10.1016/j.smim.2003.12.003; Piccirillo CA, 2001, J IMMUNOL, V167, P1137, DOI 10.4049/jimmunol.167.3.1137; Piccirillo CA, 2008, CYTOKINE, V43, P395, DOI 10.1016/j.cyto.2008.07.469; Radulovic S, 2008, J ALLERGY CLIN IMMUN, V121, P1467, DOI 10.1016/j.jaci.2008.03.013; Ralainirina N, 2007, J LEUKOCYTE BIOL, V81, P144, DOI 10.1189/jlb.0606409; RIZZO LV, 1994, J CLIN INVEST, V94, P1668, DOI 10.1172/JCI117511; Rosenzwajg M, 2015, J AUTOIMMUN, V58, P48, DOI 10.1016/j.jaut.2015.01.001; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Shaker MA, 2009, J PHARM SCI-US, V98, P2268, DOI 10.1002/jps.21596; SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876; Sojka DK, 2005, J IMMUNOL, V175, P7274, DOI 10.4049/jimmunol.175.11.7274; SUZUKI H, 1995, SCIENCE, V268, P1472, DOI 10.1126/science.7770771; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Thornton AM, 2000, J IMMUNOL, V164, P183, DOI 10.4049/jimmunol.164.1.183; Turka LA, 2008, FRONT BIOSCI-LANDMRK, V13, P1440, DOI 10.2741/2773; Venken K, 2007, J IMMUNOL METHODS, V322, P1, DOI 10.1016/j.jim.2007.01.025; Waldmann T, 2002, ARTHRITIS RES THER, V4, pS161, DOI 10.1186/ar584; Walker LSK, 2003, J EXP MED, V198, P249, DOI 10.1084/jem.20030315; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Webster AC, 2007, NEPHROLOGY, V12, pS75, DOI 10.1111/j.1440-1797.2006.00732.x; Yamazaki S, 2003, J EXP MED, V198, P235, DOI 10.1084/jem.20030422; Yu AX, 2015, DIABETES, V64, P2172, DOI 10.2337/db14-1322; Yu AX, 2009, IMMUNITY, V30, P204, DOI 10.1016/j.immuni.2008.11.014	57	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141864	10.1371/journal.pone.0141864	http://dx.doi.org/10.1371/journal.pone.0141864			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529512	Green Published, gold, Green Submitted			2022-12-26	WOS:000364032600073
J	Zhang, M; Zhang, SJ; Wen, YH; Wang, YH; Wei, YJ; Liu, HB; Zhang, DW; Su, JZ; Wang, F; Zhang, Y				Zhang, Min; Zhang, Shaojun; Wen, Yanhua; Wang, Yihan; Wei, Yanjun; Liu, Hongbo; Zhang, Dongwei; Su, Jianzhong; Wang, Fang; Zhang, Yan			DNA Methylation Patterns Can Estimate Nonequivalent Outcomes of Breast Cancer with the Same Receptor Subtypes	PLOS ONE			English	Article							PROMOTER HYPERMETHYLATION; EXPRESSION; BRCA1; HETEROGENEITY; EFFICACY; THERAPY; ALPHA; SERUM	Breast cancer has various molecular subtypes and displays high heterogeneity. Aberrant DNA methylation is involved in tumor origin, development and progression. Moreover, distinct DNA methylation patterns are associated with specific breast cancer subtypes. We explored DNA methylation patterns in association with gene expression to assess their impact on the prognosis of breast cancer based on Infinium 450K arrays (training set) from The Cancer Genome Atlas (TCGA). The DNA methylation patterns of 12 featured genes that had a high correlation with gene expression were identified through univariate and multivariable Cox proportional hazards models and used to define the methylation risk score (MRS). An improved ability to distinguish the power of the DNA methylation pattern from the 12 featured genes (p = 0.00103) was observed compared with the average methylation levels (p = 0.956) or gene expression (p = 0.909). Furthermore, MRS provided a good prognostic value for breast cancers even when the patients had the same receptor status. We found that ER-, PR-or Her2-samples with high-MRS had the worst 5-year survival rate and overall survival time. An independent test set including 28 patients with death as an outcome was used to test the validity of the MRS of the 12 featured genes; this analysis obtained a prognostic value equivalent to the training set. The predict power was validated through two independent datasets from the GEO database. The DNA methylation pattern is a powerful predictor of breast cancer survival, and can predict outcomes of the same breast cancer molecular subtypes.	[Zhang, Min; Zhang, Shaojun; Wen, Yanhua; Wang, Yihan; Wei, Yanjun; Liu, Hongbo; Su, Jianzhong; Wang, Fang; Zhang, Yan] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin 150081, Peoples R China; [Zhang, Dongwei] Harbin Med Univ, Affiliated Hosp 2, Dept Gen Surg, Harbin 150086, Peoples R China	Harbin Medical University; Harbin Medical University	Wang, F (corresponding author), Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin 150081, Peoples R China.	wangfang@ems.hrbmu.edu.cn; tyozhang@ems.hrbmu.edu.cn	Liu, Hongbo/M-2162-2015	Liu, Hongbo/0000-0002-0733-8616; Wang, Yihan/0000-0002-1163-4610	National Natural Science Foundation of China [61402139, 31401075, 31371334, 61403112, 61203262]; Natural Science Foundation of Heilongjiang Province [ZD2015003]; Natural Scientific Research Fund of Heilongjiang Provincial [QC2011C061]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province); Natural Scientific Research Fund of Heilongjiang Provincial	Funding: The authors thank the support of National Natural Science Foundation of China [grant number 61402139, 31401075, 31371334, 61403112, 61203262], the Natural Science Foundation of Heilongjiang Province [grant number ZD2015003] and the Natural Scientific Research Fund of Heilongjiang Provincial [grant number QC2011C061 to SZ].	Anderson WF, 2009, BREAST CANCER RES TR, V113, P189, DOI 10.1007/s10549-008-9918-3; Anderson WF, 2011, J NATL CANCER I, V103, P1397, DOI 10.1093/jnci/djr257; Anderson WF, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju165; Campan M, 2006, CURR TOP MICROBIOL, V310, P141; Cine N, 2014, ONCOL REP, V32, P1078, DOI 10.3892/or.2014.3277; Clare Stirzaker EZSJC, 2015, MOL CELLULAR ONCOLOG; DeSantis C, 2011, CA-CANCER J CLIN, V61, P409, DOI 10.3322/caac.20134; Dworkin AM, 2009, SEMIN CANCER BIOL, V19, P165, DOI 10.1016/j.semcancer.2009.02.007; Fiegl H, 2005, CANCER RES, V65, P1141, DOI 10.1158/0008-5472.CAN-04-2438; Gau DM, 2015, CELL CYCLE, V14, P1884, DOI 10.1080/15384101.2015.1036203; Honrado E, 2007, MODERN PATHOL, V20, P1298, DOI 10.1038/modpathol.3800969; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jiang WG, 2005, EUR J CANCER, V41, P1628, DOI 10.1016/j.ejca.2005.03.023; KOHLER BA, 2015, JNCI J NATL CANCER I, V107, DOI DOI 10.1093/JNCI/DJV048; Kurian AW, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2780; Lewis CM, 2005, CLIN CANCER RES, V11, P166; Lindstrom S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6303; Mirza S, 2007, LIFE SCI, V81, P280, DOI 10.1016/j.lfs.2007.05.012; Muller HM, 2003, CANCER RES, V63, P7641; Perez EA, 2011, ONCOLOGIST, V16, P20, DOI 10.1634/theoncologist.2011-S1-20; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Polyak K, 2011, J CLIN INVEST, V121, P3786, DOI 10.1172/JCI60534; Rudolph A, 2013, ENDOCR-RELAT CANCER, V20, P875, DOI 10.1530/ERC-13-0349; Schultz MD, 2015, NATURE; Silver DP, 2010, J CLIN ONCOL, V28, P1145, DOI 10.1200/JCO.2009.22.4725; Simon M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005097; Sofou K, 2015, MOL GENET GENOM MED, V3, P59, DOI 10.1002/mgg3.115; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stefansson OA, 2015, MOL ONCOL, V9, P555, DOI 10.1016/j.molonc.2014.10.012; Sui M, 2007, CANCER RES, V67, P5337, DOI 10.1158/0008-5472.CAN-06-4582; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Varelas X, 2014, GLYCOBIOLOGY, V24, P579, DOI 10.1093/glycob/cwu031; Veeck J, 2006, ONCOGENE, V25, P3479, DOI 10.1038/sj.onc.1209386; Vincent-Salomon A, 2007, CANCER RES, V67, P5134, DOI 10.1158/0008-5472.CAN-07-0465; Wajed SA, 2001, ANN SURG, V234, P10, DOI 10.1097/00000658-200107000-00003; Weisenberger DJ, 2015, TRANSL CANCER RES, V4, P219, DOI 10.3978/j.issn.2218-676X.2015.05.01	36	6	6	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2015	10	11							e0142279	10.1371/journal.pone.0142279	http://dx.doi.org/10.1371/journal.pone.0142279			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7AC	26550991	Green Published, gold, Green Submitted			2022-12-26	WOS:000364422800021
J	Fusser, M; Kernstock, S; Aileni, VK; Egge-Jacobsen, W; Falnes, PO; Klungland, A				Fusser, Markus; Kernstock, Stefan; Aileni, Vinay Kumar; Egge-Jacobsen, Wolfgang; Falnes, Pal O.; Klungland, Arne			Lysine Methylation of the Valosin-Containing Protein (VCP) Is Dispensable for Development and Survival of Mice	PLOS ONE			English	Article							SKELETAL-MUSCLE; ATPASE ACTIVITY; AAA-ATPASE; METHYLTRANSFERASE; GLUT4; GENE; IDENTIFICATION; DOMAIN; TUG; DNA	Valosin-containing protein (VCP) is a homohexameric ATPase involved in a multitude cellular processes and it was recently shown that VCP is trimethylated at lysine 315 by the VCP lysine methyltransferase (VCPKMT). Here, we generated and validated a constitutive knockout mouse by targeting exon 1-4 of the Vcpkmt gene. We show that Vcpkmt is ubiquitously expressed in all tissues examined and confirm the sub-cellular localization to the cytoplasm. We show by (I) mass spectrometric analysis, (II) VCPKMT-mediated in vitro methylation of VCP in cell extracts and (III) immunostaining with a methylation specific antibody, that in Vcpkmt(-/-) mice the methylation of lysine 315 in VCP is completely abolished. In contrast, VCP is almost exclusively trimethylated in wild-type mice. Furthermore, we investigated the specificity of VCPKMT with in vitro methylation assays using as source of substrate protein extracts from Vcpkmt(-/-) mouse organs or three human Vcpkmt(-/-) cell lines. The results show that VCPKMT is a highly specific enzyme, and suggest that VCP is its sole substrate. The Vcpkmt(-/-) mice were viable, fertile and had no obvious pathological phenotype. Their body weight, life span and acute endurance capacity were comparable to wild-type controls. Overall the results show that VCPKMT is an enzyme required for methylation of K315 of VCP in vivo, but VCPKMT is not essential for development or survival under unstressed conditions.	[Fusser, Markus; Klungland, Arne] Oslo Univ Hosp, Rikshosp, Inst Med Microbiol, Oslo, Norway; [Kernstock, Stefan; Aileni, Vinay Kumar; Falnes, Pal O.] Univ Oslo, Fac Math & Nat Sci, Dept Biosci, Oslo, Norway; [Egge-Jacobsen, Wolfgang] Univ Oslo, Fac Math & Nat Sci, Dept Biosci, Glyconor Mass Spectrometry, Oslo, Norway; [Klungland, Arne] Univ Oslo, Inst Basic Med Sci, Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; University of Oslo	Klungland, A (corresponding author), Oslo Univ Hosp, Rikshosp, Inst Med Microbiol, Oslo, Norway.	arne.klungland@rr-research.no	Klungland, Arne/X-1233-2019; Falnes, Pål Ø./AAA-4581-2020	Klungland, Arne/0000-0001-7274-3661; Falnes, Pal/0000-0001-8114-6025	Norwegian Research Council [32198, 191749]; Health South East Region Norway [39429]; Norwegian Cancer Society [422102107744-PR-2007-0132]; Research Programme of the EEA/Norway Grants [POL/NOR/196258/2013]	Norwegian Research Council(Research Council of NorwayEuropean Commission); Health South East Region Norway; Norwegian Cancer Society(Norwegian Cancer Society); Research Programme of the EEA/Norway Grants	This study was funded by The Norwegian Research Council (http://www.forskningsradet.no/en/Home_page/1177315753906) (# 32198 to AK and #191749 to POF), Health South East Region Norway (http://www.helse-sorost.no/#39429toAK) and The Norwegian Cancer Society (https://kreftforeningen.no/#422102107744-PR-2007-0132toPOF). Funding for open access charge was provided by: Research Programme of the EEA/Norway Grants (grant numer POL/NOR/196258/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hadid Q, 2014, MOL CELL BIOL, V34, P2903, DOI 10.1128/MCB.01634-13; Belman JP, 2014, REV ENDOCR METAB DIS, V15, P55, DOI 10.1007/s11154-013-9276-2; Bernkopf M, 2014, HUM MOL GENET, V23, P4015, DOI 10.1093/hmg/ddu115; BIRNBAUM MJ, 1989, CELL, V57, P305, DOI 10.1016/0092-8674(89)90968-9; Bogan JS, 2012, J BIOL CHEM, V287, P23932, DOI 10.1074/jbc.M112.339457; Bogan JS, 2003, NATURE, V425, P727, DOI 10.1038/nature01989; Campaner S, 2011, MOL CELL, V43, P681, DOI 10.1016/j.molcel.2011.08.007; Chapman E, 2011, MOL BIOSYST, V7, P700, DOI 10.1039/c0mb00176g; Clarke SG, 2013, TRENDS BIOCHEM SCI, V38, P243, DOI 10.1016/j.tibs.2013.02.004; Cloutier P, 2014, J PROTEOMICS, V100, P115, DOI 10.1016/j.jprot.2013.10.008; Cloutier P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003210; Davydova E, 2014, J BIOL CHEM, V289, P30499, DOI 10.1074/jbc.M114.601658; de Bot ST, 2012, BRAIN, V135, DOI 10.1093/brain/aws201; Diehl F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009748; Dzialo MC, 2014, J BIOL CHEM, V289, P30511, DOI 10.1074/jbc.M114.605527; Fueger PT, 2007, J PHYSIOL-LONDON, V582, P801, DOI 10.1113/jphysiol.2007.132902; Halawani D, 2009, MOL CELL BIOL, V29, P4484, DOI 10.1128/MCB.00252-09; Haziza S, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005388; Jakobsson ME, 2013, J BIOL CHEM, V288, P27752, DOI 10.1074/jbc.M113.483248; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Jones B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000190; Kernstock S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2041; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; Kurash JK, 2008, MOL CELL, V29, P392, DOI 10.1016/j.molcel.2007.12.025; Lanouette S, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.134974; Magen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052425; Magnani R, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1044; Malecki J, 2014, J BIOL CHEM; Meyer H, 2014, J CELL SCI, V127, P3877, DOI 10.1242/jcs.093831; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Mori-Konya C, 2009, GENES CELLS, V14, P483, DOI 10.1111/j.1365-2443.2009.01286.x; Muller JMM, 2007, BIOCHEM BIOPH RES CO, V354, P459, DOI 10.1016/j.bbrc.2006.12.206; Niwa H, 2012, J BIOL CHEM, V287, P8561, DOI 10.1074/jbc.M111.302778; Orme CM, 2012, J BIOL CHEM, V287, P6679, DOI 10.1074/jbc.M111.284232; Petrossian TC, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000976; Reiff RE, 2014, HUM MOL GENET, V23, P3456, DOI 10.1093/hmg/ddu054; Richter EA, 2013, PHYSIOL REV, V93, P993, DOI 10.1152/physrev.00038.2012; Ryder JW, 1999, FASEB J, V13, P2246, DOI 10.1096/fasebj.13.15.2246; Thiele W, 2011, J PATHOL, V225, P96, DOI 10.1002/path.2924; Tissier A, 1995, BIOCHIMIE, V77, P854, DOI 10.1016/0300-9084(95)90003-9; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Webb KJ, 2010, J BIOL CHEM, V285, P37598, DOI 10.1074/jbc.M110.170787; Yamanaka K, 2012, BBA-MOL CELL RES, V1823, P130, DOI 10.1016/j.bbamcr.2011.07.001; Zhang LL, 2014, BIOCHEM BIOPH RES CO, V451, P229, DOI 10.1016/j.bbrc.2014.07.110	45	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141472	10.1371/journal.pone.0141472	http://dx.doi.org/10.1371/journal.pone.0141472			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544960	Green Published, Green Submitted, gold			2022-12-26	WOS:000364398700026
J	Lemaitre, G; Heller, LM; Navolio, N; Zuniga-Penaranda, N				Lemaitre, Guillaume; Heller, Laurie M.; Navolio, Nicole; Zuniga-Penaranda, Nicolas			Priming Gestures with Sounds	PLOS ONE			English	Article							AUDITORY-PERCEPTION; EVENT FILES; REPRESENTATION; OBJECT; COMPATIBILITY; ASSOCIATIONS; KNOWLEDGE; SYSTEMS; STREAMS; DORSAL	We report a series of experiments about a little-studied type of compatibility effect between a stimulus and a response: the priming of manual gestures via sounds associated with these gestures. The goal was to investigate the plasticity of the gesture-sound associations mediating this type of priming. Five experiments used a primed choice-reaction task. Participants were cued by a stimulus to perform response gestures that produced response sounds; those sounds were also used as primes before the response cues. We compared arbitrary associations between gestures and sounds (key lifts and pure tones) created during the experiment (i.e. no pre-existing knowledge) with ecological associations corresponding to the structure of the world (tapping gestures and sounds, scraping gestures and sounds) learned through the entire life of the participant (thus existing prior to the experiment). Two results were found. First, the priming effect exists for ecological as well as arbitrary associations between gestures and sounds. Second, the priming effect is greatly reduced for ecologically existing associations and is eliminated for arbitrary associations when the response gesture stops producing the associated sounds. These results provide evidence that auditory-motor priming is mainly created by rapid learning of the association between sounds and the gestures that produce them. Auditory-motor priming is therefore mediated by short-term associations between gestures and sounds that can be readily reconfigured regardless of prior knowledge.	[Lemaitre, Guillaume; Heller, Laurie M.; Navolio, Nicole; Zuniga-Penaranda, Nicolas] Carnegie Mellon Univ, Dietrich Coll Humanities & Social Sci, Dept Psychol, Auditory Lab, Pittsburgh, PA 15213 USA	Carnegie Mellon University	Lemaitre, G (corresponding author), STMS IRCAM UPMC CNRS, Inst Rech & Coordinat Acoust Mus, Paris, France.	GuillaumeJLemaitre@gmail.com		Heller, Laurie/0000-0002-4735-5701	Carnegie Mellon University	Carnegie Mellon University	This work was supported by Carnegie Mellon University startup funds to L.M.H. and Carnegie Mellon University Summer Undergraduate Research Fellowship (SURF) to NZP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RB, 2002, NEUROIMAGE, V16, P361, DOI 10.1006/nimg.2002.1088; Alain C, 2001, P NATL ACAD SCI USA, V98, P12301, DOI 10.1073/pnas.211209098; Borst G, 2011, AM PSYCHOL, V66, P624, DOI 10.1037/a0024038; Bourquin NMP, 2013, BRAIN TOPOGR, V26, P152, DOI 10.1007/s10548-012-0260-z; Brass M, 2000, BRAIN COGNITION, V44, P124, DOI 10.1006/brcg.2000.1225; Brunel L, 2013, EXP PSYCHOL, V60, P100, DOI 10.1027/1618-3169/a000176; Bub DN, 2008, COGNITION, V106, P27, DOI 10.1016/j.cognition.2006.12.010; Bub DN, 2010, J EXP PSYCHOL HUMAN, V36, P341, DOI 10.1037/a0017606; Bub DN, 2003, PSYCHOL SCI, V14, P467, DOI 10.1111/1467-9280.02455; Carello C, 2005, MOVING IMAGE THEORY, P79; Castiello U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012240; Chao LL, 2000, NEUROIMAGE, V12, P478, DOI 10.1006/nimg.2000.0635; Chen CC, 2011, J HUMAN RESOURCE ADU, V9, P6; Elsner B, 2001, J EXP PSYCHOL HUMAN, V27, P229, DOI 10.1037/0096-1523.27.1.229; Engel LR, 2009, NEUROIMAGE, V47, P1778, DOI 10.1016/j.neuroimage.2009.05.041; Galati G, 2008, NEUROIMAGE, V40, P1274, DOI 10.1016/j.neuroimage.2007.12.044; Garofeanu C, 2004, EXP BRAIN RES, V159, P55, DOI 10.1007/s00221-004-1932-z; Gazzola V, 2006, CURR BIOL, V16, P1824, DOI 10.1016/j.cub.2006.07.072; Gillmeister H, 2008, BRAIN RES, V1217, P157, DOI 10.1016/j.brainres.2007.12.076; Goodale MA, 2011, VISION RES, V51, P1567, DOI 10.1016/j.visres.2010.07.027; Grassi M, 2013, ACTA PSYCHOL, V143, P96, DOI 10.1016/j.actpsy.2013.02.005; Hoeren M, 2013, EXP BRAIN RES, V229, P243, DOI 10.1007/s00221-013-3610-5; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; Hommel B, 2004, TRENDS COGN SCI, V8, P494, DOI 10.1016/j.tics.2004.08.007; Hommel B, 1996, PSYCHOL RES-PSYCH FO, V59, P176, DOI 10.1007/BF00425832; Howell DC., 2013, STAT METHODS PSYCHOL, V8; HOWELL P, 1988, PERCEPT PSYCHOPHYS, V43, P90, DOI 10.3758/BF03208978; International Standard Association, 2003, 2262003 ISO AM STAND; Klatzky RL, 2000, PRESENCE-TELEOP VIRT, V9, P399, DOI 10.1162/105474600566907; Kunde W, 2004, Q J EXP PSYCHOL-A, V57, P87, DOI 10.1080/02724980343000143; Kunde W, 2003, PSYCHOL RES-PSYCH FO, V67, P153, DOI 10.1007/s00426-002-0114-5; Kunde W, 2002, Q J EXP PSYCHOL-A, V55, P581, DOI 10.1080/02724980143000433; Kunde W, 2001, J EXP PSYCHOL HUMAN, V27, P387, DOI 10.1037//0096-1523.27.2.387; Lahav A, 2007, J NEUROSCI, V27, P308, DOI 10.1523/JNEUROSCI.4822-06.2007; Lakatos S, 1997, PERCEPT PSYCHOPHYS, V59, P1180, DOI 10.3758/BF03214206; Lemaitre G, 2013, EXP BRAIN RES, V226, P253, DOI 10.1007/s00221-013-3430-7; Lemaitre G, 2012, J ACOUST SOC AM, V131, P1337, DOI 10.1121/1.3675946; Lemaitre G, 2009, INT J HUM-COMPUT ST, V67, P976, DOI 10.1016/j.ijhcs.2009.07.002; Lewis JW, 2005, J NEUROSCI, V25, P5148, DOI 10.1523/JNEUROSCI.0419-05.2005; Lewis JW, 2004, CEREB CORTEX, V14, P1008, DOI 10.1093/cercor/bhh061; Lidji P, 2007, J EXP PSYCHOL HUMAN, V33, P1189, DOI 10.1037/0096-1523.33.5.1189; Liepelt R, 2008, J EXP PSYCHOL HUMAN, V34, P578, DOI 10.1037/0096-1523.34.3.578; Masson MEJ, 2011, J EXP PSYCHOL HUMAN, V37, P1470, DOI 10.1037/a0023509; McAdams S, 2010, J ACOUST SOC AM, V128, P1401, DOI 10.1121/1.3466867; McIntosh RD, 2009, NEUROPSYCHOLOGIA, V47, P1391, DOI 10.1016/j.neuropsychologia.2009.02.009; Memelink J, 2013, PSYCHOL RES-PSYCH FO, V77, P249, DOI 10.1007/s00426-012-0435-y; Olejnik S, 2003, PSYCHOL METHODS, V8, P434, DOI 10.1037/1082-989X.8.4.434; Pazzaglia M, 2008, CURR BIOL, V18, P1766, DOI 10.1016/j.cub.2008.09.061; Phillips JC, 2002, VIS COGN, V9, P540, DOI 10.1080/13506280143000575; Pizzamiglio L, 2005, NEUROIMAGE, V24, P852, DOI 10.1016/j.neuroimage.2004.09.025; Rauschecker JP, 2009, NAT NEUROSCI, V12, P718, DOI 10.1038/nn.2331; Saygin AP, 2003, BRAIN, V126, P928, DOI 10.1093/brain/awg082; Sedda A, 2011, EXP BRAIN RES, V209, P365, DOI 10.1007/s00221-011-2559-5; Shin YK, 2010, PSYCHOL BULL, V136, P943, DOI 10.1037/a0020541; SIMON JR, 1967, J APPL PSYCHOL, V51, P300, DOI 10.1037/h0020586; Tucker M, 2001, VIS COGN, V8, P769, DOI 10.1080/13506280042000144; Tucker M, 2004, ACTA PSYCHOL, V116, P185, DOI 10.1016/j.actpsy.2004.01.004; TULLER B, 1980, PERCEPT PSYCHOPHYS, V27, P277, DOI 10.3758/BF03206115; Vainio L, 2007, Q J EXP PSYCHOL, V60, P241, DOI 10.1080/17470210600625149; WARREN WH, 1984, J EXP PSYCHOL HUMAN, V10, P704, DOI 10.1037/0096-1523.10.5.704; Whyatt C, 2013, RES AUTISM SPECT DIS, V7, P613, DOI 10.1016/j.rasd.2013.01.003; Wiggett AJ, 2011, BRAIN COGNITION, V76, P87, DOI 10.1016/j.bandc.2011.02.014; ZATORRE RJ, 2004, THE JOURNAL OF NEURO, V24, P3637, DOI DOI 10.1523/JNEUR0SCI.5458-03.2004; Zatorre RJ, 2007, NAT REV NEUROSCI, V8, P547, DOI 10.1038/nrn2152; Zmigrod S, 2009, ATTEN PERCEPT PSYCHO, V71, P352, DOI 10.3758/APP.71.2.352	65	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141791	10.1371/journal.pone.0141791	http://dx.doi.org/10.1371/journal.pone.0141791			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV6RT	26544884	gold, Green Published, Green Submitted			2022-12-26	WOS:000364398700049
J	Park, SL; Hwang, B; Lee, SY; Kim, WT; Choi, YH; Chang, YC; Kim, WJ; Moon, SK				Park, Sung Lyea; Hwang, Byungdoo; Lee, Sun-Young; Kim, Won Tae; Choi, Yung Hyun; Chang, Young-Chae; Kim, Wun-Jae; Moon, Sung-Kwon			p21WAF1 Is Required for Interleukin-16-Induced Migration and Invasion of Vascular Smooth Muscle Cells via the p38MAPK/Sp-1/MMP-9 Pathway	PLOS ONE			English	Article							NF-KAPPA-B; DEPENDENT KINASE INHIBITOR; MATRIX-METALLOPROTEINASE-9 EXPRESSION; GROWTH-FACTOR; ARTERIAL INJURY; GENE-EXPRESSION; LYMPHOCYTE MIGRATION; UP-REGULATION; PROLIFERATION; ACTIVATION	Interleukin-16 (IL-16) is a lymphocyte chemoattractant factor well known for its role in immune responses, but its role in vascular disease is unknown. Here, we explored the novel physiological function of IL-16 in vascular smooth muscle cells (VSMCs). The expression of IL-16 and its receptor CD4 was observed in VSMCs. Treatment with IL-16 enhanced the migration and invasion by VSMCs without altering the proliferative potential. IL-16 induced MMP-9 expression via the binding activity of transcription factors NF-kappa B, AP-1, and Sp-1 motifs in VSMCs. Among the relevant signaling pathways examined, only p38MAPK phosphorylation was significantly stimulated in IL-16-treated VSMCs. Treatment with p38MAPK inhibitor SB203580 prevented the IL-16-induced migration and invasion of VSMCs. SB203580 treatment inhibited the MMP-9 expression and activation of Sp-1 binding in IL-16-treated VSMCs, and siRNA knockdown of CD4 expression blocked the induction of migration, invasion, p38MAPK phosphorylation, MMP-9 expression, and Sp-1 binding activation stimulated by IL-16. The IL-16 induced cell-cycle-inhibitor p21WAF1 expression in VSMCs, but had no effect on the expression levels of other cell-cycle negative regulators. Finally, blockage of p21WAF1 function with specific siRNA abolished the IL-16-induced elevation of migration, invasion, p38MAPK phosphorylation, MMP-9 expression, and Sp-1 binding activation in VSMCs. Taken together, p21WAF1 was required for the induction of p38MAPK-mediated MMP-9 expression via activation of the Sp-1 binding motif, which led to migration and invasion of VSMCs interacting with IL-16/CD4. These results could provide that IL-16 is a new target in the treatment of vascular diseases such as atherosclerosis and re-stenosis.	[Park, Sung Lyea; Hwang, Byungdoo; Lee, Sun-Young; Moon, Sung-Kwon] Chung Ang Univ, Dept Food & Nutr, Ansung 456756, South Korea; [Kim, Won Tae; Kim, Wun-Jae] Chungbuk Natl Univ, Dept Urol, Cheongju 361763, Chungbuk, South Korea; [Choi, Yung Hyun] Dong Eui Univ, Dept Biochem, Coll Oriental Med, Busan 614052, South Korea; [Chang, Young-Chae] Catholic Univ Daegu, Sch Med, Res Inst Biomed Engn, Daegu 705718, South Korea; [Chang, Young-Chae] Catholic Univ Daegu, Sch Med, Dept Med, Daegu 705718, South Korea	Chung Ang University; Chungbuk National University; Dong-Eui University; Catholic University of Daegu; Catholic University of Daegu	Moon, SK (corresponding author), Chung Ang Univ, Dept Food & Nutr, Ansung 456756, South Korea.	sumoon66@dreamwiz.com			National Research Foundation of Korea (NRF) grant - Korean government (MSIP) [2014007036]	National Research Foundation of Korea (NRF) grant - Korean government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (No. 2014007036).	BENDECK MP, 1994, CIRC RES, V75, P539, DOI 10.1161/01.RES.75.3.539; Bond M, 1998, FEBS LETT, V435, P29, DOI 10.1016/S0014-5793(98)01034-5; Bond M, 2001, CARDIOVASC RES, V50, P556, DOI 10.1016/S0008-6363(01)00220-6; CENTER DM, 1982, J IMMUNOL, V128, P2563; CHANG MW, 1995, J CLIN INVEST, V96, P2260, DOI 10.1172/JCI118281; Cho A, 2000, ARTERIOSCL THROM VAS, V20, P2527, DOI 10.1161/01.ATV.20.12.2527; Cho A, 2002, CIRC RES, V91, P845, DOI 10.1161/01.RES.0000040420.17366.2E; Cross DS, 2012, CURR MED RES OPIN, V28, P1819, DOI 10.1185/03007995.2012.742878; CRUIKSHANK WW, 1987, J IMMUNOL, V138, P3817; Galis ZS, 2002, CIRC RES, V91, P852, DOI 10.1161/01.RES.0000041036.86977.14; Gurjar MV, 2001, AM J PHYSIOL-HEART C, V281, pH2568, DOI 10.1152/ajpheart.2001.281.6.H2568; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Lee SJ, 2013, J BIOL CHEM, V288, P5539, DOI 10.1074/jbc.M112.410233; Lee SJ, 2008, INT IMMUNOPHARMACOL, V8, P1821, DOI 10.1016/j.intimp.2008.08.018; Lin CC, 2009, CELL SIGNAL, V21, P1652, DOI 10.1016/j.cellsig.2009.07.002; Liu C, 2007, CYTOKINE, V38, P145, DOI 10.1016/j.cyto.2007.05.016; Moon SK, 2004, J BIOL CHEM, V279, P33063, DOI 10.1074/jbc.M313462200; Moon SK, 2004, J CELL PHYSIOL, V198, P417, DOI 10.1002/jcp.10435; Nathe TJ, 2002, ARTERIOSCL THROM VAS, V22, P1293, DOI 10.1161/01.ATV.0000023428.69244.49; Newby AC, 2000, J PATHOL, V190, P300, DOI 10.1002/(SICI)1096-9896(200002)190:3<300::AID-PATH596>3.0.CO;2-I; Parada NA, 1996, CELL IMMUNOL, V168, P100, DOI 10.1006/cimm.1996.0054; Richmond J, 2014, J CELL PHYSIOL, V229, P139, DOI 10.1002/jcp.24441; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; RYAN TC, 1995, J BIOL CHEM, V270, P17081, DOI 10.1074/jbc.270.29.17081; SATO H, 1993, ONCOGENE, V8, P395; So MK, 2006, NAT PROTOC, V1, P1160, DOI 10.1038/nprot.2006.162; Weiss RH, 2000, J BIOL CHEM, V275, P10285, DOI 10.1074/jbc.275.14.10285; Yang ZY, 1996, P NATL ACAD SCI USA, V93, P7905, DOI 10.1073/pnas.93.15.7905; Yoon TJ, 2006, SMALL, V2, P209, DOI [10.1002/smll.200500360, 10.1002/511111.200500360]; Zhan YM, 2003, ARTERIOSCL THROM VAS, V23, P795, DOI 10.1161/01.ATV.0000066132.32063.F2	30	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142153	10.1371/journal.pone.0142153	http://dx.doi.org/10.1371/journal.pone.0142153			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544695	gold, Green Submitted, Green Published			2022-12-26	WOS:000364398700088
J	Nishimura, W; Kapoor, A; El Khattabi, I; Jin, WZ; Yasuda, K; Bonner-Weir, S; Sharma, A				Nishimura, Wataru; Kapoor, Archana; El Khattabi, Ilham; Jin, Wanzhu; Yasuda, Kazuki; Bonner-Weir, Susan; Sharma, Arun			Compensatory Response by Late Embryonic Tubular Epithelium to the Reduction in Pancreatic Progenitors	PLoS One			English	Article							ENDOCRINE CELL-TYPES; BETA-CELLS; EXOCRINE PANCREAS; MOUSE PANCREAS; DUCTAL CELLS; DIFFERENTIATION; BIRTH; REGENERATION; EXPRESSION; NEOGENESIS	Early in pancreatic development, epithelial cells of pancreatic buds function as primary multipotent progenitor cells (1 degrees MPC) that specify all three pancreatic cell lineages, i.e., endocrine, acinar and duct. Bipotent "Trunk" progenitors derived from 1 degrees MPC are implicated in directly regulating the specification of endocrine progenitors. It is unclear if this specification process is initiated in the 1 degrees MPC where some 1 degrees MPC become competent for later specification of endocrine progenitors. Previously we reported that in Pdx1(tTA/+); tetO(MafA) (bigenic) mice inducing expression of transcription factor MafA in Pdx1-expressing (Pdx1(+)) cells throughout embryonic development inhibited the proliferation and differentiation of 1 degrees MPC cells, resulting in reduced pancreatic mass and endocrine cells by embryonic day (E) 17.5. Induction of the transgene only until E12.5 in Pdx1(+) 1 degrees MPC was sufficient for this inhibition of endocrine cells and pancreatic mass at E17.5. However, by birth (P0), as we now report, such bigenic pups had significantly increased pancreatic and endocrine volumes with endocrine clusters containing all pancreatic endocrine cell types. The increase in endocrine cells resulted from a higher proliferation of tubular epithelial cells expressing the progenitor marker Glut2 in E17.5 bigenic embryos and increased number of Neurog3-expressing cells at E19.5. A BrdU-labeling study demonstrated that inhibiting proliferation of 1 degrees MPC by forced MafA-expression did not lead to retention of those progenitors in E17.5 tubular epithelium. Our data suggest that the forced MafA expression in the 1 degrees MPC inhibits their competency to specify endocrine progenitors only until E17.5, and after that compensatory proliferation of tubular epithelium gives rise to a distinct pool of endocrine progenitors. Thus, these bigenic mice provide a novel way to characterize the competency of 1 degrees MPC for their ability to specify endocrine progenitors, a critical limitation in our understanding of endocrine differentiation.	[Nishimura, Wataru; Kapoor, Archana; El Khattabi, Ilham; Jin, Wanzhu; Bonner-Weir, Susan; Sharma, Arun] Joslin Diabet Ctr, Sect Islet Cell & Regenerat Biol, Boston, MA 02215 USA; [Nishimura, Wataru; Kapoor, Archana; El Khattabi, Ilham; Jin, Wanzhu; Bonner-Weir, Susan; Sharma, Arun] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Nishimura, Wataru; Yasuda, Kazuki] Natl Ctr Global Hlth & Med, Res Inst, Diabet Res Ctr, Dept Metab Disorder, Tokyo, Japan; [Nishimura, Wataru] Jichi Univ, Div Anat Bioimaging & Neurocell Sci, Shimotsuke, Tochigi, Japan	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; National Center for Global Health & Medicine - Japan	Sharma, A (corresponding author), MedImmune, Cardiovasc & Metab Dis, Gaithersburg, MD 20878 USA.	arun.sharma@joslin.harvard.edu	Nishimura, Wataru/R-9215-2019	Nishimura, Wataru/0000-0002-8068-1277; Bonner-Weir, Susan/0000-0003-4682-0656	NIH [RO1 DK060127]; Juvenile Diabetes Research Foundation (JDRF); American Diabetes Association [1-12-BS-187]; Herbert Graetz Fund; Shirley and William Fleisher Family Foundation; Alexander and Margaret Stewart Trust; JDRF; JSPS [22591022]; Takeda Science Foundation; National Center for Global Health and Medicine; Okinaka Memorial Institute for Medical Research; Japan Diabetes Foundation; Media and Advanced Microscopy Cores of Joslin Diabetes Endocrinology Research Center (NIH) [DK-36836]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060127, P30DK036836] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); American Diabetes Association(American Diabetes Association); Herbert Graetz Fund; Shirley and William Fleisher Family Foundation; Alexander and Margaret Stewart Trust; JDRF(Juvenile Diabetes Research Foundation); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan); Okinaka Memorial Institute for Medical Research; Japan Diabetes Foundation; Media and Advanced Microscopy Cores of Joslin Diabetes Endocrinology Research Center (NIH); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by research grants from NIH (RO1 DK060127), Juvenile Diabetes Research Foundation (JDRF), American Diabetes Association grant 1-12-BS-187, the Herbert Graetz Fund, Shirley and William Fleisher Family Foundation, and the Alexander and Margaret Stewart Trust to AS; JDRF postdoctoral fellowship, Mary K. Iacocca Fellowship, and grants from JSPS KAKENHI (22591022), Takeda Science Foundation, National Center for Global Health and Medicine, the Okinaka Memorial Institute for Medical Research and Japan Diabetes Foundation to WN; and Media and Advanced Microscopy Cores of Joslin Diabetes Endocrinology Research Center (NIH DK-36836); and an important group of private donors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguayo-Mazzucato C, 2010, NAT REV ENDOCRINOL, V6, P139, DOI 10.1038/nrendo.2009.274; Beucher A, 2012, DEV BIOL, V361, P277, DOI 10.1016/j.ydbio.2011.10.025; Bonner-Weir S, 2010, DIABETES, V59, P2340, DOI 10.2337/db10-0084; Criscimanna A, 2011, GASTROENTEROLOGY, V141, P1451, DOI 10.1053/j.gastro.2011.07.003; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Edlund H, 1998, DIABETES, V47, P1817, DOI 10.2337/diabetes.47.12.1817; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Gannon M, 2008, DEV BIOL, V314, P406, DOI 10.1016/j.ydbio.2007.10.038; Gouzi M, 2011, DEV DYNAM, V240, P589, DOI 10.1002/dvdy.22544; Gu GQ, 2002, DEVELOPMENT, V129, P2447; GUZ Y, 1995, DEVELOPMENT, V121, P11; Hale MA, 2005, DEV BIOL, V286, P225, DOI 10.1016/j.ydbio.2005.07.026; He KH, 2014, DEV BIOL, V385, P2, DOI 10.1016/j.ydbio.2013.10.024; Holland AM, 2002, P NATL ACAD SCI USA, V99, P12236, DOI 10.1073/pnas.192255099; Inada A, 2008, P NATL ACAD SCI USA, V105, P19915, DOI 10.1073/pnas.0805803105; Johansson KA, 2007, DEV CELL, V12, P457, DOI 10.1016/j.devcel.2007.02.010; Juhl K, 2010, CURR OPIN ORGAN TRAN, V15, P79, DOI 10.1097/MOT.0b013e3283344932; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Kopinke D, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-38; Kopp JL, 2011, DEVELOPMENT, V138, P653, DOI 10.1242/dev.056499; Kushner JA, 2010, CELL METAB, V11, P2, DOI 10.1016/j.cmet.2009.12.005; Magenheim J, 2011, DEV BIOL, V359, P26, DOI 10.1016/j.ydbio.2011.08.006; Nakamura K, 2011, BIOMED RES-TOKYO, V32, P167, DOI 10.2220/biomedres.32.167; Nishimura W, 2009, DEV BIOL, V333, P108, DOI 10.1016/j.ydbio.2009.06.029; Nishimura W, 2006, DEV BIOL, V293, P526, DOI 10.1016/j.ydbio.2006.02.028; Pan FC, 2011, DEV DYNAM, V240, P530, DOI 10.1002/dvdy.22584; PANG K, 1994, P NATL ACAD SCI USA, V91, P9559, DOI 10.1073/pnas.91.20.9559; Solar M, 2009, DEV CELL, V17, P849, DOI 10.1016/j.devcel.2009.11.003; Stanger BZ, 2007, NATURE, V445, P886, DOI 10.1038/nature05537; Wang GS, 2005, LAB INVEST, V85, P675, DOI 10.1038/labinvest.3700259; Wang S, 2010, DEV BIOL, V339, P26, DOI 10.1016/j.ydbio.2009.12.009; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Zhou Q, 2007, DEV CELL, V13, P103, DOI 10.1016/j.devcel.2007.06.001	33	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142286	10.1371/journal.pone.0142286	http://dx.doi.org/10.1371/journal.pone.0142286			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540252	Green Published, gold			2022-12-26	WOS:000364303800075
J	Akhtar, S; Chandrasekhar, B; Attur, S; Dhaunsi, GS; Yousif, MHM; Benter, IF				Akhtar, Saghir; Chandrasekhar, Bindu; Attur, Sreeja; Dhaunsi, Gursev S.; Yousif, Mariam H. M.; Benter, Ibrahim F.			Transactivation of ErbB Family of Receptor Tyrosine Kinases Is Inhibited by Angiotensin-(1-7) via Its Mas Receptor	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; VASCULAR DYSFUNCTION; DIABETIC COMPLICATIONS; DEPENDENT PATHWAY; PATHOPHYSIOLOGY; MECHANISMS; SYSTEM; CANCER; EGFR; RATS	Transactivation of the epidermal growth factor receptor (EGFR or ErbB) family members, namely EGFR and ErbB2, appears important in the development of diabetes-induced vascular dysfunction. Angiotensin-(1-7) [Ang-(1-7)] can prevent the development of hyperglycemia-induced vascular complications partly through inhibiting EGFR transactivation. Here, we investigated whether Ang-(1-7) can inhibit transactivation of ErbB2 as well as other ErbB receptors in vivo and in vitro. Streptozotocin-induced diabetic rats were chronically treated with Ang-(1-7) or AG825, a selective ErbB2 inhibitor, for 4 weeks and mechanistic studies performed in the isolated mesenteric vasculature bed as well as in cultured vascular smooth muscle cells (VSMCs). Ang-(1-7) or AG825 treatment inhibited diabetes-induced phosphorylation of ErbB2 receptor at tyrosine residues Y1221/22, Y1248, Y877, as well as downstream signaling via ERK1/2, p38 MAPK, ROCK, eNOS and IkB-alpha in the mesenteric vascular bed. In VSMCs cultured in high glucose (25 mM), Ang-(1-7) inhibited src-dependent ErbB2 transactivation that was opposed by the selective Mas receptor antagonist, D-Pro(7)-Ang-(1-7). Ang-(1-7) via Mas receptor also inhibited both Angiotensin II- and noradrenaline/norephinephrine-induced transactivation of ErbB2 and/or EGFR receptors. Further, hyperglycemia-induced transactivation of ErbB3 and ErbB4 receptors could be attenuated by Ang-(1-7) that could be prevented by D-Pro(7)-Ang-(1-7) in VSMC. These data suggest that Ang-(1-7) via its Mas receptor acts as a pan-ErbB inhibitor and might represent a novel general mechanism by which Ang-(1-7) exerts its beneficial effects in many disease states including diabetes-induced vascular complications.	[Akhtar, Saghir; Chandrasekhar, Bindu; Attur, Sreeja; Yousif, Mariam H. M.; Benter, Ibrahim F.] Kuwait Univ, Dept Pharmacol & Toxicol, Fac Med, Safat 13110, Kuwait; [Dhaunsi, Gursev S.] Kuwait Univ, Dept Pediat, Fac Med, Safat 13110, Kuwait	Kuwait University; Kuwait University	Akhtar, S (corresponding author), Kuwait Univ, Dept Pharmacol & Toxicol, Fac Med, Safat 13110, Kuwait.	Saghir@hsc.edu.kw	Benter, Ibrahim Fadil/AAY-2527-2020	Yousif, Mariam/0000-0002-6464-031X; Akhtar, Saghir/0000-0003-3177-946X	Kuwait University Research Sector/Administration [MR 05/09]; OMICS Research Unit/RCF; General Facility Grant [SRUL02/13]	Kuwait University Research Sector/Administration; OMICS Research Unit/RCF; General Facility Grant	This study was supported by a grant from Kuwait University Research Sector/Administration (Project number MR 05/09). The authors also acknowledge support from the OMICS Research Unit/RCF and the General Facility Grant (SRUL02/13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067813; Akhtar S, 2013, BIOIMPACTS, V3, P5, DOI 10.5681/bi.2013.008; Akhtar S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039066; Akhtar S, 2012, BRIT J PHARMACOL, V165, P1390, DOI 10.1111/j.1476-5381.2011.01613.x; Al-Maghrebi M, 2009, PHARMACOL RES, V59, P263, DOI 10.1016/j.phrs.2008.12.008; Belmadani S, 2008, DIABETES, V57, P1629, DOI 10.2337/db07-0739; Beltowski J, 2014, CURR PHARM DESIGN, V20, P616, DOI 10.2174/138161282004140213155050; Benter IF, 2007, AM J PHYSIOL-HEART C, V292, pH666, DOI 10.1152/ajpheart.00372.2006; Benter IF, 2015, J DRUG TARGET, V23, P506, DOI 10.3109/1061186X.2015.1057150; Benter IF, 2011, J CARDIOVASC PHARM, V57, P559, DOI 10.1097/FJC.0b013e31821324b6; Benter IF, 2009, VASC PHARMACOL, V51, P236, DOI 10.1016/j.vph.2009.06.008; Benter IF, 2005, J VASC RES, V42, P284, DOI 10.1159/000085904; Benter IF, 2005, BRIT J PHARMACOL, V145, P829, DOI 10.1038/sj.bjp.0706238; BENTER IF, 1995, AM J PHYSIOL-HEART C, V269, pH313, DOI 10.1152/ajpheart.1995.269.1.H313; BENTER IF, 1993, PEPTIDES, V14, P679, DOI 10.1016/0196-9781(93)90097-Z; Cabello-Verrugio C, 2015, MED RES REV, V35, P437, DOI 10.1002/med.21343; Cao X, 2014, MOL CELL ENDOCRINOL, V393, P30, DOI 10.1016/j.mce.2014.05.024; Chappell M. C., 2014, FRONT ENDOCRINOL, V4, P1, DOI DOI 10.3389/FEND0.2013.00201; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Costa A, 2014, NITRIC OXIDE-BIOL CH, V37, P11, DOI 10.1016/j.niox.2013.12.007; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; El-Hashim AZ, 2012, BRIT J PHARMACOL, V166, P1964, DOI [10.1111/i.1476-5381.2012.01905.x, DOI 10.1111/J.1476-5381.2012.01905.X]; Forbes JM, 2013, PHYSIOL REV, V93, P137, DOI 10.1152/physrev.00045.2011; Fu Z, 2014, HYPERTENSION, V63, P1219, DOI 10.1161/HYPERTENSIONAHA.113.03025; Galan M, 2012, HYPERTENSION, V60, P71, DOI 10.1161/HYPERTENSIONAHA.112.192500; Gallagher PE, 2014, CURR MED CHEM, V21, P2417, DOI 10.2174/0929867321666140205133357; Garcia-Foncillas J, 2015, ORAL ONCOL, DOI [10.1016/j.oraloncology.2015.02.092, DOI 10.1016/J.0RAL0NC0L0GY.2015.02.092]; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Gray SP, 2014, J MOL MED, V92, P441, DOI 10.1007/s00109-014-1146-1; Higuchi S, 2007, CLIN SCI, V112, P417, DOI 10.1042/CS20060342; Jiang T, 2014, BRIT J PHARMACOL, V171, P4222, DOI 10.1111/bph.12770; Li YC, 2015, SCI REP-UK, V5, DOI 10.1038/srep08209; Liebmann C, 2011, MOL CELL ENDOCRINOL, V331, P222, DOI 10.1016/j.mce.2010.04.008; Matrougui K, 2010, DIABETES-METAB RES, V26, P13, DOI 10.1002/dmrr.1050; McKinney CA, 2014, CLIN SCI, V126, P815, DOI 10.1042/CS20130436; Patel VB, 2014, CLIN SCI, V126, P471, DOI 10.1042/CS20130344; Pernomian L, 2014, VASA, V43, P404, DOI 10.1024/0301-1526/a000387; Price KAR, 2015, ORAL ONCOL, V51, P399, DOI 10.1016/j.oraloncology.2015.01.018; Roskoski R, 2014, PHARMACOL RES, V79, P34, DOI 10.1016/j.phrs.2013.11.002; Sampaio WO, 2007, HYPERTENSION, V49, P185, DOI 10.1161/01.HYP.0000251865.35728.2f; Souza LL, 2012, J CELL PHYSIOL, V227, P2117, DOI 10.1002/jcp.22940; Sur S, 2014, CURR VASC PHARMACOL, V12, P190, DOI 10.2174/1570161112666140226123745; Tao XL, 2014, BIOL CELL, V106, P182, DOI 10.1111/boc.201400015; te Riet L, 2015, CIRC RES, V116, P960, DOI 10.1161/CIRCRESAHA.116.303587; Ulu N, 2010, BRIT J PHARMACOL, V161, P1301, DOI 10.1111/j.1476-5381.2010.00829.x; Wang XC, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00002; Yousif M. H. M., 2005, Autonomic & Autacoid Pharmacology, V25, P69, DOI 10.1111/j.1474-8673.2004.00333.x; Yousif MH, 2014, J DIABETES RES, V2014, DOI DOI 10.1155/2014/142154	48	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141657	10.1371/journal.pone.0141657	http://dx.doi.org/10.1371/journal.pone.0141657			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536590	Green Published, gold, Green Submitted			2022-12-26	WOS:000364298400074
J	Helmy, MM; Helmy, MW; El-Mas, MM				Helmy, Mai M.; Helmy, Maged W.; El-Mas, Mahmoud M.			Additive Renoprotection by Pioglitazone and Fenofibrate against Inflammatory, Oxidative and Apoptotic Manifestations of Cisplatin Nephrotoxicity: Modulation by PPARs	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ACUTE-RENAL-FAILURE; GAMMA AGONIST; IN-VITRO; ALPHA; EXPRESSION; PROTECTS; INJURY; CELL; CYCLOSPORINE	Nephrotoxicity is a major side effect for the antineoplastic drug cisplatin. Here, we employed pharmacological, biochemical, and molecular studies to investigate the role of peroxisome proliferator-activated receptors (PPARs) in cisplatin nephrotoxicity. Rats were treated with a single i.p. dose of cisplatin (5 mg/kg) alone or combined with pioglitazone (PPAR gamma agonist), fenofibrate (PPAR alpha agonist), pioglitazone plus fenofibrate, or thalidomide (Tumor necrosis factor-a inhibitor; TNF-alpha). Cisplatin nephrotoxicity was evidenced by rises in renal indices of functional (blood urea nitrogen, BUN, and creatinine), inflammatory (TNF-alpha, interleukin 6, IL-6), oxidative (increased malondialdehyde, MDA, and decreased superoxide dismutase, SOD and nitric oxide metabolites, NOx), apoptotic (caspase 3), and histological (glomerular atrophy, acute tubular necrosis and vacuolation) profiles. Cisplatin effects were partly abolished upon concurrent exposure to pioglitazone, fenofibrate, or thalidomide; more renoprotection was observed in rats treated with pioglitazaone plus fenofibrate. Immunostaining showed that renal expressions of PPAR alpha and PPAR gamma were reduced by cisplatin and restored to vehicle-treated values after simultaneous treatment with pioglitazone or fenofibrate. Fenofibrate or pioglitazone renoprotection remained unaltered after concurrent blockade of PPAR alpha (GW6471) and PPAR gamma (GW9662), respectively. To complement the rat studies, we also report that in human embryonic kidney cells (HEK293 cells), increases caused by cisplatin in inflammatory, apoptotic, and oxidative biomarkers were (i) partly improved after exposure to pioglitazone, fenofibrate, or thalidomide, and (ii) completely disappeared in cells treated with a combination of all three drugs. These data establish that the combined use of pioglitazone and fenofibrate additively improved manifestations of cisplatin nephrotoxicity through perhaps GW6471/GW9662-insensitive mechanisms.	[Helmy, Mai M.; El-Mas, Mahmoud M.] Univ Alexandria, Pharmacol & Toxicol, Fac Pharm, Alexandria, Egypt; [Helmy, Maged W.] Damanhour Univ, Pharmacol & Toxicol, Fac Pharm, Damanhour, Egypt	Egyptian Knowledge Bank (EKB); Alexandria University; Egyptian Knowledge Bank (EKB); Damanhour University	El-Mas, MM (corresponding author), Univ Alexandria, Pharmacol & Toxicol, Fac Pharm, Alexandria, Egypt.	mahelm@hotmail.com	El-Mas, Mahmoud M./B-9047-2009; Helmy, Maged/AFU-2420-2022	El-Mas, Mahmoud M./0000-0001-8855-7070; Helmy, Maged/0000-0003-0375-6762				Ahmed LA, 2014, SCI WORLD J, DOI 10.1155/2014/273870; Amirshahrokhi K, 2015, INFLAMMATION, V38, P476, DOI 10.1007/s10753-014-9953-7; Barbiero JK, 2014, PROG NEURO-PSYCHOPH, V53, P35, DOI 10.1016/j.pnpbp.2014.02.009; Brautigam K, 2011, J CANCER RES CLIN, V137, P875, DOI 10.1007/s00432-010-0952-2; Chatterjee PK, 2000, KIDNEY INT, V58, P658, DOI 10.1046/j.1523-1755.2000.00212.x; Cheng Ching-Feng, 2010, PPAR Res, V2010, P345098, DOI 10.1155/2010/345098; Choi JI, 2010, KOREAN J PAIN, V23, P172, DOI 10.3344/kjp.2010.23.3.172; Chung BH, 2005, NEPHROLOGY, V10, pS40, DOI 10.1111/j.1440-1797.2005.00456.x; Ciarimboli G, 2005, AM J PATHOL, V167, P1477, DOI 10.1016/S0002-9440(10)61234-5; El-Gowelli HM, 2014, TOXICOL APPL PHARM, V275, P88, DOI 10.1016/j.taap.2014.01.008; El-Gowelli HM, 2011, J CARDIOVASC PHARM, V58, P173, DOI 10.1097/FJC.0b013e31821ed803; El-Mas MM, 2008, J PHARMACOL EXP THER, V324, P368, DOI 10.1124/jpet.107.127498; El-Mas MM, 2015, TOXICOL APPL PHARM, V284, P1, DOI 10.1016/j.taap.2015.01.018; El-Mas MM, 2011, BIOCHEM PHARMACOL, V81, P526, DOI 10.1016/j.bcp.2010.11.013; El-Mas MM, 2009, ALCOHOL CLIN EXP RES, V33, P1158, DOI 10.1111/j.1530-0277.2009.00939.x; Fram Robert J., 1992, Current Opinion in Oncology, V4, P1073, DOI 10.1097/00001622-199212000-00012; Ghavimi H, 2015, DRUG RES, V65, P113, DOI 10.1055/s-0033-1364035; Glineur C, 2013, ARTERIOSCL THROM VAS, V33, P621, DOI 10.1161/ATVBAHA.112.300665; Goyal SN, 2011, DIABETES OBES METAB, V13, P533, DOI 10.1111/j.1463-1326.2011.01377.x; Guan YF, 2001, KIDNEY INT, V60, P14, DOI 10.1046/j.1523-1755.2001.00766.x; Guevara I, 1998, CLIN CHIM ACTA, V274, P177, DOI 10.1016/S0009-8981(98)00060-6; Helmy MW, 2014, J PHYSIOL PHARMACOL, V65, P393; Helmy MM, 2014, EUR J PHARMACOL, V730, P133, DOI 10.1016/j.ejphar.2014.03.002; Helmy MM, 2012, EUR J PHARMACOL, V683, P294, DOI 10.1016/j.ejphar.2012.03.018; Helmy MW, 2015, BR J PHARM IN PRESS; Ibrahim MA, 2014, IMMUNOPHARM IMMUNOT, V36, P130, DOI 10.3109/08923973.2014.884135; Israili ZH, 2011, AM J THER, V18, P117, DOI 10.1097/MJT.0b013e3181afbf51; Jesse CR, 2014, J APPL TOXICOL, V34, P25, DOI 10.1002/jat.2818; Johnson SA, 2015, AM J PHYSIOL-RENAL, V309, pE807, DOI 10.1152/ajprenal.00266.2015; Kadian S, 2013, EUR J PHARMACOL, V698, P388, DOI 10.1016/j.ejphar.2012.10.012; Kapoor A, 2010, SHOCK, V34, P117, DOI 10.1097/SHK.0b013e3181cd86d6; Kim CS, 2012, REGUL PEPTIDES, V174, P65, DOI 10.1016/j.regpep.2011.12.001; Kitazumi I, 2011, FEBS J, V278, P427, DOI 10.1111/j.1742-4658.2010.07975.x; Kuru Karabas Munire, 2013, ISRN Endocrinol, V2013, P858690, DOI 10.1155/2013/858690; Li LY, 2010, EXP BIOL MED, V235, P383, DOI 10.1258/ebm.2009.009218; Li SY, 2004, AM J PHYSIOL-RENAL, V287, pF990, DOI 10.1152/ajprenal.00206.2004; Mahmoud MF, 2013, FOOD CHEM TOXICOL, V51, P114, DOI 10.1016/j.fct.2012.09.006; Mao ZG, 2009, NEPHRON CLIN PRACT, V112, pC230, DOI 10.1159/000224789; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; McKinnon B, 2012, FERTIL STERIL, V97, P657, DOI 10.1016/j.fertnstert.2011.12.001; Mulay V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062667; Nasr MA, 2010, VASC PHARMACOL, V53, P53, DOI 10.1016/j.vph.2010.03.006; Oliveira ACP, 2007, EUR J PHARMACOL, V561, P194, DOI 10.1016/j.ejphar.2006.12.026; Orasanu G, 2008, J AM COLL CARDIOL, V52, P869, DOI 10.1016/j.jacc.2008.04.055; Portilla D, 2000, AM J PHYSIOL-RENAL, V278, pF667, DOI 10.1152/ajprenal.2000.278.4.F667; Ramesh G, 2004, KIDNEY INT, V65, P490, DOI 10.1111/j.1523-1755.2004.00413.x; Ramesh G, 2002, J CLIN INVEST, V110, P835, DOI 10.1172/JCI200215606; Ray DM, 2006, BIODRUGS, V20, P231, DOI 10.2165/00063030-200620040-00004; Robinson E, 2009, PHARMACOL THERAPEUT, V122, P246, DOI 10.1016/j.pharmthera.2009.03.003; Roca H, 2009, NEOPLASIA, V11, P1309, DOI 10.1593/neo.09936; Saad SY, 2002, CHEMOTHERAPY, V48, P309, DOI 10.1159/000069714; Sahu BD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105070; Sahu BD, 2013, PHYTOMEDICINE, V20, P453, DOI 10.1016/j.phymed.2012.12.001; Saleh S, 2005, BASIC CLIN PHARMACOL, V97, P91, DOI 10.1111/j.1742-7843.2005.pto_114.x; Sarafidis PA, 2006, KIDNEY INT, V70, P1223, DOI 10.1038/sj.ki.5001620; Sato K, 2004, HYPERTENS RES, V27, P417, DOI 10.1291/hypres.27.417; Schrier RW, 2002, J CLIN INVEST, V110, P743, DOI 10.1172/JCI200216568; Shafique E, 2015, FASEB J, V29; Sohn SH, 2010, BRIT J CLIN PHARMACO, V70, P547, DOI 10.1111/j.1365-2125.2010.03724.x; Ueki M, 2013, J BIOSCI BIOENG, V115, P547, DOI 10.1016/j.jbiosc.2012.11.007; Vasvari GP, 2007, INT J CANCER, V121, P1697, DOI 10.1002/ijc.22867; Yamasaki D, 2011, EUR J CELL BIOL, V90, P657, DOI 10.1016/j.ejcb.2011.02.005; Yao X, 2007, AM J MED SCI, V334, P115, DOI 10.1097/MAJ.0b013e31812dfe1e	63	33	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142303	10.1371/journal.pone.0142303	http://dx.doi.org/10.1371/journal.pone.0142303			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536032	Green Published, Green Submitted, gold			2022-12-26	WOS:000364298400150
J	Mario, JT; Fujioka, K; Ikenaka, Y; Nakayama, SMM; Mizukawa, H; Aoyama, Y; Ishizuka, M; Taira, K				Mario, Jemima Tiwaa; Fujioka, Kazutoshi; Ikenaka, Yoshinori; Nakayama, Shouta M. M.; Mizukawa, Hazuki; Aoyama, Yoshiko; Ishizuka, Mayumi; Taira, Kumiko			Relationship between Urinary N-Desmethyl-Acetamiprid and Typical Symptoms including Neurological Findings: A Prevalence Case-Control Study	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; CHRONIC KIDNEY-DISEASE; NEONICOTINOID INSECTICIDES; MYASTHENIA-GRAVIS; CLOTHIANIDIN; EXPOSURE; THIAMETHOXAM; EXPRESSION; UNIQUE	Neonicotinoid insecticides are nicotinic acetylcholine receptor agonists used worldwide. Their environmental health effects including neurotoxicity are of concern. We previously determined a metabolite of acetamiprid, N-desmethyl-acetamiprid in the urine of a patient, who exhibited some typical symptoms including neurological findings. We sought to investigate the association between urinary N-desmethyl-acetamiprid and the symptoms by a prevalence case-control study. Spot urine samples were collected from 35 symptomatic patients of unknown origin and 50 non-symptomatic volunteers (non-symptomatic group, NSG, 4-87 year-old). Patients with recent memory loss, finger tremor, and more than five of six symptoms (headache, general fatigue, palpitation/chest pain, abdominal pain, muscle pain/weakness/spasm, and cough) were in the typical symptomatic group (TSG, n = 19, 5-69 year-old); the rest were in the atypical symptomatic group (ASG, n = 16, 5-78 year-old). N-desmethyl-acetamiprid and six neonicotinoids in the urine were quantified by liquid chromatography-tandem mass spectrometry. The detection of N-desmethyl-acetamiprid was the most frequent and highest in TSG (47.4%, 6.0 ppb (frequency, maximum)), followed by in ASG (12.5%, 4.4 ppb) and in NSG (6.0%, 2.2 ppb), however acetamiprid was not detected. Thiamethoxam was detected in TSG (31.6%, 1.4 ppb), in ASG (6.3%, 1.9 ppb), but not in NSG. Nitenpyram was detected in TSG (10.5%, 1.2 ppb), in ASG (6.3%, not quantified) and in NSG (2.0%, not quantified). Clothianidin was only detected in ASG (6.3%, not quantified), and in NSG (2.0%, 1.6 ppb). Thiacloprid was detected in ASG (6.3%, 0.1 ppb). The cases in TSG with detection of N-desmethyl-acetamiprid and thiamethoxam were aged 5 to 62 years and 13 to 62 years, respectively. Detection of N-desmethyl-acetamiprid was associated with increased prevalence of the symptoms (odds ratio: 14, 95% confidence interval: 3.5-57). Urinary N-desmethyl-acetamiprid can be used as a biomarker for environmental exposure to acetamiprid. Further multi-centered clinical research in larger patients groups with more metabolites analysis is needed.	[Mario, Jemima Tiwaa; Ikenaka, Yoshinori; Nakayama, Shouta M. M.; Ishizuka, Mayumi] Hokkaido Univ, Toxicol Lab, Dept Environm Vet Sci, Fac Vet Med, Sapporo, Hokkaido 060, Japan; [Fujioka, Kazutoshi] Hawaii Inst Mol Educ, Honolulu, HI USA; [Ikenaka, Yoshinori] North West Univ, Sch Environm Sci & Dev, Water Res Grp, Potchefstroom, South Africa; [Mizukawa, Hazuki] Hokkaido Univ, Fac Vet Med, Dept Environm Vet Sci, Sapporo, Hokkaido 060, Japan; [Aoyama, Yoshiko] Aoyama Allergy Clin, Gunma, Japan; [Taira, Kumiko] Tokyo Womens Med Univ Med Ctr East, Dept Anesthesiol, Tokyo, Japan	Hokkaido University; North West University - South Africa; Hokkaido University	Taira, K (corresponding author), Tokyo Womens Med Univ Med Ctr East, Dept Anesthesiol, Tokyo, Japan.	VFG03077@nifty.com	IKENAKA, Yoshinori/F-8529-2012	Ikenaka, Yoshinori/0000-0002-6633-6637	Japan Endocrine-disruptor Preventive Action; Yamada Research Grant [182]; Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [26304043, 15K00559]	Japan Endocrine-disruptor Preventive Action; Yamada Research Grant; Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study is partially supported by the Japan Endocrine-disruptor Preventive Action awarded to Dr. K. Taira, Yamada Research Grant awarded to Dr. K. Taira (No. 182), and Grants-in-Aid for Scientific Research from Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) awarded to Dr. Y. Ikenaka (No. 26304043) and Dr. K. Taira (No. 15K00559). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Agha A, 2012, SAUDI J KIDNEY DIS T, V23, P1300, DOI 10.4103/1319-2442.103584; Akiyama Y, 2011, J PESTIC SCI, V36, P66, DOI 10.1584/jpestics.G10-63; [Anonymous], 2002, FACTSH AC, P4; Bednarska AJ, 2013, ECOTOXICOLOGY, V22, P548, DOI 10.1007/s10646-013-1047-z; Bonmatin JM, 2015, ENVIRON SCI POLLUT R, V22, P35, DOI 10.1007/s11356-014-3332-7; Brunet JL, 2008, J ENVIRON SCI HEAL B, V43, P261, DOI 10.1080/03601230701771446; Chagnon M, 2015, ENVIRON SCI POLLUT R, V22, P119, DOI 10.1007/s11356-014-3277-x; Dempsey DA, 2013, CLIN PHARMACOL THER, V94, P400, DOI 10.1038/clpt.2013.114; Di Prisco G, 2013, P NATL ACAD SCI USA, V110, P18466, DOI 10.1073/pnas.1314923110; Ding F, 2015, J PHOTOCH PHOTOBIO B, V147, P24, DOI 10.1016/j.jphotobiol.2015.03.010; Ford KA, 2006, CHEM RES TOXICOL, V19, P1549, DOI 10.1021/tx0601859; Ford KA, 2006, CHEM RES TOXICOL, V19, P944, DOI 10.1021/tx0600696; Grando SA, 2007, LIFE SCI, V80, P2181, DOI 10.1016/j.lfs.2007.03.015; Intrenational Programme on Chemical Safety, 1994, ENV HLTH CRIT; IUPAC, 1976, PURE APPL CHEM, V45, P99, DOI DOI 10.1351/PAC197645020099; Jayasumana C, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/1476-069X-14-6; Jeschke P, 2011, J AGR FOOD CHEM, V59, P2897, DOI 10.1021/jf101303g; Kimura-Kuroda J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032432; Li P, 2011, J NEUROSCI RES, V89, P1295, DOI 10.1002/jnr.22644; Lips KS, 2005, PLACENTA, V26, P735, DOI 10.1016/j.placenta.2004.10.009; MacGregor DA, 2000, ANESTHESIOLOGY, V92, P338, DOI 10.1097/00000542-200002000-00013; Matsui N, 2009, J NEUROL NEUROSUR PS, V80, P1168, DOI 10.1136/jnnp.2008.152637; Mesnage R, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/179691; Metruccio F, 2010, CLOTHIANIDIN, P20; Mommaerts V, 2010, ECOTOXICOLOGY, V19, P207, DOI 10.1007/s10646-009-0406-2; MUSHA M, 1993, TOHOKU J EXP MED, V169, P335, DOI 10.1620/tjem.169.335; Nakane S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118312; Nakanishi R, 2013, ANN REP KYOTO PREFEC, V58, P29; National Pesticide Information Center, IM TECHN FACT SHEET; Phua DH, 2009, CLIN TOXICOL, V47, P336, DOI 10.1080/15563650802644533; [Plant Products Safety Division & Plant Protection Division Food Safety and Consumer Affairs Bureau Ministry of Agriculture Firestry and Fisheries], 2013, NOYAK YOR 2012; Renaud HJ, 2011, TOXICOL SCI, V124, P261, DOI 10.1093/toxsci/kfr240; Rezonzew G, 2012, AM J PHYSIOL-RENAL, V303, pF304, DOI 10.1152/ajprenal.00661.2011; Rueter LE, 2004, CNS DRUG REV, V10, P167; Shi XY, 2009, J AGR FOOD CHEM, V57, P4861, DOI 10.1021/jf900250f; Simon-Delso N, 2015, ENVIRON SCI POLLUT R, V22, P5, DOI 10.1007/s11356-014-3470-y; Taira K, 2011, JPN CHUDOKU KENKYU, V24, P222; Taira K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080332; Todani Masaki, 2008, Chudoku Kenkyu, V21, P387; Tomizawa M, 2000, TOXICOL APPL PHARM, V169, P114, DOI 10.1006/taap.2000.9057; Tomizawa M, 2005, ANNU REV PHARMACOL, V45, P247, DOI 10.1146/annurev.pharmtox.45.120403.095930; Tomizawa M, 2000, J AGR FOOD CHEM, V48, P6016, DOI 10.1021/jf000873c; Uchida K, 2002, CLIN CHIM ACTA, V323, P121, DOI 10.1016/S0009-8981(02)00177-8; Ueyama J, 2014, J OCCUP HLTH; US Environmental Protection Agency (USEPA) Factsheet-clothianidin, 2003, FACTSH CLOTH, P12; US Environmental Protection Agency (USEPA) Factsheet-dinotefuran, 2004, FACTSH DIN, P2; US Environmental Protection Agency (USEPA) Factsheet-thiacloprid, 2003, FACTSH THIACL, P7; Vila R, 2004, J BIOL CHEM, V279, P8668, DOI 10.1074/jbc.M308137200; Yamamoto A, 2012, J ENVIRON MONITOR, V14, P2189, DOI 10.1039/c2em30296a	49	53	56	10	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142172	10.1371/journal.pone.0142172	http://dx.doi.org/10.1371/journal.pone.0142172			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26535579	Green Submitted, gold, Green Published			2022-12-26	WOS:000364298400139
J	Sekimura, T; Venkataraman, C; Madzvamuse, A				Sekimura, Toshio; Venkataraman, Chandrasekhar; Madzvamuse, Anotida			A Model for Selection of Eyespots on Butterfly Wings	PLOS ONE			English	Article							BIOLOGICAL PATTERN-FORMATION; TURING SYSTEMS; EVOLUTION; GENES	Unsolved Problem The development of eyespots on the wing surface of butterflies of the family Nympalidae is one of the most studied examples of biological pattern formation. However, little is known about the mechanism that determines the number and precise locations of eyespots on the wing. Eyespots develop around signaling centers, called foci, that are located equidistant from wing veins along the midline of a wing cell (an area bounded by veins). A fundamental question that remains unsolved is, why a certain wing cell develops an eyespot, while other wing cells do not. Key Idea and Model We illustrate that the key to understanding focus point selection may be in the venation system of the wing disc. Our main hypothesis is that changes in morphogen concentration along the proximal boundary veins of wing cells govern focus point selection. Based on previous studies, we focus on a spatially two-dimensional reaction-diffusion system model posed in the interior of each wing cell that describes the formation of focus points. Using finite element based numerical simulations, we demonstrate that variation in the proximal boundary condition is sufficient to robustly select whether an eyespot focus point forms in otherwise identical wing cells. We also illustrate that this behavior is robust to small perturbations in the parameters and geometry and moderate levels of noise. Hence, we suggest that an anterior-posterior pattern of morphogen concentration along the proximal vein may be the main determinant of the distribution of focus points on the wing surface. In order to complete our model, we propose a two stage reaction-diffusion system model, in which an one-dimensional surface reaction-diffusion system, posed on the proximal vein, generates the morphogen concentrations that act as non-homogeneous Dirichlet (i.e., fixed) boundary conditions for the two-dimensional reaction-diffusion model posed in the wing cells. The two-stage model appears capable of generating focus point distributions observed in nature. Result We therefore conclude that changes in the proximal boundary conditions are sufficient to explain the empirically observed distribution of eyespot focus points on the entire wing surface. The model predicts, subject to experimental verification, that the source strength of the activator at the proximal boundary should be lower in wing cells in which focus points form than in those that lack focus points. The model suggests that the number and locations of eyespot foci on the wing disc could be largely controlled by two kinds of gradients along two different directions, that is, the first one is the gradient in spatially varying parameters such as the reaction rate along the anterior-posterior direction on the proximal boundary of the wing cells, and the second one is the gradient in source values of the activator along the veins in the proximal-distal direction of the wing cell.	[Sekimura, Toshio] Chubu Univ, Grad Sch Biosci & Biotechnol, Dept Biol Chem, Kasugai, Aichi 4878501, Japan; [Venkataraman, Chandrasekhar] Univ St Andrews, Sch Math & Stat, St Andrews KY16 9SS, Fife, Scotland; [Madzvamuse, Anotida] Univ Sussex, Dept Math, Falmer BN1 9QH, England	Chubu University; University of St Andrews; University of Sussex	Sekimura, T (corresponding author), Chubu Univ, Grad Sch Biosci & Biotechnol, Dept Biol Chem, Kasugai, Aichi 4878501, Japan.	sekimura@isc.chubu.ac.jp; cv28@st-andrews.ac.uk	Venkataraman, Chandrasekhar/O-3368-2015; Madzvamuse, Anotida/F-9270-2012	Venkataraman, Chandrasekhar/0000-0003-4039-2056; Madzvamuse, Anotida/0000-0002-9511-8903	EPSRC [EP/J016780/1]; Leverhulme Trust [RPG-2014-149]; European Union [642866]; Simons Foundation	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Leverhulme Trust(Leverhulme Trust); European Union(European Commission); Simons Foundation	The authors acknowledge financial support from the EPSRC grant EP/J016780/1. AM and CV acknowledge financial support from the Leverhulme Trust Research Project Grant (RPG-2014-149). This research was started while CV was visiting Japan as a 2013 Japanese Society for the Promotion of Science (JSPS) Summer Fellow (http://www.jsps.go.jp/). This research was finalized whilst TS, CV and AM were participants in the Isaac Newton Institute Program, Coupling Geometric PDEs with Physics for Cell Morphology, Motility and Pattern Formation. This work (AM) has received funding from the European Union Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 642866. AM was partially supported by a grant from the Simons Foundation.	Aragon JL, 1998, FORMA, V13, P145; Beldade P, 2002, NATURE, V416, P844, DOI 10.1038/416844a; Benson DL, 1998, J MATH BIOL, V37, P381, DOI 10.1007/s002850050135; Brakefield PM, 1996, NATURE, V384, P236, DOI 10.1038/384236a0; Brunetti CR, 2001, CURR BIOL, V11, P1578, DOI 10.1016/S0960-9822(01)00502-4; CARROLL SB, 1994, SCIENCE, V265, P109, DOI 10.1126/science.7912449; CARROLL SB, 2005, DNA DIVERSITY MOL GE; Dilao R, 2004, P ROY SOC B-BIOL SCI, V271, P1565, DOI 10.1098/rspb.2004.2761; DILLON R, 1994, J MATH BIOL, V32, P345, DOI 10.1007/BF00160165; Evans TM, 2006, EVOL DEV, V8, P273, DOI 10.1111/j.1525-142X.2006.00098.x; GIERER A, 1972, KYBERNETIK, V12, P30, DOI 10.1007/BF00289234; Lakkis O, 2013, SIAM J NUMER ANAL, V51, P2309, DOI 10.1137/120880112; MEINHARDT H, 1989, DEVELOPMENT, V107, P169; Meinhardt H, 2008, CURR TOP DEV BIOL, V81, P1, DOI 10.1016/S0070-2153(07)81001-5; Murray J. D., 2001, MATH BIOL, V18; Nijhout HF, 2003, CR BIOL, V326, P717, DOI 10.1016/j.crvi.2003.08.004; NIJHOUT HF, 1994, SCIENCE, V265, P44, DOI 10.1126/science.7912450; NIJHOUT HF, 1990, PROC R SOC SER B-BIO, V239, P81, DOI 10.1098/rspb.1990.0009; Otaki JM, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-17; Page K, 2003, PHYSICA D, V181, P80, DOI 10.1016/S0167-2789(03)00068-X; Prudic KL, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.1531; Raspopovic J, 2014, SCIENCE, V345, P566, DOI 10.1126/science.1252960; Reed RD, 2007, EVOL DEV, V9, P2, DOI 10.1111/j.1525-142X.2006.00133.x; SCHNAKENBERG J, 1979, J THEOR BIOL, V81, P389, DOI 10.1016/0022-5193(79)90042-0; Sekimura Toshio, 1998, Comments on Theoretical Biology, V5, P69; Sheth R, 2012, SCIENCE, V338, P1476, DOI 10.1126/science.1226804; Shirota Y, KAMEN SEI NO SHINKA, V37; Stevens M, 2005, BIOL REV, V80, P573, DOI 10.1017/S1464793105006810	29	6	6	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141434	10.1371/journal.pone.0141434	http://dx.doi.org/10.1371/journal.pone.0141434			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536487	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000364298400064
J	Shanmuganathan, B; Malar, DS; Sathya, S; Devi, KP				Shanmuganathan, Balakrishnan; Malar, Dicson Sheeja; Sathya, Sethuraman; Devi, Kasi Pandima			Antiaggregation Potential of Padina gymnospora against the Toxic Alzheimer's Beta-Amyloid Peptide(25-35) and Cholinesterase Inhibitory Property of Its Bioactive Compounds	PLOS ONE			English	Article							PRECURSOR PROTEIN; IN-VITRO; BUTYRYLCHOLINESTERASE; AGGREGATION; EXTRACTS; DISEASE	Inhibition of beta-amyloid (A beta) aggregation in the cerebral cortex of the brain is a promising therapeutic and defensive strategy in identification of disease modifying agents for Alzheimer's disease (AD). Since natural products are considered as the current alternative trend for the discovery of AD drugs, the present study aims at the evaluation of anti-amyloidogenic potential of the marine seaweed Padina gymnospora. Prevention of aggregation and disaggregation of the mature fibril formation of A beta(25-35) by acetone extracts of P. gymnospora (ACTPG) was evaluated in two phases by Thioflavin T assay. The results were further confirmed by confocal laser scanning microscopy (CLSM) analysis and Fourier transform infrared (FTIR) spectroscopic analysis. The results of antiaggregation and disaggregation assay showed that the increase in fluorescence intensity of aggregated A beta and the co-treatment of ACTPG (250 mu g/ml) with A beta(25-35), an extensive decrease in the fluorescence intensity was observed in both phases, which suggests that ACTPG prevents the oligomers formation and disaggregation of mature fibrils. In addition, ACTPG was subjected to column chromatography and the bioactivity was screened based on the cholinesterase inhibitory activity. Finally, the active fraction was subjected to LC-MS/MS analysis for the identification of bioactive compounds. Overall, the results suggest that the bioactive compound alpha bisabolol present in the alga might be responsible for the observed cholinesterase inhibition with the IC50 value < 10 mu g/ml for both AChE and BuChE when compared to standard drug donepezil (IC50 value < 6 mu g/ml) and support its use for the treatment of neurological disorders.	[Shanmuganathan, Balakrishnan; Malar, Dicson Sheeja; Sathya, Sethuraman; Devi, Kasi Pandima] Alagappa Univ, Dept Biotechnol, Karaikkudi 630004, Tamil Nadu, India	Alagappa University	Devi, KP (corresponding author), Alagappa Univ, Dept Biotechnol, Sci Campus, Karaikkudi 630004, Tamil Nadu, India.	devikasi@yahoo.com	Devi, Kasi Pandima/J-9172-2012; Devi, Kasi Pandima/U-9565-2019	Devi, Kasi Pandima/0000-0002-6175-8961; Devi, Kasi Pandima/0000-0002-6175-8961; Sethuraman, Sathya/0000-0002-1819-2798; , Dicson Sheeja Malar/0000-0003-4253-9496	Department of Science and Technology, Government of India (DST) [SR/S0/AS-22/2012]; Bioinformatics Infrastructure Facility, Alagappa University - Department of Biotechnology, Ministry of Science and Technology, Government of India [BT/BI/25/015/2012]; DST	Department of Science and Technology, Government of India (DST)(Department of Science & Technology (India)); Bioinformatics Infrastructure Facility, Alagappa University - Department of Biotechnology, Ministry of Science and Technology, Government of India; DST(Department of Science & Technology (India))	This work was supported by Department of Science and Technology, Government of India through Major Research Grant (DST No: SR/S0/AS-22/2012, http://www.dst.gov.in/), Bioinformatics Infrastructure Facility, Alagappa University funded by the Department of Biotechnology, Ministry of Science and Technology, Government of India (No. BT/BI/25/015/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; KPD wishes to thank DST, India, for offering Major Research Grant (DST No: SR/S0/AS-22/2012). BS wishes to thank DST for providing fellowship in the form of project fellow. The authors also gratefully acknowledge the use of the Bioinformatics Infrastructure Facility, Alagappa University funded by the Department of Biotechnology, Ministry of Science and Technology, Government of India (No. BT/BI/25/015/2012).	Arendash GW, 2010, J ALZHEIMERS DIS, V20, pS117, DOI 10.3233/JAD-2010-091249; Chander M. P., 2014, International Journal of Current Microbiology and Applied Sciences, V3, P364; Choi EY, 2009, FOOD CHEM TOXICOL, V47, P134, DOI 10.1016/j.fct.2008.10.026; CUMMINGS BJ, 1995, LANCET, V346, P1524, DOI 10.1016/S0140-6736(95)92053-6; Durairajan SSK, 2008, NEUROCHEM INT, V52, P741, DOI 10.1016/j.neuint.2007.09.006; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Fujiwara H, 2009, J NEUROCHEM, V109, P1648, DOI 10.1111/j.1471-4159.2009.06069.x; Galimberti Daniela, 2011, Ther Adv Neurol Disord, V4, P203, DOI 10.1177/1756285611404470; Ghahremanitamadon F, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/798535; HAASS C, 1993, ANN NY ACAD SCI, V695, P109, DOI 10.1111/j.1749-6632.1993.tb23037.x; Hipkiss AR, 2007, J ALZHEIMERS DIS, V11, P229; Ittner LM, 2011, NAT REV NEUROSCI, V12, P67, DOI 10.1038/nrn2967; Joshi NVM., 2012, INT J BIO PHAR RES, V3, P956; Kamatou GPP, 2010, J AM OIL CHEM SOC, V87, P1, DOI 10.1007/s11746-009-1483-3; Kayalvizhi K., 2012, INT J PHARM APPL, V3, P306; Krishnamurthy V, 1970, CHECK LIST INDIAN MA, P1; Liu QA, 2011, NEUROCHEM INT, V58, P119, DOI 10.1016/j.neuint.2010.11.004; Mathew M, 2014, INDIAN J EXP BIOL, V52, P606; Mesulam MM, 2002, NEUROSCIENCE, V110, P627, DOI 10.1016/S0306-4522(01)00613-3; Munoz-Ruiz P, 2005, J MED CHEM, V48, P7223, DOI 10.1021/jm0503289; Murugan K, 2014, INDIAN J PHARM SCI, V76, P548; Nielson KA, 1996, BRAIN RES, V741, P284, DOI 10.1016/S0006-8993(96)00983-3; Oza RM, 2003, REVISED CHECKLIST IN, P1; PIKE CJ, 1995, J NEUROCHEM, V64, P253, DOI 10.1046/j.1471-4159.1995.64010253.x; Pryor NE, 2012, INT J MOL SCI, V13, P3038, DOI 10.3390/ijms13033038; Ramesh BN, 2010, NEUROSCI LETT, V475, P110, DOI 10.1016/j.neulet.2010.03.062; RATNASOORIYA WD, 1994, CONTRACEPTION, V50, P291, DOI 10.1016/0010-7824(94)90074-4; Rees T, 2003, NEUROBIOL AGING, V24, P777, DOI 10.1016/S0197-4580(02)00230-0; Reid GA, 2015, NEUROSCIENCE, V298, P424, DOI 10.1016/j.neuroscience.2015.04.039; Selkoe DJ, 1998, TRENDS CELL BIOL, V8, P447, DOI 10.1016/S0962-8924(98)01363-4; Sun YD, 2008, BIOORGAN MED CHEM, V16, P7177, DOI 10.1016/j.bmc.2008.06.045; Szabo Z, 1999, BIOCHEM BIOPH RES CO, V265, P297, DOI 10.1006/bbrc.1999.1667; Tamagno E, 2012, IUBMB LIFE, V64, P943, DOI 10.1002/iub.1099; Vauzour D, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/914273; Wu HQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109438; Zubia M, 2007, J APPL PHYCOL, V19, P449, DOI 10.1007/s10811-006-9152-5	36	32	35	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141708	10.1371/journal.pone.0141708	http://dx.doi.org/10.1371/journal.pone.0141708			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536106	Green Submitted, Green Published, gold			2022-12-26	WOS:000364298400079
J	Siah, A; Morrison, DB; Fringuelli, E; Savage, P; Richmond, Z; Johns, R; Purcell, MK; Johnson, SC; Saksida, SM				Siah, Ahmed; Morrison, Diane B.; Fringuelli, Elena; Savage, Paul; Richmond, Zina; Johns, Robert; Purcell, Maureen K.; Johnson, Stewart C.; Saksida, Sonja M.			Piscine Reovirus: Genomic and Molecular Phylogenetic Analysis from Farmed and Wild Salmonids Collected on the Canada/US Pacific Coast	PLOS ONE			English	Article							HEMORRHAGIC-SEPTICEMIA-VIRUS; SKELETAL-MUSCLE INFLAMMATION; HEMATOPOIETIC NECROSIS VIRUS; ATLANTIC SALMON; SOFTWARE PACKAGE; SALAR L.; PRV; BIOLOGY; HEART; SEQUENCES	Piscine reovirus (PRV) is a double stranded non-enveloped RNA virus detected in farmed and wild salmonids. This study examined the phylogenetic relationships among different PRV sequence types present in samples from salmonids in Western Canada and the US, including Alaska (US), British Columbia (Canada) and Washington State (US). Tissues testing positive for PRV were partially sequenced for segment S1, producing 71 sequences that grouped into 10 unique sequence types. Sequence analysis revealed no identifiable geographical or temporal variation among the sequence types. Identical sequence types were found in fish sampled in 2001, 2005 and 2014. In addition, PRV positive samples from fish derived from Alaska, British Columbia and Washington State share identical sequence types. Comparative analysis of the phylogenetic tree indicated that Canada/US Pacific Northwest sequences formed a subgroup with some Norwegian sequence types (group II), distinct from other Norwegian and Chilean sequences (groups I, III and IV). Representative PRV positive samples from farmed and wild fish in British Columbia and Washington State were subjected to genome sequencing using next generation sequencing methods. Individual analysis of each of the 10 partial segments indicated that the Canadian and US PRV sequence types clustered separately from available whole genome sequences of some Norwegian and Chilean sequences for all segments except the segment S4. In summary, PRV was genetically homogenous over a large geographic distance (Alaska to Washington State), and the sequence types were relatively stable over a 13 year period.	[Siah, Ahmed; Richmond, Zina; Johns, Robert; Saksida, Sonja M.] British Columbia Ctr Aquat Hlth Sci, Campbell River, BC, Canada; [Morrison, Diane B.] Marine Harvest Canada, Campbell River, BC, Canada; [Fringuelli, Elena; Savage, Paul] AFBI Stormont, Vet Sci Div, Belfast, Antrim, North Ireland; [Purcell, Maureen K.] US Geol Survey, Western Fisheries Res Ctr, Seattle, WA USA; [Johnson, Stewart C.] Fisheries & Oceans Canada, Pacific Biol Stn, Nanaimo, BC V9T 6N7, Canada	Agri-Food & Biosciences Institute; United States Department of the Interior; United States Geological Survey; Fisheries & Oceans Canada	Siah, A (corresponding author), British Columbia Ctr Aquat Hlth Sci, Campbell River, BC, Canada.	ahmed.siah@cahs-bc.ca	siah, ahmed/P-9359-2015	siah, ahmed/0000-0002-1961-7022; Purcell, Maureen/0000-0003-0154-8433	Marine Harvest Canada	Marine Harvest Canada	This study was funded by Marine Harvest Canada. The funder provided support in the form of salaries for authors (DBM), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Batts WN, 2008, J AQUAT ANIM HEALTH, V20, P215, DOI 10.1577/H07-050.1; Enzmann PJ, 2005, DIS AQUAT ORGAN, V66, P187, DOI 10.3354/dao066187; Ferguson HW, 2005, J FISH DIS, V28, P119, DOI 10.1111/j.1365-2761.2004.00602.x; Finstad OW, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-27; Garseth AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082202; Garseth AH, 2013, PREV VET MED, V112, P138, DOI 10.1016/j.prevetmed.2013.06.007; Garver KA, 2013, DIS AQUAT ORGAN, V104, P93, DOI 10.3354/dao02588; Hedrick RP, 2003, DIS AQUAT ORGAN, V55, P211, DOI 10.3354/dao055211; Key T, 2013, J GEN VIROL, V94, P1039, DOI 10.1099/vir.0.048637-0; Kibenge MJT, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-230; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kongtorp RT, 2004, J FISH DIS, V27, P351, DOI 10.1111/j.1365-2761.2004.00549.x; Kurath G, 2003, J GEN VIROL, V84, P803, DOI 10.1099/vir.0.18771-0; Lovoll M, 2012, DIS AQUAT ORGAN, V99, P7, DOI 10.3354/dao02451; Markussen T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070075; Marty GD, 2015, J FISH DIS, V38, P713, DOI 10.1111/jfd.12285; Nibert ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068607; Palacios G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011487; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sanjuan R, 2010, J VIROL, V84, P9733, DOI 10.1128/JVI.00694-10; Sano T, 1977, Journal Tokyo Univ Fish, V63, P81; Solomon DJ, 1979, COHO SALMON N W EURO, V49; Thompson TM, 2011, DIS AQUAT ORGAN, V96, P29, DOI 10.3354/dao02362; TILLOTSON L, 1992, J VIROL, V66, P2180, DOI 10.1128/JVI.66.4.2180-2186.1992; Wessel O, 2015, VIRUS RES, V198, P22, DOI 10.1016/j.virusres.2015.01.001; Wiik-Nielsen CR, 2012, DIS AQUAT ORGAN, V97, P255, DOI 10.3354/dao02425; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064	28	38	41	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141475	10.1371/journal.pone.0141475	http://dx.doi.org/10.1371/journal.pone.0141475			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536673	Green Published, gold			2022-12-26	WOS:000364298400066
J	Topolovec-Vranic, J; Zhang, S; Wong, H; Lam, E; Jing, RW; Russell, K; Cusimano, MD				Topolovec-Vranic, Jane; Zhang, Stanley; Wong, Hatty; Lam, Emily; Jing, Rowan; Russell, Kelly; Cusimano, Michael D.		Canadian Brain Injury Violence Res	Recognizing the Symptoms of Mental Illness following Concussions in the Sports Community: A Need for Improvement	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; PUBLIC KNOWLEDGE; FOOTBALL PLAYERS; SEX-DIFFERENCES; HEAD-INJURY; POPULATION; PROFESSIONALS; ADOLESCENTS; ENGLAND; RISK	Objective To evaluate the awareness of concussion-related symptoms amongst members of the sports community in Canada. Methods A cross-sectional national electronic survey was conducted. Youth athletes, parents, coaches and medical professionals across Canada were recruited through mailing lists from sports-related opt-in marketing databases. Participants were asked to identify, from a list of options, the symptoms of a concussion. The proportion of identified symptoms (categorized as physical, cognitive, mental health-related and overall) as well as participant factors associated with symptom recognition were analyzed. Results The survey elicited 6,937 responses. Most of the respondents (92.1%) completed the English language survey, were male (57.7%), 35-54 years of age (61.7%), with post-secondary education (58.2%), or high reported yearly household income (>$80,000; 53.0%). There were respondents from all provinces and territories with the majority of respondents from Ontario (35.2%) or British Columbia (19.1%). While participants identified most of the physical (mean = 84.2% of symptoms) and cognitive (mean = 91.2% of symptoms), they on average only identified 53.5% of the mental health-related symptoms of concussions. Respondents who were older, with higher education and household income, or resided in the Northwest Territories or Alberta identified significantly more of the mental health-related symptoms listed. Interpretation While Canadian youth athletes, parents, coaches and medical professionals are able to identify most of the physical and cognitive symptoms associated with concussion, identification of mental health-related symptoms of concussion is still lagging.	[Topolovec-Vranic, Jane; Cusimano, Michael D.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Topolovec-Vranic, Jane; Cusimano, Michael D.] St Michaels Hosp, Trauma & Neurosurg Program, Toronto, ON M5B 1W8, Canada; [Topolovec-Vranic, Jane] Univ Toronto, Fac Med Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Zhang, Stanley; Wong, Hatty; Lam, Emily; Jing, Rowan; Cusimano, Michael D.] St Michaels Hosp, Div Neurosurg, Toronto, ON M5B 1W8, Canada; [Russell, Kelly] Univ Manitoba, Dept Pediat, Winnipeg, MB R3T 2N2, Canada; [Cusimano, Michael D.] Univ Toronto, Fac Med, Toronto, ON, Canada; [Cusimano, Michael D.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Manitoba; University of Toronto; University of Toronto	Cusimano, MD (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, 30 Bond St, Toronto, ON M5B 1W8, Canada.	injuryprevention@smh.ca	Cusimano, Michael/GWR-1025-2022; Cusimano, Michael/X-4059-2019; Meijer, Anna/K-5118-2016; Topolovec-Vranic, Jane/A-5293-2013	Topolovec-Vranic, Jane/0000-0001-7695-4212; Cusimano, Michael/0000-0002-9989-0650; Russell, Kelly/0000-0002-9159-9201	Canadian Institutes of Health Research Strategic Team Grant in Applied Injury Research [TIR-103946]; Ontario Neurotrauma Foundation; Public Health Agency of Canada	Canadian Institutes of Health Research Strategic Team Grant in Applied Injury Research(Canadian Institutes of Health Research (CIHR)); Ontario Neurotrauma Foundation; Public Health Agency of Canada	This research was supported by the Canadian Institutes of Health Research Strategic Team Grant in Applied Injury Research #TIR-103946, the Ontario Neurotrauma Foundation, and Public Health Agency of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Author, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058868, DOI 10.1371/J0URNAL.P0NE.0058868]; Babul S, 2014, IOC WORLD C PREV INJ, P563, DOI [10.1136/bjsports-2014-093494.11, DOI 10.1136/BJSP0RTS-2014-093494.11]; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Blake T, 2014, BRIT J SPORT MED, V48, P570, DOI [10.1136/bjsports-2014-093494.28, DOI 10.1136/BJSP0RTS-2014-093494.28]; Burke MJ, 2012, CAN J NEUROL SCI, V39, P763, DOI 10.1017/S0317167100015584; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS210, DOI 10.1016/j.apmr.2013.06.035; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS278, DOI 10.1016/j.apmr.2013.08.295; Chrisman SPD, 2014, J ADOLESCENT HEALTH, V54, P582, DOI 10.1016/j.jadohealth.2013.10.006; Covassin T, 2009, J ATHL TRAINING, V44, P400, DOI 10.4085/1062-6050-44.4.400; Craig A. T., 2005, INTRO MATH STAT; Cusimano MD, 2013, CAN MED ASSOC J, V185, pE57, DOI 10.1503/cmaj.112017; Cusimano MD, 2009, CAN J NEUROL SCI, V36, P315, DOI 10.1017/S0317167100007046; Delaney JS, 2000, CLIN J SPORT MED, V10, P9, DOI 10.1097/00042752-200001000-00003; Demakis GJ, 2010, ARCH CLIN NEUROPSYCH, V25, P191, DOI 10.1093/arclin/acq004; Ettenhofer ML, 2009, J CLIN EXP NEUROPSYC, V31, P363, DOI 10.1080/13803390802175270; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Grubenhoff JA, 2011, BRAIN INJURY, V25, P943, DOI 10.3109/02699052.2011.597043; Guilmette TJ, 2007, BRAIN INJURY, V21, P1039, DOI 10.1080/02699050701633080; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Ilie G, 2014, BULLYING OTHER CONDU, V9, P10, DOI DOI 10.1371/J0URNAL.P0NE.0094936; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lebrun C, 2014, BRIT J SPORT MED, V48, P623, DOI [10.1136/bjsports-2014-093494.171, DOI 10.1136/BJSP0RTS-2014-093494.171]; Luis CA, 2002, J CLIN EXP NEUROPSYC, V24, P270, DOI 10.1076/jcen.24.3.270.982; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; Mckinlay A, 2011, BRAIN INJURY, V25, P761, DOI 10.3109/02699052.2011.579935; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; Papa L, 2012, CURR GERIATR REP, V1, P135, DOI 10.1007/s13670-012-0019-0; Staudenmayer KL, 2007, J TRAUMA, V63, P1364, DOI 10.1097/TA.0b013e31815b897b; Styrke J, 2013, J REHABIL MED, V45, P749, DOI 10.2340/16501977-1215; Swift TL, 2001, BRAIN INJURY, V15, P149, DOI 10.1080/026990501458380; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Whitaker S, 2012, FAM PRACT, V29, P168, DOI 10.1093/fampra/cmr079; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA	40	11	11	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141699	10.1371/journal.pone.0141699	http://dx.doi.org/10.1371/journal.pone.0141699			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV5GZ	26536016	Green Submitted, Green Published, gold			2022-12-26	WOS:000364298400078
J	Zach, F; Mueller, A; Gessner, A				Zach, Frank; Mueller, Alexandra; Gessner, Andre			Production and Functional Characterization of Murine Osteoclasts Differentiated from ER-Hoxb8-Immortalized Myeloid Progenitor Cells	PLOS ONE			English	Article							IN-VITRO; RECEPTOR ACTIVATOR; DEFICIENT MICE; BONE; PROTEIN; CANCER; LIGAND; OSTEOIMMUNOLOGY; ORGANIZATION; STIMULATION	In vitro differentiation into functional osteoclasts is routinely achieved by incubation of embryonic stem cells, induced pluripotent stem cells, or primary as well as cryopreserved spleen and bone marrow-derived cells with soluble receptor activator of nuclear factor kappa-B ligand and macrophage colony-stimulating factor. Additionally, osteoclasts can be derived from co-cultures with osteoblasts or by direct administration of soluble receptor activator of nuclear factor kappa-B ligand to RAW 264.7 macrophage lineage cells. However, despite their benefits for osteoclast-associated research, these different methods have several drawbacks with respect to differentiation yields, time and animal consumption, storage life of progenitor cells or the limited potential for genetic manipulation of osteoclast precursors. In the present study, we therefore established a novel protocol for the differentiation of osteoclasts from murine ER-Hoxb8-immortalized myeloid stem cells. We isolated and immortalized bone marrow cells from wild type and genetically manipulated mouse lines, optimized protocols for osteoclast differentiation and compared these cells to osteoclasts derived from conventional sources. In vitro generated ER-Hoxb8 osteoclasts displayed typical osteoclast characteristics such as multi-nucleation, tartrate-resistant acid phosphatase staining of supernatants and cells, F-actin ring formation and bone resorption activity. Furthermore, the osteoclast differentiation time course was traced on a gene expression level. Increased expression of osteoclast-specific genes and decreased expression of stem cell marker genes during differentiation of osteoclasts from ER-Hoxb8-immortalized myeloid progenitor cells were detected by gene array and confirmed by semi-quantitative and quantitative RT-PCR approaches. In summary, we established a novel method for the quantitative production of murine bona fide osteoclasts from ER-Hoxb8 stem cells generated from wild type or genetically manipulated mouse lines. These cells represent a standardized and theoretically unlimited source for osteoclast-associated research projects.	[Zach, Frank; Mueller, Alexandra; Gessner, Andre] Univ Hosp Regensburg, Inst Clin Microbiol & Hyg, Regensburg, Germany	University of Regensburg	Gessner, A (corresponding author), Univ Hosp Regensburg, Inst Clin Microbiol & Hyg, Regensburg, Germany.	andre.gessner@ukr.de		Zach, Frank/0000-0003-1168-8106	Bayerische Forschungsstiftung [AZ 1070-13]; Deutsche Forschungsgemeinschaft [1656, GE671/14-1]	Bayerische Forschungsstiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by grants from the Bayerische Forschungsstiftung (www.forschungsstiftung.de/; AZ 1070-13 to AG) and the Deutsche Forschungsgemeinschaft (www.dfg.de/; 1656, Ref. No. GE671/14-1 to AG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz MM, 2009, J IMMUNOL, V182, P7222, DOI 10.4049/jimmunol.0803711; Baek JM, 2014, MOLECULES, V19, P11628, DOI 10.3390/molecules190811628; Bohuslavova R, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-11; Boraschi-Diaz I, 2014, CYTOTECHNOLOGY; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Cappariello A, 2014, ARCH BIOCHEM BIOPHYS, V561, P13, DOI 10.1016/j.abb.2014.08.009; Charles JF, 2014, TRENDS MOL MED, V20, P449, DOI 10.1016/j.molmed.2014.06.001; Chen H, 2011, J BONE MINER RES, V26, P2537, DOI 10.1002/jbmr.456; Cuetara BLV, 2006, IN VITRO CELL DEV-AN, V42, P182, DOI 10.1290/0510075.1; Destaing O, 2003, MOL BIOL CELL, V14, P407, DOI 10.1091/mbc.E02-07-0389; Galson Deborah L, 2014, J Bone Metab, V21, P85, DOI 10.11005/jbm.2014.21.2.85; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Ishida N, 2002, J BIOL CHEM, V277, P41147, DOI 10.1074/jbc.M205063200; Jones D, 2011, J CLIN INVEST, V121, P2534, DOI 10.1172/JCI46262; Khan UA, 2013, J CELL BIOCHEM, V114, P1772, DOI 10.1002/jcb.24518; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Krishnaraju K, 1997, BLOOD, V90, P1840, DOI 10.1182/blood.V90.5.1840; Li RF, 2014, J HISTOCHEM CYTOCHEM, V62, P879, DOI 10.1369/0022155414551367; Li XD, 2000, ENDOCRINOLOGY, V141, P2054, DOI 10.1210/en.141.6.2054; Maria SM, 2014, J BIOMED MATER RES B, V102, P903, DOI 10.1002/jbm.b.33071; Mohrs M, 1999, J IMMUNOL, V162, P7302; Nishikawa K, 2014, J BONE MINER METAB, V32, P331, DOI 10.1007/s00774-013-0547-5; Park SJ, 2013, J MOL HISTOL, V44, P65, DOI 10.1007/s10735-012-9465-4; Patntirapong S, 2009, BIOMATERIALS, V30, P548, DOI 10.1016/j.biomaterials.2008.09.062; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Redecke V, 2013, NAT METHODS, V10, P795, DOI [10.1038/nmeth.2510, 10.1038/NMETH.2510]; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Roodman GD, 2001, J CLIN ONCOL, V19, P3562, DOI 10.1200/JCO.2001.19.15.3562; Saltel F, 2008, EUR J CELL BIOL, V87, P459, DOI 10.1016/j.ejcb.2008.01.001; Sims Natalie A, 2014, Bonekey Rep, V3, P481, DOI 10.1038/bonekey.2013.215; TAKAHASHI N, 1988, ENDOCRINOLOGY, V123, P2600, DOI 10.1210/endo-123-5-2600; TAKAHASHI N, 1988, ENDOCRINOLOGY, V122, P1373, DOI 10.1210/endo-122-4-1373; Takami M, 2002, J IMMUNOL, V169, P1516, DOI 10.4049/jimmunol.169.3.1516; Teti Anna, 2013, Bonekey Rep, V2, P449, DOI 10.1038/bonekey.2013.183; Tevlin R, 2014, JOVE-J VIS EXP, DOI 10.3791/52056; Walsh MC, 2006, ANNU REV IMMUNOL, V24, P33, DOI 10.1146/annurev.immunol.24.021605.090646; Wang GG, 2006, NAT METHODS, V3, P287, DOI 10.1038/NMETH865; Watanabe T, 2004, J ENDOCRINOL, V180, P193, DOI 10.1677/joe.0.1800193; Yamada A, 2007, IMMUNOLOGY, V120, P573, DOI 10.1111/j.1365-2567.2006.02538.x; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Yoneda T, 1998, EUR J CANCER, V34, P240, DOI 10.1016/S0959-8049(97)10132-0; Yoshitake F, 2008, J BIOL CHEM, V283, P11535, DOI 10.1074/jbc.M607999200; Youn BU, SLAT NEGATIVELY REGU	44	10	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0142211	10.1371/journal.pone.0142211	http://dx.doi.org/10.1371/journal.pone.0142211			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529319	Green Published, Green Submitted, gold			2022-12-26	WOS:000364032600111
J	Barr, RK; Verdile, G; Wijaya, LK; Morici, M; Taddei, K; Gupta, VB; Pedrini, S; Jin, L; Nicolazzo, JA; Knock, E; Fraser, PE; Martins, RN				Barr, Renae K.; Verdile, Giuseppe; Wijaya, Linda K.; Morici, Michael; Taddei, Kevin; Gupta, Veer B.; Pedrini, Steve; Jin, Liang; Nicolazzo, Joseph A.; Knock, Erin; Fraser, Paul E.; Martins, Ralph N.			Validation and Characterization of a Novel Peptide That Binds Monomeric and Aggregated beta-Amyloid and Inhibits the Formation of Neurotoxic Oligomers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMAGE PHAGE DISPLAY; ALZHEIMERS-DISEASE; A-BETA; MOUSE MODEL; TRANSGENIC MICE; IN-VIVO; NATURAL OLIGOMERS; FIBRIL FORMATION; PROTEIN BINDS; BRAIN	Although the formation of beta-amyloid (A beta) deposits in the brain is a hallmark of Alzheimer disease (AD), the soluble oligomers rather than the mature amyloid fibrils most likely contribute to A beta toxicity and neurodegeneration. Thus, the discovery of agents targeting soluble A beta oligomers is highly desirable for early diagnosis prior to the manifestation of a clinical AD phenotype and also more effective therapies. We have previously reported that a novel 15-amino acid peptide (15-mer), isolated via phage display screening, targeted A beta and attenuated its neurotoxicity (Taddei, K., Laws, S. M., Verdile, G., Munns, S., D'Costa, K., Harvey, A. R., Martins, I. J., Hill, F., Levy, E., Shaw, J. E., and Martins, R. N. (2010) Neurobiol. Aging 31, 203-214). The aim of the current study was to generate and biochemically characterize analogues of this peptide with improved stability and therapeutic potential. We demonstrated that a stable analogue of the 15-amino acid peptide (15M S.A.) retained the activity and potency of the parent peptide and demonstrated improved proteolytic resistance in vitro (stable to t = 300 min, c.f.t = 30 min for the parent peptide). This candidate reduced the formation of soluble A beta 42 oligomers, with the concurrent generation of non-toxic, insoluble aggregates measuring up to 25-30 nm diameter as determined by atomic force microscopy. The 15M S.A. candidate directly interacted with oligomeric A beta 42, as shown by coimmunoprecipitation and surface plasmon resonance/Biacore analysis, with an affinity in the low micromolar range. Furthermore, this peptide bound fibrillar A beta 42 and also stained plaques ex vivo in brain tissue from AD model mice. Given its multifaceted ability to target monomeric and aggregated A beta 42 species, this candidate holds promise for novel preclinical AD imaging and therapeutic strategies.	[Barr, Renae K.; Wijaya, Linda K.; Morici, Michael; Taddei, Kevin; Gupta, Veer B.; Pedrini, Steve; Martins, Ralph N.] Edith Cowan Univ, Sch Med Sci, Ctr Excellence Alzheimers Dis Res & Care, Joondalup, WA 6027, Australia; [Barr, Renae K.; Gupta, Veer B.; Pedrini, Steve; Martins, Ralph N.] Alzhyme Pty Ltd, Nedlands, WA 6009, Australia; [Verdile, Giuseppe] Curtin Univ, Fac Hlth Sci, Sch Biomed Sci, Bentley, WA 6102, Australia; [Taddei, Kevin; Gupta, Veer B.; Pedrini, Steve; Martins, Ralph N.] Hollywood Med Ctr, Sir James McCusker Alzheimers Dis Res Unit, Nedlands, WA 6009, Australia; [Verdile, Giuseppe; Martins, Ralph N.] Univ Western Australia, Sch Psychiat & Clin Neurosci, Crawley, WA 6009, Australia; [Jin, Liang; Nicolazzo, Joseph A.] Monash Univ, Monash Inst Pharmaceut Sci, Drug Delivery Disposit & Dynam, Parkville, Vic 3052, Australia; [Knock, Erin; Fraser, Paul E.] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON M5T 2S8, Canada	Edith Cowan University; Curtin University; University of Western Australia; Monash University; University of Toronto	Verdile, G (corresponding author), Curtin Univ, Fac Hlth Sci, Sch Biomed Sci, Bentley, WA 6102, Australia.	giuseppe.verdile@curtin.edu.au; r.martins@ecu.edu.au	Morici, Michael/AGX-5320-2022; Wijaya, Linda/CAF-1162-2022	Wijaya, Linda/0000-0003-2603-7074; Martins, Ralph/0000-0002-4828-9363; Morici, Michael/0000-0001-7101-0976; Verdile, Giuseppe/0000-0003-2475-0124; Jin, Liang/0000-0003-1695-3300; Gupta, Veer/0000-0003-4989-0764; Pedrini, Steve/0000-0002-6409-8022; Barr, Renae/0000-0003-1601-7299	National Health and Medical Research Council of Australia [595300, 430909]; Alzhyme Pty Ltd.; Edith Cowan University; Curtin University Research Fellowship [CRF140196]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Alzhyme Pty Ltd.; Edith Cowan University; Curtin University Research Fellowship	This work was supported in part by the National Health and Medical Research Council of Australia Project Grant 595300 and Postdoctoral Fellowship 430909 (to R. K. B), Alzhyme Pty Ltd., and Edith Cowan University. R. N. M. is shareholder and CSO of Alzhyme Pty, LTD. No other conflicts of interest to declare.; Supported by Curtin University Research Fellowship CRF140196. To whom correspondence may be addressed:School of Biomedical Sciences, Faculty of Health Sciences, Curtin University, Bentley, WA, Australia. Tel.: 61-89266-5618; Fax: 61-8-9266-1715; E-mail: giuseppe.verdile@curtin.edu.au.	Austen BM, 2008, BIOCHEMISTRY-US, V47, P1984, DOI 10.1021/bi701415b; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bergstrom CAS, 2012, PHARM RES-DORDR, V29, P3131, DOI 10.1007/s11095-012-0806-5; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; Bitan G, 2005, AMYLOID, V12, P88, DOI 10.1080/13506120500106958; BURDICK D, 1992, J BIOL CHEM, V267, P546; Campbell M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1852; Cerf E, 2011, FASEB J, V25, P1585, DOI 10.1096/fj.10-175976; Chacon MA, 2004, MOL PSYCHIATR, V9, P953, DOI 10.1038/sj.mp.4001516; Chakravarthy B, 2013, J NEUROCHEM, V126, P415, DOI 10.1111/jnc.12208; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Cohen SIA, 2013, P NATL ACAD SCI USA, V110, P9758, DOI 10.1073/pnas.1218402110; DeMattos RB, 2012, NEURON, V76, P908, DOI 10.1016/j.neuron.2012.10.029; Drummond ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059166; EVANS DA, 1989, JAMA-J AM MED ASSOC, V262, P2551, DOI 10.1001/jama.262.18.2551; Fluharty BR, 2013, J BIOL CHEM, V288, P7857, DOI 10.1074/jbc.M112.423954; Funamoto S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3529; Funke SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041457; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Granic I, 2010, J ALZHEIMERS DIS, V19, P991, DOI 10.3233/JAD-2010-1297; Harris JM, 2003, NAT REV DRUG DISCOV, V2, P214, DOI 10.1038/nrd1033; Hung LW, 2008, J NEUROSCI, V28, P11950, DOI 10.1523/JNEUROSCI.3916-08.2008; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Jin L, 2011, ANTIMICROB AGENTS CH, V55, P502, DOI 10.1128/AAC.01273-10; Jokerst JV, 2011, NANOMEDICINE-UK, V6, P715, DOI [10.2217/NNM.11.19, 10.2217/nnm.11.19]; Jungbauer LM, 2009, J MOL RECOGNIT, V22, P403, DOI 10.1002/jmr.948; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Ladner RC, 2004, DRUG DISCOV TODAY, V9, P525, DOI 10.1016/S1359-6446(04)03104-6; Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Ma QL, 2009, J NEUROSCI, V29, P9078, DOI 10.1523/JNEUROSCI.1071-09.2009; Mathis CA, 2004, CURR PHARM DESIGN, V10, P1469, DOI 10.2174/1381612043384772; Miles LA, 2008, J MOL BIOL, V377, P181, DOI 10.1016/j.jmb.2007.12.036; Mintun MA, 2006, NEUROLOGY, V67, P446, DOI 10.1212/01.wnl.0000228230.26044.a4; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; Nimmrich V, 2008, J NEUROSCI, V28, P788, DOI 10.1523/JNEUROSCI.4771-07.2008; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Oddo S, 2003, NEUROBIOL AGING, V24, P1063, DOI 10.1016/j.neurobiolaging.2003.08.012; Okamura N, 2010, IDRUGS, V13, P890; Ono K, 2006, CURR PHARM DESIGN, V12, P4357, DOI 10.2174/138161206778793010; Ono K, 2011, J NEUROCHEM, V117, P19, DOI 10.1111/j.1471-4159.2011.07187.x; Price JL, 2009, NEUROBIOL AGING, V30, P1026, DOI 10.1016/j.neurobiolaging.2009.04.002; Rinne JO, 2012, ACTA NEUROPATHOL, V124, P833, DOI 10.1007/s00401-012-1051-z; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Stine WB, 2011, METHODS MOL BIOL, V670, P13, DOI 10.1007/978-1-60761-744-0_2; Sumbria RK, 2012, BIOCONJUGATE CHEM, V23, P1318, DOI 10.1021/bc3001744; Sundaram RK, 2012, INT J PEPT RES THER, V18, P99, DOI 10.1007/s10989-011-9283-7; Taddei K, 2010, NEUROBIOL AGING, V31, P203, DOI 10.1016/j.neurobiolaging.2008.03.023; Tanifum EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048515; Tarawneh R, 2010, NEUROPHARMACOLOGY, V59, P310, DOI 10.1016/j.neuropharm.2010.04.006; Taylor M, 2010, BIOCHEMISTRY-US, V49, P3261, DOI 10.1021/bi100144m; Tjernberg LO, 1996, J BIOL CHEM, V271, P8545, DOI 10.1074/jbc.271.15.8545; Tomiyama T, 2010, J NEUROSCI, V30, P4845, DOI 10.1523/JNEUROSCI.5825-09.2010; van Groen T, 2008, CHEMMEDCHEM, V3, P1848, DOI 10.1002/cmdc.200800273; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; Wiesehan K, 2008, PROTEIN ENG DES SEL, V21, P241, DOI 10.1093/protein/gzm054; Wiesehan K, 2003, CHEMBIOCHEM, V4, P748, DOI 10.1002/cbic.200300631; Yates EA, 2013, J MOL BIOL, V425, P1915, DOI 10.1016/j.jmb.2013.03.022; Youmans KL, 2012, J BIOL CHEM, V287, P41774, DOI 10.1074/jbc.M112.407957	63	12	12	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					547	559		10.1074/jbc.M115.679993	http://dx.doi.org/10.1074/jbc.M115.679993			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26538562	hybrid, Green Published			2022-12-26	WOS:000367830500004
J	Maksimov, MO; Koos, JD; Zong, CH; Lisko, B; Link, AJ				Maksimov, Mikhail O.; Koos, Joseph D.; Zong, Chuhan; Lisko, Bozhena; Link, A. James			Elucidating the Specificity Determinants of the AtxE2 Lasso Peptide Isopeptidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN STRUCTURES; MICROCIN J25; ESCHERICHIA-COLI; NMR-SPECTROSCOPY; NATURAL-PRODUCTS; NOESY SPECTRA; I-III; BIOSYNTHESIS; MATURATION; ASSIGNMENT	Lasso peptide isopeptidase is an enzyme that specifically hydrolyzes the isopeptide bond of lasso peptides, rendering these peptides linear. To carry out a detailed structure-activity analysis of the lasso peptide isopeptidase AtxE2 from Asticcacaulis excentricus, we solved NMR structures of its substrates astexin-2 and astexin-3. Using in vitro enzyme assays, we show that the C-terminal tail portion of these peptides is dispensable with regards to isopeptidase activity. A collection of astexin-2 and astexin-3 variants with alanine substitutions at each position within the ring and the loop was constructed, and we showed that all of these peptides except for one were cleaved by the isopeptidase. Thus, much like the lasso peptide biosynthetic enzymes, lasso peptide isopeptidase has broad substrate specificity. Quantitative analysis of the cleavage reactions indicated that alanine substitutions in loop positions of these peptides led to reduced cleavage, suggesting that the loop is serving as a recognition element for the isopeptidase.	[Maksimov, Mikhail O.; Lisko, Bozhena; Link, A. James] Princeton Univ, Dept Chem & Biol Engn, Princeton, NJ 08544 USA; [Koos, Joseph D.; Link, A. James] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Zong, Chuhan] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA	Princeton University; Princeton University; Princeton University	Link, AJ (corresponding author), 207 Hoyt Lab, Princeton, NJ 08544 USA.	ajlink@princeton.edu	Regan, Clinton/E-6250-2012	Link, A. James/0000-0001-5066-9691; Koos, Joseph/0000-0001-9613-7949	National Institutes of Health [R01 GM107036, T32 GM7388]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007388, R01GM107036] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 GM107036 and T32 GM7388. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arnison PG, 2013, NAT PROD REP, V30, P108, DOI 10.1039/c2np20085f; Cooper LE, 2008, CHEM BIOL, V15, P1035, DOI 10.1016/j.chembiol.2008.07.020; Deane CD, 2013, ACS CHEM BIOL, V8, P1998, DOI 10.1021/cb4003392; Duquesne S, 2007, CHEM BIOL, V14, P793, DOI 10.1016/j.chembiol.2007.06.004; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hegemann JD, 2015, ACCOUNTS CHEM RES, V48, P1909, DOI 10.1021/acs.accounts.5b00156; Hegemann JD, 2014, ANGEW CHEM INT EDIT, V53, P2230, DOI 10.1002/anie.201309267; Hegemann JD, 2013, BIOPOLYMERS, V100, P527, DOI 10.1002/bip.22326; Hegemann JD, 2013, J AM CHEM SOC, V135, P210, DOI 10.1021/ja308173b; Knappe TA, 2009, CHEM BIOL, V16, P1290, DOI 10.1016/j.chembiol.2009.11.009; Li B, 2010, P NATL ACAD SCI USA, V107, P10430, DOI 10.1073/pnas.0913677107; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Maksimov MO, 2014, J IND MICROBIOL BIOT, V41, P333, DOI 10.1007/s10295-013-1357-4; Maksimov MO, 2013, J AM CHEM SOC, V135, P12038, DOI 10.1021/ja4054256; Maksimov MO, 2012, P NATL ACAD SCI USA, V109, P15223, DOI 10.1073/pnas.1208978109; Maksimov MO, 2012, NAT PROD REP, V29, P996, DOI 10.1039/c2np20070h; MUMENTHALER C, 1995, J MOL BIOL, V254, P465, DOI 10.1006/jmbi.1995.0631; Mumenthaler C, 1997, J BIOMOL NMR, V10, P351, DOI 10.1023/A:1018383106236; Pan SJ, 2012, CHEMBIOCHEM, V13, P367, DOI 10.1002/cbic.201100596; Pan SJ, 2011, J AM CHEM SOC, V133, P5016, DOI 10.1021/ja1109634; Pavlova O, 2008, J BIOL CHEM, V283, P25589, DOI 10.1074/jbc.M803995200; Piscotta FJ, 2015, CHEM COMMUN, V51, P409, DOI 10.1039/c4cc07778d; SKERRA A, 1994, GENE, V151, P131, DOI 10.1016/0378-1119(94)90643-2; Spronk CAEM, 2004, PROG NUCL MAG RES SP, V45, P315, DOI 10.1016/j.pnmrs.2004.08.003; Spronk CAEM, 2003, J BIOMOL NMR, V25, P225, DOI 10.1023/A:1022819716110; Spronk CAEM, 2002, J BIOMOL NMR, V22, P281, DOI 10.1023/A:1014971029663; Tianero MDB, 2012, J AM CHEM SOC, V134, P418, DOI 10.1021/ja208278k; Yan KP, 2012, CHEMBIOCHEM, V13, P1046, DOI 10.1002/cbic.201200016; Zimmermann M, 2014, CHEM SCI, V5, P4032, DOI 10.1039/c4sc01428f; Zimmermann M, 2013, CHEM BIOL, V20, P558, DOI 10.1016/j.chembiol.2013.03.013	30	22	23	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					30806	30812		10.1074/jbc.M115.694083	http://dx.doi.org/10.1074/jbc.M115.694083			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26534965	Green Published, hybrid			2022-12-26	WOS:000367199000014
J	Chernov, AV; Reyes, L; Peterson, S; Strongin, AY				Chernov, Andrei V.; Reyes, Leticia; Peterson, Scott; Strongin, Alex Y.			Depletion of CG-Specific Methylation in Mycoplasma hyorhinis Genomic DNA after Host Cell Invasion	PLoS One			English	Article							MALIGNANT-TRANSFORMATION; ESCHERICHIA-COLI; INFECTION; CANCER; TOLL-LIKE-RECEPTOR-9; TRANSCRIPTION; GENITALIUM; ACTIVATION	Adaptation to the environment requires pathogenic bacteria to alter their gene expression in order to increase long-term survival in the host. Here, we present the first experimental evidence that bacterial DNA methylation affects the intracellular survival of pathogenic Mycoplasma hyorhinis. Using bisulfite sequencing, we identified that the M. hyorhinis DNA methylation landscape was distinct in free-livingM. hyorhinis relative to the internalized bacteria surviving in the infected human cells. We determined that genomic GATC sites were consistently highly methylated in the bacterial chromosome suggesting that the bacterial GATC-specific 5-methylcytosine DNA methyltransferase was fully functional both pre- and post-infection. In contrast, only the low CG methylation pattern was observed in the mycoplasma genome in the infective bacteria that invaded and then survived in the host cells. In turn, two distinct populations, with either high or low CG methylation, were detected in the M. hyorhinis cultures continually grown in the rich medium independently of host cells. We also identified that M. hyorhinis efficiently evaded endosomal degradation and uses exocytosis to exit infected human cells enabling re-infection of additional cells. The well-orchestrated changes in the chromosome methylation landscape play a major regulatory role in the mycoplasma life cycle.	[Chernov, Andrei V.; Peterson, Scott; Strongin, Alex Y.] Sanford Burnham Prebys Med Discovery Inst, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA; [Reyes, Leticia] Univ Florida, Coll Vet Med, Dept Infect Dis & Pathol, Gainesville, FL USA	Sanford Burnham Prebys Medical Discovery Institute; State University System of Florida; University of Florida	Chernov, AV (corresponding author), Sanford Burnham Prebys Med Discovery Inst, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA.	achernov@sbpdiscovery.org; strongin@sbpdiscovery.org	Reyes, Leticia/H-7338-2019; Chernov, Andrei/I-1623-2019; Strongin, Alex/R-6609-2019	Chernov, Andrei/0000-0002-3294-5418; Strongin, Alex/0000-0003-3765-3016	Institute of Predictive and Personalized Medicine of Cancer, Barcelona, Spain; National Cancer Institute at the National Institutes of Health [CA077470, CA083017, CA157328]; NATIONAL CANCER INSTITUTE [R01CA083017, R01CA157328, R01CA077470] Funding Source: NIH RePORTER	Institute of Predictive and Personalized Medicine of Cancer, Barcelona, Spain; National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Research Fellowship from the Institute of Predictive and Personalized Medicine of Cancer, Barcelona, Spain (to AVC)-http://www.imppc.org/, and the National Cancer Institute at the National Institutes of Health grants CA077470, CA083017 and CA157328 (to AYS)-http://www.cancer.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barykova YA, 2011, ONCOTARGET, V2, P289; Chernov AV, 2015, EPIGENETICS-US, V10, P303, DOI 10.1080/15592294.2015.1020000; Cimolai N, 2001, CAN J MICROBIOL, V47, P691, DOI 10.1139/cjm-47-8-691; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; FREY ML, 1968, AVIAN DIS, V12, P693, DOI 10.2307/1588456; Gong MM, 2008, MOL CANCER THER, V7, P530, DOI 10.1158/1535-7163.MCT-07-2191; Goodison S, 2013, GENOME ANNOUNC, V1, DOI [10.1128/genomeA.00036-13, DOI 10.1128/GENOMEA.00036-13]; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Hackenberg M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-446; Huang S, 2001, WORLD J GASTROENTERO, V7, P266; Kahramanoglou C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1878; Kornspan JD, 2010, INFECT IMMUN, V78, P611, DOI 10.1128/IAI.01017-09; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Latz E, 2007, NAT IMMUNOL, V8, P772, DOI 10.1038/ni1479; Lipschutz JH, 2002, CURR BIOL, V12, pR212, DOI 10.1016/S0960-9822(02)00753-4; Lluch-Senar M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003191; Logunov DY, 2008, ONCOGENE, V27, P4521, DOI 10.1038/onc.2008.103; Masaki T, 2013, CELL, V152, P51, DOI 10.1016/j.cell.2012.12.014; Militello KT, 2012, FEMS MICROBIOL LETT, V328, P78, DOI 10.1111/j.1574-6968.2011.02482.x; Namiki K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006872; PETERSON SN, 1993, J BACTERIOL, V175, P7918, DOI 10.1128/JB.175.24.7918-7930.1993; Ramirez-Ortiz ZG, 2008, INFECT IMMUN, V76, P2123, DOI 10.1128/IAI.00047-08; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; Reyes L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074230; Rottem S, 2000, Subcell Biochem, V33, P199; Shell SS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003419; TSAI S, 1995, P NATL ACAD SCI USA, V92, P10197, DOI 10.1073/pnas.92.22.10197; Ueno PM, 2008, MICROBIOL-SGM, V154, P3033, DOI 10.1099/mic.0.2008/020735-0; Urbanek C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-233; Weber M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/243649; Wojciechowski M, 2013, P NATL ACAD SCI USA, V110, P105, DOI 10.1073/pnas.1207986110; Yang CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036138; Yang H, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-132	34	19	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142529	10.1371/journal.pone.0142529	http://dx.doi.org/10.1371/journal.pone.0142529			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544880	Green Submitted, Green Published, gold			2022-12-26	WOS:000364398700153
J	Hamilton, F; Graham, R; Luu, L; Peixoto, N				Hamilton, Franz; Graham, Robert; Luu, Lydia; Peixoto, Nathalia			Time-Dependent Increase in Network Response to Stimulation	PLoS One			English	Article							CORTICAL-NEURONS; DYNAMICS; CULTURES; CONNECTIVITY; ARRAYS; MEMORY	In vitro neuronal cultures have become a popular method with which to probe network-level neuronal dynamics and phenomena in controlled laboratory settings. One of the key dynamics of interest in these in vitro studies has been the extent to which cultured networks display properties indicative of learning. Here we demonstrate the effects of a high frequency electrical stimulation signal in training cultured networks of cortical neurons. Networks receiving this training signal displayed a time-dependent increase in the response to a low frequency probing stimulation, particularly in the time window of 20-50 ms after stimulation. This increase was found to be statistically significant as compared to control networks that did not receive training. The timing of this increase suggests potentiation of synaptic mechanisms. To further investigate this possibility, we leveraged the powerful Cox statistical connectivity method as previously investigated by our group. This method was used to identify and track changes in network connectivity strength.	[Hamilton, Franz; Peixoto, Nathalia] George Mason Univ, Dept Elect & Comp Engn, Fairfax, VA 22030 USA; [Graham, Robert; Luu, Lydia; Peixoto, Nathalia] George Mason Univ, Dept Bioengn, Fairfax, VA 22030 USA	George Mason University; George Mason University	Peixoto, N (corresponding author), George Mason Univ, Dept Elect & Comp Engn, Fairfax, VA 22030 USA.	npeixoto@gmu.edu		Luu, Lydia/0000-0001-6512-4686; Graham, Robert/0000-0002-9795-4614	National Science Foundation [CMMI-1300007]; George Mason University Libraries Open Access Publishing Fund	National Science Foundation(National Science Foundation (NSF)); George Mason University Libraries Open Access Publishing Fund	This work was funded by National Science Foundation grant CMMI-1300007 (NP received the funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Publication of this article was funded in part by the George Mason University Libraries Open Access Publishing Fund.	Anastassiou CA, 2011, NAT NEUROSCI, V14, P217, DOI 10.1038/nn.2727; Battaglia D, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002438; Berry T, 2012, J NEUROSCI METH, V209, P388, DOI 10.1016/j.jneumeth.2012.06.021; Bologna LL, 2010, NEUROSCIENCE, V165, P692, DOI 10.1016/j.neuroscience.2009.11.018; Chiappalone M, 2008, EUR J NEUROSCI, V28, P221, DOI 10.1111/j.1460-9568.2008.06259.x; Cox D, 2009, STOCHASTIC POINT PRO, V55, P6; Dranias MR, 2013, J NEUROSCI, V33, P1940, DOI 10.1523/JNEUROSCI.2718-12.2013; Eytan D, 2006, J NEUROSCI, V26, P8465, DOI 10.1523/JNEUROSCI.1627-06.2006; Frohlich F, 2010, NEURON, V67, P129, DOI 10.1016/j.neuron.2010.06.005; Gal A, 2010, J NEUROSCI, V30, P16332, DOI 10.1523/JNEUROSCI.4859-10.2010; Garofalo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006482; Hamilton F, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.052715; Ito SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027431; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Jimbo Y, 1999, BIOPHYS J, V76, P670, DOI 10.1016/S0006-3495(99)77234-6; Kermany E, 2010, J NEUROSCI, V30, P9588, DOI 10.1523/JNEUROSCI.0661-10.2010; Knaack GL, 2013, NEUROTOXICOLOGY, V37, P19, DOI 10.1016/j.neuro.2013.03.002; le Feber J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008871; Li YL, 2007, BIOPHYS J, V93, P4151, DOI 10.1529/biophysj.107.111153; Li YL, 2007, BIOSENS BIOELECTRON, V22, P2976, DOI 10.1016/j.bios.2006.12.018; Marom S, 2005, PROG BRAIN RES, V147, P189, DOI 10.1016/S0079-6123(04)47014-9; Marom S, 2002, Q REV BIOPHYS, V35, P63, DOI 10.1017/S0033583501003742; Masud MS, 2011, J NEUROSCI METH, V196, P201, DOI 10.1016/j.jneumeth.2011.01.003; Ozen S, 2010, J NEUROSCI, V30, P11476, DOI 10.1523/JNEUROSCI.5252-09.2010; Ruaro ME, 2005, IEEE T BIO-MED ENG, V52, P371, DOI 10.1109/TBME.2004.842975; Shahaf G, 2001, J NEUROSCI, V21, P8782, DOI 10.1523/JNEUROSCI.21-22-08782.2001; Wagenaar DA, 2005, J NEUROSCI, V25, P680, DOI 10.1523/JNEUROSCI.4209-04.2005; Wagenaar DA, 2004, J NEUROSCI METH, V138, P27, DOI 10.1016/j.jneumeth.2004.03.005; Xiang GX, 2007, BIOSENS BIOELECTRON, V22, P2478, DOI 10.1016/j.bios.2006.09.026	29	5	6	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142399	10.1371/journal.pone.0142399	http://dx.doi.org/10.1371/journal.pone.0142399			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545098	Green Published, gold, Green Submitted			2022-12-26	WOS:000364398700131
J	Kolokythas, A; Zhou, YL; Schwartz, JL; Adami, GR				Kolokythas, Antonia; Zhou, Yalu; Schwartz, Joel L.; Adami, Guy R.			Similar Squamous Cell Carcinoma Epithelium microRNA Expression in Never Smokers and Ever Smokers	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS HPV; NECK-CANCER; ORAL TONGUE; HEAD; PROLIFERATION; NONSMOKERS; SIGNATURES; DISCOVERY; PATTERNS; TOBACCO	The incidence of oral tumors in patients who never used mutagenic agents such as tobacco is increasing. In an effort to better understand these tumors we studied microRNA (miRNA) expression in tumor epithelium of never tobacco users, tumor epithelium of ever tobacco users, and nonpathological control oral epithelium. A comparison of levels among 372 miRNAs in 12 never tobacco users with oral squamous cell carcinoma (OSCC) versus 10 healthy controls was made using the reverse transcription quantitative polymerase chain reaction. A similar analysis was done with 8 ever tobacco users with OSCC. These comparisons revealed miR-10b-5p, miR-196a-5p, and miR-31-5p as enriched in the tumor epithelium in OSCC of both never and ever tobacco users. Examination of The Cancer Genome Atlas (TCGA) project miRNA data on 305 OSCCs and 30 controls revealed 100% of those miRNAs enriched in never smoker OSCCs in this patient group were also enriched in ever smoker OSCCs. Nonsupervised clustering of TCGA OSCCs was suggestive of two or four subgroups of tumors based on miRNA levels with limited evidence for differences in tobacco exposure among the groups. Results from both patient groups together stress the importance of miR196a-5p in OSCC malignancy in both never and ever smokers, and emphasize the overall similarity of miRNA expression in OSCCs in these two risk groups. It implies that there may be great similarity in etiology of OSCC in never and ever smokers and that classifying OSCC based on tobacco exposure may not be helpful in the clinic.	[Kolokythas, Antonia] Univ Illinois, Coll Dent, Dept Oral & Maxillofacial Surg, Chicago, IL 60610 USA; [Zhou, Yalu; Schwartz, Joel L.] Arphion Ltd, Chicago, IL 60612 USA; [Adami, Guy R.] Univ Illinois, Ctr Mol Biol Oral Dis, Dept Oral Med & Oral Diagnost, Chicago, IL 60610 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Adami, GR (corresponding author), Univ Illinois, Ctr Mol Biol Oral Dis, Dept Oral Med & Oral Diagnost, 801 South Paulina St, Chicago, IL 60610 USA.	gadami@uic.edu						Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Blenkiron C, 2007, HUM MOL GENET, V16, pR106, DOI 10.1093/hmg/ddm056; Braakhuis BJM, 2004, JNCI-J NATL CANCER I, V96, P998, DOI 10.1093/jnci/djh183; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen Dan, 2013, J Oral Maxillofac Res, V4, pe2, DOI 10.5037/jomr.2013.4102; Chung CH, 2004, CANCER CELL, V5, P489, DOI 10.1016/S1535-6108(04)00112-6; Corbetta S, 2010, ENDOCR-RELAT CANCER, V17, P135, DOI 10.1677/ERC-09-0134; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; De Sarkar N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104839; Di Leva G, 2014, ANNU REV PATHOL-MECH, V9, P287, DOI 10.1146/annurev-pathol-012513-104715; Durr ML, 2013, AM J OTOLARYNG, V34, P388, DOI 10.1016/j.amjoto.2013.01.017; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Farshadpour F, 2012, ORAL DIS, V18, P178, DOI 10.1111/j.1601-0825.2011.01861.x; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Heaton CM, 2014, LARYNGOSCOPE, V124, pE267, DOI 10.1002/lary.24595; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Hou T, 2014, BRIT J CANCER, V110, P1260, DOI 10.1038/bjc.2013.829; Hui ABY, 2010, CLIN CANCER RES, V16, P1129, DOI 10.1158/1078-0432.CCR-09-2166; Ide S, 2015, ANTICANCER RES, V35, P1447; John K, 2013, INT J DENT, V2013, DOI 10.1155/2013/650218; Kim YK, 2012, MOL CELL, V46, P893, DOI 10.1016/j.molcel.2012.05.036; Koch WM, 1999, LARYNGOSCOPE, V109, P1544, DOI 10.1097/00005537-199910000-00002; Kolokythas A, 2011, ORAL ONCOL, V47, P532, DOI 10.1016/j.oraloncology.2011.03.029; Kruger M, 2014, J CRANIO MAXILLO FAC; Laing Emma, 2010, BMC Res Notes, V3, P221, DOI 10.1186/1756-0500-3-221; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; Li R, 2014, HEAD NECK-J SCI SPEC; Lingen MW, 2013, ORAL ONCOL, V49, P1, DOI 10.1016/j.oraloncology.2012.07.002; Liu CJ, 2013, ANN SURG ONCOL, V20, pS406, DOI 10.1245/s10434-012-2618-6; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu YC, 2012, CANCER PREV RES, V5, P665, DOI 10.1158/1940-6207.CAPR-11-0358; Lu ZM, 2014, ONCOTARGETS THER, V7, P525, DOI 10.2147/OTT.S59871; MacLellan SA, 2014, BMC CLIN PATHOL, V14, DOI 10.1186/1472-6890-14-27; Mendez E, 2012, CANCER RES, V72, P4896, DOI 10.1158/0008-5472.CAN-12-3285; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Park YT, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-18; Pezzuto F, 2015, ONCOLOGY-BASEL, V89, P125, DOI 10.1159/000381717; Pickering CR, 2014, CLIN CANCER RES, V20, P3842, DOI 10.1158/1078-0432.CCR-14-0565; Poling JS, 2014, ORAL ONCOL, V50, P306, DOI 10.1016/j.oraloncology.2014.01.006; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; Rabinovics N, 2015, ORAL ONCOL, V51, pe23, DOI [10.1016/j.oraloncology.2015.02.004, DOI 10.1016/J.0RAL0NC0L0GY.2015.02.004]; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rhodus Nelson L, 2014, Dent Clin North Am, V58, P315, DOI 10.1016/j.cden.2013.12.004; Saito K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071480; Schwartz JL, 2008, J ORAL PATHOL MED, V37, P70, DOI 10.1111/j.1600-0714.2007.00596.x; Sebastian P, 2014, J ORAL PATHOL MED, V43, P593, DOI 10.1111/jop.12175; Severino P, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-533; Simon R, 2007, CANCER INFORM, V3, P11; Tao K, 2014, AM J TRANSL RES, V6, P391; Tay FC, 2014, ADV DRUG DELIVERY RE; Tu HF, 2013, CURR OPIN OTOLARYNGO, V21, P104, DOI 10.1097/MOO.0b013e32835e1d6e; Varghese AM, 2014, J THORAC ONCOL, V9, P892, DOI 10.1097/JTO.0000000000000142; Villegas-Ruiz V, 2014, INT J CLIN EXP PATHO, V7, P1389; Walter V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056823; Westra WH, 2014, ORAL ONCOL, V50, P771, DOI 10.1016/j.oraloncology.2014.05.004; Wu BH, 2011, ORAL ONCOL, V47, P314, DOI 10.1016/j.oraloncology.2011.03.019; Xie ZJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057502; Zhang Huan, 2012, Cancer Biology Medicine, V9, P63, DOI 10.3969/j.issn.2095-3941.2012.01.012; Zhang J, 2013, BIOCHEM BIOPH RES CO, V440, P582, DOI 10.1016/j.bbrc.2013.09.142	61	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141695	10.1371/journal.pone.0141695	http://dx.doi.org/10.1371/journal.pone.0141695			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544609	Green Published, Green Submitted, gold			2022-12-26	WOS:000364398700039
J	Wolf, C; Pauly, A; Mayr, A; Gromer, T; Lenz, B; Kornhuber, J; Friedland, K				Wolf, Carolin; Pauly, Anne; Mayr, Andreas; Groemer, Teja; Lenz, Bernd; Kornhuber, Johannes; Friedland, Kristina			Pharmacist-Led Medication Reviews to Identify and Collaboratively Resolve Drug-Related Problems in Psychiatry - A Controlled, Clinical Trial	PLOS ONE			English	Article							APPROPRIATENESS INDEX; ERRORS; INTERVENTION; EVENTS; CARE; IDENTIFICATION; CLASSIFICATION; DOCUMENTATION; HOSPITALS; OUTCOMES	Aim of the study This prospective, controlled trial aimed to assess the effect of pharmacist-led medication reviews on the medication safety of psychiatric inpatients by the resolution of Drug-Related Problems (DRP). Both the therapy appropriateness measured with the Medication Appropriateness Index (MAI) and the number of unsolved DRP per patient were chosen as primary outcome measures. Methods Depending on their time of admission, 269 psychiatric patients that were admitted to a psychiatric university hospital were allocated in control (09/2012-03/2013) or intervention group (05/2013-12/2013). In both groups, DRP were identified by comprehensive medication reviews by clinical pharmacists at admission, during the hospital stay, and at discharge. In the intervention group, recommendations for identified DRP were compiled by the pharmacists and discussed with the therapeutic team. In the control group, recommendations were not provided except for serious or life threatening DRP. As a primary outcome measure, the changes in therapy appropriateness from admission to discharge as well as from admission to three months after discharge (follow-up) assessed with the MAI were compared between both groups. The second primary outcome was the number of unsolved DRP per patient after completing the study protocol. The DRP type, the relevance and the potential of drugs to cause DRP were also evaluated. Results The intervention led to a reduced MAI score by 1.4 points per patient (95% confidence interval [CI]: 0.8-2.0) at discharge and 1.3 points (95% CI: 0.7-1.9) at follow-up compared with controls. The number of unsolved DRP in the intervention group was 1.8 (95% CI: 1.5-2.1) less than in control. Conclusion The pharmaceutical medication reviews with interdisciplinary discussion of identified DRP appears to be a worthy strategy to improve medication safety in psychiatry as reflected by less unsolved DRP per patient and an enhanced appropriateness of therapy. The promising results of this trial likely warrant further research that evaluates direct clinical outcomes and health-related costs.	[Wolf, Carolin; Pauly, Anne; Friedland, Kristina] Univ Erlangen Nurnberg, Mol & Clin Pharm, D-91054 Erlangen, Germany; [Mayr, Andreas] Univ Erlangen Nurnberg, Dept Med Informat Biometry & Epidemiol, D-91054 Erlangen, Germany; [Groemer, Teja; Lenz, Bernd; Kornhuber, Johannes] Univ Erlangen Nurnberg, Dept Psychiat & Psychotherapy, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Friedland, K (corresponding author), Univ Erlangen Nurnberg, Mol & Clin Pharm, D-91054 Erlangen, Germany.	Kristina.leuner@fau.de	Kornhuber, Johannes/B-9613-2014; Friedland, Kristina/G-4651-2015	Kornhuber, Johannes/0000-0002-8096-3987; Mayr, Andreas/0000-0001-7106-9732; Friedland, Kristina/0000-0001-8603-5957; Lenz, Bernd/0000-0001-6086-0924	Forederinitiative Pharmazeutische Betreuung e.v	Forederinitiative Pharmazeutische Betreuung e.v	This work was supported by Forederinitiative Pharmazeutische Betreuung e.v, http://www.foerderinitiative.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderman CP, 1997, J CLIN PHARM THER, V22, P27, DOI 10.1046/j.1365-2710.1997.95975959.x; BATES DW, 1995, J GEN INTERN MED, V10, P199, DOI 10.1007/BF02600255; BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; Bondesson A, 2013, EUR J CLIN PHARMACOL, V69, P647, DOI 10.1007/s00228-012-1368-5; Brownlie K, 2014, INT J CLIN PHARM-NET, V36, P303, DOI 10.1007/s11096-013-9875-8; Burnett KM, 2009, AM J HEALTH-SYST PH, V66, P854, DOI 10.2146/ajhp080176; Campbell AR, 2011, AM J PHARM EDUC, V75; Dolder C, 2008, AM J HEALTH-SYST PH, V65, P1795, DOI 10.2146/ajhp060448; Fick DM, 2001, POTENTIALLY INAPPROP, V7; GANSO M, 2007, KRANKENHAUSPHARMAZIE, V28, P273; GANSO M, 2009, KRANKENHAUSPHARMAZIE, V30, P349; Gill-Banham S, 2003, PSYCHIAT B, V27, P208; Gillespie U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062401; Gillespie U, 2009, ARCH INTERN MED, V169, P894, DOI 10.1001/archinternmed.2009.71; Graabaek T, 2013, BASIC CLIN PHARMACOL, V112, P359, DOI 10.1111/bcpt.12062; Grasso B, 2007, J PHARM FINANC EC PO, V15, P73, DOI [10.1300/J371v15n0404, DOI 10.1300/J371V15N04_04]; Grasso BC, 2003, PSYCHIAT SERV, V54, P677, DOI 10.1176/appi.ps.54.5.677; Hanlon JT, 1996, AM J MED, V100, P428, DOI 10.1016/S0002-9343(97)89519-8; HANLON JT, 1992, J CLIN EPIDEMIOL, V45, P1045, DOI 10.1016/0895-4356(92)90144-C; Haynes RB, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000011.pub3; Hellstrom LM, 2011, EUR J CLIN PHARMACOL, V67, P741, DOI 10.1007/s00228-010-0982-3; Ito H, 2003, INT J QUAL HEALTH C, V15, P207, DOI 10.1093/intqhc/mzg038; Keers RN, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006084; Krahenbuhl-Melcher A, 2007, DRUG SAFETY, V30, P379; KUNKEL M, 2009, KRANKENHAUSPHARMAZIE, V30, P156; Mann K, 2008, WORLD J BIOL PSYCHIA, V9, P24, DOI 10.1080/15622970601178056; Muller F, 2014, EUR J CLIN PHARMACOL, V70, P727, DOI 10.1007/s00228-014-1665-2; National Coordinating Council for Medication Error Reporting and Prevention, WHAT IS MED ERR; Pharmaceutical Care Network Europe Foundation, PCNE CLASS V 6 2; Post TW, UPTODATE; Preston, STOCKLEYS DRUG INTER; Procyshyn RM, 2010, CNS DRUGS, V24, P595, DOI 10.2165/11533710-000000000-00000; Rothschild JM, 2007, GEN HOSP PSYCHIAT, V29, P156, DOI 10.1016/j.genhosppsych.2006.12.002; SAMSA GP, 1994, J CLIN EPIDEMIOL, V47, P891, DOI 10.1016/0895-4356(94)90192-9; Schaefer M, 2002, PHARM WORLD SCI, V24, P120, DOI 10.1023/A:1019543029936; SCHMADER K, 1994, J AM GERIATR SOC, V42, P1241; Schmader KE, 1997, ANN PHARMACOTHER, V31, P529, DOI 10.1177/106002809703100501; Senst BL, 2001, AM J HEALTH-SYST PH, V58, P1126, DOI 10.1093/ajhp/58.12.1126; Soerensen AL, 2013, RISK MANAG HEALTHC P, V6, P23, DOI 10.2147/RMHP.S47723; Spinewine A, 2006, J AM GERIATR SOC, V54, P720, DOI 10.1111/j.1532-5415.2006.00668_8.x; Spinewine A, 2007, J AM GERIATR SOC, V55, P658, DOI 10.1111/j.1532-5415.2007.01132.x; Stubbs J, 2004, HOSP PHARM, V11, P203; [Task Force on Patient Safety American Psychiatric Association], 2003, REC APA BOARD TRUST; van den Bemt PMLA, 2000, DRUG SAFETY, V22, P321, DOI 10.2165/00002018-200022040-00005; Viktil KK, 2008, BASIC CLIN PHARMACOL, V102, P275, DOI 10.1111/j.1742-7843.2007.00206.x; Viktil KK, 2006, PHARMACOEPIDEM DR S, V15, P667, DOI 10.1002/pds.1238	46	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142011	10.1371/journal.pone.0142011	http://dx.doi.org/10.1371/journal.pone.0142011			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV6RT	26544202	Green Submitted, Green Published, gold			2022-12-26	WOS:000364398700070
J	Zhang, YJ; Kong, WJ; Gao, Y; Liu, XY; Gao, K; Xie, H; Wu, Y; Zhang, YH; Wang, JM; Gao, F; Wu, XR; Jiang, YW				Zhang, Yujia; Kong, Weijing; Gao, Yang; Liu, Xiaoyan; Gao, Kai; Xie, Han; Wu, Ye; Zhang, Yuehua; Wang, Jingmin; Gao, Feng; Wu, Xiru; Jiang, Yuwu			Gene Mutation Analysis in 253 Chinese Children with Unexplained Epilepsy and Intellectual/Developmental Disabilities	PLoS One			English	Article							MIGRATING PARTIAL SEIZURES; CHILDHOOD-ONSET EPILEPSY; BETA-SUBUNIT; K+ CHANNELS; POTASSIUM; INACTIVATION; INFANCY; ENCEPHALOPATHY; PRODUCT; KCNA1B	Objective Epilepsy and intellectual/developmental disabilities (ID/DD) have a high rate of co-occurrence. Here, we investigated gene mutations in Chinese children with unexplained epilepsy and ID/DD. Methods We used targeted next-generation sequencing to detect mutations within 300 genes related to epilepsy and ID/DD in 253 Chinese children with unexplained epilepsy and ID/DD. A series of filtering criteria was used to find the possible pathogenic variations. Validation and parental origin analyses were performed by Sanger sequencing. We reviewed the phenotypes of patients with each mutated gene. Results We identified 32 novel and 16 reported mutations within 24 genes in 46 patients. The detection rate was 18% (46/253) in the whole group and 26% (17/65) in the early-onset (before three months after birth) epilepsy group. To our knowledge, we are the first to report KCNAB1 is a disease-causing gene of epilepsy by identifying a novel de novo mutation (c. 1062dupCA p.Leu355HisfsTer5) within this gene in one patient with early infantile epileptic encephalopathy (EIEE). Patients with an SCN1A mutation accounted for the largest proportion, 17% (8/46). A total of 38% (9/24) of the mutated genes re-occurred at least 2 times and 63% (15/24) occurred only one time. Ion channel genes are the most common (8/24) and genes related to synapse are the next most common to occur (5/24). Significance We have established genetic diagnosis for 46 patients of our cohort. Early-onset epilepsy had the highest detection rate. KCNAB1 mutation was first identified in EIEE patient. We expanded the phenotype and mutation spectrum of the genes we identified. The mutated genes in this cohort are mostly isolated. This suggests that epilepsy and ID/ DD phenotypes occur as a consequence of brain dysfunction caused by a highly diverse population of mutated genes. Ion channel genes and genes related to synapse were more common mutated in this patient cohort.	[Zhang, Yujia; Kong, Weijing; Liu, Xiaoyan; Gao, Kai; Xie, Han; Wu, Ye; Zhang, Yuehua; Wang, Jingmin; Wu, Xiru; Jiang, Yuwu] Peking Univ, Hosp 1, Dept Pediat, Beijing 100871, Peoples R China; [Zhang, Yujia; Kong, Weijing; Liu, Xiaoyan; Gao, Kai; Xie, Han; Wu, Ye; Zhang, Yuehua; Wang, Jingmin; Wu, Xiru; Jiang, Yuwu] Peking Univ, Hosp 1, Pediat Epilepsy Ctr, Beijing 100871, Peoples R China; [Zhang, Yujia; Jiang, Yuwu] Beijing Inst Brain Disorders, Ctr Epilepsy, Beijing, Peoples R China; [Gao, Yang] Dalian Med Univ, Hosp 2, Dept Neurosurg, Dalian, Peoples R China; [Gao, Feng] Zhejiang Univ, Childrens Hosp, Sch Med, Hangzhou, Zhejiang, Peoples R China	Peking University; Peking University; Dalian Medical University; Zhejiang University	Jiang, YW (corresponding author), Peking Univ, Hosp 1, Dept Pediat, Beijing 100871, Peoples R China.	jiangyuwu@bjmu.edu.cn	han, xie/AAO-9359-2021; jiang, yu/HGU-0029-2022	Zhang, Yuehua/0000-0003-1432-5423	National Key Research Project [2012CB944602]; Beijing Institute for Brain Disorders, the National Key Research Project [2012CB944602]; Beijing Institute for Brain Disorders Foundation [BIBDPXM2014_014226_000016]; grant for Beijing Key Laboratory of Pediatric Genetic Disease; Key Project of Beijing Natural Science Foundation [7151010]	National Key Research Project; Beijing Institute for Brain Disorders, the National Key Research Project; Beijing Institute for Brain Disorders Foundation; grant for Beijing Key Laboratory of Pediatric Genetic Disease; Key Project of Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by the National Key Research Project (2012CB944602) and Beijing Institute for Brain Disorders, the National Key Research Project (2012CB944602), and the Beijing Institute for Brain Disorders Foundation (BIBDPXM2014_014226_000016), grant for Beijing Key Laboratory of Pediatric Genetic Disease and Key Project of Beijing Natural Science Foundation (7151010).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Barcia G, 2012, NAT GENET, V44, P1255, DOI 10.1038/ng.2441; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Berg AT, 2008, EPILEPSIA, V49, P608, DOI 10.1111/j.1528-1167.2007.01461.x; Berg AT, 2012, EPILEPSY BEHAV, V23, P193, DOI 10.1016/j.yebeh.2012.01.015; Berg AT, 2011, EPILEPSIA, V52, P7, DOI 10.1111/j.1528-1167.2010.02905.x; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Busolin G, 2011, EPILEPSY RES, V94, P110, DOI 10.1016/j.eplepsyres.2011.01.010; Camfield C, 2007, PEDIATRICS, V120, pE52, DOI 10.1542/peds.2006-3290; Campomanes CR, 2002, J BIOL CHEM, V277, P8298, DOI 10.1074/jbc.M110276200; Carvill GL, 2013, NAT GENET, V45, P825, DOI 10.1038/ng.2646; Cavalleri GL, 2007, LANCET NEUROL, V6, P970, DOI 10.1016/S1474-4422(07)70247-8; Chahine L, 2013, EPILEPSY RES, V106, P338, DOI 10.1016/j.eplepsyres.2013.07.007; Diani E, 2008, EPILEPSY RES, V80, P1, DOI 10.1016/j.eplepsyres.2008.03.001; ENGLAND SK, 1995, J BIOL CHEM, V270, P28531, DOI 10.1074/jbc.270.48.28531; ENGLAND SK, 1995, P NATL ACAD SCI USA, V92, P6309, DOI 10.1073/pnas.92.14.6309; Freilich ER, 2011, ARCH NEUROL-CHICAGO, V68, P665, DOI 10.1001/archneurol.2011.98; Geerts A, 2011, EPILEPSIA, V52, P2192, DOI 10.1111/j.1528-1167.2011.03294.x; Giese KP, 1998, LEARN MEMORY, V5, P257; Hildebrand MS, 2013, J MED GENET, V50, P271, DOI 10.1136/jmedgenet-2012-101448; Jan LY, 1997, ANNU REV NEUROSCI, V20, P91, DOI 10.1146/annurev.neuro.20.1.91; Jefferys JGR, 2010, SEIZURE-EUR J EPILEP, V19, P638, DOI 10.1016/j.seizure.2010.10.026; Kong WJ, 2015, EPILEPSIA, V56, P431, DOI 10.1111/epi.12925; Leicher T, 1998, J BIOL CHEM, V273, P35095, DOI 10.1074/jbc.273.52.35095; Leicher T, 1996, NEUROPHARMACOLOGY, V35, P787, DOI 10.1016/0028-3908(96)00133-5; Lemke JR, 2012, EPILEPSIA, V53, P1387, DOI 10.1111/j.1528-1167.2012.03516.x; Lerche H, 2013, J PHYSIOL-LONDON, V591, P753, DOI 10.1113/jphysiol.2012.240606; MCCORMACK K, 1995, FEBS LETT, V370, P32, DOI 10.1016/0014-5793(95)00785-8; Muona M, 2015, NAT GENET, V47, P39, DOI 10.1038/ng.3144; Numis AL, 2014, NEUROLOGY, V82, P368, DOI 10.1212/WNL.0000000000000060; Pan YP, 2008, NAT CHEM BIOL, V4, P708, DOI 10.1038/nchembio.114; Pandolfo M, 2013, CURR OPIN NEUROL, V26, P137, DOI 10.1097/WCO.0b013e32835f19da; Pandolfo M, 2011, SEMIN NEUROL, V31, P506, DOI 10.1055/s-0031-1299789; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; Rojo DC, 2011, NEUROLOGY, V77, P380, DOI 10.1212/WNL.0b013e318227046d; Ropers HH, 2008, CURR OPIN GENET DEV, V18, P241, DOI 10.1016/j.gde.2008.07.008; Schulte U, 2006, NEURON, V49, P697, DOI 10.1016/j.neuron.2006.01.033; Schultz D, 1996, GENOMICS, V31, P389, DOI 10.1006/geno.1996.0065; Simons C, 2015, NAT GENET, V47, P73, DOI 10.1038/ng.3153; Syrbe S, 2015, NAT GENET, V47, P393, DOI 10.1038/ng.3239	42	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141782	10.1371/journal.pone.0141782	http://dx.doi.org/10.1371/journal.pone.0141782			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544041	gold, Green Published, Green Submitted			2022-12-26	WOS:000364398700045
J	Nanson, JD; Forwood, JK				Nanson, Jeffrey D.; Forwood, Jade K.			Structural Characterisation of FabG from Yersinia pestis, a Key Component of Bacterial Fatty Acid Synthesis	PLOS ONE			English	Article							BETA-KETOACYL REDUCTASE; ACYL CARRIER PROTEIN; ESCHERICHIA-COLI; FUNCTIONAL-CHARACTERIZATION; CRYSTAL-STRUCTURE; DEHYDROGENASE; INFORMATION; METABOLISM; INTERFACE; DISCOVERY	Ketoacyl-acyl carrier protein reductases (FabG) are ubiquitously expressed enzymes that catalyse the reduction of acyl carrier protein (ACP) linked thioesters within the bacterial type II fatty acid synthesis (FASII) pathway. The products of these enzymes, saturated and unsaturated fatty acids, are essential components of the bacterial cell envelope. The FASII reductase enoyl-ACP reductase (FabI) has been the focus of numerous drug discovery efforts, some of which have led to clinical trials, yet few studies have focused on FabG. Like FabI, FabG appears to be essential for survival in many bacteria, similarly indicating the potential of this enzyme as a drug target. FabG enzymes are members of the short-chain alcohol dehydrogenase/reductase (SDR) family, and like other SDRs, exhibit highly conserved secondary and tertiary structures, and contain a number of conserved sequence motifs. Here we describe the crystal structures of FabG from Yersinia pestis (YpFabG), the causative agent of bubonic, pneumonic, and septicaemic plague, and three human pandemics. Y. pestis remains endemic in many parts of North America, South America, Southeast Asia, and Africa, and a threat to human health. YpFabG shares a high degree of structural similarity with bacterial homologues, and the ketoreductase domain of the mammalian fatty acid synthase from both Homo sapiens and Sus scrofa. Structural characterisation of YpFabG, and comparison with other bacterial FabGs and the mammalian fatty acid synthase, provides a strong platform for virtual screening of potential inhibitors, rational drug design, and the development of new antimicrobial agents to combat Y. pestis infections.	[Nanson, Jeffrey D.; Forwood, Jade K.] Charles Sturt Univ, Sch Biomed Sci, Wagga Wagga, NSW 2678, Australia; [Forwood, Jade K.] Charles Sturt Univ, Graham Ctr Agr Innovat, Wagga Wagga, NSW 2678, Australia	Charles Sturt University; Charles Sturt University	Forwood, JK (corresponding author), Charles Sturt Univ, Sch Biomed Sci, Wagga Wagga, NSW 2678, Australia.	jforwood@csu.edu.au	Nanson, Jeffrey D/E-6313-2017	Nanson, Jeffrey D/0000-0003-1306-1948; Forwood, Jade/0000-0003-3267-9997				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; Banerjee DR, 2014, ORG BIOMOL CHEM, V12, P73, DOI 10.1039/c3ob41676c; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Caceres O, 2013, GENOME ANNOUNCEMENTS, V1; Cukier CD, 2013, ACS CHEM BIOL, V8, P2518, DOI 10.1021/cb4005063; Di Tommaso P., 2011, NUCLEIC ACIDS RES; Duax WL, 2005, ANN NY ACAD SCI, V1061, P135, DOI 10.1196/annals.1336.015; Dutta D, 2013, BIOCHEM J, V450, P127, DOI 10.1042/BJ20121107; Dutta D, 2011, J STRUCT BIOL, V174, P147, DOI 10.1016/j.jsb.2010.11.012; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; Ge PF, 2015, INT J INFECT DIS, V33, P67, DOI 10.1016/j.ijid.2014.12.044; GHOSH D, 1994, STRUCTURE, V2, P629, DOI 10.1016/S0969-2126(00)00064-2; Hardwicke MA, 2014, NAT CHEM BIOL, V10, P774, DOI [10.1038/NCHEMBIO.1603, 10.1038/nchembio.1603]; Janssen HJ, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-7; Kallberg Y, 2002, EUR J BIOCHEM, V269, P4409, DOI 10.1046/j.1432-1033.2002.03130.x; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Krissinel E, 2005, LECT NOTES COMPUT SC, V3695, P67; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lai CY, 2004, J BACTERIOL, V186, P1869, DOI 10.1128/JB.186.6.1869-1878.2004; Liu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064984; Maier T, 2008, SCIENCE, V321, P1315, DOI 10.1126/science.1161269; Martinez MA, 2010, MICROBIOL-SGM, V156, P484, DOI 10.1099/mic.0.033316-0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nanson JD, 2014, ACTA CRYSTALLOGR F, V70, P101, DOI 10.1107/S2053230X13033402; Oppermann U, 2003, CHEM-BIOL INTERACT, V143, P247, DOI 10.1016/S0009-2797(02)00164-3; Parsons JB, 2013, PROG LIPID RES, V52, P249, DOI 10.1016/j.plipres.2013.02.002; Pillai S, 2003, BIOCHEM BIOPH RES CO, V303, P387, DOI 10.1016/S0006-291X(03)00321-8; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Price AC, 2001, BIOCHEMISTRY-US, V40, P12772, DOI 10.1021/bi010737g; Price AC, 2004, STRUCTURE, V12, P417, DOI 10.1016/j.str.2004.02.008; Richard V, 2015, EMERG INFECT DIS, V21, P8, DOI 10.3201/eid2101.131828; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Shen Y, 2010, P NATL ACAD SCI USA, V107, P1082, DOI 10.1073/pnas.0909181107; Sohn MJ, 2008, J ANTIBIOT, V61, P687, DOI 10.1038/ja.2008.98; Stenseth NC, 2008, PLOS MED, V5, P9, DOI 10.1371/journal.pmed.0050003; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Wickramasinghe SR, 2006, BIOCHEM J, V393, P447, DOI 10.1042/BJ20050832; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang Y, 1998, J BACTERIOL, V180, P3295, DOI 10.1128/JB.180.13.3295-3303.1998; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839	45	10	11	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141543	10.1371/journal.pone.0141543	http://dx.doi.org/10.1371/journal.pone.0141543			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26539719	Green Published, Green Submitted, gold			2022-12-26	WOS:000364303800019
J	Chung, MJY; Friesen, AL; Fox, D; Meltzoff, AN; Rao, RPN				Chung, Michael Jae-Yoon; Friesen, Abram L.; Fox, Dieter; Meltzoff, Andrew N.; Rao, Rajesh P. N.			A Bayesian Developmental Approach to Robotic Goal-Based Imitation Learning	PLOS ONE			English	Article							OTHERS; BEHAVIOR; DESIGN	A fundamental challenge in robotics today is building robots that can learn new skills by observing humans and imitating human actions. We propose a new Bayesian approach to robotic learning by imitation inspired by the developmental hypothesis that children use self-experience to bootstrap the process of intention recognition and goal-based imitation. Our approach allows an autonomous agent to: (i) learn probabilistic models of actions through self-discovery and experience, (ii) utilize these learned models for inferring the goals of human actions, and (iii) perform goal-based imitation for robotic learning and human-robot collaboration. Such an approach allows a robot to leverage its increasing repertoire of learned behaviors to interpret increasingly complex human actions and use the inferred goals for imitation, even when the robot has very different actuators from humans. We demonstrate our approach using two different scenarios: (i) a simulated robot that learns human-like gaze following behavior, and (ii) a robot that learns to imitate human actions in a tabletop organization task. In both cases, the agent learns a probabilistic model of its own actions, and uses this model for goal inference and goal-based imitation. We also show that the robotic agent can use its probabilistic model to seek human assistance when it recognizes that its inferred actions are too uncertain, risky, or impossible to perform, thereby opening the door to human-robot collaboration.	[Chung, Michael Jae-Yoon; Friesen, Abram L.; Fox, Dieter; Rao, Rajesh P. N.] Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98195 USA; [Meltzoff, Andrew N.] Univ Washington, Inst Learning & Brain Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Rao, RPN (corresponding author), Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98195 USA.	rao@cs.washington.edu	Meltzoff, Andrew N/GPC-8807-2022	Meltzoff, Andrew N/0000-0001-8683-0547; Rao, Rajesh P. N./0000-0003-0682-8952	Office of Naval Research (ONR) Science of Autonomy [N000141310817]; Office of Naval Research (ONR) Cognitive Science program [N000140910097]; National Science Foundation (NSF) [SMA-1540619, IIS-1318733]; Intel Science and Technology Center (ISTC), Seattle; NSERC; Direct For Computer & Info Scie & Enginr [1318733] Funding Source: National Science Foundation	Office of Naval Research (ONR) Science of Autonomy(Office of Naval Research); Office of Naval Research (ONR) Cognitive Science program(Office of Naval Research); National Science Foundation (NSF)(National Science Foundation (NSF)); Intel Science and Technology Center (ISTC), Seattle; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported by Office of Naval Research (ONR) Science of Autonomy, grant no. N000141310817, http://www.onr.navy.mil/; Office of Naval Research (ONR) Cognitive Science program, grant no. N000140910097, http://www.onr.navy.mil/; National Science Foundation (NSF), NSF grant no. SMA-1540619 and NSF grant no. IIS-1318733, http://www.nsf.gov/; Intel Science and Technology Center (ISTC), Seattle; and (NSERC) fellowship to A. Friesen, http://www.nserc-crsng.gc.ca/index_eng.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen RA, 2003, VISUAL NEUROSCIENCES, P1324; Asada M, 2001, ROBOT AUTON SYST, V37, P185, DOI 10.1016/S0921-8890(01)00157-9; Baker CL, 2009, COGNITION, V113, P329, DOI 10.1016/j.cognition.2009.07.005; Billard A., 2000, Proceedings of the Fourth International Conference on Autonomous Agents, P373, DOI 10.1145/336595.337544; Billard A., 2008, SPRINGER HDB ROBOTIC, P1371, DOI DOI 10.1007/978-3-540-30301-5_60; Botvinick Matthew, 2009, Adv Neural Inf Process Syst, V21, P169; Breazeal C, 2005, ARTIF LIFE, V11, P31, DOI 10.1162/1064546053278955; Breazeal C, 2002, FROM ANIM ANIMAT, P363; Cangelosi A., 2015, DEV ROBOTICS BABIES; Churchland P., 1989, PHILOS PERSPECT, V3, P225, DOI [10.2307/2214269, DOI 10.2307/2214269]; Copete JL, 2014, DEV LEARNING EPIGENE, P334, DOI DOI 10.1109/DEVLRN.2014.6983005; Davies M., 1995, FOLK PSYCHOL; Deisenroth M., 2011, P 28 INT C MACH LEAR, P465; Ek C. H., 2010, 2010 10th IEEE-RAS International Conference on Humanoid Robots (Humanoids 2010), P548, DOI 10.1109/ICHR.2010.5686348; Gopnik A., 1997, WORDS THOUGHTS THEOR; Grimes D., 2006, P ROB SCI SYST; Grimes DB, 2009, LECT NOTES ARTIF INT, V5436, P103, DOI 10.1007/978-3-642-00616-6_7; Hoppitt WJE, 2008, TRENDS ECOL EVOL, V23, P486, DOI 10.1016/j.tree.2008.05.008; Kaipa KN, 2010, NEURAL NETWORKS, V23, P1113, DOI 10.1016/j.neunet.2010.07.009; KOLLER D., 2009, PROBABILISTIC GRAPHI; Kroemer O, 2015, IEEE INT CONF ROBOT, P1503, DOI 10.1109/ICRA.2015.7139389; Kwon WY, 2012, IEEE INT CONF ROBOT, P3685, DOI 10.1109/ICRA.2012.6224673; Lungarella M, 2003, CONNECT SCI, V15, P151, DOI 10.1080/09540090310001655110; Mataric MJ, 1998, TRENDS COGN SCI, V2, P82, DOI 10.1016/S1364-6613(98)01141-3; Matuszek Cynthia, 2011, IEEE International Conference on Robotics and Automation, P4291; MELTZOFF AN, 1995, DEV PSYCHOL, V31, P838, DOI 10.1037/0012-1649.31.5.838; Meltzoff AN, 1997, EARLY DEV PARENTING, V6, P179, DOI 10.1002/(SICI)1099-0917(199709/12)6:3/4<179::AID-EDP157>3.0.CO;2-R; Meltzoff AN, 2008, DEV PSYCHOL, V44, P1257, DOI 10.1037/a0012888; Meltzoff AN, 2007, DEVELOPMENTAL SCI, V10, P126, DOI 10.1111/j.1467-7687.2007.00574.x; Meltzoff AN, 2007, ACTA PSYCHOL, V124, P26, DOI 10.1016/j.actpsy.2006.09.005; Meltzoff AN, 2010, NEURAL NETWORKS, V23, P966, DOI 10.1016/j.neunet.2010.09.005; Meltzoff AN, 2009, SCIENCE, V325, P284, DOI 10.1126/science.1175626; Metta G, 1999, NEURAL NETWORKS, V12, P1413, DOI 10.1016/S0893-6080(99)00070-2; Montemerlo Michael, 2002, AAAI IAAI, DOI DOI 10.1007/S00244-005-7058-X; Patel M, 2013, IEEE INT CONF ROBOT, P4997, DOI 10.1109/ICRA.2013.6631291; Rao RPN, 2007, IMITATION AND SOCIAL LEARNING IN ROBOTS, HUMANS AND ANIMALS: BEHAVIOURAL, SOCIAL AND COMMUNICATIVE DIMENSIONS, P217, DOI 10.1017/CBO9780511489808.016; Rasmussen C., 2003, ADV NEURAL INFORM PR, P489; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; Richardson M, 2006, MACH LEARN, V62, P107, DOI 10.1007/s10994-006-5833-1; Sauser EL, 2005, NEUROCOMPUTING, V64, P5, DOI 10.1016/j.neucom.2004.11.019; Sauser EL, 2007, LECT NOTES COMPUT SC, V4669, P768; Scassellati B., 1999, Computation for metaphors, analogy, and agents, P176; Schaal S, 1999, TRENDS COGN SCI, V3, P233, DOI 10.1016/S1364-6613(99)01327-3; Shon AP, 2007, INT J HUM ROBOT, V4, P387, DOI 10.1142/S0219843607001059; Song D., 2010, 2010 IEEE/RSJ International Conference on Intelligent Robots and Systems (IROS 2010), P1579, DOI 10.1109/IROS.2010.5649406; Tenenbaum JB, 2011, SCIENCE, V331, P1279, DOI 10.1126/science.1192788; Thrun S., 2005, PROBABILISTIC ROBOTI; Toussaint Marc, 2006, INT C MACH LEARN ICM, P945; Ugur E, 2015, IEEE T AUTON MENT DE, V7, P119, DOI 10.1109/TAMD.2015.2426192; Verma D., 2006, ADV NEURAL INFORM PR, P1393; Verma D, 2007, LECT NOTES ARTIF INT, V4701, P757; Verma D, 2006, 2006 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-12, P2382, DOI 10.1109/IROS.2006.281675; Waismeyer A, 2015, DEVELOPMENTAL SCI, V18, P175, DOI 10.1111/desc.12208; Wang ZK, 2013, INT J ROBOT RES, V32, P841, DOI 10.1177/0278364913478447	54	6	6	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141965	10.1371/journal.pone.0141965	http://dx.doi.org/10.1371/journal.pone.0141965			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536366	Green Published, Green Submitted, gold			2022-12-26	WOS:000364298400108
J	Li, X; Lu, M; Tang, DQ; Shi, YM				Li, Xin; Lu, Min; Tang, Dongqin; Shi, Yimin			Composition of Carotenoids and Flavonoids in Narcissus Cultivars and their Relationship with Flower Color	PLOS ONE			English	Article							HPLC; ANTHOCYANINS; QUANTIFICATION; IDENTIFICATION; ANTIOXIDANT; EXTRACTS; PETALS; MS/MS; NAPUS	Narcissus is widely used for cut flowers and potted plants, and is one of the most important commercial bulbous flowers in the floricultural industry. In this study, ten carotenoid and eighteen flavonoid compounds from the perianths and coronas of fifteen narcissus cultivars were measured by HPLC-APCI-MS/MS and UPLC-Q-TOF-MS/MS. Among these, six carotenoids, a total of seventeen flavonols and chlorogenic acid were identified in narcissus for the first time. A multivariate analysis was used to explore the relationship between flower color and pigment composition. We found that all-trans-violaxanthin and total carotenoid content were the main factors that affected flower color. These investigations could provide a global view of flower color formation and a theoretical basis for hybridization breeding in narcissus.	[Li, Xin; Lu, Min; Tang, Dongqin; Shi, Yimin] Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Shi, YM (corresponding author), Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai 200030, Peoples R China.	shiyimin@sjtu.edu.cn			Shanghai Chongming Project [13391912504]	Shanghai Chongming Project	This work was supported by Shanghai Chongming Project (Grant 13391912504). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auger B, 2010, J AGR FOOD CHEM, V58, P6246, DOI 10.1021/jf903619v; Bako E, 2002, J BIOCHEM BIOPH METH, V53, P241, DOI 10.1016/S0165-022X(02)00112-4; Chiste RC, 2012, J AGR FOOD CHEM, V60, P5884, DOI 10.1021/jf301904f; de Faria AF, 2009, PLANT FOOD HUM NUTR, V64, P108, DOI 10.1007/s11130-009-0111-6; de Rosso VV, 2007, J AGR FOOD CHEM, V55, P5062, DOI 10.1021/jf0705421; Ertas A, 2014, J AGR FOOD CHEM, V62, P4601, DOI 10.1021/jf500067q; Fromm M, 2012, J AGR FOOD CHEM, V60, P10733, DOI 10.1021/jf3028446; Grotewold E, 2006, ANNU REV PLANT BIOL, V57, P761, DOI 10.1146/annurev.arplant.57.032905.105248; He QL, 2011, PLOS ONE, V6, P1; Jia N, 2008, SCI HORTIC-AMSTERDAM, V117, P167, DOI 10.1016/j.scienta.2008.03.016; Kishimoto S, 2005, BIOSCI BIOTECH BIOCH, V69, P2122, DOI 10.1271/bbb.69.2122; Kishimoto S, 2004, PHYTOCHEMISTRY, V65, P2781, DOI 10.1016/j.phytochem.2004.08.038; Li CH, 2009, J AGR FOOD CHEM, V57, P8496, DOI 10.1021/jf902103b; Li L, 2013, ARCH BIOCHEM BIOPHYS, V539, P102, DOI 10.1016/j.abb.2013.07.002; Lin LZ, 2011, J AGR FOOD CHEM, V59, P12059, DOI 10.1021/jf202556p; MA YL, 2001, PHYTOCHEM ANALYSIS, V12, P159; Melendez-Martinez AJ, 2009, J SEP SCI, V32, P1838, DOI 10.1002/jssc.200800717; Ohmiya A, 2011, JARQ-JPN AGR RES Q, V45, P163, DOI 10.6090/jarq.45.163; Olsen H, 2009, J AGR FOOD CHEM, V57, P2816, DOI 10.1021/jf803693t; de Andrade JP, 2012, J PHARMACEUT BIOMED, V70, P13, DOI 10.1016/j.jpba.2012.05.009; Sanchez-Rabaneda F, 2003, J MASS SPECTROM, V38, P35, DOI 10.1002/jms.395; Santos-Gally R, 2012, J BIOGEOGR, V39, P782, DOI 10.1111/j.1365-2699.2011.02526.x; Schmitzer V, 2012, SCI HORTIC-AMSTERDAM, V146, P14, DOI 10.1016/j.scienta.2012.07.035; Shao YL, 2014, J AGR FOOD CHEM, V62, P2935, DOI 10.1021/jf404826u; Suzuki S, 2007, PLANT CELL REP, V26, P951, DOI 10.1007/s00299-006-0302-7; Tanaka Y, 2008, PLANT J, V54, P733, DOI 10.1111/j.1365-313X.2008.03447.x; Tanaka Y, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0432; VALADON LRG, 1968, BIOCHEM J, V106, P479, DOI 10.1042/bj1060479; Vera de Rosso V, 2007, J AGR FOOD CHEM, V55, P9135, DOI 10.1021/jf071316u; Wang LJ, 2014, FOOD CHEM, V160, P357, DOI 10.1016/j.foodchem.2014.03.081; Wang X, 2005, J CHROMATOGR A, V1075, P127, DOI 10.1016/j.chroma.2005.04.017; Whent M, 2012, J AGR FOOD CHEM, V60, P2129, DOI 10.1021/jf203807w; Xie ZH, 2011, J AGR FOOD CHEM, V59, P9877, DOI 10.1021/jf202069g; Yang RZ, 2009, J CHROMATOGR A, V1216, P106, DOI 10.1016/j.chroma.2008.11.046; Yun Z, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-44; Zhu CF, 2010, ARCH BIOCHEM BIOPHYS, V504, P132, DOI 10.1016/j.abb.2010.07.028; Zsila F, 2001, PLANTA, V213, P937, DOI 10.1007/s004250100569	37	28	30	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142074	10.1371/journal.pone.0142074	http://dx.doi.org/10.1371/journal.pone.0142074			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536625	Green Published, Green Submitted, gold			2022-12-26	WOS:000364298400129
J	Smithson, P; Florey, L; Salgado, SR; Hershey, CL; Masanja, H; Bhattarai, A; Mwita, A; McElroy, PD				Smithson, Paul; Florey, Lia; Salgado, S. Rene; Hershey, Christine L.; Masanja, Honorati; Bhattarai, Achuyt; Mwita, Alex; McElroy, Peter D.		Tanzania Malaria Impact Evaluation	Impact of Malaria Control on Mortality and Anemia among Tanzanian Children Less than Five Years of Age, 1999-2010	PLOS ONE			English	Article							INSECTICIDE-TREATED NETS; SUB-SAHARAN AFRICA; SULFADOXINE-PYRIMETHAMINE; TREATMENT POLICY; PUBLIC-HEALTH; PROTECTIVE EFFICACY; SYSTEMATIC ANALYSIS; MATERNAL EDUCATION; NEONATAL-MORTALITY; ATTRIBUTABLE RISK	Background Mainland Tanzania scaled up multiple malaria control interventions between 1999 and 2010. We evaluated whether, and to what extent, reductions in all-cause under-five child mortality (U5CM) tracked with malaria control intensification during this period. Methods Four nationally representative household surveys permitted trend analysis for malaria intervention coverage, severe anemia (hemoglobin <8 g/dL) prevalence (SAP) among children 6-59 months, and U5CM rates stratified by background characteristics, age, and malaria endemicity. Prevalence of contextual factors (e.g., vaccination, nutrition) likely to influence U5CM were also assessed. Population attributable risk percentage (PAR%) estimates for malaria interventions and contextual factors that changed over time were used to estimate magnitude of impact on U5CM. Results Household ownership of insecticide-treated nets (ITNs) rose from near zero in 1999 to 64% (95% CI, 61.7-65.2) in 2010. Intermittent preventive treatment of malaria in pregnancy reached 26% (95% CI, 23.6-28.0) by 2010. Sulfadoxine-pyrimethamine replaced chloroquine in 2002 and artemisinin-based combination therapy was introduced in 2007. SAP among children 6-59 months declined 50% between 2005 (11.1%; 95% CI, 10.0-12.3%) and 2010 (5.5%; 95% CI, 4.7-6.4%) and U5CM declined by 45% between baseline (1995-9) and endpoint (2005-9), from 148 to 81 deaths/1000 live births, respectively. Mortality declined 55% among children 1-23 months of age in higher malaria endemicity areas. A large reduction in U5CM was attributable to ITNs (PAR%=11) with other malaria interventions adding further gains. Multiple contextual factors also contributed to survival gains. Conclusion Marked declines in U5CM occurred in Tanzania between 1999 and 2010 with high impact from ITNs and ACTs. High-risk children (1-24 months of age in high malaria endemicity) experienced the greatest declines in mortality and SAP. Malaria control should remain a policy priority to sustain and further accelerate progress in child survival.	[Smithson, Paul; Masanja, Honorati] Ifakara Hlth Inst, Dar Es Salaam, Tanzania; [Florey, Lia] ICF Int, Rockville, MD USA; [Salgado, S. Rene; Hershey, Christine L.] US Agcy Int Dev, US Presidents Malaria Initiat, Washington, DC 20523 USA; [Bhattarai, Achuyt; McElroy, Peter D.] Ctr Dis Control & Prevent, US Presidents Malaria Initiat, Atlanta, GA USA; [Mwita, Alex] Minist Hlth & Social Welf, Natl Malaria Control Programme, Dar Es Salaam, Tanzania	Ifakara Health Institute; United States Agency for International Development (USAID); Centers for Disease Control & Prevention - USA	Smithson, P (corresponding author), Ifakara Hlth Inst, Dar Es Salaam, Tanzania.	psmithson@ihi.or.tz	Bhattarai, Achuyt/B-8760-2008	Bhattarai, Achuyt/0000-0002-0514-4850	United Republic of Tanzania Ministry of Health and Social Welfare; U. S. Agency for International Development; United Nations Children's Fund; Global Fund; Department for International Development; United Nations Population Fund; World Food Programme; United Nations Development Programme; Irish Aid	United Republic of Tanzania Ministry of Health and Social Welfare; U. S. Agency for International Development(United States Agency for International Development (USAID)); United Nations Children's Fund; Global Fund; Department for International Development; United Nations Population Fund; World Food Programme; United Nations Development Programme; Irish Aid(CGIAR)	The household surveys included in this analysis were funded in part by the United Republic of Tanzania Ministry of Health and Social Welfare, U. S. Agency for International Development, United Nations Children's Fund, The Global Fund, Department for International Development, United Nations Population Fund, World Food Programme, United Nations Development Programme, and Irish Aid. The authors received no specific funding for this work.	Abdalla SHPG, 2011, TROPICAL INFECT DIS, P1024; Abdullah S, 2007, AM J TROP MED HYG, V77, P99; Alba S, 2014, INT J EPIDEMIOL, V43, P204, DOI 10.1093/ije/dyt231; [Anonymous], 2010, LANCET, V375, P526, DOI 10.1016/S0140-6736(10)60056-6; [Anonymous], 2008, GLOB MAL ACT PLAN; [Anonymous], 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000363.PUB2; [Anonymous], 2013, 2012 TANZ POP HOUS C; [Anonymous], HLTH PEOPL AFR REG H; [Anonymous], 2012, GLOB REP UNAIDS REP; [Anonymous], 2013, UNAIDS REP GLOB AIDS; [Anonymous], 2011, TANZ DEM HLTH SURV 2; Atieli HE, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-113; Bahl R, 2005, B WORLD HEALTH ORGAN, V83, P418; Basu AM, 2005, SOC SCI MED, V60, P2011, DOI 10.1016/j.socscimed.2004.08.057; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Bhutta Z.A., 2008, LANCET, V371, P417, DOI [10.1016/S0140-6736(07)61693-6, DOI 10.1016/S0140-6736(07)61693-6]; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Blencowe H, 2010, INT J EPIDEMIOL, V39, P102, DOI 10.1093/ije/dyq027; BLOLAND PB, 1993, J INFECT DIS, V167, P932, DOI 10.1093/infdis/167.4.932; Boerma J T, 1993, World Health Stat Q, V46, P222; Bonner K, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-73; Calis JCJ, 2008, NEW ENGL J MED, V358, P888, DOI 10.1056/NEJMoa072727; Chizema-Kawesha E, 2010, AM J TROP MED HYG, V83, P480, DOI 10.4269/ajtmh.2010.10-0035; CLELAND JG, 1988, SOC SCI MED, V27, P1357, DOI 10.1016/0277-9536(88)90201-8; Cuadros DF, 2011, INT J EPIDEMIOL, V40, P931, DOI 10.1093/ije/dyq256; Drakeley CJ, 2005, J INFECT DIS, V191, P1589, DOI 10.1086/429669; Eisele TP, 2012, LANCET INFECT DIS, V12, P942, DOI 10.1016/S1473-3099(12)70222-0; Eisele TP, 2010, INT J EPIDEMIOL, V39, P88, DOI 10.1093/ije/dyq026; Farnert A, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-459; Filmer D, 1999, SOC SCI MED, V49, P1309, DOI 10.1016/S0277-9536(99)00150-1; Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3; Gething PW, 2010, NATURE, V465, P342, DOI 10.1038/nature09098; Govender T, 2014, J INFECTION, V68, pS57, DOI 10.1016/j.jinf.2013.09.015; Greenwood B, 2014, LANCET, V383, P1703, DOI 10.1016/S0140-6736(14)60044-1; Grover-Kopec E, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-6; Habicht JP, 1999, INT J EPIDEMIOL, V28, P10, DOI 10.1093/ije/28.1.10; Hanson K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-205; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hill GB, 1996, AM J PUBLIC HEALTH, V86, P1483, DOI 10.2105/AJPH.86.10.1483-a; [ICF International MEASURE DHS], 2006, GUIDE DHS STAT; Imdad A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S20; Inc. NBoSaMI, 1993, TANZ DEM HLTH SURV 1; Inc. NBoSaMI, 1997, TANZ DEM HLTH SURV 1; International Monetary Fund, 2012, ECONSTATS WORLD EC O; International Monetary Fund Staff, 2011, REG EC OUTL OCT 2011; International Research Institute, 2013, WEIGHT AN STAND PREC; Ishengoma DS, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-338; Joseph D, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-60; Karema C, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-236; KELSEY JL, 1986, METHODS OBSERVATIONA; Kleinschmidt I, 2009, AM J TROP MED HYG, V80, P882, DOI 10.4269/ajtmh.2009.80.882; Korenromp EL, 2004, TROP MED INT HEALTH, V9, P1050, DOI 10.1111/j.1365-3156.2004.01317.x; Korenromp EL, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-94; Lawn JE, 2012, HEALTH POLICY PLANN, V27, P6, DOI 10.1093/heapol/czs053; Lim SS, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001091; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lyon B, 2005, J CLIMATE, V18, P5095, DOI 10.1175/JCLI3598.1; Macro NBoSNal, 2011, MICR RES 2010 TANZ D; Magesa SM, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-34; Masanja H, 2008, LANCET, V371, P1276, DOI 10.1016/S0140-6736(08)60562-0; Mayo-Wilson E, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5094; McCurdy RJ, 2011, ACTA OBSTET GYN SCAN, V90, P779, DOI 10.1111/j.1600-0412.2011.01133.x; McDonald CM, 2013, AM J CLIN NUTR, V97, P896, DOI 10.3945/ajcn.112.047639; Mugittu K, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-55; Mugittu K, 2004, AM J TROP MED HYG, V71, P696, DOI 10.4269/ajtmh.2004.71.696; Mushi AK, 2003, HEALTH POLICY PLANN, V18, P163, DOI 10.1093/heapol/czg021; Namusoke F, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-310; [National Bureau of Statistics ORC Macro], 2005, TANZ DEM HLTH SURV 2; [National Bureau of Statistics Macro International], 2000, TANZ REPR CHILD HLTH; National Malaria Control Programme, 2008, TANZ MAL MED TERM ST; National Malaria Control Programme, 2003, TANZ MAL MED TERM ST; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; NORTHRIDGE ME, 1995, AM J PUBLIC HEALTH, V85, P1202, DOI 10.2105/AJPH.85.9.1202; O'Meara WP, 2008, AM J TROP MED HYG, V79, P185, DOI 10.4269/ajtmh.2008.79.185; Obonyo CO, 2007, AM J TROP MED HYG, V77, P23; Okiro EA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-4; Omumbo JA, 2005, TROP MED INT HEALTH, V10, P557, DOI 10.1111/j.1365-3156.2005.01424.x; Paaijmans KP, 2009, P NATL ACAD SCI USA, V106, P13844, DOI 10.1073/pnas.0903423106; PELLETIER DL, 1995, B WORLD HEALTH ORGAN, V73, P443; Pulford J, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-83; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Rapuoda B, 2003, TROP MED INT HEALTH, V8, P860, DOI 10.1046/j.1360-2276.2003.01114.x; Renggli S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-85; Reyburn H, 2005, JAMA-J AM MED ASSOC, V293, P1461, DOI 10.1001/jama.293.12.1461; Roll Back Malaria Partnership, 2011, DEC PARTN RES; Roll Back Malaria Partnership, 2009, GUID COR POP BAS IND; Rowe AK, 2007, AM J TROP MED HYG, V77, P48, DOI 10.4269/ajtmh.2007.77.48; Ruton H, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-4; Singh M, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-268; Snow RW, 2010, LANCET, V376, P137, DOI 10.1016/S0140-6736(10)60577-6; Stresman GH, 2010, ACTA TROP, V116, P167, DOI 10.1016/j.actatropica.2010.08.005; TACAIDS/Tanzania ZAC/Tanzania NBS/Tanzania OCGS/Tanzania and Macro International, 2008, TANZ HIV AIDS MAL IN; Tanzania Commission for AIDS (TACAIDS) National Bureau of Statistics (NBS) [Tanzania] & ORC Macro, 2005, TANZ HIV AIDS IND SU; The Global Fund to Fight AIDS TaM, 2010, IMPR VAL MON GLOB FU; Thwing J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S14; Trape JF, 1998, CR ACAD SCI III-VIE, V321, P689, DOI 10.1016/S0764-4469(98)80009-7; UNAIDS, 2011, GLOB REP UNAIDS REP; UNAIDS, 1999, AIDS EPIDEMIC UPDATE; [UNFPA World Bank WHO U], 2012, TRENDS MAT MORT 1990; UNICEF, 2015, COMMITTING CHILD SUR; United Nations Inter-agency Group for Child Mortality Estimation, 2013, LEV TRENDS CHILD MOR; United Nations Inter-agency Group for Child Mortality Estimation, 2011, LEV TRENDS CHILD MOR; Vega JC, 2007, TROP MED INT HEALTH, V12, P1524, DOI 10.1111/j.1365-3156.2007.01961.x; Victora CG, 2004, AM J PUBLIC HEALTH, V94, P400, DOI 10.2105/AJPH.94.3.400; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2009, GLOB PREV VIAT A DEF; World Bank, 2013, GDP PER CAP CURR US; Yazbeck AS, 2007, LANCET, V370, P1291, DOI 10.1016/S0140-6736(07)61553-0	110	32	32	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141112	10.1371/journal.pone.0141112	http://dx.doi.org/10.1371/journal.pone.0141112			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV5GZ	26536354	gold, Green Submitted, Green Published			2022-12-26	WOS:000364298400054
J	Brokordt, KB; Gonzalez, RC; Farias, WJ; Winkler, FM				Brokordt, Katherina B.; Gonzalez, Roxana C.; Farias, William J.; Winkler, Federico M.			Potential Response to Selection of HSP70 as a Component of Innate Immunity in the Abalone Haliotis rufescens	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; SPOT SYNDROME VIRUS; GENE-EXPRESSION; BODY-SIZE; VIBRIO-SPLENDIDUS; PENAEUS-MONODON; TRADE-OFFS; HERITABILITY; RESISTANCE; SYSTEM	Assessing components of the immune system may reflect disease resistance. In some invertebrates, heat shock proteins (HSPs) are immune effectors and have been described as potent activators of the innate immune response. Several diseases have become a threat to abalone farming worldwide; therefore, increasing disease resistance is considered to be a long-term goal for breeding programs. A trait will respond to selection only if it is determined partially by additive genetic variation. The aim of this study was to estimate the heritability (h(2)) and the additive genetic coefficient of variation (CVA) of HSP70 as a component of innate immunity of the abalone Haliotis rufescens, in order to assess its potential response to selection. These genetic components were estimated for the variations in the intracellular (in haemocytes) and extracellular (serum) protein levels of HSP70 in response to an immunostimulant agent in 60 full-sib families of H. rufescens. Levels of HSP70 were measured twice in the same individuals, first when they were young and again when they were pre-harvest adults, to estimate the repeatability (R), the h(2) and the potential response to selection of these traits at these life stages. High HSP70 levels were observed in abalones subjected to immunostimulation in both the intracellular and extracellular haemolymph fractions. This is the first time that changes in serum levels of HSP70 have been reported in response to an immune challenge in molluscs. HSP70 levels in both fractions and at both ages showed low h(2) and R, with values that were not significantly different from zero. However, HSP70 induced levels had a CVA of 13.3-16.2% in young adults and of 2.7-8.1% in pre-harvest adults. Thus, despite its low h(2), HSP70 synthesis in response to an immune challenge in red abalone has the potential to evolve through selection because of its large phenotypic variation and the presence of additive genetic variance, especially in young animals.	[Brokordt, Katherina B.; Gonzalez, Roxana C.; Farias, William J.; Winkler, Federico M.] Ctr Estudios Avanzados Zonas Aridas, Coquimbo, Chile; [Brokordt, Katherina B.; Gonzalez, Roxana C.; Farias, William J.; Winkler, Federico M.] Univ Catolica Norte, Dept Biol Marina, Fac Ciencias Mar, Coquimbo, Chile	Universidad Catolica del Norte	Brokordt, KB (corresponding author), Ctr Estudios Avanzados Zonas Aridas, Coquimbo, Chile.	kbrokord@ucn.cl			Fondo Nacional de Ciencia y Tecnologia (FONDECYT) [1140849]; Fondo de Fomento al Desarrollo Cientifico y Tecnologico (FONDEF) [D05I-10013]	Fondo Nacional de Ciencia y Tecnologia (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Fondo de Fomento al Desarrollo Cientifico y Tecnologico (FONDEF)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDEF)	This study was financed by Fondo Nacional de Ciencia y Tecnologia (FONDECYT) Grant No. 1140849 (http://www.conicyt.cl/fondecyt/) to KB; and Fondo de Fomento al Desarrollo Cientifico y Tecnologico (FONDEF) Grant No. D05I-10013 (http://www.conicyt.cl/fondef/) to FW.	Basu S, 2000, CELL STRESS CHAPERON, V5, P443, DOI 10.1379/1466-1268(2000)005<0443:HSPTFO>2.0.CO;2; Beardmore JA, 1998, J APPL ICHTHYOL, V14, P167, DOI 10.1111/j.1439-0426.1998.tb00637.x; Bech C, 1999, P ROY SOC B-BIOL SCI, V266, P2161, DOI 10.1098/rspb.1999.0903; Brookfield JFY, 2009, BIOL LETTERS, V5, P44, DOI 10.1098/rsbl.2008.0639; Brown T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067246; Calderwood SK, 2007, METHODS, V43, P199, DOI 10.1016/j.ymeth.2007.06.008; Calderwood SK, 2007, FEBS LETT, V581, P3689, DOI 10.1016/j.febslet.2007.04.044; Campalans M, 2009, REV BIOL MAR OCEANOG, V44, P561; Cellura C, 2007, FISH SHELLFISH IMMUN, V22, P340, DOI 10.1016/j.fsi.2006.06.007; Cellura C, 2006, DEV COMP IMMUNOL, V30, P984, DOI 10.1016/j.dci.2005.12.009; Cheng PZ, 2007, FISH SHELLFISH IMMUN, V22, P77, DOI 10.1016/j.fsi.2006.03.014; Christe P, 2000, HEREDITY, V85, P75, DOI 10.1046/j.1365-2540.2000.00732.x; Coltman DW, 2001, EVOLUTION, V55, P2116, DOI 10.1111/j.0014-3820.2001.tb01326.x; Cotter SC, 2004, J EVOLUTION BIOL, V17, P421, DOI 10.1046/j.1420-9101.2003.00655.x; Cotter SC, 2002, HEREDITY, V88, P229, DOI 10.1038/sj.hdy.6800031; Crane MS, 2013, J SHELLFISH RES, V32, P67, DOI 10.2983/035.032.0112; Crosson LM, 2014, DIS AQUAT ORGAN, V108, P261, DOI 10.3354/dao02713; Cui ZX, 2010, FISH SHELLFISH IMMUN, V28, P56, DOI 10.1016/j.fsi.2009.09.018; Decanini LI, 2007, J HERED, V98, P195, DOI 10.1093/jhered/esm008; Diggles B, 2005, DIS ASIAN AQUACULTUR, P275; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Dohm MR, 2002, FUNCT ECOL, V16, P273; Falconer D. S., 1996, INTRO QUANTITATIVE G; Fellowes MDE, 1998, P ROY SOC B-BIOL SCI, V265, P1553, DOI 10.1098/rspb.1998.0471; Flores-Aguilar RA, 2007, J SHELLFISH RES, V26, P705, DOI 10.2983/0730-8000(2007)26[705:DACSOA]2.0.CO;2; Gestal C, 2007, GENE, V406, P134, DOI 10.1016/j.gene.2007.07.030; Gestal C, 2008, REV FISH SCI, V16, P133, DOI 10.1080/10641260802325518; Gilmour A, 2009, ASREML USER GUIDE; Gjedrem T, 2009, REV-METHODS TECHNOL, V10, P1, DOI 10.1007/978-90-481-2773-3_1; Gordon HR, 2001, J SHELLFISH RES, V20, P567; Hill BJ, 2005, DEV BIOLOGICALS, V121, P3; HOULE D, 1992, GENETICS, V130, P195; Huang F, 1999, B ENTOMOL RES, V89, P449, DOI 10.1017/S0007485399000589; Institute SAS, 1999, SAS SYST WIND REL 8; JOHNSON DL, 1995, J DAIRY SCI, V78, P449, DOI 10.3168/jds.S0022-0302(95)76654-1; Kruuk LEB, 2004, PHILOS T R SOC B, V359, P873, DOI 10.1098/rstb.2003.1437; Kurtz J, 1999, P ROY SOC B-BIOL SCI, V266, P2515, DOI 10.1098/rspb.1999.0954; Kurtz J, 2003, NATURE, V425, P37, DOI 10.1038/425037a; Lacoste A, 2001, DIS AQUAT ORGAN, V46, P139, DOI 10.3354/dao046139; Langand J, 1998, J PARASITOL, V84, P739, DOI 10.2307/3284580; Lenth R., 2014, LEAST SQUARES MEANS; Loker ES, 2010, ADV EXP MED BIOL, V708, P17; Loker ES, 2004, IMMUNOL REV, V198, P10, DOI 10.1111/j.0105-2896.2004.0117.x; Lynch M., 1998, GENETIC ANAL QUANTIT; Yanez JM, 2013, AQUACULTURE, V414, P155, DOI 10.1016/j.aquaculture.2013.08.009; Merila J, 1999, HEREDITY, V83, P103, DOI 10.1038/sj.hdy.6885850; Mgaya YD, 2000, RE ADV MAR BIOTECHNO, V4, P59; Morse D, 2000, SCIENCE, V196, P298; MOUSSEAU TA, 1987, HEREDITY, V59, P181, DOI 10.1038/hdy.1987.113; Norris K, 2000, BEHAV ECOL, V11, P19, DOI 10.1093/beheco/11.1.19; Pockley AG, 2008, TRENDS BIOCHEM SCI, V33, P71, DOI 10.1016/j.tibs.2007.10.005; PRICE T, 1991, EVOLUTION, V45, P853, DOI 10.1111/j.1558-5646.1991.tb04354.x; Robert J, 2003, DEV COMP IMMUNOL, V27, P449, DOI 10.1016/S0145-305X(02)00160-X; Rungrassamee W, 2010, DEV COMP IMMUNOL, V34, P1082, DOI 10.1016/j.dci.2010.05.012; Ryder JJ, 2001, J EVOLUTION BIOL, V14, P646, DOI 10.1046/j.1420-9101.2001.00302.x; Schmitt E, 2007, J LEUKOCYTE BIOL, V81, P15, DOI 10.1189/jlb.0306167; Senar J.C., 1999, Etologuia, V17, P53; Snedecor G.W., 1989, AMES IOWA STATE U PR; Song LS, 2010, ADV EXP MED BIOL, V708, P44; Srivastava P, 2002, NAT REV IMMUNOL, V2, P185, DOI 10.1038/nri749; Stirling DG, 2002, J EVOLUTION BIOL, V15, P277, DOI 10.1046/j.1420-9101.2002.00389.x; Sung Y.Y., 2011, J AQUAC RES DEV, V3, P1, DOI 10.4172/2155-9546.S2-006; Tan JM, 2008, J VIROL METHODS, V149, P338, DOI 10.1016/j.jviromet.2007.12.019; Tsan MF, 2009, J LEUKOCYTE BIOL, V85, P905, DOI 10.1189/jlb.0109005; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; Wakelin D, 1996, IMMUNITY PARASITES; Wang B, 2006, MAR BIOTECHNOL, V8, P491, DOI 10.1007/s10126-005-6136-4; Whitehead A, 2006, P NATL ACAD SCI USA, V103, P5425, DOI 10.1073/pnas.0507648103; Witteveldt J, 2004, J VIROL, V78, P2057, DOI 10.1128/JVI.78.4.2057-2061.2004; Zhou J, 2010, J INVERTEBR PATHOL, V103, P170, DOI 10.1016/j.jip.2009.12.006	70	13	15	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141959	10.1371/journal.pone.0141959	http://dx.doi.org/10.1371/journal.pone.0141959			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529324	Green Submitted, Green Published, gold			2022-12-26	WOS:000364032600081
J	Feketa, VV; Marrelli, SP				Feketa, Viktor V.; Marrelli, Sean P.			Systemic Administration of the TRPV3 Ion Channel Agonist Carvacrol Induces Hypothermia in Conscious Rodents	PLOS ONE			English	Article							THERAPEUTIC HYPOTHERMIA; ISCHEMIC-STROKE; CAPSAICIN; HEAT	Therapeutic hypothermia is a promising new strategy for neuroprotection. However, the methods for safe and effective hypothermia induction in conscious patients are lacking. The current study explored the Transient Receptor Potential Vanilloid 3 (TRPV3) channel activation by the agonist carvacrol as a potential hypothermic strategy. It was found that carvacrol lowers core temperature after intraperitoneal and intravenous administration in mice and rats. However, the hypothermic effect at safe doses was modest, while higher intravenous doses of carvacrol induced a pronounced drop in blood pressure and substantial toxicity. Experiments on the mechanism of the hypothermic effect in mice revealed that it was associated with a decrease in whole-body heat generation, but not with a change in cold-seeking behaviors. In addition, the hypothermic effect was lost at cold ambient temperature. Our findings suggest that although TRPV3 agonism induces hypothermia in rodents, it may have a limited potential as a novel pharmacological method for induction of hypothermia in conscious patients due to suboptimal effectiveness and high toxicity.	[Feketa, Viktor V.; Marrelli, Sean P.] Baylor Coll Med, Dept Mol Physiol & Biophys, Grad Program, Cardiovasc Sci Track, Houston, TX 77030 USA; [Marrelli, Sean P.] Baylor Coll Med, Dept Anesthesiol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Marrelli, SP (corresponding author), Baylor Coll Med, Dept Mol Physiol & Biophys, Grad Program, Cardiovasc Sci Track, Houston, TX 77030 USA.	marrelli@bcm.edu			National Institute of Neurological Diseases and Stroke [NS077413, NS090129]; National Heart, Lung, and Blood Institute [HL088435]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS090129, R21NS077413] Funding Source: NIH RePORTER	National Institute of Neurological Diseases and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by funding from the National Institute of Neurological Diseases and Stroke (www.ninds.nih.gov; Grant Numbers NS077413 and NS090129) and the National Heart, Lung, and Blood Institute (www.nhlbi.nih.gov; Grant Number HL088435). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews PJD, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-8; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Cao ZJ, 2014, AM J PHYSIOL-REG I, V306, pR149, DOI 10.1152/ajpregu.00329.2013; Feketa Viktor V, 2015, Temperature (Austin), V2, P244, DOI 10.1080/23328940.2015.1024383; Fosgerau K, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-51; Gordon CJ, 2012, J THERM BIOL, V37, P654, DOI 10.1016/j.jtherbio.2012.08.004; GORDON CJ, 1988, TOXICOLOGY, V53, P161, DOI 10.1016/0300-483X(88)90211-9; Holzer M, 2002, NEW ENGL J MED, V346, P549; HORI T, 1984, PHARMACOL THERAPEUT, V26, P389, DOI 10.1016/0163-7258(84)90041-X; Karnatovskaia LV, 2014, NEUROHOSPITALIST, V4, P153, DOI 10.1177/1941874413519802; Lampe JW, 2011, ANNU REV MED, V62, P79, DOI 10.1146/annurev-med-052009-150512; Lyden PD, 2014, INT J STROKE, V9, P117, DOI 10.1111/ijs.12151; Moqrich A, 2005, SCIENCE, V307, P1468, DOI 10.1126/science.1108609; Muzzi M, 2013, J CEREBR BLOOD F MET, V33, P171, DOI 10.1038/jcbfm.2012.181; Nilius B, 2013, EXP DERMATOL, V22, P447, DOI 10.1111/exd.12163; O'Neill J, 2012, PHARMACOL REV, V64, P939, DOI 10.1124/pr.112.006163; Parnas M, 2009, CELL CALCIUM, V45, P300, DOI 10.1016/j.ceca.2008.11.009; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; Romanovsky AA, 2009, PHARMACOL REV, V61, P228, DOI 10.1124/pr.109.001263; van der Worp HB, 2014, INT J STROKE, V9, P642, DOI 10.1111/ijs.12294; Vogt-Eisele AK, 2007, BRIT J PHARMACOL, V151, P530, DOI 10.1038/sj.bjp.0707245; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692	22	8	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141994	10.1371/journal.pone.0141994	http://dx.doi.org/10.1371/journal.pone.0141994			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528923	Green Published, Green Submitted, gold			2022-12-26	WOS:000364032600088
J	Jiang, W; Zhuang, Y; Wang, SZ; Fang, BS				Jiang, Wei; Zhuang, Yuan; Wang, Shizhen; Fang, Baishan			Directed Evolution and Resolution Mechanism of 1, 3-Propanediol Oxidoreductase from Klebsiella pneumoniae toward Higher Activity by Error-Prone PCR and Bioinformatics	PLOS ONE			English	Article							1,3-PROPANEDIOL DEHYDROGENASE; MICROBIAL-PRODUCTION; ESCHERICHIA-COLI; GLYCEROL; EXPRESSION; PURIFICATION; MUTAGENESIS; GENE; CONVERSION; XYLANASE	1, 3-propanediol oxidoreductase (PDOR) is a key enzyme in glycerol bioconversion to 1,3-propanediol (1, 3-PD) which is a valuable chemical and one of the six new petrochemical products. We used error-prone PCR and activity screening to identify mutants of Klebsiella pneumoniae (K. pneumoniae) PDOR with improved activity. The activity of one of the identified mutants, PDOR'-24, which includes a single mutation, A199S, was 48 U/mg, 4.9 times that of the wild-type enzyme. Molecular docking was performed to analyze the identified mutants; and amino acids S103, H271, N366, D106, N262 and D364 were predicted to bond with NADH. The origins of the improved activity of PDOR'-24, as well as three other mutants were analyzed by simulating the interaction mechanism of the mutants with the substrate and coenzyme, respectively. This research provides useful information about the use of safranine O plate screening for the directed evolution of oxidoreductases, identifies interesting sites for improving PDOR activity, and demonstrates the utility of using molecular docking to analyze the interaction mechanism of the mutants with the substrate and coenzyme, respectively.	[Jiang, Wei; Wang, Shizhen; Fang, Baishan] Xiamen Univ, Coll Chem & Chem Engn, Dept Chem & Biochem Engn, Xiamen 361005, Fujian, Peoples R China; [Jiang, Wei; Wang, Shizhen; Fang, Baishan] Xiamen Univ, Key Lab Synthet Biotechnol Xiamen City, Xiamen 361005, Fujian, Peoples R China; [Zhuang, Yuan] Hua Qiao Univ, Key Lab Ind Biotechnol Fujian Higher Educ, Xiamen, Fujian, Peoples R China; [Fang, Baishan] Xiamen Univ, Key Lab Chem Biol Fujian Prov, Xiamen 361005, Fujian, Peoples R China	Xiamen University; Xiamen University; Huaqiao University; Xiamen University	Fang, BS (corresponding author), Xiamen Univ, Coll Chem & Chem Engn, Dept Chem & Biochem Engn, Xiamen 361005, Fujian, Peoples R China.	fbs@xmu.edu.cn			National Natural Science Foundation of China [41176111, 41306124]; State Key Program of National Natural Science Foundation of China [21336009]; Fundamental Research Funds for the Central Universities [2013121029]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (No. 41176111, No. 41306124), the State Key Program of National Natural Science Foundation of China (No. 21336009), and the Fundamental Research Funds for the Central Universities (No. 2013121029).	Ahrens K, 1998, BIOTECHNOL BIOENG, V59, P544, DOI 10.1002/(SICI)1097-0290(19980905)59:5<544::AID-BIT3>3.0.CO;2-A; Allen K. D., 1998, US, DOI 10.1097/00001503-199804000-00005, Patent No. [US 5 777 182, 5777182]; Barbirato F, 1997, ARCH MICROBIOL, V168, P160, DOI 10.1007/s002030050482; Biebl H, 1999, APPL MICROBIOL BIOT, V52, P289, DOI 10.1007/s002530051523; Cao Y, 2006, J CHEM TECHNOL BIOT, V81, P109, DOI 10.1002/jctb.1360; CHEN KQ, 1993, P NATL ACAD SCI USA, V90, P5618, DOI 10.1073/pnas.90.12.5618; Chen KQ, 1991, NAT BIOTECHNOL, V9, P1073; DANIEL R, 1995, J BACTERIOL, V177, P2151, DOI 10.1128/jb.177.8.2151-2156.1995; Hongwen C., 2005, BIOCH ENG J, V25, P47, DOI DOI 10.1016/j.bej.2005.03.011; Johannes TW, 2006, CURR OPIN MICROBIOL, V9, P261, DOI 10.1016/j.mib.2006.03.003; JOHNSON EA, 1987, J BACTERIOL, V169, P2050, DOI 10.1128/jb.169.5.2050-2054.1987; Leisola M, 2007, APPL MICROBIOL BIOT, V75, P1225, DOI 10.1007/s00253-007-0964-2; Li Wei, 2011, Electron. J. Biotechnol., V14, P7; Lin L, 2009, APPL MICROBIOL BIOT, V82, P671, DOI 10.1007/s00253-008-1789-3; Luers F, 1997, FEMS MICROBIOL LETT, V154, P337, DOI 10.1016/S0378-1097(97)00351-0; Malaoui H, 2000, ENZYME MICROB TECH, V27, P399, DOI 10.1016/S0141-0229(00)00219-2; Marcal D, 2009, J BACTERIOL, V191, P1143, DOI 10.1128/JB.01077-08; Nakamura CE, 2003, CURR OPIN BIOTECH, V14, P454, DOI 10.1016/j.copbio.2003.08.005; STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747; Stephens DE, 2009, FEMS MICROBIOL LETT, V293, P42, DOI 10.1111/j.1574-6968.2009.01519.x; TALARICO TL, 1990, APPL ENVIRON MICROB, V56, P1195, DOI 10.1128/AEM.56.4.1195-1197.1990; van Loo B, 2004, CHEM BIOL, V11, P981, DOI 10.1016/j.chembiol.2004.04.019; VEIGADACUNHA M, 1992, APPL ENVIRON MICROB, V58, P2005, DOI 10.1128/AEM.58.6.2005-2010.1992; WITT U, 1994, MACROMOL CHEM PHYSIC, V195, P793, DOI 10.1002/macp.1994.021950235; Wong TS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh028; Zhang ZG, 2010, BIORESOURCE TECHNOL, V101, P9272, DOI 10.1016/j.biortech.2010.07.060; Zhao L, 2009, J CHEM TECHNOL BIOT, V84, P626, DOI 10.1002/jctb.2092; Zhuge B, 2010, APPL MICROBIOL BIOT, V87, P2177, DOI 10.1007/s00253-010-2678-0; [No title captured], DOI DOI 10.1038/NBT0795-658	29	2	2	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141837	10.1371/journal.pone.0141837	http://dx.doi.org/10.1371/journal.pone.0141837			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528716	gold, Green Published, Green Submitted			2022-12-26	WOS:000364032600066
J	Miller, JRC; Trager, U; Andre, R; Tabrizi, SJ				Miller, James R. C.; Traeger, Ulrike; Andre, Ralph; Tabrizi, Sarah J.			Mutant Huntingtin Does Not Affect the Intrinsic Phenotype of Human Huntington's Disease T Lymphocytes	PLOS ONE			English	Article							NF-KAPPA-B; IN-VIVO; PROLIFERATION; ACTIVATION; DIFFERENTIATION; TRANSCRIPTION; PATHWAY; ONSET	Huntington's disease is a fatal neurodegenerative condition caused by a CAG repeat expansion in the huntingtin gene. The peripheral innate immune system is dysregulated in Huntington's disease and may contribute to its pathogenesis. However, it is not clear whether or to what extent the adaptive immune system is also involved. Here, we carry out the first comprehensive investigation of human ex vivo T lymphocytes in Huntington's disease, focusing on the frequency of a range of T lymphocyte subsets, as well as analysis of proliferation, cytokine production and gene transcription. In contrast to the innate immune system, the intrinsic phenotype of T lymphocytes does not appear to be affected by the presence of mutant huntingtin, with Huntington's disease T lymphocytes exhibiting no significant functional differences compared to control cells. The transcriptional profile of T lymphocytes also does not appear to be significantly affected, suggesting that peripheral immune dysfunction in Huntington's disease is likely to be mediated primarily by the innate rather than the adaptive immune system. This study increases our understanding of the effects of Huntington's disease on peripheral tissues, while further demonstrating the differential effects of the mutant protein on different but related cell types. Finally, this study suggests that the potential use of novel therapeutics aimed at modulating the Huntington's disease innate immune system should not be extended to include the adaptive immune system.	[Miller, James R. C.; Traeger, Ulrike; Andre, Ralph; Tabrizi, Sarah J.] UCL Inst Neurol, Dept Neurodegenerat Dis, London, England	University of London; University College London	Tabrizi, SJ (corresponding author), UCL Inst Neurol, Dept Neurodegenerat Dis, London, England.	s.tabrizi@ucl.ac.uk		Tabrizi, Sarah/0000-0003-2716-2045; Trager, Ulrike/0000-0002-4493-1136; Miller, James/0000-0003-2067-4136	CHDI Foundation [A-9412]; Rosetrees Trust [JS16/M220]; Medical Research Council [MR/L02053X/1]; National Institute for Health Research University College London Hospitals Biomedical Research Centre [BRC54/NS/RA, BRC230/NS/RA/101410]; Medical Research Council [1354752, MR/J003832/1, G0700877] Funding Source: researchfish; Rosetrees Trust [M220] Funding Source: researchfish; MRC [MR/L02053X/1, MR/J003832/1, G0700877] Funding Source: UKRI	CHDI Foundation; Rosetrees Trust(Rosetrees Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research University College London Hospitals Biomedical Research Centre(General Electric); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Rosetrees Trust(Rosetrees Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported financially by the following: CHDI Foundation (SJT), Grant number: A-9412, http://chdifoundation.org/; Rosetrees Trust (JRCM), Grant number: JS16/M220, http://www.rosetreestrust.co.uk/; Medical Research Council (JRCM, RA, SJT), Grant number: MR/L02053X/1, http://www.mrc.ac.uk/; and National Institute for Health Research University College London Hospitals Biomedical Research Centre (SJT, UT, RA), Grant numbers: BRC54/NS/RA, BRC230/NS/RA/101410, http://www.nihr.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, PLOS CURR; Benn CL, 2008, J NEUROSCI, V28, P10720, DOI 10.1523/JNEUROSCI.2126-08.2008; Bjorkqvist M, 2008, J EXP MED, V205, P1869, DOI 10.1084/jem.20080178; Bouchard J, 2012, J NEUROSCI, V32, P18259, DOI 10.1523/JNEUROSCI.4008-12.2012; Brownlie RJ, 2013, NAT REV IMMUNOL, V13, P257, DOI 10.1038/nri3403; Chen-Plotkin AS, 2006, NEUROBIOL DIS, V22, P233, DOI 10.1016/j.nbd.2005.11.001; Dodeller F, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1905; Ellrichmann G, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/541259; Gonzalez-Navajas JM, 2010, J CLIN INVEST, V120, P570, DOI 10.1172/JCI40055; Hawkins ED, 2007, NAT PROTOC, V2, P2057, DOI 10.1038/nprot.2007.297; Hayden MS, 2011, CELL RES, V21, P223, DOI 10.1038/cr.2011.13; Hodges A, 2006, HUM MOL GENET, V15, P965, DOI 10.1093/hmg/ddl013; Iwasaki A, 2015, NAT IMMUNOL, V16, P343, DOI 10.1038/ni.3123; KANG SM, 1992, SCIENCE, V256, P1452, DOI 10.1126/science.1604322; Khoshnan A, 2004, J NEUROSCI, V24, P7999, DOI 10.1523/JNEUROSCI.2675-04.2004; Kwan W, 2012, J CLIN INVEST, V122, P4737, DOI 10.1172/JCI64484; LI SH, 1993, NEURON, V11, P985, DOI 10.1016/0896-6273(93)90127-D; Luckheeram RV, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/925135; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Okun E, 2009, BRAIN RES REV, V59, P278, DOI 10.1016/j.brainresrev.2008.09.001; Quah BJC, 2007, NAT PROTOC, V2, P2049, DOI 10.1038/nprot.2007.296; Roederer M, 2011, CYTOM PART A, V79A, P95, DOI 10.1002/cyto.a.21010; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Shanker A, 2010, IMMUNOL LETT, V131, P107, DOI 10.1016/j.imlet.2010.04.002; Silvestroni A, 2009, NEUROREPORT, V20, P1098, DOI 10.1097/WNR.0b013e32832e34ee; Tai YF, 2007, BRAIN, V130, P1759, DOI 10.1093/brain/awm044; Trager U, 2014, BRAIN, V137, P819, DOI 10.1093/brain/awt355; Trager U, 2013, PLOS CURR, V5; Trager U, 2015, NEUROBIOL DIS, V73, P388, DOI 10.1016/j.nbd.2014.10.012; van der Burg JMM, 2009, LANCET NEUROL, V8, P765, DOI 10.1016/S1474-4422(09)70178-4; Weiss A, 2012, J CLIN INVEST, V122, P3731, DOI 10.1172/JCI64565; Zwilling D, 2011, CELL, V145, P863, DOI 10.1016/j.cell.2011.05.020	33	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141793	10.1371/journal.pone.0141793	http://dx.doi.org/10.1371/journal.pone.0141793			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529236	Green Published, Green Submitted, gold			2022-12-26	WOS:000364032600060
J	Yan, H; Tang, G; Wang, H; Hao, L; He, T; Sun, X; Ting, AH; Deng, A; Sun, S				Yan, H.; Tang, G.; Wang, H.; Hao, L.; He, T.; Sun, X.; Ting, A. H.; Deng, A.; Sun, S.			DNA methylation reactivates GAD1 expression in cancer by preventing CTCF-mediated polycomb repressive complex 2 recruitment	ONCOGENE			English	Article							MUCINOUS HISTOLOGY PREDICTS; METASTATIC COLON-CANCER; GAMMA-AMINOBUTYRIC-ACID; COLORECTAL-CANCER; GENE-EXPRESSION; AIRWAY EPITHELIUM; INDUCED APOPTOSIS; BINDING REGIONS; PROTEINS; SURVIVAL	Levels of gamma-aminobutyric acid (GABA) and glutamic acid decarboxylase 1 (GAD1), the enzyme that synthesizes GABA, are significantly increased in neoplastic tissues. However, the mechanism underlying this increase remains elusive. Instead of silencing gene transcription, we showed that the GAD1 promoter was hypermethylated in both colon and liver cancer cells, leading to the production of high levels of GAD1. GAD1 is a target gene that is silenced by H3K27me3. The key locus responsible for GAD1 reactivation was mapped to a DNA methylation-sensitive CTCF-binding site (CTCF-BS3) within the third intron of GAD1. Chromosome configuration capture (3C) analysis indicated that an intrachromosomal loop was formed by CTCF self-dimerisation in normal cells (CTCF binds to both unmethylated CTCF-BS3 and CTCF-BS2). The CTCF dimer then interacted with suppressor of zeste 12 homologue (SUZ12), which is a domain of Polycomb repressive complex 2 (PRC2), promoting the methylation of H3K27 and the silencing of GAD1 expression. This silencing was shown to be inhibited by DNA methylation in cancer cells. These findings strongly suggest that GAD1 is reactivated by DNA methylation, which provided a model for DNA methylation and the active orchestration of oncogenic gene expression by CTCF in cancer cells.	[Yan, H.; Sun, X.; Deng, A.] Second Mil Med Univ, Changhai Hosp, Dept Lab Med, 168 Changhai Rd, Shanghai 200433, Peoples R China; [Tang, G.; Sun, S.] Second Mil Med Univ, Inst Genet, Shanghai, Peoples R China; [Wang, H.; Hao, L.] Second Mil Med Univ, Changhai Hosp, Dept Colorectal Surg, Shanghai, Peoples R China; [He, T.] Second Mil Med Univ, Changhai Hosp, Div Hepatopancreatobiliary Surg, Shanghai, Peoples R China; [Ting, A. H.] Cleveland Clin Fdn, Genom Med Inst, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA	Naval Medical University; Naval Medical University; Naval Medical University; Naval Medical University; Cleveland Clinic Foundation	Yan, H; Deng, A; Sun, S (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Lab Med, 168 Changhai Rd, Shanghai 200433, Peoples R China.	hongliyan@smmu.edu.cn; amdeng70@163.com; shsun@vip.sina.com			National Natural Science Foundation of China Shanghai Pujiang Outstanding Young Scientist Project [81071680, 81272280, 81172307]	National Natural Science Foundation of China Shanghai Pujiang Outstanding Young Scientist Project	This work was supported by grants from the National Natural Science Foundation of China (grants no. 81071680, 81272280, 81172307) Shanghai Pujiang Outstanding Young Scientist Project.	Andang M, 2008, NATURE, V451, P460, DOI 10.1038/nature06488; Azuma H, 2003, CANCER RES, V63, P8090; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Catalano V, 2009, BRIT J CANCER, V100, P881, DOI 10.1038/sj.bjc.6604955; Cotter PD, 2001, MOL MICROBIOL, V40, P465, DOI 10.1046/j.1365-2958.2001.02398.x; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Du WB, 2004, DIS COLON RECTUM, V47, P78, DOI 10.1007/s10350-003-0014-9; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Euskirchen GM, 2007, GENOME RES, V17, P898, DOI 10.1101/gr.5583007; Fu XW, 2011, AM J RESP CELL MOL, V44, P222, DOI 10.1165/rcmb.2010-0109OC; Gatenby RA, 2006, CANCER RES, V66, P5216, DOI 10.1158/0008-5472.CAN-05-4193; Gius D, 2004, CANCER CELL, V6, P361, DOI 10.1016/j.ccr.2004.08.029; Ha M, 2011, GENOME RES, V21, P590, DOI 10.1101/gr.116467.110; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Hernandez A, 2012, CURR PHARM DESIGN, V18, P1317, DOI 10.2174/138161212799504894; HOLLIDAY R, 1975, SCIENCE, V187, P226, DOI 10.1126/science.1111098; Huang HS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000809; Huerta S, 2003, INT J ONCOL, V22, P663; Jaraj SJ, 2011, SCAND J UROL NEPHROL, V45, P39, DOI 10.3109/00365599.2010.521189; JOH TH, 1985, FED PROC, V44, P2773; Jorissen RN, 2008, CLIN CANCER RES, V14, P8061, DOI 10.1158/1078-0432.CCR-08-1431; Kim BN, 2005, INT J ONCOL, V26, P1217; Kimura R, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-555; Kobayashi T, 2003, BBA-GENE STRUCT EXPR, V1628, P156, DOI 10.1016/S0167-4781(03)00138-6; Labrador M, 2002, CELL, V111, P151, DOI 10.1016/S0092-8674(02)01004-8; Lai AY, 2010, J EXP MED, V207, P1939, DOI 10.1084/jem.20100204; Leopoldo S, 2008, ANN SURG ONCOL, V15, P1429, DOI 10.1245/s10434-007-9757-1; Li CM, 2004, AM J PATHOL, V165, P1943, DOI 10.1016/S0002-9440(10)63246-4; Li T, 2008, MOL CELL BIOL, V28, P6473, DOI 10.1128/MCB.00204-08; Maemura K, 2003, J GASTROEN HEPATOL, V18, P1089, DOI 10.1046/j.1440-1746.2003.03131.x; Maisano R, 2012, J CHEMOTHERAPY, V24, P212, DOI 10.1179/1973947812Y.0000000013; Matuszek M, 2001, Med Sci Monit, V7, P377; Negri FV, 2005, ANN ONCOL, V16, P1305, DOI 10.1093/annonc/mdi244; Nozoe T, 2000, J SURG ONCOL, V75, P103, DOI 10.1002/1096-9098(200010)75:2<103::AID-JSO6>3.3.CO;2-3; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Rago C, 2007, NAT PROTOC, V2, P2734, DOI 10.1038/nprot.2007.408; RAZIN A, 1980, SCIENCE, V210, P604, DOI 10.1126/science.6254144; Ren LC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031416; Renaud S, 2007, NUCLEIC ACIDS RES, V35, P1245, DOI 10.1093/nar/gkl1125; Rodriguez C, 2010, BIOCHEM BIOPH RES CO, V392, P129, DOI 10.1016/j.bbrc.2009.12.159; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Stuhmer T, 2002, CEREB CORTEX, V12, P75, DOI 10.1093/cercor/12.1.75; Wang ZH, 2009, METHODS MOL BIOL, V567, P87, DOI 10.1007/978-1-60327-414-2_6; West AG, 2004, MOL CELL, V16, P453, DOI 10.1016/j.molcel.2004.10.005; Xiang YY, 2007, NAT MED, V13, P862, DOI 10.1038/nm1604; Xu YM, 2012, GENOME RES, V22, P283, DOI 10.1101/gr.122788.111; Yan HL, 2009, EMBO J, V28, P2719, DOI 10.1038/emboj.2009.214; Zhang JW, 2016, GUT, V65, P1482, DOI 10.1136/gutjnl-2014-308614	50	20	20	5	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 28	2016	35	30					3995	4008		10.1038/onc.2015.423	http://dx.doi.org/10.1038/onc.2015.423			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DS8DJ	26549033				2022-12-26	WOS:000381013100011
J	Saran, S; Tran, DDH; Ewald, F; Koch, A; Hoffmann, A; Koch, M; Nashan, B; Tamura, T				Saran, S.; Tran, D. D. H.; Ewald, F.; Koch, A.; Hoffmann, A.; Koch, M.; Nashan, B.; Tamura, T.			Depletion of three combined THOC5 mRNA export protein target genes synergistically induces human hepatocellular carcinoma cell death	ONCOGENE			English	Article							INTERACTING PROTEIN; TREX COMPLEX; FMIP; TRANSCRIPTION; CONTRIBUTES; KINASES; MEMBER	Hepatocellular carcinoma (HCC) is a frequent form of cancer with a poor prognosis and with limited possibilities of medical intervention. It has been shown that over 100 putative driver genes are associated with multiple recurrently altered pathways in HCC, suggesting that multiple pathways will need to be inhibited for any therapeutic method. mRNA processing is regulated by a complex RNA-protein network that is essential for the maintenance of homeostasis. THOC5, a member of mRNA export complex, has a role in less than 1% of mRNA processing, and is required for cell growth and differentiation, but not for cell survival in normal fibroblasts, hepatocytes and macrophages. In this report, we show that 50% depletion of THOC5 in human HCC cell lines Huh7 and HepG2 induced apoptosis. Transcriptome analysis using THOC5-depleted cells revealed that 396 genes, such as transmembrane BAX inhibitor motif containing 4 (TMBIM4), transmembrane emp24-like trafficking protein 10 (Tmed10) and D-tyrosyl-tRNA deacylase 2 (Dtd2) genes were downregulated in both cell lines. The depletion of one of these THOC5 target genes in Huh7 or HepG2 did not significantly induce cell death, suggesting that these may be fine tuners for HCC cell survival. However, the depletion of a combination of these genes synergistically increased the number of TUNEL (terminal deoxynucleotidyl transferase dUTP nick end labeling)-positive HCC. It must be noted that the depletion of these genes did not induce cell death in the hepatocyte cell line, THLE-2 cells. THOC5 expression was enhanced in 78% of cytological differentiation grading G2 and G3 tumor in primary HCC. Furthermore, the expression of a putative glycoprotein, Tmed10, is correlated to THOC5 expression level in primary HCCs, suggesting that this protein may be a novel biomarker for HCC. These data imply that the suppression of the multiple THOC5 target genes may represent a novel strategy for HCC therapy.	[Saran, S.; Tran, D. D. H.; Koch, A.; Tamura, T.] Hannover Med Sch, Inst Biochem, OE4310,Carl Neuberg Str 1, D-30623 Hannover, Germany; [Ewald, F.; Koch, M.; Nashan, B.] Univ Med Ctr Eppendorf, Dept Hepatobiliary & Transplant Surg, Hamburg, Germany; [Hoffmann, A.] Hannover Med Sch, Klin Orthopadie, OE8893, Hannover, Germany	Hannover Medical School; University of Hamburg; University Medical Center Hamburg-Eppendorf; Hannover Medical School	Tamura, T (corresponding author), Hannover Med Sch, Inst Biochem, OE4310,Carl Neuberg Str 1, D-30623 Hannover, Germany.	Tamura.Teruko@MH-Hannover.de	Tran, Doan Duy Hai/AGU-7573-2022; Hoffmann, Andrea/AAG-4488-2020; Koch, Martina/AAJ-6611-2020; Nashan, Björn/H-9087-2019	Tran, Doan Duy Hai/0000-0003-2392-0259; Hoffmann, Andrea/0000-0003-2318-8985; Nashan, Björn/0000-0001-7587-9935	Deutsche Krebshilfe [111153]; DFG [Ta-111/13-1]; PhD program Molecular Medicine; Leistungsorientierte Mittelvergabe	Deutsche Krebshilfe(Deutsche Krebshilfe); DFG(German Research Foundation (DFG)); PhD program Molecular Medicine; Leistungsorientierte Mittelvergabe	We thank C Bruce Boschek for critically reading the manuscript and Iris Albers and Annika Hamm for technical assistance. SS and DDHT contributed equally to this work. This research was supported by Deutsche Krebshilfe (111153), DFG Ta-111/13-1, and PhD program Molecular Medicine and Leistungsorientierte Mittelvergabe with Frauenfaktor from MHH.	Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chavez S, 2001, MOL CELL BIOL, V21, P7054, DOI 10.1128/MCB.21.20.7054-7064.2001; Corkery DP, 2015, NUCLEUS-PHILA, V6, P279, DOI 10.1080/19491034.2015.1062194; Tran DDH, 2014, NUCLEIC ACIDS RES, V42, P12249, DOI 10.1093/nar/gku911; Ferrin G, 2015, HEPATIC MED-EVID RES, V7, P1, DOI 10.2147/HMER.S50161; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Griaud F, 2013, LEUKEMIA, V27, P932, DOI 10.1038/leu.2012.283; Gubser C, 2007, PLOS PATHOG, V3, P246, DOI 10.1371/journal.ppat.0030017; Guria A, 2011, RNA, V17, P1048, DOI 10.1261/rna.2607011; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jimeno S, 2002, EMBO J, V21, P3526, DOI 10.1093/emboj/cdf335; Jimeno Sonia, 2010, Journal of Biology (London), V8, P6, DOI 10.1186/jbiol217; Koch A, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/s12964-014-0073-7; Maguire SL, 2015, J PATHOL, V235, P571, DOI 10.1002/path.4483; Mancini A, 2007, ONCOGENE, V26, P1020, DOI 10.1038/sj.onc.1209853; Mancini A, 2004, ONCOGENE, V23, P6581, DOI 10.1038/sj.onc.1207841; Mancini A, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-1; Masuda S, 2005, GENE DEV, V19, P1512, DOI 10.1101/gad.1302205; Panagopoulos I, 2014, INT J ONCOL, V45, P1829, DOI 10.3892/ijo.2014.2605; Pierce A, 2008, BRIT J HAEMATOL, V141, P641, DOI 10.1111/j.1365-2141.2008.07090.x; Rehwinkel J, 2004, NAT STRUCT MOL BIOL, V11, P558, DOI 10.1038/nsmb759; Saran S, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-51; Schulze K, 2015, NAT GENET, V47, P505, DOI 10.1038/ng.3252; Tamura T, 1999, ONCOGENE, V18, P6488, DOI 10.1038/sj.onc.1203062; Tran DDH, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.409; Tran DDH, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-3; Whittaker S, 2010, ONCOGENE, V29, P4989, DOI 10.1038/onc.2010.236	27	13	14	0	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2016	35	29					3872	3879		10.1038/onc.2015.433	http://dx.doi.org/10.1038/onc.2015.433			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DS4LS	26549021				2022-12-26	WOS:000380753200012
J	Jurczyk, A; Nowosielska, A; Przewozniak, N; Aryee, KE; DiIorio, P; Blodgett, D; Yang, CX; Campbell-Thompson, M; Atkinson, M; Shultz, L; Rittenhouse, A; Harlan, D; Greiner, D; Bortell, R				Jurczyk, Agata; Nowosielska, Anetta; Przewozniak, Natalia; Aryee, Ken-Edwin; DiIorio, Philip; Blodgett, David; Yang, Chaoxing; Campbell-Thompson, Martha; Atkinson, Mark; Shultz, Leonard; Rittenhouse, Ann; Harlan, David; Greiner, Dale; Bortell, Rita			Beyond the brain: disrupted in schizophrenia 1 regulates pancreatic beta-cell function via glycogen synthase kinase-3 beta	FASEB JOURNAL			English	Article						insulin; secretion; diabetes; T2D	IMPAIRED GLUCOSE-TOLERANCE; DRUG-NAIVE PATIENTS; PROGENITOR PROLIFERATION; INSULIN-SECRETION; GENOMIC STRUCTURE; MOUSE MODELS; DISC1; EXPRESSION; PROTEIN; DISORDERS	Individuals with schizophrenia and their first-degree relatives have higher rates of type 2 diabetes (T2D) than the general population (18-30 vs. 1.2-6.3%), independent of body mass index and antipsychotic medication, suggesting shared genetic components may contribute to both diseases. The cause of this association remains unknown. Mutations in disrupted in schizophrenia 1 (DISC1) increase the risk of developing psychiatric disorders [logarithm (base 10) of odds = 7.1]. Here, we identified DISC1 as a major player controlling pancreatic beta-cell proliferation and insulin secretion via regulation of glycogen synthase kinase-3 beta (GSK3 beta). DISC1 expression was enriched in developing mouse and human pancreas and adult beta- and ductal cells. Loss of DISC1 function, through siRNA-mediated depletion or expression of a dominant-negative truncation that models the chromosomal translocation of human DISC1 in schizophrenia, resulted in decreased beta-cell proliferation (3 vs. 1%; P < 0.01), increased apoptosis (0.1 vs. 0.6%; P < 0.01), and glucose intolerance in transgenic mice. Insulin secretion was reduced (0.5 vs. 0.1 ng/ml; P < 0.05), and critical beta-cell transcription factors Pdx1 and Nkx6.1 were significantly decreased. Impaired DISC1 allowed inappropriate activation of GSK3 beta in beta cells, and antagonizing GSK3 beta (SB216763; IC50 = 34.3 nM) rescued the beta-cell defects. These results uncover an unexpected role for DISC1 in normal beta-cell physiology and suggest that DISC1 dysregulation contributes to T2D independently of its importance for cognition.	[Jurczyk, Agata; Przewozniak, Natalia; Aryee, Ken-Edwin; Blodgett, David; Yang, Chaoxing; Harlan, David; Greiner, Dale; Bortell, Rita] Univ Massachusetts, Sch Med, Diabet Ctr Excellence, Worcester, MA 01605 USA; [Nowosielska, Anetta] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Rittenhouse, Ann] Univ Massachusetts, Sch Med, Microbiol & Physiol Syst MaPS, Worcester, MA 01605 USA; [DiIorio, Philip] Univ Massachusetts, Dept Publ Hlth, Amherst, MA 01003 USA; [Campbell-Thompson, Martha; Atkinson, Mark] Univ Florida, Dept Pathol, Gainesville, FL 32611 USA; [Shultz, Leonard] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Amherst; State University System of Florida; University of Florida; Jackson Laboratory	Bortell, R (corresponding author), Univ Massachusetts, Sch Med, 368 Plantat St,AS7-2055, Worcester, MA 01605 USA.	rita.bortell@umassmed.edu	Campbell-Thompson, Martha/A-7584-2010	Campbell-Thompson, Martha/0000-0001-6878-1235	U.S. National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases [U01 DK089572]; Leona M. and Harry B. Helmsley Charitable Trust [2012PG-T1D018]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK089572] Funding Source: NIH RePORTER	U.S. National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Leona M. and Harry B. Helmsley Charitable Trust; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Linda Leehy, Linda Paquin, and Rabia Lidstrom for technical support, and Aldo Rossini and Laura Alonso for their advice and guidance. This work was supported by U.S. National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases Grant U01 DK089572, and the Leona M. and Harry B. Helmsley Charitable Trust Grant 2012PG-T1D018.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Adams P. F., 1995, VITAL HLTH STAT, V10, P82; Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Alberti KGMM, 1996, DIABETIC MED, V13, P927, DOI 10.1002/(SICI)1096-9136(199611)13:11<927::AID-DIA279>3.0.CO;2-E; Blodgett DM, 2015, DIABETES, V64, P3172, DOI 10.2337/db15-0039; Brissova M, 2005, AM J PHYSIOL-ENDOC M, V288, pE707, DOI 10.1152/ajpendo.00252.2004; Brissova M, 2002, J BIOL CHEM, V277, P11225, DOI 10.1074/jbc.M111272200; BUSCIGLIO J, 1995, NEURON, V14, P879, DOI 10.1016/0896-6273(95)90232-5; Campbell-Thompson M, 2012, DIABETES-METAB RES, V28, P608, DOI 10.1002/dmrr.2316; Cash-Padgett T, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00113; Chadda RK, 2013, J PHARMACOL PHARMACO, V4, P176, DOI 10.4103/0976-500X.114596; Chubb JE, 2008, MOL PSYCHIATR, V13, P36, DOI 10.1038/sj.mp.4002106; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; De Hert M, 2006, Clin Pract Epidemiol Ment Health, V2, P14; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Harris LW, 2013, PSYCHONEUROENDOCRINO, V38, P752, DOI 10.1016/j.psyneuen.2012.09.009; Hennah W, 2009, MOL PSYCHIATR, V14, P865, DOI 10.1038/mp.2008.22; Henquin JC, 2008, DIABETES OBES METAB, V10, P1, DOI 10.1111/j.1463-1326.2008.00968.x; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; Ishizuka K, 2011, NATURE, V473, P92, DOI 10.1038/nature09859; Johnson JD, 2003, J CLIN INVEST, V111, P1147, DOI 10.1172/JCI200316537; Kamiya A, 2005, NAT CELL BIOL, V7, P1167, DOI 10.1038/ncb1328; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; Laybutt DR, 2003, J BIOL CHEM, V278, P2997, DOI 10.1074/jbc.M210581200; LEAHY JL, 1988, J CLIN INVEST, V81, P1407, DOI 10.1172/JCI113470; Mao YW, 2009, CELL, V136, P1017, DOI 10.1016/j.cell.2008.12.044; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Millar JK, 2001, MOL PSYCHIATR, V6, P173, DOI 10.1038/sj.mp.4000784; Millar JK, 2000, GENOMICS, V67, P69, DOI 10.1006/geno.2000.6239; MUKHERJEE S, 1989, LANCET, V1, P495; Mussmann R, 2007, J BIOL CHEM, V282, P12030, DOI 10.1074/jbc.M609637200; Newburn EN, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.31; Ozeki Y, 2003, P NATL ACAD SCI USA, V100, P289, DOI 10.1073/pnas.0136913100; Palo OM, 2007, HUM MOL GENET, V16, P2517, DOI 10.1093/hmg/ddm207; PARKER DC, 1995, P NATL ACAD SCI USA, V92, P9560, DOI 10.1073/pnas.92.21.9560; Pletnikov MV, 2008, MOL PSYCHIATR, V13, P173, DOI [10.1038/sj.mp.4002079, 10.1038/sj.mp.4002144]; Pletnikov MV, 2009, PROG BRAIN RES, V179, P35, DOI 10.1016/S0079-6123(09)17905-0; Porteous D, 2008, CURR OPIN GENET DEV, V18, P229, DOI 10.1016/j.gde.2008.07.005; Rampino A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099892; Ryan MCM, 2003, AM J PSYCHIAT, V160, P284, DOI 10.1176/appi.ajp.160.2.284; Sachs NA, 2005, MOL PSYCHIATR, V10, P758, DOI 10.1038/sj.mp.4001667; Schurov IL, 2004, MOL PSYCHIATR, V9, P1100, DOI 10.1038/sj.mp.4001574; Singh KK, 2010, NEURON, V67, P33, DOI 10.1016/j.neuron.2010.06.002; Soares DC, 2011, ACS CHEM NEUROSCI, V2, P609, DOI 10.1021/cn200062k; Spelman LM, 2007, DIABETIC MED, V24, P481, DOI 10.1111/j.1464-5491.2007.02092.x; Stein J, 2013, ISLETS, V5, P156, DOI 10.4161/isl.25605; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Su P, 2014, NEURON, V84, P1302, DOI 10.1016/j.neuron.2014.11.007; TAKASHIMA A, 1993, P NATL ACAD SCI USA, V90, P7789, DOI 10.1073/pnas.90.16.7789; Venkatasubramanian G, 2007, AM J PSYCHIAT, V164, P1557, DOI 10.1176/appi.ajp.2007.07020233; Wang JJ, 2010, SCHIZOPHR RES, V124, P49, DOI 10.1016/j.schres.2010.09.013; Weir GC, 2013, ANN NY ACAD SCI, V1281, P92, DOI 10.1111/nyas.12031; Wen ZX, 2014, NATURE, V515, P414, DOI 10.1038/nature13716; Wicksteed B, 2010, DIABETES, V59, P3090, DOI 10.2337/db10-0624; Zhang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065711	56	13	14	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					983	993		10.1096/fj.15-279810	http://dx.doi.org/10.1096/fj.15-279810			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26546129	Green Published			2022-12-26	WOS:000369391900044
J	Collie, D; Glendinning, L; Govan, J; Wright, S; Thornton, E; Tennant, P; Doherty, C; McLachlan, G				Collie, David; Glendinning, Laura; Govan, John; Wright, Steven; Thornton, Elisabeth; Tennant, Peter; Doherty, Catherine; McLachlan, Gerry			Lung Microbiota Changes Associated with Chronic Pseudomonas aeruginosa Lung Infection and the Impact of Intravenous Colistimethate Sodium	PLOS ONE			English	Article							CYSTIC-FIBROSIS; COLISTIN METHANESULFONATE; PULMONARY EXACERBATIONS; SPUTUM; PHARMACOKINETICS; COMMUNITIES; DIVERSITY; DENSITY	Background Exacerbations associated with chronic lung infection with Pseudomonas aeruginosa are a major contributor to morbidity, mortality and premature death in cystic fibrosis. Such exacerbations are treated with antibiotics, which generally lead to an improvement in lung function and reduced sputum P. aeruginosa density. This potentially suggests a role for the latter in the pathogenesis of exacerbations. However, other data suggesting that changes in P. aeruginosa sputum culture status may not reliably predict an improvement in clinical status, and data indicating no significant changes in either total bacterial counts or in P. aeruginosa numbers in sputum samples collected prior to pulmonary exacerbation sheds doubt on this assumption. We used our recently developed lung segmental model of chronic Pseudomonas infection in sheep to investigate the lung microbiota changes associated with chronic P. aeruginosa lung infection and the impact of systemic therapy with colistimethate sodium (CMS). Methodology/Principal Findings We collected protected specimen brush (PSB) samples from sheep (n = 8) both prior to and 14 days after establishment of chronic local lung infection with P aeruginosa. Samples were taken from both directly infected lung segments (direct) and segments spatially remote to such sites (remote). Four sheep were treated with daily intravenous injections of CMS between days 7 and 14, and four were treated with a placebo. Necropsy examination at d14 confirmed the presence of chronic local lung infection and lung pathology in every direct lung segment. The predominant orders in lung microbiota communities before infection were Bacillales, Actinomycetales and Clostridiales. While lung microbiota samples were more likely to share similarities with other samples derived from the same lung, considerable within- and between-animal heterogeneity could be appreciated. Pseudomonadales joined the aforementioned list of predominant orders in lung microbiota communities after infection. Whilst treatment with CMS appeared to have little impact on microbial community composition after infection, or the change undergone by communities in reaching that state, when Gram negative organisms (excluding Pseudomonadales) were considered together as a group there was a significant decrease in their relative proportion that was only observed in the sheep treated with CMS. With only one exception the reduction was seen in both direct and remote lung segments. This reduction, coupled with generally increasing or stable levels of Pseudomonadales, meant that the proportion of the latter relative to total Gram negative bacteria increased in all bar one direct and one remote lung segment. Conclusions/Significance The proportional increase in Pseudomonadales relative to other Gram negative bacteria in the lungs of sheep treated with systemic CMS highlights the potential for such therapies to inadvertently select or create a niche for bacteria seeding from a persistent source of chronic infection.	[Collie, David; Glendinning, Laura; Wright, Steven; Thornton, Elisabeth; Tennant, Peter; McLachlan, Gerry] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland; [Collie, David; Glendinning, Laura; Wright, Steven; Thornton, Elisabeth; Tennant, Peter; McLachlan, Gerry] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh EH9 1QH, Midlothian, Scotland; [Govan, John; Doherty, Catherine] Univ Edinburgh, Sch Med, Edinburgh, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; University of Edinburgh	Collie, D (corresponding author), Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland.	david.collie@ed.ac.uk		Glendinning, Laura/0000-0003-4789-6644; McLachlan, Gerry/0000-0001-5362-9804; Collie, David/0000-0001-9313-8137	Biological and Biotechnological Science Research Council (BBSRC) [BB/J004243/1]; NERC [R8/H10/56]; MRC [MR/K001744/1]; Biotechnology and Biological Sciences Research Council [1358257] Funding Source: researchfish; Medical Research Council [MR/K001744/1] Funding Source: researchfish	Biological and Biotechnological Science Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Biological and Biotechnological Science Research Council (BBSRC; www.bbsrc.ac.uk). Edinburgh Genomics is partly supported through core grants from NERC (R8/H10/56), MRC (MR/K001744/1) and BBSRC (BB/J004243/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, UK CYST FIBR REG ANN; Bekele AZ, 2010, FEMS MICROBIOL LETT, V305, P49, DOI 10.1111/j.1574-6968.2010.01911.x; Boisson M, 2014, ANTIMICROB AGENTS CH, V58, P7331, DOI 10.1128/AAC.03510-14; Burkett A, 2012, EUR J CLIN MICROBIOL, V31, P1603, DOI 10.1007/s10096-011-1483-8; Carmody Lisa A, 2013, Ann Am Thorac Soc, V10, P179, DOI 10.1513/AnnalsATS.201211-107OC; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Collie D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067677; Daniels TWV, 2013, J CYST FIBROS, V12, P22, DOI 10.1016/j.jcf.2012.05.008; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dickson RP, 2015, ANN AM THORAC SOC, V12, P821, DOI 10.1513/AnnalsATS.201501-029OC; Dickson RP, 2013, EXPERT REV RESP MED, V7, P245, DOI [10.1586/ers.13.24, 10.1586/ERS.13.24]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Goddard AF, 2012, P NATL ACAD SCI USA, V109, P13769, DOI 10.1073/pnas.1107435109; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; GOVAN JRW, 1978, J ANTIMICROB CHEMOTH, V4, P233, DOI 10.1093/jac/4.3.233; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Imberti R, 2010, CHEST, V138, P1333, DOI 10.1378/chest.10-0463; King PT, 2007, RESP MED, V101, P1633, DOI 10.1016/j.rmed.2007.03.009; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Le Gall F, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-143; Li J, 2003, ANTIMICROB AGENTS CH, V47, P1364, DOI 10.1128/AAC.47.4.1364-1370.2003; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Martinez-Solano L, 2008, CLIN INFECT DIS, V47, P1526, DOI 10.1086/593186; Nguyen T, 2013, J AEROSOL MED PULMON; Nicholas B, 2009, BIOCHEM SOC T, V37, P868, DOI 10.1042/BST0370868; Price KE, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-27; REGELMANN WE, 1990, AM REV RESPIR DIS, V141, P914, DOI 10.1164/ajrccm/141.4_Pt_1.914; Reid DW, 2013, J CYST FIBROS, V12, P688, DOI 10.1016/j.jcf.2013.03.008; Rogers GB, 2014, LANCET RESP MED, V2, P988, DOI 10.1016/S2213-2600(14)70213-9; Rogers Geraint B, 2014, Ann Am Thorac Soc, V11, P496, DOI 10.1513/AnnalsATS.201310-335OC; Sanders DB, 2011, PEDIATR PULM, V46, P393, DOI 10.1002/ppul.21374; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Segal LN, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-19; Stressmann FA, 2011, J CYST FIBROS, V10, P357, DOI 10.1016/j.jcf.2011.05.002	35	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142097	10.1371/journal.pone.0142097	http://dx.doi.org/10.1371/journal.pone.0142097			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544950	Green Submitted, Green Published, gold			2022-12-26	WOS:000364398700082
J	Watt, DG; Proctor, MJ; Park, JH; Horgan, PG; McMillan, DC				Watt, David G.; Proctor, Michael J.; Park, James H.; Horgan, Paul G.; McMillan, Donald C.			The Neutrophil-Platelet Score (NPS) Predicts Survival in Primary Operable Colorectal Cancer and a Variety of Common Cancers	PLOS ONE			English	Article							SYSTEMIC INFLAMMATORY RESPONSE; LYMPHOCYTE RATIO; POSTOPERATIVE SURVIVAL; PROGNOSTIC SCORE; COUNT; COMBINATION; SURGERY	Introduction Recent in-vitro studies have suggested that a critical checkpoint early in the inflammatory process involves the interaction between neutrophils and platelets. This confirms the importance of the innate immune system in the elaboration of the systemic inflammatory response. The aim of the present study was to examine whether a combination of the neutrophil and platelet counts were predictive of survival in patients with cancer. Methods Patients with histologically proven colorectal cancer who underwent potentially curative resection at a single centre between March 1999 and May 2013 (n = 796) and patients with cancer from the Glasgow Inflammation Outcome Study, who had a blood sample taken between January 2000 and December 2007 (n = 9649) were included in the analysis. Results In the colorectal cancer cohort, there were 173 cancer and 135 non-cancer deaths. In patients undergoing elective surgery, cancer-specific survival (CSS) at 5 years ranged from 97% in patients with TNM I disease and NPS = 0 to 57% in patients with TNM III disease and NPS = 2 (p = 0.019) and in patients undergoing elective surgery for node-negative colon cancer from 98% (TNM I, NPS = 0) to 65% (TNM II, NPS = 2) (p = 0.004). In those with a variety of common cancers there were 5218 cancer and 929 non-cancer deaths. On multivariate analysis, adjusting for age and sex and stratified by tumour site, incremental increase in the NPS was significantly associated with poorer CSS (p<0.001). Conclusion The neutrophil-platelet score predicted survival in a variety of common cancers and highlights the importance of the innate immune system in patients with cancer.	[Watt, David G.; Proctor, Michael J.; Park, James H.; Horgan, Paul G.; McMillan, Donald C.] Univ Glasgow, Glasgow Royal Infirm, Sch Med, Acad Surg Unit, Glasgow G31 2ER, Lanark, Scotland	University of Glasgow	Watt, DG (corresponding author), Univ Glasgow, Glasgow Royal Infirm, Sch Med, Acad Surg Unit, Glasgow G31 2ER, Lanark, Scotland.	davidwatt1@nhs.net		McMillan, Donald/0000-0003-4260-5334				Ardi VC, 2007, P NATL ACAD SCI USA, V104, P20262, DOI 10.1073/pnas.0706438104; Feng JF, 2014, TRANSL ONCOL, V7, P632, DOI 10.1016/j.tranon.2014.07.009; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Guthrie GJK, 2013, CRIT REV ONCOL HEMAT, V88, P218, DOI 10.1016/j.critrevonc.2013.03.010; Ishizuka M, 2013, BRIT J CANCER, V109, P401, DOI 10.1038/bjc.2013.350; Ishizuka M, 2014, J SURG ONCOL, V110, P935, DOI 10.1002/jso.23753; Jain S, 2010, ARTERIOSCL THROM VAS, V30, P2362, DOI 10.1161/ATVBAHA.110.207514; Kumar R, 2015, BRIT J CANCER, V112, P1157, DOI 10.1038/bjc.2015.67; Leitch EF, 2007, BRIT J CANCER, V97, P1266, DOI 10.1038/sj.bjc.6604027; Li MX, 2014, INT J CANCER, V134, P2403, DOI 10.1002/ijc.28536; McMillan DC, 2013, CANCER TREAT REV, V39, P534, DOI 10.1016/j.ctrv.2012.08.003; Oliphant R, 2013, BRIT J SURG, V100, P1388, DOI 10.1002/bjs.9227; Park JH, 2015, ANN SURG; Proctor MJ, 2010, BRIT J CANCER, V103, P870, DOI 10.1038/sj.bjc.6605855; Proctor MJ, 2013, CANCER-AM CANCER SOC, V119, P2325, DOI 10.1002/cncr.28018; Proctor MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116206; Roxburgh CSD, 2010, FUTURE ONCOL, V6, P149, DOI 10.2217/FON.09.136; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Sreeramkumar V, 2014, SCIENCE, V346, P1234, DOI 10.1126/science.1256478; Templeton AJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju124; Ten Kate M, 2007, ANTICANCER RES, V27, P17; Wang SC, 2015, ANN SURG; Watt DG, 2015, AM J SURG, V210, P24, DOI 10.1016/j.amjsurg.2014.12.031	23	50	51	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142159	10.1371/journal.pone.0142159	http://dx.doi.org/10.1371/journal.pone.0142159			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544968	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000364398700090
J	Pless, E; Queirolo, J; Pinter-Wollman, N; Crow, S; Allen, K; Mathur, MB; Gordon, DM				Pless, Evlyn; Queirolo, Jovel; Pinter-Wollman, Noa; Crow, Sam; Allen, Kelsey; Mathur, Maya B.; Gordon, Deborah M.			Interactions Increase Forager Availability and Activity in Harvester Ants	PLOS ONE			English	Article							DIVISION-OF-LABOR; COLLECTIVE REGULATION; ORGANIZATION; HYMENOPTERA; INFORMATION; ACTIVATION; DECISIONS; NETWORKS; MASS	Social insect colonies use interactions among workers to regulate collective behavior. Harvester ant foragers interact in a chamber just inside the nest entrance, here called the 'entrance chamber'. Previous studies of the activation of foragers in red harvester ants show that an outgoing forager inside the nest experiences an increase in brief antennal contacts before it leaves the nest to forage. Here we compare the interaction rate experienced by foragers that left the nest and ants that did not. We found that ants in the entrance chamber that leave the nest to forage experienced more interactions than ants that descend to the deeper nest without foraging. Additionally, we found that the availability of foragers in the entrance chamber is associated with the rate of forager return. An increase in the rate of forager return leads to an increase in the rate at which ants descend to the deeper nest, which then stimulates more ants to ascend into the entrance chamber. Thus a higher rate of forager return leads to more available foragers in the entrance chamber. The highest density of interactions occurs near the nest entrance and the entrances of the tunnels from the entrance chamber to the deeper nest. Local interactions with returning foragers regulate both the activation of waiting foragers and the number of foragers available to be activated.	[Pless, Evlyn; Queirolo, Jovel; Gordon, Deborah M.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Pinter-Wollman, Noa] Univ Calif San Diego, BioCircuits Inst, La Jolla, CA 92093 USA; [Crow, Sam] Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98195 USA; [Allen, Kelsey] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Mathur, Maya B.] Stanford Univ, Quantitat Sci Unit, Stanford, CA 94305 USA	Stanford University; University of California System; University of California San Diego; University of Washington; University of Washington Seattle; Massachusetts Institute of Technology (MIT); Stanford University	Pless, E (corresponding author), Yale Univ, Dept Ecol & Evolut, New Haven, CT 06520 USA.	evlyn.pless@yale.edu			Stanford UAR Student Small Grant; Stanford UAR Student Major Grant; National Institutes of Health [R01GM105024]	Stanford UAR Student Small Grant; Stanford UAR Student Major Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Field work for EP in 2012 was funded by a Stanford UAR Student Small Grant, and field work for JQ in 2013 was funded by a Stanford UAR Student Major Grant (https://undergrad.stanford.edu/opportunities/research/get-funded/apply-studentgrants/grant-types). Other expenses were funded by the grant DMG received from the National Institutes of Health (grant number R01GM105024, http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER FR, 1992, AM NAT, V140, P373, DOI 10.1086/285418; Adler FR, 2003, AM NAT, V162, P529, DOI 10.1086/378856; Beverly BD, 2009, BEHAV ECOL, V20, P633, DOI 10.1093/beheco/arp041; Biesmeijer JC, 1998, BEHAV ECOL SOCIOBIOL, V42, P107, DOI 10.1007/s002650050418; Bonabeau E, 1998, PHILOS T R SOC B, V353, P1561, DOI 10.1098/rstb.1998.0310; Bonabeau E, 1997, TRENDS ECOL EVOL, V12, P188, DOI 10.1016/S0169-5347(97)01048-3; Burd M, 2010, ECOL ENTOMOL, V35, P464, DOI 10.1111/j.1365-2311.2010.01202.x; Camazine S, 1999, INSECT SOC, V46, P348, DOI 10.1007/s000400050156; CAMAZINE S, 1991, BEHAV ECOL SOCIOBIOL, V28, P61, DOI 10.1007/BF00172140; Czaczkes TJ, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.1009; Dussutour A, 2007, INSECT SOC, V54, P158, DOI 10.1007/s00040-007-0926-9; Dussutour A, 2004, NATURE, V428, P70, DOI 10.1038/nature02345; Farji-Brener AG, 2010, ANIM BEHAV, V79, P343, DOI 10.1016/j.anbehav.2009.11.009; Fernandez PC, 2003, BEHAV ECOL SOCIOBIOL, V54, P80, DOI 10.1007/s00265-003-0607-2; Gordon DM, 2008, BEHAV ECOL, V19, P217, DOI 10.1093/beheco/arm125; Gordon DM, 2013, NATURE, V498, P91, DOI 10.1038/nature12137; Gordon DM, 2011, BEHAV ECOL, V22, P429, DOI 10.1093/beheco/arq218; GORDON DM, 1992, BEHAV ECOL SOCIOBIOL, V31, P417, DOI 10.1007/BF00170609; GORDON DM, 1986, ANIM BEHAV, V34, P1402, DOI 10.1016/S0003-3472(86)80211-1; GORDON DM, 1995, ANIM BEHAV, V50, P995, DOI 10.1016/0003-3472(95)80100-6; GORDON DM, 1993, ANIM BEHAV, V45, P1083, DOI 10.1006/anbe.1993.1134; GORDON DM, 1988, BEHAVIOUR, V104, P162, DOI 10.1163/156853988X00656; Gordon DM, 2002, AM NAT, V159, P509, DOI 10.1086/339461; Gordon DM., 2010, ANT ENCOUNTERS; Greene MJ, 2007, BEHAV ECOL, V18, P451, DOI 10.1093/beheco/arl105; Greene MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052219; Greene MJ, 2003, NATURE, V423, P32, DOI 10.1038/423032a; Huang ZY, 1996, BEHAV ECOL SOCIOBIOL, V39, P147, DOI 10.1007/s002650050276; Kietzman PM, 2015, FRONT ECOL EVOL, V3, P1, DOI DOI 10.3389/FEV0.2015.00014/ABSTRACT; LIGHTON JRB, 1988, P NATL ACAD SCI USA, V85, P4765, DOI 10.1073/pnas.85.13.4765; LIGHTON JRB, 1989, PHYSIOL ZOOL, V62, P1232, DOI 10.1086/physzool.62.6.30156211; Mailleux AC, 2010, ANIM BEHAV, V79, P31, DOI 10.1016/j.anbehav.2009.09.027; Navlakha S, 2015, COMMUN ACM, V58, P94, DOI 10.1145/2678280; O'Donnell S, 2001, BEHAV ECOL, V12, P353, DOI 10.1093/beheco/12.3.353; Pinter-Wollman N, 2015, BIOL LETT IN PRESS; Pinter-Wollman N, 2013, ANIM BEHAV, V86, P197, DOI 10.1016/j.anbehav.2013.05.012; Pinter-Wollman N, 2011, J R SOC INTERFACE, V8, P1562, DOI 10.1098/rsif.2011.0059; Prabhakar B, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002670; Pratt SC, 2006, P NATL ACAD SCI USA, V103, P15906, DOI 10.1073/pnas.0604801103; R Core Team, 2021, R LANGUAGE ENV STAT; Schafer RJ, 2006, ANIM BEHAV, V71, P815, DOI 10.1016/j.anbehav.2005.05.024; Schneider SS, 2004, APIDOLOGIE, V35, P117, DOI 10.1051/apido:2004006; Sonnentag PJ, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.1101; Sumpter D. J., 2010, COLLECTIVE ANIMAL BE, DOI [10.1515/9781400837106, DOI 10.1515/9781400837106]; Toffin E, 2009, P NATL ACAD SCI USA, V106, P18616, DOI 10.1073/pnas.0902685106; WILSON EO, 1984, BEHAV ECOL SOCIOBIOL, V16, P89, DOI 10.1007/BF00293108	46	18	18	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141971	10.1371/journal.pone.0141971	http://dx.doi.org/10.1371/journal.pone.0141971			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26539724	Green Published, gold, Green Submitted			2022-12-26	WOS:000364303800039
J	Zhang, TY; Ji, S; Bozovic, D				Zhang, Tracy-Ying; Ji, Seung; Bozovic, Dolores			Synchronization of Spontaneous Active Motility of Hair Cell Bundles	PLoS One			English	Article							SPONTANEOUS OTOACOUSTIC EMISSIONS; OTOLITHIC-MEMBRANE; COCHLEAR AMPLIFIER; MECHANICAL STIMULATION; BULLFROGS SACCULUS; ADAPTATION; AMPLIFICATION; HEARING; MECHANOTRANSDUCTION; SENSITIVITY	Hair cells of the inner ear exhibit an active process, believed to be crucial for achieving the sensitivity of auditory and vestibular detection. One of the manifestations of the active process is the occurrence of spontaneous hair bundle oscillations in vitro. Hair bundles are coupled by overlying membranes in vivo; hence, explaining the potential role of innate bundle motility in the generation of otoacoustic emissions requires an understanding of the effects of coupling on the active bundle dynamics. We used microbeads to connect small groups of hair cell bundles, using in vitro preparations that maintain their innate oscillations. Our experiments demonstrate robust synchronization of spontaneous oscillations, with either 1:1 or multi-mode phase-locking. The frequency of synchronized oscillation was found to be near the mean of the innate frequencies of individual bundles. Coupling also led to an improved regularity of entrained oscillations, demonstrated by an increase in the quality factor.	[Zhang, Tracy-Ying; Bozovic, Dolores] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; [Bozovic, Dolores] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA USA; [Ji, Seung] Los Angeles Mission Coll, Dept Phys Sci, Sylmar, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Bozovic, D (corresponding author), Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA.	bozovic@physics.ucla.edu		Ji, Seung Keun/0000-0003-1249-5330	National Science Foundation [CMMI-1131842]	National Science Foundation(National Science Foundation (NSF))	Funding is provided by National Science Foundation (http://www.nsf.gov/), with grant number CMMI-1131842. Author D.B. and T.Z. received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn KH, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0525; Anishchenko V.S., 2007, NONLINEAR DYNAMICS C; Ashmore J, 2010, HEARING RES, V266, P1, DOI 10.1016/j.heares.2010.05.001; Ashmore J, 2000, CURR BIOL, V10, pR325, DOI 10.1016/S0960-9822(00)00457-7; Barral J, 2010, P NATL ACAD SCI USA, V107, P10765, DOI 10.1073/pnas.1005833107; Benser ME, 1996, J NEUROSCI, V16, P5629; BENSER ME, 1993, HEARING RES, V68, P243, DOI 10.1016/0378-5955(93)90128-N; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; Camalet S, 2000, P NATL ACAD SCI USA, V97, P3183, DOI 10.1073/pnas.97.7.3183; Choe Y, 1998, P NATL ACAD SCI USA, V95, P15321, DOI 10.1073/pnas.95.26.15321; CRAWFORD AC, 1985, J PHYSIOL-LONDON, V364, P359, DOI 10.1113/jphysiol.1985.sp015750; Dallos P, 2008, NEURON, V58, P333, DOI 10.1016/j.neuron.2008.02.028; Dierkes K, 2008, P NATL ACAD SCI USA, V105, P18669, DOI 10.1073/pnas.0805752105; Eatock RA, 2000, ANNU REV NEUROSCI, V23, P285, DOI 10.1146/annurev.neuro.23.1.285; Eguiluz VM, 2000, PHYS REV LETT, V84, P5232, DOI 10.1103/PhysRevLett.84.5232; Fettiplace R, 2006, NAT REV NEUROSCI, V7, P19, DOI 10.1038/nrn1828; Fettiplace R, 2003, CURR OPIN NEUROBIOL, V13, P446, DOI 10.1016/S0959-4388(03)00094-1; Freeman DM, 2003, HEARING RES, V180, P11, DOI 10.1016/S0378-5955(03)00072-8; Gillespie PG, 2009, CELL, V139, P33, DOI 10.1016/j.cell.2009.09.010; Gillespie PG, 2004, ANNU REV PHYSIOL, V66, P521, DOI 10.1146/annurev.physiol.66.032102.112842; GOLD T, 1948, PROC R SOC SER B-BIO, V135, P492, DOI 10.1098/rspb.1948.0025; Hudspeth AJ, 2008, NEURON, V59, P530, DOI 10.1016/j.neuron.2008.07.012; Hudspeth AJ, 2014, NAT REV NEUROSCI, V15, P600, DOI 10.1038/nrn3786; HUDSPETH AJ, 1977, P NATL ACAD SCI USA, V74, P2407, DOI 10.1073/pnas.74.6.2407; KACHAR B, 1990, HEARING RES, V45, P179, DOI 10.1016/0378-5955(90)90119-A; Kandel E. R., 2000, PRINCIPLES NEURAL SC, V4, P590; Kao A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058143; KEMP DT, 1979, SCAND AUDIOL, P35; Kennedy HJ, 2006, J NEUROSCI, V26, P2757, DOI 10.1523/JNEUROSCI.3808-05.2006; KOPPL C, 1993, HEARING RES, V71, P157, DOI 10.1016/0378-5955(93)90031-U; LeMasurier M, 2005, NEURON, V48, P403, DOI 10.1016/j.neuron.2005.10.017; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; Manley GA, 2001, P NATL ACAD SCI USA, V98, P2826, DOI 10.1073/pnas.041604998; Manley GA, 2000, P NATL ACAD SCI USA, V97, P11736, DOI 10.1073/pnas.97.22.11736; Martin P, 2003, J NEUROSCI, V23, P4533; Martin P, 2001, P NATL ACAD SCI USA, V98, P14380, DOI 10.1073/pnas.251530598; Martin P, 2001, P NATL ACAD SCI USA, V98, P14386, DOI 10.1073/pnas.251530498; Meenderink SWF, 2015, J NEUROSCI IN PRESS; Ricci AJ, 2000, J NEUROSCI, V20, P7131; Robles L, 2001, PHYSIOL REV, V81, P1305, DOI 10.1152/physrev.2001.81.3.1305; Smotherman MS, 2000, J EXP BIOL, V203, P2237; Stauffer EA, 2005, NEURON, V47, P541, DOI 10.1016/j.neuron.2005.07.024; Strimbu CE, 2010, HEARING RES, V265, P38, DOI 10.1016/j.heares.2010.03.001; Strimbu CE, 2009, HEARING RES, V256, P58, DOI 10.1016/j.heares.2009.06.015; Strimbu CE, 2011, MECH HEARING; van der Heijden M, 2014, P NATL ACAD SCI USA, V111, P14548, DOI 10.1073/pnas.1412412111; Vilfan A, 2003, BIOPHYS J, V85, P191, DOI 10.1016/S0006-3495(03)74465-8; Vilfan A, 2008, BIOPHYS J, V95, P4622, DOI 10.1529/biophysj.108.130286; Vollrath MA, 2007, ANNU REV NEUROSCI, V30, P339, DOI 10.1146/annurev.neuro.29.051605.112917; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009	50	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141764	10.1371/journal.pone.0141764	http://dx.doi.org/10.1371/journal.pone.0141764			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540409	Green Published, gold, Green Submitted			2022-12-26	WOS:000364303800027
J	Williams, VL; Loveridge, AJ; Newton, DJ; Macdonald, DW				Williams, Vivienne L.; Loveridge, Andrew J.; Newton, David J.; Macdonald, David W.			'Skullduggery': Lions Align and Their Mandibles Rock!	PLOS ONE			English	Article							PANTHERA-LEO; CONSERVATION; TIGERS	South Africa has legally exported substantial quantities of lion bones to Southeast Asia and China since 2008, apparently as part of the multinational trade substituting bones and body parts of other large cats for those of the tiger in wine and other health tonics. The legal sale of lion bones may mask an illegal trade, the size of which is only partially known. An observed component of the illegal trade is that quantities of skeletons are sometimes declared falsely/fraudulently on CITES export permits. Furthermore, there are emerging concerns that bones from tigers reared in captivity in South Africa and elsewhere are being laundered as lion bones using CITES Appendix II permits. There is therefore a need for tools to monitor the trade in lion body parts and to distinguish between lions and tigers. Our research indicates that it is possible to use skeletons, skulls and cranial sutures to detect misdeclarations in the lion bone trade. It is also possible to use the average mass of a lion skeleton to corroborate the numbers of skeletons declared on CITES permits, relative to the weight of the consolidated consignments stated on the air waybills. When the mass of consolidated consignments of skeletons destined for export was regressed against the number of skeletons in that consignment, there was a strong correlation between the variables (r(2) = 0.992) that can be used as a predictor of the accuracy of a declaration on a CITES permit. Additionally, the skulls of lions and tigers differ: two cranial sutures of lions align and their mandibles rock when placed on a flat surface, whereas the cranial sutures of tigers are not aligned and their mandibles rest naturally on two contact points. These two morphological differences between the skulls of tigers and lions are easy to observe at a glance and provide a method for distinguishing between the species if illegal trade in the bones is suspected and the skulls are present. These identifications should ideally be confirmed by a DNA test to provide rigorous evidence to prosecute offenders violating CITES regulations.	[Williams, Vivienne L.; Newton, David J.] Univ Witwatersrand, Sch Anim Plant & Environm Sci, Johannesburg, South Africa; [Loveridge, Andrew J.; Macdonald, David W.] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Oxford, England; [Newton, David J.] TRAFFIC, East Southern Africa Reg Off, Pretoria, South Africa	University of Witwatersrand; University of Oxford	Williams, VL (corresponding author), Univ Witwatersrand, Sch Anim Plant & Environm Sci, Johannesburg, South Africa.	vivwill@netdial.co.za	Williams, Vivienne Linda/M-1453-2019	Williams, Vivienne Linda/0000-0003-0698-6512	Robertson Foundation; Mackenzie Foundation; Recanati-Kaplan Foundation; National Research Foundation (South Africa); University of Witwatersrand	Robertson Foundation; Mackenzie Foundation; Recanati-Kaplan Foundation; National Research Foundation (South Africa)(National Research Foundation - South Africa); University of Witwatersrand	DWM and AJL acknowledge funding support from the Robertson Foundation, the Mackenzie Foundation, and the Recanati-Kaplan Foundation. VLW acknowledges financial support from National Research Foundation (South Africa) and the University of the Witwatersrand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanford W.T., 1888, FAUNA BRIT INDIA INC; Callister D, 1995, TIGER TREATMENTS RHI; Christiansen P, 2008, MAMM BIOL, V73, P451, DOI 10.1016/j.mambio.2007.08.001; Gratwicke B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002544; Haken J., 2011, GLOB FINANC INTEGR, V32, P11; Henry L, TALE 2 CITIES COMP S, P2; Jackson P., 1996, BIOL CONSERVATION; Johnson RN, 2014, FORENSIC SCI INT-GEN, V10, P1, DOI 10.1016/j.fsigen.2013.12.007; Kirberger RM, 2005, J ZOO WILDLIFE MED, V36, P21, DOI 10.1638/03-012; Lindsey P, 2012, S AFR J WILDL RES, V42, P11, DOI 10.3957/056.042.0103; Loveridge Andrew J., 2010, P161; Merriam J. C., 1932, FELIDAE RANCHO LA BR; Mills J. A., 1997, RHINOCEROS HORN TIGE; Moyle B, 2009, GLOB CRIME, V10, P124, DOI 10.1080/17440570902783921; Nowell K., 2007, TAMING TIGER TRADE C; Nowell K., 2000, FAR CURE TIGER TRADE; Pocock R. I., 1930, Journal of the Bombay Natural History Society, V34, P638; POCOCK R. I., 1929, JOUR BOMBAY NAT HIST SOC, V33, P505; Pocock R. I., 1939, FAUNA BRIT INDIA INC, V1; Raja S, 2009, J THERM ANAL CALORIM, V98, P173, DOI 10.1007/s10973-009-0124-2; Raptors Nest, 2008, DIFFERENCE LION TIGE; Williams VL., 2015, BONES CONTENTION ASS; Wilson-Wilde L, 2010, FORENSIC SCI MED PAT, V6, P149, DOI 10.1007/s12024-010-9179-4	23	8	9	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0135144	10.1371/journal.pone.0135144	http://dx.doi.org/10.1371/journal.pone.0135144			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536601	gold, Green Submitted, Green Published			2022-12-26	WOS:000364298400002
J	Wynendaele, E; Verbeke, F; Stalmans, S; Gevaert, B; Janssens, Y; Van De Wiele, C; Peremans, K; Burvenich, C; De Spiegeleer, B				Wynendaele, Evelien; Verbeke, Frederick; Stalmans, Sofie; Gevaert, Bert; Janssens, Yorick; Van De Wiele, Christophe; Peremans, Kathelijne; Burvenich, Christian; De Spiegeleer, Bart			Quorum Sensing Peptides Selectively Penetrate the Blood-Brain Barrier	PLOS ONE			English	Article							GUT-BRAIN; MICROBIOME; TRANSPORT; COMMUNICATION; ANXIETY; CROSS; QUANTIFICATION; TRANSCRIPTION; PATHOGENS; SYSTEMS	Bacteria communicate with each other by the use of signaling molecules, a process called 'quorum sensing'. One group of quorum sensing molecules includes the oligopeptides, which are mainly produced by Gram-positive bacteria. Recently, these quorum sensing peptides were found to biologically influence mammalian cells, promoting i.a. metastasis of cancer cells. Moreover, it was found that bacteria can influence different central nervous system related disorders as well, e.g. anxiety, depression and autism. Research currently focuses on the role of bacterial metabolites in this bacteria-brain interaction, with the role of the quorum sensing peptides not yet known. Here, three chemically diverse quorum sensing peptides were investigated for their brain influx (multiple time regression technique) and efflux properties in an in vivo mouse model (ICR-CD-1) to determine blood-brain transfer properties: PhrCACET1 demonstrated comparatively a very high initial influx into the mouse brain (K-in = 20.87 mu l/(gxmin)), while brain penetrabilities of BIP-2 and PhrANTH2 were found to be low (K-in = 2.68 mu l/(gxmin)) and very low (K-in = 0.18 mu l/(gxmin)), respectively. All three quorum sensing peptides were metabolically stable in plasma (in vitro) during the experimental time frame and no significant brain efflux was observed. Initial tissue distribution data showed remarkably high liver accumulation of BIP-2 as well. Our results thus support the potential role of some quorum sensing peptides in different neurological disorders, thereby enlarging our knowledge about the microbiome-brain axis.	[Wynendaele, Evelien; Verbeke, Frederick; Stalmans, Sofie; Gevaert, Bert; Janssens, Yorick; De Spiegeleer, Bart] Univ Ghent, Fac Pharmaceut Sci, Drug Qual & Registrat DruQuaR Grp, B-9000 Ghent, Belgium; [Van De Wiele, Christophe] Ghent Univ Hosp, Dept Radiol & Nucl Med, Fac Med & Hlth Sci, Ghent, Belgium; [Peremans, Kathelijne] Univ Ghent, Fac Vet Med, Dept Med Imaging Med & Clin Biol Small Anim, Merelbeke, Belgium; [Burvenich, Christian] Univ Ghent, Fac Vet Med, Comparat Physiol & Biometr, Merelbeke, Belgium	Ghent University; Ghent University; Ghent University Hospital; Ghent University; Ghent University	De Spiegeleer, B (corresponding author), Univ Ghent, Fac Pharmaceut Sci, Drug Qual & Registrat DruQuaR Grp, B-9000 Ghent, Belgium.	Bart.DeSpiegeleer@UGent.be	De Spiegeleer, Bart/A-2001-2008	De Spiegeleer, Bart/0000-0001-6794-3108	Special Research Fund of Ghent University [BOF 01J22510, BOF 01D38811]; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen) [121512, 131356]	Special Research Fund of Ghent University(Ghent University); Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This work was supported by the Special Research Fund of Ghent University (www.ugent.be, Grant numbers BOF 01J22510 to BDS and EW, and BOF 01D38811 to SS) and the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen, www.iwt.be, Grant numbers 121512 to BG and 131356 to FV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey G., 2002, PROTEIN PROTOCOLS HD, P963; Bailey Graham S., 1996, P673, DOI 10.1007/978-1-60327-259-9_115; Bailey MT, 2011, BRAIN BEHAV IMMUN, V25, P397, DOI 10.1016/j.bbi.2010.10.023; Bajaj JS, 2012, AM J PHYSIOL-GASTR L, V302, pG168, DOI 10.1152/ajpgi.00190.2011; BANKS WA, 1989, METHOD ENZYMOL, V168, P652; Banks WA, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-S1-S3; Begley DJ, 1996, J PHARM PHARMACOL, V48, P136, DOI 10.1111/j.2042-7158.1996.tb07112.x; Bruggemann H, 2003, P NATL ACAD SCI USA, V100, P1316, DOI 10.1073/pnas.0335853100; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Cryan JF, 2014, ADV EXPT MED BIOL MI; De Spiegeleer B, 2015, PLOS ONE, DOI [10.1371/journal,pone-.0119471, DOI 10.1371/J0URNAL.P0NE.0119471]; Deeken JF, 2007, CLIN CANCER RES, V13, P1663, DOI 10.1158/1078-0432.CCR-06-2854; Dinan TG, 2015, J PSYCHIATR RES, V63, P1, DOI 10.1016/j.jpsychires.2015.02.021; Durre P, 2004, ANAEROBE, V10, P69, DOI 10.1016/j.anaerobe.2003.11.001; Egleton Richard D, 2005, NeuroRx, V2, P44, DOI 10.1007/BF03206641; Erickson DL, 2002, INFECT IMMUN, V70, P1783, DOI 10.1128/IAI.70.4.1783-1790.2002; Finegold SM, 2002, CLIN INFECT DIS, V35, pS6, DOI 10.1086/341914; Foster JA, 2013, TRENDS NEUROSCI, V36, P305, DOI 10.1016/j.tins.2013.01.005; Fujiya M, 2007, CELL HOST MICROBE, V1, P299, DOI 10.1016/j.chom.2007.05.004; Gitzinger M, 2009, PLANT BIOTECHNOL J, V7, P73, DOI 10.1111/j.1467-7652.2008.00376.x; GJEDDE A, 1981, J NEUROCHEM, V36, P1463, DOI 10.1111/j.1471-4159.1981.tb00587.x; GJEDDE A, 1982, BRAIN RES REV, V4, P237, DOI 10.1016/0165-0173(82)90018-2; Gjedde A, 2011, NEUROKINETICS DYNAMI, DOI [10.1007/978-1-4419-7409-9, DOI 10.1007/978-1-4419-7409-9]; Grenham S, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00094; GUTIERREZ EG, 1993, J NEUROIMMUNOL, V47, P169, DOI 10.1016/0165-5728(93)90027-V; Henriques-Normark B, 2010, EXP CELL RES, V316, P1408, DOI 10.1016/j.yexcr.2010.03.003; Hong HA, 2009, RES MICROBIOL, V160, P134, DOI 10.1016/j.resmic.2008.11.002; Kang DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068322; Kastin AJ, 2003, INT J OBESITY, V27, P313, DOI 10.1038/sj.ijo.0802206; Knutsen E, 2004, J BACTERIOL, V186, P3078, DOI 10.1128/JB.186.10.3078-3085.2004; Kumar S, 2013, MBIO, V4, DOI 10.1128/mBio.00314-13; Kumari A, 2008, ANAL BIOANAL CHEM, V391, P1619, DOI 10.1007/s00216-008-2002-3; Kurihara A, 1999, CANCER RES, V59, P6159; Luna RA, 2015, CURR OPIN BIOTECH, V32, P35, DOI 10.1016/j.copbio.2014.10.007; Lyte M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003726; Mitchell J, 2011, MOL ORAL MICROBIOL, V26, P89, DOI 10.1111/j.2041-1014.2010.00601.x; Nassif X, 2002, TRENDS MICROBIOL, V10, P227, DOI 10.1016/S0966-842X(02)02349-1; Ng WL, 2009, ANNU REV GENET, V43, P197, DOI 10.1146/annurev-genet-102108-134304; Pan WH, 1998, NEUROPHARMACOLOGY, V37, P1553, DOI 10.1016/S0028-3908(98)00141-5; Paredes CJ, 2005, NAT REV MICROBIOL, V3, P969, DOI 10.1038/nrmicro1288; PATLAK CS, 1983, J CEREBR BLOOD F MET, V3, P1, DOI 10.1038/jcbfm.1983.1; Perego M, 2001, PEPTIDES, V22, P1541, DOI 10.1016/S0196-9781(01)00490-9; Ryan RP, 2008, MICROBIOL-SGM, V154, P1845, DOI 10.1099/mic.0.2008/017871-0; Schmidt C, 2015, NATURE, V518, pS12, DOI 10.1038/518S13a; Stalmans S, 2015, PROTEIN PEPTIDE LETT, V22, P768, DOI 10.2174/0929866522666150622101223; Stalmans S, 2014, PROTEIN PEPTIDE LETT, V21, P399, DOI 10.2174/09298665113206660110; Sternini C, 2004, NEUROGASTROENT MOTIL, V16, P3, DOI 10.1111/j.1743-3150.2004.00553.x; Sudo N, 2012, CHEM IMMUNOL ALLERGY, V98, P163, DOI 10.1159/000336510; TRIGUERO D, 1990, J NEUROCHEM, V54, P1882, DOI 10.1111/j.1471-4159.1990.tb04886.x; Van Dorpe S, 2012, BRAIN STRUCT FUNCT, V217, P687, DOI 10.1007/s00429-011-0375-0; Van Dorpe S, 2010, PEPTIDES, V31, P1390, DOI 10.1016/j.peptides.2010.03.029; Verbeke F, 2015, J PHARM ANAL, DOI [10.1016/j.pha.2014.12.002, DOI 10.1016/J.PHA.2014.12.002]; Verbeken M, 2015, PEPTIDES, V63, P10, DOI 10.1016/j.peptides.2014.10.010; Vergote V, 2008, PEPTIDES, V29, P1740, DOI 10.1016/j.peptides.2008.05.018; Wang Y, 2014, BRAIN BEHAV IMMUN, V38, P1, DOI 10.1016/j.bbi.2013.12.015; Williams P, 2007, MICROBIOL-SGM, V153, P3923, DOI 10.1099/mic.0.2007/012856-0; WONG DF, 1986, J CEREBR BLOOD F MET, V6, P137, DOI 10.1038/jcbfm.1986.27; Wynendaele E, 2015, BIOPOLYMERS, V104, P544, DOI 10.1002/bip.22649; Wynendaele E, 2015, PEPTIDES, V64, P40, DOI 10.1016/j.peptides.2014.12.009; Wynendaele E, 2014, CURR PHARM DESIGN, V20, P2250, DOI 10.2174/13816128113196660663; Wynendaele E, 2013, NUCLEIC ACIDS RES, V41, pD655, DOI 10.1093/nar/gks1137	61	31	31	1	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142071	10.1371/journal.pone.0142071	http://dx.doi.org/10.1371/journal.pone.0142071			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536593	Green Published, Green Submitted, gold			2022-12-26	WOS:000364298400128
J	Zhu, C; Nigam, KB; Date, RC; Bush, KT; Springer, SA; Saier, MH; Wu, W; Nigam, SK				Zhu, Christopher; Nigam, Kabir B.; Date, Rishabh C.; Bush, Kevin T.; Springer, Stevan A.; Saier, Milton H., Jr.; Wu, Wei; Nigam, Sanjay K.			Evolutionary Analysis and Classification of OATs, OCTs, OCTNs, and Other SLC22 Transporters: Structure-Function Implications and Analysis of Sequence Motifs	PLOS ONE			English	Article							ORGANIC ANION TRANSPORTER; CATION TRANSPORTER; GENOME DUPLICATION; MOLECULAR-CLONING; CHOROID-PLEXUS; FAMILY; IDENTIFICATION; DRUG; AFFINITY; POLYMORPHISMS	The SLC22 family includes organic anion transporters (OATs), organic cation transporters (OCTs) and organic carnitine and zwitterion transporters (OCTNs). These are often referred to as drug transporters even though they interact with many endogenous metabolites and signaling molecules (Nigam, S.K., Nature Reviews Drug Discovery, 14: 29-44, 2015). Phylogenetic analysis of SLC22 supports the view that these transporters may have evolved over 450 million years ago. Many OAT members were found to appear after a major expansion of the SLC22 family in mammals, suggesting a physiological and/or toxicological role during the mammalian radiation. Putative SLC22 orthologs exist in worms, sea urchins, flies, and ciona. At least six groups of SLC22 exist. OATs and OCTs form two Major clades of SLC22, within which (apart from Oat and Oct subclades), there are also clear Oat-like, Octn, and Oct-related subclades, as well as a distantly related group we term "Oat-related" (which may have different functions). Based on available data, it is arguable whether SLC22A18, which is related to bacterial drug-proton antiporters, should be assigned to SLC22. Disease-causing mutations, single nucleotide polymorphisms (SNPs) and other functionally analyzed mutations in OAT1, OAT3, URAT1, OCT1, OCT2, OCTN1, and OCTN2 map to the first extracellular domain, the large central intracellular domain, and transmembrane domains 9 and 10. These regions are highly conserved within subclades, but not between subclades, and may be necessary for SLC22 transporter function and functional diversification. Our results not only link function to evolutionarily conserved motifs but indicate the need for a revised sub-classification of SLC22.	[Zhu, Christopher; Bush, Kevin T.; Nigam, Sanjay K.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Nigam, Kabir B.; Date, Rishabh C.; Wu, Wei; Nigam, Sanjay K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Springer, Stevan A.; Nigam, Sanjay K.] Univ Calif San Diego, Dept Cellular Med, La Jolla, CA 92093 USA; [Springer, Stevan A.; Nigam, Sanjay K.] Univ Calif San Diego, Dept Mol Med, La Jolla, CA 92093 USA; [Saier, Milton H., Jr.] Univ Calif San Diego, Dept Mol Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Wu, W (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	weiwu@ucsd.edu; snigam@ucsd.edu		Saier, Milton/0000-0001-5530-0017	National Institute of General Medical Sciences (US) [R01GM104098, R01GM098449, R01GM077402]; Nancy Kaehr Chair in Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD071600] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098449, R01GM104098, R01GM077402] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (US); Nancy Kaehr Chair in Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: This work was funded by 1. National Institute of General Medical Sciences (US), Award Number: R01GM104098, Recipient: Sanjay K. Nigam; 2. National Institute of General Medical Sciences (US), Award Number: R01GM098449, Recipient: Sanjay K. Nigam; 3. National Institute of General Medical Sciences (US), Award Number: R01GM077402, Recipient: Milton H. Saier Jr. Dr. Nigam is also funded by the Nancy Kaehr Chair in Research.	Ahn SY, 2009, J BIOL CHEM, V284, P31422, DOI 10.1074/jbc.M109.024489; Ahn SY, 2009, MOL PHARMACOL, V76, P481, DOI 10.1124/mol.109.056564; Astorga B, 2011, AM J PHYSIOL-RENAL, V301, pF378, DOI 10.1152/ajprenal.00735.2010; Bahn A, 2008, J BIOL CHEM, V283, P16332, DOI 10.1074/jbc.M800737200; Bailey TL, 1997, J STEROID BIOCHEM, V62, P29, DOI 10.1016/S0960-0760(97)00013-7; Baker ME, 2005, INTEGR COMP BIOL, V45, P172, DOI 10.1093/icb/45.1.172; Bennett KM, 2011, MOL CELL BIOCHEM, V352, P143, DOI 10.1007/s11010-011-0748-y; Blair JE, 2005, MOL BIOL EVOL, V22, P2275, DOI 10.1093/molbev/msi225; Bleasby K, 2005, J PHARMACOL EXP THER, V314, P923, DOI 10.1124/jpet.105.084301; Boratyn GM, 2013, NUCLEIC ACIDS RES, V41, pW29, DOI 10.1093/nar/gkt282; Brunet FG, 2006, MOL BIOL EVOL, V23, P1808, DOI 10.1093/molbev/msl049; Burckhardt G, 2012, PHARMACOL THERAPEUT, V136, P106, DOI 10.1016/j.pharmthera.2012.07.010; Canestro C, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-208; Cesar-Razquin A, 2015, CELL, V162, P478, DOI 10.1016/j.cell.2015.07.022; Chu SH, 2014, CANCER GENE THER, V21, P103, DOI 10.1038/cgt.2014.4; Enomoto A, 2002, J BIOL CHEM, V277, P36262, DOI 10.1074/jbc.M203883200; Eraly SA, 2006, J BIOL CHEM, V281, P5072, DOI 10.1074/jbc.M508050200; Eraly SA, 2004, PHYSIOL GENOMICS, V18, P12, DOI 10.1152/physiolgenomics.00014.2004; Eraly SA, 2003, BIOCHEM BIOPH RES CO, V300, P333, DOI 10.1016/S0006-291X(02)02853-X; Eraly SA, 2002, BIOCHEM BIOPH RES CO, V297, P1159, DOI 10.1016/S0006-291X(02)02343-4; Fang G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000703; Gess RW, 2006, NATURE, V443, P981, DOI 10.1038/nature05150; GRUNDEMANN D, 1994, NATURE, V372, P549, DOI 10.1038/372549a0; Jacobsson JA, 2007, GENOMICS, V90, P595, DOI 10.1016/j.ygeno.2007.03.017; Kaler G, 2007, J BIOL CHEM, V282, P23841, DOI 10.1074/jbc.M703467200; Kaler G, 2006, BIOCHEM BIOPH RES CO, V351, P872, DOI 10.1016/j.bbrc.2006.10.136; Keller T, 2011, J BIOL CHEM, V286, P37874, DOI 10.1074/jbc.M111.289330; Koepsell H, 2013, MOL ASPECTS MED, V34, P413, DOI 10.1016/j.mam.2012.10.010; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; LopezNieto CE, 1997, J BIOL CHEM, V272, P6471, DOI 10.1074/jbc.272.10.6471; LopezNieto CE, 1996, J AM SOC NEPHROL, V7, pA0277; Markov GV, 2009, P NATL ACAD SCI USA, V106, P11913, DOI 10.1073/pnas.0812138106; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Monte JC, 2004, BIOCHEM BIOPH RES CO, V323, P429, DOI 10.1016/j.bbrc.2004.08.112; Nagle MA, 2013, NEUROSCI LETT, V534, P133, DOI 10.1016/j.neulet.2012.11.027; Nies AT, 2011, HANDB EXP PHARMACOL, P105; Nigam SK, 2015, PHYSIOL REV, V95, P83, DOI 10.1152/physrev.00025.2013; Nigam SK, 2015, NAT REV DRUG DISCOV, V14, P29, DOI 10.1038/nrd4461; Perry JL, 2006, J BIOL CHEM, V281, P38071, DOI 10.1074/jbc.M608834200; Riedmaier AE, 2012, PHARMACOL REV, V64, P421, DOI 10.1124/pr.111.004614; Saier MH, 2014, NUCLEIC ACIDS RES, V42, pD251, DOI 10.1093/nar/gkt1097; Schnabolk GW, 2006, AM J PHYSIOL-RENAL, V291, pF314, DOI 10.1152/ajprenal.00497.2005; SIMONSON GD, 1994, J CELL SCI, V107, P1065; Srimaroeng C, 2008, XENOBIOTICA, V38, P889, DOI [10.1080/00498250801927435, 10.1080/00498250801927435 ]; Sweet DH, 2002, J BIOL CHEM, V277, P26934, DOI 10.1074/jbc.M203803200; Tamai I, 1997, FEBS LETT, V419, P107, DOI 10.1016/S0014-5793(97)01441-5; Tamai I, 1998, J BIOL CHEM, V273, P20378, DOI 10.1074/jbc.273.32.20378; Tsigelny IF, 2011, CELL BIOCHEM BIOPHYS, V61, P251, DOI 10.1007/s12013-011-9191-7; Vallon V, 2012, AM J PHYSIOL-RENAL, V302, pF1293, DOI 10.1152/ajprenal.00013.2012; VanWert AL, 2010, BIOPHARM DRUG DISPOS, V31, P1, DOI 10.1002/bdd.693; Wu W, 2015, DRUG METAB DISPOS, V43, P1855, DOI 10.1124/dmd.115.065250; Wu W, 2011, MOL PHARMACOL, V79, P795, DOI 10.1124/mol.110.070607; Wu W, 2009, PHYSIOL GENOMICS, V38, P116, DOI 10.1152/physiolgenomics.90309.2008; Xu G, 2005, KIDNEY INT, V68, P1491, DOI 10.1111/j.1523-1755.2005.00612.x	56	52	54	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140569	10.1371/journal.pone.0140569	http://dx.doi.org/10.1371/journal.pone.0140569			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536134	Green Published, Green Submitted, gold			2022-12-26	WOS:000364298400025
J	Gazestani, VH; Salavati, R				Gazestani, Vahid H.; Salavati, Reza			Deciphering RNA Regulatory Elements Involved in the Developmental and Environmental Gene Regulation of Trypanosoma brucei	PLOS ONE			English	Article							LIFE-CYCLE STAGES; GENOME-WIDE; BINDING PROTEINS; MESSENGER-RNAS; COMPUTATIONAL IDENTIFICATION; EXPRESSION; RECOGNITION; REVEALS; STABILITY; DISCOVERY	Trypanosoma brucei is a vector-borne parasite with intricate life cycle that can cause serious diseases in humans and animals. This pathogen relies on fine regulation of gene expression to respond and adapt to variable environments, with implications in transmission and infectivity. However, the involved regulatory elements and their mechanisms of actions are largely unknown. Here, benefiting from a new graph-based approach for finding functional regulatory elements in RNA (GRAFFER), we have predicted 88 new RNA regulatory elements that are potentially involved in the gene regulatory network of T. brucei. We show that many of these newly predicted elements are responsive to both transcriptomic and proteomic changes during the life cycle of the parasite. Moreover, we found that 11 of predicted elements strikingly resemble previously identified regulatory elements for the parasite. Additionally, comparison with previously predicted motifs on T. brucei suggested the superior performance of our approach based on the current limited knowledge of regulatory elements in T. brucei.	[Gazestani, Vahid H.; Salavati, Reza] McGill Univ, Inst Parasitol, Montreal, PQ, Canada; [Salavati, Reza] McGill Univ, McGill Ctr Bioinformat, Montreal, PQ, Canada; [Salavati, Reza] McGill Univ, Dept Biochem, Montreal, PQ, Canada	McGill University; McGill University; McGill University	Salavati, R (corresponding author), McGill Univ, Inst Parasitol, 21111 Lakeshore Rd, Montreal, PQ, Canada.	reza.salavati@mcgill.ca			Natural Sciences and Engineering Research Council of Canada (NSERC) [328186]; CIHR Systems Biology Fellowship	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR Systems Biology Fellowship(Canadian Institutes of Health Research (CIHR))	This research was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) grant #328186 to RS. VHG is supported by a CIHR Systems Biology Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018425; Bussemaker HJ, 2001, NAT GENET, V27, P167, DOI 10.1038/84792; Butter F, 2013, MOL CELL PROTEOMICS, V12, P172, DOI 10.1074/mcp.M112.019224; Clayton CE, 2014, MOL BIOCHEM PARASIT, V195, P96, DOI 10.1016/j.molbiopara.2014.06.005; Clayton C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003680; Clery A, 2008, CURR OPIN STRUC BIOL, V18, P290, DOI 10.1016/j.sbi.2008.04.002; Das A, 2012, RNA, V18, P1968, DOI 10.1261/rna.033829.112; Droll D, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003286; Elemento O, 2007, MOL CELL, V28, P337, DOI 10.1016/j.molcel.2007.09.027; Erben ED, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004178; Fernandez-Moya SM, 2014, NUCLEIC ACIDS RES, V42, P7201, DOI 10.1093/nar/gku358; Foat BC, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.24; Foat BC, 2005, P NATL ACAD SCI USA, V102, P17675, DOI 10.1073/pnas.0503803102; Gazestani VH, 2014, TRENDS PARASITOL, V30, P234, DOI 10.1016/j.pt.2014.02.008; Goodarzi H, 2012, NATURE, V485, P264, DOI 10.1038/nature11013; Gunasekera K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-556; Hogan DJ, 2008, PLOS BIOL, V6, P2297, DOI 10.1371/journal.pbio.0060255; Hotz HR, 1998, MOL BIOCHEM PARASIT, V91, P131, DOI 10.1016/S0166-6851(97)00196-5; Hu SH, 2009, CELL, V139, P610, DOI 10.1016/j.cell.2009.08.037; Hudson BP, 2004, NAT STRUCT MOL BIOL, V11, P257, DOI 10.1038/nsmb738; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; Jensen BC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-482; Jha BA, 2015, FEBS LETT, V589, P1966, DOI 10.1016/j.febslet.2015.05.036; Khosravi P, 2014, COMPUT BIOL MED, V54, P24, DOI 10.1016/j.compbiomed.2014.08.020; Kolev NG, 2014, CELL MICROBIOL, V16, P482, DOI 10.1111/cmi.12268; Kolev NG, 2012, SCIENCE, V338, P1352, DOI 10.1126/science.1229641; Kramer S, 2011, TRENDS PARASITOL, V27, P23, DOI 10.1016/j.pt.2010.06.011; Li X, 2014, WIRES RNA, V5, P111, DOI 10.1002/wrna.1201; Li X, 2010, RNA, V16, P1096, DOI 10.1261/rna.2017210; Mao Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-355; Matthews KR, 2005, J CELL SCI, V118, P283, DOI 10.1242/jcs.01649; Mayho M, 2006, NUCLEIC ACIDS RES, V34, P5312, DOI 10.1093/nar/gkl598; Monk SL, 2013, J CELL SCI, V126, P2294, DOI 10.1242/jcs.126011; Najafabadi HS, 2013, NUCLEIC ACIDS RES, V41, P8591, DOI 10.1093/nar/gkt647; Najafabadi HS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000810; Nepusz T, 2012, NAT METHODS, V9, P471, DOI [10.1038/nmeth.1938, 10.1038/NMETH.1938]; Queiroz R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-495; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Ray D, 2009, NAT BIOTECHNOL, V27, P667, DOI 10.1038/nbt.1550; Siegel TN, 2010, NUCLEIC ACIDS RES, V38, P4946, DOI 10.1093/nar/gkq237; Urbaniak MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036619; Walrad P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000317; Yan XF, 2007, BIOINFORMATICS, V23, pI577, DOI 10.1093/bioinformatics/btm227	43	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0142342	10.1371/journal.pone.0142342	http://dx.doi.org/10.1371/journal.pone.0142342			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529602	gold, Green Published, Green Submitted			2022-12-26	WOS:000364032600114
J	Trikha, P; Sharma, N; Pena, C; Reyes, A; Pecot, T; Khurshid, S; Rawahneh, M; Moffitt, J; Stephens, JA; Fernandez, SA; Ostrowski, MC; Leone, G				Trikha, P.; Sharma, N.; Pena, C.; Reyes, A.; Pecot, T.; Khurshid, S.; Rawahneh, M.; Moffitt, J.; Stephens, J. A.; Fernandez, S. A.; Ostrowski, M. C.; Leone, G.			E2f3 in tumor macrophages promotes lung metastasis	ONCOGENE			English	Article							TRANSCRIPTION FACTOR; CELL MIGRATION; BREAST-CANCER; LIN-35 RB; FACTOR-I; EXPRESSION; ANGIOGENESIS; INVASION; MICROENVIRONMENT; INFILTRATION	The Rb-E2F axis is an important pathway involved in cell-cycle control that is deregulated in a number of cancers. E2f transcription factors have distinct roles in the control of cell proliferation, cell survival and differentiation in a variety of tissues. We have previously shown that E2fs are important downstream targets of a CSF-1 signaling cascade involved in myeloid development. In cancer, tumor-associated macrophages (TAMs) are recruited to the tumor stroma in response to cytokines secreted by tumor cells, and are believed to facilitate tumor cell invasion and metastasis. Using the MMTV-Polyoma Middle T antigen (PyMT) mouse model of human ductal carcinoma, we show that the specific ablation of E2f3 in TAMs, but not in tumor epithelial cells, attenuates lung metastasis without affecting primary tumor growth. Histological analysis and gene expression profiling suggest that E2f3 does not impact the proliferation or survival of TAMs, but rather controls a novel gene expression signature associated with cytoskeleton rearrangements, cell migration and adhesion. This E2f3 TAM gene expression signature was sufficient to predict cancer recurrence and overall survival of estrogen receptor (ER)-positive breast cancer patients. Interestingly, we find that E2f3b but not E2f3a levels are elevated in TAMs from PyMT mammary glands relative to controls, suggesting a differential role for these isoforms in metastasis. In summary, these findings identify E2f3 as a key transcription factor in TAMs, which influences the tumor microenvironment and tumor cell metastasis.	[Trikha, P.; Sharma, N.; Pena, C.; Reyes, A.; Pecot, T.; Khurshid, S.; Rawahneh, M.; Moffitt, J.; Ostrowski, M. C.; Leone, G.] Ohio State Univ, Human Canc Genet Program, Columbus, OH 43210 USA; [Trikha, P.; Sharma, N.; Pena, C.; Reyes, A.; Pecot, T.; Khurshid, S.; Rawahneh, M.; Moffitt, J.; Ostrowski, M. C.; Leone, G.] Ohio State Univ, Coll Med & Publ Hlth, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Trikha, P.; Sharma, N.; Pena, C.; Reyes, A.; Pecot, T.; Khurshid, S.; Rawahneh, M.; Moffitt, J.; Ostrowski, M. C.; Leone, G.] Ohio State Univ, Coll Biol Sci, Dept Mol Genet, Columbus, OH 43210 USA; [Stephens, J. A.; Fernandez, S. A.] Ohio State Univ, Coll Med, Ctr Biostat, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Leone, G (corresponding author), Ohio State Univ, Dept Mol Virol, Human Canc Genet Program, Ctr Comprehens Canc, 460W 12th Ave, Columbus, OH 43210 USA.	Gustavo.Leone@osumc.edu	; Ostrowski, Michael/H-3108-2011	Khurshid, Safiya/0000-0003-1620-3091; Ostrowski, Michael/0000-0003-2948-6297; Pecot, Thierry/0000-0003-0772-9753	NIH [R01CA121275, R01CA098956, P01CA097189]; T32 fellowship [CA 106196-06]; NATIONAL CANCER INSTITUTE [T32CA106196, R01CA121275, R01CA098956, P01CA097189] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); T32 fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Bryan Mcelwain for technical assistance with flow cytometry. This work was funded by NIH grants R01CA121275, R01CA098956 and P01CA097189 MC and GL to GL. PT and NS are recipients of the T32 fellowship (CA 106196-06).	Adams MR, 2000, MOL CELL BIOL, V20, P3633, DOI 10.1128/MCB.20.10.3633-3639.2000; Allavena P, 2008, CRIT REV ONCOL HEMAT, V66, P1, DOI 10.1016/j.critrevonc.2007.07.004; Blanchet E, 2011, NAT CELL BIOL, V13, P1146, DOI 10.1038/ncb2309; Bornstein P, 2002, CURR OPIN CELL BIOL, V14, P608, DOI 10.1016/S0955-0674(02)00361-7; Bosco EE, 2007, CELL CYCLE, V6, P667, DOI 10.4161/cc.6.6.3988; Brekken RA, 2003, J CLIN INVEST, V111, P487, DOI 10.1172/JCI200316804; Bronisz A, 2012, NAT CELL BIOL, V14, P159, DOI 10.1038/ncb2396; Ceol CJ, 2001, MOL CELL, V7, P461, DOI 10.1016/S1097-2765(01)00194-0; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Chiang AC, 2008, NEW ENGL J MED, V359, P2814, DOI 10.1056/NEJMra0805239; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Cooper CS, 2006, LUNG CANCER, V54, P155, DOI 10.1016/j.lungcan.2006.07.005; De Meyer T, 2009, J PATHOL, V217, P14, DOI 10.1002/path.2452; DeNardo DG, 2008, CANCER METAST REV, V27, P11, DOI 10.1007/s10555-007-9100-0; Diel Ingo J., 2000, Cancer, V88, P3080, DOI 10.1002/1097-0142(20000615)88:12+<3080::AID-CNCR27>3.0.CO;2-W; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Foster CS, 2004, ONCOGENE, V23, P5871, DOI 10.1038/sj.onc.1207800; Gauthier ML, 2007, CANCER CELL, V12, P479, DOI 10.1016/j.ccr.2007.10.017; Hurley PJ, 2012, P NATL ACAD SCI USA, V109, P14977, DOI 10.1073/pnas.1203525109; Jiang Z, 2010, J CLIN INVEST, V120, P3296, DOI 10.1172/JCI41490; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; KACINSKI BM, 1995, ANN MED, V27, P79, DOI 10.3109/07853899509031941; Kim BG, 2006, NATURE, V441, P1015, DOI 10.1038/nature04846; Leek RD, 1996, CANCER RES, V56, P4625; Leone G, 2000, MOL CELL BIOL, V20, P3626, DOI 10.1128/MCB.20.10.3626-3632.2000; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mundy GR, 1998, NEW ENGL J MED, V339, P398, DOI 10.1056/NEJM199808063390609; Myers TR, 2005, DEV CELL, V8, P117, DOI 10.1016/j.devcel.2004.11.015; Nasser MW, 2012, CANCER RES, V72, P604, DOI 10.1158/0008-5472.CAN-11-0669; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; O'Shaughnessy J, 2005, ONCOLOGIST, V10, P20, DOI 10.1634/theoncologist.10-90003-20; Olsson AY, 2007, ONCOGENE, V26, P1028, DOI 10.1038/sj.onc.1209854; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Reynolds LE, 2010, NATURE, V465, P813, DOI 10.1038/nature09106; Sangaletti S, 2003, J EXP MED, V198, P1475, DOI 10.1084/jem.20030202; STETLERSTEVENSON WG, 1993, ANNU REV CELL BIOL, V9, P541, DOI 10.1146/annurev.cb.09.110193.002545; Talmadge JE, 2007, CANCER METAST REV, V26, P373, DOI 10.1007/s10555-007-9072-0; Trikha P, 2011, J BIOL CHEM, V286, P4783, DOI 10.1074/jbc.M110.182733; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Van Nguyen A, 2002, DEV BIOL, V247, P11, DOI 10.1006/dbio.2002.0669; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wu L, 2013, ONCOGENE; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Yue W, 2009, CANCER RES, V69, P6339, DOI 10.1158/0008-5472.CAN-09-0398; Ziebold U, 2003, MOL CELL BIOL, V23, P6542, DOI 10.1128/MCB.23.18.6542-6552.2003	50	36	41	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 14	2016	35	28					3636	3646		10.1038/onc.2015.429	http://dx.doi.org/10.1038/onc.2015.429			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DR0UQ	26549026	Green Accepted			2022-12-26	WOS:000379622800003
J	Yang, H; Liu, P; Zhang, J; Peng, X; Lu, Z; Yu, S; Meng, Y; Tong, WM; Chen, J				Yang, H.; Liu, P.; Zhang, J.; Peng, X.; Lu, Z.; Yu, S.; Meng, Y.; Tong, W-M; Chen, J.			Long noncoding RNA MIR31HG exhibits oncogenic property in pancreatic ductal adenocarcinoma and is negatively regulated by miR-193b	ONCOGENE			English	Article							EXPRESSION; MICRORNAS; PROLIFERATION; PROGRESSION; LOC554202; MIGRATION; PROMOTES; TARGETS; SITES	Long noncoding RNAs (lncRNAs) play important regulatory roles in a variety of diseases, including many tumors. However, the functional roles of these transcripts and mechanisms responsible for their deregulation in pancreatic ductal adenocarcinoma (PDAC) are not thoroughly understood. In this study, we discovered that lncRNA MIR31HG is markedly upregulated in PDAC. Knockdown of MIR31HG significantly suppressed PDAC cell growth, induced apoptosis and G1/S arrest, and inhibited invasion, whereas enhanced expression of MIR31HG had the opposite effects. Online database analysis tools showed that miR-193b could target MIR31HG and we found an inverse correlation between MIR31HG and miR-193b in PDAC specimens. Inhibition of miR-193b expression significantly upregulated the MIR31HG level, while overexpression of miR-193b suppressed MIR31HG's expression and function, suggesting that MIR31HG is negatively regulated by miR-193b. Moreover, using luciferase reporter and RIP assays, we provide evidence that miR-193b directly targeted MIR31HG by binding to two microRNA binding sites in the MIR31HG sequence. On the other hand, MIR31HG may act as an endogenous 'sponge' by competing for miR-193b binding to regulate the miRNA targets. Collectively, these results demonstrate that MIR31HG functions as an oncogenic lncRNA that promotes tumor progression, and miR-193b targets not only protein-coding genes but also the lncRNA, MIR31HG.	[Yang, H.; Liu, P.; Lu, Z.; Yu, S.; Meng, Y.; Chen, J.] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Pathol, 1 Shuai Fu Yuan Hu Tong, Beijing 100730, Peoples R China; [Yang, H.; Liu, P.; Zhang, J.; Peng, X.; Lu, Z.; Yu, S.; Meng, Y.; Tong, W-M; Chen, J.] Peking Union Med Coll, Beijing 100730, Peoples R China; [Zhang, J.; Peng, X.] Chinese Acad Med Sci, Inst Basic Med Sci, State Key Lab Med Mol Biol, Beijing, Peoples R China; [Zhang, J.; Peng, X.; Tong, W-M] Chinese Acad Med Sci, Sch Basic Med, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China; [Tong, W-M] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Pathol, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS	Chen, J (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Pathol, 1 Shuai Fu Yuan Hu Tong, Beijing 100730, Peoples R China.; Chen, J (corresponding author), Peking Union Med Coll, Beijing 100730, Peoples R China.; Tong, WM (corresponding author), Chinese Acad Med Sci, Sch Basic Med, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China.; Tong, WM (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Dept Pathol, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China.; Tong, WM (corresponding author), Peking Union Med Coll, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China.	wmtong@ibms.pumc.edu.cn; xhblk@163.com			National Nature Science Foundations of China [81472326, 81172334, 31021091]; China 973 [2011CBA01104]	National Nature Science Foundations of China(National Natural Science Foundation of China (NSFC)); China 973(National Basic Research Program of China)	We sincerely thank Dr Yamei Niu for technical support and critical comments on the manuscript, Weilong Zhang for detailed bioinformatics analysis of MIR31HG, and Yongsong Yue for technical support of ISH. This work was supported by the National Nature Science Foundations of China (81472326 and 81172334 to JC, 31021091 to W-MT) and the China 973 (2011CBA01104 to W-MT).	Augoff K, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-5; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Braconi C, 2011, ONCOGENE, V30, P4750, DOI 10.1038/onc.2011.193; Brummer A, 2014, BIOESSAYS, V36, P617, DOI 10.1002/bies.201300104; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Cheetham SW, 2013, BRIT J CANCER, V108, P2419, DOI 10.1038/bjc.2013.233; Chen JM, 2011, AM J PATHOL, V179, P2162, DOI 10.1016/j.ajpath.2011.07.010; Chen X, 2013, BIOINFORMATICS, V29, P2617, DOI 10.1093/bioinformatics/btt426; Da Sacco L, 2013, INT J MOL SCI, V14, P480, DOI 10.3390/ijms14010480; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Gastaldi C, 2014, CARCINOGENESIS, V35, P1110, DOI 10.1093/carcin/bgt490; Guo G, 2015, ONCOGENE, V34, P1768, DOI 10.1038/onc.2014.131; Hansen TB, 2011, EMBO J, V30, P4414, DOI 10.1038/emboj.2011.359; Harries LW, 2012, BIOCHEM SOC T, V40, P902, DOI 10.1042/BST20120020; Ikeda Y, 2012, MOL CANCER RES, V10, P259, DOI 10.1158/1541-7786.MCR-11-0035; Izaurralde E, 2012, EMBO REP, V13, P662, DOI 10.1038/embor.2012.91; Jeggari A, 2012, BIOINFORMATICS, V28, P2062, DOI 10.1093/bioinformatics/bts344; Kallen AN, 2013, MOL CELL, V52, P101, DOI 10.1016/j.molcel.2013.08.027; Karreth FA, 2011, CELL, V147, P382, DOI 10.1016/j.cell.2011.09.032; Kim K, 2013, ONCOGENE, V32, P1616, DOI 10.1038/onc.2012.193; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leucci E, 2013, SCI REP-UK, V3, DOI 10.1038/srep02535; Lin ST, 2013, P NATL ACAD SCI USA, V110, P17468, DOI 10.1073/pnas.1317182110; Liu XH, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-92; Montes M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7967; Muers M, 2011, NAT REV GENET, V12, DOI 10.1038/nrg3088; Novikova IV, 2013, J MOL BIOL, V425, P3731, DOI 10.1016/j.jmb.2013.02.030; Paraskevopoulou MD, 2013, NUCLEIC ACIDS RES, V41, pD239, DOI 10.1093/nar/gks1246; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Shi YG, 2014, BIOCHEM BIOPH RES CO, V446, P448, DOI 10.1016/j.bbrc.2014.02.144; Siegel R, 2013, CA-CANCER J CLIN, V2013, P63; Tahira AC, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-141; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wang K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4596; Wang L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt006; Wang P, 2014, SCIENCE, V344, P310, DOI 10.1126/science.1251456; Xi SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013764; Xu CW, 2010, EUR J CANCER, V46, P2828, DOI 10.1016/j.ejca.2010.06.127; Yang F, 2013, J CANCER RES CLIN, V139, P437, DOI 10.1007/s00432-012-1324-x; Yang F, 2013, MOL CELL, V49, P1083, DOI 10.1016/j.molcel.2013.01.010; Yang X, 2014, GUT, V63, P881, DOI 10.1136/gutjnl-2013-305266; Zhang G, 2012, J CONTROL SCI ENG, V2012, P7, DOI DOI 10.1371/J0URNAL.P0NE.0044568	45	106	112	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 14	2016	35	28					3647	3657		10.1038/onc.2015.430	http://dx.doi.org/10.1038/onc.2015.430			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DR0UQ	26549028	hybrid, Green Published			2022-12-26	WOS:000379622800004
J	Zhou, L; Lyons-Rimmer, J; Ammoun, S; Muller, J; Lasonder, E; Sharma, V; Ercolano, E; Hilton, D; Taiwo, I; Barczyk, M; Hanemann, CO				Zhou, L.; Lyons-Rimmer, J.; Ammoun, S.; Mueller, J.; Lasonder, E.; Sharma, V.; Ercolano, E.; Hilton, D.; Taiwo, I.; Barczyk, M.; Hanemann, C. O.			The scaffold protein KSR1, a novel therapeutic target for the treatment of Merlin-deficient tumors	ONCOGENE			English	Article							KINASE SUPPRESSOR; HUMAN SCHWANNOMA; MAPK SCAFFOLD; GENE ENCODES; RAS; ACTIVATION; ERK; PROLIFERATION; TUMORIGENESIS; INHIBITION	Merlin has broad tumor-suppressor functions as its mutations have been identified in multiple benign tumors and malignant cancers. In all schwannomas, the majority of meningiomas and 1/3 of ependymomas Merlin loss is causative. In neurofibromatosis type 2, a dominantly inherited tumor disease because of the loss of Merlin, patients suffer from multiple nervous system tumors and die on average around age 40. Chemotherapy is not effective and tumor localization and multiplicity make surgery and radiosurgery challenging and morbidity is often considerable. Thus, a new therapeutic approach is needed for these tumors. Using a primary human in vitro model for Merlin-deficient tumors, we report that the Ras/Raf/mitogen-activated protein, extracellular signal-regulated kinase kinase (MEK)/extracellular signal-regulated kinase (ERK) scaffold, kinase suppressor of Ras 1 (KSR1), has a vital role in promoting schwannomas development. We show that KSR1 overexpression is involved in many pathological phenotypes caused by Merlin loss, namely multipolar morphology, enhanced cell-matrix adhesion, focal adhesion and, most importantly, increased proliferation and survival. Our data demonstrate that KSR1 has a wider role than MEK1/2 in the development of schwannomas because adhesion is more dependent on KSR1 than MEK1/2. Immunoprecipitation analysis reveals that KSR1 is a novel binding partner of Merlin, which suppresses KSR1's function by inhibiting the binding between KSR1 and c-Raf. Our proteomic analysis also demonstrates that KSR1 interacts with several Merlin downstream effectors, including E3 ubiquitin ligase CRL4(DCAF1). Further functional studies suggests that KSR1 and DCAF1 may co-operate to regulate schwannomas formation. Taken together, these findings suggest that KSR1 serves as a potential therapeutic target for Merlin-deficient tumors.	[Zhou, L.; Lyons-Rimmer, J.; Ammoun, S.; Ercolano, E.; Taiwo, I.; Hanemann, C. O.] Univ Plymouth, Peninsula Sch Med & Dent, Inst Translat & Stratified Med, John Bull Bldg,Plymouth Sci Pk,Res Way, Plymouth PL6 8BU, Devon, England; [Mueller, J.] Univ Warwick, Warwick Med Sch, Coventry, W Midlands, England; [Mueller, J.] Aston Univ, Aston Med Sch, Aston Med Res Inst, Birmingham, W Midlands, England; [Lasonder, E.; Sharma, V.] Univ Plymouth, Peninsula Sch Med & Dent, Sch Biomed & Healthcare Sci, Plymouth, Devon, England; [Hilton, D.] Derriford Hosp, Dept Neuropathol, Plymouth, Devon, England; [Barczyk, M.] MRC Lab Mol Biol, Cell Biol, Cambridge, England	University of Plymouth; University of Warwick; Aston University; University of Plymouth; Derriford Hospital; MRC Laboratory Molecular Biology	Zhou, L (corresponding author), Univ Plymouth, Peninsula Sch Med & Dent, Inst Translat & Stratified Med, John Bull Bldg,Plymouth Sci Pk,Res Way, Plymouth PL6 8BU, Devon, England.	lu.zhou@plymouth.ac.uk	Hanemann, C Oliver/AAV-6257-2020	Hanemann, C Oliver/0000-0002-1951-1025; Lasonder, Edwin/0000-0003-2582-3444	Children's Tumor Foundation young investigator award; Brain Tumor Research Charity PhD studentship; MRC [G0600790] Funding Source: UKRI; Medical Research Council [G0600790] Funding Source: researchfish	Children's Tumor Foundation young investigator award; Brain Tumor Research Charity PhD studentship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	LZ is supported by a Children's Tumor Foundation young investigator award. JL-R is supported by Brain Tumor Research Charity PhD studentship.	Ammoun S, 2015, MOL ONCOL, V9, P236, DOI 10.1016/j.molonc.2014.08.005; Ammoun S, 2008, CANCER RES, V68, P5236, DOI 10.1158/0008-5472.CAN-07-5849; Ammoun S, 2012, GLIA, V60, P1721, DOI 10.1002/glia.22391; Ammoun S, 2010, NEUROBIOL DIS, V37, P141, DOI 10.1016/j.nbd.2009.09.017; Brennan JA, 2002, J BIOL CHEM, V277, P5369, DOI 10.1074/jbc.M109875200; Canal F, 2011, FASEB J, V25, P2362, DOI 10.1096/fj.10-173153; Dougherty MK, 2009, MOL CELL, V34, P652, DOI 10.1016/j.molcel.2009.06.001; DOWNWARD J, 1995, CELL, V83, P831, DOI 10.1016/0092-8674(95)90198-1; Evans DGR, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-16; Flaiz C, 2007, J NEUROPATH EXP NEUR, V66, P608, DOI 10.1097/nen.0b013e318093e555; Hanemann CO, 2008, BRAIN, V131, P606, DOI 10.1093/brain/awm249; Hanemann CO, 2006, NEUROPATH APPL NEURO, V32, P605, DOI 10.1111/j.1365-2990.2006.00769.x; Hilton DA, 2009, HISTOPATHOLOGY, V55, P744, DOI 10.1111/j.1365-2559.2009.03440.x; KORNFELD K, 1995, CELL, V83, P903, DOI 10.1016/0092-8674(95)90206-6; Kortum RL, 2004, MOL CELL BIOL, V24, P4407, DOI 10.1128/MCB.24.10.4407-4416.2004; Li B, 2013, NEOPLASMA, V60, P406, DOI 10.4149/neo_2013_052; Li W, 2014, CANCER CELL, V26, P48, DOI 10.1016/j.ccr.2014.05.001; Li W, 2010, CELL, V140, P477, DOI 10.1016/j.cell.2010.01.029; Llobet D, 2011, AM J PATHOL, V178, P1529, DOI 10.1016/j.ajpath.2010.12.041; Lozano J, 2003, CANCER RES, V63, P4232; McKay MM, 2010, METHODS MOL BIOL, V661, P323, DOI 10.1007/978-1-60761-795-2_19; McKay MM, 2009, P NATL ACAD SCI USA, V106, P11022, DOI 10.1073/pnas.0901590106; Morrison DK, 2001, J CELL SCI, V114, P1609; Muller J, 2001, MOL CELL, V8, P983, DOI 10.1016/S1097-2765(01)00383-5; Ory S, 2003, CURR BIOL, V13, P1356, DOI 10.1016/S0960-9822(03)00535-9; Pelton PD, 1998, ONCOGENE, V17, P2195, DOI 10.1038/sj.onc.1202141; Rong R, 2004, P NATL ACAD SCI USA, V101, P18200, DOI 10.1073/pnas.0405971102; Rosenbaum C, 1998, NEUROBIOL DIS, V5, P55, DOI 10.1006/nbdi.1998.0179; Stebbing J, 2015, ONCOGENE, V34, P2103, DOI 10.1038/onc.2014.129; SUNDARAM M, 1995, CELL, V83, P889, DOI 10.1016/0092-8674(95)90205-8; Szatmari E, 2007, J NEUROSCI, V27, P11389, DOI 10.1523/JNEUROSCI.3473-07.2007; THERRIEN M, 1995, CELL, V83, P879, DOI 10.1016/0092-8674(95)90204-X; Utermark T, 2003, BRAIN PATHOL, V13, P352; Zhang H, 2013, BRIT J CANCER, V109, P2675, DOI 10.1038/bjc.2013.628; Zhou L, 2012, FEBS LETT, V586, P1403, DOI 10.1016/j.febslet.2012.03.016; Zhou L, 2011, NEOPLASIA, V13, P1101, DOI 10.1593/neo.111060	36	10	10	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 30	2016	35	26					3443	3453		10.1038/onc.2015.404	http://dx.doi.org/10.1038/onc.2015.404			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DQ5UI	26549023	Green Submitted, Green Accepted			2022-12-26	WOS:000379270100009
J	Hanna, MG; Mela, I; Wang, L; Henderson, RM; Chapman, ER; Edwardson, JM; Audhya, A				Hanna, Michael G.; Mela, Ioanna; Wang, Lei; Henderson, Robert M.; Chapman, Edwin R.; Edwardson, J. Michael; Audhya, Anjon			Sar1 GTPase Activity Is Regulated by Membrane Curvature	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COPII VESICLE FORMATION; ENDOPLASMIC-RETICULUM; CAENORHABDITIS-ELEGANS; ER; COAT; COMPLEX; TRANSPORT; INSIGHTS; BINDING; PROTEIN	The majority of biosynthetic secretory proteins initiate their journey through the endomembrane system from specific sub-domains of the endoplasmic reticulum. At these locations, coated transport carriers are generated, with the Sar1 GTPase playing a critical role in membrane bending, recruitment of coat components, and nascent vesicle formation. How these events are appropriately coordinated remains poorly understood. Here, we demonstrate that Sar1 acts as the curvature-sensing component of the COPII coat complex and highlight the ability of Sar1 to bind more avidly to membranes of high curvature. Additionally, using an atomic force microscopy-based approach, we further show that the intrinsic GTPase activity of Sar1 is necessary for remodeling lipid bilayers. Consistent with this idea, Sar1-mediated membrane remodeling is dramatically accelerated in the presence of its guanine nucleotide-activating protein (GAP), Sec23-Sec24, and blocked upon addition of guanosine-5 '-[(beta,gamma)-imido] triphosphate, a poorly hydrolysable analog of GTP. Our results also indicate that Sar1 GTPase activity is stimulated by membranes that exhibit elevated curvature, potentially enabling Sar1 membrane scission activity to be spatially restricted to highly bent membranes that are characteristic of a bud neck. Taken together, our data support a stepwise model in which the amino-terminal amphipathic helix of GTP-bound Sar1 stably penetrates the endoplasmic reticulum membrane, promoting local membrane deformation. As membrane bending increases, Sar1 membrane binding is elevated, ultimately culminating in GTP hydrolysis, which may destabilize the bilayer sufficiently to facilitate membrane fission.	[Audhya, Anjon] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, 440 Henry Mall, Madison, WI 53706 USA; [Mela, Ioanna; Henderson, Robert M.; Edwardson, J. Michael] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England; [Chapman, Edwin R.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Neurosci, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Cambridge; University of Wisconsin System; University of Wisconsin Madison	Audhya, A (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, 440 Henry Mall, Madison, WI 53706 USA.	audhya@wisc.edu	Mela, Ioanna/T-2085-2019	Mela, Ioanna/0000-0002-2914-9971; Chapman, Edwin/0000-0001-9787-8140	National Institutes of Health [GM110567, GM088151]; Biotechnology and Biological Sciences Research Council [BB/J018236/1]; BBSRC [BB/J018236/1] Funding Source: UKRI; MRC [MR/K000608/1] Funding Source: UKRI; Medical Research Council [MR/K000608/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008688, R01GM110567, R01GM088151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061876] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by National Institutes of Health Grants GM110567 and GM088151 (to A. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by Grant BB/J018236/1 from the Biotechnology and Biological Sciences Research Council.	Adolf F, 2013, TRAFFIC, V14, P922, DOI 10.1111/tra.12084; Bacia K, 2011, SCI REP-UK, V1, DOI 10.1038/srep00017; Bai JH, 2000, J BIOL CHEM, V275, P25427, DOI 10.1074/jbc.M906729199; Bannykh SI, 1996, J CELL BIOL, V135, P19, DOI 10.1083/jcb.135.1.19; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Bi XP, 2007, DEV CELL, V13, P635, DOI 10.1016/j.devcel.2007.10.006; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; Bielli A, 2005, J CELL BIOL, V171, P919, DOI 10.1083/jcb.200509095; Bigay J, 2005, EMBO J, V24, P2244, DOI 10.1038/sj.emboj.7600714; Bigay J, 2003, NATURE, V426, P563, DOI 10.1038/nature02108; BOLEN EJ, 1990, BIOCHEMISTRY-US, V29, P9638, DOI 10.1021/bi00493a019; Boucrot E, 2012, CELL, V149, P124, DOI 10.1016/j.cell.2012.01.047; Brandizzi F, 2013, NAT REV MOL CELL BIO, V14, P382, DOI 10.1038/nrm3588; D'Arcangelo JG, 2013, BBA-MOL CELL RES, V1833, P2464, DOI 10.1016/j.bbamcr.2013.02.003; Daum S, 2014, BIOL CHEM, V395, P801, DOI 10.1515/hsz-2014-0117; DENFERT C, 1991, J CELL BIOL, V114, P663, DOI 10.1083/jcb.114.4.663; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Futai E, 2004, EMBO J, V23, P4146, DOI 10.1038/sj.emboj.7600428; Fyfe I, 2011, J BIOL CHEM, V286, P34262, DOI 10.1074/jbc.M111.266411; Graham TR, 2010, CURR OPIN CELL BIOL, V22, P430, DOI 10.1016/j.ceb.2010.05.002; Green RA, 2011, CELL, V145, P470, DOI 10.1016/j.cell.2011.03.037; Hariri H, 2014, J MOL BIOL, V426, P3811, DOI 10.1016/j.jmb.2014.08.023; Hui EF, 2011, NAT STRUCT MOL BIOL, V18, P813, DOI 10.1038/nsmb.2075; Itoh T, 2001, SCIENCE, V291, P1047, DOI 10.1126/science.291.5506.1047; Ivan V, 2008, MOL BIOL CELL, V19, P4352, DOI 10.1091/mbc.E08-03-0246; Jones B, 2003, NAT GENET, V34, P29, DOI 10.1038/ng1145; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; KUGE O, 1994, J CELL BIOL, V125, P51, DOI 10.1083/jcb.125.1.51; Kung LF, 2012, EMBO J, V31, P1014, DOI 10.1038/emboj.2011.444; Kweon DH, 2006, MOL CELLS, V21, P428; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Long KR, 2010, J CELL BIOL, V190, P115, DOI 10.1083/jcb.201004132; Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9; Messa M, 2014, ELIFE, V3, DOI 10.7554/eLife.03311; Mondal S, 2015, ASSAY DRUG DEV TECHN, V13, P444, DOI 10.1089/adt.2015.643; Montegna EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031156; Oegema Karen, 2006, WormBook, P1, DOI 10.1895/wormbook.1.72.1; OKA T, 1991, J CELL BIOL, V114, P671, DOI 10.1083/jcb.114.4.671; Schindler AJ, 2009, P NATL ACAD SCI USA, V106, P17775, DOI 10.1073/pnas.0910342106; Schuh AL, 2015, BIOCHEM J, V466, P625, DOI 10.1042/BJ20141202; Shi AB, 2010, MOL BIOL CELL, V21, P2930, DOI 10.1091/mbc.E10-02-0149; Siddiqi S, 2010, J LIPID RES, V51, P1918, DOI 10.1194/jlr.M005611; Stachowiak JC, 2012, NAT CELL BIOL, V14, P944, DOI 10.1038/ncb2561; Stagg SM, 2008, CELL, V134, P474, DOI 10.1016/j.cell.2008.06.024; Stahelin RV, 2003, J BIOL CHEM, V278, P28993, DOI 10.1074/jbc.M302865200; TALLMADGE DH, 1989, PHOTOCHEM PHOTOBIOL, V49, P381, DOI 10.1111/j.1751-1097.1989.tb09183.x; Venditti R, 2014, TRENDS CELL BIOL, V24, P9, DOI 10.1016/j.tcb.2013.08.005; Wang L, 2014, METHODS, V68, P518, DOI 10.1016/j.ymeth.2014.03.028; Yorimitsu T, 2012, MOL BIOL CELL, V23, P2930, DOI 10.1091/mbc.E12-05-0356; YOSHIHISA T, 1993, SCIENCE, V259, P1466, DOI 10.1126/science.8451644	50	33	34	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1014	1027		10.1074/jbc.M115.672287	http://dx.doi.org/10.1074/jbc.M115.672287			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26546679	Green Published, hybrid			2022-12-26	WOS:000368068300001
J	Laakso, HA; Marolda, CL; Pinter, TB; Stillman, MJ; Heinrichs, DE				Laakso, Holly A.; Marolda, Cristina L.; Pinter, Tyler B.; Stillman, Martin J.; Heinrichs, David E.			A Heme-responsive Regulator Controls Synthesis of Staphyloferrin B in Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial transcription; biosynthesis; iron metabolism; siderophore; Staphylococcus aureus (S; aureus)	L-2,3-DIAMINOPROPIONIC ACID; IRON ACQUISITION; CITRATE SYNTHASE; IRR PROTEIN; SIDEROPHORE; GENE; IDENTIFICATION; BIOSYNTHESIS; TRANSPORT; BINDING	Staphylococcus aureus possesses a multitude of mechanisms by which it can obtain iron during growth under iron starvation conditions. It expresses an effective heme acquisition system (the iron-regulated surface determinant system), it produces two carboxylate-type siderophores staphyloferrin A and staphyloferrin B (SB), and it expresses transporters for many other siderophores that it does not synthesize. The ferric uptake regulator protein regulates expression of genes encoding all of these systems. Mechanisms of fine-tuning expression of iron-regulated genes, beyond simple iron regulation via ferric uptake regulator, have not been uncovered in this organism. Here, we identify the ninth gene of the sbn operon, sbnI, as encoding a ParB/Spo0J-like protein that is required for expression of genes in the sbn operon from sbnD onward. Expression of sbnD-I is drastically decreased in an sbnI mutant, and the mutant does not synthesize detectable SB during early phases of growth. Thus, SB-mediated iron acquisition is impaired in an sbnI mutant strain. We show that the protein forms dimers and tetramers in solution and binds to DNA within the sbnC coding region. Moreover, we show that SbnI binds heme and that heme-bound SbnI does not bind DNA. Finally, we show that providing exogenous heme to S. aureus growing in an iron-free medium results in delayed synthesis of SB. This is the first study in S. aureus that identifies a DNA-binding regulatory protein that senses heme to control gene expression for siderophore synthesis.	[Laakso, Holly A.; Marolda, Cristina L.; Heinrichs, David E.] Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5C1, Canada; [Pinter, Tyler B.; Stillman, Martin J.] Univ Western Ontario, Dept Chem, London, ON N6A 5C1, Canada; [Heinrichs, David E.] Univ Western Ontario, Ctr Human Immunol, London, ON N6A 5C1, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Heinrichs, DE (corresponding author), Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5C1, Canada.	deh@uwo.ca	Heinrichs, David/ABD-5702-2021; Stillman, Martin/O-3191-2016	Stillman, Martin/0000-0001-6799-7560; Pinter, Tyler/0000-0003-4381-3303; Heinrichs, David/0000-0002-7217-2456	Canadian Institutes of Health Research; Discovery Grant from the Natural Sciences and Engineering Council; Natural Sciences and Engineering Council	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Discovery Grant from the Natural Sciences and Engineering Council; Natural Sciences and Engineering Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported in part by an operating grant from the Canadian Institutes of Health Research (to D. E. H.) and by a Discovery Grant from the Natural Sciences and Engineering Council (to M. J. S.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a postgraduate scholarship-doctoral from the Natural Sciences and Engineering Council.	Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Beasley FC, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-199; Beasley FC, 2009, MOL MICROBIOL, V72, P947, DOI 10.1111/j.1365-2958.2009.06698.x; Bhatt G, 2004, J BACTERIOL, V186, P7896, DOI 10.1128/JB.186.23.7896-7904.2004; Cassat JE, 2013, CELL HOST MICROBE, V13, P510, DOI 10.1016/j.chom.2013.04.010; Challis GL, 2005, CHEMBIOCHEM, V6, P601, DOI 10.1002/cbic.200400283; Charpentier E, 2004, APPL ENVIRON MICROB, V70, P6076, DOI 10.1128/AEM.70.10.6076-6085.2004; Cheng AG, 2009, FASEB J, V23, P3393, DOI 10.1096/fj.09-135467; Cheung J, 2012, CHEM BIOL, V19, P1568, DOI 10.1016/j.chembiol.2012.10.003; Cheung J, 2009, MOL MICROBIOL, V74, P594, DOI 10.1111/j.1365-2958.2009.06880.x; Cooper JD, 2014, BIOCHEMISTRY-US, V53, P5060, DOI 10.1021/bi500729h; Cotton JL, 2009, BIOCHEMISTRY-US, V48, P1025, DOI 10.1021/bi801844c; Dale SE, 2004, INFECT IMMUN, V72, P29, DOI 10.1128/IAI.72.1.29-37.2004; DUMONT ME, 1994, BIOCHEMISTRY-US, V33, P7368, DOI 10.1021/bi00189a043; Fillat MF, 2014, ARCH BIOCHEM BIOPHYS, V546, P41, DOI 10.1016/j.abb.2014.01.029; Flavier AB, 1997, J BACTERIOL, V179, P7089, DOI 10.1128/jb.179.22.7089-7097.1997; Garnier F, 2006, EMERG INFECT DIS, V12, P498, DOI 10.3201/eid1203.051040; Graham TGW, 2014, GENE DEV, V28, P1228, DOI 10.1101/gad.242206.114; Grigg JC, 2010, J INORG BIOCHEM, V104, P341, DOI 10.1016/j.jinorgbio.2009.09.012; Hammer ND, 2011, ANNU REV MICROBIOL, V65, P129, DOI 10.1146/annurev-micro-090110-102851; Hamza I, 1998, J BIOL CHEM, V273, P21669, DOI 10.1074/jbc.273.34.21669; Hannauer M, 2015, FEBS LETT, V589, P730, DOI 10.1016/j.febslet.2015.02.002; Hanses F, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0093-3; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Imbert M, 1998, CURR MICROBIOL, V37, P64, DOI 10.1007/s002849900339; Johnson AP, 2005, J ANTIMICROB CHEMOTH, V56, P455, DOI 10.1093/jac/dki266; Kobylarz MJ, 2014, CHEM BIOL, V21, P379, DOI 10.1016/j.chembiol.2013.12.011; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; Mediavilla JR, 2012, CURR OPIN MICROBIOL, V15, P588, DOI 10.1016/j.mib.2012.08.003; Mesak LR, 2009, PLASMID, V61, P182, DOI 10.1016/j.plasmid.2009.01.003; Moreillon P, 2002, INFECT DIS CLIN N AM, V16, P297, DOI 10.1016/S0891-5520(01)00009-5; Muryoi N, 2008, J BIOL CHEM, V283, P28125, DOI 10.1074/jbc.M802171200; Nairz M, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00152; Nichol KA, 2011, DIAGN MICR INFEC DIS, V69, P320, DOI 10.1016/j.diagmicrobio.2010.10.028; PENG HL, 1988, J BACTERIOL, V170, P4365, DOI 10.1128/jb.170.9.4365-4372.1988; Pishchany G, 2014, J INFECT DIS, V209, P1764, DOI 10.1093/infdis/jit817; Posey JE, 2000, SCIENCE, V288, P1651, DOI 10.1126/science.288.5471.1651; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Raymond KN, 2003, P NATL ACAD SCI USA, V100, P3584, DOI 10.1073/pnas.0630018100; Reniere ML, 2008, MOL MICROBIOL, V69, P1304, DOI 10.1111/j.1365-2958.2008.06363.x; Sheldon JR, 2015, FEMS MICROBIOL REV, V39, P592, DOI 10.1093/femsre/fuv009; Sheldon JR, 2014, MOL MICROBIOL, V92, P824, DOI 10.1111/mmi.12593; Singleton C, 2010, J BIOL CHEM, V285, P16023, DOI 10.1074/jbc.M109.067215; Skaar EP, 2004, SCIENCE, V305, P1626, DOI 10.1126/science.1099930; Tahlan K, 2007, MOL MICROBIOL, V63, P951, DOI 10.1111/j.1365-2958.2006.05559.x; Torres VJ, 2006, J BACTERIOL, V188, P8421, DOI 10.1128/JB.01335-06; Visai L, 2009, MICROBIOL-SGM, V155, P667, DOI 10.1099/mic.0.025684-0; Yang JH, 2005, J BIOL CHEM, V280, P7671, DOI 10.1074/jbc.M411664200	49	29	30	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					29	40		10.1074/jbc.M115.696625	http://dx.doi.org/10.1074/jbc.M115.696625			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26534960	Green Published, hybrid			2022-12-26	WOS:000367589500003
J	Nguyen, QT; Ooi, JSG; Nguyen, NTK; Wang, SJ; Huang, M; Liu, DX; Tam, JP				Phuong Quoc Thuc Nguyen; Ooi, Justin Seng Geap; Ngan Thi Kim Nguyen; Wang, Shujing; Huang, Mei; Liu, Ding Xiang; Tam, James P.			Antiviral Cystine Knot a-Amylase Inhibitors from Alstonia scholaris	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-AMYLASE; SIGNAL PEPTIDES; DISCOVERY; CYCLOTIDES; PREDICTION	Cystine knot alpha-amylase inhibitors are cysteine-rich, proline-rich peptides found in the Amaranthaceae and Apocynaceae plant species. They are characterized by a pseudocydic backbone with two to four prolines and three disulfides arranged in a knotted motif. Similar to other knottins, cystine knot alpha-amylase inhibitors are highly resistant to degradation by heat and protease treatments. Thus far, only the alpha-amylase inhibition activity has been described for members of this family. Here, we show that cystine knot alpha-amylase inhibitors named alstotides discovered from the Alstonia scholaris plant of the Apocynaceae family display antiviral activity. 'The alstotides (As1-As4) were characterized by both proteomic and genomic methods. All four alsotides are novel, heat-stable and enzyme-stable and contain 30 residues. NMR determination of As1 and As4 structures reveals their conserved structural fold and the presence of one or more cis-proline bonds, characteristics shared by other cystine knot alpha-amylase inhibitors. Genomic analysis showed that they contain a three-domain precursor, an arrangement common to other knottins. We also showed that alstotides are antiviral and cell-permeable to inhibit the early phase of infectious bronchitis virus and Dengue infection, in addition to their ability to inhibit alpha-amylase. Taken together, our results expand membership of cystine knot alpha-amylase inhibitors in the Apocynaceae family and their bioactivity, functional promiscuity that could be exploited as leads in developing therapeutics.	[Phuong Quoc Thuc Nguyen; Ooi, Justin Seng Geap; Ngan Thi Kim Nguyen; Wang, Shujing; Huang, Mei; Liu, Ding Xiang; Tam, James P.] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Tam, JP (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore.	jptam@ntu.edu.sg	Geap, Justin Ooi Seng/AAS-3483-2021; Tam, James P/A-2176-2011	Geap, Justin Ooi Seng/0000-0003-4899-8255; Tam, James P/0000-0003-4433-198X; Nguyen, Thi Kim Ngan/0000-0003-1904-6984; Nguyen, Quoc Thuc Phuong/0000-0002-8273-730X	National Research Foundation in Singapore [NRF-CRP8-2011-05]	National Research Foundation in Singapore(National Research Foundation, Singapore)	This work was supported in part by Competitive Research Grant NRF-CRP8-2011-05 from the National Research Foundation in Singapore. The authors declare that they have no conflicts of interest with the contents of this article.	Baliga MS, 2010, INTEGR CANCER THER, V9, P261, DOI 10.1177/1534735410376068; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BERNFELD P, 1955, METHOD ENZYMOL, V1, P149, DOI 10.1016/0076-6879(55)01021-5; Carvalho AD, 2011, CURR PHARM DESIGN, V17, P4270, DOI 10.2174/138161211798999447; CHAGOLLALOPEZ A, 1994, J BIOL CHEM, V269, P23675; Craik DJ, 2013, J PEPT SCI, V19, P393, DOI 10.1002/psc.2523; Craik DJ, 1999, J MOL BIOL, V294, P1327, DOI 10.1006/jmbi.1999.3383; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; de Haan CAM, 2005, ADV VIRUS RES, V64, P165, DOI 10.1016/S0065-3527(05)64006-7; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; deSa MFG, 1997, PLANTA, V203, P295, DOI 10.1007/s004250050195; Franco OL, 2011, FEBS LETT, V585, P995, DOI 10.1016/j.febslet.2011.03.008; Giang KTN, 2011, J BIOL CHEM, V286, P24275, DOI 10.1074/jbc.M111.229922; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Jagadish K, 2010, BIOPOLYMERS, V94, P611, DOI 10.1002/bip.21433; KUMAR A, 1980, BIOCHEM BIOPH RES CO, V95, P1, DOI 10.1016/0006-291X(80)90695-6; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LI D, 1992, ARCH VIROL, V122, P307, DOI 10.1007/BF01317192; Martins JC, 2001, EUR J BIOCHEM, V268, P2379, DOI 10.1046/j.1432-1327.2001.02118.x; Nasirudeen AMA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000926; Nguyen PQT, 2015, J NAT PROD, V78, P695, DOI 10.1021/np500866c; Nguyen PQT, 2014, FEBS J, V281, P4351, DOI 10.1111/febs.12939; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Pereira PJB, 1999, STRUCTURE, V7, P1079, DOI 10.1016/S0969-2126(99)80175-0; Pinto MFS, 2012, J EVID-BASED INTEGR, V17, P40, DOI 10.1177/2156587211428077; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; SPAAN W, 1988, J GEN VIROL, V69, P2939, DOI 10.1099/0022-1317-69-12-2939; Svensson B, 2004, BBA-PROTEINS PROTEOM, V1696, P145, DOI 10.1016/j.bbapap.2003.07.004; Wang CKL, 2008, NUCLEIC ACIDS RES, V36, pD206, DOI 10.1093/nar/gkm953	30	26	26	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					31138	31150		10.1074/jbc.M115.654855	http://dx.doi.org/10.1074/jbc.M115.654855			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26546678	Green Published, hybrid			2022-12-26	WOS:000367199000041
J	Anthony, WE; Palmer-Young, EC; Leonard, AS; Irwin, RE; Adler, LS				Anthony, Winston E.; Palmer-Young, Evan C.; Leonard, Anne S.; Irwin, Rebecca E.; Adler, Lynn S.			Testing Dose-Dependent Effects of the Nectar Alkaloid Anabasine on Trypanosome Parasite Loads in Adult Bumble Bees	PLOS ONE			English	Article							INSECT HERBIVORES; PLANT DEFENSES; PREVALENCE; NICOTINE; ABILITY; MACROEVOLUTION; HONEYBEES; VIRULENCE; PATHOGEN; BOMBI	The impact of consuming biologically active compounds is often dose-dependent, where small quantities can be medicinal while larger doses are toxic. The consumption of plant secondary compounds can be toxic to herbivores in large doses, but can also improve survival in parasitized herbivores. In addition, recent studies have found that consuming nectar secondary compounds may decrease parasite loads in pollinators. However, the effect of compound dose on bee survival and parasite loads has not been assessed. To determine how secondary compound consumption affects survival and pathogen load in Bombus impatiens, we manipulated the presence of a common gut parasite, Crithidia bombi, and dietary concentration of anabasine, a nectar alkaloid produced by Nicotiana spp. using four concentrations naturally observed in floral nectar. We hypothesized that increased consumption of secondary compounds at concentrations found in nature would decrease survival of uninfected bees, but improve survival and ameliorate parasite loads in infected bees. We found medicinal effects of anabasine in infected bees; the high-anabasine diet decreased parasite loads and increased the probability of clearing the infection entirely. However, survival time was not affected by any level of anabasine concentration, or by interactive effects of anabasine concentration and infection. Crithidia infection reduced survival time by more than two days, but this effect was not significant. Our results support a medicinal role for anabasine at the highest concentration; moreover, we found no evidence for a survival-related cost of anabasine consumption across the concentration range found in nectar. Our results suggest that consuming anabasine at the higher levels of the natural range could reduce or clear pathogen loads without incurring costs for healthy bees.	[Anthony, Winston E.; Palmer-Young, Evan C.; Leonard, Anne S.; Adler, Lynn S.] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA; [Irwin, Rebecca E.] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; [Irwin, Rebecca E.] N Carolina State Univ, Dept Appl Ecol, Raleigh, NC 27695 USA	University of Massachusetts System; University of Massachusetts Amherst; Dartmouth College; University of North Carolina; North Carolina State University	Adler, LS (corresponding author), Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA.	lsadler@bio.umass.edu	Palmer-Young, Evan/AFL-1225-2022	Palmer-Young, Evan/0000-0002-9258-2073; Anthony, Winston E./0000-0001-6165-4700	National Science Foundation Division of Environmental Biology [NSF-DEB-1258096, NSF-DEB-0742923]; AFRI [USDA NRI 2008-02346]; National Science Foundation Graduate Research Fellowship; Darwin Fellowship; Graduate Program in Organismic and Evolutionary Biology; Direct For Biological Sciences [1501907] Funding Source: National Science Foundation; Division Of Environmental Biology [1258096] Funding Source: National Science Foundation	National Science Foundation Division of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); AFRI; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Darwin Fellowship; Graduate Program in Organismic and Evolutionary Biology; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The work was supported by the following: National Science Foundation Division of Environmental Biology, NSF-DEB-1258096: LSA & REI, NSF-DEB-0742923: LSA & REI, http://www.nsf.gov/div/index.jsp?div=DEB; United States Department of Agriculture, National Research Institute (now AFRI), USDA NRI 2008-02346: LSA, http://nifa.usda.gov/program/agriculture-and-foodresearch-initiative; National Science Foundation Graduate Research Fellowship: ECPY, https://www.nsfgrfp.org/; and Darwin Fellowship, Graduate Program in Organismic and Evolutionary Biology: ASL, https://www.bio.umass.edu/oeb/darwin-fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler LS, 2000, OIKOS, V91, P409, DOI 10.1034/j.1600-0706.2000.910301.x; Adler LS, 2006, ECOL LETT, V9, P960, DOI 10.1111/j.1461-0248.2006.00944.x; Adler LS, 2012, ECOL LETT, V15, P1140, DOI 10.1111/j.1461-0248.2012.01838.x; Agrawal AA, 2007, TRENDS ECOL EVOL, V22, P103, DOI 10.1016/j.tree.2006.10.012; Agrawal AA, 2012, SCIENCE, V338, P113, DOI 10.1126/science.1225977; [Anonymous], 2014, R LANG ENV STAT COMP; Baracchi David, 2015, F1000Res, V4, P73, DOI 10.12688/f1000research.6262.2; BOWERS MD, 1992, J CHEM ECOL, V18, P985, DOI 10.1007/BF00980057; Brown MJF, 2003, J ANIM ECOL, V72, P994, DOI 10.1046/j.1365-2656.2003.00770.x; Brown MJF, 2000, OIKOS, V91, P421, DOI 10.1034/j.1600-0706.2000.910302.x; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Campbell FL, 1933, J ECON ENTOMOL, V26, P500, DOI 10.1093/jee/26.2.500; Cordes N, 2012, J INVERTEBR PATHOL, V109, P209, DOI 10.1016/j.jip.2011.11.005; Costa C, 2010, APIDOLOGIE, V41, P141, DOI 10.1051/apido/2009070; Detzel Andreas, 1993, Chemoecology, V4, P8, DOI 10.1007/BF01245891; DURRER S, 1994, P ROY SOC B-BIOL SCI, V258, P299, DOI 10.1098/rspb.1994.0176; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; Fokt H., 2010, CURR RES TECHNOL ED, P481; Gegear RJ, 2005, ANIM BEHAV, V70, P209, DOI 10.1016/j.anbehav.2004.09.025; Gegear RJ, 2006, P ROY SOC B-BIOL SCI, V273, P1073, DOI 10.1098/rspb.2005.3423; Gherman BI, 2014, BEHAV ECOL SOCIOBIOL, V68, P1777, DOI 10.1007/s00265-014-1786-8; Gillespie S, 2010, ECOL ENTOMOL, V35, P737, DOI 10.1111/j.1365-2311.2010.01234.x; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Hare J. Daniel, 2002, P8, DOI 10.1017/CBO9780511542190.002; Heil M, 2011, TRENDS PLANT SCI, V16, P191, DOI 10.1016/j.tplants.2011.01.003; Heinrich B., 2004, BUMBLEBEE EC REVISED; Imdorf A, 1999, APIDOLOGIE, V30, P209, DOI 10.1051/apido:19990210; Johnson MTJ, 2014, NEW PHYTOL, V203, P267, DOI 10.1111/nph.12763; Kaczorowski RL, 2014, J CHEM ECOL, V40, P325, DOI 10.1007/s10886-014-0411-7; Kaplan I, 2010, OIKOS, V119, P1105, DOI 10.1111/j.1600-0706.2009.18311.x; Kessler SC, 2015, NATURE, V521, P74, DOI 10.1038/nature14414; Koch H, 2011, P NATL ACAD SCI USA, V108, P19288, DOI 10.1073/pnas.1110474108; Lesnoff M, 2012, R PACKAGE AOD ANAL O; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Liersch S, 1998, P ROY SOC B-BIOL SCI, V265, P221, DOI 10.1098/rspb.1998.0285; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; Manson JS, 2012, FUNCT ECOL, V26, P1100, DOI 10.1111/j.1365-2435.2012.02039.x; Manson JS, 2010, OECOLOGIA, V162, P81, DOI 10.1007/s00442-009-1431-9; Muller CB, 1996, INSECT SOC, V43, P227, DOI 10.1007/BF01242924; Otterstatter MC, 2006, PARASITOLOGY, V133, P749, DOI 10.1017/S003118200600120X; Pavia CS, 2000, J MED MICROBIOL, V49, P675, DOI 10.1099/0022-1317-49-7-675; Popp M, 2012, MICROBIOLOGYOPEN, V1, P362, DOI 10.1002/mbo3.35; PRICE PW, 1980, ANNU REV ECOL SYST, V11, P41, DOI 10.1146/annurev.es.11.110180.000353; Richardson LL, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2471; Sadd BM, 2011, EVOLUTION, V65, P2995, DOI 10.1111/j.1558-5646.2011.01345.x; Salathe RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022054; Santolamazza-Carbone S, 2014, OECOLOGIA, V174, P893, DOI 10.1007/s00442-013-2817-2; Schmid-Hempel P, 2001, NATURWISSENSCHAFTEN, V88, P147, DOI 10.1007/s001140100222; SHYKOFF JA, 1991, APIDOLOGIE, V22, P117, DOI 10.1051/apido:19910204; Singaravelan N, 2005, J CHEM ECOL, V31, P2791, DOI 10.1007/s10886-005-8394-z; Tadmor-Melamed H, 2004, FUNCT ECOL, V18, P844, DOI 10.1111/j.0269-8463.2004.00929.x; Thaler JS, 1999, NATURE, V399, P686, DOI 10.1038/21420; Therneau T.M., 2015, R PACKAGE COXME MIXE; Thomson JD, 2015, ARTHROPOD-PLANT INTE, V9, P1, DOI 10.1007/s11829-014-9350-z; Tiedeken EJ, 2014, J EXP BIOL, V217, P1620, DOI 10.1242/jeb.097543; Whitehorn PR, 2011, P ROY SOC B-BIOL SCI, V278, P1195, DOI 10.1098/rspb.2010.1550; Williams PH, 2014, BUMBLE BEES N AM; Wink M, 2000, STUD NAT PROD CHEM, V21, P3; Wright GA, 2013, SCIENCE, V339, P1202, DOI 10.1126/science.1228806; Yothers MA, 1940, J ECON ENTOMOL, V33, P800, DOI 10.1093/jee/33.5.800	60	20	20	4	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142496	10.1371/journal.pone.0142496	http://dx.doi.org/10.1371/journal.pone.0142496			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545106	Green Published, gold, Green Submitted			2022-12-26	WOS:000364398700147
J	Chen, X; Jin, YT; Hou, XM; Liu, FQ; Wang, YL				Chen, Xing; Jin, Yuting; Hou, Xiaoming; Liu, Fengqin; Wang, Yulin			Sonic Hedgehog Signaling: Evidence for Its Protective Role in Endotoxin Induced Acute Lung Injury in Mouse Model	PLOS ONE			English	Article							DIFFERENTIATION; PATHOGENESIS; PATHWAY; HUMANS; SHH	Objective To investigate the protective role of the sonic hedgehog (SHH) signaling associated with a lipopolysaccharide (LPS)-induced acute lung injury (ALI) in a mouse model. Methods Male BALB/c mice were randomly divided into four groups: control, LPS, LPS-cyclopamine group and cyclopamine group. ALI was induced by LPS ip injection (5 mg/kg). The sonic hedgehog inhibitor cyclopamine (50 mg/kg) was given to the LPS-cyclopamine group at 30 min after LPS injection as well as normal mice as control. Lung injury was observed histologically in hematoxylin and eosin (HE) stained tissue sections, semi-quantified by lung tissue injury score, and the lung tissue mass alteration was measured by wet to dry weight ratio (W/D). mRNA expression levels of TNF-alpha, SHH, Patched (PTC) and GLI1 in lung tissue were studied with real time quantitative PCR (RT-PCR), while the protein expression of SHH and GLI1 was determined by western blot analysis. Results Lung tissue injury score, thickness of alveolar septa, W/D, and TNF-alpha mRNA expression levels were significantly higher in the ALI mice than the normal mice (P<0.05). The mRNA expression levels of SHH, PTC, and GLI1 in the ALI mice were significantly higher at 12h and 24h after LPS injection, but not at the 6h time point. Protein production of SHH and GLI1 at 6h, 12h, and 24h in the lungs of ALI mice significantly increased, in a time-dependent manner, compared with that in normal mice. Cyclopamine alone has no effect on pathological changes in normal mice. Intervention with cyclopamine in ALI mice led to a reduction in mRNA levels of SHH, PTC, and GLI1 as well as SHH and GLI1 protein levels; meanwhile, the pathological injury scores of lung tissues, thickness of alveolar septa, W/D, and mRNA expression levels of TNF-alpha increased compared with mice receiving LPS only. Conclusion The SHH signaling pathway was activated in response to LPS-induced ALI, and up-regulation of SHH expression could alleviate lung injury and be involved in the repair of injured lung tissue.	[Chen, Xing; Hou, Xiaoming; Liu, Fengqin; Wang, Yulin] Shandong Univ, Shandong Prov Hosp, Dept Pediat, Jinan 250100, Shandong, Peoples R China; [Jin, Yuting] Shandong Prov Qianfoshan Hosp, Dept Pediat, Jinan, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences	Wang, YL (corresponding author), Shandong Univ, Shandong Prov Hosp, Dept Pediat, Jinan 250100, Shandong, Peoples R China.	sdmed_pediatrics@163.com	hou, xiaoming/AAE-4532-2020		Science and Technology research project - Shandong Provincial Population and Family Planning Commission [201110]; Shandong Provincial Medical Technology Development Program [2011HZ066]	Science and Technology research project - Shandong Provincial Population and Family Planning Commission; Shandong Provincial Medical Technology Development Program	This study was sponsored by the funding from Science and Technology research project (201110) awarded by Shandong Provincial Population and Family Planning Commission and Shandong Provincial Medical Technology Development Program (2011HZ066).	Aggarwal NR, 2014, AM J PHYSIOL-LUNG C, V306, pL709, DOI 10.1152/ajplung.00341.2013; Ahlfeld SK, 2012, BIRTH DEFECTS RES A, V94, P3, DOI 10.1002/bdra.22869; Apelqvist A, 1997, CURR BIOL, V7, P801, DOI 10.1016/S0960-9822(06)00340-X; Blank R, 2011, CRIT CARE CLIN, V27, P439, DOI 10.1016/j.ccc.2011.05.005; Cigna N, 2012, AM J PATHOL, V181, P2126, DOI 10.1016/j.ajpath.2012.08.019; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Dang HX, 2012, MOL MED REP, V6, P297, DOI 10.3892/mmr.2012.929; Fernandez IE, 2012, LANCET, V380, P680, DOI 10.1016/S0140-6736(12)61144-1; Franchitto Antonio, 2013, Hepatobiliary Surg Nutr, V2, P68, DOI 10.3978/j.issn.2304-3881.2012.10.11; Hojo H, 2012, J BIOL CHEM, V287, P17860, DOI 10.1074/jbc.M112.347716; Ihrie RA, 2011, NEURON, V71, P250, DOI 10.1016/j.neuron.2011.05.018; Jacob L, 2007, SCIENCE, V318, P66, DOI 10.1126/science.1147314; King Randall W, 2002, J Biol, V1, P8, DOI 10.1186/1475-4924-1-8; Kugler MC, 2015, AM J RESP CELL MOL, V52, P1, DOI 10.1165/rcmb.2014-0132TR; Kusano KF, 2005, NAT MED, V11, P1197, DOI 10.1038/nm1313; Li XN, 2011, J ALLERGY CLIN IMMUN, V127, P1457, DOI 10.1016/j.jaci.2011.01.056; Liu L, 2013, AM J RESP CELL MOL, V48, P703, DOI 10.1165/rcmb.2012-0347OC; Bolanos AL, 2012, AM J PHYSIOL-LUNG C, V303, pL978, DOI 10.1152/ajplung.00184.2012; Madurga A, 2013, AM J PHYSIOL-LUNG C, V305, pL893, DOI 10.1152/ajplung.00267.2013; Maeda Y, 2007, PHYSIOL REV, V87, P219, DOI 10.1152/physrev.00028.2006; MARTICH GD, 1991, J EXP MED, V173, P1021, DOI 10.1084/jem.173.4.1021; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; Michelotti GA, 2013, J CLIN INVEST, V123, P2380, DOI 10.1172/JCI66904; Paulis L, 2015, SCI REP-UK, V5, DOI 10.1038/srep07983; Peng YC, 2015, DEV BIOL, V400, P94, DOI 10.1016/j.ydbio.2015.01.019; Pola R, 2001, NAT MED, V7, P706, DOI 10.1038/89083; Renault MA, 2013, CIRC RES, V113, P1148, DOI 10.1161/CIRCRESAHA.113.301546; Renault MA, 2013, CIRC RES, V112, P762, DOI 10.1161/CIRCRESAHA.113.300871; Rominger CM, 2009, J PHARMACOL EXP THER, V329, P995, DOI 10.1124/jpet.109.152090; Smith KM, 1997, CRIT CARE MED, V25, P1888, DOI 10.1097/00003246-199711000-00030; Spirli Carlo, 2013, Hepatobiliary Surg Nutr, V2, P65, DOI 10.3978/j.issn.2304-3881.2012.12.05; Suh HN, 2015, BRIT J PHARMACOL, V172, P815, DOI 10.1111/bph.12947; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493; Watson S, 2010, B CANCER, V97, P1477, DOI 10.1684/bdc.2010.1231; Zhou XB, 2012, HUM MOL GENET, V21, P1325, DOI 10.1093/hmg/ddr569	36	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0140886	10.1371/journal.pone.0140886	http://dx.doi.org/10.1371/journal.pone.0140886			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545089	Green Published, Green Submitted, gold			2022-12-26	WOS:000364398700011
J	Hamatani, Y; Yamashita, Y; Esato, M; Chun, YH; Tsuji, H; Wada, H; Hasegawa, K; Abe, M; Lip, GYH; Akao, M				Hamatani, Yasuhiro; Yamashita, Yugo; Esato, Masahiro; Chun, Yeong-Hwa; Tsuji, Hikari; Wada, Hiromichi; Hasegawa, Koji; Abe, Mitsuru; Lip, Gregory Y. H.; Akao, Masaharu			Predictors for Stroke and Death in Non-Anticoagulated Asian Patients with Atrial Fibrillation: The Fushimi AF Registry	PLOS ONE			English	Article							RISK-FACTORS; ORAL ANTICOAGULANTS; FOLLOW-UP; OUTCOMES; EVENTS; ANEMIA; IMPACT; THROMBOEMBOLISM; IMPAIRMENT; VALIDATION	Background Atrial fibrillation (AF) increases the risk of stroke and death. Data on the predictors for stroke and death in 'real-world' AF patients are limited, especially from large prospective Asian cohorts. Methods The Fushimi AF Registry is a community-based prospective survey designed to enroll all AF patients who visited the participating medical institutions in Fushimi-ku, Kyoto, Japan. Follow-up data were available for 3,304 patients (median follow-up period 741 days). We explored the predictors for 'death, stroke, and systemic embolism (SE)' during follow-up in 1,541 patients not receiving oral anticoagulants (OAC) at baseline. Results The mean age was 73.1 +/- 12.5 years, and 673 (44%) patients were female. The mean CHADS2 and CHA2DS2-VASc scores were 1.76 and 3.08, respectively. Cumulative events were as follows: stroke/SE in 61 (4%) and death in 230 (15%), respectively. On multivariate analysis, advanced age (hazard ratio (HR): 1.68, 95% confidence interval (CI): 1.24-2.29), underweight (body mass index <18.5 kg/m(2)) (HR: 1.71, 95% CI: 1.25-2.32), previous stroke/SE/transient ischemic attack (HR: 1.70, 95% CI: 1.25-2.30), heart failure (HR: 1.59, 95% CI: 1.17-2.15), chronic kidney disease (HR: 1.53, 95% CI: 1.16-2.02), and anemia (HR: 2.41, 95% CI: 1.78-3.28) were independent predictors for death/stroke/SE. Cumulative numbers of these 6 risk predictors could stratify the incidence of death/stroke/SE in patients without OAC, as well as those with OAC in our registry. Conclusions Advanced age, underweight, previous stroke/SE/transient ischemic attack, heart failure, chronic kidney disease, and anemia were independently associated with the risk of death/stroke/SE in non-anticoagulated Japanese AF patients.	[Hamatani, Yasuhiro; Yamashita, Yugo; Abe, Mitsuru; Akao, Masaharu] Natl Hosp Org, Kyoto Med Ctr, Dept Cardiol, Kyoto, Japan; [Esato, Masahiro; Chun, Yeong-Hwa] Ijinkai Takeda Gen Hosp, Dept Arrhythmia, Kyoto, Japan; [Tsuji, Hikari] Tsuji Clin, Kyoto, Japan; [Wada, Hiromichi; Hasegawa, Koji] Natl Hosp Org, Kyoto Med Ctr, Div Translat Res, Kyoto, Japan; [Lip, Gregory Y. H.] Univ Birmingham, Ctr Cardiovasc Sci, City Hosp, Birmingham, W Midlands, England; [Lip, Gregory Y. H.] Aalborg Univ, Dept Clin Med, Aalborg Thrombosis Res Unit, Aalborg, Denmark	University of Birmingham; Aalborg University	Akao, M (corresponding author), Natl Hosp Org, Kyoto Med Ctr, Dept Cardiol, Kyoto, Japan.	akao@kuhp.kyoto-u.ac.jp	Yamashita, Yugo/S-7190-2019	Wada, Hiromichi/0000-0002-8980-224X	Boehringer Ingelheim; Bayer Healthcare; Pfizer; Bristol-Myers Squibb; Astellas Pharma; AstraZeneca; Daiichi-Sankyo; Novartis Pharma; MSD; Sanofi-Aventis; Takeda Pharmaceutical	Boehringer Ingelheim(Boehringer Ingelheim); Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); Pfizer(Pfizer); Bristol-Myers Squibb(Bristol-Myers Squibb); Astellas Pharma(Astellas Pharmaceuticals); AstraZeneca(AstraZeneca); Daiichi-Sankyo(Daiichi Sankyo Company Limited); Novartis Pharma; MSD; Sanofi-Aventis(Sanofi-Aventis); Takeda Pharmaceutical(Takeda Pharmaceutical Company Ltd)	The Fushimi AF Registry is supported by research funding from Boehringer Ingelheim, Bayer Healthcare, Pfizer, Bristol-Myers Squibb, Astellas Pharma, AstraZeneca, Daiichi-Sankyo, Novartis Pharma, MSD, Sanofi-Aventis and Takeda Pharmaceutical. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao M, 2014, CIRC J, V78, P2166, DOI 10.1253/circj.CJ-14-0344; Akao M, 2013, J CARDIOL, V61, P260, DOI 10.1016/j.jjcc.2012.12.002; Anderson DC, 1998, JAMA-J AM MED ASSOC, V279, P1273; [Anonymous], 1968, World Health Organ Tech Rep Ser, V405, P5; Ardestani A, 2010, AM J CARDIOL, V106, P369, DOI 10.1016/j.amjcard.2010.03.036; Badheka AO, 2010, AM J MED, V123, P646, DOI 10.1016/j.amjmed.2009.11.026; Banerjee A, 2013, J AM COLL CARDIOL, V61, P2079, DOI 10.1016/j.jacc.2013.02.035; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; Donato KA, 1998, ARCH INTERN MED, V158, P1855, DOI 10.1001/archinte.158.17.1855; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Go AS, 2009, CIRCULATION, V119, P1363, DOI 10.1161/CIRCULATIONAHA.108.816082; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Guo YT, 2013, INT J CARDIOL, V168, P1502, DOI 10.1016/j.ijcard.2012.12.099; Hamatani Y, 2015, CIRC J, V79, P1009, DOI 10.1253/circj.CJ-14-1245; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Horwich TB, 2002, J AM COLL CARDIOL, V39, P1780, DOI 10.1016/S0735-1097(02)01854-5; Inoue H, 2014, AM J CARDIOL, V113, P957, DOI 10.1016/j.amjcard.2013.11.057; Inoue H, 2009, INT J CARDIOL, V137, P102, DOI 10.1016/j.ijcard.2008.06.029; Kakkar AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063479; Lip GYH, 2007, EUR HEART J, V28, P752, DOI 10.1093/eurheartj/ehl504; Lip GYH, 2014, EUR HEART J, V35, P3365, DOI 10.1093/eurheartj/ehu374; Lip GYH, 2013, EUR HEART J, V34, P1041, DOI 10.1093/eurheartj/ehs435; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Marijon E, 2013, CIRCULATION, V128, P2192, DOI 10.1161/CIRCULATIONAHA.112.000491; Muzzarelli S, 2006, AM HEART J, V152, P991, DOI 10.1016/j.ahj.2006.06.014; Nakagawa K, 2011, AM J CARDIOL, V107, P912, DOI 10.1016/j.amjcard.2010.10.074; Ogilvie IM, 2010, AM J MED, V123, P638, DOI 10.1016/j.amjmed.2009.11.025; Overvad TF, 2013, AM J MED, V126, DOI 10.1016/j.amjmed.2012.11.024; Pathak RK, 2015, J AM COLL CARDIOL, V65, P2159, DOI 10.1016/j.jacc.2015.03.002; PETERSEN P, 1990, ARCH INTERN MED, V150, P819, DOI 10.1001/archinte.150.4.819; Piccini JP, 2013, CIRCULATION, V127, P224, DOI 10.1161/CIRCULATIONAHA.112.107128; Puurunen M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004700; Sharma S, 2009, AM HEART J, V157, P1057, DOI 10.1016/j.ahj.2009.03.009; Vaglio J, 2005, AM J CARDIOL, V96, P496, DOI 10.1016/j.amjcard.2005.04.008; Wang J, 2014, CLIN RES CARDIOL, V103, P533, DOI 10.1007/s00392-014-0681-7; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Yang YM, 2014, INT J CARDIOL, V173, P242, DOI 10.1016/j.ijcard.2014.02.040; Zeng WT, 2015, STROKE, V46, P157, DOI 10.1161/STROKEAHA.114.006881	38	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142394	10.1371/journal.pone.0142394	http://dx.doi.org/10.1371/journal.pone.0142394			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540107	gold, Green Submitted, Green Published			2022-12-26	WOS:000364303800092
J	Kremer, PHC; Jolink, WMT; Kappelle, LJ; Algra, A; Klijn, CJM				Kremer, Philip H. C.; Jolink, Wilmar M. T.; Kappelle, L. Jaap; Algra, Ale; Klijn, Catharina J. M.		SMART ESPRIT Study Grp	Risk Factors for Lobar and Non-Lobar Intracerebral Hemorrhage in Patients with Vascular Disease	PLOS ONE			English	Article							ISCHEMIC-STROKE; GENERAL-POPULATION; CEREBRAL-ISCHEMIA; ARTERIAL ORIGIN; DEEP; HISPANICS; ETIOLOGY; BLACKS; DESIGN; ESPRIT	Introduction Lobar and non-lobar non-traumatic intracerebral hemorrhage (ICH) are presumably caused by different types of small vessel diseases. The aim of this study was to assess risk factors for ICH according to location. Methods In two large prospective studies, SMART (n = 9088) and ESPRIT (n = 2625), including patients with manifest cardiovascular, cerebrovascular or peripheral artery disease or with vascular risk factors, we investigated potential risk factors for ICH during follow-up according to lobar or non-lobar location by Cox proportional hazards analyses. Results During 65,156 patient years of follow up 19 patients had lobar ICH (incidence rate 29, 95% CI 19-42 per 100,000 person-years) and 24 non-lobar ICH (incidence rate 37, 95% CI 2651 per 100,000 person-years). Age significantly increased the risk of lobar ICH (HR per 10 years increase 1.90; 95% CI 1.17-3.10) in the multivariable analysis, but not of non-lobar hemorrhage. Anticoagulant medication (HR 3.49; 95% CI 1.20-10.2) and male sex (HR 3.79; 95% CI 1.13-12.8) increased the risk of non-lobar but not lobar ICH. Conclusion This study shows an elevated risk of future ICH in patients with manifestations of, or risk factors for, cardiovascular, cerebrovascular or peripheral artery disease. Our data suggest that risk factors for ICH vary according to location, supporting the hypothesis of a differential pathophysiology of lobar and non-lobar ICH.	[Kremer, Philip H. C.; Jolink, Wilmar M. T.; Kappelle, L. Jaap; Algra, Ale; Klijn, Catharina J. M.] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Neurol & Neurosurg, Utrecht, Netherlands; [Algra, Ale] Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Klijn, Catharina J. M.] Radboud Univ Nijmegen, Med Ctr, Ctr Neurosci, Donders Inst Brain Cognit & Behav,Dept Neurol, NL-6525 ED Nijmegen, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen	Klijn, CJM (corresponding author), Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Neurol & Neurosurg, Utrecht, Netherlands.	Karin.Klijn@Radboudumc.nl	Klijn, C.J.M./E-1700-2016	Klijn, C.J.M./0000-0002-8495-4578; Visseren, Frank/0000-0003-3951-5223	Dutch Brain Foundation [BG 201302]; Dutch Heart Foundation [2012 T077, 2007B48]; ASPASIA grant from ZonMw [015008048]	Dutch Brain Foundation; Dutch Heart Foundation(Netherlands Heart Foundation); ASPASIA grant from ZonMw	The study was supported by a grant from the Dutch Brain Foundation (grant number BG 201302) to Prof. dr. L.J. Kappelle. Prof dr. C.J.M. Klijn is supported by a clinical established investigator grant of the Dutch Heart Foundation (grant number 2012 T077) and an ASPASIA grant from ZonMw (grant number 015008048). Dr. Jolink was supported by a grant from the Dutch Heart Foundation (Grant Number 2007B48).	Aguilar MI, 2010, NEUROLOGY, V75, P1343, DOI 10.1212/WNL.0b013e3181f73638; Ariesen MJ, 2003, STROKE, V34, P2060, DOI 10.1161/01.STR.0000080678.09344.8D; Bejot Y, 2013, BRAIN, V136, P658, DOI 10.1093/brain/aws349; Biffi A, 2011, STROKE, V42, P2526, DOI 10.1161/STROKEAHA.111.617225; Biffi A, 2010, ANN NEUROL, V68, P934, DOI 10.1002/ana.22134; Bos MJ, 2007, STROKE, V38, P3127, DOI 10.1161/STROKEAHA.107.489807; Dahabreh IJ, 2011, JAMA-J AM MED ASSOC, V305, P822, DOI 10.1001/jama.2011.163; De Schryver ELLM, 2000, CEREBROVASC DIS, V10, P147, DOI 10.1159/000016044; Dequatre-Ponchelle N, 2013, STROKE, V44, P350, DOI 10.1161/STROKEAHA.112.672303; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Ferket BS, 2014, NEUROLOGY, V82, P1804, DOI 10.1212/WNL.0000000000000427; Flaherty ML, 2006, NEUROLOGY, V66, P956, DOI 10.1212/01.wnl.0000218670.19577.4c; Garcia-Rodriguez LA, 2013, NEUROLOGY, V81, P566, DOI 10.1212/WNL.0b013e31829e6ffa; Halkes PHA, 2006, LANCET, V367, P1665; Howard G, 2013, STROKE, V44, P1282, DOI 10.1161/STROKEAHA.111.000529; Jackson CA, 2006, J NEUROL NEUROSUR PS, V77, P1244, DOI 10.1136/jnnp.2006.089292; Labovitz DL, 2005, NEUROLOGY, V65, P518, DOI 10.1212/01.wnl.0000172915.71933.00; Li ZH, 2003, STROKE, V34, P2085, DOI 10.1161/01.STR.0000086753.00555.0D; Maas MB, 2013, NEUROCRIT CARE, V18, P166, DOI 10.1007/s12028-012-9814-x; Martini SR, 2012, NEUROLOGY, V79, P2275, DOI 10.1212/WNL.0b013e318276896f; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Pezzini A, 2014, NEUROLOGY, V82, P529, DOI 10.1212/WNL.0000000000000108; Poon MTC, 2014, J NEUROL NEUROSUR PS, V85, P660, DOI 10.1136/jnnp-2013-306476; Rosand J, 2004, ARCH INTERN MED, V164, P880, DOI 10.1001/archinte.164.8.880; Simons PCG, 1999, EUR J EPIDEMIOL, V15, P773, DOI 10.1023/A:1007621514757; Sturgeon JD, 2007, STROKE, V38, P2718, DOI 10.1161/STROKEAHA.107.487090; van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0; van de Woestijne AP, 2014, EUR J CLIN INVEST, V44, P184, DOI 10.1111/eci.12206; Woo D, 2002, STROKE, V33, P1190, DOI 10.1161/01.STR.0000014774.88027.22; Zia E, 2006, CEREBROVASC DIS, V21, P18, DOI 10.1159/000089589	30	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142338	10.1371/journal.pone.0142338	http://dx.doi.org/10.1371/journal.pone.0142338			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540190	Green Published, Green Submitted, gold			2022-12-26	WOS:000364303800084
J	Caron, JM; Caron, JM				Caron, Joan McIntyre; Caron, Jane McIntyre			Methyl Sulfone Blocked Multiple Hypoxia- and Non-Hypoxia-Induced Metastatic Targets in Breast Cancer Cells and Melanoma Cells	PLOS ONE			English	Article							MOUSE MAMMARY-TUMOR; MANIFESTS ANTICANCER ACTIVITY; INDUCIBLE FACTOR; POSTTRANSLATIONAL MODIFICATION; TRANSFERRIN RECEPTOR; TUBULIN SYNTHESIS; IRON HOMEOSTASIS; GENE-EXPRESSION; IN-VIVO; PALMITOYLATION	Metastatic cancer causes 90% of cancer deaths. Unlike many primary tumors, metastatic tumors cannot be cured by surgery alone. Metastatic cancer requires chemotherapy. However, metastatic cells are not easily killed by chemotherapy. These problems with chemotherapy are caused in part by the metastatic cell niche: hypoxia. Here we show that the molecule, methyl sulfone, normalized metastatic metabolism of hypoxic breast cancer and melanoma cells by altering several metabolic functions of the cells. Under hypoxia, methyl sulfone decreased expression of the master regulator of hypoxia, HIF-1 alpha, and reduced levels of the glycolytic enzymes, PKM2, LDHA, GLUT1, the pro-angiogenic protein, VEGF, and the iron-sulfur metabolism molecules, miR-210 and transferrin, all of which promote metastasis. Conversely, methyl sulfone increased levels of ISCU1/2 and ferroportin, proteins associated with iron-sulfur cluster biogenesis and iron homeostasis in normal cells. These data identify methyl sulfone as a multi-targeting molecule that blocks the survival/proliferative effect of hypoxia on metastatic cells and brings normality back to cellular metabolism.	[Caron, Joan McIntyre; Caron, Jane McIntyre] JMCaron LLC, Thomaston, CT 06787 USA		Caron, JM (corresponding author), JMCaron LLC, Thomaston, CT 06787 USA.	JoanCaron@JMCaronllc.com			Methyl Sulfone Research Fund; University of Connecticut Foundation, Storrs, CT	Methyl Sulfone Research Fund; University of Connecticut Foundation, Storrs, CT	This work was supported by the Methyl Sulfone Research Fund (JoMC); this fund was managed by the University of Connecticut Foundation, Storrs, CT. Donors to this fund are Connecticut State Residents whose identity remains anonymous to JoMC. The University of Connecticut Foundation had no input into any part of this research, including study design, data collection and analysis, decision to publish, or preparation of this manuscript. The company, JMCaron, LLC, provided no funding for this study. JMCaron, LLC, has no assets, nor has the company ever had any assets. JoMC has a patent pending for the use of methyl sulfone in the treatment of metastatic cancer. JoMC's affiliation with JMCaron, LLC, does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. JoMC obtained funding through donations to the Methyl Sulfone Research Fund, an account established by the University of Connecticut Foundation for Dr. Caron. This sole source of funding covered salary, indirect costs and lab supplies for JoMC. Neither the company (JMCaron, LLC) nor the University of Connecticut Foundation (including donors) played a role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The specific contributions of the authors to this study are articulated in the "Author Contribution Section".	Airley R, 2001, CLIN CANCER RES, V7, P928; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Aye Y, 2015, ONCOGENE, V34, P2011, DOI 10.1038/onc.2014.155; Behrooz A, 1997, J BIOL CHEM, V272, P5555, DOI 10.1074/jbc.272.9.5555; Bureau USC, 2014, ANN EST RES POP; Carbonaro M, 2011, J CELL BIOL, V192, P83, DOI 10.1083/jcb.201004145; Cardenas-Navia LI, 2008, CANCER RES, V68, P5812, DOI 10.1158/0008-5472.CAN-07-6387; Caron JM, 1997, MOL BIOL CELL, V8, P621, DOI 10.1091/mbc.8.4.621; CARON JM, 1985, J CELL BIOL, V101, P1763, DOI 10.1083/jcb.101.5.1763; CARON JM, 1989, J CELL PHYSIOL, V138, P603, DOI 10.1002/jcp.1041380322; Caron JM, 2001, MOL BIOL CELL, V12, P2672, DOI 10.1091/mbc.12.9.2672; CARON JM, 1985, NATURE, V317, P648, DOI 10.1038/317648a0; Caron JM, 2007, CHEMOTHERAPY, V53, P51, DOI 10.1159/000098419; Caron JM, 2013, CHEMOTHERAPY, V59, P24, DOI 10.1159/000351099; Caron JM, 2013, CHEMOTHERAPY, V59, P14, DOI 10.1159/000351100; Caron JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011788; Carreau A, 2011, J CELL MOL MED, V15, P1239, DOI 10.1111/j.1582-4934.2011.01258.x; Chan SY, 2009, CELL METAB, V10, P273, DOI 10.1016/j.cmet.2009.08.015; Chaturvedi P, 2013, J CLIN INVEST, V123, P189, DOI 10.1172/JCI64993; Cosse JP, 2008, ANTI-CANCER AGENT ME, V8, P790, DOI 10.2174/187152008785914798; DEXTER DL, 1978, CANCER RES, V38, P3174; Drisdel RC, 2006, METHODS, V40, P127, DOI 10.1016/j.ymeth.2006.04.015; Dvorak HF, 2015, CANCER IMMUNOL RES, V3, P1, DOI 10.1158/2326-6066.CIR-14-0209; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Faber M. P JLR, 1990, EVOLUTION TIME PRODU; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Favaro E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010345; Filipp Fabian V, 2013, J Carcinog, V12, P14, DOI 10.4103/1477-3163.115423; Gosselin RE, 1984, CLIN TOXICOLOGY COMM; Haber RS, 1998, CANCER, V83, P34, DOI 10.1002/(SICI)1097-0142(19980701)83:1<34::AID-CNCR5>3.0.CO;2-E; HAGER JC, 1981, CANCER RES, V41, P1720; He M, 2012, J BIOL CHEM, V287, P43995, DOI 10.1074/jbc.M112.417501; Hirota SA, 2009, RECENT PATENTS INFLA, V3, P1, DOI 10.2174/187221309787158434; Horvath K, 2002, FOOD CHEM TOXICOL, V40, P1459, DOI 10.1016/S0278-6915(02)00086-8; Huang X, 2009, MOL CELL, V35, P856, DOI 10.1016/j.molcel.2009.09.006; Israelsen WJ, 2013, CELL, V155, P397, DOI 10.1016/j.cell.2013.09.025; Jian JL, 2011, FREE RADICAL BIO MED, V50, P841, DOI 10.1016/j.freeradbiomed.2010.12.028; Kaplan J, 2013, CURR BIOL, V23, pR642, DOI 10.1016/j.cub.2013.05.033; Kaplan J, 2011, INT J HEMATOL, V93, P14, DOI 10.1007/s12185-010-0760-0; Kieran MW, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006593; Krutilina R, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3693; Loor G, 2008, CELL DEATH DIFFER, V15, P686, DOI 10.1038/cdd.2008.13; Macedo Maria F., 2008, Inflammation & Allergy Drug Targets, V7, P41, DOI 10.2174/187152808784165162; Magnuson BA, 2007, J AGR FOOD CHEM, V55, P1033, DOI 10.1021/jf0621469; Ozols J, 1997, MOL BIOL CELL, V8, P637, DOI 10.1091/mbc.8.4.637; Piwowarczyk K, 2015, EXPERT OPIN THER TAR, V19, P163, DOI 10.1517/14728222.2014.981153; Qin Q, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/1756-9966-33-50; Rockwell S, 2009, CURR MOL MED, V9, P442, DOI 10.2174/156652409788167087; SACKETT DL, 1994, BIOCHEMISTRY-US, V33, P12868, DOI 10.1021/bi00209a019; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Shen GM, 2013, ACTA PHARMACOL SIN, V34, P336, DOI 10.1038/aps.2012.195; Sinkevicius KW, 2014, P NATL ACAD SCI USA, V111, P10299, DOI 10.1073/pnas.1404399111; Slominski A, 2014, ARCH BIOCHEM BIOPHYS, V563, P79, DOI 10.1016/j.abb.2014.06.030; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Tacchini L, 1999, J BIOL CHEM, V274, P24142, DOI 10.1074/jbc.274.34.24142; Vaupel P, 2004, ONCOLOGIST, V9, P10, DOI 10.1634/theoncologist.9-90005-10; Veatch JR, 2009, CELL, V137, P1247, DOI 10.1016/j.cell.2009.04.014; Wang WW, 2015, SCI REP-UK, V5, DOI 10.1038/srep10851; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Widmer DS, 2013, J INVEST DERMATOL, V133, P2436, DOI 10.1038/jid.2013.115; Wu XN, 2014, EUR J CANCER PREV, V23, P122, DOI 10.1097/CEJ.0b013e3283627f14; Ye H, 2010, BIOCHEMISTRY-US, V49, P4945, DOI 10.1021/bi1004798; Yoshioka Y, 2012, J BIOL CHEM, V287, P34110, DOI 10.1074/jbc.M112.356717; Younes M, 1997, CANCER-AM CANCER SOC, V80, P1046, DOI 10.1002/(SICI)1097-0142(19970915)80:6<1046::AID-CNCR6>3.0.CO;2-7; Yu L, 2013, GYNECOL ONCOL, V128, P391, DOI 10.1016/j.ygyno.2012.11.002	68	10	11	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141565	10.1371/journal.pone.0141565	http://dx.doi.org/10.1371/journal.pone.0141565			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536104	gold, Green Published, Green Submitted			2022-12-26	WOS:000364298400070
J	Galetti, M; Petronini, PG; Fumarola, C; Cretella, D; La Monica, S; Bonelli, M; Cavazzoni, A; Saccani, F; Caffarra, C; Andreoli, R; Mutti, A; Tiseo, M; Ardizzoni, A; Alfieri, RR				Galetti, Maricla; Petronini, Pier Giorgio; Fumarola, Claudia; Cretella, Daniele; La Monica, Silvia; Bonelli, Mara; Cavazzoni, Andrea; Saccani, Francesca; Caffarra, Cristina; Andreoli, Roberta; Mutti, Antonio; Tiseo, Marcello; Ardizzoni, Andrea; Alfieri, Roberta R.			Effect of ABCG2/BCRP Expression on Efflux and Uptake of Gefitinib in NSCLC Cell Lines	PLOS ONE			English	Article							TYROSINE KINASE INHIBITORS; CANCER RESISTANCE PROTEIN; BINDING CASSETTE TRANSPORTERS; MULTIDRUG TRANSPORTERS; CHEMORESISTANCE; MECHANISMS; MODULATORS; SUBSTRATE; FAMILY; ZD1839	Background BCRP/ABCG2 emerged as an important multidrug resistance protein, because it confers resistance to several classes of cancer chemotherapeutic agents and to a number of novel molecularly-targeted therapeutics such as tyrosine kinase inhibitors. Gefitinib is an orally active, selective EGFR tyrosine kinase inhibitor used in the treatment of patients with advanced non small cell lung cancer (NSCLC) carrying activating EGFR mutations. Membrane transporters may affect the distribution and accumulation of gefitinib in tumour cells; in particular a reduced intracellular level of the drug may result from poor uptake, enhanced efflux or increased metabolism. Aim The present study, performed in a panel of NSCLC cell lines expressing different ABCG2 plasma membrane levels, was designed to investigate the effect of the efflux transporter ABCG2 on intracellular gefitinib accumulation, by dissecting the contribution of uptake and efflux processes. Methods and Results Our findings indicate that gefitinib, in lung cancer cells, inhibits ABCG2 activity, as previously reported. In addition, we suggest that ABCG2 silencing or overexpression affects intracellular gefitinib content by modulating the uptake rather than the efflux. Similarly, overexpression of ABCG2 affected the expression of a number of drug transporters, altering the functional activities of nutrient and drug transport systems, in particular inhibiting MPP, glucose and glutamine uptake. Conclusions Therefore, we conclude that gefitinib is an inhibitor but not a substrate for ABCG2 and that ABCG2 overexpression may modulate the expression and activity of other transporters involved in the uptake of different substrates into the cells.	[Galetti, Maricla; Petronini, Pier Giorgio; Fumarola, Claudia; Cretella, Daniele; La Monica, Silvia; Bonelli, Mara; Cavazzoni, Andrea; Saccani, Francesca; Caffarra, Cristina; Andreoli, Roberta; Mutti, Antonio; Alfieri, Roberta R.] Univ Parma, Dept Clin & Expt Med, I-43100 Parma, Italy; [Galetti, Maricla; Mutti, Antonio] Univ Parma, Res Ctr, Italian Workers Compensat Author INAIL, I-43100 Parma, Italy; [Tiseo, Marcello] Univ Hosp Parma, Div Med Oncol, Parma, Italy; [Ardizzoni, Andrea] St Orsola Marcello Malpighi Hosp, Med Oncol Unit, Bologna, Italy	University of Parma; University Hospital of Parma; University of Parma; University of Parma; University Hospital of Parma; IRCCS Azienda Ospedaliero-Universitaria di Bologna	Petronini, PG (corresponding author), Univ Parma, Dept Clin & Expt Med, I-43100 Parma, Italy.	piergiorgio.petronini@unipr.it	Tiseo, Marcello/K-6119-2016; caffarra, cristina/I-2361-2018; Mutti, Antonio/C-1095-2011; Mutti, Antonio/ABE-3833-2021; ardizzoni, andrea/AAC-4337-2021; Cavazzoni, Andrea/J-8079-2019; Alfieri, Roberta R/G-6350-2012; Mutti, Antonio/AAB-9037-2020; Galetti, Maricla/AAJ-8927-2020; Cretella, Daniele/AAB-2482-2019; Galetti, Maricla/CAG-4178-2022	Tiseo, Marcello/0000-0002-9553-8465; caffarra, cristina/0000-0003-4582-353X; Mutti, Antonio/0000-0003-2189-3808; ardizzoni, andrea/0000-0003-2678-0714; Cavazzoni, Andrea/0000-0002-3752-1868; Mutti, Antonio/0000-0003-2189-3808; Galetti, Maricla/0000-0002-8061-8649; Galetti, Maricla/0000-0002-8061-8649; La Monica, Silvia/0000-0003-3578-3917	Associazione Italiana per la Ricerca sul Cancro (AIRC), Milan, A.VO.PRO.RI.T., Parma [IG 8856]; Associazione Augusto per la Vita (Novellara, RE); Associazione Davide Rodella, Montichiari	Associazione Italiana per la Ricerca sul Cancro (AIRC), Milan, A.VO.PRO.RI.T., Parma(Fondazione AIRC per la ricerca sul cancro); Associazione Augusto per la Vita (Novellara, RE); Associazione Davide Rodella, Montichiari	This work was supported by Associazione Italiana per la Ricerca sul Cancro (AIRC), Milan, grant IG 8856. A.VO.PRO.RI.T., Parma; Associazione Augusto per la Vita (Novellara, RE); Associazione Davide Rodella, Montichiari.	Agarwal S, 2010, J PHARMACOL EXP THER, V334, P147, DOI 10.1124/jpet.110.167601; Alfieri RR, 2006, J PHYSIOL-LONDON, V576, P391, DOI 10.1113/jphysiol.2006.115006; Alfieri RR, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-143; Anreddy N, 2014, MOLECULES, V19, P13848, DOI 10.3390/molecules190913848; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brozik A, 2011, EXPERT OPIN DRUG MET, V7, P623, DOI 10.1517/17425255.2011.562892; Cavazzoni A, 2008, MOL CANCER THER, V7, P361, DOI 10.1158/1535-7163.MCT-07-0477; Cavazzoni A, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-91; Chen YT, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017876, 10.1371/journal.pone.0021428, 10.1371/journal.pone.0017844, 10.1371/journal.pone.0024144, 10.1371/journal.pone.0027163, 10.1371/journal.pone.0027333]; Doyle LA, 1998, P NATL ACAD SCI USA, V95, P15665, DOI 10.1073/pnas.95.26.15665; Elkind NB, 2005, CANCER RES, V65, P1770, DOI 10.1158/0008-5472.CAN-04-3303; Galetti M, 2010, BIOCHEM PHARMACOL, V80, P179, DOI 10.1016/j.bcp.2010.03.033; Hadnagy A, 2006, EXP CELL RES, V312, P3701, DOI 10.1016/j.yexcr.2006.08.030; Hegedus C, 2009, CURR CANCER DRUG TAR, V9, P252; Huang Y, 2006, CANCER LETT, V239, P168, DOI 10.1016/j.canlet.2005.07.032; Kage K, 2002, INT J CANCER, V97, P626, DOI 10.1002/ijc.10100; Kathawala RJ, 2015, DRUG RESIST UPDATE, V18, P1, DOI 10.1016/j.drup.2014.11.002; Kim M, 2002, CLIN CANCER RES, V8, P22; Leggas M, 2006, CANCER RES, V66, P4802, DOI 10.1158/0008-5472.CAN-05-2915; Lemos C, 2009, BRIT J CANCER, V100, P1120, DOI 10.1038/sj.bjc.6604980; Li J, 2007, CANCER BIOL THER, V6, P432, DOI 10.4161/cbt.6.3.3763; Li XH, 2009, CHEM RES TOXICOL, V22, P1736, DOI 10.1021/tx900256y; Maliepaard M, 2001, CANCER RES, V61, P3458; Miyake K, 1999, CANCER RES, V59, P8; Nagashima S, 2006, CANCER CHEMOTH PHARM, V58, P594, DOI 10.1007/s00280-006-0212-y; Nakamura Y, 2005, CANCER RES, V65, P1541, DOI 10.1158/0008-5472.CAN-03-2417; Noguchi K, 2014, PHARMACOGN PERS MED, V7, P53, DOI 10.2147/PGPM.S38295; Ozvegy-Laczka C, 2004, MOL PHARMACOL, V65, P1485, DOI 10.1124/mol.65.6.1485; Pan GY, 2010, MOL PHARMACEUT, V7, P138, DOI 10.1021/mp900177r; Petronini PG, 2000, AM J PHYSIOL-REG I, V279, pR1580, DOI 10.1152/ajpregu.2000.279.5.R1580; Robey RW, 2003, BRIT J CANCER, V89, P1971, DOI 10.1038/sj.bjc.6601370; Schinkel AH, 2003, ADV DRUG DELIVER REV, V55, P3, DOI 10.1016/S0169-409X(02)00169-2; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Shukla S, 2012, DRUG RESIST UPDATE, V15, P70, DOI 10.1016/j.drup.2012.01.005; Stam RW, 2004, LEUKEMIA, V18, P78, DOI 10.1038/sj.leu.2403168; Stewart CF, 2004, CANCER RES, V64, P7491, DOI 10.1158/0008-5472.CAN-04-0096; Thomson S, 2008, CLIN EXP METASTAS, V25, P843, DOI 10.1007/s10585-008-9200-4; Wang XK, 2010, CURR DRUG METAB, V11, P618; Wang YJ, 2014, CANCERS, V6, P1925, DOI 10.3390/cancers6041925; Wang ZY, 2013, INT J PHARMACEUT, V441, P40, DOI 10.1016/j.ijpharm.2012.12.011; Xu JK, 2004, J BIOL CHEM, V279, P19781, DOI 10.1074/jbc.M310785200; Yanase K, 2004, MOL CANCER THER, V3, P1119; Yang CH, 2005, CANCER RES, V65, P6943, DOI 10.1158/0008-5472.CAN-05-0641; Yang K, 2015, CRIT REV ONCOL HEMAT, V93, P277, DOI 10.1016/j.critrevonc.2014.11.001; Yu HA, 2013, CLIN CANCER RES, V19, P2240, DOI 10.1158/1078-0432.CCR-12-2246	45	42	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141795	10.1371/journal.pone.0141795	http://dx.doi.org/10.1371/journal.pone.0141795			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536031	Green Published, Green Submitted, gold			2022-12-26	WOS:000364298400087
J	Haxaire, C; Tromeur, C; Couturaud, F; Leroyer, C				Haxaire, Claudie; Tromeur, Cecile; Couturaud, Francis; Leroyer, Christophe			A Qualitative Study to Appraise Patients and Family Members Perceptions, Knowledge, and Attitudes towards Venous Thromboembolism Risk	PLOS ONE			English	Article							ACTIVATED PROTEIN-C; OF-LIFE; PULMONARY-EMBOLISM; PREDICT RISK; THROMBOSIS; THROMBOPHILIA; ADHERENCE; DISEASE; ASSOCIATION; MUTATION	Objective This study aimed to examine perception, knowledge and concerns developed by patients and their family as regards venous thromboembolism (VTE) risk. Methods We conducted a qualitative study. Participants were: (1) patients with unprovoked VTE with either factor V Leiden mutation or G20210A prothrombin gene mutation or not; and (2) their first-degree relatives. Interviews took place mostly at Brest University Hospital. Participants produced narratives of the patient's illness, stressing their perception of the disorder, its mechanisms, etiology, circumstances and risk factors. Interviews were audiotaped and transcribed verbatim. On an ongoing basis, central themes were identified and data from narratives were categorized by these themes. Results A total of ten patients and 25 first-degree relatives were interviewed. Analyses of patient's narratives suggested 4 main themes: (1) concerns about initial symptoms and suspicion of VTE. The longer the duration of the initial phase, the more likely anxiety took place and persisted after diagnosis; (2) underestimation of potential life-threatening episode once being managed in emergency; (3) possible biographical disruption with inability to cope with the event; and (4) secondary prevention attitudes motivated by remains of the episode and favoring general prevention attitudes. Analyses of the first-degree relatives narratives suggested 3 main themes: (1) common interpretation of the VTE episode shared within the family; (2) diverse and sometimes confusing interpretation of the genetic status; and, (3) interpretation of clinical signs linked to VTE transmission within the family. Conclusions Construction of the risk of VTE is based on patient's initial experience and shared within the family. Collection of narratives illustrates the gap between these perceptions and current medical knowledge. These results support the need to collect the perceptions of the VTE episode and its consequences, as a prerequisite to any health education process.	[Haxaire, Claudie] Univ Brest, Univ Europeenne Bretagne, LABERS, EA 3149, Brest, France; [Haxaire, Claudie] Univ Paris 05, CNRS UMR 8211, INSERM, EHESS,CERMES3,U988, Paris, France; [Tromeur, Cecile; Couturaud, Francis; Leroyer, Christophe] Univ Brest, Univ Europeenne Bretagne, IFR148,EA3878, Hop La Cavale Blanche Dept Med Interne & Pneumol, Brest, France	Universite de Bretagne Occidentale; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Bretagne Occidentale	Leroyer, C (corresponding author), Univ Brest, Univ Europeenne Bretagne, IFR148,EA3878, Hop La Cavale Blanche Dept Med Interne & Pneumol, Brest, France.	christophe.leroyer@chu-brest.fr	Couturaud, Francis/Q-1366-2019	Couturaud, Francis/0000-0002-1855-8032; tromeur, cecile/0000-0001-9161-7521; leroyer, christophe/0000-0002-7601-1692	Groupe de Recherche de Bretagne Occidentale (GETBO); la Maison des Sciences de l'Homme de Bretagne	Groupe de Recherche de Bretagne Occidentale (GETBO); la Maison des Sciences de l'Homme de Bretagne	This study was partially funded by The Groupe de Recherche de Bretagne Occidentale (GETBO) AND la Maison des Sciences de l'Homme de Bretagne.	Anderson M A, 1991, ABNF J, V2, P28; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; Cohn DM, 2008, J THROMB HAEMOST, V6, P1099, DOI 10.1111/j.1538-7836.2008.03005.x; Couturaud F, 2005, THROMB HAEMOSTASIS, V93, P605, DOI 10.1160/TH04-11-0741; Couturaud F, 2009, CHEST, V136, P1537, DOI 10.1378/chest.09-0757; Creswell J.W., 2009, RES DESIGN QUALITATI, DOI DOI 10.1007/S11252-005-3264-6; DAHLBACK B, 1993, P NATL ACAD SCI USA, V90, P1004, DOI 10.1073/pnas.90.3.1004; Heidbuchel H, 2015, THROMB J, V13, DOI 10.1186/s12959-015-0046-0; Jones CJ, 2014, HEALTH PSYCHOL REV, V8, P253, DOI 10.1080/17437199.2013.802623; Kahn SR, 2004, J THROMB HAEMOST, V2, P2146, DOI 10.1111/j.1538-7836.2004.00957.x; Kaptein AA, 2007, HEALTH PSYCHOL, V26, P807, DOI 10.1037/0278-6133.26.6.807; Liu CP, 2011, CHINESE MED J-PEKING, V124, P2438, DOI 10.3760/cma.j.issn.0366-6999.2011.16.007; Lukas PS, 2009, THROMB HAEMOSTASIS, V102, P1219, DOI 10.1160/TH09-05-0316; Mattingly CGL, 1994, SOC SCI MED, V38, P4; Middeldorp S, 1998, ANN INTERN MED, V128, P15, DOI 10.7326/0003-4819-128-1-199801010-00003; Noack F, 2015, VASC HEALTH RISK MAN, V11, P397, DOI 10.2147/VHRM.S81411; Rosendaal FR, 1999, LANCET, V353, P1167, DOI 10.1016/S0140-6736(98)10266-0; Simioni P, 1999, THROMB HAEMOSTASIS, V81, P198, DOI 10.1055/s-0037-1614442; Staniute M, 2014, EUR J CARDIOVASC NUR, V13, P338, DOI 10.1177/1474515113496942; Turner Victor, 1990, MEANS PERFORMANCE, P1; van Es J, 2013, THROMB RES, V132, P500, DOI 10.1016/j.thromres.2013.06.016; van Geffen ME, 2015, J REHABIL MED, V47, P569, DOI 10.2340/16501977-1967; Vermeire E, 2001, J CLIN PHARM THER, V26, P331, DOI 10.1046/j.1365-2710.2001.00363.x; Wang Y, 2014, THROMB RES, V133, P550, DOI 10.1016/j.thromres.2014.01.002; Wilkinson L, 2004, RISK SOC 2004, V8, P8; Zempleni A, 1985, ETHNOGRAPHIE, V96-97, P31	26	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142070	10.1371/journal.pone.0142070	http://dx.doi.org/10.1371/journal.pone.0142070			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV5GZ	26536460	Green Published, Green Submitted, gold			2022-12-26	WOS:000364298400127
J	Wang, YZ; Wu, JH; Ma, X; Liu, B; Su, R; Jiang, Y; Wang, W; Dong, Y				Wang, Yangzi; Wu, Jianghong; Ma, Xiao; Liu, Bin; Su, Rui; Jiang, Yu; Wang, Wen; Dong, Yang			Single Base-Resolution Methylome of the Dizygotic Sheep	PLOS ONE			English	Article							TRANSGENERATIONAL EPIGENETIC INHERITANCE; CPG ISLAND METHYLATION; DNA METHYLATION; REVEALS; MEMORY	Sheep is an important livestock in the world for meat, dairy and wool production. The third version of sheep reference genome has been recently assembled, but sheep DNA methylome has not been profiled yet. In this study, we report the comprehensive sheep methylome with 94.38% cytosine coverage at single base resolution by sequencing DNA samples from Longissimus dorsi of dizygotic Sunit sheep, which were bred in different habitats. We also compared methylomes between the twin sheep. DNA methylation status at genome-scale differentially methylated regions (DMRs), functional genomic regions and 248 DMR-containing genes were identified between the twin sheep. Gene ontology (GO) and KEGG annotations of these genes were performed to discover computationally predicted function. Lipid metabolism, sexual maturity and tumor-associated categories were observed to significantly enrich DMR-containing genes. These findings could be used to illustrate the relationship between phenotypic variations and gene methylation patterns.	[Wang, Yangzi] Kunming Univ Sci & Technol, Chenggong Dist, Kunming, Peoples R China; [Wu, Jianghong; Liu, Bin; Su, Rui; Jiang, Yu; Wang, Wen; Dong, Yang] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Wu, Jianghong; Liu, Bin] Inner Mongolia Acad Agr & Anim Husb Sci, Anim Husb Inst, Hohhot, Peoples R China; [Wu, Jianghong] Chinese Acad Sci, Inner Mongolia Prataculture Res Ctr, Hohhot, Peoples R China; [Ma, Xiao] Yunnan Agr Univ, Kunming, Peoples R China; [Su, Rui] Inner Mongolia Agr Univ, Coll Anim Sci, Hohhot, Peoples R China; [Jiang, Yu] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Peoples R China	Kunming University of Science & Technology; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; Yunnan Agricultural University; Inner Mongolia Agricultural University; Northwest A&F University - China	Wang, W (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China.	wwang@mail.kiz.ac.cn; dongyang@dongyang-lab.org	Wang, Wen/AAP-9873-2020; wu, Jianghong/E-7587-2015; Jiang, Yu/O-5114-2015	wu, Jianghong/0000-0003-4027-2345; Jiang, Yu/0000-0003-4821-3585; MA, Xiao/0000-0003-0044-531X	Chinese 863 program [2013AA102506]; National Natural Science Foundations of China [31201773, 31560623]; State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, Chinese Academy of Sciences [GREKF13-02]; China Postdoctoral Science Foundation [2014M562351]	Chinese 863 program(National High Technology Research and Development Program of China); National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, Chinese Academy of Sciences(Chinese Academy of Sciences); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the Chinese 863 program (2013AA102506), the National Natural Science Foundations of China (31201773 and 31560623), the open project of the State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, Chinese Academy of Sciences (GREKF13-02) to JW, and the China Postdoctoral Science Foundation (2014M562351) to JW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson L, 2015, GENOME BIOL, P16; Aoki A, 2001, NUCLEIC ACIDS RES, V29, P3506, DOI 10.1093/nar/29.17.3506; Bauer S, 2008, BIOINFORMATICS, V24, P1650, DOI 10.1093/bioinformatics/btn250; Baylin SB, 1998, ADV CANCER RES, V72, P141; Becker C, 2011, NATURE, V480, P245, DOI 10.1038/nature10555; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Couldrey C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101853; Da Rocha ST, 2008, TRENDS GENET, V24, P306, DOI 10.1016/j.tig.2008.03.011; Daxinger L, 2012, NAT REV GENET, V13, P153, DOI 10.1038/nrg3188; Daxinger L, 2010, GENOME RES, V20, P1623, DOI 10.1101/gr.106138.110; Edwards CA, 2008, PLOS BIOL, V6, P1292, DOI 10.1371/journal.pbio.0060135; Glastad KM, 2011, INSECT MOL BIOL, V20, P553, DOI 10.1111/j.1365-2583.2011.01092.x; Hayatsu Hikoya, 2006, Nucleic Acids Symp Ser (Oxf), P69, DOI 10.1093/nass/nrl034; Hong EE, 2013, MOL CELL BIOL, V33, P2683, DOI 10.1128/MCB.00220-13; Jair KW, 2006, CANCER RES, V66, P682, DOI 10.1158/0008-5472.CAN-05-1980; Jiang L, 2013, CELL, V153, P773, DOI 10.1016/j.cell.2013.04.041; Jiang Y, 2014, SCIENCE, V344, P1168, DOI 10.1126/science.1252806; Johnson MD, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004813; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kaminen-Ahola N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000811; Khatib H, 2012, LIVESTOCK EPIGENETICS, P1, DOI 10.1002/9781119949930; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Lee JR, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-598; Li YR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000533; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lockett GA, 2010, NEUROREPORT, V21, P909, DOI 10.1097/WNR.0b013e32833e9288; MERLO A, 1995, NAT MED, V1, P686, DOI 10.1038/nm0795-686; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; NAKAMURA K, 1995, MICROBIOL-SGM, V141, P2965, DOI 10.1099/13500872-141-11-2965; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Tomizawa S, 2011, DEVELOPMENT, V138, P811, DOI 10.1242/dev.061416; Wang L, 2014, CELL, V157, P979, DOI 10.1016/j.cell.2014.04.017; Wang Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132866; WOODCOCK DM, 1987, BIOCHEM BIOPH RES CO, V145, P888, DOI 10.1016/0006-291X(87)91048-5; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Xiang H, 2010, NAT BIOTECHNOL, V28, P516, DOI 10.1038/nbt.1626; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Xie W, 2012, CELL, V148, P816, DOI 10.1016/j.cell.2011.12.035; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Ziller MJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002389	47	6	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142034	10.1371/journal.pone.0142034	http://dx.doi.org/10.1371/journal.pone.0142034			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536671	Green Submitted, Green Published, gold			2022-12-26	WOS:000364298400120
J	Rodriguez-Lima, O; Garcia-Gutierrez, P; Jimenez, L; Zarain-Herzberg, A; Lazzarini, R; Landa, A				Rodriguez-Lima, Oscar; Garcia-Gutierrez, Ponciano; Jimenez, Lucia; Zarain-Herzberg, Angel; Lazzarini, Roberto; Landa, Abraham			Molecular Cloning of a cDNA Encoding for Taenia solium TATA-Box Binding Protein 1 (TsTBP1) and Study of Its Interactions with the TATA-Box of Actin 5 and Typical 2-Cys Peroxiredoxin Genes	PLOS ONE			English	Article							RNA-POLYMERASE-II; CRYSTAL-STRUCTURE; TRANSCRIPTION; TBP; COMPLEX; DNA; CYSTICERCOSIS; RECOGNIZES; PATTERNS; CESTODA	TATA-box binding protein (TBP) is an essential regulatory transcription factor for the TATA-box and TATA-box-less gene promoters. We report the cloning and characterization of a full-length cDNA that encodes a Taenia solium TATA-box binding protein 1 (TsTBP1). Deduced amino acid composition from its nucleotide sequence revealed that encodes a protein of 238 residues with a predicted molecular weight of 26.7 kDa, and a theoretical pI of 10.6. The NH2-terminal domain shows no conservation when compared with to pig and human TBP1s. However, it shows high conservation in size and amino acid identity with taeniids TBP1s. In contrast, the TsTBP1 COOH-terminal domain is highly conserved among organisms, and contains the amino acids involved in interactions with the TATA-box, as well as with TFIIA and TFIIB. In silico TsTBP1 modeling reveals that the COOH-terminal domain forms the classical saddle structure of the TBP family, with one a-helix at the end, not present in pig and human. Native TsTBP1 was detected in T. solium cysticerci's nuclear extract by western blot using rabbit antibodies generated against two synthetic peptides located in the NH2 and COOH-terminal domains of TsTBP1. These antibodies, through immunofluorescence technique, identified the TBP1 in the nucleus of cells that form the bladder wall of cysticerci of Taenia crassiceps, an organism close related to T. solium. Electrophoretic mobility shift assays using nuclear extracts from T. solium cysticerci and antibodies against the NH2-terminal domain of TsTBP1 showed the interaction of native TsTBP1 with the TATA-box present in T. solium actin 5 (pAT5) and 2-Cys peroxiredoxin (Ts2-CysPrx) gene promoters; in contrast, when antibodies against the anti-COOH-terminal domain of TsTBP1 were used, they inhibited the binding of TsTBP1 to the TATA-box of the pAT5 promoter gene.	[Rodriguez-Lima, Oscar; Jimenez, Lucia; Landa, Abraham] Univ Nacl Autonoma Mexico, Fac Med, Dept Microbiol & Parasitol, Mexico City 04510, DF, Mexico; [Garcia-Gutierrez, Ponciano] Univ Autonoma Metropolitana Iztapalapa, Dept Quim, Mexico City 09340, DF, Mexico; [Zarain-Herzberg, Angel] Univ Nacl Autonoma Mexico, Fac Med, Dept Bioquim, Mexico City 04510, DF, Mexico; [Lazzarini, Roberto] Univ Autonoma Metropolitana Iztapalapa, Dept Biol Expt, Mexico City 09340, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Autonoma Metropolitana - Mexico; Universidad Nacional Autonoma de Mexico; Universidad Autonoma Metropolitana - Mexico	Landa, A (corresponding author), Univ Nacl Autonoma Mexico, Fac Med, Dept Microbiol & Parasitol, Mexico City 04510, DF, Mexico.	landap@unam.mx		Garcia-Gutierrez, Ponciano/0000-0001-6178-3828; Lazzarini, Roberto/0000-0003-3537-1576; Rodriguez Lima, Oscar/0000-0002-2778-3872	Direccion General de Asuntos del Personal Academico [DGAPA-PAPIIT IN215714-3]; Consejo Nacional de Ciencia y Tecnologia [CONACyT-176925]; CONACyT [240037]	Direccion General de Asuntos del Personal Academico; Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by Direccion General de Asuntos del Personal Academico (DGAPA-PAPIIT IN215714-3); Consejo Nacional de Ciencia y Tecnologia (CONACyT-176925). ORL was supported by a scholarship (240037) from CONACyT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Diaz H, 2006, PARASITOL INT, V55, pS127, DOI 10.1016/j.parint.2005.11.020; Almeida CR, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-35; Anandapadamanaban M, 2013, NAT STRUCT MOL BIOL, V20, P1008, DOI 10.1038/nsmb.2611; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Beaudoing E, 2000, GENOME RES, V10, P1001, DOI 10.1101/gr.10.7.1001; Burley SK, 1996, PHILOS T ROY SOC B, V351, P483, DOI 10.1098/rstb.1996.0046; CAMPOS A, 1990, MOL BIOCHEM PARASIT, V40, P87, DOI 10.1016/0166-6851(90)90082-W; Cang Y, 2002, P NATL ACAD SCI USA, V99, P12727, DOI 10.1073/pnas.202236699; Chalkley GE, 1999, EMBO J, V18, P4835, DOI 10.1093/emboj/18.17.4835; CHASMAN DI, 1993, P NATL ACAD SCI USA, V90, P8174, DOI 10.1073/pnas.90.17.8174; CHONG MS, 1991, POSTGRAD MED J, V67, P577, DOI 10.1136/pgmj.67.788.577; CHOY B, 1993, NATURE, V366, P531, DOI 10.1038/366531a0; CORMACK BP, 1992, CELL, V69, P685, DOI 10.1016/0092-8674(92)90232-2; Correa M, 1994, ENFERMEDADES TROPICA, V8, P335; Esquivel-Velazquez M, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/516042; Everhart ME, 2004, J PARASITOL, V90, P79, DOI 10.1645/GE-3255; Fleury A, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000805; Garcia HH, 2011, CURR OPIN INFECT DIS, V24, P423, DOI 10.1097/QCO.0b013e32834a1b20; Gilfillan S, 2005, J BIOL CHEM, V280, P6222, DOI 10.1074/jbc.M406343200; HARN DA, 1992, J IMMUNOL, V148, P562; Hasan Md Shariful, 2011, Surg Neurol Int, V2, P177, DOI 10.4103/2152-7806.90698; HERNANDEZ N, 1993, GENE DEV, V7, P1291, DOI 10.1101/gad.7.7b.1291; Jimenez L, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/453469; Juo ZS, 1996, J MOL BIOL, V261, P239, DOI 10.1006/jmbi.1996.0456; Juven-Gershon T, 2006, BIOCHEM SOC T, V34, P1047, DOI 10.1042/BST0341047; Kamada K, 2001, CELL, V106, P71, DOI 10.1016/S0092-8674(01)00417-2; KIM JL, 1994, NAT STRUCT BIOL, V1, P638, DOI 10.1038/nsb0994-638; KIM YC, 1993, NATURE, V365, P512, DOI 10.1038/365512a0; LESCURE A, 1994, EMBO J, V13, P1166, DOI 10.1002/j.1460-2075.1994.tb06366.x; LI SY, 1993, MOL BIOCHEM PARASIT, V61, P321, DOI 10.1016/0166-6851(93)90078-C; Littlefield O, 1999, P NATL ACAD SCI USA, V96, P13668, DOI 10.1073/pnas.96.24.13668; Masson C, 1996, EXP CELL RES, V226, P114, DOI 10.1006/excr.1996.0209; Molina-Lopez J, 2006, J PARASITOL, V92, P796, DOI 10.1645/GE-754R.1; NIKOLOV DB, 1992, NATURE, V360, P40, DOI 10.1038/360040a0; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; Patikoglou GA, 1999, GENE DEV, V13, P3217, DOI 10.1101/gad.13.24.3217; Reichlen MJ, 2010, J BACTERIOL, V192, P1511, DOI 10.1128/JB.01165-09; Reyes-Juarez JL, 2007, J BIOL CHEM, V282, P35554; Ricardo PU, 2012, EXP PARASITOL, V130, P32, DOI 10.1016/j.exppara.2011.10.002; RIGBY PWJ, 1993, CELL, V72, P7, DOI 10.1016/0092-8674(93)90042-O; Sanabria-Ayala V, 2015, PARASITOL RES, V114, P55, DOI 10.1007/s00436-014-4159-3; SCHMIDT EE, 1995, DEVELOPMENT, V121, P2373; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sikorski TW, 2009, CURR OPIN CELL BIOL, V21, P344, DOI 10.1016/j.ceb.2009.03.006; SOTELO J, 1990, J NEUROL, V237, P69, DOI 10.1007/BF00314663; Tan S, 1996, NATURE, V381, P127, DOI 10.1038/381127a0; Tsai IJ, 2013, NATURE, V496, P57, DOI 10.1038/nature12031; Vaca-Paniagua F, 2009, PARASITOL RES, V105, P781, DOI 10.1007/s00436-009-1461-6; Victor SA, 2013, EXP PARASITOL, V134, P495, DOI 10.1016/j.exppara.2013.05.010; Wu XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045830; Yang DY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032283	51	1	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141818	10.1371/journal.pone.0141818	http://dx.doi.org/10.1371/journal.pone.0141818			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529408	gold, Green Published, Green Submitted			2022-12-26	WOS:000364032600062
J	Wiff, R; Roa-Ureta, RH; Borchers, DL; Milessi, AC; Barrientos, MA				Wiff, Rodrigo; Roa-Ureta, Ruben H.; Borchers, David L.; Milessi, Andres C.; Barrientos, Mauricio A.			Estimating Consumption to Biomass Ratio in Non-Stationary Harvested Fish Populations	PLOS ONE			English	Article							FOOD-CONSUMPTION; GROWTH-FUNCTION; TEMPERATURE; AGE; MODEL; MORTALITY; RATES; SIZE	The food consumption to biomass ratio (C) is one of the most important population parameters in ecosystem modelling because its quantifies the interactions between predator and prey. Existing models for estimating C in fish populations are per-recruit cohort models or empirical models, valid only for stationary populations. Moreover, empirical models lack theoretical support. Here we develop a theory and derive a general modelling framework to estimate C in fish populations, based on length frequency data and the generalised von Bertalanffy growth function, in which models for stationary populations with a stable-age distributions are special cases. Estimates using our method are compared with estimates from per-recruit cohort models for C using simulated harvested fish populations of different lifespans. The models proposed here are also applied to three fish populations that are targets of commercial fisheries in southern Chile. Uncertainty in the estimation of C was evaluated using a resampling approach. Simulations showed that stationary and non-stationary population models produce different estimates for C and those differences depend on the lifespan, fishing mortality and recruitment variations. Estimates of C using the new model exhibited smoother inter-annual variation in comparison with a per-recruit model estimates and they were also smaller than C predicted by the empirical equations in all population assessed.	[Wiff, Rodrigo] Pontificia Univ Catolica Chile, Ctr Appl Ecol & Sustainabil CAPES, Santiago, Chile; [Roa-Ureta, Ruben H.] King Fahd Univ Petr & Minerals, Ctr Environm & Water, Dhahran 31261, Saudi Arabia; [Borchers, David L.] Univ St Andrews, Ctr Res Ecol & Environm Modelling, Sch Math & Stat, St Andrews KY16 9LZ, Fife, Scotland; [Milessi, Andres C.] Comis Invest Cient Prov BsAS CIC, RA-1900 La Plata, Argentina; [Milessi, Andres C.] Inst Nacl Invest & Desarrollo Pesquero INIDEP, RA-7600 Mar Del Plata, Argentina; [Barrientos, Mauricio A.] Pontificia Univ Catolica Valparaiso, Inst Matemat, Valparaiso, Chile	Pontificia Universidad Catolica de Chile; King Fahd University of Petroleum & Minerals; University of St Andrews; Comision de Investigaciones Cientificas; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National Fisheries Research & Development Institute (INIDEP); Pontificia Universidad Catolica de Valparaiso	Wiff, R (corresponding author), Pontificia Univ Catolica Chile, Ctr Appl Ecol & Sustainabil CAPES, Av Alameda 340, Santiago, Chile.	rodrigo.wiff@gmail.com	Roa-Ureta, Ruben/B-6045-2015	Roa-Ureta, Ruben/0000-0002-9620-5224; Borchers, David/0000-0002-3944-0754	CONICYT (Chile); CONICYT/FONDECYT [3130425]; CAPES Project Conicyt [FB 0002]	CONICYT (Chile)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); CONICYT/FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CAPES Project Conicyt	Rodrigo Wiff was funded by CONICYT (Chile) scholarship for postgraduate studies abroad ("Beca Presidente de la Republica para Estudios de Postgrado en el Extranjero"), CONICYT/FONDECYT post-doctoral project number 3130425 and by CAPES Project Conicyt FB 0002 (2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen NG, 2003, J FISH BIOL, V62, P395, DOI 10.1046/j.1095-8649.2003.00030.x; Aydin KY, 2004, AFR J MAR SCI, V26, P289, DOI 10.2989/18142320409504062; Beverton R.J.H., 1957, FISHERIES INVESTME 2, V19; Cailliet GM, 2006, ENVIRON BIOL FISH, V77, P211, DOI 10.1007/s10641-006-9105-5; Charnov EL, 2004, INTEGR COMP BIOL, V44, P494, DOI 10.1093/icb/44.6.494; Charnov Eric L., 1993, P1; CONDREY RE, 1982, CAN J FISH AQUAT SCI, V39, P1585, DOI 10.1139/f82-214; DAWES BEN, 1931, JOUR MARINE BIOL ASSOC UNIT KINGDOM, V17, P949; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Essington TE, 2001, CAN J FISH AQUAT SCI, V58, P2129, DOI 10.1139/cjfas-58-11-2129; Finstad AG, 2005, J FISH BIOL, V66, P33, DOI 10.1111/j.0022-1112.2005.00577.x; France R.L., 2011, INT J ENV SCI, V1, P1379; Grant SM, 1999, J FISH BIOL, V54, P396, DOI 10.1111/j.1095-8649.1999.tb00838.x; Hewitt DA, 2005, FISH B-NOAA, V103, P433; Hidalgo M, 2014, ECOL APPL, V24, P1101, DOI 10.1890/12-1777.1; IVLEV VS, 1966, J FISH RES BOARD CAN, V23, P1727, DOI 10.1139/f66-160; JOBLING M, 1980, J FISH BIOL, V17, P187, DOI 10.1111/j.1095-8649.1980.tb02752.x; Ojeda C. V., 1986, Investigacion Pesquera (Santiago), V33, P47; PALOHEIMO JE, 1965, J FISH RES BOARD CAN, V22, P521, DOI 10.1139/f65-048; Palomares MLD, 1998, MAR FRESHWATER RES, V49, P447, DOI 10.1071/MF98015; PAULY D, 1986, FISH B-NOAA, V84, P827; PAULY D, 1981, MEERESFORSCHUNG, V28, P251; Pauly D, 1996, FISH RES, V25, P25, DOI 10.1016/0165-7836(95)00436-X; Pauly D, 1990, ICES COUNC M 1990 G; Pool H., 1997, 9432 FIP; Prajneshu, 1999, CAN J FISH AQUAT SCI, V56, P1026, DOI 10.1139/cjfas-56-6-1026; Quiroz JC, 2007, BIP2007; Richter H, 2004, ECOL MODEL, V171, P381, DOI 10.1016/j.ecolmodel.2003.07.005; Roa-Ureta RH, 2010, J AGR BIOL ENVIR ST, V15, P416, DOI 10.1007/s13253-009-0009-7; Silverstein JT, 1999, J FISH BIOL, V54, P607, DOI 10.1111/j.1095-8649.1999.tb00639.x; Temming A., 1994, NAGA ICLARM Q, V17, P41; Temming A, 2009, CAN J FISH AQUAT SCI, V66, P683, DOI 10.1139/F09-028; VANSTRAALEN NM, 1985, J THEOR BIOL, V113, P331, DOI 10.1016/S0022-5193(85)80231-9; von Bertalanffy L, 1938, HUM BIOL, V10, P181, DOI DOI 10.2307/41447359; Wiff R, 2007, J APPL ICHTHYOL, V23, P270, DOI 10.1111/j.1439-0426.2007.00854.x; Wiff R, 2006, BIP2006; Wiff R, 2008, MAR FRESHWATER RES, V59, P912, DOI 10.1071/MF08053; Wiff R, 2015, J THEOR BIOL, V365, P67, DOI 10.1016/j.jtbi.2014.10.004; Xiao YS, 2000, FISH B-NOAA, V98, P835; Xiao YS, 1999, FISH B-NOAA, V97, P690	40	6	6	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141538	10.1371/journal.pone.0141538	http://dx.doi.org/10.1371/journal.pone.0141538			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528721	gold, Green Submitted, Green Published			2022-12-26	WOS:000364032600036
J	Schroder, H; Komljenovic, D; Hecker, M; Korff, T				Schroeder, Hannes; Komljenovic, Dorde; Hecker, Markus; Korff, Thomas			Transdermal drug targeting and functional imaging of tumor blood vessels in the mouse auricle	FASEB JOURNAL			English	Article						angiogenesis; blood vessel growth; bortezomib; mouse model; perfusion	UBIQUITIN-PROTEASOME SYSTEM; FLOW-INDUCED DILATION; ANTIANGIOGENIC THERAPY; DOPPLER ULTRASOUND; MULTIPLE-MYELOMA; MULTICELLULAR SPHEROIDS; COMPUTED-TOMOGRAPHY; ACTIVATOR PROTEIN-1; GENE-EXPRESSION; MICRO-CT	Subcutaneously growing tumors are widely utilized to study tumor angiogenesis and the efficacy of antiangiogenic therapies in mice. To additionally assess functional and morphologic alterations of the vasculature in the periphery of a growing tumor, we exploited the easily accessible and hierarchically organized vasculature of the mouse auricle. By site-specific subcutaneous implantation of a defined preformed mouse B16/F0 melanoma aggregate, a solid tumor nodule developed within 14 d. Growth of the tumor nodule was accompanied by a 4-fold increase in its perfusion as well as a 2-to 4-fold elevated diameter and perfusion of peripheral blood vessels that had connected to the tumor capillary microvasculature. By transdermal application of the anticancer drug bortezomib, tumor growth was significantly diminished by about 50% without provoking side effects. Moreover, perfusion and tumor microvessel diameter as well as growth and perfusion of arterial or venous blood vessels supplying or draining the tumor microvasculature were decreased under these conditions by up to 80%. Collectively, we observed that the progressive tumor growth is accompanied by the enlargement of supplying and draining extratumoral blood vessels. This process was effectively suppressed by bortezomib, thereby restricting the perfusion capacity of both extra and intratumoral blood vessels.	[Schroeder, Hannes; Hecker, Markus; Korff, Thomas] Heidelberg Univ, Div Cardiovasc Physiol, Inst Physiol & Pathophysiol, Neuenheimer Feld 326, D-69120 Heidelberg, Germany; [Komljenovic, Dorde] German Canc Res Ctr, Dept Med Phys Radiol, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Korff, T (corresponding author), Heidelberg Univ, Div Cardiovasc Physiol, Inst Physiol & Pathophysiol, Neuenheimer Feld 326, D-69120 Heidelberg, Germany.	korff@physiologie.uni-heidelberg.de			Deutsche Forschungsgemeinschaft [SFB TR 23]; Heidelberg University Faculty of Medicine; Krebs und Scharlach Stiftung Mannhein	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Heidelberg University Faculty of Medicine; Krebs und Scharlach Stiftung Mannhein	This work was supported in part by a grant from the Deutsche Forschungsgemeinschaft (SFB TR 23, project sections C5, C6, and Z1, Ursula M. Handel Animal Welfare Award), the Postdoc Fellowship Program of the Heidelberg University Faculty of Medicine, and the Krebs und Scharlach Stiftung Mannhein. The authors acknowledge the excellent technical assistance of G. Scheib (Heidelberg University) and K. Oehme (DKFZ, Heidelberg). Y. Sun (DKFZ, Heidelberg) is acknowledged for help in CT image processing.	Amiri KI, 2004, CANCER RES, V64, P4912, DOI 10.1158/0008-5472.CAN-04-0673; Barringhaus Kurt G, 2007, Exp Clin Cardiol, V12, P119; Brahimi-Horn C, 2001, TRENDS CELL BIOL, V11, pS32, DOI 10.1016/S0962-8924(01)02126-2; Bzyl J, 2013, EUR RADIOL, V23, P468, DOI 10.1007/s00330-012-2594-z; Carew JS, 2008, CANCER RES, V68, P4783, DOI 10.1158/0008-5472.CAN-07-6483; Chauhan D, 2004, BLOOD, V103, P3158, DOI 10.1182/blood-2003-08-2873; Chauhan D, 2008, BLOOD, V111, P1654, DOI 10.1182/blood-2006-10-050476; Demicheva E, 2008, CIRC RES, V103, P477, DOI 10.1161/CIRCRESAHA.108.177782; Drews O, 2010, CIRC RES, V107, P1094, DOI 10.1161/CIRCRESAHA.110.222364; Ebos JML, 2011, NAT REV CLIN ONCOL, V8, P210, DOI 10.1038/nrclinonc.2011.21; Ehling J, 2014, AM J PATHOL, V184, P431, DOI 10.1016/j.ajpath.2013.10.014; Eisa F, 2012, EUR RADIOL, V22, P900, DOI 10.1007/s00330-011-2318-9; FALCONE JC, 1993, AM J PHYSIOL, V264, pH653, DOI 10.1152/ajpheart.1993.264.2.H653; Feldner A, 2011, FASEB J, V25, P3613, DOI 10.1096/fj.11-185975; FIDLER IJ, 1973, NATURE-NEW BIOL, V242, P148, DOI 10.1038/newbio242148a0; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Goertz DE, 2002, CANCER RES, V62, P6371; Gomez-Bougie P, 2007, CANCER RES, V67, P5418, DOI 10.1158/0008-5472.CAN-06-4322; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Kiessling F, 2004, NAT MED, V10, P1133, DOI 10.1038/nm1101; Korff T, 1998, J CELL BIOL, V143, P1341, DOI 10.1083/jcb.143.5.1341; KUO L, 1990, AM J PHYSIOL, V259, pH1063, DOI 10.1152/ajpheart.1990.259.4.H1063; Lashinger LM, 2005, CANCER RES, V65, P4902, DOI 10.1158/0008-5472.CAN-04-3701; Lesinski GB, 2008, CANCER RES, V68, P8351, DOI 10.1158/0008-5472.CAN-08-0426; Limbourg A, 2009, NAT PROTOC, V4, P1737, DOI 10.1038/nprot.2009.185; McDonald DM, 2003, NAT MED, V9, P713, DOI 10.1038/nm0603-713; MUELLERKLIESER W, 1987, J CANCER RES CLIN, V113, P101, DOI 10.1007/BF00391431; Pagan J, 2013, CIRC RES, V112, P1046, DOI 10.1161/CIRCRESAHA.112.300521; Palmowski M, 2008, CANCER RES, V68, P7042, DOI 10.1158/0008-5472.CAN-08-0285; Pascarella L, 2005, J VASC SURG, V41, P303, DOI 10.1016/j.jvs.2004.10.038; Patan S, 2001, CIRC RES, V89, P732, DOI 10.1161/hh2001.097872; Pfisterer L, 2014, FASEB J, V28, P3518, DOI 10.1096/fj.14-250464; Pfisterer L, 2012, CARDIOVASC RES, V96, P120, DOI 10.1093/cvr/cvs247; Pipp F, 2004, ARTERIOSCL THROM VAS, V24, P1664, DOI 10.1161/01.ATV.0000138028.14390.e4; Prior BM, 2004, AM J PHYSIOL-HEART C, V287, pH2434, DOI 10.1152/ajpheart.00398.2004; Richardson PG, 2003, NEW ENGL J MED, V348, P2609, DOI 10.1056/NEJMoa030288; Savai R, 2009, NEOPLASIA, V11, P48, DOI 10.1593/neo.81036; Scholz Dimitri, 2001, Angiogenesis, V4, P247, DOI 10.1023/A:1016094004084; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Soriano GP, 2014, ANTIOXID REDOX SIGN, V21, P2419, DOI 10.1089/ars.2013.5794; Tung D, 2011, PHARMACOLOGY, V88, P100, DOI 10.1159/000330067; Tydlacka S, 2008, J NEUROSCI, V28, P13285, DOI 10.1523/JNEUROSCI.4393-08.2008; van Es RJJ, 1999, LAB ANIM-UK, V33, P175, DOI 10.1258/002367799780578372; Weathington NM, 2013, AM J RESP CRIT CARE, V188, P530, DOI 10.1164/rccm.201304-0754PP; Xuan JW, 2007, CANCER RES, V67, P2830, DOI 10.1158/0008-5472.CAN-06-3944; YUHAS JM, 1977, CANCER RES, V37, P3639; ZAMORA PO, 1980, CANCER RES, V40, P4631	47	2	2	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					923	932		10.1096/fj.15-279240	http://dx.doi.org/10.1096/fj.15-279240			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26546130				2022-12-26	WOS:000369391900039
J	Budd, WT; Seashols-Williams, SJ; Clark, GC; Weaver, D; Calvert, V; Petricoin, E; Dragoescu, EA; O'Hanlon, K; Zehner, ZE				Budd, William T.; Seashols-Williams, Sarah J.; Clark, Gene C.; Weaver, Danielle; Calvert, Valerie; Petricoin, Emanuel; Dragoescu, Ema A.; O'Hanlon, Katherine; Zehner, Zendra E.			Dual Action of miR-125b As a Tumor Suppressor and OncomiR-22 Promotes Prostate Cancer Tumorigenesis	PLOS ONE			English	Article							LASER-CAPTURE MICRODISSECTION; MICRORNA EXPRESSION; GENE-EXPRESSION; PROGNOSTIC IMPLICATIONS; GROWTH; CELLS; ADENOCARCINOMA; DYSREGULATION; PROGRESSION; PREDICTION	MicroRNAs (miRs) are a novel class of small RNA molecules, the dysregulation of which can contribute to cancer. A combinatorial approach was used to identify miRs that promote prostate cancer progression in a unique set of prostate cancer cell lines, which originate from the parental p69 cell line and extend to a highly tumorigenic/metastatic M12 subline. Together, these cell lines are thought to mimic prostate cancer progression in vivo. Previous network analysis and miR arrays suggested that the loss of hsa-miR-125b together with the overexpression of hsa-miR-22 could contribute to prostate tumorigenesis. The dysregulation of these two miRs was confirmed in human prostate tumor samples as compared to adjacent benign glandular epithelium collected through laser capture microdissection from radical prostatectomies. In fact, alterations in hsa-miR-125b expression appeared to be an early event in tumorigenesis. Reverse phase microarray proteomic analysis revealed ErbB2/3 and downstream members of the PI3K/AKT and MAPK/ERK pathways as well as PTEN to be protein targets differentially expressed in the M12 tumor cell compared to its parental p69 cell. Relevant luciferase+3'-UTR expression studies confirmed a direct interaction between hsa-miR-125b and ErbB2 and between hsa-miR-22 and PTEN. Restoration of hsa-miR-125b or inhibition of hsa-miR-22 expression via an antagomiR resulted in an alteration of M12 tumor cell behavior in vitro. Thus, the dual action of hsa-miR-125b as a tumor suppressor and hsa-miR-22 as an oncomiR contributed to prostate tumorigenesis by modulations in PI3K/AKT and MAPK/ERK signaling pathways, key pathways known to influence prostate cancer progression.	[Budd, William T.; Seashols-Williams, Sarah J.; Clark, Gene C.; Zehner, Zendra E.] Virginia Commonwealth Univ, Massey Canc Ctr, Dept Biochem & Mol Biol, Richmond, VA 23284 USA; [Seashols-Williams, Sarah J.] Virginia Commonwealth Univ, Dept Forens Sci, Richmond, VA USA; [Weaver, Danielle] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA USA; [Calvert, Valerie; Petricoin, Emanuel] George Mason Univ, Ctr Appl Prote & Mol Med, Manassas, VA USA; [Dragoescu, Ema A.] Virginia Commonwealth Univ, Dept Pathol, VCU Med Ctr, Richmond, VA USA; [O'Hanlon, Katherine] Amer Int Biotechnol, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; George Mason University; Virginia Commonwealth University	Zehner, ZE (corresponding author), Virginia Commonwealth Univ, Massey Canc Ctr, Dept Biochem & Mol Biol, Richmond, VA 23284 USA.	zendra.zehner@vcuhealth.org	Seashols-Williams, Sarah J/K-7455-2016	Seashols-Williams, Sarah J/0000-0003-0093-8261	National Cancer Institute [R21CA152349]; NATIONAL CANCER INSTITUTE [R21CA152349] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute, Grant Number R21CA152349 to ZEZ. The funder provided support in the form of salaries for KOH, but did not have any additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. The specific roles of this author is articulated in the "author contributions" section.	Astbury C, 2001, GENE CHROMOSOME CANC, V31, P143, DOI 10.1002/gcc.1128; BAE VL, 1994, INT J CANCER, V58, P721, DOI 10.1002/ijc.2910580517; Bae VL, 1998, PROSTATE, V34, P275, DOI 10.1002/(SICI)1097-0045(19980301)34:4<275::AID-PROS5>3.0.CO;2-G; Baffa R, 2009, J PATHOL, V219, P214, DOI 10.1002/path.2586; Bar N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010859; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Boehm M, 2006, CELL CYCLE, V5, P837, DOI 10.4161/cc.5.8.2688; Bostwick David G, 2004, Rev Urol, V6, P171; Budd WT, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-S5-S3; Budd WT, 2012, CHEM BIODIVERS, V9, P857, DOI 10.1002/cbdv.201100386; Budd WT, 2012, THESIS; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chen Dan, 2013, J Oral Maxillofac Res, V4, pe2, DOI 10.5037/jomr.2013.4102; Dubovenko A, 2015, J CANCER, V6, P490, DOI 10.7150/jca.8213; Espina V, 2006, NAT PROTOC, V1, P586, DOI 10.1038/nprot.2006.85; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; GLEASON DF, 1974, J UROLOGY, V111, P58, DOI 10.1016/S0022-5347(17)59889-4; Grubb RL, 2003, PROTEOMICS, V3, P2142, DOI 10.1002/pmic.200300598; Hammond SM, 2006, CURR OPIN GENET DEV, V16, P4, DOI 10.1016/j.gde.2005.12.005; He J, 2012, EMBO REP, V13, P1116, DOI 10.1038/embor.2012.162; Holbro T, 2003, P NATL ACAD SCI USA, V100, P8933, DOI 10.1073/pnas.1537685100; ISAACS JT, 1989, PROSTATE, P33; Joseph A, 2011, METHODS MOL BIOL, V755, P291, DOI 10.1007/978-1-61779-163-5_24; Kent OA, 2006, ONCOGENE, V25, P6188, DOI 10.1038/sj.onc.1209913; Klink JC, 2012, KOREAN J UROL, V53, P297, DOI 10.4111/kju.2012.53.5.297; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Li WX, 2008, INT J CANCER, V123, P1616, DOI 10.1002/ijc.23693; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu X, 2010, BRIT J CANCER, V102, P457, DOI 10.1038/sj.bjc.6605490; Nonn L, 2010, EXP MOL PATHOL, V88, P45, DOI 10.1016/j.yexmp.2009.10.005; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Paweletz CP, 2001, UROLOGY, V57, P160, DOI 10.1016/S0090-4295(00)00964-X; Paweletz CP, 2001, ONCOGENE, V20, P1981, DOI 10.1038/sj.onc.1204265; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Priolo C, 2014, CANCER RES, V74, P7198, DOI 10.1158/0008-5472.CAN-14-1490; Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827; Scott GK, 2007, J BIOL CHEM, P282; Seashols S, 2013, THESIS; Shi XB, 2007, P NATL ACAD SCI USA, V104, P19983, DOI 10.1073/pnas.0706641104; Shi XB, 2011, PROSTATE, V71, P538, DOI 10.1002/pros.21270; Shukla CJ, 2008, BJU INT, V101, P765, DOI 10.1111/j.1464-410X.2007.07372.x; Sorrentino A, 2008, GYNECOL ONCOL, V111, P478, DOI 10.1016/j.ygyno.2008.08.017; Srivastava A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076994; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Veerla S, 2009, INT J CANCER, V124, P2236, DOI 10.1002/ijc.24183; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; White RWD, 2009, UROL ONCOL-SEMIN ORI, V27, P307, DOI 10.1016/j.urolonc.2009.01.004; Wu YZ, 2003, ONCOGENE, V22, P8891, DOI 10.1038/sj.onc.1206898; Yee Jie Yin, 2014, BMC Res Notes, V7, P62, DOI 10.1186/1756-0500-7-62; Zhang XP, 2009, CLIN EXP METASTAS, V26, P965, DOI 10.1007/s10585-009-9287-2; Zhang XP, 2009, MOL CANCER THER, V8, P499, DOI 10.1158/1535-7163.MCT-08-0544; Zhang Y, 2011, CANCER RES, V71, P3552, DOI 10.1158/0008-5472.CAN-10-2435; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006	56	42	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142373	10.1371/journal.pone.0142373	http://dx.doi.org/10.1371/journal.pone.0142373			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544868	Green Published, Green Submitted, gold			2022-12-26	WOS:000364398700121
J	Horowitz, BB; Ospina-Giraldo, MD				Horowitz, Brent B.; Ospina-Giraldo, Manuel D.			The Pectin Methylesterase Gene Complement of Phytophthora sojae: Structural and Functional Analyses, and the Evolutionary Relationships with Its Oomycete Homologs	PLOS ONE			English	Article							PLANT; INFESTANS; PATHOGEN; EXPRESSION; FUNGI; AVR3A	Phytophthora sojae is an oomycete pathogen that causes the disease known as root and stem rot in soybean plants, frequently leading to massive economic damage. Additionally, P. sojae is increasingly being utilized as a model for phytopathogenic oomycete research. Despite the economic and scientific importance of P. sojae, the mechanism by which it penetrates the host roots is not yet fully understood. It has been found that oomycetes are not capable of penetrating the cell wall solely through mechanical force, suggesting that alternative factors facilitate breakdown of the host cell wall. Pectin methylesterases have been suggested to be important for Phytophthora pathogenicity, but no data exist on their role in the P. sojae infection process. We have scanned the newly revised version of the annotated P. sojae genome for the presence of putative pectin methylesterases genes and conducted a sequence analysis of all gene models found. We also searched for potential regulatory motifs in the promoter region of the proposed P. sojae models, and investigated the gene expression levels throughout the early course of infection on soybean plants. We found that P. sojae contains a large repertoire of pectin methylesterase-coding genes and that most of these genes display similar motifs in the promoter region, indicating the possibility of a shared regulatory mechanism. Phylogenetic analyses confirmed the evolutionary relatedness of the pectin methylesterase-coding genes within and across Phytophthora spp. In addition, the gene duplication events that led to the emergence of this gene family appear to have occurred prior to many speciation events in the genus Phytophthora. Our results also indicate that the highest levels of expression occurred in the first 24 hours post inoculation, with expression falling after this time. Our study provides evidence that pectin methylesterases may be important for the early action of the P. sojae infection process.	[Horowitz, Brent B.; Ospina-Giraldo, Manuel D.] Lafayette Coll, Dept Biol, Easton, PA 18042 USA	Lafayette College	Ospina-Giraldo, MD (corresponding author), Lafayette Coll, Dept Biol, Easton, PA 18042 USA.	elsgenomics@gmail.com		Horowitz, Brent/0000-0002-5744-7562	Lafayette College; Agriculture and Food Research Initiative competitive grant of the United States Department of Agriculture's National Institute of Food and Agriculture [2011-68004-30104]	Lafayette College; Agriculture and Food Research Initiative competitive grant of the United States Department of Agriculture's National Institute of Food and Agriculture	Funding was provided by Lafayette College and the Agriculture and Food Research Initiative competitive grant 2011-68004-30104 of the United States Department of Agriculture's National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avrova AO, 2008, CELL MICROBIOL, V10, P2271, DOI 10.1111/j.1462-5822.2008.01206.x; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Boudjeko T, 2005, J PHYTOPATHOL, V153, P409, DOI 10.1111/j.1439-0434.2005.00993.x; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CATEN CE, 1968, CAN J BOTANY, V46, P329, DOI 10.1139/b68-055; Costanzo S, 2006, PHYTOPATHOLOGY, V96, pS26; Costanzo S, 2007, CURR GENET, V52, P115, DOI 10.1007/s00294-007-0144-z; Csuros M, 2008, MOL BIOL EVOL, V25, P903, DOI 10.1093/molbev/msn039; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Hardham AR, 2001, AUSTRALAS PLANT PATH, V30, P91, DOI 10.1071/AP01006; Jia YJ, 2009, J PHYTOPATHOL, V157, P585, DOI 10.1111/j.1439-0434.2008.01533.x; Jiang RHY, 2012, ANNU REV PHYTOPATHOL, V50, P295, DOI 10.1146/annurev-phyto-081211-172912; Kale SD, 2010, CELL, V142, P284, DOI 10.1016/j.cell.2010.06.008; Kemen E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001094; Kupfer DM, 2004, EUKARYOT CELL, V3, P1088, DOI 10.1128/EC.3.5.1088-1100.2004; Li PQ, 2011, J BASIC MICROB, V51, P61, DOI 10.1002/jobm.201000317; Li WH, 2007, MOL EVOLUTION; Lionetti V, 2007, PLANT PHYSIOL, V143, P1871, DOI 10.1104/pp.106.090803; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McLeod A, 2003, FUNGAL GENET BIOL, V38, P250, DOI 10.1016/S1087-1845(02)00523-6; McLeod A, 2004, EUKARYOT CELL, V3, P91, DOI 10.1128/EC.3.1.91-99.2004; MILLER PM, 1955, PHYTOPATHOLOGY, V45, P461; Mingora C, 2014, GENE, V538, P74, DOI 10.1016/j.gene.2014.01.016; Money NP, 2004, FUNGAL GENET BIOL, V41, P872, DOI 10.1016/j.fgb.2004.06.001; Ospina-Giraldo MD, 2010, CURR GENET, V56, P495, DOI 10.1007/s00294-010-0317-z; Ospina-Giraldo MD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-525; Park BH, 2010, GLYCOBIOLOGY, V20, P1574, DOI 10.1093/glycob/cwq106; Pelloux J, 2007, TRENDS PLANT SCI, V12, P267, DOI 10.1016/j.tplants.2007.04.001; Perkins HR, 1968, CELL WALLS MEMBRANES; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Petre B, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001801; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Shen DY, 2011, CAN J MICROBIOL, V57, P84, DOI [10.1139/W10-103, 10.1139/w10-103]; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tyler BM, 2007, MOL PLANT PATHOL, V8, P1, DOI 10.1111/j.1364-3703.2006.00373.x; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; van West P, 2008, MICROBIOL-SGM, V154, P1482, DOI 10.1099/mic.0.2007/015545-0; Wawra S, 2013, MOL PLANT MICROBE IN, V26, P528, DOI 10.1094/MPMI-08-12-0200-R; Win J, 2006, FUNGAL GENET BIOL, V43, P20, DOI 10.1016/j.fgb.2005.10.003; Yaeno T, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.23865; Yaeno T, 2011, P NATL ACAD SCI USA, V108, P14682, DOI 10.1073/pnas.1106002108; Yang XB, 2001, PHYTOPATHOLOGY, V91, P769, DOI 10.1094/PHYTO.2001.91.8.769; Zerillo MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072572	43	7	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142096	10.1371/journal.pone.0142096	http://dx.doi.org/10.1371/journal.pone.0142096			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544849	Green Submitted, gold, Green Published			2022-12-26	WOS:000364398700081
J	Juarez-Ramirez, C; Theodore, FL; Villalobos, A; Jimenez-Corona, A; Lerin, S; Nigenda, G; Lewis, S				Juarez-Ramirez, Clara; Theodore, Florence L.; Villalobos, Aremis; Jimenez-Corona, Aida; Lerin, Sergio; Nigenda, Gustavo; Lewis, Sarah			Social Support of Patients with Type 2 Diabetes in Marginalized Contexts in Mexico and Its Relation to Compliance with Treatment: A Sociocultural Approach	PLOS ONE			English	Article							MORTALITY; DISEASES; BURDEN; STYLE	Objective This study aimed to describe the ways social support works in the daily life of patients with type 2 diabetes living in conditions of social and economic marginality, in order to understand how that support relates to treatment compliance. Methods Sequential mixed methods research was used. The sample of patients was obtained from primary health care units and selected considering regional representativeness, and levels of morbidity and mortality for type 2 diabetes. Results Results point to the nuclear family as the main source of support. Regardless of the area of residence, four main dimensions of support were identified: economic support, help with treatment compliance, emotional support, and material aid. Conclusions We conclude that the support network assists the patient in different ways and helps cope with the disease, but in conditions of social and economic marginality, does not guarantee the quality of attention nor enable the self-management of treatment.	[Juarez-Ramirez, Clara] Natl Inst Publ Hlth, Ctr Hlth Syst Res, Cuernavaca, Morelos, Mexico; [Theodore, Florence L.] Natl Inst Publ Hlth, Ctr Nutr Res, Cuernavaca, Morelos, Mexico; [Villalobos, Aremis] Natl Inst Publ Hlth, Ctr Populat Hlth Res, Cuernavaca, Morelos, Mexico; [Jimenez-Corona, Aida] Inst Ophthalmol Conde Valenciana IAP, Dept Ocular Epidemiol & Visual Hlth, Mexico City, DF, Mexico; [Jimenez-Corona, Aida] Minist Hlth, Directorate Epidemiol, Mexico City, DF, Mexico; [Lerin, Sergio] Ctr Res & Studies Social Anthropol, Dept Med Anthropol, Mexico City, DF, Mexico; [Nigenda, Gustavo] Morelos State Autonomous Univ, Sch Med, Cuernavaca, Morelos, Mexico; [Lewis, Sarah] Univ Calif Berkeley, Hlth Serv & Policy Anal, Berkeley, CA 94720 USA	Instituto Nacional de Salud Publica; Instituto Nacional de Salud Publica; Instituto Nacional de Salud Publica; Universidad Autonoma del Estado de Morelos; University of California System; University of California Berkeley	Juarez-Ramirez, C (corresponding author), Natl Inst Publ Hlth, Ctr Hlth Syst Res, Cuernavaca, Morelos, Mexico.	clara.juarez@insp.mx		JUAREZ-RAMIREZ, CLARA/0000-0002-1844-772X; Theodore, Florence L./0000-0002-8111-0871	National Council of Science and Technology of Mexico [FOSSIS-87041]	National Council of Science and Technology of Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The National Council of Science and Technology of Mexico (www.conacyt.mx) provided the funding for this research. Grant number: FOSSIS-87041. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Hospital Association, 2012, ENG HLTH CAR US FRAM; Barquera S, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-3; Bauman Z, 2011, SOCIAL INEQUALITIES; Berkman L. F., 2000, SOCIAL EPIDEMIOLOGY, V1, P137, DOI DOI 10.4135/9781412952576.N192]; Bonita R, 2013, LANCET, V381, P575, DOI 10.1016/S0140-6736(12)61993-X; Bourdieu P., 1979, DISTINCTION CRITIQUE; Bury M, 1982, Sociol Health Illn, V4, P167, DOI 10.1111/1467-9566.ep11339939; CASSEL J, 1976, AM J EPIDEMIOL, V104, P107, DOI 10.1093/oxfordjournals.aje.a112281; Ciechanowski P, 2004, PSYCHOSOM MED, V66, P720, DOI 10.1097/01.psy.0000138125.59122.23; COBB S, 1976, PSYCHOSOM MED, V38, P300, DOI 10.1097/00006842-197609000-00003; Coffey A, 1996, MAKING SENSE QUALITA; Daly M, 2008, THEOR SOC, V37, P537, DOI 10.1007/s11186-008-9062-4; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Di Cesare M, 2013, LANCET, V381, P585, DOI 10.1016/S0140-6736(12)61851-0; Dressler WW, 2000, AM ANTHROPOL, V102, P244, DOI 10.1525/aa.2000.102.2.244; Epple C, 2003, DIABETES CARE, V26, P2829, DOI 10.2337/diacare.26.10.2829; Garner P, 2013, LANCET, V381, P27; Geneau R, 2010, LANCET, V376, P1689, DOI 10.1016/S0140-6736(10)61414-6; GERHARDT U, 1990, SOC SCI MED, V30, P1149, DOI 10.1016/0277-9536(90)90255-Q; Hann D, 2002, J PSYCHOSOM RES, V52, P279, DOI 10.1016/S0022-3999(01)00235-5; Jimenez-Corona A, 2013, SALUD PUBLICA MEXICO, V55, pS137, DOI 10.21149/spm.v55s2.5109; Johnson N, 2008, CITIZENSHIP COHESION; Johnson RB, 2007, J MIX METHOD RES, V1, P112, DOI 10.1177/1558689806298224; Kawachi I., 2000, SOCIAL EPIDEMIOLOGY, V174, P290; King DK, 2010, DIABETES CARE, V33, P751, DOI 10.2337/dc09-1746; LOMNITZ L., 2004, REV SOCIOLOGY HUNGAR, V10, P5, DOI DOI 10.1556/REVSOC.10.2004.1.1; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mauss M, 1991, ENSAYO DONES RAZON F; Mayberry LS, 2012, DIABETES CARE, V35, P1239, DOI 10.2337/dc11-2103; Meisinger C, 2009, PSYCHOSOM MED, V71, P784, DOI 10.1097/PSY.0b013e3181ae5770; Michael YL, 2002, J PSYCHOSOM RES, V52, P285, DOI 10.1016/S0022-3999(01)00270-7; Morrish NJ, 2001, DIABETOLOGIA, V44, pS14, DOI 10.1007/PL00002934; Morse J. M., 2009, MIXED METHOD DESIGN; Oliver TR, 2006, ANNU REV PUBL HEALTH, V27, P195, DOI 10.1146/annurev.publhealth.25.101802.123126; Pan American Health Organization (PAHO), 2013, INN CAR CHRON COND O; Paulus D, 2012, KCE REPORTS; Potter J, 1987, DISCOURSE SOCIAL PSY; Putnam RD., 2000, BOWLING ALONE COLLAP; Rintala TM, 2013, J FAM NURS, V19, P3, DOI 10.1177/1074840712471899; Roglic G, 2005, DIABETES CARE, V28, P2130, DOI 10.2337/diacare.28.9.2130; Sapag JC, 2007, REV SAUDE PUBL, V41, P139, DOI 10.1590/S0034-89102007000100019; SCHLENK EA, 1984, DIABETES CARE, V7, P566, DOI 10.2337/diacare.7.6.566; Schutz A., 1995, PROBLEMA REALIDAD SO; Schutz Alfred, 1977, ESTRUCTURAS MUNDO VI; Sluzki C, 1996, RED SOCIAL FRONTERAD; THOITS PA, 1982, J COMMUNITY PSYCHOL, V10, P341, DOI 10.1002/1520-6629(198210)10:4<341::AID-JCOP2290100406>3.0.CO;2-J; Vyncke V, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-65; Weller SC, 2012, SOC SCI MED, V75, P1088, DOI 10.1016/j.socscimed.2012.05.003; Wetherell M, 1998, DISCOURSE SOC, V9, P387, DOI 10.1177/0957926598009003005; WHO, 2011, REPORT ON THE GLOBAL; Wilkinson R., 2003, THE SOLID FACTS; World Health Organisation, 1999, DEFINITION DIAGNOSIS	52	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141766	10.1371/journal.pone.0141766	http://dx.doi.org/10.1371/journal.pone.0141766			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV6RT	26545122	Green Submitted, gold, Green Published			2022-12-26	WOS:000364398700043
J	Kumari, R; Astafurov, K; Genis, A; Danias, J				Kumari, Ruma; Astafurov, Konstantin; Genis, Alina; Danias, John			Differential Effects of C1qa Ablation on Glaucomatous Damage in Two Sexes in DBA/2NNia Mice	PLOS ONE			English	Article							BRAIN MICROGLIA; MOUSE MODEL; COMPLEMENT; ACTIVATION; INDUCTION; PRESSURE; ESTROGEN; RETINA	Purpose To determine the sex and age-related effects of C1qa ablation on retinal ganglion cell (RGC) and optic nerve (ON) axonal loss in a mouse model of glaucomatous neurodegeneration. Methods Congenic C1qa mice were generated in the DBA/2NNia background. Female and male knockout (-/-), heterozygous (+/-), and wild type (+/+) mice were aged up to 14 months and IOPs were recorded in a subset of animals. Retinas of mice from all three groups at 5-6, 9-10 and 11-13 months of age were flat-mounted after retrograde labeling with Fluorogold. Imaged retinas were scored (RGC score) semi-quantitatively on a 10 point scale by two independent observers. A subset of retinas and optic nerves were also used for measurement of total number of RGCs. Semi-thin sections of ON were imaged and graded (ON score) for the amount of axonal damage semi-quantitatively, by two masked observers. Analysis of covariance (ANCOVA) was used for statistical comparisons. Microglial cells in flat-mounted retinas of 5-6 month old C1qa -/- and C1qa +/+ mice were used for assessment of microglial activation utilizing morphological criteria. Results Female C1qa -/- mice had significantly higher IOP (p<0.000001, ANOVA) between 8 and 13 months of age compared to C1qa +/+ animals. No differences in IOPs between animals of the three genotypes were observed in males. At 5-6 months of age, there was no difference in RGC or ON scores between the three genotypes in animals of either sex. At 9-10 months of age, female mice didn't show significant differences in RGC or ON scores between the three genotypes. However, male C1qa -/-and C1qa +/- mice of the same age had better RGC and ON scores (p<0.003 and p<0.05, ANCOVA, for RGC and ON scores, respectively) compared with C1qa +/+ mice. At 11-13 months of age, female C1qa -/- mice had better RGC scores (p<0.006, ANCOVA) compared to C1qa +/+ and C1qa +/-animals. Accordingly, C1qa -/- mice had higher RGC counts (p<0.03, t-test) compared to C1qa +/+ animals. In male mice, there was a tendency for 12 month old C1qa -/- animals to have better RGC scores and higher RGC counts, but this didn't reach statistical significance. ON scores in 11-13 month old animals of either sex were not different between all three genotype. Microglial activation in male 5-6 month old C1qa -/- mice was decreased compared to C1qa +/+ animals; no such effect was seen in females. Conclusions Absence of C1qa ameliorates RGC and ON loss in the DBA/2NNia strain, but this effect differs between the two sexes. C1q-mediated RGC damage seems to be more potent than IOP-mediated RGC loss. In contrast, C1qa absence provides axonal protection early on, but this protection cannot overcome the effects of significant IOP elevation.	[Kumari, Ruma; Astafurov, Konstantin; Danias, John] Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA; [Genis, Alina; Danias, John] Suny Downstate Med Ctr, Dept Ophthalmol, Brooklyn, NY 11203 USA; [Kumari, Ruma; Astafurov, Konstantin; Genis, Alina; Danias, John] SUNY, Inst Eye, Brooklyn, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; SUNY Maritime College	Kumari, R (corresponding author), Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA.	rumagrover23@gmail.com; John.Danias@downstate.edu		Astafurov, Konstantin/0000-0002-7264-4265	National Eye Institute [5R01EY015224]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY015224] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work received financial support from the following sources: grant # 5R01EY015224 from National Eye Institute to JD; Unrestricted challenge grant to the Dept. of Ophthalmology of SUNY Downstate from the Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MG, 2002, NAT GENET, V30, P81, DOI 10.1038/ng794; Astafurov K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104416; Astafurov K, 2014, MOL VIS, V20, P140; Bosco A, 2015, DIS MODEL MECH, V8, P443, DOI 10.1242/dmm.018788; Bosco A, 2011, J COMP NEUROL, V519, P599, DOI 10.1002/cne.22516; Botto M, 1998, EXP CLIN IMMUNOGENET, V15, P231, DOI 10.1159/000019076; Bourne RRA, 2013, LANCET GLOB HEALTH, V1, pE339, DOI 10.1016/S2214-109X(13)70113-X; Chang B, 1999, NAT GENET, V21, P405, DOI 10.1038/7741; Cribbs DH, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-179; Danias J, 2003, INVEST OPHTH VIS SCI, V44, P5151, DOI 10.1167/iovs.02-1101; Danias J, 2003, INVEST OPHTH VIS SCI, V44, P1138, DOI 10.1167/iovs.02-0553; Depboylu C, 2005, NEUROBIOL DIS, V20, P12, DOI 10.1016/j.nbd.2005.01.030; Filippopoulos T, 2006, INVEST OPHTH VIS SCI, V47, P1968, DOI 10.1167/iovs.05-0955; Griffiths MR, 2010, INT J INFLAMM, V2010, DOI 10.4061/2010/151097; Howell GR, 2011, J CLIN INVEST, V121, P1429, DOI 10.1172/JCI44646; Jakobs TC, 2005, J CELL BIOL, V171, P313, DOI 10.1083/jcb.200506099; Klegeris A, 2001, EXP GERONTOL, V36, P1179, DOI 10.1016/S0531-5565(00)00265-5; Krizaj D, 2014, CURR EYE RES, V39, P105, DOI 10.3109/02713683.2013.836541; Kuehn MH, 2006, EXP EYE RES, V83, P620, DOI 10.1016/j.exer.2006.03.002; Lei DL, 2003, NEUROSCIENCE, V121, P659, DOI 10.1016/S0306-4522(03)00245-8; Libby RT, 2005, VISUAL NEUROSCI, V22, P637, DOI 10.1017/S0952523805225130; Marina N, 2010, NAT PROTOC, V5, P1642, DOI 10.1038/nprot.2010.128; McGeer EG, 2003, PROG NEURO-PSYCHOPH, V27, P741, DOI 10.1016/S0278-5846(03)00124-6; McGeer PL, 2002, MUSCLE NERVE, V26, P459, DOI 10.1002/mus.10191; Mevorach D, 2010, APOPTOSIS, V15, P1114, DOI 10.1007/s10495-010-0530-8; MONDINO BJ, 1984, INVEST OPHTH VIS SCI, V25, P871; MONDINO BJ, 1986, INVEST OPHTH VIS SCI, V27, P1288; Reichstein D, 2007, EXP EYE RES, V84, P13, DOI 10.1016/j.exer.2006.08.009; Ren LZ, 2010, ADV EXP MED BIOL, V703, P95, DOI 10.1007/978-1-4419-5635-4_7; Sarvari M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088540; Schafer MKH, 2000, J IMMUNOL, V164, P5446, DOI 10.4049/jimmunol.164.10.5446; Seitz R, 2013, CELL TISSUE RES, V353, P339, DOI 10.1007/s00441-013-1666-y; SHELDON WG, 1995, LAB ANIM SCI, V45, P508; Sohn JH, 2000, INVEST OPHTH VIS SCI, V41, P3492; Sohn JH, 2000, INVEST OPHTH VIS SCI, V41, P4195; Stasi K, 2006, INVEST OPHTH VIS SCI, V47, P1024, DOI 10.1167/iovs.05-0830; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Takano Y, 2012, AM J OPHTHALMOL, V154, P825, DOI 10.1016/j.ajo.2012.03.050; Tezel G, 2013, CURR OPIN PHARMACOL, V13, P23, DOI 10.1016/j.coph.2012.09.013; Vegeto E, 2003, P NATL ACAD SCI USA, V100, P9614, DOI 10.1073/pnas.1531957100; Wang JW, 2016, J GLAUCOMA, V25, P459, DOI 10.1097/IJG.0000000000000200; ZHENG XB, 1994, OPHTHALMIC RES, V26, P200, DOI 10.1159/000267468	42	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142199	10.1371/journal.pone.0142199	http://dx.doi.org/10.1371/journal.pone.0142199			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544197	Green Published, Green Submitted, gold			2022-12-26	WOS:000364398700094
J	Upadhyay, M; Vivekanandan, P				Upadhyay, Mohita; Vivekanandan, Perumal			Depletion of CpG Dinucleotides in Papillomaviruses and Polyomaviruses: A Role for Divergent Evolutionary Pressures	PLOS ONE			English	Article							SYNONYMOUS CODON USAGE; DNA METHYLATION; VIRAL-DNA; SELECTION; TYPE-16; GENOME; VIRUS; LEVEL; COEVOLUTION; INTEGRATION	Background Papillomaviruses and polyomaviruses are small ds-DNA viruses infecting a wide-range of vertebrate hosts. Evidence supporting co-evolution of the virus with the host does not fully explain the evolutionary path of papillomaviruses and polyomaviruses. Studies analyzing CpG dinucleotide frequencies in virus genomes have provided interesting insights on virus evolution. CpG dinucleotide depletion has not been extensively studied among papillomaviruses and polyomaviruses. We sought to analyze the relative abundance of dinucleotides and the relative roles of evolutionary pressures in papillomaviruses and polyomaviruses. Methods We studied 127 full-length sequences from papillomaviruses and 56 full-length sequences from polyomaviruses. We analyzed the relative abundance of dinucleotides, effective codon number (ENC), differences in synonymous codon usage. We examined the association, if any, between the extent of CpG dinucleotide depletion and the evolutionary lineage of the infected host. We also investigated the contribution of mutational pressure and translational selection to the evolution of papillomaviruses and polyomaviruses. Results All papillomaviruses and polyomaviruses are CpG depleted. Interestingly, the evolutionary lineage of the infected host determines the extent of CpG depletion among papillomaviruses and polyomaviruses. CpG dinucleotide depletion was more pronounced among papillomaviruses and polyomaviruses infecting human and other mammals as compared to those infecting birds. Our findings demonstrate that CpG depletion among papillomaviruses is linked to mutational pressure; while CpG depletion among polyomaviruses is linked to translational selection. We also present evidence that suggests methylation of CpG dinucleotides may explain, at least in part, the depletion of CpG dinucleotides among papillomaviruses but not polyomaviruses. Conclusions The extent of CpG depletion among papillomaviruses and polyomaviruses is linked to the evolutionary lineage of the infected host. Our results highlight the existence of divergent evolutionary pressures leading to CpG dinucleotide depletion among small ds-DNA viruses infecting vertebrate hosts.	[Upadhyay, Mohita; Vivekanandan, Perumal] Indian Inst Technol Delhi, Kusuma Sch Biol Sci, New Delhi 006, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi	Vivekanandan, P (corresponding author), Indian Inst Technol Delhi, Kusuma Sch Biol Sci, New Delhi 006, India.	vperumal@bioschool.iitd.ac.in			Kusuma Trust	Kusuma Trust	This work was funded by Kusuma Trust.	Badal V, 2003, J VIROL, V77, P6227, DOI 10.1128/JVI.77.11.6227-6234.2003; Belalov IS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056642; Bernard Hans-Ulrich, 1994, Trends in Microbiology, V2, P140, DOI 10.1016/0966-842X(94)90602-5; BEUTLER E, 1989, P NATL ACAD SCI USA, V86, P192, DOI 10.1073/pnas.86.1.192; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499; Bonvicini F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033316; BURGE C, 1992, P NATL ACAD SCI USA, V89, P1358, DOI 10.1073/pnas.89.4.1358; Chaiwongkot A, 2013, INT J CANCER, V132, P2087, DOI 10.1002/ijc.27906; Chang CF, 2011, VIRUS GENES, V43, P201, DOI 10.1007/s11262-011-0627-3; Cheng XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074109; Chinnery HR, 2012, AM J PATHOL, V180, P209, DOI 10.1016/j.ajpath.2011.09.041; Cooper David N, 2010, Hum Genomics, V4, P406; Duret L, 2000, MOL BIOL EVOL, V17, P1620, DOI 10.1093/oxfordjournals.molbev.a026261; FREUND R, 1991, J VIROL, V65, P350, DOI 10.1128/JVI.65.1.350-355.1991; Gorelik L, 2011, J INFECT DIS, V204, P103, DOI 10.1093/infdis/jir198; Graham SV, 2010, FUTURE MICROBIOL, V5, P1493, DOI 10.2217/FMB.10.107; HYDEDERUYSCHER R, 1988, P NATL ACAD SCI USA, V85, P8993, DOI 10.1073/pnas.85.23.8993; JEON S, 1995, J VIROL, V69, P2989, DOI 10.1128/JVI.69.5.2989-2997.1995; Johne R, 2007, J VIROL, V81, P11554, DOI 10.1128/JVI.01178-07; Johne R, 2011, ARCH VIROL, V156, P1627, DOI 10.1007/s00705-011-1008-x; Liu QG, 2000, J GEN VIROL, V81, P359, DOI 10.1099/0022-1317-81-2-359; MAZUR S, 1995, J VIROL, V69, P3059, DOI 10.1128/JVI.69.5.3059-3066.1995; Musto H, 2003, MICROBIOL-SGM, V149, P855, DOI 10.1099/mic.0.26063-0; Nair RR, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-492; Narechania A, 2005, J GEN VIROL, V86, P1307, DOI 10.1099/vir.0.80747-0; ONG CK, 1993, J VIROL, V67, P6424, DOI 10.1128/JVI.67.11.6424-6431.1993; Park IS, 2011, CANCER PREV RES, V4, P207, DOI 10.1158/1940-6207.CAPR-10-0147; Rector A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r57; Shackelton LA, 2006, J MOL EVOL, V62, P551, DOI 10.1007/s00239-005-0221-1; Shah SD, 2010, MOL BIOL EVOL, V27, P1301, DOI 10.1093/molbev/msq015; Sunyaev SR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000368; Tweedie S, 1997, MOL CELL BIOL, V17, P1469, DOI 10.1128/MCB.17.3.1469; Upadhyay M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111793; Upadhyay M, 2013, J VIROL, V87, P13816, DOI 10.1128/JVI.02515-13; Van Doorslaer K, 2013, VIROLOGY, V445, P11, DOI 10.1016/j.virol.2013.05.012; Vivekanandan P, 2008, J VIRAL HEPATITIS, V15, P103, DOI 10.1111/j.1365-2893.2007.00905.x; Warden C. D., 2012, J BIOINFORMATICS RES, V1, P46; Wollebo HS, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-264; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Xu Q, 2007, ANIM BIOTECHNOL, V18, P231, DOI 10.1080/10495390701574838; Xu Qing, 2011, Yichuan, V33, P620, DOI 10.3724/SP.J.1005.2011.00620; Zhao KN, 2003, VIRUS RES, V98, P95, DOI 10.1016/j.virusres.2003.08.019; Zhao KN, 2011, REV MED VIROL, V21, P397, DOI 10.1002/rmv.707; Zhou J, 1999, J VIROL, V73, P4972, DOI 10.1128/JVI.73.6.4972-4982.1999	44	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142368	10.1371/journal.pone.0142368	http://dx.doi.org/10.1371/journal.pone.0142368			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544572	gold, Green Submitted, Green Published			2022-12-26	WOS:000364398700119
J	Wong, MTY; Lambeck, AJA; van der Burg, M; la Bastide-van Gemert, S; Hogendorf, LA; van Ravenswaaij-Arts, CMA; Scholvinck, EH				Wong, Monica T. Y.; Lambeck, Annechien J. A.; van der Burg, Mirjam; la Bastide-van Gemert, Sacha; Hogendorf, Lianne A.; van Ravenswaaij-Arts, Conny M. A.; Scholvinck, Elisabeth H.			Immune Dysfunction in Children with CHARGE Syndrome: A Cross-Sectional Study	PLOS ONE			English	Article							22Q11.2 DELETION SYNDROME; CONJUGATE-VACCINE; PRIMARY IMMUNODEFICIENCY; MULTIPLEX IMMUNOASSAY; PHENOTYPIC SPECTRUM; NON-IMMUNOLOGISTS; CHD7 GENE; DIPHTHERIA; IMMUNIZATION; UPDATE	CHARGE syndrome is a variable, multiple congenital malformation syndrome. Patients with CHARGE syndrome have frequent infections that are presumed to be due to anatomical anomalies of the craniofacial region and upper airway, and cranial nerve problems resulting in swallowing difficulties and aspiration. The possible contribution of immunological abnormalities to these infections has not been systematically studied even though immune deficiencies have been described in patients with 22q11.2 deletion syndrome, a condition which shares remarkable clinical overlap with CHARGE syndrome. We assessed the frequency and nature of immune dysfunction in 24 children with genetically proven CHARGE syndrome. All patients, or their parents, completed a questionnaire on infectious history. Their immune system was extensively assessed through full blood counts, immunoglobulin levels, lymphocyte subpopulations, peripheral B- and T-cell differentiation, T-receptor excision circle (TREC) analysis, T-cell function, and vaccination responses. All CHARGE patients had a history of infections (often frequent), mainly otitis media and pneumonia, leading to frequent use of antibiotics and to hospital admissions. Decreased T-cell numbers were found in 12 (50%) patients, presumably caused by insufficient thymic output since TREC amounts were also diminished in CHARGE patients. Despite normal peripheral B-cell differentiation and immunoglobulin production in all patients, 83% of patients had insufficient antibody titers to one or more early childhood vaccinations. Based on our results, we recommend immunological evaluation of CHARGE patients with recurrent infections.	[Wong, Monica T. Y.; van Ravenswaaij-Arts, Conny M. A.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Lambeck, Annechien J. A.; Hogendorf, Lianne A.] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Med Immunol, Groningen, Netherlands; [van der Burg, Mirjam] Erasmus MC, Univ Med Ctr Rotterdam, Dept Immunol, Rotterdam, Netherlands; [la Bastide-van Gemert, Sacha] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Scholvinck, Elisabeth H.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Paediat,Infect Dis & Immunol Sect, Groningen, Netherlands	University of Groningen; University of Groningen; Erasmus University Rotterdam; Erasmus MC; University of Groningen; University of Groningen	Scholvinck, EH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Paediat,Infect Dis & Immunol Sect, Groningen, Netherlands.	e.h.scholvinck@umcg.nl	la Bastide-van Gemert, Sacha/C-5151-2013	la Bastide-van Gemert, Sacha/0000-0003-0666-6690	Fonds NutsOhra [1202-023]	Fonds NutsOhra	The study is supported by Fonds NutsOhra (http://www.fondsnutsohra.nl/) with a grant (1202-023) to MTYW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergman JEH, 2011, J MED GENET, V48, P334, DOI 10.1136/jmg.2010.087106; Bergman JEH, 2012, HUM MUTAT, V33, P1251, DOI 10.1002/humu.22106; Blake KD, 1998, CLIN PEDIATR, V37, P159, DOI 10.1177/000992289803700302; Chan K, 2005, J ALLERGY CLIN IMMUN, V115, P391, DOI 10.1016/j.jaci.2004.10.012; Chopra C, 2009, ACTA PAEDIATR, V98, P408, DOI 10.1111/j.1651-2227.2008.01077.x; ComansBitter WM, 1997, J PEDIATR-US, V130, P388, DOI 10.1016/S0022-3476(97)70200-2; de Melker HE, 2003, VACCINE, V21, P716, DOI 10.1016/S0264-410X(02)00587-X; de Melker HE, 1999, EMERG INFECT DIS, V5, P694, DOI 10.3201/eid0505.990511; de Vries E, 2006, CLIN EXP IMMUNOL, V145, P204, DOI 10.1111/j.1365-2249.2006.03138.x; de Vries E, 2012, CLIN EXP IMMUNOL, V167, P108, DOI 10.1111/j.1365-2249.2011.04461.x; Driessen GJ, 2011, BLOOD, V118, P6814, DOI 10.1182/blood-2011-06-361881; Elberse KEM, 2010, CLIN VACCINE IMMUNOL, V17, P674, DOI 10.1128/CVI.00408-09; Hazenberg MD, 2001, J MOL MED, V79, P631, DOI 10.1007/s001090100271; Hollander G, 2006, IMMUNOL REV, V209, P28, DOI 10.1111/j.0105-2896.2006.00357.x; Janssen N, 2012, HUM MUTAT, V33, P1149, DOI 10.1002/humu.22086; JOLLIFF CR, 1982, CLIN CHEM, V28, P126; Jongmans MCJ, 2006, J MED GENET, V43, P306, DOI 10.1136/jmg.2005.036061; Jyonouchi S, 2009, PEDIATRICS, V123, pE871, DOI 10.1542/peds.2008-3400; McLean-Tooke A, 2011, SCAND J IMMUNOL, V73, P577, DOI 10.1111/j.1365-3083.2011.02527.x; PAGON RA, 1981, J PEDIATR-US, V99, P223, DOI 10.1016/S0022-3476(81)80454-4; Patel K, 2012, J PEDIATR-US, V161, P950, DOI 10.1016/j.jpeds.2012.06.018; Poliani PL, 2009, BLOOD, V114, P105, DOI 10.1182/blood-2009-03-211029; Randall V, 2009, J CLIN INVEST, V119, P3301, DOI 10.1172/JCI37561; Sanlaville D, 2006, J MED GENET, V43, P211, DOI 10.1136/jmg.2005.036160; Saule P, 2006, MECH AGEING DEV, V127, P274, DOI 10.1016/j.mad.2005.11.001; Spijkerman J, 2013, JAMA-J AM MED ASSOC, V310, P930, DOI 10.1001/jama.2013.228052; Stam J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025690; Theodoropoulos Demetrios S, 2003, Clin Med Res, V1, P43; van Dongen TMA, 2015, PEDIATR INFECT DIS J, V34, P355, DOI 10.1097/INF.0000000000000595; van Gageldonk PGM, 2008, J IMMUNOL METHODS, V335, P79, DOI 10.1016/j.jim.2008.02.018; van Gageldonk PGM, 2011, CLIN VACCINE IMMUNOL, V18, P1183, DOI 10.1128/CVI.05081-11; van Zelm MC, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00012; Verloes A, 2005, AM J MED GENET A, V133A, P306, DOI 10.1002/ajmg.a.30559; Wong MT, 2015, EUR J HUM GENET; Zemble R, 2010, CLIN IMMUNOL, V136, P409, DOI 10.1016/j.clim.2010.04.011	35	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142350	10.1371/journal.pone.0142350	http://dx.doi.org/10.1371/journal.pone.0142350			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544072	gold, Green Submitted, Green Published			2022-12-26	WOS:000364398700117
J	Woo, T; Okudela, K; Mitsui, H; Tajiri, M; Rino, Y; Ohashi, K; Masuda, M				Woo, Tetsukan; Okudela, Koji; Mitsui, Hideaki; Tajiri, Michihiko; Rino, Yasushi; Ohashi, Kenichi; Masuda, Munetaka			Up-Regulation of S100A11 in Lung Adenocarcinoma - Its Potential Relationship with Cancer Progression	PLoS One			English	Article							METASTASIS-ASSOCIATED PROTEINS; PROTEOMIC ANALYSIS; DOWN-REGULATION; HUMAN TISSUES; EXPRESSION; CARCINOGENESIS; CLASSIFICATION; MUTATIONS; CARCINOMA	We previously reported that patients with lung adenocarcinomas with KRAS gene mutations and strong proliferating activity had poorer outcomes, even in the early stage of the disease. The aim of the present study was to elucidate the potential molecular basis of these highly malignant lung tumors by focusing on S100 proteins (S100A2, S100A7, and S100A11), which are downstream targets of oncogenic KRAS and promoters of tumor progression. The immunohistochemical expression of S100 proteins was examined in 179 primary lung adenocarcinomas, and the potential relationships between their levels and clinicopathologic factors were analyzed. Among the three subtypes, S100A11 levels were significantly higher in adenocarcinomas with KRAS mutations and strong proliferating activity. They were also higher in adenocarcinomas with poorly differentiated tumors. Furthermore, higher levels of S100A11 were associated with shorter disease-free survival. These results suggest that the up-regulation of S100A11 plays a role in tumor progression, particularly in KRAS-mutated lung adenocarcinomas.	[Woo, Tetsukan; Rino, Yasushi; Masuda, Munetaka] Yokohama City Univ, Grad Sch Med, Dept Surg, Yokohama, Kanagawa 232, Japan; [Woo, Tetsukan] Saiseikai Yokohama City South Hosp, Dept Thorac Surg, Yokohama, Kanagawa, Japan; [Okudela, Koji; Mitsui, Hideaki; Ohashi, Kenichi] Yokohama City Univ, Grad Sch Med, Dept Pathol, Yokohama, Kanagawa 232, Japan; [Tajiri, Michihiko] Kanagawa Cardiovasc & Resp Ctr, Dept Thorac Surg, Yokohama, Kanagawa, Japan	Yokohama City University; Yokohama City University; Kanagawa Cardiovascular & Respiratory Center	Woo, T (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Surg, Yokohama, Kanagawa 232, Japan.	tetsu.n.u@cotton.ocn.ne.jp			Ministry of Education, Culture, Sports, and Science of Japan (Tokyo Japan); Yokohama Medical Facility (Yokohama, Japan)	Ministry of Education, Culture, Sports, and Science of Japan (Tokyo Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yokohama Medical Facility (Yokohama, Japan)	This work was funded by the Ministry of Education, Culture, Sports, and Science of Japan (Tokyo Japan), and Yokohama Medical Facility (Yokohama, Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asamura H, 2008, J THORAC ONCOL, V3, P46, DOI 10.1097/JTO.0b013e31815e8577; Cross SS, 2005, HISTOPATHOLOGY, V46, P256, DOI 10.1111/j.1365-2559.2005.02097.x; Goldstraw Peter, 2007, J Thorac Oncol, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Hao JT, 2012, MOL CELL BIOCHEM, V359, P323, DOI 10.1007/s11010-011-1026-8; Hoffman PC, 2000, LANCET, V355, P479, DOI 10.1016/S0140-6736(00)82038-3; Kondo A, 2002, ACTA MED OKAYAMA, V56, P31; Matsubara D, 2005, CANCER SCI, V96, P844, DOI 10.1111/j.1349-7006.2005.00121.x; Memon AA, 2005, CLIN CANCER RES, V11, P606; Mori M, 2004, ONCOL REP, V11, P1287; Okudela K, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0087193, 10.1371/journal.pone.0093359]; Okudela K, 2010, PATHOL INT, V60, P651, DOI 10.1111/j.1440-1827.2010.02580.x; Okudela K, 2009, AM J PATHOL, V175, P867, DOI 10.2353/ajpath.2009.080489; Rehman I, 2004, HUM PATHOL, V35, P1385, DOI 10.1016/j.humpath.2004.07.015; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Salama I, 2008, EJSO-EUR J SURG ONC, V34, P357, DOI 10.1016/j.ejso.2007.04.009; Song HY, 2006, J CANCER RES CLIN, V132, P92, DOI 10.1007/s00432-005-0044-x; Spira A, 2004, NEW ENGL J MED, V350, P379, DOI 10.1056/NEJMra035536; Tian T, 2007, CANCER SCI, V98, P1265, DOI 10.1111/j.1349-7006.2007.00514.x; TODOROKI H, 1991, J BIOL CHEM, V266, P18668; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Wang CY, 2013, INT J MED SCI, V10, P1552, DOI 10.7150/ijms.5986; Wang GY, 2008, INT J COLORECTAL DIS, V23, P675, DOI 10.1007/s00384-008-0464-6; Woo T, 2009, LUNG CANCER, V65, P355, DOI 10.1016/j.lungcan.2008.11.020; Xiao MB, 2012, MED ONCOL, V29, P1886, DOI 10.1007/s12032-011-0058-y; Yang P, 2005, CHEST, V128, P452, DOI 10.1378/chest.128.1.452	25	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142642	10.1371/journal.pone.0142642	http://dx.doi.org/10.1371/journal.pone.0142642			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544866	gold, Green Published, Green Submitted			2022-12-26	WOS:000364398700161
J	Ye, F; Xin, ZS; Han, W; Fan, JJ; Yin, B; Wu, SZ; Yang, W; Yuan, JG; Qiang, BQ; Sun, W; Peng, XZ				Ye, Fei; Xin, Zhongshuai; Han, Wei; Fan, Jingjing; Yin, Bin; Wu, Shuzhen; Yang, Wei; Yuan, Jiangang; Qiang, Boqin; Sun, Wei; Peng, Xiaozhong			Quantitative Proteomics Analysis of the Hepatitis C Virus Replicon High-Permissive and Low-Permissive Cell Lines	PLOS ONE			English	Article							EFFICIENT REPLICATION; CATHEPSIN-B; PROTEIN; LIVER; EXPRESSION; VIMENTIN; IDENTIFICATION; INTERFERON; INDUCTION; APOPTOSIS	Chronic hepatitis C virus (HCV) infection is one of the leading causes of severe hepatitis. The molecular mechanisms underlying HCV replication and pathogenesis remain unclear. The development of the subgenome replicon model system significantly enhanced study of HCV. However, the permissiveness of the HCV subgenome replicon greatly differs among different hepatoma cell lines. Proteomic analysis of different permissive cell lines might provide new clues in understanding HCV replication. In this study, to detect potential candidates that might account for the differences in HCV replication. Label-free and iTRAQ labeling were used to analyze the differentially expressed protein profiles between Huh7.5.1 wt and HepG2 cells. A total of 4919 proteins were quantified in which 114 proteins were commonly identified as differentially expressed by both quantitative methods. A total of 37 differential proteins were validated by qRT-PCR. The differential expression of Glutathione S-transferase P (GSTP1), Ubiquitin carboxyl-terminal hydrolase isozyme L1 (UCHL1), carboxylesterase 1 (CES1), vimentin, Proteasome activator complex subunit1 (PSME1), and Cathepsin B (CTSB) were verified by western blot. And over-expression of CTSB or knock-down of vimentin induced significant changes to HCV RNA levels. Additionally, we demonstrated that CTSB was able to inhibit HCV replication and viral protein translation. These results highlight the potential role of CTSB and vimentin in virus replication.	[Ye, Fei; Han, Wei; Yin, Bin; Yuan, Jiangang; Qiang, Boqin; Peng, Xiaozhong] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Mol Biol & Biochem, State Key Lab Med Mol Biol, Beijing 100730, Peoples R China; [Ye, Fei; Han, Wei; Fan, Jingjing; Yin, Bin; Wu, Shuzhen; Yang, Wei; Yuan, Jiangang; Qiang, Boqin; Sun, Wei; Peng, Xiaozhong] Peking Union Med Coll, Beijing 100021, Peoples R China; [Xin, Zhongshuai] Natl Inst Food & Drug Control, Div Hormone, Beijing, Peoples R China; [Wu, Shuzhen; Sun, Wei] Chinese Acad Med Sci, Inst Basic Med Sci, Core Facil Instrument, Beijing 100730, Peoples R China; [Fan, Jingjing; Yang, Wei] Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; National Institute of Food & Drug Control - China; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS	Sun, W (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Core Facil Instrument, Beijing 100730, Peoples R China.	sunwei1018@hotmail.com; pengxiaozhong@pumc.edu.cn			National Basic Research Program of China (973 Program) [2011CB504902]; Major infectious diseases project [20132X10004601-002]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Major infectious diseases project	This study was supported by National Basic Research Program of China (973 Program) Grant No. 2011CB504902 and Major infectious diseases project, Grant No. 20132X10004601-002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2004, J VIROL, V78, P491, DOI 10.1128/JVI.78.1.491-501.2004; Aly HH, 2007, J HEPATOL, V46, P26, DOI 10.1016/j.jhep.2006.08.018; Bartenschlager R, 2000, J GEN VIROL, V81, P1631, DOI 10.1099/0022-1317-81-7-1631; Bartenschlager R, 2007, VIRUS RES, V127, P195, DOI 10.1016/j.virusres.2007.02.022; Bheda A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006764; Blais DR, 2010, J BIOL CHEM, V285, P25602, DOI 10.1074/jbc.M110.135483; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Blight KJ, 2003, J VIROL, V77, P3181, DOI 10.1128/JVI.77.5.3181-3190.2003; Bouchal P, 2009, J PROTEOME RES, V8, P362, DOI 10.1021/pr800622b; Casado-Vela J, 2010, PROTEOMICS, V10, P343, DOI 10.1002/pmic.200900509; Chang JH, 2008, J VIROL, V82, P8215, DOI 10.1128/JVI.02575-07; Cheng M, 2013, J VIROL, V87, P9707, DOI 10.1128/JVI.00802-13; Date T, 2004, J BIOL CHEM, V279, P22371, DOI 10.1074/jbc.M311120200; Diao S, 2010, PROTEOMICS, V10, P3723, DOI 10.1002/pmic.201000050; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Ghosh S, 2011, J VIRAL HEPATITIS, V18, pE568, DOI 10.1111/j.1365-2893.2011.01487.x; Gilar M, 2005, ANAL CHEM, V77, P6426, DOI 10.1021/ac050923i; Gottwein JM, 2008, ADV VIRUS RES, V71, P51, DOI 10.1016/S0065-3527(08)00002-X; Gu BH, 2003, J VIROL, V77, P5352, DOI 10.1128/JVI.77.9.5352-5359.2003; Guicciardi ME, 2000, J CLIN INVEST, V106, P1127, DOI 10.1172/JCI9914; Harris D, 2006, MOL CELL PROTEOMICS, V5, P1006, DOI 10.1074/mcp.M500429-MCP200; Hussain SP, 2007, ONCOGENE, V26, P2166, DOI 10.1038/sj.onc.1210279; Ishii T, 2004, CANCER LETT, V216, P89, DOI 10.1016/j.canlet.2004.05.018; Jacobs JM, 2005, J VIROL, V79, P7558, DOI 10.1128/JVI.79.12.7558-7569.2005; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kambara H, 2012, J VIROL, V86, P1382, DOI 10.1128/JVI.06242-11; Kato N, 2009, VIRUS RES, V146, P41, DOI 10.1016/j.virusres.2009.08.006; Kato T, 2003, GASTROENTEROLOGY, V125, P1808, DOI 10.1053/j.gastro.2003.09.023; Kato T, 2005, J VIROL, V79, P592, DOI 10.1128/JVI.79.1.592-596.2005; Kato T, 2001, J MED VIROL, V64, P334, DOI 10.1002/jmv.1055; Kim W, 2003, CLIN CANCER RES, V9, P5493; Kwon J, 2004, AM J PATHOL, V165, P1367, DOI 10.1016/S0002-9440(10)63394-9; Lambert MP, 2011, J HEPATOL, V54, P705, DOI 10.1016/j.jhep.2010.07.027; Lan KH, 2002, ONCOGENE, V21, P4801, DOI 10.1038/sj.onc.1205589; Lee CF, 2008, WORLD J GASTROENTERO, V14, P6072, DOI 10.3748/wjg.14.6072; Li QS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004163; Lin LT, 2010, J VIROL, V84, P9170, DOI 10.1128/JVI.00559-10; Liu S, 2012, HEPATOLOGY, V56, P57, DOI 10.1002/hep.25642; Liu SF, 2012, HEPATOLOGY, V56, P484, DOI 10.1002/hep.25665; Liu XY, 2013, J VIROL, V87, P1649, DOI 10.1128/JVI.02201-12; Lohmann V, 2003, J VIROL, V77, P3007, DOI 10.1128/JVI.77.5.3007-3019.2003; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Majumder M, 2002, VIROLOGY, V294, P94, DOI 10.1006/viro.2001.1309; Mak TN, 2012, CELL MICROBIOL, V14, P1720, DOI 10.1111/j.1462-5822.2012.01833.x; Maqbool MA, 2013, J VIROL, V87, P5523, DOI 10.1128/JVI.00585-12; Miao RD, 2008, J BIOSCIENCES, V33, P723, DOI 10.1007/s12038-008-0092-x; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Morchang A, 2013, BIOCHEM BIOPH RES CO, V438, P20, DOI 10.1016/j.bbrc.2013.07.009; Narbus CM, 2011, J VIROL, V85, P12087, DOI 10.1128/JVI.05843-11; Nitahara-Kasahara Y, 2009, VIROLOGY, V383, P319, DOI 10.1016/j.virol.2008.10.009; Pan TT, 2006, BIOCHEM BIOPH RES CO, V347, P683, DOI 10.1016/j.bbrc.2006.06.144; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Ripoli M, 2011, VIRUS RES, V160, P74, DOI 10.1016/j.virusres.2011.05.014; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Song CX, 2010, ANAL CHEM, V82, P53, DOI 10.1021/ac9023044; Teo CSH, 2014, J VIROL, V88, P1897, DOI 10.1128/JVI.01249-13; Waggoner SA, 2009, J BIOL CHEM, V284, P9039, DOI 10.1074/jbc.M806986200; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wang HX, 2012, J PROTEOME RES, V11, P487, DOI 10.1021/pr2008225; Wang YX, 2011, PROTEOMICS, V11, P2019, DOI 10.1002/pmic.201000722; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Wu Jin-ming, 2005, Zhonghua Gan Zang Bing Za Zhi, V13, P702; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107; Xin ZS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025419; Xun M, 2008, ACTA PHARMACOL SIN, V29, P720, DOI 10.1111/j.1745-7254.2008.00789.x; Yin LM, 2000, BIOCHEMISTRY-US, V39, P10001, DOI 10.1021/bi0007019; Zhao Y, 2013, TUMOR BIOL, V34, P2121, DOI 10.1007/s13277-013-0695-1; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102; Zhu MM, 2009, MOL CELL PROTEOMICS, V8, P752, DOI 10.1074/mcp.M800343-MCP200; Zhu WH, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/840518	71	10	10	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142082	10.1371/journal.pone.0142082	http://dx.doi.org/10.1371/journal.pone.0142082			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544179	Green Published, Green Submitted, gold			2022-12-26	WOS:000364398700078
J	Zou, CB; Caterina, GL; Will, RE; Stebler, E; Turton, D				Zou, Chris B.; Caterina, Giulia L.; Will, Rodney E.; Stebler, Elaine; Turton, Donald			Canopy Interception for a Tallgrass Prairie under Juniper Encroachment	PLOS ONE			English	Article							WATER STORAGE CAPACITY; RAINFALL INTERCEPTION; FOREST; STEMFLOW; THROUGHFALL; VEGETATION; DYNAMICS; MODEL; PRECIPITATION; CONSEQUENCES	Rainfall partitioning and redistribution by canopies are important ecohydrological processes underlying ecosystem dynamics. We quantified and contrasted spatial and temporal variations of rainfall redistribution for a juniper (Juniperus virginiana, redcedar) woodland and a tallgrass prairie in the south-central Great Plains, USA. Our results showed that redcedar trees had high canopy storage capacity (S) ranging from 2.14 mm for open stands to 3.44 mm for closed stands. The canopy funneling ratios (F) of redcedar trees varied substantially among stand type and tree size. The open stands and smaller trees usually had higher F values and were more efficient in partitioning rainfall into stemflow. Larger trees were more effective in partitioning rainfall into throughfall and no significant changes in the total interception ratios among canopy types and tree size were found. The S values were highly variable for tallgrass prairie, ranging from 0.27 mm at early growing season to 3.86 mm at senescence. As a result, the rainfall interception by tallgrass prairie was characterized by high temporal instability. On an annual basis, our results showed no significant difference in total rainfall loss to canopy interception between redcedar trees and tallgrass prairie. Increasing structural complexity associated with redcedar encroachment into tallgrass prairie changes the rainfall redistribution and partitioning pattern at both the temporal and spatial scales, but does not change the overall canopy interception ratios compared with unburned and ungrazed tallgrass prairie. Our findings support the idea of convergence in interception ratio for different canopy structures under the same precipitation regime. The temporal change in rainfall interception loss from redcedar encroachment is important to understand how juniper encroachment will interact with changing rainfall regime and potentially alter regional streamflow under climate change.	[Zou, Chris B.; Caterina, Giulia L.; Will, Rodney E.; Stebler, Elaine; Turton, Donald] Oklahoma State Univ, Dept Nat Resource Ecol & Management, Stillwater, OK 74078 USA; [Caterina, Giulia L.] Univ Estadual Paulista, Botucatu, SP, Brazil	Oklahoma State University System; Oklahoma State University - Stillwater; Universidade Estadual Paulista	Zou, CB (corresponding author), Oklahoma State Univ, Dept Nat Resource Ecol & Management, Stillwater, OK 74078 USA.	chris.zou@okstate.edu	Will, Rodney/G-8111-2011; Zou, Chris/A-5039-2010	Zou, Chris/0000-0003-0080-2866	U. S. Geological Survey/National Institutes for Water Research [USGS104G (G09AP00146)]; USGS OWRRI grants; National Science Foundation/Experimental Program to Stimulate Competitive Research (EPSCoR) [NSF-1301789]; NSF Dynamics of Coupled Natural and Human Systems (CNH) program [DEB-1413900]; United States Department of Agriculture/National Institute of Food and Agriculture [2014-67010-21653]; Division Of Environmental Biology [1413900] Funding Source: National Science Foundation; Office Of The Director [1301789] Funding Source: National Science Foundation	U. S. Geological Survey/National Institutes for Water Research; USGS OWRRI grants; National Science Foundation/Experimental Program to Stimulate Competitive Research (EPSCoR); NSF Dynamics of Coupled Natural and Human Systems (CNH) program(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); United States Department of Agriculture/National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	The field equipment installation, data collection were completed with support from the U. S. Geological Survey/National Institutes for Water Research USGS104G (G09AP00146 https://niwr.net/public/Migration/niwr.net) and USGS OWRRI grants. The data analysis, re-analysis, and paper writing were partially supported with funding from National Science Foundation/Experimental Program to Stimulate Competitive Research (EPSCoR http://www.nsf.gov/od/iia/programs/epscor/nsf_oiia_epscor_index.jsp) via grant NSF-1301789, NSF Dynamics of Coupled Natural and Human Systems (CNH) program (DEB-1413900 http://www.nsf.gov/div/index.jsp?div=DEB), and United States Department of Agriculture/National Institute of Food and Agriculture (2014-67010-21653 http://nifa.usda.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre F, 2008, HYDROL PROCESS, V22, P4130, DOI 10.1002/hyp.7013; [Anonymous], 1996, INVASION OKLAHOMA RA; ARCHER S, 1995, ECOSCIENCE, V2, P83, DOI 10.1080/11956860.1995.11682272; Barker W. T., 1988, Rangelands, V10, P266; Breshears DD, 2008, ECOLOGY, V89, P41, DOI 10.1890/07-0437.1; Briggs JM, 2005, BIOSCIENCE, V55, P243, DOI 10.1641/0006-3568(2005)055[0243:AEITCA]2.0.CO;2; Briggs JM, 2002, ECOSYSTEMS, V5, P578, DOI 10.1007/s10021-002-0187-4; Carlyle-Moses D., 2002, MEASUREMENT MODELLIN; Carlyle-Moses DE, 2006, HYDROL PROCESS, V20, P3651, DOI 10.1002/hyp.6380; Carlyle-Moses DE, 2011, ECOL STUD-ANAL SYNTH, V216, P407, DOI 10.1007/978-94-007-1363-5_20; Carlyle-Moses DE, 2004, J ARID ENVIRON, V58, P181, DOI 10.1016/S0140-1963(03)00125-3; CLARK ORIN RAY, 1940, ECOL MONOGR, V10, P243, DOI 10.2307/1948607; Corbett ES, 1966, HYDROLOG SCI J, V11, P110; Crockford RH, 2000, HYDROL PROCESS, V14, P2903, DOI [10.1002/1099-1085(200011/12)14:16/17<2903::AID-HYP126>3.0.CO;2-6, 10.1002/1099-1085(200011/12)14:16/17&lt;2903::AID-HYP126&gt;3.0.CO;2-6]; Duesterhaus JL, 2008, THESIS KANSAS STATE; Dunkerley D, 2000, HYDROL PROCESS, V14, P669, DOI 10.1002/(SICI)1099-1085(200003)14:4&lt;669::AID-HYP965&gt;3.0.CO;2-I; Dunkerley DL, 1999, WATER RESOUR RES, V35, P1581, DOI 10.1029/1999WR900003; Engle D. M., 2008, ECOL STUD-ANAL SYNTH, P253; Ferguson ER, 1968, SO37 USDA FOR SERV S, P14; Fuhlendorf SD, 2004, J APPL ECOL, V41, P604, DOI 10.1111/j.0021-8901.2004.00937.x; Garcia-Estringana P, 2010, J HYDROL, V389, P363, DOI 10.1016/j.jhydrol.2010.06.017; GASH JHC, 1979, Q J ROY METEOR SOC, V105, P43, DOI 10.1002/qj.49710544304; GASH JHC, 1978, J HYDROL, V38, P49, DOI 10.1016/0022-1694(78)90131-2; GILLIAM FS, 1987, SOUTHWEST NAT, V32, P267, DOI 10.2307/3671570; HERWITZ SR, 1986, EARTH SURF PROCESSES, V11, P401, DOI 10.1002/esp.3290110406; Klaassen W, 1998, J HYDROL, V212, P36, DOI 10.1016/S0022-1694(98)00200-5; Kramer I, 2009, ECOHYDROLOGY, V2, P102, DOI 10.1002/eco.44; Levia DF, 2005, CATENA, V64, P117, DOI 10.1016/j.catena.2005.08.001; Leyton L, 1967, P INT S FOR HYDR, P163; Li XY, 2009, HYDROL EARTH SYST SC, V13, P1133; Link TE, 2004, AGR FOREST METEOROL, V124, P171, DOI 10.1016/j.agrformet.2004.01.010; Liu SG, 1998, J HYDROL, V207, P32, DOI 10.1016/S0022-1694(98)00115-2; Llorens P, 2000, J HYDROL, V240, P131, DOI 10.1016/S0022-1694(00)00339-5; Llorens P, 2007, J HYDROL, V335, P37, DOI 10.1016/j.jhydrol.2006.10.032; Murakami S., 2009, HYDROLOGICAL RES LET, V3, P32, DOI [10.3178/HRL.3.32, DOI 10.3178/HRL.3.32, 10.3178/hrl.3.32]; Naito AT, 2011, PROG PHYS GEOG, V35, P423, DOI 10.1177/0309133311403538; Owens MK, 2006, HYDROL PROCESS, V20, P3179, DOI 10.1002/hyp.6326; Pypker TG, 2005, AGR FOREST METEOROL, V130, P113, DOI 10.1016/j.agrformet.2005.03.003; Qiao L, 2015, J HYDROL, V523, P231, DOI 10.1016/j.jhydrol.2015.01.056; Rodriguez-Iturbe I, 2000, WATER RESOUR RES, V36, P3, DOI 10.1029/1999WR900210; Scholes RJ, 1997, ANNU REV ECOL SYST, V28, P517, DOI 10.1146/annurev.ecolsys.28.1.517; SEASTEDT TR, 1985, OECOLOGIA, V66, P88, DOI 10.1007/BF00378557; Staelens J, 2008, HYDROL PROCESS, V22, P33, DOI 10.1002/hyp.6610; THUROW TL, 1987, J RANGE MANAGE, V40, P455, DOI 10.2307/3899611; Van Auken OW, 2000, ANNU REV ECOL SYST, V31, P197, DOI 10.1146/annurev.ecolsys.31.1.197; Yu KL, 2012, HYDROL PROCESS, V26, P3114, DOI 10.1002/hyp.8377; Zou CB, 2014, HYDROL PROCESS, V28, P6173, DOI 10.1002/hyp.10102	47	47	49	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141422	10.1371/journal.pone.0141422	http://dx.doi.org/10.1371/journal.pone.0141422			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544182	Green Published, gold, Green Submitted			2022-12-26	WOS:000364398700022
J	Biswas, A; Rahman, F; Eriksson, C; Halim, A; Dalal, K				Biswas, Animesh; Rahman, Fazlur; Eriksson, Charli; Halim, Abdul; Dalal, Koustuv			Facility Death Review of Maternal and Neonatal Deaths in Bangladesh	PLOS ONE			English	Review							LOW-RESOURCE SETTINGS; MORTALITY; AUDIT; IMPLEMENTATION; DISTRICTS; ACHIEVE; SENEGAL; HEALTH; CARE	Objectives To explore the experiences, acceptance, and effects of conducting facility death review (FDR) of maternal and neonatal deaths and stillbirths at or below the district level in Bangladesh. Methods This was a qualitative study with healthcare providers involved in FDRs. Two districts were studied: Thakurgaon district (a pilot district) and Jamalpur district (randomly selected from three follow-on study districts). Data were collected between January and November 2011. Data were collected from focus group discussions, in-depth interviews, and document review. Hospital administrators, obstetrics and gynecology consultants, and pediatric consultants and nurses employed in the same departments of the respective facilities participated in the study. Content and thematic analyses were performed. Results FDR for maternal and neonatal deaths and stillbirths can be performed in upazila health complexes at sub-district and district hospital levels. Senior staff nurses took responsibility for notifying each death and conducting death reviews with the support of doctors. Doctors reviewed the FDRs to assign causes of death. Review meetings with doctors, nurses, and health managers at the upazila and district levels supported the preparation of remedial action plans based on FDR findings, and interventions were planned accordingly. There were excellent examples of improved quality of care at facilities as a result of FDR. FDR also identified gaps and challenges to overcome in the near future to improve maternal and newborn health. Discussion FDR of maternal and neonatal deaths is feasible in district and upazila health facilities. FDR not only identifies the medical causes of a maternal or neonatal death but also explores remediable gaps and challenges in the facility. FDR creates an enabled environment in the facility to explore medical causes of deaths, including the gaps and challenges that influence mortality. FDRs mobilize health managers at upazila and district levels to forward plan and improve healthcare delivery.	[Biswas, Animesh; Eriksson, Charli; Dalal, Koustuv] Univ Orebro, Dept Publ Hlth Sci, Sch Hlth & Med Sci, SE-70182 Orebro, Sweden; [Biswas, Animesh; Rahman, Fazlur; Halim, Abdul] Bangladesh CIPRB, Ctr Injury Prevent & Res, Dhaka, Bangladesh	Orebro University	Biswas, A (corresponding author), Univ Orebro, Dept Publ Hlth Sci, Sch Hlth & Med Sci, SE-70182 Orebro, Sweden.	animesh@ciprb.org	Dalal, Koustuv/O-6737-2017; Biswas, Animesh/D-7011-2015	Dalal, Koustuv/0000-0001-7393-796X; 	UNICEF, Bangladesh through Canadian CIDA (Department of Foreign Affairs, Trade and Development); Department for International Development (DFID) & European Commission (EC)	UNICEF, Bangladesh through Canadian CIDA (Department of Foreign Affairs, Trade and Development); Department for International Development (DFID) & European Commission (EC)	Funded by UNICEF, Bangladesh through Canadian CIDA (Department of Foreign Affairs, Trade and Development) and Department for International Development (DFID) & European Commission (EC) to initiate the piloting.	Animesh Biswas, 2015, Healthmed, V9, P329; Armstrong CE, 2014, TROP MED INT HEALTH, V19, P1087, DOI 10.1111/tmi.12353; Biswas A., 2014, Health, V6, P1669, DOI 10.4236/health.2014.614198; Bowen GA, 2008, QUAL RES, V8, P137, DOI 10.1177/1468794107085301; Bryce J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-225; Dumont A, 2006, B WORLD HEALTH ORGAN, V84, P218, DOI 10.2471/BLT.05.023903; Dumont A, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-61; Gebrehiwot Y, 2014, INT J GYNECOL OBSTET, V127, pS29, DOI 10.1016/j.ijgo.2014.08.003; Goswami D, 2013, J OBSTET GYNAECOL RE, V39, P1569, DOI 10.1111/jog.12099; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Halim A, 2014, BJOG-INT J OBSTET GY, V121, P86, DOI 10.1111/1471-0528.13010; Hofman JJ, 2014, INT J GYNECOL OBSTET, V126, P111, DOI [10.1016/j.ijgo.2014.02.014, 10.1016/]; Kalter HD, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-41; Khanam R. A., 2009, J OBSTET GYNAECOLOGY, V24, P18; Koblinsky M, 2008, J HEALTH POPUL NUTR, V26, P280; Kongnyuy Eugene J, 2008, BMC Pregnancy Childbirth, V8, P42, DOI 10.1186/1471-2393-8-42; Kongnyuy EJ, 2009, WOMEN HEALTH ISS, V19, P14, DOI 10.1016/j.whi.2008.09.008; Lewis G, 2014, INT J GYNECOL OBSTET, V127, pS17, DOI 10.1016/j.ijgo.2014.07.007; Management Information System Directorate General of Health Services, 2014, HLTH B; ManceyJones M, 1997, HEALTH POLICY PLANN, V12, P183, DOI 10.1093/heapol/12.3.183; National Institute of Population Research and Training (NIPORT) Mitra and Associates and ICF International, 2015, BANDL DEM HLTH SURV; National Institute of Population Research and Training (NIPORT) UNC-CH ICDDR B ME, 2011, BANGL MAT MORT HLTH; Okonta PI, J OBSTET GYNAECOL, V22, P626; Osman H, 2009, ACTA OBSTET GYN SCAN, V88, P1338, DOI 10.3109/00016340903318014; Pearson L, 2009, INT J GYNECOL OBSTET, V106, P89, DOI 10.1016/j.ijgo.2009.04.009; Richard F, 2009, BJOG-INT J OBSTET GY, V116, P38, DOI 10.1111/j.1471-0528.2008.01741.x; Rowe AK, 2005, LANCET, V366, P1026, DOI 10.1016/S0140-6736(05)67028-6; Sridhar RP, 2015, INT J MAT CHILD HLTH, V3, P31; Supratikto G, 2002, B WORLD HEALTH ORGAN, V80, P228; Tanzin D, 2013, J OBSTET GYN INDIA, V63, P101, DOI 10.1007/s13224-012-0264-3; Unicef, 2013, CHILD MORT REP, P1; WHO, 2004, BR MED B, V67; WHO UNICEF UNFPA Bank W & UNDP, 2014, TRENDS MAT MORT 1990; World Health Organization, 2007, STRENGTHENING CAPACI, P10; World Health Organization, 2013, B WORLD HEAL, P128	35	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141902	10.1371/journal.pone.0141902	http://dx.doi.org/10.1371/journal.pone.0141902			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540233	Green Published, gold, Green Submitted			2022-12-26	WOS:000364303800035
J	Al Kazzi, ES; Lau, B; Li, TJ; Schneider, EB; Makary, MA; Hutfless, S				Al Kazzi, Elie S.; Lau, Brandyn; Li, Tianjing; Schneider, Eric B.; Makary, Martin A.; Hutfless, Susan			Differences in the Prevalence of Obesity, Smoking and Alcohol in the United States Nationwide Inpatient Sample and the Behavioral Risk Factor Surveillance System	PLOS ONE			English	Article							HEALTH; OUTCOMES; QUALITY; VALIDITY; RECORD	Background The lack of adequate and standardized recording of leading risk factors for morbidity and mortality in medical records have downstream effects on research based on administrative databases. The measurement of healthcare is increasingly based on risk-adjusted outcomes derived from coded comorbidities in these databases. However inaccurate or haphazard assessment of risk factors for morbidity and mortality in medical record codes can have tremendous implications for quality improvement and healthcare reform. Objective We aimed to compare the prevalence of obesity, overweight, tobacco use and alcohol abuse of a large administrative database with a direct data collection survey. Materials and Methods We used the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes for four leading risk factors in the United States Nationwide Inpatient Sample (NIS) to compare them with a direct survey in the Behavioral Risk Factor Surveillance System (BRFSS) in 2011. After confirming normality of the risk factors, we calculated the national and state estimates and Pearson's correlation coefficient for obesity, overweight, tobacco use and alcohol abuse between NIS and BRFSS. Results Compared with direct participant questioning in BRFSS, NIS reported substantially lower prevalence of obesity (p<0.01), overweight (p<0.01), and alcohol abuse (p<0.01), but not tobacco use (p = 0.18). The correlation between NIS and BRFSS was 0.27 for obesity (p = 0.06), 0.09 for overweight (p = 0.55), 0.62 for tobacco use (p<0.01) and 0.40 for alcohol abuse (p<0.01). Conclusions The prevalence of obesity, overweight, tobacco smoking and alcohol abuse based on codes is not consistent with prevalence based on direct questioning. The accuracy of these important measures of health and morbidity in databases is critical for healthcare reform policies.	[Al Kazzi, Elie S.; Hutfless, Susan] Johns Hopkins Univ, Sch Med, Dept Med, Div Gastroenterol & Hepatol, Baltimore, MD 21205 USA; [Lau, Brandyn; Schneider, Eric B.; Makary, Martin A.] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; [Lau, Brandyn] Johns Hopkins Univ, Sch Med, Div Hlth Sci Informat, Baltimore, MD USA; [Lau, Brandyn] Johns Hopkins Med, Armstrong Inst Patient Safety & Qual, Baltimore, MD USA; [Li, Tianjing; Hutfless, Susan] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Makary, Martin A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Hutfless, S (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Gastroenterol & Hepatol, Baltimore, MD 21205 USA.	shutfle1@jhmi.edu	Lau, Brandyn/H-4825-2018	Lau, Brandyn/0000-0003-3575-2440; Al Kazzi, Elie/0000-0002-9285-9108; Li, Tianjing/0000-0001-5371-4558	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001079] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR001079] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Adler-Milstein J, 2013, AM J MANAG CARE, V19, pE273; Agency for Healthcare Research and Quality, CREAT COM VAR COM VE; Agency for Healthcare Research and Quality, 2014, 2011 NIS SAS LOAD PR; Agency for Healthcare Research and Quality, 2012, PAT SAF IND PSI RISK; Agency for Healthcare Research and Quality, PAT SAF IND OV; Agency for Healthcare Research and Quality, INTR HCUP NAT INP SA; Agency for Healthcare Research and Quality, OV NAT INP SAMPL NIS; [Anonymous], 2011, COMM PUBL HLTH STRAT; [Anonymous], 2013, PCORI METH REP; Balasubramaniyam N, 2013, AM J MED, V126, DOI 10.1016/j.amjmed.2013.03.021; Belletti D, 2010, PATIENT-RELAT OUTCOM, V1, P29; Berthelsen C L, 2000, Top Health Inf Manage, V21, P10; Blumenthal D, 2015, JAMA-J AM MED ASSOC, V313, P1901, DOI 10.1001/jama.2015.4862; Bordowitz R, 2007, FAM MED, V39, P274; BOWLIN SJ, 1993, J CLIN EPIDEMIOL, V46, P561, DOI 10.1016/0895-4356(93)90129-O; CDC, 2011, OV BRFSS 2011; CDC, 2014, NAT HLTH NUTR EX SUR; Centers for Disease Control and Prevention (CDC), 2011, BEH RISK FACT SURV S; Centers for Disease Control and Prevention (CDC), 2014, 2011 BRFSS SAS LOAD; Centers for Disease Control and Prevention (CDC), 2011, 2011 BRFSS SAS FORM; Centers for Disease Control and Prevention (CDC), 2011, COMP DAT BRFSS; Centers for Medicare & Medicaid Services (CMS) HHS, 2012, Fed Regist, V77, P53967; Centers for Medicare & Medicaid Services (CMS) HHS, 2010, Fed Regist, V75, P44313; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Coles J, 2010, PROMS RISK ADJ METH; CORN RF, 1980, MED CARE, V18, P416, DOI 10.1097/00005650-198004000-00006; Courtney PK, 2011, CANCER J, V17, P219, DOI 10.1097/PPO.0b013e3182270c83; Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058; DEMLO LK, 1978, MED CARE, V16, P995, DOI 10.1097/00005650-197812000-00003; Dixon BE, 2013, STUD HEALTH TECHNOL, V192, P884, DOI 10.3233/978-1-61499-289-9-884; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Golinvaux NS, 2014, SPINE J, V14, P2923, DOI 10.1016/j.spinee.2014.04.025; Gologorsky Y, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2014.3.FOCUS1459; Gupta T, 2014, AM J CARDIOL, V114, P169, DOI 10.1016/j.amjcard.2014.04.021; Hertzer NR, 2012, J VASC SURG, V55, P263, DOI 10.1016/j.jvs.2011.08.059; [HHS Centers for Medicare & Medicaid Services (CMS)], 2015, CMS ANN ENT INN ACC; [HHS Centers for Medicare & Medicaid Services (CMS)], 2013, OUTC MEAS; Hogan R W, 1993, HMO Pract, V7, P54; Hu SS, 2011, PREV CHRONIC DIS, V8; Iezzoni LI, 2004, AM J PHYS MED REHAB, V83, P316, DOI 10.1097/01.PHM.0000118041.17739.BB; James AH, 2006, CIRCULATION, V113, P1564, DOI 10.1161/CIRCULATIONAHA.105.576751; Kindig D, 2003, AM J PUBLIC HEALTH, V93, P380, DOI 10.2105/AJPH.93.3.380; Li TJ, 2014, J CLIN EPIDEMIOL, V67, P15, DOI 10.1016/j.jclinepi.2013.08.013; Lindenmayer DB, 2013, NATURE, V499, P284, DOI 10.1038/499284d; MCGINNIS JM, 1993, JAMA-J AM MED ASSOC, V270, P2207, DOI 10.1001/jama.270.18.2207; McGinnis JM, 2002, HEALTH AFFAIR, V21, P78, DOI 10.1377/hlthaff.21.2.78; O'Malley KJ, 2005, HEALTH SERV RES, V40, P1620, DOI 10.1111/j.1475-6773.2005.00444.x; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Quan H, 2004, MED CARE, V42, P801, DOI 10.1097/01.mlr.0000132391.59713.0d; Rajaram R, 2015, JAMA-J AM MED ASSOC, V313, P897, DOI 10.1001/jama.2015.52; ROMANO PS, 1994, MED CARE, V32, P81, DOI 10.1097/00005650-199401000-00006; Tai B, 2012, SUBST ABUSE REHABIL, V3, P1, DOI 10.2147/SAR.S22575; Trust for America's Health and Robert Wood Johnson Foundation, 2012, F FAT OB THREAT AM F; Zeng Xiaoming, 2011, Perspect Health Inf Manag, V8, p1b	54	40	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140165	10.1371/journal.pone.0140165	http://dx.doi.org/10.1371/journal.pone.0140165			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV5GZ	26536469	Green Published, Green Submitted, gold			2022-12-26	WOS:000364298400019
J	Ebersole, B; Petko, J; Woll, M; Murakami, S; Sokolina, K; Wong, V; Stagljar, I; Luscher, B; Levenson, R				Ebersole, Brittany; Petko, Jessica; Woll, Matthew; Murakami, Shoko; Sokolina, Kate; Wong, Victoria; Stagljar, Igor; Luescher, Bernhard; Levenson, Robert			Effect of C-Terminal S-Palmitoylation on D2 Dopamine Receptor Trafficking and Stability	PLOS ONE			English	Article							22Q11 DELETION SYNDROME; PROTEIN PALMITOYLATION; DIFFERENTIAL REGULATION; GABA(A) RECEPTORS; MAMMALIAN-CELLS; FATTY-ACYLATION; SPLIT-UBIQUITIN; MOUSE MODEL; SCHIZOPHRENIA; LOCALIZATION	We have used bioorthogonal click chemistry (BCC), a sensitive non-isotopic labeling method, to analyze the palmitoylation status of the D2 dopamine receptor (D2R), a G protein-coupled receptor (GPCR) crucial for regulation of processes such as mood, reward, and motor control. By analyzing a series of D2R constructs containing mutations in cysteine residues, we found that palmitoylation of the D2R most likely occurs on the C-terminal cysteine residue (C443) of the polypeptide. D2Rs in which C443 was deleted showed significantly reduced palmitoylation levels, plasma membrane expression, and protein stability compared to wild-type D2Rs. Rather, the C443 deletion mutant appeared to accumulate in the Golgi, indicating that palmitoylation of the D2R is important for cell surface expression of the receptor. Using the full-length D2R as bait in a membrane yeast two-hybrid (MYTH) screen, we identified the palmitoyl acyltransferase (PAT) zDHHC4 as a D2R interacting protein. Co-immunoprecipitation analysis revealed that several other PATs, including zDHHC3 and zDHHC8, also interacted with the D2R and that each of the three PATs was capable of affecting the palmitoylation status of the D2R. Finally, biochemical analyses using D2R mutants and the palmitoylation blocker, 2-bromopalmitate indicate that palmitoylation of the receptor plays a role in stability of the D2R.	[Ebersole, Brittany; Petko, Jessica; Woll, Matthew; Levenson, Robert] Penn State Coll Med, Dept Pharmacol, Hershey, PA 17033 USA; [Murakami, Shoko; Luescher, Bernhard] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Sokolina, Kate; Wong, Victoria; Stagljar, Igor] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Wong, Victoria; Stagljar, Igor] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Luescher, Bernhard] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Luescher, Bernhard] Penn State Univ, Ctr Mol Invest Neurol Disorders, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Toronto; University of Toronto; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Levenson, R (corresponding author), Penn State Coll Med, Dept Pharmacol, Hershey, PA 17033 USA.	rlevenson@hmc.psu.edu	Luscher, Bernhard/C-3528-2009	Luscher, Bernhard/0000-0003-1375-1906; Levenson, Robert/0000-0002-0936-8421	National Institute on Drug Abuse (NIDA) [DA035608]; CURE grant from the Pennsylvania Department of Health using Tobacco Settlement Funds; National Institutes of Health (NIH) [MH62391]; NATIONAL INSTITUTE OF MENTAL HEALTH [R56MH062391, R01MH099851, R01MH062391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA035608] Funding Source: NIH RePORTER	National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); CURE grant from the Pennsylvania Department of Health using Tobacco Settlement Funds; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding: This work was supported by a grant from the National Institute on Drug Abuse (NIDA, DA035608) to R.L., a CURE grant to R.L. from the Pennsylvania Department of Health using Tobacco Settlement Funds and a grant from the National Institutes of Health (NIH, MH62391) to B.L. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassett AS, 2003, AM J PSYCHIAT, V160, P1580, DOI 10.1176/appi.ajp.160.9.1580; Bearden CE, 2001, J CLIN EXP NEUROPSYC, V23, P447, DOI 10.1076/jcen.23.4.447.1228; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Bhattacharyya R, 2013, J NEUROSCI, V33, P11169, DOI 10.1523/JNEUROSCI.4704-12.2013; Charollais J, 2009, MOL MEMBR BIOL, V26, P55, DOI 10.1080/09687680802620369; Charron G, 2009, J AM CHEM SOC, V131, P4967, DOI 10.1021/ja810122f; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chini B, 2009, J MOL ENDOCRINOL, V42, P371, DOI 10.1677/JME-08-0114; Chow EWC, 2006, SCHIZOPHR RES, V87, P270, DOI 10.1016/j.schres.2006.04.007; Citrome L, 2014, J CLIN PSYCHIAT, V75, P21, DOI 10.4088/JCP.13049su1c.04; Conibear E, 2010, J CELL SCI, V123, P4007, DOI 10.1242/jcs.059287; DALTOSO R, 1989, EMBO J, V8, P4025, DOI 10.1002/j.1460-2075.1989.tb08585.x; Dalva MB, 2009, J CELL BIOL, V186, P7, DOI 10.1083/jcb.200906101; Dietrich LEP, 2004, EMBO REP, V5, P1053, DOI 10.1038/sj.embor.7400277; Drisdel RC, 2006, METHODS, V40, P127, DOI 10.1016/j.ymeth.2006.04.015; Ebersole B, 2014, ANAL BIOCHEM, V451, P25, DOI 10.1016/j.ab.2014.01.008; Fang C, 2006, J NEUROSCI, V26, P12758, DOI 10.1523/JNEUROSCI.4214-06.2006; Fiorentini C, 2008, MOL PHARMACOL, V74, P59, DOI 10.1124/mol.107.043885; Fukushima Y, 2001, BBA-MOL CELL RES, V1539, P181, DOI 10.1016/S0167-4889(01)00104-5; GIROS B, 1989, NATURE, V342, P923, DOI 10.1038/342923a0; Greaves J, 2011, TRENDS BIOCHEM SCI, V36, P245, DOI 10.1016/j.tibs.2011.01.003; Greaves J, 2010, J BIOL CHEM, V285, P24629, DOI 10.1074/jbc.M110.119289; Grunewald S, 1996, BIOCHEMISTRY-US, V35, P15149, DOI 10.1021/bi9607564; Guo W, 2003, J BIOL CHEM, V278, P4385, DOI 10.1074/jbc.C200679200; Hannoush AN, 2010, NAT CHEM BIOL, V6, P498, DOI [10.1038/NCHEMBIO.388, 10.1038/nchembio.388]; Hayashi T, 2005, NEURON, V47, P709, DOI 10.1016/j.neuron.2005.06.035; Hayashi T, 2009, NEURON, V64, P213, DOI 10.1016/j.neuron.2009.08.017; Hines RM, 2010, J BIOL CHEM, V285, P4621, DOI 10.1074/jbc.M109.069849; Huang K, 2010, NEUROBIOL DIS, V40, P207, DOI 10.1016/j.nbd.2010.05.027; Karam CS, 2010, TRENDS PHARMACOL SCI, V31, P381, DOI 10.1016/j.tips.2010.05.004; KARAYIORGOU P, 1995, P NATL ACAD SCI USA, V92, P7612, DOI 10.1073/pnas.92.17.7612; KARNIK SS, 1993, P NATL ACAD SCI USA, V90, P40, DOI 10.1073/pnas.90.1.40; Karpa KD, 1999, MOL PHARMACOL, V56, P1071, DOI 10.1124/mol.56.5.1071; Keller CA, 2004, J NEUROSCI, V24, P5881, DOI 10.1523/JNEUROSCI.1037-04.2004; Kumari B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089246; Lin R, 2005, USE YEAST 2 HYBRID S; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Maeda A, 2010, P NATL ACAD SCI USA, V107, P8428, DOI 10.1073/pnas.1000640107; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Mitchell DA, 2006, J LIPID RES, V47, P1118, DOI 10.1194/jlr.R600007-JLR200; MONSMA FJ, 1989, NATURE, V342, P926, DOI 10.1038/342926a0; Mukai J, 2004, NAT GENET, V36, P725, DOI 10.1038/ng1375; Mukai J, 2008, NAT NEUROSCI, V11, P1302, DOI 10.1038/nn.2204; NG GYK, 1994, J NEUROCHEM, V63, P1589; Ohno Y, 2006, BBA-MOL CELL BIOL L, V1761, P474, DOI 10.1016/j.bbalip.2006.03.010; Percherancier Y, 2001, J BIOL CHEM, V276, P31936, DOI 10.1074/jbc.M104013200; Petko J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067608; PULVER AE, 1994, J NERV MENT DIS, V182, P476, DOI 10.1097/00005053-199408000-00010; Qanbar R, 2003, PHARMACOL THERAPEUT, V97, P1, DOI 10.1016/S0163-7258(02)00300-5; Resh Marilyn D, 2006, Sci STKE, V2006, pre14, DOI 10.1126/stke.3592006re14; Resh MD, 2004, SUB CELL BIOCHEM, V37, P217; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Schulein R, 1996, J BIOL CHEM, V271, P28844, DOI 10.1074/jbc.271.46.28844; Seeman P, 2011, CNS NEUROSCI THER, V17, P118, DOI 10.1111/j.1755-5949.2010.00162.x; Sensoy O, 2015, BBA-BIOMEMBRANES, V1848, P976, DOI 10.1016/j.bbamem.2014.12.002; Sharma C, 2008, MOL BIOL CELL, V19, P3415, DOI 10.1091/mbc.E07-11-1164; Sobin C, 2005, CHILD NEUROPSYCHOL, V11, P39, DOI 10.1080/09297040590911167; Stagljar I, 1998, P NATL ACAD SCI USA, V95, P5187, DOI 10.1073/pnas.95.9.5187; Takeuchi Y, 2003, J NEUROCHEM, V85, P1064, DOI 10.1046/j.1471-4159.2003.01763.x; Thaminy S, 2003, GENOME RES, V13, P1744, DOI 10.1101/gr.1276503; Thomas GM, 2012, NEURON, V73, P482, DOI 10.1016/j.neuron.2011.11.021; Tian LJ, 2010, J BIOL CHEM, V285, P23954, DOI 10.1074/jbc.M110.137802; Tobin Andrew B, 2004, Methods Mol Biol, V259, P275; Usiello A, 2000, NATURE, V408, P199, DOI 10.1038/35041572; Vickery RG, 1999, J CELL BIOL, V144, P31, DOI 10.1083/jcb.144.1.31; Woodin M, 2001, GENET MED, V3, P34, DOI 10.1097/00125817-200101000-00008; Zhang J, 2008, MOL CELL PROTEOMICS, V7, P1378, DOI 10.1074/mcp.M800069-MCP200; ZHU HY, 1995, MOL ENDOCRINOL, V9, P141, DOI 10.1210/me.9.2.141; Zuckerman DM, 2011, J BIOL CHEM, V286, P19014, DOI 10.1074/jbc.M110.189977	70	26	26	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140661	10.1371/journal.pone.0140661	http://dx.doi.org/10.1371/journal.pone.0140661			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26535572	Green Published, Green Submitted, gold			2022-12-26	WOS:000364298400031
J	Feng, HS; Chai, NL; Dong, WH				Feng, Huashan; Chai, Ningli; Dong, Wenhao			Experimental Investigation on the Morphology and Adhesion Mechanism of Leech Posterior Suckers	PLOS ONE			English	Article							HIRUDO-MEDICINALIS; ARRAYS; KNEE	The posterior sucker of a leech represents a fascinating natural system that allows the leech to adhere to different terrains and substrates. However, the mechanism of adhesion and desorption has not yet to be elucidated. In order to better understand how the adhesion is performed, we analyzed the surface structure, adsorption movements, the muscles' distribution, physical characteristics, and the adsorption force of the leech posterior suckers by experimental investigation. Three conclusions can be drawn based on the obtained experimental results. First, the adhesion by the posterior sucker is wet adhesion, because the surface of the posterior sucker is smooth and the sealing can only be achieved on wet surfaces. Second, the deformation texture, consisting of soft collagen tissues and highly ductile epidermal tissues, plays a key role in adhering to rough surfaces. Finally, the adhesion and desorption is achieved by the synergetic operation of six muscle fibers working in different directions. Concrete saying, directional deformation of the collagen/epithermal interface driven by spatially-distributed muscle fibers facilitates the excretion of fluids in the sucker venter, thus allowing liquid sealing. Furthermore, we found that the adhesion strength is directly related to the size of the contact surface which is generated and affected by the sucker deformation. Such an underlying physical mechanism offers potential cues for developing innovative bio-inspired artificial adhesion systems.	[Feng, Huashan; Dong, Wenhao] Northwestern Polytech Univ, Sch Mech Engn, Xian 710072, Peoples R China; [Chai, Ningli] Chinese Peoples Liberat Army Gen Hosp, Dept Gastroenterol, Beijing, Peoples R China	Northwestern Polytechnical University; Chinese People's Liberation Army General Hospital	Chai, NL (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Gastroenterol, Beijing, Peoples R China.	csxlily@163.com			National Natural Science Foundation of China [81270564]; Northwestern Polytechnical University [Z2014008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Northwestern Polytechnical University	Funding: This project was supported by the National Natural Science Foundation of China (Grant No. 81270564) and graduate starting seed funding from Northwestern Polytechnical University (Z2014008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksak B, 2007, LANGMUIR, V23, P3322, DOI 10.1021/la062697t; Amend JR, 2012, IEEE T ROBOT, V28, P341, DOI 10.1109/TRO.2011.2171093; Asbeck AT, 2006, INT J ROBOT RES, V25, P1165, DOI 10.1177/0278364906072511; Busaba P, 2013, J VET SCI, V14, P425; Fie L., 2003, J CHINESE ELECT MICR, V22, P669; He B, 2013, OSTEOARTHR CARTILAGE, V21, P237, DOI 10.1016/j.joca.2012.10.008; Menciassi A, 2003, PHILOS T R SOC A, V361, P2287, DOI 10.1098/rsta.2003.1255; Michalsen A, 2002, ALTERN THER HEALTH M, V8, P84; Orevi M, 2000, J ZOOL, V250, P121, DOI 10.1111/j.1469-7998.2000.tb00583.x; Peter Z, 2001, U TORONTO MED J, V79, P65; Qiao N, 2015, SICHUAN J ZOOLOGY, V32, P526; Schliemann Harald, 2011, Verhandlungen des Naturwissenschaftlichen Vereins in Hamburg, P313; STERNTOMLINSON W, 1986, J COMP PHYSIOL A, V158, P593, DOI 10.1007/BF00603803; Takashi M., 2013, THESIS, P1120; Tang X-M, 2001, J CHIN ELECT MICROSC, V20, P217; Teut M, 2008, FORSCH KOMPLEMENTMED, V15, P269, DOI 10.1159/000158875; Tian JH, 2007, J COMP PHYSIOL A, V193, P1205, DOI 10.1007/s00359-007-0278-y; Tramacere F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065074; Yang T, 2001, B BIOL FR BELG, V36, P8	19	12	12	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140776	10.1371/journal.pone.0140776	http://dx.doi.org/10.1371/journal.pone.0140776			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536352	Green Submitted, Green Published, gold			2022-12-26	WOS:000364298400036
J	Fernandez-Guizan, A; Lopez-Soto, A; Acebes-Huerta, A; Huergo-Zapico, L; Villa-Alvarez, M; Nunez, LE; Moris, F; Gonzalez, S				Fernandez-Guizan, Azahara; Lopez-Soto, Alejandro; Acebes-Huerta, Andrea; Huergo-Zapico, Leticia; Villa-Alvarez, Monica; Nunez, Luz-Elena; Moris, Francisco; Gonzalez, Segundo			Pleiotropic Anti-Angiogenic and Anti-Oncogenic Activities of the Novel Mithralog Demycarosyl-3D-beta-D-Digitoxosyl-Mithramycin SK (EC-8042)	PLOS ONE			English	Article							TRANSCRIPTION FACTOR SP1; HUMAN GASTRIC-CANCER; TUMOR ANGIOGENESIS; COMBINATORIAL BIOSYNTHESIS; ANTIANGIOGENIC THERAPY; MITHRAMYCIN ANALOG; PANCREATIC-CANCER; FACTOR EXPRESSION; VEGF EXPRESSION; DOWN-REGULATION	Demycarosyl-3D-beta-D-digitoxosyl-mithramycin SK (DIG-MSK) is a recently isolated analogue of mithramycin A (MTA) that showed differences with MTA in the DNA binding strength and selectivity. These differences correlated with a better therapeutic index and less toxicity in animal studies. Herein, we show that DIG-MSK displays a potent anti-tumor activity against different types of cancer cell lines, ovarian tumor cells being particularly sensitive to this drug. Of relevance, DIG-MSK exerts low toxicity on fibroblasts and peripheral blood mononuclear cells, this toxicity being significantly lower than that of MTA. In correlation with its antitumor activity, DIG-MSK strongly inhibited Sp1-mediated transcription and endogenous Sp1 mRNA expression, which correlated with the inhibition of the expression of key Sp1-regulated genes involved in tumorigenesis, including VEGFA, BCL2L1 (Bcl-XL), hTERT, BRCA2, MYC and SRC in several ovarian cells. Significantly, DIG-MSK was a stronger inhibitor of VEGFA expression than MTA. Accordingly, DIG-MSK also exhibited potent anti-angiogenic activity on microvascular endothelial cells. Likewise, it significantly inhibited the gene expression of VEGFR1, VEGFR2, FGFR, PDGFB and PDGFRA and, additionally, it induced the expression of the anti-angiogenic factors angiostatin and tunstatin. These effects correlated with a pro-apoptotic effect on proliferating microvascular endothelial cells and the inhibition of the formation of endothelial capillary structures. Overall, the pleiotropic activity of DIG-MSK in inhibiting key oncogenic and angiogenic pathways, together with its low toxicity profile, highlight the therapeutic potential of this new drug.	[Fernandez-Guizan, Azahara; Lopez-Soto, Alejandro; Acebes-Huerta, Andrea; Huergo-Zapico, Leticia; Villa-Alvarez, Monica; Gonzalez, Segundo] Univ Oviedo, Dept Funct Biol, IUOPA, Oviedo, Spain; [Lopez-Soto, Alejandro] Hosp Univ Cent Asturias, Dept Immunol, Oviedo, Spain; [Nunez, Luz-Elena; Moris, Francisco] EntreChem SL, Oviedo 33006, Spain	University of Oviedo; Instituto Universitario de Oncologia de Asturias; Central University Hospital Asturias	Gonzalez, S (corresponding author), Univ Oviedo, Dept Funct Biol, IUOPA, Oviedo, Spain.	segundog@uniovi.es	Acebes-Huerta, Andrea/AAA-8004-2020; Gonzalez, Segundo/AAK-8719-2021; López-Soto, Alejandro/A-9779-2018; Huergo-Zapico, Leticia/S-5863-2018	Acebes-Huerta, Andrea/0000-0002-7106-3063; Gonzalez, Segundo/0000-0003-4631-9255; López-Soto, Alejandro/0000-0002-6360-5205; Huergo-Zapico, Leticia/0000-0001-9942-1144	Instituto de Salud Carlos III [PI12/01280]; FEDER program of the European Community; Principado de Asturias Government through PCTI funds; FEDER Operative Program of the Principado de Asturias [FC-11-PC-10-31]; Instituto de Salud Carlos III	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); FEDER program of the European Community(European Commission); Principado de Asturias Government through PCTI funds; FEDER Operative Program of the Principado de Asturias; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	Funding: This work has been funded by the grant PI12/01280 from the Instituto de Salud Carlos III and the FEDER program of the European Community. It was also supported by the Principado de Asturias Government through PCTI funds 2006-2009, co-financed with the FEDER Operative Program of the Principado de Asturias 2007-2013 (project FC-11-PC-10-31). A.L.S. holds a Sara Borrell fellowship from the Instituto de Salud Carlos III. The drugs MTA and DIG-MSK were provided by the company EntreChem (http://entrechem.com/es/about_us/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. EntreChem provided support in the form of salaries for authors LEN and FM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Allegra CJ, 2011, J CLIN ONCOL, V29, P11, DOI 10.1200/JCO.2010.30.0855; Barcelo F, 2010, BIOCHEMISTRY-US, V49, P10543, DOI 10.1021/bi101398s; Beishline K, 2014, FEBS J; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Cho SG, 2009, CANCER RES, V69, P7062, DOI 10.1158/0008-5472.CAN-09-0476; Deacon K, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.397042; DeVita V. T., 2005, CANC PRINCIPLES PRAC; Ebos JML, 2011, NAT REV CLIN ONCOL, V8, P210, DOI 10.1038/nrclinonc.2011.21; Fernandez-Guizan A, 2014, CHEM-BIOL INTERACT, V219, P123, DOI 10.1016/j.cbi.2014.05.019; Ferrara N, 2002, NAT REV CANCER, V2, P795, DOI 10.1038/nrc909; Gao Y, 2011, CANCER RES, V71, P5182, DOI 10.1158/0008-5472.CAN-10-2016; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Jia ZL, 2007, CANCER RES, V67, P4878, DOI 10.1158/0008-5472.CAN-06-3494; Jiang YX, 2004, CLIN EXP METASTAS, V21, P755, DOI 10.1007/s10585-005-1198-2; Kerbel R, 2002, NAT REV CANCER, V2, P727, DOI 10.1038/nrc905; Koh YJ, 2010, CANCER CELL, V18, P171, DOI 10.1016/j.ccr.2010.07.001; Kubota Yoshiaki, 2012, Keio Journal of Medicine, V61, P47; Li L, 2010, ANN ANAT, V192, P275, DOI 10.1016/j.aanat.2010.07.010; Lombo F, 2006, APPL MICROBIOL BIOT, V73, P1, DOI 10.1007/s00253-006-0511-6; Lopez-Soto A, 2009, ONCOGENE, V28, P2370, DOI 10.1038/onc.2009.117; Lopez-Soto A, 2006, J BIOL CHEM, V281, P30419, DOI 10.1074/jbc.M604868200; Lou Z, 2005, CANCER RES, V65, P1007; Mendez C, 2015, PLANTA MED IN PRESS; Murakami M, 2008, CURR OPIN HEMATOL, V15, P215, DOI 10.1097/MOH.0b013e3282f97d98; Nunez LE, 2012, J MED CHEM, V55, P5813, DOI 10.1021/jm300234t; Otjacques E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062818; Rodriguez-Rodero S, 2007, EUR J IMMUNOL, V37, P1938, DOI 10.1002/eji.200737031; Safe S, 2005, EUR J CANCER, V41, P2438, DOI 10.1016/j.ejca.2005.08.006; Safe S, 2014, EXPERT OPIN THER TAR, V18, P759, DOI 10.1517/14728222.2014.914173; Schwarzmayr L, 2008, INT J BIOCHEM CELL B, V40, P2845, DOI 10.1016/j.biocel.2008.06.001; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Wang HW, 2010, LIFE SCI, V86, P185, DOI 10.1016/j.lfs.2009.11.023; Wang LW, 2008, INT J ONCOL, V33, P161; Yao JC, 2004, CLIN CANCER RES, V10, P4109, DOI 10.1158/1078-0432.CCR-03-0628; Yuan P, 2007, CANCER-AM CANCER SOC, V110, P2682, DOI 10.1002/cncr.23092	37	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140786	10.1371/journal.pone.0140786	http://dx.doi.org/10.1371/journal.pone.0140786			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536461	gold, Green Submitted, Green Published			2022-12-26	WOS:000364298400037
J	Fujita, S; Ushio, S; Ozawa, N; Masuguchi, K; Kawashiri, T; Oishi, R; Egashira, N				Fujita, Shunsuke; Ushio, Soichiro; Ozawa, Nana; Masuguchi, Ken; Kawashiri, Takehiro; Oishi, Ryozo; Egashira, Nobuaki			Exenatide Facilitates Recovery from Oxaliplatin-Induced Peripheral Neuropathy in Rats	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; ROOT GANGLION NEURONS; INDUCED MECHANICAL ALLODYNIA; DOPAMINERGIC-NEURONS; RECEPTOR AGONIST; ANIMAL-MODEL; EXENDIN-4; NEUROPROTECTION; INVOLVEMENT; ACTIVATION	Background Oxaliplatin has widely been used as a key drug in the treatment of colorectal cancer; however, it causes peripheral neuropathy. Exenatide, a glucagon-like peptide-1 (GLP-1) agonist, is an incretin mimetic secreted from ileal L cells, which is clinically used to treat type 2 diabetes mellitus. GLP-1 receptor agonists have been reported to exhibit neuroprotective effects on the central and peripheral nervous systems. In this study, we investigated the effects of exenatide on oxaliplatin-induced neuropathy in rats and cultured cells. Methods Oxaliplatin (4 mg/kg) was administered intravenously twice per week for 4 weeks, and mechanical allodynia was evaluated using the von Frey test in rats. Axonal degeneration was assessed by toluidine blue staining of sciatic nerves. Results Repeated administration of oxaliplatin caused mechanical allodynia from day 14 to 49. Although the co-administration of extended-release exenatide (100 mu g/kg) could not inhibit the incidence of oxaliplatin-induced mechanical allodynia, it facilitated recovery from the oxaliplatin-induced neuropathy with reparation of axonal degeneration. Inhibition of neurite outgrowth was evaluated in cultured pheochromocytoma 12 (PC12) cells. Exenatide inhibited oxaliplatin-induced neurite degeneration, but did not affect oxaliplatin-induced cell injury in cultured PC12 cells. Additionally, extended-release exenatide had no effect on the anti-tumor activity of oxaliplatin in cultured murine colon adenocarcinoma 26 (C-26) cells or C-26 cell-implanted mice. Conclusion These results suggest that exenatide may be useful for treating peripheral neuropathy induced by oxaliplatin in colorectal cancer patients with type 2 diabetes.	[Fujita, Shunsuke; Ushio, Soichiro; Ozawa, Nana; Masuguchi, Ken; Kawashiri, Takehiro; Oishi, Ryozo; Egashira, Nobuaki] Kyushu Univ Hosp, Dept Pharm, Fukuoka 812, Japan	Kyushu University	Egashira, N (corresponding author), Kyushu Univ Hosp, Dept Pharm, Fukuoka 812, Japan.	n-egashi@pharm.med.kyushu-u.ac.jp	Egashira, Nobuaki/AAT-4183-2021	Kawashiri, Takehiro/0000-0002-7708-2855; Ushio, Soichiro/0000-0003-4365-7857	JSPS KAKENHI [25460335, 25870496]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Numbers 25460335 and 25870496 (https://www.jsps.go.jp/j-grantsinaid/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belsham DD, 2009, FASEB J, V23, P4256, DOI 10.1096/fj.09-133454; Benoit E, 2006, GEN PHYSIOL BIOPHYS, V25, P263; Cavaletti G, 2001, EUR J CANCER, V37, P2457, DOI 10.1016/S0959-8049(01)00300-8; Dalvi PS, 2012, ENDOCRINOLOGY, V153, P2208, DOI 10.1210/en.2011-1795; During MJ, 2003, NAT MED, V9, P1173, DOI 10.1038/nm919; Eakin K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082016; Fu Z, 2012, PEPTIDES, V37, P25, DOI 10.1016/j.peptides.2012.06.006; Gong N, 2014, J NEUROSCI, V34, P5322, DOI 10.1523/JNEUROSCI.4703-13.2014; Graham MA, 2000, CLIN CANCER RES, V6, P1205; Grothey Axel, 2005, Clin Colorectal Cancer, V5 Suppl 1, pS38, DOI 10.3816/CCC.2005.s.006; Hershman DL, 2014, J CLIN ONCOL, V32, P1941, DOI 10.1200/JCO.2013.54.0914; Himeno T, 2011, DIABETES, V60, P2397, DOI 10.2337/db10-1462; Jamieson SMF, 2005, CANCER CHEMOTH PHARM, V56, P391, DOI 10.1007/s00280-004-0953-4; Kagiava A, 2008, NEUROTOXICOLOGY, V29, P1100, DOI 10.1016/j.neuro.2008.09.005; Kan M, 2012, J NEUROPATH EXP NEUR, V71, P494, DOI 10.1097/NEN.0b013e3182580673; Kawashiri T, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-7; Kawashiri T, 2011, EUR J PAIN, V15, P344, DOI 10.1016/j.ejpain.2010.08.006; Kim S, 2009, J ENDOCRINOL, V202, P431, DOI 10.1677/JOE-09-0132; Land SR, 2007, J CLIN ONCOL, V25, P2205, DOI 10.1200/JCO.2006.08.6652; Li HT, 2015, INT J CLIN EXP PATHO, V8, P4837; Li YZ, 2009, P NATL ACAD SCI USA, V106, P1285, DOI 10.1073/pnas.0806720106; Liu WJ, 2011, BRIT J PHARMACOL, V164, P1410, DOI 10.1111/j.1476-5381.2011.01272.x; Lolignier S, 2015, CELL REP, V11, P1067, DOI 10.1016/j.celrep.2015.04.027; Mannelli LD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128080; Mannelli LD, 2014, EXP NEUROL, V261, P22, DOI 10.1016/j.expneurol.2014.06.016; Mannelli LD, 2014, NEUROPHARMACOLOGY, V79, P37, DOI 10.1016/j.neuropharm.2013.10.034; Mihara Y, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-8; Pasetto LM, 2006, CRIT REV ONCOL HEMAT, V59, P159, DOI 10.1016/j.critrevonc.2006.01.001; Perry T, 2002, J PHARMACOL EXP THER, V300, P958, DOI 10.1124/jpet.300.3.958; Perry T, 2007, EXP NEUROL, V203, P293, DOI 10.1016/j.expneurol.2006.09.028; Rachmany L, 2013, AGE, V35, P1621, DOI 10.1007/s11357-012-9464-0; Ramanathan RK, 2010, ANN ONCOL, V21, P754, DOI 10.1093/annonc/mdp509; Robinson CR, 2014, NEUROSCIENCE, V274, P308, DOI 10.1016/j.neuroscience.2014.05.051; Saif M Wasif, 2005, Ther Clin Risk Manag, V1, P249; Sakurai M, 2009, PAIN, V147, P165, DOI 10.1016/j.pain.2009.09.003; Scuteri A, 2010, NEUROSCI LETT, V486, P141, DOI 10.1016/j.neulet.2010.09.028; Scuteri A, 2009, NEUROTOXICOLOGY, V30, P312, DOI 10.1016/j.neuro.2009.01.003; Shirahama M, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-26; Ta LE, 2006, NEUROTOXICOLOGY, V27, P992, DOI 10.1016/j.neuro.2006.04.010; Teramoto S, 2011, J CEREBR BLOOD F MET, V31, P1696, DOI 10.1038/jcbfm.2011.51; Tsukamoto M, 2015, HISTOCHEM CELL BIOL, V144, P249, DOI 10.1007/s00418-015-1333-3; Tsutsumi K, 2014, NEUROSCI RES, V80, P86, DOI 10.1016/j.neures.2014.02.004; Ushio S, 2012, EUR J CANCER, V48, P1407, DOI 10.1016/j.ejca.2011.08.009; Velmurugan K, 2012, J NEUROCHEM, V123, P919, DOI 10.1111/jnc.12036; Vincenzi B, 2013, SUPPORT CARE CANCER, V21, P1313, DOI 10.1007/s00520-012-1667-5; Wilson RH, 2002, J CLIN ONCOL, V20, P1767, DOI 10.1200/JCO.2002.07.056; Xiong H, 2013, J ALZHEIMERS DIS, V37, P623, DOI 10.3233/JAD-130584; Yamamoto K, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/315848; Yoon SY, 2013, J PAIN, V14, P205, DOI 10.1016/j.jpain.2012.11.002; Zhao M, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-55; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	51	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141921	10.1371/journal.pone.0141921	http://dx.doi.org/10.1371/journal.pone.0141921			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536615	Green Published, gold, Green Submitted			2022-12-26	WOS:000364298400102
J	Kong, XZ; Liu, ZG; Huang, LJ; Wang, X; Yang, ZT; Zhou, GF; Zhen, ZL; Liu, J				Kong, Xiang-zhen; Liu, Zhaoguo; Huang, Lijie; Wang, Xu; Yang, Zetian; Zhou, Guangfu; Zhen, Zonglei; Liu, Jia			Mapping Individual Brain Networks Using Statistical Similarity in Regional Morphology from MRI	PLOS ONE			English	Article							SMALL-WORLD NETWORKS; GRAPH-THEORETICAL ANALYSIS; VOXEL-BASED MORPHOMETRY; HUMAN CORTICAL NETWORKS; ALZHEIMERS-DISEASE; CEREBRAL-CORTEX; RESTING-STATE; FUNCTIONAL CONNECTIVITY; MODULAR ORGANIZATION; TOPOLOGICAL PATTERNS	Representing brain morphology as a network has the advantage that the regional morphology of 'isolated' structures can be described statistically based on graph theory. However, very few studies have investigated brain morphology from the holistic perspective of complex networks, particularly in individual brains. We proposed a new network framework for individual brain morphology. Technically, in the new network, nodes are defined as regions based on a brain atlas, and edges are estimated using our newly-developed inter-regional relation measure based on regional morphological distributions. This implementation allows nodes in the brain network to be functionally/anatomically homogeneous but different with respect to shape and size. We first demonstrated the new network framework in a healthy sample. Thereafter, we studied the graph-theoretical properties of the networks obtained and compared the results with previous morphological, anatomical, and functional networks. The robustness of the method was assessed via measurement of the reliability of the network metrics using a test-retest dataset. Finally, to illustrate potential applications, the networks were used to measure age-related changes in commonly used network metrics. Results suggest that the proposed method could provide a concise description of brain organization at a network level and be used to investigate interindividual variability in brain morphology from the perspective of complex networks. Furthermore, the method could open a new window into modeling the complexly distributed brain and facilitate the emerging field of human connectomics.	[Kong, Xiang-zhen; Liu, Zhaoguo; Huang, Lijie; Wang, Xu; Yang, Zetian; Zhou, Guangfu; Zhen, Zonglei] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Kong, Xiang-zhen; Liu, Zhaoguo; Huang, Lijie; Wang, Xu; Yang, Zetian; Zhou, Guangfu; Zhen, Zonglei] Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing 100875, Peoples R China; [Liu, Jia] Beijing Normal Univ, Sch Psychol, Beijing 100875, Peoples R China; [Kong, Xiang-zhen; Liu, Zhaoguo; Huang, Lijie; Wang, Xu; Yang, Zetian; Zhou, Guangfu; Zhen, Zonglei; Liu, Jia] Beijing Normal Univ, Ctr Collaborat & Innovat Brain & Learning Sci, Beijing 100875, Peoples R China	Beijing Normal University; Beijing Normal University; Beijing Normal University; Beijing Normal University	Zhen, ZL (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	zhenzonglei@bnu.edu.cn; liujia@bnu.edu.cn	Zhen, Zonglei/GPG-1239-2022	Liu, Jia/0000-0003-0383-0934; Kong, Xiangzhen/0000-0002-0805-1350	National Natural Science Foundation of China [31230031, 31221003, 31470055]; National Basic Research Program of China [2014CB846101]; Changjiang Scholars Programme of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Changjiang Scholars Programme of China	This study was funded by the National Natural Science Foundation of China (31230031, 31221003, and 31470055), the National Basic Research Program of China (2014CB846101), and Changjiang Scholars Programme of China.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Alexander-Bloch A, 2013, J NEUROSCI, V33, P2889, DOI 10.1523/JNEUROSCI.3554-12.2013; Amunts K, 1999, J COMP NEUROL, V412, P319, DOI 10.1002/(SICI)1096-9861(19990920)412:2<319::AID-CNE10>3.0.CO;2-7; Amunts K, 2013, SCIENCE, V340, P1472, DOI 10.1126/science.1235381; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Batalle D, 2013, NEUROIMAGE, V83, P901, DOI 10.1016/j.neuroimage.2013.07.045; Bennett CM, 2010, ANN NY ACAD SCI, V1191, P133, DOI 10.1111/j.1749-6632.2010.05446.x; Bernhardt BC, 2011, CEREB CORTEX, V21, P2147, DOI 10.1093/cercor/bhq291; Bowman AW, 1997, APPL SMOOTHING TECHN; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chen ZJ, 2008, CEREB CORTEX, V18, P2374, DOI 10.1093/cercor/bhn003; CICCHETTI DV, 1981, AM J MENT DEF, V86, P127; Dai D, 2013, MACH VISION APPL, V24, P1445, DOI 10.1007/s00138-012-0462-0; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Epstein JN, 2007, PSYCHIAT RES-NEUROIM, V155, P75, DOI 10.1016/j.pscychresns.2006.12.009; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; He Y, 2009, BRAIN, V132, P3366, DOI 10.1093/brain/awp089; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Ingalhalikar M, 2014, P NATL ACAD SCI USA, V111, P823, DOI 10.1073/pnas.1316909110; Iturria-Medina Y, 2008, NEUROIMAGE, V40, P1064, DOI 10.1016/j.neuroimage.2007.10.060; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jiang TZ, 2004, HUM BRAIN MAPP, V22, P63, DOI 10.1002/hbm.20012; Jin SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068192; Kanai R, 2011, NAT REV NEUROSCI, V12, P231, DOI 10.1038/nrn3000; Khundrakpam BS, 2013, CEREB CORTEX, V23, P2072, DOI 10.1093/cercor/bhs187; Kong XZ, 2014, J NEUROSCI METH, V237, P103, DOI 10.1016/j.jneumeth.2014.09.003; Landman BA, 2011, NEUROIMAGE, V54, P2854, DOI 10.1016/j.neuroimage.2010.11.047; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Lerch JP, 2006, NEUROIMAGE, V31, P993, DOI 10.1016/j.neuroimage.2006.01.042; Li YH, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000395; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mechelli A, 2005, CURR MED IMAGING, V1, P105, DOI 10.2174/1573405054038726; Mechelli A, 2004, NATURE, V431, P757, DOI 10.1038/431757a; Mesulam M., 2000, PRINCIPLES BEHAV COG; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; MUGLER JP, 1990, MAGNET RESON MED, V15, P152, DOI 10.1002/mrm.1910150117; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Ponten SC, 2009, EXP NEUROL, V217, P197, DOI 10.1016/j.expneurol.2009.02.001; Raj A, 2010, NEUROIMAGE, V52, P1302, DOI 10.1016/j.neuroimage.2010.05.045; Sanabria-Diaz G, 2010, NEUROIMAGE, V50, P1497, DOI 10.1016/j.neuroimage.2010.01.028; Sanz-Arigita EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013788; Savadjiev P, 2014, MED IMAGE ANAL, V18, P1349, DOI 10.1016/j.media.2014.06.013; Scott D. W., 1992, MULTIVARIATE DENSITY, DOI 10.1002/9780470316849; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Tijms BM, 2012, CEREB CORTEX, V22, P1530, DOI 10.1093/cercor/bhr221; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel MP, 2010, J NEUROSCI, V30, P15915, DOI 10.1523/JNEUROSCI.2874-10.2010; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; Wang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021976; Wang JH, 2015, FRONT HUM NEUROSCI, V9, DOI [10.3389/fnhum.2015.00386, 10.3389/fnhum.2015.00458]; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Wang L, 2009, HUM BRAIN MAPP, V30, P638, DOI 10.1002/hbm.20530; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wen W, 2011, CURR OPIN PSYCHIATR, V24, P219, DOI 10.1097/YCO.0b013e32834591f8; Westbury CF, 1999, CEREB CORTEX, V9, P392, DOI 10.1093/cercor/9.4.392; Wu K, 2012, HUM BRAIN MAPP, V33, P552, DOI 10.1002/hbm.21232; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Yao ZJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001006; Zalesky A, 2011, BIOL PSYCHIAT, V69, P80, DOI 10.1016/j.biopsych.2010.08.022; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Zhang JR, 2011, BIOL PSYCHIAT, V70, P334, DOI 10.1016/j.biopsych.2011.05.018; Zhang LJ, 2014, EUR J RADIOL, V83, P1890, DOI 10.1016/j.ejrad.2014.06.019; Zhu WL, 2012, NEUROBIOL AGING, V33, P899, DOI 10.1016/j.neurobiolaging.2010.06.022	84	44	44	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141840	10.1371/journal.pone.0141840	http://dx.doi.org/10.1371/journal.pone.0141840			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536598	Green Published, gold, Green Submitted			2022-12-26	WOS:000364298400092
J	Serafy, JE; Shideler, GS; Araujo, RJ; Nagelkerken, I				Serafy, Joseph E.; Shideler, Geoffrey S.; Araujo, Rafael J.; Nagelkerken, Ivan			Mangroves Enhance Reef Fish Abundance at the Caribbean Regional Scale	PLOS ONE			English	Article							SEAGRASS BEDS; QUANTILE REGRESSION; CONNECTIVITY; COMMUNITIES; NURSERIES; MODELS	Several studies conducted at the scale of islands, or small sections of continental coastlines, have suggested that mangrove habitats serve to enhance fish abundances on coral reefs, mainly by providing nursery grounds for several ontogenetically-migrating species. However, evidence of such enhancement at a regional scale has not been reported, and recently, some researchers have questioned the mangrove-reef subsidy effect. In the present study, using two different regression approaches, we pursued two questions related to mangrove-reef connectivity at the Caribbean regional scale: (1) Are reef fish abundances limited by mangrove forest area?; and (2) Are mean reef fish abundances proportional to mangrove forest area after taking human population density and latitude into account? Specifically, we tested for Caribbean-wide mangrove forest area effects on the abundances of 12 reef fishes that have been previously characterized as "mangrove-dependent". Analyzed were data from an ongoing, long-term (20-year) citizen-scientist fish monitoring program; coastal human population censuses; and several wetland forest information sources. Quantile regression results supported the notion that mangrove forest area limits the abundance of eight of the 12 fishes examined. Linear mixed-effects regression results, which considered potential human (fishing and habitat degradation) and latitudinal influences, suggested that average reef fish densities of at least six of the 12 focal fishes were directly proportional to mangrove forest area. Recent work questioning the mangrove-reef fish subsidy effect likely reflects a failure to: (1) focus analyses on species that use mangroves as nurseries, (2) consider more than the mean fish abundance response to mangrove forest extent; and/or (3) quantitatively account for potentially confounding human impacts, such as fishing pressure and habitat degradation. Our study is the first to demonstrate at a large regional scale (i.e., the Wider Caribbean) that greater mangrove forest size generally functions to increase the densities on neighboring reefs of those fishes that use these shallow, vegetated habitats as nurseries.	[Serafy, Joseph E.] Natl Marine Fisheries Serv, Southeast Fisheries Sci Ctr, Miami, FL 33149 USA; [Serafy, Joseph E.; Shideler, Geoffrey S.; Araujo, Rafael J.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA; [Nagelkerken, Ivan] Univ Adelaide, Sch Biol Sci, Southern Seas Ecol Labs, Adelaide, SA, Australia; [Nagelkerken, Ivan] Univ Adelaide, Inst Environm, Adelaide, SA, Australia	National Oceanic Atmospheric Admin (NOAA) - USA; University of Miami; University of Adelaide; University of Adelaide	Serafy, JE (corresponding author), Natl Marine Fisheries Serv, Southeast Fisheries Sci Ctr, Miami, FL 33149 USA.	joe.serafy@noaa.gov	Nagelkerken, Ivan/E-1093-2011; Shideler, Geoffrey/GVS-9403-2022	Nagelkerken, Ivan/0000-0003-4499-3940; Shideler, Geoffrey/0000-0002-0160-2973; Araujo, Rafael J./0000-0003-3781-2857				[Anonymous], [No title captured]; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Bell C. D., 2009, Tourism in Marine Environments, V5, P245, DOI 10.3727/154427308788714768; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cade BS, 2003, FRONT ECOL ENVIRON, V1, P412, DOI 10.1890/1540-9295(2003)001[0412:AGITQR]2.0.CO;2; Cade BS, 1999, ECOLOGY, V80, P311, DOI 10.1890/0012-9658(1999)080[0311:EEOLFW]2.0.CO;2; Conover WJ, 2012, WIRES COMPUT STAT, V4, P432, DOI 10.1002/wics.1216; Dorenbosch M, 2007, MAR ECOL PROG SER, V334, P103, DOI 10.3354/meps334103; Dorenbosch M, 2006, BIOL CONSERV, V129, P277, DOI 10.1016/j.biocon.2005.10.032; Dorenbosch M, 2004, ESTUAR COAST SHELF S, V60, P37, DOI 10.1016/j.ecss.2003.11.018; FAO, 2007, 140 FAO; FAO, 2007, 138 FAO; Faraway J.J., 2006, C&H TEXT STAT SCI, P59; Goffredo S, 2010, ECOL APPL, V20, P2170, DOI 10.1890/09-1546.1; Green E.P., 2003, WORLD ATLAS SEAGRASS; Grol MGG, 2014, MAR ECOL PROG SER, V502, P229, DOI 10.3354/meps10682; Halpern BS, 2012, NATURE, V488, P615, DOI 10.1038/nature11397; Halpern BS, 2004, MAR ECOL PROG SER, V272, P93, DOI 10.3354/meps272093; Hamilton S, 2013, B MAR SCI, V89, P585, DOI 10.5343/bms.2012.1069; HEMMINGA MA, 1994, MAR ECOL PROG SER, V106, P291, DOI 10.3354/meps106291; Hyndes GA, 2014, BIOL REV, V89, P232, DOI 10.1111/brv.12055; Jones DL, 2010, MAR ECOL PROG SER, V401, P245, DOI 10.3354/meps08404; KOENKER R., 2013, QUANTREG QUANTILE RE; Krueger Charlene, 2004, Biol Res Nurs, V6, P151, DOI 10.1177/1099800404267682; LIN GH, 1991, AQUAT BOT, V40, P333, DOI 10.1016/0304-3770(91)90079-K; Mumby PJ, 2004, NATURE, V427, P533, DOI 10.1038/nature02286; Nagelkerken I, 2002, MAR ECOL PROG SER, V244, P299, DOI 10.3354/meps244299; Nagelkerken I, 2015, FISH FISH, V16, P362, DOI 10.1111/faf.12057; Nagelkerken I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036906; Nagelkerken I, 2009, ECOLOGICAL CONNECTIVITY AMONG TROPICAL COASTAL ECOSYSTEMS, P357, DOI 10.1007/978-90-481-2406-0_10; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; PARRISH JD, 1989, MAR ECOL PROG SER, V58, P143, DOI 10.3354/meps058143; Pattengill-Semmens CV, 2003, ENVIRON MONIT ASSESS, V81, P43, DOI 10.1023/A:1021300302208; Pinheiro J., 2019, NLME LINEAR NONLINEA; Planque B, 2008, MAR ECOL PROG SER, V357, P213, DOI 10.3354/meps07274; Schmitt EF, 1996, B MAR SCI, V59, P404; Stallings CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005333; Terrell JW, 1996, T AM FISH SOC, V125, P104, DOI 10.1577/1548-8659(1996)125<0104:MSFHLF>2.3.CO;2; Thomson JD, 1996, ECOLOGY, V77, P1698, DOI 10.2307/2265776; Verweij MC, 2008, LIMNOL OCEANOGR, V53, P1540, DOI 10.4319/lo.2008.53.4.1540; Vianna GMS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095565; Ward-Paige CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025609; Wolfe JR, 2013, CAL COOP OCEAN FISH, V54, P127	43	40	40	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142022	10.1371/journal.pone.0142022	http://dx.doi.org/10.1371/journal.pone.0142022			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536478	Green Published, Green Submitted, gold			2022-12-26	WOS:000364298400118
J	Lu, MH; Tang, B; Zeng, S; Hu, CJ; Xie, R; Wu, YY; Wang, SM; He, FT; Yang, SM				Lu, M-H; Tang, B.; Zeng, S.; Hu, C-J; Xie, R.; Wu, Y-Y; Wang, S-M; He, F-T; Yang, S-M			Long noncoding RNA BC032469, a novel competing endogenous RNA, upregulates hTERT expression by sponging miR-1207-5p and promotes proliferation in gastric cancer	ONCOGENE			English	Article							TELOMERASE ACTIVITY; CATALYTIC SUBUNIT; GENE-EXPRESSION; CELLS; MICRORNAS; DIFFERENTIATION; EVOLUTION; INVASION; GROWTH	Long noncoding RNAs (lncRNAs) are emerging as new players in gene regulation and are associated with the development of cancers. To investigate the important role and mechanism of lncRNAs in the progression of gastric cancer, we screened lncRNAs in gastric cancer tissues and corresponding adjacent tissues, and assessed the effects on gastric cancer. Here, we report that BC032469, a novel lncRNA, expressed highly in gastric cancer tissues, and the upregulation was clinically associated with larger tumor size, poor differentiation and shorter survival of gastric cancer patients. Downregulation of BC032469 resulted in a significant inhibition of proliferation in vitro and in vivo. Mechanistically, BC032469 could directly bind to miR-1207-5p and effectively functioned as a sponge for miR-1207-5p to modulate the derepression of hTERT. Thus, BC032469 may function as a ceRNA to impair miR-1207-5p-dependent hTERT downregulation, suggesting that it may be clinically valuable as a poor prognostic biomarker of gastric cancer.	[Lu, M-H; Tang, B.; Zeng, S.; Hu, C-J; Xie, R.; Wu, Y-Y; Wang, S-M; Yang, S-M] Third Mil Med Univ, Xinqiao Hosp, Dept Gastroenterol, Xinqiao St, Chongqing 400037, Peoples R China; [Lu, M-H] Luzhou Med Coll, Affiliated Hosp, Dept Gastroenterol, Luzhou, Peoples R China; [He, F-T] Third Mil Med Univ, Coll Basic Med Sci, Dept Biochem & Mol Biol, Chongqing, Peoples R China	Army Medical University; Southwest Medical University; Army Medical University	Yang, SM (corresponding author), Third Mil Med Univ, Xinqiao Hosp, Dept Gastroenterol, Xinqiao St, Chongqing 400037, Peoples R China.	shimingyang@yahoo.com	He, Feng/HHS-6457-2022	He, Feng/0000-0002-1996-0744	National Natural Science Foundation of China [81201950]; Luzhou Medical University [2014ZD-001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Luzhou Medical University	This study was supported by the National Natural Science Foundation of China (No. 81201950) and Luzhou Medical University Funding (No. 2014ZD-001). We thank Professor Xia Zhang for suggestions on the manuscript.	Aubert G, 2008, PHYSIOL REV, V88, P557, DOI 10.1152/physrev.00026.2007; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Berghoff EG, 2013, DEVELOPMENT, V140, P4407, DOI 10.1242/dev.099390; Boreiri M, 2013, ARCH IRAN MED, V16, P343, DOI 013166/AIM.007; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Cazalla D, 2010, SCIENCE, V328, P1563, DOI 10.1126/science.1187197; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Chen L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.553; Didiano D, 2006, NAT STRUCT MOL BIOL, V13, P849, DOI 10.1038/nsmb1138; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Hammell M, 2010, SEMIN CELL DEV BIOL, V21, P738, DOI 10.1016/j.semcdb.2010.01.004; Kallen AN, 2013, MOL CELL, V52, P101, DOI 10.1016/j.molcel.2013.08.027; Landthaler M, 2008, RNA, V14, P2580, DOI 10.1261/rna.1351608; Lee DY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013599; Lu MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068972; Lu MH, 2012, EXP THER MED, V3, P728, DOI 10.3892/etm.2012.471; Lu SF, 2009, NUCLEIC ACIDS RES, V37, P1878, DOI 10.1093/nar/gkp031; Ma HR, 2014, INT J MOL MED, V33, P1627, DOI 10.3892/ijmm.2014.1722; Padberg I, 2013, INT J MED MICROBIOL, V303, P463, DOI 10.1016/j.ijmm.2013.06.001; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Ramachandran V, 2008, SCIENCE, V321, P1490, DOI 10.1126/science.1163728; Saldanha SN, 2003, ANAL BIOCHEM, V315, P1, DOI 10.1016/S0003-2697(02)00663-2; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Seitz H, 2009, CURR BIOL, V19, P870, DOI 10.1016/j.cub.2009.03.059; Shi XF, 2013, CANCER LETT, V339, P159, DOI 10.1016/j.canlet.2013.06.013; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Vella MC, 2004, GENE DEV, V18, P132, DOI 10.1101/gad.1165404; Venables JP, 2009, NAT STRUCT MOL BIOL, V16, P670, DOI 10.1038/nsmb.1608; Wang JY, 2010, NUCLEIC ACIDS RES, V38, P5366, DOI 10.1093/nar/gkq285; Yadetie F, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-12; Yamaguchi A, 2012, J PLANT RES, V125, P693, DOI 10.1007/s10265-012-0513-7; Yang F, 2012, FEBS J, V279, P3159, DOI 10.1111/j.1742-4658.2012.08694.x; Yang G, 2007, CARCINOGENESIS, V28, P174, DOI 10.1093/carcin/bgl115; Yu ST, 2012, CANCER-AM CANCER SOC, V118, P1884, DOI 10.1002/cncr.26476; Yu ST, 2009, INT J ONCOL, V35, P329, DOI 10.3892/ijo_00000344; Zhang S, 2013, BIOTECH HISTOCHEM, V88, P281, DOI 10.3109/10520295.2013.769633; Zhang Z, 2013, CELL DEATH DIFFER, V20, P1558, DOI 10.1038/cdd.2013.110	38	144	149	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 7	2016	35	27					3524	3534		10.1038/onc.2015.413	http://dx.doi.org/10.1038/onc.2015.413			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DR0UD	26549025				2022-12-26	WOS:000379621500005
J	Streit, BR; Kant, R; Tokmina-Lukaszewska, M; Celis, AI; Machovina, MM; Skaar, EP; Bothner, B; DuBois, JL				Streit, Bennett R.; Kant, Ravi; Tokmina-Lukaszewska, Monika; Celis, Arianna I.; Machovina, Melodie M.; Skaar, Eric P.; Bothner, Brian; DuBois, Jennifer L.			Time-resolved Studies of IsdG Protein Identify Molecular Signposts along the Non-canonical Heme Oxygenase Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAPHYLOCOCCUS-AUREUS ISDG; PSEUDOMONAS-AERUGINOSA HEME; MYCOBACTERIUM-TUBERCULOSIS; DEGRADING ENZYMES; CRYSTAL-STRUCTURE; DEGRADATION; HYDROXYLATION; MACROCYCLE; MONOXIDE; COMPLEX	IsdGs are heme monooxygenases that break open the tetrapyrrole, releasing the iron, and thereby allowing bacteria expressing this protein to use heme as a nutritional iron source. Little is currently known about the mechanism by which IsdGs degrade heme, although the products differ from those generated by canonical heme oxygenases. A synthesis of time-resolved techniques, including in proteo mass spectrometry and conventional and stopped-flow UV/visible spectroscopy, was used in conjunction with analytical methods to define the reaction steps mediated by IsdG from Staphylococcus aureus and their time scales. An apparent meso-hydroxyheme (forming with k = 0.6 min(-1), pH7.4, 10 mM ascorbate, 10 mu M IsdG-heme, 22 degrees C) was identified as a likely common intermediate with the canonical heme oxygenases. Unlike heme oxygenases, this intermediate does not form with added H2O2 nor does it convert to verdoheme and CO. Rather, the next observable intermediates (k = 0.16 min(-1)) were a set of formyloxobilin isomers, similar to the mycobilin products of the IsdG homolog from Mycobacterium tuberculosis (MhuD). These converted in separate fast and slow phases to beta-/delta-staphylobilin isomers and formaldehyde (CH2O). Controlled release of this unusual C1 product may support IsdG's dual role as both an oxygenase and a sensor of heme availability in S. aureus.	[Streit, Bennett R.; Kant, Ravi; Tokmina-Lukaszewska, Monika; Celis, Arianna I.; Machovina, Melodie M.; Bothner, Brian; DuBois, Jennifer L.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59715 USA; [Skaar, Eric P.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Skaar, Eric P.] US Dept Vet Affairs, Tennessee Valley Healthcare Syst, Nashville, TN 37232 USA	Montana State University System; Montana State University Bozeman; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	DuBois, JL (corresponding author), Montana State Univ, Dept Chem & Biochem, 221 Chem & Biochem Bldg, Bozeman, MT 59715 USA.	jdubois@chemistry.montana.edu		Celis, Arianna/0000-0002-5116-9768	Murdock Charitable Trust; National Institutes of Health of the CoBRE program [5P20RR02437]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR002437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM110732, R01GM090260] Funding Source: NIH RePORTER	Murdock Charitable Trust; National Institutes of Health of the CoBRE program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge Dr. Jonathan Hilmer for sharing technical expertise in mass spectrometry. We thank Garrett Moraski for helpful discussions. Dr. Sunil Ojha is thanked for contributing to the initiation of this project. The mass spectrometry facility at Montana State University receives funding from the Murdock Charitable Trust and National Institutes of Health Grant 5P20RR02437 of the CoBRE program.	Bothner B, 2000, J BIOL CHEM, V275, P13455, DOI 10.1074/jbc.275.18.13455; Caignan GA, 2002, J AM CHEM SOC, V124, P14879, DOI 10.1021/ja0274960; Caignan GA, 2003, J AM CHEM SOC, V125, P11842, DOI 10.1021/ja036147i; Chim N, 2010, J MOL BIOL, V395, P595, DOI 10.1016/j.jmb.2009.11.025; Christ B, 2013, PLANT CELL, V25, P1868, DOI 10.1105/tpc.113.112151; Clark RW, 2006, P NATL ACAD SCI USA, V103, P891, DOI 10.1073/pnas.0505919103; Fetzner S, 2010, APPL MICROBIOL BIOT, V86, P791, DOI 10.1007/s00253-010-2455-0; Galbraith R, 1999, P SOC EXP BIOL MED, V222, P299, DOI 10.1046/j.1525-1373.1999.d01-147.x; Graves AB, 2014, INORG CHEM, V53, P5931, DOI 10.1021/ic500033b; Hortensteiner S, 1998, J BIOL CHEM, V273, P15335, DOI 10.1074/jbc.273.25.15335; Lee WC, 2008, J BIOL CHEM, V283, P30957, DOI 10.1074/jbc.M709486200; Liu Y, 1997, J BIOL CHEM, V272, P6909, DOI 10.1074/jbc.272.11.6909; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; Matsui T, 2013, BIOCHEMISTRY-US, V52, P3025, DOI 10.1021/bi400382p; Matsui T, 2010, ACCOUNTS CHEM RES, V43, P240, DOI 10.1021/ar9001685; Nambu S, 2013, J BIOL CHEM, V288, P10101, DOI 10.1074/jbc.M112.448399; Ortiz de Montellano P. R., 2000, ADV INORG CHEM, V51, P359; Pishchany G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002535; Pishchany G, 2010, CELL HOST MICROBE, V8, P544, DOI 10.1016/j.chom.2010.11.002; Reniere ML, 2008, MOL MICROBIOL, V69, P1304, DOI 10.1111/j.1365-2958.2008.06363.x; Reniere ML, 2011, BIOCHEMISTRY-US, V50, P6730, DOI 10.1021/bi200999q; Reniere ML, 2010, MOL MICROBIOL, V75, P1529, DOI 10.1111/j.1365-2958.2010.07076.x; Roberts GP, 2004, MICROBIOL MOL BIOL R, V68, P453, DOI 10.1128/MMBR.68.3.453-473.2004; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Schuller DJ, 1999, NAT STRUCT BIOL, V6, P860; Skaar EP, 2004, J BIOL CHEM, V279, P436, DOI 10.1074/jbc.M307952200; Sugishima M, 2002, J BIOL CHEM, V277, P45086, DOI 10.1074/jbc.M207267200; Sugiyama K, 1997, P NATL ACAD SCI USA, V94, P796, DOI 10.1073/pnas.94.3.796; Takayama SJ, 2011, P NATL ACAD SCI USA, V108, P13071, DOI 10.1073/pnas.1101459108; Wilks A, 2002, ANTIOXID REDOX SIGN, V4, P603, DOI 10.1089/15230860260220102; Wu RY, 2005, J BIOL CHEM, V280, P2840, DOI 10.1074/jbc.M409526200	31	17	17	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					862	871		10.1074/jbc.M115.666560	http://dx.doi.org/10.1074/jbc.M115.666560			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26534961	Green Published, hybrid			2022-12-26	WOS:000367830500032
J	Asamizu, S; Ozaki, T; Teramoto, K; Satoh, K; Onaka, H				Asamizu, Shumpei; Ozaki, Taro; Teramoto, Kanae; Satoh, Katsuya; Onaka, Hiroyasu			Killing of Mycolic Acid-Containing Bacteria Aborted Induction of Antibiotic Production by Streptomyces in Combined-Culture	PLOS ONE			English	Article							PROMOTES SECONDARY METABOLISM; CHEMICAL COMMUNICATION; A-FACTOR; BIOSYNTHESIS; CHROMATOGRAPHY; MORPHOGENESIS; GOADSPORIN; DIVERSITY; SUBSTANCE; RADIATION	Co-culture of Streptomyces with mycolic acid-containing bacteria (MACB), which we termed "combined-culture," alters the secondary metabolism pattern in Streptomyces and has been a useful method for the discovery of bioactive natural products. In the course of our investigation to identify the inducing factor(s) of MACB, we previously observed that production of pigments in Streptomyces lividans was not induced by factors such as culture extracts or mycolic acids. Although dynamic changes occurred in culture conditions because of MACB, the activation of pigment production by S. lividans was observed in a limited area where both colonies were in direct contact. This suggested that direct attachment of cells is a requirement and that components on the MACB cell membrane may play an important role in the response by S. lividans. Here we examined whether this response was influenced by dead MACB that possess intact mycolic acids assembled on the outer cell membrane. Formaldehyde fixation and.-irradiation were used to prepare dead cells that retain their shape and mycolic acids of three MACB species: Tsukamurella pulmonis, Rhodococcus erythropolis, and Rhodococcus opacus. Culturing tests verified that S. lividans does not respond to the intact dead cells of three MACB. Observation of combined-culture by scanning electron microscopy (SEM) indicated that adhesion of live MACB to S. lividans mycelia were a significant interaction that resulted in formation of co-aggregation. In contrast, in the SEM analysis, dead cells were not observed to adhere. Therefore, direct attachment by live MACB cells is proposed as one of the possible factors that causes Streptomyces to alter its specialized metabolism in combined-culture.	[Asamizu, Shumpei; Ozaki, Taro; Onaka, Hiroyasu] Univ Tokyo, Dept Biotechnol, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan; [Teramoto, Kanae] JEOL Ltd, Adv Technol Dept, Tokyo, Japan; [Satoh, Katsuya] Japan Atom Energy Agcy, Ion Beam Mutagenesis Res Grp, Biotechnol & Med Applicat Div, Quantum Beam Sci Ctr, Takasaki, Gunma, Japan	University of Tokyo; Jeol Ltd; JEOL Japan; Japan Atomic Energy Agency	Asamizu, S (corresponding author), Univ Tokyo, Dept Biotechnol, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan.	asamizu@mail.ecc.u-tokyo.ac.jp; aonaka@mail.ecc.u-tokyo.ac.jp	OZAKI, Taro/F-1614-2016; Asamizu, Shumpei/GOJ-8839-2022	OZAKI, Taro/0000-0002-4673-4478; Asamizu, Shumpei/0000-0002-7178-5410; Onaka, Hiroyasu/0000-0003-4536-1881	Institution for Fermentation, Osaka; Charitable Trust Araki Medical and Biochemical Research Memorial Fund; KAKENHI [26850044, 25292046]; Advanced Technology Department, JEOL Ltd.	Institution for Fermentation, Osaka; Charitable Trust Araki Medical and Biochemical Research Memorial Fund; KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Advanced Technology Department, JEOL Ltd.	This work was funded by the Institution for Fermentation, Osaka (http://www.ifo.or.jp/) (to SA, TO, and HO); the Charitable Trust Araki Medical and Biochemical Research Memorial Fund (to SA); KAKENHI Grant-in-Aid for Young Scientists B (No. 26850044) (https://www.jsps.go.jp/english/index.html) (to SA); and KAKENHI Grant-in-Aid for Scientific Research B (No. 25292046) (https://www.jsps.go.jp/english/index.html) (to HO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Advanced Technology Department, JEOL Ltd. provided support in the form of a salary for KT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.; We thank Prof. Yasuo Ohnishi at The University of Tokyo for fruitful discussion. We thank Dr. Kohsuke Honda at Osaka University for the kind gift of Rhodococcus opacus B4. The project was supported by Grants-in-Aid from the Institution for Fermentation, Osaka (to SA, TO, and HO), by the Charitable Trust Araki Medical and Biochemical Research Memorial Fund (to SA), and in part by a KAKENHI Grant-in-Aid for Young Scientists B (No. 26850044) (to SA) and for Scientific Research B (No. 25292046) (to HO).	Ahmed S, 2013, CHEMBIOCHEM, V14, P83, DOI 10.1002/cbic.201200619; ANDRES N, 1990, Z NATURFORSCH C, V45, P850; Antunes CA, 2015, MICROBIOL-SGM, V161, P639, DOI 10.1099/mic.0.000020; Bansal-Mutalik R, 2014, P NATL ACAD SCI USA, V111, P4958, DOI 10.1073/pnas.1403078111; BENDINGER B, 1993, APPL ENVIRON MICROB, V59, P3973, DOI 10.1128/AEM.59.11.3973-3977.1993; Berdy J, 2005, J ANTIBIOT, V58, P1, DOI 10.1038/ja.2005.1; Bertrand S, 2014, BIOTECHNOL ADV, V32, P1180, DOI 10.1016/j.biotechadv.2014.03.001; Butler WR, 2001, CLIN MICROBIOL REV, V14, P704, DOI 10.1128/CMR.14.4.704-726.2001; Chao YQ, 2011, APPL MICROBIOL BIOT, V92, P381, DOI 10.1007/s00253-011-3551-5; Craney A, 2012, CHEM BIOL, V19, P1020, DOI 10.1016/j.chembiol.2012.06.013; Derewacz DK, 2015, ACS CHEM BIOL; Elias S, 2012, FEMS MICROBIOL REV, V36, P990, DOI 10.1111/j.1574-6976.2012.00325.x; Horinouchi S, 2007, P JPN ACAD B-PHYS, V83, P277, DOI [10.2183/pjab.83.277, 10.2183/pjab/83.277]; Hoshino S, 2014, J ANTIBIOT TOKYO; Hoshino S, 2015, ORG LETT; Igarashi Y, 2001, J ANTIBIOT, V54, P1045, DOI 10.7164/antibiotics.54.1045; Igarashi Y, 2010, ORG LETT, V12, P3402, DOI 10.1021/ol1012982; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kimura Eiichiro, 2003, Adv Biochem Eng Biotechnol, V79, P37; Kolenbrander PE, 2010, NAT REV MICROBIOL, V8, P471, DOI 10.1038/nrmicro2381; Kolter R, 2015, NAT PROD REP; Krisko A, 2010, P NATL ACAD SCI USA, V107, P14373, DOI 10.1073/pnas.1009312107; Liu G, 2013, MICROBIOL MOL BIOL R, V77, P112, DOI 10.1128/MMBR.00054-12; Luti KJK, 2011, APPL MICROBIOL BIOT, V90, P461, DOI 10.1007/s00253-010-3032-2; Luti KJK, 2011, BIOTECHNOL LETT, V33, P113, DOI 10.1007/s10529-010-0401-y; Marmann A, 2014, MAR DRUGS, V12, P1043, DOI 10.3390/md12021043; Marrakchi H, 2014, CHEM BIOL, V21, P67, DOI 10.1016/j.chembiol.2013.11.011; Martin JF, 2004, J BACTERIOL, V186, P5197, DOI 10.1128/JB.186.16.5197-5201.2004; Martinkova L, 2009, ENVIRON INT, V35, P162, DOI 10.1016/j.envint.2008.07.018; Min JH, 2003, RADIAT ENVIRON BIOPH, V42, P189, DOI 10.1007/s00411-003-0205-8; Na KS, 2005, J BIOSCI BIOENG, V99, P378, DOI 10.1263/jbb.99.378; Nett M, 2009, NAT PROD REP, V26, P1362, DOI 10.1039/b817069j; Netzker T, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00299; Nutzmann HW, 2011, P NATL ACAD SCI USA, V108, P14282, DOI 10.1073/pnas.1103523108; Ohno M, 1999, BIOSCI BIOTECH BIOCH, V63, P1083, DOI 10.1271/bbb.63.1083; Onaka H, 2001, J ANTIBIOT, V54, P1036, DOI 10.7164/antibiotics.54.1036; Onaka H, 2011, APPL ENVIRON MICROB, V77, P400, DOI 10.1128/AEM.01337-10; PUCHTLER H, 1985, HISTOCHEMISTRY, V82, P201, DOI 10.1007/BF00501395; Recio E, 2004, J BIOL CHEM, V279, P41586, DOI 10.1074/jbc.M402340200; Rigali S, 2008, EMBO REP, V9, P670, DOI 10.1038/embor.2008.83; Schroeckh V, 2009, P NATL ACAD SCI USA, V106, P14558, DOI 10.1073/pnas.0901870106; Smith I, 2003, CLIN MICROBIOL REV, V16, P463, DOI 10.1128/CMR.16.3.463-496.2003; Straight PD, 2009, ANNU REV MICROBIOL, V63, P99, DOI 10.1146/annurev.micro.091208.073248; Sugiyama R, 2015, ORG LETT; Taga ME, 2003, P NATL ACAD SCI USA, V100, P14549, DOI 10.1073/pnas.1934514100; Teramoto Kanae, 2015, Mass Spectrom (Tokyo), V4, pA0035, DOI 10.5702/massspectrometry.A0035; Teramoto K, 2013, J ANTIBIOT, V66, P713, DOI 10.1038/ja.2013.79; Traxler MF, 2013, MBIO, V4, DOI 10.1128/mBio.00459-13; Vargas-Bautista C, 2014, J BACTERIOL, V196, P717, DOI 10.1128/JB.01022-13; Winn M, 2014, FEMS MICROBIOL LETT, V352, P157, DOI 10.1111/1574-6968.12378; Wu CS, 2015, SCI REP-UK, V5, DOI 10.1038/srep10868; Yamazaki H, 2003, J BACTERIOL, V185, P1273, DOI 10.1128/JB.185.4.1273-1283.2003; YANO I, 1972, FEBS LETT, V21, P215, DOI 10.1016/0014-5793(72)80140-6; Yoon V, 2014, J IND MICROBIOL BIOT, V41, P415, DOI 10.1007/s10295-013-1387-y; Zhang ZY, 2010, BBA-BIOMEMBRANES, V1798, P1829, DOI 10.1016/j.bbamem.2010.05.024	55	13	13	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142372	10.1371/journal.pone.0142372	http://dx.doi.org/10.1371/journal.pone.0142372			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544713	Green Submitted, gold, Green Published			2022-12-26	WOS:000364398700120
J	Llopis-Belenguer, C; Balbuena, JA; Galvan-Femenia, I; Rodriguez-Gonzalez, A				Llopis-Belenguer, Cristina; Antonio Balbuena, Juan; Galvan-Femenia, Ivan; Rodriguez-Gonzalez, Abril			Phenotypic Buffering in a Monogenean: Canalization and Developmental Stability in Shape and Size of the Haptoral Anchors of Ligophorus cephali (Monogenea: Dactylogyridae)	PLOS ONE			English	Article							FLUCTUATING ASYMMETRY; GEOMETRIC MORPHOMETRICS; MORPHOLOGICAL INTEGRATION; DROSOPHILA-MELANOGASTER; SEXUAL SELECTION; MUGIL-CEPHALUS; PLATYHELMINTHES; VARIABILITY; INSTABILITY; ANCYROCEPHALIDAE	Phenotypic variation results from the balance between sources of variation and counteracting regulatory mechanisms. Canalization and developmental stability are two such mechanisms, acting at two different levels of regulation. The issue of whether or not they act concurrently as a common developmental buffering capacity has been subject to debate. We used geometric morphometrics to quantify the mechanisms that guarantee phenotypic constancy in the haptoral anchors of Ligophorus cephali. Canalization and developmental stability were appraised by estimating inter- and intra-individual variation, respectively, in size and shape of dorsal and ventral anchors. The latter variation was estimated as fluctuating asymmetry (FA) between anchor pairs. The general-buffering-capacity hypothesis was tested by two different methods based on correlations and Principal Components Analyses of the different components of size and shape variation. Evidence for FA in the dorsal and ventral anchors in both shape and size was found. Our analyses supported the hypothesis of a general developmental buffering capacity. The evidence was more compelling for shape than for size and, particularly, for the ventral anchors than for the dorsal ones. These results are in line with previous studies of dactylogyrids suggesting that ventral anchors secure a firmer, more permanent attachment, whereas dorsal anchors are more mobile. Because fixation to the host is crucial for survival in ectoparasites, we suggest that homeostatic development of the ventral anchors has been promoted to ensure the morphological constancy required for efficient attachment. Geometric morphometrics can be readily applied to other host-monogenean models, affording not only to disentangle the effects of canalization and developmental stability, as shown herein, but to further partition the environmental and genetic components of the former.	[Llopis-Belenguer, Cristina; Antonio Balbuena, Juan; Rodriguez-Gonzalez, Abril] Univ Valencia, Marine Zool Unit, Cavanilles Inst Biodivers & Evolutionary Biol, Valencia, Spain; [Galvan-Femenia, Ivan] Univ Girona, Dept Comp Sci Appl Math & Stat, Girona, Spain	University of Valencia; Universitat de Girona	Llopis-Belenguer, C (corresponding author), Univ Valencia, Marine Zool Unit, Cavanilles Inst Biodivers & Evolutionary Biol, Valencia, Spain.	cristina.llopis.belenguer@gmail.com	Balbuena, Juan Antonio/O-6404-2014; Llopis-Belenguer, Cristina/Z-6264-2019; Femenía, Iván Galván/AAU-2847-2021; Llopis-Belenguer, Cristina/AAV-2175-2020	Balbuena, Juan Antonio/0000-0003-4006-1353; Llopis-Belenguer, Cristina/0000-0001-7672-0088; Femenía, Iván Galván/0000-0002-6124-3730; Llopis-Belenguer, Cristina/0000-0001-7672-0088; Rodriguez Gonzalez, Abril/0000-0002-9940-5299	Consejo Nacional de Ciencia y Tecnologia of the Mexican Government; Yucatan State, Mexico [204397]; National Plan for Scientific Research, Development and Technological Innovation of Spain [CGL2008-02701]; Generalitat Valenciana [II/2015/018]	Consejo Nacional de Ciencia y Tecnologia of the Mexican Government; Yucatan State, Mexico; National Plan for Scientific Research, Development and Technological Innovation of Spain; Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission)	ARG benefited from a PhD student grant from the Consejo Nacional de Ciencia y Tecnologia of the Mexican Government and Yucatan State, Mexico (Scholarship No. 204397), www.conacyt.mx. This study was funded by the National Plan for Scientific Research, Development and Technological Innovation of Spain (CGL2008-02701), www.idi.mineco.gob.es. This study was funded by the Generalitat Valenciana (Prometeo Project II/2015/018), www.gva.es.	Anderson M.J., 2005, PERMANOVA A FORTRAN; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Arya Priya Vrat, 2015, Journal of Parasitic Diseases, V39, P94, DOI 10.1007/s12639-013-0289-2; Breuker CJ, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000007; De Coster G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057966; Debat V, 2000, P ROY SOC B-BIOL SCI, V267, P423, DOI 10.1098/rspb.2000.1017; Debat V, 2001, TRENDS ECOL EVOL, V16, P555, DOI 10.1016/S0169-5347(01)02266-2; Debat V, 2006, EVOLUTION, V60, P2529, DOI 10.1554/06-045.1; Dworkin I, 2005, EVOLUTION, V59, P1500; Dworkin I, 2005, VARIATION CENTRAL CO, P131, DOI DOI 10.1016/B978-012088777-4/50010-7; Hallgrimsson B, 2002, YEARB PHYS ANTHROPOL, V45, P131, DOI 10.1002/ajpa.10182; Karvonen E, 2003, OIKOS, V100, P507, DOI 10.1034/j.1600-0706.2003.11851.x; Kearn G.C., 2014, OCEANOGRAPHY, V2, P1, DOI [10.4172/2332-2632.1000117, DOI 10.4172/2332-2632.1000117]; Kearn GC, 1999, PARASITOLOGY, V119, pS57, DOI 10.1017/S003118200008464X; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Klingenberg CP, 2010, NAT REV GENET, V11, P623, DOI 10.1038/nrg2829; Klingenberg CP, 2005, SYST BIOL, V54, P678, DOI 10.1080/10635150590947258; Klingenberg CP, 2003, EVOL DEV, V5, P522, DOI 10.1046/j.1525-142X.2003.03057.x; Klingenberg CP, 1998, EVOLUTION, V52, P1363, DOI 10.1111/j.1558-5646.1998.tb02018.x; Klingenberg CP, 2001, AM NAT, V157, P11, DOI 10.1086/317002; Mendlova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037268; Milton CC, 2003, P NATL ACAD SCI USA, V100, P13396, DOI 10.1073/pnas.1835613100; Milton CC, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000075; Mitteroecker P, 2009, EVOL BIOL, V36, P235, DOI 10.1007/s11692-009-9055-x; Moller AP, 2002, ETHOLOGY, V108, P193; Oksanen J., **DATA OBJECT**; Olstad K, 2009, PARASITOLOGY, V136, P1305, DOI 10.1017/S0031182009990680; Ozener B, 2010, AM J PHYS ANTHROPOL, V143, P112, DOI 10.1002/ajpa.21300; Palmer, 1994, DEV INSTABILITY ITS, P335, DOI DOI 10.1007/978-94-011-0830-0_; Palmer M, 2010, MAR ECOL PROG SER, V399, P261, DOI 10.3354/meps08347; Pecinkova M, 2007, J ZOOL, V272, P406, DOI 10.1111/j.1469-7998.2006.00284.x; Petrov A. A., 2015, Trudy Zoologicheskogo Instituta, V319, P244; Polak M, 2008, EVOL BIOL, V35, P208, DOI 10.1007/s11692-008-9032-9; Radwan J, 2003, BIOL J LINN SOC, V80, P499, DOI 10.1046/j.1095-8312.2003.00249.x; Rao GY, 2002, HEREDITY, V88, P197, DOI 10.1038/sj.hdy.6800027; Rodriguez-Gonzalez A, 2015, INT J PARASITOL, V45, P295, DOI 10.1016/j.ijpara.2015.01.005; Rohlf FJ, TPS SERIES; Rubtsova NY, 2006, J PARASITOL, V92, P486, DOI 10.1645/GE-747R.1; Sanchez-Garcia N, 2011, AQUACULTURE, V318, P290, DOI 10.1016/j.aquaculture.2011.05.021; Santos M, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-7; Sarabeev V., 2013, Vestnik Zoologii Supplement, V28, P1; Slice DE, 2007, ANNU REV ANTHROPOL, V36, P261, DOI 10.1146/annurev.anthro.34.081804.120613; Soria Garcia J.M., 2006, Limnetica, V25, P135; Soria J.M., 2000, VERH INT VER LIMNOL, V27, P2232, DOI DOI 10.1080/03680770.1998.11901635; Vignon M, 2011, ZOOL SCR, V40, P306, DOI 10.1111/j.1463-6409.2011.00470.x; Vignon M, 2011, BIOL J LINN SOC, V102, P694, DOI 10.1111/j.1095-8312.2010.01607.x; Vignon M, 2010, PARASITOL INT, V59, P183, DOI 10.1016/j.parint.2010.01.006; Viscosi V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025630; Weisberg S, COMPANION TO APPLIED; Willmore KE, 2007, EVOL BIOL, V34, P99, DOI 10.1007/s11692-007-9008-1; Wong WL, 2013, J EXP BIOL, V216, P3008, DOI 10.1242/jeb.076190; Yonehara Y, 2011, THE SECOND INTERNATI, P1; Zelditch ML, 2012, GEOMETRIC MORPHOMETRICS FOR BIOLOGISTS: A PRIMER, 2ND EDITION, P353, DOI 10.1016/B978-0-12-386903-6.00012-5	53	5	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142365	10.1371/journal.pone.0142365	http://dx.doi.org/10.1371/journal.pone.0142365			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544190	Green Published, Green Submitted, gold			2022-12-26	WOS:000364398700118
J	Fencl, JS; Mather, ME; Costigan, KH; Daniels, MD				Fencl, Jane S.; Mather, Martha E.; Costigan, Katie H.; Daniels, Melinda D.			How Big of an Effect Do Small Dams Have? Using Geomorphological Footprints to Quantify Spatial Impact of Low-Head Dams and Identify Patterns of Across-Dam Variation	PLOS ONE			English	Article							OF-RIVER DAMS; COMMUNITY STRUCTURE; FISH ASSEMBLAGES; UNITED-STATES; NEOSHO RIVER; REMOVAL; DOWNSTREAM; STREAM; BIODIVERSITY; THRESHOLDS	Longitudinal connectivity is a fundamental characteristic of rivers that can be disrupted by natural and anthropogenic processes. Dams are significant disruptions to streams. Over 2,000,000 low-head dams (<7.6 m high) fragment United States rivers. Despite potential adverse impacts of these ubiquitous disturbances, the spatial impacts of low-head dams on geomorphology and ecology are largely untested. Progress for research and conservation is impaired by not knowing the magnitude of low-head dam impacts. Based on the geomorphic literature, we refined a methodology that allowed us to quantify the spatial extent of low-head dam impacts (herein dam footprint), assessed variation in dam footprints across low-head dams within a river network, and identified select aspects of the context of this variation. Wetted width, depth, and substrate size distributions upstream and downstream of six low-head dams within the Upper Neosho River, Kansas, United States of America were measured. Total dam footprints averaged 7.9 km (3.0-15.3 km) or 287 wetted widths (136437 wetted widths). Estimates included both upstream (mean: 6.7 km or 243 wetted widths) and downstream footprints (mean: 1.2 km or 44 wetted widths). Altogether the six low-head dams impacted 47.3 km (about 17%) of the mainstem in the river network. Despite differences in age, size, location, and primary function, the sizes of geomorphic footprints of individual low-head dams in the Upper Neosho river network were relatively similar. The number of upstream dams and distance to upstream dams, but not dam height, affected the spatial extent of dam footprints. In summary, ubiquitous low-head dams individually and cumulatively altered lotic ecosystems. Both characteristics of individual dams and the context of neighboring dams affected low-head dam impacts within the river network. For these reasons, low-head dams require a different, more integrative, approach for research and management than the individualistic approach that has been applied to larger dams.	[Fencl, Jane S.; Costigan, Katie H.] Kansas State Univ, Div Biol, Kansas Cooperat Fish & Wildlife Res Unit, Manhattan, KS 66506 USA; [Mather, Martha E.] Kansas State Univ, Div Biol, US Geol Survey, Kansas Cooperat Fish & Wildlife Res Unit, Manhattan, KS 66506 USA; [Daniels, Melinda D.] Kansas State Univ, Dept Geog, Manhattan, KS 66506 USA	Kansas State University; Kansas State University; United States Department of the Interior; United States Geological Survey; Kansas State University	Fencl, JS (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA.	jfencl@uw.edu	Rogosch, Jane S./AAJ-9314-2020	Rogosch, Jane S./0000-0002-1748-4991	Kansas Department of Wildlife Parks and Tourism, Ecological Services State Wildlife [002505]	Kansas Department of Wildlife Parks and Tourism, Ecological Services State Wildlife	This work was funded by Kansas Department of Wildlife Parks and Tourism, Ecological Services State Wildlife Grant 002505. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ARCGIS VERS 10 2; [Anonymous], 2014, R LANG ENV STAT COMP; Bluck B. J., 1982, GRAVEL BED RIVERS, P339; BRANSON BA, 1967, AM MIDL NAT, V78, P126, DOI 10.2307/2423375; Burroughs BA, 2009, GEOMORPHOLOGY, V110, P96, DOI 10.1016/j.geomorph.2009.03.019; Carswell WJ, 1985, 854003 US GEOL SURV; City of Emporia, 2011, VIS MEN; City of Emporia, 2011, UTILITIES; Costigan KH, 2012, J HYDROL, V444, P90, DOI 10.1016/j.jhydrol.2012.04.008; Cross FB, 1952, T KANSAS ACAD SCI 19, V71, P350; Csiki S, 2010, PROG PHYS GEOG, V34, P755, DOI 10.1177/0309133310369435; Csiki SJC, 2014, GEOMORPHOLOGY, V206, P215, DOI 10.1016/j.geomorph.2013.10.009; Daniels MD, 2010, GEOMORPHOLOGY, V115, P194, DOI 10.1016/j.geomorph.2009.09.038; Dean Joseph, 2002, Transactions of the Kansas Academy of Science, V105, P232, DOI 10.1660/0022-8443(2002)105[0232:EOLDOF]2.0.CO;2; Dodds WK, 2010, J N AM BENTHOL SOC, V29, P988, DOI 10.1899/09-148.1; Doyle MW, 2005, GEOMORPHOLOGY, V71, P227, DOI 10.1016/j.geomorph.2004.04.011; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Esselman Peter C., 2011, Ecological Restoration, V29, P133, DOI 10.3368/er.29.1-2.133; Fortin D, 2013, AM NAT, V181, P827, DOI 10.1086/670243; French LM., 2009, HIST EMPORIA LYON CO; Gillette DP, 2005, COPEIA, P539, DOI 10.1643/CE-04-135R2; Graf W.L., 1993, SUSTAINING OUR WATER, P11; Graf WL, 2006, GEOMORPHOLOGY, V79, P336, DOI 10.1016/j.geomorph.2006.06.022; Hack J.T., 1957, STUDIES LONGITUDINAL, V294, P45; Hart DD, 2002, BIOSCIENCE, V52, P669, DOI 10.1641/0006-3568(2002)052[0669:DRCAOF]2.0.CO;2; Helms BS, 2011, J N AM BENTHOL SOC, V30, P1095, DOI 10.1899/10-093.1; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; JUNK W J, 1989, Canadian Special Publication of Fisheries and Aquatic Sciences, V106, P110; Juracek KE, 2000, J AM WATER RESOUR AS, V36, P633, DOI 10.1111/j.1752-1688.2000.tb04293.x; Juracek KE, 1999, 994147 US GEOL SURV; Kansas Biological Survey, DAT KANS APPL REM SE; Knighton AD., 1984, FLUVIAL FORMS PROCES; Loreau M, 2010, PHILOS T R SOC B, V365, P49, DOI 10.1098/rstb.2009.0155; Marren PM, 2014, SCI WORLD J, DOI 10.1155/2014/309673; National Inventory of Dams (NID) Data Team, 2013, CORPS MAP NAT INV DA; Obermeyer BK, 1997, J FRESHWATER ECOL, V12, P445, DOI 10.1080/02705060.1997.9663555; Pearson AJ, 2015, GEOMORPHOLOGY, V248, P382, DOI 10.1016/j.geomorph.2015.07.025; Perkin JS, 2015, AQUAT CONSERV, V25, P639, DOI 10.1002/aqc.2501; Perkin JS, 2011, FISHERIES, V36, P371, DOI 10.1080/03632415.2011.597666; PIZZUTO JE, 1995, WATER RESOUR RES, V31, P753, DOI 10.1029/94WR02532; Poff NL, 2002, BIOSCIENCE, V52, P659, DOI 10.1641/0006-3568(2002)052[0659:HDVAWI]2.0.CO;2; Poff NL, 1997, J N AM BENTHOL SOC, V16, P391, DOI 10.2307/1468026; POFF NL, 1989, CAN J FISH AQUAT SCI, V46, P1805, DOI 10.1139/f89-228; Power ME, 1996, ENVIRON MANAGE, V20, P887, DOI 10.1007/BF01205969; SCHLOSSER IJ, 1982, ECOL MONOGR, V52, P395, DOI 10.2307/2937352; Schoewe WH, 1949, KANS ACAD SCI T, V52, P261; Schwab Eaton, 2012, SERV PROJ; Skalak K, 2009, J AM WATER RESOUR AS, V45, P97, DOI 10.1111/j.1752-1688.2008.00263.x; Stanley EH, 2002, J N AM BENTHOL SOC, V21, P172, DOI 10.2307/1468307; Stokes K, 2010, KANSAS TRAVEL TOURIS; Surian N, 2002, GEOMORPHOLOGY, V43, P137, DOI 10.1016/S0169-555X(01)00127-1; Tiemann JS, 2005, J FRESHWATER ECOL, V20, P519, DOI 10.1080/02705060.2005.9664767; Tullos DD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108091; US Department of Transportation, 1995, VIS DAT TRANSP ENH C; US Geological Survey (USGS). National Hydrography Dataset, NAT HYDR DAT NAT MAP; USGS, NAT WAT INF SYST WEB; Williams G.P., 1984, REGUL RIVER, V1, P83; Wilson B., 2003, 200355E KGS OFR; Wolman M. G., 1954, T AM GEOPHYS UNION, V35, P951, DOI DOI 10.1029/TR035I006P00951; Wolock D.M, 2003, 03263 US GEOL SURV; Yan YZ, 2013, ENVIRON BIOL FISH, V96, P495, DOI 10.1007/s10641-012-0035-0	62	61	64	4	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141210	10.1371/journal.pone.0141210	http://dx.doi.org/10.1371/journal.pone.0141210			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540105	Green Published, gold, Green Submitted			2022-12-26	WOS:000364303800012
J	McClurkin, MA; Yingling, LR; Ayers, C; Cooper-McCann, R; Suresh, V; Nothwehr, A; Barrington, DS; Powell-Wiley, TM				McClurkin, Michael A.; Yingling, Leah Rae; Ayers, Colby; Cooper-McCann, Rebecca; Suresh, Visakha; Nothwehr, Ann; Barrington, Debbie S.; Powell-Wiley, Tiffany M.			Health Insurance Status as a Barrier to Ideal Cardiovascular Health for US Adults: Data from the National Health and Nutrition Examination Survey (NHANES)	PLOS ONE			English	Article							SCIENTIFIC STATEMENT; PHYSICAL-ACTIVITY; MORTALITY; COVERAGE; RISK; CARE; HYPERTENSION; DEATH; ASSOCIATIONS; MEDICAID	Background Little is known about the association between cardiovascular (CV) health and health insurance status. We hypothesized that U.S. adults without health insurance coverage would have a lower likelihood of ideal cardiovascular health. Methods and Results Using National Health and Nutrition Examination Survey (NHANES) data from 2007-2010, we examined the relationship between health insurance status and ideal CV health in U.S. adults aged >= 19 years and <65 (N = 3304). Ideal CV health was defined by the American Heart Association (AHA) as the absence of clinically manifested CV disease and the simultaneous presence of 6-7 "ideal" CV health factors and behaviors. Logistic regression modeling was used to determine the relationship between health insurance status and the odds of ideal CV health. Of the U.S. adult population, 5.4% attained ideal CV health, and 23.5% were without health insurance coverage. Those without health insurance coverage were more likely to be young (p<0.0001), male (p<0.0001), non-white (p<0.0001), with less than a high school degree (p<0.0001), have a poverty-to-income ratio less than 1 (p<0.0001) and unemployed (p<0.0001) compared to those with coverage. Lack of health insurance coverage was associated with a lower likelihood of ideal CV health; however, this relationship was attenuated by socioeconomic status. Conclusions U.S. adults without health insurance coverage are less likely to have ideal CV health. Population-based strategies and interventions directed at the community-level may be one way to improve overall CV health and reach this at-risk group.	[McClurkin, Michael A.; Yingling, Leah Rae; Cooper-McCann, Rebecca; Suresh, Visakha; Powell-Wiley, Tiffany M.] NHLBI, Cardiovasc & Pulm Branch, NIH, Bethesda, MD 20892 USA; [Ayers, Colby] Univ Texas SW Med Ctr Dallas, Donald W Reynolds Cardiovasc Clin Res Ctr, Dallas, TX 75390 USA; [Nothwehr, Ann] Univ Maryland, College Pk, MD 20742 USA; [Barrington, Debbie S.] Natl Inst Minor Hlth & Hlth Dispar, Div Intramural Res, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Texas System; University of Texas Southwestern Medical Center Dallas; University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Institute on Minority Health & Health Disparities (NIMHD)	Powell-Wiley, TM (corresponding author), NHLBI, Cardiovasc & Pulm Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	tiffany.powell-wiley@nih.gov		Suresh, Visakha/0000-0002-0950-2272; Yingling, Leah/0000-0002-7851-690X	Division of Intramural Research of NHLBI at NIH [HHSN268201300173P]; National Institutes of Health (NIH) Medical Research Scholars Program; NIH; NIH from Pfizer Inc; Doris Duke Charitable Foundation; Alexandria Real Estate Equities, Inc.; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006168] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [K22MD006133] Funding Source: NIH RePORTER	Division of Intramural Research of NHLBI at NIH; National Institutes of Health (NIH) Medical Research Scholars Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH from Pfizer Inc; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Alexandria Real Estate Equities, Inc.; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Funding for Colby Ayers is provided through a professional services contract (contract #HHSN268201300173P) through the Division of Intramural Research of NHLBI at NIH. Funding for Rebecca Cooper-McCann is provided through the National Institutes of Health (NIH) Medical Research Scholars Program, a public-private partnership supported jointly by the NIH and generous contributions to the Foundation for the NIH from Pfizer Inc, The Doris Duke Charitable Foundation, The Alexandria Real Estate Equities, Inc., Mr. and Mrs. Joel S. Marcus, and the Howard Hughes Medical Institute, as well as other private donors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Regarding the private donors, none of the research costs or authors' salaries were funded, in whole or in part, by a tobacco company. The identity of the private donors is not considered relevant to editors or reviewers' assessment of the validity of the work. The authors are not aware of any competing interests.	[Anonymous], 2009, NAT HLTH NUTR EX SUR; Appel LJ, 2006, HYPERTENSION, V47, P296, DOI 10.1161/01.HYP.0000202568.01167.B6; Ayanian JZ, 2000, JAMA-J AM MED ASSOC, V284, P2061, DOI 10.1001/jama.284.16.2061; Ayanian JZ, 2003, AM J PUBLIC HEALTH, V93, P2051, DOI 10.2105/AJPH.93.12.2051; Baker DW, 2006, MED CARE, V44, P277, DOI 10.1097/01.mlr.0000199696.41480.45; Baker DW, 2001, NEW ENGL J MED, V345, P1106, DOI 10.1056/NEJMsa002887; BLACKBURN H, 1989, ANN MED, V21, P157, DOI 10.3109/07853898909149926; Blackwell D.L., 2014, VITAL HEALTH STAT 10, V260, P1; Bowman SA, 2015, FOOD PATTERNS EQUIVA; Brook RH, 2006, HLTH INSURANCE EXPT; Brooks EL, 2010, AM J MED, V123, P741, DOI 10.1016/j.amjmed.2010.02.013; Chinn DJ, 1999, J EPIDEMIOL COMMUN H, V53, P191, DOI 10.1136/jech.53.3.191; Davidoff A., 2005, UNINSURED AM CHRONIC; DeNavas-Walt C., 2014, INCOME POVERTY US 20; DeVoe JE, 2003, AM J PUBLIC HEALTH, V93, P786, DOI 10.2105/AJPH.93.5.786; Dong CH, 2012, CIRCULATION, V125, P2975, DOI 10.1161/CIRCULATIONAHA.111.081083; Duru OK, 2007, AM J HYPERTENS, V20, P348, DOI 10.1016/j.amjhyper.2006.11.007; Fiore MC, 2008, RESP CARE, V53, P1217; Ford ES, 2012, CIRCULATION, V125, P987, DOI 10.1161/CIRCULATIONAHA.111.049122; Fowler-Brown A, 2007, J GEN INTERN MED, V22, P502, DOI 10.1007/s11606-007-0127-2; FRANKS P, 1993, JAMA-J AM MED ASSOC, V270, P737, DOI 10.1001/jama.270.6.737; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Gross CP, 2000, ARCH INTERN MED, V160, P3209, DOI 10.1001/archinte.160.21.3209; Han E, 2013, J ACAD NUTR DIET, V113, P43, DOI 10.1016/j.jand.2012.09.016; Johnson RK, 2009, CIRCULATION, V120, P1011, DOI 10.1161/CIRCULATIONAHA.109.192627; Kirkpatrick SI, 2012, J ACAD NUTR DIET, V112, P624, DOI 10.1016/j.jand.2011.11.012; Kontos EZ, 2010, J HEALTH COMMUN, V15, P216, DOI 10.1080/10810730.2010.522689; Lazzer S, 2010, OBESITY, V18, P71, DOI 10.1038/oby.2009.162; Lee JS, 2010, PUBLIC HEALTH REP, V125, P596, DOI 10.1177/003335491012500415; Levy J, 2015, US UNINSURED RATE DI; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; McWilliams JM, 2004, HEALTH AFFAIR, V23, P223, DOI 10.1377/hlthaff.23.4.223; Medalia C., 2014, CURRENT POPULATION R, P60; Mozaffarian D, 2012, CIRCULATION, V126, P1514, DOI 10.1161/CIR.0b013e318260a20b; National Health and Nutrition Examination Survey (NHANES), 2016, ANTHR PROC MAN; Pickering Thomas G., 2005, Hypertension (Baltimore), V45, P142; Pleis JR, 2010, VITAL HLTH STAT, V249, P1; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; Schiller Jeannine S, 2012, Vital Health Stat 10, P1; Schiller JS, 2010, VITAL HLTH STAT, V10, P2012; Schober SE, 2011, NCHS DATA BRIEF, V57, P1; Singleterry J, 2014, MMWR-MORBID MORTAL W, V63, P264; Sloane DC, 2003, J GEN INTERN MED, V18, P568, DOI 10.1046/j.1525-1497.2003.21022.x; Sommers BD, 2014, ANN INTERN MED, V160, P585, DOI 10.7326/M13-2275; SORLIE PD, 1994, ARCH INTERN MED, V154, P2409, DOI 10.1001/archinte.154.21.2409; Tamblyn R, 2001, JAMA-J AM MED ASSOC, V285, P421, DOI 10.1001/jama.285.4.421; U.S. Department of Health and Human Services, 2000, HLTH PEOPL 2010; US Department of Agriculture, USDA FOOD NUTR DAT D; US Department of Agriculture Agricultural Research Service Food Surveys Research Group, 2010, FOOD NUTR DAT DIET S; US Department of Health and Human Services and US Department of Agriculture, 2005, DIET GUID AM; Wang YC, 2008, PEDIATRICS, V121, pE1604, DOI 10.1542/peds.2007-2834; WEISSMAN JS, 1991, ANN INTERN MED, V114, P325, DOI 10.7326/0003-4819-114-4-325; Wilper AP, 2009, AM J PUBLIC HEALTH, V99, P2289, DOI 10.2105/AJPH.2008.157685; Wilper AP, 2009, HEALTH AFFAIR, V28, pW1151, DOI 10.1377/hlthaff.28.6.w1151; Yancey Antronette K, 2004, Prev Chronic Dis, V1, pA09; Yang QH, 2012, JAMA-J AM MED ASSOC, V307, P1273, DOI 10.1001/jama.2012.339	56	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141534	10.1371/journal.pone.0141534	http://dx.doi.org/10.1371/journal.pone.0141534			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV5GZ	26535890	Green Published, gold, Green Submitted			2022-12-26	WOS:000364298400068
J	Sharma, AM; Baraff, B; Hutchins, JT; Wong, MK; Blaisdell, GK; Cooper, ML; Daane, KM; Almeida, RPP				Sharma, Abhineet M.; Baraff, Breanna; Hutchins, John T.; Wong, Michelle K.; Blaisdell, G. Kai; Cooper, Monica L.; Daane, Kent M.; Almeida, Rodrigo P. P.			Relative Prevalence of Grapevine Leafroll-Associated Virus Species in Wine Grape-Growing Regions of California	PLOS ONE			English	Article							PSEUDOCOCCUS-LONGISPINUS; PLANOCOCCUS-FICUS; TRANSMISSION; GLRAV-3; GRAPEVINE-LEAFROLL-ASSOCIATED-VIRUS-3; INFECTION; HEMIPTERA; ECOLOGY	Some diseases manifest as one characteristic set of symptoms to the host, but can be caused by multiple pathogens. Control treatments based on plant symptoms can make it difficult to effectively manage such diseases, as the biology of the underlying pathogens can vary. Grapevine leafroll disease affects grapes worldwide, and is associated with several viral species in the family Closteroviridae. Whereas some of the viruses associated with this disease are transmitted by insect vectors, others are only graft-transmissible. In three regions of California, we surveyed vineyards containing diseased vines and screened symptomatic plants for all known viral species associated with grapevine leafroll disease. Relative incidence of each virus species differed among the three regions regions, particularly in relation to species with known vectors compared with those only known to be graft-transmitted. In one region, the pathogen population was dominated by species not known to have an insect vector. In contrast, populations in the other surveyed regions were dominated by virus species that are vector-transmissible. Our survey did not detect viruses associated with grapevine leafroll disease at some sites with characteristic disease symptoms. This could be explained either by undescribed genetic diversity among these viruses that prevented detection with available molecular tools at the time the survey was performed, or a misidentification of visual symptoms that may have had other underlying causes. Based on the differences in relative prevalence of each virus species among regions and among vineyards within regions, we expect that region and site-specific management strategies are needed for effective disease control.	[Sharma, Abhineet M.; Baraff, Breanna; Hutchins, John T.; Wong, Michelle K.; Blaisdell, G. Kai; Daane, Kent M.; Almeida, Rodrigo P. P.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Cooper, Monica L.] Univ Calif Cooperat Extens, Napa, CA 94559 USA	University of California System; University of California Berkeley; University of California System	Almeida, RPP (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	rodrigoalmeida@berkeley.edu	Almeida, Rodrigo/GZH-0682-2022	Almeida, Rodrigo/0000-0003-2888-9617	United States Department of Agriculture NIFA-SCRI [2009-51181-06027]; California Agricultural Experiment Station; American Vineyard Foundation	United States Department of Agriculture NIFA-SCRI; California Agricultural Experiment Station; American Vineyard Foundation	This research was supported by an award from the United States Department of Agriculture NIFA-SCRI (award no. 2009-51181-06027), the California Agricultural Experiment Station, and grants to MLC, KMD and RPPA from the American Vineyard Foundation.	Abdi H., 2010, ENCY RES DESIGN, V3, P1, DOI DOI 10.4135/9781412961288.N178; Al Rwahnih M, 2013, PHYTOPATHOLOGY, V103, P1069, DOI 10.1094/PHYTO-10-12-0253-R; Al Rwahnih M, 2012, VIRUS RES, V163, P302, DOI 10.1016/j.virusres.2011.10.018; Almeida RPP, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00094; Bell VA, 2015, INTEGRATED STRATEGY; Ben Salem-Fnayou A, 2006, J PHYTOPATHOL, V154, P528, DOI 10.1111/j.1439-0434.2006.01142.x; Bertazzon N, 2010, EUR J PLANT PATHOL, V127, P185, DOI 10.1007/s10658-010-9583-3; Bester R, 2012, ARCH VIROL, V157, P1815, DOI 10.1007/s00705-012-1333-8; Blaisdell GK, 2015, J ECON ENTOMOL, V108, P1531, DOI 10.1093/jee/tov153; Cabaleiro C, 1999, AM J ENOL VITICULT, V50, P40; Cabaleiro C, 1997, PLANT DIS, V81, P283, DOI 10.1094/PDIS.1997.81.3.283; Cabaleiro C, 1997, EUR J PLANT PATHOL, V103, P373, DOI 10.1023/A:1008619523666; Charles J. G., 2006, New Zealand Plant Protection, V59, P330; Douglas N, 2008, EUR J PLANT PATHOL, V122, P207, DOI 10.1007/s10658-008-9269-2; du Preez J, 2011, ARCH VIROL, V156, P1495, DOI 10.1007/s00705-011-1071-3; ENGELBRECHT D J, 1990, Phytophylactica, V22, P341; Golino DA, 2008, CALIF AGR, V62, P156, DOI 10.3733/ca.v062n04p156; HABILI N, 1995, PHYTOPATHOLOGY, V85, P1418, DOI 10.1094/Phyto-85-1418; Jooste AEC, 2011, EUR J PLANT PATHOL, V131, P371, DOI 10.1007/s10658-011-9814-2; Klaassen VA, 2011, PLANT DIS, V95, P657, DOI 10.1094/PDIS-09-10-0621; Kovacs LG, 2001, AM J ENOL VITICULT, V52, P254; Krenz B, 2012, J VIROL, V86, P7715, DOI 10.1128/JVI.00943-12; Le Maguet J, 2012, PHYTOPATHOLOGY, V102, P717, DOI 10.1094/PHYTO-10-11-0289; Mahfoudhi N, 2009, PLANT DIS, V93, P999, DOI 10.1094/PDIS-93-10-0999; Maree HJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126819; Maree HJ, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00082; Osman F, 2007, J VIROL METHODS, V141, P22, DOI 10.1016/j.jviromet.2006.11.035; Petersen CL, 1997, PLANT PATHOL, V46, P509, DOI 10.1046/j.1365-3059.1997.d01-44.x; Reynard JS, 2015, PHYTOPATHOLOGY, V105, P1262, DOI 10.1094/PHYTO-12-14-0386-R; Sandanayaka WRM, 2013, ARTHROPOD-PLANT INTE, V7, P137, DOI 10.1007/s11829-012-9238-8; Seah YM, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-235; Sether DM, 2002, PHYTOPATHOLOGY, V92, P928, DOI 10.1094/PHYTO.2002.92.9.928; Sharma AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026227; Tsai CW, 2008, PHYTOPATHOLOGY, V98, P1093, DOI 10.1094/PHYTO-98-10-1093; Tsai CW, 2012, PLANT PATHOL, V61, P977, DOI 10.1111/j.1365-3059.2011.02571.x; Tsai CW, 2010, PHYTOPATHOLOGY, V100, P830, DOI 10.1094/PHYTO-100-8-0830; Velasco L, 2014, PLANT DIS, V98, P395, DOI 10.1094/PDIS-04-13-0433-RE; Volpe RJ, 2010, CALIF AGR, V64, P42, DOI 10.3733/ca.v064n01p42	38	10	10	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0142120	10.1371/journal.pone.0142120	http://dx.doi.org/10.1371/journal.pone.0142120			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529503	Green Published, gold			2022-12-26	WOS:000364032600103
J	Ksionda, O; Melton, AA; Bache, J; Tenhagen, M; Bakker, J; Harvey, R; Winter, SS; Rubio, I; Roose, JP				Ksionda, O.; Melton, A. A.; Bache, J.; Tenhagen, M.; Bakker, J.; Harvey, R.; Winter, S. S.; Rubio, I.; Roose, J. P.			RasGRP1 overexpression in T-ALL increases basal nucleotide exchange on Ras rendering the Ras/PI3K/Akt pathway responsive to protumorigenic cytokines	ONCOGENE			English	Article							GTPASE-ACTIVATING PROTEINS; POSITIVE SELECTION; NEUROFIBROMIN 1; P120 RASGAP; LEUKEMIA; PROLIFERATION; STIMULATION; PROCEEDS; REQUIRES; GROWTH	Ras GTPases are activated by RasGEFs and inactivated by RasGAPs, which stimulate the hydrolysis of RasGTP to inactive RasGDP. GTPase-impairing somatic mutations in RAS genes, such as KRAS(G12D), are among the most common oncogenic events in metastatic cancer. A different type of cancer Ras signal, driven by overexpression of the RasGEF RasGRP1 (Ras guanine nucleotide-releasing protein 1), was recently implicated in pediatric T-cell acute lymphoblastic leukemia (T-ALL) patients and murine models, in which RasGRP1 T-ALLs expand in response to treatment with interleukins (ILs) 2, 7 and 9. Here, we demonstrate that IL-2/7/9 stimulation activates Erk and Akt pathways downstream of Ras in RasGRP1 T-ALL but not in normal thymocytes. In normal lymphocytes, RasGRP1 is recruited to the membrane by diacylglycerol (DAG) in a phospholipase C-gamma (PLC gamma)-dependent manner. Surprisingly, we find that leukemic RasGRP1-triggered Ras-Akt signals do not depend on acute activation of PLC gamma to generate DAG but rely on baseline DAG levels instead. In agreement, using three distinct assays that measure different aspects of the RasGTP/GDP cycle, we established that overexpression of RasGRP1 in T-ALLs results in a constitutively high GTP-loading rate of Ras, which is constantly counterbalanced by hydrolysis of RasGTP. KRAS(G12D) T-ALLs do not show constitutive GTP loading of Ras. Thus, we reveal an entirely novel type of leukemogenic Ras signals that is based on a RasGRP1-driven increased in flux through the RasGTP/GDP cycle, which is mechanistically very different from KRAS(G12D) signals. Our studies highlight the dynamic balance between RasGEF and RasGAP in these T-ALLs and put forth a new model in which IL-2/7/9 decrease RasGAP activity.	[Ksionda, O.; Melton, A. A.; Tenhagen, M.; Bakker, J.; Roose, J. P.] Roose Univ Calif, Dept Anat, 513 Parnassus,HSW 1326, San Francisco, CA 94143 USA; [Melton, A. A.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Bache, J.; Rubio, I.] Univ Jena, Univ Hosp, Ctr Mol Biomed, Inst Mol Cell Biol, Jena, Germany; [Harvey, R.; Winter, S. S.] Univ New Mexico, Sch Med, Dept Pediat, Albuquerque, NM 87131 USA; [Rubio, I.] Jena Univ Hosp, CSCC, Integrated Res & Treatment Ctr, Jena, Germany	University of California System; University of California San Francisco; Friedrich Schiller University of Jena; University of New Mexico; Friedrich Schiller University of Jena	Ksionda, O; Roose, JP (corresponding author), Roose Univ Calif, Dept Anat, 513 Parnassus,HSW 1326, San Francisco, CA 94143 USA.	olga.ksionda@ucsf.edu; jeroen.roose@ucsf.edu		Roose, Jeroen/0000-0003-4746-2811	NIH-NCI Physical Science Oncology Center Grant [U54CA143874]; NIH-NIAID Grant (P01 Program) [AI091580]; Gabrielle's Angel Foundation; NIH-NCI Grant [R01-CA187318]; NIH T32 training grant [5T32CA128583-05]; KWF (Dutch Cancer Society); NCI [U10 CA98543, CA180886, U10 CA98413, CA180899, U24 CA114766]; NATIONAL CANCER INSTITUTE [T32CA128583, P30CA118100, R01CA187318, U54CA143874, U10CA180899] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000041, UL1TR001449] Funding Source: NIH RePORTER	NIH-NCI Physical Science Oncology Center Grant; NIH-NIAID Grant (P01 Program); Gabrielle's Angel Foundation; NIH-NCI Grant; NIH T32 training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); KWF (Dutch Cancer Society)(KWF Kankerbestrijding); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	We thank the Roose lab members for helpful comments and Anna Hupalowska for the graphics in Figure 4. Our research was supported by an NIH-NCI Physical Science Oncology Center Grant U54CA143874, an NIH-NIAID Grant (P01 Program Project-AI091580), a Gabrielle's Angel Foundation Grant and NIH-NCI Grant (R01-CA187318) (all to JPR), as well as by an NIH T32 training grant (5T32CA128583-05) and the KWF (Dutch Cancer Society) (MT and JB). This work was also supported by grants from the NCI to the Children's Oncology Group including U10 CA98543 and CA180886 (COG Chair's Grant), U10 CA98413 and CA180899 (COG Statistical Center) and U24 CA114766 (COG Specimen Banking).	Aifantis I, 2008, NAT REV IMMUNOL, V8, P380, DOI 10.1038/nri2304; Balgobind BV, 2008, BLOOD, V111, P4322, DOI 10.1182/blood-2007-06-095075; Barata JT, 2004, HAEMATOLOGICA, V89, P1459; Barata JT, 2004, J EXP MED, V200, P659, DOI 10.1084/jem.20040789; Cichowski K, 2003, GENE DEV, V17, P449, DOI 10.1101/gad.1054703; Daley SR, 2013, ELIFE, V2, DOI 10.7554/eLife.01020; DEVRIESSMITS AMM, 1995, METHOD ENZYMOL, V255, P156; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; Downward Julian, 2003, Biochem J, V376, pe9, DOI 10.1042/BJ20031745; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; Feske S, 2012, NAT REV IMMUNOL, V12, P532, DOI 10.1038/nri3233; Gorentla BK, 2011, BLOOD, V117, P4022, DOI 10.1182/blood-2010-08-300731; Hartzell C, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003848; Hennig A, 2015, BIOL CHEM, V396, P831, DOI 10.1515/hsz-2014-0257; Iwig JS, 2013, ELIFE, V2, DOI 10.7554/eLife.00813; Jiang Y, 2000, BIOCHEM PHARMACOL, V59, P763, DOI 10.1016/S0006-2952(99)00395-0; Kim R, 2003, J VIROL, V77, P2056, DOI 10.1128/JVI.77.3.2056-2062.2003; King PD, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003669; Klinger MB, 2005, ONCOGENE, V24, P2695, DOI 10.1038/sj.onc.1208334; Krutzik PO, 2006, NAT METHODS, V3, P361, DOI 10.1038/NMETH872; Ksionda Olga, 2013, Front Biol (Beijing), V8, P508; Lapinski PE, 2011, J IMMUNOL, V187, P151, DOI 10.4049/jimmunol.1100178; Laplante M, 2013, J CELL SCI, V126, P1713, DOI 10.1242/jcs.125773; Lubeck BA, 2015, J IMMUNOL, V195, P31, DOI 10.4049/jimmunol.1402639; Mitin N, 2005, CURR BIOL, V15, pR563, DOI 10.1016/j.cub.2005.07.010; Neumann M, 2013, BLOOD, V121, P4749, DOI 10.1182/blood-2012-11-465138; Oki T, 2011, LEUKEMIA, V26, P1038; Oliver JA, 2013, MOL IMMUNOL, V55, P292, DOI 10.1016/j.molimm.2013.03.005; Roose JP, 2005, MOL CELL BIOL, V25, P4426, DOI 10.1128/MCB.25.11.4426-4441.2005; Rubio I, 2000, CURR BIOL, V10, P1225, DOI 10.1016/S0960-9822(00)00731-4; Rubio I, 2003, BIOCHEM J, V376, P571, DOI 10.1042/BJ20031410; Rubio I, 2006, BIOCHEM J, V398, P243, DOI 10.1042/BJ20060160; Rubio I, 2010, J IMMUNOL, V185, P3536, DOI 10.4049/jimmunol.1000334; Silva A, 2011, CANCER RES, V71, P4780, DOI 10.1158/0008-5472.CAN-10-3606; Stites EC, 2015, CELL REP, V10, P307, DOI 10.1016/j.celrep.2014.12.035; Zenatti PP, 2011, NAT GENET, V43, P932, DOI 10.1038/ng.924; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725	38	27	29	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 14	2016	35	28					3658	3668		10.1038/onc.2015.431	http://dx.doi.org/10.1038/onc.2015.431			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DR0UQ	26549032	Green Accepted			2022-12-26	WOS:000379622800005
J	Piegholdt, S; Rimbach, G; Wagner, AE				Piegholdt, Stefanie; Rimbach, Gerald; Wagner, Anika E.			The phytoestrogen prunetin affects body composition and improves fitness and lifespan in male Drosophila melanogaster	FASEB JOURNAL			English	Article						isoflavone; climbing activity; survival; metabolism	INNATE IMMUNE-RESPONSE; ADULT FAT-BODY; NF-KAPPA-B; DIETARY RESTRICTION; SEX-HORMONES; EXPRESSION; MODEL; DSIR2; AMPK; BACTERIAL	Dietary isoflavones, a group of secondary plant compounds that exhibit phytoestrogenic properties, are primarily found in soy. Prunetin, a representative isoflavone, was recently found to affect cell signaling in cultured cells; however, in vivo effects remain elusive. In this study, the model organism Drosophila melanogaster was used to investigate the effects of prunetin in vivo with respect to lifespan, locomotion, body composition, metabolism, and gut health. Adult flies were chronically administered a prunetin-supplemented diet. Prunetin improved median survival by 3 d, and climbing activity increased by 54% in males. In comparison with the females, male flies exhibited lower climbing activity, which was reversed by prunetin intake. Furthermore, prunetin-fed males exhibited increased expression of the longevity gene Sirtuin 1 (Sir2) (22%), as well as elevated AMPK activation (51%) and triglyceride levels (29%), whereas glucose levels decreased (36%). As females are long-lived compared with their male counterparts and exhibit higher triglyceride levels, prunetin apparently "feminizes" male flies via its estrogenicity. We conclude that the lifespan-prolonging effects of prunetin in the male fruit fly depend on changes in AMPK-regulated energy homeostasis via male "feminization." Collectively, we identified prunetin as a plant bioactive compound capable of improving health status and survival in male D. melanogaster.	[Piegholdt, Stefanie; Rimbach, Gerald; Wagner, Anika E.] Univ Kiel, Inst Human Nutr & Food Sci, Hermann Rodewald Str 6-8, D-24118 Kiel, Germany	University of Kiel	Wagner, AE (corresponding author), Univ Kiel, Inst Human Nutr & Food Sci, Hermann Rodewald Str 6-8, D-24118 Kiel, Germany.	wagner@molecularnutrition.uni-kiel.de	Wagner, Anika/AAE-3579-2019; Rimbach, Gerald/A-7178-2011	Wagner, Anika/0000-0003-3047-7128; Rimbach, Gerald/0000-0001-7888-4684	DFG Cluster of Excellence "Inflammation at Interfaces" (MP VII)	DFG Cluster of Excellence "Inflammation at Interfaces" (MP VII)	The authors are grateful to N. J. Linford and S. D. Pletcher (Institute of Integrative Physiology, University of Michigan, Ann Arbor, MI, USA), and T. Roeder and C. Fink (Zoological Institute, Molecular Physiology, University of Kiel) for their support in fly husbandry and for providing fly stocks and C. Wagner (Research Center Borstel, Priority Area Allergy and Asthma, Borstel, Germany) for donating the mutant fly strain. This work was funded by the DFG Cluster of Excellence "Inflammation at Interfaces" (MP VII). S.P. and A.E.W. designed the research, and S.P. conducted the research and analyzed the data. All authors contributed to the writing of the paper, had primary responsibility for the final content, and have read and approved the final manuscript. The authors declare no conflicts of interest.	Ahn TG, 2013, BIOCHEM PHARMACOL, V85, P1525, DOI 10.1016/j.bcp.2013.02.020; Apidianakis Y, 2011, DIS MODEL MECH, V4, P21, DOI 10.1242/dmm.003970; Bahadorani S, 2008, J GERONTOL A-BIOL, V63, P35, DOI 10.1093/gerona/63.1.35; Banerjee KK, 2013, MOL CELL BIOL, V33, P252, DOI 10.1128/MCB.00976-12; Banerjee KK, 2012, CELL REP, V2, P1485, DOI 10.1016/j.celrep.2012.11.013; Banerjee KK, 2012, AGING-US, V4, P206, DOI 10.18632/aging.100435; Bauer JH, 2009, AGING-US, V1, P38; Bazzell B, 2013, J EXP BIOL, V216, P859, DOI 10.1242/jeb.078758; Bland ML, 2010, DEV BIOL, V344, P293, DOI 10.1016/j.ydbio.2010.05.010; Branham WS, 2002, J NUTR, V132, P658, DOI 10.1093/jn/132.4.658; Buchon N, 2013, CELL REP, V3, P1725, DOI 10.1016/j.celrep.2013.04.001; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Burkewitz K, 2014, CELL METAB, V20, P10, DOI 10.1016/j.cmet.2014.03.002; Comitato R, 2015, CRIT REV FOOD SCI, V55, P227, DOI 10.1080/10408398.2011.651177; De Loof A, 1998, GEN COMP ENDOCR, V111, P245, DOI 10.1006/gcen.1998.7101; Deshpande SA, 2014, NAT METHODS, V11, P535, DOI [10.1038/NMETH.2899, 10.1038/nmeth.2899]; DuSell C. D., 2009, THESIS DUKE U DURHAM, P1; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Flatt T, 2008, J EXP BIOL, V211, P2712, DOI 10.1242/jeb.014878; Gargano JW, 2005, EXP GERONTOL, V40, P386, DOI 10.1016/j.exger.2005.02.005; Guntermann S, 2009, DEV COMP IMMUNOL, V33, P127, DOI 10.1016/j.dci.2008.07.021; Hedengren M, 1999, MOL CELL, V4, P827, DOI 10.1016/S1097-2765(00)80392-5; Hillerns PI, 2005, Z NATURFORSCH C, V60, P649; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Hoffmann J, 2013, AGING-US, V5, P315, DOI 10.18632/aging.100553; Ja WW, 2009, P NATL ACAD SCI USA, V106, P18633, DOI 10.1073/pnas.0908016106; Johnson EC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012799; Katewa SD, 2012, CELL METAB, V16, P97, DOI 10.1016/j.cmet.2012.06.005; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Libert S, 2008, MOL IMMUNOL, V45, P810, DOI 10.1016/j.molimm.2007.06.353; Lin WS, 2014, AGE, V36, P689, DOI 10.1007/s11357-013-9606-z; Linford NJ, 2013, JOVE-J VIS EXP, DOI 10.3791/50068; Liu T, 2014, J INSECT PHYSIOL, V71, P1, DOI [10.1016/j.jinsphys.2014.09.008, 10.1673/031.014.66]; Mackay TEC, 2006, ANNU REV GENOM HUM G, V7, P339, DOI 10.1146/annurev.genom.7.080505.115758; Maggio M, 2014, CURR PHARM DESIGN, V20, P3119, DOI 10.2174/13816128113196660062; McDonnell DP, 2010, CURR OPIN PHARMACOL, V10, P620, DOI 10.1016/j.coph.2010.09.007; Mortensen A, 2009, MOL NUTR FOOD RES, V53, pS266, DOI 10.1002/mnfr.200800478; Nakamura Y, 2001, J HEALTH SCI, V47, P394, DOI 10.1248/jhs.47.394; OSBORNE CK, 1995, J NATL CANCER I, V87, P746, DOI 10.1093/jnci/87.10.746; Ostberg T, 2003, BIOCHEMISTRY-US, V42, P6427, DOI 10.1021/bi027279b; Pallauf K, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/707421; Petersen AJ, 2013, GENETICS, V194, P133, DOI 10.1534/genetics.113.150854; Petrosyan A, 2007, BEHAV GENET, V37, P585, DOI 10.1007/s10519-007-9159-y; Piegholdt S, 2014, FREE RADICAL BIO MED, V70, P255, DOI 10.1016/j.freeradbiomed.2014.02.025; Rera M, 2012, P NATL ACAD SCI USA, V109, P21528, DOI 10.1073/pnas.1215849110; Rus F, 2013, EMBO J, V32, P1626, DOI 10.1038/emboj.2013.100; Schwanstecher C, 2011, HANDB EXP PHARMACOL, V203, P1, DOI 10.1007/978-3-642-17214-4_1; Schwedes C, 2011, J INSECT PHYSIOL, V57, P899, DOI 10.1016/j.jinsphys.2011.03.027; Sieber MH, 2015, CURR BIOL, V25, P993, DOI 10.1016/j.cub.2015.02.019; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Simon AF, 2003, SCIENCE, V299, P1407, DOI 10.1126/science.1080539; Simon AF, 2006, MECH AGEING DEV, V127, P647, DOI 10.1016/j.mad.2006.02.006; Stenesen D, 2013, CELL METAB, V17, P101, DOI 10.1016/j.cmet.2012.12.006; Szeri F, 2009, BBA-BIOMEMBRANES, V1788, P402, DOI 10.1016/j.bbamem.2008.11.007; Tinkerhess MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031633; Tohyama D, 2010, BIOCHEM BIOPH RES CO, V394, P112, DOI 10.1016/j.bbrc.2010.02.126; Toivonen JM, 2009, MOL CELL ENDOCRINOL, V299, P39, DOI 10.1016/j.mce.2008.07.005; Tricoire H, 2009, MECH AGEING DEV, V130, P547, DOI 10.1016/j.mad.2009.05.004; Ulgherait M, 2014, CELL REP, V8, P1767, DOI 10.1016/j.celrep.2014.08.006; Wang DY, 2014, BIOCHEM BIOPH RES CO, V446, P465, DOI 10.1016/j.bbrc.2014.02.133; Wardell SE, 2011, BIOCHEM PHARMACOL, V82, P122, DOI 10.1016/j.bcp.2011.03.031; Whitaker R, 2013, AGING-US, V5, P682, DOI 10.18632/aging.100599; Wu LP, 2001, GENETICS, V159, P189; Yu J, 2015, HUM MOL GENET, V24, P1493, DOI 10.1093/hmg/ddu557	64	21	23	2	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					948	958		10.1096/fj.15-282061	http://dx.doi.org/10.1096/fj.15-282061			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26538555				2022-12-26	WOS:000369391900041
J	Hossain, F; Arnold, J; Beighley, E; Brown, C; Burian, S; Chen, J; Mitra, A; Niyogi, D; Pielke, R; Tidwell, V; Wegner, D				Hossain, Faisal; Arnold, Jeffrey; Beighley, Ed; Brown, Casey; Burian, Steve; Chen, Ji; Mitra, Anindita; Niyogi, Dev; Pielke, Roger, Sr.; Tidwell, Vincent; Wegner, Dave			What Do Experienced Water Managers Think of Water Resources of Our Nation and Its Management Infrastructure?	PLOS ONE			English	Article								This article represents the second report by an ASCE Task Committee "Infrastructure Impacts of Landscape-drivenWeather Change" under the ASCE Watershed Management Technical Committee and the ASCE Hydroclimate Technical Committee. Herein, the 'infrastructure impacts" are referred to as infrastructure-sensitive changes in weather and climate patterns (extremes and non-extremes) that are modulated, among other factors, by changes in landscape, land use and land cover change. In this first report, the article argued for explicitly considering the well-established feedbacks triggered by infrastructure systems to the land-atmosphere system via landscape change. In this report by the ASCE Task Committee (TC), we present the results of this ASCE TC's survey of a cross section of experienced water managers using a set of carefully crafted questions. These questions covered water resources management, infrastructure resiliency and recommendations for inclusion in education and curriculum. We describe here the specifics of the survey and the results obtained in the formof statistical averages on the 'perception' of thesemanagers. Finally, we discuss what these 'perception' averages may indicate to the ASCE TC and community as a whole for stewardship of the civil engineering profession. The survey and the responses gathered are not exhaustive nor do they represent the ASCE-endorsed viewpoint. However, the survey provides a critical first step to developing the framework of a research and education plan for ASCE. Given the Water Resources Reform and Development Act passed in 2014, we must now take into account the perceived concerns of the water management community.	[Hossain, Faisal] Univ Washington, Dept Civil & Environm Engn, Seattle, WA 98195 USA; [Arnold, Jeffrey] US Army Corps Engineers, Inst Water Resources, Seattle, WA USA; [Beighley, Ed] Northeastern Univ, Dept Civil & Environm Engn, Boston, MA 02115 USA; [Brown, Casey] Univ Massachusetts Amherst, Dept Civil & Environm Engn, Amherst, MA 01003 USA; [Burian, Steve] Univ Utah, Dept Civil & Environm Engn, Salt Lake City, UT 84112 USA; [Chen, Ji] Univ Hong Kong, Dept Civil Engn, Hong Kong, Hong Kong, Peoples R China; [Mitra, Anindita] CREA Affiliates, Seattle, WA 98103 USA; [Niyogi, Dev] Purdue Univ, Earth & Atmospher Sci, W Lafayette, IN 47907 USA; [Pielke, Roger, Sr.] Univ Colorado, CIRES, Boulder, CO 80309 USA; [Tidwell, Vincent] Sandia Natl Labs, Albuquerque, NM 87185 USA; [Wegner, Dave] US House Representatives, Washington, DC 20515 USA	University of Washington; University of Washington Seattle; United States Department of Defense; United States Army; U.S. Army Corps of Engineers; Northeastern University; University of Massachusetts System; University of Massachusetts Amherst; Utah System of Higher Education; University of Utah; University of Hong Kong; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Colorado System; University of Colorado Boulder; United States Department of Energy (DOE); Sandia National Laboratories	Hossain, F (corresponding author), Univ Washington, Dept Civil & Environm Engn, More Hall 201, Seattle, WA 98195 USA.	fhossain@uw.edu	Niyogi, Dev/ABE-7554-2020; Niyogi, Dev/H-6326-2013; Chen, Ji/C-1795-2009	Niyogi, Dev/0000-0002-1848-5080; Niyogi, Dev/0000-0002-1848-5080; Burian, Steven/0000-0003-0523-4968; Beighley, Edward/0000-0003-1139-6226	ASCE Headquarters; ASCE Environment and Water Institute (EWRI)	ASCE Headquarters; ASCE Environment and Water Institute (EWRI)	The authors acknowledge the support received from the ASCE Headquarters for conducting the survey using surveymonkey subscription. In particular, Gabrielle Dunkley at ASCE headquarters in Reston, Virginia is gratefully appreciated in setting up the survey. The Watershed Management Technical Council (WMTC) under the auspices of ASCE Environment and Water Institute (EWRI) is also acknowledged for approving the survey.	Grill G, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/1/015001; Hossain F, 2015, J HYDROL ENG, DOI [http://dx.doi.org/10.1061/(ASCE)HE.1943-5584.0001210, DOI 10.1061/(ASCE)HE.1943-5584.0001210)]; Vorosmarty CJ, 2000, BIOSCIENCE, V50, P753, DOI 10.1641/0006-3568(2000)050[0753:ADOTTW]2.0.CO;2; Vorosmarty CJ, 2010, UNESCO WORLD WATER D, P10; Zarfl C, 2014, AQUATIC SCI	5	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142073	10.1371/journal.pone.0142073	http://dx.doi.org/10.1371/journal.pone.0142073			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544045	Green Published, gold, Green Submitted			2022-12-26	WOS:000364398700077
J	Kartika, T; Shimizu, N; Yoshimura, T				Kartika, Titik; Shimizu, Nobuhiro; Yoshimura, Tsuyoshi			Identification of Esters as Novel Aggregation Pheromone Components Produced by the Male Powder-Post Beetle, Lyctus africanus Lesne (Coleoptera: Lyctinae)	PLoS One			English	Article							TRUNCATUS HORN COLEOPTERA; LARGER GRAIN BORER; PROSTEPHANUS-TRUNCATUS; RHYZOPERTHA-DOMINICA; BEHAVIORAL-RESPONSES; BOSTRICHIDAE; LYCTIDAE	Lyctus africanus is a cosmopolitan powder-post beetle that is considered one of the major pests threatening timber and timber products. Because infestations of this beetle are inconspicuous, damage is difficult to detect and identification is often delayed. We identified the chemical compounds involved in the aggregation behavior of L. africanus using preparations of crude hexanic extracts from male and female beetles (ME and FE, respectively). Both male and female beetles showed significant preferences for ME, which was found to contain three esters. FE was ignored by both the sexes. Further bioassay confirmed the role of esters in the aggregation behavior of L. africanus. Three esters were identified as 2-propyl dodecanoate, 3-pentyl dodecanoate, and 3-pentyl tetradecanoate. Further behavioral bioassays revealed 3-pentyl dodecanoate to play the main role in the aggregation behavior of female L. africanus beetles. However, significantly more beetles aggregated on a paper disk treated with a blend of the three esters than on a paper disk treated with a single ester. This is the first report on pheromone identification in L. africanus; in addition, the study for the first time presents 3-pentyl dodecanoate as an insect pheromone.	[Kartika, Titik] Indonesian Inst Sci, Res Ctr Biomat, Java, Indonesia; [Yoshimura, Tsuyoshi] Kyoto Univ, Res Inst Sustainable Humanosphere, Uji, Kyoto, Japan; [Shimizu, Nobuhiro] Kyoto Gakuen Univ, Fac Bioenvironm Sci, Kameoka, Japan	Indonesian Institute of Sciences; Kyoto University	Kartika, T (corresponding author), Kyoto Univ, Res Inst Sustainable Humanosphere, Uji, Kyoto, Japan.	titikkartika@biomaterial.lipi.go.id		Shimizu, Nobuhiro/0000-0002-8658-6887; Kartika, Titik/0000-0002-9185-0400				Abood F, 2006, J TROP FOR SCI, V18, P250; Altson A. M., 1923, Journal of the Linnean Society London Zoology, V35, P217; BURKHOLDER WE, 1985, ANNU REV ENTOMOL, V30, P257, DOI 10.1146/annurev.en.30.010185.001353; CORK A, 1991, J CHEM ECOL, V17, P789, DOI 10.1007/BF00994201; CRUZLOPEZ L, 1993, MEM I OSWALDO CRUZ, V88, P535, DOI 10.1590/S0074-02761993000400006; Ebeling W., 1978, URBAN ENTOMOLOGY, P167; Edde PA, 2006, ENTOMOL EXP APPL, V119, P255, DOI 10.1111/j.1570-7458.2006.00417.x; Fadamiro HY, 1996, J STORED PROD RES, V32, P163, DOI 10.1016/0022-474X(96)00003-3; FAUSTINI DL, 1982, J CHEM ECOL, V8, P679, DOI 10.1007/BF00988309; FRANCKE W, 1979, ANGEW CHEM INT EDIT, V18, P796, DOI 10.1002/anie.197907961; Furstenau B, 2013, CHEMBIOCHEM, V14, P1450, DOI 10.1002/cbic.201300247; Furukawa N., 2009, WOOD PRESERV, V35, P260, DOI DOI 10.5990/JWPA.35.260; Gerberg E.J, 1957, REVISION NEW WORLD S; Halperin J, 1999, PHYTOPARASITICA, V27, P257, DOI 10.1007/BF02981481; IMAI T, 1990, APPL ENTOMOL ZOOL, V25, P113, DOI 10.1303/aez.25.113; Iwata R, 1982, KOKU GAICHU HOUSE HO, P60; Iwata R, 1988, ACTA COLEOPTEROLOGIC, V1, P68; KHORRAMSHAHI A, 1981, J CHEM ECOL, V7, P33, DOI 10.1007/BF00988633; Korada RR, 2009, CHEMOECOLOGY, V19, P177, DOI 10.1007/s00049-009-0020-z; LEVINSON HZ, 1978, NATURWISSENSCHAFTEN, V65, P543, DOI 10.1007/BF00439806; Mito Toshikazu, 2004, Global Environmental Research, V8, P171; Peters B. C., 2002, Australian Forestry, V65, P107; Scholz D, 1998, PHYSIOL ENTOMOL, V23, P265, DOI 10.1046/j.1365-3032.1998.233089.x; Scholz D, 1997, ENTOMOL EXP APPL, V83, P53, DOI 10.1023/A:1002919705200; Schulz S, 2004, CHEMBIOCHEM, V5, P1500, DOI 10.1002/cbic.200400110; Shimizu N, 2012, J CHEM ECOL, V38, P23, DOI 10.1007/s10886-012-0063-4; TORTO B, 1994, J CHEM ECOL, V20, P1749, DOI 10.1007/BF02059896; YINON U., 1967, J STORED PROD RES, V3, P251, DOI 10.1016/0022-474X(67)90051-3	28	9	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141799	10.1371/journal.pone.0141799	http://dx.doi.org/10.1371/journal.pone.0141799			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544984	Green Published, gold, Green Submitted			2022-12-26	WOS:000364398700050
J	Kropp, J; Roti, ECR; Ringelstetter, A; Khatib, H; Abbott, DH; Salih, SM				Kropp, Jenna; Roti, Elon C. Roti; Ringelstetter, Ashley; Khatib, Hasan; Abbott, David H.; Salih, Sana M.			Dexrazoxane Diminishes Doxorubicin-Induced Acute Ovarian Damage and Preserves Ovarian Function and Fecundity in Mice	PLOS ONE			English	Article							DOSE DENSE CHEMOTHERAPY; ADVANCED BREAST-CANCER; PROVIDES CARDIOPROTECTION; FERTILITY PRESERVATION; CLINICAL-TRIAL; FEMALE MICE; PHASE-III; EPIRUBICIN; PACLITAXEL; WOMEN	Advances in cancer treatment utilizing multiple chemotherapies have dramatically increased cancer survivorship. Female cancer survivors treated with doxorubicin (DXR) chemotherapy often suffer from an acute impairment of ovarian function, which can persist as long-term, permanent ovarian insufficiency. Dexrazoxane (Dexra) pretreatment reduces DXR-induced insult in the heart, and protects in vitro cultured murine and non-human primate ovaries, demonstrating a drug-based shield to prevent DXR insult. The present study tested the ability of Dexra pretreatment to mitigate acute DXR chemotherapy ovarian toxicity in mice through the first 24 hours post-treatment, and improve subsequent long-term fertility throughout the reproductive lifespan. Adolescent CD-1 mice were treated with Dexra 1 hour prior to DXR treatment in a 1:1 mg or 10:1 mg Dexra:DXR ratio. During the acute injury period (2-24 hours post-injection), Dexra pretreatment at a 1:1 mg ratio decreased the extent of double strand DNA breaks, diminished.H2FAX activation, and reduced subsequent follicular cellular demise caused by DXR. In fertility and fecundity studies, dams pre-treated with either Dexra:DXR dose ratio exhibited litter sizes larger than DXR-treated dams, and mice treated with a 1:1 mg Dexra:DXR ratio delivered pups with birth weights greater than DXR-treated females. While DXR significantly increased the "infertility index" (quantifying the percentage of dams failing to achieve pregnancy) through 6 gestations following treatment, Dexra pretreatment significantly reduced the infertility index following DXR treatment, improving fecundity. Low dose Dexra not only protected the ovaries, but also bestowed a considerable survival advantage following exposure to DXR chemotherapy. Mouse survivorship increased from 25% post-DXR treatment to over 80% with Dexra pretreatment. These data demonstrate that Dexra provides acute ovarian protection from DXR toxicity, improving reproductive health in a mouse model, suggesting this clinically available drug may provide ovarian protection for cancer patients.	[Kropp, Jenna; Khatib, Hasan] Univ Wisconsin, Dept Anim Sci, Madison, WI USA; [Kropp, Jenna; Roti, Elon C. Roti; Ringelstetter, Ashley; Abbott, David H.; Salih, Sana M.] Univ Wisconsin, Dept Obstet & Gynecol, Madison, WI 53706 USA; [Roti, Elon C. Roti] Univ Wisconsin, Dept Med, Madison, WI USA; [Abbott, David H.] Wisconsin Natl Primate Res Ctr, Madison, WI 53715 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Salih, SM (corresponding author), Univ Wisconsin, Dept Obstet & Gynecol, Madison, WI 53706 USA.	sanasalih5@gmail.com	Khatib, Hasan/AAA-2693-2021		University of Wisconsin start up and Research and Development funds [MSN132883]; Wisconsin Alumni Research Foundation [MSN162253]; NIH training grant [K12 HD0558941]; University of Wisconsin Cancer Center Support Grant [P30CA014520]; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER	University of Wisconsin start up and Research and Development funds; Wisconsin Alumni Research Foundation; NIH training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Wisconsin Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the University of Wisconsin start up and Research and Development funds (MSN132883), Wisconsin Alumni Research Foundation (MSN162253), and NIH training grant K12 HD0558941 to SMS; and by University of Wisconsin Cancer Center Support Grant P30CA014520.	American Cancer Society, 2014, CANC FACTS FIG; ATAYA K, 1995, BIOL REPROD, V52, P365, DOI 10.1095/biolreprod52.2.365; Aubert N, 2008, NEUROBIOL DIS, V32, P66, DOI 10.1016/j.nbd.2008.06.014; Bar J, 2003, AM J OBSTET GYNECOL, V189, P853, DOI 10.1067/S0002-9378(03)00837-8; Bar-Joseph H, 2010, REPROD TOXICOL, V30, P566, DOI 10.1016/j.reprotox.2010.07.003; Bates M, 1997, CLIN THER, V19, P167, DOI 10.1016/S0149-2918(97)80084-7; Behringer K, 2010, ANN ONCOL, V21, P2052, DOI 10.1093/annonc/mdq066; Ben-Aharon I, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-20; Beretta GL, 2008, EXPERT OPIN THER TAR, V12, P1243, DOI [10.1517/14728222.12.10.1243, 10.1517/14728222.12.10.1243 ]; Calve A, 2012, CAN J PHYSIOL PHARM, V90, P1527, DOI 10.1139/y2012-126; Davis VL, 2006, CANCER-AM CANCER SOC, V107, P1690, DOI 10.1002/cncr.22105; De Giorgi U, 2005, BONE MARROW TRANSPL, V35, pS256; De Giorgi U, 2003, BONE MARROW TRANSPL, V32, P251, DOI 10.1038/sj.bmt.1704125; De Giorgi U, 2006, INT J RADIAT ONCOL, V65, P1165, DOI 10.1016/j.ijrobp.2006.02.018; De Vos M, 2014, LANCET, V384, P1302, DOI 10.1016/S0140-6736(14)60834-5; Deng SW, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-842; Doroshow JH, 2012, CURR PHARM BIOTECHNO, V13, P1949; FDA, 2011, FDA STAT DEXR; Flaws JA, 1997, BIOL REPROD, V57, P1233, DOI 10.1095/biolreprod57.5.1233; Fowden AL, 2006, PHYSIOLOGY, V21, P29, DOI 10.1152/physiol.00050.2005; Frassineti GL, 2005, J CLIN ONCOL, V23, p102S; Gewirtz DA, 1999, BIOCHEM PHARMACOL, V57, P727, DOI 10.1016/S0006-2952(98)00307-4; Gonfloni S, 2009, NAT MED, V15, P1179, DOI 10.1038/nm.2033; Green DN, 2002, AM J OBSTET GYNECOL, V187, P1070, DOI 10.1067/mob.2002.126643; HOCHSTER H, 1992, J NATL CANCER I, V84, P1725, DOI 10.1093/jnci/84.22.1725; Howlader N, 2013, SEER CANC STAT REV 1; Jurisicova A, 2006, CELL DEATH DIFFER, V13, P1466, DOI 10.1038/sj.cdd.4401819; Kiyomiya K, 2001, CANCER RES, V61, P2467; Kujjo LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017877; Lemez P, 1997, J CLIN ONCOL, V15, P3293, DOI 10.1200/JCO.1997.15.10.3293; Li XH, 2013, J GYNECOL ONCOL, V24, P177, DOI 10.3802/jgo.2013.24.2.177; Lopez M, 1998, J CLIN ONCOL, V16, P86, DOI 10.1200/JCO.1998.16.1.86; Loren AW, 2013, J CLIN ONCOL, V31, P2500, DOI 10.1200/JCO.2013.49.2678; Mah LJ, 2010, LEUKEMIA, V24, P679, DOI 10.1038/leu.2010.6; Marty M, 2004, BREAST CANCER RES TR, V88, pS201; Marty M, 2006, ANN ONCOL, V17, P614, DOI 10.1093/annonc/mdj134; Meirow D, 2010, CLIN OBSTET GYNECOL, V53, P727, DOI 10.1097/GRF.0b013e3181f96b54; Meistrich ML, 2008, REPRODUCTION, V136, P691, DOI 10.1530/REP-08-0096; Minotti G, 2004, METHOD ENZYMOL, V378, P340; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Monnier A, 2005, J CLIN ONCOL, V23, p38S; Morgan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070117; Morita Y, 2000, NAT MED, V6, P1109, DOI 10.1038/80442; Mouridsen H, 2008, EJC SUPPL, V6, P197, DOI 10.1016/S1359-6349(08)70811-5; Paris F, 2002, NAT MED, V8, P901, DOI 10.1038/nm0902-901; Perez GI, 1997, NAT MED, V3, P1228, DOI 10.1038/nm1197-1228; Pfeifer S, 2014, FERTIL STERIL, V101, P1237, DOI 10.1016/j.fertnstert.2014.02.052; Ringelstetter AK, 2014, PLOS ONE US; Roness H, 2013, HUM REPROD, V28, P46; Rosing H, 1999, EUR J DRUG METAB PH, V24, P69, DOI 10.1007/BF03190013; Roti ECR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108174; Roti ECR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042293; Roti ECR, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097030; Salih SM, 2015, J PEDIATR ADOL GYNEC, V28, P95, DOI 10.1016/j.jpag.2014.05.012; Salih SM, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.119495; Sargent JM, 2001, BRIT J CANCER, V84, P959, DOI 10.1054/bjoc.2001.1697; Schnirer II, 2009, J CLIN ONCOL, V27; SEIFERT CF, 1994, ANN PHARMACOTHER, V28, P1063, DOI 10.1177/106002809402800912; Skaznik-Wikiel ME, 2013, FERTIL STERIL, V99, P2045, DOI 10.1016/j.fertnstert.2013.01.135; Smith MA, 1999, J NATL CANCER I, V91, P973; Sparano JA, 1999, J CLIN ONCOL, V17, P880, DOI 10.1200/JCO.1999.17.3.880; SPETH PAJ, 1988, CLIN PHARMACOKINET, V15, P15, DOI 10.2165/00003088-198815010-00002; Sterba M, 2013, ANTIOXID REDOX SIGN, V18, P899, DOI 10.1089/ars.2012.4795; Swain SM, 1997, J CLIN ONCOL, V15, P1333, DOI 10.1200/JCO.1997.15.4.1333; Swain SM, 1997, J CLIN ONCOL, V15, P1318, DOI 10.1200/JCO.1997.15.4.1318; Swain SM, 1997, J CLIN ONCOL, V15, P3294; Sydsjo G, 2011, AM J REPROD IMMUNOL, V66, P81, DOI 10.1111/j.1600-0897.2011.01035.x; TAN C, 1967, CANCER-AM CANCER SOC, V20, P333, DOI 10.1002/1097-0142(1967)20:3<333::AID-CNCR2820200302>3.0.CO;2-K; Tebbi CK, 2007, J CLIN ONCOL, V25, P493, DOI 10.1200/JCO.2005.02.3879; Testore F, 2008, AM J CARDIOVASC DRUG, V8, P257, DOI 10.2165/00129784-200808040-00005; Ting AY, 2010, J ASSIST REPROD GEN, V27, P591, DOI 10.1007/s10815-010-9463-y; Ullman-Cullere MH, 1999, LAB ANIM SCI, V49, P319; Urruticoechea A, 2008, BREAST CANCER RES TR, V110, P411, DOI 10.1007/s10549-007-9745-y; van Dalen EC, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003917.pub4; Vavrova A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076676; Venturini M, 1996, J CLIN ONCOL, V14, P3112, DOI 10.1200/JCO.1996.14.12.3112; Vrooman LM, 2011, EUR J CANCER, V47, P1373, DOI 10.1016/j.ejca.2011.03.022; Wang Pei, 2013, Zhonghua Zhong Liu Za Zhi, V35, P135, DOI 10.3760/cma.j.issn.0253-3766.2013.02.013; Zelinski MB, 2011, FERTIL STERIL, V95, P1440, DOI 10.1016/j.fertnstert.2011.01.012	79	24	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142588	10.1371/journal.pone.0142588	http://dx.doi.org/10.1371/journal.pone.0142588			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544188	Green Submitted, Green Published, gold			2022-12-26	WOS:000364398700158
J	Lluch, J; Servant, F; Paisse, S; Valle, C; Valiere, S; Kuchly, C; Vilchez, G; Donnadieu, C; Courtney, M; Burcelin, R; Amar, J; Bouchez, O; Lelouvier, B				Lluch, Jerome; Servant, Florence; Paisse, Sandrine; Valle, Carine; Valiere, Sophie; Kuchly, Claire; Vilchez, Gaelle; Donnadieu, Cecile; Courtney, Michael; Burcelin, Remy; Amar, Jacques; Bouchez, Olivier; Lelouvier, Benjamin			The Characterization of Novel Tissue Microbiota Using an Optimized 16S Metagenomic Sequencing Pipeline	PLOS ONE			English	Article							GUT MICROBIOTA; BACTERIAL; PCR; DNA; IDENTIFICATION; INHIBITION; MECHANISMS; PRIMERS; SYSTEM; BLOOD	Background Substantial progress in high-throughput metagenomic sequencing methodologies has enabled the characterisation of bacteria from various origins (for example gut and skin). However, the recently-discovered bacterial microbiota present within animal internal tissues has remained unexplored due to technical difficulties associated with these challenging samples. Results We have optimized a specific 16S rDNA-targeted metagenomics sequencing (16S meta-barcoding) pipeline based on the Illumina MiSeq technology for the analysis of bacterial DNA in human and animal tissues. This was successfully achieved in various mouse tissues despite the high abundance of eukaryotic DNA and PCR inhibitors in these samples. We extensively tested this pipeline on mock communities, negative controls, positive controls and tissues and demonstrated the presence of novel tissue specific bacterial DNA profiles in a variety of organs (including brain, muscle, adipose tissue, liver and heart). Conclusion The high throughput and excellent reproducibility of the method ensured exhaustive and precise coverage of the 16S rDNA bacterial variants present in mouse tissues. This optimized 16S metagenomic sequencing pipeline will allow the scientific community to catalogue the bacterial DNA profiles of different tissues and will provide a database to analyse host/bacterial interactions in relation to homeostasis and disease.	[Lluch, Jerome; Servant, Florence; Paisse, Sandrine; Valle, Carine; Courtney, Michael; Lelouvier, Benjamin] Vaiomer SAS, Labege, France; [Lluch, Jerome; Valiere, Sophie; Kuchly, Claire; Vilchez, Gaelle; Donnadieu, Cecile; Bouchez, Olivier] INRA, GeT PlaGe, F-31326 Castanet Tolosan, France; [Valiere, Sophie; Kuchly, Claire; Vilchez, Gaelle] INRA, UAR1209, F-31326 Castanet Tolosan, France; [Donnadieu, Cecile; Bouchez, Olivier] INRA, UMR1388, F-31326 Castanet Tolosan, France; [Burcelin, Remy; Amar, Jacques] Fac Med Toulouse, INSERM, U1048, I2MC, F-31073 Toulouse, France; [Amar, Jacques] Hop Rangueil, Dept Therapeut, Toulouse, France	INRAE; INRAE; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse	Lelouvier, B (corresponding author), Vaiomer SAS, Labege, France.	benjamin.lelouvier@vaiomer.com	Valle, Carine/X-6039-2019; burcelin, remy/M-6013-2014	kuchly, claire/0000-0001-8994-550X; Servant, Florence/0000-0003-1063-6531	DAEI (Direction de l'Action Economique et de l'Innovation) of the Midi-Pyrenees Region, France; Vaiomer SAS	DAEI (Direction de l'Action Economique et de l'Innovation) of the Midi-Pyrenees Region, France(Region Occitanie); Vaiomer SAS	This work was carried out with the financial support from the DAEI (Direction de l'Action Economique et de l'Innovation) of the Midi-Pyrenees Region, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Vaiomer SAS provided support in the form of salaries for authors [JL, FS, SP, CV, MC, BL], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "Author contributions" section.	Amar J, 2011, DIABETOLOGIA, V54, P3055, DOI 10.1007/s00125-011-2329-8; Amar J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054461; Bentley SD, 2004, ANNU REV GENET, V38, P771, DOI 10.1146/annurev.genet.38.072902.094318; Bleau C, 2015, DIABETES-METAB RES, V31, P545, DOI 10.1002/dmrr.2617; Branton WG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054673; Brekke OL, 2011, MOL IMMUNOL, V48, P2159, DOI 10.1016/j.molimm.2011.07.011; Burcelin R, 2013, DIABETES OBES METAB, V15, P61, DOI 10.1111/dom.12157; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Catanzaro R, 2015, PANMINERVA MED, V57, P127; Chen J, 2012, BIOINFORMATICS, V28, P2106, DOI 10.1093/bioinformatics/bts342; Cohan FM, 2002, ANNU REV MICROBIOL, V56, P457, DOI 10.1146/annurev.micro.56.012302.160634; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Damgaard C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120826; de Punder K, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00223; Ding T, 2014, NATURE, V509, P357, DOI 10.1038/nature13178; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Engelbrektson A, 2010, ISME J, V4, P642, DOI 10.1038/ismej.2009.153; Epstein SS, 2013, CURR OPIN MICROBIOL, V16, P636, DOI 10.1016/j.mib.2013.08.003; Eren AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066643; Erny D, 2015, NAT NEUROSCI, V18, P965, DOI 10.1038/nn.4030; Everard A, 2014, ISME J, V8, P2116, DOI 10.1038/ismej.2014.45; Frey KG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-96; Friedland RP, 2015, J ALZHEIMERS DIS, V45, P349, DOI 10.3233/JAD-142841; Ge Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099414; Goodrich JK, 2014, CELL, V158, P250, DOI 10.1016/j.cell.2014.06.037; Guido S, 2015, J FUNCT FOODS, V14, P407, DOI 10.1016/j.jff.2015.02.014; Hacker G, 2002, IMMUNOLOGY, V105, P245; Holmes E, 2012, CELL METAB, V16, P559, DOI 10.1016/j.cmet.2012.10.007; Horzempa J, 2011, J INFECT DIS, V204, P51, DOI 10.1093/infdis/jir221; Hugenholtz P, 2002, GENOME BIOL, V3; Itzhaki RE, 2004, NEUROBIOL AGING, V25, P619, DOI 10.1016/j.neurobiolaging.2003.12.021; Janda JM, 2007, J CLIN MICROBIOL, V45, P2761, DOI 10.1128/JCM.01228-07; Kim M, 2014, J MICROBIOL, V52, P355, DOI 10.1007/s12275-014-3443-3; Kim M, 2011, J MICROBIOL METH, V84, P81, DOI 10.1016/j.mimet.2010.10.020; Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Kruis T, 2014, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00510; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Laurence M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097876; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Lipford GB, 1998, TRENDS MICROBIOL, V6, P496, DOI 10.1016/S0966-842X(98)01408-5; Logares R, 2014, ENVIRON MICROBIOL, V16, P2659, DOI 10.1111/1462-2920.12250; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Luche E, 2013, MOL METAB, V2, P281, DOI 10.1016/j.molmet.2013.06.005; Makarova KS, 2001, MICROBIOL MOL BIOL R, V65, P44, DOI 10.1128/MMBR.65.1.44-79.2001; Mariette J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-462; Miyazaki M, 2012, INT J SYST EVOL MICR, V62, P1075, DOI 10.1099/ijs.0.032326-0; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Navas-Molina JA, 2013, METHOD ENZYMOL, V531, P371, DOI 10.1016/B978-0-12-407863-5.00019-8; Nelson MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094249; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Nishida H, 2013, CURR ISSUES MOL BIOL, V15, P19; Ono S, 2005, WORLD J SURG, V29, P535, DOI 10.1007/s00268-004-7618-7; Opel KL, 2010, J FORENSIC SCI, V55, P25, DOI 10.1111/j.1556-4029.2009.01245.x; Pinto AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043093; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Potgieter M, 2015, FEMS MICROBIOL REV, V39, P567, DOI 10.1093/femsre/fuv013; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Sanmiguel C, 2015, CURR OBES REP, V4, P250, DOI 10.1007/s13679-015-0152-0; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Segal Leopoldo N, 2014, Ann Am Thorac Soc, V11 Suppl 1, pS21, DOI 10.1513/AnnalsATS.201306-189MG; Soergel DAW, 2012, ISME J, V6, P1440, DOI 10.1038/ismej.2011.208; Spangler R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007010; TEDESCHI GG, 1978, EXPERIENTIA, V34, P458, DOI 10.1007/BF01935925; Tichopad A, 2004, MOL CELL PROBE, V18, P45, DOI 10.1016/j.mcp.2003.09.001; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Unno T, 2015, J MICROBIOL BIOTECHN; Vetrovsky T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057923; Wang LR, 2015, J IMMUNOL METHODS, V421, P44, DOI 10.1016/j.jim.2014.12.015; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang Y, 2014, BRAIN BEHAV IMMUN, V38, P1, DOI 10.1016/j.bbi.2013.12.015; Wang ZW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050314; Ward DM, 2008, HEREDITY, V100, P207, DOI 10.1038/sj.hdy.6801011; Ward DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039315; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Xiao L, 2015, NAT BIOTECHNOL, V33, P1103, DOI 10.1038/nbt.3353; Yamaguchi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077282; Yan AW, 2012, WORLD J HEPATOL, V4, P110, DOI 10.4254/wjh.v4.i4.110; Zhan AB, 2014, METHODS ECOL EVOL, V5, P881, DOI 10.1111/2041-210X.12230	81	94	95	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142334	10.1371/journal.pone.0142334	http://dx.doi.org/10.1371/journal.pone.0142334			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544955	Green Submitted, Green Published, gold			2022-12-26	WOS:000364398700114
J	Manesi, Z; Van Lange, PAM; Pollet, TV				Manesi, Zoi; Van Lange, Paul A. M.; Pollet, Thomas V.			Butterfly Eyespots: Their Potential Influence on Aesthetic Preferences and Conservation Attitudes	PLOS ONE			English	Article							FACE-LIKE STIMULI; NEWBORNS PREFERENCE; WATCHING EYES; CUES; COOPERATION; RELEVANT; CHOICE; ACTIVATION; PUNISHMENT; PARADIGM	Research has shown that the mere presence of stimuli that resemble eyes is sufficient to attract attention, elicit aesthetic responses, and can even enhance prosocial behavior. However, it is less clear whether eye-like stimuli could also be used as a tool for nature conservation. Several animal species, including butterflies, develop eye-like markings that are known as eyespots. In the present research, we explored whether the mere display of eyespots on butterfly wings can enhance: (a) liking for a butterfly species, and (b) attitudes and behaviors towards conservation of a butterfly species. Four online experimental studies, involving 613 participants, demonstrated that eyespots significantly increased liking for a butterfly species. Furthermore, eyespots significantly increased positive attitudes towards conservation of a butterfly species (Studies 1, 2 and 4), whereas liking mediated the eyespot effect on conservation attitudes (Study 2). However, we also found some mixed evidence for an association between eyespots and actual conservation behavior (Studies 3 and 4). Overall, these findings suggest that eyespots may increase liking for an animal and sensitize humans to conservation. We discuss possible implications for biodiversity conservation and future research directions.	[Manesi, Zoi; Van Lange, Paul A. M.; Pollet, Thomas V.] Vrije Univ Amsterdam, Fac Behav & Movement Sci, Dept Expt & Appl Psychol, Social & Org Psychol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Manesi, Z (corresponding author), Vrije Univ Amsterdam, Fac Behav & Movement Sci, Dept Expt & Appl Psychol, Social & Org Psychol, Amsterdam, Netherlands.	z.manesi@vu.nl	Pollet, Thomas/M-6346-2019; Pollet, Thomas V/H-3397-2012	Pollet, Thomas/0000-0002-4210-935X; Pollet, Thomas V/0000-0002-4210-935X; Van Lange, Paul/0000-0001-7774-6984	John Templeton Grant [43919]; Netherlands Organisation for Scientific Research (Veni, Grant) [451.10.032]	John Templeton Grant; Netherlands Organisation for Scientific Research (Veni, Grant)	Support was provided by: 1) John Templeton Grant, Grant ID: 43919 [http://www.templeton.org/what-we-fund/grants/altruism-eye-cues-and-social-value-orientation-under-what-conditions-does-a-sens]. Authors who received the funding: PAMVL TVP ZM]; 2) The Netherlands Organisation for Scientific Research (Veni, Grant ID: 451.10.032) [http://www.nwo.nl/en/research-and-results/research-projects/08/2300161108.html]. Author who received the funding: TVP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HK, 2014, PSYCHOL SCI, V25, P224, DOI 10.1177/0956797613496823; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Baillon A, 2013, EVOL HUM BEHAV, V34, P146, DOI 10.1016/j.evolhumbehav.2012.12.001; Baron-Cohen S., 1995, MINDBLINDNESS ESSAY; Bateson M, 2006, BIOL LETTERS, V2, P412, DOI 10.1098/rsbl.2006.0509; Bourrat P, 2011, EVOL PSYCHOL-US, V9, P193, DOI 10.1177/147470491100900206; Boyd R, 2010, SCIENCE, V328, P617, DOI 10.1126/science.1183665; Brakefield Paul M, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.emo122; BRAKEFIELD PM, 1984, BIOL J LINN SOC, V22, P1, DOI 10.1111/j.1095-8312.1984.tb00795.x; Breuker CJ, 2002, P ROY SOC B-BIOL SCI, V269, P1233, DOI 10.1098/rspb.2002.2005; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Burnham K. P., 2002, MODEL SELECTION AND; Burnham TC, 2007, HUM NATURE-INT BIOS, V18, P88, DOI 10.1007/s12110-007-9012-2; Butterfield ME, 2012, J EXP SOC PSYCHOL, V48, P957, DOI 10.1016/j.jesp.2012.02.010; Cai W, 2015, EVOL HUM BEHAV, V36, P110, DOI 10.1016/j.evolhumbehav.2014.09.007; Caldara R, 2006, NEUROIMAGE, V31, P313, DOI 10.1016/j.neuroimage.2005.12.011; Carbon CC, 2011, SWISS J PSYCHOL, V70, P203, DOI 10.1024/1421-0185/a000058; Cassia VM, 2004, PSYCHOL SCI, V15, P379, DOI 10.1111/j.0956-7976.2004.00688.x; Dakin R, 2011, ANIM BEHAV, V82, P21, DOI 10.1016/j.anbehav.2011.03.016; de Pinho JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088842; Dunlap RE, 2000, J SOC ISSUES, V56, P425, DOI 10.1111/0022-4537.00176; EFRON B, 1987, J AM STAT ASSOC, V82, P171, DOI 10.2307/2289144; Ekstrom M, 2012, EXP ECON, V15, P530, DOI 10.1007/s10683-011-9312-6; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; Ernest-Jones M, 2011, EVOL HUM BEHAV, V32, P172, DOI 10.1016/j.evolhumbehav.2010.10.006; Farroni T, 2005, P NATL ACAD SCI USA, V102, P17245, DOI 10.1073/pnas.0502205102; Fathi M, 2014, EVOL PSYCHOL-US, V12, P878, DOI 10.1177/147470491401200502; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fehr E, 2010, P ROY SOC B-BIOL SCI, V277, P1315, DOI 10.1098/rspb.2009.1900; GARDNER W, 1995, PSYCHOL BULL, V118, P392, DOI 10.1037/0033-2909.118.3.392; Hadjikhani N, 2009, NEUROREPORT, V20, P403, DOI 10.1097/WNR.0b013e328325a8e1; Haley KJ, 2005, EVOL HUM BEHAV, V26, P245, DOI 10.1016/j.evolhumbehav.2005.01.002; Hardin JW, 2007, GENERALIZED LINEAR M; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Hinkley DV, 1997, BOOTSTRAP METHODS AN, DOI 10.2307/1271471; Huxley J., 1957, NEW BOTTLES NEW WINE; IBM SPSS Statistics, 2011, IBM SPSS STATISTICS; Itier RJ, 2007, J COGNITIVE NEUROSCI, V19, P1815, DOI 10.1162/jocn.2007.19.11.1815; Izuma K, 2010, SOC NEUROSCI-UK, V5, P133, DOI 10.1080/17470910903202559; Johnson MH, 2005, NAT REV NEUROSCI, V6, P766, DOI 10.1038/nrn1766; JOHNSON MH, 1991, COGNITION, V40, P1, DOI 10.1016/0010-0277(91)90045-6; Keaveney SM, 2012, PSYCHOL MARKET, V29, P36, DOI 10.1002/mar.20501; Keller J, 2011, EUR J PERSONALITY, V25, P363, DOI 10.1002/per.797; Kellert S.R., 1996, VALUE LIFE BIOL DIVE; Kurzban R, 2001, J NONVERBAL BEHAV, V25, P241, DOI 10.1023/A:1012563421824; Landwehr JR, 2011, J MARKETING, V75, P132, DOI 10.1509/jmkg.75.3.132; Langton SRH, 2000, TRENDS COGN SCI, V4, P50, DOI 10.1016/S1364-6613(99)01436-9; Liu JG, 2014, CORTEX, V53, P60, DOI 10.1016/j.cortex.2014.01.013; Martin JW, 1993, TERRA, V31, P30; McCullagh P., 1989, GENERALIZED LINEAR M, DOI DOI 10.1007/978-1-4899-3242-6; Miesler L, 2011, INT J DES, V5, P17; Nettle D, 2013, EVOL HUM BEHAV, V34, P35, DOI 10.1016/j.evolhumbehav.2012.08.004; Nettle D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051738; Oda R, 2015, EVOL PSYCHOL-US, V13, DOI 10.1177/1474704915594959; Oda R, 2011, EVOL HUM BEHAV, V32, P166, DOI 10.1016/j.evolhumbehav.2010.11.002; Panagopoulos C, 2014, EVOL HUM BEHAV, V35, P279, DOI 10.1016/j.evolhumbehav.2014.02.008; Powell KL, 2012, ETHOLOGY, V118, P1096, DOI 10.1111/eth.12011; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Raihani NJ, 2012, P ROY SOC B-BIOL SCI, V279, P3556, DOI 10.1098/rspb.2012.0758; Rigdon M, 2009, J ECON PSYCHOL, V30, P358, DOI 10.1016/j.joep.2009.02.002; Robertson KA, 2005, P ROY SOC B-BIOL SCI, V272, P1541, DOI 10.1098/rspb.2005.3142; Root-Bernstein M, 2013, BIODIVERS CONSERV, V22, P1577, DOI 10.1007/s10531-013-0494-4; Sagan C., 1981, COSMOS; Simion F, 2002, DEVELOPMENTAL SCI, V5, P427, DOI 10.1111/1467-7687.00237; Sourakov A, 2013, J NAT HIST, V47, P1047, DOI 10.1080/00222933.2012.759288; Sparks A, 2013, EVOL HUM BEHAV, V34, P317, DOI 10.1016/j.evolhumbehav.2013.05.001; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159; Stein T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029361; Stevens M, 2005, BIOL REV, V80, P573, DOI 10.1017/S1464793105006810; Stokes DL, 2007, HUM ECOL, V35, P361, DOI 10.1007/s10745-006-9056-7; Sylwester K, 2010, BIOL LETTERS, V6, P659, DOI 10.1098/rsbl.2010.0209; Takezawa M., 2011, LETT EVOLUTIONARY BE, V2, P24, DOI [DOI 10.5178/LEBS.2011.15, 10.5178/lebs.2011.15]; Tam KP, 2015, BRIT J SOC PSYCHOL, V54, P187, DOI 10.1111/bjso.12076; Tam KP, 2013, J EXP SOC PSYCHOL, V49, P514, DOI 10.1016/j.jesp.2013.02.001; Tomalski P, 2009, PERCEPTION, V38, P569, DOI 10.1068/p6137; Tomasello M, 2007, J HUM EVOL, V52, P314, DOI 10.1016/j.jhevol.2006.10.001; Turati C, 2002, DEV PSYCHOL, V38, P875, DOI 10.1037//0012-1649.38.6.875; Vallin A, 2005, P ROY SOC B-BIOL SCI, V272, P1203, DOI 10.1098/rspb.2004.3034; Van Vugt M., 2007, HDB EVOLUTIONARY PSY, P531; VanLange PAM, 1997, J PERS SOC PSYCHOL, V73, P733, DOI 10.1037/0022-3514.73.4.733; Verissimo D, 2009, ANIM CONSERV, V12, P549, DOI 10.1111/j.1469-1795.2009.00282.x; Vogt S, 2015, EVOL HUM BEHAV, V36, P224, DOI 10.1016/j.evolhumbehav.2014.11.007; Voss JL, 2012, CEREB CORTEX, V22, P2354, DOI 10.1093/cercor/bhr315; Wedekind C, 2000, SCIENCE, V288, P850, DOI 10.1126/science.288.5467.850	85	15	16	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141433	10.1371/journal.pone.0141433	http://dx.doi.org/10.1371/journal.pone.0141433			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV6RT	26544692	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000364398700024
J	Nagypal, T; Gombkoto, P; Barkoczi, B; Benedek, G; Nagy, A				Nagypal, Tamas; Gombkoeto, Peter; Barkoczi, Balazs; Benedek, Gyoergy; Nagy, Attila			Activity of Caudate Nucleus Neurons in a Visual Fixation Paradigm in Behaving Cats	PLOS ONE			English	Article							FAST-SPIKING INTERNEURONS; LATERAL SUPRASYLVIAN CORTEX; RECEPTIVE-FIELD PROPERTIES; STRIATAL NEURONS; RAT NEOSTRIATUM; SENSORIMOTOR STRIATUM; CHOLINERGIC NEURONS; CORRELATED LIGHT; FIRING PATTERNS; BASAL GANGLIA	Beside its motor functions, the caudate nucleus (CN), the main input structure of the basal ganglia, is also sensitive to various sensory modalities. The goal of the present study was to investigate the effects of visual stimulation on the CN by using a behaving, head-restrained, eye movement-controlled feline model developed recently for this purpose. Extracellular multielectrode recordings were made from the CN of two cats in a visual fixation paradigm applying static and dynamic stimuli. The recorded neurons were classified in three groups according to their electrophysiological properties: phasically active (PAN), tonically active (TAN) and high-firing (HFN) neurons. The response characteristics were investigated according to this classification. The PAN and TAN neurons were sensitive primarily to static stimuli, while the HFN neurons responded primarily to changes in the visual environment i.e. to optic flow and the offset of the stimuli. The HFNs were the most sensitive to visual stimulation; their responses were stronger than those of the PANs and TANs. The majority of the recorded units were insensitive to the direction of the optic flow, regardless of group, but a small number of direction-sensitive neurons were also found. Our results demonstrate that both the static and the dynamic components of the visual information are represented in the CN. Furthermore, these results provide the first piece of evidence on optic flow processing in the CN, which, in more general terms, indicates the possible role of this structure in dynamic visual information processing.	[Nagypal, Tamas; Barkoczi, Balazs; Benedek, Gyoergy; Nagy, Attila] Univ Szeged, Fac Med, Dept Physiol, Szeged, Hungary; [Gombkoeto, Peter] Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA	Szeged University; Rutgers State University Newark; Rutgers State University New Brunswick	Nagy, A (corresponding author), Univ Szeged, Fac Med, Dept Physiol, Szeged, Hungary.	nagy.attila.1@med.u-szeged.hu		Gombkoto, Peter/0000-0001-8393-173X	Hungarian Brain Research Program Grant [KTIA_13_NAP-A-I/15]; OTKA/Hungary Grant [83810]	Hungarian Brain Research Program Grant; OTKA/Hungary Grant(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	Funded by Hungarian Brain Research Program Grant KTIA_13_NAP-A-I/15 (AN) (http://www.agykutatas.com/); OTKA/Hungary Grant 83810. (http://www.otka.hu/) (GB). T. Nagypal was a fellow of Talentum Foundation of the Gedeon Richter Plc. (https://www.richter.hu/hu-HU/felelossegvallalas/alapitvanyok/Pages/Richter-Gedeon-TalentumAlapitvany. aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS CE, 1990, J COMP NEUROL, V292, P563, DOI 10.1002/cne.902920406; Apicella P, 2002, EUR J NEUROSCI, V16, P2017, DOI 10.1046/j.1460-9568.2002.02262.x; Averkin R, 2009, 12TH MEETING OF THE; Barnes TD, 2005, NATURE, V437, P1158, DOI 10.1038/nature04053; Barnes TD, 2011, J NEUROPHYSIOL, V105, P1861, DOI 10.1152/jn.00871.2010; Berke JD, 2004, NEURON, V43, P883, DOI 10.1016/j.neuron.2004.08.035; Berke JD, 2008, J NEUROSCI, V28, P10075, DOI 10.1523/JNEUROSCI.2192-08.2008; Brosseau-Lachaine O, 2001, CEREB CORTEX, V11, P989, DOI 10.1093/cercor/11.10.989; CHUDLER EH, 1995, BRAIN RES, V674, P33, DOI 10.1016/0006-8993(94)01427-J; DUBACH M, 1987, NEUROSCI LETT, V75, P205, DOI 10.1016/0304-3940(87)90298-9; Fino E, 2011, NEUROPHARMACOLOGY, V60, P780, DOI 10.1016/j.neuropharm.2011.01.023; Gage GJ, 2010, NEURON, V67, P466, DOI 10.1016/j.neuron.2010.06.034; Galvan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050808; Gombkoto P, 2011, NEUROSCIENCE, V182, P225, DOI 10.1016/j.neuroscience.2011.02.048; GRAVELAND GA, 1985, J COMP NEUROL, V234, P317, DOI 10.1002/cne.902340304; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Hazan L, 2006, J NEUROSCI METH, V155, P207, DOI 10.1016/j.jneumeth.2006.01.017; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P799, DOI 10.1152/jn.1989.61.4.799; Hokfelt T, 1988, J Chem Neuroanat, V1, P11; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; KAWAGUCHI Y, 1995, TRENDS NEUROSCI, V18, P527, DOI 10.1016/0166-2236(95)98374-8; KAWAGUCHI Y, 1993, J NEUROSCI, V13, P4908; KEMP JM, 1971, PHILOS T R SOC B, V262, P383, DOI 10.1098/rstb.1971.0102; Kubota Y, 2009, J NEUROPHYSIOL, V102, P2142, DOI 10.1152/jn.00522.2009; Lau B, 2007, J NEUROSCI, V27, P14502, DOI 10.1523/JNEUROSCI.3060-07.2007; Luk KC, 2001, NEUROSCIENCE, V104, P93, DOI 10.1016/S0306-4522(01)00038-0; Mallet N, 2005, J NEUROSCI, V25, P3857, DOI 10.1523/JNEUROSCI.5027-04.2005; McHaffie JG, 2005, TRENDS NEUROSCI, V28, P401, DOI 10.1016/j.tins.2005.06.006; McKown MD, 2006, J NEUROSCI METH, V153, P239, DOI 10.1016/j.jneumeth.2005.10.020; MORRONE MC, 1986, J NEUROPHYSIOL, V56, P969, DOI 10.1152/jn.1986.56.4.969; Nagy A, 2003, EUR J NEUROSCI, V18, P449, DOI 10.1046/j.1460-9568.2003.02764.x; Nagy A, 2008, EUR J NEUROSCI, V27, P1801, DOI 10.1111/j.1460-9568.2008.06137.x; Nagy A, 2010, NEUROSCI LETT, V480, P148, DOI 10.1016/j.neulet.2010.06.030; Nagypal T, 2014, J NEUROSCI METH, V221, P1, DOI 10.1016/j.jneumeth.2013.09.004; PHELPS PE, 1985, J COMP NEUROL, V238, P286, DOI 10.1002/cne.902380305; Plenz D, 1998, J NEUROSCI, V18, P266; POUDEROUX G, 1979, NEUROSCI LETT, V11, P53, DOI 10.1016/0304-3940(79)90055-7; Rokszin A, 2011, BRAIN RES, V1418, P52, DOI 10.1016/j.brainres.2011.08.015; ROLLS ET, 1983, BEHAV BRAIN RES, V7, P179, DOI 10.1016/0166-4328(83)90191-2; Rymar VV, 2004, J COMP NEUROL, V469, P325, DOI 10.1002/cne.11008; Schmitzer-Torbert N, 2004, J NEUROPHYSIOL, V91, P2259, DOI 10.1152/jn.00687.2003; Schmitzer-Torbert NC, 2008, NEUROSCIENCE, V153, P349, DOI 10.1016/j.neuroscience.2008.01.081; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; SMITH Y, 1986, BRAIN RES, V372, P241, DOI 10.1016/0006-8993(86)91131-5; Stalnaker TA, 2012, J NEUROSCI, V32, P10296, DOI 10.1523/JNEUROSCI.0832-12.2012; STRECKER RE, 1985, BRAIN RES, V329, P350, DOI 10.1016/0006-8993(85)90548-7; TAKAGI H, 1984, J NEUROCYTOL, V13, P239, DOI 10.1007/BF01148118; Tepper JM, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00150; THERIAULT E, 1987, J COMP NEUROL, V256, P1, DOI 10.1002/cne.902560102; Thorn CA, 2010, NEURON, V66, P781, DOI 10.1016/j.neuron.2010.04.036; Tseng K.Y., 2010, HDB BASAL GANGLIA ST; Vicente AF, 2012, BRAIN RES, V1466, P70, DOI 10.1016/j.brainres.2012.05.037; Villeneuve MY, 2003, J NEUROSCI METH, V129, P19, DOI 10.1016/S0165-0270(03)00198-5; VINCENT SR, 1983, NEUROSCI LETT, V35, P111, DOI 10.1016/0304-3940(83)90536-0; WILSON CJ, 1993, PROG BRAIN RES, V99, P277; WILSON CJ, 1990, J NEUROSCI, V10, P508; Wise SP, 1996, CRIT REV NEUROBIOL, V10, P317, DOI 10.1615/CritRevNeurobiol.v10.i3-4.30; Yarom O, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00036	58	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142526	10.1371/journal.pone.0142526	http://dx.doi.org/10.1371/journal.pone.0142526			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544604	Green Published, Green Submitted, gold			2022-12-26	WOS:000364398700151
J	Kim, SH; Huh, K; Won, S; Lee, KW; Park, MJ				Kim, Shin Hye; Huh, Kyoung; Won, Sungho; Lee, Kuk-Wha; Park, Mi-Jung			A Significant Increase in the Incidence of Central Precocious Puberty among Korean Girls from 2004 to 2010	PLOS ONE			English	Article							PREVALENCE; CHILDREN; BREAST; AGE	Background Few studies have explored the trends in central precocious puberty (CPP) in Asian populations. This study assessed the prevalence and annual incidence of CPP among Korean children. Methods Using data from the Korean Health Insurance Review Agency from 2004 to 2010, we reviewed the records of 21,351 children, including those registered with a diagnosis of CPP for the first time and those diagnosed with CPP who were treated with gonadotropin-releasing hormone analogs. Results The prevalence of CPP was 55.9 per 100,000 girls and 1.7 per 100,000 boys, respectively. The overall incidence of CPP was 15.3 per 100,000 girls, and 0.6 per 100,000 boys. The annual incidence of CPP in girls significantly increased from 3.3 to 50.4 per 100,000 girls; whereas in boys, it gradually increased from 0.3 to 1.2 per 100,000 boys. The annual incidence of CPP in girls consistently increased at all ages year by year, with greater increases at older ages (>= 6 years of age), and smaller increases in girls aged < 6 years. In contrast, the annual incidence remained relatively constant in boys aged < 8 years, while a small increase was observed only in boys aged 8 years. The increase of annual incidence showed significant differences depending on age and gender (P < 0.0001). Conclusions The annual incidence of CPP has substantially increased among Korean girls over the past 7 years. Continued monitoring of CPP trends among Korean children will be informative.	[Kim, Shin Hye; Park, Mi-Jung] Inje Univ, Sanggye Paik Hosp, Dept Pediat, Coll Med, Seoul, South Korea; [Huh, Kyoung] Kium Pediat Clin, Seoul, South Korea; [Won, Sungho] Seoul Natl Univ, Dept Publ Hlth Sci, Seoul, South Korea; [Lee, Kuk-Wha] Univ Calif Los Angeles, David Geffen Sch Med, Div Pediat Endocrinol, Mattel Childrens Hosp, Los Angeles, CA 90095 USA	Inje University; Seoul National University (SNU); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Park, MJ (corresponding author), Inje Univ, Sanggye Paik Hosp, Dept Pediat, Coll Med, Seoul, South Korea.	PMJ@paik.ac.kr						Aksglaede L, 2009, PEDIATRICS, V123, pE932, DOI 10.1542/peds.2008-2491; Biro FM, 2010, PEDIATRICS, V126, pE583, DOI 10.1542/peds.2009-3079; Carel JC, 2008, NEW ENGL J MED, V358, P2366, DOI 10.1056/NEJMcp0800459; Herman-Giddens ME, 2006, INT J ANDROL, V29, P241, DOI 10.1111/j.1365-2605.2005.00575.x; Hong CH, 1994, KOREAN J PEDIAT, V37, P193; Kim JY, 2010, J KOREAN MED SCI, V25, P1405, DOI 10.3346/jkms.2010.25.10.1405; Klein KO, 1999, J CLIN ENDOCR METAB, V84, P411, DOI 10.1210/jc.84.2.411; Korean Statistical Information Service, 2015, VIT STAT KOR, V6, P20; Ma HM, 2011, INT J ANDROL, V34, pE435, DOI 10.1111/j.1365-2605.2011.01173.x; Ma HM, 2009, PEDIATRICS, V124, pE269, DOI 10.1542/peds.2008-2638; Oh Chang-Mo, 2012, J Prev Med Public Health, V45, P227, DOI 10.3961/jpmph.2012.45.4.227; Soriano-Guillen L, 2010, J CLIN ENDOCR METAB, V95, P4305, DOI 10.1210/jc.2010-1025; Styne DM, 2011, WILLIAMS TXB ENDOCRI, P1087; Talma H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060056; Teilmann G, 2005, PEDIATRICS, V116, P1323, DOI 10.1542/peds.2005-0012; 오경원, 2008, Clinical and Experimental Pediatrics, V51, P950; 박미정, 2006, Clinical and Experimental Pediatrics, V49, P610	17	56	56	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141844	10.1371/journal.pone.0141844	http://dx.doi.org/10.1371/journal.pone.0141844			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26539988	Green Submitted, gold, Green Published			2022-12-26	WOS:000364303800031
J	Kraut, B; Maier, HJ; Kokai, E; Fiedler, K; Boettger, T; Illing, A; Kostin, S; Walther, P; Braun, T; Wirth, T				Kraut, Baerbel; Maier, Harald J.; Kokai, Enikoe; Fiedler, Katja; Boettger, Thomas; Illing, Annett; Kostin, Sawa; Walther, Paul; Braun, Thomas; Wirth, Thomas			Cardiac-Specific Activation of IKK2 Leads to Defects in Heart Development and Embryonic Lethality	PLoS One			English	Article							NF-KAPPA-B; LIVER DEGENERATION; MICE; MYOCARDITIS; EXPRESSION; CARDIOMYOPATHY; APOPTOSIS; RECEPTOR; STAT1	The transcription factor NF-kappa B has been associated with a range of pathological conditions of the heart, mainly based on its function as a master regulator of inflammation and pro-survival factor. Here, we addressed the question what effects activation of NF-kappa B can have during murine heart development. We expressed a constitutively active (CA) mutant of IKK2, the kinase activating canonical NF-kappa B signaling, specifically in cardiomyocytes under the control of the alpha-myosin heavy chain promoter. Expression of IKK2-CA resulted in embryonic lethality around E13. Embryos showed defects in compact zone formation and the contractile apparatus, and overall were characterized by widespread inflammation with infiltration of myeloid cells. Gene expression analysis suggested an interferon type I signature, with increased expression of interferon regulatory factors. While apoptosis of cardiomyocytes was only increased at later stages, their proliferation was decreased early on, providing an explanation for the disturbed compact zone formation. Mechanistically, this could be explained by activation of the JAK/STAT axis and increased expression of the cell cycle inhibitor p21. A rescue experiment with an I kappa B alpha superrepressor demonstrated that the phenotype was dependent on NF-kappa B. We conclude that activation of NF-kappa B is detrimental during normal heart development due to excessive activation of pro-inflammatory pathways.	[Kraut, Baerbel; Maier, Harald J.; Kokai, Enikoe; Fiedler, Katja; Wirth, Thomas] Univ Ulm, Inst Physiol Chem, D-89069 Ulm, Germany; [Boettger, Thomas; Kostin, Sawa; Braun, Thomas] Max Planck Inst Heart & Lung Res, Bad Nauheim, Germany; [Illing, Annett] Univ Ulm, Inst Mol Med, D-89069 Ulm, Germany; [Walther, Paul] Univ Ulm, Core Facil Electron Microscopy, D-89069 Ulm, Germany	Ulm University; Max Planck Society; Ulm University; Ulm University	Wirth, T (corresponding author), Univ Ulm, Inst Physiol Chem, D-89069 Ulm, Germany.	thomas.wirth@uni-ulm.de	Braun, Thomas/B-2310-2008; Wirth, Thomas/X-7172-2019; Boettger, Thomas/E-3406-2012	Boettger, Thomas/0000-0003-4280-8449; Braun, Thomas/0000-0002-6165-4804				Alter P, 2006, BIOCHEM BIOPH RES CO, V339, P180, DOI 10.1016/j.bbrc.2005.10.195; Brown M, 2005, AM J PHYSIOL-HEART C, V289, pH466, DOI 10.1152/ajpheart.00170.2004; Chin YE, 1996, SCIENCE, V272, P719, DOI 10.1126/science.272.5262.719; Clowes C, 2014, GENESIS, V52, P713, DOI 10.1002/dvg.22794; Dawn B, 2001, J MOL CELL CARDIOL, V33, P161, DOI 10.1006/jmcc.2000.1291; Gordon JW, 2011, CIRC RES, V108, P1122, DOI 10.1161/CIRCRESAHA.110.226928; Herrmann O, 2005, NAT MED, V11, P1322, DOI 10.1038/nm1323; Hikoso S, 2009, CIRC RES, V105, P70, DOI 10.1161/CIRCRESAHA.108.193318; Hinz M, 2014, EMBO REP, V15, P46, DOI 10.1002/embr.201337983; Hirata H, 2006, CELLS TISSUES ORGANS, V184, P172, DOI 10.1159/000099624; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Maier HJ, 2012, P NATL ACAD SCI USA, V109, P11794, DOI 10.1073/pnas.1116584109; O'Donnell SM, 2005, J CLIN INVEST, V115, P2341, DOI 10.1172/JCI22428; Ruppert V, 2008, CARDIOVASC PATHOL, V17, P81, DOI 10.1016/j.carpath.2007.07.004; Tanaka M, 1999, IMMUNITY, V10, P421, DOI 10.1016/S1074-7613(00)80042-4; Uchida S, 2013, STEM CELL REP, V1, P397, DOI 10.1016/j.stemcr.2013.09.004; Yamamoto K, 2003, J AM COLL CARDIOL, V42, P2000, DOI 10.1016/j.jacc.2003.07.021; Yokoseki O, 2001, CIRC RES, V89, P899, DOI 10.1161/hh2201.099373; Yu ZH, 1996, CIRC RES, V79, P691, DOI 10.1161/01.RES.79.4.691	20	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141591	10.1371/journal.pone.0141591	http://dx.doi.org/10.1371/journal.pone.0141591			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26539991	Green Submitted, gold, Green Published			2022-12-26	WOS:000364303800021
J	Pirson, M; Debrulle, S; Clippe, A; Clotman, F; Knoops, B				Pirson, Marc; Debrulle, Stephanie; Clippe, Andre; Clotman, Frederic; Knoops, Bernard			Thioredoxin-2 Modulates Neuronal Programmed Cell Death in the Embryonic Chick Spinal Cord in Basal and Target-Deprived Conditions	PLOS ONE			English	Article							OXIDATIVE STRESS; MITOCHONDRIAL THIOREDOXIN; DEPENDENT ACTIVATION; PC12 CELLS; LIFE-SPAN; APOPTOSIS; GLUTATHIONE; REDUCTASE; SYSTEM; MOTONEURONS	Thioredoxin-2 (Trx2) is a mitochondrial protein using a dithiol active site to reduce protein disulfides. In addition to the cytoprotective function of this enzyme, several studies have highlighted the implication of Trx2 in cellular signaling events. In particular, growing evidence points to such roles of redox enzymes in developmental processes taking place in the central nervous system. Here, we investigate the potential implication of Trx2 in embryonic development of chick spinal cord. To this end, we first studied the distribution of the enzyme in this tissue and report strong expression of Trx2 in chick embryo post-mitotic neurons at E4.5 and in motor neurons at E6.5. Using in ovo electroporation, we go on to highlight a cytoprotective effect of Trx2 on the programmed cell death (PCD) of neurons during spinal cord development and in a novel cultured spinal cord explant model. These findings suggest an implication of Trx2 in the modulation of developmental PCD of neurons during embryonic development of the spinal cord, possibly through redox regulation mechanisms.	[Pirson, Marc; Debrulle, Stephanie; Clippe, Andre; Knoops, Bernard] Catholic Univ Louvain, ISV, Grp Anim Mol & Cellular Biol, B-1348 Louvain La Neuve, Belgium; [Clotman, Frederic] Catholic Univ Louvain, Grp Neural Differentiat, Inst Neurosci IONS, B-1200 Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain	Knoops, B (corresponding author), Catholic Univ Louvain, ISV, Grp Anim Mol & Cellular Biol, B-1348 Louvain La Neuve, Belgium.	bernard.knoops@uclouvain.be		Pirson, Magali/0000-0001-8468-3184; Pirson, Marc/0000-0001-5018-5072	Communaute francaise de Belgique-Actions de Recherche Concertees (ARC) [10/15-026]; DIANE research program of the Walloon region [816844]	Communaute francaise de Belgique-Actions de Recherche Concertees (ARC); DIANE research program of the Walloon region	This work was supported by Communaute francaise de Belgique-Actions de Recherche Concertees (ARC)" #10/15-026 of the "Direction generale de l'Enseignement non obligatoire et de la Recherche scientifique - Direction de la Recherche scientifique - Communaute francaise de Belgique" and granted by the "Academie universitaire 'Louvain"' and the DIANE research program of the Walloon region, Grant number : 816844. Marc Pirson is holder of a FRIA fellowship (FRS-FNRS, Belgium). F.C. is a Research Associate of the F.R.S.-FNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai J, 2003, J NEUROSCI, V23, P503, DOI 10.1523/JNEUROSCI.23-02-00503.2003; Brautigam L, 2011, P NATL ACAD SCI USA, V108, P20532, DOI 10.1073/pnas.1110085108; Caldero J, 1998, J NEUROSCI, V18, P356; Caldwell RB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2004-6-1-r6; Chen Y, 2006, TOXICOL APPL PHARM, V216, P256, DOI 10.1016/j.taap.2006.05.006; Conrad M, 2004, MOL CELL BIOL, V24, P9414, DOI 10.1128/MCB.24.21.9414-9423.2004; Covarrubias L, 2008, DEV BIOL, V320, P1, DOI 10.1016/j.ydbio.2008.04.041; Cui DP, 2006, PHYSIOL GENOMICS, V24, P276, DOI 10.1152/physiolgenomics.00109.2005; Dennery PA, 2010, FREE RADICAL BIO MED, V49, P1147, DOI 10.1016/j.freeradbiomed.2010.07.011; Ferretti P, 2008, CELL MOL LIFE SCI, V65, P45, DOI 10.1007/s00018-007-7430-2; Fujino G, 2007, MOL CELL BIOL, V27, P8152, DOI 10.1128/MCB.00227-07; Gertz M, 2008, P NATL ACAD SCI USA, V105, P5705, DOI 10.1073/pnas.0800691105; Halliwell B, 2007, FREE RADICALS IN BIO; Hanschmann EM, 2013, ANTIOXID REDOX SIGN, V19, P1539, DOI 10.1089/ars.2012.4599; Hanschmann EM, 2010, J BIOL CHEM, V285, P40699, DOI 10.1074/jbc.M110.185827; Hansen JM, 2006, TOXICOL SCI, V91, P643, DOI 10.1093/toxsci/kfj175; Hansen JM, 2015, BBA-GEN SUBJECTS, V1850, P1527, DOI 10.1016/j.bbagen.2014.12.001; Hellfritsch J, 2015, ANTIOXID REDOX SIGN, V22, P938, DOI 10.1089/ars.2014.5889; Horstkorte R, 2010, BIOCHEM BIOPH RES CO, V395, P296, DOI 10.1016/j.bbrc.2010.03.113; Hou Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076721; Imhoff BR, 2011, CELL MOL BIOL LETT, V16, P149, DOI 10.2478/s11658-010-0042-0; Jarvis RM, 2012, FREE RADICAL BIO MED, V53, P1522, DOI 10.1016/j.freeradbiomed.2012.08.001; Kamata H, 2005, ARCH BIOCHEM BIOPHYS, V434, P16, DOI 10.1016/j.abb.2004.07.036; Kim SU, 2014, STEM CELLS, V32, P998, DOI 10.1002/stem.1593; Koharyova M, 2008, GEN PHYSIOL BIOPHYS, V27, P71; Lawson SJ, 1997, EUR J NEUROSCI, V9, P794, DOI 10.1111/j.1460-9568.1997.tb01428.x; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; Lu J, 2012, ANTIOXID REDOX SIGN, V17, P1738, DOI 10.1089/ars.2012.4650; Mandal PK, 2010, CANCER RES, V70, P9505, DOI 10.1158/0008-5472.CAN-10-1509; Mandal PK, 2010, J BIOL CHEM, V285, P22244, DOI 10.1074/jbc.M110.121327; Masutani H, 2004, MOL NEUROBIOL, V29, P229, DOI 10.1385/MN:29:3:229; MCKAY SE, 1991, J NEUROBIOL, V22, P721, DOI 10.1002/neu.480220707; Meyer Y, 2009, ANNU REV GENET, V43, P335, DOI 10.1146/annurev-genet-102108-134201; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Navarro-Yepes J, 2014, ANTIOXID REDOX SIGN, V21, P66, DOI 10.1089/ars.2014.5837; Nonn L, 2003, MOL CELL BIOL, V23, P916, DOI 10.1128/MCB.23.3.916-922.2003; Oppenheim RW, 2000, J NEUROSCI, V20, P6117, DOI 10.1523/JNEUROSCI.20-16-06117.2000; Ostrakhovitch EA, 2013, ARCH BIOCHEM BIOPHYS, V534, P44, DOI 10.1016/j.abb.2012.08.002; Park S, 2013, SCIENCE, V339, P324, DOI 10.1126/science.1231921; Perez VI, 2008, FREE RADICAL BIO MED, V44, P882, DOI 10.1016/j.freeradbiomed.2007.11.018; Pirson M, 2015, J COMP NEUROL, V523, P2599, DOI 10.1002/cne.23807; Prasad T, 2008, DEVELOPMENT, V135, P4153, DOI 10.1242/dev.026807; Prozorovski T, 2008, NAT CELL BIOL, V10, P385, DOI 10.1038/ncb1700; Sabharwal P, 2011, NEURON, V71, P1058, DOI 10.1016/j.neuron.2011.07.028; Sanchez-Carbente MR, 2005, CELL DEATH DIFFER, V12, P279, DOI 10.1038/sj.cdd.4401560; Sayre LM, 2008, CHEM RES TOXICOL, V21, P172, DOI 10.1021/tx700210j; Sendtner M, 2000, CELL TISSUE RES, V301, P71, DOI 10.1007/s004410000217; Tanaka T, 2002, EMBO J, V21, P1695, DOI 10.1093/emboj/21.7.1695; Taylor AR, 2007, J NEUROSCI, V27, P634, DOI 10.1523/JNEUROSCI.4947-06.2007; Timme-Laragy AR, 2013, FREE RADICAL BIO MED, V65, P89, DOI 10.1016/j.freeradbiomed.2013.06.011; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Wang DM, 2006, J BIOL CHEM, V281, P7384, DOI 10.1074/jbc.M509876200; Yamamoto Y, 1999, DEV BIOL, V214, P60, DOI 10.1006/dbio.1999.9413; Yan Y, 2009, CELL, V138, P1209, DOI 10.1016/j.cell.2009.06.042; Zhang R, 2004, CIRC RES, V94, P1483, DOI 10.1161/01.RES.0000130525.37646.a7	55	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142280	10.1371/journal.pone.0142280	http://dx.doi.org/10.1371/journal.pone.0142280			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540198	Green Submitted, Green Published, gold			2022-12-26	WOS:000364303800074
J	Dwyer, T; Pezic, A; Sun, C; Cochrane, J; Venn, A; Srikanth, V; Jones, G; Shook, R; Sui, XM; Ortaglia, A; Blair, S; Ponsonby, AL				Dwyer, Terence; Pezic, Angela; Sun, Cong; Cochrane, Jenny; Venn, Alison; Srikanth, Velandai; Jones, Graeme; Shook, Robin; Sui, Xuemei; Ortaglia, Andrew; Blair, Steven; Ponsonby, Anne-Louise			Objectively Measured Daily Steps and Subsequent Long Term All-Cause Mortality: The Tasped Prospective Cohort Study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY QUESTIONNAIRE; LIFE-STYLE; RISK; METAANALYSIS; PEDOMETER; ASSOCIATION; RELIABILITY; VALIDITY; DISEASE; FITNESS	Background Self-reported physical activity has been inversely associated with mortality but the effect of objectively measured step activity on mortality has never been evaluated. The objective is to determine the prospective association of daily step activity on mortality among free-living adults. Methods and Findings Cohort study of free-living adults residing in Tasmania, Australia between 2000 and 2005 who participated in one of three cohort studies (n = 2 576 total participants). Daily step activity by pedometer at baseline at a mean of 58.8 years of age, and for a subset, repeated monitoring was available 3.7 (SD 1.3) years later (n = 1 679). All-cause mortality (n = 219 deaths) was ascertained by record-linkage to the Australian National Death Index; 90% of participants were followed-up over ten years, until June 2011. Higher daily step count at baseline was linearly associated with lower all-cause mortality (adjusted hazard ratio AHR, 0.94; 95% CI, 0.90 to 0.98 per 1 000 steps; P = 0.004). Risk was altered little by removing deaths occurring in the first two years. Increasing baseline daily steps from sedentary to 10 000 steps a day was associated with a 46% (95% CI, 18% to 65%; P = 0.004) lower risk of mortality in the decade of follow-up. In addition, those who increased their daily steps over the monitoring period had a substantial reduction in mortality risk, after adjusting for baseline daily step count (AHR, 0.39; 95% CI, 0.22 to 0.72; P = 0.002), or other factors (AHR, 0.38; 95% CI, 0.21-0.70; P = 0.002). Conclusions Higher daily step count was linearly associated with subsequent long term mortality among free living adults. These data are the first to quantify mortality reductions using an objective measure of physical activity in a free living population. They strongly underscore the importance of physical inactivity as a major public health problem.	[Dwyer, Terence] George Inst Global Hlth, Oxford, England; [Dwyer, Terence; Cochrane, Jenny; Venn, Alison; Jones, Graeme; Ponsonby, Anne-Louise] Univ Tasmania, Menzies Res Inst, Hobart, Tas, Australia; [Dwyer, Terence; Pezic, Angela; Sun, Cong; Ponsonby, Anne-Louise] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Sun, Cong; Ponsonby, Anne-Louise] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Srikanth, Velandai] Monash Univ, Sch Clin Sci, Med, Stroke & Ageing Res Grp, Melbourne, Vic 3004, Australia; [Shook, Robin; Sui, Xuemei; Ortaglia, Andrew; Blair, Steven] Iowa State Univ Sci & Technol, Ames, IA 50011 USA; [Sui, Xuemei; Blair, Steven] Univ S Carolina, Arnold Sch Publ Hlth, Dept Exercise Sci, Columbia, SC 29208 USA; [Ortaglia, Andrew; Blair, Steven] Univ S Carolina, Arnold Sch Publ Hlth, Dept Epidemiol & Biostat, Columbia, SC 29208 USA	University of Tasmania; Menzies Institute for Medical Research; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Monash University; Iowa State University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Ponsonby, AL (corresponding author), Univ Tasmania, Menzies Res Inst, Hobart, Tas, Australia.	anne-louise.ponsonby@mcri.edu.au	Ponsonby, Anne-Louise/AAE-4351-2019; Venn, Alison J/J-2803-2013	Srikanth, Velandai/0000-0002-8442-8981; Ponsonby, Anne-Louise/0000-0002-6581-3657	National Health and Medical Research Council of Australia; Commonwealth Department of Health and Aged Care; Abbott Australasia; Alphapharm; Aventis Pharmaceutical; AstraZeneca; Bristol-Myers Squibb Pharmaceuticals; Eli Lilly (Australia); GlaxoSmithKline; Janssen-Cilag (Australia); Merck Lipha; Merck Sharp and Dohme (Australia); Novartis Pharmaceutical (Australia); Novo Nordisk Pharmaceutical; Pharmacia and Upjohn; Pfizer; Roche Diagnostics; Sanofi Synthelabo (Australia); Servier Laboratories (Australia); BioRad Laboratories; Hitech Pathology; Australian Kidney Foundation; Diabetes Australia; Tasmanian Department of Health and Human Services; Physiotherapy Research Foundation; Perpetual Trustees; Brain Foundation; Royal Hobart Hospital Research Foundation; ANZ Charitable Trust; Tasmanian Community Fund; Arthritis Foundation of Australia; Masonic Centenary Medical Research Foundation; Victorian Government's Operational Infrastructure Support Program	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Commonwealth Department of Health and Aged Care; Abbott Australasia(Abbott Laboratories); Alphapharm; Aventis Pharmaceutical; AstraZeneca(AstraZeneca); Bristol-Myers Squibb Pharmaceuticals(Bristol-Myers Squibb); Eli Lilly (Australia)(Eli Lilly); GlaxoSmithKline(GlaxoSmithKline); Janssen-Cilag (Australia)(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck Lipha; Merck Sharp and Dohme (Australia)(Merck & Company); Novartis Pharmaceutical (Australia); Novo Nordisk Pharmaceutical(Novo Nordisk); Pharmacia and Upjohn; Pfizer(Pfizer); Roche Diagnostics; Sanofi Synthelabo (Australia); Servier Laboratories (Australia); BioRad Laboratories; Hitech Pathology; Australian Kidney Foundation; Diabetes Australia; Tasmanian Department of Health and Human Services; Physiotherapy Research Foundation; Perpetual Trustees; Brain Foundation; Royal Hobart Hospital Research Foundation; ANZ Charitable Trust; Tasmanian Community Fund; Arthritis Foundation of Australia; Masonic Centenary Medical Research Foundation; Victorian Government's Operational Infrastructure Support Program	The study received financial support from the National Health and Medical Research Council of Australia, the Commonwealth Department of Health and Aged Care, Abbott Australasia, Alphapharm, Aventis Pharmaceutical, AstraZeneca, Bristol-Myers Squibb Pharmaceuticals, Eli Lilly (Australia), GlaxoSmithKline, Janssen-Cilag (Australia), Merck Lipha, Merck Sharp and Dohme (Australia), Novartis Pharmaceutical (Australia), Novo Nordisk Pharmaceutical, Pharmacia and Upjohn, Pfizer, Roche Diagnostics, Sanofi Synthelabo (Australia), Servier Laboratories (Australia), BioRad Laboratories, Hitech Pathology, the Australian Kidney Foundation, Diabetes Australia, Tasmanian Department of Health and Human Services, the Physiotherapy Research Foundation, Perpetual Trustees, Brain Foundation, Royal Hobart Hospital Research Foundation, ANZ Charitable Trust, Tasmanian Community Fund; Arthritis Foundation of Australia and Masonic Centenary Medical Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Amanda Hawker for cohort data management and Helen Raschella and Rianna Chapman for manuscript preparation. We thank Andrew Kemp for literature review. This work was supported by the Victorian Government's Operational Infrastructure Support Program.	Armitage P., 2001, STAT METHODS MED RES; Australian Institute of Health and Welfare, 2012, NAT DEATH IND CANB; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; BLAIR SN, 1995, JAMA-J AM MED ASSOC, V273, P1093, DOI 10.1001/jama.273.14.1093; Bravata DM, 2007, JAMA-J AM MED ASSOC, V298, P2296, DOI 10.1001/jama.298.19.2296; Callisaya ML, 2012, GAIT POSTURE, V36, P510, DOI 10.1016/j.gaitpost.2012.05.003; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Dore D, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3689; Dore D, 2009, J BONE MINER RES, V24, P2007, DOI [10.1359/JBMR.090532, 10.1359/jbmr.090532]; Dunstan DW, 2002, DIABETES RES CLIN PR, V57, P119, DOI 10.1016/S0168-8227(02)00025-6; Dwyer T, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7249; Ekelund U, 2007, DIABETES CARE, V30, P2101, DOI 10.2337/dc07-0719; Gebel K, 2015, JAMA INT MED; Hallal PC, 2004, MED SCI SPORT EXER, V36, P556, DOI 10.1249/01.MSS.0000117161.66394.07; Hatano Y, 1993, INT COUNC HLTH PHYS, V29, P4; Helmerhorst HJF, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-103; Hodge A, 2000, AUST NZ J PUBL HEAL, V24, P576, DOI 10.1111/j.1467-842X.2000.tb00520.x; Kelley GA, 2006, ATHEROSCLEROSIS, V184, P207, DOI 10.1016/j.atherosclerosis.2005.04.005; Koster F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033118; Lee DC, 2011, CIRCULATION, V124, P2483, DOI 10.1161/CIRCULATIONAHA.111.038422; Li J, 2012, INT J ENV RES PUB HE, V9, P391, DOI 10.3390/ijerph9020391; Lollgen H, 2009, INT J SPORTS MED, V30, P213, DOI 10.1055/s-0028-1128150; Marshall SJ, 2009, AM J PREV MED, V36, P410, DOI 10.1016/j.amepre.2009.01.021; Monninkhof EM, 2007, EPIDEMIOLOGY, V18, P137, DOI 10.1097/01.ede.0000251167.75581.98; Moore SC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001335; Myers J, 2004, AM J MED, V117, P912, DOI 10.1016/j.amjmed.2004.06.047; Nocon M, 2008, EUR J CARDIOV PREV R, V15, P239, DOI 10.1097/HJR.0b013e3282f55e09; PAFFENBARGER RS, 1986, NEW ENGL J MED, V314, P605, DOI 10.1056/NEJM198603063141003; Ponsonby AL, 2011, DIABETES CARE, V34, P1497, DOI 10.2337/dc10-2386; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; Salmon J, 2003, HEALTH PSYCHOL, V22, P178, DOI 10.1037/0278-6133.22.2.178; Sattelmair J, 2011, CIRCULATION, V124, P789, DOI 10.1161/CIRCULATIONAHA.110.010710; Schmidt MD, 2009, AM J PREV MED, V37, P278, DOI 10.1016/j.amepre.2009.05.020; Tudor-Locke C, 2002, MED SCI SPORT EXER, V34, P2045, DOI 10.1097/00005768-200212000-00027; Tudor-Locke C, 2005, PREV MED, V40, P293, DOI 10.1016/j.ypmed.2004.06.003; Tudor-Locke C, 2002, SPORTS MED, V32, P795, DOI 10.2165/00007256-200232120-00004; Tudor-Locke C, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-59; Warnecke RB, 1997, ANN EPIDEMIOL, V7, P334, DOI 10.1016/S1047-2797(97)00030-6; Wen CP, 2011, LANCET, V378, P1244, DOI 10.1016/S0140-6736(11)60749-6; Woodcock J, 2011, INT J EPIDEMIOL, V40, P121, DOI 10.1093/ije/dyq104; Yates T, 2014, LANCET, V383, P1059, DOI 10.1016/S0140-6736(13)62061-9	42	78	78	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141274	10.1371/journal.pone.0141274	http://dx.doi.org/10.1371/journal.pone.0141274			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536618	Green Published, gold			2022-12-26	WOS:000364298400057
J	Klenova, AV				Klenova, Anna V.			Chick Begging Calls Reflect Degree of Hunger in Three Auk Species (Charadriiformes: Alcidae)	PLOS ONE			English	Article							PARENT-OFFSPRING RECOGNITION; PRIONS PACHYPTILA-BELCHERI; NESTLING TREE SWALLOWS; WILSONS STORM-PETRELS; INDIVIDUAL RECOGNITION; OCEANITES-OCEANICUS; ACOUSTIC PARAMETERS; MANX SHEARWATERS; SEX-DIFFERENCES; BODY CONDITION	Begging behaviour is an important element in the parent-offspring conflict; it has been studied in many avian species. However, the majority of the studies have been entirely based on the call counts, and they agreed that vocal activity was a good indicator of chick's nutritional need and/or condition. Fewer researches were dedicated to the temporal-frequency variables of the begging calls themselves and they showed contrary results. Here begging behaviour in three burrow nested, uniparous species of auks (Alcidae) was studied. These objects provide an opportunity to study the signalling value of begging calls in the absence of important confounding factors such as nestling competition and predation pressure. I recorded calls of individual chicks in two conditions: during natural feeding and after experimental four-hour food deprivation. I found that almost all measured acoustic variables contain information about the chick's state in all studied species. The hungry chicks produced calls higher in fundamental frequency and power variables and at higher calling rate compared to naturally feeding chicks. The effect of food deprivation on most acoustic variables exceeded both the effects of individuality and species. In all studied species, the frequency variables were stronger affected by hunger than the calling rate and call durations. I suppose that such strong change of acoustic variables after food deprivation can be explained by absence of vocal individual identification in these birds. As parents do not need to check individuality of the chick in the burrow, which they find visually during the day time, the chicks could use all of the acoustic variables to communicate about their nutritional needs.	Moscow MV Lomonosov State Univ, Fac Biol, Dept Vertebrate Zool, Moscow 119234, Russia	Lomonosov Moscow State University	Klenova, AV (corresponding author), Moscow MV Lomonosov State Univ, Fac Biol, Dept Vertebrate Zool, Vorobievy Gory 1-12, Moscow 119234, Russia.	anna.v.klenova@gmail.com			Russian Scientific Foundation [14-14-00237]; Russian Science Foundation [14-14-00237] Funding Source: Russian Science Foundation	Russian Scientific Foundation(Russian Science Foundation (RSF)); Russian Science Foundation(Russian Science Foundation (RSF))	Funding: To conduct this study AVK was funded by the Russian Scientific Foundation (grant 14-14-00237). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreev AV, 2010, B NESC FEB RAS, V2, P30; Bakhturina DS, 2014, B NESC FEB RAS, V3, P83; BEECHER MD, 1981, ANIM BEHAV, V29, P95, DOI 10.1016/S0003-3472(81)80156-X; Duckworth A, 2009, ACTA ORNITHOL, V44, P127, DOI 10.3161/000164509X482704; Falls JB., 1982, ACOUSTIC COMMUNICATI, P237; Fitch W.T., 2002, ACOUSTIC COMMUNICATI, V16, P65; Frommolt Karl-Heinz, 1999, Bioacoustics, V10, P219; Gaston A.J., 1998, THE AUKS; Gladbach A, 2009, J ETHOL, V27, P267, DOI 10.1007/s10164-008-0115-y; Hamer KC, 1999, ANIM BEHAV, V57, P627, DOI 10.1006/anbe.1998.0994; Insley SJ, 2003, J EXP BIOL, V206, P25, DOI 10.1242/jeb.00072; Jones IL, 1993, BIRDS N AM ONLINE, DOI [10.2173/bna.70;1993, DOI 10.2173/BNA.70;]; Jones IL, BIRDS N AM ONLINE, DOI [10.2I73/bna.594, DOI 10.2173/BNA.594;]; Jouventin P, 1999, ANIM BEHAV, V57, P1175, DOI 10.1006/anbe.1999.1086; Kedar H, 2000, P ROY SOC B-BIOL SCI, V267, P1723, DOI 10.1098/rspb.2000.1201; Kilner R, 1998, ANIM BEHAV, V56, P705, DOI 10.1006/anbe.1998.0785; Kilner R, 1997, TRENDS ECOL EVOL, V12, P11, DOI 10.1016/S0169-5347(96)10061-6; Klenova AV, 2012, ZOOL ZH, V91, P869; Klenova AV, 2013, J ORNITHOL, V154, P705, DOI 10.1007/s10336-013-0935-6; Klenova AV, 2012, ACTA ETHOL, V15, P141, DOI 10.1007/s10211-011-0120-y; Klenova AV, 2009, ACTA ETHOL, V12, P29, DOI 10.1007/s10211-009-0053-x; Kolesnikova YA, 2011, P 8 C EUR ORN UN RIG, P199; Lefevre K, 1998, ANIM BEHAV, V55, P925, DOI 10.1006/anbe.1997.0626; Leger S. A., 2015, COMMUNICATION; Leonard ML, 2006, ETHOLOGY, V112, P1020, DOI 10.1111/j.1439-0310.2006.01259.x; Leonard ML, 2005, P ROY SOC B-BIOL SCI, V272, P651, DOI 10.1098/rspb.2004.3021; Leonard ML, 2001, ANIM BEHAV, V61, P87, DOI 10.1006/anbe.2000.1575; Marques PAM, 2009, ZOOL STUD, V48, P587; Marques PAM, 2008, BIOACOUSTICS, V18, P133, DOI 10.1080/09524622.2008.9753596; Mathevon N, 2003, CR BIOL, V326, P329, DOI 10.1016/S1631-0691(03)00072-6; MONDLOCH CJ, 1995, ANIM BEHAV, V49, P601; Owings D. H., 1998, ANIMAL VOCAL COMMUNI; Piatt J.F., 2002, BIRDS N AM, DOI [10.2173/bna.603., DOI 10.2173/BNA.603]; Quillfeldt P, 2004, ANIM BEHAV, V68, P613, DOI 10.1016/j.anbehav.2003.12.002; Quillfeldt P, 2002, ANIM BEHAV, V64, P579, DOI 10.1006/anbe.2002.3090; Quillfeldt P, 2007, BEHAV ECOL SOCIOBIOL, V61, P793, DOI 10.1007/s00265-006-0310-1; Quillfeldt Petra, 2004, Acta Ethologica, V7, P73, DOI 10.1007/s10211-004-0100-6; Quillfeldt P, 2010, ACTA ETHOL, V13, P1, DOI 10.1007/s10211-009-0066-5; Quillfeldt P, 2009, GEN COMP ENDOCR, V161, P171, DOI 10.1016/j.ygcen.2008.12.006; Rector ME, 2014, BEHAV ECOL, V25, P496, DOI 10.1093/beheco/aru009; Reers Hendrik, 2011, BMC Ecology, V11, P3, DOI 10.1186/1472-6785-11-3; Royle NJ, 2002, TRENDS ECOL EVOL, V17, P434, DOI 10.1016/S0169-5347(02)02565-X; Sacchi R, 2002, BEHAV ECOL, V13, P268, DOI 10.1093/beheco/13.2.268; Searby A, 2004, ANIM BEHAV, V67, P615, DOI 10.1016/j.anbehav.2003.03.012; Smith NA, 2011, ZOOKEYS, P1, DOI 10.3897/zookeys.91.709; Trager I, 2006, WATERBIRDS, V29, P315, DOI 10.1675/1524-4695(2006)29[315:DAPOBC]2.0.CO;2; WELHAM CVJ, 1993, ANIM BEHAV, V45, P827, DOI 10.1006/anbe.1993.1099; Wilden I., 1998, Bioacoustics, V9, P171; Zollinger SA, 2008, J EXP BIOL, V211, P1978, DOI 10.1242/jeb.014092	49	12	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140151	10.1371/journal.pone.0140151	http://dx.doi.org/10.1371/journal.pone.0140151			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536362	Green Published, gold, Green Submitted			2022-12-26	WOS:000364298400018
J	Mohammad, H; Cushman, M; Seleem, MN				Mohammad, Haroon; Cushman, Mark; Seleem, Mohamed N.			Antibacterial Evaluation of Synthetic Thiazole Compounds In Vitro and In Vivo in a Methicillin-Resistant Staphylococcus aureus (MRSA) Skin Infection Mouse Model	PLOS ONE			English	Article							SOFT-TISSUE INFECTIONS; MUPIROCIN RESISTANCE; PRACTICE GUIDELINES; DISEASES SOCIETY; VANCOMYCIN; ANTIBIOTICS; COMBINATION; EPIDEMIOLOGY; CLINDAMYCIN; AMOXICILLIN	The emergence of community-associated methicillin-resistant Staphylococcus aureus (MRSA), including strains resistant to current antibiotics, has contributed to an increase in the number of skin infections reported in humans in recent years. New therapeutic options are needed to counter this public health challenge. The aim of the present study was to examine the potential of thiazole compounds synthesized by our research group to be used topically to treat MRSA skin and wound infections. The broth microdilution method confirmed that the lead thiazole compound and four analogues are capable of inhibiting MRSA growth at concentrations as low as 1.3 mu g/mL. Additionally, three compounds exhibited a synergistic relationship when combined with the topical antibiotic mupirocin against MRSA in vitro via the checkerboard assay. Thus the thiazole compounds have potential to be used alone or in combination with mupirocin against MRSA. When tested against human keratinocytes, four derivatives of the lead compound demonstrated an improved toxicity profile (were found to be non-toxic up to a concentration of 20 mu g/mL). Utilizing a murine skin infection model, we confirmed that the lead compound and three analogues exhibited potent antimicrobial activity in vivo, with similar capability as the antibiotic mupirocin, as they reduced the burden of MRSA present in skin wounds by more than 90%. Taken altogether, the present study provides important evidence that these thiazole compounds warrant further investigation for development as novel topical antimicrobials to treat MRSA skin infections.	[Mohammad, Haroon; Seleem, Mohamed N.] Purdue Univ, Coll Vet Med, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA; [Cushman, Mark] Purdue Univ, Dept Med Chem & Mol Pharmacol, Coll Pharm, W Lafayette, IN 47907 USA; [Cushman, Mark] Purdue Ctr Canc Res, W Lafayette, IN USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Seleem, MN (corresponding author), Purdue Univ, Coll Vet Med, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA.	mseleem@purdue.edu	Seleem, Mohamed/H-2774-2018	Seleem, Mohamed/0000-0003-0939-0458; Mohammad, Haroon/0000-0002-8843-8933	Showalter Research Trust [205994]; Network of Antimicrobial Resistance in Staphylococcus aureus (NARSA) program under NIAID/NIH [HHSN272200700055C]	Showalter Research Trust; Network of Antimicrobial Resistance in Staphylococcus aureus (NARSA) program under NIAID/NIH	This work was supported by the Showalter Research Trust (Grant 205994). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the Network of Antimicrobial Resistance in Staphylococcus aureus (NARSA) program supported under NIAID/NIH Contract # HHSN272200700055C for providing the MRSA strains used in this study.	Alou L, 2004, INT J ANTIMICROB AG, V23, P513, DOI 10.1016/j.ijantimicag.2003.09.030; Bassani August S, 2008, Int J Pharm Compd, V12, P270; Boyce Steven T., 1995, Journal of Burn Care and Rehabilitation, V16, P97, DOI 10.1097/00004630-199503000-00002; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; DAMOUR O, 1992, BURNS, V18, P479, DOI 10.1016/0305-4179(92)90180-3; dosSantos KRN, 1996, INFECT CONT HOSP EP, V17, P813; Dumitrescu O, 2008, CLIN MICROBIOL INFEC, V14, P384, DOI 10.1111/j.1469-0691.2007.01947.x; Giordano Philip, 2007, Ther Clin Risk Manag, V3, P309, DOI 10.2147/tcrm.2007.3.2.309; Graber CJ, 2007, EMERG INFECT DIS, V13, P491, DOI 10.3201/eid1303.060960; Guthrie HC, 2014, INJURY, V45, P1171, DOI 10.1016/j.injury.2014.05.007; Han LL, 2007, J CLIN MICROBIOL, V45, P1350, DOI 10.1128/JCM.02274-06; Institute CaLS, 2012, M07A9 I CALS; Kaplan SL, 2005, CLIN INFECT DIS, V40, P1785, DOI 10.1086/430312; Landrum ML, 2012, JAMA-J AM MED ASSOC, V308, P50, DOI 10.1001/jama.2012.7139; LaPlante KL, 2008, ANTIMICROB AGENTS CH, V52, P2156, DOI 10.1128/AAC.01046-07; LINEAWEAVER W, 1985, ARCH SURG-CHICAGO, V120, P267; Lio PA, 2004, INFECT DIS CLIN N AM, V18, P717, DOI 10.1016/j.idc.2004.04.008; Lio PA, 2011, MED CLIN N AM, V95, P703, DOI 10.1016/j.mcna.2011.03.008; Liu C, 2011, CLIN INFECT DIS, V53, P319, DOI [10.1093/cid/cir353, 10.1093/cid/ciq146]; Mayhoub AS, 2011, BIOORGAN MED CHEM, V19, P3845, DOI 10.1016/j.bmc.2011.04.041; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; Miller MA, 1996, INFECT CONT HOSP EP, V17, P811; Mohamed MF, 2014, DRUG DES DEV THER, V8, P1979, DOI 10.2147/DDDT.S72129; Mohammad H, 2015, J ANTIBIOT, V68, P259, DOI 10.1038/ja.2014.142; Mohammad H, 2015, EUR J MED CHEM, V94, P306, DOI 10.1016/j.ejmech.2015.03.015; Mohammad H, 2014, J MED CHEM, V57, P1609, DOI 10.1021/jm401905m; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Mulvey MR, 2005, EMERG INFECT DIS, V11, P844, DOI 10.3201/eid1106.041146; Nagao M, 2010, AM J INFECT CONTROL, V38, pE37, DOI 10.1016/j.ajic.2010.04.214; Orhan G, 2005, J CLIN MICROBIOL, V43, P140, DOI 10.1128/JCM.43.1.140-143.2005; Otter JA, 2010, LANCET INFECT DIS, V10, P227, DOI 10.1016/S1473-3099(10)70053-0; Qualls ML, 2012, CLIN INFECT DIS, V55, P103, DOI 10.1093/cid/cis342; Rybak MJ, 2008, J CLIN MICROBIOL, V46, P2950, DOI 10.1128/JCM.00582-08; Simor AE, 2007, ANTIMICROB AGENTS CH, V51, P3880, DOI 10.1128/AAC.00846-07; Stevens DL, 2007, J INFECT DIS, V195, P202, DOI 10.1086/510396; Stevens DL, 2014, CLIN INFECT DIS, V59, P147, DOI [10.1093/cid/ciu444, 10.1093/cid/ciu296]; Suaya JA, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-296; Suzuki M, 2011, EMERG INFECT DIS, V17, P1917, DOI 10.3201/eid1710.101365; WEBER DJ, 1984, PHARMACOTHERAPY, V4, P122	39	29	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142321	10.1371/journal.pone.0142321	http://dx.doi.org/10.1371/journal.pone.0142321			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536129	Green Published, Green Submitted, gold			2022-12-26	WOS:000364298400151
J	Park, J; Chung, H; Bang, SH; Han, AR; Seo, EK; Chang, SE; Kang, DH; Oh, ES				Park, Jisu; Chung, Heesung; Bang, Seung Hyun; Han, Ah-Reum; Seo, Eun-Kyoung; Chang, Sung Eun; Kang, Duk-Hee; Oh, Eok-Soo			(E)-4-(3,4-Dimethoxyphenyl)but-3-en-1-ol Enhances Melanogenesis through Increasing Upstream Stimulating Factor-1-Mediated Tyrosinase Expression	PLOS ONE			English	Article							MURINE MELANOMA-CELLS; ACTIVATED PROTEIN-KINASE; ZINGIBER-CASSUMUNAR; TRANSCRIPTION FACTOR; INHIBITS MELANOGENESIS; DOWN-REGULATION; PHENYLBUTENOID DIMER; SIGNALING PATHWAY; MITF DEGRADATION; GENE-EXPRESSION	We investigated the potential melanogenic effect of compounds from Zingiber cassumunar Roxb. Our data revealed that chloroform-soluble extract of Z. cassumunar enhanced melanin synthesis in B16F10 melanoma cells. Among the components of the chloroform extract, (E)-4-(3,4-dimethoxyphenyl)but-3-en-1-ol (DMPB) increased melanogenesis in both B16F10 cells and human primary melanocytes. In B16F10 cells, DMPB enhanced the activation of ERK and p38, and the level of tyrosinase. Although the level of microphthalmia-associated transcription factor was unchanged in DMPB-treated B16F10 cells, DMPB increased levels and nuclear localization of upstream stimulating factor-1 (USF1). Consistently, DMPB-mediated melanin synthesis was diminished in USF1-knockdown cells. Furthermore, DMPB induced hyperpigmentation in brown guinea pigs in vivo. Together, these data suggest that DMPB may promote melanin synthesis via USF1 dependent fashion and could be used as a clinical therapeutic agent against hypopigmentation-associated diseases.	[Park, Jisu; Chung, Heesung; Oh, Eok-Soo] Ewha Womans Univ, Res Ctr Cellular Homeostasis, Dept Life Sci, Seoul, South Korea; [Bang, Seung Hyun; Chang, Sung Eun] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Dermatol, Seoul, South Korea; [Han, Ah-Reum; Seo, Eun-Kyoung] Ewha Womans Univ, Coll Pharm, Global Res Program Top5, Seoul, South Korea; [Kang, Duk-Hee] Ewha Womans Univ, Sch Med, Ewha Med Res Ctr, Div Nephrol,Dept Internal Med, Seoul, South Korea	Ewha Womans University; University of Ulsan; Asan Medical Center; Ewha Womans University; Ewha Womans University	Kang, DH (corresponding author), Ewha Womans Univ, Sch Med, Ewha Med Res Ctr, Div Nephrol,Dept Internal Med, Seoul, South Korea.	dhkang@ewha.ac.kr; OhES@ewha.ac.kr	bang, sunghyun/AAH-1201-2020; chang, sungeun/AAH-1247-2020	Bang, Seunghyun/0000-0002-3211-7209	National Research Foundation of Korea (NRF) - Korea government (MSIP) [2012R1A5A1048236]; Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI12C0050]; Ministry of Science, ICT and Future Planning [NRF2012M3A9C4048761]	National Research Foundation of Korea (NRF) - Korea government (MSIP)(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of Korea); Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; Ministry of Science, ICT and Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea)	The work was supported by the following: National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP), grant number: 2012R1A5A1048236 (URL: www.nrf.re.kr); the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea, grant number: HI12C0050 (URL: http://www.mw.go.kr); and the Ministry of Science, ICT and Future Planning (NRF2012M3A9C4048761). The funders had roles in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JH, 2008, ARCH DERMATOL RES, V300, P325, DOI 10.1007/s00403-008-0863-0; Aksan I, 1998, MOL CELL BIOL, V18, P6930, DOI 10.1128/MCB.18.12.6930; ALBERT DM, 1979, OPHTHALMOLOGY, V86, P1145; Baron Y, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002470; Bruneton J. N., 1999, PHARMACOGNOSY PHYTOC; Chang MS, 2010, PHYTOTHER RES, V24, P1359, DOI 10.1002/ptr.3123; Chao HC, 2013, EXP DERMATOL, V22, P131, DOI 10.1111/exd.12089; Cheli Y, 2010, PIGM CELL MELANOMA R, V23, P27, DOI 10.1111/j.1755-148X.2009.00653.x; Chung H, 2014, J BIOL CHEM, V289, P21751, DOI 10.1074/jbc.M113.541177; Corre S, 2004, J BIOL CHEM, V279, P51226, DOI 10.1074/jbc.M409768200; Corre S, 2009, J BIOL CHEM, V284, P18851, DOI 10.1074/jbc.M808605200; Cui RT, 2007, CELL, V128, P853, DOI 10.1016/j.cell.2006.12.045; Gaggioli C, 2003, PIGM CELL RES, V16, P374, DOI 10.1034/j.1600-0749.2003.00057.x; Galibert MD, 2001, EMBO J, V20, P5022, DOI 10.1093/emboj/20.17.5022; Han AR, 2005, CHEM PHARM BULL, V53, P1466, DOI 10.1248/cpb.53.1466; Han AR, 2004, PLANTA MED, V70, P1095, DOI 10.1055/s-2004-832656; Horbach T, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00003; Huang HC, 2013, BIOCHEM BIOPH RES CO, V438, P375, DOI 10.1016/j.bbrc.2013.07.079; Huang YC, 2011, PHYTOMEDICINE, V18, P1244, DOI 10.1016/j.phymed.2011.06.028; Imagawa S, 2006, ARTERIOSCL THROM VAS, V26, P2407, DOI 10.1161/01.ATV.0000240318.61359.e3; Jang JY, 2012, J ETHNOPHARMACOL, V141, P338, DOI 10.1016/j.jep.2012.02.043; Jang JY, 2009, EXP DERMATOL, V18, P232, DOI 10.1111/j.1600-0625.2008.00794.x; Jung H, 2014, PIGM CELL MELANOMA R, V27, P387, DOI 10.1111/pcmr.12223; Khlgatian MK, 2002, J INVEST DERMATOL, V118, P126, DOI 10.1046/j.0022-202x.2001.01667.x; Kim DS, 2003, J CELL SCI, V116, P1699, DOI 10.1242/jcs.00366; Kim HE, 2012, BMB REP, V45, P724, DOI 10.5483/BMBRep.2012.45.12.039; Kumar CM, 2011, BIOCHIMIE, V93, P562, DOI 10.1016/j.biochi.2010.11.014; Lee CS, 2013, J INVEST DERMATOL, V133, P1063, DOI 10.1038/jid.2012.409; Lee JW, 2007, BIOL PHARM BULL, V30, P1561, DOI 10.1248/bpb.30.1561; Lee J, 2007, BIOCHEM PHARMACOL, V74, P960, DOI 10.1016/j.bcp.2007.06.007; Lu YB, 2005, J CHROMATOGR A, V1089, P258, DOI 10.1016/j.chroma.2005.06.073; Mabberley D. J., 1997, PLANT BOOK PORTABLE; Mansky KC, 2002, J BIOL CHEM, V277, P11077, DOI 10.1074/jbc.M111696200; Matsuda H, 2006, BIOL PHARM BULL, V29, P834, DOI 10.1248/bpb.29.834; Matsuda H, 2005, BIOL PHARM BULL, V28, P1229, DOI 10.1248/bpb.28.1229; Matsuda H, 2011, CHEM PHARM BULL, V59, P365, DOI 10.1248/cpb.59.365; Murase D, 2009, J BIOL CHEM, V284, P4343, DOI 10.1074/jbc.M805570200; Nagano T, 1997, JPN J PHARMACOL, V75, P363, DOI 10.1254/jjp.75.363; Nakamura S, 2009, CHEM PHARM BULL, V57, P1267, DOI 10.1248/cpb.57.1267; Sato-Jin K, 2008, FASEB J, V22, P1155, DOI 10.1096/fj.07-9080com; Shin SH, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.20; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Smalley K, 2000, FEBS LETT, V476, P198, DOI 10.1016/S0014-5793(00)01726-9; Wang CQF, 2013, J INVEST DERMATOL, V133, P2741, DOI 10.1038/jid.2013.237; Wellbrock C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002734; Yamaguchi Y, 2006, FASEB J, V20, P1486, DOI 10.1096/fj.06-5725fje	47	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141988	10.1371/journal.pone.0141988	http://dx.doi.org/10.1371/journal.pone.0141988			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26535571	Green Published, Green Submitted, gold			2022-12-26	WOS:000364298400112
J	Rosenblatt, SD; Crane, BT				Rosenblatt, Steven David; Crane, Benjamin Thomas			Influence of Visual Motion, Suggestion, and Illusory Motion on Self-Motion Perception in the Horizontal Plane	PLOS ONE			English	Article							PSYCHOMETRIC FUNCTION; PERIPHERAL-VISION; VESTIBULAR CUES; YAW ROTATION; TRANSLATION; VECTION; MAGNITUDE; ACCELERATION; ASYMMETRIES; THRESHOLDS	A moving visual field can induce the feeling of self-motion or vection. Illusory motion from static repeated asymmetric patterns creates a compelling visual motion stimulus, but it is unclear if such illusory motion can induce a feeling of self-motion or alter self-motion perception. In these experiments, human subjects reported the perceived direction of self-motion for sway translation and yaw rotation at the end of a period of viewing set visual stimuli coordinated with varying inertial stimuli. This tested the hypothesis that illusory visual motion would influence self-motion perception in the horizontal plane. Trials were arranged into 5 blocks based on stimulus type: moving star field with yaw rotation, moving star field with sway translation, illusory motion with yaw, illusory motion with sway, and static arrows with sway. Static arrows were used to evaluate the effect of cognitive suggestion on self-motion perception. Each trial had a control condition; the illusory motion controls were altered versions of the experimental image, which removed the illusory motion effect. For the moving visual stimulus, controls were carried out in a dark room. With the arrow visual stimulus, controls were a gray screen. In blocks containing a visual stimulus there was an 8s viewing interval with the inertial stimulus occurring over the final 1s. This allowed measurement of the visual illusion perception using objective methods. When no visual stimulus was present, only the 1s motion stimulus was presented. Eight women and five men (mean age 37) participated. To assess for a shift in self-motion perception, the effect of each visual stimulus on the self-motion stimulus (cm/s) at which subjects were equally likely to report motion in either direction was measured. Significant effects were seen for moving star fields for both translation (p = 0.001) and rotation (p<0.001), and arrows (p = 0.02). For the visual motion stimuli, inertial motion perception was shifted in the direction consistent with the visual stimulus. Arrows had a small effect on self-motion perception driven by a minority of subjects. There was no significant effect of illusory motion on self-motion perception for either translation or rotation (p>0.1 for both). Thus, although a true moving visual field can induce self-motion, results of this study show that illusory motion does not.	[Rosenblatt, Steven David; Crane, Benjamin Thomas] Univ Rochester, Dept Otolaryngol, Rochester, NY 14618 USA; [Crane, Benjamin Thomas] Univ Rochester, Dept Neurobiol & Anat, Rochester, NY USA; [Crane, Benjamin Thomas] Univ Rochester, Dept Bioengn, Rochester, NY USA	University of Rochester; University of Rochester; University of Rochester	Crane, BT (corresponding author), Univ Rochester, Dept Otolaryngol, Rochester, NY 14618 USA.	craneb@gmail.com			NIDCD [K23 DC011298, R01 DC0135480]; Triological Society Career Scientist Award; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K23DC011298, R01DC013580] Funding Source: NIH RePORTER	NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Triological Society Career Scientist Award; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was funded by NIDCD K23 DC011298 and R01 DC0135480. A Triological Society Career Scientist Award provided some salary support for BTC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backus BT, 2005, J VISION, V5, P1055, DOI 10.1167/5.11.10; BENSON AJ, 1989, AVIAT SPACE ENVIR MD, V60, P205; BERTHOZ A, 1975, EXP BRAIN RES, V23, P471; BRANDT T, 1973, EXP BRAIN RES, V16, P476, DOI 10.1007/BF00234474; Bubka A, 2008, PERCEPTION, V37, P704, DOI 10.1068/p5781; Bubka A, 2010, PERCEPTION, V39, P627, DOI 10.1068/p6315; CARPENTERSMITH TR, 1995, PERCEPT PSYCHOPHYS, V57, P35, DOI 10.3758/BF03211848; CARPENTERSMITH TR, 1992, ANN NY ACAD SCI, V656, P817, DOI 10.1111/j.1749-6632.1992.tb25262.x; Chi MT, 2008, ACM T GRAPHIC, V27, DOI 10.1145/1360612.1360661; Coniglio AJ, 2014, JARO-J ASSOC RES OTO, V15, P305, DOI 10.1007/s10162-013-0438-4; Conway BR, 2005, J NEUROSCI, V25, P5651, DOI 10.1523/JNEUROSCI.1084-05.2005; Crane BT, 2014, EXP BRAIN RES, V232, P3897, DOI 10.1007/s00221-014-4060-4; Crane BT, 2013, EXP BRAIN RES, V224, P165, DOI 10.1007/s00221-012-3299-x; Crane BT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051383; Crane BT, 2012, EXP BRAIN RES, V223, P89, DOI 10.1007/s00221-012-3243-0; Crane BT, 2012, EXP BRAIN RES, V219, P477, DOI 10.1007/s00221-012-3105-9; Cuturi LF, 2014, CURR BIOL, V24, P2817, DOI 10.1016/j.cub.2014.10.015; Fetsch CR, 2009, J NEUROSCI, V29, P15601, DOI 10.1523/JNEUROSCI.2574-09.2009; FRASER A, 1979, NATURE, V281, P565, DOI 10.1038/281565a0; Garcia-Perez MA, 2013, Q J EXP PSYCHOL, V66, P319, DOI 10.1080/17470218.2012.708761; GESCHEIDER GA, 1988, ANNU REV PSYCHOL, V39, P169, DOI 10.1146/annurev.psych.39.1.169; Gibson JJ, 1950, PERCEPTION VISUAL WO; Grabherr L, 2008, EXP BRAIN RES, V186, P677, DOI 10.1007/s00221-008-1350-8; Hettinger L J, 1990, Mil Psychol, V2, P171, DOI 10.1207/s15327876mp0203_4; HUANG JK, 1987, AVIAT SPACE ENVIR MD, V58, P1197; Kitaoka A., 2003, VISION, V15, P261, DOI DOI 10.11247/JSSDJ.58; Kitaoka A, 2007, PERCEPTION, V36, P1019, DOI 10.1068/p5362; Kitazaki M, 2003, PERCEPTION, V32, P475, DOI 10.1068/p5037; Kuriki I, 2008, J VISION, V8, DOI 10.1167/8.10.16; LARISH JF, 1990, J EXP PSYCHOL HUMAN, V16, P295, DOI 10.1037/0096-1523.16.2.295; LISHMAN JR, 1973, PERCEPTION, V2, P287, DOI 10.1068/p020287; MacNeilage PR, 2010, J NEUROSCI, V30, P9084, DOI 10.1523/JNEUROSCI.1304-10.2010; Nakamura S, 2013, PERCEPTION, V42, P153, DOI 10.1068/p7321; OHMI M, 1988, PERCEPTION, V17, P5, DOI 10.1068/p170005; Palmisano S, 2008, PERCEPTION, V37, P22, DOI 10.1068/p5806; Roditi RE, 2012, EXP BRAIN RES, V219, P369, DOI 10.1007/s00221-012-3099-3; Roditi RE, 2012, JARO-J ASSOC RES OTO, V13, P381, DOI 10.1007/s10162-012-0318-3; Roditi RE, 2011, 34 ANN M BALT MD, P1006; Seno T, 2013, PERCEPTION, V42, P1001, DOI 10.1068/p7511; Seno T, 2012, PERCEPTION, V41, P577, DOI 10.1068/p7184; Seno T, 2010, SEEING PERCEIVING, V23, P273, DOI 10.1163/187847510X532667; Seno T, 2009, VISION RES, V49, P2973, DOI 10.1016/j.visres.2009.09.017; TEGHTSOONIAN R, 1981, ACTA PSYCHOL, V49, P83, DOI 10.1016/0001-6918(81)90034-2; TELFORD L, 1993, PERCEPT PSYCHOPHYS, V53, P682, DOI 10.3758/BF03211744; WARREN R, 1976, J EXP PSYCHOL HUMAN, V2, P448, DOI 10.1037/0096-1523.2.3.448; WARREN WH, 1988, NATURE, V336, P162, DOI 10.1038/336162a0; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1314, DOI 10.3758/BF03194545; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; ZACHARIAS GL, 1981, EXP BRAIN RES, V41, P159	49	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142109	10.1371/journal.pone.0142109	http://dx.doi.org/10.1371/journal.pone.0142109			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV5GZ	26536235	Green Submitted, gold, Green Published			2022-12-26	WOS:000364298400134
J	Wang, HW; Milstein, JN				Wang, Haowei; Milstein, Joshua N.			Simulation Assisted Analysis of the Intrinsic Stiffness for Short DNA Molecules Imaged with Scanning Atomic Force Microscopy	PLOS ONE			English	Article							H-NS PROTEIN; CONFORMATIONAL STATISTICS; STRETCHING DNA; FOREIGN DNA; FLEXIBILITY; ELASTICITY; LENGTH; MICA; AFM; RECOGNITION	Studying the mechanical properties of short segments of dsDNA can provide insight into various biophysical phenomena, from DNA looping to the organization of nucleosomes. Scanning atomic force microscopy (AFM) is able to acquire images of single DNA molecules with near-basepair resolution. From many images, one may use equilibrium statistical mechanics to quantify the intrinsic stiffness (or persistence length) of the DNA. However, this approach is highly dependent upon both the correct microscopic polymer model and a correct image analysis of DNA contours. These complications have led to significant debate over the flexibility of dsDNA at short length scales. We first show how to extract accurate measures of DNA contour lengths by calibrating to DNA traces of simulated AFM data. After this calibration, we show that DNA adsorbed on an aminopropyl-mica surface behaves as a worm-like chain (WLC) for contour lengths as small as similar to 20 nm. We also show that a DNA binding protein can modify the mechanics of the DNA from that of a WLC.	[Wang, Haowei] Univ Sci & Technol China, Dept Opt & Opt Engn, Hefei, Anhui, Peoples R China; [Wang, Haowei] Heifi Natl Lab Phys Sci Microscale, Heifi, Anhui, Peoples R China; [Wang, Haowei; Milstein, Joshua N.] Univ Toronto, Dept Chem & Phys Sci, Mississauga, ON L5L 1C6, Canada; [Milstein, Joshua N.] Univ Toronto, Dept Phys, Toronto, ON, Canada	Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Toronto; University Toronto Mississauga; University of Toronto	Milstein, JN (corresponding author), Univ Toronto, Dept Chem & Phys Sci, Mississauga, ON L5L 1C6, Canada.	josh.milstein@utoronto.ca		Wang, Haowei/0000-0001-9197-8730	Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant [RGPIN 418251]	Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	HW and JNM were supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant (RGPIN 418251, http://www.nserc-crsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali SS, 2012, CURR OPIN MICROBIOL, V15, P175, DOI 10.1016/j.mib.2011.12.014; Amit R, 2003, BIOPHYS J, V84, P2467, DOI 10.1016/S0006-3495(03)75051-6; Baumann CG, 1997, P NATL ACAD SCI USA, V94, P6185, DOI 10.1073/pnas.94.12.6185; BRUGAL G, 1977, HISTOCHEMISTRY, V52, P241, DOI 10.1007/BF00495860; BUSTAMANTE C, 1992, BIOCHEMISTRY-US, V31, P22, DOI 10.1021/bi00116a005; Chen YF, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.020903; Cognet JAH, 1999, J MOL BIOL, V285, P997, DOI 10.1006/jmbi.1998.2322; Dame RT, 2006, NATURE, V444, P387, DOI 10.1038/nature05283; de Pablo Pedro J, 2014, Cold Spring Harb Protoc, V2014, P167, DOI 10.1101/pdb.top080473; Ficarra E, 2005, IEEE T INF TECHNOL B, V9, P508, DOI 10.1109/TITB.2005.855546; Halford SE, 2004, ANNU REV BIOPH BIOM, V33, P1, DOI 10.1146/annurev.biophys.33.110502.132711; Liu YJ, 2010, GENE DEV, V24, P339, DOI 10.1101/gad.1883510; Mantelli S, 2011, SOFT MATTER, V7, P3412, DOI 10.1039/c0sm01160f; Marilley M, 2005, MOL GENET GENOMICS, V274, P658, DOI 10.1007/s00438-005-0058-8; Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008; MATTHEWS KS, 1992, MICROBIOL REV, V56, P123, DOI 10.1128/MMBR.56.1.123-136.1992; Mazur AK, 2014, NUCLEIC ACIDS RES, V42, P14006, DOI 10.1093/nar/gku1192; Mazur AK, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.068104; Navarre WW, 2006, SCIENCE, V313, P236, DOI 10.1126/science.1128794; Rivetti C, 1996, J MOL BIOL, V264, P919, DOI 10.1006/jmbi.1996.0687; Rivetti C, 2001, ULTRAMICROSCOPY, V87, P55, DOI 10.1016/S0304-3991(00)00064-4; Sanchez-Sevilla A, 2002, ULTRAMICROSCOPY, V92, P151, DOI 10.1016/S0304-3991(02)00128-6; Seol Y, 2007, BIOPHYS J, V93, P4360, DOI 10.1529/biophysj.107.112995; SMITH SB, 1992, SCIENCE, V258, P1122, DOI 10.1126/science.1439819; Strick TR, 1996, SCIENCE, V271, P1835, DOI 10.1126/science.271.5257.1835; Struhl K, 2013, NAT STRUCT MOL BIOL, V20, P267, DOI 10.1038/nsmb.2506; Vafabakhsh R, 2012, SCIENCE, V337, P1097, DOI 10.1126/science.1224139; Vologodskii A, 2013, NUCLEIC ACIDS RES, V41, P6785, DOI 10.1093/nar/gkt396; Wang MD, 1997, BIOPHYS J, V72, P1335, DOI 10.1016/S0006-3495(97)78780-0; Wiggins PA, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021909; Wiggins PA, 2006, NAT NANOTECHNOL, V1, P137, DOI 10.1038/nnano.2006.63; Wolfe KC, 2012, J PHYS CHEM B, V116, P8556, DOI 10.1021/jp2126015; Yan J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.108108; Yuan CL, 2006, NUCLEIC ACIDS RES, V34, P4554, DOI 10.1093/nar/gkl394; Zhou Y, 2006, MACROMOLECULES, V39, P1950, DOI 10.1021/ma0512556; Zhou Y, 2003, J CHEM PHYS, V119, P4962, DOI 10.1063/1.1596911	36	3	3	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142277	10.1371/journal.pone.0142277	http://dx.doi.org/10.1371/journal.pone.0142277			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26535902	Green Published, gold, Green Submitted			2022-12-26	WOS:000364298400149
J	Zhang, ZF; Feng, J; Wu, CW; Lu, Q; Pan, ZH				Zhang, Zhifei; Feng, Jie; Wu, Chaowen; Lu, Qi; Pan, Zhuo-Hua			Targeted Expression of Channelrhodopsin-2 to the Axon Initial Segment Alters the Temporal Firing Properties of Retinal Ganglion Cells	PLOS ONE			English	Article							ACTION-POTENTIAL GENERATION; ECTOPIC EXPRESSION; PHOTORECEPTOR DEGENERATION; SODIUM-CHANNELS; RESPONSES; RESTORATION; DENDRITES; RESTORES; NEURONS; MOTIF	The axon initial segment (AIS) is essential for initiating action potentials and maintaining neuronal excitability in axon-bearing neurons in the CNS. There is increasing interest in the targeting of optogenetic tools to subcellular compartments, including the AIS, to gain precise control of neuronal activity for basic research and clinical applications. In particular, targeted expression of optogenetic tools in retinal ganglion cells (RGCs) has been explored as an approach for restoring vision after photoreceptor degeneration. Thus, understanding the effects of such targeting on spiking abilities and/or patterns is important. Here, we examined the effects of recombinant adeno-associated virus (rAAV)-mediated targeted expression of channelrhodopsin-2 (ChR2)-GFP with a NaV channel motif in mouse RGCs. We found that this targeted expression disrupted NaV channel clustering at the AIS and converted the spike firing patterns of RGCs from sustained to transient. Our results suggest that the clustering of membrane channels, including NaV channels, at the AIS is important for the ability of RGCs to generate sustained spike firing. Additionally, the targeting of optogenetic tools to the AIS with the NaV channel motif may offer a way to create transient light responses in RGCs for vision restoration.	[Zhang, Zhifei; Feng, Jie; Wu, Chaowen; Lu, Qi; Pan, Zhuo-Hua] Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA; [Feng, Jie] Xi An Jiao Tong Univ, Dept Physiol & Pathophysiol, Sch Basic Med Sci, Hlth Sci Ctr, Xian 710049, Peoples R China; [Pan, Zhuo-Hua] Wayne State Univ, Sch Med, Kresge Eye Inst, Dept Ophthalmol, Detroit, MI 48201 USA	Wayne State University; Xi'an Jiaotong University; Wayne State University	Pan, ZH (corresponding author), Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA.	zhpan@med.wayne.edu			National Institutes of Health (NIH) [EY17130]; Department of Anatomy and Cell Biology at Wayne State University [EY04068]; Dryer Foundation; Ligon Research Center of Vision; Research to Prevent Blindness to Department of Ophthalmology at Wayne State University; NATIONAL EYE INSTITUTE [P30EY004068, R01EY017130] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Anatomy and Cell Biology at Wayne State University; Dryer Foundation; Ligon Research Center of Vision; Research to Prevent Blindness to Department of Ophthalmology at Wayne State University; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health (NIH) grant EY17130, core grant EY04068 to Department of Anatomy and Cell Biology at Wayne State University, Dryer Foundation, the Ligon Research Center of Vision, and Research to Prevent Blindness to Department of Ophthalmology at Wayne State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Boycott B, 1999, INVEST OPHTH VIS SCI, V40, P1313; Garrido JJ, 2003, SCIENCE, V300, P2091, DOI 10.1126/science.1085167; Goldberg EM, 2008, NEURON, V58, P387, DOI 10.1016/j.neuron.2008.03.003; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Greenberg KP, 2011, NEURON, V69, P713, DOI 10.1016/j.neuron.2011.01.024; Grubb MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013761; Jacobs AL, 1998, J NEUROPHYSIOL, V80, P447, DOI 10.1152/jn.1998.80.1.447; Jenkins SM, 2001, J CELL BIOL, V155, P739, DOI 10.1083/jcb.200109026; Kole MHP, 2008, NAT NEUROSCI, V11, P178, DOI 10.1038/nn2040; Kole MHP, 2007, NEURON, V55, P633, DOI 10.1016/j.neuron.2007.07.031; Lemaillet G, 2003, J BIOL CHEM, V278, P27333, DOI 10.1074/jbc.M303327200; Lewis TL, 2009, NAT NEUROSCI, V12, P568, DOI 10.1038/nn.2318; Lin B, 2008, P NATL ACAD SCI USA, V105, P16009, DOI 10.1073/pnas.0806114105; Naundorf B, 2006, NATURE, V440, P1060, DOI 10.1038/nature04610; Pan ZM, 2006, J NEUROSCI, V26, P2599, DOI 10.1523/JNEUROSCI.4314-05.2006; Rasband MN, 2010, NAT REV NEUROSCI, V11, P552, DOI 10.1038/nrn2852; Tian N, 2003, NEURON, V39, P85, DOI 10.1016/S0896-6273(03)00389-1; Tomita H, 2007, INVEST OPHTH VIS SCI, V48, P3821, DOI 10.1167/iovs.06-1501; Van Wart A, 2006, J NEUROSCI, V26, P7172, DOI 10.1523/JNEUROSCI.1101-06.2006; Van Wart A, 2007, J COMP NEUROL, V500, P339, DOI 10.1002/cne.21173; Wu CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066332; Wu CW, 2011, J NEUROSCI, V31, P14654, DOI 10.1523/JNEUROSCI.1861-11.2011; Zhang Y, 2009, J NEUROSCI, V29, P9186, DOI 10.1523/JNEUROSCI.0184-09.2009; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295	26	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142052	10.1371/journal.pone.0142052	http://dx.doi.org/10.1371/journal.pone.0142052			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536117	Green Submitted, Green Published, gold			2022-12-26	WOS:000364298400124
J	Benzekri, NA; Sambou, J; Diaw, B; Sall, EI; Sall, F; Niang, A; Ba, S; Gueye, NFN; Diallo, MB; Hawes, SE; Seydi, M; Gottlieb, GS				Benzekri, Noelle A.; Sambou, Jacques; Diaw, Binetou; Sall, El Hadji Ibrahima; Sall, Fatima; Niang, Alassane; Ba, Selly; Gueye, Ndeye Fatou Ngom; Diallo, Mouhamadou Baila; Hawes, Stephen E.; Seydi, Moussa; Gottlieb, Geoffrey S.			High Prevalence of Severe Food Insecurity and Malnutrition among HIV-Infected Adults in Senegal, West Africa	PLOS ONE			English	Article							RECEIVING ANTIRETROVIRAL THERAPY; SOCIAL DETERMINANTS; NUTRITIONAL-STATUS; EARLY MORTALITY; RURAL DISTRICT; ADHERENCE; HIV/AIDS; IMPACT; SURVIVAL; HEALTH	Background Malnutrition and food insecurity are associated with increased mortality and poor clinical outcomes among people living with HIV/AIDS; however, the prevalence of malnutrition and food insecurity among people living with HIV/AIDS in Senegal, West Africa is unknown. The objective of this study was to determine the prevalence and severity of food insecurity and malnutrition among HIV-infected adults in Senegal, and to identify associations between food insecurity, malnutrition, and HIV outcomes. Methods We conducted a cross-sectional study at outpatient clinics in Dakar and Ziguinchor, Senegal. Data were collected using participant interviews, anthropometry, the Household Food Insecurity Access Scale, the Individual Dietary Diversity Scale, and chart review. Results One hundred and nine HIV-1 and/or HIV-2 participants were enrolled. The prevalence of food insecurity was 84.6% in Dakar and 89.5% in Ziguinchor. The prevalence of severe food insecurity was 59.6% in Dakar and 75.4% in Ziguinchor. The prevalence of malnutrition (BMI <18.5) was 19.2% in Dakar and 26.3% in Ziguinchor. Severe food insecurity was associated with missing clinic appointments (p = 0.01) and not taking antiretroviral therapy due to hunger (p = 0.02). Malnutrition was associated with lower CD4 cell counts (p = 0.01). Conclusions Severe food insecurity and malnutrition are highly prevalent among HIV-infected adults in both Dakar and Ziguinchor, and are associated with poor HIV outcomes. Our findings warrant further studies to determine the root causes of malnutrition and food insecurity in Senegal, and the short- and long-term impacts of malnutrition and food insecurity on HIV care. Urgent interventions are needed to address the unacceptably high rates of malnutrition and food insecurity in this population.	[Benzekri, Noelle A.; Gottlieb, Geoffrey S.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Sambou, Jacques; Sall, El Hadji Ibrahima; Niang, Alassane] Ctr Sante Ziguinchor, Ziguinchor, Senegal; [Diaw, Binetou; Sall, Fatima; Ba, Selly; Gueye, Ndeye Fatou Ngom; Diallo, Mouhamadou Baila; Seydi, Moussa] Ctr Hosp Univ Fann, Dakar, Senegal; [Hawes, Stephen E.; Gottlieb, Geoffrey S.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Hawes, Stephen E.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Benzekri, NA (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	benzekri@uw.edu		Gottlieb, Geoffrey/0000-0002-5749-481X	University of Washington Center for AIDS Research, International Pilot Grant; NIH grant [P30 AI027757]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757] Funding Source: NIH RePORTER	University of Washington Center for AIDS Research, International Pilot Grant; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by the University of Washington Center for AIDS Research, International Pilot Grant. NIH grant P30 AI027757. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argemi X, 2012, AIDS, V26, P1161, DOI 10.1097/QAD.0b013e328353f363; Au JT, 2006, AIDS, V20, P2116, DOI 10.1097/01.aids.0000247580.16073.1b; Berhe N, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-233; Birbeck GL, 2011, AM J TROP MED HYG, V85, P782, DOI 10.4269/ajtmh.2011.11-0187; Boyer S, 2011, SOC SCI MED, V72, P1383, DOI 10.1016/j.socscimed.2011.02.030; Bukusuba J, 2007, BRIT J NUTR, V98, P211, DOI 10.1017/S0007114507691806; Coates Jennifer S A, 2007, HOUSEHOLD FOOD INSEC; Conseil National de Lutte contre le Sida, 2014, RAPP SIT RIP NAT EP; Endale Worku, 2014, BMC Res Notes, V7, P130, DOI 10.1186/1756-0500-7-130; Ene-Obong HN, 2001, J HEALTH POPUL NUTR, V19, P320; Etard JF, 2006, AIDS, V20, P1181, DOI 10.1097/01.aids.0000226959.87471.01; Evans D, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-111; FAO & WFP, 2014, STAT FOOD INS WORLD; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Fielden SJ, 2014, AIDS BEHAV, V18, pS490, DOI 10.1007/s10461-013-0669-8; Gebrehiwot T, 2014, ECOL FOOD NUTR, V53, P214, DOI 10.1080/03670244.2013.811387; Gewa CA, 2013, PUBLIC HEALTH NUTR, V16, P1575, DOI 10.1017/S136898001200451X; Hadgu TH, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-943; Hailemariam S, 2013, ARCH PUBLIC HEALTH, V71, DOI 10.1186/0778-7367-71-13; Hardon AP, 2007, AIDS CARE, V19, P658, DOI 10.1080/09540120701244943; Hong SY, 2014, JAIDS-J ACQ IMM DEF, V67, pE115, DOI 10.1097/QAI.0000000000000308; Johannessen A, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-52; KANKI P, 1992, AM J EPIDEMIOL, V136, P895, DOI 10.1093/aje/136.7.895; Kazybayeva S., 2006, LIVESTOCK PRODUCTION; Kennedy Gina B T, GUID MEAS HOUS IND D; Kiefer E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029625; Knueppel D, 2010, PUBLIC HEALTH NUTR, V13, P360, DOI 10.1017/S1368980009991121; Koethe JR, 2010, AIDS, V24, P2117, DOI 10.1097/QAD.0b013e32833b784a; Lankowski AJ, 2014, AIDS BEHAV, V18, P1199, DOI 10.1007/s10461-014-0729-8; Letamo G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102675; Liu EJ, 2011, J INFECT DIS, V204, P282, DOI 10.1093/infdis/jir246; Madec Y, 2009, AIDS, V23, P853, DOI 10.1097/QAD.0b013e32832913ee; Mamlin J, 2009, AM J PUBLIC HEALTH, V99, P215, DOI 10.2105/AJPH.2008.137174; Marazzi MC, 2008, AIDS RES HUM RETROV, V24, P555, DOI 10.1089/aid.2007.0217; Moh R, 2007, AIDS, V21, P2483, DOI 10.1097/QAD.0b013e3282f09876; Msaki MM, 2014, ECOL FOOD NUTR, V53, P193, DOI 10.1080/03670244.2013.811386; Musumari PM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085327; Musumari PM, 2013, AIDS CARE, V25, P1271, DOI 10.1080/09540121.2013.764391; Nagata JM, 2012, AIDS CARE, V24, P728, DOI 10.1080/09540121.2011.630358; Oliveira I, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001587; Palermo T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062353; Partners IG, 2012, INTEGRATED FOOD SECU; Randolph TF, 2007, J ANIM SCI, V85, P2788, DOI 10.2527/jas.2007-0467; Rawat R, 2013, JAIDS-J ACQ IMM DEF, V62, P246, DOI 10.1097/QAI.0b013e3182797363; Sasaki Y, 2012, ANN CLIN MICROB ANTI, V11, DOI 10.1186/1476-0711-11-34; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Tang A.M., 2013, USE CUTOFFS MIDUPPER; Tsai AC, 2011, SOC SCI MED, V73, P1717, DOI 10.1016/j.socscimed.2011.09.026; Tuller DM, 2010, AIDS BEHAV, V14, P778, DOI 10.1007/s10461-009-9533-2; UNOCHA, 2013, SAH REG STRAT MID YE; Uthman OA, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-226; Van Dyk AC, 2010, AJAR-AFR J AIDS RES, V9, P235, DOI 10.2989/16085906.2010.530177; Weiser SD, 2014, AIDS, V28, P115, DOI 10.1097/01.aids.0000433238.93986.35; Weiser SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010340; World Food Program, 2014, AN GLOB VULN SEC AL; Zachariah R, 2006, AIDS, V20, P2355, DOI 10.1097/QAD.0b013e32801086b0	56	35	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141819	10.1371/journal.pone.0141819	http://dx.doi.org/10.1371/journal.pone.0141819			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529509	gold, Green Published, Green Submitted			2022-12-26	WOS:000364032600063
J	Lazopulo, S; Lopez, JA; Levy, P; Syed, S				Lazopulo, Stanislav; Lopez, Juan A.; Levy, Paul; Syed, Sheyum			A Stochastic Burst Follows the Periodic Morning Peak in Individual Drosophila Locomotion	PLOS ONE			English	Article							CIRCADIAN CLOCK; FUNCTIONAL-ANALYSIS; NATURAL CONDITIONS; GENE-EXPRESSION; TIME-SERIES; SPACED DATA; MELANOGASTER; LIGHT; NEURONS; CRYPTOCHROME	Coupling between cyclically varying external light and an endogenous biochemical oscillator known as the circadian clock, modulates a rhythmic pattern with two prominent peaks in the locomotion of Drosophila melanogaster. A morning peak appears around the time lights turn on and an evening peak appears just before lights turn off. The close association between the peaks and the external 12:12 hour light/dark photoperiod means that respective morning and evening peaks of individual flies are well-synchronized in time and, consequently, feature prominently in population-averaged data. Here, we report on a brief but strong stochastic burst in fly activity that, in contrast to morning and evening peaks, is detectable only in single fly recordings. This burst was observed across 3 wild-type strains of Drosophila melanogaster. In a single fly recording, the burst is likely to appear once randomly within 0.5-5 hours after lights turn on, last for only 2-3 minutes and yet show 5 times greater activity compared to the maximum of morning peak with data binned in 3 minutes. Owing to its variable timing and short duration, the burst is virtually undetectable in population-averaged data. We use a locally-built illumination system to study the burst and find that its incidence in a population correlates with light intensity, with similar to 85% of control flies showing the behavior at 8000 lux (1942 mu W/cm(2)). Consistent with that finding, several mutant flies with impaired vision show substantially reduced frequency of the burst. Additionally, we find that genetic ablation of the clock has insignificant effect on burst frequency. Together, these data suggest that the pronounced burst is likely generated by a light-activated circuit that is independent of the circadian clock.	[Lazopulo, Stanislav; Lopez, Juan A.; Levy, Paul; Syed, Sheyum] Univ Miami, Dept Phys, Coral Gables, FL 33124 USA	University of Miami	Syed, S (corresponding author), Univ Miami, Dept Phys, Coral Gables, FL 33124 USA.	s.syed@miami.edu	Lazopulo, Stanislav/AAA-5669-2020		University of Miami	University of Miami	This work was supported by funds from the University of Miami. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anholt RRH, 2004, NAT REV GENET, V5, P838, DOI 10.1038/nrg1472; Bachleitner W, 2007, P NATL ACAD SCI USA, V104, P3538, DOI 10.1073/pnas.0606870104; Beaver LM, 2004, CURR BIOL, V14, P1492, DOI 10.1016/j.cub.2004.08.022; Bellen HJ, 2011, GENETICS, V188, P731, DOI 10.1534/genetics.111.126995; Berndt A, 2007, J BIOL CHEM, V282, P13011, DOI 10.1074/jbc.M608872200; Censi A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002891; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; De J, 2013, P NATL ACAD SCI USA, V110, P8984, DOI 10.1073/pnas.1220960110; Dolezelova E, 2007, GENETICS, V177, P329, DOI 10.1534/genetics.107.076513; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; Gao SY, 2008, NEURON, V60, P328, DOI 10.1016/j.neuron.2008.08.010; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Harbison ST, 2009, TRENDS GENET, V25, P262, DOI 10.1016/j.tig.2009.04.003; Head LM, 2015, CURR BIOL, V25, P1063, DOI 10.1016/j.cub.2015.02.038; Kobayashi Y, 2015, NEURON, V86, P264, DOI 10.1016/j.neuron.2015.02.036; Koh K, 2008, SCIENCE, V321, P372, DOI 10.1126/science.1155942; Kwon Y, 2008, NAT NEUROSCI, V11, P871, DOI 10.1038/nn.2170; Lin Y, 2002, P NATL ACAD SCI USA, V99, P9562, DOI 10.1073/pnas.132269699; LOMB NR, 1976, ASTROPHYS SPACE SCI, V39, P447, DOI 10.1007/BF00648343; Luo LJ, 2010, J NEUROSCI, V30, P4261, DOI 10.1523/JNEUROSCI.4090-09.2010; Menegazzi P, 2013, J BIOL RHYTHM, V28, P3, DOI 10.1177/0748730412471303; Menegazzi P, 2012, J BIOL RHYTHM, V27, P433, DOI 10.1177/0748730412463181; Naidoo N, 1999, SCIENCE, V285, P1737, DOI 10.1126/science.285.5434.1737; Nall AH, 2013, J NEUROSCI, V33, P8534, DOI 10.1523/JNEUROSCI.0253-13.2013; Nitabach MN, 2008, CURR BIOL, V18, pR84, DOI 10.1016/j.cub.2007.11.061; OTOUSA JE, 1989, J NEUROGENET, V6, P41, DOI 10.3109/01677068909107099; Pearn MT, 1996, J BIOL CHEM, V271, P4937; Pittendrigh CS, 1976, J COMP PHYSIOL A, V331, P291; Prabhakaran PM, 2014, J COMP PHYSIOL A, V200, P849, DOI 10.1007/s00359-014-0927-x; Rieger D, 2006, J NEUROSCI, V26, P2531, DOI 10.1523/JNEUROSCI.1234-05.2006; Rieger D, 2009, J BIOL RHYTHM, V24, P271, DOI 10.1177/0748730409338508; Rode F, 2007, EUR J PHARMACOL, V564, P103, DOI 10.1016/j.ejphar.2007.02.009; Rothenfluh A, 2000, CURR BIOL, V10, P1399, DOI 10.1016/S0960-9822(00)00786-7; Ruf T, 1999, BIOL RHYTHM RES, V30, P178, DOI 10.1076/brhm.30.2.178.1422; SCARGLE JD, 1982, ASTROPHYS J, V263, P835, DOI 10.1086/160554; Seeds AM, 2014, ELIFE, V3, DOI 10.7554/eLife.02951; Shen WL, 2011, SCIENCE, V331, P1333, DOI 10.1126/science.1198904; Stoleru D, 2005, NATURE, V438, P238, DOI 10.1038/nature04192; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; Tataroglu O, 2014, METHODS, V68, P140, DOI 10.1016/j.ymeth.2014.01.001; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; Tumer EC, 2007, NATURE, V450, P1240, DOI 10.1038/nature06390; Vanin S, 2012, NATURE, V484, P371, DOI 10.1038/nature10991; Yamaguchi S, 2008, P NATL ACAD SCI USA, V105, P4910, DOI 10.1073/pnas.0711484105; Yamaguchi S, 2011, FLY, V5, P333, DOI 10.4161/fly.5.4.16419; Yao Z, 2014, SCIENCE, V343, P1516, DOI 10.1126/science.1251285; Yoshii T, 2012, PROG BRAIN RES, V199, P59, DOI 10.1016/B978-0-444-59427-3.00027-7; Zhang Y, 2010, CURR BIOL, V20, P600, DOI 10.1016/j.cub.2010.02.044	48	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0140481	10.1371/journal.pone.0140481	http://dx.doi.org/10.1371/journal.pone.0140481			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528813	Green Published, gold, Green Submitted			2022-12-26	WOS:000364032600007
J	Niemeyer, JC; Moreira-Santos, M; Ribeiro, R; Rutgers, M; Nogueira, MA; da Silva, EM; Sousa, JP				Niemeyer, Julia Carina; Moreira-Santos, Matilde; Ribeiro, Rui; Rutgers, Michiel; Nogueira, Marco Antonio; da Silva, Eduardo Mendes; Sousa, Jose Paulo			Ecological Risk Assessment of a Metal-Contaminated Area in the Tropics. Tier II: Detailed Assessment	PLOS ONE			English	Article							SOIL RESPIRATION; SITE MANAGEMENT; HEAVY-METALS; TOXICITY; POLLUTION; GROWTH; BIOAVAILABILITY; COMMUNITY; TESTS; DECOMPOSITION	This study presents data on the detailed evaluation (tier 2) of a site-specific ecological risk assessment (ssERA) in a former smelter area contaminated with metals (Santo Amaro, Bahia, Brazil). Combining information from three lines of evidence (LoE), chemical (ChemLoE), ecotoxicological (EcotoxLoE) and ecological (EcoLoE), in the Triad approach, integrated risk values were calculated to rank sites and confirm the potential risk disclosed with tier 1. Risk values were calculated for the habitat and for the retention functions in each sampling point. Habitat function included the ChemLoE calculated from total metal concentrations. The EcotoxLoE was based on reproduction tests with terrestrial invertebrates (Folsomia candida, Enchytraeus crypticus, Eisenia andrei), shoot length and plant biomass (Avena sativa, Brassica rapa). For the EcoLoE, ecological parameters (microbial parameters, soil invertebrate community, litter breakdown) were used to derive risk values. Retention function included the ChemLoE, calculated from extractable metal concentrations, and the EcotoxLoE based on eluate tests with aquatic organisms (Daphnia magna reproduction and Pseudokirchneriella subcapitata growth). Results related to the habitat function indicated that the metal residues are sufficient to cause risk to biota, while the low metal levels in extracts and the general lack of toxicity in aquatic tests indicated a high soil retention capacity in most sampling points. Integrated risk of tier 2 showed the same trend of tier 1, suggesting the need to proceed with remediation actions. The high risk levels were related to direct toxicity to organisms and indirect effects, such as failure in the establishment of vegetation and the consequent loss of habitat quality for microorganisms and soil fauna. This study shed some light on the selection of tools for the tier 2 of an ssERA in tropical metal-contaminated sites, focusing on ecological receptors at risk and using available chemical methods, ecological surveys and ecotoxicity tests.	[Niemeyer, Julia Carina; Moreira-Santos, Matilde; Ribeiro, Rui; Sousa, Jose Paulo] Univ Coimbra, Dept Life Sci, Ctr Funct Ecol, Coimbra, Portugal; [Niemeyer, Julia Carina] Univ Fed Santa Catarina, Curitibanos, SC, Brazil; [Rutgers, Michiel] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Nogueira, Marco Antonio] Embrapa Soybean, Lab Soil Biotechnol, Londrina, Parana, Brazil; [da Silva, Eduardo Mendes] Univ Fed Bahia, Inst Biol, Salvador, BA, Brazil	Universidade de Coimbra; Universidade Federal de Santa Catarina (UFSC); Netherlands National Institute for Public Health & the Environment; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal da Bahia	Niemeyer, JC (corresponding author), Univ Coimbra, Dept Life Sci, Ctr Funct Ecol, Coimbra, Portugal.	juliacarina@gmail.com	Niemeyer, Julia/E-5838-2013; Moreira-Santos, Matilde/J-2609-2013; Nogueira, Marco A./B-8768-2016; Sousa, Jose Paulo FA/H-5407-2011; Ribeiro, Rui/C-7788-2012; Niemeyer, Julia/AAG-3466-2020	Niemeyer, Julia/0000-0001-6606-0338; Moreira-Santos, Matilde/0000-0001-7067-5028; Nogueira, Marco A./0000-0001-7747-9839; Sousa, Jose Paulo FA/0000-0001-8045-4296; Ribeiro, Rui/0000-0002-0883-1939; Niemeyer, Julia/0000-0001-6606-0338	Program Alban (Brazil) [E05D058118BR]; Fundacao para a Ciencia e a Tecnologia (FCT, Portugal) [SFRH/BD/28796/2006]; Ciencia FSE fund (FCT, Portugal); POPH fund (FCT, Portugal); QREN fund (FCT, Portugal); Brazilian Research Council (CNPq); Department of Life Sciences	Program Alban (Brazil); Fundacao para a Ciencia e a Tecnologia (FCT, Portugal)(Portuguese Foundation for Science and Technology); Ciencia FSE fund (FCT, Portugal); POPH fund (FCT, Portugal); QREN fund (FCT, Portugal); Brazilian Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Department of Life Sciences	The study was partially supported through two PhD grants to JCN, from Program Alban (Brazil; E05D058118BR) and Fundacao para a Ciencia e a Tecnologia (FCT, Portugal; SFRH/BD/28796/2006) and through Ciencia 2007-FSE and POPH and QREN funds (FCT, Portugal). EMS and MAN acknowledge receiving a grant from the Brazilian Research Council (CNPq). The work was supported by Department of Life Sciences own funds and facilities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achazi Rudolf K., 2002, Journal of Soils and Sediments, V2, P174, DOI 10.1007/BF02991037; Alvarenga P, 2008, ENVIRON GEOCHEM HLTH, V30, P95, DOI 10.1007/s10653-008-9147-z; An YJ, 2006, CHEMOSPHERE, V62, P1359, DOI 10.1016/j.chemosphere.2005.07.044; Anjos J.S.A., 2003, THESIS U SAO PAULO B; Anjos JSA., 1998, THESIS U SAO PAULO S; [Anonymous], 1998, 11274 ISO; [Anonymous], 2003, 15799 ISO; [Anonymous], 1994, 11260 ISO; ASTM International, 2018, STANDARD TEST METHOD; BAIRD DJ, 1989, HYDROBIOLOGIA, V188, P403, DOI 10.1007/BF00027806; Ben Ghnaya A, 2009, CR BIOL, V332, P363, DOI 10.1016/j.crvi.2008.12.001; Boivin MEY, 2006, APPL SOIL ECOL, V34, P103, DOI 10.1016/j.apsoil.2006.03.009; Broos K, 2005, ENVIRON TOXICOL CHEM, V24, P634, DOI 10.1897/04-036R.1; Buch AC, 2013, APPL SOIL ECOL, V69, P32, DOI 10.1016/j.apsoil.2012.12.011; Carvalho Fernando Martins, 2003, Rev Panam Salud Publica, V13, P19, DOI 10.1590/S1020-49892003000100003; Chelinho S, 2011, ENVIRON TOXICOL CHEM, V30, P1050, DOI 10.1002/etc.480; Chelinho S, 2010, J SOIL SEDIMENT, V10, P568, DOI 10.1007/s11368-009-0145-2; Cortez J, 1998, SOIL BIOL BIOCHEM, V30, P783, DOI 10.1016/S0038-0717(97)00163-6; Costa A.C.A., 2001, THESIS FEDERAL U BAH; Creamer RE, 2008, SOIL USE MANAGE, V24, P37, DOI 10.1111/j.1475-2743.2007.00131.x; Critto A, 2007, SCI TOTAL ENVIRON, V379, P16, DOI 10.1016/j.scitotenv.2007.02.035; Lima LRPD, 2011, J HAZARD MATER, V189, P692, DOI 10.1016/j.jhazmat.2011.02.091; De Zwart D, 2005, ENVIRON TOXICOL CHEM, V24, P2665, DOI 10.1897/04-639R.1; Dinter A, 2008, J SOIL SEDIMENT, V8, P333, DOI 10.1007/s11368-008-0028-y; Environment Canada, 1992, 1RM25 EC EPS; Everhart JL, 2006, SCI TOTAL ENVIRON, V367, P732, DOI 10.1016/j.scitotenv.2005.12.029; Forster B, 2006, EUR J SOIL BIOL, V42, pS171, DOI 10.1016/j.ejsobi.2006.07.011; Fountain MT, 2001, ECOTOX ENVIRON SAFE, V48, P275, DOI 10.1006/eesa.2000.2007; Gong P, 2001, CHEMOSPHERE, V44, P491, DOI 10.1016/S0045-6535(00)00280-0; Gonzalez V, 2011, J SOIL SEDIMENT, V11, P1199, DOI 10.1007/s11368-011-0391-y; Grzes IM, 2010, B ENVIRON CONTAM TOX, V84, P61, DOI 10.1007/s00128-009-9893-3; Grzes IM, 2009, PEDOBIOLOGIA, V53, P65, DOI 10.1016/j.pedobi.2009.03.002; Gulser F, 2008, ENVIRON MONIT ASSESS, V145, P127, DOI 10.1007/s10661-007-0022-7; Heimbach F, 1997, SOIL BIOL BIOCHEM, V29, P671, DOI 10.1016/S0038-0717(96)00194-0; International Organization for Standardization I., 1998, 112682 ISO; *ISO, 2005, 112692 ISO; ISO, 1999, 11267 ISO; [ISO] International Organization for Standardization, 2005, 10390 ISO; ISO-International Organization for Standardization, 2003, 16387 ISO; Jaensch S., 2005, Environmental Reviews, V13, P51; Jensen J, 2006, 711701047 RIVM; Jiang JP, 2010, EUR J SOIL BIOL, V46, P18, DOI 10.1016/j.ejsobi.2009.10.001; Kapustka LA, 1999, HUM ECOL RISK ASSESS, V5, P691, DOI 10.1080/10807039.1999.9657733; Kaulbach ES, 2005, ENVIRON SCI TECHNOL, V39, P4060, DOI 10.1021/es0481833; LNEC, 1970, 239 LNECE; LONG ER, 1985, MAR POLLUT BULL, V16, P405, DOI 10.1016/0025-326X(85)90290-5; Loureiro S, 2006, ARCH ENVIRON CON TOX, V50, P182, DOI 10.1007/s00244-004-0261-3; Machado S.L., 2002, RELATORIO FINAL PROJ; Machado S.L., 2004, ENG SANIT AMBIENT, V9, P140; Mertens J, 2006, ENVIRON MICROBIOL, V8, P2170, DOI 10.1111/j.1462-2920.2006.01100.x; MONTAGNINI F, 1989, FOREST ECOL MANAG, V26, P77, DOI 10.1016/0378-1127(89)90037-6; Natal da Luz T., 2011, ECOTOX ENVIRON SAFE, V74, P1715, DOI DOI 10.1016/J.ECOENV.2011.05.017; Natal-da-Luz T, 2012, ECOTOXICOLOGY, V21, P2163, DOI 10.1007/s10646-012-0970-8; Niemeyer JC, 2012, ECOTOX ENVIRON SAFE, V86, P188, DOI 10.1016/j.ecoenv.2012.09.013; Niemeyer JC, 2010, J SOIL SEDIMENT, V10, P1557, DOI 10.1007/s11368-010-0255-x; Niemeyer JC, 2012, APPL SOIL ECOL, V59, P96, DOI 10.1016/j.apsoil.2012.03.019; Nogueira MA, 2006, AGR ECOSYST ENVIRON, V115, P237, DOI 10.1016/j.agee.2006.01.008; OECD, 2006, BREAKD ORG MATT LITT; OECD, 1998, DAPHN MAGN REPR TEST; OECD, 1984, ALG GROWTH INH TEST; OECD (Organisation for Economic Co-operation and Development), 1984, EARTHW AC TOX TESTS; Oncel I, 2000, ENVIRON POLLUT, V107, P315, DOI 10.1016/S0269-7491(99)00177-3; Pandard P, 2006, SCI TOTAL ENVIRON, V363, P114, DOI 10.1016/j.scitotenv.2005.12.016; Podgaiski LR, 2010, EUR J SOIL BIOL, V46, P394, DOI 10.1016/j.ejsobi.2010.09.001; Posthuma L, 2008, SCI TOTAL ENVIRON, V406, P503, DOI 10.1016/j.scitotenv.2008.06.065; Rombke J, 2006, ENVIRON TOXICOL CHEM, V25, P776, DOI 10.1897/04-584R.1; Rombke Jorg, 2003, EFFECTS PLANT PROTEC; Rosa R, 2010, ENVIRON MONIT ASSESS, V161, P439, DOI 10.1007/s10661-009-0759-2; ROY D, 1993, J ENVIRON SCI HEAL A, VA28, P37, DOI 10.1080/10934529309375861; Rutgers M., 2008, 711701072 RIVM; Rutgers M, 2011, DEALING WITH CONTAMINATED SITES: FROM THEORY TOWARDS PRACTICAL APPLICATION, P693, DOI 10.1007/978-90-481-9757-6_15; Schultz E, 2004, SCI TOTAL ENVIRON, V326, P71, DOI 10.1016/j.scitotenv.2003.12.008; Semenzin E, 2008, SCI TOTAL ENVIRON, V389, P71, DOI 10.1016/j.scitotenv.2007.08.032; Stein J., 1973, HDB PHYCOLOGICAL MET; Suter II G. W., 2000, ECOLOGICAL RISK ASSE; Swartjes FA, 2012, SCI TOTAL ENVIRON, V427, P1, DOI 10.1016/j.scitotenv.2012.02.078; USEPA, 2004, EPA630P04068B; Van den Brink PJ, 2008, ENVIRON SCI TECHNOL, V42, P8999, DOI 10.1021/es801991c; van Gestel CAM, 2001, ENVIRON TOXICOL CHEM, V20, P1438, DOI [10.1897/1551-5028(2001)020&lt;1438:TUOAAC&gt;2.0.CO;2, 10.1002/etc.5620200705]; van Gestel CAM, 2009, ENVIRON POLLUT, V157, P895, DOI 10.1016/j.envpol.2008.11.002; Vasseur P, 2008, ENVIRON TOXICOL, V23, P652, DOI 10.1002/tox.20401; Vijver M, 2001, ENVIRON TOXICOL CHEM, V20, P712, DOI [10.1002/etc.5620200404, 10.1897/1551-5028(2001)020&lt;0712:IOMPAS&gt;2.0.CO;2]; VROM, 2000, CIRC TARG VAL INT VA; Wagelmans M, 2009, EVALUATION IMPLEMENT; Weeks J.M., 2004, P5069TR1 ENV AG ENGL; Zak DR, 2003, ECOLOGY, V84, P2042, DOI 10.1890/02-0433; Zimakowska-Gnoinska D, 2000, ENVIRON MONIT ASSESS, V61, P301, DOI 10.1023/A:1006105329210	87	25	26	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141772	10.1371/journal.pone.0141772	http://dx.doi.org/10.1371/journal.pone.0141772			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528915	Green Submitted, gold, Green Published			2022-12-26	WOS:000364032600058
J	Figarola, JL; Singhal, J; Tompkins, JD; Rogers, GW; Warden, C; Horne, D; Riggs, AD; Awasthi, S; Singhal, SS				Figarola, James L.; Singhal, Jyotsana; Tompkins, Joshua D.; Rogers, George W.; Warden, Charles; Horne, David; Riggs, Arthur D.; Awasthi, Sanjay; Singhal, Sharad S.			SR4 Uncouples Mitochondrial Oxidative Phosphorylation, Modulates AMP-dependent Kinase (AMPK)-Mammalian Target of Rapamycin (mTOR) Signaling, and Inhibits Proliferation of HepG2 Hepatocarcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY TRANSITION PORE; HEPATOCELLULAR-CARCINOMA; THERAPEUTIC APPROACH; CANCER-THERAPY; PROTON LEAK; APOPTOSIS; PROTEIN; 6-KETOCHOLESTANOL; DIFFERENTIATION; EPIDEMIOLOGY	Mitochondrial oxidative phosphorylation produces most of the energy in aerobic cells by coupling respiration to the production of ATP. Mitochondrial uncouplers, which reduce the proton gradient across the mitochondrial inner membrane, create a futile cycle of nutrient oxidation without generating ATP. Regulation of mitochondrial dysfunction and associated cellular bioenergetics has been recently identified as a promising target for anticancer therapy. Here, we show that SR4 is a novel mitochondrial uncoupler that causes dose-dependent increase in mitochondrial respiration and dissipation of mitochondrial membrane potential in HepG2 hepatocarcinoma cells. These effects were reversed by the recoupling agent 6-ketocholestanol but not cyclosporin A and were nonexistent in mitochondrial DNA-depleted HepG2 cells. In isolated mouse liver mitochondria, SR4 similarly increased oxygen consumption independent of adenine nucleotide translocase and uncoupling proteins, decreased mitochondrial membrane potential, and promoted swelling of valinomycin-treated mitochondria in potassium acetate medium. Mitochondrial uncoupling in HepG2 cells by SR4 results in the reduction of cellular ATP production, increased ROS production, activation of the energy-sensing enzyme AMPK, and inhibition of acetyl-CoA carboxylase and mammalian target of rapamycin signaling pathways, leading to cell cycle arrest and apoptosis. Global analysis of SR4-associated differential gene expression confirms these observations, including significant induction of apoptotic genes and down-regulation of cell cycle, mitochondrial, and oxidative phosphorylation pathway transcripts at 24 h post-treatment. Collectively, our studies demonstrate that the previously reported indirect activation of AMPK and in vitro anticancer properties of SR4 as well as its beneficial effects in both animal xenograft and obese mice models could be a direct consequence of its mitochondrial uncoupling activity.	[Figarola, James L.; Singhal, Jyotsana; Tompkins, Joshua D.; Riggs, Arthur D.; Singhal, Sharad S.] Beckman Res Inst City Hope, Ctr Comprehens Canc, Dept Diabet & Metab Dis Res, Duarte, CA 91010 USA; [Horne, David] Beckman Res Inst City Hope, Ctr Comprehens Canc, Dept Mol Med, Duarte, CA 91010 USA; [Awasthi, Sanjay] Beckman Res Inst City Hope, Ctr Comprehens Canc, Dept Med Oncol, Duarte, CA 91010 USA; [Rogers, George W.] Seahorse Biosci, North Billerica, MA 01862 USA; [Warden, Charles] Univ Michigan, Bioinformat Program, Ann Arbor, MI 48109 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; University of Michigan System; University of Michigan	Singhal, SS (corresponding author), Beckman Res Inst City Hope, Ctr Comprehens Canc, Dept Diabet & Metab Dis Res, Duarte, CA 91010 USA.	ssinghal@coh.org	Awasthi, Sanjay/R-4904-2019	Riggs, Arthur/0000-0002-8184-5288; Warden, Charles/0000-0002-1827-4486; Awasthi, Sanjay/0000-0002-5214-5717	Department Chair; Beckman Research Institute of the City of Hope	Department Chair; Beckman Research Institute of the City of Hope	This work was supported by Isaac and Jacquelin Moradi. This work was also supported by the Department Chair (Prof. Arthur Riggs) and Beckman Research Institute of the City of Hope. G. W. R. is an employee of Seahorse Bioscience, which manufactures the XF instruments used in this study. The other authors declare that they have no conflicts of interest with the contents of this article.	Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233; Benard G, 2011, MITOCHONDRIAL DYNAMICS AND NEURODEGENERATION, P47, DOI 10.1007/978-94-007-1291-1_2; Boland ML, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00292; BRAND MD, 1994, BBA-BIOENERGETICS, V1187, P132, DOI 10.1016/0005-2728(94)90099-X; Brennan JP, 2006, CARDIOVASC RES, V72, P313, DOI 10.1016/j.cardiores.2006.07.019; Busiello RA, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00036; Cela O, 2010, MITOCHONDRION, V10, P487, DOI 10.1016/j.mito.2010.05.005; Chalmers S, 2012, J AM CHEM SOC, V134, P758, DOI 10.1021/ja2077922; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chen SI, 2014, MINI-REV MED CHEM, V14, P642, DOI 10.2174/1389557514666140820104444; Costantini P, 2000, ONCOGENE, V19, P307, DOI 10.1038/sj.onc.1203299; Dhanasekaran R, 2012, HEPATIC MED-EVID RES, V4, P19, DOI 10.2147/HMER.S16316; Divakaruni AS, 2011, PHYSIOLOGY, V26, P192, DOI 10.1152/physiol.00046.2010; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Figarola JL, 2013, INT J MOL MED, V31, P1166, DOI 10.3892/ijmm.2013.1313; Figarola JL, 2012, INVEST NEW DRUG, V30, P1413, DOI 10.1007/s10637-011-9711-8; Fulda S, 2010, NAT REV DRUG DISCOV, V9, P447, DOI 10.1038/nrd3137; Han HJ, 1998, HUM MOL GENET, V7, P1039, DOI 10.1093/hmg/7.6.1039; Han YH, 2008, TOXICOL IN VITRO, V22, P659, DOI 10.1016/j.tiv.2007.12.005; Han YH, 2009, TOXICOLOGY, V265, P101, DOI 10.1016/j.tox.2009.10.001; Hashiguchi K, 2009, METHODS MOL BIOL, V554, P383, DOI 10.1007/978-1-59745-521-3_23; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Inoki K, 2012, ANNU REV PHARMACOL, V52, P381, DOI 10.1146/annurev-pharmtox-010611-134537; Jara JA, 2014, J MED CHEM, V57, P2440, DOI 10.1021/jm500174v; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kenwood BM, 2014, MOL METAB, V3, P114, DOI 10.1016/j.molmet.2013.11.005; Kuruvilla S, 2003, TOXICOL SCI, V73, P348, DOI 10.1093/toxsci/kfg084; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Llovet JM, 2014, CLIN CANCER RES, V20, P2072, DOI 10.1158/1078-0432.CCR-13-0547; Lou PH, 2007, BIOCHEM J, V407, P129, DOI 10.1042/BJ20070606; Manghisi G, 1998, HEPATOLOGY, V28, P751; Marin JJG., 2008, CANC THER, V6, P711; McQuaker SJ, 2013, CHEMBIOCHEM, V14, P993, DOI 10.1002/cbic.201300115; McStay GP, 2002, BIOCHEM J, V367, P541, DOI 10.1042/BJ20011672; MITCHELL P, 1966, BIOL REV, V41, P445, DOI 10.1111/j.1469-185X.1966.tb01501.x; Modica-Napolitano JS, 2004, MITOCHONDRION, V4, P755, DOI 10.1016/j.mito.2004.07.027; Neuzil J, 2013, MITOCHONDRION, V13, P199, DOI 10.1016/j.mito.2012.07.112; Nicholls David G, 2010, J Vis Exp, DOI 10.3791/2511; Papa S, 2012, ADV EXP MED BIOL, V942, P3, DOI 10.1007/978-94-007-2869-1_1; Pardo-Andreu GL, 2011, MITOCHONDRION, V11, P255, DOI 10.1016/j.mito.2010.10.008; Reis FHZ, 2014, CHEM-BIOL INTERACT, V212, P20, DOI 10.1016/j.cbi.2014.01.015; Rogers GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021746; Rohlena J, 2011, ANTIOXID REDOX SIGN, V15, P2951, DOI 10.1089/ars.2011.3990; Samudio I, 2009, CANCER RES, V69, P2163, DOI 10.1158/0008-5472.CAN-08-3722; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schultz BE, 2001, ANNU REV BIOPH BIOM, V30, P23, DOI 10.1146/annurev.biophys.30.1.23; Seyfried TN, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-7; Shchepinova MM, 2014, BBA-BIOENERGETICS, V1837, P149, DOI 10.1016/j.bbabio.2013.09.011; Singhal SS, 2013, BIOCHEM PHARMACOL, V86, P1664, DOI 10.1016/j.bcp.2013.09.022; Singhal SS, 2012, BIOCHEM PHARMACOL, V84, P1419, DOI 10.1016/j.bcp.2012.08.020; Skulachev VP, 1998, BBA-BIOENERGETICS, V1363, P100, DOI 10.1016/S0005-2728(97)00091-1; Spitzer M, 2014, NAT METHODS, V11, P121, DOI 10.1038/nmeth.2811; Starkov AA, 1997, BBA-BIOENERGETICS, V1318, P159, DOI 10.1016/S0005-2728(96)00134-X; STARKOV AA, 1994, FEBS LETT, V355, P305, DOI 10.1016/0014-5793(94)01211-3; Starkov AA, 2006, CHEM-BIOL INTERACT, V163, P133, DOI 10.1016/j.cbi.2006.08.015; TERADA H, 1990, ENVIRON HEALTH PERSP, V87, P213, DOI 10.2307/3431027; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Velez J, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00067; Venook AP, 2010, ONCOLOGIST, V15, P5, DOI 10.1634/theoncologist.2010-S4-05; Wang F, 2010, MOL ASPECTS MED, V31, P75, DOI 10.1016/j.mam.2009.12.003; Wang P, 2012, DIABETES-METAB RES, V28, P109, DOI 10.1002/dmrr.1291; Wen SJ, 2013, FUTURE MED CHEM, V5, P53, DOI 10.4155/fmc.12.190; Weng ZQ, 2015, TOXICOLOGY, V327, P10, DOI 10.1016/j.tox.2014.11.002; Zorov DB, 2006, BBA-BIOENERGETICS, V1757, P509, DOI 10.1016/j.bbabio.2006.04.029	64	25	25	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2015	290	51					30321	30341		10.1074/jbc.M115.686352	http://dx.doi.org/10.1074/jbc.M115.686352			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY9PG	26534958	hybrid, Green Published			2022-12-26	WOS:000366738200012
J	Arteaga, O; Revuelta, M; Uriguen, L; Alvarez, A; Montalvo, H; Hilario, E				Arteaga, Olatz; Revuelta, Miren; Urigueen, Leyre; Alvarez, Antonia; Montalvo, Haizea; Hilario, Enrique			Pretreatment with Resveratrol Prevents Neuronal Injury and Cognitive Deficits Induced by Perinatal Hypoxia-Ischemia in Rats	PLOS ONE			English	Article							BRAIN-INJURY; ISCHEMIA/REPERFUSION INJURY; CEREBRAL-ISCHEMIA; OXIDATIVE STRESS; NEONATAL BRAIN; FRENCH PARADOX; MEMORY; IMPAIRMENT; MODEL; DAMAGE	Despite advances in neonatal care, hypoxic-ischemic brain injury is still a serious clinical problem, which is responsible for many cases of perinatal mortality, cerebral palsy, motor impairment and cognitive deficits. Resveratrol, a natural polyphenol with important anti-oxidant and anti-inflammatory properties, is present in grapevines, peanuts and pomegranates. The aim of the present work was to evaluate the possible neuroprotective effect of resveratrol when administered before or immediately after a hypoxic-ischemic brain event in neonatal rats by analyzing brain damage, the mitochondrial status and long-term cognitive impairment. Our results indicate that pretreatment with resveratrol protects against brain damage, reducing infarct volume, preserving myelination and minimizing the astroglial reactive response. Moreover its neuroprotective effect was found to be long lasting, as behavioral outcomes were significantly improved at adulthood. We speculate that one of the mechanisms for this neuroprotection may be related to the maintenance of the mitochondrial inner membrane integrity and potential, and to the reduction of reactive oxygen species. Curiously, none of these protective features was observed when resveratrol was administered immediately after hypoxia-ischemia.	[Arteaga, Olatz; Revuelta, Miren; Alvarez, Antonia; Montalvo, Haizea; Hilario, Enrique] Univ Basque Country UPV EHU, Dept Cell Biol & Histol, Sch Med & Dent, Leioa, Bizkaia, Spain; [Urigueen, Leyre] Univ Basque Country UPV EHU, Dept Pharmacol, Sch Med & Dent, Leioa, Bizkaia, Spain; [Urigueen, Leyre] Ctr Invest Biomed Red Mental CIBERSAM, Madrid, Spain	University of Basque Country; University of Basque Country; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM	Arteaga, O (corresponding author), Univ Basque Country UPV EHU, Dept Cell Biol & Histol, Sch Med & Dent, Leioa, Bizkaia, Spain.	olatz.arteaga@ehu.eus	Revuelta, Miren/AAH-2410-2019; Urigüen, Leyre/Z-6217-2019	Revuelta, Miren/0000-0001-8126-2050; Urigüen, Leyre/0000-0002-1296-6895; arteaga, olatz/0000-0002-4328-4408; ALVAREZ DIAZ, ANTONIA ANGELES/0000-0002-1730-7565; Hilario, Enrique/0000-0002-8876-8131	Basque Government [IT 773/13, BFI-2011-129]	Basque Government(Basque Government)	Funding was provided by Basque Government IT 773/13 and BFI-2011-129. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albani D, 2010, BIOFACTORS, V36, P370, DOI 10.1002/biof.118; Alonso-Alconada D, 2012, HISTOL HISTOPATHOL, V27, P771, DOI 10.14670/HH-27.771; Alvarez-Diaz A, 2007, NEONATOLOGY, V92, P227, DOI 10.1159/000103741; Aridas JDS, 2014, EXP NEUROL, V261, P281, DOI 10.1016/j.expneurol.2014.07.009; Arteni NS, 2003, BRAIN RES, V973, P171, DOI 10.1016/S0006-8993(03)02436-3; Arteni NS, 2010, BEHAV BRAIN RES, V1301, P100; Azra Haider Batool, 2006, Curr Probl Pediatr Adolesc Health Care, V36, P178; Baba Lisa, 2008, Adv Neonatal Care, V8, P256, DOI 10.1097/01.ANC.0000338015.25911.8a; Balduini W, 2000, BRAIN RES, V859, P318, DOI 10.1016/S0006-8993(00)01997-1; Bastianetto S, 2014, BIOCH BIOPHYS ACTA; Broadbent NJ, 2010, LEARN MEMORY, V17, P794, DOI 10.1101/lm.1650110; Butt AM, 2014, GLIA, V62, P1762, DOI 10.1002/glia.22674; Catalgol B, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00141; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Damodaran T, 2014, BEHAV BRAIN RES, V275, P252, DOI 10.1016/j.bbr.2014.09.014; DARZYNKIEWICZ Z, 1981, P NATL ACAD SCI-BIOL, V78, P2383, DOI 10.1073/pnas.78.4.2383; Dere E, 2007, NEUROSCI BIOBEHAV R, V31, P673, DOI 10.1016/j.neubiorev.2007.01.005; Dong WP, 2007, MED HYPOTHESES, V69, P700, DOI 10.1016/j.mehy.2007.01.017; du Plessis AJ, 2002, CURR OPIN NEUROL, V15, P151, DOI 10.1097/00019052-200204000-00005; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Ferretta A, 2014, BBA-MOL BASIS DIS, V1842, P902, DOI 10.1016/j.bbadis.2014.02.010; Ferriero DM, 2004, NEW ENGL J MED, V351, P1985, DOI 10.1056/NEJMra041996; Ferriero DM, 2001, DEV NEUROSCI-BASEL, V23, P198, DOI 10.1159/000046143; Girbovan C, 2015, NUTR NEUROSCI; de Cerio FG, 2013, BRAIN SCI, V3, P191, DOI 10.3390/brainsci3010191; Gulcin I, 2010, INNOV FOOD SCI EMERG, V11, P210, DOI 10.1016/j.ifset.2009.07.002; Hagberg H, 1997, ACTA PAEDIATR, V86, P85; Hagberg H, 2014, LANCET NEUROL, V13, P217, DOI 10.1016/S1474-4422(13)70261-8; Hedtjarn M, 2002, J NEUROSCI, V22, P5910; Hilario E, 2005, ACTA PAEDIATR, V94, P903, DOI 10.1080/08035250510031151; Huang ZH, 2009, BRAIN RES, V1301, P100, DOI 10.1016/j.brainres.2009.09.006; Ikeda T, 2001, BEHAV BRAIN RES, V118, P17, DOI 10.1016/S0166-4328(00)00287-4; Jiang H, 2014, ASIAN PAC J TROP MED, V7, P496, DOI 10.1016/S1995-7645(14)60082-1; Juul SE, 2014, CLIN PERINATOL, V41, P119, DOI 10.1016/j.clp.2013.09.004; Karalis F, 2011, BRAIN RES, V1425, P98, DOI 10.1016/j.brainres.2011.09.044; Kesherwani V, 2013, NEUROSCIENCE, V241, P80, DOI 10.1016/j.neuroscience.2013.03.015; Lai MC, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/609813; Lee B, 2014, KOREAN J PHYSIOL PHA, V18, P191, DOI 10.4196/kjpp.2014.18.3.191; LEVENE ML, 1985, EARLY HUM DEV, V11, P21, DOI 10.1016/0378-3782(85)90115-X; Li XJ, 2014, EXP THER MED, V8, P1241, DOI 10.3892/etm.2014.1858; Liu BL, 2007, CANCER BIOL THER, V6, P1833, DOI 10.4161/cbt.6.12.5161; Liu CJ, 2011, BRAIN RES, V1374, P100, DOI 10.1016/j.brainres.2010.11.061; Low JA, 2004, J OBSTET GYNAECOL RE, V30, P276, DOI 10.1111/j.1447-0756.2004.00194.x; Lubics A, 2005, BEHAV BRAIN RES, V157, P157, DOI 10.1016/j.bbr.2004.06.019; Meng XJ, 2014, INDIAN J PHARM SCI, V76, P125; Mokni M, 2013, IRAN J PHARM RES, V12, P867; Morin C, 2003, DRUG EXP CLIN RES, V29, P227; Morrow BA, 2002, BEHAV BRAIN RES, V129, P217, DOI 10.1016/S0166-4328(01)00338-2; Northington FJ, 2001, NEUROBIOL DIS, V8, P207, DOI 10.1006/nbdi.2000.0371; Northington FJ, 2011, ANN NEUROL, V69, P743, DOI 10.1002/ana.22419; Pereira LO, 2007, NEUROBIOL LEARN MEM, V87, P101, DOI 10.1016/j.nlm.2006.07.003; Pallas M, 2013, CURR PHARM DESIGN, V19, P6726, DOI 10.2174/1381612811319380005; Pazos MR, 2012, NEUROPHARMACOLOGY, V63, P776, DOI 10.1016/j.neuropharm.2012.05.034; Rege SD, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00218; Revuelta M, 2015, BRAIN PATHOLOGY; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Rothstein RP, 2005, DEV NEUROSCI-BASEL, V27, P149, DOI 10.1159/000085987; Sab IM, 2013, PHARMACOL BIOCHEM BE, V107, P24, DOI 10.1016/j.pbb.2013.04.004; Sahu SS, 2013, PHARMACOL BIOCHEM BE, V103, P520, DOI 10.1016/j.pbb.2012.09.012; Sanches EF, 2013, NEUROSCIENCE, V237, P208, DOI 10.1016/j.neuroscience.2013.01.066; Simola N, 2008, EXP BRAIN RES, V185, P595, DOI 10.1007/s00221-007-1186-7; Sinha K, 2002, LIFE SCI, V71, P655, DOI 10.1016/S0024-3205(02)01691-0; Sizonenko SV, 2008, INT J DEV NEUROSCI, V26, P37, DOI 10.1016/j.ijdevneu.2007.08.014; Smoliga JM, 2011, MOL NUTR FOOD RES, V55, P1129, DOI 10.1002/mnfr.201100143; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Thornton C, 2015, CLIN CHIM ACTA, V451, P35, DOI 10.1016/j.cca.2015.01.026; Vannucci SJ, 2004, J EXP BIOL, V207, P3149, DOI 10.1242/jeb.01064; Venturini CD, 2010, OXID MED CELL LONGEV, V3, P434, DOI 10.4161/oxim.3.6.14741; Vingtdeux V, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S2-S6; Volpe J J, 1998, Semin Pediatr Neurol, V5, P135, DOI 10.1016/S1071-9091(98)80030-2; Volpe JJ, 2001, MENT RETARD DEV D R, V7, P56, DOI 10.1002/1098-2779(200102)7:1<56::AID-MRDD1008>3.0.CO;2-A; Wang HD, 2013, BRIT J PHARMACOL, V170, P796, DOI 10.1111/bph.12301; Wang R, 2014, CELL PHYSIOL BIOCHEM, V34, P854, DOI 10.1159/000366304; Warner DS, 2004, J EXP BIOL, V207, P3221, DOI 10.1242/jeb.01022; West T, 2007, DEV NEUROSCI-BASEL, V29, P363, DOI 10.1159/000105477; Witte AV, 2014, J NEUROSCI, V34, P7862, DOI 10.1523/JNEUROSCI.0385-14.2014; Wong RHX, 2013, ANN NY ACAD SCI, V1290, P52, DOI 10.1111/nyas.12155; Xie CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107192; Yousuf S, 2009, BRAIN RES, V1250, P242, DOI 10.1016/j.brainres.2008.10.068; Zhao J, 2009, J HEART LUNG TRANSPL, V28, P936, DOI 10.1016/j.healun.2009.05.014	82	60	61	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142424	10.1371/journal.pone.0142424	http://dx.doi.org/10.1371/journal.pone.0142424			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544861	Green Published, Green Submitted, gold			2022-12-26	WOS:000364398700137
J	Huang, Y; Xing, N; Wang, ZG; Zhang, XJ; Zhao, XM; Du, Q; Chang, LL; Tong, DW				Huang, Yong; Xing, Na; Wang, Zengguo; Zhang, Xiujuan; Zhao, Xiaomin; Du, Qian; Chang, Lingling; Tong, Dewen			Ultrasensitive Detection of RNA and DNA Viruses Simultaneously Using Duplex UNDP-PCR Assay	PLOS ONE			English	Article							EPIDEMIC DIARRHEA VIRUS; TRANSMISSIBLE GASTROENTERITIS VIRUS; LINKED-IMMUNOSORBENT-ASSAY; PORCINE CIRCOVIRUS TYPE-2; CLASSICAL SWINE-FEVER; MOLECULAR EPIDEMIOLOGY; MULTIPLEX PCR; STRAINS; SAMPLES; CHINA	Mixed infection of multiple viruses is common in modern intensive pig rearing. However, there are no methods available to detect DNA and RNA viruses in the same reaction system in preclinical level. In this study, we aimed to develop a duplex ultrasensitive nanoparticle DNA probe-based PCR assay (duplex UNDP-PCR) that was able to simultaneously detect DNA and RNA viruses in the same reaction system. PCV2 and TGEV are selected as representatives of the two different types of viruses. PCV2 DNA and TGEV RNA were simultaneously released from the serum sample by boiling with lysis buffer, then magnetic beads and gold nanoparticles coated with single and/or duplex specific probes for TGEV and PCV2 were added to form a sandwich-like complex with nucleic acids released from viruses. After magnetic separation, DNA barcodes specific for PCV2 and TGEV were eluted using DTT and characterized by specific PCR assay for specific DNA barcodes subsequently. The duplex UNDP-PCR showed similar sensitivity as that of single UNDP-PCR and was able to detect 20 copies each of PCV2 and TGEV in the serum, showing approximately 250-fold more sensitivity than conventional duplex PCR/RT-PCR assays. No crossreaction was observed with other viruses. The positive detection rate of single MMPs-and duplex MMPs-based duplex UNDP-PCR was identical, with 29.6% for PCV2, 9.3% for TGEV and 3.7% for PCV2 and TGEV mixed infection. This duplex UNDP-PCR assay could detect TGEV (RNA virus) and PCV2 (DNA virus) from large-scale serum samples simultaneously without the need for DNA/RNA extraction, purification and reverse transcription of RNA, and showed a significantly increased positive detection rate for PCV2 (29%) and TGEV (11.7%) preclinical infection than conventional duplex PCR/RT-PCR. Therefore, the established duplex UNDP-PCR is a rapid and economical detection method, exhibiting high sensitivity, specificity and reproducibility.	[Huang, Yong; Xing, Na; Wang, Zengguo; Zhang, Xiujuan; Zhao, Xiaomin; Du, Qian; Chang, Lingling; Tong, Dewen] Northwest A&F Univ, Coll Vet Med, Yangling 712100, Shaanxi, Peoples R China	Northwest A&F University - China	Tong, DW (corresponding author), Northwest A&F Univ, Coll Vet Med, Yangling 712100, Shaanxi, Peoples R China.	dwtong@nwsuaf.edu.cn	du, qian/GYJ-7090-2022; Huang, Yong/G-9365-2011		scientific and technological project in Shaanxi province [2015NY155]; Key project of Shaanxi province science and technology innovation team [2013KCT-28]; international science and technology cooperation fund of Northwest AF University [A213021310]; scientific research program of Northwest AF University [ZD2013009, Z111021103]	scientific and technological project in Shaanxi province; Key project of Shaanxi province science and technology innovation team; international science and technology cooperation fund of Northwest AF University; scientific research program of Northwest AF University	This study was funded by grants from the scientific and technological project in Shaanxi province (Grant No. 2015NY155), Key project of Shaanxi province science and technology innovation team (2013KCT-28), international science and technology cooperation fund of Northwest A&F University (Grant No. A213021310), and the scientific research program of Northwest A&F University (No. ZD2013009 & Z111021103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan GM, 2000, J VET DIAGN INVEST, V12, P3, DOI 10.1177/104063870001200102; Brian DA, 2005, CURR TOP MICROBIOL, V287, P1, DOI 10.1007/3-540-26765-4_1; CALLEBAUT P, 1982, VET MICROBIOL, V7, P295, DOI 10.1016/0378-1135(82)90009-8; Chen JF, 2010, ARCH VIROL, V155, P1471, DOI 10.1007/s00705-010-0720-2; Chen R, 2004, J VIROL METHODS, V122, P57, DOI 10.1016/j.jviromet.2004.08.003; Ding L., 2011, CHIN J VET MED, V47, P9; DOYLE LP, 1946, J AM VET MED ASSOC, V108, P257; Dufour D, 2011, J VIROL, V85, P4963, DOI 10.1128/JVI.02317-10; Gou HC, 2015, MOL CELL PROBE, V29, P48, DOI 10.1016/j.mcp.2014.11.004; Huang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097869; Huang Y, 2013, VIRUS RES, V175, P78, DOI 10.1016/j.virusres.2013.03.014; Kim O, 2002, CAN J VET RES, V66, P112; Kim O, 2000, VET REC, V146, P637, DOI 10.1136/vr.146.22.637; Li PC, 2011, CURR MICROBIOL, V62, P1074, DOI 10.1007/s00284-010-9825-9; Luo YZ, 2014, VET MICROBIOL, V172, P1, DOI 10.1016/j.vetmic.2014.04.004; Nam JM, 2003, SCIENCE, V301, P1884, DOI 10.1126/science.1088755; Patterson AR, 2011, J VET DIAGN INVEST, V23, P206, DOI 10.1177/104063871102300203; Ramos N, 2013, INFECT GENET EVOL, V19, P23, DOI 10.1016/j.meegid.2013.06.017; SEHGAL D, 1994, ANAL BIOCHEM, V218, P87, DOI 10.1006/abio.1994.1144; [时乐 Shi Le], 2012, [西北农业学报, Acat Agriculturae Boreali-Occidentalis Sinica], V21, P6; Sun JH, 2015, ARCH VIROL, V160, P1339, DOI 10.1007/s00705-015-2373-7; Vemulapalli R, 2009, J VIROL METHODS, V162, P231, DOI 10.1016/j.jviromet.2009.08.016; Wang J, 2016, TRANSBOUND EMERG DIS, V63, pE369, DOI 10.1111/tbed.12312; Wang LT, 2013, TROP ANIM HEALTH PRO, V45, P1087, DOI 10.1007/s11250-012-0329-4; Wang YB, 2015, VIRUS GENES, V50, P401, DOI 10.1007/s11262-015-1190-0; Wang Z. S., 2010, ANXIETY STRESS COPIN, V19, P1; Xu XG, 2012, J VIROL METHODS, V183, P69, DOI 10.1016/j.jviromet.2012.03.034; Xu XG, 2013, VET MICROBIOL, V164, P212, DOI 10.1016/j.vetmic.2013.01.034; Xu XR, 2008, ANTIVIR RES, V78, P188, DOI 10.1016/j.antiviral.2007.12.012; Yang D, 2015, VIRUS RES, V206, P120, DOI 10.1016/j.virusres.2015.02.025; Zeng ZY, 2014, J VIROL METHODS, V208, P102, DOI 10.1016/j.jviromet.2014.08.001; Zhang Q, 2013, ARCH VIROL, V158, P1631, DOI 10.1007/s00705-013-1659-x; Zhao J, 2013, J VIROL METHODS, V194, P107, DOI 10.1016/j.jviromet.2013.08.008	33	11	11	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141545	10.1371/journal.pone.0141545	http://dx.doi.org/10.1371/journal.pone.0141545			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544710	Green Published, Green Submitted, gold			2022-12-26	WOS:000364398700032
J	Ouyang, L; Xu, XX; Freed, SF; Gao, YF; Yu, J; Wang, S; Ju, WY; Zhang, YQ; Jin, FL				Ouyang, Lina; Xu, Xiaoxia; Freed, Shoaib; Gao, Yanfu; Yu, Jing; Wang, Shuang; Ju, Wenyan; Zhang, Yuqing; Jin, Fengliang			Cecropins from Plutella xylostella and Their Interaction with Metarhizium anisopliae	PLOS ONE			English	Article							ANTIBACTERIAL PEPTIDE; DIAMONDBACK MOTH; HOST-DEFENSE; ANTIMICROBIAL PEPTIDES; GENE-EXPRESSION; CDNA CLONING; DROSOPHILA; SILKWORM; PURIFICATION; RESISTANCE	Cecropins are the most potent induced peptides to resist invading microorganisms. In the present study, two full length cDNA encoding cecropin2 (Px-cec2) and cecropin3 (Px-cec3) were obtained from P. xylostella by integrated analysis of genome and transcriptome data. qRT-PCR analysis revealed the high levels of transcripts of Px-cecs (Px-cec1, Px-cec2 and Px-cec3) in epidermis, fat body and hemocytes after 24, 30 and 36 h induction of Metarhizium anisopliae, respectively. Silencing of Spatzle and Dorsal separately caused the low expression of cecropins in the fat body, epidermis and hemocytes, and made the P. xylostella larvae more susceptible to M. anisopliae. Antimicrobial assays demonstrated that the purified recombinant cecropins, i.e., Px-cec1, Px-cec2 and Px-cec3, exerted a broad spectrum of antimicrobial activity against fungi, as well as Gram-positive and Gram-negative bacteria. Especially, Px-cecs showed higher activity against M. anisopliae than another selected fungi isolates. Scanning electron microscopy (SEM) and transmission electron microscopy (TEM) revealed that cecropins exerted the vital morphological alterations to the spores of M. anisopliae. Based on our results, cecropins played an imperative role in resisting infection of M. anisopliae, which will provide the foundation of biological control of insect pests by using cecorpins as a target in the future.	[Ouyang, Lina; Xu, Xiaoxia; Gao, Yanfu; Yu, Jing; Wang, Shuang; Ju, Wenyan; Zhang, Yuqing; Jin, Fengliang] South China Agr Univ, Coll Agr, Guangzhou 510642, Guangdong, Peoples R China; [Freed, Shoaib] Bahauddin Zakariya Univ, Fac Agr Sci & Technol, Dept Entomol, Multan 60800, Pakistan	South China Agricultural University; Bahauddin Zakariya University	Jin, FL (corresponding author), South China Agr Univ, Coll Agr, Guangzhou 510642, Guangdong, Peoples R China.	jflbang@scau.edu.cn			National Natural Science Foundation of China [31371989, 31071734]; National High Technology Research and Development Program ('863' Program) of China [2012AA101505]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program ('863' Program) of China(National High Technology Research and Development Program of China)	This work was supported by grants from the National Natural Science Foundation of China (31371989, 31071734) and the National High Technology Research and Development Program ('863' Program) of China (2012AA101505).	Basukriadi A, 2014, J INSECT SCI, V14, DOI 10.1093/jisesa/ieu106; Castelo Branco M., 1997, Anais da Sociedade Entomologica do Brasil, V26, P75, DOI 10.1590/S0301-80591997000100010; Charroux B, 2010, FLY, V4, P40, DOI 10.4161/fly.4.1.10810; Chen HM, 1997, BBA-GEN SUBJECTS, V1336, P171, DOI 10.1016/S0304-4165(97)00024-X; CHRISTENSEN B, 1988, P NATL ACAD SCI USA, V85, P5072, DOI 10.1073/pnas.85.14.5072; Engel E, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/s12964-014-0041-2; Epand RF, 2008, J MOL BIOL, V379, P38, DOI 10.1016/j.jmb.2008.03.047; Ferreira AG, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004507; Forde E, 2015, MOLECULES, V20, P1210, DOI 10.3390/molecules20011210; Han PF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060771; Hong SM, 2008, BIOSCI BIOTECH BIOCH, V72, P1992, DOI 10.1271/bbb.80082; Hultmark D, 2003, CURR OPIN IMMUNOL, V15, P12, DOI 10.1016/S0952-7915(02)00005-5; Imler JL, 2000, CURR OPIN MICROBIOL, V3, P16, DOI 10.1016/S1369-5274(99)00045-4; Jan PS, 2010, APPL ENVIRON MICROB, V76, P769, DOI 10.1128/AEM.00698-09; JAYNES J M, 1989, Peptide Research, V2, P157; Jin FL, 2006, PROTEIN EXPRES PURIF, V49, P39, DOI 10.1016/j.pep.2006.03.008; Jin FL, 2012, PROTEIN EXPRES PURIF, V85, P230, DOI 10.1016/j.pep.2012.08.006; KAAYA GP, 1987, INSECT BIOCHEM, V17, P309, DOI 10.1016/0020-1790(87)90073-4; Kang D L G, 1996, INSECT BIOCHEM MOLEC, V263, P19424; Kang DW, 1996, INSECT BIOCHEM MOLEC, V26, P177, DOI 10.1016/0965-1748(95)00080-1; KYLSTEN P, 1990, EMBO J, V9, P217, DOI 10.1002/j.1460-2075.1990.tb08098.x; LEE JY, 1989, P NATL ACAD SCI USA, V86, P9159, DOI 10.1073/pnas.86.23.9159; LEMAITRE B, 1995, P NATL ACAD SCI USA, V92, P9465, DOI 10.1073/pnas.92.21.9465; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Liu ZY, 2008, SPECTROSC SPECT ANAL, V28, P612; Maltseva AL, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00497; MORISATO D, 1994, CELL, V76, P677, DOI 10.1016/0092-8674(94)90507-X; Nicolas E, 1996, DEV COMP IMMUNOL, V20, P175, DOI 10.1016/0145-305X(96)00017-1; Park SC, 2011, INT J MOL SCI, V12, P5971, DOI 10.3390/ijms12095971; Ponnuvel KM, 2010, BIOINFORMATION, V5, P97, DOI 10.6026/97320630005097; Raymond B, 2011, HEREDITY, V106, P281, DOI 10.1038/hdy.2010.65; Reddy KVR, 2004, INT J ANTIMICROB AG, V24, P536, DOI 10.1016/j.ijantimicag.2004.09.005; ROSETTO M, 1993, GENE, V134, P241, DOI 10.1016/0378-1119(93)90100-H; Santos VC, 2011, NEOTROP ENTOMOL, V40, P264, DOI 10.1590/S1519-566X2011000200017; STEINER H, 1981, NATURE, V292, P246, DOI 10.1038/292246a0; STEINER H, 1988, BIOCHIM BIOPHYS ACTA, V939, P260, DOI 10.1016/0005-2736(88)90069-7; Sung WS, 2008, BIOCHEM BIOPH RES CO, V371, P551, DOI 10.1016/j.bbrc.2008.04.107; Tang WQ, 2014, DATABASE-OXFORD, DOI 10.1093/database/bat087; TRYSELIUS Y, 1992, EUR J BIOCHEM, V204, P395, DOI 10.1111/j.1432-1033.1992.tb16648.x; Xia LJ, 2013, PROTEIN EXPRES PURIF, V90, P47, DOI 10.1016/j.pep.2013.02.013; Xia XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068852; Xu XX, 2015, WORLD J MICROB BIOT, V31, P1529, DOI 10.1007/s11274-015-1901-7; Xu XX, 2007, PROTEIN EXPRES PURIF, V53, P293, DOI 10.1016/j.pep.2006.12.020; YAMANO Y, 1994, BIOSCI BIOTECH BIOCH, V58, P1476, DOI 10.1271/bbb.58.1476; Yang J, 1999, COMP BIOCHEM PHYS B, V122, P409, DOI 10.1016/S0305-0491(99)00015-2; Zhong X, 2012, INSECT BIOCHEM MOLEC, V42, P514, DOI 10.1016/j.ibmb.2012.03.009	46	21	21	6	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142451	10.1371/journal.pone.0142451	http://dx.doi.org/10.1371/journal.pone.0142451			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544076	gold, Green Submitted, Green Published			2022-12-26	WOS:000364398700141
J	Dalu, T; Wasserman, RJ; Jordaan, M; Froneman, WP; Weyl, OLF				Dalu, Tatenda; Wasserman, Ryan J.; Jordaan, Martine; Froneman, William P.; Weyl, Olaf L. F.			An Assessment of the Effect of Rotenone on Selected Non-Target Aquatic Fauna	PLOS ONE			English	Article							CAPE FLORISTIC REGION; RAINBOW-TROUT; RESTING EGGS; ERADICATION; TOXICITY; RIVER; FIELD; INVERTEBRATES; ZOOPLANKTON; DIVERSITY	Rotenone, a naturally occurring ketone, is widely employed for the management of invasive fish species. The use of rotenone poses serious challenges to conservation practitioners due to its impacts on non-target organisms including amphibians and macroinvertebrates. Using laboratory studies, we investigated the effects of different rotenone concentrations (0, 12.5, 25, 37.5, 50, 100 mu g L-1) on selected invertebrate groups; Aeshnidae, Belostomatids, Decapods, Ephemeroptera, Pulmonata and zooplankton over a period of 18 hours. Based on field observations and body size, we hypothesized that Ephemeropterans and zooplankton would be more susceptible to rotenone than Decapods, Belostomatids and snails. Experimental results supported this hypothesis and mortality and behaviour effects varied considerably between taxa, ranging from no effect (crab Potamonuates sidneyi) to 100% mortality (Daphnia pulex and Paradiaptomus lamellatus). Planktonic invertebrates were particularly sensitive to rotenone even at very low concentrations. Future research should investigate the recovery time of invertebrate communities after the application of rotenone and conduct field assessments assessing the longer term effects of rotenone exposure on the population dynamics of those less sensitive organisms.	[Dalu, Tatenda; Froneman, William P.] Rhodes Univ, Dept Zool & Entomol, ZA-6140 Grahamstown, Eastern Cape, South Africa; [Wasserman, Ryan J.; Jordaan, Martine; Weyl, Olaf L. F.] South African Inst Aquat Biodivers, Grahamstown, Eastern Cape, South Africa; [Wasserman, Ryan J.; Weyl, Olaf L. F.] South African Inst Aquat Biodivers, Ctr Invas Biol, Grahamstown, Eastern Cape, South Africa; [Jordaan, Martine] CapeNature, Sci Serv Dept, Stellenbosch, Western Cape, South Africa	Rhodes University; National Research Foundation - South Africa; South African Institute for Aquatic Biodiversity; National Research Foundation - South Africa; South African Institute for Aquatic Biodiversity	Dalu, T (corresponding author), Rhodes Univ, Dept Zool & Entomol, ZA-6140 Grahamstown, Eastern Cape, South Africa.	dalutatenda@yahoo.co.uk	Froneman, William/GLS-0460-2022; Dalu, Tatenda/K-3089-2012; Froneman, William/C-9085-2012	Froneman, William/0000-0003-0615-1355; Dalu, Tatenda/0000-0002-9019-7702; Weyl, Olaf/0000-0002-8935-3296; Wasserman, Ryan/0000-0002-4162-1503	Water Research Commission [K5/2261]; National Research Foundation of South Africa (NRF) [UID: 77444, 88746]; Department of Science and Technology-NRF Centre of Excellence in Invasion Biology (CIB)	Water Research Commission; National Research Foundation of South Africa (NRF)(National Research Foundation - South Africa); Department of Science and Technology-NRF Centre of Excellence in Invasion Biology (CIB)	This work was supported by the Water Research Commission (K5/2261) (www.wrc.org.za); the National Research Foundation of South Africa (NRF, UID: 77444 [OLFW], 88746 [RJW]) (www.nrf.ac.za); and the Department of Science and Technology-NRF Centre of Excellence in Invasion Biology (CIB) (www.academic.sun.ac.za/cib/). The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Almquist E., 1959, Report Institute of Freshwater Research Drottningholm, VNo. 40, P146; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2003, J STAT COMPUT SIM, V73, P85, DOI 10.1080/00949650215733; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; ANDERSON RS, 1970, J FISH RES BOARD CAN, V27, P1335, DOI 10.1139/f70-159; Arnekleiv J.V., 2001, P77; BEAL DL, 1993, B ENVIRON CONTAM TOX, V51, P551; Bellingan TA, 2015, AFR J AQUAT SCI, V40, P89, DOI 10.2989/16085914.2014.984651; Billman HG, 2012, N AM J FISH MANAGE, V32, P781, DOI 10.1080/02755947.2012.692349; Blakely TJ, 2005, RES DEV SERIES NZ DE, V220; Booth AJ, 2015, AFR J AQUAT SCI, V40, P95, DOI 10.2989/16085914.2014.986432; Britton JR, 2008, AQUAT CONSERV, V18, P867, DOI 10.1002/aqc.919; CHANDLER JH, 1982, PROG FISH CULT, V44, P78, DOI 10.1577/1548-8659(1982)44[78:TORTSA]2.0.CO;2; Cohen AN, 2002, DISPERSAL ECOLOGY, P374; Cooman K, 2005, ARCH ENVIRON CON TOX, V48, P191, DOI 10.1007/s00244-004-0218-6; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Duggan IC, 2015, NZ J MAR FRESH; Eilers J, 2010, DIAMOND LAKE RECOVER, P23; Ellender BR, 2015, BIOL INVASIONS, V17, P57, DOI 10.1007/s10530-014-0744-8; Finlayson B., 2010, PLANNING STANDARD OP; Finlayson BJ, 2001, CHEM RESIDUES SURFAC; Finlayson B, 2010, N AM J FISH MANAGE, V30, P102, DOI 10.1577/M09-078.1; HAIRSTON NG, 1995, ECOLOGY, V76, P1706, DOI 10.2307/1940704; Hamilton BT, 2009, N AM J FISH MANAGE, V29, P1620, DOI 10.1577/M08-178.1; HORGAN DJ, 1968, J BIOL CHEM, V243, P834; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Jordaan MS, 2013, AFR J AQUAT SCI, V38, P91, DOI 10.2989/16085914.2013.784699; Kiser RW., 1963, T AM FISH SOC, V92, P17, DOI [10.1577/1548-8659(1963)92[17:TEOROZ, DOI 10.1577/1548-8659(1963)92[17:TEOROZ]; Kjaerstad G, 2011, INT REV HYDROBIOL, V96, P58, DOI 10.1002/iroh.201111261; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Linder HP, 2010, CURR OPIN ENV SUST, V2, P109, DOI 10.1016/j.cosust.2010.02.001; Ling N, 2003, ROTENONE REV ITS TOX; Lintermans M, 2000, MAR FRESHWATER RES, V51, P799, DOI 10.1071/MF00019; Lintermans M, 2001, P WORKSH HOST DEP CO, P10; Mangum FA, 1999, J FRESHWATER ECOL, V14, P125, DOI 10.1080/02705060.1999.9663661; MARCUS NH, 1994, LIMNOL OCEANOGR, V39, P154, DOI 10.4319/lo.1994.39.1.0154; Marr SM, 2012, AFR J AQUAT SCI, V37, P131, DOI 10.2989/16085914.2012.666654; Melaas CL, 2001, HYDROBIOLOGIA, V459, P177, DOI 10.1023/A:1012514124430; MORRISON BRS, 1977, FISHERIES MANAGEMENT, V8, P128; Moyle PB, 2006, BIOSCIENCE, V56, P515, DOI 10.1641/0006-3568(2006)56[515:PISFFI]2.0.CO;2; NAESS T, 1991, MAR BIOL, V111, P455, DOI 10.1007/BF01319418; OBERG KE, 1967, EXP CELL RES, V45, P590, DOI 10.1016/0014-4827(67)90162-0; Organisation for Economic Co-operation and Development [OECD], 2005, OECD ENV HLTH SAF PU; Pham L, 2012, THESIS U OTAGO DUNED; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; Rach JJ, 1988, ACUTE CHRONIC TOXICI; Recsetar MS, 2015, N AM J FISH MANAGE, V35, P616, DOI 10.1080/02755947.2015.1017127; Shuhaimi-Othman M, 2011, J TOXICOL-US, V2011, DOI 10.1155/2011/136104; Skorupski JA., 2011, THESIS U N TEXAS; Slabbert E, 2014, AFR J AQUAT SCI, V39, P467, DOI 10.2989/16085914.2014.981144; Vander Zanden MJ, 2008, CAN J FISH AQUAT SCI, V65, P1512, DOI 10.1139/F08-099; Vinson MR, 2010, FISHERIES, V35, P61, DOI 10.1577/1548-8446-35.2.61; Ward DJ, 2011, ARCH ENVIRON CON TOX, V61, P414, DOI 10.1007/s00244-011-9646-2; Weyl OLF, 2014, FISHERIES, V39, P270, DOI 10.1080/03632415.2014.914924; Winterbourn MJ, 1981, WATER SOIL PUBLICATI, V22, P5; Woodford DJ, 2013, J INSECT CONSERV, V17, P959, DOI 10.1007/s10841-013-9578-4; Wujtewicz D, 1997, J WORLD AQUACULT SOC, V28, P249, DOI 10.1111/j.1749-7345.1997.tb00640.x	57	23	25	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142140	10.1371/journal.pone.0142140	http://dx.doi.org/10.1371/journal.pone.0142140			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540301	gold, Green Published, Green Submitted			2022-12-26	WOS:000364303800057
J	Beydoun, MA; Fanelli-Kuczmarski, MT; Allen, A; Beydoun, HA; Popkin, BM; Evans, MK; Zonderman, AB				Beydoun, May A.; Fanelli-Kuczmarski, Marie T.; Allen, Allyssa; Beydoun, Hind A.; Popkin, Barry M.; Evans, Michele K.; Zonderman, Alan B.			Monetary Value of Diet Is Associated with Dietary Quality and Nutrient Adequacy among Urban Adults, Differentially by Sex, Race and Poverty Status	PLOS ONE			English	Article							ENERGY-DENSE DIETS; SOCIOECONOMIC-STATUS; UNITED-STATES; FRENCH ADULTS; NUTRITIONAL QUALITY; FOOD EXPENDITURE; COST CONSTRAINT; HEALTHY DIET; US ADULTS; WOMEN	Objective The association between monetary value of the diet (MVD, $/day) with dietary quality was examined using a large sample of urban US adults, differentially by socio-demographic factors. Methods This was a cross-sectional study of 2,111 participants, aged 30-64y, using data from the Healthy Aging in Neighborhoods of Diversity across the Life Span Study. Dietary quality indices included Healthy Eating Index-2010 (HEI-2010) and Mean Adequacy Ratio (MAR), (two 24-hr recalls). A national food price database was used to estimate MVD. Multiple linear/logistic regression analyses were conducted stratifying separately by sex, race and poverty status. Results Women had significantly higher HEI-2010 scores than men (43.35 vs 41.57 out of 100, respectively), whereas MAR scores were higher for men (76.8 vs 69.9, out of 100), reflecting energy intake gender differentials. Importantly, a $3/day higher MVD (IQR: $3.70/d (Q1) to $6.62/d (Q4)) was associated with a 4.98 +/- 0.35 higher total HEI-2010 and a 3.88 +/- 0.37 higher MAR score, after energy-adjustment and control for key confounders. For HEI-2010 and MAR, stronger associations were observed among participants above poverty and among women, whilethe MVD vs. HEI-2010 association was additionally stronger among Whites. Sex and poverty status differentials were observed for many MAR and some HEI2010 components. Conclusions Despite positive associations between measures of dietary quality and MVD, particularly above poverty and among women, approaching compliance with the Dietary Guidelines (80 or more for HEI-2010) requires a substantially higher MVD. Thus, nutrition education may further improve people's decision-making regarding food venues and dietary choices.	[Beydoun, May A.; Evans, Michele K.; Zonderman, Alan B.] NIA, Lab Epidemiol & Populat Sci, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Fanelli-Kuczmarski, Marie T.] Univ Delaware, Dept Behav Hlth & Nutr, Newark, DE USA; [Allen, Allyssa] Univ Maryland Baltimore Cty, Baltimore, MD 21228 USA; [Beydoun, Hind A.] Eastern Virginia Med Sch, Grad Program Publ Hlth, Norfolk, VA 23501 USA; [Popkin, Barry M.] Univ N Carolina, Dept Nutr, Chapel Hill, NC USA; [Popkin, Barry M.] Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Delaware; University System of Maryland; University of Maryland Baltimore County; Eastern Virginia Medical School; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Beydoun, MA (corresponding author), NIA, Lab Epidemiol & Populat Sci, Intramural Res Program, NIH, Baltimore, MD 21224 USA.	baydounm@mail.nih.gov	Evans, Michele Kim/AAE-4776-2019; Popkin, Barry/T-6633-2019	Evans, Michele/0000-0002-8546-2831; Zonderman, Alan B/0000-0002-6523-4778	National Institute on Aging, NIA/NIH/IRP; NATIONAL INSTITUTE ON AGING [ZIAAG000513] Funding Source: NIH RePORTER	National Institute on Aging, NIA/NIH/IRP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding: This work was fully supported by the Intramural Research Program of the National Institute on Aging, NIA/NIH/IRP.	Aggarwal A, 2011, EUR J CLIN NUTR, V65, P1059, DOI 10.1038/ejcn.2011.72; Aggarwal A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037533; Agriculture. USDo, 2011, FOOD SPEND ADJ REC T; Andrieu E, 2006, EUR J CLIN NUTR, V60, P434, DOI 10.1038/sj.ejcn.1602331; Appelhans BM, 2012, AM J PREV MED, V42, P398, DOI 10.1016/j.amepre.2011.12.007; Banks Jonathan, 2012, Br J Gen Pract, V62, pe1, DOI 10.3399/bjgp12X616300; Bauer UE, 2014, LANCET, V384, P45, DOI 10.1016/S0140-6736(14)60648-6; Bernstein AM, 2010, AM J CLIN NUTR, V92, P1197, DOI 10.3945/ajcn.2010.29854; Beydoun MA, 2008, SOC SCI MED, V66, P2218, DOI 10.1016/j.socscimed.2008.01.018; Beydoun MA, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.05.017; Beydoun MA, 2011, J NUTR, V141, P304, DOI 10.3945/jn.110.132613; Beydoun MA, 2009, PUBLIC HEALTH NUTR, V12, P369, DOI 10.1017/S1368980008002140; Cade J, 1999, PUBLIC HEALTH NUTR, V2, P505, DOI 10.1017/S1368980099000683; [Cancer Control and Population Sciences National Cancer Institute AR], 2014, HEI TOOLS RES; Caplovitz David., 1967, THE POOR PAY MORE; Carlson A, 2014, PHYSIOL BEHAV, V134, P20, DOI 10.1016/j.physbeh.2014.03.001; Carlson A, 2014, J AGR RESOUR ECON, V39, P47; Carroll RJ, 1998, ADV EXP MED BIOL, V445, P139; Chung CJ, 1999, J CONSUM AFF, V33, P276, DOI 10.1111/j.1745-6606.1999.tb00071.x; Cleary J, 2012, NUTRIENTS, V4, P1759, DOI 10.3390/nu4111759; Conforti P, 2000, PUBLIC HEALTH NUTR, V3, P367, DOI 10.1017/S1368980000000410; Darmon N, 2006, J NUTR EDUC BEHAV, V38, P82, DOI 10.1016/j.jneb.2005.11.028; Darmon N, 2004, PUBLIC HEALTH NUTR, V7, P21, DOI 10.1079/PHN2003512; Darmon N, 2003, APPETITE, V41, P315, DOI 10.1016/S0195-6663(03)00113-2; Darmon N, 2002, J NUTR, V132, P3764, DOI 10.1093/jn/132.12.3764; Denny S, 2012, J ACAD NUTR DIET, V112, P1504, DOI 10.1016/j.jand.2012.07.018; Drewnowski A, 2004, AM J PREV MED, V27, P154, DOI 10.1016/j.amepre.2004.06.011; Drewnowski A, 2004, AM J CLIN NUTR, V79, P6; Drewnowski A, 2015, J HUM HYPERTENS, V29, P14, DOI 10.1038/jhh.2014.38; Drewnowski A, 2009, EUR J CLIN NUTR, V63, P674, DOI 10.1038/ejcn.2008.16; Drewnowski A, 2007, J AM DIET ASSOC, V107, P1028, DOI 10.1016/j.jada.2007.03.013; Drewnowski A, 2010, AM J CLIN NUTR, V92, P1181, DOI 10.3945/ajcn.2010.29300; Drewnowski A, 2009, NUTR REV, V67, pS36, DOI 10.1111/j.1753-4887.2009.00157.x; Evans MK, 2010, ETHNIC DIS, V20, P267; [Food Surveys Research Group US Department of Agriculture ARS], USDA FOOD NUTR DAT B; [Food Surveys Research Group US Department of Agriculture ARS], 2013, USDA FOOD PLANS COST; [Food Surveys Research Group US Department of Agriculture ARS], 2014, Q FOOD AW FROM HOM P; HECKMAN JJ, 1979, ECONOMETRICA, V47, P153, DOI 10.2307/1912352; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; *I MED FANB, 2000, DIET REF INT VIT C V; Kant AK, 2005, J AM COLL NUTR, V24, P294, DOI 10.1080/07315724.2005.10719477; Kant AK, 2004, J AM DIET ASSOC, V104, P615, DOI 10.1016/j.jada.2004.01.010; Katz DL, 2011, PUBLIC HEALTH NUTR, V14, P1693, DOI 10.1017/S1368980011000048; Lipsky LM, 2009, AM J CLIN NUTR, V90, P1397, DOI 10.3945/ajcn.2008.27384; Lopez CN, 2009, J EPIDEMIOL COMMUN H, V63, P920, DOI 10.1136/jech.2008.081208; Maillot M, 2007, AM J CLIN NUTR, V86, P690; McDermott AJ, 2010, FAM MED, V42, P280; Moeller S. M., 2007, Journal of the American Dietetic Association, V107, P1233, DOI 10.1016/j.jada.2007.03.014; Monsivais P, 2013, EUR J CLIN NUTR, V67, P1220, DOI 10.1038/ejcn.2013.176; Monsivais P, 2013, JAMA INTERN MED, V173, P1922, DOI 10.1001/jamainternmed.2013.9479; Monsivais P, 2009, J AM DIET ASSOC, V109, P814, DOI 10.1016/j.jada.2009.02.002; Morris MA, 2014, J EPIDEMIOL COMMUN H, V68, P1043, DOI 10.1136/jech-2014-204039; Moshfegh AJ, 2008, AM J CLIN NUTR, V88, P324; Murakami K, 2009, PUBLIC HEALTH NUTR, V12, P1290, DOI 10.1017/S1368980008003923; Murphy SP, 2006, J AM DIET ASSOC, V106, P425, DOI 10.1016/j.jada.2005.12.003; National Institute on Aging NNI Laboratory of Epidemiology and Population Sciences, 2014, HLTH EAT IND 2010 CA; Powell LM, 2009, HEALTH PLACE, V15, P1064, DOI 10.1016/j.healthplace.2009.05.002; Raffensperger S, 2010, J NATL MED ASSOC, V102, P923, DOI 10.1016/S0027-9684(15)30711-2; Rao M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-004277; Raper N, 2004, J FOOD COMPOS ANAL, V17, P545, DOI 10.1016/j.jfca.2004.02.013; Rauber F, 2009, J PEDIAT-BRAZIL, V85, P536, DOI [10.2223/JPED.1955, 10.1590/S0021-75572009000600011]; Rehm CD, 2015, PREV MED, V73, P70, DOI 10.1016/j.ypmed.2015.01.019; Rehm CD, 2011, AM J CLIN NUTR, V94, P1333, DOI 10.3945/ajcn.111.015560; Ryden PJ, 2011, PUBLIC HEALTH NUTR, V14, P1680, DOI 10.1017/S1368980010003642; Schroder H, 2006, INT J OBESITY, V30, P1574, DOI 10.1038/sj.ijo.0803308; Selvin S., 2004, STAT ANAL EPIDEMIOLO; Smith LPNS, EMERGING RO IN PRESS; STATA, 2013, STAT DAT AN REL 13 0; The Center for Nutrition Policy and Promotion (CNPP), 2008, FOOD PRIC DAT; Townsend MS, 2009, AM J CLIN NUTR, V89, P1220, DOI 10.3945/ajcn.2008.26916; Wang J, 2010, PUBLIC HEALTH NUTR, V13, P1049, DOI 10.1017/S1368980009991595; Waterlander WE, 2010, PUBLIC HEALTH NUTR, V13, P1599, DOI 10.1017/S1368980009992989; Wilkinson G.S, 1993, WIDE RANGE ACHIEVEME	73	26	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140905	10.1371/journal.pone.0140905	http://dx.doi.org/10.1371/journal.pone.0140905			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV5GZ	26536243	Green Published, Green Submitted, gold			2022-12-26	WOS:000364298400044
J	Han, B; Wang, CB; Tang, ZH; Ren, YK; Li, YL; Zhang, DY; Dong, YH; Zhao, XH				Han, Bin; Wang, Changbiao; Tang, Zhaohui; Ren, Yongkang; Li, Yali; Zhang, Dayong; Dong, Yanhui; Zhao, Xinghua			Genome-Wide Analysis of Microsatellite Markers Based on Sequenced Database in Chinese Spring Wheat (Triticum aestivum L.)	PLOS ONE			English	Article							SSR MARKERS; POLYMORPHISM MARKERS; ARABIDOPSIS-THALIANA; MOLECULAR MARKERS; DRAFT GENOME; REPEATS; MAIZE; TRANSFERABILITY; COLLECTION; FEATURES	Microsatellites or simple sequence repeats (SSRs) are distributed across both prokaryotic and eukaryotic genomes and have been widely used for genetic studies and molecular marker-assisted breeding in crops. Though an ordered draft sequence of hexaploid bread wheat have been announced, the researches about systemic analysis of SSRs for wheat still have not been reported so far. In the present study, we identified 364,347 SSRs from among 10,603,760 sequences of the Chinese spring wheat (CSW) genome, which were present at a density of 36.68 SSR/Mb. In total, we detected 488 types of motifs ranging from di-to hexanucleotides, among which dinucleotide repeats dominated, accounting for approximately 42.52% of the genome. The density of tri- to hexanucleotide repeats was 24.97%, 4.62%, 3.25% and 24.65%, respectively. AG/CT, AAG/CTT, AGAT/ATCT, AAAAG/CTTTT and AAAATT/AATTTT were the most frequent repeats among di-to hexanucleotide repeats. Among the 21 chromosomes of CSW, the density of repeats was highest on chromosome 2D and lowest on chromosome 3A. The proportions of di-, tri-, tetra-, penta-and hexanucleotide repeats on each chromosome, and even on the whole genome, were almost identical. In addition, 295,267 SSR markers were successfully developed from the 21 chromosomes of CSW, which cover the entire genome at a density of 29.73 per Mb. All of the SSR markers were validated by reverse electronic-Polymerase Chain Reaction (re-PCR); 70,564 (23.9%) were found to be monomorphic and 224,703 (76.1%) were found to be polymorphic. A total of 45 monomorphic markers were selected randomly for validation purposes; 24 (53.3%) amplified one locus, 8 (17.8%) amplified multiple identical loci, and 13 (28.9%) did not amplify any fragments from the genomic DNA of CSW. Then a den-drogram was generated based on the 24 monomorphic SSR markers among 20 wheat cultivars and three species of its diploid ancestors showing that monomorphic SSR markers represented a promising source to increase the number of genetic markers available for the wheat genome. The results of this study will be useful for investigating the genetic diversity and evolution among wheat and related species. At the same time, the results will facilitate comparative genomic studies and marker-assisted breeding (MAS) in plants.	[Han, Bin] Shanxi Univ, Coll Bioengn, Taiyuan 030006, Peoples R China; [Wang, Changbiao; Tang, Zhaohui; Li, Yali; Dong, Yanhui; Zhao, Xinghua] Shanxi Acad Agr Sci, Biotechnol Res Ctr, Taiyuan, Peoples R China; [Ren, Yongkang] Shanxi Acad Agr Sci, Inst Crop Sci, Taiyuan, Peoples R China; [Zhang, Dayong] Jiangsu Acad Agr Sci, Inst Biotechnol, Prov Key Lab Agrobiol, Nanjing, Jiangsu, Peoples R China	Shanxi University; Shanxi Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Shanxi Agricultural University; Jiangsu Academy of Agricultural Sciences	Wang, CB (corresponding author), Shanxi Acad Agr Sci, Biotechnol Res Ctr, Taiyuan, Peoples R China.	wcbksl@126.com; tzhhui126@126.com; cotton.z@126.com	Wang, Changbiao/S-8473-2019		Twelfth Five-year-plan in National Science and Technology for the Rural Development in China [2011AA100501]; Shanxi Provincial Scientific and Technological Research Projects [20130311001-8]; Shanxi Academy of Agricultural Sciences Breeding Project [11yzgc028]; Shanxi Academy of Agricultural Sciences Breeding Base Project [yzjc1201]; Shanxi Academy of Agricultural Science Scientific and Technological Research Projects [2013GG51]; Natural Science Foundation of Shanxi [2009021032-1]	Twelfth Five-year-plan in National Science and Technology for the Rural Development in China; Shanxi Provincial Scientific and Technological Research Projects; Shanxi Academy of Agricultural Sciences Breeding Project; Shanxi Academy of Agricultural Sciences Breeding Base Project; Shanxi Academy of Agricultural Science Scientific and Technological Research Projects; Natural Science Foundation of Shanxi(Natural Science Foundation of Shanxi Province)	This work was financially supported in part by grants from the Twelfth Five-year-plan in National Science and Technology for the Rural Development in China (2011AA100501), Shanxi Provincial Scientific and Technological Research Projects (20130311001-8), Shanxi Academy of Agricultural Sciences Breeding Project (11yzgc028), Shanxi Academy of Agricultural Sciences Breeding Base Project (yzjc1201), Shanxi Academy of Agricultural Science Scientific and Technological Research Projects (2013GG51), the Natural Science Foundation of Shanxi (2009021032-1).	Akpinar BA, 2015, PLANT BIOTECHNOL J, V13, P740, DOI 10.1111/pbi.12302; Asp T, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-36; Baenziger PS, 2006, CROP SCI, V46, P2230, DOI 10.2135/cropsci2005.11.0404gas; Balfourier F, 2007, THEOR APPL GENET, V114, P1265, DOI 10.1007/s00122-007-0517-1; Biswas MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104182; Cavagnaro PF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-569; DELSAL G, 1989, BIOTECHNIQUES, V7, P514; Gupta PK, 1999, PLANT BREEDING, V118, P369, DOI 10.1046/j.1439-0523.1999.00401.x; Hong CP, 2007, MOL CELLS, V23, P349; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; Katti MV, 2001, MOL BIOL EVOL, V18, P1161, DOI 10.1093/oxfordjournals.molbev.a003903; Landjeva S, 2007, EUPHYTICA, V156, P271, DOI 10.1007/s10681-007-9371-0; Lawson MJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r14; Li L, 2008, PROG NAT SCI-MATER, V18, P1485, DOI 10.1016/j.pnsc.2008.05.012; Ling HQ, 2013, NATURE, V496, P87, DOI 10.1038/nature11997; Lucas SJ, 2012, FUNCT INTEGR GENOMIC, V12, P173, DOI 10.1007/s10142-011-0250-3; Mahmood A, 2004, THEOR APPL GENET, V109, P1494, DOI 10.1007/s00122-004-1766-x; Makharia GK, 2014, J GASTROEN HEPATOL, V29, P666, DOI 10.1111/jgh.12514; Marone D, 2012, THEOR APPL GENET, V125, P1619, DOI 10.1007/s00122-012-1939-y; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; Metzgar D, 2000, GENOME RES, V10, P72; Mian MAR, 2005, GENOME, V48, P637, DOI [10.1139/g05-029, 10.1139/G05-029]; Nazareno AG, 2011, AM J BOT, V98, pE265, DOI 10.3732/ajb.1100163; Olango TM, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0250-8; Paux E, 2012, BIOTECHNOL ADV, V30, P1071, DOI 10.1016/j.biotechadv.2011.09.015; Qu Jingtao, 2013, BMC Res Notes, V6, P403, DOI 10.1186/1756-0500-6-403; Read BA, 2013, NATURE, V499, P209, DOI 10.1038/nature12221; Ren J, 2013, INT J MOL SCI, V14, P7061, DOI 10.3390/ijms14047061; Severson DW, 2014, DNA RES; Sonah H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021298; Tang JF, 2006, EUPHYTICA, V151, P87, DOI 10.1007/s10681-006-9131-6; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Wang Y, 2014, J INTEGRATIVE PLANT; Xu J, 2013, DNA RES, V20, P497, DOI 10.1093/dnares/dst026; Yadav HK, 2011, TREE GENET GENOMES, V7, P207, DOI 10.1007/s11295-010-0326-6; Zhang LD, 2004, BIOINFORMATICS, V20, P1081, DOI 10.1093/bioinformatics/bth043; Zhao XY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-435	37	32	33	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141540	10.1371/journal.pone.0141540	http://dx.doi.org/10.1371/journal.pone.0141540			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536014	Green Published, Green Submitted, gold			2022-12-26	WOS:000364298400069
J	Ihn, HJ; Lee, D; Lee, T; Kim, SH; Shin, HI; Bae, YC; Hong, JM; Park, EK				Ihn, Hye Jung; Lee, Doohyun; Lee, Taeho; Kim, Sang-Hyun; Shin, Hong-In; Bae, Yong Chul; Hong, Jung Min; Park, Eui Kyun			Inhibitory Effects of KP-A159, a Thiazolopyridine Derivative, on Osteoclast Differentiation, Function, and Inflammatory Bone Loss via Suppression of RANKL-Induced MAP Kinase Signaling Pathway	PLOS ONE			English	Article							NF-KAPPA-B; ACTIVATION; RESORPTION; DISEASE; DESIGN; NFATC1	Abnormally elevated formation and activation of osteoclasts are primary causes for a majority of skeletal diseases. In this study, we found that KP-A159, a newly synthesized thiazolopyridine derivative, inhibited osteoclast differentiation and function in vitro, and inflammatory bone loss in vivo. KP-A159 did not cause a cytotoxic response in bone marrow macrophages (BMMs), but significantly inhibited the formation of multinucleated tartrate-resistant acid phosphatase (TRAP)-positive osteoclasts induced by macrophage colony-stimulating factor (M-CSF) and receptor activator of nuclear factor-kappa B ligand (RANKL). KP-A159 also dramatically inhibited the expression of marker genes related to osteoclast differentiation, including TRAP (Acp5), cathepsin K (Ctsk), dendritic cell-specific transmembrane protein (Dcstamp), matrix metallopeptidase 9 (Mmp9), and nuclear factor of activated T-cells, cytoplasmic 1 (Nfatc1). Moreover, actin ring and resorption pit formation were inhibited by KP-A159. Analysis of the signaling pathway involved showed that KP-A159 inhibited RANKL-induced activation of extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and mitogen-activated protein kinase kinase1/2 (MEK1/2). In a mouse inflammatory bone loss model, KP-A159 significantly rescued lipopolysaccharide (LPS)-induced bone loss by suppressing osteoclast numbers. Therefore, KP-A159 targets osteoclasts, and may be a potential candidate compound for prevention and/or treatment of inflammatory bone loss.	[Ihn, Hye Jung; Kim, Sang-Hyun] Kyungpook Natl Univ, Dept Pharmacol, Sch Med, Daegu, South Korea; [Lee, Doohyun; Lee, Taeho] Kyungpook Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Daegu, South Korea; [Shin, Hong-In; Park, Eui Kyun] Kyungpook Natl Univ, Sch Dent, Dept Oral Pathol & Regenerat Med, IHBR, Daegu, South Korea; [Bae, Yong Chul] Kyungpook Natl Univ, Sch Dent, Dept Oral Anat & Neurobiol, Daegu, South Korea; [Hong, Jung Min] Kyungpook Natl Univ Hosp, Skeletal Dis Genome Res Ctr, Daegu, South Korea	Kyungpook National University; Kyungpook National University; Kyungpook National University; Kyungpook National University; Kyungpook National University; Kyungpook National University Hospital	Park, EK (corresponding author), Kyungpook Natl Univ, Sch Dent, Dept Oral Pathol & Regenerat Med, IHBR, Daegu, South Korea.	epark@knu.ac.kr			National Research Foundation of Korea (NRF) grant - Korean government (MSIP) [2008-0062282]	National Research Foundation of Korea (NRF) grant - Korean government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (2008-0062282). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliprantis AO, 2008, J CLIN INVEST, V118, P3775, DOI 10.1172/JCI35711; Ang E, 2011, J CELL BIOCHEM, V112, P89, DOI 10.1002/jcb.22800; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Body JJ, 2002, BONE, V30, p75S; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Darnay BG, 1998, J BIOL CHEM, V273, P20551, DOI 10.1074/jbc.273.32.20551; Frodin M, 1999, MOL CELL ENDOCRINOL, V151, P65, DOI 10.1016/S0303-7207(99)00061-1; Ghayor C, 2011, J BIOL CHEM, V286, P24458, DOI 10.1074/jbc.M111.223297; Hamade E, 2012, MED CHEM, V8, P401, DOI 10.2174/1573406411208030401; He YZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024780; Hong JM, 2014, BONE, V62, P99, DOI 10.1016/j.bone.2014.02.005; Ikeda F, 2004, J CLIN INVEST, V114, P475, DOI 10.1172/JCI200419657; Lee T, 2010, J COMB CHEM, V12, P95, DOI 10.1021/cc900147y; Miyamoto Takeshi, 2006, Mod Rheumatol, V16, P341; Ohno H, 2006, MOL CANCER THER, V5, P2634, DOI 10.1158/1535-7163.MCT-05-0313; Park HR, 2013, BIOORGAN MED CHEM, V21, P5480, DOI 10.1016/j.bmc.2013.05.066; Park JY, 2009, BIOCHEM BIOPH RES CO, V378, P645, DOI 10.1016/j.bbrc.2008.11.115; Qin YJ, 2014, BIOORG MED CHEM LETT, V24, P5279, DOI 10.1016/j.bmcl.2014.09.054; Rachner TD, 2011, LANCET, V377, P1276, DOI 10.1016/S0140-6736(10)62349-5; Ralston SH, 2012, CALCIFIED TISSUE INT, V91, P97, DOI 10.1007/s00223-012-9599-0; Rao AU, 2009, BIOORG MED CHEM LETT, V19, P6176, DOI 10.1016/j.bmcl.2009.09.006; Ruggiero SL, 2004, J ORAL MAXIL SURG, V62, P527, DOI 10.1016/j.joms.2004.02.004; Schneider TL, 2003, BIOCHEMISTRY-US, V42, P9722, DOI 10.1021/bi034792w; Sharma RN, 2009, J ENZYM INHIB MED CH, V24, P890, DOI 10.1080/14756360802519558; Shi F, 2009, BIOORG MED CHEM LETT, V19, P5565, DOI 10.1016/j.bmcl.2009.08.046; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Teitelbaum SL, 2011, ANN NY ACAD SCI, V1240, P14, DOI 10.1111/j.1749-6632.2011.06283.x; Wagner EF, 2005, IMMUNOL REV, V208, P126, DOI 10.1111/j.0105-2896.2005.00332.x; Walczynski K, 2005, EUR J MED CHEM, V40, P15, DOI 10.1016/j.ejmech.2004.09.010; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645	32	10	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142201	10.1371/journal.pone.0142201	http://dx.doi.org/10.1371/journal.pone.0142201			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536233	Green Submitted, Green Published, gold			2022-12-26	WOS:000364298400143
J	Wilcox, TM; Carim, KJ; McKelvey, KS; Young, MK; Schwartz, MK				Wilcox, Taylor M.; Carim, Kellie J.; McKelvey, Kevin S.; Young, Michael K.; Schwartz, Michael K.			The Dual Challenges of Generality and Specificity When Developing Environmental DNA Markers for Species and Subspecies of Oncorhynchus	PLOS ONE			English	Article							CUTTHROAT TROUT; CONSERVATION	Environmental DNA (eDNA) sampling is a powerful tool for detecting invasive and native aquatic species. Often, species of conservation interest co-occur with other, closely related taxa. Here, we developed qPCR (quantitative PCR) markers which distinguish westslope cutthroat trout (Oncorhynchus clarkii lewsi), Yellowstone cutthroat trout (O. clarkii bouvieri), and rainbow trout (O. mykiss), which are of conservation interest both as native species and as invasive species across each other's native ranges. We found that local polymorphisms within westslope cutthroat trout and rainbow trout posed a challenge to designing assays that are generally applicable across the range of these widely-distributed species. Further, poorly-resolved taxonomies of Yellowstone cutthroat trout and Bonneville cutthroat trout (O. c. utah) prevented design of an assay that distinguishes these recognized taxa. The issues of intraspecific polymorphism and unresolved taxonomy for eDNA assay design addressed in this study are likely to be general problems for closely-related taxa. Prior to field application, we recommend that future studies sample populations and test assays more broadly than has been typical of published eDNA assays to date.	[Wilcox, Taylor M.; Carim, Kellie J.; McKelvey, Kevin S.; Young, Michael K.; Schwartz, Michael K.] US Forest Serv, USDA, Natl Genom Ctr Wildlife & Fish Conservat, Rocky Mt Res Stn, Missoula, MT 59812 USA; [Wilcox, Taylor M.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA	United States Department of Agriculture (USDA); United States Forest Service; University of Montana System; University of Montana	Wilcox, TM (corresponding author), US Forest Serv, USDA, Natl Genom Ctr Wildlife & Fish Conservat, Rocky Mt Res Stn, Missoula, MT 59812 USA.	taylor.wilcox@umontana.edu	Wilcox, Taylor/P-7064-2019	Wilcox, Taylor/0000-0003-3341-7374	National Science Foundation [DGE-1313190]	National Science Foundation(National Science Foundation (NSF))	Region 1 of the U.S. Forest Service provided funding for this work. TMW is supported by a fellowship from the National Science Foundation (Grant No. DGE-1313190). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avise J.C., 2000, PHYLOGEOGRAPHY; Behnke R. J., 1992, AM FISHERIES SOC MON, V6; Bergsten J, 2012, SYST BIOL, V61, P851, DOI 10.1093/sysbio/sys037; Biggs J, 2015, BIOL CONSERV, V183, P19, DOI 10.1016/j.biocon.2014.11.029; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Campbell MR, 2011, T AM FISH SOC, V140, P91, DOI 10.1080/00028487.2011.557001; Drinan DP, 2011, CONSERV GENET, V12, P1513, DOI 10.1007/s10592-011-0249-2; Fukumoto S, 2015, J APPL ECOL, V52, P358, DOI 10.1111/1365-2664.12392; Goldberg CS, 2013, FRESHW SCI, V32, P792, DOI 10.1899/13-046.1; Gresswell RE, 2011, N AM J FISH MANAGE, V31, P782, DOI 10.1080/02755947.2011.608980; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Kruse Carter G., 2000, North American Journal of Fisheries Management, V20, P693, DOI 10.1577/1548-8675(2000)020<0693:SOYCTI>2.3.CO;2; Lea R.N., 2013, COMMON SCI NAMES FIS, V7; Loxterman JL, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-38; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Moyle P.B., 2002, INLAND FISHES CALIFO; Muhlfeld CC, 2015, N AM J FISH MANAGE, V35, P31, DOI 10.1080/02755947.2014.951807; NEHLSEN W, 1991, FISHERIES, V16, P4, DOI 10.1577/1548-8446(1991)016&lt;0004:PSATCS&gt;2.0.CO;2; Pedersen MW, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0383; R Core Development Team, 2013, R LANG ENV STAT COMP; Rees HC, 2014, ECOL EVOL, V4, P4023, DOI 10.1002/ece3.1272; Schmidt BR, 2013, METHODS ECOL EVOL, V4, P646, DOI 10.1111/2041-210X.12052; Shepard BB, 2005, N AM J FISH MANAGE, V25, P1426, DOI 10.1577/M05-004.1; Sigsgaard EE, 2015, BIOL CONSERV, V183, P46, DOI 10.1016/j.biocon.2014.11.023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomsen PF, 2015, BIOL CONSERV, V183, P4, DOI 10.1016/j.biocon.2014.11.019; Wilcox TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059520; Wright ES, 2014, ENVIRON MICROBIOL, V16, P1354, DOI 10.1111/1462-2920.12259; Young MK, 2013, MOL ECOL RESOUR, V13, P583, DOI 10.1111/1755-0998.12091	29	45	47	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142008	10.1371/journal.pone.0142008	http://dx.doi.org/10.1371/journal.pone.0142008			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536367	gold, Green Submitted, Green Published			2022-12-26	WOS:000364298400117
J	Yang, HX; Zhang, M; Wang, X; Zhang, HY; Zhang, J; Jing, L; Liao, LF; Wang, MQ				Yang, Hongxu; Zhang, Mian; Wang, Xin; Zhang, Hongyun; Zhang, Jing; Jing, Lei; Liao, Lifan; Wang, Meiqing			TNF Accelerates Death of Mandibular Condyle Chondrocytes in Rats with Biomechanical Stimulation-Induced Temporomandibular Joint Disease	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; MITOCHONDRIAL DYSFUNCTION; CELL-DEATH; CARTILAGE; APOPTOSIS; OSTEOARTHRITIS; CYTOKINES; EXPRESSION; MATRIX; INTERLEUKIN-1-BETA	Objective To determine if temporomandibular joint chondrocyte apoptosis is induced in rats with dental biomechanical stimulation and what a role TNF takes. Methods Thirty-two rats were divided into 4 groups (n = 8/group) and exposed to incisor mal-occlusion induced by unilateral anterior crossbite biomechanical stimulation. Two groups were sampled at 2 or 4 weeks. The other two groups were treated with local injections of a TNF inhibitor or PBS into the temporomandibular joints area at 2 weeks and then sampled at 4 weeks. Twenty-four rats either served as unilateral anterior crossbite mock operation controls (n = 8/group) with sampling at 2 or 4 weeks or received a local injection of the TNF inhibitor at 2 weeks with sampling at 4 weeks. Chondrocytes were isolated from the temporomandibular joints of 6 additional rats and treated with TNF in vitro. Joint samples were assessed using Hematoxylin&eosin, Safranin O, TUNEL and immunohistochemistry staining, real-time PCR, fluorogenic activity assays and Western blot analyses. The isolated chondrocytes were also analyzed by flow cytometry. Results Unilateral anterior crossbite stimulation led to temporomandibular joint cartilage degradation, associated with an increase in TUNEL-positive chondrocytes number, caspase-9 expression levels, and the release of cytochrome c from mitochondria at 2 weeks without changes in TNF and caspase-8 levels until after 4 weeks. TNF stimulated apoptosis of the isolated chondrocytes and up-regulated caspase-8 expression, but did not change caspase-9 expression levels. Local injection of TNF inhibitor down-regulated caspase-8 expression and reduced TUNEL-positive cell number, but did not reverse cartilage thickness reduction, caspase-9 up-regulation or cytochrome c release. Conclusions Unilateral anterior crossbite stimulation induces mitochondrion-mediated apoptosis of articular chondrocytes. TNF accelerated the unilateral anterior crossbite induced chondrocytes apoptosis via death-receptor pathway. However, anti-TNF therapy does not prevent cartilage loss in this model of temporomandibular joint.	[Yang, Hongxu; Zhang, Mian; Wang, Xin; Zhang, Hongyun; Zhang, Jing; Jing, Lei; Liao, Lifan; Wang, Meiqing] Fourth Mil Med Univ, State Key Lab Mil Stomatol, Dept Oral Anat & Physiol & TMD, Sch Stomatol, Xian 710032, Peoples R China	Air Force Military Medical University	Wang, MQ (corresponding author), Fourth Mil Med Univ, State Key Lab Mil Stomatol, Dept Oral Anat & Physiol & TMD, Sch Stomatol, 145 Changle West Rd, Xian 710032, Peoples R China.	mqwang@fmmu.edu.cn	Wang, Meiqing/K-3584-2019		National Natural Science Foundation of China [81271169, 81470762, 81500875]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China No. 81271169, 81470762, 81500875. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adan N, 2013, J CLIN INVEST, V123, P3902, DOI 10.1172/JCI69485; Aigner T, 2002, ARTHRITIS RHEUM-US, V46, P1986, DOI 10.1002/art.10554; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Blanco FJ, 2004, MITOCHONDRION, V4, P715, DOI 10.1016/j.mito.2004.07.022; Carames B, 2008, OSTEOARTHR CARTILAGE, V16, P715, DOI 10.1016/j.joca.2007.10.006; Chen J, 2012, CELLS TISSUES ORGANS, V195, P232, DOI 10.1159/000325148; Chomyn A, 1996, Methods Enzymol, V264, P197, DOI 10.1016/S0076-6879(96)64020-8; D'Lima D, 2006, ARTHRITIS RHEUM-US, V54, P1814, DOI 10.1002/art.21874; Delatte M, 2004, EUR J ORAL SCI, V112, P156, DOI 10.1111/j.0909-8836.2004.00108.x; Feldmann M, 1996, ANNU REV IMMUNOL, V14, P397, DOI 10.1146/annurev.immunol.14.1.397; Fisher BAC, 2006, J RHEUMATOL, V33, P1934; Garg AK, 2002, MOL IMMUNOL, V39, P509, DOI 10.1016/S0161-5890(02)00207-9; Goldring SR, 2004, CLIN ORTHOP RELAT R, pS27, DOI 10.1097/01.blo.0000144854.66565.8f; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Grunke M, 2006, ANN RHEUM DIS, V65, P555, DOI 10.1136/ard.2006.053272; Guilak F, 2004, CLIN ORTHOP RELAT R, P17, DOI 10.1097/01.blo.0000131233.83640.91; Gupta S., 2001, Current Molecular Medicine (Hilversum), V1, P317, DOI 10.2174/1566524013363780; Gupta S, 2002, J CLIN IMMUNOL, V22, P185, DOI 10.1023/A:1016089607548; Gupta S, 2006, AUTOIMMUN REV, V5, P264, DOI 10.1016/j.autrev.2005.09.007; Heyninck Karen, 2001, Molecular Cell Biology Research Communications, V4, P259, DOI 10.1006/mcbr.2001.0295; Jiao K, 2009, APOPTOSIS, V14, P22, DOI 10.1007/s10495-008-0279-5; John T, 2007, CYTOKINE, V40, P226, DOI 10.1016/j.cyto.2007.10.002; Kim HA, 2007, CURR DRUG TARGETS, V8, P333, DOI 10.2174/138945007779940025; Klinge RF, 2001, MICRON, V32, P551, DOI 10.1016/S0968-4328(00)00060-3; Kong DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069403; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Kumar S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110539; Landesberg R, 1996, ARCH ORAL BIOL, V41, P761, DOI 10.1016/S0003-9969(96)00068-4; Lee SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019163; Liu YD, 2014, OSTEOARTHR CARTILAGE, V22, P302, DOI 10.1016/j.joca.2013.11.014; Liu ZB, 2014, J BIOMED MATER RES A, V102, P665, DOI 10.1002/jbm.a.34729; Lopez-Armada MJ, 2006, OSTEOARTHR CARTILAGE, V14, P660, DOI 10.1016/j.joca.2006.01.005; Lopez-Armada MJ, 2006, OSTEOARTHR CARTILAGE, V14, P1011, DOI 10.1016/j.joca.2006.03.008; Lu L, J DENT RES; Lu XJ, 2013, J CELL MOL MED, V17, P664, DOI 10.1111/jcmm.12049; Magnano MD, 2007, J RHEUMATOL, V34, P1323; Maksymowych WP, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4044; Mitoma H, 2008, ARTHRITIS RHEUM-US, V58, P1248, DOI 10.1002/art.23447; Ohno S, 2006, OSTEOARTHR CARTILAGE, V14, P807, DOI 10.1016/j.joca.2006.02.002; Ohtani T, 2012, J ORAL PATHOL MED, V41, P96, DOI 10.1111/j.1600-0714.2011.01056.x; Pulsatelli L, 1999, J RHEUMATOL, V26, P1992; Qin J, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4085; Rocha FAC, 2011, BRIT J PHARMACOL, V164, P828, DOI 10.1111/j.1476-5381.2011.01469.x; Ruggiero L, 2015, ANN BIOMED ENG, V43, P2652, DOI 10.1007/s10439-015-1320-9; Schuerwegh AJ, 2003, OSTEOARTHR CARTILAGE, V11, P681, DOI 10.1016/S1063-4584(03)00156-0; Scrivani SJ, 2008, NEW ENGL J MED, V359, P2693, DOI 10.1056/NEJMra0802472; Sharif M, 2004, ARTHRITIS RHEUM-US, V50, P507, DOI 10.1002/art.20020; Suzuki S, 2004, J Orthod, V31, P138, DOI 10.1179/146531204225020436; Temple MM, 2007, OSTEOARTHR CARTILAGE, V15, P1042, DOI 10.1016/j.joca.2007.03.005; Thomas CM, 2007, OSTEOARTHR CARTILAGE, V15, P27, DOI 10.1016/j.joca.2006.06.012; Wang GW, 2010, ARCH ORAL BIOL, V55, P887, DOI 10.1016/j.archoralbio.2010.07.013; Wang M, 2013, J ORAL REHABIL, V40, P69, DOI 10.1111/j.1365-2842.2012.02333.x; Wang QY, 2012, ARCH ORAL BIOL, V57, P620, DOI 10.1016/j.archoralbio.2011.12.006; Wang YL, 2014, ORAL DIS, V20, P301, DOI 10.1111/odi.12112; WeberNordt RM, 1996, BLOOD, V88, P2549, DOI 10.1182/blood.V88.7.2549.bloodjournal8872549; Zhang HY, 2015, J ORAL REHABIL, V42, P685, DOI 10.1111/joor.12304; Zhang J, 2014, OSTEOARTHR CARTILAGE, V22, P822, DOI 10.1016/j.joca.2014.03.017; Zhang J, 2013, J DENT RES, V92, P253, DOI 10.1177/0022034512473482; Zhang X, 2013, J ORAL REHABIL, V40, P500, DOI 10.1111/joor.12072	59	23	26	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141774	10.1371/journal.pone.0141774	http://dx.doi.org/10.1371/journal.pone.0141774			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529096	Green Submitted, Green Published, gold			2022-12-26	WOS:000364032600059
J	Schulze, M; Fedorchenko, O; Zink, TG; Knobbe-Thomsen, CB; Kraus, S; Schwinn, S; Beilhack, A; Reifenberger, G; Monoranu, CM; Siren, AL; Jeanclos, E; Gohla, A				Schulze, M.; Fedorchenko, O.; Zink, T. G.; Knobbe-Thomsen, C. B.; Kraus, S.; Schwinn, S.; Beilhack, A.; Reifenberger, G.; Monoranu, C. M.; Siren, A-L; Jeanclos, E.; Gohla, A.			Chronophin is a glial tumor modifier involved in the regulation of glioblastoma growth and invasiveness	ONCOGENE			English	Article							MALIGNANT GLIOMA; CELL-LINE; COFILIN; INVASION; BRAIN; ADF/COFILIN; INHIBITION; LANDSCAPE; DELETION; MOTILITY	Glioblastoma is the most aggressive primary brain tumor in adults. Although the rapid recurrence of glioblastomas after treatment is a major clinical challenge, the relationships between tumor growth and intracerebral spread remain poorly understood. We have identified the cofilin phosphatase chronophin (gene name: pyridoxal phosphatase, PDXP) as a glial tumor modifier. Monoallelic PDXP loss was frequent in four independent human astrocytic tumor cohorts and increased with tumor grade. We found that aberrant PDXP promoter methylation can be a mechanism leading to further chronophin downregulation in glioblastomas, which correlated with shorter glioblastoma patient survival. Moreover, we observed an inverse association between chronophin protein expression and cofilin phosphorylation levels in glioma tissue samples. Chronophin-deficient glioblastoma cells showed elevated cofilin phosphorylation, an increase in polymerized actin, a higher directionality of cell migration, and elevated in vitro invasiveness. Tumor growth of chronophin-depleted glioblastoma cells xenografted into the immunodeficient mouse brain was strongly impaired. Our study suggests a mechanism whereby the genetic and epigenetic alterations of PDXP resulting in altered chronophin expression may regulate the interplay between glioma cell proliferation and invasion.	[Schulze, M.; Zink, T. G.; Jeanclos, E.; Gohla, A.] Univ Wurzburg, Inst Pharmacol & Toxicol, D-97078 Wurzburg, Bavaria, Germany; [Schulze, M.; Jeanclos, E.; Gohla, A.] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, D-97078 Wurzburg, Bavaria, Germany; [Fedorchenko, O.] Univ Dusseldorf, Inst Biochem & Mol Biol 2, Dusseldorf, Germany; [Knobbe-Thomsen, C. B.; Reifenberger, G.] Univ Dusseldorf, Dept Neuropathol, Dusseldorf, Germany; [Knobbe-Thomsen, C. B.; Reifenberger, G.] German Canc Res Ctr, German Canc Consortium DKTK, Heidelberg, Germany; [Kraus, S.; Schwinn, S.; Beilhack, A.] Univ Wurzburg, Dept Internal Med 2, D-97078 Wurzburg, Bavaria, Germany; [Kraus, S.; Schwinn, S.; Beilhack, A.] Univ Wurzburg, Ctr Interdisciplinary Clin Res, D-97078 Wurzburg, Bavaria, Germany; [Monoranu, C. M.] Univ Wurzburg, Inst Pathol, Dept Neuropathol, D-97078 Wurzburg, Bavaria, Germany; [Monoranu, C. M.] Univ Wurzburg, Comprehens Canc Ctr Mainfranken, D-97078 Wurzburg, Bavaria, Germany; [Siren, A-L] Univ Wurzburg, Dept Neurosurg, D-97078 Wurzburg, Bavaria, Germany; [Schulze, M.] Univ Regensburg, Dept Neuropathol, D-93053 Regensburg, Germany; [Fedorchenko, O.] Univ Cologne, Dept Internal Med 1, Ctr Integrated Oncol Cologne Bonn, D-50931 Cologne, Germany	University of Wurzburg; University of Wurzburg; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Helmholtz Association; German Cancer Research Center (DKFZ); University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Regensburg; University of Cologne	Gohla, A (corresponding author), Univ Wurzburg, Dept Pharmacol, Versbacher Str 9, D-97078 Wurzburg, Germany.	antje.gohla@uni-wuerzburg.de	Knobbe-Thomsen, Christiane B/D-3116-2019; Sirén, Anna-Leena/AAE-1374-2019; Fedorchenko, Oleg/AAA-6533-2021; Reifenberger, Guido/AAE-3599-2019	Sirén, Anna-Leena/0000-0002-2217-0081; Gohla, Antje/0000-0002-7442-1487; Knobbe-Thomsen, Christiane/0000-0003-1231-0076; Jeanclos, Elisabeth/0000-0001-5934-5490	Deutsche Forschungsgemeinschaft [SFB728, SFB688, FZ82, TR17]; Forschungskommission of the Medical Faculty of Heinrich Heine University Dusseldorf; IZKF Wurzburg research grant; Medical Faculty of the University of Wurzburg (Graduate School of Life Sciences); Else Kroner-Fresenius-Stiftung; Max Eder Program of the German Cancer Aid (Deutsche Krebshilfe)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Forschungskommission of the Medical Faculty of Heinrich Heine University Dusseldorf; IZKF Wurzburg research grant; Medical Faculty of the University of Wurzburg (Graduate School of Life Sciences); Else Kroner-Fresenius-Stiftung; Max Eder Program of the German Cancer Aid (Deutsche Krebshilfe)	We thank Andrea Odersky and Beate Vogt for excellent technical assistance and Miriam Ritz, Carolin Graf, Thorsten Winter and Katja Ottmuller for help with bioluminescence imaging. We also thank Stephan Kissler for the gift of viral vectors, Christian Linden for FACS sorting and Michael Krause and Lukas Rycak, Marburg University, for microarray analysis. This work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB728 to AG and GR; SFB688 and FZ82 to AG), the Forschungskommission of the Medical Faculty of Heinrich Heine University Dusseldorf (to AG) and by an IZKF Wurzburg research grant (to AB). TGZ was supported by a predoctoral fellowship from the Medical Faculty of the University of Wurzburg (Graduate School of Life Sciences) and by the Deutsche Forschungsgemeinschaft TR17. SK was supported by a fellowship of the Else Kroner-Fresenius-Stiftung, and CBKT is supported by the Max Eder Program of the German Cancer Aid (Deutsche Krebshilfe).	Bellail AC, 2004, INT J BIOCHEM CELL B, V36, P1046, DOI 10.1016/j.biocel.2004.01.013; Bernstein BW, 2006, AM J PHYSIOL-CELL PH, V291, pC828, DOI 10.1152/ajpcell.00066.2006; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Binda E, 2012, CANCER CELL, V22, P765, DOI 10.1016/j.ccr.2012.11.005; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Bugyi B, 2010, ANNU REV BIOPHYS, V39, P449, DOI 10.1146/annurev-biophys-051309-103849; Carlsson SK, 2014, EMBO MOL MED, V6, P1359, DOI 10.15252/emmm.201302627; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chopra M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081320; Clark MJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000832; Collazo J, 2014, CANCER RES, V74, P2362, DOI 10.1158/0008-5472.CAN-13-3058; de Stahl TD, 2005, GENE CHROMOSOME CANC, V44, P161, DOI 10.1002/gcc.20226; Di Tomaso E, 2000, NEUROPATH APPL NEURO, V26, P22, DOI 10.1046/j.1365-2990.2000.00214.x; Dolecek TA, 2012, NEURO-ONCOLOGY, V14, pv1, DOI 10.1093/neuonc/nos218; Floyd D, 2014, NEURO-ONCOLOGY, V16, P622, DOI 10.1093/neuonc/nou049; Frattini V, 2013, NAT GENET, V45, P1141, DOI 10.1038/ng.2734; Galluzzi L, 2012, CELL REP, V2, P257, DOI 10.1016/j.celrep.2012.06.017; Gohla A, 2005, NAT CELL BIOL, V7, P21, DOI 10.1038/ncb1201; Hall A, 2009, CANCER METAST REV, V28, P5, DOI 10.1007/s10555-008-9166-3; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hartmann C, 2004, INT J CANCER, V108, P839, DOI 10.1002/ijc.11638; Horing E, 2012, ACTA NEUROPATHOL, V124, P83, DOI 10.1007/s00401-011-0940-x; Huang TY, 2008, DEV CELL, V15, P691, DOI 10.1016/j.devcel.2008.09.017; Huse JT, 2010, NAT REV CANCER, V10, P319, DOI 10.1038/nrc2818; Ino Y, 1999, J NEUROPATH EXP NEUR, V58, P881, DOI 10.1097/00005072-199908000-00010; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; KRUSE CA, 1992, IN VITRO CELL DEV-AN, V28A, P609; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Lu KV, 2012, CANCER CELL, V22, P21, DOI 10.1016/j.ccr.2012.05.037; Maher EA, 2001, GENE DEV, V15, P1311, DOI 10.1101/gad.891601; Mizuno K, 2013, CELL SIGNAL, V25, P457, DOI 10.1016/j.cellsig.2012.11.001; Muhammad A K, 1997, Neurol Med Chir (Tokyo), V37, P606, DOI 10.2176/nmc.37.606; Muhammad AK, 1997, NEUROL MEDICOCHIRURG, V37, P611; Nagai Shoichi, 2011, Genes Cancer, V2, P859, DOI 10.1177/1947601911431839; Oskam NT, 2000, INT J CANCER, V85, P336, DOI 10.1002/(SICI)1097-0215(20000201)85:3<336::AID-IJC7>3.0.CO;2-9; Park JY, 2014, J KOREAN RELIG, V5, P5, DOI 10.1353/jkr.2014.0003; Poincloux R, 2011, P NATL ACAD SCI USA, V108, P1943, DOI 10.1073/pnas.1010396108; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ren S, 2012, CANCER CHEMOTH PHARM, V70, P415, DOI 10.1007/s00280-012-1921-z; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Salhia B, 2005, CANCER RES, V65, P8792, DOI 10.1158/0008-5472.CAN-05-0160; Sauzeau V, 2010, ONCOGENE, V29, P3781, DOI 10.1038/onc.2010.134; Seifried A, 2014, J BIOL CHEM, V289, P3416, DOI 10.1074/jbc.M113.503359; Seifried A, 2013, FEBS J, V280, P549, DOI 10.1111/j.1742-4658.2012.08633.x; Seng TJ, 2005, GENE CHROMOSOME CANC, V43, P181, DOI 10.1002/gcc.20181; Sturm D, 2014, NAT REV CANCER, V14, P92, DOI 10.1038/nrc3655; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang W, 2006, J CELL BIOL, V173, P395, DOI 10.1083/jcb.200510115; Wang WG, 2007, NAT REV CANCER, V7, P429, DOI 10.1038/nrc2148; Wiggan O, 2012, DEV CELL, V22, P530, DOI 10.1016/j.devcel.2011.12.026; Yoshioka K, 2003, P NATL ACAD SCI USA, V100, P7247, DOI 10.1073/pnas.1232344100	53	8	8	2	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 16	2016	35	24					3163	3177		10.1038/onc.2015.376	http://dx.doi.org/10.1038/onc.2015.376			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DO9GI	26549022				2022-12-26	WOS:000378092700008
J	Garcia-Trejo, JJ; Zarco-Zavala, M; Mendoza-Hoffmann, F; Hernandez-Luna, E; Ortega, R; Mendoza-Hernandez, G				Garcia-Trejo, Jose J.; Zarco-Zavala, Mariel; Mendoza-Hoffmann, Francisco; Hernandez-Luna, Eduardo; Ortega, Raquel; Mendoza-Hernandez, Guillermo			The Inhibitory Mechanism of the zeta Subunit of the F1FO-ATPase Nanomotor of Paracoccus denitrificans and Related alpha-Proteobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP SYNTHASE; ESCHERICHIA-COLI; EPSILON-SUBUNIT; REGULATORY PROTEIN; BETA-SUBUNITS; F-1-ATPASE; COMPLEX; GAMMA; IF1; BACTERIAL	The zeta subunit is a novel inhibitor of the F1FO-ATPase of Paracoccus denitrificans and related alpha-proteobacteria. It is different from the bacterial (is an element of) and mitochondrial (IF1) inhibitors. The N terminus of zeta blocks rotation of the gamma subunit of the F-1-ATPase of P. denitrificans (Zarco-Zavala, M., Morales-Rios, E., Mendoza-Hernandez, G., Ramirez-Silva, L., Perez-Hernandez, G., and Garcia-Trejo, J. J. (2014) FASEB J. 24, 599 - 608) by a hitherto unknown quaternary structure that was first modeled here by structural homology and protein docking. The F-1-ATPase and F-1-zeta models of P. denitrificans were supported by cross-linking, limited proteolysis, mass spectrometry, and functional data. The final models show that zeta enters into F-1-ATPase at the open catalytic alpha(E)/beta(E) interface, and two partial gamma rotations lock the N terminus of zeta in an "inhibition-general core region," blocking further gamma rotation, while the zeta globular domain anchors it to the closed alpha(DP)/beta(DP) interface. Heterologous inhibition of the F-1-ATPase of P. denitrificans by the mitochondrial IF1 supported both the modeled zeta binding site at the alpha(DP)/beta(DP)/gamma interface and the endosymbiotic alpha-proteobacterial origin of mitochondria. In summary, the zeta subunit blocks the intrinsic rotation of the nanomotor by inserting its N-terminal inhibitory domain at the same rotor/stator interface where the mitochondrial IF1 or the bacterial is an element of binds. The proposed pawl mechanism is coupled to the rotation of the central gamma subunit working as a ratchet but with structural differences that make it a unique control mechanism of the nanomotor to favor the ATP synthase activity over the ATPase turnover in the alpha-proteobacteria.	[Garcia-Trejo, Jose J.; Zarco-Zavala, Mariel; Mendoza-Hoffmann, Francisco; Hernandez-Luna, Eduardo; Ortega, Raquel] Univ Nacl Autonoma Mexico, Fac Quim, Dept Biol, Delegacion Coyoacan 04510, DF, Mexico; [Mendoza-Hernandez, Guillermo] Univ Nacl Autonoma Mexico, Fac Med, Dept Bioquim, Delegacion Coyoacan 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Garcia-Trejo, JJ (corresponding author), Univ Nacl Autonoma Mexico, Dept Biol, Fac Quim, Lab 206, Edificio F,S-N Ciudad Univ, Delegacion Coyoacan 04510, DF, Mexico.	jjgartre@unam.mx		Mendoza-Hoffmann, Francisco/0000-0002-2166-6632	Mexico (CONACyT) [CB-2011-01-167622]; U.N.A.M. (DGAPA) [PAPIIT-IN211012]	Mexico (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); U.N.A.M. (DGAPA)(Universidad Nacional Autonoma de Mexico)	This work was supported by Mexico (CONACyT) Grant CB-2011-01-167622 and U.N.A.M. (DGAPA) Grant PAPIIT-IN211012 (to J. J. G.-T.). The authors declare that they have no conflicts of interest with the contents of this article.	Bason JV, 2014, P NATL ACAD SCI USA, V111, P11305, DOI 10.1073/pnas.1411560111; Cabezon E, 2003, NAT STRUCT BIOL, V10, P744, DOI 10.1038/nsb966; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cingolani G, 2011, NAT STRUCT MOL BIOL, V18, P701, DOI 10.1038/nsmb.2058; DEGOMEZPUYOU MT, 1983, J BIOL CHEM, V258, P3680; Garcia JJ, 1998, J BIOL CHEM, V273, P15940, DOI 10.1074/jbc.273.26.15940; Garcia JJ, 2006, BIOCHEMISTRY-US, V45, P12695, DOI 10.1021/bi060339j; Garcia-Trejo JJ, 2008, J BIOL PHYS, V34, P197, DOI 10.1007/s10867-008-9114-z; Gledhill JR, 2007, P NATL ACAD SCI USA, V104, P15671, DOI 10.1073/pnas.0707326104; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; JOHN P, 1975, NATURE, V254, P495, DOI 10.1038/254495a0; Ku C, 2015, NATURE, V524, P427, DOI 10.1038/nature14963; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Margulis L, 1998, TRENDS MICROBIOL, V6, P342, DOI 10.1016/S0966-842X(98)01325-0; Minauro-Sanmiguel F, 2002, J BIOENERG BIOMEMBR, V34, P433, DOI 10.1023/A:1022514008462; Morales-Rios E, 2015, ACTA CRYSTALLOGR F, V71, P1309, DOI 10.1107/S2053230X15016076; Morales-Rios E, 2010, FASEB J, V24, P599, DOI 10.1096/fj.09-137356; Ogilvie I, 1999, FEBS LETT, V453, P179, DOI 10.1016/S0014-5793(99)00605-5; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rodgers AJW, 2000, NAT STRUCT BIOL, V7, P1051; SAGAN L, 1967, J THEOR BIOL, V14, P225, DOI 10.1016/0022-5193(67)90079-3; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Serrano P, 2014, J MOL BIOL, V426, P2547, DOI 10.1016/j.jmb.2014.05.004; Shirakihara Y, 2015, FEBS J, V282, P2895, DOI 10.1111/febs.13329; Tsunoda SP, 2001, P NATL ACAD SCI USA, V98, P6560, DOI 10.1073/pnas.111128098; Wilkens S, 1998, J BIOL CHEM, V273, P26645, DOI 10.1074/jbc.273.41.26645; Zarco-Zavala M, 2013, BBA-BIOENERGETICS, V1827, P60, DOI 10.1016/j.bbabio.2012.09.010; Zarco-Zavala M, 2014, FASEB J, V28, P2146, DOI 10.1096/fj.13-241430	28	14	15	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					538	546		10.1074/jbc.M115.688143	http://dx.doi.org/10.1074/jbc.M115.688143			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26546676	hybrid, Green Published			2022-12-26	WOS:000367830500003
J	Kadri, F; Pacifici, M; Wilk, A; Parker-Struckhoff, A; Del Valle, L; Hauser, KF; Knapp, PE; Parsons, C; Jeansonne, D; Lassak, A; Peruzzi, F				Kadri, Ferdous; Pacifici, Marco; Wilk, Anna; Parker-Struckhoff, Amanda; Del Valle, Luis; Hauser, Kurt F.; Knapp, Pamela E.; Parsons, Christopher; Jeansonne, Duane; Lassak, Adam; Peruzzi, Francesca			HIV-1-Tat Protein Inhibits SC35-mediated Tau Exon 10 Inclusion through Up-regulation of DYRK1A Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY VIRUS-1 TAT; SPLICING FACTOR SC35; HIV-TAT; FRONTOTEMPORAL DEMENTIA; DOWN-SYNDROME; SR PROTEINS; PHOSPHORYLATION; EXPRESSION; TRANSCRIPTION; ISOFORMS	The HIV-1 transactivator protein Tat is implicated in the neuronal damage that contributes to neurocognitive impairment affecting people living with HIV/AIDS. Aberrant splicing of TAU exon 10 results in tauopathies characterized by alterations in the proportion of TAU isoforms containing three (3R) or four (4R) microtubule-binding repeats. The splicing factor SC35/SRSF2 binds to nuclear RNA and facilitates the incorporation of exon 10 in the TAU molecule. Here, we utilized clinical samples, an animal model, and neuronal cell cultures and found that Tat promotes TAU3R up-regulation through increased levels of phosphorylated SC35, which is retained in nuclear speckles. This mechanism involved Tat-mediated increased expression of DYRK1A and was prevented by DYRK1A silencing. In addition, we found that Tat associates with TAU RNA, further demonstrating that Tat interferes with host RNA metabolism in the absence of viral infection. Altogether, our data unravel a novel mechanism of Tat-mediated neuronal toxicity through dysregulation of the SC35-dependent alternative splicing of TAU exon 10. Furthermore, the increased immunostaining of DYRK1A in HIV+ brains without pathology points at dysregulation of DYRK1A as an early event in the neuronal complications of HIV infection.	[Kadri, Ferdous; Pacifici, Marco; Wilk, Anna; Parker-Struckhoff, Amanda; Del Valle, Luis; Parsons, Christopher; Jeansonne, Duane; Lassak, Adam; Peruzzi, Francesca] Louisiana State Univ, Hlth Sci Ctr, Dept Med, Stanley S Scott Canc Ctr, New Orleans, LA 70112 USA; [Kadri, Ferdous] Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, New Orleans, LA 70112 USA; [Hauser, Kurt F.] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23284 USA; [Knapp, Pamela E.] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA 23284 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Virginia Commonwealth University; Virginia Commonwealth University	Peruzzi, F (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Med, 1700 Tulane Ave, New Orleans, LA 70112 USA.	fperuz@lsuhsc.edu	Del Valle, Luis/J-4085-2015; Regan, Clinton/E-6250-2012; Hauser, Kurt/AAX-8361-2020	Del Valle, Luis/0000-0003-3894-9206; Hauser, Kurt/0000-0001-7886-0332	National Institutes of Health NIGMS [1U54 GM104940]; National Institutes of Health [P20 GM103501, R01 DA034231, K02 DA027374]; Louisiana Cancer Research Center; Stanley S. Scott Cancer Research Center at Louisiana State University Health Sciences Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104940, P20GM103501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA034231, K02DA027374] Funding Source: NIH RePORTER	National Institutes of Health NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana Cancer Research Center; Stanley S. Scott Cancer Research Center at Louisiana State University Health Sciences Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by the National Institutes of Health NIGMS Grant 1U54 GM104940 (to F. P.), which funds the Louisiana Clinical and Translational Science Center, by the National Institutes of Health Grants P20 GM103501 (to F. P. and C. P.), R01 DA034231 (to P. E. K.), and K02 DA027374 (to K. F. H.) and by the Louisiana Cancer Research Center and the Stanley S. Scott Cancer Research Center at Louisiana State University Health Sciences Center. The authors declare that they have no conflicts of interest with the content of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahn KJ, 2006, NEUROBIOL DIS, V22, P463, DOI 10.1016/j.nbd.2005.12.006; Altafaj X, 2013, NEUROBIOL DIS, V52, P117, DOI 10.1016/j.nbd.2012.11.017; Alvarez G, 1999, FEBS LETT, V453, P260, DOI 10.1016/S0014-5793(99)00685-7; Apcher GS, 2003, FEBS LETT, V553, P200, DOI 10.1016/S0014-5793(03)01025-1; Aprea S, 2006, J NEUROSCI, V26, P4054, DOI 10.1523/JNEUROSCI.0603-06.2006; Aranda S, 2011, FASEB J, V25, P449, DOI 10.1096/fj.10-165837; Avila J, 2004, PHYSIOL REV, V84, P361, DOI 10.1152/physrev.00024.2003; Bachani M, 2013, J NEUROVIROL, V19, P82, DOI 10.1007/s13365-012-0144-8; Bourgeois CF, 2004, PROG NUCLEIC ACID RE, V78, P37, DOI 10.1016/S0079-6603(04)78002-2; Bouwman RD, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-53; Brigati C, 2003, FEMS MICROBIOL LETT, V220, P57, DOI 10.1016/S0378-1097(03)00067-3; Bruce-Keller AJ, 2008, GLIA, V56, P1414, DOI 10.1002/glia.20708; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Chen CK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5246; Chen Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091793; Dawson HN, 2007, J NEUROSCI, V27, P9155, DOI 10.1523/JNEUROSCI.5492-06.2007; Del Valle L, 2000, J NEUROVIROL, V6, P221, DOI 10.3109/13550280009015824; Dewhurst S, 2007, J NEUROIMMUNE PHARM, V2, P93, DOI 10.1007/s11481-006-9051-1; Dowjat WK, 2007, NEUROSCI LETT, V413, P77, DOI 10.1016/j.neulet.2006.11.026; Dowling D, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-18; Eldar-Finkelman H, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00032; Espinoza M, 2008, J ALZHEIMERS DIS, V14, P1; Ferrer I, 2005, NEUROBIOL DIS, V20, P392, DOI 10.1016/j.nbd.2005.03.020; Fitting S, 2013, BIOL PSYCHIAT, V73, P443, DOI 10.1016/j.biopsych.2012.09.026; Fitting S, 2012, EUR J PHARMACOL, V689, P96, DOI 10.1016/j.ejphar.2012.05.029; Fitting S, 2010, AM J PATHOL, V177, P1397, DOI 10.2353/ajpath.2010.090945; Foster NL, 1997, ANN NEUROL, V41, P706, DOI 10.1002/ana.410410606; Ghosh G, 2011, FEBS J, V278, P587, DOI 10.1111/j.1742-4658.2010.07992.x; Grau C, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00331; Hammerle B, 2011, DEVELOPMENT, V138, P2543, DOI 10.1242/dev.066167; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Hernandez F, 2004, J BIOL CHEM, V279, P3801, DOI 10.1074/jbc.M311512200; Huang YQ, 2004, P NATL ACAD SCI USA, V101, P9666, DOI 10.1073/pnas.0403533101; Jablonski JA, 2010, NUCLEIC ACIDS RES, V38, P1249, DOI 10.1093/nar/gkp1105; Jamsa A, 2004, BIOCHEM BIOPH RES CO, V319, P993, DOI 10.1016/j.bbrc.2004.05.075; Janke C, 1999, MOL BRAIN RES, V68, P119, DOI 10.1016/S0169-328X(99)00079-0; Jeansonne D, 2015, J BIOL CHEM, V290, P8067, DOI 10.1074/jbc.M114.633081; Ji X, 2013, CELL, V153, P855, DOI 10.1016/j.cell.2013.04.028; Johnson TP, 2014, CURR OPIN HIV AIDS, V9, P572, DOI 10.1097/COH.0000000000000107; Johnson TP, 2013, P NATL ACAD SCI USA, V110, P13588, DOI 10.1073/pnas.1308673110; Johri MK, 2011, EXPERT OPIN BIOL TH, V11, P269, DOI 10.1517/14712598.2011.546339; Kampers T, 1999, FEBS LETT, V451, P39, DOI 10.1016/S0014-5793(99)00522-0; Kar A, 2011, MOL CELL BIOL, V31, P1812, DOI 10.1128/MCB.01149-10; Karn J, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006916; King JE, 2006, MICROBES INFECT, V8, P1347, DOI 10.1016/j.micinf.2005.11.014; KORENBERG JR, 1994, P NATL ACAD SCI USA, V91, P4997, DOI 10.1073/pnas.91.11.4997; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Lassot I, 2007, MOL CELL, V25, P369, DOI 10.1016/j.molcel.2006.12.020; Lin SR, 2008, NAT STRUCT MOL BIOL, V15, P819, DOI 10.1038/nsmb.1461; Lin SR, 2005, MOL CELL, V20, P413, DOI 10.1016/j.molcel.2005.09.015; Liu F, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-8; Lovestone S, 1999, BIOL PSYCHIAT, V45, P995, DOI 10.1016/S0006-3223(98)00183-8; Lu M, 2011, J BIOL CHEM, V286, P10755, DOI 10.1074/jbc.M110.174540; Ma Xiaoyun, 2003, Genomics Proteomics & Bioinformatics, V1, P2; Maldarelli F, 1998, VIRUS RES, V53, P39, DOI 10.1016/S0168-1702(97)00130-5; McArthur JC, 2010, ANN NEUROL, V67, P699, DOI 10.1002/ana.22053; McMillan P, 2008, J COMP NEUROL, V511, P788, DOI 10.1002/cne.21867; Medina Miguel, 2011, Int J Alzheimers Dis, V2011, P479249, DOI 10.4061/2011/479249; Misteli T, 1998, J CELL BIOL, V143, P297, DOI 10.1083/jcb.143.2.297; Pacifici M, 2012, JOVE-J VIS EXP, DOI 10.3791/3965; Panda D, 2003, P NATL ACAD SCI USA, V100, P9548, DOI 10.1073/pnas.1633508100; Passiatore G, 2009, BBA-MOL CELL RES, V1793, P378, DOI 10.1016/j.bbamcr.2008.10.010; Paz S, 2014, NUCLEIC ACIDS RES, V42, P13812, DOI 10.1093/nar/gku1170; Peineau S, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-22; Peruzzi F, 2006, FRONT BIOSCI-LANDMRK, V11, P708, DOI 10.2741/1829; Plattner F, 2006, J BIOL CHEM, V281, P25457, DOI 10.1074/jbc.M603469200; Qian W, 2011, NUCLEIC ACIDS RES, V39, P6161, DOI 10.1093/nar/gkr195; Qian W, 2011, FEBS LETT, V585, P875, DOI 10.1016/j.febslet.2011.02.017; Rom S, 2011, BBA-MOL CELL RES, V1813, P1836, DOI 10.1016/j.bbamcr.2011.06.012; Rom S, 2010, FASEB J, V24, P2292, DOI 10.1096/fj.09-143503; Shi JH, 2011, J BIOL CHEM, V286, P14639, DOI 10.1074/jbc.M110.204453; Souchet B, 2014, NEUROBIOL DIS, V69, P65, DOI 10.1016/j.nbd.2014.04.016; Spector DL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a000646; SPECTOR DL, 1991, EMBO J, V10, P3467, DOI 10.1002/j.1460-2075.1991.tb04911.x; Takuma H, 2003, DEV BRAIN RES, V142, P121, DOI 10.1016/S0165-3806(03)00056-7; Wegiel J, 2011, FEBS J, V278, P236, DOI 10.1111/j.1742-4658.2010.07955.x; Wegiel J, 2011, J NEUROPATH EXP NEUR, V70, P36, DOI 10.1097/NEN.0b013e318202bfa1; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Yin XM, 2012, J BIOL CHEM, V287, P30497, DOI 10.1074/jbc.M112.355412; Yu QM, 2004, J NEUROCHEM, V90, P164, DOI 10.1111/j.1471-4159.2004.02477.x; Zhou ZH, 2013, CHROMOSOMA, V122, P191, DOI 10.1007/s00412-013-0407-z; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	82	15	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					30931	30946		10.1074/jbc.M115.675751	http://dx.doi.org/10.1074/jbc.M115.675751			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26534959	Green Published, hybrid			2022-12-26	WOS:000367199000025
J	Chen, C; Sun, XL; Duanmu, HZ; Zhu, D; Yu, Y; Cao, L; Liu, AL; Jia, BW; Xiao, JL; Zhu, YM				Chen, Chao; Sun, Xiaoli; Duanmu, Huizi; Zhu, Dan; Yu, Yang; Cao, Lei; Liu, Ailin; Jia, Bowei; Xiao, Jialei; Zhu, Yanming			GsCML27, a Gene Encoding a Calcium-Binding Ef-Hand Protein from Glycine soja, Plays Differential Roles in Plant Responses to Bicarbonate, Salt and Osmotic Stresses	PLOS ONE			English	Article							CALMODULIN-LIKE PROTEIN; ABIOTIC STRESS; ARABIDOPSIS-THALIANA; ABSCISIC-ACID; SIGNAL-TRANSDUCTION; CONFORMATIONAL TRANSITION; SALINITY TOLERANCE; NA+/H+ ANTIPORTER; DROUGHT STRESSES; ALKALI-STRESS	Calcium, as the most widely accepted messenger, plays an important role in plant stress responses through calcium-dependent signaling pathways. The calmodulin-like family genes (CMLs) encode Ca2+ sensors and function in signaling transduction in response to environmental stimuli. However, until now, the function of plant CML proteins, especially soybean CMLs, is largely unknown. Here, we isolated a Glycine soja CML protein GsCML27, with four conserved EF-hands domains, and identified it as a calcium-binding protein through far-UV CD spectroscopy. We further found that expression of GsCML27 was induced by bicarbonate, salt and osmotic stresses. Interestingly, ectopic expression of GsCML27 in Arabidopsis enhanced plant tolerance to bicarbonate stress, but decreased the salt and osmotic tolerance during the seed germination and early growth stages. Furthermore, we found that ectopic expression of GsCML27 decreases salt tolerance through modifying both the cellular ionic (Na+, K+) content and the osmotic stress regulation. GsCML27 ectopic expression also decreased the expression levels of osmotic stress-responsive genes. Moreover, we also showed that GsCML27 localized in the whole cell, including cytoplasm, plasma membrane and nucleus in Arabidopsis protoplasts and onion epidermal cells, and displayed high expression in roots and embryos. Together, these data present evidence that GsCML27 as a Ca2+-binding EF-hand protein plays a role in plant responses to bicarbonate, salt and osmotic stresses.	[Chen, Chao; Duanmu, Huizi; Yu, Yang; Cao, Lei; Liu, Ailin; Jia, Bowei; Xiao, Jialei; Zhu, Yanming] Northeast Agr Univ, Key Lab Agr Biol Funct Genes, Harbin, Peoples R China; [Sun, Xiaoli] Heilongjiang Bayi Agr Univ, Agron Coll, Daqing, Peoples R China; [Zhu, Dan] Qingdao Agr Univ, Coll Life Sci, Qingdao, Peoples R China	Northeast Agricultural University - China; Heilongjiang Bayi Agricultural University; Qingdao Agricultural University	Zhu, YM (corresponding author), Northeast Agr Univ, Key Lab Agr Biol Funct Genes, Harbin, Peoples R China.	ymzhu2001@neau.edu.cn		, chenchao/0000-0002-1865-7751; Sun, Xiaoli/0000-0003-1134-3976	National Natural Science Foundation of China [31171578]; Heilongjiang Provincial Higher School Science and Technology Innovation Team Building Program [2011TD005]; National basic scientific talent training fund projects [J1210069]; Ministry of Agriculture transgenic major projects [2011ZX08004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Heilongjiang Provincial Higher School Science and Technology Innovation Team Building Program; National basic scientific talent training fund projects; Ministry of Agriculture transgenic major projects	Funding: This work was supported by the National Natural Science Foundation of China (31171578), Heilongjiang Provincial Higher School Science and Technology Innovation Team Building Program (2011TD005), National basic scientific talent training fund projects (J1210069), and Ministry of Agriculture transgenic major projects (2011ZX08004).	Alhendawi RA, 1997, J PLANT NUTR, V20, P1731, DOI 10.1080/01904169709365371; Chen S, 2010, PLANT BIOLOGY, V12, P317, DOI 10.1111/j.1438-8677.2009.00301.x; Cheong YH, 2003, PLANT CELL, V15, P1833, DOI 10.1105/tpc.012393; Chinnusamy V, 2004, J EXP BOT, V55, P225, DOI 10.1093/jxb/erh005; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Correia M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116737; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Day IS, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-10-research0056; DeFalco TA, 2010, BIOCHEM J, V425, P27, DOI 10.1042/BJ20091147; Delk NA, 2005, PLANT PHYSIOL, V139, P240, DOI 10.1104/pp.105.062612; Dobney S, 2009, J BIOL CHEM, V284, P31647, DOI 10.1074/jbc.M109.056770; Gao DJ, 2004, PLANT PHYSIOL, V134, P898, DOI 10.1104/pp.103.032508; Ge Y, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-153; Ge Ying, 2009, Pratacultural Science, V26, P47; Gong B, 2014, BIOCHEM BIOPH RES CO, V446, P417, DOI 10.1016/j.bbrc.2014.03.005; Gong DM, 2004, PLANT PHYSIOL, V134, P919, DOI 10.1104/pp.103.037440; Grabarek Z, 2006, J MOL BIOL, V359, P509, DOI 10.1016/j.jmb.2006.03.066; Harshavardhan VT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110065; Hashimoto K, 2011, BIOCHIMIE, V93, P2054, DOI 10.1016/j.biochi.2011.05.019; HERZBERG O, 1986, J BIOL CHEM, V261, P2638; Huang GT, 2012, MOL BIOL REP, V39, P969, DOI 10.1007/s11033-011-0823-1; Huis R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-71; Ishitani M, 2000, PLANT CELL, V12, P1667, DOI 10.1105/tpc.12.9.1667; Jiang YQ, 2009, PLANT MOL BIOL, V69, P91, DOI 10.1007/s11103-008-9408-3; Jiang ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076130; Jin H, 2008, PLANT SCI, V175, P784, DOI 10.1016/j.plantsci.2008.07.016; Jung C, 2008, PLANT PHYSIOL, V146, P623, DOI 10.1104/pp.107.110981; Kim KN, 2000, PLANT PHYSIOL, V124, P1844, DOI 10.1104/pp.124.4.1844; Knight H, 2001, TRENDS PLANT SCI, V6, P262, DOI 10.1016/S1360-1385(01)01946-X; Kolukisaoglu U, 2004, PLANT PHYSIOL, V134, P43, DOI 10.1104/pp.103.033068; KRETSINGER RH, 1973, J BIOL CHEM, V248, P3313; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Liu JP, 2000, P NATL ACAD SCI USA, V97, P3730, DOI 10.1073/pnas.060034197; Liu L, 2011, J INTEGR PLANT BIOL, V53, P731, DOI 10.1111/j.1744-7909.2011.01066.x; Liu X, 2015, PROTOPLASMA; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Magnan F, 2008, PLANT J, V56, P575, DOI 10.1111/j.1365-313X.2008.03622.x; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; McCormack E, 2005, TRENDS PLANT SCI, V10, P383, DOI 10.1016/j.tplants.2005.07.001; McCormack E, 2003, NEW PHYTOL, V159, P585, DOI 10.1046/j.1469-8137.2003.00845.x; Niki I, 1996, J BIOCHEM, V120, P685; Nour-Eldin HH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl635; Park HC, 2010, PLANT CELL REP, V29, P1297, DOI 10.1007/s00299-010-0916-7; Perochon A, 2011, BIOCHIMIE, V93, P2048, DOI 10.1016/j.biochi.2011.07.012; Perruc E, 2004, PLANT J, V38, P410, DOI 10.1111/j.1365-313X.2004.02062.x; Reddy ASN, 2001, PLANT SCI, V160, P381, DOI 10.1016/S0168-9452(00)00386-1; Scarpeci TE, 2013, PLANT MOL BIOL, V83, P265, DOI 10.1007/s11103-013-0090-8; Shi DC, 2005, ENVIRON EXP BOT, V54, P8, DOI 10.1016/j.envexpbot.2004.05.003; Shi HZ, 2000, P NATL ACAD SCI USA, V97, P6896, DOI 10.1073/pnas.120170197; Singh R., 2015, PLOS ONE, V10; Soyka S, 1999, FEBS LETT, V458, P219, DOI 10.1016/S0014-5793(99)01125-4; Sun XL, 2013, PLANT CELL TISS ORG, V113, P199, DOI 10.1007/s11240-012-0260-4; Takahashi S, 2000, PLANT CELL PHYSIOL, V41, P898, DOI 10.1093/pcp/pcd010; Takahashi S, 2001, PLANT CELL PHYSIOL, V42, P214, DOI 10.1093/pcp/pce028; TANG CX, 1993, PLANT SOIL, V152, P269, DOI 10.1007/BF00029097; Tuteja N, 2007, METHOD ENZYMOL, V428, P419, DOI 10.1016/S0076-6879(07)28024-3; Vadassery J, 2012, PLANT PHYSIOL, V159, P1159, DOI 10.1104/pp.112.198150; WANG ZY, 1992, P NATL ACAD SCI USA, V89, P11814, DOI 10.1073/pnas.89.24.11814; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Xiong LM, 2001, PHYSIOL PLANTARUM, V112, P152, DOI 10.1034/j.1399-3054.2001.1120202.x; Yamaguchi T, 2005, P NATL ACAD SCI USA, V102, P16107, DOI 10.1073/pnas.0504437102; Yan A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085208; Yang CW, 2009, PHOTOSYNTHETICA, V47, P79, DOI 10.1007/s11099-009-0013-8; Yang Chuan-Ping, 2005, Sheng Wu Gong Cheng Xue Bao, V21, P220; Yang CW, 2008, PLANT GROWTH REGUL, V56, P179, DOI 10.1007/s10725-008-9299-y; Yang CW, 2007, PLANT SOIL, V294, P263, DOI 10.1007/s11104-007-9251-3; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095642; Zhao Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098098; Zhu D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111984; Zhu D, 2012, BIOCHEM BIOPH RES CO, V426, P273, DOI 10.1016/j.bbrc.2012.08.086; Zhu D, 2011, PLANT MOL BIOL, V77, P285, DOI 10.1007/s11103-011-9810-0; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zhu JK, 1997, CRIT REV PLANT SCI, V16, P253, DOI 10.1080/713608147; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	75	28	33	5	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2015	10	11							e0141888	10.1371/journal.pone.0141888	http://dx.doi.org/10.1371/journal.pone.0141888			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7AC	26550992	Green Submitted, Green Published, gold			2022-12-26	WOS:000364422800012
J	Wang, M; Li, CC; Lin, CY				Wang, Min; Li, Chuchu; Lin, Candise Y.			The Contributions of Segmental and Suprasegmental Information in Reading Chinese Characters Aloud	PLOS ONE			English	Article							VISUAL WORD RECOGNITION; TIME-COURSE; SEMANTIC ACTIVATION; LANGUAGE PRODUCTION; MANDARIN CHINESE; LEXICAL ACCESS; EYE-MOVEMENTS; DUAL-ROUTE; TONE; IDENTIFICATION	The Chinese writing system provides an excellent case for testing the contribution of segmental and suprasegmental information in reading words aloud within the same language. In logographic Chinese characters, neither segmental nor tonal information is explicitly represented, whereas in Pinyin, an alphabetic transcription of the character, both are explicitly represented. Two primed naming experiments were conducted in which the targets were always written characters. When logographic characters served as the primes (Experiment 1), syllable segmental and tonal information appeared to be represented and encoded as an integral unit which in turn facilitated target character naming. When Pinyin served as the primes (Experiment 2), the explicit phonetic representation facilitated encoding of both segmental and suprasegmental information, but with later access to suprasegmental information. In addition, Chinese speakers were faster to name characters than Pinyin in a simple naming task (Experiment 3), suggesting that Pinyin may be read via a phonological assembly route, whereas characters may be read via a lexical route. Taken together, our findings point to the need to consider the contributions of both segmental and suprasegmental information and the time course in the well-established models for reading aloud, as well as the cognitive mechanisms underlying the reading aloud of logographic characters versus alphabetic Pinyin script.	[Wang, Min; Li, Chuchu] Univ Maryland, Dept Human Dev & Quantitat Methodol, College Pk, MD 20742 USA; [Lin, Candise Y.] Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA; [Lin, Candise Y.] Univ So Calif, Program Hearing & Commun Neurosci, Los Angeles, CA USA	University System of Maryland; University of Maryland College Park; University of Southern California; University of Southern California	Wang, M (corresponding author), Univ Maryland, Dept Human Dev & Quantitat Methodol, College Pk, MD 20742 USA.	minwang@umd.edu	Li, Chuchu/AAZ-8662-2021	Li, Chuchu/0000-0001-6614-8989	University of Maryland; UMD Libraries Open Access Publishing Fund; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC009975] Funding Source: NIH RePORTER	University of Maryland; UMD Libraries Open Access Publishing Fund; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Funding: This study was supported by an International Travel Award from the University of Maryland to MW and a University of Maryland Graduate Fellowship to CCL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding for Open Access was provided by the UMD Libraries Open Access Publishing Fund.	Abramowitz LK, 2012, CURR OPIN GENET DEV, V22, P72, DOI 10.1016/j.gde.2011.12.001; Ashby J, 2005, COGNITION, V96, pB89, DOI 10.1016/j.cognition.2004.12.006; Bates D., 2015, LME4 LINEAR MIXED EF; Bauer RS., 1997, GRUYTER, DOI [10.1515/9783110823707, DOI 10.1515/9783110823707]; Bowey JA, 2005, J EXP CHILD PSYCHOL, V92, P203, DOI 10.1016/j.jecp.2005.06.005; Caramazza A, 1997, COGNITIVE NEUROPSYCH, V14, P177, DOI 10.1080/026432997381664; Chen HC, 2001, PSYCHON B REV, V8, P511, DOI 10.3758/BF03196186; Chen JY, 2002, J MEM LANG, V46, P751, DOI 10.1006/jmla.2001.2825; Chen TM, 2013, PSYCHON B REV, V20, P154, DOI 10.3758/s13423-012-0326-7; Chen YP, 2002, J COGNITIVE NEUROSCI, V14, P1088, DOI 10.1162/089892902320474535; Coltheart M, 2001, PSYCHOL REV, V108, P204, DOI 10.1037//0033-295X.108.1.204; COLTHEART M, 1993, PSYCHOL REV, V100, P589, DOI 10.1037/0033-295X.100.4.589; Coltheart M, 2005, BL HBK DEV PSYCHOL, P6, DOI 10.1002/9780470757642.ch1; Crystal D., 2011, DICT LINGUISTICS PHO; de Jong PF, 2009, J EXP CHILD PSYCHOL, V104, P267, DOI 10.1016/j.jecp.2009.06.002; DELL GS, 1986, PSYCHOL REV, V93, P283, DOI 10.1037/0033-295X.93.3.283; Feldman LB, 1999, J MEM LANG, V40, P559, DOI 10.1006/jmla.1998.2629; Fu D, 2014, NAT CHEM, V6, P615, DOI [10.1038/nchem.1961, 10.1038/NCHEM.1961]; GRAINGER J, 1994, J MEM LANG, V33, P218, DOI 10.1006/jmla.1994.1011; Hanley JR, 2005, SCI READING, P296; Harm MW, 2001, COGNITIVE NEUROPSYCH, V18, P71, DOI 10.1080/02643290125986; Lee CY, 2007, LANG SPEECH, V50, P101, DOI 10.1177/00238309070500010501; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; Li C., 1989, MANDARIN CHINESE FUN; Li CC, 2013, PSYCHON B REV, V20, P773, DOI 10.3758/s13423-013-0395-2; Lin CY, 2013, J CHILD LANG, V40, P885, DOI 10.1017/S0305000912000281; Lin D, 2010, PSYCHOL SCI, V21, P1117, DOI 10.1177/0956797610375447; McBride-Chang C, 2008, SCI STUD READ, V12, P171, DOI 10.1080/10888430801917290; MEYER AS, 1991, J MEM LANG, V30, P69, DOI 10.1016/0749-596X(91)90011-8; MEYER AS, 1990, J MEM LANG, V29, P524, DOI 10.1016/0749-596X(90)90050-A; Nixon J, 2014, LANG COGN NEUROSCI, V30, P1; O'Seaghdha PG, 2015, JPN PSYCHOL RES, V57, P4, DOI 10.1111/jpr.12074; O'Seaghdha PG, 2010, COGNITION, V115, P282, DOI 10.1016/j.cognition.2010.01.001; Perfetti CA, 2005, PSYCHOL REV, V112, P43, DOI 10.1037/0033-295X.112.1.43; Perfetti CA, 1998, J EXP PSYCHOL LEARN, V24, P101, DOI 10.1037/0278-7393.24.1.101; PERFETTI CA, 1991, J EXP PSYCHOL LEARN, V17, P633, DOI 10.1037/0278-7393.17.4.633; PERFETTI CA, 1988, J MEM LANG, V27, P59, DOI 10.1016/0749-596X(88)90048-4; Pollatsek A, 2000, J EXP PSYCHOL HUMAN, V26, P607, DOI 10.1037/0096-1523.26.2.607; Protopapas A, 2007, BEHAV RES METHODS, V39, P859, DOI 10.3758/BF03192979; Roelofs A, 2015, JPN PSYCHOL RES, V57, P22, DOI 10.1111/jpr.12050; Schiller NO, 2007, PSYCHON B REV, V14, P460, DOI 10.3758/BF03194089; Scliffler NO, 2006, BRAIN RES, V1112, P201, DOI 10.1016/j.brainres.2006.07.027; SEIDENBERG MS, 1985, COGNITION, V19, P1, DOI 10.1016/0010-0277(85)90029-0; Shu H, 2003, CHILD DEV, V74, P27, DOI 10.1111/1467-8624.00519; Shu H, 2008, DEVELOPMENTAL SCI, V11, P171, DOI 10.1111/j.1467-7687.2007.00654.x; Spinks JA, 2000, COGNITION, V76, pB1, DOI 10.1016/S0010-0277(00)00072-X; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tong YX, 2008, LANG COGNITIVE PROC, V23, P689, DOI 10.1080/01690960701728261; Verdonschot RG, 2015, JPN PSYCHOL RES, V57, P61, DOI 10.1111/jpr.12064; Wang M, 2011, CONTEMP EDUC PSYCHOL, V36, P142, DOI 10.1016/j.cedpsych.2011.02.001; Wong AWK, 2008, J EXP PSYCHOL LEARN, V34, P1172, DOI 10.1037/a0013000; Ye Y, 1999, LANG COGNITIVE PROC, V14, P609, DOI 10.1080/016909699386202; You WP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046595; Zhang Q, 2009, NEUROSCIENCE, V163, P252, DOI 10.1016/j.neuroscience.2009.06.015; Zhou XL, 2009, LANG COGNITIVE PROC, V24, P1009, DOI 10.1080/01690960802174514; Zhou XL, 1999, J MEM LANG, V41, P579, DOI 10.1006/jmla.1999.2663; Zovo K, 2010, ANAL CHEM, V82, P8558, DOI 10.1021/ac101583q	57	5	6	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2015	10	11							e0142060	10.1371/journal.pone.0142060	http://dx.doi.org/10.1371/journal.pone.0142060			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7AC	26551251	Green Submitted, Green Published, gold			2022-12-26	WOS:000364422800015
J	Dolan, GF; Akoopie, A; Muller, UF				Dolan, Gregory F.; Akoopie, Arvin; Mueller, Ulrich F.			A Faster Triphosphorylation Ribozyme	PLoS One			English	Article							RNA WORLD; CHEMISTRY; EVOLUTION; ACCURATE; REAGENT; LIGANDS; ORIGIN; OCEAN	In support of the RNA world hypothesis, previous studies identified trimetaphosphate (Tmp) as a plausible energy source for RNA world organisms. In one of these studies, catalytic RNAs (ribozymes) that catalyze the triphosphorylation of RNA 5'-hydroxyl groups using Tmp were obtained by in vitro selection. One ribozyme (TPR1) was analyzed in more detail. TPR1 catalyzes the triphosphorylation reaction to a rate of 0.013 min(-1) under selection conditions (50 mM Tmp, 100 mM MgCl2, 22 degrees C). To identify a triphosphorylation ribozyme that catalyzes faster triphosphorylation, and possibly learn about its secondary structure TPR1 was subjected to a doped selection. The resulting ribozyme, TPR1e, contains seven mutations relative to TPR1, displays a previously unidentified duplex that constrains the ribozyme's structure, and reacts at a 24-fold faster rate than the parent ribozyme. Under optimal conditions (150 mM Tmp, 650 mM MgCl2, 40 degrees C), the triphosphorylation rate of TRP1e reaches 6.8 min(-1).	[Dolan, Gregory F.; Akoopie, Arvin; Mueller, Ulrich F.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Muller, UF (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	ufmuller@ucsd.edu			National Aeronautics and Space Administration [NNX13AJ09G]	National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA))	This work was supported by the National Aeronautics and Space Administration under Grant No. NNX13AJ09G issued through the Science Mission Directorate (ROSES-2011), in Astrobiology/Exobiology to UFM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTEL DP, 1993, SCIENCE, V261, P1411, DOI 10.1126/science.7690155; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; ETAIX E, 1978, J CARB-NUCLEOS-NUCL, V5, P91; Hay WW, 2006, PALAEOGEOGR PALAEOCL, V240, P3, DOI 10.1016/j.palaeo.2006.03.044; Johnston WK, 2001, SCIENCE, V292, P1319, DOI 10.1126/science.1060786; KRUGER K, 1982, CELL, V31, P147, DOI 10.1016/0092-8674(82)90414-7; Martin Lyssa L., 2015, Life-Basel, V5, P247, DOI 10.3390/life5010247; Moretti JE, 2014, NUCLEIC ACIDS RES, V42, P4767, DOI 10.1093/nar/gkt1405; Mortimer SA, 2007, J AM CHEM SOC, V129, P4144, DOI 10.1021/ja0704028; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; Orgel LE, 2004, CRIT REV BIOCHEM MOL, V39, P99, DOI 10.1080/10409230490460765; ORGEL LE, 1968, J MOL BIOL, V38, P381, DOI 10.1016/0022-2836(68)90393-8; Pasek MA, 2008, ANGEW CHEM INT EDIT, V47, P7918, DOI 10.1002/anie.200802145; Pasek MA, 2013, P NATL ACAD SCI USA, V110, P10089, DOI 10.1073/pnas.1303904110; SPRENGEL G, 1981, FEBS LETT, V132, P207, DOI 10.1016/0014-5793(81)81161-1; STEWART PB, 1970, J CHEM ENG DATA, V15, P67, DOI 10.1021/je60044a001; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Turner R, 2013, RNA, V19, P1857, DOI 10.1261/rna.042374.113; WEINER MP, 1994, PCR METH APPL, V4, pS131; Woese C.R., 1967, GENETIC CODE MOL BAS	21	17	17	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142559	10.1371/journal.pone.0142559	http://dx.doi.org/10.1371/journal.pone.0142559			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545116	Green Published, gold, Green Submitted			2022-12-26	WOS:000364398700155
J	Kelbert, P; Droege, G; Barker, K; Braak, K; Cawsey, EM; Coddington, J; Robertson, T; Whitacre, J; Guntsch, A				Kelbert, Patricia; Droege, Gabriele; Barker, Katharine; Braak, Kyle; Cawsey, E. Margaret; Coddington, Jonathan; Robertson, Tim; Whitacre, Jamie; Guentsch, Anton			B-HIT - A Tool for Harvesting and Indexing Biodiversity Data	PLOS ONE			English	Article								With the rapidly growing number of data publishers, the process of harvesting and indexing information to offer advanced search and discovery becomes a critical bottleneck in globally distributed primary biodiversity data infrastructures. The Global Biodiversity Information Facility (GBIF) implemented a Harvesting and Indexing Toolkit (HIT), which largely automates data harvesting activities for hundreds of collection and observational data providers. The team of the Botanic Garden and Botanical Museum Berlin-Dahlem has extended this well-established system with a range of additional functions, including improved processing of multiple taxon identifications, the ability to represent associations between specimen and observation units, new data quality control and new reporting capabilities. The open source software B-HIT can be freely installed and used for setting up thematic networks serving the demands of particular user groups.	[Kelbert, Patricia; Droege, Gabriele; Guentsch, Anton] Free Univ Berlin, Bot Garden, Berlin, Germany; [Kelbert, Patricia; Droege, Gabriele; Guentsch, Anton] Free Univ Berlin, Bot Museum Berlin Dahlem, Berlin, Germany; [Barker, Katharine; Coddington, Jonathan; Whitacre, Jamie] Smithsonian Inst, Natl Museum Nat Hist, Washington, DC 20560 USA; [Braak, Kyle; Robertson, Tim] Global Biodivers Informat Facil, Copenhagen, Denmark; [Cawsey, E. Margaret] CSIRO Natl Res Collect Australia, Australian Natl Wildlife Collect, Canberra, ACT, Australia	Free University of Berlin; Free University of Berlin; Smithsonian Institution; Smithsonian National Museum of Natural History; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Kelbert, P (corresponding author), Free Univ Berlin, Bot Garden, Berlin, Germany.	p.kelbert@bgbm.org	Cawsey, Edith M/C-9594-2011	Guntsch, Anton/0000-0002-4325-4030; Braak, Kyle/0000-0002-3696-3496; Barker, Katharine/0000-0002-4788-0223; Coddington, Jonathan A./0000-0001-6004-7730	German Research Foundation (DFG) [BE 2283/8-1]; DFG project GGBN [GU 1109/5-1]; National Science Foundation [NSF DEB 0956426]	German Research Foundation (DFG)(German Research Foundation (DFG)); DFG project GGBN(German Research Foundation (DFG)); National Science Foundation(National Science Foundation (NSF))	The design and implementation of the B-HIT was funded by the German Research Foundation (DFG, http://www.dfg.de) project BiNHum (BE 2283/8-1). The analysis of data for GGBN was funded by the DFG project GGBN (GU 1109/5-1) as well as the National Science Foundation (http://www.nsf.gov, NSF DEB 0956426). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berendsohn WG, 2011, ZOOKEYS, P71, DOI 10.3897/zookeys.150.2166; Berendsohn WG, 2012, ZOOKEYS, P47, DOI 10.3897/zookeys.209.3179; Buck M., 2011, REV EUR COMP INT ENV, V20, P47, DOI [10.1111/j.1467-9388.2011.00703.x, DOI 10.1111/J.1467-9388.2011.00703.X]; Canhos VP, 2004, BIODIVERSITY INFORM, V1; Droege G, 2014, NUCLEIC ACIDS RES, V42, pD607, DOI 10.1093/nar/gkt928; Guentsch Anton, 2007, Ferrantia, V51, P103; Holetschek J, 2012, PLANT BIOSYST, V146, P771, DOI 10.1080/11263504.2012.740085; Holetschek J, 2009, LECT NOTES INFORM, V26, P552; Mathew Cherian, 2014, Biodivers Data J, pe4221, DOI 10.3897/BDJ.2.e4221; Miller JS, 2014, TAXON, V63, P959, DOI 10.12705/634.35; Robertson T., 2009, DARWIN CORE TEXT GUI; Robertson T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102623; Scoble Malcolm J., 2003, ENHSIN EUROPEAN NATU; Vieglas D., 1999, INTEGRATING DISPARAT; Wieczorek J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029715	15	4	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142240	10.1371/journal.pone.0142240	http://dx.doi.org/10.1371/journal.pone.0142240			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544980	Green Published, gold, Green Submitted			2022-12-26	WOS:000364398700098
J	Magner, D; Biala, E; Lisowiec-Wachnicka, J; Kierzek, E; Kierzek, R				Magner, Dorota; Biala, Ewa; Lisowiec-Wachnicka, Jolanta; Kierzek, Elzbieta; Kierzek, Ryszard			A Tandem Oligonucleotide Approach for SNP-Selective RNA Degradation Using Modified Antisense Oligonucleotides	PLOS ONE			English	Article							PRECURSOR PROTEIN GENE; SINGLE-NUCLEOTIDE POLYMORPHISMS; ALZHEIMERS-DISEASE GENES; MUTANT HUNTINGTIN; RNA/DNA DUPLEXES; INTERNAL LOOPS; NUCLEIC-ACIDS; CAG REPEATS; ALLELE; MISMATCHES	Antisense oligonucleotides have been studied for many years as a tool for gene silencing. One of the most difficult cases of selective RNA silencing involves the alleles of single nucleotide polymorphisms, in which the allele sequence is differentiated by a single nucleotide. A new approach to improve the performance of allele selectivity for antisense oligonucleotides is proposed. It is based on the simultaneous application of two oligonucleotides. One is complementary to the mutated form of the targeted RNA and is able to activate RNase H to cleave the RNA. The other oligonucleotide, which is complementary to the wild type allele of the targeted RNA, is able to inhibit RNase H cleavage. Five types of SNPs, C/G, G/C, G/A, A/G, and C/U, were analyzed within the sequence context of genes associated with neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease, ALS (Amyotrophic Lateral Sclerosis), and Machado-Joseph disease. For most analyzed cases, the application of the tandem approach increased allele-selective RNA degradation 1.5-15 fold relative to the use of a single antisense oligonucleotide. The presented study proves that differentiation between single substitution is highly dependent on the nature of the SNP and surrounding nucleotides. These variables are crucial for determining the proper length of the inhibitor antisense oligonucleotide. In the tandem approach, the comparison of thermodynamic stability of the favorable duplexes WT RNA-inhibitor and Mut RNA-gapmer with the other possible duplexes allows for the evaluation of chances for the allele-selective degradation of RNA. A larger difference in thermodynamic stability between favorable duplexes and those that could possibly form, usually results in the better allele selectivity of RNA degradation.	[Magner, Dorota; Biala, Ewa; Lisowiec-Wachnicka, Jolanta; Kierzek, Elzbieta; Kierzek, Ryszard] Polish Acad Sci, Inst Bioorgan Chem, PL-61704 Poznan, Poland	Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences	Kierzek, R (corresponding author), Polish Acad Sci, Inst Bioorgan Chem, Noskowskiego 12-14, PL-61704 Poznan, Poland.	rkierzek@ibch.poznan.pl	Lisowiec-Wachnicka, Jolanta J./O-4323-2015; Lisowiec-Wąchnicka, Jolanta/U-7618-2019	Kierzek, Elzbieta/0000-0002-5563-003X; Kierzek, Ryszard/0000-0002-7644-0016; Lisowiec-Wachnicka, Jolanta/0000-0002-3910-9682	National Science Centre Poland [UMO-2011/03/B/NZ1/00576, UMO-2011/03/B/ST5/01098, UMO-2013/08/A/ST5/00295, UMO-2013/08/M/NZ1/01062]; National Institute of Health [1R03TW008739-01]; Polish Ministry of Science and Higher Education under the KNOW Program; FOGARTY INTERNATIONAL CENTER [R03TW008739] Funding Source: NIH RePORTER	National Science Centre Poland(National Science Centre, Poland); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Polish Ministry of Science and Higher Education under the KNOW Program(Ministry of Science and Higher Education, Poland); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Funding provided by National Science Centre Poland, https://www.ncn.gov.pl/?language = en, grants no: UMO-2011/03/B/NZ1/00576 (RK), UMO-2011/03/B/ST5/01098 (RK), UMO-2013/08/A/ST5/00295 (RK), UMO-2013/08/M/NZ1/01062 (EK) and National Institute of Health, http://www.nih.gov/, grant no: 1R03TW008739-01 (EK). This publication was also supported by the Polish Ministry of Science and Higher Education under the KNOW Program.	Aiba Y, 2013, BIOCHEMISTRY-US, V52, P9329, DOI 10.1021/bi4014209; Albrecht-Buehlel G, 2009, BIOESSAYS, V31, P98, DOI 10.1002/bies.080081; Allawi HT, 1997, BIOCHEMISTRY-US, V36, P10581, DOI 10.1021/bi962590c; Alves S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003341; Bilanges B, 2005, BIOCHEM J, V388, P573, DOI 10.1042/BJ20041956; BORER PN, 1975, HDB BIOCH MOL BIOL, P589; Carroll JB, 2011, MOL THER, V19, P2178, DOI 10.1038/mt.2011.201; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CROOKE ST, 1995, BIOCHEM J, V312, P599, DOI 10.1042/bj3120599; Crooke ST, 1999, BBA-GENE STRUCT EXPR, V1489, P31, DOI 10.1016/S0167-4781(99)00148-7; Davis AR, 2011, NUCLEIC ACIDS RES, V39, P1081, DOI 10.1093/nar/gkq793; Davis AR, 2010, BIOCHEMISTRY-US, V49, P8669, DOI 10.1021/bi100146z; Dean NM, 2003, ONCOGENE, V22, P9087, DOI 10.1038/sj.onc.1207231; Ding HL, 2003, AGING CELL, V2, P209, DOI 10.1046/j.1474-9728.2003.00054.x; Drake JW, 1998, GENETICS, V148, P1667; Fasman GD, 1975, HDB BIOCH MOL BIOL N, V1, P596; Feng XR, 2006, GENE, V371, P68, DOI 10.1016/j.gene.2005.11.006; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gagnon KT, 2010, BIOCHEMISTRY-US, V49, P10166, DOI 10.1021/bi101208k; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; HENDRIKS L, 1992, NAT GENET, V1, P218, DOI 10.1038/ng0692-218; Hu JX, 2012, NUCLEIC ACIDS RES, V40, P11270, DOI 10.1093/nar/gks907; Hu JX, 2009, NAT BIOTECHNOL, V27, P478, DOI 10.1038/nbt.1539; Kierzek E, 2005, NUCLEIC ACIDS RES, V33, P5082, DOI 10.1093/nar/gki789; Kierzek E, 2003, NUCLEIC ACIDS RES, V31, P4461, DOI 10.1093/nar/gkg632; Kierzek E, 2014, NUCLEIC ACIDS RES, V42, P3492, DOI 10.1093/nar/gkt1330; Kierzek R, 1999, BIOCHEMISTRY-US, V38, P14214, DOI 10.1021/bi991186l; Kurreck J, 2002, NUCLEIC ACIDS RES, V30, P1911, DOI 10.1093/nar/30.9.1911; Lima WF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101752; Lynch M, 2010, TRENDS GENET, V26, P345, DOI 10.1016/j.tig.2010.05.003; MCBRIDE LJ, 1983, TETRAHEDRON LETT, V24, P245, DOI 10.1016/S0040-4039(00)81376-3; McDowell JA, 1996, BIOCHEMISTRY-US, V35, P14077, DOI 10.1021/bi9615710; Miller VM, 2004, NUCLEIC ACIDS RES, V32, P661, DOI 10.1093/nar/gkh208; Miller VM, 2003, P NATL ACAD SCI USA, V100, P7195, DOI 10.1073/pnas.1231012100; MONIA BP, 1993, J BIOL CHEM, V268, P14514; Nakano S, 2014, CHEM REV, V114, P2733, DOI 10.1021/cr400113m; Ohnishi Yusuke, 2006, J RNAi Gene Silencing, V2, P154; Ohnishi Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002248; Ostergaard ME, 2013, NUCLEIC ACIDS RES, V41, P9634, DOI 10.1093/nar/gkt725; Pan WH, 2006, J CELL BIOCHEM, V98, P14, DOI 10.1002/jcb.20790; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; SANTALUCIA J, 1991, BIOCHEMISTRY-US, V30, P8242, DOI 10.1021/bi00247a021; SANTALUCIA J, 1991, J AM CHEM SOC, V113, P4313, DOI 10.1021/ja00011a039; Schwarz DS, 2006, PLOS GENET, V2, P1307, DOI 10.1371/journal.pgen.0020140; Sierant M, 2011, INT J ALZHEIMERS DIS, V2011, DOI DOI 10.4061/2011/809218; Singh NN, 2009, RNA BIOL, V6, P341, DOI 10.4161/rna.6.3.8723; Skotte NH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107434; Smith RA, 2006, J CLIN INVEST, V116, P2290, DOI 10.1172/JCI25424; STEPHENSON ML, 1978, P NATL ACAD SCI USA, V75, P285, DOI 10.1073/pnas.75.1.285; STULL RA, 1995, PHARM RES-DORDR, V12, P465, DOI 10.1023/A:1016281324761; Sugimoto N, 2000, BIOCHEMISTRY-US, V39, P11270, DOI 10.1021/bi000819p; Sugimoto N, 2014, INT REV CEL MOL BIO, V307, P205, DOI 10.1016/B978-0-12-800046-5.00008-4; Turner D. H, 2000, NUCL ACIDS STRUCTURE, P259; Vickers TA, 2000, NUCLEIC ACIDS RES, V28, P1340, DOI 10.1093/nar/28.6.1340; Watkins NE, 2011, NUCLEIC ACIDS RES, V39, P1894, DOI 10.1093/nar/gkq905; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425; Xia XG, 2006, NEUROBIOL DIS, V23, P578, DOI 10.1016/j.nbd.2006.04.019; Yazbeck DR, 2002, NUCLEIC ACIDS RES, V30, P3015, DOI 10.1093/nar/gkf429; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhang Y, 2009, J NEUROCHEM, V108, P82, DOI 10.1111/j.1471-4159.2008.05734.x	61	10	10	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142139	10.1371/journal.pone.0142139	http://dx.doi.org/10.1371/journal.pone.0142139			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544037	gold, Green Published			2022-12-26	WOS:000364398700085
J	Min, HK; Kim, SM; Baek, SY; Woo, JW; Park, JS; Cho, ML; Lee, J; Kwok, SK; Kim, SW; Park, SH				Min, Hong Ki; Kim, Sung-Min; Baek, Seung-Ye; Woo, Jung-Won; Park, Jin-Sil; Cho, Mi-La; Lee, Jennifer; Kwok, Seung-Ki; Kim, Sae Woong; Park, Sung-Hwan			Anthocyanin Extracted from Black Soybean Seed Coats Prevents Autoimmune Arthritis by Suppressing the Development of Th17 Cells and Synthesis of Proinflammatory Cytokines by Such Cells, via Inhibition of NF-kappa B	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; OXIDATIVE STRESS; DOUBLE-BLIND; METHOTREXATE; INFLAMMATION; MULTICENTER; COMBINATION; ACTIVATION; MECHANISM; DISTINCT	Introduction Oxidative stress plays a role in the pathogenesis of rheumatoid arthritis (RA). Anthocyanin is a plant antioxidant. We investigated the therapeutic effects of anthocyanin extracted from black soybean seed coats (AEBS) in a murine model of collagen-induced arthritis (CIA) and human peripheral blood mononuclear cells (PBMCs) and explored possible mechanisms by which AEBS might exert anti-arthritic effects. Material and Methods CIA was induced in DBA/1J mice. Cytokine levels were measured via enzyme-linked immuno-sorbent assays. Joints were assessed in terms of arthritis incidence, clinical arthritis scores, and histological features. The extent of oxidative stress in affected joints was determined by measuring the levels of nitrotyrosine and inducible nitric oxide synthase. NF-kappa B activity was assayed by measuring the ratio of phosphorylated I kappa B to total I kappa B via Western blotting. Th17 cells were stained with antibodies against CD4, IL-17, and STAT3. Osteoclast formation was assessed via TRAP staining and measurement of osteoclast-specific mRNA levels. Results In the CIA model, AEBS decreased the incidence of arthritis, histological inflammation, cartilage scores, and oxidative stress. AEBS reduced the levels of proinflammatory cytokines in affected joints of CIA mice and suppressed NF-kappa B signaling. AEBS decreased Th17 cell numbers in spleen of CIA mice. Additionally, AEBS repressed differentiation of Th17 cells and expression of Th17-associated genes in vitro, in both splenocytes of naive DBA/1J mice and human PBMCs. In vitro, the numbers of both human and mouse tartrate-resistant acid phosphatase(+) (TRAP) multinucleated cells fell, in a dose-dependent manner, upon addition of AEBS. Conclusions The anti-arthritic effects of AEBS were associated with decreases in Th17 cell numbers, and the levels of proinflammatory cytokines synthesized by such cells, mediated via suppression of NF-kappa B signaling. Additionally, AEBS suppressed osteoclastogenesis and reduced oxidative stress levels.	[Min, Hong Ki; Kim, Sung-Min; Baek, Seung-Ye; Park, Jin-Sil; Cho, Mi-La; Lee, Jennifer; Kwok, Seung-Ki; Park, Sung-Hwan] Catholic Univ Korea, Catholic Res Inst Med Sci, Rheumatism Res Ctr, Seoul, South Korea; [Min, Hong Ki; Lee, Jennifer; Kwok, Seung-Ki; Park, Sung-Hwan] Catholic Univ Korea, Sch Med, Dept Internal Med, Div Rheumatol, Seoul, South Korea; [Woo, Jung-Won] Genexine Inc, Off Clin Dev, Songnam, Gyeonggi Do, South Korea; [Kim, Sae Woong] Catholic Univ Korea, Coll Med, Catholic Integrat Med Res Inst, Seoul, South Korea; [Kim, Sae Woong] Catholic Univ Korea, Coll Med, Dept Urol, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Catholic University of Korea	Park, SH (corresponding author), Catholic Univ Korea, Catholic Res Inst Med Sci, Rheumatism Res Ctr, Seoul, South Korea.	rapark@catholic.ac.kr	Min, Hong Ki/AHE-4068-2022	Min, Hong Ki/0000-0003-1147-1046	Ministry of Health & Welfare, Republic of Korea (Korean Health Technology RD Project) [HI13C0016]; Ministry of Education, Science and Technology, Republic of Korea (Basic Science Research Program through National Research Foundation of Korea [NRF]) [NRF-2013R1A2A2A01007720]; Genexine Inc.	Ministry of Health & Welfare, Republic of Korea (Korean Health Technology RD Project); Ministry of Education, Science and Technology, Republic of Korea (Basic Science Research Program through National Research Foundation of Korea [NRF]); Genexine Inc.	This study was supported by the Ministry of Health & Welfare, Republic of Korea (Korean Health Technology R&D Project grant HI13C0016), and by the Ministry of Education, Science and Technology, Republic of Korea (Basic Science Research Program through the National Research Foundation of Korea [NRF], NRF-2013R1A2A2A01007720). Genexine Inc. provided support in the form of salaries for author JWW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Breedveld FC, 2006, ARTHRITIS RHEUM-US, V54, P26, DOI 10.1002/art.21519; Chandel NS, 2000, J IMMUNOL, V165, P1013, DOI 10.4049/jimmunol.165.2.1013; Choung MG, 2001, J AGR FOOD CHEM, V49, P5848, DOI 10.1021/jf010550w; Cohen SB, 2006, ARTHRITIS RHEUM-US, V54, P2793, DOI 10.1002/art.22025; Decendit A, 2013, BIOCHEM PHARMACOL, V86, P1461, DOI 10.1016/j.bcp.2013.06.010; Finckh A, 2006, ARTHRIT RHEUM-ARTHR, V55, P864, DOI 10.1002/art.22353; Genovese MC, 2005, NEW ENGL J MED, V353, P1114, DOI 10.1056/NEJMoa050524; Gravallese EM, 2002, ANN RHEUM DIS, V61, P84, DOI 10.1136/ard.61.suppl_2.ii84; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hayes MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106955; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jacobs MD, 1998, CELL, V95, P749, DOI 10.1016/S0092-8674(00)81698-0; Klareskog L, 2004, LANCET, V363, P675, DOI 10.1016/S0140-6736(04)15640-7; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Noack M, 2014, AUTOIMMUN REV, V13, P668, DOI 10.1016/j.autrev.2013.12.004; O'Gradaigh D, 2004, ANN RHEUM DIS, V63, P354, DOI 10.1136/ard.2003.008458; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Peck A, 2009, CLIN IMMUNOL, V132, P295, DOI 10.1016/j.clim.2009.03.522; Ruan QG, 2012, ADV EXP MED BIOL, V946, P207, DOI 10.1007/978-1-4614-0106-3_12; Singh S, 2010, FREE RADICAL RES, V44, P1267, DOI 10.3109/10715762.2010.507670; Sohn DW, 2014, UROLOGY, DOI [10.1016/j.urology.2014.06.026, DOI 10.1016/J.UR0L0GY.2014.06.026]; SPECTOR TD, 1990, RHEUM DIS CLIN N AM, V16, P513; Sun SC, 2013, TRENDS IMMUNOL, V34, P282, DOI 10.1016/j.it.2013.01.004; Taverniti V, 2014, J AGR FOOD CHEM, V62, P8346, DOI 10.1021/jf502180j; van den Berg WB, 2009, NAT REV RHEUMATOL, V5, P549, DOI 10.1038/nrrheum.2009.179; Vasanthi P, 2009, INT J RHEUM DIS, V12, P29, DOI 10.1111/j.1756-185X.2009.01375.x; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; WINYARD PG, 1987, LANCET, V1, P69; Wruck CJ, 2011, ANN RHEUM DIS, V70, P844, DOI 10.1136/ard.2010.132720; Yoon BI, 2018, CHIN J INTEGR MED, V24, P621, DOI 10.1007/s11655-013-1547-y	35	35	37	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0138201	10.1371/journal.pone.0138201	http://dx.doi.org/10.1371/journal.pone.0138201			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544846	Green Submitted, gold, Green Published			2022-12-26	WOS:000364398700001
J	Pan, CW; Liu, H; Sun, HP; Xu, Y				Pan, Chen-Wei; Liu, Hu; Sun, Hong-Peng; Xu, Yong			Increased Difficulties in Managing Stairs in Visually Impaired Older Adults: A Community-Based Survey	PLOS ONE			English	Article							EYE DISEASES; INDIAN POPULATION; VISION IMPAIRMENT; BLINDNESS; PREVALENCE; CATARACT; FALLS; EPIDEMIOLOGY; FRACTURES; PEOPLE	Purpose Managing stairs is a challenging aspect of daily activities of living for older people. We assessed whether older adults with visual impairment (VI) have greater difficulties of managing stairs in daily lives. Methods The study was designed as a community-based cross-sectional study based on a Chinese cohort aged 60 years and older in rural China. Visual acuity (VA) was measured in both eyes using a retro-illuminated Snellen chart with tumbling-E optotypes. VI (including blindness) was defined as presenting VA of worse than 20/60 in either eye. Having any difficulties in managing stairs was self-reported based on a question drawn from the Barthel Index. Information on participants' socioeconomic status, lifestyle-related factors, diseases histories and medication intake was collected using a questionnaire. Results The Barthel Index, Activities of Daily Living questionnaire was completed by 4597 (99.7%) participants including 2218 men and 2379 women. The age of the participants ranged from 60 to 93 years with a mean of 67.6 +/- 6.3 years. In age and gender adjusted models, adults with VI had a higher likelihood of having difficulties in managing stairs (odds ratio [OR] = 2.7; 95% confidence interval [CI] 2.0, 3.7) compared with those without. The association of VI with the likelihood of having difficulties in managing stairs was stronger in older adults who lived alone (OR = 3.2; 95% CI 1.8, 4.5) compared with those who lived with other family members (OR = 2.0; 95% CI 1.3, 4.3). Compared with hypertension, diabetes, obesity and cognitive dysfunction, VI had the greatest impact on people's abilities of managing stairs. VI was associated with an increased likelihood of having difficulties in managing stairs, especially in those who lived alone. However, whether the finding could be extrapolated to other populations warrants further studies as different environmental exposures such as illumination and types of stairs may alter the association observed in this study. Conclusion VI was associated with an increased likelihood of having difficulties in managing stairs, especially in those who lived alone. However, whether the finding could be extrapolated to other populations warrants further studies as different environmental exposures such as illumination and types of stairs may alter the association observed in this study.	[Pan, Chen-Wei; Sun, Hong-Peng; Xu, Yong] Soochow Univ, Coll Med, Sch Publ Hlth, Jiangsu Key Lab Prevent & Translat Med Geriatr Di, Suzhou, Peoples R China; [Liu, Hu] Nanjing Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Nanjing, Jiangsu, Peoples R China	Soochow University - China; Nanjing Medical University	Xu, Y (corresponding author), Soochow Univ, Coll Med, Sch Publ Hlth, Jiangsu Key Lab Prevent & Translat Med Geriatr Di, Suzhou, Peoples R China.	childhealth@suda.edu.cn	Pan, Chen-Wei/L-7174-2019	Pan, Chen-Wei/0000-0003-3362-4613; Liu, Hu/0000-0002-3952-4165				Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Bourne R, 2012, ARCH OPHTHALMOL-CHIC, V130, P645, DOI 10.1001/archophthalmol.2012.1032; Brundle C, 2015, HEALTH EXPECT, V18, P2021, DOI 10.1111/hex.12355; Cheng JW, 2013, OPHTHALMIC RES, V49, P1, DOI 10.1159/000327144; Collin C, 1988, Int Disabil Stud, V10, P61; Cugati S, 2007, ARCH OPHTHALMOL-CHIC, V125, P917, DOI 10.1001/archopht.125.7.917; Duerksen R, 2003, OPHTHAL EPIDEMIOL, V10, P349, DOI 10.1076/opep.10.5.349.17326; Dunzhu S, 2003, BRIT J OPHTHALMOL, V87, P1443, DOI 10.1136/bjo.87.12.1443; Frick KD, 2003, AM J OPHTHALMOL, V135, P471, DOI 10.1016/S0002-9394(02)02110-4; Hairi NN, 2013, PREV MED, V56, P8, DOI 10.1016/j.ypmed.2012.10.016; Hong T, 2014, INVEST OPHTH VIS SCI, V55, P7589, DOI 10.1167/iovs.14-14262; Hyman L, 2001, OPHTHALMOLOGY, V108, P1751, DOI 10.1016/S0161-6420(01)00590-5; Kramer H, 2004, AM J HYPERTENS, V17, P963, DOI 10.1016/j.amjhyper.2004.06.001; Kuang TM, 2008, J CHIN MED ASSOC, V71, P467, DOI 10.1016/S1726-4901(08)70150-3; Lamoreux EL, 2008, INVEST OPHTH VIS SCI, V49, P528, DOI 10.1167/iovs.07-1036; Loriaut P, 2014, OPHTHALMIC RES, V52, P212, DOI 10.1159/000362881; McLaughlin D, 2011, J AM GERIATR SOC, V59, P1560, DOI 10.1111/j.1532-5415.2011.03530.x; Murthy GVS, 2001, OPHTHALMOLOGY, V108, P679, DOI 10.1016/S0161-6420(00)00579-0; Oh-Park M, 2011, ARCH PHYS MED REHAB, V92, P2006, DOI 10.1016/j.apmr.2011.07.193; Ong SY, 2012, ARCH OPHTHALMOL-CHIC, V130, P895, DOI 10.1001/archophthalmol.2012.152; Ong SY, 2013, INVEST OPHTH VIS SCI, V54, P799, DOI 10.1167/iovs.12-10460; Song E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112054; Swenor BK, 2015, J AM GERIATR SOC, V63, P46, DOI 10.1111/jgs.13183; Thulasiraj RD, 2003, OPHTHALMOLOGY, V110, P1491, DOI 10.1016/S0161-6420(03)00565-7; Varma R, 2004, OPHTHALMOLOGY, V111, P1132, DOI 10.1016/j.ophtha.2004.02.002; Wade D T, 1988, Int Disabil Stud, V10, P64; Wang XZ, 2014, OPHTHALMOLOGY, V121, P1837, DOI 10.1016/j.ophtha.2014.03.017; Wong TY, 2006, BRIT J OPHTHALMOL, V90, P506, DOI 10.1136/bjo.2005.083733; Wong TY, 2006, AM J OPHTHALMOL, V141, P446, DOI 10.1016/j.ajo.2005.08.063; Zhao JL, 2010, OPHTHALMOLOGY, V117, P409, DOI 10.1016/j.ophtha.2009.11.023; Zheng DD, 2016, AGING MENT HEALTH, V20, P295, DOI 10.1080/13607863.2015.1008985; Zheng YF, 2011, OPHTHALMOLOGY, V118, P1798, DOI 10.1016/j.ophtha.2011.02.014; Zou Y, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008417	33	7	7	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142516	10.1371/journal.pone.0142516	http://dx.doi.org/10.1371/journal.pone.0142516			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545238	Green Submitted, Green Published, gold			2022-12-26	WOS:000364398700148
J	Aouinti, S; Malouche, D; Giudicelli, V; Kossida, S; Lefranc, MP				Aouinti, Safa; Malouche, Dhafer; Giudicelli, Veronique; Kossida, Sofia; Lefranc, Marie-Paule			IMGT/HighV-QUEST Statistical Significance of IMGT Clonotype (AA) Diversity per Gene for Standardized Comparisons of Next Generation Sequencing Immunoprofiles of Immunoglobulins and T Cell Receptors	PLOS ONE			English	Article							FALSE DISCOVERY RATE; V-J; MULTIPLE; CONFIDENCE; BONFERRONI; ONTOLOGY	The adaptive immune responses of humans and of other jawed vertebrate species (gnasthostomata) are characterized by the B and T cells and their specific antigen receptors, the immunoglobulins (IG) or antibodies and the T cell receptors (TR) (up to 2.10(12) different IG and TR per individual). IMGT, the international ImMunoGeneTics information system (http://www.imgt.org), was created in 1989 by Marie-Paule Lefranc (Montpellier University and CNRS) to manage the huge and complex diversity of these antigen receptors. IMGT built on IMGT-ONTOLOGY concepts of identification (keywords), description (labels), classification (gene and allele nomenclature) and numerotation (IMGT unique numbering), is at the origin of immunoinformatics, a science at the interface between immunogenetics and bioinformatics. IMGT/HighV-QUEST, the first web portal, and so far the only one, for the next generation sequencing (NGS) analysis of IG and TR, is the paradigm for immune repertoire standardized outputs and immunoprofiles of the adaptive immune responses. It provides the identification of the variable (V), diversity (D) and joining (J) genes and alleles, analysis of the V-(D)-J junction and complementarity determining region 3 (CDR3) and the characterization of the 'IMGT clonotype (AA)' (AA for amino acid) diversity and expression. IMGT/HighV-QUEST compares outputs of different batches, up to one million nucleotide sequencesfor the statistical module. These high throughput IG and TR repertoire immunoprofiles are of prime importance in vaccination, cancer, infectious diseases, autoimmunity and lymphoproliferative disorders, however their comparative statistical analysis still remains a challenge. We present a standardized statistical procedure to analyze IMGT/HighV-QUEST outputs for the evaluation of the significance of the IMGT clonotype (AA) diversity differences in proportions, per gene of a given group, between NGS IG and TR	[Aouinti, Safa; Giudicelli, Veronique; Kossida, Sofia; Lefranc, Marie-Paule] Univ Montpellier, Inst Genet Humaine IGH, LIGM,Int ImMunoGeneT Informat Syst, IMGT,UPR CNRS 1142, F-34059 Montpellier 5, France; [Aouinti, Safa; Malouche, Dhafer] Univ Carthage, Higher Sch Stat & Informat Anal, Tunis, Tunisia; [Aouinti, Safa; Malouche, Dhafer] Univ Tunis El Manar, Natl Sch Engn Tunis, Informat Technol & Commun Dept, Lab U2S, Tunis, Tunisia	Ecole des Ponts ParisTech; Universite de Montpellier; Universite de Carthage; Universite de Tunis-El-Manar; Ecole Nationale d'Ingenieurs de Tunis (ENIT)	Kossida, S (corresponding author), Univ Montpellier, Inst Genet Humaine IGH, LIGM,Int ImMunoGeneT Informat Syst, IMGT,UPR CNRS 1142, F-34059 Montpellier 5, France.	sofia.kossida@igh.cnrs.fr; marie-paule.lefranc@igh.cnrs.fr	Kossida, Sofia/ABG-3526-2020	Giudicelli, Veronique/0000-0002-2258-468X; Malouche, Dhafer/0000-0002-0494-7141	IMGT; international ImMunoGeneTics information system (Montpellier University); international ImMunoGeneTics information system (CNRS)	IMGT; international ImMunoGeneTics information system (Montpellier University); international ImMunoGeneTics information system (CNRS)	The authors received no specific funding for this work. Authors Safa Aouinti, Veronique Giudicelli, Sofia Kossida and Marie-Paule Lefranc are affiliated to IMGT, the international ImMunoGeneTics information system (Montpellier University and CNRS). IMGT, the international ImMunoGeneTics information system (Montpellier University and CNRS) provided support in the form of salaries for authors SA, VG, SK and M-PL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Alamyar E., 2012, IMMUNOME RES, V8, P1, DOI [10.4172/1745-7580.1000056, DOI 10.4172/1745-7580.1000056]; Alamyar Eltaf, 2012, Methods Mol Biol, V882, P569, DOI 10.1007/978-1-61779-842-9_32; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonferroni C.E, 1936, PUBBL R 1 SUPER SCI, V8, P3; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; De Muth JE, 2006, PHARM ED SERIES; Dudoit S, 2003, STAT SCI, V18, P71, DOI 10.1214/ss/1056397487; Dudoit S, 2008, SPRINGER SER STAT, P1; Freeman JD, 2009, GENOME RES, V19, P1817, DOI 10.1101/gr.092924.109; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Giudicelli V, 2005, NEW RESEARCH ON IMMUNOLOGY, P77; Giudicelli V, 2004, NUCLEIC ACIDS RES, V32, pW435, DOI 10.1093/nar/gkh412; Giudicelli V., 2009, IMMUNOGLOBULIN GENE, P33; Giudicelli V, 2015, AUTOIMMUN INFEC DIS, V1; Giudicelli V., 2003, P EUR C COMP BIOL EC, P103; Giudicelli V, 2005, STUD HEALTH TECHNOL, V116, P3; Giudicelli Veronique, 2012, Frontiers in Genetics, V3, P79, DOI 10.3389/fgene.2012.00079; Giudicelli Veronique, 2011, Cold Spring Harb Protoc, V2011, P695, DOI 10.1101/pdb.prot5633; Giudicelli Veronique, 2011, Cold Spring Harb Protoc, V2011, P716, DOI 10.1101/pdb.prot5634; Giudicelli W, 2005, NUCLEIC ACIDS RES, V33, pD256, DOI 10.1093/nar/gki010; Goeman JJ, 2012, STAT MED, V00, P1; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; HOLM S, 1979, SCAND J STAT, V6, P65; Korn EL, 2004, J STAT PLAN INFER, V124, P379, DOI 10.1016/S0378-3758(03)00211-8; LeBlanc D.C., 2004, STAT CONCEPTS APPL S; Lefranc M.-P., 2000, CURRENT PROTOCOLS IM, pA1O1; Lefranc M-P, 2000, CURRENT PROTOCOLS IM; Lefranc M-P, 2001, IMMUNOGLOBULIN FACTS, P1; Lefranc M-P, 2001, T CELL RECEPTOR FACT, P1; Lefranc MP, 2015, NUCLEIC ACIDS RES, V43, pD413, DOI 10.1093/nar/gku1056; Lefranc MP, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00022; Li S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3333; Monod MY, 2004, BIOINFORMATICS, V20, P379, DOI 10.1093/bioinformatics/bth945; Narum SR, 2006, CONSERV GENET, V7, P783, DOI 10.1007/s10592-005-9056-y; Pires AM, 2008, REVSTAT-STAT J, V6, P165; Pollard K. S., 2005, BIOINFORMATICS COMPU, DOI DOI 10.1007/0-387-29362-0_23; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Tukey J.W., 1953, PROBLEM MULTIP UNPUB; Zhang HW, 2010, REV COLOMB ESTAD, V33, P63; Zhong S, 2004, 2004 IEEE COMPUTATIONAL SYSTEMS BIOINFORMATICS CONFERENCE, PROCEEDINGS, P425	41	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142353	10.1371/journal.pone.0142353	http://dx.doi.org/10.1371/journal.pone.0142353			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540440	Green Published, gold, Green Submitted			2022-12-26	WOS:000364303800088
J	Campos, C; Cardoso, H; Nogales, A; Svensson, J; Lopez-Raez, JA; Pozo, MJ; Nobre, T; Schneider, C; Arnholdt-Schmitt, B				Campos, Catarina; Cardoso, Helia; Nogales, Amaia; Svensson, Jan; Lopez-Raez, Juan Antonio; Jose Pozo, Maria; Nobre, Tania; Schneider, Carolin; Arnholdt-Schmitt, Birgit			Intra and Inter-Spore Variability in Rhizophagus irregularis AOX Gene	PLOS ONE			English	Article							MITOCHONDRIAL ALTERNATIVE OXIDASE; ARBUSCULAR MYCORRHIZAL FUNGI; EXPRESSION; ACID; RESPIRATION; EVOLUTION; FUSION; ACTIVATION; SELECTION; INSIGHTS	Arbuscular mycorrhizal fungi (AMF) are root-inhabiting fungi that form mutualistic symbioses with their host plants. AMF symbiosis improves nutrient uptake and buffers the plant against a diversity of stresses. Rhizophagus irregularis is one of the most widespread AMF species in the world, and its application in agricultural systems for yield improvement has increased over the last years. Still, from the inoculum production perspective, a lack of consistency of inoculum quality is referred to, which partially may be due to a high genetic variability of the fungus. The alternative oxidase (AOX) is an enzyme of the alternative respiratory chain already described in different taxa, including various fungi, which decreases the damage caused by oxidative stress. Nevertheless, virtually nothing is known on the involvement of AMF AOX on symbiosis establishment, as well on the existence of AOX variability that could affect AMF effectiveness and consequently plant performance. Here, we report the isolation and characterisation of the AOX gene of R. irregularis (RiAOX), and show that it is highly expressed during early phases of the symbiosis with plant roots. Phylogenetic analysis clustered RiAOX sequence with ancient fungi, and multiple sequence alignment revealed the lack of several regulatory motifs which are present in plant AOX. The analysis of RiAOX polymorphisms in single spores of three different isolates showed a reduced variability in one spore relatively to a group of spores. A high number of polymorphisms occurred in introns; nevertheless, some putative amino acid changes resulting from non-synonymous variants were found, offering a basis for selective pressure to occur within the populations. Given the AOX relatedness with stress responses, differences in gene variants amongst R. irregularis isolates are likely to be related with its origin and environmental constraints and might have a potential impact on inoculum production.	[Campos, Catarina; Cardoso, Helia; Nogales, Amaia; Nobre, Tania; Arnholdt-Schmitt, Birgit] Univ Evora, IIFA Inst Formacao & Invest Avancada, ICAAM, EU Marie Curie Chair, Evora, Portugal; [Svensson, Jan] Nord Genet Resource Ctr, Alnarp, Sweden; [Lopez-Raez, Juan Antonio; Jose Pozo, Maria] EEZ CSIC, Dept Soil Microbiol & Symbiot Syst, Granada, Spain; [Schneider, Carolin] Inoq GmbH, Solkau, Schnega, Germany	University of Evora; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ)	Arnholdt-Schmitt, B (corresponding author), Univ Evora, IIFA Inst Formacao & Invest Avancada, ICAAM, EU Marie Curie Chair, Evora, Portugal.	eu_chair@uevora.pt	Campos, Catarina/O-7518-2018; López-Ráez, Juan A./H-1468-2015; Pozo, Maria J./K-7775-2014; Nobre, Tania/C-9925-2012; Cardoso, Hélia/O-7562-2018; Nogales, Amaia/L-9765-2016; svensson, jan/D-1815-2009	Campos, Catarina/0000-0002-5347-1338; López-Ráez, Juan A./0000-0001-7973-9251; Pozo, Maria J./0000-0003-2780-9793; Nobre, Tania/0000-0002-1855-7451; Cardoso, Hélia/0000-0003-3688-607X; Nogales, Amaia/0000-0001-8260-6580; svensson, jan/0000-0003-2913-2990	European Commission; Spanish National R&D Plant of the Ministry of Science and Innovation (MICINN) [AGL2012-39923]; Marie Curie fellowship [321725]; Portuguese Foundation for Science and Technology - FCT [SFRH/BCC/52187/2013]; program POPH-Operational Program for Human Potential-and Fundo Europeu de Desenvolvimento Regional (FEDER) funds through the Operational Program for Competitiveness Factors-COMPETE; national funds through FCT [PEst-C/AGR/UI0115/2011, PEst-OE/AGR/UI0115/2014]	European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish National R&D Plant of the Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)); Marie Curie fellowship(European Commission); Portuguese Foundation for Science and Technology - FCT(Portuguese Foundation for Science and Technology); program POPH-Operational Program for Human Potential-and Fundo Europeu de Desenvolvimento Regional (FEDER) funds through the Operational Program for Competitiveness Factors-COMPETE; national funds through FCT(Portuguese Foundation for Science and Technology)	This work was supported by the European Commission through the project AGRO-AMF-AOX within the program Industry-Academia Partnerships and Pathways (IAPP, FP7). Still in the frame of the AGRO-AMF-AOX project, JS further acknowledges his recruitment, and CC, HC, AN, CS and BAS appreciate the further support given in the form of a secondment. Inoq GmbH provided support in the form of salary for CS, but did not have any additional role in the study design, data collection and analyses, decision to publish, or preparation of the manuscript. The specific role of CS is articulated in the 'author contributions' section. Part of this work was also supported by grant AGL2012-39923 from the Spanish National R&D Plant of the Ministry of Science and Innovation (MICINN). TN was supported by a Marie Curie fellowship (FP7-PEOPLE-2012-CIG Project Reference 321725) and by the Portuguese Foundation for Science and Technology - FCT (SFRH/BCC/52187/2013). The authors further thank the program POPH-Operational Program for Human Potential-and Fundo Europeu de Desenvolvimento Regional (FEDER) funds through the Operational Program for Competitiveness Factors-COMPETE, and national funds through FCT under the strategic project PEst-C/AGR/UI0115/2011 and PEst-OE/AGR/UI0115/2014.	Akhter S, 2003, INFECT IMMUN, V71, P5794, DOI 10.1128/IAI.71.10.5794-5802.2003; Arnholdt-Schmitt B, 2006, TRENDS PLANT SCI, V11, P281, DOI 10.1016/j.tplants.2006.05.001; Arnholdt-Schmitt B, 2016, BRIEF FUNCT GENOMICS, V15, P10, DOI 10.1093/bfgp/elv008; Arnholdt-Schmitt B, 2016, BRIEF FUNCT GENOMICS, V15, P16, DOI 10.1093/bfgp/elu049; Baar J, 2008, MYCORRHIZA, P361, DOI DOI 10.1007/978-3-540-78826-3_18; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Besserer A, 2009, PLANT SIGNAL BEHAV, V4, P75, DOI 10.4161/psb.4.1.7419; Bever JD, 2005, NATURE, V433, pE3, DOI 10.1038/nature03294; Boon E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083301; Campbell SE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003676; Camprubi A, 1996, HORTSCIENCE, V31, P366, DOI 10.21273/HORTSCI.31.3.366; Cardenas-Flores A, 2010, MYCORRHIZA, V20, P415, DOI 10.1007/s00572-009-0295-5; Cardoso H. G., 2013, DIAGNOSTICS PLANT BR, V21, P467, DOI DOI 10.1007/978-94-007-5687-8_21; Cardoso HG, 2015, ALTERNATIVE RESPIRATORY PATHWAYS IN HIGHER PLANTS, P241; CHABOT S, 1992, MYCOLOGIA, V84, P315, DOI 10.2307/3760183; Colard A, 2011, APPL ENVIRON MICROB, V77, P6510, DOI 10.1128/AEM.05696-11; Considine MJ, 2002, PLANT PHYSIOL, V129, P949, DOI 10.1104/pp.004150; Costa JH, 2014, MITOCHONDRION, V19, P172, DOI 10.1016/j.mito.2014.04.007; Crichton PG, 2005, FEBS LETT, V579, P331, DOI 10.1016/j.febslet.2004.10.107; Croll D, 2009, NEW PHYTOL, V181, P924, DOI 10.1111/j.1469-8137.2008.02726.x; Croll D, 2012, GENOME BIOL EVOL, V4, P1148, DOI 10.1093/gbe/evs091; Cuomo CA, 2012, GENOME RES, V22, P2478, DOI 10.1101/gr.142802.112; Dolgikh VV, 2011, EUKARYOT CELL, V10, P588, DOI 10.1128/EC.00283-10; Ebersberger I, 2012, MOL BIOL EVOL, V29, P1319, DOI 10.1093/molbev/msr285; Finnegan PM, 2003, FEBS LETT, V555, P425, DOI 10.1016/S0014-5793(03)01309-7; Fung RWM, 2006, J PLANT PHYSIOL, V163, P1049, DOI 10.1016/j.jplph.2005.11.003; Garg N, 2011, SUSTAINABLE AGRICULTURE, VOL 2, P907, DOI 10.1007/978-94-007-0394-0_40; Harrison MJ, 2005, ANNU REV MICROBIOL, V59, P19, DOI 10.1146/annurev.micro.58.030603.123749; Helgason T, 2009, J EXP BOT, V60, P2465, DOI 10.1093/jxb/erp144; HEWITT E. J., 1952; Hildebrandt U, 1999, J PLANT PHYSIOL, V154, P709, DOI 10.1016/S0176-1617(99)80249-1; Hoeksema JD, 2010, ECOL LETT, V13, P394, DOI 10.1111/j.1461-0248.2009.01430.x; Holtzapffel RC, 2003, BBA-BIOENERGETICS, V1606, P153, DOI 10.1016/S0005-2728(03)00112-9; Irimia M, 2008, TRENDS GENET, V24, P378, DOI 10.1016/j.tig.2008.05.007; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; James TY, 2013, CURR BIOL, V23, P1548, DOI 10.1016/j.cub.2013.06.057; Joseph-Horne T, 2001, BBA-BIOENERGETICS, V1504, P179, DOI 10.1016/S0005-2728(00)00251-6; KARLIN S, 1993, P NATL ACAD SCI USA, V90, P5873, DOI 10.1073/pnas.90.12.5873; Keeling PJ, 2004, EUKARYOT CELL, V3, P1363, DOI 10.1128/EC.3.6.1363-1369.2004; Koch AM, 2006, ECOL LETT, V9, P103, DOI 10.1111/j.1461-0248.2005.00853.x; Kruger M, 2009, NEW PHYTOL, V183, P212, DOI 10.1111/j.1469-8137.2009.02835.x; Kuhn G, 2001, NATURE, V414, P745, DOI 10.1038/414745a; Lin K, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004078; Magnani T, 2007, FEMS MICROBIOL LETT, V271, P230, DOI 10.1111/j.1574-6968.2007.00716.x; Marleau J, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-51; Rodriguez JAM, 2010, J PLANT PHYSIOL, V167, P606, DOI 10.1016/j.jplph.2009.11.014; Martins VP, 2011, EUKARYOT CELL, V10, P237, DOI 10.1128/EC.00194-10; McDonald AE, 2008, FUNCT PLANT BIOL, V35, P535, DOI 10.1071/FP08025; McDonald AE, 2009, J EXP BIOL, V212, P2627, DOI 10.1242/jeb.032151; Moore AL, 2013, ANNU REV PLANT BIOL, V64, P637, DOI 10.1146/annurev-arplant-042811-105432; Morin E, 2013, P NATL ACAD SCI USA, V110, P4146, DOI 10.1073/pnas.1300201110; Parenteau J, 2008, MOL BIOL CELL, V19, P1932, DOI 10.1091/mbc.E07-12-1254; Parniske M, 2008, NAT REV MICROBIOL, V6, P763, DOI 10.1038/nrmicro1987; PHILLIPS JM, 1970, T BRIT MYCOL SOC, V55, P158, DOI 10.1016/S0007-1536(70)80110-3; Plaxton WC, 2011, PLANT PHYSIOL, V156, P1006, DOI 10.1104/pp.111.175281; Polidoros AN, 2009, PHYSIOL PLANTARUM, V137, P342, DOI 10.1111/j.1399-3054.2009.01284.x; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Rhoads DM, 1998, J BIOL CHEM, V273, P30750, DOI 10.1074/jbc.273.46.30750; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Stockinger H, 2010, NEW PHYTOL, V187, P461, DOI 10.1111/j.1469-8137.2010.03262.x; Stockinger H, 2009, NEW PHYTOL, V183, P1176, DOI 10.1111/j.1469-8137.2009.02874.x; Tamasloukht M, 2003, PLANT PHYSIOL, V131, P1468, DOI 10.1104/pp.012898; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THEODOROU ME, 1991, PLANT PHYSIOL, V95, P1089, DOI 10.1104/pp.95.4.1089; Thomazella DPT, 2012, NEW PHYTOL, V194, P1025, DOI 10.1111/j.1469-8137.2012.04119.x; Tisserant E, 2013, P NATL ACAD SCI USA, V110, P20117, DOI 10.1073/pnas.1313452110; Torriani SFF, 2011, CURR BIOL, V21, P2017, DOI 10.1016/j.cub.2011.10.041; Trouvelot A, 1986, PHYSIOLOGICAL GENETI, P217, DOI DOI 10.1177/004057368303900411; Umbach AL, 2000, ARCH BIOCHEM BIOPHYS, V378, P234, DOI 10.1006/abbi.2000.1834; Umbach AL, 2002, BBA-BIOENERGETICS, V1554, P118, DOI 10.1016/S0005-2728(02)00219-0; Umbach AL, 1996, J BIOL CHEM, V271, P25019, DOI 10.1074/jbc.271.40.25019; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vanlerberghe GC, 2013, INT J MOL SCI, V14, P6805, DOI 10.3390/ijms14046805; Vicente C, 2008, 1 INT AOX S, P58; Williams BAP, 2002, NATURE, V418, P865, DOI 10.1038/nature00949; Xu T, 2012, J MICROBIOL, V50, P594, DOI 10.1007/s12275-012-2015-7; Yip JYH, 2001, PHYSIOL PLANTARUM, V112, P327, DOI 10.1034/j.1399-3054.2001.1120305.x	78	15	15	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142339	10.1371/journal.pone.0142339	http://dx.doi.org/10.1371/journal.pone.0142339			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540237	Green Submitted, Green Published, gold			2022-12-26	WOS:000364303800085
J	Fujita, A; Kimura, K; Yokoyama, S; Jin, W; Wachino, J; Yamada, K; Suematsu, H; Yamagishi, Y; Mikamo, H; Arakawa, Y				Fujita, Ai; Kimura, Kouji; Yokoyama, Satoru; Jin, Wanchun; Wachino, Jun-ichi; Yamada, Keiko; Suematsu, Hiroyuki; Yamagishi, Yuka; Mikamo, Hiroshige; Arakawa, Yoshichika			Characterization of Piperacillin/Tazobactam-Resistant Klebsiella oxytoca Recovered from a Nosocomial Outbreak	PLoS One			English	Article							SPECTRUM BETA-LACTAMASE; HEMORRHAGIC COLITIS; STRAINS; ENTEROBACTERIACEAE; OVERPRODUCTION; EPIDEMIOLOGY; TAZOBACTAM; PNEUMONIAE; PROMOTERS; HOSPITALS	We characterized 12 clinical isolates of Klebsiella oxytoca with the extended-spectrum beta-lactamase (ESBL) phenotype (high minimum inhibitory concentration [MIC] values of ceftriaxone) recovered over 9 months at a university hospital in Japan. To determine the clonality of the isolates, we used pulsed-field gel electrophoresis (PFGE), multi-locus sequence typing (MLST), and PCR analyses to detect bla(RBI), which encodes the beta-lactamase RbiA, OXY-2-4 with overproduce-type promoter. Moreover, we performed the isoelectric focusing (IEF) of beta-lactamases, and the determination of the MICs of beta-lactams including piperacillin/tazobactam for 12 clinical isolates and E. coli HB101 with pKOB23, which contains blaRBI, by the agar dilution method. Finally, we performed the initial screening and phenotypic confirmatory tests for ESBLs. Each of the 12 clinical isolates had an identical PFGE pulsotype and MLST sequence type (ST9). All 12 clinical isolates harbored identical blaRBI. The IEF revealed that the clinical isolate produced only one beta-lactamase. E. coli HB101 (pKOB23) and all 12 isolates demonstrated equally resistance to piperacillin/tazobactam (MICs, > 128 mu g/ml). The phenotypic confirmatory test after the initial screening test for ESBLs can discriminate beta-lactamase RbiA-producing K. oxytoca from beta-lactamase CTX-M-producing K. oxytoca. Twelve clinical isolates of K. oxytoca, which were recovered from an outbreak at one university hospital, had identical genotypes and produced beta-lactamase RbiA that conferred resistance to piperacillin/tazobactam. In order to detect K. oxytoca isolates that produce RbiA to promote research concerning beta-lactamase RbiA-producing K. oxytoca, the phenotypic confirmatory test after the initial screening test for ESBLs would be useful.	[Fujita, Ai; Kimura, Kouji; Yokoyama, Satoru; Jin, Wanchun; Wachino, Jun-ichi; Yamada, Keiko; Arakawa, Yoshichika] Nagoya Univ, Grad Sch Med, Dept Bacteriol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Suematsu, Hiroyuki; Yamagishi, Yuka; Mikamo, Hiroshige] Aichi Med Univ, Grad Sch Med, Dept Clin Infect Dis, Nagakute, Aichi 4801195, Japan	Nagoya University; Aichi Medical University	Kimura, K (corresponding author), Nagoya Univ, Grad Sch Med, Dept Bacteriol, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	koujikim@med.nagoya-u.ac.jp	Arakawa, Yoshichika/P-5997-2015; Wachino, Jun-ichi/A-1346-2016; jin, wanchun/B-8463-2016; Kimura, Kouji/C-1847-2015	Yamada, Keiko/0000-0003-4510-0948	Ministry of Health, Labour and Welfare of Japan [H21-Shinkou-Ippan-008, H24-Shinkou-Ippan-010]; Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants H21-Shinkou-Ippan-008 and H24-Shinkou-Ippan-010 from the Ministry of Health, Labour and Welfare of Japan and, in part, by a Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	ARAKAWA Y, 1989, ANTIMICROB AGENTS CH, V33, P63, DOI 10.1128/AAC.33.1.63; CHEN HY, 1993, J ANTIMICROB CHEMOTH, V32, P247, DOI 10.1093/jac/32.2.247; Clinical Laboratory Standards Institute, 2010, M100S20 CLIN LAB S S; Decre D, 2004, J ANTIMICROB CHEMOTH, V54, P881, DOI 10.1093/jac/dkh440; Edelstein M, 2003, ANTIMICROB AGENTS CH, V47, P3724, DOI 10.1128/AAC.47.12.3724-3732.2003; Fevre C, 2005, ANTIMICROB AGENTS CH, V49, P3453, DOI 10.1128/AAC.49.8.3453-3462.2005; Fournier B, 1997, ANTIMICROB AGENTS CH, V41, P1641, DOI 10.1128/AAC.41.8.1641; Fournier B, 1999, ANTIMICROB AGENTS CH, V43, P850, DOI 10.1128/AAC.43.4.850; FOURNIER B, 1994, FEMS MICROBIOL LETT, V116, P31, DOI 10.1016/0378-1097(94)90103-1; FOURNIER B, 1995, ANTIMICROB AGENTS CH, V39, P1365, DOI 10.1128/AAC.39.6.1365; Fournier B, 1996, ANTIMICROB AGENTS CH, V40, P460, DOI 10.1128/AAC.40.2.460; Fournier B, 1996, ANTIMICROB AGENTS CH, V40, P454, DOI 10.1128/AAC.40.2.454; Granier SA, 2003, ANTIMICROB AGENTS CH, V47, P2922, DOI 10.1128/AAC.47.9.2922-2928.2003; Herzog KAT, 2014, J CLIN MICROBIOL, V52, P1607, DOI 10.1128/JCM.03373-13; Hogenauer C, 2006, NEW ENGL J MED, V355, P2418, DOI 10.1056/NEJMoa054765; Hoenigl M, 2012, ANTIMICROB AGENTS CH, V56, P2158, DOI 10.1128/AAC.05440-11; Kimura K, 1996, ANTIMICROB AGENTS CH, V40, P1988, DOI 10.1128/AAC.40.9.1988; Leitner E, 2015, ANTIMICROB AGENTS CH, V59, P714, DOI 10.1128/AAC.04306-14; Li H, 2015, ANTIMICROB AGENTS CH, V59, P1794, DOI 10.1128/AAC.04191-14; LIVERMORE DM, 1995, CLIN MICROBIOL REV, V8, P557, DOI 10.1128/CMR.8.4.557; Livermore DM, 1996, J ANTIMICROB CHEMOTH, V38, P409, DOI 10.1093/jac/38.3.409; Marchese A, 1998, ANTIMICROB AGENTS CH, V42, P464; MATTHEW M, 1976, J GEN MICROBIOL, V94, P55, DOI 10.1099/00221287-94-1-55; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Potz NAC, 2004, J ANTIMICROB CHEMOTH, V53, P545, DOI 10.1093/jac/dkh112; Sirot D, 1998, ANTIMICROB AGENTS CH, V42, P2184, DOI 10.1128/AAC.42.9.2184; SYKES RB, 1982, ANTIMICROB AGENTS CH, V21, P85, DOI 10.1128/AAC.21.1.85; Thomson KS, 2001, ANTIMICROB AGENTS CH, V45, P3548, DOI 10.1128/AAC.45.12.3548-3554.2001; Wu SW, 1999, ANTIMICROB AGENTS CH, V43, P1350, DOI 10.1128/AAC.43.6.1350; Wu SW, 1999, ANTIMICROB AGENTS CH, V43, P1294, DOI 10.1128/AAC.43.5.1294; Yigit H, 2003, ANTIMICROB AGENTS CH, V47, P3881, DOI 10.1128/AAC.47.12.3881-3889.2003; Zarate MS, 2008, J CLIN MICROBIOL, V46, P2099, DOI 10.1128/JCM.00194-08	33	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142366	10.1371/journal.pone.0142366	http://dx.doi.org/10.1371/journal.pone.0142366			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26539828	Green Published, gold, Green Submitted			2022-12-26	WOS:000364303800090
J	Hasegawa, S; Goto, S; Tsuji, H; Okuno, T; Asahara, T; Nomoto, K; Shibata, A; Fujisawa, Y; Minato, T; Okamoto, A; Ohno, K; Hirayama, M				Hasegawa, Satoru; Goto, Sae; Tsuji, Hirokazu; Okuno, Tatsuya; Asahara, Takashi; Nomoto, Koji; Shibata, Akihide; Fujisawa, Yoshiro; Minato, Tomomi; Okamoto, Akira; Ohno, Kinji; Hirayama, Masaaki			Intestinal Dysbiosis and Lowered Serum Lipopolysaccharide-Binding Protein in Parkinson's Disease	PLOS ONE			English	Article							BACTERIAL OVERGROWTH; FECAL MICROBIOTA; MOUSE MODEL; HYDROGEN; LACTULOSE; MARKER; SYSTEM; WATER; RISK	Background The intestine is one of the first affected organs in Parkinson's disease (PD). PD subjects show abnormal staining for Escherichia coli and a-synuclein in the colon. Methods We recruited 52 PD patients and 36 healthy cohabitants. We measured serum markers and quantified the numbers of 19 fecal bacterial groups/genera/species by quantitative RT-PCR of 16S or 23S rRNA. Although the six most predominant bacterial groups/genera/species covered on average 71.3% of total intestinal bacteria, our analysis was not comprehensive compared to metagenome analysis or 16S rRNA amplicon sequencing. Results In PD, the number of Lactobacillus was higher, while the sum of analyzed bacteria, Clostridium coccoides group, and Bacteroides fragilis group were lower than controls. Additionally, the sum of putative hydrogen-producing bacteria was lower in PD. A linear regression model to predict disease durations demonstrated that C. coccoides group and Lactobacillus gasseri subgroup had the largest negative and positive coefficients, respectively. As a linear regression model to predict stool frequencies showed that these bacteria were not associated with constipation, changes in these bacteria were unlikely to represent worsening of constipation in the course of progression of PD. In PD, the serum lipopolysaccharide (LPS)binding protein levels were lower than controls, while the levels of serum diamine oxidase, a marker for intestinal mucosal integrity, remained unchanged in PD. Conclusions The permeability to LPS is likely to be increased without compromising the integrity of intestinal mucosa in PD. The increased intestinal permeability in PD may make the patients susceptible to intestinal dysbiosis. Conversely, intestinal dysbiosis may lead to the increased intestinal permeability. One or both of the two mechanisms may be operational in development and progression of PD.	[Hasegawa, Satoru; Goto, Sae; Fujisawa, Yoshiro; Minato, Tomomi; Hirayama, Masaaki] Nagoya Univ, Grad Sch Med, Dept Pathophysiol Lab Sci, Nagoya, Aichi 4648601, Japan; [Hasegawa, Satoru; Okuno, Tatsuya; Shibata, Akihide; Ohno, Kinji] Nagoya Univ, Grad Sch Med, Ctr Neurol Dis & Canc, Div Neurogenet, Nagoya, Aichi 4648601, Japan; [Tsuji, Hirokazu; Asahara, Takashi; Nomoto, Koji] Yakult Cent Inst, Tokyo, Japan; [Okamoto, Akira] Aichi Univ Educ, Dept Sch Hlth Sci, Kariya, Aichi 448, Japan	Nagoya University; Nagoya University; Yakult Honsha Company, Limited; Aichi University Education	Ohno, K (corresponding author), Nagoya Univ, Grad Sch Med, Ctr Neurol Dis & Canc, Div Neurogenet, Nagoya, Aichi 4648601, Japan.	ohnok@med.nagoya-u.ac.jp; hirasan@met.nagoya-u.ac.jp	Okuno, Tatsuya/ABD-6927-2020; Hirayama, Masaaki/ABH-2669-2020; Ohno, Kinji/ABD-5787-2020; Hirayama, Masaaki/I-9341-2018; Ohno, Kinji/H-4020-2012	Ohno, Kinji/0000-0002-1529-2750; Hirayama, Masaaki/0000-0003-0092-7837; Ohno, Kinji/0000-0002-1529-2750; Hirokazu, Tsuji/0000-0003-2856-6447	MEXT; MHLW of Japan; Yakult Central Institute; Grants-in-Aid for Scientific Research [25870317] Funding Source: KAKEN	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MHLW of Japan; Yakult Central Institute; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The study was supported by Grants-in-Aid from the MEXT and MHLW of Japan, as well as Yakult Central Institute. The funders did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder Yakult Central Institute provided support in the form of salaries for authors [HT, TA, and KN], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abbott RD, 2001, NEUROLOGY, V57, P456, DOI 10.1212/WNL.57.3.456; Baranowska B, 1997, METABOLISM, V46, P1384, DOI 10.1016/S0026-0495(97)90136-0; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Braak H, 2002, J NEUROL, V249, DOI [1007/s00415-002-1301-4, 10.1007/s00415-002-1301-4, DOI 10.1007/S00415-002-1301-4]; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Devos D, 2013, NEUROBIOL DIS, V50, P42, DOI 10.1016/j.nbd.2012.09.007; Ding PH, 2014, J PERIODONTAL RES, V49, P1, DOI 10.1111/jre.12081; Dorsey ER, 2007, NEUROLOGY, V68, P384, DOI 10.1212/01.wnl.0000247740.47667.03; Drossman Douglas A, 2006, J Gastrointestin Liver Dis, V15, P237; Dutta G, 2008, FUND CLIN PHARMACOL, V22, P453, DOI 10.1111/j.1472-8206.2008.00616.x; Dzamko N, 2015, NEUROSCIENCE, V302, P89, DOI 10.1016/j.neuroscience.2014.10.028; Fasano A, 2013, MOVEMENT DISORD, V28, P1241, DOI 10.1002/mds.25522; FLORENT C, 1985, J CLIN INVEST, V75, P608, DOI 10.1172/JCI111738; Forsyth CB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028032; FROON AHM, 1995, J INFECT DIS, V171, P1250, DOI 10.1093/infdis/171.5.1250; Fu Y, 2009, NEUROSCI LETT, V453, P81, DOI 10.1016/j.neulet.2009.02.016; Fujita K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007247; Fujiwara Y, 2010, GERIATR GERONTOL INT, V10, P225, DOI 10.1111/j.1447-0594.2010.00585.x; Gabrielli M, 2011, MOVEMENT DISORD, V26, P889, DOI 10.1002/mds.23566; Gasbarrini A, 2007, DIGEST DIS, V25, P237, DOI 10.1159/000103892; Goldman SM, 2014, MOVEMENT DISORD, V29, P1171, DOI 10.1002/mds.25895; Gutsmann T, 2001, INFECT IMMUN, V69, P6942, DOI 10.1128/IAI.69.11.6942-6950.2001; Hawkes CH, 2010, PARKINSONISM RELAT D, V16, P79, DOI 10.1016/j.parkreldis.2009.08.007; HIRAYAMA M, 1995, J AUTONOM NERV SYST, V53, P230, DOI 10.1016/0165-1838(95)00002-F; Ito M, 2012, MED GAS RES, V2, DOI 10.1186/2045-9912-2-15; Kajiya M, 2009, BIOCHEM BIOPH RES CO, V386, P316, DOI 10.1016/j.bbrc.2009.06.024; Katzenschlager R, 2004, CURR OPIN NEUROL, V17, P417, DOI 10.1097/01.wco.0000137531.76491.c2; Kelly LP, 2014, MOVEMENT DISORD, V29, P999, DOI 10.1002/mds.25736; Keshavarzian A, 2015, MOVEMENT DISORD, V30, P1351, DOI 10.1002/mds.26307; Kobayashi M, 2006, CHEM SENSES, V31, P335, DOI 10.1093/chemse/bjj037; Kordower JH, 2013, BRAIN, V136, P2419, DOI 10.1093/brain/awt192; LUK GD, 1980, J CLIN INVEST, V66, P66, DOI 10.1172/JCI109836; Malinen E, 2005, AM J GASTROENTEROL, V100, P373, DOI 10.1111/j.1572-0241.2005.40312.x; MARTIN TR, 1992, J CLIN INVEST, V90, P2209, DOI 10.1172/JCI116106; Matsuda K, 2007, APPL ENVIRON MICROB, V73, P32, DOI 10.1128/AEM.01224-06; Matsuda K, 2009, APPL ENVIRON MICROB, V75, P1961, DOI 10.1128/AEM.01843-08; Mitsuoka T, 1996, Asia Pac J Clin Nutr, V5, P2; Ohigashi S, 2013, DIGEST DIS SCI, V58, P1717, DOI 10.1007/s10620-012-2526-4; Parkinson J., ESSAY SHAKING PALSY1; Pierantozzi M, 2006, NEUROLOGY, V66, P1824, DOI 10.1212/01.wnl.0000221672.01272.ba; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Sakaguchi S, 2010, J CLIN MICROBIOL, V48, P1624, DOI 10.1128/JCM.01724-09; Sato J, 2014, DIABETES CARE, V37, P2343, DOI 10.2337/dc13-2817; Scheperjans F, 2015, MOVEMENT DISORD, V30, P350, DOI 10.1002/mds.26069; Schumann RR, 1999, CLIN CHEM LAB MED, V37, P271, DOI 10.1515/CCLM.1999.047; Seet RCS, 2010, FREE RADICAL BIO MED, V48, P560, DOI 10.1016/j.freeradbiomed.2009.11.026; Shannon KM, 2012, MOVEMENT DISORD, V27, P709, DOI 10.1002/mds.23838; Tan AH, 2015, PARKINSONISM RELAT D, V21, P221, DOI 10.1016/j.parkreldis.2014.12.009; Tan AH, 2014, PARKINSONISM RELAT D, V20, P535, DOI 10.1016/j.parkreldis.2014.02.019; TOBIAS PS, 1986, J EXP MED, V164, P777, DOI 10.1084/jem.164.3.777; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Yoritaka A, 2013, MOVEMENT DISORD, V28, P836, DOI 10.1002/mds.25375	52	261	271	10	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142164	10.1371/journal.pone.0142164	http://dx.doi.org/10.1371/journal.pone.0142164			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26539989	Green Submitted, Green Published, gold			2022-12-26	WOS:000364303800061
J	Liu, QH; Pan, DH; Cheng, C; Zhang, DZ; Zhang, AY; Wang, LZ; Jiang, HD; Wang, T; Liu, HR; Xu, YP; Yang, RL; Chen, F; Yang, M; Zuo, CJ				Liu, Qinghua; Pan, Donghui; Cheng, Chao; Zhang, Dazhi; Zhang, Anyu; Wang, Lizhen; Jiang, Hongdie; Wang, Tao; Liu, Hongrui; Xu, Yuping; Yang, Runlin; Chen, Fei; Yang, Min; Zuo, Changjing			Development of a Novel PET Tracer [F-18]AlF-NOTA-C6 Targeting MMP2 for Tumor Imaging	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE EXPRESSION; PROSTATE-CANCER; GELATINASE ACTIVITY; INHIBITOR; MATRIX-METALLOPROTEINASE-2; PROGRESSION; PROGNOSIS; PEPTIDE; DESIGN; CELLS	Background and Objective The overexpression of gelatinases, that is, matrix metalloproteinase MMP2 and MMP9, has been associated with tumor progression, invasion, and metastasis. To image MMP2 in tumors, we developed a novel ligand termed [F-18] AlF-NOTA-C6, with consideration that: c (KAHWGFTLD)NH2 (herein, C6) is a selective gelatinase inhibitor; Cy5.5-C6 has been visualized in many in vivo tumor models; positron emission tomography (PET) has a higher detection sensitivity and a wider field of view than optical imaging; fluorine-18 (F-18) is the optimal PET radioisotope, and the creation of a [F-18] AlF-peptide complex is a simple procedure. Methods C6 was conjugated to the bifunctional chelator NOTA (1, 4, 7-triazacyclononanetriacetic acid) for radiolabeling [F-18] AlF conjugation. The MMP2-binding characteristics and tumor-targeting efficacy of [F-18] AlF-NOTA-C6 were tested in vitro and in vivo. Results The non-decay corrected yield of [F-18] AlF-NOTA-C6 was 46.2-64.2%, and the radiochemical purity exceeded 95%. [F-18] AlF-NOTA-C6 was favorably retained in SKOV3 and PC3 cells, determined by cell uptake. Using NOTA-C6 as a competitive ligand, the uptake of [F-18] AlF-NOTA-C6 in SKOV3 cells decreased in a dose-dependent manner. In biodistribution and PET imaging studies, higher radioactivity concentrations were observed in tumors. Pre-injection of C6 caused a marked reduction in tumor tissue uptake. Immunohistochemistry showed MMP2 in tumor tissues. Conclusions [F-18]AlF-NOTA-C6 was easy to synthesize and has substantial potential as an imaging agent that targets MMP2 in tumors.	[Liu, Qinghua; Cheng, Chao; Zhang, Anyu; Jiang, Hongdie; Wang, Tao; Zuo, Changjing] Second Mil Med Univ, Changhai Hosp, Dept Nucl Med, Shanghai 200433, Peoples R China; [Pan, Donghui; Wang, Lizhen; Xu, Yuping; Yang, Runlin; Chen, Fei; Yang, Min] Minist Hlth, Key Lab Nucl Med, Jiangsu Inst Nucl Med, Wuxi 214063, Peoples R China; [Zhang, Dazhi] Second Mil Med Univ, Sch Pharm, Dept Organ Chem, Shanghai 200433, Peoples R China; [Liu, Hongrui] Fudan Univ, Sch Pharm, Dept Pharmacol, Shanghai 201203, Peoples R China	Naval Medical University; Naval Medical University; Fudan University	Liu, QH (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Nucl Med, Shanghai 200433, Peoples R China.	shlqh@126.com; ymzfk@163.com; changjing.zuo@qq.com		Yang, Min/0000-0001-6976-8526	Shanghai Municipal Natural Science Foundation of China [13ZR1409100]; National Nature Science Foundation of China [81471714]	Shanghai Municipal Natural Science Foundation of China; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was sponsored by the Shanghai Municipal Natural Science Foundation of China (grant no. 13ZR1409100) and the National Nature Science Foundation of China (grant no. 81471714).	Afzal S, 1998, HUM PATHOL, V29, P155, DOI 10.1016/S0046-8177(98)90226-X; Brooks PC, 1996, CELL, V85, P683, DOI 10.1016/S0092-8674(00)81235-0; Garzetti GG, 1995, ANTICANCER RES, V15, P2799; Gohji K, 1998, INT J CANCER, V79, P96, DOI 10.1002/(SICI)1097-0215(19980220)79:1<96::AID-IJC18>3.0.CO;2-F; Gong YX, 2014, CANCERS, V6, P1298, DOI 10.3390/cancers6031298; Hanaoka H, 2007, NUCL MED BIOL, V34, P503, DOI 10.1016/j.nucmedbio.2007.04.002; Higashi S, 2013, J BIOL CHEM, V288, P9066, DOI 10.1074/jbc.M112.441758; Kamat AA, 2006, CLIN CANCER RES, V12, P1707, DOI 10.1158/1078-0432.CCR-05-2338; Karakiulakis George, 1997, Invasion and Metastasis, V17, P158; Kawano T, 2015, INT J MOL SCI, V16, P148, DOI 10.3390/ijms16010148; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Koivunen E, 1999, NAT BIOTECHNOL, V17, P768, DOI 10.1038/11703; KOIVUNEN E, 1994, METHOD ENZYMOL, V245, P346; Kuhnast B, 2004, NUCL MED BIOL, V31, P337, DOI 10.1016/j.nucmedbio.2003.10.011; Lang LX, 2011, BIOCONJUGATE CHEM, V22, P2415, DOI 10.1021/bc200197h; Laverman P, 2010, J NUCL MED, V51, P454, DOI 10.2967/jnumed.109.066902; Lee CM, 2012, INT J CANCER, V131, P1846, DOI 10.1002/ijc.27451; Liu ZB, 2014, ANGEW CHEM INT EDIT, V53, P11876, DOI 10.1002/anie.201406258; Liu ZB, 2014, J NUCL MED, V55, P1499, DOI 10.2967/jnumed.114.137836; McBride WJ, 2009, J NUCL MED, V50, P991, DOI 10.2967/jnumed.108.060418; Medina OP, 2005, ANTICANCER RES, V25, P33; Mehta RK, 2014, J BIOL CHEM, V289, P3555, DOI [10.1074/jbc.M113.486530, 10.4331/wjbc.v5.i3.355]; Nelson AR, 2000, J CLIN ONCOL, V18, P1135, DOI 10.1200/JCO.2000.18.5.1135; Perigny M, 2008, AM J CLIN PATHOL, V129, P226, DOI 10.1309/49LA9XCBGWJ8F2KM; Roy R, 2009, J CLIN ONCOL, V27, P5287, DOI 10.1200/JCO.2009.23.5556; Scherer RL, 2008, CANCER METAST REV, V27, P679, DOI 10.1007/s10555-008-9152-9; Schmalfeldt B, 2001, CLIN CANCER RES, V7, P2396; Shao YH, 2014, MOLECULES, V19, P11600, DOI 10.3390/molecules190811600; Sprague JE, 2006, NUCL MED BIOL, V33, P227, DOI 10.1016/j.nucmedbio.2005.10.011; Trudel D, 2008, HUM PATHOL, V39, P731, DOI 10.1016/j.humpath.2007.09.021; Vandenbroucke RE, 2014, NAT REV DRUG DISCOV, V13, P904, DOI 10.1038/nrd4390; Vijayababu MR, 2006, MOL CELL BIOCHEM, V287, P109, DOI 10.1007/s11010-005-9085-3; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; W01ngler C, 2012, NATURE PROTOCOLS, P7; Wang W, 2009, MOL IMAGING BIOL, V11, P424, DOI 10.1007/s11307-009-0219-y; Xu YP, 2014, MOL IMAGING BIOL, V16, P578, DOI 10.1007/s11307-013-0712-1; Zhang J, 2014, NUCL MED BIOL, V41, P268, DOI 10.1016/j.nucmedbio.2013.12.008	37	7	7	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141668	10.1371/journal.pone.0141668	http://dx.doi.org/10.1371/journal.pone.0141668			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540114	gold, Green Submitted, Green Published			2022-12-26	WOS:000364303800022
J	Laplana, C; Sevilla, P; Arsuaga, JL; Arriaza, MC; Baquedano, E; Perez-Gonzalez, A; Lopez-Martinez, N				Laplana, Cesar; Sevilla, Paloma; Luis Arsuaga, Juan; Carmen Arriaza, Mari; Baquedano, Enrique; Perez-Gonzalez, Alfredo; Lopez-Martinez, Nieves			How Far into Europe Did Pikas (Lagomorpha: Ochotonidae) Go during the Pleistocene? New Evidence from Central Iberia	PLOS ONE			English	Article							MAMMALIA; CAVE; EURASIA; RECORD; GENUS	This paper reports the first find of pika remains in the Iberian Peninsula, at a site in central Spain. A fragmented mandible of Ochotona cf. pusilla was unearthed from Layer 3 (deposited some 63.4 +/- 5.5 ka ago as determined by thermoluminescence) of the Buena Pinta Cave. This record establishes new limits for the genus geographic distribution during the Pleistocene, shifting the previous edge of its known range southwest by some 500 km. It also supports the idea that, even though Europe's alpine mountain ranges represented a barrier that prevented the dispersal into the south to this and other taxa of small mammals from central and eastern Europe, they were crossed or circumvented at the coldest time intervals of the end of the Middle Pleistocene and of the Late Pleistocene. During those periods both the reduction of the forest cover and the emersion of large areas of the continental shelf due to the drop of the sea level probably provided these species a way to surpass this barrier. The pika mandible was found accompanying the remains of other small mammals adapted to cold climates, indicating the presence of steppe environments in central Iberia during the Late Pleistocene.	[Laplana, Cesar; Baquedano, Enrique] Museo Arqueol Reg Comunidad Madrid, Madrid, Spain; [Sevilla, Paloma; Luis Arsuaga, Juan; Lopez-Martinez, Nieves] Univ Complutense Madrid, Fac Ciencias Geol, Dept Paleontol, Madrid, Spain; [Luis Arsuaga, Juan] Ctr Mixto UCM ISCIII Evoluc & Comportamiento Huma, Madrid, Spain; [Carmen Arriaza, Mari] Univ Alcala de Henares, Dept Geol Geog & Medio Ambiente, E-28871 Alcala De Henares, Spain; [Carmen Arriaza, Mari; Baquedano, Enrique] Inst Evoluc Africa IDEA, Madrid, Spain; [Perez-Gonzalez, Alfredo] Ctr Nacl Invest Evoluc Humana CENIEH, Burgos, Spain	Complutense University of Madrid; Complutense University of Madrid; UCM-ISCIII Center for Human Evolution & Behavior; Universidad de Alcala; Centro Nacional de Investigacion de La Evolucion Humana (CENIEH)	Laplana, C (corresponding author), Museo Arqueol Reg Comunidad Madrid, Madrid, Spain.	cesar.laplana@gmail.com	del Carmen Arriaza Dorado, María/AAB-3468-2021; Sevilla, Paloma/Q-2813-2019; Baquedano, Enrique/ABE-9997-2020; Laplana, César/H-6532-2015	del Carmen Arriaza Dorado, María/0000-0003-1393-4323; Sevilla, Paloma/0000-0001-7425-7173; Laplana, César/0000-0002-2067-4091; Arsuaga, Juan Luis/0000-0001-5361-2295	Madrid Regional Government's Consejeria de Educacion I+D activities programme [S2010/BMD-2330]; Museo Arqueologico Regional de la Comunidad de Madrid; Grupo Mahou	Madrid Regional Government's Consejeria de Educacion I+D activities programme; Museo Arqueologico Regional de la Comunidad de Madrid; Grupo Mahou	Funding: This research was funded by the Madrid Regional Government's Consejeria de Educacion I+D activities programme for research groups (project number S2010/BMD-2330), and also by the Museo Arqueologico Regional de la Comunidad de Madrid and Grupo Mahou. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altuna J., 1992, LATE QUATERNARY W PY, P15; Alvarez-Lao DJ, 2010, QUATERN INT, V212, P120, DOI 10.1016/j.quaint.2009.02.029; Angelone C, 2009, J PALEONTOL, V83, P80, DOI 10.1666/07-067R2.1; [Anonymous], PLEISTOCENE HOLOCENE; [Anonymous], 2005, NEANDERTALES CANTABR; Argant Jacqueline, 2007, Geoloshki Anali Balkanskoga Poluostrva, V68, P73; Arribas O., 2004, FAUNA PAISAJE PIRINE; Bartolomei G, 1982, ANN U FERRARA, V3, P61; Callou C., 1990, DIAGNOSE DIFFERENT B; Carrion JS, 2007, J QUATERNARY SCI, V22, P191, DOI 10.1002/jqs.1024; Chaline J., 1975, NOUV ARCH MUS HIST N, V13, P3; Desclaux Emmanuel, 1997, Quaternaire, V8, P213; Desnoyers J., 1842, B SOC GEOL FR, V13, P290; Dimitrijevic V., 1988, ANN GEOL PENINS, V51, P379; Dimitrijevic Vesna, 1996, Acta Zoologica Cracoviensia, V39, P117; Dimitrijevic Vesna, 2002, Srpska Akademija Nauka i Umetnosti Posebna Izdanja, V650, P113; Erbajeva MA, 2005, PALEONTOL J+, V39, P318; Erbajeva MA, 2008, 6 M EUR ASS VERT PAL, P38; Erbajeva Margarita A., 2001, Geodiversitas, V23, P395; Erbajeva MA, 2011, PALAEONTOL ELECTRON, V14; Fisher CT, 2004, MAMMAL REV, V34, P320, DOI 10.1111/j.1365-2907.2004.00052.x; Fladerer FA, 1997, MITT KOMM QUARTARFOR, V10, P320; Fladerer FA, 1992, MITT KOMM QUARTARFOR, V8, P189; Fostowicz-Frelik L, 2008, MAMMALIA, V72, P71, DOI 10.1515/MAMM.2008.011; Frank C, 1997, MITT KOMM QUARTARFOR, V10, P275; Frank C, 1997, MITT KOMM QUARTARFOR, V10, P157; Garda Ibaibarriaga N., 2012, EST CUAT, V2, P71; Ge DY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059668; Goni MFS, 2008, QUATERNARY SCI REV, V27, P1136, DOI 10.1016/j.quascirev.2008.03.003; Guadelli JL, 2006, RAPPORT MISSION PREH, P238; Hanquet C, 2011, QUATERNAIRE, V22, P35; Harle E., 1913, B SOC PREHIST FR, V10, P337; Jeannet M, 2009, MEM SOC PREHIST FR, V50, P87; Kahlke RD, 2014, QUATERNARY SCI REV, V96, P32, DOI 10.1016/j.quascirev.2013.01.012; Koby F. E., 1958, Bulletin de la Societe Prehistorique de l'Ariege, V13, P49; Koby FE, 1960, MAM PLEIST S1, V1, P101; Kozlowski JK, 1982, EXCAVATION BACHO KIR, P52; Laplana C, 2013, 29 JORNADAS PALEONTO, P87; Laplana C, 2016, CR PALEVOL, V15, P696, DOI 10.1016/j.crpv.2015.05.010; Laplana C, 2013, QUATERNAIRE, V24, P207, DOI 10.4000/quaternaire.6617; Laplana C, 2009, J VERTEBR PALEONTOL, V29, p132A; Lavocat R, 1966, FAUNES FLORES PREHIS, P397; Lister AM, 1997, NATO ASI SER SER I, V47, P287; Lopez-Garcfa JM, 2011, MICROMAMIFEROS PLEIS; Lopez-Martinez N., 1989, MEM MUSEO PALEONTOL, V3, P1; Lopez-Martinez Nieves, 2001, Lynx (Prague), V32, P215; Malez M., 1969, Museo Civico di Storia Naturale di Verona Memorie Fuori Serie, V3, P67; MALEZ M., 1966, BULL SCI CONS ACAD RSF YOUGOSLAVIE SECT A SCI NATUR TECH MED, V11, P5; Malez M., 1979, RAD JAZU, V383, P345; Marquet J.-C., 1988, Etudes et Recherches Archeologiques de l'Universite de Liege, P105; Marquet J-C., 1993, CAHIERS CLAISE S2, V2, P1; Marquet J-C., 1982, B AFEQ, V2-3, P105; Marquet Jean-Claude, 1998, Quaternaire, V9, P303; MAYHEW DF, 1978, P K NED AKAD B PHYS, V81, P302; Moreno-Rueda G, 2009, ECOL RES, V24, P335, DOI 10.1007/s11284-008-0509-x; Motll M., 1953, MITT MUS BERGBAU GEO, V11, P14; Paunesco Alexandra-Cristina, 2000, Travaux de l'Institut de Speologie "Emile Racovitza", V36, P135; Pavlovic G, 1991, ANN GEOL PENINS BALK, V55, P221; Pokines JT, 1998, BAR INT SER, V713, P1; POPOV V V, 1988, Acta Zoologica Cracoviensia, V31, P193; Popov V.V, 1985, ACTA ZOOL BULGAR, V26, P23; Popov Vasil, 2001, Acta Zoologica Bulgarica, V53, P79; Popov VV, 2007, COUR FOR SEKENBG, V259, P79; Popov Vasil V., 1994, Historical Biology, V8, P261; Prieto Cana D., 1995, SERIE DOCUMENTOS CTR, V17, P1; Purez-GonzuYlez A., 2010, ZONA ARQUEOLOGICA, V13, P404; Pushkina D, 2007, MAMMAL REV, V37, P224, DOI 10.1111/j.1365-2907.2007.00109.x; Rabeder G, 1974, HOHLE, V25, P142; Reiner G., 1995, MITT ABT GEOL PALAON, V52-53, P135; Reiner G, 1996, MITT ABT GEOL PALAON, V54, P43; Rodriguez J, 2011, QUATERNARY SCI REV, V30, P1396, DOI 10.1016/j.quascirev.2010.02.021; Rofes J, 2012, PALAEOGEOGR PALAEOCL, V348, P67, DOI 10.1016/j.palaeo.2012.06.016; Rohling EJ, 2014, NATURE, V508, P477, DOI 10.1038/nature13230; Roksandic M, 2011, J HUM EVOL, V61, P186, DOI 10.1016/j.jhevol.2011.03.003; Ruiz Bustos A., 2000, AYUNTAMIENTO PINAR; Ruiz-Zapata B., 2008, GEOGACETA, V44, P83; Schmidt RR, 1912, DILUVIALE VORZEIT DE, P159; Smith Andrew T., 2008, P89, DOI 10.1007/978-3-540-72446-9_6; Sommer RS, 2006, MAMMAL REV, V36, P251, DOI 10.1111/j.1365-2907.2006.00093.x; Stampfli HR, 1983, RISLISBERGHOHLE ARCH, P69; Stehlin HG, 1924, DENKSCHRIFTEN SCHWEI, V61, P1; Stuart A.J., 1985, P221; Sych L., 1980, FOLIA QUATERNARIA, V51, P57; Thenius E, 1959, MITT PRAHIST KOMM OS, V8, P133; von Koenigswald Wighart, 2003, Deinsea (Rotterdam), V10, P305; von Koenigswald W, 2010, J MAMM EVOL, V17, P275, DOI 10.1007/s10914-010-9140-z; Woldrich JN, 1893, DENKSCHR KAISERL AKA, V60, P565	87	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140513	10.1371/journal.pone.0140513	http://dx.doi.org/10.1371/journal.pone.0140513			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26535576	Green Published, Green Submitted, gold			2022-12-26	WOS:000364298400022
J	Mahony, D; Mody, KT; Cavallaro, AS; Hu, QH; Mahony, TJ; Qiao, SZ; Mitter, N				Mahony, Donna; Mody, Karishma T.; Cavallaro, Antonino S.; Hu, Qiuhong; Mahony, Timothy J.; Qiao, Shizhang; Mitter, Neena			Immunisation of Sheep with Bovine Viral Diarrhoea Virus, E2 Protein Using a Freeze-Dried Hollow Silica Mesoporous Nanoparticle Formulation	PLOS ONE			English	Article							SYSTEMIC IMMUNE-RESPONSES; ADJUVANT; ANTIBODY; ANTIGEN; VACCINATION; PROTECTION; EFFICACY; DELIVERY; CARRIERS	Bovine viral diarrhoea virus 1 (BVDV-1) is arguably the most important viral disease of cattle. It is associated with reproductive, respiratory and chronic diseases in cattle across the world. In this study we have investigated the capacity of the major immunological determinant of BVDV-1, the E2 protein combined with hollow type mesoporous silica nanoparticles with surface amino functionalisation (HMSA), to stimulate immune responses in sheep. The current work also investigated the immunogenicity of the E2 nanoformulation before and after freeze-drying processes. The optimal excipient formulation for freeze-drying of the E2 nanoformulation was determined to be 5% trehalose and 1% glycine. This excipient formulation preserved both the E2 protein integrity and HMSA particle structure. Sheep were immunised three times at three week intervals by subcutaneous injection with 500 mu g E2 adsorbed to 6.2 mg HMSA as either a non-freeze-dried or freeze-dried nanoformulation. The capacity of both nanovaccine formulations to generate humoral (antibody) and cell-mediated responses in sheep were compared to the responses in sheep immunisation with Opti-E2 (500 mu g) together with the conventional adjuvant Quil-A (1 mg), a saponin from the Molina tree (Quillaja saponira). The level of the antibody responses detected to both the non-freeze-dried and freeze-dried Opti-E2/HMSA nanoformulations were similar to those obtained for Opti-E2 plus Quil-A, demonstrating the E2 nanoformulations were immunogenic in a large animal, and freeze-drying did not affect the immunogenicity of the E2 antigen. Importantly, it was demonstrated that the long term cell-mediated immune responses were detectable up to four months after immunisation. The cell-mediated immune responses were consistently high in all sheep immunised with the freeze-dried Opti-E2/HMSA nanovaccine formulation (> 2,290 SFU/million cells) compared to the non-freeze-dried nanovaccine formulation (213-500 SFU/million cells). This study is the first to demonstrate that a freeze-dried silica mesoporous nanovaccine formulation gives balanced immune responses in a production animal.	[Mahony, Donna; Mody, Karishma T.; Cavallaro, Antonino S.; Mahony, Timothy J.; Mitter, Neena] Univ Queensland, Queensland Alliance Agr & Food Innovat, Brisbane, Qld 4072, Australia; [Hu, Qiuhong; Qiao, Shizhang] Univ Adelaide, Sch Chem Engn, Adelaide, SA 5005, Australia	University of Queensland; University of Adelaide	Mitter, N (corresponding author), Univ Queensland, Queensland Alliance Agr & Food Innovat, Brisbane, Qld 4072, Australia.	n.mitter@uq.edu.au	Qiao, Shizhang/A-6057-2010; Mahony, Timothy J./C-9307-2013; mitter, neena/D-1862-2013	Qiao, Shizhang/0000-0002-4568-8422; Mahony, Timothy J./0000-0003-4573-7906; mitter, neena/0000-0001-6146-6179; Mody, Karishma/0000-0002-7499-7988; Cavallaro, Tony/0000-0002-3601-3386	Queensland Government through Department of Agriculture, Fisheries and Forestry's Reinvestment Fund	Queensland Government through Department of Agriculture, Fisheries and Forestry's Reinvestment Fund	This work was funded by the Queensland Government through The Department of Agriculture, Fisheries and Forestry's Reinvestment Fund.	Abdelwahed W, 2006, ADV DRUG DELIVER REV, V58, P1688, DOI 10.1016/j.addr.2006.09.017; Bruschke CJM, 1997, VACCINE, V15, P1940, DOI 10.1016/S0264-410X(97)00125-4; Carvalho LV, 2010, VACCINE, V28, P7829, DOI 10.1016/j.vaccine.2010.09.087; Cavallaro AS, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-57; De Rose R, 2002, VET IMMUNOL IMMUNOP, V90, P55, DOI 10.1016/S0165-2427(02)00221-0; DONIS RO, 1988, J GEN VIROL, V69, P77, DOI 10.1099/0022-1317-69-1-77; Guo HC, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-108; Gupta R K, 1995, Pharm Biotechnol, V6, P229; Horwood PF, 2011, J VIROL METHODS, V171, P360, DOI 10.1016/j.jviromet.2010.11.020; Liu W, 2005, AAPS PHARMSCITECH, V6, DOI 10.1208/pt060223; Mahony D, 2014, NANOSCALE, V6, P6617, DOI 10.1039/c4nr01202j; Mahony D, 2013, SMALL, V9, P3138, DOI 10.1002/smll.201300012; Mahony TJ., 2012, DRUG DELIV LETT, V2, P83, DOI [DOI 10.2174/2210304X11202020083, 10.2174/2210304x11202020083]; Mercuri LP, 2006, SMALL, V2, P254, DOI 10.1002/smll.200500274; Mody KT, 2014, BIOMATERIALS, V35, P9972, DOI 10.1016/j.biomaterials.2014.08.044; Mody KT, 2014, INT J PHARMACEUT, V465, P325, DOI 10.1016/j.ijpharm.2014.01.037; Mody KT, 2013, NANOSCALE, V5, P5167, DOI 10.1039/c3nr00357d; Nelson G, 2012, VACCINE, V30, P4499, DOI 10.1016/j.vaccine.2012.04.068; Pecora A, 2012, VET RES COMMUN, V36, P157, DOI 10.1007/s11259-012-9526-x; Aguirreburualde MSP, 2012, REPROD DOMEST ANIM, V47, P915, DOI 10.1111/j.1439-0531.2012.01991.x; Popat A, 2011, NANOSCALE, V3, P2801, DOI 10.1039/c1nr10224a; Rothel JS, 1998, VET IMMUNOL IMMUNOP, V63, P167, DOI 10.1016/S0165-2427(98)00093-2; Sameti M, 2003, INT J PHARMACEUT, V266, P51, DOI 10.1016/S0378-5173(03)00380-6; Scheerlinck JPY, 2006, VACCINE, V24, P1124, DOI 10.1016/j.vaccine.2005.09.009; Snider M, 2014, VACCINE, V32, P6758, DOI 10.1016/j.vaccine.2014.10.010; Thiel H-J, 2005, VIRUS TAXONOMY, P981; Thomas C, 2009, VACCINE, V27, P2387, DOI 10.1016/j.vaccine.2009.02.010; vanRijn PA, 1997, VIROLOGY, V237, P337, DOI 10.1006/viro.1997.8792; Wang TY, 2012, INT J PHARMACEUT, V436, P351, DOI 10.1016/j.ijpharm.2012.06.028	29	8	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141870	10.1371/journal.pone.0141870	http://dx.doi.org/10.1371/journal.pone.0141870			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26535891	Green Published, Green Submitted, gold			2022-12-26	WOS:000364298400095
J	Pang, W; Kim, YY; Li, X; Choi, SR; Wang, Y; Sung, CK; Im, S; Ramchiary, N; Zhou, GS; Lim, YP				Pang, Wenxing; Kim, Yoon-Young; Li, Xiaonan; Choi, Su Ryun; Wang, Yunbo; Sung, Chang-keun; Im, Subin; Ramchiary, Nirala; Zhou, Guangsheng; Lim, Yong Pyo			Anatomic Characteristics Associated with Head Splitting in Cabbage (Brassica oleracea var. capitata L.)	PLOS ONE			English	Article							DIAMONDBACK MOTH; EXPANSIN GENE; RESISTANCE; CRACKING; EXPRESSION	Cabbage belonging to Brassicaceae family is one of the most important vegetables cultivated worldwide. The economically important part of cabbage crop is head, formed by leaves which may be of splitting and non-splitting types. Cabbage varieties showing head splitting causes huge loss to the farmers and therefore finding the molecular and structural basis of splitting types would be helpful to breeders. To determine which anatomical characteristics were related to head-splitting in cabbage, we analyzed two contrasting cabbage lines and their offspring using a field emission scanning electron microscope. The inbred line "747" is an early head-splitting type, while the inbred line "748" is a head-splitting-resistant type. The petiole cells of "747" seems to be larger than those of "748" at maturity; however, there was no significant difference in petiole cell size at both pre-heading and maturity stages. The lower epidermis cells of "747" were larger than those of "748" at the pre-heading and maturity stages. "747" had thinner epidermis cell wall than "748" at maturity stage, however, there was no difference of the epidermis cell wall thickness in the two lines at the pre-heading stage. The head-splitting plants in the F-1 and F-2 population inherited the larger cell size and thinner cell walls of epidermis cells in the petiole. In the petiole cell walls of "747" and the F-1 and F-2 plants that formed splitting heads, the cellulose microfibrils were loose and had separated from each other. These findings verified that anomalous cellulose microfibrils, larger cell size and thinner-walled epidermis cells are important genetic factors that make cabbage heads prone to splitting.	[Pang, Wenxing; Kim, Yoon-Young; Li, Xiaonan; Choi, Su Ryun; Im, Subin; Lim, Yong Pyo] Chungnam Natl Univ, Mol Genet & Genom Lab, Dept Hort, Daejeon, South Korea; [Pang, Wenxing; Li, Xiaonan] Shenyang Agr Univ, Coll Hort, Shenyang 110161, Peoples R China; [Wang, Yunbo; Sung, Chang-keun] Chungnam Natl Univ, Dept Food Sci & Technol, Coll Agr & Biotechnol, Daejeon, South Korea; [Ramchiary, Nirala] Jawaharlal Nehru Univ, Sch Life Sci, Translat & Evolutionary Genom Lab, New Delhi 110067, India; [Zhou, Guangsheng] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Peoples R China	Chungnam National University; Shenyang Agricultural University; Chungnam National University; Jawaharlal Nehru University, New Delhi; Huazhong Agricultural University	Lim, YP (corresponding author), Chungnam Natl Univ, Mol Genet & Genom Lab, Dept Hort, Daejeon, South Korea.	yplim@cnu.ac.kr	Ramchiary, Nirala/AAM-7695-2021; Pang, Wenxing/GLR-9367-2022; 최, 수련/AHE-1934-2022	Sung, Changkeun/0000-0001-7929-9567; Kim, Yoon-Young/0000-0003-4954-6365	Golden Seed Project [213002-04-1-SB110]; Ministry of Agriculture, Food and Rural Affairs (MAFRA); Ministry of Oceans and Fisheries (MOF); Rural Development Administration (RDA); Korea Forest Service (KFS)	Golden Seed Project; Ministry of Agriculture, Food and Rural Affairs (MAFRA); Ministry of Oceans and Fisheries (MOF); Rural Development Administration (RDA)(Rural Development Administration (RDA), Republic of Korea); Korea Forest Service (KFS)	This work was supported by the Golden Seed Project (No. 213002-04-1-SB110), Ministry of Agriculture, Food and Rural Affairs (MAFRA), Ministry of Oceans and Fisheries (MOF), Rural Development Administration (RDA) and Korea Forest Service (KFS).	Balbontin C, 2013, CHIL J AGR RES, V73, P66, DOI 10.4067/S0718-58392013000100010; CHIANG MS, 1972, EUPHYTICA, V21, P507, DOI 10.1007/BF00039347; Christensen JV, 1976, DAN J PLANT SOIL SCI, V80, P289; Cosgrove DJ, 1998, PLANT PHYSIOL, V118, P333, DOI 10.1104/pp.118.2.333; Cosgrove DJ, 2000, CURR OPIN PLANT BIOL, V3, P73, DOI 10.1016/S1369-5266(99)00039-4; DICKSON MH, 1980, J AM SOC HORTIC SCI, V105, P782; EIGENBRODE SD, 1991, J ECON ENTOMOL, V84, P1609, DOI 10.1093/jee/84.5.1609; Fujita M, 2014, PROTOPLASMA, V251, P687, DOI 10.1007/s00709-013-0571-2; Gomez-Campo C, 1999, ANN BOT-LONDON, V83, P515, DOI 10.1006/anbo.1999.0849; Kasai S, 2008, SCI HORTIC-AMSTERDAM, V116, P194, DOI 10.1016/j.scienta.2007.12.002; Matas AJ, 2004, HORTSCIENCE, V39, P1354, DOI 10.21273/HORTSCI.39.6.1354; Niu Na, 2010, China Vegetables, P44; Pang W, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0318-1; Peet M. M., 1992, HortTechnology, V2, P216; PROCTOR JTA, 1980, CAN PLANT DIS SURV, V60, P55; Ramchiary N, 2015, THEOR APPL GENET, V128, P1209, DOI 10.1007/s00122-015-2501-5; Rose JKC, 1999, TRENDS PLANT SCI, V4, P176, DOI 10.1016/S1360-1385(99)01405-3; Rose JKC, 1997, P NATL ACAD SCI USA, V94, P5955, DOI 10.1073/pnas.94.11.5955; Su YanBin, 2012, Acta Horticulturae Sinica, V39, P1482; Weijschede J, 2008, AM J BOT, V95, P41, DOI 10.3732/ajb.95.1.41; Wolfmeier U., 2000, ULLMANNS ENCY IND CH; Yong W, 2006, J AM SOC HORTIC SCI, V131, P118, DOI 10.21273/JASHS.131.1.118; Zeng A., 2009, ACTA AGR BOREALI SIN, V24, P41; Znidarcic D., 2008, Acta Agriculturae Slovenica, V91, P361, DOI 10.2478/v10014-008-0016-3	24	5	5	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142202	10.1371/journal.pone.0142202	http://dx.doi.org/10.1371/journal.pone.0142202			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536356	Green Published, gold, Green Submitted			2022-12-26	WOS:000364298400144
J	Zhang, L; Wu, CY; Hoffman, RM				Zhang, Lei; Wu, Chengyu; Hoffman, Robert M.			Prostate Cancer Heterogeneous High-Metastatic Multi-Organ-Colonizing Chemo-Resistant Variants Selected by Serial Metastatic Passage in Nude Mice Are Highly Enriched for Multinucleate Giant Cells	PLOS ONE			English	Article							FLUORESCENT PROTEINS; MOUSE MODEL; IN-VIVO; TUMOR; CULTURE; LQ	In order to further understand the role of tumor heterogeneity in metastasis and chemoresistance, high metastatic PC-3 human prostate cancer variants were selected by injecting parental PC-3 cells, expressing green fluorescent protein (GFP) in the footpad of nude mice, which then metastasize to inguinal lymph nodes. The PC-3-GFP cells which metastasized to the inguinal lymph nodes were collected and were re-injected to the footpad. After 6 such cycles, the PC-3-GFP cells collected from inguinal lymph nodes (PC-3-GFP-LN) were again injected to the footpad. PC-3-GFP-LN showed 100% metastasis to major lymph nodes (popliteal, inguinal, axillary, and cervical), and 100% metastasis to bone and lung. The percent of giant cell variants was enriched in PC-3-GFP-LN-6 compared to parental cells and increased with each cycle of selection, which in turn had increased metastasis. PC-3-GFP-LN-6 cells were resistant to 5-fluorouracil, doxorubicin and cisplatinum, compared to parental PC-3. However, PC-3-GFP-LN-6 was sensitive to the traditional Chinese medicine (TCM) herbal mixture LQ, similar to the parental cells. These results suggest that PC-3 tumors are heterogenous and that subpopulations of highly metastatic, drug-resistant cells can be step-wise selected using a mouse model of tumor progression.	[Zhang, Lei; Hoffman, Robert M.] AntiCancer Inc, San Diego, CA USA; [Wu, Chengyu] Nanjing Univ Tradit Chinese Med, Dept Tradit Chinese Med, Nanjing, Jiangsu, Peoples R China; [Hoffman, Robert M.] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA	Anti Cancer Inc; Nanjing University of Chinese Medicine; University of California System; University of California San Diego	Wu, CY (corresponding author), Nanjing Univ Tradit Chinese Med, Dept Tradit Chinese Med, Nanjing, Jiangsu, Peoples R China.	chengyu720@yahoo.com.cn; all@anticancer.com			AntiCancer Inc.	AntiCancer Inc.(Cancer Council VictoriaCanadian Institutes of Health Research (CIHR))	Funding: The authors received no specific funding for this work. AntiCancer Inc., provided support in the form of salary for an author [LZ], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Bhatia S, 2012, NAT BIOTECHNOL, V30, P604, DOI 10.1038/nbt.2294; Bobek V, 2013, DIAGN CYTOPATHOL, V41, P413, DOI 10.1002/dc.22843; FIDLER IJ, 1977, SCIENCE, V197, P893, DOI 10.1126/science.887927; Glinskii AB, 2003, CANCER RES, V63, P4239; Hoffman RM, 1999, INVEST NEW DRUG, V17, P343, DOI 10.1023/A:1006326203858; Hoffman RM, 2006, NAT PROTOC, V1, P1429, DOI 10.1038/nprot.2006.223; Hoffman RM, 2006, NAT PROTOC, V1, P775, DOI 10.1038/nprot.2006.109; Hoffman RM, 2006, NAT PROTOC, V1, P928, DOI 10.1038/nprot.2006.119; Kolostova K, 2011, ANTICANCER RES, V31, P1535; Luo Jan, 1997, Pathol Oncol Res, V3, P264; Menen R, 2012, ANTICANCER RES, V32, P2881; Menen R, 2012, ANTICANCER RES, V32, P1573; Menen RS, 2011, ANTICANCER RES, V31, P3125; Miwa S, 2015, CELL CYCLE, V14, P621, DOI 10.4161/15384101.2014.991604; Yang M, 2005, PROSTATE, V62, P374, DOI 10.1002/pros.20125; Yang M, 1999, CANCER RES, V59, P781; Zhang L, 2015, ONCOTARGET, V6, P5292, DOI 10.18632/oncotarget.2983; Zhang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109814; Zhang L, 2013, J CELL BIOCHEM, V114, P2131, DOI 10.1002/jcb.24561	19	19	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140721	10.1371/journal.pone.0140721	http://dx.doi.org/10.1371/journal.pone.0140721			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536025	Green Published, gold, Green Submitted			2022-12-26	WOS:000364298400033
J	Chen, GS; Wang, XM; Hao, JJ; Yan, JB; Ding, JQ				Chen, Gengshen; Wang, Xiaoming; Hao, Junjie; Yan, Jianbing; Ding, Junqiang			Genome-Wide Association Implicates Candidate Genes Conferring Resistance to Maize Rough Dwarf Disease in Maize	PLOS ONE			English	Article							ANTIFREEZE PROTEINS; POPULATION; VIRUS; ACTIVATION; EXPRESSION; FIJIVIRUS	Maize rough dwarf disease (MRDD) is a destructive viral disease in China, which results in 20-30% of the maize yield losses in affected areas and even as high as 100% in severely infected fields. Understanding the genetic basis of resistance will provide important insights for maize breeding program. In this study, a diverse maize population comprising of 527 inbred lines was evaluated in four environments and a genome-wide association study (GWAS) was undertaken with over 556000 SNP markers. Fifteen candidate genes associated with MRDD resistance were identified, including ten genes with annotated protein encoding functions. The homologous of nine candidate genes were predicted to relate to plant defense in different species based on published results. Significant correlation (R-2 = 0.79) between the MRDD severity and the number of resistance alleles was observed. Consequently, we have broadened the resistant germplasm to MRDD and identified a number of resistance alleles by GWAS. The results in present study also imply the candidate genes in defense pathway play an important role in resistance to MRDD in maize.	[Chen, Gengshen; Yan, Jianbing; Ding, Junqiang] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan 430070, Peoples R China; [Wang, Xiaoming] Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100081, Peoples R China; [Hao, Junjie] Henan Acad Agr Sci, Inst Plant Protect, Zhengzhou 450002, Peoples R China; [Ding, Junqiang] Henan Agr Univ, Coll Agron, Synerget Innovat Ctr Henan Grain Crops, Zhengzhou 450002, Peoples R China; [Ding, Junqiang] Henan Agr Univ, Natl Key Lab Wheat & Maize Crop Sci, Zhengzhou 450002, Peoples R China	Huazhong Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Henan Academy of Agricultural Sciences; Henan Agricultural University; Henan Agricultural University	Ding, JQ (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan 430070, Peoples R China.	dingjunqiang1203@163.com			National Natural Science Foundation of China [31161140347]; DuPont Pioneer Company; Dunhuang Pioneer Company	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); DuPont Pioneer Company; Dunhuang Pioneer Company	This work was supported by a grant from the National Natural Science Foundation of China (31161140347) and financially supported by DuPont Pioneer Company and Dunhuang Pioneer Company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achon MA, 2013, CROP PROT, V47, P1, DOI 10.1016/j.cropro.2013.01.002; Berrocal-Lobo M, 2002, PLANT J, V29, P23, DOI 10.1046/j.1365-313x.2002.01191.x; Buschges R, 1997, CELL, V88, P695, DOI 10.1016/S0092-8674(00)81912-1; Chen Y, 2010, J HEBEI AGR SCI, V14, P42; Chen YongKun, 2006, Acta Agronomica Sinica, V32, P1848; Di Renzo MA, 2004, J AGR SCI-CAMBRIDGE, V142, P289, DOI 10.1017/S0021859604004307; Dovas CI, 2004, PLANT PATHOL, V53, P238, DOI 10.1111/j.0032-0862.2004.00973.x; Fang S, 2001, ARCH VIROL, V146, P167, DOI 10.1007/s007050170200; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Fu JJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3832; Gordon D, 2005, J CLIN INVEST, V115, P1408, DOI 10.1172/JCI24756; GRAU CR, 1982, PLANT DIS, V66, P506, DOI 10.1094/PD-66-506; Griffith M, 2004, TRENDS PLANT SCI, V9, P399, DOI 10.1016/j.tplants.2004.06.007; Guo QuTang, 1995, Plant Protection, P21; Gururani MA, 2012, PHYSIOL MOL PLANT P, V78, P51, DOI 10.1016/j.pmpp.2012.01.002; Hao DR, 2015, EUPHYTICA, V203, P109, DOI 10.1007/s10681-014-1277-z; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Harjes CE, 2008, SCIENCE, V319, P330, DOI 10.1126/science.1150255; Harpaz I, 1958, FAO PLANT PROTECT B, V7, P43; Hibino H, 1996, ANNU REV PHYTOPATHOL, V34, P249, DOI 10.1146/annurev.phyto.34.1.249; HON WC, 1995, PLANT PHYSIOL, V109, P879, DOI 10.1104/pp.109.3.879; Humphry M, 2006, MOL PLANT PATHOL, V7, P605, DOI 10.1111/j.1364-3703.2006.00362.X; Ingvarsson PK, 2011, NEW PHYTOL, V189, P909, DOI 10.1111/j.1469-8137.2010.03593.x; Jia MA, 2012, MOL PLANT PATHOL, V13, P251, DOI 10.1111/j.1364-3703.2011.00743.x; KNAPP SJ, 1985, CROP SCI, V25, P192, DOI 10.2135/cropsci1985.0011183X002500010046x; Korte A, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-29; Lenardon SL, 1998, PLANT DIS, V82, P448, DOI 10.1094/PDIS.1998.82.4.448C; Li TT, 2013, PLANT CELL, V25, P4725, DOI 10.1105/tpc.113.118802; Liu CL, 2014, EUR J PLANT PATHOL, V139, P205, DOI 10.1007/s10658-014-0383-z; Liu Z. Z., 1996, J MAIZE SCI, V4, P68; Lorenzo O, 2003, PLANT CELL, V15, P165, DOI 10.1105/tpc.007468; Louie R., 1999, COMPENDIUM CORN DIS, P49; Lu S, 2013, MOL PLANT, V6, P1592, DOI 10.1093/mp/sst047; [吕鹏 LV Peng], 2010, [玉米科学, Maize Science], V18, P113; Miao HQ, 2005, J NW SCI TECH U AGR, V33, P1; Morant AV, 2008, PHYTOCHEMISTRY, V69, P1795, DOI 10.1016/j.phytochem.2008.03.006; Ogura T, 2015, CURR OPIN PLANT BIOL, V23, P98, DOI 10.1016/j.pbi.2014.11.008; Pritchard JK, 2000, GENETICS, V155, P945; Redinbaugh Margaret G., 2009, P251, DOI 10.1007/978-0-387-79418-1_13; Rossi E.A., 2015, OPEN AGR J, P48, DOI [10.2174/1874331501509010048, DOI 10.2174/1874331501509010048]; Scharte J, 2009, P NATL ACAD SCI USA, V106, DOI 10.1073/pnas.0812902106; Seo PJ, 2010, PLANT J, V61, P661, DOI 10.1111/j.1365-313X.2009.04091.x; Sood S., 2014, GENOMICS PLANT GENET, P615, DOI [10.1007/978-94-007-7572-5_25, DOI 10.1007/978-94-007-7572-5_25]; Wang AnLe, 2005, Journal of Maize Sciences, V13, P114; Wang F., 2007, MOL PLANT BREED, V5, P178; Wang GuiYue, 2011, Acta Agriculturae Zhejiangensis, V23, P564; Yan JB, 2011, CROP SCI, V51, P433, DOI 10.2135/cropsci2010.04.0233; Yan JB, 2010, NAT GENET, V42, P322, DOI 10.1038/ng.551; Yang N, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004573; Yang XH, 2011, MOL BREEDING, V28, P511, DOI 10.1007/s11032-010-9500-7; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhou YiJun, 2000, Jiangsu Journal of Agricultural Sciences, V16, P159; Zhu CS, 2008, PLANT GENOME-US, V1, P5, DOI 10.3835/plantgenome2008.02.0089; Zuo WL, 2015, NAT GENET, V47, P151, DOI 10.1038/ng.3170	61	55	58	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0142001	10.1371/journal.pone.0142001	http://dx.doi.org/10.1371/journal.pone.0142001			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529245	Green Published, gold, Green Submitted			2022-12-26	WOS:000364032600090
J	McKinnon, EA; Stanley, CQ; Stutchbury, BJM				McKinnon, Emily A.; Stanley, Calandra Q.; Stutchbury, Bridget J. M.			Carry-Over Effects of Nonbreeding Habitat on Start-to-Finish Spring Migration Performance of a Songbird	PLOS ONE			English	Article							REPRODUCTIVE SUCCESS; WINTER HABITAT; FITNESS CONSEQUENCES; ENERGETIC CONDITION; AMERICAN REDSTARTS; SEASONAL-VARIATION; BIRD MIGRATION; STOPOVER SITE; ARRIVAL DATE; QUALITY	For migratory animals, conditions during the nonbreeding period may carry-over to influence spring migration performance. Animals in low-quality habitats are predicted to be in poorer condition, show later migration timing, and travel at slower speeds. This can result in subsequent negative effects on fitness. We tested the hypothesis that nonbreeding season body condition and habitat quality carry-over to affect spring migration performance of a long-distance migratory songbird, the Wood Thrush (Hylocichla mustelina). We tracked individual birds between multiple breeding sites in North America and nonbreeding sites in Central America. First, we compared body condition of nonbreeding birds migrating to the same general region of the breeding range with spring migration performance (timing, speed, and duration) obtained from light-level geolocators. Second, we assessed the Normalized Difference Vegetation Index (NDVI) as a proxy for nonbreeding habitat quality, and predicted that birds from wetter habitat or in wetter years (higher NDVI) would show improved migration performance relative to birds from drier sites. We found no evidence of individual-level carry-over effects of nonbreeding season body condition on spring migration performance. Lower NDVI of nonbreeding habitat resulted in delayed spring migration departure, but this effect disappeared by arrival at breeding sites. Birds occupying drier nonbreeding sites migrated faster and for fewer days, compensating for their relatively late departure. We also documented a broader pattern in NDVI and migration timing and distance, in that birds that occupied the wettest areas in the southern part of the nonbreeding range departed significantly later and migrated farther. Our results suggest that individual carry-over effects of nonbreeding habitat quality may be compensated for by a faster and shorter migration strategy. At a broad scale, consistently later spring timing and longer migration distances were associated with the wettest areas (the highest quality habitats) of the Wood Thrush nonbreeding range. This supports the theory that high-quality habitats offset the costs of farther migration, resulting in a leap-frog migration pattern.	[McKinnon, Emily A.; Stanley, Calandra Q.; Stutchbury, Bridget J. M.] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada	York University - Canada	McKinnon, EA (corresponding author), Univ Windsor, Dept Biol Sci, Windsor, ON N9B 3P4, Canada.	emilymckinnon12@gmail.com		Stanley, Calandra Q./0000-0003-1588-2248	Natural Sciences and Engineering Research Council of Canada; Schad Foundation; Molson Foundation; U.S. Fish and Wildlife Service Migratory Bird Grant	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Schad Foundation; Molson Foundation; U.S. Fish and Wildlife Service Migratory Bird Grant	This work was supported by a Natural Sciences and Engineering Research Council of Canada Discovery Grant to BJMS (http://www.nserc-crsng.gc.ca/index_eng.asp), Schad Foundation grant to BJMS, Molson Foundation grant to BJMS (http://www.kennethmolsonfoundation.ca), and U.S. Fish and Wildlife Service Migratory Bird Grant to BJMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALERSTAM T, 1980, ORNIS SCAND, V11, P196, DOI 10.2307/3676124; Alves JA, 2013, ECOLOGY, V94, P11, DOI 10.1890/12-0737.1; Angelier F, 2009, P ROY SOC B-BIOL SCI, V276, P3545, DOI 10.1098/rspb.2009.0868; Bayly NJ, 2013, IBIS, V155, P271, DOI 10.1111/ibi.12029; Bell Christopher Paul, 2005, P41; Bell CP, 1997, CONDOR, V99, P470, DOI 10.2307/1369953; Berthold P, 2001, AUK, V2nd; Boone AT, 2010, CONDOR, V112, P115, DOI 10.1525/cond.2010.090098; Bowlin MS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002154; Chin S, 2014, WILSON J ORNITHOL, V126, P599, DOI 10.1676/13-187.1; COSEWIC (Committee on the Status of Endangered Wildlife in Canada), 2012, COSEWIC ASS STAT REP; DESANTE D. F., 2009, MOSI MONITOREO SOBRE; Drake A, 2014, POLAR BIOL, V37, P181, DOI 10.1007/s00300-013-1421-6; Drent R, 2003, OIKOS, V103, P274, DOI 10.1034/j.1600-0706.2003.12274.x; Evans M, 2011, BIRDS N AM ONLINE; Fuentes-Franco R, 2015, CLIM DYNAM, V45, P425, DOI 10.1007/s00382-014-2258-6; Gallo PA, 2013, AUK, V130, P240, DOI 10.1525/auk.2013.12213; Gomez C, 2013, J ORNITHOL, V154, P107, DOI 10.1007/s10336-012-0876-5; Gonzalez-Prieto AM, 2013, J ORNITHOL, V154, P1067, DOI 10.1007/s10336-013-0975-y; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Gwinner E, 2003, CURR OPIN NEUROBIOL, V13, P770, DOI 10.1016/j.conb.2003.10.010; GWINNER E, 1978, J COMP PHYSIOL, V125, P267, DOI 10.1007/BF00656605; Harrison XA, 2011, J ANIM ECOL, V80, P4, DOI 10.1111/j.1365-2656.2010.01740.x; Hidalgo HG, 2013, J HYDROL, V495, P94, DOI 10.1016/j.jhydrol.2013.05.004; Klaassen M, 2006, J APPL ECOL, V43, P92, DOI 10.1111/j.1365-2664.2005.01109.x; Kuznetsova A., 2014, PACKAGE LMERTEST TES; Lozano GA, 1996, J AVIAN BIOL, V27, P164, DOI 10.2307/3677146; LUNDBERG S, 1986, J THEOR BIOL, V123, P403, DOI 10.1016/S0022-5193(86)80210-7; Madsen J, 2001, ARDEA, V89, P43; Maggini I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031271; Marra PP, 1998, OECOLOGIA, V116, P284, DOI 10.1007/s004420050590; McKellar AE, 2013, OECOLOGIA, V172, P595, DOI 10.1007/s00442-012-2520-8; McKinnon EA, 2015, OECOLOGIA, V179, P363, DOI 10.1007/s00442-015-3343-1; McKinnon EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105605; McKinnon Emily A., 2013, Animal Migration, V1, P31, DOI 10.2478/ami-2013-0001; Nilsson C, 2013, AM NAT, V181, P837, DOI 10.1086/670335; Norris DR, 2005, OIKOS, V109, P178, DOI 10.1111/j.0030-1299.2005.13671.x; Norris DR, 2004, P ROY SOC B-BIOL SCI, V271, P59, DOI 10.1098/rspb.2003.2569; Paxton KL, 2015, J AVIAN BIOL, V46, P495, DOI 10.1111/jav.00614; Pettorelli N, 2011, CLIM RES, V46, P15, DOI 10.3354/cr00936; Pyle P, 1997, IDENTIFICATION GUIDE, VI; R Development Core Team, 2014, R LANG ENV STAT COMP; Richards LA, 2007, J TROP ECOL, V23, P169, DOI 10.1017/S0266467406003907; Rockwell SM, 2012, AUK, V129, P744, DOI 10.1525/auk.2012.12003; Rushing CS, 2014, ECOL APPL, V24, P445, DOI 10.1890/13-1091.1; Saino N, 2004, P ROY SOC B-BIOL SCI, V271, P681, DOI 10.1098/rspb.2003.2656; Sauer JR, 2012, N AM BREEDING BIRD S; Senner NR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086588; Stanley CQ, 2015, CONSERV BIOL, V29, P164, DOI 10.1111/cobi.12352; Stanley CQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040688; Strong AM, 2000, J ANIM ECOL, V69, P883, DOI 10.1046/j.1365-2656.2000.00447.x; Studds CE, 2005, ECOLOGY, V86, P2380, DOI 10.1890/04-1145; Studds CE, 2011, P ROY SOC B-BIOL SCI, V278, P3437, DOI 10.1098/rspb.2011.0332; Stutchbury BJM, 2011, P ROY SOC B-BIOL SCI, V278, P131, DOI 10.1098/rspb.2010.1220; Stutchbury BJM, 2009, SCIENCE, V323, P896, DOI 10.1126/science.1166664; Taylor CM, 2015, ECOL APPL IN PRESS; Tottrup AP, 2012, SCIENCE, V338, P1307, DOI 10.1126/science.1227548; Tottrup AP, 2008, BIOL LETTERS, V4, P685, DOI 10.1098/rsbl.2008.0290	58	34	34	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141580	10.1371/journal.pone.0141580	http://dx.doi.org/10.1371/journal.pone.0141580			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529241	Green Published, Green Submitted, gold			2022-12-26	WOS:000364032600040
J	Shigeta, S; Toyoshima, M; Kitatani, K; Ishibashi, M; Usui, T; Yaegashi, N				Shigeta, S.; Toyoshima, M.; Kitatani, K.; Ishibashi, M.; Usui, T.; Yaegashi, N.			Transferrin facilitates the formation of DNA double-strand breaks via transferrin receptor 1: the possible involvement of transferrin in carcinogenesis of high-grade serous ovarian cancer	ONCOGENE			English	Article							FALLOPIAN-TUBE EPITHELIUM; HUMAN FOLLICULAR-FLUID; CANDIDATE PRECURSOR; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; DAMAGE RESPONSE; IRON; INFLAMMATION; WOMEN; MODEL	Fallopian tubal epithelium is a candidate for the origin of high-grade serous ovarian cancer. Transferrin-containing follicular fluid and/or retrograde menstrual blood are possible risk factors for carcinogenesis. Accumulation of DNA double-strand breaks (DNA-DSBs) in the fallopian tubal epithelium is considered to play an important role in the development of cancer. However, the mechanisms by which DNA-DSBs accumulate have not yet been fully elucidated. The hydroxyl radical, which is produced in a Fenton reaction catalyzed by an iron ion, serves as a potent DNA-DSB-inducing molecule, raising the potential of an iron ion transporter of transferrin in the formation of DNA-DSBs. We studied the potential involvement of transferrin in DNA damage and the development of ovarian cancer. Treatment with transferrin facilitated the formation of histone 2AX phosphorylated at Serine 139 (gamma H2AX), which is known as a DNA-DSB marker, in human fallopian tube secretory epithelial cells and A2780 ovarian cancer cells. Knockdown of transferrin receptor 1 (TfR1), but not transferrin receptor 2, suppressed the transferrin uptake and consequent formation of gamma H2AX. As hydroxyl radicals in reactive oxygen species (ROS) are involved in DNA-DSBs, the formation of ROS was determined. Treatment with TfR1-specific small interference RNAs significantly diminished transferrin-induced formation of ROS. Moreover, TfR1-dependent uptake of transferrin was revealed to augment the formation of DNA-DSBs in the presence of hydrogen peroxide, which served as a substrate for the Fenton reaction. An ex vivo study with murine fallopian tubes further demonstrated that transferrin treatment introduced DNA-DSBs in the fallopian tubal epithelium. Collectively, these data suggested that the transferrin-TfR1 axis accounts for the induction of DNA-DSBs that potentially lead to DNA damage/genome instability. These findings also suggested that exposure to transferrin initiates and promotes the development of ovarian cancer by aiding the accumulation of DNA-DSBs in the fallopian tubal epithelium.	[Shigeta, S.; Toyoshima, M.; Kitatani, K.; Ishibashi, M.; Yaegashi, N.] Tohoku Univ, Sch Med, Dept Obstet & Gynecol, Sendai, Miyagi, Japan; [Toyoshima, M.] Sendai Med Ctr, Dept Obstet & Gynecol, Sendai, Miyagi, Japan; [Kitatani, K.; Usui, T.] Tohoku Univ, Tohoku Med Megabank Org, Sendai, Miyagi, Japan	Tohoku University; Tohoku University	Toyoshima, M (corresponding author), Tohoku Univ, Sch Med, Dept Obstet & Gynecol, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.; Kitatani, K (corresponding author), Tohoku Univ, Tohoku Med Megabank Org, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9800873, Japan.	m-toyo@med.tohoku.ac.jp; kitatani@med.tohoku.ac.jp	Kitatani, Kazuyuki/H-7100-2019	Kitatani, Kazuyuki/0000-0002-8516-6135; xing zhi, shi zhi/0000-0003-3289-5681	JSPS KAKENHI [23791801, 26462509, 23790366, 26861304, 40539235, 24390375, 26670710]; Health Labor Sciences Research Grant [201221019A]; Kurokawa Cancer Research Foundation; Japan Society of Gynecologic Oncology; Foundation for Promotion of Cancer Research; Tohoku University Graduate School of Medicine United Center for Advanced Research and Translational Medicine; Grants-in-Aid for Scientific Research [26462509, 26670710] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Health Labor Sciences Research Grant; Kurokawa Cancer Research Foundation(Kurokawa Cancer Research Foundation); Japan Society of Gynecologic Oncology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Foundation for Promotion of Cancer Research; Tohoku University Graduate School of Medicine United Center for Advanced Research and Translational Medicine; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Drs Ronny Drapkin and Alison M Karst for kindly providing FTSECs established in their laboratory. This study was supported in part by the JSPS KAKENHI Grants (23791801 and 26462509 to MT, 23790366, 26861304 and 40539235 to KK, 24390375 and 26670710 to NY), a Health Labor Sciences Research Grant (201221019A to NY), the Kurokawa Cancer Research Foundation (MT), the Japan Society of Gynecologic Oncology (MT), the Foundation for Promotion of Cancer Research (MT) and Tohoku University Graduate School of Medicine United Center for Advanced Research and Translational Medicine (MT).	Bahar-Shany K, 2014, GYNECOL ONCOL, V132, P322, DOI 10.1016/j.ygyno.2013.12.015; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bowtell DDL, 2010, NAT REV CANCER, V10, P803, DOI 10.1038/nrc2946; Briggs DA, 1999, MOL HUM REPROD, V5, P1107, DOI 10.1093/molehr/5.12.1107; Calzolari A, 2007, BLOOD CELL MOL DIS, V39, P82, DOI 10.1016/j.bcmd.2007.02.003; CANNISTRA SA, 1993, NEW ENGL J MED, V329, P1550, DOI 10.1056/NEJM199311183292108; Carbone MC, 2003, MOL HUM REPROD, V9, P639, DOI 10.1093/molehr/gag090; CASAGRANDE JT, 1979, LANCET, V2, P170; Chen EY, 2010, J PATHOL, V222, P110, DOI 10.1002/path.2739; Dizdaroglu M, 2002, FREE RADICAL BIO MED, V32, P1102, DOI 10.1016/S0891-5849(02)00826-2; Elizur SE, 2014, GYNECOL ENDOCRINOL, V30, P705, DOI 10.3109/09513590.2014.924100; ENTMAN SS, 1987, J IN VITRO FERTIL EM, V4, P98, DOI 10.1007/BF01555447; Falconer H, 2015, J NATL CANC IN PRESS, V107; FATHALLA MF, 1971, LANCET, V2, P163; Federico A, 2007, INT J CANCER, V121, P2381, DOI 10.1002/ijc.23192; Folkins AK, 2008, GYNECOL ONCOL, V109, P168, DOI 10.1016/j.ygyno.2008.01.012; Fridlich R, 2015, DNA REPAIR, V30, P11, DOI 10.1016/j.dnarep.2015.03.002; Garcia-Canton C, 2012, TOXICOL IN VITRO, V26, P1075, DOI 10.1016/j.tiv.2012.06.006; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Gupta S, 2011, REPROD FERT DEVELOP, V23, P673, DOI 10.1071/RD10270; Havrilesky LJ, 2013, OBSTET GYNECOL, V122, P139, DOI 10.1097/AOG.0b013e318291c235; Hennet ML, 2013, J ASSIST REPROD GEN, V30, P333, DOI 10.1007/s10815-012-9925-5; Herbison CE, 2009, AM J PHYSIOL-CELL PH, V297, pC1567, DOI 10.1152/ajpcell.00649.2008; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Karst AM, 2012, NAT PROTOC, V7, P1755, DOI 10.1038/nprot.2012.097; Kawabata H, 1999, J BIOL CHEM, V274, P20826, DOI 10.1074/jbc.274.30.20826; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kumari A, 2004, ONCOGENE, V23, P2324, DOI 10.1038/sj.onc.1207379; Kurman RJ, 2011, HUM PATHOL, V42, P918, DOI 10.1016/j.humpath.2011.03.003; Kurman RJ, 2010, AM J SURG PATHOL, V34, P433, DOI 10.1097/PAS.0b013e3181cf3d79; Lau A, 2014, EXP BIOL MED, V239, P24, DOI 10.1177/1535370213508216; Lee Y, 2007, J PATHOL, V211, P26, DOI 10.1002/path.2091; Levanon K, 2010, ONCOGENE, V29, P1103, DOI 10.1038/onc.2009.402; Madsen C, 2015, ACTA OBSTET GYN SCAN, V94, P86, DOI 10.1111/aogs.12516; Mashiko S, 2015, CANCER BIOL THER, V16, P253, DOI 10.1080/15384047.2014.1001271; Meneghini R, 1997, FREE RADICAL BIO MED, V23, P783, DOI 10.1016/S0891-5849(97)00016-6; Modugno F, 2012, INT J GYNECOL CANCER, V22, pS45, DOI 10.1097/IGC.0b013e31826bd1f2; Narod SA, 2001, LANCET, V357, P1467, DOI 10.1016/S0140-6736(00)04642-0; NASCIMENTO ALTO, 1995, CARCINOGENESIS, V16, P1335, DOI 10.1093/carcin/16.6.1335; Ohshima H, 2003, ARCH BIOCHEM BIOPHYS, V417, P3, DOI 10.1016/S0003-9861(03)00283-2; Oyawoye O, 2003, HUM REPROD, V18, P2270, DOI 10.1093/humrep/deg450; Ponka P, 1999, INT J BIOCHEM CELL B, V31, P1111, DOI 10.1016/S1357-2725(99)00070-9; Pra D, 2012, MUTAT RES-FUND MOL M, V733, P92, DOI 10.1016/j.mrfmmm.2012.02.001; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sabatini L, 1999, FERTIL STERIL, V72, P1027, DOI 10.1016/S0015-0282(99)00411-2; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shaw PA, 2009, MODERN PATHOL, V22, P1133, DOI 10.1038/modpathol.2009.89; Shih IM, 2004, AM J PATHOL, V164, P1511, DOI 10.1016/S0002-9440(10)63708-X; Squires S, 2004, CELL CYCLE, V3, P1543, DOI 10.4161/cc.3.12.1272; Takabayashi H, 2013, HUM PATHOL, V44, P1038, DOI 10.1016/j.humpath.2012.09.006; Vercellini P, 2011, HUM REPROD, V26, P2262, DOI 10.1093/humrep/der211; West AP, 2000, J BIOL CHEM, V275, P38135, DOI 10.1074/jbc.C000664200	53	23	23	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 7	2016	35	27					3577	3586		10.1038/onc.2015.425	http://dx.doi.org/10.1038/onc.2015.425			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DR0UD	26549031				2022-12-26	WOS:000379621500010
J	Ludolphs, M; Schneeberger, D; Soykan, T; Schafer, J; Papadopoulos, T; Brose, N; Schindelin, H; Steinem, C				Ludolphs, Michaela; Schneeberger, Daniela; Soykan, Tolga; Schaefer, Jonas; Papadopoulos, Theofilos; Brose, Nils; Schindelin, Hermann; Steinem, Claudia			Specificity of Collybistin-Phosphoinositide Interactions: IMPACT OF THE INDIVIDUAL PROTEIN DOMAINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						GABA receptor; inositol phospholipid; lipid bilayer; lipid-protein interaction; membrane function	PLECKSTRIN HOMOLOGY DOMAINS; SOLID SUPPORTED MEMBRANES; PLASMA-MEMBRANE; PH-DOMAIN; INOSITOL PHOSPHATES; CDC42 ACTIVATION; STRUCTURAL BASIS; EXCHANGE FACTOR; HIGH-AFFINITY; BINDING	The regulatory protein collybistin (CB) recruits the receptor-scaffolding protein gephyrin to mammalian inhibitory glycinergic and GABAergic postsynaptic membranes in nerve cells. CB is tethered to the membrane via phosphoinositides. We developed an in vitro assay based on solid-supported 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine membranes doped with different phosphoinositides on silicon/silicon dioxide substrates to quantify the binding of various CB2 constructs using reflectometric interference spectroscopy. Based on adsorption isotherms, we obtained dissociation constants and binding capacities of the membranes. Our results show that full-length CB2 harboring the N-terminal Src homology 3 (SH3) domain (CB2(SH3+)) adopts a closed and autoinhibited conformation that largely prevents membrane binding. This autoinhibition is relieved upon introduction of the W24A/E262A mutation, which conformationally opens CB2(SH3+) and allows the pleckstrin homology domain to properly bind lipids depending on the phosphoinositide species with a preference for phosphatidylinositol 3-monophosphate and phosphatidylinositol 4-monophosphate. This type of membrane tethering under the control of the release of the SH3 domain of CB is essential for regulating gephyrin clustering.	[Ludolphs, Michaela; Schaefer, Jonas; Steinem, Claudia] Univ Gottingen, Inst Organ & Biomol Chem, D-37077 Gottingen, Germany; [Schneeberger, Daniela; Schindelin, Hermann] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, D-97080 Wurzburg, Germany; [Soykan, Tolga; Brose, Nils] Max Planck Inst Expt Med, Dept Mol Neurobiol, D-37075 Gottingen, Germany; [Papadopoulos, Theofilos] Univ Med Gottingen, Dept Mol Biol, D-37073 Gottingen, Germany	University of Gottingen; University of Wurzburg; Max Planck Society; University of Gottingen	Steinem, C (corresponding author), Univ Gottingen, Inst Organ & Biomol Chem, Tammannstr 2, D-37077 Gottingen, Germany.	csteine@gwdg.de	Schindelin, Hermann/Q-2697-2019; Steinem, Claudia/O-4801-2019; Steinem, Claudia/K-7534-2018	Steinem, Claudia/0000-0001-8778-9283; Papadopoulos, Theofilos/0000-0002-0684-2407	Max Planck Society; German Research Foundation (a Center of Nanoscale Microscopy and Molecular Physiology of the Brain grant); German Research Foundation [PA 2087/1-1, SCHI 425/8-1]; Rudolf Virchow Center for Experimental Biomedicine; European Commission Innovative Medicines Initiative [FP7-115300]	Max Planck Society(Max Planck Society); German Research Foundation (a Center of Nanoscale Microscopy and Molecular Physiology of the Brain grant); German Research Foundation(German Research Foundation (DFG)); Rudolf Virchow Center for Experimental Biomedicine; European Commission Innovative Medicines Initiative	This work was supported by the Max Planck Society (to N. B.), the German Research Foundation (a Center of Nanoscale Microscopy and Molecular Physiology of the Brain grant (to N. B.) and Grants PA 2087/1-1 (to T. P.) and SCHI 425/8-1 (to H. S.)) as well as funding through the Rudolf Virchow Center for Experimental Biomedicine (to H. S.), and European Commission Innovative Medicines Initiative FP7-115300 (to N. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Braunger JA, 2013, LANGMUIR, V29, P14204, DOI 10.1021/la402646k; Busse RA, 2013, AUTOPHAGY, V9, P770, DOI 10.4161/auto.23978; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Faiss S, 2008, BBA-BIOMEMBRANES, V1778, P1601, DOI 10.1016/j.bbamem.2008.01.003; Falasca M, 2007, BIOCHEM SOC T, V35, P211, DOI 10.1042/BST0350211; Ferguson CG, 2005, BIOCONJUGATE CHEM, V16, P1475, DOI 10.1021/bc050197q; Ferguson KM, 2000, MOL CELL, V6, P373, DOI 10.1016/S1097-2765(00)00037-X; Fernandes F, 2006, J LIPID RES, V47, P1521, DOI 10.1194/jlr.M600121-JLR200; Garcia P, 1995, BIOCHEMISTRY-US, V34, P16228, DOI 10.1021/bi00049a039; GAUGLITZ G, 1993, SENSOR ACTUAT B-CHEM, V11, P21, DOI 10.1016/0925-4005(93)85234-2; Harvey K, 2004, J NEUROSCI, V24, P5816, DOI 10.1523/JNEUROSCI.1184-04.2004; Herrig A, 2006, BIOCHEMISTRY-US, V45, P13025, DOI 10.1021/bi061064a; Hoon M, 2011, P NATL ACAD SCI USA, V108, P3053, DOI 10.1073/pnas.1006946108; HYVONEN M, 1995, EMBO J, V14, P4676, DOI 10.1002/j.1460-2075.1995.tb00149.x; Janke M, 2008, BIOCHEMISTRY-US, V47, P3762, DOI 10.1021/bi702542s; Kalscheuer VM, 2009, HUM MUTAT, V30, P61, DOI 10.1002/humu.20814; Kavran JM, 1998, J BIOL CHEM, V273, P30497, DOI 10.1074/jbc.273.46.30497; Kneussel M, 2000, TRENDS NEUROSCI, V23, P429, DOI 10.1016/S0166-2236(00)01627-1; Kneussel M, 2000, J PHYSIOL-LONDON, V525, P1, DOI 10.1111/j.1469-7793.2000.t01-4-00001.x; Knight JD, 2009, BIOPHYS J, V96, P566, DOI 10.1016/j.bpj.2008.10.020; Kong AM, 2006, MOL CELL BIOL, V26, P6065, DOI 10.1128/MCB.00203-06; Krick R, 2012, P NATL ACAD SCI USA, V109, pE2042, DOI 10.1073/pnas.1205128109; Kuerka N., 2011, BBA-BIOMEMBRANES, V1808, P2761, DOI DOI 10.1016/J.BBAMEM.2011.07.022; Larson I, 2000, J COLLOID INTERF SCI, V227, P152, DOI 10.1006/jcis.2000.6847; Latour RA, 2015, J BIOMED MATER RES A, V103, P949, DOI 10.1002/jbm.a.35235; LEMMON MA, 1995, P NATL ACAD SCI USA, V92, P10472, DOI 10.1073/pnas.92.23.10472; Lemmon MA, 2007, BIOCHEM SOC SYMP, V74, P81, DOI 10.1042/BSS2007c08; Lietzke SE, 2000, MOL CELL, V6, P385, DOI 10.1016/S1097-2765(00)00038-1; Lodhi IJ, 2008, MOL BIOL CELL, V19, P2718, DOI 10.1091/mbc.E08-01-0105; Lupyan D, 2010, BIOPHYS J, V98, P240, DOI 10.1016/j.bpj.2009.09.063; Maffucci T, 2003, EMBO J, V22, P4178, DOI 10.1093/emboj/cdg402; Mayer S, 2013, P NATL ACAD SCI USA, V110, P20795, DOI 10.1073/pnas.1309078110; Mitin N, 2007, NAT STRUCT MOL BIOL, V14, P814, DOI 10.1038/nsmb1290; Nakatsu F, 2012, J CELL BIOL, V199, P1003, DOI 10.1083/jcb.201206095; Papadopoulos T, 2007, EMBO J, V26, P3888, DOI 10.1038/sj.emboj.7601819; Papadopoulos T, 2015, J BIOL CHEM, V290, P8256, DOI 10.1074/jbc.M114.633024; Papadopoulos Theofilos, 2011, Front Cell Neurosci, V5, P11, DOI 10.3389/fncel.2011.00011; Poulopoulos A, 2009, NEURON, V63, P628, DOI 10.1016/j.neuron.2009.08.023; Proll Guenther, 2009, V503, P167, DOI 10.1007/978-1-60327-567-5_8; Rameh LE, 1997, J BIOL CHEM, V272, P22059, DOI 10.1074/jbc.272.35.22059; Reddy-Alla S, 2010, EUR J NEUROSCI, V31, P1173, DOI 10.1111/j.1460-9568.2010.07149.x; Roth G, 2007, CHEMBIOCHEM, V8, P323, DOI 10.1002/cbic.200600254; Saarikangas J, 2010, PHYSIOL REV, V90, P259, DOI 10.1152/physrev.00036.2009; Schutte OM, 2015, BIOPHYS J, V108, P2775, DOI 10.1016/j.bpj.2015.05.009; Soykan T, 2014, EMBO J, V33, P2113, DOI 10.15252/embj.201488143; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Stephan M, 2014, ANALYST, V139, P1987, DOI 10.1039/c4an00009a; Tyagarajan SK, 2011, J CELL SCI, V124, P2786, DOI 10.1242/jcs.086199; Vicinanza M, 2008, EMBO J, V27, P2457, DOI 10.1038/emboj.2008.169; Vilardi F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085033; Xiang S, 2006, J MOL BIOL, V359, P35, DOI 10.1016/j.jmb.2006.03.019	52	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					244	254		10.1074/jbc.M115.673400	http://dx.doi.org/10.1074/jbc.M115.673400			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26546675	Green Published, hybrid			2022-12-26	WOS:000367589500019
J	Liu, GY; Zhou, YH; Liu, D; Wang, QQ; Ruan, ZL; He, Q; Zhang, LM				Liu, Guoyan; Zhou, Yonghong; Liu, Dan; Wang, Qianqian; Ruan, Zengliang; He, Qian; Zhang, Liming			Global Transcriptome Analysis of the Tentacle of the Jellyfish Cyanea capillata Using Deep Sequencing and Expressed Sequence Tags: Insight into the Toxin- and Degenerative Disease-Related Transcripts	PLOS ONE			English	Article								Background Jellyfish contain diverse toxins and other bioactive components. However, large-scale identification of novel toxins and bioactive components from jellyfish has been hampered by the low efficiency of traditional isolation and purification methods. Results We performed de novo transcriptome sequencing of the tentacle tissue of the jellyfish Cyanea capillata. A total of 51,304,108 reads were obtained and assembled into 50,536 unigenes. Of these, 21,357 unigenes had homologues in public databases, but the remaining unigenes had no significant matches due to the limited sequence information available and species-specific novel sequences. Functional annotation of the unigenes also revealed general gene expression profile characteristics in the tentacle of C. capillata. A primary goal of this study was to identify putative toxin transcripts. As expected, we screened many transcripts encoding proteins similar to several well-known toxin families including phospholipases, metalloproteases, serine proteases and serine protease inhibitors. In addition, some transcripts also resembled molecules with potential toxic activities, including cnidarian CfTX-like toxins with hemolytic activity, plancitoxin-1, venom toxin-like peptide-6, histamine- releasing factor, neprilysin, dipeptidyl peptidase 4, vascular endothelial growth factor A, angiotensin-converting enzyme-like and endothelin-converting enzyme 1-like proteins. Most of these molecules have not been previously reported in jellyfish. Interestingly, we also characterized a number of transcripts with similarities to proteins relevant to several degenerative diseases, including Huntington's, Alzheimer's and Parkinson's diseases. This is the first description of degenerative disease-associated genes in jellyfish. Conclusion We obtained a well-categorized and annotated transcriptome of C. capillata tentacle that will be an important and valuable resource for further understanding of jellyfish at the molecular level and information on the underlying molecular mechanisms of jellyfish stinging. The findings of this study may also be used in comparative studies of gene expression profiling among different jellyfish species.	[Liu, Guoyan; Zhou, Yonghong; Liu, Dan; Wang, Qianqian; Ruan, Zengliang; Zhang, Liming] Second Mil Med Univ, Marine Biopharmaceut Inst, Shanghai 200433, Peoples R China; [Liu, Guoyan; Zhou, Yonghong; Liu, Dan; Wang, Qianqian; Ruan, Zengliang; Zhang, Liming] Second Mil Med Univ, Fac Naval Med, Dept Marine Biotechnol, Shanghai 200433, Peoples R China; [He, Qian] Second Mil Med Univ, Affiliated Hosp 3, Dept Gynecol, Shanghai 200433, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University	He, Q (corresponding author), Second Mil Med Univ, Affiliated Hosp 3, Dept Gynecol, Shanghai 200433, Peoples R China.	heqian@smmu.edu.cn; lmzhang@smmu.edu.cn	Ruan, Zengliang/CAG-5992-2022; Ruan, Zengliang/AAD-3032-2022	Ruan, Zengliang/0000-0002-9468-0232; Ruan, Zengliang/0000-0002-9468-0232; Zhou, Yonghong/0000-0002-1242-1764	National Natural Science Foundation of China [41306136]; Natural Science Foundation of Shanghai Municipal Government [12ZR1437000]; National High Technology Research and Development Program of China (863 Program) [2013M092904]; National Natural Science Foundation of China [41306136]; Natural Science Foundation of Shanghai Municipal Government [12ZR1437000]; National High Technology Research and Development Program of China (863 Program) [2013M092904]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai Municipal Government; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai Municipal Government; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	Funding: This work was supported by the Young Scientists Fund of National Natural Science Foundation of China (41306136), the Natural Science Foundation of Shanghai Municipal Government (12ZR1437000) and the National High Technology Research and Development Program of China (863 Program) (2013M092904). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird SD, 2008, COMP BIOCH PHYSL B, V150; Aird SD, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-790; Almeida DD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-362; Almeida FM, 2002, TOXICON, V40, P1041, DOI 10.1016/S0041-0101(02)00084-3; Armstrong RA, 2013, FOLIA NEUROPATHOL, V51; Arni RK, 1996, TOXICON, V34, P827, DOI 10.1016/0041-0101(96)00036-0; Bailey PM, 2005, TOXICON, V45, P233, DOI 10.1016/j.toxicon.2004.10.013; Beilei W, 2012, J CARDIOVASC PHARM, V59; Benraiss A, 2011, NEUROTHERAPEUTICS, V8, P577, DOI 10.1007/s13311-011-0075-8; Brekhman V, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1320-z; Brinkman D, 2007, TOXICON, V50, P850, DOI 10.1016/j.toxicon.2007.06.016; Brinkman DL, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1568-3; Brinkman DL, 2014, J BIOL CHEM, V289, P4798, DOI 10.1074/jbc.M113.534149; Burke WA, 2002, DERMATOLOGIC THERAPY, V15; Casewell NR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-564; Cegolon L, 2013, MAR DRUGS, V11, P523, DOI 10.3390/md11020523; Chaim OM, 2011, TOXINS BASEL, V3; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Fox JW., 2013, TOXICON, V62; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gutierrez JM, 2000, BIOCHIMIE, V82, P841, DOI 10.1016/S0300-9084(00)01163-9; Hao DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021220; Harada K, 2011, MOL MED REP, V4, P919, DOI 10.3892/mmr.2011.506; Huang Q, 2012, PLOS ONE, V7; Iseli C, 1999, P INT C INTELL SYST; Kang C, 2014, TOXICON, V86, P116, DOI 10.1016/j.toxicon.2014.04.005; Kim E, 2006, TOXICOL LETT, V167, P205, DOI 10.1016/j.toxlet.2006.09.009; Kini RM., 2005, TOXICON, V45; Learmont SA, 2006, AUSTRALASIAN EMERGEN, V9; Lee H, 2011, TOXICON, V58, P277, DOI 10.1016/j.toxicon.2011.06.007; Lee VS, 2007, INSECT MOL BIOL, V16; Li R, 2014, J PROTEOMICS, P106; Liang XX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033861; Ma Y, 2009, BMC GENOMICS, V10; Marino A, 2008, COMP BIOCH PHYSL A, V151; Mulenga A, 2005, EXP APPL ACAROL, V37, P215, DOI 10.1007/s10493-005-3261-8; Nagai H, 2002, BIOSCI BIOTECHNOL BI, V66; Nagai H, 2000, BIOCH BIOPHYS RES CO, V275; Nevalainen TJ, 2004, COMP BIOCH PHYSL B, V139; Ogawa Y, 2008, TOXICON, V51, P984, DOI 10.1016/j.toxicon.2008.02.003; Ota E, 2006, TOXICON, V48, P1002, DOI 10.1016/j.toxicon.2006.08.005; Rokyta DR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-312; Ruan Z, 2014, MAR DRUGS, V12; Ruan Z, 2014, PLOS ONE, V9; Sade YB, 2012, INT J BIOCH CELL BIO, V44; Safavi-Hemami H, 2013, J PROTEOMICS, V91, P97, DOI 10.1016/j.jprot.2013.07.007; Santoro ML, 2009, TOXICON, V54, P499, DOI 10.1016/j.toxicon.2009.05.016; Schwartz EF, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-119; Serrano SM, 2005, TOXICON, V45; Shen GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029127; Shiomi K, 2004, TOXICON, V44; Siang AS, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-24; Sugahara T, 2006, BIOSCI BIOTECHNOL BI, V70; Tao X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036234; Tibballs J, 2006, TOXICON, V48; Toom PM, 1972, COMP BIOCH PHYSL B, V43; Torres AFC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087556; Trevisan-Silva D, 2010, BIOCHIMIE, V92, P21, DOI 10.1016/j.biochi.2009.10.003; Turk T, 2009, TOXICON, V54; Turner AJ, 2001, BIOESSAYS, V23; Undheim EA, 2013, TOXINS BASEL, V5; Uri S, 2005, CONTACT DERMATITIS, V52; Vincent B, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-693; Whelan NV, 2014, GENOME BIOL EVOL, V6; Wu PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028000; Xiao L, 2010, TOXICOL IN VITRO, V24; Xiao L, 2009, TOXICON, V53, P146, DOI 10.1016/j.toxicon.2008.10.023; Yang DY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032283; Yang R, 2005, J CARDIOVASC PHARMAC, V129; Ye J., 2006, NUCL ACIDS RES, V34; Yu H, 2007, FOOD CHEM TOXICOL, V45	72	61	64	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2015	10	11							e0142680	10.1371/journal.pone.0142680	http://dx.doi.org/10.1371/journal.pone.0142680			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7AC	26551022	Green Submitted, gold, Green Published			2022-12-26	WOS:000364422800031
J	Bhattacharya, T; Ghosh, TS; Mande, SS				Bhattacharya, Tanudeep; Ghosh, Tarini Shankar; Mande, Sharmila S.			Global Profiling of Carbohydrate Active Enzymes in Human Gut Microbiome	PLOS ONE			English	Article							SYMBIOSIS; OBESITY; SIZE	Motivation Carbohydrate Active enzyme (CAZyme) families, encoded by human gut microflora, play a crucial role in breakdown of complex dietary carbohydrates into components that can be absorbed by our intestinal epithelium. Since nutritional wellbeing of an individual is dependent on the nutrient harvesting capability of the gut microbiome, it is important to understand how CAZyme repertoire in the gut is influenced by factors like age, geography and food habits. Results This study reports a comprehensive in-silico analysis of CAZyme profiles in the gut microbiomes of 448 individuals belonging to different geographies, using similarity searches of the corresponding gut metagenomic contigs against the carbohydrate active enzymes database. The study identifies a core group of 89 CAZyme families that are present across 85% of the gut microbiomes. The study detects several geography/age-specific trends in gut CAZyme repertoires of the individuals. Notably, a group of CAZymes having a positive correlation with BMI has been identified. Further this group of BMI-associated CAZymes is observed to be specifically abundant in the Firmicutes phyla. One of the major findings from this study is identification of three distinct groups of individuals, referred to as 'CAZotypes', having similar CAZyme profiles. Distinct taxonomic drivers for these CAZotypes as well as the probable dietary basis for such trends have also been elucidated. The results of this study provide a global view of CAZyme profiles across individuals of various geographies and age-groups. These results re-iterate the need of a more precise understanding of the role of carbohydrate active enzymes in human nutrition.	[Bhattacharya, Tanudeep] Teach India, Pune, Maharashtra, India; [Ghosh, Tarini Shankar; Mande, Sharmila S.] Tata Consultancy Serv Ltd, TCS Innovat Labs, Pune, Maharashtra, India	Tata Sons; Tata Consultancy Services Limited (TCS)	Mande, SS (corresponding author), Tata Consultancy Serv Ltd, TCS Innovat Labs, 54-B Hadapsar Ind Estate, Pune, Maharashtra, India.	sharmila.mande@tcs.com	Ghosh, Tarini/AAW-5456-2020	Ghosh, Tarini/0000-0001-9570-0365				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Barker M, 2003, J CHEMOMETR, V17, P166, DOI 10.1002/cem.785; BRANDLEY BK, 1986, J LEUKOCYTE BIOL, V40, P97, DOI 10.1002/jlb.40.1.97; Cantarel BL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028742; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Damgaard C, 2000, ECOLOGY, V81, P1139, DOI 10.1890/0012-9658(2000)081[1139:DIIPSO]2.0.CO;2; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; El Kaoutari A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084033; El Kaoutari A, 2013, NAT REV MICROBIOL, V11, P497, DOI 10.1038/nrmicro3050; Flint HJ, 2012, GUT MICROBES, V3, P289, DOI 10.4161/gmic.19897; Ghosh TS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095547; Ghosh TS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083823; Gini C., 1936, GEN SERIES, V208, P73; Holeman A, 2004, CURR OPIN BIOTECH, V15, P615, DOI 10.1016/j.copbio.2004.10.001; Hooper LV, 2001, GLYCOBIOLOGY, V11, p1R, DOI 10.1093/glycob/11.2.1R; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Li WZ, 2001, BIOINFORMATICS, V17, P282, DOI 10.1093/bioinformatics/17.3.282; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Sen Gupta S, 2011, GUT PATHOG, V3, DOI 10.1186/1757-4749-3-7; Sharma AR, 2010, INT J SOCIAL FORESTR, V3, P17; Tsai Franklin, 2009, Curr Gastroenterol Rep, V11, P307, DOI 10.1007/s11894-009-0045-z; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Williams LJ, 2010, WILEY INTERDISCIPLIN, V2; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	30	55	56	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142038	10.1371/journal.pone.0142038	http://dx.doi.org/10.1371/journal.pone.0142038			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544883	gold, Green Published, Green Submitted			2022-12-26	WOS:000364398700073
J	Jiang, X; Luo, X; Zhou, NY				Jiang, Xuan; Luo, Xi; Zhou, Ning-Yi			Two Polyhydroxyalkanoate Synthases from Distinct Classes from the Aromatic Degrader Cupriavidus pinatubonensis JMP134 Exhibit the Same Substrate Preference	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; IN-VIVO; DEGRADATION; CATABOLISM; PLASMIDS; BIOSYNTHESIS; CONSTRUCTION; SPECIFICITY; CLONING; GENOME	Cupriavidus pinatubonensis JMP134 utilizes a variety of aromatic substrates as sole carbon sources, including meta-nitrophenol (MNP). Two polyhydroxyalkanoate (PHA) synthase genes, phaC1 and phaC2, were annotated and categorized as class I and class II PHA synthase genes, respectively. In this study, both His-tagged purified PhaC1 and PhaC2 were shown to exhibit typical class I PHA synthase substrate specificity to make short-chain-length (SCL) PHA from 3-hydroxybutyryl-CoA and failed to make medium-chain-length (MCL) PHA from 3-hydroxyoctanoyl-CoA. The phaC1 or phaC2 deletion strain could also produce SCL PHA when grown in fructose or octanoate, but the double mutant of phaC1 and phaC2 lost this ability. The PhaC2 also exhibited substrate preference towards SCL substrates when expressed in Pseudomonas aeruginosa PAO1 phaC mutant strain. On the other hand, the transcriptional level of phaC1 was 70-fold higher than that of phaC2 in MNP-grown cells, but 240-fold lower in octanoate-grown cells. Further study demonstrated that only phaC1 was involved in PHA synthesis in MNP-grown cells. These findings suggested that phaC1 and phaC2 genes were differentially regulated under different growth conditions in this strain. Within the phaC2-containing gene cluster, a single copy of PHA synthase gene was present clustering with genes encoding enzymes in the biosynthesis of PHA precursors. This is markedly different from the genetic organization of all other previously reported class II PHA synthase gene clusters and this cluster likely comes from a distinct evolutionary path.	[Jiang, Xuan; Luo, Xi; Zhou, Ning-Yi] Chinese Acad Sci, Wuhan Inst Virol, Key Lab Agr & Environm Microbiol, Wuhan 430071, Peoples R China; [Zhou, Ning-Yi] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200240, Peoples R China; [Zhou, Ning-Yi] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200240, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhou, NY (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, Key Lab Agr & Environm Microbiol, Wuhan 430071, Peoples R China.	n.zhou@pentium.whiov.ac.cn		Jiang, Xuan/0000-0003-2749-7304	National Key Basic Research Program of China (973 Program) [2012CB725202]; National Natural Science Foundation of China [31300123]	National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by the following: 973 Program, grant no. 2012CB725202 from the National Key Basic Research Program of China (http://www.973.gov.cn/English/Index.aspx); and grant no. 31300123 from the National Natural Science Foundation of China (http://www.nsfc.gov.cn/publish/portal1/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON AJ, 1990, INT J BIOL MACROMOL, V12, P102, DOI 10.1016/0141-8130(90)90060-N; BRANDL H, 1988, APPL ENVIRON MICROB, V54, P1977, DOI 10.1128/AEM.54.8.1977-1982.1988; Chen JY, 2004, FEMS MICROBIOL LETT, V234, P231, DOI 10.1016/j.femsle.2004.03.029; Chen YF, 2014, APPL MICROBIOL BIOT, V98, P1349, DOI 10.1007/s00253-013-5001-z; Chen YJ, 2014, ENZYME MICROB TECH, V56, P60, DOI 10.1016/j.enzmictec.2014.01.005; Chuah JA, 2013, APPL ENVIRON MICROB, V79, P3813, DOI 10.1128/AEM.00564-13; Dehio C, 1997, J BACTERIOL, V179, P538, DOI 10.1128/jb.179.2.538-540.1997; DON RH, 1981, J BACTERIOL, V145, P681, DOI 10.1128/JB.145.2.681-686.1981; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; HOLLOWAY BW, 1979, MICROBIOL REV, V43, P73, DOI 10.1128/MMBR.43.1.73-102.1979; Hu F, 2014, APPL MICROBIOL BIOT, V98, P4749, DOI 10.1007/s00253-014-5567-0; HUISMAN GW, 1989, APPL ENVIRON MICROB, V55, P1949, DOI 10.1128/AEM.55.8.1949-1954.1989; Quelas JI, 2013, J BACTERIOL, V195, P3145, DOI 10.1128/JB.02203-12; KEEN NT, 1988, GENE, V70, P191, DOI 10.1016/0378-1119(88)90117-5; Kessler B, 2000, INT J SYST EVOL MICR, V50, P711, DOI 10.1099/00207713-50-2-711; Lee SY, 1996, ANN NY ACAD SCI, V782, P133, DOI 10.1111/j.1749-6632.1996.tb40555.x; Li MZ, 2005, NAT GENET, V37, P311, DOI 10.1038/ng1505; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Louie TM, 2002, J BACTERIOL, V184, P3492, DOI 10.1128/JB.184.13.3492-3500.2002; Lykidis A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009729; Matsusaki H, 1998, J BACTERIOL, V180, P6459, DOI 10.1128/JB.180.24.6459-6467.1998; Min J, 2014, APPL ENVIRON MICROB, V80, P6212, DOI 10.1128/AEM.02093-14; PEMBERTON JM, 1977, NATURE, V268, P732, DOI 10.1038/268732a0; Perez-Pantoja D, 2008, FEMS MICROBIOL REV, V32, P736, DOI 10.1111/j.1574-6976.2008.00122.x; Recinos DA, 2012, P NATL ACAD SCI USA, V109, P19420, DOI 10.1073/pnas.1213901109; Rehm BHA, 1999, INT J BIOL MACROMOL, V25, P3, DOI 10.1016/S0141-8130(99)00010-0; Rehm BHA, 2003, BIOCHEM J, V376, P15, DOI 10.1042/BJ20031254; Schenzle A, 1997, APPL ENVIRON MICROB, V63, P1421, DOI 10.1128/AEM.63.4.1421-1427.1997; Sheu DS, 2004, J BACTERIOL, V186, P4177, DOI 10.1128/JB.186.13.4177-4184.2004; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TIMM A, 1990, APPL ENVIRON MICROB, V56, P3360, DOI 10.1128/AEM.56.11.3360-3367.1990; VALENTIN HE, 1994, APPL MICROBIOL BIOT, V40, P699; Xu Y, 2013, APPL ENVIRON MICROB, V79, P6362, DOI 10.1128/AEM.02110-13; Yin Y, 2010, CURR MICROBIOL, V61, P471, DOI 10.1007/s00284-010-9640-3; Yin Y, 2010, APPL MICROBIOL BIOT, V87, P2077, DOI 10.1007/s00253-010-2666-4; ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875	36	4	4	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142332	10.1371/journal.pone.0142332	http://dx.doi.org/10.1371/journal.pone.0142332			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544851	Green Published, gold, Green Submitted			2022-12-26	WOS:000364398700113
J	Kurz, FT; Kampf, T; Buschle, LR; Schlemmer, HP; Heiland, S; Bendszus, M; Ziener, CH				Kurz, Felix T.; Kampf, Thomas; Buschle, Lukas R.; Schlemmer, Heinz-Peter; Heiland, Sabine; Bendszus, Martin; Ziener, Christian H.			Microstructural Analysis of Peripheral Lung Tissue through CPMG Inter-Echo Time R2 Dispersion	PLOS ONE			English	Article							HE-3 DIFFUSION MRI; MAGNETIC-RESONANCE BEHAVIOR; HYPERPOLARIZED HE-3; TRANSVERSE RELAXATION; BESSEL-FUNCTIONS; SELF-DIFFUSION; ALVEOLAR; FIELD; MORPHOMETRY; NUMBER	Since changes in lung microstructure are important indicators for (early stage) lung pathology, there is a need for quantifiable information of diagnostically challenging cases in a clinical setting, e.g. to evaluate early emphysematous changes in peripheral lung tissue. Considering alveoli as spherical air-spaces surrounded by a thin film of lung tissue allows deriving an expression for Carr-Purcell-Meiboom-Gill transverse relaxation rates R-2 with a dependence on inter-echo time, local air-tissue volume fraction, diffusion coefficient and alveolar diameter, within a weak field approximation. The model relaxation rate exhibits the same hyperbolic tangent dependency as seen in the Luz-Meiboom model and limiting cases agree with Brooks et al. and Jensen et al. In addition, the model is tested against experimental data for passively deflated rat lungs: the resulting mean alveolar radius of RA = 31.46 +/- 13.15 mu m is very close to the literature value (similar to 34 mu m). Also, modeled radii obtained from relaxometer measurements of ageing hydrogel foam (that mimics peripheral lung tissue) are in good agreement with those obtained from mu CT images of the same foam (mean relative error: 0.06 +/- 0.01). The model's ability to determine the alveolar radius and/or air volume fraction will be useful in quantifying peripheral lung microstructure.	[Kurz, Felix T.; Heiland, Sabine; Bendszus, Martin; Ziener, Christian H.] Heidelberg Univ, Dept Neuroradiol, Heidelberg, Germany; [Kurz, Felix T.; Buschle, Lukas R.; Schlemmer, Heinz-Peter; Ziener, Christian H.] German Canc Res Ctr, Dept Radiol, Heidelberg, Germany; [Kampf, Thomas] Univ Wurzburg, Dept Expt Phys 5, D-97070 Wurzburg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); University of Wurzburg	Kurz, FT (corresponding author), Heidelberg Univ, Dept Neuroradiol, Heidelberg, Germany.	felix.kurz@med.uni-heidelberg.de	Ziener, Christian/AAN-8411-2021	Ziener, Christian/0000-0001-8854-7358; Buschle, Lukas/0000-0002-1770-4878	Deutsche Forschungsgemeinschaft [DFG ZI 1295/2-1]; medical faculty of Heidelberg University	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); medical faculty of Heidelberg University	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (contract grant number: DFG ZI 1295/2-1) and by a postdoctoral fellowship granted to F.T.K. from the medical faculty of Heidelberg University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON PW, 1953, REV MOD PHYS, V25, P269, DOI 10.1103/RevModPhys.25.269; Baete SH, 2008, J MAGN RESON, V193, P286, DOI 10.1016/j.jmr.2008.05.010; Bauer WR, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.053412; Bauman G, 2009, MAGN RESON MED, V62, P656, DOI 10.1002/mrm.22031; BERTOLINA JA, 1992, J MAGN RESON, V99, P161, DOI 10.1016/0022-2364(92)90162-Z; Brooks RA, 2001, MAGN RESON MED, V45, P1014, DOI 10.1002/mrm.1135; BROWNSTEIN KR, 1977, J MAGN RESON, V26, P17, DOI 10.1016/0022-2364(77)90230-X; Buschle LR, 2015, MAGN RESON IMAGING, V33, P1126, DOI 10.1016/j.mri.2015.06.001; CAMPBELL H, 1952, NATURE, V170, P117, DOI 10.1038/170117a0; Carinci F, 2013, MAGN RESON MATER PHY, V26; Carinci F, 2015, J MAGN RESON IMAGING, V41, P1454, DOI 10.1002/jmri.24669; Christman RA, 1996, MAGNET RESON MED, V35, P6, DOI 10.1002/mrm.1910350103; Condorelli P, 1999, ANN BIOMED ENG, V27, P326, DOI 10.1114/1.145; CUTILLO AG, 1991, J APPL PHYSIOL, V70, P2145, DOI 10.1152/jappl.1991.70.5.2145; Cutillo AG., 1996, APPL MAGNETIC RESONA; Durand E, 2002, MAGNET RESON MED, V47, P75, DOI 10.1002/mrm.10047; Durney CH, 2000, J APPL PHYSIOL, V88, P1155, DOI 10.1152/jappl.2000.88.4.1155; Fischer A, 2008, J MAGN RESON IMAGING, V27, P63, DOI 10.1002/jmri.21235; FRASER RS, 1999, DIAGNOSIS DIS CHEST; GOTTLIEB HPW, 1985, Z ANGEW MATH PHYS, V36, P491, DOI 10.1007/BF00944640; Grebenkov DS, 2007, REV MOD PHYS, V79, P1077, DOI 10.1103/RevModPhys.79.1077; Hill WG, 2005, AM J PHYSIOL-CELL PH, V289, pC33, DOI 10.1152/ajpcell.00046.2005; HOGG JC, 1968, NEW ENGL J MED, V278, P1355, DOI 10.1056/NEJM196806202782501; Hu HH, 2011, OBES REV, V12, pe504, DOI 10.1111/j.1467-789X.2010.00824.x; Hutzler S, 1999, THE PHYS OF FOAM; Hyde DM, 2004, ANAT REC PART A, V277A, P216, DOI 10.1002/ar.a.20012; Jensen JH, 2006, MAGN RESON MED, V55, P1350, DOI 10.1002/mrm.20907; Jensen JH, 2000, MAGNET RESON MED, V43, P226, DOI 10.1002/(SICI)1522-2594(200002)43:2<226::AID-MRM9>3.0.CO;2-P; Jensen JH, 2000, MAGN RESON MED, V44, P144, DOI 10.1002/1522-2594(200007)44:1<144::AID-MRM21>3.0.CO;2-O; Knust J, 2009, ANAT REC, V292, P113, DOI 10.1002/ar.20747; Kolem H, 1989, P ANN M SOC MAGN RES, P783; KRYNICKI K, 1978, FARADAY DISCUSS, V66, P199, DOI 10.1039/dc9786600199; Kurz FT, 2014, MAGN RESON MED, V71, P1888, DOI 10.1002/mrm.25196; Laicher G, 1996, J MAGN RESON SER B, V111, P243, DOI 10.1006/jmrb.1996.0090; Lee SM, 2013, J THORAC IMAG, V28, P160, DOI 10.1097/RTI.0b013e31828d4087; Liu ZY, 2014, EUR J RADIOL, V83, P1282, DOI 10.1016/j.ejrad.2014.04.014; LUM H, 1987, J APPL PHYSIOL, V62, P1865, DOI 10.1152/jappl.1987.62.5.1865; LUZ Z, 1963, J CHEM PHYS, V39, P366, DOI 10.1063/1.1734254; MEIBOOM S, 1958, REV SCI INSTRUM, V29, P688, DOI 10.1063/1.1716296; Mezer A, 2013, NAT MED, V19, P1667, DOI 10.1038/nm.3390; Miller G., 2010, FUNDAMENTALS BIOMEDI; Miura N., 1999, AM J PHYSIOL, V276, P207; Mulkern R, 2014, CONCEPT MAGN RESON A, V43, P29, DOI 10.1002/cmr.a.21297; MURATA K, 1986, RADIOLOGY, V161, P641, DOI 10.1148/radiology.161.3.3786710; NADLER W, 1985, J CHEM PHYS, V82, P151, DOI 10.1063/1.448788; Ochs M, 2004, AM J RESP CRIT CARE, V169, P120, DOI 10.1164/rccm.200308-1107OC; Ochs M, 2006, J MICROSC-OXFORD, V222, P188, DOI 10.1111/j.1365-2818.2006.01587.x; Ortony JH, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/1/015006; Pauwels R A, 2001, Respir Care, V46, P798; Pracht ED, 2005, MAGNET RESON MED, V53, P1193, DOI 10.1002/mrm.20448; Puderbach M, 2007, EUR J RADIOL, V64, P345, DOI 10.1016/j.ejrad.2007.08.009; Quirk JD, 2015, MAGN RESON MED, V73, P1252, DOI 10.1002/mrm.25241; Quirk JD, 2011, RADIOLOGY, V260, P866, DOI 10.1148/radiol.11102226; Scarpelli EM, 1998, ANAT RECORD, V251, P491; SEN PN, 1994, PHYS REV B, V49, P215, DOI 10.1103/PhysRevB.49.215; Shioya Sumie, 1997, Tokai Journal of Experimental and Clinical Medicine, V22, P27; STONE KC, 1992, AM REV RESPIR DIS, V146, P454, DOI 10.1164/ajrccm/146.2.454; Sukstanskii AL, 2008, J MAGN RESON, V190, P200, DOI 10.1016/j.jmr.2007.10.015; SZABO A, 1980, J CHEM PHYS, V72, P4350, DOI 10.1063/1.439715; TOMKEIEFF SI, 1945, NATURE, V155, P24, DOI 10.1038/155024a0; Triphan SMF, 2015, J MAGN RESON IMAGING, V42, P610, DOI 10.1002/jmri.24840; Wolfram S., 2003, MATH BOOK; Yablonskiy DA, 2002, P NATL ACAD SCI USA, V99, P3111, DOI 10.1073/pnas.052594699; Yuan R, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-153; Ziener CH, 2007, J MAGN RESON, V184, P169, DOI 10.1016/j.jmr.2006.09.018; Ziener CH, 2010, J MAGN RESON, V202, P38, DOI 10.1016/j.jmr.2009.09.016; Ziener CH, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2949097; Ziener CH, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.046701; Ziener CH, 2005, MAGNET RESON MED, V54, P702, DOI 10.1002/mrm.20634; Ziener CH, 2006, MAGN RESON IMAGING, V24, P1341, DOI 10.1016/j.mri.2006.08.005; Ziener CH, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1142-0; Ziener CH, 2012, MAGN RESON IMAGING, V30, P540, DOI 10.1016/j.mri.2011.12.006	72	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141894	10.1371/journal.pone.0141894	http://dx.doi.org/10.1371/journal.pone.0141894			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544068	gold, Green Published, Green Submitted			2022-12-26	WOS:000364398700061
J	Nikolic, N; Duthoy, S; Destombes, A; Bodin, N; West, W; Puech, A; Bourjea, J				Nikolic, Natacha; Duthoy, Stephanie; Destombes, Antoine; Bodin, Nathalie; West, Wendy; Puech, Alexis; Bourjea, Jerome			Discovery of Genome-Wide Microsatellite Markers in Scombridae: A Pilot Study on Albacore Tuna	PLOS ONE			English	Article							THUNNUS-THYNNUS-THYNNUS; POPULATION-STRUCTURE; GENETIC DIVERSITY; ATLANTIC-OCEAN; DNA MARKERS; R-PACKAGE; ALALUNGA; MITOCHONDRIAL; MARINE; DIFFERENTIATION	Recent developments in sequencing technologies and bioinformatics analysis provide a greater amount of DNA sequencing reads at a low cost. Microsatellites are the markers of choice for a variety of population genetic studies, and high quality markers can be discovered in non-model organisms, such as tuna, with these recent developments. Here, we use a high-throughput method to isolate microsatellite markers in albacore tuna, Thunnus alalunga, based on coupling multiplex enrichment and next-generation sequencing on 454 GS-FLX Titanium pyrosequencing. The crucial minimum number of polymorphic markers to infer evolutionary and ecological processes for this species has been described for the first time. We provide 1670 microsatellite design primer pairs, and technical and molecular genetics selection resulting in 43 polymorphic microsatellite markers. On this panel, we characterized 34 random and selectively neutralmarkers ("neutral") and 9 "non-neutral" markers. The variability of "neutral" markers was screened with 136 individuals of albacore tuna from southwest Indian Ocean (42), northwest Indian Ocean (31), South Africa (31), and southeast Atlantic Ocean (32). Power analysis demonstrated that the panel of genetic markers can be applied in diversity and population genetics studies. Global genetic diversity for albacore was high with a mean number of alleles at 16.94; observed heterozygosity 66% and expected heterozygosity 77%. The number of individuals was insufficient to provide accurate results on differentiation. Of the 9 "non-neutral" markers, 3 were linked to a sequence of known function. The one is located to a sequence having an immunity function (ThuAla-Tcell-01) and the other to a sequence having energy allocation function (ThuAla-Hki-01). These two markers were genotyped on the 136 individuals and presented different diversity levels. ThuAla-Tcell-01 has a high number of alleles (20), heterozygosity (87-90%), and assignment index. ThuAla-Hki-01 has a lower number of alleles (9), low heterozygosity (24-27%), low assignment index and significant inbreeding. Finally, the 34 "neutral" and 3 "non-neutral" microsatellites markers were tested on four economically important Scombridae species-Thunnus albacares, Thunnus thynnus, Thunnus obesus, and Acanthocybium solandri.	[Nikolic, Natacha; Puech, Alexis; Bourjea, Jerome] IFREMER, Inst Francais Rech Exploitat Mer, Delegat La Reunion, Rue Jean Bertho,BP 60, F-97822 Le Port, Reunion, France; [Duthoy, Stephanie; Destombes, Antoine] GENOSCREEN, F-59000 Lille, France; [Bodin, Nathalie] IRD, UMR EME 212, Mahe, Seychelles; [West, Wendy] Dept Agr Forestry & Fisheries, ZA-8012 Cape Town, South Africa	Ifremer; Institut de Recherche pour le Developpement (IRD)	Nikolic, N (corresponding author), IFREMER, Inst Francais Rech Exploitat Mer, Delegat La Reunion, Rue Jean Bertho,BP 60, F-97822 Le Port, Reunion, France.	natacha.nikolic@ifremer.fr	Bodin, Nathalie/D-2184-2009	DESTOMBES, Antoine/0000-0002-6227-8556; Bodin, Nathalie/0000-0001-8464-0213; Bourjea, Jerome/0000-0001-7149-3648	European Fisheries Funds EU FEP [759/DMSOI/2013]; IFREMER; GENOSCREEN	European Fisheries Funds EU FEP; IFREMER; GENOSCREEN	This work was developed under the project Germon "No759/DMSOI/2013" funded by European Fisheries Funds EU FEP 2013-2015 and IFREMER. GENOSCREEN provided support in the form of salaries for authors SD and AD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. SD and AD provided technical assistance and expertise on 454 pyrosequencing. They also helped in writing the Materials and Methods section of this manuscript. The specific roles of these authors are articulated in the "Author Contributions" section.	Abdul-Muneer PM, 2014, GENET RES INT, V2014, DOI 10.1155/2014/691759; Albaina A, 2013, ANIM GENET, V44, P678, DOI 10.1111/age.12051; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andre C, 2011, HEREDITY, V106, P270, DOI 10.1038/hdy.2010.71; [Anonymous], 2014, IOTC2014WPTMT05RE; Arrizabalaga H, 2007, FISH B-NOAA, V105, P140; Barker JSF, 1993, INTEGRATED GLOBAL PR; Bauler TJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004014; BEARDSLE.GL, 1969, T AM FISH SOC, V98, P589, DOI 10.1577/1548-8659(1969)98[589:PMOATA]2.0.CO;2; Bekkevold D, 2005, EVOLUTION, V59, P2656; Belkhir K, 1996, 5000 CNRS UMR; Bourjea J, 2013, SCRS2013126; Bremer JRA, 1998, MAR BIOL, V132, P547, DOI 10.1007/s002270050420; BROOKER AL, 1994, CAN J FISH AQUAT SCI, V51, P1959, DOI 10.1139/f94-198; Carlsson J, 2013, J FISH BIOL, V82, P944, DOI 10.1111/jfb.12034; Carlsson J, 2004, MOL ECOL, V13, P3345, DOI 10.1111/j.1365-294X.2004.02336.x; Carlsson J, 2006, ICES J MAR SCI, V63, P1111, DOI 10.1016/j.icesjms.2006.04.009; Chapman JR, 2009, MOL ECOL, V18, P2746, DOI 10.1111/j.1365-294X.2009.04247.x; Chevalet C, 2010, THEOR POPUL BIOL, V77, P152, DOI 10.1016/j.tpb.2010.01.001; CHOW S, 1995, MAR BIOL, V123, P39, DOI 10.1007/BF00350321; Chybicki IJ, 2009, J HERED, V100, P106, DOI 10.1093/jhered/esn088; Ciftci Yilmaz, 2002, Turkish Journal of Fisheries and Aquatic Sciences, V2, P145; Clark TB, 2004, MOL ECOL NOTES, V4, P70, DOI 10.1046/j.1471-8286.2004.00572.x; Collette BB, 2011, SCIENCE, V333, P291, DOI 10.1126/science.1208730; Collette BB, 1983, FAO FISH SYNOPOSIS, V125, P137; Davies CA, 2011, MAR BIOL, V158, P2727, DOI 10.1007/s00227-011-1772-x; Dos Santos SMR, 2008, MOL ECOL RESOUR, V8, P1065, DOI 10.1111/j.1755-0998.2008.02156.x; Durand JD, 2005, MAR BIOL, V147, P313, DOI 10.1007/s00227-005-1564-2; Ely B, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-19; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gaggiotti OE, 2009, EVOLUTION, V63, P2939, DOI 10.1111/j.1558-5646.2009.00779.x; Gonzalez EG, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-197; Gonzalez EG, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-252; Hauser L, 2008, FISH FISH, V9, P333, DOI 10.1111/j.1467-2979.2008.00299.x; Hoban S, 2013, METHODS ECOL EVOL, V4, P299, DOI 10.1111/2041-210x.12025; IOTC, 2012, 15 SESS IOTC SCI COM; Iranawati F, 2012, INT J MOL SCI, V13, P10807, DOI 10.3390/ijms130910807; ISSF, 2014, 201409 ISSF; JAMIESON A, 1994, ANIM GENET, V25, P37, DOI 10.1111/j.1365-2052.1994.tb00401.x; Jamieson A, 1997, ANIM GENET, V28, P397, DOI 10.1111/j.1365-2052.1997.00186.x; Ji PF, 2012, INT J MOL SCI, V13, P9798, DOI 10.3390/ijms13089798; Johnson PCD, 2007, GENETICS, V175, P827, DOI 10.1534/genetics.106.064618; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Juan-Jorda MJ, 2011, P NATL ACAD SCI USA, V108, P20650, DOI 10.1073/pnas.1107743108; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kamvar ZN, 2014, PEERJ, V2, DOI 10.7717/peerj.281; Kirk H, 2011, INT J MOL SCI, V12, P3966, DOI 10.3390/ijms12063966; Kolody D, 2013, IOTC2013WPTT1513; Laconcha U, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128247; Laval G, 2004, BIOINFORMATICS, V20, P2485, DOI 10.1093/bioinformatics/bth264; Limborg MT, 2012, HEREDITY, V109, P96, DOI 10.1038/hdy.2012.18; Luikart G, 1998, CONSERV BIOL, V12, P228, DOI 10.1046/j.1523-1739.1998.96388.x; Malausa T, 2011, MOL ECOL RESOUR, V11, P638, DOI 10.1111/j.1755-0998.2011.02992.x; Meglecz E, 2010, BIOINFORMATICS, V26, P403, DOI 10.1093/bioinformatics/btp670; Miyake MP, 2004, FAO FISHERIES TECHNI; Montes I, 2012, MAR ECOL PROG SER, V471, P183, DOI 10.3354/meps09991; Muths D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063558; Nakadate M, 2005, J FISH BIOL, V66, P1545, DOI 10.1111/j.0022-1112.2005.00705.x; Nakamura I., 1985, FAO SPECIES CATALOGU, V5, P65; NEI M, 1978, GENETICS, V89, P583; Nielsen EE, 2009, MOL ECOL, V18, P3128, DOI 10.1111/j.1365-294X.2009.04272.x; Nikolic N, 2009, GENET RES, V91, P1; Nikolic N, 2014, EVOL APPL, V7, P663, DOI 10.1111/eva.12170; OConnell M, 1997, REV FISH BIOL FISHER, V7, P331, DOI 10.1023/A:1018443912945; Okumus Ibrahim, 2003, Turkish Journal of Fisheries and Aquatic Sciences, V3, P51; Oleksiak MF, 2010, J FISH BIOL, V76, P1067, DOI 10.1111/j.1095-8649.2010.02563.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Ryman N, 2006, MOL ECOL, V15, P2031, DOI 10.1111/j.1365-294X.2006.02839.x; SanCristobal M, 2006, ANIM GENET, V37, P189, DOI 10.1111/j.1365-2052.2005.01385.x; Takagi M, 2001, FISH B-NOAA, V99, P697; Takagi M, 1999, FISHERIES SCI, V65, P571, DOI 10.2331/fishsci.65.571; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vinas J, 2004, MAR BIOL, V145, P225, DOI 10.1007/s00227-004-1319-5; Wang JJ, 2012, INT J MOL SCI, V13, P3009, DOI 10.3390/ijms13033009; Waples RS, 2009, FISH FISH SER, V31, P427, DOI 10.1007/978-1-4020-9210-7_23; WARD RD, 1994, J FISH BIOL, V44, P213, DOI 10.1111/j.1095-8649.1994.tb01200.x; Ward SM, 2009, WEED SCI, V57, P593, DOI 10.1614/WS-09-082.1; Was A, 2008, ICES J MAR SCI, V65, P216, DOI 10.1093/icesjms/fsm187; Yeh S.Y., 1997, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V46, P152; Yu HT, 2002, MAR BIOTECHNOL, V4, P471, DOI 10.1007/s10126-002-0035-8	82	2	2	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141830	10.1371/journal.pone.0141830	http://dx.doi.org/10.1371/journal.pone.0141830			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544051	Green Published, gold			2022-12-26	WOS:000364398700053
J	Bonnet, A; Servin, B; Mulsant, P; Mandon-Pepin, B				Bonnet, Agnes; Servin, Bertrand; Mulsant, Philippe; Mandon-Pepin, Beatrice			Spatio-Temporal Gene Expression Profiling during In Vivo Early Ovarian Folliculogenesis: Integrated Transcriptomic Study and Molecular Signature of Early Follicular Growth	PLOS ONE			English	Article							GRANULOSA-CELLS; VITRO DEVELOPMENT; OOCYTES; FOLLICLES; IDENTIFICATION; AUTOPHAGY; APOPTOSIS; PROTEINS; FAMILY; PATHWAY	Background The successful achievement of early ovarian folliculogenesis is important for fertility and reproductive life span. This complex biological process requires the appropriate expression of numerous genes at each developmental stage, in each follicular compartment. Relatively little is known at present about the molecular mechanisms that drive this process, and most gene expression studies have been performed in rodents and without considering the different follicular compartments. Results We used RNA-seq technology to explore the sheep transcriptome during early ovarian follicular development in the two main compartments: oocytes and granulosa cells. We documented the differential expression of 3,015 genes during this phase and described the gene expression dynamic specific to these compartments. We showed that important steps occurred during primary/secondary transition in sheep. We also described the in vivo molecular course of a number of pathways. In oocytes, these pathways documented the chronology of the acquisition of meiotic competence, migration and cellular organization, while in granulosa cells they concerned adhesion, the formation of cytoplasmic projections and steroid synthesis. This study proposes the involvement in this process of several members of the integrin and BMP families. The expression of genes such as Kruppel-like factor 9 (KLF9) and BMP binding endothelial regulator (BMPER) was highlighted for the first time during early follicular development, and their proteins were also predicted to be involved in gene regulation. Finally, we selected a data set of 24 biomarkers that enabled the discrimination of early follicular stages and thus offer a molecular signature of early follicular growth. This set of biomarkers includes known genes such as SPO11 meiotic protein covalently bound to DSB (SPO11), bone morphogenetic protein 15 (BMP15) and WEE1 homolog 2 (S. pombe)(WEE2) which play critical roles in follicular development but other biomarkers are also likely to play significant roles in this process. Conclusions To our knowledge, this is the first in vivo spatio-temporal exploration of transcriptomes derived from early follicles in sheep.	[Bonnet, Agnes; Servin, Bertrand; Mulsant, Philippe] INRA, UMR GenPhySE Genet Physiol & Syst Elevage 1388, F-31326 Castanet Tolosan, France; [Bonnet, Agnes; Servin, Bertrand; Mulsant, Philippe] Univ Toulouse, INP, ENSAT, GenPhySE Genet Physiol & Syst Elevage, F-31326 Castanet Tolosan, France; [Bonnet, Agnes; Servin, Bertrand; Mulsant, Philippe] Univ Toulouse, INP, ENVT, GenPhySE Genet Physiol & Syst Elevage, F-31076 Toulouse, France; [Mandon-Pepin, Beatrice] INRA, Biol Dev & Reprod UMR1198, F-78350 Jouy En Josas, France	INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Bonnet, A (corresponding author), INRA, UMR GenPhySE Genet Physiol & Syst Elevage 1388, F-31326 Castanet Tolosan, France.	agnes.bonnet@toulouse.inra.fr	Servin, Bertrand/B-2206-2008	Servin, Bertrand/0000-0001-5141-0913; Mandon-Pepin, Beatrice/0000-0002-5424-0822	"Bioressources" grant under INRA programmes; AB	"Bioressources" grant under INRA programmes; AB	This work "BioFoll: transcrits caracteristiques ou "biomarqueurs" de la croissance folliculaire basale chez la brebis" was supported by "Bioressources 2010" grant under INRA programmes. The funding was received by AB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Archibald AL, 2010, ANIM GENET, V41, P449, DOI 10.1111/j.1365-2052.2010.02100.x; Baudat F, 2000, MOL CELL, V6, P989, DOI 10.1016/S1097-2765(00)00098-8; Beck BD, 2011, BIOCHEMISTRY-US, V50, P4360, DOI 10.1021/bi200333k; Beltowski J, 2004, POL J PHARMACOL, V56, P5; Bonnet A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-904; Bonnet A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-417; Boutin C, 2012, CURR TOP DEV BIOL, V101, P161, DOI 10.1016/B978-0-12-394592-1.00010-7; Buanne P, 2000, GENOMICS, V68, P253, DOI 10.1006/geno.2000.6288; Cacciola G, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105726; CAHILL LP, 1980, J REPROD FERTIL, V58, P321, DOI 10.1530/jrf.0.0580321; Canepa ET, 2007, IUBMB LIFE, V59, P419, DOI 10.1080/15216540701488358; Celerin M, 2000, EMBO J, V19, P2739, DOI 10.1093/emboj/19.11.2739; Choi Y, 2006, CELL MOL LIFE SCI, V63, P579, DOI 10.1007/s00018-005-5394-7; Dharma SJ, 2009, FERTIL STERIL, V91, P2025, DOI 10.1016/j.fertnstert.2008.02.088; Diaz E, 2012, J PHYSIOL-LONDON, V590, P33, DOI 10.1113/jphysiol.2011.213884; Dong YL, 2007, BIOL REPROD, V76, P892, DOI 10.1095/biolreprod.106.059089; Endow SA, 2010, J CELL SCI, V123, P3420, DOI 10.1242/jcs.064113; Escobar ML, 2008, APOPTOSIS, V13, P1253, DOI 10.1007/s10495-008-0248-z; FAIR T, 1995, MOL REPROD DEV, V42, P437, DOI 10.1002/mrd.1080420410; Fenwick MA, 2011, ENDOCRINOLOGY, V152, P3515, DOI 10.1210/en.2011-0229; Fnu S, 2011, P NATL ACAD SCI USA, V108, P540, DOI 10.1073/pnas.1013571108; Fujiwara H, 1996, HORM RES, V46, P24, DOI 10.1159/000185177; Giebel J, 1997, TISSUE CELL, V29, P525, DOI 10.1016/S0040-8166(97)80053-5; Gilchrist RB, 2004, ANIM REPROD SCI, V82-3, P431, DOI 10.1016/j.anireprosci.2004.05.017; Gougeon A, 1996, ENDOCR REV, V17, P121, DOI 10.1210/er.17.2.121; Gowri PM, 2003, MOL CELL BIOL, V23, P815, DOI 10.1128/MCB.23.3.815-825.2003; Hached K, 2011, DEVELOPMENT, V138, P2261, DOI 10.1242/dev.061317; Hamatani T, 2008, REPRODUCTION, V135, P581, DOI 10.1530/REP-07-0430; Hammer NA, 2005, REPRODUCTION, V130, P203, DOI 10.1530/rep.1.00664; Hanna CB, 2010, BIOL REPROD, V82, P1190, DOI 10.1095/biolreprod.109.081984; Houmard B, 2009, BIOL REPROD, V81, P438, DOI 10.1095/biolreprod.108.075747; Hur CG, 2009, REPRODUCTION, V137, P237, DOI 10.1530/REP-08-0035; Kanninen TT, 2013, EUR J OBSTET GYN R B, V171, P3, DOI 10.1016/j.ejogrb.2013.07.020; Katoh-Fukui Y, 1998, NATURE, V393, P688, DOI 10.1038/31482; Kezele PR, 2005, BIOL REPROD, V72, P241, DOI 10.1095/biolreprod.104.032060; Klinger FG, 2002, DEV BIOL, V244, P85, DOI 10.1006/dbio.2002.0592; Kozyulina PY, 2015, MOL CANCER RES, V13, P423, DOI 10.1158/1541-7786.MCR-14-0353; Li YX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045212; Liu K, 2006, DEV BIOL, V299, P1, DOI 10.1016/j.ydbio.2006.07.038; Magalhaes-Padilha DM, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.112.106096; Markholt S, 2012, MOL HUM REPROD, V18, P96, DOI 10.1093/molehr/gar083; Matzuk MM, 2002, SCIENCE, V296, P2178, DOI 10.1126/science.1071965; Moreau C, 2006, BIOL REPROD, V74, P75, DOI 10.1095/biolreprod.105.044545; Moser M, 2003, MOL CELL BIOL, V23, P5664, DOI 10.1128/MCB.23.16.5664-5679.2003; Natesampillai S, 2008, AM J PHYSIOL-ENDOC M, V294, pE385, DOI 10.1152/ajpendo.00480.2007; Oh JS, 2013, J CELL SCI, V126, P1081, DOI 10.1242/jcs.115592; Otsuka F, 2000, J BIOL CHEM, V275, P39523, DOI 10.1074/jbc.M007428200; Pan H, 2005, DEV BIOL, V286, P493, DOI 10.1016/j.ydbio.2005.08.023; Parker KL, 2002, RECENT PROG HORM RES, V57, P19, DOI 10.1210/rp.57.1.19; Pennetier S, 2005, BIOL REPROD, V73, P713, DOI 10.1095/biolreprod.105.041574; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rajkovic A, 2004, SCIENCE, V305, P1157, DOI 10.1126/science.1099755; Reddy P, 2008, SCIENCE, V319, P611, DOI 10.1126/science.1152257; Reynaud K, 2000, MOL REPROD DEV, V56, P483, DOI 10.1002/1098-2795(200008)56:4&lt;483::AID-MRD6&gt;3.0.CO;2-O; Rosales-Torres AM, 2000, MOL REPROD DEV, V55, P270, DOI 10.1002/(SICI)1098-2795(200003)55:3&lt;270::AID-MRD5&gt;3.0.CO;2-H; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Shuttleworth G, 2002, REPRODUCTION, V123, P807, DOI 10.1530/reprod/123.6.807; Simmen FA, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-41; Simmen RCM, 2010, J ENDOCRINOL, V204, P223, DOI 10.1677/JOE-09-0329; Stumpff J, 2012, DEV CELL, V22, P1017, DOI 10.1016/j.devcel.2012.02.013; Tasaki H, 2013, THERIOGENOLOGY, V79, P809, DOI 10.1016/j.theriogenology.2012.12.009; Tieri P, 2013, MOL BIOSYST, V9, P2401, DOI 10.1039/c3mb70242a; Tsou AP, 2003, ONCOGENE, V22, P298, DOI 10.1038/sj.onc.1206129; Vallee M, 2005, BIOL REPROD, V73, P63, DOI 10.1095/biolreprod.104.037069; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Velentzas AD, 2007, AUTOPHAGY, V3, P130, DOI 10.4161/auto.3582; Wei Z, 2013, TUMOR BIOL, V34, P181, DOI 10.1007/s13277-012-0527-8; Ye F, 2011, CURR BIOL, V21, P1584, DOI 10.1016/j.cub.2011.08.024; Yoon SJ, 2006, FERTIL STERIL, V85, P193, DOI 10.1016/j.fertnstert.2005.07.1296; Zakin L, 2010, DEV BIOL, V347, P204, DOI 10.1016/j.ydbio.2010.08.025; Zhang XL, 2001, MOL CELL ENDOCRINOL, V181, P81, DOI 10.1016/S0303-7207(01)00536-6	72	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141482	10.1371/journal.pone.0141482	http://dx.doi.org/10.1371/journal.pone.0141482			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540452	Green Published, gold, Green Submitted			2022-12-26	WOS:000364303800017
J	Adamo, HH; Stromvall, K; Nilsson, M; Bergstrom, SH; Bergh, A				Adamo, Hanibal Hani; Stromvall, Kerstin; Nilsson, Maria; Bergstrom, Sofia Halin; Bergh, Anders			Adaptive (TINT) Changes in the Tumor Bearing Organ Are Related to Prostate Tumor Size and Aggressiveness	PLOS ONE			English	Article							RAT PROSTATE; CANCER; CELLS; MACROPHAGES; GROWTH; TISSUE; STROMA; ANGIOGENESIS; PROGRESSION; CASTRATION	In order to grow, tumors need to induce supportive alterations in the tumor-bearing organ, by us named tumor instructed normal tissue (TINT) changes. We now examined if the nature and magnitude of these responses were related to tumor size and aggressiveness. Three different Dunning rat prostate tumor cells were implanted into the prostate of immune-competent rats; 1) fast growing and metastatic MatLyLu tumor cells 2) fast growing and poorly metastatic AT-1 tumor cells, and 3) slow growing and non-metastatic G tumor cells. All tumor types induced increases in macrophage, mast cell and vascular densities and in vascular cell-proliferation in the tumor-bearing prostate lobe compared to controls. These increases occurred in parallel with tumor growth. The most pronounced and rapid responses were seen in the prostate tissue surrounding MatLyLu tumors. They were, also when small, particularly effective in attracting macrophages and stimulating growth of not only micro-vessels but also small arteries and veins compared to the less aggressive AT-1 and G tumors. The nature and magnitude of tumor-induced changes in the tumor-bearing organ are related to tumor size but also to tumor aggressiveness. These findings, supported by previous observation in patient samples, suggest that one additional way to evaluate prostate tumor aggressiveness could be to monitor its effect on adjacent tissues.	[Adamo, Hanibal Hani; Stromvall, Kerstin; Nilsson, Maria; Bergstrom, Sofia Halin; Bergh, Anders] Umea Univ, Dept Med Biosci, Pathol, Umea, Sweden	Umea University	Bergh, A (corresponding author), Umea Univ, Dept Med Biosci, Pathol, Umea, Sweden.	anders.bergh@medbio.umu.se		Halin Bergstrom, Sofia/0000-0003-3475-3230	Swedish Research Council [65X-05935-32-3]; Swedish Cancer Foundation [CAN 2013/327]; Lions Cancer Research Foundation; County of Vasterbotten; Konung Gustaf V:s och Drottning Victorias Frimurare Stiftelse	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Lions Cancer Research Foundation; County of Vasterbotten; Konung Gustaf V:s och Drottning Victorias Frimurare Stiftelse	This work was supported by grants from the Swedish Research Council (65X-05935-32-3), The Swedish Cancer Foundation (CAN 2013/327), The Lions Cancer Research Foundation, The County of Vasterbotten and Konung Gustaf V:s och Drottning Victorias Frimurare Stiftelse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo HH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130076; Balkwill FR, 2012, SEMIN CANCER BIOL, V22, P33, DOI 10.1016/j.semcancer.2011.12.005; Byun JS, 2013, AM J PATHOL, V182, P1055, DOI 10.1016/j.ajpath.2013.01.009; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Fung E, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00353; Hagglof Christina, 2012, Cancers (Basel), V4, P531, DOI 10.3390/cancers4020531; Hagglof C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010747; Halin S, 2007, PROSTATE, V67, P370, DOI 10.1002/pros.20473; Halin Sofia, 2011, Expert Opin Med Diagn, V5, P37, DOI 10.1517/17530059.2011.540009; Halin S, 2010, NEOPLASIA, V12, P336, DOI 10.1593/neo.92046; Halin S, 2009, NEOPLASIA, V11, P177, DOI 10.1593/neo.81338; Hammarsten P, 2006, CLIN CANCER RES, V12, P7431, DOI 10.1158/1078-0432.CCR-06-1895; Hammarsten P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047994; Hammarsten P, 2010, CLIN CANCER RES, V16, P1245, DOI 10.1158/1078-0432.CCR-09-0103; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heaphy CM, 2009, BREAST CANCER RES TR, V118, P229, DOI 10.1007/s10549-009-0504-0; ISAACS JT, 1986, PROSTATE, V9, P261, DOI 10.1002/pros.2990090306; Johansson A, 2010, AM J PATHOL, V177, P1031, DOI 10.2353/ajpath.2010.100070; Josefsson A, 2012, SCAND J UROL NEPHROL, V46, P247, DOI 10.3109/00365599.2012.669791; Josefsson A, 2011, AM J PATHOL, V179, P1961, DOI 10.1016/j.ajpath.2011.06.005; Khmelewski E, 2004, CIRC RES, V95, pE56, DOI 10.1161/01.RES.0000143013.04985.E7; Lundholm M, SECRETED FACTO UNPUB; McAllister SS, 2014, NAT CELL BIOL, V16, P717, DOI 10.1038/ncb3015; McAllister SS, 2010, J CLIN ONCOL, V28, P4022, DOI 10.1200/JCO.2010.28.4257; Nonn L, 2009, PROSTATE, V69, P1470, DOI 10.1002/pros.20983; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Popiolek M, 2013, EUR UROL, V63, P428, DOI 10.1016/j.eururo.2012.10.002; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Rohan TE, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju136; Rudolfsson SH, 2008, J ENDOCRINOL, V196, P11, DOI 10.1677/JOE-07-0272; Schafer M, 2008, NAT REV MOL CELL BIO, V9, P628, DOI 10.1038/nrm2455; Takeda Y, 2011, NATURE, V479, P122, DOI 10.1038/nature10507; Thomasson M, 2011, INT J CANCER, V128, P2843, DOI 10.1002/ijc.25820; Tidehag V, 2014, EUR J CANCER, V50, P1829, DOI 10.1016/j.ejca.2014.03.278; Troester MA, 2009, CLIN CANCER RES, V15, P7020, DOI 10.1158/1078-0432.CCR-09-1126; Trujillo KA, 2012, PROSTATE CANCER, V2012, DOI 10.1155/2012/302894; Wikstrom P, 2009, PROSTATE, V69, P799, DOI 10.1002/pros.20927; Yu JL, 2003, BREAST CANCER RES, V5, P83, DOI 10.1186/bcr573	42	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141601	10.1371/journal.pone.0141601	http://dx.doi.org/10.1371/journal.pone.0141601			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536349	Green Submitted, Green Published, gold			2022-12-26	WOS:000364298400072
J	Docherty, KM; Borton, HM; Espinosa, N; Gebhardt, M; Gil-Loaiza, J; Gutknecht, JLM; Maes, PW; Mott, BM; Parnell, JJ; Purdy, G; Rodrigues, PAP; Stanish, LF; Walser, ON; Gallery, RE				Docherty, Kathryn M.; Borton, Hannah M.; Espinosa, Noelle; Gebhardt, Martha; Gil-Loaiza, Juliana; Gutknecht, Jessica L. M.; Maes, Patrick W.; Mott, Brendon M.; Parnell, John Jacob; Purdy, Gayle; Rodrigues, Pedro A. P.; Stanish, Lee F.; Walser, Olivia N.; Gallery, Rachel E.			Key Edaphic Properties Largely Explain Temporal and Geographic Variation in Soil Microbial Communities across Four Biomes	PLOS ONE			English	Article							BACTERIAL COMMUNITY; DIVERSITY; BIOMASS; BIOGEOGRAPHY; GRASSLAND; SEQUENCES; DYNAMICS; PH	Soil microbial communities play a critical role in nutrient transformation and storage in all ecosystems. Quantifying the seasonal and long-term temporal extent of genetic and functional variation of soil microorganisms in response to biotic and abiotic changes within and across ecosystems will inform our understanding of the effect of climate change on these processes. We examined spatial and seasonal variation in microbial communities based on 16S rRNA gene sequencing and phospholipid fatty acid (PLFA) composition across four biomes: a tropical broadleaf forest (Hawaii), taiga (Alaska), semiarid grassland-shrubland (Utah), and a subtropical coniferous forest (Florida). In this study, we used a team-based instructional approach leveraging the iPlant Collaborative to examine publicly available National Ecological Observatory Network (NEON) 16S gene and PLFA measurements that quantify microbial diversity, composition, and growth. Both profiling techniques revealed that microbial communities grouped strongly by ecosystem and were predominately influenced by three edaphic factors: pH, soil water content, and cation exchange capacity. Temporal variability of microbial communities differed by profiling technique; 16S-based community measurements showed significant temporal variability only in the subtropical coniferous forest communities, specifically through changes within subgroups of Acidobacteria. Conversely, PLFA-based community measurements showed seasonal shifts in taiga and tropical broadleaf forest systems. These differences may be due to the premise that 16S-based measurements are predominantly influenced by large shifts in the abiotic soil environment, while PLFA-based analyses reflect the metabolically active fraction of the microbial community, which is more sensitive to local disturbances and biotic interactions.	[Docherty, Kathryn M.; Borton, Hannah M.; Walser, Olivia N.] Western Michigan Univ, Dept Biol Sci, Kalamazoo, MI 49008 USA; [Espinosa, Noelle; Gebhardt, Martha; Purdy, Gayle; Gallery, Rachel E.] Univ Arizona, Sch Nat Resources & Environm, Tucson, AZ 85721 USA; [Gil-Loaiza, Juliana] Univ Arizona, Dept Soil Water & Environm Sci, Tucson, AZ USA; [Gutknecht, Jessica L. M.] Univ Minnesota, Dept Soil Water & Climate, St Paul, MN 55108 USA; [Maes, Patrick W.; Rodrigues, Pedro A. P.] Univ Arizona, Grad Interdisciplinary Program Entomol & Insect S, Tucson, AZ USA; [Mott, Brendon M.] USDA ARS, Carl Hayden Bee Res Ctr, Tucson, AZ USA; [Parnell, John Jacob; Stanish, Lee F.] Natl Ecol Observ Network, Boulder, CO USA; [Gallery, Rachel E.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA	Western Michigan University; University of Arizona; University of Arizona; University of Minnesota System; University of Minnesota Twin Cities; University of Arizona; United States Department of Agriculture (USDA); University of Arizona	Gallery, RE (corresponding author), Univ Arizona, Sch Nat Resources & Environm, Tucson, AZ 85721 USA.	rgallery@email.arizona.edu	Harmanani, Haidar/Q-7755-2019; Gutknecht, Jessica/AAI-3682-2021; Harmanani, Haidar M/U-6841-2018; Gallery, Rachel E/I-2169-2014	Harmanani, Haidar/0000-0001-5416-4383; Harmanani, Haidar M/0000-0001-5416-4383; Rodrigues, Pedro/0000-0002-3280-7576; Farella, Martha/0000-0002-2925-4093; Gallery, Rachel/0000-0002-9159-8778	National Science Foundation-EAR [1331408]; National Institute of Food and Agriculture [ARZT-1360540H12-199]; Division Of Environmental Biology [1257139] Funding Source: National Science Foundation	National Science Foundation-EAR; National Institute of Food and Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors received no specific funding for this work. REG acknowledges the National Science Foundation-EAR Award Number 1331408: Transformative Behavior of Energy, Water and Carbon in the Critical Zone II and National Institute of Food and Agriculture Award Number ARZT-1360540H12-199. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SD, 2010, NAT GEOSCI, V3, P336, DOI 10.1038/NGEO846; Anderson WA, 2011, SCIENCE, V331, P152, DOI 10.1126/science.1198280; Balser TC, 2006, PLANT SOIL, V289, P59, DOI 10.1007/s11104-006-9104-5; Balser TC, 2005, SOIL BIOL BIOCHEM, V37, P601, DOI 10.1016/j.soilbio.2004.08.019; Balser TC, 2005, BIOGEOCHEMISTRY, V73, P395, DOI 10.1007/s10533-004-0372-y; Bates ST, 2011, ISME J, V5, P908, DOI 10.1038/ismej.2010.171; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bossio DA, 1998, MICROB ECOL, V49, P50; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Chambers JQ, 2004, ECOL APPL, V14; Chu HY, 2010, ENVIRON MICROBIOL, V12, P2998, DOI 10.1111/j.1462-2920.2010.02277.x; Cleveland CC, 2007, BIOGEOCHEMISTRY, V82, P229, DOI 10.1007/s10533-006-9065-z; DeAngelis KM, 2010, ENVIRON MICROBIOL, V12, P3137, DOI 10.1111/j.1462-2920.2010.02286.x; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Evans SE, 2014, ECOL LETT, V17, P155, DOI 10.1111/ele.12206; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer Noah, 2008, P95; Fierer N, 2012, P NATL ACAD SCI USA, V109, P21390, DOI 10.1073/pnas.1215210110; Fierer N, 2012, ISME J, V6, P1007, DOI 10.1038/ismej.2011.159; Fierer N, 2011, ECOLOGY, V92, P797, DOI 10.1890/10-1170.1; Fontaine S, 2003, SOIL BIOL BIOCHEM, V35, P837, DOI 10.1016/S0038-0717(03)00123-8; Frostegard A, 1996, BIOL FERT SOILS, V22, P59, DOI 10.1007/BF00384433; Griffiths BS, 2013, FEMS MICROBIOL REV, V37, P112, DOI 10.1111/j.1574-6976.2012.00343.x; Griffiths RI, 2011, ENVIRON MICROBIOL, V13, P1642, DOI 10.1111/j.1462-2920.2011.02480.x; Gutknecht JLM, 2012, GLOBAL CHANGE BIOL, V18, P2256, DOI 10.1111/j.1365-2486.2012.02686.x; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; HILL TCJ, 1993, SOIL BIOL BIOCHEM, V25, P1779, DOI 10.1016/0038-0717(93)90183-C; Jastrow JD, 2007, CLIMATIC CHANGE, V80, P5, DOI 10.1007/s10584-006-9178-3; Jones RT, 2009, ISME J, V3, P442, DOI 10.1038/ismej.2008.127; Jones SE, 2010, P NATL ACAD SCI USA, V107, P5881, DOI 10.1073/pnas.0912765107; Kao-Kniffin J, 2008, MICROB ECOL, V56, P55, DOI 10.1007/s00248-007-9323-1; Khodadad CLM, 2011, SOIL BIOL BIOCHEM, V43, P385, DOI 10.1016/j.soilbio.2010.11.005; Kluber LA, 2011, SOIL BIOL BIOCHEM, V43, P1042, DOI 10.1016/j.soilbio.2011.01.022; Kuzyakov Y, 2000, SOIL BIOL BIOCHEM, V32, P1485, DOI 10.1016/S0038-0717(00)00084-5; Lauber CL, 2013, ISME J, V7, P1641, DOI 10.1038/ismej.2013.50; Lauber CL, 2010, FEMS MICROBIOL LETT, V307, P80, DOI 10.1111/j.1574-6968.2010.01965.x; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lennon JT, 2011, NAT REV MICROBIOL, V9, P119, DOI 10.1038/nrmicro2504; Lipson DA, 2004, APPL ENVIRON MICROB, V70, P2867, DOI 10.1128/AEM.70.5.2867-2879.2004; Liu ZZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm541; Mau RL, 2015, ISME J, V9, P1477, DOI 10.1038/ismej.2014.205; McGuire KL, 2012, MICROB ECOL, V63, P804, DOI 10.1007/s00248-011-9973-x; Miller S, 2008, SCIENCE, V322, P1329, DOI 10.1126/science.1166032; Naether A, 2012, APPL ENVIRON MICROB, V78, P7398, DOI 10.1128/AEM.01325-12; Nemergut DR, 2011, ENVIRON MICROBIOL, V13, P135, DOI 10.1111/j.1462-2920.2010.02315.x; Oksanan J, 2011, VEGAN COMMUNITY ECOL; ORNL DAAC, 2014, MODIS SUBS LAND PROD; Prevost-Boure NC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111667; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Rubin BER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070460; Schadt CW, 2003, SCIENCE, V301, P1359, DOI 10.1126/science.1086940; Schimel J, 2007, ECOLOGY, V88, P1386, DOI 10.1890/06-0219; Schimel JP, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00348; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shade A, 2014, MBIO, V5, DOI 10.1128/mBio.01371-14; Shade A, 2013, ISME J, V7, P1493, DOI 10.1038/ismej.2013.54; Uksa M, 2014, SOIL BIOL BIOCHEM, V75, P197, DOI 10.1016/j.soilbio.2014.04.018; Valentin-Vargas A, 2014, SCI TOTAL ENVIRON, V500, P314, DOI 10.1016/j.scitotenv.2014.08.107; VESTAL JR, 1989, BIOSCIENCE, V39, P535, DOI 10.2307/1310976; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wilkinson SC, 2002, SOIL BIOL BIOCHEM, V34, P189, DOI 10.1016/S0038-0717(01)00168-7; Wu YT, 2012, ECOSYSTEMS, V15, P624, DOI 10.1007/s10021-012-9533-3; Yilmaz P, 2011, NAT BIOTECHNOL, V29, P415, DOI 10.1038/nbt.1823; ZELLES L, 1992, SOIL BIOL BIOCHEM, V24, P317, DOI 10.1016/0038-0717(92)90191-Y; Zhang W, 2005, GLOBAL CHANGE BIOL, V11, P266, DOI 10.1111/j.1365-2486.2005.00902.x	66	64	67	2	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0135352	10.1371/journal.pone.0135352	http://dx.doi.org/10.1371/journal.pone.0135352			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536666	Green Published, gold, Green Submitted			2022-12-26	WOS:000364298400003
J	Gabriel, MW; Woods, LW; Wengert, GM; Stephenson, N; Higley, JM; Thompson, C; Matthews, SM; Sweitzer, RA; Purcell, K; Barrett, RH; Keller, SM; Gaffney, P; Jones, M; Poppenga, R; Foley, JE; Brown, RN; Clifford, DL; Sacks, BN				Gabriel, Mourad W.; Woods, Leslie W.; Wengert, Greta M.; Stephenson, Nicole; Higley, J. Mark; Thompson, Craig; Matthews, Sean M.; Sweitzer, Rick A.; Purcell, Kathryn; Barrett, Reginald H.; Keller, Stefan M.; Gaffney, Patricia; Jones, Megan; Poppenga, Robert; Foley, Janet E.; Brown, Richard N.; Clifford, Deana L.; Sacks, Benjamin N.			Patterns of Natural and Human-Caused Mortality Factors of a Rare Forest Carnivore, the Fisher (Pekania pennanti) in California	PLOS ONE			English	Article							MOUNTAIN LION PREDATION; MARTES-PENNANTI; TOXOPLASMA-GONDII; CANINE-DISTEMPER; DNA; RISK	Wildlife populations of conservation concern are limited in distribution, population size and persistence by various factors, including mortality. The fisher (Pekania pennanti), a North American mid-sized carnivore whose range in the western Pacific United States has retracted considerably in the past century, was proposed for threatened status protection in late 2014 under the United States Endangered Species Act by the United States Fish and Wildlife Service in its West Coast Distinct Population Segment. We investigated mortality in 167 fishers from two genetically and geographically distinct sub-populations in California within this West Coast Distinct Population Segment using a combination of gross necropsy, histology, toxicology and molecular methods. Overall, predation (70%), natural disease (16%), toxicant poisoning (10%) and, less commonly, vehicular strike (2%) and other anthropogenic causes (2%) were causes of mortality observed. We documented both an increase in mortality to (57% increase) and exposure (6%) from pesticides in fishers in just the past three years, highlighting further that toxicants from marijuana cultivation still pose a threat. Additionally, exposure to multiple rodenticides significantly increased the likelihood of mortality from rodenticide poisoning. Poisoning was significantly more common in male than female fishers and was 7 times more likely than disease to kill males. Based on necropsy findings, suspected causes of mortality based on field evidence alone tended to underestimate the frequency of disease-related mortalities. This study is the first comprehensive investigation of mortality causes of fishers and provides essential information to assist in the conservation of this species.	[Gabriel, Mourad W.; Wengert, Greta M.] Integral Ecol Res Ctr, Blue Lake, CA 95525 USA; [Gabriel, Mourad W.; Sacks, Benjamin N.] Univ Calif Davis, Mammalian Ecol & Conservat Unit, Vet Genet Lab, Davis, CA 95616 USA; [Woods, Leslie W.; Poppenga, Robert] Univ Calif Davis, Calif Anim Hlth & Food Safety Lab Syst, Davis, CA 95616 USA; [Stephenson, Nicole; Foley, Janet E.] Univ Calif Davis, Sch Vet Med, Davis, CA 95616 USA; [Higley, J. Mark] Hoopa Tribal Forestry, Dept Wildlife, Hoopa, CA USA; [Thompson, Craig; Purcell, Kathryn] US Forest Serv, Pacific Southwest Res Stn, Sierra Nevada Res Ctr, Fresno, CA USA; [Matthews, Sean M.] Wildlife Conservat Soc, Hoopa, CA USA; [Sweitzer, Rick A.; Barrett, Reginald H.] Univ Calif Berkeley, Sierra Nevada Adapt Management Project, Berkeley, CA 94720 USA; [Keller, Stefan M.; Gaffney, Patricia; Jones, Megan] Univ Calif Davis, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Brown, Richard N.] Humboldt State Univ, Dept Wildlife, Arcata, CA 95521 USA; [Clifford, Deana L.] Calif Dept Fish & Wildlife, Wildlife Invest Lab, Rancho Cordova, CA USA; [Sacks, Benjamin N.] Univ Calif Davis, Dept Populat Hlth & Reprod, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; United States Department of Agriculture (USDA); United States Forest Service; Wildlife Conservation Society; University of California System; University of California Berkeley; University of California System; University of California Davis; California State University System; California State Polytechnic University, Humboldt; University of California System; University of California Davis	Gabriel, MW (corresponding author), Integral Ecol Res Ctr, Blue Lake, CA 95525 USA.	mgabriel@IERCecology.org	Purcell, Kathryn L/S-2592-2016; Barrett, Reginald Haughton/AAC-2608-2020	Higley, Mark/0000-0002-7722-3785; Keller, Stefan/0000-0002-5428-2985	Integral Ecology Research Center; California Animal Health and Food Safety Laboratory System; Hoopa Valley Tribal Forestry; United States Forest Service; National Park Service; United States Fish and Wildlife Service; California Department of Water Resources; California Department of Fish and Wildlife; California Department of Forestry and Fire Protection; Sierra Nevada Conservancy; Sierra Nevada Adaptive Management Project; Bureau of Indian Affairs	Integral Ecology Research Center; California Animal Health and Food Safety Laboratory System; Hoopa Valley Tribal Forestry; United States Forest Service(United States Department of Agriculture (USDA)United States Forest Service); National Park Service; United States Fish and Wildlife Service(US Fish & Wildlife Service); California Department of Water Resources; California Department of Fish and Wildlife; California Department of Forestry and Fire Protection; Sierra Nevada Conservancy; Sierra Nevada Adaptive Management Project; Bureau of Indian Affairs	Funding: This work was supported by the Integral Ecology Research Center, California Animal Health and Food Safety Laboratory System, Hoopa Valley Tribal Forestry, United States Forest Service, National Park Service, United States Fish and Wildlife Service, California Department of Water Resources, California Department of Fish and Wildlife, California Department of Forestry and Fire Protection, The Sierra Nevada Conservancy, Sierra Nevada Adaptive Management Project and the Bureau of Indian Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREN H, 1988, ECOLOGY, V69, P544, DOI 10.2307/1940455; [Anonymous], 2013, EPIDEMIOLOGY; [Anonymous], 2014, R LANG ENV STAT COMP; Arnemo JM, 2006, WILDLIFE BIOL, V12, P109, DOI 10.2981/0909-6396(2006)12[109:ROCMIL]2.0.CO;2; BRAND CJ, 1976, J WILDLIFE MANAGE, V40, P416, DOI 10.2307/3799943; Buck S. G., 1982, THESIS; Burnham K. P., 1998, MODEL SELECTION INFE; Collins C, 2011, ANIM CONSERV, V14, P474, DOI 10.1111/j.1469-1795.2011.00458.x; Croissant Yves, 2012, ESTIMATION MULTINOMI; Drew RE, 2003, MOL ECOL, V12, P51, DOI 10.1046/j.1365-294X.2003.01715.x; Dubey JP, 2008, INT J PARASITOL, V38, P1257, DOI 10.1016/j.ijpara.2008.03.007; Eason C, 1998, P NZ PLANT PROT C NZ; Erickson W., 2004, POTENTIAL RISKS 9 RO, P230; Ernest HB, 2002, J WILDLIFE MANAGE, V66, P75, DOI 10.2307/3802873; Fuller MR, 2012, TECH ECOL CONSERVAT, P152; Gabriel M, 2005, W SECT WILDL SOC ANN; Gabriel M.W., 2013, WILDL PROF, P46; Gabriel MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040163; Gabriel MW, 2010, J WILDLIFE DIS, V46, P966, DOI 10.7589/0090-3558-46.3.966; Gabriel MW, 2012, BIOL CONSERVATION MA, P138; Gabriel MW, 2007, 813335G021 US FISH W, P48; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Janeway C.A., 2007, IMMUNOBIOLOGY, V7th; Keller SM, 2012, J WILDLIFE DIS, V48, P1035, DOI 10.7589/2011-12-350; KNICK ST, 1990, WILDLIFE MONOGR, P1; Kreuder C, 2003, J WILDLIFE DIS, V39, P495, DOI 10.7589/0090-3558-39.3.495; Lewis JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032726; Lofroth EC, 2010, CONSERVATION FISHERS, P174; Lyver PO, 2000, MAMMAL REV, V30, P31, DOI 10.1046/j.1365-2907.2000.00055.x; Mallery M, 2011, BERKELEY UNDERGRADUA, V23, P1; Onorato D, 2006, WILDLIFE SOC B, V34, P815, DOI 10.2193/0091-7648(2006)34[815:DOPPAE]2.0.CO;2; Origgi FC, 2012, VET PATHOL, V49, P913, DOI 10.1177/0300985812436743; Powell R.A., 1993, FISHER LIFE HIST ECO, V2nd ed.; Powell R.A., 1994, SCI BASIS CONSERVING; Raley CM, 2006, ECOLOGICAL CHARACTER, P32; Rosas-Rosas OC, 2008, RANGELAND ECOL MANAG, V61, P554, DOI 10.2111/08-038.1; Spencer W, 2011, BIOL CONSERV, V144, P788, DOI 10.1016/j.biocon.2010.10.027; Thompson C, 2014, CONSERV LETT, V7, P91, DOI 10.1111/conl.12038; Thompson CM, 2007, ECOLOGY, V88, P334, DOI 10.1890/0012-9658(2007)88[334:FWAIPC]2.0.CO;2; Truex RL, 1998, WILDLIFE MANAGEMENT, P118; Tucker JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052803; TURNER JW, 1992, CAN J ZOOL, V70, P929, DOI 10.1139/z92-132; Vandenbroucke V, 2008, J VET PHARMACOL THER, V31, P437, DOI 10.1111/j.1365-2885.2008.00979.x; Viera AJ, 2005, FAM MED, V37, P360; Webster JP, 2007, SCHIZOPHRENIA BULL, V33, P752, DOI 10.1093/schbul/sbl073; Wengert GM, 2013, THESIS; Wengert GM, 2013, WILDLIFE SOC B, V37, P659, DOI 10.1002/wsb.287; Wengert GM, 2014, J WILDLIFE MANAGE, V78, P603, DOI 10.1002/jwmg.698; Wengert GM, 2012, TECH ECOL CONSERVAT, P294; Wilbert JC, 1992, THESIS; Wisely SM, 2004, J MAMMAL, V85, P640, DOI 10.1644/BEL-011; Wobeser G.A, 2006, ESSENTIALS DIS WILD; Wobeser GA, 2007, DIS WILD ANIMALS INV; Zielinski WJ, 2012, J FISH WILDL MANAG, P3	54	30	32	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140640	10.1371/journal.pone.0140640	http://dx.doi.org/10.1371/journal.pone.0140640			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536481	Green Published, Green Submitted, gold			2022-12-26	WOS:000364298400028
J	Gonzalez, JM; Rodriguez, CA; Zuluaga, AF; Agudelo, M; Vesga, O				Gonzalez, Javier M.; Rodriguez, Carlos A.; Zuluaga, Andres F.; Agudelo, Maria; Vesga, Omar			Demonstration of Therapeutic Equivalence of Fluconazole Generic Products in the Neutropenic Mouse Model of Disseminated Candidiasis	PLOS ONE			English	Article							CHROMATOGRAPHY-MASS SPECTROMETRY; VANCOMYCIN PRODUCTS; INFECTIOUS-DISEASES; ANTIFUNGAL THERAPY; AMPHOTERICIN-B; ANIMAL-MODELS; BIOEQUIVALENCE; SURVEILLANCE; FORMULATIONS; VOLUNTEERS	Some generics of antibacterials fail therapeutic equivalence despite being pharmaceutical equivalents of their innovators, but data are scarce with antifungals. We used the neutropenic mice model of disseminated candidiasis to challenge the therapeutic equivalence of three generic products of fluconazole compared with the innovator in terms of concentration of the active pharmaceutical ingredient, analytical chemistry (liquid chromatography/mass spectrometry), in vitro susceptibility testing, single-dose serum pharmacokinetics in infected mice, and in vivo pharmacodynamics. Neutropenic, five week-old, murine pathogen free male mice of the strain Udea: ICR(CD-2) were injected in the tail vein with Candida albicans GRP-0144 (MIC = 0.25 mg/L) or Candida albicans CIB-19177 (MIC = 4 mg/L). Subcutaneous therapy with fluconazole (generics or innovator) and sterile saline (untreated controls) started 2 h after infection and ended 24 h later, with doses ranging from no effect to maximal effect (1 to 128 mg/kg per day) divided every 3 or 6 hours. The Hill's model was fitted to the data by nonlinear regression, and results from each group compared by curve fitting analysis. All products were identical in terms of concentration, chromatographic and spectrographic profiles, MICs, mouse pharmacokinetics, and in vivo pharmacodynamic parameters. In conclusion, the generic products studied were pharmaceutically and therapeutically equivalent to the innovator of fluconazole.	[Gonzalez, Javier M.; Rodriguez, Carlos A.; Zuluaga, Andres F.; Agudelo, Maria; Vesga, Omar] Univ Antioquia, GRIPE Grp Investigador Problemas Enfermedades Inf, Medellin, Colombia; [Gonzalez, Javier M.] Clin Cardio VID, Sci Direct, Medellin, Colombia; [Agudelo, Maria; Vesga, Omar] Hosp Univ San Vicente Fdn, Infect Dis Unit, Medellin, Colombia	Universidad de Antioquia	Vesga, O (corresponding author), Univ Antioquia, GRIPE Grp Investigador Problemas Enfermedades Inf, Medellin, Colombia.	omar.vesga@udea.edu.co	Rodriguez, Carlos A./P-8324-2019; Zuluaga, Andres F./K-7366-2016	Rodriguez, Carlos A./0000-0002-4042-4313; Zuluaga, Andres F./0000-0001-5656-4153	University of Antioquia (CODI); University of Antioquia (Estrategia de Sostenibilidad); Sistema General Regalias of Colombia [BPIN: 2013000100183]; Rodrigo Vesga-Meneses Scientific Foundation	University of Antioquia (CODI); University of Antioquia (Estrategia de Sostenibilidad); Sistema General Regalias of Colombia; Rodrigo Vesga-Meneses Scientific Foundation	Funding for this project came from the University of Antioquia (CODI and Estrategia de Sostenibilidad 2013-2014), Sistema General Regalias of Colombia (BPIN: 2013000100183) and the Rodrigo Vesga-Meneses Scientific Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudelo M, 2014, ANTIMICROB AGENTS CH, V58, P1005, DOI 10.1128/AAC.00350-13; Agudelo M, 2012, ANTIMICROB AGENTS CH, V56, P2659, DOI 10.1128/AAC.06012-11; Agudelo M, 2014, 54 INT C ANT AG CHEM; Agudelo M, 2011, 51 INT C ANT AG CHEM; Agudelo M, 2015, INT J ANTIMICROB AG, V45, P161, DOI 10.1016/j.ijantimicag.2014.10.014; Andes D, 2005, METH MOLEC MED, V118, P111; ANTLEY PP, 1988, INFECT IMMUN, V56, P2884, DOI 10.1128/IAI.56.11.2884-2890.1988; Arendrup MC, 2013, CLIN MICROBIOL INFEC, V19, pE343, DOI 10.1111/1469-0691.12212; Blot S, 2006, J ANTIMICROB CHEMOTH, V58, P474, DOI 10.1093/jac/dkl241; Bulitta JB, 2011, AAPS J, V13, P201, DOI 10.1208/s12248-011-9257-x; Centers for Disease Control and Prevention, 2010, NUMB RAT AV LENGTH S; Cleary JD, 2003, PHARMACOTHERAPY, V23, P572, DOI 10.1592/phco.23.5.572.32209; CLSI, 2008, M27A3 CLSI; D'Argenio D, 2009, ADAPT 5 USERS GUIDE; Eggimann P, 2012, MYCOSES, V55, P65, DOI 10.1111/j.1439-0507.2011.02151.x; Gonzalez JM, 2012, INT C ANT AG CHEM 20; Hadwiger ME, 2012, ANTIMICROB AGENTS CH, V56, P2824, DOI 10.1128/AAC.00164-12; Hoharitanon Saowanee, 2005, J Med Assoc Thai, V88 Suppl 4, pS167; HUMPHREY MJ, 1985, ANTIMICROB AGENTS CH, V28, P648, DOI 10.1128/AAC.28.5.648; Jovanovic D, 2005, CLIN THER, V27, P1588, DOI 10.1016/j.clinthera.2005.10.016; Kishimoto TK, 2008, NEW ENGL J MED, V358, P2457, DOI 10.1056/NEJMoa0803200; Lewis PO, 2014, AM J HEALTH-SYST PH, V71, P1029, DOI 10.2146/ajhp130516; Manorot M, 2000, INT J CLIN PHARM TH, V38, P355; Mastoraki E, 2008, J INFECTION, V56, P35, DOI 10.1016/j.jinf.2007.09.011; Molter CM, 2014, J ZOO WILDLIFE MED, V45, P127, DOI 10.1638/2013-0042R1.1; Nambiar S, 2012, ANTIMICROB AGENTS CH, V56, P2819, DOI 10.1128/AAC.05344-11; Pappas PG, 2009, CLIN INFECT DIS, V48, P503, DOI 10.1086/596757; Perez-Casas C, 2000, LANCET, V356, P2102, DOI 10.1016/S0140-6736(05)74314-2; Petraitis V, 2005, ANTIMICROB AGENTS CH, V49, P1642, DOI 10.1128/AAC.49.4.1642-1645.2005; Pfaller M, 2012, DIAGN MICR INFEC DIS, V74, P323, DOI 10.1016/j.diagmicrobio.2012.10.003; Richardson K., 1983, U.S. Patent, Patent No. 4404216; Rodriguez CA, 2015, ANTIMICROB AGENTS CH, V59, P53, DOI 10.1128/AAC.03633-14; Rodriguez CA, 2009, J INFECTION, V59, P277, DOI 10.1016/j.jinf.2009.08.005; Rodriguez-Tudela JL, 2007, ANTIMICROB AGENTS CH, V51, P3599, DOI 10.1128/AAC.00296-07; Slinker BK, 2001, PRIMER APPL REGRESSI, Vxxvii; Smith RM, 2013, NEW ENGL J MED, V369, P1598, DOI 10.1056/NEJMoa1213978; Valerio M, 2014, J ANTIMICROB CHEMOTH, V69, P1993, DOI 10.1093/jac/dku053; Vesga O, 2010, ANTIMICROB AGENTS CH, V54, P3271, DOI 10.1128/AAC.01044-09; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Zuluaga AF, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-55; Zuluaga AF, 2010, IATREIA, V16, P115; Zuluaga AF, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0124-4; Zuluaga AF, 2014, CLIN INFECT DIS, V59, P459, DOI 10.1093/cid/ciu306; Zuluaga AF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010744	45	2	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141872	10.1371/journal.pone.0141872	http://dx.doi.org/10.1371/journal.pone.0141872			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536105	Green Submitted, gold, Green Published			2022-12-26	WOS:000364298400097
J	Jensen, HH; Pedersen, HN; Stenkjaer, E; Pedersen, GA; Login, FH; Nejsum, LN				Jensen, Helene H.; Pedersen, Hans N.; Stenkjaer, Eva; Pedersen, Gitte A.; Login, Frederic H.; Nejsum, Lene N.			Tir Is Essential for the Recruitment of Tks5 to Enteropathogenic Escherichia coli Pedestals	PLOS ONE			English	Article							III SECRETION SYSTEM; FOCAL ADHESIONS; PODOSOME FORMATION; EFFACING LESIONS; PX DOMAIN; ACTIN; PROTEIN; NCK; RECEPTOR; WASP	Enteropathogenic Escherichia coli (EPEC) is a bacterial pathogen that infects the epithelial lining of the small intestine and causes diarrhea. Upon attachment to the intestinal epithelium, EPEC uses a Type III Secretion System to inject its own high affinity receptor Translocated intimin receptor (Tir) into the host cell. Tir facilitates tight adhesion and recruitment of actin-regulating proteins leading to formation of an actin pedestal beneath the infecting bacterium. The pedestal has several similarities with podosomes, which are basolateral actin-rich extensions found in some migrating animal cells. Formation of podosomes is dependent upon the early podosome-specific scavenger protein Tks5, which is involved in actin recruitment. Although Tks5 is expressed in epithelial cells, and podosomes and EPEC pedestals share many components in their structure and mechanism of formation, the potential role of Tks5 in EPEC infections has not been studied. The aim of this study was to determine the subcellular localization of Tks5 in epithelial cells and to investigate if Tks5 is recruited to the EPEC pedestal. In an epithelial MDCK cell line stably expressing Tks5-EGFP, Tks5 localized to actin bundles. Upon infection, EPEC recruited Tks5-EGFP. Tir, but not Tir phosphorylation was essential for the recruitment. Time-lapse microscopy revealed that Tks5-EGFP was recruited instantly upon EPEC attachment to host cells, simultaneously with actin and N-WASp. EPEC infection of cells expressing a Delta PX-Tks5 deletion version of Tks5 showed that EPEC was able to both infect and form pedestals when the PX domain was deleted from Tks5. Future investigations will clarify the role of Tks5 in EPEC infection and pedestal formation.	[Nejsum, Lene N.] Aarhus Univ, Inst Mol Biol & Genet, Aarhus, Denmark; Aarhus Univ, Interdiciplinary Nanosci Ctr, Aarhus, Denmark	Aarhus University; Aarhus University	Nejsum, LN (corresponding author), Aarhus Univ, Inst Mol Biol & Genet, CF Moellers Alle 3, Aarhus, Denmark.	nejsum@mbg.au.dk	Jensen, Helene H/V-5038-2018; Jensen, Helene/GZK-5914-2022	Jensen, Helene H/0000-0002-8426-9802; Nejsum, Lene Niemann/0000-0003-4368-8821	Lundbeck Foundation; Carlsberg Foundation; MEMBRANES	Lundbeck Foundation(Lundbeckfonden); Carlsberg Foundation(Carlsberg Foundation); MEMBRANES	This work was supported by the Lundbeck Foundation, http://lundbeckfoundation.com/; the Carlsberg Foundation, http://www.carlsbergfondet.dk/; and MEMBRANES, http://membranes.au.dk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram CL, 2003, J BIOL CHEM, V278, P16844, DOI 10.1074/jbc.M300267200; Bai L, 2008, INFECT IMMUN, V76, P361, DOI 10.1128/IAI.01199-07; Block MR, 2008, EUR J CELL BIOL, V87, P491, DOI 10.1016/j.ejcb.2008.02.012; Buschman MD, 2009, MOL BIOL CELL, V20, P1302, DOI 10.1091/mbc.E08-09-0949; Campellone KG, 2010, FEBS J, V277, P2390, DOI 10.1111/j.1742-4658.2010.07653.x; Campellone KG, 2005, MOL MICROBIOL, V56, P416, DOI 10.1111/j.1365-2958.2005.04558.x; Campellone KG, 2004, J CELL BIOL, V164, P407, DOI 10.1083/jcb.200306032; Campellone KG, 2002, MOL MICROBIOL, V43, P1227, DOI 10.1046/j.1365-2958.2002.02817.x; Cantarelli VV, 2002, INFECT IMMUN, V70, P2206, DOI 10.1128/IAI.70.4.2206-2209.2002; Cejudo-Martin P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107674; Destaing O, 2010, MOL BIOL CELL, V21, P4108, DOI 10.1091/mbc.E10-07-0580; Ellson CD, 2002, J CELL SCI, V115, P1099; FINLAY BB, 1992, INFECT IMMUN, V60, P2541, DOI 10.1128/IAI.60.6.2541-2543.1992; GAUSH CR, 1966, P SOC EXP BIOL MED, V122, P931; GIRON JA, 1991, SCIENCE, V254, P710, DOI 10.1126/science.1683004; Goosney DL, 2000, CURR BIOL, V10, P735, DOI 10.1016/S0960-9822(00)00543-1; Goosney DL, 2001, INFECT IMMUN, V69, P3315, DOI 10.1128/IAI.69.5.3315-3322.2001; Gruenheid S, 2001, NAT CELL BIOL, V3, P856, DOI 10.1038/ncb0901-856; JARVIS KG, 1995, P NATL ACAD SCI USA, V92, P7996, DOI 10.1073/pnas.92.17.7996; JERSE AE, 1990, P NATL ACAD SCI USA, V87, P7839, DOI 10.1073/pnas.87.20.7839; Kalman D, 1999, NAT CELL BIOL, V1, P389, DOI 10.1038/14087; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kenny B, 1999, MOL MICROBIOL, V31, P1229, DOI 10.1046/j.1365-2958.1999.01265.x; Kenny B, 1997, CELL, V91, P511, DOI 10.1016/S0092-8674(00)80437-7; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Kundu K, 2013, BIOINFORMATICS; Li CMC, 2013, GENE DEV, V27, P1557, DOI 10.1101/gad.222745.113; Linder S, 2003, TRENDS CELL BIOL, V13, P376, DOI 10.1016/S0962-8924(03)00128-4; Lock P, 1998, EMBO J, V17, P4346, DOI 10.1093/emboj/17.15.4346; Lommel S, 2001, EMBO REP, V2, P850, DOI 10.1093/embo-reports/kve197; LOUVARD D, 1980, P NATL ACAD SCI-BIOL, V77, P4132, DOI 10.1073/pnas.77.7.4132; Marches O, 2005, INFECT IMMUN, V73, P8411, DOI 10.1128/IAI.73.12.8411-8417.2005; Mills E, 2008, CELL HOST MICROBE, V3, P104, DOI 10.1016/j.chom.2007.11.007; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Muza-Moons MM, 2003, INFECT IMMUN, V71, P7069, DOI 10.1128/IAI.71.12.7069-7078.2003; Navarro-Garcia F, 2014, INFECT IMMUN, V82, P2255, DOI 10.1128/IAI.01386-13; Navarro-Garcia F, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/374395; Ochoa GC, 2000, J CELL BIOL, V150, P377, DOI 10.1083/jcb.150.2.377; Oikawa T, 2008, J CELL BIOL, V182, P157, DOI 10.1083/jcb.200801042; Oikawa T, 2009, CELL ADHES MIGR, V3, P195, DOI 10.4161/cam.3.2.7510; Peralta-Ramirez J, 2008, INFECT IMMUN, V76, P3854, DOI 10.1128/IAI.00072-08; Phillips N, 2004, NAT CELL BIOL, V6, P618, DOI 10.1038/ncb1148; Reilein A, 2005, J CELL BIOL, V171, P845, DOI 10.1083/jcb.200505071; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Sason H, 2009, MOL BIOL CELL, V20, P544, DOI 10.1091/mbc.E08-05-0516; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seals DF, 2005, CANCER CELL, V7, P155, DOI 10.1016/j.ccr.2005.01.006; Shaner NC, 2005, CELL MOTIL CYTOSKEL, V60, P104, DOI 10.1002/cm.20047; Shifrin Y, 2002, CELL MICROBIOL, V4, P235, DOI 10.1046/j.1462-5822.2002.00188.x; Smith K, 2010, CELL HOST MICROBE, V7, P13, DOI 10.1016/j.chom.2009.12.004; Spinardi L, 2006, EUR J CELL BIOL, V85, P191, DOI 10.1016/j.ejcb.2005.08.005; Stylli SS, 2009, J CELL SCI, V122, P2727, DOI 10.1242/jcs.046680; Swimm A, 2004, MOL BIOL CELL, V15, P3520, DOI 10.1091/mbc.E04-02-0093; Unsworth KE, 2007, CELL MICROBIOL, V9, P438, DOI 10.1111/j.1462-5822.2006.00801.x; Wong ARC, 2012, CELL MICROBIOL, V14, P1051, DOI 10.1111/j.1462-5822.2012.01778.x; Yogo K, 2006, ENDOCRINOLOGY, V147, P3307, DOI 10.1210/en.2005-1309	56	4	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141871	10.1371/journal.pone.0141871	http://dx.doi.org/10.1371/journal.pone.0141871			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536015	Green Published, Green Submitted, gold			2022-12-26	WOS:000364298400096
J	Sun, Y; Sahbaie, P; Liang, DY; Li, WW; Shi, XY; Kingery, P; Clark, JD				Sun, Yuan; Sahbaie, Peyman; Liang, DeYong; Li, Wenwu; Shi, Xiaoyou; Kingery, Paige; Clark, J. David			DNA Methylation Modulates Nociceptive Sensitization after Incision	PLOS ONE			English	Article							OPIOID RECEPTOR GENE; CPG-BINDING PROTEIN-2; CELL LUNG-CANCER; NEUROPATHIC PAIN; EPIGENETIC REGULATION; NERVE INJURY; T-CELLS; SUBSTANCE-P; SPINAL-CORD; EXPRESSION	DNA methylation is a key epigenetic mechanism controlling DNA accessibility and gene expression. Blockade of DNA methylation can significantly affect pain behaviors implicated in neuropathic and inflammatory pain. However, the role of DNA methylation with regard to postoperative pain has not yet been explored. In this study we sought to investigate the role of DNA methylation in modulating incisional pain and identify possible targets under DNA methylation and contributing to incisional pain. DNA methyltranferase (DNMT) inhibitor 5-Aza-2'-deoxycytidine significantly reduced incision-induced mechanical allodynia and thermal sensitivity. Aza-2'-deoxycytidine also reduced hindpaw swelling after incision, suggesting an anti-inflammatory effect. Global DNA methylation and DNMT3b expression were increased in skin after incision, but none of DNMT1, DNMT3a or DNMT3b was altered in spinal cord or DRG. The expression of proopiomelanocortin Pomc encoding beta-endorphin and Oprm1 encoding the mu-opioid receptor were upregulated peripherally after incision; moreover, Oprm1 expression was further increased under DNMT inhibitor treatment. Finally, local peripheral injection of the opioid receptor antagonist naloxone significantly exacerbated incision-induced mechanical hypersensitivity. These results suggest that DNA methylation is functionally relevant to incisional nociceptive sensitization, and that mu-opioid receptor signaling might be one methylation regulated pathway controlling sensitization after incision.	[Sun, Yuan; Sahbaie, Peyman; Liang, DeYong; Li, Wenwu; Shi, Xiaoyou; Kingery, Paige; Clark, J. David] Stanford Univ, Dept Anesthesiol, Sch Med, Stanford, CA 94305 USA; [Sun, Yuan; Sahbaie, Peyman; Liang, DeYong; Kingery, Paige; Clark, J. David] Vet Affairs Palo Alto Hlth Care Syst, Dept Anesthesiol, Palo Alto, CA USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Clark, JD (corresponding author), Stanford Univ, Dept Anesthesiol, Sch Med, Stanford, CA 94305 USA.	djclark@stanford.edu	liang, dy/GZA-4770-2022		NIH (Bethesda, MD, USA) [GM079126]; VA Merit Review award (Washington D.C., USA) [5I01BX000881]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079126] Funding Source: NIH RePORTER	NIH (Bethesda, MD, USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Review award (Washington D.C., USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by NIH award GM079126 (Bethesda, MD, USA) and VA Merit Review award 5I01BX000881 (Washington D.C., USA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baubec T, 2015, NATURE, V520, P243, DOI 10.1038/nature14176; Bell JT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3978; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Bigliardi-Qi M, 2004, DERMATOLOGY, V209, P183, DOI 10.1159/000079887; Bilinski P, 2012, ANN AGR ENV MED, V19, P491; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen RZ, 1998, NATURE, V395, P89, DOI 10.1038/25779; CHUANG TK, 1995, BIOCHEM BIOPH RES CO, V216, P922, DOI 10.1006/bbrc.1995.2709; Corder G, 2013, SCIENCE, V341, P1394, DOI 10.1126/science.1239403; Doehring A, 2013, PAIN, V154, P15, DOI 10.1016/j.pain.2012.06.011; Foulks JM, 2012, J BIOMOL SCREEN, V17, P2, DOI 10.1177/1087057111421212; Fu LH, 2011, ACTA PHARMACOL SIN, V32, P1373, DOI 10.1038/aps.2011.98; Gopalakrishnan S, 2009, MOL CANCER RES, V7, P1622, DOI 10.1158/1541-7786.MCR-09-0018; Grouzmann E, 2002, FASEB J, V16, P1132, DOI 10.1096/fj.01-0939fje; Guan Y, 2008, PAIN, V138, P318, DOI 10.1016/j.pain.2008.01.004; Han L, 2007, CANCER BIOL THER, V6, P1284; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hong SS, 2015, GASTROENTEROLOGY, V148, P148, DOI 10.1053/j.gastro.2014.09.032; Hwang CK, 2010, MOL PHARMACOL, V78, P58, DOI 10.1124/mol.110.064311; Jang JH, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-80; Ji WZ, 1997, MUTAT RES-FUND MOL M, V379, P33, DOI 10.1016/S0027-5107(97)00088-2; Jin BL, 2013, ADV EXP MED BIOL, V754, P3, DOI 10.1007/978-1-4419-9967-2_1; Jones PL, 1999, SEMIN CANCER BIOL, V9, P339, DOI 10.1006/scbi.1999.0134; Jung M, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0118-4; Kato T, 2014, NEUROPHARMACOLOGY, V80, P133, DOI 10.1016/j.neuropharm.2013.12.019; Kehlet H, 2001, BRIT J ANAESTH, V87, P62, DOI 10.1093/bja/87.1.62; Kingery WS, 2003, PAIN, V104, P75, DOI 10.1016/S0304-3959(02)00467-0; Klengel T, 2014, NEUROPHARMACOLOGY, V80, P115, DOI 10.1016/j.neuropharm.2014.01.013; Kline RH, 2008, J NEUROSCI, V28, P904, DOI 10.1523/JNEUROSCI.4452-07.2008; Knight LJ, 2009, INT J ONCOL, V34, P465, DOI 10.3892/ijo_00000171; Kohno T, 2005, PAIN, V117, P77, DOI 10.1016/j.pain.2005.05.035; Kraus J, 2010, MOL IMMUNOL, V48, P257, DOI 10.1016/j.molimm.2010.08.002; Labuz D, 2007, BRAIN RES, V1160, P30, DOI 10.1016/j.brainres.2007.05.049; Ma XT, 2013, EPIGENOMICS-UK, V5, P301, DOI [10.2217/EPI.13.26, 10.2217/epi.13.26]; Marsit CJ, 2015, J EXP BIOL, V218, P71, DOI 10.1242/jeb.106971; Mauck M, 2014, CURR OPIN ANESTHESIO, V27, P1, DOI 10.1097/ACO.0000000000000030; Meller R, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00102; Mi XB, 2008, ACTA PHARMACOL SIN, V29, P105, DOI 10.1111/j.1745-7254.2008.00739.x; Mika J, 2008, PAIN, V138, P587, DOI 10.1016/j.pain.2008.02.015; Milligan ED, 2006, PAIN, V126, P294, DOI 10.1016/j.pain.2006.07.009; Misawa K, 2013, TRANSL ONCOL, V6, P338, DOI 10.1593/tlo.13115; MOMPARLER RL, 1985, PHARMACOL THERAPEUT, V30, P287, DOI 10.1016/0163-7258(85)90053-1; Nesic O, 2005, J NEUROCHEM, V95, P998, DOI 10.1111/j.1471-4159.2005.03462.x; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Pollema-Mays SL, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00217; Poree LR, 1998, ANESTH ANALG, V87, P941, DOI 10.1097/00000539-199810000-00037; Pyati S, 2007, CNS DRUGS, V21, P185, DOI 10.2165/00023210-200721030-00002; Qi FH, 2013, PAIN, V154, P34, DOI 10.1016/j.pain.2012.07.031; RAZIN A, 1994, PROG NUCLEIC ACID RE, V48, P53, DOI 10.1016/S0079-6603(08)60853-3; Sahbaie P, 2012, ANESTHESIOLOGY, V117, P602, DOI 10.1097/ALN.0b013e3182655f9f; Schmidt Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079099; Spofford CM, 2012, ANESTHESIOLOGY, V117, P161, DOI 10.1097/ALN.0b013e31825a2a2b; Sun Y, 2014, J PAIN, V15, P856, DOI 10.1016/j.jpain.2014.05.003; Sun Y, 2013, ANESTHESIOLOGY, V119, P1198, DOI 10.1097/ALN.0b013e31829ce340; Sun Y, 2012, ANESTHESIOLOGY, V117, P626, DOI 10.1097/ALN.0b013e31826571aa; Suzuki H, 2012, MOL ONCOL, V6, P567, DOI 10.1016/j.molonc.2012.07.007; Tajerian M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055259; Tochiki KK, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-14; Truong W, 2003, ANN NEUROL, V53, P366, DOI 10.1002/ana.10465; Tuesta LM, 2014, EMBO J, V33, P1091, DOI 10.1002/embj.201488106; Turcot V, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-4; Ushijima T, 2005, NAT REV CANCER, V5, P223, DOI 10.1038/nrc1571; Vale ML, 2003, J PHARMACOL EXP THER, V304, P102, DOI 10.1124/jpet.102.038703; van Rietschoten JGI, 2006, BLOOD, V108, P2143, DOI 10.1182/blood-2006-01-021147; Viet CT, 2014, CLIN CANCER RES, V20, P4882, DOI 10.1158/1078-0432.CCR-14-0901; Viet CT, 2011, PAIN, V152, P2323, DOI 10.1016/j.pain.2011.06.025; Wachman EM, 2014, J PEDIATR-US, V165, P472, DOI 10.1016/j.jpeds.2014.05.040; Wang L, 2006, INT J ONCOL, V29, P201; Wang Y, 2011, BRAIN RES, V1418, P64, DOI 10.1016/j.brainres.2011.08.040; WILSON VL, 1983, CANCER RES, V43, P3493; Wood Emily J., 2012, Frontiers in Genetics, V3, P241, DOI 10.3389/fgene.2012.00241; Xu XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037621; Zhou XL, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-51	73	36	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142046	10.1371/journal.pone.0142046	http://dx.doi.org/10.1371/journal.pone.0142046			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26535894	gold, Green Published, Green Submitted			2022-12-26	WOS:000364298400122
J	An, H; Kim, JY; Oh, E; Lee, N; Cho, Y; Seo, JH				An, Hyunsook; Kim, Ji Young; Oh, Eunhye; Lee, Nahyun; Cho, Youngkwan; Seo, Jae Hong			Salinomycin Promotes Anoikis and Decreases the CD44(+)/CD24(-) Stem-Like Population via Inhibition of STAT3 Activation in MDA-MB-231 Cells	PLOS ONE			English	Article							IN-VITRO PROPAGATION; BREAST-CANCER CELLS; ELEVATED LEVELS; PATHWAY; GROWTH; IDENTIFICATION; METASTASIS; RESISTANCE; CYCLIN-D1; APOPTOSIS	Triple-negative breast cancer (TNBC) is an aggressive tumor subtype with an enriched CD44(+)/CD24(-) stem-like population. Salinomycin is an antibiotic that has been shown to target cancer stem cells (CSC); however, the mechanisms of action involved have not been well characterized. The objective of the present study was to investigate the effect of salinomycin on cell death, migration, and invasion, as well as CSC-like properties in MDA-MB-231 breast cancer cells. Salinomycin significantly induced anoikis-sensitivity, accompanied by caspase-3 and caspase-8 activation and PARP cleavage, during anchorage-independent growth. Salinomycin treatment also caused a marked suppression of cell migration and invasion with concomitant downregulation of MMP-9 and MMP-2 mRNA levels. Notably, salinomycin inhibited the formation of mammospheres and effectively reduced the CD44(+)/CD24(-) stem-like population during anchorage-independent growth. These observations were associated with the inhibition of STAT3 phosphorylation (Tyr705). Furthermore, interleukin-6 (IL-6)-induced STAT3 activation was strongly suppressed by salinomycin challenge. These findings support the notion that salinomycin may be potentially efficacious for targeting breast cancer stem-like cells through the inhibition of STAT3 activation.	[An, Hyunsook; Kim, Ji Young; Oh, Eunhye; Lee, Nahyun; Cho, Youngkwan; Seo, Jae Hong] Korea Univ, Coll Med, Dept Internal Med, Div Med Oncol, Seoul 152703, South Korea; [An, Hyunsook; Kim, Ji Young; Oh, Eunhye; Lee, Nahyun; Cho, Youngkwan; Seo, Jae Hong] Korea Univ, Coll Med, Brain Korea Program Biomed Sci 21, Seoul 152703, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Seo, JH (corresponding author), Korea Univ, Coll Med, Dept Internal Med, Div Med Oncol, Seoul 152703, South Korea.	cancer@korea.ac.kr			Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI12C1852]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI12C1852). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubaker K, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-317; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Arnold A, 2005, J CLIN ONCOL, V23, P4215, DOI 10.1200/JCO.2005.05.064; Baccelli I, 2012, J CELL BIOL, V198, P281, DOI 10.1083/jcb.201202014; Berishaj M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1680; Burke WM, 2001, ONCOGENE, V20, P7925, DOI 10.1038/sj.onc.1204990; Carpenter RL, 2014, CANCERS, V6, P897, DOI 10.3390/cancers6020897; Chavez Kathryn J, 2010, Breast Dis, V32, P35, DOI 10.3233/BD-2010-0307; Cheng HL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-126; Devarajan E, 2009, CURR MOL MED, V9, P626, DOI 10.2174/156652409788488720; Diaz N, 2006, CLIN CANCER RES, V12, P20, DOI 10.1158/1078-0432.CCR-04-1749; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fofaria NM, 2015, CARCINOGENESIS, V36, P142, DOI 10.1093/carcin/bgu233; Fofaria NM, 2014, ONCOTARGET, V5, P7051, DOI 10.18632/oncotarget.2251; Fuchs D, 2010, BIOCHEM BIOPH RES CO, V394, P1098, DOI 10.1016/j.bbrc.2010.03.138; Gilmore AP, 2005, CELL DEATH DIFFER, V12, P1473, DOI 10.1038/sj.cdd.4401723; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Grotenhuis BA, 2012, J SURG ONCOL, V106, P209, DOI 10.1002/jso.23069; Guadamillas MC, 2011, J CELL SCI, V124, P3189, DOI 10.1242/jcs.072165; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Idowu MO, 2012, HUM PATHOL, V43, P364, DOI 10.1016/j.humpath.2011.05.005; Kashyap V, 2009, STEM CELLS DEV, V18, P1093, DOI 10.1089/scd.2009.0113; Ketola K, 2012, BRIT J CANCER, V106, P99, DOI 10.1038/bjc.2011.530; Kim SY, 2013, CELL SIGNAL, V25, P961, DOI 10.1016/j.cellsig.2013.01.007; Koo KH, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.223; Kruyt FAE, 2010, BIOCHEM PHARMACOL, V80, P423, DOI 10.1016/j.bcp.2010.04.010; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Leslie K, 2006, CANCER RES, V66, P2544, DOI 10.1158/0008-5472.CAN-05-2203; Lin L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082821; Lin L, 2010, NEOPLASIA, V12, P39, DOI 10.1593/neo.91196; Ma F, 2014, CANCER LETT, V353, P153, DOI 10.1016/j.canlet.2014.06.022; Marotta LLC, 2011, J CLIN INVEST, V121, P2723, DOI 10.1172/JCI44745; Miklossy G, 2013, NAT REV DRUG DISCOV, V12, P611, DOI 10.1038/nrd4088; Munoz P, 2012, MOL ONCOL, V6, P620, DOI 10.1016/j.molonc.2012.10.006; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Neiva KG, 2009, NEOPLASIA, V11, P583, DOI 10.1593/neo.09266; Paoli P, 2013, BBA-MOL CELL RES, V1833, P3481, DOI 10.1016/j.bbamcr.2013.06.026; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Ricardo S, 2011, J CLIN PATHOL, V64, P937, DOI 10.1136/jcp.2011.090456; Sansone P, 2012, J CLIN ONCOL, V30, P1005, DOI 10.1200/JCO.2010.31.8907; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Verdoodt B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044132; Wang F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050638; Wang YX, 2013, P NATL ACAD SCI USA, V110, P16975, DOI 10.1073/pnas.1315862110; WATSON CJ, 1995, BRIT J CANCER, V71, P840, DOI 10.1038/bjc.1995.162; Zhou JB, 2007, P NATL ACAD SCI USA, V104, P16158, DOI 10.1073/pnas.0702596104; Zhou J, 2013, TOXICOL LETT, V222, P139, DOI 10.1016/j.toxlet.2013.07.022	48	66	66	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141919	10.1371/journal.pone.0141919	http://dx.doi.org/10.1371/journal.pone.0141919			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528725	Green Submitted, Green Published, gold			2022-12-26	WOS:000364032600076
J	Katiyar, SP; Jain, A; Dhanjal, JK; Sundar, D				Katiyar, Shashank Prakash; Jain, Arpit; Dhanjal, Jaspreet Kaur; Sundar, Durai			Mixed Inhibition of cPEPCK by Genistein, Using an Extended Binding Site Located Adjacent to Its Catalytic Cleft	PLOS ONE			English	Article							FLEMINGIA-VESTITA FABACEAE; ANTHELMINTIC EFFICACY; PHOSPHOENOLPYRUVATE CARBOXYKINASE; ADIPOSE-TISSUE; RAILLIETINA-ECHINOBOTHRIDA; MOLECULAR-DYNAMICS; ISOFLAVONE GENISTEIN; INSULIN SENSITIVITY; GLYCERIDE-GLYCEROL; FASCIOLOPSIS-BUSKI	Cytosolic phosphoenolpyruvate carboxykinase (cPEPCK) is a critical enzyme involved in gluconeogenesis, glyceroneogenesis and cataplerosis. cPEPCK converts oxaloacetic acid (OAA) into phosphoenol pyruvate (PEP) in the presence of GTP. cPEPCK is known to be associated with type 2 diabetes. Genistein is an isoflavone compound that shows anti-diabetic and anti-obesitic properties. Experimental studies have shown a decrease in the blood glucose level in the presence of genistein by lowering the functional activity of cPEPCK, an enzyme of gluconeogenesis. Using computational techniques such as molecular modeling, molecular docking, molecular dynamics simulation and binding free energy calculations, we identified cPEPCK as a direct target of genistein. We studied the molecular interactions of genistein with three possible conformations of cPEPCK-unbound cPEPCK (u_cPEPCK), GTP bound cPEPCK (GTP_cPEPCK) and GDP bound cPEPCK (GDP_cPEPCK). Binding of genistein was also compared with an already known cPEPCK inhibitor. We analyzed the interactions of genistein with cPEPCK enzyme and compared them with its natural substrate (OAA), product (PEP) and known inhibitor (3-MPA). Our results demonstrate that genistein uses the mechanism of mixed inhibition to block the functional activity of cPEPCK and thus can serve as a potential anti-diabetic and anti-obesity drug candidate. We also identified an extended binding site in the catalytic cleft of cPEPCK which is used by 3-MPA to inhibit cPEPCK non-competitively. We demonstrate that extended binding site of cPEPCK can further be exploited for designing new drugs against cPEPCK.	[Katiyar, Shashank Prakash; Jain, Arpit; Dhanjal, Jaspreet Kaur; Sundar, Durai] Indian Inst Technol IIT Delhi, Dept Biochem Engn & Biotechnol, New Delhi, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi	Sundar, D (corresponding author), Indian Inst Technol IIT Delhi, Dept Biochem Engn & Biotechnol, New Delhi, India.	sundar@dbeb.iitd.ac.in	Dhanjal, Jaspreet Kaur/AAQ-3504-2020	Dhanjal, Jaspreet Kaur/0000-0003-4226-3063; Jain, Arpit/0000-0003-3437-3350; Katiyar, Shashank/0000-0002-8496-5103; Sundar, Durai/0000-0002-6549-6663				[Anonymous], 2013, SCHROD REL 2013 3 MA; [Anonymous], 2013, DESMOND MOL DYNAMICS; Arora A, 1998, ARCH BIOCHEM BIOPHYS, V356, P133, DOI 10.1006/abbi.1998.0783; Babu PVA, 2013, J NUTR BIOCHEM, V24, P1777, DOI 10.1016/j.jnutbio.2013.06.003; BALLARD FJ, 1967, J BIOL CHEM, V242, P2746; Beale EG, 2004, TRENDS ENDOCRIN MET, V15, P129, DOI 10.1016/j.tem.2004.02.006; Beale EG, 2002, FASEB J, V16, P1695, DOI 10.1096/fj.02-0407rev; Behloul N, 2013, EUR J PHARMACOL, V698, P31, DOI 10.1016/j.ejphar.2012.11.013; Borras C, 2006, FASEB J, V20, P2136, DOI 10.1096/fj.05-5522fje; Borrelli KW, 2005, J CHEM THEORY COMPUT, V1, P1304, DOI 10.1021/ct0501811; Bowers KJ, 2006, P 2006 ACMIEEE C SUP, P4343; Carlson GM, 2009, J BIOL CHEM, V284, P27037, DOI 10.1074/jbc.R109.040568; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Choi MS, 2008, DIABETES-METAB RES, V24, P74, DOI 10.1002/dmrr.780; Das A, 2010, CANCER-AM CANCER SOC, V116, P164, DOI 10.1002/cncr.24699; Das B, 2004, PARASITOL RES, V93, P253, DOI 10.1007/s00436-004-1122-8; de Lemos ML, 2001, ANN PHARMACOTHER, V35, P1118, DOI 10.1345/aph.10257; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Franckhauser S, 2002, DIABETES, V51, P624, DOI 10.2337/diabetes.51.3.624; Gilbert ER, 2013, FOOD FUNCT, V4, P200, DOI 10.1039/c2fo30199g; Gomez-Valades AG, 2008, DIABETES, V57, P2199, DOI 10.2337/db07-1087; GORIN E, 1969, EUR J BIOCHEM, V8, P370, DOI 10.1111/j.1432-1033.1969.tb00537.x; Greenidge PA, 2013, J CHEM INF MODEL, V53, P201, DOI [10.1021/cI300025v, 10.1021/ci300425v]; Guo ZJ, 2010, CHEM BIOL DRUG DES, V75, P348, DOI 10.1111/j.1747-0285.2010.00951.x; Hakimi Parvin, 2005, Nutr Metab (Lond), V2, P33, DOI 10.1186/1743-7075-2-33; Halgren TA, 2009, J CHEM INF MODEL, V49, P377, DOI 10.1021/ci800324m; Hanson RW, 1994, PYME P ENOLPYRUVATE; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hwang YW, 2009, NUTR CANCER, V61, P598, DOI 10.1080/01635580902825639; JOMAINBAUM M, 1976, J BIOL CHEM, V251, P37; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kar PK, 2004, PARASITOL INT, V53, P287, DOI 10.1016/j.parint.2004.04.001; Kar PK, 2002, PARASITOL INT, V51, P249, DOI 10.1016/S1383-5769(02)00032-6; Kim SH, 2009, ANN NY ACAD SCI, V1171, P495, DOI 10.1111/j.1749-6632.2009.04899.x; Liu HX, 2010, MOL PHARMACEUT, V7, P894, DOI 10.1021/mp100041b; Madadkar-Sobhani A, 2013, NUCL ACIDS RES; Morito K, 2001, BIOL PHARM BULL, V24, P351, DOI 10.1248/bpb.24.351; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; Pal P, 1998, J BIOSCIENCE, V23, P25, DOI 10.1007/BF02728520; Pal Papri, 1998, Parasitology International, V47, P233, DOI 10.1016/S1383-5769(98)00025-7; Park SA, 2006, LIFE SCI, V79, P1207, DOI 10.1016/j.lfs.2006.03.022; Rastelli G, 2010, J COMPUT CHEM, V31, P797, DOI 10.1002/jcc.21372; RECORD IR, 1995, J NUTR BIOCHEM, V6, P481, DOI 10.1016/0955-2863(95)00076-C; RESHEF L, 1969, J BIOL CHEM, V244, P1994; Reshef L, 2003, J BIOL CHEM, V278, P30413, DOI 10.1074/jbc.R300017200; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sakamoto T, 2010, J NUTR BIOCHEM, V21, P856, DOI 10.1016/j.jnutbio.2009.06.010; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; She PX, 2003, DIABETES, V52, P1649, DOI 10.2337/diabetes.52.7.1649; Shivakumar D, 2010, J CHEM THEORY COMPUT, V6, P1509, DOI 10.1021/ct900587b; Sullivan SM, 2007, BIOCHEMISTRY-US, V46, P10078, DOI 10.1021/bi701038x; Sun Y, 2002, J BIOL CHEM, V277, P23301, DOI 10.1074/jbc.M200964200; Tandon V, 2003, PARASITOL INT, V52, P179, DOI 10.1016/S1383-5769(03)00006-0; Tandon V, 1997, PARASITOL RES, V83, P492, DOI 10.1007/s004360050286; Tilghman SM, 1976, HORMONAL REGULATION; Toner E, 2008, PARASITOLOGY, V135, P1189, DOI 10.1017/S0031182008004630; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; WEI HC, 1995, P SOC EXP BIOL MED, V208, P124; Yang JQ, 2009, J BIOL CHEM, V284, P27025, DOI 10.1074/jbc.R109.040543	63	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141987	10.1371/journal.pone.0141987	http://dx.doi.org/10.1371/journal.pone.0141987			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528723	Green Published, Green Submitted, gold			2022-12-26	WOS:000364032600086
J	Rehman, YAU; Tariq, M; Khan, OU				Rehman, Yasar Abbas Ur; Tariq, Muhammad; Khan, Omar Usman			Improved Object Localization Using Accurate Distance Estimation in Wireless Multimedia Sensor Networks	PLOS ONE			English	Article							CAMERA SENSOR	Object localization plays a key role in many popular applications of Wireless Multimedia Sensor Networks (WMSN) and as a result, it has acquired a significant status for the research community. A significant body of research performs this task without considering node orientation, object geometry and environmental variations. As a result, the localized object does not reflect the real world scenarios. In this paper, a novel object localization scheme for WMSN has been proposed that utilizes range free localization, computer vision, and principle component analysis based algorithms. The proposed approach provides the best possible approximation of distance between a wmsn sink and an object, and the orientation of the object using image based information. Simulation results report 99% efficiency and an error ratio of 0.01 (around 1 ft) when compared to other popular techniques.	[Rehman, Yasar Abbas Ur; Tariq, Muhammad; Khan, Omar Usman] Natl Univ Comp & Emerging Sci, NUSys Lab, Peshawar, Kpk, Pakistan; [Rehman, Yasar Abbas Ur] City Univ Sci & Informat Technol, Dept Elect Engn, Peshawar, Kpk, Pakistan		Tariq, M (corresponding author), Natl Univ Comp & Emerging Sci, NUSys Lab, Peshawar, Kpk, Pakistan.	tariq.khan@nu.edu.pk	Tariq, Muhammad/P-7695-2019; Khan, Omar Usman/H-3734-2012	Tariq, Muhammad/0000-0003-1296-2058; Khan, Omar Usman/0000-0003-2605-0623; rehman, yasar/0000-0002-2945-7181				Akyildiz IF, 2007, COMPUT NETW, V51, P921, DOI 10.1016/j.comnet.2006.10.002; Alaei M, 2012, EUROPEAN WIRELESS 20, P1; Assaf A. E., 2014, VEH TECHN C VTC FALL, P1, DOI [10.1109/VTCFa11.2014.6966149, DOI 10.1109/VTCFA11.2014.6966149]; Boulanouar I., 2011, P IFIP WIR DAYS WD N, P1; Bouwmans T, 2014, COMPUT SCI REV, V11-12, P31, DOI 10.1016/j.cosrev.2014.04.001; Chandrasekhar V., 2006, P 1 ACM INT WORKSH U, DOI DOI 10.1145/1161039.1161047; Costa DG, 2014, SENSORS-BASEL, V14, P2795, DOI 10.3390/s140202795; De D, 2012, PROC TECH, V1, P674, DOI 10.1016/j.protcy.2012.10.081; Gao DY, 2014, INT J COMMUN SYST, V27, P606, DOI 10.1002/dac.2492; Hu WM, 2004, IEEE T SYST MAN CY C, V34, P334, DOI 10.1109/TSMCC.2004.829274; Huang QQ, 2006, IEEE VTS VEH TECHNOL, P349; Joo-Kwan Lee, 2011, Proceedings of the 2011 International Conference on Ubiquitious Computing and Multimedia Applications (UCMA 2011), P30, DOI 10.1109/UCMA.2011.15; Kimura N, 2005, ITCC 2005: International Conference on Information Technology: Coding and Computing, Vol 2, P8, DOI 10.1109/ITCC.2005.43; Langendoen K, 2003, COMPUT NETW, V43, P499, DOI 10.1016/S1389-1286(03)00356-6; Li W, 2011, IEEE IND ELEC, P3814, DOI 10.1109/IECON.2011.6119931; Liu C, 2005, IEEE IPCCC, P59; Liu X.:, 2014, LECT NOTES ELECT ENG, V269, P1085, DOI DOI 10.1007/9789400776180_106; Martinez J R, 2011, SENSOR FUSION FDN AP; OROURKE D, 2009, INF PROC SENS NETW 2, P401; Oztarak H, 2012, COMPUTER AND INFORMATION SCIENCES II, P185, DOI 10.1007/978-1-4471-2155-8_23; Oztarak H, 2009, GLOB TELECOMM CONF, P649; Paul AK, 2011, P INT JOINT C BIOM O, P1, DOI DOI 10.1109/PACC.2011.5979044; Paul AK, 2013, J SENS ACTUAR NETW, V2, P25, DOI 10.3390/jsan2010025; Tavli B, 2012, MULTIMED TOOLS APPL, V60, P689, DOI 10.1007/s11042-011-0840-z; Nguyen TV, 2014, IEEE WIREL COMMUN, V21, P28, DOI 10.1109/MWC.2014.6882293; Tran DA, 2008, IEEE T PARALL DISTR, V19, P981, DOI 10.1109/TPDS.2007.70800; Vittal K. P., 2010, Proceedings of the 2010 Second International Conference on Computer and Network Technology (ICCNT 2010), P289, DOI 10.1109/ICCNT.2010.32; Wang C, 2006, IEEE INFOCOM SER, P1645; WANG LS, 2009, IM PROC ICIP 2009 16, P1113	30	1	2	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141558	10.1371/journal.pone.0141558	http://dx.doi.org/10.1371/journal.pone.0141558			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528919	Green Published, Green Submitted, gold			2022-12-26	WOS:000364032600038
J	Zhou, Z; Huang, JF; Wang, J; Zhang, KY; Kuang, ZM; Zhong, SQ; Song, XD				Zhou, Zhen; Huang, Jingfeng; Wang, Jing; Zhang, Kangyu; Kuang, Zhaomin; Zhong, Shiquan; Song, Xiaodong			Object-Oriented Classification of Sugarcane Using Time-Series Middle-Resolution Remote Sensing Data Based on AdaBoost	PLOS ONE			English	Article							LAND-COVER; VEGETATION INDEXES; CROP PHENOLOGY; ALGORITHMS	Most areas planted with sugarcane are located in southern China. However, remote sensing of sugarcane has been limited because useable remote sensing data are limited due to the cloudy climate of this region during the growing season and severe spectral mixing with other crops. In this study, we developed a methodology for automatically mapping sugarcane over large areas using time-series middle-resolution remote sensing data. For this purpose, two major techniques were used, the object-oriented method (OOM) and data mining (DM). In addition, time-series Chinese HJ-1 CCD images were obtained during the sugarcane growing period. Image objects were generated using a multi-resolution segmentation algorithm, and DM was implemented using the AdaBoost algorithm, which generated the prediction model. The prediction model was applied to the HJ-1 CCD time-series image objects, and then a map of the sugarcane planting area was produced. The classification accuracy was evaluated using independent field survey sampling points. The confusion matrix analysis showed that the overall classification accuracy reached 93.6% and that the Kappa coefficient was 0.85. Thus, the results showed that this method is feasible, efficient, and applicable for extrapolating the classification of other crops in large areas where the application of high-resolution remote sensing data is impractical due to financial considerations or because qualified images are limited.	[Zhou, Zhen; Huang, Jingfeng; Wang, Jing; Zhang, Kangyu; Song, Xiaodong] Zhejiang Univ, Inst Remote Sensing & Informat Applicat, Hangzhou 310003, Zhejiang, Peoples R China; [Zhou, Zhen; Wang, Jing; Zhang, Kangyu; Song, Xiaodong] Key Lab Agr Remote Sensing & Informat Syst, Hangzhou, Zhejiang, Peoples R China; [Huang, Jingfeng] Zhejiang Univ, Minist Educ, Key Lab Environm Remediat & Ecol Hlth, Hangzhou 310003, Zhejiang, Peoples R China; [Kuang, Zhaomin; Zhong, Shiquan] Guangxi Zhuang Autonomous Reg Inst Meteorol & Dis, Nanning, Peoples R China	Zhejiang University; Zhejiang University	Song, XD (corresponding author), Zhejiang Univ, Inst Remote Sensing & Informat Applicat, Hangzhou 310003, Zhejiang, Peoples R China.	xdsongy@zju.edu.cn		Song, Xiaodong/0000-0003-4174-7162; Huang, Jingfeng/0000-0003-4627-6021	National Special Research Fund for Public Welfare (Meteorology) of China [GYHY201406030]; Fundamental Research Funds for the Central Universities	National Special Research Fund for Public Welfare (Meteorology) of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The authors received funding from the National Special Research Fund for Public Welfare (Meteorology) of China (GYHY201406030) to XDS and the Fundamental Research Funds for the Central Universities to XDS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro E, 2013, J STAT SOFTW, V54, P1; Almeida TIR, 2006, INT J REMOTE SENS, V27, P4057, DOI 10.1080/01431160600857451; [Anonymous], 2008, ESTIMATION OPTIMAL I; Baatz M., 2004, ECOGNITION PROFESSIO; Bock Michael, 2005, Journal for Nature Conservation (Jena), V13, P75, DOI 10.1016/j.jnc.2004.12.002; Boschetti M, 2009, INT J REMOTE SENS, V30, P4643, DOI 10.1080/01431160802632249; Definiens AG, 2009, DEFINIENS ECOGNITION; Silva MPD, 2008, INT J REMOTE SENS, V29, P4803, DOI 10.1080/01431160801950634; El Hajj M, 2009, REMOTE SENS ENVIRON, V113, P2052, DOI 10.1016/j.rse.2009.04.009; Fayyad U, 1996, AI MAG, V17, P37; Fortes C, 2006, INT J REMOTE SENS, V27, P1395, DOI 10.1080/01431160500383863; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Friedl MA, 1997, REMOTE SENS ENVIRON, V61, P399, DOI 10.1016/S0034-4257(97)00049-7; Hansen PM, 2003, REMOTE SENS ENVIRON, V86, P542, DOI 10.1016/S0034-4257(03)00131-7; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; Jiang ZY, 2008, REMOTE SENS ENVIRON, V112, P3833, DOI 10.1016/j.rse.2008.06.006; Li CC, 2014, REMOTE SENS-BASEL, V6, P964, DOI 10.3390/rs6020964; Lin H, 2009, IEEE T GEOSCI REMOTE, V47, P2572, DOI 10.1109/TGRS.2009.2015769; Lu L, 2005, INT J REMOTE SENS, V26, P4471, DOI 10.1080/01431160500114938; Miao X, 2012, INT J REMOTE SENS, V33, P1823, DOI 10.1080/01431161.2011.602651; NAVULUR K, 2006, MULTISPECTRAL IMAGE; Pal M, 2003, REMOTE SENS ENVIRON, V86, P554, DOI 10.1016/S0034-4257(03)00132-9; Pena-Barragan JM, 2011, REMOTE SENS ENVIRON, V115, P1301, DOI 10.1016/j.rse.2011.01.009; Rouse J.W., 1974, NASA GSFC TYPE 3 FIN, P1; Sakamoto T, 2005, REMOTE SENS ENVIRON, V96, P366, DOI 10.1016/j.rse.2005.03.008; Schapire Robert E., 2013, EXPLAINING ADABOOST, P37, DOI DOI 10.1007/978-3-642-41136-6_5; SK Lodha D F, 2007, AERIAL LIDAR DATA CL; Steele BM, 2005, REMOTE SENS ENVIRON, V99, P254, DOI 10.1016/j.rse.2005.09.001; STONE M, 1974, J R STAT SOC B, V36, P111, DOI 10.1111/j.2517-6161.1974.tb00994.x; Rudorff BFT, 2010, REMOTE SENS-BASEL, V2, P1057, DOI 10.3390/rs2041057; TOWNSHEND JRG, 1987, INT J REMOTE SENS, V8, P1189, DOI 10.1080/01431168708954764; Vieira MA, 2012, REMOTE SENS ENVIRON, V123, P553, DOI 10.1016/j.rse.2012.04.011; Wang J, 2015, REMOTE SENS-BASEL, V7, P3467, DOI 10.3390/rs70403467; Witten I. H., 2005, DATA MINING PRACTICA; WOLTER PT, 1995, PHOTOGRAMM ENG REM S, V61, P1129; Xavier AC, 2006, INT J REMOTE SENS, V27, P755, DOI 10.1080/01431160500296735	36	22	22	5	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0142069	10.1371/journal.pone.0142069	http://dx.doi.org/10.1371/journal.pone.0142069			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528811	Green Published, Green Submitted, gold			2022-12-26	WOS:000364032600097
J	Silhavy, R; Silhavy, P; Prokopova, Z				Silhavy, Radek; Silhavy, Petr; Prokopova, Zdenka			Algorithmic Optimisation Method for Improving Use Case Points Estimation	PLOS ONE			English	Article								This paper presents a new size estimation method that can be used to estimate size level for software engineering projects. The Algorithmic Optimisation Method is based on Use Case Points and on Multiple Least Square Regression. The method is derived into three phases. The first phase deals with calculation Use Case Points and correction coefficients values. Correction coefficients are obtained by using Multiple Least Square Regression. New project is estimated in the second and third phase. In the second phase Use Case Points parameters for new estimation are set up and in the third phase project estimation is performed. Final estimation is obtained by using newly developed estimation equation, which used two correction coefficients. The Algorithmic Optimisation Method performs approximately 43% better than the Use Case Points method, based on their magnitude of relative error score. All results were evaluated by standard approach: visual inspection, goodness of fit measure and statistical significance.	[Silhavy, Radek; Silhavy, Petr; Prokopova, Zdenka] Tomas Bata Univ Zlin, Fac Appl Informat, Zlin, Czech Republic	Tomas Bata University Zlin	Silhavy, R (corresponding author), Tomas Bata Univ Zlin, Fac Appl Informat, Zlin, Czech Republic.	rsilhavy@fai.utb.cz	Silhavy, Petr/H-6414-2012; Silhavy, Radek/H-6422-2012; Prokopová, Zdenka/H-6371-2012	Silhavy, Petr/0000-0002-3724-7854; Silhavy, Radek/0000-0002-5637-8796; Prokopová, Zdenka/0000-0002-0762-7100	Department of Computers and Communication System of the Faculty of Applied Informatics (Tomas Bata University in Zlin)	Department of Computers and Communication System of the Faculty of Applied Informatics (Tomas Bata University in Zlin)	Funding: This study was funded by the Department of Computers and Communication System of the Faculty of Applied Informatics (Tomas Bata University in Zlin).	Azevedo S, 2012, INNOV SYST SOFTW ENG, V8, P51, DOI 10.1007/s11334-011-0177-9; Braz MR, 2006, COMP SOFTW APPL C 20; Diev S., 2006, ACM SIGSOFT SOFTWARE, V31, P1, DOI [10.1145/1218776.1218780, DOI 10.1145/1218776.1218780]; Karner G., 1993, LITHIDAEX9344 U LINK, V21; Mohagheghi P, 2005, PROC INT CONF SOFTW, P303; Ochodek M, 2011, INFORM SOFTWARE TECH, V53, P885, DOI 10.1016/j.infsof.2011.02.004; Ochodek M, 2011, INFORM SOFTWARE TECH, V53, P200, DOI 10.1016/j.infsof.2010.10.005; Pindyck R.S., 2013, ECONOMETRIC MODELS E; Robiolo G, 2009, T PATHS 2 USE CASE B, P422, DOI [10.1109/esem.2009.5316021, DOI 10.1109/ESEM.2009.5316021]; Robiolo G, 2008, INNOV SYST SOFTW ENG, V4, P31, DOI 10.1007/s11334-007-0043-y; Subriadi Apol Pribadi, 2014, Journal of Theoretical and Applied Information Technology, V59, P735; Wang F., 2009, EXTENDED USE CASE PO, P1, DOI [10.1109/cise.2009.5364706, 10.1109/CISE.2009.5364706, DOI 10.1109/CISE.2009.5364706]	12	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2015	10	11							e0141887	10.1371/journal.pone.0141887	http://dx.doi.org/10.1371/journal.pone.0141887			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7AC	26550835	Green Published, gold, Green Submitted			2022-12-26	WOS:000364422800011
J	Xie, BD; Zhang, CF; Kang, K; Jiang, SL				Xie, Baodong; Zhang, Chunfeng; Kang, Kai; Jiang, Shulin			miR-599 Inhibits Vascular Smooth Muscle Cells Proliferation and Migration by Targeting TGFB2	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; EPITHELIAL-MESENCHYMAL TRANSITION; GASTRIC-CANCER; NEOINTIMAL FORMATION; GALLBLADDER CANCER; PHENOTYPIC SWITCH; DOWN-REGULATION; EXPRESSION; MICRORNA; ATHEROSCLEROSIS	Aberrant proliferation and migration of vascular smooth muscle cells (VSMCs) play a crucial role in the pathogenesis of cardiovascular diseases including coronary heart disease, restenosis and atherosclerosis. MicroRNAs are a class of small, non-coding and endogenous RNAs that play critical roles in VSMCs function. In this study, we showed that PDGF-bb, as a stimulant, promoted VSMCs proliferation and suppressed the expression of miR-599. Moreover, overexpression of miR-599 inhibited VSMCs proliferation and also suppressed the PCNA and ki-67 expression. In addition, we demonstrated that ectopic expression of miR-599 repressed the VSMCs migration. We also showed that miR-599 inhibited type I collagen, type V collagen and proteoglycan expression. Furthermore, we identified TGFb2 as a direct target gene of miR-599 in VSMCs. Overexpression of TGFb2 reversed miR-599-induced inhibition of VSMCs proliferation and type I collagen, type V collagen and proteoglycan expression. In conclusion, our findings suggest miR-599 plays a crucial role in controlling VSMCs proliferation and matrix gene expression by regulating TGFb2 expression.	[Xie, Baodong; Zhang, Chunfeng; Kang, Kai; Jiang, Shulin] Harbin Med Univ, Affiliated Hosp 2, Dept Cardiovasc Surg, Harbin, Heilongjiang, Peoples R China	Harbin Medical University	Kang, K (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Dept Cardiovasc Surg, Harbin, Heilongjiang, Peoples R China.	kai1kang@sina.com; jiangshulin@aliyun.com			Science and Technology Research Project of Department of Education of Heilongjiang Province [12541434]; Heilongjiang Provincial Science and Technology Research Project [LC2012C03]; National Science Foundation of China [81471805]; Chinese Postdoctoral Science Foundation [2014 M551272]; Scienctific Research Project of Educational Department of Heilongjiang Province [11531109]	Science and Technology Research Project of Department of Education of Heilongjiang Province; Heilongjiang Provincial Science and Technology Research Project; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Scienctific Research Project of Educational Department of Heilongjiang Province	Funding: This research was funded by a grant from the Science and Technology Research Project of Department of Education of Heilongjiang Province (12541434), Heilongjiang Provincial Science and Technology Research Project (LC2012C03), National Science Foundation of China (81471805), Chinese Postdoctoral Science Foundation (2014 M551272), and Scienctific Research Project of Educational Department of Heilongjiang Province (11531109) to KK. URL is http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cesi V, 2011, CELL CYCLE, V10, P4149, DOI 10.4161/cc.10.23.18346; Chen J, 2014, J CELL PHYSIOL, V229, P1647, DOI 10.1002/jcp.24610; Choe N, 2013, ATHEROSCLEROSIS, V229, P348, DOI 10.1016/j.atherosclerosis.2013.05.009; Han M, 2011, CURR OPIN CARDIOL, V26, P181, DOI 10.1097/HCO.0b013e328345983d; Hou N, 2011, CLIN EXP PHARMACOL P, V38, P905, DOI 10.1111/j.1440-1681.2011.05619.x; Karnuth B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093067; Kitamura K, 2014, MOL CANCER THER, V13, P444, DOI 10.1158/1535-7163.MCT-13-0448; Li P, 2013, CIRC RES, V113, P1117, DOI 10.1161/CIRCRESAHA.113.301306; Li P, 2013, CARDIOVASC RES, V99, P185, DOI 10.1093/cvr/cvt082; Li Z, 2015, ONCOTARGET; Li Z, 2015, ONCOTARGET, V6, P17559, DOI 10.18632/oncotarget.2755; Li Z, 2015, ONCOTARGET, V6, P13914, DOI 10.18632/oncotarget.4227; Li Z, 2015, CELL PROLIFERAT, V48, P278, DOI 10.1111/cpr.12180; Li Z, 2015, CELL PROLIFERAT, V48, P1, DOI 10.1111/cpr.12160; Li Z, 2015, GASTRIC CANCER, V18, P43, DOI 10.1007/s10120-014-0340-8; Lyu XM, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-51; Ma S, 2011, CYTOKINE GROWTH F R, V22, P167, DOI 10.1016/j.cytogfr.2011.05.004; Mallat Z, 2002, CURR OPIN LIPIDOL, V13, P523, DOI 10.1097/00041433-200210000-00008; Murakami Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106314; Otaegui D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006309; Piepoli A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033663; Qiu YH, 2014, MOL BIOSYST, V10, P679, DOI 10.1039/c3mb70479c; Sabarinathan R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082699; Singh NN, 2006, CYTOKINE GROWTH F R, V17, P487, DOI 10.1016/j.cytogfr.2006.09.002; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Song L, 2012, ARCH BIOCHEM BIOPHYS, V528, P204, DOI 10.1016/j.abb.2012.08.015; Stein JJ, 2014, SURGERY, V155, P228, DOI 10.1016/j.surg.2013.08.003; Torella D, 2011, CIRC RES, V109, P880, DOI 10.1161/CIRCRESAHA.111.240150; Vrba L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054398; Wang J, 2013, EXP CELL RES, V319, P1165, DOI 10.1016/j.yexcr.2013.03.010; Wang J, 2014, TUMOR BIOL, V35, P4859, DOI 10.1007/s13277-014-1637-2; Wang YS, 2012, CARDIOVASC RES, V95, P517, DOI 10.1093/cvr/cvs223; Wojcicka A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097624; Xu XY, 2015, FEBS LETT, V589, P407, DOI 10.1016/j.febslet.2014.12.027; Yu X, 2015, ONCOTARGET; Yu X, 2015, CELL PROLIFERAT, V48, P271, DOI 10.1111/cpr.12179; Yu X, 2014, INT J MOL MED, V34, P923, DOI 10.3892/ijmm.2014.1853; Yu X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083080; Zhang H, 2013, MOL CELL BIOCHEM, V375, P11, DOI 10.1007/s11010-012-1512-7; Zhang Y, 2011, J HYPERTENS, V29, P1560, DOI 10.1097/HJH.0b013e328348ef8e; Zhang ZP, 2011, CANCER GENET-NY, V204, P486, DOI 10.1016/j.cancergen.2011.07.004; Zhao J, 2013, ARTERIOSCL THROM VAS, V33, P257, DOI 10.1161/ATVBAHA.112.300200	42	46	52	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2015	10	11							e0141512	10.1371/journal.pone.0141512	http://dx.doi.org/10.1371/journal.pone.0141512			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7AC	26551255	Green Published, Green Submitted, gold			2022-12-26	WOS:000364422800006
J	Cheng, YF; Young, GH; Lin, JT; Jang, HH; Chen, CC; Nong, JY; Chen, PK; Kuo, CY; Kao, SH; Liang, YJ; Chen, HM				Cheng, Yi-Fang; Young, Guang-Huar; Lin, Jiun-Tsai; Jang, Hyun-Hwa; Chen, Chin-Chen; Nong, Jing-Yi; Chen, Po-Ku; Kuo, Cheng-Yi; Kao, Shao-Hsuan; Liang, Yao-Jen; Chen, Han-Min			Activation of AMP-Activated Protein Kinase by Adenine Alleviates TNF-Alpha-Induced Inflammation in Human Umbilical Vein Endothelial Cells	PLOS ONE			English	Article							NF-KAPPA-B; NITRIC-OXIDE SYNTHESIS; LEUKOCYTE ADHESION MOLECULES; ACUTE KIDNEY INJURY; E-SELECTIN; IN-VIVO; VASCULAR INFLAMMATION; EXPRESSION; ICAM-1; MODULATION	The AMP-activated protein kinase (AMPK) signaling system plays a key role in cellular stress by repressing the inflammatory responses induced by the nuclear factor-kappa B (NF-kappa B) system. Previous studies suggest that the anti-inflammatory role of AMPK involves activation by adenine, but the mechanism that allows adenine to produce these effects has not yet been elucidated. In human umbilical vein endothelial cells (HUVECs), adenine was observed to induce the phosphorylation of AMPK in both a time-and dose-dependent manner as well as its downstream target acetyl Co-A carboxylase (ACC). Adenine also attenuated NF-kappa B targeting of gene expression in a dose-dependent manner and decreased monocyte adhesion to HUVECs following tumor necrosis factor (TNF-alpha) treatment. The short hairpin RNA (shRNA) against AMPK alpha 1 in HUVECs attenuated the adenine-induced inhibition of NF-kappa B activation in response to TNF-a, thereby suggesting that the anti-inflammatory role of adenine is mediated by AMPK. Following the knockdown of adenosyl phosphoribosyl transferase (APRT) in HUVECs, adenine supplementation failed to induce the phosphorylation of AMPK and ACC. Similarly, the expression of a shRNA against APRT nullified the anti-inflammatory effects of adenine in HUVECs. These results suggested that the role of adenine as an AMPK activator is related to catabolism by APRT, which increases the cellular AMP levels to activate AMPK.	[Cheng, Yi-Fang; Young, Guang-Huar; Lin, Jiun-Tsai; Jang, Hyun-Hwa; Chen, Po-Ku; Kuo, Cheng-Yi] Energenesis Biomed Co Ltd, New Taipei, Taiwan; [Chen, Chin-Chen; Liang, Yao-Jen; Chen, Han-Min] Catholic Fu Jen Univ, Dept Life Sci, Inst Appl Sci & Engn, New Taipei, Taiwan; [Nong, Jing-Yi] Natl Taiwan Univ, Collage Med, Dept Internal Med, Taipei 10764, Taiwan; [Kao, Shao-Hsuan] Chung Shan Med Univ, Inst Biochem & Biotechnol, Taichung, Taiwan	Fu Jen Catholic University; National Taiwan University; Chung Shan Medical University	Chen, HM (corresponding author), Catholic Fu Jen Univ, Dept Life Sci, Inst Appl Sci & Engn, New Taipei, Taiwan.	056489@mail.fju.edu.tw	Kao, Shao-Hsuan/I-3875-2019		Energenesis Biomedical Co. Ltd	Energenesis Biomedical Co. Ltd	Energenesis Biomedical Co. Ltd provided support in the form of salaries for authors Y.F. Cheng, H.H. Jang, J.T. Lin, G.H. Young, P.K. Chen and C.Y. Kuo, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Abbott MJ, 2009, AM J PHYSIOL-REG I, V297, pR1724, DOI 10.1152/ajpregu.00179.2009; Alexander A, 2011, FEBS LETT, V585, P952, DOI 10.1016/j.febslet.2011.03.010; BEVILACQUA MP, 1994, ANNU REV MED, V45, P361, DOI 10.1146/annurev.med.45.1.361; Boyle JG, 2008, J BIOL CHEM, V283, P11210, DOI 10.1074/jbc.M710048200; Brasier AR, 2010, CARDIOVASC RES, V86, P211, DOI 10.1093/cvr/cvq076; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Chen C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034181; Chen CC, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/692061; Chu SC, 2014, MOL PHARMACOL, V86, P609, DOI 10.1124/mol.114.094037; Collins T, 2001, J CLIN INVEST, V107, P255, DOI 10.1172/JCI10373; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; Davis BJ, 2006, DIABETES, V55, P496, DOI 10.2337/diabetes.55.02.06.db05-1064; Fisslthaler B, 2009, CIRC RES, V105, P114, DOI 10.1161/CIRCRESAHA.109.201590; FRIES JWU, 1993, AM J PATHOL, V143, P725; Giri S, 2004, J NEUROSCI, V24, P479, DOI 10.1523/JNEUROSCI.4288-03.2004; Haraldsen G, 1996, J IMMUNOL, V156, P2558; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; Hattori Y, 2006, HYPERTENSION, V47, P1183, DOI 10.1161/01.HYP.0000221429.94591.72; HOCHSTADTOZER J, 1971, J BIOL CHEM, V246, P5304; HOUSSET P, 1977, EUR J BIOCHEM, V73, P99, DOI 10.1111/j.1432-1033.1977.tb11295.x; Huang NL, 2009, INT J CARDIOL, V134, P169, DOI 10.1016/j.ijcard.2008.04.010; Krasner NM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097554; Kuo CL, 2008, J CELL BIOCHEM, V103, P931, DOI 10.1002/jcb.21466; Lee S, 2007, INT IMMUNOL, V19, P1349, DOI 10.1093/intimm/dxm104; Lin YM, 2013, CANCER LETT, V328, P135, DOI 10.1016/j.canlet.2012.08.029; LO SK, 1993, AM J PHYSIOL, V264, pL406; Marino M, 2008, J NEUROIMMUNOL, V196, P41, DOI 10.1016/j.jneuroim.2008.02.005; Mishra J, 2006, PEDIATR NEPHROL, V21, P856, DOI 10.1007/s00467-006-0055-0; Morrow VA, 2003, J BIOL CHEM, V278, P31629, DOI 10.1074/jbc.M212831200; MURRAY AW, 1971, ANNU REV BIOCHEM, V40, P811, DOI 10.1146/annurev.bi.40.070171.004115; Prasad R, 2006, J NEUROSCI RES, V84, P614, DOI 10.1002/jnr.20953; Savoia C, 2007, CLIN SCI, V112, P375, DOI 10.1042/CS20060247; SLUITER W, 1993, J CARDIOVASC PHARM, V22, pS37, DOI 10.1097/00005344-199322004-00006; Wagnerova J, 2002, J NEUROL SCI, V195, P51, DOI 10.1016/S0022-510X(01)00685-2; Wu VC, 2013, ANGIOGENESIS, V16, P609, DOI 10.1007/s10456-013-9339-8; Wung BS, 2005, J BIOMED SCI, V12, P91, DOI 10.1007/s11373-004-8170-z; Yang XD, 2010, MOL CELL BIOL, V30, P2170, DOI 10.1128/MCB.01343-09; Yang YY, 2004, ATHEROSCLEROSIS, V174, P207, DOI 10.1016/j.atherosclerosis.2004.01.024; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Young GH, 2006, PLANTA, V223, P468, DOI 10.1007/s00425-005-0103-1; Young GH, 2015, J PROTEOMICS, V120, P204, DOI 10.1016/j.jprot.2015.03.012; Young GH, 2014, ANTIOXID REDOX SIGN, V20, P1181, DOI 10.1089/ars.2013.5366; Young GH, 2012, KIDNEY INT, V81, P611, DOI 10.1038/ki.2011.461; Zhang Y, 2011, ARTERIOSCL THROM VAS, V31, P2897, DOI 10.1161/ATVBAHA.111.237453; Zhao X, 2008, AM J PHYSIOL-LUNG C, V295, pL497, DOI 10.1152/ajplung.90210.2008; Zou MH, 2004, J BIOL CHEM, V279, P43940, DOI 10.1074/jbc.M404421200	46	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142283	10.1371/journal.pone.0142283	http://dx.doi.org/10.1371/journal.pone.0142283			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544976	Green Submitted, Green Published, gold			2022-12-26	WOS:000364398700106
J	Lieske, NV; Tonby, K; Kvale, D; Dyrhol-Riise, AM; Tasken, K				Lieske, Nora V.; Tonby, Kristian; Kvale, Dag; Dyrhol-Riise, Anne M.; Tasken, Kjetil			Targeting Tuberculosis and HIV Infection-Specific Regulatory T Cells with MEK/ERK Signaling Pathway Inhibitors	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; IMMUNE-RESPONSES; MEK INHIBITORS; TNF-ALPHA; ACTIVATION; BLOOD; DISEASE; IL-2; INTERLEUKIN-2; HOMEOSTASIS	Human regulatory T cells (Tregs) are essential in maintaining immunological tolerance and suppress effector T cells. Tregs are commonly up-regulated in chronic infectious diseases such as tuberculosis (TB) and human immunodeficiency virus (HIV) infection and thereby hamper disease-specific immune responses and eradication of pathogens. The MEK/ERK signaling pathway is involved in regulation of the FoxP3 transcription factor, which directs a lineage-specific transcriptional program to define Tregs and control their suppressive function. Here, we aimed to target activation of disease-specific Tregs by inhibition of the MEK/ERK signaling pathway based on the hypothesis that this would improve anti-HIV and anti-TB immunity. Stimulation of T cells from untreated TB (n = 12) and HIV (n = 8) patients with disease-specific antigens in vitro in the presence of the MEK inhibitor (MEKI) trametinib (GSK1120212) resulted in significant down-regulation of both FoxP3 levels (MFI) and fractions of resting (CD45RA(+)FoxP3(+)) and activated (CD45RA(-)FoxP3(++)) Tregs. MEKI also reduced the levels of specific T effector cells expressing the pro-inflammatory cytokines (IFN-gamma, TNF-alpha and IL-2) in both HIV and TB patients. In conclusion, MEKIs modulate disease antigen-specific Treg activation and may have potential application in new treatment strategies in chronic infectious diseases where reduction of Treg activity would be favorable. Whether MEKIs can be used in current HIV or TB therapy regimens needs to be further investigated.	[Lieske, Nora V.; Tasken, Kjetil] Univ Oslo, Nord EMBL Partnership, Ctr Mol Med Norway, Oslo, Norway; [Tonby, Kristian; Kvale, Dag; Dyrhol-Riise, Anne M.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Tonby, Kristian; Kvale, Dag; Dyrhol-Riise, Anne M.; Tasken, Kjetil] Oslo Univ Hosp, Dept Infect Dis, Oslo, Norway; [Kvale, Dag; Dyrhol-Riise, Anne M.; Tasken, Kjetil] Univ Oslo, Kristian Gerhard Jebsen Inflammat Res Ctr, Oslo, Norway; [Tasken, Kjetil] Univ Oslo, Ctr Biotechnol, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Tasken, K (corresponding author), Univ Oslo, Nord EMBL Partnership, Ctr Mol Med Norway, Oslo, Norway.	kjetil.tasken@ncmm.uio.no		Tasken, Kjetil/0000-0003-2841-4697; Kvale, Dag/0000-0001-6410-2530	Research Council of Norway [RCN204784, RCN187615]; South Eastern Norway Regional Health Authority [11/01137-144, 2013074]; Kristian Gerhard Jebsen Inflammation Research Centre [2012/23]	Research Council of Norway(Research Council of Norway); South Eastern Norway Regional Health Authority; Kristian Gerhard Jebsen Inflammation Research Centre	This work was supported by the Research Council of Norway (RCN204784 and RCN187615, http://www.forskningsradet.no/en/Home_page/1177315753906, N.L., Kj.T.), the South Eastern Norway Regional Health Authority (11/01137-144 and 2013074, http://www.helse-sorost.no/omoss_/english_/, Kr.T and Kj.T respectively) and the Kristian Gerhard Jebsen Inflammation Research Centre (2012/23, http://www.stiftkgj.no/?lang = en, K.T.).	Abrams D, 2009, NEW ENGL J MED, V361, P1548, DOI 10.1056/NEJMoa0903175; Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; Arruvito L, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057336, DOI 10.1371/J0URNAL.P0NE.0052580]; Aukrust P, 1999, J INFECT DIS, V179, P74, DOI 10.1086/314572; Barnes PF, 2003, AM J RESP CRIT CARE, V168, P142, DOI 10.1164/rccm.2305001; Beiranvand E, 2014, INFLAMMATION ALLERGY; Belkaid Y, 2009, ANNU REV IMMUNOL, V27, P551, DOI 10.1146/annurev.immunol.021908.132723; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Bi X, 2009, EUR J IMMUNOL, V39, P301, DOI 10.1002/eji.200838667; Boaz MJ, 2003, CLIN EXP IMMUNOL, V134, P454, DOI 10.1111/j.1365-2249.2003.02307.x; Brazille P, 2003, CLIN EXP IMMUNOL, V131, P304, DOI 10.1046/j.1365-2249.2003.02064.x; Caccamo N, 2010, EUR J IMMUNOL, V40, P2211, DOI 10.1002/eji.201040455; Chatt JA, 2002, AIDS RES HUM RETROV, V18, P1367, DOI 10.1089/088922202320935447; Chen XC, 2007, CLIN IMMUNOL, V123, P50, DOI 10.1016/j.clim.2006.11.009; Chevalier MF, 2013, BLOOD, V121, P29, DOI 10.1182/blood-2012-07-409755; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Day CL, 2011, J IMMUNOL, V187, P2222, DOI 10.4049/jimmunol.1101122; Feruglio SL, 2015, CLIN EXP IMMUNOL, V179, P454, DOI 10.1111/cei.12468; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Giovannetti A, 2001, CLIN EXP IMMUNOL, V124, P21, DOI 10.1046/j.1365-2249.2001.01502.x; Gonzalez-Juarrereo M, 2012, IMMUNOTHERAPY-UK, V4, P187, DOI [10.2217/IMT.11.168, 10.2217/imt.11.168]; Guyot-Revol V, 2006, AM J RESP CRIT CARE, V173, P803, DOI 10.1164/rccm.200508-1294OC; Haraguchi Soichi, 2006, AIDS Res Ther, V3, P8, DOI 10.1186/1742-6405-3-8; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; HOBER D, 1992, CLIN IMMUNOL IMMUNOP, V62, P168, DOI 10.1016/0090-1229(92)90069-Z; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Horta A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057336; Hougardy JM, 2007, AM J RESP CRIT CARE, V176, P409, DOI 10.1164/rccm.200701-084OC; Hunt PW, 2003, J INFECT DIS, V187, P1534, DOI 10.1086/374786; JOHNSON BJ, 1995, CYTOKINES MOL THER, V1, P185; Johnson JL, 2003, AM J RESP CRIT CARE, V168, P185, DOI 10.1164/rccm.200211-1359OC; Kalland ME, 2011, J IMMUNOL, V187, P5233, DOI 10.4049/jimmunol.1101804; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Kim JM, 2011, IMMUNOTHERAPY-UK, V3, P247, DOI 10.2217/IMT.10.91; Kursar M, 2007, J IMMUNOL, V178, P2661, DOI 10.4049/jimmunol.178.5.2661; Lintermans LL, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00504; Marin ND, 2010, TUBERCULOSIS, V90, P252, DOI 10.1016/j.tube.2010.05.003; Marriott JB, 1997, AIDS RES HUM RETROV, V13, P1625, DOI 10.1089/aid.1997.13.1625; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Mills KHG, 2004, NAT REV IMMUNOL, V4, P841, DOI 10.1038/nri1485; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Moreno-Fernandez ME, 2012, J VIROL, V86, P10262, DOI 10.1128/JVI.00993-12; Pastrana Jahaira Lopez, 2012, J Clin Exp Cardiolog, V2012, P2; Popik W, 2000, J VIROL, V74, P2558, DOI 10.1128/JVI.74.6.2558-2566.2000; Prezzemolo T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00180; Ribeiro-Rodrigues R, 2006, CLIN EXP IMMUNOL, V144, P25, DOI 10.1111/j.1365-2249.2006.03027.x; Robbs BK, 2013, BBA-MOL CELL RES, V1833, P2016, DOI 10.1016/j.bbamcr.2013.04.003; Roberts L, 2010, AIDS, V24, P819, DOI 10.1097/QAD.0b013e3283367836; Roca FJ, 2013, CELL, V153, P521, DOI 10.1016/j.cell.2013.03.022; Rolf J, 2010, J IMMUNOL, V184, P6563, DOI 10.4049/jimmunol.1000202; Rouse BT, 2006, IMMUNOL REV, V212, P272, DOI 10.1111/j.0105-2896.2006.00412.x; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; Shafiani S, 2010, J EXP MED, V207, P1409, DOI 10.1084/jem.20091885; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Shindo T, 2013, BLOOD, V121, P4617, DOI 10.1182/blood-2012-12-476218; Simonetta F, 2012, J INFECT DIS, V205, P1510, DOI 10.1093/infdis/jis235; Trujillo JI, 2011, EXPERT OPIN THER PAT, V21, P1045, DOI 10.1517/13543776.2011.577068; Uhlin M, 2012, J INFECT DIS, V205, pS325, DOI 10.1093/infdis/jis197; Vella LJ, 2014, CANCER IMMUNOL RES, V2, P351, DOI 10.1158/2326-6066.CIR-13-0181; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; VONSYDOW M, 1991, AIDS RES HUM RETROV, V7, P375, DOI 10.1089/aid.1991.7.375; Wallis RS, 1996, J INFECT DIS, V174, P727, DOI 10.1093/infdis/174.4.727; Wallis RS, 2004, CLIN INFECT DIS, V39, P1254, DOI 10.1086/424455; Wang D, 2007, BBA-MOL CELL RES, V1773, P1248, DOI 10.1016/j.bbamcr.2006.11.009; Weiss L, 2004, BLOOD, V104, P3249, DOI 10.1182/blood-2004-01-0365; Wergeland I, 2011, SCAND J IMMUNOL, V73, P234, DOI 10.1111/j.1365-3083.2010.02496.x; Westby M, 1998, CLIN EXP IMMUNOL, V111, P257; World Health Organization, 2014, GLOB TUB REP; Yamane H, 2013, IMMUNOL REV, V252, P12, DOI 10.1111/imr.12032; Zhao YJ, 2014, NAT REV CLIN ONCOL, V11, P385, DOI 10.1038/nrclinonc.2014.83; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563	72	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141903	10.1371/journal.pone.0141903	http://dx.doi.org/10.1371/journal.pone.0141903			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544592	Green Submitted, gold, Green Published			2022-12-26	WOS:000364398700063
J	Potamitis, I; Rigakis, I; Fysarakis, K				Potamitis, Ilyas; Rigakis, Iraklis; Fysarakis, Konstantinos			Insect Biometrics: Optoacoustic Signal Processing and Its Applications to Remote Monitoring of McPhail Type Traps	PLOS ONE			English	Article							FRUIT-FLY; DIPTERA	Monitoring traps are important components of integrated pest management applied against important fruit fly pests, including Bactrocera oleae (Gmelin) and Ceratitis capitata (Wide-mann), Diptera of the Tephritidae family, which effect a crop-loss/per year calculated in billions of euros worldwide. Pests can be controlled with ground pesticide sprays, the efficiency of which depends on knowing the time, location and extent of infestations as early as possible. Trap inspection is currently carried out manually, using the McPhail trap, and the mass spraying is decided based on a decision protocol. We introduce the term 'insect biometrics' in the context of entomology as a measure of a characteristic of the insect (in our case, the spectrum of its wingbeat) that allows us to identify its species and make devices to help face old enemies with modern means. We modify a McPhail type trap into becoming electronic by installing an array of photoreceptors coupled to an infrared emitter, guarding the entrance of the trap. The beating wings of insects flying in the trap intercept the light and the light fluctuation is turned to a recording. Custom-made electronics are developed that are placed as an external add-on kit, without altering the internal space of the trap. Counts from the trap are transmitted using a mobile communication network. This trap introduces a new automated remote-monitoring method different to audio and vision-based systems. We evaluate our trap in large number of insects in the laboratory by enclosing the electronic trap in insectary cages. Our experiments assess the potential of delivering reliable data that can be used to initialize reliably the spraying process at large scales but to also monitor the impact of the spraying process as it eliminates the time-lag between acquiring and delivering insect counts to a central agency.	[Potamitis, Ilyas] Technol Educ Inst Crete, Dept Music Technol & Acoust, GR-74100 Rethymno Crete, Greece; [Rigakis, Iraklis] Technol Educ Inst Crete, Dept Elect, GR-73133 Khania, Greece; [Fysarakis, Konstantinos] Tech Univ Crete, Dept Elect & Comp Engn, GR-73100 Kounoupidiana, Chania, Greece	Hellenic Mediterranean University; Hellenic Mediterranean University; Technical University of Crete	Potamitis, I (corresponding author), Technol Educ Inst Crete, Dept Music Technol & Acoust, GR-74100 Rethymno Crete, Greece.	potamitis@staff.teicrete.gr	Fysarakis, Konstantinos/I-4412-2019	Fysarakis, Konstantinos/0000-0002-6871-8102; Potamitis, Ilyas/0000-0002-7111-3331	NVIDIA Corporation; TITAN-X GPU; European Union's Seventh Framework Program by REA-Research Executive Agency [605073]	NVIDIA Corporation; TITAN-X GPU; European Union's Seventh Framework Program by REA-Research Executive Agency	We gratefully acknowledge the support of NVIDIA Corporation with the donation of a TITAN-X GPU partly used for this research. The research leading to these results has received funding from the European Union's Seventh Framework Program managed by REA-Research Executive Agency (http://ec.europa.eu/research/rea) (FP7/2007-2013) under grant agreement n degrees 605073 project ENTOMATIC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARROS MD, 1991, FLA ENTOMOL, V74, P467, DOI 10.2307/3494843; Daane KM, 2010, ANNU REV ENTOMOL, V55, P151, DOI 10.1146/annurev.ento.54.110807.090553; Ellington CP, 1999, J EXP BIOL, V202, P3439; Elson-Harris M, 1992, FRUIT FLIES EC IMPOR; Engel JE, 2001, FLA ENTOMOL, V84, P336, DOI 10.2307/3496490; Fletcher B, 1983, ENTOMOLOGICA HELLENI, V1, P16; Jiang JA, 2008, COMPUT ELECTRON AGR, V62, P243, DOI 10.1016/j.compag.2008.01.005; Kirsch P, 2006, 80 ANN W ORCH PEST D; Michelakis S. E., 1983, Fruit flies of economic importance. Proceedings of the CEC/IOBC International Symposium, Athens, Greece, 16-19 November 1982, P603; MOORE A, 1986, J ECON ENTOMOL, V79, P1703, DOI 10.1093/jee/79.6.1703; MOORE A, 1991, J INSECT BEHAV, V4, P391, DOI 10.1007/BF01048285; Nardi F, 2005, MOL ECOL, V14, P2729, DOI 10.1111/j.1365-294X.2005.02610.x; NEUENSCHWANDER P, 1981, Z ANGEW ENTOMOL, V91, P193; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Plant Health Australia, 2011, AUSTR HDB ID FRUIT F; Potamitis I., 2015, 22 INT C SOUND VIBR; Potamitis I, 2015, IEEE SENS J, V15, P4621, DOI 10.1109/JSEN.2015.2424924; Potamitis I, 2014, SENSORS-BASEL, V14, P22285, DOI 10.3390/s141222285; Potamitis I, 2014, ECOL INFORM, V21, P40, DOI 10.1016/j.ecoinf.2013.11.005; Schafer P, 2014, CLASSIFYING INSECTS	20	28	28	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0140474	10.1371/journal.pone.0140474	http://dx.doi.org/10.1371/journal.pone.0140474			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544845	Green Published, gold, Green Submitted			2022-12-26	WOS:000364398700009
J	Uwatoko, T; Yoshizumi, M; Miyata, J; Ubukata, S; Fujiwara, H; Kawada, R; Kubota, M; Sasamoto, A; Sugihara, G; Aso, T; Urayama, S; Fukuyama, H; Murai, T; Takahashi, H				Uwatoko, Teruhisa; Yoshizumi, Miho; Miyata, Jun; Ubukata, Shiho; Fujiwara, Hironobu; Kawada, Ryosaku; Kubota, Manabu; Sasamoto, Akihiko; Sugihara, Genichi; Aso, Toshihiko; Urayama, Shinichi; Fukuyama, Hidenao; Murai, Toshiya; Takahashi, Hidehiko			Insular Gray Matter Volume and Objective Quality of Life in Schizophrenia	PLOS ONE			English	Article							CORTEX ABNORMALITIES; SYMPTOMS; PREDICTORS; METAANALYSIS; OUTPATIENTS; SCALE; 1ST-EPISODE; DEFICITS	Improving quality of life has been recognized as an important outcome for schizophrenia treatment, although the fundamental determinants are not well understood. In this study, we investigated the association between brain structural abnormalities and objective quality of life in schizophrenia patients. Thirty-three schizophrenia patients and 42 age-, sex-, and education-matched healthy participants underwent magnetic resonance imaging. The Quality of Life Scale was used to measure objective quality of life in schizophrenia patients. Voxel-based morphometry was performed to identify regional brain alterations that correlate with Quality of Life Scale score in the patient group. Schizophrenia patients showed gray matter reductions in the frontal, temporal, limbic, and subcortical regions. We then performed voxel-based multiple regression analysis in these regions to identify any correlations between regional gray matter volume and Quality of Life Scale scores. We found that among four subcategories of the scale, the Instrumental Role category score correlated with gray matter volume in the right anterior insula in schizophrenia patients. In addition, this correlation was shown to be mediated by negative symptoms. Our findings suggest that the neural basis of objective quality of life might differ topographically from that of subjective QOL in schizophrenia.	[Uwatoko, Teruhisa; Yoshizumi, Miho; Miyata, Jun; Ubukata, Shiho; Fujiwara, Hironobu; Kawada, Ryosaku; Kubota, Manabu; Sasamoto, Akihiko; Sugihara, Genichi; Murai, Toshiya; Takahashi, Hidehiko] Kyoto Univ, Grad Sch Med, Dept Psychiat, Kyoto, Japan; [Uwatoko, Teruhisa] Kyoto Univ Hlth Serv, Kyoto, Japan; [Aso, Toshihiko; Urayama, Shinichi; Fukuyama, Hidenao] Kyoto Univ, Grad Sch Med, Human Brain Res Ctr, Kyoto, Japan; [Fujiwara, Hironobu] Kyoto Univ Hosp, Integrated Clin Educ Ctr, Kyoto 606, Japan; [Kubota, Manabu] Natl Inst Radiol Sci, Mol Imaging Ctr, Mol Neuroimaging Program, Chiba 260, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University; National Institutes for Quantum Science & Technology	Takahashi, H (corresponding author), Kyoto Univ, Grad Sch Med, Dept Psychiat, Kyoto, Japan.	hidehiko@kuhp.kyoto-u.ac.jp	Aso, Toshihiko/C-2798-2018; Fukuyama, Hidenao/AAI-7118-2020; Miyata, Jun/S-2978-2016	Aso, Toshihiko/0000-0003-4814-089X; Miyata, Jun/0000-0003-1803-1975; Takahashi, Hidehiko/0000-0002-5102-1982; Uwatoko, Teruhisa/0000-0002-7917-9060	Japan Society for the Promotion of Science [15H01690, 26461767, 15H04893, 23680045, 23118004, 23120009, 15K09825, 15K09864, 26350831]; Takeda Science Foundation; Uehara Memorial Foundation; Senshin Medical Research Foundation; Astellas Pharma Inc.; Ministry of Education, Culture, Sports, Science and Technology of Japan; Schizophrenia Research Group; Research Program for Brain Sciences; Grants-in-Aid for Scientific Research [15H04893] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Senshin Medical Research Foundation(SENSHIN Medical Research Foundation); Astellas Pharma Inc.(Astellas Pharmaceuticals); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Schizophrenia Research Group; Research Program for Brain Sciences; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research B 15H01690), TM; the Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research C (26461767), JM; the Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research A (15H04893), TM; the Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research for Young Scientist A (23680045), HT; the Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research on Innovative Area (23118004), TM; the Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research on Innovative Area (23120009), HT; the Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research C (15K09825), GS; the Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research C (15K09864), TU; the Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research C (26350831), TU; the Takeda Science Foundation, TA; The Uehara Memorial Foundation, TM; the Senshin Medical Research Foundation, AS; the Schizophrenia Research Group, Astellas Pharma Inc., AS; and the Ministry of Education, Culture, Sports, Science and Technology of Japan, Research Program for Brain Sciences, HT. None of the funding sources had a role in study design; in the collection, analysis, and interpretation of data; in the writing of the report or in the decision to submit the manuscript for publication.	Addington J, 2008, BRIT J PSYCHIAT, V192, P67, DOI 10.1192/bjp.bp.107.039784; Aki H, 2008, PSYCHIAT RES, V158, P19, DOI 10.1016/j.psychres.2006.05.017; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Awad AG, 1997, QUAL LIFE RES, V6, P21; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bernhardt BC, 2012, ANNU REV NEUROSCI, V35, P1, DOI 10.1146/annurev-neuro-062111-150536; Bora E, 2011, SCHIZOPHR RES, V127, P46, DOI 10.1016/j.schres.2010.12.020; BREIER A, 1991, ARCH GEN PSYCHIAT, V48, P239; Browne S, 1996, ACTA PSYCHIAT SCAND, V94, P118, DOI 10.1111/j.1600-0447.1996.tb09835.x; Caron J, 2005, PSYCHIAT RES, V137, P203, DOI 10.1016/j.psychres.2005.07.002; Crespo-Facorro B, 2000, SCHIZOPHR RES, V46, P35, DOI 10.1016/S0920-9964(00)00028-1; Dickerson FB, 1998, ACTA PSYCHIAT SCAND, V98, P124, DOI 10.1111/j.1600-0447.1998.tb10053.x; Eack SM, 2007, SCHIZOPHRENIA BULL, V33, P1225, DOI 10.1093/schbul/sbl071; Ellison-Wright I, 2008, AM J PSYCHIAT, V165, P1015, DOI 10.1176/appi.ajp.2008.07101562; First M. B., 2005, STRUCTURED CLIN INTE; Fitzgerald PB, 2001, ACTA PSYCHIAT SCAND, V103, P387, DOI 10.1034/j.1600-0447.2001.00254.x; Fitzgerald PB, 2003, PSYCHIAT RES, V119, P55, DOI 10.1016/S0165-1781(03)00099-4; Fusar-Poli P, 2012, SCHIZOPHRENIA BULL, V38, P1297, DOI 10.1093/schbul/sbr134; Green MF, 1996, AM J PSYCHIAT, V153, P321; Haijma SV, 2013, SCHIZOPHRENIA BULL, V39, P1129, DOI 10.1093/schbul/sbs118; Hatton SN, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-45; HEINRICHS DW, 1984, SCHIZOPHRENIA BULL, V10, P388, DOI 10.1093/schbul/10.3.388; Ho BC, 1998, AM J PSYCHIAT, V155, P1196, DOI 10.1176/ajp.155.9.1196; Inagaki A., 2008, JPN J CLIN PSYCHOPHA, V11, P887; Kaneda Y, 2002, PSYCHIAT RES, V113, P107, DOI 10.1016/S0165-1781(02)00240-8; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Koutsouleris N, 2008, NEUROIMAGE, V39, P1600, DOI 10.1016/j.neuroimage.2007.10.029; Kurtz MM, 2012, PSYCHIAT RES, V200, P102, DOI 10.1016/j.psychres.2012.06.025; Lambert M, 2004, CNS DRUGS, V18, P5, DOI 10.2165/00023210-200418002-00002; Lamm C, 2010, BRAIN STRUCT FUNCT, V214, P579, DOI 10.1007/s00429-010-0251-3; Lehman AF, 2010, PRACTICE GUIDELINE T, V161, P1, DOI [10.1037/0003-066x.57.12.1052, DOI 10.1037/0003-066X.57.12.1052]; Lovero KL, 2009, NEUROIMAGE, V45, P976, DOI 10.1016/j.neuroimage.2008.12.070; Manoliu A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00216; Milian MJ, 2014, EUR NEUROPSYCHOPHARM, V24, P645, DOI 10.1016/j.euroneuro.2014.03.008; Miyata R, 2001, QUALITY LIFE SCALE G; Narvaez JM, 2008, SCHIZOPHR RES, V98, P201, DOI 10.1016/j.schres.2007.09.001; Norman RMG, 2000, ACTA PSYCHIAT SCAND, V102, P303, DOI 10.1034/j.1600-0447.2000.102004303.x; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Pressler M, 2005, BIOL PSYCHIAT, V57, P394, DOI 10.1016/j.biopsych.2004.11.010; Rabinowitz J, 2012, SCHIZOPHR RES, V137, P147, DOI 10.1016/j.schres.2012.01.015; Ritsner M, 2005, QUAL LIFE RES, V14, P1693, DOI 10.1007/s11136-005-2816-9; Ritsner M, 2003, J NERV MENT DIS, V191, P287, DOI 10.1097/00005053-200305000-00003; Ruesch P, 2004, SOC PSYCH PSYCH EPID, V39, P686, DOI 10.1007/s00127-004-0812-y; Shepherd AM, 2012, BIOL PSYCHIAT, V72, P775, DOI 10.1016/j.biopsych.2012.04.020; Sim K, 2004, PSYCHIAT RES, V129, P141, DOI 10.1016/j.psychres.2004.07.007; Smith MJ, 2012, SCHIZOPHR RES, V137, P196, DOI 10.1016/j.schres.2012.01.012; Smith TE, 2001, J NERV MENT DIS, V189; Tolman AW, 2012, SCHIZOPHRENIA BULL, V38, P304, DOI 10.1093/schbul/sbq077; Tomotake M, 2011, PSYCHOL REP, V99, P477; Ubukata S, 2013, J PSYCHIATR RES, V47, P548, DOI 10.1016/j.jpsychires.2013.01.002; Wang Y, 2013, PSYCHIAT RES, V210, P62, DOI 10.1016/j.psychres.2013.03.015; Wechsler D., 1981, WAIS R MANUAL WECHSL; Wilkinson G, 2000, BRIT J PSYCHIAT, V177, P42, DOI 10.1192/bjp.177.1.42; Woon PS, 2010, PROG NEURO-PSYCHOPH, V34, P463, DOI 10.1016/j.pnpbp.2010.01.014; Wylie KP, 2010, SCHIZOPHR RES, V123, P93, DOI 10.1016/j.schres.2010.08.027; Yamauchi K, 2008, PSYCHIAT CLIN NEUROS, V62, P404, DOI 10.1111/j.1440-1819.2008.01818.x	56	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142018	10.1371/journal.pone.0142018	http://dx.doi.org/10.1371/journal.pone.0142018			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV6RT	26544607	Green Published, Green Submitted, gold			2022-12-26	WOS:000364398700071
J	Sapi, J; Kovacs, L; Drexler, DA; Kocsis, P; Gajari, D; Sapi, Z				Sapi, Johanna; Kovacs, Levente; Drexler, Daniel Andras; Kocsis, Pal; Gajari, David; Sapi, Zoltan			Tumor Volume Estimation and Quasi-Continuous Administration for Most Effective Bevacizumab Therapy	PLOS ONE			English	Article							CONTROLLED PHASE-III; CELL LUNG-CANCER; NEOADJUVANT CHEMOTHERAPY; VASCULAR NORMALIZATION; ANTIANGIOGENIC THERAPY; 1ST-LINE TREATMENT; BREAST-CANCER; DOUBLE-BLIND; PLACEBO; TRIAL	Background Bevacizumab is an exogenous inhibitor which inhibits the biological activity of human VEGF. Several studies have investigated the effectiveness of bevacizumab therapy according to different cancer types but these days there is an intense debate on its utility. We have investigated different methods to find the best tumor volume estimation since it creates the possibility for precise and effective drug administration with a much lower dose than in the protocol. Materials and Methods We have examined C38 mouse colon adenocarcinoma and HT-29 human colorectal adenocarcinoma. In both cases, three groups were compared in the experiments. The first group did not receive therapy, the second group received one 200 mu g bevacizumab dose for a treatment period (protocol-based therapy), and the third group received 1.1 mu g bevacizumab every day (quasi-continuous therapy). Tumor volume measurement was performed by digital caliper and small animal MRI. The mathematical relationship between MRI-measured tumor volume and mass was investigated to estimate accurate tumor volume using caliper-measured data. A two-dimensional mathematical model was applied for tumor volume evaluation, and tumor-and therapy-specific constants were calculated for the three different groups. The effectiveness of bevacizumab administration was examined by statistical analysis. Results In the case of C38 adenocarcinoma, protocol-based treatment did not result in significantly smaller tumor volume compared to the no treatment group; however, there was a significant difference between untreated mice and mice who received quasi-continuous therapy (p = 0.002). In the case of HT-29 adenocarcinoma, the daily treatment with one-twelfth total dose resulted in significantly smaller tumors than the protocol-based treatment (p = 0.038). When the tumor has a symmetrical, solid closed shape (typically without treatment), volume can be evaluated accurately from caliper-measured data with the applied two-dimensional mathematical model. Conclusion Our results provide a theoretical background for a much more effective bevacizumab treatment using optimized administration.	[Sapi, Johanna; Kovacs, Levente] Obuda Univ, Res & Innovat Ctr, Physiol Controls Grp, Budapest, Hungary; [Drexler, Daniel Andras] Budapest Univ Technol & Econ, Dept Control Engn & Informat Technol, Budapest, Hungary; [Kocsis, Pal; Gajari, David] Gedeon Richter Plc, Preclin Imaging Ctr, Budapest, Hungary; [Sapi, Zoltan] Semmelweis Univ, Dept Pathol & Expt Canc Res 1, H-1085 Budapest, Hungary	Obuda University; Budapest University of Technology & Economics; Gedeon Richter Chemistry Works; Semmelweis University	Sapi, Z (corresponding author), Semmelweis Univ, Dept Pathol & Expt Canc Res 1, H-1085 Budapest, Hungary.	sapi.zoltan.dr@gmail.com	Kovacs, Levente/AAA-1781-2019	Kovacs, Levente/0000-0002-3188-0800	Hungarian Scientific Research Fund (OTKA) [K-112993]; Bolyai Research Scholarship of the Hungarian Academy of Sciences [425_12]	Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Bolyai Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This work was supported by Hungarian Scientific Research Fund (OTKA), http://www.otka.hu/en, No: K-112993 (Janos) and Bolyai Research Scholarship of the Hungarian Academy of Sciences, http://mta.hu/cikkek/?node_id=26057, No: 425_12. Coauthors PK and DG are employed by Gedeon Richter Ltd. Gedeon Richter Ltd. provided support in the form of salaries for authors PK and DG, and in the form of using the resources of Preclinical Imaging Center of Gedeon Richter Ltd., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Amit L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051780; [Anonymous], 2005, XEN TUM MOD PROT; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Bear HD, 2012, NEW ENGL J MED, V366, P310, DOI 10.1056/NEJMoa1111097; Carey K., 2012, NAT BIOTECHNOL, V30, P6; Cobelli C, 2014, LANCET DIABETES ENDO, V2, P679, DOI 10.1016/S2213-8587(14)70126-3; Drexler D. A., 2012, SCI B POLITEHNICA U, V57, P113; European Medicines Agency, 2005, SCI DISC AV; Feldman JP, 2009, J APPL QUANT METHODS, V4, P455, DOI DOI 10.1111/J.2042-3306.2010.TB05629.X; Friedman HS, 2009, J CLIN ONCOL, V27, P4733, DOI 10.1200/JCO.2008.19.8721; Genentech, 2013, PRESCR INF AV BEV; Goel S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006486; Heiduschka P, 2008, RETINA-J RET VIT DIS, V28, P46, DOI 10.1097/IAE.0b013e31815e9368; HEITJAN DF, 1993, CANCER RES, V53, P6042; Hollanders K, 2014, CURR EYE RES, V12, P1; Jain RK, 2007, CANCER RES, V67, P2729, DOI 10.1158/0008-5472.CAN-06-4102; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jensen M, 2008, BMC MED IMAGING, P8; Kelly WK, 2012, J CLIN ONCOL, V30, P1534, DOI 10.1200/JCO.2011.39.4767; Kim KB, 2012, J CLIN ONCOL, V30, P34, DOI 10.1200/JCO.2011.34.6270; Kindler HL, 2010, J CLIN ONCOL, V28, P3617, DOI 10.1200/JCO.2010.28.1386; Kiss B., 2013, 2013 IEEE 11th International Symposium on Intelligent Systems and Informatics (SISY), P271, DOI 10.1109/SISY.2013.6662584; Koo V, 2006, CELL ONCOL, V28, P127; Kovacs L, 2014, COMPUT METH PROG BIO, V114, pE98, DOI 10.1016/j.cmpb.2014.01.002; Kovacs L, 2011, COMPUT METH PROG BIO, V102, P105, DOI 10.1016/j.cmpb.2010.06.019; Kumaran GC, 2009, BRIT J CANCER, V100, P1, DOI 10.1038/sj.bjc.6604767; McCarroll JA, 2014, FRONT PHYSIOL, V5, DOI [10.3389/fphys.2014.00141, 10.3389/fphys.2014.00002]; Monk BJ, 2009, J CLIN ONCOL, V27, P1069, DOI 10.1200/JCO.2008.18.9043; Montero AJ, 2012, NEW ENGL J MED, V366, P374, DOI 10.1056/NEJMe1113368; Mukherji SK, 2010, AM J NEURORADIOL, V31, P235, DOI 10.3174/ajnr.A1987; Ohtsu A, 2011, J CLIN ONCOL, V29, P3968, DOI 10.1200/JCO.2011.36.2236; Pachghare V. K., 2005, COMPREHENSIVE COMPUT; Reinacher-Schick A, 2008, NAT CLIN PRACT GASTR, V5, P250, DOI 10.1038/ncpgasthep1097; Rini BI, 2010, J CLIN ONCOL, V28, P2137, DOI 10.1200/JCO.2009.26.5561; Sapi J, 2016, OPTIM CONTR APPL MET, V37, P848, DOI 10.1002/oca.2196; Sapi J, 2014, INT SYMP COMP INTELL, P443, DOI 10.1109/CINTI.2014.7028716; Sapi J, 2013, 2013 IEEE 8TH INTERNATIONAL SYMPOSIUM ON APPLIED COMPUTATIONAL INTELLIGENCE AND INFORMATICS (SACI 2013), P303, DOI 10.1109/SACI.2013.6608987; Schmoll HJ, 2012, ANN ONCOL, V23, P2479, DOI 10.1093/annonc/mds236; Soria JC, 2013, ANN ONCOL, V24, P20, DOI 10.1093/annonc/mds590; Szeles A., 2014, PERIODICA POLYTECHNI, V58, P29; Targeson, 2012, MOUSE TAIL VEIN INJE; Tebbutt NC, 2010, J CLIN ONCOL, V28, P3191, DOI 10.1200/JCO.2009.27.7723; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Tong RT, 2004, CANCER RES, V64, P3731, DOI 10.1158/0008-5472.CAN-04-0074; Vokes EE, 2013, ANN ONCOL, V24, P6, DOI 10.1093/annonc/mds608; von Minckwitz G, 2012, NEW ENGL J MED, V366, P299, DOI 10.1056/NEJMoa1111065; Zhang QY, 2006, BIOCHEM BIOPH RES CO, V342, P824, DOI 10.1016/j.bbrc.2006.02.044	47	63	64	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142190	10.1371/journal.pone.0142190	http://dx.doi.org/10.1371/journal.pone.0142190			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540189	Green Published, Green Submitted, gold			2022-12-26	WOS:000364303800064
J	Cohen, E; Bernard, JY; Ponty, A; Ndao, A; Amougou, N; Said-Mohamed, R; Pasquet, P				Cohen, Emmanuel; Bernard, Jonathan Y.; Ponty, Amandine; Ndao, Amadou; Amougou, Norbert; Said-Mohamed, Rihlat; Pasquet, Patrick			Development and Validation of the Body Size Scale for Assessing Body Weight Perception in African Populations	PLOS ONE			English	Article							IMAGE; WOMEN; OBESITY; ATTRACTIVENESS; BMI; MEN; PREFERENCES; RELIABILITY; DISCREPANCY; TRANSITION	Background The social valorisation of overweight in African populations could promote high-risk eating behaviours and therefore become a risk factor of obesity. However, existing scales to assess body image are usually not accurate enough to allow comparative studies of body weight perception in different African populations. This study aimed to develop and validate the Body Size Scale (BSS) to estimate African body weight perception. Methods Anthropometric measures of 80 Cameroonians and 81 Senegalese were used to evaluate three criteria of adiposity: body mass index (BMI), overall percentage of fat, and endomorphy (fat component of the somatotype). To develop the BSS, the participants were photographed in full face and profile positions. Models were selected for their representativeness of the wide variability in adiposity with a progressive increase along the scale. Then, for the validation protocol, participants self-administered the BSS to assess self-perceived current body size (CBS), desired body size (DBS) and provide a "body self-satisfaction index." This protocol included construct validity, test-retest reliability and convergent validity and was carried out with three independent samples of respectively 201, 103 and 1115 Cameroonians. Results The BSS comprises two sex-specific scales of photos of 9 models each, and ordered by increasing adiposity. Most participants were able to correctly order the BSS by increasing adiposity, using three different words to define body size. Test-retest reliability was consistent in estimating CBS, DBS and the "body self-satisfaction index." The CBS was highly correlated to the objective BMI, and two different indexes assessed with the BSS were consistent with declarations obtained in interviews. Conclusion The BSS is the first scale with photos of real African models taken in both full face and profile and representing a wide and representative variability in adiposity. The validation protocol proved its reliability for estimating body weight perception in Africans.	[Cohen, Emmanuel] Fac Med Sect Nord, CNRS, UMI Environm Sante Soc 3189, Marseille, France; [Cohen, Emmanuel; Bernard, Jonathan Y.; Ponty, Amandine; Ndao, Amadou; Amougou, Norbert; Said-Mohamed, Rihlat; Pasquet, Patrick] Museum Natl Hist Nat, Musee Homme, UMR Ecoanthropol & Ethnobiol 7206, CNRS, F-75231 Paris, France; [Said-Mohamed, Rihlat] Univ Witwatersrand, Fac Hlth Sci, Dept Paediat, MRC Wits Dev Pathways Hlth Res Unit, Johannesburg, South Africa	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Universite Paris Cite; University of Witwatersrand	Cohen, E (corresponding author), Fac Med Sect Nord, CNRS, UMI Environm Sante Soc 3189, Marseille, France.	ecohen@mnhn.fr	Cohen, Emmanuel/ABE-1916-2021; Bernard, Jonathan/T-7064-2017; AMOUGOU, Norbert/GXW-3348-2022	Cohen, Emmanuel/0000-0001-5643-1473; Bernard, Jonathan/0000-0002-6418-983X; Patrick, Pasquet/0000-0002-7017-3068; SAID MOHAMED, Rihlat/0000-0003-1592-5412	"Agence Nationale de la Recherche" in France [ANR-08-BLAN-0004]	"Agence Nationale de la Recherche" in France(French National Research Agency (ANR))	This work was supported by: ANR-08-BLAN-0004, http://www.agence-nationale-recherche.fr/projet-anr/?tx_lwmsuivibilan_pi2%5BCODE%5D=ANR-08-BLAN-0004, "Agence Nationale de la Recherche" in France. PP was director of the project: "Anthropologie Nutritionnelle des migrants d'Afrique Centrale a la ville et en France" (ANTRAC).	[Anonymous], 2014, J PSYCHIAT, DOI DOI 10.4172/1994-8220.1000101; Bayer AM, 2005, ADOLESC MED CLIN; Becker Diane M., 1999, Ethnicity and Disease, V9, P377; Blench R, 2013, MOTHER TONGUE; Bush HM, 2001, APPETITE, V37, P207, DOI 10.1006/appe.2001.0424; Cachelin FM, 2002, OBES RES, V10, P158, DOI 10.1038/oby.2002.25; Carter J. E. L., 1990, SOMATOTYPING DEV APP; Cash TF, 2004, INT J EAT DISORDER, V35, P305, DOI 10.1002/eat.10264; Cohen E, 2013, SOC SCI MED, V96, P24, DOI 10.1016/j.socscimed.2013.07.004; Cohen E, 2015, BMC PUBLIC IN PRESS; Cohen Emmanuel, 2011, Ethn Dis, V21, P288; Dave D, 2009, SOC SCI MED, V68, P1685, DOI 10.1016/j.socscimed.2009.02.015; Dixson BJ, 2007, ARCH SEX BEHAV, V36, P369, DOI 10.1007/s10508-006-9093-8; Duda RB, 2008, AFR J HLTH SCI, V14, P54, DOI [10.4314/ajhs.v14i1.30847, DOI 10.4314/AJHS.V14I1.30847]; DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060; Flynn K, 1996, J YOUTH ADOLESCENCE, V25, P615, DOI 10.1007/BF01537357; Flynn KJ, 1998, ANN BEHAV MED, V20, P13, DOI 10.1007/BF02893804; FROMENT A, 1984, ANN HUM BIOL, V11, P189, DOI 10.1080/03014468400007061; Gardner RM, 2010, PERS INDIV DIFFER, V48, P107, DOI 10.1016/j.paid.2009.08.017; Gardner RM, 1998, PERCEPT MOTOR SKILL, V86, P387, DOI 10.2466/pms.1998.86.2.387; Gitau TM, 2014, J CHILD ADOLESC MENT, V26, P193, DOI [10.1371/journal.pone.0109709, 10.2989/17280583.2014.901224]; Grundy SM, 2004, J CLIN ENDOCR METAB, V89, P2595, DOI 10.1210/jc.2004-0372; Harris CV, 2008, INT J OBESITY, V32, P336, DOI 10.1038/sj.ijo.0803704; Hendley Y, 2011, J WOMENS HEALTH, V20, P1805, DOI 10.1089/jwh.2010.2262; Holdsworth M, 2004, INT J OBESITY, V28, P1561, DOI 10.1038/sj.ijo.0802739; Karastergiou K, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-13; Lo WS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050017; Madowitz J, 2006, IL FAULT MANGER EATI; Marlowe FW, 2005, EVOL HUM BEHAV, V26, P458, DOI 10.1016/j.evolhumbehav.2005.07.005; Maupin JN, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-973; Mciza Z, 2005, PUBLIC HEALTH NUTR, V8, P509, DOI [10.1097/PHN2005814, 10.1079/PHN2005814]; Montano V, 2011, MOL ECOL, V20, P2693, DOI 10.1111/j.1365-294X.2011.05130.x; Mvo Z, 1999, Curationis, V22, P27; Patt Madhavi R., 2002, Ethnicity and Disease, V12, P54; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Pulvers K, 2013, EAT BEHAV, V14, P437, DOI 10.1016/j.eatbeh.2013.07.005; Pulvers KM, 2004, OBES RES, V12, P1641, DOI 10.1038/oby.2004.204; Puoane T, 2005, S AFR J CLIN NUTR, V18, P6; Puoane T, 2010, ETHN DIS; Rguibi Mohamed, 2006, Body Image, V3, P395, DOI 10.1016/j.bodyim.2006.07.007; Ritenbaugh C, 1991, Med Anthropol, V13, P173; Stewart AD, 2003, J SPORT SCI, V21, P815, DOI 10.1080/0264041031000140338; Stewart TM, 2009, BODY IMAGE, V6, P67, DOI 10.1016/j.bodyim.2009.01.006; Stunkard A J, 1983, Res Publ Assoc Res Nerv Ment Dis, V60, P115; Swami V, 2008, PERS INDIV DIFFER, V44, P1752, DOI 10.1016/j.paid.2008.02.002; Swami V, 2007, BODY IMAGE, V4, P391, DOI 10.1016/j.bodyim.2007.07.002; Swami V, 2012, BODY IMAGE, V9, P559, DOI 10.1016/j.bodyim.2012.05.006; Tovee MJ, 2002, P ROY SOC B-BIOL SCI, V269, P2205, DOI 10.1098/rspb.2002.2133; Vuron, 2007, POPULATION SOC, V435, P1; WADDEN TA, 1985, ANN INTERN MED, V103, P1062, DOI 10.7326/0003-4819-103-6-1062; Weiner J.S., 1981, PRACTICAL HUMAN BIOL; Williamson DA, 2000, INT J OBESITY, V24, P1326, DOI 10.1038/sj.ijo.0801363; WILLIAMSON DA, 1993, J PSYCHOPATHOL BEHAV, V15, P57, DOI 10.1007/BF00964324	53	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0138983	10.1371/journal.pone.0138983	http://dx.doi.org/10.1371/journal.pone.0138983			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV5GZ	26536030	gold, Green Submitted, Green Published			2022-12-26	WOS:000364298400006
J	Crookes, K; Ewing, L; Gildenhuys, JD; Kloth, N; Hayward, WG; Oxner, M; Pond, S; Rhodes, G				Crookes, Kate; Ewing, Louise; Gildenhuys, Ju-dith; Kloth, Nadine; Hayward, William G.; Oxner, Matt; Pond, Stephen; Rhodes, Gillian			How Well Do Computer-Generated Faces Tap Face Expertise?	PLOS ONE			English	Article							RECOGNITION; RACE; MEMORY; LIFE; IDENTIFICATION; PROSOPAGNOSIA; ADVANTAGE; ANIMACY; OBJECTS; IMAGES	The use of computer-generated (CG) stimuli in face processing research is proliferating due to the ease with which faces can be generated, standardised and manipulated. However there has been surprisingly little research into whether CG faces are processed in the same way as photographs of real faces. The present study assessed how well CG faces tap face identity expertise by investigating whether two indicators of face expertise are reduced for CG faces when compared to face photographs. These indicators were accuracy for identification of own-race faces and the other-race effect (ORE)-the well-established finding that own-race faces are recognised more accurately than other-race faces. In Experiment 1 Caucasian and Asian participants completed a recognition memory task for own-and other-race real and CG faces. Overall accuracy for own-race faces was dramatically reduced for CG compared to real faces and the ORE was significantly and substantially attenuated for CG faces. Experiment 2 investigated perceptual discrimination for own-and other-race real and CG faces with Caucasian and Asian participants. Here again, accuracy for own-race faces was significantly reduced for CG compared to real faces. However the ORE was not affected by format. Together these results signal that CG faces of the type tested here do not fully tap face expertise. Technological advancement may, in the future, produce CG faces that are equivalent to real photographs. Until then caution is advised when interpreting results obtained using CG faces.	[Crookes, Kate; Ewing, Louise; Gildenhuys, Ju-dith; Kloth, Nadine; Hayward, William G.; Pond, Stephen; Rhodes, Gillian] Univ Western Australia, Sch Psychol, ARC Ctr Excellence Cognit & Its Disorders, Perth, WA 6009, Australia; [Ewing, Louise] Univ London, Dept Psychol Sci, London, England; [Hayward, William G.; Oxner, Matt] Univ Hong Kong, Dept Psychol, Hong Kong, Hong Kong, Peoples R China; [Hayward, William G.; Oxner, Matt] Univ Auckland, Sch Psychol, Auckland 1, New Zealand	University of Western Australia; University of London; University of Hong Kong; University of Auckland	Ewing, L (corresponding author), Univ Western Australia, Sch Psychol, ARC Ctr Excellence Cognit & Its Disorders, Perth, WA 6009, Australia.	l.ewing@bbk.ac.uk	Kloth, Nadine/H-5207-2014; Crookes, Kate/H-8011-2013	Crookes, Kate/0000-0001-6887-6197; Pond, Stephen/0000-0002-9565-7480; Kloth, Nadine/0000-0003-1473-303X; Oxner, Matt/0000-0002-4419-6020; Hayward, William/0000-0002-7248-0301; Rhodes, Gillian/0000-0002-3631-8518; Ewing, Louise/0000-0001-5263-1267	Australian Research Council (ARC) Centre of Excellence in Cognition and its Disorders [CE110001021]; ARC [DP0877379, DP130102300]; Hong Kong Research Council [HKU744911H]	Australian Research Council (ARC) Centre of Excellence in Cognition and its Disorders(Australian Research Council); ARC(Australian Research Council); Hong Kong Research Council(Hong Kong Research Grants Council)	This research was supported by the Australian Research Council (ARC) Centre of Excellence in Cognition and its Disorders (CE110001021); ARC Professorial Fellowship to Rhodes (DP0877379); ARC Discovery Outstanding Researcher Award to Rhodes (DP130102300); and Hong Kong Research Council (HKU744911H) to Hayward.	Balas B, 2015, COMPUT HUM BEHAV, V52, P331, DOI 10.1016/j.chb.2015.06.018; Balas B, 2010, NEUROPSYCHOLOGIA, V48, P498, DOI 10.1016/j.neuropsychologia.2009.10.007; Bate S, 2014, CORTEX, V50, P55, DOI 10.1016/j.cortex.2013.08.006; Bernstein MJ, 2007, PSYCHOL SCI, V18, P706, DOI 10.1111/j.1467-9280.2007.01964.x; Bird GD, 2012, VISION RES, V60, P16, DOI 10.1016/j.visres.2012.02.014; BRUCE V, 1991, PERCEPTION, V20, P755, DOI 10.1068/p200755; Bruce V, 1999, J EXP PSYCHOL-APPL, V5, P339, DOI 10.1037/1076-898X.5.4.339; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; Corneille O, 2007, J PERS SOC PSYCHOL, V93, P335, DOI 10.1037/0022-3514.93.3.335; DeGutis J, 2014, BRAIN; Germine LT, 2011, COGNITION, V118, P201, DOI 10.1016/j.cognition.2010.11.002; Hancock KJ, 2008, BRIT J PSYCHOL, V99, P45, DOI 10.1348/000712607X199981; Havard C, 2013, APPL COGNITIVE PSYCH, V27, P50, DOI 10.1002/acp.2870; Hayward WG, 2008, COGNITION, V106, P1017, DOI 10.1016/j.cognition.2007.04.002; Koldewyn K, 2014, PSYCHON B REV, V21, P969, DOI 10.3758/s13423-013-0562-5; Looser CE, 2013, SOC COGN AFFECT NEUR, V8, P799, DOI 10.1093/scan/nss078; Looser CE, 2010, PSYCHOL SCI, V21, P1854, DOI 10.1177/0956797610388044; MacDorman KF, 2009, COMPUT HUM BEHAV, V25, P695, DOI 10.1016/j.chb.2008.12.026; Macmillan N. A., 1991, DETECTION THEORY USE; Matheson HE, 2012, CAN J EXP PSYCHOL, V66, P51, DOI 10.1037/a0026062; Matheson HE, 2011, BEHAV RES METHODS, V43, P224, DOI 10.3758/s13428-010-0029-9; McCarthy G, NEUROPSYCHO IN PRESS, DOI [10.1016/j.neuropsychologia.2014.05.019, DOI 10.1016/J.NEUR0PSYCH0L0GIA.2014.05.019]; McKone E, 2007, TRENDS COGN SCI, V11, P8, DOI 10.1016/j.tics.2006.11.002; Megreya AM, 2011, Q J EXP PSYCHOL, V64, P1473, DOI 10.1080/17470218.2011.575228; Meissner CA, 2001, PSYCHOL PUBLIC POL L, V7, P3, DOI 10.1037//1076-8971.7.1.3; Michel C, 2013, VIS COGN, V21, P1202, DOI 10.1080/13506285.2013.823141; Mori M., 1970, ENERGY, V7, P33, DOI DOI 10.1109/MRA.2012.2192811; Nasanen R, 1999, VISION RES, V39, P3824, DOI 10.1016/S0042-6989(99)00096-6; O'Toole AJ, 1999, VISION RES, V39, P3145, DOI 10.1016/S0042-6989(99)00034-6; Oosterhof NN, 2008, P NATL ACAD SCI USA, V105, P11087, DOI 10.1073/pnas.0805664105; Papesh MH, 2010, COGNITION, V116, P283, DOI 10.1016/j.cognition.2010.05.001; Papesh MH, 2009, CAN J EXP PSYCHOL, V63, P253, DOI 10.1037/a0015802; Pauker K, 2009, J PERS SOC PSYCHOL, V96, P795, DOI 10.1037/a0013265; Pitcher D, 2009, CURR BIOL, V19, P319, DOI 10.1016/j.cub.2009.01.007; Rezlescu C, 2012, COGN NEUROPSYCHOL, V29, P325, DOI 10.1080/02643294.2012.749223; RHODES G, 1993, BRAIN COGNITION, V22, P19, DOI 10.1006/brcg.1993.1022; RHODES G, 1989, BRIT J PSYCHOL, V80, P313, DOI 10.1111/j.2044-8295.1989.tb02323.x; Rossion B., 2011, OXFORD HDB FACE PERC, P215, DOI DOI 10.1093/OXFORDHB/9780199559053.013.0012; Russell R, 2007, PERCEPTION, V36, P1368, DOI 10.1068/p5779; TIEGER T, 1979, PERCEPT PSYCHOPHYS, V26, P163, DOI 10.3758/BF03208310; Wheatley T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017960; Wilson JP, 2013, SOC COGNITION, V31, P636, DOI 10.1521/soco.2013.31.6.636; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474	44	46	46	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141353	10.1371/journal.pone.0141353	http://dx.doi.org/10.1371/journal.pone.0141353			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV5GZ	26535910	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000364298400059
J	Jugulam, M; Ziauddin, A; So, KKY; Chen, S; Hall, JC				Jugulam, M.; Ziauddin, Asma; So, Kenny K. Y.; Chen, Shu; Hall, J. Christopher			Transfer of Dicamba Tolerance from Sinapis arvensis to Brassica napus via Embryo Rescue and Recurrent Backcross Breeding	PLOS ONE			English	Article							AUXINIC HERBICIDE RESISTANCE; WILD MUSTARD; WEED MANAGEMENT; IDENTIFICATION; INHERITANCE; BROADLEAF; HYBRIDS	Auxinic herbicides (e.g. dicamba) are extensively used in agriculture to selectively control broadleaf weeds. Although cultivated species of Brassicaceae (e.g. Canola) are susceptible to auxinic herbicides, some biotypes of Sinapis arvensis (wild mustard) were found dicamba resistant in Canada. In this research, dicamba tolerance from wild mustard was introgressed into canola through embryo rescue followed by conventional breeding. Intergeneric hybrids between S. arvensis (2n = 18) and B. napus (2n = 38) were produced through embryo rescue. Embryo formation and hybrid plant regeneration was achieved. Transfer of dicamba tolerance from S. arvensis into the hybrid plants was determined by molecular analysis and at the whole plant level. Dicamba tolerance was introgressed into B. napus by backcrossing for seven generations. Homozygous dicamba-tolerant B. napus lines were identified. The ploidy of the hybrid progeny was assessed by flow cytometry. Finally, introgression of the piece of DNA possibly containing the dicamba tolerance gene into B. napus was confirmed using florescence in situ hybridization (FISH). This research demonstrates for the first time stable introgression of dicamba tolerance from S. arvensis into B. napus via in vitro embryo rescue followed by repeated backcross breeding. Creation of dicamba-tolerant B. napus varieties by this approach may have potential to provide options to growers to choose a desirable herbicide-tolerant technology. Furthermore, adoption of such technology facilitates effective weed control, less tillage, and possibly minimize evolution of herbicide resistant weeds.	[Jugulam, M.] Kansas State Univ, Dept Agron, Manhattan, KS 66506 USA; [Ziauddin, Asma; So, Kenny K. Y.; Hall, J. Christopher] Univ Guelph, Sch Environm Sci, Guelph, ON N1G 2W1, Canada; [Chen, Shu] Univ Guelph, Lab Serv Div, Guelph, ON N1G 2W1, Canada	Kansas State University; University of Guelph; University of Guelph	Jugulam, M (corresponding author), Kansas State Univ, Dept Agron, Manhattan, KS 66506 USA.	mithila@ksu.edu; jchall@uoguelph.ca			Natural Science and Engineering Research Council of Canada; BASF Company (NC, USA) through NSERC-CRD grant	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); BASF Company (NC, USA) through NSERC-CRD grant(BASF)	This work was supported by a grant to JCH from the Natural Science and Engineering Research Council of Canada and BASF Company (NC, USA) through NSERC-CRD grant is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, TRENDS NEW CROPS NEW; Beckie HJ, 2004, WEED SCI, V52, P152, DOI 10.1614/P2002-163; Behrens MR, 2007, SCIENCE, V316, P1185, DOI 10.1126/science.1141596; Bing DJ, 1995, PLANT BREEDING, V114, P481, DOI 10.1111/j.1439-0523.1995.tb00840.x; Cao MX, 2011, J AGR FOOD CHEM, V59, P5830, DOI 10.1021/jf104233h; Chandler JM, 1984, WEED SCI SOC AM ANN; Figueroa DM, 2010, BRIEF FUNCT GENOMICS, V9, P95, DOI 10.1093/bfgp/elp058; Hall JC, 1996, ACS SYM SER, V645, P28; Heap I, INT SURVEY HERBICIDE; Heap I.M., 1992, WEED SCI SOC AM ANN, V32, P164; Hu Q, 2002, PLANT CELL REP, V21, P147, DOI 10.1007/s00299-002-0491-7; Inomata N, 1998, EUCARPIA CRUCIFERAE, V13, P22; JASIENIUK M, 1995, WEED SCI, V43, P192, DOI 10.1017/S0043174500081054; Jugulam M, 2005, WEED SCI, V53, P417, DOI 10.1614/WS-04-149R; Kato A, 2005, CURR OPIN PLANT BIOL, V8, P148, DOI 10.1016/j.pbi.2005.01.014; KERLAN MC, 1993, GENOME, V36, P1099, DOI 10.1139/g93-146; Kron P, 2007, ANNU REV ECOL EVOL S, V38, P847, DOI 10.1146/annurev.ecolsys.38.091206.095504; Mason AS, 2014, NEW PHYTOL, V202, P964, DOI 10.1111/nph.12706; Mithila J, 2013, IN VITRO CELL DEV-PL, V49, P461, DOI 10.1007/s11627-013-9515-y; Mithila J, 2011, WEED SCI, V59, P445, DOI 10.1614/WS-D-11-00062.1; Mithila J, 2012, PEST MANAG SCI, V68, P548, DOI 10.1002/ps.2289; Mizushima U., 1980, Brassica crops and wild allies. [I]., P89; MIZUSHIMA USABURO, 1950, TOHOKU JOUR AGRIC RES, V1, P1; Moter A, 2000, J MICROBIOL METH, V41, P85, DOI 10.1016/S0167-7012(00)00152-4; PENIUK MG, 1993, WEED RES, V33, P431, DOI 10.1111/j.1365-3180.1993.tb01959.x; Powles SB, 2006, WEED TECHNOL, V20, P282, DOI 10.1614/WT-04-142R.1; PRAKASH S, 1980, OPERA BOT, V55, P3; Schwarzacher Trude, 2009, V478, P227, DOI 10.1007/978-1-59745-379-0_14; Wright TR, 2010, P NATL ACAD SCI USA, V107, P20240, DOI 10.1073/pnas.1013154107; Zheng HG, 2001, WEED SCI, V49, P276, DOI 10.1614/0043-1745(2001)049[0276:UAHRIW]2.0.CO;2	30	6	7	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141418	10.1371/journal.pone.0141418	http://dx.doi.org/10.1371/journal.pone.0141418			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536372	Green Published, Green Submitted, gold			2022-12-26	WOS:000364298400063
J	Lane, J; van Eeden, SF; Obeidat, M; Sin, DD; Tebbutt, SJ; Timens, W; Postma, DS; Laviolette, M; Pare, PD; Bosse, Y				Lane, Jerome; van Eeden, Stephan F.; Obeidat, Ma'en; Sin, Don D.; Tebbutt, Scott J.; Timens, Wim; Postma, Dirkje S.; Laviolette, Michel; Pare, Peter D.; Bosse, Yohan			Impact of Statins on Gene Expression in Human Lung Tissues	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; C-REACTIVE PROTEIN; MORTALITY; COPD; SIMVASTATIN; REDUCE; CANCER; RISK; HOSPITALIZATION; EXACERBATIONS	Statins are 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors that alter the synthesis of cholesterol. Some studies have shown a significant association of statins with improved respiratory health outcomes of patients with asthma, chronic obstructive pulmonary disease and lung cancer. Here we hypothesize that statins impact gene expression in human lungs and may reveal the pleiotropic effects of statins that are taking place directly in lung tissues. Human lung tissues were obtained from patients who underwent lung resection or transplantation. Gene expression was measured on a custom Affymetrix array in a discovery cohort (n = 408) and two replication sets (n = 341 and 282). Gene expression was evaluated by linear regression between statin users and non-users, adjusting for age, gender, smoking status, and other covariables. The results of each cohort were combined in a meta-analysis and biological pathways were studied using Gene Set Enrichment Analysis. The discovery set included 141 statin users. The lung mRNA expression levels of eighteen and three genes were up-regulated and down-regulated in statin users (FDR < 0.05), respectively. Twelve of the up-regulated genes were replicated in the first replication set, but none in the second (p-value < 0.05). Combining the discovery and replication sets into a meta-analysis improved the significance of the 12 up-regulated genes, which includes genes encoding enzymes and membrane proteins involved in cholesterol biosynthesis. Canonical biological pathways altered by statins in the lung include cholesterol, steroid, and terpenoid backbone biosynthesis. No genes encoding inflammatory, proteases, pro-fibrotic or growth factors were altered by statins, suggesting that the direct effect of statin in the lung do not go beyond its antilipidemic action. Although more studies are needed with specific lung cell types and different classes and doses of statins, the improved health outcomes and survival observed in statin users with chronic lung diseases do not seem to be mediated through direct regulation of gene expression in the lung.	[Lane, Jerome; Laviolette, Michel; Bosse, Yohan] Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [van Eeden, Stephan F.; Obeidat, Ma'en; Sin, Don D.; Tebbutt, Scott J.; Pare, Peter D.] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [van Eeden, Stephan F.; Obeidat, Ma'en; Sin, Don D.; Tebbutt, Scott J.; Pare, Peter D.] St Pauls Hosp, Ctr Heart Lung Innovat, Vancouver, BC V6Z 1Y6, Canada; [Tebbutt, Scott J.] PROOF Ctr Excellence, Vancouver, BC, Canada; [Timens, Wim; Postma, Dirkje S.] Univ Groningen, Univ Med Ctr Groningen, GRIAC Res Inst, Groningen, Netherlands; [Bosse, Yohan] Univ Laval, Dept Mol Med, Quebec City, PQ, Canada	University of British Columbia; St. Paul's Hospital; University of Saskatchewan; University of Groningen; Laval University	Bosse, Y (corresponding author), Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada.	yohan.bosse@criucpq.ulaval.ca	Timens, Wim/K-5570-2013; Sin, Don/AAC-2219-2021; Pare, Peter D/C-7425-2011	Timens, Wim/0000-0002-4146-6363; Tebbutt, Scott/0000-0002-7908-1581	Canadian Gene Cure Foundation; Chaire de pneumologie de la Fondation JD Begin de l'Universite Laval; Fondation de l'Institut universitaire de cardiologie et de pneumologie de Quebec; Respiratory Health Network of the FRQS; Cancer Research Society and Read for the Cure; Canadian Institutes of Health Research [MOP - 123369]	Canadian Gene Cure Foundation; Chaire de pneumologie de la Fondation JD Begin de l'Universite Laval; Fondation de l'Institut universitaire de cardiologie et de pneumologie de Quebec; Respiratory Health Network of the FRQS; Cancer Research Society and Read for the Cure; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was funded by Canadian Gene Cure Foundation, the Chaire de pneumologie de la Fondation JD Begin de l'Universite Laval, the Fondation de l'Institut universitaire de cardiologie et de pneumologie de Quebec, the Respiratory Health Network of the FRQS, the Cancer Research Society and Read for the Cure, and the Canadian Institutes of Health Research (MOP - 123369).	Alexeeff SE, 2007, AM J RESP CRIT CARE, V176, P742, DOI 10.1164/rccm.200705-656OC; Arnaud C, 2005, ARTERIOSCL THROM VAS, V25, P1231, DOI 10.1161/01.ATV.0000163840.63685.0c; Bartz F, 2009, CELL METAB, V10, P63, DOI 10.1016/j.cmet.2009.05.009; Bartziokas K, 2011, PULM PHARMACOL THER, V24, P625, DOI 10.1016/j.pupt.2011.06.003; Blamoun AI, 2008, INT J CLIN PRACT, V62, P1373, DOI 10.1111/j.1742-1241.2008.01731.x; Bolstad B.M, 2001, PROBE LEVEL QUANTILE; Bosse Y, 2012, CANCER RES, V72, P3753, DOI 10.1158/0008-5472.CAN-12-1160; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Cardwell CR, 2015, CANCER EPIDEM BIOMAR, V24, P833, DOI 10.1158/1055-9965.EPI-15-0052; Criner GJ, 2014, NEW ENGL J MED, V370, P2201, DOI 10.1056/NEJMoa1403086; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Farwell WR, 2008, JNCI-J NATL CANCER I, V100, P134, DOI 10.1093/jnci/djm286; Frost FJ, 2007, CHEST, V131, P1006, DOI 10.1378/chest.06-1997; Gachotte D, 2001, J LIPID RES, V42, P150; Gazzerro P, 2012, PHARMACOL REV, V64, P102, DOI 10.1124/pr.111.004994; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hafner M, 2011, PHARMACOGENET GENOM, V21, P741, DOI 10.1097/FPC.0b013e32834a5585; Horita N, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-80; Huang CC, 2011, CLIN THER, V33, P1365, DOI 10.1016/j.clinthera.2011.08.010; Huang CC, 2011, EUR J CLIN INVEST, V41, P507, DOI 10.1111/j.1365-2362.2010.02434.x; Ingebrigtsen TS, 2015, THORAX, V70, P33, DOI 10.1136/thoraxjnl-2014-205795; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Ishida W, 2007, TOHOKU J EXP MED, V212, P265, DOI 10.1620/tjem.212.265; John S, 2005, AM HEART J, V149, DOI 10.1016/j.ahj.2004.06.027; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kamio K, 2010, EUR RESPIR J, V35, P637, DOI 10.1183/09031936.00134707; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Keddissi JI, 2007, CHEST, V132, P1764, DOI 10.1378/chest.07-0298; Khurana V, 2007, CHEST, V131, P1282, DOI 10.1378/chest.06-0931; Kugler KG, 2010, SOURCE CODE BIOL MED, V5, DOI 10.1186/1751-0473-5-3; Lahousse L, 2013, PULM PHARMACOL THER, V26, P212, DOI 10.1016/j.pupt.2012.10.008; Lee LH, 2005, AM J RESP CRIT CARE, V172, P987, DOI 10.1164/rccm.200501-041OC; Lee TM, 2008, AM J CARDIOL, V101, P530, DOI 10.1016/j.amjcard.2007.09.102; Lee TM, 2009, CLIN SCI, V116, P497, DOI 10.1042/CS20080241; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Lokhandwala T, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001279; Mancini GBJ, 2006, J AM COLL CARDIOL, V47, P2554, DOI 10.1016/j.jacc.2006.04.039; Moreau Y, 2003, TRENDS GENET, V19, P570, DOI 10.1016/j.tig.2003.08.006; Mortensen EM, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-45; Nielsen SF, 2012, NEW ENGL J MED, V367, P1792, DOI 10.1056/NEJMoa1201735; Ou XM, 2009, RESPIROLOGY, V14, P734, DOI 10.1111/j.1440-1843.2009.01549.x; Reed RM, 2011, COPD, V8, P96, DOI 10.3109/15412555.2011.558545; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Sakamoto N, 2009, INT J TOXICOL, V28, P17, DOI 10.1177/1091581809333140; Schaafsma D, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-113; Shannon CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095224; Song BL, 2005, CELL METAB, V1, P179, DOI 10.1016/j.cmet.2005.01.001; Soyseth V, 2007, EUR RESPIR J, V29, P279, DOI 10.1183/09031936.00106406; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suda K, 2011, J APPL PHYSIOL, V111, P1118, DOI 10.1152/japplphysiol.00158.2011; Tse SM, 2014, CURR MED RES OPIN, V30, P685, DOI 10.1185/03007995.2013.865599; Tse SM, 2013, AM J RESP CRIT CARE, V188, P1076, DOI 10.1164/rccm.201306-1017OC; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Watts KL, 2005, AM J RESP CELL MOL, V32, P290, DOI 10.1165/rcmb.2004-0127OC; Wright JL, 2011, AM J RESP CRIT CARE, V183, P50, DOI 10.1164/rccm.201003-0399OC; Young RP, 2013, EXPERT REV RESP MED, V7, P533, DOI 10.1586/17476348.2013.838018	57	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142037	10.1371/journal.pone.0142037	http://dx.doi.org/10.1371/journal.pone.0142037			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26535575	Green Published, gold, Green Submitted			2022-12-26	WOS:000364298400121
J	Li, Y; Zhang, B; Cheng, HS; Zheng, JM				Li, Yu; Zhang, Bin; Cheng, Huansheng; Zheng, Jianming			The Earliest Chinese Proto-Porcelain Excavated from Kiln Sites: An Elemental Analysis	PLOS ONE			English	Article							NONDESTRUCTIVE ANALYSIS; PIXE; IDENTIFICATION; PROVENANCE	In June 2012, the Piaoshan kiln site was excavated in Huzhou, Zhejiang Province, which hitherto proved to be the earliest known Chinese proto-porcelain kiln. Judging from the decorative patterns of unearthed impressed stoneware and proto-porcelain sherds, the site was determined to date to the late Xia (c.2070-c. 1600 BC), the first dynasty of China. Here, we report on proton-induced X-ray emission analyses of 118 proto-porcelain and 35 impressed stoneware sherds from Piaoshan and five subsequent kiln sites in the vicinity. Using principal components analysis on the major chemical compositions, we reveal the relationships between impressed stoneware and proto-porcelain samples from the six kiln sites. The sherds from different sites have distinctive chemical profiles. The results indicate that the raw materials were procured locally. We find a developmental tendency for early glazes towards mature calcium-based glaze. It is most likely that woody plant ashes with increased calcia-potash ratios were applied to the formula.	[Li, Yu; Zhang, Bin; Cheng, Huansheng] Fudan Univ, Inst Modern Phys, Appl Ion Beam Phys Lab, Key Lab,Minist Educ, Shanghai 200433, Peoples R China; [Zheng, Jianming] Zhejiang Prov Inst Cultural Rel & Archaeol, Hangzhou, Zhejiang, Peoples R China	Chinese Academy of Sciences; Fudan University	Zhang, B (corresponding author), Fudan Univ, Inst Modern Phys, Appl Ion Beam Phys Lab, Key Lab,Minist Educ, Shanghai 200433, Peoples R China.	binzhang@fudan.edu.cn		Li, Yu/0000-0002-3636-4872	State Administration of Cultural Heritage of China	State Administration of Cultural Heritage of China	Funding: This work was sponsored by the Compass Special Plan from the State Administration of Cultural Heritage of China (http://www.sach.gov.cn/art/2012/7/19/art_1328_97968.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	An J, 1999, JINHUAI ANS COLLECTE; An J.H., 1960, CULTURAL RELICS, V8, P68; Bin Z, 2014, NUCL TECH, V37; Campbell JL, 2000, NUCL INSTRUM METH B, V170, P193, DOI 10.1016/S0168-583X(00)00156-7; Chang K. -C, 1986, ARCHAEOLOGY ANCIENT; CHEN JX, 1980, NUCL INSTRUM METHODS, V168, P437, DOI 10.1016/0029-554X(80)91290-2; Chen T, 1999, J ARCHAEOL SCI, V26, P1003, DOI 10.1006/jasc.1999.0418; Cheng HS, 2004, NUCL INSTRUM METH B, V219, P30, DOI 10.1016/j.nimb.2004.01.023; Cheng HS, 2004, NUCL INSTRUM METH B, V219, P16, DOI 10.1016/j.nimb.2004.01.020; Cheng HS, 2002, NUCL INSTRUM METH B, V190, P488, DOI 10.1016/S0168-583X(01)01280-0; Cheng HS, 1996, NUCL INSTRUM METH B, V118, P377, DOI 10.1016/0168-583X(95)01084-X; Feng Xianming, 1982, ZHONGGUO TAOCI SHI; GOVINDARAJU K, 1984, GEOSTANDARD NEWSLETT, V8, P3, DOI 10.1111/j.1751-908X.1984.tb01069.x; GUO YY, 1987, ARCHAEOMETRY, V29, P3; Guozhen L, 1988, TECHNICAL FDN FAMOUS; HALL GEM, 1986, ANALYST, V111, P1255, DOI 10.1039/an9861101255; Hongjie L, 1996, GUISUANYAN XUEBAO, V24, P297; Jianming Z, 2012, ARCHAEOLOGY, V11, P4; Jianming Z, 2011, ARCHAEOLOGY, V7, P3; Jianming Z, 2012, ARCHAEOLOGY, V11, P61; Jiazhi L, 1992, MRS P, P571; Junming W, 2011, J CERAM, V32, P376; Kerr R., 2004, J NEEDHAM SCI TEC 12, V5; Li J, 1998, ARCHAEOLOGY, V7, P69; Li J., 1998, HIST SCI TECHNOLOGY; [李其江 Li Qijiang], 2012, [中国陶瓷, China's Ceramics], V48, P13; LIN SL, 1990, J ANAL ATOM SPECTROM, V5, P509, DOI 10.1039/ja9900500509; Liu L, 2012, CAMB WOR ARCHAEOL, P1, DOI 10.1017/CBO9781139015301; Luo Z.W., 2001, CHINESE ANCIENT ARCH; Medley Margaret, 1976, CHINESE POTTER PRACT; Mino Y, 1975, JSTOR, V37, P39; Qian H, 2012, PALACE MUSEUM J, V5, P151; STOCKLI R., 2005, BLUE MARBLE NEXT GEN; Thorp RL, 1991, JSTOR, P1; Tichane R, 1998, ASH GLAZES; Tiemei C, 2003, ARCHAEOLOGY, V7, P11; Wenquan H, 1997, ION BEAM ANAL ARCHAE; Wu J, 2002, X-RAY SPECTROM, V31, P408, DOI 10.1002/xrs.571; [吴隽 Wu Juan], 2012, [光谱实验室, Chinese Journal of Spectroscopy laboratory], V29, P3284; Wu JA, 2011, SCI CHINA TECHNOL SC, V54, P99, DOI 10.1007/s11431-010-4195-x; [吴军明 Wu Junming], 2011, [中国陶瓷, China's Ceramics], V47, P66; Wu XH, 2012, SCIENCE, V336, P1696, DOI 10.1126/science.1218643; XIONG Ying-fei, 2010, SCI CONSERVATION ARC, V22, P28, DOI DOI 10.16334/J.CNKI.CN31-1652/K.2010.04.002; Yaocheng C, 2002, P INT S ANC CER ISAC, P32; YAP CT, 1995, APPL SPECTROSC, V49, P981, DOI 10.1366/0003702953964831; YAP CT, 1994, Z NATURFORSCH A, V49, P759; Yuanfu C, 2010, CULT REIL E, V34, P6; Yueming S, 2014, CHINA CULTURAL  0801; Yuyun T, 2012, CULT RELI CENT CHINA, V1, P12; Zhang B, 2005, NUCL INSTRUM METH B, V240, P559, DOI 10.1016/j.nimb.2005.06.154; Zhang B, 2014, NUCL SCI TECH, V25; Zhang ZW, 2011, NUCL INSTRUM METH B, V269, P460, DOI 10.1016/j.nimb.2010.12.038; Zhu J, 2006, RES PROVENANCE PROTO	53	6	7	14	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0139970	10.1371/journal.pone.0139970	http://dx.doi.org/10.1371/journal.pone.0139970			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CV5GZ	26535583	Green Published, Green Submitted, gold			2022-12-26	WOS:000364298400013
J	Santamarina, AB; Oliveira, JL; Silva, FP; Carnier, J; Mennitti, LV; Santana, AA; de Souza, GHI; Ribeiro, EB; do Nascimento, CMO; Lira, FS; Oyama, LM				Santamarina, Aline B.; Oliveira, Juliana L.; Silva, Fernanda P.; Carnier, June; Mennitti, Lais V.; Santana, Aline A.; de Souza, Gabriel H. I.; Ribeiro, Eliane B.; Oller do Nascimento, Claudia M.; Lira, Fabio S.; Oyama, Lila M.			Green Tea Extract Rich in Epigallocatechin-3-Gallate Prevents Fatty Liver by AMPK Activation via LKB1 in Mice Fed a High-Fat Diet	PLOS ONE			English	Article							PROTEIN-KINASE; INSULIN-RESISTANCE; METABOLIC SYNDROME; OXIDATIVE STRESS; NONALCOHOLIC STEATOHEPATITIS; HEPATIC STEATOSIS; ENERGY-METABOLISM; LIPID-METABOLISM; RECENT PROGRESS; RAT MODEL	Supplementation with epigallocatechin-3-gallate has been determined to aid in the prevention of obesity. Decaffeinated green tea extract appears to restore a normal hepatic metabolic profile and attenuate high-fat diet (HFD)-induced effects, thereby preventing nonalcoholic fatty liver disease in mice. Mice were maintained on either a control diet (CD) or HFD for 16 weeks and supplemented with either water or green tea extract (50 mg/kg/day). The body mass increase, serum adiponectin level, and lipid profile were measured over the course of the treatment. Furthermore, the AMPK pathway protein expression in the liver was measured. From the fourth week, the weight gain in the CD + green tea extract (CE) group was lower than that in the CD + water (CW) group. From the eighth week, the weight gain in the HFD + water (HFW) group was found to be higher than that in the CW group. Moreover, the weight gain in the HFD + green tea extract (HFE) group was found to be lower than that in the HFW group. Carcass lipid content was found to be higher in the HFW group than that in the CW and HFE groups. Serum analysis showed reduced non-esterified fatty acid level in the CE and HFE groups as compared with their corresponding placebo groups. Increased adiponectin level was observed in the same groups. Increased VLDL-TG secretion was observed in the HFW group as compared with the CW and HFE groups. Increased protein expression of AdipoR2, SIRT1, pLKB1, and pAMPK was observed in the HFE group, which explained the reduced expression of ACC, FAS, SREBP-1, and ChREBP in this group. These results indicate that the effects of decaffeinated green tea extract may be related to the activation of AMPK via LKB1 in the liver of HFD-fed mice.	[Santamarina, Aline B.; Oliveira, Juliana L.; Silva, Fernanda P.; Carnier, June; Santana, Aline A.; Ribeiro, Eliane B.; Oller do Nascimento, Claudia M.; Oyama, Lila M.] Univ Fed Sao Paulo, Dept Fisiol, Sao Paulo, Brazil; [Mennitti, Lais V.] Univ Fed Sao Paulo, Programa Posgrad Interdisciplinar Ciencias Saude, Santos, Brazil; [de Souza, Gabriel H. I.] Univ Sao Judas Tadeu, Lab Movimento Humano, Sao Paulo, Brazil; [Lira, Fabio S.] Univ Estadual Paulista, UNESP, Dept Phys Educ, Exercise & Immunometab Res Grp, Presidente Prudente, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Sao Judas Tadeu; Universidade Estadual Paulista	Oyama, LM (corresponding author), Univ Fed Sao Paulo, Dept Fisiol, Sao Paulo, Brazil.	lmoyama@gmail.com	Lira, Fábio/N-7299-2019; Ribeiro, Eliane B/C-8124-2012; Lira, Fábio Santos/Q-7581-2016; Oyama, Lila M/B-7609-2012; Santamarina, Aline/AAI-7639-2020	Lira, Fábio/0000-0002-9645-1003; Ribeiro, Eliane B/0000-0002-3071-9134; Lira, Fábio Santos/0000-0002-9645-1003; Silva, Fernanda/0000-0003-3758-5797; Lopez de Oliveira, Juliana/0000-0003-2841-5980; Mennitti, Lais Vales/0000-0002-9326-7649	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2014/19508-7]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo 2014/19508-7 - grant to: Dr Lila Missae Oyama and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - grant to Aline Boveto Santamarina.	Banerjee S, 2012, NUTR RES, V32, P985, DOI 10.1016/j.nutres.2012.10.005; Bijland S, 2013, CLIN SCI, V124, P491, DOI 10.1042/CS20120536; Blachnio-Zabielska A, 2010, J CELL PHYSIOL, V225, P786, DOI 10.1002/jcp.22283; Blagih J, 2012, IMMUNOL REV, V249, P59, DOI 10.1111/j.1600-065X.2012.01157.x; Bollheimer LC, 2012, BIOGERONTOLOGY, V13, P609, DOI 10.1007/s10522-012-9405-4; Bose M, 2008, J NUTR, V138, P1677, DOI 10.1093/jn/138.9.1677; BRAZIL C, 2013, DIRETRIZ BRASILEIRA, P1; Buettner R, 2006, J MOL ENDOCRINOL; Burd N, 2014, PUBLIC HEALTH NUTR, P1; Byrne CD, 2013, P NUTR SOC, P1; Byun EH, 2010, J IMMUNOL, V185, P33, DOI 10.4049/jimmunol.0903742; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Carillon J, 2013, FREE RADICAL BIO MED, V65, P254, DOI 10.1016/j.freeradbiomed.2013.06.022; Ceddia RB, 2013, MOL CELL ENDOCRINOL, V366, P194, DOI 10.1016/j.mce.2012.06.014; Chacko Sabu M, 2010, Chin Med, V5, P13, DOI 10.1186/1749-8546-5-13; Charlton MR, 2011, GASTROENTEROLOGY, V141, P1249, DOI 10.1053/j.gastro.2011.06.061; Chen YK, 2011, J AGR FOOD CHEM, V59, P11862, DOI 10.1021/jf2029016; Choi KM, 2014, J CELL BIOCH; Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076; Costa S, 2007, FOOD CHEM TOXICOL, V45, P1910, DOI 10.1016/j.fct.2007.04.008; Cunha CA, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/635470; Darnton-Hill I, 2004, PUBLIC HEALTH NUTR, V7, P101, DOI 10.1079/PHN2003584; Davaatseren M, 2013, FOOD CHEM TOXICOL, V58, P30, DOI 10.1016/j.fct.2013.04.023; De Rosa E, 2014, NUTRITION; Derdemezis CS, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/285618; DONASCIMENTO CMO, 1986, BIOCHEM J, V239, P233; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621; Duval C, 2010, DIABETES, V59, P3181, DOI 10.2337/db10-0224; Fellner C, 2014, GERONTOLOGY, V60, P530, DOI 10.1159/000360289; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Fujimura Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037942; Gan RY, 2014, INT J MOL SCI, V15, P16698, DOI 10.3390/ijms150916698; Gillum MP, 2011, DIABETES, V60, P3235, DOI 10.2337/db11-0616; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Hasenour CM, 2013, MOL CELL ENDOCRINOL, V366, P152, DOI 10.1016/j.mce.2012.06.018; Hegarty BD, 2003, ACTA PHYSIOL SCAND, V178, P373, DOI 10.1046/j.1365-201X.2003.01162.x; Henriksen BS, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-29; Hill AM, 2007, J AM COLL NUTR, V26, p396S, DOI 10.1080/07315724.2007.10719628; Horton JD, 2004, MOL MEDIATORS HEPATI, P114; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Iizuka K, 2013, ENDOCR J, V60, P543, DOI 10.1507/endocrj.EJ13-0121; Jiang ZA, 2015, ALCOHOL CLIN EXP RES, V39, P424, DOI 10.1111/acer.12641; Kao YH, 2006, MOL NUTR FOOD RES, V50, P188, DOI 10.1002/mnfr.200500109; Kim EY, 2011, J AGR FOOD CHEM, V59, P3606, DOI 10.1021/jf104260j; Kim HS, 2014, REDOX BIOL, V2, P187, DOI 10.1016/j.redox.2013.12.022; Kobayashi-Hattori K, 2005, BIOSCI BIOTECH BIOCH, V69, P2219, DOI 10.1271/bbb.69.2219; Kohjima M, 2008, INT J MOL MED, V21, P507; Lambert JD, 2010, FOOD CHEM TOXICOL, V48, P409, DOI 10.1016/j.fct.2009.10.030; Latif R, 2013, NETH J MED, V71, P63; Lee J, 2012, DIABETES METAB J, V36, P262, DOI 10.4093/dmj.2012.36.4.262; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Liang XM, 2011, ANTIOXID REDOX SIGN, V15, P425, DOI 10.1089/ars.2010.3780; Lin JK, 2006, MOL NUTR FOOD RES, V50, P211, DOI 10.1002/mnfr.200500138; Ma QY, 2011, J FOOD SCI, V76, pH143, DOI 10.1111/j.1750-3841.2011.02184.x; Martins SV, 2010, BRIT J NUTR, V103, P869, DOI 10.1017/S000711450999256X; Masuoka HC, 2013, ANN NY ACAD SCI, V1281, P106, DOI 10.1111/nyas.12016; MURAMATSU K, 1986, J NUTR SCI VITAMINOL, V32, P613, DOI 10.3177/jnsv.32.613; O'Neill HM, 2013, MOL CELL ENDOCRINOL, V366, P135, DOI 10.1016/j.mce.2012.06.019; Ratto E, 2006, J AM SOC NEPHROL, V17, pS120, DOI 10.1681/ASN.2005121328; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Sabu MC, 2002, J ETHNOPHARMACOL, V83, P109; Seo HY, 2013, ENDOCRINOLOGY, V154, P1722, DOI 10.1210/en.2012-2009; Seo MS, 2015, TOXICOL APPL PHARM, V284, P113, DOI 10.1016/j.taap.2015.02.020; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shafiei MS, 2011, AM J PATHOL, V178, P2690, DOI 10.1016/j.ajpath.2011.02.035; Shearn CT, 2013, J NUTR BIOCH, V1, P1, DOI DOI 10.1016/J.JNUTBI0.2012.12.002; Shen L, 2013, J LIPID RES, V54, P1430, DOI 10.1194/jlr.M035907; Shen Z, 2010, AM J PHYSIOL-GASTR L, V298, pG364, DOI 10.1152/ajpgi.00456.2009; Shiniada M, 2007, BIOSCI BIOTECH BIOCH, V71, P2079, DOI 10.1271/bbb.70174; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Song CY, 2013, TOXICOL IN VITRO, V27, P1065, DOI 10.1016/j.tiv.2013.01.020; Stanhope KL, 2008, CURR OPIN LIPIDOL, V19, P16, DOI 10.1097/MOL.0b013e3282f2b24a; STANSBIE D, 1976, BIOCHEM J, V154, P225, DOI 10.1042/bj1540225; Tachibana H, 2011, P JPN ACAD B-PHYS, V87, P66, DOI 10.2183/pjab.87.66; Tian C, 2013, PLOS ONE, P8; Timmers S, 2011, CELL METAB, V14, P612, DOI 10.1016/j.cmet.2011.10.002; Turner N, 2013, DIABETOLOGIA, V56, P1638, DOI 10.1007/s00125-013-2913-1; Vigouroux C, 2011, INT J BIOCHEM CELL B, V43, P862, DOI 10.1016/j.biocel.2011.03.002; Viollet B, 2009, ACTA PHYSIOL, V196, P81, DOI 10.1111/j.1748-1716.2009.01970.x; Wang CT, 2009, MOL NUTR FOOD RES, V53, P349, DOI 10.1002/mnfr.200800013; Wang S, 2014, J NUTR BIOCHEM, V25, P1, DOI 10.1016/j.jnutbio.2013.09.001; Weng SY, 2013, J HEPATOL, V58, P619, DOI 10.1016/j.jhep.2012.09.031; Wu AH, 2011, NUTR CANCER, V63, P549, DOI 10.1080/01635581.2011.551986; Xiao J, 2014, EUR J NUTR, V53, P187, DOI 10.1007/s00394-013-0516-8; Yang ZG, 2010, J BIOL CHEM, V285, P19051, DOI 10.1074/jbc.M110.123620; Ye JP, 2013, FRONT MED-PRC, V7, P14, DOI 10.1007/s11684-013-0262-6; Zang MW, 2006, DIABETES, V55, P2180, DOI 10.2337/db05-1188; Zhang WY, 2012, DIABETES, V61, P3114, DOI 10.2337/db11-1373; Zhou J, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0084724, 10.1371/journal.pone.0096989, 10.1371/journal.pone.0087161]	90	58	62	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141227	10.1371/journal.pone.0141227	http://dx.doi.org/10.1371/journal.pone.0141227			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536464	Green Published, gold, Green Submitted			2022-12-26	WOS:000364298400055
J	Su, LJ; Wang, QJ; Wang, CX; Shan, YY				Su, Lijun; Wang, Quanjiu; Wang, Chunxia; Shan, Yuyang			Simulation Models of Leaf Area Index and Yield for Cotton Grown with Different Soil Conditioners	PLOS ONE			English	Article							EXTENDED LOGISTIC MODEL; FORAGE GRASS RESPONSE; SANDY SOIL; APPLIED NITROGEN; COLLECTION; STABILITY; MATTER; MANURE	Simulation models of leaf area index (LAI) and yield for cotton can provide a theoretical foundation for predicting future variations in yield. This paper analyses the increase in LAI and the relationships between LAI, dry matter, and yield for cotton under three soil conditioners near Korla, Xinjiang, China. Dynamic changes in cotton LAI were evaluated using modified logistic, Gaussian, modified Gaussian, log normal, and cubic polynomial models. Universal models for simulating the relative leaf area index (RLAI) were established in which the application rate of soil conditioner was used to estimate the maximum LAI (LAI(m)). In addition, the relationships between LAI(m) and dry matter mass, yield, and the harvest index were investigated, and a simulation model for yield is proposed. A feasibility analysis of the models indicated that the cubic polynomial and Gaussian models were less accurate than the other three models for simulating increases in RLAI. Despite significant differences in LAIs under the type and amount of soil conditioner applied, LAI(m) could be described by aboveground dry matter using Michaelis-Menten kinetics. Moreover, the simulation model for cotton yield based on LAI(m) and the harvest index presented in this work provided important theoretical insights for improving water use efficiency in cotton cultivation and for identifying optimal application rates of soil conditioners.	[Su, Lijun] Xian Univ Technol, Sch Sci, Xian, Shaanxi, Peoples R China; [Su, Lijun; Wang, Quanjiu; Shan, Yuyang] Xian Univ Technol, Inst Water Resources & Hydroelect Engn, Xian, Shaanxi, Peoples R China; [Wang, Chunxia] Shihezi Univ, Shihezi, Xinjiang, Peoples R China	Xi'an University of Technology; Xi'an University of Technology; Shihezi University	Su, LJ (corresponding author), Xian Univ Technol, Sch Sci, Xian, Shaanxi, Peoples R China.	sljun11@163.com			National Natural Science Foundation of China [51239009, 51409212, 51409213]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Support was provided by the National Natural Science Foundation of China (Grant No. 51239009 to Wang Quanjiu); by the National Natural Science Foundation of China (Grant No. 51409212 to Su Lijun); and by the National Natural Science Foundation of China (Grant No. 51409213 to Shan Yuyang).	AlDarby AM, 1996, SOIL TECHNOL, V9, P15, DOI 10.1016/0933-3630(95)00030-5; Arkin GF, 1977, P CROP MOD WORKSH US; Asghari S, 2011, BIOSYST ENG, V109, P90, DOI 10.1016/j.biosystemseng.2011.02.005; Asghari S, 2009, TURK J AGRIC FOR, V33, P47, DOI 10.3906/tar-0804-20; Asner GP, 2003, GLOBAL ECOL BIOGEOGR, V12, P191, DOI 10.1046/j.1466-822X.2003.00026.x; Baez-Gonzalez AD, 2002, CROP SCI, V42, P1943, DOI 10.2135/cropsci2002.1943; Barns MB, 1997, 1997 ASAE ANN INT M; Behera SK, 2010, AGR FOREST METEOROL, V150, P307, DOI 10.1016/j.agrformet.2009.11.009; De Kauwe MG, 2011, REMOTE SENS ENVIRON, V115, P767, DOI 10.1016/j.rse.2010.11.004; DEGAETANO AT, 1993, AGR FOREST METEOROL, V66, P1, DOI 10.1016/0168-1923(93)90079-W; Demarez V, 2008, AGR FOREST METEOROL, V148, P644, DOI 10.1016/j.agrformet.2007.11.015; FELTON GK, 1992, T ASAE, V35, P1153; GUPTA SC, 1977, SOIL SCI SOC AM J, V41, P601, DOI 10.2136/sssaj1977.03615995004100030035x; Hasegawa K, 2010, REMOTE SENS ENVIRON, V114, P514, DOI 10.1016/j.rse.2009.10.005; Ishihara MI, 2011, AGR FOREST METEOROL, V151, P1016, DOI 10.1016/j.agrformet.2011.02.007; Li Wen-feng, 2009, Yingyong Shengtai Xuebao, V20, P879; Li XiangLing, 2011, Acta Agronomica Sinica, V37, P321, DOI 10.3724/SP.J.1006.2011.00321; [林忠辉 Lin Zhonghui], 2003, [中国生态农业学报, Chinese journal of eco-agriculture], V11, P69; Lindsay BJ, 1998, J ENVIRON QUAL, V27, P534, DOI 10.2134/jeq1998.00472425002700030009x; Liu JianJun, 2010, Acta Pedologica Sinica, V47, P568; Lotka A. J., 1925, ELEMENTS PHYS BIOL, DOI 10.1038/116461b0; Maas S. J., 1978, 781 RES CTR PROGR MO, P78; McMaster GS, 1997, AGR FOREST METEOROL, V87, P291, DOI 10.1016/S0168-1923(97)00027-0; Michael MC, 1982, LEHNINGER PRINCIPLES; Nyamangara J, 2001, SOIL TILL RES, V62, P157, DOI 10.1016/S0167-1987(01)00215-X; Otter S, 1985, ARS38 NAT TECHN INF; OVERMAN AR, 1994, AGRON J, V86, P617, DOI 10.2134/agronj1994.00021962008600040007x; Overman AR, 1995, J PLANT NUTR, V18, P2629, DOI 10.1080/01904169509365089; Overman AR, 2003, COMMUN SOIL SCI PLAN, V34, P851, DOI 10.1081/CSS-120018979; OVERMAN AR, 1995, T ASAE, V38, P103, DOI 10.13031/2013.27817; OVERMAN AR, 1995, J PLANT NUTR, V18, P995, DOI 10.1080/01904169509364956; Rosenthal WD, 1989, MP1969 TEX AGR EXP S; Ruml M, 2010, INT J BIOMETEOROL, V54, P411, DOI 10.1007/s00484-009-0292-6; SABRAH REA, 1994, J ARID ENVIRON, V27, P363, DOI 10.1006/jare.1994.1071; Sadegian N, 2006, IRAN J AGR SCI, V37, P341; SCHJONNING P, 1994, EUR J SOIL SCI, V45, P257, DOI 10.1111/j.1365-2389.1994.tb00508.x; Schleppi P, 2011, FOREST ECOL MANAG, V261, P601, DOI 10.1016/j.foreco.2010.11.013; Setiyono TD, 2008, FIELD CROP RES, V108, P82, DOI 10.1016/j.fcr.2008.03.005; Thimonier A, 2010, EUR J FOREST RES, V129, P543, DOI 10.1007/s10342-009-0353-8; Wang CX, 2010, J SOIL WATER CONSERV, V24, P59063; Wang RuiJun, 2008, Zhongguo Shengtai Nongye Xuebao / Chinese Journal of Eco-Agriculture, V16, P139, DOI 10.3724/SP.J.1011.2008.00139; [王声锋 Wang Shengfeng], 2010, [灌溉排水学报, Journal of Irrigation and Drainage], V29, P29; Wang SS., 1990, J BIOMATH, V01, P21; Wang XL, 1989, CHINESE J AGROMETEOR, V10, P11; Wilkerson GG, 1985, SOYGRO V5 0 SOYBEAN; Willcutts JF, 1998, HORTSCIENCE, V33, P833, DOI 10.21273/HORTSCI.33.5.833; Williams LE, 2005, AGR FOREST METEOROL, V132, P201, DOI 10.1016/j.agrformet.2005.07.010; Wu ZhongDong, 2010, Transactions of the Chinese Society of Agricultural Engineering, V26, P63; Yang Lili, 2008, Nongye Jixie Xuebao = Transactions of the Chinese Society for Agricultural Machinery, V39, P81	49	17	19	6	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141835	10.1371/journal.pone.0141835	http://dx.doi.org/10.1371/journal.pone.0141835			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536468	gold, Green Submitted, Green Published			2022-12-26	WOS:000364298400091
J	Rakers, C; Schumacher, F; Meinl, W; Glatt, H; Kleuser, B; Wolber, G				Rakers, Christin; Schumacher, Fabian; Meinl, Walter; Glatt, Hansruedi; Kleuser, Burkhard; Wolber, Gerhard			In Silico Prediction of Human Sulfotransferase 1E1 Activity Guided by Pharmacophores from Molecular Dynamics Simulations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						drug design; drug metabolism; liver metabolism; molecular dynamics; molecular modeling; sulfotransferase	HUMAN ESTROGEN SULFOTRANSFERASE; SULFURYL TRANSFER; SUBSTRATE-INHIBITION; BINDING-SITE; FORCE-FIELD; METABOLISM; MECHANISM; ACTIVATION; CELLS; PAPS	Acting during phase II metabolism, sulfotransferases (SULTs) serve detoxification by transforming a broad spectrum of compounds from pharmaceutical, nutritional, or environmental sources into more easily excretable metabolites. However, SULT activity has also been shown to promote formation of reactive metabolites that may have genotoxic effects. SULT subtype 1E1 (SULT1E1) was identified as a key player in estrogen homeostasis, which is involved in many physiological processes and the pathogenesis of breast and endometrial cancer. The development of an in silico prediction model for SULT1E1 ligands would therefore support the development of metabolically inert drugs and help to assess health risks related to hormonal imbalances. Here, we report on a novel approach to develop a model that enables prediction of substrates and inhibitors of SULT1E1. Molecular dynamics simulations were performed to investigate enzyme flexibility and sample protein conformations. Pharmacophores were developed that served as a cornerstone of the model, and machine learning techniques were applied for prediction refinement. The prediction model was used to screen the DrugBank (a database of experimental and approved drugs): 28% of the predicted hits were reported in literature as ligands of SULT1E1. From the remaining hits, a selection of nine molecules was subjected to biochemical assay validation and experimental results were in accordance with the in silico prediction of SULT1E1 inhibitors and substrates, thus affirming our prediction hypotheses.	[Rakers, Christin; Wolber, Gerhard] Free Univ Berlin, Inst Pharm, D-14195 Berlin, Germany; [Meinl, Walter] German Inst Human Nutr DIfE Potsdam Rehbrucke, Dept Mol Toxicol, D-14558 Nuthetal, Germany; [Meinl, Walter; Glatt, Hansruedi] German Inst Human Nutr DIfE Potsdam Rehbrucke, Dept Nutr Toxicol, D-14558 Nuthetal, Germany; [Schumacher, Fabian; Kleuser, Burkhard] Univ Potsdam, Inst Nutr Sci, Dept Toxicol, D-14558 Nuthetal, Germany; [Schumacher, Fabian] Univ Duisburg Essen, Dept Mol Biol, D-45147 Essen, Germany	Free University of Berlin; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); University of Potsdam; University of Duisburg Essen	Wolber, G (corresponding author), Free Univ Berlin, Inst Pharm, Konigin Luise Str 2-4, D-14195 Berlin, Germany.	gerhard.wolber@fu-berlin.de	Schumacher, Fabian/ABC-1750-2020; Wolber, Gerhard/C-7133-2008; Wolber, Gerhard/ABD-4955-2020	Schumacher, Fabian/0000-0001-8703-3275; Wolber, Gerhard/0000-0002-5344-0048; Wolber, Gerhard/0000-0002-5344-0048; Meinl, Walter/0000-0003-3836-9164; Kleuser, Burkhard/0000-0002-1888-9595; Rakers, Christin/0000-0002-5668-6844	Elsa-Neumann Stipendium of the state Berlin	Elsa-Neumann Stipendium of the state Berlin	This work was supported by a Elsa-Neumann Stipendium of the state Berlin (to C. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Allali-Hassani A, 2007, PLOS BIOL, V5, P1063, DOI 10.1371/journal.pbio.0050097; BAMFORTH KJ, 1993, BIOCHEM PHARMACOL, V46, P1713, DOI 10.1016/0006-2952(93)90575-H; BAMFORTH KJ, 1992, EUR J PHARM-ENVIRON, V228, P15, DOI 10.1016/0926-6917(92)90006-X; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Berthold MR, 2008, STUD CLASS DATA ANAL, P319, DOI 10.1145/1656274.1656280; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; Bowers KJ, 2006, P 2006 ACMIEEE C SUP, P4343; Butt CM, 2013, CHEM RES TOXICOL, V26, P1692, DOI 10.1021/tx400342k; Cook I, 2013, J BIOL CHEM, V288, P34494, DOI 10.1074/jbc.M113.510974; Cook I, 2013, J BIOL CHEM, V288, P8619, DOI 10.1074/jbc.M112.445015; Cook I, 2013, BIOCHEMISTRY-US, V52, P415, DOI 10.1021/bi301492j; Cook IT, 2010, HORM MOL BIOL CLIN I, V1, P81, DOI 10.1515/HMBCI.2010.012; Coughtrie MWH, 2001, DRUG METAB DISPOS, V29, P522; Engst W, 2002, ENVIRON TOXICOL PHAR, V11, P243, DOI 10.1016/S1382-6689(02)00022-4; Falany JL, 1996, CANCER RES, V56, P1551; Feixas F, 2014, BIOPHYS CHEM, V186, P31, DOI 10.1016/j.bpc.2013.10.007; GIBB C, 1987, BIOCHEM PHARMACOL, V36, P2325, DOI 10.1016/0006-2952(87)90598-3; Glatt H, 2000, CHEM-BIOL INTERACT, V129, P141, DOI 10.1016/S0009-2797(00)00202-7; Gosavi RA, 2013, ENVIRON HEALTH PERSP, V121, P1194, DOI 10.1289/ehp.1306902; Guengerich FP, 2008, CHEM RES TOXICOL, V21, P70, DOI 10.1021/tx700079z; Hagen M, 1998, CHEM-BIOL INTERACT, V109, P249, DOI 10.1016/S0009-2797(97)00136-1; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Iyer LV, 2012, CHIRALITY, V24, P796, DOI 10.1002/chir.22072; Jancova P, 2010, BIOMED PAP, V154, P103, DOI 10.5507/bp.2010.017; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kauffman FC, 2004, DRUG METAB REV, V36, P823, DOI 10.1081/DMR-200033496; Kester MHA, 2000, ENDOCRINOLOGY, V141, P1897, DOI 10.1210/en.141.5.1897; KIM HJ, 1995, J PHARMACOL EXP THER, V275, P654; Kirchmair J, 2015, NAT REV DRUG DISCOV, V14, P387, DOI 10.1038/nrd4581; Kirchmair J, 2012, J CHEM INF MODEL, V52, P617, DOI 10.1021/ci200542m; Klaassen CD, 1997, FASEB J, V11, P404, DOI 10.1096/fasebj.11.6.9194521; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Korb O, 2009, J CHEM INF MODEL, V49, P84, DOI 10.1021/ci800298z; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Li L, 2007, J CYST FIBROS, V6, P23, DOI 10.1016/j.jcf.2006.05.001; Lin ES, 2003, J CHIN CHEM SOC-TAIP, V50, P655, DOI 10.1002/jccs.200300095; Lin P, 2006, INT J QUANTUM CHEM, V106, P2981, DOI 10.1002/qua.21123; Martiny VY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073587; Meinl W, 2006, INT J CANCER, V118, P1090, DOI 10.1002/ijc.21480; Meinl W, 2002, PHARMACOGENETICS, V12, P677, DOI 10.1097/00008571-200212000-00002; Meng SN, 2012, MOL PHARMACEUT, V9, P862, DOI 10.1021/mp200400s; Moroy G, 2012, DRUG DISCOV TODAY, V17, P44, DOI 10.1016/j.drudis.2011.10.023; Mortier J, 2015, DRUG DISCOV TODAY, V20, P686, DOI 10.1016/j.drudis.2015.01.003; Mysinger MM, 2012, J MED CHEM, V55, P6582, DOI 10.1021/jm300687e; Najmanovich RJ, 2007, BIOINFORMATICS, V23, pE104, DOI 10.1093/bioinformatics/btl292; Ohkimoto K, 2005, PESTIC BIOCHEM PHYS, V81, P32, DOI 10.1016/j.pestbp.2004.08.003; Pasqualini JR, 2009, MATURITAS, V65, pS17, DOI 10.1016/j.maturitas.2009.11.006; Pasqualini JR, 2009, ANN NY ACAD SCI, V1155, P88, DOI 10.1111/j.1749-6632.2009.04113.x; Pedersen LC, 2002, J BIOL CHEM, V277, P17928, DOI 10.1074/jbc.M111651200; Reed MC, 2010, BIOESSAYS, V32, P422, DOI 10.1002/bies.200900167; Reinen J, 2015, CURR MED CHEM, V22, P500; Reinen J, 2006, ANAL BIOCHEM, V357, P85, DOI 10.1016/j.ab.2006.07.015; Rizner TL, 2013, MOL CELL ENDOCRINOL, V381, P124, DOI [10.1016/j.mce.213.07.026, 10.1016/j.mce.2013.07.026]; SADOWSKI J, 1994, J CHEM INF COMP SCI, V34, P1000, DOI 10.1021/ci00020a039; Schomburg I, 2002, NUCLEIC ACIDS RES, V30, P47, DOI 10.1093/nar/30.1.47; Shevtsov S, 2003, ENVIRON HEALTH PERSP, V111, P884, DOI 10.1289/ehp.6056; STEVENTON GB, 1989, NEUROLOGY, V39, P883, DOI 10.1212/WNL.39.7.883; Testa B, 2012, DRUG DISCOV TODAY, V17, P549, DOI 10.1016/j.drudis.2012.01.017; Tian XG, 2015, BIOCHEM PHARMACOL, V94, P282, DOI 10.1016/j.bcp.2015.02.010; Tibbs ZE, 2015, DRUG METAB PHARMACOK, V30, P3, DOI 10.1016/j.dmpk.2014.10.004; Vietri M, 2000, EUR J CLIN PHARMACOL, V56, P81, DOI 10.1007/s002280050725; Wang T, 2014, BIOCHEMISTRY-US, V53, P6893, DOI 10.1021/bi501120p; Wang T, 2014, J BIOL CHEM, V289, P26474, DOI 10.1074/jbc.M114.573501; Warren GL, 2006, J MED CHEM, V49, P5912, DOI 10.1021/jm050362n; Witten I. H., 2005, DATA MINING PRACTICA, p[65, 214]; Wolber G, 2005, J CHEM INF MODEL, V45, P160, DOI 10.1021/ci049885e; Wolber G, 2008, DRUG DISCOV TODAY, V13, P23, DOI 10.1016/j.drudis.2007.09.007; Wolber G, 2006, J COMPUT AID MOL DES, V20, P773, DOI 10.1007/s10822-006-9078-7; Wu BJ, 2011, DRUG METAB REV, V43, P440, DOI 10.3109/03602532.2011.615320; Zhang HP, 1998, J BIOL CHEM, V273, P10888, DOI 10.1074/jbc.273.18.10888	72	20	22	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					58	71		10.1074/jbc.M115.685610	http://dx.doi.org/10.1074/jbc.M115.685610			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26542807	Green Published, hybrid			2022-12-26	WOS:000367589500005
J	Ma, D; Liu, TY; Chang, L; Rui, C; Xiao, YY; Li, SM; Hogenesch, JB; Chen, YE; Lin, JD				Ma, Di; Liu, Tongyu; Chang, Lin; Rui, Crystal; Xiao, Yuanyuan; Li, Siming; Hogenesch, John B.; Chen, Y. Eugene; Lin, Jiandie D.			The Liver Clock Controls Cholesterol Homeostasis through Trib1 Protein-mediated Regulation of PCSK9/Low Density Lipoprotein Receptor (LDLR) Axis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCADIAN AUTOPHAGY RHYTHM; GENE-EXPRESSION; GLUCOSE-METABOLISM; LOCI; SLEEP; TRANSCRIPTION; COMPONENTS; BIOLOGY; OBESITY; VARIANT	Disruption of the body clock has been recognized as a risk factor for cardiovascular disease. How the circadian pacemaker interacts with the genetic factors associated with plasma lipid traits remains poorly understood. Recent genome-wide association studies have identified an expanding list of genetic variants that influence plasma cholesterol and triglyceride levels. Here we analyzed circadian regulation of lipid-associated candidate genes in the liver and identified two distinct groups exhibiting rhythmic and non-rhythmic patterns of expression during light-dark cycles. Liver-specific inactivation of Bmal1 led to elevated plasma LDL/VLDL cholesterol levels as a consequence of the disruption of the PCSK9/LDL receptor regulatory axis. Ablation of the liver clock perturbed diurnal regulation of lipid-associated genes in the liver and markedly reduced the expression of the non-rhythmically expressed gene Trib1. Adenovirus-mediated rescue of Trib1 expression lowered plasma PCSK9 levels, increased LDL receptor protein expression, and restored plasma cholesterol homeostasis in mice lacking a functional liver clock. These results illustrate an unexpected mechanism through which the biological clock regulates cholesterol homeostasis through its regulation of non-rhythmic genes in the liver.	[Ma, Di; Liu, Tongyu; Rui, Crystal; Xiao, Yuanyuan; Li, Siming; Lin, Jiandie D.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Ma, Di; Liu, Tongyu; Rui, Crystal; Xiao, Yuanyuan; Li, Siming; Lin, Jiandie D.] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Chang, Lin; Chen, Y. Eugene] Univ Michigan, Dept Internal Med, Ctr Adv Models Translat Sci & Therapeut, Ann Arbor, MI 48109 USA; [Hogenesch, John B.] Univ Penn, Dept Pharmacol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Pennsylvania; Pennsylvania Medicine	Lin, JD (corresponding author), Univ Michigan, 5437 Life Sci Inst,210 Washtenaw Ave, Ann Arbor, MI 48109 USA.	jdlin@umich.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [DK077086, DK102456, NS054794]; Defense Advanced Research Projects Agency [DARPA-D12AP00025]; Penn Genome Frontiers Institute under a Health Research Formula Fund grant; Pennsylvania Department of Health; American Heart Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, R01DK077086, R01DK102456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054794] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Penn Genome Frontiers Institute under a Health Research Formula Fund grant; Pennsylvania Department of Health; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by National Institutes of Health Grants DK077086 and DK102456 (to J. D. L.) and NS054794 (to J. B. H.), Defense Advanced Research Projects Agency Grant DARPA-D12AP00025, and the Penn Genome Frontiers Institute under a Health Research Formula Fund grant with the Pennsylvania Department of Health. The authors declare no competing financial interests. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a predoctoral fellowship from the American Heart Association.	Asher G, 2015, CELL, V161, P84, DOI 10.1016/j.cell.2015.03.015; Asher G, 2011, CELL METAB, V13, P125, DOI 10.1016/j.cmet.2011.01.006; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Brunzell JD, 2007, NEW ENGL J MED, V357, P1009, DOI 10.1056/NEJMcp070061; Burkhardt R, 2010, J CLIN INVEST, V120, P4410, DOI 10.1172/JCI44213; Copinschi G, 2000, Novartis Found Symp, V227, P143; Czeisler CA, 1999, RECENT PROG HORM RES, V54, P97; Dallmann R, 2012, P NATL ACAD SCI USA, V109, P2625, DOI 10.1073/pnas.1114410109; Desai NR, 2015, TRENDS CARDIOVAS MED, V25, P567, DOI 10.1016/j.tcm.2015.01.009; Eckel-Mahan KL, 2012, P NATL ACAD SCI USA, V109, P5541, DOI 10.1073/pnas.1118726109; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Goldstein JL, 2015, CELL, V161, P161, DOI 10.1016/j.cell.2015.01.036; Hemandez C, 2010, CELL METAB, V12, P411, DOI 10.1016/j.cmet.2010.09.001; Horton JD, 2007, TRENDS BIOCHEM SCI, V32, P71, DOI 10.1016/j.tibs.2006.12.008; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Jacobi D, 2015, CELL METAB, V22, P709, DOI 10.1016/j.cmet.2015.08.006; Jones CR, 1999, NAT MED, V5, P1062, DOI 10.1038/12502; Kasukawa T, 2012, P NATL ACAD SCI USA, V109, P15036, DOI 10.1073/pnas.1207768109; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Lagace TA, 2014, CURR OPIN LIPIDOL, V25, P387, DOI 10.1097/MOL.0000000000000114; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Le Martelot G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000181; Li S, 2008, CELL METAB, V8, P105, DOI 10.1016/j.cmet.2008.06.013; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; Ma D, 2012, TRENDS ENDOCRIN MET, V23, P319, DOI 10.1016/j.tem.2012.03.004; Ma D, 2011, EMBO J, V30, P4642, DOI 10.1038/emboj.2011.322; Molusky MM, 2012, DIABETES, V61, P1025, DOI 10.2337/db11-0970; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Peek CB, 2013, SCIENCE, V342, P591, DOI 10.1126/science.1243417; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Shimba S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025231; Spiegel K, 2009, NAT REV ENDOCRINOL, V5, P253, DOI 10.1038/nrendo.2009.23; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Vollmers C, 2012, CELL METAB, V16, P833, DOI 10.1016/j.cmet.2012.11.004; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974; Zhang EE, 2010, NAT MED, V16, P1152, DOI 10.1038/nm.2214; Zhang R, 2014, P NATL ACAD SCI USA, V111, P16219, DOI 10.1073/pnas.1408886111	47	21	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					31003	31012		10.1074/jbc.M115.685982	http://dx.doi.org/10.1074/jbc.M115.685982			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26547624	Green Published, hybrid			2022-12-26	WOS:000367199000030
J	Kwon, DH; Kang, TJ; Kim, YH; Lee, SH				Kwon, Deok Ho; Kang, Taek-Jun; Kim, Young Ho; Lee, Si Hyeock			Phenotypic- and Genotypic-Resistance Detection for Adaptive Resistance Management in Tetranychus urticae Koch	PLOS ONE			English	Article							2-SPOTTED SPIDER-MITE; IN-FIELD POPULATIONS; INSECTICIDE RESISTANCE; ALLELE-FREQUENCY; PYRETHROID RESISTANCE; ACARICIDE RESISTANCE; POINT MUTATIONS; PHYLOGENETIC ANALYSIS; SODIUM-CHANNEL; TARGET-SITE	Rapid resistance detection is necessary for the adaptive management of acaricide-resistant populations of Tetranychus urticae. Detection of phenotypic and genotypic resistance was conducted by employing residual contact vial bioassay (RCV) and quantitative sequencing (QS) methods, respectively. RCV was useful for detecting the acaricide resistance levels of T. urticae, particularly for on-site resistance detection; however, it was only applicable for rapid-acting acaricides (12 out of 19 tested acaricides). QS was effective for determining the frequencies of resistance alleles on a population basis, which corresponded to 12 nonsynonymous point mutations associated with target-site resistance to five types of acaricides [organophosphates (monocrotophos, pirimiphos-methyl, dimethoate and chlorpyrifos), pyrethroids (fenpropathrin and bifenthrin), abamectin, bifenazate and etoxazole]. Most field-collected mites exhibited high levels of multiple resistance, as determined by RCV and QS data, suggesting the seriousness of their current acaricide resistance status in rose cultivation areas in Korea. The correlation analyses revealed moderate to high levels of positive relationships between the resistance allele frequencies and the actual resistance levels in only five of the acaricides evaluated, which limits the general application of allele frequency as a direct indicator for estimating actual resistance levels. Nevertheless, the resistance allele frequency data alone allowed for the evaluation of the genetic resistance potential and background of test mite populations. The combined use of RCV and QS provides basic information on resistance levels, which is essential for choosing appropriate acaricides for the management of resistant T. urticae.	[Kwon, Deok Ho; Kim, Young Ho; Lee, Si Hyeock] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul 151921, South Korea; [Kang, Taek-Jun] RDA, Natl Inst Hort & Herbal Sci, Dept Hort Crop Res, Jeonju 565852, South Korea; [Lee, Si Hyeock] Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151921, South Korea	Seoul National University (SNU); National Institute of Horticultural & Herbal Science (NIHHS), Republic of Korea; Rural Development Administration (RDA), Republic of Korea; Seoul National University (SNU)	Kwon, DH (corresponding author), Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul 151921, South Korea.	jota486@snu.ac.kr; shlee22@snu.ac.kr			Rural Development Administration [PJ009365]	Rural Development Administration(Rural Development Administration (RDA), Republic of Korea)	This work was supported by a grant from the Rural Development Administration (grant no. PJ009365) (http://www.rda.go.kr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alstad DN, 1996, AGBIOTECH NEWS INFOR, V8, P177; Anazawa Y, 2003, INSECT BIOCHEM MOLEC, V33, P509, DOI 10.1016/S0965-1748(03)00025-0; Andow DA, 1998, J ECON ENTOMOL, V91, P579, DOI 10.1093/jee/91.3.579; [Anonymous], 1998, WHOCDCMAL98; Auguie B, 2017, GRIDEXTRA MISCELLANE; BROGDON WG, 1989, PARASITOL TODAY, V5, P56, DOI 10.1016/0169-4758(89)90192-0; BROWN TM, 1987, ANNU REV ENTOMOL, V32, P145, DOI 10.1146/annurev.en.32.010187.001045; Clark J. Marshall, 2009, Journal of Asia-Pacific Entomology, V12, P1, DOI 10.1016/j.aspen.2008.10.007; Clark JM, 2001, PEST MANAG SCI, V57, P968, DOI 10.1002/ps.369; CROFT BA, 1988, EXP APPL ACAROL, V4, P277, DOI 10.1007/BF01196191; de Mendonca RS, 2011, EXP APPL ACAROL, V55, P1, DOI 10.1007/s10493-011-9453-5; Demaeght P, 2014, INSECT BIOCHEM MOLEC, V51, P52, DOI 10.1016/j.ibmb.2014.05.004; DENNEHY TJ, 1983, J ECON ENTOMOL, V76, P1225, DOI 10.1093/jee/76.6.1225; DENNEHY TJ, 1987, J ECON ENTOMOL, V80, P998, DOI 10.1093/jee/80.5.998; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dermauw W, 2012, INSECT BIOCHEM MOLEC, V42, P455, DOI 10.1016/j.ibmb.2012.03.002; DEVONSHIRE AL, 1992, B ENTOMOL RES, V82, P459, DOI 10.1017/S0007485300042516; DITTRICH V, 1962, J ECON ENTOMOL, V55, P644, DOI 10.1093/jee/55.5.644; Feyereisen R, 2015, PESTIC BIOCHEM PHYS, V121, P61, DOI 10.1016/j.pestbp.2015.01.004; Germer S, 2000, GENOME RES, V10, P258, DOI 10.1101/gr.10.2.258; Grbic M, 2011, NATURE, V479, P487, DOI 10.1038/nature10640; Hinomoto N, 2001, APPL ENTOMOL ZOOL, V36, P459, DOI 10.1303/aez.2001.459; Ilias A, 2014, INSECT BIOCHEM MOLEC, V48, P17, DOI 10.1016/j.ibmb.2014.02.006; Jamroz RC, 1998, INSECT BIOCHEM MOLEC, V28, P1031, DOI 10.1016/S0965-1748(98)00094-0; KCPA, 2014, AGR US GUID BOOK YEA; Khajehali J, 2011, PEST MANAG SCI, V67, P1424, DOI 10.1002/ps.2191; Khajehali J, 2010, PEST MANAG SCI, V66, P220, DOI 10.1002/ps.1884; Koh Sang-Hyun, 2009, Journal of Asia-Pacific Entomology, V12, P15, DOI 10.1016/j.aspen.2008.10.004; Kwon DH, 2010, INSECT MOL BIOL, V19, P583, DOI 10.1111/j.1365-2583.2010.01017.x; Kwon DH, 2008, J MED ENTOMOL, V45, P912, DOI 10.1603/0022-2585(2008)45[912:DOPRAF]2.0.CO;2; Kwon DH, 2014, J ASIA-PAC ENTOMOL, V17, P99, DOI 10.1016/j.aspen.2013.11.001; Kwon DH, 2012, INSECT BIOCHEM MOLEC, V42, P212, DOI 10.1016/j.ibmb.2011.12.003; Kwon DH, 2011, J ASIA-PAC ENTOMOL, V14, P379, DOI 10.1016/j.aspen.2011.05.001; Kwon DH, 2010, J ASIA-PAC ENTOMOL, V13, P333, DOI 10.1016/j.aspen.2010.05.005; Kwon DH, 2010, J ASIA-PAC ENTOMOL, V13, P229, DOI 10.1016/j.aspen.2010.02.002; Kwon DH, 2010, PESTIC BIOCHEM PHYS, V97, P93, DOI 10.1016/j.pestbp.2009.07.009; Kwon DH, 2010, PESTIC BIOCHEM PHYS, V96, P36, DOI 10.1016/j.pestbp.2009.08.013; Kwon DH, 2004, PESTIC BIOCHEM PHYS, V80, P21, DOI 10.1016/j.pestbp.2004.06.001; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee So-Young, 2004, Korean Journal of Applied Entomology, V43, P43; Liu NN, 2015, ANNU REV ENTOMOL, V60, P537, DOI 10.1146/annurev-ento-010814-020828; Liu Q, 1997, GENOME RES, V7, P389, DOI 10.1101/gr.7.4.389; Livak KJ, 1999, GENET ANAL-BIOMOL E, V14, P143, DOI 10.1016/S1050-3862(98)00019-9; Riga M, 2014, INSECT BIOCHEM MOLEC, V46, P43, DOI 10.1016/j.ibmb.2014.01.006; Seong KM, 2010, J MED ENTOMOL, V47, P592, DOI 10.1603/ME09274; SOMMER SS, 1989, MAYO CLIN PROC, V64, P1361, DOI 10.1016/S0025-6196(12)65378-6; Tabashnik BE, 2014, J ECON ENTOMOL, V107, P496, DOI 10.1603/EC13458; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tsagkarakou A, 2009, INSECT MOL BIOL, V18, P583, DOI 10.1111/j.1365-2583.2009.00900.x; Van Leeuwen T, 2008, P NATL ACAD SCI USA, V105, P5980, DOI 10.1073/pnas.0802224105; Van Leeuwen T, 2007, PEST MANAG SCI, V63, P150, DOI 10.1002/ps.1314; Van Leeuwen T, 2015, PESTIC BIOCHEM PHYS, V121, P12, DOI 10.1016/j.pestbp.2014.12.009; Van Leeuwen T, 2013, PEST MANAG SCI, V69, P156, DOI 10.1002/ps.3335; Van Leeuwen T, 2012, P NATL ACAD SCI USA, V109, P4407, DOI 10.1073/pnas.1200068109; Van Nieuwenhuyse P, 2009, PEST MANAG SCI, V65, P404, DOI 10.1002/ps.1705; Wilkening S, 2005, BIOTECHNIQUES, V39, P853, DOI 10.2144/000112027	57	16	16	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0139934	10.1371/journal.pone.0139934	http://dx.doi.org/10.1371/journal.pone.0139934			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545209	gold, Green Published			2022-12-26	WOS:000364398700004
J	Mazzeo, MF; Lippolis, R; Sorrentino, A; Liberti, S; Fragnito, F; Siciliano, RA				Mazzeo, Maria Fiorella; Lippolis, Rosa; Sorrentino, Alida; Liberti, Sarah; Fragnito, Federica; Siciliano, Rosa Anna			Lactobacillus acidophilus-Rutin Interplay Investigated by Proteomics	PLOS ONE			English	Article							TANNIC-ACID; STRESS RESPONSES; POLYPHENOLS; PLANTARUM; PROTEINS; IMPACT; METABOLISM; STARVATION; PH	Dietary polyphenols are bioactive molecules that beneficially affect human health, due to their anti-oxidant, anti-inflammatory, cardio-protective and chemopreventive properties. They are absorbed in a very low percentage in the small intestine and reach intact the colon, where they are metabolized by the gut microbiota. Although it is well documented a key role of microbial metabolism in the absorption of polyphenols and modulation of their biological activity, molecular mechanisms at the basis of the bacteria-polyphenols interplay are still poorly understood. In this context, differential proteomics was applied to reveal adaptive response mechanisms that enabled a potential probiotic Lactobacillus acidophilus strain to survive in the presence of the dietary polyphenol rutin. The response to rutin mainly modulated the expression level of proteins involved in general stress response mechanisms and, in particular, induced the activation of protein quality control systems, and affected carbohydrate and amino acid metabolism, protein synthesis and cell wall integrity. Moreover, rutin triggered the expression of proteins involved in oxidation-reduction processes. This study provides a first general view of the impact of dietary polyphenols on metabolic and biological processes of L. acidophilus.	[Mazzeo, Maria Fiorella; Sorrentino, Alida; Liberti, Sarah; Fragnito, Federica; Siciliano, Rosa Anna] CNR, Inst Food Sci, Avellino, Italy; [Lippolis, Rosa] CNR, Inst Biomembranes & Bioenerget, I-70126 Bari, Italy; [Liberti, Sarah] Univ Naples Federico II, Dept Chem Sci, Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR); Consiglio Nazionale delle Ricerche (CNR); University of Naples Federico II	Mazzeo, MF (corresponding author), CNR, Inst Food Sci, Avellino, Italy.	fmazzeo@isa.cnr.it	ALIDA, SORRENTINO/AAL-1737-2021; Siciliano, Rosa Anna/G-9822-2013; Mazzeo, Maria Fiorella/AAX-7262-2020	Mazzeo, Maria Fiorella/0000-0003-1542-0027; SICILIANO, ROSAANNA/0000-0002-1042-3424; LIPPOLIS, ROSA/0000-0001-9894-1957	Italian Ministry of Economy and Finance; ENEA [191/2009]; internal resources of CNR	Italian Ministry of Economy and Finance; ENEA(ENEA, Italy); internal resources of CNR	This work was partially supported by funds from the Italian Ministry of Economy and Finance to CNR and ENEA for the project "Innovazione e sviluppo del Mezzogiorno - Conoscenze Integrate per Sostenibilita ed Innovazione del Made in Italy Agroalimentare"-Legge n. 191/2009. All additional funding was from internal resources of CNR.	Abou Hachem M, 2013, BIOCATAL BIOTRANSFOR, V31, P226, DOI 10.3109/10242422.2013.828048; Almajano MP, 2008, FOOD CHEM, V108, P55, DOI 10.1016/j.foodchem.2007.10.040; Curiel JA, 2011, MOL NUTR FOOD RES, V55, P1454, DOI 10.1002/mnfr.201000621; Appel RD, 1999, METH MOL B, V112, P363; Ashida N, 2011, J BIOSCI BIOENG, V112, P333, DOI 10.1016/j.jbiosc.2011.06.001; Barreteau H, 2008, FEMS MICROBIOL REV, V32, P168, DOI 10.1111/j.1574-6976.2008.00104.x; Beekwilder J, 2009, APPL ENVIRON MICROB, V75, P3447, DOI 10.1128/AEM.02675-08; Bossi A, 2007, J APPL MICROBIOL, V102, P787, DOI 10.1111/j.1365-2672.2006.03118.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cecconi D, 2009, ELECTROPHORESIS, V30, P957, DOI 10.1002/elps.200800310; China R, 2012, MICROBIOL RES, V167, P500, DOI 10.1016/j.micres.2012.04.003; Crozier A, 2009, NAT PROD REP, V26, P1001, DOI 10.1039/b802662a; De Angelis M, 2004, PROTEOMICS, V4, P106, DOI 10.1002/pmic.200300497; Duda-Chodak A, 2012, J PHYSIOL PHARMACOL, V63, P497; Etxeberria U, 2013, J AGR FOOD CHEM, V61, P9517, DOI 10.1021/jf402506c; Ferain T, 1996, J BACTERIOL, V178, P5431, DOI 10.1128/JB.178.18.5431-5437.1996; GORG A, 1988, ELECTROPHORESIS, V9, P531, DOI 10.1002/elps.1150090913; Heunis T, 2014, J PROTEOME RES, V13, P4028, DOI 10.1021/pr500353x; HOCHSTRASSER DF, 1988, ANAL BIOCHEM, V173, P424, DOI 10.1016/0003-2697(88)90209-6; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Johnson B, 2013, MICROBIOL-SGM, V159, P2269, DOI 10.1099/mic.0.070755-0; Kuwana R, 2012, J BIOSCI BIOENG, V114, P9, DOI 10.1016/j.jbiosc.2012.02.010; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee J, 2010, APPL ENVIRON MICROB, V76, P4829, DOI 10.1128/AEM.02892-09; Len MCL, 2004, MICROBIOL-SGM, V150, P1353, DOI 10.1099/mic.0.26888-0; Lippolis R, 2011, J PROTEOMICS, V74, P2846, DOI 10.1016/j.jprot.2011.06.032; Majumder A, 2011, PROTEOMICS, V11, P3470, DOI 10.1002/pmic.201100115; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Nandakumar R, 2014, J DAIRY SCI, V97, P1999, DOI 10.3168/jds.2013-7470; Peil L, 2013, P NATL ACAD SCI USA, V110, P15265, DOI 10.1073/pnas.1310642110; Rechner AR, 2004, FREE RADICAL BIO MED, V36, P212, DOI 10.1016/j.freeradbiomed.2003.09.022; Rivas-Sendra A, 2011, J APPL MICROBIOL, V111, P1473, DOI 10.1111/j.1365-2672.2011.05160.x; Rodriguez-Diaz J, 2012, BIOTECHNOL BIOENG, V109, P1704, DOI 10.1002/bit.24475; Rossi M, 2013, J AGR FOOD CHEM, V61, P9551, DOI 10.1021/jf402722m; Russo M, 2012, BIOCHEM PHARMACOL, V83, P6, DOI 10.1016/j.bcp.2011.08.010; Santiago B, 2012, J BACTERIOL, V194, P2010, DOI 10.1128/JB.06737-11; Selma MV, 2009, J AGR FOOD CHEM, V57, P6485, DOI 10.1021/jf902107d; Sharma S, 2013, EXPERT OPIN INV DRUG, V22, P1063, DOI 10.1517/13543784.2013.805744; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shi LC, 2014, P NATL ACAD SCI USA, V111, P2140, DOI 10.1073/pnas.1318476111; Siciliano RA, 2012, CURR OPIN MICROBIOL, V15, P390, DOI 10.1016/j.mib.2012.03.006; Ude S, 2013, SCIENCE, V339, P82, DOI 10.1126/science.1228985; van de Guchte M, 2002, ANTON LEEUW INT J G, V82, P187, DOI 10.1023/A:1020631532202; van Duynhoven J, 2011, P NATL ACAD SCI USA, V108, P4531, DOI 10.1073/pnas.1000098107; Vasanthi HR, 2012, CURR MED CHEM, V19, P2242; Wang Y, 2005, CRYOBIOLOGY, V50, P294, DOI 10.1016/j.cryobiol.2005.03.001; Wang Y, 2011, BIOTECHNOL PROGR, V27, P342, DOI 10.1002/btpr.566; Zou SB, 2012, J BACTERIOL, V194, P413, DOI 10.1128/JB.05864-11	48	13	14	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142376	10.1371/journal.pone.0142376	http://dx.doi.org/10.1371/journal.pone.0142376			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544973	gold, Green Submitted, Green Published			2022-12-26	WOS:000364398700122
J	Morita, K; Naruto, T; Tanimoto, K; Yasukawa, C; Oikawa, Y; Masuda, K; Imoto, I; Inazawa, J; Omura, K; Harada, H				Morita, Kei-ichi; Naruto, Takuya; Tanimoto, Kousuke; Yasukawa, Chisato; Oikawa, Yu; Masuda, Kiyoshi; Imoto, Issei; Inazawa, Johji; Omura, Ken; Harada, Hiroyuki			Simultaneous Detection of Both Single Nucleotide Variations and Copy Number Alterations by Next-Generation Sequencing in Gorlin Syndrome	PLOS ONE			English	Article							CELL CARCINOMA SYNDROME; GERMLINE MUTATIONS; PTCH1 MUTATIONS; NEVUS SYNDROME; HUMAN HOMOLOG; GENE; DELETIONS; PROTEIN; FRENCH	Gorlin syndrome (GS) is an autosomal dominant disorder that predisposes affected individuals to developmental defects and tumorigenesis, and caused mainly by heterozygous germline PTCH1 mutations. Despite exhaustive analysis, PTCH1 mutations are often unidentifiable in some patients; the failure to detect mutations is presumably because of mutations occurred in other causative genes or outside of analyzed regions of PTCH1, or copy number alterations (CNAs). In this study, we subjected a cohort of GS-affected individuals from six unrelated families to next-generation sequencing (NGS) analysis for the combined screening of causative alterations in Hedgehog signaling pathway-related genes. Specific single nucleotide variations (SNVs) of PTCH1 causing inferred amino acid changes were identified in four families (seven affected individuals), whereas CNAs within or around PTCH1 were found in two families in whom possible causative SNVs were not detected. Through a targeted resequencing of all coding exons, as well as simultaneous evaluation of copy number status using the alignment map files obtained via NGS, we found that GS phenotypes could be explained by PTCH1 mutations or deletions in all affected patients. Because it is advisable to evaluate CNAs of candidate causative genes in point mutation-negative cases, NGS methodology appears to be useful for improving molecular diagnosis through the simultaneous detection of both SNVs and CNAs in the targeted genes/regions.	[Morita, Kei-ichi; Yasukawa, Chisato; Oikawa, Yu; Omura, Ken; Harada, Hiroyuki] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Oral & Maxillofacial Surg, Tokyo, Japan; [Morita, Kei-ichi; Tanimoto, Kousuke; Inazawa, Johji] Tokyo Med & Dent Univ, Bioresource Res Ctr, Tokyo, Japan; [Morita, Kei-ichi; Inazawa, Johji; Omura, Ken] Tokyo Med & Dent Univ, Hard Tissue Genome Res Ctr, Tokyo, Japan; [Naruto, Takuya] Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Stress Sci, Tokushima, Japan; [Tanimoto, Kousuke] Tokyo Med & Dent Univ, Med Res Inst, Genome Lab, Tokyo, Japan; [Tanimoto, Kousuke; Inazawa, Johji] Med Res Inst, Dept Mol Cytogenet, Tokyo, Japan; [Tanimoto, Kousuke; Inazawa, Johji] Tokyo Med & Dent Univ, Sch Biomed Sci, Grad Sch Med, Tokyo, Japan; [Masuda, Kiyoshi] Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Human Genet, Tokushima, Japan; [Omura, Ken] Tokyo Gen Hosp, Oral Canc Ctr, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokushima University; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokushima University	Morita, K (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Oral & Maxillofacial Surg, Tokyo, Japan.	keiichi.m.osur@tmd.ac.jp	Imoto, Issei/AAD-5799-2020		JSPS KAKENHI from Ministry of Education, Culture, Sports, Science and Technology, Japan [26293304]	JSPS KAKENHI from Ministry of Education, Culture, Sports, Science and Technology, Japan	This work was supported by JSPS KAKENHI Grant Number 26293304 (I.I.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	BALE AE, 1995, P ASSOC AM PHYSICIAN, V107, P253; Boutet N, 2003, J INVEST DERMATOL, V121, P478, DOI 10.1046/j.1523-1747.2003.12423.x; Fan Z, 2008, J MED GENET, V45, P303, DOI 10.1136/jmg.2007.055343; Fujii K, 2007, HUM GENET, V122, P459, DOI 10.1007/s00439-007-0419-y; Fujii K, 2014, PEDIATR INT, V56, P667, DOI 10.1111/ped.12461; Fujii K, 2013, FAM CANCER, V12, P611, DOI 10.1007/s10689-013-9623-1; Gao Wenming, 2015, Hum Genome Var, V2, P15004, DOI 10.1038/hgv.2015.4; Goncalves KD, 2011, FEBS LETT, V585, P2556, DOI 10.1016/j.febslet.2011.07.010; GORLIN RJ, 1960, NEW ENGL J MED, V262, P908, DOI 10.1056/NEJM196005052621803; GORLIN RJ, 1995, DERMATOL CLIN, V13, P113, DOI 10.1016/S0733-8635(18)30114-1; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Lindstrom E, 2006, HUM MUTAT, V27, P215, DOI 10.1002/humu.20296; Nagao K, 2011, CLIN GENET, V79, P196, DOI 10.1111/j.1399-0004.2010.01527.x; Okamoto Nana, 2014, Hum Genome Var, V1, P14022, DOI 10.1038/hgv.2014.22; RAYNER CRW, 1977, BRIT J PLAST SURG, V30, P62, DOI 10.1016/S0007-1226(77)90037-6; Reifenberger J, 2001, J INVEST DERMATOL, V116, P472, DOI 10.1046/j.1523-1747.2001.01279-2.x; Shimada Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070995; Shimada Y, 2013, J ORAL PATHOL MED, V42, P275, DOI 10.1111/j.1600-0714.2012.01202.x; Smith MJ, 2014, J CLIN ONCOL, V32, P4155, DOI 10.1200/JCO.2014.58.2569; Soufir N, 2006, BRIT J CANCER, V95, P548, DOI 10.1038/sj.bjc.6603303; Wicking C, 1997, AM J HUM GENET, V60, P21	22	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0140480	10.1371/journal.pone.0140480	http://dx.doi.org/10.1371/journal.pone.0140480			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544948	Green Submitted, gold, Green Published			2022-12-26	WOS:000364398700010
J	Rollin, HB; Kootbodien, T; Channa, K; Odland, JO				Roellin, Halina B.; Kootbodien, Tahira; Channa, Kalavati; Odland, Jon O.			Prenatal Exposure to Cadmium, Placental Permeability and Birth Outcomes in Coastal Populations of South Africa	PLOS ONE			English	Article							ENVIRONMENTAL CONTAMINANTS; ESSENTIAL ELEMENTS; RISK-ASSESSMENT; BLOOD; MICRONUTRIENTS; TRANSPORT; INTERACTS; LEAD; FOOD	Background The impact of prenatal exposure to cadmium (Cd) on birth outcomes is an area of concern. This study aimed to assess an impact of prenatal Cd exposure on birth outcomes in distinct coastal populations of South Africa. Methods Cadmium was measured in maternal blood (CdB) (n = 641), cord blood and in maternal urine (n = 317). This investigation assessed the associations between CdB (non-transformed) and birth outcomes across the 25th, 50th, and 75th percentile for birth weight, birth length and head circumference, to test for a linear trend. Associations between natural log-transformed maternal CdB, size at birth and other factors were further evaluated using linear mixed-effects modelling with random intercepts. Results The average gestational age in the total sample was 38 weeks; 47% of neonates were female, average birth weight was 3065 g and 11% were of low birth weight (< 2500 g). The geometric mean (GM) of the maternal CdB level was 0.25 mu g/L (n = 641; 95% CI, 0.230.27). The cord blood Cd level was 0.27 mu g/L (n = 317; 95% CI, 0.26-0.29) and urine (creatinine-corrected) Cd level was 0.27 mu g/L (n = 318; 95% CI, 0.24-0.29). The CdB cord: maternal ratio in the sub-cohort was 1, suggesting that the placenta offers no protective mechanism to the foetus. An inverse association was found between CdB and the lower birth weight percentile in female neonates only (beta = -0.13, p = 0.047). Mothers who reported eating vine vegetables daily had lower levels of CdB (beta = -0.55, p = 0.025). Maternal smoking was associated with an elevation in natural log-transformed CdB levels in both male and female cohorts. Discussion Significant inverse associations between prenatal Cd exposure and birth anthropometry were found in female neonates but not in male neonates, suggesting potential sex differences in the toxico-kinetics and toxico-dynamics of Cd.	[Roellin, Halina B.; Odland, Jon O.] Univ Pretoria, Fac Hlth Sci, Sch Hlth Syst & Publ Hlth, ZA-0002 Pretoria, South Africa; [Roellin, Halina B.; Kootbodien, Tahira] MRC, Environm & Hlth Res Unit, Johannesburg, South Africa; [Channa, Kalavati] Lancet Labs, Dept Analyt Chem, Johannesburg, South Africa; [Odland, Jon O.] Univ Tromso, Inst Community Med, Tromso, Norway	University of Pretoria; UiT The Arctic University of Tromso	Rollin, HB (corresponding author), Univ Pretoria, Fac Hlth Sci, Sch Hlth Syst & Publ Hlth, ZA-0002 Pretoria, South Africa.	Halina.Rollin@up.ac.za	Odland, Jon Oyvind/L-5096-2017	Odland, Jon Oyvind/0000-0002-2756-0732; Rollin, Halina/0000-0001-5247-6519	National Research Foundation (NRF), South Africa [64528]; Arctic Monitoring and Assessment Programme (AMAP), Norway	National Research Foundation (NRF), South Africa(National Research Foundation - South Africa); Arctic Monitoring and Assessment Programme (AMAP), Norway	This research was funded in part by the National Research Foundation (NRF), South Africa (Grant 64528) and the Arctic Monitoring and Assessment Programme (AMAP), Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernethy DR, 2010, PHARM RES-DORDR, V27, P750, DOI 10.1007/s11095-010-0080-3; Akesson AA, 2005, ENVIRON HEALTH PERSP, V113, P1627, DOI 10.1289/ehp.8033; Akesson A, 2014, ENVIRON HEALTH PERSP, V122, P431, DOI 10.1289/ehp.1307110; Al-Saleh I, 2014, INT J HYG ENVIR HEAL, V217, P205, DOI 10.1016/j.ijheh.2013.04.009; Authority EFS, 2009, SCI OP CADM FOOD SCI; BARANOWSKA I, 1995, OCCUP ENVIRON MED, V52, P229, DOI 10.1136/oem.52.4.229; CDC,, 2013, 4 CDCP; Chan HM, 2001, FOOD ADDIT CONTAM, V18, P607, DOI 10.1080/02652030110035660; Charania NA, 2014, ENVIRON SCI-PROC IMP, V16, P1422, DOI 10.1039/c4em00064a; Fontaine J, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-25; FRIBERG L, 1983, ANNU REV PUBL HEALTH, V4, P367, DOI 10.1146/annurev.pu.04.050183.002055; Hansen S, 2011, J ENVIRON MONITOR, V13, P2143, DOI 10.1039/c1em10051c; Hanson ML, 2012, TOXICOL APPL PHARM, V261, P196, DOI 10.1016/j.taap.2012.04.002; Hlimi T, 2012, INT J CIRCUMPOL HEAL, V71, DOI 10.3402/ijch.v71i0.17344; Hubal EAC, 2014, REGUL TOXICOL PHARM, V69, P113, DOI 10.1016/j.yrtph.2013.09.008; Johnson MD, 2003, NAT MED, V9, P1081, DOI 10.1038/nm902; Kido Shinsuke, 2012, Nihon Eiseigaku Zasshi, V67, P464; Kim C, 1998, FOOD ADDIT CONTAM A, V15, P307; Kippler M, 2013, EPIGENETICS-US, V8, P494, DOI 10.4161/epi.24401; Kippler M, 2012, ENVIRON HEALTH PERSP, V120, P284, DOI 10.1289/ehp.1103711; Kippler M, 2010, TOXICOL LETT, V192, P162, DOI 10.1016/j.toxlet.2009.10.018; Kippler M, 2009, TOXICOLOGY, V257, P64, DOI 10.1016/j.tox.2008.12.009; Kjellstrom T, 1992, IARC Sci Publ, P301; Nawrot TS, 2010, BIOMETALS, V23, P769, DOI 10.1007/s10534-010-9343-z; Needham LL, 2011, ENVIRON SCI TECHNOL, V45, P1121, DOI 10.1021/es1019614; Nordberg GF, 2007, HANDBOOK ON THE TOXICOLOGY OF METALS, 3RD EDITION, P445, DOI 10.1016/B978-012369413-3/50078-1; Nordberg M., 2002, HEAVY METALS ENV; Osman K, 2000, CLIN BIOCHEM, V33, P131, DOI 10.1016/S0009-9120(00)00052-7; Rudge CV, 2009, J ENVIRON MONITOR, V11, P1322, DOI 10.1039/b903805a; Sakamoto M, 2013, ENVIRON INT, V60, P106, DOI 10.1016/j.envint.2013.08.007; Sanders AP, 2014, EPIGENETICS-US, V9, P212, DOI 10.4161/epi.26798; Sun H, 2014, CHEMOSPHERE, V108, P33, DOI 10.1016/j.chemosphere.2014.02.080; Thompson J, 2008, REPROD TOXICOL, V25, P304, DOI 10.1016/j.reprotox.2008.02.001; Vahter M, 2002, ENVIRON RES, V88, P145, DOI 10.1006/enrs.2002.4338; Veyhe AS, 2015, INT J HYG ENVIR HEAL, V218, P254, DOI 10.1016/j.ijheh.2014.12.001; WHO, 2011, WHO TECH REP SER, V966, P1; World Health O, 2009, CADMIUM	37	36	36	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142455	10.1371/journal.pone.0142455	http://dx.doi.org/10.1371/journal.pone.0142455			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544567	gold, Green Submitted, Green Published			2022-12-26	WOS:000364398700143
J	Shin, HJ; Park, ER; Yun, SH; Kim, SH; Jung, WH; Woo, SR; Joo, HY; Jang, SH; Chung, HY; Hong, SH; Cho, MH; Park, JJ; Yun, M; Lee, KH				Shin, Hyun-Jin; Park, Eun-Ran; Yun, Sun-Hee; Kim, Su-Hyeon; Jung, Won-Hee; Woo, Seon Rang; Joo, Hyun-Yoo; Jang, Su Hwa; Chung, Hee Yong; Hong, Sung Hee; Cho, Myung-Haing; Park, Joong-Jean; Yun, Miyong; Lee, Kee-Ho			p31(comet)-Induced Cell Death Is Mediated by Binding and Inactivation of Mad2	PLoS One			English	Article							SPINDLE ASSEMBLY CHECKPOINT; ANAPHASE-PROMOTING COMPLEX; MITOTIC CHECKPOINT; CHROMOSOMAL INSTABILITY; LUNG-CANCER; P53 GENE; HEPATOCELLULAR-CARCINOMA; GENOMIC INSTABILITY; PROTEIN MAD2; EXPRESSION	Mad2, a key component of the spindle checkpoint, is closely associated with chromosomal instability and poor prognosis in cancer. p31(comet) is a Mad2-interacting protein that serves as a spindle checkpoint silencer at mitosis. In this study, we showed that p31(comet)-induced apoptosis and senescence occur via counteraction of Mad2 activity. Upon retroviral transduction of p31(comet), the majority of human cancer cell lines tested lost the ability to form colonies in a low-density seeding assay. Cancer cells with p31(comet) overexpression underwent distinct apoptosis and/or senescence, irrespective of p53 status, confirming the cytotoxicity of p31(comet). Interestingly, both cytotoxic and Mad2 binding activities were eliminated upon deletion of the C-terminal 30 amino acids of p31(comet). Point mutation or deletion of the region affecting Mad2 binding additionally abolished cytotoxic activity. Consistently, wildtype Mad2 interacting with p31(comet), but not its non-binding mutant, inhibited cell death, indicating that the mechanism of p31(comet)-induced cell death involves Mad2 inactivation. Our results clearly suggest that the regions of p31(comet) affecting interactions with Mad2, including the C-terminus, are essential for induction of cell death. The finding that p31(comet)-induced cell death is mediated by interactions with Mad2 that lead to its inactivation is potentially applicable in anticancer therapy.	[Shin, Hyun-Jin; Park, Eun-Ran; Yun, Sun-Hee; Kim, Su-Hyeon; Jung, Won-Hee; Woo, Seon Rang; Joo, Hyun-Yoo; Hong, Sung Hee; Yun, Miyong; Lee, Kee-Ho] Korea Inst Radiol & Med Sci, Div Radiat Canc Res, Seoul 139706, South Korea; [Jang, Su Hwa; Chung, Hee Yong] Hanyang Univ, Grad Sch Biomed Sci & Engn, Seoul 133791, South Korea; [Cho, Myung-Haing] Seoul Natl Univ, Coll Vet Med, Toxicol Lab, Seoul 151742, South Korea; [Park, Joong-Jean] Korea Univ, Coll Med, Dept Physiol, Seoul 136705, South Korea; [Yun, Miyong] Kyung Hee Univ, Coll Oriental Med, Seoul 130701, South Korea; [Park, Eun-Ran] Yonsei Univ, Dept Pathol, Coll Med, Seoul 120749, South Korea; [Park, Eun-Ran] Yonsei Univ, BK PLUS Project Med Sci 21, Coll Med, Seoul 120749, South Korea	Korea Institute of Radiological & Medical Sciences; Hanyang University; Seoul National University (SNU); Korea University; Korea University Medicine (KU Medicine); Kyung Hee University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Yun, M (corresponding author), Korea Inst Radiol & Med Sci, Div Radiat Canc Res, Seoul 139706, South Korea.	myyun91@khu.ac.kr; khlee@kirams.re.kr	Cho, Myung-Haing/B-7362-2014; YUN, MIYONG/S-9433-2019	Cho, Myung-Haing/0000-0002-3993-2011; Chung, Hee Yong/0000-0001-7580-0537; Jang, Su Hwa/0000-0002-3022-6612; Park, Joong-Jean/0000-0002-4534-3002	National Research Foundation of Korea [2012M3A9B6055346]; nuclear R&D program of Korea Ministry of Sciences and Technology	National Research Foundation of Korea(National Research Foundation of Korea); nuclear R&D program of Korea Ministry of Sciences and Technology	This study was supported by grants from National Research Foundation of Korea (2012M3A9B6055346), and nuclear R&D program of Korea Ministry of Sciences and Technology.	BRESSAC B, 1990, P NATL ACAD SCI USA, V87, P1973, DOI 10.1073/pnas.87.5.1973; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Date DA, 2014, J BIOL CHEM, V289, P11367, DOI 10.1074/jbc.M113.520841; Date DA, 2013, CELL CYCLE, V12, P3824, DOI 10.4161/cc.26811; DILLER L, 1990, MOL CELL BIOL, V10, P5772, DOI 10.1128/MCB.10.11.5772; Dobles M, 2000, CELL, V101, P635, DOI 10.1016/S0092-8674(00)80875-2; Fang GW, 1998, GENE DEV, V12, P1871, DOI 10.1101/gad.12.12.1871; Frio TR, 2010, NEW ENGL J MED, V363, P2628, DOI 10.1056/NEJMoa1006565; Gao N, 2001, J CANCER RES CLIN, V127, P359, DOI 10.1007/s004320000184; Grabsch H, 2003, J PATHOL, V200, P16, DOI 10.1002/path.1324; Habu T, 2002, EMBO J, V21, P6419, DOI 10.1093/emboj/cdf659; Habu T, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-562; He M, 2011, ONCOGENE, V30, P1947, DOI 10.1038/onc.2010.567; Hernando E, 2004, NATURE, V430, P797, DOI 10.1038/nature02820; Hisaoka M, 2008, PATHOL INT, V58, P329, DOI 10.1111/j.1440-1827.2008.02232.x; Jaffrey RG, 2000, CANCER RES, V60, P4349; Kato T, 2011, LUNG CANCER, V74, P124, DOI 10.1016/j.lungcan.2011.01.025; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Lin Y., 1996, Annals Academy of Medicine Singapore, V25, P22; LOWE SW, 1994, P NATL ACAD SCI USA, V91, P2026, DOI 10.1073/pnas.91.6.2026; Ma HT, 2012, J BIOL CHEM, V287, P21561, DOI 10.1074/jbc.M112.364356; Mapelli M, 2006, EMBO J, V25, P1273, DOI 10.1038/sj.emboj.7601033; MASUDA H, 1987, P NATL ACAD SCI USA, V84, P7716, DOI 10.1073/pnas.84.21.7716; Michel L, 2004, P NATL ACAD SCI USA, V101, P4459, DOI 10.1073/pnas.0306069101; Michel LS, 2001, NATURE, V409, P355, DOI 10.1038/35053094; MITSUDOMI T, 1992, ONCOGENE, V7, P171; Nowak MA, 2002, P NATL ACAD SCI USA, V99, P16226, DOI 10.1073/pnas.202617399; Prencipe M, 2009, BRIT J CANCER, V101, P1900, DOI 10.1038/sj.bjc.6605419; Salmela AL, 2013, CHROMOSOMA, V122, P431, DOI 10.1007/s00412-013-0419-8; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Shin HJ, 2003, CANCER CELL, V4, P483, DOI 10.1016/S1535-6108(03)00302-7; Sironi L, 2001, EMBO J, V20, P6371, DOI 10.1093/emboj/20.22.6371; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Sotillo R, 2010, NATURE, V464, P436, DOI 10.1038/nature08803; Sudo T, 2004, CANCER RES, V64, P2502, DOI 10.1158/0008-5472.CAN-03-2013; Teichner A, 2011, P NATL ACAD SCI USA, V108, P3187, DOI 10.1073/pnas.1100023108; Westhorpe FG, 2011, J CELL SCI, V124, P3905, DOI 10.1242/jcs.093286; Xia GH, 2004, EMBO J, V23, P3133, DOI 10.1038/sj.emboj.7600322; Yang MJ, 2007, CELL, V131, P744, DOI 10.1016/j.cell.2007.08.048; Yun M, 2009, MOL CANCER RES, V7, P371, DOI 10.1158/1541-7786.MCR-08-0056; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039; Zhang SH, 2008, HUM PATHOL, V39, P1827, DOI 10.1016/j.humpath.2008.06.003	43	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141523	10.1371/journal.pone.0141523	http://dx.doi.org/10.1371/journal.pone.0141523			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544187	Green Published, Green Submitted, gold			2022-12-26	WOS:000364398700030
J	Fan, B; Li, L; Chao, YJ; Forstner, K; Vogel, J; Borriss, R; Wu, XQ				Fan, Ben; Li, Lei; Chao, Yanjie; Foerstner, Konrad; Vogel, Joerg; Borriss, Rainer; Wu, Xiao-Qin			dRNA-Seq Reveals Genomewide TSSs and Noncoding RNAs of Plant Beneficial Rhizobacterium Bacillus amyloliquefaciens FZB42	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; SMALL REGULATORY RNAS; BINDING PROTEIN HFQ; ESCHERICHIA-COLI; MESSENGER-RNA; TRANSCRIPTIONAL LANDSCAPE; GENE-EXPRESSION; MYCOBACTERIUM-TUBERCULOSIS; LISTERIA-MONOCYTOGENES; SUBTILIS GENOME	Bacillus amyloliquefaciens subsp. plantarum FZB42 is a representative of Gram-positive plant-growth-promoting rhizobacteria (PGPR) that inhabit plant root environments. In order to better understand the molecular mechanisms of bacteria-plant symbiosis, we have systematically analyzed the primary transcriptome of strain FZB42 grown under rhizospheremimicking conditions using differential RNA sequencing (dRNA-seq). Our analysis revealed 4,877 transcription start sites for protein-coding genes, identified genes differentially expressed under different growth conditions, and corrected many previously mis-annotated genes. We also identified a large number of riboswitches and cis-encoded antisense RNAs, as well as trans-encoded small noncoding RNAs that may play important roles in the gene regulation of Bacillus. Overall, our analyses provided a landscape of Bacillus primary transcriptome and improved the knowledge of rhizobacteria-host interactions.	[Fan, Ben; Wu, Xiao-Qin] Nanjing Forestry Univ, Coll Forestry, Coinnovat Ctr Sustainable Forestry Southern China, Nanjing 210037, Jiangsu, Peoples R China; [Li, Lei; Chao, Yanjie; Foerstner, Konrad; Vogel, Joerg] Univ Wurzburg, Inst Mol Infect Biol, RNA Biol Grp, D-97080 Wurzburg, Germany; [Borriss, Rainer] Humboldt Univ, Fachgebiet Phytomed, Albrecht Daniel Thaer Inst Agr & Gartenbauwissens, Lebenswissensch Fak, D-14195 Berlin, Germany	Nanjing Forestry University; University of Wurzburg; Humboldt University of Berlin	Fan, B (corresponding author), Nanjing Forestry Univ, Coll Forestry, Coinnovat Ctr Sustainable Forestry Southern China, Nanjing 210037, Jiangsu, Peoples R China.	fanben2000@gmail.com; xqwu2000@gmail.com	Chao, Yanjie/J-1931-2014; Borriss, Rainer/C-5026-2012; Vogel, Jörg/D-5574-2011; Förstner, Konrad U./B-1531-2010; Li, Lei/S-9028-2016	Chao, Yanjie/0000-0002-5735-7954; Borriss, Rainer/0000-0003-3726-1004; Vogel, Jörg/0000-0003-2220-1404; Förstner, Konrad U./0000-0002-1481-2996; Li, Lei/0000-0003-3924-2544; Fan, Ben/0000-0001-8532-1281	National Natural Science Foundation of China [31100081]; Scientific Research Foundation of Nanjing Forestry University for Introduction of High Level Talents [YJ2012-03]; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions; Natural Science Foundation of Jiangsu Province [BK20151514]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation of Nanjing Forestry University for Introduction of High Level Talents; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	The financial support by the National Natural Science Foundation of China (No. 31100081) and Scientific Research Foundation of Nanjing Forestry University for Introduction of High Level Talents (YJ2012-03) is gratefully acknowledged, as well as the financial support given by the Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions. This study was further supported by the Natural Science Foundation of Jiangsu Province (No. BK20151514).	Adamson DN, 2013, P NATL ACAD SCI USA, V110, P13120, DOI 10.1073/pnas.1308476110; Albrecht M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r98; Arnvig KB, 2009, MOL MICROBIOL, V73, P397, DOI 10.1111/j.1365-2958.2009.06777.x; Axmann IM, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r73; Badri DV, 2009, PLANT CELL ENVIRON, V32, P666, DOI [10.1111/j.1365-3040.2009.01926.x, 10.1111/j.1365-3040.2008.01926.x]; Barrick JE, 2004, P NATL ACAD SCI USA, V101, P6421, DOI 10.1073/pnas.0308014101; Beisel CL, 2011, MOL CELL, V41, P286, DOI 10.1016/j.molcel.2010.12.027; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bohn C, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-10; Bonner ER, 2001, NUCLEIC ACIDS RES, V29, P4851, DOI 10.1093/nar/29.23.4851; Boysen A, 2010, J BIOL CHEM, V285, P10690, DOI 10.1074/jbc.M109.089755; Brantl S, 2014, RNA BIOL, V11, P443, DOI 10.4161/rna.28036; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Chao YJ, 2012, EMBO J, V31, P4005, DOI 10.1038/emboj.2012.229; Chen XH, 2009, J BIOTECHNOL, V140, P38, DOI 10.1016/j.jbiotec.2008.10.015; Chen XH, 2007, NAT BIOTECHNOL, V25, P1007, DOI 10.1038/nbt1325; Christiansen JK, 2004, J BACTERIOL, V186, P3355, DOI 10.1128/JB.186.11.3355-3362.2004; Cortes T, 2013, CELL REP, V5, P1121, DOI 10.1016/j.celrep.2013.10.031; Dambach M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055156; Dugar G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003495; Durand S, 2010, MOL MICROBIOL, V75, P1215, DOI 10.1111/j.1365-2958.2010.07044.x; Edwards AN, 2011, MOL MICROBIOL, V80, P1561, DOI 10.1111/j.1365-2958.2011.07663.x; Eijlander RT, 2014, NUCLEIC ACIDS RES, V42, pD685, DOI 10.1093/nar/gkt1007; Fan B, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-116; Fan B, 2011, J BIOTECHNOL, V151, P303, DOI 10.1016/j.jbiotec.2010.12.022; Forstner KU, 2014, BIOINFORMATICS, V30, P3421, DOI 10.1093/bioinformatics/btu533; Georg J, 2011, MICROBIOL MOL BIOL R, V75, P286, DOI 10.1128/MMBR.00032-10; Gimpel M, 2010, MOL MICROBIOL, V76, P990, DOI 10.1111/j.1365-2958.2010.07158.x; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Hammerle H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098661; Heidrich N, 2007, NUCLEIC ACIDS RES, V35, P4331, DOI 10.1093/nar/gkm439; Heidrich N, 2006, MOL MICROBIOL, V62, P520, DOI 10.1111/j.1365-2958.2006.05384.x; Hilbert DW, 2004, MICROBIOL MOL BIOL R, V68, P234, DOI 10.1128/MMBR.68.2.234-262.2004; Idris EE, 2007, MOL PLANT MICROBE IN, V20, P619, DOI 10.1094/MPMI-20-6-0619; Irnov I, 2010, NUCLEIC ACIDS RES, V38, P6637, DOI 10.1093/nar/gkq454; Kalyon B, 2011, ORG LETT, V13, P2996, DOI 10.1021/ol200809m; Kim D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002867; Koumoutsi A, 2004, J BACTERIOL, V186, P1084, DOI 10.1128/JB.186.4.1084-1096.2004; Koumoutsi A, 2007, APPL ENVIRON MICROB, V73, P6953, DOI 10.1128/AEM.00565-07; KOZAK M, 1983, MICROBIOL REV, V47, P1; Kroger C, 2013, CELL HOST MICROBE, V14, P683, DOI 10.1016/j.chom.2013.11.010; Kroger C, 2012, P NATL ACAD SCI USA, V109, pE1277, DOI 10.1073/pnas.1201061109; Kuwana R, 2003, MICROBIOL-SGM, V149, P3011, DOI 10.1099/mic.0.26432-0; Landt SG, 2008, MOL MICROBIOL, V68, P600, DOI 10.1111/j.1365-2958.2008.06172.x; Li L, 2013, NUCLEIC ACIDS RES, V41, pD233, DOI 10.1093/nar/gks1264; Loh E, 2009, CELL, V139, P770, DOI 10.1016/j.cell.2009.08.046; Luo WJ, 2013, BIOINFORMATICS, V29, P1830, DOI 10.1093/bioinformatics/btt285; Mao FL, 2009, NUCLEIC ACIDS RES, V37, pD459, DOI 10.1093/nar/gkn757; MARGOLIS PS, 1993, J BACTERIOL, V175, P528, DOI 10.1128/JB.175.2.528-540.1993; Mariappan A, 2012, J MOL MICROB BIOTECH, V22, P114, DOI 10.1159/000338804; Mars RAT, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005046; Mika F, 2014, RNA BIOL, V11, P494, DOI 10.4161/rna.28867; Moszer I, 2002, NUCLEIC ACIDS RES, V30, P62, DOI 10.1093/nar/30.1.62; NELSON DL, 1970, J BIOL CHEM, V245, P1128; Nicol JW, 2009, BIOINFORMATICS, V25, P2730, DOI 10.1093/bioinformatics/btp472; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; Perez N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007668; Preis H, 2009, J BACTERIOL, V191, P5446, DOI 10.1128/JB.00602-09; Raghavan R, 2011, GENOME RES, V21, P1487, DOI 10.1101/gr.119370.110; Rasmussen S, 2009, MOL MICROBIOL, V73, P1043, DOI 10.1111/j.1365-2958.2009.06830.x; Romeo T, 2013, ENVIRON MICROBIOL, V15, P313, DOI 10.1111/j.1462-2920.2012.02794.x; Rudner DZ, 2001, DEV CELL, V1, P733, DOI 10.1016/S1534-5807(01)00094-6; RYTER A, 1965, ANN I PASTEUR PARIS, V108, P40; Saito S, 2009, GENE, V428, P2, DOI 10.1016/j.gene.2008.09.024; Schmidtke C, 2012, NUCLEIC ACIDS RES, V40, P2020, DOI 10.1093/nar/gkr904; Schneider K, 2007, J NAT PROD, V70, P1417, DOI 10.1021/np070070k; Scholz R, 2014, J BACTERIOL, V196, P1842, DOI 10.1128/JB.01474-14; Scholz R, 2011, J BACTERIOL, V193, P215, DOI 10.1128/JB.00784-10; Sesto N, 2013, NAT REV MICROBIOL, V11, P75, DOI 10.1038/nrmicro2934; Shao Y, 2012, MOL MICROBIOL, V83, P599, DOI 10.1111/j.1365-2958.2011.07959.x; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Sierro N, 2008, NUCLEIC ACIDS RES, V36, pD93, DOI 10.1093/nar/gkm910; Silvaggi JM, 2006, J BACTERIOL, V188, P532, DOI 10.1128/JB.188.2.532-541.2006; Silvaggi JM, 2005, J BACTERIOL, V187, P6641, DOI 10.1128/JB.187.19.6641-6650.2005; Somers E, 2004, CRIT REV MICROBIOL, V30, P205, DOI 10.1080/10408410490468786; Sonnleitner E, 2011, MOL MICROBIOL, V80, P868, DOI 10.1111/j.1365-2958.2011.07620.x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Swiercz JP, 2008, NUCLEIC ACIDS RES, V36, P7240, DOI 10.1093/nar/gkn898; TAYLOR CB, 1951, NATURE, V168, P115, DOI 10.1038/168115a0; Thomason MK, 2015, J BACTERIOL, V197, P18, DOI 10.1128/JB.02096-14; Thomason MK, 2012, MOL MICROBIOL, V84, P17, DOI 10.1111/j.1365-2958.2012.07965.x; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; Turner BL, 2002, PHILOS T ROY SOC B, V357, P449, DOI 10.1098/rstb.2001.0837; Vakulskas CA, 2015, MICROBIOL MOL BIOL R, V79, P193, DOI 10.1128/MMBR.00052-14; Vogel J, 2011, NAT REV MICROBIOL, V9, P578, DOI 10.1038/nrmicro2615; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Weinberg Z, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r31; Wiegand S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-667; Winkler WC, 2005, ANNU REV MICROBIOL, V59, P487, DOI 10.1146/annurev.micro.59.030804.121336; Wurtzel O, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.11; Zhao X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117414	91	19	24	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142002	10.1371/journal.pone.0142002	http://dx.doi.org/10.1371/journal.pone.0142002			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540162	Green Submitted, gold, Green Published			2022-12-26	WOS:000364303800043
J	Lee, SH; Lee, JH; Ahn, SE; Park, MJ; Lee, DH				Lee, Soon-Hyuck; Lee, Jin-Hyuck; Ahn, Sung-Eun; Park, Min-Ji; Lee, Dae-Hee			Correlation between Quadriceps Endurance and Adduction Moment in Medial Knee Osteoarthritis	PLOS ONE			English	Article							CRUCIATE LIGAMENT RECONSTRUCTION; MUSCLE STRENGTH; FUNCTIONAL-CAPACITY; TIBIOFEMORAL JOINT; GRAVITY CORRECTION; STATIC ALIGNMENT; WALKING SPEED; DYNAMIC LOAD; GAIT; HIP	It is not clear whether the strength or endurance of thigh muscles (quadriceps and hamstring) is positively or negatively correlated with the adduction moment of osteoarthritic knees. This study therefore assessed the relationships between the strength and endurance of the quadriceps and hamstring muscles and adduction moment in osteoarthritic knees and evaluated predictors of the adduction moment. The study cohort comprised 35 patients with unilateral medial osteoarthritis and varus deformity who were candidates for open wedge osteotomy. The maximal torque (60 degrees/sec) and total work (180 degrees/sec) of the quadriceps and hamstring muscles and knee adduction moment were evaluated using an isokinetic testing device and gait analysis system. The total work of the quadriceps (r = 0.429, P = 0.037) and hamstring (r = 0.426, P = 0.045) muscles at 180 degrees/sec each correlated with knee adduction moment. Preoperative varus deformity was positively correlated with adduction moment (r = 0.421, P = 0.041). Multiple linear regression analysis showed that quadriceps endurance at 180 degrees/sec was the only factor independently associated with adduction moment (beta = 0.790, P = 0.032). The adduction moment of osteoarthritic knees correlated with the endurance, but not the strength, of the quadriceps muscle. However, knee adduction moment did not correlate with the strength or endurance of the hamstring muscle.	[Lee, Soon-Hyuck] Korea Univ, Coll Med, Anam Hosp, Dept Orthopaed Surg, Seoul 136705, South Korea; [Lee, Jin-Hyuck; Ahn, Sung-Eun; Park, Min-Ji] Korea Univ, Coll Med, Anam Hosp, Dept Sports Med Ctr, Seoul 136705, South Korea; [Lee, Dae-Hee] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Orthopaed Surg, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Sungkyunkwan University (SKKU); Samsung Medical Center	Lee, DH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Orthopaed Surg, Seoul, South Korea.	eoak22@empal.com	lee, dae hee/I-9390-2017					AAGAARD P, 1995, ACTA PHYSIOL SCAND, V154, P421, DOI 10.1111/j.1748-1716.1995.tb09927.x; Aagaard P, 1998, AM J SPORT MED, V26, P231, DOI 10.1177/03635465980260021201; Anderson DE, 2010, J BIOMECH, V43, P1220, DOI 10.1016/j.jbiomech.2009.11.036; Andriacchi TP, 2006, CURR OPIN RHEUMATOL, V18, P514, DOI 10.1097/01.bor.0000240365.16842.4e; ANDRIACCHI TP, 1977, J BIOMECH, V10, P261, DOI 10.1016/0021-9290(77)90049-5; Baliunas AJ, 2002, OSTEOARTHR CARTILAGE, V10, P573, DOI 10.1053/joca.2002.0797; Calder KM, 2014, ARTHRIT CARE RES, V66, P687, DOI 10.1002/acr.22223; Chang A, 2005, ARTHRITIS RHEUM-US, V52, P3515, DOI 10.1002/art.21406; Chang AH, 2015, OSTEOARTHR CARTILAGE, V23, P1099, DOI 10.1016/j.joca.2015.02.005; CHATTERJEE S, 1991, REGRESSION ANAL EXAM, P191; Cho Y, 2015, J PHYS THER SCI, V27, P265, DOI 10.1589/jpts.27.265; Eitzen I, 2010, J ORTHOP SPORT PHYS, V40, P705, DOI 10.2519/jospt.2010.3345; Engel K, 2015, KNEE, V22, P68, DOI 10.1016/j.knee.2014.12.003; Gur H, 2003, ARCH PHYS MED REHAB, V84, P1534, DOI 10.1016/S0003-9993(03)00288-0; Gur H, 2002, ARCH PHYS MED REHAB, V83, P308, DOI 10.1053/apmr.2002.30620; Ha Jeong Ku, 2012, Knee Surg Relat Res, V24, P151, DOI 10.5792/ksrr.2012.24.3.151; Hall M, 2014, CLIN ORTHOP RELAT R, V472, P3114, DOI 10.1007/s11999-014-3737-0; Hunt MA, 2010, KNEE, V17, P296, DOI 10.1016/j.knee.2010.02.010; Hurwitz DE, 2002, J ORTHOPAED RES, V20, P101, DOI 10.1016/S0736-0266(01)00081-X; Hurwitz DE, 2000, J ORTHOPAED RES, V18, P572, DOI 10.1002/jor.1100180409; KADABA MP, 1990, J ORTHOP RES, V8, P383, DOI 10.1002/jor.1100080310; Kean CO, 2015, CLIN BIOMECH, V30, P226, DOI 10.1016/j.clinbiomech.2015.01.008; Keating JL, 1996, J ORTHOP SPORT PHYS, V24, P142, DOI 10.2519/jospt.1996.24.3.142; Lee Dae-Hee, 2015, Knee Surg Relat Res, V27, P101, DOI 10.5792/ksrr.2015.27.2.101; Lee TQ, 2014, CLIN ORTHOP SURG, V6, P117, DOI 10.4055/cios.2014.6.2.117; Lim BW, 2008, ARTHRIT RHEUM-ARTHR, V59, P935, DOI 10.1002/art.23820; Lim BW, 2009, ARTHRIT RHEUM-ARTHR, V61, P451, DOI 10.1002/art.24278; Lloyd DG, 2001, J BIOMECH, V34, P1257, DOI 10.1016/S0021-9290(01)00095-1; Miyazaki T, 2002, ANN RHEUM DIS, V61, P617, DOI 10.1136/ard.61.7.617; Mundermann A, 2004, ARTHRITIS RHEUM-US, V50, P1172, DOI 10.1002/art.20132; O'Reilly SC, 1998, ANN RHEUM DIS, V57, P588, DOI 10.1136/ard.57.10.588; Reider B, 2003, ARTHROSCOPY, V19, P2, DOI 10.1053/jars.2003.50006; SCHIPPLEIN OD, 1991, J ORTHOPAED RES, V9, P113, DOI 10.1002/jor.1100090114; Segawa H, 2002, ARTHROSCOPY, V18, P177, DOI 10.1053/jars.2002.29894; Sharma L, 1998, AGE, V4, P13; Shelburne KB, 2006, J ORTHOP RES, V24, P1983, DOI 10.1002/jor.20255; Tsepis E, 2004, KNEE SURG SPORT TR A, V12, P22, DOI 10.1007/s00167-003-0377-4; van der Esch M, 2014, ARCH PHYS MED REHAB, V95, P1962, DOI 10.1016/j.apmr.2014.06.007; Wada M, 2001, RHEUMATOLOGY, V40, P499, DOI 10.1093/rheumatology/40.5.499; Walter JP, 2015, J ORTHOP RES; WANG JW, 1990, J BONE JOINT SURG AM, V72A, P905, DOI 10.2106/00004623-199072060-00017; Willen C, 2004, ARCH PHYS MED REHAB, V85, P1923, DOI 10.1016/j.apmr.2003.11.040; Winter D., 2009, BIOMECHANICS MOTOR C, V4th; Yaari L, 2015, CLIN ORTHOP SURG, V7, P191, DOI 10.4055/cios.2015.7.2.191; Yamada H, 2001, CLIN ORTHOP RELAT R, P179	45	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141972	10.1371/journal.pone.0141972	http://dx.doi.org/10.1371/journal.pone.0141972			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26539830	gold, Green Published, Green Submitted			2022-12-26	WOS:000364303800040
J	Moy, FM; Hoe, VCW; Hairi, NN; Chu, AHY; Bulgiba, A; Koh, D				Moy, Foong Ming; Hoe, Victor Chee Wai; Hairi, Noran Naqiah; Chu, Anne Hin Yee; Bulgiba, Awang; Koh, David			Determinants and Effects of Voice Disorders among Secondary School Teachers in Peninsular Malaysia Using a Validated Malay Version of VHI-10	PLOS ONE			English	Article							OCCUPATIONAL RISK-FACTORS; HANDICAP INDEX-10 VHI-10; QUALITY-OF-LIFE; HEALTH SURVEY; PREVALENCE; AMPLIFICATION; ADAPTATION; DYSPHONIA; TESTS; RATIO	Objectives To establish the prevalence of voice disorder using the Malay-Voice Handicap Index 10 (Malay-VHI-10) and to study the determinants, quality of life, depression, anxiety and stress associated with voice disorder among secondary school teachers in Peninsular Malaysia. Methods This study was divided into two phases. Phase I tested the reliability of the Malay-VHI-10 while Phase II was a cross-sectional study with two-stage sampling. In Phase II, a self-administered questionnaire was used to collect socio-demographic and teaching characteristics, depression, anxiety and stress scale (Malay version of DASS-21); and health-related quality of life (Malay version of SF12-v2). Complex sample analysis was conducted using multivariate Poisson regression with robust variance. Results In Phase I, the Spearman correlation coefficient and Cronbach alpha for total VHI-10 score was 0.72 (p < 0.001) and 0.77 respectively; showing good correlation and internal consistency. The ICCs ranged from 0.65 to 0.78 showing fair to good reliability and demonstrating the subscales to be reliable and stable. A total of 6039 teachers participated in Phase II. They were primarily Malays, females, married, had completed tertiary education and aged between 30 to 50 years. A total of 10.4%(95% CI 7.1, 14.9) of the teachers had voice disorder (VHI-10 score > 11). Compared to Malays, a greater proportion of ethnic Chinese teachers reported voice disorder while ethnic Indian teachers were less likely to report this problem. There was a higher prevalence ratio (PR) of voice disorder among single or divorced/widowed teachers. Teachers with voice disorder were more likely to report higher rates of absenteeism (PR: 1.70, 95% CI 1.33, 2.19), lower quality of life with lower SF12-v2 physical (0.98, 95% CI 0.96, 0.99) and mental (0.97, 95% CI 0.96, 0.98) component summary scales; and higher anxiety levels (1.04, 95% CI 1.02, 1.06). Conclusions The Malay-VHI-10 is valid and reliable. Voice disorder was associated with increased absenteeism, marginally associated with reduced health-related quality of life as well as increased anxiety among teachers.	[Moy, Foong Ming; Hairi, Noran Naqiah; Chu, Anne Hin Yee; Bulgiba, Awang] Univ Malaya, Fac Med, Dept Social & Prevent Med, Julius Ctr, Kuala Lumpur, Malaysia; [Hoe, Victor Chee Wai] Univ Malaya, Fac Med, Ctr Occupat & Environm Hlth UM, Dept Social & Prevent Med, Kuala Lumpur, Malaysia; [Koh, David] Univ Brunei Darussalam, PAPRSB Inst Hlth Sci, Brunei, Brunei Darussal, Brunei; [Chu, Anne Hin Yee; Koh, David] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore	Universiti Malaya; Universiti Malaya; University Brunei Darussalam; National University of Singapore	Moy, FM (corresponding author), Univ Malaya, Fac Med, Dept Social & Prevent Med, Julius Ctr, Kuala Lumpur, Malaysia.	moyfm@ummc.edu.my	HAIRI, NORAN/B-9339-2010; Hoe, VICTOR CW/B-5190-2010; Moy, Foong Ming/B-7899-2010; Bulgiba, Awang/B-8271-2010	HAIRI, NORAN/0000-0002-2692-9016; Hoe, VICTOR CW/0000-0002-8073-157X; Moy, Foong Ming/0000-0002-0306-4419; Koh, David/0000-0001-6803-7879; Bulgiba, Awang/0000-0002-5313-0445	Ministry of Education High Impact Research Grant [H-20001-00-E2000069]	Ministry of Education High Impact Research Grant	This study is funded by the Ministry of Education High Impact Research Grant (H-20001-00-E2000069). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir O, 2006, OTOLARYNG HEAD NECK, V135, P603, DOI 10.1016/j.otohns.2006.06.1252; Angelillo M, 2009, J Prev Med Hyg, V50, P26; Arffa RE, 2012, J VOICE, V26, P462, DOI 10.1016/j.jvoice.2011.04.006; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Bassi IB, 2011, J VOICE, V25, P192, DOI 10.1016/j.jvoice.2009.10.013; Behlau M, 2012, J VOICE, V26, DOI 10.1016/j.jvoice.2011.09.010; Behrens T, 2004, METHOD INFORM MED, V43, P505; Charn TC, 2012, J VOICE, V26, pE141, DOI 10.1016/j.jvoice.2011.05.004; Chen SH, 2010, J VOICE, V24, P183, DOI 10.1016/j.jvoice.2008.07.008; Costa T, 2013, CODAS, V25, P482, DOI 10.1590/S2317-17822013000500013; Cutiva LCC, 2013, J COMMUN DISORD, V46, P143, DOI 10.1016/j.jcomdis.2013.01.001; Gandek B, 1998, J CLIN EPIDEMIOL, V51, P1171, DOI 10.1016/S0895-4356(98)00109-7; Hogikyan ND, 2002, OTOLARYNG HEAD NECK, V126, P562, DOI 10.1067/mhn.2002.124850; Hsiung MW, 2002, EUR ARCH OTO-RHINO-L, V259, P97, DOI 10.1007/s004050100405; Kooijman PGC, 2006, FOLIA PHONIATR LOGO, V58, P159, DOI 10.1159/000091730; Lam PKY, 2006, LARYNGOSCOPE, V116, P1192, DOI 10.1097/01.mlg.0000224539.41003.93; Larsen JB, 2008, LANG SPEECH HEAR SER, V39, P451, DOI 10.1044/0161-1461(2008/07-0032); Martins RH, 2014, J VOICE; Mattiske JA, 1998, J VOICE, V12, P489, DOI 10.1016/S0892-1997(98)80058-1; Ministry of Education, 2010, MAL ED STAT 2010; Moy FM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-611; Musa R, 2007, ASEAN J PSYCHIATR, V8, P82; Nunez-Batalla F, 2007, ACTA OTORRINOLAR ESP, V58, P386, DOI 10.1016/S0001-6519(07)74954-3; Romak JJ, 2014, J VOICE, V28, P237, DOI 10.1016/j.jvoice.2013.07.015; Rosen CA, 2004, LARYNGOSCOPE, V114, P1549, DOI 10.1097/00005537-200409000-00009; Roy N, 2004, J SPEECH LANG HEAR R, V47, P281, DOI 10.1044/1092-4388(2004/023); Roy N, 2002, J SPEECH LANG HEAR R, V45, DOI 10.1044/1092-4388(2002/050); Roy N, 2003, J SPEECH LANG HEAR R, V46, P670, DOI 10.1044/1092-4388(2003/053); Sampaio MC, 2012, J VOICE, V26, DOI 10.1016/j.jvoice.2012.06.003; Shoeib RM, 2012, EGYPT J OTOLARYNGOL, V28, P142, DOI 10.7123/01.EJO.0000413577.72909.80; Sliwinska-Kowalska M, 2006, FOLIA PHONIATR LOGO, V58, P85, DOI 10.1159/000089610; Streiner DL, 2015, HLTH MEASUREMENT SCA, DOI [10.1891/1521-0987.17.3.150, DOI 10.1891/1521-0987.17.3.150]; Tavares ELM, 2007, J VOICE, V21, P407, DOI 10.1016/j.jvoice.2006.04.001; Thibeault SL, 2004, ANN EPIDEMIOL, V14, P786, DOI 10.1016/j.annepidem.2004.03.004; Titze IR, 1997, J VOICE, V11, P254, DOI 10.1016/S0892-1997(97)80002-1; van Houtte E, 2012, LOGOP PHONIATR VOCO, V37, P107, DOI 10.3109/14015439.2012.660499; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Williams NR, 2003, OCCUP MED-OXFORD, V53, P456, DOI 10.1093/occmed/kqg113	38	17	19	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141963	10.1371/journal.pone.0141963	http://dx.doi.org/10.1371/journal.pone.0141963			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV5IS	26540291	gold, Green Submitted, Green Published			2022-12-26	WOS:000364303800037
J	van der Slik, FWP; van Hout, RWNM; Schepens, JJ				van der Slik, Frans W. P.; van Hout, Roeland W. N. M.; Schepens, Job J.			The Gender Gap in Second Language Acquisition: Gender Differences in the Acquisition of Dutch among Immigrants from 88 Countries with 49 Mother Tongues	PLOS ONE			English	Article							MALE-FEMALE DIFFERENCES; SEX-DIFFERENCES; LANGUAGE; COMPREHENSION; PROFICIENCY; SCIENCE; ACCULTURATION; METAANALYSIS; STRATEGIES; VOCABULARY	Gender differences were analyzed across countries of origin and continents, and across mother tongues and language families, using a large-scale database, containing information on 27,119 adult learners of Dutch as a second language. Female learners consistently outperformed male learners in speaking and writing proficiency in Dutch as a second language. This gender gap remained remarkably robust and constant when other learner characteristics were taken into account, such as education, age of arrival, length of residence and hours studying Dutch. For reading and listening skills in Dutch, no gender gap was found. In addition, we found a general gender by education effect for all four language skills in Dutch for speaking, writing, reading, and listening. Female language learners turned out to profit more from higher educational training than male learners do in adult second language acquisition. These findings do not seem to match nurture-oriented explanatory frameworks based for instance on a human capital approach or gender-specific acculturation processes. Rather, they seem to corroborate a nature-based, gene-environment correlational framework in which language proficiency being a genetically-influenced ability interacting with environmental factors such as motivation, orientation, education, and learner strategies that still mediate between endowment and acquiring language proficiency at an adult stage.	[van der Slik, Frans W. P.; van Hout, Roeland W. N. M.] Radboud Univ Nijmegen, Dept Linguist, NL-6525 ED Nijmegen, Netherlands; [Schepens, Job J.] Max Planck Inst Human Dev, Berlin, Germany	Radboud University Nijmegen; Max Planck Society	van der Slik, FWP (corresponding author), Radboud Univ Nijmegen, Dept Linguist, NL-6525 ED Nijmegen, Netherlands.	f.v.d.slik@let.ru.nl	Schepens, Job/HHS-5741-2022; Schepens, Job/AAB-8753-2019	Schepens, Job/0000-0003-1271-2526				Ambridge B, 2010, DEV PSYCHOL, V46, P1497, DOI 10.1037/a0020668; [Anonymous], 1996, ARE GIRLS BETTER REA; BACON SM, 1992, MOD LANG J, V76, P160, DOI 10.2307/329769; BACON SMC, 1992, LANG LEARN, V42, P471, DOI 10.1111/j.1467-1770.1992.tb01041.x; Beiser M, 2000, CAN PUBLIC POL, V26, P311, DOI 10.2307/3552403; BOYLE JP, 1987, LANG LEARN, V37, P273, DOI 10.1111/j.1467-1770.1987.tb00568.x; Buchmann C, 2006, AM SOCIOL REV, V71, P515, DOI 10.1177/000312240607100401; BURSTALL C, 1975, EDUC RES, V17, P193, DOI 10.1080/0013188750170304; Carliner G, 2000, INT MIGR REV, V34, P158, DOI 10.2307/2676016; Cohen A.D., 2002, INTRO APPL LINGUISTI, P170; Cole NS, 1997, TS GENDER STUDY FEMA; Council of Europe, 2001, COMM EUR FRAM REF LA; Davies B., 2004, LANGUAGE LEARNING J, V29, P53, DOI DOI 10.1080/09571730485200111; de Bot K., 2005, 2 LANGUAGE ACQUISITI; de Bot K, 2007, BILING-LANG COGN, V10, P7, DOI 10.1017/S1366728906002732; Dediu D, 2001, HUM BIOL, V83, P279; Dornyei Z., 2001, MOTIVATION 2 LANGUAG, V23, P399; Dryer Matthew S., 2013, WORLD ATLAS LANGUAGE; Duff P.A., 2013, ROUTLEDGE HDB 2 LANG, P428; Ellis R., 1994, STUDY 2 LANGUAGE ACQ; Estabrooke IV, 2002, BRAIN LANG, V83, P143; FARHADY H, 1982, TESOL QUART, V16, P43, DOI 10.2307/3586562; Finnie R, 2005, APPL ECON, V37, P1935, DOI 10.1080/00036840500244519; GAL S, 1978, LANG SOC, V7, P1, DOI 10.1017/S0047404500005303; Gal S, 1979, LANGUAGE SHIFT DETER; Gardner R.C., 1972, ATTITUDES MOTIVATION; Gardner RC, 1979, LANGUAGE SOCIAL PSYC, P287; Gobel P., 2006, SYSTEM, V34, P194, DOI DOI 10.1016/J.SYSTEM.2005.11.002; GOLDBERG P, 1968, TRANS-ACT-SOC SCI MO, V5, P28; Goldstein H., 2011, MULTILEVEL STAT MODE, V4th; GREEN JM, 1995, TESOL QUART, V29, P261, DOI 10.2307/3587625; Gu Yongqi, 2002, RELC J, V33, P35, DOI DOI 10.1177/003368820203300102; Halpern D. F., 2002, SEX DIFFERENCES COGN; Heck RH, 2010, QUANT METH SER, P1; Herschensohn J., 2013, CAMBRIDGE HDB 2 LANG; HUTTENLOCHER J, 1991, DEV PSYCHOL, V27, P236, DOI 10.1037/0012-1649.27.2.236; HYDE JS, 1988, PSYCHOL BULL, V104, P53, DOI 10.1037/0033-2909.104.1.53; Jiang M, 2009, J MULTILING MULTICUL, V30, P481, DOI 10.1080/01434630903147898; Kidd E, 2008, DEVELOPMENTAL SCI, V11, P882, DOI 10.1111/j.1467-7687.2008.00744.x; Kimura Doreen, 1999, SEX COGNITION; Krashen S. D., 1982, PRINCIPLES PRACTICE; Kreft I. G., 1998, INTRO MULTILEVEL MOD, DOI DOI 10.4135/9781849209366; Kuijper H, 2004, STAATSEXAMEN NT2 GEW; LarsenFreeman D, 1997, APPL LINGUIST, V18, P141, DOI 10.1093/applin/18.2.141; Lietz P., 2006, STUDIES ED EVALUATIO, V32, P317, DOI DOI 10.1016/J.STUEDUC.2006.10.002; LUMSDEN KG, 1987, J ECON EDUC, V18, P365, DOI 10.2307/1182118; Lupyan G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008559; Maccoby E.E., 1978, PSYCHOL SEX DIFFEREN, V2; Masgoret AM, 2003, LANG LEARN, V53, P167, DOI 10.1111/1467-9922.00227; MERTON RK, 1968, SCIENCE, V159, P56, DOI 10.1126/science.159.3810.56; Moss-Racusin CA, 2012, P NATL ACAD SCI USA, V109, P16474, DOI 10.1073/pnas.1211286109; Narusyte J, 2008, DEV PSYCHOL, V44, P1591, DOI 10.1037/a0013911; Oxford Rebecca, 1990, LANGUAGE LEARNING ST; Pae T-l, 2004, SYSTEM, V32, P265, DOI [10.1016/j.system.2003.09.009, DOI 10.1016/J.SYSTEM.2003.09.009]; PLOMIN R, 1977, PSYCHOL BULL, V84, P309, DOI 10.1037/0033-2909.84.2.309; Polat N, 2010, J LANG IDENTITY EDUC, V9, P17, DOI 10.1080/15348450903476832; RAMER ALH, 1976, J CHILD LANG, V3, P49, DOI 10.1017/S0305000900001306; Rosen M, 2001, READ WRIT, V14, P1, DOI 10.1023/A:1007995107442; Rua P.L., 2006, PORTA LINGUARUM, V6, P99, DOI DOI 10.1353/PLA.2006.0014; RUBIN J, 1994, MOD LANG J, V78, P199, DOI 10.2307/329010; Saville-Troike M., 2005, INTRO 2 LANGUAGE ACQ; Schepens JJ, LANGUAGE LE IN PRESS; Schepens J, 2013, LANG DYN CHANG, V3, P218, DOI 10.1163/22105832-13030203; Schumann J., 1978, 2 LANGUAGE ACQUISITI, P27; Spezzini S., 2004, INT J BILING EDUC BI, V7, P412, DOI [DOI 10.1080/13670050408667823, 10.1080/13670050408667823]; Stevens G, 1999, LANG SOC, V28, P555; Stromswold K, 2001, LANGUAGE, V77, P647, DOI 10.1353/lan.2001.0247; THOMPSON I, 1991, LANG LEARN, V41, P177, DOI 10.1111/j.1467-1770.1991.tb00683.x; Ullman M, 2005, MIND CONTEXT ADULT 2, P141; Ullman MT, 2002, BRAIN LANG, V83, P141; Van der Silk FWP, 2010, STUD SECOND LANG ACQ, V32, P401, DOI 10.1017/S0272263110000021; Verhelst N. D., 1995, ONE PARAMETER LOGIST; Vinkhuyzen AAE, 2010, GENES BRAIN BEHAV, V9, P276, DOI 10.1111/j.1601-183X.2009.00554.x; Walstad WB, 1997, J ECON EDUC, V28, P155, DOI 10.2307/1182910; Willingham W. W., 1997, GENDER FAIR ASSESSME; World Economic Forum, 2014, GLOBAL GENDER GAP RE; Young D., 1997, APPL LANGUAGE LEARNI, V8, P43	77	51	52	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142056	10.1371/journal.pone.0142056	http://dx.doi.org/10.1371/journal.pone.0142056			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV5IS	26540465	Green Submitted, Green Published, gold			2022-12-26	WOS:000364303800048
J	Binka, M; Paintsil, E; Patel, A; Lindenbach, BD; Heimer, R				Binka, Mawuena; Paintsil, Elijah; Patel, Amisha; Lindenbach, Brett D.; Heimer, Robert			Survival of Hepatitis C Virus in Syringes Is Dependent on the Design of the Syringe-Needle and Dead Space Volume	PLOS ONE			English	Article							INJECTION EQUIPMENT; HCV INFECTION; RISK; HIV; TRANSMISSION; EPIDEMIOLOGY; PEOPLE; DRUGS	Background Many people who inject drugs (PWID) use syringes with detachable needles, which have high dead space (HDS). Contaminated HDS blood may substantially contribute to the transmission of HIV, hepatitis C (HCV), and other blood-borne viruses within this population. Newly designed low dead space (LDS) syringe-needle combinations seek to reduce blood-borne virus transmission among PWID. We evaluated the infectivity of HCV-contaminated residual volumes recovered from two LDS syringe-needle combinations. Methods We tested two different design approaches to reducing the dead space. One added a piston to the plunger; the other reduced the dead space within the needle. The two approaches cannot be combined. Recovery of genotype-2a reporter HCV from LDS syringe-needle combinations was compared to recovery from insulin syringes with fixed needles and standard HDS syringe-needle combinations. Recovery of HCV from syringes was determined immediately following their contamination with HCV-spiked plasma, after storage at 22 degrees C for up to 1 week, or after rinsing with water. Results Insulin syringes with fixed needles had the lowest proportion of HCV-positive syringes before and after storage. HCV recovery after immediate use ranged from 47%+/- 4% HCV-positive 1 mL insulin syringes with 27-gauge 1/2 inch needles to 98%+/- 1% HCV-positive HDS 2 mL syringes with 23-gauge 11/4 inch detachable needles. LDS combinations yielded recoveries ranging from 65%+/- 5% to 93%+/- 3%. Recovery was lower in combinations containing LDS needles than LDS syringes. After 3 days of storage, as much as 6-fold differences in virus recovery was observed, with HCV recovery being lower in combinations containing LDS needles. Most combinations with detachable needles required multiple rinses to reduce HCV infectivity to undetectable levels whereas a single rinse of insulin syringes was sufficient. Conclusions Our study, the first to assess the infectivity of HCV in residual volumes of LDS syringes and needles available to PWID, demonstrates that LDS syringe-needle combination still has the greater potential for HCV transmission than insulin syringes with fixed needles. Improved LDS designs may be able to further reduce HCV recovery, but based on the designed tested, LDS needles and syringes remain intermediate between fixed-needle syringes and HDS combinations in reducing exposure to HCV.	[Binka, Mawuena; Paintsil, Elijah; Patel, Amisha; Heimer, Robert] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA; [Paintsil, Elijah] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [Paintsil, Elijah] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Lindenbach, Brett D.] Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT USA; [Paintsil, Elijah; Heimer, Robert] Yale Univ, Ctr Interdisciplinary Res AIDS, New Haven, CT USA	Yale University; Yale University; Yale University; Yale University; Yale University	Heimer, R (corresponding author), Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA.	robert.heimer@yale.edu		Binka, Mawuena/0000-0002-9370-1708	US National Institute on Drug Abuse [1R01DA030420]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030420] Funding Source: NIH RePORTER	US National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding: This work was funded by the US National Institute on Drug Abuse 1R01DA030420 to RH, Grant Title: Parenteral HCV Transmission: Assessing Risks and Prevention Strategies in vitro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, HEP C HDB DORCHESTER; Binka M, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv017; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Ciesek S, 2010, J INFECT DIS, V201, P1859, DOI 10.1086/652803; De P, 2008, J VIRAL HEPATITIS, V15, P279, DOI 10.1111/j.1365-2893.2007.00942.x; Doerrbecker J, 2013, J VIRAL HEPATITIS, V20, P478, DOI 10.1111/jvh.12055; Ellendon N., HEPATITIS C COUNSELI; Gray R, 2012, RAPID ASSESSMENT NEE; Hagan LM, 2013, LIVER INT, V33, P68, DOI 10.1111/liv.12063; Ibragimov U, 2012, NEEDLE SYRINGE TYPES; Lindenbach BD, 2006, P NATL ACAD SCI USA, V103, P3805, DOI 10.1073/pnas.0511218103; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; MacArthur GJ, 2014, INT J DRUG POLICY, V25, P34, DOI 10.1016/j.drugpo.2013.07.001; Murray CL, 2011, ANNU REV MICROBIOL, V65, P307, DOI 10.1146/annurev-micro-090110-102954; Paintsil E, 2014, J INFECT DIS, V209, P1205, DOI 10.1093/infdis/jit648; Paintsil E, 2010, J INFECT DIS, V202, P984, DOI 10.1086/656212; Paintsil E, 2009, ADDICTION, V104, P1881, DOI 10.1111/j.1360-0443.2009.02687.x; Palmateer N, 2014, J VIRAL HEPATITIS, V21, P25, DOI 10.1111/jvh.12117; Phan T, 2009, J VIROL, V83, P8379, DOI 10.1128/JVI.00891-09; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Sigma-Aldrich, SYR NEEDL GAUG CHART; Smith BD, 2013, J INFECT DIS, V208, P1934, DOI 10.1093/infdis/jit520; Zule WA, 1997, J ACQ IMMUN DEF SYND, V14, P294; Zule WA, 1997, J ACQ IMMUN DEF SYND, V16, P309, DOI 10.1097/00042560-199712010-00015; Zule WA, 2013, INT J DRUG POLICY, V24, P1, DOI 10.1016/j.drugpo.2012.07.002; Zule WA, 2009, DRUG ALCOHOL DEPEN, V100, P204, DOI 10.1016/j.drugalcdep.2008.08.017	26	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0139737	10.1371/journal.pone.0139737	http://dx.doi.org/10.1371/journal.pone.0139737			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536599	Green Published, Green Submitted, gold			2022-12-26	WOS:000364298400011
J	Cusack, M; Vezenkova, N; Gottschalk, C; Calin-Jageman, RJ				Cusack, Margaret; Vezenkova, Nadya; Gottschalk, Christopher; Calin-Jageman, Robert J.			Direct and Conceptual Replications of Burgmer & Englich (2012): Power May Have Little to No Effect on Motor Performance	PLOS ONE			English	Article							INCREASES; SUPERSTITION; EXPERIENCE	Burgmer and Englich (2012) have reported that manipulating feelings of power can substantially improve performance on two motor tasks: golf and darts. We conducted two high-powered direct replications of the effects of power on golf, two online conceptual replications using mirror-tracing as a performance measure, and an additional conceptual replication using a cognitive performance measure (word-search). Overall, we found little to no effect of power on motor skill (d = 0.09, 95% CI[-0.07, 0.22], n = 603). We varied task difficulty, re-analyzed data without participants showing weak responses on manipulation checks, and tried adjusting performance scores for age, gender, and initial task skill. None of these secondary analyses revealed a strong effect of power on performance. A meta-analysis integrating our data with Burgmer & Englich leaves open the possibility that manipulating power could provide a modest boost in motor skill (d = 0.19, 95% CI [0.001, 0.38], n = 685). Unfortunately, the pattern of performance changes we observed was unrelated to group differences in perceived and rated power, suggesting that what motor effects do occur with this protocol may not be directly related to the construct of power. [Burgmer, P., & Englich, B. (2012). Bullseye!: How Power Improves Motor Performance. Social Psychological and Personality Science, 4(2), 224-232.]	[Cusack, Margaret; Vezenkova, Nadya; Gottschalk, Christopher; Calin-Jageman, Robert J.] Dominican Univ, Dept Psychol, River Forest, IL 60305 USA		Calin-Jageman, RJ (corresponding author), Dominican Univ, Dept Psychol, River Forest, IL 60305 USA.	rcalinjageman@dom.edu	Calin-Jageman, Robert/K-1311-2019	Calin-Jageman, Robert/0000-0002-9837-6529				Acton JD, HIST ESSAYS STUDIES; Anderson C, 2006, EUR J SOC PSYCHOL, V36, P511, DOI 10.1002/ejsp.324; Burgmer P, 2013, SOC PSYCHOL PERS SCI, V4, P224, DOI 10.1177/1948550612452014; Calin-Jageman RJ, 2014, SOC PSYCHOL-GERMANY, V45, P239, DOI 10.1027/1864-9335/a000190; Chandler J, 2014, BEHAV RES METHODS, V46, P112, DOI 10.3758/s13428-013-0365-7; Chen S, 2001, J PERS SOC PSYCHOL, DOI [10.1037/0022-3514.80.2.173, DOI 10.1037/0022-3514.80.2.173]; Cohen J.E., 1988, STAT POWER ANAL BEHA; Crump MJC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057410; Cumming G., 2013, UNDERSTANDING NEW ST; Damisch L, 2010, PSYCHOL SCI, V21, P1014, DOI 10.1177/0956797610372631; Doyen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029081; Galinsky AD, 2003, J PERS SOC PSYCHOL, V85, P453, DOI 10.1037/0022-3514.85.3.453; Galinsky AD, 2006, PSYCHOL SCI, V17, P1068, DOI 10.1111/j.1467-9280.2006.01824.x; Gigerenzer G., 1993, HDB DATA ANAL BEHAV, V1, P311, DOI DOI 10.1093/ACPROF:OSO/9780195153729.003.0013; Gigerenzer G., 2004, J SOCIO-ECON, V33, P587, DOI DOI 10.1016/J.SOCEC.2004.09.033; Goodman JK, 2013, J BEHAV DECIS MAKING, V26, P213, DOI 10.1002/bdm.1753; Gravelin CR, 2010, IMPACT POWER COMMUNA; Guinote A, 2008, J PERS SOC PSYCHOL, V95, P237, DOI 10.1037/a0012518; Guinote A, 2007, J EXP SOC PSYCHOL, V43, P685, DOI 10.1016/j.jesp.2006.06.008; Guinote A, 2007, PERS SOC PSYCHOL B, V33, P1076, DOI 10.1177/0146167207301011; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Karremans JC, 2010, PERS SOC PSYCHOL B, V36, P1010, DOI 10.1177/0146167210376761; Kifer Y, 2013, PSYCHOL SCI, V24, P280, DOI 10.1177/0956797612450891; Klein R., 2014, J OPEN PSYCHOL DATA, V2, pE4, DOI [10.5334/jopd.ad, DOI 10.5334/J0PD.AD]; Lammers J, 2013, J EXP SOC PSYCHOL, V49, P776, DOI 10.1016/j.jesp.2013.02.008; Oppenheimer DM, 2009, JUDGM DECIS MAK, V4, P326; Oppenheimer DM, 2009, J EXP SOC PSYCHOL, V45, P867, DOI 10.1016/j.jesp.2009.03.009; Rand DG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4677; Simmons J. P., 2012, DIALOGUE OFFICIAL NE, V26, P4, DOI [10.2139/ssrn.2160588, DOI 10.2139/SSRN.2160588]; Slabu L, 2010, J EXP SOC PSYCHOL, V46, P344, DOI 10.1016/j.jesp.2009.10.013; Voelcker-Rehage C, 2008, EUR REV AGING PHYS A, V5, P5, DOI 10.1007/s11556-008-0030-9; Weick M, 2008, J PERS SOC PSYCHOL, V94, P956, DOI 10.1037/0022-3514.94.6.956; Wilkinson D, 2010, PSYCHON B REV, V17, P910, DOI 10.3758/PBR.17.6.910; Young NS, 2008, PLOS MED, V5, P1418, DOI 10.1371/journal.pmed.0050201	34	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140806	10.1371/journal.pone.0140806	http://dx.doi.org/10.1371/journal.pone.0140806			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV5GZ	26536592	gold, Green Submitted, Green Published			2022-12-26	WOS:000364298400038
J	Nishino, K; Kushima, M; Matsuo, Y; Matsuo, Y; Kawamukai, M				Nishino, Kohei; Kushima, Misaki; Matsuo, Yuzy; Matsuo, Yasuhiro; Kawamukai, Makoto			Cell Lysis in S-pombe ura4 Mutants Is Suppressed by Loss of Functional Pub1, Which Regulates the Uracil Transporter Fur4	PLOS ONE			English	Article							UBIQUITIN-PROTEIN LIGASE; SCHIZOSACCHAROMYCES-POMBE; DOWN-REGULATION; PERMEASE; GENE; ENDOCYTOSIS; TRAFFICKING; DEGRADATION; EXPRESSION; CLONING	Schizosaccharomyces pombe Delta ura4 cells lyse when grown on YPD medium. A S. pombe non-essential gene deletion library was screened to determine suppressors of the lysis phenotype. Deletion of the pub1 gene, which encoded E3 ubiquitin ligase, strongly suppressed cell lysis in Delta ura4 cells. The Delta pub1 cells displayed high sensitivity to 5-fluorouracil, a toxic analog of uracil, and this sensitivity was suppressed by deletion of fur4, which encoded a uracil transporter. Fur4 localized primarily to the Golgi apparatus and vacuoles in wild-type cells, but localization was predominantly at the plasma membrane in Delta pub1 cells. Fur4 was necessary for the utilization of extracellular uracil, cytosine, or UMP. Uracil uptake activity increased in the Delta pub1 strain in a Fur4-dependent manner. In addition, uracil starvation was critical for induction of cell lysis of Delta ura4 strains and uracil supplementation suppressed lysis. In summary, the increased uracil uptake ability of Delta pub1 cells, where Fur4 was predominantly localized to the plasma membrane, resulted in suppression of cell lysis in the Delta ura4 background.	[Nishino, Kohei; Kushima, Misaki; Matsuo, Yuzy; Matsuo, Yasuhiro; Kawamukai, Makoto] Shimane Univ, Fac Life & Environm Sci, Dept Life Sci & Biotechnol, Matsue, Shimane, Japan	Shimane University	Kawamukai, M (corresponding author), Shimane Univ, Fac Life & Environm Sci, Dept Life Sci & Biotechnol, Matsue, Shimane, Japan.	kawamuka@life.shimanen-u.ac.jp	Kawamukai, Makoto/AET-1038-2022; Matsuo, Yasuhiro/AAT-6220-2021	Kawamukai, Makoto/0000-0003-2929-8798; Matsuo, Yasuhiro/0000-0002-2858-7179	Ministry of Education, Culture, Sports, Science, and Technology of Japan [25660059]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Funding provided by #25660059, the Ministry of Education, Culture, Sports, Science, and Technology of Japan (http://www.jsps.go.jp/j-grantsinaid/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACH ML, 1987, CURR GENET, V12, P527, DOI 10.1007/BF00419562; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Blondel MO, 2004, MOL BIOL CELL, V15, P883, DOI 10.1091/mbc.E03-04-0202; CHEVALLIER MR, 1982, MOL CELL BIOL, V2, P977, DOI 10.1128/MCB.2.8.977; CHEVALLIER MR, 1982, EMBO J, V1, P375, DOI 10.1002/j.1460-2075.1982.tb01177.x; De Montigny J, 1998, YEAST, V14, P1051, DOI 10.1002/(SICI)1097-0061(199808)14:11<1051::AID-YEA287>3.0.CO;2-1; Egel R, 2003, MOLECULAR BIOLOGY OF SCHIZOSACCHAROMYCES POMBE, P1; Fang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085238; GALAN JM, 1994, BIOCHEM BIOPH RES CO, V201, P769, DOI 10.1006/bbrc.1994.1767; Galan JM, 1996, J BIOL CHEM, V271, P10946, DOI 10.1074/jbc.271.18.10946; Hayashi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099038; Karagiannis J, 1999, CURR GENET, V35, P593, DOI 10.1007/s002940050457; Kato H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080572; Kawamukai M, 2016, BIOSCI BIOTECH BIOCH, V80, P23, DOI 10.1080/09168451.2015.1065172; Keener JM, 2013, TRAFFIC, V14, P412, DOI 10.1111/tra.12039; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Kitamura K, 2012, EUKARYOT CELL, V11, P302, DOI 10.1128/EC.05253-11; LOSSON R, 1983, CELL, V32, P371, DOI 10.1016/0092-8674(83)90456-7; Marchal C, 2000, J BIOL CHEM, V275, P23608, DOI 10.1074/jbc.M001735200; Matsuo Y, 2007, EUKARYOT CELL, V6, P2092, DOI 10.1128/EC.00300-07; Matsuo Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059887; MORENO S, 1991, P795; Nakase M, 2012, MICROBIOL-SGM, V158, P659, DOI 10.1099/mic.0.053389-0; Nakashima A, 2014, BIOL OPEN, V3, P542, DOI 10.1242/bio.20148367; Nefsky B, 1996, EMBO J, V15, P1301, DOI 10.1002/j.1460-2075.1996.tb00472.x; Sato M, 2005, YEAST, V22, P583, DOI 10.1002/yea.1233; Seron K, 1999, J BACTERIOL, V181, P1793; Shiozaki K, 1997, METHOD ENZYMOL, V283, P506; SILVE S, 1991, MOL CELL BIOL, V11, P1114, DOI 10.1128/MCB.11.2.1114; Tamai KK, 2002, J CELL SCI, V115, P1847; Tanae K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030472; Tanaka N, 2001, YEAST, V18, P745, DOI 10.1002/yea.725	32	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141796	10.1371/journal.pone.0141796	http://dx.doi.org/10.1371/journal.pone.0141796			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536126	gold, Green Published, Green Submitted			2022-12-26	WOS:000364298400088
J	Yokoo, M; Kubota, Y; Motoyama, K; Higashi, T; Taniyoshi, M; Tokumaru, H; Nishiyama, R; Tabe, Y; Mochinaga, S; Sato, A; Sueoka-Aragane, N; Sueoka, E; Arima, H; Irie, T; Kimura, S				Yokoo, Masako; Kubota, Yasushi; Motoyama, Keiichi; Higashi, Taishi; Taniyoshi, Masatoshi; Tokumaru, Hiroko; Nishiyama, Rena; Tabe, Yoko; Mochinaga, Sakiko; Sato, Akemi; Sueoka-Aragane, Naoko; Sueoka, Eisaburo; Arima, Hidetoshi; Irie, Tetsumi; Kimura, Shinya			2-Hydroxypropyl-beta-Cyclodextrin Acts as a Novel Anticancer Agent	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; METHYL-BETA-CYCLODEXTRIN; TYROSINE KINASE INHIBITOR; LIPID RAFTS; BCR-ABL; CELL-LINE; CHOLESTEROL DEPLETION; MYELOGENOUS LEUKEMIA; CANCER-CELLS; IN-VIVO	2-Hydroxypropyl-beta-cyclodextrin (HP-beta-CyD) is a cyclic oligosaccharide that is widely used as an enabling excipient in pharmaceutical formulations, but also as a cholesterol modifier. HP-beta-CyD has recently been approved for the treatment of Niemann-Pick Type C disease, a lysosomal lipid storage disorder, and is used in clinical practice. Since cholesterol accumulation and/or dysregulated cholesterol metabolism has been described in various malignancies, including leukemia, we hypothesized that HP-beta-CyD itself might have anticancer effects. This study provides evidence that HP-beta-CyD inhibits leukemic cell proliferation at physiologically available doses. First, we identified the potency of HP-beta-CyD in vitro against various leukemic cell lines derived from acute myeloid leukemia (AML), acute lymphoblastic leukemia and chronic myeloid leukemia (CML). HP-beta-CyD treatment reduced intracellular cholesterol resulting in significant leukemic cell growth inhibition through G(2)/M cell-cycle arrest and apoptosis. Intraperitoneal injection of HP-beta-CyD significantly improved survival in leukemia mouse models. Importantly, HP-beta-CyD also showed anticancer effects against CML cells expressing a T315I BCR-ABL mutation (that confers resistance to most ABL tyrosine kinase inhibitors), and hypoxia-adapted CML cells that have characteristics of leukemic stem cells. In addition, colony forming ability of human primary AML and CML cells was inhibited by HP-beta-CyD. Systemic administration of HP-beta-CyD to mice had no significant adverse effects. These data suggest that HP-beta-CyD is a promising anticancer agent regardless of disease or cellular characteristics.	[Yokoo, Masako; Kubota, Yasushi; Sato, Akemi; Sueoka-Aragane, Naoko; Kimura, Shinya] Saga Univ, Fac Med, Dept Internal Med, Div Hematol Resp Med & Oncol, Saga 840, Japan; [Kubota, Yasushi; Sueoka, Eisaburo] Saga Univ Hosp, Dept Transfus Med, Saga, Japan; [Motoyama, Keiichi; Higashi, Taishi; Taniyoshi, Masatoshi; Tokumaru, Hiroko; Nishiyama, Rena; Arima, Hidetoshi; Irie, Tetsumi] Kumamoto Univ, Grad Sch Pharmaceut Sci, Kumamoto, Japan; [Tabe, Yoko] Juntendo Univ, Sch Med, Dept Clin Lab Med, Tokyo 113, Japan; [Mochinaga, Sakiko] Saga Univ Hosp, Dept Pharm, Saga, Japan; [Sueoka, Eisaburo] Saga Univ, Fac Med, Dept Clin Lab Med, Saga 840, Japan; [Arima, Hidetoshi; Irie, Tetsumi] Kumamoto Univ, HIGO Program, Program Leading Grad Sch, Kumamoto, Japan	Saga University; Saga University; Kumamoto University; Juntendo University; Saga University; Saga University; Kumamoto University	Kubota, Y (corresponding author), Saga Univ, Fac Med, Dept Internal Med, Div Hematol Resp Med & Oncol, Saga 840, Japan.	kubotay@cc.saga-u.ac.jp		Irie, Tetsumi/0000-0001-8664-7048	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan [25670452]	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid for Challenging Exploratory Research 25670452 (YK) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan.	Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; ANDERSSON LC, 1979, INT J CANCER, V23, P143, DOI 10.1002/ijc.2910230202; Banker DE, 2004, BLOOD, V104, P1816, DOI 10.1182/blood-2004-01-0395; Bearss DJ, 2002, CANCER RES, V62, P2077; Caliceti C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041246; Chien YH, 2013, MOL GENET METAB, V109, P231, DOI 10.1016/j.ymgme.2013.04.003; Cortez D, 1997, ONCOGENE, V15, P2333, DOI 10.1038/sj.onc.1201400; Davis ME, 2004, NAT REV DRUG DISCOV, V3, P1023, DOI 10.1038/nrd1576; De Beule K, 2001, DRUGS, V61, P27, DOI 10.2165/00003495-200161001-00003; DEKRUIJFF B, 1974, BIOCHIM BIOPHYS ACTA, V339, P44, DOI 10.1016/0005-2736(74)90331-9; Dimitroulakos J, 1999, BLOOD, V93, P1308, DOI 10.1182/blood.V93.4.1308.404k08_1308_1318; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Duncan RE, 2004, J BIOL CHEM, V279, P33079, DOI 10.1074/jbc.M400732200; Freeman MR, 2004, J CELL BIOCHEM, V91, P54, DOI 10.1002/jcb.10724; Fromming KH, 1996, BUDAPEST, P33; Galbiati F, 2001, CELL, V106, P403, DOI 10.1016/S0092-8674(01)00472-X; George KS, 2012, TOXICOL APPL PHARM, V259, P311, DOI 10.1016/j.taap.2012.01.007; Ghalaut VS, 2006, CLIN CHIM ACTA, V366, P239, DOI 10.1016/j.cca.2005.10.022; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Gould S, 2005, FOOD CHEM TOXICOL, V43, P1451, DOI 10.1016/j.fct.2005.03.007; Hartwell KA, 2013, NAT CHEM BIOL, V9, P840, DOI [10.1038/nchembio.1367, 10.1038/NCHEMBIO.1367]; Hinzey AH, 2012, INDIAN J BIOCHEM BIO, V49, P329; Hisatomi T, 2011, BLOOD, V117, P3575, DOI 10.1182/blood-2010-02-270439; Irie T, 1997, J PHARM SCI-US, V86, P147, DOI 10.1021/js960213f; Ito T, 2007, EUR J HAEMATOL, V78, P417, DOI 10.1111/j.1600-0609.2007.00835.x; Kawauchi K, 2003, BLOOD CELL MOL DIS, V31, P11, DOI 10.1016/S1079-9796(03)00070-6; Kimura S, 2005, BLOOD, V106, P3948, DOI 10.1182/blood-2005-06-2209; Kitaura J, 2007, J IMMUNOL, V178, P455, DOI 10.4049/jimmunol.178.1.455; Kubota Y, 2009, BLOOD, V114, P4383, DOI 10.1182/blood-2009-07-230292; Kuroda J, 2003, BLOOD, V102, P2229, DOI 10.1182/blood-2003-01-0305; Li HY, 2003, BLOOD, V101, P3628, DOI 10.1182/blood-2002-07-2283; Li YC, 2006, AM J PATHOL, V168, P1107, DOI 10.2353/ajpath.2006.050959; Loftsson T, 2010, J PHARM PHARMACOL, V62, P1607, DOI 10.1111/j.2042-7158.2010.01030.x; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; Maksumova L, 2000, LEUKEMIA, V14, P1444, DOI 10.1038/sj.leu.2401856; Martin-Caballero J, 2001, CANCER RES, V61, P6234; Matsuo M, 2013, MOL GENET METAB, V109, P233, DOI 10.1016/j.ymgme.2013.04.010; Matsuo M, 2013, MOL GENET METAB, V108, P76, DOI 10.1016/j.ymgme.2012.11.005; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Minden MD, 2001, LEUKEMIA LYMPHOMA, V40, P659, DOI 10.3109/10428190109097663; Motoyama K, 2009, BIOL PHARM BULL, V32, P700, DOI 10.1248/bpb.32.700; Mulas MF, 2011, CELL PROLIFERAT, V44, P360, DOI 10.1111/j.1365-2184.2011.00758.x; Naito H, 2006, LEUKEMIA RES, V30, P1443, DOI 10.1016/j.leukres.2006.01.006; O'Hare T, 2012, NAT REV CANCER, V12, P513, DOI 10.1038/nrc3317; O'Hare T, 2009, CANCER CELL, V16, P401, DOI 10.1016/j.ccr.2009.09.028; OHTANI Y, 1989, EUR J BIOCHEM, V186, P17, DOI 10.1111/j.1432-1033.1989.tb15171.x; Onodera R, 2013, INT J PHARMACEUT, V452, P116, DOI 10.1016/j.ijpharm.2013.04.071; Onodera R, 2013, SCI REP-UK, V3, DOI 10.1038/srep01104; Orlandi L, 1999, BRIT J CANCER, V81, P252, DOI 10.1038/sj.bjc.6690685; Park EK, 2009, J PATHOL, V218, P337, DOI 10.1002/path.2531; PEGORARO L, 1983, J NATL CANCER I, V70, P447; Perl A, 2011, J CLIN INVEST, V121, P22, DOI 10.1172/JCI43605; Plazzo AP, 2012, CHEM PHYS LIPIDS, V165, P505, DOI 10.1016/j.chemphyslip.2012.03.007; Ricci C, 2002, CANCER RES, V62, P5995; Roninson IB, 2002, CANCER LETT, V179, P1, DOI 10.1016/S0304-3835(01)00847-3; Rosenbaum AI, 2011, J NEUROCHEM, V116, P789, DOI 10.1111/j.1471-4159.2010.06976.x; Rosenbaum AI, 2010, P NATL ACAD SCI USA, V107, P5477, DOI 10.1073/pnas.0914309107; Rudling M, 1998, AM J PATHOL, V153, P1923, DOI 10.1016/S0002-9440(10)65706-9; Simons K, 2002, J CLIN INVEST, V110, P597, DOI 10.1172/JCI200216390; Slavova-Azmanova NS, 2014, BIOCHEM J, V459, P455, DOI 10.1042/BJ20130903; Steelman LS, 2004, LEUKEMIA, V18, P189, DOI 10.1038/sj.leu.2403241; Szente L, 1999, ADV DRUG DELIVER REV, V36, P17, DOI 10.1016/S0169-409X(98)00092-1; Tabe Y, 2012, LEUKEMIA, V26, P883, DOI 10.1038/leu.2011.291; Takeuchi M, 2010, CELL DEATH DIFFER, V17, P1211, DOI 10.1038/cdd.2010.6; Tanaka Y, 2015, BIOL PHARM BULL, V38, P844, DOI 10.1248/bpb.b14-00726; Tilbrook PA, 2001, CANCER RES, V61, P2453; Uekama K, 1998, CHEM REV, V98, P2045, DOI 10.1021/cr970025p; VITOLS S, 1994, BLOOD, V84, P2689; Vitols S, 1997, LIPIDS, V32, P255, DOI 10.1007/s11745-997-0032-1; Wakeling AE, 2002, CANCER RES, V62, P5749; Weisberg E, 2005, CANCER CELL, V7, P129, DOI 10.1016/j.ccr.2005.01.007; Wu Q, 2002, J BIOL CHEM, V277, P36329, DOI 10.1074/jbc.M204962200; Yan J, 2012, ANTI-CANCER DRUG, V23, P22, DOI 10.1097/CAD.0b013e32834a099c; Yang WC, 2001, CANCER RES, V61, P565; Yokoo M, 2015, BIOL PHARM BULL, V38, P411, DOI 10.1248/bpb.b14-00652; Yunomae K, 2003, FEBS LETT, V536, P225, DOI 10.1016/S0014-5793(03)00059-0	76	49	51	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141946	10.1371/journal.pone.0141946	http://dx.doi.org/10.1371/journal.pone.0141946			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26535909	Green Published, gold, Green Submitted			2022-12-26	WOS:000364298400104
J	Tricoire, H; Rera, M				Tricoire, Herve; Rera, Michael			A New, Discontinuous 2 Phases of Aging Model: Lessons from Drosophila melanogaster	PLOS ONE			English	Article							INTESTINAL BARRIER; RISK	Aging is commonly described as being a continuous process affecting progressively organisms as time passes. This process results in a progressive decrease in individuals fitness through a wide range of both organismal-decreased motor activity, fertility, resistance to stress-and molecular phenotypes-decreased protein and energy homeostasis, impairment of insulin signaling. In the past 20 years, numerous genes have been identified as playing a major role in the aging process, yet little is known about the events leading to that loss of fitness. We recently described an event characterized by a dramatic increase of intestinal permeability to a blue food dye in aging flies committed to die within a few days. Importantly, flies showing this so called `Smurf' phenotype are the only ones, among a population, to show various age-related changes and exhibit a high-risk of impending death whatever their chronological age. Thus, these observations suggest that instead of being one continuous phenomenon, aging may be a discontinuous process well described by at least two distinguishable phases. In this paper we addressed this hypothesis by implementing a new 2 Phases of Aging mathematiCal model (2PAC model) to simulate longevity curves based on the simple hypothesis of two consecutive phases of lifetime presenting different properties. We first present a unique equation for each phase and discuss the biological significance of the 3 associated parameters. Then we evaluate the influence of each parameter on the shape of survival curves. Overall, this new mathematical model, based on simple biological observations, is able to reproduce many experimental longevity curves, supporting the existence of 2 phases of aging exhibiting specific properties and separated by a dramatic transition that remains to be characterized. Moreover, it indicates that Smurf survival can be approximated by one single constant parameter for a broad range of genotypes that we have tested under our environmental conditions.	[Tricoire, Herve; Rera, Michael] Univ Paris Diderot, UMR8251, Lab Degenerat Proc Stress & Aging, F-75013 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Rera, M (corresponding author), Univ Paris Diderot, UMR8251, Lab Degenerat Proc Stress & Aging, F-75013 Paris, France.	michael.rera@univ-paris-diderot.fr	Rera, Michael/AAS-5456-2021; TRICOIRE, Herve/AAP-7889-2020	Rera, Michael/0000-0002-6574-6511; TRICOIRE, Herve/0000-0001-9404-5282				Coburn C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001613; Farhadi A, 2003, J GASTROEN HEPATOL, V18, P479, DOI 10.1046/j.1440-1746.2003.03032.x; Fasano A, 2005, NAT CLIN PRACT GASTR, V2, P416, DOI 10.1038/ncpgasthep0259; Ferrandon D, 1998, EMBO J, V17, P1217, DOI 10.1093/emboj/17.5.1217; Fischer K, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001606; Frechet M, 1927, ANN SOC POLON MATH; Gompertz B., 1825, PHILOS T ROYAL SOC L, V115, P515, DOI [DOI 10.1098/RSTL.1825.0026, 10.1098/rstl.1825.0026]; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; HARRIS CE, 1992, INTENS CARE MED, V18, P38, DOI 10.1007/BF01706424; Horne BD, 2009, AM J MED, V122, P550, DOI 10.1016/j.amjmed.2008.10.043; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Medawar PB, 1952, MED J AUSTRALIA, V1, P854; Partridge L, 2005, MECH AGEING DEV, V126, P35, DOI 10.1016/j.mad.2004.09.017; Pearl R, 1922, THE BIOL DEATH; Pinto JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107541; Pletcher SD, 2002, CURR BIOL, V12, P712, DOI 10.1016/S0960-9822(02)00808-4; Rera M, 2012, P NATL ACAD SCI USA, V109, P21528, DOI 10.1073/pnas.1215849110; Sandek A, 2008, CURR OPIN CLIN NUTR, V11, P632, DOI 10.1097/MCO.0b013e32830a4c6e; WEIBULL W, 1951, J APPL MECH-T ASME, V18, P293; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x	21	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141920	10.1371/journal.pone.0141920	http://dx.doi.org/10.1371/journal.pone.0141920			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528826	Green Published, Green Submitted, gold			2022-12-26	WOS:000364032600077
J	Poisson, LM; Suhail, H; Singh, J; Datta, I; Denic, A; Labuzek, K; Hoda, MN; Shankar, A; Kumar, A; Cerghet, M; Elias, S; Mohney, RP; Rodriguez, M; Rattan, R; Mangalam, AK; Giri, S				Poisson, Laila M.; Suhail, Hamid; Singh, Jaspreet; Datta, Indrani; Denic, Aleksandar; Labuzek, Krzysztof; Hoda, Md Nasrul; Shankar, Ashray; Kumar, Ashok; Cerghet, Mirela; Elias, Stanton; Mohney, Robert P.; Rodriguez, Moses; Rattan, Ramandeep; Mangalam, Ashutosh K.; Giri, Shailendra			Untargeted Plasma Metabolomics Identifies Endogenous Metabolite with Drug-like Properties in Chronic Animal Model of Multiple Sclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRORESOLVING LIPID MEDIATORS; CENTRAL-NERVOUS-SYSTEM; TRIGGERED RESOLVIN D1; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; AMYLOID-BETA PHAGOCYTOSIS; DOCOSAHEXAENOIC ACID; FATTY-ACIDS; SUPPRESSOR-CELLS; OMEGA-3 SUPPLEMENTATION; PROMOTE RESOLUTION	We performed untargeted metabolomics in plasma of B6 mice with experimental autoimmune encephalitis (EAE) at the chronic phase of the disease in search of an altered metabolic pathway(s). Of 324 metabolites measured, 100 metabolites that mapped to various pathways (mainly lipids) linked to mitochondrial function, inflammation, and membrane stability were observed to be significantly altered between EAE and control (p < 0.05, false discovery rate < 0.10). Bioinformatics analysis revealed six metabolic pathways being impacted and altered in EAE, including alpha-linolenic acid and linoleic acid metabolism (PUFA). The metabolites of PUFAs, including omega-3 and omega-6 fatty acids, are commonly decreased in mouse models of multiple sclerosis (MS) and in patients with MS. Daily oral administration of resolvin D1, a downstream metabolite of omega-3, decreased disease progression by suppressing autoreactive T cells and inducing an M2 phenotype of monocytes/macrophages and resident brain microglial cells. This study provides a proof of principle for the application of metabolomics to identify an endogenous metabolite(s) possessing drug-like properties, which is assessed for therapy in preclinical mouse models of MS.	[Poisson, Laila M.; Datta, Indrani] Henry Ford Hlth Syst, Ctr Bioinformat, Detroit, MI 48202 USA; [Poisson, Laila M.; Datta, Indrani] Henry Ford Hlth Syst, Dept Publ Hlth Sci, Detroit, MI 48202 USA; [Suhail, Hamid; Singh, Jaspreet; Shankar, Ashray; Cerghet, Mirela; Elias, Stanton; Giri, Shailendra] Henry Ford Hlth Syst, Dept Neurol, Detroit, MI 48202 USA; [Rattan, Ramandeep] Henry Ford Hlth Syst, Div Gynecol Oncol, Dept Womens Hlth Serv, Detroit, MI 48202 USA; [Denic, Aleksandar; Rodriguez, Moses] Mayo Clin, Coll Med, Dept Neurol, Rochester, MN 55906 USA; [Rodriguez, Moses] Mayo Clin, Coll Med, Dept Immunol, Rochester, MN 55906 USA; [Labuzek, Krzysztof] Med Univ Silesia, Dept Pharmacol, PL-40752 Katowice, Poland; [Hoda, Md Nasrul] Georgia Hlth Sci Univ, Dept Neurol, Augusta, GA 30912 USA; [Hoda, Md Nasrul] Univ Georgia, Coll Pharm, Program Clin & Expt Therapeut, Augusta, GA 30912 USA; [Kumar, Ashok] Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48202 USA; [Mohney, Robert P.] Metabolon Inc, Durham, NC 27713 USA; [Mangalam, Ashutosh K.] Univ Iowa, Carver Coll Med, Dept Pathol, Iowa City, IA 52242 USA	Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Mayo Clinic; Mayo Clinic; Medical University Silesia; University System of Georgia; Augusta University; University System of Georgia; University of Georgia; Wayne State University; Metabolon; University of Iowa	Giri, S (corresponding author), Henry Ford Hosp, Dept Neurol, Div Res, Educ & Res Bldg,Rm 4051,2799 W Grand Blvd, Detroit, MI 48202 USA.	SGiri1@hfhs.org	Mangalam, Ashutosh/I-8565-2017; Regan, Clinton/E-6250-2012	Mangalam, Ashutosh/0000-0002-9926-2531; Giri, Shailendra/0000-0002-7123-829X; Denic, Aleksandar/0000-0001-9157-5405; Rodriguez, Moses/0000-0001-6328-6497; Rattan, Ramandeep/0000-0002-3532-6057	Henry Ford Hospital [A20020]; National Multiple Sclerosis Society [RG 4311A4/4, RG 5112A5/2]; National Institutes of Health [R01 GM092993]; Metabolon, Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092993] Funding Source: NIH RePORTER	Henry Ford Hospital; National Multiple Sclerosis Society(National Multiple Sclerosis Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Metabolon, Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Henry Ford Hospital Internal Funding Grant A20020, in part by National Multiple Sclerosis Society Research Grants RG 4311A4/4 and RG 5112A5/2 (to S. G.), and by National Institutes of Health Grant R01 GM092993 (to M. R). R. M. is an employee of Metabolon, Inc., and as such has affiliations with or financial involvement with Metabolon, Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aittokallio T, 2006, BRIEF BIOINFORM, V7, P243, DOI 10.1093/bib/bbl022; Bento AF, 2011, J IMMUNOL, V187, P1957, DOI 10.4049/jimmunol.1101305; Boudonck KJ, 2009, TOXICOL PATHOL, V37, P280, DOI 10.1177/0192623309332992; Buckley CD, 2014, IMMUNITY, V40, P315, DOI 10.1016/j.immuni.2014.02.009; Campbell BM, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00012; Chen F, 2014, EUR J CLIN MICROBIOL, V33, P457, DOI 10.1007/s10096-013-1978-6; Chen SL, 2014, SCI REP-UK, V4, DOI 10.1038/srep07458; Chiang N, 2012, NATURE, V484, P524, DOI 10.1038/nature11042; Choi JW, 2011, P NATL ACAD SCI USA, V108, P751, DOI 10.1073/pnas.1014154108; Croasdell A, 2015, AM J PHYSIOL-LUNG C, V309, pL888, DOI 10.1152/ajplung.00125.2015; CUNNANE SC, 1989, AM J CLIN NUTR, V50, P801, DOI 10.1093/ajcn/50.4.801; Dalli J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01940; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; De Caterina R, 2011, NEW ENGL J MED, V364, P2439, DOI 10.1056/NEJMra1008153; DeHaven CD, 2010, J CHEMINFORMATICS, V2, DOI 10.1186/1758-2946-2-9; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Evans M., 2014, METABOLOMICS, V4, P1, DOI DOI 10.4172/2153-0769.1000132; Fiala M, 2015, FASEB J, V29, P2681, DOI 10.1096/fj.14-264218; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gebregiworgis T, 2013, ACS CHEM BIOL, V8, P684, DOI 10.1021/cb300673e; Goeman JJ, 2007, BIOINFORMATICS, V23, P980, DOI 10.1093/bioinformatics/btm051; GUL S, 1970, J NEUROL NEUROSUR PS, V33, P506, DOI 10.1136/jnnp.33.4.506; Haghikia A, 2015, IMMUNITY, V43, P817, DOI 10.1016/j.immuni.2015.09.007; Ho PP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003831; HOLMAN RT, 1989, P NATL ACAD SCI USA, V86, P4720, DOI 10.1073/pnas.86.12.4720; Hsiao HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058258; Jahng A, 2004, J EXP MED, V199, P947, DOI 10.1084/jem.20031389; Jelinek GA, 2013, INT J NEUROSCI, V123, P792, DOI 10.3109/00207454.2013.803104; Johansen KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007551; Johnson CH, 2012, J CELL PHYSIOL, V227, P2975, DOI 10.1002/jcp.24002; Johnston J, 2012, DRUGS, V72, P1195, DOI 10.2165/11634010-000000000-00000; Koivisto H, 2014, J NUTR BIOCHEM, V25, P157, DOI 10.1016/j.jnutbio.2013.09.015; Kong WM, 2011, BRAIN BEHAV IMMUN, V25, P872, DOI 10.1016/j.bbi.2010.09.012; Lawton KA, 2008, PHARMACOGENOMICS, V9, P383, DOI 10.2217/14622416.9.4.383; Li LY, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-72; Lima-Garcia JF, 2011, BRIT J PHARMACOL, V164, P278, DOI 10.1111/j.1476-5381.2011.01345.x; Lin L, 2011, J PROTEOME RES, V10, P1396, DOI 10.1021/pr101161u; Lourenco AST, 2011, CURR MOL MED, V11, P326; Lukiw WJ, 2005, J CLIN INVEST, V115, P2774, DOI 10.1172/JCI25420; Lutz NW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056101; Mamas M, 2011, ARCH TOXICOL, V85, P5, DOI 10.1007/s00204-010-0609-6; Mangalam Ak, 2013, J Clin Cell Immunol, V4, DOI 10.4172/2155-9899.1000150; Mayo L, 2014, NAT MED, V20, P1147, DOI 10.1038/nm.3681; Melzer N, 2014, CLIN EXP IMMUNOL, V175, P359, DOI 10.1111/cei.12195; Miller James R, 2004, J Manag Care Pharm, V10, pS4; Mizwicki MT, 2013, J ALZHEIMERS DIS, V34, P155, DOI 10.3233/JAD-121735; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nath N, 2009, BIOCHEM BIOPH RES CO, V386, P16, DOI 10.1016/j.bbrc.2009.05.106; Nath N, 2009, J IMMUNOL, V182, P8005, DOI 10.4049/jimmunol.0803563; Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a; NIGHTINGALE S, 1990, ACTA NEUROL SCAND, V82, P43; Noga MJ, 2012, METABOLOMICS, V8, P253, DOI 10.1007/s11306-011-0306-3; Nordvik I, 2000, ACTA NEUROL SCAND, V102, P143, DOI 10.1034/j.1600-0404.2000.102003143.x; Ochando JC, 2012, IMMUNOL RES, V54, P275, DOI 10.1007/s12026-012-8335-1; OKAJIMA K, 1985, J LAB CLIN MED, V105, P132; Parsa R, 2012, DIABETES, V61, P2881, DOI 10.2337/db11-1635; Recchiuti A, 2014, FASEB J, V28, P3090, DOI 10.1096/fj.13-248393; Rius B, 2014, FASEB J, V28, P836, DOI 10.1096/fj.13-235614; Rogerio AP, 2012, J IMMUNOL, V189, P1983, DOI 10.4049/jimmunol.1101665; ROSSI S, 2015, MEDIAT INFLAMM, V2015, DOI DOI 10.1155/2015/149381; Sato Y, 2012, J LIPID RES, V53, P567, DOI 10.1194/jlr.M022376; Schilling S, 2006, CLIN EXP IMMUNOL, V145, P101, DOI 10.1111/j.1365-2249.2006.03094.x; Schulze-Topphoff U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033797; Seki H, 2010, THESCIENTIFICWORLDJO, V10, P818, DOI 10.1100/tsw.2010.72; Serhan CN, 2015, SEMIN IMMUNOL, V27, P200, DOI 10.1016/j.smim.2015.03.004; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Skripuletz T, 2015, BRAIN, V138, P398, DOI 10.1093/brain/awu358; Spite M, 2009, BRIT J PHARMACOL, V158, P1062, DOI 10.1111/j.1476-5381.2009.00234.x; Spite M, 2014, CELL METAB, V19, P21, DOI 10.1016/j.cmet.2013.10.006; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Stone TW, 2013, BRIT J PHARMACOL, V169, P1211, DOI 10.1111/bph.12230; Tang HF, 2014, J IMMUNOL, V193, P3769, DOI 10.4049/jimmunol.1400942; Titos E, 2011, J IMMUNOL, V187, P5408, DOI 10.4049/jimmunol.1100225; Torkildsen O, 2012, ARCH NEUROL-CHICAGO, V69, P1044, DOI 10.1001/archneurol.2012.283; Trushina E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032737; Umemura N, 2008, J LEUKOCYTE BIOL, V83, P1136, DOI 10.1189/jlb.0907611; Verreck FAW, 2006, J LEUKOCYTE BIOL, V79, P285, DOI 10.1189/jlb.0105015; Wang XZ, 2015, J LIPID RES, V56, P674, DOI 10.1194/jlr.P055418; Wang XZ, 2015, ALZHEIMERS DEMENT, V11, P40, DOI 10.1016/j.jalz.2013.12.024; Weber MS, 2007, NAT MED, V13, P935, DOI 10.1038/nm1620; Weinstock-Guttman B, 2005, PROSTAG LEUKOTR ESS, V73, P397, DOI 10.1016/j.plefa.2005.05.024; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Zhang AH, 2013, ANAL BIOANAL CHEM, V405, P8143, DOI 10.1007/s00216-013-7061-4; Zhang AH, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/354671; Zhu B, 2007, J IMMUNOL, V179, P5228, DOI 10.4049/jimmunol.179.8.5228	87	53	54	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					30697	+		10.1074/jbc.M115.679068	http://dx.doi.org/10.1074/jbc.M115.679068			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26546682	hybrid, Green Published			2022-12-26	WOS:000367199000004
J	Nessler, JA; Silvas, M; Carpenter, S; Newcomer, SC				Nessler, J. A.; Silvas, M.; Carpenter, S.; Newcomer, S. C.			Wearing a Wetsuit Alters Upper Extremity Motion during Simulated Surfboard Paddling	PLOS ONE			English	Article							SPACE RECONSTRUCTION PARAMETERS; JOINT POSITION SENSE; TIME-SERIES; STRIDE-INTERVAL; COMPLEX NETWORK; EMBEDDING DIMENSION; NONLINEAR DYNAMICS; BODY-TEMPERATURE; THERMAL SWIMSUIT; PRACTICAL METHOD	Surfers often wear wetsuits while paddling in the ocean. This neoprene covering may be beneficial to upper extremity movement by helping to improve proprioceptive acuity, or it may be detrimental by providing increased resistance. The purpose of this study was to evaluate the effects of wearing a wetsuit on muscle activation, upper extremity motion, heart rate, and oxygen consumption during simulated surfboard paddling in the laboratory. Twelve male, recreational surfers performed two paddling trials at a constant workload on a swim bench ergometer both with and without a wetsuit. Kinematic data and EMG were acquired from the right arm via motion capture, and oxygen consumption and heart rate were recorded with a metabolic cart and heart rate monitor. Wearing a wetsuit had no significant effect on oxygen consumption or heart rate. A significant increase in EMG activation was observed for the middle deltoid but not for any of the other shoulder muscle evaluated. Finally, approximate entropy and estimates of the maximum Lyapunov exponent increased significantly for vertical trajectory of the right wrist (i.e. stroke height) when a wetsuit was worn. These results suggest that a 2mm wetsuit has little effect on the energy cost of paddling at lower workloads but does affect arm motion. These changes may be the result of enhanced proprioceptive acuity due to mechanical compression from the wetsuit.	[Carpenter, S.] Waters Edge Phys Therapy & Wellness, Oceanside, CA USA			jnessler@csusm.edu						Abarbanel H.D.I., 1996, ANAL OBSERVED CHAOTI; Aziz W, 2006, EUR J APPL PHYSIOL, V98, P30, DOI 10.1007/s00421-006-0226-5; Bernstein N, 1967, COORDINATION REGULAT; Birmingham TB, 1998, AM J SPORT MED, V26, P562, DOI 10.1177/03635465980260041601; Buzzi UH, 2003, CLIN BIOMECH, V18, P435, DOI 10.1016/S0268-0033(03)00029-9; Cai WD, 2008, KYBERNETIKA, V44, P557; Cao LY, 1997, PHYSICA D, V110, P43, DOI 10.1016/S0167-2789(97)00118-8; Castagna O, 2013, INT J SPORTS MED, V34, P1043, DOI 10.1055/s-0033-1345136; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Cignetti F, 2009, J BIOMECH, V42, P1452, DOI 10.1016/j.jbiomech.2009.04.012; CORDIER P, 1994, HUM MOVEMENT SCI, V13, P745, DOI 10.1016/0167-9457(94)90016-7; Costa M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021906; Costa M, 2003, PHYSICA A, V330, P53, DOI 10.1016/j.physa.2003.08.022; Damouras S, 2010, GAIT POSTURE, V31, P336, DOI 10.1016/j.gaitpost.2009.12.002; Deutsch KM, 2004, J EXP CHILD PSYCHOL, V88, P319, DOI 10.1016/j.jecp.2004.04.003; Dingwell JB, 2000, CHAOS, V10, P848, DOI 10.1063/1.1324008; Dorman LE, 2009, EUR J APPL PHYSIOL, V105, P463, DOI 10.1007/s00421-008-0924-2; DUGGAN A, 1988, ERGONOMICS, V31, P3, DOI 10.1080/00140138808966645; FRASER AM, 1986, PHYS REV A, V33, P1134, DOI 10.1103/PhysRevA.33.1134; Gao ZK, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/30005; Gao ZK, 2015, EXP THERM FLUID SCI, V60, P157, DOI 10.1016/j.expthermflusci.2014.09.008; Gao ZK, 2012, NONLINEAR ANAL-REAL, V13, P947, DOI 10.1016/j.nonrwa.2011.08.029; Gates DH, 2008, EXP BRAIN RES, V187, P573, DOI 10.1007/s00221-008-1326-8; Georgoulis Anastasios D, 2006, J Clin Monit Comput, V20, P11, DOI 10.1007/s10877-006-1032-7; Harbourne RT, 2003, DEV PSYCHOBIOL, V42, P368, DOI 10.1002/dev.10110; Hausdorff JM, 1997, J APPL PHYSIOL, V82, P262; HAUSDORFF JM, 1995, J APPL PHYSIOL, V78, P349, DOI 10.1152/jappl.1995.78.1.349; Hegger R, 1999, CHAOS, V9, P413, DOI 10.1063/1.166424; Herrington Lee, 2005, Res Sports Med, V13, P37, DOI 10.1080/15438620590922077; Kaipust JP, 2012, MOTOR CONTROL, V16, P229, DOI 10.1123/mcj.16.2.229; KENNEL MB, 1992, PHYS REV A, V45, P3403, DOI 10.1103/PhysRevA.45.3403; Kim HS, 1999, PHYSICA D, V127, P48, DOI 10.1016/S0167-2789(98)00240-1; Kugiumtzis D, 1996, PHYSICA D, V95, P13, DOI 10.1016/0167-2789(96)00054-1; Kurz MJ, 2010, NONLIN DYNAM PSYCHOL, V14, P151; Lacasa L, 2008, P NATL ACAD SCI USA, V105, P4972, DOI 10.1073/pnas.0709247105; Madansingh S, 2015, J APPL BIOMECH, V31, P95, DOI [10.1123/JAB.2014-0056, 10.1123/jab.2014-0056]; Magee D., 2008, ORTHOPAEDIC PHYS ASS, V5th ed.; Moraiti C, 2007, KNEE SURG SPORT TR A, V15, P1406, DOI 10.1007/s00167-007-0373-1; Nessler JA, 2015, WEARING WETSUIT ALTE; Nessler JA, 2013, ANN BIOMED ENG, V41, P1680, DOI 10.1007/s10439-012-0657-6; Nessler JA, 2011, MOTOR CONTROL, V15, P390, DOI 10.1123/mcj.15.3.390; Nessler JA, 2009, CHAOS, V19, DOI 10.1063/1.3125762; Newell KM, 2001, HUM MOVEMENT SCI, V20, P695, DOI 10.1016/S0167-9457(01)00073-2; Newell KM, 2000, J EXPT PSYCHOL HUMAN, V29, P379; Niessen MHM, 2009, AM J PHYS MED REHAB, V88, P979, DOI 10.1097/PHM.0b013e3181c1eac1; Norkin CC, 2009, MEASUREMENT JOINT MO; Nuber G W, 1986, Am J Sports Med, V14, P7, DOI 10.1177/036354658601400102; Perc M, 2005, EUR J PHYS, V26, P525, DOI 10.1088/0143-0807/26/3/017; Pincus S.M., 1994, AM J PSYCHOL, V266, P1643; Pincus SM, 1991, CHAOS, V5, P110; Prado A, 2014, WETSUIT EFFECT PHYSL; RICHARDSON AB, 1980, AM J SPORT MED, V8, P159, DOI 10.1177/036354658000800303; Riera F, 2014, AVIAT SPACE ENVIR MD, V85, P509, DOI 10.3357/ASEM.3077.2014; Riley MA, 1999, GAIT POSTURE, V9, P65, DOI 10.1016/S0966-6362(98)00044-7; ROSENSTEIN MT, 1993, PHYSICA D, V65, P117, DOI 10.1016/0167-2789(93)90009-P; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Stergiou N., 2004, INNOVATIVE ANAL HUMA; Stergiou Nicholas, 2006, J Neurol Phys Ther, V30, P120; Tomikawa M, 2008, J SCI MED SPORT, V11, P417, DOI 10.1016/j.jsams.2007.02.005; Tomikawa M, 2009, J SCI MED SPORT, V12, P317, DOI 10.1016/j.jsams.2007.10.009; Turvey MT, 1993, VARIABILITY MOTOR CO; Ulkar B, 2004, BRIT J SPORT MED, V38, P549, DOI 10.1136/bjsm.2002.004275; Van Tiggelen D, 2008, SCAND J MED SCI SPOR, V18, P62, DOI 10.1111/j.1600-0838.2007.00649.x; Wakabayashi Hitoshi, 2007, Journal of Physiological Anthropology, V26, P179, DOI 10.2114/jpa2.26.179; Wakabayashi Hitoshi, 2006, Journal of Physiological Anthropology, V25, P331, DOI 10.2114/jpa2.25.331; Yang Y, 2008, PHYSICA A, V387, P1381, DOI 10.1016/j.physa.2007.10.055; Zhang J, 2008, PHYSICA D, V237, P2856, DOI 10.1016/j.physd.2008.05.008; Zhang J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001033	68	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2015	10	11							e0142325	10.1371/journal.pone.0142325	http://dx.doi.org/10.1371/journal.pone.0142325			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7AC	26551321	Green Published, Green Submitted, gold			2022-12-26	WOS:000364422800024
J	Chen, P; Han, Y; Pan, JX				Chen, Ping; Han, Yan; Pan, Jinxiao			High-Dynamic-Range CT Reconstruction Based on Varying Tube-Voltage Imaging	PLOS ONE			English	Article							EXPOSURE	For complicated structural components characterized by wide X-ray attenuation ranges, the conventional computed tomography (CT) imaging using a single tube-voltage at each rotation angle cannot obtain all structural information. This limitation results in a shortage of CT information, because the effective thickness of the components along the direction of X-ray penetration exceeds the limitation of the dynamic range of the X-ray imaging system. To address this problem, high-dynamic-range CT (HDR-CT) reconstruction is proposed. For this new method, the tube's voltage is adjusted several times to match the corresponding effective thickness about the local information from an object. Then, HDR fusion and HDRCT are applied to obtain the full reconstruction information. An accompanying experiment demonstrates that this new technology can extend the dynamic range of X-ray imaging systems and provide the complete internal structures of complicated structural components.	[Chen, Ping; Han, Yan; Pan, Jinxiao] North Univ China, Natl Key Lab Elect Measurement Technol, Taiyuan 030051, Peoples R China; [Chen, Ping; Han, Yan; Pan, Jinxiao] North Univ China, Key Lab Instrumentat Sci & Dynam Measurement, Taiyuan 030051, Peoples R China	North University of China; North University of China	Chen, P (corresponding author), North Univ China, Natl Key Lab Elect Measurement Technol, Taiyuan 030051, Peoples R China.	pc0912@163.com			National Natural Science Foundation of China [61227003, 61301259, 61571404]; Science Foundation of Shanxi Province [2015021099]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of Shanxi Province	This work is partially supported by grants from the National Natural Science Foundation of China (Nos. 61227003, 61301259, 61571404). This work is also supported by the Science Foundation of Shanxi Province (No. 2015021099).	Fei P, 2012, OPT EXPRESS, V20, P8824, DOI 10.1364/OE.20.008824; FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612; Hausleiter J, 2010, JACC-CARDIOVASC IMAG, V3, P1113, DOI 10.1016/j.jcmg.2010.08.016; Kalender WA, 2006, PHYS MED BIOL, V51, pR29, DOI 10.1088/0031-9155/51/13/R03; Kalra MK, 2004, RADIOLOGY, V233, P649, DOI 10.1148/radiol.2333031150; Kramer P, 2010, MEAS SCI TECHNOL, V21, DOI 10.1088/0957-0233/21/4/045105; Liu B, 2014, J X-RAY SCI TECHNOL, V22, P241, DOI 10.3233/XST-140422; MANN S, 1995, IS&T'S 48TH ANNUAL CONFERENCE - IMAGING ON THE INFORMATION SUPERHIGHWAY, FINAL PROGRAM AND PROCEEDINGS, P442; Mueller K, 1999, IEEE T MED IMAGING, V18, P538, DOI 10.1109/42.781018; Sisniega A, 2014, PHYS MED BIOL, V59, P421, DOI 10.1088/0031-9155/59/2/421; Sun GQ, 2012, NONLINEAR DYNAM, V69, P1097, DOI 10.1007/s11071-012-0330-5; Sun GQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11246; Sun GQ, 2014, COMMUN NONLINEAR SCI, V19, P1507, DOI 10.1016/j.cnsns.2013.09.016; Sun GQ, 2012, APPL MATH COMPUT, V218, P11151, DOI 10.1016/j.amc.2012.04.071; YAN XH, 1991, IEEE T MED IMAGING, V10, P462, DOI 10.1109/42.97597	15	12	12	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141789	10.1371/journal.pone.0141789	http://dx.doi.org/10.1371/journal.pone.0141789			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544723	Green Published, Green Submitted, gold			2022-12-26	WOS:000364398700048
J	Jonas, RA; Wang, YX; Yang, H; Li, JJ; Xu, L; Panda-Jonas, S; Jonas, JB				Jonas, Rahul A.; Wang, Ya Xing; Yang, Hua; Li, Jian Jun; Xu, Liang; Panda-Jonas, Songhomitra; Jonas, Jost B.			Optic Disc - Fovea Angle: The Beijing Eye Study 2011	PLoS One			English	Article							NERVE-FIBER LAYER; SUBFOVEAL CHOROIDAL THICKNESS; VISUAL-FIELD; COMPUTATIONAL MODEL; TEMPORAL RAPHE; OCULAR TORSION; GLAUCOMA; VARIABILITY; FUNDUS; SIZE	Purpose To determine the optic disc-fovea angle (defined as angle between the horizontal and the line between the optic disc center and the fovea) and to assess its relationships with ocular and systemic parameters. Methods The population-based cross-sectional Beijing Eye Study 2011 included 3468 individuals. A detailed ophthalmic examination was carried out. Using fundus photographs, we measured the disc-fovea angle. Results Readable fundus photographs were available for 6043 eyes of 3052 (88.0%) individuals with a mean age of 63.6 +/- 9.3 years (range: 50-91 years) and a mean axial length of 23.2 +/- 1.0 mm (range: 18.96-28.87 mm). Mean disc-fovea angle was 7.76 +/- 3.63 degrees (median: 7.65 degrees; range: -6.3 +/- to 28.9 degrees). The mean inter-eye difference was 4.01 +/- 2.94 degrees (median: 3.49 degrees; range: 0.00-22.3 degrees). In multivariate analysis, larger disc-fovea angle was associated (regression coefficient r(2): 0.08) with older age (P = 0.009; standardized regression coefficient beta: 0.05), thinner RNFL in the nasal superior sector (P < 0.001; beta: -0.17), superior sector (P < 0.001; beta: -0.10) and temporal superior sector (P < 0.001; beta: -0.11) and thicker RNFL in the inferior sector (P < 001; beta: 0.13), nasal inferior sector (P < 001; beta: 0.13) and nasal sector (P = 0.007; beta: 0.06), higher prevalence of retinal vein occlusion (P = 0.02; beta: 0.04), and with larger cylindrical refractive error (P = 0.04; beta: 0.04). Conclusions The optic disc-fovea angle markedly influences the regional distribution of the RNFL thickness pattern. The disc-fovea angle may routinely be taken into account in the morphological glaucoma diagnosis and in the assessment of structure-function relationship in optic nerve diseases. Future studies may address potential associations between a larger disc-fovea angle and retinal vein occlusions and between the disc-fovea angle and the neuroretinal rim shape.	[Jonas, Rahul A.; Wang, Ya Xing; Yang, Hua; Li, Jian Jun; Xu, Liang; Jonas, Jost B.] Capital Med Univ, Beijing Tongren Hosp, Beijing Ophthalmol & Visual Sci Key Lab, Beijing Inst Ophthalmol,Beijing Tongren Eye Ctr, Beijing, Peoples R China; [Jonas, Rahul A.; Panda-Jonas, Songhomitra; Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Mannheim, Germany	Capital Medical University; Ruprecht Karls University Heidelberg	Wang, YX (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Beijing Ophthalmol & Visual Sci Key Lab, Beijing Inst Ophthalmol,Beijing Tongren Eye Ctr, Beijing, Peoples R China.	yaxingw@gmail.com	wang, YA XING/K-9671-2016; Jonas, Rahul A/N-9304-2017	wang, YA XING/0000-0003-2749-7793; Jonas, Rahul/0000-0002-5389-3047	State Natural Sciences Fund [81041018]; Natural Sciences Fund of Beijing government [7092021, 7112031]	State Natural Sciences Fund(National Natural Science Foundation of China (NSFC)); Natural Sciences Fund of Beijing government	This work was supported by State Natural Sciences Fund (81041018) and the Natural Sciences Fund of Beijing government (7092021; 7112031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amini N, 2014, INVEST OPHTH VIS SCI, V55, P7332, DOI 10.1167/iovs.14-14962; Asaoka R, 2012, INVEST OPHTH VIS SCI, V53, P8396, DOI 10.1167/iovs.12-9794; Chauhan BC, 2014, OPHTHALMOLOGY, V121, P2287, DOI 10.1016/j.ophtha.2014.06.023; Choi JA, 2014, INVEST OPHTH VIS SCI, V55, P1419, DOI 10.1167/iovs.13-13604; Denniss J, 2014, INVEST OPHTH VIS SCI, V55, P1985, DOI 10.1167/iovs.13-13758; Denniss J, 2014, INVEST OPHTH VIS SCI, V55, P728, DOI 10.1167/iovs.13-13142; Denniss J, 2012, INVEST OPHTH VIS SCI, V53, P6981, DOI 10.1167/iovs.12-9657; Ganeshrao SB, 2015, OPHTHALMOLOGY, V122, P1695, DOI 10.1016/j.ophtha.2015.04.021; Garway-Heath DF, 2000, OPHTHALMOLOGY, V107, P1809, DOI 10.1016/S0161-6420(00)00284-0; Huang G, 2014, INVEST OPHTH VIS SCI, V55, P5952, DOI 10.1167/iovs.14-14893; Hwang YH, 2012, J GLAUCOMA, V21, P260, DOI 10.1097/IJG.0b013e31820719e1; Jansonius NM, 2012, EXP EYE RES, V105, P70, DOI 10.1016/j.exer.2012.10.008; Jethani J, 2010, INDIAN J OPHTHALMOL, V58, P417, DOI 10.4103/0301-4738.67060; JONAS JB, 1989, OPHTHALMOLOGY, V96, P627; JONAS JB, 1988, INVEST OPHTH VIS SCI, V29, P1151; Jonas JB, 1997, OPHTHALMOLOGY, V104, P1934, DOI 10.1016/S0161-6420(97)30004-9; JONAS JB, 1988, GRAEF ARCH CLIN EXP, V226, P531, DOI 10.1007/BF02169200; Jonas JB, 1997, AM J OPHTHALMOL, V124, P488, DOI 10.1016/S0002-9394(14)70864-5; Jonas JB, 2013, INVEST OPHTH VIS SCI, V54, P1295, DOI 10.1167/iovs.12-11352; Kim KE, 2015, OPHTHALMOLOGY, V122, P502, DOI 10.1016/j.ophtha.2014.09.031; Lamparter J, 2013, INVEST OPHTH VIS SCI, V54, P6074, DOI 10.1167/iovs.13-11902; LITTMANN H, 1982, KLIN MONATSBL AUGENH, V180, P286, DOI 10.1055/s-2008-1055068; Medeiros FA, 2012, INVEST OPHTH VIS SCI, V53, P6939, DOI 10.1167/iovs.12-10345; Pekel G, 2014, KAOHSIUNG J MED SCI, V30, P531, DOI 10.1016/j.kjms.2014.08.003; Piedrahita-Alonso E, 2014, BRIT J OPHTHALMOL, V98, P115, DOI 10.1136/bjophthalmol-2013-303680; Rohrschneider K, 2004, INVEST OPHTH VIS SCI, V45, P3257, DOI 10.1167/iovs.03-1157; Shao L, 2015, INVEST OPHTH VIS SCI, V56, P810, DOI 10.1167/iovs.14-15736; Shin KH, 2013, AM J OPHTHALMOL, V155, P177, DOI 10.1016/j.ajo.2012.07.011; Vurgese S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029692; Wang YX, 2010, AM J OPHTHALMOL, V150, P917, DOI 10.1016/j.ajo.2010.06.037; Wei WB, 2013, OPHTHALMOLOGY, V120, P175, DOI 10.1016/j.ophtha.2012.07.048; Xu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111320; Xu L, 2007, OPHTHALMOLOGY, V114, P121, DOI 10.1016/j.ophtha.2006.05.071	33	40	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141771	10.1371/journal.pone.0141771	http://dx.doi.org/10.1371/journal.pone.0141771			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545259	gold, Green Submitted, Green Published			2022-12-26	WOS:000364398700044
J	Lopez-Campos, JL; Arranz, MA; Acuna, CC; Valero, FR; Garcia, RA; Molina, AH; Perez-Grovas, RIA; Gil, FG; Maldonado, FC; Ballesteros, LC; Palop, MS; Perez-Tejero, D; Segado, A; Bonachera, JC; Sierra, BH; Domenech, A; Varela, MA; Vargas, FG; Rueda, JJC				Luis Lopez-Campos, Jose; Abad Arranz, Maria; Calero Acuna, Carmen; Romero Valero, Fernando; Ayerbe Garcia, Ruth; Hidalgo Molina, Antonio; Aguilar Perez-Grovas, Ricardo Ismael; Garcia Gil, Francisco; Casas Maldonado, Francisco; Caballero Ballesteros, Laura; Sanchez Palop, Maria; Perez-Tejero, Dolores; Segado, Alejandro; Calvo Bonachera, Jose; Hernandez Sierra, Barbara; Domenech, Adolfo; Arroyo Varela, Macarena; Gonzalez Vargas, Francisco; Cruz Rueda, Juan Jose			Clinical Audits in Outpatient Clinics for Chronic Obstructive Pulmonary Disease: Methodological Considerations and Workflow	PLOS ONE			English	Article							EUROPEAN COPD AUDIT; QUALITY-OF-CARE; HEALTH-CARE; EXACERBATIONS; ORGANIZATION; MANAGEMENT; VARIABILITY; PERFORMANCE; GUIDELINES; ADMISSIONS	Objectives Previous clinical audits for chronic obstructive pulmonary disease (COPD) have provided valuable information on the clinical care delivered to patients admitted to medical wards because of COPD exacerbations. However, clinical audits of COPD in an outpatient setting are scarce and no methodological guidelines are currently available. Based on our previous experience, herein we describe a clinical audit for COPD patients in specialized outpatient clinics with the overall goal of establishing a potential methodological workflow. Methods A pilot clinical audit of COPD patients referred to respiratory outpatient clinics in the region of Andalusia, Spain (over 8 million inhabitants), was performed. The audit took place between October 2013 and September 2014, and 10 centers (20% of all public hospitals) were invited to participate. Cases with an established diagnosis of COPD based on risk factors, clinical symptoms, and a post-bronchodilator FEV1/FVC ratio of less than 0.70 were deemed eligible. The usefulness of formally scheduled regular follow-up visits was assessed. Two different databases (resources and clinical database) were constructed. Assessments were planned over a year divided by 4 three-month periods, with the goal of determining seasonal-related changes. Exacerbations and survival served as the main endpoints. Conclusions This paper describes a methodological framework for conducting a clinical audit of COPD patients in an outpatient setting. Results from such audits can guide health information systems development and implementation in real-world settings.	[Luis Lopez-Campos, Jose; Abad Arranz, Maria; Calero Acuna, Carmen] Univ Seville, Hosp Univ Virgen del Rocio, Inst Biomed Sevilla IBiS, Unidad Med Quirurg Enfermedades Resp, Seville, Spain; [Luis Lopez-Campos, Jose; Calero Acuna, Carmen] Inst Salud Carlos III, CIBER Enfermedades Resp CIBERES, Madrid, Spain; [Romero Valero, Fernando; Hidalgo Molina, Antonio] Hosp Puerta Mar, Cadiz, Spain; [Ayerbe Garcia, Ruth; Aguilar Perez-Grovas, Ricardo Ismael] Hosp Juan Ramon Jimenez, Huelva, Spain; [Casas Maldonado, Francisco; Sanchez Palop, Maria] Hosp Univ Reina Sofia, Cordoba, Spain; [Casas Maldonado, Francisco; Sanchez Palop, Maria] Hosp Univ San Cecilio, Granada, Spain; [Perez-Tejero, Dolores; Segado, Alejandro] Hosp Infanta Margarita, Cordoba, Spain; [Calvo Bonachera, Jose; Hernandez Sierra, Barbara] Hosp Torrecardenas, Almeria, Spain; [Domenech, Adolfo; Arroyo Varela, Macarena] Hosp Reg Univ Malaga, Malaga, Spain; [Gonzalez Vargas, Francisco; Cruz Rueda, Juan Jose] Hosp Univ Virgen Nieves, Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Universidad de Cadiz; Hospital Universitario Puerta del Mar; Hospital Juan Ramon Jimenez; Hospital Universitario Reina Sofia - Cordoba; Hospital Universitario San Cecilio; Hospital Torrecardenas; Hospital Universitario Virgen de las Nieves	Lopez-Campos, JL (corresponding author), Univ Seville, Hosp Univ Virgen del Rocio, Inst Biomed Sevilla IBiS, Unidad Med Quirurg Enfermedades Resp, Seville, Spain.	lcampos@separ.es	Bodineau, José Luis López-Campos/AAG-5203-2019	Bodineau, José Luis López-Campos/0000-0003-1703-1367; Domenech del Rio, Adolfo/0000-0002-3127-9150	Laboratorios Menarini, SA (Barcelona, Spain)	Laboratorios Menarini, SA (Barcelona, Spain)	This study was financially supported by an unrestricted grant from Laboratorios Menarini, SA (Barcelona, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agabiti N, 2010, EUR RESPIR J, V35, P1031, DOI 10.1183/09031936.00056209; Asch SM, 2006, NEW ENGL J MED, V354, P1147, DOI 10.1056/NEJMsa044464; Berwick DM, 2003, MEDICAL CARE SUPPL, V41, pl30; Blumenthal D, 2010, NEW ENGL J MED, V363, P501, DOI 10.1056/NEJMp1006114; Esposito Pasquale, 2014, World J Nephrol, V3, P249, DOI 10.5527/wjn.v3.i4.249; Flottorp SA, 2010, USING AUDIT FEEDBACK, VIX; Gerber JS, 2014, JAMA-J AM MED ASSOC, V312, P2569, DOI 10.1001/jama.2014.14042; Heffner JE, 2010, CHEST, V137, P1181, DOI 10.1378/chest.09-2306; Hosker H, 2007, RESP MED, V101, P754, DOI 10.1016/j.rmed.2006.08.016; Hunter MG, 2012, SEX HEALTH, V9, P495, DOI 10.1071/SH11192; Soler-Cataluna JJ, 2009, ARCH BRONCONEUMOL, V45, P196, DOI 10.1016/j.arbres.2008.05.008; Joynt KE, 2011, JAMA-J AM MED ASSOC, V306, P45, DOI 10.1001/jama.2011.902; Kim C, 2014, INT J TUBERC LUNG D, V18, P737, DOI 10.5588/ijtld.13.0634; Liaaen ED, 2010, RESP MED, V104, P1304, DOI 10.1016/j.rmed.2010.03.007; Lopez-Campos JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110394; Lopez-Campos JL, 2014, EUR RESPIR J, V43, P754, DOI 10.1183/09031936.00074413; Lopez-Campos JL, 2014, LANCET RESP MED, V2, P54, DOI 10.1016/S2213-2600(13)70232-7; Lopez-Campos JL, 2013, EUR RESPIR J, V41, P270, DOI 10.1183/09031936.00021812; McIntyre N, 1995, J Eval Clin Pract, V1, P5; Merlo J, 2003, J EPIDEMIOL COMMUN H, V57, P550, DOI 10.1136/jech.57.8.550; Miravitlles M, 2014, ARCH BRONCONEUMOL, V50, P1, DOI 10.1016/S0300-2896(14)70070-5; Miravitlles M, 2012, ARCH BRONCONEUMOL, V48, P247, DOI 10.1016/j.arbres.2012.04.001; Nardini S, 2014, MULTIDISCIP RESP MED, V9, DOI 10.1186/2049-6958-9-40; Nonato NL, 2015, ARCH BRONCONEUMOL, V51, P315, DOI 10.1016/j.arbres.2014.02.017; Pozo-Rodriguez F, 2015, INT J CLIN PRACT, V69, P938, DOI 10.1111/ijcp.12601; Pozo-Rodriguez F, 2010, ARCH BRONCONEUMOL, V46, P349, DOI 10.1016/j.arbres.2010.04.004; Pretto JJ, 2012, INTERN MED J, V42, P380, DOI 10.1111/j.1445-5994.2011.02475.x; Roberts CM, 2013, THORAX, V68, P1169, DOI 10.1136/thoraxjnl-2013-203465; Roberts CM, 2001, EUR RESPIR J, V17, P343, DOI 10.1183/09031936.01.17303430; SIMPSON FG, 1987, BRIT J DIS CHEST, V81, P150, DOI 10.1016/0007-0971(87)90133-1; Stewart I C, 1984, Health Bull (Edinb), V42, P45; Trevest Katie, 2014, Clin Diabetes, V32, P158, DOI 10.2337/diaclin.32.4.158; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP	33	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141856	10.1371/journal.pone.0141856	http://dx.doi.org/10.1371/journal.pone.0141856			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544556	Green Published, gold, Green Submitted			2022-12-26	WOS:000364398700055
J	Sosa-Hernandez, E; Ballesteros-Rodea, G; Arias-Del-Angel, JA; Devora-Canales, D; Manning-Cela, RG; Santana-Solano, J; Santillan, M				Sosa-Hernandez, Eduardo; Ballesteros-Rodea, Gilberto; Arias-del-Angel, Jorge A.; Devora-Canales, Diego; Manning-Cela, Rebeca G.; Santana-Solano, Jesus; Santillan, Moises			Experimental and Mathematical-Modeling Characterization of Trypanosoma cruzi Epimastigote Motility	PLOS ONE			English	Article							FLAGELLUM; INFECTION	The present work is aimed at characterizing the motility of parasite T. cruzi in its epimastigote form. To that end, we recorded the trajectories of two strains of this parasite (a wildtype strain and a stable transfected strain, which contains an ectopic copy of LYT1 gene and whose motility is known to be affected). We further extracted parasite trajectories from the recorded videos, and statistically analysed the following trajectory-step features: step length, angular change of direction, longitudinal and transverse displacements with respect to the previous step, and mean square displacement. Based on the resulting observations, we developed a mathematical model to simulate parasite trajectories. The fact that the model predictions closely match most of the experimentally observed parasite-trajectory characteristics, allows us to conclude that the model is an accurate description of T. cruzi motility.	[Sosa-Hernandez, Eduardo; Arias-del-Angel, Jorge A.; Devora-Canales, Diego; Santana-Solano, Jesus; Santillan, Moises] Ctr Invest & Estudios Avanzados IPN, Unidad Monterrey, Apodaca Nl, Mexico; [Ballesteros-Rodea, Gilberto] Univ Autonoma San Luis Potosi, Fac Agron & Vet, SLP, San Luis Potosi, Mexico; [Manning-Cela, Rebeca G.] Ctr Invest & Estudios Avanzados IPN, Dept Biomed Mol, Mexico City, DF, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Universidad Autonoma de San Luis Potosi; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Santillan, M (corresponding author), Ctr Invest & Estudios Avanzados IPN, Unidad Monterrey, Apodaca Nl, Mexico.	msantillan@cinvestav.mx	Sosa-Hernández, Juan Eduardo/C-3436-2017; Santillan, Moises/A-2942-2008	Sosa-Hernández, Juan Eduardo/0000-0001-5441-4768; Santillan, Moises/0000-0001-8605-7451; Ballesteros-Rodea, Gilberto/0000-0001-5283-6975	Consejo Nacional de Ciencia y Tecnologia [60152]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by Consejo Nacional de Ciencia y Tecnologia, http://www.conacyt.mx, Grant 60152, awarded to R M-C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballesteros-Rodea G, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/520380; Ballesteros-Rodea G, 2012, VET MEXICO, V43, P29; Berg, 2018, RANDOM WALKS BIOL; Berg H C, 2003, E COLI MOTION; Bern C, 2015, NEW ENGL J MED, V373, P1882, DOI [10.1056/NEJMra1410150, 10.1056/NEJMc1510996]; BRENER Z, 1963, Rev Inst Med Trop Sao Paulo, V5, P220; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; de Souza W, 2010, MICROBIOL MONOGR, V17, P27, DOI 10.1007/978-3-642-12863-9_2; Finkelsztein EJ, 2015, EXP PARASITOL, V150, P36, DOI 10.1016/j.exppara.2015.01.007; Freire-de-Lima L, 2015, GLYCOBIOLOGY, V25, P1142, DOI 10.1093/glycob/cwv057; Hernandez-Ortiz JP, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.204501; Johnson CA, 2013, INFECT IMMUN, V81, P4139, DOI 10.1128/IAI.01459-12; Kohl L, 2003, EMBO J, V22, P5336, DOI 10.1093/emboj/cdg518; Langousis G, 2014, NAT REV MICROBIOL, V12, P505, DOI 10.1038/nrmicro3274; Lugo-Caballero C, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/493525; Pereira PCM, 2013, J VENOM ANIM TOXINS, V19, DOI 10.1186/1678-9199-19-34; Nardy AF, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/178947; OTHMER HG, 1988, J MATH BIOL, V26, P263, DOI 10.1007/BF00277392; Rodriguez A, 1997, J CELL BIOL, V137, P93, DOI 10.1083/jcb.137.1.93; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Sibley LD, 2000, TRAFFIC, V1, P100, DOI 10.1034/j.1600-0854.2000.010202.x; Theves M, 2013, BIOPHYS J, V105, P1915, DOI 10.1016/j.bpj.2013.08.047; Uppaluri S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002058; Weisse S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037296; Wu XL, 2000, PHYS REV LETT, V84, P3017, DOI 10.1103/PhysRevLett.84.3017	25	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142478	10.1371/journal.pone.0142478	http://dx.doi.org/10.1371/journal.pone.0142478			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544863	Green Published, Green Submitted, gold			2022-12-26	WOS:000364398700145
J	Wang, ZH; Zhou, J; Luo, XL; Xu, Y; She, X; Chen, L; Yin, HH; Wang, XY				Wang, Zonghua; Zhou, Juan; Luo, Xingli; Xu, Yan; She, Xi; Chen, Ling; Yin, Honghua; Wang, Xianyuan			Rasch Analysis of the Adult Strabismus Quality of Life Questionnaire (AS-20) among Chinese Adult Patients with Strabismus	PLoS One			English	Article							PSYCHOSOCIAL-ASPECTS; VERSION; VISION	Background The impact of strabismus on visual function, self-image, self-esteem, and social interactions decrease health-related quality of life (HRQoL). The purpose of this study was to evaluate and refine the adult strabismus quality of life questionnaire (AS-20) by using Rasch analysis among Chinese adult patients with strabismus. Methods We evaluated the fitness of the AS-20 with Rasch model in Chinese population by assessing unidimensionality, infit and outfit, person and item separation index and reliability, response ordering, targeting and differential item functioning (DIF). Results The overall AS-20 did not demonstrate unidimensional; however, it was achieved separately in the two Rasch-revised subscales: the psychosocial subscale (11 items) and the function subscale (9 items). The features of good targeting, optimal item infit and outfit, and no notable local dependence were found for each of the subscales. The rating scale was appropriate for the psychosocial subscale but a reduction to four response categories was required for the function subscale. No significant DIF were revealed for any demographic and clinical factors (e.g., age, gender, and strabismus types). Conclusion The AS-20 was demonstrated by Rasch analysis to be a rigorous instrument for measuring health-related quality of life in Chinese strabismus patents if some revisions were made regarding the subscale construct and response options.	[Wang, Zonghua; Zhou, Juan; Wang, Xianyuan] Third Mil Med Univ, Sch Nursing, Chongqing, Peoples R China; [Luo, Xingli; Yin, Honghua] Third Mil Med Univ, Daping Hosp, Dept Ophthalmol, Chongqing, Peoples R China; [Xu, Yan] Third Mil Med Univ, Southwest Eye Hosp, Dept Ophthalmol, Chongqing, Peoples R China; [She, Xi] Third Mil Med Univ, Xinqiao Hosp, Dept Ophthalmol, Chongqing, Peoples R China; [Chen, Ling] PLA, Hosp 324, Dept Gastroenterol, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University; Army Medical University	Wang, XY (corresponding author), Third Mil Med Univ, Sch Nursing, Chongqing, Peoples R China.	xywang_tmmu@sina.cn			 [cstc2013jcsf10014];  [cstc2012jjA10145]	; 	This work was supported by cstc2013jcsf10014 and cstc2012jjA10145 (http://www.ctin.ac.cn). The funder provided the analysis tool, and helped with data analysis and interpretation.	Beaton DE, 2003, CLIN ORTHOP RELAT R, P90, DOI 10.1097/01.blo.0000079772.06654.c8; Bian W, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0269-6; Gothwal VK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127064; Gothwal VK, 2013, INVEST OPHTH VIS SCI, V54, P4871, DOI 10.1167/iovs.13-11892; Gunton KB, 2014, CURR OPIN OPHTHALMOL, V25, P406, DOI 10.1097/ICU.0000000000000087; Hagquist C, 2009, INT J NURS STUD, V46, P380, DOI 10.1016/j.ijnurstu.2008.10.007; Hambleton RK, 2006, MED CARE, V44, pS182, DOI 10.1097/01.mlr.0000245443.86671.c4; Hatt SR, 2007, AM J OPHTHALMOL, V144, P643, DOI 10.1016/j.ajo.2007.06.032; Hatt SR, 2009, OPHTHALMOLOGY, V116, P139, DOI 10.1016/j.ophtha.2008.08.043; Khadka J, 2014, INVEST OPHTH VIS SCI, V55, P4413, DOI 10.1167/iovs.14-14017; Khadka J, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-80; Khadka J, 2011, INVEST OPHTH VIS SCI, V52, P6971, DOI 10.1167/iovs.11-7423; Leske DA, 2012, INVEST OPHTH VIS SCI, V53, P2630, DOI 10.1167/iovs.11-8308; Mallinson T, 2007, OPTOMETRY VISION SCI, V84, P675, DOI 10.1097/OPX.0b013e3181339f44; Menon V, 2002, J PEDIAT OPHTH STRAB, V39, P203, DOI 10.3928/0191-3913-20020701-07; Prieto Luis, 2003, Health Qual Life Outcomes, V1, P27, DOI 10.1186/1477-7525-1-27; SATTERFIELD D, 1993, ARCH OPHTHALMOL-CHIC, V111, P1100, DOI 10.1001/archopht.1993.01090080096024; Tennant A, 2004, MED CARE, V42, P37, DOI 10.1097/01.mlr.0000103529.63132.77; Wang CW, 2008, OPTOMETRY VISION SCI, V85, P1091, DOI 10.1097/OPX.0b013e31818b9f23; Wang ZH, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-180; Wang ZH, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-139; Xu JL, 2012, J PEDIAT OPHTH STRAB, V49, P170, DOI 10.3928/01913913-20110920-02; Yu HY, 2013, OPHTHAL EPIDEMIOL, V20, P239, DOI 10.3109/09286586.2013.809771; Zammit AR, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-64	24	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142188	10.1371/journal.pone.0142188	http://dx.doi.org/10.1371/journal.pone.0142188			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544048	gold, Green Submitted, Green Published			2022-12-26	WOS:000364398700093
J	Lee, S; Evans, MA; Chu, HX; Kim, HA; Widdop, RE; Drummond, GR; Sobey, CG				Lee, Seyoung; Evans, Megan A.; Chu, Hannah X.; Kim, Hyun Ah; Widdop, Robert E.; Drummond, Grant R.; Sobey, Christopher G.			Effect of a Selective Mas Receptor Agonist in Cerebral Ischemia In Vitro and In Vivo	PLOS ONE			English	Article							ANGIOTENSIN-(1-7) RECEPTOR; CAUSES NEUROPROTECTION; COMPOUND 21; BRAIN; MODEL; EXPRESSION; PATHWAY; STROKE; MOUSE; CEREBROPROTECTION	Functional modulation of the non-AT(1)R arm of the renin-angiotensin system, such as via AT(2)R activation, is known to improve stroke outcome. However, the relevance of the Mas receptor, which along with the AT(2)R forms the protective arm of the renin-angiotensin system, as a target in stroke is unclear. Here we tested the efficacy of a selective MasR agonist, AVE0991, in in vitro and in vivo models of ischemic stroke. Primary cortical neurons were cultured from E15-17 mouse embryos for 7-9 d, subjected to glucose deprivation for 24 h alone or with test drugs, and percentage cell death was determined using trypan blue exclusion assay. Additionally, adult male mice were subjected to 1 h middle cerebral artery occlusion and were administered either vehicle or AVE0991 (20 mg/kg i.p.) at the commencement of 23 h reperfusion. Some animals were also treated with the MasR antagonist, A779 (80 mg/kg i.p.) 1 h prior to surgery. Twenty-four h after MCAo, neurological deficits, locomotor activity and motor coordination were assessed in vivo, and infarct and edema volumes estimated from brain sections. Following glucose deprivation, application of AVE0991 (10(-8) M to 10(-6) M) reduced neuronal cell death by similar to 60% (P<0.05), an effect prevented by the MasR antagonist. By contrast, AVE0991 administration in vivo had no effect on functional or histological outcomes at 24 h following stroke. These findings indicate that the classical MasR agonist, AVE0991, can directly protect neurons from injury following glucose-deprivation. However, this effect does not translate into an improved outcome in vivo when administered systemically following stroke.	[Lee, Seyoung; Evans, Megan A.; Chu, Hannah X.; Kim, Hyun Ah; Widdop, Robert E.; Drummond, Grant R.; Sobey, Christopher G.] Monash Univ, Dept Pharmacol, Vasc Biol & Immunopharmacol Grp, Clayton, Vic 3800, Australia; [Lee, Seyoung; Evans, Megan A.; Chu, Hannah X.; Kim, Hyun Ah; Widdop, Robert E.; Drummond, Grant R.; Sobey, Christopher G.] Monash Univ, Biomed Discovery Inst, Cardiovasc Dis Program, Clayton, Vic 3800, Australia; [Drummond, Grant R.; Sobey, Christopher G.] Monash Univ, Dept Surg, Southern Clin Sch, Clayton, Vic 3800, Australia	Monash University; Monash University; Monash University	Sobey, CG (corresponding author), Monash Univ, Dept Pharmacol, Vasc Biol & Immunopharmacol Grp, Clayton, Vic 3800, Australia.	chris.sobey@monash.edu	Sobey, Christopher G/A-2786-2008	Sobey, Christopher G/0000-0001-6525-9097; Drummond, Grant/0000-0001-8556-9738; Kim, Hyun Ah/0000-0002-3175-9218; Widdop, Robert/0000-0002-6515-0435	National Health and Medical Research Council of Australia (NHMRC) [APP1041326, APP1064686, APP1062721]; NHMRC Senior Research Fellowships [CGS: APP1079467, GRD: APP1006017]; Monash Faculty Postgraduate Scholarship; Australian Postgraduate Award	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Senior Research Fellowships(National Health and Medical Research Council (NHMRC) of Australia); Monash Faculty Postgraduate Scholarship; Australian Postgraduate Award(Australian Government)	These studies were supported by Project Grants from the National Health and Medical Research Council of Australia (NHMRC) (APP1041326; APP1064686; APP1062721). The authors also acknowledge support from NHMRC Senior Research Fellowships (CGS: APP1079467; GRD: APP1006017), a Monash Faculty Postgraduate Scholarship (MAE), and an Australian Postgraduate Award (HXC).	Alhusban A, 2015, J HYPERTENS, V33, P170, DOI 10.1097/HJH.0000000000000364; Barroso L. C., 2012, INT J HYPERTENS, V2012, DOI DOI 10.1155/2012/808726; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Bosnyak S, 2011, CLIN SCI, V121, P297, DOI 10.1042/CS20110036; Calo LA, 2010, J NEPHROL, V23, P472; da Silveira KD, 2010, J IMMUNOL, V185, P5569, DOI 10.4049/jimmunol.1000314; Der Sarkissian S, 2006, PROG BIOPHYS MOL BIO, V91, P163, DOI 10.1016/j.pbiomolbio.2005.05.011; Heckman LD, 2014, ELIFE, V3, DOI 10.7554/eLife.02676; Iwata M, 2011, J MOL CELL CARDIOL, V51, P542, DOI 10.1016/j.yjmcc.2010.12.003; Jackman KA, 2009, BRIT J PHARMACOL, V156, P680, DOI 10.1111/j.1476-5381.2008.00073.x; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Jew CP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070415; Jiang T, 2014, BRIT J PHARMACOL, V171, P4222, DOI 10.1111/bph.12770; Jiang T, 2012, BRIT J PHARMACOL, V167, P1520, DOI 10.1111/j.1476-5381.2012.02105.x; Joseph JP, 2014, NEUROPHARMACOLOGY, V81, P134, DOI 10.1016/j.neuropharm.2014.01.044; Kamens HM, 2005, GENES BRAIN BEHAV, V4, P253, DOI 10.1111/j.1601-183X.2004.00100.x; Lee Seyoung, 2012, Exp Transl Stroke Med, V4, P16, DOI 10.1186/2040-7378-4-16; Lu J, 2013, NEUROPEPTIDES, V47, P289, DOI 10.1016/j.npep.2013.09.002; McCarthy CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095762; McCarthy CA, 2012, HYPERTENSION, V60, P1531, DOI 10.1161/HYPERTENSIONAHA.112.199646; McCarthy CA, 2009, STROKE, V40, P1482, DOI 10.1161/STROKEAHA.108.531509; Mecca AP, 2011, EXP PHYSIOL, V96, P1084, DOI 10.1113/expphysiol.2011.058578; METZGER R, 1995, FEBS LETT, V357, P27, DOI 10.1016/0014-5793(94)01292-9; Passos-Silva DG, 2013, CLIN SCI, V124, P443, DOI 10.1042/CS20120461; Pinheiro SVB, 2004, HYPERTENSION, V44, P490, DOI 10.1161/01.HYP.0000141438.64887.42; Regenhardt RW, 2013, NEUROPHARMACOLOGY, V71, P154, DOI 10.1016/j.neuropharm.2013.03.025; Santos RAS, 2003, P NATL ACAD SCI USA, V100, P8258, DOI 10.1073/pnas.1432869100; Savergnini SQ, 2010, HYPERTENSION, V56, P112, DOI 10.1161/HYPERTENSIONAHA.110.152942; Switonski PM, 2015, NEUROBIOL DIS, V73, P174, DOI 10.1016/j.nbd.2014.09.020; Tesanovic S, 2010, ARTERIOSCL THROM VAS, V30, P1606, DOI 10.1161/ATVBAHA.110.204453; Wiemer G, 2002, HYPERTENSION, V40, P847, DOI 10.1161/01.HYP.0000037979.53963.8F; Xia HJ, 2008, J NEUROCHEM, V107, P1482, DOI 10.1111/j.1471-4159.2008.05723.x; Xu P, 2011, AM J PHYSIOL-REG I, V300, pR804, DOI 10.1152/ajpregu.00222.2010; Zhang YD, 2008, NEUROPEPTIDES, V42, P593, DOI 10.1016/j.npep.2008.09.005; Zhao Y, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00010	35	18	19	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142087	10.1371/journal.pone.0142087	http://dx.doi.org/10.1371/journal.pone.0142087			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540167	Green Submitted, gold, Green Published			2022-12-26	WOS:000364303800053
J	Lilly, MA; Kulkulka, NA; Firmiss, PR; Ross, MJ; Flum, AS; Delos Santos, GB; Bowen, DK; Dettman, RW; Gong, EM				Lilly, Meredith A.; Kulkulka, Natalie A.; Firmiss, Paula R.; Ross, Michael J.; Flum, Andrew S.; Delos Santos, Grace B.; Bowen, Diana K.; Dettman, Robert W.; Gong, Edward M.			The Murine Bladder Supports a Population of Stromal Sca-1(+)/CD34(+)/lin(-) Mesenchymal Stem Cells	PLoS One			English	Article							PROGENITOR CELLS; SMOOTH-MUSCLE; SCA-1; PROLIFERATION; REGENERATION; EXPRESSION; CONTRIBUTE; FAILURE; VESSELS; PLAYS	Bladder fibrosis is an undesired end point of injury of obstruction and often renders the smooth muscle layer noncompliant. In many cases, the long-term effect of bladder fibrosis is renal failure. Despite our understanding of the progression of this disease, little is known about the cellular mechanisms that lead to a remodeled bladder wall. Resident stem (progenitor) cells have been identified in various organs such as the brain, heart and lung. These cells function normally during organ homeostasis, but become dysregulated after organ injury. Here, we aimed to characterize a mesenchymal progenitor cell population as a first step in understanding its role in bladder fibrosis. Using fluorescence activated cell sorting (FACS), we identified a Sca-1(+)/CD34(+)/lin(-) (PECAM(-): CD45(-): Ter119(-)) population in the adult murine bladder. These cells were localized to the stromal layer of the adult bladder and appeared by postnatal day 1. Cultured Sca-1(+)/CD34(+)/lin(-) bladder cells self-renewed, formed colonies and spontaneously differentiated into cells expressing smooth muscle genes. These cells differentiated into other mesenchymal lineages (chondrocytes, adipocytes and osteocytes) upon culture in induction medium. Both acute and partial obstruction of the bladder reduced expression of CD34 and changed localization of Sca-1 to the urothelium. Partial obstruction resulted in upregulation of fibrosis genes within the Sca-1(+)/CD34(+)/lin(-) population. Our data indicate a resident, mesenchymal stem cell population in the bladder that is altered by bladder obstruction. These findings provide new information about the cellular changes in the bladder that may be associated with bladder fibrosis.	[Flum, Andrew S.; Bowen, Diana K.; Dettman, Robert W.; Gong, Edward M.] Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA; [Lilly, Meredith A.; Kulkulka, Natalie A.; Firmiss, Paula R.; Flum, Andrew S.; Bowen, Diana K.; Dettman, Robert W.; Gong, Edward M.] Anne & Robert H Lurie Childrens Hosp Chicago, Dev Biol, Stanley Manne Childrens Res Inst, Chicago, IL 60611 USA; [Ross, Michael J.; Delos Santos, Grace B.] Loyola Univ Hlth Syst, Dept Urol, Maywood, IL USA	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Loyola University Chicago	Dettman, RW (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Urol, 303 E Chicago Ave,16-703, Chicago, IL 60611 USA.	r-dettman@northwestern.edu; emgong@northwestern.edu		Dettman, Robert/0000-0002-3074-5922	EMG's start-up funds; Hartwell Foundation Individual Biomedical Research Awards; Northwestern Department of Urology; Hartwell Individual Biomedical Research Award	EMG's start-up funds; Hartwell Foundation Individual Biomedical Research Awards; Northwestern Department of Urology; Hartwell Individual Biomedical Research Award	This work was funded by EMG's start-up funds given to him by Anne and Robert H Lurie Children's Hospital. Additional funding was provided by The Hartwell Foundation Individual Biomedical Research Awards and the Northwestern Department of Urology. EMG is a recipient of a Hartwell Individual Biomedical Research Award.	Ahn S, 2004, CELL, V118, P505, DOI 10.1016/j.cell.2004.07.023; Browning CL, 1998, DEV BIOL, V194, P18, DOI 10.1006/dbio.1997.8808; Burmeister D, 2010, TISSUE ENG PT A, V16, P2541, DOI 10.1089/ten.TEA.2009.0697; Epting CL, 2008, EXP CELL RES, V314, P1125, DOI 10.1016/j.yexcr.2007.11.010; Ghamra Ziad W, 2003, Cleve Clin J Med, V70 Suppl 1, pS2; Hannenhalli S, 2006, CIRCULATION, V114, P1269, DOI 10.1161/CIRCULATIONAHA.106.632430; Houlihan DD, 2012, NAT PROTOC, V7, P2103, DOI 10.1038/nprot.2012.125; Hu YH, 2004, J CLIN INVEST, V113, P1258, DOI 10.1172/JCI200419628; Jaureguizar Enrique, 2002, Curr Urol Rep, V3, P115, DOI 10.1007/s11934-002-0021-8; Kafadar KA, 2009, DEV BIOL, V326, P47, DOI 10.1016/j.ydbio.2008.10.036; Kanematsu A, 2005, AM J PATHOL, V166, P565, DOI 10.1016/S0002-9440(10)62278-X; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kramann R, 2015, CELL STEM CELL, V16, P51, DOI 10.1016/j.stem.2014.11.004; Long KK, 2011, FASEB J, V25, P1156, DOI 10.1096/fj.10-170308; Ma XQ, 2002, STEM CELLS, V20, P514, DOI 10.1634/stemcells.20-6-514; McQualter JL, 2009, STEM CELLS, V27, P623, DOI 10.1634/stemcells.2008-0866; Mishra R, 2011, CIRCULATION, V123, P364, DOI 10.1161/CIRCULATIONAHA.110.971622; Morris RK, 2011, EARLY HUM DEV, V87, P607, DOI 10.1016/j.earlhumdev.2011.07.004; Passman JN, 2008, P NATL ACAD SCI USA, V105, P9349, DOI 10.1073/pnas.0711382105; Peyton CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047414; Pfister O, 2010, METHODS MOL BIOL, V660, P53, DOI 10.1007/978-1-60761-705-1_4; Roth KS, 2002, CLIN PEDIATR, V41, P309, DOI 10.1177/000992280204100503; Shin K, 2011, NATURE, V472, P110, DOI 10.1038/nature09851; Shiroyanagi Y, 2007, DIFFERENTIATION, V75, P968, DOI 10.1111/j.1432-0436.2007.00187.x; Sugino Y, 2008, NEUROUROL URODYNAM, V27, P548, DOI 10.1002/nau.20552; Sutherland RS, 1996, J UROLOGY, V156, P571, DOI 10.1016/S0022-5347(01)65755-0; Tanaka ST, 2009, J UROLOGY, V182, P1769, DOI 10.1016/j.juro.2009.02.081; Torsney E, 2005, TRENDS CARDIOVAS MED, V15, P64, DOI 10.1016/j.tcm.2005.02.003; Torsney E, 2007, ATHEROSCLEROSIS, V191, P259, DOI 10.1016/j.atherosclerosis.2006.05.033; Torsney E, 2011, J MOL CELL CARDIOL, V50, P304, DOI 10.1016/j.yjmcc.2010.09.006; Whetton AD, 1999, TRENDS CELL BIOL, V9, P233, DOI 10.1016/S0962-8924(99)01559-7; Williams AR, 2011, CIRC RES, V109, P923, DOI 10.1161/CIRCRESAHA.111.243147; Wu SM, 2008, CELL, V132, P537, DOI 10.1016/j.cell.2008.02.002	33	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141437	10.1371/journal.pone.0141437	http://dx.doi.org/10.1371/journal.pone.0141437			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540309	Green Published, Green Submitted, gold			2022-12-26	WOS:000364303800016
J	Malasao, R; Okamoto, M; Chaimongkol, N; Imamura, T; Tohma, K; Dapat, I; Dapat, C; Suzuki, A; Saito, M; Saito, M; Tamaki, R; Pedrera-Rico, GAG; Aniceto, R; Quicho, RFN; Segubre-Mercado, E; Lupisan, S; Oshitani, H				Malasao, Rungnapa; Okamoto, Michiko; Chaimongkol, Natthawan; Imamura, Tadatsugu; Tohma, Kentaro; Dapat, Isolde; Dapat, Clyde; Suzuki, Akira; Saito, Mayuko; Saito, Mariko; Tamaki, Raita; Granada Pedrera-Rico, Gay Anne; Aniceto, Rapunzel; Negosa Quicho, Reynaldo Frederick; Segubre-Mercado, Edelwisa; Lupisan, Socorro; Oshitani, Hitoshi			Molecular Characterization of Human Respiratory Syncytial Virus in the Philippines, 2012-2013	PLOS ONE			English	Article							GLYCOPROTEIN G GENE; GENOTYPE ON1; G-PROTEIN; HOSPITALIZED CHILDREN; 60-NUCLEOTIDE DUPLICATION; CIRCULATION PATTERNS; ATTACHMENT PROTEIN; B GENOTYPE; SUBGROUP; VARIABILITY	Human respiratory syncytial virus (HRSV) is a major cause of acute lower respiratory tract infections in infants and children worldwide. We performed molecular analysis of HRSV among infants and children with clinical diagnosis of severe pneumonia in four study sites in the Philippines, including Biliran, Leyte, Palawan, and Metro Manila from June 2012 to July 2013. Nasopharyngeal swabs were collected and screened for HRSV using real-time polymerase chain reaction (PCR). Positive samples were tested by conventional PCR and sequenced for the second hypervariable region (2nd HVR) of the G gene. Among a total of 1,505 samples, 423 samples were positive for HRSV (28.1%), of which 305 (72.1%) and 118 (27.9%) were identified as HRSV-A and HRSV-B, respectively. Two genotypes of HRSV-A, NA1 and ON1, were identified during the study period. The novel ON1 genotype with a 72-nucleotide duplication in 2nd HVR of the G gene increased rapidly and finally became the predominant genotype in 2013 with an evolutionary rate higher than the NA1 genotype. Moreover, in the ON1 genotype, we found positive selection at amino acid position 274 (p<0.05) and massive O- and N-glycosylation in the 2nd HVR of the G gene. Among HRSV-B, BA9 was the predominant genotype circulating in the Philippines. However, two sporadic cases of GB2 genotype were found, which might share a common ancestor with other Asian strains. These findings suggest that HRSV is an important cause of severe acute respiratory infection among children in the Philippines and revealed the emergence and subsequent predominance of the ON1 genotype and the sporadic detection of the GB2 genotype. Both genotypes were detected for the first time in the Philippines.	[Malasao, Rungnapa; Okamoto, Michiko; Chaimongkol, Natthawan; Imamura, Tadatsugu; Tohma, Kentaro; Dapat, Isolde; Dapat, Clyde; Suzuki, Akira; Saito, Mayuko; Oshitani, Hitoshi] Tohoku Univ, Grad Sch Med, Sendai, Miyagi 980, Japan; [Saito, Mariko; Tamaki, Raita] Tohoku RITM Collaborating Res Ctr Emerging & Reem, Muntinlupa, Philippines; [Granada Pedrera-Rico, Gay Anne] Biliran Prov Hosp, Naval City, Philippines; [Aniceto, Rapunzel] Eastern Visayas Reg Med Ctr, Tacloban City, Philippines; [Negosa Quicho, Reynaldo Frederick] Ospital Ng Palawan, Puerto Princesa, Philippines; [Segubre-Mercado, Edelwisa; Lupisan, Socorro] Res Inst Trop Med, Muntinlupa, Philippines	Tohoku University; Research Institute for Tropical Medicine - Philippines	Oshitani, H (corresponding author), Tohoku Univ, Grad Sch Med, Sendai, Miyagi 980, Japan.	oshitanih@med.tohoku.ac.jp	Saito, Mayuko/J-4508-2018; Tohma, Kentaro/AAE-4751-2019; Oshitani, Hitoshi/AAE-4349-2019; Dapat, Clyde/B-4196-2009; Okamoto, Michiko/AAE-4373-2019	Saito, Mayuko/0000-0003-4622-7027; Tohma, Kentaro/0000-0002-0456-9355; Dapat, Clyde/0000-0002-7616-4680; Okamoto, Michiko/0000-0002-3505-5939; Malasao, Rungnapa/0000-0002-1280-8782; Suzuki, Akira/0000-0002-8223-0314	Japan Society for the Promotion of Science (JSPS) (KAKENHI) [24249041]; Science and Technology Research Partnership for Sustainable Development (SATREPS) from Japan Science and Technology Agency (JST); Japan International Cooperation Agency (JICA); Japan Agency for Medical Research and Development (AMED); Japan Initiative for Global Research Network on Infectious Diseases (JGRID) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT)	Japan Society for the Promotion of Science (JSPS) (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Science and Technology Research Partnership for Sustainable Development (SATREPS) from Japan Science and Technology Agency (JST); Japan International Cooperation Agency (JICA); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Japan Initiative for Global Research Network on Infectious Diseases (JGRID) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT)	This work was supported by a grant-in-aid from the Japan Initiative for Global Research Network on Infectious Diseases (JGRID) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) and Japan Agency for Medical Research and Development (AMED), the Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS) (KAKENHI Grant Number 24249041), the Science and Technology Research Partnership for Sustainable Development (SATREPS) from Japan Science and Technology Agency (JST), Japan International Cooperation Agency (JICA) and Japan Agency for Medical Research and Development (AMED).	Aamir UB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074018; Agoti CN, 2014, EMERG INFECT DIS, V20, P950, DOI 10.3201/eid2006.131438; Agoti CN, 2013, INFLUENZA OTHER RESP, V7, P1008, DOI 10.1111/irv.12131; AKERLIND B, 1988, J GEN VIROL, V69, P2145, DOI 10.1099/0022-1317-69-9-2145; Almajhdi FN, 2014, VIRUS GENES, V48, P252, DOI 10.1007/s11262-013-1030-z; [Anonymous], 2013, FIELDS VIROLOGY; Auksornkitti V, 2014, ARCH VIROL, V159, P499, DOI 10.1007/s00705-013-1773-9; Baek YH, 2012, ARCH VIROL, V157, P1039, DOI 10.1007/s00705-012-1267-1; Balmaks R, 2014, J MED VIROL, V86, P1971, DOI 10.1002/jmv.23855; Bonroy C, 2007, CLIN MICROBIOL INFEC, V13, P504, DOI 10.1111/j.1469-0691.2007.01682.x; CANE PA, 1993, J VIROL, V67, P1090, DOI 10.1128/JVI.67.2.1090-1093.1993; Choudhary ML, 2013, INFECT GENET EVOL, V20, P369, DOI 10.1016/j.meegid.2013.09.025; Choudhary ML, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00165-13; Collins PL, 2013, FIELDS VIROLOGY, V1, P1087; Cui GL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075020; Cui GL, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.19; Dapat IC, 2010, J CLIN MICROBIOL, V48, P3423, DOI 10.1128/JCM.00646-10; Tran DN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0045436; Drummond A, 2003, ADV PARASIT, V54, P331, DOI 10.1016/S0065-308X(03)54008-8; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duvvuri VR, 2015, SCI REP-UK, V5, DOI 10.1038/srep14268; Eshaghi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032807; Forcic D, 2012, J MED VIROL, V84, P1985, DOI 10.1002/jmv.23425; GARCIA O, 1994, J VIROL, V68, P5448; Gilca R, 2006, J INFECT DIS, V193, P54, DOI 10.1086/498526; Gove S, 1997, B WORLD HEALTH ORGAN, V75, P7; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Hirano E, 2014, INFECT GENET EVOL, V28, P183, DOI 10.1016/j.meegid.2014.09.030; Imaz MS, 2000, J MED VIROL, V61, P76, DOI 10.1002/(SICI)1096-9071(200005)61:1&lt;76::AID-JMV12&gt;3.0.CO;2-P; Khor CS, 2013, INFECT GENET EVOL, V14, P357, DOI 10.1016/j.meegid.2012.12.017; Kim YJ, 2014, INFECT GENET EVOL, V26, P103, DOI 10.1016/j.meegid.2014.05.007; Kushibuchi I, 2013, INFECT GENET EVOL, V18, P168, DOI 10.1016/j.meegid.2013.05.010; Lee WJ, 2012, J VIROL, V86, P13810, DOI 10.1128/JVI.02571-12; Murray GGR, 2016, METHODS ECOL EVOL, V7, P80, DOI 10.1111/2041-210X.12466; Ohno A, 2013, J CLIN VIROL, V57, P59, DOI 10.1016/j.jcv.2013.01.001; Pan K, 2011, J R SOC INTERFACE, V8, P1644, DOI 10.1098/rsif.2011.0105; Panayiotou C, 2014, EPIDEMIOL INFECT, V142, P2406, DOI 10.1017/S0950268814000028; Peret TCT, 1998, J GEN VIROL, V79, P2221, DOI 10.1099/0022-1317-79-9-2221; Pierangeli A, 2014, EURO SURVEILLANCE BU, V19; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Pretorius MA, 2013, J INFECT DIS, V208, pS227, DOI 10.1093/infdis/jit477; Prifert C, 2013, EMERG INFECT DIS, V19, P1029, DOI 10.3201/eid1906.121582; Rebuffo-Scheer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025468; Ren L, 2015, J MED VIROL, V87, P1, DOI 10.1002/jmv.23960; Ren L, 2014, INFECT GENET EVOL, V27, P339, DOI 10.1016/j.meegid.2014.07.030; Sato M, 2005, J CLIN MICROBIOL, V43, P36, DOI 10.1128/JCM.43.1.36-40.2005; Shaevitz JW, 2003, NATURE, V426, P684, DOI 10.1038/nature02191; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Shobugawa Y, 2009, J CLIN MICROBIOL, V47, P2475, DOI 10.1128/JCM.00115-09; SULLENDER WM, 1991, J VIROL, V65, P5425, DOI 10.1128/JVI.65.10.5425-5434.1991; Suzuki A, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-267; Tabatabai J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109191; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan L, 2013, J VIROL, V87, P8213, DOI 10.1128/JVI.03278-12; Trento A, 2006, J VIROL, V80, P975, DOI 10.1128/JVI.80.2.975-984.2006; Trento A, 2003, J GEN VIROL, V84, P3115, DOI 10.1099/vir.0.19357-0; Trento A, 2010, J VIROL, V84, P7500, DOI 10.1128/JVI.00345-10; Tsukagoshi H, 2013, MICROBIOL IMMUNOL, V57, P655, DOI 10.1111/1348-0421.12075; Valley-Omar Z, 2013, EMERG INFECT DIS, V19, P668, DOI 10.3201/eid1904.121465; WHO, 2013, RESEARCH NEEDS FOR T; Zlateva KT, 2007, J CLIN MICROBIOL, V45, P3022, DOI 10.1128/JCM.00339-07; Zlateva KT, 2005, J VIROL, V79, P9157, DOI 10.1128/JVI.79.14.9157-9167.2005	63	48	49	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142192	10.1371/journal.pone.0142192	http://dx.doi.org/10.1371/journal.pone.0142192			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540236	Green Published, gold, Green Submitted			2022-12-26	WOS:000364303800065
J	Afreen, N; Naqvi, IH; Broor, S; Ahmed, A; Parveen, S				Afreen, Nazia; Naqvi, Irshad H.; Broor, Shobha; Ahmed, Anwar; Parveen, Shama			Phylogenetic and Molecular Clock Analysis of Dengue Serotype 1 and 3 from New Delhi, India	PLOS ONE			English	Article							CO-CIRCULATION; VIRUS; INFECTION; EVOLUTION; GENOTYPE; OUTBREAK; TYPE-3; TAIWAN	Dengue fever is the most prevalent arboviral disease in the tropical and sub-tropical regions of the world. The present report describes molecular detection and serotyping of dengue viruses in acute phase blood samples collected from New Delhi, India. Phylogenetic and molecular clock analysis of dengue virus serotype 1 and 3 strains were also investigated. Dengue virus infection was detected in 68.87% out of 604 samples tested by RT-PCR between 2011 & 2014. Dengue serotype 1 was detected in 25.48% samples, dengue serotype 2 in 79.56% samples and dengue serotype 3 in 11.29% samples. Dengue serotype 4 was not detected. Co-infection by more than one dengue serotype was detected in 18.26% samples. Envelope gene of 29 DENV-1 and 14 DENV-3 strains were sequenced in the study. All the DENV-1 strains grouped with the American African genotype. All DENV-3 strains were found to belong to Genotype III. Nucleotide substitution rates of dengue 1 and 3 viruses were determined in the study. Time to the most recent common ancestor (TMRCA) of dengue 1 viruses was determined to be 132 years. TMRCA of DENV-3 viruses was estimated to be 149 years. Bayesian skyline plots were constructed for Indian DENV-1 and 3 strains which showed a decrease in population size since 2005 in case of DENV-1 strains while no change was observed in recent years in case of DENV-3 strains. The study also revealed a change in the dominating serotype in Delhi, India in recent years. The study will be helpful in formulating control strategies for the outbreaks. In addition, it will also assist in tracking the movement and evolution of this emerging virus.	[Afreen, Nazia; Parveen, Shama] Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi 110025, India; [Naqvi, Irshad H.] Jamia Millia Islamia, Dr MA Ansari Hlth Ctr, New Delhi 110025, India; [Broor, Shobha] Shree Guru Gobind Singh Tricentenary Univ, Fac Med & Hlth Sci, Dept Microbiol, Gurgaon, Haryana, India; [Ahmed, Anwar] King Saud Univ, Coll Sci, Dept Biochem, Prot Res Chair, Riyadh 11451, Saudi Arabia	Jamia Millia Islamia; Jamia Millia Islamia; King Saud University	Parveen, S (corresponding author), Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi 110025, India.	shamp25@yahoo.com	Broor, Shobha/AAX-4163-2021; Ahmed, Anwar/ADH-1445-2022; Ahmed, Anwar/AAL-7789-2021	Broor, Shobha/0000-0001-9679-4180; Ahmed, Anwar/0000-0001-8147-714X; 	University Grants Commission, Government of India;  [41-1287/2012 (SR)]	University Grants Commission, Government of India(University Grants Commission, India); 	Shama Parveen received funding from University Grants Commission, Government of India. The URL of the funder's website is http://www.ugc.ac. in. The grant number is 41-1287/2012 (SR). Nazia Afreen was supported by Senior Research Fellowship of University Grants Commission, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afreen N, 2014, MOL INVESTIGATION 20; Afreen N, 2014, MICROBIOL IMMUNOL, V58, P688, DOI 10.1111/1348-0421.12209; Anoop M, 2010, INDIAN J EXP BIOL, V48, P849; Araujo JMG, 2009, INFECT GENET EVOL, V9, P716, DOI 10.1016/j.meegid.2008.10.005; Bharaj P, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-1; Chakravarti A, 2013, ARCH VIROL, V158, P571, DOI 10.1007/s00705-012-1522-5; Das B, 2013, INFECT GENET EVOL, V16, P401, DOI 10.1016/j.meegid.2013.03.016; Dash PK, 2015, VIRUS RES, V195, P124, DOI 10.1016/j.virusres.2014.08.018; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Ho SYW, 2011, MOL ECOL RESOUR, V11, P423, DOI 10.1111/j.1755-0998.2011.02988.x; Huang JH, 2007, AM J TROP MED HYG, V77, P903, DOI 10.4269/ajtmh.2007.77.903; Huang JH, 2012, AM J TROP MED HYG, V87, P349, DOI 10.4269/ajtmh.2012.11-0666; Kukreti H, 2008, INT J INFECT DIS, V12, P542, DOI 10.1016/j.ijid.2008.02.009; Kukreti H, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-1; Kumar SRP, 2010, J GEN VIROL, V91, P707, DOI 10.1099/vir.0.017954-0; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; Mishra G, 2014, J MED VIROL, V2, P1; Nidhi Pandey, 2012, INDIAN J MED RES; Pandey A, 2007, J CLIN VIROL, V40, P87, DOI 10.1016/j.jcv.2007.05.011; Patil JA, 2012, INFECT GENET EVOL, V12, P1759, DOI 10.1016/j.meegid.2012.07.009; Patil JA, 2011, INFECT GENET EVOL, V11, P1443, DOI 10.1016/j.meegid.2011.05.011; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Sharma S, 2011, J GEN VIROL, V92, P1595, DOI 10.1099/vir.0.030437-0; Singh P, 2012, EPIDEMIOL INFECT, V140, P1337, DOI 10.1017/S0950268811001671; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WHO, 2009, WHO TECH REP SER, V958, P1; Wright WF, 2012, DIAGN MICR INFEC DIS, V73, P215, DOI 10.1016/j.diagmicrobio.2012.03.021; Wu WL, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-322	31	26	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141628	10.1371/journal.pone.0141628	http://dx.doi.org/10.1371/journal.pone.0141628			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536458	Green Published, gold, Green Submitted			2022-12-26	WOS:000364298400073
J	Germer, J; Mann, K; Worheide, G; Jackson, DJ				Germer, Juliane; Mann, Karlheinz; Woerheide, Gert; Jackson, Daniel John			The Skeleton Forming Proteome of an Early Branching Metazoan: A Molecular Survey of the Biomineralization Components Employed by the Coralline Sponge Vaceletia Sp.	PLOS ONE			English	Article							CARBONIC-ANHYDRASE; MATRIX PROTEIN; ORGANIC MATRIX; IN-DEPTH; EVOLUTION; GENOME; CHITIN; CALCIFICATION; GENERATION; PREDICTION	The ability to construct a mineralized skeleton was a major innovation for the Metazoa during their evolution in the late Precambrian/early Cambrian. Porifera (sponges) hold an informative position for efforts aimed at unraveling the origins of this ability because they are widely regarded to be the earliest branching metazoans, and are among the first multi-cellular animals to display the ability to biomineralize in the fossil record. Very few biomineralization associated proteins have been identified in sponges so far, with no transcriptome or proteome scale surveys yet available. In order to understand what genetic repertoire may have been present in the last common ancestor of the Metazoa (LCAM), and that may have contributed to the evolution of the ability to biocalcify, we have studied the skeletal proteome of the coralline demosponge Vaceletia sp. and compare this to other metazoan biomineralizing proteomes. We bring some spatial resolution to this analysis by dividing Vaceletia's aragonitic calcium carbonate skeleton into "head" and "stalk" regions. With our approach we were able to identify 40 proteins from both the head and stalk regions, with many of these sharing some similarity to previously identified gene products from other organisms. Among these proteins are known biomineralization compounds, such as carbonic anhydrase, spherulin, extracellular matrix proteins and very acidic proteins. This report provides the first proteome scale analysis of a calcified poriferan skeletal proteome, and its composition clearly demonstrates that the LCAM contributed several key enzymes and matrix proteins to its descendants that supported the metazoan ability to biocalcify. However, lineage specific evolution is also likely to have contributed significantly to the ability of disparate metazoan lineages to biocalcify.	[Germer, Juliane; Jackson, Daniel John] Univ Gottingen, Dept Geobiol, D-37073 Gottingen, Germany; [Mann, Karlheinz] Max Planck Inst Biochem, Dept Prote & Signal Transduct, Munich, Germany; [Woerheide, Gert] Univ Munich, Dept Earth & Environm Sci, Munich, Germany; [Woerheide, Gert] Univ Munich, GeoBioctr, Munich, Germany; [Woerheide, Gert] SNSB Bavarian State Collect Palaeontol & Geol, Munich, Germany	University of Gottingen; Max Planck Society; University of Munich; University of Munich	Jackson, DJ (corresponding author), Univ Gottingen, Dept Geobiol, D-37073 Gottingen, Germany.	djackso@uni-goettingen.de	Jackson, Daniel J./J-5158-2012; Mann, Karlheinz/C-4254-2008; Wörheide, Gert/C-1080-2008	Jackson, Daniel J./0000-0001-9045-381X; Wörheide, Gert/0000-0002-6380-7421	German Excellence Initiative; Deutsche Forschungsmeinschaft (DFG) [JA2108/1-2]; DFG [Wo897/7, Wo896/7-1]; Deutsche Forschungsgemeinschaft [JA2108/1-2, JA2108/1-1]	German Excellence Initiative; Deutsche Forschungsmeinschaft (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding: This work was supported by funding to DJJ through the German Excellence Initiative and Deutsche Forschungsmeinschaft (DFG) project #JA2108/1-2, as well as DFG funding to GW through project Wo897/7 (Deep Downunder).; We would like to acknowledge Matthias Mann (MPI of Biochemistry, Martinsried), for generous support, Gaby Sowa (MPI) for preparing the capillary columns, Korbinian Mayr and Igor Paron (both MPI) for keeping the mass spectrometers in excellent condition. Dorothea Hause-Reitner provided expert SEM and TEM support and Wolfgang Drose assisted with histology work. This work was supported by Deutsche Forschungsgemeinschaft funding to DJJ (JA2108/1-1 and JA2108/1-2). Collection of specimens in the Coral Sea (Australia) during the Deep DownUnder expedition was supported by DFG project Wo896/7-1 to GW.	Allemand D, 1998, J EXP BIOL, V201, P2001; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bhave G, 2012, NAT CHEM BIOL, V8, P784, DOI [10.1038/NCHEMBIO.1038, 10.1038/nchembio.1038]; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Debrenne F, 2001, PERS PALEOB, P301; Debrenne F., 2002, SYSTEMA PORIFERA GUI, V2, P1539; Dohrmann M, 2013, INTEGR COMP BIOL, V53, P503, DOI 10.1093/icb/ict008; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Ehrlich H, 2007, J EXP ZOOL PART B, V308B, P347, DOI 10.1002/jez.b.21156; Ehrlich H, 2010, INT GEOL REV, V52, P661, DOI 10.1080/00206811003679521; Erpenbeck D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-591; Falini G, 2004, TISSUE ENG, V10, P1, DOI 10.1089/107632704322791646; Fang D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035715; Feinstein Y, 1999, DEVELOPMENT, V126, P3637; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; He YW, 2004, NAT IMMUNOL, V5, P88, DOI 10.1038/ni1021; Henry RP, 1996, ANNU REV PHYSIOL, V58, P523, DOI 10.1146/annurev.ph.58.030196.002515; HewettEmmett D, 1996, MOL PHYLOGENET EVOL, V5, P50, DOI 10.1006/mpev.1996.0006; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Immel F, 2015, J STRUCT BIOL, V190, P360, DOI 10.1016/j.jsb.2015.04.001; Isowa Y, 2015, PROTEOME SCI, V13, DOI 10.1186/s12953-015-0077-2; Jackson DJ, 2010, GEOBIOLOGY, V8, P191, DOI 10.1111/j.1472-4669.2010.00236.x; Jackson DJ, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-40; Jackson DJ, 2007, SCIENCE, V316, P1893, DOI 10.1126/science.1141560; Jackson DJ, 2015, GENOME BIOL EVOL, V7, P1349, DOI 10.1093/gbe/evv074; Jackson DJ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-238; JUNQUA S, 1974, CONNECT TISSUE RES, V2, P193, DOI 10.3109/03008207409152244; Karlinska-Batres K, 2013, ANTON LEEUW INT J G, V103, P1041, DOI 10.1007/s10482-013-9884-6; Kerner A, 2011, ZOOKEYS, P381, DOI 10.3897/zookeys.150.1566; Knoll AH, 2003, REV MINERAL GEOCHEM, V54, P329, DOI 10.2113/0540329; Le Roy N, 2014, FRONT ZOOL, V11, DOI 10.1186/s12983-014-0075-8; Mann K, 2014, PROTEOME SCI, V12, DOI 10.1186/1477-5956-12-28; Mann K, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-249; Mann K, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-28; Mann K, 2010, PROTEOME SCI, V8, DOI [10.1186/1477-5956-8-6, 10.1186/1477-5956-8-33]; Mann K, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-33; Mann K, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-22; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Marie B, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-54; Marin Frederic, 2007, P273, DOI 10.1002/9783527619443.ch16; Michalski A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.011015; Moroz LL, 2014, NATURE, V510, P109, DOI 10.1038/nature13400; Morrow C, 2015, FRONT ZOOL, V12, DOI 10.1186/s12983-015-0099-8; Neuhauser N, 2012, MOL CELL PROTEOMICS, V11, P1500, DOI 10.1074/mcp.M112.020271; Palmer GD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098388; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Philippe H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000602; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; Pick KS, 2010, MOL BIOL EVOL, V27, P1983, DOI 10.1093/molbev/msq089; Rahman MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058781; Ramos-Silva P, 2013, MOL BIOL EVOL, V30, P2099, DOI 10.1093/molbev/mst109; Ramos-Silva P, 2013, P NATL ACAD SCI USA, V110, pE2144, DOI 10.1073/pnas.1303657110; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Reitner J, 2002, SYSTEMA PORIFERA GUI, P52; Reitner J, 2001, B TOHOKU U MUSEUM, V1, P229; Reitner Joachim, 1997, Courier Forschungsinstitut Senckenberg, V201, P371; Riesgo A, 2014, MOL BIOL EVOL, V31, P1102, DOI 10.1093/molbev/msu057; Romeis B, 1989, MIKROSKOPISCHE TECHN, P443; Rowland SM, 2001, J PALEONTOL, V75, P1065, DOI 10.1666/0022-3360(2001)075<1065:AAHOPI>2.0.CO;2; Ryan JF, 2013, SCIENCE, V342, P1336, DOI 10.1126/science.1242592; Scheltema RA, 2012, J PROTEOME RES, V11, P3458, DOI 10.1021/pr201219e; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sonnhammer ELL, P 6 INT C INT SYST M; Sperling EA, 2009, MOL BIOL EVOL, V26, P2261, DOI 10.1093/molbev/msp148; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793; Uriz MJ, 2012, EVOLUTION, V66, P2993, DOI 10.1111/j.1558-5646.2012.01676.x; VACELET J, 1977, CR ACAD SCI D NAT, V285, P509; Vacelet J, 2002, SYSTEMA PORIFERA GUI, P1097, DOI DOI 10.1007/978-1-4615-0747-5; Voigt O, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0230-z; WHEELER AP, 1981, SCIENCE, V212, P1397, DOI 10.1126/science.212.4501.1397; Whelan NV, 2015, INTEGR COMP BIOL, V55, P1084, DOI 10.1093/icb/icv037; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Worheide G, 2012, ADV MAR BIOL, V61, P1, DOI 10.1016/B978-0-12-387787-1.00007-6; Worheide G, 2008, MOL PHYLOGENET EVOL, V47, P433, DOI 10.1016/j.ympev.2008.01.021; Worheide Gert, 1996, P145	81	16	16	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140100	10.1371/journal.pone.0140100	http://dx.doi.org/10.1371/journal.pone.0140100			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536128	Green Published, gold, Green Submitted			2022-12-26	WOS:000364298400016
J	Toy, M; Hutton, DW; So, SK				Toy, Mehlika; Hutton, David W.; So, Samuel K.			Cost-Effectiveness and Cost Thresholds of Generic and Brand Drugs in a National Chronic Hepatitis B Treatment Program in China	PLOS ONE			English	Article							TENOFOVIR DISOPROXIL FUMARATE; NUCLEOSIDE-NAIVE PATIENTS; E-ANTIGEN SEROCONVERSION; ADEFOVIR DIPIVOXIL; HEPATOCELLULAR-CARCINOMA; PEGINTERFERON ALPHA-2A; HBSAG SEROCLEARANCE; SUSTAINED RESPONSE; VIRUS INFECTION; RESCUE THERAPY	Chronic liver disease and liver cancer associated with chronic hepatitis B (CHB) are leading causes of death among adults in China. Although newborn hepatitis B immunization has successfully reduced the prevalence of CHB in children, about 100 million Chinese adults remain chronically infected. If left unmanaged, 15-25% will die from liver cancer or liver cirrhosis. Antiviral treatment is not necessary for all patients with CHB, but when it is indicated, good response to treatment would prevent disease progression and reduce disease mortality and morbidity, and costly complications. The aim of this study is to analyze the cost-effectiveness of generic and brand antiviral drugs for CHB treatment in China, and assessing various thresholds at which a highly potent, low resistance antiviral drug would be cost-saving and/or cost-effective to introduce in a national treatment program. We developed a Markov simulation model of disease progression using effectiveness and cost data from the medical literature. We measured life-time costs, quality adjusted life years (QALYs), incremental cost-effectiveness ratios (ICERs), and clinical outcomes. The no treatment strategy incurred the highest health care costs ($12,932-$25,293) per patient, and the worst health outcomes, compared to the antiviral treatment strategies. Monotherapy with either entecavir or tenofovir yielded the most QALYs (14.10-19.02) for both HBeAg-positive and negative patients, with or without cirrhosis. Threshold analysis showed entercavir or tenofovir treatment would be cost saving if the drug price is $32-75 (195-460 RMB) per month, highly cost-effective at $62-110 (379-670 RMB) per month and cost-effective at $63-120 (384-734 RMB) per month. This study can support policy decisions regarding the implementation of a national health program for chronic hepatitis B treatment in China at the population level.	[Toy, Mehlika; So, Samuel K.] Stanford Univ, Sch Med, Dept Surg, Asian Liver Ctr, Stanford, CA 94305 USA; [Hutton, David W.] Univ Michigan, Dept Hlth Management & Policy, Ann Arbor, MI 48109 USA	Stanford University; University of Michigan System; University of Michigan	Toy, M (corresponding author), Stanford Univ, Sch Med, Dept Surg, Asian Liver Ctr, Stanford, CA 94305 USA.	mtoy@stanford.edu		Toy, Mehlika/0000-0001-7848-4816	Stanford Asian Liver Center; Stanford University	Stanford Asian Liver Center; Stanford University(Stanford University)	Funding: This study was supported by the Stanford Asian Liver Center and the CJ Huang and Ha Lin Yip Huang research funds from Stanford University.	Chang TT, 2006, NEW ENGL J MED, V354, P1001, DOI 10.1056/NEJMoa051285; Chen CH, 2006, ANTIVIR THER, V11, P771; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Chen JG, 2011, SEMIN CANCER BIOL, V21, P59, DOI 10.1016/j.semcancer.2010.11.002; Chen JD, 2010, GASTROENTEROLOGY, V138, P1747, DOI 10.1053/j.gastro.2010.01.042; Chen YC, 2010, HEPATOLOGY, V51, P435, DOI 10.1002/hep.23348; Cho JY, 2014, GUT, V63, P1943, DOI 10.1136/gutjnl-2013-306409; Chu CM, 2007, HEPATOLOGY, V45, P1187, DOI 10.1002/hep.21612; Chu CM, 2009, AM J GASTROENTEROL, V104, P1693, DOI 10.1038/ajg.2009.187; Colonno RJ, 2007, J HEPATOL, V46, pS294, DOI 10.1016/S0168-8278(07)62379-4; Colonno RJ, 2006, HEPATOLOGY, V44, P1656, DOI 10.1002/hep.21422; Cooksley WGE, 2003, J VIRAL HEPATITIS, V10, P298, DOI 10.1046/j.1365-2893.2003.00450.x; Fattovich G, 2008, J HEPATOL, V48, P335, DOI 10.1016/j.jhep.2007.11.011; Fleurence RL, 2007, PHARMACOECONOMICS, V25, P3, DOI 10.2165/00019053-200725010-00002; Gordon SC, 2013, HEPATOLOGY, V58, P505, DOI 10.1002/hep.26277; Guan ZQ, 2004, J CLIN GASTROENTEROL, V38, pS175, DOI 10.1097/00004836-200411003-00010; Heathcote EJ, 2011, GASTROENTEROLOGY, V140, P132, DOI 10.1053/j.gastro.2010.10.011; Hutton DW, 2010, HEPATOLOGY, V51, P405, DOI 10.1002/hep.23310; Kanwal F, 2005, ANN INTERN MED, V142, P821, DOI 10.7326/0003-4819-142-10-200505170-00007; Ke WX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098865; Kennedy PTF, 2008, LIVER INT, V28, P699, DOI 10.1111/j.1478-3231.2008.01717.x; Lai CL, 2003, CLIN INFECT DIS, V36, P687, DOI 10.1086/368083; Lau GKK, 2005, NEW ENGL J MED, V352, P2682, DOI 10.1056/NEJMoa043470; Lee CI, 2014, GUT LIVER, V8, P64, DOI 10.5009/gnl.2014.8.1.64; Lee YS, 2006, HEPATOLOGY, V43, P1385, DOI 10.1002/hep.21189; Lemoine M, 2013, FUTURE VIROL, V8, P371, DOI 10.2217/FVL.13.11; Levy AR, 2008, VALUE HEALTH, V11, P527, DOI 10.1111/j.1524-4733.2007.00297.x; LI N, 2012, CHINESE J HLTH POLIC, V5; Liang XF, 2009, VACCINE, V27, P6550, DOI 10.1016/j.vaccine.2009.08.048; Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364; Liaw YF, 2008, HEPATOL INT, V2, P263, DOI 10.1007/s12072-008-9080-3; Liaw YF, 2009, HEPATOL INT, V3, P425, DOI 10.1007/s12072-009-9140-3; Lin XM, 2005, J GASTROEN HEPATOL, V20, P833, DOI [10.1111/j.1440-1746.2005.03813.x, 10.1111/j.1400-1746.2005.03813.x]; Liu J, 2007, LANCET, V369, P1582, DOI 10.1016/S0140-6736(07)60723-5; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Marcellin P, 2009, J HEPATOL, V50, P227, DOI 10.1016/j.jhep.2008.10.001; Marcellin P, 2009, GASTROENTEROLOGY, V136, P2169, DOI 10.1053/j.gastro.2009.03.006; Moskovitz DN, 2005, J VIRAL HEPATITIS, V12, P398, DOI 10.1111/j.1365-2893.2005.00613.x; Papatheodoridis GV, 2010, J HEPATOL, V53, P348, DOI 10.1016/j.jhep.2010.02.035; Patterson SJ, 2011, GUT, V60, P247, DOI 10.1136/gut.2010.223206; Piratvisuth T, 2008, HEPATOL INT, V2, P102, DOI 10.1007/s12072-007-9022-5; Reijnders JGP, 2008, J HEPATOL, V48, P383, DOI 10.1016/j.jhep.2007.12.006; Reijnders JGP, 2010, GASTROENTEROLOGY, V139, P491, DOI 10.1053/j.gastro.2010.03.059; Shouval D, 2009, J HEPATOL, V50, P289, DOI 10.1016/j.jhep.2008.10.017; Tenney DJ, 2009, HEPATOLOGY, V49, P1503, DOI 10.1002/hep.22841; Toy M, 2014, HEPATOLOGY, V60, P46, DOI 10.1002/hep.26934; van Bommel F, 2004, HEPATOLOGY, V40, P1421, DOI 10.1002/hep.20464; Woo G, 2010, GASTROENTEROLOGY, V139, P1218, DOI 10.1053/j.gastro.2010.06.042; World Health Organization, 2003, WHO GUID COST EFF; Yeon JE, 2006, GUT, V55, DOI 10.1136/gut.2005.077099; Yin WY, 2009, CHINESE MED J-PEKING, V122, P1346, DOI 10.3760/cma.j.issn.0366-6999.2009.11.020; Yuen MF, 2008, GASTROENTEROLOGY, V135, P1192, DOI 10.1053/j.gastro.2008.07.008	52	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0139876	10.1371/journal.pone.0139876	http://dx.doi.org/10.1371/journal.pone.0139876			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536626	Green Submitted, Green Published, gold			2022-12-26	WOS:000364298400012
J	David, S; Mateus, ARA; Duarte, EL; Albuquerque, J; Portugal, C; Sancho, L; Lavinha, J; Goncalves, G				David, Susana; Mateus, A. R. A.; Duarte, Elsa L.; Albuquerque, Jose; Portugal, Clara; Sancho, Luisa; Lavinha, Joao; Goncalves, Guilherme			Determinants of the Sympatric Host-Pathogen Relationship in Tuberculosis	PLOS ONE			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; BRIEF EPIDEMIOLOGIC HISTORY; NEW-YORK-CITY; MYCOBACTERIUM-TUBERCULOSIS; GLOBAL DISTRIBUTION; GENETIC DIVERSITY; MIRU-VNTRPLUS; SUSCEPTIBILITY; TRANSMISSION; SUBLINEAGE	Major contributions from pathogen genome analysis and host genetics have equated the possibility of Mycobacterium tuberculosis co-evolution with its human host leading to more stable sympatric host-pathogen relationships. However, the attribution to either sympatric or allopatric categories depends on the resolution or grain of genotypic characterization. We explored the influence on the sympatric host-pathogen relationship of clinical (HIV infection and multidrug-resistant tuberculosis [MDRTB]) and demographic (gender and age) factors in regards to the genotypic grain by using spacer oligonucleotide typing (spoligotyping) for classification of M. tuberculosis strains within the Euro-American lineage. We analyzed a total of 547 tuberculosis (TB) cases, from six year consecutive sampling in a setting with high TB-HIV coinfection (32.0%). Of these, 62.0% were caused by major circulating pathogen genotypes. The sympatric relationship was defined according to spoligotype in comparison to the international spoligotype database SpolDB4. While no significant association with Euro-American lineage was observed with any of the factors analyzed, increasing the resolution with spoligotyping evidenced a significant association of MDRTB with sympatric strains, regardless of the HIV status. Furthermore, distribution curves of the prevalence of sympatric and allopatric TB in relation to patients' age showed an accentuation of the relevance of the age of onset in the allopatric relationship, as reflected in the trimodal distribution. On the contrary, sympatric TB was characterized by the tendency towards a typical (standard) distribution curve. Our results suggest that within the Euro-American lineage a greater degree of genotyping fine-tuning is necessary in modeling the biological processes behind the host-pathogen interplay. Furthermore, prevalence distribution of sympatric TB to age was suggestive of host genetic determinisms driven by more common variants.	[David, Susana; Albuquerque, Jose; Lavinha, Joao] Inst Nacl Saude Doutor Ricardo Jorge INSA, Dept Genet Humana, Lisbon, Portugal; [Mateus, A. R. A.] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Mateus, A. R. A.] Leiden Univ, Inst Biol, Leiden, Netherlands; [Duarte, Elsa L.] Univ Evora, Inst Ciencias Agr & Ambientais Mediterran, Escola Ciencias & Tecnol, Evora, Portugal; [Portugal, Clara; Sancho, Luisa] Hosp Fernando Fonseca, Serv Patol Clin, Amadora, Portugal; [Goncalves, Guilherme] Inst Ciencias Biomed Abel Salazar, Unidade Multidisciplinar Invest Biomed, Oporto, Portugal	Instituto Nacional de Saude Dr. Ricardo Jorge; Instituto Gulbenkian de Ciencia; Leiden University; Leiden University - Excl LUMC; University of Evora; Hospital Professor Doutor Fernando Fonseca, EPE; Universidade do Porto	David, S (corresponding author), Inst Nacl Saude Doutor Ricardo Jorge INSA, Dept Genet Humana, Lisbon, Portugal.	david.suzana@gmail.com		Goncalves, Guilherme/0000-0003-0030-3346; Portugal, Clara/0000-0003-3904-1486; David, Susana/0000-0001-6483-8660; Leclerc Duarte, Elsa/0000-0003-0589-3533	Luso-American Development Foundation (LACR Award program); Fundacao para a Ciencia e Tecnologia (FCT), Portugal [POCTI/ESP/44826/2002]; Fundação para a Ciência e a Tecnologia [POCTI/ESP/44826/2002] Funding Source: FCT	Luso-American Development Foundation (LACR Award program); Fundacao para a Ciencia e Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); Fundação para a Ciência e a Tecnologia	This work was supported by the Luso-American Development Foundation (LACR Award program - 2007) and the Fundacao para a Ciencia e Tecnologia (FCT), Portugal, (grant reference: POCTI/ESP/44826/2002), coparticipated by the European Community fund FEDER.	Abel L, 2000, AM J HUM GENET, V67, P274, DOI 10.1086/303033; Abel L, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0428; Alcais A., 2001, Sepsis, V4, P237, DOI 10.1023/A:1012917124511; ALLAND D, 1994, NEW ENGL J MED, V330, P1710, DOI 10.1056/NEJM199406163302403; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; Alter A, 2011, MAMM GENOME, V22, P19, DOI 10.1007/s00335-010-9287-1; [Anonymous], 2008, EUR TB NAT COORD TUB; Asante-Poku A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003370; Bellamy R, 1998, THORAX, V53, P588, DOI 10.1136/thx.53.7.588; Bellamy R, 2006, MICROBES INFECT, V8, P1119, DOI 10.1016/j.micinf.2005.10.025; Boisson-Dupuis S, 2015, IMMUNOL REV, V264, P103, DOI 10.1111/imr.12272; Briz T, 2009, REV PORTUGUESA SAUDE, V27, P19; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Bustamante J, 2014, SEMIN IMMUNOL, V26, P454, DOI 10.1016/j.smim.2014.09.008; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034; Cobat A, 2013, PUBLIC HEALTH GENOM, V16, P44, DOI 10.1159/000341499; DAVID HL, 1978, INT J SYST BACTERIOL, V28, P467; David S, 2012, INFECT GENET EVOL, V12, P1362, DOI 10.1016/j.meegid.2012.04.021; David S, 2007, INFECT GENET EVOL, V7, P609, DOI 10.1016/j.meegid.2007.05.007; Fenner L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003318; Filliol I, 2003, J CLIN MICROBIOL, V41, P1963, DOI 10.1128/JCM.41.5.1963-1970.2003; Filliol I, 2002, EMERG INFECT DIS, V8, P1347, DOI 10.3201/eid0811.020125; Fitzpatrick BM, 2008, J EVOLUTION BIOL, V21, P1452, DOI 10.1111/j.1420-9101.2008.01611.x; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Gagneux S, 2012, PHILOS T R SOC B, V367, P850, DOI 10.1098/rstb.2011.0316; Gibson AL, 2008, J CLIN MICROBIOL, V46, P1259, DOI 10.1128/JCM.02231-07; GRIGG ERN, 1958, AM REV TUBERC PULM, V78, P151; GRIGG ERN, 1958, AM REV TUBERC PULM, V78, P426; Gutacker MM, 2006, J INFECT DIS, V193, P121, DOI 10.1086/498574; Gutierrez MC, 1998, J CLIN MICROBIOL, V36, P486; Hanekom M, 2007, J CLIN MICROBIOL, V45, P2263, DOI 10.1128/JCM.02354-06; Hanekom M, 2007, J CLIN MICROBIOL, V45, P1483, DOI 10.1128/JCM.02191-06; Herb F, 2008, HUM MOL GENET, V17, P1052, DOI 10.1093/hmg/ddm378; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Hirsh AE, 2004, P NATL ACAD SCI USA, V101, P4871, DOI 10.1073/pnas.0305627101; Hollo V, 2009, EUROSURVEILLANCE, V14; Intemann CD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000577; Libert F, 1998, HUM MOL GENET, V7, P399, DOI 10.1093/hmg/7.3.399; Lipsitch M, 2002, GENETICS, V161, P1599; Maio JN, 2008, THESIS U PORTO PORTU; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Oelemann MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018256; Lazzarini LCO, 2008, J CLIN MICROBIOL, V46, P2175, DOI 10.1128/JCM.00065-08; Lazzarini LCO, 2007, J CLIN MICROBIOL, V45, P3891, DOI 10.1128/JCM.01394-07; Pasipanodya JG, 2013, INFECT GENET EVOL, V16, P433, DOI 10.1016/j.meegid.2013.02.015; Perdigao J, 2011, CLIN MICROBIOL INFEC, V17, P1397, DOI 10.1111/j.1469-0691.2010.03351.x; Perdigao J, 2008, MICROB DRUG RESIST, V14, P133, DOI 10.1089/mdr.2008.0798; Portugal I, 1999, INT J TUBERC LUNG D, V3, P207; Portugal INE, 2005, EST IM; Rahim Z., 2006, 27 ANN C EUR SOC MYC; Rastogi N., 2007, TUBERCULOSIS 2007 BA, V2007, P53; Reed MB, 2009, J CLIN MICROBIOL, V47, P1119, DOI 10.1128/JCM.02142-08; Ribeiro JN, 2008, THESIS U PORTO PORTU; SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402; Sola C, 2015, TUBERCULOSIS, V95, pS159, DOI 10.1016/j.tube.2015.02.029; Sousa AO, 1997, P NATL ACAD SCI USA, V94, P13227, DOI 10.1073/pnas.94.24.13227; Stead WW, 1997, CLIN CHEST MED, V18, P65, DOI 10.1016/S0272-5231(05)70356-7; STEAD WW, 1992, ANN INTERN MED, V116, P937, DOI 10.7326/0003-4819-116-11-937; Stead WW, 1996, TUBERCULOSIS, P77; Thye T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020908; Uplekar MW, 2001, INT J TUBERC LUNG D, V5, P220; van Crevel R, 2009, J INFECT DIS, V200, P1671, DOI 10.1086/648477; vanDeutekom H, 1997, CLIN INFECT DIS, V25, P1071, DOI 10.1086/516072; Vasconcellos SEG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107747; Vitol I, 2006, INFECT GENET EVOL, V6, P491, DOI 10.1016/j.meegid.2006.03.003; Warren RM, 2002, J CLIN MICROBIOL, V40, P4457, DOI 10.1128/JCM.40.12.4457-4465.2002; Weisenberg SA, 2012, INFECT GENET EVOL, V12, P664, DOI 10.1016/j.meegid.2011.07.018; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351	70	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0140625	10.1371/journal.pone.0140625	http://dx.doi.org/10.1371/journal.pone.0140625			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529092	Green Submitted, Green Published, gold			2022-12-26	WOS:000364032600009
J	Gallego-Iradi, MC; Clare, AM; Brown, HH; Janus, C; Lewis, J; Borchelt, DR				Gallego-Iradi, M. Carolina; Clare, Alexis M.; Brown, Hilda H.; Janus, Christopher; Lewis, Jada; Borchelt, David R.			Subcellular Localization of Matrin 3 Containing Mutations Associated with ALS and Distal Myopathy	PLOS ONE			English	Article							STRESS GRANULES; MESSENGER-RNA; PROTEIN; TDP-43; PHOSPHORYLATION; HETEROGENEITY; ACTIVATION; PHENOTYPE; G3BP1	Background Mutations in Matrin 3 [MATR3], an RNA-and DNA-binding protein normally localized to the nucleus, have been linked to amyotrophic lateral sclerosis (ALS) and distal myopathies. In the present study, we have used transient transfection of cultured cell lines to examine the impact of different disease-causing mutations on the localization of Matrin 3 within cells. Results Using CHO and human H4 neuroglioma cell models, we find that ALS/myopathy mutations do not produce profound changes in the localization of the protein. Although we did observe variable levels of Matrin 3 in the cytoplasm either by immunostaining or visualization of fluorescently-tagged protein, the majority of cells expressing either wild-type (WT) or mutant Matrin 3 showed nuclear localization of the protein. When cytoplasmic immunostaining, or fusion protein fluorescence, was seen in the cytoplasm, the stronger intensity of staining or fluorescence was usually evident in the nucleus. In similar to 80% of cells treated with sodium arsenite (Ars) to induce cytoplasmic stress granules, the nuclear localization of WT and F115C mutant Matrin 3 was not disturbed. Notably, over-expression of mutant Matrin 3 did not induce the formation of obvious large inclusion-like structures in either the cytoplasm or nucleus. Conclusions Our findings indicate that mutations in Matrin 3 that are associated with ALS and myopathy do not dramatically alter the normal localization of the protein or readily induce inclusion formation.	[Gallego-Iradi, M. Carolina; Clare, Alexis M.; Brown, Hilda H.; Janus, Christopher; Lewis, Jada; Borchelt, David R.] Univ Florida, Dept Neurosci, McKnight Brain Inst, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32610 USA; [Gallego-Iradi, M. Carolina; Brown, Hilda H.; Borchelt, David R.] Univ Florida, Santa Fe HealthCare Alzheimers Dis Res Ctr, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Borchelt, DR (corresponding author), Univ Florida, Dept Neurosci, McKnight Brain Inst, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32610 USA.	drb1@ufl.edu			McKnight Brain Institute at the University of Florida	McKnight Brain Institute at the University of Florida	Support was provided by the McKnight Brain Institute at the University of Florida [http://mbi.ufl.edu/].	Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Aulas A, 2015, J CELL BIOL, V209, P73, DOI 10.1083/jcb.201408092; BELGRADER P, 1991, J BIOL CHEM, V266, P9893; Bertrand AT, 2011, BIOCHEM SOC T, V39, P1687, DOI 10.1042/BST20110670; BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Coelho MB, 2015, EMBO J, V34, P653, DOI 10.15252/embj.201489852; Colombrita C, 2009, J NEUROCHEM, V111, P1051, DOI 10.1111/j.1471-4159.2009.06383.x; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; Da Cruz S, 2011, CURR OPIN NEUROBIOL, V21, P904, DOI 10.1016/j.conb.2011.05.029; Depreux FF, 2015, HUM MOL GENET, V24, P4284, DOI 10.1093/hmg/ddv160; Erazo A, 2011, J VIROL, V85, P568, DOI 10.1128/JVI.01611-10; Feit H, 1998, AM J HUM GENET, V63, P1732, DOI 10.1086/302166; Figley MD, 2014, J NEUROSCI, V34, P8083, DOI 10.1523/JNEUROSCI.0543-14.2014; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Giordano G, 2005, J NEUROCHEM, V94, P808, DOI 10.1111/j.1471-4159.2005.03235.x; Irvine K, 2004, INT J DEV BIOL, V48, P1065, DOI 10.1387/ijdb.041893ki; Johnson JO, 2014, NAT NEUROSCI, V17, P664, DOI 10.1038/nn.3688; Kim SH, 2006, J NEUROSCI, V26, P2413, DOI 10.1523/JNEUROSCI.3680-05.2006; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Lomen-Hoerth C, 2003, NEUROLOGY, V60, P1094, DOI 10.1212/01.WNL.0000055861.95202.8D; Long RM, 2003, MOL CELL, V11, P1126, DOI 10.1016/S1097-2765(03)00198-9; Martelli AM, 1998, J HISTOCHEM CYTOCHEM, V46, P863, DOI 10.1177/002215549804600710; Matsuki H, 2013, GENES CELLS, V18, P135, DOI 10.1111/gtc.12023; Millecamps S, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.07.016; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Muller TJ, 2014, ANN NEUROL, V76, P669, DOI 10.1002/ana.24255; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Palmio J, 2015, J NEUROL NEUROSURG P; Parker SJ, 2012, NEUROCHEM INT, V60, P415, DOI 10.1016/j.neuint.2012.01.019; Ravits JM, 2009, NEUROLOGY, V73, P805, DOI 10.1212/WNL.0b013e3181b6bbbd; Reineke LC, 2015, MBIO, V6, DOI 10.1128/mBio.02486-14; Salton M, 2010, CELL CYCLE, V9, P1568, DOI 10.4161/cc.9.8.11298; Senderek J, 2009, AM J HUM GENET, V84, P511, DOI 10.1016/j.ajhg.2009.03.006; Tanaka T, 2014, BBA-GEN SUBJECTS, V1840, P985, DOI 10.1016/j.bbagen.2013.11.002; Yedavalli VSRK, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-61; Zhang Z, 2001, CELL, V106, P465, DOI 10.1016/S0092-8674(01)00466-4	37	36	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0142144	10.1371/journal.pone.0142144	http://dx.doi.org/10.1371/journal.pone.0142144			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528920	Green Published, gold, Green Submitted			2022-12-26	WOS:000364032600108
J	Nie, D; Shan, X; Nie, L; Duan, Y; Chen, Z; Yang, Y; Li, Z; Tian, L; Gao, Q; Shan, Y; Tang, N				Nie, D.; Shan, X.; Nie, L.; Duan, Y.; Chen, Z.; Yang, Y.; Li, Z.; Tian, L.; Gao, Q.; Shan, Y.; Tang, N.			Hepatitis C virus core protein interacts with Snail and histone deacetylases to promote the metastasis of hepatocellular carcinoma	ONCOGENE			English	Article							E-CADHERIN EXPRESSION; EPITHELIAL-MESENCHYMAL TRANSITION; TRANSCRIPTION FACTOR SNAIL; B-VIRUS; REPRESSOR; PHOSPHORYLATION; REPLICATION; DIFFERENTIATION; AGGRESSIVENESS; HDAC2	Downregulation of E-cadherin by the transcriptional repressor Snail is associated with acquisition of metastatic potential. Although hepatitis C virus (HCV) core protein has been implicated in hepatocarcinogenesis, it is unclear whether Snail is involved in HCV core-induced dysregulation of E-cadherin. Herein, we investigated the mechanism by which HCV core induces E-cadherin repression and the role of Snail in HCV core-mediated invasiveness and metastasis. We found that HCV infection, especially HCV core expression, effectively induced the epithelial-mesenchymal transition (EMT) in hepatoma cells by repressing E-cadherin. HCV core interacted with Snail and enhanced its binding to the E-box in the promoter region of E-cadherin, leading to decreased E-cadherin promoter activity. We found that HCV core, Snail, and the histone deacetylases HDAC1/HDAC2 formed a co-repressor complex at the E-cadherin promoter. Moreover, HCV core was shown to stabilize Snail through activation of the PI3K/Akt/GSK3 beta pathway. Silencing Snail expression restored E-cadherin expression and inhibited HCV core-promoted tumor growth and distant lung metastasis in vivo. Collectively, these results demonstrated that HCV core induced EMT by interacting with the transcriptional repressor complex Snail/HDACs at the E-cadherin promoter, which led to E-cadherin repression and increased invasiveness of hepatoma cells. These findings increase understanding of factors regulating metastasis in hepatoma and may ultimately lead to the development of novel treatment strategies for HCV-associated hepatocellular carcinoma.	[Shan, Y.; Tang, N.] Chongqing Med Univ, Affiliated Hosp 2, Chongqing 400016, Peoples R China; Chongqing Med Univ, Key Lab Mol Biol Infect Dis, Chinese Minist Educ, Chongqing 400016, Peoples R China	Chongqing Medical University; Chongqing Medical University	Shan, Y; Tang, N (corresponding author), Chongqing Med Univ, Affiliated Hosp 2, Chongqing 400016, Peoples R China.; Shan, Y; Tang, N (corresponding author), Chongqing Med Univ, Key Lab Mol Biol Infect Dis, Chongqing 400016, Peoples R China.	shanyoulan11@163.com; nitang@cqmu.edu.cn	Tang, Ni/Z-5133-2019	Tang, Ni/0000-0001-5830-8786; Nie, Lizhu/0000-0001-6353-5211	Major National ST program [2013ZX10002002-005-003, 2012ZX10002005-003-002]; China National Natural Science Foundation [81572683, 81371827, 31171307, 81502062]; Innovation Fund Designated for Graduate Students of Chongqing Government [CYS14124]; Outstanding Young talent program of 2nd affiliated hospital of CQMU	Major National ST program; China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Innovation Fund Designated for Graduate Students of Chongqing Government; Outstanding Young talent program of 2nd affiliated hospital of CQMU	We would like to thank Dr T-C He (University of Chicago, USA) for the kind provision of adenoviruses AdGFP, AdRFP, and AdR-FLuc. We are also grateful to Dr Takaji Wakita (National Institute of Infectious Diseases, Tokyo) for providing an HCV JFH1 cDNA clone and to Dr Haizhen Zhu (Hunan University, China) for the HLCZ01 cells. This study was supported by research grants from Major National S&T program (2013ZX10002002-005-003, NT; 2012ZX10002005-003-002, NT), China National Natural Science Foundation (#81572683, #81371827, #31171307, NT; #81502062, DN), Innovation Fund Designated for Graduate Students of Chongqing Government (#CYS14124, LN) and the Outstanding Young talent program of 2nd affiliated hospital of CQMU (NT).	Aghdassi A, 2012, GUT, V61, P439, DOI 10.1136/gutjnl-2011-300060; Akkari L, 2012, J HEPATOL, V57, P1021, DOI 10.1016/j.jhep.2012.06.027; Arzumanyan A, 2012, ONCOGENE, V31, P563, DOI 10.1038/onc.2011.255; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Battaglia S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004355; Bi Y, 2009, J CELL BIOCHEM, V108, P295, DOI 10.1002/jcb.22254; Bose SK, 2012, J VIROL, V86, P13621, DOI 10.1128/JVI.02016-12; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Dominguez D, 2003, MOL CELL BIOL, V23, P5078, DOI 10.1128/MCB.23.14.5078-5089.2003; Garg Minal, 2013, World J Stem Cells, V5, P188, DOI 10.4252/wjsc.v5.i4.188; Giannini C, 2003, CELL DEATH DIFFER, V10, pS27, DOI 10.1038/sj.cdd.4401121; Giroldi LA, 1997, BIOCHEM BIOPH RES CO, V241, P453, DOI 10.1006/bbrc.1997.7831; Grimes HL, 1996, MOL CELL BIOL, V16, P6263; Hashiguchi M, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-572; Hou ZY, 2010, CANCER RES, V70, P4385, DOI 10.1158/0008-5472.CAN-10-0070; Iwatsuki M, 2010, CANCER SCI, V101, P293, DOI 10.1111/j.1349-7006.2009.01419.x; Li TY, 2010, ANN SURG ONCOL, V17, P1937, DOI 10.1245/s10434-010-0925-3; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Liu JX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023098; Mingot JM, 2009, J CELL SCI, V122, P1452, DOI 10.1242/jcs.041749; Noh JH, 2014, CANCER RES, V74, P1728, DOI 10.1158/0008-5472.CAN-13-2109; Perez-Moreno MA, 2001, J BIOL CHEM, V276, P27424, DOI 10.1074/jbc.M100827200; Quan H, 2014, ONCOGENE, V33, P2826, DOI 10.1038/onc.2013.225; MacPherson MR, 2010, MOL BIOL CELL, V21, P244, DOI 10.1091/mbc.E09-06-0504; Ropero S, 2007, MOL ONCOL, V1, P19, DOI 10.1016/j.molonc.2007.01.001; Rosen HR, 2011, NEW ENGL J MED, V364, P2429, DOI 10.1056/NEJMcp1006613; SAITO I, 1990, P NATL ACAD SCI USA, V87, P6547, DOI 10.1073/pnas.87.17.6547; Sideridou M, 2011, J CELL BIOL, V195, P1123, DOI 10.1083/jcb.201108121; Su Y, 2011, ONCOGENE, V30, P3907, DOI 10.1038/onc.2011.97; Tacke RS, 2011, J BIOL CHEM, V286, P10847, DOI 10.1074/jbc.M110.217653; Tang N, 2009, J CELL MOL MED, V13, P2448, DOI 10.1111/j.1582-4934.2008.00569.x; Tong ZT, 2012, ONCOGENE, V31, P583, DOI 10.1038/onc.2011.254; von Burstin J, 2009, GASTROENTEROLOGY, V137, P361, DOI 10.1053/j.gastro.2009.04.004; Wu ZQ, 2012, P NATL ACAD SCI USA, V109, P16654, DOI 10.1073/pnas.1205822109; Xie Q, 2014, INT J CANCER, V135, P635, DOI 10.1002/ijc.28697; Yang DR, 2014, P NATL ACAD SCI USA, V111, pE1264, DOI 10.1073/pnas.1320071111; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yook JI, 2005, J BIOL CHEM, V280, P11740, DOI 10.1074/jbc.M413878200; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	40	22	24	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 14	2016	35	28					3626	3635		10.1038/onc.2015.428	http://dx.doi.org/10.1038/onc.2015.428			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DR0UQ	26549030	Bronze			2022-12-26	WOS:000379622800002
J	Li, J; Du, XR; Shi, H; Deng, KJ; Chi, HB; Tao, WF				Li, Jiang; Du, Xingrong; Shi, Hao; Deng, Kejing; Chi, Hongbo; Tao, Wufan			Mammalian Sterile 20-like Kinase 1 (Mst1) Enhances the Stability of Forkhead Box P3 (Foxp3) and the Function of Regulatory T Cells by Modulating Foxp3 Acetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASES; HIPPO; PROMOTES; PROLIFERATION; PROTEIN; GROWTH; SCURFY; TRANSCRIPTION; TRAFFICKING; INHIBITION	Regulatory T cells (Tregs) play crucial roles in maintaining immune tolerance. The transcription factor Foxp3 is a critical regulator of Treg development and function, and its expression is regulated at both transcriptional and post-translational levels. Acetylation by lysine acetyl transferases/lysine deacetylases is one of the main post-translational modifications of Foxp3, which regulate Foxp3's stability and transcriptional activity. However, the mechanism(s) by which the activities of these lysine acetyl transferases/lysine deacetylases are regulated to preserve proper Foxp3 acetylation during Treg development and maintenance of Treg function remains to be determined. Here we report that Mst1 can enhance Foxp3 stability, its transcriptional activity, and Treg function by modulating the Foxp3 protein at the post-translational level. We discovered that Mst1 could increase the acetylation of Foxp3 by inhibiting Sirt1 activity, which requires the Mst1 kinase activity. We also found that Mst1 could attenuate Sirt1-mediated deacetylation of Foxp3 through directly interacting with Foxp3 to prevent or interfere the interaction between Sirt1 and Foxp3. Therefore, Mst1 can regulate Foxp3 stability in kinase-dependent and kinase-independent manners. Finally, we showed that treatment of Mst1(-/-) Tregs with Ex-527, a Sirt1-specific inhibitor, partially restored the suppressive function of Mst1(-/-) Tregs. Our studies reveal a novel mechanism by which Mst1 enhances Foxp3 expression and Treg function at the post-translational level.	[Li, Jiang; Du, Xingrong; Shi, Hao; Deng, Kejing; Tao, Wufan] Fudan Univ, Sch Life Sci, Collaborat Innovat Ctr Genet & Dev, Inst Dev Biol & Mol Med, Shanghai 200433, Peoples R China; [Li, Jiang; Tao, Wufan] Fudan Univ, Obstet & Gynecol Hosp, Shanghai 200011, Peoples R China; [Li, Jiang; Tao, Wufan] Fudan Univ, Inst Reprod & Dev, Shanghai Key Lab Female Reprod Endocrine Related, Shanghai 200011, Peoples R China; [Du, Xingrong; Chi, Hongbo] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA	Fudan University; Fudan University; Fudan University; St Jude Children's Research Hospital	Chi, HB (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	hongbo.chi@stjude.org; wufan_tao@fudan.edu.cn	SHI, HAO/ABE-4662-2020; Du, Xinrong/GWU-9803-2022; Chi, Hongbo/M-9397-2018	SHI, HAO/0000-0002-2796-629X; Chi, Hongbo/0000-0002-9997-2496; Du, Xingrong/0000-0001-6427-9600	National Basic Research Program of China [2013CB945304, 2011CB510102]; National Natural Science Foundation of China [31471380, 31171406, 30971666]; Science and Technology Committee of Shanghai Municipality [12JC1400600]; 211 project of the Chinese Ministry of Education; 985 project of the Chinese Ministry of Education	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Committee of Shanghai Municipality(Shanghai Science & Technology Committee); 211 project of the Chinese Ministry of Education(Ministry of Education, China); 985 project of the Chinese Ministry of Education(Ministry of Education, China)	This work was supported by National Basic Research Program of China (Grants 2013CB945304 and 2011CB510102); National Natural Science Foundation of China (Grants 31471380, 31171406, and 30971666); Key Projects Grant for Basic Research (Grant 12JC1400600) from the Science and Technology Committee of Shanghai Municipality; and the 211 and 985 projects of the Chinese Ministry of Education. The authors declare that they have no conflicts of interest with the contents of this article.	Abdollahpour H, 2012, BLOOD, V119, P3450, DOI 10.1182/blood-2011-09-378158; Beier UH, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002873; Beier UH, 2011, MOL CELL BIOL, V31, P1022, DOI 10.1128/MCB.01206-10; Bettelli E, 2005, P NATL ACAD SCI USA, V102, P5138, DOI 10.1073/pnas.0501675102; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; de Zoeten EF, 2010, GASTROENTEROLOGY, V138, P583, DOI 10.1053/j.gastro.2009.10.037; Dong YL, 2009, J IMMUNOL, V183, P3865, DOI 10.4049/jimmunol.0900678; Du TF, 2013, EXP MOL PATHOL, V95, P38, DOI 10.1016/j.yexmp.2013.04.003; Du XR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090701; Du XR, 2014, J IMMUNOL, V192, P1525, DOI 10.4049/jimmunol.1301060; Einarson M. B., 2007, CSH PROTOC; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Katagiri K, 2009, EMBO J, V28, P1319, DOI 10.1038/emboj.2009.82; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Li B, 2007, P NATL ACAD SCI USA, V104, P4571, DOI 10.1073/pnas.0700298104; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Mou F, 2012, J EXP MED, V209, P741, DOI 10.1084/jem.20111692; Nehme NT, 2012, BLOOD, V119, P3458, DOI 10.1182/blood-2011-09-378364; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Pan F, 2009, SCIENCE, V325, P1142, DOI 10.1126/science.1176077; Ramsdell F, 2014, NAT REV IMMUNOL, V14, P343, DOI 10.1038/nri3650; Ryoo HD, 2003, NAT CELL BIOL, V5, P853, DOI 10.1038/ncb1003-853; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Samanta A, 2008, P NATL ACAD SCI USA, V105, P14023, DOI 10.1073/pnas.0806726105; Saouaf SJ, 2009, EXP MOL PATHOL, V87, P99, DOI 10.1016/j.yexmp.2009.06.003; Song H, 2010, P NATL ACAD SCI USA, V107, P1431, DOI 10.1073/pnas.0911409107; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Tao WF, 1999, NAT GENET, V21, P177, DOI 10.1038/5960; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Ueda Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2105; van Loosdregt J, 2014, TRENDS IMMUNOL, V35, P368, DOI 10.1016/j.it.2014.06.005; van Loosdregt J, 2013, IMMUNITY, V39, P298, DOI 10.1016/j.immuni.2013.07.019; van Loosdregt J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019047; van Loosdregt J, 2010, BLOOD, V115, P965, DOI 10.1182/blood-2009-02-207118; VanValkenburgh J, 2011, J EXP MED, V208, P2069, DOI 10.1084/jem.20102683; Venken K, 2007, J IMMUNOL METHODS, V322, P1, DOI 10.1016/j.jim.2007.01.025; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Yan SQ, 2000, DNA CELL BIOL, V19, P79, DOI 10.1089/104454900314591; Yuan F, 2011, J BIOL CHEM, V286, P6940, DOI 10.1074/jbc.M110.182543; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	47	36	40	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					30762	30770		10.1074/jbc.M115.668442	http://dx.doi.org/10.1074/jbc.M115.668442			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26538561	hybrid, Green Published			2022-12-26	WOS:000367199000010
J	Nahar, N; Paul, RC; Sultana, R; Gurley, ES; Garcia, F; Abedin, J; Sumon, SA; Banik, KC; Asaduzzaman, M; Rimi, NA; Rahman, M; Luby, SP				Nahar, Nazmun; Paul, Repon C.; Sultana, Rebeca; Gurley, Emily S.; Garcia, Fernando; Abedin, Jaynal; Sumon, Shariful Amin; Banik, Kajal Chandra; Asaduzzaman, Mohammad; Rimi, Nadia Ali; Rahman, Mahmudur; Luby, Stephen P.			Raw Sap Consumption Habits and Its Association with Knowledge of Nipah Virus in Two Endemic Districts in Bangladesh	PLOS ONE			English	Article							DATE PALM SAP; TO-PERSON TRANSMISSION; UNPASTEURIZED MILK; RESERVOIR HOSTS; PTEROPID BATS; OUTBREAK; INFECTIONS; WEIGHT; HUMANS; ACCESS	Human Nipah virus (NiV) infection in Bangladesh is a fatal disease that can be transmitted from bats to humans who drink contaminated raw date palm sap collected overnight during the cold season. Our study aimed to understand date palm sap consumption habits of rural residents and factors associated with consumption. In November-December 2012 the field team interviewed adult respondents from randomly selected villages from Rajbari and Kushtia Districts in Bangladesh. We calculated the proportion of people who consumed raw sap and had heard about a disease from raw sap consumption. We assessed the factors associated with raw sap consumption by calculating prevalence ratios (PR) adjusted for village level clustering effects. Among the 1,777 respondents interviewed, half (50%) reported drinking raw sap during the previous sap collection season and 37% consumed raw sap at least once per month. Few respondents (5%) heard about NiV. Thirty-seven percent of respondents reported hearing about a disease transmitted through raw sap consumption, inclusive of a 10% who related it with milder illness like diarrhea, vomiting or indigestion rather than NiV. Respondents who harvested date palm trees in their household were more likely to drink sap than those who did not own date palm trees (79% vs. 65% PR 1.2, 95% CI 1.1-1.3, p<0.001). When sap was available, respondents who heard about a disease from raw sap consumption were just as likely to drink it as those who did not hear about a disease (69% vs. 67%, PR 1.0, 95% CI 0.9-1.1, p = 0.512). Respondents' knowledge of NiV was low. They might not have properly understood the risk of NiV, and were likely to drink sap when it was available. Implementing strategies to increase awareness about the risks of NiV and protect sap from bats might reduce the risk of NiV transmission.	[Nahar, Nazmun; Paul, Repon C.; Sultana, Rebeca; Gurley, Emily S.; Abedin, Jaynal; Sumon, Shariful Amin; Banik, Kajal Chandra; Asaduzzaman, Mohammad; Rimi, Nadia Ali] ICDDRB, Dhaka, Bangladesh; [Nahar, Nazmun] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Garcia, Fernando] FHI360, Washington DC Off, Washington, DC USA; [Rahman, Mahmudur] IEDCR, Dhaka, Bangladesh; [Luby, Stephen P.] Stanford Univ, Infect Dis & Geog Med, Stanford, CA 94305 USA	International Centre for Diarrhoeal Disease Research (ICDDR); University of Basel; Swiss Tropical & Public Health Institute; Stanford University	Nahar, N (corresponding author), ICDDRB, Dhaka, Bangladesh.	nahar.nazmun@yahoo.com	Abedin, Jaynal/AAB-4089-2020; Gurley, Emily S/B-7903-2010	Abedin, Jaynal/0000-0002-4830-4092; Gurley, Emily S/0000-0002-8648-9403; Sultana, Rebeca/0000-0002-4180-5679; Sumon, Shariful Amin/0000-0001-5770-1527; Nahar, Nazmun/0000-0002-4530-6009; Rimi, Nadia/0000-0002-5566-8812; Luby, Stephen/0000-0001-5385-899X	FHI 360 [GHN-A-00-09-000002-00]	FHI 360	Funding: This study was funded by FHI 360, grant number GHN-A-00-09-000002-00.	Afrin S, 2013, ASARENESS CAMPAIGN N; Antia R, 2003, NATURE, V426, P658, DOI 10.1038/nature02104; Arankalle VA, 2011, EMERG INFECT DIS, V17, P907, DOI 10.3201/eid1705.100968; BBS (Bangladesh Bureau of Statistics), 2015, POPULATION HOUSING C; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Contento I., 1995, Journal of Nutrition Education, V27, P277; Correspondent S, 2013, NIPAH KILLS 5 MORE; Davidson R, 1993, ESTIMATION INFERENCE; de Wit E, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004001; DUCLOS PJ, 1990, INT J EPIDEMIOL, V19, P673, DOI 10.1093/ije/19.3.673; Editor N, 2011, NIPAH SPREADING NO R; Gase LN, 2014, HEALTH EDUC BEHAV, V41, P431, DOI 10.1177/1090198114529128; Gurley ES, 2007, EMERG INFECT DIS, V13, P1031, DOI 10.3201/eid1307.061128; Halpin K, 2011, AM J TROP MED HYG, V85, P946, DOI 10.4269/ajtmh.2011.10-0567; Hattersley LA, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-61; Homaira N, 2010, EPIDEMIOL INFECT, V138, P1630, DOI 10.1017/S0950268810000695; ICDDRB, 2010, HLTH SCI B, V8, P6; Islam A, 2013, ECOHEALTH; Islam MS, 2012, HLTH SCI B, V10, P16; Jayarao BM, 2006, J DAIRY SCI, V89, P2451, DOI 10.3168/jds.S0022-0302(06)72318-9; Kabeer N, 2001, WORLD DEV, V29, P63, DOI 10.1016/S0305-750X(00)00081-4; Keene WE, 1997, J INFECT DIS, V176, P815, DOI 10.1086/517310; Khan MSU, 2010, ECOHEALTH, V7, P517, DOI 10.1007/s10393-010-0366-2; Khan SU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042689; LeJeune JT, 2009, CLIN INFECT DIS, V48, P93, DOI 10.1086/595007; Li F, 2009, AM J EPIDEMIOL, V169, P401, DOI 10.1093/aje/kwn398; Longenberger AH, 2013, CLIN INFECT DIS, V57, P263, DOI 10.1093/cid/cit231; Luby SP, 2006, EMERG INFECT DIS, V12, P1888; Luby SP, 2013, ANTIVIR RES, V100, P38, DOI 10.1016/j.antiviral.2013.07.011; Luby SP, 2009, CLIN INFECT DIS, V49, P1743, DOI 10.1086/647951; Luby SP, 2009, EMERG INFECT DIS, V15, P1229, DOI 10.3201/eid1508.081237; Mehta NK, 2008, AM J PREV MED, V34, P127, DOI 10.1016/j.amepre.2007.09.031; Middleton DJ, 2007, J COMP PATHOL, V136, P266, DOI 10.1016/j.jcpa.2007.03.002; Nahar N, 2014, GLOB HEALTH PROMOT, V21, P7, DOI 10.1177/1757975914528249; Nahar N, 2013, HEALTH PROMOT INT, V28, P378, DOI 10.1093/heapro/das020; Nahar N, 2010, ECOHEALTH, V7, P196, DOI 10.1007/s10393-010-0320-3; Nestle M, 1998, NUTR REV, V56, pS50, DOI 10.1111/j.1753-4887.1998.tb01732.x; Oliver SP, 2009, FOODBORNE PATHOG DIS, V6, P793, DOI 10.1089/fpd.2009.0302; Olstad DL, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-376; Rahman MA, 2012, VECTOR-BORNE ZOONOT, V12, P65, DOI 10.1089/vbz.2011.0656; Reynes JM, 2005, EMERG INFECT DIS, V11, P1042, DOI 10.3201/eid1107.041350; Sazzad HMS, 2013, EMERG INFECT DIS, V19, P210, DOI 10.3201/eid1902.120971; Tamers SL, 2014, DOES MOTIVATE BEHAV; Wacharapluesadee S, 2005, EMERG INFECT DIS, V11, P1949, DOI 10.3201/eid1112.050613; Wong S, 2007, REV MED VIROL, V17, P67, DOI 10.1002/rmv.520; Zoellner J, 2012, J NUTR EDUC BEHAV, V44, P172, DOI 10.1016/j.jneb.2011.06.010	46	18	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2015	10	11							e0142292	10.1371/journal.pone.0142292	http://dx.doi.org/10.1371/journal.pone.0142292			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7AC	26551202	Green Published, gold, Green Accepted			2022-12-26	WOS:000364422800023
J	Park, JSY; Lee, MK; Kang, S; Jin, Y; Fu, SB; Rosales, JL; Lee, KY				Park, John S. Y.; Lee, Marie-Katrina; Kang, SungMyung; Jin, Yan; Fu, Songbin; Rosales, Jesusa L.; Lee, Ki-Young			Species-Specific Expression of Full-Length and Alternatively Spliced Variant Forms of CDK5RAP2	PLoS One			English	Article							PROTEINS; COMPLEX	CDK5RAP2 is one of the primary microcephaly genes that are associated with reduced brain size and mental retardation. We have previously shown that human CDK5RAP2 exists as a full-length form (hCDK5RAP2) or an alternatively spliced variant form (hCDK5RAP2-V1) that is lacking exon 32. The equivalent of hCDK5RAP2-V1 has been reported in rat and mouse but the presence of full-length equivalent hCDK5RAP2 in rat and mouse has not been examined. Here, we demonstrate that rat expresses both a full length and an alternatively spliced variant form of CDK5RAP2 that are equivalent to our previously reported hCDK5RAP2 and hCDK5RAP2-V1, repectively. However, mouse expresses only one form of CDK5RAP2 that is equivalent to the human and rat alternatively spliced variant forms. Knowledge of this expression of different forms of CDK5RAP2 in human, rat and mouse is essential in selecting the appropriate model for studies of CDK5RAP2 and primary microcephaly but our findings further indicate the evolutionary divergence of mouse from the human and rat species.	[Park, John S. Y.; Lee, Marie-Katrina; Kang, SungMyung; Lee, Ki-Young] Univ Calgary, Dept Cell Biol & Anat, Southern Alberta Canc Res, Calgary, AB, Canada; [Park, John S. Y.; Lee, Marie-Katrina; Kang, SungMyung; Rosales, Jesusa L.; Lee, Ki-Young] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Jin, Yan; Fu, Songbin] Harbin Med Univ, Med Genet Lab, Harbin, Peoples R China; [Rosales, Jesusa L.] Univ Calgary, Dept Biochem & Mol Biol, Southern Alberta Canc Res, Calgary, AB, Canada	University of Calgary; University of Calgary; Harbin Medical University; University of Calgary	Lee, KY (corresponding author), Univ Calgary, Dept Cell Biol & Anat, Southern Alberta Canc Res, Calgary, AB, Canada.	kylee@ucalgary.ca		Rosales, Jesusa/0000-0002-2543-3801	Canadian Institutes of Health Research [MOP-123400]; NSERC [RGPIN/312985-2011, RGPIN1356448-2008]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding: This work was supported in part by grants from the Canadian Institutes of Health Research (MOP-123400) and NSERC (RGPIN/312985-2011) to KYL and NSERC (RGPIN1356448-2008) to JLR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Buchman JJ, 2010, NEURON, V66, P386, DOI 10.1016/j.neuron.2010.03.036; Ching YP, 2000, GENE, V242, P285, DOI 10.1016/S0378-1119(99)00499-0; Cox J, 2006, TRENDS MOL MED, V12, P358, DOI 10.1016/j.molmed.2006.06.006; Faheem M, 2015, BMC MED GENOMICS, V8, DOI 10.1186/1755-8794-8-S1-S4; Fong KW, 2008, MOL BIOL CELL, V19, P115, DOI 10.1091/mbc.E07-04-0371; Fong KW, 2009, MOL BIOL CELL, V20, P3660, DOI 10.1091/mbc.E09-01-0009; Hall JG, 2013, GENE, V528, P55, DOI 10.1016/j.gene.2013.03.081; Hussain MS, 2013, CLIN GENET, V83, P446, DOI 10.1111/j.1399-0004.2012.01932.x; Issa L, 2013, CEREB CORTEX, V23, P2245, DOI 10.1093/cercor/bhs212; Issa L, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-59; Kim T, 2011, CELL CYCLE, V10, P1010, DOI 10.4161/cc.10.6.15121; Kraemer N, 2011, CELL MOL LIFE SCI, V68, P1719, DOI 10.1007/s00018-011-0635-4; Lee KY, 1997, INT J BIOCHEM CELL B, V29, P951, DOI 10.1016/S1357-2725(97)00048-4; Pagnamenta AT, 2012, AM J MED GENET A, V158A, P2577, DOI 10.1002/ajmg.a.35558; Park JSY, 2011, CELL CYCLE, V10, P1331, DOI 10.4161/cc.10.8.15358; Rosales JL, 2006, BIOESSAYS, V28, P1023, DOI 10.1002/bies.20473; Rosales JL, 2010, CELL CYCLE, V9, P618, DOI 10.4161/cc.9.3.10597; Salman-Dilgimen A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003841; Wang Z, 2010, J BIOL CHEM, V285, P22658, DOI 10.1074/jbc.M110.105965; Woods CG, 2005, AM J HUM GENET, V76, P717, DOI 10.1086/429930	21	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2015	10	11							e0142577	10.1371/journal.pone.0142577	http://dx.doi.org/10.1371/journal.pone.0142577			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7AC	26550838	gold, Green Published, Green Submitted			2022-12-26	WOS:000364422800029
J	Hirata, Y; Li, HW; Takahashi, K; Ishii, H; Sykes, M; Fujisaki, J				Hirata, Yuichi; Li, Hao-Wei; Takahashi, Kazuko; Ishii, Hiroshi; Sykes, Megan; Fujisaki, Joji			MHC Class I Expression by Donor Hematopoietic Stem Cells Is Required to Prevent NK Cell Attack in Allogeneic, but Not Syngeneic Recipient Mice	PLOS ONE			English	Article							MARROW GRAFT-REJECTION; NATURAL-KILLER; LONG-TERM; ENGRAFTMENT	NK cells resist engraftment of syngeneic and allogeneic bone marrow (BM) cells lacking major histocompatibility (MHC) class I molecules, suggesting a critical role for donor MHC class I molecules in preventing NK cell attack against donor hematopoietic stem and progenitor cells (HSPCs), and their derivatives. However, using high-resolution in vivo imaging, we demonstrated here that syngeneic MHC class I knockout (KO) donor HSPCs persist with the same survival frequencies as wild-type donor HSPCs. In contrast, syngeneic MHC class I KO differentiated hematopoietic cells and allogeneic MHC class I KO HSPCs were rejected in a manner that was significantly inhibited by NK cell depletion. In vivo time-lapse imaging demonstrated that mice receiving allogeneic MHC class I KO HSPCs showed a significant increase in NK cell motility and proliferation as well as frequencies of NK cell contact with and killing of HSPCs as compared to mice receiving wild-type HSPCs. The data indicate that donor MHC class I molecules are required to prevent NK cell-mediated rejection of syngeneic differentiated cells and allogeneic HSPCs, but not of syngeneic HSPCs.	[Hirata, Yuichi; Li, Hao-Wei; Takahashi, Kazuko; Ishii, Hiroshi; Sykes, Megan; Fujisaki, Joji] Columbia Univ, Coll Physicians & Surgeons, Dept Med Surg & Microbiol Immunol, Columbia Ctr Translat Immunol, New York, NY 10027 USA; [Takahashi, Kazuko] Juntendo Univ, Sch Med, Dept Pathol, Tokyo 113, Japan	Columbia University; Juntendo University	Fujisaki, J (corresponding author), Columbia Univ, Coll Physicians & Surgeons, Dept Med Surg & Microbiol Immunol, Columbia Ctr Translat Immunol, New York, NY 10027 USA.	jf2819@cumc.columbia.edu			Schaefer Research Scholar Award; Uehara Memorial Foundation Research Fellowship Award; Office of the Director, National Institutes of Health [S10OD020056]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD020056] Funding Source: NIH RePORTER	Schaefer Research Scholar Award; Uehara Memorial Foundation Research Fellowship Award(Uehara Memorial Foundation); Office of the Director, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Schaefer Research Scholar Award (J.F.) and Uehara Memorial Foundation Research Fellowship Award (Y.H.). Research reported in this publication was performed in the CCTI Flow Cytometry Core, supported in part by the Office of the Director, National Institutes of Health under award S10OD020056.	BIX M, 1991, NATURE, V349, P329, DOI 10.1038/349329a0; Champsaur M, 2010, IMMUNOL REV, V235, P267, DOI 10.1111/j.0105-2896.2010.00893.x; Deguine J, 2010, IMMUNITY, V33, P632, DOI 10.1016/j.immuni.2010.09.016; Fujisaki J, 2011, NATURE, V474, P216, DOI 10.1038/nature10160; Geldhof AB, 1998, BLOOD, V91, P196, DOI 10.1182/blood.V91.1.196.196_196_206; Huang YM, 2004, BLOOD, V104, P873, DOI 10.1182/blood-2003-11-3910; Lee LA, 1996, TRANSPLANTATION, V61, P125, DOI 10.1097/00007890-199601150-00024; Li N, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00152; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Niederkorn JY, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00148; Niederkorn JY, 2006, NAT IMMUNOL, V7, P354, DOI 10.1038/ni1328; Oberbarnscheidt MH, 2014, J CLIN INVEST, V124, P3579, DOI 10.1172/JCI74370; OHLEN C, 1995, EUR J IMMUNOL, V25, P1286, DOI 10.1002/eji.1830250523; OHLEN C, 1989, SCIENCE, V246, P666, DOI 10.1126/science.2814488; Park D, 2012, CELL STEM CELL, V10, P259, DOI 10.1016/j.stem.2012.02.003; Shizuru J A, 1996, Biol Blood Marrow Transplant, V2, P3; Zecher D, 2009, J IMMUNOL, V183, P7810, DOI 10.4049/jimmunol.0902194	17	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141785	10.1371/journal.pone.0141785	http://dx.doi.org/10.1371/journal.pone.0141785			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544200	Green Published, gold, Green Submitted			2022-12-26	WOS:000364398700046
J	Zhao, HM; Huang, G; Li, Y; Ma, J; Sheng, JD; Jia, HT; Li, CJ				Zhao, Hongmei; Huang, Gang; Li, Yan; Ma, Jian; Sheng, Jiandong; Jia, Hongtao; Li, Congjuan			Effects of Increased Summer Precipitation and Nitrogen Addition on Root Decomposition in a Temperate Desert	PLOS ONE			English	Article							LEAF-LITTER DECOMPOSITION; GLOBAL PATTERNS; CLIMATE-CHANGE; WATER PULSES; LAND-USE; RATES; DYNAMICS; NUTRIENT; PINE; AVAILABILITY	Background Climate change scenarios that include precipitation shifts and nitrogen (N) deposition are impacting carbon (C) budgets in arid ecosystems. Roots constitute an important part of the C cycle, but it is still unclear which factors control root mass loss and nutrient release in arid lands. Methodology/Principal Findings Litterbags were used to investigate the decomposition rate and nutrient dynamics in root litter with water and N-addition treatments in the Gurbantunggut Desert in China. Water and N addition had no significant effect on root mass loss and the N and phosphorus content of litter residue. The loss of root litter and nutrient releases were strongly controlled by the initial lignin content and the lignin: N ratio, as evidenced by the negative correlations between decomposition rate and litter lignin content and the lignin: N ratio. Fine roots of Seriphidium santolinum (with higher initial lignin content) had a slower decomposition rate in comparison to coarse roots. Conclusion/Significance Results from this study indicate that small and temporary changes in rainfall and N deposition do not affect root decomposition patterns in the Gurbantunggut Desert. Root decomposition rates were significantly different between species, and also between fine and coarse roots, and were determined by carbon components, especially lignin content, suggesting that root litter quality may be the primary driver of belowground carbon turnover.	[Zhao, Hongmei; Sheng, Jiandong; Jia, Hongtao] Xinjiang Agr Univ, Coll Grassland & Environm Sci, Xinjiang Key Lab Soil & Plant Ecol Proc, Urumqi, Peoples R China; [Huang, Gang; Li, Yan; Ma, Jian] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, State Key Lab Desert & Oasis Ecol, Urumqi, Peoples R China; [Huang, Gang; Li, Yan; Ma, Jian] Chinese Acad Sci, Fukang Stn Desert Ecol, Xinjiang, Fukang, Peoples R China; [Li, Congjuan] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Natl Engn Technol Res Ctr Desert Oasis Ecol Const, Urumqi, Peoples R China	Xinjiang Agricultural University; Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS	Sheng, JD (corresponding author), Xinjiang Agr Univ, Coll Grassland & Environm Sci, Xinjiang Key Lab Soil & Plant Ecol Proc, Urumqi, Peoples R China.	sjd_2004@126.com	huang, gang/D-6427-2012; Li, Congjuan/ABH-8523-2020	huang, gang/0000-0002-8692-7856; 	Strategic Priority Research Program of Chinese Academic of Sciences [XDA05050400]; National Natural Science Foundation of China [31370010, 31300449]; Western Light Project of the Chinese Academy of Sciences [XBBS201205]	Strategic Priority Research Program of Chinese Academic of Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Western Light Project of the Chinese Academy of Sciences	This research was supported by the Strategic Priority Research Program of Chinese Academic of Sciences (No. XDA05050400), the National Natural Science Foundation of China (No. 31370010,31300449), and the Western Light Project of the Chinese Academy of Sciences (No. XBBS201205). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin AT, 2011, TRENDS ECOL EVOL, V26, P229, DOI 10.1016/j.tree.2011.02.003; Austin AT, 2010, P NATL ACAD SCI USA, V107, P4618, DOI 10.1073/pnas.0909396107; Austin AT, 2009, ECOLOGY, V90, P2642, DOI 10.1890/08-1804.1; Austin AT, 2004, OECOLOGIA, V141, P221, DOI 10.1007/s00442-004-1519-1; Jacobson TKB, 2011, ENVIRON POLLUT, V159, P2236, DOI 10.1016/j.envpol.2010.10.019; Bontti EE, 2009, GLOBAL CHANGE BIOL, V15, P1356, DOI 10.1111/j.1365-2486.2008.01815.x; Boyero L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087426; Bremner JM., 1965, METHODS SOIL ANAL, V9, P1149; Canadell J, 1996, Oecologia, V108, P583, DOI 10.1007/BF00329030; Chen H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099018; Cornwell WK, 2008, ECOL LETT, V11, P1065, DOI 10.1111/j.1461-0248.2008.01219.x; Craine JM, 2007, ECOLOGY, V88, P2105, DOI 10.1890/06-1847.1; Cusack DF, 2009, GLOBAL CHANGE BIOL, V15, P1339, DOI 10.1111/j.1365-2486.2008.01781.x; de Graaff MA, 2013, SOIL BIOL BIOCHEM, V58, P198, DOI 10.1016/j.soilbio.2012.11.015; Falster D.S., 2006, USERS GUIDE SMATR ST; Fenn ME, 2003, BIOSCIENCE, V53, P404, DOI [10.1641/0006-3568(2003)053[0404:EEONDI]2.0.CO;2, 10.1641/0006-3568(2003)053[0391:NEDAMI]2.0.CO;2]; Fornara DA, 2009, J ECOL, V97, P48, DOI 10.1111/j.1365-2745.2008.01453.x; GALLARDO A, 1993, ECOLOGY, V74, P152, DOI 10.2307/1939510; Gholz HL, 2000, GLOBAL CHANGE BIOL, V6, P751, DOI 10.1046/j.1365-2486.2000.00349.x; Gill RA, 2000, NEW PHYTOL, V147, P13, DOI 10.1046/j.1469-8137.2000.00681.x; Harmon ME, 1999, LT EC RES NETWK SER, V2, P143; Hobbie SE, 2010, OECOLOGIA, V162, P505, DOI 10.1007/s00442-009-1479-6; Hobbie SE, 2005, ECOSYSTEMS, V8, P644, DOI 10.1007/s10021-003-0110-7; Jacobson KM, 1998, J ARID ENVIRON, V38, P571, DOI 10.1006/jare.1997.0358; King JS, 1997, PLANT SOIL, V195, P171, DOI 10.1023/A:1004248232450; Knorr M, 2005, ECOLOGY, V86, P3252, DOI 10.1890/05-0150; Kuo S., 1996, Methods of soil analysis. Part 3 - chemical methods., P869; Langley JA, 2003, ECOLOGY, V84, P2302, DOI 10.1890/02-0282; Liu XJ, 2011, ENVIRON POLLUT, V159, P2251, DOI 10.1016/j.envpol.2010.08.002; Ludovici KH, 2006, CAN J FOREST RES, V36, P105, DOI 10.1139/X05-227; Martinez-Yrizar A, 2007, ACTA OECOL, V32, P291, DOI 10.1016/j.actao.2007.05.010; MCCLAUGHERTY CA, 1984, OIKOS, V42, P378, DOI 10.2307/3544408; MEENTEMEYER V, 1978, ECOLOGY, V59, P465, DOI 10.2307/1936576; Mun H.-T., 1998, Biology and Fertility of Soils, V26, P16, DOI 10.1007/s003740050336; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; OLSON JS, 1963, ECOLOGY, V44, P322, DOI 10.2307/1932179; Osanai Y, 2012, PLANT SOIL, V350, P365, DOI 10.1007/s11104-011-0920-x; Ostertag R, 1999, OECOLOGIA, V121, P564, DOI 10.1007/s004420050963; Parton W, 2007, SCIENCE, V315, P361, DOI 10.1126/science.1134853; PRESCOTT CE, 1995, PLANT SOIL, V168, P83, DOI 10.1007/BF00029316; Qian WH, 2001, CLIMATIC CHANGE, V50, P419, DOI 10.1023/A:1010673212131; Quested H, 2007, FUNCT ECOL, V21, P1016, DOI 10.1111/j.1365-2435.2007.01324.x; Rasse DP, 2005, PLANT SOIL, V269, P341, DOI 10.1007/s11104-004-0907-y; Silver WL, 2001, OECOLOGIA, V129, P407, DOI 10.1007/s004420100740; Solly EF, 2014, PLANT SOIL, V382, P203, DOI 10.1007/s11104-014-2151-4; Suseela V, 2013, NEW PHYTOL, V200, P122, DOI 10.1111/nph.12376; Throop Heather L., 2009, V70, P171, DOI 10.1007/978-3-540-68421-3_8; VANSOEST PJ, 1967, J ANIM SCI, V26, P119, DOI 10.2527/jas1967.261119x; Verburg PSJ, 2013, GLOBAL CHANGE BIOL, V19, P948, DOI 10.1111/gcb.12082; Vivanco L, 2006, OECOLOGIA, V150, P97, DOI 10.1007/s00442-006-0495-z; Walter J, 2013, SOIL BIOL BIOCHEM, V60, P10, DOI 10.1016/j.soilbio.2013.01.018; Warton DI, 2002, BIOMETRICAL J, V44, P161, DOI 10.1002/1521-4036(200203)44:2<161::AID-BIMJ161>3.0.CO;2-N; WHITFORD WG, 1986, OECOLOGIA, V68, P512, DOI 10.1007/BF00378764; Wieder WR, 2009, ECOLOGY, V90, P3333, DOI 10.1890/08-2294.1; Xu H, 2006, PLANT SOIL, V285, P5, DOI 10.1007/s11104-005-5108-9; ZAK J, 1988, AGR ECOSYST ENVIRON, V24, P87, DOI 10.1016/0167-8809(88)90058-8	56	7	10	8	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142380	10.1371/journal.pone.0142380	http://dx.doi.org/10.1371/journal.pone.0142380			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544050	Green Published, gold, Green Submitted			2022-12-26	WOS:000364398700125
J	Benoist, C; Guerin, C; Noirot, P; Dervyn, E				Benoist, Camille; Guerin, Cyprien; Noirot, Philippe; Dervyn, Etienne			Constitutive Stringent Response Restores Viability of Bacillus subtilis Lacking Structural Maintenance of Chromosome Protein	PLOS ONE			English	Article							TRANSFER-RNA SYNTHETASE; ESCHERICHIA-COLI; DNA-REPLICATION; SMC PROTEIN; RIBONUCLEOTIDE REDUCTASE; CONDENSIN COMPLEX; B. SUBTILIS; SEGREGATION; GENE; (P)PPGPP	Bacillus subtilis mutants lacking the SMC-ScpAB complex are severely impaired for chromosome condensation and partitioning, DNA repair, and cells are not viable under standard laboratory conditions. We isolated suppressor mutations that restored the capacity of a smc deletion mutant (Delta smc) to grow under standard conditions. These suppressor mutations reduced chromosome segregation defects and abrogated hypersensitivity to gyrase inhibitors of Delta smc. Three suppressor mutations were mapped in genes involved in tRNA aminoacylation and maturation pathways. A transcriptomic survey of isolated suppressor mutations pointed to a potential link between suppression of Delta smc and induction of the stringent response. This link was confirmed by (p) ppGpp quantification which indicated a constitutive induction of the stringent response in multiple suppressor strains. Furthermore, sublethal concentrations of arginine hydroxamate (RHX), a potent inducer of stringent response, restored growth of Delta smc under non permissive conditions. We showed that production of (p) ppGpp alone was sufficient to suppress the thermosensitivity exhibited by the Delta smc mutant. Our findings shed new light on the coordination between chromosome dynamics mediated by SMC-ScpAB and other cellular processes during rapid bacterial growth.	[Benoist, Camille; Noirot, Philippe; Dervyn, Etienne] INRA, Micalis UMR1319, F-78350 Jouy En Josas, France; [Benoist, Camille; Noirot, Philippe; Dervyn, Etienne] AgroParisTech, UMR Micalis 1319, F-78350 Jouy En Josas, France; [Guerin, Cyprien] INRA, Math & Informat Appl Genome Environm, UR1404, F-78350 Jouy En Josas, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Dervyn, E (corresponding author), INRA, Micalis UMR1319, F-78350 Jouy En Josas, France.	etienne.dervyn@jouy.inra.fr		Guerin, Cyprien/0000-0001-6102-7002	Ministere de l'Enseignement Superieur et de la Recherche; European Commission BaSysBio [LSHG-CT-2006-037469]; INRA AIP BioRessources Solimut	Ministere de l'Enseignement Superieur et de la Recherche; European Commission BaSysBio(European CommissionEuropean Commission Joint Research Centre); INRA AIP BioRessources Solimut	This work was supported by a grant from Ministere de l'Enseignement Superieur et de la Recherche to CB, by the European Commission BaSysBio project LSHG-CT-2006-037469 to PN and by the INRA AIP BioRessources-2009 Solimut to ED.	ANAGNOSTOPOULOS C, 1961, P NATL ACAD SCI USA, V47, P378, DOI 10.1073/pnas.47.3.378; Aravind L, 2002, PROTEINS, V48, P1, DOI 10.1002/prot.10064; Biller SJ, 2009, MOL MICROBIOL, V74, P790, DOI 10.1111/j.1365-2958.2009.06893.x; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Britton RA, 1998, GENE DEV, V12, P1254, DOI 10.1101/gad.12.9.1254; Britton RA, 1999, J BACTERIOL, V181, P5860, DOI 10.1128/JB.181.18.5860-5864.1999; Cashel M., 1996, STRINGENT RESPONSE; Cashell M, 1996, CELLULAR MOL BIOL, V1, P1458; Cobbe N, 2004, MOL BIOL EVOL, V21, P332, DOI 10.1093/molbev/msh023; Costes A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001238; D'Ambrosio C, 2008, CURR BIOL, V18, P1084, DOI 10.1016/j.cub.2008.06.058; Danilova O, 2007, MOL MICROBIOL, V65, P1485, DOI 10.1111/j.1365-2958.2007.05881.x; de la Tour CB, 2009, EXTREMOPHILES, V13, P827, DOI 10.1007/s00792-009-0270-2; De Piccoli G, 2009, CHROMOSOME RES, V17, P251, DOI 10.1007/s10577-008-9016-8; Delumeau O, 2011, PROTEOMICS, V11, P2992, DOI 10.1002/pmic.201000790; DeNapoli J, 2013, MOL MICROBIOL, V88, P93, DOI 10.1111/mmi.12172; Dervyn E, 2004, MOL MICROBIOL, V51, P1629, DOI 10.1111/j.1365-2958.2003.03951.x; Duigou S, 2005, MOL MICROBIOL, V57, P678, DOI 10.1111/j.1365-2958.2005.04725.x; El Yacoubi B, 2009, NUCLEIC ACIDS RES, V37, P2894, DOI 10.1093/nar/gkp152; Escartin F, 2008, P NATL ACAD SCI USA, V105, P9948, DOI 10.1073/pnas.0801356105; Eymann C, 2002, J BACTERIOL, V184, P2500, DOI 10.1128/JB.184.9.2500-2520.2002; Fabret C, 2002, MOL MICROBIOL, V46, P25, DOI 10.1046/j.1365-2958.2002.03140.x; Fabret C, 2011, MOL MICROBIOL, V80, P1062, DOI 10.1111/j.1365-2958.2011.07630.x; Freeman L, 2000, J CELL BIOL, V149, P811, DOI 10.1083/jcb.149.4.811; GROS MF, 1987, EMBO J, V6, P3863, DOI 10.1002/j.1460-2075.1987.tb02724.x; Gruber S, 2014, CURR BIOL, V24, P293, DOI 10.1016/j.cub.2013.12.049; Gruber S, 2009, CELL, V137, P685, DOI 10.1016/j.cell.2009.02.035; Guthlein C, 2008, J BACTERIOL, V190, P452, DOI 10.1128/JB.01315-07; Harwood CR., 1990, MODERN MICROBIOLOGIC, P5; HIRAGA S, 1991, RES MICROBIOL, V142, P189, DOI 10.1016/0923-2508(91)90029-A; Hirano T, 2005, CURR BIOL, V15, pR265, DOI 10.1016/j.cub.2005.03.037; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; IRETON K, 1994, J BACTERIOL, V176, P5320, DOI 10.1128/JB.176.17.5320-5329.1994; Lauhon CT, 2012, BIOCHEMISTRY-US, V51, P8950, DOI 10.1021/bi301233d; Lindow JC, 2002, J BACTERIOL, V184, P5317, DOI 10.1128/JB.184.19.5317-5322.2002; Livny J, 2007, J BACTERIOL, V189, P8693, DOI 10.1128/JB.01239-07; Magnusson LU, 2007, J BACTERIOL, V189, P5193, DOI 10.1128/JB.00330-07; Magnusson LU, 2005, TRENDS MICROBIOL, V13, P236, DOI 10.1016/j.tim.2005.03.008; Mascarenhas J, 2002, EMBO J, V21, P3108, DOI 10.1093/emboj/cdf314; Meile JC, 2006, PROTEOMICS, V6, P2135, DOI 10.1002/pmic.200500512; Minnen A, 2011, MOL MICROBIOL, V81, P676, DOI 10.1111/j.1365-2958.2011.07722.x; Moriya S, 1998, MOL MICROBIOL, V29, P179, DOI 10.1046/j.1365-2958.1998.00919.x; Nanamiya H, 2008, MOL MICROBIOL, V67, P291, DOI 10.1111/j.1365-2958.2007.06018.x; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; NIKI H, 1991, EMBO J, V10, P183, DOI 10.1002/j.1460-2075.1991.tb07935.x; Odsbu I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007617; Paul BJ, 2005, P NATL ACAD SCI USA, V102, P7823, DOI 10.1073/pnas.0501170102; Paul BJ, 2004, CELL, V118, P311, DOI 10.1016/j.cell.2004.07.009; Petrushenko ZM, 2011, MOL MICROBIOL, V81, P881, DOI 10.1111/j.1365-2958.2011.07763.x; Potrykus K, 2002, BIOCHEM J, V364, P857, DOI 10.1042/BJ20011488; Potrykus K, 2006, J BIOL CHEM, V281, P15238, DOI 10.1074/jbc.M601531200; Rasmussen S, 2009, MOL MICROBIOL, V73, P1043, DOI 10.1111/j.1365-2958.2009.06830.x; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rybenkov VV, 2014, J MOL MICROB BIOTECH, V24, P371, DOI 10.1159/000369099; Samarrai W, 2011, J BACTERIOL, V193, P723, DOI 10.1128/JB.00708-10; Sawitzke JA, 2000, P NATL ACAD SCI USA, V97, P1671, DOI 10.1073/pnas.030528397; SCHREIBER G, 1991, J BIOL CHEM, V266, P3760; SINHA NK, 1972, J BACTERIOL, V112, P1321, DOI 10.1128/JB.112.3.1321-1334.1972; Sneeden JL, 2004, J BIOL CHEM, V279, P40723, DOI 10.1074/jbc.M402699200; Soppa J, 2002, MOL MICROBIOL, V45, P59, DOI 10.1046/j.1365-2958.2002.03012.x; Sullivan M, 2004, CELL, V117, P471, DOI 10.1016/S0092-8674(04)00415-5; Sullivan NL, 2009, CELL, V137, P697, DOI 10.1016/j.cell.2009.04.044; Tadesse S, 2005, MICROBIOL-SGM, V151, P3729, DOI 10.1099/mic.0.28234-0; Tanaka K, 2013, NUCLEIC ACIDS RES, V41, P687, DOI 10.1093/nar/gks963; Tsang CK, 2007, EMBO J, V26, P448, DOI 10.1038/sj.emboj.7601488; Vagner V, 1998, MICROBIOL-SGM, V144, P3097, DOI 10.1099/00221287-144-11-3097; Wang JD, 2007, CELL, V128, P865, DOI 10.1016/j.cell.2006.12.043; Wang XD, 2014, CURR BIOL, V24, P287, DOI 10.1016/j.cub.2013.11.050; Weitao T, 1999, MOL MICROBIOL, V34, P157, DOI 10.1046/j.1365-2958.1999.01589.x; Wendrich TM, 1997, MOL MICROBIOL, V26, P65, DOI 10.1046/j.1365-2958.1997.5511919.x; Wolz C, 2010, INT J MED MICROBIOL, V300, P142, DOI 10.1016/j.ijmm.2009.08.017; YAMANAKA K, 1994, MOL MICROBIOL, V13, P301, DOI 10.1111/j.1365-2958.1994.tb00424.x; YANAGISAWA T, 1994, J BIOL CHEM, V269, P24304; Yu WQ, 2010, J BACTERIOL, V192, P4067, DOI 10.1128/JB.00010-10; Zeghouf M, 2004, J PROTEOME RES, V3, P463, DOI 10.1021/pr034084x	76	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142308	10.1371/journal.pone.0142308	http://dx.doi.org/10.1371/journal.pone.0142308			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26539825	Green Submitted, gold, Green Published			2022-12-26	WOS:000364303800080
J	Gifford, KA; Liu, DD; Hohman, TJ; Xu, M; Han, X; Romano, RR; Fritzsche, LR; Abel, T; Jefferson, AL				Gifford, Katherine A.; Liu, Dandan; Hohman, Timothy J.; Xu, Meng; Han, Xue; Romano, Raymond R., III; Fritzsche, Laura R.; Abel, Ty; Jefferson, Angela L.			A Mutual Self- and Informant-Report of Cognitive Complaint Correlates with Neuropathological Outcomes in Mild Cognitive Impairment	PLOS ONE			English	Article							CENTER NACC DATABASE; MINI-MENTAL-STATE; UNIFORM DATA SET; ALZHEIMER-DISEASE; MEMORY COMPLAINTS; OLDER-ADULTS; DEMENTIA; INDIVIDUALS; PREDICTION; DIAGNOSIS	Background This study examines whether different sources of cognitive complaint (i.e., self and informant) predict Alzheimer's disease (AD) neuropathology in elders with mild cognitive impairment (MCI). Methods Data were drawn from the National Alzheimer's Coordinating Center Uniform and Neuropathology Datasets (observational studies) for participants with a clinical diagnosis of MCI and postmortem examination (n = 1843, 74 +/- 8 years, 52% female). Cognitive complaint (0.9 +/- 0.5 years prior to autopsy) was classified into four mutually exclusive groups: no complaint, self-only, informant-only, or mutual (both self and informant) complaint. Postmortem neuropathological outcomes included amyloid plaques and neurofibrillary tangles. Proportional odds regression related complaint to neuropathology, adjusting for age, sex, race, education, depressed mood, cognition, APOE4 status, and last clinical visit to death interval. Results Mutual complaint related to increased likelihood of meeting NIA/Reagan Institute (OR = 6.58, p = 0.004) and Consortium to Establish a Registry for Alzheimer's Disease criteria (OR = 5.82, p = 0.03), and increased neurofibrillary tangles (OR = 3.70, p = 0.03), neuritic plaques (OR = 3.52, p = 0.03), and diffuse plaques (OR = 4.35, p = 0.02). Informant-only and self-only complaint was not associated with any neuropathological outcome (all p-values>0.12). Conclusions In MCI, mutual cognitive complaint relates to AD pathology whereas self-only or informant-only complaint shows no relation to pathology. Findings support cognitive complaint as a marker of unhealthy brain aging and highlight the importance of obtaining informant corroboration to increase confidence of underlying pathological processes.	[Gifford, Katherine A.; Hohman, Timothy J.; Romano, Raymond R., III; Fritzsche, Laura R.; Jefferson, Angela L.] Vanderbilt Univ, Med Ctr, Dept Neurol, Vanderbilt Memory & Alzheimers Ctr, Nashville, TN 37240 USA; [Liu, Dandan; Xu, Meng; Han, Xue] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA; [Abel, Ty] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Jefferson, AL (corresponding author), Vanderbilt Univ, Med Ctr, Dept Neurol, Vanderbilt Memory & Alzheimers Ctr, Nashville, TN 37240 USA.	angela.jefferson@vanderbilt.edu	Hohman, Timothy/AFN-9053-2022	Hohman, Timothy/0000-0002-3377-7014; Jefferson, Angela/0000-0002-8245-0587; Romano, Raymond/0000-0001-6121-8263	Pharmaceutical Research and Manufacturers of America Foundation Fellowship in Translational Medicine and Therapeutics; Alzheimer's Association [IIRG-08-88733]; Vanderbilt Memory & Alzheimer's Center; NIA/NIH [U01 AG016976]; NIA [P30 AG019610, P30 AG013846, P50 AG008702, P50 AG025688, P30 AG010133, P50 AG005146, P50 AG005134, P50 AG016574, P50 AG005138, P30 AG008051];  [K12-HD043483];  [NIRG-13-283276];  [K24-AG046373];  [R01-AG034962];  [R01-HL11516];  [P30 AG013854];  [P30 AG008017];  [P30 AG010161];  [P30 AG010129];  [P50 AG016573];  [P50 AG016570];  [P50 AG005131];  [P50 AG023501];  [P30 AG035982];  [P30 AG028383];  [P30 AG010124];  [P50 AG005133];  [P50 AG005142];  [P30 AG012300];  [P50 AG005136];  [P50 AG033514];  [P50 AG00568]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD043483] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG016976, K24AG046373, R01AG034962, K23AG045966] Funding Source: NIH RePORTER	Pharmaceutical Research and Manufacturers of America Foundation Fellowship in Translational Medicine and Therapeutics; Alzheimer's Association(Alzheimer's Association); Vanderbilt Memory & Alzheimer's Center; NIA/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by K12-HD043483 (KAG); NIRG-13-283276 (KAG); Pharmaceutical Research and Manufacturers of America Foundation Fellowship in Translational Medicine and Therapeutics (TJH); K24-AG046373 (ALJ); Alzheimer's Association IIRG-08-88733 (ALJ); R01-AG034962 (ALJ); R01-HL11516 (ALJ); and the Vanderbilt Memory & Alzheimer's Center. The NACC database is funded by NIA/NIH Grant U01 AG016976. NACC data are contributed by the NIA-funded ADCs: P30 AG019610 (PI Eric Reiman, MD), P30 AG013846 (PI Neil Kowall, MD), P50 AG008702 (PI Scott Small, MD), P50 AG025688 (PI Allan Levey, MD, PhD), P30 AG010133 (PI Andrew Saykin, PsyD), P50 AG005146 (PI Marilyn Albert, PhD), P50 AG005134 (PI Bradley Hyman, MD, PhD), P50 AG016574 (PI Ronald Petersen, MD, PhD), P50 AG005138 (PI Mary Sano, PhD), P30 AG008051 (PI Steven Ferris, PhD), P30 AG013854 (PI M. Marsel Mesulam, MD), P30 AG008017 (PI Jeffrey Kaye, MD), P30 AG010161 (PI David Bennett, MD), P30 AG010129 (PI Charles DeCarli, MD), P50 AG016573 (PI Frank LaFerla, PhD), P50 AG016570 (PI David Teplow, PhD), P50 AG005131 (PI Douglas Galasko, MD), P50 AG023501 (PI Bruce Miller, MD), P30 AG035982 (PI Russell Swerdlow, MD), P30 AG028383 (PI Linda Van Eldik, PhD), P30 AG010124 (PI John Trojanowski, MD, PhD), P50 AG005133 (PI Oscar Lopez, MD), P50 AG005142 (PI Helena Chui, MD), P30 AG012300 (PI Roger Rosenberg, MD), P50 AG005136 (PI Thomas Montine, MD, PhD), P50 AG033514 (PI Sanjay Asthana, MD, FRCP), and P50 AG005681 (PI John Morris, MD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Amariglio RE, 2012, NEUROPSYCHOLOGIA, V50, P2880, DOI 10.1016/j.neuropsychologia.2012.08.011; Barnes LL, 2006, NEUROLOGY, V67, P1581, DOI 10.1212/01.wnl.0000242734.16663.09; Beekly DL, 2004, ALZ DIS ASSOC DIS, V18, P270; Beekly DL, 2007, ALZ DIS ASSOC DIS, V21, P249, DOI 10.1097/WAD.0b013e318142774e; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Carr DB, 2000, NEUROLOGY, V55, P1724, DOI 10.1212/WNL.55.11.1724; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gifford KA, 2015, J ALZHEIMERS DIS, V43, P121, DOI 10.3233/JAD-131925; Gifford KA, 2014, ALZHEIMERS DEMENT, V10, P319, DOI 10.1016/j.jalz.2013.02.007; Glodzik-Sobanska L, 2007, DEMENT GERIATR COGN, V24, P177, DOI 10.1159/000105604; Hohman TJ, 2011, NEUROPSYCHOLOGY, V25, P125, DOI 10.1037/a0020859; Hyman BT, 1997, J NEUROPATH EXP NEUR, V56, P1095, DOI 10.1097/00005072-199710000-00002; Jessen F, 2010, ARCH GEN PSYCHIAT, V67, P414, DOI 10.1001/archgenpsychiatry.2010.30; Jorm AF, 2004, NEUROLOGY, V63, P1960, DOI 10.1212/01.WNL.0000144348.70643.F2; Kryscio RJ, 2014, NEUROLOGY, V83, P1359, DOI 10.1212/WNL.0000000000000856; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Mitchell AJ, 2009, J PSYCHIATR RES, V43, P411, DOI 10.1016/j.jpsychires.2008.04.014; Morris JC, 2006, ALZ DIS ASSOC DIS, V20, P210, DOI 10.1097/01.wad.0000213865.09806.92; Perrotin A, 2012, ARCH NEUROL-CHICAGO, V69, P223, DOI 10.1001/archneurol.2011.666; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Saykin AJ, 2006, NEUROLOGY, V67, P834, DOI 10.1212/01.wnl.0000234032.77541.a2; Tierney MC, 1996, ARCH NEUROL-CHICAGO, V53, P423, DOI 10.1001/archneur.1996.00550050053023; Wang L, 2004, J AM GERIATR SOC, V52, P2045, DOI 10.1111/j.1532-5415.2004.52568.x; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	25	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141831	10.1371/journal.pone.0141831	http://dx.doi.org/10.1371/journal.pone.0141831			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV5IS	26539829	gold, Green Published, Green Submitted			2022-12-26	WOS:000364303800030
J	Boiko, E; Maltsev, D; Savicheva, A; Shalepo, K; Khusnutdinova, T; Pozniak, A; Kvetnoi, I; Polyakova, V; Suetov, A				Boiko, Ernest; Maltsev, Dmitrii; Savicheva, Alevtina; Shalepo, Kira; Khusnutdinova, Tatyana; Pozniak, Alexei; Kvetnoi, Igor; Polyakova, Viktoria; Suetov, Alexei			Infection of Human Retinal Pigment Epithelium with Chlamydia trachomatis	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; PROLIFERATIVE VITREORETINOPATHY; GROWTH-FACTOR; CELL-PROLIFERATION; VIRUS RETINITIS; HERPES-SIMPLEX; EXPRESSION; INTERLEUKIN-8; PNEUMONIAE; CYTOKINES	Purpose Little is known about the susceptibility of posterior segment tissues, particularly the human retinal pigment epithelium (hRPE), to Chlamydia trachomatis. The purpose of the study was to investigate the possibility of infecting the hRPE with Chlamydia trachomatis, and to examine the infectivity of different Chlamydia trachomatis clinical isolates for hRPE cells and the hRPE cell response to the infection. Methods Cultured hRPE and McCoy cells were inoculated with eight Chlamydia trachomatis (serovar E) clinical isolates at multiplicity of infection (MOI) of 2.0 or 0.3. To detect Chlamydia trachomatis, samples were stained immunohistochemically with anti-major outer membrane protein antibodies at 24h, 48h, and 72h postinoculation (PI). The changes in the expression of signaling molecules and proteins of cytoskeleton and extracellular matrix in hRPE cells were examined immunohistochemically. Results All eight clinical isolates demonstrated ability to infect hRPE cells. At equal MOI of 0.3, the infectivity of Chlamydia trachomatis clinical isolates for RPE culture was found to be at least as high as that for McCoy cell culture. At 24h PI, the percentage of inclusion-containing cells varied from 1.5 +/- 0.52 to 14.6 +/- 3.3% in hRPE cell culture infected at MOI of 2.0 against 0.37 +/- 0.34 to 8.9 +/- 0.2% in McCoy cell culture infected at MOI of 0.3. Collagen type I, collagen type IV, basic fibroblast growth factor, transforming growth factor-beta and interleukin-8 expression at 48h PI were maximally increased, by 2.1-, 1.3-, 1.5-, 1.5- and 1.6-fold, respectively, in the Chlamydia trachomatis-infected compared with control hRPE cell culture specimens (P < 0.05). Conclusions This study, for the first time, proved the possibility of infecting hRPE cultured cells with Chlamydia trachomatis, which leads to proproliferative and proinflammatory changes in the expression of signaling molecules and extracellular matrix components.	[Boiko, Ernest; Maltsev, Dmitrii; Pozniak, Alexei; Suetov, Alexei] Mil Med Acad, Dept Ophthalmol, St Petersburg, Russia; [Boiko, Ernest] Academician S Fyodorov IRTC Eye Microsurg, St Petersburg Branch, St Petersburg, Russia; [Savicheva, Alevtina; Shalepo, Kira; Khusnutdinova, Tatyana] DO Ott Res Inst Obstet & Gynaecol, Microbiol Lab, St Petersburg, Russia; [Kvetnoi, Igor; Polyakova, Viktoria] DO Ott Res Inst Obstet & Gynaecol, Dept Pathol, St Petersburg, Russia	Russian Academy of Medical Sciences; Ott Institute of Obstetrics, Gynecology & Reproductology; Russian Academy of Medical Sciences; Ott Institute of Obstetrics, Gynecology & Reproductology	Maltsev, D (corresponding author), Mil Med Acad, Dept Ophthalmol, St Petersburg, Russia.	glaz.med@yandex.ru	Maltsev, Dmitrii/AAA-9100-2022; Khusnutdinova, Tatiana/K-1852-2018; Alexey, Suetov/AAI-4855-2020	Alexey, Suetov/0000-0002-8670-2964; Maltsev, Dmitrii/0000-0001-6598-3982; Khusnutdinova, Tatiana/0000-0002-2742-2655				Abu el-Asrar A M, 2001, Bull Soc Belge Ophtalmol, P73; Aksunger A, 1997, OPHTHALMOLOGICA, V211, P223, DOI 10.1159/000310794; Al-Mously N, 2007, J MED MICROBIOL, V56, P1025, DOI 10.1099/jmm.0.47241-0; BAUDOUIN C, 1993, OPHTHALMIC RES, V25, P52, DOI 10.1159/000267221; Boiko EV, 2014, INVEST OPHTH VIS SCI, V55, P1176, DOI 10.1167/iovs.13-13416; Buchholz KR, 2006, CELL MICROBIOL, V8, P1768, DOI 10.1111/j.1462-5822.2006.00747.x; DUTT K, 1989, INVEST OPHTH VIS SCI, V30, P1535; Feist RM, 2014, GRAEF ARCH CLIN EXP, V252, P347, DOI 10.1007/s00417-013-2531-0; Friedman A H, 1984, Trans Am Ophthalmol Soc, V82, P447; Fujimoto T, 2010, INVEST OPHTH VIS SCI, V51, P4694, DOI 10.1167/iovs.09-4464; Hoerster R, 2014, GRAEF ARCH CLIN EXP, V252, P11, DOI 10.1007/s00417-013-2377-5; Kaser T, 2015, VET IMMUNOL IMMUNOP, V166, P95, DOI 10.1016/j.vetimm.2015.06.003; Kaven C, 2000, CURR EYE RES, V20, P480, DOI 10.1076/0271-3683(200006)20:6;1-Y;FT480; Khairallah M, 2013, CURR OPIN OPHTHALMOL, V24, P574, DOI 10.1097/ICU.0b013e3283654e09; KUPPERMANN BD, 1994, AM J OPHTHALMOL, V118, P589, DOI 10.1016/S0002-9394(14)76574-2; Lou Bing-sheng, 2011, Zhonghua Yan Ke Za Zhi, V47, P1117; Luo C, 2013, EXP EYE RES, V112, P93, DOI 10.1016/j.exer.2013.04.016; Marangoni Antonella, 2014, BMC Res Notes, V7, P230, DOI 10.1186/1756-0500-7-230; Mazzoli S, 2007, EUR UROL, V51, P1385, DOI 10.1016/j.eururo.2006.10.059; Michaelis M, 2009, INVEST OPHTH VIS SCI, V50, P5419, DOI 10.1167/iovs.09-3752; Momma Y, 2003, INVEST OPHTH VIS SCI, V44, P2026, DOI 10.1167/iovs.02-0980; Munoz-Erazo L, 2012, MOL VIS, V18, P730; Nie Yuhong, 2007, Yan Ke Xue Bao, V23, P212; PEPOSE JS, 1984, OPHTHALMOLOGY, V91, P1669; PEPOSE JS, 1985, OPHTHALMOLOGY, V92, P160; Rodel J, 2000, INFECT IMMUN, V68, P3635, DOI 10.1128/IAI.68.6.3635-3641.2000; Rodel J, 1998, J RHEUMATOL, V25, P2161; Sellami H, 2014, MOL CELL PROBE, V28, P147, DOI 10.1016/j.mcp.2014.01.006; Steindl-Kuscher K, 2011, GRAEF ARCH CLIN EXP, V249, P1195, DOI 10.1007/s00417-011-1673-1; Zhang M, 2005, INVEST OPHTH VIS SCI, V46, P2047, DOI 10.1167/iovs.05-0005; Zheng M, 2005, INVEST OPHTH VIS SCI, V46, P1356, DOI 10.1167/iovs.04-1284; Zigangirova NA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/489489	32	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141754	10.1371/journal.pone.0141754	http://dx.doi.org/10.1371/journal.pone.0141754			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536616	gold, Green Published, Green Submitted			2022-12-26	WOS:000364298400084
J	Chai, SJ; Yap, YY; Foo, YC; Yap, LF; Ponniah, S; Teo, SH; Cheong, SC; Patel, V; Lim, KP				Chai, San Jiun; Yap, Yoke Yeow; Foo, Yoke Ching; Yap, Lee Fah; Ponniah, Sathibalan; Teo, Soo Hwang; Cheong, Sok Ching; Patel, Vyomesh; Lim, Kue Peng			Identification of Four-Jointed Box 1 (FJX1)-Specific Peptides for Immunotherapy of Nasopharyngeal Carcinoma	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; SQUAMOUS-CELL CARCINOMA; BREAST-CANCER PATIENTS; REGULATORY T-CELLS; PHASE-I/II TRIAL; CLINICAL-TRIAL; IMMUNE-RESPONSE; TUMOR-CELLS; VACCINE; LINES	Nasopharyngeal carcinoma (NPC) is highly prevalent in South East Asia and China. The poor outcome is due to late presentation, recurrence, distant metastasis and limited therapeutic options. For improved treatment outcome, immunotherapeutic approaches focusing on dendritic and autologous cytotoxic T-cell based therapies have been developed, but cost and infrastructure remain barriers for implementing these in low-resource settings. As our prior observations had found that four-jointed box 1 (FJX1), a tumor antigen, is overexpressed in NPCs, we investigated if short 9-20 amino acid sequence specific peptides matching to FJX1 requiring only intramuscular immunization to train host immune systems would be a better treatment option for this disease. Thus, we designed 8 FJX1-specific peptides and implemented an assay system to first, assess the binding of these peptides to HLA-A2 molecules on T2 cells. After, ELISPOT assays were used to determine the peptides immunogenicity and ability to induce potential cytotoxicity activity towards cancer cells. Also, T-cell proliferation assay was used to evaluate the potential of MHC class II peptides to stimulate the expansion of isolated T-cells. Our results demonstrate that these peptides are immunogenic and peptide stimulated T-cells were able to induce peptide-specific cytolytic activity specifically against FJX1-expressing cancer cells. In addition, we demonstrated that the MHC class II peptides were capable of inducing T-cell proliferation. Our results suggest that these peptides are capable of inducing specific cytotoxic cytokines secretion against FJX1-expressing cancer cells and serve as a potential vaccine-based therapy for NPC patients.	[Chai, San Jiun; Yap, Lee Fah; Teo, Soo Hwang; Cheong, Sok Ching; Patel, Vyomesh; Lim, Kue Peng] Canc Res Initiat Fdn CARIF, Sime Darby Med Ctr, Subang Jaya, Selangor, Malaysia; [Yap, Yoke Yeow] Univ Putra Malaysia, Dept Surg, Clin Campus Fac Med & Hlth Sci, Hosp Kuala Lumpur, Kuala Lumpur, Malaysia; [Foo, Yoke Ching] Sime Darby Med Ctr, Dept Oncol, Subang Jaya, Selangor, Malaysia; [Ponniah, Sathibalan] Uniformed Serv Univ Hlth Sci, Dept Surg, Canc Vaccine Dev Program, Bethesda, MD 20814 USA	Universiti Putra Malaysia; Uniformed Services University of the Health Sciences - USA	Lim, KP (corresponding author), Canc Res Initiat Fdn CARIF, Sime Darby Med Ctr, Subang Jaya, Selangor, Malaysia.	kuepeng.lim@carif.com.my	Yap, Lee-Fah/M-1065-2016; Teo, Soo-hwang/H-2353-2014	Yap, Lee-Fah/0000-0002-6815-3607; 	Cancer Research Initiatives Foundation (CARIF)	Cancer Research Initiatives Foundation (CARIF)	This study was funded by sponsors of the Cancer Research Initiatives Foundation (CARIF). CARIF is a non-profit research organization committed to an understanding of cancer prevention, diagnosis and treatment through a fundamental research program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Zabidi MM, 2011, THESIS; Al-Greene NT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069660; Al-Sarraf M, 1998, J CLIN ONCOL, V16, P1310, DOI 10.1200/JCO.1998.16.4.1310; Alves PMS, 2003, CANCER RES, V63, P8476; Bao YJ, 2011, J BIOCHEM, V149, P361, DOI 10.1093/jb/mvr021; BenMohamed L, 2000, HUM IMMUNOL, V61, P764, DOI 10.1016/S0198-8859(00)00139-7; Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; Bose S, 2009, J PATHOL, V217, P345, DOI 10.1002/path.2487; Brunsvig PF, 2011, CLIN CANCER RES, V17, P6847, DOI 10.1158/1078-0432.CCR-11-1385; Buckanovich RJ, 2007, J CLIN ONCOL, V25, P852, DOI 10.1200/JCO.2006.08.8583; Buckles GR, 2001, DEVELOPMENT, V128, P3533; Chan SYY, 2008, INT J CANCER, V122, P2169, DOI 10.1002/ijc.23374; Cheung ST, 1999, INT J CANCER, V83, P121, DOI 10.1002/(SICI)1097-0215(19990924)83:1<121::AID-IJC21>3.0.CO;2-F; Corthay A, 2005, IMMUNITY, V22, P371, DOI 10.1016/j.immuni.2005.02.003; Couzin-Frankel J, 2013, SCIENCE, V342, P1432, DOI 10.1126/science.342.6165.1432; Devi BCR, 2004, CANCER EPIDEM BIOMAR, V13, P482; Dhaliwal JS, 2007, ASIAN PAC J ALLERGY, V25, P47; Erfani N, 2010, CANCER INVEST, V28, P828, DOI 10.3109/07357901003630934; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gan CP, 2014, ONCOTARGET, V5, P9626, DOI 10.18632/oncotarget.2437; GEBBIA V, 1993, BRIT J CANCER, V68, P191, DOI 10.1038/bjc.1993.312; Guo Kun-yuan, 2007, Nan Fang Yi Ke Da Xue Xue Bao, V27, P247; Hamid S, 2007, INT J MOL MED, V19, P453; HOSKEN NA, 1990, SCIENCE, V248, P367, DOI 10.1126/science.2326647; Ishikawa HO, 2008, SCIENCE, V321, P401, DOI 10.1126/science.1158159; Jarvinen AK, 2008, GENE CHROMOSOME CANC, V47, P500, DOI 10.1002/gcc.20551; Gutierrez-Avino FJ, 2009, EMBO REP, V10, P1051, DOI 10.1038/embor.2009.140; Kakiuchi S, 2003, MOL CANCER RES, V1, P485; Kono K, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-141; Lee CH, 2011, J VIROL, V85, P7333, DOI 10.1128/JVI.00182-11; Lee L. K., 2007, SMJ Singapore Medical Journal, V48, P632; Lewis JJ, 2000, INT J CANCER, V87, P391, DOI 10.1002/1097-0215(20000801)87:3<391::AID-IJC13>3.0.CO;2-K; Li Jia-Xin, 2010, Chin J Cancer, V29, P82; Lim KP, 2014, HUM VACCIN IMMUNOTHE, V10; Lin CL, 2002, CANCER RES, V62, P6952; Louis CU, 2010, J IMMUNOTHER, V33, P983, DOI 10.1097/CJI.0b013e3181f3cbf4; Lu CH, 2007, CANCER RES, V67, P1757, DOI 10.1158/0008-5472.CAN-06-3700; Lutzky VP, 2014, CLIN VACCINE IMMUNOL, V21, P256, DOI 10.1128/CVI.00121-13; Marincola FM, 1996, J IMMUNOTHER, V19, P266, DOI 10.1097/00002371-199607000-00003; Marshall NA, 2003, J IMMUNOL, V170, P6183, DOI 10.4049/jimmunol.170.12.6183; Masmoudi A, 2007, CANCER TREAT REV, V33, P499, DOI 10.1016/j.ctrv.2007.04.007; Mittendorf EA, 2014, ANN ONCOL, V25, P1735, DOI 10.1093/annonc/mdu211; Morita S, 2006, JPN J CLIN ONCOL, V36, P231, DOI 10.1093/jjco/hyl005; O'Sullivan B, 2007, INT J RADIAT ONCOL, V69, pS118, DOI 10.1016/j.ijrobp.2007.04.085; Omar ZA, 2011, NATL CANC REGISTRY R; Pardoll DM, 1998, CURR OPIN IMMUNOL, V10, P588, DOI 10.1016/S0952-7915(98)80228-8; PARKER KC, 1994, J IMMUNOL, V152, P163; Parmiani G, 2002, JNCI-J NATL CANCER I, V94, P805, DOI 10.1093/jnci/94.11.805; Patil R, 2010, J AM COLL SURGEONS, V210, P140, DOI 10.1016/j.jamcollsurg.2009.10.022; Peng G, 2012, RADIOTHER ONCOL, V104, P286, DOI 10.1016/j.radonc.2012.08.013; Peoples GE, 2005, J CLIN ONCOL, V23, P7536, DOI 10.1200/JCO.2005.03.047; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Razak ARA, 2010, EUR J CANCER, V46, P1967, DOI 10.1016/j.ejca.2010.04.004; Rickinson AB, 1997, ANNU REV IMMUNOL, V15, P405, DOI 10.1146/annurev.immunol.15.1.405; Rock R, 2005, DEV DYNAM, V234, P602, DOI 10.1002/dvdy.20553; Scurr M, 2014, MUCOSAL IMMUNOL, V7, P428, DOI 10.1038/mi.2013.62; Shafer-Weaver Kimberly A, 2004, J Transl Med, V2, P31, DOI 10.1186/1479-5876-2-31; Shieh DC, 1996, TRANSFUSION, V36, P818, DOI 10.1046/j.1537-2995.1996.36996420761.x; Smith C, 2012, NASOPHARYNGEAL CARCI, P173; Snijders AM, 2005, ONCOGENE, V24, P4232, DOI 10.1038/sj.onc.1208601; Strong MJ, 2014, J VIROL, V88, P10696, DOI 10.1128/JVI.01457-14; STUBER G, 1994, EUR J IMMUNOL, V24, P765, DOI 10.1002/eji.1830240341; Tanaka T, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/262967; Taylor GS, 2014, CLIN CANCER RES, V20, P5009, DOI 10.1158/1078-0432.CCR-14-1122-T; Titcomb C P Jr, 2001, J Insur Med, V33, P235; TRUMPER PA, 1977, INT J CANCER, V20, P655, DOI 10.1002/ijc.2910200503; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; WIDMANN C, 1992, J IMMUNOL METHODS, V155, P95, DOI 10.1016/0022-1759(92)90275-X; WOLF H, 1973, NATURE-NEW BIOL, V244, P245, DOI 10.1038/newbio244245a0; Xu T, 2013, CURR ONCOL, V20, pE406, DOI 10.3747/co.20.1456; YAMASHITA S, 1985, ACTA ONCOL, V24, P315, DOI 10.3109/02841868509136058; Yang TS, 1996, AM J CLIN ONCOL-CANC, V19, P337, DOI 10.1097/00000421-199608000-00003; Yoshitake Y, 2014, CLIN CANC RES	73	12	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0130464	10.1371/journal.pone.0130464	http://dx.doi.org/10.1371/journal.pone.0130464			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536470	Green Published, Green Submitted, gold			2022-12-26	WOS:000364298400001
J	Eppley, TM; Donati, G; Ramanamanjato, JB; Randriatafika, F; Andriamandimbiarisoa, LN; Rabehevitra, D; Ravelomanantsoa, R; Ganzhorn, JU				Eppley, Timothy M.; Donati, Giuseppe; Ramanamanjato, Jean-Baptiste; Randriatafika, Faly; Andriamandimbiarisoa, Laza N.; Rabehevitra, David; Ravelomanantsoa, Robertin; Ganzhorn, Joerg U.			The Use of an Invasive Species Habitat by a Small Folivorous Primate: Implications for Lemur Conservation in Madagascar	PLOS ONE			English	Article							FOREST FRAGMENTATION; LITTORAL FOREST; HAPALEMUR-MERIDIONALIS; RIPARIAN CORRIDORS; EASTERN MADAGASCAR; TREE PLANTATIONS; BIRD ASSEMBLAGES; FOOD SOURCES; MATRIX; BIODIVERSITY	The lemurs of Madagascar are among the most threatened mammalian taxa in the world, with habitat loss due to shifting cultivation and timber harvest heavily contributing to their precarious state. Deforestation often leads to fragmentation, resulting in mixed-habitat matrices throughout a landscape where disturbed areas are prone to invasion by exotic plants. Our study site, the Mandena littoral forest (southeast Madagascar), is a matrix of littoral forest, littoral swamp, and Melaleuca swamp habitats. Here, Melaleuca quinquenervia has invaded the wetland ecosystem, creating a mono-dominant habitat that currently provides the only potential habitat corridor between forest fragments. We sought to understand the role of this invasive Melaleuca swamp on the behavioral ecology of a threatened, small-bodied folivore, the southern bamboo lemur (Hapalemur meridionalis). We collected botanical and behavioral data on four groups of H. meridionalis between January and December 2013. Our results confirm Melaleuca swamp as an important part of their home range: while lemurs seasonally limited activities to certain habitats, all groups were capable of utilizing this invasive habitat for feeding and resting. Furthermore, the fact that Hapalemur use an invasive plant species as a dispersal corridor increases our knowledge of their ecological flexibility, and may be useful in the conservation management of remaining threatened populations.	[Eppley, Timothy M.; Ganzhorn, Joerg U.] Univ Hamburg, Dept Anim Ecol & Conservat, Biozentrum Grindel, Hamburg, Germany; [Eppley, Timothy M.; Donati, Giuseppe] Oxford Brookes Univ, Nocturnal Primate Res Grp, Dept Social Sci, Oxford OX3 0BP, England; [Ramanamanjato, Jean-Baptiste; Randriatafika, Faly; Andriamandimbiarisoa, Laza N.; Rabehevitra, David; Ravelomanantsoa, Robertin] QIT Madagascar Minerals, Rio Tinto, Tolagnaro, Madagascar	University of Hamburg; Oxford Brookes University; Rio Tinto	Eppley, TM (corresponding author), Univ Hamburg, Dept Anim Ecol & Conservat, Biozentrum Grindel, Hamburg, Germany.	eppleyti@gmail.com	Ganzhorn, Joerg/AAO-6955-2020	Ganzhorn, Joerg/0000-0003-1395-9758; Donati, Giuseppe/0000-0002-4803-0642; Eppley, Timothy/0000-0003-1456-6948	American Society of Primatologists; Conservation International's Primate Action Fund; IDEAWILD; Mohamed bin Zayed Species Conservation Fund [11253008]; Primate Conservation Inc.; Primate Society of Great Britain/Knowsley Safari Park; QIT Madagascar Minerals	American Society of Primatologists; Conservation International's Primate Action Fund; IDEAWILD; Mohamed bin Zayed Species Conservation Fund; Primate Conservation Inc.; Primate Society of Great Britain/Knowsley Safari Park; QIT Madagascar Minerals	Funding: This work received funding and in-kind support from American Society of Primatologists, Conservation International's Primate Action Fund, IDEAWILD, Mohamed bin Zayed Species Conservation Fund (Project Number: 11253008), Primate Conservation Inc., and the Primate Society of Great Britain/Knowsley Safari Park. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. QIT Madagascar Minerals provided support in the form of salaries for authors [JBR, FR, LNA, DR, RR], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ABERG J, 1995, OECOLOGIA, V103, P265, DOI 10.1007/BF00328613; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Anderson J, 2007, BIOL CONSERV, V135, P212, DOI 10.1016/j.biocon.2006.10.022; Andreone F, 2005, TROP ZOOL, V18, P209, DOI 10.1080/03946975.2005.10531221; Andriamandimbiarisoa L, MADAGASCAR IN PRESS; Asner GP, 2009, CONSERV BIOL, V23, P1386, DOI 10.1111/j.1523-1739.2009.01333.x; Bakoariniaina LN, 2006, J AFR EARTH SCI, V44, P241, DOI 10.1016/j.jafrearsci.2005.10.013; Barbaro L, 2005, ECOSCIENCE, V12, P110, DOI 10.2980/i1195-6860-12-1-110.1; Barbaro L, 2008, BIODIVERS CONSERV, V17, P1073, DOI 10.1007/s10531-007-9241-z; Beattie J. C., 1998, International Zoo Yearbook, V36, P11, DOI 10.1111/j.1748-1090.1998.tb02880.x; Beier P, 1998, CONSERV BIOL, V12, P1241, DOI 10.1046/j.1523-1739.1998.98036.x; Bevers M, 1999, THEOR POPUL BIOL, V55, P61, DOI 10.1006/tpbi.1998.1392; Beyer H. L, 2012, GEOSPATIAL MODELLING; BICCAMARQUES JC, 1994, FOLIA PRIMATOL, V63, P209, DOI 10.1159/000156821; Birkinshaw C, 2003, NATURAL HIST MADAGAS, P1207; Bollen A, 2006, ORYX, V40, P57, DOI 10.1017/S0030605306000111; Bollen A, 2003, THESIS; BRAITHWAITE RW, 1989, BIOL CONSERV, V48, P189, DOI 10.1016/0006-3207(89)90118-3; Broadbent EN, 2008, BIOL CONSERV, V141, P1745, DOI 10.1016/j.biocon.2008.04.024; Brockerhoff EG, 2008, BIODIVERS CONSERV, V17, P925, DOI 10.1007/s10531-008-9380-x; Campera M, 2014, INT J PRIMATOL, V35, P957, DOI 10.1007/s10764-014-9780-6; CARO TM, 1994, SCIENCE, V263, P485, DOI 10.1126/science.8290956; Castellon TD, 2006, CONSERV BIOL, V20, P135, DOI 10.1111/j.1523-1739.2006.00332.x; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; Dray FA, 2006, CASTANEA, V71, P210, DOI 10.2179/05-27.1; Dumetz N, 1999, BIODIVERS CONSERV, V8, P273, DOI 10.1023/A:1008880718889; Eppley TM, 2015, BEHAVIOUR, V152, P1041, DOI 10.1163/1568539X-00003267; Eppley TM, 2015, BEHAV ECOL SOCIOBIOL, V69, P991, DOI 10.1007/s00265-015-1911-3; Eppley TM, 2011, PRIMATES, V52, P7, DOI 10.1007/s10329-010-0225-3; Ferreras P, 2001, BIOL CONSERV, V100, P125, DOI 10.1016/S0006-3207(00)00213-5; Ganzhorn JU, 2014, EARTH CONSERV DEV, P17; Ganzhorn JU, 1999, CONSERV BIOL, V13, P794, DOI 10.1046/j.1523-1739.1999.98245.x; GANZHORN JU, 1987, AM J PRIMATOL, V12, P205, DOI 10.1002/ajp.1350120208; Ganzhorn JU, 2001, ORYX, V35, P346, DOI 10.1046/j.1365-3008.2001.00201.x; Ganzhorn JU, 1997, BIOTROPICA, V29, P331, DOI 10.1111/j.1744-7429.1997.tb00434.x; GANZHORN JU, 1991, FOLIA PRIMATOL, V56, P171, DOI 10.1159/000156544; Gascon C, 1999, BIOL CONSERV, V91, P223, DOI 10.1016/S0006-3207(99)00080-4; Gautier L, 1994, P 13 PLEN M AETFAT, P1339; Gerard A, 2015, RESTOR ECOL, V23, P768, DOI 10.1111/rec.12246; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Gillies CS, 2008, P NATL ACAD SCI USA, V105, P19774, DOI 10.1073/pnas.0803530105; Golden CD, 2009, ORYX, V43, P386, DOI 10.1017/S0030605309000131; Gonzalez A, 1998, SCIENCE, V281, P2045, DOI 10.1126/science.281.5385.2045; Goodman SM, 2003, URAL HIST MADAGASCAR, P1351; Grassi C, 2006, AM J PHYS ANTHROPOL, V131, P50, DOI 10.1002/ajpa.20423; Grimes K., 2000, American Journal of Primatology, V51, P59; Haddad N, 2000, CONSERV BIOL, V14, P738, DOI 10.1046/j.1523-1739.2000.99041.x; Haddad NM, 1999, ECOL APPL, V9, P612, DOI 10.1890/1051-0761(1999)009[0612:CADEOI]2.0.CO;2; Hale ML, 2001, SCIENCE, V293, P2246, DOI 10.1126/science.1062574; Hannah L, 2008, BIOL LETTERS, V4, P590, DOI 10.1098/rsbl.2008.0270; Harcourt AH, 2005, J BIOGEOGR, V32, P565, DOI 10.1111/j.1365-2699.2004.01214.x; Harper GJ, 2007, ENVIRON CONSERV, V34, P325, DOI 10.1017/S0376892907004262; Hilty JA, 2004, CONSERV BIOL, V18, P126, DOI 10.1111/j.1523-1739.2004.00225.x; Hilty JA., 2012, CORRIDOR ECOLOGY SCI; Irwin MT, 2010, BIOL CONSERV, V143, P2351, DOI 10.1016/j.biocon.2010.01.023; IUCN (International Union for Conservation of Nature), 2012, 2012 IUCN RED LIST T; Kamilar JM, 2008, AM J PRIMATOL, V70, P816, DOI 10.1002/ajp.20553; Keenan R, 1997, FOREST ECOL MANAG, V99, P117, DOI 10.1016/S0378-1127(97)00198-9; Kleinpaste R., 1990, P97; Kremen C, 2008, SCIENCE, V320, P222, DOI 10.1126/science.1155193; Laurance SG, 1999, BIOL CONSERV, V91, P231, DOI 10.1016/S0006-3207(99)00077-4; Laurance WF, 2000, NATURE, V404, P836, DOI 10.1038/35009032; Laurance WF, 2009, TRENDS ECOL EVOL, V24, P659, DOI 10.1016/j.tree.2009.06.009; Lens L, 2002, SCIENCE, V298, P1236, DOI 10.1126/science.1075664; Bonilla-Sanchez YM, 2012, INT J PRIMATOL, V33, P233, DOI 10.1007/s10764-011-9569-9; Martinez Barbara, 2008, Lemur News, V13, P11; Mech SG, 2001, CONSERV BIOL, V15, P467, DOI 10.1046/j.1523-1739.2001.015002467.x; Miandrimanana C., 2014, Madagascar Conservation and Development, V9, P49, DOI 10.4314/mcd.v9i1.6; Michon G, 1995, CONSERVING BIODIVERS, P90; Mutschler T, 1999, NEW DIRECTIONS IN LEMUR STUDIES, P221; Nowak K, 2013, DEV PRIMATOL-PROG PR, P199, DOI 10.1007/978-1-4614-8839-2_14; Olson ER, 2013, INT J PRIMATOL, V34, P486, DOI 10.1007/s10764-013-9674-z; Pardini R, 2004, BIODIVERS CONSERV, V13, P2567, DOI 10.1023/B:BIOC.0000048452.18878.2d; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Development Core Team, 2014, R LANG ENV STAT COMP; Ramanamanjato JB, 2001, ANIM CONSERV, V4, P175, DOI 10.1017/S1367943001001202; Razafindratsima OH, 2015, ECOLOGY, V96, P24, DOI 10.1890/14-0684.1; Schwitzer C, 2014, SCIENCE, V343, P842, DOI 10.1126/science.1245783; Simmen B, 2007, INT J PRIMATOL, V28, P1253, DOI 10.1007/s10764-007-9217-6; Virah-Sawmy M, 2009, GLOBAL ECOL BIOGEOGR, V18, P98, DOI 10.1111/j.1466-8238.2008.00429.x; Watson JEM, 2005, BIODIVERS CONSERV, V14, P523, DOI 10.1007/s10531-004-3913-8; Wearn OR, 2012, SCIENCE, V337, P228, DOI 10.1126/science.1219013; Wethered R, 2005, BIOL CONSERV, V123, P125, DOI 10.1016/j.biocon.2004.10.013; Wethered R, 2003, BIOL CONSERV, V114, P327, DOI 10.1016/S0006-3207(03)00052-1; Williams-Guillen K, 2006, ANIM CONSERV, V9, P331, DOI 10.1111/j.1469-1795.2006.00042.x; Wilme L, 1996, COLLOQ SEMI, P349; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Wright Patricia C., 2008, Primate Conservation, V23, P5, DOI 10.1896/052.023.0102	88	31	31	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140981	10.1371/journal.pone.0140981	http://dx.doi.org/10.1371/journal.pone.0140981			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536667	Green Published, gold, Green Submitted			2022-12-26	WOS:000364298400048
J	Goldberg, JF; Tempa, T; Norbu, N; Hebblewhite, M; Mills, LS; Wangchuk, TR; Lukacs, P				Goldberg, Joshua F.; Tempa, Tshering; Norbu, Nawang; Hebblewhite, Mark; Mills, L. Scott; Wangchuk, Tshewang R.; Lukacs, Paul			Examining Temporal Sample Scale and Model Choice with Spatial Capture-Recapture Models in the Common Leopard Panthera pardus	PLOS ONE			English	Article							NATIONAL-PARK; LIVESTOCK PREDATION; HIERARCHICAL MODEL; ESTIMATING DENSITY; ACTIVITY PATTERNS; CAMERA-TRAP; POPULATION; SELECTION; INFORMATION; CARNIVORES	Many large carnivores occupy a wide geographic distribution, and face threats from habitat loss and fragmentation, poaching, prey depletion, and human wildlife-conflicts. Conservation requires robust techniques for estimating population densities and trends, but the elusive nature and low densities of many large carnivores make them difficult to detect. Spatial capture-recapture (SCR) models provide a means for handling imperfect detectability, while linking population estimates to individual movement patterns to provide more accurate estimates than standard approaches. Within this framework, we investigate the effect of different sample interval lengths on density estimates, using simulations and a common leopard (Panthera pardus) model system. We apply Bayesian SCR methods to 89 simulated datasets and camera-trapping data from 22 leopards captured 82 times during winter 20102011 in Royal Manas National Park, Bhutan. We show that sample interval length from daily, weekly, monthly or quarterly periods did not appreciably affect median abundance or density, but did influence precision. We observed the largest gains in precision when moving from quarterly to shorter intervals. We therefore recommend daily sampling intervals for monitoring rare or elusive species where practicable, but note that monthly or quarterly sample periods can have similar informative value. We further develop a novel application of Bayes factors to select models where multiple ecological factors are integrated into density estimation. Our simulations demonstrate that these methods can help identify the "true" explanatory mechanisms underlying the data. Using this method, we found strong evidence for sex-specific movement distributions in leopards, suggesting that sexual patterns of space-use influence density. This model estimated a density of 10.0 leopards/100 km(2) (95% credibility interval: 6.25-15.93), comparable to contemporary estimates in Asia. These SCR methods provide a guide to monitor and observe the effect of management interventions on leopards and other species of conservation interest.	[Goldberg, Joshua F.; Tempa, Tshering; Hebblewhite, Mark; Lukacs, Paul] Univ Montana, Coll Forestry & Conservat, Wildlife Biol Program, Dept Ecosyst & Conservat Sci, Missoula, MT 59812 USA; [Tempa, Tshering; Norbu, Nawang] Minist Agr & Forests, Ugyen Wangchuck Inst Conservat & Environm, Dept Forests & Pk Serv, Lamai Goempa, Bumthang, Bhutan; [Mills, L. Scott] N Carolina State Univ, Dept Forestry & Environm Resources, Raleigh, NC 27695 USA; [Wangchuk, Tshewang R.] Bhutan Fdn, Washington, DC USA	University of Montana System; University of Montana; University of North Carolina; North Carolina State University	Goldberg, JF (corresponding author), Univ Calif Riverside, Dept Biol, Evolut Ecol & Organismal Biol Program, Riverside, CA 92521 USA.	joshua.goldberg@umontana.edu	hebblewhite, mark/G-6164-2013; Hebblewhite, Mark/AAI-8101-2020	Hebblewhite, Mark/0000-0001-5382-1361	National Aeronautics and Space Administration [NNX11OA47G]; Ugyen Wangchuck Institute for Conservation and Environment Jigme Singye Wangchuck Research and Training Fund; Bhutan Foundation	National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); Ugyen Wangchuck Institute for Conservation and Environment Jigme Singye Wangchuck Research and Training Fund; Bhutan Foundation	Funding: National Aeronautics and Space Administration (grant # NNX11OA47G) to MH; Ugyen Wangchuck Institute for Conservation and Environment Jigme Singye Wangchuck Research and Training Fund to TT; Bhutan Foundation research grant to TT. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ando T, 2010, INT J FORECASTING, V26, P744, DOI 10.1016/j.ijforecast.2009.08.001; Bailey, 1993, AFRICAN LEOPARD ECOL; Barker RJ, 2013, AM STAT, V67, P150, DOI 10.1080/00031305.2013.791644; Bischof R, 2014, METHODS ECOL EVOL, V5, P44, DOI 10.1111/2041-210X.12115; Borah J, 2013, ORYX, P1; Borchers DL, 2008, BIOMETRICS, V64, P377, DOI 10.1111/j.1541-0420.2007.00927.x; Borchers D, 2014, METHODS ECOL EVOL, V5, P656, DOI 10.1111/2041-210X.12196; CARLIN BP, 1995, J ROY STAT SOC B MET, V57, P473; Datta A, 2008, BIOL CONSERV, V141, P1429, DOI 10.1016/j.biocon.2008.02.022; Gray TNE, 2012, J WILDLIFE MANAGE, V76, P163, DOI 10.1002/jwmg.230; Efford MG, 2009, ENVIRON ECOL STAT SE, V3, P255, DOI 10.1007/978-0-387-78151-8_11; Efford Murry, 2004, Oikos, V106, P598, DOI 10.1111/j.0030-1299.2004.13043.x; Foster RJ, 2012, J WILDLIFE MANAGE, V76, P224, DOI 10.1002/jwmg.275; Gardner B, 2010, J WILDLIFE MANAGE, V74, P318, DOI 10.2193/2009-101; Gardner B, 2009, ECOLOGY, V90, P1106, DOI 10.1890/07-2112.1; GELFAND AE, 1994, J ROY STAT SOC B MET, V56, P501; Gelfand AE, 1998, BIOMETRIKA, V85, P1, DOI 10.1093/biomet/85.1.1; Gelman A, 1995, SOCIOL METHODOL, V25, P165, DOI 10.2307/271064; Gelman A, 2014, STAT COMPUT, V24, P997, DOI 10.1007/s11222-013-9416-2; Gelman A, 2013, BRIT J MATH STAT PSY, V66, P8, DOI 10.1111/j.2044-8317.2011.02037.x; Green P.J., 1995, ANN STAT, V82, P711, DOI DOI 10.1093/BI0MET/82.4.711; Harihar A, 2011, J APPL ECOL, V48, P806, DOI 10.1111/j.1365-2664.2011.01981.x; Hooten MB, 2015, ECOL MONOGR, V85, P3, DOI 10.1890/14-0661.1; Ibrahim JG, 2001, STAT SINICA, V11, P419; Jeffreys H, 1935, P CAMBRIDGE PHILOS S; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; Kalle R, 2011, ACTA THERIOL, V56, P335, DOI 10.1007/s13364-011-0038-9; KARANTH KU, 1995, BIOL CONSERV, V71, P333, DOI 10.1016/0006-3207(94)00057-W; Karanth KU, 1998, ECOLOGY, V79, P2852; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kuo L., 1998, SANKHYA, V60, P65, DOI DOI 10.1186/1471-2105-12-186; Liu C, 2012, ECON LETT, V115, P200, DOI 10.1016/j.econlet.2011.12.034; Maffei L, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P119, DOI 10.1007/978-4-431-99495-4_8; Mills L. S., 2013, CONSERVATION WILDLIF; OConnell AF, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P1, DOI 10.1007/978-4-431-99495-4; Odden M, 2005, WILDLIFE BIOL, V11, P145, DOI 10.2981/0909-6396(2005)11[145:SAAPOL]2.0.CO;2; Paviolo A, 2008, ORYX, V42, P554, DOI 10.1017/S0030605308000641; Proffitt K, ECOGRAPHY; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Ross J, 2013, J ZOOL, V290, P96, DOI 10.1111/jzo.12018; Royle J. A., 2008, HIERARCHICAL MODELIN; Royle JA, 2008, ECOLOGY, V89, P2281, DOI 10.1890/07-0601.1; Royle JA, 2007, J COMPUT GRAPH STAT, V16, P67, DOI 10.1198/106186007X181425; Royle JA, 2013, METHODS ECOL EVOL, V4, P520, DOI 10.1111/2041-210X.12039; Royle JA, 2013, ECOLOGY, V94, P287, DOI 10.1890/12-0413.1; Royle JA, 2009, ECOLOGY, V90, P3233, DOI 10.1890/08-1481.1; Royle JA, 2009, J APPL ECOL, V46, P118, DOI 10.1111/j.1365-2664.2008.01578.x; Royle JA, 2014, SPATIAL CAPTURE-RECAPTURE, P1; Russell RE, 2012, J WILDLIFE MANAGE, V76, P1551, DOI 10.1002/jwmg.412; Sanei A, 2011, TROP ECOL, V52, P209; Sangay T, 2008, BIOL CONSERV, V141, P1272, DOI 10.1016/j.biocon.2008.02.027; [Services DoFaP DoFPS], 2014, DEP REP WILDL CRIM B; Simcharoen S, 2008, BIOL CONSERV, V141, P2242, DOI 10.1016/j.biocon.2008.06.015; Sollmann R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034575; Sollmann R, 2011, BIOL CONSERV, V144, P1017, DOI 10.1016/j.biocon.2010.12.011; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Sun CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088025; Tempa T, 2013, ORYX, V47, P207, DOI 10.1017/S0030605312001317; TERBORGH J, 1992, BIOTROPICA, V24, P283, DOI 10.2307/2388523; Tobler MW, 2013, BIOL CONSERV, V159, P109, DOI 10.1016/j.biocon.2012.12.009; Uphyrkina O, 2001, MOL ECOL, V10, P2617, DOI 10.1046/j.0962-1083.2001.01350.x; Wang SW, 2006, BIOL CONSERV, V129, P558, DOI 10.1016/j.biocon.2005.11.024; Wang SW, 2009, BIOL CONSERV, V142, P606, DOI 10.1016/j.biocon.2008.11.023; Watanabe S, 2010, J MACH LEARN RES, V11, P3571; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Wilton CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111257	67	26	28	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140757	10.1371/journal.pone.0140757	http://dx.doi.org/10.1371/journal.pone.0140757			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536231	Green Submitted, gold, Green Published			2022-12-26	WOS:000364298400035
J	Myowa-Yamakoshi, M; Yoshida, C; Hirata, S				Myowa-Yamakoshi, Masako; Yoshida, Chisato; Hirata, Satoshi			Humans but Not Chimpanzees Vary Face-Scanning Patterns Depending on Contexts during Action Observation	PLOS ONE			English	Article							MIRROR; IMITATION; RECOGNITION; PREDICTION; MOVEMENT; CHILDREN; ABILITY; ATTEND; GOALS; GAZE	Human and nonhuman primates comprehend the actions of other individuals by detecting social cues, including others' goal-directed motor actions and faces. However, little is known about how this information is integrated with action understanding. Here, we present the ontogenetic and evolutionary foundations of this capacity by comparing face-scanning patterns of chimpanzees and humans as they viewed goal-directed human actions within contexts that differ in whether or not the predicted goal is achieved. Human adults and children attend to the actor's face during action sequences, and this tendency is particularly pronounced in adults when observing that the predicted goal is not achieved. Chimpanzees rarely attend to the actor's face during the goal-directed action, regardless of whether the predicted action goal is achieved or not. These results suggest that in humans, but not chimpanzees, attention to actor's faces conveying referential information toward the target object indicates the process of observers making inferences about the intentionality of an action. Furthermore, this remarkable predisposition to observe others' actions by integrating the prediction of action goals and the actor's intention is developmentally acquired.	[Myowa-Yamakoshi, Masako; Yoshida, Chisato] Kyoto Univ, Grad Sch Educ, Sakyo Ku, Kyoto 6068501, Japan; [Myowa-Yamakoshi, Masako] RIKEN, ERATO, Japan Sci & Technol Agcy, Wako, Saitama 3510198, Japan; [Hirata, Satoshi] Kyoto Univ, Kumamoto Sanctuary, Kumamoto 8693201, Japan	Kyoto University; Japan Science & Technology Agency (JST); RIKEN; Kyoto University	Myowa-Yamakoshi, M (corresponding author), Kyoto Univ, Grad Sch Educ, Sakyo Ku, Kyoto 6068501, Japan.	myowa.masako.4x@kyoto-u.ac.jp	Myowa, Masako/E-8965-2010		Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology [24000001, 24300103, 24119005, 26245069]; ERATO, Okanoya Emotional Information Project, Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [26245069] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ERATO, Okanoya Emotional Information Project, Japan Science and Technology Agency; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding: This research was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science; the Ministry of Education, Culture, Sports, Science and Technology (24000001, 24300103, 24119005, and 26245069), https://www.jsps.go.jp/english/e-grants/index.html; ERATO, the Okanoya Emotional Information Project, Japan Science and Technology Agency, http://www.jst.go.jp/erato/project/ojj_P/ojj_P.html.	Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Aziz-Zadeh L, 2006, J NEUROSCI, V26, P2964, DOI 10.1523/JNEUROSCI.2921-05.2006; Becchio C, 2012, NEUROIMAGE, V61, P240, DOI 10.1016/j.neuroimage.2012.03.013; Brass M, 2009, PHILOS T R SOC B, V364, P2359, DOI 10.1098/rstb.2009.0066; Buccino G, 2004, NEURON, V42, P323, DOI 10.1016/S0896-6273(04)00181-3; Buttelmann D, 2007, DEVELOPMENTAL SCI, V10, pF31, DOI 10.1111/j.1467-7687.2007.00630.x; Buttelmann D, 2012, ANIM COGN, V15, P1037, DOI 10.1007/s10071-012-0528-4; Call J, 1999, CHILD DEV, V70, P381, DOI 10.1111/1467-8624.00028; Call J, 2008, TRENDS COGN SCI, V12, P187, DOI 10.1016/j.tics.2008.02.010; Cannon EN, 2012, DEVELOPMENTAL SCI, V15, P292, DOI 10.1111/j.1467-7687.2011.01127.x; Falck-Ytter T, 2006, NAT NEUROSCI, V9, P878, DOI 10.1038/nn1729; Falck-Ytter T, 2013, J AUTISM DEV DISORD, V43, P2249, DOI 10.1007/s10803-013-1776-0; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gazzola V, 2007, NEUROIMAGE, V35, P1674, DOI 10.1016/j.neuroimage.2007.02.003; Gredeback G, 2010, COGNITION, V114, P197, DOI 10.1016/j.cognition.2009.09.004; Hecht EE, 2013, CEREB CORTEX, V23, P1014, DOI 10.1093/cercor/bhs097; Heyes C, 2010, NEUROSCI BIOBEHAV R, V34, P575, DOI 10.1016/j.neubiorev.2009.11.007; Hickok G, 2009, J COGNITIVE NEUROSCI, V21, P1229, DOI 10.1162/jocn.2009.21189; Hirata S, 2010, ANIM COGN, V13, P679, DOI 10.1007/s10071-010-0316-y; Iacoboni M, 2009, ANNU REV PSYCHOL, V60, P653, DOI 10.1146/annurev.psych.60.110707.163604; Kanakogi Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1342; Kano F, 2014, PSYCHOL SCI, V25, P1691, DOI 10.1177/0956797614536402; Kano F, 2011, ANIM COGN, V14, P879, DOI 10.1007/s10071-011-0422-5; Kano F, 2009, P R SOC B, V276, P1949, DOI 10.1098/rspb.2008.1811; Krogh-Jespersen S, 2015, DEVELOPMENTAL SCI, V18, P815, DOI 10.1111/desc.12249; Mitchell JP, 2006, NEURON, V50, P655, DOI 10.1016/j.neuron.2006.03.040; Myowa-Yamakoshi M, 2000, J COMP PSYCHOL, V114, P381, DOI 10.1037/0735-7036.114.4.381; Myowa-Yamakoshi M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1695; O'Connell S., 2003, EVOL COGN, V9, P131; Phillips AT, 2002, COGNITION, V85, P53, DOI 10.1016/S0010-0277(02)00073-2; Rizzolatti G, 2005, ANAT EMBRYOL, V210, P419, DOI 10.1007/s00429-005-0039-z; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Rochat MJ, 2008, CURR BIOL, V18, P227, DOI 10.1016/j.cub.2007.12.021; Senju A, 2008, CURR BIOL, V18, P668, DOI 10.1016/j.cub.2008.03.059; Sodian B, 2004, J COGN DEV, V5, P289, DOI 10.1207/s15327647jcd0503_1; Topal J, 2008, SCIENCE, V321, P1831, DOI 10.1126/science.1161437; Turella L, 2009, BRAIN LANG, V108, P10, DOI 10.1016/j.bandl.2007.11.002; Vaish A, 2010, INFANT BEHAV DEV, V33, P79, DOI 10.1016/j.infbeh.2009.11.003; Van Overwalle F, 2009, NEUROIMAGE, V48, P564, DOI 10.1016/j.neuroimage.2009.06.009; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415	42	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0139989	10.1371/journal.pone.0139989	http://dx.doi.org/10.1371/journal.pone.0139989			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV5GZ	26535901	gold, Green Published, Green Submitted			2022-12-26	WOS:000364298400014
J	Qu, DB; Hage, A; Don-Carolis, K; Huang, E; Joselin, A; Safarpour, F; Marcogliese, PC; Rousseaux, MWC; Hewitt, SJ; Huang, TW; Im, DS; Callaghan, S; Dewar-Darch, D; Figeys, D; Slack, RS; Park, DS				Qu, Dianbo; Hage, Ali; Don-Carolis, Katie; Huang, En; Joselin, Alvin; Safarpour, Farzaneh; Marcogliese, Paul C.; Rousseaux, Maxime W. C.; Hewitt, Sarah J.; Huang, Tianwen; Im, Doo-Soon; Callaghan, Steve; Dewar-Darch, Danielle; Figeys, Daniel; Slack, Ruth S.; Park, David S.			BAG2 Gene-mediated Regulation of PINK1 Protein Is Critical for Mitochondrial Translocation of PARKIN and Neuronal Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PINK1/PARKIN-MEDIATED MITOPHAGY; DAMAGED MITOCHONDRIA; UBIQUITIN LIGASE; DEGENERATION; DISEASE; DEGRADATION; DYSFUNCTION; PATHWAY; DROSOPHILA-PINK1; PHOSPHORYLATION	Emerging evidence has demonstrated a growing genetic component in Parkinson disease (PD). For instance, loss-of-function mutations in PINK1 or PARKIN can cause autosomal recessive PD. Recently, PINK1 and PARKIN have been implicated in the same signaling pathway to regulate mitochondrial clearance through recruitment of PARKIN by stabilization of PINK1 on the outer membrane of depolarized mitochondria. The precise mechanisms that govern this process remain enigmatic. In this study, we identify Bcl2-associated athanogene 2 (BAG2) as a factor that promotes mitophagy. BAG2 inhibits PINK1 degradation by blocking the ubiquitination pathway. Stabilization of PINK1 by BAG2 triggers PARKIN-mediated mitophagy and protects neurons against 1-methyl-4-phenylpyridinium-induced oxidative stress in an in vitro cell model of PD. Collectively, our findings support the notion that BAG2 is an upstream regulator of the PINK1/PARKIN signaling pathway.	[Qu, Dianbo; Hage, Ali; Don-Carolis, Katie; Huang, En; Joselin, Alvin; Safarpour, Farzaneh; Marcogliese, Paul C.; Rousseaux, Maxime W. C.; Hewitt, Sarah J.; Huang, Tianwen; Im, Doo-Soon; Callaghan, Steve; Slack, Ruth S.; Park, David S.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada; [Qu, Dianbo; Hage, Ali; Don-Carolis, Katie; Huang, En; Joselin, Alvin; Safarpour, Farzaneh; Marcogliese, Paul C.; Rousseaux, Maxime W. C.; Hewitt, Sarah J.; Huang, Tianwen; Im, Doo-Soon; Callaghan, Steve; Dewar-Darch, Danielle; Figeys, Daniel; Slack, Ruth S.; Park, David S.] Univ Ottawa, Brain & Mind Res Inst, Ottawa, ON K1H 8M5, Canada; [Dewar-Darch, Danielle; Figeys, Daniel] Univ Ottawa, Ottawa Inst Syst Biol, Ottawa, ON K1H 8M5, Canada	University of Ottawa; University of Ottawa; University of Ottawa	Park, DS (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada.	dpark@uottawa.ca	, Dianbo/AAU-8480-2021; Marcogliese, Paul/GQY-7404-2022	, Dianbo/0000-0002-0435-9585; Slack, Ruth/0000-0002-1552-2835; Park, David/0000-0002-4490-3784; Joselin, Alvin/0000-0002-9010-0421; Marcogliese, Paul/0000-0002-8011-7852; Im, Doo Soon/0000-0001-5713-3849; Rousseaux, Maxime/0000-0002-2737-6193; Figeys, Daniel/0000-0002-5373-7546	Canadian Institutes of Health Research; Parkinson's Society Canada; Parkinson's Research Consortium Ottawa; Network of Centers of Excellence in Neurodegeneration; Heart and Stroke Foundation of Ontario; Neuroscience Brain Canada/Krembil Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Parkinson's Society Canada; Parkinson's Research Consortium Ottawa; Network of Centers of Excellence in Neurodegeneration; Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Neuroscience Brain Canada/Krembil Foundation	This work was supported by grants from the Canadian Institutes of Health Research, the Parkinson's Society Canada, the Parkinson's Research Consortium Ottawa, the Network of Centers of Excellence in Neurodegeneration, the Heart and Stroke Foundation of Ontario, and the Neuroscience Brain Canada/Krembil Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868; Arndt V, 2005, MOL BIOL CELL, V16, P5891, DOI 10.1091/mbc.E05-07-0660; Becker D, 2012, J BIOL CHEM, V287, P22969, DOI 10.1074/jbc.M112.365700; Burchell VS, 2013, NAT NEUROSCI, V16, P1257, DOI 10.1038/nn.3489; Cai Q, 2012, CURR BIOL, V22, P545, DOI 10.1016/j.cub.2012.02.005; Che XQ, 2013, BIOCHEM BIOPH RES CO, V441, P488, DOI 10.1016/j.bbrc.2013.10.086; Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Dai Q, 2005, J BIOL CHEM, V280, P38673, DOI 10.1074/jbc.M507986200; Deas E, 2009, EMBO MOL MED, V1, P152, DOI 10.1002/emmm.200900024; Demand J, 2001, CURR BIOL, V11, P1569, DOI 10.1016/S0960-9822(01)00487-0; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Fedorowicz MA, 2014, EMBO REP, V15, P86, DOI 10.1002/embr.201337294; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Geisler S, 2010, AUTOPHAGY, V6, P871, DOI 10.4161/auto.6.7.13286; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Greene AW, 2012, EMBO REP, V13, P378, DOI 10.1038/embor.2012.14; Haque ME, 2008, P NATL ACAD SCI USA, V105, P1716, DOI 10.1073/pnas.0705363105; HIRSCH E, 1988, NATURE, V334, P345, DOI 10.1038/334345a0; Huang E, 2010, NAT CELL BIOL, V12, P563, DOI 10.1038/ncb2058; Itier JM, 2003, HUM MOL GENET, V12, P2277, DOI 10.1093/hmg/ddg239; Jin SM, 2013, AUTOPHAGY, V9, P1750, DOI 10.4161/auto.26122; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Joselin AP, 2012, HUM MOL GENET, V21, P4888, DOI 10.1093/hmg/dds325; Kalia SK, 2004, NEURON, V44, P931, DOI 10.1016/j.neuron.2004.11.026; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Kitada T, 2007, P NATL ACAD SCI USA, V104, P11441, DOI 10.1073/pnas.0702717104; Kitada T, 2009, J NEUROCHEM, V111, P696, DOI 10.1111/j.1471-4159.2009.06350.x; Lin W, 2008, J NEUROCHEM, V106, P464, DOI 10.1111/j.1471-4159.2008.05398.x; Martella G, 2009, EXP NEUROL, V215, P388, DOI 10.1016/j.expneurol.2008.11.001; Martin I, 2011, ANNU REV GENOM HUM G, V12, P301, DOI 10.1146/annurev-genom-082410-101440; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Moriwaki Y, 2008, NEUROSCI RES, V61, P43, DOI 10.1016/j.neures.2008.01.006; Narendra D, 2009, AUTOPHAGY, V5, P706, DOI 10.4161/auto.5.5.8505; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Petrucelli L, 2002, NEURON, V36, P1007, DOI 10.1016/S0896-6273(02)01125-X; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Qu D, 2007, NEURON, V55, P37, DOI 10.1016/j.neuron.2007.05.033; Scarffe LA, 2014, TRENDS NEUROSCI, V37, P315, DOI 10.1016/j.tins.2014.03.004; Sterky FH, 2011, P NATL ACAD SCI USA, V108, P12937, DOI 10.1073/pnas.1103295108; Takatori S, 2008, NEUROSCI LETT, V430, P13, DOI 10.1016/j.neulet.2007.10.019; Takayama S, 1999, J BIOL CHEM, V274, P781, DOI 10.1074/jbc.274.2.781; Tanner CM, 1999, JAMA-J AM MED ASSOC, V281, P341, DOI 10.1001/jama.281.4.341; Thomas RE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004279; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wang XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086276; Weihofen A, 2008, HUM MOL GENET, V17, P602, DOI 10.1093/hmg/ddm334; Whitworth AJ, 2008, DIS MODEL MECH, V1, P168, DOI 10.1242/dmm.000109; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Zhang CG, 2014, CURR BIOL, V24, P1854, DOI 10.1016/j.cub.2014.07.014; Zhou C, 2008, P NATL ACAD SCI USA, V105, P12022, DOI 10.1073/pnas.0802814105	55	42	43	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2015	290	51					30441	30452		10.1074/jbc.M115.677815	http://dx.doi.org/10.1074/jbc.M115.677815			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY9PG	26538564	Green Published, hybrid			2022-12-26	WOS:000366738200021
J	Huang, G; Wu, LW; Yang, SC; Fei, JG; Deng, SX; Li, J; Chen, GD; Fu, Q; Deng, RH; Qiu, J; Wang, CX; Chen, LZ				Huang, Gang; Wu, Lin-wei; Yang, Shi-Cong; Fei, Ji-guang; Deng, Su-xiong; Li, Jun; Chen, Guo-dong; Fu, Qian; Deng, Rong-hai; Qiu, Jiang; Wang, Chang-xi; Chen, Li-zhong			Factors Influencing Graft Outcomes Following Diagnosis of Polyomavirus - Associated Nephropathy after Renal Transplantation	PLoS One			English	Article							BK VIRUS-INFECTION; PREEMPTIVE IMMUNOSUPPRESSION REDUCTION; SINGLE-CENTER ANALYSIS; RECIPIENTS; REPLICATION; IMPACT; STRATEGIES; ALLOGRAFTS; CLEARANCE; UTILITY	Background Polyomavirus associated nephropathy (PVAN) is a significant cause of early allograft loss and the course is difficult to predict. The aim of this study is to identify factors influencing outcome for PVAN. Methods Between 2006 and 2014, we diagnosed PVAN in 48 (7.8%) of 615 patients monitored for BK virus every 1-4 weeks after modification of maintenance immunosuppression. Logistic or Cox regression analysis were performed to determine which risk factors independently affected clinical outcome and graft loss respectively. Results After 32.1 +/- 26.4 months follow-up, the frequencies of any graft functional decline at 1 year post-diagnosis, graft loss and any graft functional decline at the last available follow-up were 27.1% (13/48), 25.0%(12/48), and 33.3% (16/48), respectively. The 1, 3, 5 year graft survival rates were 100%, 80.5% and 69.1%, respectively. The mean level of serum creatinine at 1 year post-diagnosis and long-term graft survival rates were the worst in class C (p<0.05). Thirty-eight of 46 (82.6%) BKV DNAuria patients reduced viral load by 90% with a median time of 2.75 months (range, 0.25-34.0 months) and showed better graft survival rates than the 8 patients (17.4%) without viral load reduction (p<0.001). Multivariate logistic regression analysis showed that extensive interstitial inflammation (OR 20.2, p = 0.042) and delayed fall in urinary viral load (>2.75 months for >90% decrease) in urine (OR 16.7, = 0.055) correlated with worse creatinine at 1 year post-diagnosis. Multivariate Cox regression analysis showed that extensive interstitial inflammation (HR 46988, p = 0.032) at diagnosis, and high PVAN stage (HR 162.2, p = 0.021) were associated with worse long-term graft survival rates. Conclusions The extent of interstitial inflammation influences short and long-term graft outcomes in patients with PVAN. The degree of PVAN, rate of reduction in viral load, and viral clearance also can be used as prognostic markers in PVAN.	[Huang, Gang; Wu, Lin-wei; Fei, Ji-guang; Deng, Su-xiong; Li, Jun; Chen, Guo-dong; Fu, Qian; Deng, Rong-hai; Qiu, Jiang; Wang, Chang-xi; Chen, Li-zhong] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Organ Transplantat, Guangzhou 510275, Guangdong, Peoples R China; [Yang, Shi-Cong] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Qiu, J (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Organ Transplantat, Guangzhou 510275, Guangdong, Peoples R China.	guhuil@mail.sysu.edu.cn; wangchangxi1963@126.com			National Natural Science Foundation of China [81400754]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from National Natural Science Foundation of China (No. 81400754) to G.H., http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeras C, 2008, TRANSPLANTATION, V85, P1099, DOI 10.1097/TP.0b013e31816a33d4; Brennan DC, 2005, AM J TRANSPLANT, V5, P582, DOI 10.1111/j.1600-6143.2005.00742.x; Bueghrig CK, 2003, KIDNEY INT, V64, P665; Chung BH, 2012, TRANSPL INT, V25, P687, DOI 10.1111/j.1432-2277.2012.01480.x; Drachenberg CB, 2004, AM J TRANSPLANT, V4, P2082, DOI 10.1046/j.1600-6143.2004.00603.x; Drachenberg CB, 2006, CLIN J AM SOC NEPHRO, V1, P374, DOI 10.2215/CJN.02021205; Drachenberg RC, 2001, AM J TRANSPLANT, V1, P373, DOI 10.1034/j.1600-6143.2001.10414.x; Funk GA, 2008, AM J TRANSPLANT, V8, P2368, DOI 10.1111/j.1600-6143.2008.02402.x; Gaber LW, 2006, TRANSPLANTATION, V82, P196, DOI 10.1097/01.tp.0000226176.87700.a4; Ginevri F, 2007, AM J TRANSPLANT, V7, P2727, DOI 10.1111/j.1600-6143.2007.01984.x; Helantera I, 2010, INFECT DIS CLIN N AM, V24, P339, DOI 10.1016/j.idc.2010.02.003; Hirsch HH, 2013, AM J TRANSPLANT, V13, P179, DOI 10.1111/ajt.12110; Hirsch HH, 2005, TRANSPLANTATION, V79, P1277, DOI 10.1097/01.TP.0000156165.83160.09; Huang G, 2015, DIAGN MICR INFEC DIS, V81, P21, DOI 10.1016/j.diagmicrobio.2014.09.024; Huang G, 2013, DIAGN MICR INFEC DIS, V75, P292, DOI 10.1016/j.diagmicrobio.2012.11.012; Huang G, 2010, CLIN TRANSPLANT, V24, P599, DOI 10.1111/j.1399-0012.2009.01141.x; Kuten SA, 2014, TRANSPL INFECT DIS, V16, P975, DOI 10.1111/tid.12313; Masutani K, 2012, AM J TRANSPLANT, V12, P907, DOI 10.1111/j.1600-6143.2012.03993.x; Pappo O, 1996, MODERN PATHOL, V9, P105; Pham PT, 2014, CURR OPIN ORGAN TRAN, V19, P401, DOI 10.1097/MOT.0000000000000101; PURIGHALLA R, 1995, AM J KIDNEY DIS, V26, P671, DOI 10.1016/0272-6386(95)90608-8; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; Schwarz A, 2012, TRANSPLANTATION, V94, P396, DOI 10.1097/TP.0b013e31825a505d; Sellares J, 2011, AM J TRANSPLANT, V11, P489, DOI 10.1111/j.1600-6143.2010.03415.x; Wadei HM, 2006, AM J TRANSPLANT, V6, P1025, DOI 10.1111/j.1600-6143.2006.01296.x; Weiss AS, 2008, CLIN J AM SOC NEPHRO, V3, P1812, DOI 10.2215/CJN.05691207	26	17	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142460	10.1371/journal.pone.0142460	http://dx.doi.org/10.1371/journal.pone.0142460			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544696	Green Published, Green Submitted, gold			2022-12-26	WOS:000364398700144
J	Song, XP; Zhou, SQ; Zhang, Y; Liu, YJ; Zhu, HQ; Gao, JH				Song, Xiaopeng; Zhou, Shuqin; Zhang, Yi; Liu, Yijun; Zhu, Huaiqiu; Gao, Jia-Hong			Frequency-Dependent Modulation of Regional Synchrony in the Human Brain by Eyes Open and Eyes Closed Resting-States	PLOS ONE			English	Article								The eyes-open (EO) and eyes-closed (EC) states have differential effects on BOLD-fMRI signal dynamics, affecting both the BOLD oscillation frequency of a single voxel and the regional homogeneity (ReHo) of several neighboring voxels. To explore how the two resting- states modulate the local synchrony through different frequency bands, we decomposed the time series of each voxel into several components that fell into distinct frequency bands. The ReHo in each of the bands was calculated and compared between the EO and EC conditions. The cross-voxel correlations between the mean frequency and the overall ReHo of each voxel's original BOLD series in different brain areas were also calculated and compared between the two states. Compared with the EC state, ReHo decreased with EO in a wide frequency band of 0.01-0.25 Hz in the bilateral thalamus, sensorimotor network, and superior temporal gyrus, while ReHo increased significantly in the band of 0-0.01 Hz in the primary visual cortex, and in a higher frequency band of 0.02-0.1 Hz in the higher order visual areas. The cross-voxel correlations between the frequency and overall ReHo were negative in all the brain areas but varied from region to region. These correlations were stronger with EO in the visual network and the default mode network. Our results suggested that different frequency bands of ReHo showed different sensitivity to the modulation of EO-EC states. The better spatial consistency between the frequency and overall ReHo maps indicated that the brain might adopt a stricter frequency-dependent configuration with EO than with EC.	[Song, Xiaopeng; Zhou, Shuqin; Liu, Yijun; Zhu, Huaiqiu] Peking Univ, Coll Engn, Dept Biomed Engn, Beijing 100871, Peoples R China; [Zhang, Yi] Xidian Univ, Sch Life Sci & Technol, Xian 710071, Shanxi, Peoples R China; [Gao, Jia-Hong] Peking Univ, Ctr MRI Res, Beijing 100871, Peoples R China; [Gao, Jia-Hong] Peking Univ, Beijing City Key Lab Med Phys & Engn, Beijing 100871, Peoples R China	Peking University; Xidian University; Peking University; Peking University	Gao, JH (corresponding author), Peking Univ, Ctr MRI Res, Beijing 100871, Peoples R China.	jgao@pku.edu.cn	Zhu, Huaiqiu/C-3617-2012; Zhang, Yi/J-7496-2017	Zhu, Huaiqiu/0000-0002-6376-218X; Zhang, Yi/0000-0003-0859-9735	National Natural Science Foundation of China [61131003, 81271549, 61431013, 81470816, 81430037, 31421003, 81227003]; China's National Strategic Basic Research Program (973) [2012CB720700]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China's National Strategic Basic Research Program (973)	This work was supported by the National Natural Science Foundation of China (61131003, 81271549, 61431013, 81470816, 81430037, 31421003 and 81227003) and China's National Strategic Basic Research Program (973) (2012CB720700).	Baria AT, 2011, J NEUROSCI, V31, P7910, DOI 10.1523/JNEUROSCI.1296-11.2011; Baria AT, 2013, NEUROIMAGE; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Deco G, 2013, CEREB CORTEX, pt176; Fukunaga M, 2006, MAGN RESON IMAGING, V24, P979, DOI 10.1016/j.mri.2006.04.018; He BJ, 2013, J NEUROSCI, V33, P4672, DOI 10.1523/JNEUROSCI.2922-12.2013; Hipp JF, 2012, NAT NEUROSCI, V15, P884, DOI 10.1038/nn.3101; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Jao T, 2013, NEUROIMAGE, V69, P21, DOI 10.1016/j.neuroimage.2012.12.007; Laufs H, 2006, NEUROIMAGE, V31, P1408, DOI 10.1016/j.neuroimage.2006.02.002; Li Z, 2012, PLOS ONE, V9; Liang X, 2013, P NATL ACAD SCI USA, V110, P1929, DOI 10.1073/pnas.1214900110; Liu DQ, 2013, NEUROINFORMATICS, V11, P469, DOI 10.1007/s12021-013-9187-0; Lv Y, 2013, PLOS ONE, V5; Marx E, 2004, NEUROIMAGE, V21, P1818, DOI 10.1016/j.neuroimage.2003.12.026; Marx E, 2003, NEUROIMAGE, V19, P924, DOI 10.1016/S1053-8119(03)00150-2; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Michels L, 2013, NEUROIMAGE, V81, P231, DOI 10.1016/j.neuroimage.2013.04.030; Mo J, 2013, NEUROIMAGE, V68, P112, DOI 10.1016/j.neuroimage.2012.11.058; Niazy RK, 2011, PROG BRAIN RES, V193, P259, DOI 10.1016/B978-0-444-53839-0.00017-X; Patriat R, 2013, NEUROIMAGE, V78, P463, DOI 10.1016/j.neuroimage.2013.04.013; Peng TY, 2013, MAGN RESON IMAGING, V31, P336, DOI 10.1016/j.mri.2012.06.013; Siegel M, 2012, NAT REV NEUROSCI; Song X, 2014, PLOS ONE, V1; Wu CWW, 2008, NEUROIMAGE, V42, P1047, DOI 10.1016/j.neuroimage.2008.05.035; Xie HB, 2006, COMPUT METH PROG BIO, V82, P114, DOI 10.1016/j.cmpb.2006.02.009; Yang H, 2007, NEUROIMAGE, V36, P144, DOI 10.1016/j.neuroimage.2007.01.054; Yuan BK, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00503; Yuan H, 2013, NEUROIMAGE, V79, P81, DOI 10.1016/j.neuroimage.2013.04.068; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zou O, 2015, NEUROIMAGE; Zou Q, 2015, PLOS ONE, V3; Zou QH, 2009, HUM BRAIN MAPP, V30, P3066, DOI 10.1002/hbm.20728	33	13	13	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141507	10.1371/journal.pone.0141507	http://dx.doi.org/10.1371/journal.pone.0141507			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545233	Green Published, Green Submitted, gold			2022-12-26	WOS:000364398700028
J	Stewart, PA; Parapatics, K; Welsh, EA; Muller, AC; Cao, HY; Fang, B; Koomen, JM; Eschrich, SA; Bennett, KL; Haura, EB				Stewart, Paul A.; Parapatics, Katja; Welsh, Eric A.; Mueller, Andre C.; Cao, Haoyun; Fang, Bin; Koomen, John M.; Eschrich, Steven A.; Bennett, Keiryn L.; Haura, Eric B.			A Pilot Proteogenomic Study with Data Integration Identifies MCT1 and GLUT1 as Prognostic Markers in Lung Adenocarcinoma	PLOS ONE			English	Article							PROTEOMIC ANALYSIS; SAMPLE PREPARATION; CANCER; EXPRESSION; GLUTATHIONE; SOFTWARE; PROTEIN; NORMALIZATION; METABOLISM; GLYCOLYSIS	We performed a pilot proteogenomic study to compare lung adenocarcinoma to lung squamous cell carcinoma using quantitative proteomics (6-plex TMT) combined with a customized Affymetrix GeneChip. Using MaxQuant software, we identified 51,001 unique peptides that mapped to 7,241 unique proteins and from these identified 6,373 genes with matching protein expression for further analysis. We found a minor correlation between gene expression and protein expression; both datasets were able to independently recapitulate known differences between the adenocarcinoma and squamous cell carcinoma subtypes. We found 565 proteins and 629 genes to be differentially expressed between adenocarcinoma and squamous cell carcinoma, with 113 of these consistently differentially expressed at both the gene and protein levels. We then compared our results to published adenocarcinoma versus squamous cell carcinoma proteomic data that we also processed with MaxQuant. We selected two proteins consistently overexpressed in squamous cell carcinoma in all studies, MCT1 (SLC16A1) and GLUT1 (SLC2A1), for further investigation. We found differential expression of these same proteins at the gene level in our study as well as in other public gene expression datasets. These findings combined with survival analysis of public datasets suggest that MCT1 and GLUT1 may be potential prognostic markers in adenocarcinoma and druggable targets in squamous cell carcinoma. Data are available via ProteomeXchange with identifier PXD002622.	[Stewart, Paul A.; Haura, Eric B.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Thorac Oncol, Tampa, FL 33612 USA; [Parapatics, Katja; Mueller, Andre C.; Bennett, Keiryn L.] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1090 Vienna, Austria; [Welsh, Eric A.; Eschrich, Steven A.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Canc Informat Core Facil, Tampa, FL 33612 USA; [Cao, Haoyun; Eschrich, Steven A.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Biostat & Bioinformat, Tampa, FL 33612 USA; [Fang, Bin; Koomen, John M.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Prote Core Facil, Tampa, FL 33612 USA; [Koomen, John M.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Haura, EB (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Thorac Oncol, Tampa, FL 33612 USA.	Eric.Haura@moffitt.org	Eschrich, Steven/K-6848-2013	Eschrich, Steven/0000-0002-9833-2788; Bennett, Keiryn L./0000-0001-9356-7708; Mueller, Andre/0000-0002-0608-8176	Moffitt's Total Cancer Care Initiative and Collaborative Data Services Core at the H. Lee Moffitt Cancer Center & Research Institute [P30-CA76292]; DeBartolo Family; NATIONAL CANCER INSTITUTE [P30CA076292] Funding Source: NIH RePORTER	Moffitt's Total Cancer Care Initiative and Collaborative Data Services Core at the H. Lee Moffitt Cancer Center & Research Institute; DeBartolo Family; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work has been supported in part by the Moffitt's Total Cancer Care Initiative and Collaborative Data Services Core at the H. Lee Moffitt Cancer Center & Research Institute, an NCI designated Comprehensive Cancer Center, under grant number P30-CA76292. Total Cancer Care is enabled, in part, by the generous support of the DeBartolo Family. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro JA, 2014, NAT METHODS, V11, P1107, DOI [10.1038/NMETH.3138, 10.1038/nmeth.3138]; Balendiran GK, 2004, CELL BIOCHEM FUNCT, V22, P343, DOI 10.1002/cbf.1149; Bennett KL, 2011, J PROTEOMICS, V74, P151, DOI 10.1016/j.jprot.2010.10.002; Boekel J, 2015, NAT BIOTECHNOL, V33, P137, DOI 10.1038/nbt.3134; Boja ES, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-22; Chen GA, 2002, MOL CELL PROTEOMICS, V1, P304, DOI 10.1074/mcp.M200008-MCP200; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Cox J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S12; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Doherty JR, 2014, CANCER RES, V74, P908, DOI 10.1158/0008-5472.CAN-13-2034; Doherty JR, 2013, J CLIN INVEST, V123, P3685, DOI 10.1172/JCI69741; Eilertsen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105038; Eschrich SA, 2007, BIOINFORMATICS, V23, P1562, DOI 10.1093/bioinformatics/btm127; Eschrich SA, 2008, IEEE ENG MED BIO, P2419, DOI 10.1109/IEMBS.2008.4649687; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gholami AM, 2013, CELL REP, V4, P609, DOI 10.1016/j.celrep.2013.07.018; Gomez-Morales M, 2013, HISTOPATHOLOGY, V63, P103, DOI 10.1111/his.12126; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hoaglin D. C, 2000, UNDERSTANDING ROBUST; Jagtap PD, 2014, J PROTEOME RES, V13, P5898, DOI 10.1021/pr500812t; Karpievitch YV, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S5; Kikuchi T, 2012, MOL CELL PROTEOMICS, V11, P916, DOI 10.1074/mcp.M111.015370; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Kuner R, 2009, LUNG CANCER, V63, P32, DOI 10.1016/j.lungcan.2008.03.033; Lee GH, 2011, ONCOL LETT, V2, P831, DOI 10.3892/ol.2011.353; Lehtio J, 2010, J PROTEOMICS, V73, P1851, DOI 10.1016/j.jprot.2010.05.015; Li J, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006536; Li L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6469; Linxweiler J, 2014, EUPA OPEN PROTEOMICS, V4, P25, DOI [10.1016/j.euprot.2014.05.004, DOI 10.1016/J.EUPROT.2014.05.004]; Mann M, 2013, MOL CELL, V49, P583, DOI 10.1016/j.molcel.2013.01.029; Manza LL, 2005, PROTEOMICS, V5, P1742, DOI 10.1002/pmic.200401063; McAlister GC, 2012, ANAL CHEM, V84, P7469, DOI 10.1021/ac301572t; Nesvizhskii AI, 2005, MOL CELL PROTEOMICS, V4, P1419, DOI 10.1074/mcp.R500012-MCP200; Nesvizhskii AI, 2014, NAT METHODS, V11, P1114, DOI [10.1038/NMETH.3144, 10.1038/nmeth.3144]; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Pastor MD, 2013, CLIN TRANSL ONCOL, V15, P671, DOI 10.1007/s12094-013-1034-0; Pate KT, 2014, EMBO J, V33, P1454, DOI 10.15252/embj.201488598; Polanski R, 2014, CLIN CANCER RES, V20, P926, DOI 10.1158/1078-0432.CCR-13-2270; R Core Team, 2014, R A LANGUAGE AND ENV; Rekhtman N, 2011, MODERN PATHOL, V24, P1348, DOI 10.1038/modpathol.2011.92; RStudio, 2014, RSTUDIO INTEGRATED D; Sanchez-Palencia A, 2011, INT J CANCER, V129, P355, DOI 10.1002/ijc.25704; Sandberg A, 2014, J PROTEOMICS, V96, P133, DOI 10.1016/j.jprot.2013.10.035; Sanders WS, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-115; Schuurbiers OCJ, 2014, J THORAC ONCOL, V9, P1485, DOI 10.1097/JTO.0000000000000286; Shi I, 2011, CANCER INFORM, V10, P273, DOI 10.4137/CIN.S8283; Sun H, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S8-S5; Tanaka-Okamoto M, 2009, CANCER SCI, V100, P608, DOI 10.1111/j.1349-7006.2009.01091.x; Tanvetyanon T, 2014, CANCER CONTROL, V21, P32, DOI 10.1177/107327481402100105; Terry J, 2010, AM J SURG PATHOL, V34, P1805, DOI 10.1097/PAS.0b013e3181f7dae3; Tovchigrechko A, 2014, BIOINFORMATICS, V30, P1469, DOI 10.1093/bioinformatics/btu051; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wei YH, 2011, J PROTEOME RES, V10, P161, DOI 10.1021/pr100491e; Welsh EA, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-153; Wenig P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-405; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Woo S, 2014, J PROTEOME RES, V13, P21, DOI 10.1021/pr400294c; Yang P, 2006, J CLIN ONCOL, V24, P1761, DOI 10.1200/JCO.2005.02.7110; Zhang B, 2014, NATURE, V513, P382, DOI 10.1038/nature13438; Zhang W, 2014, PROTEOMICS, V14, P795, DOI 10.1002/pmic.201300382	65	26	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142162	10.1371/journal.pone.0142162	http://dx.doi.org/10.1371/journal.pone.0142162			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26539827	Green Published, Green Submitted, gold			2022-12-26	WOS:000364303800060
J	Chowdhury, UR; Bahler, CK; Holman, BH; Dosa, PI; Fautsch, MP				Chowdhury, Uttio Roy; Bahler, Cindy K.; Holman, Bradley H.; Dosa, Peter I.; Fautsch, Michael P.			Ocular Hypotensive Effects of the ATP-Sensitive Potassium Channel Opener Cromakalim in Human and Murine Experimental Model Systems	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; INTRAOCULAR-PRESSURE; K+ CHANNEL; SULFONYLUREA RECEPTOR; SMOOTH-MUSCLE; MICE; RAT; HYPERTENSION; STRESS; LATANOPROST	Elevated intraocular pressure (IOP) is the most prevalent and only treatable risk factor for glaucoma, a leading cause of irreversible blindness worldwide. Unfortunately, all current therapeutics used to treat elevated IOP and glaucoma have significant and sometimes irreversible side effects necessitating the development of novel compounds. We evaluated the IOP lowering ability of the broad spectrum K-ATP channel opener cromakalim. Cultured human anterior segments when treated with 2 mu M cromakalim showed a decrease in pressure (19.33 +/- 2.78 mmHg at 0 hours to 13.22 +/- 2.64 mmHg at 24 hours; p<0.001) when compared to vehicle treated controls (15.89 +/- 5.33 mmHg at 0 h to 15.56 +/- 4.88 mmHg at 24 hours; p = 0.89). In wild-type C57BL/6 mice, cromakalim reduced IOP by 18.75 +/- 2.22% compared to vehicle treated contralateral eyes (17.01 +/- 0.32 mmHg at 0 hours to 13.82 +/- 0.37 mmHg at 24 hours; n = 10, p = 0.002). Cromakalim demonstrated an additive effect when used in conjunction with latanoprost free acid, a common ocular hypotensive drug prescribed to patients with elevated IOP. To examine K-ATP channel subunit specificity, K(ir)6.2((-/-)) mice were treated with cromakalim, but unlike wild-type animals, no change in IOP was noted. Histologic analysis of treated and control eyes in cultured human anterior segments and in mice showed similar cell numbers and extracellular matrix integrity within the trabecular meshwork, with no disruptions in the inner and outer walls of Schlemm's canal. Together, these studies suggest that cromakalim is a potent ocular hypotensive agent that lowers IOP via activation of Kir6.2 containing K-ATP channels, its effect is additive when used in combination with the commonly used glaucoma drug latanoprost, and is not toxic to cells and tissues of the aqueous humor outflow pathway, making it a candidate for future therapeutic development.	[Chowdhury, Uttio Roy; Bahler, Cindy K.; Holman, Bradley H.; Fautsch, Michael P.] Mayo Clin, Dept Ophthalmol, Rochester, MN 55905 USA; [Dosa, Peter I.] Univ Minnesota, Inst Therapeut Discovery & Dev, Minneapolis, MN USA	Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities	Fautsch, MP (corresponding author), Mayo Clin, Dept Ophthalmol, Rochester, MN 55905 USA.	fautsch.michael@mayo.edu		Dosa, Peter/0000-0002-0081-3867	NATIONAL EYE INSTITUTE [R01EY021727] Funding Source: NIH RePORTER; NEI NIH HHS [EY 21727, R01 EY021727] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Akaishi T, 2009, J OCUL PHARMACOL TH, V25, P401, DOI 10.1089/jop.2009.0006; Ashcroft FM, 1998, TRENDS NEUROSCI, V21, P288, DOI 10.1016/S0166-2236(98)01225-9; ASHCROFT FM, 1984, NATURE, V312, P446, DOI 10.1038/312446a0; ASHFORD MLJ, 1988, PFLUG ARCH EUR J PHY, V412, P297, DOI 10.1007/BF00582512; Babenko AP, 1998, CIRC RES, V83, P1132, DOI 10.1161/01.RES.83.11.1132; Bahler CK, 2012, AM J OPHTHALMOL, V153, P1206, DOI 10.1016/j.ajo.2011.12.017; Bar-llan A, 1984, CURR EYE RES, V3, P1305; BITO LZ, 1983, INVEST OPHTH VIS SCI, V24, P312; Bodenstine TM, 2012, FEBS LETT, V586, P27, DOI 10.1016/j.febslet.2011.11.017; Boland M. V., 2012, TREATMENT GLAUCOMA C; Brayden JE, 2002, CLIN EXP PHARMACOL P, V29, P312, DOI 10.1046/j.1440-1681.2002.03650.x; Cecchetti V, 2006, CURR TOP MED CHEM, V6, P1049, DOI 10.2174/156802606777323683; Chatterjee S, 2006, MICROCIRCULATION, V13, P633, DOI 10.1080/10739680600930255; Chatterjee S, 2003, AM J PHYSIOL-CELL PH, V285, pC959, DOI 10.1152/ajpcell.00511.2002; Chatterjee S, 2014, AM J PHYSIOL-LUNG C, V307, pL668, DOI 10.1152/ajplung.00198.2014; CHIANG CH, 1995, J OCUL PHARMACOL TH, V11, P195, DOI 10.1089/jop.1995.11.195; Chowdhury UR, 2015, INVEST OPHTH VIS SCI, V56, P2993, DOI 10.1167/iovs.15-16744; Chowdhury UR, 2013, INVEST OPHTH VIS SCI, V54, P4892, DOI 10.1167/iovs.13-11872; Chowdhury UR, 2011, INVEST OPHTH VIS SCI, V52, P6435, DOI 10.1167/iovs.11-7523; Crooke A, 2012, CURR MED CHEM, V19, P3508, DOI 10.2174/092986712801323234; Diggory P, 1996, BRIT J OPHTHALMOL, V80, P85, DOI 10.1136/bjo.80.1.85; Du RH, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-35; FRIEDEL HA, 1990, DRUGS, V39, P929, DOI 10.2165/00003495-199039060-00008; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P532; Garlid KD, 1996, J BIOL CHEM, V271, P8796, DOI 10.1074/jbc.271.15.8796; Gross GJ, 2003, AM J PHYSIOL-HEART C, V285, pH921, DOI 10.1152/ajpheart.00421.2003; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Huang HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063337; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Inagaki N, 1998, JPN J PHYSIOL, V48, P397, DOI 10.2170/jjphysiol.48.397; Inagaki N, 1996, NEURON, V16, P1011, DOI 10.1016/S0896-6273(00)80124-5; INAGAKI N, 1995, GENOMICS, V30, P102, DOI 10.1006/geno.1995.0018; Jahangir A, 2005, J MOL CELL CARDIOL, V39, P99, DOI 10.1016/j.yjmcc.2005.04.006; Jons T, 2006, J CELL SCI, V119, P3087, DOI 10.1242/jcs.03041; Johnstone MA, 1997, AM J OPHTHALMOL, V124, P544, DOI 10.1016/S0002-9394(14)70870-0; Kane GC, 2006, HUM MOL GENET, V15, P2285, DOI 10.1093/hmg/ddl154; Kane GC, 2004, DIABETES, V53, pS169, DOI 10.2337/diabetes.53.suppl_3.S169; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Kraljevic J, 2015, MED SCI SPORT EXER, V47, P2504, DOI 10.1249/MSS.0000000000000714; Kurna SA, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/460483; Landry DW, 2001, NEW ENGL J MED, V345, P588, DOI 10.1056/NEJMra002709; LANDRY DW, 1992, J CLIN INVEST, V89, P2071, DOI 10.1172/JCI115820; Lawson K, 2000, KIDNEY INT, V57, P838, DOI 10.1046/j.1523-1755.2000.00923.x; Lichter PR, 2001, OPHTHALMOLOGY, V108, P1943, DOI 10.1016/S0161-6420(01)00873-9; Liss B, 2005, NAT NEUROSCI, V8, P1742, DOI 10.1038/nn1570; MANDELL AI, 1988, ANN OPHTHALMOL, V20, P133; Miki T, 1998, P NATL ACAD SCI USA, V95, P10402, DOI 10.1073/pnas.95.18.10402; Ng KE, 2010, J MEMBRANE BIOL, V234, P137, DOI 10.1007/s00232-010-9241-x; Nguyen QH, 2014, PATIENT PREFER ADHER, V8, P853, DOI 10.2147/PPA.S53162; NOMA A, 1983, NATURE, V305, P147, DOI 10.1038/305147a0; Ota T, 2005, INVEST OPHTH VIS SCI, V46, P2006, DOI 10.1167/iovs.04-1527; Ozcan C, 2007, J CARDIOVASC PHARM, V50, P411, DOI 10.1097/FJC.0b013e31812378df; Park YB, 2011, DIABETES METAB J, V35, P219, DOI 10.4093/dmj.2011.35.3.219; Parrish RK, 2009, AM J OPHTHALMOL, V147, P717, DOI 10.1016/j.ajo.2008.10.007; Prasad SM, 2006, ANN THORAC SURG, V81, P148, DOI 10.1016/j.athoracsur.2005.06.055; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Rasmussen CA, 2014, CAN J OPHTHALMOL, V49, P534, DOI 10.1016/j.jcjo.2014.08.007; Remedi MS, 2006, DIABETOLOGIA, V49, P2368, DOI 10.1007/s00125-006-0367-4; Rodrigo GC, 2005, CURR PHARM DESIGN, V11, P1915, DOI 10.2174/1381612054021015; Saegusa N, 2005, CARDIOVASC RES, V67, P60, DOI 10.1016/j.cardiores.2005.03.011; Sebille S, 2004, CURR MED CHEM, V11, P1213, DOI 10.2174/0929867043365378; Seino S, 2000, DIABETES, V49, P311, DOI 10.2337/diabetes.49.3.311; Seino S, 2003, PROG BIOPHYS MOL BIO, V81, P133, DOI 10.1016/S0079-6107(02)00053-6; Shi L, 2009, PHYSIOL RES, V58, P645, DOI 10.33549/physiolres.931594; SPRUCE AE, 1985, NATURE, V316, P736, DOI 10.1038/316736a0; STANDEN NB, 1989, SCIENCE, V245, P177, DOI 10.1126/science.2501869; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Tinker A, 2014, BRIT J PHARMACOL, V171, P12, DOI 10.1111/bph.12407; TOMAI F, 1994, CIRCULATION, V90, P700, DOI 10.1161/01.CIR.90.2.700; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Weinreb RN, 2014, JAMA-J AM MED ASSOC, V311, P1901, DOI 10.1001/jama.2014.3192; Wistrand PJ, 1997, SURV OPHTHALMOL, V41, pS129, DOI 10.1016/S0039-6257(97)80020-3; Wu XF, 2011, PAIN, V152, P2605, DOI 10.1016/j.pain.2011.08.003; Yamada M, 1997, J PHYSIOL-LONDON, V499, P715, DOI 10.1113/jphysiol.1997.sp021963; Yokoshiki H, 1998, AM J PHYSIOL-CELL PH, V274, pC25, DOI 10.1152/ajpcell.1998.274.1.C25; Zhang H, 2014, EXP EYE RES, V121, P86, DOI 10.1016/j.exer.2014.02.004; Zingman LV, 2003, MOL PSYCHIATR, V8, P253, DOI 10.1038/sj.mp.4001323; Zingman LV, 2002, P NATL ACAD SCI USA, V99, P13278, DOI 10.1073/pnas.212315199	78	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141783	10.1371/journal.pone.0141783	http://dx.doi.org/10.1371/journal.pone.0141783			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26535899	gold, Green Submitted, Green Published			2022-12-26	WOS:000364298400086
J	Csosz, S; Heinze, J; Miko, I				Csosz, Sandor; Heinze, Juergen; Miko, Istvan			Taxonomic Synopsis of the Ponto-Mediterranean Ants of Temnothorax nylanderi Species-Group	PLOS ONE			English	Article							COLLECTIVE DECISION-MAKING; NEST-SITE SELECTION; WORKER REPRODUCTION; HYMENOPTERA; COLONIES; FORMICIDAE	In the current revisionary work, the Temnothorax nylanderi species-group of myrmicine ants is characterized. Eighteen species belonging to this group in the Ponto-Mediterranean region are described or redefined based on an integrative approach that combines exploratory analyses of morphometric data and of a 658bp fragment of the mitochondrial gene for the cytochrome c oxidase subunit I (CO I). The species group is subdivided into five species complexes: T. angustifrons complex, T. lichtensteini complex, T. nylanderi complex, T. parvulus complex, T. sordidulus complex, and two species, T. angulinodis sp. n. and T. flavicornis (Emery, 1870) form their own lineages. We describe seven new species (T. angulinodis sp. n., T. angustifrons sp. n., T. ariadnae sp. n., T. helenae sp. n., T. lucidus sp. n., T. similis sp. n., T. subtilis sp. n.), raise T. tergestinus (FINZI, 1928) stat.n. to species level, and propose a new junior synonymy for T. saxonicus (SEIFERT, 1995) syn.n. (junior synonym of T. tergestinus). We describe the worker caste and provide high quality images and distributional maps for all eighteen species. Furthermore, we provide a decision tree as an alternative identification key that visually gives an overview of this species-group. We make the first application to Formicidae of the Semantic Phenotype approach that has been used in previous taxonomic revisions.	[Csosz, Sandor] Calif Acad Sci, Entomol, San Francisco, CA 94118 USA; [Heinze, Juergen] Univ Regensburg, Zool Evolutionary Biol, D-93053 Regensburg, Germany; [Miko, Istvan] Penn State Univ, Frost Entomol Museum, University Pk, PA 16802 USA	California Academy of Sciences; University of Regensburg; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Csosz, S (corresponding author), Calif Acad Sci, Entomol, San Francisco, CA 94118 USA.	sandorcsosz2@gmail.com		Miko, Istvan/0000-0001-9719-0215	U. S. National Science Foundation [DBI-1356381]; Hungarian Eotvos scholarship	U. S. National Science Foundation(National Science Foundation (NSF)); Hungarian Eotvos scholarship	Funding: IM was supported by the U. S. National Science Foundation (grant DBI-1356381) and SC was supported by the Hungarian Eotvos scholarship, 2010.	Achenbach A, 2009, EVOLUTION, V63, P1068, DOI 10.1111/j.1558-5646.2009.00591.x; Aleksiev AS, 2008, NATURWISSENSCHAFTEN, V95, P301, DOI 10.1007/s00114-007-0329-9; Aleksiev AS, 2007, ANIM BEHAV, V74, P567, DOI 10.1016/j.anbehav.2006.12.023; [Anonymous], 2014, R LANG ENV STAT COMP; ARNOLDI K V, 1977, Entomologicheskoe Obozrenie, V56, P198; Balhoff JP, 2013, SYST BIOL, V62, P639, DOI 10.1093/sysbio/syt028; BERNARD FRANCIS, 1956, BULL SOC ZOOL FRANCE, V81, P151; Borowiec Lech, 2014, Genus (Wroclaw), V25, P1; Brandt M, 2005, BIOL REV, V80, P251, DOI 10.1017/S1464793104006669; Brunner E, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-55; Csosz S, 2014, ORG DIVERS EVOL, V14, P75, DOI 10.1007/s13127-013-0153-3; Czechowski W, 2012, FAUNA POLONIAE, P4; Dornhaus A, 2004, ANIM BEHAV, V67, P959, DOI 10.1016/j.anbehav.2003.09.004; El-Shehaby M, 2012, MYRMECOL NEWS, V17, P21; Evenhuis NL, 2013, INSECT SPIDER COLLEC; Foitzik S, 2001, P ROY SOC B-BIOL SCI, V268, P1139, DOI 10.1098/rspb.2001.1627; Fokuhl G, 2012, ACTA OECOL, V38, P71, DOI 10.1016/j.actao.2011.09.007; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Franks NR, 2008, ANIM BEHAV, V76, P323, DOI 10.1016/j.anbehav.2008.02.009; Franks NR, 2002, PHILOS T R SOC B, V357, P1567, DOI 10.1098/rstb.2002.1066; Gratiashvili N, 2015, EUR J ENTOMOL, V112, P175, DOI 10.14411/eje.2015.025; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Harris R.A., 1979, California Department of Food and Agriculture Laboratory Services-Entomology Occasional Papers, P1; Heinze J, 1997, ANIM BEHAV, V54, P849, DOI 10.1006/anbe.1996.0511; Heinze J, 2010, ANIMAL BEHAVIOUR: EVOLUTION AND MECHANISMS, P151, DOI 10.1007/978-3-642-02624-9_6; Heinze K, 2004, ADV STUD BEHAV, V34, P1, DOI 10.1016/S0065-3454(04)34001-5; Holldobler B., 1990, pi; Mallon EB, 2001, BEHAV ECOL SOCIOBIOL, V50, P352, DOI 10.1007/s002650100377; Miko I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094056; Pratt SC, 2002, BEHAV ECOL SOCIOBIOL, V52, P117, DOI 10.1007/s00265-002-0487-x; Prebus M, 2015, ZOOKEYS, P23, DOI 10.3897/zookeys.483.9111; Pusch K, 2006, BIOL J LINN SOC, V88, P223, DOI 10.1111/j.1095-8312.2006.00618.x; QGIS Development Team, 2009, QGIS GEOGR INF SYST; Radchenko A.G., 1995, Vestnik Zoologii, V4, P3; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sambrook J., 2001, MOL CLONING LAB MANU; Schlick-Steiner BC, 2010, ANNU REV ENTOMOL, V55, P421, DOI 10.1146/annurev-ento-112408-085432; Schulz A, 2007, ZOOTAXA, P1; SEIFERT B, 1996, AMEISEN BEOBACHTEN B; SEIFERT B, 2007, AMEISEN MITTEL NORDE; Seifert Bernhard, 1995, Abhandlungen und Berichte des Naturkundemuseums Goerlitz, V68, P1; Seifert B, 2015, ZOOKEYS, P37, DOI 10.3897/zookeys.479.8510; Seifert Bernhard, 2014, Beitraege zur Entomologie, V64, P47; Seifert Bernhard, 2014, Soil Organisms, V86, P85; Seifert B, 2014, MYRMECOL NEWS, V19, P1; Seifert B, 2009, MYRMECOL NEWS, V12, P149; Seifert Bernhard, 2006, Myrmecologische Nachrichten, V8, P1; SENDOVAFRANKS AB, 1994, P ROY SOC B-BIOL SCI, V256, P305, DOI 10.1098/rspb.1994.0085; Stroeymeyt N, 2007, BEHAV ECOL SOCIOBIOL, V61, P1449, DOI 10.1007/s00265-007-0377-3; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Themeau TM, 2014, R PACKAGE VERSION 4; Tinaut A, 1995, ZOOLOGICA BAETICA, V5, P89; Visscher PK, 2007, ANNU REV ENTOMOL, V52, P255, DOI 10.1146/annurev.ento.51.110104.151025; Walter B, 2011, AM NAT, V177, P368, DOI 10.1086/658396; WILSON EDWARD O., 1955, BULL MUS COMP ZOOL HARVARD UNIV, V113, P1	55	28	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140000	10.1371/journal.pone.0140000	http://dx.doi.org/10.1371/journal.pone.0140000			62	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536033	Green Published, Green Submitted, gold			2022-12-26	WOS:000364298400015
J	Geraldo, MV; Kimura, ET				Geraldo, Murilo V.; Kimura, Edna T.			Integrated Analysis of Thyroid Cancer Public Datasets Reveals Role of Post-Transcriptional Regulation on Tumor Progression by Targeting of Immune System Mediators	PLOS ONE			English	Article							PAPILLARY CARCINOMAS; DOWN-REGULATION; BRAF MUTATIONS; AUTOCRINE PRODUCTION; MACROPHAGES PROMOTE; IN-VIVO; EXPRESSION; MICRORNA; GENE; INTERLEUKIN-4	Papillary thyroid carcinoma (PTC) is a well-differentiated thyroid tumor that accounts for approximately 80% of thyroid cancer cases. On other hand, anaplastic thyroid carcinoma (ATC) is a less frequent, but aggressive subtype, with poor prognosis. MicroRNAs (miRNAs), small non-coding RNAs, have emerged as potent post-transcriptional regulators of gene expression, which modulate the expression of cancer-related genes. Computational analyses estimate that a single miRNA may modulate hundreds of mRNA targets and, at the same time, cooperate with others to regulate one single mRNA transcript. Due to the large number of predicted targets and possible interactions, only a small number of miRNAs have characterized biological roles, and the panorama of miRNA-mediated regulation in thyroid cancer remains to be understood. Taking into consideration the large amount of gene expression data deposited in public databases we aligned miRNA target prediction and gene expression data from public PTC and ATC datasets to construct a network of post-transcriptional regulation in thyroid cancer. After a gene set enrichment analysis we identified signaling pathways and biological processes potentially modulated by the miRNAs deregulated in PTC and ATC. Our results show miRNA-mRNA interaction that could contribute with the de-regulation of key tumor-host mediators, such as extra-cellular matrix molecules, interleukins and interleukin receptors, which could drive a more aggressive behavior and tumor progression. Moreover, our analysis through The Cancer Genome Atlas (TCGA) database revealed that aberrant expression of ECM and cytokines genes is frequent in PTC and is associated with aggressive behavior and decreased overall survival rate. In conclusion, we shed light on the post-transcriptional regulation of gene expression in differentiated and undifferentiated thyroid cancers, revealing a potential role of miRNAs in modulation of tumor-host interaction molecules, particularly ECM molecules and immune system mediators, which could stimulate crosstalk between tumors and the immune system to generate a more aggressive behavior. We propose a novel putative miRNA: mRNA network that could lead to a new path toward functional studies.	[Geraldo, Murilo V.; Kimura, Edna T.] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil; [Geraldo, Murilo V.] Univ Estadual Campinas, Inst Biol, Dept Struct & Funct Biol, Campinas, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual de Campinas	Kimura, ET (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil.	etkimura@usp.br	Geraldo, Murilo V/C-6427-2016; Geraldo, Murilo V/F-7211-2013; Kimura, Edna/D-7334-2012	Geraldo, Murilo V/0000-0002-9418-6103; Kimura, Edna/0000-0001-8403-4459	Sao Paulo Research Foundation [2011/52051-2, 2013/11019-4]; National Council for Scientific and Technological Development [308527/2013-5, 458505/2014-5]	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was funded by the Sao Paulo Research Foundation (http://fapesp.br/), grants 2011/52051-2 (MVG) and 2013/11019-4 (ETK), and the National Council for Scientific and Technological Development (http://cnpq.br/), grants 308527/2013-5; 458505/2014-5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreyro L, 2012, BLOOD, V120, P1290, DOI 10.1182/blood-2012-01-404699; Bauerle KT, 2014, J CLIN ENDOCR METAB, V99, pE1436, DOI 10.1210/jc.2013-3636; Braun J, 2010, ONCOGENE, V29, P4237, DOI 10.1038/onc.2010.169; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen YT, 2008, MODERN PATHOL, V21, P1139, DOI 10.1038/modpathol.2008.105; Cheng SP, 2013, CELL BIOCHEM BIOPHYS, V65, P203, DOI 10.1007/s12013-012-9419-1; Cil E, 2014, MOL BIOL REP, V41, P3091, DOI 10.1007/s11033-014-3169-7; Colamaio M, 2011, J CLIN ENDOCR METAB, V96, pE1915, DOI 10.1210/jc.2011-0408; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Fang WY, 2014, CARCINOGENESIS, V35, P1780, DOI 10.1093/carcin/bgu060; Fugazzola L, 2006, ENDOCR-RELAT CANCER, V13, P455, DOI 10.1677/erc.1.01086; Fukushima T, 2003, ONCOGENE, V22, P6455, DOI 10.1038/sj.onc.1206739; Gao LB, 2014, TUMOR BIOL, V35, P3861, DOI 10.1007/s13277-013-1512-6; Gao Y, 2010, ENDOCR J, V57, P81, DOI 10.1507/endocrj.K09E-220; Guan HY, 2013, J CLIN ENDOCR METAB, V98, pE1334, DOI 10.1210/jc.2013-1053; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102; Hung JY, 2014, LAB INVEST, V94, P371, DOI 10.1038/labinvest.2014.1; Iwahashi N, 2002, BIOCHEM BIOPH RES CO, V294, P642, DOI 10.1016/S0006-291X(02)00528-4; Kimura ET, 2003, CANCER RES, V63, P1454; Kitano M, 2011, ANN SURG ONCOL, V18, P3443, DOI 10.1245/s10434-011-1766-4; Lee JC, 2013, CANCER-AM CANCER SOC, V119, P4358, DOI 10.1002/cncr.28254; Leone V, 2011, J CLIN ENDOCR METAB, V96, pE1388, DOI 10.1210/jc.2011-0345; Liotti F, 2012, AM J CANCER RES, V2, P286; Mitsiades N, 2011, J CLIN ENDOCR METAB, V96, pE2023, DOI 10.1210/jc.2010-1908; Nikiforova MN, 2008, J CLIN ENDOCR METAB, V93, P1600, DOI 10.1210/jc.2007-2696; Nikiforova MN, 2003, J CLIN ENDOCR METAB, V88, P5399, DOI 10.1210/jc.2003-030838; Pacifico F, 2010, J CLIN ENDOCR METAB, V95, P1421, DOI 10.1210/jc.2009-1128; Pallante P, 2006, ENDOCR-RELAT CANCER, V13, P497, DOI 10.1677/erc.1.01209; Palona I, 2006, ENDOCRINOLOGY, V147, P5699, DOI 10.1210/en.2006-0400; Riesco-Eizaguirre G, 2006, ENDOCR-RELAT CANCER, V13, P257, DOI 10.1677/erc.1.01119; Rung J, 2013, NAT REV GENET, V14, P89, DOI 10.1038/nrg3394; Russell JP, 2004, J IMMUNOL, V172, P4059, DOI 10.4049/jimmunol.172.7.4059; Ryder M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054302; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Stassi G, 2003, CANCER RES, V63, P6784; Tetzlaff MT, 2007, ENDOCR PATHOL, V18, P163, DOI 10.1007/s12022-007-0023-7; Todaro M, 2006, CANCER RES, V66, P1491, DOI 10.1158/0008-5472.CAN-05-2514; Tsujikawa T, 2013, INT J CANCER, V132, P2755, DOI 10.1002/ijc.27966; Vella V, 2004, J CLIN ENDOCR METAB, V89, P2880, DOI 10.1210/jc.2003-031639; Visone R, 2007, ONCOGENE, V26, P7590, DOI 10.1038/sj.onc.1210564; Visone R, 2007, ENDOCR-RELAT CANCER, V14, P791, DOI 10.1677/ERC-07-0129; Wang MH, 2009, PROSTATE, V69, P874, DOI 10.1002/pros.20933; Ward LS, 2014, SCIENTIFICA, V2014, DOI 10.1155/2014/125450; Weber F, 2006, J CLIN ENDOCR METAB, V91, P3584, DOI 10.1210/jc.2006-0693; Xing M, 2014, J CLIN ONCOL; Xing MZ, 2007, ENDOCR REV, V28, P742, DOI 10.1210/er.2007-0007; Xiong Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024717	48	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141726	10.1371/journal.pone.0141726	http://dx.doi.org/10.1371/journal.pone.0141726			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536459	gold, Green Published, Green Submitted			2022-12-26	WOS:000364298400082
J	Zappasodi, F; Marzetti, L; Olejarczyk, E; Tecchio, F; Pizzella, V				Zappasodi, Filippo; Marzetti, Laura; Olejarczyk, Elzbieta; Tecchio, Franca; Pizzella, Vittorio			Age-Related Changes in Electroencephalographic Signal Complexity	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; CLINICAL NEUROPHYSIOLOGY; HEMISPHERIC-ASYMMETRY; SENSORIMOTOR CORTEX; QUANTITATIVE EEG; BRAIN; HEALTHY; SYNCHRONIZATION; COHERENCE; ADULTS	The study of active and healthy aging is a primary focus for social and neuroscientific communities. Here, we move a step forward in assessing electrophysiological neuronal activity changes in the brain with healthy aging. To this end, electroencephalographic (EEG) resting state activity was acquired in 40 healthy subjects (age 16-85). We evaluated Fractal Dimension (FD) according to the Higuchi algorithm, a measure which quantifies the presence of statistical similarity at different scales in temporal fluctuations of EEG signals. Our results showed that FD increases from age twenty to age fifty and then decreases. The curve that best fits the changes in FD values across age over the whole sample is a parabola, with the vertex located around age fifty. Moreover, FD changes are site specific, with interhemispheric FD asymmetry being pronounced in elderly individuals in the frontal and central regions. The present results indicate that fractal dimension well describes the modulations of brain activity with age. Since fractal dimension has been proposed to be related to the complexity of the signal dynamics, our data demonstrate that the complexity of neuronal electric activity changes across the life span of an individual, with a steady increase during young adulthood and a decrease in the elderly population.	[Zappasodi, Filippo; Marzetti, Laura; Pizzella, Vittorio] Univ G DAnnunzio, Dept Neurosci Imaging & Clin Sci, Chieti, Italy; [Zappasodi, Filippo; Marzetti, Laura; Pizzella, Vittorio] Univ G DAnnunzio, Inst Adv Biomed Technol, Chieti, Italy; [Olejarczyk, Elzbieta] Polish Acad Sci, Nalecz Inst Biocybernet & Biomed Engn, Warsaw, Poland; [Tecchio, Franca] Natl Res Council CNR, ISTC, LETS, Rome, Italy; [Tecchio, Franca] IRCCS San Raffale Pisana, Unit Imaging, Cassino, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; Polish Academy of Sciences; Nalecz Institute of Biocybernetics & Biomedical Engineering of the Polish Academy of Sciences; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR); IRCCS San Raffaele Pisana	Zappasodi, F (corresponding author), Univ G DAnnunzio, Dept Neurosci Imaging & Clin Sci, Chieti, Italy.	f.zappasodi@unich.it	Marzetti, Laura/ABC-9763-2021; Olejarczyk, Elzbieta/ABG-5529-2020; Marzetti, Laura/AAA-4231-2020; Zappasodi, Filippo/AAL-4717-2020; Marzetti, Laura/Q-2909-2016; Zappasodi, Filippo/AAC-2414-2022; tecchio, franca/AAX-2770-2020	Marzetti, Laura/0000-0002-6481-3743; Marzetti, Laura/0000-0002-6481-3743; tecchio, franca/0000-0002-1325-5059; Olejarczyk, Elzbieta/0000-0002-6821-350X	Italian Ministry of Health Cod. [GR-2008-1138642]	Italian Ministry of Health Cod.	Funding for this work came from the Italian Ministry of Health Cod. GR-2008-1138642. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accardo A, 1997, BIOL CYBERN, V77, P339, DOI 10.1007/s004220050394; Anokhin AP, 1996, ELECTROEN CLIN NEURO, V99, P63, DOI 10.1016/0921-884X(96)95573-3; Assenza G, 2013, RESTOR NEUROL NEUROS, V31, P177, DOI 10.3233/RNN-120244; Babiloni C, 2006, HUM BRAIN MAPP, V27, P162, DOI 10.1002/hbm.20175; Backman L, 2006, NEUROSCI BIOBEHAV R, V30, P791, DOI 10.1016/j.neubiorev.2006.06.005; Baker SN, 2007, CURR OPIN NEUROBIOL, V17, P649, DOI 10.1016/j.conb.2008.01.007; Barbati G, 2004, CLIN NEUROPHYSIOL, V115, P1220, DOI 10.1016/j.clinph.2003.12.015; Blais M, 2014, BEHAV BRAIN RES, V275, P34, DOI 10.1016/j.bbr.2014.08.043; BRENNER RP, 1995, ELECTROEN CLIN NEURO, V94, P1, DOI 10.1016/0013-4694(94)00234-C; Buzsaki G, 2014, NAT REV NEUROSCI, V15, P264, DOI 10.1038/nrn3687; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Chakarov V, 2009, J NEUROPHYSIOL, V102, P1115, DOI 10.1152/jn.91095.2008; Chiang AKI, 2011, CLIN NEUROPHYSIOL, V122, P1505, DOI 10.1016/j.clinph.2011.01.040; CHRISTIAN W, 1984, NERVENARZT, V55, P517; Cottone C, 2013, BRAIN TOPOGR, V26, P186, DOI 10.1007/s10548-012-0240-3; Crone NE, 1998, BRAIN, V121, P2301, DOI 10.1093/brain/121.12.2301; Di Ieva A, 2015, NEUROSCIENTIST, V21, P30, DOI 10.1177/1073858413513928; Di Ieva A, 2014, NEUROSCIENTIST, V20, P403, DOI 10.1177/1073858413513927; DUFFY FH, 1993, NEUROBIOL AGING, V14, P73, DOI 10.1016/0197-4580(93)90025-7; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Escudero J, 2006, PHYSIOL MEAS, V27, P1091, DOI 10.1088/0967-3334/27/11/004; Eyler LT, 2011, BIOL PSYCHIAT, V70, P115, DOI 10.1016/j.biopsych.2010.12.032; Ferenets R, 2006, IEEE T BIO-MED ENG, V53, P1067, DOI 10.1109/TBME.2006.873543; Gaal ZA, 2010, NEUROSCI LETT, V479, P79, DOI 10.1016/j.neulet.2010.05.037; Garrett DD, 2013, NEUROSCI BIOBEHAV R, V37, P610, DOI 10.1016/j.neubiorev.2013.02.015; GIAQUINTO S, 1986, ELECTROEN CLIN NEURO, V63, P540, DOI 10.1016/0013-4694(86)90141-0; Goldberger AL, 2002, NEUROBIOL AGING, V23, P23, DOI 10.1016/S0197-4580(01)00266-4; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; Grady CL, 2014, BRAIN IMAGING BEHAV, V8, P274, DOI 10.1007/s11682-013-9253-0; Grady CL, 2010, CEREB CORTEX, V20, P1432, DOI 10.1093/cercor/bhp207; Graziadio S, 2012, EXP NEUROL, V238, P168, DOI 10.1016/j.expneurol.2012.08.031; HIGUCHI T, 1988, PHYSICA D, V31, P277, DOI 10.1016/0167-2789(88)90081-4; Jerbi K, 2007, P NATL ACAD SCI USA, V104, P7676, DOI 10.1073/pnas.0609632104; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Marzetti L, 2007, NEUROIMAGE, V36, P48, DOI 10.1016/j.neuroimage.2007.02.034; MATEJCEK M, 1980, Revue d'Electroencephalographie et de Neurophysiologie Clinique, V10, P122, DOI 10.1016/S0370-4475(80)80044-X; McGregor KM, 2011, BEHAV BRAIN RES, V222, P158, DOI 10.1016/j.bbr.2011.03.042; McIntosh AR, 2014, CEREB CORTEX, V24, P1806, DOI 10.1093/cercor/bht030; Meador KJ, 2002, NEUROLOGY, V59, P847, DOI 10.1212/WNL.59.6.847; Milstein J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004338; Mizuno T, 2010, CLIN NEUROPHYSIOL, V121, P1438, DOI 10.1016/j.clinph.2010.03.025; NETZ J, 1995, EXP BRAIN RES, V104, P527; Niedermeyer E, 2005, ELECTROENCEPHALOGRAP, P229; Notturno F, 2014, HUM BRAIN MAPP, V35, P2220, DOI 10.1002/hbm.22322; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pakkenberg B, 1997, J COMP NEUROL, V384, P312, DOI 10.1002/(SICI)1096-9861(19970728)384:2<312::AID-CNE10>3.0.CO;2-K; Palva S, 2005, J NEUROSCI, V25, P5248, DOI 10.1523/JNEUROSCI.0141-05.2005; Pellegrino G, 2012, RESTOR NEUROL NEUROS, V30, P497, DOI 10.3233/RNN-2012-120227; Pfurtscheller G, 1996, ELECTROEN CLIN NEURO, V98, P281, DOI 10.1016/0013-4694(95)00258-8; Pierce TW, 2000, BRAIN TOPOGR, V13, P127, DOI 10.1023/A:1026659102713; Pizzella V, 2014, FUNCT NEUROL, V29, P241, DOI 10.11138/FNeur/2014.29.4.241; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Robertson IH, 2014, NEUROBIOL AGING, V35, P1375, DOI 10.1016/j.neurobiolaging.2013.11.028; Rossini PM, 2007, PROG NEUROBIOL, V83, P375, DOI 10.1016/j.pneurobio.2007.07.010; Rossini PM, 2013, CURR PHARM DESIGN, V19, P6426, DOI 10.2174/1381612811319360004; Schoffelen JM, 2005, SCIENCE, V308, P111, DOI 10.1126/science.1107027; SCHREITERGASSER U, 1993, ELECTROEN CLIN NEURO, V86, P15, DOI 10.1016/0013-4694(93)90063-2; Stam CJ, 2005, CLIN NEUROPHYSIOL, V116, P2266, DOI 10.1016/j.clinph.2005.06.011; Stam CJ, 2002, J CLIN NEUROPHYSIOL, V19, P562, DOI 10.1097/00004691-200212000-00010; STAM CJ, 1995, ELECTROEN CLIN NEURO, V95, P309, DOI 10.1016/0013-4694(95)00147-Q; Sullivan EV, 2010, NEUROBIOL AGING, V31, P464, DOI 10.1016/j.neurobiolaging.2008.04.007; Talelli P, 2008, NEUROIMAGE, V40, P1772, DOI 10.1016/j.neuroimage.2008.01.039; TallonBaudry C, 1997, J NEUROSCI, V17, P722; Tecchio F, 2008, NEUROIMAGE, V40, P256, DOI 10.1016/j.neuroimage.2007.11.038; Tecchio F, 2007, NEUROIMAGE, V35, P185, DOI 10.1016/j.neuroimage.2006.12.002; Tononi G, 1998, TRENDS COGN SCI, V2, P474, DOI 10.1016/S1364-6613(98)01259-5; van den Berg FE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017742; WANG HS, 1969, J GERONTOL, V24, P419, DOI 10.1093/geronj/24.4.419; Weiss B, 2011, BRAIN RES BULL, V84, P359, DOI 10.1016/j.brainresbull.2010.12.005; Womelsdorf T, 2006, NAT NEUROSCI, V9, P1156, DOI 10.1038/nn1748; WU X, 1993, CLIN ELECTROENCEPHAL, V24, P127, DOI 10.1177/155005949302400311; Yao DZ, 2001, PHYSIOL MEAS, V22, P693, DOI 10.1088/0967-3334/22/4/305; Yuval-Greenberg S, 2007, J NEUROSCI, V27, P1090, DOI 10.1523/JNEUROSCI.4828-06.2007; Zappasodi F, 2006, CLIN NEUROPHYSIOL, V117, P1518, DOI 10.1016/j.clinph.2006.03.016; Zappasodi F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100199	75	54	56	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141995	10.1371/journal.pone.0141995	http://dx.doi.org/10.1371/journal.pone.0141995			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536036	Green Published, gold, Green Submitted			2022-12-26	WOS:000364298400114
J	An, HY; Shin, HS; Choi, JS; Kim, HJ; Lim, JY; Kim, YM				An, Hye-Young; Shin, Hyun-Soo; Choi, Jeong-Seok; Kim, Hun Jung; Lim, Jae-Yol; Kim, Young-Mo			Adipose Mesenchymal Stem Cell Secretome Modulated in Hypoxia for Remodeling of Radiation-Induced Salivary Gland Damage	PLOS ONE			English	Article							PARACRINE MECHANISMS; STROMAL CELLS; INJURY; HEAD; NECK; TRANSPLANTATION; XEROSTOMIA; CANCER; PROLIFERATION; HYPOFUNCTION	Background and Purpose This study was conducted to determine whether a secretome from mesenchymal stem cells (MSC) modulated by hypoxic conditions to contain therapeutic factors contributes to salivary gland (SG) tissue remodeling and has the potential to improve irradiation (IR)-induced salivary hypofunction in a mouse model. Materials and Methods Human adipose mesenchymal stem cells (hAdMSC) were isolated, expanded, and exposed to hypoxic conditions (O-2 < 5%). The hypoxia-conditioned medium was then filtered to a high molecular weight fraction and prepared as a hAdMSC secretome. The hAdMSC secretome was subsequently infused into the tail vein of C3H mice immediately after local IR once a day for seven consecutive days. The control group received equal volume (500 mu L) of vehicle (PBS) only. SG function and structural tissue remodeling by the hAdMSC secretome were investigated. Human parotid epithelial cells (HPEC) were obtained, expanded in vitro, and then irradiated and treated with either the hypoxia-conditioned medium or a normoxic control medium. Cell proliferation and IR-induced cell death were examined to determine the mechanism by which the hAdMSC secretome exerted its effects. Results The conditioned hAdMSC secretome contained high levels of GM-CSF, VEGF, IL-6, and IGF-1. Repeated systemic infusion with the hAdMSC secretome resulted in improved salivation capacity and increased levels of salivary proteins, including amylase and EGF, relative to the PBS group. The microscopic structural integrity of SG was maintained and salivary epithelial (AQP-5), endothelial (CD31), myoepithelial (alpha-SMA) and SG progenitor cells (c-Kit) were successfully protected from radiation damage and remodeled. The hAdMSC secretome strongly induced proliferation of HPEC and led to a significant decrease in cell death in vivo and in vitro. Moreover, the anti-apoptotic effects of the hAdMSC secretome were found to be promoted after hypoxia-preconditioning relative to normoxia-cultured hAdMSC secretome. Conclusion These results show that the hAdMSC secretome from hypoxic-conditioned medium may provide radioprotection and tissue remodeling via release of paracrine mediators.	[An, Hye-Young; Shin, Hyun-Soo; Choi, Jeong-Seok; Lim, Jae-Yol; Kim, Young-Mo] Inha Univ, Dept Otorhinolaryngol Head & Neck Surg, Inchon, South Korea; [An, Hye-Young; Shin, Hyun-Soo; Choi, Jeong-Seok; Lim, Jae-Yol; Kim, Young-Mo] Inha Univ, Translat Res Ctr, Coll Med, Inchon, South Korea; [Kim, Hun Jung] Inha Univ, Coll Med, Dept Radiat Oncol, Inchon, South Korea	Inha University; Inha University; Inha University	Lim, JY (corresponding author), Inha Univ, Dept Otorhinolaryngol Head & Neck Surg, Inchon, South Korea.	jylim@inha.ac.kr; ymk416@inha.ac.kr	Kim, Ji-Youn/A-5779-2017	im, jaeyeol/0000-0002-9757-6414	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning [2012R1A1A2006712, 2015R1A2A2A01006528]; Inha Research Grant	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning; Inha Research Grant	This work was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and future Planning (2012R1A1A2006712 and 2015R1A2A2A01006528), and an Inha Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal MR, 2010, ANTIOXID REDOX SIGN, V12, P693, DOI 10.1089/ars.2009.2755; Azzam EI, 2012, CANCER LETT, V327, P48, DOI 10.1016/j.canlet.2011.12.012; Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; Dirix P, 2006, CANCER-AM CANCER SOC, V107, P2525, DOI 10.1002/cncr.22302; FRANZEN L, 1992, EUR J CANCER, V28A, P457, DOI 10.1016/S0959-8049(05)80076-0; Gao ZM, 2012, CYTOTHERAPY, V14, P267, DOI 10.3109/14653249.2011.616194; Jensen SB, 2010, SUPPORT CARE CANCER, V18, P1039, DOI 10.1007/s00520-010-0827-8; Jensen SB, 2010, SUPPORT CARE CANCER, V18, P1061, DOI 10.1007/s00520-010-0837-6; Jeong D, 2014, BIOMATERIALS, V35, P9302, DOI 10.1016/j.biomaterials.2014.07.047; Kamota T, 2009, J AM COLL CARDIOL, V53, P1814, DOI 10.1016/j.jacc.2009.02.015; Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC; Kojima T, 2011, LARYNGOSCOPE, V121, P1864, DOI 10.1002/lary.22080; Konings AWT, 2005, INT J RADIAT ONCOL, V62, P1187, DOI 10.1016/j.ijrobp.2004.12.051; Lee RH, 2011, J CELL BIOCHEM, V112, P3073, DOI 10.1002/jcb.23250; Lim JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071167; Lim JY, 2013, ORAL ONCOL, V49, P136, DOI 10.1016/j.oraloncology.2012.08.010; Lin CY, 2011, J DENT RES, V90, P341, DOI 10.1177/0022034510386374; Lombaert IMA, 2006, CLIN CANCER RES, V12, P1804, DOI 10.1158/1078-0432.CCR-05-2381; Lombaert IMA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002063; Maumus M, 2013, BIOCHIMIE, V95, P2229, DOI 10.1016/j.biochi.2013.04.017; Miah AB, 2013, RADIOTHER ONCOL, V106, P346, DOI 10.1016/j.radonc.2013.03.006; Nanduri LSY, 2013, RADIOTHER ONCOL, V108, P458, DOI 10.1016/j.radonc.2013.05.020; Ra JC, 2011, STEM CELLS DEV, V20, P1297, DOI 10.1089/scd.2010.0466; Sasportas LS, 2013, COST EFFECTIVENESS L; Sumita Y, 2011, INT J BIOCHEM CELL B, V43, P80, DOI 10.1016/j.biocel.2010.09.023; Tran SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061632; Vissink A, 2003, CRIT REV ORAL BIOL M, V14, P199, DOI 10.1177/154411130301400305; Vissink A, 2014, ORAL DIS; Weil BR, 2009, SURGERY, V146, P190, DOI 10.1016/j.surg.2009.03.031	29	41	42	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141862	10.1371/journal.pone.0141862	http://dx.doi.org/10.1371/journal.pone.0141862			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529411	Green Published, gold, Green Submitted			2022-12-26	WOS:000364032600072
J	Dancy, BCR; Chen, SW; Drechsler, R; Gafken, PR; Olsen, CP				Dancy, Blair C. R.; Chen, Shaw-Wen; Drechsler, Robin; Gafken, Philip R.; Olsen, Carissa Perez			C-13- and N-15-Labeling Strategies Combined with Mass Spectrometry Comprehensively Quantify Phospholipid Dynamics in C-elegans	PLOS ONE			English	Article							FATTY-ACID; STEAROYL-COENZYME; LC-MS; MEMBRANE; LIPIDS; DESATURASE-1; LIPOGENESIS; DISSECTION; METABOLISM; MECHANISMS	Membranes define cellular and organelle boundaries, a function that is critical to all living systems. Like other biomolecules, membrane lipids are dynamically maintained, but current methods are extremely limited for monitoring lipid dynamics in living animals. We developed novel strategies in C. elegans combining C-13 and N-15 stable isotopes with mass spectrometry to directly quantify the replenishment rates of the individual fatty acids and intact phospholipids of the membrane. Using multiple measurements of phospholipid dynamics, we found that the phospholipid pools are replaced rapidly and at rates nearly double the turnover measured for neutral lipid populations. In fact, our analysis shows that the majority of membrane lipids are replaced each day. Furthermore, we found that stearoyl-CoA desaturases (SCDs), critical enzymes in polyunsaturated fatty acid production, play an unexpected role in influencing the overall rates of membrane maintenance as SCD depletion affected the turnover of nearly all membrane lipids. Additionally, the compromised membrane maintenance as defined by LC-MS/MS with SCD RNAi resulted in active phospholipid remodeling that we predict is critical to alleviate the impact of reduced membrane maintenance in these animals. Not only have these combined methodologies identified new facets of the impact of SCDs on the membrane, but they also have great potential to reveal many undiscovered regulators of phospholipid metabolism.	[Dancy, Blair C. R.; Chen, Shaw-Wen; Drechsler, Robin; Olsen, Carissa Perez] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98104 USA; [Gafken, Philip R.] Fred Hutchinson Canc Res Ctr, Prote Facil, Seattle, WA 98104 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center	Olsen, CP (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1124 Columbia St, Seattle, WA 98104 USA.	cpolsen@fredhutch.org		Olsen, Carissa/0000-0003-1261-9364	Cancer Center Support Grant from the National Institutes of Health [P30CA015704]; National Institutes of Health Early Independence Award [5 DP5 OD009189]; NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD009189] Funding Source: NIH RePORTER	Cancer Center Support Grant from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Early Independence Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The Hutchinson Cancer Center's Proteomics Facility is partially funded by a Cancer Center Support Grant (P30CA015704) from the National Institutes of Health. CPO is supported by a National Institutes of Health Early Independence Award (5 DP5 OD009189). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bird SS, 2013, METABOLOMICS, V9, pS67, DOI 10.1007/s11306-012-0400-1; Bird SS, 2011, ANAL CHEM, V83, P6648, DOI 10.1021/ac201195d; Brock TJ, 2007, GENETICS, V176, P865, DOI 10.1534/genetics.107.071860; Castro C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-36; DAWIDOWICZ EA, 1987, ANNU REV BIOCHEM, V56, P43, DOI 10.1146/annurev.bi.56.070187.000355; Doria ML, 2014, FASEB J, V28, P4247, DOI 10.1096/fj.14-249672; Dowhan W, 1997, ANNU REV BIOCHEM, V66, P199, DOI 10.1146/annurev.biochem.66.1.199; FOLCH J, 1957, J BIOL CHEM, V226, P497; Greer ER, 2008, CELL METAB, V8, P118, DOI 10.1016/j.cmet.2008.06.005; Hartler J, 2011, BIOINFORMATICS, V27, P572, DOI 10.1093/bioinformatics/btq699; Holthuis JCM, 2014, NATURE, V510, P48, DOI 10.1038/nature13474; Igal RA, 2010, CARCINOGENESIS, V31, P1509, DOI 10.1093/carcin/bgq131; Kniazeva M, 2004, PLOS BIOL, V2, P1446, DOI 10.1371/journal.pbio.0020257; Lahiri S, 2015, CURR OPIN CELL BIOL, V33, P82, DOI 10.1016/j.ceb.2014.12.004; Ma DKK, 2015, CELL, V161, P1152, DOI 10.1016/j.cell.2015.04.026; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Merino DM, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-63; Miyazaki M, 2003, PROSTAG LEUKOTR ESS, V68, P113, DOI 10.1016/S0952-3278(02)00261-2; Mullaney BC, 2009, BBA-MOL CELL BIOL L, V1791, P474, DOI 10.1016/j.bbalip.2008.12.013; Murray P, 2007, P NATL ACAD SCI USA, V104, P5489, DOI 10.1073/pnas.0609590104; Ntambi JM, 2003, CURR OPIN LIPIDOL, V14, P255, DOI 10.1097/00041433-200306000-00005; Paton CM, 2009, AM J PHYSIOL-ENDOC M, V297, pE28, DOI 10.1152/ajpendo.90897.2008; Peetla C, 2010, MOL PHARMACEUT, V7, P2334, DOI 10.1021/mp100308n; Perez CL, 2008, CELL METAB, V8, P266, DOI 10.1016/j.cmet.2008.08.007; Phillips R, 2009, NATURE, V459, P379, DOI 10.1038/nature08147; Pino EC, 2013, JOVE-J VIS EXP, DOI 10.3791/50180; Ratnappan R, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004829; SATOUCHI K, 1993, LIPIDS, V28, P837, DOI 10.1007/BF02536239; Savory FR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024550; Shi X, 2013, J LIPID RES, V54, P2504, DOI 10.1194/jlr.M039669; SLEIGHT RG, 1987, ANNU REV PHYSIOL, V49, P193; Taubert S, 2006, GENE DEV, V20, P1137, DOI 10.1101/gad.1395406; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Walker AK, 2011, CELL, V147, P840, DOI 10.1016/j.cell.2011.09.045; Watts JL, 2009, TRENDS ENDOCRIN MET, V20, P58, DOI 10.1016/j.tem.2008.11.002; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799; Yang XG, 2010, MOL NEUROBIOL, V41, P138, DOI 10.1007/s12035-010-8121-9; Zhang ZH, 2014, J MED CHEM, V57, P5039, DOI 10.1021/jm401516c	38	26	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141850	10.1371/journal.pone.0141850	http://dx.doi.org/10.1371/journal.pone.0141850			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528916	Green Published, gold, Green Submitted			2022-12-26	WOS:000364032600068
J	Hussey, EK; Ward, N; Christianson, K; Kramer, AF				Hussey, Erika K.; Ward, Nathan; Christianson, Kiel; Kramer, Arthur F.			Language and Memory Improvements following tDCS of Left Lateral Prefrontal Cortex	PLOS ONE			English	Article							DIRECT-CURRENT STIMULATION; NONINVASIVE BRAIN-STIMULATION; GARDEN-PATH SENTENCES; LATENT-VARIABLE ANALYSIS; WORKING-MEMORY; COGNITIVE CONTROL; MOTOR CORTEX; BROCAS AREA; ELECTRICAL-STIMULATION; INTERFERENCE CONTROL	Recent research demonstrates that performance on executive-control measures can be enhanced through brain stimulation of lateral prefrontal regions. Separate psycholinguistic work emphasizes the importance of left lateral prefrontal cortex executive-control resources during sentence processing, especially when readers must override early, incorrect interpretations when faced with temporary ambiguity. Using transcranial direct current stimulation, we tested whether stimulation of left lateral prefrontal cortex had discriminate effects on language and memory conditions that rely on executive-control (versus cases with minimal executive-control demands, even in the face of task difficulty). Participants were randomly assigned to receive Anodal, Cathodal, or Sham stimulation of left lateral prefrontal cortex while they (1) processed ambiguous and unambiguous sentences in a word-by-word self-paced reading task and (2) performed an n-back memory task that, on some trials, contained interference lure items reputed to require executive-control. Across both tasks, we parametrically manipulated executive-control demands and task difficulty. Our results revealed that the Anodal group outperformed the remaining groups on (1) the sentence processing conditions requiring executive-control, and (2) only the most complex n-back conditions, regardless of executive-control demands. Together, these findings add to the mounting evidence for the selective causal role of left lateral prefrontal cortex for executive-control tasks in the language domain. Moreover, we provide the first evidence suggesting that brain stimulation is a promising method to mitigate processing demands encountered during online sentence processing.	[Hussey, Erika K.; Kramer, Arthur F.] Univ Illinois, Dept Psychol, Champaign, IL 61801 USA; [Christianson, Kiel] Univ Illinois, Dept Educ Psychol, Champaign, IL USA; [Hussey, Erika K.; Ward, Nathan; Christianson, Kiel; Kramer, Arthur F.] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Hussey, EK (corresponding author), Univ Illinois, Dept Psychol, Champaign, IL 61801 USA.	ehussey@illinois.edu	Ward, Nathan/AAB-5713-2021; Kramer, Arthur/AAB-2937-2019	Kramer, Arthur/0000-0001-5870-2724	National Institutes of Health [T32-HD055272]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD055272] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by a National Institutes of Health Training Grant T32-HD055272 (PI: Sarah Brown-Schmidt) to EH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann GTM, 1999, COGNITION, V73, P247, DOI 10.1016/S0010-0277(99)00059-1; Antal A, 2008, PERCEPTION, V37, P367, DOI 10.1068/p5872; Badre D, 2005, NEURON, V47, P907, DOI 10.1016/j.neuron.2005.07.023; Badre D, 2007, NEUROPSYCHOLOGIA, V45, P2883, DOI 10.1016/j.neuropsychologia.2007.06.015; Baker JM, 2010, STROKE, V41, P1229, DOI 10.1161/STROKEAHA.109.576785; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bartolotti J, 2012, COGNITIVE SCI, V36, P1129, DOI 10.1111/j.1551-6709.2012.01243.x; Berryhill ME, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00800; Bestmann S, 2015, TRENDS COGN SCI, V19, P13, DOI 10.1016/j.tics.2014.10.003; Bialystok E., 2001, BILINGUALISM DEV LAN, DOI [10.1017/CBO9780511605963, DOI 10.1017/CBO9780511605963]; Bikson M, 2010, CLIN NEUROPHYSIOL, V121, P1976, DOI 10.1016/j.clinph.2010.05.020; Bikson M, 2012, BRAIN STIMUL, V5, P430, DOI 10.1016/j.brs.2011.06.001; Blank I, 2014, J NEUROPHYSIOL, V112, P1105, DOI 10.1152/jn.00884.2013; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brunoni AR, 2014, BRAIN COGNITION, V86, P1, DOI 10.1016/j.bandc.2014.01.008; Capone F, 2014, NEUROBIOL LEARN MEM, V114, P51, DOI 10.1016/j.nlm.2014.04.013; Cappelletti M, 2013, J NEUROSCI, V33, P14899, DOI 10.1523/JNEUROSCI.1692-13.2013; Cattaneo Z, 2011, NEUROSCIENCE, V183, P64, DOI 10.1016/j.neuroscience.2011.03.058; Cerruti C, 2009, J COGNITIVE NEUROSCI, V21, P1980, DOI 10.1162/jocn.2008.21143; Christianson K, 2001, COGNITIVE PSYCHOL, V42, P368, DOI 10.1006/cogp.2001.0752; Christianson K, 2006, DISCOURSE PROCESS, V42, P205, DOI 10.1207/s15326950dp4202_6; Clifton C, 2003, J MEM LANG, V49, P317, DOI 10.1016/S0749-596X(03)00070-6; Coffman BA, 2014, NEUROIMAGE, V85, P895, DOI 10.1016/j.neuroimage.2013.07.083; Cole MW, 2012, J NEUROSCI, V32, P8988, DOI 10.1523/JNEUROSCI.0536-12.2012; D'Esposito M, 1999, NEUROPSYCHOLOGIA, V37, P1303, DOI 10.1016/S0028-3932(99)00021-4; Dahlin E, 2008, SCIENCE, V320, P1510, DOI 10.1126/science.1155466; Datta Abhishek, 2012, Front Psychiatry, V3, P91, DOI 10.3389/fpsyt.2012.00091; de Vries MH, 2010, J COGNITIVE NEUROSCI, V22, P2427, DOI 10.1162/jocn.2009.21385; Ditye T, 2012, EXP BRAIN RES, V219, P363, DOI 10.1007/s00221-012-3098-4; Dockery CA, 2009, J NEUROSCI, V29, P7271, DOI 10.1523/JNEUROSCI.0065-09.2009; Duncan J, 2010, TRENDS COGN SCI, V14, P172, DOI 10.1016/j.tics.2010.01.004; Edwards D, 2013, NEUROIMAGE, V74, P266, DOI 10.1016/j.neuroimage.2013.01.042; Elmasry J, 2015, RESTOR NEUROL NEUROS, V33, P263, DOI 10.3233/RNN-140473; Enders CK, 2007, PSYCHOL METHODS, V12, P121, DOI 10.1037/1082-989X.12.2.121; Farmer T.A., 2012, CAMBRIDGE HDB PSYCHO, P353, DOI 10.1017/CBO9781139029377.018; Fedorenko E, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00335; Fedorenko E, 2014, TRENDS COGN SCI, V18, P120, DOI 10.1016/j.tics.2013.12.006; Fedorenko E, 2013, COGNITIVE SCI, V37, P378, DOI 10.1111/cogs.12021; Fedorenko E, 2012, CURR BIOL, V22, P2059, DOI 10.1016/j.cub.2012.09.011; FERREIRA F, 1986, J MEM LANG, V25, P348, DOI 10.1016/0749-596X(86)90006-9; Ferreira F, 2001, J PSYCHOLINGUIST RES, V30, P3, DOI 10.1023/A:1005290706460; Fertonani A, 2010, BEHAV BRAIN RES, V208, P311, DOI 10.1016/j.bbr.2009.10.030; Fiori V, 2011, J COGNITIVE NEUROSCI, V23, P2309, DOI 10.1162/jocn.2010.21579; Fregni F, 2005, EXP BRAIN RES, V166, P23, DOI 10.1007/s00221-005-2334-6; Friedman NP, 2004, J EXP PSYCHOL GEN, V133, P101, DOI 10.1037/0096-3445.133.1.101; Fritsch B, 2010, NEURON, V66, P198, DOI 10.1016/j.neuron.2010.03.035; Gandiga PC, 2006, CLIN NEUROPHYSIOL, V117, P845, DOI 10.1016/j.clinph.2005.12.003; Gladwin TE, 2012, NEUROSCI LETT, V512, P33, DOI 10.1016/j.neulet.2012.01.056; Gray JR, 2003, NAT NEUROSCI, V6, P316, DOI 10.1038/nn1014; Hagoort P, 2014, CURR OPIN NEUROBIOL, V28, P136, DOI 10.1016/j.conb.2014.07.013; Hamilton AC, 2005, COGN AFFECT BEHAV NE, V5, P1; Hamilton RH, 2011, BRAIN LANG, V118, P40, DOI 10.1016/j.bandl.2011.02.005; Harty S, 2014, J NEUROSCI, V34, P3646, DOI 10.1523/JNEUROSCI.5308-13.2014; Herwig U, 2003, BRAIN TOPOGR, V16, P95, DOI 10.1023/B:BRAT.0000006333.93597.9d; Holland R, 2012, APHASIOLOGY, V26, P1169, DOI 10.1080/02687038.2011.616925; Holland R, 2011, CURR BIOL, V21, P1403, DOI 10.1016/j.cub.2011.07.021; Horvath JC, 2015, NEUROPSYCHOLOGIA, V66, P213, DOI 10.1016/j.neuropsychologia.2014.11.021; Hussey EK, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00158; Iyer MB, 2005, NEUROLOGY, V64, P872, DOI 10.1212/01.WNL.0000152986.07469.E9; Jacobson L, 2012, EXP BRAIN RES, V216, P1, DOI 10.1007/s00221-011-2891-9; Jacobson L, 2011, J COGNITIVE NEUROSCI, V23, P3380, DOI 10.1162/jocn_a_00020; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Janacsek K, 2015, BRAIN STIMUL, V8, P277, DOI 10.1016/j.brs.2014.11.008; January D, 2009, J COGNITIVE NEUROSCI, V21, P2434, DOI 10.1162/jocn.2008.21179; Javadi AH, 2012, BRAIN STIMUL, V5, P468, DOI 10.1016/j.brs.2011.08.003; Javadi AH, 2012, BRAIN STIMUL, V5, P231, DOI 10.1016/j.brs.2011.06.007; Jeon SY, 2012, ANN REHABIL MED-ARM, V36, P585, DOI 10.5535/arm.2012.36.5.585; Jones KT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121904; Jonides J, 2006, NEUROSCIENCE, V139, P181, DOI 10.1016/j.neuroscience.2005.06.042; Jung YJ, 2013, BIOMED ENG LETT, V3, P39, DOI 10.1007/s13534-013-0087-x; JUST MA, 1982, J EXP PSYCHOL GEN, V111, P228, DOI 10.1037/0096-3445.111.2.228; Kan IP, 2004, COGN AFFECT BEHAV NE, V4, P43, DOI 10.3758/CABN.4.1.43; Kane MJ, 2007, J EXP PSYCHOL LEARN, V33, P615, DOI 10.1037/0278-7393.33.3.615; Kane MJ, 2000, J EXP PSYCHOL LEARN, V26, P336, DOI 10.1037//0278-7393.26.2.336; Keeser D, 2011, J NEUROSCI, V31, P15284, DOI 10.1523/JNEUROSCI.0542-11.2011; Kim JH, 2014, NEUROSCI LETT, V564, P6, DOI 10.1016/j.neulet.2014.01.054; Kincses TZ, 2004, NEUROPSYCHOLOGIA, V42, P113, DOI 10.1016/S0028-3932(03)00124-6; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Kuo HI, 2013, BRAIN STIMUL, V6, P644, DOI 10.1016/j.brs.2012.09.010; Kuperberg GR, 2007, BRAIN RES, V1146, P23, DOI 10.1016/j.brainres.2006.12.063; Lewis RL, 2005, COGNITIVE SCI, V29, P375, DOI 10.1207/s15516709cog0000_25; Linck JA, 2012, BILING-LANG COGN, V15, P651, DOI 10.1017/S136672891100054X; Lopez-Alonso V, 2014, BRAIN STIMUL, V7, P372, DOI 10.1016/j.brs.2014.02.004; Martin DM, 2014, EXP BRAIN RES, V232, P3345, DOI 10.1007/s00221-014-4022-x; Mason RA, 2003, J EXP PSYCHOL LEARN, V29, P1319, DOI 10.1037/0278-7393.29.6.1319; McKinley RA, 2013, BEHAV NEUROSCI, V127, P936, DOI 10.1037/a0034975; Meinzer M, 2014, CORTEX, V50, P137, DOI 10.1016/j.cortex.2013.07.013; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Minhas P, 2011, CLIN NEUROPHYSIOL, V122, P637, DOI 10.1016/j.clinph.2010.09.023; Miranda PC, 2006, CLIN NEUROPHYSIOL, V117, P1623, DOI 10.1016/j.clinph.2006.04.009; Mirman D., 2014, MINDING THE BRAIN; Mirman D., 2013, MINDING THE BRAIN; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Monti A, 2008, J NEUROL NEUROSUR PS, V79, P451, DOI 10.1136/jnnp.2007.135277; Monti A, 2013, J NEUROL NEUROSUR PS, V84, P832, DOI 10.1136/jnnp-2012-302825; Nelson JK, 2003, P NATL ACAD SCI USA, V100, P11171, DOI 10.1073/pnas.1334125100; Nitsche MA, 2007, J NEUROPHYSIOL, V97, P3109, DOI 10.1152/jn.01312.2006; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Norman D. A., 1986, CONSCIOUSNESS SELF R, V4, P1; Novick JM, 2014, LANG COGN NEUROSCI, V29, P186, DOI 10.1080/01690965.2012.758297; Novick JM, 2010, LANG LINGUIST COMPAS, V4, P906, DOI 10.1111/j.1749-818x.2010.00244.x; Novick JM, 2009, COGN NEUROPSYCHOL, V26, P527, DOI 10.1080/02643290903519367; Novick JM, 2005, COGN AFFECT BEHAV NE, V5, P263, DOI 10.3758/CABN.5.3.263; Nozari N, 2014, BRAIN STIMUL, V7, P784, DOI 10.1016/j.brs.2014.07.035; Nozari N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084338; Nozari N, 2013, NEUROPSYCHOLOGIA, V51, P2770, DOI 10.1016/j.neuropsychologia.2013.08.019; Oberauer K, 2005, J EXP PSYCHOL GEN, V134, P368, DOI 10.1037/0096-3445.134.3.368; Oelhafen S, 2013, NEUROPSYCHOLOGIA, V51, P2781, DOI 10.1016/j.neuropsychologia.2013.08.012; Ohn SH, 2008, NEUROREPORT, V19, P43, DOI 10.1097/WNR.0b013e3282f2adfd; Oliveira JF, 2013, NEUROSCI LETT, V537, P60, DOI 10.1016/j.neulet.2013.01.023; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Pereira JB, 2013, BRAIN STIMUL, V6, P16, DOI 10.1016/j.brs.2012.01.006; Perry LK, 2014, BRAIN LANG, V135, P66, DOI 10.1016/j.bandl.2014.05.005; Persson J, 2013, J COGNITIVE NEUROSCI, V25, P338, DOI 10.1162/jocn_a_00321; Pirulli C, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00226; Pisoni A, 2015, NEUROPSYCHOLOGIA, V66, P267, DOI 10.1016/j.neuropsychologia.2014.11.025; Polania R, 2011, HUM BRAIN MAPP, V32, P1236, DOI 10.1002/hbm.21104; PURPURA DP, 1965, J NEUROPHYSIOL, V28, P166, DOI 10.1152/jn.1965.28.1.166; Richmond LL, 2014, J COGNITIVE NEUROSCI, V26, P2443, DOI 10.1162/jocn_a_00657; Robinson G, 1998, BRAIN, V121, P77, DOI 10.1093/brain/121.1.77; Ruffini G, 2014, NEUROIMAGE, V89, P216, DOI 10.1016/j.neuroimage.2013.12.002; Schlaug G, 2011, NEUROPSYCHOL REV, V21, P288, DOI 10.1007/s11065-011-9181-y; Schmiedek F, 2009, PSYCHOL AGING, V24, P203, DOI 10.1037/a0014685; Sela T, 2012, NEUROPSYCHOLOGIA, V50, P2271, DOI 10.1016/j.neuropsychologia.2012.05.031; Slattery TJ, 2013, J MEM LANG, V69, P104, DOI 10.1016/j.jml.2013.04.001; Sparing R, 2008, NEUROPSYCHOLOGIA, V46, P261, DOI 10.1016/j.neuropsychologia.2007.07.009; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; Sturt P, 2007, COGNITION, V105, P477, DOI 10.1016/j.cognition.2006.10.009; Suzuki K, 2012, INT J NEUROSCI, V122, P675, DOI 10.3109/00207454.2012.707715; Szmalec A, 2011, J EXP PSYCHOL HUMAN, V37, P137, DOI 10.1037/a0020365; Thompson-Schill SL, 1999, NEURON, V23, P513, DOI 10.1016/S0896-6273(00)80804-1; Thompson-Schill SL, 1997, P NATL ACAD SCI USA, V94, P14792, DOI 10.1073/pnas.94.26.14792; Thothathiri M, 2012, BRAIN LANG, V120, P259, DOI 10.1016/j.bandl.2011.12.004; Thothathiri M, 2012, J COGNITIVE NEUROSCI, V24, P212, DOI 10.1162/jocn_a_00118; Tremblay S, 2014, BRAIN STIMUL, V7, P773, DOI 10.1016/j.brs.2014.10.003; Truong DQ, 2013, NEUROIMAGE-CLIN, V2, P759, DOI 10.1016/j.nicl.2013.05.011; Tsuchida A, 2009, J COGNITIVE NEUROSCI, V21, P2263, DOI 10.1162/jocn.2008.21172; Turkeltaub PE, 2012, BRAIN STIMUL, V5, P201, DOI 10.1016/j.brs.2011.04.002; Utz KS, 2010, NEUROPSYCHOLOGIA, V48, P2789, DOI 10.1016/j.neuropsychologia.2010.06.002; Van Dyke JA, 2003, J MEM LANG, V49, P285, DOI 10.1016/S0749-596X(03)00081-0; Vosse T, 2000, COGNITION, V75, P105, DOI 10.1016/S0010-0277(00)00063-9; Vuong LC, 2014, FRONT PSYCHOL, DOI [10.3389/conf.fpsyg.2014.64.00044, DOI 10.3389/CONF.FPSYG.2014.64.00044]; Vuong LC, 2011, BRAIN LANG, V116, P22, DOI 10.1016/j.bandl.2010.09.012; Wagner T, 2007, NEUROIMAGE, V35, P1113, DOI 10.1016/j.neuroimage.2007.01.027; Wirth M, 2011, NEUROPSYCHOLOGIA, V49, P3989, DOI 10.1016/j.neuropsychologia.2011.10.015; Witzel N, 2012, J PSYCHOLINGUIST RES, V41, P105, DOI 10.1007/s10936-011-9179-x; Ye Z, 2008, BRAIN RES, V1203, P103, DOI 10.1016/j.brainres.2008.01.090; Ye Z, 2009, NEUROSCI BIOBEHAV R, V33, P1168, DOI 10.1016/j.neubiorev.2009.03.003; Ye Z, 2009, NEUROIMAGE, V48, P280, DOI 10.1016/j.neuroimage.2009.06.032; Zaehle T, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-2; Zwissler B, 2014, J NEUROSCI, V34, P4022, DOI 10.1523/JNEUROSCI.5407-13.2014	151	32	32	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141417	10.1371/journal.pone.0141417	http://dx.doi.org/10.1371/journal.pone.0141417			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528814	Green Submitted, gold, Green Published			2022-12-26	WOS:000364032600027
J	Legarrea, S; Barman, A; Marchant, W; Diffie, S; Srinivasan, R				Legarrea, Saioa; Barman, Apurba; Marchant, Wendy; Diffie, Stan; Srinivasan, Rajagopalbabu			Temporal Effects of a Begomovirus Infection and Host Plant Resistance on the Preference and Development of an Insect Vector, Bemisia tabaci, and Implications for Epidemics	PLOS ONE			English	Article							LEAF-CURL-VIRUS; YELLOW-DWARF-VIRUS; RHOPALOSIPHUM-PADI HOMOPTERA; MYZUS-PERSICAE HOMOPTERA; WHITEFLY VECTOR; NITROGEN AVAILABILITY; SOLANUM-SARRACHOIDES; UNTRANSFORMED WHEAT; HAIRY NIGHTSHADE; TOBACCO PLANTS	Persistent plant viruses, by altering phenotypic and physiological traits of their hosts, could modulate the host preference and fitness of hemipteran vectors. A majority of such modulations increase vector preference for virus-infected plants and improve vector fitness, ultimately favouring virus spread. Nevertheless, it remains unclear how these virus-induced modulations on vectors vary temporally, and whether host resistance to the pathogen influences such effects. This study addressed the two questions using a Begomovirus-whitefly-tomato model pathosystem. Tomato yellow leaf curl virus (TYLCV)-susceptible and TYLCV-resistant tomato genotypes were evaluated by whitefly-mediated transmission assays. Quantitative PCR revealed that virus accumulation decreased after an initial spike in all genotypes. TYLCV accumulation was less in resistant than in susceptible genotypes at 3, 6, and 12 weeks post inoculation (WPI). TYLCV acquisition by whiteflies over time from resistant and susceptible genotypes was also consistent with virus accumulation in the host plant. Furthermore, preference assays indicated that non-viruliferous whiteflies preferred virus-infected plants, whereas viruliferous whiteflies preferred non-infected plants. However, this effect was prominent only with the susceptible genotype at 6WPI. The development of whiteflies on non-infected susceptible and resistant genotypes was not significantly different. However, developmental time was reduced when a susceptible genotype was infected with TYLCV. Together, these results suggest that vector preference and development could be affected by the timing of infection and by host resistance. These effects could play a crucial role in TYLCV epidemics.	[Legarrea, Saioa; Barman, Apurba; Marchant, Wendy; Diffie, Stan; Srinivasan, Rajagopalbabu] Univ Georgia, Dept Entomol, Tifton, GA 31793 USA	University System of Georgia; University of Georgia	Srinivasan, R (corresponding author), Univ Georgia, Dept Entomol, Tifton, GA 31793 USA.	babusri@uga.edu	Barman, Apurba/D-9687-2011; legarrea, saioa/I-3963-2014	legarrea, saioa/0000-0002-9127-2794; Barman, Apurba K/0000-0001-8309-9998	Georgia Commodity Commission for Vegetables; United States Department of Agriculture Southern Region IPM Center	Georgia Commodity Commission for Vegetables; United States Department of Agriculture Southern Region IPM Center	Support was provided by Georgia Commodity Commission for Vegetables and the United States Department of Agriculture Southern Region IPM Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJAYI O, 1983, ANN APPL BIOL, V103, P1, DOI 10.1111/j.1744-7348.1983.tb02734.x; Diaz-Pendon JA, 2010, MOL PLANT PATHOL, V11, P441, DOI [10.1111/j.1364-3703.2010.00618.x, 10.1111/J.1364-3703.2010.00618.X]; Awmack CS, 2002, ANNU REV ENTOMOL, V47, P817, DOI 10.1146/annurev.ento.47.091201.145300; CASTLE SJ, 1993, ENTOMOL EXP APPL, V69, P51, DOI 10.1007/BF02380673; Castle SJ, 1998, ANN ENTOMOL SOC AM, V91, P661, DOI 10.1093/aesa/91.5.661; Czosnek H, 2002, ANN APPL BIOL, V140, P215, DOI 10.1111/j.1744-7348.2002.tb00175.x; Eigenbrode SD, 2002, P ROY SOC B-BIOL SCI, V269, P455, DOI 10.1098/rspb.2001.1909; Fang Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02876; Gorovits R, 2013, VIRUS RES, V171, P33, DOI 10.1016/j.virusres.2012.09.017; Guo JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011713; He WB, 2015, SCI REP-UK, V5, DOI 10.1038/srep07682; Hoffland E, 2000, J CHEM ECOL, V26, P2697, DOI 10.1023/A:1026477423988; Ingwell LL, 2012, SCI REP-UK, V2, DOI 10.1038/srep00578; Jahan SMH, 2014, J ASIA-PAC ENTOMOL, V17, P79, DOI 10.1016/j.aspen.2013.11.006; Jauset AM, 1998, ENTOMOL EXP APPL, V86, P175, DOI 10.1023/A:1003145813704; Jimenez-Martinez ES, 2004, ENVIRON ENTOMOL, V33, P1207, DOI 10.1603/0046-225X-33.5.1207; Jimenez-Martinez ES, 2004, J ECON ENTOMOL, V97, P203, DOI 10.1603/0022-0493-97.2.203; Jiu M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000182; Karley AJ, 2002, J EXP BIOL, V205, P3009; KENNEDY JS, 1951, NATURE, V168, P825, DOI 10.1038/168825a0; Kollenberg M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111968; Lapidot M, 2002, ANN APPL BIOL, V140, P109, DOI 10.1111/j.1744-7348.2002.tb00163.x; Lapidot M, 2001, PHYTOPATHOLOGY, V91, P1209, DOI 10.1094/PHYTO.2001.91.12.1209; Li M, 2011, INSECT SCI, V18, P40, DOI 10.1111/j.1744-7917.2010.01354.x; Liu BM, 2013, J VIROL, V87, P4929, DOI 10.1128/JVI.03571-12; Liu J, 2009, ANN APPL BIOL, V155, P439, DOI 10.1111/j.1744-7348.2009.00366.x; Liu J, 2010, J ZHEJIANG UNIV-SC B, V11, P30, DOI 10.1631/jzus.B0900213; Luan JB, 2014, B ENTOMOL RES, V104, P267, DOI 10.1017/S000748531400011X; Luan JB, 2013, ECOL LETT, V16, P390, DOI 10.1111/ele.12055; Maluta NKP, 2014, NEOTROP ENTOMOL, V43, P385, DOI 10.1007/s13744-014-0223-z; MARKKULA M., 1964, Annales Agriculturae Fenniae, V3, P265; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; Mauck K, 2012, FUNCT ECOL, V26, P1162, DOI 10.1111/j.1365-2435.2012.02026.x; MCELHANY P, 1995, ECOLOGY, V76, P444, DOI 10.2307/1941203; Moreno-Delafuente A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061543; Moriones E, 2000, VIRUS RES, V71, P123, DOI 10.1016/S0168-1702(00)00193-3; Muiiiz M., 2001, FAIR6CT984303 EUR WH; Pakkianathan BC, 2015, J VIROL, V89, P9791, DOI 10.1128/JVI.00779-15; Pan HP, 2013, SCI REP-UK, V3, DOI 10.1038/srep02230; Park Mi Kyung, 2009, Journal of Asia-Pacific Entomology, V12, P227, DOI 10.1016/j.aspen.2009.04.004; Polston JE, 1999, PLANT DIS, V83, P984, DOI 10.1094/PDIS.1999.83.4.397A; PONSEN M B, 1969, Netherlands Journal of Plant Pathology, V75, P360, DOI 10.1007/BF01975507; Rajabaskar D, 2014, VIRUS RES, V186, P32, DOI 10.1016/j.virusres.2013.11.005; Rotenberg D, 2009, PHYTOPATHOLOGY, V99, P404, DOI 10.1094/PHYTO-99-4-0404; Rubinstein G, 1997, J GEN VIROL, V78, P2683, DOI 10.1099/0022-1317-78-10-2683; Scholthof KBG, 2011, MOL PLANT PATHOL, V12, P938, DOI [10.1111/j.1364-3703.2011.00752.x, 10.1111/J.1364-3703.2011.00752.X]; Shi XB, 2014, SCI REP-UK, V4, DOI 10.1038/srep05230; Srininvasan R, 2006, ENVIRON ENTOMOL, V35, P546, DOI 10.1603/0046-225X-35.2.546; Srinivasan R, 2008, ENVIRON ENTOMOL, V37, P592, DOI 10.1603/0046-225X(2008)37[592:EOAAWH]2.0.CO;2; Srinivasan R, 2012, J ECON ENTOMOL, V105, P1447, DOI 10.1603/EC11402; Stout MJ, 1998, J CHEM ECOL, V24, P945, DOI 10.1023/A:1022350100718; Wang J, 2012, ENTOMOL EXP APPL, V144, P191, DOI 10.1111/j.1570-7458.2012.01278.x; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134	53	47	49	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0142114	10.1371/journal.pone.0142114	http://dx.doi.org/10.1371/journal.pone.0142114			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529402	Green Published, gold, Green Submitted			2022-12-26	WOS:000364032600102
J	Andrejevic, S; Korosec, P; Silar, M; Kosnik, M; Mijanovic, R; Bonaci-Nikolic, B; Rijavec, M				Andrejevic, Sladana; Korosec, Peter; Silar, Mira; Kosnik, Mitja; Mijanovic, Radovan; Bonaci-Nikolic, Branka; Rijavec, Matija			Hereditary Angioedema Due to C1 Inhibitor Deficiency in Serbia: Two Novel Mutations and Evidence of Genotype-Phenotype Association	PLOS ONE			English	Article							GENE; SPECTRUM; FAMILIES; SEQUENCE; PATIENT	Hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE) is a rare autosomal dominant disease characterized by recurrent life-threatening oedemas and/or abdominal pain and caused by mutations affecting the C1 inhibitor gene, SERPING1. We sought to investigate the spectrum of SERPING1 mutations in Serbia and the possible genotype-phenotype association. C1-INH-HAE was diagnosed on the basis of clinical and laboratory criteria in 40 patients from 27 families; four were asymptomatic. Mutational analysis of the SERPING1 gene was performed by sequencing and multiplex ligation-dependent probe amplification. Disease-causing mutations in SERPING1 were identified in all patients. In C1-INH-HAE type I, we identified 19 different mutations, including 6 missense mutations, 6 nonsense mutations, 2 small deletions, 1 small insertion, 2 splicing defects and 2 large deletions. Two of the mutations (c.300C>T and c.1184_1185insTA) are reported here for the first time. All C1-INH-HAE type II patients from three families harboured the same substitution (c.1396C>T). Based on the type of mutation identified in the SERPING1 gene, patients were divided into two groups: group 1 (nonsense, frameshift, large deletions/insertions, splicing defect, and mutations at Arg444) or group 2 (missense, excluding mutations at Arg444). Significant differences were found in the clinical severity score (P = 0.005), prevalence of laryngeal (P = 0.040) and facial (P = 0.013) oedema, and long-term prophylaxis (P = 0.023) between the groups with different types of mutations. Because our population consisted of related subjects, differences in the severity score between mutation groups were further confirmed using the generalized estimating equation (P = 0.038). Our study identified 20 different disease-causing mutations, including two novel mutations, in all C1-INH-HAE patients, highlighting the heterogeneity of mutations in the SERPING1 gene. Furthermore, it appears that mutations with a clear effect on C1-INH function might be responsible for a more severe disease phenotype.	[Andrejevic, Sladana; Mijanovic, Radovan; Bonaci-Nikolic, Branka] Clin Ctr Serbia, Clin Allergol & Immunol, Belgrade, Serbia; [Korosec, Peter; Silar, Mira; Kosnik, Mitja; Rijavec, Matija] Univ Clin Resp & Allerg Dis Golnik, Golnik, Slovenia	Clinical Centre of Serbia; University Clinic Golnik	Rijavec, M (corresponding author), Univ Clin Resp & Allerg Dis Golnik, Golnik, Slovenia.	matija.rijavec@klinika-golnik.si	Shaw, Heather/GQA-5799-2022; Košnik, Mitja/AAI-2295-2019; Ellis, David/A-8322-2011	Košnik, Mitja/0000-0002-4701-7374; Shaw, Heather/0000-0002-9157-7790; Ellis, David/0000-0001-6172-3323; Rijavec, Matija/0000-0002-2596-4952; Korosec, Peter/0000-0002-0835-1599; Bonaci-Nikolic, Branka/0000-0003-3014-4075				Agostoni A, 2004, J ALLERGY CLIN IMMUN, V114, pS51, DOI 10.1016/j.jaci.2004.06.047; Bafunno V, 2014, ANN HUM GENET, V78, P73, DOI 10.1111/ahg.12052; Bissler JJ, 1997, P ASSOC AM PHYSICIAN, V109, P164; Bors A, 2013, J ALLERGY CLIN IMMUN, V131, P1708, DOI 10.1016/j.jaci.2012.11.015; Bowen Tom, 2010, Allergy Asthma Clin Immunol, V6, P24, DOI 10.1186/1710-1492-6-24; Bygum A, 2011, ALLERGY, V66, P76, DOI 10.1111/j.1398-9995.2010.02456.x; Bygum A, 2009, BRIT J DERMATOL, V161, P1153, DOI 10.1111/j.1365-2133.2009.09366.x; Carey VR, 2015, GEN ESIMATION EQUATI; CARTER PE, 1991, EUR J BIOCHEM, V197, P301, DOI 10.1111/j.1432-1033.1991.tb15911.x; Cicardi M, 2012, ALLERGY, V67, P147, DOI 10.1111/j.1398-9995.2011.02751.x; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; Gosswein T, 2008, CYTOGENET GENOME RES, V121, P181, DOI 10.1159/000138883; Kalmar L, 2005, HUM MUTAT, V25, P1, DOI 10.1002/humu.20112; Kalmar L, 2003, HUM MUTAT, V22, DOI 10.1002/humu.9202; Karadza-Lapic L, 2015, 9 C1 INH DEF WORKSH; Lopez-Lera A, 2011, MOL IMMUNOL, V49, P18, DOI 10.1016/j.molimm.2011.07.010; Martinho A, 2013, MOL IMMUNOL, V53, P431, DOI 10.1016/j.molimm.2012.09.003; Monnier N, 2006, MOL IMMUNOL, V43, P2161, DOI 10.1016/j.molimm.2006.01.006; Nordenfelt P, 2014, ALLERGY ASTHMA PROC, V35, P185, DOI 10.2500/aap.2014.35.3738; Pappalardo E, 2000, J ALLERGY CLIN IMMUN, V106, P1147, DOI 10.1067/mai.2000.110471; Pappalardo E, 2008, MOL IMMUNOL, V45, P3536, DOI 10.1016/j.molimm.2008.05.007; R Core Team, 2021, R LANGUAGE ENV STAT; Rijavec M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056712; Roche O, 2005, ANN ALLERG ASTHMA IM, V94, P498, DOI 10.1016/S1081-1206(10)61121-0; Roche O, 2005, HUM MUTAT, V26, P135, DOI 10.1002/humu.20197; SKRIVER K, 1989, J BIOL CHEM, V264, P3066; Speletas M, 2015, ALLERGY, V70, P1661, DOI 10.1111/all.12714; Speletas M, 2015, J ALLERGY CLIN IMMUN, V135, P570, DOI 10.1016/j.jaci.2014.08.007; STOPPALYONNET D, 1991, AM J HUM GENET, V49, P1055; Stray-Pedersen A, 2000, J CLIN IMMUNOL, V20, P477, DOI 10.1023/A:1026416017763; Verpy E, 1996, AM J HUM GENET, V59, P308; Xu YY, 2012, ALLERGY, V67, P1430, DOI 10.1111/all.12024; Zanichelli A, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0233-x; Zuraw BL, 2000, J ALLERGY CLIN IMMUN, V105, P541, DOI 10.1067/mai.2000.104780; Zuraw BL, 2008, NEW ENGL J MED, V359, P1027, DOI 10.1056/NEJMcp0803977	35	216	219	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142174	10.1371/journal.pone.0142174	http://dx.doi.org/10.1371/journal.pone.0142174			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26535898	Green Published, Green Submitted, gold			2022-12-26	WOS:000364298400140
J	Andrews, S; Ellis, DA; Shaw, H; Piwek, L				Andrews, Sally; Ellis, David A.; Shaw, Heather; Piwek, Lukasz			Beyond Self-Report: Tools to Compare Estimated and Real-World Smartphone Use	PLOS ONE			English	Article							MOBILE PHONE; PERSONALITY; ADOLESCENTS; PREDICTORS; ADDICTION	Psychologists typically rely on self-report data when quantifying mobile phone usage, despite little evidence of its validity. In this paper we explore the accuracy of using self-reported estimates when compared with actual smartphone use. We also include source code to process and visualise these data. We compared 23 participants' actual smartphone use over a two-week period with self-reported estimates and the Mobile Phone Problem Use Scale. Our results indicate that estimated time spent using a smartphone may be an adequate measure of use, unless a greater resolution of data are required. Estimates concerning the number of times an individual used their phone across a typical day did not correlate with actual smartphone use. Neither estimated duration nor number of uses correlated with the Mobile Phone Problem Use Scale. We conclude that estimated smartphone use should be interpreted with caution in psychological research.	[Andrews, Sally] Nottingham Trent Univ, Div Psychol, Nottingham, England; [Ellis, David A.] Univ Lancaster, Dept Psychol, Lancaster LA1 4YF, England; [Ellis, David A.; Shaw, Heather] Lincoln Univ, Sch Psychol, Lincoln, England; [Piwek, Lukasz] Univ W England, Fac Business & Law, Bristol BS16 1QY, Avon, England	Nottingham Trent University; Lancaster University; University of Lincoln; University of West England	Andrews, S (corresponding author), Nottingham Trent Univ, Div Psychol, Nottingham, England.	sally.andrews@ntu.ac.uk	Shaw, Heather/GQA-5799-2022; Košnik, Mitja/AAI-2295-2019; Ellis, David/A-8322-2011	Košnik, Mitja/0000-0002-4701-7374; Shaw, Heather/0000-0002-9157-7790; Ellis, David/0000-0001-6172-3323; Rijavec, Matija/0000-0002-2596-4952; Korosec, Peter/0000-0002-0835-1599; Bonaci-Nikolic, Branka/0000-0003-3014-4075	Research Investment Fund (University of Lincoln) [RIF2014-31]	Research Investment Fund (University of Lincoln)	This work was funded by RIF2014-31 Research Investment Fund (University of Lincoln) (http://www.lincoln.ac.uk/home/research/researchsupport/researchinvestment/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharony N, 2011, PERVASIVE MOB COMPUT, V7, P643, DOI 10.1016/j.pmcj.2011.09.004; Bianchi A, 2005, CYBERPSYCHOL BEHAV, V8, P39, DOI 10.1089/cpb.2005.8.39; Billieux J, 2012, CURR PSYCHIATRY REV, V8, P299, DOI 10.2174/157340012803520522; Butt S, 2008, COMPUT HUM BEHAV, V24, P346, DOI 10.1016/j.chb.2007.01.019; Clayton RB, 2015, J COMPUT-MEDIAT COMM, V20, P119, DOI 10.1111/jcc4.12109; Dolev-Cohen M, 2013, COMPUT HUM BEHAV, V29, P58, DOI 10.1016/j.chb.2012.07.016; Ehrenberg A, 2008, CYBERPSYCHOL BEHAV, V11, P739, DOI 10.1089/cpb.2008.0030; Ellis DA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134555; Feldman G, 2011, PERS INDIV DIFFER, V51, P856, DOI 10.1016/j.paid.2011.07.020; Grondin S, 2010, ATTEN PERCEPT PSYCHO, V72, P561, DOI 10.3758/APP.72.3.561; Hadlington LJ, 2015, COMPUT HUM BEHAV, V51, P75, DOI 10.1016/j.chb.2015.04.036; Lally P, 2010, EUR J SOC PSYCHOL, V40, P998, DOI 10.1002/ejsp.674; Leung L, 2008, J CHILD MEDIA, V2, P93, DOI 10.1080/17482790802078565; Lin TTC, 2015, SOC BEHAV PERSONAL, V43, P1209, DOI 10.2224/sbp.2015.43.7.1209; Lopez-Fernandez O., 2014, PERS INDIVIDUAL DIFF, V60, pS24, DOI [10.1016/j.paid.2013.07.024, DOI 10.1016/J.PAID.2013.07.024]; MacKerron G, 2013, GLOBAL ENVIRON CHANG, V23, P992, DOI 10.1016/j.gloenvcha.2013.03.010; McIlroy T., 2015, ECONOMIST; Miller G, 2012, PERSPECT PSYCHOL SCI, V7, P221, DOI 10.1177/1745691612441215; Mohammadi Kalhori Soroush, 2015, Iran J Psychiatry, V10, P25; Oulasvirta A, 2012, PERS UBIQUIT COMPUT, V16, P105, DOI 10.1007/s00779-011-0412-2; Oz F, 2015, INT J HUMAN SCI, V12, P226; Rachman S, 2002, BEHAV RES THER, V40, P625, DOI 10.1016/S0005-7967(01)00028-6; Smith A., 2015, PEW RES CTR INTERNET; Takao M, 2009, CYBERPSYCHOL BEHAV, V12, P501, DOI 10.1089/cpb.2009.0022; Trull TJ, 2014, CURR DIR PSYCHOL SCI, V23, P466, DOI 10.1177/0963721414550706; Vallieres A, 2003, SLEEP, V26, P902, DOI 10.1093/sleep/26.7.902; Walsh SP, 2008, J ADOLESCENCE, V31, P77, DOI 10.1016/j.adolescence.2007.04.004; Walsh SP, 2010, AUST J PSYCHOL, V62, P194, DOI 10.1080/00049530903567229; White AG., 2011, INT J HUMANITIES SOC, V1, P51	29	216	219	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0139004	10.1371/journal.pone.0139004	http://dx.doi.org/10.1371/journal.pone.0139004			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV0DL	26535898	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000363918100007
